FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Matsuyama, S
   Kitamura, T
   Enomoto, A
   Fujita, T
   Ishigaini, A
   Handa, S
   Maruyama, N
   Zheng, DM
   Ikejima, K
   Takei, Y
   Sato, N
AF Matsuyama, S
   Kitamura, T
   Enomoto, A
   Fujita, T
   Ishigaini, A
   Handa, S
   Maruyama, N
   Zheng, DM
   Ikejima, K
   Takei, Y
   Sato, N
TI Senescence marker protein-30 regulates Akt activity and contributes to
   cell survival in Hep G2 cells
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE SMP30; calmodulin; Akt; TNF-alpha; apoptosis
ID NECROSIS-FACTOR-ALPHA; PHOSPHATIDYLINOSITOL 3-KINASE; IMMATURE
   THYMOCYTES; NEURONAL SURVIVAL; KNOCKOUT MOUSE; RAT-LIVER; SMP30;
   APOPTOSIS; KINASE; DEATH
AB Senescence marker protein-30 (SMP30) is highly expressed in cytosol of hepatocytes, and its amount decreases with aging. Human hepatocellular carcinoma cell line was transfected with pcDNA3/SMP30 (SMP30 transfectants), or as a control with pcDNA3 (mock transfectants). When cells were exposed to 20ng/ml tumor necrosis factor-alpha (TNF-alpha) plus 10ng/ml actinomycin D (Act-D) for 15h, the viability of cells was decreased in both SMP30 and mock transfectants. However, the viability of cells was threefold higher in SMP30 transfectants than mock transfectants. Cell death was confirmed as apoptosis by TUNEL assay. The presence of trifluoperazine, a calmodulin (CaM) inhibitor, attenuated anti-apoptotic effect of SMP30 in both transfectants, but the effect was more prominent in SMP30 transfectants. Western blot analyses revealed that Akt, which acts as a survival factor in cells, was activated in SMP30, but not mock, transfectants either in the presence or absence of TNF-alpha plus Act-D. Further, trifluoperazine inhibited Akt activation in SMP30 transfectants. We therefore propose that interplay between CaM and SMP30 regulates Akt activity, and thus SMP30 acts as a survival factor in hepatocytes. (C) 2004 Elsevier Inc. All rights reserved.
C1 Juntendo Univ, Sch Med, Dept Gastroenterol, Tokyo 113, Japan.
   Tokyo Metropolitan Inst Gerontol, Dept Mol Pathol, Tokyo, Japan.
C3 Juntendo University; Tokyo Metropolitan Institute of Gerontology
RP Kitamura, T (corresponding author), Juntendo Univ, Sch Med, Dept Gastroenterol, Tokyo 113, Japan.
EM kitamura@med.juntendo.ac.jp
OI Ishigami, Akihito/0000-0001-7875-7482
CR AW TY, 1990, ARCH BIOCHEM BIOPHYS, V283, P46, DOI 10.1016/0003-9861(90)90610-B
   BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0
   CastellanosSerra LR, 1996, ELECTROPHORESIS, V17, P1564, DOI 10.1002/elps.1150171012
   Cheng AW, 2003, J BIOL CHEM, V278, P7591, DOI 10.1074/jbc.M207232200
   COOK JA, 1989, ANAL BIOCHEM, V179, P1, DOI 10.1016/0003-2697(89)90191-7
   Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5
   DOWD DR, 1992, MOL ENDOCRINOL, V6, P1843, DOI 10.1210/me.6.11.1843
   Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X
   Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661
   Egea J, 2001, J CELL BIOL, V154, P585, DOI 10.1083/jcb.200101023
   Fischer R, 1998, FEBS LETT, V425, P175, DOI 10.1016/S0014-5793(98)00225-7
   FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0
   Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1132, P297, DOI 10.1016/0167-4781(92)90164-U
   Fujita T, 1996, MECH AGEING DEV, V87, P219, DOI 10.1016/0047-6374(96)01711-3
   Fujita T, 1996, BBA-GENE STRUCT EXPR, V1308, P49, DOI 10.1016/0167-4781(96)00064-4
   Fujita T, 1998, BIOCHEM BIOPH RES CO, V250, P374, DOI 10.1006/bbrc.1998.9327
   FUJITA T, 1995, BBA-GENE STRUCT EXPR, V1263, P249, DOI 10.1016/0167-4781(95)00120-6
   Ishigami A, 2004, BIOCHEM BIOPH RES CO, V315, P575, DOI 10.1016/j.bbrc.2004.01.091
   Ishigami A, 2002, AM J PATHOL, V161, P1273, DOI 10.1016/S0002-9440(10)64404-5
   Joyal JL, 1997, J BIOL CHEM, V272, P28183, DOI 10.1074/jbc.272.45.28183
   KAISER N, 1977, P NATL ACAD SCI USA, V74, P638, DOI 10.1073/pnas.74.2.638
   KauffmanZeh A, 1997, NATURE, V385, P544, DOI 10.1038/385544a0
   KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960
   KOHN AD, 1995, EMBO J, V14, P4288, DOI 10.1002/j.1460-2075.1995.tb00103.x
   Koller H, 1996, BRAIN, V119, P2021, DOI 10.1093/brain/119.6.2021
   Kong SK, 1997, ONCOLOGY-BASEL, V54, P55
   MCCONKEY DJ, 1989, J IMMUNOL, V143, P1801
   MCCONKEY DJ, 1988, SCIENCE, V242, P256, DOI 10.1126/science.3262923
   Mori T, 2004, PATHOL INT, V54, P167, DOI 10.1111/j.1440-1827.2003.01603.x
   Orike N, 2001, J CELL BIOL, V154, P995, DOI 10.1083/jcb.200101068
   SCHARFMAN HE, 1989, SCIENCE, V246, P257, DOI 10.1126/science.2508225
   SHIMOKAWA N, 1993, FEBS LETT, V327, P251, DOI 10.1016/0014-5793(93)80998-A
   Tang D, 2001, J BIOL CHEM, V276, P30461, DOI 10.1074/jbc.M102045200
   Xu Y, 1998, AM J PHYSIOL-CELL PH, V275, pC1058, DOI 10.1152/ajpcell.1998.275.4.C1058
   Zhou HL, 2000, J CELL BIOL, V151, P483, DOI 10.1083/jcb.151.3.483
NR 37
TC 33
Z9 42
U1 0
U2 1
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD AUG 20
PY 2004
VL 321
IS 2
BP 386
EP 390
DI 10.1016/j.bbrc.2004.06.161
PG 5
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 844EO
UT WOS:000223140500019
PM 15358188
DA 2024-02-19
ER

PT J
AU Li, FH
   Li, T
   Liu, YY
AF Li, Fanghui
   Li, Tao
   Liu, Yanying
TI Proteomics-Based Identification of the Molecular Signatures of Liver
   Tissues from Aged Rats following Eight Weeks of Medium-Intensity
   Exercise
SO OXIDATIVE MEDICINE AND CELLULAR LONGEVITY
LA English
DT Article
ID 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; OXIDATIVE STRESS; REGULAR
   EXERCISE; HEPATIC INFLAMMATION; HYDROGEN-SULFIDE; KERATIN MUTATION;
   SKELETAL-MUSCLE; ALPHA-ENOLASE; KAPPA-B; PROTEIN
AB Physical activity has emerged as a powerful intervention that promotes healthy aging by maintaining the functional capacity of critical organ systems. Here, by combining functional and proteomics analyses, we examined how hepatic phenotypes might respond to exercise treatment in aged rats. 16 male aged (20 months old) SD rats were divided into exercise and parallel control groups at random; the exercise group had 8 weeks of treadmill training with medium intensity. Whole protein samples of the liver were extracted from both groups and separated by two-dimensional gel electrophoresis. Alternatively objective protein spots with >2-fold difference in expression were selected for enzymological extraction and MS/MS identification. Results show increased activity of the manganese superoxide dismutase and elevated glutathione levels in the livers of exercise-treated animals, but malondialdehyde contents obviously decreased in the liver of the exercise group. Proteomics-based identification of differentially expressed proteins provided an integrated view of the metabolic adaptations occurring in the liver proteome during exercise, which significantly altered the expression of several proteins involved in key liver metabolic pathways including mitochondrial sulfur, glycolysis, methionine, and protein metabolism. These findings indicate that exercise may be beneficial to aged rats through modulation of hepatic protein expression profiles.
C1 [Li, Fanghui; Liu, Yanying] Zhaoqing Univ, Sch Phys Educ & Hlth, Zhaoqing 526016, Peoples R China.
   [Li, Fanghui] Shanghai Jiao Tong Univ, Exercise Hlth & Technol Ctr, Shanghai 200240, Peoples R China.
   [Li, Tao] South China Normal Univ, Lab Laser Sports Med, Guangzhou 510006, Guangdong, Peoples R China.
C3 Zhaoqing University; Shanghai Jiao Tong University; South China Normal
   University
RP Li, FH (corresponding author), Zhaoqing Univ, Sch Phys Educ & Hlth, Zhaoqing 526016, Peoples R China.; Li, FH (corresponding author), Shanghai Jiao Tong Univ, Exercise Hlth & Technol Ctr, Shanghai 200240, Peoples R China.
EM fanghuili2007@163.com
FU National Natural Science Foundation of China [31500961]; Guangdong
   Scientific Project [2014A020220015, 2015A020219015]; Distinguished Young
   Talents in Higher Education of Guangdong, China [2014KQNCX225]
FX The current project was supported by the National Natural Science
   Foundation of China (Grant 31500961) and the Guangdong Scientific
   Project (Grant 2014A020220015 and Grant 2015A020219015) and partially
   supported by the Distinguished Young Talents in Higher Education of
   Guangdong, China (Grant 2014KQNCX225).
CR Baiges I, 2010, MOL CELL PROTEOMICS, V9, P1499, DOI 10.1074/mcp.M000055-MCP201
   Barrientos RM, 2015, NEUROBIOL AGING, V36, P1483, DOI 10.1016/j.neurobiolaging.2014.12.003
   Bejma J, 2000, ACTA PHYSIOL SCAND, V169, P343
   Bertaggia E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100745
   CABRERO C, 1988, HEPATOLOGY, V8, P1530, DOI 10.1002/hep.1840080610
   Campbell JE, 2010, AM J PHYSIOL-REG I, V299, pR168, DOI 10.1152/ajpregu.00155.2010
   Capello M, 2011, FEBS J, V278, P1064, DOI 10.1111/j.1742-4658.2011.08025.x
   Caulin C, 2000, J CELL BIOL, V149, P17, DOI 10.1083/jcb.149.1.17
   Cui XY, 2003, FREE RADICAL RES, V37, P1079, DOI 10.1080/10715760310001600408
   Dahlhoff C, 2014, MOL METAB, V3, P565, DOI 10.1016/j.molmet.2014.04.010
   DAVIES KJA, 1982, BIOCHEM BIOPH RES CO, V107, P1198, DOI 10.1016/S0006-291X(82)80124-1
   Debril MB, 2005, J MOL ENDOCRINOL, V35, P503, DOI 10.1677/jme.1.01856
   Dröge W, 2002, EXP GERONTOL, V37, P1333, DOI 10.1016/S0531-5565(02)00175-4
   Finlay LA, 2012, AM J PHYSIOL-REG I, V302, pR587, DOI 10.1152/ajpregu.00393.2011
   Garee JP, 2010, J CELL BIOCHEM, V109, P312, DOI 10.1002/jcb.22420
   Gat-Yablonski G, 2016, AGING-US, V8, P1735, DOI 10.18632/aging.101009
   Gloria-Bottini F, 2007, AM J MED SCI, V334, P421, DOI 10.1097/MAJ.0b013e3180a5e934
   Gomez CR, 2008, J GERONTOL A-BIOL, V63, P1299, DOI 10.1093/gerona/63.12.1299
   Goto S, 2004, ANN NY ACAD SCI, V1019, P471, DOI 10.1196/annals.1297.085
   Goto S, 2001, ANN NY ACAD SCI, V928, P54
   Gueugneau M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1165
   Henkel C, 2011, J CELL MOL MED, V15, P2176, DOI 10.1111/j.1582-4934.2010.01204.x
   Higashitsuji H, 2002, CANCER CELL, V2, P335, DOI 10.1016/S1535-6108(02)00152-6
   Honma T, 2012, BIOGERONTOLOGY, V13, P93, DOI 10.1007/s10522-011-9363-2
   Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634
   Hu XF, 2013, PROTEOMICS, V13, P1755, DOI 10.1002/pmic.201200522
   Jelena A, 2013, J PHYSIOL BIOCHEM, V69, P45, DOI 10.1007/s13105-012-0186-7
   Ji LL, 2016, FREE RADICAL BIO MED, V98, P113, DOI 10.1016/j.freeradbiomed.2016.02.025
   Ji LL, 2002, ANN NY ACAD SCI, V959, P82, DOI 10.1111/j.1749-6632.2002.tb02085.x
   Johannsen NM, 2016, SPORTS MED, V46, P1809, DOI 10.1007/s40279-016-0548-3
   Kluwe J, 2010, GASTROENTEROLOGY, V138, P347, DOI 10.1053/j.gastro.2009.09.015
   Kondoh H, 2007, HISTOL HISTOPATHOL, V22, P85, DOI 10.14670/HH-22.85
   KRAHENBUHL S, 1992, HEPATOLOGY, V15, P1167, DOI 10.1002/hep.1840150631
   Ku NO, 2003, HEPATOLOGY, V37, P1006, DOI 10.1053/jhep.2003.50181
   Kucukoglu O, 2014, HEPATOLOGY, V60, P169, DOI 10.1002/hep.27068
   Kuhla A, 2011, J GERONTOL A-BIOL, V66, P1192, DOI 10.1093/gerona/glr124
   Lee YB, 2007, EXP CELL RES, V313, P3914, DOI 10.1016/j.yexcr.2007.06.023
   Li FH, 2016, ADV EXP MED BIOL, V923, P283, DOI 10.1007/978-3-319-38810-6_38
   Lin JJ, 2008, J BIOL CHEM, V283, P29681, DOI 10.1074/jbc.M802076200
   Lin PS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150389
   Liu R, 2016, MOL CELL PROTEOMICS, V15, P3170, DOI 10.1074/mcp.M115.054312
   Livingstone DEW, 2003, J PHARMACOL EXP THER, V305, P167, DOI 10.1124/jpet.102.044842
   Loos RJF, 2015, MED SCI SPORT EXER, V47, P1105, DOI 10.1249/MSS.0000000000000645
   Mancardi D, 2009, BBA-BIOENERGETICS, V1787, P864, DOI 10.1016/j.bbabio.2009.03.005
   Mani S, 2014, NITRIC OXIDE-BIOL CH, V41, P62, DOI 10.1016/j.niox.2014.02.006
   Mato JM, 2002, FASEB J, V16, P15, DOI 10.1096/fj.01-0401rev
   Monti DM, 2007, FEBS LETT, V581, P930, DOI 10.1016/j.febslet.2007.01.072
   NADANO D, 1994, ARCH BIOCHEM BIOPHYS, V312, P421, DOI 10.1006/abbi.1994.1328
   Nishikawa T, 2014, J HEPATOL, V60, P1203, DOI 10.1016/j.jhep.2014.02.014
   Nishinari M, 2012, CIRC J, V76, P2197, DOI 10.1253/circj.CJ-11-1444
   Nohr MK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159747
   Oesterreich S, 2000, EUR J CANCER, V36, pS43
   Omura Y, 2009, BMB REP, V42, P232, DOI 10.5483/BMBRep.2009.42.4.232
   Pancholi V, 2001, CELL MOL LIFE SCI, V58, P902, DOI 10.1007/PL00000910
   Paterson JM, 2004, P NATL ACAD SCI USA, V101, P7088, DOI 10.1073/pnas.0305524101
   Peidis P, 2011, FEBS LETT, V585, P78, DOI 10.1016/j.febslet.2010.11.054
   Peng B, 2013, J PROTEOME RES, V12, P1789, DOI 10.1021/pr3011342
   Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2
   Pizzo E, 2013, J CELL SCI, V126, P4308, DOI 10.1242/jcs.134551
   Poli Giuseppe, 2000, Molecular Aspects of Medicine, V21, P49, DOI 10.1016/S0098-2997(00)00004-2
   Predmore BL, 2010, AGE, V32, P467, DOI 10.1007/s11357-010-9150-z
   Preisler N, 2013, J CLIN ENDOCR METAB, V98, pE1235, DOI 10.1210/jc.2013-1651
   Radák Z, 2004, FASEB J, V18, P749, DOI 10.1096/fj.03-0509fje
   Radák Z, 2001, NEUROCHEM INT, V38, P17, DOI 10.1016/S0197-0186(00)00063-2
   Radák Z, 2002, EXP GERONTOL, V37, P1423, DOI 10.1016/S0531-5565(02)00116-X
   Radak Z, 2013, ANTIOXID REDOX SIGN, V18, P1208, DOI 10.1089/ars.2011.4498
   Rothwell T J, 1974, J Forensic Sci, V19, P590
   Rotty JD, 2010, NAT CELL BIOL, V12, P847, DOI 10.1038/ncb0910-847
   Siu PM, 2004, FASEB J, V18, P1150, DOI 10.1096/fj.03-1291fje
   Song W, 2006, ANTIOXID REDOX SIGN, V8, P517, DOI 10.1089/ars.2006.8.517
   Spitsyn V. A., 2001, Genetika, V37, P698
   Stojkovic T, 2009, NEW ENGL J MED, V361, P425, DOI 10.1056/NEJMc0901158
   Sun B, 2008, COMP BIOCHEM PHYS D, V3, P108, DOI 10.1016/j.cbd.2007.11.001
   Tiranti V, 2009, NAT MED, V15, P200, DOI 10.1038/nm.1907
   Weighardt F, 1999, J CELL SCI, V112, P1465
   Wiklund P, 2016, SCI REP-UK, V6, DOI 10.1038/srep24540
   Yang SG, 2013, J NEUROSCI RES, V91, P230, DOI 10.1002/jnr.23159
   Yoon S, 2014, J INT SOC SPORT NUTR, V11, DOI 10.1186/1550-2783-11-29
   Yuan HR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053887
   Zhang AH, 2013, APPL BIOCHEM BIOTECH, V169, P832, DOI 10.1007/s12010-012-0001-5
   Zhou Q, 2005, HEPATOLOGY, V41, P517, DOI 10.1002/hep.20578
   Zierath JR, 2015, CELL METAB, V22, P25, DOI 10.1016/j.cmet.2015.06.015
NR 82
TC 5
Z9 5
U1 0
U2 7
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1942-0900
EI 1942-0994
J9 OXID MED CELL LONGEV
JI Oxidative Med. Cell. Longev.
PY 2016
VL 2016
AR 3269405
DI 10.1155/2016/3269405
PG 11
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA EH9DX
UT WOS:000392073000001
PM 28116034
OA Green Published, Green Submitted, gold
DA 2024-02-19
ER

PT J
AU Nishida, N
   Iwanishi, M
   Minami, T
   Chishina, H
   Arizumi, T
   Takita, M
   Kitai, S
   Yada, N
   Ida, H
   Hagiwara, S
   Minami, Y
   Ueshirna, K
   Sakurai, T
   Kitano, M
   Kudo, M
AF Nishida, Naoshi
   Iwanishi, Mina
   Minami, Tomohiro
   Chishina, Hirokazu
   Arizumi, Tadaaki
   Takita, Masahiro
   Kitai, Satoshi
   Yada, Norihisa
   Ida, Hiroshi
   Hagiwara, Satoru
   Minami, Yasunori
   Ueshirna, Kazuomi
   Sakurai, Toshiharu
   Kitano, Masayuki
   Kudo, Masatoshi
TI Hepatic DNA Methylation Is Affected by Hepatocellular Carcinoma Risk in
   Patients with and without Hepatitis Virus
SO DIGESTIVE DISEASES
LA English
DT Article
DE DNA methylation; Hepatocellular carcinoma; Background liver; Aging;
   Diabetes mellitus
ID FATTY LIVER-DISEASE; HUMAN HEPATOCARCINOGENESIS; CLINICAL
   CHARACTERISTICS; EPIGENETIC INSTABILITY; OXIDATIVE STRESS; GENES;
   PROGRESSION; PROMOTER; CANCER
AB Objectives: Several studies revealed that the proportion of hepatocellular carcinoma (HCC) without hepatitis virus infection (NBNC-HCC) is increasing. On the other hand, epigenetic alterations are reportedly responsible for HCC development. Here, we identified HCC risk factors that are associated with DNA methylation in the background liver tissue of NBNC-HCC patients. Methods: We performed methylation analysis in 37 pairs of virus-positive and 22 pairs of NBNC-HCC and non-cancerous livers using a HumanMethylation450 BeadChip array. After the selection of differentially methylated CpGs (DM-CpGs) in cancerous and non-cancerous livers, we analyzed DNA methylation of DM-CpGs within the adjacent non-cancerous liver tissue that is affected by specific HCC risk factors. Results: A total of 38,331 CpGs were selected as DM-CpGs using the following criteria: difference of beta-value between HCC and non-cancerous liver and false discovery rate (FDR) q < 1.0E-12. We subsequently selected the DM-CpGs that had methylation differences with the background liver tissue (that has FDR q < 0.35). Among the virus-positive patients, the type of hepatitis virus was mostly associated with differences in methylation within the background liver tissues. However, we found that background methylation patterns were most significantly associated with aging in NBNC patients. Interestingly, age-related methylation differences in DM-CpGs were also observed in NBNC-HCC tissues. Conclusions: Hepatitis viruses affect the methylation profiles within background liver tissues. However, difference in background methylation was mostly associated with age in NCBC-HCC patients; some age-related methylation events could contribute to emergence of NBNC-HCC in elderly individuals. (C) 2015 S. Karger AG, Basel
C1 [Nishida, Naoshi; Iwanishi, Mina; Minami, Tomohiro; Chishina, Hirokazu; Arizumi, Tadaaki; Takita, Masahiro; Kitai, Satoshi; Yada, Norihisa; Ida, Hiroshi; Hagiwara, Satoru; Minami, Yasunori; Ueshirna, Kazuomi; Sakurai, Toshiharu; Kitano, Masayuki; Kudo, Masatoshi] Kinki Univ, Sch Med, Dept Gastroenterol & Hepatol, Osaka, Osaka 5898511, Japan.
C3 Kindai University (Kinki University)
RP Nishida, N (corresponding author), Kinki Univ, Sch Med, Dept Gastroenterol & Hepatol, 337-2 Ohno Higashi, Osaka, Osaka 5898511, Japan.
EM naoshi@med.kindai.ac.jp
RI Kudo, Masatoshi/AAA-9744-2019; Naoshi, Nishida/O-2279-2014
OI Kudo, Masatoshi/0000-0002-4102-3474; Naoshi, Nishida/0000-0002-9111-5668
FU Japanese Society for the Promotion of Science [KAKENHI: 24590997];
   Smoking Research Foundation; Japan Health Foundation; Grants-in-Aid for
   Scientific Research [15K09028] Funding Source: KAKEN
FX This work was supported in part by Grant-in-Aid for Scientific Research
   (KAKENHI: 24590997) from the Japanese Society for the Promotion of
   Science (N. Nishida), a grant from the Smoking Research Foundation (N.
   Nishida) and a grant from the Japan Health Foundation (N. Nishida).
CR Bonomini F, 2015, AGING DIS, V6, P109, DOI 10.14336/AD.2014.0305
   Herceg Z, 2011, MUTAT RES-REV MUTAT, V727, P55, DOI 10.1016/j.mrrev.2011.04.001
   Honda T, 2011, ONCOL LETT, V2, P851, DOI 10.3892/ol.2011.359
   Kawanaka M, 2014, LIVER CANCER, V3, P41, DOI 10.1159/000343857
   Kew MC, 2014, LIVER CANCER, V3, P31, DOI 10.1159/000343856
   Kudo M, 2015, LIVER CANCER, V4, P39, DOI 10.1159/000367727
   Kudo M, 2012, LIVER CANCER, V1, P62, DOI 10.1159/000342402
   Liang RR, 2014, CURR PHARM DESIGN, V20, P1715, DOI 10.2174/13816128113199990533
   Lim SO, 2008, GASTROENTEROLOGY, V135, P2128, DOI 10.1053/j.gastro.2008.07.027
   Mann DA, 2014, HEPATOLOGY, V60, P1418, DOI 10.1002/hep.27131
   Michelotti GA, 2013, NAT REV GASTRO HEPAT, V10, P656, DOI 10.1038/nrgastro.2013.183
   Murphy SK, 2013, GASTROENTEROLOGY, V145, P1076, DOI 10.1053/j.gastro.2013.07.047
   Nishida N, 2008, HEPATOLOGY, V47, P908, DOI 10.1002/hep.22110
   Nishida N, 2007, CANCER RES, V67, P4586, DOI 10.1158/0008-5472.CAN-06-3464
   Nishida N, 2014, LIVER CANCER, V3, P417, DOI 10.1159/000343860
   Nishida N, 2014, DIGEST DIS, V32, P740, DOI 10.1159/000368015
   Nishida N, 2014, DIGEST DIS, V32, P658, DOI 10.1159/000367982
   Nishida N, 2013, DIGEST DIS, V31, P459, DOI 10.1159/000355245
   Nishida N, 2013, DIGEST DIS, V31, P447, DOI 10.1159/000355243
   Nishida N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072312
   Nishida N, 2013, ONCOLOGY-BASEL, V84, P93, DOI 10.1159/000345897
   Nishida N, 2012, HEPATOLOGY, V56, P994, DOI 10.1002/hep.25706
   Nishida N, 2011, CURR GENOMICS, V12, P130, DOI 10.2174/138920211795564359
   O'Hagan HM, 2011, CANCER CELL, V20, P606, DOI 10.1016/j.ccr.2011.09.012
   Shen J, 2013, EPIGENETICS-US, V8, P34, DOI 10.4161/epi.23062
   Shibata T, 2014, NAT REV GASTRO HEPAT, V11, DOI 10.1038/nrgastro.2014.6
   Szabo G, 2015, NAT REV GASTRO HEPAT, V12, P387, DOI 10.1038/nrgastro.2015.94
   Tateishi R, 2015, J GASTROENTEROL, V50, P350, DOI 10.1007/s00535-014-0973-8
   Watanabe Y, 2015, GENOME RES, V25, P328, DOI 10.1101/gr.175240.114
   Webster DP, 2015, LANCET, V385, P1124, DOI [10.1016/S0140-6736(14)62401-6, 10.1016/S0140-6736(14)61932-2]
   Zeybel M, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0056-6
NR 31
TC 7
Z9 7
U1 0
U2 2
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0257-2753
EI 1421-9875
J9 DIGEST DIS
JI Dig. Dis.
PY 2015
VL 33
IS 6
BP 745
EP 750
DI 10.1159/000439098
PG 6
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA CV3RK
UT WOS:000364177000007
PM 26489010
DA 2024-02-19
ER

PT J
AU SPINDLER, SR
   GRIZZLE, JM
   WALFORD, RL
   MOTE, PL
AF SPINDLER, SR
   GRIZZLE, JM
   WALFORD, RL
   MOTE, PL
TI AGING AND RESTRICTION OF DIETARY CALORIES INCREASES INSULIN-RECEPTOR
   MESSENGER-RNA, AND AGING INCREASES GLUCOCORTICOID RECEPTOR MESSENGER-RNA
   IN THE LIVER OF FEMALE C3B10RF1 MICE
SO JOURNALS OF GERONTOLOGY
LA English
DT Article
ID EPIDERMAL GROWTH-FACTOR; DNA-BINDING PROTEINS; DOWN-REGULATION; C-JUN;
   CULTURED LYMPHOCYTES; GENE-EXPRESSION; FACTOR-I; S-II; TRANSCRIPTION;
   RAT
AB We investigated the influence of age and a 20% or 52% reduction in dietary calories (caloric restriction) on expression of mRNA for a number of transcription factors and signal-transducing proteins using 4, 16, and 30-month-old female mice of the long-lived C3B10RF1 strain.  In all age groups, 52% caloric restriction, which extends maximum life span by approximately 33%, increased insulin receptor mRNA by 15% to 25% over the levels in animals fed ad libitum.  Aging increased insulin receptor mRNA and glucocorticoid receptor mRNA in all dietary groups.  A similar increase in glucocorticoid receptor mRNA was not observed for male mice of three other strains, suggesting the change is sex- or strain-specific and not a general feature of aging.  These changes appear to be specific.  Neither caloric restriction nor age had an effect on the level of mRNA for insulin-like growth factor-I, RNA polymerase II elongation-factor S-II, or transcription factors Sp1, CCAAT and enhancer binding protein, or proto-oncogene c-jun.
C1 USDA,CLAY CITY,NE.
   UNIV CALIF LOS ANGELES,DEPT PATHOL,LOS ANGELES,CA 90024.
C3 United States Department of Agriculture (USDA); University of California
   System; University of California Los Angeles
RP SPINDLER, SR (corresponding author), UNIV CALIF RIVERSIDE,DEPT BIOCHEM,RIVERSIDE,CA 92521, USA.
FU NIA NIH HHS [AG-004419, AG-00424] Funding Source: Medline; NIDDK NIH HHS
   [DK07310] Funding Source: Medline
CR Ausubel FM, 1995, SHORT PROTOCOLS MOL
   BALAGE M, 1988, REPROD NUTR DEV, V28, P819, DOI 10.1051/rnd:19880517
   BALAGE M, 1990, HORM METAB RES, V22, P207, DOI 10.1055/s-2007-1004886
   BELL GI, 1986, NUCLEIC ACIDS RES, V14, P7873, DOI 10.1093/nar/14.20.7873
   BRETT LP, 1986, NEUROBIOL AGING, V7, P153, DOI 10.1016/0197-4580(86)90036-9
   CHIKARAISHI DM, 1983, NUCLEIC ACIDS RES, V11, P6437, DOI 10.1093/nar/11.18.6437
   CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005
   CRETTAZ M, 1984, DIABETES, V33, P477, DOI 10.2337/diabetes.33.5.477
   CURRAN T, 1988, CELL, V55, P395, DOI 10.1016/0092-8674(88)90024-4
   CURRY DL, 1984, AM J PHYSIOL, V247, pE385, DOI 10.1152/ajpendo.1984.247.3.E385
   DANIELSEN M, 1986, EMBO J, V5, P2513, DOI 10.1002/j.1460-2075.1986.tb04529.x
   DEPHAMPHILIS ML, 1988, CELL, V52, P635
   DONG Y, 1989, J BIOL CHEM, V264, P13679
   DYNAN WS, 1985, NATURE, V316, P774, DOI 10.1038/316774a0
   EBINA Y, 1985, CELL, V40, P747, DOI 10.1016/0092-8674(85)90334-4
   ELAHI D, 1985, ENDOCRINOLOGY, V116, P11, DOI 10.1210/endo-116-1-11
   GOLDFINE ID, 1987, ENDOCR REV, V8, P235, DOI 10.1210/edrv-8-3-235
   GOYA RG, 1989, GERONTOLOGY, V35, P181, DOI 10.1159/000213020
   HARRIS SB, 1990, J GERONTOL, V45, pB141, DOI 10.1093/geronj/45.5.B141
   HIRAI H, 1988, FEBS LETT, V238, P119, DOI 10.1016/0014-5793(88)80239-4
   HIRASHIMA S, 1988, J BIOL CHEM, V263, P3858
   IWAMA N, 1987, DIABETOLOGIA, V30, P899
   JOHNSON PF, 1989, ANNU REV BIOCHEM, V58, P799, DOI 10.1146/annurev.biochem.58.1.799
   KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0
   KALINYAK JE, 1987, J BIOL CHEM, V262, P10441
   KITAHARA A, 1979, BIOCHEM BIOPH RES CO, V87, P1207, DOI 10.1016/S0006-291X(79)80035-2
   KOIZUMI A, 1989, AGE, V12, P93, DOI 10.1007/BF02432371
   KRUPP M, 1981, J BIOL CHEM, V256, P1689
   LANDSCHULZ WH, 1988, GENE DEV, V2, P786, DOI 10.1101/gad.2.7.786
   MAASSEN JA, 1987, BIOCHIM BIOPHYS ACTA, V930, P72, DOI 10.1016/0167-4889(87)90157-1
   MAMULA PW, 1990, DIABETES CARE, V13, P288, DOI 10.2337/diacare.13.3.288
   MASORO EJ, 1989, J GERONTOL, V44, pB20, DOI 10.1093/geronj/44.1.B20
   MASORO EJ, 1984, J AM GERIATR SOC, V32, P296, DOI 10.1111/j.1532-5415.1984.tb02025.x
   McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63
   MCDONALD AR, 1987, DIABETES, V36, P779, DOI 10.2337/diabetes.36.6.779
   MCDONALD AR, 1988, J CLIN INVEST, V81, P499, DOI 10.1172/JCI113347
   MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136
   MOTE PL, 1990, MECH AGEING DEV, V53, P101, DOI 10.1016/0047-6374(90)90038-H
   MOTE PL, IN PRESS MUTAT RES
   MOTE PL, 1991, J GERONTOL BIOL SCI, V46, pB89
   OKRET S, 1986, P NATL ACAD SCI USA, V83, P5899, DOI 10.1073/pnas.83.16.5899
   QUANTIN B, 1988, NATURE, V334, P538, DOI 10.1038/334538a0
   RAPPAPORT J, 1987, J BIOL CHEM, V262, P5227
   REAVEN E, 1983, DIABETES, V32, P175, DOI 10.2337/diabetes.32.2.175
   ROSEWICZ S, 1988, J BIOL CHEM, V263, P2581
   ROSS MH, 1961, J NUTR, V75, P197, DOI 10.1093/jn/75.2.197
   ROUILLER DG, 1988, J BIOL CHEM, V263, P13185
   RUGGERI BA, 1989, CANCER RES, V49, P4130
   RYDER K, 1988, P NATL ACAD SCI USA, V85, P1487, DOI 10.1073/pnas.85.5.1487
   RYSECK RP, 1988, NATURE, V334, P535, DOI 10.1038/334535a0
   SALHANICK AI, 1983, J BIOL CHEM, V258, P4130
   SANTORO C, 1988, NATURE, V334, P218, DOI 10.1038/334218a0
   SAPOLSKY R, 1987, ENDOCRIN METAB CLIN, V16, P965, DOI 10.1016/S0889-8529(18)30453-5
   SHIBASAKI Y, 1988, BIOCHEM J, V249, P715, DOI 10.1042/bj2490715
   SPINDLER SR, 1990, J NUTR, V120, P1412, DOI 10.1093/jn/120.11.1412
   *STAT AN SYST I, 1985, SAS US GUID STAT
   SVEC F, 1988, BIOCHIM BIOPHYS ACTA, V970, P90, DOI 10.1016/0167-4889(88)90226-1
   TANNENBAUM ALBERT, 1942, CANCER RES, V2, P460
   THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201
   VOGT PK, 1989, TRENDS BIOCHEM SCI, V14, P172, DOI 10.1016/0968-0004(89)90268-5
   WEINDRUCH R, 1986, J NUTR, V116, P641, DOI 10.1093/jn/116.4.641
   WEINDRUCH R, 1988, RETARDATION AGING DI
   WHITE BA, 1982, J BIOL CHEM, V257, P8569
   WILKINSON DG, 1989, DEVELOPMENT, V106, P465
NR 64
TC 31
Z9 31
U1 0
U2 0
PU GERONTOLOGICAL SOCIETY AMER
PI WASHINGTON
PA 1275 K STREET NW SUITE 350, WASHINGTON, DC 20005-4006
SN 0022-1422
J9 J GERONTOL
JI J. Gerontol.
PD NOV
PY 1991
VL 46
IS 6
BP B233
EP B237
DI 10.1093/geronj/46.6.B233
PG 5
WC Gerontology
WE Social Science Citation Index (SSCI); Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA GN524
UT WOS:A1991GN52400008
PM 1940074
DA 2024-02-19
ER

PT J
AU Sasaki, M
   Ikeda, H
   Sato, Y
   Nakanuma, Y
AF Sasaki, Motoko
   Ikeda, Hiroko
   Sato, Yasunori
   Nakanuma, Yasuni
TI Decreased expression of Bmi1 is closely associated with cellular
   senescence in small bile ducts in primary biliary cirrhosis
SO AMERICAN JOURNAL OF PATHOLOGY
LA English
DT Article
ID CHRONIC HEPATITIS-C; REPLICATIVE SENESCENCE; HUMAN FIBROBLASTS;
   EPITHELIAL-CELLS; MITOCHONDRIAL AUTOANTIGENS; PREMATURE SENESCENCE;
   ABERRANT EXPRESSION; IDENTIFICATION; GENE; LIVER
AB Cellular senescence of biliary epithelial cells with p16(INK4a) and p21(WAF1/Cip) expression in damaged small bile ducts may be critical for progressive bile duct loss in primary biliary cirrhosis. We investigated the involvement of bmi1, a polycomb group gene repressing p16(INK4a) expression, in the pathogenesis of biliary cellular senescence. Bmi1 expression was examined immunohistochemically in livers taken from the patients with primary biliary cirrhosis (n = 18) and other diseased (n = 19) and normal livers (n = 16). We examined the effect of oxidative stress and a short interference RNA (siRNA) targeting bmi1 on cellular senescence in cultured mouse biliary epithelial cells. Bmi1 was widely expressed in the nuclei of biliary epithelial cells in the control livers. in contrast, bmi1 expression was significantly decreased in damaged small bile ducts in 43% of livers with primary biliary cirrhosis of stage 1/2, coordinating with the increased p16(INK4a) expression. in cultured billiary epithelial cells, oxidative stress by H2O2 treatment significantly decreased bmi1 expression, followed by increased P16(INK4a) expression. A knockdown of bmi1 induced increased p16(INK4a) expression, decreased cell proliferation, and increased cellular senescence. In conclusion, the decreased bmi1 expression caused by oxidative stress may be involved in the pathogenesis of cellular senescence of biliary epithelial cells in primary biliary cirrhosis.
C1 Kanazawa Univ, Grad Sch Med, Dept Human Pathol, Kanazawa, Ishikawa 9208640, Japan.
C3 Kanazawa University
RP Nakanuma, Y (corresponding author), Kanazawa Univ, Grad Sch Med, Dept Human Pathol, Kanazawa, Ishikawa 9208640, Japan.
EM pbcpsc@kenroku.kanazawa-u.ac.jp
RI Sasaki, Motoko/K-5913-2015
OI Sasaki, Motoko/0000-0003-2514-760X
CR Aboutwerat A, 2003, BBA-MOL BASIS DIS, V1637, P142, DOI 10.1016/S0925-4439(02)00225-9
   Alkema MJ, 1997, GENE DEV, V11, P226, DOI 10.1101/gad.11.2.226
   [Anonymous], 2001, PATHOLOGY LIVER
   Brodsky W Y, 1977, Int Rev Cytol, V50, P275
   Chen JH, 2004, J BIOL CHEM, V279, P49439, DOI 10.1074/jbc.M409153200
   Chen QM, 2000, ANN NY ACAD SCI, V908, P111
   DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   FUSSEY SPM, 1988, P NATL ACAD SCI USA, V85, P8654, DOI 10.1073/pnas.85.22.8654
   GERSHWIN ME, 1987, J IMMUNOL, V138, P3525
   Hernández-Muñoz I, 2005, MOL CELL BIOL, V25, P11047, DOI 10.1128/MCB.25.24.11047-11058.2005
   Honda R, 1999, EMBO J, V18, P22, DOI 10.1093/emboj/18.1.22
   Ishikawa A, 2004, LAB INVEST, V84, P629, DOI 10.1038/labinvest.3700087
   Itahana K, 2003, MOL CELL BIOL, V23, P389, DOI 10.1128/MCB.23.1.389-401.2003
   Iwasa H, 2003, GENES CELLS, V8, P131, DOI 10.1046/j.1365-2443.2003.00620.x
   Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476
   Jaiswal M, 2001, GASTROENTEROLOGY, V120, P190, DOI 10.1053/gast.2001.20875
   Jhandier MN, 2005, J BIOL CHEM, V280, P22986, DOI 10.1074/jbc.M412371200
   Kaplan MM, 1996, NEW ENGL J MED, V335, P1570, DOI 10.1056/NEJM199611213352107
   Katayanagi K, 1998, LIVER, V18, P90
   Kita H, 2002, J CLIN INVEST, V109, P1231, DOI 10.1172/JCI200214698
   LUDWIG J, 1991, SEMIN LIVER DIS, V11, P11, DOI 10.1055/s-2008-1040417
   Lunz JG, 2001, AM J PATHOL, V158, P1379, DOI 10.1016/S0002-9440(10)64089-8
   Marshall A, 2005, GASTROENTEROLOGY, V128, P33, DOI 10.1053/j.gastro.2004.09.076
   NAKANUMA Y, 1979, GASTROENTEROLOGY, V76, P1326
   NAKANUMA Y, 1989, HEPATOLOGY, V10, P174, DOI 10.1002/hep.1840100209
   Paradis V, 2001, HUM PATHOL, V32, P327, DOI 10.1053/hupa.2001.22747
   Park IK, 2004, J CLIN INVEST, V113, P175, DOI 10.1172/JCI200420800
   QUELLE DE, 1995, CELL, V83, P993
   Robles SJ, 1998, ONCOGENE, V16, P1113, DOI 10.1038/sj.onc.1201862
   Sasaki M, 2005, J PATHOL, V205, P451, DOI 10.1002/path.1729
   Sasaki M, 2001, HEPATOLOGY, V34, P631, DOI 10.1053/jhep.2001.27544
   Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501
   Shimoda S, 1998, J CLIN INVEST, V102, P1831, DOI 10.1172/JCI4213
   Sigal SH, 1999, AM J PHYSIOL-GASTR L, V276, pG1260, DOI 10.1152/ajpgi.1999.276.5.G1260
   Stein GH, 1999, MOL CELL BIOL, V19, P2109
   Sun LQ, 2004, GENE DEV, V18, P1035, DOI 10.1101/gad.1176104
   Tsuneyama K, 2002, J HEPATOL, V37, P176, DOI 10.1016/S0168-8278(02)00105-8
   VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757
   Vonlanthen S, 2001, BRIT J CANCER, V84, P1372, DOI 10.1054/bjoc.2001.1791
   Zen Y, 2002, AM J PATHOL, V161, P1475, DOI 10.1016/S0002-9440(10)64423-9
NR 41
TC 74
Z9 80
U1 0
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9440
EI 1525-2191
J9 AM J PATHOL
JI Am. J. Pathol.
PD SEP
PY 2006
VL 169
IS 3
BP 831
EP 845
DI 10.2353/ajpath.2006.051237
PG 15
WC Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology
GA 077RY
UT WOS:000240048900012
PM 16936260
OA Green Published, Bronze
DA 2024-02-19
ER

PT J
AU Inokawa, H
   Umemura, Y
   Shimba, A
   Kawakami, E
   Koike, N
   Tsuchiya, Y
   Ohashi, M
   Minami, Y
   Cui, GW
   Asahi, T
   Ono, R
   Sasawaki, Y
   Konishi, E
   Yoo, SH
   Chen, Z
   Teramukai, S
   Ikuta, K
   Yagita, K
AF Inokawa, Hitoshi
   Umemura, Yasuhiro
   Shimba, Akihiro
   Kawakami, Eiryo
   Koike, Nobuya
   Tsuchiya, Yoshiki
   Ohashi, Munehiro
   Minami, Yoichi
   Cui, Guangwei
   Asahi, Takuma
   Ono, Ryutaro
   Sasawaki, Yuh
   Konishi, Eiichi
   Yoo, Seung-Hee
   Chen, Zheng
   Teramukai, Satoshi
   Ikuta, Koichi
   Yagita, Kazuhiro
TI Chronic circadian misalignment accelerates immune senescence and
   abbreviates lifespan in mice
SO SCIENTIFIC REPORTS
LA English
DT Article
ID REGULATORY T-CELLS; GENE-EXPRESSION; DENDRITIC CELLS; GANGLION-CELLS;
   CLOCK; SHIFT; DESYNCHRONIZATION; OSCILLATIONS; ARCHITECTURE; OSTEOPONTIN
AB Modern society characterized by a 24/7 lifestyle leads to misalignment between environmental cycles and endogenous circadian rhythms. Persisting circadian misalignment leads to deleterious effects on health and healthspan. However, the underlying mechanism remains not fully understood. Here, we subjected adult, wild-type mice to distinct chronic jet-lag paradigms, which showed that long-term circadian misalignment induced significant early mortality. Non-biased RNA sequencing analysis using liver and kidney showed marked activation of gene regulatory pathways associated with the immune system and immune disease in both organs. In accordance, we observed enhanced steatohepatitis with infiltration of inflammatory cells. The investigation of senescence-associated immune cell subsets from the spleens and mesenteric lymph nodes revealed an increase in PD-1(+)CD44(high) CD4 T cells as well as CD95(+)GL7(+) germinal center B cells, indicating that the long-term circadian misalignment exacerbates immune senescence and consequent chronic inflammation. Our results underscore immune homeostasis as a pivotal interventional target against clock-related disorders.
C1 [Inokawa, Hitoshi; Umemura, Yasuhiro; Koike, Nobuya; Tsuchiya, Yoshiki; Ohashi, Munehiro; Minami, Yoichi; Ono, Ryutaro; Sasawaki, Yuh; Yagita, Kazuhiro] Kyoto Prefectural Univ Med, Dept Physiol & Syst Biosci, Kyoto 6028566, Japan.
   [Shimba, Akihiro; Cui, Guangwei; Asahi, Takuma; Ikuta, Koichi] Kyoto Univ, Inst Frontier Life & Med Sci, Dept Virus Res, Lab Immune Regulat, Kyoto 6068507, Japan.
   [Kawakami, Eiryo] RIKEN, Med Sci Innovat Hub Program, Ctr Integrat Med Sci, Yokohama, Kanagawa 2300045, Japan.
   [Kawakami, Eiryo] Chiba Univ, Grad Sch Med, Artificial Intelligence Med, Chiba 2600856, Japan.
   [Konishi, Eiichi] Kyoto Prefectural Univ Med, Dept Surg Pathol, Kyoto 6028566, Japan.
   [Yoo, Seung-Hee; Chen, Zheng] Univ Texas Hlth Sci Ctr Houston, Dept Biochem & Mol Biol, 6431 Fannin St, Houston, TX 77030 USA.
   [Teramukai, Satoshi] Kyoto Prefectural Univ Med, Dept Biostat, Kyoto 6028566, Japan.
   [Asahi, Takuma] Kyoto Univ, Grad Sch Med, Kyoto 6068501, Japan.
C3 Kyoto Prefectural University of Medicine; Kyoto University; RIKEN; Chiba
   University; Kyoto Prefectural University of Medicine; Baylor College of
   Medicine; University of Texas System; University of Texas Health Science
   Center Houston; Kyoto Prefectural University of Medicine; Kyoto
   University
RP Yagita, K (corresponding author), Kyoto Prefectural Univ Med, Dept Physiol & Syst Biosci, Kyoto 6028566, Japan.
EM kyagita@koto.kpu-m.ac.jp
RI Asahi, Takuma/IUM-2886-2023; Teramukai, Satoshi/I-2249-2019; Minami,
   Yoichi/JTV-5480-2023
OI Teramukai, Satoshi/0000-0003-2184-0597; Asahi,
   Takuma/0000-0001-6372-7563; Konishi, Eiichi/0000-0002-7122-2271; Shimba,
   Akihiro/0000-0002-5361-1310; Tsuchiya, Yoshiki/0000-0002-8962-5159;
   Ikuta, Koichi/0000-0003-1319-1021
FU Japan Society for the Promotion of Science [17KT0129, 18K15184,
   16H05172, 18H02600, 19K22516]; Joint Usage/Research Center program of
   Institute for Frontier Life and Medical Sciences Kyoto University;
   Grants-in-Aid for Scientific Research [19K22516, 16H05172, 18K15184,
   18H02600, 17KT0129] Funding Source: KAKEN
FX We thank Moe Hisatomi, Maho Inoue, Ryosuke Ikeda (Kyoto Prefectural
   University of Medicine) for technical assistance. This work was
   supported in part by grants-in-aid for scientific research from the
   Japan Society for the Promotion of Science to Y.U. (17KT0129), A.S.
   (18K15184), K.I. (16H05172), K.Y. (18H02600 and 19K22516). This work was
   partially supported by Joint Usage/Research Center program of Institute
   for Frontier Life and Medical Sciences Kyoto University (K.I. and K.Y.).
CR Ayroldi E, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123774
   Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X
   Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027
   Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Castanon-Cervantes O, 2010, J IMMUNOL, V185, P5796, DOI 10.4049/jimmunol.1001026
   Curtis AM, 2014, IMMUNITY, V40, P178, DOI 10.1016/j.immuni.2014.02.002
   Davidson AJ, 2006, CURR BIOL, V16, pR914, DOI 10.1016/j.cub.2006.09.058
   de la Iglesia HO, 2004, CURR BIOL, V14, P796, DOI 10.1016/j.cub.2004.04.034
   Della Bella S, 2007, CLIN IMMUNOL, V122, P220, DOI 10.1016/j.clim.2006.09.012
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Flurkey K., 2007, The Mouse in Biomedical Research, P637
   Fulop T, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01960
   Fülöp T, 2016, REV INVEST CLIN, V68, P84
   Golombek DA, 2013, J PHYSIOL-PARIS, V107, P310, DOI 10.1016/j.jphysparis.2013.03.007
   Gooley JJ, 2003, J NEUROSCI, V23, P7093, DOI 10.1523/JNEUROSCI.23-18-07093.2003
   Grimaldi D, 2016, HYPERTENSION, V68, P243, DOI 10.1161/HYPERTENSIONAHA.115.06847
   Hastings MH, 1997, TRENDS NEUROSCI, V20, P459, DOI 10.1016/S0166-2236(97)01087-4
   Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609
   Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004
   Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070
   Kawakami E, 2016, NUCLEIC ACIDS RES, V44, P5010, DOI 10.1093/nar/gkw355
   Kettner NM, 2016, CANCER CELL, V30, P909, DOI 10.1016/j.ccell.2016.10.007
   Knutsson A, 2003, OCCUP MED-OXFORD, V53, P103, DOI 10.1093/occmed/kqg048
   Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206
   Koronowski KB, 2019, CELL, V177, P1448, DOI 10.1016/j.cell.2019.04.025
   Kubo T, 2013, J OCCUP ENVIRON MED, V55, P1041, DOI 10.1097/JOM.0b013e31829731fd
   Lages CS, 2008, J IMMUNOL, V181, P1835, DOI 10.4049/jimmunol.181.3.1835
   Lee S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010995
   Leproult R, 2014, DIABETES, V63, P1860, DOI 10.2337/db13-1546
   Leung S, 2010, CELL MOL IMMUNOL, V7, P182, DOI 10.1038/cmi.2010.22
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Logan RW, 2012, MOL CELL ENDOCRINOL, V349, P82, DOI 10.1016/j.mce.2011.06.039
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161
   McHugh D, 2018, J CELL BIOL, V217, P65, DOI 10.1083/jcb.201708092
   Megdal SP, 2005, EUR J CANCER, V41, P2023, DOI 10.1016/j.ejca.2005.05.010
   Minami Y, 2018, SLEEP BIOL RHYTHMS, V16, P63, DOI 10.1007/s41105-017-0127-5
   Nagano M, 2003, J NEUROSCI, V23, P6141
   Nagpal Ravinder, 2018, Nutr Healthy Aging, V4, P267, DOI 10.3233/NHA-170030
   Nakamura TJ, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0064-15.2015
   Nakamura TJ, 2011, J NEUROSCI, V31, P10201, DOI 10.1523/JNEUROSCI.0451-11.2011
   Nohara K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11926-y
   Pilorz V, 2018, PFLUG ARCH EUR J PHY, V470, P227, DOI 10.1007/s00424-017-2103-y
   PITTENDRIGH CS, 1960, COLD SPRING HARB SYM, V25, P159, DOI 10.1101/SQB.1960.025.01.015
   Reddy AB, 2002, J NEUROSCI, V22, P7326
   Sakamoto K, 2016, J IMMUNOL, V197, P2177, DOI 10.4049/jimmunol.1600987
   Scheiermann C, 2012, IMMUNITY, V37, P290, DOI 10.1016/j.immuni.2012.05.021
   Shaw AC, 2010, CURR OPIN IMMUNOL, V22, P507, DOI 10.1016/j.coi.2010.05.003
   Shimatani K, 2009, P NATL ACAD SCI USA, V106, P15807, DOI 10.1073/pnas.0908805106
   Shimba A, 2018, IMMUNITY, V48, P286, DOI 10.1016/j.immuni.2018.01.004
   Sichien D, 2016, IMMUNITY, V45, P626, DOI 10.1016/j.immuni.2016.08.013
   Suzuki K, 2016, J EXP MED, V213, P2567, DOI 10.1084/jem.20160723
   Tahir S, 2015, J IMMUNOL, V194, P5725, DOI 10.4049/jimmunol.1500319
   Takahashi JS, 2017, NAT REV GENET, V18, P164, DOI 10.1038/nrg.2016.150
   Thaiss CA, 2014, CELL, V159, P514, DOI 10.1016/j.cell.2014.09.048
   Tsuchiya Y, 2015, GENES CELLS, V20, P992, DOI 10.1111/gtc.12305
   Uchiyama T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126967
   Umemura Y, 2017, P NATL ACAD SCI USA, V114, pE7479, DOI 10.1073/pnas.1703170114
   Vetter C, 2020, EUR J NEUROSCI, V51, P531, DOI 10.1111/ejn.14255
   Vetter C, 2016, JAMA-J AM MED ASSOC, V315, P1726, DOI 10.1001/jama.2016.4454
   Welz PS, 2019, CELL, V177, P1436, DOI 10.1016/j.cell.2019.05.009
   Yagita K, 2001, SCIENCE, V292, P278, DOI 10.1126/science.1059542
   Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682
   Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101
   Yu XF, 2013, SCIENCE, V342, P727, DOI 10.1126/science.1243884
NR 66
TC 62
Z9 72
U1 1
U2 9
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD FEB 13
PY 2020
VL 10
IS 1
AR 2569
DI 10.1038/s41598-020-59541-y
PG 13
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA NE8XO
UT WOS:000562888700003
PM 32054990
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Kaden, T
   Noerenberg, A
   Boldt, J
   Sagawe, C
   Johannssen, T
   Rennert, K
   Raasch, M
   Evenburg, T
AF Kaden, Tim
   Noerenberg, Astrid
   Boldt, Jennifer
   Sagawe, Carolin
   Johannssen, Timo
   Rennert, Knut
   Raasch, Martin
   Evenburg, Torge
TI Generation & characterization of expandable human liver sinusoidal
   endothelial cells and their application to assess hepatotoxicity in an
   advanced in vitro liver model
SO TOXICOLOGY
LA English
DT Article; Early Access
DE Liver sinusoidal endothelial cells; LSECs; in vitro liver models;
   Hepatocytes; Hepatic cell co-culture; Upcyte
ID RAT; TOXICITY; GLUTATHIONE; HEPATOCYTES; CULTURE; TARGET; INJURY;
   DIFFERENTIATION; ACTIVATION; INDUCTION
AB Liver sinusoidal endothelial cells (LSECs) are highly specialized endothelial cells forming the hepatic sinusoidal wall. Besides their high endocytic potential, LSECs have been demonstrated to markedly contribute to liver homeostasis and immunity, and may partially explain unexpected hepatotoxicity of drug candidates. However, their use for in vitro investigations is compromised by poor cell yields and a limited proliferation capacity. Here, we report the transient expansion of primary human LSECs from three donors by lentiviral transduction. Transduced ("upcyte (R)") LSECs were able to undergo at least 25 additional population doublings (PDs) before growth arrest due to senescence. Expanded upcyte (R) LSECs maintained several characteristics of primary LSECs, including expression of surface markers such as MMR and LYVE-1 as well as rapid uptake of acetylated LDL and ovalbumin. We further investigated the suitability of expanded upcyte (R) LSECs and proliferating upcyte (R) he-patocytes for detecting acetaminophen toxicity at millimolar concentrations (0, 0.5, 1, 2, 5, 10 mM) in static 2D cultures and a microphysiological 3D model. upcyte (R) LSECs exhibited a higher sensitivity to acetaminophen induced toxicity compared to upcyte (R) hepatocytes in 2D culture, however, culturing upcyte (R) LSECs together with upcyte (R) hepatocytes in a co-culture reduced APAP-induced toxicity compared to 2D monocultures. perfused Dynamic42 3D model was more sensitive to acetaminophen than the 2D co-culture model. Cytotoxicity in the 3D model was evident by decreased cellular viability, elevated LDH release, reduced nuclei counts and impaired cell morphology. Taken together, our data demonstrate that transient expansion of LSECs represents suitable method for generation of large quantities of cells while maintaining many characteristics of primary cells and responsiveness to acetaminophen.
C1 [Kaden, Tim; Rennert, Knut; Raasch, Martin] Dynamic42 GmbH, Jena, Germany.
   [Noerenberg, Astrid; Boldt, Jennifer; Sagawe, Carolin; Johannssen, Timo; Evenburg, Torge] upcyte technol GmbH, Hamburg, Germany.
   [Noerenberg, Astrid] upcyte technol GmbH, Osterfeldstr 12-14, D-22529 Hamburg, Germany.
RP Noerenberg, A (corresponding author), upcyte technol GmbH, Osterfeldstr 12-14, D-22529 Hamburg, Germany.
EM astrid@upcyte.com
FU German "Central Innovation Programme for small and medium-sized
   enterprises (SMEs)",; Federal Ministry for Economic Affairs and Climate
   Action;  [ZF4075601AJ5]
FX The research leading to the isolation & expansion of upcyte (R) LSECS
   for donor 444 & 475 was funded: upcyte technologies GmbH received
   funding from the German "Central Innovation Programme for small and
   medium-sized enterprises (SMEs)", a funding programme of the Federal
   Ministry for Economic Affairs and Climate Action, under Grant Agreement
   no ZF4075601AJ5.
CR Allen JW, 2005, TOXICOL SCI, V84, P110, DOI 10.1093/toxsci/kfi052
   Badmann A, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.185
   Balakrishnan B, 2019, BIOL BLOOD MARROW TR, V25
   Bashirova AA, 2001, J EXP MED, V193, P671, DOI 10.1084/jem.193.6.671
   Böttcher JP, 2013, CELL REP, V3, P779, DOI 10.1016/j.celrep.2013.02.008
   Braet Filip, 2002, Comp Hepatol, V1, P1, DOI 10.1186/1476-5926-1-1
   Burkard A, 2012, XENOBIOTICA, V42, P939, DOI 10.3109/00498254.2012.675093
   Candarlioglu P.L., 2022, BIORXIV, DOI [10.1101/2022.03.04.482954v1%0A, DOI 10.1101/2022.03.04.482954V1%0A]
   Carambia A, 2015, J HEPATOL, V62, P1349, DOI 10.1016/j.jhep.2015.01.006
   Chang SY, 2017, TOXICOL IN VITRO, V40, P170, DOI 10.1016/j.tiv.2017.01.007
   Cogger VC, 2008, AM J PHYSIOL-GASTR L, V295, pG137, DOI 10.1152/ajpgi.00069.2008
   DAHLIN DC, 1984, P NATL ACAD SCI-BIOL, V81, P1327, DOI 10.1073/pnas.81.5.1327
   Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191
   DeCicco-Skinner KL, 2014, JOVE-J VIS EXP, DOI 10.3791/51312
   DeLeve LD, 2007, SEMIN LIVER DIS, V27, P390, DOI 10.1055/s-2007-991515
   DeLeve LD, 2015, HEPATOLOGY, V61, P1740, DOI 10.1002/hep.27376
   DeLeve LD, 2013, DRUG-INDUCED LIVER DISEASE, 3RD EDITION, P135, DOI 10.1016/B978-0-12-387817-5.00008-X
   DeLeve LD, 1997, BIOCHEM PHARMACOL, V53, P1339, DOI 10.1016/S0006-2952(97)00048-8
   DeLeve LD, 2004, AM J PHYSIOL-GASTR L, V287, pG757, DOI 10.1152/ajpgi.00017.2004
   DELEVE LD, 1994, J PHARMACOL EXP THER, V268, P1261
   DeLeve LD, 2002, SEMIN LIVER DIS, V22, P27, DOI 10.1055/s-2002-23204
   DeLeve LD, 1996, HEPATOLOGY, V23, P589
   DeLeve LD, 1996, HEPATOLOGY, V24, P830, DOI 10.1002/hep.510240414
   Elvevold K, 2005, EUR J CELL BIOL, V84, P749, DOI 10.1016/j.ejcb.2005.05.003
   Elvevold K, 2008, AM J PHYSIOL-GASTR L, V294, pG391, DOI 10.1152/ajpgi.00167.2007
   FORREST JAH, 1982, CLIN PHARMACOKINET, V7, P93, DOI 10.2165/00003088-198207020-00001
   Gaitantzi H, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9030617
   Géraud C, 2010, HEPATOLOGY, V52, P313, DOI 10.1002/hep.23618
   Gomez-lechon M.J., 2007, T O T S I R U RIB N, P185
   Hammoutene A, 2019, J HEPATOL, V70, P1278, DOI 10.1016/j.jhep.2019.02.012
   Hang TC, 2012, AM J PHYSIOL-GASTR L, V302, pG375, DOI 10.1152/ajpgi.00288.2011
   Hessel-Pras S, 2020, ARCH TOXICOL, V94, P219, DOI 10.1007/s00204-019-02582-8
   Hinson Jack A, 2010, Handb Exp Pharmacol, P369, DOI 10.1007/978-3-642-00663-0_12
   HORMIA M, 1983, CELL BIOL INT REP, V7, P467, DOI 10.1016/0309-1651(83)90136-4
   Jaeschke H, 2006, AM J PHYSIOL-GASTR L, V290, pG1083, DOI 10.1152/ajpgi.00568.2005
   Jeong J., 2022, DISEASE, V75, P377, DOI [10.1016/j.jhep.2021.02.028.Alcohol-induced, DOI 10.1016/J.JHEP.2021.02.028.ALCOHOL-INDUCED]
   Kim SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050148
   Knolle PA, 1999, J IMMUNOL, V162, P1401
   Knolle PA, 2016, CELL MOL IMMUNOL, V13, P347, DOI 10.1038/cmi.2016.5
   Krause P, 2000, J HEPATOL, V32, P718, DOI 10.1016/S0168-8278(00)80239-1
   Lalor PF, 2006, WORLD J GASTROENTERO, V12, P5429, DOI 10.3748/wjg.v12.i34.5429
   Lalor PF, 1999, J CLIN PATHOL-MOL PA, V52, P214, DOI 10.1136/mp.52.4.214
   Lee KM, 2004, CYTOTECHNOLOGY, V45, P33, DOI 10.1007/s10616-004-5123-3
   Levy G, 2015, NAT BIOTECHNOL, V33, P1264, DOI 10.1038/nbt.3377
   Limmer A, 2005, EUR J IMMUNOL, V35, P2970, DOI 10.1002/eji.200526034
   Liu WL, 2004, J BIOL CHEM, V279, P18748, DOI 10.1074/jbc.M311227200
   Lu Y, 2020, J ENV SCI HEAL C-TOX, V38, P169, DOI 10.1080/26896583.2020.1769409
   Malovic I, 2007, HEPATOLOGY, V45, P1454, DOI 10.1002/hep.21639
   March S, 2009, HEPATOLOGY, V50, P920, DOI 10.1002/hep.23085
   Marrone G, 2016, J HEPATOL, V65, P608, DOI 10.1016/j.jhep.2016.04.018
   Martin-Armas M, 2006, J HEPATOL, V44, P939, DOI 10.1016/j.jhep.2005.09.020
   Matsumura T, 2004, TRANSPLANTATION, V77, P1357, DOI 10.1097/01.TP.0000124286.82961.7E
   McCuskey RS, 2006, CLIN HEMORHEOL MICRO, V34, P5
   McGill MR, 2013, PHARM RES-DORDR, V30, P2174, DOI 10.1007/s11095-013-1007-6
   Pandey E, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00873
   Parent R, 2014, BIOCHEM BIOPH RES CO, V450, P7, DOI 10.1016/j.bbrc.2014.05.038
   Poisson J, 2017, J HEPATOL, V66, P212, DOI 10.1016/j.jhep.2016.07.009
   Pusztaszeri MP, 2006, J HISTOCHEM CYTOCHEM, V54, P385, DOI 10.1369/jhc.4A6514.2005
   Rashidi H, 2016, ARCH TOXICOL, V90, P1757, DOI 10.1007/s00204-016-1689-8
   Rennert K, 2015, BIOMATERIALS, V71, P119, DOI 10.1016/j.biomaterials.2015.08.043
   Sorensen KK, 2015, COMPR PHYSIOL, V5, P1751, DOI 10.1002/cphy.c140078
   STEINBERG P, 1989, BIOCHEM J, V264, P737, DOI 10.1042/bj2640737
   Themanns M, 2019, J MOL MED, V97, P201, DOI 10.1007/s00109-018-1726-6
   Tokairin T, 2002, J HEPATOL, V36, P725, DOI 10.1016/S0168-8278(02)00048-X
   Tripathi DM, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00617
   Uhrig A, 2005, J LEUKOCYTE BIOL, V77, P626, DOI 10.1189/jlb.0604332
   Wu J, 2010, IMMUNOLOGY, V129, P363, DOI 10.1111/j.1365-2567.2009.03179.x
   Zhao XH, 2015, INT J MOL MED, V35, P617, DOI 10.3892/ijmm.2015.2067
   Zhu MY, 2018, BIOL PHARM BULL, V41, P440, DOI 10.1248/bpb.b17-00661
   Zimmermann HW, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00056
NR 70
TC 2
Z9 2
U1 0
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0300-483X
EI 1879-3185
J9 TOXICOLOGY
JI Toxicology
PD 2023 JAN 1
PY 2023
VL 483
AR 153374
DI 10.1016/j.tox.2022.153374
EA NOV 2022
PG 14
WC Pharmacology & Pharmacy; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Toxicology
GA 6X9SH
UT WOS:000896745900002
PM 36396002
DA 2024-02-19
ER

PT J
AU Li, HP
   Zhao, HJ
   Liu, WB
   Feng, YB
   Zhang, YW
   Yuan, FF
   Jia, L
AF Li, Huaping
   Zhao, Huajie
   Liu, Wenbo
   Feng, Yanbo
   Zhang, Yiwen
   Yuan, Fangfang
   Jia, Le
TI Liver and Brain Protective Effect of Sulfated Polysaccharides from
   Residue of Lion's Mane Medicinal Mushroom, <i>Hericium erinaceus</i>
   (Agaricomycetes), on D-Galactose-Induced Aging Mice
SO INTERNATIONAL JOURNAL OF MEDICINAL MUSHROOMS
LA English
DT Article
DE antiaging; antioxidation; Hericium erinaceus residue; sulfated
   polysaccharide; medicinal mushrooms
ID ANTIOXIDANT ACTIVITIES; BIOLOGICAL-ACTIVITY; LENTINUS-EDODES;
   EXTRACTION; SODIUM
AB This work describes the preparation of sulfated Hericium erinaceus residue polysaccharides (SHRPs) and investigates their antioxidant and antiaging effects on D-galactose-induced aging mice. The results indicated that the degree of SO42- substitution was 0.47 +/- 0.22 for SHRPs. In vitro analysis and in vivo animal experiments manifested that SHRPs could alleviate aging properties by scavenging radicals, elevating enzyme activities, and reducing malondialdehyde content, thus improving serum biochemical indices and enhancing immunological activity. Liver and brain injuries of mice could be remitted by SHRP interventions. Structural characteristics of SHRPs in this work were elucidated by Fourier transform infrared spectroscopy and gas chromatography-mass spectrometry, and the results suggest that SHRPs could be used as an effective dietary supplement and functional food for prevention of aging and age-related diseases.
C1 [Li, Huaping; Zhao, Huajie; Liu, Wenbo; Feng, Yanbo; Zhang, Yiwen; Yuan, Fangfang; Jia, Le] Shandong Agr Univ, Coll Life Sci, Tai An 271018, Shandong, Peoples R China.
C3 Shandong Agricultural University
RP Jia, L (corresponding author), Shandong Agr Univ, Coll Life Sci, Tai An 271018, Shandong, Peoples R China.
EM jiale0525@163.com
RI li, wl/JJC-0768-2023
FU Mushroom Technology System of Shandong Province [SDAIT-07-05]
FX This work was supported by grants from the Mushroom Technology System of
   Shandong Province (SDAIT-07-05).
CR Bae IY, 2011, INT J MED MUSHROOMS, V13, P115, DOI 10.1615/IntJMedMushr.v13.i2.30
   Chen SD, 2019, INT J MED MUSHROOMS, V21, P703, DOI 10.1615/IntJMedMushrooms.v21.i7.70
   Choi JH, 2017, INT J MED MUSHROOMS, V19, P107, DOI 10.1615/IntJMedMushrooms.v19.i2.20
   Choi SJ, 2016, INT J MOL MED, V38, P357, DOI 10.3892/ijmm.2016.2604
   Fu LL, 2010, J FOOD SCI, V75, pC322, DOI 10.1111/j.1750-3841.2010.01590.x
   Gao Z, 2018, CARBOHYD POLYM, V181, P1224, DOI 10.1016/j.carbpol.2017.12.007
   Griffith AV, 2012, AGING CELL, V11, P169, DOI 10.1111/j.1474-9726.2011.00773.x
   HOLNESS CL, 1993, J BIOL CHEM, V268, P9661
   Huang JA, 2010, ACTA OCEANOL SIN, V29, P3, DOI 10.1007/s13131-010-0045-8
   JENTSCH TJ, 1985, PFLUG ARCH EUR J PHY, V403, P175, DOI 10.1007/BF00584097
   Jia XW, 2017, INT J MED MUSHROOMS, V19, P355, DOI [10.1615/IntJMedMushrooms.v19.i4.60, 10.1615/intjmedmushrooms.v19.i4.60]
   Jiang SJ, 2014, APPL MICROBIOL BIOT, V98, P7661, DOI 10.1007/s00253-014-5955-5
   Jiang YJ, 2014, INT J MED MUSHROOMS, V16, P411, DOI 10.1615/IntJMedMushrooms.v16.i5.10
   Jing HJ, 2018, EVID-BASED COMPL ALT, V2018, DOI 10.1155/2018/1584647
   Kaur A, 2019, INT J MED MUSHROOMS, V21, P755, DOI 10.1615/IntJMedMushrooms.2019031508
   Li Y, 2016, INT J MED MUSHROOMS, V18, P721, DOI 10.1615/IntJMedMushrooms.v18.i8.80
   Liao J, 2020, CARBOHYD POLYM, V229, DOI 10.1016/j.carbpol.2019.115426
   Liao J, 2020, INT J BIOL MACROMOL, V156, P1279, DOI 10.1016/j.ijbiomac.2019.11.165
   Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673
   Liu M, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/4285161
   Liu ZN, 2019, INT J BIOL MACROMOL, V140, P697, DOI 10.1016/j.ijbiomac.2019.08.130
   Ma LS, 2012, CARBOHYD POLYM, V89, P371, DOI 10.1016/j.carbpol.2012.03.016
   Matjuskova N, 2014, INT J MED MUSHROOMS, V16, P605, DOI 10.1615/IntJMedMushrooms.v16.i6.100
   Poeggeler B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010206
   Qin T, 2020, INT J BIOL MACROMOL, V152, P1265, DOI 10.1016/j.ijbiomac.2019.10.223
   Radzki W, 2019, INT J MED MUSHROOMS, V21, P393, DOI 10.1615/IntJMedMushrooms.2019030345
   Shomali N, 2019, INT J MED MUSHROOMS, V21, P571, DOI 10.1615/IntJMedMushrooms.2019030874
   Tang HY, 2015, CURR MED CHEM, V22, P2375, DOI 10.2174/0929867322666150521091333
   Nguyen TL, 2012, CARBOHYD POLYM, V90, P1254, DOI 10.1016/j.carbpol.2012.06.060
   Wei YN, 2020, ENVIRON SCI POLLUT R, V27, P3007, DOI 10.1007/s11356-019-07138-y
   Wu HC, 2019, INT J MED MUSHROOMS, V21, P657, DOI 10.1615/IntJMedMushrooms.2019031138
   Yang T, 2014, INT J MED MUSHROOMS, V16, P125, DOI 10.1615/IntJMedMushr.v16.i2.30
   Yin CM, 2018, INT J MED MUSHROOMS, V20, P873, DOI [10.1615/IntJMedMushrooms.2018027368, 10.1615/intjmedmushrooms.2018027368]
   Yuan FF, 2019, MOLECULES, V24, DOI 10.3390/molecules24193517
   Zhang PY, 2000, CARBOHYD RES, V327, P431, DOI 10.1016/S0008-6215(00)00077-X
   Zhang ZF, 2013, CARBOHYD POLYM, V98, P1524, DOI 10.1016/j.carbpol.2013.07.052
   Zheng L, 2015, J SCI FOOD AGR, V95, P3117, DOI 10.1002/jsfa.7048
   Zhu LN, 2014, INT J MED MUSHROOMS, V16, P247, DOI 10.1615/IntJMedMushr.v16.i3.50
   Zong AZ, 2015, CARBOHYD POLYM, V129, P50, DOI 10.1016/j.carbpol.2015.04.017
   Zou L, 2017, MOLECULES, V22, DOI 10.3390/molecules22091446
NR 40
TC 6
Z9 6
U1 0
U2 12
PU BEGELL HOUSE INC
PI DANBURY
PA 50 NORTH ST, DANBURY, CT 06810 USA
SN 1521-9437
EI 1940-4344
J9 INT J MED MUSHROOMS
JI Int. J. Med. Mushrooms
PY 2021
VL 23
IS 5
BP 55
EP 65
PG 11
WC Biochemistry & Molecular Biology; Plant Sciences; Mycology; Pharmacology
   & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Plant Sciences; Mycology; Pharmacology
   & Pharmacy
GA RT8DD
UT WOS:000644685600006
PM 34347995
DA 2024-02-19
ER

PT J
AU Charni-Natan, M
   Solomon, H
   Molchadsky, A
   Jacob-Berger, A
   Goldfinger, N
   Rotter, V
AF Charni-Natan, Meital
   Solomon, Hilla
   Molchadsky, Alina
   Jacob-Berger, Adi
   Goldfinger, Naomi
   Rotter, Varda
TI Various stress stimuli rewire the profile of liver secretome in a
   p53-dependent manner
SO CELL DEATH & DISEASE
LA English
DT Article
ID DAMAGE-INDUCED PHOSPHORYLATION; DNA-DAMAGE; TUMOR SUPPRESSION; IN-VIVO;
   LIPID-METABOLISM; CATHEPSIN-B; P53; SENESCENCE; TARGET; CELLS
AB Liver is an important secretory organ that consistently manages various insults in order to retain whole-body homeostasis. Importantly, it was suggested that the tumor-suppressor p53 plays a role in a variety of liver physiological processes and thus it is being regarded as a systemic homeostasis regulator. Using high-throughput mass spectrometric analysis, we identified various p53-dependent liver secretome profiles. This allowed a global view on the role of p53 in maintaining the harmony of liver and whole-body homeostasis. We found that p53 altered the liver secretome differently under various conditions. Under physiological conditions, p53 controls factors that are related mainly to lipid metabolism and injury response. Upon exposure to various types of cancer therapy agents, the hepatic p53 is activated and induces the secretion of proteins related to additional pathways, such as hemostasis, immune response, and cell adhesion. Interestingly, we identified a possible relationship between p53-dependent liver functions and lung tumors. The latter modify differently liver secretome profile toward the secretion of proteins mainly related to cell migration and immune response. The notion that p53 may rewire the liver secretome profile suggests a new non-cell autonomous role of p53 that affect different liver functions and whole organism homeostasis.
C1 [Charni-Natan, Meital; Solomon, Hilla; Molchadsky, Alina; Jacob-Berger, Adi; Goldfinger, Naomi; Rotter, Varda] Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel.
C3 Weizmann Institute of Science
RP Rotter, V (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel.
EM varda.rotter@weizmann.ac.il
OI Charni-Natan, Meital/0000-0003-0221-1664
FU Center of Excellence from Flight Attendant Medical Research Institute
   (FAMRI); Israel Science Foundation (ISF)
FX We wish to thank Dr. Ori Brenner for tumor histology analysis, to Dr.
   Raya Eilam for the help with Immunohistochemistry staining, to Dr.
   Meital Kupervaser at the de Botton Institute for Protein Profiling, and
   The Nancy and Stephen Grand Israel National Center for Personalized
   Medicine, Weizmann Institute of Science for the mass spectrometric
   analysis. This research was supported by the Center of Excellence from
   Flight Attendant Medical Research Institute (FAMRI) and from the Israel
   Science Foundation (ISF). This publication reflects the authors' views
   and not necessarily those of the European Community. V.R. is the
   incumbent of the Norman and Helen Asher Professorial Chair Cancer
   Research at the Weizmann institute.
CR Al-Zhoughbi W, 2014, SEMIN ONCOL, V41, P281, DOI 10.1053/j.seminoncol.2014.02.005
   Allen MA, 2014, ELIFE, V3, DOI 10.7554/eLife.02200
   Armata HL, 2010, MOL CELL BIOL, V30, P5787, DOI 10.1128/MCB.00347-10
   Bankhead P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17204-5
   Ben-Ari Fuchs S, 2016, OMICS, V20, P139, DOI 10.1089/omi.2015.0168
   Bieging KT, 2014, NAT REV CANCER, V14, P359, DOI 10.1038/nrc3711
   Buchholz M, 2003, CANCER RES, V63, P4945
   Canbay A, 2003, J CLIN INVEST, V112, P152, DOI 10.1172/JCI200317740
   Charni M, 2016, CELL DEATH DIFFER, V23, P509, DOI 10.1038/cdd.2015.119
   Charni M, 2014, J MOL MED, V92, P1229, DOI 10.1007/s00109-014-1223-5
   Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0
   Engeland K, 2018, CELL DEATH DIFFER, V25, P114, DOI 10.1038/cdd.2017.172
   Goldstein I, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-9
   Goldstein I, 2013, CARCINOGENESIS, V34, P190, DOI 10.1093/carcin/bgs318
   Goldstein I, 2012, TRENDS ENDOCRIN MET, V23, P567, DOI 10.1016/j.tem.2012.06.007
   Goldstein I, 2012, J HEPATOL, V56, P656, DOI 10.1016/j.jhep.2011.08.022
   Gondi CS, 2013, EXPERT OPIN THER TAR, V17, P281, DOI 10.1517/14728222.2013.740461
   Hoenicke L, 2012, CARCINOGENESIS, V33, P1123, DOI 10.1093/carcin/bgs124
   Hoh J, 2002, P NATL ACAD SCI USA, V99, P8467, DOI 10.1073/pnas.132268899
   Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331
   Iwaki T, 2012, BRIT J HAEMATOL, V157, P291, DOI 10.1111/j.1365-2141.2012.09074.x
   Kampf C, 2014, FASEB J, V28, P2901, DOI 10.1096/fj.14-250555
   Kortlever RM, 2006, NAT CELL BIOL, V8, P877, DOI 10.1038/ncb1448
   Krizhanovsky V, 2008, COLD SH Q B, V73, P513, DOI 10.1101/sqb.2008.73.048
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698
   Lee YM, 2016, J CELL MOL MED, V20, P1076, DOI 10.1111/jcmm.12794
   Leu JIJ, 2007, GENE DEV, V21, P3095, DOI 10.1101/gad.1567107
   Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723
   Lisman T, 2007, DIGEST SURG, V24, P250, DOI 10.1159/000103655
   Lujambio A, 2013, CELL, V153, P449, DOI 10.1016/j.cell.2013.03.020
   Masri S, 2016, CELL, V165, P896, DOI 10.1016/j.cell.2016.04.039
   Mckee CM, 2015, ONCOTARGET, V6, P3784, DOI 10.18632/oncotarget.2921
   Milyavsky M, 2005, CANCER RES, V65, P4530, DOI 10.1158/0008-5472.CAN-04-3880
   Monard D, 2017, SEMIN CELL DEV BIOL, V62, P160, DOI 10.1016/j.semcdb.2016.08.012
   Olovnikov IA, 2009, SEMIN CANCER BIOL, V19, P32, DOI 10.1016/j.semcancer.2008.11.005
   Otsuka T, 2002, FEBS LETT, V532, P391, DOI 10.1016/S0014-5793(02)03714-6
   PLAKSIN D, 1992, INT J CANCER, V52, P771, DOI 10.1002/ijc.2910520517
   Reuben A, 2010, HEPATOLOGY, V52, P2065, DOI 10.1002/hep.23937
   Rodriguez R, 2006, MOL BIOL CELL, V17, P402, DOI 10.1091/mbc.E05-07-0594
   Ruhland MK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11762
   Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831
   Santini D, 2003, ANTICANCER RES, V23, P5173
   Sardi A, 1996, Oncology (Williston Park), V10, P911
   SCHAFFNER F, 1975, VET PATHOL, V12, P145, DOI 10.1177/030098587501200206
   Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X
   Sulava E, 2017, J EMERG MED, V52, P654, DOI 10.1016/j.jemermed.2016.10.016
   Tamura T, 2015, MOL CLIN ONCOL, V3, P217, DOI 10.3892/mco.2014.410
   Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152
   Tortora G., 2014, PRINCIPLES ANATOMY P, P523
   Tu HC, 2009, P NATL ACAD SCI USA, V106, P1093, DOI 10.1073/pnas.0808173106
   Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419
   Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472
   Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715
   Wu CL, 2015, BIOL REV, V90, P367, DOI 10.1111/brv.12116
   Wu QW, 2016, AM J TRANSL RES, V8, P1985
   Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529
NR 59
TC 9
Z9 9
U1 0
U2 2
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-4889
J9 CELL DEATH DIS
JI Cell Death Dis.
PD MAY 29
PY 2018
VL 9
AR 647
DI 10.1038/s41419-018-0697-4
PG 13
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA GH8LY
UT WOS:000433921200010
PM 29844359
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Dong, YZ
   Huang, JC
   Lin, X
   Zhang, SJ
   Jiao, Y
   Liang, T
   Chen, ZN
   Huang, RB
AF Dong, Yizhu
   Huang, Jianchun
   Lin, Xing
   Zhang, Shijun
   Jiao, Yang
   Liang, Tao
   Chen, Zhaoni
   Huang, Renbin
TI Hepatoprotective effects of Yulangsan polysaccharide and
   rifampicin-induced liver injury in mice against isoniazid
SO JOURNAL OF ETHNOPHARMACOLOGY
LA English
DT Article
DE Yulangsan polysaccharide (YLSPS); Hepatoprotective effects; Rifampin;
   Isoniazid
ID INDUCED HEPATOTOXICITY; OXIDATIVE-STRESS; HEPATIC-INJURY; DDB
AB Ethnopharmacological relevance: Yulangsan polysaccharide (YLSPS) is often used in popular folk medicine in the Guangxi Zhuang Autonomous Region of China as a chief ingredient of Millettia pulchra, which is used as an hepatic protection, anti-aging and memory improving agent. In this study, the hepatoprotective effects of YLSPS against isoniazid (INH) or rifampicin and isoniazid (RFP+INH)-induced liver injury were investigated in mice.
   Materials and methods: The liver injury was induced by intragastric administration of INH or RFP + INH daily for 10 days. During the experiment, the model group received INH or RFP+INH only, and the normal control group received an equal volume of saline. Treatment groups received not only INH or RFP+INH but also the corresponding drugs, DDB (200 mg/kg/day) or YLSPS (100, 200, and 400 mg/kg/day) 2 h after the administration of INH or RFP+INH.
   Results: Analysis experiments showed that YLSPS significantly alleviated liver injury as indicated by the decreased levels of ALT and AST and the increased levels of SOD, GSH and GSH-Px. Moreover, YLSPS could effectively reduce the pathological tissue damage. The research on the mechanisms underlying the hepatoprotective effect showed that YLSPS was able to reduce lipid peroxidation and activate the anti-oxidative defense system.
   Conclusion: Our results show that YLSPS is effective in attenuating hepatic injury in the INH or RFP + INH-induced mouse model, and could be developed as a new drug for treatment of liver injury. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
C1 [Dong, Yizhu; Huang, Jianchun; Lin, Xing; Zhang, Shijun; Jiao, Yang; Liang, Tao; Chen, Zhaoni; Huang, Renbin] Guangxi Med Univ, Dept Pharmacol, Nanning 530021, Peoples R China.
C3 Guangxi Medical University
RP Huang, RB (corresponding author), Guangxi Med Univ, Dept Pharmacol, Nanning 530021, Peoples R China.
EM huangrenbin518@163.com
RI Huang, Ren/HJG-5652-2022
OI Huang, Ren/0000-0002-3068-8331
FU Science and Technology Research Development of Guangxi Province
   [2012GXNSFBA053094]; Scientific Research and Technology Development
   Research Projects of Guangxi Province [0630002-2, 10124008-6]; Science
   and Technology Foundation Platform Construction Project of Guangxi
   Province [12-97-20]
FX The authors gratefully acknowledge financial support from the Science
   and Technology Research Development of Guangxi Province (No.
   2012GXNSFBA053094), Scientific Research and Technology Development
   Research Projects of Guangxi Province (Nos. 0630002-2 and 10124008-6),
   Science and Technology Foundation Platform Construction Project of
   Guangxi Province (No. 12-97-20).
CR Attri S, 2000, HUM EXP TOXICOL, V19, P517, DOI 10.1191/096032700674230830
   Dai B, 2009, CHINESE MODERN YAO M, P401
   Duan X., 2007, LISHIZHEN MED MAT ME, V18, P1592
   [段小群 DUAN Xiaoqun], 2008, [中国现代医学杂志, China Journal of Modern Medicine], V18, P423
   [付书婕 FU Shu-jie], 2009, [中国药房, China Pharmacy], V20, P406
   Gao M, 2005, LIVER INT, V25, P904, DOI 10.1111/j.1478-3231.2005.01140.x
   Georgieva N, 2004, Trakia J Sci, V2, P37, DOI DOI 10.1016/j.ecoenv.2013.09.022
   Guangxi Food and Drug Administration, 2008, STAND GUANGX ZHUANG, P72
   Hassan AA, 2010, LIFE SCI J, V7, P148
   [黄仁彬 Huang Renbin], 2003, [中国医院药学杂志, Chinese Journal of Hospital Pharmacy], V23, P321
   [黄媛恒 HUANG Yuan-heng], 2008, [中国新药杂志, Chinese Journal New Drugs], V17, P1764
   Jiao Y., 2004, J GUANGXI MED U, V21, P22
   Lin X, 2014, CARBOHYD POLYM, V101, P533, DOI 10.1016/j.carbpol.2013.09.037
   Onyema OO, 2006, INDIAN J BIOCHEM BIO, V43, P20
   Park EY, 2005, CHEM-BIOL INTERACT, V155, P82, DOI 10.1016/j.cbi.2005.04.006
   Saad EI, 2010, FOOD CHEM TOXICOL, V48, P1869, DOI 10.1016/j.fct.2010.04.026
   Santhosh S, 2007, EUR J PHARMACOL, V572, P69, DOI 10.1016/j.ejphar.2007.05.059
   Sodhi CP, 1997, DRUG CHEM TOXICOL, V20, P255, DOI 10.3109/01480549709003881
   Tasduq SA, 2005, HEPATOL RES, V31, P132, DOI 10.1016/j.hepres.2005.01.005
   *WHO, 2008, WHOHTMTB2008393
NR 20
TC 31
Z9 38
U1 0
U2 29
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-8741
J9 J ETHNOPHARMACOL
JI J. Ethnopharmacol.
PD FEB 27
PY 2014
VL 152
IS 1
BP 201
EP 206
DI 10.1016/j.jep.2014.01.001
PG 6
WC Plant Sciences; Chemistry, Medicinal; Integrative & Complementary
   Medicine; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary
   Medicine
GA AC2TD
UT WOS:000332356000019
PM 24412379
DA 2024-02-19
ER

PT J
AU Vanhooren, V
   Liu, XE
   Franceschi, C
   Gao, CF
   Libert, C
   Contreras, R
   Chen, CY
AF Vanhooren, Valerie
   Liu, Xue-En
   Franceschi, Claudio
   Gao, Chun-Fang
   Libert, Claude
   Contreras, Roland
   Chen, Cuiying
TI N-glycan profiles as tools in diagnosis of hepatocellular carcinoma and
   prediction of healthy human ageing
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE Liver cancer; N-glycan; Glycosylation; Glycomics; Ageing
ID DNA-SEQUENCING EQUIPMENT; HEPATITIS-B-VIRUS; RHEUMATOID-ARTHRITIS;
   PROTEIN GLYCOSYLATION; GLYCOMIC CHANGES; STANDARD; IGG
AB Protein glycosylation, the most common form of co-translational modification of proteins, is the enzymatic addition of sugars or oligosaccharides (glycans) to proteins. Protein glycosylation increases the diversity of the functions of proteins encoded in the genome. The result is that different glycomes of the same protein may have different functional, kinetic or physical properties. The glycosylation pathway is largely regulated by the condition of the cells, which means that the Sugar chains can be altered by the physiological or pathophysiological condition of the cell. Thus, the type of glycans produced by cells, tissues, or organism could reflect their Current physiological state. We determined the N-glycan profiles of serum proteins by using DNA sequencer-based carbohydrate analytical profiling technology. We show that two N-glycan structures (NGA2F and NA2F) present in human blood glycoproteins change with ageing, and that one triantennary glycan (NA3Fb) is correlated with tumor stage in HCC patients. Therefore, examining alterations in serum glycan fingerprint by using our platform could be a suitable tool for monitoring the healthiness of ageing and for the follow-up of pathophysiological conditions Such as liver cancer. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
C1 [Vanhooren, Valerie; Liu, Xue-En; Libert, Claude; Contreras, Roland; Chen, Cuiying] VIB, Dept Mol Biomed Res, B-9052 Ghent, Belgium.
   [Vanhooren, Valerie; Liu, Xue-En; Libert, Claude; Contreras, Roland; Chen, Cuiying] Univ Ghent, Dept Mol Biol, B-9052 Ghent, Belgium.
   [Franceschi, Claudio] Univ Bologna, Dept Expt Pathol, I-40126 Bologna, Italy.
   [Gao, Chun-Fang] Second Mil Med Univ, Eastern Hepatobiliary Hosp, Dept Lab Med, Shanghai 200433, Peoples R China.
   [Liu, Xue-En] Peking Univ, Hlth Sci Ctr, Dept Microbiol, Beijing 100083, Peoples R China.
C3 Flanders Institute for Biotechnology (VIB); Ghent University; University
   of Bologna; Naval Medical University; Peking University
RP Chen, CY (corresponding author), VIB, Dept Mol Biomed Res, Technol Pk 927, B-9052 Ghent, Belgium.
EM chitty@dmbr.ugent.be
RI Libert, Claude/A-6504-2010; Franceschi, Claudio/L-4484-2017
OI Liu, Xue-en/0000-0002-6574-4989
FU Ghent University [01106205]; Flanders-China Bilateral project [011 S605]
FX We thank Dr. Amin Breclan for editing the manuscript. This work was
   supported by a grant from Ghent University (BOF no. 01106205),
   Flanders-China Bilateral project (011 S605).
CR Afdhal NH, 2004, CLIN CHEM, V50, P1299, DOI 10.1373/clinchem.2004.035899
   Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8
   Bruix J, 2004, CANCER CELL, V5, P215, DOI 10.1016/S1535-6108(04)00058-3
   Callewaert N, 2001, GLYCOBIOLOGY, V11, P275, DOI 10.1093/glycob/11.4.275
   Callewaert N, 2004, NAT MED, V10, P429, DOI 10.1038/nm1006
   Child C G, 1964, Major Probl Clin Surg, V1, P1
   Colli A, 2006, AM J GASTROENTEROL, V101, P513, DOI 10.1111/j.1572-0241.2006.00467.x
   Comelli EM, 2006, GLYCOBIOLOGY, V16, P117, DOI 10.1093/glycob/cwj048
   FIELD MC, 1994, BIOCHEM J, V299, P261, DOI 10.1042/bj2990261
   Franceschi C, 2000, ANN NY ACAD SCI, V908, P244
   Freeze HH, 2005, CURR OPIN STRUC BIOL, V15, P490, DOI 10.1016/j.sbi.2005.08.010
   Gomez CR, 2008, EXP GERONTOL, V43, P718, DOI 10.1016/j.exger.2008.05.016
   Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752
   Koike Kazuhiko, 2005, Clin Gastroenterol Hepatol, V3, pS132, DOI 10.1016/S1542-3565(05)00700-7
   Laroy W, 2006, NAT PROTOC, V1, P397, DOI 10.1038/nprot.2006.60
   Liaw YF, 2005, SEMIN LIVER DIS, V25, P40, DOI 10.1055/s-2005-915649
   Liu XE, 2007, HEPATOLOGY, V46, P1426, DOI 10.1002/hep.21855
   Martin K, 2001, J RHEUMATOL, V28, P1531
   PAREKH RB, 1985, NATURE, V316, P452, DOI 10.1038/316452a0
   PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817
   Rabinovich GA, 2002, TRENDS IMMUNOL, V23, P313, DOI 10.1016/S1471-4906(02)02232-9
   Smith AE, 2004, SCIENCE, V304, P237, DOI 10.1126/science.1094823
   VANBENEDEN K, 2008, ANN RHEUM DIS
   Vanhooren V, 2008, BIOGERONTOLOGY, V9, P351, DOI 10.1007/s10522-008-9140-z
   Vanhooren V, 2007, REJUV RES, V10, P521, DOI 10.1089/rej.2007.0556
   von der Lieth CW, 2004, BRIEF BIOINFORM, V5, P164, DOI 10.1093/bib/5.2.164
   Wang CQ, 1996, BIOCHEMISTRY-US, V35, P7299, DOI 10.1021/bi9517704
   Weerapana E, 2006, GLYCOBIOLOGY, V16, p91R, DOI 10.1093/glycob/cwj099
NR 28
TC 44
Z9 47
U1 3
U2 17
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD JAN-FEB
PY 2009
VL 130
IS 1-2
SI SI
BP 92
EP 97
DI 10.1016/j.mad.2008.11.008
PG 6
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 407XT
UT WOS:000263398300014
PM 19070631
DA 2024-02-19
ER

PT J
AU Petrosillo, G
   Moro, N
   Paradies, V
   Ruggiero, FM
   Paradies, G
AF Petrosillo, Giuseppe
   Moro, Nicola
   Paradies, Valeria
   Ruggiero, Francesca M.
   Paradies, Giuseppe
TI Increased susceptibility to Ca2+-induced permeability transition and to
   cytochrome c release in rat heart mitochondria with aging: effect of
   melatonin
SO JOURNAL OF PINEAL RESEARCH
LA English
DT Article
DE cardiolipin; Melatonin; mitochondrial permeability transition
ID REACTIVE OXYGEN; OXIDATIVE STRESS; LIVER-MITOCHONDRIA; CARDIOLIPIN;
   APOPTOSIS; AGE; DYSFUNCTION; PORE; DERIVATIVES; SENESCENCE
AB Aging is associated with a decline of cardiac function. The mitochondrial permeability transition (MPT) may be a factor in cardiac dysfunction associated with aging. We investigated the effect of aging and long-term treatment with melatonin (approximately 10 mg/kg b.w./day for 2 months), a known natural antioxidant, on the susceptibility to Ca2+-induced MPT opening and cytochrome c release in rat heart mitochondria. The mitochondrial content of normal and oxidized cardiolipin as a function of aging and melatonin treatment was also analyzed. Mitochondria from aged rats (24 month old) displayed an increased susceptibility to Ca2+-induced MPT opening, associated with an elevated release of cytochrome c, when compared with young control animals (5 month old). Melatonin treatment counteracted both these processes. Aging was also associated with an oxidation/depletion of cardiolipin which could be counteracted as well by melatonin. It is proposed that the increased level of oxidized cardiolipin could be responsible, at least in part, for the increased susceptibility to Ca2+-induced MPT opening and cytochrome c release in rat heart mitochondria with aging. Melatonin treatment counteracts both these processes, most likely, by preventing the oxidation/depletion of cardiolipin. Our results might have implications in the necrotic and apoptotic myocytes cell death in aged myocardium, particularly in ischemia/reperfusion injury.
C1 [Paradies, Giuseppe] Univ Bari, Dept Biochem & Mol Biol, I-70126 Bari, Italy.
   Univ Bari, CNR, Inst Biomembranes & Bioenerget, I-70126 Bari, Italy.
C3 Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari
   Aldo Moro; Consiglio Nazionale delle Ricerche (CNR)
RP Paradies, G (corresponding author), Univ Bari, Dept Biochem & Mol Biol, Via E Orabona 4, I-70126 Bari, Italy.
EM g.paradies@biologia.uniba.it
OI Paradies, Valeria/0000-0003-3513-7819; PETROSILLO,
   GIUSEPPE/0000-0001-8035-8368
CR Andrabi SA, 2004, FASEB J, V18, P869, DOI 10.1096/fj.03-1031fje
   BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   Buege J A, 1978, Methods Enzymol, V52, P302
   Carretero M, 2009, J PINEAL RES, V47, P192, DOI 10.1111/j.1600-079X.2009.00700.x
   Cocheme HM, 2007, MITOCHONDRION, V7, pS94, DOI 10.1016/j.mito.2007.02.007
   Crompton M, 2004, AGING CELL, V3, P3, DOI 10.1046/j.1474-9728.2003.00073.x
   Crouser ED, 2003, ANAL BIOCHEM, V317, P67, DOI 10.1016/S0003-2697(03)00044-7
   Di Lisa F, 2005, CARDIOVASC RES, V66, P222, DOI 10.1016/j.cardiores.2005.02.009
   Gonzalvez F, 2007, APOPTOSIS, V12, P877, DOI 10.1007/s10495-007-0718-8
   Goodell S, 1998, MECH AGEING DEV, V101, P245, DOI 10.1016/S0047-6374(97)00182-6
   Harman D, 2003, ANTIOXID REDOX SIGN, V5, P557, DOI 10.1089/152308603770310202
   Hibaoui Y, 2009, J PINEAL RES, V47, P238, DOI 10.1111/j.1600-079X.2009.00707.x
   Hiona A, 2008, EXP GERONTOL, V43, P24, DOI 10.1016/j.exger.2007.10.001
   Hofer T, 2009, MECH AGEING DEV, V130, P297, DOI 10.1016/j.mad.2009.01.004
   Houtkooper RH, 2008, CELL MOL LIFE SCI, V65, P2493, DOI 10.1007/s00018-008-8030-5
   HSIEH RH, 1994, BIOCHEM MOL BIOL INT, V32, P1009
   Jou MJ, 2007, J PINEAL RES, V43, P389, DOI 10.1111/j.1600-079X.2007.00490.x
   Jou MJ, 2010, J PINEAL RES, V48, P20, DOI 10.1111/j.1600-079X.2009.00721.x
   Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727
   Kagan VE, 2004, FREE RADICAL BIO MED, V37, P1963, DOI 10.1016/j.freeradbiomed.2004.08.016
   Leung AWC, 2008, BBA-BIOENERGETICS, V1777, P946, DOI 10.1016/j.bbabio.2008.03.009
   Luchetti F, 2007, TOXICOL IN VITRO, V21, P293, DOI 10.1016/j.tiv.2006.08.003
   Mather M, 2000, BIOCHEM BIOPH RES CO, V273, P603, DOI 10.1006/bbrc.2000.2994
   Mekhloufi J, 2005, J PINEAL RES, V39, P27, DOI 10.1111/j.1600-079X.2005.00208.x
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2
   Paradies G, 2004, CIRC RES, V94, P53, DOI 10.1161/01.RES.0000109416.56608.64
   Paradies G, 2009, CELL CALCIUM, V45, P643, DOI 10.1016/j.ceca.2009.03.012
   Peschke E, 2008, J PINEAL RES, V44, P26, DOI 10.1111/j.1600-079X.2007.00519.x
   Petrosillo G, 2006, FASEB J, V20, P269, DOI 10.1096/fj.05-4692com
   Petrosillo G, 2001, FEBS LETT, V509, P435, DOI 10.1016/S0014-5793(01)03206-9
   Petrosillo G, 2008, REJUV RES, V11, P935, DOI 10.1089/rej.2008.0772
   Petrosillo G, 2006, FEBS LETT, V580, P6311, DOI 10.1016/j.febslet.2006.10.036
   Petrosillo G, 2009, FREE RADICAL BIO MED, V47, P969, DOI 10.1016/j.freeradbiomed.2009.06.032
   Peyrot F, 2008, J PINEAL RES, V45, P235, DOI 10.1111/j.1600-079X.2008.00580.x
   Rodríguez MI, 2007, FREE RADICAL RES, V41, P15, DOI 10.1080/10715760600936359
   RUGGIERO FM, 1984, LIPIDS, V19, P171, DOI 10.1007/BF02534794
   Scarpa A, 1979, Methods Enzymol, V56, P301
   Schlame M, 2000, PROG LIPID RES, V39, P257, DOI 10.1016/S0163-7827(00)00005-9
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   Skulachev VP, 2009, BBA-BIOENERGETICS, V1787, P437, DOI 10.1016/j.bbabio.2008.12.008
   Tan DX, 2007, J PINEAL RES, V42, P28, DOI 10.1111/j.1600-079X.2006.00407.x
   Tengattini S, 2008, J PINEAL RES, V44, P16, DOI 10.1111/j.1600-079X.2007.00518.x
   Tuominen EKJ, 2002, J BIOL CHEM, V277, P8822, DOI 10.1074/jbc.M200056200
NR 44
TC 63
Z9 68
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3098
EI 1600-079X
J9 J PINEAL RES
JI J. Pineal Res.
PD MAY
PY 2010
VL 48
IS 4
BP 340
EP 346
DI 10.1111/j.1600-079X.2010.00758.x
PG 7
WC Endocrinology & Metabolism; Neurosciences; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Neurosciences & Neurology; Physiology
GA 581FQ
UT WOS:000276507400006
PM 20345745
DA 2024-02-19
ER

PT J
AU YAMAMOTO, N
   TANAKA, T
   NOGUCHI, T
AF YAMAMOTO, N
   TANAKA, T
   NOGUCHI, T
TI EFFECT OF CYSTEINE ON EXPRESSION OF CYSTATHIONINE BETA-SYNTHASE IN THE
   RAT-LIVER
SO JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY
LA English
DT Article
DE CYSTATHIONINE BETA-SYNTHASE; METHIONINE-SPARING EFFECT OF CYSTEINE; GENE
   EXPRESSION; RAT LIVER
ID METHIONINE METABOLISM; CYSTINE; MAMMALS; RNA
AB Hepatic cystathionine beta-synthase activity is decreased by the addition of cysteine to the diet. This effect of cysteine was slightly greater in diets containing 0.25% methionine than in those containing 1% methionine, and was reduced during aging. Similar changes were observed in the level of the mRNA of this enzyme, although the changes in the trancscript levels were slightly greater than the changes in enzyme activity. Thus, we conclude that the addition of cysteine to a methionine-containing diet causes a decrease in cystathionine beta-synthase activity mainly by diminishing its mRNA level.
C1 FUKUOKAJOGAKUIN JR COLL,KASUGA,FUKUOKA 816,JAPAN.
   OSAKA UNIV,SCH MED,DEPT NUTR & PHYSIOL CHEM,SUITA,OSAKA 565,JAPAN.
C3 Osaka University
CR CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   CRIM MC, 1994, MODERN NUTRITION HLT, P1
   FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9
   FINKELSTEIN JD, 1967, J BIOL CHEM, V242, P873
   FINKELSTEIN JD, 1986, J BIOL CHEM, V261, P1582
   FINKELSTEIN JD, 1986, J NUTR, V116, P985, DOI 10.1093/jn/116.6.985
   FINKELSTEIN JD, 1988, J BIOL CHEM, V263, P11750
   GORNALL AG, 1949, J BIOL CHEM, V177, P751
   HOTTA K, 1991, EUR J BIOCHEM, V202, P293, DOI 10.1111/j.1432-1033.1991.tb16375.x
   KASHIWAMATA S, 1970, BIOCHIM BIOPHYS ACTA, V212, P488, DOI 10.1016/0005-2744(70)90255-X
   MCDONOUGH FE, 1989, PLANT FOOD HUM NUTR, V39, P77, DOI 10.1007/BF01092404
   NAKAGAWA H, 1971, SEIKAGAKU, V43, P1
   NEWBERNE PM, 1969, CANCER RES, V29, P230
   RAO PB, 1959, J NUTR, V73, P38
   ROGERS QR, 1965, J NUTR, V87, P267, DOI 10.1093/jn/87.3.267
   Sambrook J., 1989, MOL CLONING LABORATO, V2nd
   SWAROOP M, 1992, J BIOL CHEM, V267, P11455
   TATEISHI N, 1982, J NUTR, V11, P2217
   WORMACK M, 1941, J BIOL CHEM, V141, P375
NR 19
TC 15
Z9 15
U1 0
U2 0
PU CENTER ACAD PUBL JAPAN
PI TOKYO
PA C/O BUSINESS CTR ACAD SOC JPN, HONKOMAGOME 5-16-9, BUNKYO-KU, TOKYO 113,
   JAPAN
SN 0301-4800
J9 J NUTR SCI VITAMINOL
JI J. Nutr. Sci. Vitaminol.
PD APR
PY 1995
VL 41
IS 2
BP 197
EP 205
PG 9
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA QZ023
UT WOS:A1995QZ02300004
PM 7562113
OA gold
DA 2024-02-19
ER

PT J
AU Mune, M
   Meydani, M
   JahngenHodge, J
   Martin, A
   Smith, D
   Palmer, V
   Blumberg, JB
   Taylor, A
AF Mune, M
   Meydani, M
   JahngenHodge, J
   Martin, A
   Smith, D
   Palmer, V
   Blumberg, JB
   Taylor, A
TI Effect of calorie restriction on liver and kidney glutathione in aging
   emory mice
SO AGE
LA English
DT Article
ID DIETARY RESTRICTION; GSH CONTENT; MOUSE; AGE; DISULFIDES; MEMBRANES;
   CATARACT
AB Increases in antioxidant defense capacity have been associated with increases in the health and life span of calorie restricted animals. Emery mice develop late-life cataract, a lesion associated with oxidative damage and loss of lens glutathione (GSH). The effect of calorie restriction on GSH in liver and kidney in this model has not been explored. GSH and oxidized GSH (GSSG) were measured by HPLC in liver and kidney of Emery mice fed a control diet (C; 85% calories of ad-lib fed mice) or 60% calorie intake of C (R; 40% calorie restriction relative to C mice) for up to 22 mo age. Liver GSH concentration increased significantly in C and R mice from 4.5 to 12 mo old with no difference observed between the two groups. At 22 mo of age, liver GSH was lower than that of 12 mo old in both groups. As compared with GSH at 12 mo old, this decrease was almost twice as greater in C (70%, p=0.001) than in R mice (36%, p=0.02), so that R mice had a significantly higher concentration of GSH in liver than C mice at 22 mo of age (R=32.8+/-5.1, C=22.1+/-8.3 imol GSH/g protein, p<0.01). Liver GSSG was similar in C and R mice at 12 mo of age (4.45+/-1.35 vs. 4.75+/-1.83 imol GSSG/g protein), but increased in R mice at 22 mo (R=5.43+/-1.48; C=3.22+/-1.02, p<0.01). Therefore, at 22 mo old, total liver glutathione (GSH+GSSG) was higher in R than in C mice. There was no significant difference in GSH, GSSG and total GSH in kidney from C and R mice at these ages. Thus, calorie restriction reduces the age-related loss of GSH antioxidant capacity in liver but not kidney of Emery mice.
C1 TUFTS UNIV,USDA,JEAN MAYER HUMAN NUTR RES CTR,BOSTON,MA 02111.
C3 Tufts University; United States Department of Agriculture (USDA)
RI Blumberg, Jeffrey/ABH-7888-2020
CR BEUTLER E, 1989, ANNU REV NUTR, V9, P287, DOI 10.1146/annurev.nu.09.070189.001443
   BRIGELIUS R, 1983, BIOCHEM PHARMACOL, V32, P2529, DOI 10.1016/0006-2952(83)90014-X
   CHENEY KE, 1983, J GERONTOL, V38, P420, DOI 10.1093/geronj/38.4.420
   FARISS MW, 1987, METHOD ENZYMOL, V143, P101
   FAVILLI F, 1994, NEUROBIOL AGING, V15, P429, DOI 10.1016/0197-4580(94)90074-4
   FURUKAWA T, 1987, MECH AGEING DEV, V38, P107, DOI 10.1016/0047-6374(87)90071-6
   GIBSON DD, 1985, LIPIDS, V20, P704, DOI 10.1007/BF02534391
   GONG X, 1995, INVEST OPHTH VIS SCI, V36, pS525
   HAZELTON GA, 1980, BIOCHEM J, V188, P25, DOI 10.1042/bj1880025
   IMANISHI H, 1985, MECH AGEING DEV, V32, P57, DOI 10.1016/0047-6374(85)90035-1
   JULIUS M, 1994, J CLIN EPIDEMIOL, V47, P1021, DOI 10.1016/0895-4356(94)90117-1
   KAMEI A, 1993, BIOL PHARM BULL, V16, P870
   KRETZSCHMAR M, 1993, SPORTS MED, V15, P196, DOI 10.2165/00007256-199315030-00005
   KUCK JFR, 1990, EXP EYE RES, V50, P659, DOI 10.1016/0014-4835(90)90110-G
   LAGANIERE S, 1989, MECH AGEING DEV, V48, P207, DOI 10.1016/0047-6374(89)90083-3
   LANG CA, 1992, J LAB CLIN MED, V120, P720
   Larsson A., 1983, Functions of glutathione: biochemical, physiological, toxicological, and clinical aspects
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MANNERVIK B, 1985, METHOD ENZYMOL, V113, P490
   MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431
   MURA CV, 1993, CURR EYE RES, V12, P1081, DOI 10.3109/02713689309033506
   NEAL RA, 1980, TOXICOLOGY BASIC SCI, P56
   RAO G, 1990, J NUTR, V120, P602, DOI 10.1093/jn/120.6.602
   REED DJ, 1986, BIOCHEM PHARMACOL, V35, P7, DOI 10.1016/0006-2952(86)90545-9
   RICHIE JP, 1994, FASEB J, V8, P1302, DOI 10.1096/fasebj.8.15.8001743
   STIO M, 1994, BIOCHEM CELL BIOL, V72, P58, DOI 10.1139/o94-010
   STOHS SJ, 1980, AGE, V3, P11, DOI 10.1007/BF02435000
   TAYLOR A, 1995, MECH AGEING DEV, V79, P33, DOI 10.1016/0047-6374(94)01541-S
   TAYLOR A, 1989, FASEB J, V3, P1741, DOI 10.1096/fasebj.3.6.2703107
   TAYLOR A, 1995, IN PRESS EXP EYE RES
   TAYLOR A, 1992, ANTIOXIDANTS CHEM PH, P349
   TERAMOTO S, 1992, COMP BIOCHEM PHYS A, V102, P693
   VOGT BL, 1993, BIOCHEM PHARMACOL, V46, P257, DOI 10.1016/0006-2952(93)90412-P
   WEINDRUCH R, 1986, J NUTR, V116, P641, DOI 10.1093/jn/116.4.641
   WINKLER BS, 1986, EXP EYE RES, V43, P829, DOI 10.1016/S0014-4835(86)80013-6
   YU BP, 1988, OXYGEN RADICALS BIOL, P1067
NR 36
TC 14
Z9 14
U1 0
U2 0
PU AMER AGING ASSOC
PI CHESTER
PA 2129 PROVIDENCE AVENUE, CHESTER, PA 19013
SN 0161-9152
J9 AGE
JI Age
PD APR
PY 1995
VL 18
IS 2
BP 43
EP 49
DI 10.1007/BF02432518
PG 7
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA TK929
UT WOS:A1995TK92900001
DA 2024-02-19
ER

PT J
AU Faingelernt, Y
   Nassar, R
   Ling, G
   Kodman, Y
   Feuerstein, T
   Yerushalmi, B
AF Faingelernt, Yaniv
   Nassar, Raouf
   Ling, Galina
   Kodman, Yona
   Feuerstein, Tamar
   Yerushalmi, Baruch
TI Early-life liver cirrhosis and variable clinical presentation in
   telomere disease
SO ACTA PAEDIATRICA
LA English
DT Article; Early Access
DE bone marrow failure; chronic recurrent multifocal osteomyelitis;
   hepatopulmonary syndrome; liver cirrhosis; telomere disease
ID HEPATOPULMONARY SYNDROME; TRANSPLANTATION
AB Aim Telomeres are DNA sequences of tandem TTAGGG repeats that protect chromosome ends from degradation and instability. Constitutional loss-of-function telomerase mutations result in rapid telomere shortening, premature senescence and cell death. Liver cirrhosis is rare and has only been reported in adults. We present five family members of Bedouin-Muslim origin, all of which carry the same mutation, and yet demonstrate an extremely variable phenotypical presentation, including liver cirrhosis during early childhood. Methods A multidisciplinary long-term follow-up of two healthy and three affected patients was analysed. The mutation (r.95G>C) was identified in all patients using Sanger sequencing. Telomere length samples were obtained and analysed. Results Clinical phenotypes were extremely variable, including age at first symptoms, organ involvement, disease severity and patient prognosis. The most prominent clinical phenotype is liver involvement, including end-stage liver disease early in life, which affects three members of the family. Affected patients had markedly shorter telomeres. Conclusion We describe an unusual presentation of early liver failure in telomere disease patients. Little, if any, is known about the association between the genotype and phenotype among children with telomere disease and whether the mutation we have described (r.95G>C) is predisposed to early severe hepatic involvement.
C1 [Faingelernt, Yaniv; Nassar, Raouf; Ling, Galina; Yerushalmi, Baruch] Soroka Univ Med Ctr, Paediat Gastroenterol Unit, Beer Sheva, Israel.
   [Faingelernt, Yaniv; Nassar, Raouf; Ling, Galina; Yerushalmi, Baruch] Ben Gurion Univ Negev, Fac Hlth Sci, Beer Sheva, Israel.
   [Kodman, Yona; Feuerstein, Tamar] Schneider Childrens Med Ctr Israel, Immune Phenotype Lab, Dept Haematol Oncol, Petah Tiqwa, Israel.
C3 Ben Gurion University; Soroka Medical Center; Ben Gurion University
RP Nassar, R (corresponding author), Soroka Univ Med Ctr, Paediat Gastroenterol Unit, Beer Sheva, Israel.
EM raouf.n@gmail.com
RI Faingelernt, Yaniv/HSG-4034-2023
OI Faingelernt, Yaniv/0000-0003-0121-7319; Nassar,
   Raouf/0000-0003-3942-8859
CR Aikata H, 2000, EXP CELL RES, V256, P578, DOI 10.1006/excr.2000.4862
   Calado RT, 2008, BLOOD, V111, P4446, DOI 10.1182/blood-2007-08-019729
   Calado RT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007926
   Callea M, 2022, GENES-BASEL, V13, DOI 10.3390/genes13030496
   Collopy LC, 2015, BLOOD, V126, P176, DOI 10.1182/blood-2015-03-633388
   Collopy LC, 2014, HAEMATOLOGICA, V99, DOI 10.3324/haematol.2014.105320
   de Leon AD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010680
   Dokal I, 1999, BRIT J HAEMATOL, V105, P11
   Gorgy AI, 2015, CHEST, V148, P1019, DOI 10.1378/chest.15-0825
   Kapuria D, 2019, HEPATOLOGY, V69, P2579, DOI 10.1002/hep.30578
   Kolb JM, 2020, HEPATOLOGY, V72, P356, DOI 10.1002/hep.31111
   Lebeer M, 2018, TRANSPLANTATION, V102, P1747, DOI 10.1097/TP.0000000000002198
   Mahansaria SS, 2015, J CLIN EXP HEPATOL, V5, P344, DOI 10.1016/j.jceh.2015.10.003
   Martínez P, 2017, J CELL BIOL, V216, P875, DOI 10.1083/jcb.201610111
   MULLER H. J., 1932, Proceedings. 6th Int. Congr. Genet., V1, P213
   Savage SA, 2010, GENET MED, V12, P753, DOI 10.1097/GIM.0b013e3181f415b5
   Townsley DM, 2016, NEW ENGL J MED, V374, P1922, DOI 10.1056/NEJMoa1515319
   Turner KJ, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8010073
   Valenti L, 2013, J HEPATOL, V58, P399, DOI 10.1016/j.jhep.2012.09.011
   Wallace DJ, 2010, NEW ENGL J MED, V362, P1150, DOI 10.1056/NEJMc1000801
NR 20
TC 1
Z9 1
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0803-5253
EI 1651-2227
J9 ACTA PAEDIATR
JI Acta Paediatr.
PD 2022 DEC
PY 2022
VL 111
IS 12
BP 2416
EP 2421
DI 10.1111/apa.16539
EA SEP 2022
PG 6
WC Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pediatrics
GA 6A2DO
UT WOS:000853008000001
PM 36070080
DA 2024-02-19
ER

PT J
AU Arora, AS
   Zafar, S
   Latif, U
   Llorens, F
   Mihm, S
   Kumar, P
   Tahir, W
   Thüne, K
   Shafiq, M
   Schmitz, M
   Zerr, I
AF Arora, Amandeep Singh
   Zafar, Saima
   Latif, Umair
   Llorens, Franc
   Mihm, Sabine
   Kumar, Prateek
   Tahir, Waqas
   Thuene, Katrin
   Shafiq, Mohsin
   Schmitz, Matthias
   Zerr, Inga
TI The role of cellular prion protein in lipid metabolism in the liver
SO PRION
LA English
DT Article
DE PrPC; liver; proteomics; ingenuity pathway analysis; non-alcoholic fatty
   liver disease
ID OXIDATIVE STRESS; AUTOPHAGIC FLUX; GENE-EXPRESSION; PRPC; STEATOSIS;
   DISEASE; PATHOPHYSIOLOGY; MITOCHONDRIA; APOPTOSIS; FIBROSIS
AB Cellular prion protein (PrPC) is a plasma membrane glycophosphatidylinositol-anchored protein and it is involved in multiple functions, including neuroprotection and oxidative stress. So far, most of the PrPC functional research is done in neuronal tissue or cell lines; the role of PrPC in non-neuronal tissues such as liver is only poorly understood. To characterize the role of PrPC in the liver, a proteomics approach was applied in the liver tissue of PrPC knockout mice. The proteome analysis and biochemical validations showed an excessive fat accumulation in the liver of PrPC knockout mice with a change in mRNA expression of genes linked to lipid metabolism. In addition, the higher Bax to Bcl2 ratio, up-regulation of tgfb1 mRNA expression in PrPC knockout mice liver, further showed the evidences of metabolic disease. Over-expression of PrPC in fatty acid-treated AML12 hepatic cell line caused a reduction in excessive intracellular fat accumulation; shows association of PrPC levels and lipid metabolism. Therefore, based on observation of excessive fat globules in the liver of ageing PrPC knockout mice and the reduction of fat accumulation in AML12 cell line with PrPC over-expression, the role of PrPC in lipid metabolism is described.
C1 [Arora, Amandeep Singh; Zafar, Saima; Llorens, Franc; Kumar, Prateek; Tahir, Waqas; Thuene, Katrin; Shafiq, Mohsin; Schmitz, Matthias; Zerr, Inga] Univ Med Ctr Gottingen, Clin Dementia Ctr, Dept Neurol, Robert Koch Str 40, D-37075 Gottingen, Germany.
   [Arora, Amandeep Singh; Zafar, Saima; Llorens, Franc; Kumar, Prateek; Tahir, Waqas; Thuene, Katrin; Shafiq, Mohsin; Schmitz, Matthias; Zerr, Inga] German Ctr Neurodegenerat Dis DZNE, Robert Koch Str 40, D-37075 Gottingen, Germany.
   [Latif, Umair; Mihm, Sabine] Univ Med Ctr Gottingen, Dept Gastroenterol Endocrinol, Gottingen, Germany.
   [Llorens, Franc] CIBERNED, Inst Carlos III, Network Ctr Biomed Res Neurodegenerat Dis, Hosp Llobregat, Madrid, Spain.
   [Kumar, Prateek] Indiana Univ Sch Med, Dept Neurol Surg, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA.
C3 University of Gottingen; Helmholtz Association; German Center for
   Neurodegenerative Diseases (DZNE); University of Gottingen; CIBERNED;
   Indiana University System; Indiana University Bloomington
RP Arora, AS (corresponding author), Univ Med Ctr Gottingen, Clin Dementia Ctr, Dept Neurol, Robert Koch Str 40, D-37075 Gottingen, Germany.; Arora, AS (corresponding author), German Ctr Neurodegenerat Dis DZNE, Robert Koch Str 40, D-37075 Gottingen, Germany.
EM amanbiochem83@gmail.com
RI Zafar, Saima/AAE-2799-2019; Zafar, Saima/GWZ-7001-2022; Shafiq,
   Mohsin/ISB-8110-2023; kumar, prateek/AHA-0283-2022
OI Zafar, Saima/0000-0002-4261-0339; Shafiq, Mohsin/0000-0002-4974-8955;
   kumar, prateek/0000-0001-5875-4065; Reis,
   AlessanRSS/0000-0001-8486-7469; Arora, Amandeep
   Singh/0000-0003-1045-1967
FU JPND -DEMTEST [01ED1201A]; PRIORITY [FP7-KBBE-2007-2A]; Robert Koch
   Institute [1369-341]
FX This work was supported by the JPND -DEMTEST [01ED1201A]; PRIORITY
   [FP7-KBBE-2007-2A]; Robert Koch Institute through funds [1369-341].
CR Abdelmegeed MA, 2011, J NUTR, V141, P603, DOI 10.3945/jn.110.135210
   ANNONI G, 1992, J HEPATOL, V14, P259, DOI 10.1016/0168-8278(92)90168-O
   Arora AS, 2015, ELECTROPHORESIS, V36, P3026, DOI 10.1002/elps.201500244
   Barbieri G, 2011, AUTOPHAGY, V7, P840, DOI 10.4161/auto.7.8.15615
   Braunersreuther V, 2012, WORLD J GASTROENTERO, V18, P727, DOI 10.3748/wjg.v18.i8.727
   BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0
   den Boer M, 2004, ARTERIOSCL THROM VAS, V24, P644, DOI 10.1161/01.ATV.0000116217.57583.6e
   Ford MJ, 2002, NEUROSCIENCE, V111, P533, DOI 10.1016/S0306-4522(01)00603-0
   Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899
   Haffar T, 2015, ENDOPLASMIC RETICULU, V2, P53, DOI 10.1515/ersc-2015-0004
   HORIUCHI M, 1995, J GEN VIROL, V76, P2583, DOI 10.1099/0022-1317-76-10-2583
   Ikeda K, 1998, AM J PATHOL, V153, P1695, DOI 10.1016/S0002-9440(10)65683-0
   Jalouli M, 2003, ENDOCRINOLOGY, V144, P101, DOI 10.1210/en.2002-220630
   Jeong JK, 2019, MOL CELL ENDOCRINOL, V481, P84, DOI 10.1016/j.mce.2018.11.013
   Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000
   Kohjima M, 2008, INT J MOL MED, V21, P507
   Kuhla A, 2011, J GERONTOL A-BIOL, V66, P1192, DOI 10.1093/gerona/glr124
   Kwanten WJ, 2014, WORLD J GASTROENTERO, V20, P7325, DOI 10.3748/wjg.v20.i23.7325
   Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007
   Moudjou M, 2001, J GEN VIROL, V82, P2017, DOI 10.1099/0022-1317-82-8-2017
   Nakamuta M, 2005, INT J MOL MED, V16, P631
   Nassir F, 2014, INT J MOL SCI, V15, P8713, DOI 10.3390/ijms15058713
   Norata GD, 2015, TRENDS PHARMACOL SCI, V36, P675, DOI 10.1016/j.tips.2015.07.001
   Oh JM, 2012, AUTOPHAGY, V8, P1448, DOI 10.4161/auto.21164
   Hernández-Cáceres MP, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00176
   Peralta OA, 2012, MOL REPROD DEV, V79, P488, DOI 10.1002/mrd.22057
   Ramljak S, 2008, J PROTEOME RES, V7, P2681, DOI 10.1021/pr7007187
   ROOS R, 1971, NEUROLOGY, V21, P397
   Savas MC, 2010, TRAK UNIV TIP FAK DE, V27, P373, DOI 10.5174/tutfd.2009.02284.1
   Song YM, 2012, AUTOPHAGY, V8, P1085, DOI 10.4161/auto.20260
   Stärkel P, 2003, J HEPATOL, V39, P538, DOI 10.1016/S0168-8278(03)00360-X
   Strable MS, 2010, CRIT REV BIOCHEM MOL, V45, P199, DOI 10.3109/10409231003667500
   TANAKA M, 1992, NEUROLOGY, V42, P1249, DOI 10.1212/WNL.42.6.1249
   Tu QQ, 2014, ACTA PHARMACOL SIN, V35, P504, DOI 10.1038/aps.2013.170
   Walsh MJ, 2004, HEPATOLOGY, V39, P1230, DOI 10.1002/hep.20179
   Wang K, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.499
   Wieckowska A, 2006, HEPATOLOGY, V44, P27, DOI 10.1002/hep.21223
   Yalcin EB, 2013, DRUG METAB DISPOS, V41, P1642, DOI 10.1124/dmd.113.050930
   Zafar S, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.384
NR 39
TC 2
Z9 2
U1 1
U2 7
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1933-6896
EI 1933-690X
J9 PRION
JI Prion
PD JAN 1
PY 2020
VL 14
IS 1
BP 95
EP 108
DI 10.1080/19336896.2020.1729074
PG 14
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA KS3JS
UT WOS:000518207300001
PM 32138593
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Chesnokova, V
   Zhou, CQ
   Ben-Shlomo, A
   Zonis, S
   Tani, Y
   Ren, SG
   Melmed, S
AF Chesnokova, Vera
   Zhou, Cuiqi
   Ben-Shlomo, Anat
   Zonis, Svetlana
   Tani, Yuji
   Ren, Song-Guang
   Melmed, Shlomo
TI Growth hormone is a cellular senescence target in pituitary and
   nonpituitary cells
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE pituitary hormone; acromegaly
ID GENE-EXPRESSION; THYROID-HORMONE; P53 PATHWAY; FACTOR I; PROLIFERATION;
   ADENOMAS; CANCER; ACTIVATION; MECHANISM; APOPTOSIS
AB Premature proliferative arrest in benign or early-stage tumors induced by oncoproteins, chromosomal instability, or DNA damage is associated with p53/p21 activation, culminating in either senescence or apoptosis, depending on cell context. Growth hormone (GH) elicits direct peripheral metabolic actions as well as growth effects mediated by insulin-like growth factor 1 (IGF1). Locally produced peripheral tissue GH, in contrast to circulating pituitary-derived endocrine GH, has been proposed to be both proapoptotic and prooncogenic. Pituitary adenomas expressing and secreting GH are invariably benign and exhibit DNA damage and a senescent phenotype. We therefore tested effects of nutlin-induced p53-mediated senescence in rat and human pituitary cells. We show that DNA damage senescence induced by nutlin triggers the p53/p21 senescent pathway, with subsequent marked induction of intracellular pituitary GH in vitro. In contrast, GH is not induced in cells devoid of p53. Furthermore we show that p53 binds specific GH promoter motifs and enhances GH transcription and secretion in senescent pituitary adenoma cells and also in nonpituitary (human breast and colon) cells. In vivo, treatment with nutlin results in up-regulation of both p53 and GH in the pituitary gland, as well as increased GH expression in nonpituitary tissues (lung and liver). Intracrine GH acts in pituitary cells as an apoptosis switch for p53-mediated senescence, likely protecting the pituitary adenoma from progression to malignancy. Unlike in the pituitary, in nonpituitary cells GH exerts antiapoptotic properties. Thus, the results show that GH is a direct p53 transcriptional target and fulfills criteria as a p53 target gene. Induced GH is a readily measurable cell marker for p53-mediated cellular senescence.
C1 [Chesnokova, Vera; Zhou, Cuiqi; Ben-Shlomo, Anat; Zonis, Svetlana; Tani, Yuji; Ren, Song-Guang; Melmed, Shlomo] Cedars Sinai Med Ctr, Dept Med, Pituitary Ctr, Los Angeles, CA 90048 USA.
C3 Cedars Sinai Medical Center
RP Melmed, S (corresponding author), Cedars Sinai Med Ctr, Dept Med, Pituitary Ctr, Los Angeles, CA 90048 USA.
EM melmed@csmc.edu
RI Ben-Shlomo, Anat/AAH-6009-2021; Chesnokova, Vera/AAI-4168-2020
FU National Institutes of Health [CA75979]; Doris Factor Molecular
   Endocrinology Laboratory
FX We thank Dr. Yunguang Tong for computer analysis of potential p53
   binding sites on rat GH promoter, and Dr. Kolja Wawrowsky for confocal
   imaging of pituitary tumors. This work was supported by National
   Institutes of Health Grant CA75979 (to S.M.) and the Doris Factor
   Molecular Endocrinology Laboratory.
CR Abbud RA, 2005, MOL ENDOCRINOL, V19, P1383, DOI 10.1210/me.2004-0403
   Arnold RE, 2004, NEUROIMMUNOMODULAT, V11, P149, DOI 10.1159/000076764
   BANDO H, 1992, ENDOCRINOL JAPON, V39, P355
   Barclay JL, 2010, MOL ENDOCRINOL, V24, P204, DOI 10.1210/me.2009-0233
   Bavik C, 2006, CANCER RES, V66, P794, DOI 10.1158/0008-5472.CAN-05-1716
   BRENT GA, 1989, J BIOL CHEM, V264, P178
   Brooks AJ, 2008, INT J BIOCHEM CELL B, V40, P1984, DOI 10.1016/j.biocel.2007.07.008
   Brooks AJ, 2010, NAT REV ENDOCRINOL, V6, P515, DOI 10.1038/nrendo.2010.123
   Brunet-Dunand SE, 2009, ENDOCRINOLOGY, V150, P1341, DOI 10.1210/en.2008-0608
   Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497
   Bustamante JJ, 2010, GROWTH HORM IGF RES, V20, P298, DOI 10.1016/j.ghir.2010.03.007
   Campisi J, 2005, SCIENCE, V309, P886, DOI 10.1126/science.1116801
   Cannata Dara, 2010, Adv Pediatr, V57, P331, DOI 10.1016/j.yapd.2010.09.003
   CarterSu C, 1996, ANNU REV PHYSIOL, V58, P187, DOI 10.1146/annurev.physiol.58.1.187
   Ceseña TI, 2007, MOL GENET METAB, V90, P126, DOI 10.1016/j.ymgme.2006.10.006
   Chesnokova V, 2008, P NATL ACAD SCI USA, V105, P17498, DOI 10.1073/pnas.0804810105
   Chesnokova V, 2007, CANCER RES, V67, P10564, DOI 10.1158/0008-5472.CAN-07-0974
   Chesnokova V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017924
   Clemmons DR, 2004, J CLIN INVEST, V113, P25, DOI 10.1172/JCI200420660
   COPP RP, 1989, MOL ENDOCRINOL, V3, P790, DOI 10.1210/mend-3-5-790
   Coppé JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009188
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Delbridge ARD, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008789
   DiGirolamo DJ, 2007, J BIOL CHEM, V282, P31666, DOI 10.1074/jbc.M705219200
   Donangelo I, 2006, ENDOCRINOLOGY, V147, P4781, DOI 10.1210/en.2006-0544
   Endo S, 2011, CANCER SCI, V102, P605, DOI 10.1111/j.1349-7006.2010.01821.x
   Farrell WE, 2006, ENDOCR-RELAT CANCER, V13, P707, DOI 10.1677/erc.1.01131
   Farrell WE, 2003, ENDOCR-RELAT CANCER, V10, P323, DOI 10.1677/erc.0.0100323
   FOX SR, 1990, MOL ENDOCRINOL, V4, P1069, DOI 10.1210/mend-4-7-1069
   Giustina A, 1998, ENDOCR REV, V19, P717, DOI 10.1210/er.19.6.717
   Giustina A, 2008, ENDOCR REV, V29, P535, DOI 10.1210/er.2007-0036
   Ho YG, 2011, MOL ENDOCRINOL, V25, P877, DOI 10.1210/me.2010-0411
   Khoury Marie P, 2011, Genes Cancer, V2, P453, DOI 10.1177/1947601911408893
   Kiseljak-Vassiliades K, 2012, ENDOCRINE, V42, P18, DOI 10.1007/s12020-012-9660-9
   Kleinberg D, 2008, J MAMMARY GLAND BIOL, V13, P353, DOI 10.1007/s10911-008-9103-7
   Kontogeorgos G, 2006, NEUROENDOCRINOLOGY, V83, P179, DOI 10.1159/000095526
   Kovacs K, 2001, J NEURO-ONCOL, V54, P121, DOI 10.1023/A:1012945129981
   Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698
   Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610
   Kulig E, 1999, AM J PATHOL, V154, P767, DOI 10.1016/S0002-9440(10)65323-0
   Kurz DJ, 2000, J CELL SCI, V113, P3613
   KYLE CV, 1981, J CLIN ENDOCR METAB, V53, P1138, DOI 10.1210/jcem-53-6-1138
   Levy A, 2003, FRONT NEUROENDOCRIN, V24, P94, DOI 10.1016/S0091-3022(03)00012-8
   List EO, 2011, ENDOCR REV, V32, P356, DOI 10.1210/er.2010-0009
   Liu Y, 2006, P NATL ACAD SCI USA, V103, P976, DOI 10.1073/pnas.0510146103
   Lobie PE, 1996, ENDOCRINOLOGY, V137, P4037, DOI 10.1210/en.137.9.4037
   Mazal PR, 2001, CLIN NEUROPATHOL, V20, P163
   Melmed S, 2003, J CLIN INVEST, V112, P1603, DOI 10.1172/JCI20401
   Melmed S, 2006, NEW ENGL J MED, V355, P2558, DOI 10.1056/NEJMra062453
   Melmed S, 2011, NAT REV ENDOCRINOL, V7, P257, DOI 10.1038/nrendo.2011.40
   Menendez D, 2009, NAT REV CANCER, V9, P724, DOI 10.1038/nrc2730
   Mukhina S, 2004, P NATL ACAD SCI USA, V101, P15166, DOI 10.1073/pnas.0405881101
   Nakonechnaya AO, 2013, J CELL BIOCHEM, V114, P1322, DOI 10.1002/jcb.24473
   Nyberg F, 2000, FRONT NEUROENDOCRIN, V21, P330, DOI 10.1006/frne.2000.0200
   Obari A, 2008, ENDOCR PATHOL, V19, P82, DOI 10.1007/s12022-008-9029-z
   Pan D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054006
   Perry JK, 2006, GROWTH HORM IGF RES, V16, P277, DOI 10.1016/j.ghir.2006.09.006
   Ruan WF, 1999, ENDOCRINOLOGY, V140, P5075, DOI 10.1210/en.140.11.5075
   Ruan WF, 1999, ENDOCRINOLOGY, V140, P1984, DOI 10.1210/en.140.5.1984
   Schaufele F, 1996, J BIOL CHEM, V271, P21484, DOI 10.1074/jbc.271.35.21484
   Scheithauer BW, 2006, NEUROSURGERY, V59, P341, DOI 10.1227/01.NEU.0000223437.51435.6E
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   Sharpless NE, 2004, J CLIN INVEST, V113, P160, DOI 10.1172/JCI200420761
   Suliman M, 2001, CLIN ENDOCRINOL, V54, P317, DOI 10.1046/j.1365-2265.2001.01195.x
   Svensson AL, 2008, P NATL ACAD SCI USA, V105, P7304, DOI 10.1073/pnas.0802531105
   Thapar K, 1996, NEUROSURGERY, V38, P765, DOI 10.1227/00006123-199604000-00027
   Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472
   VOJTESEK B, 1993, J CELL SCI, V105, P607
   Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037
   Waters MJ, 2004, P NATL ACAD SCI USA, V101, P14992, DOI 10.1073/pnas.0406396101
   Wierinckx A, 2007, ENDOCR-RELAT CANCER, V14, P887, DOI 10.1677/ERC-07-0062
   Wierinckx A, 2010, MOL CELL ENDOCRINOL, V326, P30, DOI 10.1016/j.mce.2010.02.043
   Xu XQ, 2005, J BIOL CHEM, V280, P23987, DOI 10.1074/jbc.M503869200
   YAMADA S, 1993, NEUROSURGERY, V33, P20
   Yu R, 2003, ENDOCRINOLOGY, V144, P4991, DOI 10.1210/en.2003-0305
   Zhao JT, 2011, J CLIN ENDOCR METAB, V96, pE1188, DOI 10.1210/jc.2010-2679
   Zhu T, 2005, CANCER RES, V65, P317
NR 77
TC 54
Z9 58
U1 0
U2 16
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD AUG 27
PY 2013
VL 110
IS 35
BP E3331
EP E3339
DI 10.1073/pnas.1310589110
PG 9
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 206ZC
UT WOS:000323564600012
PM 23940366
OA Bronze, Green Published
DA 2024-02-19
ER

PT J
AU Zhou, QS
   Zhang, FR
   Kerbl-Knapp, J
   Korbelius, M
   Kuentzel, KB
   Vujic, N
   Akhmetshina, A
   Hörl, G
   Paar, M
   Steyrer, E
   Kratky, D
   Madl, T
AF Zhou, Qishun
   Zhang, Fangrong
   Kerbl-Knapp, Jakob
   Korbelius, Melanie
   Kuentzel, Katharina Barbara
   Vujic, Nemanja
   Akhmetshina, Alena
   Hoerl, Gerd
   Paar, Margret
   Steyrer, Ernst
   Kratky, Dagmar
   Madl, Tobias
TI Phosphatidylethanolamine <i>N</i>-Methyltransferase Knockout Modulates
   Metabolic Changes in Aging Mice
SO BIOMOLECULES
LA English
DT Article
DE metabolomics; NMR; PEMT; knockout; aging; mice; liver; intestine; white;
   brown adipose tissue
ID WHITE ADIPOSE-TISSUE; DENSITY LIPOPROTEIN SECRETION; ATP PRODUCTION;
   PHOSPHATIDYLCHOLINE SYNTHESIS; PHOSPHOLIPID METHYLATION;
   LIPID-METABOLISM; CHOLINE; LIVER; PATHWAY; DIET
AB Phospholipid metabolism, including phosphatidylcholine (PC) biosynthesis, is crucial for various biological functions and is associated with longevity. Phosphatidylethanolamine N-methyltransferase (PEMT) is a protein that catalyzes the biosynthesis of PC, the levels of which change in various organs such as the brain and kidneys during aging. However, the role of PEMT for systemic PC supply is not fully understood. To address how PEMT affects aging-associated energy metabolism in tissues responsible for nutrient absorption, lipid storage, and energy consumption, we employed NMR-based metabolomics to study the liver, plasma, intestine (duodenum, jejunum, and ileum), brown/white adipose tissues (BAT and WAT), and skeletal muscle of young (9-10 weeks) and old (91-132 weeks) wild-type (WT) and PEMT knockout (KO) mice. We found that the effect of PEMT-knockout was tissue-specific and age-dependent. A deficiency of PEMT affected the metabolome of all tissues examined, among which the metabolome of BAT from both young and aged KO mice was dramatically changed in comparison to the WT mice, whereas the metabolome of the jejunum was only slightly affected. As for aging, the absence of PEMT increased the divergence of the metabolome during the aging of the liver, WAT, duodenum, and ileum and decreased the impact on skeletal muscle. Overall, our results suggest that PEMT plays a previously underexplored, critical role in both aging and energy metabolism.
C1 [Zhou, Qishun; Zhang, Fangrong; Kerbl-Knapp, Jakob; Madl, Tobias] Med Univ Graz, Gottfried Schatz Res Ctr Cell Signaling Metab & A, Div Mol Biol & Biochem, Res Unit Integrat Struct Biol, A-8010 Graz, Austria.
   [Zhang, Fangrong] Fujian Med Univ, Key Lab Gastrointestinal Canc, Minist Educ, Fuzhou 350122, Peoples R China.
   [Korbelius, Melanie; Kuentzel, Katharina Barbara; Vujic, Nemanja; Akhmetshina, Alena; Steyrer, Ernst; Kratky, Dagmar] Med Univ Graz, Gottfried Schatz Res Ctr Cell Signaling Metab & A, Mol Biol & Biochem, A-8010 Graz, Austria.
   [Hoerl, Gerd; Paar, Margret] Med Univ Graz, Otto Loewi Res Ctr, Div Med Chem, A-8010 Graz, Austria.
   [Kratky, Dagmar; Madl, Tobias] BioTechMed Graz, A-8010 Graz, Austria.
C3 Medical University of Graz; Fujian Medical University; Medical
   University of Graz; Medical University of Graz
RP Madl, T (corresponding author), Med Univ Graz, Gottfried Schatz Res Ctr Cell Signaling Metab & A, Div Mol Biol & Biochem, Res Unit Integrat Struct Biol, A-8010 Graz, Austria.; Madl, T (corresponding author), BioTechMed Graz, A-8010 Graz, Austria.
EM tobias.madl@medunigraz.at
RI Madl, Tobias/B-1682-2012; Kratky, Dagmar/ABF-5699-2021; Zhang,
   Fangrong/O-1599-2017
OI Madl, Tobias/0000-0002-9725-5231; Korbelius,
   Melanie/0000-0002-7609-9436; Paar, Margret/0000-0001-5494-8890; Zhou,
   Qishun/0000-0001-6181-0638; Vujic, Nemanja/0000-0003-2977-7799;
   Kuentzel, Katharina Barbara/0000-0002-1445-5466; Hoerl,
   Gerd/0000-0002-0884-0851; Zhang, Fangrong/0000-0002-8974-2902
FU Austrian Science Fund (FWF) [P28854, I3792, DOC-130, DK-MCD W1226];
   Austrian Research Promotion Agency (FFG) [864690, 870454]; Integrative
   Metabolism Research Center Graz; Austrian Infrastructure Program;
   Styrian Government (Zukunftsfonds, doc.fund program); BioTechMed-Graz
   (flagship project); FWF [DK-MCD W1226, SFB F73, P32400, P30882, DOC 31];
   Province of Styria; City of Graz [A27102000025]; Startup Fund for
   High-level Talents of Fujian Medical University [XRCZX2021020]; Natural
   Science Foundation of Fujian Province [2022J01660]
FX T.M. was supported by the Austrian Science Fund (FWF) grants P28854,
   I3792, DOC-130, and DK-MCD W1226; the Austrian Research Promotion Agency
   (FFG) grants 864690 and 870454; the Integrative Metabolism Research
   Center Graz; the Austrian Infrastructure Program 2016/2017; the Styrian
   Government (Zukunftsfonds, doc.fund program); and BioTechMed-Graz
   (flagship project). D.K. was supported by the FWF (SFB F73, DK-MCD
   W1226, P32400, P30882, DOC 31), the Province of Styria, and the City of
   Graz. G.H. was supported by the city of Graz (A27102000025). F.Z. was
   trained within the frame of the PhD program Molecular Medicine (MolMed),
   at the Medical University of Graz, and supported by the Startup Fund for
   High-level Talents of Fujian Medical University (XRCZX2021020) and
   Natural Science Foundation of Fujian Province (2022J01660), and Q.Z. and
   A.A. were trained within the frame of the PhD program Metabolic and
   Cardiovascular Disease (DK-MCD), Medical University of Graz.
CR Adav SS, 2021, AGING DIS, V12, P646, DOI 10.14336/AD.2020.0909
   Amelio I, 2014, TRENDS BIOCHEM SCI, V39, P191, DOI 10.1016/j.tibs.2014.02.004
   Antonsson B, 1997, BBA-LIPID LIPID MET, V1348, P179, DOI 10.1016/S0005-2760(97)00105-7
   Banoglu E, 2001, EUR J DRUG METAB PH, V26, P235, DOI 10.1007/BF03226377
   Boumann HA, 2003, BIOCHEMISTRY-US, V42, P3054, DOI 10.1021/bi026801r
   Braun F, 2016, AGING-US, V8, P441, DOI 10.18632/aging.100900
   Brosnan ME, 2020, J NUTR, V150, p2570S, DOI 10.1093/jn/nxaa079
   Chitraju C, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108348
   Chung KW, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10040880
   Cruzat V, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111564
   Cui LJ, 2019, PROTEIN CELL, V10, P921, DOI 10.1007/s13238-019-00661-1
   CUI Z, 1993, J BIOL CHEM, V268, P16655
   Dai YC, 2021, FRONT PHYSIOL, V12, DOI 10.3389/fphys.2021.775648
   DeLong CJ, 1999, J BIOL CHEM, V274, P29683, DOI 10.1074/jbc.274.42.29683
   DiLoreto R, 2015, MOL BIOL CELL, V26, P4524, DOI 10.1091/mbc.E14-06-1084
   Duncan RE, 2007, ANNU REV NUTR, V27, P79, DOI 10.1146/annurev.nutr.27.061406.093734
   FAELLI A, 1970, BIOCHEM PHARMACOL, V19, P2551, DOI 10.1016/0006-2952(70)90003-1
   Fagone P, 2013, BBA-MOL CELL BIOL L, V1831, P523, DOI 10.1016/j.bbalip.2012.09.009
   Fernández-Murray JP, 2005, J BIOL CHEM, V280, P38290, DOI 10.1074/jbc.M507700200
   Fink BD, 2017, AM J PHYSIOL-CELL PH, V313, pC146, DOI 10.1152/ajpcell.00086.2017
   Fushimi T, 2001, J NUTR, V131, P1973, DOI 10.1093/jn/131.7.1973
   Gao AW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02539-w
   Gao X, 2015, J LIPID RES, V56, P1701, DOI 10.1194/jlr.M059287
   Gao X, 2015, BBA-MOL CELL BIOL L, V1851, P152, DOI 10.1016/j.bbalip.2014.11.006
   GAYNOR PM, 1990, BIOCHIM BIOPHYS ACTA, V1045, P156, DOI 10.1016/0005-2760(90)90145-N
   Gibellini F, 2010, IUBMB LIFE, V62, P414, DOI 10.1002/iub.337
   Hörl G, 2011, J BIOL CHEM, V286, P17338, DOI 10.1074/jbc.M111.234534
   Hu HH, 2020, AGEING RES REV, V60, DOI 10.1016/j.arr.2020.101063
   Jacobs RL, 2010, J BIOL CHEM, V285, P22403, DOI 10.1074/jbc.M110.108514
   Johnson AA, 2019, AGING CELL, V18, DOI 10.1111/acel.13048
   Johnson JM, 2020, MOL METAB, V31, P55, DOI 10.1016/j.molmet.2019.10.007
   Jump DB, 2011, CURR OPIN CLIN NUTR, V14, P115, DOI 10.1097/MCO.0b013e328342991c
   Keogh MR, 2009, J BIOL CHEM, V284, P15439, DOI 10.1074/jbc.M109.005991
   Kim SH, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/2860642
   Koks S, 2016, MECH AGEING DEV, V160, P41, DOI 10.1016/j.mad.2016.10.001
   Krivoruchko A, 2015, METAB ENG, V28, P28, DOI 10.1016/j.ymben.2014.11.009
   Lawton KA, 2008, PHARMACOGENOMICS, V9, P383, DOI 10.2217/14622416.9.4.383
   Leong SC, 2016, TOXINS, V8, DOI 10.3390/toxins8120358
   Li J, 2020, EUR HEART J, V41, P2645, DOI 10.1093/eurheartj/ehaa209
   Li ZY, 2008, J LIPID RES, V49, P1187, DOI 10.1194/jlr.R700019-JLR200
   Li ZY, 2011, BBA-MOL CELL BIOL L, V1811, P278, DOI 10.1016/j.bbalip.2011.01.006
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Loria JP, 1999, J AM CHEM SOC, V121, P2331, DOI 10.1021/ja983961a
   Lu SC., 2020, LIVER RES, V4, P64, DOI DOI 10.1016/J.LIVRES.2020.05.003
   Luise D, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10050887
   Maltais-Payette I, 2018, NUTR METAB, V15, DOI 10.1186/s12986-018-0316-5
   Martínez-Reyes I, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13668-3
   Moaddel R, 2021, AGING CELL, V20, DOI 10.1111/acel.13325
   Moessinger C, 2014, BMC CELL BIOL, V15, DOI 10.1186/s12860-014-0043-3
   MORASH SC, 1988, BIOCHIM BIOPHYS ACTA, V961, P194, DOI 10.1016/0005-2760(88)90114-2
   Mutlu AS, 2021, DEV CELL, V56, P1394, DOI 10.1016/j.devcel.2021.03.034
   Nakatsuka A, 2016, SCI REP-UK, V6, DOI 10.1038/srep21721
   Nilsson Å, 2019, AM J PHYSIOL-GASTR L, V316, pG425, DOI 10.1152/ajpgi.00320.2018
   Noga AA, 2002, J BIOL CHEM, V277, P42358, DOI 10.1074/jbc.M204542200
   Pang ZQ, 2021, NUCLEIC ACIDS RES, V49, pW388, DOI 10.1093/nar/gkab382
   Papaconstantinou J, 2009, MOL CELL ENDOCRINOL, V299, P89, DOI 10.1016/j.mce.2008.11.025
   Park S, 2021, MECH AGEING DEV, V197, DOI 10.1016/j.mad.2021.111498
   PARTHASARATHY S, 1974, BIOCHEMISTRY-US, V140, P503, DOI 10.1042/bj1400503
   Pietzke M, 2020, MOL METAB, V33, P23, DOI 10.1016/j.molmet.2019.05.012
   de Almeida AJPO, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/7941563
   Preston J., 2021, MEDICINE, V49, P1, DOI [10.1016/J.MPMED.2020.10.011, DOI 10.1016/J.MPMED.2020.10.011, 10.1016/j.mpmed.2020.10.011]
   Reo NV, 2002, BBA-MOL CELL BIOL L, V1580, P171, DOI 10.1016/S1388-1981(01)00202-5
   Rockenfeller P, 2015, CELL DEATH DIFFER, V22, P499, DOI 10.1038/cdd.2014.219
   Saito RD, 2022, FRONT IMMUNOL, V13, DOI 10.3389/fimmu.2022.768606
   Santos GM, 2015, BBA-GEN SUBJECTS, V1850, P691, DOI 10.1016/j.bbagen.2015.01.002
   Serviddio G, 2008, GUT, V57, P957, DOI 10.1136/gut.2007.147496
   Shi YG, 2009, AM J PHYSIOL-ENDOC M, V297, pE10, DOI 10.1152/ajpendo.90949.2008
   SHIAO YJ, 1995, BIOCHEM J, V310, P673, DOI 10.1042/bj3100673
   Shinde AB, 2021, FRONT ENDOCRINOL, V12, DOI 10.3389/fendo.2021.651763
   Skotland T, 2020, CANCER METAST REV, V39, P343, DOI 10.1007/s10555-020-09872-z
   Soares Furtado VC, 2007, APMIS, V115, P814, DOI 10.1111/j.1600-0463.2007.apm_718.x
   Song JN, 2005, FASEB J, V19, P1266, DOI 10.1096/fj.04-3580com
   Sonkar K, 2019, NMR BIOMED, V32, DOI 10.1002/nbm.4112
   Staels B, 2009, DIABETES CARE, V32, pS237, DOI 10.2337/dc09-S355
   Stegeman R, 2017, J MOL BIOL, V429, P2427, DOI 10.1016/j.jmb.2017.06.019
   Stryeck S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42937-w
   Stryeck S, 2017, MICROB CELL, V4, P240, DOI 10.15698/mic2017.08.584
   Sun WF, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2116125118
   Sun XJ, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00548
   Tanaka T, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-287
   Tarasov AI, 2012, CELL CALCIUM, V52, P28, DOI 10.1016/j.ceca.2012.03.003
   Trayhurn P, 2001, P NUTR SOC, V60, P329, DOI 10.1079/PNS200194
   Tretter L, 2016, BBA-BIOENERGETICS, V1857, P1086, DOI 10.1016/j.bbabio.2016.03.012
   van der Veen JN, 2019, FASEB J, V33, P5045, DOI 10.1096/fj.201802117R
   van der Veen JN, 2017, BBA-BIOMEMBRANES, V1859, P1558, DOI 10.1016/j.bbamem.2017.04.006
   van der Veen JN, 2014, DIABETES, V63, P2620, DOI 10.2337/db13-0993
   van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330
   Vance DE, 1997, BBA-LIPID LIPID MET, V1348, P142, DOI 10.1016/S0005-2760(97)00108-2
   Vance DE, 2014, BBA-BIOMEMBRANES, V1838, P1477, DOI 10.1016/j.bbamem.2013.10.018
   Vance DE, 2013, BBA-MOL CELL BIOL L, V1831, P626, DOI 10.1016/j.bbalip.2012.07.017
   Vance JE, 2015, TRAFFIC, V16, P1, DOI 10.1111/tra.12230
   Vandamme TF, 2014, J PHARM BIOALLIED SC, V6, P2, DOI 10.4103/0975-7406.124301
   Verkade HJ, 2007, J LIPID RES, V48, P2058, DOI 10.1194/jlr.M700278-JLR200
   Verkerke ARP, 2019, NAT METAB, V1, P876, DOI 10.1038/s42255-019-0111-2
   Vignoli A, 2019, ANGEW CHEM INT EDIT, V58, P968, DOI 10.1002/anie.201804736
   Voshol PJ, 2000, GASTROENTEROLOGY, V118, P173, DOI 10.1016/S0016-5085(00)70426-4
   Walkey CJ, 1997, P NATL ACAD SCI USA, V94, P12880, DOI 10.1073/pnas.94.24.12880
   Wan S, 2019, FASEB J, V33, P10986, DOI 10.1096/fj.201900679R
   Watanabe M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092647
   Watkins SM, 2003, J NUTR, V133, P3386, DOI 10.1093/jn/133.11.3386
   Xia JG, 2010, NUCLEIC ACIDS RES, V38, pW71, DOI 10.1093/nar/gkq329
   Yang YB, 2018, J BIOL CHEM, V293, P6230, DOI 10.1074/jbc.R117.000582
   YAO ZM, 1988, J BIOL CHEM, V263, P2998
   YAO ZM, 1989, J BIOL CHEM, V264, P11373
   Yu JH, 2015, BBA-MOL CELL RES, V1853, P918, DOI 10.1016/j.bbamcr.2015.01.020
   Zampino M, 2020, NUTRIENTS, V12, DOI 10.3390/nu12103061
   Zhang FR, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11020235
   Zhao Y, 2009, ARTERIOSCL THROM VAS, V29, P1349, DOI 10.1161/ATVBAHA.109.188672
   Zhou J, 2018, BRIT J NUTR, V120, P241, DOI 10.1017/S0007114518001101
   Zhou QS, 2022, METABOLITES, V12, DOI 10.3390/metabo12010017
   Zhu XN, 2003, BIOCHEM J, V370, P987, DOI 10.1042/BJ20021523
NR 111
TC 2
Z9 2
U1 4
U2 12
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2218-273X
J9 BIOMOLECULES
JI Biomolecules
PD SEP
PY 2022
VL 12
IS 9
AR 1270
DI 10.3390/biom12091270
PG 27
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 4T5SD
UT WOS:000858175800001
PM 36139111
OA Green Submitted, gold, Green Published
DA 2024-02-19
ER

PT J
AU LOPEZTORRES, M
   PEREZCAMPO, R
   ROJAS, C
   CADENAS, S
   BARJA, G
AF LOPEZTORRES, M
   PEREZCAMPO, R
   ROJAS, C
   CADENAS, S
   BARJA, G
TI SIMULTANEOUS INDUCTION OF SOD, GLUTATHIONE-REDUCTASE, GSH, AND ASCORBATE
   IN LIVER AND KIDNEY CORRELATES WITH SURVIVAL DURING AGING
SO FREE RADICAL BIOLOGY AND MEDICINE
LA English
DT Article
DE SUPEROXIDE DISMUTASE; CATALASE; GLUTATHIONE REDUCTASE; GSH; ASCORBATE;
   AGING; FREE RADICALS; LIFE SPAN
ID PERFORMANCE LIQUID-CHROMATOGRAPHY; INDUCED LIPID-PEROXIDATION;
   AGE-RELATED-CHANGES; SUPEROXIDE-DISMUTASE; ANTIOXIDANT ENZYMES;
   RAT-LIVER; INORGANIC PEROXIDES; OXYGEN-CONSUMPTION; FOOD RESTRICTION;
   OXIDATIVE STRESS
AB Catalase was continuously inhibited with aminotriazole in the liver and kidney during 33 months in large populations of old and young frogs in order to study the effects of the modification of the tissue antioxidant/prooxidant balance on the life span of a vertebrate species showing an oxygen consumption rate similar to that of humans. Free-radical-related parameters were measured during three consecutive years at 2.5, 14.5, and 26.5 months of experimentation. Aging per se did not decrease antioxidant enzymes and did not increase peroxidation (thiobarbituric acid positive substances, or high-pressure liquid chromatography [HPLC]-malondialdehyde), either cross sectionally or longitudinally. Long-term catalase inhibition leads to time-dependent increases (100-900%) of endogenous superoxide dismutase, GSH, ascorbate, and especially glutathione reductase at 2.5 and 14.5 months of experimentation. This was positively correlated with a higher survival of treated animals (91% in treated versus 46% in controls at 14.5 months of experimentation). The loss of those inductions after 26.5 months leads to a sharp increase in mortality rate. The results show for the first time that simultaneous induction of various tissue antioxidant enzymes and nonenzymatic antioxidants can increase the mean life span of a vertebrate animal. It is concluded that the tissue antioxidant/prooxidant balance is a strong determinant of mean life span.
C1 UNIV COMPLUTENSE MADRID, FAC BIOL, DEPT ANIM BIOL ANIM PHYSIOL 2, E-28040 MADRID, SPAIN.
C3 Complutense University of Madrid
RI Gustavo, Barja/B-5591-2012; Barja, Gustavo/AAA-5903-2019; Cadenas,
   Susana/D-1523-2016
OI Barja, Gustavo/0000-0001-5736-4735; Cadenas, Susana/0000-0003-0726-0369
CR ALLEN RG, 1983, BIOCHEM J, V216, P503, DOI 10.1042/bj2160503
   ANSARI KA, 1989, GROWTH DEVELOP AGING, V53, P117
   BEERS RF, 1952, J BIOL CHEM, V195, P133
   BORDONI A, 1988, BIOCHEM INT, V17, P1001
   BULL AW, 1985, ANAL BIOCHEM, V149, P284, DOI 10.1016/0003-2697(85)90506-8
   CARRILLO MC, 1989, MECH AGEING DEV, V47, P1, DOI 10.1016/0047-6374(89)90002-X
   COMSTOCK GW, 1991, AM J CLIN NUTR, V53, pS260, DOI 10.1093/ajcn/53.1.260S
   Cutler R., 1984, Free Radicals in Biology, V6, P371
   DEQUIROGA GB, 1989, COMP BIOCHEM PHYS C, V94, P391, DOI 10.1016/0742-8413(89)90087-X
   DEQUIROGA GB, 1991, ANAL BIOCHEM, V199, P81
   DEQUIROGA GB, 1990, BIOCHEM J, V272, P247
   DEVASAGAYAM TPA, 1986, MECH AGEING DEV, V34, P13, DOI 10.1016/0047-6374(86)90101-6
   DEVASAGAYAM TPA, 1986, FEBS LETT, V205, P246, DOI 10.1016/0014-5793(86)80906-1
   ESTERBAUER H, 1984, METHOD ENZYMOL, V105, P319
   GEY KF, 1990, BIOCHEM SOC T, V18, P1041, DOI 10.1042/bst0181041
   GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   KOIZUMI A, 1987, J NUTR, V117, P361, DOI 10.1093/jn/117.2.361
   KUROBE N, 1990, BIOMED RES-TOKYO, V11, P187, DOI 10.2220/biomedres.11.187
   LAGANIERE S, 1989, MECH AGEING DEV, V48, P221, DOI 10.1016/0047-6374(89)90084-5
   LAMMIKEEFE CJ, 1984, GERONTOLOGY, V30, P153, DOI 10.1159/000212623
   LAWRENCE RA, 1976, BIOCHEM BIOPH RES CO, V71, P952, DOI 10.1016/0006-291X(76)90747-6
   LOPEZTORRES M, 1990, PHARMACOL TOXICOL, V66, P27, DOI 10.1111/j.1600-0773.1990.tb00696.x
   LOPEZTORRES M, 1991, J COMP PHYSIOL B, V160, P655, DOI 10.1007/BF00571264
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MASORO EJ, 1991, ANN NY ACAD SCI, V621, P337
   MASSEY V, 1965, J BIOL CHEM, V240, P4470
   MUNKRES KD, 1990, FREE RADICAL BIO MED, V9, P23, DOI 10.1016/0891-5849(90)90046-L
   PAGLIA DE, 1967, J LAB CLIN MED, V276, P368
   PAOLETTI F, 1986, ANAL BIOCHEM, V154, P536, DOI 10.1016/0003-2697(86)90026-6
   RIKANS LE, 1988, BIOCHIM BIOPHYS ACTA, V966, P269, DOI 10.1016/0304-4165(88)90076-1
   RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632
   SMITH L, 1955, Methods Biochem Anal, V2, P427, DOI 10.1002/9780470110188.ch13
   SOHAL RS, 1990, FREE RADICAL BIO MED, V9, P495, DOI 10.1016/0891-5849(90)90127-5
   SOHAL RS, 1984, MECH AGEING DEV, V24, P175, DOI 10.1016/0047-6374(84)90069-1
   STORZ G, 1990, SCIENCE, V248, P189, DOI 10.1126/science.2183352
   TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5
   VATASSERY GT, 1984, J NEUROCHEM, V43, P409, DOI 10.1111/j.1471-4159.1984.tb00916.x
NR 38
TC 79
Z9 83
U1 0
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0891-5849
EI 1873-4596
J9 FREE RADICAL BIO MED
JI Free Radic. Biol. Med.
PD AUG
PY 1993
VL 15
IS 2
BP 133
EP 142
DI 10.1016/0891-5849(93)90052-V
PG 10
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA LP109
UT WOS:A1993LP10900003
PM 8375690
DA 2024-02-19
ER

PT J
AU Lambert, AJ
   Portero-Otin, M
   Pamplona, R
   Merry, BJ
AF Lambert, AJ
   Portero-Otin, M
   Pamplona, R
   Merry, BJ
TI Effect of ageing and caloric restriction on specific markers of protein
   oxidative damage and membrane peroxidizability in rat liver mitochondria
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE glutamic semialdehyde; aminoadipic semialdehyde;
   N-epsilon-(carboxyethyl)lysine; N-epsilon-(carboxymethyl)lysine;
   N-epsilon-(malondialdehyde)lysine; polyunsaturated fatty acids; free
   radicals
ID FREE-RADICAL GENERATION; FATTY-ACID UNSATURATION; MAXIMUM LIFE-SPAN;
   DIETARY RESTRICTION; DNA-DAMAGE; LIPID-PEROXIDATION; AGE; ACCUMULATION;
   INCREASES; CARBONYLS
AB To gain insight into the anti-ageing mechanisms of caloric restriction (CR), liver mitochondria were isolated from male Brown-Norway rats of different ages (fully fed control and CR) and various specific markers of non-enzymatic protein modification (by oxidative, glyco- and lipoxidative-reactions) were measured by GC/MS and Western blotting. A membrane peroxidizability index (PI) was calculated from the fatty acid profiles. Between 6 and 18 months of age, there were significant decreases in the concentration of all markers of damage in mitochondria from both the fully fed and CR groups. In contrast, between the ages of 18 and 28 months, there were significant increases in the concentrations of all markers of damage. In mitochondria from both fully fed and CR groups, there were significant increases in N-epsilon (N-epsilon)-(carboxymethyl)lysine (CML) and N-epsilon-(malondialdehyde)lysine (MDAL) between 6 and 28 months of age. In general, damage tended to be lower in mitochondria from CR animals, but the effects were not significant, except for the concentration of N-epsilon-(carboxymethyl)lysine at 28 months of age. PI increased steadily and significantly with age in fully fed animals, whilst CR induced a significant decrease in this index at 28 months of age. It is concluded that for male rats of the Brown-Norway strain, and mitochondria from liver (i) old (but not mature) age is associated with an increased membrane PI and protein oxidative damage and (ii) CR does not lead to a general reversion in age-related protein damage, but it does prevent the age-induced increase in PI very late in life. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
C1 Univ Liverpool, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England.
   Univ Lleida, Fac Med, Dept Basic Med Sci, Metab Physiopathol Res Grp, Lleida 25198, Spain.
C3 University of Liverpool; Universitat de Lleida
RP Lambert, AJ (corresponding author), MRC, Dunn Human Nutr Unit, Hills Rd, Cambridge CB2 2XY, England.
EM adrian.lambert@mrc-dunn.cam.ac.uk
RI Portero-Otin, Manuel/B-7122-2009; Pamplona, Reinald/A-7359-2010
OI Portero-Otin, Manuel/0000-0002-1823-0299; Pamplona,
   Reinald/0000-0003-4337-6107
CR Ahmed MU, 1997, BIOCHEM J, V324, P565, DOI 10.1042/bj3240565
   Bakala H, 2003, EUR J BIOCHEM, V270, P2295, DOI 10.1046/j.1432-1033.2003.03598.x
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   Bejma J, 2000, ACTA PHYSIOL SCAND, V169, P343
   BIELSKI BHJ, 1983, J BIOL CHEM, V258, P4759
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8
   CHUNG MH, 1992, FREE RADICAL BIO MED, V12, P523, DOI 10.1016/0891-5849(92)90105-P
   CLEJAN S, 1986, LIPIDS, V21, P677, DOI 10.1007/BF02537240
   COSGROVE JP, 1987, LIPIDS, V22, P299, DOI 10.1007/BF02533996
   Davies SMK, 2001, FREE RADICAL BIO MED, V31, P181, DOI 10.1016/S0891-5849(01)00576-7
   Dubey A, 1996, ARCH BIOCHEM BIOPHYS, V333, P189, DOI 10.1006/abbi.1996.0380
   Gredilla R, 2001, FASEB J, V15, P1589, DOI 10.1096/fj.00-0764fje
   Gredilla R, 2001, J BIOENERG BIOMEMBR, V33, P279, DOI 10.1023/A:1010603206190
   HALEYZITLIN V, 1993, MUTAT RES, V295, P237, DOI 10.1016/0921-8734(93)90023-V
   Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341
   Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698
   Judge S, 2004, AM J PHYSIOL-REG I, V286, pR254, DOI 10.1152/ajpregu.00502.2003
   Kaneko T, 1997, FREE RADICAL BIO MED, V23, P76, DOI 10.1016/S0891-5849(96)00622-3
   KNECHT KJ, 1991, DIABETES, V40, P190, DOI 10.2337/diabetes.40.2.190
   KOIZUMI A, 1987, J NUTR, V117, P361, DOI 10.1093/jn/117.2.361
   LAGANIERE S, 1987, BIOCHEM BIOPH RES CO, V145, P1185, DOI 10.1016/0006-291X(87)91562-2
   LAGANIERE S, 1993, GERONTOLOGY, V39, P7, DOI 10.1159/000213509
   Lambert AJ, 2004, EXP GERONTOL, V39, P289, DOI 10.1016/j.exger.2003.12.009
   Lambert AJ, 2004, AM J PHYSIOL-REG I, V286, pR71, DOI 10.1152/ajpregu.00341.2003
   LEON TI, 2001, LIPIDS, V36, P589
   López-Torres M, 2002, FREE RADICAL BIO MED, V32, P882, DOI 10.1016/S0891-5849(02)00773-6
   Nagai M, 2000, BIOGERONTOLOGY, V1, P321, DOI 10.1023/A:1026590819033
   Pamplona R, 2002, MECH AGEING DEV, V123, P1437, DOI 10.1016/S0047-6374(02)00076-3
   Pamplona R, 1996, MECH AGEING DEV, V86, P53, DOI 10.1016/0047-6374(95)01673-2
   Pamplona R, 2002, FREE RADICAL RES, V36, P47, DOI 10.1080/10715760210165
   Pamplona R, 1998, J LIPID RES, V39, P1989
   PARADIES G, 1991, ARCH BIOCHEM BIOPHYS, V284, P332, DOI 10.1016/0003-9861(91)90304-2
   Pedersen P L, 1978, Methods Cell Biol, V20, P411, DOI 10.1016/S0091-679X(08)62030-0
   Pleshakova OV, 1998, MECH AGEING DEV, V103, P45, DOI 10.1016/S0047-6374(98)00012-8
   Porter RK, 1996, AM J PHYSIOL-REG I, V271, pR1550, DOI 10.1152/ajpregu.1996.271.6.R1550
   Portero-Otín M, 1999, DIABETES, V48, P2215, DOI 10.2337/diabetes.48.11.2215
   Portero-Otín M, 2001, LIPIDS, V36, P491, DOI 10.1007/s11745-001-0748-y
   Qu B, 2000, FEBS LETT, V473, P85, DOI 10.1016/S0014-5793(00)01506-4
   RAEDERSTORFF D, 1991, LIPIDS, V26, P781, DOI 10.1007/BF02536158
   Requena JR, 1997, BIOCHEM J, V322, P317, DOI 10.1042/bj3220317
   Requena JR, 2001, P NATL ACAD SCI USA, V98, P69, DOI 10.1073/pnas.011526698
   Sell DR, 2003, J GERONTOL A-BIOL, V58, P508
   SOHAL RS, 1994, MECH AGEING DEV, V74, P121, DOI 10.1016/0047-6374(94)90104-X
   Sohal RS, 2002, FREE RADICAL BIO MED, V33, P575, DOI 10.1016/S0891-5849(02)00886-9
   STARKEREED PE, 1989, ARCH BIOCHEM BIOPHYS, V275, P559, DOI 10.1016/0003-9861(89)90402-5
   Thorpe SR, 2003, AMINO ACIDS, V25, P275, DOI 10.1007/s00726-003-0017-9
   Vittorini S, 1999, J GERONTOL A-BIOL, V54, pB318, DOI 10.1093/gerona/54.8.B318
   Weindruch R. H., 1988, RETARDATION AGEING D
   Wilson P D, 1975, Adv Exp Med Biol, V53, P171
   YOUNGMAN LD, 1992, P NATL ACAD SCI USA, V89, P9112, DOI 10.1073/pnas.89.19.9112
   Yu BP, 2002, J NUTR SCI VITAMINOL, V48, P257, DOI 10.3177/jnsv.48.257
NR 52
TC 59
Z9 67
U1 1
U2 10
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
EI 1872-6216
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD AUG
PY 2004
VL 125
IS 8
BP 529
EP 538
DI 10.1016/j.mad.2004.06.002
PG 10
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 855ZM
UT WOS:000224013400002
PM 15336910
DA 2024-02-19
ER

PT J
AU Li, Q
   Wu, S
   Li, SY
   Lopez, FL
   Du, M
   Kajstura, J
   Anversa, P
   Ren, J
AF Li, Qun
   Wu, Shan
   Li, Shi-Yan
   Lopez, Faye L.
   Du, Min
   Kajstura, Jan
   Anversa, Piero
   Ren, Jun
TI Cardiac-specific overexpression of insulin-like growth factor 1
   attenuates aging-associated cardiac diastolic contractile dysfunction
   and protein damage
SO AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
LA English
DT Article; Proceedings Paper
CT 15th World Congress of Pharmacology
CY JUL 02-07, 2006
CL Beijing, PEOPLES R CHINA
DE cardiomyocytes; contractile function; calcium regulatory protein;
   senescence
ID GROWTH-FACTOR-I; VENTRICULAR MYOCYTES; RETICULUM CA2+-ATPASE; OXIDATIVE
   STRESS; PHOSPHOLAMBAN; HORMONE; HEART
AB Aging is associated with hepatic growth hormone resistance resulting in a fall in serum insulin-like growth factor 1 (IGF-1) level. However, whether loss of IGF-1 contributes to cardiac aging is unclear. This study was designed to examine the effect of cardiac overexpression of IGF-1 on cardiomyocyte contractile function in young (3 mo) and old (26-28 mo) mice. Cardiomyocyte contractile function was evaluated, including peak shortening (PS), time to 90% PS, time to 90% relengthening (TR90), and maximal velocity of shortening/relengthening (+/- dL/dt). Levels of advanced glycation end product, protein carbonyl, sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA2a), phospholamban, and Na+/Ca2+ exchanger were assessed by Western blot analysis. SERCA activity was measured by Ca-45(2+) uptake. Aging induced a decline in plasma IGF-1 levels. Aged cells exhibited depressed +/- dL/dt, prolonged TR90, and a steeper PS decline in response to increasing stimulus frequency compared with those in young myocytes. IGF-1 transgene alleviated aging-induced loss in plasma IGF-1 and aging-induced mechanical defects with little effect in young mice. The beneficial effect of IGF-1 transgene on aging-associated cardiomyocyte contractile dysfunction was somewhat mimicked by short-term in vitro treatment of recombinant IGF-1 (500 nM). Advanced glycation end product and protein carbonyl levels were higher in aged mice, which were not affected by IGF-1. Expression of SERCA2a (but not Na+/Ca2+ exchanger and phospholamban) and SERCA activity were reduced with aging, which was ablated by the IGF-1 transgene. Collectively, our data suggest a beneficial role of IGF-1 in aging-induced cardiac contractile dysfunction, possibly related to improved Ca2+ uptake.
C1 Univ Wyoming, Div Pharmaceut Sci, Laramie, WY 82071 USA.
   Univ Wyoming, Ctr Cardiovac Res & Alternat Med, Laramie, WY 82071 USA.
   Univ Wyoming, Dept Anim Sci, Laramie, WY 82071 USA.
   New York Med Coll, Dept Med, Valhalla, NY 10595 USA.
C3 University of Wyoming; University of Wyoming; University of Wyoming; New
   York Medical College
RP Ren, J (corresponding author), Univ Wyoming, Div Pharmaceut Sci, POB 3375, Laramie, WY 82071 USA.
EM jren@uwyo.edu
RI Du, Min/H-4311-2011; Ren, Jun/ACG-5366-2022; Wu, Shan/GRX-6905-2022;
   Norby, Faye/S-3729-2017
OI Du, Min/0000-0002-7232-072X; Ren, Jun/0000-0002-0275-0783; Norby,
   Faye/0000-0002-1975-0405
FU NIAAA NIH HHS [1 R15-AA-13575-01] Funding Source: Medline; NIA NIH HHS
   [1 R03-AG-21324-01] Funding Source: Medline
CR Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a
   Delafontaine P, 2000, ANN ENDOCRINOL-PARIS, V61, P22
   Duan JH, 2002, AM J PHYSIOL-HEART C, V282, pH1216, DOI 10.1152/ajpheart.00780.2001
   FLEG JL, 1995, JAMA-J AM MED ASSOC, V273, P1371, DOI 10.1001/jama.273.17.1371
   HOVEMADSEN L, 1993, CIRC RES, V73, P820, DOI 10.1161/01.RES.73.5.820
   Huke S, 2004, J MOL CELL CARDIOL, V37, P795, DOI 10.1016/j.yjmcc.2004.06.003
   Kajstura J, 2001, DIABETES, V50, P1414, DOI 10.2337/diabetes.50.6.1414
   Kass DA, 2001, CIRCULATION, V104, P1464, DOI 10.1161/hc3801.097806
   Lakatta EG, 2000, CLIN GERIATR MED, V16, P419, DOI 10.1016/S0749-0690(05)70021-5
   Lakatta EG, 1999, J AM GERIATR SOC, V47, P613, DOI 10.1111/j.1532-5415.1999.tb02579.x
   LAKATTA EG, 1987, J AM COLL CARDIOL, V10, P42
   Li L, 1998, AM J PHYSIOL-HEART C, V274, pH1335, DOI 10.1152/ajpheart.1998.274.4.H1335
   Li SY, 2006, DIABETOLOGIA, V49, P1434, DOI 10.1007/s00125-006-0229-0
   Li SY, 2005, J ENDOCRINOL, V186, P491, DOI 10.1677/joe.1.06168
   Li SY, 2004, J BIOL CHEM, V279, P11244, DOI 10.1074/jbc.M308011200
   Li SY, 2005, AGING CELL, V4, P57, DOI 10.1111/j.1474-9728.2005.00146.x
   Lombardi G, 2000, ANN ENDOCRINOL-PARIS, V61, P16
   Norby FL, 2004, J ENDOCRINOL, V180, P175, DOI 10.1677/joe.0.1800175
   Paolisso G, 1997, J CLIN ENDOCR METAB, V82, P2204, DOI 10.1210/jc.82.7.2204
   Reiss K, 1996, P NATL ACAD SCI USA, V93, P8630, DOI 10.1073/pnas.93.16.8630
   Ren J, 1999, J MOL CELL CARDIOL, V31, P2049, DOI 10.1006/jmcc.1999.1036
   Ren J, 2000, CARDIOVASC RES, V46, P162, DOI 10.1016/S0008-6363(00)00011-0
   Zhao W, 2006, CIRCULATION, V113, P995, DOI 10.1161/CIRCULATIONAHA.105.583351
NR 23
TC 84
Z9 94
U1 0
U2 4
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0363-6135
J9 AM J PHYSIOL-HEART C
JI Am. J. Physiol.-Heart Circul. Physiol.
PD MAR
PY 2007
VL 292
IS 3
BP H1398
EP H1403
DI 10.1152/ajpheart.01036.2006
PG 6
WC Cardiac & Cardiovascular Systems; Physiology; Peripheral Vascular
   Disease
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology; Physiology
GA 142VS
UT WOS:000244679300021
PM 17085535
DA 2024-02-19
ER

PT J
AU Wu, SJ
   Tung, YJ
   Yen, MH
   Ng, LT
AF Wu, Shu-Jing
   Tung, Yi-Jou
   Yen, Ming-Hong
   Ng, Lean-Teik
TI Chemical composition and anti-aging effects of standardized herbal
   chicken essence on D-galactose- induced senescent mice
SO FRONTIERS IN NUTRITION
LA English
DT Article
DE chicken essence; anti-aging; D-galactose; anti-inflammation; SIRT1
ID CHRONIC INFLAMMATION; OXIDATIVE STRESS; FERULIC ACID; SIRT1;
   SUPPLEMENTATION; RESTRICTION; RESVERATROL; ANTIOXIDANT; INHIBITION;
   IMPAIRMENT
AB This study aimed to examine the chemical and anti-aging properties of chicken essence (CE) prepared with Sesamum indicum, Angelica acutiloba, and Zingiber officinale (HCE). HCE was analyzed for nutritional and phytochemical composition, and its anti-aging effects were investigated on the D-galactose (Gal)-induced aging mice. Results showed that HCE possessed significantly higher calories and contents of valine and total phenols than CE; it also contained significant amounts of ferulic acid, sesamin, and sesamolin. HCE significantly decreased MDA and NO levels in serum and liver and increased liver GSH levels in the D-Gal-induced mice. HCE greatly enhanced SOD and CAT activities in serum and liver, and liver GPx activity, as well as upregulating SIRT1 expression and downregulating TNF-alpha, IL-1 beta, IL-6, iNOS, Cox-2, and MCP-1 expression in liver tissues. This study demonstrates that HCE was effective in suppressing the aging process through enhancing antioxidant and anti-inflammatory activities and modulating the aging-related gene expression.
C1 [Wu, Shu-Jing; Tung, Yi-Jou] Chia Nan Univ Pharm & Sci, Dept Nutr Hlth, Tainan, Taiwan.
   [Yen, Ming-Hong] Kaohsiung Med Univ, Grad Inst Nat Prod, Coll Pharm, Kaohsiung, Taiwan.
   [Ng, Lean-Teik] Natl Taiwan Univ, Dept Agr Chem, Taipei, Taiwan.
C3 Chia Nan University of Pharmacy & Science; Kaohsiung Medical University;
   National Taiwan University
RP Ng, LT (corresponding author), Natl Taiwan Univ, Dept Agr Chem, Taipei, Taiwan.
EM nglt97@ntu.edu.tw
RI Yen, Ming-Hong/C-4956-2009
FU Industrial Development Bureau (Ministry of Economic Affairs of Taiwan);
   Pure Day Ltd., Co. (New Taipei City, Taiwan);  [10311201042-3-21]
FX This study received funding from the Industrial Development Bureau
   (Ministry of Economic Affairs of Taiwan) and Pure Day Ltd., Co. (New
   Taipei City, Taiwan). The funders were not involved in the study design,
   collection, analysis, interpretation of data, the writing of this
   article or the decision to submit it for publication.
CR Alberro A, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-83991-7
   Aquino L, 2020, Plant Cell Biotechnology and Molecular Biology, V21, P115
   Arcusa R, 2022, FRONT NUTR, V9, DOI 10.3389/fnut.2022.809621
   Baiocchi L, 2021, HEPATOL COMMUN, V5, P1125, DOI 10.1002/hep4.1725
   Barone E, 2009, BIOGERONTOLOGY, V10, P97, DOI 10.1007/s10522-008-9160-8
   Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616
   Braidy N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019194
   Butt MS, 2011, CRIT REV FOOD SCI, V51, P383, DOI 10.1080/10408391003624848
   Chan SH, 2017, REDOX BIOL, V13, P301, DOI 10.1016/j.redox.2017.05.027
   Cheng Fu-Chou, 2006, Int J Biomed Sci, V2, P284
   Chiao YA, 2011, CIRC-CARDIOVASC GENE, V4, P455, DOI 10.1161/CIRCGENETICS.111.959981
   Chung HY, 2019, AGING DIS, V10, P367, DOI 10.14336/AD.2018.0324
   D'Antona G, 2010, CELL METAB, V12, P362, DOI 10.1016/j.cmet.2010.08.016
   de la Lastra CA, 2005, MOL NUTR FOOD RES, V49, P405
   Delwing-Dal Magro D, 2016, BIOMED PHARMACOTHER, V83, P1422, DOI 10.1016/j.biopha.2016.08.057
   Di Lorenzo C, 2021, NUTRIENTS, V13, DOI 10.3390/nu13010273
   DiNicolantonio JJ, 2022, OPEN HEART, V9, DOI 10.1136/openhrt-2021-001801
   Ebert T, 2020, TOXINS, V12, DOI 10.3390/toxins12040227
   Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057
   Galkin F, 2019, AGEING RES REV, V49, P104, DOI 10.1016/j.arr.2018.11.008
   Gessner DK, 2017, J ANIM PHYSIOL AN N, V101, P605, DOI 10.1111/jpn.12579
   Han H, 2021, FRONT PHYSIOL, V12, DOI 10.3389/fphys.2021.634283
   Hartmann A, 2021, FRONT GENET, V12, DOI 10.3389/fgene.2021.686320
   Herranz D, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1001
   Herranz D, 2010, AGING-US, V2, P315, DOI 10.18632/aging.100156
   Hwang JW, 2013, FREE RADICAL BIO MED, V61, P95, DOI 10.1016/j.freeradbiomed.2013.03.015
   Inadera H, 1999, J INTERF CYTOK RES, V19, P1179, DOI 10.1089/107999099313127
   Jia YN, 2018, INT IMMUNOPHARMACOL, V56, P105, DOI 10.1016/j.intimp.2018.01.014
   Jin JL, 2011, HEPATOLOGY, V54, P989, DOI 10.1002/hep.24471
   Kaur J, 2020, TRANSL RES, V226, P96, DOI 10.1016/j.trsl.2020.06.007
   Kong SZ, 2018, MAR DRUGS, V16, DOI 10.3390/md16060181
   Kozakiewicz M, 2019, CLIN INTERV AGING, V14, P763, DOI 10.2147/CIA.S201250
   Le TD, 2019, EUR REV MED PHARMACO, V23, P1826, DOI 10.26355/eurrev_201902_17146
   Lee EB, 2018, BIOMOL THER, V26, P568, DOI 10.4062/biomolther.2017.215
   Li C, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8090381
   Li J, 2017, ONCOTARGET, V8, P65717, DOI 10.18632/oncotarget.20084
   Li YF, 2012, J FOOD SCI, V77, pR105, DOI 10.1111/j.1750-3841.2012.02625.x
   Liguori I, 2018, CLIN INTERV AGING, V13, P757, DOI 10.2147/CIA.S158513
   Liu L, 2022, ALLERGOL IMMUNOPATH, V50, P104, DOI 10.15586/aei.v50i2.533
   Lo HI, 2005, CHINESE J PHYSIOL, V48, P187
   Nagai Hajime, 1996, Applied Human Science, V15, P281, DOI 10.2114/jpa.15.281
   Nakatani Y, 2018, EUR J NUTR, V57, P1137, DOI 10.1007/s00394-017-1396-0
   Namiki M, 2007, CRIT REV FOOD SCI, V47, P651, DOI 10.1080/10408390600919114
   Orlandi I, 2017, REDOX BIOL, V12, P745, DOI 10.1016/j.redox.2017.04.015
   Pinke KH, 2013, IMMUN AGEING, V10, DOI 10.1186/1742-4933-10-22
   Sahardi NFNM, 2019, EVID-BASED COMPL ALT, V2019, DOI 10.1155/2019/5054395
   Sasaki T, 2006, AGING CELL, V5, P413, DOI 10.1111/j.1474-9726.2006.00235.x
   Shan Q, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/564737
   Sidorova Y, 2020, METHOD PROTOCOL, V3, DOI 10.3390/mps3040066
   Singh V, 2020, INFLAMMATION, V43, P1589, DOI 10.1007/s10753-020-01242-9
   Su SW, 2014, TOXICOL LETT, V224, P257, DOI 10.1016/j.toxlet.2013.10.034
   Uto T, 2015, PHYTOTHER RES, V29, P1956, DOI 10.1002/ptr.5490
   Vatner SF, 2020, AGEING RES REV, V64, DOI 10.1016/j.arr.2020.101194
   Wu MS, 2019, MOLECULES, V24, DOI 10.3390/molecules24244426
   Wu SJ, 2008, LWT-FOOD SCI TECHNOL, V41, P323, DOI 10.1016/j.lwt.2007.03.003
   Xiao Q, 2022, CHIN MED-UK, V17, DOI 10.1186/s13020-022-00601-y
   Yang HG, 2016, INT J FOOD SCI NUTR, V67, P806, DOI 10.1080/09637486.2016.1198890
   Yousefzadeh MJ, 2018, AGING CELL, V17, DOI 10.1111/acel.12706
   Zain Azhar Md, 2003, Malays J Nutr, V9, P19
   Zhang F, 2018, BIOMED PHARMACOTHER, V107, P1523, DOI 10.1016/j.biopha.2018.08.136
   Zhao YL, 2022, FRONT MED-LAUSANNE, V9, DOI 10.3389/fmed.2022.842024
NR 61
TC 1
Z9 1
U1 6
U2 17
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-861X
J9 FRONT NUTR
JI Front. Nutr.
PD SEP 13
PY 2022
VL 9
AR 989067
DI 10.3389/fnut.2022.989067
PG 12
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 5C7TZ
UT WOS:000864459500001
PM 36176640
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU de Zegher, F
   Beltrán, CG
   López-Bermejo, A
   Ibáñez, L
AF de Zegher, Francis
   Garcia Beltran, Cristina
   Lopez-Bermejo, Abel
   Ibanez, Lourdes
TI Metformin for Rapidly Maturing Girls with Central Adiposity: Less Liver
   Fat and Slower Bone Maturation
SO HORMONE RESEARCH IN PAEDIATRICS
LA English
DT Article
DE Hepatic fat; Visceral fat; Bone maturation; Adrenarche; Pubarche;
   Metformin; Low birth weight
ID LOW-BIRTH-WEIGHT; PRECOCIOUS PUBARCHE; EARLY PUBERTY; PRENATAL GROWTH;
   AGE; ADRENARCHE
AB Background/Aims: Girls with low-birth weight (LBW) and postnatal weight catch-up tend to develop visceral and hepatic fat excess, which may be accompanied by an upregulated adrenarche with precocious pubarche (PP) and by a rapidly progressive puberty with early menarche and shorter stature. A pilot study suggested that metformin treatment for 4 years reduces central adiposity in LBW-PP girls and normalizes puberty and adult height. In this cohort, we studied the relationship between metformin treatment, bone maturation, and body composition. Methods: Longitudinal hand X-rays (0-4 years, analyzed by BoneXpert) were available from 34 LBW-PP girls (89% of the original cohort; n = 17 untreated, n = 17 metformin-treated; age at the start of treatment 8 years) along with body composition (0-4 years, by DXA), hepatic fat, and abdominally subcutaneous and visceral fat (posttreatment, by MRI). Results: The tempo of bone aging was accelerated in untreated girls (approximate to 16% faster vs. chronological aging) and normal in metformin-treated girls (approximate to 20% slower vs. untreated girls). Metformin-treated girls gained more height per bone-age year and had less visceral and hepatic fat. The tempo of bone maturation was associated (R = 0.55; p < 0.001) with hepatic fat. Conclusion: Metformin treatment in rapidly maturing girls with central adiposity normalized bone maturation. This normalization was accompanied by less central fat and was related closely to hepatic fat. (C) 2017 S. Karger AG, Basel
C1 [de Zegher, Francis] Univ Hosp Gasthuisberg, Pediat Endocrinol, Leuven, Belgium.
   [Garcia Beltran, Cristina; Ibanez, Lourdes] Univ Barcelona, Pediat Res Inst, Hosp St Joan de Deu, Esplugues, Spain.
   [Garcia Beltran, Cristina; Ibanez, Lourdes] ISCIII, Ctr Invest Biomed Red Diabet & Enfermedades Metab, Madrid, Spain.
   [Lopez-Bermejo, Abel] Dr Josep Trueta Hosp, Dept Pediat, Girona, Spain.
   [Lopez-Bermejo, Abel] Girona Inst Biomed Res, Girona, Spain.
C3 KU Leuven; University Hospital Leuven; University of Barcelona;
   Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica
   en Red; CIBERDEM; Universitat de Girona; Girona University Hospital Dr.
   Josep Trueta
RP Ibáñez, L (corresponding author), Univ Barcelona, Hosp St Joan de Deu, Passeig St Joan de Deu 2, ES-08950 Esplugues, Spain.
EM libanez@hsjdbcn.org
RI Ibanez, Lourdes/F-8316-2014
OI Ibanez, Lourdes/0000-0003-4595-7191; Garcia Beltran,
   Cristina/0000-0001-6720-7936
FU Innovation and Science Ministry, Health Institute Carlos III; European
   Fund for Regional Development (FEDER), Madrid, Spain [PI11/0443]
FX This study was supported by the Innovation and Science Ministry, Health
   Institute Carlos III, and the European Fund for Regional Development
   (FEDER), Madrid, Spain (PI11/0443). C.G.B. and L.I. are Clinical
   Investigators of the Network Biomedical Research Center of Diabetes and
   Associated Metabolic Disorders, Health Institute Carlos III, Madrid,
   Spain (www.ciberdem.org). A.L.B. is an Investigator of the I3 Fund for
   Scientific Research (Ministry of Education and Science, Spain).
CR Charkaluk ML, 2004, EUR J PEDIATR, V163, P89, DOI 10.1007/s00431-003-1358-9
   de Zegher F, 2017, OBESITY, V25, P1486, DOI 10.1002/oby.21935
   Ibáñez L, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.5.e72
   Ibáñez L, 2006, PEDIATRICS, V117, P117, DOI 10.1542/peds.2005-0664
   Ibáñez L, 2003, CLIN ENDOCRINOL, V58, P372, DOI 10.1046/j.1365-2265.2003.01728.x
   Ibáñez L, 2008, J CLIN ENDOCR METAB, V93, P1841, DOI 10.1210/jc.2008-0013
   Ibáñez L, 2006, J CLIN ENDOCR METAB, V91, P2888, DOI 10.1210/jc.2006-0336
   Ibáñez L, 2011, J CLIN ENDOCR METAB, V96, pE1262, DOI 10.1210/jc.2011-0555
   Ibáñez L, 2011, FERTIL STERIL, V95, P727, DOI 10.1016/j.fertnstert.2010.08.052
   Ibáñez L, 2010, J PEDIATR-US, V156, P98, DOI 10.1016/j.jpeds.2009.07.012
   Ong KK, 2004, J CLIN ENDOCR METAB, V89, P2647, DOI 10.1210/jc.2003-031848
   Sebastiani G, 2016, PEDIATR OBES, V11, P251, DOI 10.1111/ijpo.12053
   Thodberg HH, 2009, J CLIN ENDOCR METAB, V94, P2239, DOI 10.1210/jc.2008-2474
   Thomas I, 2017, PEDIATR DIABETES, V18, P10, DOI 10.1111/pedi.12473
NR 14
TC 16
Z9 17
U1 0
U2 3
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1663-2818
EI 1663-2826
J9 HORM RES PAEDIAT
JI Horm. Res. Paediatr.
PY 2018
VL 89
IS 2
BP 136
EP 140
DI 10.1159/000479369
PG 5
WC Endocrinology & Metabolism; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Pediatrics
GA FY6XT
UT WOS:000427006900008
PM 29131093
DA 2024-02-19
ER

PT J
AU Sundaram, V
   Jalan, R
   Shah, P
   Singal, AK
   Patel, AA
   Wu, T
   Noureddin, M
   Mahmud, N
   Wong, RJ
AF Sundaram, Vinay
   Jalan, Rajiv
   Shah, Parth
   Singal, Ashwani K.
   Patel, Arpan A.
   Wu, Tiffany
   Noureddin, Mazen
   Mahmud, Nadim
   Wong, Robert J.
TI Acute on Chronic Liver Failure From Nonalcoholic Fatty Liver Disease: A
   Growing and Aging Cohort With Rising Mortality
SO HEPATOLOGY
LA English
DT Article; Early Access
ID TRANSPLANTATION; STEATOHEPATITIS; OBESITY; CIRRHOSIS; PREVALENCE;
   INFECTION; ADULTS
AB Background and Aims We assessed the burden of nonalcoholic fatty liver disease (NAFLD)-related acute on chronic liver failure (ACLF) among transplant candidates in the United States, along with waitlist outcomes for this population.
   Approach and Results We analyzed the United Network for Organ Sharing registry from 2005 to 2017. Patients with ACLF were identified using the European Association for the Study of the Liver/Chronic Liver Failure criteria and categorized into NAFLD, alcohol-associated liver disease (ALD), and hepatitis C virus (HCV) infection. We used linear regression and Chow's test to determine significance in trends and evaluated waitlist outcomes using Fine and Gray's competing risks regression and Cox proportional hazards regression. Between 2005 and 2017, waitlist registrants for NAFLD-ACLF rose by 331.6% from 134 to 574 candidates (P < 0.001), representing the largest percentage increase in the study population. ALD-ACLF also increased by 206.3% (348-1,066 registrants; P < 0.001), whereas HCV-ACLF declined by 45.2% (P < 0.001). As of 2017, the NAFLD-ACLF population consisted primarily of persons aged >= 60 years (54.1%), and linear regression demonstrated a significant rise in the proportion of patients aged >= 65 in this group (beta = 0.90; P = 0.011). Since 2014, NAFLD-ACLF grade 1 was associated with a greater risk of waitlist mortality relative to ALD-ACLF (subhazard ratio [SHR] = 1.24; 95% confidence interval [CI], 1.05-1.44) and HCV-ACLF (SHR = 1.35; 95% CI, 1.08-1.71), among patients aged >= 60 years. Mortality was similar among the three groups for patients with ACLF grade 2 or 3.
   Conclusions NAFLD is the fastest rising etiology of cirrhosis associated with ACLF among patients listed in the United States. As the NAFLD population continues to grow and age, patients with NAFLD-ACLF will likely have the highest risk of waitlist mortality.
C1 [Sundaram, Vinay; Shah, Parth; Wu, Tiffany; Noureddin, Mazen] Cedars Sinai Med Ctr, Karsh Div Gastroenterol & Hepatol, 8900 Beverly Blvd,Suite 250, Los Angeles, CA USA.
   [Sundaram, Vinay; Shah, Parth; Wu, Tiffany; Noureddin, Mazen] Cedars Sinai Med Ctr, Comprehens Transplant Ctr, 8900 Beverly Blvd,Suite 250, Los Angeles, CA USA.
   [Jalan, Rajiv] UCL Med Sch, Inst Liver & Digest Hlth, Liver Failure Grp, London, England.
   [Singal, Ashwani K.] Univ South Dakota, Sanford Sch Med, Sioux Falls, SD USA.
   [Singal, Ashwani K.] Univ South Dakota, Avera Transplant Inst, Sioux Falls, SD USA.
   [Patel, Arpan A.] Vet Affairs VA Greater Los Angeles Healthcare Sys, Los Angeles, CA USA.
   [Patel, Arpan A.] Univ Calif Los Angeles, David Geffen Sch Med, Div Digest Dis, Los Angeles, CA USA.
   [Mahmud, Nadim] Hosp Univ Penn, Div Gastroenterol, Philadelphia, PA USA.
   [Wong, Robert J.] Vet Affairs Palo Alto Healthcare Syst, Div Gastroenterol & Hepatol, Palo Alto, CA USA.
   [Wong, Robert J.] Stanford Univ, Div Gastroenterol & Hepatol, Sch Med, Stanford, CA USA.
C3 Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of
   London; University College London; University of South Dakota;
   University of South Dakota; University of California System; University
   of California Los Angeles; University of California Los Angeles Medical
   Center; David Geffen School of Medicine at UCLA; University of
   Pennsylvania; US Department of Veterans Affairs; Veterans Health
   Administration (VHA); VA Palo Alto Health Care System; Stanford
   University
RP Sundaram, V (corresponding author), Cedars Sinai Med Ctr, Karsh Div Gastroenterol & Hepatol, 8900 Beverly Blvd,Suite 250, Los Angeles, CA USA.; Sundaram, V (corresponding author), Cedars Sinai Med Ctr, Comprehens Transplant Ctr, 8900 Beverly Blvd,Suite 250, Los Angeles, CA USA.
EM Vinay.Sundaram@cshs.org
RI Singal, Ashwani/H-6181-2019
OI Singal, Ashwani/0000-0003-1207-3998; Wong, Robert/0000-0002-8923-2806;
   Sundaram, Vinay/0000-0002-1450-7756; Patel, Arpan/0000-0002-6548-4531
CR Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643
   Agopian VG, 2012, ANN SURG, V256, P624, DOI 10.1097/SLA.0b013e31826b4b7e
   Altman DG., 2007, BMJ, V335
   Artzner T, 2020, AM J TRANSPLANT, V20, P2437, DOI 10.1111/ajt.15852
   Bushyhead Daniel, 2017, Curr Hepatol Rep, V16, P12, DOI 10.1007/s11901-017-0327-0
   Chalasani N, 2020, GASTROENTEROLOGY, V158, P1334, DOI 10.1053/j.gastro.2019.11.296
   Cholankeril G, 2019, TRANSPLANTATION, V103, P131, DOI 10.1097/TP.0000000000002471
   Cotter TG, 2019, HEPATOLOGY, V69, P2381, DOI 10.1002/hep.30540
   Dimou FM, 2016, SURGERY, V160, P1533, DOI 10.1016/j.surg.2016.06.051
   Estes C, 2018, HEPATOLOGY, V67, P123, DOI 10.1002/hep.29466
   Fay MP, 2006, BIOMETRICS, V62, P847, DOI 10.1111/j.1541-0420.2006.00528.x
   Goldberg D, 2017, GASTROENTEROLOGY, V152, P1090, DOI 10.1053/j.gastro.2017.01.003
   Gustot T, 2015, HEPATOLOGY, V62, P243, DOI 10.1002/hep.27849
   Haldar D, 2019, J HEPATOL, V71, P313, DOI 10.1016/j.jhep.2019.04.011
   Hernaez R, 2020, J HEPATOL, V73, P1425, DOI 10.1016/j.jhep.2020.06.005
   Hernaez R, 2019, J HEPATOL, V70, P639, DOI 10.1016/j.jhep.2018.12.018
   Jalan R, 2014, J HEPATOL, V61, P1038, DOI 10.1016/j.jhep.2014.06.012
   Kim D, 2018, GASTROENTEROLOGY, V155, P1154, DOI 10.1053/j.gastro.2018.07.008
   Kim RG, 2017, CLIN GASTROENTEROL H, V15, P1521, DOI 10.1016/j.cgh.2017.04.039
   Kok B, 2018, LIVER INT, V38, P1230, DOI 10.1111/liv.13648
   Lee BP, 2018, GASTROENTEROLOGY, V155, P422, DOI 10.1053/j.gastro.2018.04.009
   Mahmud N, 2019, HEPATOLOGY, V69, P2150, DOI 10.1002/hep.30494
   Mathurin P, 2011, NEW ENGL J MED, V365, P1790, DOI 10.1056/NEJMoa1105703
   Miles Clifford D, 2018, Curr Transplant Rep, V5, P1, DOI 10.1007/s40472-018-0175-z
   Moreau R, 2013, GASTROENTEROLOGY, V144, P1426, DOI 10.1053/j.gastro.2013.02.042
   Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40
   Piano S, 2017, J HEPATOL, V67, P1177, DOI 10.1016/j.jhep.2017.07.008
   SALMAN M, 2020, SURG ENDOSC
   Sersté T, 2018, J HEPATOL, V69, P318, DOI 10.1016/j.jhep.2018.02.022
   Su F, 2016, GASTROENTEROLOGY, V150, P441, DOI 10.1053/j.gastro.2015.10.043
   Sundaram V, 2015, ALIMENT PHARM THER, V42, P1271, DOI 10.1111/apt.13426
   Sundaram V, 2020, ALIMENT PHARM THER, V52, P1204, DOI 10.1111/apt.15988
   Sundaram V, 2020, LIVER TRANSPLANT, V26, P1594, DOI 10.1002/lt.25831
   Sundaram V, 2020, J HEPATOL, V72, P481, DOI 10.1016/j.jhep.2019.10.013
   Sundaram V, 2019, HEPATOLOGY, V70, P334, DOI 10.1002/hep.30624
   Sundaram V, 2019, GASTROENTEROLOGY, V156, P1381, DOI 10.1053/j.gastro.2018.12.007
   Sundaram V, 2018, J HEPATOL, V69, P617, DOI 10.1016/j.jhep.2018.04.016
   Tapper EB, 2018, BMJ-BRIT MED J, V362, DOI [10.1136/bm1k2817, 10.1136/bmj.k2817]
   Vilar-Gomez E, 2020, HEPATOLOGY, V71, P495, DOI 10.1002/hep.30368
   Vilar-Gomez E, 2018, GASTROENTEROLOGY, V155, P443, DOI 10.1053/j.gastro.2018.04.034
   Villanueva C, 2019, LANCET, V393, P1597, DOI 10.1016/S0140-6736(18)31875-0
   Wong RJ, 2015, GASTROENTEROLOGY, V148, P547, DOI 10.1053/j.gastro.2014.11.039
   Wong RJ, 2014, HEPATOLOGY, V59, P2188, DOI 10.1002/hep.26986
   Younossi ZM, 2019, J HEPATOL, V70, P531, DOI 10.1016/j.jhep.2018.10.033
NR 44
TC 28
Z9 28
U1 2
U2 5
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD 2021 MAY
PY 2021
VL 73
IS 5
BP 1932
EP 1944
DI 10.1002/hep.31566
EA MAR 2021
PG 13
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA RU6XT
UT WOS:000632471700001
PM 32961608
OA Green Published
DA 2024-02-19
ER

PT J
AU Lenaz, G
   D'Aurelio, M
   Pich, MM
   Geneva, ML
   Ventura, B
   Bovina, C
   Formiggini, G
   Castelli, GP
AF Lenaz, G
   D'Aurelio, M
   Pich, MM
   Geneva, ML
   Ventura, B
   Bovina, C
   Formiggini, G
   Castelli, GP
TI Mitochondrial bioenergetics in aging
SO BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
LA English
DT Article; Proceedings Paper
CT 11th European Bioenergetics Conference (EBEC)
CY SEP 09-14, 2000
CL UNIV SUSSEX, BRIGHTON, ENGLAND
HO UNIV SUSSEX
DE mitochondria; aging; respiratory chain; coenzyme Q; metabolic control;
   platelet
ID CYTOCHROME-C-OXIDASE; COENZYME-Q REDUCTASE; COMPLEX-I; OXIDATIVE STRESS;
   NONSYNAPTIC MITOCHONDRIA; LIPID-PEROXIDATION; PLASMA-MEMBRANE; POINT
   MUTATIONS; AGED SUBJECTS; RAT-LIVER
AB Mitochondria are strongly involved in the production of reactive oxygen species, considered as the pathogenic agent of many diseases and of aging. The mitochondrial theory of aging considers somatic mutations of mitochondrial DNA induced by oxygen radicals as the primary cause of energy decline; experimentally, complex I appears to be mostly affected and to become strongly rate limiting for electron transfer. Mitochondrial bioenergetics is also deranged in human platelets upon aging, as shown by the decreased Pasteur effect (enhancement of lactate production by respiratory chain inhibition). Cells counteract oxidative stress by antioxidants; among lipophilic antioxidants, coenzyme Q is the only one of endogenous biosynthesis. Exogenous coenzyme Q, however, protects cells from oxidative stress by conversion into its reduced antioxidant form by cellular reductases. (C) 2000 Elsevier Science B.V. All rights reserved.
C1 Univ Bologna, Dipartimento Biochim G Moruzzi, I-40126 Bologna, Italy.
C3 University of Bologna
RP Lenaz, G (corresponding author), Univ Bologna, Dipartimento Biochim G Moruzzi, Via Irnerio 48, I-40126 Bologna, Italy.
EM lenaz@biocfarm.unibo.it
RI Genova, Maria Luisa/H-6921-2012; Lenaz, Giorgio/B-5751-2013; Ventura,
   Barbara/B-8819-2009
OI Genova, Maria Luisa/0000-0002-9176-3630; Ventura,
   Barbara/0000-0002-8207-1659
CR Andersson M, 1995, MECH AGEING DEV, V85, P1, DOI 10.1016/0047-6374(95)01642-2
   APPELKVIST EL, 1994, MOL ASPECTS MED, V15, P37, DOI 10.1016/0098-2997(94)90011-6
   Barogi S, 2000, MECH AGEING DEV, V113, P1, DOI 10.1016/S0047-6374(99)00089-5
   BATTINO M, 1995, MECH AGEING DEV, V78, P173, DOI 10.1016/0047-6374(94)01535-T
   Beal MF, 1999, BIOFACTORS, V9, P261, DOI 10.1002/biof.5520090222
   Beal MF, 1998, BBA-BIOENERGETICS, V1366, P211, DOI 10.1124/jpet.112.192138
   Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127
   BEYER RE, 1994, J BIOENERG BIOMEMBR, V26, P349, DOI 10.1007/BF00762775
   Beyer RE, 1996, P NATL ACAD SCI USA, V93, P2528, DOI 10.1073/pnas.93.6.2528
   Biagini G, 1998, MECH AGEING DEV, V101, P269, DOI 10.1016/S0047-6374(97)00181-4
   BLASI MA, 2000, IN PRESS OPHTHALMOLO
   Carelli V, 1999, ANN NEUROL, V45, P320, DOI 10.1002/1531-8249(199903)45:3<320::AID-ANA7>3.0.CO;2-L
   Cavazzoni M, 1999, FEBS LETT, V449, P53, DOI 10.1016/S0014-5793(99)00400-7
   Crane FL, 1997, MOL ASPECTS MED, V18, pS1
   ERNSTER L, 1995, BBA-MOL BASIS DIS, V1271, P195, DOI 10.1016/0925-4439(95)00028-3
   ERNSTER L, 1992, BIOFACTORS, V3, P241
   Esposti MD, 1998, BBA-BIOENERGETICS, V1364, P222, DOI 10.1016/S0005-2728(98)00029-2
   ESPOSTI MD, 1994, FEBS LETT, V352, P375, DOI 10.1016/0014-5793(94)00971-6
   Formiggini G, 1996, BIOCHEM MOL BIOL INT, V39, P1135
   GENOVA ML, 1995, BIOCHEM J, V311, P105, DOI 10.1042/bj3110105
   Genova ML, 1997, FEBS LETT, V410, P467
   GOTZ ME, 1994, PHARMACOL THERAPEUT, V63, P37, DOI 10.1016/0163-7258(94)90055-8
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HAYASHI JI, 1994, J BIOL CHEM, V269, P6878
   HOLMSEN H, 1980, THROMB HAEMOSTASIS, V42, P1460
   Huertas JR, 1999, BIOFACTORS, V9, P337, DOI 10.1002/biof.5520090233
   Isobe K, 1998, J BIOL CHEM, V273, P4601, DOI 10.1074/jbc.273.8.4601
   Kacser H, 1979, BIOCHEM SOC T, V7, P1149, DOI 10.1042/bst0071149
   KARLSSON J, 1993, CLIN INVESTIGATOR, V71, pS84
   Kuznetsov AV, 1997, BBA-MOL BASIS DIS, V1360, P142, DOI 10.1016/S0925-4439(96)00072-5
   Laderman KA, 1996, J BIOL CHEM, V271, P15891, DOI 10.1074/jbc.271.27.15891
   LAWEN A, 1994, MOL ASPECTS MED, V15, P13
   Lenaz G, 1997, MOL CELL BIOCHEM, V174, P329, DOI 10.1023/A:1006854619336
   Lenaz G, 1998, BBA-BIOENERGETICS, V1364, P207, DOI 10.1016/S0005-2728(98)00028-0
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   Morré DM, 2000, J EXP BIOL, V203, P1513
   MULLERHOCKER J, 1992, MUTAT RES, V275, P115, DOI 10.1016/0921-8734(92)90016-I
   Nohl H, 1996, FREE RADICAL BIO MED, V20, P207, DOI 10.1016/0891-5849(95)02038-1
   Ozawa T, 1997, PHYSIOL REV, V77, P425, DOI 10.1152/physrev.1997.77.2.425
   OZAWA T, 1995, BBA-MOL BASIS DIS, V1271, P177, DOI 10.1016/0925-4439(95)00026-Z
   Pallotti F, 1996, AM J HUM GENET, V59, P591
   Paradies G, 1997, BBA-BIOENERGETICS, V1319, P5, DOI 10.1016/S0005-2728(97)00012-1
   Pich MM, 1996, FEBS LETT, V380, P176, DOI 10.1016/0014-5793(96)00037-3
   Schapira AHV, 1998, BBA-BIOENERGETICS, V1366, P225, DOI 10.1016/S0005-2728(98)00115-7
   SCHON EA, 1996, CELLULAR AGING CELL, P19
   SOHAL RS, 1995, J BIOL CHEM, V270, P15671, DOI 10.1074/jbc.270.26.15671
   TAKAHASHI T, 1995, BIOCHEM J, V309, P883, DOI 10.1042/bj3090883
   VALLS V, 1994, BIOCHEM MOL BIOL INT, V33, P633
   VILLALBA JM, 1995, P NATL ACAD SCI USA, V92, P4887, DOI 10.1073/pnas.92.11.4887
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zhang YY, 1996, J NUTR, V126, P2089, DOI 10.1093/jn/126.9.2089
NR 52
TC 146
Z9 172
U1 1
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0005-2728
EI 0006-3002
J9 BBA-BIOENERGETICS
JI Biochim. Biophys. Acta-Bioenerg.
PD AUG 15
PY 2000
VL 1459
IS 2-3
BP 397
EP 404
DI 10.1016/S0005-2728(00)00177-8
PG 8
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Biochemistry & Molecular Biology; Biophysics
GA 348RW
UT WOS:000089001100022
PM 11004456
OA hybrid
DA 2024-02-19
ER

PT J
AU Song, ZX
   Shah, S
   Lv, BX
   Ji, N
   Liu, X
   Yan, LF
   Khan, M
   Zhao, YF
   Wu, PY
   Liu, SF
   Zheng, L
   Su, LB
   Wang, XF
   Lv, ZJ
AF Song, Zhixue
   Shah, Suleman
   Lv, Baixue
   Ji, Ning
   Liu, Xin
   Yan, Lifang
   Khan, Murad
   Zhao, Yufang
   Wu, Peiyuan
   Liu, Shufeng
   Zheng, Long
   Su, Libo
   Wang, Xiufang
   Lv, Zhanjun
TI Anti-aging and anti-oxidant activities of murine short interspersed
   nuclear element antisense RNA
SO EUROPEAN JOURNAL OF PHARMACOLOGY
LA English
DT Article; Early Access
DE Genetically engineered murine B1 antisense; RNA; Naturally senescent
   mice; Anti-aging; Anti-oxidative; Short interspersed nuclear element
ID OXIDATIVE STRESS; GENE-EXPRESSION; ALU; SENESCENCE; TRANSCRIPTION;
   MUTATIONS; SEQUENCES; DEFICITS; DISEASE; SIRT1
AB Short interspersed nuclear elements (SINEs) play a key role in regulating gene expression, and SINE RNAs are involved in age-related diseases. We investigated the anti-aging effects of a genetically engineered murine SINE B1 antisense RNA (B1as RNA) and explored its mechanism of action in naturally senescent BALB/c (>14 months) and moderately senscent C57BL/6N (>9 months) mice. After tail vein injection, B1as RNA was available in the blood of mice for approximately 30 min, persisted for approximately 2-4 h in most detected tissues and persisted approximately 48 h in lungs. We found that treatment with B1as RNA improved stamina and promoted hair regrowth in aged mice. Treatment with B1as RNA also partially rescued the increase in mitochondrial DNA copy number in liver and spleen tissues observed in aged and moderately senescent mice. Finally, treatment with B1as RNA increased the activities of superoxide dismutase and glutathione peroxidase in aged and moderately senescent mice, reduced these animals' malondialdehyde and reactive oxygen species levels, and modulated the expression of several aging-associated genes, including Sirtuin 1, p21, p16Ink4a, p15Ink4b and p19Arf, and antioxidant genes (Sesn1 and Sesn 2). These data suggest that B1as RNA inhibits the aging process by enhancing antioxidant activity, promoting the scavenging of free radicals, and modulating the expression of agingassociated genes. This is the first report describing the anti-aging activity of SINE antisense RNA, which may serve as an effective nucleic acid drug for the treatment of age-related diseases.
C1 [Song, Zhixue; Shah, Suleman; Ji, Ning; Liu, Xin; Yan, Lifang; Khan, Murad; Zhao, Yufang; Wu, Peiyuan; Liu, Shufeng; Zheng, Long; Su, Libo; Wang, Xiufang; Lv, Zhanjun] Hebei Med Univ, Dept Genet, Hebei Key Lab Lab Anim, 361 Zhongshan East Rd, Shijiazhuang 050017, Hebei, Peoples R China.
   [Lv, Baixue] Huazhong Univ Sci & Technol, Union Hosp, Dept Ultrasound, Tongji Med Coll, Wuhan 430022, Hubei, Peoples R China.
   [Lv, Baixue] Hubei Prov Key Lab Mol Imaging, Wuhan 430022, Hubei, Peoples R China.
C3 Hebei Medical University; Huazhong University of Science & Technology
RP Wang, XF; Lv, ZJ (corresponding author), Hebei Med Univ, Dept Genet, Hebei Key Lab Lab Anim, 361 Zhongshan East Rd, Shijiazhuang 050017, Hebei, Peoples R China.
EM 18701394@hebmu.edu.cn; 72019010@stu.hebmu.edu.cn; snowlv0318@126.com;
   15613380807@163.com; lx950114@163.com; lifangyiyaa@163.com;
   genetics6630@gmail.com; zhao_yufang@sina.com; wupeiyuanwu@163.com;
   liushf@126.com; zhenglong-1022@163.com; libo_su@yahoo.com;
   wangxf1966@hebmu.edu.cn; lslab@hebmu.edu.cn
RI Yan, Lifang/AAI-1808-2020
FU National Natural Science Foundation of China [81771499]; Natural Science
   Foundation of Hebei Province, China [H2018206099]; Construction Program
   of Scientific Fundamental Conditions, and a Resource Sharing Special
   Project of the Science and Technology Department of Hebei Province
   [18964802D]; Youth Fund of National Natural Science Foundation of China
   [31702076]
FX We thank Dr. Angelika Hofmann for editorial assistance. This work was
   supported by the National Natural Science Foundation of China (grant
   number 81771499); the Natural Science Foundation of Hebei Province,
   China (grant number H2018206099); the Construction Program of Scientific
   Fundamental Conditions, and a Resource Sharing Special Project of the
   Science and Technology Department of Hebei Province (grant number
   18964802D); and the Youth Fund of National Natural Science Foundation of
   China (grant number 31702076).
CR Baboo S, 2014, NUCLEUS-PHILA, V5, P281, DOI 10.4161/nucl.29577
   Baek JH, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8030247
   Baryakin DN, 2013, ACTA NATURAE, V5, P83, DOI 10.32607/20758251-2013-5-4-83-93
   Bolotin E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-560
   Bovia F, 1997, NUCLEIC ACIDS RES, V25, P318, DOI 10.1093/nar/25.2.318
   Butterfield DA, 2014, BBA-MOL BASIS DIS, V1842, P1693, DOI 10.1016/j.bbadis.2014.06.010
   Román AC, 2011, GENOME RES, V21, P422, DOI 10.1101/gr.111203.110
   Chang DY, 1996, NUCLEIC ACIDS RES, V24, P4165, DOI 10.1093/nar/24.21.4165
   Chen CF, 2002, P NATL ACAD SCI USA, V99, P2930, DOI 10.1073/pnas.052692099
   Chen GH, 2017, BIOL CHEM, V398, P499, DOI 10.1515/hsz-2016-0211
   Czauderna F, 2003, NUCLEIC ACIDS RES, V31, P2705, DOI 10.1093/nar/gkg393
   Davalli P, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3565127
   Dulcy CP, 2012, J NEUROSCI RES, V90, P2053, DOI 10.1002/jnr.23080
   Ganapathi M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-126
   Häsler J, 2006, NUCLEIC ACIDS RES, V34, P5491, DOI 10.1093/nar/gkl706
   Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446
   Herranz D, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1001
   Herranz D, 2010, AGING-US, V2, P315, DOI 10.18632/aging.100156
   Herskovits AZ, 2014, NEURON, V81, P471, DOI 10.1016/j.neuron.2014.01.028
   Ishii M, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.628062
   Jacinto TA, 2018, BIOL RES, V51, DOI 10.1186/s40659-018-0182-7
   Jo-Watanabe A, 2014, AGING CELL, V13, P519, DOI 10.1111/acel.12204
   Ke YL, 2018, FREE RADICAL BIO MED, V116, P88, DOI 10.1016/j.freeradbiomed.2018.01.007
   Khan M, 2020, ANAL BIOCHEM, V599, DOI 10.1016/j.ab.2020.113737
   Kriegs JO, 2007, TRENDS GENET, V23, P158, DOI 10.1016/j.tig.2007.02.002
   Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x
   Leonov G, 2015, INT J BIOCHEM CELL B, V69, P75, DOI 10.1016/j.biocel.2015.10.006
   Liu C, 2017, MICROB CELL FACT, V16, DOI 10.1186/s12934-017-0800-z
   Ma ZH, 2017, MOL GENET GENOMICS, V292, P833, DOI 10.1007/s00438-017-1312-6
   Matheu A, 2007, NATURE, V448, P375, DOI 10.1038/nature05949
   Matheu A, 2009, AGING CELL, V8, P152, DOI 10.1111/j.1474-9726.2009.00458.x
   Mukherjee A, 2015, EXP GERONTOL, V69, P211, DOI 10.1016/j.exger.2015.06.022
   O'Leary TP, 2018, BEHAV BRAIN RES, V337, P256, DOI 10.1016/j.bbr.2017.09.009
   Peiris H, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/520316
   Rattan SIS, 2014, AGING DIS, V5, P196, DOI 10.14336/AD.2014.0500196
   Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320
   Scherz-Shouval R, 2011, TRENDS BIOCHEM SCI, V36, P30, DOI 10.1016/j.tibs.2010.07.007
   Sharova LV, 2009, DNA RES, V16, P45, DOI 10.1093/dnares/dsn030
   Song WQ, 2015, GENET MOL RES, V14, P18268, DOI 10.4238/2015.December.23.14
   Tatone C, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/659687
   Tsirigos A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000610
   ULLU E, 1984, NATURE, V312, P171, DOI 10.1038/312171a0
   Wang HG, 2011, GENET MOL RES, V10, P1866, DOI 10.4238/vol10-3gmr1169
   Wang JR, 2011, CELL CYCLE, V10, P3016, DOI 10.4161/cc.10.17.17543
   Wang XF, 2009, GENES GENOM, V31, P209, DOI 10.1007/BF03191192
   Wang XF, 2016, INT J BIOCHEM CELL B, V79, P24, DOI 10.1016/j.biocel.2016.08.004
   Wang XF, 2014, AGEING RES REV, V13, P46, DOI 10.1016/j.arr.2013.11.001
   White GRM, 2002, BRIT J CANCER, V86, P1920, DOI 10.1038/sj.bjc.6600417
   Yu WF, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-73
   Zhang ZP, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111873
   Zhao X, 2019, J NANOBIOTECHNOL, V17, DOI 10.1186/s12951-019-0528-5
   Zhen YZ, 2016, EXP THER MED, V11, P303, DOI 10.3892/etm.2015.2858
   Zheng L, 2014, CANCER LETT, V355, P18, DOI 10.1016/j.canlet.2014.09.004
NR 53
TC 3
Z9 3
U1 0
U2 9
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0014-2999
EI 1879-0712
J9 EUR J PHARMACOL
JI Eur. J. Pharmacol.
PD 2021 DEC 5
PY 2021
VL 912
AR 174577
DI 10.1016/j.ejphar.2021.174577
EA OCT 2021
PG 13
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA XF3YE
UT WOS:000724009000004
PM 34688636
OA hybrid
DA 2024-02-19
ER

PT J
AU Nishio, N
   Isobe, KI
AF Nishio, Naomi
   Isobe, Ken-ichi
TI Hen egg only diets support healthy aging in adult mice
SO JOURNAL OF ANIMAL PHYSIOLOGY AND ANIMAL NUTRITION
LA English
DT Article; Early Access
DE egg-only diet; low carbohydrates; mice
ID LOW-CARBOHYDRATE; HEPATIC STEATOSIS; KETONE-BODIES; HIGH-FAT;
   INSULIN-RESISTANCE; ENERGY-EXPENDITURE; METABOLIC SYNDROME;
   GROWTH-FACTOR; ROLES; LIVER
AB Hen eggs (eggs) are a conventional food, known to contain the nutrients required for the growth of chicken embryos. These eggs are rich in important proteins and fats, with a very low amount of carbohydrate, and include all of the vitamins and minerals needed for the development of mice. We found that mice fed eggs grew to the same weight as mice fed a normal chow diet (ND) and remained healthy until the 20-months. As expected, the serological indicators of fat content were higher in egg-only mice than in ND mice. However, surprisingly the serum glucose levels in the egg-only mice were nearly identical to those in the ND mice. Given the high fat content in eggs, we expected that our egg-only mice would develop fatty liver or other metabolic diseases. However, we observed no pathological changes in the livers of egg-only mice until 20-months with their serological indicators (ALT and AST) and histological features (no fat droplets) remaining normal. However, when we examined the pups nursed by mothers of the egg-only diet group we noted that almost the animals died 2 to 4 weeks after birth. This is likely because these pups presented with reduced enzymes for metabolism in their liver when compared to pups of the ND group. In addition, we also found that the expression of various development proteins were severely lacking in liver of these pups. From these results, our report suggested that eggs could support healthy aging in adult mice, but not in pups.
C1 [Nishio, Naomi] Saitama Univ, Fac Educ, Dept Sch Hlth, Saitama, Japan.
   [Isobe, Ken-ichi] Nagoya Womens Univ, Dept Food Sci & Nutr, Nagoya, Japan.
   [Isobe, Ken-ichi] Shubun Univ, Fac Med Sci, Dept Med technol, Ichinomiya, Japan.
   [Nishio, Naomi] Saitama Univ, Fac Educ, Dept Sch Hlth, 255Shimo Okubo,Sakura-ku, Saitama 3388570, Japan.
C3 Saitama University; Saitama University
RP Nishio, N (corresponding author), Saitama Univ, Fac Educ, Dept Sch Hlth, 255Shimo Okubo,Sakura-ku, Saitama 3388570, Japan.
EM nishio@mail.saitama-u.ac.jp
OI Nishio, Naomi/0000-0002-2292-4701
FU Urakami Foundation for Food and Food Culture Promotion [R02209]; JSPS
   KAKENHI [JP16H05280, JP19K11687]
FX Urakami Foundation for Food and Food Culture Promotion, Grant/Award
   Number: R02209; JSPS KAKENHI, Grant/Award Numbers: JP16H05280,
   JP19K11687
CR Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x
   Anton S, 2013, EXP GERONTOL, V48, P1003, DOI 10.1016/j.exger.2013.04.011
   Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002
   Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422
   Chyau CC, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21010360
   Coutant A, 2002, HEPATOLOGY, V36, P1079, DOI 10.1053/jhep.2002.36160
   Davis K, 2016, EXP GERONTOL, V86, P84, DOI 10.1016/j.exger.2016.05.001
   Douris N, 2017, MOL METAB, V6, P854, DOI 10.1016/j.molmet.2017.05.017
   Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280
   Fernando HA, 2019, NUTRIENTS, V11, DOI 10.3390/nu11020478
   Filippou CD, 2020, ADV NUTR, V11, P1150, DOI 10.1093/advances/nmaa041
   Foster GD, 2003, NEW ENGL J MED, V348, P2082, DOI 10.1056/NEJMoa022207
   Fraulob JC, 2010, J CLIN BIOCHEM NUTR, V46, P212, DOI 10.3164/jcbn.09-83
   Garbow JR, 2011, AM J PHYSIOL-GASTR L, V300, pG956, DOI 10.1152/ajpgi.00539.2010
   Hegardt FG, 1999, BIOCHEM J, V338, P569, DOI 10.1042/0264-6021:3380569
   Isobe K., 2020, BIOMEDICAL RES REV, V3, P132, DOI [10.31021/brr.20203132, DOI 10.31021/BRR.20203132]
   Ito Y, 2000, HEPATOLOGY, V32, P1370, DOI 10.1053/jhep.2000.19815
   Jornayvaz FR, 2010, AM J PHYSIOL-ENDOC M, V299, pE808, DOI 10.1152/ajpendo.00361.2010
   Laffel L, 1999, DIABETES-METAB RES, V15, P412, DOI 10.1002/(SICI)1520-7560(199911/12)15:6<412::AID-DMRR72>3.0.CO;2-8
   Lagiou P, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4026
   Leitao C, 2022, NUTRIENTS, V14, DOI 10.3390/nu14030554
   Leonce J, 2006, PLACENTA, V27, pS103, DOI 10.1016/j.placenta.2006.02.006
   Li JL, 2020, EXP ANIM TOKYO, V69, P326, DOI 10.1538/expanim.19-0148
   Li MY, 2020, NUTRIENTS, V12, DOI 10.3390/nu12071995
   Marsman D, 2018, EUR J NUTR, V57, pS15, DOI 10.1007/s00394-018-1723-0
   Mazza E, 2021, J NUTR HEALTH AGING, V25, P1076, DOI 10.1007/s12603-021-1675-6
   Miranda JM, 2015, NUTRIENTS, V7, P706, DOI 10.3390/nu7010706
   Missimer A, 2017, NUTRIENTS, V9, DOI 10.3390/nu9020089
   Newman JC, 2014, TRENDS ENDOCRIN MET, V25, P42, DOI 10.1016/j.tem.2013.09.002
   Nishio N., 2018, DO MICE GROW NORMALL, DOI [10.7287/peerj.preprints.27000v1, DOI 10.7287/PEERJ.PREPRINTS.27000V1]
   Nishio N, 2015, SCI REP-UK, V5, DOI 10.1038/srep13519
   Petersen MC, 2017, NAT REV ENDOCRINOL, V13, P572, DOI 10.1038/nrendo.2017.80
   Puchalska P, 2017, CELL METAB, V25, P262, DOI 10.1016/j.cmet.2016.12.022
   Rizza W, 2014, AGEING RES REV, V13, P38, DOI 10.1016/j.arr.2013.11.002
   Roberts MN, 2017, CELL METAB, V26, P539, DOI 10.1016/j.cmet.2017.08.005
   Shai I, 2008, NEW ENGL J MED, V359, P229, DOI 10.1056/NEJMoa0708681
   Srinivasan M, 2008, TRENDS ENDOCRIN MET, V19, P146, DOI 10.1016/j.tem.2007.12.001
   Wang YP, 1999, HEPATOLOGY, V30, P682, DOI 10.1002/hep.510300318
   Westman EC, 2007, AM J CLIN NUTR, V86, P276, DOI 10.1093/ajcn/86.2.276
   Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392
   Yu S, 2021, MOL METAB, V53, DOI 10.1016/j.molmet.2021.101257
NR 41
TC 0
Z9 0
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0931-2439
EI 1439-0396
J9 J ANIM PHYSIOL AN N
JI J. Anim. Physiol. Anim. Nutr.
PD 2023 JUL
PY 2023
VL 107
IS 4
BP 1110
EP 1124
DI 10.1111/jpn.13805
EA JAN 2023
PG 15
WC Agriculture, Dairy & Animal Science; Veterinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Agriculture; Veterinary Sciences
GA L4VV9
UT WOS:000916876600001
PM 36688451
DA 2024-02-19
ER

PT J
AU Sharda, DR
   Miller-Lee, JL
   Kanski, GM
   Hunter, JC
   Lang, CH
   Kennett, MJ
   Korzick, DH
AF Sharda, Daniel R.
   Miller-Lee, Jennifer L.
   Kanski, Gregory M.
   Hunter, J. Craig
   Lang, Charles H.
   Kennett, Mary J.
   Korzick, Donna H.
TI Comparison of the agar block and Lieber-DeCarli diets to study chronic
   alcohol consumption in an aging model of Fischer 344 female rats
SO JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
LA English
DT Article
DE Alcoholism; Estrogen; Postmenopause; Phytoestrogens; Ovariectomy;
   Senescence
ID SEX-DEPENDENT DIFFERENCES; LIVER-INJURY; ETHANOL-METABOLISM; PURKINJE
   NEURONS; FATTY LIVER; ESTROGEN; CARDIOMYOPATHY; ACTIVATION; AGE;
   DEHYDROGENASE
AB Introduction: Post-menopausal women have a greater risk of developing alcoholic complications compared to age-matched men. Unfortunately, animal models of chronic ethanol consumption with estrogen deficiency are lacking. Here, we characterize the ability of the agar block and Lieber-DeCarli models of chronic ethanol consumption to produce elevated blood alcohol content (BAC) and liver pathology in the F344 postmenopausal animal model of aging. Methods: Adult (3 mo) and aged (18 mo) F344 ovary-intact or ovariectomized rats were administered ethanol for 14-20 weeks as follows: diet 1, standard chow access, 10% ethanol in drinking water, and 40% ethanol in agar blocks; diet 2, diet 1 plus low phytoestrogen chow (known to affect ethanol metabolism) for the final 4 weeks; diet 3, Lieber-DeCarli all liquid diet with 36% kcal ethanol. Control animals were matched isocalorically with dextrin. Results: For the agar block diet, average BAC was 13 +/- 4 mg/dL across groups. BAC was unaffected by reducing dietary phytoestrogen content (12 +/- 4 mg/dL), which is known to interfere with ethanol metabolism. Liver pathology was unaffected by the agar block diet. In contrast, the Lieber-DeCarli diet resulted in BAC of 45 +/- 5 mg/dL in conjunction with more severe hepatopathology. Discussion: We conclude that the Lieber-DeCarli diet produces greater BAC and hepatopathology to study the effects of chronic ethanol administration in the F344 postmenopausal rodent model of aging when compared to an ethanol agar block diet. (C) 2012 Elsevier Inc. All rights reserved.
C1 [Sharda, Daniel R.; Miller-Lee, Jennifer L.; Kanski, Gregory M.; Hunter, J. Craig; Korzick, Donna H.] Penn State Univ, Dept Kinesiol, University Pk, PA 16802 USA.
   [Lang, Charles H.; Korzick, Donna H.] Penn State Univ, Inter Coll Grad Program Physiol, University Pk, PA 16802 USA.
   [Lang, Charles H.] PSU, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17036 USA.
   [Kennett, Mary J.] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA.
C3 Pennsylvania Commonwealth System of Higher Education (PCSHE);
   Pennsylvania State University; Pennsylvania State University -
   University Park; Pennsylvania Commonwealth System of Higher Education
   (PCSHE); Pennsylvania State University; Pennsylvania State University -
   University Park; Pennsylvania Commonwealth System of Higher Education
   (PCSHE); Pennsylvania State University; Pennsylvania State University -
   University Park
RP Korzick, DH (corresponding author), Penn State Univ, Dept Kinesiol, 106 Noll Lab, University Pk, PA 16802 USA.
EM dhk102@psu.edu
FU NIH [RC2 AA019403, RO1 HL091097, R37 AA11290]
FX This project was supported by NIH RC2 AA019403 and RO1 HL091097 to DHK;
   R37 AA11290 to CHL.
CR Augustyniak A, 2005, NUTRITION, V21, P925, DOI 10.1016/j.nut.2005.01.006
   Bautista AP, 1997, HEPATOLOGY, V25, P335, DOI 10.1002/hep.510250214
   Becker U, 1996, HEPATOLOGY, V23, P1025, DOI 10.1002/hep.510230513
   Bykov I, 2004, ALCOHOL ALCOHOLISM, V39, P499, DOI 10.1093/alcalc/agh103
   Chen JR, 2009, J BONE MINER RES, V24, P221, DOI 10.1359/JBMR.081011
   Clark JM, 2002, GASTROENTEROLOGY, V122, P1649, DOI 10.1053/gast.2002.33573
   DeNucci SM, 2010, GASTROENT RES PRACT, V2010, DOI 10.1155/2010/312790
   Dlugos CA, 1997, ALCOHOL ALCOHOLISM, V32, P161
   Dlugos CA, 2006, CEREBELLUM, V5, P155, DOI 10.1080/14734220600697187
   Eagon PK, 2010, WORLD J GASTROENTERO, V16, P1377, DOI 10.3748/wjg.v16.i11.1377
   Eagon PK, 2001, AM J PHYSIOL-GASTR L, V281, pG342, DOI 10.1152/ajpgi.2001.281.2.G342
   ERICKSON CK, 1984, ALCOHOL CLIN EXP RES, V8, P491, DOI 10.1111/j.1530-0277.1984.tb05710.x
   Fauchier L, 2000, EUR HEART J, V21, P306, DOI 10.1053/euhj.1999.1761
   FernandezSola J, 1997, AM J CARDIOL, V80, P481, DOI 10.1016/S0002-9149(97)00399-8
   Fogle RL, 2011, PHYSIOL GENOMICS, V43, P346, DOI 10.1152/physiolgenomics.00203.2010
   Fogle RL, 2010, ALCOHOL CLIN EXP RES, V34, P1226, DOI 10.1111/j.1530-0277.2010.01200.x
   GAVALER JS, 1993, ALCOHOL CLIN EXP RES, V17, P355, DOI 10.1111/j.1530-0277.1993.tb00775.x
   Grobe YG, 2010, ANN HEPATOL, V9, P402, DOI 10.1016/S1665-2681(19)31616-3
   Hunter JC, 2005, MECH AGEING DEV, V126, P535, DOI 10.1016/j.mad.2004.11.003
   Järveläinen HA, 2001, J HEPATOL, V35, P46, DOI 10.1016/S0168-8278(01)00050-2
   Jung KI, 2011, NEUROSCI LETT, V487, P149, DOI 10.1016/j.neulet.2010.10.011
   Kano M, 2002, J NUTR, V132, P238, DOI 10.1093/jn/132.2.238
   KHANNA JM, 1990, ALCOHOL, V7, P429, DOI 10.1016/0741-8329(90)90027-A
   Lang CH, 1998, ALCOHOL CLIN EXP RES, V22, P823, DOI 10.1111/j.1530-0277.1998.tb03874.x
   Laonigro I, 2009, EUR J HEART FAIL, V11, P453, DOI 10.1093/eurjhf/hfp037
   LI TK, 1984, ALCOHOL CLIN EXP RES, V8, P485
   LIEBER CS, 1965, J CLIN INVEST, V44, P1009, DOI 10.1172/JCI105200
   LIEBER CS, 1989, ALCOHOL ALCOHOLISM, V24, P197
   Lin RC, 1998, AM J CLIN NUTR, V68, p1512S, DOI 10.1093/ajcn/68.6.1512S
   LINDROS KO, 1983, LIVER, V3, P79
   Maddrey W C, 2000, Clin Liver Dis, V4, P115, DOI 10.1016/S1089-3261(05)70099-4
   McKenna CJ, 1998, AM HEART J, V135, P833, DOI 10.1016/S0002-8703(98)70042-0
   Novotny JL, 2009, ENDOCRINOLOGY, V150, P889, DOI 10.1210/en.2008-0708
   OTT JF, 1985, ALCOHOL CLIN EXP RES, V9, P59, DOI 10.1111/j.1530-0277.1985.tb05051.x
   Paquette A, 2007, MATURITAS, V58, P182, DOI 10.1016/j.maturitas.2007.08.002
   PENTNEY RJ, 1990, ALCOHOL CLIN EXP RES, V14, P878, DOI 10.1111/j.1530-0277.1990.tb01831.x
   Pentney Roberta J, 2002, Cerebellum, V1, P79, DOI 10.1080/147342202753203113
   RACHAMIN G, 1980, BIOCHEM J, V186, P483, DOI 10.1042/bj1860483
   Rajasingh J, 2007, ENDOCRINOLOGY, V148, P3618, DOI 10.1210/en.2006-1357
   RIKANS LE, 1987, ALCOHOL CLIN EXP RES, V11, P562, DOI 10.1111/j.1530-0277.1987.tb00175.x
   Savonenko AV, 2003, NEUROSCIENCE, V119, P821, DOI 10.1016/S0306-4522(03)00213-6
   Sone K, 2007, EXP ANIM TOKYO, V56, P139, DOI 10.1538/expanim.56.139
   Tadic SD, 2002, J APPL PHYSIOL, V93, P1057, DOI 10.1152/japplphysiol.00568.2001
   Tajuddin NF, 1996, ALCOHOL CLIN EXP RES, V20, P144, DOI 10.1111/j.1530-0277.1996.tb01057.x
   URBANOMARQUEZ A, 1995, JAMA-J AM MED ASSOC, V274, P149, DOI 10.1001/jama.274.2.149
   Vary TC, 2001, AM J PHYSIOL-HEART C, V281, pH1242, DOI 10.1152/ajpheart.2001.281.3.H1242
   Vary TC, 2007, AM J PHYSIOL-REG I, V292, pR778, DOI 10.1152/ajpregu.00203.2006
   Yin M, 2000, HEPATOLOGY, V31, P117, DOI 10.1002/hep.510310119
   Zhu PL, 2000, J MOL CELL CARDIOL, V32, P2091, DOI 10.1006/jmcc.2000.1233
NR 49
TC 9
Z9 9
U1 1
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1056-8719
EI 1873-488X
J9 J PHARMACOL TOX MET
JI J. Pharmacol. Toxicol. Methods
PD NOV-DEC
PY 2012
VL 66
IS 3
BP 257
EP 263
DI 10.1016/j.vascn.2012.08.166
PG 7
WC Pharmacology & Pharmacy; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Toxicology
GA 042RQ
UT WOS:000311489100007
PM 22951285
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Sumbalová, Z
   Ulicná, O
   Kucharská, J
   Rausová, Z
   Vancová, O
   Melichercík, L
   Tvrdík, T
   Nemec, M
   Kasparová, S
AF Sumbalova, Zuzana
   Ulicna, Ol'ga
   Kucharska, Jarmila
   Rausova, Zuzana
   Vancova, Ol'ga
   Melichercik, L'ubomir
   Tvrdik, Tomas
   Nemec, Marek
   Kasparova, Svatava
TI D-galactose-induced aging in rats - The effect of metformin on
   bioenergetics of brain, skeletal muscle and liver
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article; Early Access
DE Aging; D-galactose model; Metformin; Mitochondria respiration; P-31 MRS;
   Coenzyme Q
ID COENZYME Q(10); MITOCHONDRIAL DYSFUNCTION; ALZHEIMERS-DISEASE;
   INSULIN-RESISTANCE; COGNITIVE FUNCTION; ENERGY-METABOLISM; MODEL; HEART;
   QUANTIFICATION; COMBINATION
AB Chronic D-galactose administration induces accelerated aging in rodents. The aim of the study was to find by in vivo P-31 MRS suitable markers of early stages of brain degeneration on this metabolic model in rats. Additionally, we studied the therapeutic effect of antidiabetic drug metformin. The study has been extended by in vitro determination of mitochondrial function in brain, skeletal muscle and liver mitochondria, oxidative stress parameter thiobarbituric acid reactive substances (TBARS), and lipophilic antioxidants levels.
   In vivo P-31 MRS revealed lower intracellular pH (pHi) and lower inorganic phosphate to ATP ratio (Pi/ATP), with higher index of oxidative phosphorylation - phosphocreatine (PCr) to Pi ratio - in brain of rats chronically administered with D-galactose.
   The function of brain mitochondria was not affected. Administration of metformin diminished changes in brain pHi and plasma TBARS. The function of skeletal muscle mitochondria and their coenzyme Q (CoQ) content were considerably reduced after D-galactose administration. Metformin administered simultaneously with D-galactose did not prevent these changes.
   The results of in vivo P-31 MRS revealed evidence of early stage of neurodegeneration that may indicate preinflammation. Our data show different susceptibility of brain, skeletal muscle, and liver to the chronic exposure to D-galactose and metformin. The D-galactose model presented in the literature as a model for "age-related dementia" had much more devastating effects on skeletal muscle than on the brain.
C1 [Sumbalova, Zuzana; Ulicna, Ol'ga; Kucharska, Jarmila; Rausova, Zuzana; Vancova, Ol'ga] Comenius Univ, Fac Med, Pharmacobiochem Lab, Dept Internal Med 3, Sasinkova 4, Bratislava 81108, Slovakia.
   [Melichercik, L'ubomir; Tvrdik, Tomas; Nemec, Marek; Kasparova, Svatava] Slovak Univ Technol Bratislava, Fac Chem & Food Technol, NMR & MS Lab, Cent Labs, Bratislava, Slovakia.
   [Melichercik, L'ubomir; Tvrdik, Tomas] Comenius Univ, Slovak Med Univ, Fac Med, Dept Radiol, Bratislava, Slovakia.
   [Melichercik, L'ubomir; Tvrdik, Tomas] Univ Hosp Bratislava, Bratislava, Slovakia.
   [Nemec, Marek] EMPA Swiss Fed Labs Mat Sci & Technol, Bldg Energy Mat & Components Lab, Dubendorf, Switzerland.
C3 Comenius University Bratislava; Slovak University of Technology
   Bratislava; Slovak Medical University Bratislava; Comenius University
   Bratislava; Slovak Medical University Bratislava; Swiss Federal
   Institutes of Technology Domain; Swiss Federal Laboratories for
   Materials Science & Technology (EMPA)
RP Sumbalová, Z (corresponding author), Comenius Univ, Fac Med, Pharmacobiochem Lab, Dept Internal Med 3, Sasinkova 4, Bratislava 81108, Slovakia.
EM zuzana.sumbalova@fmed.uniba.sk
RI Kasparova, Svatava/JPL-8012-2023
OI Kasparova, Svatava/0000-0002-0204-7967; Rausova,
   Zuzana/0000-0002-3651-3145
FU  [VEGA 1/0415/16];  [APVV-150077]
FX This work was supported by grants VEGA 1/0415/16 and APVV-150077.
   Technical assistance: Anna.Stetkova and Jana Bertalanova from
   Pharmacobiochemical Laboratory of 3rd Department of Internal Medicine,
   Comenius University in Bratislava. We appreciate the help of Ladislav
   Ba.ciak, PhD. from Slovak University of Technology in Bratislava with
   AMARES program.
CR ABELL LL, 1952, J BIOL CHEM, V195, P357
   Rojas LBA, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-6
   Al-Dalaen, 2014, J BIOSCI BIOENG, V2, P60, DOI [10.11648/j.bio.20140205.11, DOI 10.11648/J.BIO.20140205.11]
   [Anonymous], SUIT005
   Azman KF, 2019, BIOGERONTOLOGY, V20, P763, DOI 10.1007/s10522-019-09837-y
   Baker Laura D, 2011, Arch Neurol, V68, P51, DOI 10.1001/archneurol.2010.225
   Banji OJF, 2014, FOOD CHEM TOXICOL, V74, P51, DOI 10.1016/j.fct.2014.08.020
   Begriche K, 2006, MITOCHONDRION, V6, P1, DOI 10.1016/j.mito.2005.10.004
   Begriche K, 2013, HEPATOLOGY, V58, P1497, DOI 10.1002/hep.26226
   Bo-Htay C, 2018, J CELL MOL MED, V22, P1392, DOI 10.1111/jcmm.13472
   Boengler K, 2017, J CACHEXIA SARCOPENI, V8, P349, DOI 10.1002/jcsm.12178
   CAMERON NE, 1992, EXP PHYSIOL, V77, P89, DOI 10.1113/expphysiol.1992.sp003585
   Campbell JM, 2018, J ALZHEIMERS DIS, V65, P1225, DOI 10.3233/JAD-180263
   Cardoso A, 2015, REJUV RES, V18, P497, DOI 10.1089/rej.2015.1684
   Chang L, 2014, J MED FOOD, V17, P357, DOI 10.1089/jmf.2013.2830
   Chen CN, 2015, AM J PHYSIOL-ENDOC M, V308, pE942, DOI 10.1152/ajpendo.00508.2014
   COTTER MA, 1992, EXP PHYSIOL, V77, P829, DOI 10.1113/expphysiol.1992.sp003649
   Dalle-Donne I, 2006, CLIN CHEM, V52, P601, DOI 10.1373/clinchem.2005.061408
   Miceli DD, 2018, OPEN VET J, V8, P193, DOI 10.4314/ovj.v8i2.13
   de Graaf RA., 2007, IN VIVO NMR SPECTROS
   Du F, 2008, P NATL ACAD SCI USA, V105, P6409, DOI 10.1073/pnas.0710766105
   Fan JJ, 2017, ONCOTARGET, V8, P17475, DOI [10.18632/oncotarget.15420, 10.18632/oncotarget.15728]
   Fatemi I, 2018, IRAN J BASIC MED SCI, V21, P19, DOI 10.22038/IJBMS.2017.24331.6071
   Fontaine E, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00753
   Forster MJ, 1996, P NATL ACAD SCI USA, V93, P4765, DOI 10.1073/pnas.93.10.4765
   Garg G, 2017, REJUV RES, V20, P173, DOI 10.1089/rej.2016.1883
   Ghadge A, 2016, GENES NUTR, V11, DOI 10.1186/s12263-016-0518-4
   Gnaiger E., 2020, MITOCHONDRIAL PATHWA, V2020, P2, DOI DOI 10.26124/BEC:2020-0002
   Graveron-Demilly D, 2014, MAGN RESON MATER PHY, V27, P113, DOI 10.1007/s10334-013-0393-4
   Grimm A, 2017, J NEUROCHEM, V143, P418, DOI 10.1111/jnc.14037
   Hadzi-Petrushev N, 2015, PHYSIOL RES, V64, P61, DOI 10.33549/physiolres.932786
   Ikawa M, 2021, BBA-GEN SUBJECTS, V1865, DOI 10.1016/j.bbagen.2020.129832
   JANERO DR, 1989, LIPIDS, V24, P125, DOI 10.1007/BF02535249
   JOVER A, 1963, J LIPID RES, V4, P228
   Kasparová S, 2006, NEUROCHEM INT, V48, P93, DOI 10.1016/j.neuint.2005.09.002
   Kasparova S., 2019, MAGNETIC MOMENTS CEN, P28
   Kaviani E, 2017, BEHAV BRAIN RES, V334, P55, DOI 10.1016/j.bbr.2017.07.029
   Kenawy S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183565
   Kucharská J, 2007, PHYSIOL RES, V56, pS49, DOI 10.33549/physiolres.931397
   Kucharská J, 2021, PHYSIOL RES, V70, P723, DOI 10.33549/physiolres.934664
   Kulkarni AS, 2020, CELL METAB, V32, P15, DOI 10.1016/j.cmet.2020.04.001
   Kulkarni AS, 2018, AGING CELL, V17, DOI 10.1111/acel.12723
   LANG JK, 1986, ANAL BIOCHEM, V157, P106, DOI 10.1016/0003-2697(86)90203-4
   Larsen S, 2012, DIABETOLOGIA, V55, P443, DOI 10.1007/s00125-011-2340-0
   Lay IS, 2021, J ADV RES, V28, P35, DOI 10.1016/j.jare.2020.06.015
   Leuner K, 2012, ANTIOXID REDOX SIGN, V16, P1421, DOI 10.1089/ars.2011.4173
   Li M, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01039
   Longo VD, 2015, AGING CELL, V14, P497, DOI 10.1111/acel.12338
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Madiraju AK, 2018, NAT MED, V24, P1384, DOI 10.1038/s41591-018-0125-4
   Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270
   Makova M., 2019, THESIS SLOVENSKA TEC
   Mandal PK, 2012, J ALZHEIMERS DIS, V31, pS75, DOI 10.3233/JAD-2012-120166
   Melicherck L., 2019, MAGNETIC MOMENTS CEN, P56
   Moreira PI, 2014, ANN TRANSL MED, V2, DOI 10.3978/j.issn.2305-5839.2014.06.10
   Mosca F, 2002, ANAL BIOCHEM, V305, P49, DOI 10.1006/abio.2002.5653
   Naressi A, 2001, MAGN RESON MATER PHY, V12, P141, DOI 10.1016/S1352-8661(01)00111-9
   Otsyula M, 2003, INT J TOXICOL, V22, P423, DOI 10.1080/10915810390251410
   Pecinová A, 2019, BIOFACTORS, V45, P703, DOI 10.1002/biof.1548
   Pecinova A, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/7038603
   Pessayre D, 2005, J HEPATOL, V42, P928, DOI 10.1016/j.jhep.2005.03.004
   Rapoport SI, 1996, NEURODEGENERATION, V5, P473, DOI 10.1006/neur.1996.0065
   Rijpma A, 2018, NEUROIMAGE-CLIN, V18, P254, DOI 10.1016/j.nicl.2018.01.031
   Rivera EJ, 2005, J ALZHEIMERS DIS, V8, P247
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Sammut IA, 1998, CRYOBIOLOGY, V36, P49, DOI 10.1006/cryo.1997.2063
   Sanchez-Rangel E, 2017, DIABETOLOGIA, V60, P1586, DOI 10.1007/s00125-017-4336-x
   Shin Kyung Rim, 2003, Nurs Health Sci, V5, P245, DOI 10.1046/j.1442-2018.2003.00161.x
   Shwe T, 2018, EXP GERONTOL, V101, P13, DOI 10.1016/j.exger.2017.10.029
   Sumbalová Z, 2010, CELL MOL NEUROBIOL, V30, P751, DOI 10.1007/s10571-010-9501-4
   Tasci I, 2014, ANN TRANSL MED, V2, DOI 10.3978/j.issn.2305-5839.2014.06.06
   TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0
   Tusková R, 2015, BEHAV BRAIN RES, V284, P257, DOI 10.1016/j.bbr.2015.02.016
   Tyrtyshnaia AA, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0747-8
   Vanhamme L, 1997, J MAGN RESON, V129, P35, DOI 10.1006/jmre.1997.1244
   Vial G, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00294
   Viollet B, 2013, ANN ENDOCRINOL-PARIS, V74, P123, DOI 10.1016/j.ando.2013.03.006
   Wang Y, 2019, CELL REP, V29, P1511, DOI 10.1016/j.celrep.2019.09.070
   Wei HF, 2005, BEHAV BRAIN RES, V157, P245, DOI 10.1016/j.bbr.2004.07.003
   Wessels B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100525
   Xu Y, 2009, BIOGERONTOLOGY, V10, P153, DOI 10.1007/s10522-008-9158-2
   Yager C, 2004, MOL GENET METAB, V81, P105, DOI 10.1016/j.ymgme.2003.10.001
   Yanar K, 2019, REJUV RES, V22, P521, DOI 10.1089/rej.2019.2185
NR 83
TC 3
Z9 3
U1 6
U2 20
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD 2022 JUN 15
PY 2022
VL 163
AR 111770
DI 10.1016/j.exger.2022.111770
EA MAR 2022
PG 10
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 1C1RB
UT WOS:000792903900005
PM 35314269
DA 2024-02-19
ER

PT J
AU Parini, P
   Angelin, B
   Rudling, M
AF Parini, P
   Angelin, B
   Rudling, M
TI Cholesterol and lipoprotein metabolism in aging - Reversal of
   hypercholesterolemia by growth hormone treatment in old rats
SO ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
LA English
DT Article
DE aging; cholesterol; cholesterol 7 alpha-hydroxylase; growth hormone; LDL
   receptor
ID LOW-DENSITY-LIPOPROTEIN; BILE-ACID SYNTHESIS; HUMAN-LIVER MICROSOMES;
   AGE-RELATED-CHANGES; APOLIPOPROTEIN-B; REGULATION INVIVO;
   LIPID-METABOLISM; LDL RECEPTOR; COENZYME-A; 7-ALPHA-HYDROXYLASE
AB Plasma cholesterol levels increase with age, as does the incidence of coronary heart disease. The mechanisms responsible for the age-related hypercholesterolemia are not well understood. An interesting hypothesis suggests that the relative deficiency in growth hormone (GH), which occurs with aging, contributes to the development of the age-related hypercholesterolemia, because GH has beneficial effects on cholesterol metabolism. In the present work, we tested this hypothesis by the administration of GH to normal rats of varying ages. Plasma lipids and hepatic cholesterol metabolism were characterized in 2-, 12-, and Is-month-old male Sprague-Dawley rats. In 2-month-old rats, GH specifically stimulated the hepatic low density lipoprotein (LDL) receptor expression in a dose-dependent way, both at the protein level and at the mRNA level. Concomitantly, plasma cholesterol increased by approximate to 30% within the large high density lipoprotein and LDL fractions. In 12-month-old animals, cholesterol 7 alpha-hydroxylase (C7 alpha OH) activity was reduced, whereas hepatic LDL receptors and plasma total cholesterol were unchanged. GH treatment (1 mg kg(-1) d(-1)) normalized the activity of C7 alpha OH and had effects on plasma cholesterol and LDL receptors similar to these seen In 2-month-old animals. In 18-month-old rats, plasma cholesterol was increased 2-fold, whereas hepatic LDL receptor expression and C7 alpha OH activity were similar to those of the 12-month-old animals. Infusion of CH to 18-month-old rats had similar effects on hepatic C7 alpha OH and LDL receptors as seen in 12-month-old rats. However, GH treatment strongly reduced the hypercholesterolemia in 18-month-old animals. We conclude that the age-dependent increase of plasma cholesterol in rats can be reversed by the administration of GH, presumably through the pleiotropic effects of this hormone on Lipoprotein metabolism.
C1 Huddinge Univ Hosp, Karolinska Inst, Novum, Metab Unit,Ctr Metab & Endocrinol,Dept Med, S-14186 Huddinge, Sweden.
   Huddinge Univ Hosp, Karolinska Inst, Novum, Mol Nutr Unit,Ctr Nutr & Toxicol, S-14186 Huddinge, Sweden.
C3 Karolinska Institutet; Karolinska Institutet
RP Rudling, M (corresponding author), Huddinge Univ Hosp, M63, S-14186 Huddinge, Sweden.
EM mats.rudling@cnt.ki.se
CR ABBOTT RD, 1983, ARTERIOSCLEROSIS, V3, P260, DOI 10.1161/01.ATV.3.3.260
   AKERLUND JE, 1991, GASTROENTEROLOGY, V100, P1046, DOI 10.1016/0016-5085(91)90281-O
   ANGELIN B, 1984, J LIPID RES, V25, P1159
   Angelin Bo, 1994, Current Opinion in Lipidology, V5, P160, DOI 10.1097/00041433-199405030-00002
   BANG P, 1991, ACTA ENDOCRINOL-COP, V124, P620, DOI 10.1530/acta.0.1240620
   BAUM CL, 1990, J BIOL CHEM, V265, P19263
   BROWN MS, 1981, SCIENCE, V212, P628, DOI 10.1126/science.6261329
   CARLSON LA, 1968, GERONTOLOGY, V14, P65, DOI 10.1159/000211644
   CASTELLI WP, 1989, AM J CARDIOL, V63, P12
   CHOI YS, 1987, EXP GERONTOL, V22, P339, DOI 10.1016/0531-5565(87)90032-5
   CORPAS E, 1993, ENDOCR REV, V14, P20, DOI 10.1210/er.14.1.20
   DAVIDSON MB, 1987, ENDOCR REV, V8, P115, DOI 10.1210/edrv-8-2-115
   EINARSSON K, 1985, NEW ENGL J MED, V313, P277, DOI 10.1056/NEJM198508013130501
   EINARSSON K, 1986, J LIPID RES, V27, P82
   EINARSSON K, 1989, J LIPID RES, V30, P739
   ELAM MB, 1992, ENDOCRINOLOGY, V131, P2717, DOI 10.1210/en.131.6.2717
   ERICSSON S, 1991, J CLIN INVEST, V87, P591, DOI 10.1172/JCI115034
   GRUNDY SM, 1985, ARTERIOSCLEROSIS, V5, P623, DOI 10.1161/01.ATV.5.6.623
   HEISS G, 1980, CIRCULATION, V61, P302, DOI 10.1161/01.CIR.61.2.302
   KOVANEN PT, 1981, P NATL ACAD SCI-BIOL, V78, P1194, DOI 10.1073/pnas.78.2.1194
   LEVINE GN, 1995, NEW ENGL J MED, V332, P512, DOI 10.1056/NEJM199502233320807
   MAHLEY RW, 1983, BIOCHIM BIOPHYS ACTA, V737, P197, DOI 10.1016/0304-4157(83)90001-1
   MAHLEY RW, 1981, J CLIN INVEST, V68, P1197, DOI 10.1172/JCI110365
   MILLAR JS, 1995, J LIPID RES, V36, P1155
   MILLER NE, 1984, LANCET, V1, P263
   NANJEE MN, 1988, BIOCHIM BIOPHYS ACTA, V959, P378, DOI 10.1016/0005-2760(88)90212-3
   NOSHIRO M, 1990, J BIOL CHEM, V265, P10036
   OLIVECRONA H, 1995, ARTERIOSCL THROM VAS, V15, P847, DOI 10.1161/01.ATV.15.7.847
   PARINI P, 1995, ENDOCRINOLOGY, V136, P3767, DOI 10.1210/en.136.9.3767
   Parini P, 1997, ARTERIOSCL THROM VAS, V17, P1800, DOI 10.1161/01.ATV.17.9.1800
   RUDLING M, 1993, P NATL ACAD SCI USA, V90, P8851, DOI 10.1073/pnas.90.19.8851
   Rudling M, 1997, J CLIN INVEST, V99, P2239, DOI 10.1172/JCI119398
   Rudling M, 1996, J CLIN INVEST, V97, P292, DOI 10.1172/JCI118415
   RUDLING M, 1992, J LIPID RES, V33, P493
   RUDLING M, 1992, P NATL ACAD SCI USA, V89, P6983, DOI 10.1073/pnas.89.15.6983
   RUDLING M, 1993, J CLIN INVEST, V91, P2796, DOI 10.1172/JCI116522
   RUDLING MJ, 1990, P NATL ACAD SCI USA, V87, P3469, DOI 10.1073/pnas.87.9.3469
   SCHNEEMAN BO, 1993, J NUTR, V123, P28
   Schwarz M, 1996, J BIOL CHEM, V271, P18024, DOI 10.1074/jbc.271.30.18017
   SJOBERG A, 1994, ENDOCRINOLOGY, V134, P790, DOI 10.1210/en.134.2.790
   SJOBERG A, 1992, ENDOCRINOLOGY, V130, P3356, DOI 10.1210/en.130.6.3356
   Snedecor G. W., 1980, STAT METHODS
   SONNTAG WE, 1980, ENDOCRINOLOGY, V107, P1875, DOI 10.1210/endo-107-6-1875
   SPADY DK, 1995, J CLIN INVEST, V96, P700, DOI 10.1172/JCI118113
   SPARKS CE, 1981, J LIPID RES, V22, P519
   STAHLBERG D, 1991, LIPIDS, V26, P349, DOI 10.1007/BF02537197
   STANGE EF, 1984, J LIPID RES, V25, P703
   Steinberg D., 1988, ATHEROSCLER REV, V18, P1
   STORY JA, 1981, LIPIDS, V16, P87, DOI 10.1007/BF02535679
   SUNDSETH SS, 1990, J BIOL CHEM, V265, P15090
   VLAHCEVIC ZR, 1991, HEPATOLOGY, V13, P590, DOI 10.1016/0270-9139(91)90317-O
NR 51
TC 70
Z9 76
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1079-5642
J9 ARTERIOSCL THROM VAS
JI Arterioscler. Thromb. Vasc. Biol.
PD APR
PY 1999
VL 19
IS 4
BP 832
EP 839
DI 10.1161/01.ATV.19.4.832
PG 8
WC Hematology; Peripheral Vascular Disease
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Hematology; Cardiovascular System & Cardiology
GA 184NE
UT WOS:000079617600003
PM 10195906
OA Bronze
DA 2024-02-19
ER

PT J
AU Brandt, T
   Mourier, A
   Tain, LS
   Partridge, L
   Larsson, NG
   Kühlbrandt, W
AF Brandt, Tobias
   Mourier, Arnaud
   Tain, Luke S.
   Partridge, Linda
   Larsson, Nils-Goeran
   Kuehlbrandt, Werner
TI Changes of mitochondrial ultrastructure and function during ageing in
   mice and <i>Drosophila</i>
SO ELIFE
LA English
DT Article
ID ELEGANS LIFE-SPAN; ATP SYNTHASE; CAENORHABDITIS-ELEGANS; DIETARY
   RESTRICTION; MATRIX GRANULES; INNER-MEMBRANE; CYTOCHROME-C; MOUSE HEART;
   CRISTAE; AGE
AB Ageing is a progressive decline of intrinsic physiological functions. We examined the impact of ageing on the ultrastructure and function of mitochondria in mouse and fruit flies (Drosophila melanogaster) by electron cryo-tomography and respirometry. We discovered distinct age-related changes in both model organisms. Mitochondrial function and ultrastructure are maintained in mouse heart, whereas subpopulations of mitochondria from mouse liver show age-related changes in membrane morphology. Subpopulations of mitochondria from young and old mouse kidney resemble those described for apoptosis. In aged flies, respiratory activity is compromised and the production of peroxide radicals is increased. In about 50% of mitochondria from old flies, the inner membrane organization breaks down. This establishes a clear link between inner membrane architecture and functional decline. Mitochondria were affected by ageing to very different extents, depending on the organism and possibly on the degree to which tissues within the same organism are protected against mitochondrial damage.
C1 [Brandt, Tobias; Kuehlbrandt, Werner] Max Planck Inst Biophys, Dept Biol Struct, Frankfurt, Germany.
   [Mourier, Arnaud; Larsson, Nils-Goeran] Max Planck Inst Biol Ageing, Dept Mitochondrial Biol, Cologne, Germany.
   [Mourier, Arnaud] Univ Bordeaux, Inst Biochim & Genet Cellulaires, UMR 5095, Bordeaux, France.
   [Mourier, Arnaud] CNRS, Inst Biochim & Genet Cellulaires, UMR 5095, Bordeaux, France.
   [Tain, Luke S.; Partridge, Linda] Max Planck Inst Biol Ageing, Dept Biol Mech Ageing, Cologne, Germany.
   [Partridge, Linda] UCL, Dept Genet Evolut & Environm, Inst Hlth Ageing, London, England.
   [Larsson, Nils-Goeran] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden.
C3 Max Planck Society; Max Planck Society; Universite de Bordeaux; Centre
   National de la Recherche Scientifique (CNRS); CNRS - National Institute
   for Biology (INSB); Centre National de la Recherche Scientifique (CNRS);
   CNRS - National Institute for Biology (INSB); Universite de Bordeaux;
   Max Planck Society; University of London; University College London;
   Karolinska Institutet
RP Kühlbrandt, W (corresponding author), Max Planck Inst Biophys, Dept Biol Struct, Frankfurt, Germany.
EM werner.kuehlbrandt@biophys.mpg.de
RI Partridge, Linda/A-5501-2010; tain, luke s/A-6388-2009; MOURIER,
   Arnaud/F-9657-2019; Larsson, Nils-Göran/GVS-5578-2022
OI MOURIER, Arnaud/0000-0002-5413-611X; Larsson,
   Nils-Göran/0000-0001-5100-996X; Partridge, Linda/0000-0001-9615-0094;
   Tain, Luke/0000-0002-5845-7383; Kuhlbrandt, Werner/0000-0002-2013-4810
FU Max-Planck-Gesellschaft; Deutsche Forschungsgemeinschaft
FX Max-Planck-Gesellschaft Werner Kuhlbrandt; Deutsche
   Forschungsgemeinschaft Werner Kuhlbrandt
CR Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343
   Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162
   Brust D, 2010, AGING CELL, V9, P761, DOI 10.1111/j.1474-9726.2010.00609.x
   Cho J, 2011, EXP GERONTOL, V46, P331, DOI 10.1016/j.exger.2010.08.010
   Cochemé HM, 2011, CELL METAB, V13, P340, DOI 10.1016/j.cmet.2011.02.003
   Dai DF, 2009, CIRCULATION, V119, P2789, DOI 10.1161/CIRCULATIONAHA.108.822403
   Daum B, 2013, P NATL ACAD SCI USA, V110, P15301, DOI 10.1073/pnas.1305462110
   DAVID H, 1961, Z ZELLFORSCH MIK ANA, V53, P857, DOI 10.1007/BF00345158
   Davies KM, 2012, P NATL ACAD SCI USA, V109, P13602, DOI 10.1073/pnas.1204593109
   Davies KM, 2011, P NATL ACAD SCI USA, V108, P14121, DOI 10.1073/pnas.1103621108
   de Magalhaes J. P., 2011, An Introduction to Gerontology, P21, DOI DOI 10.1017/CB39780511973697.002
   Ding WX, 2012, J BIOL CHEM, V287, P42373, DOI 10.1074/jbc.M112.413674
   Doonan R, 2008, GENE DEV, V22, P3236, DOI 10.1101/gad.504808
   Dröse S, 2012, ADV EXP MED BIOL, V748, P145, DOI 10.1007/978-1-4614-3573-0_6
   Ferguson M, 2005, BIOCHEM J, V390, P501, DOI 10.1042/BJ20042130
   Frangakis AS, 2001, J STRUCT BIOL, V135, P239, DOI 10.1006/jsbi.2001.4406
   Freyer C, 2012, NAT GENET, V44, P1282, DOI 10.1038/ng.2427
   Ghadially F.N, 1988, ULTRASTRUCTURAL PATH, V3rd ed., P191
   Ghadially FN, 2001, ULTRASTRUCT PATHOL, V25, P243
   Gilkerson RW, 2003, FEBS LETT, V546, P355, DOI 10.1016/S0014-5793(03)00633-1
   Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100
   Gruber J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019444
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Heidler T, 2010, BIOGERONTOLOGY, V11, P183, DOI 10.1007/s10522-009-9239-x
   HERTSENS RC, 1986, J ULTRA MOL STRUCT R, V94, P1, DOI 10.1016/0889-1605(86)90047-9
   Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115
   Itsara LS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1003974
   JACOB WA, 1994, MICROSC RES TECHNIQ, V27, P307, DOI 10.1002/jemt.1070270406
   Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013
   Lee SJ, 2010, CURR BIOL, V20, P2131, DOI 10.1016/j.cub.2010.10.057
   Lenaz G, 2012, ADV EXP MED BIOL, V942, P93, DOI 10.1007/978-94-007-2869-1_5
   Leslie AGW, 1999, BIOCHEM SOC T, V27, P37, DOI 10.1042/bst0270037
   Linford NJ, 2013, JOVE-J VIS EXP, DOI 10.3791/50068
   LUDATSCHER R, 1983, EXP GERONTOL, V18, P113, DOI 10.1016/0531-5565(83)90004-9
   MACDONALD R, 1961, ARCH INTERN MED, V107, P335, DOI 10.1001/archinte.1961.03620030023003
   Malliaras K, 2013, EMBO MOL MED, V5, P191, DOI 10.1002/emmm.201201737
   Merkwirth C, 2008, GENE DEV, V22, P476, DOI 10.1101/gad.460708
   Mourier A, 2014, HUM MOL GENET, V23, P2580, DOI 10.1093/hmg/ddt652
   Mourier A, 2010, BBA-BIOENERGETICS, V1797, P255, DOI 10.1016/j.bbabio.2009.10.011
   Mulligan CM, 2014, J GERONTOL A-BIOL, V69, P799, DOI 10.1093/gerona/glt209
   Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221
   Pfanner N, 2014, J CELL BIOL, V204, P1083, DOI 10.1083/jcb.201401006
   Rhodenizer D, 2008, EXP GERONTOL, V43, P739, DOI 10.1016/j.exger.2008.04.011
   Rinkevich Y, 2014, CELL REP, V7, P1270, DOI 10.1016/j.celrep.2014.04.018
   Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474
   Scheckhuber CQ, 2008, MOL GENET GENOMICS, V280, P365, DOI 10.1007/s00438-008-0378-6
   Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2
   SLAUTTER.DB, 1965, J CELL BIOL, V24, P1, DOI 10.1083/jcb.24.1.1
   SMITH DS, 1963, J CELL BIOL, V19, P115, DOI 10.1083/jcb.19.1.115
   SOHAL RS, 1970, EXP GERONTOL, V5, P213, DOI 10.1016/0531-5565(70)90040-9
   STEPHENS RJ, 1965, J CELL BIOL, V24, P500, DOI 10.1083/jcb.24.3.500
   Strauss M, 2008, EMBO J, V27, P1154, DOI 10.1038/emboj.2008.35
   Stuart Jeffrey A, 2014, Longev Healthspan, V3, P4, DOI 10.1186/2046-2395-3-4
   Sun MG, 2007, NAT CELL BIOL, V9, P1057, DOI 10.1038/ncb1630
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Turturro A, 2002, J GERONTOL A-BIOL, V57, pB379, DOI 10.1093/gerona/57.11.B379
   Van Raamsdonk JM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000361
   Vogel F, 2006, J CELL BIOL, V175, P237, DOI 10.1083/jcb.200605138
   Votyakova TV, 2001, J NEUROCHEM, V79, P266, DOI 10.1046/j.1471-4159.2001.00548.x
   Walker DW, 2004, P NATL ACAD SCI USA, V101, P10290, DOI 10.1073/pnas.0403767101
   WEINDRUCH RH, 1980, MECH AGEING DEV, V12, P375, DOI 10.1016/0047-6374(80)90070-6
   WILSON PD, 1975, GERONTOLOGY, V21, P95, DOI 10.1159/000212036
   WILSON PD, 1975, GERONTOLOGY, V21, P81, DOI 10.1159/000212035
   WROGEMANN K, 1985, BIOCHIM BIOPHYS ACTA, V806, P1, DOI 10.1016/0005-2728(85)90075-1
   Yang W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000556
   YEN TC, 1991, BIOCHEM BIOPH RES CO, V178, P124, DOI 10.1016/0006-291X(91)91788-E
NR 68
TC 98
Z9 103
U1 1
U2 19
PU ELIFE SCIENCES PUBLICATIONS LTD
PI CAMBRIDGE
PA SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND
SN 2050-084X
J9 ELIFE
JI eLife
PD JUL 12
PY 2017
VL 6
AR e24662
DI 10.7554/eLife.24662
PG 19
WC Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics
GA FF9TZ
UT WOS:000409361500001
PM 28699890
OA Green Submitted, Green Published, gold
DA 2024-02-19
ER

PT J
AU Xia, WZ
   Zhuang, L
   Deng, X
   Hou, M
AF Xia, Wenzheng
   Zhuang, Lei
   Deng, Xia
   Hou, Meng
TI Long noncoding RNA-p21 modulates cellular senescence via the
   Wnt/β-catenin signaling pathway in mesenchymal stem cells
SO MOLECULAR MEDICINE REPORTS
LA English
DT Article
DE mesenchymal stem cell; senescence; long noncoding RNA-p21;
   Wnt/beta-catenin signaling pathway; oxidative stress
ID EPIGENETIC REGULATION; OXIDATIVE STRESS; BETA-CATENIN; RNAS;
   TRANSPLANTATION; DISEASE; REPAIR
AB Mesenchymal stem cell (MSC)-based therapies have demonstrated efficacy in animal models of cardiovascular diseases. However, MSCs decrease in quantity and quality with age, which reduces their capacity for damage repair. Long noncoding (lnc) RNAs regulate gene transcription and the fate of post-transcriptional mRNA, affecting a broad range of age-associated physiological and pathological conditions, including cardiovascular disease and cancer cell senescence. However, the functional role of lncRNAs in stem cell senescence remains largely unknown. The present study isolated bone marrow-derived MSCs from young (8-week-old) and aged (18-month-old) male C57BL/6 mice. Cell proliferation was measured using a Cell Counting kit-8 assay, and the secretion of vascular endothelial growth factor, basic fibroblast growth factor, hepatocyte growth factor and insulin-like growth factor was measured by ELISA. Western blotting was performed to investigate beta-catenin protein expression. Oxidative stress was evaluated by detecting reactive oxygen species, and the activity of superoxide dismutase and malondialdehyde. MSCs isolated from aged mice demonstrated reduced proliferation and paracrine signaling, and increased oxidative stress and expression of lincRNA-p21compared with MSCs from younger mice. Silencing lincRNA-p21 in aged MSCs using small interfering RNA (siRNA) enhanced cell growth and paracrine function, and decreased oxidative stress. These results were reversed when beta-catenin expression was silenced using siRNA. In conclusion, lincRNA-p21 may serve a role in MSC senescence, and silencing lincRNA-p21 may rejuvenate MSCs by interacting with the Wnt/beta-catenin signaling pathway. Targeting lincRNA-p21 may therefore have important therapeutic implications for restoring endogenous MSCs in aged individuals.
C1 [Xia, Wenzheng] Wenzhou Med Univ, Affiliated Hosp 1, Dept Neurosurg, Wenzhou 325000, Zhejiang, Peoples R China.
   [Zhuang, Lei] Wenzhou Med Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Wenzhou 325000, Zhejiang, Peoples R China.
   [Deng, Xia; Hou, Meng] Wenzhou Med Univ, Affiliated Hosp 1, Dept Radiat Oncol, 2 Fuxue Lane, Wenzhou 325000, Zhejiang, Peoples R China.
C3 Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical
   University
RP Hou, M (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Radiat Oncol, 2 Fuxue Lane, Wenzhou 325000, Zhejiang, Peoples R China.
EM 244517813@qq.com
RI hou, meng/ISS-7950-2023
FU National Natural Science Foundation of China [81500261]; Science and
   Technology Planning Project of Wenzhou [Y20160125]
FX The present study was supported by the National Natural Science
   Foundation of China (grant no. 81500261; to M.H.) and the Science and
   Technology Planning Project of Wenzhou (grant no. Y20160125; to M.H.).
CR Almeida M, 2007, J BIOL CHEM, V282, P27298, DOI 10.1074/jbc.M702811200
   [Anonymous], 2015, J MOL CELL CARDIOL, DOI DOI 10.1016/j.yjmcc.2015.01.011
   Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012
   Blume CJ, 2015, LEUKEMIA, V29, P2015, DOI 10.1038/leu.2015.119
   Brunt KR, 2012, AM J PATHOL, V181, P2067, DOI 10.1016/j.ajpath.2012.08.021
   Dimmeler S, 2008, CIRC RES, V102, P1319, DOI 10.1161/CIRCRESAHA.108.175943
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   Florian MC, 2013, NATURE, V503, P392, DOI 10.1038/nature12631
   Gharibi B, 2014, STEM CELLS, V32, P2256, DOI 10.1002/stem.1709
   Hall JR, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.67
   Henson SM, 2014, J CLIN INVEST, V124, P4004, DOI 10.1172/JCI75051
   Hou M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085808
   Kornfeld JW, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00057
   Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776
   Liang HL, 2013, EUR HEART J, V34, P1681, DOI 10.1093/eurheartj/ehr131
   Liu WH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055487
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Madonna R, 2013, CIRC RES, V113, P902, DOI 10.1161/CIRCRESAHA.113.301690
   Malhotra S, 2009, CELL STEM CELL, V4, P27, DOI 10.1016/j.stem.2008.12.004
   Mercer TR, 2013, NAT STRUCT MOL BIOL, V20, P300, DOI 10.1038/nsmb.2480
   Nemeth MJ, 2007, P NATL ACAD SCI USA, V104, P15436, DOI 10.1073/pnas.0704747104
   Orlic D, 2001, P NATL ACAD SCI USA, V98, P10344, DOI 10.1073/pnas.181177898
   Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587
   Paige SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011134
   Shi Y, 2014, CELL DEATH DIFFER, V21, P612, DOI 10.1038/cdd.2013.186
   Stamm C, 2003, LANCET, V361, P45, DOI 10.1016/S0140-6736(03)12110-1
   Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005
   Wang J, 2015, ONCOTARGET, V6, P37852, DOI 10.18632/oncotarget.5635
   Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018
   Wollert KC, 2004, LANCET, V364, P141, DOI 10.1016/S0140-6736(04)16626-9
   Yang N, 2015, ONCOTARGET, V6, P28151, DOI 10.18632/oncotarget.4661
   Yoon JH, 2012, MOL CELL, V47, P648, DOI 10.1016/j.molcel.2012.06.027
   Zhang JH, 2005, NEUROSCI LETT, V373, P171, DOI 10.1016/j.neulet.2003.08.085
   Zhao XY, 2015, TRENDS BIOCHEM SCI, V40, P586, DOI 10.1016/j.tibs.2015.08.002
NR 34
TC 34
Z9 42
U1 0
U2 13
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1791-2997
EI 1791-3004
J9 MOL MED REP
JI Mol. Med. Rep.
PD NOV
PY 2017
VL 16
IS 5
BP 7039
EP 7047
DI 10.3892/mmr.2017.7430
PG 9
WC Oncology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Research & Experimental Medicine
GA FM0ZU
UT WOS:000414698900170
PM 28901439
OA Bronze
DA 2024-02-19
ER

PT J
AU Szczesny, B
   Mitra, S
AF Szczesny, B
   Mitra, S
TI Effect of aging on intracellular distribution of abasic (AP)
   endonuclease 1 in the mouse liver
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE APE1; abasic sited; intracellular distribution; mouse liver
ID MITOCHONDRIAL-DNA DAMAGE; NEGATIVE GENE-REGULATION; BASE
   EXCISION-REPAIR; RAT-LIVER; APURINIC/APYRIMIDINIC ENDONUCLEASE;
   OXIDATIVE DAMAGE; HUMAN-CELLS; PROTEIN; NUCLEAR; APE/REF-1
AB The abasic (AP) endonuclease (APE I) plays a central role in the base excision repair (BER) pathway for repairing oxidatively damaged bases and abasic sites in mammalian genomes. We have investigated age-dependent changes in APE activity, contributed primarily by APEI, in total extracts as well as in nuclear, mitochondrial, and cytoplasmic compartments of mouse hepatocytes. The APEI protein and mRNA levels did not differ significantly between the livers of 4-mo (young), 10-mo (middle-aged), and 20-mo (old) mice, and corresponds with similar APE activity. However, we observed a 2-fold increase in specific activity of APEI in the nucleus, a 2-fold decrease in the cytoplasm, and a 6-fold increase in the mitochondrial matrix of hepatocytes of the old relative to the young animals. Surprisingly, in the middle-age animals we observed 30% increase in APE activity in the nucleus but 6-fold in the mitochondrial matrix. These results indicate age-dependent accumulation of APE I in the nucleus and mitochondria. Such redistribution occurred early in the mitochondria during the aging process and preferential accumulation of APE in the nucleus was more gradual which may reflect distinct levels of oxidative stress in these organelles. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
C1 Univ Texas, Med Branch, Sealy Ctr Mol Sci, Dept Human Biol Chem & Genet, Galveston, TX 77555 USA.
C3 University of Texas System; University of Texas Medical Branch Galveston
RP Mitra, S (corresponding author), Univ Texas, Med Branch, Sealy Ctr Mol Sci, Dept Human Biol Chem & Genet, Galveston, TX 77555 USA.
EM samitra@utmb.edu
FU NIA NIH HHS [P01 AG10514] Funding Source: Medline; NIEHS NIH HHS [R01
   ES08457, P01 ES06676] Funding Source: Medline
CR Anitha V, 1996, MECH AGEING DEV, V90, P91, DOI 10.1016/0047-6374(96)01749-6
   Arai T, 2002, RES VET SCI, V72, P241, DOI 10.1053/rvsc.2002.0558
   Ardail D, 2003, BIOCHEM J, V371, P1013, DOI 10.1042/BJ20021834
   Bhakat KK, 2003, EMBO J, V22, P6299, DOI 10.1093/emboj/cdg595
   Bohr VA, 2002, FREE RADICAL BIO MED, V32, P804, DOI 10.1016/S0891-5849(02)00787-6
   Boiteux S, 2004, DNA REPAIR, V3, P1, DOI 10.1016/j.dnarep.2003.10.002
   CHEN DS, 1991, NUCLEIC ACIDS RES, V19, P5907, DOI 10.1093/nar/19.21.5907
   DEMPLE B, 1991, P NATL ACAD SCI USA, V88, P11450, DOI 10.1073/pnas.88.24.11450
   DIZDAROGLU M, 1992, MUTAT RES, V275, P331, DOI 10.1016/0921-8734(92)90036-O
   DODSON ML, 1994, J BIOL CHEM, V269, P32709
   DOMENA JD, 1985, BIOCHEMISTRY-US, V24, P7320, DOI 10.1021/bi00346a045
   DUGUID JR, 1995, CANCER RES, V55, P6097
   Edwards M, 1998, J NEUROSCI RES, V54, P635, DOI 10.1002/(SICI)1097-4547(19981201)54:5<635::AID-JNR8>3.0.CO;2-H
   ERICKSON RJ, 1961, NEW ENGL J MED, V265, P478, DOI 10.1056/NEJM196109072651006
   Evans AR, 2000, MUTAT RES-DNA REPAIR, V461, P83, DOI 10.1016/S0921-8777(00)00046-X
   Fountoulakis M, 2002, ELECTROPHORESIS, V23, P311, DOI 10.1002/1522-2683(200202)23:2<311::AID-ELPS311>3.0.CO;2-0
   Frossi B, 2002, J CELL PHYSIOL, V193, P180, DOI 10.1002/jcp.10159
   Fuchs S, 2003, J HYPERTENS, V21, P327, DOI 10.1097/00004872-200302000-00024
   Gordon DM, 2001, BIOCHEM J, V356, P207, DOI 10.1042/0264-6021:3560207
   Hadi MZ, 2000, ENVIRON MOL MUTAGEN, V36, P312, DOI 10.1002/1098-2280(2000)36:4<312::AID-EM7>3.3.CO;2-B
   Izumi T, 1998, CARCINOGENESIS, V19, P525, DOI 10.1093/carcin/19.3.525
   Izumi T, 2005, P NATL ACAD SCI USA, V102, P5739, DOI 10.1073/pnas.0500986102
   Kakolyris S, 1999, J PATHOL, V189, P351, DOI 10.1002/(SICI)1096-9896(199911)189:3<351::AID-PATH435>3.0.CO;2-1
   Krimmer T, 2001, CHEMBIOCHEM, V2, P505, DOI 10.1002/1439-7633(20010803)2:7/8<505::AID-CBIC505>3.3.CO;2-K
   LeDoux SP, 2001, PROG NUCLEIC ACID RE, V68, P273
   Lee HC, 1997, J FORMOS MED ASSOC, V96, P770
   LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0
   McDonald TG, 2003, BASIC RES CARDIOL, V98, P219, DOI 10.1007/s00395-003-0417-8
   MCHAFFE CS, 1995, BONE, P11
   MILLER JH, 1984, CELL, V37, P675, DOI 10.1016/0092-8674(84)90400-8
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   Mitra S, 1997, MOL CELLS, V7, P305
   Nash HM, 1996, CURR BIOL, V6, P968, DOI 10.1016/S0960-9822(02)00641-3
   OKAZAKI T, 1994, J BIOL CHEM, V269, P27855
   OKAZAKI T, 1992, J CLIN INVEST, V89, P1268, DOI 10.1172/JCI115711
   Osiewacz HD, 2002, GENE, V286, P65, DOI 10.1016/S0378-1119(01)00804-6
   Perez-Campo R, 1998, J COMP PHYSIOL B, V168, P149, DOI 10.1007/s003600050131
   Pfanner N, 2000, CURR BIOL, V10, pR412, DOI 10.1016/S0960-9822(00)00507-8
   Ramana CV, 1998, P NATL ACAD SCI USA, V95, P5061, DOI 10.1073/pnas.95.9.5061
   Rassow J, 2000, TRAFFIC, V1, P457, DOI 10.1034/j.1600-0854.2000.010603.x
   RUSINOL AE, 1994, J BIOL CHEM, V269, P27494
   Saito H, 2000, AM J PHYSIOL-HEART C, V279, pH2241, DOI 10.1152/ajpheart.2000.279.5.H2241
   Schülke N, 1999, J BIOL CHEM, V274, P22847, DOI 10.1074/jbc.274.32.22847
   SEKI S, 1991, J BIOL CHEM, V266, P20797
   SOHAL RS, 1995, FREE RADICAL BIO MED, V19, P499, DOI 10.1016/0891-5849(95)00037-X
   Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142
   Suh D, 1997, NUCLEIC ACIDS RES, V25, P2495, DOI 10.1093/nar/25.12.2495
   Szczesny B, 2004, MECH AGEING DEV, V125, P755, DOI 10.1016/j.mad.2004.07.005
   Szczesny B, 2003, P NATL ACAD SCI USA, V100, P10670, DOI 10.1073/pnas.1932854100
   Takao M, 1998, NUCLEIC ACIDS RES, V26, P2917, DOI 10.1093/nar/26.12.2917
   Tell G, 2000, NUCLEIC ACIDS RES, V28, P1099, DOI 10.1093/nar/28.5.1099
   Tell G, 2001, MUTAT RES-DNA REPAIR, V485, P143, DOI 10.1016/S0921-8777(00)00068-9
   TOMKINSON AE, 1988, J BIOL CHEM, V263, P12532
   Wei YH, 1998, P SOC EXP BIOL MED, V217, P53
   WILSON RE, 2000, MATH INDUST, V1, P293
   XANTHOUDAKIS S, 1992, EMBO J, V11, P3323, DOI 10.1002/j.1460-2075.1992.tb05411.x
   Xanthoudakis S, 1996, P NATL ACAD SCI USA, V93, P8919, DOI 10.1073/pnas.93.17.8919
   XANTHOUDAKIS S, 1994, P NATL ACAD SCI USA, V91, P23, DOI 10.1073/pnas.91.1.23
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
NR 59
TC 32
Z9 35
U1 0
U2 3
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
EI 1872-6216
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD OCT
PY 2005
VL 126
IS 10
BP 1071
EP 1078
DI 10.1016/j.mad.2005.04.001
PG 8
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 972HM
UT WOS:000232444900008
PM 15951004
DA 2024-02-19
ER

PT J
AU Donati, A
   Cavallini, G
   Carresi, C
   Gori, Z
   Parentini, L
   Bergamini, E
AF Donati, A
   Cavallini, G
   Carresi, C
   Gori, Z
   Parentini, L
   Bergamini, E
TI Anti-aging effects of anti-lipolytic drugs
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE aging; antilipolytic drugs; insulin; autophagy; dolichol; rat liver
ID STIMULATED INSULIN-SECRETION; ISOLATED RAT HEPATOCYTES; CIRCULATING
   FATTY-ACIDS; AUTOPHAGIC PROTEOLYSIS; PROTEIN-DEGRADATION;
   GROWTH-HORMONE; LIFE-SPAN; AGENT 3,5-DIMETHYLPYRAZOLE; DIETARY
   RESTRICTION; C-ELEGANS
AB Genetic disruption of insulin and insulin-like signaling pathways may extend lifespan. Hyperinsulinemia and insulin resistance may accelerate aging. The hypothesis was tested that a once-a-week life-long inhibition of insulin secretion by the administration of anti-lipolytic drugs might have anti-aging effects. Groups of 3-month-old male Sprague-Dawley rats were (a) given standard laboratory food ad libitum (AL); (b) fed AL 6 days and fasted 1 day every week (FW); (c) fed AL every other day (EOD), (d) fed like FW and given Acipimox (50 mg/kg b.w.) on the day of fasting (FWA) by the gastric tube. The AL, FW and EOD groups received saline intragastrically. Treatment with ACIPIMOX transiently decreased plasma free fatty acids, glucose and insulin and increased valine plasma levels, and had no long-term effect on food consumption and body weight. By age 6, 12 and 24 months subgroups were taken and the age-related changes in liver dolichol and autophagic proteolysis-which are correlated with life-expectancy-were measured. Liver dolichol levels increased and autophagic proteolysis decreased in mature and older AL rats; EOD and FWA fully counteracted these changes; FW rats had significant but smaller beneficial effects. It is concluded that life-long weekly-repeated transient inhibition of insulin secretion by antilipolytic drugs may have an anti-aging effect, additive to the anti-aging effect of a milder caloric restriction. Speculation is that transiently lower plasma insulin levels might stimulate the anti-aging cell-repair mechanism autophagy, which has longer lasting effects on cell housekeeping. (C) 2004 Elsevier Inc. All rights reserved.
C1 Univ Pisa, Ctr Ric Interdipartimentale Invecchiamento, I-56126 Pisa, Italy.
C3 University of Pisa
RP Bergamini, E (corresponding author), Univ Pisa, Ctr Ric Interdipartimentale Invecchiamento, Via Roma 55, I-56126 Pisa, Italy.
EM ebergami@med.unipi.it
CR Bartke A, 2001, TRENDS ENDOCRIN MET, V12, P233, DOI 10.1016/S1043-2760(01)00426-X
   Bergamini E, 2003, BIOMED PHARMACOTHER, V57, P203, DOI 10.1016/S0753-3322(03)00048-9
   BERGAMINI E, 1993, EXP MOL PATHOL, V59, P13, DOI 10.1006/exmp.1993.1023
   Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x
   Blommaart EFC, 1997, HISTOCHEM J, V29, P365, DOI 10.1023/A:1026486801018
   Blüher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223
   BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0
   Carter CS, 2002, TRENDS GENET, V18, P295, DOI 10.1016/S0168-9525(02)02696-3
   Cavallini G, 2002, AGING CLIN EXP RES, V14, P152
   Cavallini G, 2001, EXP GERONTOL, V36, P497, DOI 10.1016/S0531-5565(00)00224-2
   CUBEDDU TL, 1985, BIOCHIM BIOPHYS ACTA, V839, P96, DOI 10.1016/0304-4165(85)90186-2
   CUERVO MA, 2003, SCI SAGE KE, V36, pPE25
   Del Roso A, 2003, EXP GERONTOL, V38, P519, DOI 10.1016/S0531-5565(03)00002-0
   Dobbins RL, 1998, DIABETES, V47, P1613, DOI 10.2337/diabetes.47.10.1613
   Dolfi C, 2003, BIOGERONTOLOGY, V4, P113, DOI 10.1023/A:1023304021679
   Donati A, 2001, J GERONTOL A-BIOL, V56, pB375, DOI 10.1093/gerona/56.9.B375
   Duffy PH, 2001, AGING-CLIN EXP RES, V13, P263
   GERRITSEN GC, 1965, DIABETES, V14, P507, DOI 10.2337/diab.14.8.507
   HERBERT V, 1965, J CLIN ENDOCR METAB, V25, P1375, DOI 10.1210/jcem-25-10-1375
   Kenyon C, 2001, CELL, V105, P165, DOI 10.1016/S0092-8674(01)00306-3
   KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0
   Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942
   Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717
   LOCCICUBEDDU T, 1983, BIOCHEM PHARMACOL, V32, P1807, DOI 10.1016/0006-2952(83)90133-8
   Marino M, 1998, J GERONTOL A-BIOL, V53, pB87, DOI 10.1093/gerona/53A.2.B87
   MARINO M, 1990, BIOCHIM BIOPHYS ACTA, V1047, P192, DOI 10.1016/0005-2760(90)90047-2
   Masiello P, 2002, METABOLISM, V51, P110, DOI 10.1053/meta.2002.28969
   MASORO EJ, 2003, SCI SAGE KE
   Mattison JA, 2003, EXP GERONTOL, V38, P35, DOI 10.1016/S0531-5565(02)00146-8
   Meléndez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782
   Mortimore G E, 1996, Subcell Biochem, V27, P93
   Norrelund H, 2003, J CLIN ENDOCR METAB, V88, P4371, DOI 10.1210/jc.2003-030267
   PARRILLA R, 1974, DIABETES, V23, P725, DOI 10.2337/diab.23.9.725
   Peino R, 1996, J CLIN ENDOCR METAB, V81, P909, DOI 10.1210/jc.81.3.909
   REAVEN E, 1983, DIABETES, V32, P175, DOI 10.2337/diabetes.32.2.175
   SCHEIN PS, 1971, ENDOCRINOLOGY, V89, P827, DOI 10.1210/endo-89-3-827
   Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5
   SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889
   Stein DT, 1996, J CLIN INVEST, V97, P2728, DOI 10.1172/JCI118727
   TAPUHI Y, 1981, ANAL BIOCHEM, V115, P123, DOI 10.1016/0003-2697(81)90534-0
   Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987
   Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447
   VENERANDO R, 1994, AM J PHYSIOL, V266, pC455, DOI 10.1152/ajpcell.1994.266.2.C455
   WARD W, 1991, HEPATOLOGY, V14, P935, DOI 10.1002/hep.1840140529
   Ward Walter F, 2002, Prog Mol Subcell Biol, V29, P35
   YU BP, 1985, J GERONTOL, V40, P657, DOI 10.1093/geronj/40.6.657
NR 46
TC 31
Z9 35
U1 0
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD JUL
PY 2004
VL 39
IS 7
BP 1061
EP 1067
DI 10.1016/j.exger.2004.03.025
PG 7
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 840YC
UT WOS:000222895300009
PM 15236765
DA 2024-02-19
ER

PT J
AU He, YQ
   Yang, T
   Du, YM
   Qin, L
   Ma, FF
   Wu, ZP
   Ling, H
   Yang, L
   Wang, ZT
   Zhou, QD
   Ge, GB
   Lu, YL
AF He, Yuqi
   Yang, Tao
   Du, Yimei
   Qin, Lin
   Ma, Feifei
   Wu, Zunping
   Ling, Hua
   Yang, Li
   Wang, Zhengtao
   Zhou, Qingdi
   Ge, Guangbo
   Lu, Yanliu
TI High fat diet significantly changed the global gene expression profile
   involved in hepatic drug metabolism and pharmacokinetic system in mice
SO NUTRITION & METABOLISM
LA English
DT Article
DE High fat diet; Drug metabolism and pharmacokinetic; RNA-Seq;
   Transcriptome
ID INDUCED OBESITY; ACID; CYTOCHROME-P450; GLUCURONIDATION; ENZYMES; LIVER;
   STEATOSIS; PEPTIDE; RATS; 1A1
AB Background High fat diet impact transcription of hepatic genes responsible for drug metabolism and pharmacokinetics. Until now, researches just focused on a couple specific genes without a global profile showing. Age-dependent manner was also not noted well. This study aims to investigate the high fat diet effect on transcriptome of drug metabolism and pharmacokinetic system in mouse livers and show the age-dependent evidence. Methods C57BL/6 male mice were used in this experiment. High fat diet was used to treat mice for 16 and 38 weeks. Serum total cholesterol, low density lipoprotein cholesterol, aspartate transaminase, and alanine transaminaselevels were measured. Meanwhile, Histology, RNA-Seq, RT-PCR analysis and fourteen major hepatic bile acids quantification were performed for the liver tissues. Data was mined at levels of genes, drug metabolism and pharmacokinetic sysem, and genome wide. Results Treatment with high fat diet for 38 weeks significantly increased levels of serum lipids as well as aspartate transaminase, and alanine transaminase. Meanwhile, lipid accumulation in livers was observed. At week 38 of the experiment, the profile of 612 genes involved in drug metabolism and pharmacokinetics was significantly changed, indicated by a heatmap visulization and a principal component analysis. In total 210 genes were significantly regulated. Cyp3a11, Cyp4a10, and Cyp4a14 were down-regulated by 10-35 folds, while these three genes also were highly expressed in the liver. High fat diet regulated 11% of genome-wide gene while 30% of genes involved in the hepatic drug metabolism and pharmacokinetic system. Genes, including Adh4, Aldh1b1, Cyp3a11, Cyp4a10, Cyp8b1, Fmo2, Gsta3, Nat8f1, Slc22a7, Slco1a4, Sult5a1, and Ugt1a9, were regulated by high fat diet as an aging-dependent manner. Bile acids homeostasis, in which many genes related to metabolism and transportation were enriched, was also changed by high fat diet with an aging-dependet manner. Expression of genes in drug metabolism and disposition system significantly correlated to serum lipid profiles, and frequently correlated with each other. Conclusions High fat diet changed the global transcription profile of hepatic drug metabolism and pharmacokinetic system with a age-dependent manner.
C1 [He, Yuqi; Yang, Tao; Du, Yimei; Qin, Lin; Ma, Feifei; Wu, Zunping; Ge, Guangbo; Lu, Yanliu] Zunyi Med Univ, Sch Pharm, Key Lab, Minstry Educ Basic Pharmacol, 6 West Xue Fu Rd, Zunyi City 563009, Guizhou, Peoples R China.
   [He, Yuqi; Yang, Tao; Du, Yimei; Qin, Lin; Ma, Feifei; Wu, Zunping; Ge, Guangbo; Lu, Yanliu] Zunyi Med Univ, Sch Pharm, Joint Int Res Lab Ethnomed, Minist Educ, 6 West Xue Fu Rd, Zunyi City 563009, Guizhou, Peoples R China.
   [He, Yuqi; Yang, Li; Wang, Zhengtao; Lu, Yanliu] Shanghai Univ Tradit Chinese Med, Shanghai Key Lab Complex Prescript, Inst Chinese Mat Med, Shanghai, Peoples R China.
   [He, Yuqi; Yang, Li; Wang, Zhengtao; Lu, Yanliu] Shanghai Univ Tradit Chinese Med, Minist Educ MOE, Key Lab Standardizat Chinese Med, Shanghai, Peoples R China.
   [Ling, Hua] Philadelphia Coll Osteopath Med, Sch Pharm, Suwanee, GA USA.
   [Zhou, Qingdi] Univ Sydney, Sch Chem, Camperdown, NSW 2006, Australia.
   [Ge, Guangbo] Shanghai Univ Tradit Chinese Med, Inst Interdisciplinary Integrat Med Res, Shanghai, Peoples R China.
C3 Zunyi Medical University; Zunyi Medical University; Shanghai University
   of Traditional Chinese Medicine; Shanghai University of Traditional
   Chinese Medicine; University of Sydney; Shanghai University of
   Traditional Chinese Medicine
RP Ge, GB; Lu, YL (corresponding author), Zunyi Med Univ, Sch Pharm, Key Lab, Minstry Educ Basic Pharmacol, 6 West Xue Fu Rd, Zunyi City 563009, Guizhou, Peoples R China.; Ge, GB; Lu, YL (corresponding author), Zunyi Med Univ, Sch Pharm, Joint Int Res Lab Ethnomed, Minist Educ, 6 West Xue Fu Rd, Zunyi City 563009, Guizhou, Peoples R China.; Lu, YL (corresponding author), Shanghai Univ Tradit Chinese Med, Shanghai Key Lab Complex Prescript, Inst Chinese Mat Med, Shanghai, Peoples R China.; Lu, YL (corresponding author), Shanghai Univ Tradit Chinese Med, Minist Educ MOE, Key Lab Standardizat Chinese Med, Shanghai, Peoples R China.; Ge, GB (corresponding author), Shanghai Univ Tradit Chinese Med, Inst Interdisciplinary Integrat Med Res, Shanghai, Peoples R China.
EM geguangbo@dicp.ac.cn; yanliu.lu@foxmail.com
RI Zhang, Yihao/JGM-3514-2023; Du, Yimei/K-3232-2019; 王, 娅冰/JGE-0541-2023;
   sun, jiamin/JPY-2155-2023; Liu, Yixuan/JFJ-2820-2023
OI Du, Yimei/0000-0003-1125-0294; Yang, Li/0000-0002-5484-0895
FU National Nature Science Foundation of China [81560673, 81660685,
   81402985]; Ministry of Science and Technology of China [2017YFC1702005];
   Opening Project of Shanghai Key Laboratory of Complex Prescription;
   Ministry of Education (MOE) Key Laboratory for Standardization of
   Chinese Medicines [14DZ2271000, ZK1802]; Department of Science and
   Technology of Guizhou Province of China [QKHZDZXZ ([2015]6010), QKHZC
   [2019]2961, QKHZC [2019]2953, QKHPTRC [2019]5657]; Zunyi City of China
   [ZSKHSZ [2016]15, [2019]3]; Program for Excellent Young Talents of Zunyi
   Medical University [15zy-004]; Chun hui Plan of the Ministry of
   Education of China [Z2016003]
FX The study was supported by the National Nature Science Foundation of
   China (nos. 81560673, 81660685, and 81402985), the Ministry of Science
   and Technology of China (2017YFC1702005), Opening Project of Shanghai
   Key Laboratory of Complex Prescription and the Ministry of Education
   (MOE) Key Laboratory for Standardization of Chinese Medicines
   (14DZ2271000, and ZK1802), the Department of Science and Technology of
   Guizhou Province of China (nos. QKHZDZXZ ([2015]6010, [2019]3001), QKHZC
   [2019]2961, QKHZC [2019]2953, and QKHPTRC [2019]5657) and Zunyi City of
   China (ZSKHSZ ([2016]15, [2019]3),, Program for Excellent Young Talents
   of Zunyi Medical University (15zy-004), and Chun hui Plan of the
   Ministry of Education of China (Z2016003).
CR Abdelmegeed MA, 2016, FREE RADICAL BIO MED, V91, P188, DOI 10.1016/j.freeradbiomed.2015.12.016
   Almazroo OA, 2017, CLIN LIVER DIS, V21, P1, DOI 10.1016/j.cld.2016.08.001
   Core Team R, 2018, R LANG ENV STAT COMP
   Ghose R, 2011, LIFE SCI, V89, P57, DOI 10.1016/j.lfs.2011.05.005
   Hanagama Masakazu, 2008, Legal Medicine, V10, P177, DOI 10.1016/j.legalmed.2007.12.006
   Jang HH, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-27
   Jiao N, 2018, GUT, V67, P1881, DOI 10.1136/gutjnl-2017-314307
   John H, 2008, EUR J MED RES, V13, P73
   Katsila T, 2012, MASS SPECTROM REV, V31, P110, DOI 10.1002/mas.20340
   Kersemaekers WM, 2015, ANTIMICROB AGENTS CH, V59, P3385, DOI 10.1128/AAC.05000-14
   La Frano MR, 2017, NUTR RES, V46, P11, DOI 10.1016/j.nutres.2017.07.006
   Lépine J, 2004, J CLIN ENDOCR METAB, V89, P5222, DOI 10.1210/jc.2004-0331
   Li Y, 2019, XENOBIOTICA, V49, P152, DOI 10.1080/00498254.2018.1432087
   Lu YL, 2018, EVID-BASED COMPL ALT, V2018, DOI 10.1155/2018/8098059
   Luo T, 2016, J AGR FOOD CHEM, V64, P7492, DOI 10.1021/acs.jafc.6b03401
   Miyagi SJ, 2012, DRUG METAB DISPOS, V40, P1321, DOI 10.1124/dmd.111.043752
   Mukai M, 2014, PHARMAZIE, V69, P829, DOI 10.1691/ph.2014.4564
   Ning MR, 2017, DRUG METAB DISPOS, V45, P707, DOI 10.1124/dmd.117.075655
   Osabe M, 2008, DRUG METAB DISPOS, V36, P294, DOI 10.1124/dmd.107.017731
   Pozzo L, 2016, LIFE SCI, V166, P149, DOI 10.1016/j.lfs.2016.09.022
   Qi CL, 2019, XENOBIOTICA, V49, P276, DOI 10.1080/00498254.2018.1440657
   Qi YP, 2015, BBA-MOL CELL BIOL L, V1851, P19, DOI 10.1016/j.bbalip.2014.04.008
   Rae JM, 2001, J PHARMACOL EXP THER, V299, P849
   Rohart F, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005752
   Ruschel LR, 2017, GENET MOL RES, V16, DOI 10.4238/gmr16029598
   Sachan S., 2016, P 18 MED EL C MELECO, P1
   Siddens LK, 2014, BIOCHEM PHARMACOL, V89, P141, DOI 10.1016/j.bcp.2014.02.006
   Tabur S, 2016, OBES RES CLIN PRACT, V10, P719, DOI 10.1016/j.orcp.2016.03.001
   Wang CH, 2016, ENVIRON TOXICOL PHAR, V45, P52, DOI 10.1016/j.etap.2016.05.014
   Wang S, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-77
   Wang WC, 2017, OBESITY, V25, P132, DOI 10.1002/oby.21692
   Warnes G.R.B.B., 2020, GENTLEMAN R R PACKAG
   Wells MA, 2016, PROSTAG OTH LIPID M, V125, P19, DOI 10.1016/j.prostaglandins.2016.07.002
   Wickham H, 2016, GGPLOT2 ELEGANT GRAP
   Yang N, 2018, MOL PHARMACOL, V93, P216, DOI 10.1124/mol.117.110668
   Yang ZZ, 2017, ACTA PHARMACOL SIN, V38, P1184, DOI 10.1038/aps.2016.157
   Yu AM, 2016, ACTA PHARM SIN B, V6, P361, DOI 10.1016/j.apsb.2016.08.003
   Yun KU, 2010, ARCH TOXICOL, V84, P939, DOI 10.1007/s00204-010-0520-1
   Zeng J, 2018, ACTA PHARMACOL SIN, V39, P1393, DOI 10.1038/aps.2017.144
   Zhang L, 2019, BIOCHEM PHARMACOL, V164, P368, DOI 10.1016/j.bcp.2019.05.002
   Zhang XY, 2017, P NATL ACAD SCI USA, V114, P3181, DOI 10.1073/pnas.1700172114
   Zhang YC, 2010, J LIPID RES, V51, P3230, DOI 10.1194/jlr.M007641
NR 42
TC 13
Z9 14
U1 2
U2 36
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1743-7075
J9 NUTR METAB
JI Nutr. Metab.
PD MAY 24
PY 2020
VL 17
IS 1
AR 37
DI 10.1186/s12986-020-00456-w
PG 15
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA LT2ZV
UT WOS:000536941100003
PM 32489392
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Hsieh, CC
   Papaconstantinou, J
AF Hsieh, CC
   Papaconstantinou, J
TI The effect of aging on p38 signaling pathway activity in the mouse liver
   and in response to ROS generated by 3-nitropropionic acid
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE p38 MAPK; MKK3; 3-nitropropionic acid; oxidative stress; aging; mouse
   liver
ID PROTEIN-KINASE; C-JUN; OXIDATIVE STRESS; SELECTIVE ACTIVATION;
   TRANSDUCTION PATHWAY; GENE; JNK; AGE; PHOSPHORYLATION; ISOFORMS
AB Since mitochondrial dysfunction is a major source of oxidative stress in aged tissues, we asked whether the basal activities of stress response signaling pathway(s) are indicative of oxidative stress in aged tissues. To address this issue we asked whether: (a) aging affects the basal activity of the p38 MAPK stress signaling pathway; (b) the p38 MAPK pathway is activated by 3-nitropropionic acid (3-NPA), an inhibitor of complex 11 (succinic dehydrogenase) and generator of reactive oxygen species (ROS); (c) aging affects the response of the p38alpha signaling pathway to 3-NPA. Our studies have shown that the basal kinase activities of p38alpha, its upstream activator, MKK3, and its downstream substrate, ATF-2, are elevated in livers of aged C57BL/6 male mice and that these kinase activities, which are induced by 3-NPA in young livers, do not occur in aged livers. Furthermore, although aging does not affect their protein pool levels there are specific increases in phosphorylation of threonine residues in the p38alpha and ATF-2 catalytic sites that might account for the increased basal level kinase activities in the aged livers. Our studies suggest that failure to respond to 3-NPA may be a factor in the susceptibility of aged tissue to oxidative damage, and support our hypothesis that aged tissues (especially liver) develop a state of chronic stress even in the absence of a challenge. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
C1 Univ Texas, Med Branch, Dept Human Biol Chem & Genet, Galveston, TX 77555 USA.
C3 University of Texas System; University of Texas Medical Branch Galveston
RP Papaconstantinou, J (corresponding author), Univ Texas, Med Branch, Dept Human Biol Chem & Genet, 613 Basic Sci Bldg,Rt 0643, Galveston, TX 77555 USA.
EM jpapacon@utmb.edu
RI Papaconstantinou, John/E-3312-2010
FU NIA NIH HHS [P02 AG10514, P30 AG024832] Funding Source: Medline
CR ALAM T, 1993, J BIOL CHEM, V268, P15681
   AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   Aulak KS, 2001, P NATL ACAD SCI USA, V98, P12056, DOI 10.1073/pnas.221269198
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   BOSSI SR, 1993, NEUROREPORT, V4, P73, DOI 10.1097/00001756-199301000-00019
   COLES CJ, 1979, J BIOL CHEM, V254, P5161
   Conrad PW, 1999, J BIOL CHEM, V274, P23570, DOI 10.1074/jbc.274.33.23570
   DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144
   Enslen H, 1998, J BIOL CHEM, V273, P1741, DOI 10.1074/jbc.273.3.1741
   Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   FU YT, 1995, TOXICON, V33, P327, DOI 10.1016/0041-0101(94)00173-6
   GALCHEVAGARGOVA Z, 1994, SCIENCE, V265, P806, DOI 10.1126/science.8047888
   Golden TR, 2001, MECH AGEING DEV, V122, P1577, DOI 10.1016/S0047-6374(01)00288-3
   Goto S, 1999, MECH AGEING DEV, V107, P245, DOI 10.1016/S0047-6374(98)00133-X
   GOULD DH, 1985, TOXICOL LETT, V27, P83, DOI 10.1016/0378-4274(85)90123-7
   GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938
   Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698
   HAMILTON V, 1987, PSYCHOANAL PSYCHOL, V3, P67
   HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135
   Hsieh CC, 1998, MOL BIOL CELL, V9, P1479, DOI 10.1091/mbc.9.6.1479
   Kallunki T, 1996, CELL, V87, P929, DOI 10.1016/S0092-8674(00)81999-6
   KAPPUS H, 1986, BIOCHEM PHARMACOL, V35, P1, DOI 10.1016/0006-2952(86)90544-7
   Keesler GA, 1998, PROTEIN EXPRES PURIF, V14, P221, DOI 10.1006/prep.1998.0947
   KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0
   Li ZJ, 1996, BIOCHEM BIOPH RES CO, V228, P334, DOI 10.1006/bbrc.1996.1662
   LIN AN, 1995, SCIENCE, V268, P286, DOI 10.1126/science.7716521
   LIVINGSTONE C, 1995, EMBO J, V14, P1785, DOI 10.1002/j.1460-2075.1995.tb07167.x
   LUDOLPH AC, 1992, ANN NY ACAD SCI, V648, P300, DOI 10.1111/j.1749-6632.1992.tb24562.x
   Martin GM, 1996, NAT GENET, V13, P25, DOI 10.1038/ng0596-25
   Melov S, 1999, P NATL ACAD SCI USA, V96, P846, DOI 10.1073/pnas.96.3.846
   MINDEN A, 1994, MOL CELL BIOL, V14, P6683, DOI 10.1128/MCB.14.10.6683
   Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6
   PAPACONSTANTINOU J, 1994, ANN NY ACAD SCI, V719, P195, DOI 10.1111/j.1749-6632.1994.tb56829.x
   RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420
   Raingeaud J, 1996, MOL CELL BIOL, V16, P1247
   Saito H, 2001, J BIOL CHEM, V276, P29307, DOI 10.1074/jbc.M103740200
   Saito H, 1999, BIOCHEM BIOPH RES CO, V263, P270, DOI 10.1006/bbrc.1999.1373
   SANCHEZ I, 1994, NATURE, V372, P794, DOI 10.1038/372794a0
   SLUSS HK, 1994, MOL CELL BIOL, V14, P8376, DOI 10.1128/MCB.14.12.8376
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   Sohal RS, 1995, LIFE SCI R, V56, P109
   Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142
   Suh YS, 2001, MECH AGEING DEV, V122, P1797, DOI 10.1016/S0047-6374(01)00301-3
   SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2
   Wang XS, 1997, J BIOL CHEM, V272, P23668, DOI 10.1074/jbc.272.38.23668
   Wang YB, 1998, J BIOL CHEM, V273, P2161, DOI 10.1074/jbc.273.4.2161
   Wysk M, 1999, P NATL ACAD SCI USA, V96, P3763, DOI 10.1073/pnas.96.7.3763
   Yan LJ, 1997, P NATL ACAD SCI USA, V94, P11168, DOI 10.1073/pnas.94.21.11168
   ZHANG DE, 1990, J BIOL CHEM, V265, P3382
NR 52
TC 39
Z9 44
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
EI 1872-6216
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD SEP
PY 2002
VL 123
IS 11
BP 1423
EP 1435
AR PII S0047-6374(02)00084-2
DI 10.1016/S0047-6374(02)00084-2
PG 13
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 618JN
UT WOS:000179415100001
PM 12425949
DA 2024-02-19
ER

PT J
AU Han, LL
   Sun, RR
   Wang, Y
   Luo, JM
   Peng, XC
AF Han, Lulu
   Sun, Rongrong
   Wang, Yong
   Luo, Jianming
   Peng, Xichun
TI Soybean diacylglycerol regulates lipid metabolism in d-galactose-induced
   aging rats by altering gut microbiota and gene expression of colonic
   epithelial cells
SO FOOD & FUNCTION
LA English
DT Article; Early Access
ID HORMONE-SENSITIVE LIPASE; ACID-BINDING PROTEIN; FAT; STREPTOCOCCUS;
   DISEASE
AB Lipid metabolism is closely related to the health of aging bodies and its disorder often leads to cardiovascular diseases and chronic diseases. Dietary fat is one of the important sources of body fat, which affects the body's lipid metabolism. However, how dietary fat affects lipid metabolism in aging bodies has not been reported. Thus, the effects of soybean diacylglycerol (DAG) on lipid metabolism in d-galactose-induced aging rats were investigated by detecting the serum biochemical indexes, hepatocyte morphology, gut microbiota changes, and gene expression of colonic epithelial cells. The results showed that DAG alleviated the lipid metabolism disorders, and the hepatocyte morphology of aging rats fed DAG was normal. 16S rDNA analysis showed that DAG restored Eisenbergiella and Veillonella that were missing in aging rats. The relative abundances of Romboutsia and Ruminococcus_2 decreased and the relative abundance of Lachnospiraceae NK4A136 group increased significantly with the influence of DAG (P < 0.05). Gene expression profiles showed that the gene expression of colon epithelial cells was altered by DAG and DAG downregulated the genes Lipe and Fabp4 related to the lipolysis of adipocytes. In conclusion, DAG regulated the lipid metabolism of aging rats by regulating gut microbiota and gene expression of colonic epithelial cells.
C1 [Han, Lulu; Sun, Rongrong; Wang, Yong; Luo, Jianming; Peng, Xichun] Jinan Univ, Dept Food Sci & Engn, Guangzhou 510630, Peoples R China.
C3 Jinan University
RP Luo, JM; Peng, XC (corresponding author), Jinan Univ, Dept Food Sci & Engn, Guangzhou 510630, Peoples R China.
EM luojm@jnu.edu.cn; tpxchun@jnu.edu.cn
RI wang, wenjuan/JGD-0428-2023; wu, p/JDW-5015-2023
OI wang, wenjuan/0000-0002-4220-8817; 
FU China National Key Research and Development Projects [2017YFD0400200]
FX This work was supported by the China National Key Research and
   Development Projects (No. 2017YFD0400200).
CR Alves-Bezerra M, 2018, COMPR PHYSIOL, V8, P1, DOI 10.1002/cphy.c170012
   Anantharaju A, 2002, GERONTOLOGY, V48, P343, DOI 10.1159/000065506
   Bäckhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101
   Indiani CMDP, 2018, CHILD OBES, V14, P501, DOI 10.1089/chi.2018.0040
   Duncan RE, 2007, ANNU REV NUTR, V27, P79, DOI 10.1146/annurev.nutr.27.061406.093734
   Fang XB, 2017, MEAT SCI, V131, P107, DOI 10.1016/j.meatsci.2017.05.003
   Hall AB, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0490-5
   Henke MT, 2019, P NATL ACAD SCI USA, V116, P12672, DOI 10.1073/pnas.1904099116
   Howell WH, 1997, AM J CLIN NUTR, V65, P1747, DOI 10.1093/ajcn/65.6.1747
   Huang W, 2020, J HAZARD MATER, V384, DOI 10.1016/j.jhazmat.2019.121310
   Just S, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0510-8
   Kralisch S, 2013, DIABETOLOGIA, V56, P10, DOI 10.1007/s00125-012-2737-4
   Le Roy T, 2013, GUT, V62, P1787, DOI 10.1136/gutjnl-2012-303816
   Li J, 2017, J CLIN PHARM THER, V42, P649, DOI 10.1111/jcpt.12559
   [李瑞芳 Li Ruifang], 2020, [中华消化杂志, Chinese Journal of Digestion], V40, P861
   López-Torres M, 2002, FREE RADICAL BIO MED, V32, P882, DOI 10.1016/S0891-5849(02)00773-6
   Ma LY, 2020, GUT MICROBES, V12, DOI 10.1080/19490976.2020.1832857
   Maeso-Díaz R, 2018, AGING CELL, V17, DOI 10.1111/acel.12829
   Magne F, 2020, NUTRIENTS, V12, DOI 10.3390/nu12051474
   Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123
   Mashima I, 2014, ANAEROBE, V28, P54, DOI 10.1016/j.anaerobe.2014.05.003
   Mashima I, 2013, INT J SYST EVOL MICR, V63, P1443, DOI 10.1099/ijs.0.042515-0
   Mc Auley MT, 2014, EXPERT REV ENDOCRINO, V9, P357, DOI 10.1586/17446651.2014.921569
   Partridge L, 2018, NATURE, V561, P45, DOI 10.1038/s41586-018-0457-8
   Prentice KJ, 2019, J LIPID RES, V60, P734, DOI [10.1194/jlr.S091793, 10.1194/jlr.s091793]
   Rovery C, 2005, EMERG INFECT DIS, V11, P1112, DOI 10.3201/eid1107.041361
   Schoeler M, 2019, REV ENDOCR METAB DIS, V20, P461, DOI 10.1007/s11154-019-09512-0
   Shiau MY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47908-9
   Smith AJ, 2007, J BIOL CHEM, V282, P32424, DOI 10.1074/jbc.M703730200
   Tada N, 2003, CURR OPIN LIPIDOL, V14, P29, DOI 10.1097/00041433-200302000-00006
   Togo A. H., 2016, New Microbes and New Infections, V13, P15, DOI 10.1016/j.nmni.2016.05.015
   van den Bogert B, 2013, FEMS MICROBIOL ECOL, V85, P376, DOI 10.1111/1574-6941.12127
   [汪勇 Wang Yong], 2010, [中国粮油学报, Journal of the Chinese Cereals and Oils Association], V25, P119
   Xie JL, 2019, FOOD NUTR RES, V63, DOI 10.29219/fnr.v63.1559
   Xu PF, 2017, J PINEAL RES, V62, DOI 10.1111/jpi.12399
   Xue B, 2016, FOOD FUNCT, V7, P1501, DOI 10.1039/c5fo01438g
   Yanai H, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-43
   Zechner R, 2014, CELL METAB, V20, P199, DOI 10.1016/j.cmet.2014.07.018
NR 38
TC 1
Z9 2
U1 4
U2 29
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2042-6496
EI 2042-650X
J9 FOOD FUNCT
JI Food Funct.
PD 2022 FEB 7
PY 2022
VL 13
IS 3
BP 1437
EP 1446
DI 10.1039/d1fo04140a
EA DEC 2021
PG 10
WC Biochemistry & Molecular Biology; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Food Science & Technology
GA YU3WY
UT WOS:000744559100001
PM 35048932
DA 2024-02-19
ER

PT J
AU SCHNEEMAN, BO
   RICHTER, D
AF SCHNEEMAN, BO
   RICHTER, D
TI CHANGES IN PLASMA AND HEPATIC LIPIDS, SMALL-INTESTINAL HISTOLOGY AND
   PANCREATIC-ENZYME ACTIVITY DUE TO AGING AND DIETARY FIBER IN RATS
SO JOURNAL OF NUTRITION
LA English
DT Article
DE DIETARY FIBER; GASTROINTESTINAL; AGING; CHOLESTEROL; RATS
ID CHOLESTEROL; PROTEIN
AB Rats were fed either a control diet or a control diet supplemented with wheat bran, psyllium husk or oat bran to increase intake of fiber. Groups of rats were killed after 3.5, 10, 15, or 18.5 mo of consuming the diets. Plasma cholesterol and triglyceride concentrations were significantly higher in 18.5-mo-old than younger animals. Fiber supplementation did not prevent the age-related increase in lipids. Cecal weight, including contents, was higher in the psyllium husk and oat bran groups than control, and smooth muscle thickness in the ileum of psyllium husk and oat bran animals was greater than control. The score for torn villi in the small intestine was lower than expected in the wheat bran group. Amylase activity in the pancreas declined significantly with age in all groups. In aging animals fiber supplementation may enhance ileal compensation for decreases in proximal intestinal function but does not prevent age-related changes in the gut or in lipid concentrations.
RP SCHNEEMAN, BO (corresponding author), UNIV CALIF DAVIS,DEPT NUTR,DAVIS,CA 95616, USA.
OI Schneeman, Barbara/0000-0001-7390-536X
FU NIDDK NIH HHS [DK20446] Funding Source: Medline
CR ADLER G, 1975, HORM METAB RES, V7, P290, DOI 10.1055/s-0028-1093717
   ALLAIN CC, 1974, CLIN CHEM, V20, P470
   BARTOS V, 1969, GERONTOL CLIN, V11, P56, DOI 10.1159/000245215
   CARLSON SE, 1977, CLIN CHIM ACTA, V79, P575, DOI 10.1016/0009-8981(77)90178-4
   CASSIDY MM, 1981, AM J CLIN NUTR, V34, P218, DOI 10.1093/ajcn/34.2.218
   CUMMINGS JH, 1986, CRC HDB DIETARY FIBE, P211
   DARMENTON P, 1989, MECH AGEING DEV, V50, P49, DOI 10.1016/0047-6374(89)90058-4
   DESCHRIJVER R, 1990, J NUTR, V120, P1624, DOI 10.1093/jn/120.12.1624
   DYGERT S, 1965, ANAL BIOCHEM, V13, P367, DOI 10.1016/0003-2697(65)90327-1
   EIFFERT KC, 1991, J NUTR, V121, P1081, DOI 10.1093/jn/121.7.1081
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   GREENBERG RE, 1986, DIGEST DIS SCI, V31, P970, DOI 10.1007/BF01303218
   Health. & N.R.C.U.C.o.D.a., 1989, DIET HLTH IMPLICATIO
   HINEGARDNER RT, 1971, ANAL BIOCHEM, V39, P197, DOI 10.1016/0003-2697(71)90476-3
   HOLT PR, 1984, J GERONTOL, V39, P642, DOI 10.1093/geronj/39.6.642
   HUMMEL BCW, 1959, CAN J BIOCHEM PHYS, V37, P1393, DOI 10.1139/o59-157
   JACOBS LR, 1984, AM J PHYSIOL, V246, pG378, DOI 10.1152/ajpgi.1984.246.4.G378
   JOHNSON IT, 1986, BRIT J NUTR, V55, P497, DOI 10.1079/BJN19860057
   LAURELL CB, 1966, ANAL BIOCHEM, V15, P45, DOI 10.1016/0003-2697(66)90246-6
   NEY DM, 1986, J NUTR, V116, P2106, DOI 10.1093/jn/116.11.2106
   REVILLE M, 1991, J NUTR, V121, P498, DOI 10.1093/jn/121.4.498
   RICHTER BD, 1987, J NUTR, V117, P247, DOI 10.1093/jn/117.2.247
   SCHNEEMAN BO, 1982, J NUTR, V112, P283, DOI 10.1093/jn/112.2.283
   SCHNEEMAN BO, 1983, J NUTR, V113, P921, DOI 10.1093/jn/113.4.921
   STRUMEYE.DH, 1967, ANAL BIOCHEM, V19, P61, DOI 10.1016/0003-2697(67)90134-0
   THOMSON ABR, 1986, CAN J PHYSIOL PHARM, V64, P30, DOI 10.1139/y86-004
   1989, GASTROINTESTINAL ADA
   1988, 8850210 US DEP HLTH
NR 28
TC 29
Z9 29
U1 0
U2 2
PU AMER INST NUTRITION
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814
SN 0022-3166
J9 J NUTR
JI J. Nutr.
PD JUL
PY 1993
VL 123
IS 7
BP 1328
EP 1337
DI 10.1093/jn/123.7.1328
PG 10
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA LK562
UT WOS:A1993LK56200017
PM 7686573
OA Bronze
DA 2024-02-19
ER

PT J
AU Park, JY
   Cho, MO
   Leonard, S
   Calder, B
   Mian, IS
   Kim, WH
   Wijnhoven, S
   van Steeg, H
   Mitchell, J
   van der Horst, GTJ
   Hoeijmakers, J
   Cohen, P
   Vijg, J
   Suh, Y
AF Park, Jung Yoon
   Cho, Mi-Ook
   Leonard, Shanique
   Calder, Brent
   Mian, I. Saira
   Kim, Woo Ho
   Wijnhoven, Susan
   van Steeg, Harry
   Mitchell, James
   van der Horst, Gijsbertus T. J.
   Hoeijmakers, Jan
   Cohen, Pinchas
   Vijg, Jan
   Suh, Yousin
TI Homeostatic Imbalance between Apoptosis and Cell Renewal in the Liver of
   Premature Aging Xpd<SUP>TTD</SUP> Mice
SO PLOS ONE
LA English
DT Article
ID DNA-REPAIR; GENOMIC INSTABILITY; SOMATIC MUTATIONS; LIFE-SPAN; P53;
   GENE; DEFICIENT; FAS; MECHANISMS; PATHWAYS
AB Unrepaired or misrepaired DNA damage has been implicated as a causal factor in cancer and aging. Xpd(TTD) mice, harboring defects in nucleotide excision repair and transcription due to a mutation in the Xpd gene (R722W), display severe symptoms of premature aging but have a reduced incidence of cancer. To gain further insight into the molecular basis of the mutant-specific manifestation of age-related phenotypes, we used comparative microarray analysis of young and old female livers to discover gene expression signatures distinguishing Xpd(TTD) mice from their age-matched wild type controls. We found a transcription signature of increased apoptosis in the Xpd(TTD) mice, which was confirmed by in situ immunohistochemical analysis and found to be accompanied by increased proliferation. However, apoptosis rate exceeded the rate of proliferation, resulting in homeostatic imbalance. Interestingly, a metabolic response signature was observed involving decreased energy metabolism and reduced IGF-1 signaling, a major modulator of life span. We conclude that while the increased apoptotic response to endogenous DNA damage contributes to the accelerated aging phenotypes and the reduced cancer incidence observed in the Xpd(TTD) mice, the signature of reduced energy metabolism is likely to reflect a compensatory adjustment to limit the increased genotoxic stress in these mutants. These results support a general model for premature aging in DNA repair deficient mice based on cellular responses to DNA damage that impair normal tissue homeostasis.
C1 [Park, Jung Yoon; Cho, Mi-Ook; Suh, Yousin] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA.
   [Leonard, Shanique] Univ Texas, Hlth Sci Ctr San Antonio, Barshop Inst Longevity & Aging Stud, Dept Physiol, San Antonio, TX USA.
   [Calder, Brent; Vijg, Jan] Buck Inst Age Res, Novato, CA USA.
   [Mian, I. Saira] Lawrence Berkeley Natl Lab, Berkeley, CA USA.
   [Kim, Woo Ho] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul, South Korea.
   [Wijnhoven, Susan; van Steeg, Harry] Natl Inst Publ Hlth & Env, Lab Toxicol, Pathol & Genet, Bilthoven, Netherlands.
   [Mitchell, James; van der Horst, Gijsbertus T. J.; Hoeijmakers, Jan] Erasmus MC, MGC Dept Cell Biol & Genet, Rotterdam, Netherlands.
   [Cohen, Pinchas] Univ Calif Los Angeles, Los Angeles, CA USA.
   [Park, Jung Yoon; Cho, Mi-Ook; Suh, Yousin] Albert Einstein Coll Med, Dept Mol Genet, Bronx, NY USA.
C3 Yeshiva University; Albert Einstein College of Medicine; University of
   Texas System; University of Texas Health Science Center at San Antonio;
   Buck Institute for Research on Aging; United States Department of Energy
   (DOE); Lawrence Berkeley National Laboratory; Seoul National University
   (SNU); Erasmus University Rotterdam; Erasmus MC; University of
   California System; University of California Los Angeles; Yeshiva
   University; Albert Einstein College of Medicine
RP Park, JY (corresponding author), Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA.
EM ysuh@aecom.yu.edu
RI Meigs, James/P-3927-2019; Hoeijmakers, Jan/AAX-6972-2021; van der Horst,
   Gijsbertus (Bert)/E-3661-2015; Kim, Wooho/G-3703-2011
OI Meigs, James/0000-0002-2439-2657; van der Horst, Gijsbertus
   (Bert)/0000-0002-7773-6396; 
FU US National Institute of Health [RO1 AG024391, RO3 AG023292, PO1
   AG17242, RO1AG20438, UO1ES11044]
FX This work was supported by grants from the US National Institute of
   Health (RO1 AG024391 and RO3 AG023292) awarded to YS, and (PO1 AG17242,
   RO1AG20438, UO1ES11044) awarded to JV.
CR Andressoo JO, 2006, CELL CYCLE, V5, P2886, DOI 10.4161/cc.5.24.3565
   Bartke A, 2005, ENDOCRINOLOGY, V146, P3718, DOI 10.1210/en.2005-0411
   Bohr VA, 2005, DNA REPAIR, V4, P293, DOI 10.1016/j.dnarep.2004.09.010
   Compe E, 2005, MOL CELL BIOL, V25, P6065, DOI 10.1128/MCB.25.14.6065-6076.2005
   de Boer J, 1998, MOL CELL, V1, P981, DOI 10.1016/S1097-2765(00)80098-2
   de Boer J, 2002, SCIENCE, V296, P1276, DOI 10.1126/science.1070174
   Desagher S, 2005, J BIOL CHEM, V280, P5693, DOI 10.1074/jbc.M408971200
   DEVRIES A, 1995, NATURE, V377, P169, DOI 10.1038/377169a0
   Dollé MET, 2006, MUTAT RES-FUND MOL M, V596, P22, DOI 10.1016/j.mrfmmm.2005.11.008
   Dubaele S, 2003, MOL CELL, V11, P1635, DOI 10.1016/S1097-2765(03)00182-5
   Fraser AG, 2004, NAT GENET, V36, P559, DOI 10.1038/ng1370
   Giese H, 1999, ONCOGENE, V18, P1257, DOI 10.1038/sj.onc.1202404
   Haga S, 2003, J CLIN INVEST, V112, P989, DOI 10.1172/JCI200317970
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Hasty P, 2004, AGING CELL, V3, P55, DOI 10.1111/j.1474-9728.2004.00082.x
   Hatano E, 2007, J GASTROEN HEPATOL, V22, pS43, DOI 10.1111/j.1440-1746.2006.04645.x
   Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232
   Lakin ND, 1999, ONCOGENE, V18, P7644, DOI 10.1038/sj.onc.1203015
   Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1
   Liedtke C, 2004, J HEPATOL, V40, P874, DOI 10.1016/j.jhep.2004.02.020
   Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x
   Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404
   Mak SK, 2004, J BIOL CHEM, V279, P39075, DOI 10.1074/jbc.M406643200
   Malhi H, 2006, HEPATOLOGY, V43, pS31, DOI 10.1002/hep.21062
   Masoro EJ, 2000, EXP GERONTOL, V35, P299, DOI 10.1016/S0531-5565(00)00084-X
   Mostoslavsky R, 2006, CELL, V124, P315, DOI [10.1016/j.cell.2005.11.044, 10.1016/J.CEL.2005.11.044]
   Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456
   Papaconstantinou J, 2005, MECH AGEING DEV, V126, P692, DOI 10.1016/j.mad.2005.01.002
   Pinkoski MJ, 2000, AM J PHYSIOL-GASTR L, V278, pG354, DOI 10.1152/ajpgi.2000.278.3.G354
   PORTERACAILLIAU C, 1994, P NATL ACAD SCI USA, V91, P974, DOI 10.1073/pnas.91.3.974
   Suh Y, 2006, ANTIOXID REDOX SIGN, V8, P559, DOI 10.1089/ars.2006.8.559
   Suh YS, 2000, CANCER RES, V60, P5067
   van de Ven M, 2007, MECH AGEING DEV, V128, P58, DOI 10.1016/j.mad.2006.11.011
   van de Ven Marieke, 2006, PLoS Genet, V2, pe192, DOI 10.1371/journal.pgen.0020192
   vanderHorst GTJ, 1997, CELL, V89, P425, DOI 10.1016/S0092-8674(00)80223-8
   Vijg J, 2006, NATURE, V440, P874, DOI 10.1038/440874a
   Vijg J, 2005, AGING CELL, V4, P331, DOI 10.1111/j.1474-9726.2005.00179.x
   Vijg J, 2000, MUTAT RES-FUND MOL M, V447, P117, DOI 10.1016/S0027-5107(99)00202-X
   Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675
   Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147
   Wijnhoven SWP, 2005, DNA REPAIR, V4, P1314, DOI 10.1016/j.dnarep.2005.07.002
   Willson TM, 2002, NAT REV DRUG DISCOV, V1, P259, DOI 10.1038/nrd753
NR 42
TC 22
Z9 27
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 11
PY 2008
VL 3
IS 6
AR e2346
DI 10.1371/journal.pone.0002346
PG 10
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 405UD
UT WOS:000263248800008
PM 18545656
OA Green Submitted, Green Published, gold
DA 2024-02-19
ER

PT J
AU Sanzen, T
   Harada, K
   Yasoshima, M
   Kawamura, Y
   Ishibashi, M
   Nakanuma, Y
AF Sanzen, T
   Harada, K
   Yasoshima, M
   Kawamura, Y
   Ishibashi, M
   Nakanuma, Y
TI Polycystic kidney rat is a novel animal model of Caroli's disease
   associated with congenital hepatic fibrosis
SO AMERICAN JOURNAL OF PATHOLOGY
LA English
DT Article
ID INTRAHEPATIC BILE-DUCT; APOPTOSIS-RELATED PROTEINS; CELL-PROLIFERATION;
   MURINE MODEL; CPK MOUSE; EXPRESSION; LIVER; GENE; MALFORMATION; KI-67
AB Caroli's disease (congenital intrahepatic biliary dilatation) associated with congenital hepatic fibrosis is an autosomal recessive polycystic kidney disease. Recently, the polycystic kidney (PCK) rat, a spontaneous mutant derived from a colony of Crj:CD rats with polycystic lesions in the liver and an autosomal recessive mode of inheritance, was reported. In the present study, the pathology of the hepatobiliary system and the biliary cell-kinetics were evaluated in fetuses (day 18 to 21 of gestation) and neonates and adults (1 day to 4 months after delivery) of PCK rats. Crj:CD rats were used as a control. Multiple segmental and saccular dilatations of intrahepatic bile ducts were first observed in fetuses at 19 days of gestation. The dilatation spread throughout the liver and the degree of dilatation increased with aging. Gross and histological features characterizing ductal plate malformation were common in the intrahepatic bile ducts. Overgrowth of portal connective tissue was evident and progressive after delivery. These features were very similar to those of Caroli's disease with congenital hepatic fibrosis. Proliferative activity in the biliary epithelial cells was greater in PCK rats than controls during the development. In contrast, the biliary epithelial apoptosis was less extensive in PCK rats than the controls until 1 week after delivery, but greater after 3 weeks, suggesting that the remodeling defect in immature bile ducts associated with the imbalance of cell kinetics plays a role in the occurrence of intrahepatic biliary anomalies in PCK rats. The PCK rat could be a useful and promising animal model of Caroli's disease with congenital hepatic fibrosis.
C1 Kanazawa Univ, Sch Med, Dept Pathol 2, Kanazawa, Ishikawa 9208640, Japan.
   Toyama Chem Co Ltd, Drug Safety Res Lab, Toyama, Japan.
   Azabu Univ, Coll Environm Hlth, Sagamihara, Kanagawa, Japan.
C3 Kanazawa University; Toyama Chemical Co., Ltd.; Azabu University
RP Nakanuma, Y (corresponding author), Kanazawa Univ, Sch Med, Dept Pathol 2, Kanazawa, Ishikawa 9208640, Japan.
CR Bloom W, 1926, AM J ANAT, V36, P451, DOI 10.1002/aja.1000360304
   CROCKER JFS, 1987, KIDNEY INT, V31, P1088, DOI 10.1038/ki.1987.112
   DESMET VJ, 1992, HEPATOLOGY, V16, P1069, DOI 10.1002/hep.1840160434
   EGGI KD, 1989, AUTOSOMAL RECESSIVE, P73
   ENZAN H, 1974, ACTA PATHOL JAPON, V24, P427
   Faa G, 1998, J HEPATOL, V29, P628, DOI 10.1016/S0168-8278(98)80158-X
   FLAHERTY L, 1995, KIDNEY INT, V47, P552, DOI 10.1038/ki.1995.69
   FRY JL, 1985, J UROLOGY, V134, P828, DOI 10.1016/S0022-5347(17)47448-9
   Gattone VH, 1996, ANAT REC, V245, P488
   Gerlach C, 1997, HEPATOLOGY, V26, P573, DOI 10.1053/jhep.1997.v26.pm0009303485
   GRIMM PC, 1990, J EXP PATHOL, V71, P119
   Guay-Woodford LM, 2000, HUM MOL GENET, V9, P769, DOI 10.1093/hmg/9.5.769
   Ishak K., 1994, DEV ABNORMALITIES LI, P83
   Katsuyama M, 2000, EXP ANIM TOKYO, V49, P51, DOI 10.1538/expanim.49.51
   Kranzlin B, 1997, KIDNEY INT, V51, P1160, DOI 10.1038/ki.1997.159
   Lu WN, 1999, NAT GENET, V21, P160, DOI 10.1038/5944
   MARCHAL GJ, 1986, RADIOLOGY, V158, P507, DOI 10.1148/radiology.158.2.3510448
   MCGEOCH JEM, 1976, J PATHOL, V119, P221, DOI 10.1002/path.1711190406
   MOYER JH, 1994, SCIENCE, V264, P1329, DOI 10.1126/science.8191288
   NAKANUMA Y, 1982, LIVER, V2, P346
   NAUTA J, 1993, PEDIATR NEPHROL, V7, P163, DOI 10.1007/BF00864387
   SANZEN T, 1995, HEPATOLOGY, V22, P944, DOI 10.1002/hep.1840220336
   SCHLUTER C, 1993, J CELL BIOL, V123, P513, DOI 10.1083/jcb.123.3.513
   Sergi C, 2000, AM J PATHOL, V156, P1589, DOI 10.1016/S0002-9440(10)65031-6
   SHERLOCK S, 1997, CYSTS CONGENITAL BIL, P579
   SHIOJIRI N, 1991, CANCER RES, V51, P2611
   TERADA T, 1994, HEPATOLOGY, V20, P388, DOI 10.1016/0270-9139(94)90191-0
   TERADA T, 1995, AM J PATHOL, V146, P67
   TERADA T, 1993, LAB INVEST, V68, P261
   VANEYKEN P, 1988, HEPATOLOGY, V8, P1586, DOI 10.1002/hep.1840080619
   VANEYKEN P, 1988, LAB INVEST, V59, P52
   Vogler C, 1999, J AM SOC NEPHROL, V10, P2534
   WERDER AA, 1984, J LAB CLIN MED, V103, P399
   WILSON JW, 1963, ANN NY ACAD SCI, V111, P8, DOI 10.1111/j.1749-6632.1963.tb36945.x
   WOOD RL, 1965, ANAT RECORD, V151, P507, DOI 10.1002/ar.1091510403
   Wu GQ, 1998, CELL, V93, P177, DOI 10.1016/S0092-8674(00)81570-6
NR 36
TC 67
Z9 73
U1 0
U2 3
PU AMER SOC INVESTIGATIVE PATHOLOGY, INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3993 USA
SN 0002-9440
J9 AM J PATHOL
JI Am. J. Pathol.
PD MAY
PY 2001
VL 158
IS 5
BP 1605
EP 1612
DI 10.1016/S0002-9440(10)64116-8
PG 8
WC Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology
GA 429ZR
UT WOS:000168549000008
PM 11337358
OA Green Submitted, Green Published, Bronze
DA 2024-02-19
ER

PT J
AU Li, E
   Wang, YH
   Li, Q
   Li, L
   Wei, LJ
AF Li, Erzhuo
   Wang, Yunhao
   Li, Qiao
   Li, Li
   Wei, Lijun
TI Protective Effects of Sal B on Oxidative Stress-Induced Aging by
   Regulating the Keap1/Nrf2 Signaling Pathway in Zebrafish
SO MOLECULES
LA English
DT Article
DE salvianolic acid B; zebrafish; aging; oxidative stress
ID SALVIANOLIC ACID-B; CARBONIC-ANHYDRASE; DANIO-RERIO; MODEL; CELLS;
   SENESCENCE
AB The models of oxidative damage-induced aging were established by adding ethanol (C2H5OH), hydrogen peroxide (H2O2) and 6-hydroxydopamine (6-OHDA) to zebrafish embryos in this research. To find effective protective drugs/foods, Salvianolic acid B (Sal B) was added after the embryos were treated by these oxidative reagents. After being treated with ethanol, H2O2 and 6-OHDA, the morphological changes were obvious and the deformities included spinal curvature, heart bleeding, liver bleeding, yolk sac deformity and pericardial edema, and the expression of oxidative stress-related genes Nrf2b, sod1 and sod2 and aging-related genes myl2a and selenbp1 were significantly up-regulated compared to the control group. While after adding 0.05 mu g/mL and 0.5 mu g/mL Sal B to the ethanol-treated group, death rates and MDA levels decreased, the activity of antioxidant enzyme (SOD, CAT and GSH-Px) changed and Nrf2b, sod1, sod2, myl2a, selenbp1, p53 and p21 were down-regulated compared to the ethanol-treated group. The bioinformatics analysis also showed that oxidative stress-related factors were associated with a variety of cellular functions and physiological pathways. In conclusion, Sal B can protect against aging through regulating the Keap1/Nrf2 pathway as well as antioxidative genes and enzyme activity.
C1 [Li, Erzhuo; Wei, Lijun] Harbin Inst Technol, State Key Lab Urban Water Resource & Environm, Harbin 150090, Peoples R China.
   [Li, Erzhuo; Wang, Yunhao; Li, Qiao; Li, Li; Wei, Lijun] Harbin Instituted Technol, Sch Life Sci & Technol, Harbin 150001, Peoples R China.
C3 Harbin Institute of Technology
RP Wei, LJ (corresponding author), Harbin Inst Technol, State Key Lab Urban Water Resource & Environm, Harbin 150090, Peoples R China.; Li, L; Wei, LJ (corresponding author), Harbin Instituted Technol, Sch Life Sci & Technol, Harbin 150001, Peoples R China.
EM 1182800217@stu.hit.edu.cn; wangyunhao666@sina.com;
   17B928007@stu.hit.edu.cn; lilili@hit.edu.cn; weilijun@hit.edu.cn
RI wei, li/GSD-3630-2022; LI, WEI/ISS-1208-2023; wei, li/ISB-3361-2023; 黎,
   伟/GXM-4040-2022
FU Open Project of the State Key Laboratory of Urban Water Resource and
   Environment, Harbin Institute of Technology [ESK202101]
FX This research was supported by the Open Project of the State Key
   Laboratory of Urban Water Resource and Environment, Harbin Institute of
   Technology, grant number ESK202101.
CR Cao W, 2012, CHIN J INTEGR MED, V18, P316, DOI [10.1007/s11655-012-1052-8, 10.1007/s11655-011-012-1052-8]
   Clark KA, 2002, ANNU REV CELL DEV BI, V18, P637, DOI 10.1146/annurev.cellbio.18.012502.105840
   Cui L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034647
   Eisen JS, 1996, CELL, V87, P969, DOI 10.1016/S0092-8674(00)81792-4
   Feng SQ, 2018, GENE EXPR PATTERNS, V29, P47, DOI 10.1016/j.gep.2018.04.007
   Gannon J, 2008, INT J MOL MED, V22, P33
   Georgalis T, 2006, J EXP BIOL, V209, P518, DOI 10.1242/jeb.02018
   Gilbert MJH, 2014, EXP GERONTOL, V50, P106, DOI 10.1016/j.exger.2013.11.013
   Gomes AL, 2018, BIOMED PHARMACOTHER, V106, P1686, DOI 10.1016/j.biopha.2018.07.121
   Gueugneau M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1165
   Guo YB, 2014, J ETHNOPHARMACOL, V155, P1401, DOI 10.1016/j.jep.2014.07.058
   Hwang CY, 2014, PROTEOMICS, V14, P121, DOI 10.1002/pmic.201200497
   Jeong JY, 2009, BIOCHEM BIOPH RES CO, V379, P583, DOI 10.1016/j.bbrc.2008.12.110
   Keller ET, 2004, COMP BIOCHEM PHYS C, V138, P335, DOI 10.1016/j.cca.2004.04.001
   Kida E, 2006, J NEUROPATH EXP NEUR, V65, P664, DOI 10.1097/01.jnen.0000225905.52002.3e
   Kishi S, 2003, EXP GERONTOL, V38, P777, DOI 10.1016/S0531-5565(03)00108-6
   Kishi S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000152
   Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610
   Lay IS, 2003, J SURG RES, V115, P279, DOI 10.1016/S0022-4804(03)00226-9
   Li M.Q., 2018, THESIS ZHEJIANG U HA
   Li S.M., 2011, CHIN J GERONTOL, V31, P3869
   Liu J., 2018, THESIS NANJING MEDIC
   Liu Y.-R., 2023, CHIN J INTEGR MED, P1, DOI DOI 10.19540/J.CNKI.CJCMM.20230123.201
   LOWEY S, 1993, NATURE, V365, P454, DOI 10.1038/365454a0
   Marazita MC, 2016, REDOX BIOL, V7, P78, DOI 10.1016/j.redox.2015.11.011
   Porat A, 2000, J BIOL CHEM, V275, P14457, DOI 10.1074/jbc.275.19.14457
   Qiao JT, 2019, FOOD FUNCT, V10, P6184, DOI [10.1039/c9fo01246j, 10.1039/C9FO01246J]
   Sender S, 1999, J HISTOCHEM CYTOCHEM, V47, P43, DOI 10.1177/002215549904700105
   STREISINGER G, 1981, NATURE, V291, P293, DOI 10.1038/291293a0
   Tan FHP, 2021, J ETHNOPHARMACOL, V279, DOI 10.1016/j.jep.2021.114389
   Tsai SB, 2007, AGING CELL, V6, P209, DOI 10.1111/j.1474-9726.2007.00278.x
   [王丽丽 Wang Lili], 2017, [中国骨质疏松杂志, Chinese Journal of Osteoporosis], V23, P281
   Wang R, 2018, J FUNCT FOODS, V46, P288, DOI 10.1016/j.jff.2018.04.047
   Wang YL, 2015, FREE RADICAL BIO MED, V79, P186, DOI 10.1016/j.freeradbiomed.2014.11.015
   Xiao Z, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.572373
   Yan H.L., 2011, MED REV, V17, P682
   Yu JH, 2015, INT J CLIN EXP MED, V8, P14793
   Zhang L.Y., 2021, LIFE SCI RES, DOI [10.16605/j.cnki.1007-7847.2021.03.0138, DOI 10.16605/J.CNKI.1007-7847.2021.03.0138]
   Zheng ZW, 2020, J CELL MOL MED, V24, P6883, DOI 10.1111/jcmm.15345
   Zhu H.G, 2007, J FUDAN U, V4, P617
NR 40
TC 7
Z9 7
U1 8
U2 40
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1420-3049
J9 MOLECULES
JI Molecules
PD SEP
PY 2021
VL 26
IS 17
AR 5239
DI 10.3390/molecules26175239
PG 15
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA UN9QD
UT WOS:000694340500001
PM 34500674
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Folkmann, JK
   Loft, S
   Moller, P
AF Folkmann, Janne Kjaersgaard
   Loft, Steffen
   Moller, Peter
TI Oxidatively damaged DNA in aging dyslipidemic <i>ApoE</i><SUP>-/-</SUP>
   and wild-type mice
SO MUTAGENESIS
LA English
DT Article
ID APOE-DEFICIENT MICE; COMET ASSAY; FORMAMIDOPYRIMIDINE-DNA; DIETARY
   RESTRICTION; LIPID-PEROXIDATION; ATHEROSCLEROSIS; AGE; GLYCOSYLASE;
   REPAIR; MOUSE
AB The free radical theory of aging depicts an accumulation of cellular oxidatively damaged DNA. In this study, we investigated this theory in mice with knocked-out apolipoprotein E gene (ApoE(-/-)), which develops atherosclerosis and wild-type counterparts. The level of oxidatively damaged DNA was investigated as strand breaks, endonuclease III- and formamidopyrimidine DNA glycosylase-sensitive sites by the comet assay. The level of DNA damage was mainly increased with age in the liver of ApoE(-/-) mice, whereas no increase was observed in the aorta or lung of the mice. This suggests that the accumulation of oxidized DNA in the liver of dyslipidemic ApoE(-/-) mice could be secondary to dysfunction of the lipid metabolism. Visually, the aortas of the ApoE(-/-) mice were clearly atherosclerotic as indicated by rigid texture and yellowish in color. However, the unaltered levels of oxidized DNA in severely atherosclerotic aortas of old (similar to 70 weeks) ApoE(-/-) mice indicate that oxidative stress may not be a generalized phenomenon, but rather related locally to the individual plaques. In conclusion, the results of this study suggest that dyslipidemic ApoE(-/-) mice suffer from hepatic oxidative stress in terms of oxidized DNA, and this effect could be due to the dysfunction of lipid metabolism.
C1 Univ Copenhagen, Inst Publ Hlth, Dept Occupat & Environm Hlth, DK-1014 Copenhagen K, Denmark.
C3 University of Copenhagen
RP Moller, P (corresponding author), Univ Copenhagen, Inst Publ Hlth, Dept Occupat & Environm Hlth, Oster Farimagsgade 5,Bldg 5,2nd Floor, DK-1014 Copenhagen K, Denmark.
EM p.moller@pubhealth.ku.dk
CR Anson RM, 1999, FREE RADICAL BIO MED, V27, P456, DOI 10.1016/S0891-5849(99)00091-X
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   BOITEUX S, 1987, EMBO J, V6, P3177, DOI 10.1002/j.1460-2075.1987.tb02629.x
   Collins A, 2002, CARCINOGENESIS, V23, P2129, DOI 10.1093/carcin/23.12.2129
   Collip JB, 1923, J BIOL CHEM, V57, P65
   Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev
   DeFlora S, 1997, FASEB J, V11, P1021, DOI 10.1096/fasebj.11.12.9337155
   Evans MD, 2004, MUTAT RES-REV MUTAT, V567, P1, DOI 10.1016/j.mrrev.2003.11.001
   Ferré N, 2001, MOL CELL BIOCHEM, V218, P165, DOI 10.1023/A:1007296919243
   Gedik CM, 2005, EUR J NUTR, V44, P263, DOI 10.1007/s00394-004-0520-0
   Guo ZM, 2001, MECH AGEING DEV, V122, P1771, DOI 10.1016/S0047-6374(01)00298-6
   Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698
   ITOUFELLA H, 2006, NAT MED, V12, P178
   Kaneko T, 1997, FREE RADICAL BIO MED, V23, P76, DOI 10.1016/S0891-5849(96)00622-3
   Kemeleva EA, 2006, MUTAT RES-FUND MOL M, V599, P88, DOI 10.1016/j.mrfmmm.2006.01.008
   Kitajima K, 2006, ARTERIOSCL THROM VAS, V26, P1852, DOI 10.1161/01.ATV.0000231520.26490.54
   Kuipers F, 1996, HEPATOLOGY, V24, P241
   López-Diazguerrero NE, 2005, LIFE SCI, V77, P2840, DOI 10.1016/j.lfs.2005.05.034
   Martinet W, 2002, CIRCULATION, V106, P927, DOI 10.1161/01.CIR.0000026393.47805.21
   Martinet W, 2001, CIRC RES, V88, P733, DOI 10.1161/hh0701.088684
   Meir KS, 2004, ARTERIOSCL THROM VAS, V24, P1006, DOI 10.1161/01.ATV.0000128849.12617.f4
   Mensenkamp AR, 2004, J HEPATOL, V40, P599, DOI 10.1016/j.jhep.2003.12.011
   Moller P, 2005, BASIC CLIN PHARMACOL, V96, P9
   Moller P, 2004, FREE RADICAL RES, V38, P1207, DOI 10.1080/10715760400016824
   Moller P, 2000, CANCER EPIDEM BIOMAR, V9, P1005
   Mori M, 2001, FREE RADICAL BIO MED, V30, P1130, DOI 10.1016/S0891-5849(01)00511-1
   OCONNOR TR, 1988, NUCLEIC ACIDS RES, V16, P5879, DOI 10.1093/nar/16.13.5879
   Osterod M, 2001, CARCINOGENESIS, V22, P1459, DOI 10.1093/carcin/22.9.1459
   PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G
   Praticò D, 1998, NAT MED, V4, P1189, DOI 10.1038/2685
   REDDICK RL, 1994, ARTERIOSCLER THROMB, V14, P141, DOI 10.1161/01.ATV.14.1.141
   Risom L, 2003, FREE RADICAL RES, V37, P957, DOI 10.1080/1071576031000150788
   RISOM L, IN PRESS FREE RADIC
   Sarria AJ, 2006, FRONT BIOSCI-LANDMRK, V11, P955, DOI 10.2741/1852
   Schmerold I, 2001, EXP GERONTOL, V36, P1375, DOI 10.1016/S0531-5565(01)00103-6
   Servais S, 2005, FREE RADICAL RES, V39, P305, DOI 10.1080/10715760400011098
   Smith CC, 2006, MUTAGENESIS, V21, P185, DOI 10.1093/mutage/gel019
   Speit G, 2004, TOXICOL LETT, V146, P151, DOI 10.1016/j.toxlet.2003.09.010
   't Hoen PAC, 2003, CIRC RES, V93, P262, DOI 10.1161/01.RES.0000082978.92494.B1
   Tenger C, 2003, IMMUNOLOGY, V109, P392, DOI 10.1046/j.1365-2567.2003.01665.x
   Tous M, 2005, MOL CELL BIOCHEM, V268, P53, DOI 10.1007/s11010-005-2997-0
   VANREE JH, 1994, ATHEROSCLEROSIS, V111, P25, DOI 10.1016/0021-9150(94)90188-0
   Walker LC, 1997, AM J PATHOL, V151, P1371
   Wolf FI, 2005, EXP GERONTOL, V40, P181, DOI 10.1016/j.exger.2004.11.002
   Wong YT, 2006, FREE RADICAL RES, V40, P393, DOI 10.1080/10715760600556074
   ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543
NR 46
TC 35
Z9 37
U1 0
U2 4
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0267-8357
EI 1464-3804
J9 MUTAGENESIS
JI Mutagenesis
PD MAR
PY 2007
VL 22
IS 2
BP 105
EP 110
DI 10.1093/mutage/gel059
PG 6
WC Genetics & Heredity; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity; Toxicology
GA 142PT
UT WOS:000244662700002
PM 17234687
OA Bronze
DA 2024-02-19
ER

PT J
AU Petropoulos, I
   Conconi, M
   Wang, X
   Hoenel, B
   Brégégère, F
   Milner, Y
   Friguet, B
AF Petropoulos, I
   Conconi, M
   Wang, X
   Hoenel, B
   Brégégère, F
   Milner, Y
   Friguet, B
TI Increase of oxidatively modified protein is associated with a decrease
   of proteasome activity and content in aging epidermal cells
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
ID CROSS-LINKED PROTEIN; AGE-RELATED-CHANGES; OXIDIZED PROTEINS; 20S
   PROTEASOME; IMMUNOCHEMICAL DETECTION; LIVER; STRESS; SKIN; DEGRADATION;
   DISEASE
AB For the process of aging in epidermal cells to be characterized, the status of oxidized and damaged protein accumulation and removal by the proteasome has been investigated. Modified protein content and proteasome activity were assayed in lysates of epidermal cells from donors of different ages. Increased levels of oxidized proteins, glycated proteins, and proteins modified by the lipid peroxidation product 4-hydroxy-2-nonenal were observed in cells from old donors, At the same time, a decline of chymotrypsin-like and peptidylglutamyl-peptide hydrolase activities of the proteasome was found in aging keratinocytes. This age-related decline of the proteasome peptidase activities can be explained, at least in part, by a decreased proteasome content as observed by immunoblotting and enzyme-linked immunosorbent assay. In keratinocyte cultures, a decrease of proteasome activity and content was observed upon serial passaging. In cultures, as well as in skin, an inverse relationship was found between the aging marker P-galactosidase and the proteasome content. These results suggest that proteasome is downregulated during replicative senescence as well as in aged cells in, vivo, possibly resulting in the accumulation of modified proteins.
C1 Univ Paris 07, Lab Biol & Biochim Cellulaire Vieillissement, F-75251 Paris 05, France.
   Hebrew Univ Jerusalem, Dept Biol Chem, Jerusalem, Israel.
C3 Universite Paris Cite; Hebrew University of Jerusalem
RP Friguet, B (corresponding author), Univ Paris 07, Lab Biol & Biochim Cellulaire Vieillissement, CC 7128,2 Pl Jussieu, F-75251 Paris 05, France.
EM bfriguet@paris7.jussieu.fr
OI Petropoulos, Isabelle/0000-0001-9205-7458; Friguet,
   Bertrand/0000-0001-8085-1961
CR AKIYAMA K, 1994, FEBS LETT, V343, P85, DOI 10.1016/0014-5793(94)80612-8
   Anselmi B, 1998, J GERONTOL A-BIOL, V53, pB173, DOI 10.1093/gerona/53A.3.B173
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313
   BOSMANN HB, 1976, NATURE, V261, P499, DOI 10.1038/261499a0
   CARNEY JM, 1991, P NATL ACAD SCI USA, V88, P3633, DOI 10.1073/pnas.88.9.3633
   Cohn JA, 1996, ARCH BIOCHEM BIOPHYS, V328, P158, DOI 10.1006/abbi.1996.0156
   Conconi M, 1998, BIOCHEM J, V333, P407, DOI 10.1042/bj3330407
   Conconi M, 1996, ARCH BIOCHEM BIOPHYS, V331, P232, DOI 10.1006/abbi.1996.0303
   Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101
   DAVIES KJA, 1987, J BIOL CHEM, V262, P9908
   Dick TP, 1998, J BIOL CHEM, V273, P25637, DOI 10.1074/jbc.273.40.25637
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Dreyfus J C, 1978, Curr Top Cell Regul, V14, P243
   Friguet B, 1997, FEBS LETT, V405, P21, DOI 10.1016/S0014-5793(97)00148-8
   FRIGUET B, 1994, J BIOL CHEM, V269, P21639
   GOTO S, 1995, MCBU, P151
   GRANDHEE SK, 1991, J BIOL CHEM, V266, P11649
   Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0
   Grossman D, 1997, ARCH DERMATOL, V133, P1263, DOI 10.1001/archderm.133.10.1263
   GRUNE T, 1995, J BIOL CHEM, V270, P2344, DOI 10.1074/jbc.270.5.2344
   Grune T, 1996, J BIOL CHEM, V271, P15504, DOI 10.1074/jbc.271.26.15504
   Grune T, 1997, FASEB J, V11, P526, DOI 10.1096/fasebj.11.7.9212076
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Hayashi T, 1998, MECH AGEING DEV, V102, P55, DOI 10.1016/S0047-6374(98)00011-6
   HAYFLICK L, 1992, EXP GERONTOL, V27, P363, DOI 10.1016/0531-5565(92)90066-9
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097
   MADERSBACHER S, 1991, J IMMUNOL METHODS, V138, P121, DOI 10.1016/0022-1759(91)90071-M
   Maksymowych WP, 1998, INFECT IMMUN, V66, P4624, DOI 10.1128/IAI.66.10.4624-4632.1998
   Nousari HC, 1995, CURR OPIN IMMUNOL, V7, P844, DOI 10.1016/0952-7915(95)80058-1
   OLIVER CN, 1987, J BIOL CHEM, V262, P5488
   PACIFICI RE, 1989, FREE RADICAL BIO MED, V7, P521, DOI 10.1016/0891-5849(89)90028-2
   RATTAN SIS, 1994, CELL TISSUE CULTURE
   READ MA, 1995, IMMUNITY, V2, P493, DOI 10.1016/1074-7613(95)90030-6
   RHEINWALD JG, 1975, CELL, V6, P317, DOI 10.1016/0092-8674(75)90183-X
   RIVETT AJ, 1985, J BIOL CHEM, V260, P2600
   ROTHSTEIN M, 1977, MECH AGEING DEV, V6, P241, DOI 10.1016/0047-6374(77)90025-2
   SALMON JK, 1994, WESTERN J MED, V160, P146
   Shibatani T, 1996, J GERONTOL A-BIOL, V51, pB316, DOI 10.1093/gerona/51A.5.B316
   SMITH CD, 1991, P NATL ACAD SCI USA, V88, P10540, DOI 10.1073/pnas.88.23.10540
   SOHAL RS, 1993, P NATL ACAD SCI USA, V90, P7255, DOI 10.1073/pnas.90.15.7255
   STARKEREED PE, 1989, ARCH BIOCHEM BIOPHYS, V275, P559, DOI 10.1016/0003-9861(89)90402-5
   STOSCHECK CM, 1990, J CELL BIOCHEM, V43, P229, DOI 10.1002/jcb.240430304
   UCHIDA K, 1993, P NATL ACAD SCI USA, V90, P8742, DOI 10.1073/pnas.90.18.8742
   VALDIMARSSON H, 1995, IMMUNOL TODAY, V16, P145, DOI 10.1016/0167-5699(95)80132-4
   van der Loo B, 1998, EXP CELL RES, V241, P309, DOI 10.1006/excr.1998.4035
   Verbeke P, 1997, J HISTOCHEM CYTOCHEM, V45, P1059, DOI 10.1177/002215549704500804
   VLASSARA H, 1994, LAB INVEST, V70, P138
   WAGNER BJ, 1995, ARCH BIOCHEM BIOPHYS, V323, P455, DOI 10.1006/abbi.1995.0067
   Yan LJ, 1997, P NATL ACAD SCI USA, V94, P11168, DOI 10.1073/pnas.94.21.11168
   Yan LJ, 1998, P NATL ACAD SCI USA, V95, P12896, DOI 10.1073/pnas.95.22.12896
NR 52
TC 162
Z9 182
U1 0
U2 3
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD MAY
PY 2000
VL 55
IS 5
BP B220
EP B227
DI 10.1093/gerona/55.5.B220
PG 8
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA 331XU
UT WOS:000088044600002
PM 10819308
DA 2024-02-19
ER

PT J
AU Lara-Aguilar, V
   Crespo-Bermejo, C
   Llamas-Adán, M
   Grande-García, S
   Cortijo-Alfonso, ME
   Martín-Carbonero, L
   Domínguez, L
   Ryan, P
   de los Santos, I
   Bartolomé-Sanchez, S
   Valle-Millares, D
   Jiménez-Sousa, MA
   Briz, V
   Fernández-Rodríguez, A
AF Lara-Aguilar, Violeta
   Crespo-Bermejo, Celia
   Llamas-Adan, Manuel
   Grande-Garcia, Sergio
   Cortijo-Alfonso, Maria Engracia
   Martin-Carbonero, Luz
   Dominguez, Lourdes
   Ryan, Pablo
   de los Santos, Ignacio
   Bartolome-Sanchez, Sofia
   Valle-Millares, Daniel
   Jimenez-Sousa, Maria Angeles
   Briz, Veronica
   Fernandez-Rodriguez, Amanda
CA Multidisciplinary HIV Hepatitis
TI HCV spontaneous clearers showed low senescence profile in people living
   with HIV under long ART
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE HCV; HIV; oxidative stress; SASP; senescence; spontaneous clearance;
   telomere
ID LEUKOCYTE TELOMERE LENGTH; HEPATITIS-C; NITRIC-OXIDE; OXIDATIVE STRESS;
   CELLULAR SENESCENCE; LIVER FIBROSIS; DNA-DAMAGE; INFECTION; EXPRESSION;
   IMMUNOSENESCENCE
AB Coinfection with hepatitis C virus (HCV) and human immunodeficiency virus (HIV) increases immune activation, inflammation, and oxidative stress that could lead to premature senescence. Different HCV infections, either acute or chronic infection, could lead to distinct premature cellular senescence in people living with HIV (PLWHIV). Observational study in 116 PLWHIV under antiretroviral treatment with different HCV status: (i) n = 45 chronically infected with HCV (CHC); (ii) n = 36 individuals who spontaneously clarify HCV (SC); (iii) n = 35 HIV controls. Oxidative stress biomarkers were analyzed at lipid, DNA, protein, and nitrates levels, as well as antioxidant capacity and glutathione reductase enzyme. Replicative senescence was evaluated by relative telomere length (RTL) measurement. Additionally, 26 markers of Senescence-Associated Secretory Phenotype (SASP) were analyzed by multiplex immunoassays (Luminex xMAP technology). Differences were evaluated by generalized linear model (GLMs) adjusted by most significant covariates. The SC group had a senescence signature similar to the HIV control group and slightly lower SASP levels. However, significant differences were observed with respect to the CHC group, where an increase in the nitrate concentration [adjusted arithmetic mean ratio, aAMR = 1.73 (1.27-2.35), p < 0.001, q = 0.009] and the secretion of 13 SASP-associated factors [granulocyte macrophage colony-stimulating factor (GM-CSF), interferon-& beta;, interleukin (IL)-1 & beta;, IL-2, IL-8, IL-13, tumor necrosis factor (TNF)-& alpha;, IL-1 & alpha;, IL-1RA, IL-7, IL-15, C-X-C motif chemokine ligand 10 (IP-10), stem cell factor (SCF); q < 0.1)] was detected. The CHC group also showed higher values of IL-1 & alpha;, IP-10, and placental growth factor 1 (PIGF-1) than HIV controls. The SC group showed a slightly lower senescence profile than the HIV group, which could indicate a more efficient control of viral-induced senescence due to their immune strengths. Chronic HCV infection in PLWHIV led to an increase in nitrate and elevated SASP biomarkers favoring the establishment of viral persistence.
C1 [Lara-Aguilar, Violeta; Crespo-Bermejo, Celia; Llamas-Adan, Manuel; Grande-Garcia, Sergio; Cortijo-Alfonso, Maria Engracia; Bartolome-Sanchez, Sofia; Valle-Millares, Daniel; Jimenez-Sousa, Maria Angeles; Briz, Veronica; Fernandez-Rodriguez, Amanda] Inst Hlth Carlos III, Natl Ctr Microbiol, Viral Hepatitis Reference & Res Lab, Madrid, Majadahonda, Spain.
   [Martin-Carbonero, Luz] La Paz Univ Hosp IdiPAZ, Internal Med Serv, Madrid, Spain.
   [Dominguez, Lourdes] Doce Octubre Hosp, Internal Med Serv, VIH Unit, Biomed Res Inst Imas12, Madrid, Spain.
   [Dominguez, Lourdes] Kings Coll London Univ, London, England.
   [Ryan, Pablo; de los Santos, Ignacio; Jimenez-Sousa, Maria Angeles; Fernandez-Rodriguez, Amanda] Inst Hlth Carlos III, Ctr Invest Biomed Red Enfermedades Infecciosas CI, Madrid, Spain.
   [Ryan, Pablo] Infanta Leonor Univ Hosp, Dept Infect Dis, HIV Hepatitis Internal Med Serv, Madrid, Spain.
   [de los Santos, Ignacio] La Princesa Univ Hosp, Internal Med Infect Dis Serv, Madrid, Spain.
   [Briz, Veronica; Fernandez-Rodriguez, Amanda] Inst Hlth Carlos III, Natl Ctr Microbiol, Viral Hepatitis Reference & Res Lab, Pozuelo Rd 28, Madrid 28222, Majadahonda, Spain.
   [Fernandez-Rodriguez, Amanda] Inst Hlth Carlos III, Ctr Invest Biomed Red Enfermedades Infecciosas CI, Pozuelo Rd 28, Madrid 28222, Majadahonda, Spain.
C3 Instituto de Salud Carlos III; Centro Nacional de Microbiologia (CNM);
   Hospital Universitario La Paz; Hospital Universitario 12 de Octubre;
   Hospital Universitario Infanta Leonor; Instituto de Salud Carlos III;
   Centro Nacional de Microbiologia (CNM)
RP Briz, V; Fernández-Rodríguez, A (corresponding author), Inst Hlth Carlos III, Natl Ctr Microbiol, Viral Hepatitis Reference & Res Lab, Pozuelo Rd 28, Madrid 28222, Majadahonda, Spain.; Fernández-Rodríguez, A (corresponding author), Inst Hlth Carlos III, Ctr Invest Biomed Red Enfermedades Infecciosas CI, Pozuelo Rd 28, Madrid 28222, Majadahonda, Spain.
EM veronica.briz@isciii.es
RI Rodríguez, Amanda Fernández/Q-4062-2016; Rodríguez, Amanda
   Fernández/E-6510-2011; Domínguez-Domínguez, Lourdes/S-4652-2019
OI Rodríguez, Amanda Fernández/0000-0002-5110-2213; Rodríguez, Amanda
   Fernández/0000-0002-5110-2213; Domínguez-Domínguez,
   Lourdes/0000-0001-6018-9026; De Los Santos Gil,
   Ignacio/0000-0001-7073-5211; Lara Aguilar, Violeta/0000-0003-0015-5961
FU Ministerio de Ciencia e Innovacion [PID2021-126781OB-I00]; MCIN/AEI by
   ERDF A way of making Europe; Instituto de Salud Carlos III
   [PI15CIII/00031, PI18CIII/00020]; Fundacion Universidad Alfonso X el
   Sabio (FUAX)- Santander [1.010.932]; Centro de Investigacion Biomedica
   en Red (CIBER) en Enfermedades Infecciosas [CB21/13/00044,
   CB21/13/00107]
FX Ministerio de Ciencia e Innovacion, Grant/Award Number:
   PID2021-126781OB-I00; MCIN/AEI/10.13039/501100011033 by "ERDF A way of
   making Europe"; Instituto de Salud Carlos III, Grant/Award Numbers:
   PI15CIII/00031, PI18CIII/00020; Fundacion Universidad Alfonso X el Sabio
   (FUAX)- Santander, Grant/Award Number: 1.010.932; Centro de
   Investigacion Biomedica en Red (CIBER) en Enfermedades Infecciosas,
   Grant/Award Numbers: CB21/13/00044, CB21/13/00107
CR Alhetheel AF, 2022, FRONT VIROL-LAUSANNE, V1, DOI 10.3389/fviro.2021.810231
   Angel CJL, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2022928118
   Anticoli S, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/6452390
   Barathan M, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7100165
   Baz-Martinez M, 2016, SCI REP-UK, V6, DOI 10.1038/srep37007
   Birch J, 2020, GENE DEV, V34, P1565, DOI 10.1101/gad.343129.120
   Breen EJ, 2015, CYTOKINE, V71, P188, DOI 10.1016/j.cyto.2014.10.030
   Brochado-Kith O, 2019, J CLIN MED, V8, DOI 10.3390/jcm8060849
   Bruno R, 2008, J INFECT DIS, V198, P1262, DOI 10.1086/592173
   Choi J, 2006, AM J PHYSIOL-GASTR L, V290, pG847, DOI 10.1152/ajpgi.00522.2005
   Chung HT, 2001, BIOCHEM BIOPH RES CO, V282, P1075, DOI 10.1006/bbrc.2001.4670
   Cohen J, 2017, AGEING RES REV, V36, P117, DOI 10.1016/j.arr.2016.12.004
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Côté HCF, 2018, J INFECT DIS, V218, P1521, DOI 10.1093/infdis/jiy365
   Di Micco R, 2021, NAT REV MOL CELL BIO, V22, P75, DOI 10.1038/s41580-020-00314-w
   Essa S, 2021, PATHOGENS, V10, DOI 10.3390/pathogens10111519
   Fukushima Y, 2018, INFLAMM REGEN, V38, DOI 10.1186/s41232-018-0082-9
   Garcia-Broncano P, 2020, J INFECTION, V80, P99, DOI 10.1016/j.jinf.2019.09.020
   Grady BPX, 2016, IMMUN AGEING, V13, DOI 10.1186/s12979-016-0065-0
   Helby J, 2017, HAEMATOLOGICA, V102, P1457, DOI 10.3324/haematol.2016.161943
   Hoare M, 2010, J HEPATOL, V53, P252, DOI 10.1016/j.jhep.2010.03.005
   Hohensinner PJ, 2011, AGING DIS, V2, P524
   Indolfi G, 2014, WORLD J GASTROENTERO, V20, P9245, DOI 10.3748/wjg.v20.i28.9245
   Innes H, 2017, J HEPATOL, V66, P19, DOI 10.1016/j.jhep.2016.08.004
   Ivanov AV, 2013, VIRUSES-BASEL, V5, P439, DOI 10.3390/v5020439
   Jiménez-Sousa MA, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-6
   Karakousis ND, 2020, LIVER INT, V40, P2917, DOI 10.1111/liv.14659
   Kelley WJ, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.02708-2020
   Kerkerian G, 2017, INFECT DIS REP, V9, P91, DOI 10.4081/idr.2017.7142
   Kohli J, 2021, EMBO REP, V22, DOI 10.15252/embr.202052243
   Laskus T, 2007, J INFECT DIS, V195, P124, DOI 10.1086/509897
   Lee YA, 2014, ANTIVIR RES, V107, P23, DOI 10.1016/j.antiviral.2014.03.012
   Li T, 2018, J EXP MED, V215, P1287, DOI 10.1084/jem.20180139
   Loo TM, 2020, CANCER SCI, V111, P304, DOI 10.1111/cas.14266
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Luisa M., 2023, DOCUMENTO MANEJO ENF
   Majano PL, 2003, CELL DEATH DIFFER, V10, pS13, DOI 10.1038/sj.cdd.4401115
   Malikova AZ, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22094559
   Mascia C, 2017, CLIN RES HEPATOL GAS, V41, P644, DOI 10.1016/j.clinre.2017.04.007
   Minciullo PL, 2016, ARCH IMMUNOL THER EX, V64, P111, DOI 10.1007/s00005-015-0377-3
   Molina-Carrión S, 2020, J CLIN MED, V9, DOI 10.3390/jcm9082407
   Naggie Susanna, 2017, Top Antivir Med, V25, P3
   Napoli J, 1996, HEPATOLOGY, V24, P759
   Omland LH, 2010, J HEPATOL, V53, P36, DOI 10.1016/j.jhep.2010.01.033
   Vernot JP, 2020, FRONT MOL BIOSCI, V7, DOI 10.3389/fmolb.2020.00063
   Rea IM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00586
   Rebbani K, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/7425628
   Ripa M, 2017, VIRULENCE, V8, P508, DOI 10.1080/21505594.2017.1292197
   Rockstroh JK, 2014, CURR OPIN HIV AIDS, V9, P365, DOI 10.1097/COH.0000000000000064
   Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001
   Satra M, 2005, J VIRAL HEPATITIS, V12, P488, DOI 10.1111/j.1365-2893.2005.00550.x
   Sekoguchi S, 2007, J GASTROEN HEPATOL, V22, P182, DOI 10.1111/j.1440-1746.2006.04454.x
   Tache DE, 2014, ROM J MORPHOL EMBRYO, V55, P539
   Teulière J, 2023, MOL BIOL EVOL, V40, DOI 10.1093/molbev/msad012
   Thomas DL, 2000, JAMA-J AM MED ASSOC, V284, P450, DOI 10.1001/jama.284.4.450
   Tripathi U, 2021, AGING-US, V13, P21838, DOI 10.18632/aging.203560
   Wandrer F, 2018, ALIMENT PHARM THER, V48, P270, DOI 10.1111/apt.14802
   Willeit P, 2010, ARTERIOSCL THROM VAS, V30, P1649, DOI 10.1161/ATVBAHA.110.205492
   Wykes MN, 2018, NAT REV IMMUNOL, V18, P91, DOI 10.1038/nri.2017.112
   Yu QJ, 2015, CELL REP, V11, P785, DOI 10.1016/j.celrep.2015.03.069
   Zaki ME, 2010, IMMUNOL INVEST, V39, P598, DOI 10.3109/08820131003720710
   Zhao J, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0015-4
NR 63
TC 1
Z9 1
U1 2
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD JUL
PY 2023
VL 95
IS 7
DI 10.1002/jmv.28955
PG 14
WC Virology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Virology
GA N6WL5
UT WOS:001038390400033
PM 37465865
OA hybrid, Green Submitted
DA 2024-02-19
ER

PT J
AU Lowton, K
   Hiley, C
   Higgs, P
AF Lowton, Karen
   Hiley, Chris
   Higgs, Paul
TI Constructing embodied identity in a 'new' ageing population: A
   qualitative study of the pioneer cohort of childhood liver transplant
   recipients in the UK
SO SOCIAL SCIENCE & MEDICINE
LA English
DT Article
DE United Kingdom; Organ transplant; Identity; Embodiment; Corporeality;
   Childhood; New ageing populations; Qualitative
ID ORGAN-TRANSPLANTATION; CHRONIC ILLNESS; HISTORY; CANCER
AB Medical innovations have created a future of survivorship for many groups of people with a variety of conditions that were previously untreatable or untreated. This has led not only to an expansion of medical activity in a whole variety of new areas but also to the emergence of new groups of individuals defined or defining themselves through their experiences, diagnosis and treatment. Through analysis of in-depth interviews with 27 of the now-adult survivors of the pioneer cohort of children receiving liver transplants in Britain in the early 1980s and 1990s, this paper presents how this group not only illustrate the capacities of modern medicine and healthcare to transform the survival prospects of a' more diversified population, but also create new narratives of embodied identity. Specifically, we examine how childhood identities were shaped in three settings; home, hospital and school. At home, parents appeared to shape their child's identity through controlling tightly a daily medical regime focused on the concept of 'body as machine', celebrating their survival as a transplant recipient, yet at the same time socialising their child as a 'normal' child, albeit one who had a serious illness. The hospital appeared instrumental in shaping parents' focus on their child's body, and offered a way, through other patients with liver disease, for children to feel 'normal' in their difference. It was in school, through interaction with 'healthy' children and teachers, that corporeality and embodiment appeared most salient, and where social identity was negotiated and more often held in contention. Adult survivors of childhood liver transplant straddle the different discourses of normality and difference as their embodied experiences shape their narratives of identity and shed light on an underexplored aspect of the relationship between medicine and society. Crown Copyright (C) 2016 Published by Elsevier Ltd. All rights reserved.
C1 [Lowton, Karen] Univ Sussex, Dept Sociol, Freeman Bldg, Brighton BN1 9RH, E Sussex, England.
   [Hiley, Chris] Kings Coll London, Inst Gerontol, London WC2R 2LS, England.
   [Higgs, Paul] UCL, Div Psychiat, London WC1E 6BT, England.
C3 University of Sussex; University of London; King's College London;
   University of London; University College London
RP Lowton, K (corresponding author), Univ Sussex, Dept Sociol, Freeman Bldg, Brighton BN1 9RH, E Sussex, England.
EM k.lowton@sussex.ac.uk
RI Higgs, Paul f d/C-1328-2009; Higgs, Paul/ABH-3641-2020
OI Higgs, Paul f d/0000-0003-0077-0710; Higgs, Paul/0000-0003-0077-0710;
   Lowton, Karen/0000-0001-8453-0196
FU Institute of Gerontology, King's College London; Economic and Social
   Research Council [RES-062-23-3363]; Economic and Social Research Council
   [ES/J002445/1] Funding Source: researchfish; ESRC [ES/J002445/1] Funding
   Source: UKRI
FX We acknowledge the support from the Institute of Gerontology, King's
   College London, where Lowton was based when this study received funding
   and data collection was conducted.; The Economic and Social Research
   Council funded this study, reference RES-062-23-3363.
CR [Anonymous], AGEING POLITY
   [Anonymous], 1991, EXPLAINING HLTH ILLN
   [Anonymous], CHILDHOOD BODIES SOC
   [Anonymous], 1985, BEN STORY BEN HARDWI
   [Anonymous], 2014, SOCIAL IDENTITY
   [Anonymous], 2014, IDENTITY SOCIOLOGICA
   Beck U, 2007, BRIT J SOCIOL, V58, P679, DOI 10.1111/j.1468-4446.2007.00171.x
   Bell K, 2012, CULT MED PSYCHIAT, V36, P584, DOI 10.1007/s11013-012-9276-9
   Burt RS, 2005, BROKERAGE CLOSURE IN
   Bury M, 1982, Sociol Health Illn, V4, P167, DOI 10.1111/1467-9566.ep11339939
   Craig GM, 2012, HEALTH RISK SOC, V14, P627, DOI 10.1080/13698575.2012.717610
   Crowley--Matoka Megan, 2006, Mortality, V11, P166
   Dyer KE, 2015, SOC SCI MED, V132, P20, DOI 10.1016/j.socscimed.2015.02.033
   Ennew J., 1994, CHILDHOOD MATTERS SO, P125
   Fox ReneeC., 1992, Spare Parts: Organ Replacement in American Society
   Fox ReneeC., 1974, COURAGE FAIL SOCIAL
   Giddens A., 1991, Modernity and self-identity. Self and society in the late modern age
   Giddens A., 1990, The Consequences of Modernity
   Gilleard C., 2014, Ageing, corporeality and embodiment
   James A., 1993, CHILDHOOD IDENTITIES
   Jones IR, 2010, SOC SCI MED, V71, P1513, DOI 10.1016/j.socscimed.2010.07.022
   Kaiser K, 2008, SOC SCI MED, V67, P79, DOI 10.1016/j.socscimed.2008.03.036
   Lock Margaret, 2008, Transplant Rev (Orlando), V22, P154, DOI 10.1016/j.trre.2008.04.007
   Lowton K, 2003, SOC SCI MED, V56, P1355, DOI 10.1016/S0277-9536(02)00134-X
   Lowton Karen, 2010, Nurs Older People, V22, P10
   Mayall B, 1998, SOCIOL HEALTH ILL, V20, P269, DOI 10.1111/1467-9566.00102
   MAYALL B, 1998, EMOTIONS SOCIAL LIFE
   Moran, 2015, IDENTITY CAPITALISM
   Otte JB, 2002, PEDIATR TRANSPLANT, V6, P378, DOI 10.1034/j.1399-3046.2002.01082.x
   SCHEPER-HUGHES N, 1987, Medical Anthropology Quarterly, V1, P6, DOI 10.1525/maq.1987.1.1.02a00020
   SHARP LA, 1995, MED ANTHROPOL Q, V9, P357, DOI 10.1525/maq.1995.9.3.02a00050
   Shilling C., 2003, BODY SOCIAL THEORY, V2nd
   Starzl TE, 2000, WORLD J SURG, V24, P759, DOI 10.1007/s002680010124
   Stigma Goffman E., 1963, Behavior in Public Places: Notes on the Social Organization of Gatherings
   Thomas C, 2012, SOC THEOR HEALTH, V10, P209, DOI 10.1057/sth.2012.7
   Tong A, 2009, J PEDIATR-US, V155, P542, DOI 10.1016/j.jpeds.2009.04.009
   Trusson D, 2016, SOC SCI MED, V151, P121, DOI 10.1016/j.socscimed.2016.01.011
   WILLIAMS G, 1984, SOCIOL HEALTH ILL, V6, P175, DOI 10.1111/1467-9566.ep10778250
   Williams R, 2009, TRANSPLANTATION, V87, P1268, DOI 10.1097/TP.0b013e3181a36a4a
NR 39
TC 7
Z9 8
U1 1
U2 11
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0277-9536
EI 1873-5347
J9 SOC SCI MED
JI Soc. Sci. Med.
PD JAN
PY 2017
VL 172
BP 1
EP 9
DI 10.1016/j.socscimed.2016.11.015
PG 9
WC Public, Environmental & Occupational Health; Social Sciences, Biomedical
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health; Biomedical Social Sciences
GA EI5SG
UT WOS:000392554300001
PM 27855347
OA Green Submitted, Green Accepted
DA 2024-02-19
ER

PT J
AU Sun, L
   Li, FH
   Han, C
   Wang, ZZ
   Gao, KK
   Qiao, YB
   Ma, S
   Xie, T
   Wang, J
AF Sun, Lei
   Li, Fang-Hui
   Han, Chong
   Wang, Zhuang-Zhi
   Gao, Ke-Ke
   Qiao, Yi-Bo
   Ma, Song
   Xie, Tian
   Wang, Jing
TI Alterations in mitochondrial biogenesis and respiratory activity,
   inflammation of the senescence-associated secretory phenotype, and
   lipolysis in the perirenal fat and liver of rats following lifelong
   exercise and detraining
SO FASEB JOURNAL
LA English
DT Article
DE detraining; lifelong exercise; lipolysis; mitochondrial function; SASP
ID GROWTH-FACTOR-BETA; PHYSICAL PERFORMANCE; INSULIN-RESISTANCE;
   BODY-COMPOSITION; ADIPOSE-TISSUE; CALORIC RESTRICTION; OXIDATIVE STRESS;
   PROTEIN; SERUM; LONG
AB The primary aims of this study were to determine the effects of lifelong exercise and detraining on age-related alterations in mitochondrial function, inflammation associated with senescence-associated secretory phenotype (SASP), and lipolysis in the perirenal fat and liver of rats. Female Sprague-Dawley rats were randomly assigned to four groups: young control (n = 12), old control (n = 12), detraining (n = 12), and lifelong exercise (n = 12). We then investigated mitochondrial function, SASP-associated inflammation, and lipolysis in the perirenal fat and liver using qRT-PCR and western blotting to assess the expression of AKT, hypoxia-inducible factor 1 alpha (HIF-1 alpha), nuclear factor-kappa B (NF-kappa B), c-jun kinase (JNK), and p38 mitogen-activated protein kinase (p38MAPK). In the tissues of both the perirenal fat and liver, lifelong exercise significantly improved mitochondrial function, SASP-associated inflammation, and lipolysis. Meanwhile, pathways associated with inflammatory regulation were inhibited, predominantly via the activation of phosphorylated-AKT (p-AKT) and suppression of HIF-1 alpha in both tissues, and via JNK in the perirenal fat and p38MAPK in the liver. Furthermore, detraining activated NF-kappa B expression in both tissues and induced the upregulation of serum high-sensitivity C-reactive protein (hsCRP) levels. Collectively, lifelong exercise was found to exert beneficial effects by ameliorating age-related alterations in mitochondrial function, SASP-associated inflammation, and lipolysis in perirenal fat and liver tissues, potentially inhibiting inflammation via the JNK and p38 MAPK pathways, respectively, as well as the HIF-1 alpha and AKT pathways in both tissues. In contrast, detraining induced high levels of circulating hsCRP by activating the NF-kappa B signaling pathway in both tissues.
C1 [Sun, Lei; Li, Fang-Hui; Han, Chong; Wang, Zhuang-Zhi; Gao, Ke-Ke; Qiao, Yi-Bo; Ma, Song; Xie, Tian; Wang, Jing] Nanjing Normal Univ, Sch Sport Sci, Nanjing, Peoples R China.
C3 Nanjing Normal University
RP Li, FH (corresponding author), Nanjing Normal Univ, Coll Sports Sci, 1 Wenyuan Rd Qixia Dist, Nanjing 210023, Peoples R China.
EM 12356@njnu.edu.cn
RI Ma, Song/ADQ-9054-2022
OI Ma, Song/0000-0001-7794-4606; Sun, Lei/0000-0002-3444-3251
FU National Natural Science Foundation of China [31971099]; Postgraduate
   Research & Practice Innovation Program of Jiangsu Province [KYCX21_1313]
FX This work was supported by the National Natural Science Foundation of
   China [grant no. 31971099] and the Postgraduate Research & Practice
   Innovation Program of Jiangsu Province [grant no. KYCX21_1313]
CR Aguiar SS, 2020, EXP GERONTOL, V130, DOI 10.1016/j.exger.2019.110806
   Austad SN, 2016, CELL METAB, V23, P1022, DOI 10.1016/j.cmet.2016.05.019
   Briken S, 2016, J NEUROIMMUNOL, V299, P53, DOI 10.1016/j.jneuroim.2016.08.007
   Camell CD, 2017, NATURE, V550, P119, DOI 10.1038/nature24022
   Chapman J, 2019, FEBS LETT, V593, P1566, DOI 10.1002/1873-3468.13498
   Chen HT, 2018, EXP GERONTOL, V112, P112, DOI 10.1016/j.exger.2018.09.015
   Chen SY, 2006, INT J OBESITY, V30, P40, DOI 10.1038/sj.ijo.0803073
   Cunha TF, 2017, J APPL PHYSIOL, V122, P817, DOI 10.1152/japplphysiol.00182.2016
   Teixeira AAD, 2020, LIFE SCI, V261, DOI 10.1016/j.lfs.2020.118453
   Demine S, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080795
   Dong M, 2013, CELL METAB, V18, P118, DOI 10.1016/j.cmet.2013.06.003
   Finelli C, 2013, AGEING RES REV, V12, P996, DOI 10.1016/j.arr.2013.05.007
   Ghosh AK, 2019, J GERONTOL A-BIOL, V74, P1709, DOI 10.1093/gerona/gly290
   González-Rodríguez A, 2012, AGING CELL, V11, P284, DOI 10.1111/j.1474-9726.2011.00786.x
   Guan RJ, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00263
   Han MS, 2013, SCIENCE, V339, P218, DOI 10.1126/science.1227568
   Huda N, 2019, WORLD J GASTROENTERO, V25, P5069, DOI 10.3748/wjg.v25.i34.5069
   Hunt NJ, 2019, COMPUT STRUCT BIOTEC, V17, P1151, DOI 10.1016/j.csbj.2019.07.021
   Johnson ML, 2010, J APPL PHYSIOL, V109, P1573, DOI 10.1152/japplphysiol.00116.2010
   Kang EB, 2013, APOPTOSIS, V18, P1332, DOI 10.1007/s10495-013-0884-9
   Koelman L, 2020, NUTRIENTS, V12, DOI 10.3390/nu12123636
   Lana A, 2016, AGE AGEING, V45, P819, DOI 10.1093/ageing/afw142
   Lavin KM, 2020, J APPL PHYSIOL, V128, P87, DOI 10.1152/japplphysiol.00495.2019
   Lee YS, 2014, CELL, V157, P1339, DOI 10.1016/j.cell.2014.05.012
   Li FH, 2018, EXP GERONTOL, V113, P150, DOI 10.1016/j.exger.2018.10.006
   Lin JY, 2020, AGING-US, V12, P6852, DOI 10.18632/aging.103046
   Mennes E, 2014, J GERONTOL A-BIOL, V69, P1060, DOI 10.1093/gerona/glt156
   Mujika I, 2000, SPORTS MED, V30, P79, DOI 10.2165/00007256-200030020-00002
   Nilsson MI, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210863
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Pereira DS, 2013, AGE, V35, P2455, DOI 10.1007/s11357-013-9515-1
   PETERSON PK, 1994, CLIN INFECT DIS, V19, P1158, DOI 10.1093/clinids/19.6.1158
   Ponti F, 2020, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00861
   Ranallo RF, 1998, SPORTS MED, V26, P29, DOI 10.2165/00007256-199826010-00003
   Rius-Pérez S, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/1452696
   Rosety-Rodriguez M, 2014, J INTELL DISABIL RES, V58, P874, DOI 10.1111/jir.12096
   Schafer MJ, 2016, DIABETES, V65, P1606, DOI 10.2337/db15-0291
   Schaum N, 2020, NATURE, V583, P596, DOI 10.1038/s41586-020-2499-y
   Schulze-Osthoff K, 2017, FEBS J, V284, P4196, DOI 10.1111/febs.14330
   Seco J, 2013, REHABIL NURS, V38, P37, DOI 10.1002/rnj.64
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   Rojas JXS, 2016, J GERONTOL A-BIOL, V71, P310, DOI 10.1093/gerona/glv117
   Snodgrass RG, 2016, J BIOL CHEM, V291, P413, DOI 10.1074/jbc.M115.686709
   Soro-Arnaiz I, 2016, CELL REP, V16, P2991, DOI 10.1016/j.celrep.2016.08.041
   Sternfeld B, 2002, AM J EPIDEMIOL, V156, P110, DOI 10.1093/aje/kwf023
   Tang Y, 2017, CLIN EXP PHARMACOL P, V44, P9, DOI 10.1111/1440-1681.12758
   Teich T, 2017, J APPL PHYSIOL, V123, P1625, DOI 10.1152/japplphysiol.01115.2016
   Thompson D, 2010, J APPL PHYSIOL, V108, P769, DOI 10.1152/japplphysiol.00822.2009
   Viña J, 2016, J PHYSIOL-LONDON, V594, P1989, DOI 10.1113/JP270536
   Wang GX, 2017, SCI REP-UK, V7, DOI 10.1038/srep45006
   Wang T, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/9029327
   Wiley CD, 2016, CELL METAB, V23, P303, DOI 10.1016/j.cmet.2015.11.011
   You TJ, 2007, J GERONTOL A-BIOL, V62, P1082, DOI 10.1093/gerona/62.10.1082
   Young DG, 1999, CLIN EXP IMMUNOL, V117, P476
   Yu ZP, 2020, MOL MED REP, V22, P1351, DOI 10.3892/mmr.2020.11207
   Zhao Y, 2020, LIFE SCI, V251, DOI 10.1016/j.lfs.2020.117603
NR 56
TC 7
Z9 7
U1 3
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD OCT
PY 2021
VL 35
IS 10
AR e21890
DI 10.1096/fj.202100868R
PG 15
WC Biochemistry & Molecular Biology; Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA UZ5IH
UT WOS:000702238200065
PM 34460990
DA 2024-02-19
ER

PT J
AU Jiang, S
   Li, T
   Yang, Z
   Yi, W
   Di, SY
   Sun, Y
   Wang, DJ
   Yang, Y
AF Jiang, Shuai
   Li, Tian
   Yang, Zhi
   Yi, Wei
   Di, Shouyin
   Sun, Yang
   Wang, Dongjin
   Yang, Yang
TI AMPK orchestrates an elaborate cascade protecting tissue from fibrosis
   and aging
SO AGEING RESEARCH REVIEWS
LA English
DT Article
DE AMP-activated protein kinase; Fibrosis; Fibrogenesis; Aging;
   Inflammation; Excessive extracellular matrix
ID ACTIVATED PROTEIN-KINASE; TRANSMEMBRANE CONDUCTANCE REGULATOR;
   IDIOPATHIC PULMONARY-FIBROSIS; VENTRICULAR HYPERTROPHY; MICE;
   INFLAMMATION; DYSFUNCTION; INHIBITION; STRESS; INJURY
AB Fibrosis is a common process characterized by excessive extracellular matrix (ECM) accumulation after inflammatory injury, which is also a crucial cause of aging. The process of fibrosis is involved in the pathogenesis of most diseases of the heart, liver, kidney, lung, and other organs/tissues. However, there are no effective therapies for this pathological alteration. Annually, fibrosis represents a huge financial burden for the USA and the world. 5'-AMP-activated protein kinase (AMPK) is a pivotal energy sensor that alleviates or delays the process of fibrogenesis. In this review, we first present basic background information on AMPK and fibrogenesis and describe the protective roles of AMPK in three fibrogenic phases. Second, we analyze the protective action of AMPK during fibrosis in myocardial, hepatic, renal, pulmonary, and other organs/tissues. Third, we present a comprehensive discussion of AMPK during fibrosis and draw a conclusion. This review highlights recent advances, vital for basic research and clinical drug design, in the regulation of AMPK during fibrosis. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Jiang, Shuai; Yang, Yang] Northwest Univ, Key Lab Resource Biol & Biotechnol Western China, Minist Educ, Fac Life Sci, 229 Taibai North Rd, Xian 710069, Shaanxi, Peoples R China.
   [Jiang, Shuai] Fourth Mil Med Univ, Dept Aerosp Med, 169 Changle West Rd, Xian 710032, Shaanxi, Peoples R China.
   [Li, Tian; Yang, Zhi; Yang, Yang] Fourth Mil Med Univ, Dept Biomed Engn, 169 Changle West Rd, Xian 710032, Shaanxi, Peoples R China.
   [Yi, Wei] Fourth Mil Med Univ, Xijing Hosp, Dept Cardiovasc Surg, 127 Changle West Rd, Xian 710032, Shaanxi, Peoples R China.
   [Di, Shouyin] Fourth Mil Med Univ, Tangdu Hosp, Dept Thorac Surg, 1 Xinsi Rd, Xian 710038, Shaanxi, Peoples R China.
   [Sun, Yang] Fourth Mil Med Univ, Xijing Hosp, Dept Geriatr, 127 Changle West Rd, Xian 710032, Shaanxi, Peoples R China.
   [Wang, Dongjin] Nanjing Univ, Med Sch, Affiliated Drum Tower Hosp, Dept Thorac & Cardiovasc Surg, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China.
C3 Northwest University Xi'an; Air Force Military Medical University; Air
   Force Military Medical University; Air Force Military Medical
   University; Air Force Military Medical University; Air Force Military
   Medical University; Nanjing University
RP Yang, Y (corresponding author), Northwest Univ, Key Lab Resource Biol & Biotechnol Western China, Minist Educ, Fac Life Sci, 229 Taibai North Rd, Xian 710069, Shaanxi, Peoples R China.
EM yang200214yy@163.com
RI Di, Shouyin/W-5890-2018; Jiang, Shuai/M-6907-2017
OI Di, Shouyin/0000-0002-5704-259X; Jiang, Shuai/0000-0002-6083-9081; Li,
   Tian/0000-0002-8281-4459; Yi, Wei/0000-0002-4349-910X
FU National Natural Science Foundation of China [81500263, 81600306]; China
   Postdoctoral Science Foundation [2016T90973, 2015M572681]
FX This work was supported by the National Natural Science Foundation of
   China (81500263 and 81600306) and China Postdoctoral Science Foundation
   (2016T90973 and 2015M572681).
CR Arad M, 2003, CIRCULATION, V107, P2850, DOI 10.1161/01.CIR.0000075270.13497.2B
   Armanios M, 2012, NEW ENGL J MED, V367, P384, DOI 10.1056/NEJMc1206730
   Birbrair A, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt512
   Cao T., 2014, PLOS ONE, V9
   CARLING D, 1994, J BIOL CHEM, V269, P11442
   Carling D, 2015, CELL METAB, V21, P799, DOI 10.1016/j.cmet.2015.05.005
   Cavaglieri RC, 2015, MOL CELL ENDOCRINOL, V412, P116, DOI 10.1016/j.mce.2015.06.006
   Chen KH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106554
   Cho YR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083204
   Cieslik KA, 2013, J MOL CELL CARDIOL, V63, P26, DOI 10.1016/j.yjmcc.2013.07.005
   Daskalopoulos EP, 2016, J MOL CELL CARDIOL, V91, P188, DOI 10.1016/j.yjmcc.2016.01.001
   Dirks AJ, 2006, AGEING RES REV, V5, P179, DOI 10.1016/j.arr.2006.03.002
   Elborn J. S., 2016, LANCET
   Friis RMN, 2014, CELL REP, V7, P565, DOI 10.1016/j.celrep.2014.03.029
   Gulati A, 2013, JAMA-J AM MED ASSOC, V309, P896, DOI 10.1001/jama.2013.1363
   Hallows KR, 2006, J BIOL CHEM, V281, P4231, DOI 10.1074/jbc.M511029200
   Hallows KR, 2003, J BIOL CHEM, V278, P998, DOI 10.1074/jbc.M210621200
   Hallows KR, 2000, J CLIN INVEST, V105, P1711, DOI 10.1172/JCI9622
   Hardman SE, 2014, EXP GERONTOL, V55, P120, DOI 10.1016/j.exger.2014.04.007
   Heinrichs D, 2014, FASEB J, V28, P5136, DOI 10.1096/fj.14-256776
   Hermida N, 2013, CARDIOVASC RES, V99, P44, DOI 10.1093/cvr/cvt070
   Hong-Brown LQ, 2015, J CELL BIOCHEM, V116, P91, DOI 10.1002/jcb.24945
   Hu W, 2016, J PINEAL RES, V60, P121, DOI 10.1111/jpi.12302
   Iwata T, 2015, SURG TODAY, V45, P1263, DOI 10.1007/s00595-014-1071-5
   Jackaman C, 2017, AGEING RES REV, V36, P105, DOI 10.1016/j.arr.2017.03.008
   Jenkins Gisli, 2014, Clin Med (Lond), V14 Suppl 6, ps45, DOI 10.7861/clinmedicine.14-6-s45
   Jiang SY, 2016, EXP THER MED, V11, P2547, DOI 10.3892/etm.2016.3174
   Jiang S, 2016, EXPERT OPIN THER TAR, V20, P1413, DOI 10.1080/14728222.2016.1250887
   Jin YP, 2016, FEBS LETT, V590, P672, DOI 10.1002/1873-3468.12090
   Jo HK, 2014, BIOL PHARM BULL, V37, P1341, DOI 10.1248/bpb.b14-00281
   Ju KD, 2016, AM J PHYSIOL-RENAL, V310, pF342, DOI 10.1152/ajprenal.00204.2015
   Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003
   Kang HM, 2015, NAT MED, V21, P37, DOI 10.1038/nm.3762
   Kato MF, 2008, J HYPERTENS, V26, P1669, DOI 10.1097/HJH.0b013e328302f0f7
   Kim EK, 2004, J BIOL CHEM, V279, P19970, DOI 10.1074/jbc.M402165200
   Kim H, 2015, AM J PHYSIOL-RENAL, V308, pF226, DOI 10.1152/ajprenal.00495.2014
   King JD, 2012, J BIOL CHEM, V287, P33389, DOI 10.1074/jbc.M112.396036
   King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582
   Konishi M, 2011, CARDIOVASC RES, V89, P309, DOI 10.1093/cvr/cvq335
   Kumar P., 2014, PLOS ONE, V9
   Lakshmanan AP, 2012, BIOCHEM PHARMACOL, V83, P653, DOI 10.1016/j.bcp.2011.11.018
   Lambert GA, 2009, J NEUROSCI METH, V177, P420, DOI 10.1016/j.jneumeth.2008.10.033
   Lee HJ, 2015, J BIOL CHEM, V290, P12014, DOI 10.1074/jbc.M114.615377
   Lei H, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-015-0492-7
   Li T., 2016, CELL MOL LIFE SCI
   Lorenz DR, 2009, P NATL ACAD SCI USA, V106, P1145, DOI 10.1073/pnas.0812551106
   Lu JM, 2015, LIFE SCI, V127, P59, DOI 10.1016/j.lfs.2015.01.042
   Luo T, 2016, DIABETES, V65, P2295, DOI 10.2337/db15-1122
   Ma XW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129971
   Malik FA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130313
   Mann JP, 2016, HEPATOLOGY, V63, P745, DOI 10.1002/hep.28374
   Matsuo K, 2015, J MOL CELL CARDIOL, V79, P195, DOI 10.1016/j.yjmcc.2014.11.019
   Mia S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135235
   Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a
   Morais AD, 2010, CLIN SCI, V118, P411, DOI 10.1042/CS20090293
   Muanprasat C, 2013, BIOL PHARM BULL, V36, P522, DOI 10.1248/bpb.b12-00711
   Murça TM, 2012, REGUL PEPTIDES, V177, P107, DOI 10.1016/j.regpep.2012.05.093
   Myerburg MM, 2010, AM J RESP CELL MOL, V42, P676, DOI 10.1165/2009-0147OC
   Nanthakumar CB, 2015, NAT REV DRUG DISCOV, V14, P693, DOI 10.1038/nrd4592
   Noppe G, 2014, J MOL CELL CARDIOL, V74, P32, DOI 10.1016/j.yjmcc.2014.04.018
   Oakhill JS, 2010, P NATL ACAD SCI USA, V107, P19237, DOI 10.1073/pnas.1009705107
   Park CS, 2012, BIOCHEM PHARMACOL, V84, P1660, DOI 10.1016/j.bcp.2012.09.025
   POPPER H, 1982, HEPATOLOGY, V2, P874, DOI 10.1002/hep.1840020623
   Proshkina EN, 2015, AGEING RES REV, V24, P218, DOI 10.1016/j.arr.2015.08.005
   Qiu SL, 2015, J PATHOL, V237, P330, DOI 10.1002/path.4579
   Reznick RM, 2007, CELL METAB, V5, P151, DOI 10.1016/j.cmet.2007.01.008
   Salminen A, 2016, AGEING RES REV, V28, P15, DOI 10.1016/j.arr.2016.04.003
   Salminen A, 2012, AGEING RES REV, V11, P230, DOI 10.1016/j.arr.2011.12.005
   Sato N, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0420-x
   Schaffer JM, 2015, JAMA-J AM MED ASSOC, V313, P936, DOI 10.1001/jama.2015.1175
   SCHMID R, 1989, HEPATOLOGY, V9, P669, DOI 10.1002/hep.1840090502
   Smith JP, 2014, PANCREAS, V43, P1050, DOI 10.1097/MPA.0000000000000194
   Spindler SR, 2010, AGEING RES REV, V9, P324, DOI 10.1016/j.arr.2009.10.003
   Strait JB, 2012, HEART FAIL CLIN, V8, P143, DOI 10.1016/j.hfc.2011.08.011
   Suchy R, 2014, RADIOLOGE, V54, P1199, DOI 10.1007/s00117-014-2739-y
   Sun LJ, 2014, INT J INFECT DIS, V23, P75, DOI 10.1016/j.ijid.2013.12.017
   Sun Y, 2013, CIRCULATION, V128, pS113, DOI 10.1161/CIRCULATIONAHA.112.000010
   Taguchi Y, 2015, RESPIR INVESTIG, V53, P279, DOI 10.1016/j.resinv.2015.06.002
   Takata T, 2014, J INTEGR MED-JIM, V12, P495, DOI 10.1016/S2095-4964(14)60052-2
   Tang XL, 2015, J AGR FOOD CHEM, V63, P552, DOI 10.1021/jf504926n
   Wang M, 2016, RENAL FAILURE, V38, P614, DOI 10.3109/0886022X.2016.1149770
   Yang J, 2013, J AM SOC NEPHROL, V24, P1644, DOI 10.1681/ASN.2013030217
   Yang Y, 2016, J PINEAL RES, V60, P228, DOI 10.1111/jpi.12306
   Yang YB, 2015, J GASTROEN HEPATOL, V30, P609, DOI 10.1111/jgh.12723
   Yi W, 2012, CIRCULATION, V125, P3159, DOI 10.1161/CIRCULATIONAHA.112.099937
   Yuan F, 2014, MOL MED REP, V9, P2293, DOI 10.3892/mmr.2014.2133
   Yuan YX, 2015, AM J PHYSIOL-ENDOC M, V308, pE891, DOI 10.1152/ajpendo.00450.2014
   Zhang CX, 2011, CLIN EXP PHARMACOL P, V38, P55, DOI 10.1111/j.1440-1681.2010.05461.x
   Zhang P, 2008, HYPERTENSION, V52, P918, DOI 10.1161/HYPERTENSIONAHA.108.114702
   Zhang W, 2012, CLIN EXP PHARMACOL P, V39, P1026, DOI 10.1111/1440-1681.12020
   Zhang YM, 2014, FREE RADICAL BIO MED, V71, P208, DOI 10.1016/j.freeradbiomed.2014.03.018
   Zhang Y, 2015, ANN RHEUM DIS, V74, P1432, DOI 10.1136/annrheumdis-2013-204599
   Zhang Z, 2014, J MOL ENDOCRINOL, V53, P145, DOI 10.1530/JME-14-0027
   Zheng QJ, 2011, ARTERIOSCL THROM VAS, V31, P2616, DOI 10.1161/ATVBAHA.111.231050
NR 94
TC 90
Z9 96
U1 3
U2 22
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 1568-1637
EI 1872-9649
J9 AGEING RES REV
JI Ageing Res. Rev.
PD SEP
PY 2017
VL 38
BP 18
EP 27
DI 10.1016/j.arr.2017.07.001
PG 10
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA FF8UH
UT WOS:000409292800003
PM 28709692
DA 2024-02-19
ER

PT J
AU Liu, S
   Cao, WJ
   Niu, YC
   Luo, JY
   Zhao, YH
   Hu, ZY
   Zong, CH
AF Liu, Shou
   Cao, Wenjian
   Niu, Yichi
   Luo, Jiayi
   Zhao, Yanhua
   Hu, Zhiying
   Zong, Chenghang
TI Single-PanIN-seq unveils that <i>ARID1A</i> deficiency promotes
   pancreatic tumorigenesis by attenuating <i>KRAS</i>-induced senescence
SO ELIFE
LA English
DT Article
ID BIOCONDUCTOR PACKAGE; CANCER; CELLS; ALIGNMENT; ELEMENTS; BURDEN;
   GROWTH; LIVER; P53
AB ARID1A is one of the most frequently mutated epigenetic regulators in a wide spectrum of cancers. Recent studies have shown that ARID1A deficiency induces global changes in the epigenetic landscape of enhancers and promoters. These broad and complex effects make it challenging to identify the driving mechanisms of ARID1A deficiency in promoting cancer progression. Here, we identified the anti-senescence effect of Arid1a deficiency in the progression of pancreatic intraepithelial neoplasia (PanIN) by profiling the transcriptome of individual PanINs in a mouse model. In a human cell line model, we found that ARID1A deficiency upregulates the expression of aldehyde dehydrogenase 1 family member Al (ALDH1A1), which plays an essential role in attenuating the senescence induced by oncogenic KRAS through scavenging reactive oxygen species. As a subunit of the SWI/SNF chromatin remodeling complex, our ATAC sequencing data showed that ARID1A deficiency increases the accessibility of the enhancer region of ALDH1A1. This study provides the first evidence that ARID1A deficiency promotes pancreatic tumorigenesis by attenuating KRAS-induced senescence through the upregulation of ALDH1A1 expression.
C1 [Liu, Shou; Cao, Wenjian; Niu, Yichi; Luo, Jiayi; Zhao, Yanhua; Hu, Zhiying; Zong, Chenghang] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
   [Cao, Wenjian; Niu, Yichi; Zong, Chenghang] Baylor Coll Med, Genet & Genom Grad Program, Houston, TX 77030 USA.
   [Luo, Jiayi; Zong, Chenghang] Baylor Coll Med, Canc & Cell, Biol Grad Program, Houston, TX 77030 USA.
   [Zong, Chenghang] Baylor Coll Med, DAn L Duncan Comprehens Canc Ctr, Houston, TX 77030 USA.
   [Zong, Chenghang] Baylor Coll Med, McNair Med Inst, Houston, TX 77030 USA.
C3 Baylor College of Medicine; Baylor College of Medicine; Baylor College
   of Medicine; Baylor College of Medicine; Baylor College of Medicine
RP Zong, CH (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.; Zong, CH (corresponding author), Baylor Coll Med, Genet & Genom Grad Program, Houston, TX 77030 USA.; Zong, CH (corresponding author), Baylor Coll Med, Canc & Cell, Biol Grad Program, Houston, TX 77030 USA.; Zong, CH (corresponding author), Baylor Coll Med, DAn L Duncan Comprehens Canc Ctr, Houston, TX 77030 USA.; Zong, CH (corresponding author), Baylor Coll Med, McNair Med Inst, Houston, TX 77030 USA.
EM czong@bcm.edu
RI Luo, Jiayi/GWC-1880-2022; Zong, Chenghang/F-3243-2013
OI Luo, Jiayi/0000-0002-9873-0671; Niu, Yichi/0000-0002-4376-7792; Zong,
   Chenghang/0000-0002-8337-8038
FU NIH Office of the Director [1DP2EB020399]
FX NIH Office of the Director 1DP2EB020399 Chenghang Zong; Robert and
   Janice McNair Foundation McNair Scholarship Chenghang Zong; The funders
   had no role in study design, data collection and interpretation, or the
   decision to submit the work for publication.
CR Aguirre AJ, 2017, CANCER CELL, V32, P185, DOI 10.1016/j.ccell.2017.07.007
   Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638
   Bailey P, 2016, NATURE, V531, P47, DOI 10.1038/nature16965
   Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600
   De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247
   Gao XL, 2008, P NATL ACAD SCI USA, V105, P6656, DOI 10.1073/pnas.0801802105
   Ghandi M, 2019, NATURE, V569, P503, DOI 10.1038/s41586-019-1186-3
   Gopinathan A, 2015, DIS MODEL MECH, V8, P1185, DOI 10.1242/dmm.021055
   Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004
   Kadoch C, 2013, NAT GENET, V45, P592, DOI 10.1038/ng.2628
   Kimura Y, 2018, GASTROENTEROLOGY, V155, P194, DOI 10.1053/j.gastro.2018.03.039
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]
   Li SQ, 2018, NAT REV CANCER, V18, P767, DOI 10.1038/s41568-018-0076-6
   Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004
   Livshits G, 2018, ELIFE, V7, DOI 10.7554/eLife.35216
   Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653
   Mathur R, 2017, NAT GENET, V49, P296, DOI 10.1038/ng.3744
   McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630
   McLeay RC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-165
   Mei SL, 2017, NUCLEIC ACIDS RES, V45, pD658, DOI 10.1093/nar/gkw983
   Morton JP, 2010, P NATL ACAD SCI USA, V107, P246, DOI 10.1073/pnas.0908428107
   Ogiwara H, 2019, CANCER CELL, V35, P177, DOI 10.1016/j.ccell.2018.12.009
   Ou JH, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4559-3
   Pignolo RJ, 2020, TRENDS MOL MED, V26, P630, DOI 10.1016/j.molmed.2020.03.005
   Raha D, 2014, CANCER RES, V74, P3579, DOI 10.1158/0008-5472.CAN-13-3456
   Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155
   Ramírez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Rovira M, 2010, P NATL ACAD SCI USA, V107, P75, DOI 10.1073/pnas.0912589107
   Sen M, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-019-0690-5
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   Sheng KW, 2017, NAT METHODS, V14, P267, DOI [10.1038/nmeth.4145, 10.1038/NMETH.4145]
   Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040
   Storz Peter, 2017, Small GTPases, V8, P38, DOI 10.1080/21541248.2016.1192714
   Sun XX, 2017, CANCER CELL, V32, P574, DOI 10.1016/j.ccell.2017.10.007
   Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169
   Wang SC, 2019, GUT, V68, P1259, DOI 10.1136/gutjnl-2017-315490
   Wu JN, 2013, CANCER DISCOV, V3, P35, DOI 10.1158/2159-8290.CD-12-0361
   Wu S, 2017, CELL CYCLE, V16, P2313, DOI 10.1080/15384101.2017.1377503
   Zhang L, 2018, TECHNOL CANCER RES T, V17, DOI 10.1177/1533034618754475
   Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137
NR 44
TC 8
Z9 8
U1 0
U2 1
PU ELIFE SCIENCES PUBLICATIONS LTD
PI CAMBRIDGE
PA SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND
SN 2050-084X
J9 ELIFE
JI eLife
PD MAY 13
PY 2021
VL 10
AR e64204
DI 10.7554/eLife.64204
PG 22
WC Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics
GA ST2GA
UT WOS:000662267100001
PM 33983114
OA Green Submitted, gold, Green Published
DA 2024-02-19
ER

PT J
AU Carreira, MC
   Izquierdo, AG
   Amil, M
   Casanueva, FF
   Crujeiras, AB
AF Carreira, Marcos C.
   Izquierdo, Andrea G.
   Amil, Maria
   Casanueva, Felipe F.
   Crujeiras, Ana B.
TI Oxidative Stress Induced by Excess of Adiposity Is Related to a
   Downregulation of Hepatic SIRT6 Expression in Obese Individuals
SO OXIDATIVE MEDICINE AND CELLULAR LONGEVITY
LA English
DT Article
ID GENE-EXPRESSION; FATTY LIVER; HEPATOCELLULAR-CARCINOMA; OVERWEIGHT;
   SIRTUINS; DISEASE; MICE
AB Sirt6 is a member of the sirtuin family involved in physiological and pathological processes including aging, cancer, obesity, diabetes, and energy metabolism. This study is aimed at evaluating the relationship between liver SIRT6 gene expression and the oxidative stress network depending on adiposity levels in Zucker rats, an animal model of metabolic syndrome. We observed that liver-specific SIRT6 expression is reduced in an in vivo model of spontaneous obesity and metabolic syndrome. We also observed that SIRT6 expression in the liver is positively associated with SIRTI and GST-M2 expressions, two proteins involved in antioxidant protection pathways and inversely related to body weight and plasmatic oxidative status. Interestingly, the SIRT6 expression is upregulated after energy restriction-induced weight loss concomitantly with an improvement in oxidative stress markers. These results suggest that SIRT6 may be a potential therapeutic target for the treatment of obesity and associated metabolic disorders, such as liver disease.
C1 [Carreira, Marcos C.; Amil, Maria; Casanueva, Felipe F.] CHUS, Inst Invest Sanitaria Santiago IDIS, Lab Mol & Cellular Endocrinol, Santiago De Compostela, Spain.
   [Carreira, Marcos C.; Izquierdo, Andrea G.; Amil, Maria; Casanueva, Felipe F.; Crujeiras, Ana B.] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBERobn, Madrid, Spain.
   [Izquierdo, Andrea G.; Crujeiras, Ana B.] CHUS, SERGAS, Inst Invest Sanitaria Santiago IDIS, Lab Epigen Endocrinol & Nutr,Epigen Unit, Santiago De Compostela, Spain.
   [Casanueva, Felipe F.] USC, Santiago De Compostela, Spain.
C3 Complexo Hospitalario Universitario de Santiago de Compostela; CIBER -
   Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud
   Carlos III; Complexo Hospitalario Universitario de Santiago de
   Compostela; Universidade de Santiago de Compostela
RP Casanueva, FF (corresponding author), CHUS, Inst Invest Sanitaria Santiago IDIS, Lab Mol & Cellular Endocrinol, Santiago De Compostela, Spain.; Casanueva, FF; Crujeiras, AB (corresponding author), Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBERobn, Madrid, Spain.; Crujeiras, AB (corresponding author), CHUS, SERGAS, Inst Invest Sanitaria Santiago IDIS, Lab Epigen Endocrinol & Nutr,Epigen Unit, Santiago De Compostela, Spain.; Casanueva, FF (corresponding author), USC, Santiago De Compostela, Spain.
EM endocrine@usc.es; anabelencrujeiras@hotmail.com
RI Crujeiras, Ana B/ABA-8866-2021; Izquierdo, Andrea G/HLX-1356-2023
OI Crujeiras, Ana B/0000-0003-4392-0301; Izquierdo, Andrea
   G/0000-0002-0846-8834; CASANUEVA, FELIPE F./0000-0002-9052-8161
FU Centro de Investigacion Biomedica en Red de Fisiopatologia de la
   Obesidad y Nutricion (CIBERobn); Instituto de Salud Carlos III
   [PI17/01287, CP17/00088]; European Regional Development Fund (FEDER);
   CIBERobn
FX Authors thank Maribel Rendo from the Department of Molecular and
   Cellular Endocrinology of Instituto de Investigacion Sanitaria de
   Santiago (IDIS) for her support of research data management. This study
   was supported by Centro de Investigacion Biomedica en Red de
   Fisiopatologia de la Obesidad y Nutricion (CIBERobn) and grants from the
   Instituto de Salud Carlos III (PI17/01287) cofinanced by the European
   Regional Development Fund (FEDER). Andrea G. Izquierdo is funded by
   CIBERobn and Ana B. Crujeiras is funded by a research contract "Miguel
   Servet" (CP17/00088) from the Instituto de Salud Carlos III, cofinanced
   by the European Regional Development Fund (FEDER).
CR Beltrán-Ramírez O, 2010, TRANSL ONCOL, V3, P142, DOI 10.1593/tlo.09298
   Crujeiras AB, 2008, EUR J CLIN INVEST, V38, P672, DOI 10.1111/j.1365-2362.2008.01998.x
   Crujeiras AB, 2008, J PHYSIOL BIOCHEM, V64, P211, DOI 10.1007/BF03178844
   Crujeiras AB, 2009, EUR J NUTR, V48, P341, DOI 10.1007/s00394-009-0019-9
   Dizdar Ö, 2004, MED HYPOTHESES, V63, P790, DOI 10.1016/j.mehy.2004.01.046
   Dominy JE, 2012, MOL CELL, V48, P900, DOI 10.1016/j.molcel.2012.09.030
   Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897
   Kanfi Y, 2008, FEBS LETT, V582, P543, DOI [10.1016/j.febslet.2008.01.019, 10.1016/j.febslet.2008.06.005]
   Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815
   Kanfi Y, 2010, AGING CELL, V9, P162, DOI 10.1111/j.1474-9726.2009.00544.x
   Kim HS, 2010, CELL METAB, V12, P224, DOI 10.1016/j.cmet.2010.06.009
   Kuang JY, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00135
   Kuang JY, 2017, DIABETES, V66, P1159, DOI 10.2337/db16-1225
   Lim CS, 2007, MED HYPOTHESES, V69, P231, DOI 10.1016/j.mehy.2006.11.036
   Marengo A, 2016, ANNU REV MED, V67, P103, DOI 10.1146/annurev-med-090514-013832
   Marrero JA, 2002, HEPATOLOGY, V36, P1349, DOI 10.1053/jhep.2002.36939
   Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140
   Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033
   Moschen AR, 2013, J HEPATOL, V59, P1315, DOI 10.1016/j.jhep.2013.07.027
   Sánchez-Pérez Y, 2005, CANCER LETT, V217, P25, DOI 10.1016/j.canlet.2004.07.019
   Streba LAM, 2015, WORLD J GASTROENTERO, V21, P4103, DOI 10.3748/wjg.v21.i14.4103
   Tasselli L, 2016, NAT STRUCT MOL BIOL, V23, P434, DOI 10.1038/nsmb.3202
   Vincent HK, 2007, DIABETES OBES METAB, V9, P813, DOI 10.1111/j.1463-1326.2007.00692.x
   Vincent HK, 2006, INT J OBESITY, V30, P400, DOI 10.1038/sj.ijo.0803177
   Zhang P, 2014, P NATL ACAD SCI USA, V111, P10684, DOI 10.1073/pnas.1411026111
NR 25
TC 20
Z9 21
U1 0
U2 1
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1942-0900
EI 1942-0994
J9 OXID MED CELL LONGEV
JI Oxidative Med. Cell. Longev.
PY 2018
VL 2018
AR 6256052
DI 10.1155/2018/6256052
PG 7
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA HG2VP
UT WOS:000454825200001
PM 30671172
OA Green Published, Green Submitted, gold
DA 2024-02-19
ER

PT J
AU Sanz, N
   Díez-Fernández, C
   Alvarez, AM
   Fernández-Simón, L
   Cascales, M
AF Sanz, N
   Díez-Fernández, C
   Alvarez, AM
   Fernández-Simón, L
   Cascales, M
TI Age-related changes on parameters of experimentally-induced liver injury
   and regeneration
SO TOXICOLOGY AND APPLIED PHARMACOLOGY
LA English
DT Article
DE senescence; hepatotoxicity; hepatic regeneration; DNA in cell cycle
ID TUMOR-NECROSIS-FACTOR; NITRIC-OXIDE SYNTHASE; RAT-LIVER; HEPATOCYTES;
   THIOACETAMIDE; CELLS; IDENTIFICATION; CYTOKINES; DAMAGE; LEVEL
AB Age-dependent changes related to liver injury and regeneration were studied in rats aged 2, 12, and 30 months in a time period of 96 hr following a sublethal dose of thioacetamide (6.6 mmoles/kg body wt). Serum aspartate aminotransferase activity increased earlier in young rats, but the severity of injury was higher in those aged 12 months when compared to young and to old. Microsomal hepatocyte FAD monooxygenase activity was induced earlier in 2-month-old rats following intoxication and the increase was significantly lower both in the youngest and in the oldest groups when compared to adults. As a parameter of hepatocellular postnecrotic regeneration, DNA synthesis (2C --> 4C) was evaluated. The population of hepatocytes in S phase peaked more sharply and earlier in young rat hepatocytes, and was 8 to 12 times higher than the initial in hepatocytes from 2- and 12-month-old rats, while the rise was only 3 times in the oldest group. At 96 hr of intoxication the restoration towards normal in all these parameters was complete in young, incomplete in adult, and slightly detected in the oldest. Serum proliferative activity, assayed on mouse NIH 3T3 fibroblast cultures, increased preceding the necrosis and this increase was higher in 2- and 12-month-old (171% and 224%, respectively), while in the oldest the increase was only 110%. This mitogenic activity decreased in all groups during necrosis, showing a second peak, nondetectable in rats aged 30 months, parallel to regeneration. Serum TNF alpha level was absent in untreated animals and increased markedly following intoxication, the highest values being recorded at 72 hr of intoxication in serum from rats aged 12 months (347 +/- 30 pg/ml) and the lowest at 30 months (4.1 +/- 0.3 pg/ml). The serum ability to induce nitric oxide synthase activity on peritoneal macrophages ex vivo showed significant time- and age-dependent changes in nitric oxide release: a decrease throughout necrosis and an increase during regeneration. We conclude that the main age-related changes in the sequenced process of liver injury and regeneration are the delayed response in the development of cell killing and regeneration and the decreased regenerative ability, which significantly delays the restoration of liver function. (C) 1999 Academic Press.
C1 Univ Complutense Madrid, Fac Farm, Inst Bioquim, CSIC, Madrid 28040, Spain.
   Univ Complutense Madrid, Fac Farm, Ctr Citometria Flujo, Madrid 28040, Spain.
   Inst Nacl Toxicol, Madrid 28002, Spain.
C3 Complutense University of Madrid; Consejo Superior de Investigaciones
   Cientificas (CSIC); Complutense University of Madrid
RP Cascales, M (corresponding author), Univ Complutense Madrid, Fac Farm, Inst Bioquim, CSIC, Plaza Ramon & Cajal SN, Madrid 28040, Spain.
EM cascales@eucmax.sim.ucm.es
RI Alvarez-Barrientos, Alberto/L-9299-2014; Álvarez, Antonio M.
   Rabasco/F-2598-2016
OI Alvarez-Barrientos, Alberto/0000-0003-4761-0212; Álvarez, Antonio M.
   Rabasco/0000-0002-8861-6090
CR BIRNBAUM LS, 1991, ANNU REV PHARMACOL, V31, P101
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   CALABRESE EJ, 1993, TOXICOL APPL PHARM, V121, P1, DOI 10.1006/taap.1993.1121
   DECKER K, 1990, EUR J BIOCHEM, V192, P245, DOI 10.1111/j.1432-1033.1990.tb19222.x
   DEJUAN C, 1992, EXP CELL RES, V202, P495, DOI 10.1016/0014-4827(92)90104-G
   DiezFernandez C, 1997, BRIT J PHARMACOL, V121, P820, DOI 10.1038/sj.bjp.0701191
   DiezFernandez C, 1996, J HEPATOL, V24, P460, DOI 10.1016/S0168-8278(96)80167-X
   DIEZFERNANDEZ C, 1993, HEPATOLOGY, V18, P912, DOI 10.1002/hep.1840180424
   DYROFF MC, 1981, CANCER RES, V41, P3430
   FRANCESCHI C, 1994, INT J IMMUNOPATH PH, V7, P227
   GELLER DA, 1993, P NATL ACAD SCI USA, V90, P522, DOI 10.1073/pnas.90.2.522
   GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X
   HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2
   HORTELANO S, 1992, J BIOL CHEM, V267, P24937
   JANSEN PLM, 1990, SCAND J GASTROENTERO, V25, P112, DOI 10.3109/00365529009107931
   KAPLOWITZ N, 1985, ANNU REV PHARMACOL, V25, P715, DOI 10.1146/annurev.pharmtox.25.1.715
   KITANI K, 1994, ARCH GERONTOL GERIAT, V19, P145, DOI 10.1016/0167-4943(94)90036-1
   MEHENDALE HM, 1991, BIOCHEM PHARMACOL, V42, P1155, DOI 10.1016/0006-2952(91)90249-5
   MICHALOPOULOS GK, 1990, FASEB J, V4, P176, DOI 10.1096/fasebj.4.2.2404819
   MOHN KL, 1991, MOL CELL BIOL, V11, P381, DOI 10.1128/MCB.11.1.381
   NADAL C, 1992, TR ADV LIV, P123
   Norwood TH, 1996, EXP GERONTOL, V31, P61, DOI 10.1016/0531-5565(95)02020-9
   OBOLENSKAYA M, 1994, BIOCHEM BIOPH RES CO, V204, P1305, DOI 10.1006/bbrc.1994.2605
   PLEWKA A, 1994, MECH AGEING DEV, V74, P79, DOI 10.1016/0047-6374(94)90100-7
   Rattan SIS, 1996, EXP GERONTOL, V31, P33, DOI 10.1016/0531-5565(95)02022-5
   RIKANS LE, 1993, DRUG METAB DISPOS, V21, P605
   ROCK CS, 1991, J SURG RES, V51, P434, DOI 10.1016/0022-4804(91)90146-D
   SANGREN IP, 1991, CELL, V66, P245
   Sanz N, 1997, J HEPATOL, V27, P525, DOI 10.1016/S0168-8278(97)80358-3
   SANZ N, 1998, BIOCHIM BIOPHYS ACTA, V1348, P66
   SATOH M, 1991, Molecular Biotherapy, V3, P136
   SATOH M, 1992, J CELL PHYSIOL, V150, P134, DOI 10.1002/jcp.1041500118
   SCUDERI P, 1986, LANCET, V2, P1364
   Seglen PO, 1993, METHODS TOXICOL, P231
   SIMPSON JF, 1992, HUM PATHOL, V23, P323
   SUM CY, 1982, BIOCHEM PHARMACOL, V31, P69, DOI 10.1016/0006-2952(82)90238-6
   VINDELOV LL, 1983, CYTOMETRY, V3, P323, DOI 10.1002/cyto.990030503
   WEISMAN GA, 1988, J BIOL CHEM, V263, P12367
   WOODHOUSE K, 1992, BIOPHARM DRUG DISPOS, V13, P311, DOI 10.1002/bdd.2510130502
NR 39
TC 52
Z9 55
U1 0
U2 1
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0041-008X
J9 TOXICOL APPL PHARM
JI Toxicol. Appl. Pharmacol.
PD JAN 1
PY 1999
VL 154
IS 1
BP 40
EP 49
DI 10.1006/taap.1998.8541
PG 10
WC Pharmacology & Pharmacy; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Toxicology
GA 158YJ
UT WOS:000078144800005
PM 9882590
DA 2024-02-19
ER

PT J
AU Rahimi, VB
   Askari, VR
   Mousavi, SH
AF Rahimi, Vafa Baradaran
   Askari, Vahid Reza
   Mousavi, Seyed Hadi
TI Ellagic acid dose and time-dependently abrogates D-galactose-induced
   animal model of aging: Investigating the role of PPAR-γ
SO LIFE SCIENCES
LA English
DT Article
DE Ellagic acid; D-Galactose; Aging; PPAR-gamma; Metformin;
   Anti-inflammatory
ID PERITONEAL ADHESION; CELLULAR SENESCENCE; PIOGLITAZONE; INFLAMMATION;
   BRAIN; MECHANISMS; PROTECTS; SH-SY5Y; EXTRACT; DAMAGE
AB Aims: The world's population is becoming aged and the proportion of older persons is growing in almost every country in the world. Ellagic acid (FA) shows abundant pharmacological properties. Therefore, we aimed to determine the mechanism of anti-aging effects of low and high doses of EA.
   Main methods: Aging model was induced by D-galactose (DG), and the anti-aging effect of EA alone or in the presence of PPAR-gamma antagonist GW9662, and in combination with metformin were evaluated. The activities of ALT, AST, and AChE, the levels of FBS, HbA1c, testosterone and DHEA-SO4, MDA, GSH, TNF-alpha, IL-6, advanced glycation end products (AGEs), and BDNF were measured in serum, liver or brain.
   Key findings: DG led to increasing in the levels of IL-6, TNF-alpha, MDA, AChE, AGEs, ALT, AST, FBS, and HbA1c, in which decrease in the levels of body weight, GSH, BDNF, DHEA-SO4 and testosterone. Metformin (300 mg/kg) abrogated the effects of DG-induced aging model. We also found that the low dose of EA (30 mg/kg) decreases the deteriorative effects of DG-induced aging at 10 weeks of treatment only, however, high dose of EA (100 mg/kg) was effective at both 6 and 10 weeks of treatment. The addition of GW9662 completely reversed the effects of the low dose of EA, but not for the high dose, on DG-induced aging model.
   Significance: We revealed that daily and oral administration of EA provides anti-aging effects at low dose in a PPAR-gamma receptor-dependent fashion, but not at the high dose.
C1 [Rahimi, Vafa Baradaran; Askari, Vahid Reza] Mashhad Univ Med Sci, Pharmacol Res Ctr Med Plants, Mashhad, Razavi Khorasan, Iran.
   [Rahimi, Vafa Baradaran; Askari, Vahid Reza] Mashhad Univ Med Sci, Dept Pharmacol, Student Res Comm, Fac Med, Mashhad, Razavi Khorasan, Iran.
   [Askari, Vahid Reza] Mashhad Univ Med Sci, Neurogen Inflammat Res Ctr, Mashhad, Razavi Khorasan, Iran.
   [Mousavi, Seyed Hadi] Mashhad Univ Med Sci, Med Toxicol Res Ctr, Mashhad, Razavi Khorasan, Iran.
C3 Mashhad University Medical Science; Mashhad University Medical Science;
   Mashhad University Medical Science; Mashhad University Medical Science
RP Mousavi, SH (corresponding author), Mashhad Univ Med Sci, Dept Pharmacol, Fac Med, Mashhad, Razavi Khorasan, Iran.
EM mousavih@mums.ac.ir
RI Mousavi, Seyed Hadi/AAM-6802-2020; Askari, Vahid Reza/ABB-8991-2020;
   Rahimi, Vafa Baradaran/AAR-4523-2021
OI Mousavi, Seyed Hadi/0000-0002-6467-7307; Askari, Vahid
   Reza/0000-0001-9268-6270; Rahimi, Vafa Baradaran/0000-0003-2320-5095
FU research council of Mashhad University of Medical Sciences [960196]
FX This study financially supported by the research council of Mashhad
   University of Medical Sciences (Grant Number: 960196). This work was
   extracted from the Ph.D. thesis of the first author Vafa Baradaran
   Rahimi.
CR Ahangarpour A, 2016, INT J REPROD BIOMED, V14, P205
   [Anonymous], 2015, METF LONG STUD MILES
   [Anonymous], 2017, WORLD POP PROSP 2017
   Askari VR, 2019, LIFE SCI, V219, P40, DOI 10.1016/j.lfs.2018.12.059
   Askari VR, 2019, BIOCHEM PHARMACOL, V159, P154, DOI 10.1016/j.bcp.2018.12.001
   Askari VR, 2018, BIOMED PHARMACOTHER, V99, P346, DOI 10.1016/j.biopha.2018.01.068
   Bansal N, 2017, DRUG RES, V67, P425, DOI 10.1055/s-0043-108552
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   Chen P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19732-0
   Chung HY, 2009, AGEING RES REV, V8, P18, DOI 10.1016/j.arr.2008.07.002
   El-Garhy AM, 2014, J BIOCHEM MOL TOXIC, V28, P472, DOI 10.1002/jbt.21587
   El-Shitany NA, 2014, INT IMMUNOPHARMACOL, V19, P290, DOI 10.1016/j.intimp.2014.02.004
   Ernst Orna, 2010, J Vis Exp, DOI 10.3791/1918
   Firdaus F, 2018, TOXICOL REP, V5, P411, DOI 10.1016/j.toxrep.2018.02.017
   Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003
   Fulop T, 2010, BIOGERONTOLOGY, V11, P547, DOI 10.1007/s10522-010-9287-2
   Garg G, 2017, REJUV RES, V20, P173, DOI 10.1089/rej.2016.1883
   Goyal Y, 2019, ENVIRON TOXICOL, V34, P804, DOI 10.1002/tox.22747
   Hadzi-Petrushev N, 2015, PHYSIOL RES, V64, P61, DOI 10.33549/physiolres.932786
   Kenawy S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183565
   Kianmehr M, 2017, FOOD CHEM TOXICOL, V99, P119, DOI 10.1016/j.fct.2016.11.019
   Liu J, 2019, FOOD SCI NUTR, V7, P969, DOI 10.1002/fsn3.907
   Liu YY, 2013, NEUROCHEM INT, V62, P603, DOI 10.1016/j.neuint.2012.12.010
   Ma YJ, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/8938207
   Majdi A, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00194
   Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192
   Mehan D. S., 2015, NEUROPROTECTIVE EFFE
   Mohammadirad A, 2013, IRAN J BASIC MED SCI, V16, P1170
   Nankar RP, 2017, PHYTOMEDICINE, V37, P4, DOI 10.1016/j.phymed.2017.10.014
   Nankar RP, 2015, J FUNCT FOODS, V15, P1, DOI 10.1016/j.jff.2015.03.010
   Novelle MG, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a025932
   Prakash A, 2013, CLIN EXP PHARMACOL P, V40, P644, DOI 10.1111/1440-1681.12144
   Rahimi VB, 2019, MOLECULES, V24, DOI 10.3390/molecules24010139
   Rahimi VB, 2018, BIOMED PHARMACOTHER, V108, P1712, DOI 10.1016/j.biopha.2018.10.024
   Rahimi VB, 2017, BIOMED PHARMACOTHER, V92, P849, DOI 10.1016/j.biopha.2017.05.114
   García-Niño WR, 2015, PHARMACOL RES, V97, P84, DOI 10.1016/j.phrs.2015.04.008
   Rena G, 2017, DIABETOLOGIA, V60, P1577, DOI 10.1007/s00125-017-4342-z
   Ríos JL, 2018, PLANTA MED, V84, P1068, DOI 10.1055/a-0633-9492
   Rozentsvit A, 2017, CELL PHYSIOL BIOCHEM, V44, P1174, DOI 10.1159/000485448
   Saadat S, 2019, RESP RES, V20, DOI 10.1186/s12931-019-1054-6
   Salminen A, 2016, AGEING RES REV, V28, P15, DOI 10.1016/j.arr.2016.04.003
   Shen D, 2018, EXP GERONTOL, V102, P101, DOI 10.1016/j.exger.2017.12.002
   Shwe T, 2018, EXP GERONTOL, V101, P13, DOI 10.1016/j.exger.2017.10.029
   Xu LQ, 2016, FOOD FUNCT, V7, P4545, DOI 10.1039/c6fo01057a
   Ye Hong-Mei, 2013, Zhong Yao Cai, V36, P438
   Zeb A, 2018, MOL CELL BIOCHEM, V448, P27, DOI 10.1007/s11010-018-3310-3
   Zhang HL, 2019, EUR J PHARMACOL, V851, P133, DOI 10.1016/j.ejphar.2019.02.037
   Zhao HD, 2018, FOOD NUTR RES, V62, DOI 10.29219/fnr.v62.1371
   Zhu K, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.3000091
NR 49
TC 30
Z9 30
U1 3
U2 27
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0024-3205
EI 1879-0631
J9 LIFE SCI
JI Life Sci.
PD SEP 1
PY 2019
VL 232
AR 116595
DI 10.1016/j.lfs.2019.116595
PG 17
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA IR7LT
UT WOS:000481623100023
PM 31238053
DA 2024-02-19
ER

PT J
AU Wang, XH
   Quail, E
   Hung, NJ
   Tan, YJ
   Ye, HG
   Costa, RH
AF Wang, XH
   Quail, E
   Hung, NJ
   Tan, YJ
   Ye, HG
   Costa, RH
TI Increased levels of forkhead box M1B transcription factor in transgenic
   mouse hepatocytes prevent age-related proliferation defects in
   regenerating liver
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
ID CYCLIN B1; CAENORHABDITIS-ELEGANS; FACTOR TRIDENT; DNA-BINDING; S-PHASE;
   EXPRESSION; HEAD; GROWTH; PROTEIN; FAMILY
AB The forkhead box (Fox) family of transcription factors share homology in the winged helix/forkhead DNA-binding domain and play important roles in regulating cellular proliferation, differentiation, longevity, and cellular transformation. Forkhead box M1B (FoxM1B) is a ubiquitously expressed member of the Fox transcription factor family whose expression is restricted to proliferating cells and that mediates hepatocyte entry into DNA synthesis and mitosis during liver regeneration. Recent cDNA microarray studies indicated that age-related defects in cellular proliferation are associated with diminished expression of the FoxM1B transcription factor. Here, we show that increased levels of FoxM1B in regenerating liver of old transgenic mice restore the sharp peaks in hepatocyte DNA replication and mitosis that are the hallmarks of young regenerating mouse liver. Restoration of the young regenerating liver phenotype is associated with increased expression of numerous cell cycle regulatory genes that include cyclin D1, cyclin A2, cyclin F, cyclin B1, cyclin B2, Cdc25B, and p55cdc. Cotransfection assays in the human hepatoma HepG2 cell line demonstrated that FoxM1B protein stimulated expression of both the cyclin B1 and cyclin D1 promoters, suggesting that these cyclin genes are a direct FoxM1B transcriptional target. These results suggest that FoxM1B controls the transcriptional network of genes that are essential for cell division and exit from mitosis. Our results indicate that reduced expression of the FoxM1B transcription factor contributes to the decline in cellular proliferation observed in the aging process.
C1 Univ Illinois, Coll Med, Dept Mol Genet, Chicago, IL 60607 USA.
   Univ Western Australia, Dept Biochem, Crawley, WA 6009, Australia.
C3 University of Illinois System; University of Illinois Chicago;
   University of Illinois Chicago Hospital; University of Western Australia
RP Costa, RH (corresponding author), Univ Illinois, Coll Med, Dept Mol Genet, M-C 669,900 S Ashland Ave,Rm 2220 MBRB, Chicago, IL 60607 USA.
OI Quail, Elizabeth/0000-0002-0505-2438
FU NIDDK NIH HHS [R01 DK54687, R01 DK054687] Funding Source: Medline
CR ALBANESE C, 1995, J BIOL CHEM, V270, P23589, DOI 10.1074/jbc.270.40.23589
   CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0
   COGSWELL JP, 1995, MOL CELL BIOL, V15, P2782
   Costa RH, 2001, AM J PHYSIOL-LUNG C, V280, pL823, DOI 10.1152/ajplung.2001.280.5.L823
   Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379
   Duncan SA, 2000, DEV DYNAM, V219, P131, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1051>3.3.CO;2-E
   Factor VM, 1997, HEPATOLOGY, V26, P1434
   Fausto N, 1995, FASEB J, V9, P1527, DOI 10.1096/fasebj.9.15.8529831
   Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200
   Kaestner KH, 2000, TRENDS ENDOCRIN MET, V11, P281, DOI 10.1016/S1043-2760(00)00271-X
   Kaestner KH, 2000, GENE DEV, V14, P142
   Kaufmann E, 1996, MECH DEVELOP, V57, P3, DOI 10.1016/0925-4773(96)00539-4
   Kong M, 2000, EMBO J, V19, P1378, DOI 10.1093/emboj/19.6.1378
   Korver W, 1998, CURR BIOL, V8, P1327, DOI 10.1016/S0960-9822(07)00563-5
   Korver W, 1997, NUCLEIC ACIDS RES, V25, P1715, DOI 10.1093/nar/25.9.1715
   LAI E, 1991, GENE DEV, V5, P416, DOI 10.1101/gad.5.3.416
   Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319
   Ly DH, 2000, SCIENCE, V287, P2486, DOI 10.1126/science.287.5462.2486
   Ma Y, 2000, ONCOGENE, V19, P4815, DOI 10.1038/sj.onc.1203834
   Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60
   Nilsson I, 2000, Prog Cell Cycle Res, V4, P107
   Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194
   Perl AKT, 1999, CLIN GENET, V56, P14, DOI 10.1034/j.1399-0004.1999.560103.x
   Rausa FM, 2000, MOL CELL BIOL, V20, P8264, DOI 10.1128/MCB.20.21.8264-8282.2000
   Scheidler S, 1996, P NATL ACAD SCI USA, V93, P9805, DOI 10.1073/pnas.93.18.9805
   SEBASTIAN B, 1993, P NATL ACAD SCI USA, V90, P3521, DOI 10.1073/pnas.90.8.3521
   Taub R, 1996, FASEB J, V10, P413, DOI 10.1096/fasebj.10.4.8647340
   Trembley JH, 1996, CELL GROWTH DIFFER, V7, P903
   Wang XH, 2001, HEPATOLOGY, V33, P1404, DOI 10.1053/jhep.2001.24666
   XU XO, 1995, ENDOCRINOLOGY, V136, P4551, DOI 10.1210/en.136.10.4551
   Yamada Y, 1997, P NATL ACAD SCI USA, V94, P1441, DOI 10.1073/pnas.94.4.1441
   Yao KM, 1997, J BIOL CHEM, V272, P19827, DOI 10.1074/jbc.272.32.19827
   Ye HG, 1999, MOL CELL BIOL, V19, P8570
   Ye HG, 1997, MOL CELL BIOL, V17, P1626, DOI 10.1128/MCB.17.3.1626
   Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039
   Zaret K, 1999, DEV BIOL, V209, P1, DOI 10.1006/dbio.1999.9228
NR 36
TC 166
Z9 207
U1 1
U2 2
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD SEP 25
PY 2001
VL 98
IS 20
BP 11468
EP 11473
DI 10.1073/pnas.201360898
PG 6
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 476PC
UT WOS:000171237100088
PM 11572993
OA Green Published
DA 2024-02-19
ER

PT J
AU Hide, D
   Warren, A
   Fernández-Iglesias, A
   Maeso-Díaz, R
   Peralta, C
   Le Couteur, DG
   Bosch, J
   Cogger, VC
   Gracia-Sancho, J
AF Hide, Diana
   Warren, Alessandra
   Fernandez-Iglesias, Anabel
   Maeso-Diaz, Raquel
   Peralta, Carmen
   Le Couteur, David G.
   Bosch, Jaime
   Cogger, Victoria C.
   Gracia-Sancho, Jordi
TI Ischemia/Reperfusion Injury in the Aged Liver: The Importance of the
   Sinusoidal Endothelium in Developing Therapeutic Strategies for the
   Elderly
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
DE Liver sinusoidal endothelial cells; LSEC; Hepatic hemodynamic;
   Intrahepatic vascular resistance; Statins
ID HEPATIC ISCHEMIA-REPERFUSION; NITRIC-OXIDE; PORTAL PRESSURE;
   VASCULAR-TONE; RAT; SIMVASTATIN; TRANSPLANTATION; DYSFUNCTION;
   SUPEROXIDE; DECREASES
AB The liver endothelium plays a key role in the progression and resolution of liver diseases in young and adult individuals. However, its role in older people remains unknown. We have herein evaluated the importance of the sinusoidal endothelium in the pathophysiology of acute liver injury, and investigated the applicability of simvastatin, in aged animals. Eighteen-months-old male Wistar rats underwent 60 minutes of partial warm ischemia followed by 2 hours of reperfusion (WIR). A group of aged rats received simvastatin for 3 days before WIR. Endothelial phenotype, parenchymal injury, oxidative and nitrosative stress, and fenestrae dynamics were analyzed. The effects of WIR and simvastatin were investigated in primary LSEC from aged animals. The results of this study demonstrated that WIR significantly damages the liver endothelium and its effects are markedly worse in old animals. WIR-aged livers exhibited reduced vasodilation and sinusoidal capillarization, associated with liver damage and cellular stress. Simvastatin prevented the detrimental effects of WIR in aged livers. In conclusion, the liver sinusoidal endothelium of old animals is highly vulnerable to acute insult, thus targeted protection is especially relevant in preventing liver damage. Simvastatin represents a useful therapeutic strategy in aging.
C1 [Hide, Diana; Fernandez-Iglesias, Anabel; Maeso-Diaz, Raquel; Bosch, Jaime; Gracia-Sancho, Jordi] Univ Barcelona, Sch Med, IDIBAPS Biomed Res Inst, Liver Vasc Biol Res Grp,Barcelona Hepat Hemodynam, Barcelona, Spain.
   [Hide, Diana; Fernandez-Iglesias, Anabel; Peralta, Carmen; Bosch, Jaime; Gracia-Sancho, Jordi] Biomed Res Network Ctr Hepat & Digest Dis CIBEREH, Madrid, Spain.
   [Warren, Alessandra; Le Couteur, David G.; Cogger, Victoria C.] Univ Sydney, Ctr Educ & Res Ageing, Sydney, NSW, Australia.
   [Warren, Alessandra; Le Couteur, David G.; Cogger, Victoria C.] Univ Sydney, ANZAC Res Inst, Sydney, NSW, Australia.
   [Warren, Alessandra; Le Couteur, David G.; Cogger, Victoria C.] Concord Hosp, Concord, NSW, Australia.
   [Peralta, Carmen] IDIBAPS, Protect Strategies Hepat Ischemia Reperfus Grp, Barcelona, Spain.
   [Bosch, Jaime; Gracia-Sancho, Jordi] Bern Univ, Inselspital, Dept Biomed Res, Hepatol, Bern, Switzerland.
C3 University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS;
   University of Sydney; University of Sydney; ANZAC Research Institute;
   Concord Repatriation General Hospital; University of Barcelona; Hospital
   Clinic de Barcelona; IDIBAPS; University of Bern; University Hospital of
   Bern
RP Gracia-Sancho, J (corresponding author), Inst Invest Biomed August Pi & Sunyer IDIBAPS, Liver Vasc Biol Res Grp, Rossello 149,4th Floor, Barcelona 08036, Spain.
EM jordi.gracia@idibaps.org
RI Fernández-Iglesias, Anabel/AAB-3143-2021; Fernández-Iglesias,
   Anabel/AAD-6811-2020; Bosch, Jaime/AFF-8344-2022; Research Institute,
   ANZAC/CAE-9030-2022; Bosch, Jaime/AAF-1006-2022; Peralta,
   Carmen/M-8170-2014; Gracia-Sancho, Jordi/C-8920-2014
OI Fernández-Iglesias, Anabel/0000-0003-2364-6675; Fernández-Iglesias,
   Anabel/0000-0003-2364-6675; Hide, Diana/0000-0001-7189-9111; Le Couteur,
   David/0000-0002-4227-5817; Peralta, Carmen/0000-0002-5767-0676;
   Gracia-Sancho, Jordi/0000-0001-7736-4089
FU Instituto de Salud Carlos III [FIS PI14/00029, PI17/00012, CD15/00050,
   iPFIS IFI15/00037]; European Union FEDER Funds; una manera de hacer
   Europa; CERCA Program from the Generalitat de Catalunya
FX This work was supported by the Instituto de Salud Carlos III (FIS
   PI14/00029 and PI17/00012 to J.G.-S.), the European Union FEDER Funds,
   "una manera de hacer Europa," and the CERCA Program from the Generalitat
   de Catalunya. CIBEREHD is funded by the Instituto de Salud Carlos III.
   A.F.-I. has a Sara Borrell contract from the Instituto de Salud Carlos
   III (CD15/00050). R.M.-D. has a fellowship from the Instituto de Salud
   Carlos III (iPFIS IFI15/00037).
CR Abraldes JG, 2007, J HEPATOL, V46, P1040, DOI 10.1016/j.jhep.2007.01.020
   Abraldes JG, 2016, GASTROENTEROLOGY, V150, P1160, DOI 10.1053/j.gastro.2016.01.004
   Abu-Amara M, 2010, LIVER TRANSPLANT, V16, P1016, DOI 10.1002/lt.22117
   BILLIAR TR, 1995, GASTROENTEROLOGY, V108, P603, DOI 10.1016/0016-5085(95)90093-4
   Braet Filip, 2002, Comp Hepatol, V1, P1, DOI 10.1186/1476-5926-1-1
   Brandes RP, 2005, KIDNEY INT, V67, P1662, DOI 10.1111/j.1523-1755.2005.00258.x
   Carpenter B, 2005, DEVELOPMENT, V132, P3293, DOI 10.1242/dev.01902
   Casillas-Ramírez A, 2009, ENDOCRINOLOGY, V150, P3153, DOI 10.1210/en.2008-1458
   Clavien PA, 2003, ANN SURG, V238, P843, DOI 10.1097/01.sla.0000098620.27623.7d
   Fraser R, 2012, PATHOLOGY, V44, P181, DOI 10.1097/PAT.0b013e328351bcc8
   Gracia-Sancho J, 2019, NAT REV GASTRO HEPAT, V16, P221, DOI 10.1038/s41575-018-0097-3
   Gracia-Sancho J, 2008, HEPATOLOGY, V47, P1248, DOI 10.1002/hep.22166
   Gracia-Sancho J, 2007, GASTROENTEROLOGY, V133, P959, DOI 10.1053/j.gastro.2007.06.021
   Gracia-Sancho J, 2011, GUT, V60, P517, DOI 10.1136/gut.2010.220913
   Helmy MM, 2012, PHARMACOL REP, V64, P698, DOI 10.1016/S1734-1140(12)70864-2
   Hide D, 2016, SCI REP-UK, V6, DOI 10.1038/srep22107
   Hide D, 2014, CLIN SCI, V127, P527, DOI 10.1042/CS20140125
   Hilmer SN, 2005, HEPATOLOGY, V42, P1349, DOI 10.1002/hep.20937
   Iwakiri Y, 2015, TRENDS PHARMACOL SCI, V36, P524, DOI 10.1016/j.tips.2015.05.001
   Jaeschke H, 2006, AM J PHYSIOL-GASTR L, V290, pG1083, DOI 10.1152/ajpgi.00568.2005
   Jain MK, 2005, NAT REV DRUG DISCOV, V4, P977, DOI 10.1038/nrd1901
   Jiménez-Castro MB, 2015, J HEPATOL, V62, P83, DOI 10.1016/j.jhep.2014.07.031
   La Mura V, 2013, HEPATOLOGY, V57, P1172, DOI 10.1002/hep.26127
   Le Couteur DG, 2015, J GERONTOL A-BIOL, V70, P1499, DOI 10.1093/gerona/glu196
   Le Couteur DG, 2005, CLIN PHARMACOKINET, V44, P187, DOI 10.2165/00003088-200544020-00004
   Le Couteur DG, 2001, HEPATOLOGY, V33, P537, DOI 10.1053/jhep.2001.22754
   LECOUTEUR DG, 1994, TRANSPLANTATION, V58, P531, DOI 10.1097/00007890-199409150-00001
   Limani P, 2016, ANN SURG, V264, P797, DOI 10.1097/SLA.0000000000001765
   Maeso-Díaz R, 2019, AGING DIS, V10, P684, DOI 10.14336/AD.2019.0127
   Maeso-Díaz R, 2018, AGING CELL, V17, DOI 10.1111/acel.12829
   O'Reilly JN, 2010, J ELECTRON MICROSC, V59, P65, DOI 10.1093/jmicro/dfp039
   Okaya T, 2005, SHOCK, V24, P421, DOI 10.1097/01.shk.0000181282.14050.11
   Ortega-Ribera M, 2018, BIOTECHNOL BIOENG, V115, P2585, DOI 10.1002/bit.26776
   Peralta C, 2001, TRANSPLANTATION, V71, P529, DOI 10.1097/00007890-200102270-00008
   Peralta C, 2013, J HEPATOL, V59, P1094, DOI 10.1016/j.jhep.2013.06.017
   Rodríguez S, 2017, SCI REP-UK, V7, DOI 10.1038/srep40461
   Russo L, 2012, HEPATOLOGY, V55, P921, DOI 10.1002/hep.24755
   Selzner M, 2007, LIVER TRANSPLANT, V13, P382, DOI 10.1002/lt.21100
   Shah V, 2003, LIVER TRANSPLANT, V9, P1, DOI 10.1053/jlts.2003.36244
   Singh P, 2011, J GERONTOL A-BIOL, V66, P944, DOI 10.1093/gerona/glr094
   Sorensen A, 2008, OBESITY, V16, P566, DOI 10.1038/oby.2007.58
   Sorensen KK, 2012, AM J PHYSIOL-REG I, V303, pR1217, DOI 10.1152/ajpregu.00686.2011
   Trebicka J, 2007, HEPATOLOGY, V46, P242, DOI 10.1002/hep.21673
   Tripathi DM, 2018, GASTROENTEROLOGY, V155, P1564, DOI 10.1053/j.gastro.2018.07.022
   Wang JH, 2011, GASTROENTEROLOGY, V141, P2188, DOI 10.1053/j.gastro.2011.08.005
   Wang Y, 1998, SHOCK, V10, P20, DOI 10.1097/00024382-199807000-00004
   Wisse E, 1996, TOXICOL PATHOL, V24, P100, DOI 10.1177/019262339602400114
   WULF E, 1979, P NATL ACAD SCI USA, V76, P4498, DOI 10.1073/pnas.76.9.4498
   Yokomori H, 2004, LAB INVEST, V84, P857, DOI 10.1038/labinvest.3700114
   Zafra C, 2004, GASTROENTEROLOGY, V126, P749, DOI 10.1053/j.gastro.2003.12.007
NR 50
TC 19
Z9 19
U1 0
U2 7
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD FEB
PY 2020
VL 75
IS 2
BP 268
EP 277
DI 10.1093/gerona/glz012
PG 10
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA LU0FZ
UT WOS:000537440500010
PM 30649272
OA hybrid, Green Published
DA 2024-02-19
ER

PT J
AU Lu, MC
   Lee, IT
   Hong, LZ
   Ben-Arie, E
   Lin, YH
   Lin, WT
   Kao, PY
   Yang, MD
   Chan, YC
AF Lu, Meng-Chun
   Lee, I-Te
   Hong, Ling-Zong
   Ben-Arie, Eyal
   Lin, Yu-Hsuan
   Lin, Wei-Ting
   Kao, Pei-Yu
   Yang, Mei-Due
   Chan, Yin-Ching
TI Coffeeberry Activates the CaMKII/CREB/BDNF Pathway, Normalizes Autophagy
   and Apoptosis Signaling in Nonalcoholic Fatty Liver Rodent Model
SO NUTRIENTS
LA English
DT Article
DE nonalcoholic fatty liver disease; coffeeberry; redox status;
   <p>CaMKII/CREB/BDNF & nbsp;</p>; autophagy; apoptosis
ID HEPATIC LIPID-METABOLISM; NEUROTROPHIC FACTOR; CAFFEINE; DISEASE; CREB;
   INHIBITION; EXTRACT; STRESS; BDNF; IMPAIRMENT
AB Nonalcoholic fatty liver disease (NAFLD) shows extensive liver cell destruction with lipid accumulation, which is frequently accompanied by metabolic comorbidities and increases mortality. This study aimed to investigate the effects of coffeeberry (CB) on regulating the redox status, the CaMKII/CREB/BDNF pathway, autophagy, and apoptosis signaling by a NAFLD rodent model senescence-accelerated mice prone 8 (SAMP8). Three-month-old male SAMP8 mice were divided into a control group and three CB groups (50, 100, and 200 mg/kg BW), and fed for 12 weeks. The results show that CB reduced hepatic malondialdehyde and carbonyl protein levels. CB significantly enhanced Ca2+/calmodulin-dependent protein kinase II (CaMKII) and brain-derived neurotrophic factor (BDNF) and reduced the phospho-cAMP response element-binding protein (p-CREB)/CREB ratio. In addition, CB increased the silent information regulator T1 level, promoted Beclin 1 and microtubule-associated protein light chain 3 II expressions, and reduced phosphorylated mammalian target of rapamycin and its downstream p-p70s6k levels. CB also inhibited the expressions of apoptosis-related factors poly (ADP-ribose) polymerase-1 and the apoptosis-inducing factor. In conclusion, CB might protect the liver by reducing oxidative stress, activating the CaMKII/CREB/BDNF pathway, and improving autophagic and apoptotic expressions in a dose-dependent manner.
C1 [Lu, Meng-Chun] China Med Univ Hosp, Dept Clin Nutr, Taichung 406040, Taiwan.
   [Lu, Meng-Chun] China Med Univ, Dept Nutr, Taichung 406040, Taiwan.
   [Lu, Meng-Chun; Lin, Yu-Hsuan; Lin, Wei-Ting; Chan, Yin-Ching] Providence Univ, Dept Food & Nutr, Taichung 43301, Taiwan.
   [Lee, I-Te] Taichung Vet Gen Hosp, Div Endocrinol & Metab, Taichung 40705, Taiwan.
   [Hong, Ling-Zong] Taichung Vet Gen Hosp, Dept Med Res, Taichung 40705, Taiwan.
   [Ben-Arie, Eyal] China Med Univ, Coll Chinese Med, Grad Inst Acupuncture Sci, Taichung 406040, Taiwan.
   [Kao, Pei-Yu] China Med Univ Hosp, Dept Surg, Div Thorac Surg, Taichung 406040, Taiwan.
   [Yang, Mei-Due] China Med Univ Hosp, Dept Surg, Div Gen Surg, Taichung 406040, Taiwan.
C3 China Medical University Taiwan; China Medical University Hospital -
   Taiwan; China Medical University Taiwan; Providence University - Taiwan;
   Taichung Veterans General Hospital; Taichung Veterans General Hospital;
   China Medical University Taiwan; China Medical University Taiwan; China
   Medical University Hospital - Taiwan; China Medical University Taiwan;
   China Medical University Hospital - Taiwan
RP Chan, YC (corresponding author), Providence Univ, Dept Food & Nutr, Taichung 43301, Taiwan.
EM itlee@vghtc.gov.tw; lzhong1950@gmail.com; benarie19@gmail.com;
   ludouto@gmail.com; d5218@mail.cmuh.org.tw
OI Lee, I-Te/0000-0003-2665-3635; Chan, Yin Ching/0000-0001-9602-0775;
   Ben-Arie, Eyal/0000-0001-7556-794X
FU China Medical University Hospital, Taiwan [DMR-106-111, DMR-107-102];
   Taichung Veterans General Hospital, Providence University, Taichung,
   Taiwan [TCVGH-PU1058001, TCVGH-PU1068102]; Ministry of Science and
   Technology (MOST), Taiwan [MOST 108-2320-B-126-002-MY3]
FX This work was supported by grants from China Medical University
   Hospital, Taiwan (DMR-106-111 and DMR-107-102), Taichung Veterans
   General Hospital, Providence University (TCVGH-PU1058001 and
   TCVGH-PU1068102), Taichung, Taiwan, and in part by the Ministry of
   Science and Technology (MOST), Taiwan (MOST 108-2320-B-126-002-MY3).
CR Abounit Kadija, 2012, World J Biol Chem, V3, P1, DOI 10.4331/wjbc.v3.i1.1
   Alcendor RR, 2007, CIRC RES, V100, P1512, DOI 10.1161/01.RES.0000267723.65696.4a
   [Anonymous], 2020, Ministry of Health and Welfare
   Barco A, 2006, J NEUROCHEM, V97, P1520, DOI 10.1111/j.1471-4159.2006.03870.x
   Camer D, 2015, MOL CELL ENDOCRINOL, V412, P36, DOI 10.1016/j.mce.2015.05.018
   Chan YC, 2019, NUTRIENTS, V11, DOI 10.3390/nu11071631
   Chan YC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178916
   Chao MV, 2006, CLIN SCI, V110, P167, DOI 10.1042/CS20050163
   Chen JC, 2014, NUTR CANCER, V66, P700, DOI 10.1080/01635581.2014.902974
   Chen SH, 2014, J GASTROEN HEPATOL, V29, P435, DOI 10.1111/jgh.12422
   Czaja MJ, 2016, DIGEST DIS SCI, V61, P1304, DOI 10.1007/s10620-015-4025-x
   Deng XQ, 2007, LIVER INT, V27, P708, DOI 10.1111/j.1478-3231.2007.01497.x
   Devasagayam TPA, 1996, BBA-BIOMEMBRANES, V1282, P63, DOI 10.1016/0005-2736(96)00040-5
   Duangjai Acharaporn, 2018, Kobe J Med Sci, V64, pE84
   Gariani K, 2017, J HEPATOL, V66, P132, DOI 10.1016/j.jhep.2016.08.024
   Genzer Y, 2017, INT J BIOCHEM CELL B, V88, P69, DOI 10.1016/j.biocel.2017.05.008
   Halvorsen BL, 2006, AM J CLIN NUTR, V84, P95, DOI 10.1093/ajcn/84.1.95
   Hashida R, 2021, LIFE-BASEL, V11, DOI 10.3390/life11080799
   He YN, 2020, ANN HEPATOL, V19, P44, DOI 10.1016/j.aohep.2019.06.023
   Heimbach JT, 2010, FOOD CHEM TOXICOL, V48, P2517, DOI 10.1016/j.fct.2010.06.025
   Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131
   Herzig S, 2003, NATURE, V426, P190, DOI 10.1038/nature02110
   Houglum K, 1997, J CLIN INVEST, V99, P1322, DOI 10.1172/JCI119291
   Hsu CS, 2012, J FORMOS MED ASSOC, V111, P527, DOI 10.1016/j.jfma.2012.07.002
   Islam R, 2019, NUTRIENTS, V11, DOI 10.3390/nu11040888
   Kang JW, 2014, CELL PHYSIOL BIOCHEM, V33, P23, DOI 10.1159/000356647
   Khambu Bilon, 2018, Liver Res, V2, P112, DOI 10.1016/j.livres.2018.09.004
   Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022
   Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011
   Li YJ, 2017, INT J MOL MED, V40, P1405, DOI 10.3892/ijmm.2017.3145
   Li ZH, 2015, INT J BIOL SCI, V11, P672, DOI 10.7150/ijbs.11883
   Liu K, 2013, CELL DEATH DIFFER, V20, P3, DOI 10.1038/cdd.2012.63
   Lu Meng-Chun, 2020, Taiwanese Journal of Agricultural Chemistry and Food Science, V58, P1, DOI 10.6578/TJACFS.202002_58(1).0001
   McDaniel D.H., 2009, Cosmet. Dermatol. Cedark Knollis, V22, P610
   Mukhopadhyay P, 2017, J HEPATOL, V66, P589, DOI 10.1016/j.jhep.2016.10.023
   Nakadera E, 2016, BIOCHEM BIOPH RES CO, V469, P1104, DOI 10.1016/j.bbrc.2015.12.010
   Ostojic SM, 2012, SCI SPORT, V27, P308, DOI 10.1016/j.scispo.2011.12.008
   Ostojic Sergej M, 2008, Res Sports Med, V16, P281, DOI 10.1080/15438620802523345
   Ozcan L, 2012, CELL METAB, V15, P739, DOI 10.1016/j.cmet.2012.03.002
   Reed RA, 2019, J COGN ENHANCE, V3, P193, DOI 10.1007/s41465-018-0118-8
   Refolo MG, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051518
   Reyes-Izquierdo T, 2013, BRIT J NUTR, V110, P420, DOI 10.1017/S0007114512005338
   Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823
   Saiki S, 2011, AUTOPHAGY, V7, P176, DOI 10.4161/auto.7.2.14074
   Salomone F, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101086
   Salomone F, 2017, NUTRIENTS, V9, DOI 10.3390/nu9010085
   SHARP DS, 1995, AM J EPIDEMIOL, V141, P480, DOI 10.1093/oxfordjournals.aje.a117455
   SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483
   Shu HC, 2019, INT J CLIN EXP PATHO, V12, P2368
   Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976
   Sinha RA, 2014, HEPATOLOGY, V59, P1366, DOI 10.1002/hep.26667
   Suggs Amanda, 2014, Inflammation & Allergy Drug Targets, V13, P168
   Takahashi K, 2017, NUTRITION, V38, P1, DOI 10.1016/j.nut.2016.12.021
   Vásquez CE, 2014, NEUROCHEM INT, V79, P88, DOI 10.1016/j.neuint.2014.09.007
   VISTISEN K, 1992, CARCINOGENESIS, V13, P1561, DOI 10.1093/carcin/13.9.1561
   Vitaglione P, 2010, HEPATOLOGY, V52, P1652, DOI 10.1002/hep.23902
   Wang YF, 2009, EXP NEUROL, V218, P193, DOI 10.1016/j.expneurol.2009.03.020
   Wang ZL, 2019, MED ONCOL, V36, DOI 10.1007/s12032-019-1323-8
   Xie WJ, 2019, ANN TRANSL MED, V7, DOI 10.21037/atm.2019.09.39
   Yamanaka M, 2007, DIABETES OBES METAB, V9, P879, DOI 10.1111/j.1463-1326.2006.00675.x
   Yan H, 2018, J BIOSCIENCES, V43, P287, DOI 10.1007/s12038-018-9746-5
   Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005
   Ye X, 2004, HISTOL HISTOPATHOL, V19, P1141, DOI 10.14670/HH-19.1141
   Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431
   Zadernowski R, 2005, J AGR FOOD CHEM, V53, P2118, DOI 10.1021/jf040411p
   Zhang Y, 2018, LIPIDS HEALTH DIS, V17, DOI 10.1186/s12944-018-0916-0
   Zhou R, 2018, CELL PHYSIOL BIOCHEM, V51, P2397, DOI 10.1159/000495898
   Zong Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044107
NR 68
TC 3
Z9 3
U1 2
U2 10
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD OCT
PY 2021
VL 13
IS 10
AR 3652
DI 10.3390/nu13103652
PG 13
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA WS1GX
UT WOS:000714937500001
PM 34684653
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Zheng, W
   Liu, YL
   Shang, HB
   Zhang, Y
   Ma, DW
   Hou, N
   Wang, J
   Sun, XT
   Peng, Y
   Pan, L
   Wang, ZL
   Tang, XR
   Xiao, RP
   Zhang, XQ
AF Zheng, Wen
   Liu, Yuli
   Shang, Haibao
   Zhang, Yan
   Ma, Dongwei
   Hou, Ning
   Wang, Jue
   Sun, Xueting
   Peng, Ying
   Pan, Lin
   Wang, Zhilong
   Tang, Xinran
   Xiao, Rui-Ping
   Zhang, Xiuqin
TI Characterization of spontaneously-developed non-alcoholic fatty liver
   disease in aged rhesus monkeys
SO DIABETOLOGY & METABOLIC SYNDROME
LA English
DT Article
DE Non-alcoholic fatty liver disease; Non-human primates; Ultrasonographic
   steatosis score; Metabolic syndrome
ID METABOLIC SYNDROME; HEPATIC STEATOSIS; ABDOMINAL ULTRASOUND; MACAQUE
   GENOME; OBESE-PATIENTS; FOLLOW-UP; STEATOHEPATITIS; POPULATION;
   DIAGNOSIS; FIBROSIS
AB Background: Non-alcoholic fatty liver disease (NAFLD) is a global epidemic afflicting 20-30% in the general population. The animal model of NAFLD available at the present are less clinically relevant. In this study. We aimed to establish a NAFLD model of rhesus monkeys and develop an ultrasonographic steatosis score (USS) system to grade hepatic steatosis in this model.
   Methods: We performed hepatic ultrasonography and blood biochemical tests on 86 rhesus monkeys with and without metabolic syndrome (MetS), among which 45 animals were further assessed by histopathological analysis.
   Results: The liver histological features of rhesus monkeys NAFLD were resemble to those of NAFLD patients. There was a close correlation between the histological steatosis grade and the USS (Spearman's coefficient, 0.705, p < 0.001). The USS sensitivity was 87.5% and the specificity was 94.6% when the cut-off was USS2. In addition, the prevalence of MetS was significantly higher in the USS2-3 group. Multiple risk factors of cardiometabolic disease, including obesity, insulin resistance and dyslipidemia were significantly correlated with the USS.
   Conclusions: NAFLD was developed spontaneously among aging in rhesus monkeys (with increased prevalence in the MetS monkeys), which provided an ideal model for NAFLD. The newly developed USS system can be used to evaluate fatty liver in the rhesus monkey. The model as well as the noninvasive assessment methodology will provide a powerful tool for mechanistic studies and preclinical test of novel therapies for NAFLD.
C1 [Zheng, Wen; Liu, Yuli; Zhang, Yan; Ma, Dongwei; Hou, Ning; Wang, Jue; Sun, Xueting; Xiao, Rui-Ping; Zhang, Xiuqin] Peking Univ, Inst Mol Med, Beijing 100871, Peoples R China.
   [Zheng, Wen; Liu, Yuli; Ma, Dongwei; Hou, Ning; Wang, Jue; Sun, Xueting; Xiao, Rui-Ping; Zhang, Xiuqin] Peking Univ, Beijing Key Lab Cardiometabol Mol Med, Beijing 100871, Peoples R China.
   [Shang, Haibao] Peking Univ, Lab Anim Ctr, Beijing 100871, Peoples R China.
   [Peng, Ying] Peking Univ, Hosp 3, Beijing 100191, Peoples R China.
   [Pan, Lin] China Japan Friendship Hosp, Beijing 100029, Peoples R China.
   [Wang, Zhilong] Peking Univ, Peoples Hosp, Beijing 100044, Peoples R China.
   [Tang, Xinran] INC Res, Beijing 100020, Peoples R China.
   [Xiao, Rui-Ping] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China.
C3 Peking University; Peking University; Peking University; Peking
   University; China-Japan Friendship Hospital; Peking University; Peking
   University
RP Zhang, XQ (corresponding author), Peking Univ, Inst Mol Med, Beijing 100871, Peoples R China.; Zhang, XQ (corresponding author), Peking Univ, Beijing Key Lab Cardiometabol Mol Med, Beijing 100871, Peoples R China.
EM zhangxq@pku.edu.cn
RI Yimei, Wang/AAE-4083-2019; wangwangwang, yuanyaunyuan/HHN-6432-2022;
   liu, jiaming/IWE-3196-2023; Wang, Jue/X-1696-2019; zhang,
   xu/JEO-4879-2023; LI, SHA/JNR-9956-2023; Xiao, Rui-Ping/AAE-2629-2019
OI Wang, Zhilong/0000-0003-4640-3297; Zhang, Xiuqin/0000-0001-8692-7146
FU National Science and Technology Major Projects for "Major New Drug
   Innovation and Development" [2013ZX09501014]; National Natural Science
   Foundation of China [31521062, 81270883, 30870996, 81471063, 31221002,
   81170100, 81630008, 81370234]; National Key Basic Research Program of
   China [2013CB531200, 2012CB518000]
FX This work was supported by the National Science and Technology Major
   Projects for "Major New Drug Innovation and Development"
   (2013ZX09501014), the National Natural Science Foundation of China
   (31521062, 81270883, 30870996, 81471063, 31221002, 81170100, 81630008,
   and 81370234), and the National Key Basic Research Program of China
   (2013CB531200 and 2012CB518000).
CR Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014
   Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80
   Angulo P, 2015, GASTROENTEROLOGY, V149, P389, DOI 10.1053/j.gastro.2015.04.043
   Arienti V, 2012, INTERN EMERG MED, V7, pS283, DOI 10.1007/s11739-012-0824-7
   Ballestri S, 2016, J GASTROEN HEPATOL, V31, P936, DOI 10.1111/jgh.13264
   Bellentani S, 2000, ANN INTERN MED, V132, P112, DOI 10.7326/0003-4819-132-2-200001180-00004
   Bergen WG, 2005, J NUTR, V135, P2499, DOI 10.1093/jn/135.11.2499
   Bril F, 2015, LIVER INT, V35, P2139, DOI 10.1111/liv.12840
   Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466
   Chaves GV, 2009, REV ASSOC MED BRAS, V55, P45, DOI 10.1590/S0104-42302009000100014
   Choudhury Jayanta, 2004, Clin Liver Dis, V8, P575, DOI 10.1016/j.cld.2004.04.006
   Clark JM, 2002, GASTROENTEROLOGY, V122, P1649, DOI 10.1053/gast.2002.33573
   Cusi K, 2014, J HEPATOL, V60, P167, DOI 10.1016/j.jhep.2013.07.042
   Dasarathy S, 2009, J HEPATOL, V51, P1061, DOI 10.1016/j.jhep.2009.09.001
   Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2
   Dhawan V, 2005, MOL CELL BIOCHEM, V269, P1, DOI 10.1007/s11010-005-1810-4
   Diehl AM, 2005, GUT, V54, P303, DOI 10.1136/gut.2003.024935
   Díez JJ, 2003, EUR J ENDOCRINOL, V148, P293, DOI 10.1530/eje.0.1480293
   Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247
   Hamaguchi M, 2007, AM J GASTROENTEROL, V102, P2708, DOI 10.1111/j.1572-0241.2007.01526.x
   Ivester P, 2003, ALCOHOL CLIN EXP RES, V27, P1831, DOI 10.1097/01.ALC.0000095633.26284.FA
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Lee AS, 2008, HUM MOL GENET, V17, P1127, DOI 10.1093/hmg/ddn002
   Li CM, 2015, TURK J GASTROENTEROL, V26, P408, DOI 10.5152/tjg.2015.6336
   Lupsor Monica, 2005, Rom J Gastroenterol, V14, P419
   Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161
   Mishra P, 2007, AM J GASTROENTEROL, V102, P2716, DOI 10.1111/j.1572-0241.2007.01520.x
   Nagarajan P, 2008, LIVER INT, V28, P856, DOI 10.1111/j.1478-3231.2008.01706.x
   Neuman MG, 2014, CAN J GASTROENTEROL, V28, P607, DOI 10.1155/2014/757929
   Paschos P, 2009, HIPPOKRATIA, V13, P9
   Pawlosky RJ, 2004, ALCOHOL CLIN EXP RES, V28, P1569, DOI 10.1097/01.ALC.0000141810.22855.4E
   Rafiq N, 2009, CLIN GASTROENTEROL H, V7, P234, DOI 10.1016/j.cgh.2008.11.005
   Ramesh S, 2005, J HEPATOL, V42, pS2, DOI 10.1016/j.jhep.2004.11.022
   SAVERYMUTTU SH, 1986, BRIT MED J, V292, P13, DOI 10.1136/bmj.292.6512.13
   Shannon A, 2011, J PEDIATR GASTR NUTR, V53, P190, DOI 10.1097/MPG.0b013e31821b4b61
   Söderberg C, 2010, HEPATOLOGY, V51, P595, DOI 10.1002/hep.23314
   Tigno XT, 2004, J GERONTOL A-BIOL, V59, P1081, DOI 10.1093/gerona/59.11.1081
   Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038
   Zhang SJ, 2014, MOL BIOL EVOL, V31, DOI 10.1093/molbev/msu084
   Zhang SJ, 2013, NUCLEIC ACIDS RES, V41, pD892, DOI 10.1093/nar/gks835
   Zhang XQ, 2011, CIRCULATION, V124, P77, DOI 10.1161/CIRCULATIONAHA.110.990333
   Zhong XM, 2016, MOL BIOL EVOL, V33, P1370, DOI 10.1093/molbev/msw025
   Zhu JZ, 2015, DIGEST DIS SCI, V60, P3194, DOI 10.1007/s10620-015-3728-3
NR 43
TC 5
Z9 5
U1 1
U2 15
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1758-5996
J9 DIABETOL METAB SYNDR
JI Diabetol. Metab. Syndr.
PD SEP 10
PY 2018
VL 10
AR 68
DI 10.1186/s13098-018-0370-1
PG 10
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA GT1UF
UT WOS:000444260900001
PM 30214501
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Shen, L
   Fan, JG
   Shao, Y
   Zeng, MD
   Wang, JR
   Luo, GH
   Li, JQ
   Chen, SY
AF Shen, L
   Fan, JG
   Shao, Y
   Zeng, MD
   Wang, JR
   Luo, GH
   Li, JQ
   Chen, SY
TI Prevalence of nonalcoholic fatty liver among administrative officers in
   Shanghai: an epidemiological survey
SO WORLD JOURNAL OF GASTROENTEROLOGY
LA English
DT Article
ID CHRONIC HEPATITIS-C; INSULIN-RESISTANCE; METABOLIC SYNDROME;
   CLINICAL-FEATURES; NATURAL-HISTORY; FUNCTION TESTS; STEATOHEPATITIS;
   DISEASE; STEATOSIS; ASSOCIATION
AB AIM: To determine the prevalence of nonalcoholic fatty liver in a specific population in Shanghai by an epidemiological survey, and to analyze risk factors of fatty liver.
   METHODS: Total 4009 administrative officers who denied regular alcohol drinking participated in the survey, and underwent physical examination and laboratory tests. The important parameters were body mass index (BMI), waist hip circumferences ratio (WHR) and levels of serum lipids. Diagnosis of fatty liver was based on established real-time ultrasonographic criteria, the presence of an ultrasonographic pattern consistent with "bright liver", with evident ultrasonographic contrast between hepatic and renal parenchyma, vessel blurring, and narrowing of the lumen of the hepatic veins. Analysis of data was performed through SPSS for Windows statistical package.
   RESULTS: The overall prevalence of fatty liver was 12.9%, 15.8% in males and 7.5% in females, and the prevalence of fatty liver in males younger than 50 years old, was significantly higher (13.3%) than that of in females (2.7%). But the difference between the sexes became less significant in people older than 50 years (19.1% vs 18.1%). The prevalence of fatty liver was increased with age; this was markedly presented in females younger than 50 years. Multiple variant regression analysis demonstrated that the prevalence of fatty liver was positively correlated to several risk factors, including male, aging (> 50yr), hyperlipidemia, impaired glucose tolerance/diabetes mellitus, hypertension and overweight/obesity.
   CONCLUSION: There is a high prevalence of nonalcoholic fatty liver among certain population in Shanghai, to which overweight and hyperlipidemia are closely relevant.
C1 First Peoples Hosp, Dept Gastroenterol, Shanghai 200080, Peoples R China.
   Second Med Univ, Renji Hosp, Dept Gastroenterol, Shanghai 200001, Peoples R China.
   Cent Hosp Putou Dist, Shanghai, Peoples R China.
   Zhongshan Hosp, Shanghai, Peoples R China.
C3 Naval Medical University; Fudan University
RP Fan, JG (corresponding author), First Peoples Hosp, Dept Gastroenterol, Shanghai 200080, Peoples R China.
CR Angulo P, 1999, HEPATOLOGY, V30, P1356, DOI 10.1002/hep.510300604
   Angulo P, 2001, SEMIN LIVER DIS, V21, P81, DOI 10.1055/s-2001-12931
   Araújo LMB, 1998, DIABETES METAB, V24, P458
   Assy N, 2000, DIGEST DIS SCI, V45, P1929, DOI 10.1023/A:1005661516165
   BACON BR, 1994, GASTROENTEROLOGY, V107, P1103, DOI 10.1016/0016-5085(94)90235-6
   Bellentani S, 2000, ANN INTERN MED, V132, P112, DOI 10.7326/0003-4819-132-2-200001180-00004
   Brunt EM, 2001, SEMIN LIVER DIS, V21, P3, DOI 10.1055/s-2001-12925
   Chitturi S, 2002, HEPATOLOGY, V35, P373, DOI 10.1053/jhep.2002.30692
   Chitturi S, 2001, SEMIN LIVER DIS, V21, P27, DOI 10.1055/s-2001-12927
   Cortez-Pinto H, 1999, JAMA-J AM MED ASSOC, V282, P1659, DOI 10.1001/jama.282.17.1659
   ELHASSAN AY, 1992, BRIT J RADIOL, V65, P774, DOI 10.1259/0007-1285-65-777-774
   Falck-Ytter Y, 2001, SEMIN LIVER DIS, V21, P17, DOI 10.1055/s-2001-12926
   FAN JG, 1999, SHIJIE HUAREN XIAOHU, V7, P75
   FAN JG, 2001, SHIJIE HUAREN XIAOHU, V9, P6
   Fong DG, 2000, HEPATOLOGY, V32, P3, DOI 10.1053/jhep.2000.8978
   Giannini E, 2001, J HEPATOL, V35, P432, DOI 10.1016/S0168-8278(01)00107-6
   HULTCRANTZ R, 1993, J INTERN MED, V233, P7, DOI 10.1111/j.1365-2796.1993.tb00640.x
   James O, 1999, LANCET, V353, P1634, DOI 10.1016/S0140-6736(99)00163-4
   JOSEPH AEA, 1991, CLIN RADIOL, V43, P26, DOI 10.1016/S0009-9260(05)80350-2
   Kumar KS, 2000, MAYO CLIN PROC, V75, P733
   Lai MMC, 2002, GASTROENTEROLOGY, V122, P568, DOI 10.1053/gast.2002.31474
   LAYER G, 1991, J CLIN ULTRASOUND, V19, P193, DOI 10.1002/jcu.1870190402
   Loguercio C, 2001, J HEPATOL, V35, P568, DOI 10.1016/S0168-8278(01)00192-1
   Lonardo A, 1999, DIGEST DIS, V17, P80, DOI 10.1159/000016909
   Lonardo A, 1997, ITAL J GASTROENTEROL, V29, P351
   Lonardo A, 2000, J GASTROEN HEPATOL, V15, P775, DOI 10.1046/j.1440-1746.2000.02226.x
   LUDWIG J, 1980, MAYO CLIN PROC, V55, P434
   Luyckx FH, 2000, DIABETES METAB, V26, P98
   Marceau P, 1999, J CLIN ENDOCR METAB, V84, P1513, DOI 10.1210/jc.84.5.1513
   Marchesini G, 1999, AM J MED, V107, P450, DOI 10.1016/S0002-9343(99)00271-5
   Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844
   Mathiesen UL, 1999, SCAND J GASTROENTERO, V34, P85
   Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8
   McCullough AJ, 1999, HEPATOLOGY, V29, P1328, DOI 10.1002/hep.510290451
   Mendler MH, 1998, J HEPATOL, V28, P785, DOI 10.1016/S0168-8278(98)80228-6
   Mensenkamp AR, 2001, J HEPATOL, V35, P816, DOI 10.1016/S0168-8278(01)00249-5
   Nehra V, 2001, DIGEST DIS SCI, V46, P2347, DOI 10.1023/A:1012338828418
   Ong JP, 2001, LIVER, V21, P266, DOI 10.1034/j.1600-0676.2001.021004266.x
   Pagano G, 2002, HEPATOLOGY, V35, P367, DOI 10.1053/jhep.2002.30690
   Paradis V, 2001, HEPATOLOGY, V34, P738, DOI 10.1053/jhep.2001.28055
   POWELL EE, 1990, HEPATOLOGY, V11, P74, DOI 10.1002/hep.1840110114
   Reid AE, 2001, GASTROENTEROLOGY, V121, P710, DOI 10.1053/gast.2001.27126
   Sabir N, 2001, Eur J Ultrasound, V14, P121, DOI 10.1016/S0929-8266(01)00153-7
   Sanyal AJ, 2001, AM J GASTROENTEROL, V96, P274
   Sharabi Y, 2000, AM J MED, V109, P171, DOI 10.1016/S0002-9343(00)00434-4
   Skelly MM, 2001, J HEPATOL, V35, P195, DOI 10.1016/S0168-8278(01)00094-0
   Sonsuz A, 2000, AM J GASTROENTEROL, V95, P1370
   Sonsuz A, 2002, AM J GASTROENTEROL, V97, P495
   TOMINAGA K, 1995, DIGEST DIS SCI, V40, P2002, DOI 10.1007/BF02208670
   Urso R, 2002, LANCET, V359, P355, DOI 10.1016/S0140-6736(02)07566-9
   Willner IR, 2001, AM J GASTROENTEROL, V96, P2957
   XU ZJ, 2002, SHIJIE HUAREN XIAOHU, V10, P392
   Yano E, 2001, J CLIN EPIDEMIOL, V54, P945, DOI 10.1016/S0895-4356(01)00355-9
NR 53
TC 133
Z9 157
U1 0
U2 8
PU W J G PRESS
PI BEIJING
PA PO BOX 2345, BEIJING 100023, PEOPLES R CHINA
SN 1007-9327
J9 WORLD J GASTROENTERO
JI World J. Gastroenterol.
PD MAY
PY 2003
VL 9
IS 5
BP 1106
EP 1110
PG 5
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 681ML
UT WOS:000183039900044
PM 12717867
DA 2024-02-19
ER

PT J
AU BOLOGNIA, JL
AF BOLOGNIA, JL
TI AGING SKIN
SO AMERICAN JOURNAL OF MEDICINE
LA English
DT Article; Proceedings Paper
CT Symposium on Androgens and Womens Health, at an NICHD Conference
CY MAR 29-30, 1994
CL ROCKVILLE, MD
SP NIH, NICHD
ID AGE-RELATED-CHANGES; ANDROGEN RECEPTOR; HORMONE REPLACEMENT; SEBACEOUS
   GLANDS; COLLAGEN CONTENT; THICKNESS; MENOPAUSE; 5-ALPHA-REDUCTASE;
   LOCALIZATION; FIBROBLASTS
AB Aging of the skin is a composite of actinic damage, chronologic aging, and hormonal influences. The majority of changes associated with aging, such as wrinkles and solar lentigines (''liver spots''), are due to photoaging and reflect cumulative sun exposure as well as skin pigmentation. Classically, chronologic aging includes those cutaneous changes that occur in non-sun-exposed areas, such as the buttocks, and are observed in both men and women. A clinical example would be soft tissue sagging due to elastic fiber degeneration. In women, investigations into the effect of hormones on aging of the skin have concentrated on estrogens; in men, there have been a limited number of studies on the influence of testosterone. The latter have Shown an age-dependent decrease in tissue androgens in pubic skin, but not scrotal or thigh skin. To date, age has not been shown to have an effect on androgen receptor binding, although a decrease in foreskin 5 alpha-reductase activity with increasing age has been described. In fibroblast cultures from foreskins, there have been conflicting results as to whether 5 alpha-reductase activity decreases in an age-dependent manner. Some of the skin changes that have been categorized as secondary to chronologic aging, such as decreased sebaceous gland activity and decreased hair growth, may actually represent a decline in the concentration of tissue androgens with increasing age. The influence of androgens on age-related changes in keratinocyte and fibroblast function remains speculative.
RP BOLOGNIA, JL (corresponding author), YALE UNIV,SCH MED,DEPT DERMATOL,500 LCI,333 CEDAR ST,NEW HAVEN,CT 06520, USA.
CR Black M M, 1970, Br Med J, V4, P773
   BLAUER M, 1991, J INVEST DERMATOL, V97, P264, DOI 10.1111/1523-1747.ep12480373
   BOLOGNIA JL, 1989, MATURITAS, V11, P295, DOI 10.1016/0378-5122(89)90026-1
   BRANCHET MC, 1990, GERONTOLOGY, V36, P28
   BRINCAT M, 1987, BRIT J OBSTET GYNAEC, V94, P126, DOI 10.1111/j.1471-0528.1987.tb02338.x
   BRINCAT M, 1985, BRIT J OBSTET GYNAEC, V92, P256, DOI 10.1111/j.1471-0528.1985.tb01091.x
   BRINCAT M, 1987, OBSTET GYNECOL, V70, P840
   BULLOUGH WS, 1950, ACTA ENDOCRINOL-COP, V4, P291, DOI 10.1530/acta.0.0040291
   CASTELOBRANCO C, 1992, MATURITAS, V15, P113, DOI 10.1016/0378-5122(92)90245-Y
   CERIMELE D, 1990, BR J DERMATOL S, V35, P13
   CHOUDHRY R, 1992, J ENDOCRINOL, V133, P467, DOI 10.1677/joe.0.1330467
   DESLYPERE JP, 1981, J CLIN ENDOCR METAB, V53, P430, DOI 10.1210/jcem-53-2-430
   DIJKSTRA AC, 1987, J INVEST DERMATOL, V89, P87, DOI 10.1111/1523-1747.ep12580432
   DOWNING DT, 1986, DERMATOL CLIN, V4, P419, DOI 10.1016/S0733-8635(18)30804-0
   EBLING FJ, 1957, J ENDOCRINOL, V15, P297, DOI 10.1677/joe.0.0150297
   EBLING FJG, 1991, TXB DERMATOLOGY, P125
   FENSKE NA, 1986, J AM ACAD DERMATOL, V15, P571, DOI 10.1016/S0190-9622(86)70208-9
   GILCHREST BA, 1982, J AM GERIATR SOC, V30, P139, DOI 10.1111/j.1532-5415.1982.tb01289.x
   ITAMI S, 1991, J INVEST DERMATOL, V96, P57, DOI 10.1111/1523-1747.ep12514729
   JACOBSEN E, 1985, J INVEST DERMATOL, V85, P483, DOI 10.1111/1523-1747.ep12277224
   KAUFMAN M, 1977, SOMAT CELL GENET, V3, P17, DOI 10.1007/BF01550984
   KAUFMAN M, 1975, EXP CELL RES, V96, P31, DOI 10.1016/S0014-4827(75)80033-4
   KEENAN BS, 1974, J CLIN ENDOCR METAB, V38, P1143, DOI 10.1210/jcem-38-6-1143
   LAMBERIGTS G, 1979, J CLIN ENDOCR METAB, V48, P924, DOI 10.1210/jcem-48-6-924
   LEYDEN JJ, 1990, BRIT J DERMATOL, V122, P1, DOI 10.1111/j.1365-2133.1990.tb16118.x
   LIANG T, 1993, J INVEST DERMATOL, V100, P663, DOI 10.1111/1523-1747.ep12472330
   LUUTHE V, 1994, J INVEST DERMATOL, V102, P221, DOI 10.1111/1523-1747.ep12371766
   MILEWICH L, 1986, J CLIN ENDOCR METAB, V62, P739, DOI 10.1210/jcem-62-4-739
   MONTAGNA W, 1990, BRIT J DERMATOL, V122, P61, DOI 10.1111/j.1365-2133.1990.tb16127.x
   MOWSZOWICZ I, 1981, J CLIN ENDOCR METAB, V52, P338, DOI 10.1210/jcem-52-2-338
   OLIVER RF, 1988, CLIN DERMATOL, V6, P74, DOI 10.1016/0738-081X(88)90069-7
   PINSKY L, 1978, AM J MED GENET, V1, P407, DOI 10.1002/ajmg.1320010404
   PLEWIG G, 1978, J INVEST DERMATOL, V70, P314, DOI 10.1111/1523-1747.ep12543478
   POCHI PE, 1979, J INVEST DERMATOL, V73, P108, DOI 10.1111/1523-1747.ep12532792
   PUNNONEN R, 1972, ACTA OBSTET GYNECO S, V21, P5
   ROZENBERG S, 1988, MATURITAS, V10, P215, DOI 10.1016/0378-5122(88)90024-2
   SAWAYA ME, 1992, J INVEST DERMATOL, V98, P92
   STERN RS, 1986, ARCH DERMATOL, V122, P537, DOI 10.1001/archderm.122.5.537
   WILSON JD, 1969, J CLIN INVEST, V48, P371, DOI 10.1172/JCI105994
   WILSON JD, 1975, J BIOL CHEM, V250, P3498
NR 40
TC 52
Z9 59
U1 0
U2 9
PU CAHNERS PUBL CO
PI NEW YORK
PA 249 WEST 17 STREET, NEW YORK, NY 10011
SN 0002-9343
J9 AM J MED
JI Am. J. Med.
PD JAN 16
PY 1995
VL 98
SU 1A
BP S99
EP S103
DI 10.1016/S0002-9343(99)80066-7
PG 5
WC Medicine, General & Internal
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA QE657
UT WOS:A1995QE65700016
PM 7825648
DA 2024-02-19
ER

PT J
AU NOVIKOV, LB
   BALANSKII, RM
   ANISIMOV, VN
   KHANSON, KP
AF NOVIKOV, LB
   BALANSKII, RM
   ANISIMOV, VN
   KHANSON, KP
TI PROTOONCOGENE EXPRESSION IN THE MALE-RAT LIVER AT DIFFERENT AGES
SO BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE
LA English
DT Article
DE PROTOONCOGENES; LIVER; AGING; RAT
ID TISSUE
C1 NN PETROV ONCOL RES INST,EXPTL TUMORS LAB,LENINGRAD 188646,USSR.
C3 N.N. Petrov Research Institute of Oncology
RP NOVIKOV, LB (corresponding author), NN PETROV ONCOL RES INST,BIOCHEM LAB,LENINGRAD 188646,USSR.
CR ANISIMOV VN, 1989, J EXP CLIN CANC RES, V8, P254
   BALMAIN A, 1988, ADV CANCER RES, V51, P147, DOI 10.1016/S0065-230X(08)60222-5
   CUTLER RG, 1989, J GERONTOL, V44, P25, DOI 10.1093/geronj/44.6.25
   MATOCHA MF, 1987, BIOCHEM BIOPH RES CO, V147, P1, DOI 10.1016/S0006-291X(87)80078-5
   NOVIKOV LB, 1969, EKSP ONKOL, V11, P14
   ONO T, 1989, MUTAT RES, V219, P39, DOI 10.1016/0921-8734(89)90039-8
   SEMSEI I, 1989, ONCOGENE, V4, P465
   STREHLER BL, 1986, EXP GERONTOL, V21, P283, DOI 10.1016/0531-5565(86)90038-0
   WARD JM, 1983, J NATL CANCER I, V71, P815
   Watson J. D., 1970, MOL BIOL GENE
   WHITE BA, 1982, J BIOL CHEM, V257, P8569
   ZHANG XK, 1988, CANCER LETT, V41, P147, DOI 10.1016/0304-3835(88)90111-5
NR 12
TC 0
Z9 0
U1 0
U2 0
PU PLENUM PUBL CORP
PI NEW YORK
PA CONSULTANTS BUREAU 233 SPRING ST, NEW YORK, NY 10013
SN 0007-4888
J9 B EXP BIOL MED+
JI Bull. Exp. Biol. Med.
PD MAY
PY 1991
VL 111
IS 5
BP 679
EP 681
DI 10.1007/BF00841016
PG 3
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA GK774
UT WOS:A1991GK77400032
DA 2024-02-19
ER

PT J
AU Jordanova, M
   Miteva, N
   Rocha, E
AF Jordanova, Maja
   Miteva, Nada
   Rocha, Eduardo
TI A Qualitative and Quantitative Study of the Hepatic Pigmented Macrophage
   Aggregates During the Breeding Cycle of Ohrid Trout, <i>Salmo
   letnica</i> Kar. (Teloestei, Salmonidae)
SO MICROSCOPY RESEARCH AND TECHNIQUE
LA English
DT Article
DE ohrid trout; liver; macrophages; breeding cycle; stereology
ID CARP CYPRINUS-CARPIO; BROWN TROUT; RAINBOW-TROUT; TRUTTA-FARIO;
   RICHARDSON LIVER; FUNCTIONAL UNITS; RODLET CELLS; CENTERS; TELEOSTEI;
   FISH
AB It is well known that factors such as aging and water quality may influence pigmented macrophages (PMacs) in fishes, but it is not established yet if PMacs undergo seasonal and breeding dependent variations. This study explored this caveat and reports qualitative histological and stereological data on liver PMacs from wild female Ohrid trout, Salmo letnica, during the annual breeding cycle. Data showed that a minority of PMacs contained melanin and that the vast majority of them contained only hemosiderin or hemosiderin and lipofuscin/ceroid pigment. It was suggested that this is the normal scenario for the species. One remarkable result was the demonstration of a striking increase, after spawning, of the relative and total volumes of the hepatic macrophages, both parenchyma and stroma located. Because the melano PMacs did not vary, those changes were due to fluctuations in the hemosiderin-laden PMacs. We concluded that Ohrid trout presented a pigment composition in liver macrophages that differed from other fish, including salmonids, where most liver phagocytes essentially display melanin. Our quantitative data support interspecies differences in the amount of liver macrophages and also that after spawning expansion of the m acrophage pool is crucial and most likely connected with the needs of liver remodeling (leading to a decrease in hepatic mass). So, we suggested that the hormonal (sex steroidal) constellation influenced the liver macrophage pool. Additionally, we proved that the use of fish liver macrophages for biomonitoring should take into account the considerable natural breeding/seasonal dependent variations that are expected to occur. Microsc. Res. Tech. 71:822-830, 2008. (C) 2008 Wiley-Liss. Inc.
C1 [Jordanova, Maja; Miteva, Nada] Inst Biol, Lab Histol & Embryol, Fac Nat Sci & Math, Skopje 1000, Macedonia.
   [Rocha, Eduardo] Univ Porto, Inst Biomed Sci Abel Salazar ICBAS, Lab Histol & Embryol, P-4099003 Oporto, Portugal.
   [Rocha, Eduardo] Univ Porto, CIMAR Associate Lab, Interdisciplinary Ctr Marine & Environm Res CIMAR, Lab Cellular & Mol Studies, P-4050123 Oporto, Portugal.
C3 Universidade do Porto; Universidade do Porto
RP Jordanova, M (corresponding author), Inst Biol, Lab Histol & Embryol, Fac Nat Sci & Math, Gazi Baba BB,BO 162, Skopje 1000, Macedonia.
EM majaj@iunona.pmf.ukim.edu.mk
RI Rocha, Eduardo/H-6786-2019
OI Rocha, Eduardo/0000-0001-9813-4389; Jordanova, Maja/0000-0002-6272-0738
CR AGIUS C, 1979, J FISH DIS, V2, P337, DOI 10.1111/j.1365-2761.1979.tb00175.x
   Agius C, 2003, J FISH DIS, V26, P499, DOI 10.1046/j.1365-2761.2003.00485.x
   Agius C., 1985, P85
   Alcorn SW, 2002, FISH SHELLFISH IMMUN, V12, P303, DOI 10.1006/fsim.2001.0373
   [Anonymous], SYSTEMATIC PATHOLOGY
   BLAZER VS, 1994, MODULATORS OF FISH IMMUNE RESPONSES, VOL 1, P169
   BLAZER VS, 1997, ENV TOXICOLOGY RISK, V6, P360
   Collet B, 2001, EUR J BIOCHEM, V268, P1577, DOI 10.1046/j.1432-1033.2001.02021.x
   Couillard CM, 1996, ENVIRON TOXICOL CHEM, V15, P1844, DOI 10.1002/etc.5620151027
   Elston RA, 1997, DIS AQUAT ORGAN, V31, P109, DOI 10.3354/dao031109
   FACEY DE, 1998, STRESS FISH S P, P83
   FERGUSON HW, 1976, J COMP PATHOL, V86, P377, DOI 10.1016/0021-9975(76)90005-0
   Figueiredo-Fernandes AM, 2006, J MORPHOL, V267, P221, DOI 10.1002/jmor.10396
   FOSTIER A, 1983, FISH PHYSIOL, V9, P277
   Fournie JW, 2001, J AQUAT ANIM HEALTH, V13, P105, DOI 10.1577/1548-8667(2001)013<0105:UOSMAA>2.0.CO;2
   FREERE R. H., 1967, J ROY MICROSC SOC, V87, P25
   GONZALEZ G, 1993, J FISH BIOL, V43, P363, DOI 10.1006/jfbi.1993.1138
   HAMPTON JA, 1988, ANAT RECORD, V221, P619, DOI 10.1002/ar.1092210208
   HAMPTON JA, 1989, AM J ANAT, V185, P58, DOI 10.1002/aja.1001850107
   HINTON DE, 1992, SETAC SP P, P155
   Holzer AS, 2001, PARASITOLOGY, V122, P55, DOI 10.1017/S003118200000706X
   Jordanova M, 2007, FISH SHELLFISH IMMUN, V23, P473, DOI 10.1016/j.fsi.2006.11.004
   KARAMAN S, 1924, PISCES MACEDONIAE
   KRANZ H, 1989, DIS AQUAT ORGAN, V6, P167, DOI 10.3354/dao006167
   Kruger R, 1996, INT REV GES HYDROBIO, V81, P635, DOI 10.1002/iroh.19960810420
   Leknes IL, 2001, J FISH BIOL, V59, P1412, DOI 10.1006/jfbi.2001.1728
   Meinelt T, 1997, ENVIRON SCI POLLUT R, V4, P32, DOI 10.1007/BF02986262
   Miyazaki T, 2001, DIS AQUAT ORGAN, V44, P109, DOI 10.3354/dao044109
   Montero D, 1999, AQUACULTURE, V179, P523, DOI 10.1016/S0044-8486(99)00185-4
   Narnaware YK, 2000, J APPL ICHTHYOL, V16, P86, DOI 10.1046/j.1439-0426.2000.00113.x
   Nowak BF, 2003, DIS AQUAT ORGAN, V56, P135, DOI 10.3354/dao056135
   O'Farrell CL, 2000, DIS AQUAT ORGAN, V43, P199, DOI 10.3354/dao043199
   Roberts R.J., 1975, P399
   Roberts RJ, 1978, FISH PATHOL, V25, P125
   ROBERTSON JC, 1992, J MORPHOL, V211, P41, DOI 10.1002/jmor.1052110106
   Rocha E, 2003, FISH ADAPTATIONS, P383
   Rocha E, 1999, ICHTHYOLOGY: RECENT RESEARCH ADVANCES, P321
   ROCHA E, 1995, J MORPHOL, V223, P1, DOI 10.1002/jmor.1052230103
   Rocha E, 2001, HISTOL HISTOPATHOL, V16, P423, DOI 10.14670/HH-16.423
   ROCHA E, 1994, J ANAT, V185, P241
   Rocha E, 1996, J SUBMICR CYTOL PATH, V28, P357
   Rocha E, 1999, J SUBMICR CYTOL PATH, V31, P91
   ROCHA E, 1994, CAN J ZOOL, V72, P1683, DOI 10.1139/z94-225
   Rocha E, 1997, ANAT RECORD, V247, P317
   Rocha E., 2000, THESIS U PORTO PORTU
   Rocha E, 2009, ICHTHYOL RES, V56, P43, DOI 10.1007/s10228-008-0066-x
   TAKAHASHI K, 1977, Tohoku Journal of Agricultural Research, V28, P103
   Triebskorn R, 2002, ECOTOXICOLOGY, V11, P451, DOI 10.1023/A:1021009418421
   Tyler CR, 1996, REV FISH BIOL FISHER, V6, P287, DOI 10.1007/BF00122584
   VANBOHEMEN CG, 1981, GEN COMP ENDOCR, V44, P94, DOI 10.1016/0016-6480(81)90360-9
   Vigliano FA, 2006, FISH SHELLFISH IMMUN, V21, P467, DOI 10.1016/j.fsi.2005.12.012
   WANG R, 1994, DEV COMP IMMUNOL, V18, P377, DOI 10.1016/0145-305X(94)90003-5
   WANG R, 1995, DEV COMP IMMUNOL, V19, P327, DOI 10.1016/0145-305X(95)00018-O
   Watanuki H, 2002, COMP BIOCHEM PHYS C, V132, P407, DOI 10.1016/S1532-0456(02)00100-X
   Wolke R. E., 1985, PARASITOLOGY PATHOLO, P93
NR 55
TC 28
Z9 30
U1 0
U2 17
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1059-910X
J9 MICROSC RES TECHNIQ
JI Microsc. Res. Tech.
PD NOV
PY 2008
VL 71
IS 11
BP 822
EP 830
DI 10.1002/jemt.20626
PG 9
WC Anatomy & Morphology; Biology; Microscopy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Anatomy & Morphology; Life Sciences & Biomedicine - Other Topics;
   Microscopy
GA 373EU
UT WOS:000260954600008
PM 18767051
DA 2024-02-19
ER

PT J
AU Kashiwagi, K
   Shinkai, T
   Kajii, E
   Kashiwagi, A
AF Kashiwagi, K
   Shinkai, T
   Kajii, E
   Kashiwagi, A
TI The effects of reactive oxygen species on amphibian aging
SO COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY
LA English
DT Article
DE antioxidant enzymes; antioxidant defense system; reactive oxygen
   species; ROS detoxification mechanism; oxidative damage; frog aging;
   frog liver
ID PROTEIN OXIDATIVE DAMAGE; SUPEROXIDE-DISMUTASE; LIFE-SPAN;
   GLUTATHIONE-PEROXIDASE; LIPID-PEROXIDATION; ANTIOXIDANT DEFENSES;
   CALORIE RESTRICTION; CATALASE; LIVER; ENZYMES
AB To clarify the role of reactive oxygen species (ROS) in the aging process of amphibians, antioxidant enzyme activity and indexes of ROS damage were investigated biochemically using the livers of 3- and 10-year-old Rana nigromaculata frog males and females. Findings revealed no significant difference in survival rate between males and females. Antioxidant enzyme activity displayed an age-related decline. Superoxide dismutase (SOD), catalase, and glutathione peroxidase (GPx) activity in 10-year-old liver decreased 40-80% from 3-year-old liver levels. In contrast, urate oxidase activity in the 10-year-old liver increased more than 200% from 3-year-old liver levels. At the same time levels of ROS damage, including the concentration of inorganic peroxide and thiobarbituric acid reactive substances (TBARS), greatly increased with age. Liver catalase from 10-year-old frogs proved to be more susceptible to aminotriazole and urea, losing approximately 80% of its original activity after 30 min of treatment. It seems likely that liver catalase in older frogs has diverged from liver catalase in younger frogs through oxidative modification. These findings suggest that a decrease in the activity of antioxidant enzymes over time results in increased levels of ROS damage in the livers of older frogs. (c) 2005 Elsevier Inc. All rights reserved.
C1 Hiroshima Univ, Grad Sch Sci, Inst Amphibian Biol, Higashihiroshima 7398526, Japan.
   Tokyo Metropolitan Inst Gerontol, Dept Neurobiol, Itabashi Ku, Tokyo 1730015, Japan.
   Jichi Med Sch, Div Community & Family Med, Ctr Community Med, Minamimaki, Tochigi 3290498, Japan.
C3 Hiroshima University; Tokyo Metropolitan Institute of Gerontology; Jichi
   Medical University
RP Kashiwagi, A (corresponding author), Hiroshima Univ, Grad Sch Sci, Inst Amphibian Biol, Higashihiroshima 7398526, Japan.
EM akashiwa@hiroshima-u.ac.jp
CR AGRAWAL B B L, 1970, Federation Proceedings, V29, P732
   AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   Anantharaju A, 2002, GERONTOLOGY, V48, P343, DOI 10.1159/000065506
   Armeni T, 1997, MOL ASPECTS MED, V18, pS247
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313
   Bernt E., 1974, Methods of Enzymatic Analysis, VVolume 14, P2246, DOI DOI 10.1016/B978-0-12-091304-6.50090-2
   Borrás C, 2003, FREE RADICAL BIO MED, V34, P546, DOI 10.1016/S0891-5849(02)01356-4
   Buege J A, 1978, Methods Enzymol, V52, P302
   BURROWS RB, 1980, MECH AGEING DEV, V13, P307, DOI 10.1016/0047-6374(80)90075-5
   CAND F, 1989, FREE RADICAL BIO MED, V7, P59, DOI 10.1016/0891-5849(89)90101-9
   CHIPALKATTI S, 1983, J NUTR, V113, P944, DOI 10.1093/jn/113.5.944
   CHOI JH, 1995, FREE RADICAL BIO MED, V18, P133, DOI 10.1016/0891-5849(94)00106-T
   CIOLEK E, 1989, COMP BIOCHEM PHYS B, V93, P477, DOI 10.1016/0305-0491(89)90110-7
   Claiborne A.J.F.C.P., 1985, HDB METHODS OXYGEN R, DOI DOI 10.1016/0531-5565(85)90021-X
   COHEN G, 1970, ANAL BIOCHEM, V34, P30, DOI 10.1016/0003-2697(70)90083-7
   DAUCA M, 1982, J EXP ZOOL, V223, P57, DOI 10.1002/jez.1402230110
   Dixon M., 1964, Enzymes
   FEINSTEI.RN, 1967, ARCH BIOCHEM BIOPHYS, V120, P165, DOI 10.1016/0003-9861(67)90609-1
   Forster MJ, 1996, P NATL ACAD SCI USA, V93, P4765, DOI 10.1073/pnas.93.10.4765
   FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533
   Glasson EJ, 2003, AM J HUM BIOL, V15, P192, DOI 10.1002/ajhb.10132
   Harman D, 1998, EXP GERONTOL, V33, P95, DOI 10.1016/S0531-5565(97)00059-4
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Hebert Karen, 2004, BMJ, V329, P250, DOI 10.1136/bmj.329.7460.250-a
   IMRE S, 1984, MECH AGEING DEV, V28, P297, DOI 10.1016/0047-6374(84)90030-7
   Ingram DK, 2004, ANN NY ACAD SCI, V1019, P412, DOI 10.1196/annals.1297.074
   Ishii N, 1998, NATURE, V394, P694, DOI 10.1038/29331
   JONES GL, 1976, COMP BIOCHEM PHYS B, V55, P511, DOI 10.1016/0305-0491(76)90009-2
   Kashiwagi A, 1998, COMP BIOCHEM PHYS B, V119, P235, DOI 10.1016/S0305-0491(97)00321-0
   Kashiwagi A, 1997, COMP BIOCHEM PHYS B, V118, P499, DOI 10.1016/S0305-0491(97)00216-2
   KU HH, 1993, MECH AGEING DEV, V72, P67, DOI 10.1016/0047-6374(93)90132-B
   Lass A, 1997, J BIOL CHEM, V272, P19199, DOI 10.1074/jbc.272.31.19199
   LOPEZTORRES M, 1993, FREE RADICAL BIO MED, V15, P133, DOI 10.1016/0891-5849(93)90052-V
   LOPEZTORRES M, 1991, J COMP PHYSIOL B, V160, P655, DOI 10.1007/BF00571264
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Massafra C, 2002, CLIN ENDOCRINOL, V57, P663, DOI 10.1046/j.1365-2265.2002.01657.x
   MATSUO M, 1992, MECH AGEING DEV, V64, P273, DOI 10.1016/0047-6374(92)90084-Q
   Melov S, 2000, SCIENCE, V289, P1567, DOI 10.1126/science.289.5484.1567
   Merry BJ, 2002, INT J BIOCHEM CELL B, V34, P1340, DOI 10.1016/S1357-2725(02)00038-9
   MO JQ, 1995, MECH AGEING DEV, V81, P73, DOI 10.1016/0047-6374(95)01586-O
   ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730
   PAOLETTI F, 1986, ANAL BIOCHEM, V154, P536, DOI 10.1016/0003-2697(86)90026-6
   Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534
   PEREZCAMPO R, 1993, MECH AGEING DEV, V67, P115, DOI 10.1016/0047-6374(93)90116-9
   RAO G, 1990, MECH AGEING DEV, V53, P49, DOI 10.1016/0047-6374(90)90033-C
   SAWADA M, 1990, J CELL BIOCHEM, V44, P153, DOI 10.1002/jcb.240440304
   Schöneich C, 1999, EXP GERONTOL, V34, P19, DOI 10.1016/S0531-5565(98)00066-7
   SEMSEI I, 1991, MECH AGEING DEV, V58, P13, DOI 10.1016/0047-6374(91)90116-H
   SOHAL RS, 1990, FREE RADICAL BIO MED, V9, P495, DOI 10.1016/0891-5849(90)90127-5
   SOHAL RS, 1990, MECH AGEING DEV, V56, P223, DOI 10.1016/0047-6374(90)90084-S
   SOHAL RS, 1994, MECH AGEING DEV, V74, P121, DOI 10.1016/0047-6374(94)90104-X
   SOHAL RS, 1993, P NATL ACAD SCI USA, V90, P7255, DOI 10.1073/pnas.90.15.7255
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   SOHAL RS, 1995, FREE RADICAL BIO MED, V19, P499, DOI 10.1016/0891-5849(95)00037-X
   Sohal RS, 2002, FREE RADICAL BIO MED, V33, P575, DOI 10.1016/S0891-5849(02)00886-9
   SOHAL RS, 1995, MECH AGEING DEV, V81, P15, DOI 10.1016/0047-6374(94)01578-A
   Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142
   STARKEREED PE, 1989, ARCH BIOCHEM BIOPHYS, V275, P559, DOI 10.1016/0003-9861(89)90402-5
   Sun JT, 2002, GENETICS, V161, P661
   Sun JT, 1999, MOL CELL BIOL, V19, P216
   Taub J, 1999, NATURE, V399, P162, DOI 10.1038/20208
   TAYLOR AC, 1946, ANAT REC, V94, P7, DOI 10.1002/ar.1090940103
   Tian LQ, 1998, FREE RADICAL BIO MED, V24, P1477, DOI 10.1016/S0891-5849(98)00025-2
   Wang H, 2003, EXP GERONTOL, V38, P507, DOI 10.1016/S0531-5565(03)00036-6
   Weinert BT, 2003, J APPL PHYSIOL, V95, P1706, DOI 10.1152/japplphysiol.00288.2003
   Wilmoth JR, 2000, SCIENCE, V289, P2366, DOI 10.1126/science.289.5488.2366
   YAMAMOTO Y, 1993, ARCH BIOCHEM BIOPHYS, V305, P541, DOI 10.1006/abbi.1993.1458
   Yin DZ, 1996, FREE RADICAL BIO MED, V21, P871, DOI 10.1016/0891-5849(96)00175-X
   Yu BP, 1996, ANN NY ACAD SCI, V786, P44, DOI 10.1111/j.1749-6632.1996.tb39050.x
NR 70
TC 12
Z9 14
U1 0
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1532-0456
EI 1878-1659
J9 COMP BIOCHEM PHYS C
JI Comp. Biochem. Physiol. C-Toxicol. Pharmacol.
PD FEB
PY 2005
VL 140
IS 2
BP 197
EP 205
DI 10.1016/j.cca.2005.02.001
PG 9
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism;
   Toxicology; Zoology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism;
   Toxicology; Zoology
GA 933HH
UT WOS:000229619000006
PM 15907765
DA 2024-02-19
ER

PT J
AU Lee, JS
   Ward, WO
   Wolf, DC
   Allen, JW
   Mills, C
   DeVito, MJ
   Corton, JC
AF Lee, Janice S.
   Ward, William O.
   Wolf, Douglas C.
   Allen, James W.
   Mills, Camilla
   DeVito, Michael J.
   Corton, J. Christopher
TI Coordinated changes in xenobiotic metabolizing enzyme gene expression in
   aging male rats
SO TOXICOLOGICAL SCIENCES
LA English
DT Article
DE xenobiotic metabolism; aging; liver; gene expression; susceptibility;
   microarrays
ID GROWTH-HORMONE REGULATION; MIXED-FUNCTION OXIDASES; DRUG-METABOLISM;
   TRANSCRIPTIONAL REGULATION; CYTOCHROME-P450 ISOFORMS; HEPATIC
   LIPOGENESIS; PHASE-II; IN-VIVO; LIVER; AGE
AB In order to gain insight into the effects of aging on susceptibility to environmental toxins, we characterized the expression of xenobiotic metabolizing enzymes (XMEs) from the livers of male F344 and Brown Norway (BN) rats across the adult lifespan. Using full-genome Affymetrix arrays, principal component analysis showed a clear age-dependent separation between young and old animals in both rat strains. Out of 1135 or 1435 genes altered between the old and young groups in the F344 or BN rats, 7 or 3% were XMEs and included members of the phase I, II, and III classes of genes. There was a 20 or 32% overlap in the gene expression profile between the two strains for F344 or BN, respectively. Lipid, ergosterol, alcohol, and fatty acid metabolism genes were also altered with age in both strains. Some of the genes altered by age exhibited a gender-dependent expression pattern in young adult rats, suggesting an increasingly feminized pattern of gene expression with age in male rats. To examine transcriptional responses across lifespan after challenge with a xenobiotic compound, BN rats were exposed to toluene by oral gavage. Toluene exposure decreased the expression of glutathione synthetase, and dramatically increased the number of phase III genes being downregulated. The expression of CYP2B2 and glutathione-S-transferase decreased with age but increased in all age groups after toluene exposure. Decreased ability to detoxify and transport chemicals out of the body with age could result in increased susceptibility to some classes of chemicals in the aging population.
C1 [Corton, J. Christopher] US EPA, Natl Hlth & Environm Effects Res Lab, Div Environm Carcinogenesis, ORD, Res Triangle Pk, NC 27711 USA.
   [Mills, Camilla] N Carolina Cent Univ, Durham, NC 27707 USA.
   [Corton, J. Christopher] US EPA, NHEERL Toxicogenom Core, Res Triangle Pk, NC 27711 USA.
C3 United States Environmental Protection Agency; University of North
   Carolina; North Carolina Central University; United States Environmental
   Protection Agency
RP Corton, JC (corresponding author), US EPA, Natl Hlth & Environm Effects Res Lab, Div Environm Carcinogenesis, ORD, 109 TW Alexander Dr,MD-B143-06, Res Triangle Pk, NC 27711 USA.
EM corton.chris@epa.gov
RI Allen, James/AAG-6465-2019; Wolf, Douglas/V-7776-2019
OI Lee, Janice/0000-0002-4331-8452; DeVito, Michael/0000-0003-1258-4894;
   Wolf, Douglas/0000-0003-1868-9574
CR [Anonymous], 2005, 65 US CURRENT POPULA
   ANTTIPOIKA M, 1987, E BROWNINGS TOXICITY, P38
   BAKER N, 1981, LIPIDS, V16, P568, DOI 10.1007/BF02534901
   Beckstead MJ, 2000, MOL PHARMACOL, V57, P1199
   BIRNBAUM LS, 1991, ANNU REV PHARMACOL, V31, P101
   BIRNBAUM LS, 1978, EXP GERONTOL, V13, P299, DOI 10.1016/0531-5565(78)90038-4
   Bleasby K, 2006, XENOBIOTICA, V36, P963, DOI 10.1080/00498250600861751
   Boedigheimer MJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-285
   BOORMAN GA, 1984, ENVIRON HEALTH PERSP, V56, P213, DOI 10.2307/3429847
   Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483
   CHAPMAN DE, 1990, DRUG METAB DISPOS, V18, P929
   Chen J, 2006, J GERONTOL A-BIOL, V61, P20, DOI 10.1093/gerona/61.1.20
   Chen JY, 1997, DRUG METAB DISPOS, V25, P1165
   Cruz SL, 1998, J PHARMACOL EXP THER, V286, P334
   DeVito MJ, 1996, J TOXICOL ENV HEALTH, V47, P379, DOI 10.1080/009841096161717
   Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863
   Francis GA, 2003, ANNU REV PHYSIOL, V65, P261, DOI 10.1146/annurev.physiol.65.092101.142528
   FUJITA S, 1990, J PHARMACOL EXP THER, V253, P369
   Geller AM, 2005, ENVIRON HEALTH PERSP, V113, P1257, DOI 10.1289/ehp.7569
   Ginsberg G, 2005, ENVIRON HEALTH PERSP, V113, P1243, DOI 10.1289/ehp.7568
   Glanemann C, 2003, APPL MICROBIOL BIOT, V61, P61, DOI 10.1007/s00253-002-1191-5
   Godin SJ, 2007, DRUG METAB DISPOS, V35, P1664, DOI 10.1124/dmd.107.015388
   Guengrich FP, 1999, ANNU REV PHARMACOL, V39, P1, DOI 10.1146/annurev.pharmtox.39.1.1
   GURWITZ JH, 2005, CLIN PHARM
   HANIOKA H, 1995, XENOBIOTICA, V25, P1207, DOI 10.3109/00498259509046677
   HERZBERG GR, 1981, BRIT J NUTR, V45, P529, DOI 10.1079/BJN19810131
   Huang HZ, 2005, CHEM RES TOXICOL, V18, P1371, DOI 10.1021/tx050072+
   Karanth S, 2000, TOXICOL SCI, V58, P282, DOI 10.1093/toxsci/58.2.282
   Kinirons MT, 2004, BRIT J CLIN PHARMACO, V57, P540, DOI 10.1111/j.1365-2125.2004.02096.x
   Klaassen CD, 1998, CHEM-BIOL INTERACT, V109, P299, DOI 10.1016/S0009-2797(97)00141-5
   Klaassen CD, 2008, TOXICOL SCI, V101, P186, DOI 10.1093/toxsci/kfm214
   Klaunig JE, 2003, CRIT REV TOXICOL, V33, P655, DOI 10.1080/713608372
   Köhle C, 2007, BIOCHEM PHARMACOL, V73, P1853, DOI 10.1016/j.bcp.2007.01.009
   LEGRAVEREND C, 1992, MOL ENDOCRINOL, V6, P259, DOI 10.1210/me.6.2.259
   Lipman RD, 1999, J GERONTOL A-BIOL, V54, pB478, DOI 10.1093/gerona/54.11.B478
   McLean AJ, 2004, PHARMACOL REV, V56, P163, DOI 10.1124/pr.56.2.4
   Mori K, 2007, TOXICOL PATHOL, V35, P242, DOI 10.1080/01926230601156286
   Nadon NL, 2006, AM COLL LAB, P761, DOI 10.1016/B978-012074903-4/50028-5
   Nadon NL, 2004, LAB ANIMAL, V33, P36, DOI 10.1038/laban0904-36
   Nakajima T, 1997, BIOCHEM PHARMACOL, V53, P271, DOI 10.1016/S0006-2952(96)00652-1
   Nakajima T, 1997, J OCCUP HEALTH, V39, P83, DOI 10.1539/joh.39.83
   NAKAJIMA T, 1994, INT J BIOCHEM, V26, P1333
   Nakata K, 2006, DRUG METAB PHARMACOK, V21, P437, DOI 10.2133/dmpk.21.437
   NEWBERNE PM, 1979, CANCER RES, V39, P3986
   PERERA F, 1989, ENVIRON HEALTH PERSP, V79, P315, DOI 10.2307/3430563
   Slatter JG, 2006, XENOBIOTICA, V36, P902, DOI 10.1080/00498250600861694
   Sprott Richard L., 1997, ILAR J, V38, P104
   SRIVASTAVA PK, 1993, BIOCHEM J, V294, P159, DOI 10.1042/bj2940159
   Staskal DF, 2005, TOXICOL SCI, V84, P225, DOI 10.1093/toxsci/kfi090
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Sukhodub AL, 1999, MECH AGEING DEV, V106, P273, DOI 10.1016/S0047-6374(98)00120-1
   SUNDSETH SS, 1992, J BIOL CHEM, V267, P3907
   Thomas RP, 2002, J GASTROINTEST SURG, V6, P445, DOI 10.1016/S1091-255X(01)00010-5
   Turturro A, 1999, J GERONTOL A-BIOL, V54, pB492, DOI 10.1093/gerona/54.11.B492
   VANDERBEEKEN Y, 1981, AM J REPROD IMMUNOL, V1, P236, DOI 10.1111/j.1600-0897.1981.tb00047.x
   Walisser JA, 2005, P NATL ACAD SCI USA, V102, P17858, DOI 10.1073/pnas.0504757102
   Waxman DJ, 2006, MOL ENDOCRINOL, V20, P2613, DOI 10.1210/me.2006-0007
   WU D, 2008, J LEUKOCYTE BIOL, V84, P1
   Yamazaki Y, 2005, WORLD J GASTROENTERO, V11, P5966, DOI 10.3748/wjg.v11.i38.5966
   Zhou T, 2001, TOXICOL SCI, V61, P76, DOI 10.1093/toxsci/61.1.76
NR 60
TC 29
Z9 29
U1 0
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1096-6080
EI 1096-0929
J9 TOXICOL SCI
JI Toxicol. Sci.
PD NOV
PY 2008
VL 106
IS 1
BP 263
EP 283
DI 10.1093/toxsci/kfn144
PG 21
WC Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Toxicology
GA 359GU
UT WOS:000259975200027
PM 18653662
OA Bronze
DA 2024-02-19
ER

PT J
AU Peng, XY
   Kong, BH
   Yu, HY
   Diao, XP
AF Peng, Xinyan
   Kong, Baohua
   Yu, Haiyang
   Diao, Xinping
TI Protective effect of whey protein hydrolysates against oxidative stress
   in D-galactose-induced ageing rats
SO INTERNATIONAL DAIRY JOURNAL
LA English
DT Article
ID ANTIOXIDANT ACTIVITY; ACTIVE PEPTIDES; MICE; DAMAGE; BRAIN; RADICALS;
   DISEASES
AB The protective effect of whey protein hydrolysate (WPH) against oxidation was studied in D-galactose-induced ageing rats. The rats were divided into a normal group, a D-galactose model group, low-, middle-, and high-dose WPH groups, and an ascorbic acid group. The three WPH groups and the ascorbic acid group also received D-galactose treatment. Administration of WPH significantly increased body weight gain, spleen index and high-density lipoprotein content (P < 0.05) and decreased the triglyceride and low- density lipoprotein contents (P < 0.05) compared with the ageing model group. WPH had a protective effect against D-galactose-induced ageing in rats as shown by the increased activities of superoxide dismutase, catalase and glutathione peroxidase and decrease in the malonaldehyde contents (P < 0.05) in the serum, spleen, liver, and lungs. The protective effect of WPH on D-galactose-induced ageing in rats can be attributed to enhanced antioxidant defences and the elevation of antioxidase activity. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Peng, Xinyan] Ludong Univ, Coll Food Engn, Yantai 264025, Shandong, Peoples R China.
   [Peng, Xinyan; Kong, Baohua] Northeast Agr Univ, Coll Food Sci, Harbin 150030, Heilongjiang, Peoples R China.
   [Yu, Haiyang] Shandong Business Inst, Dept Food Engn, Yantai 264670, Shandong, Peoples R China.
   [Diao, Xinping] Northeast Agr Univ, Coll Anim Sci, Harbin 150030, Heilongjiang, Peoples R China.
C3 Ludong University; Northeast Agricultural University - China; Northeast
   Agricultural University - China
RP Kong, BH (corresponding author), Northeast Agr Univ, Coll Food Sci, Harbin 150030, Heilongjiang, Peoples R China.
EM kongbh63@hotmail.com
FU Foundation for Innovative Research Team of Higher Education of
   Heilongjiang Province [2010td11]; 863 Plan of the Ministry of Science
   and Technology of China [2008AA10Z315]
FX This study was supported by the Foundation for Innovative Research Team
   of Higher Education of Heilongjiang Province (Grant No. 2010td11) and
   the 863 Plan of the Ministry of Science and Technology of China (Grant
   No. 2008AA10Z315).
CR AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292
   BURTON GW, 1990, ANNU REV NUTR, V10, P357, DOI [10.1146/annurev.nu.10.070190.002041, 10.1146/annurev.nutr.10.1.357]
   Chen B, 2010, BRAIN RES, V1344, P43, DOI 10.1016/j.brainres.2010.04.082
   Chen CF, 2006, PSYCHONEUROENDOCRINO, V31, P805, DOI 10.1016/j.psyneuen.2006.03.004
   Cui X, 2006, J NEUROSCI RES, V84, P647, DOI 10.1002/jnr.20899
   Floyd RA, 2002, NEUROBIOL AGING, V23, P795, DOI 10.1016/S0197-4580(02)00019-2
   FRIDOVICH I, 1978, SCIENCE, V201, P875, DOI 10.1126/science.210504
   Gill I, 1996, ENZYME MICROB TECH, V18, P162, DOI 10.1016/0141-0229(95)00097-6
   Gonzales S, 2002, REGUL PEPTIDES, V106, P67, DOI 10.1016/S0167-0115(02)00032-0
   HALLIWELL B, 1990, METHOD ENZYMOL, V186, P1
   HALLIWELL B, 1995, FOOD CHEM TOXICOL, V33, P601, DOI 10.1016/0278-6915(95)00024-V
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   Hernández-Ledesma B, 2005, J AGR FOOD CHEM, V53, P588, DOI 10.1021/jf048626m
   Hsieh HM, 2009, FOOD CHEM TOXICOL, V47, P625, DOI 10.1016/j.fct.2008.12.026
   Kong BH, 2012, FOOD CHEM, V135, P540, DOI 10.1016/j.foodchem.2012.04.122
   Kumar A, 2011, J ASIAN NAT PROD RES, V13, P42, DOI 10.1080/10286020.2010.544253
   Lei M, 2008, BIOCHEM BIOPH RES CO, V369, P1082, DOI 10.1016/j.bbrc.2008.02.151
   Lindmark-Månsson H, 2000, BRIT J NUTR, V84, pS103
   Liu AJ, 2009, BIOSCI BIOTECH BIOCH, V73, P1461, DOI 10.1271/bbb.80558
   Liu Q, 2011, FOOD CHEM TOXICOL, V49, P1316, DOI 10.1016/j.fct.2011.03.013
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   National Research Council, 2011, GUIDE CARE USE LAB A, DOI DOI 10.17226/12910
   Nazeer RA, 2012, PEPTIDES, V35, P261, DOI 10.1016/j.peptides.2012.03.028
   Pena-Ramos EA, 2001, J DAIRY SCI, V84, P2577, DOI 10.3168/jds.S0022-0302(01)74711-X
   Peña-Ramos EA, 2003, MEAT SCI, V64, P259, DOI 10.1016/S0309-1740(02)00187-0
   Peng XY, 2009, FOOD CHEM, V113, P196, DOI 10.1016/j.foodchem.2008.07.068
   Peng XY, 2010, INT DAIRY J, V20, P360, DOI 10.1016/j.idairyj.2009.11.019
   PericMataruga V, 1997, J INSECT PHYSIOL, V43, P101, DOI 10.1016/S0022-1910(96)00018-2
   Song X, 1999, MECH AGEING DEV, V108, P239, DOI 10.1016/S0047-6374(99)00022-6
   Tomkin GH., 2012, J ATHEROSCLER THROMB, V5, P13, DOI DOI 10.2174/1876506801205010013
   Vora SR, 2009, INDIAN J EXP BIOL, V47, P338
   Zhong SZ, 2009, J NEUROL SCI, V277, P58, DOI 10.1016/j.jns.2008.10.008
NR 33
TC 23
Z9 37
U1 1
U2 51
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0958-6946
EI 1879-0143
J9 INT DAIRY J
JI Int. Dairy J.
PD JAN
PY 2014
VL 34
IS 1
BP 80
EP 85
DI 10.1016/j.idairyj.2013.08.004
PG 6
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA 238VJ
UT WOS:000325979200012
DA 2024-02-19
ER

PT J
AU Zhao, Y
   Liao, AM
   Liu, N
   Huang, JH
   Lv, X
   Yang, CR
   Chen, WJ
   Hou, YC
   Ma, LJ
   Hui, M
AF Zhao, Yi
   Liao, Ai-Mei
   Liu, Na
   Huang, Ji-Hong
   Lv, Xing
   Yang, Can-Rui
   Chen, Wen-Jing
   Hou, Yin-Chen
   Ma, Li-Juan
   Hui, Ming
TI Potential anti-aging effects of fermented wheat germ in aging mice
SO FOOD BIOSCIENCE
LA English
DT Article; Early Access
DE Fermented wheat germ; Anti-aging; Gut microbiota; Oxidative stress
ID DEPRESSIVE-LIKE BEHAVIOR; OXIDATIVE STRESS; GUT MICROBIOTA; ANTIOXIDANT
   ACTIVITY; BRAIN; RATS; ANTHOCYANINS; DEFICIT; HEALTH; DAMAGE
AB Fermented wheat germ (FWG) is a valuable food ingredient and is naturally rich in antioxidant components; fermentation can improve the antioxidant capacity of wheat germ. The complex anti-aging effect of WG is not fully understood. This study was carried out to explore the functional properties of FWG: BALB/c mice with D-galactose (D-gal; 300 mg/kg/d) induced aging were treated with FWG (20 mg/kg/d) for 6 wk. The control mice were compared to mice with D-gal induced aging and aging mice administered FWG. FWG increased organ indices and enhanced learning and memory. The amount of total cholesterol, triglycerides, and glucose in the serum of aging mice also decreased after supplementation with FWG. FWG intake enhanced antioxidant activity in aging mice. FWG significantly increased the levels of antioxidant enzymes, such as superoxide dismutase, glutathione peroxidase, and total antioxidant capacity; it decreased the level of malondialdehyde in different tissues, including the liver, brain, intestine and serum. High-throughput sequencing results showed that the ratio of Bacteroidetes to Firmicutes index and the number of beneficial bacteria in the FWG group increased, and the growth of pathogens was suppressed in the intestines. These results suggested that FWG holds a great potential as a functional food by reducing oxidative damage, maintaining the stability of intestinal bacteria, and delaying aging.
C1 [Zhao, Yi; Liao, Ai-Mei; Liu, Na; Huang, Ji-Hong; Lv, Xing; Yang, Can-Rui; Chen, Wen-Jing; Hui, Ming] Henan Univ Technol, Sch Biol Engn, Zhengzhou, Henan, Peoples R China.
   [Liao, Ai-Mei; Huang, Ji-Hong] Henan Prov Key Lab Biol Proc & Nutr Funct Wheat, Zhengzhou, Henan, Peoples R China.
   [Huang, Ji-Hong; Hou, Yin-Chen] Henan Cooperat Med Sci & Technol Res Inst Co Ltd, Luoyang, Henan, Peoples R China.
   [Hou, Yin-Chen] Henan Univ Anim Husb & Econ, Sch Food & Bioengn, Zhengzhou, Henan, Peoples R China.
   [Ma, Li-Juan] Tianjin Univ Sci & Technol, Coll Biotechnol, Ind Microbiol Key Lab, Tianjin, Peoples R China.
C3 Henan University of Technology; Henan University of Animal Husbandry &
   Economy; Tianjin University Science & Technology
RP Liao, AM; Huang, JH (corresponding author), Zhengzhou High Tech Dev Zone, 100 Lian Hua St, Zhengzhou 450001, Henan, Peoples R China.
EM aimeiliao@haut.edu.cn; huangjihong@haut.edu.cn
RI chen, wenjing/IZE-8536-2023
FU Zhongyuan Scholars Foundation [192101510004]; Ministry of Industry and
   Information Technology [2018-71]; Youth Talent Support Program of Henan
   Province in China [2018HYTP014]; Key Project Foundation of the Natural
   Science Research of the Universities of Henan Province in China
   [20A550004]; Strategic Consulting Research Project of the Henan
   Institute of Chinese Engineering Development Strategies [2020HENZT13];
   Henan Provincial Colleges and the Universities at Henan University of
   Technology [HAUT-2018QNJH13]; Major Science and Technology Projects for
   Public Welfare of Henan Province [201300110300]
FX This work was supported by the Zhongyuan Scholars Foundation (NO.
   192101510004) , the Project of Green Manufacturing of Wheat2025 China
   (NO. Ministry of Industry and Information Technology, 2018-71) , the
   Youth Talent Support Program of Henan Province in China (NO.
   2018HYTP014) , the Key Project Foundation of the Natural Science
   Research of the Universities of Henan Province in China (NO. 20A550004)
   , the Strategic Consulting Research Project of the Henan Institute of
   Chinese Engineering Development Strategies (NO. 2020HENZT13) , the Henan
   Provincial Colleges and the Universities at Henan University of
   Technology (NO. HAUT-2018QNJH13) and the Major Science and Technology
   Projects for Public Welfare of Henan Province (NO. 201300110300) .
CR Abildgaard A, 2017, PSYCHONEUROENDOCRINO, V79, P40, DOI 10.1016/j.psyneuen.2017.02.014
   An L, 2018, FOOD FUNCT, V9, P4755, DOI 10.1039/c8fo00702k
   BARNES CA, 1980, CAN J PSYCHOL, V34, P29, DOI 10.1037/h0081022
   Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205
   Biagi E, 2013, PHARMACOL RES, V69, P11, DOI 10.1016/j.phrs.2012.10.005
   Budni J, 2017, METAB BRAIN DIS, V32, P811, DOI 10.1007/s11011-017-9972-9
   Chang AY, 2019, LANCET PUBLIC HEALTH, V4, pE159, DOI 10.1016/S2468-2667(19)30019-2
   Chikara S, 2018, CANCER LETT, V413, P122, DOI 10.1016/j.canlet.2017.11.002
   Coda R, 2013, FOOD MICROBIOL, V33, P243, DOI 10.1016/j.fm.2012.09.023
   Cole JH, 2019, MOL PSYCHIATR, V24, P266, DOI 10.1038/s41380-018-0098-1
   Cryan JF, 2019, PHYSIOL REV, V99, P1877, DOI 10.1152/physrev.00018.2018
   Dose J, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010103
   El-Tantawy W.H., 2016, J TRADIT COMPLEMEN M, V6, P327, DOI 10.1016/j.jtcme.2015.02.001
   Elfawy HA, 2019, LIFE SCI, V218, P165, DOI 10.1016/j.lfs.2018.12.029
   Floyd RA, 2002, NEUROBIOL AGING, V23, P795, DOI 10.1016/S0197-4580(02)00019-2
   Franceschi C, 2018, NAT REV ENDOCRINOL, V14, P576, DOI 10.1038/s41574-018-0059-4
   Haider S, 2015, LIFE SCI, V124, P110, DOI 10.1016/j.lfs.2015.01.016
   He SD, 2019, FOOD FUNCT, V10, P4291, DOI 10.1039/c9fo00791a
   Hor YY, 2019, PHARMACOL RES, V146, DOI 10.1016/j.phrs.2019.104312
   Hou Y. C., 2018, CHINA BREWING, V37, P66
   Hu JJ, 2018, MICROB PATHOGENESIS, V119, P86, DOI 10.1016/j.micpath.2018.03.053
   Jamari H, 2020, PERTANIKA J SCI TECH, V28, P293
   Jiang CM, 2017, J ALZHEIMERS DIS, V58, P1, DOI 10.3233/JAD-161141
   Jiang QQ, 2019, J AGR FOOD CHEM, V67, P9820, DOI 10.1021/acs.jafc.9b03827
   Kennedy BK, 2015, ONCOTARGET, V6, P590, DOI 10.18632/oncotarget.3173
   Lagkouvardos I, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0637-2
   Li W, 2019, CARBOHYD POLYM, V223, DOI 10.1016/j.carbpol.2019.115065
   Li X, 2016, BIOL TRACE ELEM RES, V173, P433, DOI 10.1007/s12011-016-0681-8
   Liu FR, 2017, FOOD BIOSCI, V20, P141, DOI 10.1016/j.fbio.2017.10.002
   Liu M, 2017, SCI REP-UK, V7, DOI 10.1038/srep43212
   Lu J, 2006, BEHAV BRAIN RES, V171, P251, DOI 10.1016/j.bbr.2006.03.043
   Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123
   Matés JM, 1999, CLIN BIOCHEM, V32, P595, DOI 10.1016/S0009-9120(99)00075-2
   Messaoudi M, 2011, BRIT J NUTR, V105, P755, DOI 10.1017/S0007114510004319
   Mitsuoka T, 1996, Asia Pac J Clin Nutr, V5, P2
   O'Toole PW, 2015, SCIENCE, V350, P1214, DOI 10.1126/science.aac8469
   O'Toole PW, 2013, WORLD REV NUTR DIET, V107, P25, DOI 10.1159/000345748
   Ojo BA, 2019, J NUTR, V149, P1107, DOI 10.1093/jn/nxz061
   Pang YH, 2018, FOOD CHEM, V240, P212, DOI 10.1016/j.foodchem.2017.07.095
   Parshukov AN, 2019, J APPL MICROBIOL, V127, P379, DOI 10.1111/jam.14302
   Poniedzialek B, 2015, TOXICOL IN VITRO, V29, P926, DOI 10.1016/j.tiv.2015.03.023
   Ramos-Romero S, 2014, OBESITY, V22, P976, DOI 10.1002/oby.20640
   Rizzello CG, 2011, FOOD CHEM, V127, P952, DOI 10.1016/j.foodchem.2011.01.063
   Saraswati S, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00764
   Sha JY, 2019, J AGR FOOD CHEM, V67, P10342, DOI 10.1021/acs.jafc.9b04614
   Shu ZX, 2019, FOOD BIOSCI, V31, DOI 10.1016/j.fbio.2019.100440
   SOCCI DJ, 1995, BRAIN RES, V693, P88, DOI 10.1016/0006-8993(95)00707-W
   Song JH, 2014, FOOD SCI BIOTECHNOL, V23, P1327, DOI 10.1007/s10068-014-0182-5
   Tuikhar N, 2019, MECH AGEING DEV, V179, P23, DOI [10.1016/j.mad.2019.02.001, 10.1016/j.mad.2019.02.00]
   Vaiserman AM, 2017, AGEING RES REV, V35, P36, DOI 10.1016/j.arr.2017.01.001
   Verni M, 2019, FRONT NUTR, V6, DOI 10.3389/fnut.2019.00042
   Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116
   Wang JJ, 2019, NEUROSCI LETT, V704, P106, DOI 10.1016/j.neulet.2019.04.002
   Wang LS, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01084
   Wasay M, 2016, LANCET NEUROL, V15, P1008, DOI 10.1016/S1474-4422(16)30171-5
   Wei J, 2017, J AGR FOOD CHEM, V65, P5973, DOI 10.1021/acs.jafc.7b02136
   Wong ML, 2016, MOL PSYCHIATR, V21, P797, DOI 10.1038/mp.2016.46
   Wong SYW, 2017, GENET MED, V19, P1226, DOI 10.1038/gim.2017.41
   Woodmansey EJ, 2007, J APPL MICROBIOL, V102, P1178, DOI 10.1111/j.1365-2672.2007.03400.x
   Wu J., 2016, SCI TECHNOLOGY FOOD, V37, P06
   Xiao Y, 2018, FOOD CHEM TOXICOL, V119, P141, DOI 10.1016/j.fct.2018.05.017
   Xu LQ, 2016, FOOD FUNCT, V7, P4545, DOI 10.1039/c6fo01057a
   Yang Lei, 2013, China Oils and Fats, V38, P31
   Yang MH, 2019, MED SCI MONITOR, V25, P2511, DOI 10.12659/MSM.915518
   Yang RQ, 2011, J AGR FOOD CHEM, V59, P3598, DOI 10.1021/jf104998s
   Zhai SX, 2018, MICROBIOLOGYOPEN, V7, DOI 10.1002/mbo3.612
   Zhang DJ, 2018, J AGR FOOD CHEM, V66, P5510, DOI 10.1021/acs.jafc.8b00446
   Zhang HY, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00187
   Zhang X, 2019, J ETHNOPHARMACOL, V234, P44, DOI 10.1016/j.jep.2018.12.050
   Zhao JC, 2018, FOOD FUNCT, V9, P917, DOI [10.1039/c7fo01574g, 10.1039/C7FO01574G]
   Zhao L, 2019, J FUNCT FOODS, V52, P587, DOI 10.1016/j.jff.2018.11.044
   Zhao Y, 2019, INT J AGRIC BIOL, V22, P1599, DOI 10.17957/IJAB/15.1240
   Zhou YM, 2019, J FOOD SCI, V84, P3833, DOI 10.1111/1750-3841.14958
   Zhou Y, 2013, FOOD CHEM TOXICOL, V59, P412, DOI 10.1016/j.fct.2013.06.009
NR 74
TC 13
Z9 13
U1 8
U2 44
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2212-4292
EI 2212-4306
J9 FOOD BIOSCI
JI Food Biosci.
PD 2021 AUG
PY 2021
VL 42
AR 101182
DI 10.1016/j.fbio.2021.101182
EA JUN 2021
PG 10
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA UE3IC
UT WOS:000687784500010
DA 2024-02-19
ER

PT J
AU Tian, LQ
   Cai, QY
   Wei, HC
AF Tian, LQ
   Cai, QY
   Wei, HC
TI Alterations of antioxidant enzymes and oxidative damage to
   macromolecules in different organs of rats during aging
SO FREE RADICAL BIOLOGY AND MEDICINE
LA English
DT Article
DE antioxidant enzymes; lipid peroxidation; protein oxidation; aging;
   Fisher 344 rats; free radical
ID FREE-RADICAL THEORY; PROTEIN OXIDATION; BRAIN; MITOCHONDRIA; KIDNEY;
   STRESS; LIVER
AB Oxygen free radicals have been hypothesized to play an important role in the aging process. To investigate the correlation between the oxidative stress and aging, we have determined the levels of oxidative protein damage and lipid peroxidation in the brain and liver, and activities of antioxidant enzymes in the brain, liver, heart, kidney, and serum from the Fisher 344 rats at ages of 1, 6, 12, 18, and 24 months. The results showed that the level of oxidative protein damage (measured as carbonyl content) in the brain and liver was significantly higher in older animals than in young animals. No statistical difference was observed in the lipid peroxidation of the liver and brain between young and old animals. The activities of antioxidant enzymes in most tissues displayed an age-dependent decline. Superoxide dismutases in the heart, kidney, and serum, glutathione peroxidase activities in the serum and kidney, and catalase activities in the brain, liver, and kidney, significantly decreased during aging. Cytochrome c oxidase, an enzyme involved in electron transport in mitochondria, initially increased, but subsequently decreased in the aged brain, whereas no significant alteration was observed in the liver mitochondrial antioxidant enzymes. The present studies suggest that the accumulation of oxidized proteins during aging is most likely to be linked with an age-related decline of antioxidant enzyme activities, whereas lipid peroxidation is less sensitive to predict the aging process. (C) 1998 Elsevier Science Inc.
C1 CUNY Mt Sinai Sch Med, Dept Dermatol, New York, NY 10029 USA.
C3 Icahn School of Medicine at Mount Sinai; City University of New York
   (CUNY) System
RP Wei, HC (corresponding author), CUNY Mt Sinai Sch Med, Dept Dermatol, Box 1047,1425 Madison Ave, New York, NY 10029 USA.
EM hw@doc.mssm.edu
CR ALLEN RG, 1993, FREE RADICALS AGING, P12
   APRILLE JR, 1981, ARCH BIOCHEM BIOPHYS, V212, P689, DOI 10.1016/0003-9861(81)90413-6
   BENZI G, 1992, NEUROBIOL AGING, V13, P361, DOI 10.1016/0197-4580(92)90109-B
   CABALASPICOT I, 1992, MUTAT RES, V275, P281
   CALHOUN MW, 1994, TRENDS BIOCHEM SCI, V19, P325, DOI 10.1016/0968-0004(94)90071-X
   Claiborne AL., 1986, CRC HDB METHODS OXYG, P283
   CUTLER RG, 1991, ANN NY ACAD SCI, V621, P1
   DAVIES KJA, 1988, CELLULAR ANTIOXIDANT, V2, P25
   DEAN RT, 1992, MUTAT RES, V275, P387, DOI 10.1016/0921-8734(92)90041-M
   Errede B, 1978, Methods Enzymol, V53, P40
   FEUERS RJ, 1993, MUTAT RES, V295, P191, DOI 10.1016/0921-8734(93)90020-4
   FUCCI L, 1983, P NATL ACAD SCI-BIOL, V80, P1521, DOI 10.1073/pnas.80.6.1521
   HARMAN D, 1992, MUTAT RES, V275, P257, DOI 10.1016/0921-8734(92)90030-S
   HOLMES GE, 1992, MUTAT RES, V275, P305, DOI 10.1016/0921-8734(92)90034-M
   LEVINE RL, 1990, METHOD ENZYMOL, V186, P464
   LOPEZTORRES M, 1993, FREE RADICAL BIO MED, V15, P133, DOI 10.1016/0891-5849(93)90052-V
   MATSUO M, 1993, FREE RADICALS AGING, P148
   Mestro-Del R.F, 1986, CRC HDB METHODS OXYG, P291
   MOHANDAS J, 1984, CANCER RES, V44, P5086
   MUSCARI C, 1990, BIOCHIM BIOPHYS ACTA, V1015, P200, DOI 10.1016/0005-2728(90)90021-U
   NOHL H, 1978, EUR J BIOCHEM, V82, P563, DOI 10.1111/j.1432-1033.1978.tb12051.x
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   OLIVER CN, 1990, P NATL ACAD SCI USA, V87, P5144, DOI 10.1073/pnas.87.13.5144
   PACIFICI RE, 1991, GERONTOLOGY, V37, P166
   SATAV JG, 1982, MOL CELL ENDOCRINOL, V28, P173, DOI 10.1016/0303-7207(82)90030-2
   SHOAL RS, 1991, MECH AGEING DEV, V57, P187
   SHOAL RS, 1993, FREE RADIC BIOL MED, V14, P583
   SHOAL RS, 1992, MUTAT RES, V275, P295
   SMITH CD, 1991, P NATL ACAD SCI USA, V88, P10540, DOI 10.1073/pnas.88.23.10540
   STARKEREED PE, 1989, ARCH BIOCHEM BIOPHYS, V275, P559, DOI 10.1016/0003-9861(89)90402-5
   SUN Y, 1990, FREE RADIC BIOL MED, V8, P585
NR 31
TC 252
Z9 270
U1 0
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0891-5849
EI 1873-4596
J9 FREE RADICAL BIO MED
JI Free Radic. Biol. Med.
PD JUN
PY 1998
VL 24
IS 9
BP 1477
EP 1484
DI 10.1016/S0891-5849(98)00025-2
PG 8
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA ZT981
UT WOS:000074148900015
PM 9641266
DA 2024-02-19
ER

PT J
AU So-Armah, K
   Freiberg, M
   Cheng, D
   Lim, JK
   Gnatienko, N
   Patts, G
   Doyle, M
   Fuster, D
   Lioznov, D
   Krupitsky, E
   Samet, J
AF So-Armah, Kaku
   Freiberg, Matthew
   Cheng, Debbie
   Lim, Joseph K.
   Gnatienko, Natalia
   Patts, Gregory
   Doyle, Margaret
   Fuster, Daniel
   Lioznov, Dmitry
   Krupitsky, Evgeny
   Samet, Jeffrey
TI Liver fibrosis and accelerated immune dysfunction (immunosenescence)
   among HIV-infected Russians with heavy alcohol consumption-an
   observational cross-sectional study
SO BMC GASTROENTEROLOGY
LA English
DT Article
DE HIV; Liver fibrosis; Immune senescence; Russia; Alcohol
ID REPLICATIVE SENESCENCE; T-CELLS; DRINKING; RELIABILITY; EXPRESSION;
   DEPENDENCE; CIRRHOSIS
AB Background The multifactorial mechanisms driving negative health outcomes among risky drinkers with HIV may include immunosenescence. Immunosenescence, aging of the immune system, may be accentuated in HIV and leads to poor outcomes. The liver regulates innate immunity and adaptive immune tolerance. HIV-infected people have high prevalence of liver-related comorbidities. We hypothesize that advanced liver fibrosis/cirrhosis is associated with alterations in T-cell subsets consistent with immunosenescence. Methods ART-naive people with HIV with a recent history of heavy drinking were recruited into a clinical trial of zinc supplementation. Flow cytometry was used to characterize T-cell subsets. The two primary dependent variables were CD8+ and CD4+ T-cells expressing CD28-CD57+ (senescent cell phenotype). Secondary dependent variables were CD8+ and CD4+ T-cells expressing CD45RO + CD45RA- (memory phenotype), CD45RO-CD45RA+ (naive phenotype), and the naive phenotype to memory phenotype T-cell ratio (lower ratios associated with immunosenescence). Advanced liver fibrosis/cirrhosis was defined as FIB-4 > 3.25, APRI >= 1.5, or Fibroscan measurement >= 10.5 kPa. Analyses were conducted using multiple linear regression adjusted for potential confounders. Results Mean age was 34 years; 25% female; 88% hepatitis C. Those with advanced liver fibrosis/cirrhosis (N = 25) had higher HIV-1 RNA and more hepatitis C. Advanced liver fibrosis/cirrhosis was not significantly associated with primary or secondary outcomes in adjusted analyses. Conclusions Advanced liver fibrosis/cirrhosis was not significantly associated with these senescent T-cell phenotypes in this exploratory study of recent drinkers with HIV. Future studies should assess whether liver fibrosis among those with HIV viral suppression and more advanced, longstanding liver disease is associated with changes in these and other potentially senescent T-cell subsets.
C1 [So-Armah, Kaku] Boston Univ, Dept Med, Sch Med, 801 Massachusetts Ave,Crosstown Bldg,2nd Floor, Boston, MA 02118 USA.
   [Freiberg, Matthew] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA.
   [Freiberg, Matthew] Tennessee Valley Healthcare Syst, Nashville Vet Affairs Med Ctr, Nashville, TN 37212 USA.
   [Cheng, Debbie; Patts, Gregory] Boston Univ, Dept Biostat, Sch Publ Hlth, Boston, MA USA.
   [Lim, Joseph K.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA.
   [Gnatienko, Natalia] Boston Med Ctr, Dept Med, Boston, MA USA.
   [Patts, Gregory] Boston Univ, Data Coordinating Ctr, Sch Publ Hlth, Boston, MA USA.
   [Doyle, Margaret] Univ Vermont, Dept Pathol & Lab Med, Burlington, VT USA.
   [Fuster, Daniel] Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, Dept Internal Med, Badalona, Spain.
   [Lioznov, Dmitry] First Pavlov State Med Univ, Smorodintsev Res Inst Influenza, Dept Infect Dis & Epidemiol, St Petersburg, Russia.
   [Krupitsky, Evgeny] First Pavlov State Med Univ, VM Bekhterev Natl Res Med Ctr Psychiat & Neurol, St Petersburg, Russia.
   [Samet, Jeffrey] Boston Univ, Sch Med, Dept Med, Boston Med Ctr, Boston, MA 02118 USA.
C3 Boston University; Vanderbilt University; US Department of Veterans
   Affairs; Veterans Health Administration (VHA); VA Tennessee Valley
   Healthcare System; Boston University; Yale University; Boston Medical
   Center; Boston University; University of Vermont; Autonomous University
   of Barcelona; Hospital Germans Trias i Pujol; Pavlov First Saint
   Petersburg State Medical University; V.M. Bekhterev National Research
   Medical Center Psychiatry & Neurology; Pavlov First Saint Petersburg
   State Medical University; Boston University; Boston Medical Center
RP So-Armah, K (corresponding author), Boston Univ, Dept Med, Sch Med, 801 Massachusetts Ave,Crosstown Bldg,2nd Floor, Boston, MA 02118 USA.; Freiberg, M (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA.; Freiberg, M (corresponding author), Tennessee Valley Healthcare Syst, Nashville Vet Affairs Med Ctr, Nashville, TN 37212 USA.
EM kaku@bu.edu; matthew.s.freiberg@vanderbilt.edu
RI Fuster, Daniel/C-6659-2019; Krupitsky, Evgeny/M-5935-2016
OI Fuster, Daniel/0000-0003-1262-5860; So-Armah, Kaku/0000-0003-1505-6384;
   Krupitsky, Evgeny/0000-0002-0529-4525; Doyle,
   Margaret/0000-0001-6769-5386
FU National Institute on Alcohol Abuse and Alcoholism at the National
   Institutes of Health [U01AA020780, U24AA020778, U24AA020779,
   U01AA021989-03S1, K01 HL1314701]; National Heart, Lung, and Blood
   Institute
FX This work was supported by the National Institute on Alcohol Abuse and
   Alcoholism at the National Institutes of Health: Grant numbers:
   U01AA020780, U24AA020778, U24AA020779, U01AA021989-03S1. KS was
   supported by grant K01 HL1314701 from the National Heart, Lung, and
   Blood Institute. Funding bodies did not have a role in study design, or
   collection, analysis and interpretation of data, or manuscript writing.
CR Braithwaite RS, 2010, ALCOHOL RES HEALTH, V33, P280
   Brenchley JM, 2003, BLOOD, V101, P2711, DOI 10.1182/blood-2002-07-2103
   Chou R, 2013, ANN INTERN MED, V158, P807, DOI 10.7326/0003-4819-158-11-201306040-00005
   COOK RT, 1995, ALCOHOL CLIN EXP RES, V19, P555, DOI 10.1111/j.1530-0277.1995.tb01548.x
   DARKE S, 1991, AIDS, V5, P181, DOI 10.1097/00002030-199102000-00008
   Dock JN, 2011, AGING DIS, V2, P382
   Galvan FH, 2002, J STUD ALCOHOL, V63, P179, DOI 10.15288/jsa.2002.63.179
   Gnatienko N, 2018, HIV CLIN TRIALS, V19, P101, DOI 10.1080/15284336.2018.1459344
   Hahn JA, 2018, JAIDS-J ACQ IMM DEF, V77, P492, DOI 10.1097/QAI.0000000000001624
   Hahn Judith A, 2010, Curr HIV/AIDS Rep, V7, P226, DOI 10.1007/s11904-010-0060-6
   Hao L., 2007, Quantile Regression
   HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119
   Justice AC, 2006, MED CARE, V44, pS13, DOI 10.1097/01.mlr.0000223741.02074.66
   Klibansky DA, 2012, J VIRAL HEPATITIS, V19, pE184, DOI 10.1111/j.1365-2893.2011.01493.x
   Koenker R., 2005, QUANTILE REGRESSION, DOI DOI 10.1017/CBO9780511754098
   Laso FJ, 2000, CYTOMETRY, V42, P290, DOI 10.1002/1097-0320(20001015)42:5<290::AID-CYTO6>3.3.CO;2-X
   Li FL, 2013, CELL MOL IMMUNOL, V10, P292, DOI 10.1038/cmi.2013.7
   Malbergier A, 2015, AIDS CARE, V27, P54, DOI 10.1080/09540121.2014.947235
   Márquez M, 2009, CLIN EXP IMMUNOL, V158, P219, DOI 10.1111/j.1365-2249.2009.04005.x
   Samet JH, 2007, JAIDS-J ACQ IMM DEF, V46, P194, DOI 10.1097/QAI.0b013e318142aabb
   So-Armah KA, 2016, ALCOHOL CLIN EXP RES, V40, P1737, DOI 10.1111/acer.13142
   SOBELL MB, 1986, ADDICT BEHAV, V11, P149, DOI 10.1016/0306-4603(86)90040-7
   Strioga M, 2011, IMMUNOLOGY, V134, P17, DOI 10.1111/j.1365-2567.2011.03470.x
   Vivar N, 2008, AIDS, V22, P1083, DOI 10.1097/QAD.0b013e3282fce613
   Weng NP, 2006, IMMUNITY, V24, P495, DOI 10.1016/j.immuni.2006.05.001
   Williams EC, 2016, ALCOHOL CLIN EXP RES, V40, P2056, DOI 10.1111/acer.13204
NR 26
TC 4
Z9 5
U1 1
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-230X
J9 BMC GASTROENTEROL
JI BMC Gastroenterol.
PD DEC 31
PY 2019
VL 20
IS 1
AR 1
DI 10.1186/s12876-019-1136-4
PG 8
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA JZ3MV
UT WOS:000505006900001
PM 31892306
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Kim, YJ
   Yokozawa, T
   Chung, HY
AF Kim, YJ
   Yokozawa, T
   Chung, HY
TI Suppression of oxidative stress in aging NZB/NZW mice: Effect of fish
   oil feeding on hepatic antioxidant status and guanidino compounds
SO FREE RADICAL RESEARCH
LA English
DT Article
DE dietary fish oil; reactive species; lipid peroxidation; xanthine
   oxidase; antioxidant defenses; guanidino compound
ID FATTY-ACIDS; GLUTATHIONE-REDUCTASE; LIPID-PEROXIDATION; SUPEROXIDE
   ANIONS; GENE-EXPRESSION; N-3; METABOLISM; LIVER; ENZYMES; SYSTEM
AB Oxidative stress caused by excessive reactive species (RS) and lipid peroxidation is known to be casually linked to age-related inflammation. To test the hypothesis that fish oil (FO) intake has a beneficial effect on nephritis due to its suppressive action of oxidative stress and the enhancement of antioxidant defenses, we examined the effect of dietary FO on various oxidative stress-related parameters and guanidino compound (GC) levels using (NZB x NZW) F-1 (B/W) mice. These mice were fed diets supplemented with either 5% corn oil (control) or 5% FO. At 4 and 9 months of age, the hepatic oxidative status was estimated by assessing RS generation produced from xanthine oxidase, the prostaglandin pathway and lipid peroxidation. To evaluate the effect of FO on redox status, including antioxidant defenses, GSH and GSSG levels and antioxidant enzyme activities were measured. To correlate the extent of oxidative status with the nephritic condition, creatinine, guanidino acetic acid and arginine levels were measured. Results indicated that increased levels of lipid peroxidation, RS generation and xanthine oxidase activity with age were all significantly suppressed by FO feeding. Furthermore, reduced GSH levels, GSH/GSSG ratio and antioxidant enzyme activities in the FO-fed mice were effectively enhanced compared to the corn oil-fed mice. Among several GCs, the age-related increase of creatinine level was blunted by FO. Based on these results, we propose that dietary FO exerts beneficial effects in aged, nephritic mice by suppressing RS, superoxide and lipid peroxidation, and by maintaining a higher GSH/GSSG ratio and antioxidant enzyme activities.
C1 Pusan Natl Univ, Dept Pharm, Longev Life Sci Inst, Pusan 609735, South Korea.
   Pusan Natl Univ, Inst Technol, Pusan 609735, South Korea.
   Pusan Womens Coll, Dept Gosmetol, Pusan, South Korea.
   Toyama Med & Pharmaceut Univ, Inst Nat Med, Toyama 9300194, Japan.
C3 Pusan National University; Pusan National University; University of
   Toyama
RP Chung, HY (corresponding author), Pusan Natl Univ, Dept Pharm, Longev Life Sci Inst, Pusan 609735, South Korea.
EM hyjung@pusan.ac.kr
CR AEBI H, 1984, METHOD ENZYMOL, V105, P121
   ALI SF, 1992, NEUROTOXICOLOGY, V13, P637
   BECKMAN JS, 1989, FREE RADICAL BIO MED, V6, P607, DOI 10.1016/0891-5849(89)90068-3
   Bhattacharya A, 2003, J AM COLL NUTR, V22, P388, DOI 10.1080/07315724.2003.10719322
   Borges F, 2002, CURR MED CHEM, V9, P195, DOI 10.2174/0929867023371229
   CeballosPicot I, 1996, FREE RADICAL BIO MED, V21, P845, DOI 10.1016/0891-5849(96)00233-X
   CHANDRASEKAR B, 1994, BIOCHEM BIOPH RES CO, V200, P893, DOI 10.1006/bbrc.1994.1534
   Chung H Y, 1999, J Nutr Health Aging, V3, P19
   Chung HY, 2002, MICROSC RES TECHNIQ, V59, P264, DOI 10.1002/jemt.10203
   Das UN, 2000, PROSTAG LEUKOTR ESS, V63, P351, DOI 10.1054/plef.2000.0226
   DECATERINA R, 1994, ARTERIOSCLER THROMB, V14, P1829, DOI 10.1161/01.ATV.14.11.1829
   Donadio JV, 2001, J AM SOC NEPHROL, V12, P791, DOI 10.1681/ASN.V124791
   Du CY, 2003, BIOL PHARM BULL, V26, P766, DOI 10.1248/bpb.26.766
   EKLOW L, 1984, EUR J BIOCHEM, V138, P459, DOI 10.1111/j.1432-1033.1984.tb07938.x
   FERNANDES G, 1994, J IMMUNOL, V152, P5979
   FUNAHASHI M, 1981, J BIOCHEM-TOKYO, V89, P1347, DOI 10.1093/oxfordjournals.jbchem.a133326
   HABIG WH, 1974, J BIOL CHEM, V249, P7130
   HIGASHIDATE S, 1984, BUNSEKI KAGAKU, V33, P366
   Himmelfarb J, 2003, CURR OPIN NEPHROL HY, V12, P593, DOI 10.1097/00041552-200311000-00004
   Ibrahim W, 1997, J NUTR, V127, P1401, DOI 10.1093/jn/127.7.1401
   Kakarla P, 2005, J EXP ZOOL PART A, V303A, P203, DOI 10.1002/jez.a.149
   KAKIMOTO Y, 1970, J BIOL CHEM, V245, P5751
   Kikugawa K, 2004, YAKUGAKU ZASSHI, V124, P653, DOI 10.1248/yakushi.124.653
   Kikugawa K, 2003, J AGR FOOD CHEM, V51, P6073, DOI 10.1021/jf030141v
   Kim HJ, 2000, FREE RADICAL BIO MED, V28, P683, DOI 10.1016/S0891-5849(99)00274-9
   Kim JW, 2002, ARCH GERONTOL GERIAT, V34, P9, DOI 10.1016/S0167-4943(01)00178-9
   KIM YJ, IN PRESS BR J NUTR
   KOSUGI H, 1993, LIPIDS, V28, P337, DOI 10.1007/BF02536320
   Levillain O, 2001, PFLUG ARCH EUR J PHY, V442, P558, DOI 10.1007/s004240100581
   LEVILLAIN O, 1995, KIDNEY INT, V47, P464, DOI 10.1038/ki.1995.59
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Marescau B, 1997, METABOLISM, V46, P1024, DOI 10.1016/S0026-0495(97)90273-0
   MCCORD JM, 1988, FREE RADICAL BIO MED, V5, P363, DOI 10.1016/0891-5849(88)90109-8
   Miret S, 2003, BRIT J NUTR, V89, P11, DOI 10.1079/BJN2002737
   Nohara Y, 2002, CHEM PHARM BULL, V50, P179, DOI 10.1248/cpb.50.179
   Nyska A, 2002, TOXICOL PATHOL, V30, P620, DOI 10.1080/01926230290166724
   Pandey A, 1996, J ENZYM INHIB, V11, P141, DOI 10.3109/14756369609036541
   Rahman Q, 1999, CRIT REV TOXICOL, V29, P543, DOI 10.1080/10408449991349276
   Reich EE, 2001, J NEUROSCI, V21, P5993, DOI 10.1523/JNEUROSCI.21-16-05993.2001
   RIKANS LE, 1991, ARCH GERONTOL GERIAT, V13, P263, DOI 10.1016/0167-4943(91)90048-U
   SUPARI F, 1995, CIRCULATION, V91, P1123, DOI 10.1161/01.CIR.91.4.1123
   TAPPEL AL, 1989, FREE RADICAL BIO MED, V7, P361, DOI 10.1016/0891-5849(89)90122-6
   VENKATRAMAN JT, 1994, LIPIDS, V29, P561, DOI 10.1007/BF02536628
   Yokozawa T, 2002, NEPHRON, V92, P356, DOI 10.1159/000063301
NR 44
TC 12
Z9 12
U1 0
U2 5
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1071-5762
EI 1029-2470
J9 FREE RADICAL RES
JI Free Radic. Res.
PD OCT
PY 2005
VL 39
IS 10
BP 1101
EP 1110
DI 10.1080/10715760500250083
PG 10
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 967QE
UT WOS:000232105500008
PM 16298735
DA 2024-02-19
ER

PT J
AU Tan, DY
   Cernadas, MR
   Aragoncillo, P
   Castilla, MA
   Arroyo, MVA
   Farre, AJL
   Casado, S
   Caramelo, C
AF Tan, DY
   Cernadas, MR
   Aragoncillo, P
   Castilla, MA
   Arroyo, MVA
   Farre, AJL
   Casado, S
   Caramelo, C
TI Role of nitric oxide-related mechanisms in renal function in ageing rats
SO NEPHROLOGY DIALYSIS TRANSPLANTATION
LA English
DT Article
DE ageing; L-arginine; L-glycine; renal function
ID L-ARGININE; AMINO-ACIDS; KIDNEY; RESPONSES; AGENTS
AB Background. The impaired renal function and vasodilatation that accompany age need to be re-addressed based upon the new knowledge concerning vascular nitric oxide (NO)-dependent systems. The present study examined the effects of age on the NO-related renal response.
   Methods. The study was performed in euvolaemic, conscious Wistar rats, aged 5 and 18 months. Renal function and haemodynamic measurements with fluorescent microspheres were employed to assess differences between groups.
   Results. A first set of experiments showed that ageing rats had a reduced natriuretic and diuretic response to acetylcholine, whereas the response to sodium nitroprusside was preserved. In the same regard, a reduction of the renal functional effects of L-arginine (L-Arg) and L-glycine (L-Gly) was found in the older rats. In the ageing rats, these responses were accompanied by an enhanced effect of the L-Arg competitive analogue, NwNLA, which provoked a marked reduction of renal function. This effect of NwNLA was blocked by the simultaneous administration of a small dose of L-Arg in the ageing but not in the young rats. Systemic haemodynamic studies revealed that in ageing rats, NwNLA reduced renal blood flow and increased renal vascular resistances in a significantly higher proportion than in younger animals. However, flow to other organs, namely, brain, spleen or liver, was affected in a similar manner in both young and old rats. Ultrastructural alterations were found in endothelial cells, which might constitute the anatomical basis for the observed functional derangements.
   Conclusions. The present experiments reveal that ageing is accompanied by significant differences in NO-related responses in the kidney which do not appear to affect blood flow to other organs. The response to L-Arg and L-Arg competitive analogues supports the existence of a marked dependency on NO-related mechanisms in the ageing rats, but not of a decreased baseline activity of the NO-dependent pathways.
C1 Univ Autonoma Madrid, Fdn Jimenez Diaz, Lab Nefrol, E-28040 Madrid, Spain.
   Univ Complutense Madrid, Hosp Clin Sao Carlos, Serv Anat Patol, Madrid, Spain.
C3 Autonomous University of Madrid; Complutense University of Madrid
RP Caramelo, C (corresponding author), Univ Autonoma Madrid, Fdn Jimenez Diaz, Lab Nefrol, Reyes Catolicos 2, E-28040 Madrid, Spain.
OI LOPEZ FARRE, ANTONIO/0000-0003-0301-067X
CR BAYLIS C, 1990, AM J KIDNEY DIS, V15, P244, DOI 10.1016/S0272-6386(12)80769-4
   BOLTON WK, 1980, AM J PATHOL, V98, P339
   BRENNER BM, 1989, J CLIN INVEST, V84, P1373, DOI 10.1172/JCI114309
   CARAMELO C, 1986, HEPATOLOGY, V6, P129, DOI 10.1002/hep.1840060125
   CERNADAS MR, 1992, J PHARMACOL EXP THER, V263, P1023
   CHEN C, 1992, AM J PHYSIOL, V263, pR510, DOI 10.1152/ajpregu.1992.263.3.R510
   DOCHERTY JR, 1990, PHARMACOL REV, V42, P103
   DOHI Y, 1990, BRIT J PHARMACOL, V100, P889, DOI 10.1111/j.1476-5381.1990.tb14110.x
   ELSAYED AA, 1991, CLIN SCI, V81, P427, DOI 10.1042/cs0810427
   GALLEGO MJ, 1993, AM J PHYSIOL, V33, pH708
   GARDINER SM, 1990, BRIT J PHARMACOL, V101, P625, DOI 10.1111/j.1476-5381.1990.tb14131.x
   Giugliano D, 1997, J CLIN INVEST, V99, P433, DOI 10.1172/JCI119177
   GLENNY RW, 1993, J APPL PHYSIOL, V74, P2585, DOI 10.1152/jappl.1993.74.5.2585
   GRANDES S, 1991, AM J PHYSIOL, V261, pH1109, DOI 10.1152/ajpheart.1991.261.4.H1109
   HOLLENBERG NK, 1974, CIRC RES, V34, P309, DOI 10.1161/01.RES.34.3.309
   HYNES MR, 1987, J PHARMACOL EXP THER, V241, P387
   IGNARRO LJ, 1989, CIRC RES, V65, P1, DOI 10.1161/01.RES.65.1.1
   KING AJ, 1991, J AM SOC NEPHROL, V1, P1271
   KOGA T, 1988, J HYPERTENS, V6, pS243, DOI 10.1097/00004872-198812040-00073
   KOMATSU K, 1995, HYPERTENSION, V25, P207, DOI 10.1161/01.HYP.25.2.207
   LEE TJF, 1987, BLOOD VESSELS, V24, P132
   MCPHERSON RW, 1995, STROKE, V26, P682, DOI 10.1161/01.STR.26.4.682
   MUNOZ DF, 1985, AM J PHYSIOL, V249, pG316
   NAKAMURA T, 1994, JPN HEART J, V35, P363
   OSHAUGHNESSY KM, 1992, EXP PHYSIOL, V77, P285, DOI 10.1113/expphysiol.1992.sp003588
   Palmer R M, 1993, Curr Opin Nephrol Hypertens, V2, P122, DOI 10.1097/00041552-199301000-00018
   RECKELHOFF JF, 1993, AM J PHYSIOL, V265, pR1126, DOI 10.1152/ajpregu.1993.265.5.R1126
   REES DD, 1989, P NATL ACAD SCI USA, V86, P3375, DOI 10.1073/pnas.86.9.3375
   SHIMIZU I, 1986, BRIT J PHARMACOL, V89, P769, DOI 10.1111/j.1476-5381.1986.tb11181.x
   TANK JE, 1994, AM J PHYSIOL, V266, pF942, DOI 10.1152/ajprenal.1994.266.6.F942
   VANHOUTTE PM, 1988, J CARDIOVASC PHARM, V12, pS11, DOI 10.1097/00005344-198806128-00004
   VANOOSTERHOUT NFM, 1995, AM J PHYSIOL-HEART C, V269, pH725, DOI 10.1152/ajpheart.1995.269.2.H725
   WAKABAYASHI I, 1990, LIFE SCI, V47, P771, DOI 10.1016/0024-3205(90)90549-7
   WALKER LA, 1983, AM J PHYSIOL, V245, pF67, DOI 10.1152/ajprenal.1983.245.1.F67
NR 34
TC 23
Z9 28
U1 0
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0931-0509
EI 1460-2385
J9 NEPHROL DIAL TRANSPL
JI Nephrol. Dial. Transplant.
PD MAR
PY 1998
VL 13
IS 3
BP 594
EP 601
DI 10.1093/ndt/13.3.594
PG 8
WC Transplantation; Urology & Nephrology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Transplantation; Urology & Nephrology
GA ZC757
UT WOS:000072614500014
PM 9550633
OA Bronze
DA 2024-02-19
ER

PT J
AU Accomando, R
   Viarengo, A
   Moore, MN
   Marchi, B
AF Accomando, R
   Viarengo, A
   Moore, MN
   Marchi, B
TI Effects of ageing on nuclear DNA integrity and metabolism in mussel
   cells (<i>Mytilus edulis</i> L)
SO INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
LA English
DT Article
DE ageing; DNA damage; DNA repair; oxidative damage; mussel
ID LIPID-PEROXIDATION; GALLOPROVINCIALIS LAM; POLYMERASE-BETA; REPAIR
   SYNTHESIS; DIGESTIVE GLAND; OXYGEN RADICALS; EXCISION REPAIR; STRAND
   BREAKS; MOUSE-BRAIN; LIVER-CELLS
AB As the age of a cell increases, so does the potential for DNA damage. Recent theories on ageing suggest accumulative DNA damage is the primary cause of cellular senescence, possibly due to the decreased ability of DNA to act as a template for gene expression.
   In this paper we investigate the effects of ageing on the level of nuclear DNA damage in tissues of wild mussels of three different age groups; 2-4 years (group I), 6-8 years (group II) and 10 years (group III). In the digestive land and haemolymph cells, a significant age-dependent increase of DNA damage was observed, as evaluated by the fluorimetric alkaline DNA unwinding technique, which is able to detect both direct single strand DNA breaks as well as alkali-labile apurinic sites.
   In addition, the rate of DNA polymerase activity was studied in order to determine whether DNA damage was dependent on DNA alteration, or because of a reduced rate of DNA repair. Unscheduled DNA repair synthesis in isolated nuclei of digestive gland cells in older mussels, was significantly decreased in comparison to younger mussels (-42% in group II and -37% in group III, p < 0.01), In the digestive gland, salt extraction gives a slight, but significant, decrease of aphidicolin-sensitive DNA polymerase activity in age group III of -25%, p < 0.05,
   Finally, we looked at the age variation in relation to oxidative stress. This was evaluated by:measuring malondialdehyde accumulation in mussel cells. Digestive gland cells of group III, showed a significant age-related increase in malondialdehyde content of 170%, p < 0.01, indicative of enhanced peroxidative processes.
   Taken together, these data suggest that the accumulation of DNA damage in group II is mainly dependent on the impairment of DNA repair systems. This is contrary to group III DNA damage, where a possible relationship between oxidative stress and alteration of nuclear DNA metabolism is found, probably deriving from an antioxidant defence decline. (C) 1999 Published by Elsevier Science Ltd. All rights reserved.
C1 Univ Genoa, Ist Fisiol Gen, I-16132 Genoa, Italy.
   Univ Turin, Dipartimento Sci & Tecnol Avanzate, Alessandria, Italy.
   Plymouth Marine Lab, NERC, CCMS, Plymouth PL1 2PB, Devon, England.
C3 University of Genoa; University of Turin; University of Eastern Piedmont
   Amedeo Avogadro; UK Research & Innovation (UKRI); Natural Environment
   Research Council (NERC); Plymouth Marine Laboratory
RP Accomando, R (corresponding author), Univ Genoa, Ist Fisiol Gen, C Europa 26, I-16132 Genoa, Italy.
OI Viarengo, Aldo/0000-0002-1557-6526
CR ACCOMANDO R, 1990, COMP BIOCHEM PHYS C, V95, P271, DOI 10.1016/0742-8413(90)90116-Q
   ACCOMANDO R, 1989, COMP BIOCHEM PHYS B, V93, P747, DOI 10.1016/0305-0491(89)90040-0
   ACCOMANDO R, 1991, INT J BIOCHEM, V23, P227, DOI 10.1016/0020-711X(91)90194-R
   AGARWAL S, 1994, P NATL ACAD SCI USA, V91, P12332, DOI 10.1073/pnas.91.25.12332
   AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   BARNETT YA, 1995, MUTAT RES-DNAGING G, V338, P115, DOI 10.1016/0921-8734(95)00017-Z
   Bayne BL., 1976, MARINE MUSSELS THEIR, P121
   BIRNBOIM HC, 1981, CANCER RES, V41, P1889
   BOHR VA, 1995, MUTAT RES-DNAGING G, V338, P25, DOI 10.1016/0921-8734(95)00008-T
   BREEN AP, 1995, FREE RADICAL BIO MED, V18, P1033, DOI 10.1016/0891-5849(94)00209-3
   BURTON K, 1956, BIOCHEMISTRY-US, V6, P315
   Canesi L, 1997, COMP BIOCHEM PHYS B, V116, P217, DOI 10.1016/S0305-0491(96)00223-4
   CHETSANGA CJ, 1977, BIOCHIM BIOPHYS ACTA, V474, P180, DOI 10.1016/0005-2787(77)90192-7
   Chicca MC, 1996, MUTAT RES-DNAGING G, V316, P201, DOI 10.1016/S0921-8734(96)90004-1
   DEAN RG, 1978, EXP GERONTOL, V13, P287, DOI 10.1016/0531-5565(78)90036-0
   DICE JF, 1993, PHYSIOL REV, V73, P149, DOI 10.1152/physrev.1993.73.1.149
   FINCH CE, 1979, AGE, V2, P45, DOI 10.1007/BF02432255
   FRAGA CG, 1988, BIOCHEM J, V252, P893, DOI 10.1042/bj2520893
   GAUBATZ JW, 1994, ANN NY ACAD SCI, V719, P97, DOI 10.1111/j.1749-6632.1994.tb56822.x
   GAUBATZ JW, 1993, MUTAT RES, V295, P81, DOI 10.1016/0921-8734(93)90004-M
   GROSSMAN L, 1981, ARCH BIOCHEM BIOPHYS, V211, P511, DOI 10.1016/0003-9861(81)90485-9
   HAMMOND RA, 1990, BIOCHEMISTRY-US, V29, P191
   HARTREE EF, 1972, ANAL BIOCHEM, V48, P422, DOI 10.1016/0003-2697(72)90094-2
   HAYFLICK L, 1985, EXP GERONTOL, V20, P145, DOI 10.1016/0531-5565(85)90032-4
   HIGAMI Y, 1994, MUTAT RES-DNAGING G, V316, P59, DOI 10.1016/0921-8734(94)90008-6
   HIGAMI Y, 1994, LAB INVEST, V71, P650
   HOLMES GE, 1992, MUTAT RES, V275, P305, DOI 10.1016/0921-8734(92)90034-M
   JONES DP, 1985, OXIDATIVE STRESS, P152
   KAUFMANN WK, 1982, BIOCHEM BIOPH RES CO, V108, P1040, DOI 10.1016/0006-291X(82)92104-0
   KING CM, 1994, MUTAT RES-DNAGING G, V316, P79, DOI 10.1016/0921-8734(94)90010-8
   LAWSON T, 1985, MECH AGEING DEV, V30, P179, DOI 10.1016/0047-6374(85)90006-5
   Mori N, 1982, Arch Gerontol Geriatr, V1, P143, DOI 10.1016/0167-4943(82)90014-0
   MULLAART E, 1988, MECH AGEING DEV, V45, P41, DOI 10.1016/0047-6374(88)90017-6
   MULLAART E, 1990, MUTAT RES, V237, P9, DOI 10.1016/0921-8734(90)90027-O
   NAKANISHI K, 1979, MECH AGEING DEV, V10, P273, DOI 10.1016/0047-6374(79)90041-1
   PACIFICI RE, 1991, GERONTOLOGY, V37, P166
   PARK IS, 1991, CELL BIOL TOXICOL, V7, P49, DOI 10.1007/BF00121329
   POPANDA O, 1992, BIOCHIM BIOPHYS ACTA, V1129, P155, DOI 10.1016/0167-4781(92)90480-N
   RANJBAR S, 1993, MUTAT RES, V285, P225, DOI 10.1016/0027-5107(93)90110-2
   RAO KS, 1994, BIOCHEM MOL BIOL INT, V34, P287
   REMACLE J, 1992, FREE RADICALS AGING, P99
   SARKER AH, 1995, MUTAT RES-DNA REPAIR, V337, P85, DOI 10.1016/0921-8777(95)00012-9
   SHUGART L, 1994, ENVIRON HEALTH PERSP, V102, P13, DOI 10.1289/ehp.94102s1213
   SINGH NP, 1991, MUTAT RES, V256, P1, DOI 10.1016/0921-8734(91)90026-8
   Sobol RW, 1996, NATURE, V379, P183, DOI 10.1038/379183a0
   SRIVASTAVA VK, 1992, BIOCHEM BIOPH RES CO, V182, P712, DOI 10.1016/0006-291X(92)91790-W
   SUMMERFIELD FW, 1984, ANAL BIOCHEM, V143, P265, DOI 10.1016/0003-2697(84)90662-6
   TARGOVNIK HS, 1985, INT J RADIAT BIOL, V47, P255, DOI 10.1080/09553008514550381
   Tice R.R., 1985, HDB BIOL AGING, P173
   TOLLEFSBOL TO, 1986, EXP GERONTOL, V21, P129, DOI 10.1016/0531-5565(86)90067-7
   TURNER DR, 1981, MECH AGEING DEV, V17, P305, DOI 10.1016/0047-6374(81)90068-3
   VACA CE, 1989, BIOCHIM BIOPHYS ACTA, V1001, P35, DOI 10.1016/0005-2760(89)90304-4
   VIARENGO A, 1989, MAR ENVIRON RES, V28, P291, DOI 10.1016/0141-1136(89)90246-8
   VIARENGO A, 1991, EXPERIENTIA, V47, P454, DOI 10.1007/BF01959942
   VIARENGO A, 1990, COMP BIOCHEM PHYS C, V97, P37, DOI 10.1016/0742-8413(90)90168-9
   WEI QY, 1993, P NATL ACAD SCI USA, V90, P1614, DOI 10.1073/pnas.90.4.1614
   WIEBAUER K, 1990, P NATL ACAD SCI USA, V87, P5842, DOI 10.1073/pnas.87.15.5842
   Wood RD, 1997, CARCINOGENESIS, V18, P605, DOI 10.1093/carcin/18.4.605
   ZAHN RK, 1987, MECH AGEING DEV, V41, P73, DOI 10.1016/0047-6374(87)90055-8
   ZONCHEDDU A, 1984, INT J BIOCHEM, V16, P39
NR 60
TC 10
Z9 10
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1357-2725
J9 INT J BIOCHEM CELL B
JI Int J. Biochem. Cell Biol.
PD MAR-APR
PY 1999
VL 31
IS 3-4
BP 443
EP 450
DI 10.1016/S1357-2725(98)00154-X
PG 8
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA 182DB
UT WOS:000079482300011
DA 2024-02-19
ER

PT J
AU Muskhelishvili, L
   Turturro, A
   Hart, RW
   James, SJ
AF Muskhelishvili, L
   Turturro, A
   Hart, RW
   James, SJ
TI pi-class glutathione-S-transferase-positive hepatocytes in aging B6C3F1
   mice undergo apoptosis induced by dietary restriction
SO AMERICAN JOURNAL OF PATHOLOGY
LA English
DT Article
ID ANDROGEN RECEPTOR GENE; PROGRAMMED CELL-DEATH; CALORIC RESTRICTION;
   RAT-LIVER; C-JUN; DEPENDENT EXPRESSION; PRENEOPLASTIC FOCI; FOOD
   RESTRICTION; CARCINOGENESIS; PROLIFERATION
AB Liver sections front aging ad libitum-fed and diet-restricted B6C3F1 male mice were evaluated immunohistochemically pi-class glutathione S-transferase (GST-II). GST-II immunostaining of hepatocytes was diffuse and occurred in periportal regions of hepatic acinus, whereas perivenous areas were weakly stained or were stain-free. Expression of GST-II was significantly diminished in diet-restricted mice in all age groups and was associated with a marked decrease in liver tumor development. As most spontaneous liver tumors were GST-II positive, it can be speculated that they developed from GST-II-positive initiated hepatocytes, To determine whether dietary restriction induces apoptosis ill GST-II-positive hepatocytes, 24-month-old ad libitum-fed mice were introduced to 40% diet restriction. After 1 week of diet restriction, a decrease in GST-II expression tons associated with a threefold increase its the frequency of apoptotic bodies as detected by terminal deoxynucleotidyl transferase-mediated d-UTP nick end labeling of DNA fragments. A two-step immunohistochemical procedure revealed that approximately 70% of apoptotic bodies were GST-II positive, These results suggest that spontaneous, potentially preneoplastic hepatocytes in tumor-prone B6C3F1 mice are eliminated by apoptosis with dietary restriction.
C1 US FDA,NATL CTR TOXICOL RES,DIV NUTR TOXICOL,JEFFERSON,AR 72079.
   US FDA,NATL CTR TOXICOL RES,DIV BIOMETRY & RISK ASSESSMENT,JEFFERSON,AR 72079.
C3 US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)
CR ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2
   BATIST G, 1986, J BIOL CHEM, V261, P5544
   BERGENDAHL M, 1992, NEUROENDOCRINOLOGY, V56, P913, DOI 10.1159/000126324
   CHIK CL, 1987, ACTA ENDOCRINOL-COP, V115, P507, DOI 10.1530/acta.0.1150507
   DRAGAN YP, 1994, CARCINOGENESIS, V15, P2587, DOI 10.1093/carcin/15.11.2587
   FUJITA T, 1991, BIOCHEM BIOPH RES CO, V178, P1485, DOI 10.1016/0006-291X(91)91061-G
   GRASLKRAUPP B, 1994, P NATL ACAD SCI USA, V91, P9995, DOI 10.1073/pnas.91.21.9995
   HATAYAMA I, 1993, CARCINOGENESIS, V14, P537, DOI 10.1093/carcin/14.3.537
   HATAYAMA I, 1986, BIOCHEM BIOPH RES CO, V140, P581, DOI 10.1016/0006-291X(86)90771-0
   JAMES SJ, 1994, CANCER RES, V54, P5508
   JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U
   KAKIZOE S, 1989, CANCER RES, V49, P3985
   KODATE C, 1986, GANN, V77, P226
   KOIZUMI A, 1989, MECH AGEING DEV, V49, P93, DOI 10.1016/0047-6374(89)90093-6
   KOUZARIDES T, 1988, NATURE, V336, P646, DOI 10.1038/336646a0
   KYPRIANOU N, 1988, ENDOCRINOLOGY, V122, P552, DOI 10.1210/endo-122-2-552
   LEDDACOLUMBANO GM, 1991, APOPTOSIS MOL BASIS, P101
   MERCILLE S, 1994, C APPL AP CAMBR HLTH
   MOOLGAVKAR SH, 1993, ENVIRON HEALTH PERSP, V101, P91, DOI 10.2307/3431848
   MOORE MA, 1987, CARCINOGENESIS, V8, P483, DOI 10.1093/carcin/8.3.483
   MUSKHELISHVILI L, 1995, AM J PATHOL, V147, P20
   NAKANO H, 1994, CARCINOGENESIS, V15, P1853, DOI 10.1093/carcin/15.9.1853
   OKUDA A, 1989, J BIOL CHEM, V264, P16919
   Poole TM, 1996, CARCINOGENESIS, V17, P191, DOI 10.1093/carcin/17.2.191
   RUGGERI B, 1991, CANCER NUTRITION HUM, P187
   RUGGERI BA, 1989, CANCER RES, V49, P4130
   SAKAI M, 1988, P NATL ACAD SCI USA, V85, P9456, DOI 10.1073/pnas.85.24.9456
   SATOH K, 1989, CARCINOGENESIS, V10, P2107, DOI 10.1093/carcin/10.11.2107
   SCHULTEHERMANN R, 1993, ENVIRON HEALTH PERSP, V101, P87, DOI 10.2307/3431847
   SCHWARTZMAN RA, 1993, ENDOCR REV, V14, P133, DOI 10.1210/er.14.2.133
   SHELDON WG, 1995, TOXICOL PATHOL, V23, P458, DOI 10.1177/019262339502300403
   SMITH GS, 1973, J NATL CANCER I, V50, P1195, DOI 10.1093/jnci/50.5.1195
   SONG CS, 1991, ENDOCRINOLOGY
   SUPAKAR PC, 1995, J BIOL CHEM, V270, P837, DOI 10.1074/jbc.270.2.837
   SUPAKAR PC, 1993, J BIOL CHEM, V268, P26400
   TERRIER P, 1990, AM J PATHOL, V137, P845
   TILLEY WD, 1989, P NATL ACAD SCI USA, V86, P327, DOI 10.1073/pnas.86.1.327
   TOMEI LD, 1994, APOPTOSIS, V2, P377
   TURTURRO A, 1994, ANN NY ACAD SCI, V719, P159, DOI 10.1111/j.1749-6632.1994.tb56827.x
   WARD JM, 1990, CANCER LETT, V52, P187, DOI 10.1016/0304-3835(90)90186-2
   WEINDRUCH R, 1991, HEMATOL ONCOL CLIN N, V5, P79, DOI 10.1016/S0889-8588(18)30455-6
   WITT WM, 1989, LAB ANIM, V18, P37
   YANGYEN HF, 1990, CELL, V62, P1205, DOI 10.1016/0092-8674(90)90396-V
NR 43
TC 22
Z9 22
U1 0
U2 0
PU AMER SOC INVESTIGATIVE PATHOLOGY, INC
PI BALTIMORE
PA 428 EAST PRESTON ST, BALTIMORE, MD 21202-3993
SN 0002-9440
J9 AM J PATHOL
JI Am. J. Pathol.
PD NOV
PY 1996
VL 149
IS 5
BP 1585
EP 1591
PG 7
WC Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology
GA VQ237
UT WOS:A1996VQ23700019
PM 8909248
DA 2024-02-19
ER

PT J
AU Hu, B
   Ding, GY
   Fu, PY
   Zhu, XD
   Ji, Y
   Shi, GM
   Shen, YH
   Cai, JB
   Yang, Z
   Zhou, J
   Fan, J
   Sun, HC
   Kuang, M
   Huang, C
AF Hu, Bo
   Ding, Guang-Yu
   Fu, Pei-Yao
   Zhu, Xiao-Dong
   Ji, Yuan
   Shi, Guo-Ming
   Shen, Ying-Hao
   Cai, Jia-Bin
   Yang, Zhen
   Zhou, Jian
   Fan, Jia
   Sun, Hui-Chuan
   Kuang, Ming
   Huang, Cheng
TI NOD-like receptor X1 functions as a tumor suppressor by inhibiting
   epithelial-mesenchymal transition and inducing aging in hepatocellular
   carcinoma cells
SO JOURNAL OF HEMATOLOGY & ONCOLOGY
LA English
DT Article
DE Hepatocellular carcinoma; NLRX1; Epithelial-mesenchymal-transition;
   Tumor suppressor; Senescence; Transition; Tumor suppressor; Senescence
ID INFLAMMATORY RESPONSES; EARLY RECURRENCE; NLRX1; SENESCENCE; EXPRESSION;
   MAVS
AB Background: This study was performed to investigate the role of nucleotide-binding oligomerization domain (NOD)-like receptor X1 (NLRX1) in regulating hepatocellular carcinoma (HCC) progression.
   Methods: Expression levels of NLRX1 in clinical specimens and cell lines were determined by reverse transcription-polymerase chain reaction (RT-PCR) and western blot (WB). Transwell assays were conducted to evaluate the effect of NLRX1 on cell invasion, and flow cytometry was used to assess apoptosis. Expression patterns of key molecules in the phosphoinositide 3-kinase (PI3K)-AKT pathways were determined via WB. The effect of NLRX1 on cell senescence was evaluated with beta-galactosidase assays. Kaplan-Meier analyses and Cox regression models were used for prognostic evaluation.
   Results: NLRX1 was downregulated in tumor tissue compared with adjacent normal liver tissue. Low tumor NLRX1 expression was identified as an independent indicator for HCC prognosis (recurrence: hazard ratio [HR] 1.87, 95% confidence interval [CI] 1.26-2.76, overall survival [OS] 2.26, 95% CI 1.44-3.56). NLRX1 over-expression (OE) significantly inhibited invasiveness ability and induced apoptosis in HCC cells. In vivo experiments showed that NLRX1 knock-down (KD) significantly promoted HCC growth. Mechanistically, NLRX1 exhibited a suppressor function by decreasing phosphorylation of AKT and thus downregulating Snail1 expression, which inhibited epithelial-mesenchymal-transition (EMT) in HCC cells. Moreover, NLRX1 OE could induce cell senescence via an AKT-P21-dependent manner.
   Conclusions: NLRX1 acted as a tumor suppressor in HCC by inducing apoptosis, promoting senescence, and decreasing invasiveness by repressing PI3K-AKT signaling pathway. Future investigations will focus on restoring expression of NLRX1 to provide new insights into HCC treatment.
C1 [Hu, Bo; Ding, Guang-Yu; Fu, Pei-Yao; Zhu, Xiao-Dong; Shi, Guo-Ming; Shen, Ying-Hao; Cai, Jia-Bin; Zhou, Jian; Fan, Jia; Sun, Hui-Chuan; Huang, Cheng] Fudan Univ, Liver Canc Inst, Dept Liver Surg & Transplant, 136 Yi Xue Yuan Rd, Shanghai 200032, Peoples R China.
   [Hu, Bo; Ding, Guang-Yu; Fu, Pei-Yao; Zhu, Xiao-Dong; Shi, Guo-Ming; Shen, Ying-Hao; Cai, Jia-Bin; Zhou, Jian; Fan, Jia; Sun, Hui-Chuan; Huang, Cheng] Fudan Univ, Zhongshan Hosp, 136 Yi Xue Yuan Rd, Shanghai 200032, Peoples R China.
   [Hu, Bo; Ding, Guang-Yu; Fu, Pei-Yao; Zhu, Xiao-Dong; Shi, Guo-Ming; Shen, Ying-Hao; Cai, Jia-Bin; Zhou, Jian; Fan, Jia; Sun, Hui-Chuan; Huang, Cheng] Chinese Minist Educ, Key Lab Carcinogenesis & Canc Invas, Shanghai, Peoples R China.
   [Ji, Yuan] Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai, Peoples R China.
   [Kuang, Ming] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Liver Surg, 58 Zhong Shan Rd 2, Guangzhou 510080, Guangdong, Peoples R China.
   [Yang, Zhen] CAS MPG Partner Inst Computat Biol, Key Lab Computat Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.
C3 Fudan University; Fudan University; Fudan University; Sun Yat Sen
   University; Chinese Academy of Sciences; Max Planck Society
RP Huang, C (corresponding author), Fudan Univ, Liver Canc Inst, Dept Liver Surg & Transplant, 136 Yi Xue Yuan Rd, Shanghai 200032, Peoples R China.; Huang, C (corresponding author), Fudan Univ, Zhongshan Hosp, 136 Yi Xue Yuan Rd, Shanghai 200032, Peoples R China.; Kuang, M (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Liver Surg, 58 Zhong Shan Rd 2, Guangzhou 510080, Guangdong, Peoples R China.
EM kuangm@mail.sysu.edu.cn; huang.cheng@zs-hospital.sh.cn
RI feng, chen/JLM-8296-2023; Jiang, Tao/IWM-7503-2023; ZHAO,
   S/IWV-4219-2023; Li, Tao/IWU-9607-2023; sheng, chen/JEO-8801-2023; Fan,
   Jia/C-6689-2017; Ding, guangyu/HQZ-7051-2023; shen, ying/HHS-5635-2022
OI Sun, Hui-Chuan/0000-0003-3761-7058; Zhou, Jian/0000-0002-7650-7540
FU National Natural Science Foundation of China [81572298, 81502006]
FX This study was supported by the National Natural Science Foundation of
   China (No. 81572298 and No. 81502006).
CR Allen IC, 2011, IMMUNITY, V34, P854, DOI 10.1016/j.immuni.2011.03.026
   Ally A, 2017, CELL, V169, P1327, DOI 10.1016/j.cell.2017.05.046
   Bruix J, 2016, GASTROENTEROLOGY, V150, P835, DOI 10.1053/j.gastro.2015.12.041
   Chai ZT, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-015-0150-4
   Coutermarsh-Ott S, 2016, ONCOTARGET, V7, P33096, DOI 10.18632/oncotarget.8861
   Désert R, 2017, HEPATOLOGY, V66, P1502, DOI 10.1002/hep.29254
   Eitas TK, 2014, J BIOL CHEM, V289, P4173, DOI 10.1074/jbc.M113.533034
   Feng H, 2017, NAT IMMUNOL, V18, P1299, DOI 10.1038/ni.3853
   Finn RS, 2018, HEPATOLOGY, V67, P422, DOI 10.1002/hep.29486
   Gerbes A, 2018, GUT, V67, P380, DOI 10.1136/gutjnl-2017-315068
   Jayachandran A, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0307-9
   Jiang LX, 2017, HEPATOLOGY, V66, P1529, DOI 10.1002/hep.29312
   Kaji K, 2018, INT J CANCER, V142, P1712, DOI 10.1002/ijc.31193
   Ko E, 2018, HEPATOLOGY, V67, P1378, DOI 10.1002/hep.29604
   Kobayashi T, 2017, HEPATOB PANCREAT DIS, V16, P279, DOI 10.1016/S1499-3872(16)60181-9
   Koblansky AA, 2016, CELL REP, V14, P2562, DOI 10.1016/j.celrep.2016.02.064
   Kolly P, 2017, J HEPATOL, V67, P876, DOI 10.1016/j.jhep.2017.07.007
   Leber A, 2017, J IMMUNOL, V198, P2260, DOI 10.4049/jimmunol.1601547
   Lei Y, 2016, ONCOGENE, V35, P4698, DOI 10.1038/onc.2016.11
   Lei Y, 2012, IMMUNITY, V36, P933, DOI 10.1016/j.immuni.2012.03.025
   Li D, 2016, HEPATOLOGY, V64, P1105, DOI [10.1002/hep.28637, 10.1002/hep.28837]
   Li HY, 2016, MOL IMMUNOL, V76, P90, DOI 10.1016/j.molimm.2016.06.013
   Liang Y, 2018, HEPATOLOGY, V67, P1807, DOI 10.1002/hep.29661
   Lupfer C, 2013, IMMUNOL REV, V255, P13, DOI 10.1111/imr.12089
   Ma JL, 2017, CANCER LETT, V411, P117, DOI [10.1016/j.canlet.2017.09.041, 10.1016/j.canlet.2017.10.026]
   Mohan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034561
   Nault JC, 2018, J HEPATOL, V68, P783, DOI 10.1016/j.jhep.2017.10.004
   Peng JM, 2018, HEPATOLOGY, V67, P2226, DOI 10.1002/hep.29678
   Siegel RL, 2017, CA-CANCER J CLIN, V67, P7
   Sun YF, 2018, CLIN CANCER RES, V24, P547, DOI 10.1158/1078-0432.CCR-17-1063
   Tattoli I, 2016, CELL REP, V14, P2576, DOI 10.1016/j.celrep.2016.02.065
   Wan S, 2018, HEPATOLOGY, V67, P1842, DOI 10.1002/hep.29669
   Wan Y, 2017, HEPATOLOGY, V66, P528, DOI 10.1002/hep.29138
   Wang XK, 2017, CANCER MED-US, V6, P2660, DOI 10.1002/cam4.1202
   Wu H, 2017, HEPATOLOGY, V66, P1952, DOI 10.1002/hep.29374
   Xia XJ, 2011, IMMUNITY, V34, P843, DOI 10.1016/j.immuni.2011.02.022
   Zhang YL, 2016, HEPATOLOGY, V63, P880, DOI 10.1002/hep.28395
   Zhou SL, 2015, CANCER LETT, V358, P124, DOI 10.1016/j.canlet.2014.11.044
NR 38
TC 33
Z9 36
U1 0
U2 5
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1756-8722
J9 J HEMATOL ONCOL
JI J. Hematol. Oncol.
PD FEB 26
PY 2018
VL 11
AR 28
DI 10.1186/s13045-018-0573-9
PG 13
WC Oncology; Hematology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Hematology
GA HM8SH
UT WOS:000459750700001
PM 29482578
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Bhullar, KS
   Wu, JP
AF Bhullar, Khushwant S.
   Wu, Jianping
TI Dietary peptides in aging: Evidence and prospects
SO FOOD SCIENCE AND HUMAN WELLNESS
LA English
DT Article
DE Dietary peptides; Anti-aging; Aging biomarkers
ID HEPATIC INSULIN-RESISTANCE; BIOACTIVE PEPTIDES; LIFE-SPAN; IN-VITRO;
   PHASEOLUS-VULGARIS; GLUCOSE-UPTAKE; HEPG2 CELLS; SUPEROXIDE-DISMUTASE;
   ANTIOXIDANT ACTIVITY; INHIBITORY PEPTIDES
AB With improvements in healthcare and lifestyle, the proportion of the aging population is rising steadily across the world. Many physiological functions are altered during aging and resemble those occurring in disease conditions involving metabolic and mitochondrial disturbances. Thus, there is an urge to better develop dietary or medicinal interventions targeting the mechanisms underlying aging and aging-related diseases. Many reports indicate that in geroscience, dietary interventions such as bioactive peptides to slow aging are a matter of 'when' rather than 'if'. Leading targets for peptides include the metabolic-mitochondrial pathway accompanied by improved nutrient sensing. Modulation of these pathways diminish aging biomarkers in various model organisms and confers protection against a growing list of age-related pathophysiologies. Food derived bioactive peptides are characterized modulators of these pathways, while some verified in vivo and even clinically approved, and numerous others are under development. This brief review focuses on the latest scientific advances in understanding the anti-aging ability of bioactive peptides as well as delineates the possible future directions in this process. (C) 2020 "Society information". Production and hosting by Elsevier B.V. on behalf of KeAi Communications Co., Ltd.
C1 [Bhullar, Khushwant S.; Wu, Jianping] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada.
   [Bhullar, Khushwant S.] Univ Alberta, Dept Pharmacol, Edmonton, AB, Canada.
C3 University of Alberta; University of Alberta
RP Wu, JP (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada.
EM jwu3@ualberta.ca
RI Wu, Jian/AAU-5221-2020; Wu, Jian/AAU-5221-2020
OI Wu, Jian/0000-0001-9933-7364; Wu, Jian/0000-0002-3394-1507
FU Natural Sciences and Engineering Research Council of Canada (NSERC)
FX This work is funded by Natural Sciences and Engineering Research Council
   of Canada (NSERC).
CR Aiello G, 2018, J FUNCT FOODS, V45, P363, DOI 10.1016/j.jff.2018.04.023
   Aoyama T, 2000, BIOSCI BIOTECH BIOCH, V64, P2594, DOI 10.1271/bbb.64.2594
   Aubert G, 2008, PHYSIOL REV, V88, P557, DOI 10.1152/physrev.00026.2007
   BELL G, 1984, AM NAT, V124, P600, DOI 10.1086/284300
   Beltrán-Sánchez H, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a025957
   Ben Henda Y, 2015, J FUNCT FOODS, V17, P1, DOI 10.1016/j.jff.2015.04.050
   Bouglé D, 2017, CRIT REV FOOD SCI, V57, P335, DOI 10.1080/10408398.2013.873766
   Carmen I., 2019, CHOLESTEROL DUCING F
   Carrico C, 2018, CELL METAB, V27, P497, DOI 10.1016/j.cmet.2018.01.016
   Coelho MS, 2018, PLANT FOOD HUM NUTR, V73, P101, DOI 10.1007/s11130-018-0668-z
   Corrochano AR, 2019, FOOD CHEM, V288, P306, DOI 10.1016/j.foodchem.2019.03.009
   Craige SM, 2016, SCI REP-UK, V6, DOI 10.1038/srep38210
   Crimmins E.M., 2019, ANN REV SOCIOL, V45
   Escudero E, 2013, FOOD CHEM, V138, P1282, DOI 10.1016/j.foodchem.2012.10.133
   Fields K, 2009, J COSMET DERMATOL-US, V8, P8, DOI 10.1111/j.1473-2165.2009.00416.x
   Finkel T, 2015, NAT MED, V21, P1416, DOI 10.1038/nm.3998
   Fraga MF, 2007, TRENDS GENET, V23, P413, DOI 10.1016/j.tig.2007.05.008
   Franceschi C, 2000, ANN NY ACAD SCI, V908, P244
   FRIEDMAN DB, 1988, GENETICS, V118, P75
   Gallego M, 2018, FOOD CHEM, V258, P8, DOI 10.1016/j.foodchem.2018.03.035
   Gallego M, 2018, FOOD RES INT, V105, P873, DOI 10.1016/j.foodres.2017.12.006
   Galvez AF, 2012, IDENTIFICATION LUNAS
   García-Mora P, 2017, FOOD CHEM, V221, P464, DOI 10.1016/j.foodchem.2016.10.087
   Girgih AT, 2014, J FUNCT FOODS, V6, P384, DOI 10.1016/j.jff.2013.11.005
   Gong E, 2019, J HEALTH ECON, V67, DOI 10.1016/j.jhealeco.2019.06.006
   Gong F, 2019, MAR DRUGS, V17, DOI 10.3390/md17040244
   Gorouhi F., 2009, International Journal of Cosmetic Science, V31, P327, DOI 10.1111/j.1468-2494.2009.00490.x
   Haber C, 2004, J GERONTOL A-BIOL, V59, P515, DOI 10.1093/gerona/59.6.B515
   Han BK, 2016, J SCI FOOD AGR, V96, P116, DOI 10.1002/jsfa.7067
   Han S, 2012, TRENDS CELL BIOL, V22, P42, DOI 10.1016/j.tcb.2011.11.001
   Haque E, 2009, FOOD REV INT, V25, P28, DOI 10.1080/87559120802458198
   Harraan D., 1955, Aging: A theory based on free radical and radiation chemistry
   HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094
   Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622
   Imai S, 2014, TRENDS CELL BIOL, V24, P464, DOI 10.1016/j.tcb.2014.04.002
   Jakubczyk A, 2017, FOOD RES INT, V100, P489, DOI 10.1016/j.foodres.2017.07.046
   Jemil I, 2016, FOOD RES INT, V89, P347, DOI 10.1016/j.foodres.2016.08.020
   Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318
   Jones DP, 2015, REDOX BIOL, V5, P71, DOI 10.1016/j.redox.2015.03.004
   Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570
   Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815
   Kashima Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105073
   KENNEDY BK, 1995, CELL, V80, P485, DOI 10.1016/0092-8674(95)90499-9
   KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0
   Khavinson VK, 2016, B EXP BIOL MED+, V160, P347, DOI 10.1007/s10517-016-3167-y
   Kitts DD, 2003, CURR PHARM DESIGN, V9, P1309, DOI 10.2174/1381612033454883
   Lammi C, 2016, J AGR FOOD CHEM, V64, P9601, DOI 10.1021/acs.jafc.6b04041
   Lammi C, 2016, J FUNCT FOODS, V23, P230, DOI 10.1016/j.jff.2016.02.042
   Lammi C, 2015, INT J MOL SCI, V16, P27362, DOI 10.3390/ijms161126029
   Lammi C, 2015, J AGR FOOD CHEM, V63, P7945, DOI 10.1021/acs.jafc.5b03497
   Lammi C, 2015, J FUNCT FOODS, V14, P469, DOI 10.1016/j.jff.2015.02.021
   Lee MK, 2019, MAR DRUGS, V17, DOI 10.3390/md17050284
   Li SS, 2018, FOOD FUNCT, V9, P42, DOI 10.1039/c7fo01323j
   Li XJ, 2018, MAR DRUGS, V16, DOI 10.3390/md16090325
   Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126
   Lo HY, 2016, FOOD CHEM, V204, P298, DOI 10.1016/j.foodchem.2016.02.135
   Lu JL, 2012, J NUTR BIOCHEM, V23, P1449, DOI 10.1016/j.jnutbio.2011.09.007
   Maegawa S, 2010, GENOME RES, V20, P332, DOI 10.1101/gr.096826.109
   Majumder K, 2011, FOOD CHEM, V126, P1614, DOI 10.1016/j.foodchem.2010.12.039
   Majumder K, 2010, FOOD RES INT, V43, P1371, DOI 10.1016/j.foodres.2010.04.027
   Mannick JB, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009892
   Soares RAM, 2015, INT J MOL SCI, V16, P4150, DOI 10.3390/ijms16024150
   Marques MR, 2015, FOOD CHEM, V168, P288, DOI 10.1016/j.foodchem.2014.07.049
   McCay CM, 1939, J NUTR, V18, P1
   McDonagh M, 2016, J MANAG CARE SPEC PH, V22, P641, DOI 10.18553/jmcp.2016.22.6.641
   Medawar P., 1952, UNSOLVED PROBLEM BIO
   Moayedi A, 2017, APPL BIOCHEM BIOTECH, V181, P48, DOI 10.1007/s12010-016-2198-1
   Mojica L, 2017, J SCI FOOD AGR, V97, P2401, DOI 10.1002/jsfa.8053
   Mojica L, 2017, J FUNCT FOODS, V31, P274, DOI 10.1016/j.jff.2017.02.006
   Möller NP, 2008, EUR J NUTR, V47, P171, DOI 10.1007/s00394-008-0710-2
   Mudgil P, 2018, FOOD CHEM, V259, P46, DOI 10.1016/j.foodchem.2018.03.082
   Nesic35 D., 2018, AGING HUM RIGHTS, V82
   North BJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-224
   Olshansky SJ, 2002, SCI AM, V286, P92, DOI 10.1038/scientificamerican0602-92
   Omodei D, 2011, FEBS LETT, V585, P1537, DOI 10.1016/j.febslet.2011.03.015
   Toledo ME, 2016, J FUNCT FOODS, V27, P160, DOI 10.1016/j.jff.2016.09.001
   Oseguera-Toledo ME, 2015, FOOD RES INT, V76, P839, DOI 10.1016/j.foodres.2015.07.046
   Ozanne SE, 2004, NATURE, V427, P411, DOI 10.1038/427411b
   Pak VV, 2005, CHEM NAT COMPD+, V41, P710, DOI 10.1007/s10600-006-0017-6
   Pal S, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600584
   Pan H, 2017, J BIOL CHEM, V292, P6452, DOI 10.1074/jbc.R116.771915
   Park Sun-Jae, 2007, Entomological Research, V37, P19, DOI 10.1111/j.1748-5967.2007.00046.x
   Paul A, 2007, MECH AGEING DEV, V128, P706, DOI 10.1016/j.mad.2007.10.013
   Ren Y, 2016, J FUNCT FOODS, V26, P439, DOI 10.1016/j.jff.2016.07.024
   Ribaric S, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/741468
   Richardson B, 2003, AGEING RES REV, V2, P245, DOI 10.1016/S1568-1637(03)00010-2
   Rizzello CG, 2017, INT J FOOD MICROBIOL, V241, P252, DOI 10.1016/j.ijfoodmicro.2016.10.035
   Roblet C, 2014, FOOD CHEM, V147, P124, DOI 10.1016/j.foodchem.2013.09.108
   Rocha TD, 2015, FOOD RES INT, V76, P150, DOI 10.1016/j.foodres.2015.04.041
   ROSE M, 1980, NATURE, V287, P141, DOI 10.1038/287141a0
   Salminen A, 2012, AGEING RES REV, V11, P230, DOI 10.1016/j.arr.2011.12.005
   Serrano M, 2017, NEW ENGL J MED, V376, P1083, DOI 10.1056/NEJMcibr1615878
   Shen WL, 2017, FOOD FUNCT, V8, P4306, DOI [10.1039/c7fo01185g, 10.1039/C7FO01185G]
   Shi M, 2019, J FUNCT FOODS, V56, P92, DOI 10.1016/j.jff.2019.03.002
   Shi W, 2019, J FUNCT FOODS, V54, P136, DOI 10.1016/j.jff.2019.01.001
   Shrikant Sharma, 2011, International Journal BIOAutomation, V15, P223
   Sniderman AD, 2008, LANCET, V371, P1547, DOI 10.1016/s0140-6736(08)60313-x
   Son MJ, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201700602
   Song JJ, 2018, J FUNCT FOODS, V45, P190, DOI 10.1016/j.jff.2018.03.044
   Song JJ, 2017, J FUNCT FOODS, V31, P287, DOI 10.1016/j.jff.2017.02.005
   Sun JT, 2002, GENETICS, V161, P661
   Tachibana N, 2014, NUTR RES, V34, P160, DOI 10.1016/j.nutres.2013.12.001
   Takemori K, 2015, LIFE SCI, V120, P48, DOI 10.1016/j.lfs.2014.10.011
   Talens RP, 2012, AGING CELL, V11, P694, DOI 10.1111/j.1474-9726.2012.00835.x
   van de Ven RAH, 2017, TRENDS MOL MED, V23, P320, DOI 10.1016/j.molmed.2017.02.005
   WARNER HR, 1994, FREE RADICAL BIO MED, V17, P249, DOI 10.1016/0891-5849(94)90080-9
   Yang H, 2019, PROCEEDINGS OF THE 28TH USENIX SECURITY SYMPOSIUM, P55
   You LJ, 2011, FOOD CHEM, V124, P188, DOI 10.1016/j.foodchem.2010.06.007
   Yuan Q, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00225
   Zambrowicz A, 2015, AMINO ACIDS, V47, P369, DOI 10.1007/s00726-014-1869-x
   Zanoni C, 2017, J AGR FOOD CHEM, V65, P8829, DOI 10.1021/acs.jafc.7b02742
   Zanoni C, 2017, J FUNCT FOODS, V32, P1, DOI 10.1016/j.jff.2017.02.009
   Zhang RL, 2019, MOLECULES, V24, DOI 10.3390/molecules24193527
   Zhao S., 2019, SCI REP, V9, p1 13, DOI DOI 10.1038/s41598-018-37186-2
NR 114
TC 19
Z9 20
U1 2
U2 27
PU KEAI PUBLISHING LTD
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING, DONGHENG DISTRICT 100717,
   PEOPLES R CHINA
EI 2213-4530
J9 FOOD SCI HUM WELL
JI Food Sci. Human Wellness
PD MAR
PY 2020
VL 9
IS 1
BP 1
EP 7
DI 10.1016/j.fshw.2020.01.001
PG 7
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Food Science & Technology; Nutrition & Dietetics
GA KW0GO
UT WOS:000520851800001
OA gold
DA 2024-02-19
ER

PT J
AU Wang, Z
   Li, YJ
   Wu, DL
   Yu, S
   Wang, YL
   Chan, FL
AF Wang, Zhu
   Li, Youjia
   Wu, Dinglan
   Yu, Shan
   Wang, Yuliang
   Chan, Franky Leung
TI Nuclear receptor HNF4α performs a tumor suppressor function in prostate
   cancer via its induction of p21-driven cellular senescence
SO ONCOGENE
LA English
DT Article
ID TRANSCRIPTION FACTOR; FACTOR 4-ALPHA; GENE-EXPRESSION; EPITHELIAL-CELLS;
   THERAPEUTIC TARGET; ANDROGEN RECEPTOR; FACTOR-4-ALPHA; PROLIFERATION;
   PROMOTES; GROWTH
AB Hepatocyte nuclear factor 4 alpha (HNF4 alpha, NR2A1) is a highly conserved member of the nuclear receptor superfamily. Recent advances reveal that it is a key transcriptional regulator of genes, broadly involved in xenobiotic and drug metabolism and also cancers of gastrointestinal tract. However, the exact functional roles of HNF4 alpha in prostate cancer progression are still not fully understood. In this study, we determined the functional significance of HNF4 alpha in prostate cancer. Our results showed that HNF4 alpha exhibited a reduced expression pattern in clinical prostate cancer tissues, prostate cancer cell lines and xenograft model of castration-relapse prostate cancer. Stable HNF4 alpha knockdown not only could promote cell proliferation and suppress doxorubicin (Dox)-induced cellular senescence in prostate cancer cells, but also confer resistance to paclitaxel treatment and enhance colony formation capacity and in vivo tumorigenicity of prostate cancer cells. On the contrary, ectopic overexpression of HNF4 alpha could significantly inhibit the cell proliferation of prostate cancer cells, induce cell-cycle arrest at G(2)/M phase and trigger the cellular senescence in prostate cancer cells by activation of p21 signal pathway in a p53-independent manner via its direct transactivation of CDKN1A. Together, our results show that HNF4 alpha performs a tumor suppressor function in prostate cancer via a mechanism of p21-driven cellular senescence.
C1 [Wang, Zhu] Southern Med Univ, Peoples Hosp Longhua, Dept Urol, Shenzhen 518109, Guangdong, Peoples R China.
   [Wang, Zhu; Li, Youjia; Wu, Dinglan; Yu, Shan; Wang, Yuliang; Chan, Franky Leung] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Peoples R China.
C3 Southern Medical University - China; The People's Hospital of Longhua,
   Shenzhen; Chinese University of Hong Kong
RP Wang, YL; Chan, FL (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Peoples R China.
EM yuliang.wang816@gmail.com; franky-chan@cuhk.edu.hk
OI Wang, Yuliang/0000-0001-6975-4503; Wu, Dinglan/0000-0002-5057-9626;
   Wang, Zhu/0000-0002-5457-3731
FU CUHK [2015.1.064]; Research Grants Council of Hong Kong [461012];
   Shenzhen Science and Technology Program (Basic Research Project)
   [JCYJ20180228163919346]
FX This work was supported by a Direct Grant for Research 2015-2016 from
   CUHK (grant no. 2015.1.064), a General Research Fund (project number
   461012) from the Research Grants Council of Hong Kong (to Chan FL), and
   Shenzhen Science and Technology Program (Basic Research Project; project
   number JCYJ20180228163919346 to ZW)
CR Ahn SH, 2008, INFLAMM BOWEL DIS, V14, P908, DOI 10.1002/ibd.20413
   Alimonti A, 2010, J CLIN INVEST, V120, P681, DOI 10.1172/JCI40535
   Attard G, 2016, LANCET, V387, P70, DOI 10.1016/S0140-6736(14)61947-4
   Barrett JC, 2009, NAT GENET, V41, P1330, DOI 10.1038/ng.483
   Bonzo JA, 2012, J BIOL CHEM, V287, P7345, DOI 10.1074/jbc.M111.334599
   Cairns P, 1997, CANCER RES, V57, P4997
   CHARTIER FL, 1994, GENE, V147, P269, DOI 10.1016/0378-1119(94)90079-5
   Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918
   Cheung CP, 2005, J CLIN ENDOCR METAB, V90, P1830, DOI 10.1210/jc.2004-1421
   Chiba H, 2005, EXP CELL RES, V302, P11, DOI 10.1016/j.yexcr.2004.08.014
   Chu JH, 2009, PROSTATE, V69, P428, DOI 10.1002/pros.20897
   Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772
   Darsigny M, 2010, CANCER RES, V70, P9423, DOI 10.1158/0008-5472.CAN-10-1697
   Darsigny M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007609
   Dhe-Paganon S, 2002, J BIOL CHEM, V277, P37973, DOI 10.1074/jbc.C200420200
   Drewa T., 2010, Experimental Oncology, V32, P228
   Duncan SA, 1997, DEVELOPMENT, V124, P279
   Erdmann S, 2007, BIOL CHEM, V388, P91, DOI 10.1515/BC.2007.011
   Grigo K, 2008, BIOL CHEM, V389, P179, DOI 10.1515/BC.2008.011
   Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001
   Hertz R, 1998, NATURE, V392, P512, DOI 10.1038/33185
   Hwang-Verslues WW, 2010, CURR OPIN PHARMACOL, V10, P698, DOI 10.1016/j.coph.2010.08.010
   Lazarevich N, 2004, HEPATOLOGY, V39, P1038, DOI 10.1002/hep.20155
   Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943
   Li JX, 2000, GENE DEV, V14, P464
   Loaiza N, 2016, BBA-REV CANCER, V1865, P155, DOI 10.1016/j.bbcan.2016.01.007
   Lucas B, 2005, ONCOGENE, V24, P6418, DOI 10.1038/sj.onc.1208794
   Marcil V, 2012, GENES IMMUN, V13, P556, DOI 10.1038/gene.2012.37
   MIQUEROL L, 1994, J BIOL CHEM, V269, P8944
   Moschini M, 2017, EUR UROL, V72, P238, DOI 10.1016/j.eururo.2017.03.009
   Muller M, 2009, ANTIOXID REDOX SIGN, V11, P59, DOI 10.1089/ars.2008.2104
   Nanni S, 2006, MOL CANCER RES, V4, P79, DOI 10.1158/1541-7786.MCR-05-0098
   Ning BF, 2010, CANCER RES, V70, P7640, DOI 10.1158/0008-5472.CAN-10-0824
   Olsen CL, 2002, ONCOGENE, V21, P6328, DOI 10.1038/sj.onc.1205780
   Oshima T, 2007, PATHOL INT, V57, P82, DOI 10.1111/j.1440-1827.2006.02061.x
   Parviz F, 2003, NAT GENET, V34, P292, DOI 10.1038/ng1175
   Pihlajamaa P, 2014, EMBO J, V33, P312, DOI 10.1002/embj.201385895
   Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112
   Rieck S, 2012, MOL ENDOCRINOL, V26, P1590, DOI 10.1210/me.2012-1019
   Sel S, 1996, CANCER LETT, V101, P205, DOI 10.1016/0304-3835(96)04136-5
   Sharma S, 2010, PATHOLOGY, V42, P507, DOI 10.3109/00313025.2010.508791
   SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353
   Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356
   STEPHENSON RA, 1992, J NATL CANCER I, V84, P951, DOI 10.1093/jnci/84.12.951
   Sugai M, 2008, PATHOL INT, V58, P681, DOI 10.1111/j.1440-1827.2008.02293.x
   Sugano M, 2013, AM J SURG PATHOL, V37, P211, DOI 10.1097/PAS.0b013e31826be303
   Tanaka T, 2006, J PATHOL, V208, P662, DOI 10.1002/path.1928
   Tang DG, 2001, SCIENCE, V291, P868, DOI 10.1126/science.1056780
   THALMANN GN, 1994, CANCER RES, V54, P2577
   Walesky C, 2013, HEPATOLOGY, V57, P2480, DOI 10.1002/hep.26251
   Walesky C, 2013, AM J PHYSIOL-GASTR L, V304, pG26, DOI 10.1152/ajpgi.00064.2012
   Wallace TA, 2008, CANCER RES, V68, P927, DOI 10.1158/0008-5472.CAN-07-2608
   Wang Z, 2018, ENDOCR-RELAT CANCER, V25, P35, DOI 10.1530/ERC-17-0280
   Wisely GB, 2002, STRUCTURE, V10, P1225, DOI 10.1016/S0969-2126(02)00829-8
   Wu DL, 2015, J PATHOL, V236, P103, DOI 10.1002/path.4505
   Xiang X, 2015, CANCER LETT, V359, P187, DOI 10.1016/j.canlet.2015.01.008
   Xiao LJ, 2018, CANCER RES, V78, P2205, DOI 10.1158/0008-5472.CAN-17-2341
   Xu L, 2001, CANCER RES, V61, P3176
   Yamagata K, 2014, VITAM HORM, V95, P407, DOI 10.1016/B978-0-12-800174-5.00016-8
   Yu S, 2008, ONCOGENE, V27, P3313, DOI 10.1038/sj.onc.1210986
   Yu SA, 2007, CANCER RES, V67, P4904, DOI 10.1158/0008-5472.CAN-06-3855
   Yu S, 2014, J PATHOL, V234, P514, DOI 10.1002/path.4413
   Yu S, 2013, CANCER LETT, V328, P83, DOI 10.1016/j.canlet.2012.09.006
   Yu S, 2009, BIOCHEM BIOPH RES CO, V382, P756, DOI 10.1016/j.bbrc.2009.03.110
   Yusuf D, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r24
   Zou C, 2014, J PATHOL, V233, P61, DOI 10.1002/path.4329
NR 66
TC 28
Z9 28
U1 1
U2 5
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0950-9232
EI 1476-5594
J9 ONCOGENE
JI Oncogene
PD FEB
PY 2020
VL 39
IS 7
BP 1572
EP 1589
DI 10.1038/s41388-019-1080-3
PG 18
WC Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics &
   Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics &
   Heredity
GA KL2WP
UT WOS:000513289600013
PM 31695151
OA hybrid, Green Published
DA 2024-02-19
ER

PT J
AU Rocha, EM
   Carvalho, CRO
   Saad, MJA
   Velloso, LA
AF Rocha, EM
   Carvalho, CRO
   Saad, MJA
   Velloso, LA
TI The influence of ageing on the insulin signalling system in rat lacrimal
   and salivary glands
SO ACTA OPHTHALMOLOGICA SCANDINAVICA
LA English
DT Article
DE ageing; insulin receptor; lacrimal gland; salivary gland; tyrosine
   kinase
ID TYROSINE PHOSPHORYLATION; SENSITIVE TISSUES; RECEPTOR KINASE; TEAR FILM;
   PROTEIN; SHC; TRANSDUCTION; PATHWAY; GENDER; LIVER
AB Purpose: Ageing adversely affects the structure and function of lacrimal and salivary glands (LG and SG) and leads to marked insulin resistance that correlates with reduced insulin signal transduction. The aim of this study was to investigate whether ageing affects insulin signal transduction in LG and SG in vivo.
   Methods: Male Wistar rats aged 20 months and 2 months (control group) were compared (n = 8/group). Samples were removed under anaesthesia after i.v. injection of insulin, homogenized, immunoprecipitated with anti-insulin receptor (IR), Shc and STAT-1 antibodies and immunoblotted with antiphosphotyrosine antibody.
   Results: The 20-month-old rats were significantly hyperinsulinaemic and presented a reduced rate of blood glucose disappearance in response to insulin, compared to the 2-month-old rats. The level of phosphorylation determined by densitometry in the older group of rats showed that ageing significantly reduced insulin-induced IR phosphorylation in LG and SG and STAT-1 phosphorylation in SG, compared to in the control group, but did not alter Shc phosphorylation.
   Conclusions: Ageing influences insulin signal transduction in the LG and SG of rats. Considering the major anabolic actions of insulin, these observations may help to explain the mechanisms of LG and SG dysfunctions observed in ageing.
C1 Univ Estadual Campinas, Fac Ciencias Med, Dept Clin Med, Lab Fisiopatol Med, BR-13081970 Campinas, SP, Brazil.
   Univ Sao Paulo, ICB, Dept Physiol, BR-09500900 Sao Paulo, Brazil.
C3 Universidade Estadual de Campinas; Universidade de Sao Paulo
RP Rocha, EM (corresponding author), Univ Estadual Campinas, Fac Ciencias Med, Dept Clin Med, Lab Fisiopatol Med, BR-13081970 Campinas, SP, Brazil.
EM emrocha@unicamp.br
RI Saad, Mario/ABD-8262-2020; Rocha, Eduardo Melani/D-6002-2011; Velloso,
   Licio/AAJ-3778-2020; Carvalho, Carla R. O./H-6476-2018
OI Rocha, Eduardo Melani/0000-0001-9888-7313; Carvalho, Carla R.
   O./0000-0001-5824-8656
CR Bach ME, 1999, P NATL ACAD SCI USA, V96, P5280, DOI 10.1073/pnas.96.9.5280
   BAUM BJ, 1982, MECH AGEING DEV, V19, P27, DOI 10.1016/0047-6374(82)90047-1
   BROMBERG BB, 1985, EXP EYE RES, V40, P313, DOI 10.1016/0014-4835(85)90015-6
   CARRASCOSA JM, 1989, BIOCHEM BIOPH RES CO, V160, P303, DOI 10.1016/0006-291X(89)91656-2
   Carvalho CRO, 1996, ENDOCRINOLOGY, V137, P151, DOI 10.1210/en.137.1.151
   Chuang LM, 1997, BIOCHEM BIOPH RES CO, V235, P317, DOI 10.1006/bbrc.1997.6771
   Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803
   DAMATO BE, 1984, BRIT J OPHTHALMOL, V68, P674, DOI 10.1136/bjo.68.9.674
   DIGUGLIELMO GM, 1994, EMBO J, V13, P4269, DOI 10.1002/j.1460-2075.1994.tb06747.x
   Dogru M, 2001, OPHTHALMOLOGY, V108, P586, DOI 10.1016/S0161-6420(00)00599-6
   Emanuelli B, 2000, J BIOL CHEM, V275, P15985, DOI 10.1074/jbc.275.21.15985
   Evans JL, 2002, ENDOCR REV, V23, P599, DOI 10.1210/er.2001-0039
   Frölich L, 1998, J NEURAL TRANSM, V105, P423, DOI 10.1007/s007020050068
   HANN LE, 1991, INVEST OPHTH VIS SCI, V32, P2610
   HANN LE, 1988, ACTA OPHTHALMOL, V66, P87
   Haspel RL, 1996, EMBO J, V15, P6262, DOI 10.1002/j.1460-2075.1996.tb01016.x
   ISHIZUKA T, 1993, METABOLISM, V42, P420, DOI 10.1016/0026-0495(93)90097-8
   KIM SK, 1980, EXP GERONTOL, V15, P77, DOI 10.1016/0531-5565(80)90078-9
   KONO S, 1988, AM J PHYSIOL, V254, pE27
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LAMMERS R, 1990, J BIOL CHEM, V265, P16886
   Mathers WD, 1996, CORNEA, V15, P229, DOI 10.1097/00003226-199605000-00001
   MCGILL JI, 1984, BRIT J OPHTHALMOL, V68, P316, DOI 10.1136/bjo.68.5.316
   Myers MG, 1996, ANNU REV PHARMACOL, V36, P615, DOI 10.1146/annurev.pa.36.040196.003151
   NADIV O, 1994, BIOCHEM J, V298, P443, DOI 10.1042/bj2980443
   Páez-Espinosa EV, 1999, MOL CELL ENDOCRINOL, V156, P121, DOI 10.1016/S0303-7207(99)00137-9
   Páez-Espinosa V, 1998, ENDOCRINE, V8, P193, DOI 10.1385/ENDO:8:2:193
   PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L
   Pessin JE, 2000, J CLIN INVEST, V106, P165, DOI 10.1172/JCI10582
   Rocha EM, 1998, ADV EXP MED BIOL, V438, P485
   Rocha EM, 2002, INVEST OPHTH VIS SCI, V43, P963
   Rocha EM, 2002, ENDOCRINE, V18, P191, DOI 10.1385/ENDO:18:2:191
   Rocha EM, 2000, CURR EYE RES, V21, P833, DOI 10.1076/ceyr.21.5.833.5535
   ROCHA EM, 2000, LACRIMAL GLAND TEAR
   ROCHA EM, 2000, CORNEA S, V19, P117
   Saad MJA, 1996, J BIOL CHEM, V271, P22100, DOI 10.1074/jbc.271.36.22100
   SAAD MJA, 1994, BRAZ J MED BIOL RES, V27, P941
   Saad MJA, 1997, DIABETOLOGIA, V40, P179, DOI 10.1007/s001250050660
   Saltiel AR, 2000, J CLIN INVEST, V106, P163, DOI 10.1172/JCI10533
   Schein OD, 1997, AM J OPHTHALMOL, V124, P723, DOI 10.1016/S0002-9394(14)71688-5
   Shuai K, 1996, MOL CELL BIOL, V16, P4932
   Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583
   SITT AW, 2001, BR J OPHTHALMOL, V85, P746
   SREEBNY LM, 1988, ORAL SURG ORAL MED O, V66, P451, DOI 10.1016/0030-4220(88)90268-X
   SREEBNY LM, 1989, ORAL SURG ORAL MED O, V68, P419, DOI 10.1016/0030-4220(89)90140-0
   Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206
   SULLIVAN DA, 1990, ACTA OPHTHALMOL, V68, P188
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   Velloso LA, 1996, P NATL ACAD SCI USA, V93, P12490, DOI 10.1073/pnas.93.22.12490
   Vissink A, 1996, Spec Care Dentist, V16, P95, DOI 10.1111/j.1754-4505.1996.tb00842.x
   Waters SB, 1996, J BIOL CHEM, V271, P18224, DOI 10.1074/jbc.271.30.18224
   Wörtwein G, 1998, J NEUROSCI RES, V52, P322
   Xu XW, 1996, AM J PHYSIOL-ENDOC M, V271, pE903, DOI 10.1152/ajpendo.1996.271.5.E903
NR 53
TC 16
Z9 20
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1395-3907
J9 ACTA OPHTHALMOL SCAN
JI Acta Ophthalmol. Scand.
PD DEC
PY 2003
VL 81
IS 6
BP 639
EP 645
DI 10.1111/j.1395-3907.2003.00162.x
PG 7
WC Ophthalmology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Ophthalmology
GA 748UD
UT WOS:000186878700016
PM 14641268
DA 2024-02-19
ER

PT J
AU McClintick, JN
   Crabb, DW
   Tian, HJ
   Pinaire, J
   Smith, JR
   Jerome, RE
   Edenberg, HJ
AF McClintick, Jeanette N.
   Crabb, David W.
   Tian, Huijun
   Pinaire, Jane
   Smith, Jennifer R.
   Jerome, Ronald E.
   Edenberg, Howard J.
TI Global effects of vitamin A deficiency on gene expression in rat liver:
   evidence for hypoandrogenism
SO JOURNAL OF NUTRITIONAL BIOCHEMISTRY
LA English
DT Article
DE vitamin A deficiency; liver; expression profiling; microarrays;
   senescence; retinol
ID GROWTH-FACTOR-I; MESSENGER-RNA EXPRESSION; RETINOIC ACID;
   BINDING-PROTEIN; HEPATIC GLUCONEOGENESIS; NUCLEAR RECEPTORS; HORMONE
   PROFILES; DOWN-REGULATION; INSULIN; TISSUE
AB Vitamin A (retinol) metabolites are ligands for transcription factors that regulate many genes. The liver is the main storage depot for retinol and plays a role in vitamin A homeostasis. To better understand the effects of vitamin A deficiency on liver gene expression, we produced retinol deficiency in male rats by feeding a diet low in retinol for 53 days after weaning and examined the effects on gene expression in liver using Affymetrix oligonucleotide microarrays. We detected expression of 41% of the 8799 probe sets represented on the RGU-34A GeneChips. Vitamin A deficiency resulted in major changes in liver gene expression: 805 genes (22% of all genes detected) differed at P <=.05 (false discovery rate < 0.143). Genes involved in fatty acid metabolism, peroxisomal function, glycolysis, glutamate metabolism and the urea cycle were altered. The expression of many sexually dimorphic genes was altered toward a feminized or senescent pattern of gene expression in the liver. Retinol deficiency also produces a shift toward increased protein and fat catabolism and decreased fatty acid synthesis. (c) 2006 Elsevier Inc. All rights reserved.
C1 Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA.
   Indiana Univ, Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA.
   Indiana Univ, Sch Med, Dept Med, Indianapolis, IN 46202 USA.
   Richard Roudebush VA Med Ctr, Indianapolis, IN 46202 USA.
   Indiana Univ, Sch Med, Dept Physiol, Indianapolis, IN 46202 USA.
   Indiana Univ, Sch Med, Ctr Med Genom, Indianapolis, IN 46202 USA.
C3 Indiana University System; Indiana University-Purdue University
   Indianapolis; Indiana University System; Indiana University-Purdue
   University Indianapolis; Indiana University System; Indiana
   University-Purdue University Indianapolis; US Department of Veterans
   Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA
   Medical Center; Indiana University System; Indiana University-Purdue
   University Indianapolis; Indiana University System; Indiana
   University-Purdue University Indianapolis
RP Edenberg, HJ (corresponding author), Indiana Univ, Sch Med, Dept Biochem & Mol Biol, MS 4063, Indianapolis, IN 46202 USA.
EM edenberg@iupui.edu
OI Edenberg, Howard/0000-0003-0344-9690
FU NIAAA NIH HHS [AA06434, AA07462, AA07611] Funding Source: Medline
CR Agrawal AK, 2001, MOL CELL ENDOCRINOL, V173, P167, DOI 10.1016/S0303-7207(00)00401-9
   Ahluwalia A, 2004, MOL ENDOCRINOL, V18, P747, DOI 10.1210/me.2003-0138
   AKAZAWA N, 1989, JPN J VET SCI, V51, P1209
   Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   Andreola F, 2004, J BIOL CHEM, V279, P3434, DOI 10.1074/jbc.M305832200
   Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X
   Bauer M, 2004, PHYSIOL GENOMICS, V17, P230, DOI 10.1152/physiolgenomics.00203.2003
   BAUMANN G, 1987, J CLIN ENDOCR METAB, V64, P657, DOI 10.1210/jcem-64-4-657
   BOLEDA MD, 1993, ARCH BIOCHEM BIOPHYS, V307, P85, DOI 10.1006/abbi.1993.1564
   Butler AA, 2001, ANNU REV PHYSIOL, V63, P141, DOI 10.1146/annurev.physiol.63.1.141
   Deaciuc IV, 2004, J HEPATOL, V40, P219, DOI 10.1016/j.jhep.2003.10.021
   Dhir RN, 2003, P NATL ACAD SCI USA, V100, P15224, DOI 10.1073/pnas.2434273100
   Dhir RN, 2002, DRUG METAB DISPOS, V30, P141, DOI 10.1124/dmd.30.2.141
   DILEEPAN KN, 1981, P SOC EXP BIOL MED, V167, P248, DOI 10.3181/00379727-167-41158
   Fu ZW, 2002, J NUTR SCI VITAMINOL, V48, P453, DOI 10.3177/jnsv.48.453
   Fujita T, 1999, BIOCHEM BIOPH RES CO, V254, P1, DOI 10.1006/bbrc.1998.9841
   HENDRIKS HFJ, 1988, EUR J BIOCHEM, V171, P237, DOI 10.1111/j.1432-1033.1988.tb13782.x
   Jalouli M, 2003, ENDOCRINOLOGY, V144, P101, DOI 10.1210/en.2002-220630
   KATO S, 1993, J NUTR SCI VITAMINOL, V39, P545, DOI 10.3177/jnsv.39.545
   Klaassen CD, 1998, CHEM-BIOL INTERACT, V109, P299, DOI 10.1016/S0009-2797(97)00141-5
   Kliewer SA, 1999, SCIENCE, V284, P757, DOI 10.1126/science.284.5415.757
   Lakshman AR, 2004, ALCOHOL, V34, P45, DOI 10.1016/j.alcohol.2004.08.004
   LAWRENCE JW, 1995, BIOCHEM PHARMACOL, V49, P915, DOI 10.1016/0006-2952(95)00002-H
   Lieber CS, 1999, ALCOHOL CLIN EXP RES, V23, P991, DOI 10.1111/j.1530-0277.1999.tb04217.x
   Livera G, 2002, REPRODUCTION, V124, P173, DOI 10.1530/rep.0.1240173
   MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7
   MARTINI R, 1995, J PHARMACOL EXP THER, V273, P427
   McClintick JN, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-4
   MIHARA K, 1990, J BIOCHEM-TOKYO, V108, P1022, DOI 10.1093/oxfordjournals.jbchem.a123301
   Molotkov A, 2003, J BIOL CHEM, V278, P36085, DOI 10.1074/jbc.M303709200
   Murray M, 2005, FEBS LETT, V579, P3669, DOI 10.1016/j.febslet.2005.05.052
   Nelson D R, 1998, Methods Mol Biol, V107, P15
   OSULLIVAN U, 1989, ENDOCRINOLOGY, V125, P2793, DOI 10.1210/endo-125-5-2793
   Perozzi G, 1998, Z ERNAHRUNGSWISS, V37, P29
   Pinaire J, 2000, ALCOHOL CLIN EXP RES, V24, P1759, DOI 10.1111/j.1530-0277.2000.tb01978.x
   RAJAN N, 1990, J LIPID RES, V31, P821
   RAMACHANDRAN CK, 1986, P SOC EXP BIOL MED, V182, P73
   Ruiz-Torres A, 2002, NOVART FDN SYMP, V242, P143
   Shin DJ, 1997, J NUTR, V127, P1274, DOI 10.1093/jn/127.7.1274
   SHULL JD, 1995, ENDOCRINOLOGY, V136, P2120, DOI 10.1210/en.136.5.2120
   SRIVASTAVA PK, 1993, BIOCHEM J, V294, P159, DOI 10.1042/bj2940159
   Ståhlberg N, 2004, ENDOCRINOLOGY, V145, P1972, DOI 10.1210/en.2003-0874
   Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346
   Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100
   THISSEN JP, 1990, ENDOCRINOLOGY, V126, P908, DOI 10.1210/endo-126-2-908
   Thissen JP, 1999, NUTR REV, V57, P167, DOI 10.1111/j.1753-4887.1999.tb06939.x
   THISSEN JP, 1991, ENDOCRINOLOGY, V128, P885, DOI 10.1210/endo-128-2-885
   VERMA AK, 1992, J NUTR, V122, P2144, DOI 10.1093/jn/122.11.2144
   Wiwi CA, 2004, GROWTH FACTORS, V22, P79, DOI 10.1080/08977190410001715172
   WUARIN J, 1990, CELL, V63, P1257, DOI 10.1016/0092-8674(90)90421-A
   Yamamoto Y, 2000, FASEB J, V14, P2119, DOI 10.1096/fj.00-0061com
   Zaiger G, 2004, EUR J NUTR, V43, P259, DOI 10.1007/s00394-004-0466-2
   Zar JH., 2014, Biostatistical analysis: Pearson new international edition, V5
NR 54
TC 28
Z9 33
U1 0
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0955-2863
EI 1873-4847
J9 J NUTR BIOCHEM
JI J. Nutr. Biochem.
PD MAY
PY 2006
VL 17
IS 5
BP 345
EP 355
DI 10.1016/j.jnutbio.2005.08.006
PG 11
WC Biochemistry & Molecular Biology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Nutrition & Dietetics
GA 044BE
UT WOS:000237646300006
PM 16214324
DA 2024-02-19
ER

PT J
AU Loo, TM
   Kamachi, F
   Watanabe, Y
   Yoshimoto, S
   Kanda, H
   Arai, Y
   Nakajima-Takagi, Y
   Iwama, A
   Koga, T
   Sugimoto, Y
   Ozawa, T
   Nakamura, M
   Kumagai, M
   Watashi, K
   Taketo, MM
   Aoki, T
   Narumiya, S
   Oshima, M
   Arita, M
   Hara, E
   Ohtani, N
AF Loo, Tze Mun
   Kamachi, Fumitaka
   Watanabe, Yoshihiro
   Yoshimoto, Shin
   Kanda, Hiroaki
   Arai, Yuriko
   Nakajima-Takagi, Yaeko
   Iwama, Atsushi
   Koga, Tomoaki
   Sugimoto, Yukihiko
   Ozawa, Takayuki
   Nakamura, Masaru
   Kumagai, Miho
   Watashi, Koichi
   Taketo, Makoto M.
   Aoki, Tomohiro
   Narumiya, Shuh
   Oshima, Masanobu
   Arita, Makoto
   Hara, Eiji
   Ohtani, Naoko
TI Gut Microbiota Promotes Obesity-Associated Liver Cancer through
   PGE<sub>2</sub>-Mediated Suppression of Antitumor Immunity
SO CANCER DISCOVERY
LA English
DT Article
ID HEPATOCELLULAR-CARCINOMA; SENESCENT CELLS; INFLAMMATION; MEDIATOR;
   DISEASE; GROWTH; STEATOHEPATITIS; SURVEILLANCE; RESOLUTION; MECHANISM
AB Obesity increases the risk of cancers, including hepatocellular carcinomas (HCC). However, the precise molecular mechanisms through which obesity promotes HCC development are still unclear. Recent studies have shown that gut microbiota may influence liver diseases by transferring its metabolites and components. Here, we show that the hepatic translocation of obesity-induced lipoteichoic acid (LTA), a Gram-positive gut microbial component, promotes HCC development by creating a tumor-promoting microenvironment. LTA enhances the senescence-associated secretory phenotype (SASP) of hepatic stellate cells (HSC) collaboratively with an obesity-induced gut microbial metabolite, deoxycholic acid, to upregulate the expression of SASP factors and COX2 through Toll-like receptor 2. Interestingly, COX2-mediated prostaglandin E-2 (PGE(2)) production suppresses the antitumor immunity through a PTGER4 receptor, thereby contributing to HCC progression. Moreover, COX2 overexpression and excess PGE2 production were detected in HSCs in human HCCs with noncirrhotic, nonalcoholic steatohepatitis (NASH), indicating that a similar mechanism could function in humans.
   SIGNIFICANCE: We showed the importance of the gut-liver axis in obesity-associated HCC. The gut microbiota-driven COX2 pathway produced the lipid mediator PGE2 in senescent HSCs in the tumor microenvironment, which plays a pivotal role in suppressing antitumor immunity, suggesting that PGE(2) and its receptor may be novel therapeutic targets for noncirrhotic NASH-associated HCC. (C) 2017 AACR.
C1 [Loo, Tze Mun; Kamachi, Fumitaka; Watanabe, Yoshihiro; Arai, Yuriko; Ozawa, Takayuki; Nakamura, Masaru; Kumagai, Miho; Ohtani, Naoko] Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biol Sci, Chiba, Japan.
   [Yoshimoto, Shin; Arai, Yuriko; Hara, Eiji] Japanese Fdn Canc Res, Canc Inst, Div Canc Biol, Tokyo, Japan.
   [Yoshimoto, Shin] LSI Medience Corp, Tokyo, Japan.
   [Kanda, Hiroaki] Japanese Fdn Canc Res, Canc Inst, Div Pathol, Tokyo, Japan.
   [Nakajima-Takagi, Yaeko; Iwama, Atsushi] Chiba Univ, Grad Sch Med, Dept Cellular & Mol Med, Chiba, Japan.
   [Koga, Tomoaki; Sugimoto, Yukihiko] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Pharmaceut Biochem, Kumamoto, Japan.
   [Watashi, Koichi] Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan.
   [Watashi, Koichi] Japan Sci & Technol Agcy JST, CREST, Saitama, Japan.
   [Taketo, Makoto M.] Kyoto Univ, Grad Sch Med, Dept Pharmacol, Yoshida Konoe Cho, Kyoto, Japan.
   [Aoki, Tomohiro; Narumiya, Shuh] Kyoto Univ, Grad Sch Med, Ctr Innovat Immunoregulat Technol & Therapeut, Kyoto, Japan.
   [Narumiya, Shuh] Kyoto Univ, Grad Sch Med, Med Innovat Ctr, Kyoto, Japan.
   [Narumiya, Shuh; Oshima, Masanobu; Hara, Eiji] Japan Agcy Med Res & Dev, CREST, AMED, Tokyo, Japan.
   [Oshima, Masanobu] Kanazawa Univ, Canc Res Inst, Div Genet, Kanazawa, Ishikawa, Japan.
   [Arita, Makoto] RIKEN, Ctr Integrat Med Sci, Lab Metabol, Kanagawa, Japan.
   [Arita, Makoto] Yokohama City Univ, Grad Sch Med Life Sci, Yokohama, Kanagawa, Japan.
   [Arita, Makoto; Ohtani, Naoko] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan.
   [Arita, Makoto] Keio Univ, Grad Sch Pharmaceut Sci, Div Physiol Chem & Metab, Tokyo, Japan.
   [Hara, Eiji] Osaka Univ, Res Inst Microbial Dis, Dept Mol Microbiol, Osaka, Japan.
   [Ohtani, Naoko] Osaka City Univ, Grad Sch Med, Dept Pathophysiol, Osaka, Japan.
C3 Tokyo University of Science; Japanese Foundation for Cancer Research;
   Japanese Foundation for Cancer Research; Chiba University; Kumamoto
   University; National Institute of Infectious Diseases (NIID); Japan
   Science & Technology Agency (JST); Kyoto University; Kyoto University;
   Kyoto University; Japan Science & Technology Agency (JST); Kanazawa
   University; RIKEN; Yokohama City University; Japan Science & Technology
   Agency (JST); Keio University; Osaka University; Osaka Metropolitan
   University
RP Ohtani, N (corresponding author), Osaka City Univ, Grad Sch Med, Dept Pathophysiol, Osaka, Japan.; Ohtani, N (corresponding author), Osaka City Univ, Dept Pathophysiol, Grad Sch Med, Abeno Ku, Asahimachi 1-4-3, Osaka 5458585, Japan.
EM ohtani.naoko@med.osaka-cu.ac.jp
RI Oshima, Masanobu/F-9958-2014; Ohtani, Naoko/AAB-1891-2021; Sugimoto,
   Yukihiko/AAV-6470-2021; Yoshimoto, Shin/ACD-1941-2022
OI Oshima, Masanobu/0000-0002-3304-0004; Ohtani, Naoko/0000-0001-8934-0797;
   Sugimoto, Yukihiko/0000-0001-6973-932X; Yoshimoto,
   Shin/0000-0001-8405-0301; Watashi, Koichi/0000-0002-4536-9966; Arita,
   Makoto/0000-0001-9902-0463; Loo, Tze Mun/0000-0001-5725-1423
FU MEXT, Japan [26115005, 15H05898]; JSPS KAKENHI [16H04699, 15K19031,
   26713014, 26250028, 15H04648]; Precursory Research for Embryonic Science
   and Technology (PRESTO) from the Japan Science and Technology
   Corporation (JST) [10104022]; AMED, Japan Agency for Medical Research
   and Development, Japan [15654813]; Japan Society for Promotion of
   Science (JSPS) [14J0-6998]; Yakult Bio-science Foundation; Ono Medical
   Research Foundation; Grants-in-Aid for Scientific Research [26713014,
   15H05897, 15H04648, 15K19031, 15H05898, 26115005, 17H03990, 26670030,
   14J06998, 16H04699, 15H05905, 15K12709, 26250028, 16H06276, 17H01531]
   Funding Source: KAKEN
FX This work was supported in part by Grant in Aid for Scientific Research
   on Innovative Areas from MEXT, Japan, #26115005 (N. Ohtani, "Stem cell
   aging and disease"), #15H05898 (M. Arita, "Quality of lipids in
   biological systems"), JSPS KAKENHI #16H04699 (N. Ohtani), #15K19031 (F.
   Kamachi), #26713014 (S. Yoshimoto), #26250028 (E. Hara), #15H04648 (M.
   Arita), Precursory Research for Embryonic Science and Technology
   (PRESTO) from the Japan Science and Technology Corporation (JST),
   10104022 (N. Ohtani), and AMED, Japan Agency for Medical Research and
   Development, Japan, 15654813 (N. Ohtani). T.M. Loo was supported in part
   by a fellowship and a grant from the Japan Society for Promotion of
   Science (JSPS; 14J0-6998). This work was also supported by the Yakult
   Bio-science Foundation (N. Ohtani) and the Ono Medical Research
   Foundation (N. Ohtani).
CR Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784
   Arita M, 2012, J BIOCHEM, V152, P313, DOI 10.1093/jb/mvs092
   Bauer CA, 2014, J CLIN INVEST, V124, P2425, DOI 10.1172/JCI66375
   Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408
   Campisi J, 2011, SEMIN CANCER BIOL, V21, P354, DOI 10.1016/j.semcancer.2011.09.001
   Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221
   Chen JH, 2015, NAT MED, V21, P327, DOI 10.1038/nm.3831
   Cichowski K, 2008, CELL, V133, P958, DOI 10.1016/j.cell.2008.05.027
   Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772
   Dapito DH, 2012, CANCER CELL, V21, P504, DOI 10.1016/j.ccr.2012.02.007
   Davalos AR, 2013, J CELL BIOL, V201, P613, DOI 10.1083/jcb.201206006
   Demaria M, 2014, DEV CELL, V31, P722, DOI 10.1016/j.devcel.2014.11.012
   Deng T, 2016, ANNU REV PATHOL-MECH, V11, P421, DOI 10.1146/annurev-pathol-012615-044359
   Font-Burgada J, 2016, CELL METAB, V23, P48, DOI 10.1016/j.cmet.2015.12.015
   Forman D., 2014, World cancer report 2014, V2014, P16
   Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0
   Fuertes MB, 2011, J EXP MED, V208, P2005, DOI 10.1084/jem.20101159
   Fukui H, 2015, WORLD J HEPATOL, V7, P425, DOI 10.4254/wjh.v7.i3.425
   Goodman ZD, 2014, CLIN LIVER DIS, V18, P33, DOI 10.1016/j.cld.2013.09.010
   Harris SG, 2002, TRENDS IMMUNOL, V23, P144, DOI 10.1016/S1471-4906(01)02154-8
   Joyce JA, 2015, SCIENCE, V348, P74, DOI 10.1126/science.aaa6204
   Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070
   Kang C, 2015, SCIENCE, V349, DOI 10.1126/science.aaa5612
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Kaplon J, 2013, NATURE, V498, P109, DOI 10.1038/nature12154
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Kurtova AV, 2015, NATURE, V517, P209, DOI 10.1038/nature14034
   Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a
   Michelotti GA, 2013, NAT REV GASTRO HEPAT, V10, P656, DOI 10.1038/nrgastro.2013.183
   Miura K, 2014, WORLD J GASTROENTERO, V20, P7381, DOI 10.3748/wjg.v20.i23.7381
   Morita M, 2013, CELL, V153, P112, DOI 10.1016/j.cell.2013.02.027
   Muñoz-Espín D, 2013, CELL, V155, P1104, DOI 10.1016/j.cell.2013.10.019
   Okumura Y, 2017, BIOORG MED CHEM LETT, V27, P1186, DOI 10.1016/j.bmcl.2017.01.067
   Oshima H, 2006, GASTROENTEROLOGY, V131, P1086, DOI 10.1053/j.gastro.2006.07.014
   Perumpail RB, 2015, DIGEST DIS SCI, V60, P3142, DOI 10.1007/s10620-015-3821-7
   Pribluda A, 2013, CANCER CELL, V24, P242, DOI 10.1016/j.ccr.2013.06.005
   Rai TS, 2014, GENE DEV, V28, P2712, DOI 10.1101/gad.247528.114
   Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094
   Sawey ET, 2011, CANCER CELL, V19, P347, DOI 10.1016/j.ccr.2011.01.040
   Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877
   Soontrapa K, 2011, P NATL ACAD SCI USA, V108, P6668, DOI 10.1073/pnas.1018625108
   Storer M, 2013, CELL, V155, P1119, DOI 10.1016/j.cell.2013.10.041
   Takahashi A, 2012, MOL CELL, V45, P123, DOI 10.1016/j.molcel.2011.10.018
   Takuma Y, 2010, WORLD J GASTROENTERO, V16, P1436, DOI 10.3748/wjg.v16.i12.1436
   Tasdemir N, 2016, CANCER DISCOV, V6, P612, DOI 10.1158/2159-8290.CD-16-0217
   Vigneron A, 2010, AGING-US, V2, P471, DOI 10.18632/aging.100189
   Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809
   Wang LR, 2016, CELL HOST MICROBE, V19, P227, DOI 10.1016/j.chom.2016.01.003
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
   Zelenay S, 2015, CELL, V162, P1257, DOI 10.1016/j.cell.2015.08.015
NR 50
TC 289
Z9 310
U1 11
U2 91
PU AMER ASSOC CANCER RESEARCH
PI PHILADELPHIA
PA 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA
SN 2159-8274
EI 2159-8290
J9 CANCER DISCOV
JI Cancer Discov.
PD MAY
PY 2017
VL 7
IS 5
BP 522
EP 538
DI 10.1158/2159-8290.CD-16-0932
PG 17
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA ET4QH
UT WOS:000400269300023
PM 28202625
OA Green Submitted
HC Y
HP N
DA 2024-02-19
ER

PT J
AU Zubkova, EV
   Robaire, B
AF Zubkova, EV
   Robaire, B
TI Effect of glutathione depletion on antioxidant enzymes in the
   epididymis, seminal vesicles, and liver and on spermatozoa motility in
   the aging brown Norway rat
SO BIOLOGY OF REPRODUCTION
LA English
DT Article
DE aging; epididymis; seminal vesicles; sperm; stress
ID SUPEROXIDE-DISMUTASE; OXIDATIVE STRESS; SPERM MOTILITY; SEMEN QUALITY;
   AGE; DNA; PEROXIDASE; BIOLOGY; DAMAGE; MODEL
AB Reactive oxygen species (ROS) play a role in male infertility, where excessive amounts impair spermatozoal motility. Epididymal antioxidant enzymes protect spermatozoa from oxidative damage in the epididymal lumen. Antioxidant secretions from the seminal vesicle protect spermatozoa after ejaculation. As it is known that with age there is increased generation of ROS, the goals of this study were to determine how aging affects the response of antioxidant enzymes in the epididymis, seminal vesicles, and liver to L-buthionine-S,R-sulfoximine (BSO) mediated glutathione (GSH) depletion, and to examine the impact of GSH depletion on motility parameters of spermatozoa from the cauda epididymidis in young (4-mo-old) and old (21-mo-old) rats. Levels of GSH and glutathione disulfide (GSSG), as well as activities of glutathione peroxidase, glutathione reductase, catalase, and superoxide dismutase, were measured in the caput, corpus and cauda epididymidis, seminal vesicles, and liver. Spermatozoal motility was assessed by computer-assisted sperm analysis. Significant age-related changes in antioxidant enzyme activities were found in the liver and cauda epididymidis. Glutathione depletion clearly affected tissues in both young and old. The compounding effect of age was most evident in the cauda epididymidis, seminal vesicles, and liver, where antioxidant enzyme activities changed significantly. Additionally, spermatozoa motility was adversely affected after BSO treatment in both age groups, but significantly more so in older animals. In summary, the male reproductive tissues and liver undergo age-related changes in antioxidant enzyme activities and in their response to GSH depletion.
C1 McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada.
   McGill Univ, Dept Obstet & Gynecol, Montreal, PQ H3G 1Y6, Canada.
C3 McGill University; McGill University
RP Robaire, B (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, 3655 Promenade Sir Willian Osler, Montreal, PQ H3G 1Y6, Canada.
EM bernard.robaire@mcgill.ca
CR AEBI H, 1984, METHOD ENZYMOL, V105, P121
   Aitken RJ, 2001, REPRODUCTION, V122, P497, DOI 10.1530/rep.0.1220497
   AITKEN RJ, 1994, REPROD FERT DEVELOP, V6, P19, DOI 10.1071/RD9940019
   Amicarelli F, 1997, MECH AGEING DEV, V97, P215, DOI 10.1016/S0047-6374(97)00061-4
   ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548
   Armstrong JS, 1999, FREE RADICAL BIO MED, V26, P869, DOI 10.1016/S0891-5849(98)00275-5
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   CARLBERG I, 1985, METHOD ENZYMOL, V113, P484
   Chen H, 2002, REPRODUCTION, V124, P491, DOI 10.1530/reprod/124.4.491
   CLAVERT A, 1990, ANDROLOGIA, V22, P185
   DELAMIRANDE E, 1992, J ANDROL, V13, P379
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   Fouchécourt S, 2000, BIOL REPROD, V62, P1790, DOI 10.1095/biolreprod62.6.1790
   Gomez E, 1998, INT J ANDROL, V21, P81
   GRIFFITH OW, 1982, J BIOL CHEM, V257, P13704
   GRUENEWALD DA, 1994, J GERONTOL, V49, pB42, DOI 10.1093/geronj/49.2.B42
   Hinton BT, 1995, REPROD FERT DEVELOP, V7, P731, DOI 10.1071/RD9950731
   Ho YS, 1997, J BIOL CHEM, V272, P16644, DOI 10.1074/jbc.272.26.16644
   HOLMES GE, 1992, MUTAT RES, V275, P305, DOI 10.1016/0921-8734(92)90034-M
   IWASAKI A, 1992, FERTIL STERIL, V57, P409, DOI 10.1016/s0015-0282(16)54855-9
   Jang I, 1998, EXP ANIM TOKYO, V47, P247, DOI 10.1538/expanim.47.247
   Kidd SA, 2001, FERTIL STERIL, V75, P237, DOI 10.1016/S0015-0282(00)01679-4
   Lane N, 2003, J THEOR BIOL, V225, P531, DOI 10.1016/S0022-5193(03)00304-7
   Maria CS, 1996, FREE RADICAL RES, V25, P401, DOI 10.3109/10715769609149062
   Mueller A, 1998, J ANDROL, V19, P450
   Ochsendorf FR, 1998, HUM REPROD, V13, P353, DOI 10.1093/humrep/13.2.353
   Okado-Matsumoto A, 2001, ANAL BIOCHEM, V298, P337, DOI 10.1006/abio.2001.5385
   Palomero J, 2001, FREE RADICAL BIO MED, V30, P836, DOI 10.1016/S0891-5849(01)00471-3
   PERRY ACF, 1993, BIOCHEM J, V293, P21, DOI 10.1042/bj2930021
   PIGEOLET E, 1990, MECH AGEING DEV, V51, P283, DOI 10.1016/0047-6374(90)90078-T
   Praticò D, 2001, TRENDS ENDOCRIN MET, V12, P243, DOI 10.1016/S1043-2760(01)00411-8
   Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027
   Robaire B., 1988, P999
   Sakata Y, 2002, FEBS LETT, V516, P229, DOI 10.1016/S0014-5793(02)02529-2
   Saleh RA, 2002, J ANDROL, V23, P737
   Sanz N, 1997, J HEPATOL, V27, P525, DOI 10.1016/S0168-8278(97)80358-3
   SLOTT VL, 1991, REPROD TOXICOL, V5, P449, DOI 10.1016/0890-6238(91)90009-5
   Storey BT, 1997, MOL HUM REPROD, V3, P203, DOI 10.1093/molehr/3.3.203
   Syntin P, 1996, BIOL REPROD, V55, P956, DOI 10.1095/biolreprod55.5.956
   Syntin P, 2001, J ANDROL, V22, P235
   Tramer F, 1998, BIOL REPROD, V59, P753, DOI 10.1095/biolreprod59.4.753
   Urata K, 2001, FERTIL STERIL, V76, P163, DOI 10.1016/S0015-0282(01)01850-7
   Vernet P, 1999, MOL REPROD DEV, V54, P362, DOI 10.1002/(SICI)1098-2795(199912)54:4&lt;362::AID-MRD6&gt;3.0.CO;2-#
   WANG C, 1993, ENDOCRINOLOGY, V133, P2773, DOI 10.1210/en.133.6.2773
   Wei YH, 2002, EXP BIOL MED, V227, P671, DOI 10.1177/153537020222700901
   WRIGHT WW, 1993, J ANDROL, V14, P110
   YEN TC, 1994, FREE RADICAL BIO MED, V16, P207, DOI 10.1016/0891-5849(94)90145-7
   Zini A, 2002, UROL RES, V30, P321, DOI 10.1007/s00240-002-0283-0
   ZIRKIN BR, 1993, J ANDROL, V14, P118
NR 49
TC 51
Z9 59
U1 0
U2 5
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0006-3363
EI 1529-7268
J9 BIOL REPROD
JI Biol. Reprod.
PD SEP
PY 2004
VL 71
IS 3
BP 1002
EP 1008
DI 10.1095/biolreprod.104.028373
PG 7
WC Reproductive Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Reproductive Biology
GA 849LX
UT WOS:000223541200037
PM 15151930
OA Bronze
DA 2024-02-19
ER

PT J
AU Wu, KY
   Xu, CY
   Qiu, GZ
   Guo, QW
   Chen, CC
   Liu, W
   Liu, JJ
   Liu, KD
   Zhu, FQ
AF Wu, Kaiyu
   Xu, Chunyan
   Qiu, Guozhen
   Guo, Qiwen
   Chen, Chunchun
   Liu, Wei
   Liu, Jianjun
   Liu, Kangding
   Zhu, Feiqi
TI Association of lower liver function with cognitive impairment in the
   Shenzhen ageing-related disorder cohort in China
SO FRONTIERS IN AGING NEUROSCIENCE
LA English
DT Article
DE cognitive impairment; liver function; albumin; triglyceride; aspartate
   aminotransferase to alanine aminotransferase ratio
ID DENSITY-LIPOPROTEIN; SERUM-LIPIDS; ALZHEIMERS; GLUTAMATE; DEMENTIA;
   ALBUMIN; MEMORY
AB BackgroundAccumulating evidence suggests that alterations in liver function may play an important role in the pathogenesis of Alzheimer's disease (AD). However, it remains unclear whether there is any relationship between lower liver function and cognitive impairment among the elderly. MethodsFrom 2017 to 2018, we recruited 7,201 older people (over 60 years old) from 51 community health centers in the Luohu District of Shenzhen City. According to the Mini-Mental State Examination (MMSE) score and education level, participants were divided into a cognitive impairment group (n = 372) and a normal cognitive function group (n = 6,829). Nonparametric test, chi-square tests, and binary logistic regression were used to analyze the data. ResultsCognitive impairment group exhibits older age, more female sex, lower education level, and lower levels of albumin and triglyceride. Additionally, the aspartate aminotransferase (AST) to alanine aminotransferase (ALT) ratio was mainly distributed in the range of 1.17 to 1.3 in the cognitive impairment group, and 0.85 to 1.00 in the normal cognitive function group (chi 2 = 10.02, p = 0.04). Binary logistic regression showed that cognitive impairment was significantly associated with age (OR = 0.934, 95%CI: 0.886-0.985, p = 0.017), female sex (OR = 2.255, 95%CI: 1.761-2.888, p < 0.001), lower education level (less than senior high school) (OR = 11.509, 95%CI: 9.064-14.613, p < 0.001), and lower albumin (OR = 1.023, 95%CI: 1.004-1.043, p = 0.011). ConclusionExcept for age, female sex, and lower education level, lower level of albumin and elevated AST to ALT ratio correlate with cognitive impairment. Whether lower liver function plays a role in AD needs to be further studied.
C1 [Wu, Kaiyu; Liu, Kangding] First Hosp Jilin Univ, Dept Neurol, Changchun, Jilin, Peoples R China.
   [Wu, Kaiyu; Xu, Chunyan; Qiu, Guozhen; Guo, Qiwen; Chen, Chunchun; Zhu, Feiqi] Shenzhen Univ, Cognit Impairment Ward, Affiliated Hosp3, Med Coll,Neurol Dept, Shenzhen, Guangdong, Peoples R China.
   [Liu, Wei; Liu, Jianjun] Shenzhen Ctr Dis Control & Prevent, Key Lab Modern Toxicol Shenzhen, Shenzhen Med Key Subject Hlth Toxicol 2020 2024, Shenzhen, Guangdong, Peoples R China.
C3 Jilin University; Shenzhen University; Shenzhen Center for Disease
   Control & Prevention (SZCDC)
RP Zhu, FQ (corresponding author), Shenzhen Univ, Cognit Impairment Ward, Affiliated Hosp3, Med Coll,Neurol Dept, Shenzhen, Guangdong, Peoples R China.
EM zfqzsu2004@aliyun.com
RI LI, XIAO/JCE-6169-2023; Zhu, Feiqi/AAE-2897-2020
FU Sanming Project of Medicine in Shenzhen; Key project of Shenzhen Science
   and Technology Commission;  [SZSM201801014];  [JCYJ20200109143431341]
FX Funding This work was supported by Sanming Project of Medicine in
   Shenzhen (SZSM201801014) and Key project of Shenzhen Science and
   Technology Commission (JCYJ20200109143431341).
CR Agarwal M, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.12008
   Cassano T, 2016, CURR ALZHEIMER RES, V13, P185, DOI 10.2174/1567205013666151218132725
   Clarke JR, 2018, J ALZHEIMERS DIS, V64, pS405, DOI 10.3233/JAD-179911
   Dimache AM, 2021, NUTRIENTS, V13, DOI 10.3390/nu13062118
   Dimopoulos N, 2007, J GERIATR PSYCH NEUR, V20, P138, DOI 10.1177/0891988707301867
   Estrada LD, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00174
   Han SW, 2022, J ALZHEIMERS DIS, V88, P1371, DOI 10.3233/JAD-220343
   Henderson VW, 2003, J NEUROL NEUROSUR PS, V74, P1530, DOI 10.1136/jnnp.74.11.1530
   Herholz K, 2018, J CEREBR BLOOD F MET, V38, P1796, DOI 10.1177/0271678X17718436
   Holmes C, 2013, NEUROPATH APPL NEURO, V39, P51, DOI 10.1111/j.1365-2990.2012.01307.x
   Jia JP, 2014, ALZHEIMERS DEMENT, V10, P1, DOI 10.1016/j.jalz.2013.01.012
   Kaiyu W, 2022, CHINA J ALZHEIMERS D, V5, P38, DOI [10.3969/j.issn.2096-5516.2022.01.007, DOI 10.3969/J.ISSN.2096-5516.2022.01.007]
   Kamada Y, 2016, BBA CLIN, V5, P101, DOI 10.1016/j.bbacli.2016.02.004
   Kanekiyo T, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00093
   Lane CA, 2018, EUR J NEUROL, V25, P59, DOI 10.1111/ene.13439
   Lepara O, 2009, BOSNIAN J BASIC MED, V9, P215, DOI 10.17305/bjbms.2009.2809
   Lim ST, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10110804
   Lu YF, 2021, J ALZHEIMERS DIS, V79, P1775, DOI 10.3233/JAD-201241
   Maarouf CL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203659
   Mapstone M, 2020, ALZH DEMENT-DADM, V12, DOI 10.1002/dad2.12028
   McDade E, 2017, NATURE, V547, P153, DOI 10.1038/547153a
   Ng TP, 2009, J AM GERIATR SOC, V57, P101, DOI 10.1111/j.1532-5415.2008.02086.x
   Nho K, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.7978
   Parsons CG, 1998, DRUG NEWS PERSPECT, V11, P523, DOI 10.1358/dnp.1998.11.9.863689
   Reiman EM, 2011, J CLIN PSYCHIAT, V72, P1190, DOI [10.4088/JCP.10087tx2c, 10.4088/JCP.10087co1c, 10.4088/JCP.10087colc]
   Ribeiro FM, 2017, PHARMACOL RES, V115, P179, DOI 10.1016/j.phrs.2016.11.013
   Sayed A, 2020, J NEUROIMMUNOL, V349, DOI 10.1016/j.jneuroim.2020.577398
   Sehgal N, 2012, P NATL ACAD SCI USA, V109, P3510, DOI 10.1073/pnas.1112209109
   Serre-Miranda C, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.02045
   Stanyon HF, 2012, J BIOL CHEM, V287, P28163, DOI 10.1074/jbc.C112.360800
   van Exel E, 2002, ANN NEUROL, V51, P716, DOI 10.1002/ana.10220
   Wang HL, 2019, J GLOB HEALTH, V9, DOI 10.7189/jogh.09.020321
   Weinstein G, 2019, LIVER INT, V39, P1713, DOI 10.1111/liv.14161
   Woreta TA, 2014, MED CLIN N AM, V98, P1, DOI 10.1016/j.mcna.2013.09.005
   Xie HS, 2021, FRONT MOL BIOSCI, V7, DOI 10.3389/fmolb.2020.629520
   Zhang XL, 2023, ALZHEIMERS DEMENT, V19, P181, DOI 10.1002/alz.12641
   Zheng H, 2019, J PROTEOME RES, V18, P1218, DOI 10.1021/acs.jproteome.8b00847
   Zheng H, 2018, BBA-MOL BASIS DIS, V1864, P263, DOI 10.1016/j.bbadis.2017.10.028
   Zhong XM, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00859
   Zhou MG, 2019, LANCET, V394, P1145, DOI 10.1016/S0140-6736(19)30427-1
NR 40
TC 1
Z9 1
U1 2
U2 4
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1663-4365
J9 FRONT AGING NEUROSCI
JI Front. Aging Neurosci.
PD OCT 13
PY 2022
VL 14
AR 1012219
DI 10.3389/fnagi.2022.1012219
PG 6
WC Geriatrics & Gerontology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology; Neurosciences & Neurology
GA 5T4HO
UT WOS:000875830000001
PM 36313027
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Murray, TVA
   Dong, XB
   Sawyer, GJ
   Caldwell, A
   Halket, J
   Sherwood, R
   Quaglia, A
   Dew, T
   Anilkumar, N
   Burr, S
   Mistry, RK
   Martin, D
   Schroeder, K
   Brandes, RP
   Hughes, RD
   Shah, AM
   Brewer, AC
AF Murray, Thomas V. A.
   Dong, Xuebin
   Sawyer, Greta J.
   Caldwell, Anna
   Halket, John
   Sherwood, Roy
   Quaglia, Alberto
   Dew, Tracy
   Anilkumar, Narayana
   Burr, Simon
   Mistry, Rajesh K.
   Martin, Daniel
   Schroeder, Katrin
   Brandes, Ralf P.
   Hughes, Robin D.
   Shah, Ajay M.
   Brewer, Alison C.
TI NADPH oxidase 4 regulates homocysteine metabolism and protects against
   acetaminophen-induced liver damage in mice
SO FREE RADICAL BIOLOGY AND MEDICINE
LA English
DT Article
DE Betaine-homocysteine-methyltransferase (BHMT); Glutathione;
   Hepatotoxicity; Nox4; Redox-signaling
ID CONGENITAL HEART-DEFECTS; GLUTATHIONE SYNTHESIS; OXIDATIVE STRESS;
   S-METHYLTRANSFERASE; PLASMA HOMOCYSTEINE; MURINE MODEL; IN-VIVO; REDOX;
   NOX4; BETAINE
AB Glutathione is the major intracellular redox buffer in the liver and is critical for hepatic detoxification of xenobiotics and other environmental toxins. Hepatic glutathione is also a major systemic store for other organs and thus impacts on pathologies such as Alzheimer's disease, Sickle Cell Anaemia and chronic diseases associated with aging. Glutathione levels are determined in part by the availability of cysteine, generated from homocysteine through the transsulfuration pathway. The partitioning of homocysteine between remethylation and transsulfuration pathways is known to be subject to redox-dependent regulation, but the underlying mechanisms are not known. An association between plasma Hcy and a single nucleotide polymorphism within the NADPH oxidase 4 locus led us to investigate the involvement of this reactive oxygen species- generating enzyme in homocysteine metabolism. Here we demonstrate that NADPH oxidase 4 ablation in mice results in increased flux of homocysteine through the betaine-dependent remethylation pathway to methionine, catalysed by betaine-homocysteine-methyltransferase within the liver. As a consequence NADPH oxidase 4-null mice display significantly lowered plasma homocysteine and the flux of homocysteine through the transsulfuration pathway is reduced, resulting in lower hepatic cysteine and glutathione levels. Mice deficient in NADPH oxidase 4 had markedly increased susceptibility to acetaminophen-induced hepatic injury which could be corrected by administration of N-acetyl cysteine. We thus conclude that under physiological conditions, NADPH oxidase 4-derived reactive oxygen species is a regulator of the partitioning of the metabolic flux of homocysteine, which impacts upon hepatic cysteine and glutathione levels and thereby upon defence against environmental toxins. (C) 2015 The Authors. Published by Elsevier Inc.
C1 [Murray, Thomas V. A.; Dong, Xuebin; Sawyer, Greta J.; Anilkumar, Narayana; Burr, Simon; Mistry, Rajesh K.; Martin, Daniel; Shah, Ajay M.; Brewer, Alison C.] Kings Coll London, Cardiovasc Div, London E5 0AD, England.
   [Caldwell, Anna; Halket, John] Kings Coll London, Mass Spectrometry Facil, London E1 9NH, England.
   [Sherwood, Roy; Dew, Tracy] Kings Coll Hosp London, NHS Fdn Trust, London SE5 9RS, England.
   [Quaglia, Alberto; Hughes, Robin D.] Kings Coll London, Inst Liver Studies, London SE5 9RS, England.
   [Schroeder, Katrin; Brandes, Ralf P.] Goethe Univ Frankfurt, Inst Kardiovaskulare Physiol, D-60596 Frankfurt, Germany.
C3 University of London; King's College London; University of London;
   King's College London; Oxford University Hospitals NHS Foundation Trust;
   King's College Hospital NHS Foundation Trust; King's College Hospital;
   University of London; King's College London; Goethe University Frankfurt
RP Brewer, AC (corresponding author), Kings Coll London, British Heart Fdn Ctr Res Excellence, James Black Ctr, Cardiovasc Div, London SE5 9NU, England.
EM alison.brewer@kcl.ac.uk
RI Schröder, Katrin/E-6874-2013; Brandes, Ralf P/L-3058-2017; Shah,
   Azhar-ul-Haq/I-1522-2015
OI Schröder, Katrin/0000-0002-3099-526X; Brandes, Ralf
   P/0000-0002-8035-0048; Shah, Ajay/0000-0002-6547-0631; Murray,
   Thomas/0000-0003-3019-2739
FU British Heart Foundation (BHF) [PG/11/124/29318, RG/08/110/25922]; BHF
   Centre of Excellence Award [RE/13/2/30182]; Foundation Leducq
   Transatlantic Network of Excellence Award [09CVD01]; British Heart
   Foundation [RG/13/11/30384, PG/11/124/29318] Funding Source:
   researchfish
FX This work was supported by grants from the British Heart Foundation
   (BHF), nos. PG/11/124/29318 and RG/08/110/25922, a BHF Centre of
   Excellence Award-RE/13/2/30182 and a Foundation Leducq Transatlantic
   Network of Excellence Award grant no. 09CVD01.
CR Anilkumar N, 2008, ARTERIOSCL THROM VAS, V28, P1347, DOI 10.1161/ATVBAHA.108.164277
   Anilkumar N, 2013, ARTERIOSCL THROM VAS, V33, pE104, DOI 10.1161/ATVBAHA.112.300956
   Babelova A, 2012, FREE RADICAL BIO MED, V53, P842, DOI 10.1016/j.freeradbiomed.2012.06.027
   Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005
   Bellanti F, 2014, SYSTEMS BIOL FREE RA, P1809
   Brewer AC, 2011, FREE RADICAL BIO MED, V51, P205, DOI 10.1016/j.freeradbiomed.2011.04.022
   Burgoon JM, 2002, TERATOLOGY, V65, P219, DOI 10.1002/tera.10040
   Burgoyne JR, 2013, ANTIOXID REDOX SIGN, V18, P1042, DOI 10.1089/ars.2012.4817
   Burgoyne JR, 2010, METHOD ENZYMOL, V473, P281, DOI 10.1016/S0076-6879(10)73015-9
   Castro C, 2008, ARCH BIOCHEM BIOPHYS, V472, P26, DOI 10.1016/j.abb.2008.01.017
   Chen K, 2008, J CELL BIOL, V181, P1129, DOI 10.1083/jcb.200709049
   Chew TW, 2011, J NUTR, V141, P1475, DOI 10.3945/jn.111.138859
   Fernàndez-Roig S, 2013, AM J CLIN NUTR, V97, P1252, DOI 10.3945/ajcn.112.054189
   FINKELSTEIN JD, 1990, J NUTR BIOCHEM, V1, P228, DOI 10.1016/0955-2863(90)90070-2
   Friedman AN, 2001, J AM SOC NEPHROL, V12, P2181, DOI 10.1681/ASN.V12102181
   GAITONDE MK, 1967, BIOCHEM J, V104, P627, DOI 10.1042/bj1040627
   Geiszt M, 2000, P NATL ACAD SCI USA, V97, P8010, DOI 10.1073/pnas.130135897
   Hinson Jack A, 2010, Handb Exp Pharmacol, P369, DOI 10.1007/978-3-642-00663-0_12
   Hobbs CA, 2005, AM J CLIN NUTR, V82, P598, DOI 10.1093/ajcn/82.3.598
   Hodgman MJ, 2012, CRIT CARE CLIN, V28, P499, DOI 10.1016/j.ccc.2012.07.006
   Innis SM, 2006, J NUTR, V136, P2226, DOI 10.1093/jn/136.8.2226
   Jaeschke H, 2012, DRUG METAB REV, V44, P88, DOI 10.3109/03602532.2011.602688
   Joseph J, 2013, NUTRIENTS, V5, P3235, DOI 10.3390/nu5083235
   Kuroda J, 2010, P NATL ACAD SCI USA, V107, P15565, DOI 10.1073/pnas.1002178107
   LAUTERBURG BH, 1984, HEPATOLOGY, V4, P586, DOI 10.1002/hep.1840040402
   Leopold JA, 2005, ARTERIOSCL THROM VAS, V25, P1332, DOI 10.1161/01.ATV.0000163846.51473.09
   Li DQ, 2005, AM J CLIN NUTR, V82, P188, DOI 10.1093/ajcn/82.1.188
   Lu SC, 2000, CURR TOP CELL REGUL, V36, P95
   Lyons J, 2000, P NATL ACAD SCI USA, V97, P5071, DOI 10.1073/pnas.090083297
   Martin HL, 2009, FASEB J, V23, P3263, DOI 10.1096/fj.08-125443
   McCord JM, 2000, AM J MED, V108, P652, DOI 10.1016/S0002-9343(00)00412-5
   McGregor DO, 2001, KIDNEY INT, V59, P2267, DOI 10.1046/j.1523-1755.2001.00743.x
   Mosharov E, 2000, BIOCHEMISTRY-US, V39, P13005, DOI 10.1021/bi001088w
   Murray TVA, 2013, J BIOL CHEM, V288, P15745, DOI 10.1074/jbc.M112.439844
   Paré G, 2009, CIRC-CARDIOVASC GENE, V2, P142, DOI 10.1161/CIRCGENETICS.108.829804
   Park EI, 1999, J BIOL CHEM, V274, P7816, DOI 10.1074/jbc.274.12.7816
   Possamai LA, 2013, CRIT CARE MED, V41, P2543, DOI 10.1097/CCM.0b013e31829791a2
   Ray R, 2011, ARTERIOSCL THROM VAS, V31, P1368, DOI 10.1161/ATVBAHA.110.219238
   Reid M, 2001, CURR OPIN CLIN NUTR, V4, P65, DOI 10.1097/00075197-200101000-00012
   Schalinske KL, 2012, ADV NUTR, V3, P755, DOI 10.3945/an.112.002758
   Sekhar RV, 2011, DIABETES CARE, V34, P162, DOI 10.2337/dc10-1006
   Sethuraman M, 2004, MOL CELL PROTEOMICS, V3, P273, DOI 10.1074/mcp.T300011-MCP200
   Shah D, 2013, IMMUNOBIOLOGY, V218, P620, DOI 10.1016/j.imbio.2012.07.030
   Simpson K, 2003, LAB INVEST, V83, P199, DOI 10.1097/01.LAB.0000057002.16935.84
   Singh Simendra, 2012, J Exp Ther Oncol, V9, P303
   Stipanuk MH, 2006, J NUTR, V136, p1652S, DOI 10.1093/jn/136.6.1652S
   Takac I, 2011, J BIOL CHEM, V286, P13304, DOI 10.1074/jbc.M110.192138
   Teng YW, 2011, J BIOL CHEM, V286, P36258, DOI 10.1074/jbc.M111.265348
   Townsend DM, 2003, BIOMED PHARMACOTHER, V57, P145, DOI 10.1016/S0753-3322(03)00043-X
   Truong TH, 2012, BIOCHEMISTRY-US, V51, P9954, DOI 10.1021/bi301441e
   Vitvitsky V, 2004, AM J PHYSIOL-REG I, V287, pR39, DOI 10.1152/ajpregu.00036.2004
   Wijekoon EP, 2005, DIABETES, V54, P3245, DOI 10.2337/diabetes.54.11.3245
   Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.10.2783S
   Zhang M, 2010, P NATL ACAD SCI USA, V107, P18121, DOI 10.1073/pnas.1009700107
NR 54
TC 22
Z9 37
U1 0
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0891-5849
EI 1873-4596
J9 FREE RADICAL BIO MED
JI Free Radic. Biol. Med.
PD DEC
PY 2015
VL 89
BP 918
EP 930
DI 10.1016/j.freeradbiomed.2015.09.015
PG 13
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA CY4CI
UT WOS:000366355800086
PM 26472193
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU Kennedy, L
   Meadows, V
   Sybenga, A
   Demieville, J
   Chen, LX
   Hargrove, L
   Ekser, B
   Dar, W
   Ceci, L
   Kundu, D
   Kyritsi, K
   Pham, L
   Zhou, TH
   Glaser, S
   Meng, FY
   Alpini, G
   Francis, H
AF Kennedy, Lindsey
   Meadows, Vik
   Sybenga, Amelia
   Demieville, Jennifer
   Chen, Lixian
   Hargrove, Laura
   Ekser, Burcin
   Dar, Wasim
   Ceci, Ludovica
   Kundu, Debjyoti
   Kyritsi, Konstantina
   Pham, Linh
   Zhou, Tianhao
   Glaser, Shannon
   Meng, Fanyin
   Alpini, Gianfranco
   Francis, Heather
TI Mast Cells Promote Nonalcoholic Fatty Liver Disease Phenotypes and
   Microvesicular Steatosis in Mice Fed a Western Diet
SO HEPATOLOGY
LA English
DT Article; Early Access
ID PRIMARY SCLEROSING CHOLANGITIS; LIPID-PEROXIDATION; HEPATIC STEATOSIS;
   BILIARY HYPERPLASIA; FIBROSIS; INHIBITION; STEATOHEPATITIS; DEFICIENCY;
   ACTIVATION; PREVENTS
AB Background and Aims Nonalcoholic fatty liver disease (NAFLD) is simple steatosis but can develop into nonalcoholic steatohepatitis (NASH), characterized by liver inflammation, fibrosis, and microvesicular steatosis. Mast cells (MCs) infiltrate the liver during cholestasis and promote ductular reaction (DR), biliary senescence, and liver fibrosis. We aimed to determine the effects of MC depletion during NAFLD/NASH.
   Approach and Results Wild-type (WT) and Kit(W-sh) (MC-deficient) mice were fed a control diet (CD) or a Western diet (WD) for 16 weeks; select WT and Kit(W-sh) WD mice received tail vein injections of MCs 2 times per week for 2 weeks prior to sacrifice. Human samples were collected from normal, NAFLD, or NASH mice. Cholangiocytes from WT WD mice and human NASH have increased insulin-like growth factor 1 expression that promotes MC migration/activation. Enhanced MC presence was noted in WT WD mice and human NASH, along with increased DR. WT WD mice had significantly increased steatosis, DR/biliary senescence, inflammation, liver fibrosis, and angiogenesis compared to WT CD mice, which was significantly reduced in Kit(W-sh) WD mice. Loss of MCs prominently reduced microvesicular steatosis in zone 1 hepatocytes. MC injection promoted WD-induced biliary and liver damage and specifically up-regulated microvesicular steatosis in zone 1 hepatocytes. Aldehyde dehydrogenase 1 family, member A3 (ALDH1A3) expression is reduced in WT WD mice and human NASH but increased in Kit(W-sh) WD mice. MicroRNA 144-3 prime (miR-144-3p) expression was increased in WT WD mice and human NASH but reduced in Kit(W-sh) WD mice and was found to target ALDH1A3.
   Conclusions MCs promote WD-induced biliary and liver damage and may promote microvesicular steatosis development during NAFLD progression to NASH through miR-144-3p/ALDH1A3 signaling. Inhibition of MC activation may be a therapeutic option for NAFLD/NASH treatment.
C1 [Pham, Linh] Texas A&M Univ Texas, Dept Sci & Math, Killeen, TX USA.
   [Kennedy, Lindsey; Meadows, Vik; Chen, Lixian; Ceci, Ludovica; Kundu, Debjyoti; Kyritsi, Konstantina; Pham, Linh; Meng, Fanyin; Alpini, Gianfranco; Francis, Heather] Indiana Univ Sch Med, Dept Med, Div Gastroenterol & Hepatol, Indianapolis, IN 46202 USA.
   [Sybenga, Amelia] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA.
   [Demieville, Jennifer] Texas A&M Univ, Coll Med, Cent Texas Vet Hlth Care Syst, Bryan, TX USA.
   [Hargrove, Laura; Zhou, Tianhao; Glaser, Shannon] Texas A&M Univ, Coll Med, Dept Med Physiol, Bryan, TX USA.
   [Ekser, Burcin] Indiana Univ Sch Med, Dept Transplant Surg, Indianapolis, IN 46202 USA.
   [Dar, Wasim] Univ Texas Hlth Sci Ctr Houston, Dept Surg, Div Immunol & Organ Transplantat, Houston, TX 77030 USA.
   [Meng, Fanyin; Alpini, Gianfranco; Francis, Heather] Indiana Univ Sch Med, Richard L Roudebush VA Med Ctr, Indianapolis, IN 46202 USA.
C3 Indiana University System; Indiana University Bloomington; Vanderbilt
   University; Texas A&M University System; Texas A&M University College
   Station; Texas A&M University System; Texas A&M University College
   Station; Indiana University System; Indiana University Bloomington;
   University of Texas System; University of Texas Health Science Center
   Houston; Indiana University System; Indiana University Bloomington; US
   Department of Veterans Affairs; Veterans Health Administration (VHA);
   Richard L. Roudebush VA Medical Center
RP Francis, H (corresponding author), Indiana Univ, Richard L Roudebush VA Med Ctr, Gastroenterol,Med, 702 Rotary Circle,Rm 013C, Indianapolis, IN 46202 USA.
EM heafranc@iu.edu
RI Ekser, Burcin/I-3288-2019; Chen, Lixian/ABH-3076-2021
OI Ekser, Burcin/0000-0003-0741-8007; Kennedy, Lindsey/0000-0001-9224-8940;
   Dar, Wasim/0000-0001-8095-248X
FU Hickam Endowed Chair, Gastroenterology, Medicine, Indiana University;
   Indiana University Health-Indiana University School of Medicine
   Strategic Research Initiative; SRCS Award from the US Department of
   Veteran's Affairs, Biomedical Laboratory Research and Development
   Service; VA Merit awards from the US Department of Veteran's Affairs,
   Biomedical Laboratory Research and Development Service [5I01BX000574,
   1I01BX003031]; National Institutes of Health [DK108959, DK119421,
   DK054811]
FX Supported by the Hickam Endowed Chair, Gastroenterology, Medicine,
   Indiana University, and the Indiana University Health-Indiana University
   School of Medicine Strategic Research Initiative, the SRCS Award, and VA
   Merit awards (5I01BX000574, to G.A.; 1I01BX003031, to H.F.) from the US
   Department of Veteran's Affairs, Biomedical Laboratory Research and
   Development Service, and the National Institutes of Health (DK108959 and
   DK119421, to H.F.; DK054811, to G.A. and S.G.). This material is the
   result of work supported by resources at the Central Texas Veterans
   Health Care System (Temple, TX) and the Richard L. Roudebush VA Medical
   Center (Indianapolis, IN).
CR Ahmad SF, 2015, IMMUNOBIOLOGY, V220, P889, DOI 10.1016/j.imbio.2015.01.008
   Azzimato V, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aaw9709
   Beaven MA, 2009, EUR J IMMUNOL, V39, P11, DOI 10.1002/eji.200838899
   Brown JF, 1998, BRIT J PHARMACOL, V123, P31, DOI 10.1038/sj.bjp.0701576
   Chmelar J, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00524
   Ciupinska-Kajor M, 2013, HEPATOL INT, V7, P233, DOI 10.1007/s12072-011-9320-9
   Coulon S, 2012, CYTOKINE, V59, P442, DOI 10.1016/j.cyto.2012.05.001
   Ferri F, 2019, CAN J GASTROENTEROL, V2019, DOI 10.1155/2019/5862985
   Franceschini B, 2007, J VIRAL HEPATITIS, V14, P549, DOI 10.1111/j.1365-2893.2007.00859.x
   FROMENTY B, 1995, PHARMACOL THERAPEUT, V67, P101, DOI 10.1016/0163-7258(95)00012-6
   Fromenty Bernard, 1997, Journal of Hepatology, V26, P13, DOI 10.1016/S0168-8278(97)82328-8
   Hargrove L, 2017, HEPATOLOGY, V65, P1991, DOI 10.1002/hep.29079
   Hargrove L, 2016, LAB INVEST, V96, P1198, DOI 10.1038/labinvest.2016.89
   HSU LC, 1994, GENOMICS, V24, P333, DOI 10.1006/geno.1994.1624
   Hua TNM, 2018, J RECEPT SIG TRANSD, V38, P191, DOI 10.1080/10799893.2018.1468781
   Johnson C, 2016, AM J PATHOL, V186, P123, DOI 10.1016/j.ajpath.2015.09.016
   Jones H, 2016, HEPATOLOGY, V64, P1202, DOI 10.1002/hep.28704
   Kennedy L, 2020, LAB INVEST, V100, P837, DOI 10.1038/s41374-020-0405-8
   Kennedy L, 2018, HEPATOLOGY, V68, P1042, DOI 10.1002/hep.29898
   Kennedy L, 2018, AM J PATHOL, V188, P600, DOI 10.1016/j.ajpath.2017.11.016
   Kennedy LL, 2014, LAB INVEST, V94, P1406, DOI 10.1038/labinvest.2014.129
   Konishi M, 2006, J GASTROEN HEPATOL, V21, P1821, DOI 10.1111/j.1440-1746.2006.04420.x
   Lessmann E, 2006, EXP HEMATOL, V34, P1532, DOI 10.1016/j.exphem.2006.05.022
   Letteron P, 1996, J HEPATOL, V24, P200, DOI 10.1016/S0168-8278(96)80030-4
   Liu J, 2009, NAT MED, V15, P940, DOI 10.1038/nm.1994
   Lombardo J, 2019, HUM PATHOL, V86, P129, DOI 10.1016/j.humpath.2018.11.029
   Macdonald GA, 2001, J GASTROEN HEPATOL, V16, P599, DOI 10.1046/j.1440-1746.2001.02445.x
   Morita M, 2012, FREE RADICAL RES, V46, P758, DOI 10.3109/10715762.2012.677840
   Natarajan SK, 2006, J GASTROEN HEPATOL, V21, P1240, DOI 10.1111/j.1440-1746.2006.04313.x
   Nobili V, 2012, HEPATOLOGY, V56, P2142, DOI 10.1002/hep.25742
   Pettinelli P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205747
   Popescu M, 2016, ROM J MORPHOL EMBRYO, V57, P1295
   Ratziu V, 2002, HEPATOLOGY, V35, P1485, DOI 10.1053/jhep.2002.33324
   Richardson MM, 2007, GASTROENTEROLOGY, V133, P80, DOI 10.1053/j.gastro.2007.05.012
   Schilderink R, 2016, AM J PHYSIOL-GASTR L, V310, pG1138, DOI 10.1152/ajpgi.00411.2015
   Smith DD, 2012, AM J PHYSIOL-HEART C, V302, pH2612, DOI 10.1152/ajpheart.00879.2011
   Tandra S, 2011, J HEPATOL, V55, P654, DOI 10.1016/j.jhep.2010.11.021
   Tashiro K, 2010, HEPATOL RES, V40, P514, DOI 10.1111/j.1872-034X.2010.00627.x
   Vega-Badillo J, 2016, LIVER INT, V36, P1383, DOI 10.1111/liv.13109
   Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038
   Wu N, 2017, FASEB J, V31, P4305, DOI 10.1096/fj.201700097R
   Yamashiro M, 1998, VIRCHOWS ARCH, V433, P471, DOI 10.1007/s004280050276
   Yin HY, 2011, CHEM REV, V111, P5944, DOI 10.1021/cr200084z
   Yokoyama M, 2004, GASTROENTEROLOGY, V127, P892, DOI 10.1053/j.gastro.2004.06.020
NR 44
TC 25
Z9 27
U1 0
U2 16
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD 2021 JUL
PY 2021
VL 74
IS 1
BP 164
EP 182
DI 10.1002/hep.31713
EA MAY 2021
PG 19
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA TN1VG
UT WOS:000653111600001
PM 33434322
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Stucchi, P
   Guzmán-Ruiz, R
   Gil-Ortega, M
   Merino, B
   Somoza, B
   Cano, V
   de Castro, J
   Sevillano, J
   Ramos, MP
   Fernández-Alfonso, MS
   Ruiz-Gayo, M
AF Stucchi, Paula
   Guzman-Ruiz, Rocio
   Gil-Ortega, Marta
   Merino, Beatriz
   Somoza, Beatriz
   Cano, Victoria
   de Castro, Javier
   Sevillano, Julio
   Pilar Ramos, M.
   Fernandez-Alfonso, Maria S.
   Ruiz-Gayo, Mariano
TI Leptin resistance develops spontaneously in mice during adult life in a
   tissue-specific manner. Consequences for hepatic steatosis
SO BIOCHIMIE
LA English
DT Article
DE STAT3; Akt; Leptin receptors; Leptin resistance; Liver
ID DIET-INDUCED OBESITY; INSULIN-RESISTANCE; LIPOREGULATION; SENSITIVITY;
   METABOLISM
AB Leptin is an adipocyte-derived hormone which stimulates beta-oxidation in peripheral tissues and prevents steatosis. Because leptin production naturally increases during adult life, we have hypothesized that leptin receptors might undergo a physiological and gradual desensitization during ageing. Therefore we have characterized in three- five- and ten-month old mice i) the weight of different white adipose pads, heart and liver, ii) lipid content in these tissues/organs, and iii) responsiveness to acute leptin, measured in terms of phosphorylation of signal transducer and activator of transcription 3 (STAT3) and protein kinase B (Akt). In this study we have detected that leptin-mediated STAT3 phosphorylation appears to be preserved in cardiac tissue even in 10-month old animals but not in adipose tissue and liver of five- and ten-month old mice, respectively. Nevertheless, leptin increased pAkt content in the liver of these mice. In a parallel study we have analyzed the functionality of leptin signalling pathways in 10-month old obese mice and we have observed that the STAT3 pathway appears to be only operative in the heart whereas the Akt pathway remains functional both in heart and liver. Nevertheless, hepatic lipids increased almost 300% compared to age-matched lean controls. Our data demonstrate that during adult life there is a lost of leptin receptor functionality which is tissue-dependent and mainly affects the STAT3 pathway. Otherwise we demonstrate that the antisteatotic effect of leptin is independent of the Akt signalling pathway. (C) 2011 Elsevier Masson SAS. All rights reserved.
C1 [Guzman-Ruiz, Rocio; Gil-Ortega, Marta; Merino, Beatriz; Somoza, Beatriz; Cano, Victoria; Ruiz-Gayo, Mariano] Univ CEU San Pablo, Fac Farm, Dept Ciencias Farmaceut & Alimentac, Madrid 28668, Spain.
   [Stucchi, Paula; Fernandez-Alfonso, Maria S.] Univ Complutense, Inst Pluridisciplinar, E-28040 Madrid, Spain.
   [de Castro, Javier; Sevillano, Julio; Pilar Ramos, M.] Univ CEU San Pablo, Fac Farm, Dept Biol, Madrid 28668, Spain.
C3 San Pablo CEU University; Complutense University of Madrid; San Pablo
   CEU University
RP Ruiz-Gayo, M (corresponding author), Univ CEU San Pablo, Fac Farm, Dept Ciencias Farmaceut & Alimentac, Madrid 28668, Spain.
EM ruigayo@ceu.es
RI Guzmán-Ruiz, Rocio/G-1432-2016; Somoza, Beatriz/M-1260-2017; Cano,
   Victoria/GRO-4093-2022; PALACIOS, BEATRIZ MERINO/F-5517-2017; Sevillano,
   Julio J/K-6387-2014; Ramos-Alvarez, Maria P./B-6359-2011; Ruiz-Gayo,
   Mariano/H-3720-2015; Guzman-Ruiz, Rocio/V-8462-2019; Gil-Ortega,
   Marta/M-8742-2015; Fernández-Alfonso, María S./F-5066-2016
OI Sevillano, Julio J/0000-0001-7726-6673; Ramos-Alvarez, Maria
   P./0000-0002-7727-7783; Ruiz-Gayo, Mariano/0000-0002-2805-5076;
   Gil-Ortega, Marta/0000-0002-6366-8214; Fernández-Alfonso, María
   S./0000-0002-9110-8070; Somoza Hernandez, Beatriz/0000-0003-1232-7791;
   Cano, Victoria/0000-0003-3694-6183
FU Ministerio de Ciencia e Innovacion [SAF 2009-09714, SAF 2008-02703,
   SAF2010-19603, SAF 2007-64881]; Fundacion Universitaria San Pablo-CEU;
   Society for the Study of Cardiometabolic Health (SESCAMET); Universidad
   Complutense [UCM GR-921641]
FX Supported by Ministerio de Ciencia e Innovacion (SAF 2009-09714, SAF
   2008-02703, SAF2010-19603 and SAF 2007-64881), Fundacion Universitaria
   San Pablo-CEU, Society for the Study of Cardiometabolic Health
   (SESCAMET) and Universidad Complutense (UCM GR-921641). PS, BM and MG-O
   are supported by grants of Ministerio de Ciencia e Innovacion. RG-R is a
   fellow from CEU-Universidad San Pablo. We acknowledge J.M. Garrido, I.
   Bordallo and J. Bravo for skilful animal care.
CR Abdul-Ghani MA, 2006, DIABETES CARE, V29, P1130, DOI 10.2337/dc05-2179
   Ahren B, 1997, AM J PHYSIOL-REG I, V273, pR113, DOI 10.1152/ajpregu.1997.273.1.R113
   BJORNTORP P, 1995, METABOLISM, V44, P21, DOI 10.1016/0026-0495(95)90315-1
   Cacho J, 2008, AM J PHYSIOL-ENDOC M, V295, pE1269, DOI 10.1152/ajpendo.90207.2008
   Ernst MB, 2009, J NEUROSCI, V29, P11582, DOI 10.1523/JNEUROSCI.5712-08.2009
   Fishman S, 2007, FASEB J, V21, P53, DOI 10.1096/fj.06-6557com
   GOTO T, 1995, INT J OBESITY, V19, P841
   Guzmán-Ruiz R, 2010, ENDOCRINOLOGY, V151, P1010, DOI 10.1210/en.2009-1170
   He LN, 2010, AM J PATHOL, V176, P2302, DOI 10.2353/ajpath.2010.090931
   HERRERA E, 1972, J LIPID RES, V13, P802
   Kim F, 2008, ARTERIOSCL THROM VAS, V28, P1982, DOI 10.1161/ATVBAHA.108.169722
   Lee Y, 2001, J BIOL CHEM, V276, P5629, DOI 10.1074/jbc.M008553200
   Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100
   Münzberg H, 2004, ENDOCRINOLOGY, V145, P4880, DOI 10.1210/en.2004-0726
   Ryysy L, 2000, DIABETES, V49, P749, DOI 10.2337/diabetes.49.5.749
   Sáinz N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006808
   Shimabukuro M, 1997, P NATL ACAD SCI USA, V94, P4637, DOI 10.1073/pnas.94.9.4637
   Somoza B, 2007, ENDOCRINOLOGY, V148, P924, DOI 10.1210/en.2006-0914
   Unger RH, 2003, ENDOCRINOLOGY, V144, P5159, DOI 10.1210/en.2003-0870
   Unger RH, 2001, FASEB J, V15, P312, DOI 10.1096/fj.00-0590
   Wang ZW, 1999, P NATL ACAD SCI USA, V96, P10373, DOI 10.1073/pnas.96.18.10373
   You J, 2010, MOL CELL BIOL, V30, P1650, DOI 10.1128/MCB.01307-09
   Zhou YT, 2000, P NATL ACAD SCI USA, V97, P1784, DOI 10.1073/pnas.97.4.1784
NR 23
TC 19
Z9 20
U1 0
U2 5
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 0300-9084
EI 1638-6183
J9 BIOCHIMIE
JI Biochimie
PD OCT
PY 2011
VL 93
IS 10
BP 1779
EP 1785
DI 10.1016/j.biochi.2011.06.020
PG 7
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 823FK
UT WOS:000295107700018
PM 21740952
DA 2024-02-19
ER

PT J
AU Maclaine, KD
   Stebbings, KA
   Llano, DA
   Rhodes, JS
AF Maclaine, Kendra D.
   Stebbings, Kevin A.
   Llano, Daniel A.
   Rhodes, Justin S.
TI Voluntary wheel running has no impact on brain and liver mitochondrial
   DNA copy number or mutation measures in the PolG mouse model of aging
SO PLOS ONE
LA English
DT Article
ID HIPPOCAMPAL NEUROGENESIS; CELL-PROLIFERATION; OXIDATIVE STRESS;
   EXERCISE; RENEWAL
AB The mitochondrial theory of aging attributes much of the aging process to mitochondrial DNA damage. The polymerase gamma (PolG) mutant mouse was designed to evaluate this theory and thus carries a mutated proofreading region of polymerase gamma (D257A) that exclusively transcribes the mitochondrial genome. As a result, PolGD(257A) mice accumulate mitochondrial DNA (mtDNA) mutations that lead to premature aging, as evidenced by hair loss, weight loss, kyphosis, increased rates of apoptosis, organ damage, and an early death, occurring around 12 months of age. Research has shown that exercise decreases skeletal muscle mtDNA mutations and normalizes protein levels in PolG mice. However, brain mtDNA changes with exercise in PolG mice have not been studied. We found no effects of exercise on mtDNA mutations or copy number in either the brain or liver of PolG mice, despite changes to body mass. Our results suggest that mitochondrial mutations play little role in exercise-brain interactions in the PolG model of accelerated aging. In addition to evaluating the effect of exercise on mtDNA outcomes, we also implemented novel methods for both extracting mtDNA and measuring mtDNA mutations, with aims for improving the efficiency and accuracy of these methods.
C1 [Maclaine, Kendra D.; Stebbings, Kevin A.; Llano, Daniel A.; Rhodes, Justin S.] Univ Illinois, Beckman Inst, Urbana, IL 61801 USA.
   [Stebbings, Kevin A.; Llano, Daniel A.; Rhodes, Justin S.] Univ Illinois, Neurosci Program, Beckman Inst, Urbana, IL 61801 USA.
   [Llano, Daniel A.] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL USA.
   [Rhodes, Justin S.] Univ Illinois, Dept Psychol, Champaign, IL 61820 USA.
C3 University of Illinois System; University of Illinois Urbana-Champaign;
   University of Illinois System; University of Illinois Urbana-Champaign;
   University of Illinois System; University of Illinois Urbana-Champaign;
   University of Illinois System; University of Illinois Urbana-Champaign
RP Rhodes, JS (corresponding author), Univ Illinois, Beckman Inst, Urbana, IL 61801 USA.; Rhodes, JS (corresponding author), Univ Illinois, Neurosci Program, Beckman Inst, Urbana, IL 61801 USA.; Rhodes, JS (corresponding author), Univ Illinois, Dept Psychol, Champaign, IL 61820 USA.
EM jrhodes@illinois.edu
OI , Kendra/0000-0003-0750-6365; Llano, Daniel/0000-0003-0933-1837
FU MCB SROP, Jenner award [AG059103]; Beckman Neurotechnology for Memory
   and Cognition undergraduate fellowship
FX This project was funded by grant AG059103 (to D.A.L.) and MCB SROP,
   Jenner award and Beckman Neurotechnology for Memory and Cognition
   undergraduate fellowship (to K.D. M.). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Bronte V, 2013, IMMUNITY, V39, P806, DOI 10.1016/j.immuni.2013.10.010
   Brummelte S, 2010, NEUROSCIENCE, V168, P680, DOI 10.1016/j.neuroscience.2010.04.023
   CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407
   Chu HT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S7-S5
   Clark PJ, 2011, GENES BRAIN BEHAV, V10, P345, DOI 10.1111/j.1601-183X.2010.00674.x
   Clark PJ, 2009, HIPPOCAMPUS, V19, P937, DOI 10.1002/hipo.20543
   Clark-Matott J, 2015, NEUROBIOL AGING, V36, P2972, DOI 10.1016/j.neurobiolaging.2015.07.020
   EDWARDS JL, 1961, AM J PATHOL, V38, P437
   Faraci C, 2018, REPRODUCTION, V156, P185, DOI 10.1530/REP-18-0061
   Foote K, 2018, AGING CELL, V17, DOI 10.1111/acel.12773
   Herbst A, 2016, AGING CELL, V15, P1132, DOI 10.1111/acel.12520
   Ibarguchi G, 2006, GENOME, V49, P1438, DOI 10.1139/G06-107
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293
   Kamakura R, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12703
   Kramer AF, 2006, J APPL PHYSIOL, V101, P1237, DOI 10.1152/japplphysiol.00500.2006
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lezi E, 2014, NEUROBIOL AGING, V35, P2574, DOI 10.1016/j.neurobiolaging.2014.05.033
   Lezi E, 2013, EXP PHYSIOL, V98, P207, DOI 10.1113/expphysiol.2012.066688
   Lightfoot JT, 2004, PHYSIOL GENOMICS, V19, P270, DOI 10.1152/physiolgenomics.00125.2004
   Ma H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201304
   Magami Y, 2002, LIVER, V22, P419, DOI 10.1034/j.1600-0676.2002.01702.x
   Malik AN, 2016, MITOCHONDRION, V29, P59, DOI 10.1016/j.mito.2016.05.003
   Manouze H, 2019, ENEURO, V6, DOI 10.1523/ENEURO.0179-18.2019
   Puente-Maestu L, 2011, THORAX, V66, P121, DOI 10.1136/thx.2010.153031
   Quiros PM, 2017, CURR PROTOC MOUSE BI, V7, P47
   Quispe-Tintaya W, 2013, BIOTECHNIQUES, V55, P133, DOI 10.2144/000114077
   Ross JM, 2019, AGING CELL, V18, DOI 10.1111/acel.13029
   Safdar A, 2016, CURR OPIN GENET DEV, V38, P127, DOI 10.1016/j.gde.2016.06.011
   Safdar A, 2011, P NATL ACAD SCI USA, V108, P4135, DOI 10.1073/pnas.1019581108
   Steiner JL, 2011, J APPL PHYSIOL, V111, P1066, DOI 10.1152/japplphysiol.00343.2011
   Svensson M, 2016, NEUROBIOL STRESS, V5, P8, DOI 10.1016/j.ynstr.2016.09.002
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Turner MJ, 2005, PHYSIOL GENOMICS, V22, P76, DOI 10.1152/physiolgenomics.00243.2004
   van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005
   van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368
   Zhang P, 2017, GENOMICS, V109, P457, DOI 10.1016/j.ygeno.2017.07.002
NR 36
TC 6
Z9 9
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 2
PY 2020
VL 15
IS 3
AR e0226860
DI 10.1371/journal.pone.0226860
PG 17
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA LQ8JT
UT WOS:000535245300004
PM 32119683
OA Green Published, gold, Green Submitted
DA 2024-02-19
ER

PT J
AU Cougnoux, A
   Dalmasso, G
   Martinez, R
   Buc, E
   Delmas, J
   Gibold, L
   Sauvanet, P
   Darcha, C
   Déchelotte, P
   Bonnet, M
   Pezet, D
   Wodrich, H
   Darfeuille-Michaud, A
   Bonnet, R
AF Cougnoux, Antony
   Dalmasso, Guillaume
   Martinez, Ruben
   Buc, Emmanuel
   Delmas, Julien
   Gibold, Lucie
   Sauvanet, Pierre
   Darcha, Claude
   Dechelotte, Pierre
   Bonnet, Mathilde
   Pezet, Denis
   Wodrich, Harald
   Darfeuille-Michaud, Arlette
   Bonnet, Richard
TI Bacterial genotoxin colibactin promotes colon tumour growth by inducing
   a senescence-associated secretory phenotype
SO GUT
LA English
DT Article
ID ESCHERICHIA-COLI; COLORECTAL-CANCER; GENOMIC INSTABILITY; INFLAMMATION;
   MODEL; TUMORIGENESIS; CARCINOGENESIS; ACTIVATION; MODULATE; MUCIN
AB Background Escherichia coli strains harbouring the pks island (pks+ E. coli) are often seen in human colorectal tumours and have a carcinogenic effect independent of inflammation in an AOM/IL-10(-/-) (azoxymethane/interleukin) mouse model.
   Objective To investigate the mechanism sustaining pks+ E. coli-induced carcinogenesis.
   Method Underlying cell processes were investigated in vitro and in vivo (xenograft model) using intestinal epithelial cells infected by pks+ E. coli or by an isogenic mutant defective for pks (pks- E. coli). The results were supported by data obtained from an AOM/DSS (azoxymethane/dextran sodium sulphate) colon cancer mouse model and from human colon cancer biopsy specimens colonised by pks+ E. coli or pks- E. coli.
   Results Colibactin-producing E. coli enhanced tumour growth in both xenograft and AOM/DSS models. Growth was sustained by cellular senescence (a direct consequence of small ubiquitin-like modifier (SUMO)conjugated p53 accumulation), which was accompanied by the production of hepatocyte growth factor (HGF). The underlying mechanisms involve microRNA-20a-5p, which targets SENP1, a key protein regulating p53 deSUMOylation. These results are consistent with the expression of SENP1, microRNA-20a-5p, HGF and phosphorylation of HGF receptor found in human and mouse colon cancers colonised by pks+ E. coli.
   Conclusion These data reveal a new paradigm for carcinogenesis, in which colibactin-induced senescence has an important role.
C1 [Cougnoux, Antony; Dalmasso, Guillaume; Buc, Emmanuel; Delmas, Julien; Gibold, Lucie; Sauvanet, Pierre; Bonnet, Mathilde; Pezet, Denis; Darfeuille-Michaud, Arlette; Bonnet, Richard] Univ Auvergne, Clermont Univ, INSERM, UMR 1071, Clermont Ferrand, France.
   [Cougnoux, Antony; Dalmasso, Guillaume; Buc, Emmanuel; Delmas, Julien; Gibold, Lucie; Sauvanet, Pierre; Bonnet, Mathilde; Pezet, Denis; Darfeuille-Michaud, Arlette; Bonnet, Richard] INRA, USC 2018, Clermont Ferrand, France.
   [Martinez, Ruben; Wodrich, Harald] Univ Bordeaux Segalen, CNRS, UMR 5234, Bordeaux, France.
   [Buc, Emmanuel; Sauvanet, Pierre; Pezet, Denis] Ctr Hosp Univ, Serv Chirurg Digest, Clermont Ferrand, France.
   [Delmas, Julien; Gibold, Lucie; Bonnet, Richard] Ctr Hosp Univ, Serv Bacteriol, Clermont Ferrand, France.
   [Darcha, Claude; Dechelotte, Pierre] CHU Clermont Ferrand, Serv Anatomopathol, Clermont Ferrand, France.
C3 Institut National de la Sante et de la Recherche Medicale (Inserm);
   Universite Clermont Auvergne (UCA); INRAE; Centre National de la
   Recherche Scientifique (CNRS); CNRS - National Institute for Biology
   (INSB); Universite de Bordeaux; CHU Clermont Ferrand; CHU Clermont
   Ferrand; CHU Clermont Ferrand
RP Bonnet, R (corresponding author), CHU, Lab Bacteriol, 58 Rue Montalembert, F-63000 Clermont Ferrand, France.
EM rbonnet@chu-clermontferrand.fr
RI Pezet, Denis/I-4423-2017; Buc, Emmanuel/JEP-6444-2023; Wodrich,
   Harald/P-1777-2019; Bonnet, Mathilde/T-2835-2017; Dalmasso,
   Guillaume/N-2443-2018; Bonnet, Richard/C-8544-2015
OI Pezet, Denis/0000-0001-9416-2876; Wodrich, Harald/0000-0002-4764-1708;
   Bonnet, Mathilde/0000-0003-3629-7267; Dalmasso,
   Guillaume/0000-0002-3433-870X; Cougnoux, Antony/0000-0001-9407-7540;
   MARTINEZ, Ruben/0009-0008-1414-1695
FU Ministere de la Recherche et de la Technologie; Institut National de la
   Sante et de la Recherche Medicale [UMR Inserm U1071]; Institut National
   de la Recherche Agronomique [USC-2018]; Ligue Contre le Cancer; Centre
   Hospitalier Regional Universitaire de Clermont-Ferrand, France
FX This work was supported by the Ministere de la Recherche et de la
   Technologie, the Institut National de la Sante et de la Recherche
   Medicale (UMR Inserm U1071), the Institut National de la Recherche
   Agronomique (USC-2018), the Ligue Contre le Cancer and the Centre
   Hospitalier Regional Universitaire de Clermont-Ferrand, France.
CR Abdulamir AS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-249
   Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820
   Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013
   Bischof O, 2007, CELL CYCLE, V6, P677, DOI 10.4161/cc.6.6.4021
   BOLAND CR, 1990, GASTROENTEROLOGY, V98, P1170, DOI 10.1016/0016-5085(90)90330-4
   Bonifacio LN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012519
   Buc E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056964
   CAMPBELL BJ, 1995, J CLIN INVEST, V95, P571, DOI 10.1172/JCI117700
   Cuevas-Ramos G, 2010, P NATL ACAD SCI USA, V107, P11537, DOI 10.1073/pnas.1001261107
   de Martel C, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70137-7
   Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191
   Dove WF, 1997, CANCER RES, V57, P812
   Dreux N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003141
   Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005
   FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I
   Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516
   Goodwin AC, 2011, P NATL ACAD SCI USA, V108, P15354, DOI 10.1073/pnas.1010203108
   Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013
   Guerra L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008924
   Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698
   Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560
   Lax AJ, 2005, NAT REV MICROBIOL, V3, P343, DOI 10.1038/nrmicro1130
   Maddocks ODK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005517
   Martin HM, 2004, GASTROENTEROLOGY, V127, P80, DOI 10.1053/j.gastro.2004.03.054
   Matsui S, 2010, INT J ONCOL, V37, P289, DOI 10.3892/ijo_00000677
   Matsuo K, 1997, GUT, V40, P782, DOI 10.1136/gut.40.6.782
   Mikolajczyk J, 2007, J BIOL CHEM, V282, P26217, DOI 10.1074/jbc.M702444200
   Muehlbauer M, 2013, GASTROENTEROLOGY, V144, pS144
   Nougayrède JP, 2006, SCIENCE, V313, P848, DOI 10.1126/science.1127059
   Nougayrède JP, 2005, TRENDS MICROBIOL, V13, P103, DOI 10.1016/j.tim.2005.01.002
   O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677
   Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094
   Sliwinska MA, 2009, MECH AGEING DEV, V130, P24, DOI 10.1016/j.mad.2008.04.011
   Stein U, 2009, NAT MED, V15, P59, DOI 10.1038/nm.1889
   Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943
   Swidsinski A, 1998, GASTROENTEROLOGY, V115, P281, DOI 10.1016/S0016-5085(98)70194-5
   Tanaka T, 2003, CANCER SCI, V94, P965, DOI 10.1111/j.1349-7006.2003.tb01386.x
   Tjalsma H, 2012, NAT REV MICROBIOL, V10, P575, DOI 10.1038/nrmicro2819
   Uronis JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006026
   Wang XM, 2007, GASTROENTEROLOGY, V132, P551, DOI 10.1053/j.gastro.2006.11.040
   Witty J, 2010, BIOCHEM J, V428, P247, DOI 10.1042/BJ20091948
   Wu SG, 2007, J CELL SCI, V120, P1944, DOI 10.1242/jcs.03455
   Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015
   Yates KE, 2008, AGING CELL, V7, P609, DOI 10.1111/j.1474-9726.2008.00411.x
NR 44
TC 288
Z9 326
U1 7
U2 88
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0017-5749
EI 1468-3288
J9 GUT
JI Gut
PD DEC
PY 2014
VL 63
IS 12
BP 1932
EP 1942
DI 10.1136/gutjnl-2013-305257
PG 11
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA AS0AA
UT WOS:000343938200016
PM 24658599
HC Y
HP N
DA 2024-02-19
ER

PT J
AU Stojkovski, V
   Hadzi-Petrushev, N
   Ilieski, V
   Sopi, R
   Gjorgoski, I
   Mitrov, D
   Jankulovski, N
   Mladenov, M
AF Stojkovski, V.
   Hadzi-Petrushev, N.
   Ilieski, V.
   Sopi, R.
   Gjorgoski, I.
   Mitrov, D.
   Jankulovski, N.
   Mladenov, M.
TI Age and Heat Exposure-Dependent Changes in Antioxidant Enzymes
   Activities in Rat's Liver and Brain Mitochondria: Role of α-tocopherol
SO PHYSIOLOGICAL RESEARCH
LA English
DT Article
DE Antioxidant enzymes; Mitochondria; Liver; Brain; Aging; Heat exposure
ID VITAMIN-E SUCCINATE; LIPID-PEROXIDATION; HYDROGEN-PEROXIDE; GLUTATHIONE;
   HEPATOCYTES; STRESS
AB To investigate the role of mitochondrial antioxidant capacity during increased susceptibility to heat accompanied by the aging, young and aged Wistar rats were exposed on heat for 60 min. After heat exposure, hepatic and brain mitochondria were isolated. Our results revealed changes in antioxidant enzyme activities in liver and brain mitochondria from young and to a greater extent in aged rats. Our measurements of MnSOD, GPx and GR activity indicate greater reactive oxygen species production from the mitochondria of aged heat exposed in comparison to young heat exposed rats. Also in the aged rats, the effect of alpha-tocopherol treatment in the prevention of oxidative stress occurred as a result of heat exposure, is less pronounced. Taken together, our data suggest that mitochondria in aged rats are more vulnerable and less able to prevent oxidative changes that occur in response to acute heat exposure.
C1 [Hadzi-Petrushev, N.; Sopi, R.; Gjorgoski, I.; Mladenov, M.] Ss Cyril & Methodius Univ, Inst Biol, Fac Nat Sci & Math, Skopje, North Macedonia.
   [Stojkovski, V.; Ilieski, V.; Mitrov, D.] Ss Cyril & Methodius Univ, Fac Vet Med, Skopje, North Macedonia.
   [Jankulovski, N.] Ss Cyril & Methodius Univ, Fac Med, Skopje, North Macedonia.
C3 Saints Cyril & Methodius University of Skopje; Saints Cyril & Methodius
   University of Skopje; Saints Cyril & Methodius University of Skopje
RP Mladenov, M (corresponding author), Sts Cyril & Methodius Univ, Inst Biol, Fac Nat Sci & Math, POB 162, Skopje 1000, North Macedonia.
EM mitkom@pmf.ukim.mk
RI Ilieski, Vlatko/Q-9254-2019; Sopi, Ramadan/GYU-9796-2022; Mladennov,
   Mitko/HDM-7959-2022
OI Mladennov, Mitko/0000-0003-3475-2131
FU Ss. Cyril and Methodius University in Skopje
FX We wish to thank Prof. Anton Kossev from the Institute of Biophysics,
   Bulgarian Academy of Sciences in Sofia for assistance with manuscript
   preparation. We acknowledge the financial support from the Ss. Cyril and
   Methodius University in Skopje.
CR APRILLE JR, 1981, ARCH BIOCHEM BIOPHYS, V212, P689, DOI 10.1016/0003-9861(81)90413-6
   Aydin AF, 2010, BIOGERONTOLOGY, V11, P103, DOI 10.1007/s10522-009-9232-4
   Berg BM, 2004, BRAIN BEHAV IMMUN, V18, P149, DOI 10.1016/S0889-1591(03)00113-2
   Carretero M, 2009, J PINEAL RES, V47, P192, DOI 10.1111/j.1600-079X.2009.00700.x
   Chow CK, 1999, FREE RADICAL BIO MED, V27, P580, DOI 10.1016/S0891-5849(99)00121-5
   Del MAESTRO RF, 1983, OXY RADICALS THEIR S, P16
   Djordjevic J, 2010, PHYSIOL RES, V59, P729, DOI 10.33549/physiolres.931862
   Fariss MW, 2003, TOXICOLOGY, V189, P129, DOI 10.1016/S0300-483X(03)00158-6
   Fariss MW, 2001, FREE RADICAL BIO MED, V31, P530, DOI 10.1016/S0891-5849(01)00615-3
   Godbout JP, 2005, J NEUROIMMUNOL, V169, P97, DOI 10.1016/j.jneuroim.2005.08.003
   Godbout JP, 2004, J NEUROIMMUNOL, V149, P101, DOI 10.1016/j.jneuroim.2003.12.017
   Hadzi-Petrushev N, 2011, J PHYSIOL SCI, V61, P437, DOI 10.1007/s12576-011-0165-8
   Hadzi-Petrushev N, 2012, J THERM BIOL, V37, P361, DOI 10.1016/j.jtherbio.2011.12.013
   Iqbal M, 2002, POULTRY SCI, V81, P252, DOI 10.1093/ps/81.2.252
   JAESCHKE H, 1990, J PHARMACOL EXP THER, V255, P935
   Knight TR, 2001, TOXICOL SCI, V62, P212, DOI 10.1093/toxsci/62.2.212
   LAWRENCE RA, 1976, BIOCHEM BIOPH RES CO, V71, P952, DOI 10.1016/0006-291X(76)90747-6
   Liu JK, 2002, ANN NY ACAD SCI, V959, P133, DOI 10.1111/j.1749-6632.2002.tb02090.x
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Mladenov M, 2008, J THERM BIOL, V33, P431, DOI 10.1016/j.jtherbio.2008.07.001
   Mladenov M, 2006, J THERM BIOL, V31, P588, DOI 10.1016/j.jtherbio.2006.08.001
   Morrison JP, 2005, J APPL PHYSIOL, V99, P2271, DOI 10.1152/japplphysiol.00412.2005
   MURPHY DJ, 1981, BIOCHIM BIOPHYS ACTA, V663, P390, DOI 10.1016/0005-2760(81)90168-5
   OLAFSDOTTIR K, 1988, BIOCHIM BIOPHYS ACTA, V964, P377, DOI 10.1016/0304-4165(88)90038-4
   Öztürk G, 2012, EXP GERONTOL, V47, P706, DOI 10.1016/j.exger.2012.06.011
   RACKER E, 1955, J BIOL CHEM, V217, P855
   Rikans LE, 1997, BBA-MOL BASIS DIS, V1362, P116, DOI 10.1016/S0925-4439(97)00067-7
   Tretter L, 2000, J NEUROSCI, V20, P8972
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   YEN TC, 1994, FREE RADICAL BIO MED, V16, P207, DOI 10.1016/0891-5849(94)90145-7
   Zhang JG, 2001, CHEM-BIOL INTERACT, V138, P267, DOI 10.1016/S0009-2797(01)00278-2
   Zhang JG, 2001, ARCH BIOCHEM BIOPHYS, V393, P87, DOI 10.1006/abbi.2001.2486
NR 32
TC 10
Z9 10
U1 0
U2 9
PU ACAD SCIENCES CZECH REPUBLIC, INST PHYSIOLOGY
PI PRAGUE 4
PA VIDENSKA 1083, PRAGUE 4 142 20, CZECH REPUBLIC
SN 0862-8408
EI 1802-9973
J9 PHYSIOL RES
JI Physiol. Res.
PY 2013
VL 62
IS 5
BP 503
EP 510
DI 10.33549/physiolres.932514
PG 8
WC Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology
GA 258FM
UT WOS:000327444700004
PM 24020814
OA gold
DA 2024-02-19
ER

PT J
AU Wu, SX
   Han, XM
   Jiang, XW
   Tao, J
AF Wu, Su-Xi
   Han, Xiao-Miao
   Jiang, Xue-Wei
   Tao, Jun
TI The Effects of Two Different Multivitamins on Aging Mice
SO CHINESE JOURNAL OF PHYSIOLOGY
LA English
DT Article
DE aging; anti-aging; antioxidases; mechanism; multivitamin
ID AMELIORATES COGNITION DEFICITS; ATTENUATES OXIDATIVE DAMAGE;
   MONOAMINE-OXIDASE; D-GALACTOSE; BRAIN; MECHANISMS
AB Investigating anti-aging factors that is more effective than antioxidants has important theoretical significance and application value. In search for nutritional ingredients that are more effective in anti-aging, two different multivitamins (multivitamin-1 at a dose of 2.5 mg/kg body weight [BW]/day; multivitamin-2 at a dose of 5.4 mg/kg BW/day) were administered to aging mice (N = 40) induced by D-galactose. The content or activity of the biochemical components associated with aging and anti-aging in the brain and the liver of the experimental mice was then determined for analysis of statistically significant difference among the groups. Results showed the mice in the aging model group exhibited obvious senility symptoms. However, the mice in the multivitamin-1 and multivitamin-2 groups were essentially similar to those of the control group, but were obviously better than the mice in the aging model group. Multivitamin-1 and multivitamin-2 decreased significantly the malondialdehyde (MDA) content and monoamine oxidase (MAO) activity (P < 0.01), and increased significantly the activity of glutathione peroxidase (GSH-Px), copper/zinc-superoxide dismutase (Cu/Zn-SOD) and manganese-superoxide dismutase (Mn-SOD) (P < 0.01) in the brain and the liver of the aging mice. There was no significant difference (P > 0.05) between the effects of the two multivitamins on the components associated with aging and anti-aging. In conclusions, this work showed that vitamins B-1, B-2, B-6 and PP (Nicotinic acid or vitamin B-3) play key roles in the anti-aging process of multivitamin-2. Vitamins B-1, B-2, B-6, and PP are more effective nutrients in anti-aging in mice.
C1 [Wu, Su-Xi; Han, Xiao-Miao; Jiang, Xue-Wei; Tao, Jun] Changsha Univ Sci & Technol, Sch Chem & Bioengn, 960 Southern Wanjiali Rd, Changsha 410004, Hunan, Peoples R China.
C3 Changsha University of Science & Technology
RP Tao, J (corresponding author), Changsha Univ Sci & Technol, Sch Chem & Bioengn, 960 Southern Wanjiali Rd, Changsha 410004, Hunan, Peoples R China.
EM taojun1954@126.com
FU Construct Program of the Key Discipline in Hunan Province; Key Research
   and Development Program in Hunan Province [2016NK2136]
FX This study was supported by the Construct Program of the Key Discipline
   in Hunan Province and Key Research and Development Program in Hunan
   Province (2016NK2136).
CR BENEDETTI MS, 1989, BIOCHEM PHARMACOL, V38, P555, DOI 10.1016/0006-2952(89)90198-6
   Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202
   Bjelakovic G, 2007, JAMA-J AM MED ASSOC, V297, P842, DOI 10.1001/jama.297.8.842
   Chen JF, 2000, PROG BIOCHEM BIOPHYS, V27, P504
   Chocano-Bedoya PO, 2011, AM J CLIN NUTR, V93, P1080, DOI 10.3945/ajcn.110.009530
   Chondrogianni N, 2014, FREE RADICAL BIO MED, V71, P303, DOI 10.1016/j.freeradbiomed.2014.03.031
   Gariballa S, 2014, INT J VITAM NUTR RES, V84, P12, DOI 10.1024/0300-9831/a000188
   Huang C., 2003, MED NUTR, P62
   Jilani T, 2015, INT J VITAM NUTR RES, V85, P39, DOI 10.1024/0300-9831/a000222
   [李国星 LI GuoXing], 2007, [中国老年学杂志, Chinese Journal of Gerontology], V27, P820
   Li HY, 2009, TOXICON, V53, P595, DOI 10.1016/j.toxicon.2008.11.005
   Li M, 2013, COMP BIOCHEM PHYS C, V157, P310, DOI 10.1016/j.cbpc.2013.02.003
   Lindley SE, 2005, PSYCHONEUROENDOCRINO, V30, P785, DOI 10.1016/j.psyneuen.2005.03.007
   Lu J, 2007, BIOCHEM PHARMACOL, V74, P1078, DOI 10.1016/j.bcp.2007.07.007
   Pan MH, 2012, MOL NUTR FOOD RES, V56, P88, DOI 10.1002/mnfr.201100509
   Pauling L., 1989, NEW NUTR HLTH LONGEV, P73
   Peter L, 2011, GEN COMP ENDOCR, V172, P39, DOI 10.1016/j.ygcen.2011.02.005
   Ribeiro ML, 2007, MECH AGEING DEV, V128, P577, DOI 10.1016/j.mad.2007.08.002
   Shang F, 2011, FREE RADICAL BIO MED, V51, P5, DOI 10.1016/j.freeradbiomed.2011.03.031
   Song X, 1999, MECH AGEING DEV, V108, P239, DOI 10.1016/S0047-6374(99)00022-6
   Wang J., 2002, BIOCHEMISTRY-US, P433
   Wu K., 2005, NUTR FOOD HYGIENE, P77
   Wu SX, 2017, AFR J TRADIT COMPLEM, V14, P52, DOI [10.21010/ajtcam.v14i1.7, 10.21010/ajtcam.v14i1.4256]
   Zhang XL, 2007, PHARMACOL BIOCHEM BE, V88, P64, DOI 10.1016/j.pbb.2007.07.004
NR 24
TC 2
Z9 3
U1 1
U2 13
PU CHINESE PHYSIOLOGICAL SOC
PI TAIPEI
PA CHINA MEDICAL UNIVERSITY HOSPITAL, UNIV MEDICAL CENTER OF AGING
   RESEARCH, TAIPEI, TAICHUNG 40402, TAIWAN
SN 0304-4920
J9 CHINESE J PHYSIOL
JI Chin. J. Physiol.
PD OCT
PY 2017
VL 60
IS 5
BP 284
EP 292
DI 10.4077/CJP.2017.BAG496
PG 9
WC Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology
GA FL6KU
UT WOS:000414354400004
PM 28950693
DA 2024-02-19
ER

PT J
AU van Santen, DK
   van der Loeff, MFS
   van Dissel, JC
   Martens, JPD
   van der Valk, M
   Prins, M
AF van Santen, Daniela K.
   van der Loeff, Maarten F. Schim
   van Dissel, Judith Cartier
   Martens, Jonie P. D.
   van der Valk, Marc
   Prins, Maria
TI High proportions of liver fibrosis and cirrhosis in an ageing population
   of people who use drugs in Amsterdam, The Netherlands
SO EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
LA English
DT Article
DE cirrhosis; fibrosis; hepatitis C virus; HIV; liver; people who use drugs
ID HEPATITIS-C-VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; INJECT DRUGS; TRANSIENT
   ELASTOGRAPHY; NATURAL-HISTORY; 2 DECADES; HIV; DISEASE; PROGRESSION;
   INFECTION
AB BackgroundThe incidence and prevalence of hepatitis C virus (HCV) infection among people who use drugs (PWUD) peaked in the 1980s in Amsterdam. As liver cirrhosis develops several decades after HCV infection and PWUD have other risk factors for liver fibrosis, we hypothesized that significant liver fibrosis or cirrhosis is now common among PWUD in Amsterdam.MethodsPWUD were recruited from the Amsterdam Cohort Studies, methadone programmes and addiction clinics during 2009-2016. Transient elastography was performed to assess liver stiffness. We estimated METAVIR fibrosis levels on the basis of the following liver stiffness measurements (LSMs) cut-offs: F0-F2 (no/mild) less than 7.65kPa; F2-F3 (moderate/severe) at least 7.65 to less than 13kPa; and F4 (cirrhosis) at least 13kPa. Using linear regression models, we assessed the association between LSM and sociodemographic, clinical and behavioural determinants in (a) all PWUD and (b) chronic hepatitis C virus (cHCV)-infected PWUD.ResultsFor 140 PWUD, the median LSM was 7.6kPa (interquartile range=4.9-12.0); 26.4% had moderate/severe fibrosis and 22.9% had cirrhosis. Of 104 chronically infected PWUD, 57.7% had evidence of significant fibrosis (F2). In multivariable analysis including all PWUD, increased LSM was associated significantly with cHCV monoinfection and HIV/HCV coinfection. In cHCV-infected PWUD, older age was associated significantly with increased LSM. In all groups, longer duration of heavy alcohol drinking was associated with increased LSM.ConclusionA high proportion of PWUD had significant fibrosis or cirrhosis that were associated with cHCV infection, HIV/HCV coinfection and duration of heavy alcohol drinking. Increased uptake of HCV treatment and interventions to reduce alcohol use are needed to decrease the liver disease burden in this population.
C1 [van Santen, Daniela K.; van der Loeff, Maarten F. Schim; van Dissel, Judith Cartier; Martens, Jonie P. D.; Prins, Maria] Publ Hlth Serv Amsterdam, Dept Infect Dis Res & Prevent, Amsterdam, Netherlands.
   [van der Loeff, Maarten F. Schim; Prins, Maria] AMC, Dept Infect Dis, AI&II, Amsterdam, Netherlands.
   [van der Valk, Marc] HIV Monitoring Fdn, Amsterdam, Netherlands.
C3 Public Health Service Amsterdam; University of Amsterdam; Academic
   Medical Center Amsterdam
RP van Santen, DK (corresponding author), Nieuwe Achtergracht 100, NL-1018 WT Amsterdam, Netherlands.
EM dvsanten@ggd.amsterdam.nl
RI van Santen, Daniela/AAF-9260-2020; van der valk, marc/AAQ-9026-2020
OI van der valk, marc/0000-0002-8290-6425
FU Center for Infectious Disease Control of The Netherlands National
   Institute for Public Health and the Environment
FX The authors thank ACS and non-ACS participants for their contribution;
   ACS research nurses Wendy van der Veldt, Maja Totte and Laura del Grande
   for data collection and cohort management; Gerben-Rienk Visser and Linda
   May for data management support; Katherine Kooij for FibroScan technical
   support; Ronald Geskus and Anders Boyd for critically reviewing the
   manuscript; and Lucy Phillips for editing the final manuscript. The
   Amsterdam Cohort Studies (ACS) on HIV infection and AIDS is a
   collaboration between the Public Health Service of Amsterdam, the
   Academic Medical Center of the University of Amsterdam, Sanquin Blood
   Supply Foundation, Medical Center Jan van Goyen and the HIV Focus Center
   of the DC-Clinics. ACS is part of the Dutch HIV Monitoring Foundation
   and is financially supported by the Center for Infectious Disease
   Control of The Netherlands National Institute for Public Health and the
   Environment.
CR Alferink LJM, 2017, J HEPATOL, V67, P339, DOI 10.1016/j.jhep.2017.03.013
   Bajis S, 2017, INT J DRUG POLICY, V47, P34, DOI 10.1016/j.drugpo.2017.07.002
   Bouscaillou J, 2014, INT J DRUG POLICY, V25, P871, DOI 10.1016/j.drugpo.2014.01.007
   BUNING EC, 1990, BRIT J ADDICT, V85, P1247
   Castera L, 2014, HIV MED, V15, P30, DOI 10.1111/hiv.12082
   Chan J, 2018, DIGEST DIS SCI, V63, P486, DOI 10.1007/s10620-017-4749-x
   de Vos AS, 2013, ADDICTION, V108, P1070, DOI 10.1111/add.12125
   Degenhardt L, 2017, LANCET GLOB HEALTH, V5, pE1192, DOI 10.1016/S2214-109X(17)30375-3
   European Centre for Disease Prevention and Control, 2012, THEM REP PEOPL WHO I
   Friedrich-Rust M, 2008, GASTROENTEROLOGY, V134, P960, DOI 10.1053/j.gastro.2008.01.034
   Friedrich-Rust M, 2016, NAT REV GASTRO HEPAT, V13, P402, DOI 10.1038/nrgastro.2016.86
   Gordon SC, 2015, AM J GASTROENTEROL, V110, P1169, DOI 10.1038/ajg.2015.203
   Grady BPX, 2015, J VIRAL HEPATITIS, V22, P263, DOI 10.1111/jvh.12303
   Grady BP, 2013, CLIN INFECT DIS, V57, pS105, DOI 10.1093/cid/cit301
   Jerkeman A, 2014, SCAND J INFECT DIS, V46, P340, DOI 10.3109/00365548.2013.879994
   Kielland KB, 2014, J HEPATOL, V60, P260, DOI 10.1016/j.jhep.2013.09.022
   Kirk GD, 2013, ANN INTERN MED, V158, P658, DOI 10.7326/0003-4819-158-9-201305070-00604
   Larsen C, 2010, J MED VIROL, V82, P1647, DOI 10.1002/jmv.21850
   Lee YA, 2014, ANTIVIR RES, V107, P23, DOI 10.1016/j.antiviral.2014.03.012
   Marshall AD, 2015, INT J DRUG POLICY, V26, P984, DOI 10.1016/j.drugpo.2015.07.002
   Matser A, 2012, ADDICTION, V107, P614, DOI 10.1111/j.1360-0443.2011.03654.x
   Micallef JM, 2006, J VIRAL HEPATITIS, V13, P34, DOI 10.1111/j.1365-2893.2005.00651.x
   Moessner BK, 2011, ADDICTION, V106, P970, DOI 10.1111/j.1360-0443.2010.03246.x
   PLATT JJ, 1976, HEROIN ADDICTION THE
   Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8
   Probst A, 2011, J VIRAL HEPATITIS, V18, P745, DOI 10.1111/j.1365-2893.2011.01481.x
   Rai R, 2002, HEPATOLOGY, V35, P1247, DOI 10.1053/jhep.2002.33151
   Scott DR, 2010, ANTIVIR THER, V15, P1, DOI 10.3851/IMP1474
   Smit C, 2008, JAIDS-J ACQ IMM DEF, V47, P221, DOI 10.1097/QAI.0b013e31815d2f59
   Smith DJ, 2015, INT J DRUG POLICY, V26, P911, DOI 10.1016/j.drugpo.2015.07.004
   Talwalkar JA, 2007, CLIN GASTROENTEROL H, V5, P1214, DOI 10.1016/j.cgh.2007.07.020
   Thein HH, 2008, AIDS, V22, P1979, DOI 10.1097/QAD.0b013e32830e6d51
   Thrift AP, 2017, NAT REV GASTRO HEPAT, V14, P122, DOI 10.1038/nrgastro.2016.176
   Van den Berg C, 2007, ADDICTION, V102, P1454, DOI 10.1111/j.1360-0443.2007.01912.x
   van den Berg CHSB, 2007, EUR J EPIDEMIOL, V22, P183, DOI 10.1007/s10654-006-9089-7
   van der Knaap N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059125
   van Houdt R, 2009, J MED VIROL, V81, P1163, DOI 10.1002/jmv.21504
   van Santen DK, 2017, INT J DRUG POLICY, V47, P95, DOI 10.1016/j.drugpo.2017.05.026
   van Santen DK, 2014, AIDS, V28, P2589, DOI 10.1097/QAD.0000000000000450
   VANDENHOEK JAR, 1988, AIDS, V2, P55, DOI 10.1097/00002030-198802000-00010
   VANHAASTRECHT HJA, 1991, AM J PUBLIC HEALTH, V81, P59, DOI 10.2105/AJPH.81.1.59
   Vergniol J, 2009, J VIRAL HEPATITIS, V16, P132, DOI [10.1111/j.1365-2893.2008.01055.x, 10.1111/j.1365-2893.2008.01050.x]
   Wilson LE, 2006, HEPATOLOGY, V43, P788, DOI 10.1002/hep.21091
NR 43
TC 7
Z9 7
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0954-691X
EI 1473-5687
J9 EUR J GASTROEN HEPAT
JI Eur. J. Gastroenterol. Hepatol.
PD OCT
PY 2018
VL 30
IS 10
BP 1168
EP 1176
DI 10.1097/MEG.0000000000001213
PG 9
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Gastroenterology & Hepatology
GA GV0LC
UT WOS:000445751300010
PM 30028776
DA 2024-02-19
ER

PT J
AU LUTTRELL, WE
   CASTLE, MC
AF LUTTRELL, WE
   CASTLE, MC
TI ENHANCEMENT OF HEPATIC-MICROSOMAL ESTERASE-ACTIVITY FOLLOWING SOMAN
   PRETREATMENT IN GUINEA-PIGS
SO BIOCHEMICAL PHARMACOLOGY
LA English
DT Article
DE ENZYME ENHANCEMENT; SOMAN; PINACOLONE; PINACOLYL ALCOHOL; ACETONE;
   CARBOXYLESTERASES; HYDROXYLASES; ESTERASES
ID RAT-LIVER; INHIBITION; INVIVO; INVITRO; MICE
AB Soman (pinacolyl methylphosphonofluoridate), a highly toxic organophosphate compound, has been found to be a strong inhibitor of hepatic microsomal carboxylesterase in vitro, but an enhancer of carboxylesterase when administered in vivo. In response to this paradoxical observation, the objective of this study was to determine if soman could cause true enhancement of the metabolism of drugs in the guinea pig and, if so, to characterize the enhanced enzyme activity. Following the pretreatment of guinea pigs with 90% LD(50) soman, enhancement of microsomal esterase activity was noted 12 and 24 hr after pretreatment. Using Michaelis-Menten enzyme kinetic studies, enhancement was found to occur with liver carboxylesterase and procaine esterase, but not with aniline hydroxylase. Since the soman-enzyme complex was known to undergo aging with the release of pinacolyl alcohol and the subsequent formation of pinacolone, the effects of these metabolites on the activity of liver microsomal enzymes in vitro were explored. Pinacolone and pinacolyl alcohol produced enzyme enhancement in vitro in a manner similar to that produced by soman pretreatment. These effects were compared with those made by acetone in the same incubations, since the enhancing influence of acetone has already been well documented. Similarity was found between the in vitro effects of acetone and the effects of pinacolone and pinacolyl alcohol. Lastly, the in vivo effects of pinacolone on the activities of the same liver microsomal enzymes were studied following pretreatment of the guinea pigs with 90% LD(Lo) (lowest published lethal dose) pinacolone. Pretreating guinea pigs with pinacolone prior to killing them enhanced liver microsomal carboxylesterase and procaine esterase activities, but had no effect on microsomal aniline hydroxylase activity. This pattern of enzyme enhancement was similar to that observed after soman pretreatment. Therefore, soman was found to enhance hepatic microsomal esterase activity in the guinea pig in a manner similar to that seen with its metabolites, as well as acetone. This information may give insight into how the efficacy and toxicity of therapeutic drugs, other xenobiotics, and endogenous materials may be altered in individuals who survive an exposure to soman.
RP LUTTRELL, WE (corresponding author), EASTERN VIRGINIA MED SCH,DEPT PHARMACOL,NORFOLK,VA 23501, USA.
CR AKAO T, 1972, J BIOCHEM, V72, P1245, DOI 10.1093/oxfordjournals.jbchem.a130012
   ANDERS MW, 1968, ARCH BIOCHEM BIOPHYS, V126, P269, DOI 10.1016/0003-9861(68)90583-3
   ANDERS MW, 1971, ANNU REV PHARMACOLOG, V11, P37, DOI 10.1146/annurev.pa.11.040171.000345
   ANDERS MW, 1969, BIOCHEM PHARMACOL, V18, P2561, DOI 10.1016/0006-2952(69)90371-2
   BANHEGYI G, 1988, BIOCHEM PHARMACOL, V37, P4157, DOI 10.1016/0006-2952(88)90110-4
   BENSCHOP HP, 1984, TOXICOL APPL PHARM, V72, P61, DOI 10.1016/0041-008X(84)90249-7
   BRANDT E, 1980, BIOCHEM PHARMACOL, V29, P1927, DOI 10.1016/0006-2952(80)90105-7
   CASTLE MC, 1989, XENOBIOTICA, V19, P115, DOI 10.3109/00498258909034683
   CASTLE MC, 1988, ARCH INT PHARMACOD T, V295, P7
   CHOW AYK, 1973, BIOCHEM PHARMACOL, V22, P689, DOI 10.1016/0006-2952(73)90401-2
   CLEMENT JG, 1985, FUND APPL TOXICOL, V5, pS61, DOI 10.1016/0272-0590(85)90115-0
   DOMSCHKE W, 1970, ARCH TOXIKOL, V26, P76
   FLEISHER JH, 1965, BIOCHEM PHARMACOL, V14, P641, DOI 10.1016/0006-2952(65)90082-1
   Gibson GG, 1986, INTRO DRUG METABOLIS
   KITADA M, 1978, JPN J PHARMACOL, V28, P213, DOI 10.1254/jjp.28.213
   KRISCH K, 1966, BIOCHIM BIOPHYS ACTA, V122, P265, DOI 10.1016/0926-6593(66)90067-1
   Lewis R. J., 1982, REGISTRY TOXIC EFFEC
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   LUTTRELL WE, 1988, FUND APPL TOXICOL, V11, P323, DOI 10.1016/0272-0590(88)90157-1
   MAXWELL DM, 1987, TOXICOL APPL PHARM, V88, P66, DOI 10.1016/0041-008X(87)90270-5
   Purshottam T., 1992, Indian Journal of Physiology and Pharmacology, V36, P197
   REYNOLDS ML, 1985, TOXICOL APPL PHARM, V80, P409, DOI 10.1016/0041-008X(85)90385-0
   SATO A, 1991, ANN OCCUP HYG, V35, P525, DOI 10.1093/annhyg/35.5.525
   SHIH ML, 1991, BIOL MASS SPECTROM, V20, P717, DOI 10.1002/bms.1200201111
NR 24
TC 3
Z9 3
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0006-2952
J9 BIOCHEM PHARMACOL
JI Biochem. Pharmacol.
PD DEC 3
PY 1993
VL 46
IS 11
BP 2083
EP 2092
DI 10.1016/0006-2952(93)90651-C
PG 10
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA MM435
UT WOS:A1993MM43500025
PM 8267657
DA 2024-02-19
ER

PT J
AU Bazzar, W
   Bocci, M
   Hejll, E
   Tabor, VH
   Hydbring, P
   Grandien, A
   Alzrigat, M
   Larsson, LG
AF Bazzar, Wesam
   Bocci, Matteo
   Hejll, Eduar
   Hogqvist Tabor, Vedrana
   Hydbring, Per
   Grandien, Alf
   Alzrigat, Mohammad
   Larsson, Lars-Gunnar
TI Pharmacological inactivation of CDK2 inhibits MYC/BCL-XL-driven leukemia
   in vivo through induction of cellular senescence
SO CELL CYCLE
LA English
DT Article; Early Access
DE MYC; CDK2; leukemia; senescence; BCL-X-L; mouse models
AB Deregulated expression of the MYC oncogene is a frequent event during tumorigenesis and generally correlates with aggressive disease and poor prognosis. While MYC is a potent inducer of apoptosis, it often suppresses cellular senescence, which together with apoptosis is an important barrier against tumor development. For this latter function, MYC is dependent on cyclin-dependent kinase 2 (CDK2). Here, we utilized a MYC/BCL-X-L-driven mouse model of acute myeloblastic leukemia (AML) to investigate whether pharmacological inhibition of CDK2 can inhibit MYC-driven tumorigenesis through induction of senescence. Purified mouse hematopoietic stem cells transduced with MYC and BCL-X-L were transplanted into lethally irradiated mice, leading to the development of massive leukemia and subsequent death 15-17 days after transplantation. Upon disease onset, mice were treated with the selective CDK2 inhibitor CVT2584 or vehicle either by daily intraperitoneal injections or continuous delivery via mini-pumps. CVT2584 treatment delayed disease onset and moderately but significantly improved survival of mice. Flow cytometry revealed a significant decrease in tumor load in the spleen, liver and bone marrow of CVT2584-treated compared to vehicle-treated mice. This was correlated with induced senescence evidenced by reduced cell proliferation, increased senescence-associated beta-galactosidase activity and heterochromatin foci, expression of p19(ARF) and p21(CIP1), and reduced phosphorylation (activation) of pRb, while very few apoptotic cells were observed. In addition, phosphorylation of MYC at Ser-62 was decreased. In summary, inhibition of CDK2 delayed MYC/BCL-X-L-driven AML linked to senescence induction. Our results suggest that CDK2 is a promising target for pro-senescence cancer therapy, in particular for MYC-driven tumors, including leukemia.
C1 [Bazzar, Wesam; Bocci, Matteo; Hejll, Eduar; Hogqvist Tabor, Vedrana; Hydbring, Per; Alzrigat, Mohammad; Larsson, Lars-Gunnar] Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, Stockholm, Sweden.
   [Grandien, Alf] Karolinska Univ Hosp Huddinge, Ctr Hematol & Regenerat Med, Dept Med, Stockholm, Sweden.
   [Bocci, Matteo] Lund Univ, Div Translat Canc Res, Canc Ctr Medicon Village, Lund, Sweden.
   [Hejll, Eduar] Agilent Technol, Barcelona, Spain.
   [Hogqvist Tabor, Vedrana] BOOST Thyroid VLM Hlth UG, Berlin, Germany.
   [Hydbring, Per] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden.
C3 Karolinska Institutet; Karolinska Institutet; Karolinska University
   Hospital; Lund University; Agilent Technologies; Karolinska Institutet
RP Larsson, LG (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, Stockholm, Sweden.
EM Lars-Gunnar.Larsson@ki.se
RI Bocci, Matteo/AAB-5016-2021; Larsson, Lars-Gunnar O/D-9747-2012
OI Alzrigat, Mohammad/0000-0001-5514-8625; Bocci,
   Matteo/0000-0002-8774-0006; Hogqvist Tabor, Vedrana/0000-0001-9224-208X
FU Barncancerfonden [PR20150123, PR2019-0063, TJ2019-0018, PR2017-0161];
   Cancerfonden [CAN 2017/781, 19 0561 Pj]; Karolinska Institutet
   [2018-02235]; Radiumhemmets Forskningsfonder [191182]
FX This work was supported by the Barncancerfonden [PR20150123];
   Barncancerfonden [PR2019-0063]; Barncancerfonden [TJ2019-0018];
   Barncancerfonden [PR2017-0161]; Cancerfonden [CAN 2017/781];
   Cancerfonden [19 0561 Pj]; Karolinska Institutet [2018-02235]; and
   Radiumhemmets Forskningsfonder [191182].
CR Abraham SA, 2016, NATURE, V534, P341, DOI 10.1038/nature18288
   Acosta JC, 2012, TRENDS CELL BIOL, V22, P211, DOI 10.1016/j.tcb.2011.11.006
   AKIYAMA T, 1992, P NATL ACAD SCI USA, V89, P7900, DOI 10.1073/pnas.89.17.7900
   Anders L, 2011, CANCER CELL, V20, P620, DOI 10.1016/j.ccr.2011.10.001
   Baker A, 2016, CANCER RES, V76, P1158, DOI 10.1158/0008-5472.CAN-15-1070
   Bisso A, 2019, IMMUNOL REV, V288, P178, DOI 10.1111/imr.12734
   Bolin S, 2018, ONCOGENE, V37, P2850, DOI 10.1038/s41388-018-0135-1
   Bots M, 2014, BLOOD, V123, P1341, DOI 10.1182/blood-2013-03-488114
   Brooks EE, 1997, J BIOL CHEM, V272, P29207, DOI 10.1074/jbc.272.46.29207
   Campaner S, 2010, NAT CELL BIOL, V12, P54, DOI 10.1038/ncb2004
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   Casey SC, 2016, SCIENCE, V352, P227, DOI 10.1126/science.aac9935
   CONACCISORRELL M, 2014, CSH PERSPECT MED, V4, DOI DOI 10.1101/CSHPERSPECT.A014357
   Delgado M Dolores, 2010, Genes Cancer, V1, P605, DOI 10.1177/1947601910377495
   Fry DW, 2004, MOL CANCER THER, V3, P1427
   Gabay M, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014241
   Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005
   Hernandez-Segura A, 2018, TRENDS CELL BIOL, V28, P436, DOI 10.1016/j.tcb.2018.02.001
   Herrera-Abreu MT, 2016, CANCER RES, V76, P2301, DOI 10.1158/0008-5472.CAN-15-0728
   Högstrand K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031366
   Horiuchi D, 2012, P NATL ACAD SCI USA, V109, pE1019, DOI 10.1073/pnas.1111317109
   Hydbring P, 2017, GENES-BASEL, V8, DOI 10.3390/genes8070174
   Hydbring P, 2010, P NATL ACAD SCI USA, V107, P58, DOI 10.1073/pnas.0900121106
   Jones L, 2010, J EXP MED, V207, P2581, DOI 10.1084/jem.20091071
   Juan J, 2014, GENE DEV, V28, P561, DOI 10.1101/gad.233627.113
   Kalkat M, 2017, GENES-BASEL, V8, DOI 10.3390/genes8060151
   KARASUYAMA H, 1988, EUR J IMMUNOL, V18, P97, DOI 10.1002/eji.1830180115
   Kortlever RM, 2017, CELL, V171, P1301, DOI 10.1016/j.cell.2017.11.013
   Kress TR, 2015, NAT REV CANCER, V15, P593, DOI 10.1038/nrc3984
   Larsson LG, 2011, SEMIN CANCER BIOL, V21, P347, DOI 10.1016/j.semcancer.2011.11.001
   Mallette FA, 2007, J BIOL CHEM, V282, P34938, DOI 10.1074/jbc.M707074200
   Milanovic M, 2018, NATURE, V553, P96, DOI 10.1038/nature25167
   Molenaar JJ, 2009, P NATL ACAD SCI USA, V106, P12968, DOI 10.1073/pnas.0901418106
   Muñoz-Espín D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823
   Musa J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12071-2
   Nardella C, 2011, NAT REV CANCER, V11, P503, DOI 10.1038/nrc3057
   Nyakeriga AM, 2005, SCAND J IMMUNOL, V61, P545, DOI 10.1111/j.1365-3083.2005.01607.x
   Ohanian M, 2019, LEUKEMIA LYMPHOMA, V60, P37, DOI 10.1080/10428194.2018.1464158
   Rader J, 2013, CLIN CANCER RES, V19, P6173, DOI 10.1158/1078-0432.CCR-13-1675
   Schick M, 2017, BRIT J HAEMATOL, V179, P724, DOI 10.1111/bjh.14917
   Schreiner S, 2001, CANCER RES, V61, P6480
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   Stine ZE, 2015, CANCER DISCOV, V5, P1024, DOI 10.1158/2159-8290.CD-15-0507
   Swartling FJ, 2010, GENE DEV, V24, P1059, DOI 10.1101/gad.1907510
   Tabor V, 2014, CANCER RES, V74, P4222, DOI 10.1158/0008-5472.CAN-13-3234
   Tadesse S, 2020, DRUG DISCOV TODAY, V25, P406, DOI 10.1016/j.drudis.2019.12.001
   Van Hooser A, 1998, J CELL SCI, V111, P3497
   van Riggelen J, 2010, GENE DEV, V24, P1281, DOI 10.1101/gad.585710
   Whittaker SR, 2017, PHARMACOL THERAPEUT, V173, P83, DOI 10.1016/j.pharmthera.2017.02.008
   Wu CH, 2007, P NATL ACAD SCI USA, V104, P13028, DOI 10.1073/pnas.0701953104
   Ying MD, 2018, BLOOD, V131, P2698, DOI 10.1182/blood-2017-10-813139
   Yun S, 2019, LEUKEMIA RES, V84, DOI 10.1016/j.leukres.2019.106194
   Zhu Y, 2016, AGING CELL, V15, P428, DOI 10.1111/acel.12445
   Zhuang D, 2008, ONCOGENE, V27, P6623, DOI 10.1038/onc.2008.258
   Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334
   Zuber J, 2009, GENE DEV, V23, P877, DOI 10.1101/gad.1771409
NR 57
TC 7
Z9 8
U1 0
U2 1
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1538-4101
EI 1551-4005
J9 CELL CYCLE
JI Cell Cycle
PD 2021 JAN 2
PY 2021
VL 20
IS 1
BP 23
EP 38
DI 10.1080/15384101.2020.1855740
EA DEC 2020
PG 16
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA PZ0HH
UT WOS:000603801800001
PM 33356836
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU Yi, G
   He, ZM
   Zhou, XK
   Xian, LW
   Yuan, TZ
   Jia, XT
   Hong, J
   He, L
   Liu, JF
AF Yi, Gao
   He, Zhimin
   Zhou, Xinke
   Xian, Lewu
   Yuan, Taize
   Jia, Xiaoting
   Hong, Jian
   He, Lu
   Liu, Jifang
TI Low concentration of metformin induces a p53-dependent senescence in
   hepatoma cells via activation of the AMPK pathway
SO INTERNATIONAL JOURNAL OF ONCOLOGY
LA English
DT Article
DE metformin; cellular senescence; hepatocellular carcinoma; AMP-activated
   protein kinase
ID PROTEIN-KINASE; CELLULAR SENESCENCE; CANCER; P53; LIVER; INHIBITION;
   BIOMARKER; THERAPY; CULTURE; MICE
AB The induction of senescence for cancer treatment has provoked considerable interest recently. Metformin, a first-line drug for diabetes mellitus type 2, appears to be associated with a lower risk and improved outcomes in hepatocellular carcinoma (HCC). The mechanism involved in function of metformin in HCC is poorly understood. We show that low doses of metformin induced hepatoma cell senescence characterized by accumulation of senescence-associated beta-galactosidase activity (SA-beta-gal) and the senescence marker Dec1, whereas the higher doses initiated apoptotic cell death. Metformin-induced senescence was accompanied by enhanced phosphorylation levels of AMP-activated protein kinase (AMPK) and its downstream target acetyl-CoA carboxylase (ACC). The expression of acetylated p53 at Lys382 (Ac-p53) and p21 was also increased, while phosphorylation of p53 at Ser15 (p-p53), p53, p16 and pRB was rarely altered after metformin treatment. Moreover, inhibition of AMPK decreased p-AMPK, p-ACC, Ac-p53 and p21 expression, diminished SA-beta-gal staining and restored hepatoma cell proliferation. In addition, p53 siRNA transfection attenuated metformin-induced SA-beta-gal staining. Intriguingly, co-expression of SIRT1 and p53 dramatically reduced the levels of Ac-p53, however, low doses of metformin treatment partially reversed the effect of SIRT1 on p53 acetylation and elevated SA-beta-gal activity. These observations indicate that activation of the AMPK pathway promotes senescence in hepatoma cells exposed to low concentrations of metformin in a p53-dependent manner. Further, low doses of metformin may have the potential to be used as an adjuvant to HCC therapy.
C1 [Yi, Gao; Xian, Lewu] Guangzhou Med Univ, Affiliated Tumor Hosp, Dept Intens Care Unit, Guangzhou 510095, Guangdong, Peoples R China.
   [He, Zhimin; Jia, Xiaoting; Liu, Jifang] Guangzhou Med Univ, Affiliated Tumor Hosp, Dept Canc Res, Guangzhou 510095, Guangdong, Peoples R China.
   [Zhou, Xinke; Hong, Jian; He, Lu] Guangzhou Med Univ, Affiliated Tumor Hosp, Dept Hepatobiliary Surg, Guangzhou 510095, Guangdong, Peoples R China.
   [Yuan, Taize] Guangzhou Med Univ, Affiliated Tumor Hosp, Dept Radiotherapy, Guangzhou 510095, Guangdong, Peoples R China.
C3 Guangzhou Medical University; Guangzhou Medical University; Guangzhou
   Medical University; Guangzhou Medical University
RP Liu, JF (corresponding author), Guangzhou Med Univ, Canc Res Inst, Guangzhou 510095, Guangdong, Peoples R China.
EM yzhbb2012@126.com
OI He, Lu/0000-0002-0391-0208
FU Star of Science and Technology of Guangzhou [A20110231]; Health Bureau
   of Guangzhou [20121A011163]
FX We would like to thank Dr Kai Luo, Min Deng, Min Hou and Min Liang for
   technical assistance and suggestions. This study was supported by grant
   A20110231 from Star of Science and Technology of Guangzhou and
   20121A011163 from Health Bureau of Guangzhou.
CR Acosta JC, 2012, TRENDS CELL BIOL, V22, P211, DOI 10.1016/j.tcb.2011.11.006
   Aljada A, 2012, PHARMACOL THERAPEUT, V133, P108, DOI 10.1016/j.pharmthera.2011.09.004
   Ben Sahra I, 2011, CANCER RES, V71, P4366, DOI 10.1158/0008-5472.CAN-10-1769
   Cairney CJ, 2012, DRUG DISCOV TODAY, V17, P269, DOI 10.1016/j.drudis.2012.01.019
   Chen HP, 2013, GUT, V62, P606, DOI 10.1136/gutjnl-2011-301708
   Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003
   Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772
   Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191
   Del Barco S, 2011, ONCOTARGET, V2, P896, DOI 10.18632/oncotarget.387
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Ewald JA, 2010, JNCI-J NATL CANCER I, V102, P1536, DOI 10.1093/jnci/djq364
   Guarente L, 2000, GENE DEV, V14, P1021
   Imamura K, 2001, BIOCHEM BIOPH RES CO, V287, P562, DOI 10.1006/bbrc.2001.5627
   JEMAL A, 2011, CA-CANCER J CLIN, V61, P69, DOI DOI 10.3322/CAAC.20107
   Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610
   Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383
   Lee MS, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-20
   Liu JF, 2012, ONCOL REP, V28, P1406, DOI 10.3892/or.2012.1932
   Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4
   Mallette FA, 2004, ONCOGENE, V23, P91, DOI 10.1038/sj.onc.1206886
   Mariño G, 2008, HUM MOL GENET, V17, P2196, DOI 10.1093/hmg/ddn120
   Nardella C, 2011, NAT REV CANCER, V11, P503, DOI 10.1038/nrc3057
   Pollak M, 2012, CANCER PREV RES, V5, P500, DOI 10.1158/1940-6207.CAPR-12-0080
   Qian YJ, 2008, J BIOL CHEM, V283, P2896, DOI 10.1074/jbc.M708624200
   Qu Z, 2012, HEPATOL RES, V42, P922, DOI 10.1111/j.1872-034X.2012.01007.x
   Sung JY, 2011, BIOCHEM BIOPH RES CO, V413, P143, DOI 10.1016/j.bbrc.2011.08.071
   Wang WG, 2003, J BIOL CHEM, V278, P27016, DOI 10.1074/jbc.M300318200
   Wang Y, 2011, FEBS LETT, V585, P986, DOI 10.1016/j.febslet.2010.11.047
   Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529
   Zhang ZJ, 2012, J CLIN ENDOCR METAB, V97, P2347, DOI 10.1210/jc.2012-1267
   Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505
   Zu Y, 2010, CIRC RES, V106, P1384, DOI 10.1161/CIRCRESAHA.109.215483
   Zwerschke W, 2003, BIOCHEM J, V376, P403, DOI 10.1042/BJ20030816
NR 35
TC 66
Z9 78
U1 1
U2 36
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1019-6439
EI 1791-2423
J9 INT J ONCOL
JI Int. J. Oncol.
PD NOV
PY 2013
VL 43
IS 5
BP 1503
EP 1510
DI 10.3892/ijo.2013.2077
PG 8
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA 225SN
UT WOS:000324982700020
PM 23982736
OA Bronze
DA 2024-02-19
ER

PT J
AU Sezgin, O
   Akpinar, H
   Özer, B
   Törüner, M
   Bal, K
   Bor, S
AF Sezgin, Orhan
   Akpinar, Hale
   Ozer, Birol
   Toruner, Murat
   Bal, Kadir
   Bor, Serhat
TI The Abdominal Ultrasonography Results of Cappadocia Cohort Study of
   Turkey Reveals High Prevalence of Fatty Liver
SO TURKISH JOURNAL OF GASTROENTEROLOGY
LA English
DT Article
DE Cholelithiasis; community-based screening; fatty liver;
   gastroenterology; hepatic steatosis; mass screening; NAFLD;
   transabdominal ultrasonography
ID GALL STONE DISEASE; PHYSICAL-ACTIVITY; NONINVASIVE ASSESSMENT; GALLSTONE
   DISEASE; POLYPOID LESIONS; GALLBLADDER; EPIDEMIOLOGY; POPULATION;
   INSULIN; ASSOCIATION
AB <bold>Background: </bold>There is limited data about the prevalence of frequent gastrointestinal diseases in developing parts of the world based on community-based screening studies. Therefore, we aimed to present the detailed transabdominal ultrasonography results of the previously completed Turkey Cappadocia cohort study, which included a population-based evaluation of gastrointestinal symptoms and diseases in adults.<bold>Methods: </bold>This cross-sectional study was conducted in Cappadocia cohort. The transabdominal ultrasonography, anthropometric measurements, and disease questionnaires were applied to cohort persons.<bold>Results: </bold>Transabdominal ultrasonography was performed in 2797 subjects (62.3% were female and the mean age was 51 & PLUSMN; 15 years). Among them, 36% were overweight, 42% were obese, and 14% had diabetes mellitus. The most common pathological finding in transabdominal ultrasonography was hepatic steatosis (60.1%). The severity of hepatic steatosis was mild in 53.3%, moderate in 38.8%, and severe in 7.9%. Age, body mass index, liver size, portal vein, splenic vein diameter, hypertension, diabetes mellitus, and hyperlipidemia were significantly higher while physical activities were significantly lower in hepatic steatosis group. Ultrasonographic grade of hepatic steatosis was positively correlated with liver size, portal vein and splenic vein diameter, frequency of diabetes mellitus, hypertension, and coronary artery disease. Hepatic steatosis was observed in none of the underweight, 11.4% of the normal weights, 53.3% of the overweight, and 86.7% of the obese subjects. The percentage of hepatic steatosis cases with normal weight (lean nonalcoholic fatty liver disease) was 3.5%. The rate of lean nonalcoholic fatty liver disease in the entire cohort was 2.1%. Regression analysis revealed male gender (hazard ratio [HR]: 3.2), hypertension (HR: 1.5), and body mass index (body mass index: 25-30 HR: 9.3, body mass index >30 HR: 75.2) as independent risk factors for hepatic steatosis. The second most common ultrasonographic finding was gallbladder stone (7.6%). In the regression analysis, female gender (HR: 1.4), body mass index (body mass index: 25-30 HR: 2.1, body mass index >30 HR: 2.9), aging (30-39 age range HR: 1.5, >70 years HR: 5.8), and hypertension (HR: 1.4) were the most important risk factors for gallbladder stone.<bold>Conclusions: </bold>Cappadocia cohort study in Turkey revealed a high prevalence of hepatic steatosis (60.1%) while the prevalence of gallbladder stones was 7.6% among the participants. The results of the Cappadocia cohort located in central Anatolia, where overweight and lack of physical activity are characteristic, showed that Turkey is one of the leading countries in the world for nonalcoholic fatty liver disease.Similar ar
C1 [Sezgin, Orhan] Mersin Univ, Dept Gastroenterol, Med Fac, Mersin, Turkiye.
   [Akpinar, Hale] Dokuz Eylul Univ, Dept Gastroenterol, Izmir, Turkiye.
   [Ozer, Birol] Baskent Univ, Dept Gastroenterol, Adana, Turkiye.
   [Toruner, Murat] Ankara Univ, Dept Gastroenterol, Fac Med, Ankara, Turkiye.
   [Bal, Kadir] Istanbul Univ Cerrahpasa, Dept Gastroenterol, Istanbul, Turkiye.
   [Bor, Serhat] Ege Univ, Dept Gastroenterol, Fac Med, Izmir, Turkiye.
C3 Mersin University; Dokuz Eylul University; Baskent University; Ankara
   University; Istanbul University - Cerrahpasa; Ege University
RP Sezgin, O (corresponding author), Mersin Univ, Dept Gastroenterol, Med Fac, Mersin, Turkiye.
EM drorhansezgin@gmail.com
CR Aerts R, 2003, ALIMENT PHARM THER, V18, P49, DOI 10.1046/j.0953-0673.2003.01721.x
   Akyuz U, 2015, SCAND J GASTROENTERO, V50, P341, DOI 10.3109/00365521.2014.983160
   Altun L, 2005, J HYPERTENS, V23, P1817
   American Gastroenterological Association, 2001, BURD GASTR DIS
   [Anonymous], 2018, NIGER J CLIN PRACT, V21, P653
   [Anonymous], 1991, TURK KARDIYOL DERN A
   Bennion CJ, 1978, NEW ENGL J MED, V229, P1221
   Berghöfer A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-200
   Beyler AR, 1993, TURK J GASTROENTEROL, V4, P434
   Celebi S, 2006, AKAD GASTROENTEROLOJ, V5, P41
   Charatcharoenwitthaya Phunchai, 2007, Clin Liver Dis, V11, P37, DOI 10.1016/j.cld.2007.02.014
   Cortés VA, 2020, OBES REV, V21, DOI 10.1111/obr.12983
   CREAGHBARRY M, 1986, CLIN RADIOL, V37, P239, DOI 10.1016/S0009-9260(86)80325-7
   Degertekin B, 2021, TURK J GASTROENTEROL, V32, P302, DOI 10.5152/tjg.2021.20062
   DEWBURY KC, 1980, BRIT J RADIOL, V53, P774, DOI 10.1259/0007-1285-53-632-774
   Diehl AK, 2000, HEPATOLOGY, V31, P528, DOI 10.1002/hep.510310238
   Eguchi Y, 2012, J GASTROENTEROL, V47, P586, DOI 10.1007/s00535-012-0533-z
   EMAMIAN SA, 1993, AM J ROENTGENOL, V160, P83, DOI 10.2214/ajr.160.1.8416654
   Estes C, 2018, J HEPATOL, V69, P896, DOI 10.1016/j.jhep.2018.05.036
   FINBERG HJ, 1979, RADIOLOGY, V133, P693, DOI 10.1148/133.3.693
   Fracanzani AL, 2017, CLIN GASTROENTEROL H, V15, P1604, DOI 10.1016/j.cgh.2017.04.045
   Hamaguchi M, 2007, AM J GASTROENTEROL, V102, P2708, DOI 10.1111/j.1572-0241.2007.01526.x
   Hawaz Y., 2012, East Cent. Afr. J. Surg., V17, P90
   Johansson G, 2008, INT J OBESITY, V32, P1031, DOI 10.1038/ijo.2008.42
   JORGENSEN T, 1989, GUT, V30, P528, DOI 10.1136/gut.30.4.528
   JORGENSEN T, 1990, SCAND J GASTROENTERO, V25, P281
   Kayikçioglu M, 2018, TURK KARDIYOL DERN A, V46, P556, DOI 10.5543/tkda.2018.23450
   Khammas ASA, 2021, J MED ULTRASOUND, V29, P26, DOI 10.4103/JMU.JMU_53_20
   Lee KF, 2004, AM J SURG, V188, P186, DOI 10.1016/j.amjsurg.2003.11.043
   Leung JCF, 2017, HEPATOLOGY, V65, P54, DOI 10.1002/hep.28697
   Li Q, 2018, WORLD J HEPATOL, V10, P530, DOI 10.4254/wjh.v10.i8.530
   Luntsi G, 2016, AFR HEALTH SCI, V16, P1163, DOI 10.4314/ahs.v16i4.35
   Lupsor-Platon M, 2014, MED ULTRASON, V16, P236
   Mazhar SM, 2009, CLIN GASTROENTEROL H, V7, P135, DOI 10.1016/j.cgh.2008.11.023
   Mustapic S, 2018, CAN J GASTROENTEROL, V2018, DOI 10.1155/2018/8490242
   Myers RP, 2002, CAN J GASTROENTEROL, V16, P187, DOI 10.1155/2002/787598
   NIEDERAU C, 1983, RADIOLOGY, V149, P537, DOI 10.1148/radiology.149.2.6622701
   Ogden CL., 2015, NCHS Data Brief, P1, DOI DOI 10.1001/jama.2014.732
   Okur G, 2016, NORTH CLIN ISTANB, V3, P111, DOI 10.14744/nci.2016.28199
   Onodera H, 1987, J GASTROENT MASS SUR, V74, P41
   Ozutemiz O, 1992, KLIN GELISIM, V5, P1737
   Pagliarulo M, 2004, DIGEST LIVER DIS, V36, P130, DOI 10.1016/j.dld.2003.10.007
   Pamukcu B, 2022, J HUM HYPERTENS, V36, P437, DOI 10.1038/s41371-020-00480-6
   Perumpail BJ, 2017, WORLD J GASTROENTERO, V23, P8263, DOI 10.3748/wjg.v23.i47.8263
   Ruhl CE, 2000, HEPATOLOGY, V31, P299, DOI 10.1002/hep.510310206
   Ryu S, 2015, J HEPATOL, V63, P1229, DOI 10.1016/j.jhep.2015.07.010
   SAMPLINER RE, 1970, NEW ENGL J MED, V283, P1358, DOI 10.1056/NEJM197012172832502
   Satman I, 2002, DIABETES CARE, V25, P1551, DOI 10.2337/diacare.25.9.1551
   Satman I, 2013, EUR J EPIDEMIOL, V28, P169, DOI 10.1007/s10654-013-9771-5
   SAVERYMUTTU SH, 1986, BRIT MED J, V292, P13, DOI 10.1136/bmj.292.6512.13
   SCRAGG RKR, 1984, BMJ-BRIT MED J, V289, P521, DOI 10.1136/bmj.289.6444.521
   SCRAGG RKR, 1984, BRIT MED J, V288, P1113, DOI 10.1136/bmj.288.6424.1113
   Sezgin O, 2022, DIGEST DIS SCI, V67, P293, DOI 10.1007/s10620-021-06844-3
   Sezgin O, 2019, TURK J GASTROENTEROL, V30, P1009, DOI 10.5152/tjg.2019.19882
   Terzi C, 2000, SURGERY, V127, P622, DOI 10.1067/msy.2000.105870
   Timmis A, 2018, EUR HEART J, V39, P508, DOI 10.1093/eurheartj/ehx628
   Unal S., 2018, Turkish Journal of Public Health, V16, P190
   Ural D, 2018, TURK KARDIYOL DERN A, V46, P577, DOI 10.5543/tkda.2018.62200
   Wei HL, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011939
   Yilmaz MB, 2018, TURK KARDIYOL DERN A, V46, P546, DOI 10.5543/tkda.2018.88225
   Younes R, 2019, SEMIN LIVER DIS, V39, P86, DOI 10.1055/s-0038-1677517
   Younossi Z, 2019, HEPATOLOGY, V69, P2672, DOI 10.1002/hep.30251
   Younossi ZM, 2015, HEPATOLOGY, V62, p739A
   Yu XZ, 2020, EUR J INFLAMM, V18, DOI 10.1177/2058739220961194
NR 64
TC 0
Z9 0
U1 3
U2 3
PU AVES
PI SISLI
PA BUYUKDERE CAD 105-9, MECIDIYEKOY, SISLI, ISTANBUL 34394, Turkiye
EI 2148-5607
J9 TURK J GASTROENTEROL
JI Turk. J. Gastroenterol.
PD JUN
PY 2023
VL 34
IS 6
DI 10.5152/tjg.2023.23067
PG 105
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA K5NI5
UT WOS:001016901900010
PM 37303246
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Kamino, H
   Hiratsuka, M
   Toda, T
   Nishigaki, R
   Osaki, M
   Ito, H
   Inoue, T
   Oshimura, M
AF Kamino, H
   Hiratsuka, M
   Toda, T
   Nishigaki, R
   Osaki, M
   Ito, H
   Inoue, T
   Oshimura, M
TI Searching for genes involved in arteriosclerosis: Proteomic analysis of
   cultured human umbilical vein endothelial cells undergoing replicative
   senescence
SO CELL STRUCTURE AND FUNCTION
LA English
DT Article
DE proteomics; endothelium; HUVEC; senescence; arterioscierosis; cathepsin
   B
ID DISULFIDE-ISOMERASE SUBUNIT; CENTRAL MHC GENE; PROLYL 4-HYDROXYLASE;
   CATHEPSIN-B; IN-VIVO; PROTEIN; EXPRESSION; IDENTIFICATION; LIVER; BAT1
AB It is known that replicative senescence of endothelium in vivo contributes at least partially to age-related vascular disorders such as arteriosclerosis. However, the genes involved in this process remain to be identified. In this study, we employed a proteomics-based approach to identify candidate genes using in vitro cultured human umbilical vein endothelial cells (HUVECs) as an experimental model for replicative senescence. By comparing protein spots from young and senescent HUVECs using two-dimensional electrophoresis, we identified three up-regulated proteins and five down-regulated proteins in senescent HUVECs as compared to young HUVECs, whose alteration was not observed during replicative senescence of primary human fibroblasts. Consistent results were obtained in Western blotting analysis using specific antibodies raised against some of these proteins, whereas there were no significant changes in the mRNA levels of these genes during senescence of HUVECs, Among them, cathepsin B, a protease participating in both intracellular proteolysis and extracellular matrix remodeling was observed to be dramatically up-regulated in senescent HUVECs and whose activity is known to be up-regulated in atherosclerotic lesions with senescence-associated phenotypes in vivo. Additional proteins, including cytoskeletal proteins and proteins involved in the processes of synthesis, turnover and modification of protein, were identified, whose function in endothelium was previously unsuspected. These proteins identified by a proteomics-based approach using cultured HUVECs may be involved not only in replicative senescence but also in functional alterations in vascular endothelial cells with senescence-associated phenotypes and may serve as molecular markers for these processes.
C1 Tottori Univ, Grad Sch Med Sci, Dept Biomed Sci Regenerat Med & Biofunct, Yonago, Tottori 6838503, Japan.
   Tottori Univ, Grad Sch Med Sci, Dept Mol & Cell Genet Human Genome Sci Kirin Brew, Yonago, Tottori 6838503, Japan.
   Tottori Univ, Fac Med, Dept Microbiol & Pathol, Div Organ Pathol, Yonago, Tottori 6838503, Japan.
   Tokyo Metropolitan Inst Gerontol, Proteom Collaborat Res Grp, Tokyo 1730015, Japan.
C3 Tottori University; Tottori University; Tottori University; Tokyo
   Metropolitan Institute of Gerontology
RP Oshimura, M (corresponding author), Tottori Univ, Grad Sch Med Sci, Dept Biomed Sci Regenerat Med & Biofunct, Nishimachi 86, Yonago, Tottori 6838503, Japan.
EM oshimura@grape.med.tottori-u.ac.jp
OI KAMINO, HIROKI/0000-0002-2489-0453
CR Allcock RJN, 1999, EXP CLIN IMMUNOGENET, V16, P98, DOI 10.1159/000019100
   Allcock RJN, 2001, GENES CELLS, V6, P487, DOI 10.1046/j.1365-2443.2001.00435.x
   ANDREOTTI L, 1985, ANGIOLOGY, V36, P872, DOI 10.1177/000331978503601206
   Annunen P, 1997, J BIOL CHEM, V272, P17342, DOI 10.1074/jbc.272.28.17342
   Annunen P, 1998, J BIOL CHEM, V273, P5989, DOI 10.1074/jbc.273.11.5989
   Chen JQ, 2002, CIRCULATION, V105, P2766, DOI 10.1161/01.CIR.0000017860.20619.23
   Cines DB, 1998, BLOOD, V91, P3527
   Cristofalo VJ, 1998, P NATL ACAD SCI USA, V95, P10614, DOI 10.1073/pnas.95.18.10614
   de Crom R, 1999, BBA-MOL CELL BIOL L, V1437, P378, DOI 10.1016/S1388-1981(99)00017-7
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Gorvel JP, 1998, FEBS LETT, V422, P269, DOI 10.1016/S0014-5793(98)00020-9
   Grillari J, 2000, EXP GERONTOL, V35, P187, DOI 10.1016/S0531-5565(00)00080-2
   Groysman M, 2002, J BIOL CHEM, V277, P50121, DOI 10.1074/jbc.M204299200
   Hiratsuka M, 2003, BIOCHEM BIOPH RES CO, V309, P558, DOI 10.1016/j.bbrc.2003.08.029
   Keppler D, 2000, CELL TISSUE RES, V302, P181, DOI 10.1007/s004410000269
   Kivirikko KI, 1998, MATRIX BIOL, V16, P357, DOI 10.1016/S0945-053X(98)90009-9
   Kivirikko KI, 1998, ADV ENZYMOL RAMB, V72, P325
   LEFFERS H, 1993, EXP CELL RES, V209, P165, DOI 10.1006/excr.1993.1298
   MAZZARELLA RA, 1987, J BIOL CHEM, V262, P8875
   Minamino T, 2002, CIRCULATION, V105, P1541, DOI 10.1161/01.CIR.0000013836.85741.17
   MOIN K, 1992, BIOCHEM J, V285, P427, DOI 10.1042/bj2850427
   Myllyharju J, 2001, ANN MED, V33, P7, DOI 10.3109/07853890109002055
   Nishigaki R, 2002, BIOCHEM BIOPH RES CO, V295, P112, DOI 10.1016/S0006-291X(02)00640-X
   Nissi R, 2001, J HISTOCHEM CYTOCHEM, V49, P1143, DOI 10.1177/002215540104900908
   Olofsson B, 1999, CELL SIGNAL, V11, P545, DOI 10.1016/S0898-6568(98)00063-1
   PEELMAN LJ, 1995, GENOMICS, V26, P210, DOI 10.1016/0888-7543(95)80203-X
   SASAHARA M, 1988, ATHEROSCLEROSIS, V70, P53, DOI 10.1016/0021-9150(88)90099-8
   Sloane B F, 1990, Semin Cancer Biol, V1, P137
   SLOANE BF, 1990, CANCER METAST REV, V9, P333, DOI 10.1007/BF00049523
   Toda T, 1998, ELECTROPHORESIS, V19, P344, DOI 10.1002/elps.1150190232
   Yawata T, 2003, ONCOGENE, V22, P281, DOI 10.1038/sj.onc.1206143
NR 31
TC 26
Z9 31
U1 0
U2 7
PU JAPAN SOC CELL BIOLOGY
PI KYOTO
PA C/O NAKANISHI PRINTING SHIMODACHIURI OGAWA HIGASHI, KAMIGYO-KU, KYOTO,
   602-8048, JAPAN
SN 0386-7196
EI 1347-3700
J9 CELL STRUCT FUNCT
JI Cell Struct. Funct.
PD DEC
PY 2003
VL 28
IS 6
BP 495
EP 503
DI 10.1247/csf.28.495
PG 9
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 809LO
UT WOS:000220638400001
PM 15004419
OA Bronze
DA 2024-02-19
ER

PT J
AU Montes-Cortes, DH
   Olivares-Corichi, IM
   Rosas-Barrientos, JV
   Manuel-Apolinar, L
   Martínez-Godinez, MD
   Hernández-López, JC
   Cruz-Dominguez, MD
AF Hector Montes-Cortes, Daniel
   Olivares-Corichi, Ivonne M.
   Vicente Rosas-Barrientos, Jose
   Manuel-Apolinar, Leticia
   de los Angeles Martinez-Godinez, Maria
   Carlos Hernandez-Lopez, Juan
   del Pilar Cruz-Dominguez, Maria
TI Characterization of Oxidative Stress and Ammonia According to the
   Different Grades of Hepatic Encephalopathy
SO DIGESTIVE DISEASES
LA English
DT Article
DE Lipid peroxidation; Protein oxidation; Ammonia; Chronic liver disease;
   Hepatic encephalopathy
ID IMMUNOGLOBULIN-G; FREE-RADICALS; SERUM; ANTIOXIDANT; DAMAGE;
   PATHOGENESIS; PEROXIDATION; BILIRUBIN; CIRRHOSIS; PROTEINS
AB Background: Hepatic encephalopathy (HE) in patients with chronic liver disease (CLD) is one of the main causes of reentry to the emergency department. Oxidative stress (OxS) regulated by ammonia leads to cerebral edema and astrocytes senescence in animal models, but seems to be different in humans. Objective: To analyze if OxS and ammonia in plasma are related to each other in the different grades of HE-CLD and to compare them with healthy volunteers (HV). Methods: In a cross-sectional study, we included 60 subjects in 2 groups: (a) 30 HV and (b) 30 HE patients. Plasma levels of oxidation lipids/proteins, ammonia, and West-Haven score were evaluated. Student t test, Spearman's correlation, and ANOVA with Dunn's post hoc test were performed. Results: Ammonia in HV and HE patients was 39-49 vs. 95-345 mu mol/L, respectively (p < 0.0001). Malondialdehyde (MDA) in HV was 6.58 +/- 3.11 compared to 16.69 +/- 6.19 mu mol/L in HE (p < 0.0001). Protein oxidation by osazone (carbonyls), formazan, and dityrosines was higher in HE than in HV (p < 0.0001). Ammonia level was directly associated to HE severity, but without correlation with lipid MDA or protein OxS formazan, carbonyls, and dityrosines. Lipid peroxidation showed higher levels at degree 2 and protein oxidation at degree 3 of HE. Conclusions: We confirm that OxS accompanies hyperammonemia in HE; however they contribute in different proportions to their natural progression. Early reduction of OxS in HE could contribute to minimize the neurotoxicity into CLD.
C1 [Hector Montes-Cortes, Daniel] Hosp Gen Ctr Med Nacl La Raza, Inst Mexicano Seguro Social, Dept Emergency, Mexico City, DF, Mexico.
   [Olivares-Corichi, Ivonne M.] Inst Politecn Nacl, Lab Oxidat Stress, Escuela Super Med, Res & Grad Studies Sect, Mexico City, DF, Mexico.
   [Hector Montes-Cortes, Daniel; Vicente Rosas-Barrientos, Jose] Inst Seguridad & Serv Sociales Trabajadores Estad, Teaching & Res Coordinat, Mexico City, DF, Mexico.
   [Manuel-Apolinar, Leticia] Ctr Med Nacl Siglo XXI, Hosp Especialidades, Inst Mexicano Seguro Social, Endocrine Res Unit, Mexico City, DF, Mexico.
   [de los Angeles Martinez-Godinez, Maria] Inst Politecn Nacl, Res & Grad Studies Sect, Lab Mol Biol, Escuela Super Med, Mexico City, DF, Mexico.
   [Carlos Hernandez-Lopez, Juan; del Pilar Cruz-Dominguez, Maria] Ctr Med Natl La Raza, Hosp Especialidades, Div Hlth Res, Inst Mexicano Seguro Social, Seris y Zaachila S-N, Mexico City 02990, DF, Mexico.
C3 Instituto Mexicano del Seguro Social; Instituto Politecnico Nacional -
   Mexico; Instituto Mexicano del Seguro Social; Instituto Politecnico
   Nacional - Mexico; Instituto Mexicano del Seguro Social
RP Cruz-Dominguez, MD (corresponding author), Ctr Med Natl La Raza, Hosp Especialidades, Div Hlth Res, Inst Mexicano Seguro Social, Seris y Zaachila S-N, Mexico City 02990, DF, Mexico.
EM drapilarcd@live.com.mx
RI MC, Dan/AAI-5008-2020; Manuel, Leticia/ABC-7215-2020
OI Manuel-Apolinar, Leticia/0000-0001-8175-4215; MARTINEZ GODINEZ, MARIA DE
   LOS ANGELES/0000-0002-7677-8690; Cruz-Dominguez, Maria del
   Pilar/0000-0002-7118-9395; Hernandez Lopez, Juan
   Carlos/0000-0002-7104-2676
CR Aksoy H, 2003, TURKISH J BIOCH, V28, P32
   American Association for the Study of Liver DiseasesEuropean Association for the Study of the Liver, 2014, J HEPATOL, V61, P642
   Ayala A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/360438
   Bosoi CR, 2014, LIVER INT, V34, P1322, DOI 10.1111/liv.12414
   Bosoi CR, 2013, METAB BRAIN DIS, V28, P175, DOI 10.1007/s11011-012-9351-5
   BRUNK UT, 1989, ADV EXP MED BIOL, V266, P313
   Butterworth RF, 2002, METAB BRAIN DIS, V17, P221, DOI 10.1023/A:1021989230535
   Butterworth RF, 2020, METAB BRAIN DIS, V35, P75, DOI 10.1007/s11011-019-00463-8
   Büyükasik NS, 2016, TURK J MED SCI, V46, P1281, DOI 10.3906/sag-1508-107
   Comporti M, 2009, HISTOL HISTOPATHOL, V24, P893, DOI 10.14670/HH-24.893
   Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2
   Dhanda S, 2018, METAB BRAIN DIS, V33, P209, DOI 10.1007/s11011-017-0136-8
   Ferenci P, 2017, GASTROENTEROL REP, V5, P138, DOI 10.1093/gastro/gox013
   Frederick R Todd, 2011, Gastroenterol Hepatol (N Y), V7, P222
   Ge PS, 2014, JAMA-J AM MED ASSOC, V312, P643, DOI 10.1001/jama.2014.2398
   GIESEG SP, 1993, BIOCHEMISTRY-US, V32, P4780, DOI 10.1021/bi00069a012
   Giménez-Garzó C, 2018, FREE RADICAL RES, V52, P118, DOI 10.1080/10715762.2017.1420183
   Görg B, 2018, J CLIN EXP HEPATOL, V8, P294, DOI 10.1016/j.jceh.2018.05.003
   Gonzàlez-Quintela A, 2003, HEPATO-GASTROENTEROL, V50, P2121
   Gupta A, 2014, INDIAN J CLIN BIOCHE, V29, P63, DOI 10.1007/s12291-013-0333-0
   Heidari R, 2018, CLIN EXP HEPATOL, V4, P72, DOI 10.5114/ceh.2018.75956
   Heinecke A, 2014, INT CONF HIGH PERFOR, P3, DOI 10.1109/SC.2014.6
   Kaur H, 2003, FEBS LETT, V543, P113, DOI 10.1016/S0014-5793(03)00420-4
   Kawakami A, 2006, FEBS J, V273, P3346, DOI 10.1111/j.1742-4658.2006.05341.x
   Koruk M, 2002, ANN CLIN LAB SCI, V32, P252
   Kountouras J, 2017, FREE RADICAL RES, V51, P73, DOI 10.1080/10715762.2016.1271122
   Krones E, 2015, DIGEST DIS, V33, P367, DOI 10.1159/000371689
   LEVEEN HH, 1994, BIOMED PHARMACOTHER, V48, P157, DOI 10.1016/0753-3322(94)90104-X
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Malencik DA, 1996, ANAL BIOCHEM, V242, P202, DOI 10.1006/abio.1996.0454
   MANS AM, 1994, J NEUROCHEM, V63, P1829
   McCord JM, 2000, AM J MED, V108, P652, DOI 10.1016/S0002-9343(00)00412-5
   Montes-Cortes DH, 2010, METABOLISM, V59, P935, DOI 10.1016/j.metabol.2009.10.013
   Murthy CRK, 2001, J NEUROSCI RES, V66, P282, DOI 10.1002/jnr.1222
   Neish AS, 2013, FREE RADICAL RES, V47, P950, DOI 10.3109/10715762.2013.833331
   Otagiri M, 2009, BIOL PHARM BULL, V32, P527, DOI 10.1248/bpb.32.527
   Parola M, 1996, FREE RADICAL BIO MED, V20, P351, DOI 10.1016/0891-5849(96)02055-2
   PUPPO A, 1988, BIOCHEM J, V249, P185, DOI 10.1042/bj2490185
   Rasheed Z, 2008, CLIN BIOCHEM, V41, P663, DOI 10.1016/j.clinbiochem.2008.02.013
   REZNICK AZ, 1994, METHOD ENZYMOL, V233, P357
   Romero-Gómez M, 2004, J HEPATOL, V41, P49, DOI 10.1016/j.jhep.2004.03.021
   Sathyasaikumar KV, 2007, NEUROCHEM RES, V32, P517, DOI 10.1007/s11064-006-9265-x
   Sies H, 2015, REDOX BIOL, V4, P180, DOI 10.1016/j.redox.2015.01.002
   Skowronska M, 2013, NEUROCHEM INT, V62, P731, DOI 10.1016/j.neuint.2012.10.013
   STADTMAN ER, 1993, ANNU REV BIOCHEM, V62, P797, DOI 10.1146/annurev.bi.62.070193.004053
   STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864
   Swaminathan M, 2018, HEPATIC MED-EVID RES, V10, P1, DOI 10.2147/HMER.S118964
   TSUKAMOTO H, 1995, J GASTROEN HEPATOL, V10, pS50, DOI 10.1111/j.1440-1746.1995.tb01798.x
   Uesugi M, 2000, J IMMUNOL, V165, P6532, DOI 10.4049/jimmunol.165.11.6532
   VINCE AJ, 1980, J MED MICROBIOL, V13, P177, DOI 10.1099/00222615-13-2-177
   Viveiros A, 2018, LIVER TRANSPLANT, V24, P343, DOI 10.1002/lt.24981
   Witting PK, 1996, J LIPID RES, V37, P853
   Yagi K, 1998, Methods Mol Biol, V108, P107
NR 53
TC 7
Z9 7
U1 0
U2 4
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0257-2753
EI 1421-9875
J9 DIGEST DIS
JI Dig. Dis.
PD MAY
PY 2020
VL 38
IS 3
BP 240
EP 250
DI 10.1159/000503097
PG 11
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA LR7YX
UT WOS:000535913800010
PM 31578013
DA 2024-02-19
ER

PT J
AU Slotkin, TA
   Thai, L
   McCook, EC
   Saleh, JL
   Zhang, J
   Seidler, FJ
AF Slotkin, TA
   Thai, L
   McCook, EC
   Saleh, JL
   Zhang, J
   Seidler, FJ
TI Aging and glucocorticoids: Effects on cell signaling mediated through
   adenylyl cyclase
SO JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
LA English
DT Article
ID BETA-ADRENERGIC RECEPTORS; AGE-RELATED-CHANGES; RAT-LIVER;
   MESSENGER-RNA; BINDING-SITES; CATECHOLAMINE-RESPONSIVENESS; ORNITHINE
   DECARBOXYLASE; REGULATORY PROTEIN; PERIPHERAL-TISSUES; BROWN FAT
AB Abnormalities of hypothalamus-pituitary-adrenal axis regulation are common in the elderly and excess glucocorticoids have been implicated in the loss of neural function in aging. In the current study, we examined cell signaling mediated through adenylyl cyclase in brain regions, heart and liver of young and aged rats given continuous infusions of dexamethasone (10 or 50 mu g/kg/day) for 26 days. Aged control animals showed significant deficits in total adenylyl cyclase activity (assessed with forskolin-Mn++) in the brain regions and the heart; superimposed on this change, the striatum and the heart displayed interference with the response mediated either at the level of G-protein coupling to cyclase (striatum) or neurotransmitter receptor coupling to G-proteins (heart). Administration of dexamethasone to young rats did not reproduce the effects of aging on any of the measures of adenylyl cyclase, despite the fact that the higher dose produced Cushingoid effects. The same dexamethasone regimens given to aged rats produced alterations in G-protein coupling mechanisms in the cortex and in serotonergic-mediated cyclase responses in the striatum, and also decreased basal enzyme activity in the heart. In contrast to the brain regions and the heart, the liver showed unique effects of aging and dexamethasone. Total adenylyl cyclase activity, the enzymatic response to beta adrenergic stimulation and the number of beta adrenergic receptors were all elevated in aged animals as compared to the younger cohort. Dexamethasone decreased both hepatic beta receptor numbers and isoproterenol responsiveness in young animals, but increased receptor binding in aged animals. These data indicate that the defects associated with aging in the central nervous system and the cardiac cell signaling mediated through adenylyl cyclase are not a result of glucocorticoid excess; however, central and peripheral tissues respond differently to glucocorticoids in aged vs. young animals, Given the high incidence of hypothalamus-pituitary-adrenal axis dysregulation in the elderly, and particularly in elderly depression, effects of glucocorticoids on cell signaling may contribute to disruption of cell function and to hypo- or hyper-reactivity to drugs, such as antidepressants, that act by altering synaptic transmission.
RP Slotkin, TA (corresponding author), DUKE UNIV,MED CTR,DEPT PHARMACOL,BOX 3813,DURHAM,NC 27710, USA.
FU NIMH NIH HHS [MH-40159] Funding Source: Medline
CR ABRASS IB, 1981, ENDOCRINOLOGY, V108, P977, DOI 10.1210/endo-108-3-977
   AHIMA RS, 1991, ENDOCRINOLOGY, V129, P226, DOI 10.1210/endo-129-1-226
   ARORA RC, 1986, EUR J PHARMACOL, V123, P415, DOI 10.1016/0014-2999(86)90717-X
   ARRANZ B, 1993, BRAIN RES, V620, P163, DOI 10.1016/0006-8993(93)90286-V
   BENEDIKTSDOTTIR VE, 1995, EUR J PHARM-MOLEC PH, V289, P419, DOI 10.1016/0922-4106(95)90150-7
   BIAN XP, 1993, TERATOLOGY, V48, P169, DOI 10.1002/tera.1420480211
   BIAN XP, 1990, J DEV PHYSIOL, V14, P125
   BRANCONNIER RJ, 1984, PSYCHOPHARMACOLOGY, V84, P274, DOI 10.1007/BF00427458
   BRODDE OE, 1995, J CARDIOVASC PHARM, V26, P20, DOI 10.1097/00005344-199507000-00004
   CARROLL BJ, 1975, ENDOCRINOLOGY, V97, P290, DOI 10.1210/endo-97-2-290
   CARROLL BJ, 1976, PSYCHOL MED, V6, P235, DOI 10.1017/S0033291700013775
   CHAN MY, 1985, PHARMACOL RES COMMUN, V17, P619, DOI 10.1016/0031-6989(85)90069-4
   CHAUDHRY A, 1992, AM J PHYSIOL, V263, pR34, DOI 10.1152/ajpregu.1992.263.1.R34
   CHAUDHRY A, 1991, AM J PHYSIOL, V261, pR403, DOI 10.1152/ajpregu.1991.261.2.R403
   Chin JH, 1996, MECH AGEING DEV, V86, P11, DOI 10.1016/0047-6374(95)01676-7
   DAVIDOFF MS, 1991, J HIRNFORSCH, V32, P745
   DAVIES AO, 1981, J CLIN ENDOCR METAB, V53, P703, DOI 10.1210/jcem-53-4-703
   DAVIES AO, 1984, ANNU REV PHYSIOL, V46, P119
   DAX EM, 1987, ENDOCRINOLOGY, V120, P1534, DOI 10.1210/endo-120-4-1534
   DEKLOET ER, 1991, FRONT NEUROENDOCRIN, V12, P95
   EAKES AT, 1996, AM J PHYSIOL, V33, pE126
   Fumagalli F, 1996, BRAIN RES, V719, P225, DOI 10.1016/0006-8993(96)00119-9
   FUXE K, 1994, METH NEUROSCI, V22, P372
   HARA H, 1992, NEUROSCIENCE, V46, P475, DOI 10.1016/0306-4522(92)90067-C
   HEINSIMER JA, 1985, J AM GERIATR SOC, V33, P184, DOI 10.1111/j.1532-5415.1985.tb04890.x
   HUFF RA, 1991, LIFE SCI, V48, P1059, DOI 10.1016/0024-3205(91)90507-8
   JESBERGER JA, 1985, BIOL PSYCHIAT, V20, P764, DOI 10.1016/0006-3223(85)90156-8
   KATZ MS, 1987, BIOCHEM BIOPH RES CO, V147, P724, DOI 10.1016/0006-291X(87)90990-9
   KATZ MS, 1993, EXP GERONTOL, V28, P329, DOI 10.1016/0531-5565(93)90060-Q
   KATZ MS, 1988, AM J PHYSIOL, V254, pE54, DOI 10.1152/ajpendo.1988.254.1.E54
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Makman M H, 1978, Adv Exp Med Biol, V113, P211
   MAKMAN MH, 1980, BRAIN RES, V192, P177, DOI 10.1016/0006-8993(80)91017-3
   MAKMAN MH, 1979, FED PROC, V38, P1922
   MALBON CC, 1988, TRENDS PHARMACOL SCI, V9, P33, DOI 10.1016/0165-6147(88)90240-4
   Masoro EJ, 1995, AGING-CLIN EXP RES, V7, P407, DOI 10.1007/BF03324354
   MCEWEN BS, 1992, PROG BRAIN RES, V93, P365
   MCLELLAN AR, 1992, J MOL ENDOCRINOL, V9, P237, DOI 10.1677/jme.0.0090237
   MCMILLIAN MK, 1983, J PHARMACOL EXP THER, V227, P181
   MEANEY MJ, 1995, EXP GERONTOL, V30, P229, DOI 10.1016/0531-5565(94)00065-B
   Metz LD, 1996, J MOL CELL CARDIOL, V28, P1033, DOI 10.1006/jmcc.1996.0096
   MIYAMOTO A, 1994, EUR J PHARM-MOLEC PH, V266, P147, DOI 10.1016/0922-4106(94)90104-X
   MOBLEY PL, 1980, NATURE, V286, P608, DOI 10.1038/286608a0
   MUSCARI C, 1992, CARDIOSCIENCE, V3, P67
   NARAYANAN N, 1982, MECH AGEING DEV, V19, P127, DOI 10.1016/0047-6374(82)90004-5
   NARAYANAN N, 1986, MECH AGEING DEV, V34, P249, DOI 10.1016/0047-6374(86)90077-1
   NAVARRO HA, 1991, BIOL NEONATE, V60, P127
   NAVARRO HA, 1991, LIFE SCI, V48, P269, DOI 10.1016/0024-3205(91)90354-E
   NOGUCHI A, 1983, European Journal of Pharmacology, V86, P43
   NOGUCHI A, 1981, DEV PHARMACOL THERAP, V3, P179, DOI 10.1159/000457439
   OXENKRUG GF, 1984, BIOL PSYCHIAT, V19, P413
   PFOHL B, 1985, ARCH GEN PSYCHIAT, V42, P897
   RAITT MH, 1995, J GERONTOL A-BIOL, V50, pB213, DOI 10.1093/gerona/50A.4.B213
   RITCHIE JC, 1990, BIOL PSYCHIAT, V27, pA45
   RODAN SB, 1986, ENDOCRINOLOGY, V118, P2510, DOI 10.1210/endo-118-6-2510
   ROTH GS, 1995, EXP GERONTOL, V30, P361, DOI 10.1016/0531-5565(94)00029-3
   SAITO N, 1989, P NATL ACAD SCI USA, V86, P3906, DOI 10.1073/pnas.86.10.3906
   SANCHEZCAPELO A, 1994, BIOL NEONATE, V66, P119
   SANGHANI MP, 1994, J GERONTOL, V49, pB60, DOI 10.1093/geronj/49.2.B60
   SAPOLSKY RM, 1986, ENDOCR REV, V7, P284, DOI 10.1210/edrv-7-3-284
   SAPOLSKY RM, 1994, ANN NY ACAD SCI, V746, P294
   SCARPACE P J, 1991, Drugs and Aging, V1, P116
   Scarpace PJ, 1996, J CARDIOVASC PHARM, V27, P86, DOI 10.1097/00005344-199601000-00014
   SCARPACE PJ, 1986, MECH AGEING DEV, V35, P255, DOI 10.1016/0047-6374(86)90128-4
   SCARPACE PJ, 1992, EXP GERONTOL, V27, P169, DOI 10.1016/0531-5565(92)90041-W
   SCARPACE PJ, 1994, J APPL PHYSIOL, V77, P737, DOI 10.1152/jappl.1994.77.2.737
   SEAMON K, 1981, J BIOL CHEM, V256, P9799
   SEAMON KB, 1986, ADV CYCLIC NUCL PROT, V20, P1
   SHARMA RP, 1988, BIOL PSYCHIAT, V24, P555, DOI 10.1016/0006-3223(88)90166-7
   SHU Y, 1994, J CARDIOVASC PHARM, V23, P188, DOI 10.1097/00005344-199402000-00003
   SLOTKIN TA, 1990, LIFE SCI, V47, P1561, DOI 10.1016/0024-3205(90)90185-T
   SLOTKIN TA, 1986, TOXICOLOGY, V41, P95, DOI 10.1016/0300-483X(86)90107-1
   SLOTKIN TA, 1996, IN PRESS BIOL PSYCHI
   Snedecor G.W. C., 1989, Statistical methods/George W. Snedecor and William G. Cochran
   STANGL D, 1986, J AFFECT DISORDERS, V11, P185, DOI 10.1016/0165-0327(86)90069-8
   STEINBEHRENS BA, 1992, AGING-CLIN EXP RES, V4, P197
   STILES ML, 1994, AM J HOSP PHARM, V51, P514, DOI 10.1093/ajhp/51.4.514
   TSUJIMOTO G, 1987, AM J PHYSIOL, V252, pH513, DOI 10.1152/ajpheart.1987.252.3.H513
   TURNER N, 1989, MECH AGEING DEV, V49, P235
   URASAWA K, 1991, JPN CIRC J, V55, P676, DOI 10.1253/jcj.55.676
   VANEEKELEN JAM, 1991, DEV BRAIN RES, V61, P33, DOI 10.1016/0165-3806(91)90111-U
   VANERMEN A, 1992, MOL PHARMACOL, V42, P649
   VANLUIJTELAAR MGPA, 1988, NEUROSCI LETT, V95, P93, DOI 10.1016/0304-3940(88)90638-6
   VENERO JL, 1993, BRAIN RES, V631, P89, DOI 10.1016/0006-8993(93)91191-T
   WHITE M, 1994, CIRCULATION, V90, P1225, DOI 10.1161/01.CIR.90.3.1225
   XIAO RP, 1994, J CLIN INVEST, V94, P2051, DOI 10.1172/JCI117559
   YAMAGUCHI T, 1991, NEUROCHEM RES, V16, P469, DOI 10.1007/BF00965568
   YI SJ, 1994, MOL CELL NEUROSCI, V5, P385, DOI 10.1006/mcne.1994.1048
   ZHONG HY, 1993, MOL PHARMACOL, V44, P1085
NR 89
TC 10
Z9 10
U1 0
U2 1
PU WILLIAMS & WILKINS
PI BALTIMORE
PA 351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436
SN 0022-3565
J9 J PHARMACOL EXP THER
JI J. Pharmacol. Exp. Ther.
PD NOV
PY 1996
VL 279
IS 2
BP 478
EP 491
PG 14
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA VT122
UT WOS:A1996VT12200006
PM 8930149
DA 2024-02-19
ER

PT J
AU Kim, HS
   Son, TG
   Park, HR
   Lee, Y
   Jung, Y
   Ishigami, A
   Lee, J
AF Kim, Hyun Soo
   Son, Tae Gen
   Park, Hee Ra
   Lee, Yonghyun
   Jung, Yunjin
   Ishigami, Akihito
   Lee, Jaewon
TI Senescence marker protein 30 deficiency increases Parkinson's pathology
   by impairing astrocyte activation
SO NEUROBIOLOGY OF AGING
LA English
DT Article
DE Aging; Neurodegenerative diseases; Vitamin C biosynthesis; Oxidative
   stress
ID SMP30/GNL KNOCKOUT MICE; MPTP MOUSE MODEL; HEP G2 CELLS; OXIDATIVE
   STRESS; HUNTINGTONS-DISEASE; RAT-LIVER; BRAIN; STRATEGIES;
   NEURODEGENERATION; THERAPY
AB Senescence marker protein 30 (SMP30) was recently identified as gluconolactonase, which is involved in vitamin C (VC) biosynthesis. Therefore, the antioxidant property of SMP30 is thought to be mediated by its gluconolactonase function. However, pathologic effects of SMP30 deficiency independent of VC biosynthesis have not been studied in models of neurodegenerative diseases. In the present study, we evaluated the effect of SMP30 deficiency on Parkinson's disease (PD) in SMP30 knockout (KO) mice. Wild type and SMP30 KO mice supplemented with VC were treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Our results showed that MPTP-induced dopaminergic neuronal loss and motor function impairment were more significant in the SMP30 KO mice. Reactive oxygen species generation and microglia activation were higher in MPTP-treated SMP30 KO mice. However, SMP30 deficiency mitigated MPTP-induced astrocyte activation and glia-derived neurotrophic factor production. Cultures of astrocytes recovered from wild type and SMP30 KO mice revealed that SMP30 deficiency abolished 1-methyl-4-phenyl-pyridinium-induced astroglial activation by blocking the extracellular signal-regulated kinase pathway. Taken together, our findings demonstrate for the first time that SMP30 deficiency increases the severity of PD and suggest a beneficial role of SMP30 in protective astrocyte activation in response to neurodegeneration. The present study shows that modulation of astrocytic SMP30 can be a promising target for treating PD. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Kim, Hyun Soo; Park, Hee Ra; Lee, Yonghyun; Jung, Yunjin; Lee, Jaewon] Pusan Natl Univ, Coll Pharm, Longev Life Sci & Technol Inst, Pusan 609735, South Korea.
   [Kim, Hyun Soo; Park, Hee Ra; Lee, Yonghyun; Jung, Yunjin; Lee, Jaewon] Pusan Natl Univ, Longev Life Sci & Technol Inst, Res Inst Drug Dev, Pusan 609735, South Korea.
   [Son, Tae Gen] Dongnam Inst Radiol & Med Sci, Res Ctr, Dept Expt Radiat, Pusan, South Korea.
   [Ishigami, Akihito] Tokyo Metropolitan Inst Gerontol, Tokyo, Japan.
C3 Pusan National University; Pusan National University; Korea Institute of
   Radiological & Medical Sciences; Tokyo Metropolitan Institute of
   Gerontology
RP Lee, J (corresponding author), Pusan Natl Univ, Coll Pharm, Dept Pharm, Longev Life Sci & Technol Inst, Pusan 609735, South Korea.
EM neuron@pusan.ac.kr
RI Lee, Yonghyun/AAP-5990-2020; Lee, Jaewon/N-9064-2013; Lee,
   Jaewon/IQR-8432-2023
OI Lee, Jaewon/0000-0003-3203-2130; Ishigami, Akihito/0000-0001-7875-7482
FU Basic Science Research Program though the National Research Foundation
   of Korea (NRF); Ministry of Education, Science, and Technology
   [2009-0072954]; National Research Foundation of Korea (NRF); Korea
   government (MEST) [20090083538]
FX This research was supported by the Basic Science Research Program though
   the National Research Foundation of Korea (NRF) funded by the Ministry
   of Education, Science, and Technology (no. 2009-0072954). This work was
   also supported by National Research Foundation of Korea (NRF) grant
   funded by the Korea government (MEST) (No. 20090083538).
CR Anderson G, 2007, EXP NEUROL, V207, P4, DOI 10.1016/j.expneurol.2007.05.010
   ANDERSSON PB, 1991, NEUROSCIENCE, V42, P201, DOI 10.1016/0306-4522(91)90159-L
   Ara J, 1998, P NATL ACAD SCI USA, V95, P7659, DOI 10.1073/pnas.95.13.7659
   Chen LW, 2005, CURR DRUG TARGETS, V6, P821, DOI 10.2174/138945005774574506
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7
   Fujita T, 1996, MECH AGEING DEV, V87, P219, DOI 10.1016/0047-6374(96)01711-3
   Fujita T, 1998, BIOCHEM BIOPH RES CO, V250, P374, DOI 10.1006/bbrc.1998.9327
   Fukaya Y, 2004, BIOL PHARM BULL, V27, P1444, DOI 10.1248/bpb.27.1444
   Giralt A, 2010, GENE THER, V17, P1294, DOI 10.1038/gt.2010.71
   Grünblatt E, 2000, J NEUROL, V247, P95
   Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x
   Handa S, 2009, BIOL PHARM BULL, V32, P1645, DOI 10.1248/bpb.32.1645
   Harrison FE, 2009, FREE RADICAL BIO MED, V46, P719, DOI 10.1016/j.freeradbiomed.2008.12.018
   Houeland G, 2010, J NEUROSCI, V30, P13089, DOI 10.1523/JNEUROSCI.0457-10.2010
   Hwang IK, 2006, BRAIN RES, V1072, P215, DOI 10.1016/j.brainres.2005.12.012
   Jenner P, 2003, PARKINSONISM RELAT D, V9, P131, DOI 10.1016/S1353-8020(02)00115-3
   Joglar B, 2009, J NEUROCHEM, V109, P656, DOI 10.1111/j.1471-4159.2009.05999.x
   Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103
   Kondo Y, 2008, BIOCHEM BIOPH RES CO, V377, P291, DOI 10.1016/j.bbrc.2008.09.132
   KOPIN IJ, 1992, ANN NY ACAD SCI, V648, P96, DOI 10.1111/j.1749-6632.1992.tb24527.x
   Maruyama N, 2004, ANN NY ACAD SCI, V1019, P383, DOI 10.1196/annals.1297.068
   McGeer PL, 2008, MOVEMENT DISORD, V23, P474, DOI 10.1002/mds.21751
   McLennan GP, 2008, J NEUROCHEM, V107, P1753, DOI 10.1111/j.1471-4159.2008.05745.x
   Moon M, 2009, NEUROTOX RES, V15, P332, DOI 10.1007/s12640-009-9037-x
   Praticò D, 2008, ANN NY ACAD SCI, V1147, P70, DOI 10.1196/annals.1427.010
   RajaSankara S, 2009, NEUROSCI LETT, V454, P11, DOI 10.1016/j.neulet.2009.02.044
   Reynolds A, 2007, INT REV NEUROBIOL, V82, P297, DOI 10.1016/S0074-7742(07)82016-2
   Sato Y, 2008, BIOCHEM BIOPH RES CO, V375, P346, DOI 10.1016/j.bbrc.2008.08.020
   Son TG, 2008, ARCH PHARM RES, V31, P872, DOI 10.1007/s12272-001-1240-3
   Son TG, 2009, J NEUROSCI RES, V87, P2890, DOI 10.1002/jnr.22122
   Son TG, 2006, MECH AGEING DEV, V127, P451, DOI 10.1016/j.mad.2006.01.005
   Stack EC, 2008, ANN NY ACAD SCI, V1147, P79, DOI 10.1196/annals.1427.008
   Surendran S, 2010, NEUROL SCI, V31, P531, DOI 10.1007/s10072-010-0245-1
   Teismann P, 2004, CELL TISSUE RES, V318, P149, DOI 10.1007/s00441-004-0944-0
   Teismann P, 2003, MOVEMENT DISORD, V18, P121, DOI 10.1002/mds.10332
   Zhang HN, 2010, NEUROSCI LETT, V474, P99, DOI 10.1016/j.neulet.2010.03.016
   Zhao Q, 2010, BRAIN RES, V1346, P224, DOI 10.1016/j.brainres.2010.05.018
   Zhou C, 2008, ANN NY ACAD SCI, V1147, P93, DOI 10.1196/annals.1427.023
NR 38
TC 14
Z9 18
U1 0
U2 21
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0197-4580
J9 NEUROBIOL AGING
JI Neurobiol. Aging
PD APR
PY 2013
VL 34
IS 4
BP 1177
EP 1183
DI 10.1016/j.neurobiolaging.2012.10.008
PG 7
WC Geriatrics & Gerontology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology; Neurosciences & Neurology
GA 086ST
UT WOS:000314708000019
PM 23122412
DA 2024-02-19
ER

PT J
AU Svistounov, DN
   Berg, TJ
   McCourt, PAG
   Zykova, SN
   Elvevold, KH
   Nagai, R
   Horiuchi, S
   Smedsrod, BH
AF Svistounov, DN
   Berg, TJ
   McCourt, PAG
   Zykova, SN
   Elvevold, KH
   Nagai, R
   Horiuchi, S
   Smedsrod, BH
TI Lack of recognition of <i>N</i><SUP>ε</SUP>-(carboxymethyl)lysine by the
   mouse liver reticulo-endothelial system:: implications for
   pathophysiology
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE advanced glycation end products; carboxymethyllysine; liver endothelial
   cells; Kupffer cells; scavenger receptor
ID GLYCATION END-PRODUCTS; MACROPHAGE SCAVENGER RECEPTOR; MEDIATED
   ENDOCYTIC UPTAKE; LOW-DENSITY-LIPOPROTEIN; ENDOTHELIAL-CELLS; RAT-LIVER;
   DIABETIC COMPLICATIONS; ALZHEIMERS-DISEASE; SERUM-ALBUMIN; HUMAN TISSUES
AB Advanced glycation end products (AGEs) are known to be associated with a number of pathological conditions, such as diabetes mellitus, Alzheimer's disease, uremia, as well as with normal aging. This study was undertaken to investigate whether N-epsilon-(carboxymethyl)lysine (CML), a major structure among numerous AGEs, engenders hepatic AGE clearance. For this purpose uptake of BSA substituted with heterogeneous AGEs or with CML only was monitored in vivo and in cultured hepatic scavenger cells. Here, we show that following intravenous administration of I-125-AGE-BSA and I-125-CML-BSA, blood radioactivity was reduced by 50% after 50s and > 100min, respectively. Recoveries from the circulation at 6min after injection were: 5% for AGE-BSA, 95% for CML-BSA. More than 80% of the injected AGE-BSA was recovered from the liver. AGE-BSA, but not CML-BSA, was avidly endocytosed by cultured liver scavenger cells. Our results suggest that CML does not engender AGE-BSA clearance. Macromolecules substituted with CML only may escape elimination and cause pathological effects. (C) 2003 Elsevier Inc. All rights reserved.
C1 Univ Tromso, Fac Med, Dept Expt Pathol, Tromso, Norway.
   Aker Univ Hosp, Oslo, Norway.
   Kumamoto Univ, Sch Med, Kumamoto 860, Japan.
C3 UiT The Arctic University of Tromso; University of Oslo; Kumamoto
   University
RP Svistounov, DN (corresponding author), Univ Tromso, Fac Med, Dept Expt Pathol, Tromso, Norway.
RI McCourt, Peter/B-3043-2009
OI McCourt, Peter/0000-0001-5072-4590; Smedsrod, Bard/0000-0002-3308-8948
CR Baynes JW, 1999, DIABETES, V48, P1, DOI 10.2337/diabetes.48.1.1
   Baynes JW, 2000, FREE RADICAL BIO MED, V28, P1708, DOI 10.1016/S0891-5849(00)00228-8
   Berg TJ, 1998, DIABETES CARE, V21, P1997, DOI 10.2337/diacare.21.11.1997
   BLOMHOFF R, 1984, BIOCHEM J, V218, P81, DOI 10.1042/bj2180081
   BLOMHOFF R, 1984, J BIOL CHEM, V259, P8898
   Brownlee M, 2000, METABOLISM, V49, P9, DOI 10.1016/S0026-0495(00)80078-5
   Dawnay A, 1998, CELL MOL BIOL, V44, P1081
   FALKENBERG P, 1990, BIOCHIM BIOPHYS ACTA, V1034, P253, DOI 10.1016/0304-4165(90)90046-Y
   FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0
   Friedman EA, 1999, DIABETES CARE, V22, pB65
   GEMPEL KE, 1993, HORM METAB RES, V25, P250, DOI 10.1055/s-2007-1002089
   Hammes HP, 1999, INVEST OPHTH VIS SCI, V40, P1855
   Hori O, 1996, NEPHROL DIAL TRANSPL, V11, P13
   Horie K, 1997, BIOCHEM BIOPH RES CO, V236, P327, DOI 10.1006/bbrc.1997.6944
   Ikeda K, 1996, BIOCHEMISTRY-US, V35, P8075, DOI 10.1021/bi9530550
   Itabe H, 1998, BBA-MOL BASIS DIS, V1406, P28, DOI 10.1016/S0925-4439(97)00069-0
   Kilhovd BK, 1999, DIABETES CARE, V22, P1543, DOI 10.2337/diacare.22.9.1543
   Kislinger T, 1999, J BIOL CHEM, V274, P31740, DOI 10.1074/jbc.274.44.31740
   LAURENT TC, 1986, BIOCHEM J, V234, P653, DOI 10.1042/bj2340653
   Ling X, 1998, LAB INVEST, V78, P1591
   Matsumoto K, 2000, BIOCHEM J, V352, P233, DOI 10.1042/0264-6021:3520233
   McCourt PAG, 1999, HEPATOLOGY, V30, P1276, DOI 10.1002/hep.510300521
   MELKKO J, 1994, J EXP MED, V179, P405, DOI 10.1084/jem.179.2.405
   Munch G, 1997, BRAIN RES REV, V23, P134, DOI 10.1016/S0165-0173(96)00016-1
   Nagai R, 2000, DIABETES, V49, P1714, DOI 10.2337/diabetes.49.10.1714
   Park' L, 1998, NAT MED, V4, P1025, DOI 10.1038/2012
   PEARSON AM, 1993, J BIOL CHEM, V268, P3546
   SAKURAI T, 1998, MAILLARD REACTION FO, P351
   Sano H, 1998, J BIOL CHEM, V273, P8630, DOI 10.1074/jbc.273.15.8630
   Schleicher ED, 1997, J CLIN INVEST, V99, P457, DOI 10.1172/JCI119180
   Schmidt AM, 1999, CIRC RES, V84, P489, DOI 10.1161/01.RES.84.5.489
   Singh R, 2001, DIABETOLOGIA, V44, P129, DOI 10.1007/s001250051591
   SMEDSROD B, 1985, J LEUKOCYTE BIOL, V38, P213, DOI 10.1002/jlb.38.2.213
   Smedsrod B, 1997, BIOCHEM J, V322, P567, DOI 10.1042/bj3220567
   SMEDSROD B, 1989, BIOCHEM J, V261, P37, DOI 10.1042/bj2610037
   Thornalley PJ, 1998, CELL MOL BIOL, V44, P1013
   van Oosten M, 1998, INFECT IMMUN, V66, P5107, DOI 10.1128/IAI.66.11.5107-5112.1998
   WESTWOOD ME, 1994, J BIOL CHEM, V269, P32293
   Westwood ME, 1997, BBA-MOL CELL RES, V1356, P84, DOI 10.1016/S0167-4889(96)00154-1
   YEN TTT, 1970, P SOC EXP BIOL MED, V133, P307
   Zoccali C, 2000, NEPHROL DIAL TRANSPL, V15, P7, DOI 10.1093/ndt/15.suppl_1.7
NR 41
TC 7
Z9 9
U1 0
U2 2
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD OCT 3
PY 2003
VL 309
IS 4
BP 786
EP 791
DI 10.1016/j.bbrc.2003.08.080
PG 6
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 729LE
UT WOS:000185774300012
PM 13679041
DA 2024-02-19
ER

PT J
AU Haussig, JM
   Burgold, J
   Hafalla, JCR
   Matuschewski, K
   Kooij, TWA
AF Haussig, J. M.
   Burgold, J.
   Hafalla, J. C. R.
   Matuschewski, K.
   Kooij, T. W. A.
TI Signatures of malaria vaccine efficacy in ageing murine immune memory
SO PARASITE IMMUNOLOGY
LA English
DT Article
DE CD8(+) T cells; genetically arrested parasites; immunosenescence;
   malaria
ID PLASMODIUM-BERGHEI; LIVER-STAGES; IRRADIATED SPOROZOITES; PROTECTIVE
   IMMUNITY; T-CELLS; PARASITES; IMMUNIZATION; RESPONSES; MICE; AGE
AB Malaria transmission occurs by mosquito bite. Thereafter, Plasmodium sporozoites specifically invade the liver, where they develop into thousands of merozoites that initiate blood-stage infection and clinical malaria. The pre-erythrocytic phase of a Plasmodium infection is the target of experimental whole-parasite vaccines against malaria. Repeated immunizations with high doses of live, metabolically active sporozoites can induce protracted protection against Plasmodium reinfection. Parasites lacking a Plasmodium-specific apicoplast protein, termed PALM, arrest very late during intrahepatic development just prior to liver merozoite release and can elicit sterile protection with two immunization doses only. In this report, we show in the robust Plasmodium berghei-C57BL/6 model that partial protection extends beyond 1year after the last immunization. In ageing mice, intracellular cytokine staining of Plasmodium peptide-stimulated intrahepatic CD8(+) T cells revealed elevated levels of interferon gamma in vaccinated mice. We conclude that antigen-specific T cells persist in the target organ and are critical signatures of lasting protection. Our data also support the notions that memory T-cell responses generated early in life remain largely intact well into old age and that murine Plasmodium vaccination and infection models are suitable to study the mechanisms of maintenance and efficiency of adaptive immunity during immunosenescence.
C1 [Haussig, J. M.; Burgold, J.; Matuschewski, K.; Kooij, T. W. A.] Max Planck Inst Infect Biol, Parasitol Unit, D-10117 Berlin, Germany.
   [Burgold, J.] Humboldt Univ, Charite Univ Med Berlin, D-10099 Berlin, Germany.
   [Burgold, J.] Free Univ Berlin, Berlin, Germany.
   [Hafalla, J. C. R.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Immunol & Infect, London WC1, England.
   [Matuschewski, K.] Humboldt Univ, Inst Biol, D-10099 Berlin, Germany.
C3 Max Planck Society; Free University of Berlin; Humboldt University of
   Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin;
   University of London; London School of Hygiene & Tropical Medicine;
   Humboldt University of Berlin
RP Matuschewski, K (corresponding author), Max Planck Inst Infect Biol, Parasitol Unit, D-10117 Berlin, Germany.
EM matuschewski@mpiib-berlin.mpg.de
RI Kooij, Taco W.A./L-5623-2015
OI Kooij, Taco W.A./0000-0002-8547-7523; Haussig, Joana
   M./0000-0002-5216-3472; Matuschewski, Kai/0000-0001-6147-8591
FU Max Planck Society; EviMalaR Network of Excellence [34]; Royal Society
   (UK) University Research Fellowship
FX This work was supported by the Max Planck Society and, in part, by the
   EviMalaR Network of Excellence (partner #34). JCRH is supported by a
   Royal Society (UK) University Research Fellowship. The authors declare
   that they have no conflict of interest.
CR Beaudoin RL, 1977, EXP PARASITOL, V41, P1
   Borrmann S, 2011, TRENDS MOL MED, V17, P527, DOI 10.1016/j.molmed.2011.05.008
   Bruña-Romero O, 2001, INT J PARASITOL, V31, P1499, DOI 10.1016/S0020-7519(01)00265-X
   Butler NS, 2011, CELL HOST MICROBE, V9, P451, DOI 10.1016/j.chom.2011.05.008
   Castle SC, 2000, CLIN INFECT DIS, V31, P578, DOI 10.1086/313947
   CLYDE DF, 1973, AM J MED SCI, V266, P169, DOI 10.1097/00000441-197309000-00002
   de Souza JB, 2010, PARASITOLOGY, V137, P755, DOI 10.1017/S0031182009991715
   Douradinha B, 2007, INT J PARASITOL, V37, P1511, DOI 10.1016/j.ijpara.2007.05.005
   FERREIRA A, 1986, SCIENCE, V232, P881, DOI 10.1126/science.3085218
   Friesen J, 2011, VACCINE, V29, P7002, DOI 10.1016/j.vaccine.2011.07.034
   Friesen J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001058
   GOODRICK CL, 1975, J GERONTOL, V30, P257, DOI 10.1093/geronj/30.3.257
   Goronzy JJ, 2013, NAT IMMUNOL, V14, P428, DOI 10.1038/ni.2588
   Gwadz R W, 1979, Bull World Health Organ, V57 Suppl 1, P165
   Hafalla JCR, 2006, EUR J IMMUNOL, V36, P1179, DOI 10.1002/eji.200535712
   Hafalla JC, 2011, IMMUNOL REV, V240, P297, DOI 10.1111/j.1600-065X.2010.00988.x
   Hafalla JCR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003303
   Haussig JM, 2011, MOL MICROBIOL, V81, P1511, DOI 10.1111/j.1365-2958.2011.07787.x
   Haynes L, 2003, P NATL ACAD SCI USA, V100, P15053, DOI 10.1073/pnas.2433717100
   Haynes L, 2009, CURR OPIN IMMUNOL, V21, P414, DOI 10.1016/j.coi.2009.05.009
   Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409
   Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007
   Jobe O, 2007, J INFECT DIS, V196, P599, DOI 10.1086/519743
   Kumar KA, 2006, NATURE, V444, P937, DOI 10.1038/nature05361
   Matuschewski K, 2002, EMBO J, V21, P1597, DOI 10.1093/emboj/21.7.1597
   Mueller AK, 2005, NATURE, V433, P164, DOI 10.1038/nature03188
   Mueller AK, 2007, AM J PATHOL, V171, P107, DOI 10.2353/ajpath.2007.060792
   Nganou-Makamdop K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036508
   NUSSENZWEIG RS, 1967, NATURE, V216, P160, DOI 10.1038/216160a0
   Roberts AD, 2005, J EXP MED, V202, P123, DOI 10.1084/jem.20050137
   Roestenberg M, 2011, LANCET, V377, P1770, DOI 10.1016/S0140-6736(11)60360-7
   Roestenberg M, 2009, NEW ENGL J MED, V361, P468, DOI 10.1056/NEJMoa0805832
   SCHELLER LF, 1995, P NATL ACAD SCI USA, V92, P4066, DOI 10.1073/pnas.92.9.4066
   Silvie O, 2002, PARASITE IMMUNOL, V24, P221, DOI 10.1046/j.1365-3024.2002.00450.x
   Silvie O, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000086
   Silvie O, 2008, CURR OPIN MICROBIOL, V11, P352, DOI 10.1016/j.mib.2008.06.005
   Turturro A, 2002, J GERONTOL A-BIOL, V57, pB379, DOI 10.1093/gerona/57.11.B379
   van Dijk MR, 2005, P NATL ACAD SCI USA, V102, P12194, DOI 10.1073/pnas.0500925102
   Yu XC, 2008, NATURE, V455, P532, DOI 10.1038/nature07231
NR 39
TC 4
Z9 4
U1 0
U2 7
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0141-9838
EI 1365-3024
J9 PARASITE IMMUNOL
JI Parasite Immunol.
PD MAY
PY 2014
VL 36
IS 5
BP 199
EP 206
DI 10.1111/pim.12104
PG 8
WC Immunology; Parasitology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Parasitology
GA AE4PT
UT WOS:000333965700002
PM 24495208
DA 2024-02-19
ER

PT J
AU Grazi, GL
   Cescon, M
   Ravaioli, M
   Ercolani, G
   Pierangeli, F
   D'Errico, A
   Ridolfi, L
   Cavallari, A
   Mazziotti, A
AF Grazi, GL
   Cescon, M
   Ravaioli, M
   Ercolani, G
   Pierangeli, F
   D'Errico, A
   Ridolfi, L
   Cavallari, A
   Mazziotti, A
TI A revised consideration on the use of very aged donors for liver
   transplantation
SO AMERICAN JOURNAL OF TRANSPLANTATION
LA English
DT Article
DE aging; hepatic artery; liver transplantation; postoperative
   complications; tissue donors
ID ELDERLY DONORS; GRAFT FUNCTION; RISK-FACTORS; OLDER; ALLOGRAFTS; SAFE
AB The upper age limit for organ donation for liver transplantation has increased over the past few years. A retrospective case control study was carried out to evaluate the outcome of 36 liver transplants (group A) performed with grafts procured from donors over 70 years old in the period 1996 to April 2000, matched with 36 transplants (group B) chronologically performed thereafter with organs procured from donors below the age of 40 yr. The groups were comparable as regards main clinical characteristics. Mean follow-up was 14.5 months. Clinical and laboratory parameters of the donors, cold ischemia period, intra-operative blood transfusions, 30-d mortality, incidence of primary graft nonfunction, acute rejection episodes, arterial complications and long-term survival of recipients were considered. The main postoperative biochemical parameters were also collected and compared. A liver biopsy was obtained in 20/36 old donors, revealing less than 25% of steatosis in all but one, which showed steatosis involving 70% of the hepatocytes. There were two postoperative deaths (5.6%) in group A and one (2.8%) in group B (p = NS). Seven postoperative arterial complications (19.4%) occurred in group A, leading to the patient's death because of rupture of the hepatic artery in one case, to successful surgical revascularization in three cases and to retransplantation in three cases. Only one patient in group B (2.8%) experienced hepatic artery thrombosis (p = 0.055). One-year patient survival rates were 77.4% for group A and 88.8% for group B (p = NS); 1-yr graft survival rates were 73.3% for group A and 85.7% for group B (p = NS). In conclusion, donors over 70 should not be excluded a priori for liver transplantation in elective settings. Great attention should be paid to the pathological conditions of arterial vessels caused by athero-sclerosis, i.e. the presence of calcified plaques on the hepatic artery, which might represent the source of severe complications.
C1 Univ Bologna, Dept Surg & Transplantat, I-40138 Bologna, Italy.
   Univ Bologna, Dept Pathol F Addarii, Bologna, Italy.
   AIRT Interreg Ctr, Emilia Romagna Reg Transplant Reference Ctr, Bologna, Italy.
C3 University of Bologna; University of Bologna
RP Grazi, GL (corresponding author), Univ Bologna, Dept Surg & Transplantat, Via Massarenti 9, I-40138 Bologna, Italy.
RI Grazi, Gian Luca/J-7215-2018; D'ERRICO, ANTONIETTA/HGU-1912-2022;
   ercolani, giorgio/AAD-1462-2022; Ravaioli, Matteo/D-6314-2016
OI Grazi, Gian Luca/0000-0002-3279-0313; D'ERRICO,
   ANTONIETTA/0000-0003-2747-3732; Ravaioli, Matteo/0000-0001-5862-6151;
   Ercolani, Giorgio/0000-0003-4334-5167; Cescon,
   Matteo/0000-0003-1715-3794
CR ADAM R, 1993, TRANSPLANT P, V25, P1556
   ADAM R, 1995, TRANSPLANT P, V27, P1181
   ALEXANDER JW, 1991, TRANSPLANT P, V23, P905
   Detre K M, 1995, Liver Transpl Surg, V1, P311, DOI 10.1002/lt.500010507
   Emre S, 1996, TRANSPLANTATION, V62, P62, DOI 10.1097/00007890-199607150-00013
   Grande L, 1997, TRANSPLANT P, V29, P3289, DOI 10.1016/S0041-1345(97)00914-7
   GRAZI GL, 1991, TRANSPLANT P, V23, P2483
   Hoofnagle JH, 1996, HEPATOLOGY, V24, P89, DOI 10.1053/jhep.1996.v24.pm0008707288
   Marino IR, 1995, HEPATOLOGY, V22, P1754, DOI 10.1002/hep.1840220622
   Mazziotti A, 1999, HEPATO-GASTROENTEROL, V46, P1819
   MIMEAULT R, 1989, TRANSPLANT P, V21, P3355
   Mor E, 1997, TRANSPLANT P, V29, P3079, DOI 10.1016/S0041-1345(97)00791-4
   PLOEG RJ, 1993, TRANSPLANTATION, V55, P807, DOI 10.1097/00007890-199304000-00024
   POPPER H, 1986, PROG LIVER DIS, V8, P659
   POST J, 1993, TRANSPLANT P, V25, P1570
   STANSBY GP, 1992, ANN ROY COLL SURG, V74, P260
   STRASBERG SM, 1994, HEPATOLOGY, V20, P829, DOI 10.1002/hep.1840200410
   WALL W, 1993, LANCET, V341, P121, DOI 10.1016/0140-6736(93)92604-R
   WALL WJ, 1990, TRANSPLANTATION, V49, P377, DOI 10.1097/00007890-199002000-00030
   Washburn WK, 1996, TRANSPLANTATION, V61, P1062, DOI 10.1097/00007890-199604150-00013
   YERSIZ H, 1995, TRANSPLANTATION, V60, P790, DOI 10.1097/00007890-199510270-00005
NR 21
TC 59
Z9 64
U1 0
U2 0
PU BLACKWELL MUNKSGAARD
PI COPENHAGEN
PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
SN 1600-6135
J9 AM J TRANSPLANT
JI Am. J. Transplant.
PD MAY
PY 2001
VL 1
IS 1
BP 61
EP 68
DI 10.1034/j.1600-6143.2001.010112.x
PG 8
WC Surgery; Transplantation
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Surgery; Transplantation
GA 512PM
UT WOS:000173332800012
PM 12095041
DA 2024-02-19
ER

PT J
AU Thompson, MD
   Derse, A
   Ferey, JLA
   Reid, M
   Xie, Y
   Christ, M
   Chatterjee, D
   Nguyen, C
   Harasymowicz, N
   Guilak, F
   Moley, KH
   Davidson, NO
AF Thompson, Michael D.
   Derse, Alaina
   Ferey, Jeremie L. A.
   Reid, Michaela
   Xie, Yan
   Christ, Miranda
   Chatterjee, Deyali
   Nguyen, Chau
   Harasymowicz, Natalia
   Guilak, Farshid
   Moley, Kelle H.
   Davidson, Nicholas Oliver
TI Transgenerational impact of maternal obesogenic diet on offspring bile
   acid homeostasis and nonalcoholic fatty liver disease
SO AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
LA English
DT Article
DE bile acid metabolism; fatty liver; liver fibrosis; maternal
   high-fat/high-sucrose diet
ID METABOLIC-SYNDROME; MITOCHONDRIAL DYSFUNCTION; PROTEIN RESTRICTION;
   PROGRAMS; OBESITY; PREGNANCY; FIBROSIS; LACTATION; MICE; STEATOHEPATITIS
AB Studies show maternal obesity is a risk factor for metabolic syndrome and nonalcoholic fatty liver disease (NAFLD) in offspring. Here we evaluated potential mechanisms underlying these phenotypes. Female C57B16 mice were fed chow or an obesogenic high-fat/high-sucrose (HF/HS) diet with subsequent mating of F-1 and F-2 female offspring to lean males to develop F-2 and F-3 generations, respectively. Offspring were fed chow or fibrogenic (high transfat, cholesterol, fructose) diets, and histopathological, metabolic changes, and bile acid (BA) homeostasis was evaluated. Chow-fed F-1 offspring from maternal HF/HS lineages (HF/HS) developed periportal fibrosis and inflammation with aging, without differences in hepatic steatosis but increased BA pool size and shifts in BA composition. F-1, but not F-2 or F-3. offspring from HF/HS showed increased steatosis on a fibrogenic diet, yet inflammation and fibrosis were paradoxically decreased in F-1 offspring, a trend continued in F-2 and F-3 offspring. HF/HS feeding leads to increased periportal fibrosis and inflammation in chow-fed offspring without increased hepatic steatosis. By contrast, fibrogenic diet-fed F-1 offspring from HF/HS dams exhibited worse hepatic steatosis but decreased inflammation and fibrosis. These findings highlight complex adaptations in NAFLD phenotypes with maternal diet.
C1 [Thompson, Michael D.; Derse, Alaina; Christ, Miranda; Nguyen, Chau] Washington Univ, Dept Pediat, Div Endocrinol & Diabet, St Louis, MO 63110 USA.
   [Ferey, Jeremie L. A.; Reid, Michaela; Moley, Kelle H.] Washington Univ, Ctr Reprod Hlth Sci, Dept Obstet & Gynecol, St Louis, MO 63110 USA.
   [Xie, Yan; Davidson, Nicholas Oliver] Washington Univ, Dept Med, Div Gastroenterol, St Louis, MO 63110 USA.
   [Chatterjee, Deyali] Washington Univ, Dept Pathol, St Louis, MO 63110 USA.
   [Harasymowicz, Natalia; Guilak, Farshid] Washington Univ, Dept Orthoped Surg, St Louis, MO 63110 USA.
C3 Washington University (WUSTL); Washington University (WUSTL); Washington
   University (WUSTL); Washington University (WUSTL); Washington University
   (WUSTL)
RP Thompson, MD (corresponding author), Washington Univ, Sch Med, Dept Pediat, Div Endocrinol, 660 South Euclid Ave,Campus Box 8116, St Louis, MO 63110 USA.
EM thompsonmd@wustl.edu
OI Ferey, Jeremie/0000-0003-3382-2935
FU Child Health Research Center at Washington University School of Medicine
   NIH [K12-HD-076224]; Digestive Diseases Research Cores Center
   [DK-52574]; Washington University Institute for Clinical and
   Translational Science Just in Time Award; NIH [DK-56260, HL-38180,
   HL-140848, HD-83895]
FX This work was supported by Child Health Research Center at Washington
   University School of Medicine NIH Grant K12-HD-076224 (M. D. Thompson),
   Digestive Diseases Research Cores Center Grant DK-52574 (M. D. Thompson,
   N. O. Davidson), a Washington University Institute for Clinical and
   Translational Science Just in Time Award (M. D. Thompson), and NIH
   Grants DK-56260 (N. O. Davidson), HL-38180 (N. O. Davidson), HL-140848
   (J. L. A. Ferey), and HD-83895 (K. H. Moley).
CR Angulo P, 2015, GASTROENTEROLOGY, V149, P389, DOI 10.1053/j.gastro.2015.04.043
   Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808
   Bruce KD, 2009, HEPATOLOGY, V50, P1796, DOI 10.1002/hep.23205
   Brumbaugh DE, 2013, J PEDIATR-US, V162, P930, DOI 10.1016/j.jpeds.2012.11.017
   Brunt EM, 2009, HEPATOLOGY, V49, P809, DOI 10.1002/hep.22724
   Carpino G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157246
   Gadd VL, 2014, HEPATOLOGY, V59, P1393, DOI 10.1002/hep.26937
   Gälman C, 2003, J LIPID RES, V44, P859, DOI 10.1194/jlr.D200043-JLR200
   Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4
   Habbout A, 2013, J NUTR, V143, P553, DOI 10.3945/jn.112.172825
   Hanson MA, 2014, PHYSIOL REV, V94, P1027, DOI 10.1152/physrev.00029.2013
   Hinkle SN, 2012, MATERN CHILD HLTH J, V16, P1339, DOI 10.1007/s10995-011-0898-2
   Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001
   Katafuchi T, 2015, CELL METAB, V21, P898, DOI 10.1016/j.cmet.2015.05.004
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Burgueño AL, 2013, J NUTR BIOCHEM, V24, P6, DOI 10.1016/j.jnutbio.2011.12.008
   Li J, 2018, DIABETOLOGIA, V61, P1862, DOI 10.1007/s00125-018-4635-x
   Machado MV, 2015, J HEPATOL, V63, P962, DOI 10.1016/j.jhep.2015.05.031
   Machado MV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127991
   McCommis KS, 2017, HEPATOLOGY, V65, P1543, DOI 10.1002/hep.29025
   Mouralidarane A, 2013, HEPATOLOGY, V58, P128, DOI 10.1002/hep.26248
   Nobili V, 2012, HEPATOLOGY, V56, P2142, DOI 10.1002/hep.25742
   Oben JA, 2010, J HEPATOL, V52, P913, DOI 10.1016/j.jhep.2009.12.042
   Ornellas F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124737
   Plagemann A, 1997, INT J OBESITY, V21, P451, DOI 10.1038/sj.ijo.0800429
   Plagemann A, 1997, DIABETOLOGIA, V40, P1094, DOI 10.1007/s001250050792
   Qasem RJ, 2016, CLIN EXP PHARMACOL P, V43, P494, DOI 10.1111/1440-1681.12545
   Qasem RJ, 2010, NUTR RES, V30, P410, DOI 10.1016/j.nutres.2010.05.008
   Rizki G, 2006, J LIPID RES, V47, P2280, DOI 10.1194/jlr.M600198-JLR200
   Saben JL, 2016, CELL REP, V16, P1, DOI 10.1016/j.celrep.2016.05.065
   Sanchez LHG, 2018, HEPATOL COMMUN, V2, P1493, DOI 10.1002/hep4.1265
   Schwimmer JB, 2013, ALIMENT PHARM THER, V38, P1267, DOI 10.1111/apt.12518
   Schwinnner JB, 2005, HEPATOLOGY, V42, P641, DOI 10.1002/hep.20842
   Seki Y, 2017, ENDOCRINOLOGY, V158, P2860, DOI 10.1210/en.2017-00334
   Soderborg TK, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06929-0
   Tandra S, 2011, J HEPATOL, V55, P654, DOI 10.1016/j.jhep.2010.11.021
   Thompson Michael D., 2016, Gene Expression-The Journal of Liver Research, V17, P47, DOI 10.3727/105221616X692135
   Thorn SR, 2014, DIABETES, V63, P2702, DOI 10.2337/db14-0276
   Wankhade UD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34453-0
   Wankhade UD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175675
   Xie Y, 2017, J LIPID RES, V58, P1692, DOI [10.1194/jlr.M077479, 10.1194/jlr.m077479]
   Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431
   Zeybel M, 2012, NAT MED, V18, P1369, DOI 10.1038/nm.2893
NR 43
TC 19
Z9 20
U1 0
U2 8
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0193-1849
EI 1522-1555
J9 AM J PHYSIOL-ENDOC M
JI Am. J. Physiol.-Endocrinol. Metab.
PD APR
PY 2019
VL 316
IS 4
BP E674
EP E686
DI 10.1152/ajpendo.00474.2018
PG 13
WC Endocrinology & Metabolism; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Physiology
GA HS0BG
UT WOS:000463524900011
PM 30860882
OA Bronze, Green Published
DA 2024-02-19
ER

PT J
AU Hu, B
   Du, Q
   Deng, S
   An, HM
   Pan, CF
   Shen, KP
   Xu, L
   Wei, MM
   Wang, SS
AF Hu, Bing
   Du, Qin
   Deng, Shan
   An, Hong-Mei
   Pan, Chuan-Fang
   Shen, Ke-Ping
   Xu, Ling
   Wei, Meng-Meng
   Wang, Shuang-Shuang
TI <i>Ligustrum lucidum</i> Ait. fruit extract induces apoptosis and cell
   senescence in human hepatocellular carcinoma cells through upregulation
   of p21
SO ONCOLOGY REPORTS
LA English
DT Article
DE hepatocellular carcinoma; Ligustrum lucidum fruit; apoptosis; cell
   senescence; p21
ID TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; IN-VITRO; ACCELERATED
   SENESCENCE; CANCER-CELLS; TUMOR-CELLS; INDUCTION; THERAPY; FORMULA;
   ARREST; DEATH
AB Nu-zhen-zi, the fruit of Ligustrum lucidum Ait., is one of the most frequently used liver Yin tonifying Chinese herbs for the treatment of liver cancer. However, the effect of Ligustrum lucidum fruit on hepatocarcinoma cells remains unknown. In the present study, we evaluated the effects of a Ligustrum lucidum fruit extract (LLFE) on human hepatocellular carcinoma Bel-7402 cells. The results showed that LLFE inhibited the proliferation of the Bel-7402 cells in a dose- and time-dependent manner. LLFE induced apoptosis in Bel-7402 cells accompanied by activation of caspase-3, -8 and -9. LLFE-induced apoptosis was completely abrogated by a pan caspase inhibitor, Z-VAD-FMK. LLFE treatment also caused a large and fiat morphologic cellular change, positive SA-beta-gal staining, and G(0)/G(1) phase cell cycle arrest in the Bel-7402 cells, accompanied by upregulation of p21 and downregulation of RB phosphorylation. Specific knockdown of p21 expression by RNA interference partially abrogated LLFE-induced apoptosis, and significantly abrogated LLFE-induced cell senescence. These observations suggest that Nu-zhen-zi is a potential anticancer herb and support the traditional use of NU-zhen-zi for hepatocarcinoma treatment.
C1 [Hu, Bing; Du, Qin; Deng, Shan; Pan, Chuan-Fang; Shen, Ke-Ping; Xu, Ling; Wei, Meng-Meng; Wang, Shuang-Shuang] Shanghai Univ Tradit Chinese Med, Dept Oncol, Longhua Hosp, Shanghai 202032, Peoples R China.
   [Hu, Bing; Du, Qin; Deng, Shan; Xu, Ling; Wei, Meng-Meng; Wang, Shuang-Shuang] Shanghai Univ Tradit Chinese Med, Longhua Hosp, Inst Tradit Chinese Med Oncol, Shanghai 202032, Peoples R China.
   [An, Hong-Mei] Shanghai Univ Tradit Chinese Med, Longhua Hosp, Dept Sci & Technol, Shanghai 200032, Peoples R China.
C3 Shanghai University of Traditional Chinese Medicine; Shanghai University
   of Traditional Chinese Medicine; Shanghai University of Traditional
   Chinese Medicine
RP Hu, B (corresponding author), Shanghai Univ Tradit Chinese Med, Dept Oncol, Longhua Hosp, Shanghai 202032, Peoples R China.
EM beearhu@hotmail.com
OI An, Hong-Mei/0000-0001-6656-9409
FU National Natural Science Foundation of China [81273726]; Three-year
   Action Program of Shanghai Municipality for Traditional Chinese Medicine
   [ZYSNXD-CC-ZDYJ017]; Xing-Lin Scholars Program; Long-Yi Scholars and
   Research Team Program from the State Clinical Research Center of TCM in
   Longhua Hospital [LYTD-04]; Shanghai Shen Kang Platform Grant
   [SHDC12007206]
FX This study was partially supported by the National Natural Science
   Foundation of China (81273726), the Three-year Action Program of
   Shanghai Municipality for Traditional Chinese Medicine
   (ZYSNXD-CC-ZDYJ017), the Xing-Lin Scholars Program, the Long-Yi Scholars
   and Research Team Program from the State Clinical Research Center of TCM
   in Longhua Hospital (LYTD-04), and the Shanghai Shen Kang Platform Grant
   (SHDC12007206). We also thank the Shanghai Key Laboratory of Tissue
   Engineering for technical assistance.
CR Ahmad N, 2001, CLIN CANCER RES, V7, P1466
   [Anonymous], WORLD J INTEGR TRADI
   Bo X, 1994, J BEIJING UNION U NA, V8, P58
   Brown JM, 2005, NAT REV CANCER, V5, P231, DOI 10.1038/nrc1560
   Chiantore MV, 2009, CURR MED CHEM, V16, P287, DOI 10.2174/092986709787002691
   Di X, 2009, BIOCHEM PHARMACOL, V77, P1139, DOI 10.1016/j.bcp.2008.12.016
   Dimri GP, 2005, CANCER CELL, V7, P505, DOI 10.1016/j.ccr.2005.05.025
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Gewirtz DA, 2008, BIOCHEM PHARMACOL, V76, P947, DOI 10.1016/j.bcp.2008.06.024
   Han ZY, 2002, J BIOL CHEM, V277, P17154, DOI 10.1074/jbc.M112401200
   Hu B, 2011, ONCOL REP, V26, P1465, DOI 10.3892/or.2011.1414
   Hu B, 2011, CANCER BIOTHER RADIO, V26, P97, DOI 10.1089/cbr.2010.0853
   JEMAL A, 2011, CA-CANCER J CLIN, V61, P69, DOI DOI 10.3322/CAAC.20107
   Jeong JC, 2011, PHYTOTHER RES, V25, P429, DOI 10.1002/ptr.3265
   Kagawa S, 1999, CELL DEATH DIFFER, V6, P765, DOI 10.1038/sj.cdd.4400549
   Li YL, 2000, TIANJIN TRADIT CHINE, V17, P12
   Liu Qing, 2005, Zhong Xi Yi Jie He Xue Bao, V3, P260
   Liu WK, 2008, J NAT PROD, V71, P842, DOI 10.1021/np8001223
   Lodygin D, 2002, J CLIN INVEST, V110, P1717, DOI 10.1172/JCI200216588
   Meier P, 2007, MOL CELL, V28, P746, DOI 10.1016/j.molcel.2007.11.016
   Meng MB, 2008, J ALTERN COMPLEM MED, V14, P1027, DOI 10.1089/acm.2008.0060
   Nardella C, 2011, NAT REV CANCER, V11, P503, DOI 10.1038/nrc3057
   Peng CC, 2007, J ETHNOPHARMACOL, V109, P93, DOI 10.1016/j.jep.2006.07.009
   Roninson IB, 2003, CANCER RES, V63, P2705
   Schmitt CA, 2007, BBA-REV CANCER, V1775, P5, DOI 10.1016/j.bbcan.2006.08.005
   Shoemaker M, 2005, PHYTOTHER RES, V19, P649, DOI 10.1002/ptr.1702
   Shu Xiaojuan, 2005, Integr Cancer Ther, V4, P219, DOI 10.1177/1534735405279927
   te Poele RH, 2002, CANCER RES, V62, P1876
   Thaler S, 2009, CANCER RES, V69, P1748, DOI 10.1158/0008-5472.CAN-08-1377
   Wakoh T, 2009, BIOCHEM BIOPH RES CO, V380, P807, DOI 10.1016/j.bbrc.2009.01.171
   Wu XF, 2008, J N CHINA COAL MED C, V10, P303
   Yan JG, 2010, CHIN J INTEGR TRADIT, V20, P189
   Yu Y, 2009, CANCER-AM CANCER SOC, V115, P5132, DOI 10.1002/cncr.24567
   Zhang JF, 2011, INTEGR CANCER THER, V10, P85, DOI 10.1177/1534735410373921
   Zhao YL, 2004, SPECTROSC SPECT ANAL, V24, P305
   潘敏求, 1993, 中医杂志, V34, P239
NR 36
TC 34
Z9 39
U1 5
U2 22
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1021-335X
EI 1791-2431
J9 ONCOL REP
JI Oncol. Rep.
PD SEP
PY 2014
VL 32
IS 3
BP 1037
EP 1042
DI 10.3892/or.2014.3312
PG 6
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA AM6NZ
UT WOS:000339983200021
PM 25017491
OA Bronze
DA 2024-02-19
ER

PT J
AU LEE, HC
   PANG, CY
   HSU, HS
   WEI, YH
AF LEE, HC
   PANG, CY
   HSU, HS
   WEI, YH
TI DIFFERENTIAL ACCUMULATIONS OF 4,977 BP DELETION IN MITOCHONDRIAL-DNA OF
   VARIOUS TISSUES IN HUMAN AGING
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
LA English
DT Article
DE MITOCHONDRIAL DNA; DELETION; HUMAN AGING; MUSCLE; LIVER; TESTIS
ID DISEASE; REPLICATION; INCREASE; DAMAGE; MUTATIONS; SEQUENCE; STRIATUM;
   MODEL
AB Several types of deletions in mitochondrial DNA (mtDNA) have been recently identified in various tissues of old humans. In order to determine whether there are differences in the incidence and proportion of deleted mtDNAs in different tissues during human ageing, we examined the 4,977 bp deletion in mtDNA of various tissues from subjects of different ages. Total DNA was extracted from each of the biopsied tissues and was serially diluted by two-fold with distilled water. A 533 bp DNA fragment was amplified by PCR from total mtDNA using a pair of primers L3304-3323 and H3817-3836, and another 524 bp PCR product was amplified from 4,977 bp deleted mtDNA by identical conditions using another pair of primers L8150-8166 and H13631-13650. The maximum dilution fold of each sample that still allowed the ethidium bromide-stained PCR product (533 bp or 524 bp) in the agarose gel to be visible under UV light illumination was taken as the relative abundance of the mtDNA (wild-type or mutant) in the original sample. By this method, we were able to determine the proportion of deleted mtDNA in human tissues. We found that the 4,977 bp deletion started to appear in the second and third decades of life in human muscle and liver tissues. But the deletion was not detectable in the testis until the age of 60 years. Moreover, the proportion of deleted mtDNA varied greatly in different tissues. Among the tissues examined, muscle was found to harbor higher proportion of deleted mtDNA than the other tissues. The average proportion of the 4,977 bp deleted mtDNA of the muscle from subjects over 70 years old was approximately 0.06%, and that of the liver and the testis was 0.0076% and 0.05%, respectively. These findings suggest that the frequency and proportion of the deleted mtDNA in human tissues increase with age and that the mtDNA deletions occur more frequently and abundantly in high energy-demanding tissues during the ageing process of the human.
C1 NATL YANG MING MED COLL,DEPT BIOCHEM,TAIPEI 11221,TAIWAN.
   VET GEN HOSP TAIPEI,DEPT UROL,TAIPEI,TAIWAN.
   NATL YANG MING MED COLL,INST BIOCHEM,TAIPEI,TAIWAN.
C3 National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung
   University
RI Wei, Yau-Huei/ABA-6841-2021; Pang, Cheng-Yoong/AFO-1562-2022; Pang,
   Cheng-Yoong/R-4990-2019; Lee, Hsin-Chen/H-6767-2019
OI Wei, Yau-Huei/0000-0002-6429-2546; Pang,
   Cheng-Yoong/0000-0002-9063-2858; Lee, Hsin-Chen/0000-0001-7455-9593
CR AMES BN, 1983, SCIENCE, V221, P1256, DOI 10.1126/science.6351251
   AMES BN, 1989, MUTAT RES, V214, P41, DOI 10.1016/0027-5107(89)90196-6
   AMES BN, 1988, IARC SCI PUBL, V89, P407
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   BANDY B, 1990, FREE RADICAL BIO MED, V8, P523, DOI 10.1016/0891-5849(90)90152-9
   BROWN MD, 1992, FASEB J, V6, P2791, DOI 10.1096/fasebj.6.10.1634041
   CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527
   CLAYTON DA, 1991, ANNU REV CELL BIOL, V7, P453, DOI 10.1146/annurev.cb.07.110191.002321
   CLAYTON DA, 1974, P NATL ACAD SCI USA, V71, P2777, DOI 10.1073/pnas.71.7.2777
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   CORRALDEBRINSKI M, 1991, JAMA-J AM MED ASSOC, V266, P1812, DOI 10.1001/jama.266.13.1812
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   FUKANAGA M, 1979, BIOCHEM BIOPH RES CO, V90, P582
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HSIEH RH, 1994, UNPUB BIOCH MOL BIOL
   IKEBE S, 1990, BIOCHEM BIOPH RES CO, V170, P1044, DOI 10.1016/0006-291X(90)90497-B
   MUNSCHER C, 1993, FEBS LETT, V317, P27, DOI 10.1016/0014-5793(93)81484-H
   OZAWA T, 1990, BIOCHEM BIOPH RES CO, V172, P483, DOI 10.1016/0006-291X(90)90698-M
   PALVA TK, 1985, FEBS LETT, V192, P267, DOI 10.1016/0014-5793(85)80122-8
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   SHIH KD, 1991, BIOCHEM BIOPH RES CO, V174, P1109, DOI 10.1016/0006-291X(91)91535-K
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   SIMMONETI S, 1992, BIOCHIM BIOPHYS ACTA, V1180, P113
   Tanaka M, 1992, METHOD MOL BIOL, V13, P1
   WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8
   WALLACE DC, 1987, CURR GENET, V12, P81, DOI 10.1007/BF00434661
   WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523
   WEI YH, 1992, MUTAT RES, V275, P145, DOI 10.1016/0921-8734(92)90019-L
   YANG JH, 1994, IN PRESS ARCH DERMAT
   YEN TC, 1991, BIOCHEM BIOPH RES CO, V178, P124, DOI 10.1016/0006-291X(91)91788-E
   YEN TC, 1992, BIOCHEM INT, V26, P457
   YEN TC, 1994, IN PRESS FREE RADIC
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
NR 35
TC 212
Z9 223
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0925-4439
J9 BBA-MOL BASIS DIS
JI Biochim. Biophys. Acta-Mol. Basis Dis.
PD APR 12
PY 1994
VL 1226
IS 1
BP 37
EP 43
DI 10.1016/0925-4439(94)90056-6
PG 7
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA NG545
UT WOS:A1994NG54500006
PM 8155737
DA 2024-02-19
ER

PT J
AU Ishii, K
   Tsubaki, T
   Fujita, K
   Ishigami, A
   Maruyama, N
   Akita, M
AF Ishii, K
   Tsubaki, T
   Fujita, K
   Ishigami, A
   Maruyama, N
   Akita, M
TI Immunohistochemical localization of senescence marker protein-30 (SMP30)
   in the submandibular gland and ultrastructural changes of the granular
   duct cells in SMP30 knockout mice
SO HISTOLOGY AND HISTOPATHOLOGY
LA English
DT Article
DE SMP30; submandibular gland; granular duct; alpha-isoproterenol;
   immunohistochemistry
ID PAROTID ACINAR-CELLS; SALIVARY SECRETION; RAT-LIVER
AB Senescence Marker Protein-30 (SMP30) is a calcium-regulating protein that decreases in an androgen-independent manner as aging occurs. An enzyme-labeled antibody technique has demonstrated that SMP30 localized to the ducts (granular, intercalated, and striated ducts) of mouse submandibular glands. Immunoelectronmicroscopy demonstrated that the granular duct cells were strongly positive for SMP30, but that pillar cells in the granular duct were negative for the protein. In SMP30-knockout (KO) mice, the granular ducts were smaller in diameter. Swelling of mitochondria in the granular duct cells was observed; however, this phenomenon was not observed in the pillar cells. After administration of alpha-isoproterenol, a beta-adrenergic stimulant, a large numbers of small secretory granules were present in the granular duct cells and an expansion of the rough endoplasmic reticulum in SMP30-wild type (WT) mice; in contrast, little change was observed in SMP30-KO mice. These results suggest that SMP30 may be closely related to a signal transduction pathway in the granular duct cells of submandibular glands.
C1 Jichi Med Sch, Omiya Med Ctr, Dept Otolaryngol, Omiya, Saitama, Japan.
   Saitama Med Sch, Dept Anat, Moroyama, Saitama, Japan.
   Tokyo Metropolitan Inst Gerontol, Organ Disorder & Aging Res Grp, Tokyo, Japan.
C3 Jichi Medical University; Saitama Medical University; Tokyo Metropolitan
   Institute of Gerontology
EM makita@saitama-med.ac.jp
CR BRENNER GM, 1981, J PHARMACOL EXP THER, V218, P608
   FUJITA T, 1991, BIOCHEM BIOPH RES CO, V178, P1485, DOI 10.1016/0006-291X(91)91061-G
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7
   Fujita T, 1996, BBA-GENE STRUCT EXPR, V1308, P49, DOI 10.1016/0167-4781(96)00064-4
   Fujita T, 1998, BIOCHEM BIOPH RES CO, V250, P374, DOI 10.1006/bbrc.1998.9327
   FUJITA T, 1995, BBA-GENE STRUCT EXPR, V1263, P249, DOI 10.1016/0167-4781(95)00120-6
   HANZENMARTIN DJ, 1986, ANAT REC, V214, P253
   HASHIMOTO J, 1992, Archives d'Anatomie et de Cytologie Pathologiques, V40, P79
   HENRIKSSON R, 1982, AM J PHYSIOL, V242, pG481, DOI 10.1152/ajpgi.1982.242.5.G481
   Ishigami A, 2002, AM J PATHOL, V161, P1273, DOI 10.1016/S0002-9440(10)64404-5
   JACOBY F, 1959, J ANAT, V93, P201
   KANAGASUNTHERAM P, 1976, BIOCHEM J, V160, P547, DOI 10.1042/bj1600547
   LUBERT S, 1991, BIOCHEMISTRY-US, P981
   Nezu A, 2000, JPN J PHARMACOL, V84, P25, DOI 10.1254/jjp.84.25
   SCHNEYER LH, 1972, PHYSIOL REV, V52, P720, DOI 10.1152/physrev.1972.52.3.720
   Segawa A, 2000, EUR J MORPHOL, V38, P237, DOI 10.1076/0924-3860(200010)38:4;1-O;FT237
   SRINIVASON R, 1975, ANAT REC, V192, P29
   TAKEDA M, 1978, ARCH ORAL BIOL, V23, P857, DOI 10.1016/0003-9969(78)90287-X
   THAYSEN JH, 1954, AM J PHYSIOL, V178, P155, DOI 10.1152/ajplegacy.1954.178.1.155
   UEDA T, 1985, J ELECTRON MICROSC, V34, P85
   Xue JH, 2000, J CELL BIOCHEM, V80, P285
NR 21
TC 13
Z9 21
U1 0
U2 0
PU F HERNANDEZ
PI MURCIA
PA PLAZA FUENSANTA 2-7 C, 30008 MURCIA, SPAIN
SN 0213-3911
EI 1699-5848
J9 HISTOL HISTOPATHOL
JI Histol. Histopath.
PD JUL
PY 2005
VL 20
IS 3
BP 761
EP 768
PG 8
WC Cell Biology; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Pathology
GA 942MS
UT WOS:000230287100012
PM 15944925
DA 2024-02-19
ER

PT J
AU de Abechuco, EL
   Bilbao, E
   Soto, M
   Díez, G
AF Lopez de Abechuco, E.
   Bilbao, E.
   Soto, M.
   Diez, G.
TI Molecular cloning and measurement of telomerase reverse transcriptase
   (TERT) transcription patterns in tissues of European hake (<i>Merluccius
   merluccius</i>) and Atlantic cod (<i>Gadus morhua</i>) during aging
SO GENE
LA English
DT Article
DE Telomerase; Aging; Hake; Cod; Telomeres
ID REAL-TIME PCR; CATALYTIC SUBUNIT; CELLULAR SENESCENCE; VERTEBRATE MODEL;
   JAPANESE MEDAKA; IN-VIVO; EXPRESSION; LENGTH; GENE; AGE
AB Telomerase is a reverse transcriptase ribonucleoprotein that maintains the ends of linear chromosomes. This enzyme plays a major role in cell processes like proliferation, differentiation and tumorigenesis, being associated with aging and survival of species. In this study, the gene coding for TERT (Telomerase Reverse Transcriptase) of two commercial fish species, European hake (Merluccius merluccius) and Atlantic cod (Gadus morhua), has been partially cloned. A fragment of 1581 bp (hake) and 633 bp (cod) showed high homology (identity 74%, query cover 99%, E-value = 0) with known Perciformes TERT sequences. TERT transcription patterns were assessed by qRT-PCR in different tissues of hake (brain, ovary, testis, muscle, skin, gills, liver and kidney) and cod (brain, muscle and skin) of different sizes/ages in order to understand its role in the physiological aging of teleosts. TERT was found to be ubiquitously transcribed in all tissues and size/age groups studied in both species. Significantly higher relative transcription levels (p < 0.05) were found with increasing size/age of M. merluccius in the kidney, muscle, skin and gonad, the latter exhibiting particularly high relative transcription levels. Male hakes showed higher TEAT relative transcription levels in the brain, gonad and liver than females, although these differences were not statistically significant (p < 0.05). In G. morhua, higher TERT relative transcription levels were recorded in the muscle and brain of fry and juvenile individuals. Therefore, TERT relative transcription pattern exhibited a higher telomerase demand in early developmental stages and also in mature stages, suggesting tissue renewal or regeneration processes as a conserved mechanism for maintaining long-term cell proliferation capacity and preventing senescence. Thus, it can be concluded that TERT relative transcription level was species and tissue specific and changed with the age of fishes. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Lopez de Abechuco, E.; Diez, G.] AZTI Tecnalia, Div Marine Res, Sukarrieta 48395, Bizkaia, Spain.
   [Bilbao, E.; Soto, M.] Univ Basque Country, Res Ctr Expt Marine Biol & Biotechnol PIE UPV EHU, Dept Zool & Anim Cell Biol, Plentzia, Bizkaia, Spain.
C3 AZTI; University of Basque Country
RP Díez, G (corresponding author), AZTI Tecnalia, Div Marine Res, Sukarrieta 48395, Bizkaia, Spain.
RI Soto, Manu/C-3995-2017; , Eiderb/Y-6831-2018
OI Soto, Manu/0000-0002-4541-8182; , Eiderb/0000-0001-7155-2724; Lopez de
   Abechuco, Estibaliz/0000-0003-2606-0688
FU AZTI-Tecnalia; Departamento de Agricultura, Pesca y Alimentacion of
   Basque Government [ATM2010telom]; Spanish Ministerio de Economia y
   Competitividad [CTM2010-21856-C03-03]; Inaki Goenaga Foundation
   (OTELOFISH)
FX This work was funded by the AZTI-Tecnalia, the Departamento de
   Agricultura, Pesca y Alimentacion of Basque Government (grant:
   ATM2010telom) and the Spanish Ministerio de Economia y Competitividad
   (grant: CTM2010-21856-C03-03). We are very grateful to SINTEF staff and
   the Atlantic Cod Farms Company. We wish to thank also the staff from
   Molecular Biology Laboratory of the Food Research Division in AZTI and
   Marina Santurtun for their help and support. Estibaliz Lopez de Abechuco
   work was supported by a research grant from the Inaki Goenaga Foundation
   (OTELOFISH).
CR Anchelin M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016955
   Au DWT, 2009, COMP BIOCHEM PHYS C, V149, P161, DOI 10.1016/j.cbpc.2008.08.005
   Aubert G, 2008, PHYSIOL REV, V88, P557, DOI 10.1152/physrev.00026.2007
   Autexier C, 2006, ANNU REV BIOCHEM, V75, P493, DOI 10.1146/annurev.biochem.75.103004.142412
   Blackburn E, 1999, MT SINAI J MED, V66, P292
   Blasco MA, 2002, NAT REV CANCER, V2, P627, DOI 10.1038/nrc862
   Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797
   Campisi J, 2003, NAT REV CANCER, V3, P339, DOI 10.1038/nrc1073
   Campisi J, 2001, EXP GERONTOL, V36, P1619, DOI 10.1016/S0531-5565(01)00160-7
   Chan SRWL, 2004, PHILOS T R SOC B, V359, P109, DOI 10.1098/rstb.2003.1370
   CovielloMcLaughlin GM, 1997, NUCLEIC ACIDS RES, V25, P3051, DOI 10.1093/nar/25.15.3051
   de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080
   Dunshea G, 2011, MOL ECOL RESOUR, V11, P225, DOI 10.1111/j.1755-0998.2010.02976.x
   Elmore LW, 2008, EXP BIOL MED, V233, P958, DOI 10.3181/0712-RM-345
   Fleige S, 2006, BIOTECHNOL LETT, V28, P1601, DOI 10.1007/s10529-006-9127-2
   Forsyth NR, 2002, DIFFERENTIATION, V69, P188, DOI 10.1046/j.1432-0436.2002.690412.x
   Gomes NMV, 2010, COMPARATIVE BIOLOGY OF AGING, P227, DOI 10.1007/978-90-481-3465-6_11
   Grabowski P, 2005, BLOOD, V105, P4807, DOI 10.1182/blood-2004-11-4394
   GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0
   Hall TA., 1999, Nucleic Acids Symposium Series, V41, P95, DOI 10.1021/bk-1999-0734.ch008
   Hartmann N, 2009, MECH AGEING DEV, V130, P290, DOI 10.1016/j.mad.2009.01.003
   Hatakeyama H, 2008, MECH AGEING DEV, V129, P550, DOI 10.1016/j.mad.2008.05.006
   Haussmann MF, 2007, EXP GERONTOL, V42, P610, DOI 10.1016/j.exger.2007.03.004
   Henriques CM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003214
   HIYAMA K, 1995, J IMMUNOL, V155, P3711
   Horn T, 2008, AUST J ZOOL, V56, P207, DOI 10.1071/ZO08046
   Imamura S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003364
   KARA TC, 1994, GERONTOLOGY, V40, P161, DOI 10.1159/000213585
   Kishi S, 2003, EXP GERONTOL, V38, P777, DOI 10.1016/S0531-5565(03)00108-6
   Klapper W, 1998, FEBS LETT, V434, P409, DOI 10.1016/S0014-5793(98)01020-5
   Kong RYC, 2008, AQUAT TOXICOL, V86, P131, DOI 10.1016/j.aquatox.2007.10.011
   Kuramoto M, 2001, GENE, V277, P101, DOI 10.1016/S0378-1119(01)00684-9
   LAMOND AI, 1989, TRENDS BIOCHEM SCI, V14, P202, DOI 10.1016/0968-0004(89)90022-4
   Lau BWM, 2007, J MOL NEUROSCI, V32, P160, DOI 10.1007/s12031-007-0031-6
   LINGNER J, 1997, SCIENCE, V276, P561, DOI DOI 10.1126/SCIENCE.276.5312.561
   Lund TC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007688
   Matsubara Y, 2006, BIOCHEM BIOPH RES CO, V341, P128, DOI 10.1016/j.bbrc.2005.12.163
   McChesney PA, 2005, ZEBRAFISH, V1, P349, DOI 10.1089/zeb.2005.1.349
   Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3
   Mok O.L.H., 2008, RELATING MUSCLE TELO, P161
   Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955
   Oguchi K, 1999, FEBS LETT, V457, P465, DOI 10.1016/S0014-5793(99)01083-2
   Ohtani N, 2013, CANCER SCI, V104, P525, DOI 10.1111/cas.12118
   Osanai M, 2006, GENE, V376, P281, DOI 10.1016/j.gene.2006.04.022
   Otxotorena U, 2010, FISH RES, V106, P337, DOI 10.1016/j.fishres.2010.09.001
   Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Pfennig F, 2008, DEV GROWTH DIFFER, V50, P131, DOI [10.1111/j.1440-169x.2008.00986.x, 10.1111/j.1440-169X.2008.00986.x]
   Piñeiro C, 2003, ICES J MAR SCI, V60, P1086, DOI 10.1016/S1054-3139(03)00086-9
   PROWSE KR, 1995, P NATL ACAD SCI USA, V92, P4818, DOI 10.1073/pnas.92.11.4818
   Shay JW, 2005, CARCINOGENESIS, V26, P867, DOI 10.1093/carcin/bgh296
   Sykorová E, 2009, BIOL CELL, V101, P375, DOI 10.1042/BC20080205
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Wright WE, 2002, NAT BIOTECHNOL, V20, P682, DOI 10.1038/nbt0702-682
   Wright WE, 2001, CURR OPIN GENET DEV, V11, P98, DOI 10.1016/S0959-437X(00)00163-5
   Yu RM, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-27
NR 57
TC 9
Z9 9
U1 0
U2 18
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0378-1119
EI 1879-0038
J9 GENE
JI Gene
PD MAY 10
PY 2014
VL 541
IS 1
BP 8
EP 18
DI 10.1016/j.gene.2014.03.006
PG 11
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA AL0NI
UT WOS:000338823200002
PM 24607378
DA 2024-02-19
ER

PT J
AU Jackson, TW
   Henriquez, AR
   Snow, SJ
   Schladweiler, MC
   Fisher, AA
   Alewel, D
   House, JS
   Kodavanti, UP
AF Jackson, Thomas W.
   Henriquez, Andres R.
   Snow, Samantha J.
   Schladweiler, Mette C.
   Fisher, Anna A.
   Alewel, Devin, I
   House, John S.
   Kodavanti, Urmila P.
TI Adrenal Stress Hormone Regulation of Hepatic Homeostatic Function After
   an Acute Ozone Exposure in Wistar-Kyoto Male Rats
SO TOXICOLOGICAL SCIENCES
LA English
DT Article; Early Access
DE stress response; neuroendocrine; ozone; glucocorticoids; catecholamines;
   metabolic response; pituitary hormones; adrenalectomy
ID PARTICULATE MATTER; AIR-POLLUTION; INHALED OZONE; METABOLISM; GLUCOSE;
   GLUCOCORTICOIDS; DYSFUNCTION; PULMONARY; PATHWAY; SYSTEM
AB Ozone-induced lung injury, inflammation, and pulmonary/hypothalamus gene expression changes are diminished in adrenalectomized (AD) rats. Acute ozone exposure induces metabolic alterations concomitant with increases in epinephrine and corticosterone. We hypothesized that adrenal hormones are responsible for observed hepatic ozone effects, and in AD rats, these changes would be diminished. In total, 5-7 days after sham (SH) or AD surgeries, male Wistar-Kyoto rats were exposed to air or 0.8-ppm ozone for 4 h. Serum samples were analyzed for metabolites and liver for transcriptional changes immediately post-exposure. Ozone increased circulating triglycerides, cholesterol, free fatty-acids, and leptin in SH but not AD rats. Ozone-induced inhibition of glucose-mediated insulin release was absent in AD rats. Unlike diminution of ozone-induced hypothalamus and lung mRNA expression changes, AD in air-exposed rats (AD-air/SH-air) caused differential hepatic expression of similar to 1000 genes. Likewise, ozone in AD rats caused differential expression of similar to 1000 genes (AD-ozone/AD-air). Ozone-induced hepatic changes in SH rats reflected enrichment for pathways involving metabolic processes, including acetyl-CoA biosynthesis, TCA cycle, and sirtuins. Upstream predictor analysis identified similarity to responses produced by glucocorticoids and pathways involving forskolin. These changes were absent in AD rats exposed to ozone. However, ozone caused unique changes in AD liver mRNA reflecting activation of synaptogenesis, neurovascular coupling, neuroinflammation, and insulin signaling with inhibition of senescence pathways. In these rats, upstream predictor analysis identified numerous microRNAs likely involved in glucocorticoid insufficiency. These data demonstrate the critical role of adrenal stress hormones in ozone-induced hepatic homeostasis and necessitate further research elucidating their role in propagating environmentally driven diseases.
C1 [Jackson, Thomas W.; Henriquez, Andres R.; Alewel, Devin, I] Oak Ridge Inst Sci & Educ Res Participat Program, Oak Ridge, TN USA.
   [Jackson, Thomas W.; Snow, Samantha J.; Schladweiler, Mette C.; Fisher, Anna A.; Kodavanti, Urmila P.] US Environm Protect Agcy, Publ Hlth & Integrated Toxicol Div, Ctr Publ Hlth & Environm Assessment, Res Triangle Pk, NC 27711 USA.
   [House, John S.] Natl Inst Environm Hlth Sci, Natl Inst Hlth, Div Intramural Res, Dept Hlth & Human Serv, Res Triangle Pk, Res Triangle Pk, NC 27709 USA.
   [Henriquez, Andres R.] Hlth Canada, Environm Hlth Sci & Res Bur, Ottawa, ON K1A 0K9, Canada.
   [Snow, Samantha J.] ICF Int Inc, Durham, NC 27713 USA.
C3 United States Environmental Protection Agency; National Institutes of
   Health (NIH) - USA; NIH National Institute of Environmental Health
   Sciences (NIEHS); Health Canada
RP Jackson, TW (corresponding author), US Environm Protect Agcy, Publ Hlth & Integrated Toxicol Div, Ctr Publ Hlth & Environm Assessment, Res Triangle Pk, NC 27711 USA.
EM jackson.thomas@epa.gov
RI Jackson, Thomas W/AIC-9702-2022; Alewel, Devin/HLG-7042-2023; Henriquez,
   Andres/AAQ-6113-2021; House, John S/A-1933-2013
OI Jackson, Thomas W/0000-0002-7996-0412; Henriquez,
   Andres/0000-0002-1917-4153; House, John S/0000-0002-8447-7871;
   Kodavanti, Urmila/0000-0001-6333-1024
FU U.S. Environmental Protection Agency (EPA); Intramural Research Program
   of the NIH, National Institute of Environmental Health Sciences; DOE
   [DE-SC0014664]
FX This research was supported by the intramural research program of the
   U.S. Environmental Protection Agency (EPA). Partial support also came
   through an appointment of T.W.J., A.R.H., and D.I.A. to the U.S. EPA
   Research Participation Program administered by the Oak Ridge Institute
   for Science and Education (ORISE) through an interagency agreement
   between the U.S. Department of Energy (DOE) and the U.S. EPA. ORISE is
   managed by ORAU under DOE contract number DE-SC0014664. In addition,
   this research was supported in part by the Intramural Research Program
   of the NIH, National Institute of Environmental Health Sciences.
CR Alewel DI, 2021, J TOXICOL ENV HEAL A, V84, P235, DOI 10.1080/15287394.2020.1858466
   Bass V, 2013, TOXICOL APPL PHARM, V273, P551, DOI 10.1016/j.taap.2013.09.029
   Bromberg PA, 2016, BBA-GEN SUBJECTS, V1860, P2771, DOI 10.1016/j.bbagen.2016.07.015
   Brook RD, 2008, J OCCUP ENVIRON MED, V50, P32, DOI 10.1097/JOM.0b013e31815dba70
   Brook RD, 2013, DIABETES CARE, V36, P3313, DOI 10.2337/dc12-2189
   Carnino JM, 2022, TOXICOL SCI, V187, P162, DOI 10.1093/toxsci/kfac025
   Carvalho C, 2019, J CELL SCI, V132, DOI 10.1242/jcs.230748
   Colonna CH, 2021, TOXICOL SCI, V181, P229, DOI 10.1093/toxsci/kfab025
   Fang H, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0384-y
   Fry RC, 2014, AM J PHYSIOL-LUNG C, V306, pL1129, DOI 10.1152/ajplung.00348.2013
   Fuentes N, 2018, BIOL SEX DIFFER, V9, DOI 10.1186/s13293-018-0177-7
   Gackière F, 2011, J NEUROCHEM, V117, P961, DOI 10.1111/j.1471-4159.2011.07267.x
   Galati A, 2021, J NEUROL SCI, V430, DOI 10.1016/j.jns.2021.120004
   Henriquez A.R., 2022, BIORXIV, DOI [10.1101/2021.12.09.471963, DOI 10.1101/2021.12.09.471963]
   Henriquez A.R., 2022, BIORXIV
   Henriquez A, 2017, TOXICOL APPL PHARM, V329, P249, DOI 10.1016/j.taap.2017.06.009
   Henriquez AR, 2021, TOXICOLOGY, V458, DOI 10.1016/j.tox.2021.152823
   Henriquez AR, 2019, TOXICOL SCI, V172, P38, DOI 10.1093/toxsci/kfz182
   Henriquez AR, 2018, TOXICOL SCI, V166, P288, DOI 10.1093/toxsci/kfy198
   Hu H, 2015, ENVIRON HEALTH PERSP, V123, P853, DOI 10.1289/ehp.1408456
   Jadeja RN, 2018, CURR DRUG TARGETS, V19, P938, DOI 10.2174/1389450118666170619090219
   Jöerns A, 2010, PANCREAS, V39, P1167, DOI 10.1097/MPA.0b013e3181dfce4f
   Jopek K, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041111
   Joung JY, 2019, BRAIN BEHAV, V9, DOI 10.1002/brb3.1235
   Khan S, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00822
   Kim JW, 2014, TOX RESEARCH, V30, P65, DOI 10.5487/TR.2014.30.2.065
   Krämer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703
   Kuhn V, 2017, ANTIOXID REDOX SIGN, V26, P718, DOI 10.1089/ars.2016.6954
   Kuo T, 2015, ADV EXP MED BIOL, V872, P99, DOI 10.1007/978-1-4939-2895-8_5
   Leach S, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01235
   Love M., 2014, Genome Biol, V15, P10, DOI DOI 10.1186/S13059-014-0550-8
   Macfarlane DP, 2008, J ENDOCRINOL, V197, P189, DOI 10.1677/JOE-08-0054
   Metz CN, 2018, AM J PHYSIOL-GASTR L, V315, pG651, DOI 10.1152/ajpgi.00195.2018
   Miller DB, 2016, TOXICOL APPL PHARM, V306, P47, DOI 10.1016/j.taap.2016.06.027
   Miller DB, 2016, TOXICOL SCI, V150, P312, DOI 10.1093/toxsci/kfv331
   Miller DB, 2015, TOXICOL APPL PHARM, V286, P65, DOI 10.1016/j.taap.2015.03.025
   Miller MR, 2020, CARDIOVASC RES, V116, P279, DOI 10.1093/cvr/cvz228
   Moullé VS, 2019, AM J PHYSIOL-ENDOC M, V317, pE234, DOI 10.1152/ajpendo.00385.2018
   Oster H, 2020, J ENDOCRINOL, V247, pR13, DOI 10.1530/JOE-20-0124
   Qian Y, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00770
   Rajagopalan S, 2012, DIABETES, V61, P3037, DOI 10.2337/db12-0190
   Rao XQ, 2015, TOXICOL SCI, V143, P231, DOI 10.1093/toxsci/kfu250
   Ravnskjaer K, 2016, HANDB EXP PHARMACOL, V233, P29, DOI 10.1007/164_2015_32
   Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024
   Shirif AZ, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22137206
   Smith GJ, 2021, PHYSIOL REP, V9, DOI 10.14814/phy2.15054
   Smith Sean M, 2006, Dialogues Clin Neurosci, V8, P383
   Soulage C, 2004, NEUROCHEM INT, V45, P979, DOI 10.1016/j.neuint.2004.06.015
   Su Y, 2016, MOL CELL ENDOCRINOL, V422, P125, DOI 10.1016/j.mce.2015.12.011
   Thiering E, 2015, TRENDS ENDOCRIN MET, V26, P384, DOI 10.1016/j.tem.2015.05.002
   Thomson EM, 2013, TOXICOL SCI, V135, P169, DOI 10.1093/toxsci/kft137
   Uyama N, 2004, ANAT REC PART A, V280A, P808, DOI 10.1002/ar.a.20086
   van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193
   Yaribeygi H, 2017, EXCLI J, V16, P1057, DOI 10.17179/excli2017-480
   Zhang J, 2016, SCI REP-UK, V6, DOI 10.1038/srep29551
NR 55
TC 4
Z9 4
U1 1
U2 32
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1096-6080
EI 1096-0929
J9 TOXICOL SCI
JI Toxicol. Sci.
PD 2022 AUG 25
PY 2022
VL 189
IS 1
BP 73
EP 90
DI 10.1093/toxsci/kfac065
EA JUN 2022
PG 18
WC Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Toxicology
GA 4A0OQ
UT WOS:000821717300001
PM 35737395
OA Green Published
DA 2024-02-19
ER

PT J
AU Li, JY
   Guo, YH
   Cheng, YL
   Pi, FW
   Yao, WR
   Xie, YF
   Qi, H
AF Li, Jiayi
   Guo, Yahui
   Cheng, Yuliang
   Pi, Fuwei
   Yao, Weirong
   Xie, Yunfei
   Qi, He
TI Determination of the Molecular Mechanism of Torularhodin against Hepatic
   Oxidative Damage by Transcriptome Analysis
SO OXIDATIVE MEDICINE AND CELLULAR LONGEVITY
LA English
DT Article
ID REACTIVE OXYGEN; STRESS; LIVER; CAROTENOIDS; TORULENE; ANTIOXIDANTS;
   APOPTOSIS; SURFACE; YEASTS; INJURY
AB Torularhodin, extracted from Sporidiobolus pararoseus, is a significant carotenoid that is similar to lycopene in structure. Some studies have indicated torularhodin as having antioxidative activities. However, it has not been thoroughly studied with respect to its antioxidative activity and molecular mechanisms in liver injury. Therefore, the aim of this study was to elucidate the antioxidative activity of torularhodin against hydrogen peroxide- (H2O2-) induced damage and the mechanism involved through transcriptome analysis and to explore its antioxidant potential. BRL cells were first subjected to H2O2 damage and then treated with torularhodin. The results showed that at 10(-5) g/ml, torularhodin had significant protective effects against H2O2-induced oxidative damage. Morphological and immunofluorescence staining showed that torularhodin could maintain cell integrity and enhance the activity of antioxidant enzymes in the cells. According to transcriptome analysis, 2808 genes were significantly differentially expressed (1334 upregulated and 1474 downregulated) after torularhodin treatment. These genes were involved in three major Gene Ontology categories (biological process, cellular component, and molecular function). Moreover, torularhodin was involved in some cellular pathways, such as cancer inhibition, antioxidation, and aging delay. Our data highlighted the importance of multiple pathways in the antioxidative damage of liver treated with torularhodin and will contribute to get the molecular mechanisms of torularhodin inhibition of hepatic oxidative damage.
C1 [Li, Jiayi; Guo, Yahui; Cheng, Yuliang; Pi, Fuwei; Yao, Weirong; Xie, Yunfei; Qi, He] Jiangnan Univ, Dept Sch Food Sci & Technol, Wuxi 214122, Jiangsu, Peoples R China.
C3 Jiangnan University
RP Qi, H (corresponding author), Jiangnan Univ, Dept Sch Food Sci & Technol, Wuxi 214122, Jiangsu, Peoples R China.
EM amtf168168@126.com
RI PI, Fuwei/P-2534-2014; Guo, Yahui/ABE-2248-2020; Li,
   Jinghong/JVP-2806-2024; Guo, Yahui/GQP-9675-2022; LI, Jing/HNB-5575-2023
OI Guo, Yahui/0000-0002-6512-355X; 
FU National Key Research and Development Program of China [2017YFC1601806,
   2017YFC1601704]; Natural Science Foundation of Jiangsu Province
   [BK20160178]; National Natural Science Foundation of China [21603087];
   National First-Class Discipline Program of Food Science and Technology
   [JUFSTR20180303]; Science and Technology Support Plan of Jiangsu
   Province [BE2018316]; Science and Technology Support Plan of Changzhou
   City [CE20172002]; Science and Technology Projects of Jintan District,
   Changzhou City [KJ201717]
FX The work reported in this article is supported by the National Key
   Research and Development Program of China (Project Nos. 2017YFC1601806
   and 2017YFC1601704), Natural Science Foundation of Jiangsu Province (No.
   BK20160178), National Natural Science Foundation of China (No.
   21603087), National First-Class Discipline Program of Food Science and
   Technology (No. JUFSTR20180303), Science and Technology Support Plan of
   Jiangsu Province (No. BE2018316), Science and Technology Support Plan of
   Changzhou City (No. CE20172002), and Science and Technology Projects of
   Jintan District, Changzhou City (No. KJ201717).
CR Allen AM, 2016, HEPATOLOGY, V64, P2165, DOI 10.1002/hep.28812
   Bashan N, 2009, PHYSIOL REV, V89, P27, DOI 10.1152/physrev.00014.2008
   Bhosale P, 2002, CURR SCI INDIA, V83, P303
   Mata-Gómez LC, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-12
   Delgado R. M., 2013, FOOD CHEM, V139, p[583, 86]
   Du C, 2017, FREE RADICAL RES, V51, P113, DOI 10.1080/10715762.2017.1285024
   Du C, 2016, BIOCHEM BIOPH RES CO, V469, P1146, DOI 10.1016/j.bbrc.2015.12.112
   Dufossé L, 2016, WOODHEAD PUBL FOOD S, V295, P337, DOI 10.1016/B978-0-08-100371-8.00016-6
   Evans JL, 2002, ENDOCR REV, V23, P599, DOI 10.1210/er.2001-0039
   Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004
   Fang YZ, 2002, NUTRITION, V18, P872, DOI 10.1016/S0899-9007(02)00916-4
   Fraser PD, 2004, PROG LIPID RES, V43, P228, DOI 10.1016/j.plipres.2003.10.002
   Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002
   Herz S, 2007, PHYTOCHEMISTRY, V68, P2503, DOI 10.1016/j.phytochem.2007.05.019
   Kaiser J, 2014, SCIENCE, V343, P477, DOI 10.1126/science.343.6170.477
   Kieliszek M, 2019, MOL BIOL REP, V46, P1797, DOI 10.1007/s11033-019-04630-z
   Kim SM, 2011, PHYTOCHEM ANALYSIS, V22, P322, DOI 10.1002/pca.1283
   Kot Anna M, 2018, Microb Cell Fact, V17, P49, DOI 10.1186/s12934-018-0893-z
   Kot AM, 2016, APPL MICROBIOL BIOT, V100, P6103, DOI 10.1007/s00253-016-7611-8
   Krinsky Norman I., 2005, Molecular Aspects of Medicine, V26, P459
   Lee HC, 2007, EXP BIOL MED, V232, P592
   Li AN, 2014, NUTRIENTS, V6, P6020, DOI 10.3390/nu6126020
   Li S, 2015, INT J MOL SCI, V16, P26087, DOI 10.3390/ijms161125942
   Maoka T, 2011, MAR DRUGS, V9, P278, DOI 10.3390/md9020278
   Mena S, 2009, MUTAT RES-GEN TOX EN, V674, P36, DOI 10.1016/j.mrgentox.2008.09.017
   Merry BJ, 2004, AGING CELL, V3, P7, DOI 10.1046/j.1474-9728.2003.00074.x
   Moline M, 2014, COLD ADAPTED YEASTS, P193, DOI [10.1007/978-3-642-39681-6 9, DOI 10.1007/978-3-642-39681-69, 10.1007/978-3-662-45759-7_9, DOI 10.1007/978-3-662-45759-7_9]
   Palma HE, 2014, MOL CELL BIOCHEM, V386, P199, DOI 10.1007/s11010-013-1858-5
   Peng C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/831841
   Rudich A, 2007, TRENDS ENDOCRIN MET, V18, P291, DOI 10.1016/j.tem.2007.08.006
   Sakaki H, 2000, J BIOSCI BIOENG, V89, P203, DOI 10.1016/S1389-1723(00)88739-3
   Sakaki H, 2002, J BIOSCI BIOENG, V93, P338, DOI 10.1263/jbb.93.338
   Sharma Haripaul, 2014, PLoS One, V9, pe91588, DOI 10.1371/journal.pone.0091588
   Ungureanu C., 2012, Adv. Sci. Lett, V18, P50, DOI [10.1166/asl.2012.4403, DOI 10.1166/ASL.2012.4403]
   Ungureanu C, 2016, BIOELECTROCHEMISTRY, V107, P14, DOI 10.1016/j.bioelechem.2015.09.001
   Ungureanu C, 2014, MAT SCI ENG C-MATER, V42, P726, DOI 10.1016/j.msec.2014.06.020
   Vuda M, 2012, EXP TOXICOL PATHOL, V64, P855, DOI 10.1016/j.etp.2011.03.006
   Walter MH, 2011, NAT PROD REP, V28, P663, DOI 10.1039/c0np00036a
   Wu JL, 2015, PHARMAZIE, V70, P17, DOI 10.1691/ph.2015.4699
   Zhou Y, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13060522
NR 40
TC 6
Z9 6
U1 0
U2 12
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1942-0900
EI 1942-0994
J9 OXID MED CELL LONGEV
JI Oxidative Med. Cell. Longev.
PD JUL 14
PY 2019
VL 2019
AR 7417263
DI 10.1155/2019/7417263
PG 11
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA IM2UX
UT WOS:000477848500001
PM 31396306
OA Green Submitted, gold, Green Published
DA 2024-02-19
ER

PT J
AU Guimaraes, JT
   Paiva, MQ
   Moura, D
   Guimaraes, S
AF Guimaraes, JT
   Paiva, MQ
   Moura, D
   Guimaraes, S
TI Influence of maturation and ageing on the biotransformation of
   noradrenaline in the rat
SO JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT
LA English
DT Article; Proceedings Paper
CT 6th Rappaport Symposium/7th Amine Oxidase Workshop
CY JUN, 1996
CL SHAVEI ZION, ISRAEL
SP Rappaport Family Inst Res Med Sci, Israel Inst Technol, Technion, Bruce Rappaport Fac Med, Israel Inst Technol, Int Union Biochem & Molec Biol, Hoffman La Roche Ltd, Switzerland, Synthelabo Rech, France, DeVries & Co Ltd, Israel, Teva Pharm Ind Ltd, Israel
ID EXTRANEURONAL UPTAKE; H-3 NORADRENALINE; SAPHENOUS-VEIN; METABOLISM;
   ADRENALINE; DISPOSITION
AB The present investigation was undertaken to study the influence of maturation and ageing on the disposition of noradrenaline by the aorta, heart (ventricle), liver and kidney of the rat. Slices of these tissues taken from rats aged less than 18h, 2.5-3 months or 18-24, months were incubated with 0.1 mu mol.l(-1) (3)H-amine during 30min. At the end of this period, the accumulation of the intact amine in the tissue, as well as the (3)H-metabolites formed (3,4-dihydroxyphenylethylglycol, 3,4-dihydroxymandelic acid, normetanephrine and O-methylated deaminated metabolites) were determined by scintillation counting. The results obtained show that in the rat: 1) at any age, noradrenaline is preferentially deaminated; 2) while the capacity of the sympathetic nerve terminals in accumulating noradrenaline is rather well developed at birth. the metabolic system for its degradation is still immature 3) aldehyde dehydrogenase activity or that of its co-factor (or both) of the heart is apparently missing at birth; 4) removal of noradrenaline by the liver and the kidney did not change with ageing, while that by the aorta decreased and that by the heart increased.
C1 Fac Med Porto, Inst Pharmacol & Therapeut, P-4200 Oporto, Portugal.
   Fac Med Porto, Dept Biochem, P-4200 Oporto, Portugal.
C3 Universidade do Porto; Universidade do Porto
RP Guimaraes, S (corresponding author), Fac Med Porto, Inst Pharmacol & Therapeut, P-4200 Oporto, Portugal.
RI Guimarães, Serafim/HPD-3506-2023; Guimarães, João Tiago/T-3079-2017
OI Guimarães, João Tiago/0000-0003-4836-6311; Moura,
   Daniel/0000-0003-3848-3362
CR BLATCHFORD D, 1976, BRIT J PHARMACOL, V57, P279, DOI 10.1111/j.1476-5381.1976.tb07478.x
   DAHLSTRO.A, 1967, ACTA PHYSIOL SCAND, V69, P153, DOI 10.1111/j.1748-1716.1967.tb03506.x
   DOCHERTY JR, 1990, PHARMACOL REV, V42, P103
   EISENHOFER G, 1994, N-S ARCH PHARMACOL, V349, P259
   EISENHOFER G, 1994, J PHARMACOL EXP THER, V268, P1242
   FIEBIG ER, 1978, N-S ARCH PHARMACOL, V303, P21, DOI 10.1007/BF00496182
   GARRETT J, 1977, BLOOD VESSELS, V14, P43
   GRAEFE KH, 1973, BIOCHEM PHARMACOL, V22, P1177
   GUIMARAES S, 1977, N-S ARCH PHARMACOL, V296, P279, DOI 10.1007/BF00498694
   GUIMARAES S, 1991, ADV BIOSCI, V82, P11
   GUIMARAES S, 1978, N-S ARCH PHARMACOL, V305, P185, DOI 10.1007/BF00508291
   GUIMARAES S, 1975, EUR J PHARMACOL, V34, P9, DOI 10.1016/0014-2999(75)90220-4
   LADURON P, 1968, LIFE SCI PT 1 PHYSI, V7, P1, DOI 10.1016/0024-3205(68)90355-X
   MARTEL F, 1993, N-S ARCH PHARMACOL, V348, P450
   MOURA D, 1993, N-S ARCH PHARMACOL, V347, P186
   PAIVA MQ, 1978, N-S ARCH PHARMACOL, V303, P221
   STEINBERG P, 1988, N-S ARCH PHARMACOL, V337, P392
   SU C, 1977, BLOOD VESSELS, V14, P12
   TRENDELENBURG U, 1983, N-S ARCH PHARMACOL, V323, P128, DOI 10.1007/BF00634260
NR 19
TC 2
Z9 2
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0303-6995
J9 J NEURAL TRANSM-SUPP
JI J. Neural Transm.-Suppl.
PY 1998
IS 52
BP 225
EP 232
PG 8
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Neurosciences & Neurology
GA ZE895
UT WOS:000072842400024
PM 9580421
DA 2024-02-19
ER

PT J
AU Sherr, L
   Harding, R
   Lampe, F
   Johnson, M
   Anderson, J
   Zetler, S
   Fisher, M
   Arthur, G
   Norwood, S
   Leake-Date, H
   Edwards, S
AF Sherr, Lorraine
   Harding, Richard
   Lampe, Fiona
   Johnson, Margaret
   Anderson, Jane
   Zetler, Sarah
   Fisher, Martin
   Arthur, Gilly
   Norwood, Sally
   Leake-Date, Heather
   Edwards, Simon
TI Clinical and behavioural aspects of aging with HIV infection
SO PSYCHOLOGY HEALTH & MEDICINE
LA English
DT Article
DE HIV/AIDS; ageing; symptom burden
ID SOCIAL SUPPORT; ANTIRETROVIRAL THERAPY; OLDER AGE; MEN; PREVALENCE;
   DISCLOSURE; STIGMA
AB Scant attention has been paid to the effects of ageing and HIV. This study examined age distribution and explored the impact of age on the experience of illness. One thousand and seven consecutive attenders at five UK HIV clinics were approached, 904 met inclusion criteria and 778 agreed to participate (86% response rate). They provided detailed information on demographics, experience of illness, physical and psychological symptoms, quality of life, treatment experience and doctor-patient communications. Twelve percent were aged over 50. There were significantly more males in the over 50s (86% vs. 75%), more gay males x(2) = 7, p = 0.04 and fewer females (14% vs. 25%) x(2) = 5; p = 0.03. No significant differences were found on measures of education, employment or migration status or physical symptom experience. The older group had significantly lower psychological and global burden scores and were more likely to take antiretrovirals (88% vs. 79%; p = 0.04). Triggers for treatment switching showed older participants significantly less burdened by food restrictions, pill burden, taste, nausea, diarrhoea, sleep disturbance, concentration problems, anxiety depression, skin rashes, liver complaints or a need for a simpler regimen. The older group were similar in employment, education and disclosure, but complained less and reported much higher tolerance.
C1 [Sherr, Lorraine; Lampe, Fiona; Johnson, Margaret] Royal Free & Univ Coll Med Sch, Dept Thorac Med, London WC1E 6BT, England.
   [Harding, Richard] Kings Coll London, Dept Palliat Care Policy & Rehabil, London WC2R 2LS, England.
   [Anderson, Jane; Zetler, Sarah] Homerton Univ Hosp, NHS Fdn Trust, Ctr Study Sexual Hlth & HIV, London, England.
   [Fisher, Martin; Leake-Date, Heather] Brighton & Sussex Univ Hosp, NHS Trust, HIV GUM, Brighton, E Sussex, England.
   [Arthur, Gilly] Archway Sexual Hlth Clin, GU Med, London, England.
   [Norwood, Sally] UCL, Anna Freud Ctr, London, England.
C3 University of London; University College London; University of London;
   King's College London; Oxford University Hospitals NHS Foundation Trust;
   University of London; Queen Mary University London; Brighton and Sussex
   University Hospitals NHS Trust; University of London; University College
   London; The Anna Freud Centre
RP Sherr, L (corresponding author), Royal Free & Univ Coll Med Sch, Dept Thorac Med, London WC1E 6BT, England.
EM l.sherr@pcps.ucl.ac.uk
RI Lampe, Fiona/I-5826-2019; Date, Heather A Leake/B-2460-2016; Anderson,
   Jane/A-1632-2012
OI Lampe, Fiona/0000-0001-6851-5471; Date, Heather A
   Leake/0000-0003-2037-0685; Anderson, Jane/0000-0001-5294-8707; Harding,
   Richard/0000-0001-9653-8689; Sherr, Lorraine/0000-0002-5902-8011
FU GlaxoSmithKline; Adherence Strategy Group
FX The authors acknowledge the contribution of Ms. A. Jayakody, research
   nurses at participating clinics, and all survey respondents. This
   research was assisted with an unrestricted educational grant from
   GlaxoSmithKline, with input from the Adherence Strategy Group.
CR Alisky JM, 2007, MED HYPOTHESES, V69, P1140, DOI 10.1016/j.mehy.2007.02.030
   Becker JT, 2004, AIDS, V18, pS11, DOI 10.1097/00002030-200401001-00003
   Chang VT, 2004, CANCER INVEST, V22, P526, DOI 10.1081/CNV-200026487
   Cherner M, 2004, AIDS, V18, pS27, DOI 10.1097/00002030-200401001-00005
   Chesney MA, 2003, JAIDS-J ACQ IMM DEF, V33, pS185, DOI 10.1097/00126334-200306012-00016
   Crystal S, 2003, JAIDS-J ACQ IMM DEF, V33, pS76, DOI 10.1097/00126334-200306012-00004
   Elford J, 2003, JAIDS-J ACQ IMM DEF, V32, P545, DOI 10.1097/00126334-200304150-00013
   Emlet CA, 2004, HEALTH SOC WORK, V29, P86, DOI 10.1093/hsw/29.2.86
   Emlet CA, 2006, GERONTOLOGIST, V46, P781, DOI 10.1093/geront/46.6.781
   Emlet CA, 2006, HEALTH SOC WORK, V31, P299, DOI 10.1093/hsw/31.4.299
   Emlet CA, 2006, AIDS PATIENT CARE ST, V20, P350, DOI 10.1089/apc.2006.20.350
   Grabar S, 2004, AIDS, V18, P2029, DOI 10.1097/00002030-200410210-00007
   Heckman TG, 2000, J NATL MED ASSOC, V92, P436
   Justice AC, 2004, AIDS, V18, pS49, DOI 10.1097/00002030-200401001-00008
   Kalichman SC, 2003, J BEHAV MED, V26, P315, DOI 10.1023/A:1024252926930
   Kalichman SC, 2000, PSYCHIATR SERV, V51, P903, DOI 10.1176/appi.ps.51.7.903
   Manfredi R, 2004, AGEING RES REV, V3, P31, DOI 10.1016/j.arr.2003.07.001
   Nogueras M, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-159
   Shah Sanjiv, 2006, Curr Infect Dis Rep, V8, P241, DOI 10.1007/s11908-006-0065-x
   Sherr L, 2008, AIDS CARE, V20, P442, DOI 10.1080/09540120701867032
   Sherr L, 2007, INT J STD AIDS, V18, P700, DOI 10.1258/095646207782193821
   Silverberg MJ, 2007, ARCH INTERN MED, V167, P684, DOI 10.1001/archinte.167.7.684
   Tumbarello M, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-46
   Valcour VG, 2004, AIDS, V18, pS79, DOI 10.1097/00002030-200401001-00012
   WILLIAMS A, 1990, HEALTH POLICY, V16, P199
   Zingmond DS, 2003, JAIDS-J ACQ IMM DEF, V33, pS84, DOI 10.1097/00126334-200306012-00005
NR 26
TC 21
Z9 26
U1 0
U2 12
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1354-8506
EI 1465-3966
J9 PSYCHOL HEALTH MED
JI Psychol. Health Med.
PY 2009
VL 14
IS 3
BP 273
EP 279
DI 10.1080/13548500902865964
PG 7
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA 514NU
UT WOS:000271402400003
PM 19444705
DA 2024-02-19
ER

PT J
AU Yang, L
   Chen, JH
   Xu, T
   Nie, MH
   Yang, HK
AF Yang, Lin
   Chen, Jia-Hou
   Xu, Tong
   Nie, Ming-Hao
   Yang, Hong-Kun
TI Hypocholesterolemic effect of rice protein is due to regulating hepatic
   cholesterol metabolism in adult rats
SO GENE
LA English
DT Article
DE Rice protein; Gene expression; Enzyme activity; Cholesterol output;
   Adult rats
ID GENE-EXPRESSION PROFILES; ORYZA-SATIVA L.; MOLECULAR-CLONING;
   MESSENGER-RNA; SOY PROTEIN; 2 CULTIVARS; LIVER; TRIGLYCERIDE;
   ABSORPTION; SECRETION
AB Aging is one of major risk factors for developing hypercholesterolemia. To elucidate the cholesterol-lowering mechanism exerted by rice protein (RP), the effects on hepatic cholesterol outputs and cholesterol metabolism related enzymes were investigated in adult rats, which were fed by casein (CAS) and RP without cholesterol in diets. After 2 weeks of feeding, the significant cholesterol-lowering effect was observed in adult rats fed by RP compared to CAS. The hepatic total- and VLDL-cholesterol secretions into circulation were significantly depressed in RP group, whereas biliary outputs of bile acids and cholesterol were effectively stimulated by RP-feeding, causing an increase in fecal sterol excretion compared to CAS. As a result, the apparent cholesterol absorption was significantly inhibited by RP. RP-feeding significantly increased the activity and gene expression of cholesterol 7 alpha-hydroxylase, whereas acyl-CoA:cholesterol acyltransferase-2 activity and gene expression were significantly decreased by RP as compared with CAS. Neither activity nor gene expression of 3-hydroxy-3-methylglutaryl coenzyme A reductase of RP did differ from CAS in the liver. The present study demonstrates that rice protein can prevent hypercholesterolemia through modifying hepatic cholesterol metabolism under cholesterol-free dietary condition. The findings suggest that hypocholesterolemic action induced by rice protein is attributed in part to the inhibition of cholesterol absorption during the adult period. (c) 2012 Elsevier B.V. All rights reserved.
C1 [Yang, Lin] Harbin Inst Technol, Sch Food Sci & Engn, Dept Food Sci, Harbin 150090, Heilongjiang Pr, Peoples R China.
   [Chen, Jia-Hou; Yang, Hong-Kun] Heilongjiang Prov Environm Monitoring Cent Stn, Harbin 150056, Peoples R China.
   [Xu, Tong; Nie, Ming-Hao] Heilongjiang Prov Hosp, Harbin 150036, Peoples R China.
C3 Harbin Institute of Technology
RP Yang, L (corresponding author), Harbin Inst Technol, Sch Food Sci & Engn, Dept Food Sci, 73 Huanghe Rd, Harbin 150090, Heilongjiang Pr, Peoples R China.
EM ly6617@hit.edu.cn
FU National Natural Science Foundation of China [31071526]; National
   Natural Science Foundation of Heilongjiang Province [C201027]
FX We are grateful to Rice Research Institute of Heilongjiang Academy of
   Agricultural Science for providing rice grains. This work was in part
   supported by National Natural Science Foundation of China (31071526) and
   National Natural Science Foundation of Heilongjiang Province (C201027).
CR Boukaftane Y, 1997, GENE, V195, P121, DOI 10.1016/S0378-1119(97)00067-X
   Bu SY, 2010, J LIPID RES, V51, P3270, DOI 10.1194/jlr.M009407
   Chen X, 2012, GENE, V495, P170, DOI 10.1016/j.gene.2011.12.051
   Chiang JYL, 2001, GENE, V262, P257, DOI 10.1016/S0378-1119(00)00518-7
   CHOI YS, 1989, BRIT J NUTR, V61, P531, DOI 10.1079/BJN19890141
   Dasu MRK, 2004, GENE, V327, P51, DOI 10.1016/j.gene.2003.11.015
   Dawson PA, 1999, CURR OPIN LIPIDOL, V10, P315, DOI 10.1097/00041433-199908000-00005
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Green RM, 2000, GENE, V241, P117, DOI 10.1016/S0378-1119(99)00460-6
   Gudbrandsen OA, 2005, BRIT J NUTR, V94, P321, DOI 10.1079/BJN20051496
   Gudbrandsen OA, 2006, BRIT J NUTR, V96, P249, DOI 10.1079/BJN20061837
   HOEKMAN MFM, 1993, GENE, V130, P217, DOI 10.1016/0378-1119(93)90422-Y
   HYLEMON PB, 2001, LIVER BIOL PATHOBIOL, P231
   Jelinek DA, 2012, GENE, V491, P128, DOI 10.1016/j.gene.2011.10.010
   Jung CG, 2012, GENE, V505, P9, DOI 10.1016/j.gene.2012.05.060
   Kang S, 2000, BBA-MOL CELL BIOL L, V1529, P223, DOI 10.1016/S1388-1981(00)00151-7
   Kim S, 2004, GENE, V340, P99, DOI 10.1016/j.gene.2004.06.015
   Kishine M, 2008, J AGR FOOD CHEM, V56, P4605, DOI 10.1021/jf800141y
   Lo Sasso G, 2008, BBA-MOL CELL BIOL L, V1781, P79, DOI 10.1016/j.bbalip.2007.12.002
   Mashek DG, 2006, J LIPID RES, V47, P2004, DOI 10.1194/jlr.M600150-JLR200
   MIETTINEN TA, 1991, EUR J CLIN PHARMACOL, V40, pS19, DOI 10.1007/BF01409402
   Nissinen MJ, 2008, BRIT J NUTR, V99, P370, DOI 10.1017/S0007114507811998
   Ohtsubo K, 2007, J AGR FOOD CHEM, V55, P1501, DOI 10.1021/jf062737z
   REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939
   Shelness GS, 2001, CURR OPIN LIPIDOL, V12, P151, DOI 10.1097/00041433-200104000-00008
   SUGANO M, 1982, J NUTR, V112, P855, DOI 10.1093/jn/112.5.855
   Temel RE, 2007, J LIPID RES, V48, P1618, DOI 10.1194/jlr.M700109-JLR200
   Tran TU, 2005, J AGR FOOD CHEM, V53, P1108, DOI 10.1021/jf049064+
   UCHIDA K, 1978, J LIPID RES, V19, P544
   VAHOUNY GV, 1984, AM J CLIN NUTR, V40, P1156, DOI 10.1093/ajcn/40.6.1156
   Wergedahl H, 2004, J NUTR, V134, P1320, DOI 10.1093/jn/134.6.1320
   Wu GY, 2009, AMINO ACIDS, V37, P1, DOI 10.1007/s00726-009-0269-0
   Wu GY, 1998, J NUTR, V128, P1249, DOI 10.1093/jn/128.8.1249
   Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001
   Yang L, 2007, BIOSCI BIOTECH BIOCH, V71, P694, DOI 10.1271/bbb.60480
   Yang L, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-24
   Yang L, 2012, FOOD CHEM, V132, P925, DOI 10.1016/j.foodchem.2011.11.068
   Yang L, 2011, INT J MOL SCI, V12, P7594, DOI 10.3390/ijms12117594
   Yang L, 2011, J MED FOOD, V14, P445, DOI 10.1089/jmf.2010.1405
   Yang L, 2009, ANN NUTR METAB, V54, P283, DOI 10.1159/000230671
   Zhang HJ, 2011, J AGR FOOD CHEM, V59, P10927, DOI 10.1021/jf202721z
NR 41
TC 27
Z9 28
U1 0
U2 22
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0378-1119
EI 1879-0038
J9 GENE
JI Gene
PD JAN 10
PY 2013
VL 512
IS 2
BP 470
EP 476
DI 10.1016/j.gene.2012.10.042
PG 7
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 073UP
UT WOS:000313768900046
PM 23107769
DA 2024-02-19
ER

PT J
AU VANERMEN, A
   FRAEYMAN, NH
AF VANERMEN, A
   FRAEYMAN, NH
TI THE INFLUENCE OF AGE ON THE ALPHA-1-ADRENERGIC RECEPTORS IN RAT-LIVER
   PLASMA-MEMBRANES
SO AGE
LA English
DT Article
ID HEPATIC GLYCOGENOLYSIS; INOSITOL PHOSPHATES; ADRENERGIC CONTROL;
   SUBTYPES; CHLORETHYLCLONIDINE; IDENTIFICATION; HEPATOCYTES
AB Receptor density, equilibrium dissociation constant and receptor subtypes for alpha-1-adrenoceptors were studied in plasma membrane preparations from livers of newborn (2 to 4 days), mature (2 to 3 months) and senescent (24 to 26 months) rats.
   Receptor density increased significantly upon maturation and decreased slightly during post-maturational aging. Ligand affinity was unaffected by the age of the animal.
   Experiments with the alpha-1A-selective antagonists WB 4101 and phentolamine and with the irreversible alpha-1B-alkylating agent chloroethylclonidine suggest the presence of almost exclusively alpha-1B-adrenoceptors in the liver throughout the life span of the rat.
C1 HEYMANS INST PHARMACOL,DE PINTELAAN 185,B-900 GHENT,BELGIUM.
C3 Ghent University
CR AGERBECK M, 1980, BIOCHEM PHARMACOL, V29, P643
   BENDECK JL, 1985, PEDIATR RES, V19, P862, DOI 10.1203/00006450-198508000-00018
   BLAIR JB, 1979, J BIOL CHEM, V254, P7579
   BORST SE, 1990, MECH AGEING DEV, V56, P275, DOI 10.1016/0047-6374(90)90088-W
   BORST SE, 1990, BRIT J PHARMACOL, V101, P650, DOI 10.1111/j.1476-5381.1990.tb14135.x
   CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
   DAX EM, 1987, ENDOCRINOLOGY, V120, P1534, DOI 10.1210/endo-120-4-1534
   GARCIASAINZ JA, 1985, P NATL ACAD SCI USA, V82, P6727, DOI 10.1073/pnas.82.20.6727
   GRAHAM SM, 1987, ENDOCRINOLOGY, V253, pE277
   HAN C, 1987, MOL PHARMACOL, V32, P505
   HAN C, 1990, MOL PHARMACOL, V37, P903
   HUERTABAHENA J, 1984, BIOCHIM BIOPHYS ACTA, V845, P131
   JOHNSON RD, 1987, MOL PHARMACOL, V31, P239
   KATZ MS, 1987, BIOCHEM BIOPH RES CO, V147, P724, DOI 10.1016/0006-291X(87)90990-9
   MACART M, 1982, CLIN CHIM ACTA, V122, P93, DOI 10.1016/0009-8981(82)90100-0
   MCMILLIAN MK, 1983, J PHARMACOL EXP THER, V227, P181
   MICHEL AD, 1989, BRIT J PHARMACOL, V98, P883, DOI 10.1111/j.1476-5381.1989.tb14617.x
   MINNEMAN KP, 1988, PHARMACOL REV, V40, P87
   MINNEMAN KP, 1988, MOL PHARMACOL, V33, P509
   MORGAN NG, 1983, J BIOL CHEM, V258, P5103
   MOTULSKY HJ, 1987, GRAPHPAD PLOT ANAL D
   NOKUBO M, 1985, J GERONTOL, V40, P409, DOI 10.1093/geronj/40.4.409
   SNEDECOR GW, 1973, STATISTICAL METHODS, P447
   STUDER RK, 1982, J BIOL CHEM, V257, P7987
   TERMAN BI, 1990, MOL PHARMACOL, V37, P526
   TSUJIMOTO G, 1989, MOL PHARMACOL, V36, P166
   VANSCHEEUWIJCK P, 1989, EUR J PHARM-MOLEC PH, V172, P373, DOI 10.1016/0922-4106(89)90018-7
   WILSON KM, 1990, J BIOL CHEM, V265, P17601
NR 28
TC 1
Z9 1
U1 0
U2 0
PU AMER AGING ASSOC
PI CHESTER
PA 2129 PROVIDENCE AVENUE, CHESTER, PA 19013
SN 0161-9152
J9 AGE
JI Age
PD JUL
PY 1992
VL 15
IS 3
BP 83
EP 87
DI 10.1007/BF02435006
PG 5
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA JA441
UT WOS:A1992JA44100003
DA 2024-02-19
ER

PT J
AU Choi, SW
   Friso, S
   Keyes, MK
   Mason, JB
AF Choi, SW
   Friso, S
   Keyes, MK
   Mason, JB
TI Folate supplementation increases genomic DNA methylation in the liver of
   elder rats
SO BRITISH JOURNAL OF NUTRITION
LA English
DT Article
DE folate; DNA methylation; ageing; liver; rat
ID S-ADENOSYLHOMOCYSTEINE; PLASMA HOMOCYSTEINE; MASS-SPECTROMETRY;
   DIETARY-FOLATE; AMINO-ACIDS; HYPOMETHYLATION; DEFICIENCY; DEPLETION;
   GENE; DECREASES
AB The availability of folate is implicated as a determinant of DNA methylation, a functionally important feature of DNA. Nevertheless, when this phenomenon has been examined in the rodent model, the effect has not always been observed. Several reasons have been postulated for the inconsistency between studies: the rodent is less dependent on folate as a methyl source than man; juvenile animals, which most studies use, are more resistant to folate depletion than old animals; methods to measure genomic DNA methylation might not be sensitive enough to detect differences. We therefore examined the relationship between folate and genomic DNA methylation in an elder rat model with a newly developed method that can measure genomic DNA methylation sensitively and precisely. Thirty-nine 1-year-old rats were divided into three groups and fed a diet containing 0, 4.5 or 18 mumol folate/kg (folate-deplete, -replete and -supplemented groups, respectively). Rats were killed at 8 and 20 weeks. At both time points, mean liver folate concentrations increased incrementally between the folate-deplete, -replete and -supplemented rats (P for trend <0.001) and by 20 weeks hepatic DNA methylation also increased incrementally between the folate-deplete, -replete and -supplemented rats (P for trend=0.025). At both time points folate-supplemented rats had significantly increased levels of DNA methylation compared with folate-deplete rats (P<0.05). There was a strong correlation between hepatic folate concentration and genomic DNA methylation in the liver (r 0.48, P=0.004). In the liver of this animal model, dietary folate over a wide range of intakes modulates genomic DNA methylation.
C1 Tufts Univ, USDA, Jean Mayer Human Nutr Res Ctr Aging, Vitamins & Carcinogenesis Lab, Boston, MA 02111 USA.
   Univ Verona, Policlin GB Rossi, Dept Clin & Expt Med, I-37134 Verona, Italy.
   Tufts Univ, Sch Med, Div Clin Nutr & Gastroenterol, Boston, MA 02111 USA.
C3 United States Department of Agriculture (USDA); Tufts University;
   University of Verona; Azienda Ospedaliera Universitaria Integrata
   Verona; Tufts University
RP Choi, SW (corresponding author), Tufts Univ, USDA, Jean Mayer Human Nutr Res Ctr Aging, Vitamins & Carcinogenesis Lab, Washington St, Boston, MA 02111 USA.
EM sang.choi@tufts.edu
RI Friso, Simonetta/K-4715-2016
FU NCI NIH HHS [R03 CA96004-02, K05 CA100048, U54 CA100971] Funding Source:
   Medline
CR ANTEQUERA F, 1989, CELL, V58, P509, DOI 10.1016/0092-8674(89)90431-5
   BALAGHI M, 1993, BIOCHEM J, V291, P145, DOI 10.1042/bj2910145
   BILLS ND, 1991, J NUTR, V121, P1643, DOI 10.1093/jn/121.10.1643
   Caudill MA, 2001, J NUTR, V131, P2811, DOI 10.1093/jn/131.11.2811
   Choi SW, 2003, J NUTR, V133, P1206, DOI 10.1093/jn/133.4.1206
   Choi SW, 1998, GUT, V43, P93, DOI 10.1136/gut.43.1.93
   Choumenkovitch Silvina F., 2002, Journal of Nutrition, V132, P2157
   CRAIN PF, 1990, METHOD ENZYMOL, V193, P782, DOI 10.1016/0076-6879(90)93450-Y
   DECABO SF, 1995, CYTOGENET CELL GENET, V71, P187, DOI 10.1159/000134104
   DRINKWATER RD, 1989, MUTAT RES, V219, P29, DOI 10.1016/0921-8734(89)90038-6
   FELL D, 1985, J CHROMATOGR, V345, P150, DOI 10.1016/0378-4347(85)80146-8
   Friso S, 2002, J NUTR, V132, p2382S, DOI 10.1093/jn/132.8.2382S
   Friso S, 2002, P NATL ACAD SCI USA, V99, P5606, DOI 10.1073/pnas.062066299
   Friso S, 2002, ANAL CHEM, V74, P4526, DOI 10.1021/ac020050h
   GOODMAN JI, 1993, ENVIRON HEALTH PERSP, V101, P169, DOI 10.2307/3431863
   HOALVANHELDEN EG, 1989, MUTAT RES, V219, P263, DOI 10.1016/0921-8734(89)90027-1
   HOLLIDAY R, 1987, SCIENCE, V238, P163, DOI 10.1126/science.3310230
   HOLLIDAY R, 1986, EXP CELL RES, V166, P543, DOI 10.1016/0014-4827(86)90499-4
   Jacob RA, 1998, J NUTR, V128, P1204, DOI 10.1093/jn/128.7.1204
   KIM YI, 1995, AM J CLIN NUTR, V61, P1083, DOI 10.1093/ajcn/61.5.1083
   Kim YI, 1997, AM J CLIN NUTR, V65, P46, DOI 10.1093/ajcn/65.1.46
   Kim YI, 1996, GUT, V39, P732, DOI 10.1136/gut.39.5.732
   Mackenzie R., 1984, FOLATE PTERINS, V1, P255
   MAYSHOOPES L, 1986, DEV GENET, V7, P65, DOI 10.1002/dvg.1020070202
   Rampersaud GC, 2000, AM J CLIN NUTR, V72, P998
   RAZIN A, 1991, MICROBIOL REV, V55, P451, DOI 10.1128/MMBR.55.3.451-458.1991
   REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939
   RONUCCI L, 1988, CANCER, V62, P2373
   Sohn KJ, 2003, CARCINOGENESIS, V24, P81, DOI 10.1093/carcin/24.1.81
   TAMURA T, 1990, CONT ISSUES CLIN NUT, V13, P121
   VARELAMOREIRAS G, 1992, J NUTR, V122, P986, DOI 10.1093/jn/122.4.986
   WALZEM RL, 1988, J NUTR, V118, P1089, DOI 10.1093/jn/118.9.1089
   WILSON V L, 1983, Science (Washington D C), V220, P1055, DOI 10.1126/science.6844925
   WILSON VL, 1987, J BIOL CHEM, V262, P9948
   Yi P, 2000, J BIOL CHEM, V275, P29318, DOI 10.1074/jbc.M002725200
NR 35
TC 51
Z9 66
U1 0
U2 5
PU C A B I PUBLISHING
PI WALLINGFORD
PA C/O PUBLISHING DIVISION, WALLINGFORD OX10 8DE, OXON, ENGLAND
SN 0007-1145
J9 BRIT J NUTR
JI Br. J. Nutr.
PD JAN
PY 2005
VL 93
IS 1
BP 31
EP 35
DI 10.1079/BJN20041283
PG 5
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 896FI
UT WOS:000226919600006
PM 15705222
OA Bronze
DA 2024-02-19
ER

PT J
AU Pérez-López, M
   Rodríguez, FS
   Hernández-Moreno, D
   Rigueira, L
   Fidalgo, LE
   Beceiro, AL
AF Perez-Lopez, Marcos
   Soler Rodriguez, Francisco
   Hernandez-Moreno, David
   Rigueira, Lucas
   Eusebio Fidalgo, Luis
   Lopez Beceiro, Ana
TI Bioaccumulation of cadmium, lead and zinc in liver and kidney of red fox
   (<i>Vulpes vulpes</i>) from NW Spain: influence of gender and age
SO TOXICOLOGICAL AND ENVIRONMENTAL CHEMISTRY
LA English
DT Article
DE red fox; lead; cadmium; zinc; gender; age
ID HEAVY-METAL CONCENTRATIONS; SMALL MAMMALS; CANIS-LUPUS;
   CLETHRIONOMYS-GLAREOLUS; SILVER FOXES; WOOD MICE; POLLUTION; TISSUES;
   COPPER; ORGANOCHLORINE
AB Cd, Pb, and Zn were quantified in liver and kidney of red foxes (Vulpes vulpes) which were hunted during the 2003-2011 hunting seasons in Galicia (NW Spain). The effects of age and gender were evaluated to determine whether these variables should be included in future biomonitoring studies. The concentrations of hepatic and renal Cd (average 0.6 and 1.3 mu g/g) and Pb (0.8 and 0.06 mu g/g, respectively) were similar to background levels, with no known toxicological relevance. Similarly, the average levels of Zn in liver and kidney (77 and 17 mu g/g) were in the range of physiological levels for canids. Although no significant gender-dependent variations were observed, the effect of aging was evident: the levels of hepatic Pb and both hepatic and renal Cd were higher in adults than in juveniles. Age should be included as a parameter during future biomonitoring programs focusing on trace metal bioaccumulation in red foxes.
C1 [Perez-Lopez, Marcos; Soler Rodriguez, Francisco; Hernandez-Moreno, David] Univ Extremadura, Toxicol Area, Fac Vet Med, Caceres, Spain.
   [Hernandez-Moreno, David] Univ Autonoma Chile, Santiago, Chile.
   [Rigueira, Lucas; Eusebio Fidalgo, Luis; Lopez Beceiro, Ana] Univ Santiago de Compostela, Fac Vet Med, Dept Vet Clin Sci, Lugo, Spain.
C3 Universidad de Extremadura; Universidad Autonoma de Chile; Universidade
   de Santiago de Compostela
RP Pérez-López, M (corresponding author), Univ Extremadura, Toxicol Area, Fac Vet Med, Caceres, Spain.
EM marcospl@unex.es
RI Pérez-López, Marcos/C-3054-2013; Hernandez-Moreno, David/C-2153-2012;
   Hernandez, David/IAP-1221-2023; Rodriguez, Francisco Soler/M-1287-2018
OI Pérez-López, Marcos/0000-0003-2823-1671; Hernandez-Moreno,
   David/0000-0002-1189-9299; Rodriguez, Francisco
   Soler/0000-0002-4925-1092; /0000-0003-3646-2816; Fidalgo, Luis
   Eusebio/0000-0001-9184-0942
CR ADRIAN WJ, 1979, J WILDLIFE DIS, V15, P125, DOI 10.7589/0090-3558-15.1.125
   Alleva E, 2006, ARCH ENVIRON CON TOX, V51, P123, DOI 10.1007/s00244-005-0218-1
   Beernaert J, 2007, ENVIRON POLLUT, V145, P443, DOI 10.1016/j.envpol.2006.04.025
   Bilandzic N, 2010, B ENVIRON CONTAM TOX, V85, P486, DOI 10.1007/s00128-010-0146-2
   Broova A., 2014, ENVIRON SCI POLLUT R, V22, P3175
   Burger J, 2007, ENVIRON RES, V104, P153, DOI 10.1016/j.envres.2006.08.001
   Cardoso L, 2013, VET PARASITOL, V196, P90, DOI 10.1016/j.vetpar.2012.12.060
   Clarke JU, 1998, ENVIRON SCI TECHNOL, V32, P177, DOI 10.1021/es970521v
   Cooke John A., 1996, P377
   Corsolini S, 1999, ENVIRON MONIT ASSESS, V54, P87, DOI 10.1023/A:1005974014029
   Cybulski W, 2009, POL J VET SCI, V12, P339
   Cybulski W, 2009, B VET I PULAWY, V53, P65
   Dietz R, 1998, AMAP ASSESSMENT REPO, P373
   Dip R, 2001, ARCH ENVIRON CON TOX, V40, P551, DOI 10.1007/s002440010209
   Fossi MC, 2003, PURE APPL CHEM, V75, P2235, DOI 10.1351/pac200375112235
   FRANK A, 1986, SCI TOTAL ENVIRON, V57, P57, DOI 10.1016/0048-9697(86)90009-4
   Fritsch C, 2010, ENVIRON POLLUT, V158, P827, DOI 10.1016/j.envpol.2009.09.027
   Garcia-Fernandez A.J., 1994, IMPREGNACION PLOMO C
   González XI, 2008, CHEMOSPHERE, V71, P2060, DOI 10.1016/j.chemosphere.2008.01.036
   GOYER RA, 1995, METAL TOXICOLOGY, P389
   Hernández-Moreno D, 2013, ENVIRON MONIT ASSESS, V185, P10421, DOI 10.1007/s10661-013-3341-x
   Hoekstra PF, 2003, SCI TOTAL ENVIRON, V309, P81, DOI 10.1016/S0048-9697(02)00684-8
   Hoffmann SR, 2010, B ENVIRON CONTAM TOX, V85, P481, DOI 10.1007/s00128-010-0126-6
   Hyvärinen H, 2003, B ENVIRON CONTAM TOX, V70, P278, DOI 10.1007/s00128-002-0188-1
   Ikeda M, 2000, SCI TOTAL ENVIRON, V249, P373, DOI 10.1016/S0048-9697(99)00527-6
   Jankovská I, 2010, ARCH ENVIRON CON TOX, V58, P469, DOI 10.1007/s00244-009-9355-2
   Kidawa D, 2011, ACTA THERIOL, V56, P209, DOI 10.1007/s13364-011-0031-3
   Lambertucci SA, 2011, BIOL CONSERV, V144, P1464, DOI 10.1016/j.biocon.2011.01.015
   Ma Wei-Chun, 1996, P281
   Millán J, 2008, SCI TOTAL ENVIRON, V399, P193, DOI 10.1016/j.scitotenv.2008.03.038
   Milton A, 2003, ARCH ENVIRON CON TOX, V44, P405, DOI 10.1007/s00244-002-2014-5
   Naccari C, 2013, ECOTOX ENVIRON SAFE, V90, P41, DOI 10.1016/j.ecoenv.2012.12.011
   Piskorová L, 2003, CZECH J ANIM SCI, V48, P134
   Robillard S, 2002, ARCTIC, V55, P1
   Saeed I, 2006, VET PARASITOL, V139, P168, DOI 10.1016/j.vetpar.2006.02.015
   Sanchez-Chardi A, 2007, CHEMOSPHERE, V70, P101, DOI 10.1016/j.chemosphere.2007.06.047
   Shore RF, 2001, SCI TOTAL ENVIRON, V280, P45, DOI 10.1016/S0048-9697(01)00802-6
   Tête N, 2014, SCI TOTAL ENVIRON, V481, P167, DOI 10.1016/j.scitotenv.2014.02.029
   Topolska K, 2004, POL J ENVIRON STUD, V13, P103
   WIECZOREK J, 2005, CHEM INZYNIERIA EKOL, V12, P127
NR 40
TC 16
Z9 16
U1 0
U2 29
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0277-2248
EI 1029-0486
J9 TOXICOL ENVIRON CHEM
JI Toxicol Environ. Chem.
PD JAN 2
PY 2016
VL 98
IS 1
BP 109
EP 117
DI 10.1080/02772248.2015.1107065
PG 9
WC Environmental Sciences; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Environmental Sciences & Ecology; Toxicology
GA CX4CP
UT WOS:000365646100010
DA 2024-02-19
ER

PT J
AU Karunadharma, PP
   Basisty, N
   Dai, DF
   Chiao, YA
   Quarles, EK
   Hsieh, EJ
   Crispin, D
   Bielas, JH
   Ericson, NG
   Beyer, RP
   MacKay, VL
   MacCoss, MJ
   Rabinovitch, PS
AF Karunadharma, Pabalu P.
   Basisty, Nathan
   Dai, Dao-Fu
   Chiao, Ying A.
   Quarles, Ellen K.
   Hsieh, Edward J.
   Crispin, David
   Bielas, Jason H.
   Ericson, Nolan G.
   Beyer, Richard P.
   MacKay, Vivian L.
   MacCoss, Michael J.
   Rabinovitch, Peter S.
TI Subacute calorie restriction and rapamycin discordantly alter mouse
   liver proteome homeostasis and reverse aging effects
SO AGING CELL
LA English
DT Article
DE aging; calorie restriction; liver; mammalian target of rapamycin;
   protein turnover; rapamycin
ID EXTENDS LIFE-SPAN; GENETICALLY HETEROGENEOUS MICE; CHRONIC DIETARY
   RESTRICTION; SHORT-TERM; TURNOVER; MTOR; TRANSLATION; INCREASE; RAT;
   MITOCHONDRIA
AB Calorie restriction (CR) and rapamycin (RP) extend lifespan and improve health across model organisms. Both treatments inhibit mammalian target of rapamycin (mTOR) signaling, a conserved longevity pathway and a key regulator of protein homeostasis, yet their effects on proteome homeostasis are relatively unknown. To comprehensively study the effects of aging, CR, and RP on protein homeostasis, we performed the first simultaneous measurement of mRNA translation, protein turnover, and abundance in livers of young (3 month) and old (25 month) mice subjected to 10-week RP or 40% CR. Protein abundance and turnover were measured in vivo using H-2(3)-leucine heavy isotope labeling followed by LC-MS/MS, and translation was assessed by polysome profiling. We observed 35-60% increased protein half-lives after CR and 15% increased half-lives after RP compared to age-matched controls. Surprisingly, the effects of RP and CR on protein turnover and abundance differed greatly between canonical pathways, with opposite effects in mitochondrial (mt) dysfunction and eIF2 signaling pathways. CR most closely recapitulated the young phenotype in the top pathways. Polysome profiles indicated that CR reduced polysome loading while RP increased polysome loading in young and old mice, suggesting distinct mechanisms of reduced protein synthesis. CR and RP both attenuated protein oxidative damage. Our findings collectively suggest that CR and RP extend lifespan in part through the reduction of protein synthetic burden and damage and a concomitant increase in protein quality. However, these results challenge the notion that RP is a faithful CR mimetic and highlight mechanistic differences between the two interventions.
C1 [Karunadharma, Pabalu P.; Basisty, Nathan; Dai, Dao-Fu; Chiao, Ying A.; Quarles, Ellen K.; Crispin, David; Bielas, Jason H.; Rabinovitch, Peter S.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA.
   [Hsieh, Edward J.; MacCoss, Michael J.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.
   [Bielas, Jason H.] Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98109 USA.
   [Bielas, Jason H.; Ericson, Nolan G.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA.
   [Beyer, Richard P.] Univ Washington, Dept Environm Hlth & Biostat, Seattle, WA 98195 USA.
   [MacKay, Vivian L.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA.
C3 University of Washington; University of Washington Seattle; University
   of Washington; University of Washington Seattle; Fred Hutchinson Cancer
   Center; Fred Hutchinson Cancer Center; University of Washington;
   University of Washington Seattle; University of Washington; University
   of Washington Seattle
RP Rabinovitch, PS (corresponding author), Univ Washington, Dept Pathol, 1959 NE Pacific St,HSB-K081, Seattle, WA 98195 USA.
EM petersr@u.washington.edu
RI Basisty, Nathan B/J-9294-2014; Quarles, Ellen/V-1712-2019; Dai,
   Dao-Fu/AAB-7547-2022; Dai, Dao-Fu/AAM-4396-2021
OI Basisty, Nathan B/0000-0001-6173-1139; Dai, Dao-Fu/0000-0001-7724-321X;
   Quarles, Ellen/0000-0002-7160-3939
FU NIH [P30 AG0132280, RO1 HL101186, RO1 AG038550]; Ellison Medical
   Foundation [AG-SS-2535-10]; American Federation for Aging Research
   Breakthroughs in Gerontology award; Ellison Medical Foundation New
   Scholar Award; Outstanding New Environmental Scientist Award from
   National Institute of Environmental Health Sciences [R01ES019319]
FX The authors wish to thank Jeanne Fredrickson, Elena Lattore-Esteves, and
   Cathy Styer for their assistance with polysome profiling and Michael
   Garelick for his input during polysome experimental setup. We thank
   Calvin Ngo and Tony Chen for their assistance in mouse euthanization and
   protein extraction, the University of San Antonio for providing
   encapsulated rapamycin, and Martin Jarvos for Rapa blood measurements.
   Grant support was provided by NIH P30 AG0132280, RO1 HL101186, and RO1
   AG038550, by the Ellison Medical Foundation grant AG-SS-2535-10, an
   American Federation for Aging Research Breakthroughs in Gerontology
   award to P.S.R, an Ellison Medical Foundation New Scholar Award to
   J.H.B., and an Outstanding New Environmental Scientist Award from the
   National Institute of Environmental Health Sciences (R01ES019319 to
   J.H.B).
CR Alvers AL, 2009, AUTOPHAGY, V5, P847, DOI 10.4161/auto.8824
   Beretta L, 1996, EMBO J, V15, P658, DOI 10.1002/j.1460-2075.1996.tb00398.x
   BLACKWELL BN, 1995, TOXICOL PATHOL, V23, P570, DOI 10.1177/019262339502300503
   Cerqueira FM, 2012, FREE RADICAL BIO MED, V52, P1236, DOI 10.1016/j.freeradbiomed.2012.01.011
   Chondrogianni N, 2005, EXP GERONTOL, V40, P931, DOI 10.1016/j.exger.2005.09.004
   Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105
   Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635
   Conn CS, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003520
   Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322
   Dai DF, 2014, AGING CELL, V13, P529, DOI 10.1111/acel.12203
   Dani D, 2010, BIOGERONTOLOGY, V11, P321, DOI 10.1007/s10522-009-9254-y
   Drake JC, 2013, J GERONTOL A-BIOL, V68, P1493, DOI 10.1093/gerona/glt047
   Fang YM, 2013, CELL METAB, V17, P456, DOI 10.1016/j.cmet.2013.02.008
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   Fok WC, 2014, AGING CELL, V13, P311, DOI 10.1111/acel.12175
   Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201
   GOLDSPINK DF, 1987, EXP GERONTOL, V22, P67, DOI 10.1016/0531-5565(87)90016-7
   Hansen M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040024
   Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221
   Hipkiss AR, 2007, MECH AGEING DEV, V128, P412, DOI 10.1016/j.mad.2007.03.002
   Hipkiss AR, 2006, EXP GERONTOL, V41, P464, DOI 10.1016/j.exger.2006.03.004
   Hsieh EJ, 2012, MOL CELL PROTEOMICS, V11, P1468, DOI 10.1074/mcp.O112.017699
   Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861
   Kaul G, 2011, CELL BIOCHEM FUNCT, V29, P227, DOI 10.1002/cbf.1740
   Kim TY, 2012, MOL CELL PROTEOMICS, V11, P1586, DOI 10.1074/mcp.M112.021162
   Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135
   LEWIS SEM, 1985, EXP GERONTOL, V20, P253, DOI 10.1016/0531-5565(85)90050-6
   MERRY BJ, 1987, MECH AGEING DEV, V39, P189, DOI 10.1016/0047-6374(87)90008-X
   Miller BF, 2013, J GERONTOL A-BIOL, V68, P530, DOI 10.1093/gerona/gls219
   Miller RA, 2011, J GERONTOL A-BIOL, V66, P191, DOI 10.1093/gerona/glq178
   Price JC, 2012, MOL CELL PROTEOMICS, V11, P1801, DOI 10.1074/mcp.M112.021204
   Price JC, 2010, P NATL ACAD SCI USA, V107, P14508, DOI 10.1073/pnas.1006551107
   Ramanathan A, 2009, P NATL ACAD SCI USA, V106, P22229, DOI 10.1073/pnas.0912074106
   Ryazanov AG, 2002, MECH AGEING DEV, V123, P207, DOI 10.1016/S0047-6374(01)00337-2
   Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200
   Stanfel MN, 2009, BBA-GEN SUBJECTS, V1790, P1067, DOI 10.1016/j.bbagen.2009.06.007
   Wilkinson JE, 2012, AGING CELL, V11, P675, DOI 10.1111/j.1474-9726.2012.00832.x
   Yu Z, 2015, J GERONTOL A-BIOL, V70, P410, DOI 10.1093/gerona/glu053
   Zhang J, 2008, PROTEOMICS, V8, P1564, DOI 10.1002/pmic.200700851
   Zid BM, 2009, CELL, V139, P149, DOI 10.1016/j.cell.2009.07.034
NR 40
TC 61
Z9 70
U1 0
U2 16
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD AUG
PY 2015
VL 14
IS 4
BP 547
EP 557
DI 10.1111/acel.12317
PG 11
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA CM8IC
UT WOS:000357941900005
PM 25807975
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Wang, C
   Vegna, S
   Jin, HJ
   Benedict, B
   Lieftink, C
   Ramirez, C
   de Oliveira, RL
   Morris, B
   Gadiot, J
   Wang, W
   du Chatinier, A
   Wang, LQ
   Gao, DM
   Evers, B
   Jin, GZ
   Xue, Z
   Schepers, A
   Jochems, F
   Sanchez, AM
   Mainardi, S
   te Riele, H
   Beijersbergen, RL
   Qin, WX
   Akkari, L
   Bernards, R
AF Wang, Cun
   Vegna, Serena
   Jin, Haojie
   Benedict, Bente
   Lieftink, Cor
   Ramirez, Christel
   de Oliveira, Rodrigo Leite
   Morris, Ben
   Gadiot, Jules
   Wang, Wei
   du Chatinier, Aimee
   Wang, Liqin
   Gao, Dongmei
   Evers, Bastiaan
   Jin, Guangzhi
   Xue, Zheng
   Schepers, Arnout
   Jochems, Fleur
   Sanchez, Antonio Mulero
   Mainardi, Sara
   te Riele, Hein
   Beijersbergen, Roderick L.
   Qin, Wenxin
   Akkari, Leila
   Bernards, Rene
TI Inducing and exploiting vulnerabilities for the treatment of liver
   cancer
SO NATURE
LA English
DT Article
ID SENESCENCE; DISTINCT; KINASE; TARGET
AB Liver cancer remains difficult to treat, owing to a paucity of drugs that target critical dependencies(1,2); broad-spectrum kinase inhibitors such as sorafenib provide only a modest benefit to patients with hepatocellular carcinoma(3). The induction of senescence may represent a strategy for the treatment of cancer, especially when combined with a second drug that selectively eliminates senescent cancer cells (senolysis)(4,5). Here, using a kinome-focused genetic screen, we show that pharmacological inhibition of the DNA-replication kinase CDC7 induces senescence selectively in liver cancer cells with mutations in TP53. A follow-up chemical screen identified the antidepressant sertraline as an agent that kills hepatocellular carcinoma cells that have been rendered senescent by inhibition of CDC7. Sertraline suppressed mTOR signalling, and selective drugs that target this pathway were highly effective in causing the apoptotic cell death of hepatocellular carcinoma cells treated with a CDC7 inhibitor. The feedback reactivation of mTOR signalling after its inhibition(6) is blocked in cells that have been treated with a CDC7 inhibitor, which leads to the sustained inhibition of mTOR and cell death. Using multiple in vivo mouse models of liver cancer, we show that treatment with combined inhibition of of CDC7 and mTOR results in a marked reduction of tumour growth. Our data indicate that exploiting an induced vulnerability could be an effective treatment for liver cancer.
C1 [Wang, Cun; Jin, Haojie; Qin, Wenxin] Shanghai Jiao Tong Univ, Renji Hosp, State Key Lab Oncogenes & Related Genes, Shanghai Canc Inst,Sch Med, Shanghai, Peoples R China.
   [Wang, Cun; Jin, Haojie; Lieftink, Cor; de Oliveira, Rodrigo Leite; Morris, Ben; du Chatinier, Aimee; Wang, Liqin; Evers, Bastiaan; Xue, Zheng; Schepers, Arnout; Jochems, Fleur; Sanchez, Antonio Mulero; Mainardi, Sara; Beijersbergen, Roderick L.; Bernards, Rene] Netherlands Canc Inst, Div Mol Carcinogenesis, Oncode Inst, Amsterdam, Netherlands.
   [Vegna, Serena; Benedict, Bente; Ramirez, Christel; Gadiot, Jules; te Riele, Hein; Akkari, Leila] Netherlands Canc Inst, Div Tumour Biol & Immunol, Oncode Inst, Amsterdam, Netherlands.
   [Wang, Wei] Netherlands Canc Inst, Div Cell Biol, Amsterdam, Netherlands.
   [Gao, Dongmei] Fudan Univ, Zhongshan Hosp, Key Lab Carcinogenesis & Canc Invas, Liver Canc Inst,Minist Educ, Shanghai, Peoples R China.
   [Jin, Guangzhi] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Pathol, Shanghai, Peoples R China.
C3 Shanghai Jiao Tong University; Netherlands Cancer Institute; Netherlands
   Cancer Institute; Netherlands Cancer Institute; Fudan University; Naval
   Medical University
RP Qin, WX (corresponding author), Shanghai Jiao Tong Univ, Renji Hosp, State Key Lab Oncogenes & Related Genes, Shanghai Canc Inst,Sch Med, Shanghai, Peoples R China.; Bernards, R (corresponding author), Netherlands Canc Inst, Div Mol Carcinogenesis, Oncode Inst, Amsterdam, Netherlands.; Akkari, L (corresponding author), Netherlands Canc Inst, Div Tumour Biol & Immunol, Oncode Inst, Amsterdam, Netherlands.
EM wxqin@sjtu.edu.cn; l.akkari@nki.nl; r.bernards@nki.nl
OI Benedict, Bente/0000-0002-7503-8527; Mulero Sanchez,
   Antonio/0000-0003-1668-7022; Jin, Haojie/0000-0001-9295-1951; Akkari,
   Leila/0000-0001-5479-641X; Qin, Wenxin/0000-0002-1989-3027; Wang,
   Liqin/0000-0002-9881-6432; Wang, Wei/0000-0003-4869-6716
FU European Research Council (ERC) [787925]; Dutch Cancer Society through
   the Oncode Institute [KWF 12049/2018-2, 6702/2014]; Center for Cancer
   Genomics (CGC); National Basic Research Program of China (973 Program)
   [2015CB553905]; National Key Sci-Tech Special Projects of Infectious
   Diseases of China [2018ZX10732202-002-003]; National Natural Science
   Foundation of China [81920108025, 81421001, 81672933, 81874229];
   Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant
   Support [20181703]; Shanghai Municipal Commission of Health and Family
   Planning [2017YQ064, 2018YQ20]; Shanghai Rising-Star Program
   [18QA1403900]; European Research Council (ERC) [787925] Funding Source:
   European Research Council (ERC)
FX We thank L. Zender, R. Smits, X. Qiao and L. Li for the kind gift of
   cell lines. This work was funded by grants from the European Research
   Council (ERC 787925 to R.B.), the Dutch Cancer Society (KWF 12049/2018-2
   to L.A., 6702/2014 to B.B. and H.t.R) through the Oncode Institute and
   the Center for Cancer Genomics (CGC: http://cancergenomics.nl), the
   National Basic Research Program of China (973 Program: 2015CB553905),
   the National Key Sci-Tech Special Projects of Infectious Diseases of
   China (2018ZX10732202-002-003), the National Natural Science Foundation
   of China (81920108025, 81421001, 81672933, and 81874229), Shanghai
   Municipal Education Commission-Gaofeng Clinical Medicine Grant Support
   (20181703), Shanghai Municipal Commission of Health and Family Planning
   (2017YQ064 and 2018YQ20) and Shanghai Rising-Star Program (18QA1403900).
   We thank the facilities of Netherlands Cancer Institute: Animal
   Laboratory, Mouse Clinic Imaging Unit, Experimental Animal Pathology,
   Flow Cytometry, Sequencing and BioImaging.
CR Ally A, 2017, CELL, V169, P1327, DOI 10.1016/j.cell.2017.05.046
   Chang JH, 2016, NAT MED, V22, P78, DOI 10.1038/nm.4010
   Dauch D, 2016, NAT MED, V22, P744, DOI 10.1038/nm.4107
   Eggert T, 2016, CANCER CELL, V30, P533, DOI 10.1016/j.ccell.2016.09.003
   Evers B, 2016, NAT BIOTECHNOL, V34, P631, DOI 10.1038/nbt.3536
   Faget DV, 2019, NAT REV CANCER, V19, P439, DOI 10.1038/s41568-019-0156-2
   Flynn MJ, 2019, HEPATOLOGY, V69, P2258, DOI 10.1002/hep.30337
   Fortanet JG, 2016, J MED CHEM, V59, P7773, DOI 10.1021/acs.jmedchem.6b00680
   Fridman AL, 2008, ONCOGENE, V27, P5975, DOI 10.1038/onc.2008.213
   Georgilis A, 2018, CANCER CELL, V34, P85, DOI 10.1016/j.ccell.2018.06.007
   Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.21492, 10.3322/caac.20107]
   Keng VW, 2009, NAT BIOTECHNOL, V27, P264, DOI 10.1038/nbt.1526
   Koelzer VH, 2018, HISTOPATHOLOGY, V73, P397, DOI 10.1111/his.13528
   Koltun ES, 2012, BIOORG MED CHEM LETT, V22, P3727, DOI 10.1016/j.bmcl.2012.04.024
   Lin CJ, 2010, CANCER RES, V70, P3199, DOI 10.1158/0008-5472.CAN-09-4072
   Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857
   Llovet JM, 2016, NAT REV DIS PRIMERS, V2, DOI [10.1038/nrdp.2016.18, 10.1038/nrdp.2016.19]
   Milanovic M, 2018, NATURE, V553, P96, DOI 10.1038/nature25167
   Montagnoli A, 2010, CLIN CANCER RES, V16, P4503, DOI 10.1158/1078-0432.CCR-10-0185
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5
   Peng T, 2002, MOL CELL BIOL, V22, P5575, DOI 10.1128/MCB.22.15.5575-5584.2002
   Rodrik-Outmezguine VS, 2011, CANCER DISCOV, V1, P248, DOI 10.1158/2159-8290.CD-11-0085
   Sieben CJ, 2018, TRENDS CELL BIOL, V28, P723, DOI 10.1016/j.tcb.2018.04.006
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Wang C, 2018, CELL RES, V28, P690, DOI 10.1038/s41422-018-0020-z
   Wang LQ, 2017, CELL REP, V21, P773, DOI 10.1016/j.celrep.2017.09.085
   Zucman-Rossi J, 2015, GASTROENTEROLOGY, V149, P1226, DOI 10.1053/j.gastro.2015.05.061
NR 28
TC 218
Z9 230
U1 5
U2 157
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD OCT 10
PY 2019
VL 574
IS 7777
BP 268
EP +
DI 10.1038/s41586-019-1607-3
PG 19
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA JD2DB
UT WOS:000489784200052
PM 31578521
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Feng, GJ
   Zheng, K
   Cao, T
   Zhang, JL
   Lian, M
   Huang, D
   Wei, CB
   Gu, ZF
   Feng, XM
AF Feng, Guijuan
   Zheng, Ke
   Cao, Tong
   Zhang, Jinlong
   Lian, Min
   Huang, Dan
   Wei, Changbo
   Gu, Zhifeng
   Feng, Xingmei
TI Repeated stimulation by LPS promotes the senescence of DPSCs via
   TLR4/MyD88-NF-κB-p53/p21 signaling
SO CYTOTECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 30th National Meeting of the
   Japanese-Association-for-Animal-Cell-Technology (JAACT)
CY 2017
CL Matsuyama, JAPAN
SP Japanese Assoc Anim Cell Technol
DE Dental pulp stem cells (DPSCs); Lipopolysaccharide (LPS); Senescence;
   TLR4/MyD88; NF-kappa B-p53/p21
ID MESENCHYMAL STEM-CELLS; CELLULAR SENESCENCE; BETA-GALACTOSIDASE;
   BONE-MARROW; OXIDATIVE STRESS; UP-REGULATION; LIVER-INJURY;
   DIFFERENTIATION; P53; INFLAMMATION
AB Dental pulp stem cells (DPSCs), one type of mesenchymal stem cells, are considered to be a type of tool cells for regenerative medicine and tissue engineering. Our previous studies found that the stimulation with lipopolysaccharide (LPS) might introduce senescence of DPSCs, and this senescence would have a positive correlation with the concentration of LPS. The beta-galactosidase (SA-beta-gal) staining was used to evaluate the senescence of DPSCs and immunofluorescence to show the morphology of DPSCs. Our findings suggested that the activity of SA-beta-gal has increased after repeated stimulation with LPS and the morphology of DPSCs has changed with the stimulation with LPS. We also found that LPS bound to the Toll-like receptor 4 (TLR4)/myeloid differentiation factor (MyD) 88 signaling pathway. Protein and mRNA expression of TLR4, MyD88 were enhanced in DPSCs with LPS stimulation, resulting in the activation of nuclear factor-kappa B (NF-kappa B) signaling, which exhibited the expression of p65 improved in the nucleus while the decreasing of I kappa B-alpha. Simultaneously, the expression of p53 and p21, the downstream proteins of the NF-kappa B signaling, has increased. In summary, DPSCs tend to undergo senescence after repeated stimulation in an inflammatory microenvironment. Ultimately, these findings may lead to a new direction for cell-based therapy in oral diseases and other regenerative medicines.
C1 [Feng, Guijuan; Lian, Min; Huang, Dan; Feng, Xingmei] Nantong Univ, Dept Stomatol, Affiliated Hosp, Nantong 226001, Peoples R China.
   [Zheng, Ke] Wuxi 2 Peoples Hosp, Dept Stomatol, Wuxi 214000, Peoples R China.
   [Cao, Tong] Nantong Univ, Dept Provosts Off, Affiliated Hosp, Nantong 226001, Peoples R China.
   [Zhang, Jinlong] Nantong Univ, Affiliated Hosp 2, Dept Spine Surg, Nantong 226001, Peoples R China.
   [Wei, Changbo] Sun Yat Sen Univ, Guanghua Sch Stomatol, Hosp Stomatol, Guangzhou 510055, Guangdong, Peoples R China.
   [Gu, Zhifeng] Nantong Univ, Dept Rheumatol, Affiliated Hosp, Nantong 226001, Peoples R China.
C3 Nantong University; Nantong University; Nantong University; Sun Yat Sen
   University; Nantong University
RP Feng, XM (corresponding author), Nantong Univ, Dept Stomatol, Affiliated Hosp, Nantong 226001, Peoples R China.; Gu, ZF (corresponding author), Nantong Univ, Dept Rheumatol, Affiliated Hosp, Nantong 226001, Peoples R China.
EM guzhifeng@126.com; fengxingmeint@126.com
RI zhang, jin/GXV-9154-2022; Gu, Zhifeng/AAP-9566-2021; Liu,
   Jing/IQX-0664-2023; wang, zhiwen/JDV-9990-2023
OI Feng, xingmei/0000-0001-8046-3336
FU Natural Science Foundation of China [81500809, 81501076]; Jiangsu
   Province Young Medical Key Talents Project of China [QNRC2016407];
   Nantong Health Bureau Youth Foundation of China [WQ2015016]
FX This work was supported by Natural Science Foundation of China Grant
   (Nos. 81500809, 81501076). Jiangsu Province Young Medical Key Talents
   Project of China (QNRC2016407). Nantong Health Bureau Youth Foundation
   of China (WQ2015016).
CR Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391
   Alongi DJ, 2010, REGEN MED, V5, P617, DOI 10.2217/RME.10.30
   Andonegui G, 2009, J CLIN INVEST, V119, P1921, DOI 10.1172/JCI36411
   Beauséjour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417
   Botero TM, 2010, J DENT RES, V89, P264, DOI 10.1177/0022034509357556
   Brennen WN, 2013, ENDOCR-RELAT CANCER, V20, pR269, DOI 10.1530/ERC-13-0151
   Broad A, 2007, IMMUNOLOGY, V120, P103, DOI 10.1111/j.1365-2567.2006.02485.x
   Cinel I, 2009, CRIT CARE MED, V37, P291, DOI 10.1097/CCM.0b013e31819267fb
   D'Alimonte I, 2013, STEM CELL RES, V11, P611, DOI 10.1016/j.scr.2013.04.002
   Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191
   Debelec-Butuner B, 2014, MOL CARCINOGEN, V53, P85, DOI 10.1002/mc.21948
   Dierick JF, 2002, BIOCHEM PHARMACOL, V64, P1011, DOI 10.1016/S0006-2952(02)01171-1
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Dunzendorfer S, 2004, J IMMUNOL, V173, P1166, DOI 10.4049/jimmunol.173.2.1166
   Faner R, 2012, AM J RESP CRIT CARE, V186, P306, DOI 10.1164/rccm.201202-0282PP
   Feng XM, 2014, CELL TISSUE RES, V356, P369, DOI 10.1007/s00441-014-1799-7
   Feng XM, 2013, CELL MOL NEUROBIOL, V33, P1023, DOI 10.1007/s10571-013-9965-0
   Ferrand M, 2015, AGING-US, V7, P986, DOI 10.18632/aging.100845
   Genov M, 2016, J CANCER, V7, P555, DOI 10.7150/jca.13614
   Gu Z, 2013, EXP CLIN ENDOCR DIAB, V121, P607, DOI 10.1055/s-0033-1354380
   Hernandez A, 2016, J LEUKOCYTE BIOL, V100, P1311, DOI 10.1189/jlb.1A0216-072R
   Hilkens P, 2013, CELL TISSUE RES, V353, P65, DOI 10.1007/s00441-013-1630-x
   Huang YH, 2015, MOL MED REP, V11, P3547, DOI 10.3892/mmr.2014.3120
   Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043
   Imam F, 2015, PHARMACOL RES, V102, P1, DOI 10.1016/j.phrs.2015.09.001
   Jung YS, 2016, ACTA PHARMACOL SIN, V37, P1031, DOI 10.1038/aps.2016.51
   Kalaiyarasu S, 2016, CYTOKINE, V85, P140, DOI 10.1016/j.cyto.2016.06.022
   Kim JE, 2017, ONCOGENE, V36, P219, DOI 10.1038/onc.2016.193
   Kim SH, 2016, SCI REP-UK, V6, DOI 10.1038/srep30311
   Kolf CM, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0223-x
   Kurz DJ, 2000, J CELL SCI, V113, P3613
   Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x
   Libro R, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00559
   Liu XC, 2016, CURR STEM CELL RES T, V11, P593, DOI 10.2174/1574888X11666160429122858
   Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006
   Mantovani C, 2014, NEURAL REGEN RES, V9, P10, DOI 10.4103/1673-5374.125324
   Marques LCF, 2016, PLANTA MED, V82, P1463, DOI 10.1055/s-0042-108856
   Meng QY, 2015, SCI REP-UK, V5, DOI 10.1038/srep17802
   O'Prey J, 2010, CELL CYCLE, V9, P947, DOI 10.4161/cc.9.5.10872
   Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183
   Price JS, 2002, AGING CELL, V1, P57, DOI 10.1046/j.1474-9728.2002.00008.x
   Qu Y, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040522
   Rovillain E, 2011, ONCOGENE, V30, P2356, DOI 10.1038/onc.2010.611
   Rutherford RB, 2000, EUR J ORAL SCI, V108, P202, DOI 10.1034/j.1600-0722.2000.108003202.x
   Smyth K, 2013, INT IMMUNOPHARMACOL, V15, P67, DOI 10.1016/j.intimp.2012.10.019
   Sui BD, 2016, J DENT RES, V95, P1333, DOI 10.1177/0022034516653589
   Tran JR, 2016, CURR OPIN CELL BIOL, V40, P124, DOI 10.1016/j.ceb.2016.03.004
   Trial J, 2016, J MOL CELL CARDIOL, V91, P28, DOI 10.1016/j.yjmcc.2015.12.017
   Wang ML, 2016, BIOCHEM BIOPH RES CO, V478, P1006, DOI 10.1016/j.bbrc.2016.08.004
   Wang XM, 2016, EXP CELL RES, V346, P147, DOI 10.1016/j.yexcr.2016.06.020
   Yang RC, 2016, ACS APPL MATER INTER, V8, P26638, DOI 10.1021/acsami.6b10377
   Yang XC, 2012, J CELL BIOCHEM, V113, P669, DOI 10.1002/jcb.23396
   Yao H, 2016, INT IMMUNOPHARMACOL, V36, P132, DOI 10.1016/j.intimp.2016.04.023
   Yu HM, 2012, NEUROIMMUNOMODULAT, V19, P131, DOI 10.1159/000330254
   Yu XL, 2016, GENE, V589, P12, DOI 10.1016/j.gene.2016.05.014
   Zhang WX, 2016, ENVIRON TOXICOL PHAR, V45, P193, DOI 10.1016/j.etap.2016.06.002
   Zhao R, 2017, CELL MOL IMMUNOL, V14, P830, DOI 10.1038/cmi.2016.31
   Zhao WY, 2014, P IEEE INT FREQ CONT, P162
   Zhou N, 2016, SCI REP-UK, V6, DOI 10.1038/srep22628
   Zhu GY, 2013, BIOCHEM BIOPH RES CO, V433, P526, DOI 10.1016/j.bbrc.2013.03.018
NR 60
TC 31
Z9 34
U1 2
U2 19
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0920-9069
EI 1573-0778
J9 CYTOTECHNOLOGY
JI Cytotechnology
PD JUN
PY 2018
VL 70
IS 3
SI SI
BP 1023
EP 1035
DI 10.1007/s10616-017-0180-6
PG 13
WC Biotechnology & Applied Microbiology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Biotechnology & Applied Microbiology; Cell Biology
GA GK9KH
UT WOS:000436566500014
PM 29480340
OA Green Published, Bronze
DA 2024-02-19
ER

PT J
AU Liu, YJ
   Liu, Y
   Guo, YT
   Xu, L
   Wang, H
AF Liu, Yaojie
   Liu, Ying
   Guo, Yatu
   Xu, Lin
   Wang, Hao
TI Phlorizin exerts potent effects against aging induced by d-galactose in
   mice and PC12 cells
SO FOOD & FUNCTION
LA English
DT Article
ID OXIDATIVE STRESS; RATS; DYSFUNCTION; PHLORETIN; INHIBITOR; METFORMIN;
   MEMORY; LIVER
AB Phlorizin is the main active ingredient of apple peel and has potential utilization value. Some recent studies have suggested that phlorizin may have antioxidant capacity and protect the liver. The injection of a low dose of d-galactose can cause some changes that resemble accelerated aging in mice. This study explored the protective effects of phlorizin on d-galactose-induced mice and PC12 cells. In this study, ICR mice were divided into a normal group (NOR), a d-galactose model group (d-gal) and phlorizin treatment groups (100 mg kg(-1), 200 mg kg(-1) and 400 mg kg(-1)). In addition to the NOR group, four other groups were injected with d-galactose (120 mg kg(-1)) for 12 weeks. The results showed that phlorizin reduced the decline of strength, coordination and spatial memory caused by aging, increased the activity of superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GSH-Px), increased total antioxidant capacity (T-AOC), and reduced the content of malondialdehyde (MDA). On the other hand, phlorizin increased the levels of interleukin-2 (IL-2) and acetylcholine (ACh), reduced the release of interleukin-6 (IL-6), aspartate aminotransferase (AST) and alanine aminotransferase (ALT), and decreased the activity of acetylcholinesterase (AChE) in the brain, improved the expression of antioxidant genes related to the nuclear factor E2-related factor 2 (Nrf2) pathway, and reduced the occurrence of morphological lesions in the hippocampus and liver. In addition, phlorizin improved cell viability and reduced the cytotoxicity of d-galactose-induced oxidative stress in PC12 cells. Meanwhile, the protective effect of phlorizin was abolished in Nrf2 gene knockdown PC12 cells. Furthermore, molecular docking showed that phlorizin could bind Keap1 protein, which can interact with Nrf2 protein. Therefore, these results suggest that phlorizin may delay senescence and enhance antioxidant capacity through the Nrf2 pathway.
C1 [Liu, Yaojie; Liu, Ying; Wang, Hao] Tianjin Univ Sci & Technol, Coll Food Sci & Engn, State Key Lab Food Nutr & Safety, Tianjin 300457, Peoples R China.
   [Guo, Yatu] Tianjin Eye Hosp, Tianjin Eye Inst, Tianjin Key Lab Ophthalmol & Visual Sci, Tianjin 300384, Peoples R China.
   [Xu, Lin] Tianjin Municipal Publ Secur Hosp, Pathol Dept, Tianjin 300042, Peoples R China.
C3 Tianjin University Science & Technology; Tianjin Medical University
RP Wang, H (corresponding author), Tianjin Univ Sci & Technol, Coll Food Sci & Engn, State Key Lab Food Nutr & Safety, Tianjin 300457, Peoples R China.
EM wanghao@tust.edu.cn
CR Allen EN, 2014, BEHAV BRAIN RES, V267, P119, DOI 10.1016/j.bbr.2014.03.032
   Belviranli M, 2019, BEHAV BRAIN RES, V364, P245, DOI 10.1016/j.bbr.2019.02.030
   Bharath LP, 2020, CELL METAB, V32, P44, DOI 10.1016/j.cmet.2020.04.015
   Bialuk I, 2020, BIOGERONTOLOGY, V21, P29, DOI 10.1007/s10522-019-09841-2
   Boccia MM, 1999, NEUROBIOL LEARN MEM, V71, P104, DOI 10.1006/nlme.1998.3856
   Cai YS, 2020, CELL RES, V30, P574, DOI 10.1038/s41422-020-0314-9
   Chang WT, 2012, FOOD CHEM, V134, P972, DOI 10.1016/j.foodchem.2012.03.002
   Chen P, 2020, RSC ADV, V10, P8027, DOI 10.1039/d0ra00774a
   Cheng J, 2019, J FUNCT FOODS, V60, DOI 10.1016/j.jff.2019.103445
   D'Mello C, 2014, BRAIN BEHAV IMMUN, V35, P9, DOI 10.1016/j.bbi.2013.10.009
   Dai Z, 2020, FOOD FUNCT, V11, P2489, DOI 10.1039/c9fo02453k
   Detienne G, 2018, AGEING RES REV, V44, P33, DOI 10.1016/j.arr.2018.03.005
   Fang L, 2018, SCI HORTIC-AMSTERDAM, V235, P460, DOI 10.1016/j.scienta.2018.02.051
   Fatemi I, 2018, IRAN J BASIC MED SCI, V21, P19, DOI 10.22038/IJBMS.2017.24331.6071
   Gao J.M, 2016, CHIN J NEW DRUGS, V10, P12
   HALL JL, 1992, PHARMACOL BIOCHEM BE, V41, P295, DOI 10.1016/0091-3057(92)90101-K
   He SD, 2019, FOOD FUNCT, V10, P4291, DOI 10.1039/c9fo00791a
   Helton TD, 2019, HIPPOCAMPUS, V29, P78, DOI 10.1002/hipo.23012
   Hengemihle JM, 1999, NEUROBIOL AGING, V20, P9, DOI 10.1016/S0197-4580(99)00016-0
   Inta D, 2013, BEHAV BRAIN RES, V241, P27, DOI 10.1016/j.bbr.2012.11.042
   Katsuda Y, 2015, EXP ANIM TOKYO, V64, P161, DOI 10.1538/expanim.14-0084
   Liu MJ, 2020, CELL MOL NEUROBIOL, V40, P1029, DOI 10.1007/s10571-020-00791-9
   Medhat E, 2020, METAB BRAIN DIS, V35, P111, DOI 10.1007/s11011-019-00504-2
   Mendes RA, 2018, J MOL MODEL, V24, DOI 10.1007/s00894-018-3632-9
   Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003
   Noda S, 2020, MOL BRAIN, V13, DOI 10.1186/s13041-020-00585-6
   Padmanabhan B, 2006, MOL CELL, V21, P689, DOI 10.1016/j.molcel.2006.01.013
   Parameshwaran K, 2010, REJUV RES, V13, P729, DOI 10.1089/rej.2010.1020
   Rahimi VB, 2018, BIOMED PHARMACOTHER, V108, P1712, DOI 10.1016/j.biopha.2018.10.024
   Sipahi C, 2006, J ORAL REHABIL, V33, P666, DOI 10.1111/j.1365-2842.2006.01648.x
   Sun LY, 2020, BIOCHEM BIOPH RES CO, V521, P113, DOI 10.1016/j.bbrc.2019.10.088
   Supramaniam A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217998
   Tian Y, 2018, J FOOD BIOCHEM, V42, DOI 10.1111/jfbc.12644
   Trist BG, 2019, AGING CELL, V18, DOI 10.1111/acel.13031
   Ungvari Z, 2010, AM J PHYSIOL-HEART C, V299, pH18, DOI 10.1152/ajpheart.00260.2010
   Vo QV, 2019, RSC ADV, V9, P42020, DOI 10.1039/c9ra08381b
   Wang H, 2019, J FOOD BIOCHEM, V43, DOI 10.1111/jfbc.12744
   Wang H, 2018, J FOOD BIOCHEM, V42, DOI 10.1111/jfbc.12445
   Wang HL, 2020, J FUNCT FOODS, V74, DOI 10.1016/j.jff.2020.104136
   Wei HY, 2017, MAR DRUGS, V15, DOI 10.3390/md15030077
   Xu SQ, 2018, J NEUROCHEM, V145, P312, DOI 10.1111/jnc.14297
   Yang J., 2019, NUTRIENTS, V11, P32
   Youn JS, 2019, FOOD SCI BIOTECHNOL, V28, P201, DOI 10.1007/s10068-018-0352-y
   Yu SL, 2010, ACTA PHARMACOL SIN, V31, P1532, DOI 10.1038/aps.2010.152
   Zhou B, 2019, J BIOENERG BIOMEMBR, V51, P291, DOI 10.1007/s10863-019-09804-9
   Zhou HM, 2019, FOOD FUNCT, V10, P2774, DOI [10.1039/C8FO01734D, 10.1039/c8fo01734d]
NR 46
TC 22
Z9 22
U1 8
U2 58
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2042-6496
EI 2042-650X
J9 FOOD FUNCT
JI Food Funct.
PD MAR 7
PY 2021
VL 12
IS 5
BP 2148
EP 2160
DI 10.1039/d0fo02707c
PG 13
WC Biochemistry & Molecular Biology; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Food Science & Technology
GA QW9RH
UT WOS:000628984700022
PM 33565551
DA 2024-02-19
ER

PT J
AU Ménard, L
   Taras, D
   Grigoletto, A
   Haurie, V
   Nicou, A
   Dugot-Senant, N
   Costet, P
   Rousseau, B
   Rosenbaum, J
AF Menard, Ludovic
   Taras, Daniele
   Grigoletto, Aude
   Haurie, Valerie
   Nicou, Alexandra
   Dugot-Senant, Nathalie
   Costet, Pierre
   Rousseau, Benoit
   Rosenbaum, Jean
TI <i>In vivo</i> silencing of Reptin blocks the progression of human
   hepatocellular carcinoma in xenografts and is associated with
   replicative senescence
SO JOURNAL OF HEPATOLOGY
LA English
DT Article
DE Liver cancer; Apoptosis; Senescence; shRNA; Doxycycline; Reptin
ID CHROMATIN REMODELING COMPLEX; INDUCIBLE RNA INTERFERENCE; THERAPEUTIC
   TARGET; CELL-PROLIFERATION; DNA HELICASE; C-MYC; PROTEINS; PONTIN; GENE;
   GROWTH
AB Background & Aims: We previously showed that Reptin is overexpressed in hepatocellular carcinoma (HCC), and that in vitro depletion of Reptin with siRNAs led to HCC cell growth arrest and apoptosis. Here, we asked whether in vivo targeting of Reptin in established tumours had a therapeutic effect.
   Methods: We used lentiviral vectors to construct HuH7 and Hep3B cell lines with doxycycline (Dox)-dependent expression of Reptin (R2) or control shRNA (GL2). Cells were injected subcutaneously into immunodeficient mice, and Dox was given when tumours reached a volume of 250 mm(3).
   Results: In vitro, the growth of GL2 - Dox, GL2 + Dox, and R2 - Dox cells was undistinguishable whereas that of R2 + Dox cells stopped 4 days after Dox treatment. The growth decrease was associated with increased apoptosis, and evidence of replicative senescence, as shown by staining for acid p-galactosidase and the presence of senescence-associated heterochromatin foci. In xenografted mice, R2 + Dox tumour growth stagnated or even regressed with prolonged treatment in contrast with the GL2 - Dox, GL2 + Dox, and R2 - Dox tumours that progressed steadily. The blockage of tumour progression was associated with the induction of senescence and reduced cell proliferation.
   Conclusions: In vivo Reptin depletion leads to tumour growth arrest. Reptin may prove a valuable target in HCC. (C) 2010 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
C1 [Menard, Ludovic; Taras, Daniele; Grigoletto, Aude; Haurie, Valerie; Nicou, Alexandra; Rosenbaum, Jean] INSERM, U889, F-75654 Paris 13, France.
   [Menard, Ludovic; Taras, Daniele; Grigoletto, Aude; Haurie, Valerie; Nicou, Alexandra; Dugot-Senant, Nathalie; Rosenbaum, Jean] Univ Bordeaux, Inst Federatif Rech 66, F-33076 Bordeaux, France.
   [Rosenbaum, Jean] CHU Bordeaux, F-33076 Bordeaux, France.
C3 Institut National de la Sante et de la Recherche Medicale (Inserm);
   Universite de Bordeaux; CHU Bordeaux; Universite de Bordeaux
RP Rosenbaum, J (corresponding author), INSERM, U889, F-75654 Paris 13, France.
EM jean.rosenbaum@gref.u-bordeaux2.fr
RI Rosenbaum, Jean/F-5547-2013
OI Rosenbaum, Jean/0000-0001-8585-5152
FU Institut National du Cancer; Association pour la Recherche sur le
   Cancer; Agence Nationale pour la Recherche sur le SIDA et les Hepatites
   Virales; Ligue Nationale Contre le Cancer; Conseil Regional d'Aquitaine
FX J.R. was supported by grants from the Institut National du Cancer,
   Association pour la Recherche sur le Cancer, Agence Nationale pour la
   Recherche sur le SIDA et les Hepatites Virales, Ligue Nationale Contre
   le Cancer, and Conseil Regional d'Aquitaine. V.H. was supported by a
   fellowship from the Agence Nationale pour la Recherche sur le SIDA et
   les Hepatites Virales and A.N. by a fellowship from the Institut
   National du Cancer.
CR Adams PD, 2007, GENE, V397, P84, DOI 10.1016/j.gene.2007.04.020
   Ammelburg M, 2006, J STRUCT BIOL, V156, P2, DOI 10.1016/j.jsb.2006.05.002
   Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101
   Bauer A, 2000, EMBO J, V19, P6121, DOI 10.1093/emboj/19.22.6121
   Bellosta P, 2005, P NATL ACAD SCI USA, V102, P11799, DOI 10.1073/pnas.0408945102
   Blanc JF, 2005, PROTEOMICS, V5, P3778, DOI 10.1002/pmic.200401194
   Chan HM, 2005, GENE DEV, V19, P196, DOI 10.1101/gad.1280205
   Cheng H, 2006, CANCER RES, V66, P10613, DOI 10.1158/0008-5472.CAN-06-0028
   DEUSCHLE U, 1995, MOL CELL BIOL, V15, P1907
   Etard C, 2005, MECH DEVELOP, V122, P545, DOI 10.1016/j.mod.2004.11.010
   Feng Y, 2003, CANCER RES, V63, P8726
   GREINER DL, 1995, AM J PATHOL, V146, P888
   Hannon GJ, 2004, NATURE, V431, P371, DOI 10.1038/nature02870
   Haurie V, 2009, HEPATOLOGY, V50, P1871, DOI 10.1002/hep.23215
   Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9
   Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207
   Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010
   Jin JY, 2005, J BIOL CHEM, V280, P41207, DOI 10.1074/jbc.M509128200
   Jónsson ZO, 2001, J BIOL CHEM, V276, P16279, DOI 10.1074/jbc.M011523200
   Kanemaki M, 1999, J BIOL CHEM, V274, P22437, DOI 10.1074/jbc.274.32.22437
   Ke N, 2006, EXP CELL RES, V312, P2726, DOI 10.1016/j.yexcr.2006.05.001
   Kim JH, 2005, NATURE, V434, P921, DOI 10.1038/nature03452
   Kubicka S, 1997, HEPATOLOGY, V25, P867, DOI 10.1002/hep.510250414
   Li LM, 2005, CANCER RES, V65, P7249, DOI 10.1158/0008-5472.CAN-04-4426
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Matsukura S, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng077
   Matthess Y, 2005, ONCOGENE, V24, P2973, DOI 10.1038/sj.onc.1208472
   Mueller-Klieser W, 2000, CRIT REV ONCOL HEMAT, V36, P123, DOI 10.1016/S1040-8428(00)00082-2
   Neaud V, 2004, J BIOL CHEM, V279, P5200, DOI 10.1074/jbc.M306679200
   Parkin DM, 2001, LANCET ONCOL, V2, P533, DOI 10.1016/S1470-2045(01)00486-7
   PROCHAZKA M, 1992, P NATL ACAD SCI USA, V89, P3290, DOI 10.1073/pnas.89.8.3290
   Rottbauer W, 2002, CELL, V111, P661, DOI 10.1016/S0092-8674(02)01112-1
   Rousseau B, 2007, HEPATOLOGY, V46, P1108, DOI 10.1002/hep.21770
   Salzer U, 1999, BBA-GENE STRUCT EXPR, V1446, P365, DOI 10.1016/S0167-4781(99)00104-9
   Schmeichel KL, 2003, J CELL SCI, V116, P2377, DOI 10.1242/jcs.00503
   Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123
   Taulli R, 2006, CANCER RES, V66, P4742, DOI 10.1158/0008-5472.CAN-05-4292
   Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231
   Venteicher AS, 2008, CELL, V132, P945, DOI 10.1016/j.cell.2008.01.019
   Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101
   Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003
   Wood MA, 2000, MOL CELL, V5, P321, DOI 10.1016/S1097-2765(00)80427-X
NR 42
TC 46
Z9 53
U1 0
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-8278
EI 1600-0641
J9 J HEPATOL
JI J. Hepatol.
PD MAY
PY 2010
VL 52
IS 5
BP 681
EP 689
DI 10.1016/j.jhep.2009.12.029
PG 9
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 606HS
UT WOS:000278414200013
PM 20346530
OA Green Submitted
DA 2024-02-19
ER

PT J
AU Mendes, C
   Lopes, AMD
   do Amaral, FG
   Peliciari-Garcia, RA
   Turati, AD
   Hirabara, SM
   Falcao, JHS
   Cipolla-Neto, J
AF Mendes, Caroline
   de Souza Lopes, Ana Maria
   do Amaral, Fernanda Gaspar
   Peliciari-Garcia, Rodrigo A.
   Turati, Ariane de Oliveira
   Hirabara, Sandro M.
   Scialfa Falcao, Julieta H.
   Cipolla-Neto, Jose
TI Adaptations of the aging animal to exercise: role of daily
   supplementation with melatonin
SO JOURNAL OF PINEAL RESEARCH
LA English
DT Article
DE aging; exercise; melatonin; metabolic adaptations; pineal gland
ID INSULIN-RECEPTOR SUBSTRATE-1; ADIPOSE-TISSUE ADAPTABILITY; ACTIVATED
   PROTEIN-KINASE; MITOCHONDRIAL BIOGENESIS; GLUCOSE-TRANSPORT; OXIDATIVE
   DAMAGE; GLYCOGEN-CONTENT; GENE-EXPRESSION; GLUT4 GENE; MUSCLE
AB The pineal gland, through melatonin, seems to be of fundamental importance in determining the metabolic adaptations of adipose and muscle tissues to physical training. Evidence shows that pinealectomized animals fail to develop adaptive metabolic changes in response to aerobic exercise and therefore do not exhibit the same performance as control-trained animals. The known prominent reduction in melatonin synthesis in aging animals led us to investigate the metabolic adaptations to physical training in aged animals with and without daily melatonin replacement. Male Wistar rats were assigned to four groups: sedentary control (SC), trained control (TC), sedentary treated with melatonin (SM), and trained treated with melatonin (TM). Melatonin supplementation lasted 16wk, and the animals were subjected to exercise during the last 8wk of the experiment. After euthanasia, samples of liver, muscle, and adipose tissues were collected for analysis. Trained animals treated with melatonin presented better results in the following parameters: glucose tolerance, physical capacity, citrate synthase activity, hepatic and muscular glycogen content, body weight, protein expression of phosphatidylinositol 3-kinase (PI3K), mitogen-activated protein kinase (MAPK), and protein kinase activated by adenosine monophosphate (AMPK) in the liver, as well as the protein expression of the glucose transporter type 4 (GLUT4) and AMPK in the muscle. In conclusion, these results demonstrate that melatonin supplementation in aging animals is of great importance for the required metabolic adaptations induced by aerobic exercise. Adequate levels of circulating melatonin are, therefore, necessary to improve energetic metabolism efficiency, reducing body weight and increasing insulin sensitivity.
C1 [Mendes, Caroline; de Souza Lopes, Ana Maria; do Amaral, Fernanda Gaspar; Peliciari-Garcia, Rodrigo A.; Turati, Ariane de Oliveira; Scialfa Falcao, Julieta H.; Cipolla-Neto, Jose] Univ Sao Paulo, Inst Biomed Sci 1, Dept Physiol & Biophys, BR-05508000 Sao Paulo, Brazil.
   [Hirabara, Sandro M.] Univ Cruzeiro Sul, Inst Phys Act Sci & Sports, Program Postgrad Human Movement Sci, Sao Paulo, Brazil.
C3 Universidade de Sao Paulo; Universidade Cruzeiro do Sul
RP Cipolla-Neto, J (corresponding author), Univ Sao Paulo, Inst Biomed Sci 1, Dept Physiol & Biophys, Av Prof Lineu Prestes 1524,1st Floor,Room 118,Cid, BR-05508000 Sao Paulo, Brazil.
EM cipolla@icb.usp.br
RI Cipolla-Neto, Jose/B-1619-2009; Peliciari-Garcia, Rodrigo
   Antonio/Y-7533-2019; Amaral, Fernanda/O-3071-2019; Peliciari-Garcia,
   Rodrigo Antonio/K-7803-2012; Hirabara, Sandro Massao/C-4014-2012
OI Cipolla-Neto, Jose/0000-0003-3748-3731; Peliciari-Garcia, Rodrigo
   Antonio/0000-0003-1752-1593; Amaral, Fernanda/0000-0003-4492-4822;
   Peliciari-Garcia, Rodrigo Antonio/0000-0003-1752-1593; Hirabara, Sandro
   Massao/0000-0002-7392-0444; Mendes, Caroline/0000-0002-2625-5744
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [09/52920-0]; Conselho Nacional de Pesquisa (CNPq); Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [09/52920-0] Funding Source:
   FAPESP
FX This work was supported by grants from Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) grant 09/52920-0 and Conselho Nacional de
   Pesquisa (CNPq).
CR Acuña-Castroviejo D, 2001, J PINEAL RES, V30, P65, DOI 10.1034/j.1600-079X.2001.300201.x
   Agil A, 2011, J PINEAL RES, V50, P207, DOI 10.1111/j.1600-079X.2010.00830.x
   ALESSIO HM, 1988, J APPL PHYSIOL, V64, P1333, DOI 10.1152/jappl.1988.64.4.1333
   Alonso-Vale MIC, 2004, HORM METAB RES, V36, P474, DOI 10.1055/s-2004-825723
   Alonso-Vale MIC, 2004, METABOLISM, V53, P500, DOI 10.1016/j.metabol.2003.11.009
   ALP PR, 1976, BIOCHEM J, V154, P689, DOI 10.1042/bj1540689
   Anhê GF, 2004, J NEUROCHEM, V90, P559, DOI 10.1111/j.1471-4159.2004.02514.x
   ARMSTRONG SM, 1989, EXPERIENTIA, V45, P932, DOI 10.1007/BF01953050
   Bassett DR, 1997, MED SCI SPORT EXER, V29, P591, DOI 10.1097/00005768-199705000-00002
   BenEzra V, 1995, J APPL PHYSIOL, V79, P2029, DOI 10.1152/jappl.1995.79.6.2029
   BERGSTROM J, 1967, ACTA PHYSIOL SCAND, V71, P140, DOI 10.1111/j.1748-1716.1967.tb03720.x
   Borges-Silva CN, 2005, J PINEAL RES, V38, P278, DOI 10.1111/j.1600-079X.2004.00203.x
   Borges-Silva CD, 2007, J PINEAL RES, V43, P96, DOI 10.1111/j.1600-079X.2007.00450.x
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   BRAUN B, 1995, J APPL PHYSIOL, V78, P300, DOI 10.1152/jappl.1995.78.1.300
   BROOKS GA, 1986, MED SCI SPORT EXER, V18, P360, DOI 10.1249/00005768-198606000-00019
   BROOKS GA, 1978, J APPL PHYSIOL, V45, P1009, DOI 10.1152/jappl.1978.45.6.1009
   Buxton OM, 1997, J BIOL RHYTHM, V12, P568, DOI 10.1177/074873049701200611
   Campos LA, 2013, INT J HYPERTENS, V2013, DOI 10.1155/2013/521783
   Alonso-Vale MIC, 2008, J PINEAL RES, V45, P422, DOI 10.1111/j.1600-079X.2008.00610.x
   Alonso-Vale MIC, 2009, J PINEAL RES, V47, P221, DOI 10.1111/j.1600-079X.2009.00705.x
   Carvalho CRO, 1996, ENDOCRINOLOGY, V137, P151, DOI 10.1210/en.137.1.151
   Dufloth DL, 1997, AM J PHYSIOL-REG I, V273, pR1271, DOI 10.1152/ajpregu.1997.273.4.R1271
   ERLICH SS, 1985, J NEUROSURG, V63, P321, DOI [DOI 10.3171/JNS.1985.63.3.0321, 10.3171/jns.1985.63.3.0321]
   Escames G, 2012, J PINEAL RES, V52, P1, DOI 10.1111/j.1600-079X.2011.00924.x
   Evans WJ, 1997, J AM DIET ASSOC, V97, P632, DOI 10.1016/S0002-8223(97)00160-0
   Ferreira DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038795
   FRASCHINI F, 1990, ACTA ONCOL, V29, P775, DOI 10.3109/02841869009092998
   García-Macia M, 2011, J PINEAL RES, V50, P54, DOI 10.1111/j.1600-079X.2010.00809.x
   Ghosh G, 2007, J PINEAL RES, V42, P71, DOI 10.1111/j.1600-079X.2006.00386.x
   Goldman BD, 2001, J BIOL RHYTHM, V16, P283, DOI 10.1177/074873001129001980
   HAGERMAN FC, 1992, MED SCI SPORT EXER, V24, pS309
   Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x
   Huang C, 2005, J BIOL CHEM, V280, P19426, DOI 10.1074/jbc.M412317200
   Kaya O, 2006, NEUROENDOCRINOL LETT, V27, P263
   Korkmaz A, 2012, MOL CELL ENDOCRINOL, V349, P128, DOI 10.1016/j.mce.2011.10.013
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LEVEILLE GA, 1967, J NUTR, V93, P546, DOI 10.1093/jn/93.4.546
   Lima FB, 1998, AM J PHYSIOL-ENDOC M, V275, pE934
   López-Lluch G, 2006, P NATL ACAD SCI USA, V103, P1768, DOI 10.1073/pnas.0510452103
   Mazepa RC, 1999, LIFE SCI, V66, P153
   Musi N, 2001, AM J PHYSIOL-ENDOC M, V280, pE677, DOI 10.1152/ajpendo.2001.280.5.E677
   Nduhirabandi F, 2011, J PINEAL RES, V50, P171, DOI 10.1111/j.1600-079X.2010.00826.x
   NEGRAO CE, 1992, J APPL PHYSIOL, V72, P1749, DOI 10.1152/jappl.1992.72.5.1749
   NISHIMURA H, 1988, AM J PHYSIOL, V254, pE92, DOI 10.1152/ajpendo.1988.254.1.E92
   Nogueira TC, 2011, ENDOCRINOLOGY, V152, P1253, DOI 10.1210/en.2010-1088
   Ochoa JJ, 2011, J PINEAL RES, V51, P373, DOI 10.1111/j.1600-079X.2011.00899.x
   PANG SF, 1990, J PINEAL RES, V8, P179, DOI 10.1111/j.1600-079X.1990.tb00678.x
   Picinato MC, 2002, J PINEAL RES, V33, P172, DOI 10.1034/j.1600-079X.2002.02925.x
   Popovich IG, 2005, INT J BIOCHEM CELL B, V37, P1117, DOI 10.1016/j.biocel.2004.08.002
   Radák Z, 1999, FREE RADICAL BIO MED, V27, P69, DOI 10.1016/S0891-5849(99)00038-6
   Rasmussen DD, 2003, J PINEAL RES, V34, P127, DOI 10.1034/j.1600-079X.2003.00019.x
   Rasmussen DD, 1999, ENDOCRINOLOGY, V140, P1009, DOI 10.1210/en.140.2.1009
   REITER RJ, 1981, ENDOCRINOLOGY, V109, P1295, DOI 10.1210/endo-109-4-1295
   Reiter RJ, 2004, POL J PHARMACOL, V56, P159
   Reiter RJ, 2013, MINI-REV MED CHEM, V13, P373
   Reiter RJ, 2010, ANN MED, V42, P276, DOI 10.3109/07853890903485748
   Reynolds TH, 1997, AM J PHYSIOL-ENDOC M, V272, pE320, DOI 10.1152/ajpendo.1997.272.2.E320
   Richter EA, 1998, AM J PHYSIOL-ENDOC M, V274, pE89, DOI 10.1152/ajpendo.1998.274.1.E89
   Sánchez-Campos S, 2001, J PINEAL RES, V31, P159, DOI 10.1034/j.1600-079x.2001.310210.x
   Sanchez-Hidalgo M, 2009, EXP GERONTOL, V44, P328, DOI 10.1016/j.exger.2009.02.002
   Seraphim PM, 1997, PINEAL UPDATE, P99
   Simoes HG, 1999, EUR J APPL PHYSIOL O, V80, P34, DOI 10.1007/s004210050555
   Smith SC, 2007, AM J MED, V120, pS3, DOI 10.1016/j.amjmed.2007.01.002
   STALLKNECHT B, 1991, AM J PHYSIOL, V261, pE410, DOI 10.1152/ajpendo.1991.261.3.E410
   Tan DX, 2011, OBES REV, V12, P167, DOI 10.1111/j.1467-789X.2010.00756.x
   Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801
   Watve MG, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-61
   Winder WW, 2007, CELL BIOCHEM BIOPHYS, V47, P332, DOI 10.1007/s12013-007-0008-7
   Yin W, 2008, STROKE, V39, P3057, DOI 10.1161/STROKEAHA.108.520114
   Zanquetta MM, 2003, J PINEAL RES, V35, P141, DOI 10.1034/j.1600-079X.2003.00067.x
   Zanuto R, 2013, J PINEAL RES, V55, P156, DOI 10.1111/jpi.12056
NR 72
TC 36
Z9 37
U1 1
U2 22
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3098
EI 1600-079X
J9 J PINEAL RES
JI J. Pineal Res.
PD OCT
PY 2013
VL 55
IS 3
BP 229
EP 239
DI 10.1111/jpi.12065
PG 11
WC Endocrinology & Metabolism; Neurosciences; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Neurosciences & Neurology; Physiology
GA 213BE
UT WOS:000324027100003
PM 23711171
DA 2024-02-19
ER

PT J
AU Xu, XS
   Chen, W
   Miao, RC
   Zhou, YY
   Wang, ZX
   Zhang, LQ
   Wan, Y
   Dong, YF
   Qu, K
   Liu, C
AF Xu, Xinsen
   Chen, Wei
   Miao, Runchen
   Zhou, Yanyan
   Wang, Zhixin
   Zhang, Lingqiang
   Wan, Yong
   Dong, Yafeng
   Qu, Kai
   Liu, Chang
TI miR-34a induces cellular senescence via modulation of telomerase
   activity in human hepatocellular carcinoma by targeting FoxM1/c-Myc
   pathway
SO ONCOTARGET
LA English
DT Article
DE miR-34a; HCC; senescence; telomerase; telomere
ID TUMOR-SUPPRESSOR; DOWN-REGULATION; C-MYC; CATALYTIC SUBUNIT;
   GASTRIC-CANCER; LIVER; ACTIVATION; MICRORNAS; GROWTH; CELLS
AB Increasing evidence suggests that miRNAs can act as either tumor suppressors or oncogenes in carcinogenesis. In the present study, we identified the role of miR-34a in regulating telomerase activity, with subsequent effect on cellular senescence and viability. We found the higher expression of miR-34a was significantly correlated with the advanced clinicopathologic parameters in hepatocellular carcinoma. Furthermore, tumor tissues of 75 HCC patients demonstrated an inverse correlation between the miR-34a level and telomere indices (telomere length and telomerase activity). Transient introduction of miR-34a into HCC cell lines inhibited the telomerase activity and telomere length, which induced senescence-like phenotypes and affected cellular viability. We discovered that miR-34a potently targeted c-Myc and FoxM1, both of which were involved in the activation of telomerase reverse transcriptase (hTERT) transcription, essential for the sustaining activity of telomerase to avoid senescence. Taken together, our results demonstrate that miR-34a functions as a potent tumor suppressor through the modulation of telomere pathway in cellular senescence.
C1 [Xu, Xinsen; Chen, Wei; Miao, Runchen; Zhou, Yanyan; Wang, Zhixin; Zhang, Lingqiang; Wan, Yong; Qu, Kai; Liu, Chang] Xi An Jiao Tong Univ, Dept Hepatobiliary Surg, Affiliated Hosp 1, Xian 710061, Peoples R China.
   [Dong, Yafeng] Univ Kansas, Dept Obstet & Gynecol, Sch Med, Kansas City, KS 66160 USA.
C3 Xi'an Jiaotong University; University of Kansas; University of Kansas
   Medical Center
RP Liu, C (corresponding author), Xi An Jiao Tong Univ, Dept Hepatobiliary Surg, Affiliated Hosp 1, Xian 710061, Peoples R China.
EM joanne8601@163.com; liuchangdoctor@163.com
RI Liu, Chang/ISV-3950-2023; liu, chang/HCI-5413-2022; Liu,
   Chang/HOC-0971-2023; Xu, Xinsen/ABF-2110-2021; wang,
   zhixin/GZH-2500-2022; LI, XIAO/JCE-6169-2023
FU National Natural Science Foundation of China [81201549, 81272644,
   81402022, 81472247]; Project of Innovative Research Team for Key Science
   and Technology in Xi'an Jiaotong University [2003KCJ-23]
FX This research was supported by the National Natural Science Foundation
   of China (Grant No. 81201549, 81272644, 81402022 and 81472247) and
   Project of Innovative Research Team for Key Science and Technology in
   Xi'an Jiaotong University (Grant No. 2003KCJ-23).
CR [Anonymous], 2010, P AM THOR SOC INT 20, DOI DOI 10.1164/AJRCCM-CONFERENCE.2010.181.1_MEETINGABSTRACTS.A2297
   Bai XY, 2011, J AM SOC NEPHROL, V22, P1252, DOI 10.1681/ASN.2010040367
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Blanco-Bose WE, 2008, HEPATOLOGY, V48, P1302, DOI 10.1002/hep.22475
   Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068
   Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997
   Chen F, 2012, J BIOCHEM MOL TOXIC, V26, P79, DOI 10.1002/jbt.20412
   Chen L, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.553
   Christoffersen NR, 2010, CELL DEATH DIFFER, V17, P236, DOI 10.1038/cdd.2009.109
   Cole KA, 2008, MOL CANCER RES, V6, P735, DOI 10.1158/1541-7786.MCR-07-2102
   Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003
   Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634
   Daniel M, 2012, GENE, V498, P135, DOI 10.1016/j.gene.2012.01.095
   Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003
   He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939
   Jin K, 2014, TUMOR BIOL, V35, P1503, DOI 10.1007/s13277-013-1207-z
   Kumamoto K, 2008, CANCER RES, V68, P3193, DOI 10.1158/0008-5472.CAN-07-2780
   Lechel A, 2007, GASTROENTEROLOGY, V132, P1465, DOI 10.1053/j.gastro.2007.01.045
   Li N, 2009, CANCER LETT, V275, P44, DOI 10.1016/j.canlet.2008.09.035
   Maluccio M, 2012, CA-CANCER J CLIN, V62, P394, DOI 10.3322/caac.21161
   Ménard L, 2010, J HEPATOL, V52, P681, DOI 10.1016/j.jhep.2009.12.029
   Mitomo S, 2008, CANCER SCI, V99, P280, DOI 10.1111/j.1349-7006.2007.00666.x
   Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955
   Nakayama JI, 1998, NAT GENET, V18, P65, DOI 10.1038/ng0198-65
   Ozturk M, 2009, CANCER LETT, V286, P103, DOI 10.1016/j.canlet.2008.10.048
   Qu K, 2014, FRONT MED-PRC, V8, P227, DOI 10.1007/s11684-014-0327-1
   Qu K, 2013, CANCER LETT, V331, P105, DOI 10.1016/j.canlet.2012.12.008
   Senturk S, 2010, HEPATOLOGY, V52, P966, DOI 10.1002/hep.23769
   Sharpless NE, 2004, J CLIN INVEST, V113, P160, DOI 10.1172/JCI200420761
   Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208
   Sukata T, 2011, TOXICOL LETT, V200, P46, DOI 10.1016/j.toxlet.2010.10.013
   Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104
   te Poele RH, 2002, CANCER RES, V62, P1876
   Tryndyak VP, 2009, MOL CARCINOGEN, V48, P479, DOI 10.1002/mc.20484
   Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   Wierstra I, 2006, FEBS J, V273, P4645, DOI 10.1111/j.1742-4658.2006.05468.x
   Williams SCP, 2013, NAT MED, V19, P6, DOI 10.1038/nm0113-6
   Wu KJ, 1999, NAT GENET, V21, P220, DOI 10.1038/6010
   Zeng JP, 2009, J PATHOL, V218, P419, DOI 10.1002/path.2530
   Zhang Y, 2013, CANCER RES, V73, P5996, DOI 10.1158/0008-5472.CAN-13-0881
NR 41
TC 81
Z9 92
U1 1
U2 7
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
EI 1949-2553
J9 ONCOTARGET
JI Oncotarget
PD FEB 28
PY 2015
VL 6
IS 6
BP 3988
EP 4004
DI 10.18632/oncotarget.2905
PG 17
WC Oncology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Cell Biology
GA CF6WB
UT WOS:000352696200043
PM 25686834
OA Green Submitted, Green Published, gold
DA 2024-02-19
ER

PT J
AU AMES, BN
   SHIGENAGA, MK
   HAGEN, TM
AF AMES, BN
   SHIGENAGA, MK
   HAGEN, TM
TI MITOCHONDRIAL DECAY IN AGING
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
LA English
DT Article; Proceedings Paper
CT Nobel Symposium 90: Mitochondrial Diseases
CY JUL 02-06, 1994
CL SALTSJOBADEN, SWEDEN
SP Nobel Fdn
DE MITOCHONDRIAL FUNCTION; PROTON LEAKAGE; CARDIOLIPIN; AGING
ID CYTOCHROME-C-OXIDASE; OXIDATIVE DAMAGE; HUMAN BRAIN; DEGENERATIVE
   DISEASES; LIVER-MITOCHONDRIA; DNA DELETION; AGE; RAT; MUTATIONS;
   INCREASES
AB Several mitochondrial functions decline with age. The contributing factors include, the intrinsic rate of proton leakage across the inner mitochondrial membrane (a correlate of oxidant formation), decreased membrane fluidity, and decreased levels and function of cardiolipin, which supports the function of many of the proteins of the inner mitochondrial membrane. Oxidants generated by mitochondria appear to be the major source of the oxidative lesions that accumulate with age. Evidence supports the suggestion that age-associated accumulation of mitochondrial deficits due to oxidative damage is likely to be a major contributor to cellular, tissue, and organismal aging.
RP AMES, BN (corresponding author), UNIV CALIF BERKELEY, DIV BIOCHEM & MOLEC BIOL, BARKER HALL, BERKELEY, CA 94720 USA.
FU NCI NIH HHS [CA39910] Funding Source: Medline; NIEHS NIH HHS [ESO1896]
   Funding Source: Medline
CR ADACHI K, 1993, BIOCHEM BIOPH RES CO, V195, P945, DOI 10.1006/bbrc.1993.2135
   AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   ARNHEIM N, 1992, MUTAT RES, V275, P157, DOI 10.1016/0921-8734(92)90020-P
   ASANO K, 1991, MECH AGEING DEV, V60, P275, DOI 10.1016/0047-6374(91)90040-7
   BANDY B, 1990, FREE RADICAL BIO MED, V8, P523, DOI 10.1016/0891-5849(90)90152-9
   BOFFOLI D, 1994, BBA-MOL BASIS DIS, V1226, P73, DOI 10.1016/0925-4439(94)90061-2
   BOWLING AC, 1993, J NEUROCHEM, V60, P1964, DOI 10.1111/j.1471-4159.1993.tb13430.x
   BRUSTOVETSKY NN, 1989, COMP BIOCHEM PHYS B, V94, P537, DOI 10.1016/0305-0491(89)90193-4
   BULPITT KJ, 1984, BRAIN RES, V300, P41, DOI 10.1016/0006-8993(84)91339-8
   BYRNE E, 1992, MUTAT RES, V275, P125, DOI 10.1016/0921-8734(92)90017-J
   CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   DIMONTE DA, 1993, NEURODEGENERATION, V2, P93
   FERNANDEZSILVA P, 1991, BIOCHEM BIOPH RES CO, V176, P645, DOI 10.1016/S0006-291X(05)80233-5
   FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533
   FREI B, 1990, P NATL ACAD SCI USA, V87, P4879, DOI 10.1073/pnas.87.12.4879
   GADALETA MN, 1992, MUTAT RES, V275, P181, DOI 10.1016/0921-8734(92)90022-H
   HANSFORD RG, 1983, BIOCHIM BIOPHYS ACTA, V726, P41, DOI 10.1016/0304-4173(83)90010-1
   HATCH GM, 1993, BIOCHEM J, V293, P143, DOI 10.1042/bj2930143
   HAYAKAWA M, 1991, BIOCHEM BIOPH RES CO, V179, P1023, DOI 10.1016/0006-291X(91)91921-X
   HOCH FL, 1988, PROG LIPID RES, V27, P199, DOI 10.1016/0163-7827(88)90013-6
   HOCH FL, 1992, BIOCHIM BIOPHYS ACTA, V1113, P71, DOI 10.1016/0304-4157(92)90035-9
   HUBER LA, 1991, EUR J IMMUNOL, V21, P2761, DOI 10.1002/eji.1830211117
   KIRKWOOD TBL, 1989, MUTAT RES, V219, P1, DOI 10.1016/0921-8734(89)90035-0
   KU HH, 1993, FREE RADICAL BIO MED, V15, P621, DOI 10.1016/0891-5849(93)90165-Q
   LAGANIERE S, 1993, GERONTOLOGY, V39, P7, DOI 10.1159/000213509
   LINNANE AW, 1992, MUTAT RES, V275, P195, DOI 10.1016/0921-8734(92)90023-I
   LINNANE AW, 1990, BIOCHEM INT, V22, P1067
   MALIS CD, 1990, P NATL ACAD SCI USA, V87, P8845, DOI 10.1073/pnas.87.22.8845
   MARNETT LJ, 1985, MUTAT RES, V148, P25
   MECOCCI P, 1993, ANN NEUROL, V34, P609, DOI 10.1002/ana.410340416
   MULLERHOCKER J, 1992, MUTAT RES, V275, P115, DOI 10.1016/0921-8734(92)90016-I
   MULLERHOCKER J, 1990, J NEUROL SCI, V100, P14, DOI 10.1016/0022-510X(90)90006-9
   MUNSCHER C, 1993, BIOL CHEM H-S, V374, P1099, DOI 10.1515/bchm3.1993.374.7-12.1099
   MUNSCHER C, 1993, FEBS LETT, V317, P27, DOI 10.1016/0014-5793(93)81484-H
   NOHL H, 1978, EUR J BIOCHEM, V82, P563, DOI 10.1111/j.1432-1033.1978.tb12051.x
   PAPPU AS, 1978, BIOCHEM J, V172, P349, DOI 10.1042/bj1720349
   PIKO L, 1988, MECH AGEING DEV, V43, P279, DOI 10.1016/0047-6374(88)90037-1
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   RICHTER C, 1995, IN PRESS DAHLEM K 74
   SATO T, 1982, MECH AGEING DEV, V20, P111, DOI 10.1016/0047-6374(82)90063-X
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   Sies H., 1991, OXIDATIVE STRESS OXI
   SOHAL RS, 1990, MECH AGEING DEV, V53, P217, DOI 10.1016/0047-6374(90)90040-M
   SOHAL RS, 1991, MECH AGEING DEV, V57, P187, DOI 10.1016/0047-6374(91)90034-W
   SOHAL RS, 1994, FREE RADICAL BIO MED, V16, P621, DOI 10.1016/0891-5849(94)90062-0
   SOHAL RS, 1992, MUTAT RES, V275, P295, DOI 10.1016/0921-8734(92)90033-L
   SOHAL RS, 1989, MECH AGEING DEV, V49, P129, DOI 10.1016/0047-6374(89)90096-1
   SOONG NW, 1992, NAT GENET, V2, P318
   Spoerri P E, 1984, Monogr Dev Biol, V17, P210
   STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616
   TAKAMURA T, 1987, ARZNEIMITTEL-FORSCH, V37-1, P153
   TORII K, 1992, AM J RESP CELL MOL, V6, P88, DOI 10.1165/ajrcmb/6.1.88
   TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0
   VANDENBERG JJM, 1993, BIOCHEMISTRY-US, V32, P4962, DOI 10.1021/bi00069a035
   VONZGLINICKI T, 1991, MECH AGEING DEV, V58, P49, DOI 10.1016/0047-6374(91)90119-K
   VONZGLINICKI T, 1987, J MICROSC, P77
   WALLACE DC, 1987, CURR GENET, V12, P81, DOI 10.1007/BF00434661
   WALLACE DC, 1995, DAHLEM K 74 MOL ASPE
   Wilson P D, 1975, Adv Exp Med Biol, V53, P171
   YEN TC, 1989, BIOCHEM BIOPH RES CO, V165, P994, DOI 10.1016/0006-291X(89)92701-0
   YEO HC, 1994, ANAL BIOCHEM, V220, P391, DOI 10.1006/abio.1994.1355
   YU BP, 1992, MECH AGEING DEV, V65, P17, DOI 10.1016/0047-6374(92)90123-U
NR 64
TC 311
Z9 353
U1 2
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0925-4439
EI 0006-3002
J9 BBA-MOL BASIS DIS
JI Biochim. Biophys. Acta-Mol. Basis Dis.
PD MAY 24
PY 1995
VL 1271
IS 1
BP 165
EP 170
DI 10.1016/0925-4439(95)00024-X
PG 6
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA RD691
UT WOS:A1995RD69100024
PM 7599204
OA hybrid
DA 2024-02-19
ER

PT J
AU Ando, M
   Katagiri, K
   Yamamoto, S
   Wakamatsu, K
   Kawahara, I
   Asanuma, S
   Usuda, M
   Sasaki, K
AF Ando, M
   Katagiri, K
   Yamamoto, S
   Wakamatsu, K
   Kawahara, I
   Asanuma, S
   Usuda, M
   Sasaki, K
TI Age-related effects of heat stress on protective enzymes for peroxides
   and microsomal monooxygenase in rat liver
SO ENVIRONMENTAL HEALTH PERSPECTIVES
LA English
DT Article
DE aging; catalase; cytochrome P450; electron transport; glutathione
   peroxidase; heat stress; hyperthermia; lipid peroxidation;
   monooxygenase; oxygen radicals
ID GLUTATHIONE-PEROXIDASE; MITOCHONDRIA; PURIFICATION; DAMAGE; ACID;
   CYTOCHROME-P-450; HYPERTHERMIA; REDUCTASE; PROTEINS; TISSUE
AB To evaluate the age-related response of essential cell functions against peroxidative damage in hyperthermia, we studied the biochemical response to heat stress in both young and aged rats. Passive hyperthermia was immediately observed in rats after exposure to hot environments. In aged rats, the rectal temperature maintained thermal homeostasis and increased to the same degree as in young rats. In these aged animals, the damage from heat stress was more serious : than in young animals. In aged rats under normal environmental conditions, hepatic cytosolic glutathione peroxidase (GSH peroxidase) activities were markedly higher than those activities in younger rats. Hepatic cytosolic GSH peroxidase activities were induced by heat stress in young rats but were decreased by hot environments in aged rats. Hepatic catalase activities in young rats were not affected by hot environments, whereas in aged rats, hepatic catalase activities were seriously decreased. Catalase activities in the kidney of aged rats were also reduced by hot environments. Lipid peroxidation in the liver was markedly induced in both young and aged rats. Because the protective enzymes for oxygen radicals in aged rats were decreased by hot environments, lipid peroxidation in the liver was highly induced. In aged rats, lipid peroxidation in intracellular structures such as mitochondria and microsomes was also markedly induced by hot environments. In both young and aged rats, hyperthermia greatly increased the development of hypertrophy and vacuolated degeneration in hepatic cells. In aged rats, both mitochondria and endoplasmic reticulum of the hepatic cells showed serious distortion in shape as a result of exposures to hot environments. Microsoma electron transport systems, such as cytochrome P450 monooxygenase activities, were seriously decreased by heat stress in aged rats but not in young rats. Although the mitochondrial electron transport systems were not affected by acute heat stress in young rats, their activities were simultaneously inhibited after long-lasting heat exposure. In isolated hepatic cells and polymorphonuclear leukocytes in animals, the 70-kDa heat shock-induced proteins were markedly increased by heat stress. In conclusion, the heat stress-inducible oxygen radical damage becomes more severe according to the age of rats. Because aging and hyperthermia have a synergistic effect on lipid peroxidation, protective enzyme activities for oxygen radicals may be essential for surviving and recovering from thermal injury in aged animals and also in humans.
C1 FUKUOKA WOMENS UNIV, DEPT BIOL, FUKUOKA, JAPAN.
   MATSUMOTO DENT COLL, DEPT BIOL, SHIOJIRI, NAGANO, JAPAN.
   JAPAN INST RURAL MED, USUDA, NAGANO, JAPAN.
C3 Matsumoto Dental University
RP Ando, M (corresponding author), NATL INST ENVIRONM STUDIES, DIV REG ENVIRONM, TSUKUBA, IBARAKI 305, JAPAN.
CR AEBI H, 1984, METHOD ENZYMOL, V105, P121
   ANDO M, 1985, CHEM-BIOL INTERACT, V55, P317, DOI 10.1016/S0009-2797(85)80138-1
   ANDO M, 1985, TOXICOL APPL PHARM, V81, P517, DOI 10.1016/0041-008X(85)90422-3
   ANDO M, 1994, J THERM BIOL, V19, P177, DOI 10.1016/0306-4565(94)90029-9
   ASAKI Y, 1985, JPN J BIOMETEOR, V22, P43
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   BURDON RH, 1986, BIOCHEM J, V240, P313, DOI 10.1042/bj2400313
   Burk R.F, 1978, FUNCTIONS GLUTATHION, P114
   Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P577
   Centers for Disease Control and Prevention (CDC), 1994, MMWR Morb Mortal Wkly Rep, V43, P453
   DENIS M, 1989, CANCER RES, V49, pS2275
   Estabrook R W, 1978, Methods Enzymol, V52, P212
   FLOYD RA, 1993, OXYGEN FREE RADICALS, P93
   FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533
   FREEMAN ML, 1985, CANCER RES, V46, P1984
   GAUBATZ JW, 1993, MUTAT RES, V295, P81, DOI 10.1016/0921-8734(93)90004-M
   HABIG WH, 1974, J BIOL CHEM, V249, P7130
   Hales JRS., 1996, Handbook of Physiology, P279
   HALES JRS, 1987, HEAT STRESS PHYSICAL
   Halliwell B., 2007, FREE RADICAL BIO MED, DOI [10.1016/0748-5514(85)90140-0, DOI 10.1016/0748-5514(85)90140-0]
   HRUSZKEWYCZ AM, 1978, TOXICOL APPL PHARM, V46, P695, DOI 10.1016/0041-008X(78)90314-9
   IMAI M, 1989, P NATL ACAD SCI USA, V86, P7823, DOI 10.1073/pnas.86.20.7823
   KEATINGE WR, 1986, AM J MED, V81, P795, DOI 10.1016/0002-9343(86)90348-7
   KENNEDY CH, 1992, FREE RADICAL BIO MED, V12, P381, DOI 10.1016/0891-5849(92)90087-W
   KHOGALI M, 1987, HEAT STRESS PHYSICAL, P21
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LAWRENCE RA, 1978, J NUTR, V108, P211, DOI 10.1093/jn/108.2.211
   LAWRENCE RA, 1976, BIOCHEM BIOPH RES CO, V71, P952, DOI 10.1016/0006-291X(76)90747-6
   LOVEN DP, 1985, CANCER RES, V45, P3029
   MARMOR M, 1978, ENVIRON RES, V17, P102, DOI 10.1016/0013-9351(78)90065-8
   McMichael A.J., 1996, Climate Change and Human Health
   MILLER DM, 1993, ARCH BIOCHEM BIOPHYS, V301, P1, DOI 10.1006/abbi.1993.1107
   Morimoto RI., 1990, Stress proteins in biology and medicine
   NEUBURGER M, 1982, ARCH BIOCHEM BIOPHYS, V217, P312, DOI 10.1016/0003-9861(82)90507-0
   O'Brien P J, 1978, Methods Enzymol, V52, P407
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   OMURA T, 1964, J BIOL CHEM, V239, P2370
   OMURA T, 1970, J BIOCHEM-TOKYO, V67, P249, DOI 10.1093/oxfordjournals.jbchem.a129248
   Omura T., 1993, Cytochrome P-450, V2nd ed.
   ORRENIUS S, 1965, J CELL BIOL, V26, P713, DOI 10.1083/jcb.26.3.713
   OSTERMANN J, 1989, NATURE, V341, P125, DOI 10.1038/341125a0
   PAGLIA DE, 1967, J LAB CLIN MED, V70, P158
   PONTI V, 1978, CHEM-BIOL INTERACT, V23, P281, DOI 10.1016/0009-2797(78)90090-X
   PRATT WB, 1989, CANCER RES, V49, pS2222
   PRIVALLE CT, 1987, P NATL ACAD SCI USA, V84, P2723, DOI 10.1073/pnas.84.9.2723
   PRYOR WA, 1992, FREE RADICAL BIO MED, V12, P365, DOI 10.1016/0891-5849(92)90085-U
   SADIS S, 1990, BIOCHEMISTRY-US, V29, P8199, DOI 10.1021/bi00488a001
   Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5
   SNEDECOR G W, 1980
   STEPHEN J, 1982, JAMA-J AM MED ASSOC, V247, P3327
   TAKESUE S, 1970, J BIOCHEM-TOKYO, V67, P267, DOI 10.1093/oxfordjournals.jbchem.a129250
   Tamura K., 1995, JPN J BIOMETEOR, V32, P111, DOI DOI 10.11227/SEIKISHO1966.32.111
   Tarr M., 1993, OXYGEN FREE RADICALS, V1st
   TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5
   TYDER P, 1995, J THERM BIOL, V20, P1
   Welch, 1990, STRESS PROTEINS BIOL, P223
   Werringloer J, 1978, Methods Enzymol, V52, P297
   ZHANG J, 1990, JPN J BIOMETER, V27, P77
NR 58
TC 44
Z9 50
U1 1
U2 8
PU US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE
PI RES TRIANGLE PK
PA NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA
SN 0091-6765
EI 1552-9924
J9 ENVIRON HEALTH PERSP
JI Environ. Health Perspect.
PD JUL
PY 1997
VL 105
IS 7
BP 726
EP 733
DI 10.2307/3433728
PG 8
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Toxicology
GA XV547
UT WOS:A1997XV54700019
PM 9294719
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Ikeyama, S
   Wang, XT
   Li, J
   Podlutsky, A
   Martindale, JL
   Kokkonen, G
   van Huizen, R
   Gorospe, M
   Holbrook, NJ
AF Ikeyama, S
   Wang, XT
   Li, J
   Podlutsky, A
   Martindale, JL
   Kokkonen, G
   van Huizen, R
   Gorospe, M
   Holbrook, NJ
TI Expression of the pro-apoptotic gene <i>gadd153</i>/<i>chop</i> is
   elevated in liver with aging and sensitizes cells to oxidant injury
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID ACTIVATED PROTEIN-KINASE; EXTENDED LIFE-SPAN; OXIDATIVE STRESS;
   CAENORHABDITIS-ELEGANS; ENDOPLASMIC-RETICULUM; CALORIC RESTRICTION;
   SIGNAL-TRANSDUCTION; HYDROGEN-PEROXIDE; CELLULAR-RESPONSE; GROWTH
AB Aging is generally accompanied by reduced tolerance to oxidative stress and altered responsiveness to proliferative signals. We have shown that hepatocytes derived from aged rats (24-26 months) exhibit greater sensitivity to H2O2 treatment and reduced proliferation following epidermal growth factor (EGF) treatment than cells of young adult rats (5-6 months). Here we examined the effects of aging and calorie restriction (CR) on expression of the oxidative stress-inducible and pro-apoptotic gene gadd153 (chop) in these hepatocytes, and we investigated its influence on sensitivity to oxidants. We show that aging was associated with elevated expression of gadd153, both basally and in response to H2O2 treatment. CR, which attenuates age-associated declines in stress tolerance, prevented the age-related increase in gadd153 expression. EGF treatment also resulted in gadd153 induction in old cells. This effect was absent in young cells and in old cells of CR rats. gadd153 induction by EGF was reactive oxygen species-dependent and correlated with heightened sensitivity to subsequent H2O2 treatment, suggesting that elevated Gadd153 contributes to the greater sensitivity of EGF-pretreated old cells to oxidative stress. Additional support for this hypothesis was provided by experiments with Rat1 fibroblasts in which conditional expression of Gadd153 conferred increased sensitivity to H2O2. We propose a model whereby the diminished ability of old hepatocytes to overcome an EGF-triggered reactive oxygen species load leads to induction of the proapoptotic gene gadd153, which, in turn, sensitizes the cells to oxidant injury. Our findings point to gadd153 expression levels as an important factor in liver aging.
C1 Yale Univ, Sch Med, Sect Geriatr, New Haven, CT 06520 USA.
   NIA, Biol Cellulaire & Mol Lab, IRP, Baltimore, MD 21224 USA.
C3 Yale University; National Institutes of Health (NIH) - USA; NIH National
   Institute on Aging (NIA)
RP Holbrook, NJ (corresponding author), Yale Univ, Sch Med, Sect Geriatr, Dept Internal Med, POB 208025, New Haven, CT 06511 USA.
EM nikki-holbrook@yale.edu
RI Martindale, Jennifer Luethy/AAD-1963-2022; Podlutsky, Andrej/F-5421-2015
OI Martindale, Jennifer Luethy/0000-0002-3234-6861; 
FU NIA NIH HHS [T30AG21342] Funding Source: Medline; PHS HHS [T30-3489]
   Funding Source: Medline
CR AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   Anantharaju A, 2002, GERONTOLOGY, V48, P343, DOI 10.1159/000065506
   [Anonymous], HDB BIOL AGING
   Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   BURDON RH, 1995, FREE RADICAL BIO MED, V18, P775, DOI 10.1016/0891-5849(94)00198-S
   CARLSON SG, 1993, MOL CELL BIOL, V13, P4736, DOI 10.1128/MCB.13.8.4736
   Chen CH, 1996, ONCOGENE, V13, P1659
   Dröge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001
   Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497
   Finkel T, 1998, CURR OPIN CELL BIOL, V10, P248, DOI 10.1016/S0955-0674(98)80147-6
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   FORNACE AJ, 1989, MOL CELL BIOL, V9, P4196, DOI 10.1128/MCB.9.10.4196
   Gately DP, 1996, BRIT J CANCER, V73, P18, DOI 10.1038/bjc.1996.4
   GOOD RA, 1992, INT J IMMUNOPHARMACO, V14, P361, DOI 10.1016/0192-0561(92)90165-H
   Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700
   Guyton KZ, 1996, J BIOL CHEM, V271, P4138, DOI 10.1074/jbc.271.7.3604
   Hall DM, 2000, FASEB J, V14, P78, DOI 10.1096/fasebj.14.1.78
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Holbrook NJ, 2002, BIOCHEM PHARMACOL, V64, P999, DOI 10.1016/S0006-2952(02)01169-3
   HORNSBY PJ, 2001, HDB BIOL AGING, P207
   Ikeyama S, 2002, FASEB J, V16, pA1163, DOI 10.1096/fj.01-0409fje
   IKEYAMA S, 2003, IN PRESS EXP GERONTO
   Knebel A, 1996, EMBO J, V15, P5314, DOI 10.1002/j.1460-2075.1996.tb00916.x
   KRIEGERBRAUER HI, 1995, BIOCHEM J, V307, P549, DOI 10.1042/bj3070549
   LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905
   Lee CK, 2002, P NATL ACAD SCI USA, V99, P14988, DOI 10.1073/pnas.232308999
   Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046
   Lin YJ, 1998, SCIENCE, V282, P943, DOI 10.1126/science.282.5390.943
   LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540
   LIU Y, 2002, HDB BIOL AGING, P179
   LO YYC, 1995, J BIOL CHEM, V270, P11727, DOI 10.1074/jbc.270.20.11727
   LUETHY JD, 1990, J BIOL CHEM, V265, P16521
   Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119
   McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001
   Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311
   Murakami S, 1996, GENETICS, V143, P1207
   Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194
   PARNHAM MJ, 1984, BIOCHEM PHARMACOL, V33, P3247, DOI 10.1016/0006-2952(84)90085-6
   RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439
   SACHSENMAIER C, 1994, CELL, V78, P963, DOI 10.1016/0092-8674(94)90272-0
   SCHIEVEN GL, 1994, J BIOL CHEM, V269, P20718
   Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5
   SOBAL RS, 2002, FREE RADIC BIOL MED, V33, P37
   STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616
   SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296
   WANG JF, 1992, HEPATOLOGY, V15, P1112, DOI 10.1002/hep.1840150623
   Wang XZ, 1996, MOL CELL BIOL, V16, P4273
   Zanella CL, 1996, CANCER RES, V56, P5334
   Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982
NR 50
TC 68
Z9 73
U1 0
U2 3
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD MAY 9
PY 2003
VL 278
IS 19
BP 16726
EP 16731
DI 10.1074/jbc.M300677200
PG 6
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 677QG
UT WOS:000182818600038
PM 12609979
OA hybrid
DA 2024-02-19
ER

PT J
AU Bloomer, SA
   Kregel, KC
   Brown, KE
AF Bloomer, Steven A.
   Kregel, Kevin C.
   Brown, Kyle E.
TI Heat stress stimulates hepcidin mRNA expression and C/EBPα protein
   expression in aged rodent liver
SO ARCHIVES OF GERONTOLOGY AND GERIATRICS
LA English
DT Article
DE Iron; Hypoferremia; Inflammation; IL-6; STAT3
ID HEREDITARY HEMOCHROMATOSIS PROTEIN; ANTIMICROBIAL PEPTIDE; HEPATIC IRON;
   TIME-COURSE; OLD RATS; ANEMIA; INTERLEUKIN-6; HFE; HYPOFERREMIA;
   MODULATION
AB Elevations in hepatic iron content occur with aging and physiological stressors, which may promote oxidative injury to the liver. Since dysregulation of the iron regulatory hormone, hepcidin, can cause iron accumulation, our goal was to characterize the regulation of hepcidin in young (6 mo) and old (24 mo) Fischer 344 rats exposed to environmental heat stress. Liver and blood samples were taken in the control condition and after heating. Hepcidin expression did not differ between young and old rats in the control condition, despite higher levels of hepatic iron and IL-6 mRNA in the latter. Following heat stress, pSTAT3 increased in both groups, but C/EBP alpha and hepcidin mRNA increased only in old rats. Despite this, serum iron decreased in both age groups 2 h after heat stress, suggesting hepcidin-independent hypoferremia in the young rats. The differential regulation of hepcidin between young and old rats after hyperthermia may be due to the enhanced expression of C/EBP alpha protein in old rats. These data support the concept of "inflammaging" and suggest that repeated exposures to stressors may contribute to the development of anemia in older individuals. (C) 2013 Elsevier Ireland Ltd. All rights reserved.
C1 [Bloomer, Steven A.] Penn State Abington Coll, Div Sci & Engn, Abington, PA USA.
   [Bloomer, Steven A.; Kregel, Kevin C.] Univ Iowa, Dept Hlth & Human Physiol, Iowa City, IA 52242 USA.
   [Brown, Kyle E.] Iowa City Vet Adm Med Ctr, Iowa City, IA 52242 USA.
   [Brown, Kyle E.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Div Gastroenterol Hepatol, Iowa City, IA 52242 USA.
   [Kregel, Kevin C.; Brown, Kyle E.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Program Free Radical & Radiat Biol, Iowa City, IA 52242 USA.
C3 Pennsylvania Commonwealth System of Higher Education (PCSHE);
   Pennsylvania State University; University of Iowa; University of Iowa;
   University of Iowa
RP Bloomer, SA (corresponding author), Penn State Abington, Div Sci & Engn, 1600 Woodland Rd, Abington, PA 19001 USA.
EM sab320@psu.edu
OI Brown, Kyle/0000-0002-8206-036X
CR Argaud L, 2007, ARCH INTERN MED, V167, P2177, DOI 10.1001/archinte.167.20.ioi70147
   Babitt JL, 2007, J CLIN INVEST, V117, P1933, DOI 10.1172/JCI31342
   Bloomer SA, 2008, AM J PHYSIOL-REG I, V294, pR1165, DOI 10.1152/ajpregu.00719.2007
   Brown KE, 2007, TOXICOL APPL PHARM, V223, P180, DOI 10.1016/j.taap.2007.05.011
   Burgess-Beusse BL, 1998, MOL CELL BIOL, V18, P7269, DOI 10.1128/MCB.18.12.7269
   Camargo CA, 1997, HEPATOLOGY, V26, P1513, DOI 10.1002/hep.510260619
   Casale G, 1981, Age Ageing, V10, P119, DOI 10.1093/ageing/10.2.119
   Constante M, 2006, AM J PHYSIOL-GASTR L, V291, pG229, DOI 10.1152/ajpgi.00092.2006
   Cook CI, 1998, MECH AGEING DEV, V102, P1, DOI 10.1016/S0047-6374(98)00005-0
   COOK JD, 1976, BLOOD, V48, P449
   COOK JD, 1973, BRIT J HAEMATOL, V25, P695, DOI 10.1111/j.1365-2141.1973.tb01782.x
   Courselaud B, 2002, J BIOL CHEM, V277, P41163, DOI 10.1074/jbc.M202653200
   Falzacappa MVV, 2007, BLOOD, V109, P353, DOI 10.1182/blood-2006-07-033969
   Ferrucci L, 2010, BLOOD, V115, P3810, DOI 10.1182/blood-2009-02-201087
   Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016
   Gao JW, 2010, BLOOD, V115, P3374, DOI 10.1182/blood-2009-09-245209
   Gao JW, 2009, CELL METAB, V9, P217, DOI 10.1016/j.cmet.2009.01.010
   Goswami T, 2006, J BIOL CHEM, V281, P28494, DOI 10.1074/jbc.C600197200
   Haak JL, 2009, AM J PHYSIOL-REG I, V296, pR812, DOI 10.1152/ajpregu.90708.2008
   Hall DM, 2000, J APPL PHYSIOL, V89, P749, DOI 10.1152/jappl.2000.89.2.749
   Hong F, 2002, ONCOGENE, V21, P32, DOI 10.1038/sj.onc.1205016
   HUBBARD RW, 1976, AM J PHYSIOL, V231, P1119, DOI 10.1152/ajplegacy.1976.231.4.1119
   Kawabata H, 2005, BLOOD, V105, P376, DOI 10.1182/blood-2004-04-1416
   Kemna E, 2005, BLOOD, V106, P1864, DOI 10.1182/blood-2005-03-1159
   KEW M, 1970, AM J MED, V49, P192, DOI 10.1016/S0002-9343(70)80075-4
   Klein C, 2005, J CLIN INVEST, V115, P860, DOI 10.1172/JCI200523640
   Krause A, 2000, FEBS LETT, V480, P147, DOI 10.1016/S0014-5793(00)01920-7
   Laftah AH, 2006, BIOCHEM J, V397, P61, DOI 10.1042/BJ20060215
   Layoun A, 2012, AM J PATHOL, V180, P2340, DOI 10.1016/j.ajpath.2012.01.046
   Lee P, 2008, BLOOD CELL MOL DIS, V41, P252, DOI 10.1016/j.bcmd.2008.06.005
   Leon LR, 2006, J APPL PHYSIOL, V100, P1400, DOI 10.1152/japplphysiol.01040.2005
   Macdougall IC, 2010, CLIN J AM SOC NEPHRO, V5, P1681, DOI 10.2215/CJN.05990809
   Mackey SL, 2004, J BIOL CHEM, V279, P16206, DOI 10.1074/jbc.M400737200
   Makipour S, 2008, SEMIN HEMATOL, V45, P250, DOI 10.1053/j.seminhematol.2008.06.003
   Moshage H, 1997, J PATHOL, V181, P257, DOI 10.1002/(SICI)1096-9896(199703)181:3<257::AID-PATH756>3.0.CO;2-U
   Mysliwska J, 1998, MECH AGEING DEV, V100, P313, DOI 10.1016/S0047-6374(97)00154-1
   Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235
   Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742
   Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945
   Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686
   Oberley TD, 2008, J HISTOCHEM CYTOCHEM, V56, P615, DOI 10.1369/jhc.2008.950873
   Oliveira SJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006618
   Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200
   Pietrangelo A, 2007, GASTROENTEROLOGY, V132, P294, DOI 10.1053/j.gastro.2006.10.018
   Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200
   Rivera S, 2005, BLOOD, V106, P2196, DOI 10.1182/blood-2005-04-1766
   Rivera S, 2005, BLOOD, V105, P1797, DOI 10.1182/blood-2004-08-3375
   Sakamori R, 2010, J GASTROENTEROL, V45, P244, DOI 10.1007/s00535-009-0159-y
   Semenza JC, 1996, NEW ENGL J MED, V335, P84, DOI 10.1056/NEJM199607113350203
   Sohal RS, 1999, FREE RADICAL BIO MED, V27, P287, DOI 10.1016/S0891-5849(99)00052-0
   Timchenko NA, 1998, NUCLEIC ACIDS RES, V26, P3293, DOI 10.1093/nar/26.13.3293
   Torrance J. D., 1980, IRON
   Vecchi C, 2009, SCIENCE, V325, P877, DOI 10.1126/science.1176639
   Waheed A, 2008, ARCH BIOCHEM BIOPHYS, V474, P193, DOI 10.1016/j.abb.2008.02.041
   Wallace DF, 2007, GASTROENTEROLOGY, V132, P301, DOI 10.1053/j.gastro.2006.11.028
   Weinstein DA, 2002, BLOOD, V100, P3776, DOI 10.1182/blood-2002-04-1260
   Welc SS, 2012, AM J PHYSIOL-CELL PH, V303, pC455, DOI 10.1152/ajpcell.00028.2012
   Wrighting DM, 2006, BLOOD, V108, P3204, DOI 10.1182/blood-2006-06-027631
   Xu JZ, 2010, MECH AGEING DEV, V131, P487, DOI 10.1016/j.mad.2010.04.007
   Zhang HJ, 2004, FASEB J, V18, P1547, DOI 10.1096/fj.04-1629fje
   Zhang HJ, 2003, FASEB J, V17, P2293, DOI 10.1096/fj.03-0139fje
NR 61
TC 15
Z9 16
U1 0
U2 17
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0167-4943
EI 1872-6976
J9 ARCH GERONTOL GERIAT
JI Arch. Gerontol. Geriatr.
PD JAN-FEB
PY 2014
VL 58
IS 1
BP 145
EP 152
DI 10.1016/j.archger.2013.07.012
PG 8
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 238XG
UT WOS:000325984500026
PM 23993269
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Miao, SS
   Li, Y
   Mu, TM
   Wang, XM
   Zhao, WY
   Li, R
   Dong, XY
   Zou, XT
AF Miao, Sasa
   Li, Yan
   Mu, Tianming
   Wang, Xiaoming
   Zhao, Wenyan
   Li, Ru
   Dong, Xinyang
   Zou, Xiaoting
TI Dietary Coated Sodium Butyrate Ameliorates Hepatic Lipid Accumulation
   and Inflammation via Enhancing Antioxidative Function in Post-Peaking
   Laying Hens
SO METABOLITES
LA English
DT Article
DE coated sodium butyrate; lipid metabolism; oxidative stress;
   antioxidative function; laying hen
ID FATTY-ACIDS; PRODUCTION PERFORMANCE; INTESTINAL HEALTH; OXIDATIVE
   STRESS; CECAL MICROBIOTA; GENE-EXPRESSION; RECEPTOR-ALPHA; METABOLISM;
   MITOCHONDRIAL; QUALITY
AB During the aging process of laying hens, hepatic oxidative stress damage and lipid accumulation are prone to occur, leading to the deterioration of egg quality and a decline in production properties. This research was designed to explore the effects of different levels of coated sodium butyrate (CSB) addition on oxidation resistance, inflammatory reaction, lipid metabolism and hepatic oxidative damage-related gene expression in aged laying hens. A total of 720 healthy 52 weeks old Huafeng laying hens were arbitrarily divided into 5 groups of 6 replicates with 24 birds each and fed a basal diet supplemented with 0, 250, 500, 750 and 1000 mg/kg CSB for 8 weeks, respectively. The CSB quadratically upgraded GSH-Px activities and downgraded MDA content in the liver and serum. The LDL-C, NEFA and TG contents decreased quadratically in CSB groups and significantly reduced the fatty vacuoles as well as the formation of fat granules in the liver (p < 0.05). Meanwhile, the CSB quadratically upregulated the gene expression of IL-10, Nrf2 and HO1, but downregulated the gene expression of IFN-?, TNF-a and Keap1 in a quadratic manner (p < 0.05). Moreover, the CSB quadratically degraded the mRNA level of fatty acid synthesis but increased the gene level of key enzymes of fatty acid catabolism (p < 0.05). In conclusion, dietary CSB supplementation has a favorable effect in protecting against liver injury and alleviating lipid accumulation and inflammation by enhancing hepatic antioxidative function in aged laying hens.
C1 [Miao, Sasa; Li, Yan; Mu, Tianming; Wang, Xiaoming; Zhao, Wenyan; Li, Ru; Dong, Xinyang; Zou, Xiaoting] Zhejiang Univ, Key Lab Anim Feed & Nutr Zhejiang Prov, Key Lab Anim Nutr & Feed Sci Eastern China, Minist Agr & Rural Affairs,Key Lab Mol Anim Nutr,M, Hangzhou 310058, Peoples R China.
C3 Ministry of Agriculture & Rural Affairs; Zhejiang University
RP Zou, XT (corresponding author), Zhejiang Univ, Key Lab Anim Feed & Nutr Zhejiang Prov, Key Lab Anim Nutr & Feed Sci Eastern China, Minist Agr & Rural Affairs,Key Lab Mol Anim Nutr,M, Hangzhou 310058, Peoples R China.
EM xtzou@zju.edu.cn
RI Zhang, Yanyan/JFA-9161-2023
FU Science and Technology Development project of Hangzhou [202003A02];
   Twinning service plan of the Zhejiang Provincial Team Science and
   Technology Special Commissioner of China; Modern Argo-Industry
   Technology Research System of China [CARS-40-K10]
FX This research was supported by the Science and Technology Development
   project of Hangzhou (202003A02), the Twinning service plan of the
   Zhejiang Provincial Team Science and Technology Special Commissioner of
   China and the Modern Argo-Industry Technology Research System of China
   (CARS-40-K10).
CR Adeyanju OA, 2021, BIOMED PHARMACOTHER, V133, DOI 10.1016/j.biopha.2020.110994
   Bloomer S, 2019, J ANIM SCI, V97, P132
   Bortoluzzi C, 2017, POULTRY SCI, V96, P3981, DOI 10.3382/ps/pex218
   Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8
   Calder PC, 2022, BRIT J NUTR, V127, P1455, DOI 10.1017/S0007114522000782
   Dong YL, 2017, BMC GASTROENTEROL, V17, DOI 10.1186/s12876-017-0634-5
   Du SY, 2020, DRUG DELIV, V27, P953, DOI 10.1080/10717544.2020.1775722
   Elnesr SS, 2019, ANIMAL, V13, P1234, DOI 10.1017/S1751731118002732
   Feng J, 2021, J ANIM SCI BIOTECHNO, V12, DOI 10.1186/s40104-021-00600-3
   Gao H, 2022, FOOD CHEM, V390, DOI 10.1016/j.foodchem.2022.133138
   Gao XN, 2019, POULTRY SCI, V98, P2201, DOI 10.3382/ps/pey586
   Gharib-Naseri K, 2021, POULTRY SCI, V100, DOI 10.1016/j.psj.2021.101214
   Grant RW, 2015, OBESITY, V23, P512, DOI 10.1002/oby.21003
   Gu YF, 2021, POULTRY SCI, V100, DOI 10.1016/j.psj.2021.101478
   Guo ZY, 2021, FOOD FUNCT, V12, P6925, DOI [10.1039/d0fo03094e, 10.1039/D0FO03094E]
   Hu H, 2020, POULTRY SCI, V99, P1454, DOI 10.1016/j.psj.2019.11.001
   Hu YM, 2018, ENVIRON TOXICOL PHAR, V64, P112, DOI 10.1016/j.etap.2018.09.002
   Huang JB, 2013, J AGR FOOD CHEM, V61, P8565, DOI 10.1021/jf402004x
   Huang YP, 2017, ONCOTARGET, V8, P13073, DOI 10.18632/oncotarget.14375
   Hunkeler M, 2018, NATURE, V558, P470, DOI 10.1038/s41586-018-0201-4
   Kersten S, 2002, P NUTR SOC, V61, P371, DOI 10.1079/PNS2002169
   Koizumi T, 1996, TOXICOLOGY, V114, P125, DOI 10.1016/S0300-483X(96)03477-4
   Lan RX, 2020, VET MED SCI, V6, P491, DOI 10.1002/vms3.250
   Lee BK, 2010, POULTRY SCI, V89, P2660, DOI 10.3382/ps.2010-00686
   Li C, 2014, INT J MOL SCI, V15, P7124, DOI 10.3390/ijms15057124
   Li HZ, 2022, ANTIOXIDANTS-BASEL, V11, DOI 10.3390/antiox11091843
   Lin FH, 2020, ANIM FEED SCI TECH, V263, DOI 10.1016/j.anifeedsci.2020.114464
   Liu JY, 2023, POULTRY SCI, V102, DOI 10.1016/j.psj.2023.102674
   Liu YY, 2021, ANIM NUTR, V7, P421, DOI 10.1016/j.aninu.2020.08.005
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lomonaco R, 2016, DIABETES CARE, V39, P632, DOI 10.2337/dc15-1876
   Louet JF, 2001, BIOCHEM J, V354, P189, DOI 10.1042/0264-6021:3540189
   Ma NN, 2018, BMC VET RES, V14, DOI 10.1186/s12917-018-1591-0
   Miao LP, 2020, ECOTOX ENVIRON SAFE, V193, DOI 10.1016/j.ecoenv.2020.110372
   Miao SS, 2021, ITAL J ANIM SCI, V20, P1452, DOI 10.1080/1828051X.2021.1960209
   Nishitsuji K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16189-5
   Raso GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068626
   Schadinger SE, 2005, AM J PHYSIOL-ENDOC M, V288, pE1195, DOI 10.1152/ajpendo.00513.2004
   Schoonjans K, 1996, J LIPID RES, V37, P907
   Shi Z, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061691
   Shini A, 2019, AVIAN PATHOL, V48, P25, DOI 10.1080/03079457.2018.1538550
   Tang DZ, 2019, POULTRY SCI, V98, P664, DOI 10.3382/ps/pey415
   Trott K A, 2014, Vet Pathol, V51, P787, DOI 10.1177/0300985813503569
   Uscátegui YL, 2019, MOLECULES, V24, DOI 10.3390/molecules24020237
   Wang HJ, 2019, THERANOSTICS, V9, P6031, DOI 10.7150/thno.37397
   Wang Q, 2019, ONCOL LETT, V17, P3305, DOI 10.3892/ol.2019.10007
   Xing XG, 2016, J PHYSIOL BIOCHEM, V73, P405, DOI 10.1007/s13105-017-0568-y
   Yang BW, 2022, ANIM NUTR, V11, P283, DOI 10.1016/j.aninu.2022.08.003
   Yang C, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20205205
   Zhang Q, 2022, POULTRY SCI, V101, DOI 10.1016/j.psj.2022.102020
   Zhang WH, 2011, POULTRY SCI, V90, P2592, DOI 10.3382/ps.2011-01446
   Zhang WH, 2011, BRIT POULTRY SCI, V52, P292, DOI 10.1080/00071668.2011.578121
   Zhang Y, 2022, ECOTOX ENVIRON SAFE, V245, DOI 10.1016/j.ecoenv.2022.114134
   Zhang Y, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/6059058
   Zhao HW, 2017, WORLD J GASTROENTERO, V23, P999, DOI 10.3748/wjg.v23.i6.999
   Zhao LS, 2016, MOLECULES, V21, DOI 10.3390/molecules21070952
   Zhou JB, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0289-1
   Zhu Y, 2022, POULTRY SCI, V101, DOI 10.1016/j.psj.2022.101870
   Zhuang Y, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46183-y
NR 59
TC 2
Z9 2
U1 9
U2 17
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2218-1989
J9 METABOLITES
JI Metabolites
PD MAY 10
PY 2023
VL 13
IS 5
AR 650
DI 10.3390/metabo13050650
PG 16
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA H6DP3
UT WOS:000996849900001
PM 37233691
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Prunier, C
   Alay, A
   van Dijk, M
   Ammerlaan, KL
   van Gelderen, S
   Marvin, DL
   Teunisse, A
   Slieker, RC
   Szuhai, K
   Jochemsen, AG
   Solé, X
   ten Dijke, P
   Ritsma, L
AF Prunier, Chloe
   Alay, Ania
   van Dijk, Michiel
   Ammerlaan, Kelly L.
   van Gelderen, Sharon
   Marvin, Dieuwke L.
   Teunisse, Amina
   Slieker, Roderick C.
   Szuhai, Karoly
   Jochemsen, A. G.
   Sole, Xavier
   ten Dijke, Peter
   Ritsma, Laila
TI Breast cancer dormancy is associated with a 4NG1 state and not
   senescence
SO NPJ BREAST CANCER
LA English
DT Article
ID MAMMARY-CARCINOMA CELLS; CELLULAR SENESCENCE; TUMOR-CELLS;
   GENE-EXPRESSION; MECHANISMS; PROLIFERATION; METASTASIS; INHIBITION;
   OUTGROWTH; PATHWAYS
AB Reactivation of dormant cancer cells can lead to cancer relapse, metastasis, and patient death. Dormancy is a nonproliferative state and is linked to late relapse and death. No targeted therapy is currently available to eliminate dormant cells, highlighting the need for a deeper understanding and reliable models. Here, we thoroughly characterize the dormant D2.OR and ZR-75-1, and proliferative D2A1 breast cancer cell line models in vivo and/or in vitro, and assess if there is overlap between a dormant and a senescent phenotype. We show that D2.OR but not D2A1 cells become dormant in the liver of an immunocompetent model. In vitro, we show that D2.OR and ZR-75-1 cells in response to a 3D environment or serum-free conditions are growth-arrested in G1, of which a subpopulation resides in a 4NG1 state. The dormancy state is reversible and not associated with a senescence phenotype. This will aid future research on breast cancer dormancy.
C1 [Prunier, Chloe; van Dijk, Michiel; Ammerlaan, Kelly L.; van Gelderen, Sharon; Marvin, Dieuwke L.; Teunisse, Amina; Slieker, Roderick C.; Szuhai, Karoly; Jochemsen, A. G.; ten Dijke, Peter; Ritsma, Laila] Leiden Univ, Med Ctr, Dept Cell & Chem Biol, NL-2333 ZC Leiden, Netherlands.
   [Prunier, Chloe; van Dijk, Michiel; Ammerlaan, Kelly L.; van Gelderen, Sharon; Marvin, Dieuwke L.; Teunisse, Amina; Slieker, Roderick C.; Szuhai, Karoly; Jochemsen, A. G.; ten Dijke, Peter; Ritsma, Laila] Leiden Univ, Med Ctr, Oncode Inst, NL-2333 ZC Leiden, Netherlands.
   [Prunier, Chloe; Marvin, Dieuwke L.; ten Dijke, Peter; Ritsma, Laila] Oncode Inst, Utrecht, Netherlands.
   [Alay, Ania; Sole, Xavier] Catalan Inst Oncol, Unit Bioinformat Precis Oncol, Barcelona, Spain.
   [Alay, Ania; Sole, Xavier] Bellvitge Biomed Res Inst IDIBELL, Mol Mech & Expt Therapy Oncol Program Oncobell, Barcelona, Spain.
   [Sole, Xavier] CIBER Epidemiol & Publ Hlth CIBERESP, Madrid, Spain.
   [Prunier, Chloe] Inovot SAS, R&D Dept, F-38700 La Tronche, France.
C3 Leiden University - Excl LUMC; Leiden University; Leiden University
   Medical Center (LUMC); Leiden University; Leiden University Medical
   Center (LUMC); Leiden University - Excl LUMC; Institut Catala
   d'Oncologia; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL);
   CIBER - Centro de Investigacion Biomedica en Red; CIBERESP
RP Ritsma, L (corresponding author), Leiden Univ, Med Ctr, Dept Cell & Chem Biol, NL-2333 ZC Leiden, Netherlands.; Ritsma, L (corresponding author), Leiden Univ, Med Ctr, Oncode Inst, NL-2333 ZC Leiden, Netherlands.; Ritsma, L (corresponding author), Oncode Inst, Utrecht, Netherlands.
EM L.M.A.Ritsma@lumc.nl
RI Prunier, Chloé/HKV-2140-2023; Dijke, Peter ten/AAG-4660-2021; Szuhai,
   Karoly/A-1100-2008
OI Dijke, Peter ten/0000-0002-7234-342X; Slieker,
   Roderick/0000-0003-0961-9152; Szuhai, Karoly/0000-0002-1228-4245;
   Ammerlaan, Kelly/0000-0002-1549-0845; Alay, Ania/0000-0002-5090-2913;
   Sole, Xavier/0000-0002-2197-3325
FU Leiden University Profile area Bioscience: the science base of health
   'Building Pipelines for Drug Discovery'; Leiden University Medical
   Center (LUMC); Netherlands Organisation for Scientific Research (NWO)
   [016.176.081]; Leids Universiteits Fonds (LUF) [CWB 7204]; Cancer
   Genomics Center Netherlands; Spanish Ministry of Science and Innovation
   [RTI2018-102134-A-I00]
FX We would like to acknowledge 1. all (former) members of the Ritsma and
   ten Dijke lab for help, support, and critical comments; 2. the CCB
   microscopy facility for microscopy support; 3. The LUMC FACS sort
   facility for flow cytometry support; and 4. Willem Sloos for general
   lab/IT support. We also acknowledge our funders: CP was supported by
   Leiden University Profile area Bioscience: the science base of health
   `Building Pipelines for Drug Discovery'. LR was supported by a Gisela
   Thier fellowship from the Leiden University Medical Center (LUMC), a
   Veni grant from the Netherlands Organisation for Scientific Research
   (NWO, 016.176.081), and a subsidy from the Leids Universiteits Fonds
   (LUF, CWB 7204). CP, LR, and PtD members were supported by a subsidy
   from the Cancer Genomics Center Netherlands. XS was supported by the
   Spanish Ministry of Science and Innovation, RTI2018-102134-A-I00
   (MCIU/AEI/FEDER, UE).
CR Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256
   Albrengues J, 2018, SCIENCE, V361, P1353, DOI 10.1126/science.aao4227
   Andreassen PR, 1996, MUTAT RES-FUND MOL M, V372, P181, DOI 10.1016/S0027-5107(96)00138-8
   Bajar BT, 2016, NAT METHODS, V13, P993, DOI [10.1038/NMETH.4045, 10.1038/nmeth.4045]
   Barkan D, 2008, CANCER RES, V68, P6241, DOI 10.1158/0008-5472.CAN-07-6849
   Barney LE, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz4157
   Bartosh TJ, 2016, P NATL ACAD SCI USA, V113, pE6447, DOI 10.1073/pnas.1612290113
   Basisty N, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000599
   Blagosklonny MV, 2011, AGING-US, V3, P94, DOI 10.18632/aging.100281
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Cheng Q, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0407-9
   Childs BG, 2015, NAT MED, V21, P1424, DOI 10.1038/nm.4000
   Collado M, 2006, NAT REV CANCER, V6, P472, DOI 10.1038/nrc1884
   Cumbo F, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-016-1419-5
   Dey-Guha I, 2011, P NATL ACAD SCI USA, V108, P12845, DOI 10.1073/pnas.1109632108
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207
   Flynn AL, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11640-9
   Fridman AL, 2008, ONCOGENE, V27, P5975, DOI 10.1038/onc.2008.213
   Ganem NJ, 2007, CELL, V131, P437, DOI 10.1016/j.cell.2007.10.024
   Ge JY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16170-3
   Goddard ET, 2018, NAT CELL BIOL, V20, P1240, DOI 10.1038/s41556-018-0214-0
   Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005
   Goss PE, 2010, NAT REV CANCER, V10, P871, DOI 10.1038/nrc2933
   Kienast Y, 2010, NAT MED, V16, P116, DOI 10.1038/nm.2072
   Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610
   Kurppa KJ, 2020, CANCER CELL, V37, P104, DOI 10.1016/j.ccell.2019.12.006
   Ledford H, 2018, NATURE, V558, P355, DOI 10.1038/d41586-018-05445-x
   Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015
   Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323
   Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   MAHONEY KH, 1985, J LEUKOCYTE BIOL, V38, P573, DOI 10.1002/jlb.38.5.573
   Marxer M, 2014, ONCOGENE, V33, P3550, DOI 10.1038/onc.2013.325
   MILLER FR, 1989, CANCER RES, V49, P6091
   Montagner M, 2020, NAT CELL BIOL, V22, P289, DOI 10.1038/s41556-020-0474-3
   MORRIS VL, 1994, CLIN EXP METASTAS, V12, P357, DOI 10.1007/BF01755879
   MORRIS VL, 1993, CLIN EXP METASTAS, V11, P103, DOI 10.1007/BF00880071
   Naumov GN, 2003, BREAST CANCER RES TR, V82, P199, DOI 10.1023/B:BREA.0000004377.12288.3c
   Naumov GN, 2002, CANCER RES, V62, P2162
   Neri S, 2001, CLIN DIAGN LAB IMMUN, V8, P1131, DOI 10.1128/CDLI.8.6.1131-1135.2001
   Netanely D, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0724-2
   Ogba N, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0489-4
   Pfefferle AD, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-11-r125
   Prunier C, 2019, TRENDS CANCER, V5, P66, DOI 10.1016/j.trecan.2018.10.010
   Rieder CL, 2004, DEV CELL, V7, P637, DOI 10.1016/j.devcel.2004.09.002
   Saleh T, 2019, CANCER RES, V79, P1044, DOI 10.1158/0008-5472.CAN-18-3437
   Salony, 2016, MOL CANCER THER, V15, P142, DOI 10.1158/1535-7163.MCT-15-0414
   Shibue T, 2013, CANCER CELL, V24, P481, DOI 10.1016/j.ccr.2013.08.012
   Shibue T, 2012, CANCER DISCOV, V2, P706, DOI 10.1158/2159-8290.CD-11-0239
   Shibue T, 2009, P NATL ACAD SCI USA, V106, P10290, DOI 10.1073/pnas.0904227106
   Siegel RL, 2019, CA-CANCER J CLIN, V69, P7, DOI 10.3322/caac.21551
   Sosa MS, 2014, NAT REV CANCER, V14, P611, DOI 10.1038/nrc3793
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Szuhai K, 2006, NAT PROTOC, V1, P264, DOI 10.1038/nprot.2006.41
   Terzi MY, 2016, MOL BIOL REP, V43, P1213, DOI 10.1007/s11033-016-4065-0
   Tolar J, 2007, STEM CELLS, V25, P371, DOI 10.1634/stemcells.2005-0620
   Vera-Ramirez L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04070-6
   Zhang BY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04010-4
NR 59
TC 6
Z9 6
U1 0
U2 4
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
EI 2374-4677
J9 NPJ BREAST CANCER
JI npj Breast Cancer
PD OCT 27
PY 2021
VL 7
IS 1
AR 140
DI 10.1038/s41523-021-00347-0
PG 12
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA WO6TN
UT WOS:000712584600001
PM 34707097
OA Green Submitted, Green Published, gold
DA 2024-02-19
ER

PT J
AU Nascimbeni, F
   Lugari, S
   Cassinerio, E
   Motta, I
   Cavicchioli, A
   Dalla Salda, A
   Bursi, S
   Donatiello, S
   Spina, V
   Cappellini, MD
   Andreone, P
   Carubbi, F
AF Nascimbeni, Fabio
   Lugari, Simonetta
   Cassinerio, Elena
   Motta, Irene
   Cavicchioli, Alessia
   Dalla Salda, Annalisa
   Bursi, Serena
   Donatiello, Salvatore
   Spina, Vincenzo
   Cappellini, Maria Domenica
   Andreone, Pietro
   Carubbi, Francesca
TI Liver steatosis is highly prevalent and is associated with metabolic
   risk factors and liver fibrosis in adult patients with type 1 Gaucher
   disease
SO LIVER INTERNATIONAL
LA English
DT Article
DE controlled attenuation parameter; enzyme replacement therapy;
   glucocerebrosidase deficiency; liver stiffness; metabolic
   dysfunction&#8208; associated fatty liver disease
ID CONTROLLED ATTENUATION PARAMETER; INSULIN-RESISTANCE; HEPATIC STEATOSIS;
   LIPID-METABOLISM; TRANSIENT; DIAGNOSIS; CAP; EPIDEMIOLOGY; COFACTOR;
   THERAPY
AB Background and Aims Gaucher disease (GD) is associated with peculiar metabolic abnormalities (ie hypermetabolic state, peripheral insulin resistance, dyslipidaemia), partially reverted by enzyme replacement therapy (ERT) at the expense of weight gain. Such metabolic alterations together with an unhealthy lifestyle acquired by an ageing GD population may favour the development of liver steatosis. We aimed at evaluating the prevalence of significant liver steatosis and at identifying the factors associated with liver steatosis in a cohort of patients with type 1 GD.
   Methods Twenty adult type 1 GD patients from an Italian academic referral centre were prospectively submitted to vibration-controlled transient elastography (Fibroscan (R)) with controlled attenuation parameter (CAP); significant steatosis was defined as CAP values >= 250 dB/min.
   Results Median CAP values were 234 [165-358] dB/min and 8 patients (40%) had significant steatosis. Significant steatosis was associated with indices of adiposity (weight, BMI and waist circumference), high blood pressure, insulin resistance and metabolic syndrome. GD-related variables and dose and duration of ERT were not associated with significant steatosis. In the subgroup of 16 patients on stable ERT for at least 24 months, CAP resulted significantly and positively associated with liver stiffness (rho 0.559, P = .024).
   Conclusions Significant steatosis is highly prevalent in adult type 1 GD patients and is strongly associated with a worse metabolic profile, featuring metabolic dysfunction-associated fatty liver disease (MAFLD). MAFLD may determine liver fibrosis progression in GD patients on stable ERT and may be a risk factor for long-term liver-related complications.
C1 [Nascimbeni, Fabio; Lugari, Simonetta; Cavicchioli, Alessia; Dalla Salda, Annalisa; Bursi, Serena; Andreone, Pietro; Carubbi, Francesca] Univ Modena & Reggio Emilia, Reg Referral Ctr Lysosomal Storage Dis, Div Internal Med & Metab, Civil Hosp,AOU Modena, Modena, Italy.
   [Cassinerio, Elena; Motta, Irene; Cappellini, Maria Domenica] Ca Granda Fdn IRCCS, Dept Med & Med Special, Rare Dis Ctr, Milan, Italy.
   [Donatiello, Salvatore; Spina, Vincenzo] AOU Modena, Civil Hosp, Radiol Div, Modena, Italy.
C3 Universita di Modena e Reggio Emilia; IRCCS Ca Granda Ospedale Maggiore
   Policlinico
RP Carubbi, F (corresponding author), AOU Modena, Civil Hosp, Div Internal Med & Metab, Reg Referral Ctr Lysosomal Storage Dis, Via Giardini 1355, I-41126 Modena, Italy.
EM carubbi@unimore.it
RI Andreone, Pietro/K-8050-2016; Motta, Irene/AAC-3087-2019
OI Andreone, Pietro/0000-0002-4794-9809; 
CR Aerts JM, 2011, ADV EXP MED BIOL, V721, P99, DOI 10.1007/978-1-4614-0650-1_7
   [Anonymous], 2017, DIGEST LIVER DIS, V49, P471, DOI [DOI 10.1016/J.DLD.2017.01.147, 10.1016/j.dld.2017.01.147]
   Ballabio A, 2020, NAT REV MOL CELL BIO, V21, P101, DOI 10.1038/s41580-019-0185-4
   Ballestri S, 2019, EXPERT REV GASTROENT, V13, P667, DOI 10.1080/17474124.2019.1621164
   Bellentani S, 2017, LIVER INT, V37, P81, DOI 10.1111/liv.13299
   CORSSMIT EPM, 1995, J CLIN ENDOCR METAB, V80, P2653, DOI 10.1210/jc.80.9.2653
   de Fost M, 2006, BLOOD CELL MOL DIS, V36, P53, DOI 10.1016/j.bcmd.2005.08.004
   de Lédinghen V, 2014, J HEPATOL, V60, P1026, DOI 10.1016/j.jhep.2013.12.018
   de Lédinghen V, 2012, LIVER INT, V32, P911, DOI 10.1111/j.1478-3231.2012.02820.x
   Eslam M, 2020, J HEPATOL, V73, P202, DOI 10.1016/j.jhep.2020.03.039
   Fouad Y, 2020, LIVER INT, V40, P1254, DOI 10.1111/liv.14478
   Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143
   Hollak CEM, 1997, AM J MED, V103, P185, DOI 10.1016/S0002-9343(97)00134-4
   Hughes D, 2019, J BONE MINER RES, V34, P996, DOI 10.1002/jbmr.3734
   Ilan Y, 2016, AM J PHYSIOL-GASTR L, V310, pG1102, DOI 10.1152/ajpgi.00095.2016
   JAMES SP, 1981, GASTROENTEROLOGY, V80, P126
   Karlas T, 2017, J HEPATOL, V66, P1022, DOI 10.1016/j.jhep.2016.12.022
   Kwak MS, 2018, LIVER INT, V38, P915, DOI 10.1111/liv.13558
   Langeveld A, 2008, BLOOD CELL MOL DIS, V40, P428, DOI 10.1016/j.bcmd.2007.09.002
   Langeveld M, 2008, J CLIN ENDOCR METAB, V93, P845, DOI 10.1210/jc.2007-1702
   Lipinski P, 2020, MOL GENET METAB, V129, P125, DOI 10.1016/j.ymgme.2019.10.013
   Lonardo A, 2018, J HEPATOL, V68, P335, DOI 10.1016/j.jhep.2017.09.021
   Mistry PK, 2011, AM J HEMATOL, V86, P110, DOI 10.1002/ajh.21888
   Motta I, 2016, EUR J HAEMATOL, V96, P352, DOI 10.1111/ejh.12596
   Myers RP, 2012, LIVER INT, V32, P902, DOI 10.1111/j.1478-3231.2012.02781.x
   Nascimbeni F, 2020, DIGEST LIVER DIS, V52, P359, DOI 10.1016/j.dld.2019.12.005
   Nascimbeni F, 2018, MOL GENET METAB, V125, P64, DOI 10.1016/j.ymgme.2018.08.004
   Nascimbeni F, 2018, BLOOD CELL MOL DIS, V68, P74, DOI 10.1016/j.bcmd.2016.10.012
   Petta S, 2011, LIVER INT, V31, P507, DOI 10.1111/j.1478-3231.2011.02453.x
   Piccinni R, 2020, LIVER INT, V40, P1151, DOI 10.1111/liv.14325
   Pocovi M, 1998, LANCET, V351, P1919, DOI 10.1016/S0140-6736(97)09490-7
   Powell EE, 2005, GASTROENTEROLOGY, V129, P1937, DOI 10.1053/j.gastro.2005.09.015
   Powell EE, 2005, HEPATOLOGY, V42, P5, DOI 10.1002/hep.20750
   Regenboog M, 2018, J INHERIT METAB DIS, V41, P819, DOI 10.1007/s10545-018-0142-y
   Sasso M, 2010, ULTRASOUND MED BIOL, V36, P1825, DOI 10.1016/j.ultrasmedbio.2010.07.005
   Settembre C, 2013, NAT CELL BIOL, V15, P647, DOI 10.1038/ncb2718
   Webb M, 2018, BLOOD CELL MOL DIS, V68, P143, DOI 10.1016/j.bcmd.2016.12.010
   Weinreb NJ, 2010, GENET MED, V12, P44, DOI 10.1097/GIM.0b013e3181c39194
   Weinreb NJ, 2002, AM J MED, V113, P112, DOI 10.1016/S0002-9343(02)01150-6
   Younossi Z, 2018, NAT REV GASTRO HEPAT, V15, P11, DOI 10.1038/nrgastro.2017.109
   Younossi ZM, 2019, CLIN GASTROENTEROL H, V17, P1625, DOI 10.1016/j.cgh.2018.11.033
   Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431
   ZIMRAN A, 1992, MEDICINE, V71, P337, DOI 10.1097/00005792-199211000-00002
NR 43
TC 13
Z9 13
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1478-3223
EI 1478-3231
J9 LIVER INT
JI Liver Int.
PD DEC
PY 2020
VL 40
IS 12
BP 3061
EP 3070
DI 10.1111/liv.14640
PG 10
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA OY1EV
UT WOS:000593997100018
PM 32810900
OA Green Published
DA 2024-02-19
ER

PT J
AU Kim, SM
   Baek, JM
   Lim, SM
   Kim, JY
   Kim, J
   Choi, I
   Cho, KH
AF Kim, Seong-Min
   Baek, Ji-Mi
   Lim, So-Mang
   Kim, Jae-Yong
   Kim, Jihoe
   Choi, Inho
   Cho, Kyung-Hyun
TI Modified Lipoproteins by Acrylamide Showed More Atherogenic Properties
   and Exposure of Acrylamide Induces Acute Hyperlipidemia and Fatty Liver
   Changes in Zebrafish
SO CARDIOVASCULAR TOXICOLOGY
LA English
DT Article
DE Acrylamide; Lipoprotein; Zebrafish; Senescence; Atherosclerosis; Dermal
   cells
ID HIGH-DENSITY-LIPOPROTEIN; APOLIPOPROTEIN-A-I; HEMOGLOBIN ADDUCTS
AB Acrylamide is a well-known potent carcinogen and neurotoxin that, until now, has not been sufficiently investigated with regard to its effects on lipid metabolism. We investigated physiological effects of acrylamide (AA) on lipoprotein metabolism using human macrophages, dermal cells, and zebrafish models. Functional and structural properties of lipoproteins were modified by AA (final concentration of 5-100 mM) with loss of antioxidant ability and multimerization of apoA-I in vitro. AA exacerbated LDL oxidation, degradation, and LDL uptake into macrophages with increased ROS production. In human cells, treatment of AA (1-100 mu M) caused cellular senescence of dermal cells with severe cytotoxicity. Waterborne exposure of zebrafish in cage water containing AA (300 ppm) resulted in acute death within 26 h along with elevation of body weight, blood glucose, triglyceride, and hepatic inflammation. AA exposure caused fat accumulation in liver in a dose-dependent manner. In conclusion, AA affected lipoprotein metabolism to result exacerbation of atherosclerosis. Exposure of zebrafish to AA resulted in acute inflammatory death with hyperlipidemia.
C1 [Kim, Seong-Min; Baek, Ji-Mi; Lim, So-Mang; Kim, Jae-Yong; Kim, Jihoe; Choi, Inho; Cho, Kyung-Hyun] Yeungnam Univ, Sch Biotechnol, Gyongsan 712749, South Korea.
   [Kim, Seong-Min; Baek, Ji-Mi; Lim, So-Mang; Kim, Jae-Yong; Kim, Jihoe; Choi, Inho; Cho, Kyung-Hyun] Yeungnam Univ, Res Inst Prot Sensor, Gyongsan 712749, South Korea.
   [Kim, Seong-Min; Baek, Ji-Mi; Lim, So-Mang; Kim, Jae-Yong; Kim, Jihoe; Choi, Inho; Cho, Kyung-Hyun] Yeungnam Univ, BK21plus Program Serum Biomed Res, Gyongsan 712749, South Korea.
   [Kim, Seong-Min; Baek, Ji-Mi; Lim, So-Mang; Kim, Jae-Yong; Kim, Jihoe; Choi, Inho; Cho, Kyung-Hyun] Yeungnam Univ, Educ Team, Gyongsan 712749, South Korea.
C3 Yeungnam University; Yeungnam University; Yeungnam University; Yeungnam
   University
RP Cho, KH (corresponding author), Yeungnam Univ, Sch Biotechnol, Gyongsan 712749, South Korea.
EM chok@yu.ac.kr
FU National Research Foundation of Korea (NRF) [2014-11049455,
   2010-020910]; BK21 plus program of the National Research Foundation
FX This work was supported by the Mid-carrier Researcher Program
   (2014-11049455) and Basic Science Research (2010-020910) program through
   the National Research Foundation of Korea (NRF). The authors are
   grateful for the BK21 plus program of the National Research Foundation
   for the support of graduate students.
CR Bergmark E, 1997, CHEM RES TOXICOL, V10, P78, DOI 10.1021/tx960113p
   Bjellaas T, 2007, TOXICOL SCI, V98, P110, DOI 10.1093/toxsci/kfm091
   BLOIS MS, 1958, NATURE, V181, P1199, DOI 10.1038/1811199a0
   Brantsæter AL, 2008, FOOD CHEM TOXICOL, V46, P2808, DOI 10.1016/j.fct.2008.05.020
   Catalgol B, 2009, HUM EXP TOXICOL, V28, P611, DOI 10.1177/0960327109350664
   Cho KH, 2009, BMB REP, V42, P393, DOI 10.5483/BMBRep.2009.42.7.393
   Feng H, 2009, CURR OPIN ENDOCRINOL, V16, P156, DOI 10.1097/MED.0b013e32832922fc
   Friedman M, 2003, J AGR FOOD CHEM, V51, P4504, DOI 10.1021/jf030204+
   HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182
   Hogervorst JGF, 2010, CRIT REV TOXICOL, V40, P485, DOI 10.3109/10408440903524254
   Jang W, 2011, MOL CELLS, V31, P461, DOI 10.1007/s10059-011-1009-3
   Jin S, 2011, FOOD CHEM TOXICOL, V49, P1521, DOI 10.1016/j.fct.2011.03.043
   Kim JY, 2011, FOOD CHEM TOXICOL, V49, P2899, DOI 10.1016/j.fct.2011.08.001
   LoPachin RM, 2008, NEUROTOXICOLOGY, V29, P871, DOI 10.1016/j.neuro.2008.04.016
   LoPachin RM, 2012, ENVIRON HEALTH PERSP, V120, P1650, DOI 10.1289/ehp.1205432
   Mottram DS, 2002, NATURE, V419, P448, DOI 10.1038/419448a
   NOBLE RP, 1968, J LIPID RES, V9, P693
   Nusslein-Volhard C., 2002, ZEBRAFISH PRACTICAL
   Owusu-Ansah E, 2008, NAT GENET, V40, P356, DOI 10.1038/ng.2007.50
   Park KH, 2011, FISH SHELLFISH IMMUN, V31, P904, DOI 10.1016/j.fsi.2011.08.006
   Park KH, 2011, J GERONTOL A-BIOL, V66, P511, DOI 10.1093/gerona/glr016
   Park KH, 2010, J GERONTOL A-BIOL, V65, P600, DOI 10.1093/gerona/glq034
   Park KH, 2010, BIOCHEM BIOPH RES CO, V392, P295, DOI 10.1016/j.bbrc.2009.12.179
   Shipp A, 2006, CRIT REV TOXICOL, V36, P481, DOI 10.1080/10408440600851377
   Stoletov K, 2009, CIRC RES, V104, P952, DOI 10.1161/CIRCRESAHA.108.189803
   Svensson K, 2003, FOOD CHEM TOXICOL, V41, P1581, DOI 10.1016/S0278-6915(03)00188-1
   Toker A, 2013, BIOTECH HISTOCHEM, V88, P103, DOI 10.3109/10520295.2012.745950
   Yoon JH, 2012, REJUV RES, V15, P313, DOI 10.1089/rej.2011.1246
NR 28
TC 20
Z9 20
U1 1
U2 35
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 1530-7905
EI 1559-0259
J9 CARDIOVASC TOXICOL
JI Cardiovasc. Toxicol.
PD OCT
PY 2015
VL 15
IS 4
BP 300
EP 308
DI 10.1007/s12012-014-9294-7
PG 9
WC Cardiac & Cardiovascular Systems; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology; Toxicology
GA CR8MB
UT WOS:000361605900002
PM 25503949
DA 2024-02-19
ER

PT J
AU Holzer, K
   Drucker, E
   Roessler, S
   Dauch, D
   Heinzmann, F
   Waldburger, N
   Eiteneuer, EM
   Herpel, E
   Breuhahn, K
   Zender, L
   Schirmacher, P
   Ori, A
   Singer, S
AF Holzer, Kerstin
   Drucker, Elisabeth
   Roessler, Stephanie
   Dauch, Daniel
   Heinzmann, Florian
   Waldburger, Nina
   Eiteneuer, Eva-Maria
   Herpel, Esther
   Breuhahn, Kai
   Zender, Lars
   Schirmacher, Peter
   Ori, Alessandro
   Singer, Stephan
TI Proteomic Analysis Reveals GMP Synthetase as p53 Repression Target in
   Liver Cancer
SO AMERICAN JOURNAL OF PATHOLOGY
LA English
DT Article
ID ONCOGENE-INDUCED SENESCENCE; HEPATOCELLULAR-CARCINOMA; DNA-DAMAGE;
   PROTEIN; EXPRESSION; APOPTOSIS; GENES; CYCLE; METABOLISM; MECHANISM
AB Disruption of the tumor-suppressive p53 network is a key event in human malignancies, including primary liver cancer. In response to different types of stress, p53 mediates several antiproliferative cellular outcomes, such as cell cycle arrest, apoptosis, and senescence, by activation or repression of its target genes. Metabolic alterations initiating or being part of the p53 response have become an actively studied research area in the p53 field, with several aspects that still remain to be elucidated. Herein, we identified GMP synthetase (GMPS), a key enzyme of de novo purine biosynthesis, as an important p53 repression target using a Large-scale proteomics approach. This p53-mediated repression of GMPS could be validated by immunoblotting in Sk-Hep1, HepG2, and HuH6 cells. Moreover, we found GMPS transcriptionally repressed in a p21-dependent manner and its repression maintained in the context of p53-mediated cellular senescence. More important, direct knockdown of GMPS by RNA interference resulted in reduced cell viability and was sufficient to trigger cellular senescence. Finally, by comparing murine hepatocellular carcinomas, which developed in p53 wild type ((+/+)) versus p53 null ((-/-)) mice, we observed higher GMPS expression in the latter, supporting the in vivo relevance of our findings. We conclude that repression of GMPS by p53 through p21 is a functionally relevant part of the p53-mediated senescence program limiting tumor cell growth in Liver cancer.
C1 [Holzer, Kerstin; Drucker, Elisabeth; Roessler, Stephanie; Waldburger, Nina; Eiteneuer, Eva-Maria; Herpel, Esther; Breuhahn, Kai; Schirmacher, Peter; Singer, Stephan] Univ Heidelberg Hosp, Inst Pathol, Neuenheimer Feld 224, D-69120 Heidelberg, Germany.
   [Dauch, Daniel; Heinzmann, Florian; Zender, Lars] Univ Tubingen, Dept Internal Med 1, Div Translat Gastrointestinal Oncol, Tubingen, Germany.
   [Ori, Alessandro] Leibniz Inst Aging, Fritz Lipmann Inst, Jena, Germany.
   [Singer, Stephan] European Mol Biol Lab, Struct & Computat Biol Unit, Heidelberg, Germany.
C3 Ruprecht Karls University Heidelberg; Eberhard Karls University of
   Tubingen; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut
   (FLI); European Molecular Biology Laboratory (EMBL)
EM stephan.singer@med.uni-heidelberg.de
RI Roessler, Stephanie/J-8432-2019; Ori, Alessandro/M-8586-2019
OI Roessler, Stephanie/0000-0002-5333-5942; Ori,
   Alessandro/0000-0002-3046-0871; Breuhahn, Kai/0000-0002-2462-1229
FU Rahel-Goitein-Straus Program (Medical Faculty Heidelberg); Deutsche
   Forschungsgemeinschaft (DFG) grants [RO 4673, Si1487/3-1];
   Olympia-Morata Program (Medical Faculty Heidelberg);
   Brigitte-Schiebenlange Fellowship (Federal State Baden-Wurttemberg);
   Nationales Centrum fur Tumorerkrankungen (NCT) Heidelberg School of
   Oncology Fellowship; Alexander von Humboldt Foundation; Marie Curie
   Actions; Hella-Buehler-Foundation; Heidelberg Research Center for
   Molecular Medicine Career Development Fellowship
FX Supported by the Rahel-Goitein-Straus Program (Medical Faculty
   Heidelberg) (K.H.), Deutsche Forschungsgemeinschaft (DFG) grants RO 4673
   (S.R.) and Si1487/3-1 (S.S.), the Olympia-Morata Program (Medical
   Faculty Heidelberg; S.R.), Brigitte-Schiebenlange Fellowship (Federal
   State Baden-Wurttemberg; S.R.), Nationales Centrum fur Tumorerkrankungen
   (NCT) Heidelberg School of Oncology Fellowship (S.R.), postdoctoral
   fellowships [Alexander von Humboldt Foundation and Marie Curie Actions
   (A.O.)], Hella-Buehler-Foundation (S.S.), and a Heidelberg Research
   Center for Molecular Medicine Career Development Fellowship (S.S.).
CR Aird KM, 2013, CELL REP, V3, P1252, DOI 10.1016/j.celrep.2013.03.004
   Beckerman R, 2009, GENE DEV, V23, P1364, DOI 10.1101/gad.1795709
   Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036
   Berkers CR, 2013, CELL METAB, V18, P617, DOI 10.1016/j.cmet.2013.06.019
   CARLIER MF, 1982, MOL CELL BIOCHEM, V47, P97
   Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095
   Dauch D, 2016, NAT MED, V22, P744, DOI 10.1038/nm.4107
   Di Agostino S, 2006, CANCER CELL, V10, P191, DOI 10.1016/j.ccr.2006.08.013
   El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061
   FEITELSON MA, 1993, ONCOGENE, V8, P1109
   Holzer K, 2016, INT J ONCOL, V48, P1679, DOI 10.3892/ijo.2016.3388
   Jung YS, 2010, CELL SIGNAL, V22, P1003, DOI 10.1016/j.cellsig.2010.01.013
   Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916
   Liu G, 2002, ONCOGENE, V21, P7195, DOI 10.1038/sj.onc.1205862
   Mannava S, 2013, AM J PATHOL, V182, P142, DOI 10.1016/j.ajpath.2012.09.011
   PAGE T, 1984, INT J BIOCHEM, V16, P117, DOI 10.1016/0020-711X(84)90061-2
   POGSON CI, 1974, AM J CLIN NUTR, V27, P380, DOI 10.1093/ajcn/27.4.380
   Reddy BA, 2014, MOL CELL, V53, P458, DOI 10.1016/j.molcel.2013.12.017
   Roessler S, 2012, GASTROENTEROLOGY, V142, P957, DOI 10.1053/j.gastro.2011.12.039
   Roessler S, 2010, CANCER RES, V70, P10202, DOI 10.1158/0008-5472.CAN-10-2607
   Scian MJ, 2008, ONCOGENE, V27, P2583, DOI 10.1038/sj.onc.1210898
   Singer S, 2012, MOL CELL, V48, P799, DOI 10.1016/j.molcel.2012.09.020
   Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114
   UEDA H, 1995, NAT GENET, V9, P41, DOI 10.1038/ng0195-41
   Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037
   WANG XW, 1994, P NATL ACAD SCI USA, V91, P2230, DOI 10.1073/pnas.91.6.2230
   WEBER G, 1983, CLIN BIOCHEM, V16, P57, DOI 10.1016/S0009-9120(83)94432-6
   Wilson PM, 2009, NUCLEIC ACIDS RES, V37, P78, DOI 10.1093/nar/gkn910
   Winkler J, 2014, HEPATOLOGY, V60, P884, DOI 10.1002/hep.27207
   Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529
NR 30
TC 22
Z9 27
U1 0
U2 15
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9440
EI 1525-2191
J9 AM J PATHOL
JI Am. J. Pathol.
PD FEB
PY 2017
VL 187
IS 2
BP 228
EP 235
DI 10.1016/j.ajpath.2016.09.022
PG 8
WC Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology
GA EI5XQ
UT WOS:000392570000001
PM 27939741
OA Bronze
DA 2024-02-19
ER

PT J
AU Nayak, SB
   Jena, BS
   Patnaik, BK
AF Nayak, SB
   Jena, BS
   Patnaik, BK
TI Effects of age and manganese (II) chloride on peroxidase activity of
   brain and liver of the teleost, <i>Channa punctatus</i>
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE peroxidase; liver; brain; age; manganese (II) chloride; murrel
ID ANTIOXIDANT ENZYME-ACTIVITIES; GLUTATHIONE-PEROXIDASE;
   SUPEROXIDE-DISMUTASE; CATALASE ACTIVITY; FREE-RADICALS;
   DEFENSE-MECHANISMS; LIPID-PEROXIDATION; OXIDATIVE STRESS; RAINBOW-TROUT;
   RATS
AB Fish provide enormous spectrum of longevity and thus present the possibility of multiple mechanisms of senescence. Oxidative stress as a causative agent of senescence and the protective role of antioxidant enzymes were tasted in the teleost, Channa punctatus taking peroxidase (POD) (EC 1.11.1.7) as the representative enzyme. The activity of POD in brain and liver declined during maturation phase (young vs middle-aged). During senescence phase (middle-aged to old) the enzyme activity increased in liver but remained stabilized in brain. The degree of increase in peroxidase activity following in vitro MnCl2 treatment was always higher in liver than in brain. The rate of MnCl2 induced increase in POD activity of both tissues showed an increasing trend with age. However statistical significance was observed only in brain during senescence phase. No significant loss of enzyme activity in both the tissues and greater degree of increase by MnCl2, in brain suggest that antioxidant capacity is not impaired in old murrels. (C) 1999 Elsevier Science Inc. All rights reserved.
C1 Govt Sci Coll, Chatrapur, Orissa, India.
   Berhampur Univ, Dept Zool, Berhampur 760007, Orissa, India.
C3 Berhampur University
RP Patnaik, BK (corresponding author), Govt Sci Coll, Chatrapur, Orissa, India.
RI Jena, Bhabani Sankar/AAC-2937-2022; B, Satheesha Nayak/H-4709-2019
OI B, Satheesha Nayak/0000-0003-1421-8222
CR [Anonymous], 2012, FREE RADICALS BIOL
   ARCHIBALD FS, 1982, ARCH BIOCHEM BIOPHYS, V214, P452, DOI 10.1016/0003-9861(82)90049-2
   CARRILLO MC, 1992, MECH AGEING DEV, V65, P187, DOI 10.1016/0047-6374(92)90035-C
   CHANG EC, 1989, J BIOL CHEM, V264, P12172
   DAVIES KJA, 1982, BIOCHEM BIOPH RES CO, V107, P1198, DOI 10.1016/S0006-291X(82)80124-1
   DEQUIROGA GB, 1990, J NEUROSCI RES, V26, P370, DOI 10.1002/jnr.490260314
   DESOLE MS, 1995, NEUROPHARMACOLOGY, V34, P289, DOI 10.1016/0028-3908(94)00140-N
   Finch C.E., 1990, RAPID SENESCENCE SUD, P43
   FRIDOVICH I, 1986, ANNU REV PHYSIOL, V48, P693
   GANTAYAT SC, 1980, EXP GERONTOL, V15, P373, DOI 10.1016/0531-5565(80)90045-5
   Gille G, 1995, FOLIA MICROBIOL, V40, P131, DOI 10.1007/BF02815413
   HARMAN D, 1992, MUTAT RES, V275, P257, DOI 10.1016/0921-8734(92)90030-S
   IGARASHI T, 1983, J PHARMACOBIO-DYNAM, V6, P941
   JENA BS, 1992, GERONTOLOGY, V38, P252
   Jena BS, 1998, ARCH GERONTOL GERIAT, V26, P119, DOI 10.1016/S0167-4943(97)00038-1
   LOPEZTORRES M, 1993, FREE RADICAL BIO MED, V15, P133, DOI 10.1016/0891-5849(93)90052-V
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MAHAPATRO N, 1993, MECH AGEING DEV, V68, P47, DOI 10.1016/0047-6374(93)90139-I
   MATSUO M, 1992, MECH AGEING DEV, V64, P273, DOI 10.1016/0047-6374(92)90084-Q
   MCELDOON JP, 1991, J BIOL CHEM, V266, P14288
   MICHIELS C, 1988, EUR J BIOCHEM, V177, P435, DOI 10.1111/j.1432-1033.1988.tb14393.x
   MICHIELS C, 1988, EXP CELL RES, V179, P581, DOI 10.1016/0014-4827(88)90296-0
   MICHIELS C, 1994, FREE RADICAL BIO MED, V17, P235, DOI 10.1016/0891-5849(94)90079-5
   NISTICO G, 1992, FREE RADICAL BIO MED, V12, P177, DOI 10.1016/0891-5849(92)90024-B
   OTTO DME, 1995, PHARMACOL TOXICOL, V77, P281, DOI 10.1111/j.1600-0773.1995.tb01028.x
   Otto DME, 1996, FISH PHYSIOL BIOCHEM, V15, P349, DOI 10.1007/BF02112362
   PATNAIK BK, 1994, GERONTOLOGY, V40, P113, DOI 10.1159/000213582
   PATNAIK BK, 1994, GERONTOLOGY, V40, P221, DOI 10.1159/000213589
   PEREZCAMPO R, 1993, COMP BIOCHEM PHYS B, V105, P749, DOI 10.1016/0305-0491(93)90116-M
   QASIM S. Z., 1966, HYDROBIOLOGIA, V27, P289, DOI 10.1007/BF00042692
   RADI AAR, 1988, COMP BIOCHEM PHYS C, V90, P69, DOI 10.1016/0742-8413(88)90099-0
   RADI ALR, 1985, ACTA BIOL HUNG, V36, P169
   RAES M, 1987, FREE RADICAL BIO MED, V3, P3, DOI 10.1016/0891-5849(87)90032-3
   Rokyta R, 1996, Cesk Fysiol, V45, P4
   SASTRE J, 1992, MECH AGEING DEV, V62, P181, DOI 10.1016/0047-6374(92)90054-H
   SATAPATHY NK, 1980, EXP GERONTOL, V15, P499, DOI 10.1016/0531-5565(80)90001-7
   SOHAL RS, 1989, MECH AGEING DEV, V49, P129, DOI 10.1016/0047-6374(89)90096-1
   STELLA AMG, 1987, GERONTOLOGY, V33, P136
   SUTTORP N, 1986, AM J PHYSIOL, V251, pC671, DOI 10.1152/ajpcell.1986.251.5.C671
   VERTECHY M, 1993, EXP GERONTOL, V28, P77, DOI 10.1016/0531-5565(93)90022-6
   WADHWA R, 1988, MECH AGEING DEV, V45, P277, DOI 10.1016/0047-6374(88)90008-5
   WEST ES, 1974, TXB BIOCH, P1396
   WOODHEAD AD, 1978, EXP GERONTOL, V13, P125, DOI 10.1016/0531-5565(78)90005-0
   YU BP, 1994, PHYSIOL REV, V74, P139, DOI 10.1152/physrev.1994.74.1.139
NR 44
TC 17
Z9 18
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
J9 EXP GERONTOL
JI Exp. Gerontol.
PD JUN
PY 1999
VL 34
IS 3
BP 365
EP 374
DI 10.1016/S0531-5565(99)00021-2
PG 10
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 210FM
UT WOS:000081094500006
PM 10433390
DA 2024-02-19
ER

PT J
AU Duicu, OM
   Mirica, SN
   Gheorgheosu, DE
   Privistirescu, AI
   Fira-Mladinescu, O
   Muntean, DM
AF Duicu, Oana M.
   Mirica, Silvia N.
   Gheorgheosu, Dorina E.
   Privistirescu, Andreea I.
   Fira-Mladinescu, Ovidiu
   Muntean, Danina M.
TI Ageing-induced decrease in cardiac mitochondrial function in healthy
   rats
SO CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
LA English
DT Article
DE ageing; oxidative phosphorylation; reactive oxygen species; calcium
   retention capacity
ID CYTOCHROME-C RELEASE; FREE-RADICAL THEORY; ELECTRON-TRANSPORT;
   PERMEABILITY TRANSITION; OXIDATIVE STRESS; HEART; COMPLEX; AGE; DAMAGE;
   LIVER
AB It is widely recognized that mitochondrial dysfunction is a key component of the multifactorial process of ageing. The effects of age on individual components of mitochondrial function vary across species and strains. In this study we investigated the oxygen consumption, the mitochondrial membrane potential (Delta psi), the sensitivity of mitochondrial permeability transition pore (mPTP) to calcium overload, and the production of reactive oxygen species (ROS) in heart mitochondria isolated from old compared with adult healthy Sprague-Dawley rats. Respirometry studies and Delta psi measurements were performed with an Oxygraph-2k equipped with a tetraphenylphosphonium electrode. ROS production and calcium retention capacity were measured spectrofluorimetrically. Our results show an important decline for all bioenergetic parameters for both complex I and complex II supported-respiration, a decreased Delta psi in mitochondria energized with complex I substrates, and an increased mitochondrial ROS production in the old compared with the adult group. Mitochondrial sensitivity to Ca2+-induced mPTP opening was also increased in the old compared with the adult animals. Moreover, the protective effect of cyclosporine A on mPTP opening was significantly reduced in the old group. We conclude that healthy ageing is associated with a decrease in heart mitochondria function in Sprague-Dawley rats.
C1 [Duicu, Oana M.; Mirica, Silvia N.; Gheorgheosu, Dorina E.; Privistirescu, Andreea I.; Fira-Mladinescu, Ovidiu; Muntean, Danina M.] Victor Babes Univ Med & Pharm Timisoara, Dept Pathophysiol, Timisoara 300173, Timis, Romania.
C3 Victor Babes University of Medicine & Pharmacy, Timisoara
RP Muntean, DM (corresponding author), Victor Babes Univ Med & Pharm Timisoara, Dept Pathophysiol, 14 Tudor Vladimirescu St, Timisoara 300173, Timis, Romania.
EM daninamuntean@umft.ro
RI Mirica, Silvia Nicoleta/AAH-4515-2019; Fira-Mladinescu,
   Ovidiu/C-5736-2011; Mirica, Silvia/AAO-7171-2020; MUNTEAN, Danina
   M./G-3138-2016
OI Fira-Mladinescu, Ovidiu/0000-0002-9034-5218; MUNTEAN, Danina
   M./0000-0001-6186-5321; , ANECHITEI/0009-0008-2094-5681
FU POSDRU fellowship [1.5/88/S/ID 63117];  [HU-RO/0901/137/2.2.2]
FX This work was supported by the HU-RO/0901/137/2.2.2 cross-border project
   and the POSDRU fellowship 1.5/88/S/ID 63117. The authors are very
   grateful to Melanie Paillard, Ludovic Gomez, and Abdallah Gharib (INSERM
   U 886, Universite Claude Bernard, Lyon, France) for all of their
   invaluable advice regarding the techniques of CRC, CS activity, and
   H<INF>2</INF>O<INF>2</INF> production. O.D. and D. G. gratefully
   acknowledge the support of COST action FA0602 allowing them to gather
   specific skills in studying mitochondria function through the STSMs
   FA0602-06082 and FA0602-6930, respectively.
CR Andreu AL, 1998, BIOCHEM BIOPH RES CO, V252, P577, DOI 10.1006/bbrc.1998.9703
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   Bratic I, 2010, BBA-BIOENERGETICS, V1797, P961, DOI 10.1016/j.bbabio.2010.01.004
   CAPOZZA G, 1994, ARCH GERONTOL GERIAT, P31, DOI 10.1016/S0167-4943(05)80045-7
   CHIU YJD, 1980, EXP GERONTOL, V15, P511, DOI 10.1016/0531-5565(80)90003-0
   DEDUVE C, 1967, ENZYME CYTOLOGY
   deGrey ADNJ, 1997, BIOESSAYS, V19, P161, DOI 10.1002/bies.950190211
   Di Lisa F, 2005, CARDIOVASC RES, V66, P222, DOI 10.1016/j.cardiores.2005.02.009
   Di Lisa F, 2006, CARDIOVASC RES, V70, P191, DOI 10.1016/j.cardiores.2006.01.016
   Duicu O, 2012, MED-SURG J, V116, P207
   Fannin SW, 1999, ARCH BIOCHEM BIOPHYS, V372, P399, DOI 10.1006/abbi.1999.1508
   Gharib A, 2012, J MOL CELL CARDIOL, V52, P1091, DOI 10.1016/j.yjmcc.2012.02.005
   Gnaiger E, 1995, J BIOENERG BIOMEMBR, V27, P583, DOI 10.1007/BF02111656
   Gnaiger E, 2008, DRUG INDUCED MITOCHO, P327, DOI DOI 10.1002/9780470372531.CH12
   Gnaiger E, 2009, INT J BIOCHEM CELL B, V41, P1837, DOI 10.1016/j.biocel.2009.03.013
   Gomez L, 2007, AM J PHYSIOL-HEART C, V293, pH1654, DOI 10.1152/ajpheart.01378.2006
   GORNALL AG, 1949, J BIOL CHEM, V177, P751
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   Heinen A, 2008, ANESTHESIOLOGY, V109, P830, DOI 10.1097/ALN.0b013e3181895aa0
   ILAR (Institute of Laboratory Animal Resources), 1996, NIH PUBLICATION
   KIM JH, 1988, MECH AGEING DEV, V46, P279, DOI 10.1016/0047-6374(88)90130-3
   Knorre DA, 2012, BIOCHEMISTRY-MOSCOW+, V77, P793, DOI 10.1134/S0006297912070127
   Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61
   Labajova A, 2006, ANAL BIOCHEM, V353, P37, DOI 10.1016/j.ab.2006.03.032
   Lemieux H, 2010, J GERONTOL A-BIOL, V65, P1157, DOI 10.1093/gerona/glq141
   LIU L, 2011, ACTA ANAESTH SCAND, V255, P623, DOI DOI 10.1111/J.1399-6576.2011.02421.X.PMID:21827445
   Maklashina E, 2004, AGING CELL, V3, P21, DOI 10.1111/j.1474-9728.2003.00078.x
   MCMILLIN JB, 1993, CARDIOVASC RES, V27, P2222, DOI 10.1093/cvr/27.12.2222
   Moghaddas S, 2003, ARCH BIOCHEM BIOPHYS, V414, P59, DOI 10.1016/S0003-9861(03)00166-8
   Moreau R, 2004, BIOCHEM BIOPH RES CO, V325, P48, DOI 10.1016/j.bbrc.2004.10.011
   Navarro A, 2007, AM J PHYSIOL-CELL PH, V292, pC670, DOI 10.1152/ajpcell.00213.2006
   Petrosillo G, 2010, J PINEAL RES, V48, P340, DOI 10.1111/j.1600-079X.2010.00758.x
   Petrosillo G, 2009, FREE RADICAL BIO MED, V46, P88, DOI 10.1016/j.freeradbiomed.2008.09.031
   Phaneuf S, 2002, AM J PHYSIOL-REG I, V282, pR423, DOI 10.1152/ajpregu.00296.2001
   Picard Martin, 2010, Aging Cell, V9, P1032, DOI 10.1111/j.1474-9726.2010.00628.x
   PULLIAM DA, 2012, ANTIOXID REDOX SIGN, DOI DOI 10.1089/ARS.2012.4950.PMID:23025472
   RENNERSATTLER K, 2010, MITOCHONDRIAL PHYSL, P1
   ROTTENBERG H, 1984, J MEMBRANE BIOL, V81, P127, DOI 10.1007/BF01868977
   Salmon AB, 2010, FREE RADICAL BIO MED, V48, P642, DOI 10.1016/j.freeradbiomed.2009.12.015
   Savitha S, 2006, MECH AGEING DEV, V127, P349, DOI 10.1016/j.mad.2005.12.004
   Serviddio G, 2007, REDOX REP, V12, P91, DOI 10.1179/135100007X162112
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   SUGIYAMA S, 1993, BIOCHEM MOL BIOL INT, V30, P937
   Szibor M, 2003, BASIC RES CARDIOL, V98, P210, DOI 10.1007/s00395-003-0421-z
   TAKASAWA M, 1993, EXP GERONTOL, V28, P269, DOI 10.1016/0531-5565(93)90034-B
   Tatarková Z, 2011, PHYSIOL RES, V60, P281, DOI 10.33549/physiolres.932019
   TRANCOTA S, 2010, TIMISOARA MED J S, V2, P25
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
NR 48
TC 33
Z9 34
U1 2
U2 15
PU CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS
PI OTTAWA
PA 65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA
SN 0008-4212
EI 1205-7541
J9 CAN J PHYSIOL PHARM
JI Can. J. Physiol. Pharmacol.
PD AUG
PY 2013
VL 91
IS 8
BP 593
EP 600
DI 10.1139/cjpp-2012-0422
PG 8
WC Pharmacology & Pharmacy; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Physiology
GA 190HR
UT WOS:000322330500003
PM 23889593
DA 2024-02-19
ER

PT J
AU Serrano, R
   Villar, M
   Gallardo, N
   Carrascosa, JM
   Martinez, C
   Andrés, A
AF Serrano, Rosario
   Villar, Margarita
   Gallardo, Nilda
   Carrascosa, Jose M.
   Martinez, Carmen
   Andres, Antonio
TI The effect of aging on insulin signalling pathway is tissue dependent:
   Central role of adipose tissue in the insulin resistance of aging
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE Insulin resistance; Aging; Insulin signalling; Adipose tissue; Liver;
   Skeletal muscle
ID PROTEIN-KINASE-B; SKELETAL-MUSCLE; RECEPTOR SUBSTRATE-1;
   GLUCOSE-INTOLERANCE; PHOSPHATIDYLINOSITOL 3-KINASE; RAT ADIPOCYTES;
   IN-VIVO; ACTIVATION; OBESITY; LIVER
AB insulin resistance progressively increases with age, resulting in excessively high incidence of T2D in the elderly population. To investigate the molecular mechanisms underlying insulin resistance of aging, we carried out a comparative study of insulin signalling cascade in adipose tissue, liver and skeletal muscle. We measured the protein levels in different subcellular compartments and the phosphorylation status of key components of the insulin signalling pathway in response to in vivo insulin infusion. White adipose tissue (WAT) from old rats shows altered subcellular distribution of insulin receptor (IR) and insulin receptor substrate 1 (IRS-1) and a marked reduction in the insulin-stimulated IR tyrosine phosphorylation. Furthermore, activation of Akt, as well as GLUT4 translocation to the plasma membrane, is impaired. Quadriceps muscle from old rats also has a defect in GLUT4 trafficking but, in contrast to WAT, insulin signalling at the level of IR and Akt is increased. In liver, we found no major differences in the ability of insulin to induce autophosphorylation of the IR or activation of Akt between adult and old animals. These data, therefore, show at the molecular level that insulin resistance in adipose tissue precedes the development of liver and muscle insulin resistance in aged rats. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
C1 [Serrano, Rosario; Villar, Margarita; Gallardo, Nilda; Martinez, Carmen; Andres, Antonio] Univ Castilla La Mancha, Area Bioquim, Fac Quim, CRIB, E-13071 Ciudad Real, Spain.
   [Carrascosa, Jose M.] Univ Autonoma Madrid, Fac Ciencias, Ctr Biol Mol Severo Ochoa, UAM CSIC, E-28049 Madrid, Spain.
C3 Universidad de Castilla-La Mancha; Autonomous University of Madrid;
   Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de
   Biologia Molecular Severo Ochoa (CBM)
RP Martinez, C (corresponding author), Univ Castilla La Mancha, Area Bioquim, Fac Quim, CRIB, E-13071 Ciudad Real, Spain.
EM carmen.martinez@uclm.es
RI ANDRES, ANTONIO/G-8794-2015; Serrano, Rosario/F-3906-2016; Carrascosa,
   Jose M/ABE-3526-2021; Martinez, Carmen/P-6661-2017; Gallardo,
   Nilda/AAR-3104-2021; Villar-Rayo, Marga/J-4155-2012
OI ANDRES, ANTONIO/0000-0002-9892-8338; Serrano,
   Rosario/0000-0002-0853-597X; Carrascosa, Jose M/0000-0002-3574-9076;
   Martinez, Carmen/0000-0001-7226-9154; Gallardo,
   Nilda/0000-0003-3211-569X; Villar-Rayo, Marga/0000-0003-4172-9079
FU Ministerio de Ciencia y Tecnologia (MCYT, Spain)
   [BFU2005-07647-C03-03/BFI]; Junta de Comunidades de Castilla-La Mancha
   (JCCM, Spain); Ramon Areces Foundation
FX We greatly appreciate the technical assistance of Sergio Moreno. This
   work was supported by Research Grants BFU2005-07647-C03-03/BFI from
   Ministerio de Ciencia y Tecnologia (MCYT, Spain), PAC-05-003-1 and
   PCI08-0136 from Junta de Comunidades de Castilla-La Mancha (JCCM,
   Spain). The Centro de Biologia Molecular is recipient of institutional
   aid from the Ramon Areces Foundation. M.V. and R.S. were recipients of
   predoctoral fellowships from MCYT and from JCCM, respectively.
CR Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575
   Alberti KGMM, 2007, DIABETIC MED, V24, P451, DOI 10.1111/j.1464-5491.2007.02157.x
   Balbis A, 2000, ENDOCRINOLOGY, V141, P4041, DOI 10.1210/en.141.11.4041
   BEVAN AP, 1995, J BIOL CHEM, V270, P10784, DOI 10.1074/jbc.270.18.10784
   Blüher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223
   Blüher M, 2002, DEV CELL, V3, P25, DOI 10.1016/S1534-5807(02)00199-5
   CARRASCOSA JM, 1989, BIOCHEM BIOPH RES CO, V160, P303, DOI 10.1016/0006-291X(89)91656-2
   Carvalho CRO, 1996, ENDOCRINOLOGY, V137, P151, DOI 10.1210/en.137.1.151
   Cleasby ME, 2007, MOL ENDOCRINOL, V21, P215, DOI 10.1210/me.2006-0154
   CUSIN I, 1990, BIOCHEM J, V267, P99, DOI 10.1042/bj2670099
   DEFRONZO RA, 1981, DIABETES CARE, V4, P493, DOI 10.2337/diacare.4.4.493
   Dombrowski L, 2000, DIABETES, V49, P1772, DOI 10.2337/diabetes.49.11.1772
   Escriva F, 1997, ENDOCRINOLOGY, V138, P49, DOI 10.1210/en.138.1.49
   Escrivá F, 2007, J ENDOCRINOL, V194, P131, DOI 10.1677/joe.1.07043
   Gabriely I, 2002, DIABETES, V51, P2951, DOI 10.2337/diabetes.51.10.2951
   Groop LC, 1999, DIABETES OBES METAB, V1, pS1, DOI 10.1046/j.1463-1326.1999.0010s1001.x
   He J, 2003, AM J PHYSIOL-REG I, V284, pR1138, DOI 10.1152/ajpregu.00560.2002
   Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842
   Kim SP, 2003, DIABETES, V52, P2453, DOI 10.2337/diabetes.52.10.2453
   KONO S, 1990, AM J PHYSIOL, V259, pE27, DOI 10.1152/ajpendo.1990.259.1.E27
   KRAEGEN EW, 1991, DIABETES, V40, P1397, DOI 10.2337/diabetes.40.11.1397
   Leibiger B, 2001, MOL CELL, V7, P559, DOI 10.1016/S1097-2765(01)00203-9
   Logie L, 2007, DIABETES, V56, P2218, DOI 10.2337/db07-0343
   Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005
   Molero JC, 1998, FEBS LETT, V425, P298, DOI 10.1016/S0014-5793(98)00258-0
   Molero JC, 2002, MOL CELL ENDOCRINOL, V189, P77, DOI 10.1016/S0303-7207(01)00737-7
   MUNOZ P, 1995, BIOCHEM J, V312, P393, DOI 10.1042/bj3120393
   NARIMIYA M, 1984, AM J PHYSIOL, V246, pE397, DOI 10.1152/ajpendo.1984.246.5.E397
   Petersen KF, 2007, P NATL ACAD SCI USA, V104, P12587, DOI 10.1073/pnas.0705408104
   RUIZ P, 1992, ARCH BIOCHEM BIOPHYS, V296, P231, DOI 10.1016/0003-9861(92)90567-G
   Smith U, 2002, INT J OBESITY, V26, P897, DOI 10.1038/sj.ijo.0802028
   Song XM, 1999, AM J PHYSIOL-REG I, V277, pR1690, DOI 10.1152/ajpregu.1999.277.6.R1690
   Thong FSL, 2005, PHYSIOLOGY, V20, P271, DOI 10.1152/physiol.00017.2005
   Turcotte LP, 1999, J APPL PHYSIOL, V87, P285, DOI 10.1152/jappl.1999.87.1.285
   Ueno M, 2005, DIABETOLOGIA, V48, P506, DOI 10.1007/s00125-004-1662-6
   Uhles S, 2007, FASEB J, V21, P1609, DOI 10.1096/fj.06-7589com
   Villar M, 2006, BBA-MOL CELL RES, V1763, P197, DOI 10.1016/j.bbamcr.2005.12.005
   Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246
   Wijkander J, 1997, J BIOL CHEM, V272, P21520, DOI 10.1074/jbc.272.34.21520
   Wu DY, 2007, J IMMUNOL, V179, P4829, DOI 10.4049/jimmunol.179.7.4829
   Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451
   Zhu M, 2005, NUTRITION, V21, P378, DOI 10.1016/j.nut.2004.06.030
NR 42
TC 22
Z9 25
U1 0
U2 12
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
EI 1872-6216
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD MAR
PY 2009
VL 130
IS 3
BP 189
EP 197
DI 10.1016/j.mad.2008.11.005
PG 9
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 414OC
UT WOS:000263873000009
PM 19063913
DA 2024-02-19
ER

PT J
AU Lee, J
   Padhye, A
   Sharma, A
   Song, GS
   Miao, J
   Mo, YY
   Wang, L
   Kemper, JK
AF Lee, Jiyoung
   Padhye, Amruta
   Sharma, Abhilasha
   Song, Guisheng
   Miao, Ji
   Mo, Yin-Yuan
   Wang, Li
   Kemper, Jongsook Kim
TI A Pathway Involving Farnesoid X Receptor and Small Heterodimer Partner
   Positively Regulates Hepatic Sirtuin 1 Levels via MicroRNA-34a
   Inhibition
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID BILE-ACID; METABOLIC DISEASE; LIPID-METABOLISM; FXR; SHP; P53;
   PGC-1-ALPHA; ACTIVATION; PROTECTS; GLUCOSE
AB Sirtuin 1 (SIRT1) is a NAD-dependent deacetylase that is critically involved in diverse cellular processes including metabolic disease, cancer, and possibly aging. Despite extensive studies on SIRT1 function, how SIRT1 levels are regulated remains relatively unknown. Here, we report that the nuclear bile acid receptor farnesoid X receptor (FXR) inhibits microRNA-34a (miR34a) in the liver, which results in a positive regulation of SIRT1 levels. Activation of FXR by the synthetic agonist GW4064 decreases hepatic miR-34a levels in normal mice, and consistently, hepatic miR-34a levels are elevated in FXR-null mice. FXR induces expression of small heterodimer partner (SHP), an orphan nuclear receptor and transcriptional corepressor, which in turn results in repression of p53, a key activator of the miR34a gene, by inhibiting p53 occupancy at the promoter. MiR-34a decreased SIRT1 levels by binding to the 3'-untranslated region of SIRT1 mRNA, and adenovirus-mediated overexpression of miR-34a substantially decreased SIRT1 protein levels in mouse liver. Remarkably, miR-34a levels were elevated, and SIRT1 protein levels were reduced in diet-induced obese mice, and FXR activation in these mice reversed the miR-34a and SIRT1 levels, indicating an intriguing link among FXR activation, decreased miR-34a, and subsequently, increased SIRT1 levels. Our study demonstrates an unexpected role of the FXR/SHP pathway in controlling SIRT1 levels via miR-34a inhibition and that elevated miR-34a levels in obese mice contribute to decreased SIRT1 levels. Manipulation of this regulatory network may be useful for treating diseases of aging, such as metabolic disease and cancer.
C1 [Lee, Jiyoung; Padhye, Amruta; Sharma, Abhilasha; Miao, Ji; Kemper, Jongsook Kim] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA.
   [Song, Guisheng; Wang, Li] Univ Utah, Sch Med, Huntsman Canc Inst, Dept Med, Salt Lake City, UT 84132 USA.
   [Song, Guisheng; Wang, Li] Univ Utah, Sch Med, Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT 84132 USA.
   [Mo, Yin-Yuan] So Illinois Univ, Sch Med, Dept Med Microbiol Immunol & Cell Biol, Springfield, IL 62794 USA.
C3 University of Illinois System; University of Illinois Urbana-Champaign;
   Utah System of Higher Education; University of Utah; Huntsman Cancer
   Institute; Utah System of Higher Education; University of Utah; Huntsman
   Cancer Institute; Southern Illinois University System; Southern Illinois
   University
RP Kemper, JK (corresponding author), 407 S Goodwin Ave, Urbana, IL 61801 USA.
EM jongsook@uiuc.edu
RI Miao, Ji/F-9398-2015; song, guisheng/E-4913-2011; Mo,
   Yin-Yuan/R-8255-2019; Padhye, Amruta/ABB-3858-2020
OI Miao, Ji/0000-0003-0869-4492; Padhye, Amruta/0000-0002-1524-5612
FU National Institutes of Health [DK062777, DK080032]; American Diabetes
   Association Basic Science Award
FX This work was supported, in whole or in part, by National Institutes of
   Health Grants DK062777 and DK080032. This work was also supported by an
   American Diabetes Association Basic Science Award (to J.K.K.).
CR Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354
   Cantó C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813
   Cariou B, 2005, FEBS LETT, V579, P4076, DOI 10.1016/j.febslet.2005.06.033
   Cariou B, 2007, TRENDS PHARMACOL SCI, V28, P236, DOI 10.1016/j.tips.2007.03.002
   Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010
   Coste A, 2008, P NATL ACAD SCI USA, V105, P17187, DOI 10.1073/pnas.0808207105
   Duran-Sandoval D, 2005, J BIOL CHEM, V280, P29971, DOI 10.1074/jbc.M501931200
   Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005
   Fang SS, 2007, MOL CELL BIOL, V27, P1407, DOI 10.1128/MCB.00944-06
   Fang S, 2008, J BIOL CHEM, V283, P35086, DOI 10.1074/jbc.M803531200
   Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017
   Fiorucci S, 2007, TRENDS MOL MED, V13, P298, DOI 10.1016/j.molmed.2007.06.001
   Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4
   Guarente L, 2007, COLD SPRING HARB SYM, V72, P483, DOI 10.1101/sqb.2007.72.024
   He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939
   Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651
   Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200
   Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127
   Kemper JK, 2004, MOL CELL BIOL, V24, P7707, DOI 10.1128/MCB.24.17.7707-7719.2004
   Kemper JK, 2009, CELL METAB, V10, P392, DOI 10.1016/j.cmet.2009.09.009
   Krützfeldt J, 2007, NUCLEIC ACIDS RES, V35, P2885, DOI 10.1093/nar/gkm024
   Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013
   Lee FY, 2006, TRENDS BIOCHEM SCI, V31, P572, DOI 10.1016/j.tibs.2006.08.002
   Lee YK, 2000, MOL CELL BIOL, V20, P187, DOI 10.1128/MCB.20.1.187-195.2000
   Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2
   Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4
   Ma K, 2006, J CLIN INVEST, V116, P1102, DOI 10.1172/JCI25604
   Miao J, 2009, GENE DEV, V23, P986, DOI 10.1101/gad.1773909
   Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6
   Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034
   Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104
   Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354
   Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3
   Song GS, 2008, NUCLEIC ACIDS RES, V36, P5727, DOI 10.1093/nar/gkn567
   van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089
   Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025
   Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105
   Yamakuchi M, 2009, CELL CYCLE, V8, P712, DOI 10.4161/cc.8.5.7753
   Zhang YQ, 2004, GENE DEV, V18, P157, DOI 10.1101/gad.1138104
   Zhang YQ, 2006, P NATL ACAD SCI USA, V103, P1006, DOI 10.1073/pnas.0506982103
NR 40
TC 206
Z9 226
U1 0
U2 11
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI ROCKVILLE
PA 11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD APR 23
PY 2010
VL 285
IS 17
BP 12604
EP 12611
DI 10.1074/jbc.M109.094524
PG 8
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 584XO
UT WOS:000276787800018
PM 20185821
OA hybrid, Green Published
DA 2024-02-19
ER

PT J
AU Hou, H
   Zhang, Y
   Liu, HM
   Li, DP
AF Hou, Hui
   Zhang, Yan
   Liu, Huimin
   Li, Danping
TI Effect of IL-1β on migration, invasion and senescence of bile duct
   epithelial cells
SO INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE
LA English
DT Article
DE Interleukin-1 beta; epithelial-mesenchymal transition; human
   intrahepatic bile duct epithelial cell; cell migration; cell invasion;
   cell senescence
ID E-CADHERIN/BETA-CATENIN; MESENCHYMAL TRANSITION; LIVER FIBROSIS;
   EXPRESSION; PROTEINS; COMPLEX; INJURY
AB Objective: To investigate the effects of interleukin-1 beta (IL-1 beta) on migration, invasion and senescence of Human intrahepatic bile duct epithelial cells (HIBECs). Methods: HIBECs were stimulated with different concentrations of IL-1 beta (0, 10, 20 and 30 ng/mL), and their migration, invasion and senescence were evaluated by scratch and Transwell tests, and beta-galactosidase staining respectively. Real-time fluorescence quantitative PCR and western blot were used to detect epithelial-mesenchymal transition (EMT) related markers such as E-cadherin, beta-catenin, CK19, fibronectin, vimentin, N-cadherin and invasion-related MMP-1 mRNA and proteins respectively. Results: After continuous stimulation of HIBECs with IL-1 beta for 24 h, migration and invasion were significantly increased compared with the untreated cells (all P<0.05). In addition, the number of beta-galactosidase-positive senescent HIBECs also significantly increased upon IL-1 beta stimulation (all P<0.05). Under high levels of IL-1 beta, the expression of interstitial cell markers (fibronectin, vimentin, N-cadherin) and invasion-related genes (MMP-1) significantly increased (all P<0.05), and that of epithelial markers (E-cadherin, beta-catenin and CK19) significantly decreased (all P<0.05). Conclusion: IL-1 beta stimulation can induce EMT in HIBECs and increase their invasion and migration, as well as promote malignant transformation and senescence.
C1 [Hou, Hui; Liu, Huimin; Li, Danping] Xinjiang Med Univ, Affiliated Hosp 5, Dept Gastroenterol, 118 Henan Rd, Urumqi 830000, Xinjiang Uygur, Peoples R China.
   [Zhang, Yan] Xinjiang Med Univ, Affiliated Hosp 5, Dept Nephrol, Urumqi, Xinjiang Uygur, Peoples R China.
C3 Xinjiang Medical University; Xinjiang Medical University
RP Hou, H (corresponding author), Xinjiang Med Univ, Affiliated Hosp 5, Dept Gastroenterol, 118 Henan Rd, Urumqi 830000, Xinjiang Uygur, Peoples R China.
EM houhui27@163.com
RI Li, Dan/HJA-0406-2022
CR Chen HN, 2016, CANCER RES, V76, P1122, DOI 10.1158/0008-5472.CAN-15-1962
   Dimri M, 2017, DEVELOPMENT, V144, P2595, DOI 10.1242/dev.147397
   Dong W, 2016, ONCOL REP, V36, P2126, DOI 10.3892/or.2016.4979
   Dyson JK, 2015, NAT REV GASTRO HEPAT, V12, P147, DOI 10.1038/nrgastro.2015.12
   Gehrke N, 2018, J HEPATOL, V68, P986, DOI 10.1016/j.jhep.2018.01.008
   Huang QS, 2016, TOHOKU J EXP MED, V240, P269, DOI 10.1620/tjem.240.269
   Jeffery HC, 2016, J HEPATOL, V64, P1118, DOI 10.1016/j.jhep.2015.12.017
   Jiang GX, 2016, MOL MED REP, V13, P1563, DOI 10.3892/mmr.2015.4706
   Kanamori Y, 2017, J BIOL CHEM, V292, P10275, DOI 10.1074/jbc.M116.770974
   Kim JW, 2018, AM J PATHOL, V188, P967, DOI 10.1016/j.ajpath.2017.12.010
   Kwon H, 2017, AM J PATHOL, V187, P2288, DOI 10.1016/j.ajpath.2017.06.014
   Labernadie A, 2017, NAT CELL BIOL, V19, P224, DOI 10.1038/ncb3478
   Li R, 2018, J CELL BIOCHEM, V119, P2135, DOI 10.1002/jcb.26375
   Mitselou A, 2016, ANTICANCER RES, V36, P2271
   Ning ZW, 2017, ANTIOXID REDOX SIGN, V27, P1, DOI 10.1089/ars.2016.6669
   Saeki N, 2015, ANTICANCER RES, V35, P2619
   So J, 2018, HEPATOLOGY, V67, P2352, DOI 10.1002/hep.29752
   Takashima Y, 2015, HEPATOLOGY, V61, P1003, DOI 10.1002/hep.27436
   Wang M, 2016, INT J ONCOL, V48, P595, DOI 10.3892/ijo.2015.3270
   Xao YT, 2015, PEDIATR RES, V77, P310, DOI 10.1038/pr.2014.181
   Yang HP, 2015, LUNG CANCER, V87, P249, DOI 10.1016/j.lungcan.2014.12.015
NR 21
TC 0
Z9 0
U1 1
U2 4
PU E-CENTURY PUBLISHING CORP
PI MADISON
PA 40 WHITE OAKS LN, MADISON, WI 53711 USA
SN 1940-5901
J9 INT J CLIN EXP MED
JI Int. J. Clin. Exp. Med.
PY 2019
VL 12
IS 2
BP 1562
EP 1569
PG 8
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA HN2GB
UT WOS:000460002600025
DA 2024-02-19
ER

PT J
AU LECOUTEUR, D
   RIVORY, LP
   YI, C
   POND, SM
AF LECOUTEUR, D
   RIVORY, LP
   YI, C
   POND, SM
TI AGING, ACUTE OXIDATIVE INJURY AND HEPATOCELLULAR GLUCOSE-TRANSPORT IN
   THE RAT
SO INTERNATIONAL HEPATOLOGY COMMUNICATIONS
LA English
DT Article
DE GLUCOSE TRANSPORT; PERFUSED RAT LIVER; AGING; HYDROGEN PEROXIDE;
   MULTIPLE INDICATOR-DILUTION
ID CELL-MEMBRANES; LIVER; EXPRESSION; DECREASE; ISOFORMS
AB We studied the effects of aging and acute exposure to hydrogen peroxide on hepatocellular glucose transport to determine whether (1) acute oxidative stress impairs glucose transport, (2) aging is associated with reduced glucose transport and (3) there are similarities between these changes that may provide insight into the aging process. Glucose transport was measured in the perfused livers of young and aged rats using the multiple indicator-dilution method. There were significant reductions in the rate constants for glucose influx (P < 0.001) and a significant increase in the extracellular volume in the livers from aged rats (aged: 0.39 +/- 0.05 ml/g, young: 0.27 +/- 0.04 ml/g), However, the K-m and V-max for glucose influx in the livers from aged rats (44 +/- 22 mM, 7.1 +/- 1.4 mu mol.s(-1)g(-1) respectively) were not significantly different from the values in young rats (64 +/- 20 mM, 8.8 +/- 1.3 mu mol.s(-1)g(-1)). In the livers of young rats, treatment with hydrogen peroxide caused a significant reduction in glucose transport from 1.18 +/- 0.22 to 0.49 +/- 0.25 mu mol.s(-1)g(-1). This was partly restored to 0.69 +/- 0.20 mu mol.s(-1)g(-1) by occluding the outflow catheter and expanding the extracellular space. Thus, although aging did not influence the rate of glucose transport in the perfused rat liver, this may be due to a compensatory age-related increase in the extracellular volume. In conclusion, the changes observed in hepatocellular glucose transport in the aged liver could be simulated by oxidative injury in the young liver, suggesting a role for oxidative injury in the aging process.
RP LECOUTEUR, D (corresponding author), UNIV QUEENSLAND,PRINCESS ALEXANDRA HOSP,DEPT MED,IPSWICH RD,BRISBANE,QLD 4102,AUSTRALIA.
OI Le Couteur, David/0000-0002-4227-5817; Rivory,
   Laurent/0000-0002-1734-7882
CR GARVEY WT, 1992, DIABETES CARE, V15, P396, DOI 10.2337/diacare.15.3.396
   GORESKY CA, 1974, J CLIN INVEST, V53, P634, DOI 10.1172/JCI107598
   HARMAN D, 1993, DRUG AGING, V3, P60, DOI 10.2165/00002512-199303010-00006
   HEGNER D, 1980, MECH AGEING DEV, V14, P101, DOI 10.1016/0047-6374(80)90109-8
   ISHII EL, 1987, BIOCHEM PHARMACOL, V36, P1417, DOI 10.1016/0006-2952(87)90107-9
   JOURDHEUIL D, 1993, AMJ PHYSL, V24, pG1009
   LECOUTEUR D, 1992, BIOCHEM PHARMACOL, V43, P913, DOI 10.1016/0006-2952(92)90264-J
   LECOUTEUR DG, 1994, J GASTROEN HEPATOL, V9, P385
   LIN JL, 1991, DIABETOLOGIA, V34, P477, DOI 10.1007/BF00403283
   NOKUBO M, 1985, J GERONTOL, V40, P409, DOI 10.1093/geronj/40.4.409
   OHTA M, 1988, BIOCHEM PHARMACOL, V37, P935
   OKA Y, 1992, GERONTOLOGY, V38, P3
   PANG KS, 1991, AM J PHYSIOL, V261, pG929, DOI 10.1152/ajpgi.1991.261.6.G929
   PIERI C, 1975, EXP GERONTOL, V10, P291, DOI 10.1016/0531-5565(75)90006-6
   ROHN TT, 1993, BIOCHEM PHARMACOL, V46, P525, DOI 10.1016/0006-2952(93)90530-A
   THORENS B, 1992, INT REV CYTOL, V137A, P209
   UYSAL M, 1989, MECH AGEING DEV, V48, P85, DOI 10.1016/0047-6374(89)90028-6
   ZSNAGY I, 1991, LIVER AGING, P321
   ZSNAGY I, 1982, LIVER AGING 1982, P215
NR 19
TC 15
Z9 15
U1 0
U2 0
PU ELSEVIER SCI PUBL IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0928-4346
J9 INT HEPATOL COMMUN
JI Int. Hepatol. Commun.
PD MAY
PY 1995
VL 3
IS 5
BP 244
EP 253
DI 10.1016/0928-4346(94)00186-9
PG 10
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA QV960
UT WOS:A1995QV96000003
DA 2024-02-19
ER

PT J
AU Ye, M
   Chen, WX
   Qiu, T
   Yuan, RY
   Ye, YW
   Cai, JM
AF Ye, Ming
   Chen, Wu-xi
   Qiu, Tao
   Yuan, Ru-yue
   Ye, Ying-wang
   Cai, Jing-min
TI Structural characterisation and anti-ageing activity of extracellular
   polysaccharide from a strain of <i>Lachnum</i> sp.
SO FOOD CHEMISTRY
LA English
DT Article
DE Lachnum; Exopolysaccharide; Purification; beta(1 -> 3)-D-Glucan;
   Anti-ageing activity
ID WATER-SOLUBLE POLYSACCHARIDE; PAPYRACEUM KARST KARST; ANTIMICROBIAL
   ACTIVITIES; BIOLOGICAL-ACTIVITIES; OXIDATIVE STRESS; PURIFICATION; MICE;
   METABOLITES; MUSHROOM; RICH
AB A homogeneous extracellular polysaccharide of Lachnum YM261(LEPS-1) with a molecular weight of 21670 Da was characterised. According to HPGPC, IR, periodate oxidation and Smith degradation, GC-MS and H-1 NMR analysis, the results indicated that LEPS-1 was a glucan linked by the beta-(1 -> 3)-D-pyran glycosidic bond. The effect of LEPS-1 on anti-ageing in D-gal model mice was also studied. It was found that LEPS-1 significantly increased the activities of antioxidant enzymes (i.e. SOD superoxide dismutase, CAT catalase, GSH-PX glutathione peroxidase) and decreased malondialdehyde (MDA) content in liver, brain and serum of D-gal model mice. These results showed that LEPS-1 had a strong anti-ageing activity. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Ye, Ming; Chen, Wu-xi; Qiu, Tao; Yuan, Ru-yue; Ye, Ying-wang] Hefei Univ Technol, Coll Biotechnol & Food Engn, Hefei 230009, Peoples R China.
   [Cai, Jing-min] Hefei Univ, Dept Biol & Environm Engn, Hefei 230022, Peoples R China.
C3 Hefei University of Technology; Hefei University
RP Ye, M (corresponding author), Hefei Univ Technol, Coll Biotechnol & Food Engn, Hefei 230009, Peoples R China.
EM yeming123@sina.com
RI Zhang, Yihao/JGM-3514-2023
FU National Natural Science Foundation of China [31070021]; Universities
   Natural Science Foundation of Anhui Province of China [kj2010zd10]
FX This work was financially supported by the National Natural Science
   Foundation of China (31070021) and the Universities Natural Science
   Foundation of major programme of Anhui Province of China (kj2010zd10).
CR Alvarado C, 2006, DEV COMP IMMUNOL, V30, P1168, DOI 10.1016/j.dci.2006.03.004
   Andrès E, 2006, PATHOL BIOL, V54, P420, DOI 10.1016/j.patbio.2006.07.004
   Bekheit MM, 2011, INT J BIOL MACROMOL, V48, P558, DOI 10.1016/j.ijbiomac.2011.01.018
   Chen SC, 2005, FEMS MICROBIOL LETT, V249, P247, DOI 10.1016/j.femsle.2005.06.033
   ERBING B, 1995, CARBOHYD RES, V273, P197, DOI 10.1016/0008-6215(95)00099-F
   He JZ, 2010, CHINESE J ANAL CHEM, V38, P372, DOI 10.3724/SP.J.1096.2010.00372
   Hwang HJ, 2005, LIFE SCI, V76, P3069, DOI 10.1016/j.lfs.2004.12.019
   Kim YT, 2000, CARBOHYD RES, V328, P331, DOI 10.1016/S0008-6215(00)00105-1
   Kirk P. M., 2008, AINSWORTH BISBYS DIC
   Li HP, 2010, NUTRITION, V26, P556, DOI 10.1016/j.nut.2009.06.009
   Li XM, 2007, J ETHNOPHARMACOL, V111, P504, DOI 10.1016/j.jep.2006.12.024
   Linnane AW, 2006, ANN NY ACAD SCI, V1067, P47, DOI 10.1196/annals.1354.008
   [刘润芝 Liu Runzhi], 2002, [激光生物学报, Acta laser biology sinica], V11, P119
   Mitry RR, 2000, HEPATOLOGY, V31, P885, DOI 10.1053/he.2000.5631
   Mondal S, 2004, CARBOHYD RES, V339, P1135, DOI 10.1016/j.carres.2004.02.019
   Rout D, 2008, CARBOHYD RES, V343, P982, DOI 10.1016/j.carres.2007.12.022
   [阮征 RUAN Zheng], 2007, [光谱实验室, Chinese Journal of Spectroscopy laboratory], V24, P496
   Schuessel K, 2006, FREE RADICAL BIO MED, V40, P850, DOI 10.1016/j.freeradbiomed.2005.10.041
   Shan RD, 1996, J ANTIBIOT, V49, P447, DOI 10.7164/antibiotics.49.447
   STADLER M, 1993, J ANTIBIOT, V46, P961
   Sun YX, 2008, BIORESOURCE TECHNOL, V99, P900, DOI 10.1016/j.biortech.2007.01.029
   Virkki L, 2005, CARBOHYD POLYM, V59, P357, DOI 10.1016/j.carbpol.2004.10.006
   Wang Y, 2010, FITOTERAPIA, V81, P397, DOI 10.1016/j.fitote.2009.11.008
   Wei Y. A., 1989, PHARM SINICA, V24, P532
   Xie JH, 2010, FOOD CHEM, V119, P1626, DOI 10.1016/j.foodchem.2009.09.055
   Xie S.Q., 2008, J MED COLL PLA, V23, P167
   Yan JC, 2003, CHEM J CHINESE U, V24, P1189
   Ye M, 2011, CARBOHYD POLYM, V86, P285, DOI 10.1016/j.carbpol.2011.04.051
   Ye Ming, 2009, Journal of Zhejiang University (Agriculture and Life Sciences), V35, P153
   Yu M., 2009, MYCOSYSTEMA, V28, P813
   Yüksel S, 2006, J THERM BIOL, V31, P313, DOI 10.1016/j.jtherbio.2005.12.007
   Zhang H, 2011, CARBOHYD POLYM, V84, P638, DOI 10.1016/j.carbpol.2010.12.044
   Zhang W. J, 1999, BASIS ROTORDYNAMIC T
NR 33
TC 45
Z9 48
U1 5
U2 83
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0308-8146
J9 FOOD CHEM
JI Food Chem.
PD MAY 1
PY 2012
VL 132
IS 1
BP 338
EP 343
DI 10.1016/j.foodchem.2011.10.087
PG 6
WC Chemistry, Applied; Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry; Food Science & Technology; Nutrition & Dietetics
GA 894ZD
UT WOS:000300465100044
PM 26434299
DA 2024-02-19
ER

PT J
AU Park, KH
   Kim, JM
   Cho, KH
AF Park, Ki-Hoon
   Kim, Jong-Min
   Cho, Kyung-Hyun
TI Elaidic acid (EA) generates dysfunctional high-density lipoproteins and
   consumption of EA exacerbates hyperlipidemia and fatty liver change in
   zebrafish
SO MOLECULAR NUTRITION & FOOD RESEARCH
LA English
DT Article
DE Atherosclerosis; Elaidic acid; Embryo; HDL; Trans-fatty acid; Zebrafish
ID APOLIPOPROTEIN-A-I; CHOLESTERYL ESTER TRANSFER; TRANSFER
   PROTEIN-ACTIVITY; HEART-DISEASE; LIPID-FREE; TRANS; SENESCENCE; HDL;
   METAANALYSIS; MEMBRANE
AB Scope: It is well known that trans-fatty acids have proatherogenic properties while HDL has antiatherogenic activities in plasma. However, there has been no report on the effects of trans-fat on the functional and structural properties of HDL.
   Methods and results: To compare physiological properties, we synthesized reconstituted HDL (rHDL) containing stearic acid (18:0), oleic acid (18:1, cis), or elaidic acid (EA, 18:1, trans). An rHDL containing EA (EA-rHDL) showed loss of antioxidant ability and induced the highest uptake of oxidized LDL into human macrophages. EA-rHDL caused the strongest cellular senescence in human dermal fibroblast cells along with the highest production of inflammatory species in macrophages co-treated with fructose. Injection of EA-rHDL into zebrafish embryos resulted in acute embryonic toxicity with the lowest survivability. Consumption of trans-fat for 20 weeks resulted in remarkable hyperlipidemia, elevation of serum cholesteryl ester transfer protein activity, hepatic inflammation, and fatty liver changes.
   Conclusion: Incorporation of EA impaired the beneficial effects of rHDL against atherogenesis. In zebrafish, EA-rHDL resulted in acute embryonic toxicity, and consumption of EA caused remarkable hyperlipidemia, inflammation, and fatty liver changes.
C1 [Park, Ki-Hoon; Kim, Jong-Min; Cho, Kyung-Hyun] Yeungnam Univ, Sch Biotechnol, Kyongsan 712749, South Korea.
   [Park, Ki-Hoon; Kim, Jong-Min; Cho, Kyung-Hyun] Yeungnam Univ, Res Inst Prot Sensor, Kyongsan 712749, South Korea.
   [Park, Ki-Hoon; Kim, Jong-Min; Cho, Kyung-Hyun] Yeungnam Univ, BK21plus Program Serum Biomed Res & Educ Team, Kyongsan 712749, South Korea.
C3 Yeungnam University; Yeungnam University; Yeungnam University
RP Cho, KH (corresponding author), Yeungnam Univ, Sch Biotechnol, Kyongsan 712749, South Korea.
EM chok@yu.ac.kr
RI Park, Ki-Hoon/AAF-2009-2021
FU National Research Foundation of Korea (NRF) [2011-0015529, 2010-020910]
FX This work was supported by the Mid-carreer Researcher Program
   (2011-0015529) and Basic Science Research Program (2010-020910) through
   the National Research Foundation of Korea (NRF).
CR ABBEY M, 1994, ATHEROSCLEROSIS, V106, P99, DOI 10.1016/0021-9150(94)90086-8
   Adams TH, 2010, BRIT J NUTR, V103, P91, DOI 10.1017/S0007114509991516
   Aronis KN, 2012, AM J CLIN NUTR, V96, P1093, DOI 10.3945/ajcn.112.040576
   Bendsen NT, 2011, EUR J CLIN NUTR, V65, P773, DOI 10.1038/ejcn.2011.34
   BREWER HB, 1986, METHOD ENZYMOL, V128, P223
   Butt MS, 2009, J AOAC INT, V92, P1277
   Carlson S E, 1997, Am J Clin Nutr, V66, p715S
   CHEN YH, 1972, BIOCHEMISTRY-US, V11, P4120, DOI 10.1021/bi00772a015
   Cho KH, 2011, J GERONTOL A-BIOL, V66, P1274, DOI 10.1093/gerona/glr169
   Cho KH, 2009, MOL CELLS, V27, P291, DOI 10.1007/s10059-009-0037-8
   ESTERBAUER H, 1989, FREE RADICAL RES COM, V6, P67, DOI 10.3109/10715768909073429
   Fournier N, 2012, BBA-MOL CELL BIOL L, V1821, P303, DOI 10.1016/j.bbalip.2011.10.005
   FRAENKELCONRAT H, 1957, METHOD ENZYMOL, V4, P247, DOI 10.1016/0076-6879(57)04059-8
   Gatto LM, 2003, AM J CLIN NUTR, V77, P1119, DOI 10.1093/ajcn/77.5.1119
   Gatto LM, 2002, J NUTR, V132, P1242, DOI 10.1093/jn/132.6.1242
   Hadfield KA, 2013, BIOCHEM J, V449, P531, DOI 10.1042/BJ20121210
   Han JM, 2005, J LIPID RES, V46, P589, DOI 10.1194/jlr.M400468-JLR200
   Hu JF, 2011, EUR J CANCER PREV, V20, P530, DOI 10.1097/CEJ.0b013e328348fbfb
   Jin S, 2011, FOOD CHEM TOXICOL, V49, P1521, DOI 10.1016/j.fct.2011.03.043
   Khosla P, 1997, J NUTR, V127, pS531, DOI 10.1093/jn/127.3.531S
   Lichtenstein AH, 2006, CIRCULATION, V114, P82, DOI 10.1161/CIRCULATIONAHA.106.176158
   MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9
   MATZ CE, 1982, J BIOL CHEM, V257, P4535
   Micha R, 2009, NAT REV ENDOCRINOL, V5, P335, DOI 10.1038/nrendo.2009.79
   Morton RE, 2000, BBA-MOL CELL BIOL L, V1486, P275, DOI 10.1016/S1388-1981(00)00064-0
   Mozaffarian D, 2006, NEW ENGL J MED, V354, P1601, DOI 10.1056/NEJMra054035
   Nusslein-Volhard C., 2002, ZEBRAFISH PRACTICAL
   Park KH, 2011, FISH SHELLFISH IMMUN, V31, P904, DOI 10.1016/j.fsi.2011.08.006
   Park KH, 2011, J GERONTOL A-BIOL, V66, P511, DOI 10.1093/gerona/glr016
   Park KH, 2010, J GERONTOL A-BIOL, V65, P600, DOI 10.1093/gerona/glq034
   Park KH, 2010, BIOCHEM BIOPH RES CO, V392, P295, DOI 10.1016/j.bbrc.2009.12.179
   Sheila M. I., 2006, ATHEROSCLEROSIS SUPP, V7, P17
   STAROS JV, 1982, BIOCHEMISTRY-US, V21, P3950, DOI 10.1021/bi00260a008
   Teegala SM, 2009, J AOAC INT, V92, P1250
   Thompson AK, 2008, NUTR RES REV, V21, P174, DOI 10.1017/S0954422408110964
   VANTOL A, 1995, ATHEROSCLEROSIS, V115, P129, DOI 10.1016/0021-9150(94)05509-H
NR 36
TC 26
Z9 26
U1 1
U2 35
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1613-4125
EI 1613-4133
J9 MOL NUTR FOOD RES
JI Mol. Nutr. Food Res.
PD JUL
PY 2014
VL 58
IS 7
BP 1537
EP 1545
DI 10.1002/mnfr.201300955
PG 9
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA AL3CC
UT WOS:000339001900015
PM 24863413
DA 2024-02-19
ER

PT J
AU Sun, WB
   Han, BL
   Peng, ZM
   Li, K
   Ji, O
   Chen, J
   Wang, HZ
   Ma, RL
AF Sun, WB
   Han, BL
   Peng, ZM
   Li, K
   Ji, O
   Chen, J
   Wang, HZ
   Ma, RL
TI Effect of aging on cytoskeleton system of Kupffer cell and its
   phagocytic capacity
SO WORLD JOURNAL OF GASTROENTEROLOGY
LA English
DT Article
AB AIM To investigate the age-related alterations of cytoskeleton system in liver Kupffer cell and their relation to the changed phagocytic function.
   METHODS The phagocytic function of Kupffer cells from rats of various ages (6 mo, 12 mo, 18 mo and 24 mo) were quantitatively evaluated by phagocytosis of polystyrene beads. The actin distribution and measurement of Kupffer cell were determined by a phalloidin-TRITC method; and the myosin and vimentin distribution and measurement with indirect immunochemical staining.
   RESULTS Aging resulted in significant alterations of actin, myosin and vimentin distributions and reductions in Kupffer cell; the 3 cytoskeleton components of 24-mo-old Kupffer cell were significantly decreased to 68.0%,84.9% and 75.5%, respectively of these of 6-mo-old Kupffer cell(P<0.01,0.01 and 0.01). And these decreases had significant positive relations with the damaged phagocytosis of the aged Kupffer cell. gamma values were 0.96 (P < 0.05), 0.99 (P < 0.01) and 0.95 (P<0.05) respectively.
   CONCLUSION The cytoskeleton system of the aged Kupffer cell presents an evident state of senescence, which may be an important mechanism of decreased phagocytosis of the aged Kupffer cell.
C1 Third Mil Med Univ, SW Hosp, Hepatobiliary Surg Ctr, Chongqing 400038, Peoples R China.
C3 Army Medical University
RP Sun, WB (corresponding author), Third Mil Med Univ, SW Hosp, Hepatobiliary Surg Ctr, Chongqing 400038, Peoples R China.
CR ALBRIGHT JW, 1994, IMMUNOL LETT, V40, P279, DOI 10.1016/0165-2478(94)00066-2
   BRETSCHER A, 1991, ANNU REV CELL BIOL, V7, P337, DOI 10.1146/annurev.cellbio.7.1.337
   BROUWER A, 1995, CLIN SCI, V88, P211, DOI 10.1042/cs0880211
   HIROSE M, 1993, J GASTROEN HEPATOL, V8, P348, DOI 10.1111/j.1440-1746.1993.tb01526.x
   KNOOK DL, 1989, IMMUNOL INVEST, V18, P339
   SUN WB, 1995, CHIN J EXPE SURG, V12, P263
   SUN WB, 1995, CHIN J GERIAT, V14, P357
   WULF E, 1979, P NATL ACAD SCI USA, V76, P4498, DOI 10.1073/pnas.76.9.4498
NR 8
TC 22
Z9 26
U1 0
U2 2
PU W J G PRESS
PI BEIJING
PA PO BOX 2345, BEIJING 100023, PEOPLES R CHINA
SN 1007-9327
J9 WORLD J GASTROENTERO
JI World J. Gastroenterol.
PD FEB
PY 1998
VL 4
IS 1
BP 77
EP 79
PG 3
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 127AD
UT WOS:000076326800029
PM 11819239
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU Evangelou, K
   Veroutis, D
   Paschalaki, K
   Foukas, PG
   Lagopati, N
   Dimitriou, M
   Papaspyropoulos, A
   Konda, B
   Hazapis, O
   Polyzou, A
   Havaki, S
   Kotsinas, A
   Kittas, C
   Tzioufas, AG
   De Leval, L
   Vassilakos, D
   Tsiodras, S
   Stripp, BR
   Papantonis, A
   Blandino, G
   Karakasiliotis, I
   Barnes, PJ
   Gorgoulis, VG
AF Evangelou, Konstantinos
   Veroutis, Dimitris
   Paschalaki, Koralia
   Foukas, Periklis G.
   Lagopati, Nefeli
   Dimitriou, Marios
   Papaspyropoulos, Angelos
   Konda, Bindu
   Hazapis, Orsalia
   Polyzou, Aikaterini
   Havaki, Sophia
   Kotsinas, Athanassios
   Kittas, Christos
   Tzioufas, Athanasios G.
   De Leval, Laurence
   Vassilakos, Demetris
   Tsiodras, Sotirios
   Stripp, Barry R.
   Papantonis, Argyris
   Blandino, Giovanni
   Karakasiliotis, Ioannis
   Barnes, Peter J.
   Gorgoulis, Vassilis G.
TI Pulmonary infection by SARS-CoV-2 induces senescence accompanied by an
   inflammatory phenotype in severe COVID-19: possible implications for
   viral mutagenesis
SO EUROPEAN RESPIRATORY JOURNAL
LA English
DT Article
ID CELLULAR SENESCENCE; EARLY-STAGE; QUERCETIN; APOPTOSIS; IMMUNITY;
   DISEASE
AB Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection of the respiratory system can progress to a multisystemic disease with aberrant inflammatory response. Cellular senescence promotes chronic inflammation, named senescence-associated secretory phenotype (SASP). We investigated whether coronavirus disease 2019 (COVID-19) is associated with cellular senescence and SASP.
   Methods Autopsy lung tissue samples from 11 COVID-19 patients and 43 age-matched non-COVID-19 controls with similar comorbidities were analysed by immunohistochemistry for SARS-CoV-2, markers of senescence and key SASP cytokines. Virally induced senescence was functionally recapitulated in vitro, by infecting epithelial Vero-E6 cells and a three-dimensional alveosphere system of alveolar type 2 (AT2) cells with SARS-CoV-2 strains isolated from COVID-19 patients.
   Results SARS-CoV-2 was detected by immunocytochemistry and electron microscopy predominantly in AT2 cells. Infected AT2 cells expressed angiotensin-converting enzyme 2 and exhibited increased senescence (p16(INK4A) and SenTraGor positivity) and interleukin (IL)-1 beta and IL-6 expression. In vitro, infection of Vero-E6 cells with SARS-CoV-2 induced senescence (SenTraGor), DNA damage (gamma-H2AX) and increased cytokine (IL-1 beta, IL-6, CXCL8) and apolipoprotein B mRNA-editing (APOBEC) enzyme expression. Next-generation sequencing analysis of progenies obtained from infected/senescent Vero-E6 cells demonstrated APOBEC-mediated SARS-CoV-2 mutations. Dissemination of the SARS-CoV-2-infection and senescence was confirmed in extrapulmonary sites (kidney and liver) of a COVID-19 patient.
   Conclusions We demonstrate that in severe COVID-19, AT2 cells infected by SARS-CoV-2 exhibit senescence and a proinflammatory phenotype. In vitro, SARS-CoV-2 infection induces senescence and inflammation. Importantly, infected senescent cells may act as a source of SARS-CoV-2 mutagenesis mediated by APOBEC enzymes. Therefore, SARS-CoV-2-induced senescence may be an important molecular mechanism of severe COVID-19, disease persistence and mutagenesis.
C1 [Evangelou, Konstantinos; Veroutis, Dimitris; Lagopati, Nefeli; Papaspyropoulos, Angelos; Hazapis, Orsalia; Polyzou, Aikaterini; Havaki, Sophia; Kotsinas, Athanassios; Kittas, Christos; Vassilakos, Demetris; Gorgoulis, Vassilis G.] Natl & Kapodistrian Univ Athens, Sch Med, Dept Histol & Embryol, Mol Carcinogenesis Grp, Athens, Greece.
   [Veroutis, Dimitris; Lagopati, Nefeli; Papaspyropoulos, Angelos; Gorgoulis, Vassilis G.] Acad Athens, Biomed Res Fdn, Athens, Greece.
   [Paschalaki, Koralia; Barnes, Peter J.] Imperial Coll London, Natl Heart & Lung Inst, London, England.
   [Foukas, Periklis G.; Dimitriou, Marios] Natl & Kapodistrian Univ Athens, Attikon Univ Hosp, Sch Med, Dept Pathol 2, Athens, Greece.
   [Dimitriou, Marios; Karakasiliotis, Ioannis] Democritus Univ Thrace, Dept Med, Lab Biol, Alexandroupolis, Greece.
   [Konda, Bindu; Stripp, Barry R.] Cedars Sinai Med Ctr, Lung & Regenerat Med Inst, Los Angeles, CA USA.
   [Kittas, Christos; Gorgoulis, Vassilis G.] Univ Surrey, Fac Hlth & Med Sci, Guildford, Surrey, England.
   [Kotsinas, Athanassios] Natl & Kapodistrian Univ Athens, Sch Med, Dept Pathophysiol, Athens, Greece.
   [De Leval, Laurence] Lausanne Univ Hosp, Inst Pathol, Lausanne, Switzerland.
   [Tsiodras, Sotirios] Univ Athens, Attikon Univ Hosp, Sch Med, Dept Internal Med 4, Athens, Greece.
   [Tsiodras, Sotirios] Hellen Ctr Dis Control & Prevent, Athens, Greece.
   [Papantonis, Argyris] Univ Med Ctr Gottingen, Inst Pathol, Translat Epigenet Grp, Gottingen, Germany.
   [Papantonis, Argyris] Univ Cologne, Ctr Mol Med, Cologne, Germany.
   [Blandino, Giovanni] IRCCS, Regina Elena Natl Canc Inst, Oncogen & Epigenet Unit, Rome, Italy.
   [Gorgoulis, Vassilis G.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Inst Canc Sci, Manchester, Lancs, England.
   [Gorgoulis, Vassilis G.] Natl & Kapodistrian Univ Athens, Sch Med, Ctr New Biotechnol & Precis Med, Athens, Greece.
C3 Athens Medical School; National & Kapodistrian University of Athens;
   Academy of Athens; Imperial College London; National & Kapodistrian
   University of Athens; University Hospital Attikon; Athens Medical
   School; Democritus University of Thrace; Cedars Sinai Medical Center;
   University of Surrey; National & Kapodistrian University of Athens;
   Athens Medical School; University of Lausanne; Centre Hospitalier
   Universitaire Vaudois (CHUV); University Hospital Attikon; Athens
   Medical School; National & Kapodistrian University of Athens; University
   of Gottingen; University of Cologne; University of Manchester; Athens
   Medical School; National & Kapodistrian University of Athens
RP Gorgoulis, VG (corresponding author), Natl & Kapodistrian Univ Athens, Sch Med, Dept Histol & Embryol, Mol Carcinogenesis Grp, Athens, Greece.; Gorgoulis, VG (corresponding author), Acad Athens, Biomed Res Fdn, Athens, Greece.; Gorgoulis, VG (corresponding author), Univ Surrey, Fac Hlth & Med Sci, Guildford, Surrey, England.; Gorgoulis, VG (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Inst Canc Sci, Manchester, Lancs, England.; Gorgoulis, VG (corresponding author), Natl & Kapodistrian Univ Athens, Sch Med, Ctr New Biotechnol & Precis Med, Athens, Greece.
EM vgorg@med.uoa.gr
RI de Leval, Laurence/M-4889-2017; TSIODRAS, SOTIRIOS/AAD-8273-2019;
   Kotsinas, Thanos/JJC-9655-2023; Paschalaki, Koralia/B-4465-2018
OI de Leval, Laurence/0000-0003-3994-516X; TSIODRAS,
   SOTIRIOS/0000-0002-0463-4321; Dimitriou, Marios/0000-0001-5699-2289;
   Stripp, Barry/0000-0003-4348-2137; Barnes, Peter/0000-0002-5122-4018
FU National Public Investment Program of the Ministry of Development and
   Investment/General Secretariat for Research and Technology
   [2020SE01300001]; Horizon 2020 Marie Sklodowska-Curie training programme
   [722729]; Welfare Foundation for Social and Cultural Sciences, Athens,
   Greece (KIKPE); Hellenic Foundation for Research and Innovation (HFRI)
   [775, 3782]; European Regional Development Fund of the European Union;
   Greek national funds through the Operational Program Competitiveness,
   Entrepreneurship and Innovation, under the call RESEARCH -CREATE
   -INNOVATE [T1EDK-02939]; NKUA-SARG [70/3/8916]; National Heart and Lung
   Institute - Imperial College London; British Heart Foundation
   [PG/19/75/34686]; Marie Curie Actions (MSCA) [722729] Funding Source:
   Marie Curie Actions (MSCA)
FX This work was supported by the National Public Investment Program of the
   Ministry of Development and Investment/General Secretariat for Research
   and Technology, in the framework of the Flagship Initiative to address
   SARS-CoV-2 (2020SE01300001); Horizon 2020 Marie Sklodowska-Curie
   training programme number 722729 (SYNTRAIN); Welfare Foundation for
   Social and Cultural Sciences, Athens, Greece (KIKPE); H. Pappas
   donation; Hellenic Foundation for Research and Innovation (HFRI) grant
   numbers 775 and 3782; the European Regional Development Fund of the
   European Union and Greek national funds through the Operational Program
   Competitiveness, Entrepreneurship and Innovation, under the call
   RESEARCH -CREATE -INNOVATE (project code: T1EDK-02939) and NKUA-SARG
   grant 70/3/8916. K. Paschalaki is financially supported by National
   Heart and Lung Institute -Imperial College London and a British Heart
   Foundation Project Grant (PG/19/75/34686). Funding information for this
   article has been deposited with the Crossref Funder Registry.
CR Barnes PJ, 2019, AM J RESP CRIT CARE, V200, P556, DOI 10.1164/rccm.201810-1975TR
   Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268
   Basisty N, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000599
   Baz-Martinez M, 2016, SCI REP-UK, V6, DOI 10.1038/srep37007
   Belogiannis K, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13061143
   Botvinnik A, 2021, FEBS J, V288, P6063, DOI 10.1111/febs.16025
   Braciale TJ, 2012, NAT REV IMMUNOL, V12, P295, DOI 10.1038/nri3166
   Camell CD, 2021, SCIENCE, V373, DOI 10.1126/science.abe4832
   Childs BG, 2014, EMBO REP, V15, P1139, DOI 10.15252/embr.201439245
   Chu H, 2020, LANCET MICROBE, V1, pE14, DOI 10.1016/S2666-5247(20)30004-5
   Chuprin A, 2013, GENE DEV, V27, P2356, DOI 10.1101/gad.227512.113
   Clemente V, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21103492
   Del Valle DM, 2020, NAT MED, V26, P1636, DOI [10.1038/s41591-020-1051-9, 10.1101/2020.05.28.20115758]
   Di Pierro F, 2021, INT J GEN MED, V14, P2807, DOI 10.2147/IJGM.S318949
   Di Pierro F, 2021, INT J GEN MED, V14, P2359, DOI 10.2147/IJGM.S318720
   Elbe S, 2017, GLOB CHALL, V1, P33, DOI 10.1002/gch2.1018
   Evangelou K, 2021, bioRxiv, DOI [10.1101/2021.01.02.424917, 10.1101/2021.01.02.424917, DOI 10.1101/2021.01.02.424917]
   Evangelou K, 2017, AGING CELL, V16, P192, DOI 10.1111/acel.12545
   Faget DV, 2019, NAT REV CANCER, V19, P439, DOI 10.1038/s41568-019-0156-2
   Fan Y, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00396
   Frisch SM, 2020, AGING CELL, V19, DOI 10.1111/acel.13234
   Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005
   Gorgoulis VG, 2018, J PATHOL, V246, P12, DOI 10.1002/path.5097
   Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485
   Hekman RM, 2021, MOL CELL, V81, P212, DOI 10.1016/j.molcel.2020.12.028
   Heo I, 2018, NAT MICROBIOL, V3, P814, DOI 10.1038/s41564-018-0177-8
   Hu B, 2021, NAT REV MICROBIOL, V19, P141, DOI 10.1038/s41579-020-00459-7
   Karakasiliotis I, 2023, FEBS J, V290, P1384, DOI 10.1111/febs.16230
   Kelley WJ, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.02708-2020
   Kohli J, 2021, NAT PROTOC, V16, DOI 10.1038/s41596-021-00505-5
   Kohli J, 2021, EMBO REP, V22, DOI 10.15252/embr.202052243
   Komseli ES, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-017-4375-1
   Lagopati N, 2021, J VIROL METHODS, V289, DOI 10.1016/j.jviromet.2020.114044
   Lee S, 2021, NATURE, V599, P283, DOI 10.1038/s41586-021-03995-1
   Li SF, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00334-0
   Li Z, 2020, FRONT MOL BIOSCI, V7, DOI 10.3389/fmolb.2020.00184
   Matsuyama S, 2005, P NATL ACAD SCI USA, V102, P12543, DOI 10.1073/pnas.0503203102
   Meyer K, 2021, J VIROL, V95, DOI 10.1128/JVI.00794-21
   Mocarski ES, 2012, NAT REV IMMUNOL, V12, P79, DOI 10.1038/nri3131
   Mulay A, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.109055
   Myrianthopoulos V, 2019, PHARMACOL THERAPEUT, V193, P31, DOI 10.1016/j.pharmthera.2018.08.006
   Nalbandian A, 2021, NAT MED, V27, P601, DOI 10.1038/s41591-021-01283-z
   Nehme J, 2020, AGING CELL, V19, DOI 10.1111/acel.13237
   Osada N, 2014, DNA RES, V21, P673, DOI 10.1093/dnares/dsu029
   Özcan S, 2016, AGING-US, V8, P1316, DOI 10.18632/aging.100971
   Poland GA, 2020, LANCET, V396, P1595, DOI 10.1016/S0140-6736(20)32137-1
   Prabhu P, 2016, FEBS J, V283, P112, DOI 10.1111/febs.13556
   Ratcliff J, 2021, VIROLOGY, V556, P62, DOI 10.1016/j.virol.2020.12.018
   Rendeiro AF, 2021, NATURE, V593, P564, DOI 10.1038/s41586-021-03475-6
   Robba C, 2020, RESP PHYSIOL NEUROBI, V279, DOI 10.1016/j.resp.2020.103455
   Rouse BT, 2010, NAT REV IMMUNOL, V10, P514, DOI 10.1038/nri2802
   Schneider JL, 2021, CELL, V184, P1990, DOI 10.1016/j.cell.2021.03.005
   Seoane R, 2020, BIOLOGY-BASEL, V9, DOI 10.3390/biology9120455
   Shu YL, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.13.30494
   Tang YJ, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01708
   Venkatesan S, 2021, CANCER DISCOV, V11, P2456, DOI 10.1158/2159-8290.CD-20-0725
   Victor J, 2021, BIOCHEM BIOPH RES CO, V579, P141, DOI 10.1016/j.bbrc.2021.09.024
   Wang QH, 2020, CELL, V181, P894, DOI 10.1016/j.cell.2020.03.045
   Wang Y, 2017, ONCOTARGET, V8, P54285, DOI 10.18632/oncotarget.17348
   Wurtz N, 2021, EUR J CLIN MICROBIOL, V40, P477, DOI 10.1007/s10096-020-04106-0
   Zamaraev AV, 2020, BIOCHEMISTRY-MOSCOW+, V85, P1191, DOI 10.1134/S0006297920100077
   Zhang F, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00263-y
   Zhao J, 2020, AGING-US, V12, P4688, DOI 10.18632/aging.102863
NR 63
TC 39
Z9 40
U1 4
U2 14
PU EUROPEAN RESPIRATORY SOC JOURNALS LTD
PI SHEFFIELD
PA 442 GLOSSOP RD, SHEFFIELD S10 2PX, ENGLAND
SN 0903-1936
EI 1399-3003
J9 EUR RESPIR J
JI Eur. Resp. J.
PD AUG 1
PY 2022
VL 60
IS 2
AR 2102951
DI 10.1183/13993003.02951-2021
PG 15
WC Respiratory System
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Respiratory System
GA 6J2HH
UT WOS:000886648200011
PM 35086840
OA hybrid, Green Published
HC Y
HP N
DA 2024-02-19
ER

PT J
AU Horvath, S
   Haghani, A
   Peng, SC
   Hales, EN
   Zoller, JA
   Raj, K
   Larison, B
   Robeck, TR
   Petersen, JL
   Bellone, RR
   Finno, CJ
AF Horvath, Steve
   Haghani, Amin
   Peng, Sichong
   Hales, Erin N.
   Zoller, Joseph A.
   Raj, Ken
   Larison, Brenda
   Robeck, Todd R.
   Petersen, Jessica L.
   Bellone, Rebecca R.
   Finno, Carrie J.
TI DNA methylation aging and transcriptomic studies in horses
SO NATURE COMMUNICATIONS
LA English
DT Article
ID SQUAMOUS-CELL CARCINOMA; ALL-CAUSE MORTALITY; EPIGENETIC AGE; BIOLOGICAL
   AGE; EXPRESSION; BLOOD; THERAPY; CLOCKS; MODELS; GENES
AB Cytosine methylation patterns have not yet been thoroughly studied in horses. Here, we profile n = 333 samples from 42 horse tissue types at loci that are highly conserved between mammalian species using a custom array (HorvathMammalMethylChip40). Using the blood and liver tissues from horses, we develop five epigenetic aging clocks: a multi-tissue clock, a blood clock, a liver clock and two dual-species clocks that apply to both horses and humans. In addition, using blood methylation data from three additional equid species (plains zebra, Grevy's zebras and Somali asses), we develop another clock that applies across all equid species. Castration does not significantly impact the epigenetic aging rate of blood or liver samples from horses. Methylation and RNA data from the same tissues define the relationship between methylation and RNA expression across horse tissues. We expect that the multi-tissue atlas will become a valuable resource.
C1 [Horvath, Steve; Haghani, Amin] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA.
   [Horvath, Steve; Zoller, Joseph A.] Univ Calif Los Angeles, Dept Biostat, Fielding Sch Publ Hlth, Los Angeles, CA 90095 USA.
   [Peng, Sichong; Hales, Erin N.; Bellone, Rebecca R.; Finno, Carrie J.] Univ Calif Los Angeles, Davis Sch Vet Med, Dept Populat Hlth & Reprod, Los Angeles, CA 90095 USA.
   [Raj, Ken] Publ Hlth England, Ctr Radiat Chem & Environm Hazards, Radiat Effects Dept, Didcot, Oxon, England.
   [Larison, Brenda] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA.
   [Larison, Brenda] Univ Calif Los Angeles, Ctr Trop Res, Inst Environm & Sustainabil, Los Angeles, CA USA.
   [Robeck, Todd R.] SeaWorld Pk & Entertainment, Zool Operat, 7007 SeaWorld Dr, Orlando, FL USA.
   [Petersen, Jessica L.] Univ Nebraska, Dept Anim Sci, Lincoln, NE USA.
   [Bellone, Rebecca R.] Univ Calif Davis, Vet Genet Lab, Sch Vet Med, Davis, CA 95616 USA.
C3 University of California System; University of California Los Angeles;
   University of California Los Angeles Medical Center; David Geffen School
   of Medicine at UCLA; University of California System; University of
   California Los Angeles; University of California System; University of
   California Los Angeles; Public Health England; University of California
   System; University of California Los Angeles; University of California
   System; University of California Los Angeles; University of Nebraska
   System; University of Nebraska Lincoln; University of California System;
   University of California Davis
RP Horvath, S (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA.; Horvath, S (corresponding author), Univ Calif Los Angeles, Dept Biostat, Fielding Sch Publ Hlth, Los Angeles, CA 90095 USA.; Finno, CJ (corresponding author), Univ Calif Los Angeles, Davis Sch Vet Med, Dept Populat Hlth & Reprod, Los Angeles, CA 90095 USA.
EM shorvath@mednet.ucla.edu; cjfinno@ucdavis.edu
RI Petersen, Jessica/ABF-2462-2020; Haghani, Amin/C-5543-2015
OI Petersen, Jessica/0000-0001-5438-8555; Raj, Kenneth/0000-0002-3744-265X;
   Hales, Erin/0000-0002-8007-6552; Horvath, Steve/0000-0002-4110-3589;
   Zoller, Joseph/0000-0001-6309-0291; Bellone,
   Rebecca/0000-0001-8838-7227; Peng, Sichong/0000-0003-3400-298X; Larison,
   Brenda/0000-0002-0264-7276; Haghani, Amin/0000-0002-6052-8793
FU Paul G. Allen Frontiers Group; Grayson Jockey Club Foundation; USDA
   NRSP-8; UC Davis Center for Equine Health; National Institutes of Health
   (NIH) [K01OD015134, L40 TR001136]
FX This work was supported by the Paul G. Allen Frontiers Group (SH).
   Funding for horse tissue sample collection was provided by the Grayson
   Jockey Club Foundation, USDA NRSP-8, and the UC Davis Center for Equine
   Health. Support for C.J.F. was provided by the National Institutes of
   Health (NIH) (K01OD015134 and L40 TR001136). Grevy's zebra and Somali
   wild ass samples were provided by White Oak Conservation.
CR ARIGHI M, 1989, J EQUINE VET SCI, V9, P20, DOI 10.1016/S0737-0806(89)80112-1
   Arighi M., 1985, P 31 ANN CONV AM ASS, P591
   Arneson A, 2021, bioRxiv, DOI [10.1101/2021.01.07.425637, 10.1101/2021.01.07.425637, DOI 10.1101/2021.01.07.425637, 10.1101/2021.01.07.425637v2, DOI 10.1101/2021.01.07.425637V2]
   Bell CG, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1824-y
   Bernhart SH, 2016, SCI REP-UK, V6, DOI 10.1038/srep37393
   Burns EN, 2018, ANIM GENET, V49, P564, DOI 10.1111/age.12717
   Chen BH, 2016, AGING-US, V8, P1844, DOI 10.18632/aging.101020
   Christiansen L, 2016, AGING CELL, V15, P149, DOI 10.1111/acel.12421
   Clark SJ, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0944-x
   Cole JJ, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1185-3
   COX JE, 1989, ANIM REPROD SCI, V18, P43, DOI 10.1016/0378-4320(89)90006-7
   de Magalhaes JP, 2007, J GERONTOL A-BIOL, V62, P149
   de Magalhaes JP, 2005, NUCLEIC ACIDS RES, V33, pD537, DOI 10.1093/nar/gki017
   Dunican DS, 2020, BMC BIOL, V18, DOI 10.1186/s12915-020-0752-3
   Eppig JT, 2015, NUCLEIC ACIDS RES, V43, pD726, DOI 10.1093/nar/gku967
   Ernst J, 2020, bioRxiv, DOI [10.1101/2020.11.17.387134, 10.1101/2020.11.17.387134, DOI 10.1101/2020.11.17.387134]
   Fahy GM, 2019, AGING CELL, V18, DOI 10.1111/acel.13028
   Ferrucci L, 2020, AGING CELL, V19, DOI 10.1111/acel.13080
   Field AE, 2018, MOL CELL, V71, P882, DOI 10.1016/j.molcel.2018.08.008
   Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01
   Harley EH, 2009, S AFR J WILDL RES, V39, P155, DOI 10.3957/056.039.0206
   Horvath S., 2020, bioRxiv, DOI [10.1101/2020.11.29.402891, 10.1101/2020.11.29.402891, DOI 10.1101/2020.11.29.402891]
   Horvath S., [No title captured], DOI 10.5281/zenodo.5711978
   Horvath S, 2021, GEROSCIENCE, V43, P2441, DOI 10.1007/s11357-021-00429-8
   Horvath S, 2021, GEROSCIENCE, V43, P2413, DOI 10.1007/s11357-021-00438-7
   Horvath S, 2018, AIDS, V32, P1465, DOI [10.1097/QAD.0000000000001854, 10.1097/qad.0000000000001854]
   Horvath S, 2018, NAT REV GENET, V19, P371, DOI 10.1038/s41576-018-0004-3
   Horvath S, 2015, AGING-US, V7, P1159, DOI 10.18632/aging.100861
   Horvath S, 2015, AGING-US, V7, P1130, DOI 10.18632/aging.100859
   Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115
   Hu YJ, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0950-z
   Issa JP, 2014, J CLIN INVEST, V124, P24, DOI 10.1172/JCI69735
   Jylhävä J, 2017, EBIOMEDICINE, V21, P29, DOI 10.1016/j.ebiom.2017.03.046
   Kabacik S, 2018, AGING-US, V10, P2800, DOI 10.18632/aging.101588
   Kafarnik C, 2009, VET OPHTHALMOL, V12, P6, DOI 10.1111/j.1463-5224.2009.00666.x
   Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559
   Larison B, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-02935-z
   Levine ME, 2018, AGING-US, V10, P573, DOI 10.18632/aging.101414
   Li X, 2020, ELIFE, V9, DOI 10.7554/eLife.51507
   Linker SM, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1644-0
   Lu AT, 2019, AGING-US, V11, P303, DOI 10.18632/aging.101684
   Lu AT, 2021, BIORXIV, DOI [DOI 10.1101/2021.01.18.426733, 10.1101/2021.01.18.426733v1]
   Marioni RE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0584-6
   McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630
   Meer MV, 2018, ELIFE, V7, DOI 10.7554/eLife.40675
   Michau TM, 2012, VET OPHTHALMOL, V15, P245, DOI 10.1111/j.1463-5224.2011.00977.x
   Morgello S, 2001, NEUROPATH APPL NEURO, V27, P326, DOI 10.1046/j.0305-1846.2001.00334.x
   Mosunic CB, 2004, JAVMA-J AM VET MED A, V225, P1733, DOI 10.2460/javma.2004.225.1733
   Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197
   Perna L, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0228-z
   Petkovich DA, 2017, CELL METAB, V25, P954, DOI 10.1016/j.cmet.2017.03.016
   Prado NA, 2021, AGING CELL, V20, DOI 10.1111/acel.13414
   Raj K, 2021, GEROSCIENCE, V43, P2363, DOI 10.1007/s11357-021-00445-8
   Raj K, 2020, EXP BIOL MED, V245, P1532, DOI 10.1177/1535370220918329
   Rakyan VK, 2010, GENOME RES, V20, P434, DOI 10.1101/gr.103101.109
   Robeck TR, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-02179-x
   Schachtschneider KM, 2021, GEROSCIENCE, V43, P2467, DOI 10.1007/s11357-021-00439-6
   Schaffer PA, 2013, JAVMA-J AM VET MED A, V242, P99, DOI 10.2460/javma.242.1.99
   Stubbs TM, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1203-5
   Sugrue VJ, 2021, ELIFE, V10, DOI 10.7554/eLife.64932
   Tallmadge RL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202646
   Teschendorff AE, 2010, GENOME RES, V20, P440, DOI 10.1101/gr.103606.109
   Thompson MJ, 2018, AGING-US, V10, P2832, DOI 10.18632/aging.101590
   Thompson MJ, 2017, AGING-US, V9, P1055, DOI 10.18632/aging.101211
   van Eijk KR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-636
   Wang TN, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1186-2
   Zabek T, 2019, INT J GENOMICS, V2019, DOI 10.1155/2019/2839614
   Zhou WD, 2018, NUCLEIC ACIDS RES, V46, DOI 10.1093/nar/gky691
NR 68
TC 23
Z9 25
U1 1
U2 8
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
EI 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD JAN 10
PY 2022
VL 13
IS 1
AR 40
DI 10.1038/s41467-021-27754-y
PG 13
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 0W8FP
UT WOS:000789256700001
PM 35013267
OA gold, Green Published, Green Submitted
DA 2024-02-19
ER

PT J
AU Song, EK
   Park, H
   Kim, HS
AF Song, Eun-Kyung
   Park, Hyunjin
   Kim, Hyun-Sook
TI Additive effect of walnut and chokeberry on regulation of antioxidant
   enzyme gene expression and attenuation of lipid peroxidation in
   d-galactose-induced aging-mouse model
SO NUTRITION RESEARCH
LA English
DT Article
DE Antioxidant; Additive effect; Walnut; Chokeberry; Aging
ID ARONIA-MELANOCARPA; OXIDATIVE STRESS; IN-VITRO; ALPHA-TOCOPHEROL; MICE;
   ANTHOCYANINS; EXTRACTS; PLASMA; RIBES; RATS
AB Studies have highlighted the association between the cellular damage caused by reactive oxygen species and aging. The reducing sugar d-galactose causes aging-related changes and oxidative stress. Lipids are the first target of free radicals, and lipid peroxidation is related to aging. Walnut (Juglans regia Chandler) kernel contains antioxidant phenolic compounds, and chokeberry (Aronia melanocarpa) is one of the richest sources of polyphenols, including anthocyanins, among other fruits. Polyphenols from chokeberry exhibit antioxidant and anti-inflammatory activities. In this study, the additive antioxidative effect of walnut and chokeberry mixture was evaluated by oxidative stress index in d-galactose-induced aging model. Thirty-five Balb/c mice (8 weeks old) were divided into following five groups (n = 7 in each group): normal control (C), d-galactose control (D), d-galactose with chokeberry diet (CH), d-galactose with walnut diet (W), and d-galactose with walnut and chokeberry mixture diet (WCH). In all treatment diets groups, the levels of serum, hepatic, and kidney malonaldehyde were significantly lower than D group and the levels were approaching to control level. Moreover, the kidney malondialdehyde levels were significantly lower in WCH group compared with the control group. This study also confirmed the activities of antioxidant enzymes in liver, as the levels of superoxide dismutase, and glutathione peroxidase were significantly increased in CH group compared to in W or CH groups. The results of this study supported the additive effect of walnut and chokeberry on increment of antioxidant enzyme gene expression in liver and consequently the attenuation of lipid peroxidation in serum, liver, and kidney in d-galactose-induced aging-mouse model. Further studies are needed to investigate the detailed mechanism underlying the additive antioxidative effects in various tissues. (C) 2018 Elsevier Inc. All rights reserved.
C1 [Song, Eun-Kyung; Kim, Hyun-Sook] Sookmyung Womens Univ, Coll Human Ecol, Dept Food & Nutr, Cheongpa Ro 47 Gil 100,Cheongpa Dong 2 I Ga, Seoul 04310, South Korea.
   [Park, Hyunjin] ICAN Nutr Educ & Res, Seoul, South Korea.
C3 Sookmyung Women's University
RP Kim, HS (corresponding author), Sookmyung Womens Univ, Sunhun Bldg 307,Cheongpa Ro 47 Gil 100, Seoul 04310, South Korea.
EM hskim@sookmyung.ac.kr
FU National Research Foundation of Korea (NRF) - Korea government (MSIP)
   [2011-0030074]
FX This work was supported by the National Research Foundation of Korea
   (NRF) grant funded by the Korea government (MSIP) (No. 2011-0030074).
CR Anand KV, 2012, GERIATR GERONTOL INT, V12, P741, DOI 10.1111/j.1447-0594.2012.00843.x
   Anderson KJ, 2001, J NUTR, V131, P2837, DOI 10.1093/jn/131.11.2837
   Bulló M, 2010, NUTRITION, V26, P823, DOI 10.1016/j.nut.2009.09.002
   Çoban J, 2014, GERIATR GERONTOL INT, V14, P490, DOI 10.1111/ggi.12096
   Denev PN, 2012, COMPR REV FOOD SCI F, V11, P471, DOI 10.1111/j.1541-4337.2012.00198.x
   Faff J, 2003, BIOL SPORT, V20, P15
   Floegel A, 2011, J FOOD COMPOS ANAL, V24, P1043, DOI 10.1016/j.jfca.2011.01.008
   Franzini L, 2012, NUTR METAB CARDIOVAS, V22, P50, DOI 10.1016/j.numecd.2010.04.001
   Gasiorowski K, 1997, CANCER LETT, V119, P37, DOI 10.1016/S0304-3835(97)00248-6
   Graversen HB, 2008, EUR FOOD RES TECHNOL, V226, P737, DOI 10.1007/s00217-007-0585-0
   Hadzi-Petrushev N, 2015, PHYSIOL RES, V64, P61, DOI 10.33549/physiolres.932786
   Hadzi-Petrushev N, 2017, METAB BRAIN DIS, P1
   HALLIWELL B, 1991, AM J MED, V91, pS14, DOI 10.1016/0002-9343(91)90279-7
   Halvorsen BL, 2006, AM J CLIN NUTR, V84, P95, DOI 10.1093/ajcn/84.1.95
   Han Guang-Liang, 2005, Wei Sheng Yan Jiu, V34, P581
   He M, 2009, BIOL PHARM BULL, V32, P55, DOI 10.1248/bpb.32.55
   Ho SC, 2003, BIOGERONTOLOGY, V4, P15, DOI 10.1023/A:1022417102206
   Jakobek L, 2011, INT J FOOD SCI NUTR, V62, P345, DOI 10.3109/09637486.2010.534438
   Kadoma Y, 2006, IN VIVO, V20, P823
   Kornsteiner M, 2006, FOOD CHEM, V98, P381, DOI 10.1016/j.foodchem.2005.07.033
   Kowalczyk E, 2003, ACTA BIOCHIM POL, V50, P543
   Kowalczyk E, 2004, POL J ENV STUD, V13
   Kulling SE, 2008, PLANTA MED, V74, P1625, DOI 10.1055/s-0028-1088306
   Kumar A., 2011, INT J ALZHEIMERS DIS, V2011
   Lala G, 2006, NUTR CANCER, V54, P84, DOI 10.1207/s15327914nc5401_10
   Lee J, 2004, COMPR REV FOOD SCI F, V3, P21, DOI 10.1111/j.1541-4337.2004.tb00058.x
   Li XM, 2007, J ETHNOPHARMACOL, V111, P504, DOI 10.1016/j.jep.2006.12.024
   Lila Mary Ann, 2009, P305, DOI 10.1007/978-0-387-77335-3_10
   Mishra N, 2010, FOOD CHEM TOXICOL, V48, P3316, DOI 10.1016/j.fct.2010.08.029
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   Pandey KB, 2010, OXID MED CELL LONGEV, V3, P2, DOI 10.4161/oxim.3.1.10476
   Pawar S, 2017, EFFECT BACOSIDE A LI
   Pellegrini N, 2006, MOL NUTR FOOD RES, V50, P1030, DOI 10.1002/mnfr.200600067
   Ramassamy C, 2006, EUR J PHARMACOL, V545, P51, DOI 10.1016/j.ejphar.2006.06.025
   Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3
   Rikans LE, 1997, BIOCHIM BIOPHYS ACTA, V1362, P116
   Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034
   Shimoda H, 2009, J AGR FOOD CHEM, V57, P1786, DOI 10.1021/jf803441c
   Sreejayan, 1997, J PHARM PHARMACOL, V49, P105, DOI 10.1111/j.2042-7158.1997.tb06761.x
   Tian Y, 2011, FOOD CHEM TOXICOL, V49, P1728, DOI 10.1016/j.fct.2011.04.018
   Valcheva-Kuzmanova S, 2007, METHOD FIND EXP CLIN, V29, P101, DOI 10.1358/mf.2007.29.2.1075349
   Vinson JA, 2012, FOOD FUNCT, V3, P134, DOI 10.1039/c2fo10152a
   Wang S, 2011, J AGR FOOD CHEM, V59, P960, DOI 10.1021/jf1040977
   Ward WF, 2005, J GERONTOL A-BIOL, V60, P847, DOI 10.1093/gerona/60.7.847
   Wu XL, 2004, J AGR FOOD CHEM, V52, P7846, DOI 10.1021/jf0486850
   Zapolska-Downar D, 2006, ATHEROSCLEROSIS SUPP, V7, P223, DOI 10.1016/S1567-5688(06)80879-2
   Zhang ZJ, 2009, FOOD CHEM, V113, P160, DOI 10.1016/j.foodchem.2008.07.061
   Zhen YZ, 2016, EXP THER MED, V11, P303, DOI 10.3892/etm.2015.2858
NR 48
TC 7
Z9 8
U1 1
U2 41
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0271-5317
J9 NUTR RES
JI Nutr. Res.
PD OCT
PY 2019
VL 70
SI SI
BP 60
EP 69
DI 10.1016/j.nutres.2018.09.011
PG 10
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA JV5QG
UT WOS:000502419400010
PM 30446253
DA 2024-02-19
ER

PT J
AU Zahr, T
   Liu, LH
   Chan, M
   Zhou, QZ
   Cai, BS
   He, Y
   Aaron, N
   Accili, D
   Sun, L
   Qiang, L
AF Zahr, Tarik
   Liu, Longhua
   Chan, Michelle
   Zhou, Qiuzhong
   Cai, Bishuang
   He, Ying
   Aaron, Nicole
   Accili, Domenico
   Sun, Lei
   Qiang, Li
TI PPARγ (Peroxisome Proliferator-Activated Receptor γ) Deacetylation
   Suppresses Aging-Associated Atherosclerosis and Hypercholesterolemia
SO ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
LA English
DT Article
DE aging; atherosclerosis; cardiovascular disease; hypercholesterolemia;
   inflammation
ID FATTY LIVER-DISEASE; GENE-EXPRESSION; PROMOTES ATHEROSCLEROSIS;
   LIPID-METABOLISM; ADIPOSE-TISSUE; BLOOD-PRESSURE; INFLAMMATION;
   MACROPHAGES; CHOLESTEROL; THIAZOLIDINEDIONES
AB Background:Atherosclerosis is a medical urgency manifesting at the onset of hypercholesterolemia and is associated with aging. Activation of PPAR gamma (peroxisome proliferator-activated receptor gamma) counteracts metabolic dysfunction influenced by aging, and its deacetylation displays an atheroprotective property. Despite the marked increase of PPAR gamma acetylation during aging, it is unknown whether PPAR gamma acetylation is a pathogenic contributor to aging-associated atherosclerosis. Methods:Mice with constitutive deacetylation-mimetic PPAR gamma mutations on lysine residues K268 and K293 (2KR) in an LDL (low-density lipoprotein)-receptor knockout (Ldlr(-/-)) background (2KR:Ldlr(-/-)) were aged for 18 months on a standard laboratory diet to examine the cardiometabolic phenotype, which was confirmed in Western-type diet-fed 2KR:Ldlr(+/-) mice. Whole-liver RNA-sequencing and in vitro studies in bone marrow-derived macrophages were conducted to decipher the mechanism. Results:In contrast to severe atherosclerosis in WT:Ldlr(-/-) mice, aged 2KR:Ldlr(-/-) mice developed little to no plaque, which was underlain by a significantly improved plasma lipid profile, with particular reductions in circulating LDL. The protection from hypercholesterolemia was recapitulated in Western-type diet-fed 2KR:Ldlr(+/-) mice. Liver RNA-sequencing analysis revealed suppression of liver inflammation rather than changes in cholesterol metabolism. This anti-inflammatory effect of 2KR was attributed to polarized M2 activation of macrophages. Additionally, the upregulation of core circadian component Bmal1 (brain and muscle ARNT-like 1), perceived to be involved in anti-inflammatory immunity, was observed in the liver and bone marrow-derived macrophages. Conclusions:PPAR gamma deacetylation in mice prevents the development of aging-associated atherosclerosis and hypercholesterolemia, in association with the anti-inflammatory phenotype of 2KR macrophages.
C1 [Zahr, Tarik; Liu, Longhua; Chan, Michelle; He, Ying; Aaron, Nicole; Accili, Domenico; Qiang, Li] Columbia Univ, Naomi Berrie Diabet Ctr, New York, NY USA.
   [Zahr, Tarik; Aaron, Nicole] Columbia Univ, Dept Mol Pharmacol & Therapeut, New York, NY USA.
   [Liu, Longhua; He, Ying; Qiang, Li] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA.
   [Accili, Domenico] Columbia Univ, Dept Med, New York, NY USA.
   [Zhou, Qiuzhong; Sun, Lei] Duke NUS Med Sch, Cardiovasc & Metab Disorders Program, Singapore, Singapore.
   [Cai, Bishuang] Icahn Sch Med Mt Sinai, Dept Med, Div Liver Dis, New York, NY USA.
   [Qiang, Li] Columbia Univ, Naomi Berrie Diabet Ctr, New York, NY 10032 USA.
C3 Columbia University; Columbia University; Columbia University; Columbia
   University; National University of Singapore; Icahn School of Medicine
   at Mount Sinai; Columbia University
RP Qiang, L (corresponding author), Columbia Univ, Naomi Berrie Diabet Ctr, New York, NY 10032 USA.
EM lq2123@cumc.columbia.edu
RI Zhou, Qiuzhong/JTS-4553-2023; He, Ying/IQT-7288-2023
OI He, Ying/0000-0003-0110-8497; Chan, Michelle/0000-0001-6037-7051; Zahr,
   Tarik/0000-0002-2754-6092
FU National Institutes of Health [R01DK112943, R01DK128848, P01HL087123,
   R35GM147269, R00DK115778]; American Heart Association Career Development
   Award [937920]
FX This work was supported by the National Institutes of Health grants
   R01DK112943 (L. Qiang), R01DK128848 (L. Qiang), P01HL087123 (L. Qiang,
   D. Accili), R35GM147269 (B. Cai), R00DK115778 (B. Cai), and American
   Heart Association Career Development Award no. 937920 (B. Cai). The
   content in this article is solely the responsibility of the authors and
   does not necessarily represent the official views of the National
   Institutes of Health or the American Heart Association.
CR Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159
   Akashi M, 2005, NAT STRUCT MOL BIOL, V12, P441, DOI 10.1038/nsmb925
   Alexander RK, 2020, ELIFE, V9, DOI 10.7554/eLife.54090
   Anan F, 2007, EUR J CLIN INVEST, V37, P709, DOI 10.1111/j.1365-2362.2007.01854.x
   Andrews S., 2010, FASTQC A QUALITY CON
   Anea CB, 2009, CIRCULATION, V119, P1510, DOI 10.1161/CIRCULATIONAHA.108.827477
   Barbieri M, 2004, EXP GERONTOL, V39, P1095, DOI 10.1016/j.exger.2004.03.034
   Benjamin EJ, 2018, CIRCULATION, V137, pE67, DOI [10.1161/CIR.0000000000000530, 10.1161/CIR.0000000000000558, 10.1161/CIR.0000000000000485]
   Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010
   Brunmeir R, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061738
   Cai BS, 2017, J CLIN INVEST, V127, P564, DOI 10.1172/JCI90520
   Carlsson M, 2000, ARTERIOSCL THROM VAS, V20, P1588, DOI 10.1161/01.ATV.20.6.1588
   Ceriello A, 2008, DIABETES-METAB RES, V24, P14, DOI 10.1002/dmrr.790
   Chawla A, 2001, NAT MED, V7, P48, DOI 10.1038/83336
   Choi SS, 2014, BMB REP, V47, P599, DOI 10.5483/BMBRep.2014.47.11.174
   Consoli A, 2005, LUPUS, V14, P794, DOI 10.1191/0961203305lu2223oa
   Cuaranta-Monroy I, 2015, EUR J CLIN INVEST, V45, P964, DOI 10.1111/eci.12491
   Curtis AM, 2014, IMMUNITY, V40, P178, DOI 10.1016/j.immuni.2014.02.002
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Doran AC, 2020, NAT REV IMMUNOL, V20, P254, DOI 10.1038/s41577-019-0240-6
   Einarson TR, 2018, CARDIOVASC DIABETOL, V17, DOI 10.1186/s12933-018-0728-6
   Fairweather D, 2014, CLIN MED INSIGHTS-CA, V8, P49, DOI 10.4137/CMC.S17068
   Gaggini M, 2013, NUTRIENTS, V5, P1544, DOI 10.3390/nu5051544
   Gallardo-Soler A, 2008, MOL ENDOCRINOL, V22, P1394, DOI 10.1210/me.2007-0525
   Gao Z, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.750078
   Gelain ME, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01220
   Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1161/01.cir.0000437741.48606.98, 10.1016/j.jacc.2013.11.005]
   Han LM, 2010, NUCLEIC ACIDS RES, V38, P7458, DOI 10.1093/nar/gkq609
   Haramizu S, 2011, J GERONTOL A-BIOL, V66, P646, DOI 10.1093/gerona/glr037
   Hernandez-Quiles M, 2021, FRONT ENDOCRINOL, V12, DOI 10.3389/fendo.2021.624112
   Huang Chien-Da, 2014, Biomed J, V37, P191, DOI 10.4103/2319-4170.132890
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Huo MY, 2017, FASEB J, V31, P1097, DOI 10.1096/fj.201601030R
   Janani C, 2015, DIABETES METAB SYND, V9, P46, DOI 10.1016/j.dsx.2014.09.015
   Ji J, 2018, AGING CELL, V17, DOI 10.1111/acel.12774
   Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184
   Karalliedde J, 2007, DRUG SAFETY, V30, P741, DOI 10.2165/00002018-200730090-00002
   Kraakman MJ, 2018, J CLIN INVEST, V128, P2600, DOI 10.1172/JCI98709
   Larsen TM, 2003, INT J OBESITY, V27, P147, DOI 10.1038/sj.ijo.802223
   Lebovitz HE, 2019, CURR DIABETES REP, V19, DOI 10.1007/s11892-019-1270-y
   Liang SC, 2020, EXP THER MED, V20, DOI 10.3892/etm.2020.9259
   Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656
   Libby P, 2019, NAT REV DIS PRIMERS, V5, DOI [10.1038/s41572-019-0116-x, 10.1038/s41572-019-0106-z]
   Lim S, 2019, OBES REV, V20, P599, DOI 10.1111/obr.12820
   Lin CP, 2022, ARTERIOSCL THROM VAS, V42, P565, DOI 10.1161/ATVBAHA.121.316480
   Lin CP, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-14
   Liu LH, 2020, DIABETES, V69, P1793, DOI 10.2337/db20-0217
   Lonardo A, 2018, J HEPATOL, V68, P335, DOI 10.1016/j.jhep.2017.09.021
   López-Melgar B, 2020, J AM COLL CARDIOL, V75, P1617, DOI 10.1016/j.jacc.2020.02.026
   Machado-Oliveira G, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9102146
   McLoughlin SC, 2015, METHOD ENZYMOL, V552, P211, DOI 10.1016/bs.mie.2014.11.029
   Moore KJ, 2001, NAT MED, V7, P41, DOI 10.1038/83328
   Nguyen KD, 2013, SCIENCE, V341, P1483, DOI 10.1126/science.1240636
   Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894
   Oishi Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07100-3
   Pan XY, 2022, HEPATOLOGY, V76, P78, DOI 10.1002/hep.32196
   Pan XY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13011
   Parico GCG, 2020, P NATL ACAD SCI USA, V117, P27971, DOI 10.1073/pnas.1920653117
   Pati P, 2021, AM J PHYSIOL-REG I, V320, pR960, DOI 10.1152/ajpregu.00128.2020
   Pelham CJ, 2013, AM J PHYSIOL-REG I, V304, pR690, DOI 10.1152/ajpregu.00607.2012
   Qiang L, 2012, CELL, V150, P620, DOI 10.1016/j.cell.2012.06.027
   Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007
   Schwartz SM, 2007, ARTERIOSCL THROM VAS, V27, P705, DOI 10.1161/01.ATV.0000261709.34878.20
   Shen Y, 2022, BBA-MOL BASIS DIS, V1868, DOI 10.1016/j.bbadis.2022.166450
   Staels B, 2005, CURR MED RES OPIN, V21, pS13, DOI 10.1185/030079905X36440
   Stump M, 2015, CURR HYPERTENS REP, V17, DOI 10.1007/s11906-015-0601-x
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Szanto A, 2010, IMMUNITY, V33, P699, DOI 10.1016/j.immuni.2010.11.009
   Talayero Beatriz G, 2011, Curr Cardiol Rep, V13, P544, DOI 10.1007/s11886-011-0220-3
   Tall AR, 2015, NAT REV IMMUNOL, V15, P104, DOI 10.1038/nri3793
   Timmons GA, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.700431
   Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5
   Trapani L, 2012, WORLD J HEPATOL, V4, P184, DOI 10.4254/wjh.v4.i6.184
   Ulrich-Lai YM, 2013, EXP GERONTOL, V48, P671, DOI 10.1016/j.exger.2012.08.011
   Wang JC, 2012, CIRC RES, V111, P245, DOI 10.1161/CIRCRESAHA.111.261388
   Wang NN, 2008, CELL METAB, V8, P482, DOI 10.1016/j.cmet.2008.10.009
   Wang XL, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.586399
   Wang Y, 2014, CIRC RES, V114, P421, DOI 10.1161/CIRCRESAHA.114.302153
   Whicher J, 1999, CLIN CHEM LAB MED, V37, P495, DOI 10.1515/CCLM.1999.080
   Wool GD, 2007, CURR DRUG TARGETS, V8, P1203, DOI 10.2174/138945007782403856
   Xie MR, 2020, CIRC RES, V126, pE15, DOI 10.1161/CIRCRESAHA.119.315502
   Xu LY, 2020, AGING CELL, V19, DOI 10.1111/acel.13267
   Xu LY, 2018, AGING CELL, V17, DOI 10.1111/acel.12721
   Yang GR, 2020, ARTERIOSCL THROM VAS, V40, P1523, DOI 10.1161/ATVBAHA.120.314318
   Yin F, 2022, ACTA PHARMACOL SIN, V43, P2351, DOI 10.1038/s41401-022-00863-0
   Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001
   Zhou YW, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.640521
   Zhu MJ, 2018, AM J TRANSL RES, V10, P3150
NR 88
TC 5
Z9 5
U1 5
U2 9
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1079-5642
EI 1524-4636
J9 ARTERIOSCL THROM VAS
JI Arterioscler. Thromb. Vasc. Biol.
PD JAN
PY 2023
VL 43
IS 1
BP 30
EP 44
DI 10.1161/ATVBAHA.122.318061
PG 15
WC Hematology; Peripheral Vascular Disease
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Hematology; Cardiovascular System & Cardiology
GA 8S4OU
UT WOS:000928563700006
PM 36453279
OA Bronze
DA 2024-02-19
ER

PT J
AU Bauer, KC
   Huus, KE
   Brown, EM
   Bozorgmehr, T
   Petersen, C
   Cirstea, MS
   Woodward, SE
   McCoy, J
   Hun, J
   Pamplona, R
   Ayala, V
   Finlay, BB
AF Bauer, K. C.
   Huus, K. E.
   Brown, E. M.
   Bozorgmehr, T.
   Petersen, C.
   Cirstea, M. S.
   Woodward, S. E.
   McCoy, J.
   Hun, J.
   Pamplona, R.
   Ayala, V
   Finlay, B. B.
TI Dietary Intervention Reverses Fatty Liver and Altered Gut Microbiota
   during Early-Life Undernutrition
SO MSYSTEMS
LA English
DT Article
DE gut-liver axis; metabolomics; microbiome; NAFLD; undernutrition
ID RETINOIC ACID; CHILD UNDERNUTRITION; FOOD INSECURITY; LOW-INCOME;
   DISEASE; METABOLISM; HEALTH; ENTEROPATHY; BACTERIA; DATABASE
AB Nonalcoholic fatty liver disease (NAFLD), largely studied as a condition of overnutrition, also presents in undernourished populations. Like NAFLD, undernutrition disrupts systemic metabolism and has been linked to gut microbiota dysbiosis. Indeed, chronic exposures to fecal microbes contribute to undernutrition pathology in regions with poor sanitation. Despite a growing prevalence of fatty liver disease, the influence of undernutrition and the gut microbiota remain largely unexplored. Here, we utilize an established murine model (C57BL/6J mice placed on a malnourished diet that received iterative Escherichia coli/Bacteroidales gavage [MBG mice]) that combines a protein/fat-deficient diet and iterative exposure to specific, fecal microbes. Fecal-oral contamination exacerbates triglyceride accumulation in undernourished mice. MBG livers exhibit diffuse lipidosis accompanied by striking shifts in fatty acid, glycerophospholipid, and retinol metabolism. Multiomic analyses revealed metabolomic pathways linked to the undernourished gut microbiome and hepatic steatosis, including phenylacetate metabolism. Intriguingly, fatty liver features were observed only in the early-life, but not adult, MBG model despite similar liver metabolomic profiles. Importantly, we demonstrate that dietary intervention largely mitigates aberrant metabolomic and microbiome features in MBG mice. These findings indicate a crucial window in early-life development that, when disrupted by nutritional deficiency, may significantly influence liver function. Our work provides a multifaceted study of how diet and gut microbes inform fatty liver progression and reversal during undernutrition.
   IMPORTANCE Nonalcoholic fatty liver disease (NAFLD) remains a global epidemic, but it is often studied in the context of obesity and aging. Nutritional deficits, however, also trigger hepatic steatosis, influencing health trajectories in undernourished pediatric populations. Here, we report that exposure to specific gut microbes impacts fatty liver pathology in mice fed a protein/fat-deficient diet. We utilize a multiomics approach to (i) characterize NAFLD in the context of early undernutrition and (ii) examine the impact of diet and gut microbes in the pathology and reversal of hepatic steatosis. We provide compelling evidence that an early-life, critical development window facilitates undernutrition-induced fatty liver pathology. Moreover, we demonstrate that sustained dietary intervention largely reverses fatty liver features and microbiome shifts observed during early-life malnutrition.
C1 [Bauer, K. C.; Huus, K. E.; Brown, E. M.; Bozorgmehr, T.; Petersen, C.; Cirstea, M. S.; Woodward, S. E.; McCoy, J.; Finlay, B. B.] Univ British Columbia, Michael Smith Labs, Vancouver, BC, Canada.
   [Bauer, K. C.; Huus, K. E.; Brown, E. M.; Cirstea, M. S.; Woodward, S. E.; Finlay, B. B.] Univ British Columbia, Microbiol & Immunol Dept, Vancouver, BC, Canada.
   [Hun, J.] Univ Victoria, Metabol Innovat Ctr, Victoria, BC, Canada.
   [Pamplona, R.; Ayala, V] Inst Recerca Biomed Lleida IRB Lleida, Lleida, Spain.
   [Pamplona, R.; Ayala, V] Univ Lleida, Dept Metabol Physiol, Lleida, Spain.
   [Finlay, B. B.] Univ British Columbia, Biochem & Mol Biol Dept, Vancouver, BC, Canada.
   [Brown, E. M.] Harvard Univ, Broad Inst, Cambridge, MA 02138 USA.
C3 University of British Columbia; University of British Columbia;
   University of Victoria; Institut de Recerca Biomedica - IRB Lleida;
   Universitat de Lleida; University of British Columbia; Harvard
   University; Massachusetts Institute of Technology (MIT); Broad Institute
RP Finlay, BB (corresponding author), Univ British Columbia, Michael Smith Labs, Vancouver, BC, Canada.; Finlay, BB (corresponding author), Univ British Columbia, Microbiol & Immunol Dept, Vancouver, BC, Canada.; Finlay, BB (corresponding author), Univ British Columbia, Biochem & Mol Biol Dept, Vancouver, BC, Canada.
EM bfinlay@mslubc.ca
RI Pamplona, Reinald/A-7359-2010; Woodward, Sarah E./GSJ-1632-2022; Ayala,
   Maria Victoria/A-7391-2010
OI Pamplona, Reinald/0000-0003-4337-6107; Ayala, Maria
   Victoria/0000-0002-1496-966X; Huus, Kelsey
   Elizabeth/0000-0002-7580-1924; Bauer, Kylynda C./0000-0002-5689-6016;
   Woodward, Sarah E/0000-0002-6688-0595
FU UBC; Canadian Tri-Agency Council; Vanier Canada Graduate Scholarships
   (CGS); NSERC-Vanier scholarship; Generalitat of Catalonia; Instituto de
   Salud Carlos III; ERDF (European Regional Development Fund -European
   Commission); Bill and Melinda Gates Foundation; CIHR; Spanish Government
FX UBC research trainees were funded by UBC, the Canadian Tri-Agency
   Council, and Vanier Canada Graduate Scholarships (CGS). K. C. Bauer is
   the recipient of an NSERC-Vanier scholarship. The Ayala and Pamplona
   labs received funding through the Generalitat of Catalonia, Spanish
   Government, Instituto de Salud Carlos III, and ERDF (European Regional
   Development Fund -European Commission). B. B. Finlay serves as a Peter
   Wall Distinguished Professor at UBC, CIFAR-Humans and the Microbiome
   Director, and CIHR Foundation Grant recipient. The Finlay lab is
   grateful for support from operating grants received from CIHR and the
   Bill and Melinda Gates Foundation.
CR Amengual J, 2012, INT J BIOCHEM CELL B, V44, P2019, DOI 10.1016/j.biocel.2012.07.026
   Arranz L, 2013, AGE, V35, P621, DOI 10.1007/s11357-012-9391-0
   Bazinet RP, 2014, NAT REV NEUROSCI, V15, P771, DOI 10.1038/nrn3820
   Beaucage KL, 2014, PURINERG SIGNAL, V10, P291, DOI 10.1007/s11302-013-9388-x
   Bendtsen KMB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046231
   Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8
   Blanton LV, 2016, SCIENCE, V352, DOI 10.1126/science.aad9359
   Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242
   Bolick DT, 2013, J MED MICROBIOL, V62, P896, DOI 10.1099/jmm.0.046300-0
   Brown EM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8806
   Bush H, 2017, CHILDREN-BASEL, V4, DOI 10.3390/children4060048
   Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]
   Calzada E, 2016, INT REV CEL MOL BIO, V321, P29, DOI 10.1016/bs.ircmb.2015.10.001
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303
   Carrero C, 2018, DATA MINING BIG DATA, P748
   Caspi R, 2008, NUCLEIC ACIDS RES, V36, pD623, DOI [10.1093/nar/gkt1103, 10.1093/nar/gkm900]
   Chong J, 2018, BIOINFORMATICS, V34, P4313, DOI 10.1093/bioinformatics/bty528
   Clemente MG, 2016, WORLD J GASTROENTERO, V22, P8078, DOI 10.3748/wjg.v22.i36.8078
   Crane RJ, 2015, FOOD NUTR BULL, V36, pS76, DOI 10.1177/15648265150361S113
   de Souza AS, 2008, NUTR NEUROSCI, V11, P119, DOI 10.1179/147683008X301504
   DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05
   Douglas GM., 2019, BIORXIV, DOI [DOI 10.1101/672295, 10.1101/672295]
   Duwaerts CC, 2019, CELL MOL GASTROENTER, V7, P749, DOI 10.1016/j.jcmgh.2019.02.001
   Dyson JK, 2014, FRONTLINE GASTROENTE, V5, P211, DOI 10.1136/flgastro-2013-100403
   Gorden DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022775
   Guerrant RL, 2013, NAT REV GASTRO HEPAT, V10, P220, DOI 10.1038/nrgastro.2012.239
   Hadi H, 2000, AM J CLIN NUTR, V71, P507
   Hall JA, 2011, IMMUNITY, V34, P435, DOI 10.1016/j.immuni.2011.03.003
   He XX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162368
   Hoyles L, 2018, NAT MED, V24, P1070, DOI 10.1038/s41591-018-0061-3
   Humphrey JH, 2009, LANCET, V374, P1032, DOI 10.1016/S0140-6736(09)60950-8
   Huus KE, 2020, CELL HOST MICROBE, V27, P909, DOI 10.1016/j.chom.2020.03.012
   Kalhan SC, 2011, METABOLISM, V60, P404, DOI 10.1016/j.metabol.2010.03.006
   Kau AL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4877
   Kawada N, 2009, J GASTROENTEROL, V44, P1190, DOI 10.1007/s00535-009-0112-0
   Ke J, 2015, PAED CHILD HEALT-CAN, V20, P89, DOI 10.1093/pch/20.2.89
   Kneeman JM, 2012, THER ADV GASTROENTER, V5, P199, DOI 10.1177/1756283X11430859
   Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13
   Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559
   Leonardi R, 2009, J BIOL CHEM, V284, P27077, DOI 10.1074/jbc.M109.031336
   Li ML, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/437107
   Li ZY, 2006, CELL METAB, V3, P321, DOI 10.1016/j.cmet.2006.03.007
   Liu Y, 2015, AM J CLIN NUTR, V102, P130, DOI 10.3945/ajcn.114.105155
   Magnusson KR, 2015, NEUROSCIENCE, V300, P128, DOI 10.1016/j.neuroscience.2015.05.016
   Morales Mary E, 2016, Curr Nutr Rep, V5, P54, DOI 10.1007/s13668-016-0153-y
   O'Byrne SM, 2013, J LIPID RES, V54, P1731, DOI 10.1194/jlr.R037648
   Pereira A.L., 2017, Innocenti Working Paper 2017-09, P1, DOI 10.18356/ae253274-en
   Puri P, 2018, HEPATOLOGY, V67, P534, DOI 10.1002/hep.29359
   Roser M, 2013, Hunger and undernourishment
   Sedgh G, 2000, J NUTR, V130, P2520, DOI 10.1093/jn/130.10.2520
   Seligman HK, 2010, J NUTR, V140, P304, DOI 10.3945/jn.109.112573
   Semba RD, 2016, SCI REP-UK, V6, DOI 10.1038/srep28009
   Sharpton SR, 2019, HEPATOL COMMUN, V3, P29, DOI 10.1002/hep4.1284
   SOMMER A, 1983, LANCET, V2, P585
   Sommer A, 2008, J NUTR, V138, P1835, DOI 10.1093/jn/138.10.1835
   Suhre K, 2008, NUCLEIC ACIDS RES, V36, pW481, DOI 10.1093/nar/gkn194
   Swann JR, 2011, P NATL ACAD SCI USA, V108, P4523, DOI 10.1073/pnas.1006734107
   Takahashi Y, 2014, WORLD J GASTROENTERO, V20, P15539, DOI 10.3748/wjg.v20.i42.15539
   Tapiero H, 2002, BIOMED PHARMACOTHER, V56, P215, DOI 10.1016/S0753-3322(02)00193-2
   TEODOSIO NR, 1990, ARCH LATINOAM NUTR, V40, P533
   Tofail F, 2018, LANCET CHILD ADOLESC, V2, P255, DOI 10.1016/S2352-4642(18)30031-2
   van Zutphen T, 2016, J HEPATOL, V65, P1198, DOI 10.1016/j.jhep.2016.05.046
   Videla LA, 2004, FREE RADICAL BIO MED, V37, P1499, DOI 10.1016/j.freeradbiomed.2004.06.033
   Vonaesch P, 2018, P NATL ACAD SCI USA, V115, pE8489, DOI 10.1073/pnas.1806573115
   Yan J, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000012773
   Yki-Järvinen H, 2014, LANCET DIABETES ENDO, V2, P901, DOI 10.1016/S2213-8587(14)70032-4
   Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431
   Zeng HW, 2016, J NUTR BIOCHEM, V35, P30, DOI 10.1016/j.jnutbio.2016.05.015
   Zhang JD, 2019, J GASTROEN HEPATOL, V34, P1368, DOI 10.1111/jgh.14536
   Ziouzenkova O, 2007, NAT MED, V13, P695, DOI 10.1038/nm1587
NR 70
TC 4
Z9 4
U1 1
U2 14
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2379-5077
J9 MSYSTEMS
JI mSystems
PD SEP-OCT
PY 2020
VL 5
IS 5
AR e00499-20
DI 10.1128/mSystems.00499-20
PG 20
WC Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology
GA OC7WM
UT WOS:000579368300002
PM 32900869
OA Green Published
DA 2024-02-19
ER

PT J
AU Chishti, MA
   Kaya, N
   BinBakheet, A
   Al-Mohanna, F
   Goyns, MH
   Colak, D
AF Chishti, Muhammad A.
   Kaya, Namik
   BinBakheet, Al-Bandary
   Al-Mohanna, Falah
   Goyns, Malcolm H.
   Colak, Dilek
TI Induction of cell proliferation in old rat liver can reset certain gene
   expression levels characteristic of old liver to those associated with
   young liver
SO AGE
LA English
DT Article
DE Liver; Aging; Hepatectomy; Microarray; Global gene expression;
   Regeneration; Longevity
ID DIFFERENTIAL DISPLAY ANALYSIS; AGE-RELATED-CHANGES; EXTENDS LIFE-SPAN;
   CALORIC RESTRICTION; HEPATOCELLULAR-CARCINOMA; TRANSCRIPTIONAL PROFILE;
   HUMAN MUSCLE; IN-VIVO; MICROARRAY; GROWTH
AB During the past decade, it has become increasingly clear that consistent changes in the levels of expression of a small cohort of genes accompany the aging of mammalian tissues. In many cases, these changes have been shown to generate features that are characteristic of the senescent phenotype. Previously, a small pilot study indicated that some of these changes might be reversed in rat liver, if the liver cells became malignant and were proliferating. The present study has tested the hypothesis that inducing proliferation in old rat liver can reset the levels of expression of these age-related genes to that observed in young tissue. A microarray approach was used to identify genes that exhibited the greatest changes in their expression during aging. The levels of expression of these markers were then examined in transcriptomes of both proliferating hepatomas from old animals and old rat liver lobes that had regenerated after partial hepatectomy but were again quiescent. We have found evidence that over 20 % of the aging-related genes had their levels of expression reset to young levels by stimulating proliferation, even in cells that had undergone a limited number of cell cycles and then become quiescent again. Moreover, our network analysis indicated alterations in MAPK/ERK and Jun-N-terminal kinase pathways and the potential important role of PAX3, VCAN, ARRB2, NR1H2, and ITGA5 that may provide insights into mechanisms involved in longevity and regeneration that are distinct from cancer.
C1 [Chishti, Muhammad A.; Al-Mohanna, Falah] King Faisal Specialist Hosp & Res Ctr, Dept Comparat Med, Riyadh 11211, Saudi Arabia.
   [Kaya, Namik; BinBakheet, Al-Bandary] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia.
   [Goyns, Malcolm H.] King Faisal Specialist Hosp & Res Ctr, Childrens Canc Ctr, Riyadh 11211, Saudi Arabia.
   [Colak, Dilek] King Faisal Specialist Hosp & Res Ctr, Dept Biostat Epidemiol & Sci Comp, Riyadh 11211, Saudi Arabia.
C3 King Faisal Specialist Hospital & Research Center; King Faisal
   Specialist Hospital & Research Center; King Faisal Specialist Hospital &
   Research Center; King Faisal Specialist Hospital & Research Center
RP Colak, D (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Biostat Epidemiol & Sci Comp, Riyadh 11211, Saudi Arabia.
EM mchishti@ksu.edu.sa; dcolakkaya@kfshrc.edu.sa
RI Almohanna, Falah/IYJ-6603-2023; Kaya, Namik/GQA-7857-2022; Colak,
   Dilek/IQT-4246-2023
OI Colak, Dilek/0000-0001-6485-8768
FU King Faisal Specialist Hospital and Research Center; King Saud
   University
FX The authors wish to thank Dr. Maqbool Ahmad for his kind help in RNA
   isolation. We would like to thank the King Faisal Specialist Hospital
   and Research Center for the financial support. This project is supported
   by King Faisal Specialist Hospital and Research Center's seed grants and
   Deanship of Scientific Research, King Saud University.
CR Anderson J, 2001, AM J PATHOL, V159, P1089, DOI 10.1016/S0002-9440(10)61784-1
   Boyault S, 2007, HEPATOLOGY, V45, P42, DOI 10.1002/hep.21467
   Cao SX, 2001, P NATL ACAD SCI USA, V98, P10630, DOI 10.1073/pnas.191313598
   Chang KCN, 2008, MOL ENDOCRINOL, V22, P2407, DOI 10.1210/me.2008-0232
   Charlton MA, 1999, CANCER LETT, V143, P45, DOI 10.1016/S0304-3835(99)00173-1
   Colak D, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-146
   Conboy IM, 2011, AGING-US, V3, P555, DOI 10.18632/aging.100333
   Gems D, 1998, GENETICS, V150, P129
   Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80
   Gerisch B, 2001, DEV CELL, V1, P841, DOI 10.1016/S1534-5807(01)00085-5
   Goyns MH, 2002, MECH AGEING DEV, V123, P791, DOI 10.1016/S0047-6374(01)00424-9
   Goyns MH, 1998, MECH AGEING DEV, V101, P73, DOI 10.1016/S0047-6374(97)00166-8
   Hong SE, 2010, AGE, V32, P15, DOI 10.1007/s11357-009-9106-3
   ITO N, 1989, CARCINOGENESIS, V10, P2255, DOI 10.1093/carcin/10.12.2255
   Karpac J, 2009, AGING CELL, V8, P288, DOI 10.1111/j.1474-9726.2009.00476.x
   Kayo T, 2001, P NATL ACAD SCI USA, V98, P5093, DOI 10.1073/pnas.081061898
   Kume S, 2010, J CLIN INVEST, V120, P1043, DOI 10.1172/JCI41376
   Lee CK, 2002, P NATL ACAD SCI USA, V99, P14988, DOI 10.1073/pnas.232308999
   Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390
   Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046
   Li Y, 1997, INVEST OPHTH VIS SCI, V38, P100
   Liu YF, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-107
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661
   Ly DH, 2000, SCIENCE, V287, P2486, DOI 10.1126/science.287.5462.2486
   Mas VR, 2009, MOL MED, V15, P85, DOI 10.2119/molmed.2008.00110
   MASORO EJ, 1992, AM J CLIN NUTR, V55, P1250
   Matsumura I, 2003, CELL CYCLE, V2, P333, DOI 10.4161/cc.2.4.428
   Mori K, 2007, TOXICOL PATHOL, V35, P242, DOI 10.1080/01926230601156286
   Nasarre C, 2010, ONCOGENE, V29, P2381, DOI 10.1038/onc.2010.9
   Pérez-Carreón JI, 2006, NEOPLASIA, V8, P373, DOI 10.1593/neo.05841
   Rodwell GEJ, 2004, PLOS BIOL, V2, P2191, DOI 10.1371/journal.pbio.0020427
   Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01
   Salehi M, 1996, EXPERIENTIA, V52, P888, DOI 10.1007/BF01938876
   Schumacher B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000161
   Swindell WR, 2008, MECH AGEING DEV, V129, P580, DOI 10.1016/j.mad.2008.06.001
   Tanaka F, 2002, J BIOCHEM, V131, P39, DOI 10.1093/oxfordjournals.jbchem.a003075
   Thomas PD, 2006, NUCLEIC ACIDS RES, V34, pW645, DOI 10.1093/nar/gkl229
   Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403
   Thomas RP, 2002, J GASTROINTEST SURG, V6, P445, DOI 10.1016/S1091-255X(01)00010-5
   Tollet-Egnell P, 2001, MOL ENDOCRINOL, V15, P308, DOI 10.1210/me.15.2.308
   Valle A, 2010, AGING CELL, V9, P882, DOI 10.1111/j.1474-9726.2010.00613.x
   Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030
   Wang MC, 2003, DEV CELL, V5, P811, DOI 10.1016/S1534-5807(03)00323-X
   Wang XH, 2001, P NATL ACAD SCI USA, V98, P11468, DOI 10.1073/pnas.201360898
   Wayneforth HB, 1980, EXPT SURG TECHNIQUES
   Welle S, 2003, PHYSIOL GENOMICS, V14, P149, DOI 10.1152/physiolgenomics.00049.2003
   Wurmbach E, 2007, HEPATOLOGY, V45, P938, DOI 10.1002/hep.21622
   Yamaza H, 2010, AGING CELL, V9, P372, DOI 10.1111/j.1474-9726.2010.00563.x
   Yoshida S, 2002, INVEST OPHTH VIS SCI, V43, P2554
   Zahn JM, 2006, PLOS GENET, V2, P1058, DOI 10.1371/journal.pgen.0020115
NR 51
TC 6
Z9 6
U1 0
U2 6
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0161-9152
J9 AGE
JI Age
PD JUN
PY 2013
VL 35
IS 3
BP 719
EP 732
DI 10.1007/s11357-012-9404-z
PG 14
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 133XL
UT WOS:000318174100016
PM 22477361
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU Laish, I
   Mannasse-Green, B
   Hadary, R
   Biron-Shental, T
   Konikoff, FM
   Amiel, A
   Kitay-Cohen, Y
AF Laish, Ido
   Mannasse-Green, Batya
   Hadary, Ruth
   Biron-Shental, Tal
   Konikoff, Fred M.
   Amiel, Aliza
   Kitay-Cohen, Yona
TI Telomere Dysfunction in Nonalcoholic Fatty Liver Disease and Cryptogenic
   Cirrhosis
SO CYTOGENETIC AND GENOME RESEARCH
LA English
DT Article
DE Cryptogenic cirrhosis; Fatty liver; Fluorescence in situ hybridization;
   Telomeres
ID CELLULAR SENESCENCE; METABOLIC SYNDROME; OXIDATIVE STRESS;
   GENE-EXPRESSION; NATURAL-HISTORY; IMMORTAL CELLS; DNA-DAMAGE;
   STEATOHEPATITIS; LENGTH; CAPTURE
AB Nonalcoholic fatty liver disease (NAFLD) and cryptogenic cirrhosis (CC) are considered preneoplastic conditions that might progress to hepatocellular carcinoma. We evaluated parameters of telomere dysfunction in these patient groups to study the correlation between telomere length and the progression of NAFLD. We analyzed peripheral lymphocytes from 22 patients with NAFLD, 20 patients with CC, and 20 healthy, age-matched controls. Telomere length was analyzed using quantitative fluorescence in situ hybridization, and cellular senescence was evaluated by the percentage of cells with senescence-associated heterochromatin foci. The expression of telomerase reverse transcriptase (hTERT) mRNA was measured using polymerase chain reaction, and telomere capture (TC) was assessed with 2 Cytocell probes, 15qter and 13qter. Shorter telomere length and increased cellular senescence was demonstrated in patients with NAFLD, compared to the CC patients and healthy controls. While hTERT mRNA was significantly decreased, TC was increased in CC patients, compared to the NAFLD group and healthy individuals. Thus, there is a correlation between hTERT mRNA expression and telomere length in patients with NAFLD, which might be related to associated metabolic disorders and the risk of malignant transformation. Patients with CC, on the contrary, elongate their telomeres through the TC mechanism. (C) 2016 S. Karger AG, Basel
C1 [Laish, Ido; Konikoff, Fred M.] Meir Med Ctr, Gastroenterol & Hepatol Inst, 59 Tschernihovsky St, IL-44281 Kefar Sava, Israel.
   [Mannasse-Green, Batya; Amiel, Aliza] Meir Med Ctr, Genet Inst, Kefar Sava, Israel.
   [Hadary, Ruth; Kitay-Cohen, Yona] Meir Med Ctr, Liver Unit, Kefar Sava, Israel.
   [Biron-Shental, Tal] Meir Med Ctr, Dept Obstet & Gynecol, Kefar Sava, Israel.
   [Laish, Ido; Hadary, Ruth; Biron-Shental, Tal; Konikoff, Fred M.; Kitay-Cohen, Yona] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel.
   [Amiel, Aliza] Bar Ilan Univ, Fac Life Sci, Ramat Gan, Israel.
C3 Sackler Faculty of Medicine; Sackler Faculty of Medicine; Sackler
   Faculty of Medicine; Sackler Faculty of Medicine; Sackler Faculty of
   Medicine; Bar Ilan University
RP Laish, I (corresponding author), Meir Med Ctr, Gastroenterol & Hepatol Inst, 59 Tschernihovsky St, IL-44281 Kefar Sava, Israel.
EM ido.laish@gmail.com
RI Biron-Shental, Tal/L-6035-2019
FU Josefina Maus and Gabriela Cesarman Chair for Research in Liver
   Diseases, the Tel Aviv University
FX This study was supported in part by the Josefina Maus and Gabriela
   Cesarman Chair for Research in Liver Diseases, the Tel Aviv University.
CR ABDELMALEK M, 1995, J CLIN GASTROENTEROL, V20, P127, DOI 10.1097/00004836-199503000-00011
   Amiel A, 2005, CANCER GENET CYTOGEN, V163, P12, DOI 10.1016/j.cancergencyto.2005.04.007
   Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031
   Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157
   Ascha MS, 2010, HEPATOLOGY, V51, P1972, DOI 10.1002/hep.23527
   Atkinson SP, 2005, CANCER RES, V65, P7585, DOI 10.1158/0008-5472.CAN-05-1715
   Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013
   Calado RT, 2011, HEPATOLOGY, V53, P1600, DOI 10.1002/hep.24173
   Cao Y, 2008, CANCER SCI, V99, P1092, DOI 10.1111/j.1349-7006.2008.00815.x
   Chaiteerakij R, 2011, HEPATOLOGY, V53, P1430, DOI 10.1002/hep.24304
   Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762
   COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x
   Friedrich U, 2000, MECH AGEING DEV, V119, P89, DOI 10.1016/S0047-6374(00)00173-1
   Georgin-Lavialle S, 2010, AUTOIMMUN REV, V9, P646, DOI 10.1016/j.autrev.2010.04.004
   Goldberg-Bittman L, 2009, CANCER GENET CYTOGEN, V191, P63, DOI 10.1016/j.cancergencyto.2009.01.013
   HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0
   Hug N, 2006, CHROMOSOMA, V115, P413, DOI 10.1007/s00412-006-0067-3
   Kim H, 2009, HEPATOLOGY, V50, P752, DOI 10.1002/hep.23072
   KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428
   Lafferty-Whyte K, 2009, ONCOGENE, V28, P3765, DOI 10.1038/onc.2009.238
   Laish I, 2015, DIGEST LIVER DIS, V47, P790, DOI 10.1016/j.dld.2015.05.002
   Ma D, 2013, J ENDOCRINOL INVEST, V36, P1032, DOI 10.3275/9036
   Maclntyre A, 2008, ANN RHEUM DIS, V67, P1780, DOI 10.1136/ard.2007.086652
   MELTZER PS, 1993, NAT GENET, V4, P252, DOI 10.1038/ng0793-252
   Nakajima T, 2006, LIVER INT, V26, P23, DOI 10.1111/j.1478-3231.2005.01178.x
   Narita M, 2006, CELL, V126, P503, DOI 10.1016/j.cell.2006.05.052
   Oikawa S, 2001, BIOCHEMISTRY-US, V40, P4763, DOI 10.1021/bi002721g
   Paradis V, 2009, HEPATOLOGY, V49, P851, DOI 10.1002/hep.22734
   Plentz RR, 2004, HEPATOLOGY, V40, P80, DOI 10.1002/hep.20271
   POWELL EE, 1990, HEPATOLOGY, V11, P74, DOI 10.1002/hep.1840110114
   Preston RJ, 1997, RADIAT RES, V147, P529, DOI 10.2307/3579618
   Révész D, 2014, J CLIN ENDOCR METAB, V99, P4607, DOI 10.1210/jc.2014-1851
   Rode L, 2014, J CLIN ENDOCR METAB, V99, pE1671, DOI 10.1210/jc.2014-1161
   Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004
   Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x
   Volpi A, 2005, CELL ONCOL, V27, P347
   von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2
   Wiemann SU, 2005, ONCOGENE, V24, P1501, DOI 10.1038/sj.onc.1208308
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
NR 39
TC 34
Z9 34
U1 0
U2 5
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1424-8581
EI 1424-859X
J9 CYTOGENET GENOME RES
JI Cytogenet. Genome Res.
PY 2016
VL 150
IS 2
BP 93
EP 99
DI 10.1159/000454654
PG 7
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA EL9XA
UT WOS:000394972200003
PM 28006764
DA 2024-02-19
ER

PT J
AU Jacomelli, M
   Pitozzi, V
   Zaid, M
   Larrosa, M
   Tonini, G
   Martini, A
   Urbani, S
   Taticchi, A
   Servili, M
   Dolara, P
   Giovannelli, L
AF Jacomelli, Michela
   Pitozzi, Vanessa
   Zaid, Mohamed
   Larrosa, Mar
   Tonini, Giulia
   Martini, Andrea
   Urbani, Stefania
   Taticchi, Agnese
   Servili, Maurizio
   Dolara, Piero
   Giovannelli, Lisa
TI Dietary extra-virgin olive oil rich in phenolic antioxidants and the
   aging process: long-term effects in the rat
SO JOURNAL OF NUTRITIONAL BIOCHEMISTRY
LA English
DT Article
DE Fatty acids; High calorie diet; Liver steatosis; Olive oil phenols;
   Oxidative damage
ID OXIDATIVE DNA-DAMAGE; LIFE-SPAN; FATTY-ACIDS; HYDROXYTYROSOL; STRESS;
   RESTRICTION; MODERATE; HEALTH; AGE; CONSUMPTION
AB The aim of the present work was to verify whether extra-virgin olive oil, a food naturally containing phenolic antioxidants, has the potential to protect from the pro-aging effects of a high-calorie diet. Male rats were fed from age 12 months to senescence a high-calorie diet containing either corn oil (CO), or extra-virgin olive oil with high (H-EVOO) or low (L-EVOO) amounts of phenols. The prolonged high fat intake led to obesity, liver lipid degeneration and insulin resistance, which were not counteracted by high phenol intake. No difference in overall survival was found at the end of the experiment in the animals treated with H-EVOO compared to the other groups. However, we did detect a protective effect of olive oil on some age-related pathologies and on blood pressure, of which the former was associated with the antioxidant content. Concomitantly, a decrease in DNA oxidative damage in blood cells and plasma TBARS and an increase in liver superoxide dismutase were detected following H-EVOO consumption. Thus, although olive oil phenols cannot reversethe detrimental effects of a prolonged intake of high amounts of fat, improving the quality of olive oil in terms of antioxidant content can be beneficial. (C) 2010 Elsevier Inc. All rights reserved.
C1 [Jacomelli, Michela; Pitozzi, Vanessa; Zaid, Mohamed; Larrosa, Mar; Dolara, Piero; Giovannelli, Lisa] Univ Florence, Dipartimento Farmacol Preclin & Clin, I-50139 Florence, Italy.
   [Tonini, Giulia] Sci Inst Tuscany, ISPO, Biostat Unit, Florence, Italy.
   [Martini, Andrea] Univ Florence, Dept Anim Sci, I-50139 Florence, Italy.
   [Urbani, Stefania; Taticchi, Agnese; Servili, Maurizio] Univ Perugia, Dept Food Sci, I-06100 Perugia, Italy.
C3 University of Florence; University of Florence; University of Perugia
RP Giovannelli, L (corresponding author), Univ Florence, Dipartimento Farmacol Preclin & Clin, I-50139 Florence, Italy.
EM lisa.giovannelli@unifi.it
RI LARROSA, MAR/H-6012-2012; Martini, Andrea/G-8297-2012; Martini,
   Andrea/JDM-7861-2023; Zaid, Mohamed/A-2221-2013; Giovannelli,
   Lisa/H-3766-2012
OI LARROSA, MAR/0000-0002-8863-4686; Martini, Andrea/0000-0003-1011-7352;
   Zaid, Mohamed/0000-0001-8992-1727; Giovannelli, Lisa/0000-0002-4027-4693
FU MIUR; Ministero della Universita e della Ricerca Scientifica e
   Tecnologica; University of Florence; EU [FLAVO 2005-513960]; Network of
   Excellence in Nutrigenomics [NuGO FOOD-CT-2004-506360]; Spanish Ministry
   of Science and Innovation
FX This work was financially supported by the MIUR project FISR entitled
   "Miglioramento delle proprieta sensoriali e nutrizionali di prodotti
   alimentari di origine vegetale relativi alla prima e alla seconda
   trasformazione", by the Ministero della Universita e della Ricerca
   Scientifica e Tecnologica, by the University of Florence, by the EU
   program FLAVO 2005-513960 and by the Network of Excellence in
   Nutrigenomics, NuGO FOOD-CT-2004-506360. Mar Larrosa has a post-doctoral
   fellowship of the Spanish Ministry of Science and Innovation.
CR *AM I CANC RES WOR, FOOD NUTR PHYS ACT P
   Aruoma OI, 1998, J AGR FOOD CHEM, V46, P5181, DOI 10.1021/jf980649b
   Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354
   Blagosklonny MV, 2007, DRUG DISCOV TODAY, V12, P218, DOI 10.1016/j.drudis.2007.01.004
   Bondia-Pons I, 2007, J NUTR, V137, P84, DOI 10.1093/jn/137.1.84
   Colivicchi MA, 2004, EUR J PHARMACOL, V495, P209, DOI 10.1016/j.ejphar.2004.05.004
   Covas MI, 2006, ANN INTERN MED, V145, P333, DOI 10.7326/0003-4819-145-5-200609050-00006
   Dominguez LJ, 2020, ENCYCLOPEDIA OF BIOMEDICAL GERONTOLOGY, VOL 2, P400, DOI [10.1097/00008469-200410000-00014, 10.1016/B978-0-12-801238-3.62178-5]
   Escrivá F, 2007, J ENDOCRINOL, V194, P131, DOI 10.1677/joe.1.07043
   Everitt AV, 2006, CLIN INTERV AGING, V1, P11, DOI 10.2147/ciia.2006.1.1.11
   Giovannelli L, 2003, MUTAT RES-GEN TOX EN, V538, P71, DOI 10.1016/S1383-5718(03)00090-1
   Greer EL, 2008, ACTA PHYSIOL, V192, P19, DOI 10.1111/j.1748-1716.2007.01780.x
   Grigg D., 1999, GeoJournal, V48, P259, DOI 10.1023/A:1007047007738
   Hillestrom PR, 2006, FREE RADICAL BIO MED, V41, P1133, DOI 10.1016/j.freeradbiomed.2006.06.013
   Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298
   Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549
   Ingram DK, 2006, AGING CELL, V5, P97, DOI 10.1111/j.1474-9726.2006.00202.x
   Jozwik M, 1999, MOL HUM REPROD, V5, P409, DOI 10.1093/molehr/5.5.409
   Kris-Etherton PM, 2004, NUTR REV, V62, P414, DOI 10.1111/j.1753-4887.2004.tb00013.x
   Lavelli V, 2002, J AGR FOOD CHEM, V50, P7704, DOI 10.1021/jf020749o
   Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4
   Luceri C, 2004, SCAND J GASTROENTERO, V39, P1128, DOI 10.1080/00365520410007908
   Luceri C, 2008, FOOD CHEM TOXICOL, V46, P1213, DOI 10.1016/j.fct.2007.10.007
   Machowetz A, 2007, FASEB J, V21, P45, DOI 10.1096/fj.06-6328com
   Manna C, 1997, J NUTR, V127, P286, DOI 10.1093/jn/127.2.286
   Masala G, 2007, BRIT J NUTR, V98, P406, DOI 10.1017/S0007114507704981
   Méndez-Sánchez N, 2007, CURR MED CHEM, V14, P1988
   Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311
   Miró-Casas E, 2003, EUR J CLIN NUTR, V57, P186, DOI 10.1038/sj.ejcn.1601532
   Muller FL, 2007, FREE RADICAL BIO MED, V43, P477, DOI 10.1016/j.freeradbiomed.2007.03.034
   Pérez-Jiménez F, 2007, MOL NUTR FOOD RES, V51, P1199, DOI [10.1002/mnfr.200600273, 10.1002/mnfr.200790023]
   Psomiadou E, 1998, J AGR FOOD CHEM, V46, P5132, DOI 10.1021/jf980250n
   Quiles JL, 2004, EXP GERONTOL, V39, P1189, DOI 10.1016/j.exger.2004.05.002
   Salvini S, 2006, BRIT J NUTR, V95, P742, DOI 10.1079/BJN20051674
   Selvaggini R, 2006, J AGR FOOD CHEM, V54, P2832, DOI 10.1021/jf0527596
   Servili M, 2004, J CHROMATOGR A, V1054, P113, DOI [10.1016/j.chroma.2004.08.070, 10.1016/S0021-9673(04)01423-2]
   Sinclair DA, 2005, MECH AGEING DEV, V126, P987, DOI 10.1016/j.mad.2005.03.019
   Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987
   Truswell AS, 1998, EUR J CLIN NUTR, V52, P312, DOI 10.1038/sj.ejcn.1600566
   *UN FAO, 2003, FAOSTAT
   Visioli F, 2000, CIRCULATION, V102, P2169
   Visioli F, 2001, FREE RADICAL RES, V34, P301, DOI 10.1080/10715760100300271
   Visioli F, 2002, MED RES REV, V22, P65, DOI 10.1002/med.1028
   Willett WC, 2007, J CARDIOVASC MED, V8, pS42, DOI 10.2459/01.JCM.0000289275.72556.13
NR 44
TC 40
Z9 41
U1 1
U2 11
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0955-2863
EI 1873-4847
J9 J NUTR BIOCHEM
JI J. Nutr. Biochem.
PD APR
PY 2010
VL 21
IS 4
BP 290
EP 296
DI 10.1016/j.jnutbio.2008.12.014
PG 7
WC Biochemistry & Molecular Biology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Nutrition & Dietetics
GA 574DF
UT WOS:000275968100006
PM 19369055
DA 2024-02-19
ER

PT J
AU Quinlan, RA
   Giblin, F
AF Quinlan, Roy A.
   Giblin, Frank
TI The eye lens as an aging paradigm<i> par</i><i> excellence</i>
SO EXPERIMENTAL EYE RESEARCH
LA English
DT Article; Early Access
DE Eye lens; Cataract; Myopia; Alzheimers disease; Diabetes; Arthritis;
   Cardiovascular disease; Gender dysphoria; Liver; Brain; Retina; Heart;
   Proteomics; RNA-seq; Transcriptomics; Ionising radiation; Aging;
   Multimorbidity; Nutrigenics; ROS; Glycation
ID AGE-RELATED-CHANGES; OXIDATIVE STRESS; GENETIC POLYMORPHISMS;
   INFLAMMATORY RESPONSE; REFRACTIVE-INDEX; NATURAL COURSE; AMYLOID-BETA;
   CATARACT; FILAMENT; PROTEIN
C1 [Quinlan, Roy A.] Univ Durham, Dept Biosci, Upper Mountjoy Sci Site, Durham DH1 3LE, England.
   [Giblin, Frank] Oakland Univ, Eye Res Inst, Rochester, MI 48309 USA.
C3 Durham University; Oakland University
RP Quinlan, RA (corresponding author), Univ Durham, Dept Biosci, Upper Mountjoy Sci Site, Durham DH1 3LE, England.; Giblin, F (corresponding author), Oakland Univ, Eye Res Inst, Rochester, MI 48309 USA.
EM r.a.quinlan@durham.ac.uk; giblin@oakland.edu
CR Agrawal SA, 2015, HUM GENET, V134, P717, DOI 10.1007/s00439-015-1554-5
   Anderson DM, 2020, J MASS SPECTROM, V55, DOI 10.1002/jms.4473
   Barnard SGR, 2018, INT J RADIAT BIOL, V94, P1116, DOI 10.1080/09553002.2018.1532609
   Barnes S, 2017, EXP EYE RES, V156, P87, DOI 10.1016/j.exer.2016.03.024
   Barnum CE, 2020, HUM MOL GENET, V29, P2076, DOI 10.1093/hmg/ddaa096
   Bawa G, 2013, BIOMED OPT EXPRESS, V4, P2585, DOI 10.1364/BOE.4.002585
   Bei L, 2015, EXP EYE RES, V140, P117, DOI 10.1016/j.exer.2015.03.010
   Benito A, 2016, INVEST OPHTH VIS SCI, V57, P163, DOI 10.1167/iovs.15-17897
   Berry V, 2022, OPHTHALMIC GENET, V43, P218, DOI 10.1080/13816810.2021.1998556
   Berry V, 2020, BRIT J OPHTHALMOL, V104, P1331, DOI 10.1136/bjophthalmol-2019-315282
   Birch-Hirschfeld G.V.A., 1908, KLIN MONATSBLATTER A, V46, P129
   Borchman D, 2021, J LIPID RES, V62, DOI 10.1194/jlr.TR120000874
   Braakhuis AJ, 2019, NUTRIENTS, V11, DOI 10.3390/nu11051186
   Brennan L, 2021, EXP EYE RES, V209, DOI 10.1016/j.exer.2021.108682
   Cain DW, 2020, NAT REV IMMUNOL, V20, P587, DOI 10.1038/s41577-020-00421-x
   Cannan WJ, 2016, J CELL PHYSIOL, V231, P3, DOI 10.1002/jcp.25048
   Cantrell LS, 2021, J AM SOC MASS SPECTR, V32, P2755, DOI 10.1021/jasms.1c00193
   Carlsson E, 2021, CHILDREN-BASEL, V8, DOI 10.3390/children8080646
   Cekic O, 1998, BRIT J OPHTHALMOL, V82, P186, DOI 10.1136/bjo.82.2.186
   Cheignon C, 2018, REDOX BIOL, V14, P450, DOI 10.1016/j.redox.2017.10.014
   Chen JJ, 2017, INVEST OPHTH VIS SCI, V58, P2207, DOI 10.1167/iovs.17-21469
   Cheng C, 2019, AGING-US, V11, P12497, DOI 10.18632/aging.102584
   Christen W G, 1998, Ophthalmic Epidemiol, V5, P133, DOI 10.1076/opep.5.3.133.8368
   Conway MD, 2018, CURR OPIN OPHTHALMOL, V29, P69, DOI 10.1097/ICU.0000000000000438
   Costanian C, 2020, MENOPAUSE, V27, P263, DOI 10.1097/GME.0000000000001477
   Craig JE, 2003, ARCH OPHTHALMOL-CHIC, V121, P1753, DOI 10.1001/archopht.121.12.1753
   Delile J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13929
   Desai RV, 2021, SCIENCE, V373, P870, DOI 10.1126/science.abc6506
   Dewi CU, 2021, EXP EYE RES, V202, DOI 10.1016/j.exer.2020.108317
   DICKEY JB, 1993, AM J OPHTHALMOL, V115, P234, DOI 10.1016/S0002-9394(14)73929-7
   Donaldson Paul J, 2017, Prog Retin Eye Res, V56, pe1, DOI 10.1016/j.preteyeres.2016.09.002
   Dotson RJ, 2017, BIOPHYS J, V112, P2336, DOI 10.1016/j.bpj.2017.04.046
   Dubois VDJP, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009493.pub2
   Evert J, 2003, J GERONTOL A-BIOL, V58, P232
   Fan XJ, 2009, J BIOL CHEM, V284, P34618, DOI 10.1074/jbc.M109.032094
   Findl O, 2010, INVEST OPHTH VIS SCI, V51, P1547, DOI 10.1167/iovs.09-3989
   FitzGerald P, 2016, MOL VIS, V22, P970
   Floyd KA, 2011, EXP EYE RES, V92, P120, DOI 10.1016/j.exer.2010.12.006
   Frederikse PH, 1996, J BIOL CHEM, V271, P10169, DOI 10.1074/jbc.271.17.10169
   GAESTEL M, 1993, GENE, V128, P279, DOI 10.1016/0378-1119(93)90575-N
   Garner B, 2000, EXP EYE RES, V71, P599, DOI 10.1006/exer.2000.0912
   Garner WH, 2016, INVEST OPHTH VIS SCI, V57, P2851, DOI 10.1167/iovs.15-18413
   Gebreyesus ST, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-021-27778-4
   Ghosh KS, 2011, BIOCHEMISTRY-US, V50, P3279, DOI 10.1021/bi200091q
   GIBLIN FJ, 1984, EXP EYE RES, V38, P87, DOI 10.1016/0014-4835(84)90142-8
   GIBLIN FJ, 1987, EXP EYE RES, V45, P77, DOI 10.1016/S0014-4835(87)80080-5
   GIBLIN FJ, 1988, INVEST OPHTH VIS SCI, V29, P1312
   GIBLIN FJ, 1985, EXP EYE RES, V41, P423, DOI 10.1016/S0014-4835(85)80033-6
   Giblin FJ, 2000, J OCUL PHARMACOL TH, V16, P121, DOI 10.1089/jop.2000.16.121
   GIBLIN FJ, 1995, EXP EYE RES, V60, P219, DOI 10.1016/S0014-4835(05)80105-8
   Giblin FJ, 2011, INVEST OPHTH VIS SCI, V52, P3667, DOI 10.1167/iovs.10-6885
   Gilgenkrantz H, 2018, AM J PATHOL, V188, P1316, DOI 10.1016/j.ajpath.2018.03.008
   Giovanzana S, 2017, BIOMED OPT EXPRESS, V8, P4827, DOI 10.1364/BOE.8.004827
   Graw J, 2017, EXP EYE RES, V156, P5, DOI 10.1016/j.exer.2015.11.006
   Guilliams M, 2022, CELL, V185, P379, DOI 10.1016/j.cell.2021.12.018
   Guo G, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23461-w
   Gupta V, 2009, EXP EYE RES, V88, P248, DOI 10.1016/j.exer.2008.04.003
   HARDING JJ, 1995, BRIT J OPHTHALMOL, V79, P199, DOI 10.1136/bjo.79.3.199
   Haslbeck M, 2019, J BIOL CHEM, V294, P2121, DOI 10.1074/jbc.REV118.002809
   Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032
   Hosokawa M, 2007, DEV BIOL, V301, P38, DOI 10.1016/j.ydbio.2006.10.046
   Huang HM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140419
   Hugosson M, 2020, UPSALA J MED SCI, V125, P311, DOI 10.1080/03009734.2020.1802375
   Inui T, 2021, NUTRIENTS, V13, DOI 10.3390/nu13072222
   Iribarren R, 2015, PROG RETIN EYE RES, V47, P86, DOI 10.1016/j.preteyeres.2015.02.002
   Ismail VS, 2016, BBA-BIOMEMBRANES, V1858, P2763, DOI 10.1016/j.bbamem.2016.06.026
   Jacob L, 2021, EYE, V35, P791, DOI 10.1038/s41433-020-0962-5
   Jee D, 2021, ANN MED, V53, P707, DOI 10.1080/07853890.2021.1928275
   Jiang J, 2018, INVEST OPHTH VIS SCI, V59, P4986, DOI 10.1167/iovs.18-25067
   Jongenelen S, 2015, INVEST OPHTH VIS SCI, V56, P7029, DOI 10.1167/iovs.15-18047
   Kador PF, 2014, J OCUL PHARMACOL TH, V30, P593, DOI 10.1089/jop.2014.0016
   Kalligeraki AA, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73625-9
   Karmakar S, 2018, PROTEIN PEPTIDE LETT, V25, P275, DOI 10.2174/0929866525666171229230611
   Kim S, 2019, CELL, V179, P106, DOI 10.1016/j.cell.2019.08.033
   KING RJB, 1987, J STEROID BIOCHEM, V27, P471, DOI 10.1016/0022-4731(87)90342-6
   KLEIN BEK, 1994, ARCH OPHTHALMOL-CHIC, V112, P85, DOI 10.1001/archopht.1994.01090130095025
   Kubo E, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103093
   Kuszak JR, 2006, VET OPHTHALMOL, V9, P266, DOI 10.1111/j.1463-5224.2006.00506.x
   Kuszak JR, 2006, MOL VIS, V12, P251
   Kuszak JR, 2004, EXP EYE RES, V78, P673, DOI 10.1016/j.exer.2003.09.016
   Langford-Smith A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147576
   Laurell CG, 1997, ACTA OPHTHALMOL SCAN, V75, P401
   Li N, 2017, ONCOTARGET, V8, P3628, DOI 10.18632/oncotarget.12275
   Li Y, 2021, FRONT CHEM, V9, DOI 10.3389/fchem.2021.767696
   LIOU W, 1988, CELL MOTIL CYTOSKEL, V9, P17, DOI 10.1002/cm.970090104
   Little JA, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66642-1
   Liu J, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.202002154
   Liu ZZ, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm-2019-rcs-03
   Löfgren S, 2017, EXP EYE RES, V156, P112, DOI 10.1016/j.exer.2016.05.026
   Logan CM, 2019, EXP BIOL MED, V244, P1240, DOI 10.1177/1535370219867296
   Longo SK, 2021, NAT REV GENET, V22, P627, DOI 10.1038/s41576-021-00370-8
   Maddala R, 2016, AM J PHYSIOL-CELL PH, V310, pC115, DOI 10.1152/ajpcell.00111.2015
   Maddala R, 2011, DEV BIOL, V357, P179, DOI 10.1016/j.ydbio.2011.06.036
   Maddirala Y, 2017, BMC OPHTHALMOL, V17, DOI 10.1186/s12886-017-0443-1
   Mainz A, 2012, J BIOL CHEM, V287, P1128, DOI 10.1074/jbc.M111.309047
   Martinez-Enriquez E, 2020, INVEST OPHTH VIS SCI, V61, DOI 10.1167/iovs.61.4.11
   Mathias RT, 2007, J MEMBRANE BIOL, V216, P1, DOI 10.1007/s00232-007-9019-y
   Matos B, 2021, OPEN BIOL, V11, DOI 10.1098/rsob.200322
   Meier F, 2021, MOL CELL PROTEOMICS, V20, DOI 10.1016/j.mcpro.2021.100138
   Michael R, 2014, EXP EYE RES, V119, P44, DOI 10.1016/j.exer.2013.11.016
   Millar A., 1997, NOVA ACTA LEOPOLDIAN, V299, P169
   Moffat BA, 2002, OPTOMETRY VISION SCI, V79, P148, DOI 10.1097/00006324-200203000-00008
   Moffat BA, 2002, VISION RES, V42, P1683, DOI 10.1016/S0042-6989(02)00078-0
   Neumayer T, 2017, CURR EYE RES, V42, P1604, DOI 10.1080/02713683.2017.1343852
   Nguyen H, 2020, GERIATR GERONTOL INT, V20, P1126, DOI 10.1111/ggi.14051
   Nicholl ID, 1998, MOL MED, V4, P594, DOI 10.1007/BF03401759
   Nishioka M, 2017, INTERNAL MED, V56, P1987, DOI 10.2169/internalmedicine.56.8231
   Ortwerth BJ, 1999, BIOCHEM BIOPH RES CO, V259, P706, DOI 10.1006/bbrc.1999.0841
   Pak HH, 2021, NAT METAB, V3, P1327, DOI 10.1038/s42255-021-00466-9
   PALMQUIST BM, 1984, BRIT J OPHTHALMOL, V68, P113, DOI 10.1136/bjo.68.2.113
   Park S, 2017, MENOPAUSE, V24, P996, DOI 10.1097/GME.0000000000000887
   Peng Y, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms222212442
   Perng MD, 2005, EXP CELL RES, V305, P1, DOI 10.1016/j.yexcr.2004.11.021
   Perng MD, 2007, EXP CELL RES, V313, P2180, DOI 10.1016/j.yexcr.2007.04.005
   Pichaud F., 2021, SEMIN CELL DEV BIOL, DOI [10.1016/j.semcdb.2021.11.002.S1084-9521(21)00278-0, DOI 10.1016/J.SEMCDB.2021.11.002.S1084-9521(21)00278-0]
   PIRIE A, 1968, INVEST OPHTH VISUAL, V7, P634
   Plesnar E, 2018, BBA-BIOMEMBRANES, V1860, P434, DOI 10.1016/j.bbamem.2017.10.020
   REDDY VN, 1984, CIBA F SYMP, V106, P65
   Rolfs Z, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-26842-3
   Roskamp KW, 2020, BIOCHEMISTRY-US, V59, P2371, DOI 10.1021/acs.biochem.0c00293
   Roskamp KW, 2019, BIOCHEMISTRY-US, V58, P4505, DOI 10.1021/acs.biochem.9b00507
   Sandilands A, 2003, EXP EYE RES, V76, P385, DOI 10.1016/S0014-4835(02)00330-5
   Sandilands Aileen, 2004, Experimental Eye Research, V78, P875, DOI 10.1016/j.exer.2003.09.028
   Sasaki H, 1998, INVEST OPHTH VIS SCI, V39, P544
   Saxena P, 2000, INVEST OPHTH VIS SCI, V41, P1473
   Sheil CJ, 2017, BIOMED OPT EXPRESS, V8, P4172, DOI 10.1364/BOE.8.004172
   Shi YR, 2009, J CELL SCI, V122, P1607, DOI 10.1242/jcs.045203
   Shihan MH, 2019, CURR MED RES OPIN, V35, P1971, DOI 10.1080/03007995.2019.1647012
   Shoji T, 2020, JPN J OPHTHALMOL, V64, P93, DOI 10.1007/s10384-019-00700-8
   Sideri O, 2019, SURV OPHTHALMOL, V64, P668, DOI 10.1016/j.survophthal.2019.03.003
   Sies H, 2020, NAT REV MOL CELL BIO, V21, P363, DOI 10.1038/s41580-020-0230-3
   Skiljic D, 2016, BMC OPHTHALMOL, V16, DOI 10.1186/s12886-016-0392-0
   Slingsby C, 2013, PROTEIN SCI, V22, P367, DOI 10.1002/pro.2229
   Song SH, 2009, J CLIN INVEST, V119, P1837, DOI 10.1172/JCI38277
   Steinmetz JD, 2021, LANCET GLOB HEALTH, V9, pE144, DOI 10.1016/S2214-109X(20)30489-7
   Sugiyama Y, 2016, MECH DEVELOP, V139, P10, DOI 10.1016/j.mod.2016.01.003
   Sugiyama Y, 2011, ORGANOGENESIS, V7, P191, DOI 10.4161/org.7.3.18421
   Takayama M, 2007, J GERONTOL A-BIOL, V62, P774, DOI 10.1093/gerona/62.7.774
   Tanno B, 2022, RADIAT RES, V197, P22, DOI 10.1667/RADE-20-00245.1
   Taylor MJ, 2021, J AM SOC MASS SPECTR, V32, P872, DOI 10.1021/jasms.0c00439
   Taylor VL, 1996, INVEST OPHTH VIS SCI, V37, P1396
   Tedja MS, 2019, INVEST OPHTH VIS SCI, V60, pM89, DOI 10.1167/iovs.18-25965
   Tkatchenko TV, 2021, GENOMICS, V113, P2780, DOI 10.1016/j.ygeno.2021.06.021
   Tkatchenko TV, 2021, BMC MED GENOMICS, V14, DOI 10.1186/s12920-021-01005-x
   Tkatchenko TV, 2019, BMC MED GENOMICS, V12, DOI 10.1186/s12920-019-0560-1
   Tkatchenko TV, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006021
   Tu CF, 2021, AUTOPHAGY, V17, P3848, DOI 10.1080/15548627.2021.1894058
   Uwineza A, 2019, MUTAT RES-REV MUTAT, V779, P68, DOI 10.1016/j.mrrev.2019.02.004
   Vaghefi E, 2018, AM J PHYSIOL-REG I, V315, pR994, DOI 10.1152/ajpregu.00180.2018
   VONSALLMANN L, 1952, AMA ARCH OPHTHALMOL, V47, P305, DOI 10.1001/archopht.1952.01700030313005
   Wagh K, 2021, TRENDS CELL BIOL, V31, P457, DOI 10.1016/j.tcb.2021.02.008
   Wen YL, 2021, GENE, V803, DOI 10.1016/j.gene.2021.145893
   Woitowich NC, 2020, ELIFE, V9, DOI 10.7554/eLife.56344
   Worgul B V, 1989, Lens Eye Toxic Res, V6, P559
   Worzala K, 2001, ARCH INTERN MED, V161, P1448, DOI 10.1001/archinte.161.11.1448
   Wu XH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172092
   Zhang Y, 2013, CELL STRESS CHAPERON, V18, P703, DOI 10.1007/s12192-013-0420-4
   Zhang Y, 2012, OPHTHALMOLOGY, V119, P900, DOI 10.1016/j.ophtha.2011.11.004
   Zhang Y, 2011, MOL VIS, V17, P2325
NR 159
TC 2
Z9 2
U1 0
U2 12
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0014-4835
EI 1096-0007
J9 EXP EYE RES
JI Exp. Eye Res.
PD 2022 MAY
PY 2022
VL 218
AR 109003
DI 10.1016/j.exer.2022.109003
EA APR 2022
PG 10
WC Ophthalmology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Ophthalmology
GA 1Q6MR
UT WOS:000802799400001
PM 35218728
DA 2024-02-19
ER

PT J
AU Chattopadhyay, T
   Maniyadath, B
   Bagul, HP
   Chakraborty, A
   Shukla, N
   Budnar, S
   Rajendran, A
   Shukla, A
   Kamat, SS
   Kolthur-Seetharam, U
AF Chattopadhyay, Tandrika
   Maniyadath, Babukrishna
   Bagul, Hema P.
   Chakraborty, Arindam
   Shukla, Namrata
   Budnar, Srikanth
   Rajendran, Abinaya
   Shukla, Arushi
   Kamat, Siddhesh S.
   Kolthur-Seetharam, Ullas
TI Spatiotemporal gating of SIRT1 functions by O-GlcNAcylation is essential
   for liver metabolic switching and prevents hyperglycemia
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE fed-fast cycle; gluconeogenesis; PGC1 alpha; insulin signaling;
   ubiquitinylation
ID TRANSCRIPTION FACTORS; GLUCOSE-METABOLISM; HEPATIC STEATOSIS; GLCNAC;
   MICE; NUTRIENT; HOMEOSTASIS; MECHANISMS; ACTIVATORS; REGULATOR
AB Inefficient physiological transitions are known to cause metabolic disorders. Therefore, investigating mechanisms that constitute molecular switches in a central metabolic organ like the liver becomes crucial. Specifically, upstream mechanisms that control temporal engagement of transcription factors, which are essential to mediate physiological fed-fast-refed transitions are less understood. SIRT1, a NAD(+)-dependent deacetylase, is pivotal in regulating hepatic gene expression and has emerged as a key therapeutic target. Despite this, if/how nutrient inputs regulate SIRT1 interactions, stability, and therefore downstream functions are still unknown. Here, we establish nutrient-dependent O-GlcNAcylation of SIRT1, within its N-terminal domain, as a crucial determinant of hepatic functions. Our findings demonstrate that during a fasted-to-refed transition, glycosylation of SIRT1 modulates its interactions with various transcription factors and a nodal cytosolic kinase involved in insulin signaling. Moreover, sustained glycosylation in the fed state causes nuclear exclusion and cytosolic ubiquitin-mediated degradation of SIRT1. This mechanism exerts spatiotemporal control over SIRT1 functions by constituting a previously unknown molecular relay. Of note, loss of SIRT1 glycosylation discomposed these interactions resulting in aberrant gene expression, mitochondrial dysfunctions, and enhanced hepatic gluconeogenesis. Expression of nonglycosylatable SIRT1 in the liver abrogated metabolic flexibility, resulting in systemic insulin resistance, hyperglycemia, and hepatic inflammation, highlighting the physiological costs associated with its overactivation. Conversely, our study also reveals that hyperglycosylation of SIRT1 is associated with aging and high-fat-induced obesity. Thus, we establish that nutrient-dependent glycosylation of SIRT1 is essential to gate its functions and maintain physiological fitness.
C1 [Chattopadhyay, Tandrika; Maniyadath, Babukrishna; Bagul, Hema P.; Chakraborty, Arindam; Shukla, Namrata; Budnar, Srikanth; Shukla, Arushi; Kolthur-Seetharam, Ullas] Tata Inst Fundamental Res, Dept Biol Sci, Mumbai 400005, Maharashtra, India.
   [Rajendran, Abinaya; Kamat, Siddhesh S.] Indian Inst Sci Educ & Res, Dept Biol, Pune 411008, Maharashtra, India.
   [Budnar, Srikanth] Univ Queensland, Inst Mol Biosci, Div Cell Biol & Mol Med, Brisbane, Qld 4072, Australia.
C3 Tata Institute of Fundamental Research (TIFR); Indian Institute of
   Science Education & Research (IISER) Pune; University of Queensland
RP Kolthur-Seetharam, U (corresponding author), Tata Inst Fundamental Res, Dept Biol Sci, Mumbai 400005, Maharashtra, India.
EM ullas@tifr.res.in
RI Budnar, Srikanth/A-6076-2011; Budnar, Srikanth/J-1827-2014
OI Maniyadath, Babukrishna/0000-0002-5634-5388; Kamat,
   Siddhesh/0000-0001-6132-7574; Budnar, Srikanth/0000-0002-8951-9081
FU Department of Atomic EnergyTata Institute of Fundamental Research
   (Government of India) [12P0122]; Wellcome Trust DBT India Alliance
   Intermediate Fellowship [IA/I/15/2/502058]; Council of Scientific &
   Industrial Research
FX We thank Dr. Sachin Atole, Dr. Sagar Tarate, and Ms. Ritika Gupta from
   the National Facility for Gene Function in Health and Disease, Indian
   Institute of Science Education and Research Pune; and Dr. Kalidas Kohale
   and Dr. Shital Suryavanshi from the Tata Institute of Fundamental
   Research animal facilities for the help with animal experiments. We
   acknowledge funding from the Department of Atomic EnergyTata Institute
   of Fundamental Research (Government of India) Grant 12P0122 (to
   U.K.-S.); Wellcome Trust DBT India Alliance Intermediate Fellowship
   Grant IA/I/15/2/502058 (to S.S.K.); and a graduate student fellowship
   from the Council of Scientific & Industrial Research (to A.R.).
CR Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072
   Babu MM, 2016, BIOCHEM SOC T, V44, P1185, DOI 10.1042/BST20160172
   Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014
   Bond MR, 2013, ANNU REV NUTR, V33, P205, DOI 10.1146/annurev-nutr-071812-161240
   Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x
   Butkinaree C, 2010, BBA-GEN SUBJECTS, V1800, P96, DOI 10.1016/j.bbagen.2009.07.018
   Chaix A, 2019, CELL METAB, V29, P303, DOI 10.1016/j.cmet.2018.08.004
   Chaix A, 2014, CELL METAB, V20, P991, DOI 10.1016/j.cmet.2014.11.001
   CHEN C, 1992, HORM METAB RES, V24, P161, DOI 10.1055/s-2007-1003285
   Dang FB, 2016, SCI REP-UK, V6, DOI 10.1038/srep36926
   Deota S, 2017, CELL REP, V18, P3069, DOI 10.1016/j.celrep.2017.03.012
   Ding RB, 2017, INT J BIOL SCI, V13, P852, DOI 10.7150/ijbs.19370
   Ford J, 2008, CELL CYCLE, V7, P3091, DOI 10.4161/cc.7.19.6799
   Gao ZG, 2011, J BIOL CHEM, V286, P22227, DOI 10.1074/jbc.M111.228874
   Geisler CE, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0122-x
   Ghisays F, 2015, CELL REP, V10, P1665, DOI 10.1016/j.celrep.2015.02.036
   Guo SD, 2014, J ENDOCRINOL, V220, pT1, DOI 10.1530/JOE-13-0327
   Han CF, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01654-6
   Hart GW, 1997, ANNU REV BIOCHEM, V66, P315, DOI 10.1146/annurev.biochem.66.1.315
   Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019
   Herranz D, 2010, NAT REV CANCER, V10, P819, DOI 10.1038/nrc2962
   Horton JD, 1998, P NATL ACAD SCI USA, V95, P5987, DOI 10.1073/pnas.95.11.5987
   Hubbard BP, 2014, TRENDS PHARMACOL SCI, V35, P146, DOI 10.1016/j.tips.2013.12.004
   Issad T, 2008, TRENDS ENDOCRIN MET, V19, P380, DOI 10.1016/j.tem.2008.09.001
   Jitrapakdee S, 2012, INT J BIOCHEM CELL B, V44, P33, DOI 10.1016/j.biocel.2011.10.001
   Kanfi Y, 2008, FEBS LETT, V582, P543, DOI [10.1016/j.febslet.2008.01.019, 10.1016/j.febslet.2008.06.005]
   Kang H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006611
   Kawashima T, 2011, J MOL CELL CARDIOL, V51, P1026, DOI 10.1016/j.yjmcc.2011.09.013
   Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500
   Kinouchi K, 2018, CELL REP, V25, P3299, DOI 10.1016/j.celrep.2018.11.077
   Kong DL, 2016, AGING CELL, V15, P1092, DOI 10.1111/acel.12515
   Krzysiak TC, 2018, MOL CELL, V72, P985, DOI 10.1016/j.molcel.2018.10.007
   Kwon HS, 2008, TRENDS BIOCHEM SCI, V33, P517, DOI 10.1016/j.tibs.2008.08.001
   Leney AC, 2017, P NATL ACAD SCI USA, V114, pE7255, DOI 10.1073/pnas.1620529114
   Li XL, 2013, ACTA BIOCH BIOPH SIN, V45, P51, DOI 10.1093/abbs/gms108
   Liang FX, 2009, NAT REV ENDOCRINOL, V5, P367, DOI 10.1038/nrendo.2009.101
   Lim JH, 2010, MOL CELL, V38, P864, DOI 10.1016/j.molcel.2010.05.023
   Longo VD, 2006, CELL, V126, P257, DOI 10.1016/j.cell.2006.07.002
   Longo VD, 2016, CELL METAB, V23, P1048, DOI 10.1016/j.cmet.2016.06.001
   Maniyadath B, 2019, CELL REP, V26, P2212, DOI 10.1016/j.celrep.2019.01.087
   MEZEY E, 1978, GASTROENTEROLOGY, V74, P770
   Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261
   Naïmi M, 2010, TRENDS ENDOCRIN MET, V21, P75, DOI 10.1016/j.tem.2009.09.003
   Narita T, 2019, NAT REV MOL CELL BIO, V20, P156, DOI 10.1038/s41580-018-0081-3
   Nasrin N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008414
   Pan M, 2012, J BIOL CHEM, V287, P2468, DOI 10.1074/jbc.M111.285031
   Peng LR, 2015, J BIOL CHEM, V290, P8904, DOI 10.1074/jbc.M114.612796
   Petersen MC, 2017, NAT REV ENDOCRINOL, V13, P572, DOI 10.1038/nrendo.2017.80
   Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105
   Ponugoti B, 2010, J BIOL CHEM, V285, P33959, DOI 10.1074/jbc.M110.122978
   Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006
   Ramachandran D, 2011, FEBS J, V278, P1167, DOI 10.1111/j.1742-4658.2011.08042.x
   Revollo JR, 2013, TRENDS BIOCHEM SCI, V38, P160, DOI 10.1016/j.tibs.2012.12.004
   Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104
   Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354
   Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024
   Sasaki T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004020
   Schenk S, 2011, J CLIN INVEST, V121, P4281, DOI 10.1172/JCI58554
   Slawson C, 2006, J CELL BIOCHEM, V97, P71, DOI 10.1002/jcb.20676
   Soeters MR, 2012, AM J PHYSIOL-ENDOC M, V303, pE1397, DOI 10.1152/ajpendo.00397.2012
   Sugden MC, 2010, J ENDOCRINOL, V204, P93, DOI 10.1677/JOE-09-0359
   Sulli G, 2018, TRENDS PHARMACOL SCI, V39, P812, DOI 10.1016/j.tips.2018.07.003
   Sundaresan NR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001465
   Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200
   Tong C, 2013, FASEB J, V27, P4332, DOI 10.1096/fj.12-216473
   Vilà L, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2016.72
   Wang RH, 2011, J CLIN INVEST, V121, P4477, DOI 10.1172/JCI46243
   Wells L, 2003, BIOCHEM BIOPH RES CO, V302, P435, DOI 10.1016/S0006-291X(03)00175-X
   Whelan SA, 2008, J BIOL CHEM, V283, P21411, DOI 10.1074/jbc.M800677200
   Wu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023058
   Xu F, 2010, ENDOCRINOLOGY, V151, P2504, DOI 10.1210/en.2009-1013
   Yang TL, 2006, TRENDS ENDOCRIN MET, V17, P186, DOI 10.1016/j.tem.2006.04.002
   Yang XY, 2017, NAT REV MOL CELL BIO, V18, P452, DOI 10.1038/nrm.2017.22
   Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007
   Zschoernig B, 2008, BIOCHEM BIOPH RES CO, V376, P251, DOI 10.1016/j.bbrc.2008.08.137
NR 75
TC 26
Z9 27
U1 1
U2 7
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD MAR 24
PY 2020
VL 117
IS 12
BP 6890
EP 6900
DI 10.1073/pnas.1909943117
PG 11
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA KX4AI
UT WOS:000521821800078
PM 32152092
OA Green Published, Bronze
DA 2024-02-19
ER

PT J
AU Nieh, YC
   Chou, YT
   Wang, CY
   Lin, SX
   Ciou, SC
   Yuh, CH
   Wang, HD
AF Nieh, Yu-Chin
   Chou, Yu-Ting
   Wang, Chao-Yung
   Lin, Shi-Xian
   Ciou, Shih-Ci
   Yuh, Chiou-Hwa
   Wang, Horng-Dar
TI Suppression of Ribose-5-Phosphate Isomerase a Induces ROS to Activate
   Autophagy, Apoptosis, and Cellular Senescence in Lung Cancer
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE ribose-5-phosphate isomerase A; autophagy; apoptosis; cellular
   senescence; lung cancer
ID PENTOSE-PHOSPHATE PATHWAY; ONCOGENE-INDUCED SENESCENCE; DUAL PI3K/MTOR
   INHIBITOR; OXIDATIVE STRESS; DNA-DAMAGE; LIFE-SPAN; CELLS;
   TUMORIGENESIS; DEATH; PROLIFERATION
AB Ribose-5-phosphate isomerase A (RPIA) regulates tumorigenesis in liver and colorectal cancer. However, the role of RPIA in lung cancer remains obscure. Here we report that the suppression of RPIA diminishes cellular proliferation and activates autophagy, apoptosis, and cellular senescence in lung cancer cells. First, we detected that RPIA protein was increased in the human lung cancer versus adjust normal tissue via tissue array. Next, the knockdown of RPIA in lung cancer cells displayed autophagic vacuoles, enhanced acridine orange staining, GFP-LC3 punctae, accumulated autophagosomes, and showed elevated levels of LC3-II and reduced levels of p62, together suggesting that the suppression of RPIA stimulates autophagy in lung cancer cells. In addition, decreased RPIA expression induced apoptosis by increasing levels of Bax, cleaved PARP and caspase-3 and apoptotic cells. Moreover, RPIA knockdown triggered cellular senescence and increased p53 and p21 levels in lung cancer cells. Importantly, RPIA knockdown elevated reactive oxygen species (ROS) levels. Treatment of ROS scavenger N-acetyl-L-cysteine (NAC) reverts the activation of autophagy, apoptosis and cellular senescence by RPIA knockdown in lung cancer cells. In conclusion, RPIA knockdown induces ROS levels to activate autophagy, apoptosis, and cellular senescence in lung cancer cells. Our study sheds new light on RPIA suppression in lung cancer therapy.
C1 [Nieh, Yu-Chin; Chou, Yu-Ting; Lin, Shi-Xian; Ciou, Shih-Ci; Wang, Horng-Dar] Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu 300044, Taiwan.
   [Chou, Yu-Ting] Univ Calif San Francisco, Helen Diller Comprehens Canc Ctr, Dept Med, Div Hematol & Oncol, San Francisco, CA 94158 USA.
   [Wang, Chao-Yung] Chang Gung Univ, Chang Gung Memory Hosp, Dept Cardiol, Linkou Main Branch, Taoyuan 33305, Taiwan.
   [Yuh, Chiou-Hwa] Natl Hlth Res Inst, Inst Mol & Genom Med, Zhunan 35053, Taiwan.
   [Yuh, Chiou-Hwa] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu 300044, Taiwan.
   [Yuh, Chiou-Hwa] Natl Yang Ming Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu 300093, Taiwan.
   [Yuh, Chiou-Hwa] Kaohsiung Med Univ, PhD Program Environm & Occupat Med, Kaohsiung 807378, Taiwan.
   [Wang, Horng-Dar] Natl Tsing Hua Univ, Inst Syst Neurosci, Hsinchu 300044, Taiwan.
   [Wang, Horng-Dar] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu 300044, Taiwan.
C3 National Tsing Hua University; University of California System;
   University of California San Francisco; UCSF Medical Center; UCSF Helen
   Diller Family Comprehensive Cancer Center; Chang Gung University; Chang
   Gung Memorial Hospital; National Health Research Institutes - Taiwan;
   National Tsing Hua University; National Yang Ming Chiao Tung University;
   Kaohsiung Medical University; National Tsing Hua University; National
   Tsing Hua University
RP Wang, HD (corresponding author), Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu 300044, Taiwan.; Yuh, CH (corresponding author), Natl Hlth Res Inst, Inst Mol & Genom Med, Zhunan 35053, Taiwan.; Yuh, CH (corresponding author), Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu 300044, Taiwan.; Yuh, CH (corresponding author), Natl Yang Ming Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu 300093, Taiwan.; Yuh, CH (corresponding author), Kaohsiung Med Univ, PhD Program Environm & Occupat Med, Kaohsiung 807378, Taiwan.; Wang, HD (corresponding author), Natl Tsing Hua Univ, Inst Syst Neurosci, Hsinchu 300044, Taiwan.; Wang, HD (corresponding author), Natl Tsing Hua Univ, Dept Life Sci, Hsinchu 300044, Taiwan.
EM judy0872@gmail.com; ytchou@life.nthu.edu.tw; cwang@ocean.ag;
   lss339840@gmail.com; asb3851@gmail.com; chyuh@nhri.edu.tw;
   hdwang@life.nthu.edu.tw
RI Chou, Yu-Ting/IYT-3589-2023; qi, li/JFE-7167-2023; Liu,
   Jing/IQX-0664-2023
OI Chou, Yu-Ting/0000-0001-8524-4220; Wang, Horng-Dar/0000-0001-9570-3611;
   Chou, Yu-Ting/0000-0001-9274-8603; Yuh, Chiou-Hwa/0000-0002-2356-1551
FU National Tsing Hua University [107Q2514E1, 109Q2506E1, 111F7MDSE1];
   Chang Gung University [107Q2514E1, 109Q2506E1, 111F7MDSE1]; Taiwan
   Ministry of Science and Technology [MOST 106-2311-B007-006-MY2,
   108-2320-B-400-005-MY3, 109-2311-B-007-002, 110-2320-B-007-003];
   National Health Research Institutes [MG-109-PP-06]
FX The research was funded by the collaboration projects between National
   Tsing Hua University and Chang Gung University, grant number 107Q2514E1,
   109Q2506E1, 111F7MDSE1, and supported by Taiwan Ministry of Science and
   Technology, grant number MOST 106-2311-B007-006-MY2,
   108-2320-B-400-005-MY3, 109-2311-B-007-002, 110-2320-B-007-003, and
   National Health Research Institutes, grant number MG-109-PP-06.
CR Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657
   Aird KM, 2015, CANCER LETT, V356, P204, DOI 10.1016/j.canlet.2014.01.017
   Bennecke M, 2010, CANCER CELL, V18, P135, DOI 10.1016/j.ccr.2010.06.013
   Bensaad K, 2007, TRENDS CELL BIOL, V17, P286, DOI 10.1016/j.tcb.2007.04.004
   Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4
   Bunn PA, 2012, ARCH PATHOL LAB MED, V136, P1478, DOI 10.5858/arpa.2012-0295-SA
   Buzzai M, 2005, ONCOGENE, V24, P4165, DOI 10.1038/sj.onc.1208622
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   Chou YT, 2012, CELL DEATH DIFFER, V19, P2015, DOI 10.1038/cdd.2012.91
   Chou YT, 2019, CARCINOGENESIS, V40, P461, DOI 10.1093/carcin/bgy155
   Chou YT, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2003714
   Ciou SC, 2015, INT J CANCER, V137, P104, DOI 10.1002/ijc.29361
   Couraud S, 2012, EUR J CANCER, V48, P1299, DOI 10.1016/j.ejca.2012.03.007
   Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301
   Diaz-Moralli S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025323
   Du WJ, 2013, NAT CELL BIOL, V15, P991, DOI 10.1038/ncb2789
   Eum KH, 2011, MOL CELL BIOCHEM, V348, P61, DOI 10.1007/s11010-010-0638-8
   Fan QW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001017
   Finkel T, 2007, NATURE, V448, P767, DOI 10.1038/nature05985
   Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095
   Gechev TS, 2006, BIOESSAYS, V28, P1091, DOI 10.1002/bies.20493
   Ghafourifar P, 2008, FRONT BIOSCI-LANDMRK, V13, P3116, DOI 10.2741/2913
   Haraoka Y, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-29061-6
   Heintze J, 2016, CELL SIGNAL, V28, P1380, DOI 10.1016/j.cellsig.2016.06.015
   Helmbold H, 2006, ONCOGENE, V25, P5257, DOI 10.1038/sj.onc.1209613
   Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615
   Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.21492, 10.3322/caac.20107]
   Klarer AC, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-2
   Lee JNFJ, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms222212402
   Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257
   Lin LY, 2014, J APPL CLIN MED PHYS, V15, P297, DOI 10.1120/jacmp.v15i3.4748
   Lu Si-Zhao, 2013, World J Biol Chem, V4, P64, DOI 10.4331/wjbc.v4.i3.64
   Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239
   Maruyama J, 2009, CURR MED CHEM, V16, P1229, DOI 10.2174/092986709787846613
   Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048
   Ouyang L, 2012, CELL PROLIFERAT, V45, P487, DOI 10.1111/j.1365-2184.2012.00845.x
   Perl A, 2011, TRENDS MOL MED, V17, P395, DOI 10.1016/j.molmed.2011.01.014
   Puissant A, 2012, AM J CANCER RES, V2, P397
   Pyo JO, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3300
   Qiu ZP, 2015, GASTROENTEROLOGY, V149, P1587, DOI 10.1053/j.gastro.2015.07.050
   Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039
   Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422
   Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094
   Roos WP, 2006, TRENDS MOL MED, V12, P440, DOI 10.1016/j.molmed.2006.07.007
   Samland AK, 2009, INT J BIOCHEM CELL B, V41, P1482, DOI 10.1016/j.biocel.2009.02.001
   Seitz C, 2013, INT J CANCER, V132, P2682, DOI 10.1002/ijc.27935
   Serra V, 2008, CANCER RES, V68, P8022, DOI 10.1158/0008-5472.CAN-08-1385
   Sooro MA, 2018, INT J CANCER, V143, P2116, DOI 10.1002/ijc.31398
   SPENCER N, 1980, ANN HUM GENET, V43, P335, DOI 10.1111/j.1469-1809.1980.tb01567.x
   Sritharan N, 2014, THORAX, V69, P54, DOI 10.1136/thoraxjnl-2013-203400
   Sui X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.350
   Szwarc MM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31372-y
   Tanida I, 2010, METHODS MOL BIOL, V648, P193, DOI 10.1007/978-1-60761-756-3_13
   Vaziri H, 1999, ONCOGENE, V18, P7676, DOI 10.1038/sj.onc.1203016
   Wamelink M, 2008, J INHERIT METAB DIS, V31, P703, DOI 10.1007/s10545-008-1015-6
   Wang CT, 2012, AGING CELL, V11, P93, DOI 10.1111/j.1474-9726.2011.00762.x
   Wang SR, 2008, BIOORG MED CHEM LETT, V18, P6505, DOI 10.1016/j.bmcl.2008.10.047
   Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014
   Wittig R, 2007, PERSPECT MED CHEM, V1, P64
   Xu XJ, 2009, INT J CANCER, V124, P1330, DOI 10.1002/ijc.24078
   Yang ZNJ, 2011, MOL CANCER THER, V10, P1533, DOI 10.1158/1535-7163.MCT-11-0047
   Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058
   Yu L, 2006, P NATL ACAD SCI USA, V103, P4952, DOI 10.1073/pnas.0511288103
   Zhou YY, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20140141
   Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025
NR 65
TC 3
Z9 4
U1 0
U2 10
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1661-6596
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD JUL
PY 2022
VL 23
IS 14
AR 7883
DI 10.3390/ijms23147883
PG 18
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA 3J0RB
UT WOS:000833111200001
PM 35887232
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Tollet-Egnell, P
   Flores-Morales, A
   Odeberg, J
   Lundeberg, J
   Norstedt, G
AF Tollet-Egnell, P
   Flores-Morales, A
   Odeberg, J
   Lundeberg, J
   Norstedt, G
TI Differential cloning of growth hormone-regulated hepatic transcripts in
   the aged rat
SO ENDOCRINOLOGY
LA English
DT Article
ID GLUTATHIONE-S-TRANSFERASE; MIGRATION INHIBITORY FACTOR; ACETYL-COA
   CARBOXYLASE; GH-REPLACEMENT THERAPY; GENE-EXPRESSION; D-DOPACHROME;
   FACTOR-I; ALPHA-MACROGLOBULINS; MESSENGER-RNA; ATP SYNTHASE
AB It has been suggested that aging or at least some of its symptoms are related to a physiological decline in GH levels with age. This study was performed to elucidate age-related changes in GH-dependent effects at the level of gene expression. Through the application of complementary DNA representational difference analysis (RDA) we have identified gene products that are reduced during aging in rat liver. The expression of these genes was restored upon GH treatment. Results from reverse Northern and ribonuclease protection analysis confirmed that the RDA products were truly differentially expressed. In addition to well characterized GH-regulated genes, including CYP2C12, CYP2C13, and alpha(2u)-globulin, we demonstrate the differential expression of at least 11 genes previously not known to be under GH control. Several hepatic transcripts encoding enzymes and receptors involved in the metabolism of protein, carbohydrates, and lipids were identified. Other RDA products consisted of transcripts encoding proteins involved in ATP synthesis, detoxification of reactive oxygen species, or immune responses. This list of GH-regulated genes in the old rat may shed further light on the action and mechanism behind the positive effects of GH on, for example, body composition and the immune system that have been observed in different animal and human studies.
C1 Karolinska Hosp, Karolinska Inst, Dept Mol Med, S-17176 Stockholm, Sweden.
   Royal Inst Technol, Dept Biochem & Biotechnol, S-10044 Stockholm, Sweden.
C3 Karolinska Institutet; Karolinska University Hospital; Royal Institute
   of Technology
RP Tollet-Egnell, P (corresponding author), Karolinska Hosp, Karolinska Inst, Dept Mol Med, CMM L801, S-17176 Stockholm, Sweden.
EM petra.tollet.egnell@molmed.ki.se
RI Odeberg, Jacob/HPF-9349-2023; Odeberg, Jacob O/O-3336-2014
OI Odeberg, Jacob/0000-0003-0996-1644; Odeberg, Jacob O/0000-0003-0996-1644
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   Angelin Bo, 1994, Current Opinion in Lipidology, V5, P160, DOI 10.1097/00041433-199405030-00002
   ARCE VM, 1991, NEUROENDOCRINOLOGY, V53, P467, DOI 10.1159/000125759
   ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cb.04.110188.001445
   Berneis K, 1996, BAILLIERE CLIN ENDOC, V10, P337, DOI 10.1016/S0950-351X(96)80470-8
   BESHYAH SA, 1995, J INTERN MED, V237, P35, DOI 10.1111/j.1365-2796.1995.tb01137.x
   Burgess W, 1999, NEUROIMMUNOMODULAT, V6, P56, DOI 10.1159/000026365
   CHRISTIANSEN JS, 1991, HORM RES, V36, P66
   CORPAS E, 1993, ENDOCR REV, V14, P20, DOI 10.1210/er.14.1.20
   CUNEO RC, 1991, CLIN SCI, V81, P587, DOI 10.1042/cs0810587
   DAUGHADAY WH, 1989, ENDOCR REV, V10, P68, DOI 10.1210/edrv-10-1-68
   Donnelly SC, 1997, MOL MED TODAY, V3, P502, DOI 10.1016/S1357-4310(97)01133-7
   DURNAM DM, 1983, ANAL BIOCHEM, V131, P385, DOI 10.1016/0003-2697(83)90188-4
   DYER MR, 1993, BIOCHEM J, V293, P51, DOI 10.1042/bj2930051
   EGGERTSEN G, 1991, MOL BIOL MED, V8, P287
   Esumi N, 1998, MAMM GENOME, V9, P753, DOI 10.1007/s003359900858
   FLORINI JR, 1981, MECH AGEING DEV, V15, P165, DOI 10.1016/0047-6374(81)90072-5
   GORDON AH, 1976, BIOCHEM J, V159, P643, DOI 10.1042/bj1590643
   GUSTAFSSON JA, 1983, ANNU REV PHYSIOL, V45, P51, DOI 10.1146/annurev.ph.45.030183.000411
   HA JH, 1994, P NATL ACAD SCI USA, V91, P9951, DOI 10.1073/pnas.91.21.9951
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   HAYES JD, 1995, FREE RADICAL RES, V22, P193, DOI 10.3109/10715769509147539
   HERNANDO N, 1992, EXP EYE RES, V55, P711, DOI 10.1016/0014-4835(92)90175-R
   HOUSTEK J, 1995, J BIOL CHEM, V270, P7689, DOI 10.1074/jbc.270.13.7689
   HUBANK M, 1994, NUCLEIC ACIDS RES, V22, P5640, DOI 10.1093/nar/22.25.5640
   ISAKSSON OGP, 1985, ANNU REV PHYSIOL, V47, P483, DOI 10.1146/annurev.ph.47.030185.002411
   Johnson FB, 1999, CELL, V96, P291, DOI 10.1016/S0092-8674(00)80567-X
   JORGENSEN JOL, 1993, J CLIN ENDOCR METAB, V77, P1589, DOI 10.1210/jc.77.6.1589
   JORGENSEN JOL, 1989, LANCET, V1, P1221
   Kann P, 1998, CLIN ENDOCRINOL, V48, P561, DOI 10.1046/j.1365-2265.1998.00439.x
   KELIJMAN M, 1991, J AM GERIATR SOC, V39, P295, DOI 10.1111/j.1532-5415.1991.tb01654.x
   Ketterer B, 1998, FREE RADICAL RES, V28, P647, DOI 10.3109/10715769809065820
   KIM KH, 1989, FASEB J, V3, P2250, DOI 10.1096/fasebj.3.11.2570725
   Kim KH, 1997, ANNU REV NUTR, V17, P77, DOI 10.1146/annurev.nutr.17.1.77
   KOSTYO JL, 1968, ANN NY ACAD SCI, V148, P389, DOI 10.1111/j.1749-6632.1968.tb20365.x
   Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390
   LEGRAVEREND C, 1992, MOL ENDOCRINOL, V6, P259, DOI 10.1210/me.6.2.259
   LISITSYN N, 1993, SCIENCE, V259, P946, DOI 10.1126/science.8438152
   MADISON LL, 1968, METABOLISM, V17, P301, DOI 10.1016/0026-0495(68)90097-8
   MAGER WH, 1988, BIOCHIM BIOPHYS ACTA, V949, P1, DOI 10.1016/0167-4781(88)90048-6
   Mates J M, 1999, Front Biosci, V4, pD339
   Melià MJ, 1998, ENDOCRINOLOGY, V139, P688, DOI 10.1210/en.139.2.688
   MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035
   MODE A, 1989, MOL ENDOCRINOL, V3, P1142, DOI 10.1210/mend-3-7-1142
   MORGENSTERN R, 1982, EUR J BIOCHEM, V128, P243
   NEDEL U, 1983, NUCLEIC ACIDS RES, V11, P17759
   NELSON RL, 1977, BIOCHEM GENET, V15, P87, DOI 10.1007/BF00484550
   Nishihira J, 1998, BIOCHEM BIOPH RES CO, V243, P538, DOI 10.1006/bbrc.1998.8123
   ODEBERG J, IN PRESS BIOTECHNIQU
   ODH G, 1993, BIOCHEM BIOPH RES CO, V197, P619, DOI 10.1006/bbrc.1993.2524
   Pfeifer M, 1999, J CLIN ENDOCR METAB, V84, P453, DOI 10.1210/jc.84.2.453
   POTTER JJ, 1993, BIOCHEM BIOPH RES CO, V191, P1040, DOI 10.1006/bbrc.1993.1322
   Rodríguez-Arnao J, 1998, CLIN ENDOCRINOL, V48, P455
   ROSEN T, 1990, LANCET, V336, P285, DOI 10.1016/0140-6736(90)91812-O
   Rosengren E, 1996, MOL MED, V2, P143, DOI 10.1007/BF03402210
   RUDMAN D, 1990, NEW ENGL J MED, V323, P1, DOI 10.1056/NEJM199007053230101
   Sangawa H, 1997, J BIOL CHEM, V272, P6034, DOI 10.1074/jbc.272.9.6034
   SONNTAG WE, 1995, NEUROENDOCRINOLOGY, V61, P601, DOI 10.1159/000126885
   SOTTRUPJENSEN L, 1989, J BIOL CHEM, V264, P11539
   STROBL JS, 1994, PHARMACOL REV, V46, P1
   THAMPY KG, 1989, J BIOL CHEM, V264, P17631
   TIMSIT J, 1992, J CLIN ENDOCR METAB, V75, P183, DOI 10.1210/jc.75.1.183
   Vance M L, 1998, Trans Am Clin Climatol Assoc, V109, P87
   VANDEWEGHE M, 1993, CLIN ENDOCRINOL, V39, P409, DOI 10.1111/j.1365-2265.1993.tb02387.x
   Velasco B, 1998, ENDOCRINOLOGY, V139, P1314, DOI 10.1210/en.139.3.1314
   Verhelst J, 1997, CLIN ENDOCRINOL, V47, P485, DOI 10.1046/j.1365-2265.1997.3041112.x
   WALKER JE, 1994, FEBS LETT, V346, P39, DOI 10.1016/0014-5793(94)00368-8
   WALKER JE, 1991, BIOCHEMISTRY-US, V30, P5369, DOI 10.1021/bi00236a007
   Wei YH, 1998, ANN NY ACAD SCI, V854, P155, DOI 10.1111/j.1749-6632.1998.tb09899.x
   XU XO, 1995, ENDOCRINOLOGY, V136, P4551, DOI 10.1210/en.136.10.4551
   YAN WL, 1994, GENOMICS, V24, P375, DOI 10.1006/geno.1994.1631
   ZAPHIROPOULOS PG, 1989, TRENDS PHARMACOL SCI, V10, P149, DOI 10.1016/0165-6147(89)90167-3
   ZHANG M, 1995, FEBS LETT, V373, P203, DOI 10.1016/0014-5793(95)01041-C
NR 73
TC 28
Z9 30
U1 0
U2 3
PU ENDOCRINE SOC
PI WASHINGTON
PA 2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA
SN 0013-7227
EI 1945-7170
J9 ENDOCRINOLOGY
JI Endocrinology
PD MAR
PY 2000
VL 141
IS 3
BP 910
EP 921
DI 10.1210/en.141.3.910
PG 12
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 337WH
UT WOS:000088385700008
PM 10698165
OA Bronze
DA 2024-02-19
ER

PT J
AU Feng, QX
   Lu, XC
   Yuan, GX
   Zhang, Q
   An, LP
AF Feng, Qingxia
   Lu, Xuechun
   Yuan, Guangxin
   Zhang, Qian
   An, Liping
TI Effects of <i>Agaricus blazei</i> polypeptide on cell senescence by
   regulation of Keap1/Nrf2/ARE and TLR4/NF-κBp65 signaling pathways and
   its mechanism in D-gal-induced NIH/3T3 cells
SO JOURNAL OF FUNCTIONAL FOODS
LA English
DT Article
DE Agaricus blazei; ABp-RQR; Aging; Nrf2/ARE; TLR4/NF-kappa Bp65
ID IN-VITRO; ANTIOXIDATION; EXTRACT; INJURY; LIVER
AB Agaricus blazei is a kind of fungus plant with an edible as well as a medicinal use. Previous experiments have shown its crude peptide to possess an obvious anti-aging effect. In the present study three active components viz. ABp-RRQ, ABp-RQR and ABp-TRAR were obtained from the Agaricus blazei polypeptide. ABp-RQR was the main active component with a molecular weight of 458 Dalton, and HPLC confirmed it's a purity > 98%. When the D-galactose(D-gal)-induced NIH/3T3 cells were treated with ABp-RQR, changes were observed in the oxidative stress activities and the contents of inflammatory factors. Cell morphology and the percentage of positive cells were observed using the beta-galactosidase staining. Western blot was used to detect the expression levels of the proteins modulated in the inflammatory and antioxidant signaling pathways. Our study suggests that ABp-RQR may play an anti-aging role by alleviating the oxidative inflammatory reactions in D-gal-induced NIH/3T3 cells.
C1 [Feng, Qingxia; Yuan, Guangxin; Zhang, Qian; An, Liping] Beihua Univ, Coll Pharm, Jilin 132013, Jilin, Peoples R China.
   [Lu, Xuechun] Peoples Liberat Army Gen Hosp, Dept Hematol, Beijing 100853, Peoples R China.
C3 Beihua University; Chinese People's Liberation Army General Hospital
RP An, LP (corresponding author), Beihua Univ, Coll Pharm, Jilin 132013, Jilin, Peoples R China.
EM lpan@beihua.edu.cn
OI Yuan, Guangxin/0000-0003-1333-8767
FU Development and Reform Commission of Jilin Province [2018C046-3];
   Science and Technology Bureau of Jilin City [201731201]; Jilin
   Provincial Administration of Traditional Chinese Medicine [2019128];
   National and Local United Engineering Research and Development Center
   [2019128]
FX This work was funded by "Project 2018C046-3" supported by the
   Development and Reform Commission of Jilin Province, "Project 201731201"
   supported by the Science and Technology Bureau of Jilin City, and
   "Project 2019128" supported by the Jilin Provincial Administration of
   Traditional Chinese Medicine, and National and Local United Engineering
   Research and Development Center for research on active peptides of
   medicinal plants and animals in Changbai Mountains.
CR An HJ, 2018, BIOL PHARM BULL, V41, P29, DOI 10.1248/bpb.b17-00371
   Chang JB, 2011, IN VIVO, V25, P971
   Chang JZ, 2018, FUTURE ONCOL, V14, P719, DOI 10.2217/fon-2017-0584
   de Souza ACD, 2017, CURR PHARM DESIGN, V23, P2807, DOI 10.2174/1381612823666170119093719
   Ding JF, 2011, FOOD HYDROCOLLOID, V25, P1350, DOI 10.1016/j.foodhyd.2010.12.013
   Fei TY, 2017, EXP GERONTOL, V97, P89, DOI 10.1016/j.exger.2017.07.015
   Feng QingXia, 2020, Shipin Kexue / Food Science, V41, P164, DOI 10.7506/spkx1002-6630-20190319-249
   Feng Y, 2016, PHARM BIOL, V54, P1027, DOI 10.3109/13880209.2015.1093510
   Gao JB, 2018, ENERG FUEL, V32, P2450, DOI 10.1021/acs.energyfuels.7b03404
   Gasparrini M, 2018, FOOD CHEM TOXICOL, V114, P128, DOI 10.1016/j.fct.2018.02.038
   Hu L. F., 2017, RARE MET, V1, P1, DOI DOI 10.1007/S12011-017-1174-0
   Huang QH, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/7953850
   Ismail I. A., 2018, INT J PHYSL PATH PHA, V10, P884, DOI DOI 10.1016/J.EXGER.2015.11.021
   Jeong Y, 2017, CANCER DISCOV, V7, P86, DOI 10.1158/2159-8290.CD-16-0127
   Jiang LY, 2018, ONCOL LETT, V15, P3429, DOI 10.3892/ol.2018.7794
   Li QS, 2018, BRAIN RES BULL, V137, P311, DOI 10.1016/j.brainresbull.2018.01.007
   Liu XJ, 2016, J FUNCT FOODS, V25, P50, DOI 10.1016/j.jff.2016.05.009
   Maltese G, 2017, J CELL MOL MED, V21, P621, DOI 10.1111/jcmm.12996
   Paudel P, 2018, ARCH PHARM RES, V41, P677, DOI 10.1007/s12272-018-1040-4
   Pu Junliang, 2017, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V33, P936
   Qu MY, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/3209407
   Ren C., 2018, AGR BIOTECHNOLOGY, V7, P110, DOI DOI 10.1016/J.IJBIOMAC.2013.08.031
   Shi CX, 2018, EUR REV MED PHARMACO, V22, P1770, DOI 10.26355/eurrev_201803_14595
   Sun ZW, 2018, PHYTOTHER RES, V32, P1741, DOI 10.1002/ptr.6100
   Tian B, 2004, LUMINESCENCE, V19, P78, DOI 10.1002/bio.761
   Wang Jin, 2012, TEXTILIS MCCLURE MOL, V17, P12297, DOI DOI 10.3390/MOLECULES25030596
   Xu JJ, 2017, FOOD BIOSCI, V18, P9, DOI 10.1016/j.fbio.2017.03.002
   Zhou HM, 2019, FOOD FUNCT, V10, P2774, DOI [10.1039/C8FO01734D, 10.1039/c8fo01734d]
NR 28
TC 7
Z9 7
U1 3
U2 29
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1756-4646
J9 J FUNCT FOODS
JI J. Funct. Food.
PD SEP
PY 2020
VL 72
AR 104037
DI 10.1016/j.jff.2020.104037
PG 11
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA MO7PA
UT WOS:000551711700004
OA gold
DA 2024-02-19
ER

PT J
AU Lambert, AJ
   Merry, BJ
AF Lambert, AJ
   Merry, BJ
TI Use of primary cultures of rat hepatocytes for the study of ageing and
   caloric restriction
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE ageing; calorie restriction; rat hepatocytes; primary cell culture;
   protein synthesis; protein degradation; albumin
ID LIVER PROTEIN-SYNTHESIS; LONG-TERM CULTURE; DIETARY RESTRICTION; FOOD
   RESTRICTION; PARENCHYMAL-CELLS; SANDWICH CONFIGURATION; COLLAGEN
   SANDWICH; DEGRADATION RATE; AMINO-ACIDS; INVIVO
AB Primary cultures of hepatocytes are widely used to investigate liver function, but this technology has not been exploited fully in the study of ageing and caloric restriction (CR). Hepatocytes were isolated from adult and aged, fully fed, and calorie restricted male Sprague-Dawley rats and their viability and biochemical status assessed over 48 h in primary culture. The in vivo differences in cellular protein and DNA content due to age and CR were maintained over the 48 h experimental period. The results of this study confirm earlier reports that protein synthesis and degradation rates decline with age in liver tissue, and this decline is retarded by CR. Rates of protein synthesis and degradation in the first year of life were depressed in response to CR feeding and were only significantly higher than recorded for control animals during the second year of life. Cells from rats of both ages and diets maintained linear rates of extracellular protein synthesis, intracellular protein synthesis, protein degradation and albumin secretion between 24 and 48 h in culture. These findings indicate that hepatocytes from CR rats did not respond adversely to the relatively rich culture medium and cells from CR animals did not immediately revert to the fully fed phenotype. (C) 2000 Elsevier Science Inc. All rights reserved.
C1 Univ Liverpool, Sch Biol Sci, Liverpool L69 3BX, Merseyside, England.
C3 University of Liverpool
RP Merry, BJ (corresponding author), Univ Liverpool, Sch Biol Sci, Derby Bldg, Liverpool L69 3BX, Merseyside, England.
CR AGARWAL S, 1994, ARCH BIOCHEM BIOPHYS, V309, P24, DOI 10.1006/abbi.1994.1078
   BIRCHENALLSPARKS MC, 1985, J NUTR, V115, P944, DOI 10.1093/jn/115.7.944
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Cochran, 1982, STAT METHODS
   Conconi M, 1996, ARCH BIOCHEM BIOPHYS, V331, P232, DOI 10.1006/abbi.1996.0303
   CRANE LJ, 1983, MOL CELL BIOCHEM, V53-4, P89
   DUNN JCY, 1989, FASEB J, V3, P174, DOI 10.1096/fasebj.3.2.2914628
   DUNN JCY, 1991, BIOTECHNOL PROGR, V7, P237, DOI 10.1021/bp00009a007
   DUNN JCY, 1992, J CELL BIOL, V116, P1043, DOI 10.1083/jcb.116.4.1043
   ELSNER P, 1994, BBA-GEN SUBJECTS, V1199, P157, DOI 10.1016/0304-4165(94)90111-2
   ENGELMANN GL, 1981, MECH AGEING DEV, V16, P385, DOI 10.1016/0047-6374(81)90023-3
   FERLAND G, 1992, MECH AGEING DEV, V64, P49, DOI 10.1016/0047-6374(92)90095-U
   FLAIM KE, 1985, AM J PHYSIOL, V249, pE447, DOI 10.1152/ajpendo.1985.249.5.E447
   GAHAN PB, 1986, MOD TRENDS AGEING RE, V147, P169
   GOLDSPINK DF, 1985, COMP BIOCHEM PHYS B, V82, P849, DOI 10.1016/0305-0491(85)90534-6
   GRUNNET N, 1989, ALCOHOL CLIN EXP RES, V13, P25, DOI 10.1111/j.1530-0277.1989.tb00278.x
   GUILLOUZO A, 1986, RES ISOLATED CULTURE
   Gurr J A, 1980, Ann N Y Acad Sci, V349, P57, DOI 10.1111/j.1749-6632.1980.tb29514.x
   HASS BS, 1992, CARCINOGENESIS, V13, P2419, DOI 10.1093/carcin/13.12.2419
   HASS BS, 1993, MUTAT RES, V295, P281, DOI 10.1016/0921-8734(93)90026-Y
   HERLIHY JT, 1990, MECH AGEING DEV, V53, P9, DOI 10.1016/0047-6374(90)90030-J
   HUTSON SM, 1987, AM J PHYSIOL, V252, pE291, DOI 10.1152/ajpendo.1987.252.3.E291
   IKEDA T, 1992, ARCH GERONTOL GERIAT, V15, P181, DOI 10.1016/0167-4943(92)90017-X
   ISHIGAMI A, 1990, ARCH BIOCHEM BIOPHYS, V277, P189, DOI 10.1016/0003-9861(90)90568-J
   ISHIGAMI A, 1990, ARCH BIOCHEM BIOPHYS, V283, P362, DOI 10.1016/0003-9861(90)90655-I
   ISHIGAMI A, 1988, MECH AGEING DEV, V46, P125, DOI 10.1016/0047-6374(88)90120-0
   KIMBALL SR, 1995, AM J PHYSIOL-ENDOC M, V268, pE6, DOI 10.1152/ajpendo.1995.268.1.E6
   MASORO EJ, 1992, J GERONTOL, V47, pB202, DOI 10.1093/geronj/47.6.B202
   MERRY BJ, 1991, MECH AGEING DEV, V58, P139, DOI 10.1016/0047-6374(91)90088-H
   MERRY BJ, 1985, EXP GERONTOL, V20, P15, DOI 10.1016/0531-5565(85)90005-1
   MERRY BJ, 1987, MECH AGEING DEV, V39, P189, DOI 10.1016/0047-6374(87)90008-X
   MERRY BJ, 1991, REV CLIN GERONTOL, V1, P203
   MERRY BJ, 1985, MOL BIOL AGING, P117
   SCHWARZE PE, 1982, IN VITRO CELL DEV B, V18, P43
   SEGLEN PO, 1977, BIOCHIM BIOPHYS ACTA, V496, P182, DOI 10.1016/0304-4165(77)90126-X
   Shaddock JG, 1996, MUTAGENESIS, V11, P281, DOI 10.1093/mutage/11.3.281
   Shibatani T, 1996, J GERONTOL A-BIOL, V51, pB175, DOI 10.1093/gerona/51A.2.B175
   SOMMERCORN JM, 1981, J BIOL CHEM, V256, P4816
   STARKEREED PE, 1989, ARCH BIOCHEM BIOPHYS, V275, P559, DOI 10.1016/0003-9861(89)90402-5
   TANAKA K, 1978, J BIOCHEM-TOKYO, V84, P937, DOI 10.1093/oxfordjournals.jbchem.a132207
   VANBEZOOIJEN CFA, 1977, MECH AGEING DEV, V6, P293, DOI 10.1016/0047-6374(77)90031-8
   VANBEZOOIJEN CFA, 1981, MECH AGEING DEV, V17, P11, DOI 10.1016/0047-6374(81)90124-X
   Vittorini S, 1995, AGING-CLIN EXP RES, V7, P476, DOI 10.1007/BF03324376
   WARD W, 1991, HEPATOLOGY, V14, P935, DOI 10.1002/hep.1840140529
   WARD WF, 1988, J GERONTOL, V43, pB121, DOI 10.1093/geronj/43.5.B121
   WARD WF, 1988, J GERONTOL, V43, pB50, DOI 10.1093/geronj/43.2.B50
   WIEDERANDERS B, 1984, MECH AGEING DEV, V24, P265, DOI 10.1016/0047-6374(84)90112-X
NR 47
TC 13
Z9 18
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
J9 EXP GERONTOL
JI Exp. Gerontol.
PD AUG
PY 2000
VL 35
IS 5
BP 583
EP 594
DI 10.1016/S0531-5565(00)00101-7
PG 12
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 358TU
UT WOS:000089573900007
PM 10978680
DA 2024-02-19
ER

PT J
AU Ohata, K
   Hamasaki, K
   Toriyama, K
   Matsumoto, K
   Saeki, A
   Yanagi, K
   Abiru, S
   Nakagawa, Y
   Shigeno, M
   Miyazoe, S
   Ichikawa, T
   Ishikawa, H
   Nakao, K
   Eguchi, K
AF Ohata, K
   Hamasaki, K
   Toriyama, K
   Matsumoto, K
   Saeki, A
   Yanagi, K
   Abiru, S
   Nakagawa, Y
   Shigeno, M
   Miyazoe, S
   Ichikawa, T
   Ishikawa, H
   Nakao, K
   Eguchi, K
TI Hepatic steatosis is a risk factor for hepatocellular carcinoma in
   patients with chronic hepatitis C virus infection
SO CANCER
LA English
DT Article
DE core protein; hepatic steatosis; hepatitis C virus; hepatocellular
   carcinoma
ID NONALCOHOLIC FATTY LIVER; CORE PROTEIN; IRREGULAR REGENERATION;
   MULTIVARIATE-ANALYSIS; OXIDATIVE STRESS; TRANSGENIC MICE; UNITED-STATES;
   CIRRHOSIS; OBESITY; DISEASE
AB BACKGROUND. Hepatic steatosis is one of the histopathologic features of chronic hepatitis C. It was reported recently that the expression of hepatitis C virus (HCV) core protein in transgenic mice induced hepatocellular carcinoma (HCC) in association with steatosis. The objective of this study was to determine the relation between hepatic steatosis and hepatocarcinogenesis in patients with chronic HCV infection.
   METHODS. The authors studied 161 patients with chronic HCV infection who were diagnosed at Nagasaki University Hospital, Nagasaki, Japan, between January 1980 and December 1999. Age, gender, body mass index (BMI), habitual drinking, diabetes mellitus, serum alanine aminotransferase (ALT) level, HCV serotype, serum level of HCV core protein, interferon (IFN) treatment, hepatic fibrosis inflammation, and hepatic steatosis were studied with regard to their significance in the development of HCC using univariate and multivariate analyses.
   RESULTS. The cumulative incidence rates of HCC were 24%, 51%, and 63% at 5 years, 10 years, and 15 years, respectively. Multivariate analysis identified hepatic steatosis, together with aging, cirrhosis, and no IFN treatment, as independent and significant risk factors for HCC (P 0.0135, P = 0.0390, P = 0.0068, and P 0.0142, respectively). In addition, hepatic steatosis was correlated with BMI, serum ALT levels, and triglyceride levels.
   CONCLUSIONS. The findings of the current study indicate that hepatic steatosis is a risk factor for HCC in patients with chronic HCV infection. Patients with chronic HCV and hepatic steatosis should be monitored carefully for HCC. (C) 2003 American Cancer Society.
C1 Nagasaki Univ, Sch Med, Dept Internal Med 1, Nagasaki 8528501, Japan.
   Nagasaki Univ, Dept Pathol, Inst Trop Med, Nagasaki 8528501, Japan.
   Nagasaki Univ, Hlth Res Ctr, Nagasaki 852, Japan.
C3 Nagasaki University; Nagasaki University; Nagasaki University
RP Eguchi, K (corresponding author), Nagasaki Univ, Sch Med, Dept Internal Med 1, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.
EM f1072@cc.nagasaki-u.ac.jp
CR Adinolfi LE, 2001, HEPATOLOGY, V33, P1358, DOI 10.1053/jhep.2001.24432
   BACH N, 1992, HEPATOLOGY, V15, P572, DOI 10.1002/hep.1840150403
   Barba G, 1997, P NATL ACAD SCI USA, V94, P1200, DOI 10.1073/pnas.94.4.1200
   Bellentani S, 2000, ANN INTERN MED, V132, P112, DOI 10.7326/0003-4819-132-2-200001180-00004
   Brunetto MR, 1998, LANCET, V351, P1535
   Bruno S, 1997, HEPATOLOGY, V25, P754, DOI 10.1002/hep.510250344
   Chiba T, 1996, J GASTROENTEROL, V31, P552, DOI 10.1007/BF02355056
   Costet P, 1998, J BIOL CHEM, V273, P29577, DOI 10.1074/jbc.273.45.29577
   CZAJA AJ, 1993, GASTROENTEROLOGY, V105, P1824, DOI 10.1016/0016-5085(93)91081-R
   Delladetsima JK, 1996, J HEPATOL, V24, P27, DOI 10.1016/S0168-8278(96)80182-6
   DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629
   Deuffic S, 1998, LANCET, V351, P214, DOI 10.1016/S0140-6736(05)78179-4
   El-Serag HB, 1999, NEW ENGL J MED, V340, P745, DOI 10.1056/NEJM199903113401001
   Fujie H, 1999, J MED VIROL, V59, P141, DOI 10.1002/(SICI)1096-9071(199910)59:2&lt;141::AID-JMV3&gt;3.0.CO;2-5
   GOODMAN ZD, 1995, SEMIN LIVER DIS, V15, P70, DOI 10.1055/s-2007-1007264
   HAMASAKI K, 1993, J MED VIROL, V40, P146, DOI 10.1002/jmv.1890400212
   HASHEM B, 2002, HEPATOLOGY, V36, pS74
   Hourigan LF, 1999, HEPATOLOGY, V29, P1215, DOI 10.1002/hep.510290401
   IKEDA K, 1993, HEPATOLOGY, V18, P47, DOI 10.1016/0270-9139(93)90505-H
   LEFKOWITCH JH, 1993, GASTROENTEROLOGY, V104, P595, DOI 10.1016/0016-5085(93)90432-C
   Lerat H, 2002, GASTROENTEROLOGY, V122, P352, DOI 10.1053/gast.2002.31001
   Lin HZ, 2000, NAT MED, V6, P998, DOI 10.1038/79697
   Marrero JA, 2002, HEPATOLOGY, V36, P1349, DOI 10.1053/jhep.2002.36939
   Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8
   Moradpour D, 1996, VIROLOGY, V222, P51, DOI 10.1006/viro.1996.0397
   Moriya K, 2001, CANCER RES, V61, P4365
   Moriya K, 1998, NAT MED, V4, P1065, DOI 10.1038/2053
   Nair S, 2002, HEPATOLOGY, V36, P150, DOI 10.1053/jhep.2002.33713
   Nakao K, 2002, AM J GASTROENTEROL, V97, P1796, DOI 10.1111/j.1572-0241.2002.05846.x
   OKUDA K, 1987, CANCER RES, V47, P4967
   Okuda M, 2002, GASTROENTEROLOGY, V122, P366, DOI 10.1053/gast.2002.30983
   Rubbia-Brandt L, 2000, J HEPATOL, V33, P106, DOI 10.1016/S0168-8278(00)80166-X
   Rubbia-Brandt L, 2001, HISTOPATHOLOGY, V39, P119, DOI 10.1046/j.1365-2559.2001.01208.x
   SCHEUER PJ, 1992, HEPATOLOGY, V15, P567, DOI 10.1002/hep.1840150402
   Shibata M, 1998, LANCET, V351, P1773, DOI 10.1016/S0140-6736(97)08002-1
   Silini E, 1996, GASTROENTEROLOGY, V111, P199, DOI 10.1053/gast.1996.v111.pm8698200
   TAKANO S, 1995, HEPATOLOGY, V21, P650
   Tanaka E, 2000, HEPATOLOGY, V32, P388, DOI 10.1053/jhep.2000.9112
   TANAKA T, 1994, HEPATOLOGY, V19, P1347, DOI 10.1016/0270-9139(94)90226-7
   TaylorRobinson SD, 1997, LANCET, V350, P1142, DOI 10.1016/S0140-6736(05)63789-0
   Toyoda H, 2001, CANCER-AM CANCER SOC, V91, P957
   Ueno Y, 2001, HEPATOLOGY, V33, P357, DOI 10.1053/jhep.2001.21902
   Yang J, 2001, CANCER RES, V61, P4010
   Yoshida H, 1999, ANN INTERN MED, V131, P174, DOI 10.7326/0003-4819-131-3-199908030-00003
NR 44
TC 258
Z9 281
U1 1
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0008-543X
EI 1097-0142
J9 CANCER-AM CANCER SOC
JI Cancer
PD JUN 15
PY 2003
VL 97
IS 12
BP 3036
EP 3043
DI 10.1002/cncr.11427
PG 8
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA 686WC
UT WOS:000183343100015
PM 12784339
OA Bronze
DA 2024-02-19
ER

PT S
AU Fang, C
   Xu, H
   Guo, SD
   Mertens-Talcott, SU
   Sun, YX
AF Fang, Chuo
   Xu, Hang
   Guo, Shaodong
   Mertens-Talcott, Susanne U.
   Sun, Yuxiang
BE Wu, Q
   Zheng, R
TI Ghrelin Signaling in Immunometabolism and Inflamm-Aging
SO NEURAL REGULATION OF METABOLISM
SE Advances in Experimental Medicine and Biology
LA English
DT Article; Book Chapter
DE Aging; Ghrelin; Inflammation; Insulin resistance; Adipose tissue
   macrophages
ID HEPATIC INSULIN-RESISTANCE; NECROSIS-FACTOR-ALPHA;
   CORONARY-HEART-DISEASE; DIET-INDUCED OBESITY; ADIPOSE-TISSUE; MACROPHAGE
   POLARIZATION; GLUCOSE-HOMEOSTASIS; RECEPTOR EXPRESSION; CYTOKINE
   PRODUCTION; SKELETAL-MUSCLE
AB Intracellular changes in immune cells lead to metabolic dysfunction, which is termed immunometabolism. Chronic inflammation is a hallmark of aging; this phenomenon is described as inflamm-aging. Immunometabolism and inflamm-aging are closely linked to obesity, insulin resistance, type 2 diabetes (T2D), cardiovascular diseases, and cancers, which consequently reduce life span and health span of the elderly. Ghrelin is an orexigenic hormone that regulates appetite and food intake. Ghrelin's functions are mediated through its receptor, growth hormone secretagogue receptor (GHS-R). Ghrelin and GHS-R have important roles in age-associated obesity, insulin resistance, and T2D. In this chapter, we have discussed the roles of ghrelin signaling in diet-induced obesity and normal aging as it relates to energy metabolism and inflammation in key metabolic tissues and organs. The new findings reveal that ghrelin signaling is an important regulatory mechanism for immunometabolism and inflamm-aging. Ghrelin signaling offers an exciting novel therapeutic strategy for treatment of obesity and insulin resistance of the elderly.
C1 [Fang, Chuo; Xu, Hang; Guo, Shaodong; Mertens-Talcott, Susanne U.; Sun, Yuxiang] Texas A&M Univ, Dept Nutr & Food Sci, College Stn, TX 77843 USA.
C3 Texas A&M University System; Texas A&M University College Station
RP Sun, YX (corresponding author), Texas A&M Univ, Dept Nutr & Food Sci, College Stn, TX 77843 USA.
EM Yuxiang.Sun@tamu.edu
RI Guo, Shaodong/W-5552-2019
CR Abbasi F, 2002, J AM COLL CARDIOL, V40, P937, DOI 10.1016/S0735-1097(02)02051-X
   [Anonymous], 2014, MULTIPLE CHRONIC CON
   Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233
   BODEN G, 1994, J CLIN INVEST, V93, P2438, DOI 10.1172/JCI117252
   Boden G, 2008, ENDOCRIN METAB CLIN, V37, P635, DOI 10.1016/j.ecl.2008.06.007
   Boden Guenther, 2006, Curr Diab Rep, V6, P177, DOI 10.1007/s11892-006-0031-x
   Boehmer ED, 2004, J LEUKOCYTE BIOL, V75, P342, DOI 10.1189/jlb.0803389
   Bruunsgaard H, 2003, AM J MED, V115, P278, DOI 10.1016/S0002-9343(03)00329-2
   Calhoun DA, 2008, HYPERTENSION, V51, P1403, DOI 10.1161/HYPERTENSIONAHA.108.189141
   Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989
   Cappellari GG, 2016, DIABETES, V65, P874, DOI 10.2337/db15-1019
   Castoldi A, 2016, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00637
   Chabot F, 2014, WORLD J DIABETES, V5, P328, DOI 10.4239/wjd.v5.i3.328
   Chelvarajan RL, 2005, J LEUKOCYTE BIOL, V77, P503, DOI 10.1189/jlb.0804449
   Chinetti-Gbaguidi G, 2011, CURR OPIN LIPIDOL, V22, P365, DOI 10.1097/MOL.0b013e32834a77b4
   Claeys S, 2003, ALLERGY, V58, P748, DOI 10.1034/j.1398-9995.2003.00180.x
   Coll AP, 2007, CELL, V129, P251, DOI 10.1016/j.cell.2007.04.001
   Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8
   Cummings DE, 2002, NEW ENGL J MED, V346, P1623, DOI 10.1056/NEJMoa012908
   Czaja AJ, 2014, WORLD J GASTROENTERO, V20, P2515, DOI 10.3748/wjg.v20.i10.2515
   DeFronzo RA, 2009, DIABETES CARE, V32, pS157, DOI 10.2337/dc09-S302
   Dong XC, 2006, J CLIN INVEST, V116, P101, DOI 10.1172/JCI25735
   Ershler WB, 2000, ANNU REV MED, V51, P245, DOI 10.1146/annurev.med.51.1.245
   Franceschi C, 2000, ANN NY ACAD SCI, V908, P244
   Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057
   Fujiwara Nagatoshi, 2005, Current Drug Targets - Inflammation and Allergy, V4, P281, DOI 10.2174/1568010054022024
   Gibon E, 2016, REGEN ENG TRANSL MED, V2, P98, DOI 10.1007/s40883-016-0016-5
   Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783
   Guillory B, 2017, AGING CELL, V16, P859, DOI 10.1111/acel.12618
   Guo SD, 2014, J ENDOCRINOL, V220, pT1, DOI 10.1530/JOE-13-0327
   Hassouna R, 2010, J NEUROENDOCRINOL, V22, P793, DOI 10.1111/j.1365-2826.2010.02019.x
   Health UDo Services H, 2010, MULTIPLE CHRONIC CON
   Hong EG, 2009, DIABETES, V58, P2525, DOI 10.2337/db08-1261
   HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183
   Juhas U, 2015, POSTEP HIG MED DOSW, V69, P496, DOI 10.5604/17322693.1150133
   Kabakov Emma, 2006, J Cardiometab Syndr, V1, P95, DOI 10.1111/j.1559-4564.2006.05513.x
   Kaeberlein M, 2015, SCIENCE, V350, P1191, DOI 10.1126/science.aad3267
   Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498
   Klover PJ, 2003, DIABETES, V52, P2784, DOI 10.2337/diabetes.52.11.2784
   Lam TKT, 2002, AM J PHYSIOL-ENDOC M, V283, pE682, DOI 10.1152/ajpendo.00038.2002
   Landi F, 2016, NUTRIENTS, V8, DOI 10.3390/nu8020069
   Lee JH, 2016, DIABETES, V65, P2169, DOI 10.2337/db15-1587
   Lin LG, 2016, AGING-US, V8, P178, DOI 10.18632/aging.100888
   Lin LG, 2014, AGING-US, V6, P1019, DOI 10.18632/aging.100706
   Lin LG, 2011, AGING CELL, V10, P996, DOI 10.1111/j.1474-9726.2011.00740.x
   Linehan E, 2014, AGING CELL, V13, P699, DOI 10.1111/acel.12223
   Liu YC, 2014, INT J BIOL SCI, V10, P520, DOI 10.7150/ijbs.8879
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076
   Ma X, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.41
   Martin ASG, 2006, AM J CLIN NUTR, V83, p461S, DOI 10.1093/ajcn/83.2.461s
   McArdle Maeve A, 2013, Front Endocrinol (Lausanne), V4, P52, DOI 10.3389/fendo.2013.00052
   Murphy S., 2012, National Vital Statistics Report, V60, P1
   NATHAN CF, 1987, J CLIN INVEST, V79, P319, DOI 10.1172/JCI112815
   Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200
   Nieto-Vazquez I, 2008, DIABETES, V57, P3211, DOI 10.2337/db07-1062
   O'Mahony L, 1998, CLIN EXP IMMUNOL, V113, P213
   Ogden Cynthia L, 2015, NCHS Data Brief, P1
   Olah Mark E, 2003, Mol Interv, V3, P370, DOI 10.1124/mi.3.7.370
   Organization WH, 2015, Fact sheet no 311. 2015
   Orr JS, 2012, DIABETES, V61, P2718, DOI 10.2337/db11-1595
   Paredes-Turrubiarte G, 2016, CLIN EXP MED, V16, P193, DOI 10.1007/s10238-015-0347-4
   Pfannenberg C, 2010, DIABETES, V59, P1789, DOI 10.2337/db10-0004
   Ponnappan S, 2011, ANTIOXID REDOX SIGN, V14, P1551, DOI 10.1089/ars.2010.3228
   Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327
   Pradhan G, 2013, CURR OPIN CLIN NUTR, V16, P619, DOI 10.1097/MCO.0b013e328365b9be
   Renshaw M, 2002, J IMMUNOL, V169, P4697, DOI 10.4049/jimmunol.169.9.4697
   Ridker PM, 2000, CIRCULATION, V101, P1767, DOI 10.1161/01.CIR.101.15.1767
   RIMM EB, 1995, AM J EPIDEMIOL, V141, P1117, DOI 10.1093/oxfordjournals.aje.a117385
   Roubenoff R, 1998, J GERONTOL A-BIOL, V53, pM20, DOI 10.1093/gerona/53A.1.M20
   Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200
   Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898
   Souza SC, 2003, J CELL BIOCHEM, V89, P1077, DOI 10.1002/jcb.10565
   Sun YX, 2007, ENDOCRINOLOGY, V148, P1323, DOI 10.1210/en.2006-0782
   Torres SH, 2004, J ENDOCRINOL, V181, P419, DOI 10.1677/joe.0.1810419
   van der Heijden RA, 2015, AGING-US, V7, P256, DOI 10.18632/aging.100738
   van Duin D, 2007, J IMMUNOL, V178, P970, DOI 10.4049/jimmunol.178.2.970
   Varela L, 2012, EMBO REP, V13, P1079, DOI 10.1038/embor.2012.174
   Wang N, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00614
   Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3
   Ward BW, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130389
   Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246
   Weiss CO, 2007, JAMA-J AM MED ASSOC, V298, P1160, DOI 10.1001/jama.298.10.1160-a
   Wong CK, 2017, J IMMUNOL, V199, P1060, DOI 10.4049/jimmunol.1700397
   Wu CS, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040832
   Xu XY, 2013, CELL METAB, V18, P816, DOI 10.1016/j.cmet.2013.11.001
   Zhang HH, 2002, DIABETES, V51, P2929, DOI 10.2337/diabetes.51.10.2929
NR 87
TC 12
Z9 13
U1 0
U2 2
PU SPRINGER INTERNATIONAL PUBLISHING AG
PI CHAM
PA GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND
SN 0065-2598
EI 2214-8019
BN 978-9-8113-1286-1
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PY 2018
VL 1090
BP 165
EP 182
DI 10.1007/978-981-13-1286-1_9
D2 10.1007/978-981-13-1286-1
PG 18
WC Endocrinology & Metabolism; Neurosciences
WE Book Citation Index – Science (BKCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Neurosciences & Neurology
GA BL9PQ
UT WOS:000458007600009
PM 30390290
DA 2024-02-19
ER

PT J
AU Iwama, M
   Kondo, Y
   Shimokado, K
   Maruyama, N
   Ishigami, A
AF Iwama, Mizuki
   Kondo, Yoshitaka
   Shimokado, Kentaro
   Maruyama, Naoki
   Ishigami, Akihito
TI Uric Acid Levels in Tissues and Plasma of Mice during Aging
SO BIOLOGICAL & PHARMACEUTICAL BULLETIN
LA English
DT Article
DE aging; uric acid; uricase; mouse tissue
ID DEHYDROASCORBIC ACID; URATE OXIDASE; DISEASE; GLUT9; LIVER;
   PEROXYNITRITE; ASCORBATE; CLONING
AB Here we quantified the uric acid (UA) levels in 11 tissues and plasma of C57BL/6 male mice to track its turnover during 3 to 30 months of aging. UA levels in the adrenal glands, heart, and spleen increased with aging until 30 months of age. Similarly, UA levels in the liver, kidneys, pancreas, and testes increased until the mice were 24 months old. UA levels also rose in the lungs and skeletal muscles from 3 to 6 months and 6 to 12 months, respectively, and then remained at almost the same levels until 30 months of age. In the skin, UA decreased from 3 to 6 months and then stayed nearly constant until 30 months of age. Moreover, the small intestines and plasma had quite stable UA levels during aging. Thus, our assessment of 11 tissue types from mice showed that the UA levels increased in most tissues during aging.
C1 [Iwama, Mizuki; Kondo, Yoshitaka; Maruyama, Naoki; Ishigami, Akihito] Tokyo Metropolitan Inst Gerontol, Tokyo 1730015, Japan.
   [Iwama, Mizuki; Shimokado, Kentaro] Tokyo Med & Dent Univ, Dept Geriatr & Vasc Med, Tokyo 1138510, Japan.
C3 Tokyo Metropolitan Institute of Gerontology; Tokyo Medical & Dental
   University (TMDU)
RP Ishigami, A (corresponding author), Tokyo Metropolitan Inst Gerontol, Tokyo 1730015, Japan.
EM ishigami@tmig.or.jp
RI Yoshitaka, Kondo/AFK-7721-2022
OI Yoshitaka, Kondo/0000-0002-0046-9429; Ishigami,
   Akihito/0000-0001-7875-7482
FU Ministry of Education, Culture, Sports, Science and Technology of Japan;
   Grants-in-Aid for Scientific Research [23790122] Funding Source: KAKEN
FX This study is supported by a Grant-in-Aid for Scientific Research from
   the Ministry of Education, Culture, Sports, Science and Technology of
   Japan (to A.I.). We thank Ms. P. Minick for the excellent English
   editorial assistance.
CR AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858
   Augustin R, 2004, J BIOL CHEM, V279, P16229, DOI 10.1074/jbc.M312226200
   BECKER BF, 1993, FREE RADICAL BIO MED, V14, P615, DOI 10.1016/0891-5849(93)90143-I
   Bibert S, 2009, AM J PHYSIOL-RENAL, V297, pF612, DOI 10.1152/ajprenal.00139.2009
   FRIEDMAN M, 1948, J BIOL CHEM, V175, P727
   Hille R, 2005, ARCH BIOCHEM BIOPHYS, V433, P107, DOI 10.1016/j.abb.2004.08.012
   Kang DH, 2002, J AM SOC NEPHROL, V13, P2888, DOI 10.1097/01.ASN.0000034910.58454.FD
   Keembiyehetty C, 2006, MOL ENDOCRINOL, V20, P686, DOI 10.1210/me.2005-0010
   Kuzkaya N, 2005, BIOCHEM PHARMACOL, V70, P343, DOI 10.1016/j.bcp.2005.05.009
   Li XN, 2009, J CHROMATOGR B, V877, P853, DOI 10.1016/j.jchromb.2009.02.008
   Moran ME, 2003, FRONT BIOSCI-LANDMRK, V8, pS1339, DOI 10.2741/1178
   MOTOJIMA K, 1988, J BIOL CHEM, V263, P16677
   Perichon R, 1996, MECH AGEING DEV, V87, P115, DOI 10.1016/0047-6374(96)01705-8
   Phay JE, 2000, GENOMICS, V66, P217, DOI 10.1006/geno.2000.6195
   PROCTOR P, 1970, NATURE, V228, P868, DOI 10.1038/228868a0
   Sato Y, 2010, BIOL PHARM BULL, V33, P364, DOI 10.1248/bpb.33.364
   So A, 2010, J CLIN INVEST, V120, P1791, DOI 10.1172/JCI42344
   Vida C, 2011, J PHYSIOL BIOCHEM, V67, P551, DOI 10.1007/s13105-011-0100-8
   Whiteman M, 2002, ANN NY ACAD SCI, V962, P242, DOI 10.1111/j.1749-6632.2002.tb04072.x
   WU XW, 1992, J MOL EVOL, V34, P78, DOI 10.1007/BF00163854
   WU XW, 1994, P NATL ACAD SCI USA, V91, P742, DOI 10.1073/pnas.91.2.742
NR 21
TC 6
Z9 7
U1 2
U2 9
PU PHARMACEUTICAL SOC JAPAN
PI TOKYO
PA 2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN
SN 0918-6158
J9 BIOL PHARM BULL
JI Biol. Pharm. Bull.
PD AUG
PY 2012
VL 35
IS 8
BP 1367
EP 1370
DI 10.1248/bpb.b12-00198
PG 4
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 982JN
UT WOS:000307039400027
PM 22863939
OA Bronze
DA 2024-02-19
ER

PT J
AU Mohammed, S
   Nicklas, EH
   Thadathil, N
   Selvarani, R
   Royce, GH
   Kinter, M
   Richardson, A
   Deepa, SS
AF Mohammed, Sabira
   Nicklas, Evan H.
   Thadathil, Nidheesh
   Selvarani, Ramasamy
   Royce, Gordon H.
   Kinter, Michael
   Richardson, Arlan
   Deepa, Sathyaseelan S.
TI Role of necroptosis in chronic hepatic inflammation and fibrosis in a
   mouse model of increased oxidative stress
SO FREE RADICAL BIOLOGY AND MEDICINE
LA English
DT Article; Early Access
DE Necroptosis; Inflammation; Hepatocellular carcinoma; Fibrosis; Cu/Zn
   superoxide dismutase; Oxidative stress; Necrostatin-1s; Non-alcoholic
   hepatosteatosis; Non-alcoholic fatty liver disease; Autophagy
ID ACCELERATED AGING PHENOTYPE; FATTY LIVER-DISEASE; CELL-DEATH;
   ACCUMULATION; ACTIVATION; INHIBITOR; PROTECTS; LEADS; MICE
AB Mice deficient in the antioxidant enzyme Cu/Zn-superoxide dismutase (Sod1(-/-) or Sod1KO mice) have increased oxidative stress, show accelerated aging and develop spontaneous hepatocellular carcinoma (HCC) with age. Similar to humans, HCC development in Sod1KO mice progresses from non-alcoholic fatty liver disease (NAFLD) to non-alcoholic steatohepatitis (NASH) with fibrosis, which eventually progresses to HCC. Oxidative stress plays a role in NAFLD to NASH progression, and liver inflammation is the main mechanism that drives the disease progression from NASH to fibrosis. Because necroptosis is a major source of inflammation, we tested the hypothesis that increased necroptosis in the liver plays a role in increased inflammation and fibrosis in Sod1KO mice. Phosphorylation of MLKL (P-MLKL), a well-accepted marker of necroptosis, and expression of MLKL protein were significantly increased in the livers of Sod1KO mice compared to wild type (WT) mice indicating increased necroptosis. Similarly, phosphorylation of RIPK3 and RIPK3 protein levels were also significantly increased. Markers of pro-inflammatory M1 macrophages, NLRP3 inflammasome, and transcript levels of pro inflammatory cytokines and chemokines, e.g., TNF alpha, IL-6, IL-1 beta, and Ccl2 that are associated with human NASH, were significantly increased. Expression of antioxidant enzymes and heat shock proteins, and markers of fibrosis and oncogenic transcription factor STAT3 were also upregulated and autophagy was downregulated in the livers of Sod1KO mice. Short term treatment of Sod1KO mice with necrostatin-1s (Nec-1s), a necroptosis inhibitor, reversed these conditions. Our data show for the first time that necroptosis-mediated inflammation contributes to fibrosis in a mouse model of increased oxidative stress and accelerated aging, that also exhibits progressive HCC development.
C1 [Mohammed, Sabira; Richardson, Arlan; Deepa, Sathyaseelan S.] Stephenson Canc Ctr, Oklahoma City, OK USA.
   [Nicklas, Evan H.; Thadathil, Nidheesh; Selvarani, Ramasamy; Royce, Gordon H.; Richardson, Arlan; Deepa, Sathyaseelan S.] Dept Biochem & Mol Biol, Oklahoma City, OK USA.
   [Richardson, Arlan; Deepa, Sathyaseelan S.] Univ Oklahoma, Hlth Sci Ctr, Oklahoma Ctr Gerosci & Brain Aging, Norman, OK 73019 USA.
   [Kinter, Michael] Oklahoma Med Res Fdn, Aging & Metab Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.
   [Richardson, Arlan] Oklahoma City VA Med Ctr, Oklahoma City, OK USA.
C3 University of Oklahoma System; University of Oklahoma Health Sciences
   Center; University of Oklahoma System; University of Oklahoma Health
   Sciences Center; University of Oklahoma - Norman; Oklahoma Medical
   Research Foundation; University of Oklahoma System; University of
   Oklahoma Health Sciences Center
RP Deepa, SS (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Oklahoma Ctr Gerosci & Brain Aging, Stephenson Canc Ctr,Dept Biochem & Mol Biol, 975 NE 10th St,BRC 1368B, Oklahoma City, OK 73104 USA.
EM Deepa-Sathyaseelan@ouhsc.edu
RI Thadathil, Nidheesh/IWE-4992-2023
OI T, Nidheesh/0000-0003-2168-8337; Jazir, Sabira
   Mohammed/0000-0002-0332-3660
FU Oklahoma Center for the Advancement of Science and Technology
   [HR18-053]; Presbyterian Health Foundation (OUHSC); NIH [R01AG059718,
   R01AG057424]; Oklahoma Nathan Shock Aging Center [P30AG050911];
   Department of Veterans Affairs [I01BX004538]
FX The efforts of authors were supported by Oklahoma Center for the
   Advancement of Science and Technology research grant (HR18-053) (SD),
   Presbyterian Health Foundation (OUHSC) Seed grant (SD), NIH grants
   R01AG059718 (SD),R01AG057424 (AR), and the Oklahoma Nathan Shock Aging
   Center [P30AG050911 (AR, MS)] and a Senior Career Research Award (AR)
   and a Merit grant I01BX004538 (AR) from the Department of Veterans
   Affairs.
CR Afonso MB, 2015, CLIN SCI, V129, P721, DOI 10.1042/CS20140732
   ALEGRE F, 2017, CYTOKINE GROWTH F R, V37, P119, DOI DOI 10.1055/S-0037-1601350
   BEGRICHE K, 2006, FREE RADICAL BIO MED, V6, P1, DOI DOI 10.1016/J.MITO.2005.10.004
   Bhaskaran S, 2018, EMBO REP, V19, DOI 10.15252/embr.201745009
   BRAUNERSREUTHER V, 2012, FREE RADICAL BIO MED, V18, P727, DOI DOI 10.3748/WJG.V18.I8.727
   Breitzig M, 2016, AM J PHYSIOL-CELL PH, V311, pC537, DOI 10.1152/ajpcell.00101.2016
   Byass P, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0159-5
   Canli Ö, 2016, BLOOD, V127, P139, DOI 10.1182/blood-2015-06-654194
   Capece D, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/187204
   Cong M, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/158547
   Dalleau S, 2013, CELL DEATH DIFFER, V20, P1615, DOI 10.1038/cdd.2013.138
   Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2
   Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711
   Elchuri S, 2005, ONCOGENE, V24, P367, DOI 10.1038/sj.onc.1208207
   Febbraio MA, 2019, CELL METAB, V29, P18, DOI 10.1016/j.cmet.2018.10.012
   Fernandes J, 2015, BIOCHEMISTRY-US, V54, P4008, DOI 10.1021/acs.biochem.5b00375
   FRIEDMAN SL, 2008, TRENDS CELL BIOL, V134, P1655, DOI DOI 10.1053/J.GASTRO.2008.03.003
   Gautheron J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11869
   Gautheron J, 2014, EMBO MOL MED, V6, P1062, DOI 10.15252/emmm.201403856
   Goh GBB, 2016, DIGEST DIS SCI, V61, P1226, DOI 10.1007/s10620-016-4095-4
   Han CH, 2018, BIOCHEM BIOPH RES CO, V495, P2178, DOI 10.1016/j.bbrc.2017.12.100
   He GB, 2010, CANCER CELL, V17, P286, DOI 10.1016/j.ccr.2009.12.048
   HE S, 2016, AUTOPHAGY, V73, P2177
   HUI L, 2007, COMPR PHYSIOL, V39, P741
   Ito Y, 2016, SCIENCE, V353, P603, DOI 10.1126/science.aaf6803
   Johnston AN, 2020, P NATL ACAD SCI USA, V117, P6521, DOI 10.1073/pnas.1916503117
   KAUSHIK S, 2012, BIOCHEM BIOPH RES CO, V22, P407
   Kinter CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050016
   Koyama Y, 2017, J CLIN INVEST, V127, P55, DOI 10.1172/JCI88881
   KURAHASHI T, 2015, P NATL ACAD SCI USA, V467, P866
   Land Walter G, 2015, Sultan Qaboos Univ Med J, V15, pe9
   Lee Ga Young, 2018, Exp Mol Med, V50, P1, DOI 10.1038/s12276-018-0089-y
   Léveillé M, 2019, METABOLITES, V9, DOI 10.3390/metabo9100233
   Li J-X, 2014, Cell Death Dis, V5, pe1278, DOI 10.1038/cddis.2014.241
   LIAO D, 2014, CELL DEATH DIS, V5, P333, DOI DOI 10.1039/C3MD00278K
   Logan S, 2019, GEROSCIENCE, V41, P591, DOI 10.1007/s11357-019-00105-y
   Luedde T, 2014, GASTROENTEROLOGY, V147, P765, DOI 10.1053/j.gastro.2014.07.018
   MAEDA S, 2005, MATRIX BIOL, V121, P977, DOI DOI 10.1016/J
   Majdi A, 2020, J HEPATOL, V72, P627, DOI 10.1016/j.jhep.2019.11.008
   Mandal P, 2014, MOL CELL, V56, P481, DOI 10.1016/j.molcel.2014.10.021
   Marcellin P, 2018, LIVER INT, V38, P2, DOI 10.1111/liv.13682
   Marengo A, 2016, ANNU REV MED, V67, P103, DOI 10.1146/annurev-med-090514-013832
   Muller FL, 2006, FREE RADICAL BIO MED, V40, P1993, DOI 10.1016/j.freeradbiomed.2006.01.036
   Newton K, 2016, ANNU REV BIOCHEM, V85, P743, DOI 10.1146/annurev-biochem-060815-014830
   NIKOLICPATERSON AR, 1996, MITOCHONDRION, V54, pS88
   Ofengeim D, 2015, CELL REP, V10, P1836, DOI 10.1016/j.celrep.2015.02.051
   OREILLY S, 2012, AM J PHYSIOL-CELL PH, V23, P99, DOI DOI 10.1016/J.CYTOGFR.2012.04.003
   PARK EJ, 2010, BIOCHEM BIOPH RES CO, V140, P197, DOI DOI 10.1016/J.CELL.2009.12.052
   PARK SH, 2002, AUTOPHAGY, V92, P2475
   Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191
   PUCHE JE, 2013, INT J HEPATOL, V3, P1473, DOI DOI 10.1002/CPHY.C120035
   Rawla P, 2018, WSPOLCZESNA ONKOL, V22, P141, DOI 10.5114/wo.2018.78941
   Ren Y, 2017, J MED CHEM, V60, P972, DOI 10.1021/acs.jmedchem.6b01196
   ROEB E, 2018, SEMIN LIVER DIS, V68, P463, DOI DOI 10.1016/J.MATBIO.2017.12.012
   Royce GH, 2019, GEROSCIENCE, V41, P795, DOI 10.1007/s11357-019-00131-w
   Roychowdhury S, 2016, HEPATOLOGY, V64, P1518, DOI 10.1002/hep.28676
   Saeed WK, 2019, PHARMACOL RES, V148, DOI 10.1016/j.phrs.2019.104439
   Sakiyama H, 2016, FREE RADICAL RES, V50, P666, DOI 10.3109/10715762.2016.1164856
   SAKURAI T, 2006, NAT GENET, V103, P10544
   Sakurai T, 2008, CANCER CELL, V14, P156, DOI 10.1016/j.ccr.2008.06.016
   Schuster S, 2018, NAT REV GASTRO HEPAT, V15, P349, DOI 10.1038/s41575-018-0009-6
   Takahashi N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.176
   Takemoto K, 2014, FEBS OPEN BIO, V4, P777, DOI 10.1016/j.fob.2014.08.007
   Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001
   Uchida K, 1995, ARCH BIOCHEM BIOPHYS, V324, P241, DOI 10.1006/abbi.1995.0036
   Uchiyama S, 2006, J BIOL CHEM, V281, P31713, DOI 10.1074/jbc.M603422200
   Villanueva Augusto, 2016, Clin Liver Dis (Hoboken), V8, P89, DOI 10.1002/cld.578
   WANG L, 2012, AUTOPHAGY, V53, P1689, DOI DOI 10.1016/J
   Weinlich R, 2017, NAT REV MOL CELL BIO, V18, P127, DOI 10.1038/nrm.2016.149
   Wu XQ, 2020, AUTOPHAGY, V16, P1351, DOI 10.1080/15548627.2020.1760624
   Xu HX, 2019, MOL METAB, V23, P14, DOI 10.1016/j.molmet.2019.02.003
   Youm YH, 2013, CELL METAB, V18, P519, DOI 10.1016/j.cmet.2013.09.010
   Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431
   YU R, 2018, P NATL ACAD SCI USA, V18, P51, DOI DOI 10.1186/S12876-018-0776-0
   Yuan JY, 2019, NAT REV NEUROSCI, V20, P19, DOI 10.1038/s41583-018-0093-1
   Zhang YQ, 2017, REDOX BIOL, V11, P30, DOI 10.1016/j.redox.2016.10.014
   Zhang YQ, 2016, MECH AGEING DEV, V154, P1, DOI 10.1016/j.mad.2016.01.005
   Zhang YQ, 2013, FREE RADICAL BIO MED, V60, P300, DOI 10.1016/j.freeradbiomed.2013.02.026
NR 78
TC 52
Z9 53
U1 2
U2 9
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0891-5849
EI 1873-4596
J9 FREE RADICAL BIO MED
JI Free Radic. Biol. Med.
PD 2021 FEB 20
PY 2021
VL 164
BP 315
EP 328
DI 10.1016/j.freeradbiomed.2020.12.449
EA JAN 2021
PG 14
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA QL8JZ
UT WOS:000621328400006
PM 33429022
OA Green Accepted, hybrid
DA 2024-02-19
ER

PT J
AU Mumcuoglu, M
   Gurkan-Alp, AS
   Buyukbingol, E
   Cetin-Atalay, R
AF Mumcuoglu, Mine
   Gurkan-Alp, A. Selen
   Buyukbingol, Erdem
   Cetin-Atalay, Rengul
TI Retinoid
   <i>N</i>-(1<i>H</i>-benzo[d]imidazol-2-yl)-5,5,8,8-tetramethyl-5,6,7,8-t
   etrahydronaphthalene-2-carboxamide induces p21-dependent senescence in
   breast cancer cells
SO STEROIDS
LA English
DT Article
DE Retinoid; Cytotoxicity; Breast cancer; Senescence; RXR
ID UNION-OF-PHARMACOLOGY; CELLULAR SENESCENCE; ACID RECEPTORS;
   UP-REGULATION; DOWN-REGULATION; C-MYC; ARREST; INHIBITION; EXPRESSION;
   PATHWAYS
AB Retinoids have been implicated as pharmacological agents for the prevention and treatment of various types of cancers, including breast cancers. We analyzed 27 newly synthesized retinoids for their bioactivity on breast, liver, and colon cancer cells. Majority of the retinoids demonstrated selective bioactivity on breast cancer cells. Retinoid 17 had a significant inhibitory activity (IC50 3.5 mu M) only on breast cancer cells while no growth inhibition observed with liver and colon cancer cells. The breast cancer selective growth inhibitory action by retinoid 17 was defined as p21-dependent cell death, reminiscent of senescence, which is an indicator of targeted receptor mediated bioactivity. A comparative analysis of retinoid receptor gene expression levels in different breast cancer cells and IC50 values of 17 indicated the involvement of Retinoid X receptors in the cytotoxic bioactivity of retinoid 17 in the senescence associated cell death. Furthermore, siRNA knockdown studies with RXR gamma induced decrease in cell proliferation. Therefore, we suggest that retinoid derivatives that target RXR gamma, can be considered for breast cancer therapies. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Mumcuoglu, Mine; Cetin-Atalay, Rengul] LOSEV, Canc Genet Res Lab, Ankara, Turkey.
   [Mumcuoglu, Mine] Bilkent Univ, Dept Mol Biol & Genet, TR-06800 Ankara, Turkey.
   [Gurkan-Alp, A. Selen; Buyukbingol, Erdem] Ankara Univ, Fac Pharm, Dept Pharmaceut Chem, TR-06100 Ankara, Turkey.
   [Cetin-Atalay, Rengul] METU, Canc Syst Biol Lab, Grad Sch Informat, TR-06800 Ankara, Turkey.
C3 Ihsan Dogramaci Bilkent University; Ankara University; Middle East
   Technical University
RP Cetin-Atalay, R (corresponding author), Middle E Tech Univ, ODTU, Canc Syst Biol Lab, Grad Sch Informat, TR-06800 Ankara, Turkey.
EM rengul@metu.edu.tr
RI Buyukbingol, Erdem/ADC-5389-2022; ALP, Selen/AAF-3183-2020;
   Cetin-Atalay, Rengul/O-9826-2014
OI Buyukbingol, Erdem/0000-0001-8344-7905; Cetin-Atalay,
   Rengul/0000-0003-2408-6606
FU Scientific and Technical Research Council of Turkey, TUBITAK [106S359]
FX This work was supported by the Scientific and Technical Research Council
   of Turkey, TUBITAK (project #106S359). We thank Ms. R. Nelson for
   editing the English of the final version of our manuscript.
CR Altucci L, 2001, NAT REV CANCER, V1, P181, DOI 10.1038/35106036
   Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013
   Bertucci F, 2009, INT J CANCER, V124, P1338, DOI 10.1002/ijc.24055
   Bosch A, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3247
   Bray F, 2013, INT J CANCER, V132, P1133, DOI 10.1002/ijc.27711
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Chang BD, 1999, CANCER RES, V59, P3761
   Chang BD, 2000, P NATL ACAD SCI USA, V97, P4291, DOI 10.1073/pnas.97.8.4291
   Chen YH, 1999, BLOOD, V94, P251, DOI 10.1182/blood.V94.1.251.413k42_251_259
   Dimberg A, 2002, BLOOD, V99, P2199, DOI 10.1182/blood.V99.6.2199
   Dimri GP, 2005, CANCER CELL, V7, P505, DOI 10.1016/j.ccr.2005.05.025
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Eroles P, 2012, CANCER TREAT REV, V38, P698, DOI 10.1016/j.ctrv.2011.11.005
   Fontana JA, 2002, LEUKEMIA, V16, P463, DOI 10.1038/sj.leu.2402414
   Furmick JK, 2012, CHEMMEDCHEM, V7, P1551, DOI 10.1002/cmdc.201200319
   Garattini E, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3245
   García J, 2009, CHEMBIOCHEM, V10, P1252, DOI 10.1002/cbic.200900030
   Germain P, 2006, PHARMACOL REV, V58, P712, DOI 10.1124/pr.58.4.4
   Germain P, 2006, PHARMACOL REV, V58, P760, DOI 10.1124/pr.58.4.7
   Grosdidier A., 2011, J COMPUT CHEM
   Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366
   Gurkan AS, 2011, EUR J MED CHEM, V46, P468, DOI 10.1016/j.ejmech.2010.11.021
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   Hong Z, 2007, J CELL PHYSIOL, V210, P567, DOI 10.1002/jcp.20919
   Lange CA, 2011, ENDOCR-RELAT CANCER, V18, pC19, DOI 10.1530/ERC-11-0112
   Lim JS, 2011, BIOCHEM BIOPH RES CO, V412, P500, DOI 10.1016/j.bbrc.2011.07.130
   Mangiarotti R, 1998, BRIT J CANCER, V77, P186, DOI 10.1038/bjc.1998.32
   Mumcuoglu M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011288
   Ozturk N, 2006, P NATL ACAD SCI USA, V103, P2178, DOI 10.1073/pnas.0510877103
   Park SH, 2011, CANCER LETT, V310, P232, DOI 10.1016/j.canlet.2011.07.009
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Ross SA, 2000, PHYSIOL REV, V80, P1021, DOI 10.1152/physrev.2000.80.3.1021
   Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951
   SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107
   Smith MA, 2001, CLIN CANCER RES, V7, P2955
   Soprano DR, 2004, ANNU REV NUTR, V24, P201, DOI 10.1146/annurev.nutr.24.012003.132407
   Soprano KJ, 2006, ONCOGENE, V25, P5315, DOI 10.1038/sj.onc.1209679
   Tang XH, 2011, ANNU REV PATHOL-MECH, V6, P345, DOI 10.1146/annurev-pathol-011110-130303
   Tuncbilek M, 2012, J MED CHEM, V55, P3058, DOI 10.1021/jm3001532
   Wang LP, 2005, DEV GROWTH DIFFER, V47, P119
   Zanardi S, 2006, ENDOCR-RELAT CANCER, V13, P51, DOI 10.1677/erc.1.00938
   Zhu WY, 1997, EXP CELL RES, V234, P293, DOI 10.1006/excr.1997.3589
NR 42
TC 4
Z9 4
U1 0
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0039-128X
EI 1878-5867
J9 STEROIDS
JI Steroids
PD APR
PY 2016
VL 108
BP 31
EP 38
DI 10.1016/j.steroids.2016.02.008
PG 8
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA DI6ZK
UT WOS:000373648700004
PM 26898539
OA Green Published
DA 2024-02-19
ER

PT J
AU Suh, Y
AF Suh, Y
TI Cell signaling in aging and apoptosis
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE DNA damage; alkylating agents; apoptosis; cancer; aging;
   mitogen-activated protein kinase (MAPK)
ID ACTIVATED PROTEIN-KINASE; LIVER-REGENERATION; DIFFERENTIAL ACTIVATION;
   METHYL METHANESULFONATE; OLD MICE; STRESS; PATHWAY; DEATH; TRANSDUCTION;
   RESTRICTION
AB Alterations in apoptotic potential, due to perturbations in cell signaling cascades, could underlie age-related organ-specific cellular degeneration and death. While increased apoptosis could lead to cell loss, as in neuronal degeneration, loss of apoptosis competence might well result in the loss of phenotypic fidelity of somatic cells, which could explain to some extent, the age-related increase in cancer incidence. Results from our laboratory indicate that after subjecting young and old rats to genotoxic stress in the form of methyl methanesulfonate (MMS), an apoptotic response is quickly mounted in the liver of the young animals but virtually absent in the same organ of old animals (Nature Med. 8 (2002) 3). To address the possible molecular signaling defect(s) responsible for the age-related dysfunction of apoptosis in response to MMS, mitogen-activated protein kinases (MAPKs), extracellular signal-regulated kinases (ERKs), c-Jun NH2-terminal kinases (JNKs) and p38 MAPKs, were evaluated in the liver of young and old rats after MMS treatment. The results demonstrated distinct age-specific patterns of MMS-induced MAPKs activation, suggesting that the balance between cell survival and apoptosis after genotoxic stress may be impaired during aging. These results are discussed in terms of the relative importance in aging of biological redundancy, a concept put forward by the late Bernard Strehler, and cellular fidelity. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
C1 Seoul Natl Univ, Coll Med, Dept Biochem, Seoul 110799, South Korea.
   Seoul Natl Univ, Coll Med, Dept Biol Mol, Seoul 110799, South Korea.
   Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul 110799, South Korea.
C3 Seoul National University (SNU); Seoul National University (SNU); Seoul
   National University (SNU)
RP Suh, Y (corresponding author), Seoul Natl Univ, Coll Med, Dept Biochem, 28 Yongon Dong,Jongno Gu, Seoul 110799, South Korea.
EM suhys@plaza1.snu.ac.kr
CR Awad MM, 2000, J BIOL CHEM, V275, P38716, DOI 10.1074/jbc.M008040200
   BARR PJ, 1994, BIO-TECHNOL, V12, P487, DOI 10.1038/nbt0594-487
   Bronson R.T., 1990, GENETICS AGING, P280
   BRONSON RT, 1991, GROWTH DEVELOP AGING, V55, P169
   CHEN MH, 1996, HELICOBACTER, V1, P271
   Cobb MH, 1999, PROG BIOPHYS MOL BIO, V71, P479, DOI 10.1016/S0079-6107(98)00056-X
   CRADDOCK VM, 1979, CHEM-BIOL INTERACT, V27, P81, DOI 10.1016/0009-2797(79)90151-0
   DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694
   Diehl AM, 1996, FASEB J, V10, P215, DOI 10.1096/fasebj.10.2.8641555
   Dolle MET, 1997, NAT GENET, V17, P431, DOI 10.1038/ng1297-431
   Franceschi C, 1989, Aging (Milano), V1, P3
   Gaubatz JW, 1997, MUTAT RES-FUND MOL M, V375, P25, DOI 10.1016/S0027-5107(96)00246-1
   GRASLKRAUPP B, 1994, P NATL ACAD SCI USA, V91, P9995, DOI 10.1073/pnas.91.21.9995
   Hayakawa J, 1999, J BIOL CHEM, V274, P31648, DOI 10.1074/jbc.274.44.31648
   HURSTING SD, 1994, P NATL ACAD SCI USA, V91, P7036, DOI 10.1073/pnas.91.15.7036
   JAMES SJ, 1994, CANCER RES, V54, P5508
   Jarvis WD, 1999, J PHARMACOL EXP THER, V290, P1384
   Jarvis WD, 1998, MOL PHARMACOL, V54, P844, DOI 10.1124/mol.54.5.844
   Kanzler S, 2000, SEMIN CANCER BIOL, V10, P173, DOI 10.1006/scbi.2000.0318
   KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483
   KERR JFR, 1971, J PATHOL, V105, P13, DOI 10.1002/path.1711050103
   KHARBANDA S, 1995, NATURE, V376, P785, DOI 10.1038/376785a0
   Kharbanda S, 1995, J BIOL CHEM, V270, P30278, DOI 10.1074/jbc.270.51.30278
   Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390
   LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0
   LIU Y, 2001, HDB BIOL AGING, P179
   Liu ZG, 1996, NATURE, V384, P273, DOI 10.1038/384273a0
   Mattson MP, 2001, APOPTOSIS, V6, P69, DOI 10.1023/A:1009676112184
   MICHALOPOULOS G, 1992, LAB INVEST, V67, P413
   Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60
   Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6
   Osborn MT, 1996, J BIOL CHEM, V271, P30950, DOI 10.1074/jbc.271.48.30950
   Pandey P, 1996, J BIOL CHEM, V271, P23775, DOI 10.1074/jbc.271.39.23775
   Paul A, 1997, CELL SIGNAL, V9, P403, DOI 10.1016/S0898-6568(97)00042-9
   Price MA, 1996, EMBO J, V15, P6552, DOI 10.1002/j.1460-2075.1996.tb01046.x
   RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0
   Sánchez-Perez I, 1998, ONCOGENE, V16, P533, DOI 10.1038/sj.onc.1201578
   STREHLER BL, 1980, MECH AGEING DEV, V14, P15, DOI 10.1016/0047-6374(80)90103-7
   Suh Y, 2002, NAT MED, V8, P3, DOI 10.1038/nm0102-3
   Suh Y, 2001, MUTAT RES-GEN TOX EN, V497, P11, DOI 10.1016/S1383-5718(01)00207-8
   Suh YS, 2001, MECH AGEING DEV, V122, P1797, DOI 10.1016/S0047-6374(01)00301-3
   Suh YS, 2000, CANCER RES, V60, P5067
   Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0
   Talarmin H, 1999, MOL CELL BIOL, V19, P6003
   Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a
   Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0
   Vijg J, 2000, MUTAT RES-FUND MOL M, V447, P117, DOI 10.1016/S0027-5107(99)00202-X
   Warner HR, 1997, J AM GERIATR SOC, V45, P1140, DOI 10.1111/j.1532-5415.1997.tb05981.x
   WARNER HR, 1999, ANN NY ACAD SCI, V88, P1
   Wilhelm D, 1997, MOL CELL BIOL, V17, P4792, DOI 10.1128/MCB.17.8.4792
   XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326
   Zanke BW, 1996, CURR BIOL, V6, P606, DOI 10.1016/S0960-9822(02)00547-X
   Zhang YP, 2002, MECH AGEING DEV, V123, P245, DOI 10.1016/S0047-6374(01)00349-9
NR 53
TC 40
Z9 45
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD APR 30
PY 2002
VL 123
IS 8
BP 881
EP 890
AR PII S0047-6374(02)00025-8
DI 10.1016/S0047-6374(02)00025-8
PG 10
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 580MN
UT WOS:000177238500009
PM 12044936
DA 2024-02-19
ER

PT J
AU Hampl, V
   Martin, C
   Aigner, A
   Hoebel, S
   Singer, S
   Frank, N
   Sarikas, A
   Ebert, O
   Prywes, R
   Gudermann, T
   Muehlich, S
AF Hampl, Veronika
   Martin, Claudia
   Aigner, Achim
   Hoebel, Sabrina
   Singer, Stephan
   Frank, Natalie
   Sarikas, Antonio
   Ebert, Oliver
   Prywes, Ron
   Gudermann, Thomas
   Muehlich, Susanne
TI Depletion of the transcriptional coactivators megakaryoblastic leukaemia
   1 and 2 abolishes hepatocellular carcinoma xenograft growth by inducing
   oncogene-induced senescence
SO EMBO MOLECULAR MEDICINE
LA English
DT Article
DE DLC1; MKL1; MKL2; MRTF; senescence
ID SERUM RESPONSE FACTOR; TUMOR-SUPPRESSOR GENE; CELLULAR SENESCENCE;
   TERNARY COMPLEX; HETEROCHROMATIN FORMATION; ACTIN DYNAMICS; TARGET
   GENES; FACTOR SRF; IN-VIVO; CANCER
AB Megakaryoblastic leukaemia 1 and 2 (MKL1/2) are coactivators of the transcription factor serum response factor (SRF). Here, we provide evidence that depletion of MKL1 and 2 abolishes hepatocellular carcinoma (HCC) xenograft growth. Loss of the tumour suppressor deleted in liver cancer 1 (DLC1) and the subsequent activation of RhoA were prerequisites for MKL1/2 knockdown-mediated growth arrest. We identified oncogene-induced senescence as the molecular mechanism underlying the anti-proliferative effect of MKL1/2 knockdown. MKL1/2 depletion resulted in Ras activation, elevated p16 expression and hypophosphorylation of the retinoblastoma (Rb) protein in DLC1-deficient HCC cells. Interestingly, reconstitution of HuH7 HCC cells with DLC1 also induced senescence. Evaluation of the therapeutic efficacy of MKL1/2 knockdown in vivo revealed that systemic treatment of nude mice bearing HuH7 tumour xenografts with MKL1/2 siRNAs complexed with polyethylenimine (PEI) completely abolished tumour growth. The regression of the xenografts was associated with senescence. Importantly, PEI-complexed MKL1 siRNA alone was sufficient for complete abrogation of HCC xenograft growth. Thus, MKL1/2 represent promising novel therapeutic targets for the treatment of HCCs characterized by DLC1 loss.
C1 [Hampl, Veronika; Martin, Claudia; Frank, Natalie; Gudermann, Thomas; Muehlich, Susanne] Univ Munich, Walther Straub Inst Pharmacol & Toxicol, Munich, Germany.
   [Aigner, Achim; Hoebel, Sabrina] Univ Leipzig, Rudolf Boehm Inst Pharmacol & Toxicol, D-04109 Leipzig, Germany.
   [Singer, Stephan] Univ Heidelberg Hosp, Inst Pathol, Heidelberg, Germany.
   [Sarikas, Antonio] Tech Univ Munich, Inst Pharmacol & Toxicol, D-80290 Munich, Germany.
   [Ebert, Oliver] Tech Univ Munich, Klinikum Rechts Isar, Dept Med, D-80290 Munich, Germany.
   [Prywes, Ron] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.
C3 University of Munich; Leipzig University; Ruprecht Karls University
   Heidelberg; Technical University of Munich; Technical University of
   Munich; Columbia University
RP Muehlich, S (corresponding author), Univ Munich, Walther Straub Inst Pharmacol & Toxicol, Munich, Germany.
EM susanne.muehlich@lrz.uni-muenchen.de
RI Aigner, Achim/R-4429-2017
OI Aigner, Achim/0000-0002-2778-6256
FU German Research Foundation (DFG) [MU 2737/2-1]
FX The work was funded by grant MU 2737/2-1 from the German Research
   Foundation (DFG) to SM. We thank Prof. Darius Moradpour and Prof.
   Michael Nassal for the HuH7 and HepG2 Tet-off cells and Prof. Monilola
   Olayioye for the DLC1 vector.
CR Angstenberger M, 2007, GASTROENTEROLOGY, V133, P1948, DOI 10.1053/j.gastro.2007.08.078
   [Anonymous], 1989, MOL CLONING LAB MANU
   Braumüller H, 2013, NATURE, V494, P361, DOI 10.1038/nature11824
   Buchwalter G, 2004, GENE, V324, P1, DOI 10.1016/j.gene.2003.09.028
   Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399
   Cen B, 2003, MOL CELL BIOL, V23, P6597, DOI 10.1128/MCB.23.18.6597-6608.2003
   Chicas A, 2010, CANCER CELL, V17, P376, DOI 10.1016/j.ccr.2010.01.023
   ConnellCrowley L, 1997, MOL BIOL CELL, V8, P287, DOI 10.1091/mbc.8.2.287
   Demidenko ZN, 2009, CELL CYCLE, V8, P1896, DOI 10.4161/cc.8.12.8809
   Descot A, 2008, MOL CELL BIOL, V28, P6171, DOI 10.1128/MCB.00303-08
   Descot A, 2009, MOL CELL, V35, P291, DOI 10.1016/j.molcel.2009.07.015
   Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327
   El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061
   Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934
   HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0
   Höbel S, 2010, METHODS MOL BIOL, V623, P283, DOI 10.1007/978-1-60761-588-0_18
   Höbel S, 2010, J GENE MED, V12, P287, DOI 10.1002/jgm.1431
   HSU IC, 1993, CARCINOGENESIS, V14, P987, DOI 10.1093/carcin/14.5.987
   JOHANSEN FE, 1995, BBA-REV CANCER, V1242, P1, DOI 10.1016/0304-419X(94)00014-S
   Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560
   Lahoz A, 2008, GENE DEV, V22, P1724, DOI 10.1101/gad.1691408
   Larsson LG, 2011, SEMIN CANCER BIOL, V21, P367, DOI 10.1016/j.semcancer.2011.10.005
   Lee SM, 2010, J BIOL CHEM, V285, P22036, DOI 10.1074/jbc.M110.108878
   Li SJ, 2006, MOL CELL BIOL, V26, P5797, DOI 10.1128/MCB.00211-06
   Ma ZG, 2001, NAT GENET, V28, P220, DOI 10.1038/90054
   Medjkane S, 2009, NAT CELL BIOL, V11, P257, DOI 10.1038/ncb1833
   Mercher T, 2009, J CLIN INVEST, V119, P852, DOI 10.1172/JCI35901
   Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2
   Muehlich S, 2012, ONCOGENE, V31, P3913, DOI 10.1038/onc.2011.560
   Muehlich S, 2008, MOL CELL BIOL, V28, P6302, DOI 10.1128/MCB.00427-08
   Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X
   Narita M, 2006, CELL, V126, P503, DOI 10.1016/j.cell.2006.05.052
   NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0
   Oh JY, 2005, P NATL ACAD SCI USA, V102, P15122, DOI 10.1073/pnas.0507346102
   Ohtani Naoko, 2004, J Med Invest, V51, P146, DOI 10.2152/jmi.51.146
   Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890
   Pipes GCT, 2006, GENE DEV, V20, P1545, DOI 10.1101/gad.1428006
   Plentz RR, 2007, HEPATOLOGY, V45, P968, DOI 10.1002/hep.21552
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   SESHADRI T, 1990, SCIENCE, V247, P205, DOI 10.1126/science.2104680
   Shaw PE, 2003, INT J BIOCHEM CELL B, V35, P1210, DOI 10.1016/S1357-2725(03)00031-1
   SHAW PE, 1989, CELL, V56, P563, DOI 10.1016/0092-8674(89)90579-5
   Sun Y, 2006, MOL CELL BIOL, V26, P5809, DOI 10.1128/MCB.00024-06
   TAKEDA S, 1992, J BIOL CHEM, V267, P16957
   TREISMAN R, 1986, CELL, V46, P567, DOI 10.1016/0092-8674(86)90882-2
   Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084
   Werth D, 2010, EUR J CELL BIOL, V89, P216, DOI 10.1016/j.ejcb.2009.12.002
   Xue W, 2008, GENE DEV, V22, P1439, DOI 10.1101/gad.1672608
   Yuan BZ, 2007, EXP CELL RES, V313, P3868, DOI 10.1016/j.yexcr.2007.08.009
   Yuan BZ, 1998, CANCER RES, V58, P2196
   Yuan BZ, 2004, ONCOGENE, V23, P1405, DOI 10.1038/sj.onc.1207291
   Zhang T, 2009, CANCER LETT, V283, P59, DOI 10.1016/j.canlet.2009.03.025
   Zhou XL, 2004, ONCOGENE, V23, P1308, DOI 10.1038/sj.onc.1207246
NR 53
TC 42
Z9 44
U1 0
U2 6
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1757-4676
J9 EMBO MOL MED
JI EMBO Mol. Med.
PD SEP
PY 2013
VL 5
IS 9
BP 1367
EP 1382
DI 10.1002/emmm.201202406
PG 16
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA 209TN
UT WOS:000323783000008
PM 23853104
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Liu, P
   Hu, YA
   Guo, DH
   Lu, BR
   Rahman, K
   Mu, LH
   Wang, DX
AF Liu, Ping
   Hu, Yuan
   Guo, Dai-Hong
   Lu, Bao-Rong
   Rahman, Khalid
   Mu, Li-Hua
   Wang, Dong-Xiao
TI Antioxidant activity of oligosaccharide ester extracted from <i>Polygala
   tenuifolia</i> roots in senescence-accelerated mice
SO PHARMACEUTICAL BIOLOGY
LA English
DT Article
DE Accelerated senescence-prone mouse; antioxidant activity; glutathione
   peroxidase; oligosaccharide ester; malondialdehyde; superoxide dismutase
ID PERFORMANCE; PEROXIDE; TISSUE; MOUSE; ASSAY; ACID
AB The constituents of the ethanol extract from the root of Polygala tenuifolia Willd. (Polygalaceae) were investigated for antioxidant activity in senescence-accelerated mice. Consequently, two relevant samples were obtained, a fraction separated by macroporous resin (YZ-OE), and a major pure crystal of 3,6'-disinapoyl sucrose (DISS). Based on HPLC-ESI-MS analysis, the most constituents in the YZ-OE fraction from the extract of P. tenuifolia were oligosaccharide esters. The antioxidant activities of these two samples were evaluated using the accelerated senescence-prone, short-lived mice (SAMP) in vivo. The activities of superoxide dismutase (SOD) and glutathione peroxidase (GSH-PX) were increased significantly in SAMP mice fed oligosaccharide esters (YZ-OE 50 mg/kg) and its constituents (DISS 50 mg/kg). However, the content of malondialdehyde (MDA) was increased in the blood and liver of SAMP mice. But when given YZ-OE, it could be decreased, by 44.3% and 47.5%, respectively, compared with the SAMP model. Results from the analyses indicated that the oligosaccharide esters (YZ-OE) from roots of P. tenuifolia had a high in vivo antioxidant activity.
C1 [Liu, Ping; Hu, Yuan; Guo, Dai-Hong; Mu, Li-Hua; Wang, Dong-Xiao] Chinese Peoples Liberat Army Gen Hosp, Pharm Care Ctr, Dept Clin Pharmacol, Beijing 100853, Peoples R China.
   [Lu, Bao-Rong] Fudan Univ, Inst Biodivers Sci, Minist Educ Key Lab Biodivers Sci & Ecol Engn, Shanghai 200433, Peoples R China.
   [Rahman, Khalid] Liverpool John Moores Univ, Sch Biomol Sci, Fac Sci, Liverpool L3 5UX, Merseyside, England.
C3 Chinese People's Liberation Army General Hospital; Fudan University;
   Liverpool John Moores University
RP Hu, YA (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Pharm Care Ctr, Dept Clin Pharmacol, 28 Fuxing Rd, Beijing 100853, Peoples R China.
EM huyuan1980619@126.com; brlu@fudan.edu.cn
RI hu, yuan/HTL-4197-2023; Hu, Yuan/G-5244-2011; Lu, Bao-Rong/C-3130-2009;
   Wang, dongxiao/GPZ-7141-2022
OI Lu, Bao-Rong/0000-0002-0214-2390; 
FU National Natural Science Foundation of China [30801524, 90209036]
FX This research was supported by the National Natural Science Foundation
   of China ( grant no. 30801524 and no. 90209036).
CR Arivazhagan P, 2000, J NUTR BIOCHEM, V11, P122, DOI 10.1016/S0955-2863(99)00079-0
   Cheung LM, 2003, FOOD CHEM, V81, P249, DOI 10.1016/S0308-8146(02)00419-3
   FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533
   Girotti A W, 1985, J Free Radic Biol Med, V1, P87
   [Institute of Laboratory Animal Research Commission on Life Sciences National Research Council], 1996, GUID CAR US LAB AN
   Kim HM, 1998, J ETHNOPHARMACOL, V61, P201, DOI 10.1016/S0378-8741(98)00040-3
   Li L, 2005, LIFE SCI, V77, P230, DOI 10.1016/j.lfs.2004.12.024
   Liu P, 2008, CHINESE PHARM J, P1391
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MASANORI H, 2002, MECH AGEING DEV, V123, P1553
   MISRA HP, 1972, J BIOL CHEM, V247, P3170
   *NIH, 1985, PRINCIPLES LAB ANIMA, V8623
   NISHIYAMA N, 1994, BIOL PHARM BULL, V17, P1481, DOI 10.1248/bpb.17.1481
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   Park CH, 2002, J NEUROSCI RES, V70, P484, DOI 10.1002/jnr.10429
   PICCOLI G, 1994, J CHROMATOGR A, V676, P239, DOI 10.1016/0021-9673(94)80465-6
   TAMURA M, 1982, J BIOCHEM-TOKYO, V92, P1019, DOI 10.1093/oxfordjournals.jbchem.a134017
   Tu Hai-Hua, 2008, Zhongguo Zhong Yao Za Zhi, V33, P1278
   Wickens AP, 2001, RESP PHYSIOL, V128, P379, DOI 10.1016/S0034-5687(01)00313-9
   Zheng XY, 2000, PHARMACOPOEIA PEOPLE, P297
NR 20
TC 25
Z9 32
U1 5
U2 32
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1388-0209
EI 1744-5116
J9 PHARM BIOL
JI Pharm. Biol.
PD JUL
PY 2010
VL 48
IS 7
BP 828
EP 833
DI 10.3109/13880200903283707
PG 6
WC Plant Sciences; Medical Laboratory Technology; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Plant Sciences; Medical Laboratory Technology; Pharmacology & Pharmacy
GA 620LZ
UT WOS:000279502700017
PM 20645784
OA Bronze
DA 2024-02-19
ER

PT J
AU Xu, JZ
   Zhou, YM
   Zhang, LL
   Chen, XJ
   Yang, YY
   Zhang, D
   Zhu, KC
   Kong, XK
   Sun, LH
   Tao, B
   Zhao, HY
   Liu, JM
AF Xu, Jing-zun
   Zhou, Yan-man
   Zhang, Lin-lin
   Chen, Xiao-jing
   Yang, Yu-ying
   Zhang, Deng
   Zhu, Ke-cheng
   Kong, Xiao-ke
   Sun, Li-hao
   Tao, Bei
   Zhao, Hong-yan
   Liu, Jian-min
TI BMP9 reduces age-related bone loss in mice by inhibiting osteoblast
   senescence through Smad1-Stat1-P21 axis
SO CELL DEATH DISCOVERY
LA English
DT Article
ID DEFICIENCY-INDUCED OSTEOPOROSIS; CELLULAR SENESCENCE; OXIDATIVE STRESS;
   CELLS; DIFFERENTIATION; MECHANISMS; MITOPHAGY; PROMOTES; PATHWAY;
   PROTEIN
AB Age-related osteoporosis is characterized by the accumulation of senescent osteoblastic cells in bone microenvironment and significantly reduced osteogenic differentiation. Clearing of the senescent cells is helpful to improve bone formation in aged mice. Bone morphogenetic protein 9 (BMP9), a multifunctional protein produced and secreted by liver, was reported to improve osteoporosis caused by estrogen withdrawal. However, the mechanism of BMP9 has not been fully elucidated, and its effect on senile osteoporosis has not been reported. This study reveals that BMP9 significantly increases bone mass and improves bone biomechanical properties in aged mice. Furthermore, BMP9 reduces expression of senescent genes in bone microenvironment, accompanied by decreased senescence-associated secretory phenotypes (SASPs) such as Cc15, Mmp9, Hmgb1, Nfkb1, and Vcam1. In vitro, Bmp9 treatment inhibits osteoblast senescence through activating Smad1, which suppresses the transcriptional activity of Stat1, thereby inhibits P21 expression and SASPs production. Furthermore, inhibiting the Smad1 signal in vivo can reverse the inhibitory effect of BMP9 on Stat1 and downstream senescent genes, which eliminates the protection of BMP9 on age-related osteoporosis. These findings highlight the critical role of BMP9 on reducing age-related bone loss by inhibiting osteoblast senescence through Smad1-Stat1-P21 axis.
C1 [Xu, Jing-zun; Zhou, Yan-man; Zhang, Lin-lin; Chen, Xiao-jing; Yang, Yu-ying; Zhang, Deng; Zhu, Ke-cheng; Kong, Xiao-ke; Sun, Li-hao; Tao, Bei; Zhao, Hong-yan; Liu, Jian-min] Shanghai Jiao Tong Univ, Ruijin Hosp, Shanghai Inst Endocrine & Metab Dis, Dept Endocrine & Metab Dis,Sch Med, Shanghai, Peoples R China.
   [Xu, Jing-zun; Zhou, Yan-man; Zhang, Lin-lin; Chen, Xiao-jing; Yang, Yu-ying; Zhang, Deng; Zhu, Ke-cheng; Kong, Xiao-ke; Sun, Li-hao; Tao, Bei; Zhao, Hong-yan; Liu, Jian-min] Shanghai Jiao Tong Univ, Shanghai Natl Clin Res Ctr Metab Dis, Natl Hlth Commiss PR China,Ruijin Hosp,Sch Med,St, Shanghai Key Lab Endocrine Tumor,Key Lab Endocrin, Shanghai, Peoples R China.
   [Zhou, Yan-man] Shandong First Med Univ, Dept Nephrol, Prov Hosp, Jinan, Shandong, Peoples R China.
C3 Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shandong
   First Medical University & Shandong Academy of Medical Sciences
RP Zhao, HY; Liu, JM (corresponding author), Shanghai Jiao Tong Univ, Ruijin Hosp, Shanghai Inst Endocrine & Metab Dis, Dept Endocrine & Metab Dis,Sch Med, Shanghai, Peoples R China.; Zhao, HY; Liu, JM (corresponding author), Shanghai Jiao Tong Univ, Shanghai Natl Clin Res Ctr Metab Dis, Natl Hlth Commiss PR China,Ruijin Hosp,Sch Med,St, Shanghai Key Lab Endocrine Tumor,Key Lab Endocrin, Shanghai, Peoples R China.
EM hyanzhao@163.com; ljm10586@rjh.com.cn
OI Yang, Yu-Ying/0000-0001-5167-3262
FU National Natural Science Foundation of China [81970758, 82070865]
FX This work was supported by the National Natural Science Foundation of
   China (NO. 81970758, 82070865).
CR Bouvard C, 2022, CARDIOVASC RES, V118, P1805, DOI 10.1093/cvr/cvab187
   Chai PW, 2021, CLIN TRANSL MED, V11, DOI 10.1002/ctm2.271
   Chandra A, 2020, J BONE MINER RES, V35, P1119, DOI 10.1002/jbmr.3978
   Chen XJ, 2017, ACTA BIOCH BIOPH SIN, V49, P867, DOI 10.1093/abbs/gmx087
   Childs BG, 2015, NAT MED, V21, P1424, DOI 10.1038/nm.4000
   Choi DH, 2020, STEM CELL RES THER, V11, DOI 10.1186/s13287-020-01860-y
   Cohen Katsenelson Ksenya, 2019, Elife, V8, DOI 10.7554/eLife.48609
   Colaianni G, 2021, J BONE MINER RES, V36, P305, DOI 10.1002/jbmr.4192
   Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805
   Farr JN, 2019, J BONE MINER RES, V34, P1407, DOI 10.1002/jbmr.3729
   Farr JN, 2019, BONE, V121, P121, DOI 10.1016/j.bone.2019.01.015
   Farr JN, 2017, NAT MED, V23, P1072, DOI 10.1038/nm.4385
   Farr JN, 2016, J BONE MINER RES, V31, P1920, DOI 10.1002/jbmr.2892
   Gao L, 2021, ACS CHEM NEUROSCI, V12, P2320, DOI 10.1021/acschemneuro.1c00024
   Geng QH, 2019, INT J BIOL SCI, V15, P58, DOI 10.7150/ijbs.25783
   Guo YY, 2021, REDOX BIOL, V41, DOI 10.1016/j.redox.2021.101915
   Jain S, 2021, ENDOCRIN METAB CLIN, V50, P223, DOI 10.1016/j.ecl.2021.03.007
   Jiao SM, 2012, MOL CELL BIOCHEM, V365, P9, DOI 10.1007/s11010-011-1197-3
   Khosla S, 2018, J CLIN ENDOCR METAB, V103, P1282, DOI 10.1210/jc.2017-02694
   Kim HN, 2019, AGING CELL, V18, DOI 10.1111/acel.12923
   Kim J, 2015, ARTERIOSCL THROM VAS, V35, P2020, DOI 10.1161/ATVBAHA.115.306142
   Kua HY, 2012, NAT CELL BIOL, V14, P727, DOI 10.1038/ncb2528
   Lee K, 2016, BBA-GEN SUBJECTS, V1860, P2416, DOI 10.1016/j.bbagen.2016.07.009
   Leyton-Jaimes MF, 2019, P NATL ACAD SCI USA, V116, P14755, DOI 10.1073/pnas.1904665116
   Li J, 2020, AM J TRANSL RES, V12, P672
   Liang C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05974-z
   Liu CW, 2016, FREE RADICAL BIO MED, V95, P180, DOI 10.1016/j.freeradbiomed.2016.03.019
   Liu F, 2021, REDOX BIOL, V43, DOI 10.1016/j.redox.2021.101963
   Lynch RA, 2007, CANCER RES, V67, P1254, DOI 10.1158/0008-5472.CAN-06-2439
   Madani AY, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10020334
   Marie PJ, 2014, J BONE MINER RES, V29, P1311, DOI 10.1002/jbmr.2190
   Mijit M, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10030420
   Napione L, 2012, ANGIOGENESIS, V15, P713, DOI 10.1007/s10456-012-9286-9
   Nickel J, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8121579
   Novais EJ, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-25453-2
   Piemontese M, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93771
   Qadir A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21010349
   Ruiz AR, 2022, RHEUMATOLOGY, V61, P856, DOI 10.1093/rheumatology/keab440
   Sakunrangsit N, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-98108-3
   Shahbandi A, 2020, CELL DEATH DIFFER, V27, P3097, DOI 10.1038/s41418-020-0564-6
   Shen L, 2020, CANCER LETT, V472, P40, DOI 10.1016/j.canlet.2019.12.013
   SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191
   Suzuki R, 2020, J BONE MINER RES, V35, P1992, DOI 10.1002/jbmr.4053
   van Caam A, 2016, OSTEOARTHR CARTILAGE, V24, P1235, DOI 10.1016/j.joca.2016.02.008
   Vincent E, 2020, DEVELOPMENT, V147, DOI 10.1242/dev.170829
   Wang X, 2017, MOL MED REP, V15, P2537, DOI 10.3892/mmr.2017.6302
   Warren DT, 2015, CELL DEATH DIFFER, V22, P1540, DOI 10.1038/cdd.2015.12
   Wiese DM, 2019, STEM CELL TRANSL MED, V8, P945, DOI 10.1002/sctm.18-0246
   Xu C, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abf5089
   Yang J, 2018, CANCER SCI, V109, P3115, DOI 10.1111/cas.13640
   Yu B, 2016, TRENDS MOL MED, V22, P641, DOI 10.1016/j.molmed.2016.06.002
   Zhao X, 2021, AM J TRANSL RES, V13, P4233
   Zhou YM, 2020, J BONE MINER RES, V35, P978, DOI 10.1002/jbmr.3957
NR 53
TC 4
Z9 4
U1 3
U2 19
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
EI 2058-7716
J9 CELL DEATH DISCOV
JI Cell Death Discov.
PD MAY 6
PY 2022
VL 8
IS 1
AR 254
DI 10.1038/s41420-022-01048-8
PG 14
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 1A5MA
UT WOS:000791799400004
PM 35523787
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Palazzo, A
   Hernandez-Vargas, H
   Goehrig, D
   Médard, JJ
   Vindrieux, D
   Flaman, JM
   Bernard, D
AF Palazzo, Alberta
   Hernandez-Vargas, Hector
   Goehrig, Delphine
   Medard, Jean-Jacques
   Vindrieux, David
   Flaman, Jean-Michel
   Bernard, David
TI Transformed cells after senescence give rise to more severe tumor
   phenotypes than transformed non-senescent cells
SO CANCER LETTERS
LA English
DT Article; Early Access
DE Cellular senescence; RAS oncogene; p53 tumor suppressor; Tumor
   aggressiveness
ID CANCER; SURVEILLANCE; P53
AB Oncogenic stress-induced senescence initially inhibits tumor initiation by blocking proliferation and by attracting immune cells to clear potentially harmful cells. If these cells are not eliminated they may resume proliferation upon loss-of-tumor suppressors, and be at risk of transformation. During tumor formation, depending on the sequence of events of gain-of-oncogenes and/or loss-of-tumor suppressors, cancer cells may emerge from se-nescent cells. Here, we show that these transformed cells after senescence (TS) display more aggressive tumorigenic features, with a greater capacity to migrate and a higher resistance to anti-tumoral drugs than cells having undergone transformation without senescence. Bulk transcriptomic analysis and single cell RNA sequencing revealed a signature unique to TS cells. A score of this signature was then generated and a high score was correlated with decreased survival of patients with lung adenocarcinoma, head-neck squamous cell carci-noma, adrenocortical carcinoma, liver hepatocellular carcinoma, skin cutaneous melanoma and low-grade gli-oma. Together, these findings strongly support that cancer cells arising from senescent cells are more dangerous, and that a molecular signature of these cells may be of prognostic value for some human cancers. It also raises questions about modeling human tumors, using cells or mice, without regards to the sequence of events leading to transformation.
C1 [Palazzo, Alberta; Hernandez-Vargas, Hector; Goehrig, Delphine; Medard, Jean-Jacques; Vindrieux, David; Flaman, Jean-Michel; Bernard, David] Univ Lyon, Ctr Rech Cancerol Lyon, Inserm U1052, Ctr Leon Berard,CNRS UMR 5286, Lyon, France.
C3 UNICANCER; Centre Leon Berard; Centre National de la Recherche
   Scientifique (CNRS); CNRS - National Institute for Biology (INSB);
   Universite Claude Bernard Lyon 1; Institut National de la Sante et de la
   Recherche Medicale (Inserm)
RP Flaman, JM; Bernard, D (corresponding author), Univ Lyon, Ctr Rech Cancerol Lyon, Inserm U1052, Ctr Leon Berard,CNRS UMR 5286, Lyon, France.
EM jean-michel.flaman@lyon.unicancer.fr; david.bernard@lyon.unicancer.fr
RI Bernard, David/D-6265-2018
OI Bernard, David/0000-0002-1557-2074; flaman,
   jean-michel/0000-0003-3544-0199
FU Fondation ARC pour la recherche sur le cancer [PJA 20181208136]; la
   Ligue regionale contre le cancer, comite de la Soane et Loire; Fondation
   pour la Recherche Medicale FRM
FX We thank the laboratory members, Nicolas Aznar and Gabriel Ichim for
   helpful discussions. We thank Brigitte Manship for critical reading of
   the manuscript. This work was carried out with the support of the
   Fondation ARC pour la recherche sur le cancer (PJA 20181208136) to DB,
   la Ligue regionale contre le cancer, comite de la Soane et Loire, to JMF
   and by the Fondation pour la Recherche Medicale FRM to AP.
CR Alimirah F, 2020, CANCER RES, V80, P3606, DOI 10.1158/0008-5472.CAN-20-0108
   Amstad PA, 1997, MOL CARCINOGEN, V20, P231, DOI 10.1002/(SICI)1098-2744(199710)20:2<231::AID-MC10>3.0.CO;2-B
   Azazmeh N, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16475-3
   Beauséjour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417
   Bernard D, 2018, NAT REV MOL CELL BIO, V19, P618, DOI 10.1038/s41580-018-0042-x
   Berthenet K, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107731
   Colaprico A, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1507
   Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a
   Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191
   Deschênes-Simard X, 2013, GENE DEV, V27, P900, DOI 10.1101/gad.203984.112
   Eggert T, 2016, CANCER CELL, V30, P533, DOI 10.1016/j.ccell.2016.09.003
   Foroutan M, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2435-4
   Hahn WC., 2002, NEW ENGL J MED, V347, P1593, DOI [DOI 10.1056/NEJMRA021902, 10.1056/NEJMra021902]
   Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013
   Herbet M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002700
   Hu L, 2022, FRONT CELL DEV BIOL, V10, DOI 10.3389/fcell.2022.822816
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377
   LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0
   Lüönd F, 2021, BRIT J CANCER, V125, P164, DOI 10.1038/s41416-021-01328-7
   Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890
   Milanovic M, 2018, NATURE, V553, P96, DOI 10.1038/nature25167
   Mosteiro L, 2016, SCIENCE, V354, DOI 10.1126/science.aaf4445
   Nassour J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10399
   Payea MJ, 2021, MOL CELL BIOL, V41, DOI 10.1128/MCB.00512-20
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   Silva Tiago C, 2016, F1000Res, V5, P1542, DOI 10.12688/f1000research.8923.2
   Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031
   Sun Y, 2018, TRENDS MOL MED, V24, P871, DOI 10.1016/j.molmed.2018.08.002
   Takasugi M, 2023, FEBS J, V290, P1348, DOI 10.1111/febs.16381
   Ulgen E, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00858
   WEINBERG RA, 1989, CANCER RES, V49, P3713
NR 35
TC 3
Z9 3
U1 1
U2 2
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0304-3835
EI 1872-7980
J9 CANCER LETT
JI Cancer Lett.
PD 2022 OCT 10
PY 2022
VL 546
AR 215850
DI 10.1016/j.canlet.2022.215850
EA AUG 2022
PG 10
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA 4Y2LX
UT WOS:000861362800002
PM 35926818
OA Green Submitted, hybrid
DA 2024-02-19
ER

PT J
AU Cherif, H
   Tarry, JL
   Ozanne, SE
   Hales, CN
AF Cherif, H
   Tarry, JL
   Ozanne, SE
   Hales, CN
TI Ageing and telomeres: a study into organ- and gender-specific telomere
   shortening
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID PULSE PRESSURE; CELLS; LENGTH; EXPRESSION; GROWTH; MICE; REPLICATION;
   EPITHELIUM; REDUCTION; CARCINOMA
AB Telomeres, the non-coding sequences at the ends of chromosomes, in the absence of telomerase, progressively shorten with each cell division. Shortening of telomeres can induce cell cycle arrest and apoptosis. The aim of this study was to investigate age- and gender-related changes in telomere length in the rat and to detect possible tissue- specific rates of telomere shortening. Changes with age in telomere lengths were assessed by Southern blotting in the kidney, pancreas, liver, lung and brain of male and female rats. We determined the percentage of telomeres in various molecular size regions rather than measuring the average telomere length. The latter was unable to detect telomere shortening in the tissues. The percentage of short telomeres increased with age in the kidney, liver, pancreas and lung of both males and females, but not in the brain. Males had shorter telomeres than females in all organs analysed except the brain, where the lengths were similar. These findings indicate that telomeres shorten in the rat kidney, liver, pancreas and the lung in an age-dependent manner. These data also provide a novel mechanism for the gender-related differences in lifespan and suggest a tissue-specific regulation of telomere length during development and ageing in the rat.
C1 Univ Cambridge, Addenbrookes Hosp, Dept Clin Biochem, Cambridge CB2 2QR, England.
C3 Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's
   Hospital; University of Cambridge
RP Cherif, H (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Clin Biochem, Box 232,Hills Rd, Cambridge CB2 2QR, England.
EM hc248@cam.ac.uk
OI Ozanne, Susan/0000-0001-8753-5144
FU Wellcome Trust Funding Source: Medline
CR Aikata H, 2000, EXP CELL RES, V256, P578, DOI 10.1006/excr.2000.4862
   [Anonymous], TELOMERES TELOMERASE
   Artandi SE, 2000, NAT MED, V6, P852, DOI 10.1038/78595
   Benetos A, 2001, HYPERTENSION, V37, P381, DOI 10.1161/01.HYP.37.2.381
   Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4
   Blasco Maria A., 1999, Genes and Development, V13, P2353, DOI 10.1101/gad.13.18.2353
   BROCCOLI D, 1995, P NATL ACAD SCI USA, V92, P9082, DOI 10.1073/pnas.92.20.9082
   BROWN WRA, 1989, NATURE, V338, P774, DOI 10.1038/338774a0
   Campisi J, 1996, EXP GERONTOL, V31, P7, DOI 10.1016/0531-5565(95)02024-1
   CHEN Q, 1994, P NATL ACAD SCI USA, V91, P4130, DOI 10.1073/pnas.91.10.4130
   COUNTER CM, 1994, P NATL ACAD SCI USA, V91, P2900, DOI 10.1073/pnas.91.8.2900
   DELANGE T, 1990, MOL CELL BIOL, V10, P518, DOI 10.1128/MCB.10.2.518
   Dunham MA, 2000, NAT GENET, V26, P447, DOI 10.1038/82586
   Franceschi C, 2000, AGING-CLIN EXP RES, V12, P77, DOI 10.1007/BF03339894
   GINA M, 1997, NUCLEIC ACIDS RES, V25, P3051
   Golubovskaya VM, 1999, MOL CARCINOGEN, V24, P209, DOI 10.1002/(SICI)1098-2744(199903)24:3<209::AID-MC7>3.0.CO;2-F
   GREIDER CW, 1994, CURR OPIN GENET DEV, V4, P203, DOI 10.1016/S0959-437X(05)80046-2
   GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9
   Guralnik JM, 2000, AGING CLIN EXP RES, V12, P65, DOI 10.1007/BF03339893
   Hales CN, 1996, BIOCHEM SOC T, V24, P341, DOI 10.1042/bst0240341
   HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0
   HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0
   Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9
   Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950
   Jeanclos E, 2000, HYPERTENSION, V36, P195, DOI 10.1161/01.HYP.36.2.195
   Jennings BJ, 1999, FEBS LETT, V448, P4, DOI 10.1016/S0014-5793(99)00336-1
   Kajstura J, 2000, AM J PATHOL, V156, P813, DOI 10.1016/S0002-9440(10)64949-8
   KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428
   KIPLING D, 1990, NATURE, V347, P400, DOI 10.1038/347400a0
   Kyo S, 1999, CANCER RES, V59, P5917
   LEBLOND C. P., 1964, NAT CANCER INST MONOGR, V14, P119
   Melk A, 2000, J AM SOC NEPHROL, V11, P444, DOI 10.1681/ASN.V113444
   MEYNE J, 1989, P NATL ACAD SCI USA, V86, P7049, DOI 10.1073/pnas.86.18.7049
   Misiti S, 2000, MOL CELL BIOL, V20, P3764, DOI 10.1128/MCB.20.11.3764-3771.2000
   Pendergrass WR, 2001, EXP EYE RES, V73, P221, DOI 10.1006/exer.2001.1033
   PROWSE KR, 1995, P NATL ACAD SCI USA, V92, P4818, DOI 10.1073/pnas.92.11.4818
   Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2
   SLAGBOOM PE, 1994, AM J HUM GENET, V55, P876
   Son NH, 2000, J IMMUNOL, V165, P1191, DOI 10.4049/jimmunol.165.3.1191
   Takubo K, 2001, Nihon Shokakibyo Gakkai Zasshi, V98, P144
   Varon D, 1997, CANCER RES, V57, P5605
   Yamaguchi Y, 1998, EXP CELL RES, V242, P120, DOI 10.1006/excr.1998.4102
   YU GL, 1990, NATURE, V344, P126, DOI 10.1038/344126a0
   Zakian VA, 1996, ANNU REV GENET, V30, P141, DOI 10.1146/annurev.genet.30.1.141
   Zijlmans JMJM, 1997, P NATL ACAD SCI USA, V94, P7423, DOI 10.1073/pnas.94.14.7423
NR 45
TC 182
Z9 217
U1 1
U2 33
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD MAR 1
PY 2003
VL 31
IS 5
BP 1576
EP 1583
DI 10.1093/nar/gkg208
PG 8
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 652WU
UT WOS:000181404500024
PM 12595567
OA Bronze, Green Published
DA 2024-02-19
ER

PT J
AU Rodriguez, KA
   Gaczynska, M
   Osmulski, PA
AF Rodriguez, Karl A.
   Gaczynska, Maria
   Osmulski, Pawel A.
TI Molecular mechanisms of proteasome plasticity in aging
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE Proteasome; Aging; Mouse; Liver; Compartmentalization
ID MULTICATALYTIC PROTEINASE COMPLEX; RAT-LIVER; DEGRADATION; EXPRESSION;
   INHIBITORS; CELLS; VISUALIZATION; LOCALIZATION; RESTRICTION; YEAST
AB The ubiquitin-proteasome pathway plays a crucial role in regulation of intracellular protein turnover. Proteasome, the central protease of the pathway, encompasses multi-subunit assemblies sharing a common catalytic core supplemented by regulatory modules and localizing to different subcellular compartments. To better comprehend age-related functions of the proteasome we surveyed content, composition and catalytic properties of the enzyme in cytosolic, microsomal and nuclear fractions obtained from mouse livers subjected to organismal aging. We found that during aging subunit composition and subcellular distribution of proteasomes changed without substantial alterations in the total level of core complexes. We observed that the general decline in proteasomes functions was limited to nuclear and cytosolic compartments. Surprisingly, the observed changes in activity and specificity were linked to the amount of the activator module and distinct composition of the catalytic subunits. In contrast, activity, specificity and composition of the microsomal-associated proteasomes remained mostly unaffected by aging; however their relative contribution to the total activity was substantially elevated. Unexpectedly, the nuclear proteasomes were affected most profoundly by aging possibly triggering significant changes in cellular signaling and transcription. Collectively, the data indicate an age-related refocusing of proteasome from the compartment-specific functions towards general protein maintenance. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
C1 [Rodriguez, Karl A.; Gaczynska, Maria; Osmulski, Pawel A.] Univ Texas Hlth Sci Ctr San Antonio, Inst Biotechnol, Dept Mol Med, San Antonio, TX 78245 USA.
C3 University of Texas System; University of Texas Health Science Center at
   San Antonio
RP Gaczynska, M (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Inst Biotechnol, Dept Mol Med, 15355 Lambda Dr, San Antonio, TX 78245 USA.
EM osmulski@uthsca.edu
RI Rodriguez, Karl A/F-2689-2012; Osmulski, Pawel/C-7751-2019
OI Osmulski, Pawel/0000-0002-5359-9200
FU NIA [T32 AG021890, P30 AG13319, R36 AG033401, R03 AG021267]
FX The work was supported by NIA grants T32 AG021890 and P30 AG13319, as
   well as R36 AG033401 (KR) and R03 AG021267 (MG). We also thank the Sam
   and Ann Barshop Institute for Longevity and Aging Studies, and
   especially Dr. Arlan Richardson and Dr. Walter Ward, for continuous
   support and inspiration.
CR Anselmi B, 1998, J GERONTOL A-BIOL, V53, pB173, DOI 10.1093/gerona/53A.3.B173
   Arcangeletti C, 1997, J STRUCT BIOL, V119, P35, DOI 10.1006/jsbi.1997.3871
   Arendt CS, 1997, P NATL ACAD SCI USA, V94, P7156, DOI 10.1073/pnas.94.14.7156
   ARIZTI P, 1993, ENZYME PROTEIN, V47, P285, DOI 10.1159/000468686
   BIRCHENALLSPARKS MC, 1985, MECH AGEING DEV, V32, P99, DOI 10.1016/0047-6374(85)90039-9
   Breusing N, 2009, MECH AGEING DEV, V130, P748, DOI 10.1016/j.mad.2009.09.004
   Conconi M, 1997, MOL BIOL REP, V24, P45, DOI 10.1023/A:1006852506884
   Dahlmann B, 2000, J MOL BIOL, V303, P643, DOI 10.1006/jmbi.2000.4185
   Dasuri K, 2009, MECH AGEING DEV, V130, P777, DOI 10.1016/j.mad.2009.10.003
   de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078
   DESA MFG, 1988, J CELL SCI, V89, P151
   Drews O, 2007, PROTEOMICS, V7, P1047, DOI 10.1002/pmic.200600574
   Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863
   El-Khodor BF, 2001, DEV BRAIN RES, V129, P47, DOI 10.1016/S0165-3806(01)00181-X
   Elsasser S, 2005, METHOD ENZYMOL, V398, P353, DOI 10.1016/S0076-6879(05)98029-4
   Enenkel C, 1998, EMBO J, V17, P6144, DOI 10.1093/emboj/17.21.6144
   Ferrington DA, 2005, FASEB J, V19, P664, DOI 10.1096/fj.04-2578fje
   Gaczynska M, 2005, METHOD ENZYMOL, V398, P425, DOI 10.1016/S0076-6879(05)98035-X
   Gaczynska M, 2001, MECH AGEING DEV, V122, P235, DOI 10.1016/S0047-6374(00)00246-3
   Gaczynska Maria, 2005, V301, P3
   Gao XL, 2004, ARCH BIOCHEM BIOPHYS, V425, P158, DOI 10.1016/j.abb.2004.03.021
   Gavilán MP, 2009, J NEUROCHEM, V108, P260, DOI 10.1111/j.1471-4159.2008.05762.x
   Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001
   Groll M, 2005, CHEMBIOCHEM, V6, P222, DOI 10.1002/cbic.200400313
   Hanna J, 2007, FEBS LETT, V581, P2854, DOI 10.1016/j.febslet.2007.03.053
   Hayashi T, 1998, MECH AGEING DEV, V102, P55, DOI 10.1016/S0047-6374(98)00011-6
   Jung T, 2008, IUBMB LIFE, V60, P743, DOI 10.1002/iub.114
   Kisselev AF, 2006, J BIOL CHEM, V281, P8582, DOI 10.1074/jbc.M509043200
   Klare N, 2007, J MOL BIOL, V373, P1, DOI 10.1016/j.jmb.2007.07.038
   Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390
   LEWIS SEM, 1985, EXP GERONTOL, V20, P253, DOI 10.1016/0531-5565(85)90050-6
   Liu JB, 2006, FASEB J, V20, P362, DOI 10.1096/fj.05-4869fje
   Matiuhin Y, 2008, MOL CELL, V32, P415, DOI 10.1016/j.molcel.2008.10.011
   McCracken AA, 2005, CURR TOP MICROBIOL, V300, P17
   *MILL CORP, 2005, COMP PROT EXTR KIT P
   MILLER AE, 1980, ENDOCRINOLOGY, V106, P1579, DOI 10.1210/endo-106-5-1579
   PAL JK, 1988, J CELL SCI, V90, P555
   Palmer A, 1996, BIOCHEM J, V316, P401, DOI 10.1042/bj3160401
   PETERSON LE, 2006, CHPST2C V 1 18 SOFTW
   Rechsteiner M, 2005, TRENDS CELL BIOL, V15, P27, DOI 10.1016/j.tcb.2004.11.003
   Reits EAJ, 1997, EMBO J, V16, P6087, DOI 10.1093/emboj/16.20.6087
   RIVETT AJ, 1992, J HISTOCHEM CYTOCHEM, V40, P1165, DOI 10.1177/40.8.1619280
   Rivett AJ, 1998, CURR OPIN IMMUNOL, V10, P110, DOI 10.1016/S0952-7915(98)80040-X
   Rock KL, 2002, ADV IMMUNOL, V80, P1, DOI 10.1016/S0065-2776(02)80012-8
   RYABOVA LV, 1994, MOL REPROD DEV, V37, P99, DOI 10.1002/mrd.1080370114
   Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349
   SCHAPIRO H, 1982, EXPERIENTIA, V38, P1075, DOI 10.1007/BF01955375
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Shibatani T, 1996, J GERONTOL A-BIOL, V51, pB316, DOI 10.1093/gerona/51A.5.B316
   Vernace VA, 2007, FASEB J, V21, P2672, DOI 10.1096/fj.06-6751com
   Vernace VA, 2007, AGING CELL, V6, P599, DOI 10.1111/j.1474-9726.2007.00329.x
   Wójcik C, 2003, INT J BIOCHEM CELL B, V35, P579, DOI 10.1016/S1357-2725(02)00380-1
NR 52
TC 30
Z9 38
U1 0
U2 2
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD FEB
PY 2010
VL 131
IS 2
BP 144
EP 155
DI 10.1016/j.mad.2010.01.002
PG 12
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 574LV
UT WOS:000275991600010
PM 20080121
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Zhang, TP
   Kho, DH
   Wang, Y
   Harazono, Y
   Nakajima, K
   Xie, Y
   Raz, A
AF Zhang, Tianpeng
   Kho, Dhong Hyo
   Wang, Ying
   Harazono, Yosuke
   Nakajima, Kosei
   Xie, Youming
   Raz, Avraham
TI Gp78, an E3 Ubiquitin Ligase Acts as a Gatekeeper Suppressing
   Nonalcoholic Steatohepatitis (NASH) and Liver Cancer
SO PLOS ONE
LA English
DT Article
ID ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; ER-ASSOCIATED
   DEGRADATION; MOTILITY FACTOR-RECEPTOR; HMG-COA REDUCTASE; DISEASE;
   INSIG-1; CELLS; KAI1
AB Nonalcoholic steatohepatitis (NASH) is related to metabolic dysregulation and the perturbation of endoplasmic reticulum (ER) homeostasis that frequently develops into hepatocellular carcinoma (HCC). Gp78 is E3 ligase, which regulates endoplasmic reticulum-associated degradation (ERAD) by ubiquitinylation of misfolded ER proteins. Here, we report that upon ageing (12 months), gp78(-/-) mice developed obesity, recapitulating age-related human NASH. Liver histology of gp78(-/-) mice revealed typical steatosis, hepatic inflammation and fibrosis, followed by progression to hepatocellular tumors. Acute ER stress revealed that loss of gp78 results in up regulation of unfolded protein response (UPR) pathways and SREBP-1 regulating de novo lipogenesis, responsible for fatty liver. Tissue array of human hepatocellular carcinoma (HCC) demonstrated that the expression of gp78 was inversely correlated with clinical grades of cancer. Here, we have described the generation of the first preclinical experimental model system which spontaneously develops age-related NASH and HCC, linking ERAD to hepatosteatosis, cirrhosis, and cancer. It suggests that gp78 is a regulator of normal liver homeostasis and a tumor suppressor in human liver.
C1 [Raz, Avraham] Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI 48202 USA.
   Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA.
   Karmanos Canc Inst, Detroit, MI USA.
C3 Wayne State University; Wayne State University; Barbara Ann Karmanos
   Cancer Institute
RP Raz, A (corresponding author), Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI 48202 USA.
EM raza@karmanos.org
CR Anstee QM, 2006, INT J EXP PATHOL, V87, P1, DOI 10.1111/j.0959-9673.2006.00465.x
   Basseri S, 2008, DEV CELL, V15, P795, DOI 10.1016/j.devcel.2008.11.013
   Brodsky JL, 2012, CELL, V151, P1163, DOI 10.1016/j.cell.2012.11.012
   Brown MK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00263
   Chen ZL, 2014, J GENET GENOMICS, V41, P357, DOI 10.1016/j.jgg.2014.05.005
   Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265
   Curtis R, 2005, NAT REV DRUG DISCOV, V4, P569, DOI 10.1038/nrd1777
   DeZwaan-McCabe D, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003937
   Espenshade PJ, 2007, ANNU REV GENET, V41, P401, DOI 10.1146/annurev.genet.41.110306.130315
   Fairbank M, 2009, MOL BIOSYST, V5, P793, DOI 10.1039/b820820b
   Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598
   Fu M, 2011, CELL DEATH DIFFER, V18, P1057, DOI 10.1038/cdd.2010.181
   Gougelet A, 2012, J HEPATOL, V2012, DOI [10.1155/2012/816125, DOI 10.1155/2012/816125]
   Hansen GM, 2008, GENOME RES, V18, P1670, DOI 10.1101/gr.078352.108
   Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270
   Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034
   Joshi B, 2010, J BIOL CHEM, V285, P8830, DOI 10.1074/jbc.M109.074344
   Kho DH, 2014, CANCER RES, V74, P2229, DOI 10.1158/0008-5472.CAN-13-2937
   Kho DH, 2013, CANCER RES, V73, P1411, DOI 10.1158/0008-5472.CAN-12-2149
   Li GT, 2006, P NATL ACAD SCI USA, V103, P8348, DOI 10.1073/pnas.0602747103
   Liu TF, 2012, CELL METAB, V16, P213, DOI 10.1016/j.cmet.2012.06.014
   Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005
   Marra F, 2008, TRENDS MOL MED, V14, P72, DOI 10.1016/j.molmed.2007.12.003
   Müller JMM, 2007, BIOCHEM BIOPH RES CO, V354, P459, DOI 10.1016/j.bbrc.2006.12.206
   Naik A, 2013, GENOMICS, V102, P84, DOI 10.1016/j.ygeno.2013.03.007
   Pagliassotti MJ, 2012, ANNU REV NUTR, V32, P17, DOI 10.1146/annurev-nutr-071811-150644
   Römisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250
   Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009
   Starley BQ, 2010, HEPATOLOGY, V51, P1820, DOI 10.1002/hep.23594
   Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779
   Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359
   Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1
   Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780
   Tsai YC, 2007, NAT MED, V13, P1504, DOI 10.1038/nm1686
   Tsai YC, 2012, MOL BIOL CELL, V23, P4484, DOI 10.1091/mbc.E12-08-0631
   Tsai Yien Che, 2010, Genes Cancer, V1, P764
   Vandewynckel YP, 2013, ANTICANCER RES, V33, P4683
   Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546
   Wang Y, 2014, ONCOTARGET, V5, P2044, DOI 10.18632/oncotarget.1478
   Yagishita N, 2005, J BIOL CHEM, V280, P7909, DOI 10.1074/jbc.M410863200
   Ye J, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004754
NR 41
TC 43
Z9 43
U1 3
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 19
PY 2015
VL 10
IS 3
AR e0118448
DI 10.1371/journal.pone.0118448
PG 15
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA CD9NQ
UT WOS:000351425400031
PM 25789613
OA Green Published, gold, Green Submitted
DA 2024-02-19
ER

PT J
AU Okuno, T
   Motobayashi, S
   Ueno, H
   Nakamuro, K
AF Okuno, T
   Motobayashi, S
   Ueno, H
   Nakamuro, K
TI Purification and characterization of mouse hepatic enzyme that converts
   selenomethionine to methylselenol by its α,γ-elimination
SO BIOLOGICAL TRACE ELEMENT RESEARCH
LA English
DT Article
DE seleno-L-methionine; mouse liver; metabolism; methylselenol;
   alpha,gamma-elimination enzyme; enzyme purification
ID METHIONINE GAMMA-LYASE; THIOREDOXIN REDUCTASE; PSEUDOMONAS-OVALIS;
   CANCER PREVENTION; RAT-LIVER; IN-VITRO; SELENIUM; SELENOCYSTEINE;
   METABOLISM; IDENTIFICATION
AB The objective of this study was to purify and characterize a mouse hepatic enzyme that directly generates CH3SeH from seleno-L-methionine (L-SeMet) by the alpha,gamma-elimination reaction. The L-SeMet alpha,gamma-elimination enzyme was ubiquitous in tissues from ICR mice and the activity was relatively high in the large intestine, brain, and muscle, as well as the liver. Aging and sex of the mice did not have any significant influence on the activity in the liver. The enzyme was purified from the mouse liver by ammonium sulfate precipitation and four kinds of column chromatography. These procedures yielded a homogeneous enzyme, which was purified approx 1000-fold relative to mouse liver extract. Overall recovery was approx 8%. The purified enzyme had a molecular mass of approx 160 kDa with four identical subunits. The K-m value of the enzyme for the catalysis Of L-SeMet was 15.5 mM, and the V-max was 0.29 units/mg protein. Pyridoxal 5'-phosphate (pyridoxal-P) was required as a cofactor because the holoenzyme could be resolved to the apoenzyme by incubation with hydroxylamine and reconstituted by addition of pyridoxal-P. The enzyme showed the optimum activity at around pH 8.0 and the highest activity at 50 degrees C; it catalyzed the alpha,gamma-elimination reactions of several analogs such as D,L-homocysteine and L-homoserine in addition to L-SeMet. This enzyme also catalyzed the alpha,beta-elimination reaction of Se-methylseleno-L-cysteine.
C1 Setsunan Univ, Fac Pharmaceut Sci, Div Environm Hlth, Hirakata, Osaka 5730101, Japan.
C3 Setsunan University
RP Okuno, T (corresponding author), Setsunan Univ, Fac Pharmaceut Sci, Div Environm Hlth, 45-1 Nagaotoge Cho, Hirakata, Osaka 5730101, Japan.
CR BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Clark LC, 1996, JAMA-J AM MED ASSOC, V276, P1957, DOI 10.1001/jama.276.24.1957
   Dias B, 1998, APPL ENVIRON MICROB, V64, P3327
   DROTAR A, 1987, APPL ENVIRON MICROB, V53, P2111, DOI 10.1128/AEM.53.9.2111-2118.1987
   ESAKI N, 1981, BIOCHEMISTRY-US, V20, P4492, DOI 10.1021/bi00518a039
   ESAKI N, 1982, J BIOL CHEM, V257, P4386
   ESAKI N, 1979, BIOCHEMISTRY-US, V18, P407, DOI 10.1021/bi00570a003
   Ganther HE, 1999, CARCINOGENESIS, V20, P1657, DOI 10.1093/carcin/20.9.1657
   GANTHER HE, 1987, J AM COLL TOXICOL, V5, P1
   Ganther HE, 2001, J NUTR, V131, P301, DOI 10.1093/jn/131.2.301
   GANTHER HE, 1979, ADV NUTR RES, V2, P107
   Gromer S, 2002, J BIOL CHEM, V277, P9701, DOI 10.1074/jbc.M109234200
   Hasegawa T, 1996, ARCH TOXICOL, V71, P39, DOI 10.1007/s002040050356
   HIMENO S, 2002, HEAVY METALS ENV, P591
   Inoue H, 2000, BIOSCI BIOTECH BIOCH, V64, P2336, DOI 10.1271/bbb.64.2336
   Ip C, 2000, CANCER RES, V60, P2882
   KAJANDER EO, 1991, BIOL TRACE ELEM RES, V28, P39, DOI 10.1007/BF02990463
   KREIS W, 1973, CANCER RES, V33, P1862
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036
   LOCKWOOD BC, 1991, BIOCHEM J, V279, P675, DOI 10.1042/bj2790675
   MIZUTANI T, 1991, FEBS LETT, V289, P59, DOI 10.1016/0014-5793(91)80908-L
   MIZUTANI T, 1992, BIOCHEM J, V284, P827, DOI 10.1042/bj2840827
   NAKAYAMA T, 1984, ANAL BIOCHEM, V138, P421, DOI 10.1016/0003-2697(84)90832-7
   Nakayma T., 1894, Agric. Biol. Chem, V48, P2367, DOI [10.1271/bbb1961.48.2367, DOI 10.1271/BBB1961.48.2367]
   Nelson M A, 1999, Semin Urol Oncol, V17, P91
   Okuno T, 2001, TOXICOL APPL PHARM, V176, P18, DOI 10.1006/taap.2001.9260
   OLSON OE, 1987, J AM COLL TOXICOL, V5, P45
   Schrauzer G. N., 1998, J MED FOOD, V1, P201, DOI DOI 10.1089/JMF.1998.1.201
   Schrauzer GN, 2000, CELL MOL LIFE SCI, V57, P1864, DOI 10.1007/PL00000668
   Soda K, 1999, BIOFACTORS, V10, P257, DOI 10.1002/biof.5520100225
   SODA K, 1967, AGR BIOL CHEM TOKYO, V31, P1054, DOI 10.1080/00021369.1967.10858916
   TAKAHASHI K, 1987, ARCH BIOCHEM BIOPHYS, V256, P677, DOI 10.1016/0003-9861(87)90624-2
   TANAKA H, 1977, BIOCHEMISTRY-US, V16, P100, DOI 10.1021/bi00620a016
   TANAKA H, 1985, ENZYME MICROB TECH, V7, P530, DOI 10.1016/0141-0229(85)90094-8
   TANAKA H, 1976, FEBS LETT, V66, P307, DOI 10.1016/0014-5793(76)80528-5
   Yarimizu J, 2000, ANTIOXID REDOX SIGN, V2, P643, DOI 10.1089/ars.2000.2.4-643
   YASUMOTO K, 1988, J AGR FOOD CHEM, V36, P463, DOI 10.1021/jf00081a014
NR 38
TC 18
Z9 23
U1 0
U2 4
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 0163-4984
EI 1559-0720
J9 BIOL TRACE ELEM RES
JI Biol. Trace Elem. Res.
PD JUL
PY 2005
VL 106
IS 1
BP 77
EP 93
DI 10.1385/BTER:106:1:077
PG 17
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA 953SI
UT WOS:000231100400006
PM 16037612
DA 2024-02-19
ER

PT J
AU Sun, LY
   Bokov, AF
   Richardson, A
   Miller, RA
AF Sun, Liou Y.
   Bokov, Alex F.
   Richardson, Arlan
   Miller, Richard A.
TI Hepatic response to oxidative injury in long-lived Ames dwarf mice
SO FASEB JOURNAL
LA English
DT Article
DE ERK; Nrf2; aging; stress
ID GENE-EXPRESSION PROFILE; LIFE-SPAN; STRESS RESISTANCE; TRANSCRIPTION
   FACTOR; CELL-SURVIVAL; MUTANT MICE; BCL2 FAMILY; MAP KINASE; GROWTH;
   ACTIVATION
AB Multiple stress resistance pathways were evaluated in the liver of Ames dwarf mice before and after exposure to the oxidative toxin diquat, seeking clues to the exceptional longevity conferred by this mutation. Before diquat treatment, Ames dwarf mice, compared with nonmutant littermate controls, had 2- to 6-fold higher levels of expression of mRNAs for immediate early genes and 2- to 5-fold higher levels of mRNAs for genes dependent on the transcription factor Nrf2. Diquat led to a 2-fold increase in phosphorylation of the stress kinase ERK in control (but not Ames dwarf) mice and to a 50% increase in phosphorylation of the kinase JNK2 in Ames dwarf (but not control) mice. Diquat induction of Nrf2 protein was higher in dwarf mice than in controls. Of 6 Nrf2-responsive genes evaluated, 4 (HMOX, NQO-1, MT-1, and MT-2) remained 2- to 10-fold lower in control than in dwarf liver after diquat, and the other 2 (GCLM and TXNRD) reached levels already seen in dwarf liver at baseline. Thus, livers of Ames dwarf mice differ systematically from controls in multiple stress resistance pathways before and after exposure to diquat, suggesting mechanisms for stress resistance and extended longevity in Ames dwarf mice.-Sun, L. Y., Bokov, A. F., Richardson, A., Miller, R. A. Hepatic response to oxidative injury in long-lived Ames dwarf mice. FASEB J. 25, 398-408 (2011). www.fasebj.org
C1 [Sun, Liou Y.; Miller, Richard A.] Univ Michigan, Geriatr Ctr, Ann Arbor, MI 48109 USA.
   [Sun, Liou Y.; Miller, Richard A.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA.
   [Miller, Richard A.] Ann Arbor Vet Affairs Med Ctr, Ann Arbor, MI USA.
   [Bokov, Alex F.; Richardson, Arlan] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA.
   [Bokov, Alex F.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA.
   [Richardson, Arlan] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA.
C3 University of Michigan System; University of Michigan; University of
   Michigan System; University of Michigan; US Department of Veterans
   Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare
   System; University of Texas System; University of Texas Health Science
   Center at San Antonio; University of Texas System; University of Texas
   Health Science Center at San Antonio; University of Texas System;
   University of Texas Health Science Center at San Antonio
RP Miller, RA (corresponding author), Univ Michigan, Geriatr Ctr, Rm 3001,BSRB Box 2200,109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.
EM millerr@umich.edu
FU National Institute on Aging [AG-031736, AG-024824, AG-013283,
   AG-021890]; San Antonio Nathan Shock Aging Center [1P30-AG-13319]
FX This work was supported by National Institute on Aging grants AG-031736,
   AG-024824, and AG-013283 (to R.A.M.); AG-021890 (to A.F.B.); and San
   Antonio Nathan Shock Aging Center 1P30-AG-13319 (to A.R.). The authors
   thank Marian Sabia and Vivian Diaz for assistance.
CR Adamson ED, 2002, TUMOR BIOL, V23, P93, DOI 10.1159/000059711
   Amador-Noguez D, 2004, AGING CELL, V3, P423, DOI 10.1111/j.1474-9728.2004.00125.x
   Bartke A, 2005, ENDOCRINOLOGY, V146, P3718, DOI 10.1210/en.2005-0411
   Beidelschies MA, 2008, J CELL PHYSIOL, V217, P652, DOI 10.1002/jcp.21539
   Bianchet MA, 2008, VITAM HORM, V78, P63, DOI 10.1016/S0083-6729(07)00004-0
   Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904
   Bokov AF, 2009, J GERONTOL A-BIOL, V64, P819, DOI 10.1093/gerona/glp052
   BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0
   Cabodi S, 2009, J CELL PHYSIOL, V218, P294, DOI 10.1002/jcp.21603
   Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000
   Cobbett C, 2002, ANNU REV PLANT BIOL, V53, P159, DOI 10.1146/annurev.arplant.53.100301.135154
   Coschigano KT, 2000, ENDOCRINOLOGY, V141, P2608, DOI 10.1210/en.141.7.2608
   Dickinson DA, 2004, FREE RADICAL BIO MED, V37, P1152, DOI 10.1016/j.freeradbiomed.2004.06.011
   FARRINGTON JA, 1973, BIOCHIM BIOPHYS ACTA, V314, P372, DOI 10.1016/0005-2728(73)90121-7
   Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898
   Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885
   Harper JM, 2006, MECH AGEING DEV, V127, P687, DOI 10.1016/j.mad.2006.04.002
   Hsieh CC, 2009, AGING-US, V1, P784, DOI 10.18632/aging.100077
   Ikeno Y, 2003, J GERONTOL A-BIOL, V58, P291
   Jones GM, 2000, J TOXICOL-CLIN TOXIC, V38, P123, DOI 10.1081/CLT-100100926
   Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev
   Kapahi P, 1999, FREE RADICAL BIO MED, V26, P495, DOI 10.1016/S0891-5849(98)00323-2
   Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035
   Kennedy MA, 2003, EXP GERONTOL, V38, P997, DOI 10.1016/S0531-5565(03)00164-5
   Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046
   Kinney BA, 2001, HORM BEHAV, V39, P277, DOI 10.1006/hbeh.2001.1654
   Kobayashi M, 2005, ANTIOXID REDOX SIGN, V7, P385, DOI 10.1089/ars.2005.7.385
   Korb A, 2006, ARTHRITIS RHEUM, V54, P2745, DOI 10.1002/art.22080
   LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905
   Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390
   Legos JJ, 2001, BRAIN RES, V892, P70, DOI 10.1016/S0006-8993(00)03228-5
   Leiser SF, 2010, MOL CELL BIOL, V30, P871, DOI 10.1128/MCB.01145-09
   Levine B, 2008, AUTOPHAGY, V4, P600, DOI 10.4161/auto.6260
   Li J, 2004, EXP GERONTOL, V39, P735, DOI 10.1016/j.exger.2004.02.008
   Li Y, 2008, CELL METAB, V8, P38, DOI 10.1016/j.cmet.2008.05.004
   Lin YJ, 1998, SCIENCE, V282, P943, DOI 10.1126/science.282.5390.943
   Lithgow G. J., 2008, MOL BIOL AGING
   Martin GM, 1996, NAT GENET, V13, P25, DOI 10.1038/ng0596-25
   Maynard SP, 2006, AGING CELL, V5, P89, DOI 10.1111/j.1474-9726.2006.00187.x
   McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001
   Meyer Y, 2009, ANNU REV GENET, V43, P335, DOI 10.1146/annurev-genet-102108-134201
   Miller RA, 2005, AGING CELL, V4, P119, DOI 10.1111/j.1474-9726.2005.00152.x
   Miller RA, 2009, J GERONTOL A-BIOL, V64, P179, DOI 10.1093/gerona/gln072
   Morse D, 2009, FREE RADICAL BIO MED, V47, P1, DOI 10.1016/j.freeradbiomed.2009.04.007
   Murakami S, 2003, FASEB J, V17, P1565, DOI 10.1096/fj.02-1092fje
   Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200
   Oppermann U, 2007, ANNU REV PHARMACOL, V47, P293, DOI 10.1146/annurev.pharmtox.47.120505.105316
   ORENTREICH N, 1993, J NUTR, V123, P269
   Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373
   Pearson KJ, 2008, P NATL ACAD SCI USA, V105, P2325, DOI 10.1073/pnas.0712162105
   Piantadosi CA, 2008, FREE RADICAL BIO MED, V45, P562, DOI 10.1016/j.freeradbiomed.2008.05.013
   Rabkin SW, 2009, J HEART VALVE DIS, V18, P653
   Salmon AB, 2005, AM J PHYSIOL-ENDOC M, V289, pE23, DOI 10.1152/ajpendo.00575.2004
   Salmon AB, 2008, J GERONTOL A-BIOL, V63, P219, DOI 10.1093/gerona/63.3.219
   Sierra F, 2006, J GERONTOL A-BIOL, V61, P557, DOI 10.1093/gerona/61.6.557
   Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587
   SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0
   Sun LY, 2006, ENDOCRINOLOGY, V147, P5480, DOI 10.1210/en.2006-0586
   Sun LY, 2009, FREE RADICAL BIO MED, V47, P1753, DOI 10.1016/j.freeradbiomed.2009.09.021
   Surh YJ, 2003, NAT REV CANCER, V3, P768, DOI 10.1038/nrc1189
   Sykiotis GP, 2008, DEV CELL, V14, P76, DOI 10.1016/j.devcel.2007.12.002
   Thiel G, 2002, J CELL PHYSIOL, V193, P287, DOI 10.1002/jcp.10178
   Torres F, 2010, MOL CARCINOGEN, V49, P464, DOI 10.1002/mc.20619
   Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030
   Weindruch R, 1997, NEW ENGL J MED, V337, P986, DOI 10.1056/NEJM199710023371407
   Weindruch R, 2001, J NUTR, V131, p918S, DOI 10.1093/jn/131.3.918S
   Yang E, 1996, BLOOD, V88, P386, DOI 10.1182/blood.V88.2.386.bloodjournal882386
   Zinkel S, 2006, CELL DEATH DIFFER, V13, P1351, DOI 10.1038/sj.cdd.4401987
NR 68
TC 27
Z9 29
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD JAN
PY 2011
VL 25
IS 1
BP 398
EP 408
DI 10.1096/fj.10-164376
PG 11
WC Biochemistry & Molecular Biology; Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 702BL
UT WOS:000285869500036
PM 20826540
OA Green Published, Green Submitted
DA 2024-02-19
ER

PT J
AU IMAOKA, S
   FUJITA, S
   FUNAE, Y
AF IMAOKA, S
   FUJITA, S
   FUNAE, Y
TI AGE-DEPENDENT EXPRESSION OF CYTOCHROME-P-450S IN RAT-LIVER
SO BIOCHIMICA ET BIOPHYSICA ACTA
LA English
DT Article
DE CYTOCHROME-P-450; AGING; WESTERN BLOTTING; (RAT HEPATIC MICROSOME)
ID SEX-SPECIFIC FORMS; FEMALE RATS; HEPATIC CYTOCHROME-P-450; MICROSOMAL
   CYTOCHROME-P-450; GROWTH-HORMONE; INDUCIBLE CYTOCHROME-P-450; RENAL
   CYTOCHROME-P-450; OMEGA-HYDROXYLATION; CONSTITUTIVE FORMS;
   DRUG-METABOLISM
AB Age-related changes in the levels of multiple forms of cytochrome P-450 as well as in the testosterone hydroxylation activities of hepatic microsomes of male and female rats of different ages from 1 week to 104 weeks (24 months) were investigated. The total cytochrome P-450 measured photometrically did not change much with age in either male and female rats. Testosterone 2-alpha-, 2-beta-, 6-beta-, 15-alpha-, 16-alpha- and 16-beta-hydroxylation activities of male rats were much higher than those in female rats and were induced developmentally. These activities in male rats declined with aging to the very low level in female rats by 104 weeks of age. Testosterone 7-alpha-hydroxylation activity was maximum at 3 weeks of age in rats of both sexes. The levels of individual cytochrome P-450s were measured by immunoblotting. P450IA1 and IA2 (3-methylcholanthrene-inducible forms) and P450IIB1 and IIB2 (phenobarbital-inducible forms) were detected at low levels in rats of both sexes at all ages. P450IIA2, IIC11 and IVA2 were detected in male rats only and were induced developmentally. These male-specific forms disappeared in male rat liver at 104 weeks of age. P450IIC12, a typical female-specific form, was induced developmentally in female rats and was also detected in male rats at 3 and 104 weeks of age. P450IIIA2 (testosterone 6-beta-hydroxylase) was induced developmentally in male rats, but disappeared when the rats were 104 weeks of age. In female rats, P450IIIA2 was detected only at 1 and 3 weeks of age. P450IIA1, IIC6, IIE1 and IVA3 were detected in rats of both sexes at any age. P450IIC6 and IVA3 were induced developmentally and detected at a similar level in rats of both sexes. The level of P450IIA1 was maximum at 3 weeks of age in rats of both sexes. The changes in the level of P450IIE1 during aging were small compared with the changes in other cytochrome P-450s used in this study. These observations provide concrete evidence to our earlier hypothesis that each of the forms of cytochrome P-450 in male rats alter with aging in different patterns resulting in a practical feminization of over-all cytochrome P-450 composition at old age.
C1 HOKKAIDO UNIV,FAC VET MED,DEPT TOXICOL,SAPPORO,HOKKAIDO 060,JAPAN.
C3 Hokkaido University
RP IMAOKA, S (corresponding author), OSAKA CITY UNIV,SCH MED,CHEM LAB,1-4-54 ASAHIMACHI,ABENO KU,OSAKA 545,JAPAN.
CR AOYAMA T, 1990, J LIPID RES, V31, P1477
   BANDIERA S, 1986, ARCH BIOCHEM BIOPHYS, V248, P658, DOI 10.1016/0003-9861(86)90521-7
   EDEN S, 1979, ENDOCRINOLOGY, V105, P555, DOI 10.1210/endo-105-2-555
   FUJITA S, 1985, BIOCHEM BIOPH RES CO, V126, P117, DOI 10.1016/0006-291X(85)90579-0
   FUJITA S, 1990, J PHARMACOL EXP THER, V253, P369
   FUJITA S, 1985, BIOCHEM PHARMACOL, V34, P1861, DOI 10.1016/0006-2952(85)90666-5
   FUNAE Y, 1985, BIOCHIM BIOPHYS ACTA, V842, P119, DOI 10.1016/0304-4165(85)90193-X
   IMAOKA S, 1988, BIOCHEM BIOPH RES CO, V152, P680, DOI 10.1016/S0006-291X(88)80092-5
   IMAOKA S, 1986, BIOCHEM BIOPH RES CO, V141, P711, DOI 10.1016/S0006-291X(86)80230-3
   IMAOKA S, 1987, J BIOCHEM-TOKYO, V102, P843, DOI 10.1093/oxfordjournals.jbchem.a122124
   IMAOKA S, 1990, ARCH BIOCHEM BIOPHYS, V278, P168, DOI 10.1016/0003-9861(90)90245-T
   IMAOKA S, 1989, BIOCHEM INT, V18, P731
   IMAOKA S, 1988, J BIOCHEM-TOKYO, V104, P481, DOI 10.1093/oxfordjournals.jbchem.a122494
   IMAOKA S, 1987, BIOCHIM BIOPHYS ACTA, V916, P358, DOI 10.1016/0167-4838(87)90181-6
   IMAOKA S, 1990, BIOCHIM BIOPHYS ACTA, V1036, P18, DOI 10.1016/0304-4165(90)90208-E
   KAMATAKI T, 1985, J PHARMACOL EXP THER, V233, P222
   KAMATAKI T, 1983, ARCH BIOCHEM BIOPHYS, V225, P758, DOI 10.1016/0003-9861(83)90087-5
   KATO R, 1986, J BIOCHEM-TOKYO, V100, P895, DOI 10.1093/oxfordjournals.jbchem.a121802
   KITAGAWA H, 1985, BIOCHEM PHARMACOL, V34, P579, DOI 10.1016/0006-2952(85)90193-5
   LEVIN W, 1987, ARCH BIOCHEM BIOPHYS, V258, P630, DOI 10.1016/0003-9861(87)90386-9
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MAEDA K, 1984, BIOCHEM PHARMACOL, V33, P509, DOI 10.1016/0006-2952(84)90252-1
   NEBERT DW, 1991, DNA CELL BIOL, V10, P1, DOI 10.1089/dna.1991.10.1
   OMURA T, 1964, J BIOL CHEM, V239, P2370
   PATTEN CJ, 1986, ARCH BIOCHEM BIOPHYS, V251, P629, DOI 10.1016/0003-9861(86)90373-5
   ROBINSON RC, 1990, ARCH BIOCHEM BIOPHYS, V277, P42, DOI 10.1016/0003-9861(90)90547-C
   RYAN DE, 1986, ARCH BIOCHEM BIOPHYS, V246, P633, DOI 10.1016/0003-9861(86)90319-X
   SCHENKMAN JB, 1989, DRUG METAB REV, V20, P557, DOI 10.3109/03602538909103562
   SCHWARTZMAN ML, 1989, J BIOL CHEM, V264, P11658
   THUMMEL KE, 1988, ARCH BIOCHEM BIOPHYS, V266, P319, DOI 10.1016/0003-9861(88)90264-0
   WAXMAN DJ, 1983, J BIOL CHEM, V258, P1937
   WAXMAN DJ, 1988, BIOCHEM PHARMACOL, V37, P71, DOI 10.1016/0006-2952(88)90756-3
   WAXMAN DJ, 1985, BIOCHEMISTRY-US, V24, P4409, DOI 10.1021/bi00337a023
   WAXMAN DJ, 1984, J BIOL CHEM, V259, P5481
   WAXMAN DJ, 1989, ENDOCRINOLOGY, V124, P2954, DOI 10.1210/endo-124-6-2954
   WOOD AW, 1983, J BIOL CHEM, V258, P8839
   YAMAZOE Y, 1986, J BIOCHEM-TOKYO, V100, P1095, DOI 10.1093/oxfordjournals.jbchem.a121790
   YAMAZOE Y, 1987, J BIOL CHEM, V262, P7423
NR 38
TC 103
Z9 107
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0006-3002
J9 BIOCHIM BIOPHYS ACTA
PD OCT 21
PY 1991
VL 1097
IS 3
BP 187
EP 192
DI 10.1016/0925-4439(91)90034-7
PG 6
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA GP154
UT WOS:A1991GP15400006
PM 1932143
DA 2024-02-19
ER

PT J
AU Farzanegi, P
   Abbaszadeh, H
   Farokhi, F
   Rahmati-Ahmadabad, S
   Hosseini, SA
   Abdi, A
   Mazandarani, MR
   Rezaei, I
   Shokrie, M
   Vizvari, E
   Alinejad, H
   Azarbayjani, MA
AF Farzanegi, Parvin
   Abbaszadeh, Hajar
   Farokhi, Farzaneh
   Rahmati-Ahmadabad, Saleh
   Hosseini, Seyed Ali
   Abdi, Ahmad
   Mazandarani, Mohammad Reza
   Rezaei, Iraj
   Shokrie, Mohammad
   Vizvari, Exir
   Alinejad, Hadi
   Azarbayjani, Mohammad Ali
TI Attenuated Renal and Hepatic Cells Apoptosis Following Swimming Exercise
   Supplemented with Garlic Extract in Old Rats
SO CLINICAL INTERVENTIONS IN AGING
LA English
DT Article
DE apoptosis; garlic extract; antioxidant; oxidative stress; swimming
   exercise; old rats
ID OXIDATIVE STRESS; DIPHENYL DISELENIDE; ACTIVATION; IMPROVES; MARKERS;
   KIDNEY; BRAIN; DIET
AB Background/Objective: One of the problems associated with aging is the development of apoptosis in different tissues. There is evidence that physical activity and herbal remedies can be useful. This study aimed to determine the effect of swimming training (SW) alone or combined with garlic extract on renal and hepatic cells apoptosis, as wellas on the liver and kidney function biomarkers in old rats.
   Methods: A total of 35 old rats (aged 40-50 weeks) were randomly divided into 5 groups including control, saline (S), exercise training (ET), garlic (G) and exercise training+ garlic (ET. G) groups. Exercise was started for 5 min/day and then gradually extended to 60 min/day and the G and E+G groups received 1 mL/kg of this mixture by gavage. Twenty-four hours after completion of 8 weeks training, liver, kidney and blood samples were collected for histopathological examinations, liver and kidney functions, oxidative stress and apoptosis biomarkers.
   Results: The tissue sections of the SW exercise, control and saline groups showed some mild histopathological changes in liver and kidney, while SW supplemented with garlic prevented these damages. The SW alone or supplemented with garlic significantly increased the Bcl-2 value and declined the BAX level in both liver and kidney (p<0.05). The activities of catalase (CAT) and superoxide dismutase (SOD) in the liver and kidney of the control and saline groups were lower than those in E, G and G+E groups, while a significant increase for malondialdehyde (MDA) value was found in the control and saline groups. Furthermore, the E+G significantly declined the activity of hepatic (ALT, AST and ALP) and renal damage (uric acid, urea and creatinine) biomarkers compared to the control and saline groups (p<0.05).
   Discussion: Swimming exercise supplemented with garlic extract not only improves antioxidant capacity but also declines oxidative damages and apoptosis through reducing Bax levels and enhancing Bcl-2 value.
C1 [Farzanegi, Parvin; Abbaszadeh, Hajar; Rezaei, Iraj; Shokrie, Mohammad; Alinejad, Hadi] Islamic Azad Univ, Dept Exercise Physiol, Sari Branch, Sari, Iran.
   [Farokhi, Farzaneh] Islamic Azad Univ, Fac Basic Sci, Dept Biol, Sari Branch, Sari, Iran.
   [Rahmati-Ahmadabad, Saleh] Islamic Azad Univ, Dept Phys Educ, Pardis Branch, Pardis, Iran.
   [Hosseini, Seyed Ali] Islamic Azad Univ, Dept Sport Physiol, Marvdasht Branch, Marvdasht, Iran.
   [Abdi, Ahmad] Islamic Azad Univ, Fac Phys Educ, Dept Phys Educ, Ayatollah Amoli Branch, Amol, Iran.
   [Mazandarani, Mohammad Reza] Farhangian Univ, Dept Phys Educ, Gorgan, Golestan, Iran.
   [Vizvari, Exir] Shams Inst Higher Educ, Fac Humanities, Dept Exercise Physiol, Gonbad Kavous, Iran.
   [Azarbayjani, Mohammad Ali] Islamic Azad Univ, Dept Exercise Physiol, Cent Tehran Branch, Tehran, Iran.
C3 Islamic Azad University; Islamic Azad University; Islamic Azad
   University; Islamic Azad University; Islamic Azad University; Islamic
   Azad University
RP Farzanegi, P (corresponding author), Islamic Azad Univ, Dept Exercise Physiol, Sari Branch, Sari, Iran.
EM parvin.farzanegi@gmail.com
RI farzanegi, parvin/AAP-2661-2021; Azarbayjani, Mohammad
   Ali/AGW-7332-2022; Abdi, Ahmad/AAO-2204-2021; Rahmati, Saleh/C-6859-2018
OI Azarbayjani, Mohammad Ali/0000-0002-3502-7487; Abdi,
   Ahmad/0000-0002-7734-7518; Rahmati, Saleh/0000-0001-8751-1759;
   Farzanegi, Parvin/0000-0003-2182-3068
FU Exercise Physiology, Faculty of Humanities, Islamic Azad University,
   Sari Branch, Iran; Islamic Azad University, Sari Branch, Iran
FX This work was supported by the Exercise Physiology, Faculty of
   Humanities, Islamic Azad University, Sari Branch, Iran. We would also
   like to appreciate the staffs of the exercise physiology centers of
   Islamic Azad University, Sari, Iran. This study was supported by a grant
   received from Islamic Azad University, Sari Branch, Iran. All authors
   contributed to data analysis, drafting or revising the article, gave
   final approval of the version to be published, and agree to be
   accountable for all aspects of the work.
CR Almeida OFX, 2000, FASEB J, V14, P779, DOI 10.1096/fasebj.14.5.779
   Cao G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152461
   Chen KC, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/368450
   Chen WC, 2014, MED SCI SPORT EXER, V46, P1517, DOI 10.1249/MSS.0000000000000272
   Cheng SM, 2014, CELL BIOCHEM FUNCT, V32, P133, DOI 10.1002/cbf.2982
   Chicco AJ, 2006, J APPL PHYSIOL, V100, P519, DOI 10.1152/japplphysiol.00148.2005
   Claudio ERG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064806
   Darnley MJ, 2000, MED SCI SPORT EXER, V32, P576, DOI 10.1097/00005768-200003000-00005
   Elikov AV, 2016, B EXP BIOL MED+, V162, P180, DOI 10.1007/s10517-016-3570-4
   Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337
   Fealy CE, 2012, J APPL PHYSIOL, V113, P1, DOI 10.1152/japplphysiol.00127.2012
   Ghyasi R, 2019, J CARDIOVASC THORAC, V11, P61, DOI 10.15171/jcvtr.2019.10
   Heck SO, 2017, J CELL BIOCHEM, V118, P1574, DOI 10.1002/jcb.25819
   Ide N, 2001, J NUTR, V131, p1020S, DOI 10.1093/jn/131.3.1020S
   Jin JJ, 2014, J EXERC REHABIL, V10, P69, DOI 10.12965/jer.140103
   Kanth VR, 2008, ACTA DIABETOL, V45, P243, DOI 10.1007/s00592-008-0051-x
   Krüger K, 2014, EXERC IMMUNOL REV, V20, P117
   Lanzotti V, 2006, J CHROMATOGR A, V1112, P3, DOI 10.1016/j.chroma.2005.12.016
   Leite MR, 2016, EXP GERONTOL, V82, P1, DOI 10.1016/j.exger.2016.05.006
   Lima FD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055668
   Luiz RD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055363
   Marcelino TB, 2013, NEUROSCIENCE, V246, P28, DOI 10.1016/j.neuroscience.2013.04.043
   Martins RR, 2011, APPL PHYSIOL NUTR ME, V36, P693, DOI [10.1139/H11-074, 10.1139/h11-074]
   Nishimura H, 2004, BIOFACTORS, V21, P277, DOI 10.1002/biof.552210154
   Pal R, 2006, WORLD J GASTROENTERO, V12, P636, DOI 10.3748/wjg.v12.i4.636
   Park SY, 2016, J EXERC REHABIL, V12, P113, DOI 10.12965/jer.1632598.299
   Peng CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037388
   Phaneuf S, 2001, MED SCI SPORT EXER, V33, P393, DOI 10.1097/00005768-200103000-00010
   Pinheiro-Mulder A, 2010, PATHOL RES PRACT, V206, P168, DOI 10.1016/j.prp.2009.11.004
   Pinto JT, 2001, J NUTR, V131, p1058S, DOI 10.1093/jn/131.3.1058S
   Podhorska-Okolow M, 2006, HISTOL HISTOPATHOL, V21, P459, DOI 10.14670/HH-21.459
   Pollack M, 2002, ANN NY ACAD SCI, V959, P93, DOI 10.1111/j.1749-6632.2002.tb02086.x
   Seo DY, 2014, NUTR RES PRACT, V8, P177, DOI [10.4162/nrp.2014.8.1.177, 10.4162/nrp.2014.8.2.177]
   Sun Y, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/8381242
   Vucicevic K, 2016, J MED BIOCHEM, V35, P150, DOI 10.1515/jomb-2015-0017
   Zare A, 2008, IRAN J ALLERGY ASTHM, V7, P133, DOI 07.03/ijaai.133141
   Zeiss CJ, 2003, VET PATHOL, V40, P481, DOI 10.1354/vp.40-5-481
NR 37
TC 5
Z9 5
U1 0
U2 4
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
EI 1178-1998
J9 CLIN INTERV AGING
JI Clin. Interv. Aging
PY 2020
VL 15
BP 1409
EP 1418
DI 10.2147/CIA.S250321
PG 10
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA OH3OK
UT WOS:000582478300001
PM 32884250
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU MISHRA, SK
   DAS, BR
AF MISHRA, SK
   DAS, BR
TI A PILOT-STUDY ON ALTERATIONS OF BRAIN CHROMOSOMAL
   PROTEIN-PHOSPHORYLATION BY STEROIDS DURING AGING
SO BIOLOGICAL CHEMISTRY HOPPE-SEYLER
LA English
DT Article
DE PHOSPHORYLATION; ESTRADIOL-17-BETA; HYDROCORTISONE; HISTONE;
   NON-HISTONE-CHROMOSOMAL (NHC) PROTEINS
ID TRANSCRIPTION; LIVER; DNA
AB The modulatory effects of the steroid hormones estradiol-17-beta and hydrocortisone on phosphorylation of chromosomal proteins of the cerebral hemispheres (CH) of young and old rats was studied in vitro. The results indicate that the extent of phosphorylation decreases in both histone and non-histone-chromosomal (NHC) protein fractions as the age proceeds. Besides, both the hormones stimulate phosphorylation in young as well as old rats. However the pattern of stimulation shown by estradiol differs from that by hydrocortisone. In addition the extent of stimulation by these hormones is significantly reduced in old rats. Modulation of phosphorylation as provoked by these two hormones seems to play an important role in differential gene expression during ageing.
C1 INST LIFE SCI,MOLEC BIOL & GENET ENGN UNIT,301 SAHID NAGAR,BHUBANESWAR 751007,ORISSA,INDIA.
C3 Department of Biotechnology (DBT) India; Institute of Life Sciences
   India (ILS)
RI Jansen, Heiko T./A-5770-2008
OI Jansen, Heiko T./0000-0003-0178-396X
CR ALLFREY VG, 1977, COLD SPRING HARB SYM, V42, P1211
   ALLFREY VG, 1971, HISTONES NUCLEOHISTO, P241
   CHUNG DM, 1976, SCIENCE, V193, P60
   CUTLER RG, 1975, EXP GERONTOL, V10, P37, DOI 10.1016/0531-5565(75)90014-5
   DAHMUS ME, 1965, P NATL ACAD SCI USA, V54, P1370, DOI 10.1073/pnas.54.5.1370
   ELGIN SCR, 1970, BIOCHEMISTRY-US, V9, P4440, DOI 10.1021/bi00824a027
   FRAMBROUGH DM, 1966, BIOCHEMISTRY-US, V5, P2563
   HEWISH DR, 1973, BIOCHEM BIOPH RES CO, V52, P504, DOI 10.1016/0006-291X(73)90740-7
   JUNGMANN RA, 1977, INT J BIOCHEM, V8, P819, DOI 10.1016/0020-711X(77)90049-0
   KADOHAMA N, 1976, CAN J BIOCHEM, V55, P513
   KANUNGO MS, 1975, NATURE, V253, P366, DOI 10.1038/253366a0
   KANUNGO MS, 1975, J THEOR BIOL, V53, P253, DOI 10.1016/S0022-5193(75)80002-6
   KLUG A, 1980, NATURE, V287, P509, DOI 10.1038/287509a0
   KURTZ DI, 1967, BIOCHIM BIOPHYS ACTA, V145, P840, DOI 10.1016/0005-2787(67)90146-3
   LANGAN TA, 1969, P NATL ACAD SCI USA, V64, P1276, DOI 10.1073/pnas.64.4.1276
   MEDVEDEV ZA, 1977, GERONTOLOGY, V23, P334, DOI 10.1159/000212205
   MEDVEDEV ZA, 1980, IRCS MED SCI-BIOCHEM, V8, P431
   OFFENBACHER S, 1975, BIOCHEM BIOPH RES CO, V66, P375, DOI 10.1016/S0006-291X(75)80338-X
   OMALLEY BW, 1976, SCI AM, V234, P32, DOI 10.1038/scientificamerican0276-32
   PANYIM S, 1969, ARCH BIOCHEM BIOPHYS, V130, P337, DOI 10.1016/0003-9861(69)90042-3
   SHIMAMURA A, 1989, MOL CELL BIOL, V9, P5573, DOI 10.1128/MCB.9.12.5573
   TENG CS, 1969, P NATL ACAD SCI USA, V63, P465, DOI 10.1073/pnas.63.2.465
   Thomas J O, 1978, Methods Cell Biol, V18, P429
   WEINTRAUB H, 1984, CELL, V38, P17, DOI 10.1016/0092-8674(84)90522-1
   WILSON EM, 1973, BIOCHIM BIOPHYS ACTA, V322, P145, DOI 10.1016/0005-2795(73)90185-2
NR 25
TC 2
Z9 2
U1 0
U2 0
PU WALTER DE GRUYTER & CO
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 0177-3593
J9 BIOL CHEM H-S
JI Biol. Chem. Hoppe-Seyler
PD FEB
PY 1992
VL 373
IS 2
BP 89
EP 92
DI 10.1515/bchm3.1992.373.1.89
PG 4
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA HJ519
UT WOS:A1992HJ51900008
PM 1571111
DA 2024-02-19
ER

PT J
AU Mennitti, LV
   Carpenter, AAM
   Loche, E
   Pantaleao, LC
   Fernandez-Twinn, DS
   Schoonejans, JM
   Blackmore, HL
   Ashmore, TJ
   Pisani, LP
   Tadross, JA
   Hargreaves, I
   Ozanne, SE
AF Mennitti, Lais Vales
   Carpenter, Asha A. M.
   Loche, Elena
   Pantaleao, Lucas C.
   Fernandez-Twinn, Denise S.
   Schoonejans, Josca M.
   Blackmore, Heather L.
   Ashmore, Thomas J.
   Pisani, Luciana Pellegrini
   Tadross, John A.
   Hargreaves, Iain
   Ozanne, Susan E.
TI Effects of maternal diet-induced obesity on metabolic disorders and
   age-associated miRNA expression in the liver of male mouse offspring
SO INTERNATIONAL JOURNAL OF OBESITY
LA English
DT Article; Early Access
ID DNA COPY NUMBER; FATTY LIVER; OXIDATIVE STRESS; SCORING SYSTEM;
   ADIPOSE-TISSUE; DISEASE; DYSFUNCTION; HEALTH; PATHOGENESIS; MICRORNAS
AB Objective This study investigated the effect of maternal obesity on aged-male offspring liver phenotype and hepatic expression of a programmed miRNA. Methods A mouse model (C57BL/6 J) of maternal diet-induced obesity was used to investigate fasting-serum metabolites, hepatic lipid content, steatosis, and relative mRNA levels (RT-PCR) and protein expression (Western blotting) of key components involved in hepatic and mitochondrial metabolism in 12-month-old offspring. We also measured hepatic lipid peroxidation, mitochondrial content, fibrosis stage, and apoptosis in the offspring. To investigate potential mechanisms leading to the observed phenotype, we also measured the expression of miR-582 (a miRNA previously implicated in liver cirrhosis) in 8-week-old and 12-month-old offspring. Results Body weight and composition was similar between 8-week-old offspring, however, 12-month-old offspring from obese mothers had increased body weight and fat mass (19.5 +/- 0.8 g versus 10.4 +/- 0.9 g, p < 0.001), as well as elevated serum levels of LDL and leptin and hepatic lipid content (21.4 +/- 2.1 g versus 12.9 +/- 1.8 g, p < 0.01). This was accompanied by steatosis, increased Bax/Bcl-2 ratio, and overexpression of p-SAPK/JNK, Tgf beta 1, Map3k14, and Col1a1 in the liver. Decreased levels of Bcl-2, p-AMPK alpha, total AMPK alpha and mitochondrial complexes were also observed. Maternal obesity was associated with increased hepatic miR-582-3p (p < 0.001) and miR-582-5p (p < 0.05). Age was also associated with an increase in both miR-582-3p and miR-582-5p, however, this was more pronounced in the offspring of obese dams, such that differences were greater in 12-month-old animals (-3p: 7.34 +/- 1.35 versus 1.39 +/- 0.50, p < 0.0001 and -5p: 4.66 +/- 1.16 versus 1.63 +/- 0.65, p < 0.05). Conclusion Our findings demonstrate that maternal diet-induced obesity has detrimental effects on offspring body composition as well as hepatic phenotype that may be indicative of accelerated-ageing phenotype. These whole-body and cellular phenotypes were associated with age-dependent changes in expression of miRNA-582 that might contribute mechanistically to the development of metabolic disorders in the older progeny.
C1 [Mennitti, Lais Vales; Pisani, Luciana Pellegrini] Univ Fed Sao Paulo, Dept Biosci, Lab Nutr & Endocrine Physiol, BR-11015020 Santos, SP, Brazil.
   [Mennitti, Lais Vales; Carpenter, Asha A. M.; Loche, Elena; Pantaleao, Lucas C.; Fernandez-Twinn, Denise S.; Schoonejans, Josca M.; Blackmore, Heather L.; Ashmore, Thomas J.; Pisani, Luciana Pellegrini; Tadross, John A.; Ozanne, Susan E.] Univ Cambridge, Metab Res Labs, Cambridge CB2 OQQ, England.
   [Mennitti, Lais Vales; Carpenter, Asha A. M.; Loche, Elena; Pantaleao, Lucas C.; Fernandez-Twinn, Denise S.; Schoonejans, Josca M.; Blackmore, Heather L.; Ashmore, Thomas J.; Pisani, Luciana Pellegrini; Tadross, John A.; Ozanne, Susan E.] Univ Cambridge, MRC Metab Dis Unit, Cambridge CB2 OQQ, England.
   [Tadross, John A.] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England.
   [Hargreaves, Iain] Liverpool John Moores Univ, Dept Pharm & Biomol Sci, Byrom St, Liverpool L3 5UA, Merseyside, England.
C3 Universidade Federal de Sao Paulo (UNIFESP); University of Cambridge;
   University of Cambridge; University of Cambridge; Liverpool John Moores
   University
RP Ozanne, SE (corresponding author), Univ Cambridge, Metab Res Labs, Cambridge CB2 OQQ, England.; Ozanne, SE (corresponding author), Univ Cambridge, MRC Metab Dis Unit, Cambridge CB2 OQQ, England.
EM seo10@cam.ac.uk
RI Schoonejans, Josca/GPW-7472-2022; Tadross, John/E-7513-2012;
   Fernandez-Twinn, Denise/B-3881-2011
OI Schoonejans, Josca/0000-0003-2893-7199; Tadross,
   John/0000-0002-8424-1252; Fernandez-Twinn, Denise/0000-0003-2610-277X;
   Pisani, Luciana/0000-0001-6579-6167
FU Sao Paulo Research Foundation (FAPESP) [2017/16637-9, 2014/10683-0,
   2019/22635-4]; Medical Research Council [MC_UU_12012/4, MC_UU_00014/4,
   MC_UU_00014/5]; British Heart Foundation [RG/17/12/33167,
   FS/16/53/32729]; National Institute for Health Research [CL-2019-14-504]
FX The authors gratefully acknowledge Sao Paulo Research Foundation (FAPESP
   grant #2017/16637-9, #2014/10683-0, and #2019/22635-4), the Medical
   Research Council (MC_UU_12012/4, MC_UU_00014/4, and MC_UU_00014/5), the
   British Heart Foundation (RG/17/12/33167 and FS/16/53/32729), and the
   National Institute for Health Research (clinical lectureship:
   CL-2019-14-504). Also, the authors would like to thank Claire Custance
   for expert technical assistance and James Warner from the MRC Metabolic
   Diseases Unit for his histological expertise (MRC Metabolic Diseases
   Unit [MC_UU_00014/5]). Serum-lipid analyses were carried out by the Core
   Biochemical Assay Laboratory, Cambridge University Hospitals NHS
   Foundation Trust, Cambridge, UK.
CR Afonso MB, 2019, CLIN SCI, V133, P2245, DOI 10.1042/CS20190068
   Alfaradhi MZ, 2016, ENDOCRINOLOGY, V157, P4246, DOI 10.1210/en.2016-1314
   Alfaradhi MZ, 2014, AM J PHYSIOL-REG I, V307, pR26, DOI 10.1152/ajpregu.00049.2014
   Apovian CM, 2016, AM J MANAG CARE, V22
   Assalin HB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210454
   Bankhead P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17204-5
   Barker DJP, 1998, CLIN SCI, V95, P115, DOI 10.1042/CS19980019
   Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282
   Bautista CJ, 2017, REPROD FERT DEVELOP, V29, P1950, DOI [10.1071/RD16277, 10.1071/rd16277]
   Bedossa P, 2012, HEPATOLOGY, V56, P1751, DOI 10.1002/hep.25889
   Beeson JH, 2018, MOL METAB, V16, P35, DOI 10.1016/j.molmet.2018.06.009
   Benatti RO, 2014, BRIT J NUTR, V111, P2112, DOI 10.1017/S0007114514000579
   Blackmore HL, 2014, ENDOCRINOLOGY, V155, P3970, DOI 10.1210/en.2014-1383
   Borengasser SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024068
   Castellani CA, 2020, MITOCHONDRION, V53, P214, DOI 10.1016/j.mito.2020.06.004
   Contu L, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01045
   Dearden L, 2018, MOL METAB, V15, P8, DOI 10.1016/j.molmet.2018.04.007
   DeFilippis AP, 2013, ATHEROSCLEROSIS, V227, P429, DOI 10.1016/j.atherosclerosis.2013.01.022
   El Bassat H, 2014, ARAB J GASTROENTEROL, V15, P6, DOI 10.1016/j.ajg.2014.01.009
   Elshenawy S, 2016, MOL CELL ENDOCRINOL, V435, P2, DOI 10.1016/j.mce.2016.07.002
   Faria JD, 2017, SCI REP-UK, V7, DOI 10.1038/srep44949
   Fernandez-Twinn DS, 2019, DIABETOLOGIA, V62, P1789, DOI 10.1007/s00125-019-4951-9
   Fernandez-Twinn DS, 2017, SCI REP-UK, V7, DOI 10.1038/srep44650
   Fernandez-Twinn DS, 2014, MOL METAB, V3, P325, DOI 10.1016/j.molmet.2014.01.007
   FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
   Godfrey KM, 1998, EUR J OBSTET GYN R B, V78, P141, DOI 10.1016/S0301-2115(98)00060-8
   González-Sánchez LE, 2021, J DIABETES, V13, P792, DOI 10.1111/1753-0407.13166
   GRUBBS FE, 1969, TECHNOMETRICS, V11, P1, DOI 10.2307/1266761
   Im YR, 2021, HEPATOLOGY, V74, P1884, DOI 10.1002/hep.31897
   Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64
   Jaeger K, 2017, PHYSIOLOGY, V32, P51, DOI 10.1152/physiol.00017.2016
   Jeon SM, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.81
   Kale J, 2018, CELL DEATH DIFFER, V25, P65, DOI 10.1038/cdd.2017.186
   King T., 1967, METHOD ENZYMOL, V10, P217
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Landrier JF, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080859
   Langley-Evans S, 2014, J HUM NUTR DIET, V27, P105, DOI 10.1111/jhn.12204
   Li M, 2009, WORLD J SURG, V33, P667, DOI 10.1007/s00268-008-9836-x
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Loche E, 2018, CARDIOVASC RES, V114, P1372, DOI 10.1093/cvr/cvy082
   Lomas-Soria C, 2018, J PHYSIOL-LONDON, V596, P4611, DOI 10.1113/JP276372
   Lynch C, 2017, J DEV ORIG HLTH DIS, V8, P263, DOI 10.1017/S2040174416000805
   Marra F, 2002, GASTROENTEROLOGY, V122, P1529, DOI 10.1053/gast.2002.33369
   NHS Digital, 2019, Statistics on obesity, physical activity and diet, England
   Nicholas LM, 2016, INT J OBESITY, V40, P229, DOI 10.1038/ijo.2015.178
   NMPA Project Team, 2019, NAT MAT PER AUD CLIN
   Ozanne SE, 2004, NATURE, V427, P411, DOI 10.1038/427411b
   Park Jeong Hyun, 2006, Korean J Hepatol, V12, P16
   Perlman H, 1999, CELL DEATH DIFFER, V6, P48, DOI 10.1038/sj.cdd.4400453
   Ragan C. I., 1987, MITOCHONDRIA PRACTIC
   Rodríguez-González GL, 2015, INT J OBESITY, V39, P549, DOI 10.1038/ijo.2014.209
   Rodríguez-González GL, 2019, J PHYSIOL-LONDON, V597, P5549, DOI 10.1113/JP278232
   Rooney JP, 2015, METHODS MOL BIOL, V1241, P23, DOI 10.1007/978-1-4939-1875-1_3
   Saben JL, 2016, CELL REP, V16, P1, DOI 10.1016/j.celrep.2016.05.065
   Salminen A, 2016, AGEING RES REV, V28, P15, DOI 10.1016/j.arr.2016.04.003
   Seki E, 2012, GASTROENTEROLOGY, V143, P307, DOI 10.1053/j.gastro.2012.06.004
   Selak MA, 2000, PEDIATR NEUROL, V23, P54, DOI 10.1016/S0887-8994(00)00145-4
   Shepherd D., 1969, CITRATE SYNTHASE RAT, V13, P11
   Smith BK, 2016, AM J PHYSIOL-ENDOC M, V311, pE730, DOI 10.1152/ajpendo.00225.2016
   Sud N, 2017, J NUTR BIOCHEM, V43, P125, DOI 10.1016/j.jnutbio.2017.02.003
   Sun Y, 2020, J HEPATOL, V73, P603, DOI 10.1016/j.jhep.2020.03.050
   Szabo G, 2013, NAT REV GASTRO HEPAT, V10, P542, DOI 10.1038/nrgastro.2013.87
   Tarry-Adkins Jane L, 2019, Subcell Biochem, V91, P1, DOI 10.1007/978-981-13-3681-2_1
   Tsai PY, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071570
   Vogel RO, 2007, BBA-BIOENERGETICS, V1767, P1215, DOI 10.1016/j.bbabio.2007.07.008
   Vuppalanchi R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074471
   Wadhera RK, 2016, J CLIN LIPIDOL, V10, P472, DOI 10.1016/j.jacl.2015.11.010
   Wharton DC, 1967, METHOD ENZYMOL, V10, P245
   Wilczynska A, 2015, CELL DEATH DIFFER, V22, P22, DOI 10.1038/cdd.2014.112
   Yasuda D, 2020, BIOL PHARM BULL, V43, P616, DOI 10.1248/bpb.b19-00338
NR 70
TC 9
Z9 10
U1 2
U2 4
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 0307-0565
EI 1476-5497
J9 INT J OBESITY
JI Int. J. Obes.
PD 2022 FEB
PY 2022
VL 46
IS 2
BP 269
EP 278
DI 10.1038/s41366-021-00985-1
EA OCT 2021
PG 10
WC Endocrinology & Metabolism; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA YQ3IK
UT WOS:000708345400003
PM 34663892
OA Green Accepted, Green Published, hybrid
DA 2024-02-19
ER

PT J
AU Nilsson, O
   Mitchum, RD
   Schrier, L
   Ferns, SP
   Barnes, KM
   Troendle, JF
   Baron, J
AF Nilsson, O
   Mitchum, RD
   Schrier, L
   Ferns, SP
   Barnes, KM
   Troendle, JF
   Baron, J
TI Growth plate senescence is associated with loss of DNA methylation
SO JOURNAL OF ENDOCRINOLOGY
LA English
DT Article
ID CATCH-UP GROWTH; HUMAN FIBROBLASTS; RESTING ZONE; HUMAN-CELLS;
   LIFE-SPAN; CULTURE; DIFFERENTIATION; TELOMERASE; CARTILAGE; BIOLOGY
AB The overall body size of vertebrates is primarily determined by longitudinal bone growth at the growth plate. With age, the growth plate undergoes programmed senescence, causing longitudinal bone growth to slow and eventually cease. Indirect evidence suggests that growth plate senescence occurs because stem-like cells in the growth plate resting zone have a finite proliferative capacity that is gradually exhausted. Similar limits on replication have been observed when many types of animal cells are placed in cell culture, an effect known as the Hayflick phenomenon. However, we found that the number of population doublings of rabbit resting zone chondrocytes in culture did not depend on the age of the animal from which the cells were harvested, suggesting that the mechanisms limiting replicative capacity of growth plate chondrocytes in vivo are distinct from those in vitro. We also observed that the level of DNA methylation in resting zone chondrocytes decreased with age in vivo. This loss of methylation appeared to occur specifically with the slow proliferation of resting zone chondrocytes in vivo and was not observed with the rapid proliferation of proliferative zone chondrocytes in vivo (i.e. the level of DNA methylation did not change from the resting zone to the hypertrophic zone), with proliferation of chondrocytes in vitro, or with growth of the liver in vivo. Thus, the overall level of DNA methylation decreases during growth plate senescence. This finding is consistent with the hypothesis that the mechanism limiting replication of growth plate chondrocytes in vivo involves loss of DNA methylation and, thus, loss of DNA methylation might be a fundamental biological mechanism that limits longitudinal bone growth in mammals, thereby determining the overall adult size of the organism.
C1 NICHD, Dev Endocrinol Branch, NIH, Bethesda, MD 20892 USA.
   NICHD, Biometry & Math Stat Branch, NIH, Bethesda, MD 20892 USA.
C3 National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver
   National Institute of Child Health & Human Development (NICHD); National
   Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National
   Institute of Child Health & Human Development (NICHD)
RP Nilsson, O (corresponding author), NICHD, Dev Endocrinol Branch, NIH, Bldg CRC,Room 1-3330,10 Ctr Dr MSC 1103, Bethesda, MD 20892 USA.
EM oia.nilsson@nih.gov
RI Nilsson, Ola/C-4609-2008; Schrier, Lenneke/IUN-0742-2023
OI Nilsson, Ola/0000-0002-9986-8138; Baron, Jeffrey/0000-0002-7311-9112
CR Abad V, 2002, ENDOCRINOLOGY, V143, P1851, DOI 10.1210/en.143.5.1851
   BARON J, 1994, ENDOCRINOLOGY, V135, P1367, DOI 10.1210/en.135.4.1367
   BESTOR TH, 1984, MOL CELL BIOL, V4, P1800, DOI 10.1128/MCB.4.9.1800
   Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4
   Campisi J, 1997, EUR J CANCER, V33, P703, DOI 10.1016/S0959-8049(96)00058-5
   Cheung JOP, 2001, J BONE MINER RES, V16, P309, DOI 10.1359/jbmr.2001.16.2.309
   Chrysis D, 2002, ENDOCRINE, V18, P271, DOI 10.1385/ENDO:18:3:271
   Chung UI, 2001, J CLIN INVEST, V107, P295, DOI 10.1172/JCI11706
   CRISTOFALO VJ, 1993, PHYSIOL REV, V73, P617, DOI 10.1152/physrev.1993.73.3.617
   Cristofalo VJ, 1998, P NATL ACAD SCI USA, V95, P10614, DOI 10.1073/pnas.95.18.10614
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Eden S, 1998, NATURE, V394, P842, DOI 10.1038/29680
   EVANS CH, 1983, MECH AGEING DEV, V22, P179, DOI 10.1016/0047-6374(83)90111-2
   FAIRWEATHER DS, 1987, EXP CELL RES, V168, P153, DOI 10.1016/0014-4827(87)90424-1
   Gafni RI, 2001, PEDIATR RES, V50, P618, DOI 10.1203/00006450-200111000-00014
   GOLDSTEIN S, 1974, EXP CELL RES, V88, P359, DOI 10.1016/0014-4827(74)90252-3
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   Hemann MT, 2000, NUCLEIC ACIDS RES, V28, P4474, DOI 10.1093/nar/28.22.4474
   Holliday R, 1985, Basic Life Sci, V35, P269
   Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947
   KAJI K, 1979, EXP GERONTOL, V14, P329, DOI 10.1016/0531-5565(79)90045-7
   Martin JA, 2002, J GERONTOL A-BIOL, V57, pB48, DOI 10.1093/gerona/57.2.B48
   Martin JA, 2001, J GERONTOL A-BIOL, V56, pB172, DOI 10.1093/gerona/56.4.B172
   MASOUD I, 1986, J ORTHOP RES, V4, P221, DOI 10.1002/jor.1100040211
   *NAT RES COUNC, 2003, GUID CAR US LAB AN
   Nwosu BU, 2005, HORM RES, V63, P125, DOI 10.1159/000084687
   SHAPIRO F, 1977, J BONE JOINT SURG AM, V59, P703, DOI 10.2106/00004623-197759060-00001
   STANULISPRAEGER BM, 1987, MECH AGEING DEV, V38, P1, DOI 10.1016/0047-6374(87)90109-6
   STEIN R, 1982, P NATL ACAD SCI-BIOL, V79, P61, DOI 10.1073/pnas.79.1.61
   Stevens DG, 1999, J PEDIATR ORTHOPED, V19, P398, DOI 10.1097/00004694-199905000-00022
   Sun LQ, 2004, GENE DEV, V18, P1035, DOI 10.1101/gad.1176104
   WALKER KVR, 1972, CELL TISSUE KINET, V5, P409, DOI 10.1111/j.1365-2184.1972.tb00379.x
   Weise M, 2001, P NATL ACAD SCI USA, V98, P6871, DOI 10.1073/pnas.121180498
   WIGLER M, 1981, CELL, V24, P33, DOI 10.1016/0092-8674(81)90498-0
   WILSON VL, 1983, SCIENCE, V220, P1054
   WROBLEWSKI J, 1995, J BONE MINER RES, V10, P735
   Young JI, 2001, J BIOL CHEM, V276, P19610, DOI 10.1074/jbc.M009470200
NR 38
TC 35
Z9 37
U1 0
U2 3
PU BIOSCIENTIFICA LTD
PI BRISTOL
PA STARLING HOUSE, 1600 BRISTOL PARKWAY N, BRISTOL, ENGLAND
SN 0022-0795
EI 1479-6805
J9 J ENDOCRINOL
JI J. Endocrinol.
PD JUL
PY 2005
VL 186
IS 1
BP 241
EP 249
DI 10.1677/joe.1.06016
PG 9
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 947UD
UT WOS:000230671900023
PM 16002553
OA Bronze
DA 2024-02-19
ER

PT J
AU Yamaguchi, Y
   Nozawa, K
   Savoysky, E
   Hayakawa, N
   Nimura, Y
   Yoshida, S
AF Yamaguchi, Y
   Nozawa, K
   Savoysky, E
   Hayakawa, N
   Nimura, Y
   Yoshida, S
TI Change in telomerase activity of rat organs during growth and aging
SO EXPERIMENTAL CELL RESEARCH
LA English
DT Article
DE telomerase; rat; organs; regenerating liver; growth; aging
ID IMMORTAL CELL-LINES; BILIARY DRAINAGE; HL-60 CELLS; DIFFERENTIATION;
   LIVER; TISSUES; CANCER; REGENERATION; REPLICATION; NEOPLASMS
AB Telomerase activity is usually undetectable in adult human tissues, hut is positive in embryonic tissues and in cancers. In rodents, however, several organs of normal adult animals express substantial amounts of telomerase activity. In this study, we observed the changes in the telomerase activity in rat organs during growth and aging and found that telomerase activity showed chronological patterns which were characteristic to organs. In lung and brain, the high telomerase activity of embryonic stage decreased rapidly after birth. In lymphoid tissues, telomerase activity increased after birth and reached to its maximum at 4 to 7 week. In liver, it stayed at nearly constant level throughout life. The telomerase activity in regenerating rat liver decreased temporally immediately after partial hepatectomy, then increased to a level that is higher than normal control. In contrast, it rapidly diminished in the occluded lobes after ligation of portal veils branch. (C) 1998 Academic Press.
C1 Nagoya Univ, Sch Med, Dis Mechanism & Control Res Inst, Canc Cell Biol Lab,Showa Ku, Nagoya, Aichi 466, Japan.
   Nagoya Univ, Sch Med, Dept Surg 1, Showa Ku, Nagoya, Aichi 466, Japan.
   Chugai Biopharmaceut Inc, San Diego, CA 92121 USA.
C3 Nagoya University; Nagoya University; Chugai Pharmaceutical Co., Ltd.;
   Roche Holding
RP Yoshida, S (corresponding author), Nagoya Univ, Sch Med, Dis Mechanism & Control Res Inst, Canc Cell Biol Lab,Showa Ku, Tsurumai Cho 65, Nagoya, Aichi 466, Japan.
CR Albanell J, 1996, CANCER RES, V56, P1503
   Bestilny LJ, 1996, CANCER RES, V56, P3796
   BLACKBURN EH, 1991, TRENDS BIOCHEM SCI, V16, P378, DOI 10.1016/0968-0004(91)90155-O
   BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   BROCCOLI D, 1995, P NATL ACAD SCI USA, V92, P9082, DOI 10.1073/pnas.92.20.9082
   Burger AM, 1997, BRIT J CANCER, V75, P516, DOI 10.1038/bjc.1997.90
   CHADENEAU C, 1995, CANCER RES, V55, P2533
   FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491
   Golubovskaya VM, 1997, ONCOGENE, V15, P1233, DOI 10.1038/sj.onc.1201278
   Greider CW, 1991, CURR OPIN CELL BIOL, V3, P444, DOI 10.1016/0955-0674(91)90072-7
   GREIDER CW, 1991, MOL CELL BIOL, V11, P4572, DOI 10.1128/MCB.11.9.4572
   HARLEY CB, 1991, MUTAT RES, V256, P271, DOI 10.1016/0921-8734(91)90018-7
   Higgins GM, 1931, ARCH PATHOL, V12, P186
   Hiyama E, 1996, J NATL CANCER I, V88, P116, DOI 10.1093/jnci/88.2.116
   HIYAMA K, 1995, J NATL CANCER I, V87, P895, DOI 10.1093/jnci/87.12.895
   HIYAMA K, 1995, J IMMUNOL, V155, P3711
   Holt SE, 1996, MOL CELL BIOL, V16, P2932
   IYOMASA S, 1992, EUR SURG RES, V24, P265, DOI 10.1159/000129215
   KEENAN KP, 1995, TOXICOL PATHOL, V23, P269, DOI 10.1177/019262339502300305
   KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428
   Kim NW, 1997, NUCLEIC ACIDS RES, V25, P2595, DOI 10.1093/nar/25.13.2595
   Kruk PA, 1996, BIOCHEM BIOPH RES CO, V224, P487, DOI 10.1006/bbrc.1996.1054
   LEVY MZ, 1992, J MOL BIOL, V225, P951, DOI 10.1016/0022-2836(92)90096-3
   MACIEIRACOELHO A, 1988, ANTICANCER RES, V8, P669
   Meeker AK, 1996, ENDOCRINOLOGY, V137, P5743, DOI 10.1210/en.137.12.5743
   Mizuno S, 1996, J SURG RES, V60, P249, DOI 10.1006/jsre.1996.0039
   NAGINO M, 1995, HEPATOLOGY, V21, P434, DOI 10.1002/hep.1840210226
   ODA H, 1995, BIOCHEM BIOPH RES CO, V212, P800, DOI 10.1006/bbrc.1995.2039
   PROWSE KR, 1995, P NATL ACAD SCI USA, V92, P4818, DOI 10.1073/pnas.92.11.4818
   RHYU MS, 1995, J NATL CANCER I, V87, P884, DOI 10.1093/jnci/87.12.884
   Savoysky E, 1996, BIOCHEM BIOPH RES CO, V226, P329, DOI 10.1006/bbrc.1996.1356
   Sharma HW, 1995, P NATL ACAD SCI USA, V92, P12343, DOI 10.1073/pnas.92.26.12343
   STEINER PE, 1961, AM J PATHOL, V39, P257
   SUZUKI H, 1994, HEPATOLOGY, V20, P1318, DOI 10.1002/hep.1840200532
   TAHARA H, 1995, CANCER RES, V55, P2734
   Takeuchi E, 1996, J SURG RES, V65, P15, DOI 10.1006/jsre.1996.0337
   Taylor RS, 1996, J INVEST DERMATOL, V106, P759, DOI 10.1111/1523-1747.ep12345811
   TERASAKI M, 1991, JPN J CANCER RES, V82, P170, DOI 10.1111/j.1349-7006.1991.tb01825.x
   Wright WE, 1996, DEV GENET, V18, P173
   Xu D, 1996, LEUKEMIA, V10, P1354
   Yoshimi N, 1996, MOL CARCINOGEN, V16, P1, DOI 10.1002/(SICI)1098-2744(199605)16:1<1::AID-MC1>3.0.CO;2-N
NR 42
TC 48
Z9 52
U1 0
U2 3
PU ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0014-4827
J9 EXP CELL RES
JI Exp. Cell Res.
PD JUL 10
PY 1998
VL 242
IS 1
BP 120
EP 127
DI 10.1006/excr.1998.4102
PG 8
WC Oncology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Cell Biology
GA 102MD
UT WOS:000074927400014
PM 9665809
DA 2024-02-19
ER

PT J
AU Chen, P
   Chen, FC
   Zhou, BH
AF Chen, Peng
   Chen, Fuchao
   Zhou, Benhong
TI Antioxidative, anti-inflammatory and anti-apoptotic effects of ellagic
   acid in liver and brain of rats treated by D-galactose
SO SCIENTIFIC REPORTS
LA English
DT Article
ID IN-VITRO ANTIOXIDANT; MEMORY IMPAIRMENT; URINARY METABOLOMICS; COGNITIVE
   IMPAIRMENT; COLONIC METABOLITE; ALZHEIMERS-DISEASE; DYSFUNCTION;
   OXIDATION; PROTECTS; EXTRACT
AB Accumulating evidence has suggested that oxidative stress and apoptosis are involved in the ageing process. D-galactose (gal) has been reported to cause symptoms of ageing in rats, accompanied by liver and brain injuries. Our study aimed to investigate the potential antioxidative, anti-inflammatory and anti-apoptotic effects of ellagic acid and to explore how these effects act on rats in a D-gal-induced ageing model. Ageing was induced by subcutaneous injection of D-gal (100 mg/kg/d for 8 weeks). Ellagic acid was simultaneously administered to the D-gal-induced ageing rats once daily by intragastric gavage. Finally, the mental condition, body weight, organ index, levels of inflammatory cytokines, antioxidative enzymes, and liver function, as well as the expression of pro-and anti-apoptotic proteins, were monitored. Our results showed that ellagic acid could improve the mental condition, body weight, organ index and significantly decrease the levels of inflammatory cytokines, normalize the activities of antioxidative enzymes, and modulate the expression of apoptotic protein in ageing rats. In conclusion, the results of this study illustrate that ellagic acid was suitable for the treatment of some ageing-associated problems, such as oxidative stress, and had beneficial effects for age-associated diseases.
C1 [Chen, Peng; Zhou, Benhong] Wuhan Univ, Renmin Hosp, Dept Pharm, Wuhan 430060, Hubei, Peoples R China.
   [Zhou, Benhong] Wuhan Univ, Sch Pharmaceut Sci, Wuhan 430071, Hubei, Peoples R China.
   [Chen, Fuchao] Hubei Univ Med, Dongfeng Hosp, Dept Pharm, Shi Yan 442008, Hubei, Peoples R China.
C3 Wuhan University; Wuhan University; Hubei University of Medicine
RP Zhou, BH (corresponding author), Wuhan Univ, Renmin Hosp, Dept Pharm, Wuhan 430060, Hubei, Peoples R China.; Zhou, BH (corresponding author), Wuhan Univ, Sch Pharmaceut Sci, Wuhan 430071, Hubei, Peoples R China.
EM benhongzh@whu.edu.cn
OI chen, fuchao/0000-0001-9738-6744; Zhou, Benhong/0000-0002-6129-0182
FU National Science Foundation of China [31570349]
FX This work was supported by National Science Foundation of China (No.
   31570349).
CR Aydin AF, 2016, METAB BRAIN DIS, V31, P337, DOI 10.1007/s11011-015-9755-0
   Baek B, 2016, KOREAN J PHYSIOL PHA, V20, P269, DOI 10.4196/kjpp.2016.20.3.269
   Bagheri SM, 2015, AM J ALZHEIMERS DIS, V30, P607, DOI 10.1177/1533317515576388
   Bharti K, 2016, BIOMETALS, V29, P399, DOI 10.1007/s10534-016-9922-8
   Cardoso A, 2015, REJUV RES, V18, P497, DOI 10.1089/rej.2015.1684
   Chang Yan-fen, 2016, Yaoxue Xuebao, V51, P86, DOI 10.16438/j.0513-4870.2015-0597
   Dolatshahi M, 2015, IRAN J BASIC MED SCI, V18, P38
   El-Shishtawy Samia Hassan, 2016, Electron Physician, V8, P1966, DOI 10.19082/1966
   Feng Y, 2016, PHARM BIOL, V54, P1027, DOI 10.3109/13880209.2015.1093510
   Griebling TL, 2016, J UROLOGY, V196, P1217, DOI 10.1016/j.juro.2016.07.029
   Grippa A, 2015, J CELL BIOL, V211, P829, DOI 10.1083/jcb.201502070
   Hoffman A, 1997, INT J NEUROSCI, V90, P223, DOI 10.3109/00207459709000640
   Hritcu L, 2015, NEUROCHEM RES, V40, P1799, DOI 10.1007/s11064-015-1662-6
   Huidekoper HH, 2005, MOL GENET METAB, V84, P265, DOI 10.1016/j.ymgme.2004.09.013
   Ibero-Baraibar I, 2016, FOOD FUNCT, V7, P1924, DOI [10.1039/C5FO01191D, 10.1039/c5fo01191d]
   James EL, 2015, J PROTEOME RES, V14, P1854, DOI 10.1021/pr501221g
   Ji ZH, 2015, J MOL NEUROSCI, V55, P678, DOI 10.1007/s12031-014-0407-3
   Lakshmi BVS, 2015, BIOL TRACE ELEM RES, V165, P67, DOI 10.1007/s12011-015-0229-3
   Li YJ, 2016, ONCOTARGET, V7, P17393, DOI 10.18632/oncotarget.8165
   Liu XY, 2012, FOOD AGR IMMUNOL, V23, P69, DOI 10.1080/09540105.2011.604770
   Lv RX, 2014, UNDERSEA HYPERBAR M, V41, P183
   Ma KS, 2014, PAK J ZOOL, V46, P215
   Portugal EMM, 2015, CNS NEUROL DISORD-DR, V14, P1209, DOI 10.2174/1871527315666151111121749
   NAG NK, 1981, J CATAL, V68, P77, DOI 10.1016/0021-9517(81)90041-5
   Neprasova M., 2016, DIS MARKERS, V2016, P1
   Oliveira M. R. D., 2016, NEUROCHEM RES, V41, P1
   Omur AD, 2016, VET MED-CZECH, V61, P10, DOI 10.17221/8677-VETMED
   Park JH, 2016, CENT EUR J IMMUNOL, V41, P324, DOI 10.5114/ceji.2016.63134
   Patel D, 2015, J AM COLL SURGEONS, V221, pS61, DOI 10.1016/j.jamcollsurg.2015.07.135
   Promsong A, 2015, J ORAL PATHOL MED, V44, P214, DOI 10.1111/jop.12223
   Qiu ZP, 2013, FOOD CHEM TOXICOL, V59, P428, DOI 10.1016/j.fct.2013.06.025
   Qu Z, 2016, PHYSIOL BEHAV, V154, P114, DOI 10.1016/j.physbeh.2015.11.016
   Rathod R, 2016, J BIOMED SCI, V23, DOI 10.1186/s12929-016-0241-8
   Rehman SU, 2017, MOL NEUROBIOL, V54, P255, DOI 10.1007/s12035-015-9604-5
   Jordao JBR, 2017, PLANTA MED, V83, P830, DOI 10.1055/s-0043-103281
   Sayar I, 2016, J OBSTET GYNAECOL RE, V42, P52, DOI 10.1111/jog.12858
   Schmedes M, 2016, MOL NUTR FOOD RES, V60, P1661, DOI 10.1002/mnfr.201500785
   Senn AC, 2017, GEOCHIM COSMOCHIM AC, V202, P341, DOI 10.1016/j.gca.2016.12.033
   Shaikh N.H., 2015, Ajpcr, V8, P72
   Tsai CT, 2016, J MED FOOD, V19, P300, DOI 10.1089/jmf.2014.3340
   Turgut N. H., 2015, PHARMBIOL, V54, P1
   Turgut NH, 2015, TURK J MED SCI, V45, P1127, DOI 10.3906/sag-1405-95
   Minh Doan V, 2015, FOOD FUNCT, V6, P1712, DOI [10.1039/C5FO00238A, 10.1039/c5fo00238a]
   Ortiz-Ruiz CV, 2016, J DERMATOL SCI, V82, P115, DOI 10.1016/j.jdermsci.2016.02.004
   Wang DL, 2012, BIOL PHARM BULL, V35, P2128, DOI 10.1248/bpb.b12-00238
   Wang HY, 2016, INT J IMMUNOPATH PH, V29, P376, DOI 10.1177/0394632016634348
   Wang T, 2015, J PHARM PHARMACOL, V67, P1284, DOI 10.1111/jphp.12413
   Wang Y, 2015, TOXICOL IN VITRO, V29, P1107, DOI 10.1016/j.tiv.2015.04.008
   Wu J, 2017, POLYM DEGRAD STABIL, V135, P43, DOI 10.1016/j.polymdegradstab.2016.11.017
   Xiao J, 2015, FOOD SCI BIOTECHNOL, V24, P1487, DOI 10.1007/s10068-015-0192-y
   Xiong LN, 2016, J MED FOOD, V19, P54, DOI 10.1089/jmf.2015.3462
   Xu LQ, 2016, FOOD FUNCT, V7, P4545, DOI 10.1039/c6fo01057a
   Yang C, 2015, J CELL PHYSIOL, V230, P2403, DOI 10.1002/jcp.24970
   Yang H., 2016, INT J FOOD SCI NUTR, V67, P1
   Yasui Yuko, 2016, J Drug Alcohol Res, V5
   Yousef Amany I, 2016, Asian Pac J Cancer Prev, V17, P743
   Yu XY, 2015, RSC ADV, V5, P69800, DOI 10.1039/c5ra10668k
   Zhen YZ, 2016, EXP THER MED, V11, P303, DOI 10.3892/etm.2015.2858
   Zou W, 2016, EXP THER MED, V11, P1653, DOI 10.3892/etm.2016.3142
NR 59
TC 120
Z9 125
U1 5
U2 42
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JAN 23
PY 2018
VL 8
AR 1465
DI 10.1038/s41598-018-19732-0
PG 10
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA FT3KS
UT WOS:000423046600009
PM 29362375
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Golubovskaya, VM
   Filatov, LV
   Behe, CI
   Presnell, SC
   Hooth, MJ
   Smith, GJ
   Kaufmann, WK
AF Golubovskaya, VM
   Filatov, LV
   Behe, CI
   Presnell, SC
   Hooth, MJ
   Smith, GJ
   Kaufmann, WK
TI Telomere shortening, telomerase expression, and chromosome instability
   in rat hepatic epithelial stem-like cells
SO MOLECULAR CARCINOGENESIS
LA English
DT Article
DE telomere; telomerase; rat; stem cell; hepatocarcinogenesis
ID PAPILLOMAVIRUS TYPE-16 E6; IMMORTAL HUMAN-CELLS; CATALYTIC SUBUNIT;
   HUMAN FIBROBLASTS; CHECKPOINT FUNCTION; RNA COMPONENT; LIVER; CANCER;
   LENGTH; (TTAGGG)N
AB Telomeres, which are specialized structures consisting of T(2)AG(3) repeats and proteins at the ends of chromosomes, may be essential for genomic stability. To test whether telomere length maintenance preserves genomic stability in rats (Rattus rattus and Fischer 344), we assayed telomerase activity and telomere length in the rat hepatic epithelial stem-like cell line WB-F344 during aging in vitro and in tumor-derived lines. Telomerase activity in the parental WB-F344 line was repressed at low and intermediate passage levels in vitro and reexpressed at high passages. Southern blot hybridization and quantitative fluorescence in situ hybridization analyses demonstrated that telomeres were significantly eroded at intermediate passage levels, when telomerase was repressed, and at high passage levels, when telomerase was expressed. Fluorescence in situ hybridization analysis also revealed interstitial telomeric sequences in rat chromosomes. Tumor-derived WB-F344 cell lines that express telomerase had variably shortened telomeres. Cytogenetic analyses performed on WB-F344 cells at low, intermediate, and high passages demonstrated that chromosome instability was most severe in the intermediate passage cells. These data suggest that telomere shortening during aging of rat hepatic epithelial stem-like WB-F344 cells in vitro and during selection of tumorigenic lines in vivo may destabilize chromosomes. Expression of telomerase in high passage cells appeared to partially stabilize chromosomes. Mol. Carcinog. 24:209-217, 1999. (C) 1999 Wiley-Liss. Inc.
C1 Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.
   Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA.
   Univ N Carolina, Curriculum Toxicol, Chapel Hill, NC 27599 USA.
C3 University of North Carolina; University of North Carolina Chapel Hill;
   University of North Carolina; University of North Carolina Chapel Hill;
   University of North Carolina; University of North Carolina Chapel Hill
RP Golubovskaya, VM (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, CB 7295,Rm 351, Chapel Hill, NC 27599 USA.
FU NCI NIH HHS [CA 59486, CA 59496] Funding Source: Medline; NIEHS NIH HHS
   [ES 07126] Funding Source: Medline
CR ASHLEY T, 1993, CYTOGENET CELL GENET, V62, P169, DOI 10.1159/000133464
   Balajee AS, 1996, MUTAT RES-FUND MOL M, V372, P163, DOI 10.1016/S0027-5107(96)00136-4
   BLACKBURN EH, 1992, ANNU REV BIOCHEM, V61, P113, DOI 10.1146/annurev.bi.61.070192.000553
   BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0
   Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4
   Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349
   Bryan TM, 1997, HUM MOL GENET, V6, P921, DOI 10.1093/hmg/6.6.921
   BRYAN TM, 1995, EMBO J, V14, P4240, DOI 10.1002/j.1460-2075.1995.tb00098.x
   COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x
   Counter CM, 1997, P NATL ACAD SCI USA, V94, P9202, DOI 10.1073/pnas.94.17.9202
   FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491
   Filatov L, 1998, ONCOGENE, V16, P1825, DOI 10.1038/sj.onc.1201711
   Gilley D, 1996, MOL CELL BIOL, V16, P66
   Golubovskaya VM, 1997, ONCOGENE, V15, P1233, DOI 10.1038/sj.onc.1201278
   Greaves M, 1996, TRENDS GENET, V12, P127, DOI 10.1016/0168-9525(96)30016-4
   GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9
   GRISHAM JW, 1993, P SOC EXP BIOL MED, V204, P270
   HARLEY CB, 1994, COLD SPRING HARB SYM, V59, P307, DOI 10.1101/SQB.1994.059.01.035
   HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0
   HASTIE ND, 1989, TRENDS GENET, V5, P326, DOI 10.1016/0168-9525(89)90137-6
   Hooth MJ, 1998, HEPATOLOGY, V28, P78, DOI 10.1002/hep.510280112
   Kaufmann WK, 1997, CELL GROWTH DIFFER, V8, P1105
   KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428
   KIPLING D, 1990, NATURE, V347, P400, DOI 10.1038/347400a0
   Lansdorp PM, 1996, HUM MOL GENET, V5, P685, DOI 10.1093/hmg/5.5.685
   Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345
   LEE LW, 1989, AM J PATHOL, V135, P63
   Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561
   MAKAROV VL, 1993, CELL, V73, P775, DOI 10.1016/0092-8674(93)90256-P
   Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3
   MEYNE J, 1990, CHROMOSOMA, V99, P3, DOI 10.1007/BF01737283
   MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622
   MURAMATSU Y, 1994, MAMM GENOME, V5, P832, DOI 10.1007/BF00292031
   Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955
   Nakayama JI, 1997, CELL, V88, P875, DOI 10.1016/S0092-8674(00)81933-9
   Niida H, 1998, NAT GENET, V19, P203, DOI 10.1038/580
   Ohashi K, 1996, JPN J CANCER RES, V87, P419, DOI 10.1111/j.1349-7006.1996.tb00239.x
   OLOVNIKOV A M, 1971, Doklady Biochemistry, V201, P394
   ROGAN EM, 1995, MOL CELL BIOL, V15, P4745
   Sargent L, 1996, CANCER RES, V56, P2985
   Shay JW, 1996, TRENDS GENET, V12, P129, DOI 10.1016/0168-9525(96)30018-8
   TSAO MS, 1987, AM J PATHOL, V127, P168
   TSAO MS, 1984, EXP CELL RES, V154, P38, DOI 10.1016/0014-4827(84)90666-9
   vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0
   Vermeesch JR, 1997, HUM GENET, V99, P735, DOI 10.1007/s004390050440
   WEBER B, 1991, MAMM GENOME, V1, P211, DOI 10.1007/BF00352327
   WELLS RA, 1990, GENOMICS, V8, P699, DOI 10.1016/0888-7543(90)90257-U
   WynfordThomas D, 1997, NATURE, V389, P551, DOI 10.1038/39207
   YOSHIDA Y, 1992, CLIN EXP METASTAS, V10, P337, DOI 10.1007/BF00058173
   Zakian VA, 1997, CELL, V91, P1, DOI 10.1016/S0092-8674(01)80001-5
   ZAKIAN VA, 1995, SCIENCE, V270, P1601, DOI 10.1126/science.270.5242.1601
   Zijlmans JMJM, 1997, P NATL ACAD SCI USA, V94, P7423, DOI 10.1073/pnas.94.14.7423
NR 52
TC 23
Z9 25
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0899-1987
EI 1098-2744
J9 MOL CARCINOGEN
JI Mol. Carcinog.
PD MAR
PY 1999
VL 24
IS 3
BP 209
EP 217
DI 10.1002/(SICI)1098-2744(199903)24:3<209::AID-MC7>3.0.CO;2-F
PG 9
WC Biochemistry & Molecular Biology; Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Oncology
GA 185BP
UT WOS:000079648500007
PM 10204805
DA 2024-02-19
ER

PT J
AU Li, YC
   Li, X
   Xue, Q
   Wang, JT
   Tan, J
AF Li, Yuchen
   Li, Xia
   Xue, Qian
   Wang, Jingtong
   Tan, Jiang
TI High-fat diet and dyslipidemia synergistically contribute to T cell
   senescence in gut associated lymphoid tissue
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article; Early Access
DE T cell senescence; Gut-associated lymphoid tissue; Intestinal immunity;
   Obesity; High-fat diet
ID THYMIC INVOLUTION; RESISTANT MICE; OBESITY; IMMUNE; INFECTION; IMPACT;
   IMMUNOSENESCENCE; ACCUMULATION; PATHOGENESIS; LYMPHOCYTES
AB Obesity can compromise immune response and immune surveillance. Recent studies have linked obesity with systemic T cell senescence and thymus involution. However, these studies failed to distinguish the influence of obesity from the influence of diet composition on premature T cell senescence. High-fat diet (HFD) can influence the immunity of gut-associated lymphoid tissue (GALT) preceding the onset of obesity. Despite GALT is sensitive to the changes in the dietary composition and metabolic status, it still remains elusive how HFD and obesity contribute to T cell senescence in the GALT. In this study, we illustrated the interplay of the HFD, obesity and intestinal immunity by comparing the immune features of diet-induced obese (DIO) to those of diet-resistant (DR) mice. As expected, DIO mice exhibited increased serum lipid levels and liver steatosis whereas dyslipidemia was absent in DR mice. DIO mice demonstrated a shift from naive to effector-memory (EM) phenotype in the T cells derived from the spleens and PPs. Moreover, DIO mice showed up-regulation of PD1 and KLRG1 on the T cells. Similar but mild trends were observed in the naive and EM T cells from DR mice. Furthermore, we proved that the senescent-like changes in splenic and PPs-derived T cells positively correlated with the serum lipid concentrations. Taken together, our results indicate that HFD components function synergistically with dyslipidemia to induce T cell senescence in the GALT.
C1 [Li, Yuchen; Li, Xia; Xue, Qian; Wang, Jingtong; Tan, Jiang] Peking Univ, Dept Geriatr, Peoples Hosp, 11 Xizhimen South St, Beijing, Peoples R China.
   [Tan, Jiang] First Peoples Hosp Yunnan, 157 Jinbi Rd, Kunming, Yunnan, Peoples R China.
C3 Peking University
RP Wang, JT (corresponding author), Peking Univ, Dept Geriatr, Peoples Hosp, 11 Xizhimen South St, Beijing, Peoples R China.
EM luckylee@bjmu.edu.cn; wangjingtong@pkuph.edu.cn
RI Li, Yuchen/HJI-4026-2023
CR Araújo JR, 2017, BIOCHIMIE, V141, P97, DOI 10.1016/j.biochi.2017.05.019
   Boi SK, 2016, OBESITY, V24, P2140, DOI 10.1002/oby.21620
   Coulter TI, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02043
   Decman V, 2012, J IMMUNOL, V188, P1933, DOI 10.4049/jimmunol.1101098
   den Braber I, 2012, IMMUNITY, V36, P288, DOI 10.1016/j.immuni.2012.02.006
   Elderman M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184274
   Frydrych L, 2018, J LEUKOCYTE BIOL, V104, P525, DOI 10.1002/JLB.5VMR0118-021RR
   Fukushima Y, 2018, INFLAMM REGEN, V38, DOI 10.1186/s41232-018-0082-9
   Funderburg NT, 2015, JAIDS-J ACQ IMM DEF, V68, P396, DOI 10.1097/QAI.0000000000000478
   Gallagher EJ, 2015, PHYSIOL REV, V95, P727, DOI 10.1152/physrev.00030.2014
   Ganusov VV, 2007, TRENDS IMMUNOL, V28, P514, DOI 10.1016/j.it.2007.08.009
   George AJT, 1996, IMMUNOL TODAY, V17, P267, DOI 10.1016/0167-5699(96)80543-3
   Habtezion A, 2016, GASTROENTEROLOGY, V150, P340, DOI 10.1053/j.gastro.2015.10.046
   Harrington KA, 2018, BRIT J RADIOL, V91, DOI 10.1259/bjr.20170609
   Henson SM, 2009, AGE, V31, P285, DOI 10.1007/s11357-009-9100-9
   Honce R, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01071
   Hong CP, 2017, GASTROENTEROLOGY, V152, P1998, DOI 10.1053/j.gastro.2017.02.016
   Le Foll C, 2015, AM J PHYSIOL-REG I, V308, pR188, DOI 10.1152/ajpregu.00367.2014
   Lee KA, 2016, AGING CELL, V15, P291, DOI 10.1111/acel.12435
   Liang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115922
   Liu F, 2017, HUM VACC IMMUNOTHER, V13, P1014, DOI 10.1080/21645515.2016.1274475
   Melis L, 2014, ANN RHEUM DIS, V73, P1223, DOI 10.1136/annrheumdis-2013-203881
   Odorizzi PM, 2015, J EXP MED, V212, P1125, DOI 10.1084/jem.20142237
   Proto JD, 2018, J CLIN INVEST, V128, P2370, DOI 10.1172/JCI97785
   Sato K, 2017, J IMMUNOL, V199, P138, DOI 10.4049/jimmunol.1602005
   Schulz MD, 2014, NATURE, V514, P508, DOI 10.1038/nature13398
   Shin NR, 2014, GUT, V63, P727, DOI 10.1136/gutjnl-2012-303839
   Shirakawa K, 2016, J CLIN INVEST, V126, P4626, DOI 10.1172/JCI88606
   Sohrab SS, 2017, CURR DRUG METAB, V18, P798, DOI 10.2174/1389200218666170116110443
   Song YZ, 2018, AGING CELL, V17, DOI 10.1111/acel.12716
   Spielmann G, 2014, CLIN EXP IMMUNOL, V176, P246, DOI 10.1111/cei.12267
   Tahir S, 2015, J IMMUNOL, V194, P5725, DOI 10.4049/jimmunol.1500319
   Tanigawa T, 2004, ATHEROSCLEROSIS, V173, P295, DOI 10.1016/j.atherosclerosis.2003.12.019
   Tavenier J, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0136-6
   Thome JJC, 2014, CELL, V159, P814, DOI 10.1016/j.cell.2014.10.026
   Wang B, 2014, CELL IMMUNOL, V288, P39, DOI 10.1016/j.cellimm.2014.02.003
   Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862
   Yang H, 2009, BLOOD, V114, P3803, DOI 10.1182/blood-2009-03-213595
   Yu HT, 2017, J AM HEART ASSOC, V6, DOI [10.1161/JAHA.117.006535, 10.1161/jaha.117.006535]
   Zidar DA, 2016, ARTERIOSCL THROM VAS, V36, P389, DOI 10.1161/ATVBAHA.115.306112
NR 40
TC 4
Z9 4
U1 1
U2 14
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD 2021 AUG
PY 2021
VL 151
AR 111404
DI 10.1016/j.exger.2021.111404
EA MAY 2021
PG 8
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA SS8BL
UT WOS:000661977800013
PM 34019944
DA 2024-02-19
ER

PT J
AU MARIA, CS
   REVILLA, R
   AYALA, A
   DELACRUZ, CP
   MACHADO, A
AF MARIA, CS
   REVILLA, R
   AYALA, A
   DELACRUZ, CP
   MACHADO, A
TI CHANGES IN THE HISTIDINE-RESIDUES OF CU/ZN SUPEROXIDE-DISMUTASE DURING
   AGING
SO FEBS LETTERS
LA English
DT Article
DE CU/ZN SUPEROXIDE DISMUTASE; PROTEIN OXIDATION; CARBONYL GROUP; AGING
ID LIVER 6-PHOSPHOGLUCONATE DEHYDROGENASE; FUNCTION OXIDATION REACTIONS;
   ENZYMATIC-ACTIVITY; PROTEIN-TURNOVER
AB Cu/Zn-Superoxide dismutase activity (Cu/Zn-SOD) was studied in liver from 3- and 24-month-old rat. A significant decrease of enzyme activity in liver of the aged rat was found. Various amino acid residues and protein carbonyl groups (GO) were measured in purified young and old enzyme, It was found that the 'old' enzyme had one histidine fewer and higher CO content than the 'young' Cu/Zn-SOD. Inactivation 'in vitro' of purified commercial bovine erythrocyte Cu/Zn-SOD led to a decrease in the enzymatic activity, an increase in the CO and one histidine residue modified. A similar behavior between aging and oxidation was suggested.
C1 UNIV SEVILLA,FAC FARM,DEPT BIOQUIM BROMATOL & TOXICOL,E-41012 SEVILLE,SPAIN.
C3 University of Sevilla
RI Ayala, Antonio/N-7591-2019; IBIS, ENVEJECIMIENTO/O-9381-2015
OI Ayala, Antonio/0000-0001-9711-3711; 
CR BRAY RC, 1974, BIOCHEM J, V39, P43
   CHAUSER J, 1972, LABORATORY TECHNIQUE, P423
   CUTLER RG, 1983, GERONTOLOGY, V29, P113, DOI 10.1159/000213102
   ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6
   FUCCI L, 1983, P NATL ACAD SCI-BIOL, V80, P1521, DOI 10.1073/pnas.80.6.1521
   GORDILLO E, 1988, J BIOL CHEM, V263, P8053
   GORDILLO E, 1989, J BIOL CHEM, V264, P17024
   GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114
   Gutteridge J. M. C., 1989, FREE RADICALS BIOL M
   HALLIWELL B, 1990, METHOD ENZYMOL, V186, P1
   HARMAN D, 1992, MUTAT RES, V275, P257, DOI 10.1016/0921-8734(92)90030-S
   KOHTARO A, 1984, ANAL BIOCHEM, V136, P336
   LENZ AG, 1989, ANAL BIOCHEM, V117, P419
   LEVINE RL, 1983, J BIOL CHEM, V258, P1828
   LOWRY OH, 1959, J BIOL CHEM, V193, P265
   MARIA CS, 1988, MECH AGEING DEV, V277, P115
   MCCORD JM, 1969, J BIOL CHEM, V244, P6049
   OLIVER CN, 1987, J AM GERIATR SOC, V35, P947, DOI 10.1111/j.1532-5415.1987.tb02297.x
   OLIVER CN, 1985, CELLULAR REGULATION, P320
   OLIVER CN, 1987, J BIOL CHEM, V262, P5486
   REISS U, 1976, EUR J BIOCHEM, V63, P617, DOI 10.1111/j.1432-1033.1976.tb10266.x
   STADTMAN ER, 1986, TRENDS BIOCHEM SCI, V11, P11, DOI 10.1016/0968-0004(86)90221-5
   TOPHAM CM, 1986, EUR J BIOCHEM, V155, P87, DOI 10.1111/j.1432-1033.1986.tb09461.x
   TUENGLER P, 1977, BIOCHIM BIOPHYS ACTA, V484, P1, DOI 10.1016/0005-2744(77)90108-5
   UCHIDA K, 1994, J BIOL CHEM, V269, P2405
   YAMASAKI RB, 1981, ANAL BIOCHEM, V111, P220, DOI 10.1016/0003-2697(81)90557-1
NR 26
TC 25
Z9 28
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0014-5793
J9 FEBS LETT
JI FEBS Lett.
PD OCT 23
PY 1995
VL 374
IS 1
BP 85
EP 88
PG 4
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA TB831
UT WOS:A1995TB83100019
PM 7589519
DA 2024-02-19
ER

PT J
AU Kaewtunjai, N
   Wongpoomchai, R
   Imsumran, A
   Pompimon, W
   Athipornchai, A
   Suksamrarn, A
   Lee, TR
   Tuntiwechapikul, W
AF Kaewtunjai, Navakoon
   Wongpoomchai, Rawiwan
   Imsumran, Arisa
   Pompimon, Wilart
   Athipornchai, Anan
   Suksamrarn, Apichart
   Lee, T. Randall
   Tuntiwechapikul, Wirote
TI Ginger Extract Promotes Telomere Shortening and Cellular Senescence in
   A549 Lung Cancer Cells
SO ACS OMEGA
LA English
DT Article
ID DIETARY PHYTOCHEMICALS; ZINGIBER-OFFICINALE; CHEMOPREVENTION; APOPTOSIS;
   INHIBITION; ANTICANCER; 6-SHOGAOL; CURCUMIN; PATHWAY
AB Replicative senescence, which is caused by telomere shortening from the end replication problem, is considered one of the tumor-suppressor mechanisms in eukaryotes. However, most cancers escape this replicative senescence by reactivating telomerase, an enzyme that extends the 3'-ends of the telomeres. Previously, we reported the telomerase inhibitory effect of a crude Zingiber officinale extract (ZOE), which suppressed hTERT expression, leading to a reduction in hTERT protein and telomerase activity in A549 lung cancer cells. In the present study, we found that ZOE-induced telomere shortening and cellular senescence during the period of 60 days when these A549 cells were treated with subcytotoxic doses of ZOE. Using assay-guided fractionation and gas chromatography/mass spectrometry analysis, we found that the major compounds in the active subfractions were paradols and shogaols of various chain lengths. The results from studies of pure 6-paradol and 6-shogaol confirmed that these two compounds could suppress hTERT expression as well as telomerase activity in A549 cells. These results suggest that these paradols and shogaols are likely the active compounds in ZOE that suppress hTERT expression and telomerase activity in these cells. Furthermore, ZOE was found to be nontoxic and had an anticlastogenic effect against diethylnitrosamine-induced liver micronucleus formation in rats. These findings suggest that ginger extract can potentially be useful in dietary cancer prevention.
C1 [Kaewtunjai, Navakoon; Wongpoomchai, Rawiwan; Imsumran, Arisa; Tuntiwechapikul, Wirote] Chiang Mai Univ, Fac Med, Dept Biochem, Chiang Mai 50200, Thailand.
   [Pompimon, Wilart] Lampang Rajabhat Univ, Lab Nat Prod, Dept Chem, Fac Sci, Lampang 52100, Thailand.
   [Pompimon, Wilart] Lampang Rajabhat Univ, Ctr Innovat Chem, Lampang 52100, Thailand.
   [Athipornchai, Anan] Burapha Univ, Ctr Excellence Innovat Chem, Dept Chem, Chon Buri 20131, Thailand.
   [Suksamrarn, Apichart] Ramkhamhang Univ, Fac Sci, Dept Chem, Bangkok 10240, Thailand.
   [Suksamrarn, Apichart] Ramkhamhang Univ, Fac Sci, Ctr Excellence Innovat Chem, Bangkok 10240, Thailand.
   [Lee, T. Randall] Univ Houston, Dept Chem, Univ Pk, Houston, TX 77204 USA.
   [Lee, T. Randall] Univ Houston, Texas Ctr Supercond, Houston, TX 77204 USA.
C3 Chiang Mai University; Lampang Rajabhat University; Lampang Rajabhat
   University; Burapha University; Ramkhamhaeng University; Ramkhamhaeng
   University; University of Houston System; University of Houston;
   University of Houston System; University of Houston
RP Tuntiwechapikul, W (corresponding author), Chiang Mai Univ, Fac Med, Dept Biochem, Chiang Mai 50200, Thailand.
EM wirotetunti@yahoo.com
RI Tuntiwechapikul, Wirote/AAL-3628-2021; Lee, T. Randall/G-6666-2019;
   Suksamrarn, Apichart/R-8782-2019
OI Lee, T. Randall/0000-0001-9584-8861; Tuntiwechapikul,
   Wirote/0000-0003-1365-476X; Bonness, Arisa/0000-0002-2787-2461
FU Office of the National Research Council of Thailand [NRMS 42913, 68044];
   Graduate Student Supportive Fund; Faculty of Medicine, Chiang Mai
   University; Thailand Research Fund [RSA5880007, DBG6180030]; Center of
   Excellence for Innovation in Chemistry; Office of the Higher Education
   Commission; Robert A. Welch Foundation [E-1320]
FX This work was supported by grants from the Office of the National
   Research Council of Thailand (NRMS 42913 and 68044), Graduate Student
   Supportive Fund, Faculty of Medicine, Chiang Mai University of the
   budget year 2014-2016 for N.K., The Thailand Research Fund (RSA5880007
   and DBG6180030), Center of Excellence for Innovation in Chemistry,
   Office of the Higher Education Commission, and the Robert A. Welch
   Foundation (grant no. E-1320).
CR Alibakhshi A, 2016, CURR MED CHEM, V23, P2380, DOI 10.2174/0929867323666160425113705
   [Anonymous], 2008, OECD GUIDELINES TEST
   Ruiz RB, 2016, MATURITAS, V94, P13, DOI 10.1016/j.maturitas.2016.08.004
   Benarroch-Popivker D, 2016, MOL CELL, V61, P274, DOI 10.1016/j.molcel.2015.12.009
   Cohen SB, 2007, SCIENCE, V315, P1850, DOI 10.1126/science.1138596
   Collett NP, 2010, SEMIN ONCOL, V37, P258, DOI 10.1053/j.seminoncol.2010.06.014
   Eren D, 2016, CHEM-BIOL INTERACT, V258, P257, DOI 10.1016/j.cbi.2016.09.012
   Gomez DLM, 2016, CURR TOP MED CHEM, V16, P2432, DOI 10.2174/1568026616666160212122425
   Gurung RL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012124
   Habib SHM, 2008, CLINICS, V63, P807, DOI 10.1590/S1807-59322008000600017
   Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9
   Hsu YL, 2015, J AGR FOOD CHEM, V63, P1730, DOI 10.1021/jf504934m
   Hung JY, 2009, J AGR FOOD CHEM, V57, P9809, DOI 10.1021/jf902315e
   Jolad SD, 2004, PHYTOCHEMISTRY, V65, P1937, DOI 10.1016/j.phytochem.2004.06.008
   Kang CG, 2016, J NAT PROD, V79, P156, DOI 10.1021/acs.jnatprod.5b00796
   Kaur IP, 2016, CURR PHARM DESIGN, V22, P4160, DOI 10.2174/1381612822666160608115350
   Khaw AK, 2013, J CELL BIOCHEM, V114, P1257, DOI 10.1002/jcb.24466
   KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428
   Kotecha R, 2016, ONCOTARGET, V7, P52517, DOI 10.18632/oncotarget.9593
   Kumar M, 2016, GENES-BASEL, V7, DOI 10.3390/genes7080043
   Kundu JK, 2009, FORUM NUTR, V61, P182, DOI 10.1159/000212750
   Mansour MA, 2010, BIOFACTORS, V36, P483, DOI 10.1002/biof.122
   Martínez P, 2010, AGING CELL, V9, P653, DOI 10.1111/j.1474-9726.2010.00596.x
   Meena Jitendra, 2015, Recent Results Cancer Res, V200, P61, DOI 10.1007/978-3-319-20291-4_3
   Merghoub N, 2016, NUTR CANCER, V68, P131, DOI 10.1080/01635581.2016.1115105
   Merghoub N, 2017, J CELL BIOCHEM, V118, P1689, DOI 10.1002/jcb.25826
   Moghaddasi M. S., 2012, Journal of Medicinal Plants Research, V6, P4255
   Naasani I, 1998, BIOCHEM BIOPH RES CO, V249, P391, DOI 10.1006/bbrc.1998.9075
   Nazim UM, 2015, ONCOL REP, V33, P2331, DOI 10.3892/or.2015.3869
   Nigam N, 2009, MOL TARGETS THERAPEU, P225
   Ohtani N, 2009, CANCER SCI, V100, P792, DOI 10.1111/j.1349-7006.2009.01123.x
   Punvittayagul C, 2016, NUTR CANCER, V68, P646, DOI 10.1080/01635581.2016.1158289
   Ramlee M. K., 2016, GENES, V7, pE50, DOI DOI 10.3390/GENES7080050)
   Scalbert A, 2011, J AGR FOOD CHEM, V59, P4331, DOI 10.1021/jf200591d
   Shay JW, 2008, BRIT J CANCER, V98, P677, DOI 10.1038/sj.bjc.6604209
   Shay JW, 2000, NAT REV MOL CELL BIO, V1, P72, DOI 10.1038/35036093
   Surh Y. J., 2013, NAT REV CANCER, V10, P768
   Szatmari I, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.2.e3
   Taka T, 2013, BIOORGAN MED CHEM, V21, P883, DOI 10.1016/j.bmc.2012.12.020
   Tao Y, 2009, J AGR FOOD CHEM, V57, P10014, DOI 10.1021/jf9020224
   Tomita K, 2007, CELL, V130, P113, DOI 10.1016/j.cell.2007.05.024
   Tuntiwechapikul W, 2010, J MED FOOD, V13, P1347, DOI 10.1089/jmf.2010.1191
   Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179
   Victorelli S, 2017, EBIOMEDICINE, V21, P14, DOI 10.1016/j.ebiom.2017.03.027
   Wang CZ, 2015, AM J CHINESE MED, V43, P1351, DOI 10.1142/S0192415X15500767
   Warin RF, 2014, J AGR FOOD CHEM, V62, P1352, DOI 10.1021/jf405573e
   Zhang F, 2017, J AGR FOOD CHEM, V65, P2089, DOI 10.1021/acs.jafc.7b00095
NR 47
TC 13
Z9 14
U1 1
U2 11
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2470-1343
J9 ACS OMEGA
JI ACS Omega
PD DEC
PY 2018
VL 3
IS 12
BP 18572
EP 18581
DI 10.1021/acsomega.8b02853
PG 10
WC Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry
GA HL1FG
UT WOS:000458439900039
PM 32010796
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Ceci, L
   Francis, H
   Zhou, TH
   Giang, T
   Yang, ZH
   Meng, FY
   Wu, N
   Kennedy, L
   Kyritsi, K
   Meadows, V
   Wu, CD
   Liangpunsakul, S
   Franchitto, A
   Sybenga, A
   Ekser, B
   Mancinelli, R
   Onori, P
   Gaudio, E
   Glaser, S
   Alpini, G
AF Ceci, Ludovica
   Francis, Heather
   Zhou, Tianhao
   Giang, Thao
   Yang, Zhihong
   Meng, Fanyin
   Wu, Nan
   Kennedy, Lindsey
   Kyritsi, Konstantina
   Meadows, Vik
   Wu, Chaodong
   Liangpunsakul, Suthat
   Franchitto, Antonio
   Sybenga, Amelia
   Ekser, Burcin
   Mancinelli, Romina
   Onori, Paolo
   Gaudio, Eugenio
   Glaser, Shannon
   Alpini, Gianfranco
TI Knockout of the Tachykinin Receptor 1 in the Mdr2<SUP>-/-</SUP>
   (<i>Abcb4</i><SUP>-/-</SUP>) Mouse Model of Primary Sclerosing
   Cholangitis Reduces Biliary Damage and Liver Fibrosis
SO AMERICAN JOURNAL OF PATHOLOGY
LA English
DT Article
ID SUBSTANCE-P; CELL-PROLIFERATION; STELLATE CELLS; PROTECT MICE;
   CHOLANGIOCYTES; ACTIVATION; SENESCENCE; EXPRESSION; SECRETION; CIRRHOSIS
AB Activation of the substance P (SP)/neurokinin 1 receptor (NK1R) axis triggers biliary damage/senescence and liver fibrosis in bile duct ligated and Mdr2(-/-) (alias Abcb4(-/-)) mice through enhanced transforming growth factor-beta 1 (TGF-beta 1) biliary secretion. Recent evidence indicates a role for miR-31 (MIR31) in TGF-beta 1-induced liver fibrosis. We aimed to define the role of the SP/NK1R/TGF-beta 1/miR-31 axis in regulating biliary proliferation and liver fibrosis during cholestasis. Thus, we generated a novel model with double knockout of Mdr2(-/-) and NK1R(-/) (alias Tacr1(-/-)) to further address the role of the SP/NK1R axis during chronic cholestasis. In vivo studies were performed in the following 12-week-old male mice: (i) NK1R(-/-); (ii) Mdr2(-/-); and (iii) NK1R(-/-)/Mdr2(-/-) (Tacr1(-/-)/Abcb4(-/-)) and their corresponding wild-type controls. Liver tissues and cholangiocytes were collected, and liver damage, changes in biliary mass/senescence, and inflammation as well as liver fibrosis were evaluated by both immunohistochemistry in liver sections and real-time PCR. miR-31 expression was measured by real-time PCR in isolated cholangiocytes. Decreased ductular reaction, liver fibrosis, biliary senescence, and biliary inflammation were observed in NK1R(-/-)/Mdr2(-/-) mice compared with Mdr2(-/-) mice. Elevated expression of miR-31 was observed in Mdr2(-/-) mice, which was reduced in NK1R(-/-)/Mdr2(-/-) mice. Targeting the SP/NK1R and/or miR-31 may be a potential approach in treating human cholangiopathies, including primary sclerosing cholangitis.
C1 [Ceci, Ludovica; Francis, Heather; Yang, Zhihong; Meng, Fanyin; Wu, Nan; Kennedy, Lindsey; Kyritsi, Konstantina; Meadows, Vik; Liangpunsakul, Suthat; Alpini, Gianfranco] Indiana Univ, Div Hepatol & Gastroenterol, Med, Indianapolis, IN 46202 USA.
   [Ekser, Burcin] Indiana Univ, Div Transplant Surg, Dept Surg, Indianapolis, IN 46202 USA.
   [Francis, Heather; Meng, Fanyin; Liangpunsakul, Suthat; Alpini, Gianfranco] Richard L Roudebush VA Med Ctr, Indianapolis, IN USA.
   [Zhou, Tianhao; Giang, Thao; Glaser, Shannon] Texas A&M Univ, Dept Med Physiol, Bryan, TX USA.
   [Wu, Chaodong] Texas A&M Univ, College Stn, TX USA.
   [Franchitto, Antonio] Eleonora Lorillard Spencer Cenci Fdn, Rome, Italy.
   [Sybenga, Amelia] Univ Vermont, Med Ctr, Dept Pathol & Lab Med, Burlington, VT USA.
   [Mancinelli, Romina; Onori, Paolo; Gaudio, Eugenio] Sapienza Univ Rome, Dept Anat Histol Forens Med & Orthoped Sci, Rome, Italy.
C3 Indiana University System; Indiana University-Purdue University
   Indianapolis; Indiana University System; Indiana University-Purdue
   University Indianapolis; US Department of Veterans Affairs; Veterans
   Health Administration (VHA); Richard L. Roudebush VA Medical Center;
   Texas A&M University System; Texas A&M University College Station; Texas
   A&M University System; Texas A&M University College Station; University
   of Vermont Medical Center; University of Vermont; Sapienza University
   Rome
RP Alpini, G (corresponding author), Richard L Roudebush VA Med Ctr, Indiana Ctr Liver Res, 1481 W 10th St,Dedicat Wing,Room D-2004, Indianapolis, IN 46202 USA.; Alpini, G (corresponding author), Indiana Univ, Gastroenterol, 1481 W 10th St,Dedicat Wing,Room D-2004, Indianapolis, IN 46202 USA.
EM gianfranco.alpini@va.gov
RI Zhou, Tianhao/AAO-3542-2021; Onori, Paolo/J-9394-2013; Meadows,
   Vik/AAB-4672-2021; Ekser, Burcin/I-3288-2019
OI Zhou, Tianhao/0000-0002-5722-6954; Onori, Paolo/0000-0002-7195-3760;
   Ekser, Burcin/0000-0003-0741-8007; Meadows, Vik/0000-0002-8983-4305
FU Hickam Endowed Chair, Gastroenterology, Medicine, Indiana University;
   Indiana University HealtheIndiana University School of Medicine
   Strategic Research Initiative; US Department of Veteran's Affairs,
   Biomedical Laboratory Research and Development Service VA Merit awards
   [5I01BX000574, 1I01BX003031, 1I01BX001724]; NIH [DK108959, DK119421,
   DK054811, DK115184, DK076898, DK107310, DK110035, DK062975, AA025997,
   AA025157]; PSC Partners Seeking a Cure; Sapienza University
   [RM1181642BEF570E]
FX Supported by the Hickam Endowed Chair, Gastroenterology, Medicine,
   Indiana University; the Indiana University HealtheIndiana University
   School of Medicine Strategic Research Initiative; US Department of
   Veteran's Affairs, Biomedical Laboratory Research and Development
   Service VA Merit awards 5I01BX000574 (G.A.), 1I01BX003031 (H.F.) and
   1I01BX001724 (F.M.); NIH grants DK108959 (H.F.), DK119421 (H.F.),
   DK054811, DK115184, DK076898, DK107310, DK110035, DK062975, AA025997,
   and AA025157 (all to G.A., F.M. and S.G.); the PSC Partners Seeking a
   Cure (G.A. and F.M.); and Sapienza University funds RM1181642BEF570E
   (P.O.). This material is the result of work supported by resources at
   the Central Texas Veterans Health Care System (Temple, TX), the Richard
   L. Roudebush VA Medical Center (Indianapolis, IN), and the Medical
   Physiology, Medical Research Building (Temple, TX).
CR Alpini G, 2011, HEPATOLOGY, V53, P628, DOI 10.1002/hep.24041
   Baghdasaryan A, 2011, HEPATOLOGY, V54, P1303, DOI 10.1002/hep.24537
   Bang R, 2004, J PHARMACOL EXP THER, V308, P1174, DOI 10.1124/jpet.103.059329
   Bang R, 2003, J PHARMACOL EXP THER, V305, P31, DOI 10.1124/jpet.102.043539
   Beery RMM, 2014, J CLIN TRANSL HEPATO, V2, P266, DOI 10.14218/JCTH.2014.00024
   Fang K, 2018, AM J PATHOL, V188, P586, DOI 10.1016/j.ajpath.2017.10.023
   Glaser S, 2014, GASTROENTEROLOGY, V146, P1795, DOI 10.1053/j.gastro.2014.02.030
   Glaser S, 2011, AM J PHYSIOL-GASTR L, V301, pG297, DOI 10.1152/ajpgi.00418.2010
   Glaser S, 2010, HEPATOLOGY, V52, P204, DOI 10.1002/hep.23657
   Glaser SS, 2007, LAB INVEST, V87, P914, DOI 10.1038/labinvest.3700602
   Guicciardi ME, 2020, HEPATOLOGY, V71, P741, DOI 10.1002/hep.31067
   Hu JF, 2015, CLIN SCI, V129, P305, DOI 10.1042/CS20140012
   Ikenaga N, 2015, AM J PATHOL, V185, P325, DOI 10.1016/j.ajpath.2014.10.013
   Inoue T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200432
   Kanno N, 2001, AM J PHYSIOL-GASTR L, V281, pG612, DOI 10.1152/ajpgi.2001.281.3.G612
   Karlsen TH, 2017, J HEPATOL, V67, P1298, DOI 10.1016/j.jhep.2017.07.022
   Kennedy L, 2019, FASEB J, V33, P10269, DOI 10.1096/fj.201802606R
   Killingsworth Cheryl R., 1997, American Journal of Physiology, V273, pL1073
   Lazaridis KN, 2004, GASTROENTEROLOGY, V127, P1565, DOI 10.1053/j.gastro.2004.08.006
   Lee FY, 1997, AM J GASTROENTEROL, V92, P2080
   LeSage G, 1999, GASTROENTEROLOGY, V117, P191, DOI 10.1016/S0016-5085(99)70567-6
   Lv C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01059-5
   Mariotti V, 2019, BBA-MOL BASIS DIS, V1865, P954, DOI 10.1016/j.bbadis.2018.07.025
   Maroni L, 2015, CELL MOL GASTROENTER, V1, P368, DOI 10.1016/j.jcmgh.2015.05.005
   Meng FY, 2014, AM J PHYSIOL-GASTR L, V306, pG759, DOI 10.1152/ajpgi.00018.2014
   Meng LK, 2015, AM J PATHOL, V185, P602, DOI 10.1016/j.ajpath.2014.10.027
   Morini Sergio, 2005, Italian Journal of Anatomy and Embryology, V110, P193
   O'Connor TM, 2004, J CELL PHYSIOL, V201, P167, DOI 10.1002/jcp.20061
   Palacios RS, 2008, LAB INVEST, V88, P1192, DOI 10.1038/labinvest.2008.91
   Peng L, 2019, NEUROPEPTIDES, V76, DOI 10.1016/j.npep.2019.101941
   Peng L, 2017, TOXICOL APPL PHARM, V329, P293, DOI 10.1016/j.taap.2017.06.020
   Popov Y, 2005, J HEPATOL, V43, P1045, DOI 10.1016/j.jhep.2005.06.025
   Que KT, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0930-0
   Raven A, 2017, NATURE, V547, P350, DOI 10.1038/nature23015
   Rizvi S, 2015, CLIN GASTROENTEROL H, V13, P2152, DOI 10.1016/j.cgh.2015.05.035
   Tabibian JH, 2014, HEPATOLOGY, V59, P2263, DOI 10.1002/hep.26993
   Tanino T, 2018, BIOCHEM PHARMACOL, V158, P318, DOI 10.1016/j.bcp.2018.11.001
   Wan Y, 2019, LAB INVEST, V99, P764, DOI 10.1038/s41374-018-0178-5
   Wan Y, 2017, HEPATOLOGY, V66, P528, DOI 10.1002/hep.29138
   WEINSTOCK JV, 1988, J IMMUNOL, V141, P961
   Wu N, 2016, HEPATOLOGY, V64, P865, DOI 10.1002/hep.28622
   Yang MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085353
   Zhang BB, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00066
   Zhang YX, 2014, HEPATOLOGY, V60, P919, DOI 10.1002/hep.27121
   Zhou TH, 2018, LAB INVEST, V98, P1449, DOI 10.1038/s41374-018-0093-9
NR 45
TC 9
Z9 9
U1 1
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0002-9440
EI 1525-2191
J9 AM J PATHOL
JI Am. J. Pathol.
PD NOV
PY 2020
VL 190
IS 11
BP 2251
EP 2266
DI 10.1016/j.ajpath.2020.07.007
PG 16
WC Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology
GA OF1BX
UT WOS:000580953600007
PM 32712019
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU GREGER, JL
   RADZANOWSKI, GM
AF GREGER, JL
   RADZANOWSKI, GM
TI TISSUE ALUMINUM DISTRIBUTION IN GROWING, MATURE AND AGING RATS -
   RELATIONSHIP TO CHANGES IN GUT, KIDNEY AND BONE METABOLISM
SO FOOD AND CHEMICAL TOXICOLOGY
LA English
DT Article
ID ALZHEIMER-DISEASE; BRAIN ALUMINUM; ORAL ALUMINUM; ABSORPTION; PROTEIN;
   EXCRETION; EXPOSURE; CITRATE; ASSAY; ZINC
AB The purpose of this study was to determine whether accumulation and turnover of aluminium differed among growing (2 month old), mature (8 month old) and ageing (19 month old) rats and assess whether these differences could be ascribed to physiological changes with age. One day after a large oral dose (0.8 mmol Al in 0.75 M citrate) growing rats had the highest concentrations of aluminium in tibias, whereas ageing rats had the highest concentrations of aluminium in kidneys. The half-life of aluminium in tibias (38 v. 58 v. 173 days in growing, mature and ageing rats, respectively) and kidneys (9 v. 12 v. 16 days) lengthened with age. According to stepwise multiple regression analysis, 73% variation in tibia aluminium concentrations was explained by final body weight of rats, length of time after dosing, tibia weights, haematocrits, urinary hydroxyproline excretion, ulna calcium concentrations, and urinary creatinine excretion but 57% variation in kidney aluminium concentrations was explained by length of time after dosing and feed intake. Although age, per se, was a significant predictor of spleen and liver aluminium concentrations, the measured changes in gut, kidney, bone and mineral metabolism were less predictive of aluminium concentrations in livers and spleens than in bone.
RP GREGER, JL (corresponding author), UNIV WISCONSIN, DEPT NUTR SCI, 1415 LINDEN DR, MADISON, WI 53706 USA.
FU NIDDK NIH HHS [DK 41116] Funding Source: Medline
CR ALLEN DD, 1992, J NEUROCHEM, V58, P903, DOI 10.1111/j.1471-4159.1992.tb09342.x
   BROWN TS, 1992, BIOL TRACE ELEM RES, V34, P1, DOI 10.1007/BF02783892
   BURGESS E, 1992, AM J MED, V92, P471, DOI 10.1016/0002-9343(92)90742-T
   CANNATA JB, 1991, KIDNEY INT, V39, P799, DOI 10.1038/ki.1991.98
   ECELBARGER CA, 1994, NUTR RES, V14, P577, DOI 10.1016/S0271-5317(05)80221-0
   ECELBARGER CA, 1994, TOXICOL LETT, V73, P249, DOI 10.1016/0378-4274(94)90064-7
   ECELBARGER CA, 1991, J NUTR, V121, P1755, DOI 10.1093/jn/121.11.1755
   FULTON B, 1989, FUND APPL TOXICOL, V12, P144, DOI 10.1016/0272-0590(89)90069-9
   GANROT PO, 1986, ENVIRON HEALTH PERSP, V65, P363, DOI 10.2307/3430204
   GOLDSTEIN RS, 1988, FASEB J, V2, P2241, DOI 10.1096/fasebj.2.7.3280378
   GOVERDE BC, 1972, CLIN CHIM ACTA, V41, P29, DOI 10.1016/0009-8981(72)90492-5
   GREGER JL, 1993, ANNU REV NUTR, V13, P43, DOI 10.1146/annurev.nu.13.070193.000355
   GREGER JL, 1986, FOOD CHEM TOXICOL, V24, P1331, DOI 10.1016/0278-6915(86)90067-0
   GREGER JL, 1980, J NUTR, V110, P2243, DOI 10.1093/jn/110.11.2243
   GREGER JL, 1994, P SOC EXP BIOL MED, V207, P89, DOI 10.3181/00379727-207-43796
   GREGER JL, 1992, TOXICOLOGY, V76, P119, DOI 10.1016/0300-483X(92)90159-C
   GUPTA SK, 1986, J PHARM SCI, V75, P586, DOI 10.1002/jps.2600750613
   HAHN TJ, 1989, BONE MINERAL RES, V6, P219
   HEWITT CD, 1990, CLIN LAB MED, V10, P403, DOI 10.1016/S0272-2712(18)30576-6
   JACOBS RW, 1989, CAN J NEUROL SCI, V16, P498, DOI 10.1017/S0317167100029838
   JOHNSON MA, 1994, FASEB J, V8, P609, DOI 10.1096/fasebj.8.9.8005389
   KAWASE M, 1989, J BONE MINER RES, V4, P359
   LEE DY, 1989, P SOC EXP BIOL MED, V190, P211, DOI 10.3181/00379727-190-42852
   LEROY EC, 1967, ADV CLIN CHEM, P213
   LINDEMAN RD, 1990, AM J KIDNEY DIS, V16, P275, DOI 10.1016/S0272-6386(12)80002-3
   MARKESBERY WR, 1981, ANN NEUROL, V10, P511
   MASSIE HR, 1988, MECH AGEING DEV, V45, P145, DOI 10.1016/0047-6374(88)90104-2
   MCDERMOTT JR, 1979, NEUROLOGY, V29, P809, DOI 10.1212/WNL.29.6.809
   MCNEELEY MDD, 1980, GRADWOHLS CLIN LABOR, P506
   NAYLOR GJ, 1990, BIOL PSYCHIAT, V27, P884, DOI 10.1016/0006-3223(90)90469-I
   NEUHAUS OW, 1978, NEPHRON, V22, P570, DOI 10.1159/000181537
   Peters JH, 1942, J BIOL CHEM, V146, P179
   PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4
   QUARLES LD, 1990, AM J PHYSIOL, V258, pE576, DOI 10.1152/ajpendo.1990.258.4.E576
   RUSSELL RM, 1992, AM J CLIN NUTR, V55, P1203
   SALEH AEC, 1968, CLIN CHIM ACTA, V21, P445, DOI 10.1016/0009-8981(68)90075-2
   WILHELM M, 1990, PHARMACOL TOXICOL, V66, P4, DOI 10.1111/j.1600-0773.1990.tb00692.x
   YOKEL RA, 1988, TOXICOL APPL PHARM, V95, P32, DOI 10.1016/S0041-008X(88)80005-X
   1985, SAS USERS GUIDE STAT
NR 39
TC 15
Z9 15
U1 0
U2 4
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0278-6915
EI 1873-6351
J9 FOOD CHEM TOXICOL
JI Food Chem. Toxicol.
PD OCT
PY 1995
VL 33
IS 10
BP 867
EP 875
DI 10.1016/0278-6915(95)00059-B
PG 9
WC Food Science & Technology; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Toxicology
GA TF961
UT WOS:A1995TF96100008
PM 7590531
DA 2024-02-19
ER

PT J
AU Kim, JH
   Sim, HA
   Jung, DY
   Lim, EY
   Kim, YT
   Kim, BJ
   Jung, MH
AF Kim, Ji-Hyun
   Sim, Hyun A.
   Jung, Dae Young
   Lim, Eun Yeong
   Kim, Yun Tai
   Kim, Byung Joo
   Jung, Myeong Ho
TI <i>Poria cocus</i> Wolf Extract Ameliorates Hepatic Steatosis through
   Regulation of Lipid Metabolism, Inhibition of ER Stress, and Activation
   of Autophagy via AMPK Activation
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE Poria cocos Wolf; hepatic steatosis; AMP-activated protein kinase;
   endoplasmic reticulum stress; autophagy; lipogenesis; fatty acid
   oxidation
ID FATTY LIVER-DISEASE; ENDOPLASMIC-RETICULUM STRESS; MECHANISMS
AB Poria cocos Wolf (PCW) is an edible, pharmaceutical mushroom with remarkable biological properties including anti-tumor, anti-inflammation, anti-oxidation, anti-ageing, and anti-diabetic effects. In the current study, we investigated the effects of PCW extract on hepatic steatosis under in vitro and in vivo conditions, and elucidated the underlying mechanisms. In this study, a mixture of HepG2 cells treated with free fatty acid (FFA)-palmitic and oleic acid-and high-fat diet (HFD)-fed obese mice were used; in this background, the triglyceride (TG) levels in HepG2 cells and mice liver were measured, and the expression levels of genes associated with lipogenesis, fatty acid oxidation, endoplasmic reticulum (ER) stress, and autophagy were determined. Treatment of HepG2 cells with FFA enhanced intracellular TG levels in HepG2 cells, but co-treatment with PCW significantly attenuated the TG levels. Notably, PCW significantly enhanced the phosphorylation of AMP-activated protein kinase (AMPK), acetyl-CoA carboxylase (ACC), and sterol regulatory element-binding protein-1c (SREBP-1c) in FFA-treated HepG2 cells. PCW downregulated the expression of lipogenesis-related genes, but upregulated the expression of genes associated with fatty acid oxidation. Further, PCW inhibited FFA-induced expression of ER stress markers and induced autophagy proteins. However, inhibition of AMPK significantly attenuated the beneficial effects of PCW in HepG2 cells. Moreover, PCW efficiently decreased HFD-induced hepatic TG accumulation in vivo and increased the phosphorylation of hepatic AMPK. Three compounds present in PCW including poricoic acid, pachymic acid, and ergosterol, significantly decreased FFA-induced increase in intracellular TG levels, consistent with increased AMPK phosphorylation, suggesting that poricoic acid, pachymic acid, and ergosterol are responsible for PCW-mediated amelioration of hepatic steatosis. Taken together, these results demonstrated that PCW ameliorates hepatic steatosis through the regulation of lipid metabolism, inhibition of ER stress, and activation of autophagy in an AMPK-dependent manner. This suggested that PCW can be potentially used for the treatment of hepatic steatosis.
C1 [Kim, Ji-Hyun; Jung, Dae Young; Kim, Byung Joo; Jung, Myeong Ho] Pusan Natl Univ, Sch Korean Med, Hlth Aging Korean Med Res Ctr, Yangsan 50612, South Korea.
   [Sim, Hyun A.; Kim, Byung Joo; Jung, Myeong Ho] Pusan Natl Univ, Sch Korean Med, Div Longev & Biofunct Med, Yangsan 50612, South Korea.
   [Lim, Eun Yeong; Kim, Yun Tai] Korea Food Res Inst, Div Funct Food Res, Jeollabuk Do 55365, South Korea.
   [Lim, Eun Yeong; Kim, Yun Tai] Korea Univ Sci & Technol, Dept Food Biotechnol, Daejeon 34113, South Korea.
C3 Pusan National University; Pusan National University; Korea Food
   Research Institute (KFRI); University of Science & Technology (UST)
RP Jung, MH (corresponding author), Pusan Natl Univ, Sch Korean Med, Hlth Aging Korean Med Res Ctr, Yangsan 50612, South Korea.; Jung, MH (corresponding author), Pusan Natl Univ, Sch Korean Med, Div Longev & Biofunct Med, Yangsan 50612, South Korea.
EM kimji77@pusan.ac.kr; andrea0224@naver.com; dyjung999@naver.com;
   50005@kfri.re.kr; ytkim@kfri.re.kr; vision@pusan.ac.kr;
   jung0603@pusan.ac.kr
RI Kim, Byung Joo/ABG-7715-2021
OI Kim, Byung Joo/0000-0001-8835-9103; Kim, Yun Tai/0000-0002-3404-6977
FU National Research Foundation of Korea (NRF) - Korean government (MSIP)
   [2014R1A5A2009936]
FX This study was supported by the National Research Foundation of Korea
   (NRF) grant funded by the Korean government (MSIP) (No.
   2014R1A5A2009936).
CR Ahn D.K., 2012, ILLUSTRATED GUIDE CL, P211
   Bagherniya M, 2018, PHARMACOL RES, V130, P213, DOI 10.1016/j.phrs.2017.12.020
   Bando Y, 2000, AM J PHYSIOL-CELL PH, V278, pC1172, DOI 10.1152/ajpcell.2000.278.6.C1172
   Dai B, 2016, J ETHNOPHARMACOL, V192, P382, DOI 10.1016/j.jep.2016.07.024
   Day EA, 2017, TRENDS ENDOCRIN MET, V28, P545, DOI 10.1016/j.tem.2017.05.004
   Fan JG, 2009, J HEPATOL, V50, P204, DOI 10.1016/j.jhep.2008.10.010
   Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973
   Garcia D, 2017, MOL CELL, V66, P789, DOI 10.1016/j.molcel.2017.05.032
   Jeong JW, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-101
   Jung TW, 2018, J BIOL CHEM, V293, P3981, DOI 10.1074/jbc.RA117.000885
   Jung TW, 2018, J PHARMACOL EXP THER, V365, P485, DOI 10.1124/jpet.117.246686
   Lebeaupin C, 2018, J HEPATOL, V69, P927, DOI 10.1016/j.jhep.2018.06.008
   Li HL, 2014, BBA-MOL BASIS DIS, V1842, P1844, DOI 10.1016/j.bbadis.2014.07.002
   Parafati M, 2015, J NUTR BIOCHEM, V26, P938, DOI 10.1016/j.jnutbio.2015.03.008
   Schulze RJ, 2017, BBA-MOL CELL BIOL L, V1862, P1178, DOI 10.1016/j.bbalip.2017.06.008
   Shore GC, 2011, CURR OPIN CELL BIOL, V23, P143, DOI 10.1016/j.ceb.2010.11.003
   Sun YC, 2014, INT J BIOL MACROMOL, V68, P131, DOI 10.1016/j.ijbiomac.2014.04.010
   Tamargo-Gómez I, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123812
   Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005
   Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025
NR 20
TC 59
Z9 63
U1 4
U2 32
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD OCT
PY 2019
VL 20
IS 19
AR 4801
DI 10.3390/ijms20194801
PG 17
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA JK4FF
UT WOS:000494798300142
PM 31569635
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Men'shchikova, EB
   Shabalina, IG
   Zenkov, NK
   Kolosova, NG
AF Men'shchikova, EB
   Shabalina, IG
   Zenkov, NK
   Kolosova, NG
TI Generation of reactive oxygen species by mitochondria in
   senescence-accelerated OXYS rats
SO BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE
LA English
DT Article
DE OXYS rats; reactive oxygen species; mitochondria
ID APOPTOSIS
AB Chemiluminescence assay showed that oxygen reduction and production of superoxide anion and hydrogen peroxide by liver mitochondria in OXYS rats highly sensitive to oxidative stress were less intensive than in Wistar rats. Experiments with cytochrome c oxidase inhibitors showed that decreased O-2(.) generation in mitochondria of OXYS rats is probably associated with changes in complex III of the electron transport chain.
C1 Russian Acad Med Sci, Siberian Div, Res Ctr Clin & Expt Med, Moscow 109801, Russia.
   Russian Acad Med Sci, Siberian Div, Inst Biochem, Moscow 109801, Russia.
   Russian Acad Sci, Siberian Div, Inst Cytol & Genet, Novosibirsk, Russia.
C3 Russian Academy of Medical Sciences; Russian Academy of Sciences;
   Russian Academy of Medical Sciences; Russian Academy of Sciences;
   Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS
RI Zenkov, Nikolay/P-8952-2016; Kolosova, Nataliya G/AAR-7409-2020;
   Menshchikova, Elena/GZA-6631-2022; Shabalina, Irina/AAC-3720-2019;
   Menshchikova, Elena/P-1488-2019; Kolosova, Nataliya G/P-3178-2015;
   Shabalina, Irina G/A-4225-2011; Menshchikova, Elena/N-2062-2015
OI Zenkov, Nikolay/0000-0003-1476-4098; Kolosova, Nataliya
   G/0000-0003-2398-8544; Menshchikova, Elena/0000-0003-2367-0114;
   Shabalina, Irina/0000-0002-2915-6450; Menshchikova,
   Elena/0000-0003-2367-0114; Kolosova, Nataliya G/0000-0003-2398-8544;
   Shabalina, Irina G/0000-0002-2915-6450; Menshchikova,
   Elena/0000-0003-2367-0114
CR BEYER RE, 1990, FREE RADICAL BIO MED, V8, P545, DOI 10.1016/0891-5849(90)90154-B
   Brand MD, 2000, EXP GERONTOL, V35, P811, DOI 10.1016/S0531-5565(00)00135-2
   Floyd RA, 2001, EXP GERONTOL, V36, P619, DOI 10.1016/S0531-5565(00)00231-X
   Kolosova N G, 1996, Biull Eksp Biol Med, V121, P282
   Kolosova N. G., 2001, B EKSP BIOL MED, V132, P235
   LI L, 1993, BIOTECHNOL BIOENG, V41, P1112, DOI 10.1002/bit.260411115
   Li YB, 1999, BBA-GEN SUBJECTS, V1428, P1, DOI 10.1016/S0304-4165(99)00040-9
   LOSKUTOVA LV, 2000, B EKSP BIOL MED, V129, P155
   LUSHNIKOVA EL, 1999, B EKSP BIOL MED, V128, P233
   Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009
   Papa S, 1997, MOL CELL BIOCHEM, V174, P305, DOI 10.1023/A:1006873518427
   SALGANIK RI, 1994, BIOCHEM BIOPH RES CO, V199, P726, DOI 10.1006/bbrc.1994.1289
   Shabalina I G, 1995, Biokhimiia, V60, P2045
   SOLOVEVA NA, 1975, GENETIKA+, V11, P63
   1996, RAT GENOME, V12, P52
NR 15
TC 5
Z9 5
U1 0
U2 1
PU CONSULTANTS BUREAU
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0007-4888
J9 B EXP BIOL MED+
JI Bull. Exp. Biol. Med.
PD FEB
PY 2002
VL 133
IS 2
BP 175
EP 177
DI 10.1023/A:1015559124601
PG 3
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA 579EF
UT WOS:000177164800022
PM 12428288
DA 2024-02-19
ER

PT J
AU FEUERS, RJ
   WEINDRUCH, R
   HART, RW
AF FEUERS, RJ
   WEINDRUCH, R
   HART, RW
TI CALORIC RESTRICTION, AGING, AND ANTIOXIDANT ENZYMES
SO MUTATION RESEARCH
LA English
DT Article
DE ANTIOXIDANTS; AGING; CATALASE; FREE RADICALS; SUPEROXIDE DISMUTASE;
   CALORIC RESTRICTION
ID MITOCHONDRIAL-DNA MUTATIONS; DIETARY RESTRICTION; HEART-MITOCHONDRIA;
   SKELETAL-MUSCLE; RAT-LIVER; DEGENERATIVE DISEASES; SUPEROXIDE RADICALS;
   LIPID-PEROXIDATION; HYDROGEN-PEROXIDE; FOOD RESTRICTION
AB The basic mechanisms of aging and its retardation by caloric restriction (CR) remain unclear. One suggested means by which CR could retard aging is based on production of mitochondrial free radicals, and efficiency of their subsequent metabolism. Currently, there is little information concerning the influences of age and CR on the rates of in vivo mitochondrial free radical production. However, evidence for CR-induced modulation of free radical detoxification capacities is mounting. The direction of the influence of CR on free radical detoxification is tissue-specific, These effects are broad and appear to provide positive advantage.
C1 NATL CTR TOXICOL RES,DIV BIOMETRY & RISK ASSESSMENT,JEFFERSON,AR 72079.
   UNIV WISCONSIN,DEPT MED,MADISON,WI 53706.
   GRECC,VA,MADISON,WI 53706.
C3 US Food & Drug Administration (FDA); University of Wisconsin System;
   University of Wisconsin Madison; Geriatric Research Education & Clinical
   Center
RP FEUERS, RJ (corresponding author), NATL CTR TOXICOL RES,DIV GENET TOXICOL,3900 NCTR RD,JEFFERSON,AR 72079, USA.
CR ARNHEIM N, 1992, MUTAT RES, V275, P157, DOI 10.1016/0921-8734(92)90020-P
   BANDY B, 1990, FREE RADICAL BIO MED, V8, P523, DOI 10.1016/0891-5849(90)90152-9
   CADENAS E, 1977, ARCH BIOCHEM BIOPHYS, V180, P248, DOI 10.1016/0003-9861(77)90035-2
   CARILLO MC, 1992, MECH AGEING DEV, V65, P187
   CERUTTI PA, 1985, SCIENCE, V227, P375, DOI 10.1126/science.2981433
   CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527
   CHEN F, 1993, UNPUB INFLUENCES CAL
   CHUNG MH, 1992, FREE RADICAL BIO MED, V12, P523, DOI 10.1016/0891-5849(92)90105-P
   FEUERS RJ, 1993, FREE RADICAL BIO MED, V15, P223, DOI 10.1016/0891-5849(93)90063-Z
   FEUERS RJ, 1990, ANN REV CHRONOPHARMA, V7, P189
   FEUERS RJ, 1991, MECH AGEING DEV, V3, P399
   FEUERS RJ, 1993, IN PRESS AGE
   FLEMING JE, 1982, GERONTOLOGY, V28, P44, DOI 10.1159/000212510
   FRIDOVICH I, 1986, ARCH BIOCHEM BIOPHYS, V247, P1, DOI 10.1016/0003-9861(86)90526-6
   HARMAN D, 1983, AGE, V6, P86, DOI 10.1007/BF02432509
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   Harman D., 1986, FREE RADICALS AGING, P3
   HUNTER JD, 1990, ANN R CHRON, V7, P99
   JI LL, 1990, AM J PHYSIOL, V258, pR918, DOI 10.1152/ajpregu.1990.258.4.R918
   JOHNSON JE, 1986, FREE RADICALS AGING
   JOVE HM, 1986, ARCH BIOCHEM BIOPHYS, V248, P71
   KIRKMAN HN, 1987, J BIOL CHEM, V262, P660
   KOIZUMI A, 1987, J NUTR, V117, P361, DOI 10.1093/jn/117.2.361
   LAGANIERE S, 1987, BIOCHEM BIOPH RES CO, V145, P1185, DOI 10.1016/0006-291X(87)91562-2
   LAGANIERE S, 1989, MECH AGEING DEV, V48, P221, DOI 10.1016/0047-6374(89)90084-5
   LAMMIKEEFE CJ, 1984, J NUTR, V114, P2235, DOI 10.1093/jn/114.12.2235
   LEE CM, 1993, J GERONTOL, V48, P201
   Lee D W, 1990, Aging (Milano), V2, P357
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   LIPPE G, 1991, BIOCHEM BIOPH RES CO, V181, P764, DOI 10.1016/0006-291X(91)91256-C
   LOSCHEN G, 1974, FEBS LETT, V42, P68, DOI 10.1016/0014-5793(74)80281-4
   LUHTALA TA, 1993, IN PRESS J GERONTOL
   MANJGALADZE M, 1993, MUTAT RES, V295, P201, DOI 10.1016/0921-8734(93)90021-T
   MIQUEL J, 1986, FREE RADICALS AGING, P51
   NOHL H, 1986, BIOCHEM BIOPH RES CO, V138, P533, DOI 10.1016/S0006-291X(86)80529-0
   NOHL H, 1987, FEBS LETT, V214, P269, DOI 10.1016/0014-5793(87)80068-6
   NOHL H, 1978, EUR J BIOCHEM, V82, P563, DOI 10.1111/j.1432-1033.1978.tb12051.x
   ORIAKU ET, 1993, UNPUB BENEFICIAL INF
   RADI R, 1991, J BIOL CHEM, V266, P22028
   RAO G, 1990, J NUTR, V120, P602, DOI 10.1093/jn/120.6.602
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   RIKANS LE, 1992, GERONTOLOGY, V38, P133
   RIKANS LE, 1991, BIOCHIM BIOPHYS ACTA, V1074, P195, DOI 10.1016/0304-4165(91)90061-K
   SALMINEN A, 1988, COMP BIOCHEM PHYS B, V89, P695, DOI 10.1016/0305-0491(88)90310-0
   SOHAL RS, 1992, MUTAT RES, V275, P295, DOI 10.1016/0921-8734(92)90033-L
   SRIVASTAVA VK, 1993, MUTAT RES, V295, P265, DOI 10.1016/0921-8734(93)90025-X
   THOMAS JP, 1990, J BIOL CHEM, V265, P454
   TURRENS JF, 1990, FEBS LETT, V227, P43
   VERTECHY M, 1989, EXP GERONTOL, V24, P211, DOI 10.1016/0531-5565(89)90012-0
   VONZGLINICKI T, 1987, MECH AGEING DEV, V38, P179, DOI 10.1016/0047-6374(87)90077-7
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   WEINDRUCH R, 1986, J NUTR, V116, P641, DOI 10.1093/jn/116.4.641
   WEINDRUCH R, 1988, RETARDATION AGING DI
   Weindruch R., 1993, FREE RADICALS AGING, P269
   WEINDRUCH RH, 1980, MECH AGEING DEV, V12, P375, DOI 10.1016/0047-6374(80)90070-6
   YOUNGMAN LD, 1992, P NATL ACAD SCI USA, V89, P9112, DOI 10.1073/pnas.89.19.9112
   Yu BP, 1993, FREE RADICALS AGING
   ZHANG Y, 1990, J BIOL CHEM, V265, P16330
   ZURLO F, 1990, J CLIN INVEST, V86, P1423, DOI 10.1172/JCI114857
NR 60
TC 71
Z9 72
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-8262
J9 MUTAT RES
PD DEC
PY 1993
VL 295
IS 4-6
BP 191
EP 200
DI 10.1016/0921-8734(93)90020-4
PG 10
WC Genetics & Heredity; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity; Toxicology
GA MV034
UT WOS:A1993MV03400005
PM 7507557
DA 2024-02-19
ER

PT J
AU Patil, I
   Sancheti, H
   Stiles, BL
   Cadenas, E
AF Patil, Ishan
   Sancheti, Harsh
   Stiles, Bangyan L.
   Cadenas, Enrique
TI Brain metabolic and functional alterations in a liver-specific PTEN
   knockout mouse model
SO PLOS ONE
LA English
DT Article
ID ALZHEIMERS-DISEASE; INSULIN-RESISTANCE; LIPOIC ACID; GLUCOSE-METABOLISM;
   DELETION; MICE; DYSFUNCTION; ASTROCYTES; NEURONS; STRESS
AB Insulin resistance-as observed in aging, diabetes, obesity, and other pathophysiological situations, affects brain function, for insulin signaling is responsible for neuronal glucose transport and control of energy homeostasis and is involved in the regulation of neuronal growth and synaptic plasticity. This study investigates brain metabolism and function in a liver-specific Phosphatase and Tensin Homologue (Pten) knockout mouse model (Liver-PtenKO), a negative regulator of insulin signaling. The Liver-PtenKO mouse model showed an increased flux of glucose into the liver-thus resulting in an overall hypoglycemic and hypoinsulinemic state-and significantly lower hepatic production of the ketone body beta-hydroxybutyrate (as compared with age-matched control mice). The Liver-PtenKO mice exhibited increased brain glucose uptake, improved rate of glycolysis and flux of metabolites in the TCA cycle, and improved synaptic plasticity in the hippocampus. Brain slices from both control- and Liver-PtenKO mice responded to the addition of insulin (in terms of pAKT/AKT levels), thereby neglecting an insulin resistance scenario. This study underscores the significance of insulin signaling in brain bioenergetics and function and helps recognize deficits in diseases associated with insulin resistance.
C1 [Patil, Ishan; Stiles, Bangyan L.; Cadenas, Enrique] Univ Southern Calif, Sch Pharm, Pharmacol & Pharmaceut Sci, Los Angeles, CA 90007 USA.
   [Sancheti, Harsh] Medtronic Inc, Medtronic Neurovasc, Irvine, CA USA.
C3 University of Southern California; Medtronic
RP Cadenas, E (corresponding author), Univ Southern Calif, Sch Pharm, Pharmacol & Pharmaceut Sci, Los Angeles, CA 90007 USA.
EM cadenas@usc.edu
OI Cadenas, Enrique/0000-0001-5199-2423
FU NIH [R01CA154986-01]; NIDDK [R01DK084241-01]; Packer/Wenz Endowment;
   Medtronic Inc.
FX This work was partially supported by NIH grants R01CA154986-01 (to BLS).
   Dr. Stiles also acknowledges support from NIDDK (R01DK084241-01). Thanks
   for partial support from the Packer/Wenz Endowment. The funding agencies
   did not have any role in the study design, data collection and analysis,
   decision to publish or preparation of the manuscript. Medtronic
   Neurovascular, Medtronic Inc. provided support in the form of salaries
   for author HS, but did not have any additional role in the study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Bingham EM, 2002, DIABETES, V51, P3384, DOI 10.2337/diabetes.51.12.3384
   de la Monte SM, 2014, BIOCHEM PHARMACOL, V88, P548, DOI 10.1016/j.bcp.2013.12.012
   de la Monte SM, 2012, J ALZHEIMERS DIS, V30, pS231, DOI 10.3233/JAD-2012-111727
   Debebe A, 2017, ONCOGENE, V36, P6020, DOI 10.1038/onc.2017.207
   Galicia VA, 2010, GASTROENTEROLOGY, V139, P2170, DOI 10.1053/j.gastro.2010.09.002
   Galindo MF, 2010, J NEUROCHEM, V114, P933, DOI 10.1111/j.1471-4159.2010.06814.x
   Gibson GE, 1998, J NEURAL TRANSM, V105, P855, DOI 10.1007/s007020050099
   Hassel B, 1997, J CEREBR BLOOD F MET, V17, P1230, DOI 10.1097/00004647-199711000-00012
   Hauptmann S, 2009, NEUROBIOL AGING, V30, P1574, DOI 10.1016/j.neurobiolaging.2007.12.005
   He LN, 2010, AM J PATHOL, V176, P2302, DOI 10.2353/ajpath.2010.090931
   Holland WL, 2008, ENDOCR REV, V29, P381, DOI 10.1210/er.2007-0025
   Jiang TY, 2013, AGING CELL, V12, P1021, DOI 10.1111/acel.12127
   Kanamori K, 2001, J MAGN RESON, V153, P193, DOI 10.1006/jmre.2001.2432
   Kao Y, 1999, GEN COMP ENDOCR, V114, P405, DOI 10.1006/gcen.1999.7265
   Kondziella D, 2006, NEUROPSYCHOPHARMACOL, V31, P1880, DOI 10.1038/sj.npp.1300993
   Kopelman MD, 2009, ALCOHOL ALCOHOLISM, V44, P148, DOI 10.1093/alcalc/agn118
   Kraegen EW, 2008, CURR OPIN LIPIDOL, V19, P235, DOI 10.1097/01.mol.0000319118.44995.9a
   Kurlawalla-Martinez C, 2005, MOL CELL BIOL, V25, P2498, DOI 10.1128/MCB.25.6.2498-2510.2005
   Langeveld M, 2009, PROG LIPID RES, V48, P196, DOI 10.1016/j.plipres.2009.03.002
   Li C, 2013, FREE RADICAL BIO MED, V60, P29, DOI 10.1016/j.freeradbiomed.2013.01.013
   Li Y, 2013, J BIOL CHEM, V288, P25007, DOI 10.1074/jbc.M113.450353
   Liu ZX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131086
   Liu ZG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05217-z
   Moon BC, 2012, ARTERIOSCL THROM VAS, V32, P236, DOI 10.1161/ATVBAHA.111.241356
   Mosconi Lisa, 2005, Eur J Nucl Med Mol Imaging, V32, P486, DOI 10.1007/s00259-005-1762-7
   Nehlig A, 2004, J CEREBR BLOOD F MET, V24, P1004, DOI 10.1097/01.WCB.0000128533.84196.D8
   Nilsen LH, 2013, J CEREBR BLOOD F MET, V33, P684, DOI 10.1038/jcbfm.2012.212
   Palian BM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004789
   Perry W, 2008, DIGEST DIS SCI, V53, P307, DOI 10.1007/s10620-007-9896-z
   Porter DW, 2010, DIABETES OBES METAB, V12, P891, DOI 10.1111/j.1463-1326.2010.01259.x
   Qu H, 2000, DEV NEUROSCI-BASEL, V22, P429, DOI 10.1159/000017472
   Rowland AF, 2011, TRAFFIC, V12, P672, DOI 10.1111/j.1600-0854.2011.01178.x
   Sancheti H, 2014, J CEREBR BLOOD F MET, V34, P1749, DOI 10.1038/jcbfm.2014.137
   Sancheti H, 2014, J CEREBR BLOOD F MET, V34, P288, DOI 10.1038/jcbfm.2013.196
   Sancheti H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069830
   Schmidt KS, 2005, DEMENT GERIATR COGN, V20, P286, DOI 10.1159/000088306
   Schubert D, 2005, AGEING RES REV, V4, P240, DOI 10.1016/j.arr.2005.02.003
   Stefanelli Manuela, 2014, Recent Pat CNS Drug Discov, V9, P54
   Stiles B, 2004, P NATL ACAD SCI USA, V101, P2082, DOI 10.1073/pnas.0308617100
   Tong M, 2010, BMC ENDOCR DISORD, V10, DOI 10.1186/1472-6823-10-4
   Tong M, 2009, J ALZHEIMERS DIS, V17, P827, DOI 10.3233/JAD-2009-1115
   Waniewski RA, 1998, J NEUROSCI, V18, P5225, DOI 10.1523/JNEUROSCI.18-14-05225.1998
   Weiss Jeffrey J, 2006, Curr HIV/AIDS Rep, V3, P176, DOI 10.1007/s11904-006-0013-2
   Wijesekara N, 2005, MOL CELL BIOL, V25, P1135, DOI 10.1128/MCB.25.3.1135-1145.2005
   Yang KT, 2014, DIABETOLOGIA, V57, P352, DOI 10.1007/s00125-013-3085-8
   Yao J, 2009, P NATL ACAD SCI USA, V106, P14670, DOI 10.1073/pnas.0903563106
   Zeng N, 2011, MOL CANCER RES, V9, P1708, DOI 10.1158/1541-7786.MCR-11-0299
NR 47
TC 5
Z9 5
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 20
PY 2018
VL 13
IS 9
AR e0204043
DI 10.1371/journal.pone.0204043
PG 16
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA GU8XH
UT WOS:000445626400054
PM 30235271
OA gold, Green Published, Green Submitted
DA 2024-02-19
ER

PT J
AU Ma, XH
   Muzumdar, R
   Yang, XM
   Gabriely, I
   Berger, R
   Barzilai, N
AF Ma, XH
   Muzumdar, R
   Yang, XM
   Gabriely, I
   Berger, R
   Barzilai, N
TI Aging is associated with resistance to effects of leptin on fat
   distribution and insulin action
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
ID VISCERAL FAT; SIGNAL-TRANSDUCTION; SERUM LEPTIN; WEIGHT-LOSS; AGED RATS;
   ADIPOSITY; OBESE; OVERWEIGHT; GENE; MORTALITY
AB Leptin has been shown to modulate total body fat and visceral fat distribution and to enhance insulin action in young rats. We hypothesize that failure of leptin action may contribute to the increase in visceral fat and insulin resistance in aging. By chronic subcutaneous infusion of leptin over 7 days, we increased leptin levels in young rats to match the levels in aging ad libitum fed rats. Leptin induced an similar to50% decrease in food intake compared with saline controls, an similar to50% decrease in visceral fat, and improved hepatic (fourfold) and peripheral (30%) insulin action (euglycemic hyperinsulinemic clamp technique) compared with the pair-fed group (p < .001). Although the plasma leptin level was doubled in aging rats, leptin failed to produce a significant change in food intake, in fat mass and its distribution, and in hepatic and peripheral insulin action. Increasing plasma leptin levels failed to suppress leptin gene expression in aging rats as compared with the similar to50% suppression seen in young rats (p < .01). We propose that leptin resistance may play a causative role in the metabolic decline seen with aging.
C1 Albert Einstein Coll Med, Inst Aging Res, Bronx, NY 10461 USA.
   Albert Einstein Coll Med, Ctr Diabet Res & Training, Bronx, NY 10461 USA.
   Childrens HOsp Montefiore, Div Pediat Endocrinol, Bronx, NY USA.
C3 Yeshiva University; Albert Einstein College of Medicine; Yeshiva
   University; Albert Einstein College of Medicine; Yeshiva University;
   Albert Einstein College of Medicine; Childrens Hospital at Montefiore
RP Barzilai, N (corresponding author), Albert Einstein Coll Med, Inst Aging Res, Belfer Bldg 701,1300 Morris Pk Av, Bronx, NY 10461 USA.
RI Muzumdar, Radhika/D-9860-2014
FU NIA NIH HHS [R01-AG18381] Funding Source: Medline; NIDDK NIH HHS [DK
   20541] Funding Source: Medline
CR Ahren B, 1997, AM J PHYSIOL-REG I, V273, pR113, DOI 10.1152/ajpregu.1997.273.1.R113
   Banerji MA, 1999, J CLIN ENDOCR METAB, V84, P137, DOI 10.1210/jc.84.1.137
   Barnes CA, 2001, INT REV NEUROBIOL, V45, P339
   BARZILAI N, 1995, AM J PHYSIOL-ENDOC M, V269, pE591, DOI 10.1152/ajpendo.1995.269.3.E591
   Barzilai N, 1999, AM J PHYSIOL-ENDOC M, V277, pE291, DOI 10.1152/ajpendo.1999.277.2.E291
   Barzilai N, 1997, J CLIN INVEST, V100, P3105, DOI 10.1172/JCI119865
   Barzilai N, 1998, J CLIN INVEST, V101, P1353, DOI 10.1172/JCI485
   Barzilai N, 1999, DIABETES, V48, P94, DOI 10.2337/diabetes.48.1.94
   Barzilai N, 1999, ANN NY ACAD SCI, V892, P58, DOI 10.1111/j.1749-6632.1999.tb07785.x
   Baumgartner RN, 1999, OBES RES, V7, P141, DOI 10.1002/j.1550-8528.1999.tb00695.x
   Bjorbæk C, 1999, J BIOL CHEM, V274, P30059, DOI 10.1074/jbc.274.42.30059
   Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501
   Dhillon H, 2001, REGUL PEPTIDES, V99, P69, DOI 10.1016/S0167-0115(01)00237-3
   ENZI G, 1986, AM J CLIN NUTR, V44, P739, DOI 10.1093/ajcn/44.6.739
   Fernández-Galaz C, 2001, J ENDOCRINOL, V171, P23, DOI 10.1677/joe.0.1710023
   Ferrannini E, 1996, DIABETES, V45, P947, DOI 10.2337/diabetes.45.7.947
   FRAZE E, 1987, J AM GERIATR SOC, V35, P212
   Gupta G, 2000, AM J PHYSIOL-ENDOC M, V278, pE985, DOI 10.1152/ajpendo.2000.278.6.E985
   Gupta G, 2000, AM J PHYSIOL-REG I, V278, pR111, DOI 10.1152/ajpregu.2000.278.1.R111
   HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777
   Heymsfield SB, 1999, JAMA-J AM MED ASSOC, V282, P1568, DOI 10.1001/jama.282.16.1568
   Isidori AM, 2000, J CLIN ENDOCR METAB, V85, P1954, DOI 10.1210/jc.85.5.1954
   Kotz CM, 1999, CLIN GERIATR MED, V15, P391
   KUCZMARSKI RJ, 1994, JAMA-J AM MED ASSOC, V272, P238
   Li H, 1997, DIABETES, V46, P2035, DOI 10.2337/diabetes.46.12.2035
   Li H, 1998, AM J PHYSIOL-ENDOC M, V275, pE405, DOI 10.1152/ajpendo.1998.275.3.E405
   Maresh GA, 2001, LIFE SCI, V69, P67, DOI 10.1016/S0024-3205(01)01093-1
   Moller N, 1998, J CLIN ENDOCR METAB, V83, P931, DOI 10.1210/jc.83.3.931
   Qiu J, 2001, ENDOCRINOLOGY, V142, P348, DOI 10.1210/en.142.1.348
   REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595
   RENTSCH J, 1995, BIOCHEM BIOPH RES CO, V214, P131, DOI 10.1006/bbrc.1995.2266
   Rinn W E, 1988, J Geriatr Psychiatry Neurol, V1, P144, DOI 10.1177/089198878800100304
   ROSSETTI L, 1990, J CLIN INVEST, V85, P1785, DOI 10.1172/JCI114636
   Rossetti L, 1997, J BIOL CHEM, V272, P27758, DOI 10.1074/jbc.272.44.27758
   Sánchez-Rodríguez M, 2000, ARCH MED RES, V31, P425, DOI 10.1016/S0188-4409(99)00079-X
   Scarpace PJ, 2000, DIABETES, V49, P431, DOI 10.2337/diabetes.49.3.431
   Scarpace PJ, 2000, NEUROPHARMACOLOGY, V39, P1872, DOI 10.1016/S0028-3908(00)00014-9
   Scarpace PJ, 2001, NEUROSCIENCE, V104, P1111, DOI 10.1016/S0306-4522(01)00142-7
   Shek EW, 2000, REGUL PEPTIDES, V92, P65, DOI 10.1016/S0167-0115(00)00151-8
   SHIMOKATA H, 1989, J GERONTOL, V44, P66
   Wang ZW, 2000, BIOCHEM BIOPH RES CO, V277, P20, DOI 10.1006/bbrc.2000.3615
   Wang ZW, 2001, FASEB J, V15, P108, DOI 10.1096/fj.00-0310com
   WILLIAMSON DF, 1995, AM J EPIDEMIOL, V141, P1128, DOI 10.1093/oxfordjournals.aje.a117386
NR 43
TC 67
Z9 70
U1 0
U2 2
PU GERONTOLOGICAL SOCIETY AMER
PI WASHINGTON
PA 1275 K STREET NW SUITE 350, WASHINGTON, DC 20005-4006 USA
SN 1079-5006
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD JUN
PY 2002
VL 57
IS 6
BP B225
EP B231
DI 10.1093/gerona/57.6.B225
PG 7
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA 558RG
UT WOS:000175979900002
PM 12023258
OA Bronze
DA 2024-02-19
ER

PT J
AU Gong, Z
   Shang, BX
   Chu, YP
   Chen, XD
   Li, Q
   Liu, KL
   Chen, YJ
   Huang, Y
   Hang, YY
   Shang, QW
   Zheng, ZY
   Song, L
   Li, YN
   Liu, R
   Xu, CC
   Zhang, XR
   Liu, BC
   Wang, LW
   Shao, CS
   Wang, Y
   Shi, YF
AF Gong, Zheng
   Shang, Bingxue
   Chu, Yunpeng
   Chen, Xiaodong
   Li, Qing
   Liu, Keli
   Chen, Yongjing
   Huang, Yin
   Hang, Yanyan
   Shang, Qianwen
   Zheng, Zhiyuan
   Song, Lin
   Li, Yanan
   Liu, Rui
   Xu, Chenchang
   Zhang, Xiaoren
   Liu, Baochi
   Wang, Luowei
   Shao, Changshun
   Wang, Ying
   Shi, Yufang
TI Fibrotic liver microenvironment promotes Dll4 and SDF-1-dependent T-cell
   lineage development
SO CELL DEATH & DISEASE
LA English
DT Article
ID CHEMOKINE RECEPTOR CXCR4; IMMUNE RECONSTITUTION; PROGENITOR CELLS;
   DIFFERENTIATION; LYMPHOPOIESIS; MYELOPOIESIS; MIGRATION; RESPONSES;
   THYMUS; HIV-1
AB The reconstitution of the T-cell repertoire and quantity is a major challenge in the clinical management of HIV infection/AIDS, cancer, and aging-associated diseases. We previously showed that autologous bone marrow transfusion (BMT) via the hepatic portal vein could effectively restore CD4+ T-cell count in AIDS patients also suffering from decompensated liver cirrhosis. In the current study, we characterized T-cell reconstitution in a mouse model of liver fibrosis induced by CCl4 and found that T-cell reconstitution after BMT via hepatic portal vein was also greatly enhanced. The expression of Dll4 (Delta-like 4), which plays an important role in T-cell progenitor expansion, was elevated in hepatocytes of fibrotic livers when compared to normal livers. This upregulation of Dll4 expression was found to be induced by TNF alpha in an NF kappa B-dependent manner. Liver fibroblasts transfected with Dll4 (LF-Dll4) also gained the capacity to promote T-cell lineage development from hematopoietic stem cells (HSCs), resulting in the generation of DN2 (CD4 and CD8 DN 2) and DN3 T-cell progenitors in vitro, which underwent a normal maturation program when adoptively transferred into Rag-2 deficient hosts. We also demonstrated a pivotal role of SDF-1 produced by primary liver fibroblasts (primary LF) in T-lineage differentiation from HSCs. These results suggest that Dll4 and SDF-1 in fibrotic liver microenvironment could promote extrathymic T-cell lineage development. These results expand our knowledge of T-cell development and reconstitution under pathological conditions.
C1 [Gong, Zheng; Shang, Bingxue; Chu, Yunpeng; Chen, Yongjing; Shang, Qianwen; Zheng, Zhiyuan; Song, Lin; Li, Yanan; Liu, Rui; Xu, Chenchang; Shao, Changshun; Shi, Yufang] Soochow Univ, Med Coll, Inst Translat Med,Key Lab Stem Cells & Med Biomat, State Key Lab Radiat Med & Protect,Affiliated Hos, Suzhou, Peoples R China.
   [Gong, Zheng; Chen, Xiaodong; Li, Qing; Liu, Keli; Huang, Yin; Hang, Yanyan; Zhang, Xiaoren; Wang, Ying; Shi, Yufang] Univ Chinese Acad Sci, Chinese Acad Sci, Inst Hlth Sci, Shanghai Inst Biol Sci,Key Lab Tissue Microenviro, Shanghai, Peoples R China.
   [Liu, Baochi] Fudan Univ, Dept Surg, Shanghai Publ Hlth Clin Ctr, Shanghai, Peoples R China.
   [Wang, Luowei] Second Mil Med Univ, Changhai Hosp, Dept Gastroenterol, Shanghai, Peoples R China.
C3 Soochow University - China; Chinese Academy of Sciences; University of
   Chinese Academy of Sciences, CAS; Fudan University; Naval Medical
   University
RP Shao, CS; Shi, YF (corresponding author), Soochow Univ, Med Coll, Inst Translat Med,Key Lab Stem Cells & Med Biomat, State Key Lab Radiat Med & Protect,Affiliated Hos, Suzhou, Peoples R China.; Wang, Y; Shi, YF (corresponding author), Univ Chinese Acad Sci, Chinese Acad Sci, Inst Hlth Sci, Shanghai Inst Biol Sci,Key Lab Tissue Microenviro, Shanghai, Peoples R China.; Wang, LW (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Gastroenterol, Shanghai, Peoples R China.
EM wangluoweimd@126.com; shaoc@suda.edu.cn; yingwang@sibs.ac.cn;
   yfshi@suda.edu.cn
RI chen, xin/IQW-3432-2023; zhang, lin/IZQ-4870-2023; Huang,
   Yin/AAH-6871-2020; Huang, Yin/IQX-1427-2023; Shi, Yufang/AAE-4431-2020;
   chen, xia/GXM-5435-2022; chen, xia/GYR-3948-2022; Shao,
   Changshun/AAD-8977-2022; Zheng, Zhiyuan/IQR-7425-2023; chen,
   xi/GXH-3653-2022
OI Huang, Yin/0000-0001-5602-9871; Shi, Yufang/0000-0001-8964-319X; Shao,
   Changshun/0000-0003-2618-9342; Wang, Luowei/0000-0002-6647-786X; Liu,
   Rui/0000-0002-5002-7311; Li, Yanan/0000-0002-2224-9451
FU National Key R&D Program of China [2018YFA0107500]; National Natural
   Science Foundation of China [81530043, 81330046, 81702869, 81861138015,
   31771641, 81571612]; Youth Innovation Promotion Association research
   fund from the Chinese Academy of Sciences; Soochow University;
   Department of Science and Technology of Jiangsu Province research fund
   [BE2016671]; China Postdoctoral Science Foundation [2016M591917];
   Postdoctoral Science Foundation of Jiangsu Province [1501063A, 1601027C]
FX This study was supported by grants from the National Key R&D Program of
   China (2018YFA0107500), the National Natural Science Foundation of China
   (81530043, 81330046, 81702869, 81861138015, 31771641, and 81571612), the
   Youth Innovation Promotion Association research fund from the Chinese
   Academy of Sciences, a start-up fund from Soochow University, the
   Department of Science and Technology of Jiangsu Province research fund
   (BE2016671), the Project funded by China Postdoctoral Science Foundation
   (2016M591917), and the Postdoctoral Science Foundation of Jiangsu
   Province (1501063A and 1601027C).
CR Abo T, 2001, INT IMMUNOPHARMACOL, V1, P1261, DOI 10.1016/S1567-5769(01)00057-1
   Abo T, 2000, IMMUNOL REV, V174, P135, DOI 10.1034/j.1600-0528.2002.017415.x
   Aiuti A, 1999, EUR J IMMUNOL, V29, P1823, DOI 10.1002/(SICI)1521-4141(199906)29:06<1823::AID-IMMU1823>3.0.CO;2-B
   Atamas S. P., 2015, RHEUMATOLOGY, P119
   Blackburn CC, 1996, P NATL ACAD SCI USA, V93, P5742, DOI 10.1073/pnas.93.12.5742
   Blom B, 2006, ANNU REV IMMUNOL, V24, P287, DOI 10.1146/annurev.immunol.24.021605.090612
   Bredenkamp N, 2014, NAT CELL BIOL, V16, P902, DOI 10.1038/ncb3023
   Campbell JJ, 1999, J IMMUNOL, V163, P2353
   Castelo-Branco C, 2014, GYNECOL ENDOCRINOL, V30, P16, DOI 10.3109/09513590.2013.852531
   Chen PF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075222
   de Pooter R, 2007, CURR OPIN IMMUNOL, V19, P163, DOI 10.1016/j.coi.2007.02.011
   Durand CM, 2013, CLIN PHARMACOL THER, V93, P382, DOI 10.1038/clpt.2013.22
   FOLKS TM, 1988, SCIENCE, V242, P919, DOI 10.1126/science.2460922
   Gao JA, 2010, J GENET GENOMICS, V37, P475, DOI 10.1016/S1673-8527(09)60067-9
   Germain RN, 2002, NAT REV IMMUNOL, V2, P309, DOI 10.1038/nri798
   Holmes Roxanne, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.prot5156
   Kawabata T, 1999, P NATL ACAD SCI USA, V96, P5663, DOI 10.1073/pnas.96.10.5663
   Kim CH, 1998, BLOOD, V91, P4434, DOI 10.1182/blood.V91.12.4434.412k45_4434_4443
   Kong M, 2018, INT J CLIN EXP PATHO, V11, P1674
   Liu B, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.261
   Love PE, 2011, NAT REV IMMUNOL, V11, P469, DOI 10.1038/nri2989
   Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135
   Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448
   Mackall CL, 2000, BLOOD, V96, P754
   McNamara LA, 2011, CURR OPIN HIV AIDS, V6, P43, DOI 10.1097/COH.0b013e32834086b3
   Mohtashami M, 2013, INT IMMUNOL, V25, P601, DOI 10.1093/intimm/dxt027
   Mohtashami M, 2010, J IMMUNOL, V185, P867, DOI 10.4049/jimmunol.1000782
   Moir S, 2011, ANNU REV PATHOL-MECH, V6, P223, DOI 10.1146/annurev-pathol-011110-130254
   Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0
   Nehls M, 1996, SCIENCE, V272, P886, DOI 10.1126/science.272.5263.886
   Nordoy T, 2001, BONE MARROW TRANSPL, V28, P681, DOI 10.1038/sj.bmt.1703228
   Onai N, 2000, BLOOD, V96, P2074
   Rabson AB, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.373
   Ramirez PW, 2014, CELL REP, V7, P2019, DOI 10.1016/j.celrep.2014.05.015
   Rosenkilde MM, 2004, J BIOL CHEM, V279, P3033, DOI 10.1074/jbc.M309546200
   Rothenberg EV, 2010, IMMUNOL REV, V238, P150, DOI 10.1111/j.1600-065X.2010.00964.x
   Sambandam A, 2005, NAT IMMUNOL, V6, P663, DOI 10.1038/ni1216
   Shimizu T, 2000, EUR J HAEMATOL, V64, P416, DOI 10.1034/j.1600-0609.2000.90158.x
   Shukla S, 2017, NAT METHODS, V14, P531, DOI 10.1038/nmeth.4258
   Small TN, 1999, BLOOD, V93, P467, DOI 10.1182/blood.V93.2.467.402k22_467_480
   Suzuki G, 1999, J IMMUNOL, V162, P5981
   Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261
   Tan JB, 2005, NAT IMMUNOL, V6, P671, DOI 10.1038/ni1217
   Visan I, 2006, IMMUNOL REV, V209, P76, DOI 10.1111/j.0105-2896.2006.00360.x
   Weinreich MA, 2008, J IMMUNOL, V181, P2265, DOI 10.4049/jimmunol.181.4.2265
   Williams KA, 2007, SEMIN IMMUNOL, V19, P318, DOI 10.1016/j.smim.2007.10.004
   Yu VWC, 2015, J EXP MED, V212, P759, DOI 10.1084/jem.20141843
   Zaitseva MB, 1998, J IMMUNOL, V161, P3103
   Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269
   Zuklys S, 2016, NAT IMMUNOL, V17, P1206, DOI 10.1038/ni.3537
NR 50
TC 0
Z9 0
U1 0
U2 10
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-4889
J9 CELL DEATH DIS
JI Cell Death Dis.
PD JUN 5
PY 2019
VL 10
AR 440
DI 10.1038/s41419-019-1630-1
PG 16
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA IC4LF
UT WOS:000470936500003
PM 31165736
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Zhang, L
   Yang, ZJ
   Ma, AH
   Qu, YL
   Xia, SH
   Xu, DX
   Ge, C
   Qiu, BJ
   Xia, Q
   Li, JJ
   Liu, YZ
AF Zhang, Li
   Yang, Zhaojuan
   Ma, Aihui
   Qu, Yulan
   Xia, Suhua
   Xu, Dongxu
   Ge, Chao
   Qiu, Bijun
   Xia, Qiang
   Li, Jinjun
   Liu, Yongzhong
TI Growth Arrest and DNA Damage 45G Down-Regulation Contributes to Janus
   Kinase/Signal Transducer and Activator of Transcription 3 Activation and
   Cellular Senescence Evasion in Hepatocellular Carcinoma
SO HEPATOLOGY
LA English
DT Article
ID NF-KAPPA-B; TUMOR-SUPPRESSOR; P53; GADD45-GAMMA; STAT3; KERATINOCYTES;
   TUMORIGENESIS; PROGRESSION; MUTATIONS; GADD45G
AB Growth arrest and DNA damage 45G (GADD45G), a stress sensor with multiple implications in various biological processes, is down-regulated in a broad spectrum of cancers. However, little is known about the biological effects of GADD45G on hepatocellular carcinoma (HCC) cells and the related mechanisms. In the present study, we found that GADD45G was commonly down-regulated in oncogene-transformed mouse liver cells and in human and mouse HCC. Ectopic expression of GADD45G robustly elicited senescence in HCC cells and suppressed tumor growth in vivo. Furthermore, GADD45G-induced senescence occurred in HCC cells independently of p53, p16(INK4a) (p16), and retinoblastoma (Rb). Instead, the prompt inhibition of Janus kinase 2 (Jak2), tyrosine kinase 2 (Tyk2), and signal transducer and activator of transcription 3 (Stat3) activation was observed in cells undergoing senescence. Impairment of Jak-Stat3 activation caused by GADD45G expression was associated with activation of SH2 domain-containing protein tyrosine phosphatase-2 (Shp2). Expression of constitutively activated Stat3 or human telomerase reverse transcriptase (hTERT), as well as knockdown of Shp2f, efficiently counteracted GADD45G-induced senescence. More important, in clinical HCC specimens, we found that GADD45G expression was inversely correlated with phosphorylated Stat3 expression in tumor cells and disease progression. Conclusion: GADD45G functions as a negative regulator of the Jak-Stat3 pathway and inhibits HCC by inducing cellular senescence. The decrease or absence of GADD45G expression may be a key event for tumor cells or premalignant liver cells to bypass cellular senescence. (Hepatology 2014;58:178-189)
C1 [Zhang, Li; Yang, Zhaojuan; Ma, Aihui; Qu, Yulan; Xia, Suhua; Xu, Dongxu; Ge, Chao; Li, Jinjun; Liu, Yongzhong] Shanghai Jiao Tong Univ, Sch Med, State Key Lab Oncogenes & Related Genes, Shanghai Canc Inst,Renji Hosp, Shanghai 200240, Peoples R China.
   [Qiu, Bijun; Xia, Qiang] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Liver Surg, Shanghai 200240, Peoples R China.
C3 Shanghai Jiao Tong University; Shanghai Jiao Tong University
RP Liu, YZ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, State Key Lab Oncogenes & Related Genes, Shanghai Canc Inst,Renji Hosp, Wenxuan Med Bldg,800 Dongchuan Rd, Shanghai 200240, Peoples R China.
EM liuyzg@shsci.org
RI wang, yixuan/JGM-3893-2023; yang, yun/IZE-1092-2023; Ma,
   Xiaodong/JAN-7473-2023
OI Liu, Yongzhong/0000-0002-1477-116X
FU National Natural Science Foundation of China [81201542]; Natural Science
   Foundation of Shanghai [12ZR1430100]; Chinese National Key Project
   [2013ZX10002-011]; State Key Laboratory of Oncogenes and Related Genes
   [91-12-03]
FX This work received support by grants from the National Natural Science
   Foundation of China (no. 81201542), the Natural Science Foundation of
   Shanghai (no. 12ZR1430100), the Chinese National Key Project (no.
   2013ZX10002-011), and the State Key Laboratory of Oncogenes and Related
   Genes (no. 91-12-03).
CR Bard-Chapeau EA, 2011, CANCER CELL, V19, P629, DOI 10.1016/j.ccr.2011.03.023
   BARGONETTI J, 1992, GENE DEV, V6, P1886, DOI 10.1101/gad.6.10.1886
   Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5
   Campanero MR, 2008, ONCOGENE, V27, P1263, DOI 10.1038/sj.onc.1210735
   Cipriano R, 2011, P NATL ACAD SCI USA, V108, P8668, DOI 10.1073/pnas.1015022108
   Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772
   Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000
   Gierl MS, 2012, DEV CELL, V23, P1032, DOI 10.1016/j.devcel.2012.09.014
   Harada H, 2003, MOL CANCER RES, V1, P729
   He GB, 2011, CELL RES, V21, P159, DOI 10.1038/cr.2010.183
   JEMAL A, 2011, CA-CANCER J CLIN, V61, P69, DOI DOI 10.3322/CAAC.20107
   JIANG D, 1993, ONCOGENE, V8, P2805
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Kong XN, 2012, HEPATOLOGY, V56, P1150, DOI 10.1002/hep.25744
   Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610
   Lee TKW, 2011, CELL STEM CELL, V9, P50, DOI 10.1016/j.stem.2011.06.005
   Lesina M, 2011, CANCER CELL, V19, P456, DOI 10.1016/j.ccr.2011.03.009
   Lin HK, 2010, NATURE, V464, P374, DOI 10.1038/nature08815
   Ménard L, 2010, J HEPATOL, V52, P681, DOI 10.1016/j.jhep.2009.12.029
   Nishida N, 2011, CURR GENOMICS, V12, P130, DOI 10.2174/138920211795564359
   Pilati C, 2011, J EXP MED, V208, P1359, DOI 10.1084/jem.20110283
   Prieur A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1473
   Senturk S, 2010, HEPATOLOGY, V52, P966, DOI 10.1002/hep.23769
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   Siddiquee KAZ, 2008, CELL RES, V18, P254, DOI 10.1038/cr.2008.18
   Sun LH, 2003, MOL BIOL REP, V30, P249, DOI 10.1023/A:1026370726763
   Tannapfel A, 2001, ONCOGENE, V20, P7104, DOI 10.1038/sj.onc.1204902
   Tront JS, 2006, CANCER RES, V66, P8448, DOI 10.1158/0008-5472.CAN-06-2013
   Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529
   Yang Z, 2011, PLOS ONE, V6
   Ying JM, 2005, CLIN CANCER RES, V11, P6442, DOI 10.1158/1078-0432.CCR-05-0267
   Zender L, 2005, COLD SH Q B, V70, P251, DOI 10.1101/sqb.2005.70.059
   Zerbini LF, 2005, CELL CYCLE, V4, P18, DOI 10.4161/cc.4.1.1363
NR 33
TC 45
Z9 55
U1 1
U2 20
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD JAN
PY 2014
VL 59
IS 1
BP 178
EP 189
DI 10.1002/hep.26628
PG 12
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 276GZ
UT WOS:000328738400021
PM 23897841
DA 2024-02-19
ER

PT J
AU Vuguin, P
   Raab, E
   Liu, B
   Barzilai, N
   Simmons, R
AF Vuguin, P
   Raab, E
   Liu, B
   Barzilai, N
   Simmons, R
TI Hepatic insulin resistance precedes the development of diabetes in a
   model of intrauterine growth retardation
SO DIABETES
LA English
DT Article
ID ENDOGENOUS GLUCOSE-PRODUCTION; FREE FATTY-ACIDS; PHOSPHOENOLPYRUVATE
   CARBOXYKINASE; GENE-EXPRESSION; PROTEIN-KINASE; IN-VIVO;
   MAGNETIC-RESONANCE; TRANSGENIC MICE; VISCERAL FAT; AGING RATS
AB Intrauterine growth retardation (IUGR) has been linked to the development of type 2 diabetes in adulthood. We developed an IUGR model in rats whereby at age 3-6 months the animals develop a diabetes that is associated with insulin resistance. Hyperinsulinemic-euglycemic clamp studies were performed at age 8 weeks, before the onset of obesity and diabetes. Basal hepatic glucose production (HGP) was significantly higher in IUGR than in control rats (14.6 +/- 0.4 vs. 12.3 +/- 0.3 mg (.) kg(-1 .) min(-1); P < 0.05). Insulin suppression of HGP was blunted in IUGR versus control rats (10.4 +/- 0.6 vs. 6.5 +/- 1.0 mg (.) kg(-1) (.) min(-1); P < 0.01); however, rates of glucose uptake and glycogenolysis were similar between the two groups. Insulin-stimulated insulin receptor substrate 2 and Akt-2 phosphorylation were significantly blunted in IUGR rats. PEPCK and glucose-6-phosphatase mRNA levels were increased at least threefold in liver of IUGR compared with control rats. These studies suggest that an aberrant intrauterine milieu permanently impairs insulin signaling in the liver so that gluconeogenesis is augmented in the IUGR rat. These processes occur early in life, before the onset of hyperglycemia, and indicate that uteroplacental insufficiency causes a primary defect in gene expression and hepatic metabolism that leads to the eventual development of overt hyperglycemia.
C1 Childrens Hosp, Montefiore Med Ctr, Albert Einstein Coll Med, Bronx, NY USA.
   Univ Penn, Philadelphia, PA 19104 USA.
   Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA.
   Albert Einstein Coll Med, Inst Aging Res, Bronx, NY 10467 USA.
   Albert Einstein Coll Med, Ctr Diabet, Bronx, NY 10467 USA.
C3 Montefiore Medical Center; Yeshiva University; Albert Einstein College
   of Medicine; University of Pennsylvania; University of Pennsylvania;
   Pennsylvania Medicine; Childrens Hospital of Philadelphia; Yeshiva
   University; Albert Einstein College of Medicine; Yeshiva University;
   Albert Einstein College of Medicine
RP Vuguin, P (corresponding author), Div Pediat Endocrinol, 111 E 210th St, Bronx, NY 10476 USA.
EM vuguin@aecom.yu.edu
OI Simmons, Rebecca/0000-0002-2901-8904; vuguin,
   patricia/0000-0002-4982-0400
FU NIA NIH HHS [R01-AG-18381, AG-20898] Funding Source: Medline; NICHD NIH
   HHS [K08-HD-042172] Funding Source: Medline; NIDDK NIH HHS [DK-55704,
   DK-19525] Funding Source: Medline
CR Banerjee S, 1997, AM J PHYSIOL-REG I, V273, pR1534, DOI 10.1152/ajpregu.1997.273.4.R1534
   Barthel A, 2003, AM J PHYSIOL-ENDOC M, V285, pE685, DOI 10.1152/ajpendo.00253.2003
   BARZILAI N, 1995, AM J PHYSIOL-ENDOC M, V269, pE591, DOI 10.1152/ajpendo.1995.269.3.E591
   Barzilai N, 1999, AM J PHYSIOL-ENDOC M, V277, pE291, DOI 10.1152/ajpendo.1999.277.2.E291
   Barzilai N, 1996, DIABETES, V45, P1329, DOI 10.2337/diabetes.45.10.1329
   Barzilai N, 1998, J CLIN INVEST, V101, P1353, DOI 10.1172/JCI485
   Barzilai N, 1999, DIABETES, V48, P94, DOI 10.2337/diabetes.48.1.94
   Boden G, 2001, DIABETES, V50, P810, DOI 10.2337/diabetes.50.4.810
   BONTEMPS F, 1978, BIOCHEM J, V174, P603, DOI 10.1042/bj1740603
   Burns SP, 1997, J CLIN INVEST, V100, P1768, DOI 10.1172/JCI119703
   Burns SP, 2000, NMR BIOMED, V13, P82
   CAMPBELL PJ, 1988, J CLIN INVEST, V82, P21
   Chen XH, 1999, J CLIN INVEST, V103, P365, DOI 10.1172/JCI5479
   Cherrington AD, 1999, DIABETES, V48, P1198, DOI 10.2337/diabetes.48.5.1198
   Cherrington AD, 1998, DIABETOLOGIA, V41, P987, DOI 10.1007/s001250051021
   Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728
   Cichy SB, 1998, J BIOL CHEM, V273, P6482, DOI 10.1074/jbc.273.11.6482
   CONSOLI A, 1989, DIABETES, V38, P550, DOI 10.2337/diabetes.38.5.550
   DEFRONZO R, 1982, DIABETOLOGIA, V21, P313
   Desai M, 1997, AM J PHYSIOL-GASTR L, V273, pG899, DOI 10.1152/ajpgi.1997.273.4.G899
   Desai M, 1997, AM J PHYSIOL-GASTR L, V272, pG1083, DOI 10.1152/ajpgi.1997.272.5.G1083
   Gastaldelli A, 2001, DIABETES, V50, P1807, DOI 10.2337/diabetes.50.8.1807
   Gupta G, 2000, AM J PHYSIOL-ENDOC M, V278, pE985, DOI 10.1152/ajpendo.2000.278.6.E985
   Gupta G, 2000, AM J PHYSIOL-REG I, V278, pR111, DOI 10.1152/ajpregu.2000.278.1.R111
   Hawkins M, 1997, J CLIN INVEST, V99, P2173, DOI 10.1172/JCI119390
   Keppler D., 1974, GLYCOGEN DETERMINATI
   Kubota N, 2000, DIABETES, V49, P1880, DOI 10.2337/diabetes.49.11.1880
   Lane RH, 2002, ENDOCRINOLOGY, V143, P2486, DOI 10.1210/en.143.7.2486
   Lochhead PA, 2001, DIABETES, V50, P937, DOI 10.2337/diabetes.50.5.937
   Martín D, 2002, J BIOL CHEM, V277, P42943, DOI 10.1074/jbc.M201070200
   Mittelman SD, 1997, J CLIN INVEST, V100, P3121, DOI 10.1172/JCI119867
   Murata H, 2003, J BIOL CHEM, V278, P50226, DOI 10.1074/jbc.M310171200
   Nyirenda MJ, 1998, J CLIN INVEST, V101, P2174, DOI 10.1172/JCI1567
   OGATA ES, 1986, METABOLISM, V35, P970, DOI 10.1016/0026-0495(86)90064-8
   Ozanne SE, 1996, AM J PHYSIOL-ENDOC M, V271, pE1128, DOI 10.1152/ajpendo.1996.271.6.E1128
   Ozanne SE, 1996, AM J PHYSIOL-ENDOC M, V270, pE559, DOI 10.1152/ajpendo.1996.270.4.E559
   Peterside IE, 2003, AM J PHYSIOL-ENDOC M, V285, pE1258, DOI 10.1152/ajpendo.00437.2002
   Previs SF, 2000, J BIOL CHEM, V275, P38990, DOI 10.1074/jbc.M006490200
   REAVEN GM, 1995, DIABETOLOGIA, V38, P3, DOI 10.1007/BF02369347
   Rebrin K, 1996, J CLIN INVEST, V98, P741, DOI 10.1172/JCI118846
   Roden M, 2001, RECENT PROG HORM RES, V56, P219, DOI 10.1210/rp.56.1.219
   Roden M, 2000, DIABETES, V49, P701, DOI 10.2337/diabetes.49.5.701
   SIMMONS RA, 1992, PEDIATR RES, V31, P59, DOI 10.1203/00006450-199201000-00011
   Simmons RA, 2001, DIABETES, V50, P2279, DOI 10.2337/diabetes.50.10.2279
   Stingl H, 2001, DIABETOLOGIA, V44, P48, DOI 10.1007/s001250051579
   Sun Y, 2002, J BIOL CHEM, V277, P23301, DOI 10.1074/jbc.M200964200
   SUTHERLAND C, 1995, J BIOL CHEM, V270, P15501, DOI 10.1074/jbc.270.26.15501
   UNTERMAN T, 1990, ENDOCRINOLOGY, V127, P2035, DOI 10.1210/endo-127-4-2035
   VALERA A, 1994, P NATL ACAD SCI USA, V91, P9151, DOI 10.1073/pnas.91.19.9151
   Vuguin P, 2001, PEDIATR RES, V49, P468, DOI 10.1203/00006450-200104000-00006
   ZAWADZKI JK, 1988, DIABETES, V37, P154, DOI 10.2337/diabetes.37.2.154
NR 51
TC 102
Z9 122
U1 0
U2 6
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0012-1797
J9 DIABETES
JI Diabetes
PD OCT
PY 2004
VL 53
IS 10
BP 2617
EP 2622
DI 10.2337/diabetes.53.10.2617
PG 6
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 857KU
UT WOS:000224116100014
PM 15448092
OA Bronze
DA 2024-02-19
ER

PT J
AU Ling, MY
   Tang, CM
   Yang, XC
   Yu, N
   Song, YP
   Ding, WJ
   Sun, Y
   Yan, R
   Wang, SP
   Li, XH
   Gao, HQ
   Zhang, Z
   Xing, YQ
AF Ling, Mingying
   Tang, Congmin
   Yang, Xuechun
   Yu, Na
   Song, Yiping
   Ding, Wenjing
   Sun, Yan
   Yan, Rong
   Wang, Shaopeng
   Li, Xuehui
   Gao, Haiqing
   Zhang, Zhen
   Xing, Yanqiu
TI Integrated metabolomics and phosphoproteomics reveal the protective role
   of exosomes from human umbilical cord mesenchymal stem cells in
   naturally aging mouse livers
SO EXPERIMENTAL CELL RESEARCH
LA English
DT Article; Early Access
DE Aging; Exosomes; Liver; Phosphoproteomics; Metabolomics; Mesenchymal
   stem cells
ID EXTRACELLULAR VESICLES; SURVIVAL; CANCER; SWITCH
AB Background: Aging is characterized by a general decline in cellular function, which ultimately affects whole body homeostasis. This study aimed to investigate the effects and underlying mechanisms of exosomes derived from human umbilical cord mesenchymal stem cells (hUCMSC-exos) on the livers of naturally aging mice. Method: Twenty-two-month-old C57BL6 mice were used as a natural aging animal model, divided into a salinetreated wild-type aged control group (WT-AC) and a hUCMSC-exo-treated group (WT-AEX), and then detected by morphology, metabolomics and phosphoproteomics. Results: Morphological analysis showed that hUCMSC-exos ameliorated structural disorder and decreased markers of senescence and genome instability in aging livers. Metabolomics showed that hUCMSC-exos decreased the contents of saturated glycerophospholipids, palmitoyl-glycerols and eicosanoid derivatives associated with lipotoxicity and inflammation, consistent with the decreased phosphorylation of metabolic enzymes, such as propionate-CoA ligase (Acss2), at S267 detected by phosphoproteomics. Moreover, phosphoproteomics indicated that hUCMSC-exos reduced the phosphorylation of proteins participating in nuclear transport and cancer signaling, such as heat shock protein HSP90-beta (Hsp90ab1) at S226 and nucleoprotein TPR (Tpr) at S453 and S379, while increasing those involved in intracellular communication, such as calnexin (Canx) at S563 and PDZ domain-containing protein 8 (Pdzd8). Finally, phosphorylated HSP908 and Tpr were verified predominantly in hepatocytes. Conclusion: HUCMSC-exos improved metabolic reprogramming and genome stability mainly associated with phosphorylated HSP908 in hepatocytes in natural aging livers. This work provides a comprehensive resource of biological data by omics to support future investigations of hUCMSC-exos in aging.
C1 [Ling, Mingying; Tang, Congmin; Yang, Xuechun; Song, Yiping; Ding, Wenjing; Sun, Yan; Yan, Rong; Li, Xuehui; Gao, Haiqing; Zhang, Zhen; Xing, Yanqiu] Shandong Univ, Qilu Hosp, Dept Geriatr Med, Key Lab Cardiovasc Prote Shandong Prov, Jinan 250012, Shandong, Peoples R China.
   [Yu, Na; Wang, Shaopeng] Shandong Precis Med Engn Lab Bacterial Antitumor D, Jinan 250101, Shandong, Peoples R China.
   [Yu, Na] Shandong Univ, Coll Clin Med, Jinan 250012, Shandong, Peoples R China.
C3 Shandong University; Shandong University
RP Xing, YQ (corresponding author), Shandong Univ, Qilu Hosp, Dept Geriatr Med, Key Lab Cardiovasc Prote Shandong Prov, Jinan 250012, Shandong, Peoples R China.
EM xingyanqiu@sina.com
FU National Natural Science Foundation of China [82100472, 81700725];
   Science and Technology Foundation of Jinan City [201805057]; Natural
   Science Foundation of Shandong Province [ZR2017BH003, ZR2020MH313]; Key
   Research and Development Program of Shandong Province [2017GSF218101];
   Medical and Health Science and Technology Development Foundation of
   Shandong Province [2016WS0366]; Major Key Technology Research Projects
   of Shandong Province [2022CXGC010510]; Science and Technology Innovation
   Development Foundation of Jinan City; Construction of Technical Platform
   for Clinical Evaluation of New Drugs for Cardiovascular Disease
   Prevention and Treatment [2012ZX09303016-003]
FX This study was supported by the National Natural Science Founda-tion of
   China (82100472 and 81700725) , the Science and Technology Foundation of
   Jinan City (201805057) , the Natural Science Foundation of Shandong
   Province (ZR2017BH003 and ZR2020MH313) , the Key Research and
   Development Program of Shandong Province (2017GSF218101) , the Medical
   and Health Science and Technology Development Foundation of Shandong
   Province (2016WS0366) , the Major Key Technology Research Projects of
   Shandong Province (2022CXGC010510) , the Science and Technology
   Innovation Develop-ment Foundation of Jinan City (2022) , and the
   Construction of Tech-nical Platform for Clinical Evaluation of New Drugs
   for Cardiovascular Disease Prevention and Treatment (2012ZX09303016-003)
   .
CR Aksenova V, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18266-2
   Fafián-Labora JA, 2020, CELL METAB, V32, P71, DOI 10.1016/j.cmet.2020.06.004
   Aragón-Herrera A, 2021, FASEB J, V35, DOI 10.1096/fj.202002620RR
   Asantewaa G, 2021, CURR OPIN BIOTECH, V68, P292, DOI 10.1016/j.copbio.2021.03.001
   Baba T., BBA-MOL CELL RES, V2021
   Bai YX, 2021, CANCERS, V13, DOI 10.3390/cancers13225635
   Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932
   Bhatia V, 2014, NATURE, V511, P362, DOI 10.1038/nature13374
   Cahill MA, 2017, BIOSCI TRENDS, V11, P179, DOI 10.5582/bst.2017.01009
   Cappel DA, 2019, CELL METAB, V29, P1291, DOI 10.1016/j.cmet.2019.03.014
   Chen WY, 2021, STEM CELL RES THER, V12, DOI 10.1186/s13287-021-02271-3
   Chu XG, 2022, AGING DIS, V13, P568, DOI 10.14336/AD.2021.0830
   Ciraku L, 2022, ONCOGENE, V41, P2122, DOI 10.1038/s41388-022-02237-6
   Dang Y, 2020, AGING CELL, V19, DOI 10.1111/acel.13060
   Del Fattore A, 2015, EXPERT OPIN BIOL TH, V15, P495, DOI 10.1517/14712598.2015.997706
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Faitot F, 2019, HPB, V21, P1354, DOI 10.1016/j.hpb.2019.02.008
   Frohlich J, 2021, BBA-MOL CELL BIOL L, V1866, DOI 10.1016/j.bbalip.2021.158920
   Gutiérrez T, 2020, SCI SIGNAL, V13, DOI 10.1126/scisignal.aax6660
   Han CS, 2019, MAT SCI ENG C-MATER, V99, P322, DOI 10.1016/j.msec.2019.01.122
   He L, 2020, TRENDS PHARMACOL SCI, V41, P868, DOI 10.1016/j.tips.2020.09.001
   Hirabayahi Y, 2017, SCIENCE, V358, P623, DOI 10.1126/science.aan6009
   Huang B, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0792-1
   Humphrey SJ, 2015, TRENDS ENDOCRIN MET, V26, P676, DOI 10.1016/j.tem.2015.09.013
   La T, 2021, THERANOSTICS, V11, P9605, DOI 10.7150/thno.63763
   Li WJ, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24816-z
   Li XJ, 2017, MOL CELL, V66, P684, DOI 10.1016/j.molcel.2017.04.026
   Ling MY, 2022, ARCH BIOCHEM BIOPHYS, V731, DOI 10.1016/j.abb.2022.109430
   Lou GH, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.63
   Lu L, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22115884
   Moskalev A, 2022, TRENDS ENDOCRIN MET, V33, P266, DOI 10.1016/j.tem.2022.01.007
   Romero R, 2017, NAT MED, V23, P1362, DOI 10.1038/nm.4407
   Schopf FH, 2017, NAT REV MOL CELL BIO, V18, P345, DOI 10.1038/nrm.2017.20
   Shirane M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18413-9
   Steensels S, 2020, HEPATOLOGY, V72, P857, DOI 10.1002/hep.31409
   Stetz G, 2020, J CHEM THEORY COMPUT, V16, P4706, DOI 10.1021/acs.jctc.0c00280
   Sun PB, 2021, REPROD BIOL ENDOCRIN, V19, DOI 10.1186/s12958-021-00723-2
   Théry C, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2018.1535750
   Timofeev O, 2020, CANCER RES, V80, P5231, DOI 10.1158/0008-5472.CAN-20-2002
   Wang YQ, 2022, ECOTOX ENVIRON SAFE, V248, DOI 10.1016/j.ecoenv.2022.114327
   Weeraphan C, 2019, PROTEOMICS, V19, DOI 10.1002/pmic.201800159
   Yang WJ, 2020, MOL THER, V28, P1200, DOI 10.1016/j.ymthe.2020.02.003
   Yang XY, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01123
   Zhang N, 2020, STEM CELL RES THER, V11, DOI 10.1186/s13287-020-01782-9
   Zheng JX, 2021, FASEB J, V35, DOI 10.1096/fj.202100235R
NR 45
TC 3
Z9 3
U1 5
U2 6
PU ELSEVIER INC
PI SAN DIEGO
PA 525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0014-4827
EI 1090-2422
J9 EXP CELL RES
JI Exp. Cell Res.
PD 2023 JUN 1
PY 2023
VL 427
IS 1
AR 113566
DI 10.1016/j.yexcr.2023.113566
EA APR 2023
PG 17
WC Oncology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Cell Biology
GA F1WN6
UT WOS:000980321700001
PM 37004949
DA 2024-02-19
ER

PT J
AU Yamada, Y
   Nakajima, A
   Sekihara, H
AF Yamada, Y
   Nakajima, A
   Sekihara, H
TI Supplement. Anti-apoptotic effect of dehydroepiandrosterone and its role
   in an aging society
SO INTERNAL MEDICINE
LA English
DT Article; Proceedings Paper
CT 100th Annual Meeting of the Japanese-Society-of-Internal-Medicine
CY APR   01, 2003
CL Tokyo, JAPAN
SP Japanese Soc Internal Med
DE dehydroepiandrosterone (DHEA); apoptosis; hepatitis; diabetes
ID ELEVATED HEPATIC GLUCOSE-6-PHOSPHATASE; REPLACEMENT THERAPY;
   C57BL/KSJ-DB/DB MICE; SUPPRESSES; WOMEN; TROGLITAZONE; REDUCTION;
   DISEASE; HUMANS; TRIAL
C1 Yokohama City Univ, Sch Med, Dept Internal Med 3, Kanagawa 2360004, Japan.
C3 Yokohama City University
RP Yamada, Y (corresponding author), Yokohama City Univ, Sch Med, Dept Internal Med 3, Kanagawa 2360004, Japan.
CR Alexandersen P, 1996, ATHEROSCLEROSIS, V125, P1, DOI 10.1016/0021-9150(96)05864-9
   Aoki K, 1999, DIABETES, V48, P1579, DOI 10.2337/diabetes.48.8.1579
   Aoki K, 2000, ENDOCR J, V47, P799, DOI 10.1507/endocrj.47.799
   Arlt W, 2001, J CLIN ENDOCR METAB, V86, P4686, DOI 10.1210/jc.86.10.4686
   Callies F, 2001, J CLIN ENDOCR METAB, V86, P1968, DOI 10.1210/jc.86.5.1968
   Casson PR, 1996, INT J FERTIL MENOP S, V41, P412
   COLEMAN DL, 1982, DIABETES, V31, P830, DOI 10.2337/diabetes.31.9.830
   Dillon JS, 2000, DIABETES, V49, P2012, DOI 10.2337/diabetes.49.12.2012
   Du CG, 2001, J IMMUNOL, V167, P7094, DOI 10.4049/jimmunol.167.12.7094
   Flynn MA, 1999, J CLIN ENDOCR METAB, V84, P1527, DOI 10.1210/jc.84.5.1527
   GORDON GB, 1988, J CLIN INVEST, V82, P712, DOI 10.1172/JCI113652
   Hunt PJ, 2000, J CLIN ENDOCR METAB, V85, P4650, DOI 10.1210/jc.85.12.4650
   Kimura M, 1998, ENDOCRINOLOGY, V139, P3249, DOI 10.1210/en.139.7.3249
   Labrie F, 1998, J ENDOCRINOL INVEST, V21, P399, DOI 10.1007/BF03350777
   Labrie F, 1997, J CLIN ENDOCR METAB, V82, P3498, DOI 10.1210/jc.82.10.3498
   Lasco A, 2001, EUR J ENDOCRINOL, V145, P457, DOI 10.1530/eje.0.1450457
   Lovås K, 2003, J CLIN ENDOCR METAB, V88, P1112, DOI 10.1210/jc.2002-020769
   MORALES AJ, 1995, J CLIN ENDOCR METAB, V80, P2799
   Roth GS, 2002, SCIENCE, V297, P811, DOI 10.1126/science.1071851
   Yu CK, 1999, CLIN EXP ALLERGY, V29, P414, DOI 10.1046/j.1365-2222.1999.00484.x
NR 20
TC 0
Z9 0
U1 0
U2 0
PU JAPAN SOC INTERNAL MEDICINE
PI TOKYO
PA 34-3 3-CHOME HONGO BUNKYO-KU, TOKYO, 113, JAPAN
SN 0918-2918
J9 INTERNAL MED
JI Intern. Med.
PD FEB
PY 2004
VL 43
IS 2
BP 158
EP 160
DI 10.2169/internalmedicine.43.158
PG 3
WC Medicine, General & Internal
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA 778YW
UT WOS:000189269800019
PM 15005265
OA Bronze
DA 2024-02-19
ER

PT J
AU Ichinoseki-Sekine, N
   Kakigi, R
   Miura, S
   Naito, H
AF Ichinoseki-Sekine, Noriko
   Kakigi, Ryo
   Miura, Susumu
   Naito, Hisashi
TI Whey peptide ingestion suppresses body fat accumulation in
   senescence-accelerated mouse prone 6 (SAMP6)
SO EUROPEAN JOURNAL OF NUTRITION
LA English
DT Article
DE Whey peptide hydrolysate; Adipose tissue; Fatty acid oxidation; Skeletal
   muscle; Mouse
ID SKELETAL-MUSCLE; ADIPOSE-TISSUE; RED MEAT; PROTEINS; HEALTH; LIVER;
   YOUNG; MILK; SIZE; AMPK
AB Body weight in young growing and young adult animals was reduced by a high dietary density of whey protein concentrate; however, it is unclear whether dietary proteins similarly affect body weight in aging animals. Here, we examined whether whey protein or whey peptide ingestion suppressed body fat accumulation and affected protein expression and phosphorylation in skeletal muscle in aging mice.
   Twenty-six male senescence-accelerated mouse prone 6 (SAMP6) mice were assigned randomly to three dietary treatment groups: 18.7 % casein control (CON), 18.7 % whey protein (WPR), and 18.7 % whey peptide (WPE). After 28 weeks of treatment, skeletal tissues were dissected and weighed for analysis. Western blotting was performed to examine the expression of AMP-activated protein kinase (AMPK), acetyl-CoA carboxylase (ACC), and adipose triglyceride lipase (ATGL) in quadriceps muscles.
   Body (CON: 47.6 +/- A 2.2 g, WPR: 48.2 +/- A 2.7 g, WPE: 38.3 +/- A 2.0 g) and relative white adipose tissue (CON: 38.5 +/- A 3.5 mg/g, WPR: 43.8 +/- A 4.0 mg/g, WPE: 21.1 +/- A 4.4 mg/g) weights were lower in the WPE group compared with the other two groups (p < 0.05), and no significant differences were observed between the CON and WPR groups. The relative weights of tibialis anterior muscle (CON: 1.04 +/- A 0.04 mg/g, WPR: 0.97 +/- A 0.03 mg/g, 1.23 +/- A 0.05 mg/g) and gastrocnemius muscle (CON: 3.02 +/- A 0.12 mg/g, WPR: 2.92 +/- A 0.15 mg/g, WPE: 3.65 +/- A 0.18 mg/g) were higher in the WPE group compared with the other groups (p < 0.05). The phosphorylation of AMPK (WPR: 1.03 +/- A 0.11, WPE: 1.36 +/- A 0.12; fold change from control) and ACC (WPR: 1.08 +/- A 0.07, WPE: 1.18 +/- A 0.05; fold change from control) in WPE was higher than in CON (p < 0.05). There were no significant differences in the expression levels of ATGL among the three groups.
   These data suggest that a normal (or moderate excess) dietary density of whey peptide attenuates body fat accumulation via upregulation of fatty acid oxidation in skeletal muscle in aging mice.
C1 [Ichinoseki-Sekine, Noriko; Naito, Hisashi] Juntendo Univ, Grad Sch Hlth & Sports Sci, Chiba 2701695, Japan.
   [Kakigi, Ryo] Juntendo Univ, Sch Med, Bunkyo Ku, Tokyo 1138421, Japan.
   [Miura, Susumu] Megmilk Snow Brand Co Ltd, Shinjuku Ku, Tokyo 1608575, Japan.
C3 Juntendo University; Juntendo University
RP Naito, H (corresponding author), Juntendo Univ, Grad Sch Hlth & Sports Sci, 1-1 Hiragagakuendai, Chiba 2701695, Japan.
EM hnaitou@juntendo.ac.jp
RI Naito, Hisashi/F-5655-2011; Ichinoseki-Sekine, Noriko/F-9075-2011
OI Naito, Hisashi/0000-0002-0522-9512; Ichinoseki-Sekine,
   Noriko/0000-0002-0467-3312
FU Megmilk Snow Brand Co., Ltd.
FX The authors have read the journal's policy and declare the following
   conflicts: SM is an employee of Megmilk Snow Brand Co., Ltd, Japan and
   HN received a research fund from Megmilk Snow Brand Co., Ltd. The
   sponsor had no control over the study design, decision to publish, or
   preparation of the manuscript. There are no patents, products in
   development, or marketed products to declare.
CR Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843
   Belobrajdic DP, 2004, J NUTR, V134, P1454, DOI 10.1093/jn/134.6.1454
   Belobrajdic DP, 2003, CANCER LETT, V198, P43, DOI 10.1016/S0304-3835(03)00307-0
   Boirie Y, 1997, P NATL ACAD SCI USA, V94, P14930, DOI 10.1073/pnas.94.26.14930
   Calbet JAL, 2004, EUR J NUTR, V43, P127, DOI 10.1007/s00394-004-0448-4
   Candow DG, 2005, J GERONTOL A-BIOL, V60, P148, DOI 10.1093/gerona/60.2.148
   Chen H, 2006, TISSUE CELL, V38, P325, DOI 10.1016/j.tice.2006.08.001
   Dangin M, 2002, J NUTR, V132, p3228S, DOI 10.1093/jn/131.10.3228S
   Griffiths RD, 1996, NUTRITION, V12, P456, DOI 10.1016/S0899-9007(96)00141-4
   Ha E, 2003, J NUTR BIOCHEM, V14, P251, DOI 10.1016/S0955-2863(03)00030-5
   Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311
   Hirofuji C, 2000, NEUROREPORT, V11, P823, DOI 10.1097/00001756-200003200-00033
   Kakigi R, 2011, J PHYSIOL SCI, V61, P131, DOI 10.1007/s12576-010-0130-y
   Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009
   Morifuji M, 2005, NUTRITION, V21, P1052, DOI 10.1016/j.nut.2005.01.010
   MOUGHAN PJ, 1991, J PEDIATR GASTR NUTR, V12, P253, DOI 10.1097/00005176-199102000-00019
   Niimi K, 2009, COMPARATIVE MED, V59, P431
   Park H, 2002, J BIOL CHEM, V277, P32571, DOI 10.1074/jbc.M201692200
   Pennings B, 2011, AM J CLIN NUTR, V93, P997, DOI 10.3945/ajcn.110.008102
   REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939
   ROGERS P, 1980, BRIT J NUTR, V43, P83, DOI 10.1079/BJN19800066
   Ruderman NB, 2003, ACTA PHYSIOL SCAND, V178, P435, DOI 10.1046/j.1365-201X.2003.01164.x
   Sakuma K, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/204164
   Short K R, 2000, Curr Opin Clin Nutr Metab Care, V3, P39, DOI 10.1097/00075197-200001000-00007
   Short KR, 2004, AM J PHYSIOL-ENDOC M, V286, pE92, DOI 10.1152/ajpendo.00366.2003
   Smirnova E, 2006, EMBO REP, V7, P106, DOI 10.1038/sj.embor.7400559
   SUGIURA T, 1990, BIOMED RES-TOKYO, V11, P87, DOI 10.2220/biomedres.11.87
   Wolfe RR, 2006, AM J CLIN NUTR, V84, P475, DOI 10.1093/ajcn/84.3.475
   Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747
NR 29
TC 6
Z9 6
U1 0
U2 14
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1436-6207
EI 1436-6215
J9 EUR J NUTR
JI Eur. J. Nutr.
PD JUN
PY 2015
VL 54
IS 4
BP 551
EP 556
DI 10.1007/s00394-014-0736-6
PG 6
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA CI4KG
UT WOS:000354716500006
PM 25018031
DA 2024-02-19
ER

PT J
AU Meehan, B
   Dombrovsky, A
   Lau, K
   Lai, T
   Magnus, N
   Montermini, L
   Rak, J
AF Meehan, Brian
   Dombrovsky, Alexander
   Lau, Karrie
   Lai, Tiffany
   Magnus, Nathalie
   Montermini, Laura
   Rak, Janusz
TI Impact of host ageing on the metastatic phenotype
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE Ageing; Tumor dissemination; Tumor heterogeneity; Cellular impedance
ID LIVER EPITHELIAL-CELLS; TISSUE FACTOR; TUMOR-GROWTH; AGE; CANCER;
   MICROENVIRONMENT; ANGIOGENESIS; INHIBITION; EXPRESSION; INDUCTION
AB Ageing impacts multiple host mechanisms involved in cancer progression. Here we show that poorly metastatic Lewis lung carcinoma (LLC) cells form less bulky metastatic deposits in aged mice (>52 weeks) relative to their young (4-6 weeks) counterparts. Serial selection of LLC cells for increased metastatic capability in either young or old mice led in both cases to exaggerated growth of pulmonary nodules after only 5 cycles of in vivo passage. The respective metastatic cellular variants established in young (Y-series) or old (O-series) mice differed in cell morphology and constitutive activity of growth factor receptors, especially phospho-PDGFRa and phospho-EPHA7. These cell lines also exhibited marked differences in their time dependent profiles of cellular impedance (CI), which reflects their physical properties, such as cell shape, adhesion and interactions with substrata. In confluent monolayer culture Y-series cell lines generated high and increasing CI values, while these values remained low and constant in the O-series of cell lines. These observations suggest that the selective pressure of the metastatic microenvironment in young versus old hosts is sufficiently different to results in the enrichment of distinct, age-related metastatic phenotypes of cancer cells. Thus, age could inform therapeutic approaches to metastatic cancers. (c) 2013 Elsevier Ireland Ltd. All rights reserved.
C1 [Meehan, Brian; Dombrovsky, Alexander; Lau, Karrie; Lai, Tiffany; Magnus, Nathalie; Montermini, Laura; Rak, Janusz] McGill Univ, Montreal Childrens Hosp, RI MUHC, Montreal, PQ H3H 1P3, Canada.
C3 McGill University
RP Rak, J (corresponding author), Montreal Childrens Hosp, Pl Toulon,4060 Ste Catherine West,PT 232 Montreal, Montreal, PQ H3Z 2Z3, Canada.
EM janusz.rak@mcgill.ca
FU Canadian Cancer Society Research Institute (CCSRI) Innovation
   initiative; FRSQ doctoral studentship
FX This work was supported by operating grants to J.R. from the Canadian
   Cancer Society Research Institute (CCSRI) Innovation initiative. The
   infrastructure support was provided by Fonds de recherche en sante du
   Quebec (FRSQ). J.R. is the Jack Cole Chair in Pediatric
   Hematology/Oncology at McGill University. NM is a recipient of the FRSQ
   doctoral studentship. We are indebted to our families and colleagues for
   their unending support and feedback.
CR Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708
   Anisimov VN, 2006, FRONT BIOSCI-LANDMRK, V11, P412, DOI 10.2741/1808
   ANISIMOV VN, 1988, CANCER LETT, V40, P77, DOI 10.1016/0304-3835(88)90264-9
   Balducci L, 2005, NAT REV CANCER, V5, P655, DOI 10.1038/nrc1675
   Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374
   Chiang AC, 2008, NEW ENGL J MED, V359, P2814, DOI 10.1056/NEJMra0805239
   Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106
   Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9
   Emmerechts J., 2012, THROMB DIATH HAEMO, P108
   ERSHLER WB, 1983, J AM GERIATR SOC, V31, P673, DOI 10.1111/j.1532-5415.1983.tb04153.x
   ERSHLER WB, 1984, CANCER RES, V44, P5677
   Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213
   Faury D, 2007, J CLIN ONCOL, V25, P1196, DOI 10.1200/JCO.2006.07.8626
   Ferrara N, 2005, ONCOLOGY-BASEL, V69, P11, DOI 10.1159/000088479
   FIDLER IJ, 1973, NATURE-NEW BIOL, V242, P148, DOI 10.1038/newbio242148a0
   Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098
   Folkman J, 2003, CANC MED, P161
   Francia G, 2011, NAT REV CANCER, V11, P135, DOI 10.1038/nrc3001
   GIAEVER I, 1984, P NATL ACAD SCI-BIOL, V81, P3761, DOI 10.1073/pnas.81.12.3761
   Hong J, 2011, ANALYST, V136, P237, DOI 10.1039/c0an00560f
   Hunter K, 2006, NAT REV CANCER, V6, P141, DOI 10.1038/nrc1803
   Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186
   Kaptzan T, 2006, MECH AGEING DEV, V127, P398, DOI 10.1016/j.mad.2005.12.011
   Karnezis T, 2012, CANCER CELL, V21, P181, DOI 10.1016/j.ccr.2011.12.026
   Klement H, 2007, AM J PATHOL, V171, P1342, DOI 10.2353/ajpath.2007.070298
   Leibovici J, 2009, MECH AGEING DEV, V130, P76, DOI 10.1016/j.mad.2008.03.004
   Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203
   Magnus N, 2010, BLOOD, V116, P815, DOI 10.1182/blood-2009-10-250639
   Margalit O, 2003, BRIT J CANCER, V89, P314, DOI 10.1038/sj.bjc.6600977
   MCCULLOUGH KD, 1994, CANCER RES, V54, P3668
   McCullough KD, 1998, P NATL ACAD SCI USA, V95, P15333, DOI 10.1073/pnas.95.26.15333
   McCullough KD, 1997, CANCER RES, V57, P1807
   Meehan B, 2011, BJU INT, V107, P416, DOI 10.1111/j.1464-410X.2010.09569.x
   NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840
   Oricchio E, 2012, CELL CYCLE, V11, P1076, DOI 10.4161/cc.11.6.19451
   Palumbo JS, 2007, BLOOD, V110, P133, DOI 10.1182/blood-2007-01-065995
   Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396
   Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753
   PILI R, 1994, JNCI-J NATL CANCER I, V86, P1303, DOI 10.1093/jnci/86.17.1303
   RAK J, 1995, CANCER RES, V55, P4575
   RAK J, 1995, J CELL BIOL, V131, P1587, DOI 10.1083/jcb.131.6.1587
   Rak J, 2008, APMIS, V116, P660, DOI 10.1111/j.1600-0463.2008.01058.x
   Rauscher FM, 2003, CIRCULATION, V108, P457, DOI 10.1161/01.CIR.0000082924.75945.48
   Rivard A, 1999, CIRCULATION, V99, P111, DOI 10.1161/01.CIR.99.1.111
   Spicer JD, 2012, CANCER RES, V72, P3919, DOI 10.1158/0008-5472.CAN-11-2393
   Stämpfli SF, 2010, ARTERIOSCL THROM VAS, V30, P1960, DOI 10.1161/ATVBAHA.110.206920
   Steeg PS, 2011, NAT REV CANCER, V11, P352, DOI 10.1038/nrc3053
   VANDERGEER P, 1994, ANNU REV CELL BIOL, V10, P251, DOI 10.1146/annurev.cellbio.10.1.251
   Versteeg HH, 2008, BLOOD, V111, P190, DOI 10.1182/blood-2007-07-101048
   Wang L, 2008, LAB CHIP, V8, P872, DOI 10.1039/b804130j
   Wu X, 2012, NATURE, V482, P529, DOI 10.1038/nature10825
   Yang LJ, 2011, ANAL BIOANAL CHEM, V399, P1823, DOI 10.1007/s00216-010-4584-9
   Zhu Wen-Hui, 2003, Angiogenesis, V6, P193, DOI 10.1023/B:AGEN.0000021397.18713.9c
NR 53
TC 7
Z9 8
U1 0
U2 3
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
EI 1872-6216
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD MAR-APR
PY 2013
VL 134
IS 3-4
BP 118
EP 129
DI 10.1016/j.mad.2013.02.001
PG 12
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 120DH
UT WOS:000317150500007
PM 23403123
OA Green Submitted
DA 2024-02-19
ER

PT J
AU Xiong, QT
   Shuai, W
   Zhou, CL
   Dong, WG
AF Xiong, Qiutang
   Shuai, Wei
   Zhou, Chen-liang
   Dong, Weiguo
TI Circulating bilirubin level is determined by both erythrocyte amounts
   and the proportion of aged erythrocytes in ageing and cardiovascular
   diseases
SO BIOMEDICINE & PHARMACOTHERAPY
LA English
DT Article
DE Ageing; Bilirubin; Erythrocytes; Cardiovascular diseases; Anemia
ID SERUM BILIRUBIN; RISK; ANEMIA; ASSOCIATION
AB Background: Bilirubin has been involved in the process of ageing and the pathology of ageing-related diseases. Circulating bilirubin is mainly derived from the clearance of disintegrated erythrocytes in the blood. However, the change of serum bilirubin level and its regulation during ageing and in ageing-related diseases remain to be elucidated.
   Methods: A retrospective study was conducted by analyzing the blood cell test results and liver function results of 14,049 healthy research subjects at the Physical Examination Center and 2052 patients with various types of cardiovascular diseases (CVD) at the Department of Cardiology in Renmin Hospital of Wuhan University. Spearman correlation analysis and linear-regression analysis were used for correlation studies. Differences between male and female were investigated.
   Results: Whereas the erythrocyte counts continuously decreased along with age, the proportion of aged erythrocytes was significantly increased in both male and female. The level of total circulating bilirubin was positively correlated with age and erythrocyte counts. The increase of bilirubin was associated with the increased morphological deviation of erythrocytes during ageing. Compared with health controls, the level of circulating bilirubin in CVD patients was significantly decreased consistent with the decline of erythrocyte counts and hemoglobin.
   Conclusions: Ageing may be accompanied by an increased ageing rate of erythrocytes, which contributes to the ageing-related decline of erythrocyte counts. Both erythrocyte counts and the proportion of aged erythrocytes coordinately might determine the circulating level of bilirubin during ageing. In CVD, the decline of circulating bilirubin may be largely attributed to concurrent anemia.
C1 [Xiong, Qiutang; Dong, Weiguo] Wuhan Univ, Renmin Hosp, Dept Gastroenterol, Wuhan 430060, Hubei, Peoples R China.
   [Shuai, Wei] Wuhan Univ, Renmin Hosp, Dept Cardiol, Wuhan 430060, Peoples R China.
   [Zhou, Chen-liang] Wuhan Univ, Renmin Hosp, Intens Care Unit, Wuhan 430060, Hubei, Peoples R China.
C3 Wuhan University; Wuhan University; Wuhan University
RP Zhou, CL; Dong, WG (corresponding author), 95 Zhangzhidong Rd, Wuhan 430060, Hubei, Peoples R China.
EM 54665420@qq.com; dongweiguo@whu.edu.cn
FU National Natural Science Foundation of China [81870392]
FX This work was supported by grants from the National Natural Science
   Foundation of China (No. 81870392).
CR Acharya S, 2009, ADV MATER, V21, P2959, DOI 10.1002/adma.200802648
   Ahmed T, 2010, CLIN INTERV AGING, V5, P207
   Andreotti F, 2017, J APPL PHYSIOL, V122, P414, DOI 10.1152/japplphysiol.00995.2015
   [Anonymous], [No title captured]
   [Anonymous], [No title captured]
   Bhutani VK, 2015, SEMIN FETAL NEONAT M, V20, P6, DOI 10.1016/j.siny.2014.12.008
   Boland BS, 2014, J CLIN EXP HEPATOL, V4, P1, DOI 10.1016/j.jceh.2014.01.003
   Cevenini E, 2013, CURR OPIN CLIN NUTR, V16, P14, DOI 10.1097/MCO.0b013e32835ada13
   Djoussé L, 2001, AM J CARDIOL, V87, P1196, DOI 10.1016/S0002-9149(01)01494-1
   HSIA DYY, 1965, PEDIATR CLIN N AM, V12, P713
   Kaiafa G, 2015, INT J CARDIOL, V186, P117, DOI 10.1016/j.ijcard.2015.03.159
   Kamisako T, 2000, J GASTROENTEROL, V35, P659, DOI 10.1007/s005350070044
   Kikuchi G, 2005, BIOCHEM BIOPH RES CO, V338, P558, DOI 10.1016/j.bbrc.2005.08.020
   Lamberts SWJ, 1997, SCIENCE, V278, P419, DOI 10.1126/science.278.5337.419
   Marconi VC, 2018, J AM HEART ASSOC, V7, DOI [10.1161/JAHA.117.007792, 10.1161/jaha.117.007792]
   McArdle PF, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-16
   Nolting PRWD, 2011, J LIPID RES, V52, P1755, DOI 10.1194/jlr.P013193
   Patriarca S, 2007, BIOGERONTOLOGY, V8, P365, DOI 10.1007/s10522-006-9079-x
   Peyton KJ, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00048
   Poulose N, 2014, AGING DIS, V5, P101, DOI 10.14336/AD.2014.0500101
   Sarnak MJ, 2002, J AM COLL CARDIOL, V40, P27, DOI 10.1016/S0735-1097(02)01938-1
   SCHWERTNER HA, 1994, CLIN CHEM, V40, P18
   Sedlak TW, 2009, P NATL ACAD SCI USA, V106, P5171, DOI 10.1073/pnas.0813132106
   Shavelle RM, 2012, INT J HEMATOL, V95, P248, DOI 10.1007/s12185-012-1007-z
   Suh S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193041
   Vítek L, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00055
   Vogel ME, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.004820
   Wagner KH, 2015, CLIN SCI, V129, P1, DOI 10.1042/CS20140566
   WANG CQ, 1995, J CELL PHYSIOL, V162, P134, DOI 10.1002/jcp.1041620116
   Zelenka J, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/6190609
NR 30
TC 5
Z9 5
U1 1
U2 7
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 0753-3322
EI 1950-6007
J9 BIOMED PHARMACOTHER
JI Biomed. Pharmacother.
PD MAR
PY 2020
VL 123
AR 109744
DI 10.1016/j.biopha.2019.109744
PG 6
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA KF8HB
UT WOS:000509476800021
PM 31862475
OA gold
DA 2024-02-19
ER

PT J
AU Guo, X
   Dong, Z
   Li, Q
   Wan, DG
   Zhong, JB
   Dongzhi, D
   Huang, MZ
AF Guo, Xiao
   Dong, Zhen
   Li, Qien
   Wan, Digao
   Zhong, Jiangbin
   Dongzhi, Duojie
   Huang, Meizhou
TI Flavonoids from<i> Rhododendron</i><i> nivale</i><i> Hook.</i> f delay
   aging via modulation of gut microbiota and glutathione metabolism
SO PHYTOMEDICINE
LA English
DT Article
DE Rhododendron nivale; Flavonoids; Anti-aging; Intestinal flora;
   Metabolomics
ID ANTIOXIDANT ACTIVITY; SYSTEM; FLORA; DRUG; SENESCENCE; EXTRACT; STRESS;
   TARGET; OIL
AB Background: Rhododendron nivale Hook. f (R.n), one of the four Manna Stash used in Tibetan medicine to delay aging, possesses anti-aging pharmacological activity. However, which R.n ingredients contain anti-aging properties and the underlying mechanisms involved are unclear.Hypothesis/Purpose: Based on interactions between gut microbiota and natural medicines and the important role of gut microbiota in anti-aging, the study investigated the hypothesis that R.n possesses anti-aging properties and the interaction of gut microbiota with R.n is responsible for its anti-aging effects.Study Design: The primary active ingredients of R.n and their target function and pathway enrichment were explored. An aging mouse model was used to clarify the underlying anti-aging mechanisms of R.n.Methods: Chromatography, spectroscopy, nuclear magnetic technology, and pharmacology were used to reveal the major active ingredients of ethanol extract residues of R.n (RNEA). The target function and pathway enrichment of these active ingredients were explored. Plasma metabolomics coupled with intestinal flora evaluation and bioinformatics analysis was used to clarify the underlying anti-aging mechanisms of RNEA.Results: Myricetin-3-13-D-xylopyranoside, hyperin, goospetin-8-methyl ether 3-13-D-galactoside, and diplomorphanin B were separated and identified from RNEA. The network pharmacology study revealed that the active ingredients' target function and pathway enrichment focused mainly on the glutathione antioxidant system. In a D-galactose-induced mouse model of aging, RNEA was shown to possess suitable anti-aging pharmacological activity, as indicated by the amelioration of memory loss and weakened superoxide dismutase and glutathione peroxidase activities. Plasma metabolomics coupled with intestinal flora examination and bioinformatics analysis revealed that RNEA could regulate the expression of glutathione-related enzymes and ameliorate D-galactose-induced imbalances in methionine, glycine, and serine, and betaine and galactose metabolism. The results showed that RNEA reshaped the disordered intestinal flora and mitigated the D -galactose-mediated decline in glutathione oxidase expression, further confirming that the anti-aging effect of RNEA was closely related to regulation of the glutathione antioxidant system.Conclusion: RNEA, consisting of myricetin-3-13-D-xylopyranoside, hyperin, goospetin-8-methyl ether 3-13-Dgalactoside, and diplomorphanin B, possesses anti-aging activity. The anti-aging effect of RNEA might be due to reshaping intestinal flora homeostasis, increasing the expression of glutathione peroxidase 4 in the intestines and liver, enhancing glutathione peroxidase activity, and reinforcing the glutathione antioxidant system.
C1 [Guo, Xiao; Li, Qien; Wan, Digao; Zhong, Jiangbin; Dongzhi, Duojie] Qinghai Univ, Tibetan Medicial Coll, Tibetan Med Res Ctr, State Key Lab Tibetan Med Res & Dev, Xining 810016, Qinghai, Peoples R China.
   [Huang, Meizhou] Affiliated Hosp Southwest Med Univ, Acad Expert Workstat Sichuan Prov, Luzhou 646000, Peoples R China.
   [Dong, Zhen] Hunan Agr Univ, Coll Vet Med, Changsha 410128, Peoples R China.
C3 Qinghai University; Hunan Agricultural University
RP Huang, MZ (corresponding author), Affiliated Hosp Southwest Med Univ, Acad Expert Workstat Sichuan Prov, Luzhou 646000, Peoples R China.
EM 13141254071@163.com
RI Dong, Zhen/GQP-4736-2022
OI Dong, Zhen/0000-0003-2122-8541; Huang, Mei-Zhou/0000-0003-2538-0217
FU Project of Qinghai Science and Technology Department [2018-ZJ-924Q];
   National Natural Science Foundation of China [82160800]; Natural Science
   Foundation of Sichuan Province [2022NSFSC1321]; Doctoral Research
   Startup Fund of Affiliated Hospital of Southwest Medical University
   [19063]; Luzhou Municipal Government-Southwest Medical University
   Cooperation Application Foundation [2021LZXNYD-J01]; Southwest Medical
   University [2021ZKMS025]; Young Qihuang Scholars Project [20207]
FX This work was funded by the Project of Qinghai Science and Technology
   Department (2018-ZJ-924Q) , the National Natural Science Foundation of
   China (82160800) , Natural Science Foundation of Sichuan Province
   (2022NSFSC1321) , the Doctoral Research Startup Fund of Affiliated
   Hospital of Southwest Medical University (19063) , Luzhou Municipal
   Government-Southwest Medical University Cooperation Application
   Foundation (2021LZXNYD-J01) and Southwest Medical University applied
   basic research project (Grant No. 2021ZKMS025) , and the Young Qihuang
   Scholars Project (20207) .
CR Abrahams S, 2019, NEUROSCIENCE, V406, P1, DOI 10.1016/j.neuroscience.2019.02.020
   Ahn E, 2021, AGING-US, V13, P21009, DOI 10.18632/aging.203509
   Amberger JS, 2015, NUCLEIC ACIDS RES, V43, pD789, DOI 10.1093/nar/gku1205
   Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI [10.1093/nar/gkh131, 10.1093/nar/gkw1099]
   Badal VD, 2020, NUTRIENTS, V12, DOI 10.3390/nu12123759
   Baker DJ, 2004, NAT GENET, V36, P744, DOI 10.1038/ng1382
   Biagi E, 2016, CURR BIOL, V26, P1480, DOI 10.1016/j.cub.2016.04.016
   Bosco N, 2021, GENES IMMUN, V22, P289, DOI 10.1038/s41435-021-00126-8
   Brunt VE, 2019, J PHYSIOL-LONDON, V597, P2361, DOI 10.1113/JP277336
   Buford TW, 2020, J GERONTOL A-BIOL, V75, P1229, DOI 10.1093/gerona/glaa103
   Campisi J, 2019, NATURE, V571, P183, DOI 10.1038/s41586-019-1365-2
   Celano R, 2017, FOOD RES INT, V99, P298, DOI 10.1016/j.foodres.2017.05.036
   Chen LL, 2019, AGING CELL, V18, DOI 10.1111/acel.12951
   Clements SJ, 2018, CRIT REV FOOD SCI, V58, P651, DOI 10.1080/10408398.2016.1211086
   Dai LX, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.599778
   Daina A, 2019, NUCLEIC ACIDS RES, V47, pW357, DOI 10.1093/nar/gkz382
   Dong Z, 2022, VET SCI, V9, DOI 10.3390/vetsci9010011
   Duan JJ, 2019, AGING-US, V11, P12080, DOI 10.18632/aging.102541
   Espinoza SE, 2008, J GERONTOL A-BIOL, V63, P505, DOI 10.1093/gerona/63.5.505
   Filippopoulou K, 2017, FREE RADICAL BIO MED, V103, P256, DOI 10.1016/j.freeradbiomed.2016.12.042
   Goncharova ND, 2007, B EXP BIOL MED+, V144, P730, DOI 10.1007/s10517-007-0418-y
   Gruber J, 2013, BIOTECHNOL ADV, V31, P563, DOI 10.1016/j.biotechadv.2012.09.005
   Guerra-Araiza C, 2013, FREE RADICAL RES, V47, P451, DOI 10.3109/10715762.2013.795649
   Guo X, 2017, ULTRASON SONOCHEM, V38, P246, DOI 10.1016/j.ultsonch.2017.03.021
   Guo X, 2017, VET PARASITOL, V236, P51, DOI 10.1016/j.vetpar.2017.01.028
   Hano Christophe, 2020, Medicines (Basel), V7, DOI 10.3390/medicines7050026
   Homma T, 2015, CURR DRUG METAB, V16, P560, DOI 10.2174/1389200216666151015114515
   Hopkins AL, 2007, NAT BIOTECHNOL, V25, P1110, DOI 10.1038/nbt1007-1110
   Hou YJ, 2019, NAT REV NEUROL, V15, P565, DOI 10.1038/s41582-019-0244-7
   Hseu YC, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/2576823
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923
   Huang JC, 2016, J FOOD SCI, V81, pH2273, DOI 10.1111/1750-3841.13411
   Induri SNR, 2022, ANNU REV PHARMACOL, V62, P85, DOI 10.1146/annurev-pharmtox-051920-093829
   Islam F, 2022, EVID-BASED COMPL ALT, V2022, DOI 10.1155/2022/6144733
   Kapahi P, 2010, CELL METAB, V11, P453, DOI 10.1016/j.cmet.2010.05.001
   Ke YL, 2018, FREE RADICAL BIO MED, V116, P88, DOI 10.1016/j.freeradbiomed.2018.01.007
   Khaltourina D, 2020, MECH AGEING DEV, V189, DOI 10.1016/j.mad.2020.111230
   [李雪峰 LI Xuefeng], 2008, [天然产物研究与开发, Natural Product R & D], V20, P1125
   Liochev SI, 2013, FREE RADICAL BIO MED, V60, P1, DOI 10.1016/j.freeradbiomed.2013.02.011
   Lopez Oscar L, 2011, Am J Manag Care, V17 Suppl 13, pS339
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Luo J, 2020, AGEING RES REV, V57, DOI 10.1016/j.arr.2019.100982
   Ly DH, 2000, SCIENCE, V287, P2486, DOI 10.1126/science.287.5462.2486
   Martel J, 2019, MED RES REV, V39, P1515, DOI 10.1002/med.21559
   Mitra S, 2022, BIOMED PHARMACOTHER, V149, DOI 10.1016/j.biopha.2022.112877
   Monti DM, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/7450693
   Nosareva OL, 2017, B EXP BIOL MED+, V164, P199, DOI 10.1007/s10517-017-3957-x
   Othman M, 2008, CURR OPIN GASTROEN, V24, P11, DOI 10.1097/MOG.0b013e3282f2b0d7
   Paneni F, 2017, J AM COLL CARDIOL, V69, P1952, DOI 10.1016/j.jacc.2017.01.064
   Pérez-Cano FJ, 2014, ANTIOXIDANTS-BASEL, V3, P649, DOI 10.3390/antiox3040649
   Popescu R, 2013, J ETHNOPHARMACOL, V147, P42, DOI 10.1016/j.jep.2013.02.022
   Prasad KN, 2017, MECH AGEING DEV, V164, P61, DOI 10.1016/j.mad.2017.04.004
   Qu C, 2022, J ADV RES, V35, P231, DOI 10.1016/j.jare.2021.03.012
   Rampelli S, 2020, MSYSTEMS, V5, DOI 10.1128/mSystems.00124-20
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   Shang XF, 2017, VET PARASITOL, V240, P17, DOI 10.1016/j.vetpar.2017.04.019
   Shimizu C, 2016, J PHARM PHARM SCI, V19, P430, DOI 10.18433/J3990V
   Singh RJ, 2002, J LAB CLIN MED, V140, P380, DOI 10.1067/mlc.2002.129505
   Song CM, 2021, EXP GERONTOL, V153, DOI 10.1016/j.exger.2021.111476
   Stelzer Gil, 2016, Curr Protoc Bioinformatics, V54, DOI 10.1002/cpbi.5
   Szklarczyk D, 2021, NUCLEIC ACIDS RES, V49, pD605, DOI 10.1093/nar/gkaa1074
   Vaiserman A, 2020, FRONT BIOENG BIOTECH, V7, DOI 10.3389/fbioe.2019.00447
   Vaiserman AM, 2017, AGEING RES REV, V35, P36, DOI 10.1016/j.arr.2017.01.001
   van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193
   Cuong VT, 2019, EXP GERONTOL, V117, P99, DOI 10.1016/j.exger.2018.11.016
   Wang H, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.651191
   Wang X, 2017, NUCLEIC ACIDS RES, V45, pW356, DOI 10.1093/nar/gkx374
   Wang Z, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0223-0
   Widowati W, 2020, TROP LIFE SCI RES, V31, P127, DOI 10.21315/tlsr2020.31.3.9
   Xu ZF, 2017, AGING DIS, V8, P760, DOI 10.14336/AD.2016.0620
   Hui Y, 2019, INT J BIOL MACROMOL, V121, P1203, DOI 10.1016/j.ijbiomac.2018.10.096
   Yun J, 2014, CELL METAB, V19, P757, DOI 10.1016/j.cmet.2014.01.011
   Zhang XY, 2020, GUT MICROBES, V12, DOI 10.1080/19490976.2020.1842990
   Zhao DY, 2016, J NUTR BIOCHEM, V38, P116, DOI 10.1016/j.jnutbio.2016.09.005
   Zhao S, 2012, ANNU REV PHARMACOL, V52, P505, DOI 10.1146/annurev-pharmtox-010611-134520
   Ziada AS, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.575645
   Zofia NL, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/5307614
NR 78
TC 7
Z9 9
U1 24
U2 72
PU ELSEVIER GMBH
PI MUNICH
PA HACKERBRUCKE 6, 80335 MUNICH, GERMANY
SN 0944-7113
EI 1618-095X
J9 PHYTOMEDICINE
JI Phytomedicine
PD SEP
PY 2022
VL 104
AR 154270
DI 10.1016/j.phymed.2022.154270
PG 16
WC Plant Sciences; Chemistry, Medicinal; Integrative & Complementary
   Medicine; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary
   Medicine
GA 2U1OS
UT WOS:000822932800004
PM 35760023
DA 2024-02-19
ER

PT J
AU Wu, HY
   Yuan, J
   Yin, HX
   Jing, B
   Sun, C
   Tsopmejio, ISN
   Jin, ZY
   Song, H
AF Wu, Haoyuan
   Yuan, Jing
   Yin, Haixu
   Jing, Bo
   Sun, Chang
   Tsopmejio, Ivan Steve Nguepi
   Jin, Zhouyu
   Song, Hui
TI Flammulina velutipes stem regulates oxidative damage and synthesis of
   yolk precursors in aging laying hens by regulating the liver-blood-ovary
   axis br
SO POULTRY SCIENCE
LA English
DT Article; Early Access
DE Flammulina velutipes stem; liver-blood-ovary signal axis; oxidative
   stress; reproductive hormone; yolk precursor synthesis
ID STRESS-RESPONSE; EXPRESSION; GRANULOSA; ANTIOXIDANT; RECEPTOR;
   PROLIFERATION; PERFORMANCE; APOPTOSIS; HORMONES; SYSTEM
AB Egg production levels in late laying hens are negatively correlated with increasing age. Decreased liver and ovarian function in aging laying hens is accom-panied by decreased antioxidant capacity, reproductive hormone levels, and follicular development, resulting in decreased synthesis of yolk precursors. The golden nee-dle mushroom (Flammulina velutipes) has been reported to exhibit anti-inflammatory, antioxidant, and hypolipi-demic properties. We aimed to reveal the therapeutic effects of F. velutipes stem (FVS) on liver-blood-ovary axis and investigate the underlying mechanisms. A total of 360 sixty-seven-wk-old laying hens were randomized into 4 treatment groups: 1) basal maize-soybean meal diet (CON); 2) basal maize + 20 g/kg FVS (2% FVS); 3) basal maize + 40 g/kg FVS (4% FVS); and 4) basal maize + 60 g/kg FVS (6% FVS). FVS groups demon-strated significantly increased egg production and ovar-ian development compared with the CON group. The addition of FVS increased the levels of antioxidant enzymes (GSH-Px, T-SOD, and T-AOC) in the liver, serum, and ovaries and decreased malondialdehyde levels by regulating the expression of proteins related to the Keap1-Nrf2/ARE signaling pathway. Additionally, FVS significantly decreased ovarian apoptosis by regu-lating Bax, Bcl-2, and caspase3 mRNA and protein expression levels. FVS significantly increased the expres-sion levels of estradiol, progesterone, luteinizing hor-mone, and follicle stimulating hormone and their respective receptors. With increased levels of estradiol transported to the liver through the bloodstream, tar-geted binding to estrogen receptor (ER) -a and ER -b led to significant increases in ApoVLDL II, ApoB, and VTG II mRNA expression associated with yolk precursor syn-thesis. FVS decreased the levels of triglyceride and total cholesterol and significantly increased the expression of lipid metabolism, and transport-related mRNAs (FAS, PPAR-a/g, and MTTP) in the liver. Therefore, the die-tary supplementation of FVS can maintain the produc-tive performance of aging laying hens by alleviating the degree of oxidative stress and regulating the transport of functional substances along the liver-blood-ovary axis, thereby improving the synthesis of yolk precursors.
C1 [Wu, Haoyuan; Yuan, Jing; Yin, Haixu; Jing, Bo; Sun, Chang; Tsopmejio, Ivan Steve Nguepi; Jin, Zhouyu; Song, Hui] Jilin Agr Univ, Sch Life Sci, Changchun 130118, Peoples R China.
   [Song, Hui] Chinenese Minist Educ Bioreactor & Pharmaceut Dev, Engn Res Ctr, Changchun 130118, Jilin, Peoples R China.
   [Song, Hui] Chinese Minist Educ Edible & Med Fungi, Engn Res Ctr, Changchun 130118, Jilin, Peoples R China.
C3 Jilin Agricultural University
RP Song, H (corresponding author), Jilin Agr Univ, Sch Life Sci, Changchun 130118, Peoples R China.; Song, H (corresponding author), Chinenese Minist Educ Bioreactor & Pharmaceut Dev, Engn Res Ctr, Changchun 130118, Jilin, Peoples R China.; Song, H (corresponding author), Chinese Minist Educ Edible & Med Fungi, Engn Res Ctr, Changchun 130118, Jilin, Peoples R China.
EM songhuisk@jlau.edu.cn
RI Zhouyu, Jin/ABE-2480-2022
FU Key R&D Project of Jilin Provincial Department of Science and Technology
   "R&D of new safe and efficient feed products" [20180201019NY]
FX This work was supported by the Key R & D Project of Jilin Provincial
   Department of Science and Technology "R & D of new safe and efficient
   feed products" (20180201019NY).Haoyuan Wu: drafting the manuscript,
   conception and design; Jing Yuan and Haixu Yin: performed the
   experiments; Bo Jing and Zhouyu Jin: analyzed the data; Ivan Steve
   Nguepi Tsopmejio: revising the manuscript. Chang Sun: Given final
   approval of the version to be published. Hui Song: Agreed to be
   accountable for all aspects of the work in ensuring that questions
   related to the accuracy or integrity of any part of the work are
   appropriately investigated and resolved. All authors read and approved
   the final manuscript.
CR Amevor FK, 2021, ANIMALS-BASEL, V11, DOI 10.3390/ani11071915
   BARBER DL, 1991, J BIOL CHEM, V266, P18761
   BUJO H, 1994, EMBO J, V13, P5165, DOI 10.1002/j.1460-2075.1994.tb06847.x
   Rivas REC, 2016, ASIAN AUSTRAL J ANIM, V29, P487, DOI 10.5713/ajas.15.0310
   Chen M, 2020, PAK J ZOOL, V52, P389, DOI 10.17582/journal.pjz/2020.52.1.sc6
   Chen PY, 2015, INT J MED MUSHROOMS, V17, P287, DOI 10.1615/IntJMedMushrooms.v17.i3.80
   Ciccone NA, 2005, GEN COMP ENDOCR, V144, P20, DOI 10.1016/j.ygcen.2005.04.009
   Cui ZF, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10122348
   Dai HJ, 2021, POULTRY SCI, V100, DOI 10.1016/j.psj.2021.101499
   Gao YY, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/3139689
   Gawel Stefan, 2004, Wiad Lek, V57, P453
   Gu YF, 2021, POULTRY SCI, V100, DOI 10.1016/j.psj.2021.101478
   He L, 2017, CELL PHYSIOL BIOCHEM, V44, P532, DOI 10.1159/000485089
   Hu QH, 2016, FOOD CHEM, V204, P274, DOI 10.1016/j.foodchem.2016.02.138
   Hu YN, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8080298
   Hwang CS, 2006, J STEROID BIOCHEM, V101, P246, DOI 10.1016/j.jsbmb.2006.06.020
   Ko SH, 2020, NUTRIENTS, V12, DOI 10.3390/nu12010202
   Kushairi N, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8080261
   Lee YH, 2016, J PHARMACOPUNCT, V19, P59, DOI 10.3831/KPI.2016.19.008
   Li JC, 2019, VET RES, V50, DOI 10.1186/s13567-019-0703-6
   Li J, 2021, ECOTOX ENVIRON SAFE, V225, DOI 10.1016/j.ecoenv.2021.112771
   Li J, 2014, THERIOGENOLOGY, V82, P517, DOI 10.1016/j.theriogenology.2014.05.003
   Liang QX, 2022, FRONT NUTR, V9, DOI 10.3389/fnut.2022.841230
   Liu XT, 2018, J ZHEJIANG UNIV-SC B, V19, P390, DOI [10.1631/jzus.B1700054, 10.1631/jzus.b1700054]
   Liu XT, 2018, AGING-US, V10, P2016, DOI 10.18632/aging.101526
   Liu XT, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/9390810
   Liu XZ, 2020, J ANIM SCI BIOTECHNO, V11, DOI 10.1186/s40104-020-00449-y
   Liu XZ, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10010082
   Loboda A, 2016, CELL MOL LIFE SCI, V73, P3221, DOI 10.1007/s00018-016-2223-0
   Luderer U, 2014, VITAM HORM, V94, P99, DOI 10.1016/B978-0-12-800095-3.00004-3
   Ma S, 2021, MOLECULES, V26, DOI 10.3390/molecules26206205
   Ma Y, 2021, BIOL TRACE ELEM RES, V199, P2707, DOI 10.1007/s12011-020-02398-z
   Mahfuz S, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9090692
   Mahfuz S, 2019, J SCI FOOD AGR, V99, P703, DOI 10.1002/jsfa.9236
   Mahfuz S, 2018, ASIAN AUSTRAL J ANIM, V31, P705, DOI 10.5713/ajas.17.0787
   Manolagas SC, 2010, ENDOCR REV, V31, P266, DOI 10.1210/er.2009-0024
   May-Panloup P, 2016, HUM REPROD UPDATE, V22, P725, DOI 10.1093/humupd/dmw028
   Meng XT, 2013, GEN COMP ENDOCR, V194, P198, DOI 10.1016/j.ygcen.2013.09.007
   Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003
   Nateghi R, 2019, BIOPRESERV BIOBANK, V17, P148, DOI 10.1089/bio.2018.0101
   NIMPF J, 1991, J NUTR, V121, P1471, DOI 10.1093/jn/121.9.1471
   Omer NA, 2018, J ANIM SCI BIOTECHNO, V9, DOI 10.1186/s40104-017-0218-9
   Rahman MA, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/403023
   Rozenboim I, 2016, POULTRY SCI, V95, P612, DOI 10.3382/ps/pev367
   Sack MN, 2017, J AM COLL CARDIOL, V70, P196, DOI 10.1016/j.jacc.2017.05.034
   SCHNEIDER WJ, 1992, CLIN INVESTIGATOR, V70, P385
   Shen M, 2017, AUTOPHAGY, V13, P1364, DOI 10.1080/15548627.2017.1327941
   Sies H, 1997, EXP PHYSIOL, V82, P291, DOI 10.1113/expphysiol.1997.sp004024
   Sirtori CR, 2005, ANN MED, V37, P423, DOI 10.1080/07853890510044586
   Sobinoff AP, 2013, TOXICOL APPL PHARM, V271, P156, DOI 10.1016/j.taap.2013.05.009
   Tramunt B, 2021, METABOLITES, V11, DOI 10.3390/metabo11080502
   Tsopmejio ISN, 2022, FOOD BIOSCI, V47, DOI 10.1016/j.fbio.2021.101426
   Walzem RL, 1999, J NUTR, V129, p467S, DOI 10.1093/jn/129.2.467S
   Wang JP, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10091422
   Wang L, 2021, J CELL PHYSIOL, V236, P7966, DOI 10.1002/jcp.30468
   Xing CH, 2020, POULTRY SCI, V99, P1019, DOI 10.1016/j.psj.2019.10.009
   Yang CM, 2012, J AGR FOOD CHEM, V60, P1576, DOI 10.1021/jf204451n
   Yang JX, 2018, J ANIM PHYSIOL AN N, V102, P505, DOI 10.1111/jpn.12778
   Yang XT, 2019, LIFE SCI, V229, P166, DOI 10.1016/j.lfs.2019.05.040
   Yeh MY, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/352385
   YOSHIMURA Y, 1988, POULTRY SCI, V67, P814, DOI 10.3382/ps.0670814
   Zhang CQ, 1997, GEN COMP ENDOCR, V105, P402, DOI 10.1006/gcen.1996.6843
   Zhu MK, 2021, ECOTOX ENVIRON SAFE, V214, DOI 10.1016/j.ecoenv.2021.112091
NR 63
TC 5
Z9 7
U1 6
U2 15
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0032-5791
EI 1525-3171
J9 POULTRY SCI
JI Poult. Sci.
PD 2023 JAN
PY 2023
VL 102
IS 1
AR 102261
DI 10.1016/j.psj.2022.102261
EA NOV 2022
PG 16
WC Agriculture, Dairy & Animal Science
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Agriculture
GA 6Z0BB
UT WOS:000897448100010
PM 36410067
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Yen, SSC
   Laughlin, GA
AF Yen, SSC
   Laughlin, GA
TI Aging and the adrenal cortex
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article; Proceedings Paper
CT 4th International Symposium on the Neurobiology and Neuroendocrinology
   of Aging
CY JUL 26-31, 1998
CL BREGENZ, AUSTRIA
SP SO Ill Univ, Sch Med, RW Johnson Pharmaceut Res Inst, Junifur Fdn, Orentreich Fdn Advancement Sci, Searle Pharmaceut, SO Ill Univ, Grad Sch
DE adrenal; aging; cortisol; DHEAS; IGF-I
ID GROWTH-FACTOR-I; HUMAN ADRENOCORTICAL-CELLS; DEHYDROEPIANDROSTERONE
   REPLACEMENT THERAPY; ENDOCRINE-METABOLIC PARAMETERS; POSTMENOPAUSAL
   WOMEN; CORTISOL-LEVELS; NORMAL MEN; IGF-I; STEROIDOGENIC ENZYME;
   COGNITIVE FUNCTION
AB Aging in humans is accompanied by an increase in adrenal glucocorticoid secretion and a decline in adrenal androgen synthesis and secretion. The intense interest in adrenal function in aging individuals in recent years is in large measure related to the potential impact of cortisol excess in the development of cognitive impairment and hippocampal neuronal loss, and to the desire to provide hormone replacement and healthy aging. Although the preliminary data is tantalizing, solid scientific evidence are not at hand. It is apparent that both issues are extremely complex. Dehydroepiandrosterone (DHEA) and its 3 beta-sulfate are fascinating molecules, including their synthesis and actions in the brain. Recent studies have shown that DHEA-sulfate (DHEA-S), but not DHEA, activates peroxisome proliferator-activated receptor alpha (PPAR alpha) in the liver, an intracellular receptor belonging to the steroid receptor superfamily. Thus, DHEA-S may serve as a physiological modulator of liver fatty acid metabolism and peroxisomal enzyme expression, and thereby may contribute to the anticarcinogenic and chemoprotective properties of this intriguing class of endogenous steroids. The life-sustaining role of adrenal cortisol secretion and its regulation of metabolism via catabolic actions may be modulated by its partner DHEA and DHEA-S. During the anabolic growth period (childhood and early adulthood) the body is exposed to relatively high levels of DHEA/DHEA-S but to relatively or absolutely high levels of cortisol during infancy and the aging phase. The cortisol/DHEA-S ratio during the life span follows a U-shape curve, which may be telling us to explore these two critical adrenal steroids in tandem. (C) 1998 Elsevier Science Inc.
C1 Univ Calif San Diego, La Jolla, CA 92093 USA.
C3 University of California System; University of California San Diego
RP Yen, SSC (corresponding author), Dept Reprod Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.
EM dnye@ucsd.ed
CR ALBERT DH, 1980, J BIOL CHEM, V255, P618
   BAULIEU EE, 1960, J CLIN ENDOCR METAB, V20, P900, DOI 10.1210/jcem-20-6-900
   Baulieu EE, 1997, RECENT PROG HORM RES, V52, P1
   BELANGER A, 1994, J CLIN ENDOCR METAB, V79, P1086
   BIRD CE, 1978, J CLIN ENDOCR METAB, V47, P818, DOI 10.1210/jcem-47-4-818
   Butenandt A, 1934, Z PHYSL CHEM, V229, P192
   CARLSTROM K, 1988, MATURITAS, V10, P297, DOI 10.1016/0378-5122(88)90065-5
   CORPAS E, 1993, ENDOCR REV, V14, P20, DOI 10.1210/er.14.1.20
   deLeon MJ, 1997, J CLIN ENDOCR METAB, V82, P3251, DOI 10.1210/jc.82.10.3251
   DEPERGOLA G, 1993, INT J OBESITY, V17, P481
   Deuschle M, 1997, LIFE SCI, V61, P2239, DOI 10.1016/S0024-3205(97)00926-0
   Diamond P, 1996, J ENDOCRINOL, V150, pS43
   Endoh A, 1996, J CLIN ENDOCR METAB, V81, P3558, DOI 10.1210/jc.81.10.3558
   FRIESS E, 1995, AM J PHYSIOL-ENDOC M, V268, pE107, DOI 10.1152/ajpendo.1995.268.1.E107
   Givalois L, 1997, MOL BRAIN RES, V48, P107, DOI 10.1016/S0169-328X(97)00088-0
   Guazzo EP, 1996, J CLIN ENDOCR METAB, V81, P3951, DOI 10.1210/jc.81.11.3951
   GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902
   HESSE V, 1994, EXP CLIN ENDOCRINOL, V102, P289, DOI 10.1055/s-0029-1211294
   HOLLOWAY L, 1994, J CLIN ENDOCR METAB, V79, P470, DOI 10.1210/jc.79.2.470
   Huizenga NATM, 1998, J CLIN ENDOCR METAB, V83, P47, DOI 10.1210/jc.83.1.47
   ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0
   JACOBSON L, 1991, ENDOCR REV, V12, P118, DOI 10.1210/edrv-12-2-118
   Kern W, 1996, J GERONTOL A-BIOL, V51, pM3, DOI 10.1093/gerona/51A.1.M3
   Kirschbaum C, 1996, J CLIN ENDOCR METAB, V81, P3639, DOI 10.1210/jc.81.10.3639
   Kristiansen SB, 1997, STEROIDS, V62, P258, DOI 10.1016/S0039-128X(96)00223-1
   Kudielka BM, 1998, J CLIN ENDOCR METAB, V83, P1756, DOI 10.1210/jc.83.5.1756
   Labrie F, 1997, J CLIN ENDOCR METAB, V82, P3498, DOI 10.1210/jc.82.10.3498
   LAllemand D, 1996, J CLIN ENDOCR METAB, V81, P3892, DOI 10.1210/jc.81.11.3892
   LEGRAIN S, 1995, GERONTOLOGY, V41, P343, DOI 10.1159/000213706
   LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953
   Magri F, 1997, CHRONOBIOL INT, V14, P385, DOI 10.3109/07420529709001459
   MAJEWSKA MD, 1992, PROG NEUROBIOL, V38, P379, DOI 10.1016/0301-0082(92)90025-A
   Majewska MD, 1995, ANN NY ACAD SCI, V774, P111, DOI 10.1111/j.1749-6632.1995.tb17375.x
   MCEWEN BS, 1995, CURR OPIN NEUROBIOL, V5, P205, DOI 10.1016/0959-4388(95)80028-X
   MCEWEN BS, 1991, TRENDS PHARMACOL SCI, V12, P141, DOI 10.1016/0165-6147(91)90531-V
   Meaney MJ, 1996, DEV NEUROSCI-BASEL, V18, P49, DOI 10.1159/000111395
   MEIKLE AW, 1988, METABOLISM, V37, P514, DOI 10.1016/0026-0495(88)90164-3
   MIGEON CJ, 1954, J BIOL CHEM, V209, P767
   MORALES AJ, 1994, J CLIN ENDOCR METAB, V78, P1360, DOI 10.1210/jc.78.6.1360
   MORALES AJ, 1998, IN PRESS CLIN ENDOCR
   MORTOLA JF, 1990, J CLIN ENDOCR METAB, V71, P696, DOI 10.1210/jcem-71-3-696
   Munson PL, 1944, J BIOL CHEM, V152, P67
   NESTLER JE, 1988, J CLIN ENDOCR METAB, V66, P57, DOI 10.1210/jcem-66-1-57
   ORENTREICH N, 1984, J CLIN ENDOCR METAB, V59, P551, DOI 10.1210/jcem-59-3-551
   ORENTREICH N, 1992, J CLIN ENDOCR METAB, V75, P1002, DOI 10.1210/jc.75.4.1002
   Paolisso G, 1997, J CLIN ENDOCR METAB, V82, P2204, DOI 10.1210/jc.82.7.2204
   PARE WP, 1965, J GERONTOL, V20, P78, DOI 10.1093/geronj/20.1.78
   Parker CR, 1997, J CLIN ENDOCR METAB, V82, P3898, DOI 10.1210/jc.82.11.3898
   PARKER CR, 1995, P ANN M SOC GYN INV
   Peters JM, 1996, MOL PHARMACOL, V50, P67
   PHAMHUUTRUNG MT, 1991, J STEROID BIOCHEM, V39, P903, DOI 10.1016/0960-0760(91)90348-9
   Ravaglia G, 1996, J CLIN ENDOCR METAB, V81, P1173, DOI 10.1210/jc.81.3.1173
   Robel P, 1995, CRIT REV NEUROBIOL, V9, P383
   Robel P, 1995, ANN NY ACAD SCI, V774, P82, DOI 10.1111/j.1749-6632.1995.tb17374.x
   ROTTER JI, 1985, METABOLISM, V34, P731, DOI 10.1016/0026-0495(85)90023-X
   RUDMAN D, 1990, NEW ENGL J MED, V323, P1, DOI 10.1056/NEJM199007053230101
   SAPOLSKY RM, 1993, BEHAV BRAIN RES, V57, P175, DOI 10.1016/0166-4328(93)90133-B
   SAPOLSKY RM, 1990, J NEUROSCI, V10, P2897, DOI 10.1523/jneurosci.10-09-02897.1990
   SAPOLSKY RM, 1983, EXP GERONTOL, V18, P55, DOI 10.1016/0531-5565(83)90051-7
   Sheline YI, 1996, P NATL ACAD SCI USA, V93, P3908, DOI 10.1073/pnas.93.9.3908
   SLADEK CD, 1987, ENDOCRINOLOGY, V120, P1576, DOI 10.1210/endo-120-4-1576
   STARKMAN MN, 1992, BIOL PSYCHIAT, V32, P756, DOI 10.1016/0006-3223(92)90079-F
   THOMAS G, 1994, J CLIN ENDOCR METAB, V79, P1273, DOI 10.1210/jc.79.5.1273
   THOMPSON JL, 1995, J CLIN ENDOCR METAB, V80, P1845, DOI 10.1210/jc.80.6.1845
   USISKIN KS, 1990, INT J OBESITY, V14, P457
   VAMVAKOPOULOS NC, 1993, J CLIN INVEST, V92, P1896, DOI 10.1172/JCI116782
   VanCauter E, 1996, J CLIN ENDOCR METAB, V81, P2468, DOI 10.1210/jc.81.7.2468
   VANCOEVORDEN A, 1991, AM J PHYSIOL, V260, pE651, DOI 10.1152/ajpendo.1991.260.4.E651
   VANDERVOORT AA, 1990, J GERONTOL, V45, pB125, DOI 10.1093/geronj/45.4.B125
   WAHLI W, 1995, CHEM BIOL, V2, P261, DOI 10.1016/1074-5521(95)90045-4
   WELLE S, 1990, J CLIN ENDOCR METAB, V71, P1259, DOI 10.1210/jcem-71-5-1259
   Wilkinson CW, 1997, NEUROENDOCRINOLOGY, V65, P79, DOI 10.1159/000127167
   Wolf OT, 1997, BIOL PSYCHIAT, V42, P845, DOI 10.1016/S0006-3223(97)00323-5
NR 73
TC 70
Z9 77
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD NOV-DEC
PY 1998
VL 33
IS 7-8
BP 897
EP 910
DI 10.1016/S0531-5565(98)00046-1
PG 14
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Geriatrics & Gerontology
GA 150EH
UT WOS:000077650200023
PM 9951633
DA 2024-02-19
ER

PT J
AU Choi, J
   Yu, JS
   Cho, ES
   Kim, JH
   Chung, JJ
AF Choi, Jiae
   Yu, Jeong-Sik
   Cho, Eun-Suk
   Kim, Joo Hee
   Chung, Jae-Joon
TI Hepatic cavernous hemangiomas: long-term (&gt; 5 years) follow-up
   changes on contrast-enhanced dynamic computed tomography or magnetic
   resonance imaging and determinant factors of the size change
SO RADIOLOGIA MEDICA
LA English
DT Article
DE Hepatic hemangioma; Interval change; Computed tomography; Magnetic
   resonance imaging; Liver cirrhosis
ID POSSIBLE ASSOCIATION; LIVER; MRI; ESTROGEN; BENIGN; TUMORS
AB To investigate the very long-term (> 5 years) follow-up changes of hepatic cavernous hemangiomas and to evaluate possible determinant factors for the changes.
   Among 1115 consecutive patients suspected of having hepatic hemangiomas based on imaging features, 101 patients with comparable computed tomography or magnetic resonance imaging data during a 5-year follow-up interval in the Picture Archiving and Communication System were analyzed. Two radiologists independently determined the largest dimension of each lesion on axial images. In addition to background liver fibrosis or steatosis on imaging, histories of use of chemotherapeutic agents were checked from the patients' records. The final size change of the hemangioma was categorized into three groups compared with the initial diameter (increased, > 120%; no change, 80-120%; decreased, < 80%).
   Among the 101 hemangiomas, 32 lesions (31.7%) were enlarged and 21 lesions (20.8%) were shrunken during intervals of 60-157 (median, 81) months. Younger patients showed a higher prevalence of lesion enlargement (mean age: enlarged, 47.3 years; no change, 52.8 years; shrunken, 57.1 years; p = 0.003). In 15 patients with cirrhosis, the lesions (shrunken, n = 7; enlarged, n = 1) showed a higher tendency of size decrease (p = 0.009), whereas other factors did not show statistical significance (p > 0.05). Only a minor proportion (1%, n = 1) of the lesions showed size fluctuation during follow-up.
   During the long-term (5-13 years) follow-up, about 50% of the hepatic hemangiomas were enlarged or shrunken to > 20% of the initial diameter. Aside from the cirrhosis and aging factors, the size changes seemed sporadic.
C1 [Choi, Jiae; Yu, Jeong-Sik; Cho, Eun-Suk; Kim, Joo Hee; Chung, Jae-Joon] Yonsei Univ, Gangnam Severance Hosp, Dept Radiol, Coll Med, Seoul 06273, South Korea.
C3 Yonsei University; Yonsei University Health System
RP Yu, JS (corresponding author), Yonsei Univ, Gangnam Severance Hosp, Dept Radiol, Coll Med, Seoul 06273, South Korea.
EM yjsrad97@yuhs.ac
OI Chung, Jae-Joon/0000-0002-7447-1193; KIM, JOO HEE/0000-0001-5383-3602;
   CHOI, JIAE/0000-0003-3191-9469; Yu, Jeong-Sik/0000-0002-8171-5838
CR Bajenaru N, 2015, J Med Life, V8 Spec Issue, P4
   BAKER ER, 1985, CLIN PEDIATR, V24, P596, DOI 10.1177/000992288502401010
   Bioulac-Sage P, 2008, SEMIN LIVER DIS, V28, P302, DOI 10.1055/s-0028-1085098
   Brancatelli G, 2001, RADIOLOGY, V219, P69, DOI 10.1148/radiology.219.1.r01ap3269
   CONTER RL, 1988, ANN SURG, V207, P115, DOI 10.1097/00000658-198802000-00001
   Dodd GD, 1999, AM J ROENTGENOL, V173, P1185, DOI 10.2214/ajr.173.5.10541086
   Doo KW, 2009, AM J ROENTGENOL, V193, pW490, DOI 10.2214/AJR.08.1732
   Giannitrapani L, 2006, ANN NY ACAD SCI, V1089, P228, DOI 10.1196/annals.1386.044
   Glinkova V, 2004, GUT, V53, P1352, DOI 10.1136/gut.2003.038646
   Hasan HY, 2014, JAMA SURG, V149, P1266, DOI 10.1001/jamasurg.2014.477
   Jaggers DC, 1996, J ENDOCRINOL, V150, P457, DOI 10.1677/joe.0.1500457
   KARHUNEN PJ, 1986, J CLIN PATHOL, V39, P183, DOI 10.1136/jcp.39.2.183
   Kim GE, 2006, LIVER INT, V26, P334, DOI 10.1111/j.1478-3231.2005.01226.x
   Li J, 2016, HEPATOL RES, V46, P727, DOI 10.1111/hepr.12610
   Li YL, 2015, CELL BIOCHEM BIOPHYS, V73, P469, DOI 10.1007/s12013-015-0680-y
   Park YS, 2011, RADIOLOGY, V258, P760, DOI 10.1148/radiol.10101233
   Schnaper HW, 1996, CLIN EXP PHARMACOL P, V23, P247, DOI 10.1111/j.1440-1681.1996.tb02605.x
   Schoen FJ., 1999, ROBBINS PATHOLOGIC B, P493
   Takahashi T, 1998, DIGEST DIS SCI, V43, P1553, DOI 10.1023/A:1018875117599
   Yu J S, 2000, Korean J Radiol, V1, P185
   Yu JS, 2002, J COMPUT ASSIST TOMO, V26, P411, DOI 10.1097/00004728-200205000-00016
   Yu JS, 1998, JMRI-J MAGN RESON IM, V8, P1079, DOI 10.1002/jmri.1880080512
NR 22
TC 3
Z9 7
U1 0
U2 8
PU SPRINGER-VERLAG ITALIA SRL
PI MILAN
PA VIA DECEMBRIO, 28, MILAN, 20137, ITALY
SN 0033-8362
EI 1826-6983
J9 RADIOL MED
JI Radiol. Med.
PD MAY
PY 2018
VL 123
IS 5
BP 323
EP 330
DI 10.1007/s11547-018-0854-y
PG 8
WC Radiology, Nuclear Medicine & Medical Imaging
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Radiology, Nuclear Medicine & Medical Imaging
GA GC1TI
UT WOS:000429564600001
PM 29357040
DA 2024-02-19
ER

PT J
AU SANGHANI, MP
   SCARPACE, PJ
AF SANGHANI, MP
   SCARPACE, PJ
TI ATYPICAL BETA-ADRENERGIC RECEPTORS IN RAT-LIVER - EVIDENCE FOR TRANSIENT
   EXPRESSION DURING AGING
SO JOURNALS OF GERONTOLOGY
LA English
DT Article
ID AGE-RELATED-CHANGES; ADENYLATE-CYCLASE; BETA-2-ADRENERGIC RECEPTORS;
   BETA-3-ADRENERGIC RECEPTOR; MOLECULAR-CLONING; GLYCOGENOLYSIS; SUBTYPES;
   BINDING; TISSUES; AGONIST
AB This study was designed to determine whether functional beta(3)-adrenergic receptors exist in the rat liver and whether there are alterations in the beta(3)-adrenergic response with age in a manner similar to that which occurs for beta(2)-adrenergic receptors. The beta(3) stimulation of adenylyl cyclase activity was assessed using the novel beta(3)-specific agonist, CGP-12177A. Adenylyl cyclase activation by CGP-12177A was seen only in the adults. Isoproterenol-stimulated adenylyl cyclase activity was high in the neonates, declined by 45% in the adults, and was high again in the senescent rats. ICI 118551, a beta(2)-selective antagonist, attenuated the isoproterenol-stimulated activity by two-thirds but had no effect on the CGP-12177A-stimulated activity. These data demonstrated the presence of the beta(3)-adrenergic receptor in the rat liver, although only at the adult stage of development. In addition, these data confirm earlier findings that beta(2)-adrenergic activation of adenylyl cyclase is biphasic with age and indicate that the emergence of rite beta(3)-stimulated activity. coincides with the attenuation of beta(2)-stimulated activity.
C1 VET AFFAIRS MED CTR,CTR GERIATR RES EDUC & CLIN,GAINESVILLE,FL 32608.
   UNIV FLORIDA,DEPT PHARMACOL & THERAPEUT,GAINESVILLE,FL 32610.
C3 Geriatric Research Education & Clinical Center; US Department of
   Veterans Affairs; Veterans Health Administration (VHA); State University
   System of Florida; University of Florida
CR ARCH JRS, 1989, P NUTR SOC, V48, P215, DOI 10.1079/PNS19890032
   BENDECK JL, 1985, PEDIATR RES, V19, P862, DOI 10.1203/00006450-198508000-00018
   BIANCHETTI A, 1990, BRIT J PHARMACOL, V100, P831, DOI 10.1111/j.1476-5381.1990.tb14100.x
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   EMORINE LJ, 1989, SCIENCE, V245, P1118, DOI 10.1126/science.2570461
   GRAHAM SM, 1987, AM J PHYSIOL, V253, pE277, DOI 10.1152/ajpendo.1987.253.3.E277
   GRANNEMAN JG, 1992, ENDOCRINOLOGY, V130, P109, DOI 10.1210/en.130.1.109
   GRANNEMAN JG, 1991, MOL PHARMACOL, V40, P895
   HUFF RA, 1991, LIFE SCI, V48, P1059, DOI 10.1016/0024-3205(91)90507-8
   KATZ MS, 1987, BIOCHEM BIOPH RES CO, V147, P724, DOI 10.1016/0006-291X(87)90990-9
   KATZ MS, 1985, AM J PHYSIOL, V248, pE712, DOI 10.1152/ajpendo.1985.248.6.E712
   MINNEMAN KP, 1979, J PHARMACOL EXP THER, V211, P502
   MORGAN NG, 1983, J BIOL CHEM, V258, P5103
   MUZZIN P, 1991, J BIOL CHEM, V266, P24053
   ROSSBY SP, 1991, J CELL PHYSIOL, V147, P55, DOI 10.1002/jcp.1041470108
   SCARPACE P J, 1991, Drugs and Aging, V1, P116
   SCARPACE PJ, 1982, J PHARMACOL EXP THER, V223, P327
   SCARPACE PJ, 1991, AM J PHYSIOL, V260, pE226, DOI 10.1152/ajpendo.1991.260.2.E226
   SCHLEIFER LS, 1989, J CELL PHYSIOL, V140, P52, DOI 10.1002/jcp.1041400107
   SCHUTZ W, 1992, TRENDS PHARMACOL SCI, V13, P376, DOI 10.1016/0165-6147(92)90116-N
   STAEHELIN M, 1983, J BIOL CHEM, V258, P3496
NR 21
TC 11
Z9 11
U1 0
U2 0
PU GERONTOLOGICAL SOCIETY AMER
PI WASHINGTON
PA 1275 K STREET NW SUITE 350, WASHINGTON, DC 20005-4006
SN 0022-1422
J9 J GERONTOL
JI J. Gerontol.
PD MAR
PY 1994
VL 49
IS 2
BP B60
EP B64
DI 10.1093/geronj/49.2.B60
PG 5
WC Gerontology
WE Social Science Citation Index (SSCI); Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA NB102
UT WOS:A1994NB10200018
PM 7907351
DA 2024-02-19
ER

PT J
AU Tiong, JDR
   Gosney, E
   Ding, J
   Chin, E
   Kopchick, JJ
AF Tiong, Jean D. R.
   Gosney, Elahu
   Ding, Juan
   Chin, Edward
   Kopchick, John J.
TI A liver specific gene that is expressed in growth hormone transgenic
   mice and in normal female mice as a function of age
SO GROWTH HORMONE & IGF RESEARCH
LA English
DT Article
DE GH; GH-regulated genes; GH transgenic mice; sexual dimorphism; liver
   regeneration; subtractive cDNA hybridization; alpha-1B-glycoprotein;
   immunoglobulin super family; aging
ID FACTOR-I; TRANSCRIPTIONAL CONTROL; HYPOPHYSECTOMIZED RATS;
   DEOXYRIBONUCLEIC-ACID; RECEPTOR DIMERIZATION; REGENERATION; PROTEIN; GH;
   HOMOLOGY; SYSTEM
AB Growth hormone (GH) acts on various organs to exert its growth and metabolic effects. GH induces transcription of a number of genes in different organs including liver. By performing subtractive hybridization analysis on liver cDNAs of GH transgenic and non-transgenic mice, differentially expressed cDNAs were obtained. This paper describes the isolation and characterization of a liver cDNA, termed cDNA #5, that contains 1897 bp and is predicted to encode a protein (P5) of 512 aa residues. P5 has five immunoglobulin related domains thus allowing it to be classified as a member of the immunoglobulin super family (IGSF). Also, P5 shows significant similarity to both rat and human alpha-1-B glycoprotein which is an acidic serum protein of unknown function.
   mRNA #5 was detected in the liver hepatocytes of mate and female GH transgenic mice and in the liver of female, but not of male, non-transgenic mice. mRNA #5 was not present in dwarf mice including the Ames dwarf, those that express a GH antagonist and those with the GH receptor and binding protein gene disrupted. These findings suggest that induction of mRNA #5 in the liver requires a continuous pattern of GH secretion and an intact GH-GH receptor-signaling complex. mRNA #5 levels in female non-transgenic mice were observed to vary with age implying that gender-specific age-dependent factor(s) may be involved in the induction of mRNA #5. The appearance of mRNA #5 in post-hepatectornized liver that coincides with the proliferative phase of liver regeneration suggests that it may be involved in hepatocyte proliferation. Together these data suggest that expression of cDNA #5 is liver-specific, sexually dimorphic, age-dependent, and may be involved in hepatocyte hyperplasia and liver enlargement. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Ohio Univ, Edison Biotechnol Inst, Konneker Res Labs, Athens, OH 45701 USA.
   Ohio Univ, Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA.
   Univ Alabama Birmingham, Dept Med, Div Endocrinol, Birmingham, AL 35294 USA.
   NINDS, NIH, Cellular & Dev Neurobiol Sect, Bethesda, MD 20892 USA.
C3 University System of Ohio; Ohio University; University System of Ohio;
   Ohio University; University of Alabama System; University of Alabama
   Birmingham; National Institutes of Health (NIH) - USA; NIH National
   Institute of Neurological Disorders & Stroke (NINDS)
RP Kopchick, JJ (corresponding author), Ohio Univ, Edison Biotechnol Inst, Konneker Res Labs, Athens, OH 45701 USA.
EM kopchick@ohio.edu
RI Sustarsic, Elahu G/M-5168-2013; Sustarsic, Elahu/AAJ-7076-2020; Ding,
   Juan/L-5149-2013
OI Sustarsic, Elahu G/0000-0002-4792-4740; Sustarsic,
   Elahu/0000-0002-4792-4740; 
FU NIA NIH HHS [AG19899-02] Funding Source: Medline
CR Ahluwalia A, 2004, MOL ENDOCRINOL, V18, P747, DOI 10.1210/me.2003-0138
   ASAKAWA K, 1989, J ENDOCRINOL INVEST, V12, P343, DOI 10.1007/BF03350004
   Barbour LA, 2005, J BIOL CHEM, V280, P37489, DOI 10.1074/jbc.M506967200
   BUCHER NLR, 1963, INT REV CYTOL, V15, P245, DOI 10.1016/S0074-7696(08)61119-5
   CHEN WY, 1991, MOL ENDOCRINOL, V5, P1845, DOI 10.1210/mend-5-12-1845
   CHIN E, 1993, J CLIN INVEST, V91, P1810, DOI 10.1172/JCI116392
   DAVIDSON MB, 1987, ENDOCR REV, V8, P115, DOI 10.1210/edrv-8-2-115
   EKBERG S, 1992, J ENDOCRINOL, V135, P59, DOI 10.1677/joe.0.1350059
   Fausto N, 1995, FASEB J, V9, P1527, DOI 10.1096/fasebj.9.15.8529831
   Fausto Nelson, 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P117
   Flores-Morales A, 2001, ENDOCRINOLOGY, V142, P3163, DOI 10.1210/en.142.7.3163
   FORCE AGH, 2003, ENDOCR PRACT, V9, P64
   Gardmo C, 2002, MOL CELL ENDOCRINOL, V190, P125, DOI 10.1016/S0303-7207(02)00004-7
   Gardmo C, 2001, ENDOCRINOLOGY, V142, P2695, DOI 10.1210/en.142.6.2695
   Gent J, 2002, P NATL ACAD SCI USA, V99, P9858, DOI 10.1073/pnas.152294299
   Giustina A, 2000, J CLIN ENDOCR METAB, V85, P526, DOI 10.1210/jc.85.2.526
   Harding PA, 1996, J BIOL CHEM, V271, P6708, DOI 10.1074/jbc.271.12.6708
   Higgins GM, 1931, ARCH PATHOL, V12, P186
   Hoffman AR, 2005, GROWTH HORM IGF RES, V15, pS48, DOI 10.1016/j.ghir.2005.06.010
   HOVANEC GM, 1999, END SOC 81 ANN M SAN, P556
   ISHIOKA N, 1986, P NATL ACAD SCI USA, V83, P2363, DOI 10.1073/pnas.83.8.2363
   Katznelson L, 2005, GROWTH HORM IGF RES, V15, pS31, DOI 10.1016/j.ghir.2005.06.007
   Kopchick JJ, 2002, ENDOCR REV, V23, P623, DOI 10.1210/er.2001-0022
   Lamberts SWJ, 1996, NEW ENGL J MED, V334, P246, DOI 10.1056/NEJM199601253340408
   Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012
   Melmed S, 1998, J CLIN ENDOCR METAB, V83, P2646, DOI 10.1210/jc.83.8.2646
   MELMED S, 1990, NEW ENGL J MED, V322, P966, DOI 10.1056/NEJM199004053221405
   Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60
   MILLARD WJ, 1990, NEUROBIOL AGING, V11, P229, DOI 10.1016/0197-4580(90)90550-J
   MOOLTEN FL, 1970, CANCER RES, V30, P2353
   Neves-Ferreira AGC, 2002, J BIOL CHEM, V277, P13129, DOI 10.1074/jbc.M200589200
   Ohlsson C, 1998, ENDOCR REV, V19, P55, DOI 10.1210/er.19.1.55
   Park JY, 2000, PHARMACOGENETICS, V10, P123, DOI 10.1097/00008571-200003000-00004
   PRESS M, 1988, DIABETES METAB REV, V4, P391, DOI 10.1002/dmr.5610040406
   QUAIFE CJ, 1989, ENDOCRINOLOGY, V124, P40, DOI 10.1210/endo-124-1-40
   RABES HM, 1969, CANCER RES, V29, P817
   Rocha SLG, 2002, EUR J BIOCHEM, V269, P6052, DOI 10.1046/j.1432-1033.2002.03308.x
   RONIS MJJ, 1992, BIOCHEM PHARMACOL, V43, P567, DOI 10.1016/0006-2952(92)90580-C
   Shoba L, 1999, MOL CELL ENDOCRINOL, V152, P125, DOI 10.1016/S0303-7207(99)00045-3
   Snibson KJ, 1999, LIVER, V19, P242, DOI 10.1111/j.1478-3231.1999.tb00042.x
   Taub R, 1996, FASEB J, V10, P413, DOI 10.1096/fasebj.10.4.8647340
   TAUB R, 1999, 8 BIENN INT C LIV DE, V5, P425
   THEILL LE, 1993, ENDOCR REV, V14, P670, DOI 10.1210/er.14.6.670
   THISSEN JP, 1994, ENDOCRINOLOGY, V134, P1570, DOI 10.1210/en.134.3.1570
   TIONG JDR, 2000, 11 INT C END SYDN AU, P35
   Trainer PJ, 2000, NEW ENGL J MED, V342, P1171, DOI 10.1056/NEJM200004203421604
   Udby L, 2004, BIOCHEMISTRY-US, V43, P12877, DOI 10.1021/bi048823e
   UNTERMAN TG, 1986, ENDOCRINOLOGY, V119, P185, DOI 10.1210/endo-119-1-185
   UTHNE K, 1972, ACTA ENDOCRINOL-COP, V71, P255, DOI 10.1530/acta.0.0710255
   van der Lely AJ, 2001, LANCET, V358, P1754, DOI 10.1016/S0140-6736(01)06844-1
   WANKE R, 1992, HORM RES, V37, P74, DOI 10.1159/000182406
   Waxman D J, 2000, Novartis Found Symp, V227, P61
   Waxman David J., 1995, P391
   Xu WX, 2000, BIOCHEM BIOPH RES CO, V278, P318, DOI 10.1006/bbrc.2000.3792
   Zhou YH, 1997, P NATL ACAD SCI USA, V94, P13215, DOI 10.1073/pnas.94.24.13215
NR 55
TC 7
Z9 8
U1 0
U2 2
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 1096-6374
EI 1532-2238
J9 GROWTH HORM IGF RES
JI Growth Horm. IGF Res.
PD JUN
PY 2006
VL 16
IS 3
BP 145
EP 156
DI 10.1016/j.ghir.2006.03.011
PG 12
WC Cell Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Endocrinology & Metabolism
GA 077WO
UT WOS:000240062600001
PM 16723264
DA 2024-02-19
ER

PT J
AU FURUYA, H
   KATO, Y
AF FURUYA, H
   KATO, Y
TI DIFFERENT EFFECT OF AGING ON SPECIFIC BINDING OF
   VASOACTIVE-INTESTINAL-PEPTIDE TO RAT-LIVER AND SPLEEN-CELL
   MEMBRANE-RECEPTORS
SO BIOMEDICAL RESEARCH-TOKYO
LA English
DT Article; Proceedings Paper
CT 5TH INTERNATIONAL SYMP ON VIP ( VASOACTIVE INTESTINAL PEPTIDE ) AND
   RELATED PEPTIDES
CY NOV 12-15, 1991
CL SHIZUOKA, JAPAN
SP JAPAN FEDERAT ECON ORG, OSAKA PHARM MANUFACTURERS ASSOC, PHARM MANUFACTURERS ASSOC TOKYO, BANYU PHARM, DAICEL CHEM IND, DAIICHI RADIO ISOTOPE LABS, DAINABOT, EARTH CHEM, EIWEISS CHEM, ICI PHARMA
ID PERIPHERAL-BLOOD LYMPHOCYTES; ADENYLATE-CYCLASE; POLYPEPTIDE;
   MODULATION; VIP
AB Vasoactive intestinal peptide (VIP) has been implicated as an immunoregulatory neuropeptide. Specific receptors for VIP have been identified in a variety of lymphoid cells. There is a decline in the function of the immune system with age. However, age-related changes in VIP receptors remain to be elucidated. In the present study, we examined the effect of aging on the specific binding of VIP to plasma membrane fractions obtained from the spleen and liver of Wistar strain male rats. The animals were divided into two groups based on their age: young rats (three months) and aged rats (15 months). I-125-3-Tyr-VIP and plasma membrane fractions were incubated in the presence or absence of different concentrations of unlabeled VIP (10(-11) - 10(-6) M). Scatchard analysis revealed high and low affinity binding sites of both VIP receptors in the spleen and liver. In young rats, the mean (+/-SD) value of the dissociation constant (Kd) of high affinity receptors in the spleen was larger than that in the liver (0.505+/-0.166 vs. 0.258+/-0.029 nM, p<0.01), whereas the maximum binding capacity (Bmax) of the spleen was smaller than that of the liver (22.8+/-3.7 vs. 221.1+/-56.4 fmol/mg protein, p<0.005). In aged rats, the mean Kd and Bmax of high affinity binding sites    of I-125-VIP in the spleen were larger than those in young rats (Kd: 1.411+/-0.302 nM, p<0.005; Bmax 126.5+/-42.9 fmol/mg protein, p<0.01), whereas the Kd and Bmax in the liver of aged rats were not different from those of young rats (Kd 0.252+/-0.077 nM, Bmax 208.2+/-44.3 fmol/mg protein). These findings suggest that there are age-related and tissue specific changes in VIP receptors in the immune system.
RP FURUYA, H (corresponding author), SHIMANE MED UNIV,DEPT MED,DIV 1,IZUMO,SHIMANE 693,JAPAN.
CR CALVO JR, 1986, GEN PHARMACOL, V17, P185, DOI 10.1016/0306-3623(86)90137-0
   DANEK A, 1983, J IMMUNOL, V131, P1173
   GALVO JR, 1986, PEPTIDES, V7, P177
   GUERRERO JM, 1981, MOL CELL ENDOCRINOL, V21, P151, DOI 10.1016/0303-7207(81)90052-6
   GUIJARRO L, 1989, REGUL PEPTIDES, V25, P37, DOI 10.1016/0167-0115(89)90246-2
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MIYATA A, 1989, BIOCHEM BIOPH RES CO, V164, P567, DOI 10.1016/0006-291X(89)91757-9
   NGUYEN TD, 1986, BIOCHEMISTRY-US, V25, P361, DOI 10.1021/bi00350a013
   ODORISIO MS, 1981, J IMMUNOL, V127, P2551
   OTTAWAY CA, 1984, J IMMUNOL, V132, P417
   OTTAWAY CA, 1984, J EXP MED, V160, P1054, DOI 10.1084/jem.160.4.1054
   PANDOL SJ, 1986, AM J PHYSIOL, V250, pG553, DOI 10.1152/ajpgi.1986.250.4.G553
   PEURIERE S, 1990, REGUL PEPTIDES, V27, P117, DOI 10.1016/0167-0115(90)90210-N
   ROBICHON A, 1987, J BIOL CHEM, V262, P11539
   ROLAPLESZCZYNSKI M, 1985, J IMMUNOL, V135, P2569
   SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x
   SEGURA JJ, 1991, REGUL PEPTIDES, V33, P133, DOI 10.1016/0167-0115(91)90208-X
   STANISZ AM, 1986, J IMMUNOL, V136, P152
   TATSUNO I, 1991, ENDOCRINOLOGY, V128, P728, DOI 10.1210/endo-128-2-728
   WIIK P, 1985, REGUL PEPTIDES, V12, P143
NR 20
TC 3
Z9 3
U1 0
U2 0
PU BIOMED RES FOUND
PI TOKYO
PA KANDA PO BOX 182 CHIYODAKU, TOKYO 101-91, JAPAN
SN 0388-6107
J9 BIOMED RES-TOKYO
JI Biomed. Res.
PY 1992
VL 13
SU 2
BP 121
EP 125
PG 5
WC Medicine, Research & Experimental
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA KQ830
UT WOS:A1992KQ83000021
DA 2024-02-19
ER

PT J
AU Li, D
   Fu, J
   Du, M
   Zhang, HB
   Li, L
   Cen, J
   Li, WY
   Chen, XT
   Lin, YF
   Conway, EM
   Pikarsky, E
   Wang, HY
   Pan, GY
   Ji, Y
   Wang, HY
   Hui, LJ
AF Li, Dan
   Fu, Jing
   Du, Min
   Zhang, Haibin
   Li, Lu
   Cen, Jin
   Li, Weiyun
   Chen, Xiaotao
   Lin, Yunfei
   Conway, Edward M.
   Pikarsky, Eli
   Wang, Hongyan
   Pan, Guoyu
   Ji, Yuan
   Wang, Hong-Yang
   Hui, Lijian
TI Hepatocellular Carcinoma Repression by TNFα-Mediated Synergistic Lethal
   Effect of Mitosis Defect-Induced Senescence and Cell Death Sensitization
SO HEPATOLOGY
LA English
DT Article
ID PHASE-II TRIAL; POLO-LIKE KINASES; INHIBITOR BI 2536; LIVER-CANCER;
   APOPTOSIS PROTEINS; AURORA KINASES; TUMOR-GROWTH; SURVIVIN; YM155; DRUG
AB Hepatocellular carcinoma (HCC) is a cancer lacking effective therapies. Several measures have been proposed to treat HCCs, such as senescence induction, mitotic inhibition, and cell death promotion. However, data from other cancers suggest that single use of these approaches may not be effective. Here, by genetic targeting of Survivin, an inhibitor of apoptosis protein (IAP) that plays dual roles in mitosis and cell survival, we identified a tumor necrosis factor alpha (TNF alpha)-mediated synergistic lethal effect between senescence and apoptosis sensitization in malignant HCCs. Survivin deficiency results in mitosis defect-associated senescence in HCC cells, which triggers local inflammation and increased TNF alpha. Survivin inactivation also sensitizes HCC cells to TNF alpha-triggered cell death, which leads to marked HCC regression. Based on these findings, we designed a combination treatment using mitosis inhibitor and proapoptosis compounds. This treatment recapitulates the therapeutic effect of Survivin deletion and effectively eliminates HCCs, thus representing a potential strategy for HCC therapy. Conclusion: Survivin ablation dramatically suppresses human and mouse HCCs by triggering senescence-associated TNF alpha and sensitizing HCC cells to TNF alpha-induced cell death. Combined use of mitotic inhibitor and second mitochondrial-derived activator of caspases mimetic can induce senescence-associated TNF alpha and enhance TNF alpha-induced cell death and synergistically eliminate HCC.
C1 [Li, Dan; Li, Lu; Cen, Jin; Li, Weiyun; Chen, Xiaotao; Wang, Hongyan; Hui, Lijian] Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, State Key Lab Cell Biol, Room 915,New Biochem Bldg,320 Yueyang Rd, Shanghai 200031, Peoples R China.
   [Fu, Jing; Zhang, Haibin; Wang, Hong-Yang] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, 225 Changhai Rd, Shanghai 200438, Peoples R China.
   [Du, Min; Ji, Yuan] Fudan Univ, Zhongshan Hosp, Dept Pathol, 180 Fenglin Rd, Shanghai 200032, Peoples R China.
   [Lin, Yunfei; Pan, Guoyu] Chinese Acad Sci, Shanghai Inst Mat Med, Ctr Drug Safety Evaluat & Res, Shanghai, Peoples R China.
   [Conway, Edward M.] Univ British Columbia, Div Hematol Oncol, Dept Med, Ctr Blood Res, Vancouver, BC, Canada.
   [Pikarsky, Eli] Hadassah Hebrew Univ, Med Ctr, Dept Immunol & Canc Res, Inst Med Res Israel Canada, Jerusalem, Israel.
   [Pikarsky, Eli] Hadassah Hebrew Univ, Med Ctr, Dept Pathol, Jerusalem, Israel.
C3 Chinese Academy of Sciences; Center for Excellence in Molecular Cell
   Science, CAS; Naval Medical University; Fudan University; Chinese
   Academy of Sciences; Shanghai Institute of Materia Medica, CAS;
   University of British Columbia; Hebrew University of Jerusalem; Hadassah
   University Medical Center; Hebrew University of Jerusalem; Hadassah
   University Medical Center
RP Hui, LJ (corresponding author), Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, State Key Lab Cell Biol, Room 915,New Biochem Bldg,320 Yueyang Rd, Shanghai 200031, Peoples R China.; Wang, HY (corresponding author), Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, 225 Changhai Rd, Shanghai 200438, Peoples R China.; Ji, Y (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Pathol, 180 Fenglin Rd, Shanghai 200032, Peoples R China.
EM ji.yuan@zs-hospital.sh.cn; hywangk@vip.sina.com; ljhui@sibcb.ac.cn
RI Zhang, Yunxuan/IXD-9283-2023; pikarsky, eli/GXV-7099-2022; Li,
   Dan/JQV-2990-2023
OI Li, Dan/0000-0002-8777-4580; Li, Weiping/0000-0001-5829-3094; pikarsky,
   eli/0000-0003-4186-7105; Conway, Edward/0000-0003-0081-0305
FU Ministry of Science and Technology (MOST) of China [2014CB910601,
   2012CB945001, 2012ZX10002]; National Science Foundation of China (NSFC)
   [31225016, 31501111, 81221061, 81471948]; Shanghai Science and
   Technology Committee [15JC1400200, 14XD1404200]; Postdoctor Research
   Program of Shanghai Institutes for Biological Sciences, Chinese Academy
   of Sciences [2014KIP302]; China Postdoctoral Science Foundation
   [2015M580361]
FX This study is funded by the Ministry of Science and Technology (MOST) of
   China (2014CB910601, 2012CB945001, and 2012ZX10002), the National
   Science Foundation of China (NSFC) (31225016, 31501111, 81221061,
   81471948, and 81471948), Shanghai Science and Technology Committee
   (15JC1400200, 14XD1404200). Dr. Dan Li is supported by the Postdoctor
   Research Program of Shanghai Institutes for Biological Sciences, Chinese
   Academy of Sciences (2014KIP302), and the China Postdoctoral Science
   Foundation (2015M580361).
CR Acosta JC, 2012, TRENDS CELL BIOL, V22, P211, DOI 10.1016/j.tcb.2011.11.006
   Altieri DC, 2013, CANCER LETT, V332, P225, DOI 10.1016/j.canlet.2012.03.005
   Altieri DC, 2010, BIOCHEM J, V430, P199, DOI 10.1042/BJ20100814
   Braumüller H, 2013, NATURE, V494, P361, DOI 10.1038/nature11824
   Carmena M, 2012, NAT REV MOL CELL BIO, V13, P789, DOI 10.1038/nrm3474
   El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683
   Ellis PM, 2013, CLIN LUNG CANCER, V14, P19, DOI 10.1016/j.cllc.2012.04.003
   Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0
   Fulda S, 2014, CLIN CANCER RES, V20, P289, DOI 10.1158/1078-0432.CCR-13-0227
   Giaccone G, 2009, J CLIN ONCOL, V27, P4481, DOI 10.1200/JCO.2008.21.1862
   Goldenberg MM, 1999, CLIN THER, V21, P75, DOI 10.1016/S0149-2918(00)88269-7
   Holmes D, 2012, NAT MED, V18, P842, DOI 10.1038/nm0612-842b
   Houghton PJ, 2012, PEDIATR BLOOD CANCER, V58, P636, DOI 10.1002/pbc.23167
   Infante JR, 2014, J CLIN ONCOL, V32, P3103, DOI 10.1200/JCO.2013.52.3993
   Johmura Y, 2014, MOL CELL, V55, P73, DOI 10.1016/j.molcel.2014.05.003
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560
   Lens SMA, 2010, NAT REV CANCER, V10, P825, DOI 10.1038/nrc2964
   Lewis KD, 2011, INVEST NEW DRUG, V29, P161, DOI 10.1007/s10637-009-9333-6
   Li D, 2013, HEPATOLOGY, V58, P2109, DOI 10.1002/hep.26601
   Liu Y, 2013, EMBO MOL MED, V5, P149, DOI 10.1002/emmm.201201378
   Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857
   Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014
   Mesri M, 2001, J CLIN INVEST, V108, P981, DOI 10.1172/JCI200112983
   Michelotti GA, 2013, NAT REV GASTRO HEPAT, V10, P656, DOI 10.1038/nrgastro.2013.183
   Min LH, 2012, NAT CELL BIOL, V14, P1203, DOI 10.1038/ncb2590
   Mross K, 2012, BRIT J CANCER, V107, P280, DOI 10.1038/bjc.2012.257
   Nakahara T, 2007, CANCER RES, V67, P8014, DOI 10.1158/0008-5472.CAN-07-1343
   de Castro IP, 2013, CANCER RES, V73, P6804, DOI 10.1158/0008-5472.CAN-13-0586
   Pérez-Mancera PA, 2014, NAT REV CANCER, V14, P547, DOI 10.1038/nrc3773
   Pribluda A, 2013, CANCER CELL, V24, P242, DOI 10.1016/j.ccr.2013.06.005
   Schöffski P, 2010, EUR J CANCER, V46, P2206, DOI 10.1016/j.ejca.2010.03.039
   Sebastian M, 2010, J THORAC ONCOL, V5, P1060, DOI 10.1097/JTO.0b013e3181d95dd4
   Shi J, 2008, CANCER RES, V68, P3269, DOI 10.1158/0008-5472.CAN-07-6699
   Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037
   Tunquist BJ, 2010, MOL CANCER THER, V9, P2046, DOI 10.1158/1535-7163.MCT-10-0033
   Walczak H, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008698
   Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036
   Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529
   Yang D, 2010, P NATL ACAD SCI USA, V107, P13836, DOI 10.1073/pnas.1008366107
   Zalevsky J, 2007, J IMMUNOL, V179, P1872, DOI 10.4049/jimmunol.179.3.1872
   Zitouni S, 2014, NAT REV MOL CELL BIO, V15, P433, DOI 10.1038/nrm3819
NR 44
TC 32
Z9 33
U1 0
U2 15
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD OCT
PY 2016
VL 64
IS 4
BP 1105
EP 1120
DI 10.1002/hep.28637
PG 16
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA DX7FP
UT WOS:000384552300012
PM 27641691
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU Shah, GN
   Li, JP
   Mooradian, AD
AF Shah, GN
   Li, JP
   Mooradian, AD
TI Novel translational repressor (NAT-1) expression is modified by thyroid
   state and age in brain and liver
SO EUROPEAN JOURNAL OF ENDOCRINOLOGY
LA English
DT Article
ID PROTEIN-SYNTHESIS; HORMONE ACTION; MESSENGER-RNA; ADULT-RAT; DNA;
   FRAGMENTS; GENE
AB The technique of reverse transcriptase-polymerase chain reaction differential display was used to identify thyroid hormone (TH) responsive mRNAs in the adult rat cerebral tissue. A partial cDNA (0.76 kb) was cloned and sequenced. Comparison of the sequence to the GenBank data base showed almost 100% homology to mouse translational repressor (NAT-1) mRNA 3'-end, In a northern blot analysis this cDNA hybridized with a mRNA whose expression in hyperthyroid rat cerebral tissue was approximately 6-fold higher than in euthyroid rats. The time course studies showed a rapid induction of this mRNA within 3 h following thyroxine administration. This mRNA is widely expressed in various tissues, and in hepatic tissue it is also TH responsive,
   To determine if TH responsiveness of this mRNA persists during aging, 25-month-old aged rats were studied and the results were compared with those of 4-month-old rats. Unlike young mature rats, the TH responsiveness of NAT-1 mRNA in both the cerebral and hepatic tissue of aged rats was blunted. It is concluded that cerebral tissue in aging rats beyond the developmental stages, like the hepatic tissue, is associated with altered TH responsiveness.
C1 St Louis Univ, Sch Med, Div Endocrinol, Dept Internal Med, St Louis, MO 63104 USA.
C3 Saint Louis University
RP Mooradian, AD (corresponding author), St Louis Univ, Sch Med, Div Endocrinol, Dept Internal Med, 1402 S Grand Blvd, St Louis, MO 63104 USA.
RI Mooradian, Arshag/IAP-5640-2023
CR BRENT GA, 1994, NEW ENGL J MED, V331, P847
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   DICKSON PW, 1987, J BIOL CHEM, V262, P13907
   EKSTROM R, 1980, GERONTOLOGY, V26, P121, DOI 10.1159/000212405
   FANDO JL, 1980, NEUROCHEM RES, V5, P373, DOI 10.1007/BF00964226
   FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9
   GIORDANO T, 1992, MOL BRAIN RES, V16, P239, DOI 10.1016/0169-328X(92)90231-Y
   INIQUEZ MA, 1992, J CLIN INVEST, V90, P554
   JOFFE RT, 1994, CRIT REV NEUROBIOL, V8, P45
   LEHRACH H, 1977, BIOCHEMISTRY-US, V16, P4743, DOI 10.1021/bi00640a033
   LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393
   LIANG P, 1993, NUCLEIC ACIDS RES, V21, P3269, DOI 10.1093/nar/21.14.3269
   MANO H, 1993, BIOCHEM BIOPH RES CO, V191, P943, DOI 10.1006/bbrc.1993.1308
   MELLSTROM B, 1994, ENDOCRINOLOGY BALTIM, V135, P483
   Mooradian AD, 1996, AM J PHYSIOL-REG I, V271, pR1602, DOI 10.1152/ajpregu.1996.271.6.R1602
   MOORADIAN AD, 1994, EUR J ENDOCRINOL, V131, P451, DOI 10.1530/eje.0.1310451
   Mooradian AD, 1998, BRAIN RES, V793, P302, DOI 10.1016/S0006-8993(98)00144-9
   MOORADIAN AD, 1991, J AM GERIATR SOC, V39, P717, DOI 10.1111/j.1532-5415.1991.tb03628.x
   NOWAK FV, 1996, ENCY GERONTOLOGY, V1, P477
   OPPENHEIMER JH, 1987, ENDOCR REV, V8, P288, DOI 10.1210/edrv-8-3-288
   Richardson A, 1983, REV BIOL RES AGING, V1, P255
   RODRIGUEZPENA A, 1993, J CLIN INVEST, V91, P812, DOI 10.1172/JCI116301
   SANGER DJ, 1977, PHARMACOL BIOCHEM BE, V7, P1, DOI 10.1016/0091-3057(77)90003-X
   SCHMITT CA, 1986, J BIOL CHEM, V261, P439
   Shah GN, 1997, BIOCHEM J, V327, P617
   SILVA JE, 1984, J CLIN INVEST, V74, P1035, DOI 10.1172/JCI111471
   STRAIT KA, 1992, MOL ENDOCRINOL, V6, P1874, DOI 10.1210/me.6.11.1874
   THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201
   VANBEZOOIJEN CFA, 1977, MECH AGEING DEV, V6, P293, DOI 10.1016/0047-6374(77)90031-8
   VANBEZOOIJEN CFA, 1981, MECH AGEING DEV, V17, P11, DOI 10.1016/0047-6374(81)90124-X
   Yamanaka S, 1997, GENE DEV, V11, P321, DOI 10.1101/gad.11.3.321
NR 31
TC 13
Z9 13
U1 0
U2 1
PU SCANDINAVIAN UNIVERSITY PRESS
PI OSLO
PA PO BOX 2959 TOYEN, JOURNAL DIVISION CUSTOMER SERVICE, N-0608 OSLO,
   NORWAY
SN 0804-4643
J9 EUR J ENDOCRINOL
JI Eur. J. Endocrinol.
PD DEC
PY 1998
VL 139
IS 6
BP 649
EP 653
DI 10.1530/eje.0.1390649
PG 5
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 155ZT
UT WOS:000077977500017
PM 9916872
OA Green Submitted
DA 2024-02-19
ER

PT J
AU Wu, JS
   Chiu, V
   Lan, CC
   Wang, MC
   Tzeng, IS
   Kuo, CY
   Hsieh, PC
AF Wu, Jiunn-Sheng
   Chiu, Valeria
   Lan, Chou-Chin
   Wang, Ming-Chieh
   Tzeng, I-Shiang
   Kuo, Chan-Yen
   Hsieh, Po-Chun
TI Chrysophanol Prevents Lipopolysaccharide-Induced Hepatic Stellate Cell
   Activation by Upregulating Apoptosis, Oxidative Stress, and the Unfolded
   Protein Response
SO EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE
LA English
DT Article
ID LIVER FIBROSIS; PATHWAY
AB Hepatic stellate cell (HSC) activation is a vital driver of liver fibrosis. Recent research efforts have emphasized the clearance of activated HSCs by apoptosis, senescence, or reversion to the quiescent state. LPS induces human HSC activation directly and contributes to liver disease progression. Chrysophanol is an anthraquinone with hepatoprotective and anti-inflammatory effects. This study aimed to investigate the pharmacological effects and mechanisms of chrysophanol in an LPS-induced activated rat HSC cell line (HSC-T6). The fibrosis phenotype was identified from the expression of alpha-smooth muscle actin (alpha-SMA), connective tissue growth factor (CTGF), and integrin beta 1 by western blot analysis. We examined DNA fragmentation by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining. We detected the apoptotic markers p53 and cleaved caspase-3 by western blot analysis. Intracellular ROS were labeled with 2',7'-dichlorofluorescein diacetate (DCF-DA) and the levels were measured by flow cytometry. Finally, we evaluated the ER stress markers binding immunoglobulin protein (BiP) and C/EBP homologous protein (CHOP) by Western blot analysis. Our results showed that chrysophanol decreased HSC-T6 cell viability in LPS-induced activated HSCs. Chrysophanol increased the expression of alpha-SMA, CTGF, integrin beta I, p53, cleaved caspase-3, and DNA fragmentation. Chrysophanol also elevated ROS levels and increased the expression of BiP and CHOP. Pretreatment with chrysophanol prevented LPS-induced HSC-T6 cell activation by upregulating apoptosis, ROS accumulation, unfolded protein response (UPR) activation, and the UPR proapoptotic effect.
C1 [Wu, Jiunn-Sheng] Taipei Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Div Infect Dis, New Taipei, Taiwan.
   [Chiu, Valeria] Buddhist Tzu Chi Med Fdn, Taipei Tzu Chi Hosp, Div Phys Med & Rehabil, New Taipei, Taiwan.
   [Lan, Chou-Chin] Buddhist Tzu Chi Med Fdn, Taipei Tzu Chi Hosp, Div Pulm Med, New Taipei, Taiwan.
   [Wang, Ming-Chieh] Buddhist Tzu Chi Med Fdn, Taipei Tzu Chi Hosp, Dept Pharm, New Taipei, Taiwan.
   [Tzeng, I-Shiang; Kuo, Chan-Yen] Buddhist Tzu Chi Med Fdn, Taipei Tzu Chi Hosp, Dept Res, New Taipei, Taiwan.
   [Hsieh, Po-Chun] Buddhist Tzu Chi Med Fdn, Taipei Tzu Chi Hosp, Dept Chinese Med, New Taipei, Taiwan.
C3 Buddhist Tzu Chi General Hospital; Taipei Tzu Chi Hospital; Buddhist Tzu
   Chi General Hospital; Taipei Tzu Chi Hospital; Buddhist Tzu Chi General
   Hospital; Taipei Tzu Chi Hospital; Buddhist Tzu Chi General Hospital;
   Taipei Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Taipei Tzu
   Chi Hospital; Buddhist Tzu Chi General Hospital; Taipei Tzu Chi Hospital
RP Kuo, CY (corresponding author), Buddhist Tzu Chi Med Fdn, Taipei Tzu Chi Hosp, Dept Res, New Taipei, Taiwan.; Hsieh, PC (corresponding author), Buddhist Tzu Chi Med Fdn, Taipei Tzu Chi Hosp, Dept Chinese Med, New Taipei, Taiwan.
EM cykuo863135@gmail.com; pchsieh.tcm@gmail.com
RI Tzeng, I-Shiang/AAD-8063-2019
OI Tzeng, I-Shiang/0000-0002-9047-8141; Lan, Chou-Chin/0000-0001-9376-6539;
   Kuo, Chan-Yen/0000-0002-5702-5730; Hsieh, Po-Chun/0000-0002-0416-8797
FU Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei
   City, Taiwan [TCRD-TPE-108-66]
FX The authors appreciate the research assistants, Mrs. Yi-Ying Lin and
   Ming-Cheng Lee, for troubleshooting of flow cytometry and Western blot,
   respectively. The authors also thank Mr. Po Wang for his help in using
   the confocal microscopy for TUNEL staining. All the above are at the
   core laboratory, Department of Research, Taipei Tzu Chi Hospital,
   Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan. This study
   was supported by Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical
   Foundation, New Taipei City, Taiwan (TCRD-TPE-108-66).
CR Anthony B, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-60
   Balabaud C, 2004, J HEPATOL, V40, P1023, DOI 10.1016/j.jhep.2004.04.003
   Bonis PAL, 2001, NEW ENGL J MED, V344, P452, DOI 10.1056/NEJM200102083440610
   Bravo R, 2013, INT REV CEL MOL BIO, V301, P215, DOI 10.1016/B978-0-12-407704-1.00005-1
   Chen M, 2017, AUTOPHAGY, V13, P1813, DOI 10.1080/15548627.2017.1356550
   Dhall D, 2018, AM J SURG PATHOL, V42, P1617, DOI 10.1097/PAS.0000000000001163
   Fang J, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/2945803
   Fouts DE, 2012, J HEPATOL, V56, P1283, DOI 10.1016/j.jhep.2012.01.019
   Friedman SL, 2010, NAT REV GASTRO HEPAT, V7, P425, DOI 10.1038/nrgastro.2010.97
   Gandhi Chandrashekhar R, 2012, Trends Cell Mol Biol, V7, P1
   Henderson NC, 2013, NAT MED, V19, P1617, DOI 10.1038/nm.3282
   Jiang WJ, 2016, RSC ADV, V6, P38192, DOI 10.1039/c5ra19841k
   Li XH, 2015, INFLAMM RES, V64, P1, DOI 10.1007/s00011-014-0772-y
   Lin YL, 2008, PLANTA MED, V74, P1246, DOI 10.1055/s-2008-1074581
   LUMSDEN AB, 1988, HEPATOLOGY, V8, P232, DOI 10.1002/hep.1840080207
   Martin K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12502
   Mühlbauer M, 2004, BIOCHEM BIOPH RES CO, V325, P191, DOI 10.1016/j.bbrc.2004.10.020
   Murphy FR, 2002, J BIOL CHEM, V277, P11069, DOI 10.1074/jbc.M111490200
   Paik YH, 2003, HEPATOLOGY, V37, P1043, DOI 10.1053/jhep.2003.50182
   Paradis V, 2002, LAB INVEST, V82, P767, DOI 10.1097/01.LAB.0000017365.18894.D3
   Park S, 2018, TOXICOL APPL PHARM, V360, P201, DOI 10.1016/j.taap.2018.10.010
   Parsa CJ, 2003, J CLIN INVEST, V112, P999, DOI 10.1172/JCI200318200
   Prateeksha, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9020068
   Su SY, 2020, BIOMED PHARMACOTHER, V125, DOI 10.1016/j.biopha.2020.110002
   Tsuchida T, 2017, NAT REV GASTRO HEPAT, V14, P397, DOI 10.1038/nrgastro.2017.38
   Tu Y, 2014, J ETHNOPHARMACOL, V156, P115, DOI 10.1016/j.jep.2014.08.035
   Xie L, 2019, J PHARM PHARMACOL, V71, P1475, DOI 10.1111/jphp.13143
   Yao ZC, 2018, INT J CLIN EXP PATHO, V11, P4917
   Yoon YJ, 2016, SEMIN LIVER DIS, V36, P87, DOI 10.1055/s-0036-1571295
   Zhang CY, 2016, WORLD J GASTROENTERO, V22, P10512, DOI 10.3748/wjg.v22.i48.10512
   Zhao YM, 2018, EUR J PHARMACOL, V818, P1, DOI 10.1016/j.ejphar.2017.10.016
NR 31
TC 5
Z9 6
U1 5
U2 18
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1741-427X
EI 1741-4288
J9 EVID-BASED COMPL ALT
JI Evid.-based Complement Altern. Med.
PD JUL 4
PY 2020
VL 2020
AR 8426051
DI 10.1155/2020/8426051
PG 11
WC Integrative & Complementary Medicine
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Integrative & Complementary Medicine
GA MQ3NG
UT WOS:000552802900004
PM 32714424
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Adam, AC
   Faudou, V
   Paschen, SA
   Adam, OM
   Kahl, P
   Drebber, U
   Fischer, HP
   Büttner, R
AF Adam, Alexander C.
   Faudou, Viola
   Paschen, Stefan A.
   Adam, Olaf M.
   Kahl, Philip
   Drebber, Uta
   Fischer, Hans-Peter
   Buettner, Reinhard
TI Hepatocarcinogenesis in non-cirrhotic liver is associated with a reduced
   number of clonal hepatocellular patches in non-tumorous liver parenchyma
SO JOURNAL OF PATHOLOGY
LA English
DT Article
DE cytochrome c oxidase; liver stem cell; liver patches; carcinogenesis
ID MITOCHONDRIAL-DNA MUTATIONS; STEM-CELL NICHE; CARCINOMA; EXPANSION;
   CIRRHOSIS; LINEAGE; CANCER
AB We investigated circumscribed cell proliferations in healthy livers in comparison to non-cirrhotic livers bearing hepatocellular carcinoma. Using histochemical staining for cytochrome c oxidase, the fourth complex of the respiratory chain, we visualized patch-forming descendents of regeneratively active liver cells. The clonal nature of these patches was verified by laser-capture microdissection and Sanger sequencing of the enzyme's core subunits in patches carrying marker mutations on the mtDNA. We demonstrate a highly significant increase of the patch size and also a highly significant increase in the number of patches carrying marker mutations between hepatocellular carcinoma-free and -bearing livers. Thus, the carcinoma-bearing livers accumulated more genetic damage on mtDNA than the control group. Furthermore, for the first time, we present evidence in hepatocellular carcinoma-bearing non-cirrhotic livers of a significantly reduced pool of regeneratively active liver cells that are genetically and functionally altered. The analogy to ageing-related changes is suggestive of premature ageing of stem cells in non-cirrhotic hepatocellular carcinoma-bearing liver as an early step to hepatocarcinogenesis. Copyright (c) 2012 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
C1 [Adam, Alexander C.] Univ Cologne, Inst Pathol, Dept Pathol, D-50969 Cologne, Germany.
   [Adam, Olaf M.] Physiol Ludwig Maximilians Univ, Munich, Germany.
   [Fischer, Hans-Peter] Univ Bonn, Dept Pathol, Bonn, Germany.
   [Paschen, Stefan A.] AbD Serotec, Puchheim, Germany.
C3 University of Cologne; University of Munich; University of Bonn;
   MorphoSys
RP Adam, AC (corresponding author), Univ Cologne, Inst Pathol, Dept Pathol, Kerpener Str 62, D-50969 Cologne, Germany.
EM alexander.adam@uk-koeln.de
FU Medical Faculty, Rheinischen Friedrich-Wilhelms-University of Bonn,
   Germany; Huhnlein/Kurscheid Foundation, Cologne, Germany
FX The authors thank Mrs Eva Schetter and Mrs Susanne Steiner for excellent
   technical assistance. This work was supported by grants to ACA from the
   BON-FOR programme of the Medical Faculty, Rheinischen
   Friedrich-Wilhelms-University of Bonn, Germany, and to OMA from the
   Huhnlein/Kurscheid Foundation, Cologne, Germany.
CR ABUERREISH GM, 1978, MECH AGEING DEV, V7, P425, DOI 10.1016/0047-6374(78)90083-0
   Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   Alison MR, 2009, J PATHOL, V217, P282, DOI 10.1002/path.2453
   Alison MR, 2004, CELL PROLIFERAT, V37, P1, DOI 10.1111/j.1365-2184.2004.00297.x
   BRALET MP, 1994, AM J PATHOL, V144, P896
   Evert M, 2008, PATHOLOGE, V29, P47, DOI 10.1007/s00292-007-0953-3
   Fellous TG, 2009, STEM CELLS, V27, P1410, DOI 10.1002/stem.67
   Fellous TG, 2009, HEPATOLOGY, V49, P1655, DOI 10.1002/hep.22791
   Ferrer-Costa C, 2005, BIOINFORMATICS, V21, P3176, DOI 10.1093/bioinformatics/bti486
   Greaves LC, 2006, P NATL ACAD SCI USA, V103, P714, DOI 10.1073/pnas.0505903103
   Hasty P, 2003, SCIENCE, V299, P1355, DOI 10.1126/science.1079161
   Kuwahara R, 2008, HEPATOLOGY, V47, P1994, DOI 10.1002/hep.22218
   Lin WR, 2010, HEPATOLOGY, V51, P1017, DOI 10.1002/hep.23483
   Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028
   McDonald SAC, 2006, CELL CYCLE, V5, P808, DOI 10.4161/cc.5.8.2641
   Mcdonald SAC, 2008, GASTROENTEROLOGY, V134, P500, DOI 10.1053/j.gastro.2007.11.035
   Mi H, NUCL ACIDS RES, V38, pD204
   MULLERHOCKER J, 1990, J NEUROL SCI, V100, P14, DOI 10.1016/0022-510X(90)90006-9
   MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167
   NESBITT MN, 1974, DEV BIOL, V38, P202, DOI 10.1016/0012-1606(74)90272-3
   Nzeako UC, 1996, AM J CLIN PATHOL, V105, P65
   OKUDA K, 1989, GASTROENTEROLOGY, V97, P140, DOI 10.1016/0016-5085(89)91427-3
   Overturf K, 1999, AM J PATHOL, V155, P2135, DOI 10.1016/S0002-9440(10)65531-9
   Ruzankina Y, 2007, BRIT J CANCER, V97, P1189, DOI 10.1038/sj.bjc.6604029
   Stroffolini T, 1998, J HEPATOL, V29, P944, DOI 10.1016/S0168-8278(98)80122-0
   Tang Y, 2008, P NATL ACAD SCI USA, V105, P2445, DOI 10.1073/pnas.0705395105
   Tavtigian SV, 2006, J MED GENET, V43, P295, DOI 10.1136/jmg.2005.033878
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Thomas PD, 2006, NUCLEIC ACIDS RES, V34, pW645, DOI 10.1093/nar/gkl229
   Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403
   TREVISANI F, 1995, CANCER-AM CANCER SOC, V75, P2220, DOI 10.1002/1097-0142(19950501)75:9<2220::AID-CNCR2820750906>3.0.CO;2-4
   WEST JD, 1976, J EMBRYOL EXP MORPH, V36, P151
   Yu MC, 2004, GASTROENTEROLOGY, V127, pS72, DOI 10.1016/j.gastro.2004.09.018
   ZAJICEK G, 1985, LIVER, V5, P293
NR 34
TC 2
Z9 3
U1 0
U2 5
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3417
J9 J PATHOL
JI J. Pathol.
PD NOV
PY 2012
VL 228
IS 3
BP 333
EP 340
DI 10.1002/path.4060
PG 8
WC Oncology; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Pathology
GA 021WL
UT WOS:000309916000008
PM 22685011
DA 2024-02-19
ER

PT J
AU Choi, SW
   Friso, S
AF Choi, SW
   Friso, S
TI Interactions between folate and aging for carcinogenesis
SO CLINICAL CHEMISTRY AND LABORATORY MEDICINE
LA English
DT Article; Proceedings Paper
CT 4th Conference on Hyperhomocysteinemia
CY APR 14-16, 2005
CL Saarbrucken, GERMANY
DE aging; carcinogenesis; DNA methylation; folate; one-carbon metabolism;
   uracil misincorporation into DNA
ID GENOMIC DNA METHYLATION; DIETARY-FOLATE; PLASMA HOMOCYSTEINE; COLONIC
   NEOPLASIA; FOLIC-ACID; RAT-LIVER; DEFICIENCY; CANCER; VITAMIN-B12;
   METABOLISM
AB Inadequate folate intake and aging are each strongly implicated as important risk factors for certain cancers. Since both folate depletion and aging are strongly associated with hyperhomocysteinemia, genomic DNA hypomethylation, and increased uracil misincorporation into DNA, it appears that each of them enhances carcinogenesis by inducing a derangement of one-carbon metabolism that supplies one-carbons to biological methylation reactions and nucleotide synthesis. Recent studies have demonstrated that inadequate dietary folate and aging may interact and synergistically disturb the normal homeostasis of one-carbon metabolism, thereby provoking subsequent biochemical and molecular aberrations, including alterations in critical gene expression related to carcinogenesis. These studies have further indicated that modest folate supplementation may reverse or partially ameliorate those adverse effects induced by folate depletion and aging.
C1 Tufts Univ, USDA, Human Nutr Res Ctr Aging, Vitamins & Carcinogenesis Lab, Boston, MA 02111 USA.
   Univ Verona, Sch Med, Dept Clin & Expt Med, Verona, Italy.
C3 United States Department of Agriculture (USDA); Tufts University;
   University of Verona
RP Choi, SW (corresponding author), Tufts Univ, USDA, Human Nutr Res Ctr Aging, Vitamins & Carcinogenesis Lab, 711 Washington St, Boston, MA 02111 USA.
EM sang.choi@tufts.edu
RI Friso, Simonetta/K-4715-2016
CR BAILEY LB, 1990, J NUTR, V120, P1508, DOI 10.1093/jn/120.suppl_11.1508
   BAKER H, 1978, J AM GERIATR SOC, V26, P218, DOI 10.1111/j.1532-5415.1978.tb01962.x
   BALAGHI M, 1993, BIOCHEM J, V291, P145, DOI 10.1042/bj2910145
   BENITO E, 1993, INT J CANCER, V55, P213, DOI 10.1002/ijc.2910550208
   BENITO E, 1991, INT J CANCER, V49, P161, DOI 10.1002/ijc.2910490202
   BLOUNT BC, 1994, ANAL BIOCHEM, V219, P195, DOI 10.1006/abio.1994.1257
   Blount BC, 1997, P NATL ACAD SCI USA, V94, P3290, DOI 10.1073/pnas.94.7.3290
   BUCKBINDER L, 1995, NATURE, V377, P646, DOI 10.1038/377646a0
   Choi SW, 2005, BRIT J NUTR, V93, P31, DOI 10.1079/BJN20041283
   Choi SW, 2003, J NUTR, V133, P1206, DOI 10.1093/jn/133.4.1206
   Choi SW, 2002, J NUTR, V132, p2413S, DOI 10.1093/jn/132.8.2413S
   Choi SW, 2000, J NUTR, V130, P129, DOI 10.1093/jn/130.2.129
   Coppola A, 2000, SEMIN THROMB HEMOST, V26, P243, DOI 10.1055/s-2000-8469
   Costello JF, 2001, J MED GENET, V38, P285, DOI 10.1136/jmg.38.5.285
   Craig SAS, 2004, AM J CLIN NUTR, V80, P539
   CRAVO ML, 1992, CANCER RES, V52, P5002
   Crott JW, 2005, MUTAT RES-FUND MOL M, V570, P63, DOI 10.1016/j.mrfmmm.2004.09.009
   Crott JW, 2004, CARCINOGENESIS, V25, P69, DOI 10.1093/carcin/bgg150
   Fenech M, 1998, CARCINOGENESIS, V19, P1163, DOI 10.1093/carcin/19.7.1163
   FREUDENHEIM JL, 1991, INT J EPIDEMIOL, V20, P368, DOI 10.1093/ije/20.2.368
   Friso S, 2002, J NUTR, V132, p2382S, DOI 10.1093/jn/132.8.2382S
   Friso S, 2002, ANAL CHEM, V74, P4526, DOI 10.1021/ac020050h
   GALLETTI P, 1995, BIOCHEM J, V306, P313, DOI 10.1042/bj3060313
   GARRY PJ, 1984, J AM GERIATR SOC, V32, P719, DOI 10.1111/j.1532-5415.1984.tb04170.x
   Ghandour H, 2002, J NUTR, V132, P1357, DOI 10.1093/jn/132.6.1357
   GIOVANNUCCI E, 1995, JNCI-J NATL CANCER I, V87, P265, DOI 10.1093/jnci/87.4.265
   GIOVANNUCCI E, 1993, J NATL CANCER I, V85, P875, DOI 10.1093/jnci/85.11.875
   GOELZ SE, 1985, SCIENCE, V228, P187, DOI 10.1126/science.2579435
   HANGER HC, 1991, J AM GERIATR SOC, V39, P1155, DOI 10.1111/j.1532-5415.1991.tb03566.x
   Hernanz A, 2000, LIFE SCI, V67, P1317, DOI 10.1016/S0024-3205(00)00722-0
   HOLLIDAY R, 1987, SCIENCE, V238, P163, DOI 10.1126/science.3310230
   Ingenbleek Y, 2004, NUTR RES REV, V17, P135, DOI 10.1079/NRR200489
   Ingenbleek Y, 2002, NUTRITION, V18, P40, DOI 10.1016/S0899-9007(01)00783-3
   Issa JP, 2000, CURR TOP MICROBIOL, V249, P101
   ISSA JPJ, 1994, NAT GENET, V7, P536, DOI 10.1038/ng0894-536
   Jacob RA, 1998, J NUTR, V128, P1204, DOI 10.1093/jn/128.7.1204
   KIM YI, 1995, AM J CLIN NUTR, V61, P1083, DOI 10.1093/ajcn/61.5.1083
   Kim YI, 1999, J NUTR BIOCHEM, V10, P66, DOI 10.1016/S0955-2863(98)00074-6
   Kim YI, 1996, GUT, V39, P732, DOI 10.1136/gut.39.5.732
   LASHNER BA, 1993, J CANCER RES CLIN, V119, P549, DOI 10.1007/BF01686465
   LASHNER BA, 1989, GASTROENTEROLOGY, V97, P255, DOI 10.1016/0016-5085(89)90058-9
   Liu L, 2003, MECH AGEING DEV, V124, P989, DOI 10.1016/j.mad.2003.08.001
   Lucock M, 2000, MOL GENET METAB, V71, P121, DOI 10.1006/mgme.2000.3027
   Mackenzie R., 1984, FOLATE PTERINS, V1, P255
   MILLER JW, 1994, BIOCHEM J, V298, P415, DOI 10.1042/bj2980415
   ONO T, 1993, AGE AGEING, V22, pS34, DOI 10.1093/ageing/22.suppl_1.S34
   PASPATIS GA, 1995, DIS COLON RECTUM, V38, P64, DOI 10.1007/BF02053860
   Perna AF, 2001, AM J KIDNEY DIS, V38, pS85, DOI 10.1053/ajkd.2001.27411
   Pogribny IP, 1997, CARCINOGENESIS, V18, P2071, DOI 10.1093/carcin/18.11.2071
   Rampersaud GC, 2000, AM J CLIN NUTR, V72, P998
   REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939
   Richardson B, 2003, AGEING RES REV, V2, P245, DOI 10.1016/S1568-1637(03)00010-2
   Robertson KD, 2000, CARCINOGENESIS, V21, P461, DOI 10.1093/carcin/21.3.461
   RUSSELL RM, 1986, GASTROENTEROLOGY, V91, P1476, DOI 10.1016/0016-5085(86)90204-0
   Schneede J, 2000, SEMIN THROMB HEMOST, V26, P263, DOI 10.1055/s-2000-8471
   SELHUB J, 1993, JAMA-J AM MED ASSOC, V270, P2693, DOI 10.1001/jama.270.22.2693
   SHANE B, 1989, VITAM HORM, V45, P263
   SLAGBOOM PE, 1990, MECH AGEING DEV, V53, P243, DOI 10.1016/0047-6374(90)90042-E
   Sohn KJ, 2003, CARCINOGENESIS, V24, P81, DOI 10.1093/carcin/24.1.81
   VANYUSHIN BF, 1973, BIOCHIM BIOPHYS ACTA, V299, P397, DOI 10.1016/0005-2787(73)90264-5
   VARELAMOREIRAS G, 1992, J NUTR, V122, P986, DOI 10.1093/jn/122.4.986
   VARELAMOREIRAS G, 1994, INT J VITAM NUTR RES, V64, P294
   Verhoef P, 2004, AM J CLIN NUTR, V80, P674
   WEBSTER SGP, 1979, J AM GERIATR SOC, V27, P451, DOI 10.1111/j.1532-5415.1979.tb01725.x
   Weissbach H, 1970, Vitam Horm, V28, P415
   Yi P, 2000, J BIOL CHEM, V275, P29318, DOI 10.1074/jbc.M002725200
   Young AL, 2001, J BIOL CHEM, V276, P37161, DOI 10.1074/jbc.M106682200
NR 67
TC 35
Z9 39
U1 0
U2 7
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 1434-6621
EI 1437-4331
J9 CLIN CHEM LAB MED
JI Clin. Chem. Lab. Med.
PY 2005
VL 43
IS 10
BP 1151
EP 1157
DI 10.1515/CCLM.2005.200
PG 7
WC Medical Laboratory Technology
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Medical Laboratory Technology
GA 979CY
UT WOS:000232921200030
PM 16197313
DA 2024-02-19
ER

PT J
AU Kang, JM
   Kim, N
   Kim, JH
   Oh, E
   Lee, BY
   Lee, BH
   Shin, CM
   Park, JH
   Lee, MK
   Nam, RH
   Lee, HE
   Lee, HS
   Kim, JS
   Jung, HC
   Song, IS
AF Kang, Jung Mook
   Kim, Nayoung
   Kim, Joo-Hyon
   Oh, Euichaul
   Lee, Bong-Yong
   Lee, Byoung Hwan
   Shin, Cheol Min
   Park, Ji Hyun
   Lee, Mi Kyoung
   Nam, Ryoung Hee
   Lee, Hee Eun
   Lee, Hye Seung
   Kim, Joo Sung
   Jung, Hyun Chae
   Song, In Sung
TI Effect of aging on gastric mucosal defense mechanisms: ROS, apoptosis,
   angiogenesis, and sensory neurons
SO AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
LA English
DT Article
DE Egr-1; PTEN; caspase-3; glycosaminoglycan; aging gastropathy; CGRP;
   lipid hydroperoxide; reactive oxygen species
ID ENDOTHELIAL GROWTH-FACTOR; SENESCENCE-ACCELERATED MICE; LIPID
   HYDROPEROXIDE LEVEL; EARLY REPARATIVE PHASE; HELICOBACTER-PYLORI;
   CALORIE RESTRICTION; OXIDATIVE STRESS; EPITHELIAL-CELLS; MESSENGER-RNA;
   UP-REGULATION
AB Kang JM, Kim N, Kim J, Oh E, Lee B, Lee BH, Shin CM, Park JH, Lee MK, Nam RH, Lee HE, Lee HS, Kim JS, Jung HC, Song IS. Effect of aging on gastric mucosal defense mechanisms: ROS, apoptosis, angiogenesis, and sensory neurons. Am J Physiol Gastrointest Liver Physiol 299: G1147-G1153, 2010. First published August 19, 2010; doi: 10.1152/ajpgi.00218.2010.-Aging changes in the stomach lead to a decreased capacity for tissue repair in response to gastric acid. The aim of this study was to determine the mechanism associated with the increased susceptibility to injury of aging mucosa including reactive oxygen species (5), apoptosis, angiogenesis, and sensory neuron activity. Fischer 344 rats at four different ages (6, 31, 74 wk, and 2 yr of age) were studied. The connective tissue indicators [salt-soluble collagen and sulfated glycosaminoglycan (sGAG)], lipid hydroperoxide (LPO), myeloperoxidase (MPO), and hexosamine were assessed. We also evaluated the expression of early growth response-1 (Egr-1), phosphatase and tension homologue deleted on chromosome 10 (PTEN), caspase-9 (index of apoptosis), VEGF (index of angiogenesis), calcitonin gene-related peptide (CGRP, index of sensory neurons), and neuronal nitric oxide synthase (nNOS). The histological connective tissue area in the lower part of rat gastric mucosa increased with aging, with increase of salt-soluble collagen and sGAG. LPO and MPO in old rats were significantly greater than in the young rats, whereas hexosamine was significantly reduced. The old gastric mucosa had increased expression of Egr-1, PTEN, and caspase-9, whereas the VEGF, CGRP, and nNOS expression were significantly reduced. These results indicate that the lower part of rat gastric mucosa was found to be replaced by connective tissue with accumulation of oxidative products with aging. In addition, impairment of apoptosis, angiogenesis, and sensory neuron activity via the activation of Egr-1 and PTEN might increase the susceptibility of gastric mucosa to injury during aging.
C1 [Kang, Jung Mook; Kim, Nayoung; Park, Ji Hyun; Lee, Mi Kyoung; Kim, Joo Sung; Jung, Hyun Chae; Song, In Sung] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea.
   [Kang, Jung Mook; Kim, Nayoung; Park, Ji Hyun; Lee, Mi Kyoung; Kim, Joo Sung; Jung, Hyun Chae; Song, In Sung] Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea.
   [Kim, Nayoung; Lee, Byoung Hwan; Shin, Cheol Min; Nam, Ryoung Hee] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Songnam, Gyeonggi, South Korea.
   [Kim, Joo-Hyon; Oh, Euichaul; Lee, Bong-Yong] SK Chem, Life Sci R&D Ctr, Suwon, Gyeonggi, South Korea.
   [Lee, Hee Eun; Lee, Hye Seung] Seoul Natl Univ, Bundang Hosp, Dept Pathol, Songnam, Gyeonggi, South Korea.
C3 Seoul National University (SNU); Seoul National University (SNU); Seoul
   National University (SNU); SK Group; Seoul National University (SNU)
RP Kim, N (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Internal Med, 300 Gumi Dong, Songnam 463707, Gyeonggi Do, South Korea.
EM nayoungkim49@empal.com
RI Lee, Hye Seung/G-6419-2011; Kim, Jung M/D-3112-2015; Lee, Hee
   Eun/G-6372-2011; Jung, Hyun Chae/J-5654-2012; Kim, Nayoung/J-5387-2012;
   kim, nayoung/IWV-4038-2023; Kim, Joo Sung/D-5765-2012
OI Lee, Hye Seung/0000-0002-1667-7986; Kim, Jung M/0000-0002-6506-7519;
   Shin, Cheol Min/0000-0003-2265-9845
FU Seoul National University Bundang Hospital [06-2009-032]
FX This work was supported by grant no 06-2009-032 from the Seoul National
   University Bundang Hospital Research fund.
CR Abdel-Latif MMM, 2004, INFECT IMMUN, V72, P3549, DOI 10.1128/IAI.72.6.3549-3560.2004
   Abdel-Latif MMM, 2009, J CELL BIOCHEM, V108, P249, DOI 10.1002/jcb.22247
   Atchison CR, 2000, DIGEST DIS SCI, V45, P614, DOI 10.1023/A:1005422029918
   Aw TY, 1998, FREE RADICAL RES, V28, P637, DOI 10.3109/10715769809065819
   Barros R, 2009, SCAND J GASTROENTERO, V44, P124, DOI 10.1080/00365520802530846
   Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240
   Chung HY, 2001, ANN NY ACAD SCI, V928, P327
   CRYER B, 1992, GASTROENTEROLOGY, V102, P1118
   FLIGIEL SEG, 1994, LAB INVEST, V70, P764
   Geokas M C, 1985, Clin Geriatr Med, V1, P177
   Goto H, 2001, CLIN EXP PHARMACOL P, V28, P659, DOI 10.1046/j.1440-1681.2001.03497.x
   GOTO H, 1992, BIOCHEM BIOPH RES CO, V186, P1443, DOI 10.1016/S0006-291X(05)81568-2
   GRONBECH JE, 1995, AM J PHYSIOL-GASTR L, V269, pG737, DOI 10.1152/ajpgi.1995.269.5.G737
   HOLLANDER D, 1989, DIGEST DIS SCI, V34, P1692, DOI 10.1007/BF01540046
   Holt PR, 1998, J GERONTOL A-BIOL, V53, pB168, DOI 10.1093/gerona/53A.3.B168
   Holzer P, 1998, GASTROENTEROLOGY, V114, P823, DOI 10.1016/S0016-5085(98)70597-9
   Holzer P, 2007, CURR OPIN PHARMACOL, V7, P563, DOI 10.1016/j.coph.2007.09.004
   Huang JH, 2002, J BIOL CHEM, V277, P10760, DOI 10.1074/jbc.M110219200
   Ichikawa T, 2000, AM J PHYSIOL-GASTR L, V279, pG82, DOI 10.1152/ajpgi.2000.279.1.G82
   JAMES OFW, 1983, CLIN GASTROENTEROL, V12, P671
   KANG JM, 2009, DIG DIS SCI     0107
   Kang JM, 2010, J KOREAN MED SCI, V25, P875, DOI 10.3346/jkms.2010.25.6.875
   Keates S, 2005, GUT, V54, P1363, DOI 10.1136/gut.2005.066977
   LEE M, 1994, GASTROENTEROLOGY, V107, P1746, DOI 10.1016/0016-5085(94)90816-8
   Lee M, 1996, GERONTOLOGY, V42, P290, DOI 10.1159/000213805
   Lee M, 1997, GUT, V41, P425, DOI 10.1136/gut.41.4.425
   Lenaz G, 2002, ANN NY ACAD SCI, V959, P199, DOI 10.1111/j.1749-6632.2002.tb02094.x
   Liu L, 1998, AM J PHYSIOL-GASTR L, V275, pG943, DOI 10.1152/ajpgi.1998.275.5.G943
   Majumdar A P N, 2003, J Physiol Pharmacol, V54 Suppl 4, P143
   MAJUMDAR APN, 1990, DIGEST DIS SCI, V35, P1364, DOI 10.1007/BF01536742
   Matsugo S, 2000, NEUROSCI LETT, V278, P105, DOI 10.1016/S0304-3940(99)00907-6
   Mazure NM, 1997, BLOOD, V90, P3322, DOI 10.1182/blood.V90.9.3322
   McMahon SB, 1996, J LEUKOCYTE BIOL, V60, P159, DOI 10.1002/jlb.60.2.159
   Miyake H, 1996, DIGEST DIS SCI, V41, P339, DOI 10.1007/BF02093826
   NEUHAUS OW, 1957, ANAL CHEM, V29, P1230, DOI 10.1021/ac60128a042
   RELAN NK, 1995, LAB INVEST, V73, P717
   Rivard A, 2000, J BIOL CHEM, V275, P29643, DOI 10.1074/jbc.M001029200
   Rivard A, 1999, CIRCULATION, V99, P111, DOI 10.1161/01.CIR.99.1.111
   Salles N, 2005, EXP GERONTOL, V40, P353, DOI 10.1016/j.exger.2005.01.007
   Shian WM, 2000, SURG TODAY, V30, P49, DOI 10.1007/PL00010046
   Sies H, 2005, J NUTR, V135, P969, DOI 10.1093/jn/135.5.969
   Son TG, 2005, FREE RADICAL RES, V39, P283, DOI 10.1080/10715760500053461
   Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8
   TARNAWSKI A, BIOCH BIOPHYS RES CO, V394, P291
   Tarnawski A, 2007, GASTROENTEROLOGY, V133, P1938, DOI 10.1053/j.gastro.2007.08.037
   Thiel G, 2002, J CELL PHYSIOL, V193, P287, DOI 10.1002/jcp.10178
   Tokumaru S, 1996, MECH AGEING DEV, V86, P67, DOI 10.1016/0047-6374(95)01674-0
   UCHIDA M, 1990, DIGEST DIS SCI, V35, P80, DOI 10.1007/BF01537227
   Virolle T, 2001, NAT CELL BIOL, V3, P1124, DOI 10.1038/ncb1201-1124
   Vogiagis D, 2000, AM J PHYSIOL-GASTR L, V278, pG820, DOI 10.1152/ajpgi.2000.278.5.G820
   Wallace JL, 2000, GASTROENTEROLOGY, V119, P512, DOI 10.1053/gast.2000.9304
   Winterbourn CC, 2000, CURR OPIN HEMATOL, V7, P53, DOI 10.1097/00062752-200001000-00010
   Wu XY, 1998, P NATL ACAD SCI USA, V95, P15587, DOI 10.1073/pnas.95.26.15587
   Xiao ZQ, 2001, MECH AGEING DEV, V122, P1849, DOI 10.1016/S0047-6374(01)00323-2
   Yasui F, 2003, NEUROSCI LETT, V350, P66, DOI 10.1016/S0304-3940(03)00827-9
NR 55
TC 48
Z9 53
U1 0
U2 5
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0193-1857
EI 1522-1547
J9 AM J PHYSIOL-GASTR L
JI Am. J. Physiol.-Gastroint. Liver Physiol.
PD NOV
PY 2010
VL 299
IS 5
BP G1147
EP G1153
DI 10.1152/ajpgi.00218.2010
PG 7
WC Gastroenterology & Hepatology; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology; Physiology
GA 673IZ
UT WOS:000283654200016
PM 20724528
DA 2024-02-19
ER

PT J
AU Wasselin, T
   Zahn, S
   Le Maho, Y
   Van Dorsselaer, A
   Raclot, T
   Bertile, F
AF Wasselin, Thierry
   Zahn, Sandrine
   Le Maho, Yvon
   Van Dorsselaer, Alain
   Raclot, Thierry
   Bertile, Fabrice
TI Exacerbated oxidative stress in the fasting liver according to fuel
   partitioning
SO PROTEOMICS
LA English
DT Article
DE Animal proteomics; Food deprivation; Omics technologies; Protein wasting
ID FREE-RADICALS; STARVATION; BODY; ANTIOXIDANTS; METABOLISM; PROTEOMICS;
   PROTEINS; INSIGHTS; INCREASE; OBESITY
AB Complete starvation may prove lethal due to excessive loss of body proteins. However, it is still not completely understood whether responses to food deprivation are time-dependently induced or triggered in relation with the successive phases of protein sparing and wasting that characterize prolonged fasting. As the liver has a wide range of vital functions, we examined the hepatic regulatory mechanisms elicited during prolonged fasting. We showed that fasting-induced transcriptome/proteome changes occur in close relation with fuel partitioning, independently of ATP levels. Omics data suggesting a worsening of oxidative stress during the proteolytic stage of fasting were further validated using biochemical assays. Low levels of antioxidant factors were indeed paralleled by their decreased activity that could be impaired by low NADPH levels. Oxidative damage to lipids and proteins was accordingly increased only during late fasting. At this stage, the gene/protein expression of several chaperones was also repressed. Together with the impairment of metabolic achievements, a vicious cycle involving protein misfolding and oxidative stress could jeopardize liver function when the proteolytic stage of fasting is reached. Thus, monitoring of liver impairments should help to better manage or treat catabolic and/or oxidative stress conditions, such as ageing and degeneration.
C1 [Wasselin, Thierry; Zahn, Sandrine; Le Maho, Yvon; Van Dorsselaer, Alain; Raclot, Thierry; Bertile, Fabrice] CNRS, UMR7178, Strasbourg, France.
   [Wasselin, Thierry; Van Dorsselaer, Alain; Bertile, Fabrice] Univ Strasbourg, IPHC, Dept Analyt Sci, F-67087 Strasbourg, France.
   [Zahn, Sandrine; Le Maho, Yvon; Raclot, Thierry] Univ Strasbourg, IPHC, Dept Ecol Physiol & Ethol, F-67087 Strasbourg, France.
C3 Universites de Strasbourg Etablissements Associes; Universite de
   Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS -
   National Institute of Nuclear and Particle Physics (IN2P3); Universites
   de Strasbourg Etablissements Associes; Universite de Strasbourg;
   Universites de Strasbourg Etablissements Associes; Universite de
   Strasbourg
RP Bertile, F (corresponding author), Univ Strasbourg, CNRS, Lab Spectrometrie Masse Bioorgan, IPHC,UMR7178, 25 Rue Becquerel, F-67087 Strasbourg, France.
EM fbertile@unistra.fr
RI Bertile, Fabrice/ABE-1479-2020; Bertile, Fabrice/F-1287-2019
OI Bertile, Fabrice/0000-0001-5510-4868; Bertile,
   Fabrice/0000-0001-5510-4868
FU Agence Nationale de la Recherche [ANR-05-BLAN-0069]; French Proteomics
   Infrastructure (ProFi); Centre National de la Recherche Scientifique
   (CNRS); Bruker Daltonics Company; Agence Nationale de la Recherche (ANR)
   [ANR-05-BLAN-0069] Funding Source: Agence Nationale de la Recherche
   (ANR)
FX Proteomics data reported here follow the latest MIAPE guidelines. The
   authors thank Chrystel Husser and Mathilde Arrive for their technical
   assistance in Western blot experiments and biochemical measurements,
   Drs. Christelle Thibault-Carpentier, Doulaye Dembele, and Violaine
   Alunni for their involvement in transcriptomics experiments, Dr. Patrick
   Guterl for developing the programs needed to automatically extract GO
   annotations, and finally Joanna Lignot (Munro Language Services) for
   English editing. This study was funded by the Agence Nationale de la
   Recherche (Programme Proteonutr ANR-05-BLAN-0069) and the French
   Proteomics Infrastructure (ProFi). T. W. was supported by the Centre
   National de la Recherche Scientifique (CNRS) and the Bruker Daltonics
   Company.
CR [Anonymous], 2011, The state of food insecurity in the world 2011
   Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556
   Bauer M, 2004, PHYSIOL GENOMICS, V17, P230, DOI 10.1152/physiolgenomics.00203.2003
   Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200
   Bertile F, 2008, CURR MED CHEM, V15, P2545, DOI 10.2174/092986708785908950
   Bertile F., 2007, MESSENGER RNA RES PE, P95
   Bertile F, 2009, PROTEOMICS, V9, P148, DOI 10.1002/pmic.200701001
   Bertile F, 2006, CURR NUTR FOOD SCI, V2, P127, DOI 10.2174/157340106776818862
   Bertile F, 2011, J NUTR BIOCHEM, V22, P372, DOI 10.1016/j.jnutbio.2010.03.005
   Cahill G F Jr, 1970, N Engl J Med, V282, P668, DOI 10.1056/NEJM197003052821026
   Carapito C, 2014, PROTEOMICS, V14, P1014, DOI 10.1002/pmic.201300415
   CHEREL Y, 1991, PHYSIOL BEHAV, V50, P345, DOI 10.1016/0031-9384(91)90076-Z
   CHEREL Y, 1991, CLIN SCI, V81, P611, DOI 10.1042/cs0810611
   Choi J, 2013, NAT CHEM BIOL, V9, P68, DOI 10.1038/nchembio.1167
   Coe H, 2009, GEN PHYSIOL BIOPHYS, V28, pF96
   Dalle-Donne I, 2006, CLIN CHEM, V52, P601, DOI 10.1373/clinchem.2005.061408
   de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078
   Desert C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-611
   Dröge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001
   Fink AL, 1999, PHYSIOL REV, V79, P425, DOI 10.1152/physrev.1999.79.2.425
   Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539
   Friedman MI, 2007, DRUG NEWS PERSPECT, V20, P573, DOI 10.1358/dnp.2007.20.9.1162243
   Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263
   Gregersen N, 2010, METHODS MOL BIOL, V648, P3, DOI 10.1007/978-1-60761-756-3_1
   Groscolas R, 2001, COMP BIOCHEM PHYS A, V128, P645, DOI 10.1016/S1095-6433(00)00341-X
   Hegde PS, 2003, CURR OPIN BIOTECH, V14, P647, DOI 10.1016/j.copbio.2003.10.006
   Lagranha CJ, 2010, CIRC RES, V106, P1681, DOI 10.1161/CIRCRESAHA.109.213645
   LEMAHO Y, 1988, NEWS PHYSIOL SCI, V3, P21
   Li RY, 2006, BIOCHEM BIOPH RES CO, V344, P562, DOI 10.1016/j.bbrc.2006.03.155
   Malhotra JD, 2008, P NATL ACAD SCI USA, V105, P18525, DOI 10.1073/pnas.0809677105
   Marczuk-Krynicka Dorota, 2003, Med Sci Monit, V9, pBR131
   Morales AE, 2004, COMP BIOCHEM PHYS C, V139, P153, DOI 10.1016/j.cca.2004.10.008
   Nishihara M, 1998, Transpl Int, V11 Suppl 1, pS417
   Nyska A, 2002, TOXICOL PATHOL, V30, P620, DOI 10.1080/01926230290166724
   Palou M, 2008, PFLUG ARCH EUR J PHY, V456, P825, DOI 10.1007/s00424-008-0461-1
   PANDOLFI PP, 1995, EMBO J, V14, P5209, DOI 10.1002/j.1460-2075.1995.tb00205.x
   Rigaud D, 2000, AM J CLIN NUTR, V72, P355
   Ryan T, 2011, J BIOL CHEM, V286, P17060, DOI 10.1074/jbc.M110.197186
   Sokolovic M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-528
   Sorensen M, 2006, FREE RADICAL RES, V40, P339, DOI 10.1080/10715760500250182
   Team RC, 2020, R: A Language and Environment for Statistical
   Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008
   Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001
   Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185
   Zhang F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027553
NR 45
TC 25
Z9 27
U1 0
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1615-9853
EI 1615-9861
J9 PROTEOMICS
JI Proteomics
PD AUG
PY 2014
VL 14
IS 16
BP 1905
EP 1921
DI 10.1002/pmic.201400051
PG 17
WC Biochemical Research Methods; Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA AN2NH
UT WOS:000340422000007
PM 24920225
OA Bronze
DA 2024-02-19
ER

PT J
AU Xiong, F
   Dai, CH
   Hou, FR
   Zhu, PP
   He, RH
   Ma, HL
AF Xiong, Feng
   Dai, Chun-Hua
   Hou, Fu-Rong
   Zhu, Pei-Pei
   He, Rong-Hai
   Ma, Hai-Le
TI Study on the Ageing Method and Antioxidant Activity of Black Garlic
   Residues
SO CZECH JOURNAL OF FOOD SCIENCES
LA English
DT Article
DE ageing conditions; antioxidant ability; garlic residues product
ID THERMAL-PROCESSING STEPS; INDUCED OXIDATIVE STRESS; EXTRACT; RATS
AB Garlic residue (GR), a co-product of garlic oil extraction, contains most of the nutrients of raw garlic (RG). Preparation of black garlic residue (BGR) is considered to be an effective method of processing GR. The main objective of this study was to optimise the ageing conditions of GR based on moisture, polyphenol and 5-hydroxymethyl-2-furaldehyde (HMF) levels. In addition, the antioxidant capacity of BGR was also evaluated in vitro and in vivo and compared with black garlic (BR) and RG. The results indicate that optimum ageing resulting in polyphenol and HMF contents of 25.80 mg/g and 3.84 mg/g, respectively, were achieved using a temperature of 90 degrees C and humidity of 95% for four days. Both BGR and BR had stronger capacities to scavenge alpha,alpha-diphenyl-beta-picrylhydrazyl (DPPH) than RG with half maximal inhibitory concentration (IC50) values of 0.454, 0.514 and 4.236 mg/ml, respectively. Experiments on mice demonstrated that there was no obvious difference in antioxidant activity between BGR and BR in vivo. BGR and BR consumption significantly decreased malondialdehyde (MDA) levels in serum and liver, in addition to markedly increasing superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) activities.
C1 [Xiong, Feng; Dai, Chun-Hua; Hou, Fu-Rong; Zhu, Pei-Pei; He, Rong-Hai; Ma, Hai-Le] Jiangsu Univ, Sch Food & Biol Engn, Zhenjiang, Peoples R China.
   [Dai, Chun-Hua; He, Rong-Hai; Ma, Hai-Le] Jiangsu Univ, Jiangsu Key Lab Agr Prod Phys Proc, Zhenjiang, Peoples R China.
C3 Jiangsu University; Jiangsu University
RP He, RH (corresponding author), Jiangsu Univ, Sch Food & Biol Engn, Zhenjiang, Peoples R China.; He, RH (corresponding author), Jiangsu Univ, Jiangsu Key Lab Agr Prod Phys Proc, Zhenjiang, Peoples R China.
EM heronghai@163.com
RI Ma, Haile/JPA-4500-2023; Zhu, Peipei/JMQ-1093-2023
OI Ma, Haile/0000-0002-1604-0387; He, Ronghai/0000-0002-0904-0522
FU Primary Research & Development Plan of Jiangsu Province [BE2017308,
   201635]; Jiangsu Province Postdoctoral Science Foundation [1402001B];
   Science and Technology Support Program (Agriculture) of Jiangsu Province
   [BE2016355]
FX Supported by the Primary Research & Development Plan of Jiangsu
   Province, Projects No. BE2017308 & 201635, Jiangsu Province Postdoctoral
   Science Foundation, Grant No. 1402001B, and Science and Technology
   Support Program (Agriculture) of Jiangsu Province, Project No.
   BE2016355.
CR Angeles TMM, 2016, FOOD CHEM, V199, P135, DOI 10.1016/j.foodchem.2015.11.128
   Bae SE, 2012, LWT-FOOD SCI TECHNOL, V46, P532, DOI 10.1016/j.lwt.2011.11.013
   Durling LJK, 2009, FOOD CHEM TOXICOL, V47, P880, DOI 10.1016/j.fct.2009.01.022
   HALLIWELL B, 1990, METHOD ENZYMOL, V186, P1
   [韩德权 HAN Dequan], 2008, [食品工业科技, Science & Technology of Food Industry], V29, P285
   [黄亮 HUANG Ling], 2008, [食品工业科技, Science & Technology of Food Industry], V29, P197
   Kanth VR, 2008, ACTA DIABETOL, V45, P243, DOI 10.1007/s00592-008-0051-x
   Kim JS, 2013, FOOD SCI BIOTECHNOL, V22, P283, DOI 10.1007/s10068-013-0039-3
   Kim JS, 2013, J FUNCT FOODS, V5, P80, DOI 10.1016/j.jff.2012.08.006
   Kim SH, 2012, J PHOTOCH PHOTOBIO B, V117, P104, DOI 10.1016/j.jphotobiol.2012.08.013
   Leong J, 2010, MEAT SCI, V84, P699, DOI 10.1016/j.meatsci.2009.11.006
   Li NY, 2015, J FOOD PROCESS ENG, V38, P329, DOI 10.1111/jfpe.12156
   Li W., 2011, Phys. Res. Int, V2011, P3, DOI [DOI 10.1155/2011/791545, 10.1155/2011/791545]
   Liao WZ, 2014, J AGR FOOD CHEM, V62, P8648, DOI 10.1021/jf502359x
   MacDonald-Wicks LK, 2006, J SCI FOOD AGR, V86, P2046, DOI 10.1002/jsfa.2603
   Moustafa GG, 2016, BIOMED PHARMACOTHER, V84, P687, DOI 10.1016/j.biopha.2016.09.092
   Naderi R, 2015, ACTA PHYSIOL HUNG, V102, P380, DOI 10.1556/036.102.2015.4.5
   Nencini C, 2011, PLANT FOOD HUM NUTR, V66, P11, DOI 10.1007/s11130-010-0204-2
   Pokluda R., 2001, HORTCUL SCI UZPI CZE, V28, P112
   Quéguineur B, 2012, FOOD CHEM TOXICOL, V50, P2886, DOI 10.1016/j.fct.2012.05.026
   Ramalingam M, 2014, FREE RADICAL RES, V48, P347, DOI 10.3109/10715762.2013.869588
   Robards K, 1999, FOOD CHEM, V66, P401, DOI 10.1016/S0308-8146(99)00093-X
   Sallam KI, 2004, LEBENSM-WISS TECHNOL, V37, P849, DOI 10.1016/j.lwt.2004.04.001
   Sayin VI, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007653
   Wang D., 2010, MED AROMAT PLANT SCI, V4, P37
   Yang XB, 2013, FOOD CHEM, V138, P1256, DOI 10.1016/j.foodchem.2012.10.030
   Zhang K. C., 2014, J ANHUI AGR SCI TU, P2014
   Zhang RF, 2011, J AGR FOOD CHEM, V59, P5935, DOI 10.1021/jf201593n
   Zhang XY, 2016, J SCI FOOD AGR, V96, P2366, DOI 10.1002/jsfa.7351
   Zhang ZS, 2015, J FOOD BIOCHEM, V39, P39, DOI 10.1111/jfbc.12102
   Zong Wei, 2014, China Condiment, V39, P20
NR 31
TC 12
Z9 12
U1 1
U2 16
PU CZECH ACADEMY AGRICULTURAL SCIENCES
PI PRAGUE
PA TESNOV 17, PRAGUE, 117 05, CZECH REPUBLIC
SN 1212-1800
EI 1805-9317
J9 CZECH J FOOD SCI
JI Czech. J. Food Sci.
PY 2018
VL 36
IS 1
BP 88
EP 97
DI 10.17221/420/2016-CJFS
PG 10
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA GE9FO
UT WOS:000431535600013
OA gold
DA 2024-02-19
ER

PT J
AU Tchaikovskaya, T
   Fraifeld, V
   Urphanishvili, T
   Andorfer, JH
   Davies, P
   Listowsky, I
AF Tchaikovskaya, T
   Fraifeld, V
   Urphanishvili, T
   Andorfer, JH
   Davies, P
   Listowsky, I
TI Glutathione S-transferase hGSTM3 and ageing-associated
   neurodegeneration: relationship to Alzheimer's disease
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article; Proceedings Paper
CT Conference on Old Age - Searching for Human Longevity Genes
CY DEC 01-04, 2003
CL ISRAEL
DE glutathione S-transferases; hGSTM5 subunit; Alzheimer's disease;
   microglia; brain; ageing
ID CENTRAL-NERVOUS-SYSTEM; OXIDATIVE STRESS; RAT-BRAIN; LIPID-PEROXIDATION;
   VENTRICULAR FLUID; EXPRESSION; LIVER; LOCALIZATION; CEREBELLUM;
   METABOLISM
AB Glutathione S-transferases (GSTs) are detoxification enzymes that can counter ageing-associated oxidative and chemical stresses. The transcript of a distinct subclass of human GSTs (hGSTM3) was shown by RNA blot analysis to be widely distributed in different regions of adult brain. HPLC profiles indicated that the hGSTM3 subunit was the second most abundant GST subunit in brain. Immumocytochemistry performed with hGSTM3-specific antisera, showed prominent staining of neuritic plaques, neurofibrillary tangles and microglia in sections of hippocampus obtained from patients with Alzheimer's disease. The staining pattern was distinct from that obtained with normal brains. Because hGSTM3 is rich in cysteine residues and readily undergoes S-glutathiolation reactions, deposition of this protein could originate from cross-links produced by oxidative stress. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
C1 Yeshiva Univ Albert Einstein Coll Med, Bronx, NY 10461 USA.
   Ben Gurion Univ Negev, IL-84105 Beer Sheva, Israel.
C3 Yeshiva University; Albert Einstein College of Medicine; Ben Gurion
   University
RP Listowsky, I (corresponding author), Yeshiva Univ Albert Einstein Coll Med, 1300 Morris Pk Ave, Bronx, NY 10461 USA.
EM irving@aecom.yu.edu
OI Fraifeld, Vadim/0000-0002-4525-0535
FU NCI NIH HHS [CA 42448] Funding Source: Medline
CR ABRAMOVITZ M, 1988, J NEUROCHEM, V50, P50, DOI 10.1111/j.1471-4159.1988.tb13228.x
   ADAMS JD, 1991, MOL CHEM NEUROPATHOL, V14, P213, DOI 10.1007/BF03159937
   Aksenov MY, 2001, NEUROSCIENCE, V103, P373, DOI 10.1016/S0306-4522(00)00580-7
   Aksenov MY, 2001, NEUROSCI LETT, V302, P141, DOI 10.1016/S0304-3940(01)01636-6
   Bruce-Keller AJ, 1998, J NEUROPATH EXP NEUR, V57, P257, DOI 10.1097/00005072-199803000-00007
   Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8
   CAMMER W, 1989, J NEUROCHEM, V52, P876, DOI 10.1111/j.1471-4159.1989.tb02536.x
   CAMPBELL E, 1990, J BIOL CHEM, V265, P9188
   CHEN TS, 1989, P SOC EXP BIOL MED, V190, P399
   Cooper AJL, 1997, BIOL CHEM, V378, P793
   Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X
   Dringen R, 2003, BIOL CHEM, V384, P505, DOI 10.1515/BC.2003.059
   Finch CE, 2003, NEUROBIOL AGING, V24, pS123, DOI 10.1016/S0197-4580(03)00051-4
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   Gopal PV, 2000, GERONTOLOGY, V46, P7, DOI 10.1159/000022126
   Halliwell B, 2001, DRUG AGING, V18, P685, DOI 10.2165/00002512-200118090-00004
   HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x
   Harman D, 2002, ANN NY ACAD SCI, V959, P384, DOI 10.1111/j.1749-6632.2002.tb02109.x
   HARMAN D, 1994, ANN NY ACAD SCI, V717, P1, DOI 10.1111/j.1749-6632.1994.tb12069.x
   Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491
   Hayes JD, 2000, BIOCHEM SOC T, V28, P33, DOI 10.1042/bst0280033
   Hirrlinger J, 2000, DEV NEUROSCI-BASEL, V22, P384, DOI 10.1159/000017464
   Kaur J, 2001, NEUROSCI LETT, V301, P1, DOI 10.1016/S0304-3940(01)01576-2
   Lovell MA, 1997, NEUROBIOL AGING, V18, P457, DOI 10.1016/S0197-4580(97)00108-5
   Lovell MA, 1998, NEUROLOGY, V51, P1562, DOI 10.1212/WNL.51.6.1562
   MANNERVIK B, 1992, BIOCHEM J, V282, P305, DOI 10.1042/bj2820305
   MANNERVIK B, 1988, CRC CR REV BIOCH MOL, V23, P283, DOI 10.3109/10409238809088226
   Markesbery WR, 1997, FREE RADICAL BIO MED, V23, P134, DOI 10.1016/S0891-5849(96)00629-6
   Markesbery WR, 1999, ARCH NEUROL-CHICAGO, V56, P1449, DOI 10.1001/archneur.56.12.1449
   Martínez-Lara E, 2003, NEUROBIOL AGING, V24, P501, DOI 10.1016/S0197-4580(02)00139-2
   MEISTER A, 1995, METHOD ENZYMOL, V252, P26
   MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431
   Minghetti L, 1998, PROG NEUROBIOL, V54, P99, DOI 10.1016/S0301-0082(97)00052-X
   Montine KS, 1997, J NEUROPATH EXP NEUR, V56, P866, DOI 10.1097/00005072-199708000-00004
   Muradian KK, 2002, FREE RADICAL BIO MED, V33, P1736, DOI 10.1016/S0891-5849(02)01196-6
   Muradian KK, 2002, ARCH GERONTOL GERIAT, V35, P205, DOI 10.1016/S0167-4943(02)00025-0
   Patskovsky YV, 2000, J BIOL CHEM, V275, P3296, DOI 10.1074/jbc.275.5.3296
   Patskovsky YV, 1999, BIOCHEMISTRY-US, V38, P16187, DOI 10.1021/bi991714t
   Patskovsky YV, 1999, ARCH BIOCHEM BIOPHYS, V361, P85, DOI 10.1006/abbi.1998.0964
   Perry G, 2002, FREE RADICAL BIO MED, V33, P1475, DOI 10.1016/S0891-5849(02)01113-9
   PERRY TL, 1987, ANN NEUROL, V21, P331, DOI 10.1002/ana.410210403
   Rowe JD, 1997, BIOCHEM J, V325, P481, DOI 10.1042/bj3250481
   Rowe JD, 1998, J BIOL CHEM, V273, P9593, DOI 10.1074/jbc.273.16.9593
   Rowe JD, 1998, J ANDROL, V19, P558
   Sandhu SK, 2002, BIOGERONTOLOGY, V3, P161, DOI 10.1023/A:1015643107449
   Schenk DB, 2002, NEUROBIOL AGING, V23, P677, DOI 10.1016/S0197-4580(02)00034-9
   Sidell KR, 2003, J NEUROPATH EXP NEUR, V62, P146, DOI 10.1093/jnen/62.2.146
   TCHAIKOVSKAYA T, 2002, NEURAL PLAST, V9, P119
   Thimmulappa RK, 2002, CANCER RES, V62, P5196
NR 49
TC 40
Z9 40
U1 0
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD FEB
PY 2005
VL 126
IS 2
BP 309
EP 315
DI 10.1016/j.mad.2004.08.029
PG 7
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Cell Biology; Geriatrics & Gerontology
GA 891EN
UT WOS:000226564200014
PM 15621212
DA 2024-02-19
ER

PT J
AU Vulinovic, MP
   Turcic, P
   Micek, V
   Ljubojevic, M
AF Vulinovic, Mirela Pavic
   Turcic, Petra
   Micek, Vedran
   Ljubojevic, Marija
TI Light and heavy ferritin chain expression in the liver and kidneys of
   Wistar rats: aging, sex differences, and impact of gonadectomy
SO ARHIV ZA HIGIJENU RADA I TOKSIKOLOGIJU-ARCHIVES OF INDUSTRIAL HYGIENE
   AND TOXICOLOGY
LA English
DT Article
DE ferritin nanocage; hepatocytes; immunofluorescence; intercalated cells;
   iron metabolism; macula densa; nephron; steroid hormones; western blot
ID METALLOTHIONEINS MT1; IRON ACCUMULATION; HOMEOSTASIS; TISSUES
AB Ferritin is the main intracellular storage of iron. Animal studies show that female liver and kidney express more ferritin and accumulate more iron than male. However, no study so far has investigated sex and age differences in light (FtL) and heavy (FtH) ferritin chain expression. To address this, we relied on specific antibodies and immunochemical methods to analyse the expression of both ferritin chains in the liver and kidney of 3-month and 2-year-old male and female Wistar rats. To see how sex hormones may affect expression we also studied adult animals gonadectomised at the age of 10 weeks. FtL and FtH were more expressed in both organs of female rats, while gonadectomy increased the expression in males and decreased it in females, which suggests that it is stimulated by female and inhibited by male steroid hormones. Normal kidney ferritin distribution and change with aging warrant more attention in studies of (patho) physiological and toxicological processes.
C1 [Vulinovic, Mirela Pavic] Univ Zagreb, Fac Vet Med, Dept Anat Histol & Embryol, Zagreb, Croatia.
   [Turcic, Petra] Univ Zagreb, Fac Pharm & Biochem, Dept Pharmacol, Zagreb, Croatia.
   [Micek, Vedran; Ljubojevic, Marija] Inst Med Res & Occupat Hlth, Zagreb, Croatia.
C3 University of Zagreb; University of Zagreb; Institute for Medical
   Research & Occupational Health (IMROH)
RP Ljubojevic, M (corresponding author), Inst Med Res & Occupat Hlth, Mol Toxicol Unit, Ksaverska Cesta 2, Zagreb 10000, Croatia.
EM mljubo@imi.br
FU Ministry of Science and Education of the Republic of Croatia; project
   AGEMETAR - Croatian Science Foundation [IP-11-2013-1481]
FX This work was supported by the Ministry of Science and Education of the
   Republic of Croatia Program financing for ML and by a grant from the
   project AGEMETAR funded by the Croatian Science Foundation (grant
   number: IP-11-2013-1481) for ML and VM.
CR Andersen RV, 2004, BLOOD, V103, P2914, DOI 10.1182/blood-2003-10-3564
   Anderson GJ, 2017, AM J CLIN NUTR, V106, p1559S, DOI 10.3945/ajcn.117.155804
   Arosio P, 2017, IUBMB LIFE, V69, P414, DOI 10.1002/iub.1621
   Arosio P, 2010, BBA-GEN SUBJECTS, V1800, P783, DOI 10.1016/j.bbagen.2010.02.005
   Arvapalli RK, 2010, CARDIOVASC TOXICOL, V10, P108, DOI 10.1007/s12012-010-9068-9
   Atrian Silvia, 2013, Biomol Concepts, V4, P143, DOI 10.1515/bmc-2012-0049
   Baird SK, 2006, BIOCHEM J, V394, P275, DOI 10.1042/BJ20051143
   Balla J, 2019, PHARMACEUTICALS-BASE, V12, DOI 10.3390/ph12020096
   Bessone F, 2019, CELL MOL LIFE SCI, V76, P99, DOI 10.1007/s00018-018-2947-0
   BJORKLID E, 1970, BIOCHIM BIOPHYS ACTA, V221, P583, DOI 10.1016/0005-2795(70)90230-8
   Broeker KAE, 2022, J PHYSIOL-LONDON, V600, P671, DOI 10.1113/JP282615
   Bulvik BE, 2012, AGE, V34, P693, DOI 10.1007/s11357-011-9268-7
   Alfredo SIC, 2018, PHARMACOL RES, V134, P92, DOI 10.1016/j.phrs.2018.06.013
   Cohen LA, 2010, BLOOD, V116, P1574, DOI 10.1182/blood-2009-11-253815
   Congdon EE, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00372
   Harrison-Findik DD, 2010, WORLD J HEPATOL, V2, P302, DOI 10.4254/wjh.v2.i8.302
   Jung SH, 2008, EXP PHYSIOL, V93, P407, DOI 10.1113/expphysiol.2007.039453
   KALDOR I., 1958, AUSTRALIAN JOUR EXPTL BIOL AND MED SCI, V36, P173, DOI 10.1038/icb.1958.19
   KALDOR I., 1957, AUSTRALIAN JOUR EXPTL BIOL AND M SCI, V35, P123, DOI 10.1038/icb.1957.15
   Kong WN, 2014, BIOL TRACE ELEM RES, V160, P258, DOI 10.1007/s12011-014-0051-3
   Li W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117435
   LINDER MC, 1973, BIOCHIM BIOPHYS ACTA, V297, P70, DOI 10.1016/0304-4165(73)90050-0
   Lista P, 2011, J CELL MOL MED, V15, P1443, DOI 10.1111/j.1582-4934.2011.01293.x
   Ljubojevic M, 2019, J TRACE ELEM MED BIO, V53, P98, DOI 10.1016/j.jtemb.2019.02.010
   Mahroum N, 2022, J AUTOIMMUN, V126, DOI 10.1016/j.jaut.2021.102778
   Masaldan S, 2018, REDOX BIOL, V14, P100, DOI 10.1016/j.redox.2017.08.015
   McCullough K, 2020, SEMIN NEPHROL, V40, P160, DOI 10.1016/j.semnephrol.2020.01.007
   Meynard D, 2014, BLOOD, V123, P168, DOI 10.1182/blood-2013-06-427757
   Muckenthaler MU, 2017, CELL, V168, P344, DOI 10.1016/j.cell.2016.12.034
   Orct T, 2017, J TRACE ELEM MED BIO, V40, P104, DOI 10.1016/j.jtemb.2016.12.015
   Orihuela R, 2011, CHEM COMMUN, V47, P12155, DOI 10.1039/c1cc14819b
   Pavic M, 2019, ARH HIG RADA TOKSIKO, V70, P256, DOI 10.2478/aiht-2019-70-3317
   Pietsch EC, 2003, J BIOL CHEM, V278, P2361, DOI 10.1074/jbc.M210664200
   Plays M, 2021, METALLOMICS, V13, DOI 10.1093/mtomcs/mfab021
   Roy A, 2015, CLIN J AM SOC NEPHRO, V10, P305, DOI 10.2215/CJN.08880914
   Sabolic I, 2018, J TRACE ELEM MED BIO, V46, P62, DOI 10.1016/j.jtemb.2017.11.011
   Sangkhae V, 2017, ADV NUTR, V8, P126, DOI 10.3945/an.116.013961
   Shapiro JS, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.005459
   Stockwell BR, 2017, CELL, V171, P273, DOI 10.1016/j.cell.2017.09.021
   Terman A, 2013, ANTIOXID REDOX SIGN, V18, P888, DOI 10.1089/ars.2012.4885
   Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635
   van Swelm RPL, 2020, NAT REV NEPHROL, V16, P77, DOI 10.1038/s41581-019-0197-5
   WIDDOWSON EM, 1953, BIOCHEM J, V53, P173, DOI 10.1042/bj0530173
   WIDDOWSON EM, 1948, BIOCHEM J, V42, P577, DOI 10.1042/bj0420577
   Xu JZ, 2012, INT J MOL SCI, V13, P2368, DOI 10.3390/ijms13022368
   Zhang YH, 2010, ANTIOXID REDOX SIGN, V13, P999, DOI 10.1089/ars.2010.3129
NR 46
TC 2
Z9 2
U1 0
U2 1
PU SCIENDO
PI WARSAW
PA BOGUMILA ZUGA 32A, WARSAW, MAZOVIA, POLAND
SN 0004-1254
EI 1848-6312
J9 ARH HIG RADA TOKSIKO
JI Arh. Hig. Rada. Toksikol.
PD APR 7
PY 2022
VL 73
IS 1
BP 48
EP 61
DI 10.2478/aiht-2022-73-3621
PG 14
WC Public, Environmental & Occupational Health; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Public, Environmental & Occupational Health; Toxicology
GA 0J0FP
UT WOS:000779786000006
PM 35390238
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Kimura, F
   Miyazaki, M
   Suwa, T
   Kakizaki, S
AF Kimura, F
   Miyazaki, M
   Suwa, T
   Kakizaki, S
TI Reduction of hepatic acute phase response after partial hepatectomy in
   elderly patients
SO RESEARCH IN EXPERIMENTAL MEDICINE
LA English
DT Article
DE aging; partial hepatectomy; interleukin-6; acute phase protein;
   infection
ID NECROSIS-FACTOR-ALPHA; C-REACTIVE PROTEIN; SERUM INTERLEUKIN-6; LIVER
   RESECTION; SURGERY; AGE; COMPLICATIONS; ENDOTOXIN; CARCINOMA; REACTANT
AB The hepatic capacity for acute phase protein synthesis after partial hepatectomy in the elderly patients was prospectively studied. Forty-one patients who consecutively underwent a partial hepatectomy were grouped according to age of greater or less than 70 years; 12 were in the older group and 29 in the younger. The changes in the levels of serum interleukin-6, alpha(1)-antitrypsin, alpha(1)-acid glycoprotein, haptoglobin, and plasma fibrinogen were measured after surgery. The postoperative changes in standard liver function tests were also measured. The incidence of postoperative infected complications was 25% in the older group and 7% in the younger (P = 0.28). Although postoperative levels of serum interleukin-6 were similar between the two groups, those of serum alpha(1)-antitrypsin, alpha(1)-acid glycoprotein, and haptoglobin were significantly lower in the elderly (P<0.05). Postoperative levels of serum al-antitrypsin and plasma fibrinogen showed an increase of about 30% compared with the preoperative values (P<0.05) in the younger group, but no significant increase in the older. Postoperative deterioration of serum albumin levels and hepaplastin test values was also significantly more severe in the older group (P<0.05). We conclude that in the older patients, a reduction of acute phase protein synthesis occurs after partial hepatectomy as a result of a global deterioration of liver function, and may render patients liable to infection.
C1 CHIBA UNIV,SCH MED,DEPT SURG 1,CHUO KU,CHIBA 260,JAPAN.
C3 Chiba University
RP Kimura, F (corresponding author), OMIYA RED CROSS HOSP,DEPT SURG,903 KAMIOCHIAI,YONO 338,JAPAN.
RI Satoru, Kakizaki/AAB-9521-2019
CR ALCORN JM, 1992, HEPATOLOGY, V15, P122, DOI 10.1002/hep.1840150121
   ARII S, 1985, J LAB CLIN MED, V105, P668
   BYL B, 1993, GASTROENTEROLOGY, V104, P1492, DOI 10.1016/0016-5085(93)90361-F
   COLE DJ, 1992, AM SURGEON, V58, P88
   EKBERG H, 1986, SURGERY, V100, P1
   FILKINS JP, 1976, P SOC EXP BIOL MED, V151, P84
   FORTNER JG, 1990, ANN SURG, V211, P141, DOI 10.1097/00000658-199002000-00005
   FREEDMAN HH, 1959, P SOC EXP BIOL MED, V102, P504, DOI 10.3181/00379727-102-25296
   GREENBURG AG, 1985, AM J SURG, V150, P65, DOI 10.1016/0002-9610(85)90011-X
   HEINRICH PC, 1990, BIOCHEM J, V265, P621, DOI 10.1042/bj2650621
   JAMES OFW, 1983, CLIN GASTROENTEROL, V12, P671
   JORI A, 1972, PHARMACOLOGY, V8, P273, DOI 10.1159/000136343
   JORI A, 1972, PHARMACOLOGY, V28, P96
   Kimura F, 1996, EUR SURG RES, V28, P96, DOI 10.1159/000129445
   Kimura F, 1996, BRIT J SURG, V83, P1002, DOI 10.1002/bjs.1800830738
   LESER HG, 1991, GASTROENTEROLOGY, V101, P782, DOI 10.1016/0016-5085(91)90539-W
   MILLAND J, 1990, AM J PHYSIOL, V259, pG340, DOI 10.1152/ajpgi.1990.259.3.G340
   MULCAHY HE, 1994, BRIT J SURG, V81, P736, DOI 10.1002/bjs.1800810540
   MURATA A, 1990, IMMUNOL INVEST, V19, P271, DOI 10.3109/08820139009041842
   NIJSTEN MWN, 1991, SURGERY, V109, P761
   OHZATO H, 1992, SURGERY, V111, P201
   Owren PA, 1969, FARMAKOTERAPI, V25, P14
   SCHREIBER G, 1983, PLASMA PROTEIN SECRE, P423
   SESTO ME, 1987, SURGERY, V102, P846
   SHEPHERD AMM, 1977, BRIT J CLIN PHARMACO, V4, P315, DOI 10.1111/j.1365-2125.1977.tb00719.x
   SHERLOCK S, 1950, J LAB CLIN MED, V35, P823
   SKAUNIC V, 1978, LIVER AGING 1978, P115
   SPANGA G, 1985, ARCH SURG-CHICAGO, V120, P187
   STIMPSON REJ, 1987, AM J SURG, V153, P189, DOI 10.1016/0002-9610(87)90812-9
   TOBIAS PS, 1985, INFECT IMMUN, V50, P73, DOI 10.1128/IAI.50.1.73-76.1985
   TOBIAS PS, 1986, J EXP MED, V164, P777, DOI 10.1084/jem.164.3.777
   VANVUGT H, 1986, BRIT J EXP PATHOL, V67, P313
   WARREN HS, 1987, REV INFECT DIS, V9, pS630
   YANAGA K, 1988, AM J SURG, V155, P238, DOI 10.1016/S0002-9610(88)80703-7
   YANAGA K, 1986, ANN SURG, V203, P148, DOI 10.1097/00000658-198602000-00007
   YOUNG VR, 1975, NATURE, V253, P192, DOI 10.1038/253192a0
NR 36
TC 16
Z9 16
U1 0
U2 0
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0300-9130
J9 RES EXP MED
JI Res. Exp. Med.
PD NOV
PY 1996
VL 196
IS 5
BP 281
EP 290
DI 10.1007/s004330050037
PG 10
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA WE914
UT WOS:A1996WE91400003
PM 9010960
DA 2024-02-19
ER

PT J
AU Zheng, H
   Jiang, L
   Tsuduki, T
   Conrad, M
   Toyokuni, S
AF Zheng, Hao
   Jiang, Li
   Tsuduki, Tsuyoshi
   Conrad, Marcus
   Toyokuni, Shinya
TI Embryonal erythropoiesis and aging exploit ferroptosis
SO REDOX BIOLOGY
LA English
DT Article; Early Access
DE Ferroptosis; Iron; 4-Hydroxy-2-nonenal; Erythropoiesis; Aging
ID GLUTATHIONE-PEROXIDASE 4; RENAL-CELL CARCINOMA; OXIDATIVE STRESS;
   CANCER-CELLS; WISTAR RATS; IRON; DEATH; CARCINOGENESIS; INDUCTION;
   NITRILOTRIACETATE
AB Ferroptosis is a form of regulated cell necrosis, as a consequence of Fe(II)-dependent lipid peroxidation. Although ferroptosis has been linked to cancer cell death, neurodegeneration and reperfusion injury, physiological roles of ferroptosis have not been elucidated to date mostly due to the lack of appropriate methodologies. Here, we show that 4-hydroxy-2-nonenal (HNE)-modified proteins detected by a HNEJ-1 mouse monoclonal antibody is a robust immunohistochemical technology to locate ferroptosis in tissues in combination with morphological nuclear information, based on various models of ferroptosis, including erastin-induced cysteine-deprivation, conditional Gpx4 knockout and Fe(II)-dependent renal tubular injury, as well as other types of regulated cell death. Specificity of HNEJ-1 with ferroptosis was endorsed by non-selective identification of HNE-modified proteins in an Fe (II)-dependent renal tubular injury model. We further comprehensively searched for signs of ferroptosis in different developmental stages of Fischer-344 rats from E9.5-2.5 years of age. We observed that there was a significant age-dependent increase in ferroptosis in the kidney, spleen, liver, ovary, uterus, cerebellum and bone marrow, which was accompanied by iron accumulation. Not only phagocytic cells but also parenchymal cells were affected. Epidermal ferroptosis in ageing SAMP8 mice was significantly promoted by high-fat or carbohydrate-restricted diets. During embryogenesis of Fischer-344 rats, we found ferroptosis in nucleated erythrocytes at E13.5, which disappeared in enucleated erythrocytes at E18.5. Administration of a ferroptosis inhibitor, liproxstatin-1, significantly delayed erythrocyte enucleation. Therefore, our results demonstrate for the first time the involvement of ferroptosis in physiological processes, such as embryonic erythropoiesis and aging, suggesting the evolutionally acquired mechanism and the inevitable side effects, respectively.
C1 [Zheng, Hao; Jiang, Li; Toyokuni, Shinya] Nagoya Univ, Grad Sch Med, Dept Pathol & Biol Responses, Nagoya, Aichi 4668550, Japan.
   [Tsuduki, Tsuyoshi] Tohoku Univ, Grad Sch Agr, Lab Food & Biomol Sci, Aoba Ku, 468-1 Aoba, Sendai, Miyagi 9800845, Japan.
   [Conrad, Marcus] Helmholtz Zentrum Munchen, Inst Metab & Cell Death, D-85764 Neuherberg, Germany.
   [Conrad, Marcus] Pirogov Natl Res Med Univ, Lab Expt Oncol, Ostrovityanova 1, Moscow 117997, Russia.
   [Toyokuni, Shinya] Nagoya Univ, Ctr Low Temp Plasma Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648603, Japan.
C3 Nagoya University; Tohoku University; Helmholtz Association;
   Helmholtz-Center Munich - German Research Center for Environmental
   Health; Pirogov Russian National Research Medical University; Nagoya
   University
RP Toyokuni, S (corresponding author), Nagoya Univ, Grad Sch Med, Dept Pathol & Biol Responses, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi, Japan.
EM toyokuni@med.nagoya-u.ac.jp
RI Toyokuni, Shinya/ABE-7714-2021; Toyokuni, Shinya/C-1358-2010; Conrad,
   Marcus/E-8792-2015
OI Toyokuni, Shinya/0000-0002-5757-1109; Toyokuni,
   Shinya/0000-0002-5757-1109; Tsuduki, Tsuyoshi/0000-0001-7810-0528;
   Conrad, Marcus/0000-0003-1140-5612
FU JST CREST [JPMJCR19H4]; JSPS Kakenhi [JP19H05462, JP20H05502]; Deutsche
   Forschungsgemeinschaft (DFG) [CO 291/7-1, CO 291/9-1, CO 291/10-1];
   Ministry of Science and Higher Education of the Russian Federation
   [075-15-2019-1933]; European Research Council (ERC) under the European
   Union [884754]; European Research Council (ERC) [884754] Funding Source:
   European Research Council (ERC)
FX This work was supported, in part, by JST CREST (Grant Number JPMJCR19H4)
   and JSPS Kakenhi (Grant Number JP19H05462 and JP20H05502). Mass
   spectrometric analyses were supported by Kentaro Taki, Division of
   Medical Research Engineering, Nagoya University Graduate School of
   Medicine. We thank Nobuaki Misawa (Department Pathology and Biological
   Responses, Nagoya University Graduate School of Medicine) for excellent
   technical assistance. Work in the Conrad laboratory is supported by
   funding from the Deutsche Forschungsgemeinschaft (DFG) CO 291/7-1, CO
   291/9-1 and CO 291/10-1, the Ministry of Science and Higher Education of
   the Russian Federation (075-15-2019-1933), and the European Research
   Council (ERC) under the European Union's Horizon 2020 research and
   innovation program (Grant Agreement No. GA 884754).
CR Akatsuka S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043403
   Allam R, 2012, J AM SOC NEPHROL, V23, P1375, DOI 10.1681/ASN.2011111077
   Altamura S, 2020, HAEMATOLOGICA, V105, P937, DOI 10.3324/haematol.2018.212977
   Angeli JPF, 2014, NAT CELL BIOL, V16, P1180, DOI 10.1038/ncb3064
   Belaoussoff M, 1998, DEVELOPMENT, V125, P5009
   Bittorf T, 2000, J MOL ENDOCRINOL, V25, P253, DOI 10.1677/jme.0.0250253
   Boucher DM, 1996, REPROD FERT DEVELOP, V8, P765, DOI 10.1071/RD9960765
   Brea R, 2018, BBA-MOL BASIS DIS, V1864, P325, DOI 10.1016/j.bbadis.2017.11.001
   Canli Ö, 2016, BLOOD, V127, P139, DOI 10.1182/blood-2015-06-654194
   Chen LJ, 2015, J BIOL CHEM, V290, P28097, DOI 10.1074/jbc.M115.680090
   Dixon SJ, 2015, ACS CHEM BIOL, V10, P1604, DOI 10.1021/acschembio.5b00245
   Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042
   Do Van B, 2016, NEUROBIOL DIS, V94, P169, DOI 10.1016/j.nbd.2016.05.011
   Drake J, 2004, NEUROSCI LETT, V356, P155, DOI 10.1016/j.neulet.2003.11.047
   EBINA Y, 1986, J NATL CANCER I, V76, P107
   Gil L, 2006, FREE RADICAL RES, V40, P495, DOI 10.1080/10715760600592962
   Guiney SJ, 2017, NEUROCHEM INT, V104, P34, DOI 10.1016/j.neuint.2017.01.004
   Gveric-Ahmetasevic S, 2009, FREE RADICAL RES, V43, P376, DOI 10.1080/10715760902783285
   Hambright WS, 2017, REDOX BIOL, V12, P8, DOI 10.1016/j.redox.2017.01.021
   Hangauer MJ, 2017, NATURE, V551, P247, DOI 10.1038/nature24297
   Hu D, 2010, INT J DEV BIOL, V54, P341, DOI 10.1387/ijdb.082768dh
   Ito F, 2020, REDOX BIOL, V36, DOI 10.1016/j.redox.2020.101616
   Jiang L, 2021, REDOX BIOL, V43, DOI 10.1016/j.redox.2021.101989
   Kim CH, 2006, J GERONTOL A-BIOL, V61, P332, DOI 10.1093/gerona/61.4.332
   Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496
   Knutson MD, 2005, P NATL ACAD SCI USA, V102, P1324, DOI 10.1073/pnas.0409409102
   KUHN H, 1990, J BIOL CHEM, V265, P1454
   Li SS, 2020, BIOMED PHARMACOTHER, V129, DOI 10.1016/j.biopha.2020.110389
   Li Y, 2019, CELL DEATH DIFFER, V26, P2284, DOI 10.1038/s41418-019-0299-4
   Liao C, 2018, FREE RADICAL BIO MED, V127, P165, DOI 10.1016/j.freeradbiomed.2018.04.578
   Muckenthaler MU, 2017, CELL, V168, P344, DOI 10.1016/j.cell.2016.12.034
   Nishiyama Y, 1995, JPN J CANCER RES, V86, P1150, DOI 10.1111/j.1349-7006.1995.tb03308.x
   Ouled-Haddou H, 2020, BLOOD ADV, V4, P5666, DOI 10.1182/bloodadvances.2020003100
   Ozeki M, 2005, J CHROMATOGR B, V827, P119, DOI 10.1016/j.jchromb.2005.02.025
   Petkovic I, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9020150
   Rademacher M, 2020, FASEB J, V34, P14318, DOI 10.1096/fj.202000408RR
   RAPOPORT SM, 1979, EUR J BIOCHEM, V96, P545, DOI 10.1111/j.1432-1033.1979.tb13068.x
   Skouta R, 2014, J AM CHEM SOC, V136, P4551, DOI 10.1021/ja411006a
   Stamenkovic A, 2021, AM J PHYSIOL-HEART C, V320, pH1170, DOI 10.1152/ajpheart.00237.2020
   Stockwell BR, 2017, CELL, V171, P273, DOI 10.1016/j.cell.2017.09.021
   Sun DX, 1996, J BIOL CHEM, V271, P24055, DOI 10.1074/jbc.271.39.24055
   TOYOKUNI S, 1995, FEBS LETT, V359, P189, DOI 10.1016/0014-5793(95)00033-6
   Toyokuni S, 1996, FREE RADICAL BIO MED, V20, P553, DOI 10.1016/0891-5849(95)02111-6
   Toyokuni S, 1997, LAB INVEST, V76, P365
   TOYOKUNI S, 1994, P NATL ACAD SCI USA, V91, P2616, DOI 10.1073/pnas.91.7.2616
   Toyokuni S, 1997, FREE RADICAL BIO MED, V22, P1019, DOI 10.1016/S0891-5849(96)00489-3
   Toyokuni S, 2020, CANCERS, V12, DOI 10.3390/cancers12113320
   Toyokuni S, 2020, CANCER SCI, V111, P2665, DOI 10.1111/cas.14496
   Toyokuni S, 2017, FREE RADICAL BIO MED, V108, P610, DOI 10.1016/j.freeradbiomed.2017.04.024
   Toyokuni S, 2016, PATHOL INT, V66, P245, DOI 10.1111/pin.12396
   Toyokuni S, 2009, CANCER SCI, V100, P9, DOI 10.1111/j.1349-7006.2008.01001.x
   UCHIDA K, 1993, P NATL ACAD SCI USA, V90, P8742, DOI 10.1073/pnas.90.18.8742
   Viswanathan VS, 2017, NATURE, V547, P453, DOI 10.1038/nature23007
   Wu QM, 2019, BIOGERONTOLOGY, V20, P71, DOI 10.1007/s10522-018-9777-1
   Yamaki K, 2000, J PHARMACOL EXP THER, V293, P206
   Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010
   Youssef LA, 2018, BLOOD, V131, P2581, DOI 10.1182/blood-2017-12-822619
   Yuan H, 2016, BIOCHEM BIOPH RES CO, V478, P1338, DOI 10.1016/j.bbrc.2016.08.124
   Zhang HQ, 2021, ARCH BIOCHEM BIOPHYS, V699, DOI 10.1016/j.abb.2020.108749
   Zhao BB, 2016, EXP HEMATOL, V44, P975, DOI 10.1016/j.exphem.2016.06.249
   Zhou BY, 2005, ENDOCRINOLOGY, V146, P64, DOI 10.1210/en.2004-1011
NR 61
TC 31
Z9 34
U1 3
U2 32
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2213-2317
J9 REDOX BIOL
JI Redox Biol.
PD 2021 DEC
PY 2021
VL 48
AR 102175
DI 10.1016/j.redox.2021.102175
EA NOV 2021
PG 15
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA WV1KO
UT WOS:000716996300002
PM 34736120
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Pavlica, S
   Piscioneri, A
   Peinemann, F
   Keller, M
   Milosevic, J
   Staeudte, A
   Heilmann, A
   Schulz-Siegmund, M
   Laera, S
   Favia, P
   De Bartolo, L
   Bader, A
AF Pavlica, Sanja
   Piscioneri, Antonella
   Peinemann, Frank
   Keller, Mario
   Milosevic, Javorina
   Staeudte, Andrea
   Heilmann, Andreas
   Schulz-Siegmund, Michaela
   Laera, Stefania
   Favia, Pietro
   De Bartolo, Loredana
   Bader, Augustinus
TI Rat embryonic liver cell expansion and differentiation on NH<sub>3</sub>
   plasma-grafted PEEK-WC-PU membranes
SO BIOMATERIALS
LA English
DT Article
DE PEEK-WC-PU membranes; Plasma processing; Membrane bioreactor; Rat
   embryonic liver cells; Proliferation
ID SMALL-SCALE BIOREACTOR; HUMAN HEPATOCYTES; GENE-EXPRESSION;
   IMMOBILIZATION; CULTIVATION; TELOMERASE; GENERATION; POLYMERS
AB Biomaterials can potentially influence stem and progenitor cell proliferation and differentiation in both a positive and a negative way. Herein, we report on the expansion and differentiation of rat embryonic (E17) liver (RLC-18) cells on new bioactive membrane made of PEEK-WC-PU, whose surface was grafted with nitrogen functionalities by means of NH3 glow discharges. The performance of the developed membrane was evaluated by analyzing the expression of the liver specific functions of cells cultured in a 6-well gas-permeable bioreactor. It was found that native and NH3 plasma-grafted PEEK-WC-PU membranes enabled expansion of liver cells in the bioreactor. Liver embryonic cells on the membranes exhibited higher functional activities compared to those cultured on conventional culture dishes as demonstrated by higher albumin and urea production. They showed gene expression of alpha-fetoprotein and albumin in a time-dependent manner of the hepatic differentiation process. LDH assay and SEM analyses revealed that a high number of viable liver stem cells attached to the membranes. Unexpectedly, liver progenitors cultured on membranes had higher telomerase activity than ones in the plates, preventing cell senescence. Thus, membranes are able to sustain in vitro the same in vivo liver functions and to allow the expansion of progenitor cells. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Pavlica, Sanja; Peinemann, Frank; Keller, Mario; Bader, Augustinus] Univ Leipzig, Dept Cell Technol & Appl Stem Cell Biol, Biomed Biotechnol Ctr, Fac Med, D-04103 Leipzig, Germany.
   [Piscioneri, Antonella; De Bartolo, Loredana] Univ Calabria, Inst Membrane Technol, Natl Res Council, ITM CNR, I-87030 Arcavacata Di Rende, CS, Italy.
   [Milosevic, Javorina] Univ Leipzig, Translat Ctr Regenerat Med Leipzig TRM Leipzig, D-04103 Leipzig, Germany.
   [Staeudte, Andrea; Heilmann, Andreas] Fraunhofer Inst Mech Mat, D-06120 Halle, Germany.
   [Schulz-Siegmund, Michaela] Univ Leipzig, Dept Pharmaceut Technol, D-04103 Leipzig, Germany.
   [Laera, Stefania; Favia, Pietro] Univ Bari UNIBA, Dept Chem, I-70126 Bari, Italy.
C3 Leipzig University; Consiglio Nazionale delle Ricerche (CNR); Istituto
   per la Tecnologia delle Membrane (ITM-CNR); University of Calabria;
   Leipzig University; Fraunhofer Gesellschaft; Leipzig University;
   Universita degli Studi di Bari Aldo Moro
RP Pavlica, S (corresponding author), Univ Leipzig, Dept Cell Technol & Appl Stem Cell Biol, Biomed Biotechnol Ctr, Fac Med, Deutsch Pl 5, D-04103 Leipzig, Germany.
EM sanja.pavlica@bbz.uni-leipzig.de
RI De Bartolo, Loredana/E-5074-2015; Piscioneri, Antonella/N-6910-2018
OI De Bartolo, Loredana/0000-0003-3774-9114; Piscioneri,
   Antonella/0000-0002-1052-1550; Favia, Pietro/0000-0002-5896-895X;
   Schulz-Siegmund, Michaela/0000-0003-1340-1850
FU EU [LIVE-BIOMAT NMP3-CT-013653]
FX The work was funded by EU through the EU-project LIVE-BIOMAT
   NMP3-CT-013653. Prof R. d'Agostino (Dept. Chemistry, Univ. Bari) is
   acknowledged for fruitful discussions. Mr Savino Cosmai (Dept.
   Chemistry, Univ. Bari) and Mrs. Angela Hennig (BBZ, University of
   Leipzig) are acknowledged for technical assistance.
CR Bader A, 1998, XENOBIOTICA, V28, P815, DOI 10.1080/004982598239074
   De Bartolo L, 2005, BIOMATERIALS, V26, P6625, DOI 10.1016/j.biomaterials.2005.04.021
   De Bartolo L, 2007, BIOMOL ENG, V24, P23, DOI 10.1016/j.bioeng.2006.07.001
   Diekmann S, 2007, INT J ARTIF ORGANS, V30, P192, DOI 10.1177/039139880703000303
   Favia P, 2008, NATO SCI PEACE SEC A, P203
   Favia P, 2005, PLASMA PROCESS POLYM, P271
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Inui T, 2002, EXP CELL RES, V273, P147, DOI 10.1006/excr.2001.5446
   Laera S, 2009, PLASMA PROCESS POLYM, V6, pS81, DOI 10.1002/ppap.200930307
   Lopez LC, 2006, ADV FUNCT MATER, V16, P1417, DOI 10.1002/adfm.200500502
   Memoli B, 2007, BIOMATERIALS, V28, P4836, DOI 10.1016/j.biomaterials.2007.05.043
   Milosevic J, 2005, J NEUROCHEM, V92, P718, DOI 10.1111/j.1471-4159.2004.02893.x
   MUGLIA L, 1984, NUCLEIC ACIDS RES, V12, P6751, DOI 10.1093/nar/12.17.6751
   Neuss S, 2008, BIOMATERIALS, V29, P302, DOI 10.1016/j.biomaterials.2007.09.022
   NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Rudolph KL, 2000, SCIENCE, V287, P1253, DOI 10.1126/science.287.5456.1253
   Salerno S, 2009, BIOMATERIALS, V30, P4348, DOI 10.1016/j.biomaterials.2009.04.052
   Sardella E, 2006, PLASMA PROCESS POLYM, V3, P456, DOI 10.1002/ppap.200600041
   Schmitmeier S, 2006, BIOTECHNOL BIOENG, V95, P1198, DOI 10.1002/bit.21089
   SHIOJIRI N, 1991, CANCER RES, V51, P2611
   Siow KS, 2006, PLASMA PROCESS POLYM, V3, P392, DOI 10.1002/ppap.200600021
   Stoehr SA, 2003, HEPATOLOGY, V38, P1125, DOI 10.1053/jhep.2003.50418
   TAKAOKA T, 1975, JPN J EXP MED, V45, P317
   Yang J, 2002, BIOMATERIALS, V23, P2607, DOI 10.1016/S0142-9612(01)00400-8
   Ye SH, 2005, BIOMATERIALS, V26, P5032, DOI 10.1016/j.biomaterials.2005.01.049
NR 26
TC 20
Z9 22
U1 1
U2 22
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2009
VL 30
IS 33
BP 6514
EP 6521
DI 10.1016/j.biomaterials.2009.08.024
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Engineering; Materials Science
GA 511FI
UT WOS:000271148900004
PM 19726080
DA 2024-02-19
ER

PT J
AU TOUITOU, Y
AF TOUITOU, Y
TI EFFECTS OF AGING ON ENDOCRINE AND NEUROENDOCRINE RHYTHMS IN HUMANS
SO HORMONE RESEARCH
LA English
DT Article; Proceedings Paper
CT 37th International Henri-Pierre Klotz Symposium - Endocrine Functions
   and Ageing
CY MAY 05-06, 1994
CL PARIS, FRANCE
DE AGING; ELDERLY; CIRCADIAN RHYTHMS; CIRCANNUAL RHYTHMS; MELATONIN;
   PROLACTIN; CORTISOL; GROWTH HORMONE; TESTOSTERONE; LUTEINIZING HORMONE;
   FOLLICLE-STIMULATING HORMONE
ID ELDERLY HUMAN-SUBJECTS; PLASMA MELATONIN; CIRCADIAN-RHYTHM;
   LUTEINIZING-HORMONE; MENTAL CONDITION; HUMAN PROLACTIN; GROWTH-HORMONE;
   AGING MEN; SLEEP; SEX
AB Biological rhythms in blood variables are now fairly well documented in young healthy adults whereas reports in elderly subjects are few for obvious reasons including the difficulty of setting up a group of elderly subjects comparable in age and social background and moreover free of major liver, heart, kidney, bone or any other degenerative disease and consequently not requiring medication. We have observed that the parameters characteristic of the biological rhythm may be modified with ageing. However, the modifications are different from one function or variable to the next. Differences in acrophases, mesors and amplitudes could be demonstrated. For instance the acrophase may be phase-advanced in the elderly for plasma cortisol, DHEA-S, 18-OHDOC, the amplitude may be modified for testosterone, 18-OHDOC, proteins, melatonin, gonadotrophins. The administration as a function of time of drugs or agents used as a diagnostic tool made it possible to ascertain the importance of the time structure in this field. Both validity and interpretation of such administration depend upon the timing of the agent administration in the 24-hour scale. Therefore, the temporal organization of the subjects undergoing such treatments should be taken into account. In the near future this kind of investigation on various biological variables may lead to an improvement of the desired drug effects in elderly patients.
RP TOUITOU, Y (corresponding author), UNIV PARIS 06,SERV BIOCHIM MED,91 BLVD HOP,F-75013 PARIS,FRANCE.
RI Weydahl, Andi/C-6391-2008
OI Touitou, Yvan/0000-0002-5990-0244
CR [Anonymous], 1988, ANN REV CHRONOPHARMA
   ARENDT J, 1978, NEUROSCI LETT, V7, P327, DOI 10.1016/0304-3940(78)90221-5
   BECKFRIIS J, 1984, PSYCHONEUROENDOCRINO, V9, P261, DOI 10.1016/0306-4530(84)90005-2
   BREMNER WJ, 1983, J CLIN ENDOCR METAB, V56, P1278, DOI 10.1210/jcem-56-6-1278
   CUGINI P, 1982, J GERONTOL, V37, P403, DOI 10.1093/geronj/37.4.403
   DESIR D, 1982, J CLIN ENDOCR METAB, V55, P849, DOI 10.1210/jcem-55-5-849
   DJURSING H, 1981, ACTA ENDOCRINOL-COP, V97, P1
   FINKELSTEIN JW, 1972, J CLIN ENDOCR METAB, V35, P665, DOI 10.1210/jcem-35-5-665
   GALA RR, 1977, ACTA ENDOCRINOL-COP, V86, P257, DOI 10.1530/acta.0.0860257
   HARMAN SM, 1980, J CLIN ENDOCR METAB, V51, P35, DOI 10.1210/jcem-51-1-35
   HAUS E, 1989, CHRONOBIOLOGIA, V16, P331
   HAUS E, 1980, J CLIN ENDOCR METAB, V51, P632, DOI 10.1210/jcem-51-3-632
   HO KKY, 1993, HORM RES, V40, P80, DOI 10.1159/000183771
   IGUCHI H, 1982, J CLIN ENDOCR METAB, V55, P27, DOI 10.1210/jcem-55-1-27
   ILLNEROVA H, 1985, BRAIN RES, V328, P186, DOI 10.1016/0006-8993(85)91342-3
   PARKER L, 1981, METABOLISM, V30, P601, DOI 10.1016/0026-0495(81)90139-6
   POEGGELER B, 1993, J PINEAL RES, V14, P151, DOI 10.1111/j.1600-079X.1993.tb00498.x
   REDMAN J, 1983, SCIENCE, V219, P1089, DOI 10.1126/science.6823571
   REINBERG A, 1978, ACTA ENDOCRINOL-COP, V88, P417, DOI 10.1530/acta.0.0880417
   SASSIN JF, 1972, SCIENCE, V177, P1205, DOI 10.1126/science.177.4055.1205
   SASSIN JF, 1973, J CLIN ENDOCR METAB, V37, P436, DOI 10.1210/jcem-37-3-436
   SHERMAN B, 1985, J CLIN ENDOCR METAB, V61, P439, DOI 10.1210/jcem-61-3-439
   SPARROW D, 1988, J CLIN ENDOCR METAB, V51, P508
   STEARNS EL, 1974, AM J MED, V57, P761, DOI 10.1016/0002-9343(74)90850-X
   TARQUINI B, 1979, AM J MED, V66, P229, DOI 10.1016/0002-9343(79)90536-9
   TOUITOU Y, 1985, ACTA ENDOCRINOL-COP, V108, P135, DOI 10.1530/acta.0.1080135
   TOUITOU Y, 1983, J ENDOCRINOL, V96, P53, DOI 10.1677/joe.0.0960053
   TOUITOU Y, 1982, J ENDOCRINOL, V93, P201, DOI 10.1677/joe.0.0930201
   TOUITOU Y, 1981, J ENDOCRINOL, V91, P467, DOI 10.1677/joe.0.0910467
   TOUITOU Y, 1983, J ENDOCRINOL, V96, P15, DOI 10.1677/joe.0.0960015
   TOUITOU Y, 1984, ACTA ENDOCRINOL-COP, V106, P145, DOI 10.1530/acta.0.1060145
   TOUITOU Y, 1983, J ENDOCRINOL, V96, P65, DOI 10.1677/joe.0.0960065
   TOUITOU Y, 1994, BIOL RHYTHMS CLIN LA
   TOUITOU Y, 1994, BIOL RHYTHMS CLIN LA, P188
   VANCOEVORDEN A, 1991, AM J PHYSIOL, V260, pE651, DOI 10.1152/ajpendo.1991.260.4.E651
   VERMEULE.A, 1972, J CLIN ENDOCR METAB, V34, P730, DOI 10.1210/jcem-34-4-730
NR 36
TC 34
Z9 34
U1 0
U2 3
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0301-0163
J9 HORM RES
JI Horm. Res.
PY 1995
VL 43
IS 1-3
BP 12
EP 19
DI 10.1159/000184231
PG 8
WC Endocrinology & Metabolism
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA QB799
UT WOS:A1995QB79900003
PM 7721256
DA 2024-02-19
ER

PT J
AU Li, JM
   Tan, RZ
   Wu, J
   Guo, WJ
   Wang, YP
   You, GX
   Zhang, YT
   Yu, ZY
   Geng, Y
   Zan, J
   Su, JF
AF Li, Jiaming
   Tan, Rongzhi
   Wu, Jie
   Guo, Wenjie
   Wang, Yupeng
   You, Guoxing
   Zhang, Yuting
   Yu, Zhiyong
   Geng, Yan
   Zan, Jie
   Su, Jianfen
TI A cellular senescence-related genes model allows for prognosis and
   treatment stratification of hepatocellular carcinoma: A bioinformatics
   analysis and experimental verification
SO FRONTIERS IN GENETICS
LA English
DT Article
DE hepatocellular carcinoma; cellular senescence; stratified model;
   precision medication; immune checkpoint; clinical treatment
ID CHROMOGRANIN-A; PREMATURE SENESCENCE; EXPRESSION; PATHWAY;
   GLUCOSE-6-PHOSPHATE-DEHYDROGENASE; DOWNSTREAM; CHALLENGES; THERAPY;
   EZH2; CDX2
AB Introduction: Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer with low 5-year survival rate. Cellular senescence, characterized by permanent and irreversible cell proliferation arrest, plays an important role in tumorigenesis and development. This study aims to develop a cellular senescence-based stratified model, and a multivariable-based nomogram for guiding clinical therapy for HCC.Materials and methods: The mRNAs expression data of HCC patients and cellular senescence-related genes were obtained from TCGA and CellAge database, respectively. Through multiple analysis, a four cellular senescence-related genes-based prognostic stratified model was constructed and its predictive performance was validated through various methods. Then, a nomogram based on the model was constructed and HCC patients stratified by the model were analyzed for tumor mutation burden, tumor microenvironment, immune infiltration, drug sensitivity and immune checkpoint. Functional enrichment analysis was performed to explore potential biological pathways. Finally, we verified this model by siRNA transfection, scratch assay and Transwell Assay.Results: We established an cellular senescence-related genes-based stratified model, and a multivariable-based nomogram, which could accurately predict the prognosis of HCC patients in the ICGC database. The low and high risk score HCC patients stratified by the model showed different tumor mutation burden, tumor microenvironment, immune infiltration, drug sensitivity and immune checkpoint expressions. Functional enrichment analysis suggested several biological pathways related to the process and prognosis of HCC. Scratch assay and transwell assay indicated the promotion effects of the four cellular senescence-related genes (EZH2, G6PD, CBX8, and NDRG1) on the migraiton and invasion of HCC.Conclusion: We established a cellular senescence-based stratified model, and a multivariable-based nomogram, which could predict the survival of HCC patients and guide clinical treatment.
C1 [Li, Jiaming; Tan, Rongzhi; Guo, Wenjie; Wang, Yupeng; You, Guoxing; Zhang, Yuting; Yu, Zhiyong; Geng, Yan; Zan, Jie] Guangdong Univ Technol, Sch Biomed & Pharmaceut Sci, Guangzhou, Peoples R China.
   [Li, Jiaming; Su, Jianfen] Guangzhou Panyu Cent Hosp, Dept Pharm, Guangzhou, Peoples R China.
   [Wu, Jie] Southern Med Univ, Sch Clin Med 2, Guangzhou, Guangdong, Peoples R China.
C3 Guangdong University of Technology; Southern Medical University - China
RP Zan, J (corresponding author), Guangdong Univ Technol, Sch Biomed & Pharmaceut Sci, Guangzhou, Peoples R China.; Su, JF (corresponding author), Guangzhou Panyu Cent Hosp, Dept Pharm, Guangzhou, Peoples R China.
EM zanj@gdut.edu.cn; suphen_so@163.com
RI Li, Li/IAQ-0885-2023; Zhang, Yuting/JRW-3937-2023; zhang,
   yu/HNS-5948-2023; ZHANG, YUTING/HOH-4131-2023; Zhang,
   Yuting/JZE-2800-2024; Jiang, Yu/JEZ-9814-2023
FU Science and Technology Planning Project of Guangzhou [202102020119];
   Science and Technology Commissioner Project of Guangdong Province
   [GDKTP2021003800]; Guangzhou Panyu Central Hospital [2021Y001]; People's
   Livelihood Science and Technology Program of Guangzhou [202103000002]
FX This study was supported by the Science and Technology Planning Project
   of Guangzhou (202102020119), Science and Technology Commissioner Project
   of Guangdong Province (GDKTP2021003800), Guangzhou Panyu Central
   Hospital (Grant no. 2021Y001) and the People's Livelihood Science and
   Technology Program of Guangzhou (202103000002).
CR Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542
   Cao F, 2021, CELL SIGNAL, V87, DOI 10.1016/j.cellsig.2021.110098
   Castelo-Branco C, 2014, GYNECOL ENDOCRINOL, V30, P16, DOI 10.3109/09513590.2013.852531
   Cheng AL, 2020, J HEPATOL, V72, P307, DOI 10.1016/j.jhep.2019.09.025
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Dalerba P, 2016, NEW ENGL J MED, V374, P211, DOI 10.1056/NEJMoa1506597
   Dang H, 2020, CELL ONCOL, V43, P931, DOI 10.1007/s13402-020-00540-6
   de Miguel M, 2020, CANCER CELL, V38, P326, DOI 10.1016/j.ccell.2020.07.004
   Duan R, 2020, J HEMATOL ONCOL, V13, DOI 10.1186/s13045-020-00937-8
   Fan T, 2011, MOL CANCER RES, V9, P418, DOI 10.1158/1541-7786.MCR-10-0511
   Ferrero E, 2004, FASEB J, V18, P554, DOI 10.1096/fj.03-0922fje
   Glantzounis GK, 2022, CANCERS, V14, DOI 10.3390/cancers14184387
   Grainger S, 2010, DEV BIOL, V339, P155, DOI 10.1016/j.ydbio.2009.12.025
   Hänzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7
   Ho HY, 2000, FREE RADICAL BIO MED, V29, P156, DOI 10.1016/S0891-5849(00)00331-2
   Hu M, 2022, FRONT GENET, V13, DOI 10.3389/fgene.2022.1005658
   Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.21492, 10.3322/caac.20107]
   Leal JFM, 2008, ONCOGENE, V27, P1961, DOI 10.1038/sj.onc.1210846
   Lee SH, 2016, BIOCHEM BIOPH RES CO, V469, P884, DOI 10.1016/j.bbrc.2015.12.070
   Lei D, 2022, J ONCOL, V2022, DOI 10.1155/2022/2659563
   Leone N, 2002, CLIN EXP MED, V2, P119, DOI 10.1007/s102380200016
   Li JW, 2022, BMC UROL, V22, DOI 10.1186/s12894-022-01106-4
   Liu YY, 2019, EXP CELL RES, V379, P19, DOI 10.1016/j.yexcr.2019.03.029
   Lohitesh K, 2018, CANCER CELL INT, V18, DOI 10.1186/s12935-018-0538-7
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Lu M, 2018, ACTA BIOCH BIOPH SIN, V50, P370, DOI 10.1093/abbs/gmy009
   Lu WJ, 2014, CARCINOGENESIS, V35, P915, DOI 10.1093/carcin/bgt401
   Miao T G, 2022, Zhonghua Gan Zang Bing Za Zhi, V30, P923, DOI 10.3760/cma.j.cn501113-20220703-00365
   Miyata T, 2022, LANGENBECK ARCH SURG, V407, P2373, DOI 10.1007/s00423-022-02513-9
   Mizukoshi E, 2019, J HEMATOL ONCOL, V12, DOI 10.1186/s13045-019-0742-5
   Nakahara Y, 2022, BRAIN SCI, V12, DOI 10.3390/brainsci12040473
   Nardella C, 2011, NAT REV CANCER, V11, P503, DOI 10.1038/nrc3057
   Okamura K, 2022, TOXICOL APPL PHARM, V454, DOI 10.1016/j.taap.2022.116231
   Prasanna PG, 2021, JNCI-J NATL CANCER I, V113, P1285, DOI 10.1093/jnci/djab064
   Prieto LI, 2019, GERONTOLOGY, V65, P505, DOI 10.1159/000500683
   Reveron-Thornton RF, 2022, HEPATOL COMMUN, V6, P1813, DOI 10.1002/hep4.1923
   Schmitt CA, 2022, NAT REV CLIN ONCOL, V19, P619, DOI 10.1038/s41571-022-00668-4
   Seregni E, 2001, ANN ONCOL, V12, pS69, DOI 10.1093/annonc/12.suppl_2.S69
   Shih CT, 2017, AGING CELL, V16, P797, DOI 10.1111/acel.12607
   Stanton RC, 2012, IUBMB LIFE, V64, P362, DOI 10.1002/iub.1017
   Tzatsos A, 2011, J BIOL CHEM, V286, P33061, DOI 10.1074/jbc.M111.257667
   Wan DD, 2022, CLIN EXP PHARMACOL P, V49, P1179, DOI 10.1111/1440-1681.13701
   Wang HH, 2022, FRONT BIOENG BIOTECH, V10, DOI 10.3389/fbioe.2022.929979
   Wang ZQ, 2021, OPEN LIFE SCI, V16, P1037, DOI 10.1515/biol-2021-0101
   Wen YL, 2022, FRONT PHARMACOL, V13, DOI 10.3389/fphar.2022.1040163
   Xiao LS, 2019, AGING-US, V11, P7123, DOI 10.18632/aging.102241
   Yoshihara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3612
   Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118
   Zeng Sulin, 2018, Cancer Transl Med, V4, P70, DOI 10.4103/ctm.ctm_22_18
   Zhang H H, 2020, Zhonghua Gan Zang Bing Za Zhi, V28, P457, DOI 10.3760/cma.j.cn501113-20200602-00288
   Zhou J, 2019, IMMUNITY, V50, P403, DOI 10.1016/j.immuni.2018.12.024
   Zhu AX, 2022, IMMUNOTHERAPY-UK, V14, P1341, DOI 10.2217/imt-2022-0089
NR 52
TC 1
Z9 1
U1 8
U2 12
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 1664-8021
J9 FRONT GENET
JI Front. Genet.
PD JAN 12
PY 2023
VL 13
AR 1099148
DI 10.3389/fgene.2022.1099148
PG 14
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 8K0OO
UT WOS:000922809900001
PM 36712870
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Tang, YQ
   Guo, CB
   Chen, CL
   Zhang, YQ
AF Tang, Yuqin
   Guo, Chengbin
   Chen, Chuanliang
   Zhang, Yongqiang
TI Characterization of cellular senescence patterns predicts the prognosis
   and therapeutic response of hepatocellular carcinoma
SO FRONTIERS IN MOLECULAR BIOSCIENCES
LA English
DT Article
DE cellular senescence; immune microenvironment; therapeutic response;
   prognosis; hepatocellular carcinoma
ID LIVER-CANCER; EXPRESSION; CHEMOTHERAPY; PROGRESSION; SIGNATURE;
   DIAGNOSIS; TARGETS; MARKERS; ALPHA
AB Background: Hepatocellular carcinoma (HCC) is a prevalent malignancy with a high mortality rate. Cellular senescence, an irreversible state of cell cycle arrest, plays a paradoxical role in cancer progression. Here, we aimed to identify Hepatocellular carcinoma subtypes by cellular senescence-related genes (CSGs) and to construct a cellular senescence-related gene subtype predictor as well as a novel prognostic scoring system, which was expected to predict clinical outcomes and therapeutic response of Hepatocellular carcinoma. Methods: RNA-seq data and clinical information of Hepatocellular carcinoma patients were derived from The Cancer Genome Atlas (TCGA) and International Cancer Genome Consortium (ICGC). The "multi-split " selection was used to screen the robust prognostic cellular senescence-related genes. Unsupervised clustering was performed to identify CSGs-related subtypes and a discriminant model was obtained through multiple statistical approaches. A CSGs-based prognostic model-CSGscore, was constructed by LASSO-Cox regression and stepwise regression. Immunophenoscore (IPS) and Tumor Immune Dysfunction and Exclusion (TIDE) were utilized to evaluate the immunotherapy response. Tumor stemness indices mRNAsi and mDNAsi were used to analyze the relationship between CSGscore and stemness. Results: 238 robust prognostic differentially expressed cellular senescence-related genes (DECSGs) were used to categorize all 336 hepatocellular carcinoma patients of the TCGA-LIHC cohort into two groups with different survival. Two hub genes, TOP2A and KIF11 were confirmed as key indicators and were used to form a precise and concise cellular senescence-related gene subtype predictor. Five genes (PSRC1, SOCS2, TMEM45A, CCT5, and STC2) were selected from the TCGA training dataset to construct the prognostic CSGscore signature, which could precisely predict the prognosis of hepatocellular carcinoma patients both in the training and validation datasets. Multivariate analysis verified it as an independent prognostic factor. Besides, CSGscore was also a valuable predictor of therapeutic responses in hepatocellular carcinoma. More downstream analysis revealed the signature genes were significantly associated with stemness and tumor progression. Conclusion: Two subtypes with divergent outcomes were identified by prognostic cellular senescence-related genes and based on that, a subtype indicator was established. Moreover, a prognostic CSGscore system was constructed to predict the survival outcomes and sensitivity of therapeutic responses in hepatocellular carcinoma, providing novel insight into hepatocellular carcinoma biomarkers investigation and design of tailored treatments depending on the molecular characteristics of individual patients.
C1 [Tang, Yuqin; Chen, Chuanliang] Zhengzhou Univ, Henan Prov Peoples Hosp, Clin Bioinformat Expt Ctr, Zhengzhou, Peoples R China.
   [Guo, Chengbin] Macau Univ Sci & Technol, Fac Med, Macau, Peoples R China.
   [Zhang, Yongqiang] Guangzhou Med Univ, Guangzhou Women & Childrens Med Ctr, Guangzhou, Peoples R China.
C3 Zhengzhou University; Macau University of Science & Technology;
   Guangzhou Medical University
RP Chen, CL (corresponding author), Zhengzhou Univ, Henan Prov Peoples Hosp, Clin Bioinformat Expt Ctr, Zhengzhou, Peoples R China.; Zhang, YQ (corresponding author), Guangzhou Med Univ, Guangzhou Women & Childrens Med Ctr, Guangzhou, Peoples R China.
EM henanccl@163.com; zyq1014zyq1014@163.com
RI 张, 永强/JJC-8910-2023
OI 张, 永强/0000-0002-1033-1132
CR Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7
   Cai WY, 2020, THERANOSTICS, V10, P8633, DOI 10.7150/thno.47938
   Calcinotto A, 2017, SWISS MED WKLY, V147, DOI [10.4414/smw.2017.14367, 10.57187/smw.2017.14367]
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   Charoentong P, 2017, CELL REP, V18, P248, DOI 10.1016/j.celrep.2016.12.019
   Chen QP, 2023, CELL DEATH DIFFER, V30, P137, DOI 10.1038/s41418-022-01051-7
   Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7
   Cho H, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071517
   Colaprico A, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1507
   Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a
   Couri T, 2019, HEPATOL INT, V13, P125, DOI 10.1007/s12072-018-9919-1
   Dang W, 2021, INT J BIOL SCI, V17, P514, DOI 10.7150/ijbs.54074
   Dasika GK, 1999, ONCOGENE, V18, P7883, DOI 10.1038/sj.onc.1203283
   Ewald JA, 2010, JNCI-J NATL CANCER I, V102, P1536, DOI 10.1093/jnci/djq364
   Fan ST, 2012, NAT REV GASTRO HEPAT, V9, P732, DOI 10.1038/nrgastro.2012.158
   Fei PW, 2003, ONCOGENE, V22, P5774, DOI 10.1038/sj.onc.1206677
   Flamant L, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-391
   Fonseca AL, 2014, J SURG ONCOL, V110, P712, DOI 10.1002/jso.23673
   Forner A, 2010, SEMIN LIVER DIS, V30, P61, DOI 10.1055/s-0030-1247133
   Geeleher P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107468
   Gertler R, 2004, J CLIN ONCOL, V22, P1807, DOI 10.1200/JCO.2004.09.160
   Gewirtz DA, 2008, BIOCHEM PHARMACOL, V76, P947, DOI 10.1016/j.bcp.2008.06.024
   Guo CB, 2022, FRONT IMMUNOL, V13, DOI 10.3389/fimmu.2022.958161
   Guo CB, 2021, FRONT MOL BIOSCI, V8, DOI 10.3389/fmolb.2021.645388
   Hänzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7
   Huang A, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00264-x
   Huang LF, 2022, STEM CELL RES THER, V13, DOI 10.1186/s13287-022-02988-9
   Huang YH, 2021, CELL BIOSCI, V11, DOI 10.1186/s13578-021-00683-5
   Jackson JG, 2012, CANCER CELL, V21, P793, DOI 10.1016/j.ccr.2012.04.027
   Jiang P, 2018, NAT MED, V24, P1550, DOI 10.1038/s41591-018-0136-1
   Jungwirth G, 2021, CANCER LETT, V506, P1, DOI 10.1016/j.canlet.2021.02.016
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Kent LN, 2019, NAT REV CANCER, V19, P326, DOI 10.1038/s41568-019-0143-7
   Kita Y, 2011, ANN SURG ONCOL, V18, P261, DOI 10.1245/s10434-010-1271-1
   Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610
   Lambrechts D, 2018, NAT MED, V24, P1277, DOI 10.1038/s41591-018-0096-5
   Lee RC, 2019, EXPERT REV ANTICANC, V19, P343, DOI 10.1080/14737140.2019.1585245
   Lee TKW, 2013, CANCER LETT, V338, P101, DOI 10.1016/j.canlet.2012.05.001
   Li Y, 2022, BRIT J CANCER, V126, P1684, DOI 10.1038/s41416-022-01747-0
   Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004
   Liu JH, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.739660
   Liu J, 2021, CELL RES, V31, P80, DOI 10.1038/s41422-020-0372-z
   Liu T, 2019, MOL ONCOL, V13, P1047, DOI 10.1002/1878-0261.12457
   Liu YN, 2019, INT J CANCER, V145, P1609, DOI 10.1002/ijc.32487
   Lujambio A, 2013, CELL, V153, P449, DOI 10.1016/j.cell.2013.03.020
   Luo HY, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aax7533
   Malta TM, 2018, CELL, V173, P338, DOI 10.1016/j.cell.2018.03.034
   Mangé A, 2012, CLIN CANCER RES, V18, P1992, DOI 10.1158/1078-0432.CCR-11-2527
   Meng YL, 2021, BIOCHEM BIOPH RES CO, V567, P222, DOI 10.1016/j.bbrc.2021.04.105
   Meroni M, 2021, CANCERS, V13, DOI 10.3390/cancers13081783
   Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/NMETH.3337, 10.1038/nmeth.3337]
   Ohtani Naoko, 2014, Nihon Rinsho Meneki Gakkai Kaishi, V37, P390, DOI 10.2177/jsci.37.390
   Ou HL, 2021, MOL ONCOL, V15, P2634, DOI 10.1002/1878-0261.12807
   Pérez-Mancera PA, 2014, NAT REV CANCER, V14, P547, DOI 10.1038/nrc3773
   Petrick JL, 2020, INT J CANCER, V147, P317, DOI 10.1002/ijc.32723
   Petrova NV, 2016, AGING CELL, V15, P999, DOI 10.1111/acel.12518
   Qie S, 2022, J EXP CLIN CANC RES, V41, DOI 10.1186/s13046-022-02370-w
   Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007
   Ruhland MK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11762
   Sangro B, 2013, J HEPATOL, V59, P81, DOI 10.1016/j.jhep.2013.02.022
   Seidel JA, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00086
   Takei Y, 2012, BONE, V50, P998, DOI 10.1016/j.bone.2012.01.006
   Tang YQ, 2022, FRONT IMMUNOL, V13, DOI 10.3389/fimmu.2022.862527
   Tang YQ, 2020, BIOMED RES INT-UK, V2020, DOI 10.1155/2020/4251761
   Wang XM, 2022, BRIEF BIOINFORM, V23, DOI 10.1093/bib/bbac118
   Wang ZH, 2021, BRIEF BIOINFORM, V22, DOI 10.1093/bib/bbab032
   Wei JM, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.648279
   Wiley CD, 2021, NAT METAB, V3, P1290, DOI 10.1038/s42255-021-00483-8
   Wilkerson MD, 2010, BIOINFORMATICS, V26, P1572, DOI 10.1093/bioinformatics/btq170
   Wrzesinski T, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1530-4
   Xu RH, 2017, NAT MATER, V16, P1155, DOI [10.1038/nmat4997, 10.1038/NMAT4997]
   Yang JD, 2019, NAT REV GASTRO HEPAT, V16, P589, DOI 10.1038/s41575-019-0186-y
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
   Zhang YQ, 2023, GENES DIS, V10, P1657, DOI 10.1016/j.gendis.2022.07.005
   Zhang YQ, 2021, AGING-US, V13, P12865, DOI 10.18632/aging.202957
   Zhao H, 2008, CLIN NEUROPATHOL, V27, P83
NR 76
TC 3
Z9 3
U1 0
U2 4
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 2296-889X
J9 FRONT MOL BIOSCI
JI Front. Mol. Biosci.
PD DEC 16
PY 2022
VL 9
AR 1100285
DI 10.3389/fmolb.2022.1100285
PG 19
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 7L4RM
UT WOS:000905955000001
PM 36589233
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Li, RC
   Liu, YL
   Xie, J
   Huang, XD
   Zhang, L
   Liu, H
   Li, LH
AF Li, Ruichan
   Liu, Yanli
   Xie, Jing
   Huang, Xudong
   Zhang, Li
   Liu, Hua
   Li, Lihua
TI Sirt3 mediates the protective effect of hydrogen in inhibiting
   ROS-induced retinal senescence
SO FREE RADICAL BIOLOGY AND MEDICINE
LA English
DT Article
DE Hydrogen; Sirt3; Retinal oxidative stress injury; Senescence; DNA repair
ID OXIDATIVE STRESS; RICH WATER; MOLECULAR-HYDROGEN; GROWTH ARREST; DNA
   DAMAGE; MITOCHONDRIAL; DEGENERATION; ANTIOXIDANT; LIVER; MECHANISMS
AB Hydrogen possesses antioxidative effects and cures numerous types of ophthalmopathy, but the mechanism of hydrogen on ROS-induced retinal senescence remains elusive. In this study, retinal morphology revealed that hydrogen reduced the number and size of vitreous black deposits in Bruch's membrane in NaIO3 mice. Hydrogen also reduced ROS levels in the retina as assessed by DHE staining. Moreover, this result was consistent with the downregulation of expression of the oxidative stress hallmark OGG1. These findings suggested that hydrogen can reduce retinal oxidative stress induced by NaIO3, and this result was further verified using the antioxidant ALCAR. Mechanistic analysis revealed that hydrogen significantly inhibited the downregulation of Sirt3 expression, and this notion was confirmed using AICAR, which restores Sirt3 expression and activity. Moreover, hydrogen reduced the expression of p53, p21 and p16 and the number of blue-green precipitations in the retinas of NaIO3 mice as assessed by SA-beta-gal staining. We also found that hydrogen decreased the expression of the DNA damage-related protein ATM, cyclinD1 and NF-kappa B but increased the expression of the DNA repair-related protein HMGB1, suggesting that hydrogen inhibits senescence in retinas of NaIO3 mice. Additionally, OCT examination revealed that hydrogen suppressed retinal high reflex formation significantly and prevented the retina from thinning. This result was supported by ERG assays that demonstrated that hydrogen prevented the reduction in a- and b-wave amplitude induced by NaIO3 in mice. Thus, our data suggest that hydrogen may inhibit retinal senescence by suppressing the downregulation of Sirt3 expression through reduced oxidative stress reactions.
C1 [Li, Ruichan; Liu, Yanli; Xie, Jing; Li, Lihua] Taizhou Univ, Dept Cell Biol, Taizhou, Peoples R China.
   [Huang, Xudong] Chengdu Normal Univ, Chem & Life Coll, Chengdu, Sichuan, Peoples R China.
   [Zhang, Li] Jinzhoushi Oral Cav Hosp, Jinzhou, Peoples R China.
   [Liu, Hua] Jinzhou Med Univ, Dept Cell Biol, Jinzhou, Peoples R China.
C3 Taizhou University; Chengdu Normal University; Jinzhou Medical
   University
RP Li, LH (corresponding author), 1139 Shifu Rd, Taizhou 375000, Peoples R China.
EM 305610378@qq.com; Ly11217117453@163.com; 347584368@qq.com;
   huangxudong939@163.com; 2533032555@qq.com; liuhua51789@163.com;
   lilihua1018@sina.com
FU Natural Science Foundation of Liaoning Province [201602292]; Liaoning
   BaiQianWan Talents Program [2017101]
FX This study was supported by the Natural Science Foundation of Liaoning
   Province [No. 201602292] and Liaoning BaiQianWan Talents Program [No.
   2017101].
CR Ambati J, 2012, NEURON, V75, P26, DOI 10.1016/j.neuron.2012.06.018
   Ashok BT, 1999, EXP GERONTOL, V34, P293, DOI 10.1016/S0531-5565(99)00005-4
   Ban N, 2017, NPJ AGING MECH DIS, V3, DOI 10.1038/s41514-017-0017-8
   Bause AS, 2013, EXP GERONTOL, V48, P634, DOI 10.1016/j.exger.2012.08.007
   Blasiak J, 2013, INT J MOL SCI, V14, P2996, DOI 10.3390/ijms14022996
   Cabrera AP, 2016, INVEST OPHTH VIS SCI, V57, P5910, DOI 10.1167/iovs.16-19727
   Chen CJ, 2013, BIOCHEM BIOPH RES CO, V430, P798, DOI 10.1016/j.bbrc.2012.11.066
   Cheng X, 2018, BIOMED PHARMACOTHER, V103, P490, DOI 10.1016/j.biopha.2018.04.074
   Cheung KG, 2015, J BIOL CHEM, V290, P10981, DOI 10.1074/jbc.M114.607960
   Chowers G, 2017, INVEST OPHTH VIS SCI, V58, P2239, DOI 10.1167/iovs.16-21255
   Curcio CA, 2009, PROG RETIN EYE RES, V28, P393, DOI 10.1016/j.preteyeres.2009.08.001
   De Jong PTVM, 2018, EYE, V32, P904, DOI 10.1038/eye.2017.298
   Ding L, 2017, MOL MED REP, V16, P9521, DOI 10.3892/mmr.2017.7789
   Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564
   Gharib B, 2001, CR ACAD SCI III-VIE, V324, P719, DOI 10.1016/S0764-4469(01)01350-6
   Hu QD, 2018, ONCOTARGET, V9, P4223, DOI 10.18632/oncotarget.23786
   Ito H, 2015, EMBO MOL MED, V7, P78, DOI 10.15252/emmm.201404392
   Jonak K, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-016-0293-0
   Kang HT, 2017, NAT CHEM BIOL, V13, P616, DOI 10.1038/nchembio.2342
   Kannan R, 2014, NEURAL REGEN RES, V9, P2044, DOI 10.4103/1673-5374.147927
   Lin CP, 2017, WORLD J GASTROENTERO, V23, P4920, DOI 10.3748/wjg.v23.i27.4920
   Lin JB, 2018, EBIOMEDICINE, V32, P9, DOI 10.1016/j.ebiom.2018.05.035
   Liu JX, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.564
   Liu Q, 2016, MOL MED REP, V13, P3588, DOI 10.3892/mmr.2016.4954
   McDonnell E, 2015, TRENDS ENDOCRIN MET, V26, P486, DOI 10.1016/j.tem.2015.06.001
   Morigi M, 2015, J CLIN INVEST, V125, P715, DOI 10.1172/JCI77632
   Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577
   Ohta S, 2015, METHOD ENZYMOL, V555, P289, DOI 10.1016/bs.mie.2014.11.038
   Ota H, 2006, ONCOGENE, V25, P176, DOI 10.1038/sj.onc.1209049
   Qi LS, 2015, INVEST OPHTH VIS SCI, V56, P8268, DOI 10.1167/iovs.15-17034
   Sadowska-Bartosz I, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/404680
   Shaw PX, 2016, AIMS MOL SCI, V3, P196, DOI 10.3934/molsci.2016.2.196
   Shi Q, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/685043
   Smith JR, 1996, SCIENCE, V273, P63, DOI 10.1126/science.273.5271.63
   Stros M, 2018, BBA-GENE REGUL MECH, V1861, P200, DOI 10.1016/j.bbagrm.2018.02.002
   Strzeszewska A, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0069-5
   Sun W, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/7293861
   Tao Y, 2016, THER CLIN RISK MANAG, V12, P799, DOI 10.2147/TCRM.S102518
   Tomofuji T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05534
   Valentijn FA, 2018, J CELL COMMUN SIGNAL, V12, P69, DOI 10.1007/s12079-017-0434-2
   Wang Wei, 2017, J Cancer Metastasis Treat, V3, P45, DOI 10.20517/2394-4722.2017.03
   Wong T, 2008, OPHTHALMOLOGY, V115, P116, DOI 10.1016/j.ophtha.2007.03.008
   Xing SS, 2018, MECH AGEING DEV, V175, P1, DOI 10.1016/j.mad.2017.12.005
   Yang QX, 2017, MOL CLIN ONCOL, V7, P891, DOI 10.3892/mco.2017.1409
   Yang WX, 2015, NEUROCHEM RES, V40, P1576, DOI 10.1007/s11064-015-1630-1
   Yuan J, 2018, J SURG RES, V228, P238, DOI 10.1016/j.jss.2018.03.024
   Yue Le, 2015, Zhonghua Yi Xue Za Zhi, V95, P1483
   Zhang JY, 2012, HEPATO-GASTROENTEROL, V59, P1026, DOI 10.5754/hge11883
   Zhang JL, 2015, INT J MOL SCI, V16, P1644, DOI 10.3390/ijms16011644
   Zhang K, 2012, NAT REV DRUG DISCOV, V11, P541, DOI 10.1038/nrd3745
   Zhou X, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.530
   2016, CELL METAB, V23, P128, DOI DOI 10.1016/J.CMET.2015.10.013
   2010, CANCER RES, V70, P8802, DOI DOI 10.1158/0008-5472.CAN-10-0312
   2010, FREE RADIC BIOL MED, V49, P1230, DOI DOI 10.1016/J.FREERADBIOMED.2010.07.009
   2010, CELL, V143, P802, DOI DOI 10.1016/J.CELL.2010.10.002
   2013, CELL STEM CELL, V12, P152, DOI DOI 10.1016/J.STEM.2013.01.001
   2014, INVEST OPHTH VIS SCI, V55, P1941, DOI DOI 10.1167/IOVS.13-13075
   2009, CANCER RES, V69, P4974, DOI DOI 10.1158/0008-5472.CAN-08-4671
   2008, NEUROSCI LETT, V441, P167, DOI DOI 10.1016/J.NEULET.2008.05.077
NR 59
TC 24
Z9 27
U1 2
U2 26
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0891-5849
EI 1873-4596
J9 FREE RADICAL BIO MED
JI Free Radic. Biol. Med.
PD MAY 1
PY 2019
VL 135
BP 116
EP 124
DI 10.1016/j.freeradbiomed.2019.02.005
PG 9
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA HV3ZS
UT WOS:000465927200012
PM 30735837
DA 2024-02-19
ER

PT J
AU Zhu, SY
   Jiang, N
   Tu, J
   Yang, J
   Zhou, Y
AF Zhu Shu Yun
   Jiang Ning
   Tu Jie
   Yang Jing
   Zhou Yue
TI Antioxidant and Anti-aging Activities of &ITSilybum Marianum&IT Protein
   Hydrolysate in Mice Treated with D-galactose
SO BIOMEDICAL AND ENVIRONMENTAL SCIENCES
LA English
DT Article
DE Silybum marianum protein hydrolysate; Antioxidant; Anti-aging;
   D-galactose
ID MITOCHONDRIA-TARGETED ANTIOXIDANTS; OXIDATIVE STRESS;
   LIPID-PEROXIDATION; MEDICINAL-PLANTS; MEMORY LOSS; DAMAGE; DYSFUNCTION;
   DISEASE; BRAIN; DEGENERATION
AB Objective In the present study, we investigated the antioxidant and anti-aging effects of Silybum marianum protein hydrolysate (SMPH) in D-galactose-treated mice.& para;& para;Methods D-galactose (500 mg/kg body weight) was intraperitoneally injected daily for 7 weeks to accelerate aging, and SMPH (400, 800, 1,200 mg/kg body weight, respectively) was simultaneously administered orally. The antioxidant and anti-aging effects of SMPH in the liver and brain were measured by biochemical assays. Transmission electron microscopy (TEM) was performed to study the ultrastructure of liver mitochondria.& para;& para;Results SMPH decreased triglyceride and cholesterol levels in the D-galactose-treated mice. It significantly elevated the activities of superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px), and total antioxidant capacity (T-AOC), which were suppressed by D-galactose. Monoamine oxidase (MAO) and malondialdehyde (MDA) levels as well as the concentrations of caspase-3 and 8-OHdG in the liver and brain were significantly reduced by SMPH. Moreover, it increased Bcl-2 levels in the liver and brain. Furthermore, SMPH significantly attenuated D-galactose-induced liver mitochondrial dysfunction by improving the activities of Na+-K+-ATPase and Ca2+-Mg2+-ATPase as well as mitochondrial membrane potential (AWm) and fluidity. TEM showed that the degree of liver mitochondrial damage was significantly decreased by SMPH.& para;& para;Conclusion The results indicated that SMPH protects against D-galactose-induced accelerated aging in mice through its antioxidant and anti-aging activities.
C1 [Zhu Shu Yun; Yang Jing; Zhou Yue] Jiangsu Univ, Sch Food & Biol Engn, Zhenjiang 212013, Jiangsu, Peoples R China.
   [Zhu Shu Yun] Jiangsu Hengshun Grp Co Ltd, Zhenjiang 212000, Jiangsu, Peoples R China.
   [Jiang Ning] Jiangsu Acad Agr Sci, Inst Vegetables, Nanjing 210014, Jiangsu, Peoples R China.
   [Tu Jie] Jiangsu Univ Sci & Technol, Coll Biotechnol, Zhenjiang 212018, Jiangsu, Peoples R China.
C3 Jiangsu University; Jiangsu Academy of Agricultural Sciences; Jiangsu
   University of Science & Technology
RP Zhu, SY (corresponding author), Jiangsu Univ, Sch Food & Biol Engn, Zhenjiang 212013, Jiangsu, Peoples R China.; Zhu, SY (corresponding author), Jiangsu Hengshun Grp Co Ltd, Zhenjiang 212000, Jiangsu, Peoples R China.
EM shyzhu@ujs.edu.cn
FU University natural science foundation of Jiangsu Province [16KJB550001];
   Postdoctoral research funding project of Jiangsu Province [1601058A];
   key research and development plan of Zhenjiang city [NY2016020]
FX This study was supported by University natural science foundation of
   Jiangsu Province (16KJB550001); Postdoctoral research funding project of
   Jiangsu Province (1601058A); and key research and development plan of
   Zhenjiang city (NY2016020). ZHU Shu Yun and JIANG Ning contributed
   equally to this work and should be considered co-first authors.
CR Abenavoli L, 2010, PHYTOTHER RES, V24, P1423, DOI 10.1002/ptr.3207
   Abuja PM, 2001, CLIN CHIM ACTA, V306, P1, DOI 10.1016/S0009-8981(01)00393-X
   Acharya MM, 2005, EXP NEUROL, V192, P79, DOI 10.1016/j.expneurol.2004.11.004
   Anand KV, 2012, GERIATR GERONTOL INT, V12, P741, DOI 10.1111/j.1447-0594.2012.00843.x
   Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   Bhat AH, 2015, BIOMED PHARMACOTHER, V74, P101, DOI 10.1016/j.biopha.2015.07.025
   Cui X, 2004, BIOGERONTOLOGY, V5, P317, DOI 10.1007/s10522-004-2570-3
   Cui X, 2006, J NEUROSCI RES, V84, P647, DOI 10.1002/jnr.20899
   Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1
   García-Sáez AJ, 2012, CELL DEATH DIFFER, V19, P1733, DOI 10.1038/cdd.2012.105
   Golden TR, 2001, MECH AGEING DEV, V122, P1577, DOI 10.1016/S0047-6374(01)00288-3
   Harman D, 2003, ANTIOXID REDOX SIGN, V5, P557, DOI 10.1089/152308603770310202
   Ho SC, 2003, BIOGERONTOLOGY, V4, P15, DOI 10.1023/A:1022417102206
   Jomova K, 2010, MOL CELL BIOCHEM, V345, P91, DOI 10.1007/s11010-010-0563-x
   Judge S, 2007, AM J PHYSIOL-CELL PH, V292, pC1983, DOI 10.1152/ajpcell.00285.2006
   Khan MZ, 2016, BIOMED PHARMACOTHER, V84, P387, DOI 10.1016/j.biopha.2016.09.055
   Kumar A, 2010, FOOD CHEM TOXICOL, V48, P626, DOI 10.1016/j.fct.2009.11.043
   Kumar A, 2009, N-S ARCH PHARMACOL, V380, P431, DOI 10.1007/s00210-009-0442-8
   Li JX, 1999, EUR J APPL PHYSIOL, V80, P113, DOI 10.1007/s004210050566
   Loguercio C, 2011, WORLD J GASTROENTERO, V17, P2288, DOI 10.3748/wjg.v17.i18.2288
   Lu J, 2006, BEHAV BRAIN RES, V171, P251, DOI 10.1016/j.bbr.2006.03.043
   Leo EEM, 2016, BIOMED PHARMACOTHER, V83, P816, DOI 10.1016/j.biopha.2016.07.051
   Nasri H, 2014, IRAN J PUBLIC HEALTH, V43, P255
   Navarro A, 2008, ADV DRUG DELIVER REV, V60, P1534, DOI 10.1016/j.addr.2008.05.002
   Oyewole AO, 2015, FASEB J, V29, P4766, DOI 10.1096/fj.15-275404
   Paradies G, 2011, NEUROCHEM INT, V58, P447, DOI 10.1016/j.neuint.2010.12.016
   Rafieian-Kopaei M, 2013, J RES MED SCI, V18, P628
   Ren Y, 2011, J AGR FOOD CHEM, V59, P206, DOI 10.1021/jf103938e
   Schon EA, 2003, J CLIN INVEST, V111, P303, DOI 10.1172/JCI200317741
   Shayganni E, 2016, PHYTOMEDICINE, V23, P1119, DOI 10.1016/j.phymed.2015.11.004
   Shen YX, 2002, J PINEAL RES, V32, P173, DOI 10.1034/j.1600-079x.2002.1o850.x
   Su GW, 2016, FOOD RES INT, V82, P112, DOI 10.1016/j.foodres.2016.01.022
   Szeto HH, 2006, AAPS J, V8, pE521, DOI 10.1208/aapsj080362
   Tang YH, 2012, FOOD CHEM TOXICOL, V50, P1194, DOI 10.1016/j.fct.2012.02.008
   Tian Y, 2011, FOOD CHEM TOXICOL, V49, P1728, DOI 10.1016/j.fct.2011.04.018
   Torres-Fuentes C, 2015, FOOD CHEM, V180, P194, DOI 10.1016/j.foodchem.2015.02.046
   Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001
   Xu DF, 2007, FOOD RES DEV, V28, P157
   Xu MY, 2017, FOOD CHEM TOXICOL, V103, P246, DOI 10.1016/j.fct.2017.03.013
   Zhang XL, 2008, FOOD CHEM TOXICOL, V46, P2888, DOI 10.1016/j.fct.2008.05.032
   Zhou XM, 2006, BIOL PHARM BULL, V29, P2502, DOI 10.1248/bpb.29.2502
   Zhu SY, 2014, PHARMACOGN MAG, V10, pS92, DOI 10.4103/0973-1296.127353
   [朱淑云 Zhu Shuyun], 2015, [中国粮油学报, Journal of the Chinese Cereals and Oils Association], V30, P97
   Zhu SY, 2013, J FOOD AGRIC ENVIRON, V11, P136
   [朱淑云 Zhu Shuyun], 2011, [中国粮油学报, Journal of the Chinese Cereals and Oils Association], V26, P71
   [朱淑云 ZHU Shuyun], 2011, [食品工业科技, Science & Technology of Food Industry], V32, P256
   [朱淑云 Zhu Shuyun], 2011, [中国粮油学报, Journal of the Chinese Cereals and Oils Association], V26, P68
NR 47
TC 16
Z9 19
U1 6
U2 40
PU CHINESE CENTER DISEASE CONTROL & PREVENTION
PI BEIJING
PA 155 CHANGBAI RD, CHANGPING DISTRICT, BEIJING, 102206, PEOPLES R CHINA
SN 0895-3988
J9 BIOMED ENVIRON SCI
JI Biomed. Environ. Sci.
PD SEP
PY 2017
VL 30
IS 9
BP 623
EP 631
DI 10.3967/bes2017.083
PG 9
WC Environmental Sciences; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA FN1KT
UT WOS:000415748000001
PM 29081336
DA 2024-02-19
ER

PT J
AU Müller, K
   Honcharova-Biletska, H
   Koppe, C
   Egger, M
   Chan, LK
   Schneider, AT
   Küsgens, L
   Böhm, F
   Boege, Y
   Healy, ME
   Schmitt, J
   Comtesse, S
   Castoldi, M
   Preisinger, C
   Szydlowska, M
   Focaccia, E
   Gaisa, NT
   Loosen, SH
   Jörs, S
   Tacke, F
   Roderburg, C
   Keitel, V
   Bode, JG
   Boor, P
   Davis, RJ
   Longerich, T
   Geisler, F
   Heikenwalder, M
   Weber, A
   Vucur, M
   Luedde, T
AF Mueller, Katrin
   Honcharova-Biletska, Hanna
   Koppe, Christiane
   Egger, Michele
   Chan, Lap Kwan
   Schneider, Anne T.
   Kuesgens, Lena
   Boehm, Friederike
   Boege, Yannick
   Healy, Marc E.
   Schmitt, Johannes
   Comtesse, Sarah
   Castoldi, Mirco
   Preisinger, Christian
   Szydlowska, Marta
   Focaccia, Enrico
   Gaisa, Nadine T.
   Loosen, Sven H.
   Joers, Simone
   Tacke, Frank
   Roderburg, Christoph
   Keitel, Verena
   Bode, Johannes G.
   Boor, Peter
   Davis, Roger J.
   Longerich, Thomas
   Geisler, Fabian
   Heikenwalder, Mathias
   Weber, Achim
   Vucur, Mihael
   Luedde, Tom
TI JNK signaling prevents biliary cyst formation through a
   CASPASE-8-dependent function of RIPK1 during aging
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE cholangiocytes; liver cysts; liver; programmed cell death; MK2
AB The c-Jun N-terminal kinase (JNK) signaling pathway mediates adaptation to stress signals and has been associated with cell death, cell proliferation, and malignant transformation in the liver. However, up to now, its function was experimentally studied mainly in young mice. By generating mice with combined conditional ablation of Jnk1 and Jnk2 in liver parenchymal cells (LPCs) (JNK1/2(LPC-KO) mice; KO, knockout), we unraveled a function of the JNK pathway in the regulation of liver homeostasis during aging. Aging JNK1/2(LPC-KO) mice spontaneously developed large biliary cysts that originated from the biliary cell compartment. Mechanistically, we could showthat cyst formation in livers of JNK1/2(LPC-KO) mice was dependent on receptor-interacting protein kinase 1 (RIPK1), a known regulator of cell survival, apoptosis, and necroptosis. In line with this, we showed that RIPK1 was overexpressed in the human cyst epithelium of a subset of patients with polycystic liver disease. Collectively, these data reveal a functional interaction between JNK signaling and RIPK1 in age-related progressive cyst development. Thus, they provide a functional linkage between stress adaptation and programmed cell death (PCD) in the maintenance of liver homeostasis during aging.
C1 [Mueller, Katrin; Koppe, Christiane; Schneider, Anne T.; Kuesgens, Lena; Castoldi, Mirco] Univ Hosp Rhein Westfalische TH RWTH Aachen, Div Biliary & Gastrointestinal Oncol, D-52074 Aachen, Germany.
   [Honcharova-Biletska, Hanna; Egger, Michele; Chan, Lap Kwan; Boehm, Friederike; Boege, Yannick; Healy, Marc E.; Schmitt, Johannes; Comtesse, Sarah; Weber, Achim] Univ Zurich, Dept Pathol & Mol Pathol, CH-8091 Zurich, Switzerland.
   [Honcharova-Biletska, Hanna; Egger, Michele; Chan, Lap Kwan; Boehm, Friederike; Boege, Yannick; Healy, Marc E.; Schmitt, Johannes; Comtesse, Sarah; Weber, Achim] Univ Hosp Zurich, CH-8091 Zurich, Switzerland.
   [Castoldi, Mirco; Loosen, Sven H.; Keitel, Verena; Bode, Johannes G.; Vucur, Mihael; Luedde, Tom] Heinrich Heine Univ, Univ Hosp Duesseldorf, Med Fac, Dept Gastroenterol Hepatol & Infect Dis, D-40225 Dusseldorf, Germany.
   [Preisinger, Christian] Univ Hosp RWTH Aachen, Interdisciplinary Ctr Clin Res, Prote Core Facil, D-52074 Aachen, Germany.
   [Szydlowska, Marta; Focaccia, Enrico; Heikenwalder, Mathias] German Canc Res Ctr, Div Chron Inflammat & Canc, D-69120 Heidelberg, Germany.
   [Gaisa, Nadine T.; Boor, Peter] Univ Hosp RWTH Aachen, Inst Pathol, D-52074 Aachen, Germany.
   [Joers, Simone; Geisler, Fabian] Tech Univ Munich, Klinikum Rechts Isar, Internal Med 2, D-81675 Munich, Germany.
   [Tacke, Frank; Roderburg, Christoph] Charite Univ Med Ctr Berlin, Dept Hepatol & Gastroenterol, D-10117 Berlin, Germany.
   [Boor, Peter] Univ Hosp RWTH Aachen, Dept Nephrol & Immunol, D-52074 Aachen, Germany.
   [Davis, Roger J.] Univ Massachusetts, Program Mol Med, Med Sch, Worcester, MA 01605 USA.
   [Longerich, Thomas] Univ Hosp Heidelberg, Inst Pathol, D-69120 Heidelberg, Germany.
   [Weber, Achim] Univ Zurich, Inst Mol Canc Res, CH-8057 Zurich, Switzerland.
C3 University of Zurich; University of Zurich; University Zurich Hospital;
   Heinrich Heine University Dusseldorf; RWTH Aachen University; RWTH
   Aachen University Hospital; Helmholtz Association; German Cancer
   Research Center (DKFZ); RWTH Aachen University; RWTH Aachen University
   Hospital; Technical University of Munich; Free University of Berlin;
   Humboldt University of Berlin; Charite Universitatsmedizin Berlin; RWTH
   Aachen University; RWTH Aachen University Hospital; University of
   Massachusetts System; University of Massachusetts Worcester; Ruprecht
   Karls University Heidelberg; University of Zurich
RP Weber, A (corresponding author), Univ Zurich, Dept Pathol & Mol Pathol, CH-8091 Zurich, Switzerland.; Weber, A (corresponding author), Univ Hosp Zurich, CH-8091 Zurich, Switzerland.; Luedde, T (corresponding author), Heinrich Heine Univ, Univ Hosp Duesseldorf, Med Fac, Dept Gastroenterol Hepatol & Infect Dis, D-40225 Dusseldorf, Germany.; Weber, A (corresponding author), Univ Zurich, Inst Mol Canc Res, CH-8057 Zurich, Switzerland.
EM achim.weber@usz.ch; luedde@hhu.de
RI Luedde, Tom/AAE-9135-2022; Roderburg, Christoph/AAR-3051-2021; Loosen,
   Sven/AHC-5236-2022; Roderburg, Christoph/AHC-8101-2022; Tacke,
   Frank/ABF-2212-2020
OI Luedde, Tom/0000-0002-6288-8821; Loosen, Sven/0000-0002-2799-2287;
   Roderburg, Christoph/0000-0002-1409-7697; Vucur,
   Mihael/0000-0003-4078-1668; Keitel, Verena/0000-0003-1383-7662;
   Szydlowska, Marta/0000-0002-4660-899X; Castoldi,
   Mirco/0000-0003-2484-936X; Honcharova-Biletska,
   Hanna/0000-0002-9032-5137; Chan, Lap Kwan/0000-0002-9165-6982; Davis,
   Roger/0000-0002-0130-1652; Healy, Marc/0000-0001-9441-1166
FU European Research Council (ERC) under the European Union's Horizon 2020
   research and innovation program through the ERC Consolidator Grant
   PhaseControl [771083]; German Cancer Aid (Deutsche Krebshilfe) [110043];
   German Research Foundation [SFBTRR57/P06, LU 1360/3-1, LU 1360/3-2,
   SFB-CRC 1382]; medical faculty of the Heinrich Heine University;
   Interdisciplinary Centre for Clinical Research within the Faculty of
   Medicine at RWTH Aachen University (IZKF Aachen) [O3-8]; Krebsliga
   Schweiz (Oncosuisse); Swiss National Foundation [320030_182764];
   Excellence of Sciences grant (Flanders, Belgium); ERC consolidator grant
   (HepatoMetaboPath) [SFBTR 209]; Deutsches Krebsforschungszentrum;
   Ministry of Science and Technology cooperation program; NIH [DK107220];
   German Research Foundation (DFG) [SFB-TRR57, SFB-TRR219, BO3755/3-1,
   BO3755/6-1]; German Ministry of Education and Research (BMBF)
   [STOP-FSGS-01GM1901A]; Deutsche Forschungsgemeinschaft [LO 1674/4-1,
   SFB-TRR209, GE 2289/1-2, GE 2289/3-1]; German Cancer Aid (Mildred Scheel
   Professorship); Swiss National Science Foundation (SNF) [320030_182764]
   Funding Source: Swiss National Science Foundation (SNF)
FX We express our gratitude to the following scientists for kindly
   providing mouse models: W. Alexander and the Walter and Eliza Hall
   Institute of Medical Research (WEHI) (Melbourne, Australia) for MLKLFL
   and R. Hakem (Toronto, Canada) for Caspase-8FL mice. We thank Larissa
   Tenten, Karina Wehr, Christina Gianussis, and Friederike Neuheuser for
   excellent technical assistance. Work in the laboratory of T. Luedde was
   funded by the European Research Council (ERC) under the European Union's
   Horizon 2020 research and innovation program through the ERC
   Consolidator Grant PhaseControl (Grant Agreement 771083). The laboratory
   of T. Luedde was further supported by German Cancer Aid (Deutsche
   Krebshilfe 110043 and a Mildred Scheel Professorship), the German
   Research Foundation (SFBTRR57/P06, LU 1360/3-1, LU 1360/3-2, and SFB-CRC
   1382), and the medical faculty of the Heinrich Heine University. M.V.
   was supported by the Interdisciplinary Centre for Clinical Research
   within the Faculty of Medicine at RWTH Aachen University (IZKF Aachen
   O3-8). The laboratory of A.W. was supported by grants from the Krebsliga
   Schweiz (Oncosuisse) and Swiss National Foundation 320030_182764. M.H.
   was supported by an Excellence of Sciences grant (Flanders, Belgium).
   The laboratory of M.H. was supported by an ERC consolidator grant
   (HepatoMetaboPath), SFBTR 209, and the Deutsches Krebsforschungszentrum
   and Ministry of Science and Technology cooperation program. R.J.D. was
   supported by NIH Grant DK107220. The laboratory of P.B. was financially
   supported by the German Research Foundation (DFG; SFB-TRR57, SFB-TRR219,
   BO3755/3-1, BO3755/6-1) and the German Ministry of Education and
   Research (BMBF; STOP-FSGS-01GM1901A). T. Longerich was supported by
   grants from the Deutsche Forschungsgemeinschaft (LO 1674/4-1, SFB-TRR209
   Project B08). F.G. was supported by the Deutsche Forschungsgemeinschaft
   (GE 2289/1-2 and GE 2289/3-1).
CR Acar S, 2017, TRANSPL P, V49, P603, DOI 10.1016/j.transproceed.2017.01.033
   Bettermann K, 2010, CANCER CELL, V17, P481, DOI 10.1016/j.ccr.2010.03.021
   Boege Y, 2017, CANCER CELL, V32, P342, DOI 10.1016/j.ccell.2017.08.010
   CAROLI J, 1958, Sem Hop, V34, P496
   CAROLI J, 1958, Sem Hop, V34, P488
   Das M, 2007, P NATL ACAD SCI USA, V104, P15759, DOI 10.1073/pnas.0707782104
   Dhanasekaran Danny N, 2017, Genes Cancer, V8, P682, DOI 10.18632/genesandcancer.155
   Dondelinger Y, 2017, NAT CELL BIOL, V19, P1237, DOI 10.1038/ncb3608
   Dondelinger Y, 2015, MOL CELL, V60, P63, DOI 10.1016/j.molcel.2015.07.032
   Falgarone G, 2009, ADV CANCER RES, V104, P139, DOI 10.1016/S0065-230X(09)04008-1
   Hama T, 2017, AM J PHYSIOL-RENAL, V313, pF1223, DOI 10.1152/ajprenal.00697.2016
   Han MS, 2013, SCIENCE, V339, P218, DOI 10.1126/science.1227568
   Heinrichsdorff J, 2008, EMBO REP, V9, P1048, DOI 10.1038/embor.2008.149
   Jacobs Ans, 2016, Curr Protoc Mouse Biol, V6, P185, DOI 10.1002/cpmo.3
   Kellendonk C, 2000, GENESIS, V26, P151, DOI 10.1002/(SICI)1526-968X(200002)26:2<151::AID-GENE17>3.0.CO;2-E
   Kim N, 2012, J CELL PHYSIOL, V227, P1157, DOI 10.1002/jcp.22836
   Kopp JL, 2011, DEVELOPMENT, V138, P653, DOI 10.1242/dev.056499
   Koppe C, 2019, CANCERS, V11, DOI 10.3390/cancers11070999
   Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8
   Lai XY, 2008, PROTEOM CLIN APPL, V2, P1140, DOI 10.1002/prca.200780140
   Li CZ, 2019, ONCOTARGETS THER, V12, P9029, DOI 10.2147/OTT.S215276
   Liccardi G, 2019, MOL CELL, V73, P413, DOI 10.1016/j.molcel.2018.11.010
   Mamone G, 2019, ABDOM RADIOL, V44, P2156, DOI 10.1007/s00261-019-01966-9
   Manieri E, 2020, P NATL ACAD SCI USA, V117, P16492, DOI 10.1073/pnas.2002672117
   Mavlikeev M, 2019, CLIN J GASTROENTEROL, V12, P106, DOI 10.1007/s12328-018-0917-6
   Menon MB, 2017, NAT CELL BIOL, V19, P1248, DOI 10.1038/ncb3614
   Murphy JM, 2013, IMMUNITY, V39, P443, DOI 10.1016/j.immuni.2013.06.018
   Omori S, 2006, J AM SOC NEPHROL, V17, P1604, DOI 10.1681/ASN.2004090800
   Perugorria MJ, 2014, NAT REV GASTRO HEPAT, V11, P750, DOI 10.1038/nrgastro.2014.155
   Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V
   Sabapathy K, 1999, MECH DEVELOP, V89, P115, DOI 10.1016/S0925-4773(99)00213-0
   Sabio G, 2014, SEMIN IMMUNOL, V26, P237, DOI 10.1016/j.smim.2014.02.009
   Salmena L, 2003, GENE DEV, V17, P883, DOI 10.1101/gad.1063703
   Schneider AT, 2017, CANCER CELL, V31, P94, DOI 10.1016/j.ccell.2016.11.009
   Schneider AT, 2016, HEPATOLOGY, V64, P306, DOI 10.1002/hep.28225
   Schwabe RF, 2018, NAT REV GASTRO HEPAT, V15, P738, DOI 10.1038/s41575-018-0065-y
   Seki E, 2012, GASTROENTEROLOGY, V143, P307, DOI 10.1053/j.gastro.2012.06.004
   van de Laarschot LFM, 2018, BBA-MOL BASIS DIS, V1864, P1491, DOI 10.1016/j.bbadis.2017.08.003
   Vernia S, 2014, CELL METAB, V20, P512, DOI 10.1016/j.cmet.2014.06.010
   Vucur M, 2017, MOL CELL ONCOL, V4, DOI 10.1080/23723556.2017.1304191
   Vucur M, 2013, CELL REP, V4, P776, DOI 10.1016/j.celrep.2013.07.035
   Wang C, 2015, ONCOTARGET, V6, P2903, DOI 10.18632/oncotarget.3093
   Yonem O, 2007, WORLD J GASTROENTERO, V13, P1934, DOI 10.3748/wjg.v13.i13.1934
   Yu WF, 2010, J BIOL CHEM, V285, P10243, DOI 10.1074/jbc.M109.070821
   Zheng WJ, 2017, ONCOTARGET, V8, P52321, DOI 10.18632/oncotarget.13674
NR 45
TC 6
Z9 7
U1 3
U2 10
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD MAR 23
PY 2021
VL 118
IS 12
AR e2007194118
DI 10.1073/pnas.2007194118
PG 11
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA RB1HY
UT WOS:000631868600005
PM 33798093
OA hybrid, Green Published
DA 2024-02-19
ER

PT J
AU GIORDANO, AT
   RASKAEMERY, P
   MONTGOMERY, MR
   VESELY, DL
AF GIORDANO, AT
   RASKAEMERY, P
   MONTGOMERY, MR
   VESELY, DL
TI INCREASED ATRIAL-NATRIURETIC-FACTOR PROHORMONE PEPTIDES WITH AGING IN
   THE HEART, BUT NOT IN LUNG, LIVER, OR INTESTINE
SO GROWTH DEVELOPMENT AND AGING
LA English
DT Article
DE AGING; ATRIAL NATRIURETIC PEPTIDES; HEART; LUNG; LIVER; INTESTINE;
   PROHORMONE
ID INCREASED CIRCULATING CONCENTRATION; WEIGHT-REDUCTION DECREASES;
   N-TERMINAL FRAGMENT; PLASMA-CONCENTRATIONS; ALDOSTERONE PRODUCTION;
   DIVING INCREASES; ANF
AB Atrial natriuretic factor (ANF) has been found to be increased in the circulation of aged rats. The present investigation was designed to determine if the N-terminal ANF prohormone peptides with blood pressure lowering properties are increased in the circulation of ''aged'' (24-26 months) versus ''adult'' (4-6 month old) Fisher 344 rats. We utilized two sensitive and specific radioimmunoassays that immunologically recognize the 98 amino acid (a.a.) N-terminus (proANF 1-98) and a.a. 31-67 (proANF 31-67, Vessel dilator) from the midportion of the N-terminus of the 126 a.a. ANF prohormone. ProANF 1-98, and proANF 31-67, as well as ANF, were found to be elevated in the circulation of aged versus adult animals with proANF 31-67 and ANF elevations being significant at p<0.05. To determine the potential source of the increased atrial natriuretic peptides in aged animals four tissue sources (liver, lung, heart, and intestine) from both adult and aged animals were examined. Hearts of aged animals contained significantly (P < 0.05; ANOVA) more proANF 1-98, proANF 31-67, and ANF than hearts of adult animals. There was no significant difference in the concentration of proANF 1-98, proANF 31-67, or ANF in the lung, liver, or intestine of the aged versus the adult animals. These results indicate that aged animals contained increased N-terminal and C-terminal ANF prohormone peptides in the circulation. The source of these increased peptides appears to be the heart.
C1 UNIV S FLORIDA HLTH SCI, COLL MED,DEPT MED, TAMPA, FL 33612 USA.
   UNIV S FLORIDA HLTH SCI, DEPT BIOPHYS, TAMPA, FL 33612 USA.
   UNIV S FLORIDA HLTH SCI, COLL MED,DEPT PHYSIOL, TAMPA, FL 33612 USA.
   JAMES A HALEY VET ADM MED CTR, MED RES SERV, TAMPA, FL 33612 USA.
   UNIV S FLORIDA HLTH SCI, COLL PUBL HLTH, TAMPA, FL 33612 USA.
C3 State University System of Florida; University of South Florida; State
   University System of Florida; University of South Florida; State
   University System of Florida; University of South Florida; US Department
   of Veterans Affairs; Veterans Health Administration (VHA); James A.
   Haley Veterans Hospital; State University System of Florida; University
   of South Florida
FU NHLBI NIH HHS [HL34793] Funding Source: Medline; NIA NIH HHS [AG07801]
   Funding Source: Medline
CR ATARASHI K, 1984, SCIENCE, V224, P992, DOI 10.1126/science.6326267
   BAEYENS DA, 1989, COMP BIOCHEM PHYS A, V94, P515, DOI 10.1016/0300-9629(89)90131-X
   BURNETT JC, 1984, AM J PHYSIOL, V247, pF863, DOI 10.1152/ajprenal.1984.247.5.F863
   DENKER PS, 1990, J STEROID BIOCHEM, V37, P617, DOI 10.1016/0960-0760(90)90410-M
   GARDNER DG, 1986, P NATL ACAD SCI USA, V83, P6697, DOI 10.1073/pnas.83.18.6697
   HALLER BGD, 1987, J HYPERTENS, V5, P551, DOI 10.1097/00004872-198710000-00007
   ITOH H, 1988, HYPERTENSION, V11, P52
   JOHANSSON B, 1987, BIOCHEM BIOPH RES CO, V148, P1087, DOI 10.1016/S0006-291X(87)80243-7
   KORYTKOWSKI MT, 1991, J GERONTOL, V46, pB107, DOI 10.1093/geronj/46.3.B107
   MARTIN DR, 1990, AM J PHYSIOL, V258, pF1401, DOI 10.1152/ajprenal.1990.258.5.F1401
   MATSUBARA H, 1989, AM HEART J, V118, P494, DOI 10.1016/0002-8703(89)90263-9
   MCMURRAY RW, 1989, METABOLISM, V38, P1231, DOI 10.1016/0026-0495(89)90164-9
   MCMURRAY RW, 1992, AM J MED SCI, V303, P2, DOI 10.1097/00000441-199201000-00003
   MELEAGROS L, 1988, BRIT HEART J, V60, P39
   MONTGOMERY MR, 1987, BIOCHIM BIOPHYS ACTA, V890, P271, DOI 10.1016/0005-2728(87)90028-4
   NGO L, 1989, AM HEART J, V117, P385, DOI 10.1016/0002-8703(89)90784-9
   OHASHI M, 1987, J CLIN ENDOCR METAB, V64, P81, DOI 10.1210/jcem-64-1-81
   PATERSON J F, 1989, Journal of Cell Biology, V109, p24A
   SUNDSFJORD JA, 1988, J CLIN ENDOCR METAB, V66, P605, DOI 10.1210/jcem-66-3-605
   VESELY DL, 1990, J CLIN ENDOCR METAB, V71, P1138, DOI 10.1210/jcem-71-5-1138
   VESELY DL, 1992, PEPTIDES, V13, P165, DOI 10.1016/0196-9781(92)90158-Y
   VESELY DL, 1989, CLIN EXP HYPERTENS A, V11, P353, DOI 10.3109/10641968909035348
   VESELY DL, 1991, COMP BIOCHEM PHYS A, V98, P67, DOI 10.1016/0300-9629(91)90579-2
   VESELY DL, 1992, ATRIAL NATRIURETIC H
   WINTERS CJ, 1989, CIRCULATION, V80, P438, DOI 10.1161/01.CIR.80.3.438
   WINTERS CJ, 1988, BIOCHEM BIOPH RES CO, V150, P231, DOI 10.1016/0006-291X(88)90510-4
   WINTERS CJ, 1988, CHRONOBIOL INT, V5, P403, DOI 10.3109/07420528809067785
   YOSHIKAWA TT, 1990, INTERNAL MED, P2426
NR 28
TC 8
Z9 8
U1 0
U2 0
PU GROWTH PUBLISHING CO INC
PI HULLS COVE
PA PO BOX 205, HULLS COVE, ME 04644-0205 USA
SN 1041-1232
J9 GROWTH DEVELOP AGING
JI Growth Dev. Aging
PD SUM
PY 1993
VL 57
IS 2
BP 111
EP 120
PG 10
WC Developmental Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Developmental Biology; Geriatrics & Gerontology
GA LC434
UT WOS:A1993LC43400005
PM 8495993
DA 2024-02-19
ER

PT J
AU Li, LL
   Peng, Z
   Hu, Q
   Xu, LJ
   Zou, X
   Huang, DM
   Yi, P
AF Li, Ling-Li
   Peng, Ze
   Hu, Qian
   Xu, Li-Jun
   Zou, Xin
   Huang, Dong-Mei
   Yi, Ping
TI Berberine retarded the growth of gastric cancer xenograft tumors by
   targeting hepatocyte nuclear factor 4α
SO WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY
LA English
DT Article
DE Berberine; Gastric cancer; Xenograft models; Hepatocyte nuclear factor 4
   alpha; WNT5a
ID MESENCHYMAL TRANSITION; DIABETES-MELLITUS; CURRENT KNOWLEDGE; WNT5A;
   FACTOR-4-ALPHA; PROLIFERATION; TRANSCRIPTION; INVOLVEMENT; INTEGRATION;
   EXPRESSION
AB BACKGROUND Gastric cancer is the third deadliest cancer in the world and ranks second in incidence and mortality of cancers in China. Despite advances in prevention, diagnosis, and therapy, the absolute number of cases is increasing every year due to aging and the growth of high-risk populations, and gastric cancer is still a leading cause of cancer-related death. Gastric cancer is a consequence of the complex interaction of microbial agents, with environmental and host factors, resulting in the dysregulation of multiple oncogenic and tumor-suppressing signaling pathways. Global efforts have been made to investigate in detail the genomic and epigenomic heterogeneity of this disease, resulting in the identification of new specific and sensitive predictive and prognostic biomarkers. Trastuzumab, a monoclonal antibody against the HER2 receptor, is approved in the first-line treatment of patients with HER2+ tumors, which accounts for 13%-23% of the gastric cancer population. Ramucirumab, a monoclonal antibody against VEGFR2, is currently recommended in patients progressing after first-line treatment. Several clinical trials have also tested novel agents for advanced gastric cancer but mostly with disappointing results, such as anti-EGFR and anti-MET monoclonal antibodies. Therefore, it is still of great significance to screen specific molecular targets for gastric cancer and drugs directed against the molecular targets. AIM To investigate the effect and mechanism of berberine against tumor growth in gastric cancer xenograft models and to explore the role of hepatocyte nuclear factor 4 alpha (HNF4 alpha)-WNT5a/beta-catenin pathways played in the antitumor effects of berberine. METHODS MGC803 and SGC7901 subcutaneous xenograft models were established. The control group was intragastrically administrated with normal saline, and the berberine group was administrated intragastrically with 100 mg/kg/d berberine. The body weight of nude mice during the experiment was measured to assess whether berberine has any adverse reaction. The volume of subcutaneous tumors during this experiment was recorded to evaluate the inhibitory effect of berberine on the growth of MGC803 and SGC7901 subcutaneous transplantation tumors. Polymerase chain reaction assays were conducted to evaluate the alteration of transcriptional expression of HNF4 alpha, WNT5a and beta-catenin in tumor tissues and liver tissues from the MGC803 and SGC7901 xenograft models. Western blotting and IHC were performed to assess the protein expression of HNF4 alpha, WNT5a and beta-catenin in tumor tissues and liver tissues from the MGC803 and SGC7901 xenograft models. RESULTS In the both MGC803 and SGC7901 xenograft tumor models, berberine significantly reduced tumor volume and weight and thus retarded the growth rate of tumors. In the SGC7901 and MGC803 subcutaneously transplanted tumor models, berberine down-regulated the expression of HNF4 alpha, WNT5a and beta-catenin in tumor tissues from both transcription and protein levels. Besides, berberine also suppressed the protein expression of HNF4 alpha, WNT5a and beta-catenin in liver tissues. CONCLUSION Berberine retarded the growth of MGC803 and SGC7901 xenograft model tumors, and the mechanism behind these anti-growth effects might be the downregulation of the expression of HNF4 alpha-WNT5a/beta-catenin signaling pathways both in tumor tissues and liver tissues of the xenograft models. (C) The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
EM pyi219@163.com
RI Li, Lingli/IST-7827-2023; xu, li/GNH-3667-2022; Li, Lingli/HIR-7951-2022
FU National Natural Science Foundation of China [81673757, 81573787]
FX Supported by the National Natural Science Foundation of China, No.
   81673757 and No. 81573787
CR Abudawood M, 2019, J RES MED SCI, V24, DOI 10.4103/jrms.JRMS_242_19
   Ara H, 2016, CANCER SCI, V107, P133, DOI 10.1111/cas.12848
   Babeu JP, 2014, WORLD J GASTROENTERO, V20, P22, DOI 10.3748/wjg.v20.i1.22
   Bang YJ, 2010, LANCET, V376, P1302
   Barbetti F, 2018, BEST PRACT RES CL EN, V32, P575, DOI 10.1016/j.beem.2018.06.008
   Camargo MC, 2019, HELICOBACTER, V24, DOI 10.1111/hel.12642
   Chandra V, 2013, NATURE, V495, P394, DOI 10.1038/nature11966
   Chang HR, 2016, GUT, V65, P19, DOI 10.1136/gutjnl-2014-307918
   Dai BL, 2019, PHYTOTHER RES, V33, P745, DOI 10.1002/ptr.6267
   Dai W, 2019, MED SCI MONITOR, V25, P730, DOI 10.12659/MSM.912082
   Jucá PCDC, 2017, DIAGN PATHOL, V12, DOI 10.1186/s13000-017-0635-2
   Endo M, 2015, INT REV CEL MOL BIO, V314, P117, DOI 10.1016/bs.ircmb.2014.10.003
   Fuchs CS, 2014, LANCET, V383, P31, DOI 10.1016/S0140-6736(13)61719-5
   Gao YH, 2019, ONCOL REP, V42, P1066, DOI 10.3892/or.2019.7214
   Geng B, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0876-2
   Gong J, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00042
   Hu Q, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01150
   Huang KW, 2020, MOL THER-NUCL ACIDS, V19, P361, DOI 10.1016/j.omtn.2019.10.044
   Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.21492, 10.3322/caac.20107]
   Jiang Shuying, 2003, Nucl Recept, V1, P5, DOI 10.1186/1478-1336-1-5
   Kikuchi A, 2012, ACTA PHYSIOL, V204, P17, DOI 10.1111/j.1748-1716.2011.02294.x
   Kim W, 2013, BIOCHEM J, V450, P9, DOI 10.1042/BJ20121284
   Kleszcz Robert, 2019, Postepy Biochem, V65, P183, DOI 10.18388/pb.2019_268
   Kojima K, 2006, PATHOLOGY, V38, P548, DOI 10.1080/00313020601024011
   Koyama T, 2011, HUM PATHOL, V42, P1777, DOI 10.1016/j.humpath.2011.04.002
   Kumar A, 2015, EUR J PHARMACOL, V761, P288, DOI 10.1016/j.ejphar.2015.05.068
   Leng SH, 2004, ACTA PHARMACOL SIN, V25, P496
   Li HL, 2016, MOL MED REP, V14, P1430, DOI 10.3892/mmr.2016.5361
   Li TG, 2010, J LIPID RES, V51, P832, DOI 10.1194/jlr.M002782
   Liu ZL, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0651-6
   Lu H, 2016, ACTA PHARM SIN B, V6, P393, DOI 10.1016/j.apsb.2016.07.003
   Nakajima N, 2018, HISTOPATHOLOGY, V73, P38, DOI 10.1111/his.13500
   Nam S, 2014, ONCOGENE, V33, P4941, DOI 10.1038/onc.2014.80
   Orsolini L, 2015, CYBERPSYCH BEH SOC N, V18, P296, DOI 10.1089/cyber.2014.0486
   Pai SG, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0471-6
   Pellino A, 2019, WORLD J GASTROENTERO, V25, P5773, DOI 10.3748/wjg.v25.i38.5773
   Ranc K, 2014, DIABETOLOGIA, V57, P927, DOI 10.1007/s00125-014-3186-z
   Serra O, 2019, CANCER TREAT REV, V77, P29, DOI 10.1016/j.ctrv.2019.05.005
   Shi J, 2019, HEMATOL ONCOL, V37, P474, DOI 10.1002/hon.2651
   Shojima K, 2015, SCI REP-UK, V5, DOI 10.1038/srep08042
   Tian YT, 2016, ASIAN J ANDROL, V18, P607, DOI 10.4103/1008-682X.169997
   Tillhon M, 2012, BIOCHEM PHARMACOL, V84, P1260, DOI 10.1016/j.bcp.2012.07.018
   Wang JX, 2016, ONCOTARGET, V7, P76076, DOI 10.18632/oncotarget.12589
   Wang N, 2015, J ETHNOPHARMACOL, V176, P35, DOI 10.1016/j.jep.2015.10.028
   Wang SS, 2018, J ALZHEIMERS DIS, V65, P1385, DOI 10.3233/JAD-180497
   Wei SN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152097
   Wu D, 2018, NATURE, V559, P637, DOI 10.1038/s41586-018-0350-5
   Xu WQ, 2007, J CELL SCI, V120, P3337, DOI 10.1242/jcs.013771
   Xue YJ, 2019, MED SCI MONITOR, V25, P1663, DOI 10.12659/MSM.912338
   Yan Zhong-Qing, 2008, Zhongguo Zhong Yao Za Zhi, V33, P2105
   Yang HJ, 2020, GASTRIC CANCER, V23, P382, DOI 10.1007/s10120-019-01033-8
   Yang YH, 2018, DRUG DES DEV THER, V12, P393, DOI 10.2147/DDDT.S155993
   Yao MJ, 2019, BMC COMPLEM ALTERN M, V19, DOI 10.1186/s12906-019-2615-4
   Yi TT, 2015, NUTR CANCER, V67, P523, DOI 10.1080/01635581.2015.1004733
   Yue SJ, 2019, AM J PHYSIOL-ENDOC M, V316, pE73, DOI 10.1152/ajpendo.00256.2018
   Zhang C, 2019, BIOCHEM BIOPH RES CO, V509, P201, DOI 10.1016/j.bbrc.2018.12.104
   Zhang W, 2019, BIOMED PHARMACOTHER, V118, DOI 10.1016/j.biopha.2019.109131
   Zhang X, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1132-6
   Zhang YJ, 2015, ONCOTARGET, V6, P7244, DOI 10.18632/oncotarget.3133
   Zhao LY, 2017, EBIOMEDICINE, V16, P87, DOI 10.1016/j.ebiom.2017.01.021
   Zheng J, 2018, BRIT J SURG, V105, P1799, DOI 10.1002/bjs.10930
NR 61
TC 3
Z9 3
U1 3
U2 8
PU BAISHIDENG PUBLISHING GROUP INC
PI PLEASANTON
PA 7041 Koll Center Parkway, Suite 160, PLEASANTON, CA, UNITED STATES
SN 1948-5204
J9 WORLD J GASTRO ONCOL
JI World J. Gastrointest. Oncol.
PD APR 15
PY 2022
VL 14
IS 4
DI 10.4251/wjgo.v14.i4.842
PG 17
WC Oncology; Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Gastroenterology & Hepatology
GA 2B5DY
UT WOS:000810209900007
PM 35582103
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Predmore, BL
   Alendy, MJ
   Ahmed, KI
   Leeuwenburgh, C
   Julian, D
AF Predmore, Benjamin L.
   Alendy, Maikel J.
   Ahmed, Khadija I.
   Leeuwenburgh, Christiaan
   Julian, David
TI The hydrogen sulfide signaling system: changes during aging and the
   benefits of caloric restriction
SO AGE
LA English
DT Article
DE H2S; Gasotransmitter; Aging; Caloric restriction; Aorta; Liver
ID NITRIC-OXIDE SYNTHASE; ENDOGENOUS MODULATOR; RADICAL GENERATION;
   OXIDATIVE STRESS; 3RD GAS; MUSCLE; RAT; H2S; LIVER; EXPRESSION
AB Hydrogen sulfide gas (H2S) is a putative signaling molecule that causes diverse effects in mammalian tissues including relaxation of blood vessels and regulation of perfusion in the liver, but the effects of aging on H2S signaling are unknown. Aging has negative impacts on the cardiovascular system. However, the liver is more resilient with age. Caloric restriction (CR) attenuates affects of age in many tissues. We hypothesized that the H2S signaling system is negatively affected by age in the vasculature but not in the liver, which is typically more resilient to age, and that a CR diet minimizes the age affect in the vasculature. To investigate this, we determined protein and mRNA expression of the H2S-producing enzymes cystathionine gamma-lyase (CSE) and cystathionine beta-synthase (CBS), H2S production rates in the aorta and liver, and the contractile response of aortic rings to exogenous H2S. Tissue was collected from Fisher 344 x Brown Norway rats from 8-38 months of age, which had been maintained on an ad libitum (AL) or CR diet. The results demonstrate that age and diet have differential effects on the H2S signaling system in aorta and liver. The aorta showed a sizeable effect of both age and diet, whereas the liver only showed a sizeable effect of diet. Aortic rings showed increased contractile sensitivity to H2S and increased protein expression of CSE and CBS with age, consistent with a decrease in H2S concentration with age. CR appears to benefit CSE and CBS protein in both aorta and liver, potentially by reducing oxidative stress and ameliorating the negative effect of age on H2S concentration. Therefore, CR may help maintain the H2S signaling system during aging.
C1 [Predmore, Benjamin L.; Alendy, Maikel J.; Ahmed, Khadija I.; Julian, David] Univ Florida, Dept Biol, Gainesville, FL 32611 USA.
   [Leeuwenburgh, Christiaan] Univ Florida, Dept Aging & Geriatr, Gainesville, FL 32611 USA.
C3 State University System of Florida; University of Florida; State
   University System of Florida; University of Florida
RP Julian, D (corresponding author), Univ Florida, Dept Biol, Gainesville, FL 32611 USA.
EM djulian@ufl.edu
OI Leeuwenburgh, Christiaan/0000-0003-0826-4257; Julian,
   David/0000-0003-1143-2813
FU National Institute of Health [T32 HL083810, AG21042]; National Science
   Foundation [IBN-0422139]
FX We would like to thank Dr. Christy Carter for donation of rat aorta
   tissue used in the myography experiments. This work was supported by
   National Institute of Health T32 HL083810 to BP, National Institute of
   Health AG21042 to CL and National Science Foundation IBN-0422139 to DJ.
CR Abe K, 1996, J NEUROSCI, V16, P1066
   Ali MY, 2006, BRIT J PHARMACOL, V149, P625, DOI 10.1038/sj.bjp.0706906
   Anantharaju A, 2002, GERONTOLOGY, V48, P343, DOI 10.1159/000065506
   Anderson RM, 2010, TRENDS ENDOCRIN MET, V21, P134, DOI 10.1016/j.tem.2009.11.005
   Aspnes LE, 1997, FASEB J, V11, P573, DOI 10.1096/fasebj.11.7.9212081
   Barja G, 2002, AGEING RES REV, V1, P397, DOI 10.1016/S1568-1637(02)00008-9
   BEAUCHAMP RO, 1984, CRC CR REV TOXICOL, V13, P25, DOI 10.3109/10408448409029321
   Calvert JW, 2009, CIRC RES, V105, P365, DOI 10.1161/CIRCRESAHA.109.199919
   Carter CS, 2009, J GERONTOL A-BIOL, V64, P850, DOI 10.1093/gerona/glp060
   Castello L, 2005, FASEB J, V19, P1863, DOI 10.1096/fj.04-2864fje
   Cernadas MR, 1998, CIRC RES, V83, P279, DOI 10.1161/01.RES.83.3.279
   Chen YH, 2005, CHEST, V128, P3205, DOI 10.1378/chest.128.5.3205
   Dombkowski RA, 2005, AM J PHYSIOL-REG I, V288, pR243, DOI 10.1152/ajpregu.00324.2004
   Dombkowski RA, 2006, J EXP BIOL, V209, P3234, DOI 10.1242/jeb.02376
   Ebrahimkhani MR, 2005, GUT, V54, P1668, DOI 10.1136/gut.2004.056556
   Fiorucci S, 2005, GASTROENTEROLOGY, V129, P1210, DOI 10.1053/j.gastro.2005.07.060
   Fiorucci S, 2005, HEPATOLOGY, V42, P539, DOI 10.1002/hep.20817
   Fujii K, 2005, ANTIOXID REDOX SIGN, V7, P788, DOI 10.1089/ars.2005.7.788
   Gainey LF, 2005, BIOL BULL-US, V209, P11, DOI 10.2307/3593138
   Geng B, 2004, BIOCHEM BIOPH RES CO, V318, P756, DOI 10.1016/j.bbrc.2004.04.094
   Geng B, 2004, BIOCHEM BIOPH RES CO, V313, P362, DOI 10.1016/j.bbrc.2003.11.130
   GILBOAGARBER N, 1971, ANAL BIOCHEM, V43, P129, DOI 10.1016/0003-2697(71)90116-3
   Goettsch W, 2001, BIOCHEM BIOPH RES CO, V280, P908, DOI 10.1006/bbrc.2000.4180
   GOODWIN LR, 1989, J ANAL TOXICOL, V13, P105, DOI 10.1093/jat/13.2.105
   Gredilla R, 2004, ANN NY ACAD SCI, V1019, P333, DOI 10.1196/annals.1297.057
   Gredilla R, 2001, FASEB J, V15, P1589, DOI 10.1096/fj.00-0764fje
   Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720
   Hofer T, 2009, MECH AGEING DEV, V130, P297, DOI 10.1016/j.mad.2009.01.004
   Hosoki R, 1997, BIOCHEM BIOPH RES CO, V237, P527, DOI 10.1006/bbrc.1997.6878
   Julian D, 2005, BIOL BULL-US, V209, P6, DOI 10.2307/3593137
   Julian D, 2002, COMP BIOCHEM PHYS A, V133, P105, DOI 10.1016/S1095-6433(02)00122-8
   Kimura H, 2005, ANTIOXID REDOX SIGN, V7, P795, DOI 10.1089/ars.2005.7.795
   Kimura H, 2000, BIOCHEM BIOPH RES CO, V267, P129, DOI 10.1006/bbrc.1999.1915
   KITANI K, 1991, ARCH GERONTOL GERIAT, V12, P133, DOI 10.1016/0167-4943(91)90024-K
   KITANI K, 1994, ARCH GERONTOL GERIAT, V19, pR3
   Koenitzer JR, 2007, AM J PHYSIOL-HEART C, V292, pH1953, DOI 10.1152/ajpheart.01193.2006
   Kubo S, 2007, TOXICOLOGY, V232, P138, DOI 10.1016/j.tox.2006.12.023
   Labinskyy N, 2006, CURR MED CHEM, V13, P989, DOI 10.2174/092986706776360987
   LAKATTA EG, 1993, PHYSIOL REV, V73, P413, DOI 10.1152/physrev.1993.73.2.413
   Leeuwenburgh C, 1997, ARCH BIOCHEM BIOPHYS, V346, P74, DOI 10.1006/abbi.1997.0297
   Leeuwenburgh C, 2006, ANTIOXID REDOX SIGN, V8, P503, DOI 10.1089/ars.2006.8.503
   Lim JJ, 2008, AM J PHYSIOL-CELL PH, V295, pC1261, DOI 10.1152/ajpcell.00195.2008
   Lowicka E, 2007, PHARMACOL REP, V59, P4
   Marzetti E, 2008, MECH AGEING DEV, V129, P542, DOI 10.1016/j.mad.2008.05.005
   Minamiyama Y, 2007, J PHARMACOL EXP THER, V320, P535, DOI 10.1124/jpet.106.110460
   Olson KR, 2008, J EXP BIOL, V211, P2205, DOI 10.1242/jeb.016766
   Olson KR, 2006, J EXP BIOL, V209, P4011, DOI 10.1242/jeb.02480
   Olson KR, 2009, ACTA HISTOCHEM, V111, P244, DOI 10.1016/j.acthis.2008.11.004
   Olson KR, 2009, BBA-BIOENERGETICS, V1787, P856, DOI 10.1016/j.bbabio.2009.03.019
   Olson KR, 2005, ANTIOXID REDOX SIGN, V7, P804, DOI 10.1089/ars.2005.7.804
   Payne AM, 2003, J APPL PHYSIOL, V95, P2554, DOI 10.1152/japplphysiol.00758.2003
   Pryor WA, 2006, AM J PHYSIOL-REG I, V291, pR491, DOI 10.1152/ajpregu.00614.2005
   Raitakari M, 2004, ARTERIOSCL THROM VAS, V24, P124, DOI 10.1161/01.ATV.0000109749.11042.7c
   Sasaki S, 2002, AM J HYPERTENS, V15, P302, DOI 10.1016/S0895-7061(01)02322-6
   Schmucker DL, 1998, J GERONTOL A-BIOL, V53, pB315, DOI 10.1093/gerona/53A.5.B315
   Sharifi AM, 2008, ACTA PHYSIOL HUNG, V95, P55, DOI 10.1556/APhysiol.95.2008.1.3
   Shibuya N, 2009, J BIOCHEM, V146, P623, DOI 10.1093/jb/mvp111
   Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]
   STIPANUK MH, 1982, BIOCHEM J, V206, P267, DOI 10.1042/bj2060267
   Szabó C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425
   Taddei S, 2006, CURR HYPERTENS REP, V8, P84, DOI 10.1007/s11906-006-0045-4
   Tanaka Yoshio, 2006, Journal of Smooth Muscle Research, V42, P131, DOI 10.1540/jsmr.42.131
   Ungvari Z, 2008, CIRC RES, V102, P519, DOI 10.1161/CIRCRESAHA.107.168369
   van der Loo B, 2005, BIOGERONTOLOGY, V6, P325, DOI 10.1007/s10522-005-4807-1
   van der Loo B, 2000, J EXP MED, V192, P1731, DOI 10.1084/jem.192.12.1731
   Wallace JL, 2007, TRENDS PHARMACOL SCI, V28, P501, DOI 10.1016/j.tips.2007.09.003
   Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp
   Wang YF, 2008, CHINESE MED J-PEKING, V121, P420, DOI 10.1097/00029330-200803010-00010
   Webb GD, 2008, J PHARMACOL EXP THER, V324, P876, DOI 10.1124/jpet.107.133538
   Whiteman M, 2006, BIOCHEM BIOPH RES CO, V343, P303, DOI 10.1016/j.bbrc.2006.02.154
   Whiteman M, 2004, J NEUROCHEM, V90, P765, DOI 10.1111/j.1471-4159.2004.02617.x
   Whitfield NL, 2008, AM J PHYSIOL-REG I, V294, pR1930, DOI 10.1152/ajpregu.00025.2008
   Wood CE, 2005, AM J PHYSIOL-REG I, V289, pR613, DOI 10.1152/ajpregu.00722.2004
   Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667
   Yang H, 2004, J GERONTOL A-BIOL, V59, P316
   Zanardo RCO, 2006, FASEB J, V20, P2118, DOI 10.1096/fj.06-6270fje
   Zeeh J, 2002, GERONTOLOGY, V48, P121, DOI 10.1159/000052829
   Zhao WM, 2003, CAN J PHYSIOL PHARM, V81, P848, DOI 10.1139/Y03-077
   Zhao WM, 2002, AM J PHYSIOL-HEART C, V283, pH474, DOI 10.1152/ajpheart.00013.2002
   Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008
NR 80
TC 38
Z9 45
U1 0
U2 10
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0161-9152
EI 1574-4647
J9 AGE
JI Age
PD DEC
PY 2010
VL 32
IS 4
BP 467
EP 481
DI 10.1007/s11357-010-9150-z
PG 15
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA 679IB
UT WOS:000284154000004
PM 20502969
OA Green Published
DA 2024-02-19
ER

PT J
AU Leng, LG
   Yuan, ZQ
   Su, X
   Chen, ZL
   Yang, SC
   Chen, MQ
   Zhuang, K
   Lin, H
   Sun, H
   Li, HF
   Xue, MQ
   Xu, J
   Yan, JQ
   Chen, ZY
   Yuan, TF
   Zhang, J
AF Leng, Lige
   Yuan, Ziqi
   Su, Xiao
   Chen, Zhenlei
   Yang, Shangchen
   Chen, Meiqin
   Zhuang, Kai
   Lin, Hui
   Sun, Hao
   Li, Huifang
   Xue, Maoqiang
   Xu, Jun
   Yan, Jingqi
   Chen, Zhenyi
   Yuan, Tifei
   Zhang, Jie
TI Hypothalamic Menin regulates systemic aging and cognitive decline
SO PLOS BIOLOGY
LA English
DT Article
ID SERINE RACEMASE; GENE-EXPRESSION; NMDA RECEPTORS; SF1 NEURONS; ENERGY;
   MICROINFLAMMATION; PROTEIN; LEPTIN; LIVER; MICE
AB Aging is a systemic process, which is a risk factor for impaired physiological functions, and finally death. The molecular mechanisms driving aging process and the associated cognitive decline are not fully understood. The hypothalamus acts as the arbiter that orchestrates systemic aging through neuroinflammatory signaling. Our recent findings revealed that Menin plays important roles in neuroinflammation and brain development. Here, we found that the hypothalamic Menin signaling diminished in aged mice, which correlates with systemic aging and cognitive deficits. Restoring Menin expression in ventromedial nucleus of hypothalamus (VMH) of aged mice extended lifespan, improved learning and memory, and ameliorated aging biomarkers, while inhibiting Menin in VMH of middle-aged mice induced premature aging and accelerated cognitive decline. We further found that Menin epigenetically regulates neuroinflammatory and metabolic pathways, including D-serine metabolism. Aging-associated Menin reduction led to impaired D-serine release by VMH-hippocampus neural circuit, while D-serine supplement rescued cognitive decline in aged mice. Collectively, VMH Menin serves as a key regulator of systemic aging and aging-related cognitive decline.
C1 [Leng, Lige; Yuan, Ziqi; Su, Xiao; Chen, Zhenlei; Yang, Shangchen; Zhuang, Kai; Lin, Hui; Sun, Hao; Li, Huifang; Zhang, Jie] Xiamen Univ, Inst Neurosci, Coll Med, Fujian Prov Key Lab Neurodegenerat Dis & Aging Res, Xiamen, Fujian, Peoples R China.
   [Chen, Meiqin] Hebei Med Univ, Coll Basic Med, Shijiazhuang, Hebei, Peoples R China.
   [Xue, Maoqiang] Xiamen Univ, Sch Med, Dept Basic Med Sci, Xiamen, Fujian, Peoples R China.
   [Xu, Jun] Nanjing Univ Informat Sci & Technol, Inst AI Med, Sch Automat, Nanjing, Peoples R China.
   [Yan, Jingqi] Cleveland State Univ, Ctr Gene Regulat Hlth & Dis, Cleveland, OH USA.
   [Chen, Zhenyi; Zhang, Jie] Xiamen Univ, Affiliated Hosp 1, Dept Anesthesiol, Xiamen, Fujian, Peoples R China.
   [Yuan, Tifei] Shanghai Jiao Tong Univ, Shanghai Mental Hlth Ctr, Sch Med, Shanghai, Peoples R China.
C3 Xiamen University; Hebei Medical University; Xiamen University; Nanjing
   University of Information Science & Technology; University System of
   Ohio; Cleveland State University; Xiamen University; Shanghai Jiao Tong
   University
RP Leng, LG; Zhang, J (corresponding author), Xiamen Univ, Inst Neurosci, Coll Med, Fujian Prov Key Lab Neurodegenerat Dis & Aging Res, Xiamen, Fujian, Peoples R China.; Zhang, J (corresponding author), Xiamen Univ, Affiliated Hosp 1, Dept Anesthesiol, Xiamen, Fujian, Peoples R China.
EM lenglige@xum.edu.cn; jiezhang@xmu.edu.cn
FU National Natural Science Foundation of China [81925010, 91849205,
   U1905207, 92049202, :81801337, 82071520]; National Key Research and
   Development Program of China [2021YFA1101402]; Fundamental Research
   Funds for the Central Universities [20720190118, 20720180049]; Xiamen
   Municipal Health Commission, Xiamen Municipal Bureau of Science and
   Technology [3502Z20209005]; Fujian Province Nature Science Foundation
   [2019J05006]; Xiamen Youth Innovation Fund [3502Z20206031]
FX This work was supported by the National Natural Science Foundation of
   China (Grant: 81925010, 91849205, U1905207 and 92049202 to J.Z.; Grant:
   81801337 and 82071520 to L.L.); The National Key Research and
   Development Program of China (Grant: 2021YFA1101402 to J.Z.); The
   Fundamental Research Funds for the Central Universities (Grant:
   20720190118 and 20720180049 to J.Z.); Xiamen Municipal Health
   Commission, Xiamen Municipal Bureau of Science and Technology
   (3502Z20209005); Fujian Province Nature Science Foundation (Grant:
   2019J05006 to L.L.); Xiamen Youth Innovation Fund (Grant: 3502Z20206031
   to L.L). The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Amelio I, 2014, TRENDS BIOCHEM SCI, V39, P191, DOI 10.1016/j.tibs.2014.02.004
   Balu DT, 2018, BIOL PSYCHIAT, V83, P273, DOI 10.1016/j.biopsych.2017.08.012
   Balu DT, 2012, NEUROSCI LETT, V517, P77, DOI 10.1016/j.neulet.2012.04.020
   Basu AC, 2009, MOL PSYCHIATR, V14, P719, DOI 10.1038/mp.2008.130
   Benneyworth MA, 2012, CELL MOL NEUROBIOL, V32, P613, DOI 10.1007/s10571-012-9808-4
   Cai DS, 2019, CELL METAB, V30, P19, DOI 10.1016/j.cmet.2019.05.021
   Crabtree JS, 2003, MOL CELL BIOL, V23, P6075, DOI 10.1128/MCB.23.17.6075-6085.2003
   Dhillon H, 2006, NEURON, V49, P191, DOI 10.1016/j.neuron.2005.12.021
   Fossat P, 2012, CEREB CORTEX, V22, P595, DOI 10.1093/cercor/bhr130
   Jurk D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5172
   Katona BW, 2020, MOL CANCER THER, V19, P2319, DOI 10.1158/1535-7163.MCT-20-0101
   Kim KW, 2012, J CLIN INVEST, V122, P2578, DOI 10.1172/JCI62848
   Kim KW, 2011, MOL CELL ENDOCRINOL, V336, P219, DOI 10.1016/j.mce.2010.11.019
   Kim MS, 2015, NAT IMMUNOL, V16, P525, DOI 10.1038/ni.3133
   Kleinridders A, 2009, CELL METAB, V10, P249, DOI 10.1016/j.cmet.2009.08.013
   Le Bail M, 2015, P NATL ACAD SCI USA, V112, pE204, DOI 10.1073/pnas.1416668112
   Leng LG, 2018, NEURON, V100, P551, DOI 10.1016/j.neuron.2018.08.031
   Liu SS, 2017, HEPATOLOGY, V66, P631, DOI 10.1002/hep.29202
   Luo XR, 1995, PHILOS T R SOC B, V350, P279, DOI 10.1098/rstb.1995.0162
   LUO XR, 1995, ENDOCR RES, V21, P517, DOI 10.3109/07435809509030469
   Matkar S, 2013, TRENDS BIOCHEM SCI, V38, P394, DOI [10.1016/j.tibs.2013.0S.005, 10.1016/j.tibs.2013.05.005]
   Mensah-Osman E, 2008, AM J PHYSIOL-GASTR L, V295, pG843, DOI 10.1152/ajpgi.00607.2007
   Milanski M, 2009, J NEUROSCI, V29, P359, DOI 10.1523/JNEUROSCI.2760-08.2009
   Miles AR, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.181529
   Mitchell SJ, 2016, CELL METAB, V23, P1093, DOI 10.1016/j.cmet.2016.05.027
   Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926
   Otte DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067131
   Papouin T, 2012, CELL, V150, P633, DOI 10.1016/j.cell.2012.06.029
   Satoh A, 2013, CELL METAB, V18, P416, DOI 10.1016/j.cmet.2013.07.013
   Scacheri PC, 2004, MAMM GENOME, V15, P872, DOI 10.1007/s00335-004-2395-z
   Senn SS, 2019, AM J PHYSIOL-REG I, V317, pR451, DOI 10.1152/ajpregu.00111.2019
   Sun XL, 2012, METABOLOMICS, V8, pS81, DOI 10.1007/s11306-012-0399-3
   Svoboda LK, 2018, J PATHOL, V245, P324, DOI 10.1002/path.5085
   Tang YZ, 2015, TRENDS NEUROSCI, V38, P36, DOI 10.1016/j.tins.2014.10.002
   Timper K, 2017, CELL REP, V19, P267, DOI 10.1016/j.celrep.2017.03.043
   Wilson JL, 2020, CELL REP, V30, P1542, DOI 10.1016/j.celrep.2020.01.011
   Wolosker H, 2011, BBA-PROTEINS PROTEOM, V1814, P1558, DOI 10.1016/j.bbapap.2011.01.001
   Xing BW, 2019, J CELL BIOL, V218, P855, DOI 10.1083/jcb.201805049
   Xu Y, 2010, CELL METAB, V12, P88, DOI 10.1016/j.cmet.2010.05.002
   Zhang G, 2013, NATURE, V497, P211, DOI 10.1038/nature12143
   Zhang WQ, 2020, NAT REV MOL CELL BIO, V21, P137, DOI 10.1038/s41580-019-0204-5
   Zhang ZD, 2020, NAT METAB, V2, P663, DOI 10.1038/s42255-020-0247-0
   Zhuang K, 2018, CELL REP, V24, P701, DOI 10.1016/j.celrep.2018.06.055
NR 43
TC 5
Z9 5
U1 4
U2 16
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1544-9173
EI 1545-7885
J9 PLOS BIOL
JI PLoS. Biol.
PD MAR
PY 2023
VL 21
IS 3
AR e3002033
DI 10.1371/journal.pbio.3002033
PG 25
WC Biochemistry & Molecular Biology; Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics
GA A2FA7
UT WOS:000953329800002
PM 36928253
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Houtkooper, RH
   Argmann, C
   Houten, SM
   Cantó, C
   Jeninga, EH
   Andreux, PA
   Thomas, C
   Doenlen, R
   Schoonjans, K
   Auwerx, J
AF Houtkooper, Riekelt H.
   Argmann, Carmen
   Houten, Sander M.
   Canto, Carles
   Jeninga, Ellen H.
   Andreux, Penelope A.
   Thomas, Charles
   Doenlen, Raphael
   Schoonjans, Kristina
   Auwerx, Johan
TI The metabolic footprint of aging in mice
SO SCIENTIFIC REPORTS
LA English
DT Article
ID INSULIN-RECEPTOR SUBSTRATE-1; LIFE-SPAN; SKELETAL-MUSCLE; MITOCHONDRIAL
   DYSFUNCTION; TYROSINE PHOSPHORYLATION; ENERGY-EXPENDITURE; ACTIVATING
   SIRT1; FATTY-ACID; AMPK; MOUSE
AB Aging is characterized by a general decline in cellular function, which ultimately will affect whole body homeostasis. Although DNA damage and oxidative stress all contribute to aging, metabolic dysfunction is a common hallmark of aging at least in invertebrates. Since a comprehensive overview of metabolic changes in otherwise healthy aging mammals is lacking, we here compared metabolic parameters of young and 2 year old mice. We systemically integrated in vivo phenotyping with gene expression, biochemical analysis, and metabolomics, thereby identifying a distinguishing metabolic footprint of aging. Among the affected pathways in both liver and muscle we found glucose and fatty acid metabolism, and redox homeostasis. These alterations translated in decreased long chain acylcarnitines and increased free fatty acid levels and a marked reduction in various amino acids in the plasma of aged mice. As such, these metabolites serve as biomarkers for aging and healthspan.
C1 [Houtkooper, Riekelt H.; Canto, Carles; Jeninga, Ellen H.; Andreux, Penelope A.; Schoonjans, Kristina; Auwerx, Johan] Ecole Polytech Fed Lausanne, Lab Integrat & Syst Physiol, CH-1015 Lausanne, Switzerland.
   [Argmann, Carmen] Acad Med Ctr, Lab Med Biochem, NL-1105 AZ Amsterdam, Netherlands.
   [Houten, Sander M.] AMC, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands.
   [Thomas, Charles; Doenlen, Raphael] Ecole Polytech Fed Lausanne, Ctr Phenogenom, CH-1015 Lausanne, Switzerland.
C3 Swiss Federal Institutes of Technology Domain; Ecole Polytechnique
   Federale de Lausanne; University of Amsterdam; Academic Medical Center
   Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam;
   Swiss Federal Institutes of Technology Domain; Ecole Polytechnique
   Federale de Lausanne
RP Auwerx, J (corresponding author), Ecole Polytech Fed Lausanne, Lab Integrat & Syst Physiol, CH-1015 Lausanne, Switzerland.
EM admin.auwerx@epfl.ch
RI Houten, Sander/Y-3599-2019; Houtkooper, Riekelt H/E-1602-2011; Auwerx,
   Johan/ABE-9307-2021; Houtkooper, Riekelt/P-5001-2019; Thomas,
   charles/C-7130-2019
OI Houten, Sander/0000-0002-6167-9147; Houtkooper, Riekelt
   H/0000-0001-9961-0842; Thomas, charles/0000-0001-9998-6698; Canto,
   Carles/0000-0002-5167-7922; Auwerx, Johan/0000-0002-5065-5393;
   Schoonjans, Kristina/0000-0003-1247-4265
FU Netherlands Organization for Scientific Research; Ecole Polytechnique
   Federale de Lausanne; EU [ERC-2008-AdG-23118]; Velux Stiftung; Swiss
   National Science Foundation [31003A-124713, 31003A-125487]; Netherlands
   Organization for Scientific Research (NWO) [016.086.336]; Swiss National
   Science Foundation (SNF) [31003A_125487] Funding Source: Swiss National
   Science Foundation (SNF)
FX We thank team members of the Auwerx lab and the mouse phenotyping unit
   for technical support and helpful discussions. RHH is supported by a
   Rubicon fellowship of the Netherlands Organization for Scientific
   Research. JA is the Nestle Chair in Energy Metabolism. The work in the
   laboratories of the authors is supported by grants of the Ecole
   Polytechnique Federale de Lausanne, the EU Ideas program
   (ERC-2008-AdG-23118), the Velux Stiftung, the Swiss National Science
   Foundation (31003A-124713 and 31003A-125487) and the Netherlands
   Organization for Scientific Research (NWO VIDI No. 016.086.336 to SMH).
CR Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200
   Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004
   Bergmeyer H.U., 1986, Methods of Enzymatic Analysis, V3
   Biddinger SB, 2005, DIABETES, V54, P1314, DOI 10.2337/diabetes.54.5.1314
   Cantó C, 2010, CELL METAB, V11, P213, DOI 10.1016/j.cmet.2010.02.006
   Cantó C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813
   Cantó C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4
   Chace DH, 2003, CLIN CHEM, V49, P1797, DOI 10.1373/clinchem.2003.022178
   Champy MF, 2008, MAMM GENOME, V19, P318, DOI 10.1007/s00335-008-9107-z
   Champy MF, 2004, MAMM GENOME, V15, P768, DOI 10.1007/s00335-004-2393-1
   Costa CCG, 1999, PEDIATR RES, V46, P440, DOI 10.1203/00006450-199910000-00013
   D'Antona G, 2010, CELL METAB, V12, P362, DOI 10.1016/j.cmet.2010.08.016
   Dacremont G, 1995, J INHERIT METAB DIS, V18, P84, DOI 10.1007/BF00711431
   de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078
   Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016
   Edwards MG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-80
   Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539
   Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004
   Gall WE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010883
   Gao ZG, 2002, J BIOL CHEM, V277, P48115, DOI 10.1074/jbc.M209459200
   Gonzalez AA, 2004, AM J PHYSIOL-REG I, V287, pR1270, DOI 10.1152/ajpregu.00409.2004
   Grandison RC, 2009, NATURE, V462, P1061, DOI 10.1038/nature08619
   Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007
   Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250
   Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221
   Heikkinen S., 2007, CURR PROTOC MOL BIOL, DOI DOI 10.1002/0471142727.MB29B03S77
   Houtkooper RH, 2010, CELL, V142, P9, DOI 10.1016/j.cell.2010.06.029
   Hyyti OM, 2010, AM J PHYSIOL-HEART C, V299, pH868, DOI 10.1152/ajpheart.00931.2009
   Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980
   Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013
   Lawton KA, 2008, PHARMACOGENOMICS, V9, P383, DOI 10.2217/14622416.9.4.383
   Lemieux H, 2010, J GERONTOL A-BIOL, V65, P1157, DOI 10.1093/gerona/glq141
   Li Y, 2004, J BIOL CHEM, V279, P45304, DOI 10.1074/jbc.C400186200
   Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292
   Mair W, 2011, NATURE, V470, P404, DOI 10.1038/nature09706
   Mandillo S, 2008, PHYSIOL GENOMICS, V34, P243, DOI 10.1152/physiolgenomics.90207.2008
   Miller RA, 2005, AGING CELL, V4, P119, DOI 10.1111/j.1474-9726.2005.00152.x
   Möller KÄ, 2008, J NEUROSCI METH, V174, P1, DOI 10.1016/j.jneumeth.2008.06.017
   Moeschel K, 2004, J BIOL CHEM, V279, P25157, DOI 10.1074/jbc.M402477200
   Morino K, 2006, DIABETES, V55, pS9, DOI 10.2337/db06-S002
   Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002
   Pan F, 2007, NUCLEIC ACIDS RES, V35, pD756, DOI 10.1093/nar/gkl798
   Paz K, 1997, J BIOL CHEM, V272, P29911, DOI 10.1074/jbc.272.47.29911
   Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822
   Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011
   Piraud M, 2003, RAPID COMMUN MASS SP, V17, P1297, DOI 10.1002/rcm.1054
   Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500
   Reznick RM, 2007, CELL METAB, V5, P151, DOI 10.1016/j.cmet.2007.01.008
   Rui LY, 2001, J CLIN INVEST, V107, P181, DOI 10.1172/JCI10934
   Russell SJ, 2007, NAT REV MOL CELL BIO, V8, P681, DOI 10.1038/nrm2234
   Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787
   Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584
   Suhre K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013953
   Tucker MZ, 2002, AM J PHYSIOL-ENDOC M, V282, pE1102, DOI 10.1152/ajpendo.00175.2001
   Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866
   Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
   Xia JG, 2010, NUCLEIC ACIDS RES, V38, pW71, DOI 10.1093/nar/gkq329
   Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356
   Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025
NR 60
TC 381
Z9 418
U1 1
U2 60
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD OCT 31
PY 2011
VL 1
AR 134
DI 10.1038/srep00134
PG 11
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 896EY
UT WOS:000300549400001
PM 22355651
OA Green Published, gold, Green Submitted
DA 2024-02-19
ER

PT J
AU Guzzardi, MA
   La Rosa, F
   Campani, D
   Collado, MC
   Monleon, D
   Insilla, AC
   Tripodi, M
   Zega, A
   Dattilo, A
   Brunetto, MR
   Maffei, M
   Bonino, F
   Iozzo, P
AF Guzzardi, Maria Angela
   La Rosa, Federica
   Campani, Daniela
   Carmen Collado, Maria
   Monleon, Daniel
   Insilla, Andrea Cacciato
   Tripodi, Maria
   Zega, Alessandro
   Dattilo, Alessia
   Brunetto, Maurizia Rossana
   Maffei, Margherita
   Bonino, Ferruccio
   Iozzo, Patricia
TI Liver and White/Brown Fat Dystrophy Associates with Gut Microbiota and
   Metabolomic Alterations in 3xTg Alzheimer's Disease Mouse Model
SO METABOLITES
LA English
DT Article
DE Alzheimer's disease mouse model; liver inflammation; adipose tissues;
   gut microbiota; metabolome; PET-CT imaging
ID PLASMINOGEN-ACTIVATOR INHIBITOR-1; INTRANASAL INSULIN; HEPATIC
   STEATOSIS; A-BETA; LEPTIN; CONTRIBUTES; DYSFUNCTION; FIBROSIS; DEFICITS;
   OBESITY
AB Metabolic impairments and liver and adipose depots alterations were reported in subjects with Alzheimer's disease (AD), highlighting the role of the liver-adipose-tissue-brain axis in AD pathophysiology. The gut microbiota might play a modulating role. We investigated the alterations to the liver and white/brown adipose tissues (W/BAT) and their relationships with serum and gut metabolites and gut bacteria in a 3xTg mouse model during AD onset (adulthood) and progression (aging) and the impact of high-fat diet (HFD) and intranasal insulin (INI). Glucose metabolism ((18)FDG-PET), tissue radiodensity (CT), liver and W/BAT histology, BAT-thermogenic markers were analyzed. 16S-RNA sequencing and mass-spectrometry were performed in adult (8 months) and aged (14 months) 3xTg-AD mice with a high-fat or control diet. Generalized and HFD resistant deficiency of lipid accumulation in both liver and W/BAT, hypermetabolism in WAT (adulthood) and BAT (aging), abnormal cytokine-hormone profiles, and liver inflammation were observed in 3xTg mice; INI could antagonize all these alterations. Specific gut microbiota-metabolome profiles correlated with a significant disruption of the gut-microbiota-liver-adipose axis in AD mice. In conclusion, fat dystrophy in liver and adipose depots contributes to AD progression, and associates with altered profiles of the gut microbiota, which candidates as an appealing early target for preventive intervention.
C1 [Guzzardi, Maria Angela; La Rosa, Federica; Tripodi, Maria; Zega, Alessandro; Maffei, Margherita; Iozzo, Patricia] Inst Clin Physiol, Natl Res Council CNR, I-56124 Pisa, Italy.
   [Campani, Daniela; Insilla, Andrea Cacciato] Pisa Univ Hosp, Dept Surg Med Mol Pathol & Crit Care Med, Div Pathol, I-56124 Pisa, Italy.
   [Carmen Collado, Maria] Inst Agrochem & Food Technol Natl Res Council IAT, Valencia 46980, Spain.
   [Monleon, Daniel] Univ Valencia, Fac Med, Hlth Res Inst INCLIVA, CIBERFES Frailty & Hlth Aging, Valencia 46003, Spain.
   [Dattilo, Alessia] Scuola Super Sant Anna, I-56127 Pisa, Italy.
   [Brunetto, Maurizia Rossana] Univ Pisa, Dept Clin & Expt Med, I-56124 Pisa, Italy.
   [Brunetto, Maurizia Rossana] Pisa Univ Hosp, Dept Med Specialties, Hepatol Unit, Lab Mol Genet & Pathol Hepatitis Viruses, I-56124 Pisa, Italy.
   [Brunetto, Maurizia Rossana; Bonino, Ferruccio] Inst Biostruct & Bioimaging IBB, Natl Res Council CNR, I-80145 Naples, Italy.
C3 Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica
   (IFC-CNR); University of Pisa; Azienda Ospedaliero Universitaria Pisana;
   University of Valencia; Scuola Superiore Sant'Anna; University of Pisa;
   University of Pisa; Azienda Ospedaliero Universitaria Pisana; Consiglio
   Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini
   (IBB-CNR)
RP Guzzardi, MA (corresponding author), Inst Clin Physiol, Natl Res Council CNR, I-56124 Pisa, Italy.
EM m.guzzardi@ifc.cnr.it; larosa.fed@gmail.com; daniela.campani@unipi.it;
   mcolam@iata.csic.es; daniel.monleon@uv.es;
   andrea.cacciatoinsilla@gmail.com; maria.t@email.it;
   alessandro.zega@ifc.cnr.it; a.dattilo@santannapisa.it;
   maurizia.brunetto@unipi.it; m.maffei@ifc.cnr.it;
   ferruccio.bonino@unipi.it; patricia.iozzo@ifc.cnr.it
RI Monleon, Daniel/A-5078-2010; Bonino, Ferruccio/C-6036-2018; La Rosa,
   Federica/IWM-5435-2023; COLLADO, MARIA CARMEN/H-4924-2012; GUZZARDI,
   MARIAANGELA/K-1389-2016
OI Monleon, Daniel/0000-0002-4803-1573; Bonino,
   Ferruccio/0000-0001-9942-0328; La Rosa, Federica/0000-0003-1671-6057;
   COLLADO, MARIA CARMEN/0000-0002-6204-4864; CAMPANI,
   DANIELA/0000-0001-5987-734X; BRUNETTO, MAURIZIA
   ROSSANA/0000-0001-8364-9152; GUZZARDI, MARIAANGELA/0000-0001-9574-5088
FU JPI-HDHL-INTIMIC Knowledge Platform of Food, Diet, Intestinal
   Microbiomics, and Human Health [KP-778, 23092/7303/19 MISVILUPPO];
   JPI-HDHL-INTIMIC Joint Transnational Research program [INTIMIC-085
   GUTMOM, 946/2019]; Fund for Scientific Research (FRS-FNRS, Belgium);
   Research Foundation-Flanders (FWO, Belgium); INSERM Institut National de
   la Sante et de la Recherche Medicale (France); Federal Ministry of Food
   and Agriculture (BMEL); Ministry of Education, University and Research
   (MIUR); Ministry of agricultural, food, and forestry policies (MiPAAF);
   National Institute of Health (ISS) on behalf of the Ministry of Health
   (Italy); National Institute of Health Carlos III (Spain); Netherlands
   Organisation for Health Research and Development (ZonMw, The
   Netherlands); Austrian Research Promotion Agency (FFG) on behalf of the
   Austrian Federal Ministry for Education, Science, and Research (BMBWF);
   Ministry of Science and Technology (Israel); Formas (Sweden); Ministry
   of Science and Innovation of Spain [ACPIN2017-117, PID2019-108973RB-C22]
FX This study was conducted within the JPI-HDHL-INTIMIC Knowledge Platform
   of Food, Diet, Intestinal Microbiomics, and Human Health (sub-project
   no. KP-778 MISVILUPPO, Italian Ministry of Agricultural, Food and
   Forestry Policies, Ministry Decree 23092/7303/19), and the
   JPI-HDHL-INTIMIC Joint Transnational Research program (project no.
   INTIMIC-085 GUTMOM, Italian Ministry of Education, University and
   Research, Ministry Decree no. 946/2019). The funders had no role in
   study design, data collection and analysis, or preparation of the
   manuscript. Projects supported by the Joint Action "European Joint
   Programming Initiative: A Healthy Diet for a Healthy Life (JPI HDHL)"
   are funded by the respective national/regional funding organisations:
   Fund for Scientific Research (FRS-FNRS, Belgium); Research
   Foundation-Flanders (FWO, Belgium); INSERM Institut National de la Sante
   et de la Recherche Medicale (France); Federal Ministry of Food and
   Agriculture (BMEL) represented by Federal Office for Agriculture and
   Food (BLE, Germany); Ministry of Education, University and Research
   (MIUR), Ministry of agricultural, food, and forestry policies (MiPAAF),
   National Institute of Health (ISS) on behalf of the Ministry of Health
   (Italy); the National Institute of Health Carlos III (Spain); The
   Netherlands Organisation for Health Research and Development (ZonMw, The
   Netherlands), Austrian Research Promotion Agency (FFG) on behalf of the
   Austrian Federal Ministry for Education, Science, and Research (BMBWF),
   Ministry of Science and Technology (Israel), Formas (Sweden). DM
   gratefully acknowledges funding from the Ministry of Science and
   Innovation of Spain (ACPIN2017-117 and PID2019-108973RB-C22).
CR Alessi MC, 2003, ARTERIOSCL THROM VAS, V23, P1262, DOI 10.1161/01.ATV.0000077401.36885.BB
   Angulo P, 2015, GASTROENTEROLOGY, V149, P389, DOI 10.1053/j.gastro.2015.04.043
   Arias N, 2020, NUTRIENTS, V12, DOI 10.3390/nu12082340
   Bernotiene E, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2004
   Bosoi CR, 2021, HEPATOL COMMUN, V5, P446, DOI 10.1002/hep4.1609
   Chen YX, 2014, EXP NEUROL, V261, P610, DOI 10.1016/j.expneurol.2014.06.004
   Coleman RA, 2017, MOL IMAGING, V16, P1, DOI 10.1177/1536012117704557
   Craft S, 2012, ARCH NEUROL-CHICAGO, V69, P29, DOI 10.1001/archneurol.2011.233
   Faggioni R, 1999, AM J PHYSIOL-REG I, V276, pR136, DOI 10.1152/ajpregu.1999.276.1.R136
   Farr SA, 2006, PEPTIDES, V27, P1420, DOI 10.1016/j.peptides.2005.10.006
   Gancheva S, 2015, DIABETES, V64, P1966, DOI 10.2337/db14-0892
   Gerenu G, 2017, BBA-MOL BASIS DIS, V1863, P991, DOI 10.1016/j.bbadis.2017.01.023
   Granado-Serrano AB, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38874-3
   Harach T, 2017, SCI REP-UK, V7, DOI 10.1038/srep41802
   Heni M, 2017, DIABETES, V66, P1797, DOI 10.2337/db16-1380
   Honda T, 2017, METABOLISM, V69, P177, DOI 10.1016/j.metabol.2016.12.013
   Ishii M, 2016, BBA-MOL BASIS DIS, V1862, P966, DOI 10.1016/j.bbadis.2015.10.029
   Ishii M, 2014, J NEUROSCI, V34, P9096, DOI 10.1523/JNEUROSCI.0872-14.2014
   Iwen KA, 2014, J CLIN ENDOCR METAB, V99, pE246, DOI 10.1210/jc.2013-3169
   Kadooka Y, 2010, EUR J CLIN NUTR, V64, P636, DOI 10.1038/ejcn.2010.19
   Kim DG, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-015-0467-5
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085
   Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a
   Liu RM, 2011, NEUROBIOL AGING, V32, P1079, DOI 10.1016/j.neurobiolaging.2009.06.003
   Lloret A, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00508
   Ma J, 2016, CURR ALZHEIMER RES, V13, P223, DOI 10.2174/156720501303160217111434
   Mao YF, 2016, AGING CELL, V15, P893, DOI 10.1111/acel.12498
   McGuire MJ, 2016, CELL MOL NEUROBIOL, V36, P203, DOI 10.1007/s10571-015-0282-7
   Moreno-Fernandez ME, 2021, NUTR DIABETES, V11, DOI 10.1038/s41387-021-00157-0
   Nho K, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.7978
   Oh J, 2014, EXP GERONTOL, V60, P87, DOI 10.1016/j.exger.2014.10.004
   Pinçon A, 2019, METABOLITES, V9, DOI 10.3390/metabo9050104
   Rajasekaran M, 2019, J ENDOCRINOL, V242, P91, DOI 10.1530/JOE-19-0190
   Sanborn V, 2020, J ALZHEIMERS DIS, V77, P1279, DOI 10.3233/JAD-191247
   Sanguinetti E, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00188
   Sanguinetti E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23261-1
   Seo SW, 2016, NEUROLOGY, V86, P1136, DOI 10.1212/WNL.0000000000002498
   Signore AP, 2008, J NEUROCHEM, V106, P1977, DOI 10.1111/j.1471-4159.2008.05457.x
   Takahashi A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174169
   THIE JA, 1995, J NUCL MED, V36, P711
   Tournissac M, 2019, MOL METAB, V22, P110, DOI 10.1016/j.molmet.2019.01.008
   Vandal M, 2016, NEUROBIOL AGING, V43, P47, DOI 10.1016/j.neurobiolaging.2016.03.024
   Vandal M, 2014, DIABETES, V63, P4291, DOI 10.2337/db14-0375
   Vogt NM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13601-y
   Wieckowska-Gacek A, 2021, FRONT AGING NEUROSCI, V13, DOI 10.3389/fnagi.2021.654509
   Woting A, 2014, MBIO, V5, DOI 10.1128/mBio.01530-14
   Yamaguchi K, 2007, HEPATOLOGY, V45, P1366, DOI 10.1002/hep.21655
   Yoneshiro T, 2019, NATURE, V572, P614, DOI 10.1038/s41586-019-1503-x
   Zietak M, 2016, CELL METAB, V23, P1216, DOI 10.1016/j.cmet.2016.05.001
NR 50
TC 0
Z9 0
U1 6
U2 18
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2218-1989
J9 METABOLITES
JI Metabolites
PD APR
PY 2022
VL 12
IS 4
AR 278
DI 10.3390/metabo12040278
PG 18
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 0R3IS
UT WOS:000785493800001
PM 35448465
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Yin, ST
   Dong, YH
   Li, JH
   Lü, JX
   Hu, HB
AF Yin, Shutao
   Dong, Yinhui
   Li, Jinhua
   Lue, Junxuan
   Hu, Hongbo
TI Penta-1,2,3,4,6-<i>O</i>-Galloyl-Beta-D-Glucose Induces Senescence-Like
   Terminal S-Phase Arrest in Human Hepatoma and Breast Cancer Cells
SO MOLECULAR CARCINOGENESIS
LA English
DT Article
DE PGG; liver and breast cancer cells; permanent growth arrest; ROS;
   p53/p21
ID BETA-D-GLUCOSE; CHEMOPREVENTIVE AGENTS; TEA POLYPHENOLS; GROWTH ARREST;
   TUMOR-GROWTH; IN-VITRO; P53; PENTAGALLOYLGLUCOSE; PHYTOCHEMICALS;
   FIBROBLAST
AB Senescence is a permanent growth arrest and has been implicated as an efficient anti-carcinogenesis mechanism. The purpose of this study was designed to test the hypothesis that penta-1,2,3,4,6-O-galloyl-beta-D-glucose (PGG), a naturally occurring polyphonolic gallotannin compound, might induce this type of permanent growth arrest in cancer cells. Our results show, for the first time, that PGG-induced senescence-like S-phase arrest in HepG2, Huh-7 human hepatoma cells, and SKBr3 human breast cancer cells at sublethal doses, judged by cellular morphological changes, increased senescence-associated beta-galactosidase (SA-beta-gal) activity, together with loss of proliferative capacity after being released from the treatment. This senescence-like response was mediated by intracellular ROS generation, but was not attributed to p53 Ser15 phosphorylative activation and was uncoupled from the p21cip1 axis, which has been shown to mediate Pten loss-induced cellular senescence or oncogene-driven senescence. The findings of the present study implicate a novel mechanism of PGG action to induce an atypical cellular senescence, adding to its promise as a potential chemopreventive agent. (C) 2011 Wiley-Liss, Inc.
C1 [Yin, Shutao; Dong, Yinhui; Li, Jinhua; Hu, Hongbo] China Agr Univ, Coll Food Sci & Nutr Engn, Div Nutr & Hlth, Beijing 100083, Peoples R China.
   [Lue, Junxuan] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA.
C3 China Agricultural University; University of Minnesota System
RP Hu, HB (corresponding author), China Agr Univ, Coll Food Sci & Nutr Engn, Div Nutr & Hlth, 17 Qinghua E Rd, Beijing 100083, Peoples R China.
OI Lu, Junxuan/0000-0002-2354-7186
FU National Natural Science Foundation of China (NSFC) [31071533,
   30972172]; Chinese Universities Scientific Fund [2009-2-11]; National
   Institute of Health USA [CA136953]
FX This work was supported by grants from National Natural Science
   Foundation of China (NSFC, 31071533, 30972172), Chinese Universities
   Scientific Fund (2009-2-11), and National Institute of Health USA
   (CA136953).
CR Alimonti A, 2010, J CLIN INVEST, V120, P681, DOI 10.1172/JCI40535
   Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003
   Catalano A, 2005, EMBO J, V24, P170, DOI 10.1038/sj.emboj.7600502
   Chai YB, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2634
   CHEN Q, 1994, P NATL ACAD SCI USA, V91, P4130, DOI 10.1073/pnas.91.10.4130
   Chen WJ, 2003, BIOCHEM PHARMACOL, V65, P1777, DOI 10.1016/S0006-2952(03)00156-4
   Christov KT, 2003, EUR J CANCER, V39, P230, DOI 10.1016/S0959-8049(02)00497-5
   Gewirtz DA, 2008, BIOCHEM PHARMACOL, V76, P947, DOI 10.1016/j.bcp.2008.06.024
   GOLDSTEIN S, 1990, SCIENCE, V249, P1129, DOI 10.1126/science.2204114
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   Heiss EH, 2007, J BIOL CHEM, V282, P26759, DOI 10.1074/jbc.M703229200
   Hornsby PJ, 2007, J CLIN ONCOL, V25, P1852, DOI 10.1200/JCO.2006.10.3101
   Hu HB, 2008, MOL CANCER THER, V7, P2681, DOI 10.1158/1535-7163.MCT-08-0456
   Hu HB, 2009, MOL CANCER THER, V8, P2833, DOI 10.1158/1535-7163.MCT-09-0288
   Hu HB, 2009, CARCINOGENESIS, V30, P818, DOI 10.1093/carcin/bgp059
   Huh JE, 2005, CARCINOGENESIS, V26, P1436, DOI 10.1093/carcin/bgi097
   Hula KT, 2006, MOL CARCINOGEN, V45, P551, DOI 10.1002/mc.20226
   Jiang C, 2001, CANCER RES, V61, P3062
   Khan N, 2009, NUTR CANCER, V61, P836, DOI 10.1080/01635580903285056
   Kuo PT, 2009, J AGR FOOD CHEM, V57, P3331, DOI 10.1021/jf803725h
   Lambert JD, 2003, MUTAT RES-FUND MOL M, V523, P201, DOI 10.1016/S0027-5107(02)00336-6
   Lee HH, 2004, CARCINOGENESIS, V25, P1109, DOI 10.1093/carcin/bgh106
   Li L, 2011, J PHARMACEUT BIOMED, V54, P545, DOI 10.1016/j.jpba.2010.09.028
   Mizushina Y, 2010, BIOCHEM PHARMACOL, V80, P1125, DOI 10.1016/j.bcp.2010.06.031
   Oh GS, 2001, CANCER LETT, V174, P17, DOI 10.1016/S0304-3835(01)00680-2
   ROTHE G, 1990, J LEUKOCYTE BIOL, V47, P440, DOI 10.1002/jlb.47.5.440
   Sharpless NE, 2005, NATURE, V436, P636, DOI 10.1038/436636a
   Sporn MB, 2002, NAT REV CANCER, V2, P537, DOI 10.1038/nrc844
   Surh YJ, 2003, NAT REV CANCER, V3, P768, DOI 10.1038/nrc1189
   Thomasset SC, 2007, INT J CANCER, V120, P451, DOI 10.1002/ijc.22419
   Yaswen P, 2007, CELL, V128, P233, DOI 10.1016/j.cell.2007.01.005
NR 31
TC 17
Z9 19
U1 1
U2 15
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0899-1987
EI 1098-2744
J9 MOL CARCINOGEN
JI Mol. Carcinog.
PD AUG
PY 2011
VL 50
IS 8
BP 592
EP 600
DI 10.1002/mc.20743
PG 9
WC Biochemistry & Molecular Biology; Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Oncology
GA 790PJ
UT WOS:000292601400003
PM 21319227
DA 2024-02-19
ER

PT J
AU Frol'kis, VV
AF Frol'kis, VV
TI Hypothalamic mechanisms of aging and anti-aging
SO NEUROPHYSIOLOGY
LA English
DT Article
ID OXIDATIVE STRESS
AB A stress-age syndrome is one of the main phenomena related to the aging process. This phenomenon contributes to effective adaptation of an organism under the usual conditions of vital activity, but in the case of the influence of additional stress factors it promotes the development of age-related pathologies. In this respect, age-related modifications of the hypothalamic mechanisms deserve special attention. The electrical activity of the hypothalamic nuclei undergoes age-related modifications; in particular, the parameters of the spike activity of hypothalamic neurons demonstrate specific changes. Hypothalamic stimulation affects the induction of synthesis of a few enzymes (tyrosine aminotransferase, tryptophan pyrolase, glucose-6-phosphatase, and fructose-1,6-diphosphatase) in the liver, and in old rats these effects become weaker. Long-Lasting stimulation of the hypothalamus results in an increase in the content of an active chromatin fraction in hepatocytes of old rats; such stimulation intensifies the transcriptive activity of this chromatin and decreases the protein/DNA ratio. In old rats, long-lasting stimulation of the lateral hypothalamic region increases the mean and maximum remaining lifespan of the experimental animals.
C1 Acad Med Sci Ukraine, Inst Gerontol, Kyiv, Ukraine.
C3 National Academy of Medical Sciences of Ukraine; D. F. Chebotarev
   Institute of Gerontology of the National Academy of Medical Sciences of
   Ukraine
CR Adams JD, 1996, ANN NY ACAD SCI, V786, P135, DOI 10.1111/j.1749-6632.1996.tb39058.x
   ANGELUCCI ML, 1997, AGING S, V9, P9
   CHABANY VN, 1990, Z ALTERNSFORSCHUNG, V45, P77
   CHABANY VN, 1990, Z ALTERNFORSCH S, V45, P24
   Dilman V. M., 1987, Four Models of Medicine
   EVERITT AV, 1980, MECH AGEING DEV, V12, P161, DOI 10.1016/0047-6374(80)90092-5
   FROLKIS VV, 1970, REGULATION ADAPTAION
   FROLKIS VV, 1982, AGING NEUROHUMORAL M
   FROLKIS VV, 1986, FIZIOL ZH, V37, P118
   Kritchevsky SB, 1996, J AM GERIATR SOC, V44, P873, DOI 10.1111/j.1532-5415.1996.tb03751.x
   MOZZHUKHINA TG, 1991, GERONTOLOGY, V37, P181
   Wilkinson CW, 1997, NEUROENDOCRINOLOGY, V65, P79, DOI 10.1159/000127167
NR 12
TC 1
Z9 1
U1 0
U2 1
PU PLENUM PUBL CORP
PI NEW YORK
PA CONSULTANTS BUREAU, 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-2977
J9 NEUROPHYSIOLOGY+
JI Neurophysiology
PD JAN-FEB
PY 1999
VL 31
IS 1
BP 1
EP 4
DI 10.1007/BF02515000
PG 4
WC Neurosciences; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Physiology
GA 259UW
UT WOS:000083913200001
DA 2024-02-19
ER

PT J
AU Suzuki, T
   Michishita, E
   Ogino, H
   Fujii, M
   Ayusawa, D
AF Suzuki, T
   Michishita, E
   Ogino, H
   Fujii, M
   Ayusawa, D
TI Synergistic induction of the senescence-associated genes by
   5-bromodeoxyuridine and AT-binding ligands in HeLa cells
SO EXPERIMENTAL CELL RESEARCH
LA English
DT Article
DE 5-bromodeoxyuridine; AT-binding ligands; senescence-associated genes;
   scaffold/nuclear matrix attachment region; nuclear matrix
ID NUCLEAR SCAFFOLD PROTEINS; ATTACHMENT REGION DNA; REPETITIVE BENT DNA;
   CELLULAR SENESCENCE; HUMAN-CHROMOSOMES; MITOTIC CLOCK; DISTAMYCIN-A;
   RAT-LIVER; CHROMATIN; MATRIX
AB 5-Bromodeoxyuridine induces a senescence-like phenomenon in mammalian cells. This effect was dramatically potentiated by AT-binding ligands such as distamycin A, netropsin, and Hoechst 33258. The genes most remarkably affected by these ligands include the widely used senescence-associated genes and were located on or nearby Giemsa-dark bands of human chromosomes. We hypothesize that AT-rich scaffold/nuclear matrix attachment region sequences are involved in this phenomenon. In fact, upon substitution of thymine with 5-bromouracil, a rat S/MAR sequence reduced its degree of bending and became insensitive to cancellation of the bending by distamycin A The S/MAR sequence containing 5-bromouracil also bound more tightly to nuclear scaffold proteins in vitro and this binding was not inhibited by distamycin A. Under the same conditions, the S/MAR sequence containing thymine easily dissociated from the nuclear scaffold proteins. Taken together, the synergistic induction of the genes may be explained not only by opening of condensed chromatin by distamycin A but also by increase in the binding of 5-bromouracil-containing S/MAR sequences to the nuclear scaffolds. (C) 2002 Elsevier Science (USA).
C1 Yokohama City Univ, Kihara Inst Biol Res, Yokohama, Kanagawa 2440813, Japan.
   Yokohama City Univ, Grad Sch Integrated Sci, Yokohama, Kanagawa 2440813, Japan.
C3 Yokohama City University; Yokohama City University
RP Ayusawa, D (corresponding author), Yokohama City Univ, Kihara Inst Biol Res, Maioka Cho 641-12, Yokohama, Kanagawa 2440813, Japan.
EM dayusawa@yokohama-cu.ac.jp
RI Suzuki, Toshikazu/F-4387-2011
OI Suzuki, Toshikazu/0000-0002-4398-4762
CR Alvarez JD, 2000, GENE DEV, V14, P521
   Aravind L, 1998, NUCLEIC ACIDS RES, V26, P4413, DOI 10.1093/nar/26.19.4413
   Bode J, 2000, CRIT REV EUKAR GENE, V10, P73
   BODE J, 1992, SCIENCE, V255, P195, DOI 10.1126/science.1553545
   BROGGINI M, 1989, NUCLEIC ACIDS RES, V17, P1051, DOI 10.1093/nar/17.3.1051
   Campisi J, 1997, EUR J CANCER, V33, P703, DOI 10.1016/S0959-8049(96)00058-5
   DORN A, 1992, EMBO J, V11, P279, DOI 10.1002/j.1460-2075.1992.tb05050.x
   Finzer P, 2001, ONCOGENE, V20, P4768, DOI 10.1038/sj.onc.1204652
   GASSER SM, 1989, INT REV CYTOL, V119, P57
   GOYANES VJ, 1981, CANCER GENET CYTOGEN, V4, P45, DOI 10.1016/0165-4608(81)90007-8
   HARLEY CB, 1991, MUTAT RES, V256, P271, DOI 10.1016/0921-8734(91)90018-7
   Hart CM, 1998, CURR OPIN GENET DEV, V8, P519, DOI 10.1016/S0959-437X(98)80005-1
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   HIBINO Y, 1993, BIOCHIM BIOPHYS ACTA, V1174, P162, DOI 10.1016/0167-4781(93)90110-Y
   HIBINO Y, 1993, BIOCHEM BIOPH RES CO, V197, P336, DOI 10.1006/bbrc.1993.2480
   HIBINO Y, 1992, BIOCHEM BIOPH RES CO, V184, P853, DOI 10.1016/0006-291X(92)90668-B
   Hibino Y, 2000, BIOCHEM BIOPH RES CO, V279, P282, DOI 10.1006/bbrc.2000.3938
   KABACK MM, 1964, EXP CELL RES, V34, P182, DOI 10.1016/0014-4827(64)90193-4
   KAS E, 1989, J MOL BIOL, V210, P587, DOI 10.1016/0022-2836(89)90134-4
   KAS E, 1993, EMBO J, V12, P115, DOI 10.1002/j.1460-2075.1993.tb05637.x
   Kipp M, 2000, MOL CELL BIOL, V20, P7480, DOI 10.1128/MCB.20.20.7480-7489.2000
   Kortschak RD, 2000, TRENDS BIOCHEM SCI, V25, P294, DOI 10.1016/S0968-0004(00)01597-8
   LUCK G, 1977, NUCLEIC ACIDS RES, V4, P2655, DOI 10.1093/nar/4.8.2655
   MATSUKUMA S, 1978, EXP CELL RES, V113, P453, DOI 10.1016/0014-4827(78)90390-7
   MELNIKOVA AF, 1975, MOL BIOL REP, V2, P135, DOI 10.1007/BF00357544
   Michishita E, 2002, BIOSCI BIOTECH BIOCH, V66, P877, DOI 10.1271/bbb.66.877
   Michishita E, 1999, J BIOCHEM-TOKYO, V126, P1052
   MIRKOVITCH J, 1984, CELL, V39, P223, DOI 10.1016/0092-8674(84)90208-3
   Mochii M, 1999, P NATL ACAD SCI USA, V96, P15020, DOI 10.1073/pnas.96.26.15020
   NAKAMURA K, 1991, BIOCHEM INT, V25, P355
   Nie ZQ, 2000, MOL CELL BIOL, V20, P8879, DOI 10.1128/MCB.20.23.8879-8888.2000
   Ogino H, 2002, DNA RES, V9, P25, DOI 10.1093/dnares/9.1.25
   PJURA PE, 1987, J MOL BIOL, V197, P257, DOI 10.1016/0022-2836(87)90123-9
   RADIC MZ, 1992, CHROMOSOMA, V101, P602, DOI 10.1007/BF00360537
   RONNE M, 1983, HEREDITAS, V98, P241, DOI 10.1111/j.1601-5223.1983.tb00601.x
   RONNE M, 1983, HEREDITAS, V99, P245, DOI 10.1111/j.1601-5223.1983.tb00896.x
   Shay JW, 2001, SCIENCE, V291, P839, DOI 10.1126/science.1058546
   Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5
   Steinert S, 2002, EXP CELL RES, V272, P146, DOI 10.1006/excr.2001.5409
   Strick R, 1995, CELL, V83, P1137, DOI 10.1016/0092-8674(95)90140-X
   Suzuki T, 2001, EXP GERONTOL, V36, P465, DOI 10.1016/S0531-5565(00)00223-0
   Suzuki T, 2001, EXP CELL RES, V266, P53, DOI 10.1006/excr.2001.5194
   Tomaszewski R, 1997, NUCLEIC ACIDS RES, V25, P458, DOI 10.1093/nar/25.3.458
   TSUTSUI K, 1993, J BIOL CHEM, V268, P12886
   WEINTRAUB H, 1973, NATURE-NEW BIOL, V244, P142, DOI 10.1038/newbio244142a0
   WILT FH, 1972, DEV BIOL, V28, P443
   Yamamura J, 2001, FEBS LETT, V489, P166, DOI 10.1016/S0014-5793(01)02098-1
   Young J, 2000, EXP GERONTOL, V35, P23, DOI 10.1016/S0531-5565(99)00076-5
   ZAKHAROV AF, 1974, CHROMOSOMA, V44, P343
NR 49
TC 30
Z9 32
U1 0
U2 1
PU ELSEVIER INC
PI SAN DIEGO
PA 525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0014-4827
EI 1090-2422
J9 EXP CELL RES
JI Exp. Cell Res.
PD JUN 10
PY 2002
VL 276
IS 2
BP 174
EP 184
DI 10.1006/excr.2002.5524
PG 11
WC Oncology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Cell Biology
GA 560WM
UT WOS:000176104400004
PM 12027447
DA 2024-02-19
ER

PT J
AU Ohno, T
   Yoo, MJ
   Swanson, ER
   Hirano, S
   Ossoff, RH
   Rousseau, B
AF Ohno, Tsunehisa
   Yoo, Mi Jin
   Swanson, Erik R.
   Hirano, Shigeru
   Ossoff, Robert H.
   Rousseau, Bernard
TI Regeneration of Aged Rat Vocal Folds Using Hepatocyte Growth Factor
   Therapy
SO LARYNGOSCOPE
LA English
DT Article; Proceedings Paper
CT 130th Annual Meeting of the American-Laryngological-Association/Combined
   Otolaryngology Spring Meeting
CY MAY 28-29, 2009
CL Phoenix, AZ
SP Amer Laryngol Assoc
DE Regenerative effect; hepatocyte growth factor; aged rat vocal fold;
   collagen; matrix metalloproteinase; hyaluronan
ID MATRIX METALLOPROTEINASES; CANINE MODEL; AGING VOICE; EXPRESSION; GENE;
   HYALURONAN; MICE
AB Objectives/Hypothesis: We investigated acute changes in extracellular matrix gene expression and histologic changes in the deposition of collagen and hyaluronan (HA) from hepatocyte growth factor (HGF) treatment of the aged rat vocal fold. We hypothesized that: 1) HGF induces matrix metalloproteinase gene expression, which might contribute to the downregulation of collagen; and 2) HGF induces hyaluronan synthase (HAS) gene expression, which might play a role in the upregulation of extracellular matrix HA.
   Study Design: Prospective animal study.
   Methods: Fifteen, 18-month-old, Sprague-Dawley rats were involved in this study. For gene expression analyses, 10 rats were divided into two groups and received serial injections of sham (saline) or HGF (2 ng/mu L) and sacrificed 2 weeks after the initial injection to investigate acute changes in extracellular matrix gene expression. A separate group of five animals received the above treatment and were sacrificed 4 weeks after the initial injection to investigate histologic changes in the deposition of collagen and HA.
   Results: Real-time polymerase chain reaction revealed significantly upregulated matrix metalloproteinase(MMP)-2, -9, and HAS-3 messenger RNA (mRNA) expression and significantly downregulated procollagen type I mRNA expression in the HGF-treatment group, compared to the sham-treatment group. Histologic staining revealed significantly reduced collagen deposition and increased deposition of HA in the HGF-treated vocal fold, compared to the sham-treated vocal fold.
   Conclusions: HGF induced the upregulation of MMP-2, -9, and HAS-3, and downregulated the expression of procollagen type I. Histologically, aged vocal folds treated with HGF revealed decreased collagen deposition, and increased deposition of HA, compared to sham-treated vocal folds.
C1 [Ohno, Tsunehisa; Yoo, Mi Jin; Swanson, Erik R.; Ossoff, Robert H.; Rousseau, Bernard] Vanderbilt Univ, Dept Otolaryngol, Bill Wilkerson Ctr Otolaryngol & Commun Sci, Nashville, TN 37232 USA.
   [Hirano, Shigeru] Kyoto Univ, Dept Otolaryngol Head & Neck Surg, Grad Sch Med, Kyoto, Japan.
C3 Vanderbilt University; Kyoto University
RP Rousseau, B (corresponding author), Vanderbilt Univ, Dept Otolaryngol, Bill Wilkerson Ctr Otolaryngol & Commun Sci, 1313 21st Ave S,Room 602, Nashville, TN 37232 USA.
EM bernard.rousseau@vanderbilt.edu
FU NIDCD NIH HHS [R21 DC 009873, R21 DC009873-02, R21 DC009873, R21
   DC009873-01] Funding Source: Medline
CR Butler JE, 2001, LARYNGOSCOPE, V111, P907, DOI 10.1097/00005537-200105000-00029
   Ford C, 2004, ARCH OTOLARYNGOL, V130, P1117, DOI 10.1001/archotol.130.9.1117
   Fujisaki K, 2006, LIFE SCI, V78, P1975, DOI 10.1016/j.lfs.2005.08.036
   Hammond TH, 2000, ANN OTO RHINOL LARYN, V109, P913, DOI 10.1177/000348940010901004
   Hirano S, 2004, LARYNGOSCOPE, V114, P2161, DOI 10.1097/01.mlg.0000149450.37640.db
   Liuzzi GM, 2004, BRAIN, V127, P398, DOI 10.1093/brain/awh049
   Manuel JA, 2006, MATRIX BIOL, V25, P505, DOI 10.1016/j.matbio.2006.07.008
   Matsumoto K, 2001, KIDNEY INT, V59, P2023, DOI 10.1046/j.1523-1755.2001.00717.x
   Mizuno S, 2005, FASEB J, V19, P580, DOI 10.1096/fj.04-1535fje
   Ohno T, 2008, ANN OTO RHINOL LARYN, V117, P696, DOI 10.1177/000348940811700912
   Ohno T, 2007, ANN OTO RHINOL LARYN, V116, P762, DOI 10.1177/000348940711601008
   Oishi Y, 2003, BIOSCI BIOTECH BIOCH, V67, P736, DOI 10.1271/bbb.67.736
   Price SJ, 2001, J BIOL CHEM, V276, P7549, DOI 10.1074/jbc.M010242200
   Ramig LO, 2001, FOLIA PHONIATR LOGO, V53, P252, DOI 10.1159/000052680
   Rousseau B, 2004, ANN OTO RHINOL LARYN, V113, P767, DOI 10.1177/000348940411301001
   Rousseau B, 2004, J VOICE, V18, P116, DOI 10.1016/j.jvoice.2003.06.001
   Rousseau B, 2003, LARYNGOSCOPE, V113, P620, DOI 10.1097/00005537-200304000-00007
   Sato K, 2002, ANN OTO RHINOL LARYN, V111, P15, DOI 10.1177/000348940211100103
   Song WW, 2006, CARDIOVASC DIABETOL, V5, DOI 10.1186/1475-2840-5-3
   Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463
   Tateya T, 2005, ANN OTO RHINOL LARYN, V114, P183, DOI 10.1177/000348940511400303
NR 21
TC 15
Z9 16
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0023-852X
EI 1531-4995
J9 LARYNGOSCOPE
JI Laryngoscope
PD JUL
PY 2009
VL 119
IS 7
BP 1424
EP 1430
DI 10.1002/lary.20497
PG 7
WC Medicine, Research & Experimental; Otorhinolaryngology
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Research & Experimental Medicine; Otorhinolaryngology
GA 467KO
UT WOS:000267737800029
PM 19507223
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Biggins, SW
   Bambha, KM
   Terrault, NA
   Inadomi, J
   Shiboski, S
   Dodge, JL
   Gralla, J
   Rosen, HR
   Roberts, JP
AF Biggins, Scott W.
   Bambha, Kiran M.
   Terrault, Norah A.
   Inadomi, John
   Shiboski, Stephen
   Dodge, Jennifer L.
   Gralla, Jane
   Rosen, Hugo R.
   Roberts, John P.
TI Projected future increase in aging hepatitis C virus-infected liver
   transplant candidates: A potential effect of hepatocellular carcinoma
SO LIVER TRANSPLANTATION
LA English
DT Article
ID UNITED-STATES; PROGNOSTIC-FACTORS; DISEASE; MODEL; PREVALENCE;
   MORTALITY; RISK; RECIPIENTS; CIRRHOSIS; OUTCOMES
AB In the United States, the peak hepatitis C virus (HCV) antibody prevalence of 4% occurred in persons born in the calendar years 1940-1965. The goal of this study was to examine observed and projected age-specific trends in the demand for liver transplantation (LT) among patients with HCV-associated liver disease stratified by concurrent hepatocellular carcinoma (HCC). All new adult LT candidates registered with the Organ Procurement and Transplantation Network for LT between 1995 and 2010 were identified. Patients who had primary, secondary, or text field diagnoses of HCV with or without HCC were identified. There were 126,862 new primary registrants for LT, and 52,540 (41%) had HCV. The number of new registrants with HCV dramatically differed by the age at calendar year, and this suggested a birth cohort effect. When the candidates were stratified by birth year in 5-year intervals, the birth cohorts with the highest frequency of HCV were as follows (in decreasing order): 1951-1955, 1956-1960, 1946-1950, and 1941-1945. These 4 birth cohorts, spanning from 1941 to 1960, accounted for 81% of all new registrants with HCV. A 4-fold increase in new registrants with HCV and HCC occurred between the calendar years 2000 and 2010 in the 1941-1960 birth cohorts. By 2015, we anticipate that an increasing proportion of new registrants with HCV will have HCC and be =60 years old (born in or before 1955). In conclusion, the greatest demand for LT due to HCV-associated liver disease is occurring among individuals born between 1941 and 1960. This demand appears to be driven by the development of HCC in patients with HCV. During the coming decade, the projected increase in the demand for LT from an aging HCV-infected population will challenge the transplant community to reconsider current treatment paradigms. Liver Transpl, 2012. (c) 2012 AASLD.
C1 [Biggins, Scott W.; Bambha, Kiran M.; Rosen, Hugo R.] Univ Colorado Denver, Div Gastroenterol & Hepatol, Aurora, CO 80045 USA.
   [Gralla, Jane] Univ Colorado Denver, Dept Pediat, Aurora, CO 80045 USA.
   [Gralla, Jane] Univ Colorado Denver, Dept Biostat & Informat, Aurora, CO 80045 USA.
   [Terrault, Norah A.] Univ Calif San Francisco, Div Gastroenterol & Hepatol, San Francisco, CA 94143 USA.
   [Shiboski, Stephen] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.
   [Dodge, Jennifer L.; Roberts, John P.] Univ Calif San Francisco, Dept Surg, San Francisco, CA USA.
   [Inadomi, John] Univ Washington, Div Gastroenterol & Hepatol, Seattle, WA 98195 USA.
C3 Children's Hospital Colorado; University of Colorado System; University
   of Colorado Anschutz Medical Campus; Children's Hospital Colorado;
   University of Colorado System; University of Colorado Anschutz Medical
   Campus; University of Colorado System; University of Colorado Anschutz
   Medical Campus; Children's Hospital Colorado; University of California
   System; University of California San Francisco; University of California
   System; University of California San Francisco; University of California
   System; University of California San Francisco; University of
   Washington; University of Washington Seattle
RP Biggins, SW (corresponding author), Univ Colorado Denver, Div Gastroenterol & Hepatol, 7th Floor,1635 Aurora Court,Mail Stop B-154, Aurora, CO 80045 USA.
EM scott.biggins@ucdenver.edu
RI Inadomi, John M/A-6221-2014; biggins, scott/AAQ-6532-2020; Bambha,
   Kiran/JDN-1914-2023; Inadomi, John/JVP-0473-2024; Dodge,
   Jennifer/AAY-2530-2020
OI Inadomi, John M/0000-0001-6776-8661; Bambha, Kiran/0000-0002-8223-5246; 
FU National Center for Research Resources [KL2 RR024130]; National
   Institute of Diabetes and Digestive and Kidney Diseases [DK076565];
   Agency for Healthcare Research and Quality [DK076565]
FX This work was funded in part by grants from the National Center for
   Research Resources (KL2 RR024130), the National Institute of Diabetes
   and Digestive and Kidney Diseases (DK076565), and the Agency for
   Healthcare Research and Quality (DK076565).
CR Aduen JF, 2009, MAYO CLIN PROC, V84, P973, DOI 10.1016/S0025-6196(11)60667-8
   Aloia TA, 2010, LIVER TRANSPLANT, V16, P950, DOI 10.1002/lt.22098
   Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802
   Armstrong GL, 2000, HEPATOLOGY, V31, P777, DOI 10.1002/hep.510310332
   Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004
   Asahina Y, 2010, HEPATOLOGY, V52, P518, DOI 10.1002/hep.23691
   Berg CL, 2009, AM J TRANSPLANT, V9, P907, DOI 10.1111/j.1600-6143.2009.02567.x
   Centers for Disease Control and Prevention, TEST REC CHRON HEP C
   Cherqui D, 2009, ANN SURG, V250, P738, DOI 10.1097/SLA.0b013e3181bd582b
   Davis GL, 2010, GASTROENTEROLOGY, V138, P513, DOI 10.1053/j.gastro.2009.09.067
   Davis GL, 2003, LIVER TRANSPLANT, V9, P331, DOI 10.1053/jlts.2003.50073
   El-Serag H, 2003, ANN INTERN MED, V139, P817, DOI 10.7326/0003-4819-139-10-200311180-00009
   El-Serag HB, 2005, J CLIN GASTROENTEROL, V39, P152
   El-Serag HB, 2004, GASTROENTEROLOGY, V127, pS27, DOI 10.1053/j.gastro.2004.09.013
   El-Serag HB, 1999, NEW ENGL J MED, V340, P745, DOI 10.1056/NEJM199903113401001
   Guiltinan AM, 2008, AM J EPIDEMIOL, V167, P743, DOI 10.1093/aje/kwm370
   Kim WR, 2009, GASTROENTEROLOGY, V137, P1680, DOI 10.1053/j.gastro.2009.07.047
   Lake JR, 2005, AM J TRANSPLANT, V5, P549, DOI 10.1111/j.1600-6143.2005.00741.x
   Litwin AH, 2012, DIGEST LIVER DIS, V44, P497, DOI 10.1016/j.dld.2011.12.014
   McGarry LJ, 2012, HEPATOLOGY, V55, P1344, DOI 10.1002/hep.25510
   Morris-Stiff G, 2009, SURG ONCOL, V18, P298, DOI 10.1016/j.suronc.2008.08.003
   N'Kontchou G, 2009, HEPATOLOGY, V50, P1475, DOI 10.1002/hep.23181
   Pelletier SJ, 2009, LIVER TRANSPLANT, V15, P859, DOI 10.1002/lt.21778
   Pietrosi G, 2009, J VASC INTERV RADIOL, V20, P896, DOI 10.1016/j.jvir.2009.03.032
   Rein DB, 2012, ANN INTERN MED, V156, P263, DOI 10.7326/0003-4819-156-4-201202210-00378
   Singhal A, 2010, EXP CLIN TRANSPLANT, V8, P196
   Smith BD, 2012, CLIN INFECT DIS, V55, pS49, DOI 10.1093/cid/cis363
   Sotiropoulos GC, 2009, DIGEST DIS SCI, V54, P2264, DOI 10.1007/s10620-008-0604-4
   Thuluvath PJ, 2010, AM J TRANSPLANT, V10, P1003, DOI 10.1111/j.1600-6143.2010.03037.x
   Tomaszewski Kenneth J, 2012, Am J Public Health, V102, pe101, DOI 10.2105/AJPH.2011.300488
   Volk ML, 2011, AM J TRANSPLANT, V11, P958, DOI 10.1111/j.1600-6143.2011.03487.x
   Wise M, 2008, HEPATOLOGY, V47, P1128, DOI 10.1002/hep.22165
   Wong JB, 2000, AM J PUBLIC HEALTH, V90, P1562, DOI 10.2105/AJPH.90.10.1562
NR 33
TC 63
Z9 64
U1 0
U2 2
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1527-6465
J9 LIVER TRANSPLANT
JI Liver Transplant.
PD DEC
PY 2012
VL 18
IS 12
BP 1471
EP 1478
DI 10.1002/lt.23551
PG 8
WC Gastroenterology & Hepatology; Surgery; Transplantation
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology; Surgery; Transplantation
GA 053UD
UT WOS:000312298800010
PM 23008049
OA Green Accepted, Bronze, Green Submitted
DA 2024-02-19
ER

PT J
AU Kim, JH
   Qu, AJ
   Reddy, JK
   Gao, B
   Gonzalez, FJ
AF Kim, Jung-Hwan
   Qu, Aijuan
   Reddy, Janardan K.
   Gao, Bin
   Gonzalez, Frank J.
TI Hepatic Oxidative Stress Activates the <i>Gadd45b</i> Gene by Way of
   Degradation of the Transcriptional Repressor STAT3
SO HEPATOLOGY
LA English
DT Article
ID NF-KAPPA-B; PPAR-ALPHA; HYDROGEN-PEROXIDE; IKK-BETA; CELLS; APOPTOSIS;
   PROMOTER; LIVER; HEPATOCARCINOGENESIS; PROLIFERATION
AB Growth arrest and DNA damage-inducible beta (GADD45b) plays an important role in many intracellular events, such as cell cycle arrest, DNA repair, cell survival, apoptosis, and senescence. However, its mechanism of transcriptional regulation remains unclear. In this study the mechanism of peroxisome proliferator-activated receptor (PPAR) ligand induction of the Gadd45b gene in mouse liver was investigated. Gadd45b messenger RNA (mRNA) was markedly induced by the PPAR agonist Wy-14,643 in wild-type mice but not in Ppara-null mice. Signal transducer and activator of transcription 3 (STAT3) was found to be a repressor of the Gadd45b gene through binding to upstream regulatory elements. The role of STAT3 in control of Gadd45b was confirmed using liver-specific Stat3-null mice. Wy-14,643 treatment stimulated STAT3 ubiquitination leading to activation of the Gadd45b gene as a result of loss of Gadd45b repression by STAT3. STAT3 degradation was induced by forced overexpression of the PPAR target gene-encoded enzyme ACOX1, which produces increased H2O2 as a byproduct of fatty acid -oxidation. H2O2 also stimulated expression of Gadd45b in cultured cells. Conclusion: PPAR indirectly induces the Gadd45b gene in liver through promoting degradation of the repressor STAT3 as a result of elevated oxidative stress.
C1 [Kim, Jung-Hwan; Qu, Aijuan; Gonzalez, Frank J.] NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.
   [Reddy, Janardan K.] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA.
   [Gao, Bin] NIAAA, Lab Liver Dis, NIH, Bethesda, MD USA.
C3 National Institutes of Health (NIH) - USA; NIH National Cancer Institute
   (NCI); Northwestern University; Feinberg School of Medicine; National
   Institutes of Health (NIH) - USA; NIH National Institute on Alcohol
   Abuse & Alcoholism (NIAAA)
RP Gonzalez, FJ (corresponding author), NCI, Lab Metab, NIH, Bethesda, MD 20892 USA.
EM gonzalef@mail.nih.gov
RI Kim, Jinsoo/G-6348-2012
OI Kim, Jinsoo/0000-0002-1376-9498; Kim, Jung Hwan/0000-0002-2975-4899;
   Gonzalez, Frank/0000-0002-7990-2140
FU National Cancer Institute Intramural Research Program
FX Supported by the National Cancer Institute Intramural Research Program.
CR ABDOLLAHI A, 1991, ONCOGENE, V6, P165
   Chakravarthy MV, 2009, CELL, V138, P476, DOI 10.1016/j.cell.2009.05.036
   Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715
   Chen XL, 2004, ARCH BIOCHEM BIOPHYS, V422, P197, DOI 10.1016/j.abb.2003.12.023
   De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560
   Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649
   Hays T, 2005, CARCINOGENESIS, V26, P219, DOI 10.1093/carcin/bgh285
   Ichiba M, 1998, J BIOL CHEM, V273, P6132, DOI 10.1074/jbc.273.11.6132
   Jiang C, 2007, ANTICANCER RES, V27, P3783
   Jin RG, 2002, DNA CELL BIOL, V21, P491, DOI 10.1089/104454902320219059
   Kang KA, 2012, TUMOR BIOL, V33, P403, DOI 10.1007/s13277-012-0322-6
   Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223
   Klampfer L, 2006, CURR CANCER DRUG TAR, V6, P107, DOI 10.2174/156800906776056491
   Klaunig JE, 2003, CRIT REV TOXICOL, V33, P655, DOI 10.1080/713608372
   Liebermann Dan A, 2008, J Mol Signal, V3, P15, DOI 10.1186/1750-2187-3-15
   Lim SO, 2008, GASTROENTEROLOGY, V135, P2128, DOI 10.1053/j.gastro.2008.07.027
   Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014
   Maeda S, 2003, IMMUNITY, V19, P725, DOI 10.1016/S1074-7613(03)00301-7
   Moh A, 2007, LAB INVEST, V87, P1018, DOI 10.1038/labinvest.3700630
   Müller S, 1998, EMBO J, V17, P61, DOI 10.1093/emboj/17.1.61
   Na YK, 2010, MOL CELLS, V30, P89, DOI 10.1007/s10059-010-0092-1
   Papa S, 2004, NAT CELL BIOL, V6, P146, DOI 10.1038/ncb1093
   Peters JM, 2012, NAT REV CANCER, V12, P181, DOI 10.1038/nrc3214
   Peters JM, 1997, CARCINOGENESIS, V18, P2029, DOI 10.1093/carcin/18.11.2029
   Pyper Sean R, 2010, Nucl Recept Signal, V8, pe002, DOI 10.1621/nrs.08002
   Rhee SG, 2010, MOL CELLS, V29, P539, DOI 10.1007/s10059-010-0082-3
   Roberts RA, 2004, TOXICOL LETT, V149, P37, DOI 10.1016/j.toxlet.2003.12.065
   Shimada H, 2011, PATHOL RES PRACT, V207, P225, DOI 10.1016/j.prp.2011.01.007
   Tochigi M, 2013, INT J ONCOL, V42, P863, DOI 10.3892/ijo.2013.1769
   Troyano A, 2003, CELL DEATH DIFFER, V10, P889, DOI 10.1038/sj.cdd.4401249
   Vairapandi M, 1996, ONCOGENE, V12, P2579
   VARANASI U, 1994, P NATL ACAD SCI USA, V91, P3107, DOI 10.1073/pnas.91.8.3107
   Woods CG, 2007, TOXICOL SCI, V98, P366, DOI 10.1093/toxsci/kfm104
   Yakar S, 1999, P NATL ACAD SCI USA, V96, P7324, DOI 10.1073/pnas.96.13.7324
NR 34
TC 50
Z9 55
U1 1
U2 9
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD FEB
PY 2014
VL 59
IS 2
BP 695
EP 704
DI 10.1002/hep.26683
PG 10
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 298FT
UT WOS:000330310300035
PM 23939942
OA Green Accepted, Bronze
DA 2024-02-19
ER

PT J
AU WALKER, RF
   NESS, GC
   ZHAO, ZH
   BERCU, BB
AF WALKER, RF
   NESS, GC
   ZHAO, ZH
   BERCU, BB
TI EFFECTS OF STIMULATED GROWTH-HORMONE SECRETION ON AGE-RELATED-CHANGES IN
   PLASMA-CHOLESTEROL AND HEPATIC LOW-DENSITY-LIPOPROTEIN MESSENGER-RNA
   CONCENTRATIONS
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE LDL RECEPTOR MESSENGER-RNA; CHOLESTEROL; CHOLESTEROL ALPHA-7-REDUCTASE;
   GROWTH HORMONE RELEASING HORMONE; GROWTH HORMONE RELEASING HEXAPEPTIDE
ID GH-RELEASING HEXAPEPTIDE; REDUCTASE-ACTIVITY; THYROID-HORMONE; RATS;
   ESTRADIOL; RECEPTOR; LIVER; SEX
AB Growth hormone (GH) secretion declines during aging. Since GH alters plasma cholesterol (PC) concentrations, it was of interest to determine how GH secretagogues affect age-related hypercholesterolemia. Fischer 344 rats (3 and 14 months old) were co-administered (s.c.) GH releasing hormone (3 mu g/kg; GHRH) and GH releasing hexapeptide (100 mu g/kg; GHRP) for 120 consecutive days. Aging was associated with a progressive increase in PC, which was reduced in rats administered GHRH and GHRP compared to those administered vehicle, i.e. changes in PC during the study were 26.5 +/- 1.2 mg/dl vs. 40.1 +/- 0.9 mg/dl (P < 0.05) in the younger rats and 17.6 +/- 2.3 mg/dl vs. 31.6 +/- 5.3 mg/dl (P < 0.05) in the older rats, respectively. The lower concentrations of PC in GH secretagogue-treated older rats were associated with higher mean concentrations of hepatic LDL receptor mRNA (1.27 +/- 0.4 vs. 0.4 +/- 0.1; P < 0.05) but not cholesterol 7-alpha hydroxylase mRNA. Although GH secretagogue treatment was also associated with lower plasma cholesterol in the younger rats, it was not accompanied by quantitative changes in mean group concentrations of hepatic LDL receptor mRNA. Instead, daily administration of GHRH and GHRP in the younger rats correlated with a significant reciprocal relationship (P < 0.05) between PC and hepatic LDL receptor mRNA for individual group members. The results of this study suggest that reduced GH secretion during aging contributes, at least in part, to a progressive increase in plasma cholesterol that can be partially prevented with GH secretagogues. Furthermore, the effects on PC may result from GH-mediated, qualitative and quantitative changes in hepatic LDL receptor mRNA that increase receptor-mediated cholesterol clearance.
C1 UNIV S FLORIDA,COLL MED,DEPT PEDIAT,TAMPA,FL 33612.
   UNIV S FLORIDA,COLL MED,DEPT PHARMACOL & THERAPEUT,TAMPA,FL 33612.
   UNIV S FLORIDA,COLL MED,DEPT BIOCHEM & MOLEC BIOL,TAMPA,FL 33612.
C3 State University System of Florida; University of South Florida; State
   University System of Florida; University of South Florida; State
   University System of Florida; University of South Florida
CR BERCU BB, 1991, ENDOCRINOLOGY, V129, P2592, DOI 10.1210/endo-129-5-2592
   BERCU BB, 1992, ENDOCRINOLOGY, V130, P2579, DOI 10.1210/en.130.5.2579
   BOWERS CY, 1991, ENDOCRINOLOGY, V128, P2027, DOI 10.1210/endo-128-4-2027
   BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311
   ERICSSON S, 1991, J CLIN INVEST, V87, P591, DOI 10.1172/JCI115034
   FRIEDMAN M, 1974, METABOLISM, V23, P905, DOI 10.1016/0026-0495(74)90039-0
   FRIEDMAN M, 1970, NATURE, V255, P464
   GRUNDY SM, 1985, ARTERIOSCLEROSIS, V5, P623, DOI 10.1161/01.ATV.5.6.623
   HO KY, 1987, J CLIN ENDOCR METAB, V64, P51, DOI 10.1210/jcem-64-1-51
   KOVANEN PT, 1979, J BIOL CHEM, V254, P1367
   MA PTS, 1986, P NATL ACAD SCI USA, V83, P792, DOI 10.1073/pnas.83.3.792
   Myant N., 2012, CHOLESTEROL METABOLI, DOI DOI 10.1016/B978-0-12-512300-6.50007-7
   NESS GC, 1990, BIOCHEM BIOPH RES CO, V172, P1150, DOI 10.1016/0006-291X(90)91568-D
   NESS GC, 1991, J BIOL CHEM, V266, P14854
   NESS GC, 1979, LIPIDS, V14, P447, DOI 10.1007/BF02533460
   RUDLING M, 1992, P NATL ACAD SCI USA, V89, P6983, DOI 10.1073/pnas.89.15.6983
   RUDMAN D, 1981, J CLIN INVEST, V67, P1361, DOI 10.1172/JCI110164
   SHULMAN DI, 1987, ACTA ENDOCRINOL-COP, V116, P138, DOI 10.1530/acta.0.1160138
   STEINBERG M, 1967, ENDOCRINOLOGY, V81, P340, DOI 10.1210/endo-81-2-340
   WALKER RF, 1991, LIFE SCI, V49, P1499, DOI 10.1016/0024-3205(91)90050-L
   WALKER RF, IN PRESS GROWTH HORM, V2
NR 21
TC 9
Z9 11
U1 0
U2 0
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD SEP
PY 1994
VL 75
IS 3
BP 215
EP 226
DI 10.1016/0047-6374(94)90011-6
PG 12
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA PK319
UT WOS:A1994PK31900004
PM 7845055
DA 2024-02-19
ER

PT J
AU Kim, YS
   Hong, D
   Lee, DJ
   Joo, NS
   Kim, KM
AF Kim, Young-Sang
   Hong, Doohee
   Lee, Duck-Joo
   Joo, Nam-Seok
   Kim, Kwang-Min
TI Total testosterone may not decline with ageing in Korean men aged 40
   years or older
SO CLINICAL ENDOCRINOLOGY
LA English
DT Article
ID HORMONE-BINDING GLOBULIN; SERUM TESTOSTERONE; METABOLIC SYNDROME;
   LONGITUDINAL CHANGES; LUTEINIZING-HORMONE; GONADAL-FUNCTION; ANDROGEN
   LEVELS; RISK-FACTORS; ELDERLY-MEN; METAANALYSIS
AB Objective It is generally believed that gonadal function in men declines with ageing. However, observations on ageing-related decrease in total testosterone (TT) are not consistent. The aim of this study is to examine the ageing-related changes of testosterone and to investigate the influence of the ageing-related factors on TT. Design Changes of TT with ageing were observed in longitudinal design in a single health promotion centre. Subjects A total of 220 Korean men aged =40 similar to years were included between 2002 and 2011. TT assay was repeated for all subjects, with an interval of =3 similar to years. Measurements Information of medical history and lifestyle habits was collected. Anthropometry and blood pressure were measured. TT, glucose, creatinine, highly sensitive C-reactive protein, liver enzymes and lipid profiles were tested. Results Mean TT level did not decline significantly with ageing during median 4.3 similar to years follow-up (18.1 vs 17.8 similar to nm, P similar to=similar to 0.439). Longitudinal change of TT was approximately similar to+similar to 0.8% per year. TT was negatively correlated with body mass index (BMI), waist circumference and glucose. With mixed effects model, diabetes (P similar to=similar to 0.038) and BMI (P similar to=similar to 0.007) affected TT level, but age and follow-up interval did not. Conclusions TT did not change significantly in 220 Korean men for a median 4.3 similar to years follow-up. TT was not influenced by the age and follow-up interval. BMI and diabetes mellitus affected TT decline.
C1 [Hong, Doohee; Lee, Duck-Joo; Joo, Nam-Seok; Kim, Kwang-Min] Ajou Univ, Sch Med, Dept Family Med, Suwon 443721, Gyeonggi Do, South Korea.
   [Kim, Young-Sang] Cha Univ, Sch Med, Dept Family Med, Pochon, South Korea.
C3 Ajou University; Pochon Cha University
RP Kim, KM (corresponding author), Ajou Univ, Sch Med, Dept Family Med, 206 Worldcup Ro, Suwon 443721, Gyeonggi Do, South Korea.
EM gaksi@ajou.ac.kr
CR Allan CA, 2010, CURR OPIN ENDOCRINOL, V17, P224, DOI 10.1097/MED.0b013e3283398ee2
   Bhasin S, 1997, J CLIN ENDOCR METAB, V82, P3, DOI 10.1210/jc.82.1.3
   Bhasin S, 2010, J CLIN ENDOCR METAB, V95, P2536, DOI 10.1210/jc.2009-2354
   Brand JS, 2011, INT J EPIDEMIOL, V40, P189, DOI 10.1093/ije/dyq158
   Feldman HA, 2002, J CLIN ENDOCR METAB, V87, P589, DOI 10.1210/jc.87.2.589
   Ferrini RL, 1998, AM J EPIDEMIOL, V147, P750
   Fukai S, 2010, GERIATR GERONTOL INT, V10, P32, DOI 10.1111/j.1447-0594.2009.00552.x
   GRAY A, 1991, J CLIN ENDOCR METAB, V73, P1016, DOI 10.1210/jcem-73-5-1016
   GRAY A, 1991, J CLIN EPIDEMIOL, V44, P671, DOI 10.1016/0895-4356(91)90028-8
   Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404
   Halmenschlager G, 2011, WORLD J UROL, V29, P541, DOI 10.1007/s00345-011-0724-x
   Haring R, 2009, DIABETES, V58, P2027, DOI 10.2337/db09-0031
   HARMAN SM, 1980, J CLIN ENDOCR METAB, V51, P35, DOI 10.1210/jcem-51-1-35
   Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724
   Hsing AW, 2007, CANCER EPIDEM BIOMAR, V16, P1004, DOI 10.1158/1055-9965.EPI-06-0792
   Kalme T, 2003, J STEROID BIOCHEM, V86, P197, DOI 10.1016/S0960-0760(03)00268-1
   Kang Y G, 2003, Aging Male, V6, P8, DOI 10.1080/713604735
   Kaplan SA, 2006, J UROLOGY, V176, P1524, DOI 10.1016/j.juro.2006.06.003
   Kaufman JM, 1997, BAILLIERE CLIN ENDOC, V11, P289, DOI 10.1016/S0950-351X(97)80302-3
   Kaufman JM, 2005, ENDOCR REV, V26, P833, DOI 10.1210/er.2004-0013
   Laaksonen DE, 2005, J CLIN ENDOCR METAB, V90, P712, DOI 10.1210/jc.2004-0970
   Li J-Y, 2005, Aging Male, V8, P203, DOI 10.1080/13685530500356010
   Liu PY, 2007, J CLIN ENDOCR METAB, V92, P3599, DOI 10.1210/jc.2007-0862
   Matsumoto AM, 2002, J GERONTOL A-BIOL, V57, pM76, DOI 10.1093/gerona/57.2.M76
   Morley JE, 1997, METABOLISM, V46, P410, DOI 10.1016/S0026-0495(97)90057-3
   NIESCHLAG E, 1982, J CLIN ENDOCR METAB, V55, P676, DOI 10.1210/jcem-55-4-676
   Nieschlag E, 2005, Aging Male, V8, P56
   SPARROW D, 1980, J CLIN ENDOCR METAB, V51, P508, DOI 10.1210/jcem-51-3-508
   St Sauver JL, 2011, AM J EPIDEMIOL, V173, P787, DOI 10.1093/aje/kwq438
   Traish AM, 2011, AM J MED, V124, P578, DOI 10.1016/j.amjmed.2010.12.027
   Travison TG, 2007, J CLIN ENDOCR METAB, V92, P549, DOI 10.1210/jc.2006-1859
   Travison TG, 2007, J CLIN ENDOCR METAB, V92, P196, DOI 10.1210/jc.2006-1375
   Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666
   World Health Organization Western Pacific Region; International Association for the Study of Obesity; International Obesity Task Force, 2000, AS PAC PERSP RED OB
   Wu FCW, 2008, J CLIN ENDOCR METAB, V93, P2737, DOI 10.1210/jc.2007-1972
NR 35
TC 13
Z9 13
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0300-0664
EI 1365-2265
J9 CLIN ENDOCRINOL
JI Clin. Endocrinol.
PD AUG
PY 2012
VL 77
IS 2
BP 296
EP 301
DI 10.1111/j.1365-2265.2012.04375.x
PG 6
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 971SF
UT WOS:000306223400019
PM 22372615
DA 2024-02-19
ER

PT J
AU Li, H
   Zhai, BT
   Sun, J
   Fan, Y
   Zou, JB
   Cheng, JX
   Zhang, XF
   Shi, YJ
   Guo, DY
AF Li, Huan
   Zhai, Bingtao
   Sun, Jing
   Fan, Yu
   Zou, Junbo
   Cheng, Jiangxue
   Zhang, Xiaofei
   Shi, Yajun
   Guo, Dongyan
TI Antioxidant, Anti-Aging and Organ Protective Effects of Total Saponins
   from <i>Aralia taibaiensis</i>
SO DRUG DESIGN DEVELOPMENT AND THERAPY
LA English
DT Article
DE Aralia taibaiensis total saponins; D-galactose; antioxidant; anti-aging
ID FREE-RADICAL THEORY; D-GALACTOSE; IN-VITRO; TRITERPENOID SAPONINS;
   COGNITIVE IMPAIRMENT; OXIDATIVE STRESS; POLYSACCHARIDES; MECHANISMS;
   PROTEIN; MODEL
AB Aim: Aralia taibaiensis is a natural medicinal and food plant that is rich in triterpenoid saponins with hypoglycaemic, antioxidant, hepatoprotective, anti-gastric ulcer and antiinflammatory effects. This study has significance in terms of the antioxidant, anti-aging and organ protective effects of Aralia taibaiensis total saponins (TSAT) in D-galactose induced aging rats.
   Methods: The saponin composition of TSAT was determined and quantified by high performance liquid chromatography (HPLC). We consolidated the antioxidant and enzyme inhibitory activities of TSAT in vitro and assessed the effects of TSAT on daily mobility, body weight, behaviour, organ indices, oxidation-related indices and pathological changes in aging rats.
   Results: In vitro experiments showed that TSAT had a scavenging effect on 1,1-diphenyl-2-picrylhydrazyl (DPPH), 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS), tyrosinase, hydroxyl radicals (HO center dot) and superoxide radicals (center dot O2-) and was closely related to the dose of TSAT. In vivo experiments showed that after 8 weeks of continuous gavage administration, the rats gradually recovered their body weight, daily activity ability, learning and memory ability and organ index and effectively improved D-gal-induced organ injury. Specifically, TSAT significantly increased the levels of superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GSH-Px) and total antioxidant capacity (T-AOC) and significantly decreased malondialdehyde (MDA) levels in the serum, brain, heart, lung, spleen and kidney of aging rats compared to the model group. In addition, TSAT significantly inhibited the D-gal-induced upregulation of hepatic alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels. The histopathological results showed that TSAT reversed D-gal induced damage to the brain, heart, lung, kidney, liver and spleen to varying degrees.
   Conclusion: TSAT is a high-quality natural product with antioxidant and anti-aging properties that can alleviate D-gal-induced aging damage in rats.
C1 [Li, Huan; Zhai, Bingtao; Sun, Jing; Zou, Junbo; Cheng, Jiangxue; Zhang, Xiaofei; Shi, Yajun; Guo, Dongyan] Shaanxi Univ Chinese Med, State Key Lab Res & Dev Characterist Qin Med Reso, Xian 712046, Peoples R China.
   [Li, Huan; Zhai, Bingtao; Sun, Jing; Zou, Junbo; Cheng, Jiangxue; Zhang, Xiaofei; Shi, Yajun; Guo, Dongyan] Shaanxi Univ Chinese Med, Key Lab Basic & New Drug Res Tradit Chinese Med, Xian 712046, Peoples R China.
   [Fan, Yu] Shaanxi Univ Chinese Med, Coll Basic Med, Xian 712046, Peoples R China.
C3 Shaanxi University of Chinese Medicine; Shaanxi University of Chinese
   Medicine; Shaanxi University of Chinese Medicine
RP Guo, DY (corresponding author), Shaanxi Univ Chinese Med, State Key Lab Res & Dev Characterist Qin Med Reso, Xian 712046, Peoples R China.; Guo, DY (corresponding author), Shaanxi Univ Chinese Med, Key Lab Basic & New Drug Res Tradit Chinese Med, Xian 712046, Peoples R China.
EM xmc2051080@163.com
RI zhang, xiaofei/HJA-9117-2022; Zou, Junbo/AAZ-2475-2021; Shi,
   Yajun/GPS-8969-2022
OI Shi, Yajun/0000-0002-4657-7337
FU National Natural Science Foundation of China [81703925]; disciplinary
   innovation team construction project of Shaanxi University of
   Traditional Chinese Medicine [2019-YL11]
FX This study was supported by the National Natural Science Foundation of
   China (No. 81703925) and the disciplinary innovation team construction
   project of Shaanxi University of Traditional Chinese Medicine
   (2019-YL11) .
CR Adefegha SA, 2021, J FOOD BIOCHEM, V45, DOI 10.1111/jfbc.13276
   Amorati R, 2012, CHEM COMMUN, V48, P11904, DOI 10.1039/c2cc36531f
   Angelova PR, 2016, FREE RADICAL BIO MED, V100, P81, DOI 10.1016/j.freeradbiomed.2016.06.005
   Atif F, 2008, J BIOCHEM MOL TOXIC, V22, P202, DOI 10.1002/jbt.20230
   Bi LL, 2012, FITOTERAPIA, V83, P234, DOI 10.1016/j.fitote.2011.11.002
   Butterfield DA, 2006, J NEUROCHEM, V98, P1697, DOI 10.1111/j.1471-4159.2006.03995.x
   Chan MS, 2015, ORG BIOMOL CHEM, V13, P7307, DOI 10.1039/c5ob00643k
   Chatatikun M, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1994-7
   Chen NY, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/4757520
   Cui J, 2013, LIFE SCI, V92, P131, DOI 10.1016/j.lfs.2012.11.014
   de Morais DV, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207510
   Du YY, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00180
   Duan JL, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/7609765
   Farhat Z, 2018, ENVIRON INT, V112, P287, DOI 10.1016/j.envint.2017.12.033
   Harman D, 2006, ANN NY ACAD SCI, V1067, P10, DOI 10.1196/annals.1354.003
   Hasegawa T, 2010, INT J MOL SCI, V11, P1082, DOI 10.3390/ijms11031082
   Hewitt G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1708
   Huang CX, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1163-z
   Khan SS, 2017, AGING CELL, V16, P624, DOI 10.1111/acel.12601
   Kregel KC, 2007, AM J PHYSIOL-REG I, V292, pR18, DOI 10.1152/ajpregu.00327.2006
   Li C, 2021, DRUG DES DEV THER, V15, P1441, DOI 10.2147/DDDT.S304885
   Li GW, 2018, BIOMED PHARMACOTHER, V99, P113, DOI 10.1016/j.biopha.2018.01.006
   Li L, 2016, NEURAL REGEN RES, V11, P807, DOI 10.4103/1673-5374.182709
   Li SS, 2018, INT J BIOL MACROMOL, V109, P457, DOI 10.1016/j.ijbiomac.2017.12.108
   Li YN, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/320513
   Liang J, 2019, INT J BIOL MACROMOL, V126, P414, DOI 10.1016/j.ijbiomac.2018.12.230
   Liochev SI, 2013, FREE RADICAL BIO MED, V60, P1, DOI 10.1016/j.freeradbiomed.2013.02.011
   Liu BH, 2019, EVID-BASED COMPL ALT, V2019, DOI 10.1155/2019/3152324
   Liu YF, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/4598167
   Martins D, 2014, ANTIOXID REDOX SIGN, V21, P1490, DOI 10.1089/ars.2013.5575
   Min F, 2020, EUR J PHARMACOL, V881, DOI 10.1016/j.ejphar.2020.173214
   Ozer JS, 2010, REGUL TOXICOL PHARM, V56, P237, DOI 10.1016/j.yrtph.2009.11.001
   Rafique R, 2020, BIOORG CHEM, V94, DOI 10.1016/j.bioorg.2019.103410
   Ramesh T, 2012, EXP GERONTOL, V47, P77, DOI 10.1016/j.exger.2011.10.007
   Ruan QW, 2014, GERONTOLOGY, V60, P424, DOI 10.1159/000358235
   Seven A, 2008, CLIN BIOCHEM, V41, P538, DOI 10.1016/j.clinbiochem.2008.01.029
   Sun YX, 2010, CARBOHYD POLYM, V82, P510, DOI 10.1016/j.carbpol.2010.05.010
   Tang H. F., 1996, Yaoxue Xuebao, V31, P517
   Tang T, 2013, AFR J TRADIT COMPLEM, V10, P12, DOI 10.4314/ajtcam.v10i4.3
   Tapondjou LA, 2011, CARBOHYD RES, V346, P2699, DOI 10.1016/j.carres.2011.09.014
   Wang M, 2016, ENVIRON RES, V149, P15, DOI 10.1016/j.envres.2016.04.031
   Wang M, 2017, J CELL MOL MED, V21, P1870, DOI 10.1111/jcmm.13107
   Wang SC, 2020, BIOMED PHARMACOTHER, V129, DOI 10.1016/j.biopha.2020.110403
   Wang X, 2014, PAK J PHARM SCI, V27, P1099
   Wang YH, 2019, BBA-MOL BASIS DIS, V1865, P1853, DOI 10.1016/j.bbadis.2018.12.008
   Weng Y, 2014, J ETHNOPHARMACOL, V152, P553, DOI 10.1016/j.jep.2014.02.001
   Wu ZW, 2020, J AGR FOOD CHEM, V68, P6977, DOI 10.1021/acs.jafc.0c01476
   Xi MM, 2010, REDOX REP, V15, P20, DOI 10.1179/174329210X12650506623041
   Xu XY, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8120572
   Yang XX, 2018, ENVIRON SCI TECHNOL, V52, P850, DOI 10.1021/acs.est.7b05057
   Zhang HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070090
   Zhao HP, 2017, AGING DIS, V8, P721, DOI 10.14336/AD.2017.0724
   Zhao X, 2021, DRUG DES DEV THER, V15, P1903, DOI 10.2147/DDDT.S305033
   Zhong SZ, 2009, J NEUROL SCI, V277, P58, DOI 10.1016/j.jns.2008.10.008
   Zolghadri S, 2019, J ENZYM INHIB MED CH, V34, P279, DOI 10.1080/14756366.2018.1545767
NR 55
TC 18
Z9 20
U1 5
U2 24
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1177-8881
J9 DRUG DES DEV THER
JI Drug Des. Dev. Ther.
PY 2021
VL 15
BP 4025
EP 4042
DI 10.2147/DDDT.S330222
PG 18
WC Chemistry, Medicinal; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA WC6MQ
UT WOS:000704370700003
PM 34594101
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Xu, JJ
   Yun, XJ
   Jiang, JH
   Wei, YY
   Wu, YH
   Zhang, W
   Liu, YH
   Wang, WZ
   Wen, YM
   Gu, JX
AF Xu, Jiejie
   Yun, Xiaojing
   Jiang, Jianhai
   Wei, Yuanyan
   Wu, Yihong
   Zhang, Wei
   Liu, Yeheng
   Wang, Wenzhong
   Wen, Yumei
   Gu, Jianxin
TI Hepatitis B Virus X Protein Blunts Senescence-Like Growth Arrest of
   Human Hepatocellular Carcinoma by Reducing Notch1 Cleavage
SO HEPATOLOGY
LA English
DT Article
ID HUMAN-CELLS; IDENTIFICATION; ACTIVATION; GENE; ONCOGENE; RECEPTOR;
   PATHWAY; CANCER; E1AF
AB One of the serious sequelae of chronic hepatitis B virus (HBV) infection is hepatocellular carcinoma (HCC). Among all the proteins encoded by the HBV genome, hepatitis B virus X protein (HBx) is highly associated with the development of HCC. Although Notch1 signaling has been found to exert a tumor-suppressive function during HCC development, the mechanism of interaction between HBx expression and Notch1 signaling needs to be explored. In this study, we report that HBx expression in hepatic and hepatoma cells resulted in decreased endogenous protein levels of Notch1 intracellular domain (ICN1) and messenger RNA levels of its downstream target genes. These effects were due to a reduction of Notch1 cleavage by HBx through the suppression of presenilin1 (Psen1) transcription rather than inhibition of Notch1 transcription or its ligands' expression. Through transient HBx expression, decreased ICN1 resulted in enhanced cell proliferation, induced G1-S cell cycle progression, and blunted cellular senescence in vitro. Furthermore, the effect of blunted senescence-like growth arrest by stable HBx expression through suppression of ICN1 was shown in a nude mouse xenograft transplantation model. The correlation of inhibited Psen1-dependent Notch1 signaling and blunted senescence-like growth arrest was also observed in HBV-associated HCC patient tumor samples. Conclusion: Our results reveal a novel function of HBx in blunting senescence-like growth arrest by decreasing Notch1 signaling, which could be a putative molecular mechanism mediating HBV-associated hepatocarcinogenesis. (HEPATOLOGY 2010;52:142-154)
C1 [Yun, Xiaojing; Jiang, Jianhai; Wei, Yuanyan; Wu, Yihong; Zhang, Wei; Liu, Yeheng; Wang, Wenzhong; Gu, Jianxin] Fudan Univ, Shanghai Med Coll, Ctr Gene Res, Shanghai 200032, Peoples R China.
   [Yun, Xiaojing; Jiang, Jianhai; Wei, Yuanyan; Wu, Yihong; Zhang, Wei; Liu, Yeheng; Wang, Wenzhong; Gu, Jianxin] Fudan Univ, Minist Hlth, Key Lab Glycoconjuates Res, Shanghai Med Coll, Shanghai 200032, Peoples R China.
   [Xu, Jiejie; Wen, Yumei] Fudan Univ, Key Lab Med Mol Virol, Inst Med Microbiol, Minist Educ & Hlth,Shanghai Med Coll, Shanghai 200032, Peoples R China.
C3 Fudan University; Fudan University; Fudan University
RP Gu, JX (corresponding author), Fudan Univ, Shanghai Med Coll, Ctr Gene Res, Shanghai 200032, Peoples R China.
EM ymwen@shmu.edu.cn; jxgu@shmu.edu.cn
RI wen, yu/AAJ-7482-2021; long, chen/JVM-8568-2024; wei,
   yuanyan/IQT-4080-2023
OI Gu, Jianxin/0000-0002-7454-6722
FU State Key Project Specialized for Infectious Diseases of China
   [2008ZX10002-015, 2008ZX10002-021, 2008ZX10001-02]; Shanghai Leading
   Academic Discipline Project [B110]; National Fund Program of Personnel
   Training in Basic Science [J0730860]; National Basic Research Program of
   China 973 Program [2010CB912100, 2010CB912104]; National Natural Science
   Fund [30770426, 30930025, 30900266]
FX Supported by grants from the State Key Project Specialized for
   Infectious Diseases of China (2008ZX10002-015. 2008ZX10002-021,
   2008ZX10001-02), the Shanghai Leading Academic Discipline Project
   (B110), the National Fund Program of Personnel Training in Basic Science
   (J0730860), the National Basic Research Program of China 973 Program
   (2010CB912100, 2010CB912104), and the National Natural Science Fund
   (30770426, 30930025, 30900266).
CR Aravalli RN, 2008, HEPATOLOGY, V48, P2047, DOI 10.1002/hep.22580
   Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770
   ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513
   BEASLEY RP, 1981, LANCET, V2, P1129
   Bolós V, 2007, ENDOCR REV, V28, P339, DOI 10.1210/er.2006-0046
   Bouchard MJ, 2004, J VIROL, V78, P12725, DOI 10.1128/JVI.78.23.12725-12734.2004
   Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009
   Bréchot C, 2004, GASTROENTEROLOGY, V127, pS56, DOI 10.1053/j.gastro.2004.09.016
   Cha MY, 2004, HEPATOLOGY, V39, P1683, DOI 10.1002/hep.20245
   Croquelois A, 2005, HEPATOLOGY, V41, P487, DOI 10.1002/hep.20571
   Di Bisceglie AM, 2009, HEPATOLOGY, V49, pS56, DOI 10.1002/hep.22962
   Dimri GP, 2005, CANCER CELL, V7, P505, DOI 10.1016/j.ccr.2005.05.025
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061
   Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934
   Gao B, 2009, HEPATOLOGY, V50, P424, DOI 10.1002/hep.23011
   Hübscher SG, 2005, HEPATOLOGY, V41, P439, DOI 10.1002/hep.20640
   Jiang JH, 2007, MOL CELL BIOL, V27, P8770, DOI 10.1128/MCB.02302-06
   Kang DE, 2002, CELL, V110, P751, DOI 10.1016/S0092-8674(02)00970-4
   KIM CM, 1991, NATURE, V351, P317, DOI 10.1038/351317a0
   Kim H, 2009, HEPATOLOGY, V50, P752, DOI 10.1002/hep.23072
   Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045
   Lee WM, 1997, NEW ENGL J MED, V337, P1733, DOI 10.1056/NEJM199712113372406
   Leong KG, 2006, BLOOD, V107, P2223, DOI 10.1182/blood-2005-08-3329
   Li T, 2007, J BIOL CHEM, V282, P32264, DOI 10.1074/jbc.M703649200
   Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1
   Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098
   MAGUIRE HF, 1991, SCIENCE, V252, P842, DOI 10.1126/science.1827531
   Mooi WJ, 2006, NEW ENGL J MED, V355, P1037, DOI 10.1056/NEJMra062285
   Qi RZ, 2003, CANCER RES, V63, P8323
   Radtke F, 2003, NAT REV CANCER, V3, P756, DOI 10.1038/nrc1186
   SETO E, 1990, NATURE, V344, P72, DOI 10.1038/344072a0
   Su Q, 1998, HEPATOLOGY, V27, P1109, DOI 10.1002/hep.510270428
   Sun BS, 1998, HEPATOLOGY, V27, P228, DOI 10.1002/hep.510270135
   Wang CM, 2009, J BIOL CHEM, V284, P16183, DOI 10.1074/jbc.M109.002105
   Wei YY, 2008, J HEPATOL, V49, P1029, DOI 10.1016/j.jhep.2008.09.003
   WU JY, 1990, CELL, V63, P687, DOI 10.1016/0092-8674(90)90135-2
   Xia XF, 2001, P NATL ACAD SCI USA, V98, P10863, DOI 10.1073/pnas.191284198
   Zhang YW, 2007, P NATL ACAD SCI USA, V104, P10613, DOI 10.1073/pnas.0703903104
   Zhu XY, 2005, J BIOL CHEM, V280, P12503, DOI 10.1074/jbc.M413631200
NR 40
TC 65
Z9 66
U1 0
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD JUL
PY 2010
VL 52
IS 1
BP 142
EP 154
DI 10.1002/hep.23613
PG 13
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 619DK
UT WOS:000279409200016
PM 20578140
OA Bronze
DA 2024-02-19
ER

PT J
AU Feng, Y
   Yu, YH
   Wang, ST
   Ren, J
   Camer, D
   Hua, YZ
   Zhang, Q
   Huang, J
   Xue, DL
   Zhang, XF
   Huang, XF
   Liu, Y
AF Feng, Yan
   Yu, Ying-Hua
   Wang, Shu-Ting
   Ren, Jing
   Camer, Danielle
   Hua, Yu-Zhou
   Zhang, Qian
   Huang, Jie
   Xue, Dan-Lu
   Zhang, Xiao-Fei
   Huang, Xu-Feng
   Liu, Yi
TI Chlorogenic acid protects d-galactose-induced liver and kidney injury
   via antioxidation and anti-inflammation effects in mice
SO PHARMACEUTICAL BIOLOGY
LA English
DT Article
DE CGA; oxidative stress; d-gal
ID INDUCED OXIDATIVE STRESS; MOLECULAR-MECHANISMS; MOUSE-LIVER
AB Context Oxidative stress and inflammation are implicated in the aging process and its related hepatic and renal function decline. Chlorogenic acid (CGA) is one of the most abundant polyphenol compounds in the human diet. Recently, CGA has shown in vivo and in vitro antioxidant properties.
   Objective The current study investigates the effects of protective effects of chlorogenic acid (CGA) on d-galactose-induced liver and kidney injury.
   Materials and methods Hepatic and renal injuries were induced in a mouse model by subcutaneously injection of d-galactose (d-gal; 100 mg/kg) once a day for 8 consecutive weeks and orally administered simultaneously with CGA included in the food (200 mg/kg of diet). The liver and renal functions were examined. Histological analyses of liver and kidney were done by haematoxylin and eosin staining. The oxidative stress markers and pro-inflammatory cytokines in the liver and the kidney were measured.
   Results CGA significantly reduced the serum aminotransferase, serum creatinine (SCr) and blood urea nitrogen (BUN) levels in d-gal mice (p <0.05). CGA also restored superoxide dismutase, catalase, and malondialdehyde levels and decreased glutathione content in the liver and kidney in d-gal mice (p <0.05). Improvements in liver and kidney were also noted in histopathological studies. CGA reduced tumour necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) protein levels in the liver and kidney in d-gal mice (p <0.05).
   Discussion and conclusion These findings suggest that CGA attenuates d-gal-induced chronic liver and kidney injury and that this protection may be due to its antioxidative and anti-inflammatory activities.
C1 [Feng, Yan; Wang, Shu-Ting; Ren, Jing; Hua, Yu-Zhou; Zhang, Qian; Huang, Jie; Xue, Dan-Lu; Zhang, Xiao-Fei; Liu, Yi] Xuzhou Med Coll, Jiangsu Key Lab New Drug Res & Clin Pharm, 209 Tongshan Rd, Xuzhou 221004, Jiangsu, Peoples R China.
   [Yu, Ying-Hua; Huang, Xu-Feng] SRI, Sydney, NSW, Australia.
   [Yu, Ying-Hua; Camer, Danielle; Huang, Xu-Feng] Univ Wollongong, Sch Med, Illawarra Hlth & Med Res Inst, Northfields Ave, Wollongong, NSW 2522, Australia.
C3 Xuzhou Medical University; University of Wollongong
RP Liu, Y (corresponding author), Xuzhou Med Coll, Jiangsu Key Lab New Drug Res & Clin Pharm, 209 Tongshan Rd, Xuzhou 221004, Jiangsu, Peoples R China.; Huang, XF (corresponding author), Univ Wollongong, Fac Sci Med & Hlth, Sch Med, Illawarra Hlth & Med Res Inst, Northfields Ave, Wollongong, NSW 2522, Australia.
EM xhuang@uow.edu.au; Njuliuyi@163.com
RI Huang, Xu-Feng/D-6053-2013; zhang, xiaofei/HJA-9117-2022; 黄,
   旭/JFJ-8744-2023; Huang, Xu/HOH-0307-2023
OI Huang, Xu-Feng/0000-0002-5895-2253; Yu, Yinghua/0000-0003-2508-7512
FU National Natural Science Foundation of China [81341084]; Superiority
   Academic Discipline Construction Project of Jiangsu Higher Education
   Institutions; Post-doctoral Fund in Jiangsu Province [1201036B];
   ''Qing-Lan'' Project of Jiangsu Province; ''Six-Talents Summit'' Project
   of Jiangsu Province [2011-YY-13]; Industrialization of Scientific
   Research Promotion Projects of Universities and Colleges in Jiangsu
   Province [2011-16]; Natural Science Fund for Universities and Colleges
   in Jiangsu Province [11KJB350005]; Jiangsu Key Laboratory of New Drug
   Research and Clinical Pharmacy [2011YKJ004]; Foundation of Xuzhou
   Medical College Key Laboratory of Tumor Biology Therapy for Tumor
   [C0904, JSBL0803, C0903]; Science and Technology Plan Projects of Xuzhou
   [XF11C037, XF11C062, XZZD1227, XZZD1219]; research project of Xuzhou
   [BRA201205]
FX This work was supported by the National Natural Science Foundation of
   China (81341084), Superiority Academic Discipline Construction Project
   of Jiangsu Higher Education Institutions, the Post-doctoral Fund in
   Jiangsu Province (1201036B), the ''Qing-Lan'' Project of Jiangsu
   Province, ''Six-Talents Summit'' Project of Jiangsu Province
   (2011-YY-13), the Industrialization of Scientific Research Promotion
   Projects of Universities and Colleges in Jiangsu Province (2011-16), the
   Natural Science Fund for Universities and Colleges in Jiangsu Province
   (11KJB350005), Jiangsu Key Laboratory of New Drug Research and Clinical
   Pharmacy (2011YKJ004), the Foundation of Xuzhou Medical College Key
   Laboratory of Tumor Biology Therapy for Tumor (C0904, JSBL0803, and
   C0903), the Science and Technology Plan Projects of Xuzhou (XF11C037;
   XF11C062, XF11C062; XZZD1227; XZZD1219), the research project of Xuzhou
   (BRA201205).
CR Aebi H, 1984, Methods Enzymol, V105, P121
   Bekedam EK, 2008, J AGR FOOD CHEM, V56, P2055, DOI 10.1021/jf073157k
   Chen S, 2008, KIDNEY INT, V74, P1128, DOI 10.1038/ki.2008.380
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Dong M, 2013, MOL MED REP, V7, P1919, DOI 10.3892/mmr.2013.1443
   Fan SH, 2009, INT IMMUNOPHARMACOL, V9, P91, DOI 10.1016/j.intimp.2008.10.008
   Heitman E, 2017, NUTR NEUROSCI, V20, P32, DOI 10.1179/1476830514Y.0000000146
   Kozlov AV, 2010, INFLAMMATION, V33, P295, DOI 10.1007/s10753-010-9185-4
   Kulinsky VI, 2007, BIOCHEMISTRY-MOSCOW+, V72, P595, DOI 10.1134/S0006297907060028
   Li JJ, 2015, BRAIN RES, V1595, P19, DOI 10.1016/j.brainres.2014.10.012
   Li L, 2005, LIFE SCI, V77, P230, DOI 10.1016/j.lfs.2004.12.024
   Lu J, 2007, BIOCHEM PHARMACOL, V74, P1078, DOI 10.1016/j.bcp.2007.07.007
   Malhi H, 2008, GASTROENTEROLOGY, V134, P1641, DOI 10.1053/j.gastro.2008.03.002
   Mei CL, 2009, SEMIN NEPHROL, V29, P555, DOI 10.1016/j.semnephrol.2009.07.002
   Nowak M, 2000, AM J PHYSIOL-REG I, V278, pR1202, DOI 10.1152/ajpregu.2000.278.5.R1202
   REITMAN S, 1957, AM J CLIN PATHOL, V28, P56, DOI 10.1093/ajcp/28.1.56
   Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006
   Ruan QW, 2013, MECH AGEING DEV, V134, P89, DOI 10.1016/j.mad.2012.12.005
   Sarkar D, 2006, CANCER LETT, V236, P13, DOI 10.1016/j.canlet.2005.04.009
   Sato Y, 2011, INT J PHARMACEUT, V403, P136, DOI 10.1016/j.ijpharm.2010.09.035
   Shi M, 2004, IMMUNOL LETT, V95, P233, DOI 10.1016/j.imlet.2004.07.003
   SUN Y, 1990, FREE RADICAL BIO MED, V8, P583, DOI 10.1016/0891-5849(90)90156-D
   Theiss AL, 2009, GASTROENTEROLOGY, V137, P199, DOI 10.1053/j.gastro.2009.03.033
   Tolosano E, 2002, BLOOD, V100, P4201, DOI 10.1182/blood-2002-04-1270
   Tsuchiya T, 1996, BIOSCI BIOTECH BIOCH, V60, P765, DOI 10.1271/bbb.60.765
   UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1
   Wei HF, 2005, BEHAV BRAIN RES, V157, P245, DOI 10.1016/j.bbr.2004.07.003
   Xu YX, 2010, INFLAMM RES, V59, P871, DOI 10.1007/s00011-010-0199-z
   Yu YH, 2015, MOL CELL BIOCHEM, V403, P287, DOI 10.1007/s11010-015-2358-6
   Yun N, 2012, J NUTR BIOCHEM, V23, P1249, DOI 10.1016/j.jnutbio.2011.06.018
   Zhang X, 2010, INJURY, V41, P746, DOI 10.1016/j.injury.2010.02.029
   Zhang ZF, 2009, J AGR FOOD CHEM, V57, P7731, DOI 10.1021/jf9012357
   Zhang ZF, 2009, FOOD CHEM TOXICOL, V47, P496, DOI 10.1016/j.fct.2008.12.005
NR 33
TC 95
Z9 104
U1 8
U2 84
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1388-0209
EI 1744-5116
J9 PHARM BIOL
JI Pharm. Biol.
PD JUN 2
PY 2016
VL 54
IS 6
BP 1027
EP 1034
DI 10.3109/13880209.2015.1093510
PG 8
WC Plant Sciences; Medical Laboratory Technology; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Plant Sciences; Medical Laboratory Technology; Pharmacology & Pharmacy
GA DJ1QF
UT WOS:000373977600012
PM 26810301
OA Green Submitted, Bronze
DA 2024-02-19
ER

PT J
AU Hahn, O
   Stubbs, TM
   Reik, W
   Grönke, S
   Beyer, A
   Partridge, L
AF Hahn, Oliver
   Stubbs, Thomas M.
   Reik, Wolf
   Groenke, Sebastian
   Beyer, Andreas
   Partridge, Linda
TI Hepatic gene body hypermethylation is a shared epigenetic signature of
   murine longevity
SO PLOS GENETICS
LA English
DT Article
ID GROWTH-FACTOR RECEPTOR-3; FATAL NEOPLASTIC DISEASES; DNA METHYLATION
   PATTERNS; ELEMENT-BINDING PROTEIN; INCREASE LIFE-SPAN; AMES DWARF MICE;
   CALORIC RESTRICTION; DIETARY RESTRICTION; HEPATOCELLULAR-CARCINOMA;
   TRANSCRIPTIONAL CONTROL
AB Dietary, pharmacological and genetic interventions can extend health- and lifespan in diverse mammalian species. DNA methylation has been implicated in mediating the beneficial effects of these interventions; methylation patterns deteriorate during ageing, and this is prevented by lifespan-extending interventions. However, whether these interventions also actively shape the epigenome, and whether such epigenetic reprogramming contributes to improved health at old age, remains underexplored. We analysed published, whole genome, BS-seq data sets from mouse liver to explore DNA methylation patterns in aged mice in response to three lifespan-extending interventions: dietary restriction (DR), reduced TOR signaling (rapamycin), and reduced growth (Ames dwarf mice). Dwarf mice show enhanced DNA hypermethylation in the body of key genes in lipid biosynthesis, cell proliferation and somatotropic signaling, which strongly correlates with the pattern of transcriptional repression. Remarkably, DR causes a similar hypermethylation in lipid biosynthesis genes, while rapamycin treatment increases methylation signatures in genes coding for growth factor and growth hormone receptors. Shared changes of DNA methylation were restricted to hypermethylated regions, and they were not merely a consequence of slowed ageing, thus suggesting an active mechanism driving their formation. By comparing the overlap in ageing-independent hypermethylated patterns between all three interventions, we identified four regions, which, independent of genetic background or gender, may serve as novel biomarkers for longevity-extending interventions. In summary, we identified gene body hypermethylation as a novel and partly conserved signature of lifespan-extending interventions in mouse, highlighting epigenetic reprogramming as a possible intervention to improve health at old age.
C1 [Hahn, Oliver; Groenke, Sebastian; Partridge, Linda] Max Planck Inst Biol Ageing, Cologne, Germany.
   [Hahn, Oliver; Beyer, Andreas] Univ Cologne, Cellular Networks & Syst Biol, CECAD, Cologne, Germany.
   [Stubbs, Thomas M.; Reik, Wolf] Babraham Inst, Epigenet Programme, Cambridge, England.
   [Reik, Wolf] Wellcome Trust Sanger Inst, Cambridge, England.
   [Beyer, Andreas] Univ Cologne, Ctr Mol Med Cologne, Cologne, Germany.
   [Partridge, Linda] UCL, Inst Hlth Ageing, Dept Genet Evolut & Environm, London, England.
C3 Max Planck Society; University of Cologne; UK Research & Innovation
   (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC);
   Babraham Institute; Wellcome Trust Sanger Institute; University of
   Cologne; University of London; University College London
RP Grönke, S; Partridge, L (corresponding author), Max Planck Inst Biol Ageing, Cologne, Germany.; Beyer, A (corresponding author), Univ Cologne, Cellular Networks & Syst Biol, CECAD, Cologne, Germany.; Beyer, A (corresponding author), Univ Cologne, Ctr Mol Med Cologne, Cologne, Germany.; Partridge, L (corresponding author), UCL, Inst Hlth Ageing, Dept Genet Evolut & Environm, London, England.
EM Sebastian.Groenke@age.mpg.de; Andreas.beyer@uni-koeln.de;
   Partridge@age.mpg.de
RI Reik, Wolf/I-6794-2012; Beyer, Andreas/AAQ-5519-2020; Partridge,
   Linda/A-5501-2010; Hahn, Oliver/AAK-1468-2020; Hahn, Oliver/G-7518-2017
OI Beyer, Andreas/0000-0002-3891-2123; Hahn, Oliver/0000-0001-9015-4545;
   Partridge, Linda/0000-0001-9615-0094; Reik, Wolf/0000-0003-0216-9881;
   Gronke, Sebastian/0000-0002-1539-5346
FU Max Planck Society; Bundesministerium fur Bildung und Forschung Grant
   [SyBACol 0315893A-B]; European Research Council under the European
   Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant [268739];
   BBSRC; Wellcome Trust; EU EpiGeneSys; BLUEPRINT; BBSRC
   [BBS/E/B/000C0423, BBS/E/B/000C0425] Funding Source: UKRI
FX We acknowledge funding from the Max Planck Society (to LP;
   https://www.mpg.de/de), Bundesministerium fur Bildung und Forschung
   Grant SyBACol 0315893A-B (to AB and LP; https://www.sybacol.org/) and
   the European Research Council under the European Union's Seventh
   Framework Programme (FP7/2007-2013)/ERC grant agreement number 268739
   (to LP; https://ec.europa.eu/research/fp7/index_en.cfm). Work in the
   Reik laboratory was supported by BBSRC
   (https://bbsrc.ukri.org/funding/), Wellcome Trust
   (https://wellcome.ac.uk/funding), EU EpiGeneSys
   (https://www.epigenesys.eu/es/) and BLUEPRINT. The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Ai X, 2015, ONCOL LETT, V10, P543, DOI 10.3892/ol.2015.3231
   Alexa A., 2010, BIOCONDUCTOR TOPGO R
   Anderson Rozalyn M., 2007, V35, P18
   Anderson RM, 2010, TRENDS ENDOCRIN MET, V21, P134, DOI 10.1016/j.tem.2009.11.005
   Anisimov VN, 2013, CRIT REV ONCOL HEMAT, V87, P201, DOI 10.1016/j.critrevonc.2013.01.005
   Bacalini MG, 2017, J GERONTOL A-BIOL, V72, P1015, DOI 10.1093/gerona/glw185
   Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932
   Bartke A, 2001, NATURE, V414, P412, DOI 10.1038/35106646
   Bartke A, 2013, PHYSIOL REV, V93, P571, DOI 10.1152/physrev.00006.2012
   Bartke Andrzej, 2012, Frontiers in Genetics, V3, P288, DOI 10.3389/fgene.2012.00288
   Beerman I, 2013, CELL STEM CELL, V12, P413, DOI 10.1016/j.stem.2013.01.017
   Benayoun BA, 2015, NAT REV MOL CELL BIO, V16, P593, DOI 10.1038/nrm4048
   Bené H, 2001, BIOCHEM BIOPH RES CO, V284, P1194, DOI 10.1006/bbrc.2001.5102
   Berasain C, 2014, J GASTROENTEROL, V49, P9, DOI 10.1007/s00535-013-0907-x
   Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102
   Blaas L, 2010, HEPATOLOGY, V51, P1319, DOI 10.1002/hep.23469
   Bonkowski MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004567
   Booth LN, 2016, MOL CELL, V62, P728, DOI 10.1016/j.molcel.2016.05.013
   Boylston WH, 2004, AGING CELL, V3, P283, DOI 10.1111/j.1474-9728.2004.00115.x
   Bridle KR, 2009, LIVER TRANSPLANT, V15, P1315, DOI 10.1002/lt.21804
   Brown-Borg HM, 2015, AM J PHYSIOL-ENDOC M, V309, pE503, DOI 10.1152/ajpendo.00262.2015
   BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0
   Cava E, 2013, WILL CALORIE RESTRIC
   Chaveroux C, 2013, CELL METAB, V17, P586, DOI 10.1016/j.cmet.2013.03.003
   Chia DJ, 2014, MOL ENDOCRINOL, V28, P1012, DOI 10.1210/me.2014-1099
   Clancy DJ, 2002, SCIENCE
   Cole JJ, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1185-3
   Colman RJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4557
   Coschigano KT, 2000, ENDOCRINOLOGY, V141, P2608, DOI 10.1210/en.141.7.2608
   Du XN, 2012, CANCER RES, V72, P5843, DOI 10.1158/0008-5472.CAN-12-1329
   Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247
   Ficz G, 2013, CELL STEM CELL, V13, P351, DOI 10.1016/j.stem.2013.06.004
   Finkel T, 2015, NAT MED, V21, P1416, DOI 10.1038/nm.3998
   Flurkey K, 2002, MECH AGEING DEV, V123, P121, DOI 10.1016/S0047-6374(01)00339-6
   Flurkey K, 2010, J GERONTOL A-BIOL, V65, P1275, DOI 10.1093/gerona/glq155
   Fok WC, 2014, AGING CELL, V13, P311, DOI 10.1111/acel.12175
   Foldynova-Trantirkova S, 2012, HUM MUTAT, V33, P29, DOI 10.1002/humu.21636
   Fontana L, 2015, CELL, V161, P106, DOI 10.1016/j.cell.2015.02.020
   Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539
   Forster MJ, 2003, FASEB J, V17, P690, DOI 10.1096/fj.02-0533fje
   Garcia AM, 2008, MECH AGEING DEV, V129, P528, DOI 10.1016/j.mad.2008.04.013
   González L, 2010, J ENDOCRINOL, V204, P299, DOI 10.1677/JOE-09-0372
   Gu HC, 2011, NAT PROTOC, V6, P468, DOI 10.1038/nprot.2010.190
   Gu H, 2010, NAT METHODS, V7, P133, DOI 10.1038/nmeth.1414
   Hadad N, 2018, NEUROBIOL AGING, V67, P53, DOI 10.1016/j.neurobiolaging.2018.03.009
   Hahn O, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1187-1
   Han S, 2007, PROTEIN SCI, V16, P2272, DOI 10.1110/ps.073068407
   Harada N, 2012, BIOCHEM BIOPH RES CO, V423, P128, DOI 10.1016/j.bbrc.2012.05.094
   Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221
   Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111
   Hayashi AA, 2007, AM J PHYSIOL-ENDOC M, V292, pE1647, DOI 10.1152/ajpendo.00674.2006
   Hill CM, 2016, AGING CELL, V15, P509, DOI 10.1111/acel.12467
   Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100
   Horvath S, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1030-0
   Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115
   Ide T, 2004, NAT CELL BIOL, V6, P351, DOI 10.1038/ncb1111
   Ikeno Y, 2003, J GERONTOL A-BIOL, V58, P291
   Ikeno Y, 2013, PATHOBIOL AGING AGE, V3, DOI 10.3402/pba.v3i0.20833
   Ikeno Y, 2009, J GERONTOL A-BIOL, V64, P522, DOI 10.1093/gerona/glp017
   Illingworth RS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001134
   Jin CY, 2006, NAT STRUCT MOL BIOL, V13, P331, DOI 10.1038/nsmb1063
   Jjingo D, 2012, ONCOTARGET, V3, P462, DOI 10.18632/oncotarget.497
   Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230
   Jonkers I, 2014, ELIFE, V3, DOI 10.7554/eLife.02407
   Junnila RK, 2016, ENDOCRINOLOGY, V157, P4502, DOI 10.1210/en.2016-1649
   Kamileri I, 2012, P NATL ACAD SCI USA, V109, P2995, DOI 10.1073/pnas.1114941109
   Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059
   Katoh M, 2016, INT J MOL MED, V38, P3, DOI 10.3892/ijmm.2016.2620
   Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102
   Kim CH, 2016, AGING CELL, V15, P1074, DOI 10.1111/acel.12513
   Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36
   King MA, 2016, ONCOGENE, V35, P4518, DOI 10.1038/onc.2015.511
   Knight BL, 2005, BIOCHEM J, V389, P413, DOI 10.1042/BJ20041896
   Komposch K, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010030
   Krueger F, 2012, NAT METHODS, V9, P145, DOI [10.1038/NMETH.1828, 10.1038/nmeth.1828]
   Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167
   Kulis M, 2012, NAT GENET, V44, P1236, DOI 10.1038/ng.2443
   Kwon S, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0211-x
   Lahuna O, 2000, MOL ENDOCRINOL, V14, P285, DOI 10.1210/me.14.2.285
   Latasa MJ, 2000, P NATL ACAD SCI USA, V97, P10619, DOI 10.1073/pnas.180306597
   Lehner F, 2007, FASEB J, V21, P1445, DOI 10.1096/fj.06-6575com
   Lehner F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013344
   Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Li J, 2014, CELL METAB, V19, P373, DOI 10.1016/j.cmet.2014.01.001
   Liao CY, 2010, AGING CELL, V9, P92, DOI 10.1111/j.1474-9726.2009.00533.x
   Liu SQ, 2011, CELL RES, V21, P6, DOI 10.1038/cr.2010.170
   Longo VD, 2015, AGING CELL, V14, P497, DOI 10.1111/acel.12338
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Ma L, 2006, J BIOL CHEM, V281, P28721, DOI 10.1074/jbc.M601576200
   Maegawa S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00607-3
   Mandl M, 2014, MOL MED, V20, P215, DOI 10.2119/molmed.2014.00032
   Mao K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04805-5
   Masser DR, 2017, AGING CELL, V16, P1342, DOI 10.1111/acel.12681
   Masser DR, 2015, JOVE-J VIS EXP, DOI 10.3791/52488
   Masternak MM, 2007, PPAR RES, V2007, DOI 10.1155/2007/28436
   Masternak MM, 2010, J GERONTOL A-BIOL, V65, P24, DOI 10.1093/gerona/glp172
   Masternak MM, 2014, EXPERT REVIEW OF END, V1, P775
   Mathieu ME, 2012, STEM CELL REV REP, V8, P1, DOI 10.1007/s12015-011-9261-7
   Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662
   Matter MS, 2014, J HEPATOL, V60, P855, DOI 10.1016/j.jhep.2013.11.031
   Mattison JA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14063
   Mei SL, 2017, NUCLEIC ACIDS RES, V45, pD658, DOI 10.1093/nar/gkw983
   Merry BJ, 2008, MECH AGEING DEV, V129, P341, DOI 10.1016/j.mad.2008.04.004
   Miller RA, 2014, AGING CELL, V13, P468, DOI 10.1111/acel.12194
   Miquet JG, 2010, GROWTH HORM IGF RES, V20, P118, DOI 10.1016/j.ghir.2009.11.003
   Mitchell SJ, 2016, CELL METAB, V23, P1093, DOI 10.1016/j.cmet.2016.05.027
   Morton SD, 2015, ONCOTARGET, V6, P26052, DOI 10.18632/oncotarget.4482
   Mueller KM, 2012, MOL CELL ENDOCRINOL, V361, P1, DOI 10.1016/j.mce.2012.03.026
   Mueller KM, 2011, HEPATOLOGY, V54, P1398, DOI 10.1002/hep.24509
   Nadon NL, 2008, AGE, V30, P187, DOI 10.1007/s11357-008-9048-1
   Nicola NA, 2015, CYTOKINE GROWTH F R, V26, P533, DOI 10.1016/j.cytogfr.2015.07.001
   Ornitz DM, 2015, WIRES DEV BIOL, V4, P215, DOI 10.1002/wdev.176
   Orozco LD, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-5-r68
   Palmes D, 2008, VIRCHOWS ARCH, V452, P545, DOI 10.1007/s00428-008-0604-y
   Paur J, 2015, HEPATOLOGY, V62, P1767, DOI 10.1002/hep.28023
   Petkovich DA, 2017, CELL METAB, V25, P954, DOI 10.1016/j.cmet.2017.03.016
   Pifferi F, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0024-8
   Plank M, 2012, MOL BIOSYST, V8, P1339, DOI 10.1039/c2mb05255e
   Poupeau A, 2011, BBA-MOL BASIS DIS, V1812, P995, DOI 10.1016/j.bbadis.2011.03.015
   Qiu WH, 2005, WORLD J GASTROENTERO, V11, P5266, DOI 10.3748/wjg.v11.i34.5266
   Rastegar M, 2000, MOL CELL ENDOCRINOL, V164, P1, DOI 10.1016/S0303-7207(00)00263-X
   Reed BD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000133
   Regan JC, 2016, ELIFE, V5, DOI 10.7554/eLife.10956
   Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900
   Robertson IB, 2015, MATRIX BIOL, V47, P44, DOI 10.1016/j.matbio.2015.05.005
   Rome S, 2008, PHYSIOL GENOMICS, V34, P327, DOI 10.1152/physiolgenomics.90211.2008
   Rosenbloom KR, 2015, NUCLEIC ACIDS RES, V43, pD670, DOI 10.1093/nar/gku1177
   Rowland JE, 2005, MOL CELL BIOL, V25, P66, DOI 10.1128/MCB.25.1.66-77.2005
   Salmon AB, 2005, AM J PHYSIOL-ENDOC M, V289, pE23, DOI 10.1152/ajpendo.00575.2004
   Sandhu DS, 2014, HEPATOLOGY, V59, P1166, DOI 10.1002/hep.26679
   Schultz MD, 2015, NATURE, V523, P212, DOI 10.1038/nature14465
   Schumacher B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000161
   Selman C, 2008, FASEB J, V22, P807, DOI 10.1096/fj.07-9261com
   Sharp ZD, 2005, J GERONTOL A-BIOL, V60, P293, DOI 10.1093/gerona/60.3.293
   Shikama A, 2015, BIOCHEM BIOPH RES CO, V465, P857, DOI 10.1016/j.bbrc.2015.08.101
   Slack C, 2015, CELL, V162, P72, DOI 10.1016/j.cell.2015.06.023
   SLAGBOOM PE, 1990, FEBS LETT, V269, P128, DOI 10.1016/0014-5793(90)81136-C
   Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354
   Solon-Biet SM, 2015, CELL REP, V11, P1529, DOI 10.1016/j.celrep.2015.05.007
   Stiedl P, 2015, HEPATOLOGY, V61, P613, DOI 10.1002/hep.27408
   Strong R, 2008, AGING CELL, V7, P641, DOI 10.1111/j.1474-9726.2008.00414.x
   Stubbs TM, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1203-5
   Swindell WR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-585
   Swindell WR, 2009, MECH AGEING DEV, V130, P393, DOI 10.1016/j.mad.2009.03.004
   Swindell WR, 2007, BMC GENOMICS, V8
   Sziráki A, 2018, AGING CELL, V17, DOI 10.1111/acel.12738
   Tan YJ, 2006, GASTROENTEROLOGY, V130, P1283, DOI 10.1053/j.gastro.2006.01.010
   Tsuchiya T, 2004, PHYSIOL GENOMICS, V17, P307, DOI 10.1152/physiolgenomics.00039.2004
   van der Pluijm I, 2007, PLOS BIOL, V5, P23, DOI 10.1371/journal.pbio.0050002
   Veloso A, 2014, GENOME RES, V24, P896, DOI 10.1101/gr.171405.113
   Wang TN, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1186-2
   Wang YH, 2015, NAT REV MOL CELL BIO, V16, P678, DOI 10.1038/nrm4074
   Weidner CI, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r24
   Weindruch R, 1996, TOXICOL PATHOL, V24, P742, DOI 10.1177/019262339602400618
   Weindruch R, 1986, J NUTR
   Wu H, 2014, CELL, V156, P45, DOI 10.1016/j.cell.2013.12.019
   Xu X, 2013, SEMIN LIVER DIS, V33, P301, DOI 10.1055/s-0033-1358523
   Yu GC, 2016, MOL BIOSYST, V12, P477, DOI 10.1039/c5mb00663e
   Zhang N, 2015, ANIMAL NUTR
NR 160
TC 6
Z9 7
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7404
J9 PLOS GENET
JI PLoS Genet.
PD NOV
PY 2018
VL 14
IS 11
AR e1007766
DI 10.1371/journal.pgen.1007766
PG 37
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA HD3WD
UT WOS:000452454300027
PM 30462643
OA Green Published, gold, Green Submitted
DA 2024-02-19
ER

PT J
AU Brodsky, V
   Golichenkov, V
   Zvezdina, N
   Dubovaya, T
   Fateeva, V
   Mal'chenko, L
   Burlakova, O
   Bespyatykh, A
AF Brodsky, V. Ya.
   Golichenkov, V. A.
   Zvezdina, N. D.
   Dubovaya, T. K.
   Fateeva, V. I.
   Mal'chenko, L. A.
   Burlakova, O. V.
   Bespyatykh, A. Yu.
TI Melatonin promotes and synchronizes protein synthesis in hepatocyte
   culture from old rats
SO RUSSIAN JOURNAL OF DEVELOPMENTAL BIOLOGY
LA English
DT Article
DE cell-cell interactions; cell self-organization; aging; hepatocytes;
   melatonin; protein synthesis rhythm
AB The effect of 1 to 1000 nM melatonin was studied on daily cultures of rat hepatocytes on slides in serum-free medium. The minimum melatonin concentration (1 nM) proved to synchronize protein synthesis in asynchronous sparse cultures of hepatocytes from rats of different age, and a circahoralian rhythm of protein synthesis was revealed in them. In dense weekly synchronous hepatocytes from old rats (2.5 years old with the weight of about 600 g), melatonin improved cell synchronization to the level of young animals. Melatonin treatment increased the mean rate of protein synthesis in rats of different age.
C1 [Brodsky, V. Ya.; Zvezdina, N. D.; Fateeva, V. I.; Mal'chenko, L. A.] Russian Acad Sci, Koltsov Inst Dev Biol, Moscow 119991, Russia.
   [Golichenkov, V. A.; Burlakova, O. V.; Bespyatykh, A. Yu.] Moscow MV Lomonosov State Univ, Moscow 119992, Russia.
   [Dubovaya, T. K.] Russian State Med Univ, Moscow 117997, Russia.
C3 Russian Academy of Sciences; Koltzov Institute of Developmental Biology
   of the Russian Academy of Sciences; Lomonosov Moscow State University;
   Pirogov Russian National Research Medical University
RP Brodsky, V (corresponding author), Russian Acad Sci, Koltsov Inst Dev Biol, Ul Vavilova 26, Moscow 119991, Russia.
EM brodsky.idb@bk.ru
RI Nartsissova, Burlakova/J-8415-2012; Gusev, Vladislav B/HJY-3186-2023
OI Gusev, Vladislav B/0000-0001-7936-180X
FU Russian Foundation for Basic Research [06-04-48109, 05-04-48293]
FX This work was supported by the Russian Foundation for Basic Research (
   project nos. 06-04-48109 and 05-04-48293).
CR ANISIMOV VN, 2004, MELATONIN NORME PATO
   Arendt J., 1995, MELATONIN MAMMALIAN
   Brodskii V Ia, 2006, Ontogenez, V37, P384
   Brodsky V. Ya., 2005, Ontogenez, V36, P9
   Brodsky VY, 1997, IZV AKAD NAUK BIOL+, P389
   Brodsky VY, 2006, BIOL REV, V81, P143, DOI 10.1017/S1464793105006937
   Kireev RA, 2007, J PINEAL RES, V42, P64, DOI 10.1111/j.1600-079X.2006.00385.x
   KOMAROV FI, 2004, MELATONIN NORME PATO
   Sampson SR, 2006, MOL CELL ENDOCRINOL, V252, P82, DOI 10.1016/j.mce.2006.03.033
   Sjöblom M, 2003, AM J PHYSIOL-GASTR L, V284, pG1034, DOI 10.1152/ajpgi.00500.2002
   TANG F, 1985, NEUROENDOCRINOLOGY, V40, P160, DOI 10.1159/000124068
   Zvezdina N D, 2008, Ontogenez, V39, P198
   ZVEZDINA ND, 2003, IZV AKAD NAUK BIOL+, P14
NR 13
TC 3
Z9 4
U1 0
U2 2
PU MAIK NAUKA/INTERPERIODICA/SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013-1578 USA
SN 1062-3604
EI 1608-3326
J9 RUSS J DEV BIOL+
JI Russ. J. Dev. Biol.
PD NOV
PY 2008
VL 39
IS 6
BP 357
EP 361
DI 10.1134/S1062360408060052
PG 5
WC Developmental Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Developmental Biology
GA 377YS
UT WOS:000261288900005
DA 2024-02-19
ER

PT J
AU Keisala, T
   Minasyan, A
   Lou, YR
   Zou, J
   Kalueff, AV
   Pyykkö, I
   Tuohimaa, P
AF Keisala, Tiina
   Minasyan, Anna
   Lou, Yan-Ru
   Zou, Jing
   Kalueff, Allan V.
   Pyykko, Ilmari
   Tuohimaa, Pentti
TI Premature aging in vitamin D receptor mutant mice
SO JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
LA English
DT Article
DE Vitamin D; Aging; Fgf-23; Klotho; Vitamin D receptor; Aging-related
   genes
ID NF-KAPPA-B; SENSORINEURAL HEARING-LOSS; MINERAL ION HOMEOSTASIS; D
   DEFICIENCY; GROWTH-FACTOR; GENE-EXPRESSION; KNOCKOUT MICE; OXIDATIVE
   STRESS; CANCER INCIDENCE; ABLATED MICE
AB Hypervitaminosis vitamin D(3) has been recently implicated in premature aging through the regulation of 1 alpha hydroxylase expression by klotho and fibroblast growth factor-23 (Fgf-23). Here we examined whether the lack of hormonal function of vitamin D(3) in mice is linked to aging phenomena. For this, we used vitamin D(3) receptor (VDR) "Tokyo" knockout (KO) mice (fed with a special rescue diet) and analyzed their growth, skin and cerebellar morphology, as well as overall motor performance. We also studied the expression of aging-related genes, such as Fgf-23, nuclear factor kappaB (NF-kappaB), p53, insulin like growth factor 1 (IGF1) and IGF1 receptor (IGF1 R), in liver, as well as klotho in liver, kidney and prostate tissues. Overall, VDR KO mice showed several aging related phenotypes, including poorer survival, early alopecia, thickened skin, enlarged sebaceous glands and development of epidermal cysts. There was no difference either in the structure of cerebellum or in the number of Purkinje cells. Unlike the wildtype controls, VDR KO mice lose their ability to swim after 6 months of age. Expression of all the genes was lower in old VDR KO mice, but only NF-kappaB, Fgf-23, p53 and IGF1 R were significantly lower. Since the phenotype of aged VDR knockout mice is similar to mouse models with hypervitaminosis D(3), our study suggests that VDR genetic ablation promotes premature aging in mice, and that vitamin D(3) homeostasis regulates physiological aging. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Keisala, Tiina; Minasyan, Anna; Lou, Yan-Ru; Tuohimaa, Pentti] Univ Tampere, Sch Med, Dept Anat, Tampere 33014, Finland.
   [Zou, Jing; Pyykko, Ilmari] Univ Tampere, Sch Med, Dept Otolaryngol, Tampere 33014, Finland.
   [Kalueff, Allan V.] Georgetown Univ, Sch Med, Dept Physiol & Biophys, Washington, DC 20007 USA.
   [Kalueff, Allan V.] Tulane Univ, Sch Med, Dept Pharmacol, New Orleans, LA 70112 USA.
   [Tuohimaa, Pentti] Tampere Univ Hosp, Dept Clin Chem, FIN-33521 Tampere, Finland.
C3 Tampere University; Tampere University; Georgetown University; Tulane
   University; Tampere University; Tampere University Hospital
RP Keisala, T (corresponding author), Univ Tampere, Sch Med, Dept Anat, Tampere 33014, Finland.
EM tiina.keisala@uta.fi
RI Lou, Yan-Ru/K-4348-2012; Lou, Yan-Ru/AAX-4008-2020; Kalueff,
   Allan/AAB-8620-2022; Kalueff, Allan V/B-3647-2010; Zou, Jing/L-3736-2013
OI Lou, Yan-Ru/0000-0001-7717-6010; Lou, Yan-Ru/0000-0001-7717-6010;
   Kalueff, Allan/0000-0002-7525-1950; Kalueff, Allan
   V/0000-0002-7525-1950; Zou, Jing/0000-0002-0315-7092
FU Tampere University Hospital; Finnish Cancer Foundation; Finnish Cultural
   Foundation
FX We thank Professor Shigeaki Kato (University of Tokyo, Japan) for
   providing the initial knockout mice. Special thanks also go to Ms
   Marianne Kuuslahti for preparing the samples for morphology, Professor
   Markku Pelto-Huikko and Dr Heimo Syval for technical guiding in
   morphology, and Mr. Peter Hart for his help with editing the MS. This
   study was supported by the Competitive Research Funding of the Pirkanmaa
   Hospital District, Tampere University Hospital, Finnish Cancer
   Foundation and by the Finnish Cultural Foundation.
CR Adamo ML, 2006, AGEING RES REV, V5, P310, DOI 10.1016/j.arr.2006.05.001
   Adler AS, 2007, GENE DEV, V21, P3244, DOI 10.1101/gad.1588507
   ALTEMUS KL, 1987, PHYSIOL BEHAV, V39, P435, DOI 10.1016/0031-9384(87)90369-6
   Amling M, 1999, ENDOCRINOLOGY, V140, P4982, DOI 10.1210/en.140.11.4982
   Audo I, 2003, INVEST OPHTH VIS SCI, V44, P4192, DOI 10.1167/iovs.02-1198
   Beauséjour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417
   Becker A, 2005, BEHAV BRAIN RES, V161, P306, DOI 10.1016/j.bbr.2005.02.015
   Berryman DE, 2008, GROWTH HORM IGF RES, V18, P455, DOI 10.1016/j.ghir.2008.05.005
   Bikle DD, 2006, J CELL PHYSIOL, V207, P340, DOI 10.1002/jcp.20578
   Bokov A, 2004, MECH AGEING DEV, V125, P811, DOI 10.1016/j.mad.2004.07.009
   Boonen S, 1995, AGING CLIN EXP RES, V7, P414, DOI 10.1007/BF03324355
   Bouillon R, 2008, ENDOCR REV, V29, P726, DOI 10.1210/er.2008-0004
   Brewer LD, 2006, CELL CALCIUM, V40, P277, DOI 10.1016/j.ceca.2006.04.001
   BROOKES GB, 1985, OTOLARYNG HEAD NECK, V93, P313, DOI 10.1177/019459988509300305
   BROOKES GB, 1985, AM J OTOL, V6, P102
   Brown J, 2003, NEUROSCI LETT, V343, P139, DOI 10.1016/S0304-3940(03)00303-3
   Burke SN, 2006, NAT REV NEUROSCI, V7, P30, DOI 10.1038/nrn1809
   Burne THJ, 2006, BRAIN RES BULL, V69, P74, DOI 10.1016/j.brainresbull.2005.10.014
   Burne THJ, 2004, BEHAV BRAIN RES, V154, P549, DOI 10.1016/j.bbr.2004.03.023
   Carmeliet G, 2003, BEST PRACT RES CL EN, V17, P529, DOI 10.1016/j.beem.2003.08.001
   Carswell S., 1997, Vitamin D., P1197
   COHEN HN, 1979, LANCET, V1, P985
   Cohen-Lahav M, 2006, NEPHROL DIAL TRANSPL, V21, P889, DOI 10.1093/ndt/gfi254
   Cranney A, 2008, AM J CLIN NUTR, V88, p513S, DOI 10.1093/ajcn/88.2.513S
   Dusso AS, 2005, AM J PHYSIOL-RENAL, V289, pF8, DOI 10.1152/ajprenal.00336.2004
   Ellison TI, 2008, J INVEST DERMATOL, V128, P2508, DOI 10.1038/jid.2008.131
   Endo I, 2003, ENDOCRINOLOGY, V144, P5138, DOI 10.1210/en.2003-0502
   Eyles DW, 2005, J CHEM NEUROANAT, V29, P21, DOI 10.1016/j.jchemneu.2004.08.006
   Féron F, 2005, BRAIN RES BULL, V65, P141, DOI 10.1016/j.brainresbull.2004.12.007
   Floyd RA, 2002, NEUROBIOL AGING, V23, P795, DOI 10.1016/S0197-4580(02)00019-2
   Foster TC, 2002, NEUROSCIENTIST, V8, P297, DOI 10.1177/107385840200800404
   Freeman SH, 2008, J NEUROPATH EXP NEUR, V67, P1205, DOI 10.1097/NEN.0b013e31818fc72f
   Garcion E, 2002, TRENDS ENDOCRIN MET, V13, P100, DOI 10.1016/S1043-2760(01)00547-1
   Giovannucci E, 2006, JNCI-J NATL CANCER I, V98, P451, DOI 10.1093/jnci/djj101
   Giovannucci E, 2005, CANCER CAUSE CONTROL, V16, P83, DOI 10.1007/s10552-004-1661-4
   Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704
   Holick MF, 2008, AM J CLIN NUTR, V87, p1080S
   Hyppönen E, 2001, LANCET, V358, P1500, DOI 10.1016/S0140-6736(01)06580-1
   IKEDA K, 1989, AM J OTOL, V10, P11
   IKEDA K, 1987, LARYNGOSCOPE, V97, P1075
   Ishida S, 2001, INTERNAL MED, V40, P110, DOI 10.2169/internalmedicine.40.110
   Johnson FB, 1999, CELL, V96, P291, DOI 10.1016/S0092-8674(00)80567-X
   Kalueff A, 2006, NEUROREPORT, V17, P717, DOI 10.1097/01.wnr.0000215770.79281.e4
   Kalueff AV, 2004, NEUROREPORT, V15, P1271, DOI 10.1097/01.wnr.0000129370.04248.92
   Kalueff AV, 2004, PHYSIOL BEHAV, V82, P405, DOI 10.1016/j.physbeh.2004.04.010
   Kalueff AV, 2004, BRAIN RES BULL, V64, P25, DOI 10.1016/j.brainresbull.2004.04.015
   KAMEI Y, 1995, GENE, V152, P281, DOI 10.1016/0378-1119(94)00735-B
   Kato S, 2002, HORM RES, V57, P73, DOI 10.1159/000057955
   Kato S, 1999, J STEROID BIOCHEM, V69, P247, DOI 10.1016/S0960-0760(99)00042-4
   Kokoszka JE, 2001, P NATL ACAD SCI USA, V98, P2278, DOI 10.1073/pnas.051627098
   Kommagani R, 2007, J BIOL CHEM, V282, P29847, DOI 10.1074/jbc.M703641200
   KUNINGAS M, 2007, NEUROBIOL AGING
   Kuro-o M, 2001, TRENDS MOL MED, V7, P179, DOI 10.1016/S1471-4914(01)01921-9
   Kuro-o M, 2008, TRENDS ENDOCRIN MET, V19, P239, DOI 10.1016/j.tem.2008.06.002
   Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285
   Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766
   Langub MC, 2001, NEUROSCIENCE, V104, P49, DOI 10.1016/S0306-4522(01)00049-5
   Lanske B, 2007, J NUTR BIOCHEM, V18, P771, DOI 10.1016/j.jnutbio.2007.02.002
   Laron Z, 2008, HORM-INT J ENDOCRINO, V7, P24, DOI 10.14310/horm.2002.1111034
   Li YC, 1998, ENDOCRINOLOGY, V139, P4391, DOI 10.1210/en.139.10.4391
   Makrantonaki E, 2007, ANN NY ACAD SCI, V1119, P40, DOI 10.1196/annals.1404.027
   Malloy PJ, 1999, ENDOCR REV, V20, P156, DOI 10.1210/er.20.2.156
   Gómez JM, 2006, CURR PHARM BIOTECHNO, V7, P125
   Masuda H, 2005, MECH AGEING DEV, V126, P1274, DOI 10.1016/j.mad.2005.07.007
   Masuyama R, 2003, J BONE MINER RES, V18, P1217, DOI 10.1359/jbmr.2003.18.7.1217
   Matheu A, 2008, CANCER RES, V68, P6031, DOI 10.1158/0008-5472.CAN-07-6851
   Matilainen M, 2005, NUCLEIC ACIDS RES, V33, P5521, DOI 10.1093/nar/gki872
   MINASYAN A, 2009, J STEROID BIOCH MOL
   Montero-Odasso Manuel, 2005, Molecular Aspects of Medicine, V26, P203, DOI 10.1016/j.mam.2005.01.005
   NARVAEZ CJ, 2008, ENDOCRINOLOGY
   Prüfer K, 1999, J CHEM NEUROANAT, V16, P135, DOI 10.1016/S0891-0618(99)00002-2
   PURVES D, 2001, NEUROSCIENCE, P346
   Razzaque MS, 2006, FASEB J, V20, P720, DOI 10.1096/fj.05-5432fje
   Russell SJ, 2007, NAT REV MOL CELL BIO, V8, P681, DOI 10.1038/nrm2234
   Shiozaki M, 2008, NEUROSCIENCE, V152, P924, DOI 10.1016/j.neuroscience.2008.01.032
   Sonntag WE, 2005, AGEING RES REV, V4, P195, DOI 10.1016/j.arr.2005.02.001
   Takahashi Y, 2000, P NATL ACAD SCI USA, V97, P12407, DOI 10.1073/pnas.210382097
   Toescu EC, 2004, TRENDS NEUROSCI, V27, P614, DOI 10.1016/j.tins.2004.07.010
   Tuohimaa P, 2008, NUTR REV, V66, pS147, DOI 10.1111/j.1753-4887.2008.00095.x
   Walbert T, 2001, HORM METAB RES, V33, P525, DOI 10.1055/s-2001-17210
   Yoshizawa T, 1997, NAT GENET, V16, P391, DOI 10.1038/ng0897-391
   Zittermann A, 2008, CURR OPIN CLIN NUTR, V11, P752, DOI 10.1097/MCO.0b013e328312c33f
   Zou J, 2008, AUDIOL NEURO-OTOL, V13, P219, DOI 10.1159/000115431
NR 83
TC 106
Z9 111
U1 0
U2 14
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-0760
J9 J STEROID BIOCHEM
JI J. Steroid Biochem. Mol. Biol.
PD JUL
PY 2009
VL 115
IS 3-5
BP 91
EP 97
DI 10.1016/j.jsbmb.2009.03.007
PG 7
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA 463SZ
UT WOS:000267453700003
PM 19500727
DA 2024-02-19
ER

PT J
AU Schnabl, B
   Choi, YH
   Olsen, JC
   Hagedorn, CH
   Brenner, DA
AF Schnabl, B
   Choi, YH
   Olsen, JC
   Hagedorn, CH
   Brenner, DA
TI Immortal activated human hepatic stellate cells generated by ectopic
   telomerase expression
SO LABORATORY INVESTIGATION
LA English
DT Article
ID FAT-STORING CELLS; SMOOTH-MUSCLE-ACTIN; RAT-LIVER; HUMAN FIBROBLASTS;
   ITO CELLS; PRIMARY CULTURES; TUMOR-CELLS; LIFE-SPAN; IN-VITRO; LIPOCYTES
AB Telomere shortening controls the entry of cells into senescence. Functional expression of the telomerase catalytic subunit (human telomerase reverse transcriptase or hTERT) stabilizes telomere length and extends the life span of various normal human cells. Our aim was to assess the role of telomerase activity and telomere maintenance in regulating the proliferation of activated human hepatic stellate cells (HSCs), to establish an immortal human HSC cell line. Human HSCs were isolated from surgical specimens of normal liver and infected with a retrovirus expressing hTERT. Ectopic expression of hTERT reconstituted telomerase activity and maintained telomere length in human HSCs. Control human HSCs, which were either not infected or infected with a retroviral vector containing only the neomycin resistance gene, showed no detectable telomerase activity and had slightly shortened telomeres. These telomerase-negative HSCs entered a nondividing state after about 9 to 15 passages and senesced. In contrast, telomerase-positive HSCs to date have undergone 69 passages. Telomerase-positive HSCs did not undergo oncogenic transformation and exhibit morphologic and functional characteristics of activated HSCs. Microarray and RT-PCR analysis showed that mRNA expression patterns in telomerase-positive HSCs are very similar to those in activated human HSCs. Plating telomerase-positive HSCs on a basement membrane-like matrix reverts them toward a more quiescent phenotype. In conclusion, introduction of hTERT into activated human HSCs immortalizes them and maintains their activated phenotype. This newly developed cell line will be a useful tool to study the cell biology of human HSCs in culture.
C1 Univ N Carolina, Dept Med, Div Digest Dis & Nutr, Chapel Hill, NC 27599 USA.
   Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.
   Emory Univ, Sch Med, Dept Med, Atlanta, GA USA.
C3 University of North Carolina; University of North Carolina Chapel Hill;
   University of North Carolina; University of North Carolina Chapel Hill;
   Emory University
RP Brenner, DA (corresponding author), Univ N Carolina, Dept Med, Div Digest Dis & Nutr, CB 7038,Glaxo Res Bldg,Rm 156, Chapel Hill, NC 27599 USA.
OI Brenner, David/0000-0003-2573-525X
FU NIAAA NIH HHS [AA11605] Funding Source: Medline; NIDDK NIH HHS [DK34987]
   Funding Source: Medline; NIGMS NIH HHS [GM41804] Funding Source: Medline
CR ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114
   BLOMHOFF R, 1991, FASEB J, V5, P271, DOI 10.1096/fasebj.5.3.2001786
   Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349
   Counter CM, 1998, P NATL ACAD SCI USA, V95, P14723, DOI 10.1073/pnas.95.25.14723
   COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x
   COX AD, 1994, METHOD ENZYMOL, V238, P277
   DELANGE T, 1990, MOL CELL BIOL, V10, P518, DOI 10.1128/MCB.10.2.518
   DELEEUW AM, 1984, HEPATOLOGY, V4, P392
   FRIEDMAN SL, 1992, HEPATOLOGY, V15, P234, DOI 10.1002/hep.1840150211
   FRIEDMAN SL, 1989, J BIOL CHEM, V264, P10756
   Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247
   Funk WD, 2000, EXP CELL RES, V258, P270, DOI 10.1006/excr.2000.4945
   GEERTS A, 1991, HEPATOLOGY, V13, P1193, DOI 10.1016/0270-9139(91)92491-P
   GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0
   Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780
   HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0
   Johnson LG, 1998, J VIROL, V72, P8861, DOI 10.1128/JVI.72.11.8861-8872.1998
   Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321
   KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428
   Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962
   Knittel T, 1999, GASTROENTEROLOGY, V117, P1205, DOI 10.1016/S0016-5085(99)70407-5
   Kojima H, 1997, GASTROENTEROLOGY, V112, P493, DOI 10.1053/gast.1997.v112.pm9024303
   Lang A, 2000, J HEPATOL, V33, P49, DOI 10.1016/S0168-8278(00)80159-2
   Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345
   Liu KB, 1999, P NATL ACAD SCI USA, V96, P5147, DOI 10.1073/pnas.96.9.5147
   MAHER JJ, 1988, J CLIN INVEST, V82, P450, DOI 10.1172/JCI113618
   MAHER JJ, 1990, J CLIN INVEST, V86, P1641, DOI 10.1172/JCI114886
   MAK KM, 1984, GASTROENTEROLOGY, V87, P188
   Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3
   Morales CP, 1999, NAT GENET, V21, P115, DOI 10.1038/5063
   MORIN GB, 1989, CELL, V59, P521, DOI 10.1016/0092-8674(89)90035-4
   MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622
   MURAKAMI K, 1995, LAB INVEST, V72, P731
   Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955
   Neubauer K, 1996, J HEPATOL, V24, P719, DOI 10.1016/S0168-8278(96)80269-8
   Niida H, 1998, NAT GENET, V19, P203, DOI 10.1038/580
   NOUCHI T, 1991, LIVER, V11, P100
   RAMADORI G, 1990, VIRCHOWS ARCH B, V59, P349, DOI 10.1007/BF02899424
   RIPPE RA, 1995, HEPATOLOGY, V22, P241, DOI 10.1002/hep.1840220135
   Sahi J, 2000, XENOBIOTICA, V30, P273, DOI 10.1080/004982500237668
   SCHMITTGRAFF A, 1991, AM J PATHOL, V138, P1233
   Schnabl B, 2001, HEPATOLOGY, V34, P89, DOI 10.1053/jhep.2001.25349
   Stefanovic A, 2000, NUCLEIC ACIDS RES, V28, P641, DOI 10.1093/nar/28.2.641
   TAKAHARA T, 1988, LAB INVEST, V59, P509
   Vaziri H, 1998, CURR BIOL, V8, P279, DOI 10.1016/S0960-9822(98)70109-5
   Vögele J, 2000, HEALTH PLACE, V6, P41, DOI 10.1016/S1353-8292(99)00029-5
   Weill FX, 1997, LAB INVEST, V77, P63
   WRIGHT WE, 1995, NUCLEIC ACIDS RES, V23, P3794, DOI 10.1093/nar/23.18.3794
   Yang JW, 1999, J BIOL CHEM, V274, P26141, DOI 10.1074/jbc.274.37.26141
NR 49
TC 91
Z9 101
U1 2
U2 7
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0023-6837
J9 LAB INVEST
JI Lab. Invest.
PD MAR
PY 2002
VL 82
IS 3
BP 323
EP 333
DI 10.1038/labinvest.3780426
PG 11
WC Medicine, Research & Experimental; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pathology
GA 534ZK
UT WOS:000174619500010
PM 11896211
OA hybrid
DA 2024-02-19
ER

PT J
AU Schreyer, L
   Mittermeier, C
   Franz, MJ
   Meier, MA
   Martin, DE
   Maier, KC
   Huebner, K
   Schneider-Stock, R
   Singer, S
   Holzer, K
   Fischer, D
   Ribback, S
   Liebl, B
   Gudermann, T
   Aigner, A
   Muehlich, S
AF Schreyer, Laura
   Mittermeier, Constanze
   Franz, Miriam J.
   Meier, Melanie A.
   Martin, Dietmar E.
   Maier, Kerstin C.
   Huebner, Kerstin
   Schneider-Stock, Regine
   Singer, Stephan
   Holzer, Kerstin
   Fischer, Dagmar
   Ribback, Silvia
   Liebl, Bernhard
   Gudermann, Thomas
   Aigner, Achim
   Muehlich, Susanne
TI Tetraspanin 5 (TSPAN5), a Novel Gatekeeper of the Tumor Suppressor DLC1
   and Myocardin-Related Transcription Factors (MRTFs), Controls HCC Growth
   and Senescence
SO CANCERS
LA English
DT Article
DE DLC1; TSPAN5; MKL1; MRTF; SRF
ID E-CADHERIN; PML; CANCER; SIRNA; DNA; HETEROCHROMATIN; NETWORKS;
   PATHWAYS; DELIVERY; PROTEIN
AB Simple SummaryHepatocellular carcinoma (HCC) ranks second among the leading causes of cancer-related death. Since current therapeutic options are very limited, a deeper understanding of the molecular mechanisms underlying the tumor onset and progression of HCC holds great potential for improved therapeutic options. Although it has been shown that deleted in liver cancer 1 (DLC1) acts as a tumor suppressor whose allele is lost in 50% of liver cancers, alterations in gene expression initiated by DLC1 loss have not yet been the primary focus of liver cancer research. To identify novel gene targets that allow for a personalized medicine approach for HCC therapy, we performed gene expression profiling for HepG2 cells stably expressing DLC1shRNA. We provide evidence that TSPAN5 is required for HCC growth, migration and invasion, and dissected the underlying molecular mechanisms involving myocardin-related transcription factors. Thus, TSPAN5 represents a novel therapeutic target for the treatment of HCC characterized by DLC1 loss.Human hepatocellular carcinoma (HCC) is among the most lethal and common cancers in the human population, and new molecular targets for therapeutic intervention are urgently needed. Deleted in liver cancer 1 (DLC1) was originally identified as a tumor suppressor gene in human HCC. DLC1 is a Rho-GTPase-activating protein (RhoGAP) which accelerates the return of RhoGTPases to an inactive state. We recently described that the restoration of DLC1 expression induces cellular senescence. However, this principle is not amenable to direct therapeutic targeting. We therefore performed gene expression profiling for HepG2 cells depleted of DLC1 to identify druggable gene targets mediating the effects of DLC1 on senescence induction. This approach revealed that versican (VCAN), tetraspanin 5 (TSPAN5) and N-cadherin (CDH2) were strongly upregulated upon DLC1 depletion in HCC cells, but only TSPAN5 affected the proliferation of HCC cells and human HCC. The depletion of TSPAN5 induced oncogene-induced senescence (OIS), mediated by the p16(INK4a)/pRb pathways. Mechanistically, silencing TSPAN5 reduced actin polymerization and thereby myocardin-related transcription factor A- filamin A (MRTF-A-FLNA) complex formation, resulting in decreased expression of MRTF/SRF-dependent target genes and senescence induction in vitro and in vivo. Our results identify TSPAN5 as a novel druggable target for HCC.
C1 [Schreyer, Laura; Franz, Miriam J.; Meier, Melanie A.; Fischer, Dagmar; Muehlich, Susanne] Friedrich Alexander Univ Erlangen Nurnberg, Dept Chem & Pharm, D-91058 Erlangen, Germany.
   [Mittermeier, Constanze] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117599, Singapore.
   [Martin, Dietmar E.; Maier, Kerstin C.] Ludwig Maximilians Univ Munchen, Gene Ctr, Dept Chem & Pharm, D-81377 Munich, Germany.
   [Huebner, Kerstin; Schneider-Stock, Regine] Friedrich Alexander Univ Erlangen Nurnberg, Univ Hosp, Inst Pathol, Expt Tumor Pathol, D-91054 Erlangen, Germany.
   [Singer, Stephan; Holzer, Kerstin] Univ Hosp Tuebingen, Dept Pathol, D-72076 Tubingen, Germany.
   [Ribback, Silvia] Univ Greifswald, Inst Pathol, D-17475 Greifswald, Germany.
   [Liebl, Bernhard] LGL Bayer Landesamt Gesundheit & Lebensmittelsich, D-85764 Oberschleissheim, Germany.
   [Gudermann, Thomas] Ludwig Maximilians Univ Munchen, Walther Straub Inst Pharmacol & Toxicol, D-80336 Munich, Germany.
   [Aigner, Achim] Univ Leipzig, Rudolf Boehm Inst Pharmacol & Toxicol, Clin Pharmacol, D-04107 Leipzig, Germany.
C3 University of Erlangen Nuremberg; National University of Singapore;
   University of Munich; University of Erlangen Nuremberg; Eberhard Karls
   University of Tubingen; Eberhard Karls University Hospital; Universitat
   Greifswald; Bavarian Health & Food Safety Authority; University of
   Munich; Leipzig University
RP Muehlich, S (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg, Dept Chem & Pharm, D-91058 Erlangen, Germany.
EM laura.ls.schreyer@fau.de; constanze.mittermeier@nus.edu.sg;
   miriam.franz@fau.de; melanie.a.meier@fau.de; martin@genzentrum.lmu.de;
   kerstin.maier@mpibpc.mpg.de; kerstin.huebner@uk-erlangen.de;
   regine.schneider-stock@uk-erlangen.de;
   stephan.singer@med.uni-tuebingen.de;
   kerstin.singer@med.uni-tuebingen.de; dagmar.fischer@fau.de;
   silvia.ribback@uni-greifswald.de; Liebl@lgl-bayern.de;
   thomas.gudermann@lrz.uni-muenchen.de;
   achim.aigner@medizin.uni-leipzig.de; susanne.muehlich@fau.de
RI Maier, Kerstin/JBJ-1008-2023; Aigner, Achim/R-4429-2017
OI Aigner, Achim/0000-0002-2778-6256; Huebner, Kerstin/0009-0009-8791-0317
FU Deutsche Forschungsgemeinschaft (DFG) [MU 2737/2-2, GRK1910]
FX The work was funded by the Deutsche Forschungsgemeinschaft (DFG) (MU
   2737/2-2, GRK1910 to S.M. and MI 2596/1-1 to C.M.).
CR Aigner A, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/71659
   Alcorta DA, 1996, P NATL ACAD SCI USA, V93, P13742, DOI 10.1073/pnas.93.24.13742
   Badvie S, 2000, POSTGRAD MED J, V76, P4, DOI 10.1136/pmj.76.891.4
   Bellanti F, 2018, REDOX BIOL, V15, P86, DOI 10.1016/j.redox.2017.11.016
   Berx G, 1996, ONCOGENE, V13, P1919
   Bischof O, 2002, EMBO J, V21, P3358, DOI 10.1093/emboj/cdf341
   Borchardt H, 2021, CANCER LETT, V503, P174, DOI 10.1016/j.canlet.2021.01.018
   Borchardt H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51881-8
   Boucheix C, 2001, Expert Rev Mol Med, V2001, P1, DOI 10.1017/S1462399401002381
   Braumüller H, 2013, NATURE, V494, P361, DOI 10.1038/nature11824
   Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   CREWS CM, 1993, CELL, V74, P215, DOI 10.1016/0092-8674(93)90411-I
   Derycke LDM, 2004, INT J DEV BIOL, V48, P463, DOI 10.1387/ijdb.041793ld
   Di Micco R, 2011, NAT CELL BIOL, V13, P292, DOI 10.1038/ncb2170
   Facciorusso A, 2013, CURR DIABETES REV, V9, P382, DOI 10.2174/15733998113099990068
   Ferbeyre G, 2000, GENE DEV, V14, P2015
   Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003
   Gawrieh S, 2010, OBES SURG, V20, P1698, DOI 10.1007/s11695-010-0171-6
   Hampl V, 2013, EMBO MOL MED, V5, P1367, DOI 10.1002/emmm.201202406
   Hara E, 1996, MOL CELL BIOL, V16, P859
   Hemler ME, 2014, NAT REV CANCER, V14, P49, DOI 10.1038/nrc3640
   Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736
   Heo K, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10030388
   Hermanns C, 2017, ONCOGENE, V36, P3464, DOI 10.1038/onc.2016.496
   Höbel S, 2013, WIRES NANOMED NANOBI, V5, P484, DOI 10.1002/wnan.1228
   Höbel S, 2010, J GENE MED, V12, P287, DOI 10.1002/jgm.1431
   Ibrahim AF, 2011, CANCER RES, V71, P5214, DOI 10.1158/0008-5472.CAN-10-4645
   Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.21492, 10.3322/caac.20107]
   Kircher P, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aad2959
   Kitadokoro K, 2001, EMBO J, V20, P12, DOI 10.1093/emboj/20.1.12
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560
   Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2
   Muehlich S, 2012, ONCOGENE, V31, P3913, DOI 10.1038/onc.2011.560
   Muenzner JK, 2018, J CELL MOL MED, V22, P6238, DOI 10.1111/jcmm.13911
   Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X
   Nishio K, 2005, HISTOCHEM CELL BIOL, V123, P263, DOI 10.1007/s00418-005-0766-5
   Park SC, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.94
   Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127
   Peñas PF, 2000, J INVEST DERMATOL, V114, P1126, DOI 10.1046/j.1523-1747.2000.00998.x
   Petrova YI, 2016, MOL BIOL CELL, V27, P3233, DOI 10.1091/mbc.E16-01-0058
   Qi YY, 2020, CANCER CELL INT, V20, DOI 10.1186/s12935-020-01353-1
   Rana S, 2011, BIOCHEM SOC T, V39, P559, DOI 10.1042/BST0390559
   Ribatti D, 2017, REPROD TOXICOL, V70, P97, DOI 10.1016/j.reprotox.2016.11.004
   Saint-Pol J, 2017, J BIOL CHEM, V292, P9551, DOI 10.1074/jbc.M116.765669
   Schäfer J, 2010, BIOMATERIALS, V31, P6892, DOI 10.1016/j.biomaterials.2010.05.043
   Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501
   Takahashi A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15287
   Vernier M, 2011, GENE DEV, V25, P41, DOI 10.1101/gad.1975111
   Voringer S, 2020, ONCOGENE, V39, P2328, DOI 10.1038/s41388-019-1140-8
   WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2
   Werth S, 2006, J CONTROL RELEASE, V112, P257, DOI 10.1016/j.jconrel.2006.02.009
   Whittaker S, 2010, ONCOGENE, V29, P4989, DOI 10.1038/onc.2010.236
   Xue W, 2008, GENE DEV, V22, P1439, DOI 10.1101/gad.1672608
   Yáñez-Mó M, 2009, TRENDS CELL BIOL, V19, P434, DOI 10.1016/j.tcb.2009.06.004
   Yokoi A, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax8849
   Yuan BZ, 1998, CANCER RES, V58, P2196
NR 58
TC 5
Z9 6
U1 0
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6694
J9 CANCERS
JI Cancers
PD NOV
PY 2021
VL 13
IS 21
AR 5373
DI 10.3390/cancers13215373
PG 23
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA XC0QS
UT WOS:000721726200001
PM 34771537
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Thompson, ACS
   Bruss, MD
   Price, JC
   Khambatta, CF
   Holmes, WE
   Colangelo, M
   Dalidd, M
   Roberts, LS
   Astle, CM
   Harrison, DE
   Hellerstein, MK
AF Thompson, Airlia C. S.
   Bruss, Matthew D.
   Price, John C.
   Khambatta, Cyrus F.
   Holmes, William E.
   Colangelo, Marc
   Dalidd, Marcy
   Roberts, Lindsay S.
   Astle, Clinton M.
   Harrison, David E.
   Hellerstein, Marc K.
TI Reduced <i>in vivo</i> hepatic proteome replacement rates but not cell
   proliferation rates predict maximum lifespan extension in mice
SO AGING CELL
LA English
DT Article
DE calorie restriction; cell proliferation; maximum lifespan extension;
   proteome dynamics; rapamycin; Snell Dwarf
ID GENETICALLY HETEROGENEOUS MICE; CALORIE RESTRICTION; GROWTH-HORMONE;
   SNELL DWARF; DIETARY RESTRICTION; MUTANT MICE; RAPAMYCIN; LONGEVITY;
   MOUSE; TRANSLATION
AB Combating the social and economic consequences of a growing elderly population will require the identification of interventions that slow the development of age-related diseases. Preserved cellular homeostasis and delayed aging have been previously linked to reduced cell proliferation and protein synthesis rates. To determine whether changes in these processes may contribute to or predict delayed aging in mammals, we measured cell proliferation rates and the synthesis and replacement rates (RRs) of over a hundred hepatic proteins in vivo in three different mouse models of extended maximum lifespan (maxLS): Snell Dwarf, calorie-restricted (CR), and rapamycin (Rapa)-treated mice. Cell proliferation rates were not consistently reduced across the models. In contrast, reduced hepatic protein RRs (longer half-lives) were observed in all three models compared to controls. Intriguingly, the degree of mean hepatic protein RR reduction was significantly correlated with the degree of maxLS extension across the models and across different Rapa doses. Absolute rates of hepatic protein synthesis were reduced in Snell Dwarf and CR, but not Rapa-treated mice. Hepatic chaperone levels were unchanged or reduced and glutathione S-transferase synthesis was preserved or increased in all three models, suggesting a reduced demand for protein renewal, possibly due to reduced levels of unfolded or damaged proteins. These data demonstrate that maxLS extension in mammals is associated with improved hepatic proteome homeostasis, as reflected by a reduced demand for protein renewal, and that reduced hepatic protein RRs hold promise as an early biomarker and potential target for interventions that delay aging in mammals.
C1 [Thompson, Airlia C. S.; Bruss, Matthew D.; Colangelo, Marc; Dalidd, Marcy; Roberts, Lindsay S.; Hellerstein, Marc K.] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Morgan Hall Room 309, Berkeley, CA 94720 USA.
   [Price, John C.; Khambatta, Cyrus F.; Holmes, William E.; Colangelo, Marc; Dalidd, Marcy; Hellerstein, Marc K.] KineMed Inc, Emeryville, CA 94608 USA.
   [Astle, Clinton M.; Harrison, David E.] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.
   [Thompson, Airlia C. S.] Stanford Univ, Dept Biol, 337 Campus Dr,Lorry Lokey Room 164, Stanford, CA 94305 USA.
   [Bruss, Matthew D.] PPD Inc, Middleton, WI 53562 USA.
   [Price, John C.] Brigham Young Univ, Dept Chem & Biochem, Provo, UT 84602 USA.
C3 University of California System; University of California Berkeley;
   Kinemed Inc; Jackson Laboratory; Stanford University; Brigham Young
   University
RP Thompson, ACS; Hellerstein, MK (corresponding author), Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Morgan Hall Room 309, Berkeley, CA 94720 USA.; Thompson, ACS (corresponding author), Stanford Univ, Dept Biol, 337 Campus Dr,Lorry Lokey Room 164, Stanford, CA 94305 USA.
EM airlia.thompson@gmail.com; mhellerstein@kinemed.com
FU NIH [AG034297-01, AG038560, AG022308, AG032333, CA034196]; College of
   Natural Resources, University of California at Berkeley; KineMed, Inc.
FX This work was supported by NIH grant AG034297-01 and College of Natural
   Resources, University of California at Berkeley, support to MKH; funds
   from KineMed, Inc.; and NIH grants AG038560, AG022308, and AG032333 to
   DEH plus The Jackson Laboratory's CA034196 (for work at TJL).
CR [Anonymous], 2014, 65+ in the United States: 2010
   Ballesteros M, 2001, EMBO J, V20, P5280, DOI 10.1093/emboj/20.18.5280
   BATES PC, 1988, J ENDOCRINOL, V119, P31, DOI 10.1677/joe.0.1190031
   BLACKWELL BN, 1995, TOXICOL PATHOL, V23, P570, DOI 10.1177/019262339502300503
   Bridger JM, 2004, EXP GERONTOL, V39, P717, DOI 10.1016/j.exger.2004.02.002
   Bruss MD, 2011, AM J PHYSIOL-ENDOC M, V300, pE735, DOI 10.1152/ajpendo.00661.2010
   Conn CS, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003520
   de Magalhaes JP, 2008, BIOESSAYS, V30, P567, DOI 10.1002/bies.20760
   Decaris ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123311
   Drake JC, 2013, J GERONTOL A-BIOL, V68, P1493, DOI 10.1093/gerona/glt047
   Fanara P, 2012, J CLIN INVEST, V122, P3159, DOI 10.1172/JCI64575
   Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898
   Flurkey K, 2002, MECH AGEING DEV, V123, P121, DOI 10.1016/S0047-6374(01)00339-6
   Fok WC, 2013, J GERONTOL A-BIOL, V68, P108, DOI 10.1093/gerona/gls127
   Garelick MG, 2013, CELL CYCLE, V12, P2493, DOI 10.4161/cc.25512
   Harrison DE, 2014, AGING CELL, V13, P273, DOI 10.1111/acel.12170
   Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221
   Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857
   Hipkiss AR, 2007, MECH AGEING DEV, V128, P412, DOI 10.1016/j.mad.2007.03.002
   Hsieh CC, 2004, MECH AGEING DEV, V125, P785, DOI 10.1016/j.mad.2004.07.008
   Kapahi P, 2010, CELL METAB, V11, P453, DOI 10.1016/j.cmet.2010.05.001
   Karunadharma PP, 2015, AGING CELL, V14, P547, DOI 10.1111/acel.12317
   Kennedy BK, 2009, AGING CELL, V8, P617, DOI 10.1111/j.1474-9726.2009.00522.x
   Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717
   Liang HY, 2003, EXP GERONTOL, V38, P1353, DOI 10.1016/j.exger.2003.10.019
   LOK E, 1990, CANCER LETT, V51, P67, DOI 10.1016/0304-3835(90)90232-M
   McElwee JJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r132
   Messmer BT, 2005, J CLIN INVEST, V115, P755, DOI 10.1172/JCI23409
   Miller RA, 2005, AGING CELL, V4, P119, DOI 10.1111/j.1474-9726.2005.00152.x
   Miller RA, 2002, MILBANK Q, V80, P155, DOI 10.1111/1468-0009.00006
   Miller RA, 2007, AGING CELL, V6, P565, DOI 10.1111/j.1474-9726.2007.00311.x
   Miller RA, 2014, AGING CELL, V13, P468, DOI 10.1111/acel.12194
   Miller RA, 2011, J GERONTOL A-BIOL, V66, P191, DOI 10.1093/gerona/glq178
   Min JN, 2008, MOL CELL BIOL, V28, P4018, DOI 10.1128/MCB.00296-08
   PENDERGRASS WR, 1993, J CELL PHYSIOL, V156, P96, DOI 10.1002/jcp.1041560114
   Price JC, 2012, MOL CELL PROTEOMICS, V11, P1801, DOI 10.1074/mcp.M112.021204
   Price JC, 2012, ANAL BIOCHEM, V420, P73, DOI 10.1016/j.ab.2011.09.007
   Rattan SIS, 2010, ADV EXP MED BIOL, V694, P1
   Sherman MY, 2013, TRENDS BIOCHEM SCI, V38, P585, DOI 10.1016/j.tibs.2013.09.003
   Varma S, 2007, BBA-GEN SUBJECTS, V1770, P71, DOI 10.1016/j.bbagen.2006.07.016
   Wang M, 2012, AGING CELL, V11, P668, DOI 10.1111/j.1474-9726.2012.00833.x
   WEINDRUCH R, 1986, J NUTR, V116, P641, DOI 10.1093/jn/116.4.641
   WOLF NS, 1995, EXP CELL RES, V217, P317, DOI 10.1006/excr.1995.1092
   Wu CC, 2004, ANAL CHEM, V76, P4951, DOI 10.1021/ac049208j
   Yamasaki S, 2008, CURR OPIN CELL BIOL, V20, P222, DOI 10.1016/j.ceb.2008.01.013
NR 45
TC 22
Z9 28
U1 0
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9726
J9 AGING CELL
JI Aging Cell
PD FEB
PY 2016
VL 15
IS 1
BP 118
EP 127
DI 10.1111/acel.12414
PG 10
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA DH6CQ
UT WOS:000372879000013
PM 26541492
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Okano, H
   Isono, Y
   Tanaka, H
   Ishihara, Y
   Matsusaki, S
   Aoki, M
   Sase, T
   Saitou, T
   Mukai, K
   Nishimura, A
   Takemoto, M
   Yokote, K
AF Okano, Hiroshi
   Isono, Yoshiaki
   Tanaka, Hiroki
   Ishihara, Yoshiko
   Matsusaki, Shimpei
   Aoki, Masatoshi
   Sase, Tomohiro
   Saitou, Tomonori
   Mukai, Katsumi
   Nishimura, Akira
   Takemoto, Minoru
   Yokote, Koutaro
TI Primary liver tumor associated with Werner syndrome (adult progeria)
SO HEPATOLOGY RESEARCH
LA English
DT Article
DE aging; gene analysis; hepatoma; malignancy; Werner syndrome
ID SYNDROME GENE; FAT; MUTATIONS; CANCER
AB A 57-year-old woman was admitted to our hospital with characteristic aging of the face and thin body. Before admission, she had been treated for diabetes mellitus type 2 and had undergone amputation of the right leg due to ischemic disease. Abdominal computed tomography revealed primary liver tumor. Biopsy of the liver mass revealed poorly differentiated adenocarcinoma, not hepatocellular carcinoma. Genetic sequencing indicated a homozygous mutation in the Werner syndrome gene (WRN) and she was diagnosed with Werner syndrome with primary liver tumor. She declined medications for the liver tumor and eventually died 6 months after diagnosis. Werner syndrome is a rare autosomal recessive disorder associated with premature aging, and most cases of Werner syndrome have been reported from Japan. The main causes of death with Werner syndrome are malignancy and atherosclerotic vascular disease. With respect to malignancy, non-epithelial tumors are more common in Werner syndrome patients than in the general population. Some cases also show complications of epithelial tumors, as in the present case. When a liver tumor of unknown etiology is accompanied by characteristic aging of the face, Werner syndrome should be suspected and a comprehensive search for other tumors and complications of metabolic disorders undertaken.
C1 [Okano, Hiroshi; Isono, Yoshiaki; Tanaka, Hiroki; Ishihara, Yoshiko; Matsusaki, Shimpei; Aoki, Masatoshi; Sase, Tomohiro; Saitou, Tomonori; Mukai, Katsumi; Nishimura, Akira] Suzuka Gen Hosp, Dept Gastroenterol, Suzuka, Mie 5138630, Japan.
   [Takemoto, Minoru; Yokote, Koutaro] Chiba Univ, Grad Sch Med, Dept Clin Cell Biol & Med, Chuo Ku, Chiba, Japan.
C3 Chiba University
RP Okano, H (corresponding author), Suzuka Gen Hosp, Dept Gastroenterol, 1275-1253 Yasuduka Cho, Suzuka, Mie 5138630, Japan.
EM oohh1969@yahoo.co.jp
CR Chen Lishan, 2002, Journal of Biomedicine & Biotechnology, V2, P46, DOI 10.1155/S1110724302201011
   Ding SL, 2008, CLIN INTERV AGING, V3, P431, DOI 10.2147/CIA.S1957
   Doh Yun Jeong, 2009, Korean Journal of Internal Medicine, V24, P68, DOI 10.3904/kjim.2009.24.1.68
   EPSTEIN CJ, 1966, MEDICINE, V45, P177, DOI 10.1097/00005792-196605000-00001
   Friedrich K, 2010, HUM GENET, V128, P103, DOI 10.1007/s00439-010-0832-5
   Goto M, 1997, HUM GENET, V99, P191, DOI 10.1007/s004390050336
   Goto M, 1996, CANCER EPIDEM BIOMAR, V5, P239
   Goto M, 2008, BIOSCI TRENDS, V2, P81
   Izumino K, 1997, J CLIN ENDOCR METAB, V82, P2391, DOI 10.1210/jc.82.8.2391
   Kelly IE, 1999, DIABETES CARE, V22, P288, DOI 10.2337/diacare.22.2.288
   Mori S, 2001, INT J OBESITY, V25, P292, DOI 10.1038/sj.ijo.0801529
   Muftuoglu M, 2008, HUM GENET, V124, P369, DOI 10.1007/s00439-008-0562-0
   Ohnishi S, 2010, GERIATR GERONTOL INT, V10, P319, DOI 10.1111/j.1447-0594.2010.00638.x
   Otto W, 1904, THESIS KIEL U
   Ramírez CL, 2007, CELL MOL LIFE SCI, V64, P155, DOI 10.1007/s00018-006-6349-3
   Renard D, 2009, STROKE, V40, pE11, DOI 10.1161/STROKEAHA.108.531780
   Yokote K, 2004, J AM GERIATR SOC, V52, P1582, DOI 10.1111/j.1532-5415.2004.52430_4.x
   Yu CE, 1997, AM J HUM GENET, V60, P330
   Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258
NR 19
TC 1
Z9 1
U1 0
U2 1
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1386-6346
J9 HEPATOL RES
JI Hepatol. Res.
PD DEC
PY 2011
VL 41
IS 12
BP 1260
EP 1265
DI 10.1111/j.1872-034X.2011.00877.x
PG 6
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 854OO
UT WOS:000297504300015
PM 22118305
DA 2024-02-19
ER

PT J
AU Sanchez-Roman, I
   Gómez, A
   Pérez, I
   Sanchez, C
   Suarez, H
   Naudí, A
   Jové, M
   Lopez-Torres, M
   Pamplona, R
   Barja, G
AF Sanchez-Roman, Ines
   Gomez, Alexia
   Perez, Irene
   Sanchez, Carlota
   Suarez, Henar
   Naudi, Alba
   Jove, Mariona
   Lopez-Torres, Monica
   Pamplona, Reinald
   Barja, Gustavo
TI Effects of aging and methionine restriction applied at old age on ROS
   generation and oxidative damage in rat liver mitochondria
SO BIOGERONTOLOGY
LA English
DT Article
DE Calorie restriction; Methionine restriction; Diet; Mitochondria;
   Reactive oxygen species
ID FREE-RADICAL PRODUCTION; LIFE-SPAN EXTENSION; CALORIC RESTRICTION;
   COMPLEX-I; DNA-DAMAGE; DIETARY RESTRICTION; SUPEROXIDE-PRODUCTION;
   PROTEIN RESTRICTION; FOOD RESTRICTION; STRESS
AB It is known that a global decrease in food ingestion (dietary restriction, DR) lowers mitochondrial ROS generation (mitROS) and oxidative stress in young immature rats. This seems to be caused by the decreased methionine ingestion of DR animals. This is interesting since isocaloric methionine restriction in the diet (MetR) also increases, like DR, rodent maximum longevity. However, it is not known if old rats maintain the capacity to lower mitROS generation and oxidative stress in response to MetR similarly to young immature animals, and whether MetR implemented at old age can reverse aging-related variations in oxidative stress. In this investigation the effects of aging and 7 weeks of MetR were investigated in liver mitochondria of Wistar rats. MetR implemented at old age decreased mitROS generation, percent free radical leak at the respiratory chain and mtDNA oxidative damage without changing oxygen consumption. Protein oxidation, lipoxidation and glycoxidation increased with age, and MetR in old rats partially or totally reversed these age-related increases. Aging increased the amount of SIRT1, and MetR decreased SIRT1 and TFAM and increased complex IV. No changes were observed in the protein amounts of PGC1, Nrf2, MnSOD, AIF, complexes I, II and III, and in the extent of genomic DNA methylation. In conclusion, treating old rats with isocaloric short-term MetR lowers mitROS production and free radical leak and oxidative damage to mtDNA, and reverses aging-related increases in protein modification. Aged rats maintain the capacity to lower mitochondrial ROS generation and oxidative stress in response to a short-term exposure to restriction of a single dietary substance: methionine.
C1 [Sanchez-Roman, Ines; Gomez, Alexia; Perez, Irene; Sanchez, Carlota; Suarez, Henar; Lopez-Torres, Monica; Barja, Gustavo] Univ Complutense Madrid, Dept Anim Physiol 2, Fac Biol Sci, Madrid, Spain.
   [Naudi, Alba; Jove, Mariona; Pamplona, Reinald] Univ Lleida IRBLLEIDA, Dept Expt Med, Fac Med, Lleida, Spain.
C3 Complutense University of Madrid; Universitat de Lleida
RP Barja, G (corresponding author), Univ Complutense Madrid, Dept Anim Physiol 2, Fac Biol Sci, C Jose Antonio Novais 2, Madrid, Spain.
EM gbarja@bio.ucm.es
RI Naudí, Alba/B-5594-2009; Pamplona, Reinald/A-7359-2010; Pérez-Liébana,
   Irene/ABF-1616-2020; Jové, Mariona/M-9104-2016; Gustavo,
   Barja/B-5591-2012; Barja, Gustavo/AAA-5903-2019
OI Naudí, Alba/0000-0003-0699-1004; Pamplona, Reinald/0000-0003-4337-6107;
   Pérez-Liébana, Irene/0000-0003-4504-6259; Jové,
   Mariona/0000-0001-5577-6162; Barja, Gustavo/0000-0001-5736-4735;
   Sanchez-Roman, Ines/0000-0003-4844-5781
FU Spanish Ministry of Science and Innovation [BFU2008-00335/BFI,
   BFU2009-118/79BFI]; UCM/BSCH; Generalitat of Catalonia [2009SGR735];
   Spanish Ministry of Education (FPU); Spanish Ministry of Science and
   Innovation (FPI)
FX This investigation was supported in part by I + D grants from the
   Spanish Ministry of Science and Innovation (BFU2008-00335/BFI) and a
   UCM/BSCH Grant in 2010 to G. Barja; and I + D grants from the Spanish
   Ministry of Science and Innovation (BFU2009-118/79BFI) and the
   Generalitat of Catalonia (2009SGR735) to R. Pamplona. I. Sanchez
   received a pre-doctoral fellowship from the Spanish Ministry of
   Education (FPU) and A. Gomez received a fellowship from the Spanish
   Ministry of Science and Innovation (FPI). We thank David Argiles for
   excellent technical assistance.
CR Ayala V, 2007, J GERONTOL A-BIOL, V62, P352, DOI 10.1093/gerona/62.4.352
   Barja G, 1998, J BIOENERG BIOMEMBR, V30, P235, DOI 10.1023/A:1020592719405
   Barja G, 2004, BIOL REV, V79, P235, DOI 10.1017/S1464793103006213
   Barja G, 2004, TRENDS NEUROSCI, V27, P595, DOI 10.1016/j.tins.2004.07.005
   Baur JA, 2010, SCIENCE, V328, P321
   Caro P, 2008, BIOGERONTOLOGY, V9, P183, DOI 10.1007/s10522-008-9130-1
   Caro P, 2009, REJUV RES, V12, P421, DOI 10.1089/rej.2009.0902
   Caro P, 2009, BIOGERONTOLOGY, V10, P579, DOI 10.1007/s10522-008-9200-4
   Castro MD, 2012, EXP GERONTOL, V47, P29, DOI 10.1016/j.exger.2011.10.002
   DeLaAsuncion JG, 1996, FASEB J, V10, P333, DOI 10.1096/fasebj.10.2.8641567
   Dhahbi JM, 2001, MECH AGEING DEV, V122, P1033, DOI 10.1016/S0047-6374(01)00230-5
   Gomez J, 2009, J BIOENERG BIOMEMBR, V41, P309, DOI 10.1007/s10863-009-9229-3
   Grandison RC, 2009, NATURE, V462, P1061, DOI 10.1038/nature08619
   Gredilla R, 2005, ENDOCRINOLOGY, V146, P3713, DOI 10.1210/en.2005-0378
   Gredilla R, 2001, FASEB J, V15, P1589, DOI 10.1096/fj.00-0764fje
   Hajnóczky G, 2007, SCIENCE, V315, P607, DOI 10.1126/science.1138825
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   Hasek BE, 2010, AM J PHYSIOL-REG I, V299, pR728, DOI 10.1152/ajpregu.00837.2009
   Hayes JD, 2010, ANTIOXID REDOX SIGN, V13, P1713, DOI 10.1089/ars.2010.3221
   Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119
   Kabil H, 2011, P NATL ACAD SCI USA, V108, P16831, DOI 10.1073/pnas.1102008108
   Kästle M, 2011, CURR PHARM DESIGN, V17, P4007, DOI 10.2174/138161211798764898
   Kalhan SC, 2011, J BIOL CHEM, V286, P5266, DOI 10.1074/jbc.M110.185991
   Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046
   LATORRE A, 1986, P NATL ACAD SCI USA, V83, P8649, DOI 10.1073/pnas.83.22.8649
   Liu BT, 2011, ADV NUTR, V2, P511, DOI 10.3945/an.111.001057
   López-Lluch G, 2006, P NATL ACAD SCI USA, V103, P1768, DOI 10.1073/pnas.0510452103
   López-Torres M, 2002, FREE RADICAL BIO MED, V32, P882, DOI 10.1016/S0891-5849(02)00773-6
   López-Torres M, 2008, BBA-GEN SUBJECTS, V1780, P1337, DOI 10.1016/j.bbagen.2008.01.007
   Madrigano J, 2012, EPIGENETICS, V7
   Mair W, 2008, ANNU REV BIOCHEM, V77, P727, DOI 10.1146/annurev.biochem.77.061206.171059
   Malloy VL, 2006, AGING CELL, V5, P305, DOI 10.1111/j.1474-9726.2006.00220.x
   Min KJ, 2006, MECH AGEING DEV, V127, P643, DOI 10.1016/j.mad.2006.02.005
   Naudí A, 2007, REJUV RES, V10, P473, DOI 10.1089/rej.2007.0538
   Newby PK, 2005, AM J CLIN NUTR, V81, P1267
   Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728
   Pamplona R, 2002, ANN NY ACAD SCI, V959, P475, DOI 10.1111/j.1749-6632.2002.tb02118.x
   Pamplona R, 2011, BIOGERONTOLOGY, V12, P409, DOI 10.1007/s10522-011-9348-1
   Pamplona R, 2011, CHEM-BIOL INTERACT, V192, P14, DOI 10.1016/j.cbi.2011.01.007
   Park SK, 2005, AGEING RES REV, V4, P55, DOI 10.1016/j.arr.2004.09.003
   Passarino G, 2010, BIOGERONTOLOGY, V11, P575, DOI 10.1007/s10522-010-9294-3
   Perez-Campo R, 1998, J COMP PHYSIOL B, V168, P149, DOI 10.1007/s003600050131
   Petti AA, 2011, P NATL ACAD SCI USA, V108, pE1089, DOI 10.1073/pnas.1101494108
   Piper MDW, 2011, CELL METAB, V14, P154, DOI 10.1016/j.cmet.2011.06.013
   Porter AG, 2006, BIOESSAYS, V28, P834, DOI 10.1002/bies.20444
   RICHIE JP, 1994, FASEB J, V8, P1302, DOI 10.1096/fasebj.8.15.8001743
   Robert L, 2010, BIOGERONTOLOGY, V11, P387, DOI 10.1007/s10522-010-9262-y
   Sanchez-Roman I, 2011, J BIOENERG BIOMEMBR, V43, P699, DOI 10.1007/s10863-011-9389-9
   Sanz A, 2006, J BIOENERG BIOMEMBR, V38, P327, DOI 10.1007/s10863-006-9051-0
   Sanz A, 2004, J BIOENERG BIOMEMBR, V36, P545, DOI 10.1007/s10863-004-9001-7
   Sanz A, 2006, HDB MODELS HUMAN AGI, P183
   Sanz A, 2006, ANN NY ACAD SCI, V1067, P200, DOI 10.1196/annals.1354.024
   Sanz A, 2010, P NATL ACAD SCI USA, V107, P9105, DOI 10.1073/pnas.0911539107
   SOHAL RS, 1994, MECH AGEING DEV, V74, P121, DOI 10.1016/0047-6374(94)90104-X
   St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200
   Sun L, 2009, J GERONTOL A-BIOL, V64, P711, DOI 10.1093/gerona/glp051
   Taguchi A, 2008, ANNU REV PHYSIOL, V70, P191, DOI 10.1146/annurev.physiol.70.113006.100533
   Treberg JR, 2011, J BIOL CHEM, V286, P27103, DOI 10.1074/jbc.M111.252502
   Vahsen N, 2004, EMBO J, V23, P4679, DOI 10.1038/sj.emboj.7600461
   Vang A, 2008, ANN NUTR METAB, V52, P96, DOI 10.1159/000121365
NR 60
TC 51
Z9 58
U1 0
U2 29
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1389-5729
EI 1573-6768
J9 BIOGERONTOLOGY
JI Biogerontology
PD AUG
PY 2012
VL 13
IS 4
BP 399
EP 411
DI 10.1007/s10522-012-9384-5
PG 13
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 985HQ
UT WOS:000307254400005
PM 22580750
DA 2024-02-19
ER

PT J
AU He, SD
   Zhang, ZY
   Sun, HJ
   Zhu, YC
   Cao, XD
   Ye, YK
   Wang, JH
   Cao, YP
AF He, Shudong
   Zhang, Zuoyong
   Sun, Hanju
   Zhu, Yuchen
   Cao, Xiaodong
   Ye, Yongkang
   Wang, Junhui
   Cao, Yanping
TI Potential effects of rapeseed peptide Maillard reaction products on
   aging-related disorder attenuation and gut microbiota modulation in
   d-galactose induced aging mice
SO FOOD & FUNCTION
LA English
DT Article
ID AMELIORATES COGNITION DEFICITS; OXIDATIVE STRESS; MELANOIDINS; DAMAGE;
   BRAIN; MODEL; IMPAIRMENT; PROTECTION; QUERCETIN; DYSBIOSIS
AB As a good flavor enhancer, rapeseed peptide Maillard reaction products (MRPs) were developed, and the effects of MRPs on d-galactose induced aging Kunming mice were investigated for 6 weeks with low (200 mg kg(-1) day(-1)), medium (400 mg kg(-1) day(-1)) and high (800 mg kg(-1) day(-1)) doses. Compared with the natural aging group and d-galactose induced aging mice, the mice with MRP administration showed increases in body weight gain, food intake, organ indexes, feces color and urine fluorescence intensity. MRP intake significantly decreased the MDA content and elevated the activities of CAT, SOD and GSH-Px, and T-AOC in the serum and tissues of the liver, kidney and brain. Additionally, AChE activity was decreased in the brain, while Na+-K+ ATPase and Ca2+-Mg2+ ATPase activity increased in a dose-dependent manner, and decreasing levels of IL-1 beta, IL-6 and TNF-alpha were observed in the liver and kidney. Histopathological analysis suggested an attenuation of inflammatory cell infiltration in the liver and kidney without cell necrosis. High-throughput sequencing results revealed that the ratio of Firmicutes to Bacteroidetes increased in MRP groups, and the pathogenic bacteria were significantly inhibited, while some beneficial bacteria were significantly increased in the intestine. Overall, our results indicated that MRP consumption might have potential beneficial effects on postponing the aging process via reducing the oxidative stress and gut microflora modulation.
C1 [He, Shudong; Zhang, Zuoyong; Sun, Hanju; Cao, Xiaodong; Ye, Yongkang; Wang, Junhui] Hefei Univ Technol, Minist Educ, Engn Res Ctr Bioproc, Sch Food & Biol Engn, Hefei 230009, Anhui, Peoples R China.
   [He, Shudong; Cao, Yanping] Beijing Technol & Business Univ, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Beijing 100048, Peoples R China.
   [He, Shudong; Sun, Hanju; Cao, Xiaodong; Ye, Yongkang; Wang, Junhui] Anhui Qiangwang Seasoning Food Co Ltd, Anhui Prov Key Lab Funct Compound Seasoning, Jieshou 236500, Anhui, Peoples R China.
   [Zhu, Yuchen] China Agr Univ, Coll Food Sci & Nutr Engn, Beijing 100083, Peoples R China.
C3 Hefei University of Technology; Beijing Technology & Business
   University; China Agricultural University
RP Sun, HJ (corresponding author), Hefei Univ Technol, Minist Educ, Engn Res Ctr Bioproc, Sch Food & Biol Engn, Hefei 230009, Anhui, Peoples R China.; Cao, YP (corresponding author), Beijing Technol & Business Univ, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Beijing 100048, Peoples R China.; Sun, HJ (corresponding author), Anhui Qiangwang Seasoning Food Co Ltd, Anhui Prov Key Lab Funct Compound Seasoning, Jieshou 236500, Anhui, Peoples R China.
EM sunhanjv@yeah.net; caoyp@th.btbu.edu.cn
RI Ye, Yongkang/I-4091-2018; Ye, Yongkang/Q-3275-2019; He,
   Shudong/H-4396-2014; He, Shudong/ABF-4582-2021; cao, yanping/E-3381-2010
OI Ye, Yongkang/0000-0001-7703-8697; Ye, Yongkang/0000-0001-7703-8697; He,
   Shudong/0000-0002-1155-4928; 
FU National Natural Science Foundation of China [31701524, 31701728]; Anhui
   Provincial Natural Science Foundation [1708085MC70]; Fundamental
   Research Funds for the Central Universities [JZ2018HGTB0245]; China
   Postdoctoral Science Foundation [2017M611208, 2018T11021]; Anhui
   Provincial Science and Technology Major Project [16030701073]; Open
   Foundation of Beijing Advanced Innovation Center for Food Nutrition and
   Human Health, Beijing Technology and Business University (BTBU)
   [20181017]
FX The authors are grateful for the financial support from the National
   Natural Science Foundation of China (No. 31701524 and 31701728), the
   Anhui Provincial Natural Science Foundation (No. 1708085MC70), the
   Fundamental Research Funds for the Central Universities (No.
   JZ2018HGTB0245), the Financial Grant from China Postdoctoral Science
   Foundation (No. 2017M611208 and 2018T11021), the Anhui Provincial
   Science and Technology Major Project (No. 16030701073), and the Open
   Foundation of Beijing Advanced Innovation Center for Food Nutrition and
   Human Health, Beijing Technology and Business University (BTBU) (No.
   20181017). The authors would like to thank Ms Min Yu, Mr Lijun Tu, Mr
   Xianbao Sun and Mr Mingming Tang, School of Food and Biological
   Engineering, Hefei University of Technology, for helping in animal
   feeding and treatments. The authors thank Biomarker Biotechnology Co.,
   Beijing, China, for the technical assistance in gut microbial analysis.
CR ALJahdali N, 2017, DIGEST DIS SCI, V62, P3370, DOI 10.1007/s10620-017-4767-8
   Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331
   Biagi E, 2013, PHARMACOL RES, V69, P11, DOI 10.1016/j.phrs.2012.10.005
   Borrelli RC, 2005, MOL NUTR FOOD RES, V49, P673, DOI 10.1002/mnfr.200500011
   Chan-Min L., 2010, FOOD CHEM TOXICOL, V48, P2809
   Chen P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19732-0
   Delgado-Andrade C, 2018, ANNU REV FOOD SCI T, V9, P271, DOI 10.1146/annurev-food-030117-012441
   Eric K, 2014, FOOD RES INT, V57, P242, DOI 10.1016/j.foodres.2014.01.030
   Faist V, 2001, ANN NUTR METAB, V45, P1, DOI 10.1159/000046699
   He C, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00639
   He SD, 2019, IND CROP PROD, V128, P455, DOI 10.1016/j.indcrop.2018.11.048
   He SD, 2019, FOOD CHEM TOXICOL, V125, P62, DOI 10.1016/j.fct.2018.12.045
   Helena D., 2011, FOOD IND PROCESSES M, P281
   Hiramoto S, 2004, HELICOBACTER, V9, P429, DOI 10.1111/j.1083-4389.2004.00263.x
   Hwang IG, 2011, FOOD CHEM, V126, P221, DOI 10.1016/j.foodchem.2010.10.103
   Jin SL, 2012, FOOD CHEM TOXICOL, V50, P3814, DOI 10.1016/j.fct.2012.07.046
   Jin WY, 2018, FOOD FUNCT, V9, P2853, DOI 10.1039/c7fo02002c
   Kaakoush NO, 2015, FRONT CELL INFECT MI, V5, DOI [10.3309/fcimb.2015.00004, 10.3389/fcimb.2015.00084]
   Kumar A, 2010, FOOD CHEM TOXICOL, V48, P626, DOI 10.1016/j.fct.2009.11.043
   Lei YF, 2012, FOOD CHEM, V135, P2702, DOI 10.1016/j.foodchem.2012.07.043
   Li BL, 2018, FOOD FUNCT, V9, P6587, DOI 10.1039/c8fo01768a
   Li TY, 2016, FOOD FUNCT, V7, P1147, DOI 10.1039/c5fo01036e
   Lin LZ, 2018, J FUNCT FOODS, V47, P11, DOI 10.1016/j.jff.2018.05.033
   Min Y., 2017, FOOD CHEM, V243, P249
   Nooshkam M, 2019, FOOD CHEM, V275, P644, DOI 10.1016/j.foodchem.2018.09.083
   Poprac P, 2017, TRENDS PHARMACOL SCI, V38, P592, DOI 10.1016/j.tips.2017.04.005
   Ramos-Romero S, 2014, OBESITY, V22, P1575, DOI 10.1002/oby.20769
   Rashid K, 2013, FOOD CHEM TOXICOL, V62, P584, DOI 10.1016/j.fct.2013.09.026
   Saraswati S, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00764
   Shin NR, 2015, TRENDS BIOTECHNOL, V33, P496, DOI 10.1016/j.tibtech.2015.06.011
   Shu Yun Z., 2014, PHARMACOGN MAG, V10, P92
   Soprano M, 2016, CURR DIABETES REV, V12, P84, DOI 10.2174/1573399811666150722124701
   Sun SW, 2007, NUTR RES, V27, P169, DOI 10.1016/j.nutres.2007.01.010
   Tian Y, 2011, FOOD CHEM TOXICOL, V49, P1728, DOI 10.1016/j.fct.2011.04.018
   Troise AD, 2018, FOOD CHEM, V243, P365, DOI 10.1016/j.foodchem.2017.09.153
   Tropek R, 2016, ENVIRON SCI POLLUT R, V23, P13653, DOI 10.1007/s11356-015-4382-1
   Ullah F, 2015, NEUROCHEM INT, V90, P114, DOI 10.1016/j.neuint.2015.07.001
   Vaiserman AM, 2017, AGEING RES REV, V35, P36, DOI 10.1016/j.arr.2017.01.001
   Wang HY, 2011, FOOD CHEM, V128, P573, DOI 10.1016/j.foodchem.2011.03.075
   Wang YJ, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02509
   Xiao SM, 2014, FEMS MICROBIOL ECOL, V87, P357, DOI 10.1111/1574-6941.12228
   Xu LQ, 2016, FOOD FUNCT, V7, P4545, DOI 10.1039/c6fo01057a
   Yang WN, 2013, PHARMACOL BIOCHEM BE, V114, P31, DOI 10.1016/j.pbb.2013.10.027
   Yi Ren, 2011, Journal of Agricultural and Food Chemistry, V59, P206
   Yin DZ, 1996, FREE RADICAL BIO MED, V21, P871, DOI 10.1016/0891-5849(96)00175-X
   Yu M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115153
   Yun Z. S., 2017, BIOMED ENVIRON SCI, V30, P623
   Zhai S., 2018, MICROBIOLOGYOPEN, V7, P1
   Zhang DJ, 2018, J AGR FOOD CHEM, V66, P5510, DOI 10.1021/acs.jafc.8b00446
   Zhang J, 2017, J DAIRY SCI, V100, P6025, DOI 10.3168/jds.2016-12480
   Zhang XL, 2007, PHARMACOL BIOCHEM BE, V88, P64, DOI 10.1016/j.pbb.2007.07.004
   Zhang ZY, 2018, INT J BIOL MACROMOL, V120, P2137, DOI 10.1016/j.ijbiomac.2018.09.082
   Zhao L, 2017, FOOD FUNCT, V8, P4644, DOI [10.1039/C7FO01383C, 10.1039/c7fo01383c]
   Zhuang YL, 2017, FOOD CHEM TOXICOL, V108, P554, DOI 10.1016/j.fct.2017.01.022
NR 54
TC 20
Z9 23
U1 5
U2 113
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2042-6496
EI 2042-650X
J9 FOOD FUNCT
JI Food Funct.
PD JUL 1
PY 2019
VL 10
IS 7
BP 4291
EP 4303
DI 10.1039/c9fo00791a
PG 13
WC Biochemistry & Molecular Biology; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Food Science & Technology
GA IK6GK
UT WOS:000476683600041
PM 31265043
DA 2024-02-19
ER

PT J
AU Hoffler, U
   Hobbie, K
   Wilson, R
   Bai, R
   Rahman, A
   Malarkey, D
   Travlos, G
   Ghanayem, BI
AF Hoffler, Undi
   Hobbie, Kristen
   Wilson, Ralph
   Bai, Re
   Rahman, Akef
   Malarkey, David
   Travlos, Greg
   Ghanayem, Burhan I.
TI Diet-induced obesity is associated with hyperleptinemia,
   hyperinsulinemia, hepatic steatosis, and glomerulopathy in C57Bl/6J mice
SO ENDOCRINE
LA English
DT Article
DE Diet-induced obesity; Hyperinsulinemia; Hyperleptinemia; Diabetes;
   Hepatic steatosis; Glomerulopathy; Mice
ID PLASMINOGEN-ACTIVATOR INHIBITOR-1; HIGH-FAT DIET; TYPE-2
   DIABETES-MELLITUS; IGF-BINDING PROTEIN-1; INSULIN-RESISTANCE; LEPTIN
   RESISTANCE; GENE-EXPRESSION; CARDIOVASCULAR-DISEASE; CYTOCHROME-P450
   2E1; ENDOTHELIAL-CELLS
AB Obesity and obesity-related illnesses are global epidemics impacting the health of adults and children. The purpose of the present work is to evaluate a genetically intact obese mouse model that more accurately reflects the impact of aging on diet-induced obesity and type 2 diabetes in humans. Male C57Bl/6J mice consumed either a control diet or one in which 60% kcal were due to lard beginning at 5-6 weeks of age. Body weight and fat measurements were obtained and necropsy performed at 15, 20, 30, and 40 weeks of age. Serum chemistry, histopathology, gene expression of the liver, and renal and hepatic function were also evaluated. In concert with significant increases in percent body fat and weight, mice fed the high-fat versus control diet had significantly increased levels of serum cholesterol. At ages 20 and 30 weeks, serum glucose was significantly higher in obese versus controls, while serum insulin levels were a parts per thousand yen4-fold higher in obese mice at ages 30 and 40 weeks. The effect of age exacerbated the effects of consuming a high-fat diet. In addition to being hyperinsulinemic and leptin resistant, older obese mice exhibited elevated hepatic PAI-1 and downregulation of GLUT4, G6PC, IGFBP-1, and leptin receptor mRNA in the liver, steatosis with subsequent inflammation, glomerular mesangial proliferation, elevated serum ALT, AST, and BUN, and increased numbers of pancreatic islets.
C1 [Hoffler, Undi; Wilson, Ralph; Rahman, Akef; Ghanayem, Burhan I.] NIEHS, Pharmacol Lab, NIH, Res Triangle Pk, NC 27709 USA.
   [Wilson, Ralph; Malarkey, David; Travlos, Greg] NIEHS, Cellular & Mol Pathol Branch, NIH, Res Triangle Pk, NC 27709 USA.
   [Hobbie, Kristen] Integrated Syst Lab, Res Triangle Pk, NC USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute of
   Environmental Health Sciences (NIEHS); National Institutes of Health
   (NIH) - USA; NIH National Institute of Environmental Health Sciences
   (NIEHS)
RP Ghanayem, BI (corresponding author), NIEHS, Pharmacol Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.
EM ghanayem@niehs.nih.gov
FU NIH; National Institute of Environmental Health Sciences
FX We extend our thanks to Drs. Retha Newbold and Susan Elmore for their
   commentary and careful review of this manuscript. We also sincerely
   appreciate Dr. Grace Kissling for her assistance with the statistical
   analyses. This research was supported by the Intramural Research Program
   of the NIH, National Institute of Environmental Health Sciences.
CR Alessi MC, 2003, ARTERIOSCL THROM VAS, V23, P1262, DOI 10.1161/01.ATV.0000077401.36885.BB
   Angulo Paul, 2002, Ann Hepatol, V1, P12
   [Anonymous], 2003, JOINT WHO FAO EXP CO
   Aso Y, 2002, METABOLISM, V51, P471, DOI 10.1053/meta.2002.31334
   BAILER AJ, 1988, J PHARMACOKINET BIOP, V16, P303, DOI 10.1007/BF01062139
   Banks WA, 1999, PEPTIDES, V20, P1341, DOI 10.1016/S0196-9781(99)00139-4
   Banks WA, 2004, DIABETES, V53, P1253, DOI 10.2337/diabetes.53.5.1253
   Bianchini F, 2002, LANCET ONCOL, V3, P565, DOI 10.1016/S1470-2045(02)00849-5
   Bulló M, 2003, OBES RES, V11, P525, DOI 10.1038/oby.2003.74
   Calle EE, 2004, ONCOGENE, V23, P6365, DOI 10.1038/sj.onc.1207751
   Caro AA, 2004, ANNU REV PHARMACOL, V44, P27, DOI 10.1146/annurev.pharmtox.44.101802.121704
   Ceddia RB, 2002, FASEB J, V16, DOI 10.1096/fj.02-0158rev
   CHANDRASAGAR D, 2005, EMBRO REP, V6, P1137
   Cinti S, 2005, PROSTAG LEUKOTR ESS, V73, P9, DOI 10.1016/j.plefa.2005.04.010
   Danko IM, 2005, EXP ONCOL, V27, P248
   Deng SP, 2004, DIABETES, V53, P624, DOI 10.2337/diabetes.53.3.624
   Dey A, 2007, HEPATOLOGY, V45, P1355, DOI 10.1002/hep.21603
   Dimova E, 2008, THROMB HAEMOSTASIS, V100, P992, DOI 10.1160/TH08-07-0490
   Fehmann HC, 1997, PEPTIDES, V18, P1267, DOI 10.1016/S0196-9781(97)00135-6
   García-Monzón C, 2000, J HEPATOL, V33, P716, DOI 10.1016/S0168-8278(00)80301-3
   Grinspoon S, 1996, J CLIN ENDOCR METAB, V81, P3861, DOI 10.1210/jc.81.11.3861
   Han DC, 2001, KIDNEY INT, V59, P1315, DOI 10.1046/j.1523-1755.2001.0590041315.x
   Hileman SM, 2002, ENDOCRINOLOGY, V143, P775, DOI 10.1210/en.143.3.775
   HOLLY JMP, 1991, CLIN ENDOCRINOL, V34, P275, DOI 10.1111/j.1365-2265.1991.tb03766.x
   Jiang T, 2005, J BIOL CHEM, V280, P32317, DOI 10.1074/jbc.M500801200
   Kambham N, 2001, KIDNEY INT, V59, P1498, DOI 10.1046/j.1523-1755.2001.0590041498.x
   Karasawa H, 2009, METABOLISM, V58, P296, DOI 10.1016/j.metabol.2008.09.028
   Kregel KC, 2007, AM J PHYSIOL-REG I, V292, pR18, DOI 10.1152/ajpregu.00327.2006
   LANDIN K, 1990, METABOLISM, V39, P1044, DOI 10.1016/0026-0495(90)90164-8
   Leclercq IA, 2000, BIOCHEM BIOPH RES CO, V268, P337, DOI 10.1006/bbrc.2000.2125
   Lieber CS, 1997, PHYSIOL REV, V77, P517, DOI 10.1152/physrev.1997.77.2.517
   Lin S, 2000, INT J OBESITY, V24, P639, DOI 10.1038/sj.ijo.0801209
   Liu ZJ, 2007, HORM METAB RES, V39, P489, DOI 10.1055/s-2007-981680
   McLaughlin T, 2002, CIRCULATION, V106, P2908, DOI 10.1161/01.CIR.0000041046.32962.86
   Meyerhardt JA, 2008, J CLIN ONCOL, V26, P4109, DOI 10.1200/JCO.2007.15.6687
   Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185
   Mühlfeld AS, 2004, KIDNEY INT, V66, P1393, DOI 10.1111/j.1523-1755.2004.00854.x
   Muoio DM, 2006, ANNU REV BIOCHEM, V75, P367, DOI 10.1146/annurev.biochem.75.103004.142512
   Murray M, 2006, CURR DRUG METAB, V7, P67, DOI 10.2174/138920006774832569
   Nangaku M, 2005, NEPHROL DIAL TRANSPL, V20, P2661, DOI 10.1093/ndt/gfi096
   National Research Council, 1996, GUID CAR US LAB AN
   Norata GD, 2004, BRIT J HAEMATOL, V127, P97, DOI 10.1111/j.1365-2141.2004.05163.x
   Parekh PI, 1998, METABOLISM, V47, P1089, DOI 10.1016/S0026-0495(98)90283-9
   Poirier P, 2006, ARTERIOSCL THROM VAS, V26, P968, DOI 10.1161/01.ATV.0000216787.85457.f3
   Qi L, 2009, CELL METAB, V9, P277, DOI 10.1016/j.cmet.2009.01.006
   Reaven G, 2003, DIABETES CARE, V26, P539, DOI 10.2337/diacare.26.2.539
   Remuzzi G, 2002, NEW ENGL J MED, V346, P1145, DOI 10.1056/NEJMcp011773
   Rossmeisl M, 2003, DIABETES, V52, P1958, DOI 10.2337/diabetes.52.8.1958
   Roytblat L, 2000, OBES RES, V8, P673, DOI 10.1038/oby.2000.86
   Schindler TH, 2006, J AM COLL CARDIOL, V47, P1188, DOI 10.1016/j.jacc.2005.10.062
   Schwartz MW, 1997, DIABETES CARE, V20, P1476, DOI 10.2337/diacare.20.9.1476
   Seufert J, 2004, DIABETES, V53, pS152, DOI 10.2337/diabetes.53.2007.S152
   Seufert J, 1999, J CLIN ENDOCR METAB, V84, P670, DOI 10.1210/jc.84.2.670
   Söderberg S, 2001, EUR J ENDOCRINOL, V144, P283, DOI 10.1530/eje.0.1440283
   Steinberg GR, 2002, AM J PHYSIOL-ENDOC M, V282, pE593, DOI 10.1152/ajpendo.00303.2001
   SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163
   Tanizawa Y, 1997, ENDOCRINOLOGY, V138, P4513, DOI 10.1210/en.138.10.4513
   Townsend KL, 2008, ENDOCRINE, V33, P176, DOI 10.1007/s12020-008-9070-1
   Unger RH, 2001, DIABETES, V50, pS118, DOI 10.2337/diabetes.50.2007.S118
   Wang ZQ, 2003, BRIT J CLIN PHARMACO, V55, P77, DOI 10.1046/j.1365-2125.2003.01731.x
   Weltman MD, 1998, HEPATOLOGY, V27, P128, DOI 10.1002/hep.510270121
   Wilcox Gisela, 2005, Clin Biochem Rev, V26, P19
   Wilsey J, 2003, AM J PHYSIOL-REG I, V285, pR1011, DOI 10.1152/ajpregu.00193.2003
   Wolk R, 2006, DIABETES OBES METAB, V8, P250, DOI 10.1111/j.1463-1326.2005.00508.x
   Yoon KH, 2003, J CLIN ENDOCR METAB, V88, P2300, DOI 10.1210/jc.2002-020735
   Yoshinari K, 2006, BIOL PHARM BULL, V29, P1634, DOI 10.1248/bpb.29.1634
   YUAN JH, 1993, J PHARM SCI, V82, P761, DOI 10.1002/jps.2600820718
   Yudkin JS, 1999, THROMB RES, V96, P1, DOI 10.1016/S0049-3848(99)00061-4
   Yudkin JS, 1999, ARTERIOSCL THROM VAS, V19, P972, DOI 10.1161/01.ATV.19.4.972
   Zhao RZ, 2008, MOL CELL BIOCHEM, V317, P197, DOI 10.1007/s11010-008-9851-0
   Zheng SR, 2008, J AM SOC NEPHROL, V19, P2077, DOI 10.1681/ASN.2007080967
NR 71
TC 77
Z9 86
U1 0
U2 10
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1355-008X
EI 1559-0100
J9 ENDOCRINE
JI Endocrine
PD OCT
PY 2009
VL 36
IS 2
BP 311
EP 325
DI 10.1007/s12020-009-9224-9
PG 15
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 498UO
UT WOS:000270169800020
PM 19669948
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Wu, SY
   Wu, YQ
   Chen, JN
   Zhuang, P
   Zhang, Y
   Jiao, JJ
AF Wu, Shanyun
   Wu, Yuqi
   Chen, Jingnan
   Zhuang, Pan
   Zhang, Yu
   Jiao, Jingjing
TI Lifelong docosahexaenoic acid intervention ameliorates aging in the
   telomere-DNA-mitochondria axis in telomerase-deficient mice *
SO JOURNAL OF NUTRITIONAL BIOCHEMISTRY
LA English
DT Article; Early Access
DE Docosahexaenoic acid; telomere; mitochondria; aging; lifelong
   intervention
ID OXIDATIVE STRESS; SKELETAL-MUSCLE; FATTY-ACIDS; DYSFUNCTION; DAMAGE;
   METABOLISM; EXPRESSION; PATHWAYS; HEALTH; LIVER
AB The health benefits of n-3 polyunsaturated fatty acids (PUFAs) in multiple age-related diseases are associated with telomere length. Telomerase is inti-mately related to inflammation and oxidative stress, but whether the underlying function of n-3 PUFAs on telomere maintenance is based on telomerase activation or related mechanisms remains unclear. Herein, we utilized late-generation (G4) telomerase-deficient (Terc-/-) mice to perform a lifelong do-cosahexaenoic acid (DHA) intervention to determine the potential of DHA in telomere maintenance and health promotion. Unfortunately, DHA failed to prolong mouse longevity in either intrinsic or premature aging. However, intriguingly, lifelong dietary DHA intervention slowed the aging phenotypes and profoundly attenuated telomere attrition in blood leukocytes and multiple tissues, consistent with decreased beta-galactosidase activity and other senes-cence hallmarks with no observed sex differences. Notably, DHA intervention alleviated telomere attrition-induced gamma-H2AX accumulation dependent on poly (ADP-ribose) polymerase 1 (PARP1) recruitment, and further regulated mitochondrial dysfunction critically involved in the DNA damage response. To-gether with the improvement of mitochondria function, the blocked reactive oxygen species (ROS) accumulation and suppression of the nuclear factor -KB (NF-KB)/nucleotide-binding domain-like receptor protein 3 (NLRP3)/caspase-1 pathways partially indicated anti-oxidative and anti-inflammatory effects of DHA. These data revealed a regulatory paradigm involving DHA in the telomere-DNA-mitochondria feedback loop mediated by DNA damage response and inflammation in alleviating senescence, which may hold potential as a translatable intervention in telomere-related diseases during aging. (c) 2022 Elsevier Inc. All rights reserved.
C1 [Wu, Shanyun; Jiao, Jingjing] Zhejiang Univ, Affiliated Hosp 2, Dept Endocrinol, Sch Med, Hangzhou, Zhejiang, Peoples R China.
   [Wu, Shanyun; Wu, Yuqi; Chen, Jingnan; Zhuang, Pan; Zhang, Yu] Zhejiang Univ, Coll Biosyst Engn & Food Sci, Natl Engn Lab Intelligent Food Technol & Equipment, Zhejiang Key Lab Agrofood Proc, Hangzhou, Zhejiang, Peoples R China.
   [Jiao, Jingjing] Zhejiang Univ, Sch Publ Hlth, Dept Nutr, Sch Med, Hangzhou, Zhejiang, Peoples R China.
   [Jiao, Jingjing] 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.
C3 Zhejiang University; Zhejiang University; Zhejiang University
RP Jiao, JJ (corresponding author), 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.
EM jingjingjiao@zju.edu.cn
OI Jiao, Jingjing/0000-0003-4167-1567
FU Zhejiang Provincial Natural Science Foundation of China;  [R18C200001]
FX * Funding sources Zhejiang Provincial Natural Science Foundation of
   China (Grant No. R18C200001) .
CR Amano H, 2019, CELL METAB, V29, P1274, DOI 10.1016/j.cmet.2019.03.001
   Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343
   Barja G, 2019, EXP GERONTOL, V124, DOI 10.1016/j.exger.2019.05.016
   Bhattacharjee RN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011873
   Chen JN, 2017, ONCOTARGET, V8, P7301, DOI 10.18632/oncotarget.14236
   Cheng FF, 2021, LANCET DIABETES ENDO, V9, P117, DOI 10.1016/S2213-8587(20)30365-X
   Childs CE, 2008, P NUTR SOC, V67, P19, DOI 10.1017/S0029665108005983
   D'Onofrio N, 2018, ANTIOXID REDOX SIGN, V28, P711, DOI 10.1089/ars.2017.7178
   Damale MG, 2020, EUR J MED CHEM, V207, DOI 10.1016/j.ejmech.2020.112712
   Demanelis K, 2020, SCIENCE, V369, P1333, DOI 10.1126/science.aaz6876
   EDER K, 1995, J CHROMATOGR B, V671, P113, DOI 10.1016/0378-4347(95)00142-6
   Fang EF, 2016, NAT REV MOL CELL BIO, V17, P308, DOI 10.1038/nrm.2016.14
   Ferrara-Romeo L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204909
   Galiè S, 2020, ADV NUTR, V11, P576, DOI 10.1093/advances/nmz107
   Gao JL, 2019, NUTRIENTS, V11, DOI 10.3390/nu11071699
   Giorgio M, 2016, AGING CELL, V15, P446, DOI 10.1111/acel.12448
   Gómez A, 2014, AGING CELL, V13, P551, DOI 10.1111/acel.12205
   Gomez M, 2006, MOL BIOL CELL, V17, P1686, DOI 10.1091/mbc.E05-07-0672
   Heng D, 2021, AGING CELL, V20, DOI 10.1111/acel.13304
   Hewitt G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1708
   Jiao JJ, 2012, ANAL BIOANAL CHEM, V403, P157, DOI 10.1007/s00216-012-5783-3
   Jin X, 2022, OXID MED CELL LONGEV, V2022, DOI 10.1155/2022/3711371
   Jurk D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5172
   Kang YH, 2018, CELL REP, V22, P3493, DOI 10.1016/j.celrep.2018.02.071
   Kozyreva E., PRESERVING TELOMERE
   Lesnefsky EJ, 2016, CIRC RES, V118, P1593, DOI 10.1161/CIRCRESAHA.116.307505
   López-Armada MJ, 2013, MITOCHONDRION, V13, P106, DOI 10.1016/j.mito.2013.01.003
   Madaan A., 2014, J. Biol. Methods, V1, P1, DOI [10.14440/jbm.2014.12, DOI 10.14440/JBM.2014.12, 10.14440/jbm.20 14.12]
   Makino N, 2011, J MOL CELL CARDIOL, V50, P670, DOI 10.1016/j.yjmcc.2010.12.014
   Maleki M, 2020, LIFE SCI, V259, DOI 10.1016/j.lfs.2020.118341
   Martínez P, 2016, AGING CELL, V15, P1113, DOI 10.1111/acel.12517
   Moslehi J, 2012, CIRC RES, V110, P1226, DOI 10.1161/CIRCRESAHA.111.246868
   Nagano T, 2016, SCI REP-UK, V6, DOI 10.1038/srep31758
   Navarro S, 2017, THORAX, V72, P451, DOI 10.1136/thoraxjnl-2016-208964
   Olovnikov AM, 1996, EXP GERONTOL, V31, P443, DOI 10.1016/0531-5565(96)00005-8
   Sahin E, 2010, NATURE, V464, P520, DOI 10.1038/nature08982
   Sakai C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187934
   Saki M, 2017, FREE RADICAL BIO MED, V107, P216, DOI 10.1016/j.freeradbiomed.2016.11.050
   Simopoulos AP, 2016, NUTRIENTS, V8, DOI 10.3390/nu8030128
   Toldo S, 2022, PHARMACOL THERAPEUT, V236, DOI 10.1016/j.pharmthera.2021.108053
   Torres P, 2020, NEUROTHERAPEUTICS, V17, P269, DOI 10.1007/s13311-019-00808-2
   Tsai CH, 2017, FOOD CHEM TOXICOL, V108, P276, DOI 10.1016/j.fct.2017.08.010
   Ulmann L, 2017, MINI-REV MED CHEM, V17, P1112, DOI 10.2174/1389557516666160722132736
   Varela-Lopez A, 2018, J NUTR BIOCHEM, V52, P36, DOI 10.1016/j.jnutbio.2017.09.007
   Xiong SQ, 2015, CELL REP, V12, P1391, DOI 10.1016/j.celrep.2015.07.047
   Yamagata K, 2016, PROSTAG LEUKOTR ESS, V104, P11, DOI 10.1016/j.plefa.2015.10.006
   Zárate R, 2017, CLIN TRANSL MED, V6, DOI 10.1186/s40169-017-0153-6
NR 47
TC 4
Z9 4
U1 1
U2 9
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0955-2863
EI 1873-4847
J9 J NUTR BIOCHEM
JI J. Nutr. Biochem.
PD 2023 FEB
PY 2023
VL 112
AR 109202
DI 10.1016/j.jnutbio.2022.109202
EA NOV 2022
PG 11
WC Biochemistry & Molecular Biology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Nutrition & Dietetics
GA 7K4MY
UT WOS:000905259900006
PM 36347449
DA 2024-02-19
ER

PT J
AU Bastati, N
   Beer, L
   Ba-Ssalamah, A
   Poetter-Lang, S
   Ambros, R
   Kristic, A
   Lauber, D
   Pomej, K
   Binter, T
   Simbrunner, B
   Semmler, G
   Balcar, L
   Bican, Y
   Hodge, JC
   Wrba, T
   Trauner, M
   Reiberger, T
   Mandorfer, M
AF Bastati, Nina
   Beer, Lucian
   Ba-Ssalamah, Ahmed
   Poetter-Lang, Sarah
   Ambros, Raphael
   Kristic, Antonia
   Lauber, David
   Pomej, Katharina
   Binter, Teresa
   Simbrunner, Benedikt
   Semmler, Georg
   Balcar, Lorenz
   Bican, Yesim
   Hodge, Jacqueline C.
   Wrba, Thomas
   Trauner, Michael
   Reiberger, Thomas
   Mandorfer, Mattias
TI Gadoxetic acid-enhanced MRI-derived functional liver imaging score
   (FLIS) and spleen diameter predict outcomes in ACLD
SO JOURNAL OF HEPATOLOGY
LA English
DT Article; Early Access
DE Magnetic resonance imaging; Cirrhosis; Portal hypertension;
   hep-atobiliary contrast agent; gadolinium methoxybenzyl DTPA
ID PORTAL-HYPERTENSION; CLINICAL DECOMPENSATION; CIRRHOSIS; RISK;
   ENLARGEMENT; PREVENTION
AB Background & Aims: Functional liver imaging score (FLIS) - derived from gadoxetic acid-enhanced MRI - correlates with liver function and independently predicts liver-related mortality in patients with chronic liver disease (CLD), while splenic cra-niocaudal diameter (SCCD) is a marker of portal hypertension. The aim of this study was to investigate the accuracy of a com-bination of FLIS and SCCD for predicting hepatic decompensa-tion, acute-on-chronic liver failure (ACLF), and mortality in patients with advanced CLD (ACLD). Methods: We included 397 patients with CLD who underwent gadoxetic acid-enhanced liver MRI. The FLIS was calculated by summing the points (0-2) of 3 hepatobiliary-phase features: hepatic enhancement, biliary excretion, and portal vein signal intensity. Patients were stratified into 3 groups according to liver fibrosis severity and presence/history of hepatic decompensa-tion: non-ACLD, compensated ACLD (cACLD), and decom-pensated ACLD (dACLD).Results: SCCD showed excellent intra-and inter-reader agree-ment. Importantly, SCCD was an independent risk factor for hepatic decompensation in patients with cACLD (per cm; adjusted hazard ratio [aHR] 1.13; 95% CI 1.04-1.23; p = 0.004). Patients with cACLD and a FLIS of 0-3 points and/or a SCCD of >13 cm were at increased risk of hepatic decompensation (aHR 3.07; 95% CI 1.43-6.59; p = 0.004). In patients with dACLD, a FLIS of 0-3 was independently associated with an increased risk of ACLF (aHR 2.81; 95% CI 1.16-6.84; p = 0.02), even after adjusting for other prognostic factors. Finally, a FLIS and SCCD-based al-gorithm was independently predictive of transplant-free mor-tality and stratified the probability of transplant-free survival (TFS) in ACLD (p <0.001): FLIS 4-6 and SCCD <-13 cm (5-year TFS of 84%) vs. FLIS 4-6 and SCCD >13 cm (5-year TFS of 70%) vs. FLIS 0-3 (5-year TFS of 24%).Conclusion: The FLIS and SCCD are simple imaging markers that provide complementary information for risk stratification in patients with compensated and decompensated ACLD.Lay summary: Magnetic resonance imaging (MRI) can be used to assess the state of the liver. Previously the functional liver im-aging score, which is based on MRI criteria, was developed as a measure of liver function and to predict the risk of liver-related complications or death. By combining this score with a mea-surement of spleen diameter, also using MRI, we generated an algorithm that could predict the risk of adverse liver-related outcomes in patients with advanced chronic liver disease.(c) 2022 The Author(s). Published by Elsevier B.V. on behalf of Euro-pean Association for the Study of the Liver. This is an open access article under the CC BY license (http://creativecommons.org/licenses/ by/4.0/).
C1 [Bastati, Nina; Beer, Lucian; Ba-Ssalamah, Ahmed; Poetter-Lang, Sarah; Ambros, Raphael; Kristic, Antonia; Lauber, David; Bican, Yesim; Hodge, Jacqueline C.] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria.
   [Pomej, Katharina; Binter, Teresa; Simbrunner, Benedikt; Semmler, Georg; Balcar, Lorenz; Trauner, Michael; Reiberger, Thomas; Mandorfer, Mattias] Med Univ Vienna, Dept Internal Medicine3, Div Gastroenterol & Hepatol, Vienna, Austria.
   [Pomej, Katharina; Binter, Teresa; Simbrunner, Benedikt; Semmler, Georg; Balcar, Lorenz; Reiberger, Thomas; Mandorfer, Mattias] Med Univ Vienna, Dept Internal Medicine3, Div Gastroenterol & Hepatol, Vienna Hepat Hemodynam Lab, Vienna, Austria.
   [Wrba, Thomas] Med Univ Vienna, IT4Science, Vienna, Austria.
   [Ba-Ssalamah, Ahmed] Med Univ, Gen Hosp Vienna AKH, Dept Biomed Imaging & Image Guided Therapy, Waehringer Guertel 18-20, A-1090 Vienna, Austria.
C3 Medical University of Vienna; Medical University of Vienna; Medical
   University of Vienna; Medical University of Vienna
RP Ba-Ssalamah, A (corresponding author), Med Univ, Gen Hosp Vienna AKH, Dept Biomed Imaging & Image Guided Therapy, Waehringer Guertel 18-20, A-1090 Vienna, Austria.
EM ahmed.ba-ssalamah@meduniwien.ac.at
RI Reiberger, Thomas/H-7613-2019; Semmler, Georg/O-3323-2019; Balcar,
   Lorenz/HNQ-1094-2023
OI Reiberger, Thomas/0000-0002-4590-3583; Semmler,
   Georg/0000-0002-0411-166X; Trauner, Michael/0000-0002-1275-6425; Pomej,
   Katharina/0000-0002-2807-3565; Balcar, Lorenz/0000-0002-6708-3061;
   Ambros, Raphael/0000-0002-5925-2056; Mandorfer,
   Mattias/0000-0003-2330-0017
FU AbbVie; Albireo; Cymabay; Falk; Gilead; Intercept; MSD; Takeda;
   Boehringer Ingelheim; Philips; W. L. Gore Associates
FX A.B. received honoraria for lectures and a consultancy from Bayer, but
   disclosed no relation to the present article. D.B.received travel
   support from AbbVie and Gilead, as well asspeaker fees from AbbVie. B.S.
   received travel support fromAbbVie and Gilead. M.T. served as a speaker
   and/or consultantand/or advisory board member for Albireo, Boehringer
   Ingel-heim, Bristol-Myers Squibb, Falk, Genfit, Gilead, Intercept,
   MSD,Novartis, Phenex, Regulus and Shire, and received travel supportfrom
   AbbVie, Falk, Gilead, and Intercept, as well as grants/research support
   from Albireo, Cymabay, Falk, Gilead, Intercept,MSD, and Takeda. He is
   also co-inventor of patents on themedical use of 24-norursodeoxycholic
   acid. T.R. served as aspeaker and/or consultant and/or advisory board
   member forAbbVie, Bayer, Boehringer Ingelheim, Gilead, Intercept,
   MSD,Siemens, and W. L. Gore & Associates and received grants/research
   support from AbbVie, Boehringer Ingelheim, Gilead,MSD, Philips, and W.
   L. Gore & Associates as well as travel sup-port from Boehringer
   Ingelheim and Gilead. M.M. served as aspeaker and/or consultant and/or
   advisory board member forAbbVie, Gilead, Collective Acumen, and W. L.
   Gore & Associatesand received travel support from AbbVie and Gilead. All
   otherauthors declare no relationships with any companies whoseproducts
   or services may be related to the subject matter ofthe article.
CR Ba-Ssalamah A, 2017, J MAGN RESON IMAGING, V45, P646, DOI 10.1002/jmri.25518
   Bastati N, 2020, RADIOLOGY, V294, P98, DOI 10.1148/radiol.2019190734
   Bastati N, 2016, INVEST RADIOL, V51, P728, DOI 10.1097/RLI.0000000000000286
   Beer L, 2019, EUR RADIOL, V29, P6600, DOI 10.1007/s00330-019-06182-z
   Bernardi M, 2020, GUT, V69, P1127, DOI 10.1136/gutjnl-2019-318843
   Berzigotti A, 2008, CLIN GASTROENTEROL H, V6, P1129, DOI 10.1016/j.cgh.2008.05.004
   Berzigotti A, 2021, J HEPATOL, V75, P659, DOI 10.1016/j.jhep.2021.05.025
   Berzigotti A, 2013, GASTROENTEROLOGY, V144, P102, DOI 10.1053/j.gastro.2012.10.001
   Berzigotti A, 2011, HEPATOLOGY, V54, P555, DOI 10.1002/hep.24418
   Bolognesi M, 2002, DIGEST LIVER DIS, V34, P144, DOI 10.1016/S1590-8658(02)80246-8
   Bosch J, 2020, GUT, V69, P953, DOI 10.1136/gutjnl-2019-318237
   García-Pagán JC, 2020, JHEP REP, V2, DOI 10.1016/j.jhepr.2020.100122
   Chan AWH, 2015, J GASTROEN HEPATOL, V30, P1391, DOI 10.1111/jgh.12938
   de Franchis R, 2022, J HEPATOL, V76, P959, DOI 10.1016/j.jhep.2021.12.022
   de Franchis R, 2015, J HEPATOL, V63, P743, DOI 10.1016/j.jhep.2015.05.022
   De Odorico I, 1999, J ULTRAS MED, V18, P231, DOI 10.7863/jum.1999.18.3.231
   Ehlken H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164224
   Etzion O, 2018, HEPATOL COMMUN, V2, P923, DOI 10.1002/hep4.1198
   Garcia-Tsao G, 2017, HEPATOLOGY, V65, P310, DOI 10.1002/hep.28906
   Goksuluk D, 2016, R J, V8, P213
   Haider L, 2018, CONTRAST MEDIA MOL I, DOI 10.1155/2018/8489709
   Hiraoka A, 2017, LIVER CANCER, V6, P204, DOI 10.1159/000452846
   Iranmanesh P, 2014, J HEPATOL, V60, P969, DOI 10.1016/j.jhep.2013.12.015
   Jachs M, 2021, CLIN LIVER DIS, V25, P311, DOI 10.1016/j.cld.2021.01.004
   Jalan R, 2021, J HEPATOL, V75, pS14, DOI 10.1016/j.jhep.2021.01.018
   Jung F, 2019, CLIN GASTROENTEROL H, V17, P2613, DOI 10.1016/j.cgh.2018.12.033
   Lee H, 2023, EUR CHILD ADOLES PSY, V32, P283, DOI 10.1007/s00787-021-01860-0
   Mandorfer M, 2019, HEPATOLOGY BALTIMORE
   Mandorfer M, 2021, CLIN LIVER DIS, V25, P291, DOI 10.1016/j.cld.2021.01.003
   Mandorfer M, 2020, SEMIN LIVER DIS, V40, P240, DOI 10.1055/s-0040-1708806
   Moreau R, 2013, GASTROENTEROLOGY, V144, P1426, DOI 10.1053/j.gastro.2013.02.042
   Peng Y, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002877
   Reiberger T, 2020, JOVE-J VIS EXP, DOI 10.3791/58819
   Ripoll C, 2007, GASTROENTEROLOGY, V133, P481, DOI 10.1053/j.gastro.2007.05.024
   Scheiner B, 2019, LIVER INT, V39, P127, DOI 10.1111/liv.13943
   Simón-Talero M, 2018, GASTROENTEROLOGY, V154, P1694, DOI 10.1053/j.gastro.2018.01.028
   Van Beers BE, 2012, J HEPATOL, V57, P421, DOI 10.1016/j.jhep.2012.01.031
   Wibmer QA, 2012, LIVER TRANSPLANTATIO
   Yan SP, 2015, EUR J GASTROEN HEPAT, V27, P335, DOI 10.1097/MEG.0000000000000269
   Yoo J, 2021, EUR RADIOL, V31, P1432, DOI 10.1007/s00330-020-07209-6
   Zardi EM, 2014, ANN MED, V46, P8, DOI 10.3109/07853890.2013.857831
NR 41
TC 8
Z9 8
U1 1
U2 4
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0168-8278
EI 1600-0641
J9 J HEPATOL
JI J. Hepatol.
PD 2022 OCT
PY 2022
VL 77
IS 4
BP 1005
EP 1013
DI 10.1016/j.jhep.2022.04.032
EA SEP 2022
PG 10
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 5I4IE
UT WOS:000868321600015
PM 35525337
OA hybrid
DA 2024-02-19
ER

PT J
AU Luu, YK
   Ozcivici, E
   Capilla, E
   Adler, B
   Chan, E
   Shroyer, K
   Rubin, J
   Judex, S
   Pessin, JE
   Rubin, CT
AF Luu, Y. K.
   Ozcivici, E.
   Capilla, E.
   Adler, B.
   Chan, E.
   Shroyer, K.
   Rubin, J.
   Judex, S.
   Pessin, J. E.
   Rubin, C. T.
TI Development of diet-induced fatty liver disease in the aging mouse is
   suppressed by brief daily exposure to low-magnitude mechanical signals
SO INTERNATIONAL JOURNAL OF OBESITY
LA English
DT Article
DE diet-induced obesity; aging; liver steatosis; mechanical loading;
   triglycerides; free fatty acids
ID HIGH-FREQUENCY; ADIPOGENESIS; EXERCISE; OBESITY; WOMEN
AB The age-induced decline in the body's ability to fight disease is exacerbated by obesity and metabolic disease. Using a mouse model of diet-induced obesity, the combined challenge of a high-fat diet and age on liver morphology and biochemistry was characterized, while evaluating the potential of 15 min per day of high frequency ( 90 Hz), extremely low-magnitude (0.2 G) mechanical signals (LMMS) to suppress lipid accumulation in the liver. Following a 36-week protocol ( animals 43 weeks of age), suppression of hepatomegaly and steatosis was reflected by a 29% lower liver mass in LMMS animals as compared with controls. Average triglyceride content was 101.7 +/- 19.4 mu g mg(-1) tissue in the livers of high-fat diet control (HFD) animals, whereas HFD+LMMS animals realized a 27% reduction to 73.8 +/- 22.8 mu g mg(-1) tissue. In HFD+LMMS animals, liver free fatty acids were also reduced to 0.026 +/- 0.009 mu Eq mg(-1) tissue from 0.035 +/- 0.005 mu Eq mg(-1) tissue in HFD. Moderate to severe micro- and macrovesicular steatosis in HFD was contrasted to a 49% reduction in area covered by the vacuoles of at least 15 mm 2 in size in HFD+LMMS animals. These data provide preliminary evidence of the ability of LMMS to attenuate the progression of fatty liver disease, most likely achieved indirectly by suppressing adipogenesis and thus the total adipose burden through life, thereby reducing a downstream challenge to liver morphology and function. International Journal of Obesity ( 2010) 34, 401-405; doi: 10.1038/ijo.2009.240; published online 24 November 2009
C1 [Luu, Y. K.; Ozcivici, E.; Adler, B.; Chan, E.; Judex, S.; Rubin, C. T.] SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA.
   [Luu, Y. K.; Pessin, J. E.] Albert Einstein Coll Med, Diabet Res Ctr, Div Endocrinol, Dept Med, Bronx, NY 10467 USA.
   [Capilla, E.] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA.
   [Shroyer, K.] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA.
   [Rubin, J.] Univ N Carolina, Dept Med, Chapel Hill, NC USA.
C3 State University of New York (SUNY) System; State University of New York
   (SUNY) Stony Brook; Yeshiva University; Albert Einstein College of
   Medicine; State University of New York (SUNY) System; State University
   of New York (SUNY) Stony Brook; State University of New York (SUNY)
   System; State University of New York (SUNY) Stony Brook; University of
   North Carolina; University of North Carolina Chapel Hill
RP Rubin, CT (corresponding author), SUNY Stony Brook, Dept Biomed Engn, Psychol A Bldg,3rd Floor, Stony Brook, NY 11794 USA.
EM clinton.rubin@sunysb.edu
RI Adler, Benjamin/D-2078-2009; Capilla, Encarnación/L-6143-2014; Ozcivici,
   Engin/AAN-1313-2021
OI Capilla, Encarnación/0000-0002-0863-9728; Ozcivici,
   Engin/0000-0003-4464-0475
FU National Institutes of Health [AR 43498]
FX We thank S Lublinsky for help with animal imaging. This work was
   supported by the National Institutes of Health Grant AR 43498.
CR Duvnjak M, 2007, WORLD J GASTROENTERO, V13, P4539, DOI 10.3748/wjg.v13.i34.4539
   Fonseca-Alaniz MH, 2007, J PEDIAT-BRAZIL, V83, pS192, DOI [10.1590/S0021-75572007000700011, 10.2223/JPED.1709]
   Frank LL, 2005, OBES RES, V13, P615, DOI 10.1038/oby.2005.66
   Gilsanz V, 2006, J BONE MINER RES, V21, P1464, DOI 10.1359/JBMR.060612
   Griffin JJ, 2001, HDB HUMAN VIBRATION
   Huang PL, 2009, DIS MODEL MECH, V2, P231, DOI 10.1242/dmm.001180
   *INT STAND ORG, 1985, 26311 ISO
   Judex S, 2007, J BIOMECH, V40, P1333, DOI 10.1016/j.jbiomech.2006.05.014
   Kashyap SR, 2009, OBESITY, V17, P1696, DOI 10.1038/oby.2009.89
   Kris-Etherton PM, 2002, J AM DIET ASSOC, V102, P503, DOI 10.1016/S0002-8223(02)90116-1
   Luu YK, 2009, MED ENG PHYS, V31, P34, DOI 10.1016/j.medengphy.2008.03.006
   Luu YK, 2009, J BONE MINER RES, V24, P50, DOI 10.1359/JBMR.080817
   Mensink M, 2005, OBES RES, V13, P1354, DOI 10.1038/oby.2005.164
   Rubin CT, 2007, P NATL ACAD SCI USA, V104, P17879, DOI 10.1073/pnas.0708467104
   RUBIN CT, 1984, J THEOR BIOL, V107, P321, DOI 10.1016/S0022-5193(84)80031-4
   Ryan AS, 2000, SPORTS MED, V30, P327, DOI 10.2165/00007256-200030050-00002
   Sen B, 2008, ENDOCRINOLOGY, V149, P6065, DOI 10.1210/en.2008-0687
NR 17
TC 15
Z9 23
U1 1
U2 2
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0307-0565
EI 1476-5497
J9 INT J OBESITY
JI Int. J. Obes.
PD FEB
PY 2010
VL 34
IS 2
BP 401
EP 405
DI 10.1038/ijo.2009.240
PG 5
WC Endocrinology & Metabolism; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA 555JZ
UT WOS:000274508100022
PM 19935747
OA Green Accepted, Green Submitted
DA 2024-02-19
ER

PT J
AU Toniolo, L
   Formoso, L
   Torelli, L
   Crea, E
   Bergamo, A
   Sava, G
   Giacomello, E
AF Toniolo, Luana
   Formoso, Luca
   Torelli, Lucio
   Crea, Emanuela
   Bergamo, Alberta
   Sava, Gianni
   Giacomello, Emiliana
TI Long-term resveratrol treatment improves the capillarization in the
   skeletal muscles of ageing C57BL/6J mice
SO INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION
LA English
DT Article; Early Access
DE Capillaries; fibre type; muscle fatigue; resveratrol; sarcopenia;
   tubular aggregates
ID METABOLITES; SARCOPENIA; CAPACITY; PROTECTS; FATIGUE; TISSUE; LIVER;
   SIRT1
AB We recently showed that the treatment with Resveratrol (RES) contrasts the effects of ageing on the skeletal muscle (SKM), reduces the appearance of tubular aggregates (TAs), and improves the fatigue resistance. Since fatigue resistance depends on the SKM capillary network, and RES has been described to improve vascularisation, we analysed the SKM capillarization in naturally ageing C57BL/6J male mice, fed with 0.04% RES in the diet for 6 months, which showed a better fatigue resistance in a previous work. Our data show an inverse correlation between the number of capillaries per fibre (CAF) and TAs in both control and treated type IIB fibres, and an increase of CAF in ageing SKM upon RES-treatment. The present work suggests that capillarization is one of the determinants of the development of TAs and fatigue resistance, and that RES can be considered a good candidate to counteract capillary rarefaction in the SKM tissue.
C1 [Toniolo, Luana] Univ Padua, Dept Biomed Sci, Padua, Italy.
   [Formoso, Luca] Univ Siena, Dept Mol & Dev Med, Siena, Italy.
   [Torelli, Lucio; Crea, Emanuela; Giacomello, Emiliana] Univ Trieste, Dept Med Surg & Hlth Sci, I-34127 Trieste, Italy.
   [Bergamo, Alberta; Sava, Gianni] Callerio Fdn Onlus, Trieste, Italy.
   [Bergamo, Alberta; Sava, Gianni] Univ Trieste, Dept Life Sci, Trieste, Italy.
C3 University of Padua; University of Siena; University of Trieste;
   University of Trieste
RP Giacomello, E (corresponding author), Univ Trieste, Dept Med Surg & Hlth Sci, I-34127 Trieste, Italy.
EM egiacomello@units.it
RI Toniolo, Luana/B-9647-2014; Giacomello, Emiliana/E-3080-2018
OI Toniolo, Luana/0000-0001-7160-5638; Giacomello,
   Emiliana/0000-0003-3329-6269
FU Regione Toscana Grant "Bando Salute 2009" [132]; MIUR-Finanziamento
   delle attivita base di ricerca (FFABR)
FX This work was supported by the Regione Toscana Grant "Bando Salute 2009"
   132 to E. Giacomello and from MIUR-Finanziamento delle attivita base di
   ricerca (FFABR) to L. Toniolo.
CR Agbulut O, 2000, HISTOCHEM CELL BIOL, V114, P477
   Andres-Lacueva C, 2012, J AGR FOOD CHEM, V60, P4833, DOI 10.1021/jf3001108
   Ballak SB, 2016, AGE, V38, DOI 10.1007/s11357-016-9894-1
   Barnouin Y, 2017, J CACHEXIA SARCOPENI, V8, P647, DOI 10.1002/jcsm.12194
   Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354
   Bosutti A, 2015, SCI REP-UK, V5, DOI 10.1038/srep08093
   Bresciani L, 2014, NUTR METAB CARDIOVAS, V24, P408, DOI 10.1016/j.numecd.2013.09.008
   Breuss JM, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071523
   Chen Y, 2007, IN VIVO, V21, P365
   Chevessier F, 2004, NEUROMUSCULAR DISORD, V14, P208, DOI 10.1016/j.nmd.2003.11.007
   Desquiret-Dumas V, 2013, J BIOL CHEM, V288, P36662, DOI 10.1074/jbc.M113.466490
   Diaz M, 2016, EXP GERONTOL, V85, P41, DOI 10.1016/j.exger.2016.09.016
   Dutta S, 2016, LIFE SCI, V152, P244, DOI 10.1016/j.lfs.2015.10.025
   Flurkey K., 2007, The Mouse in Biomedical Research, P637
   Giacomello E, 2015, AM J PHYSIOL-CELL PH, V308, pC123, DOI 10.1152/ajpcell.00090.2014
   Gliemann L, 2014, AM J PHYSIOL-HEART C, V307, pH1111, DOI 10.1152/ajpheart.00168.2014
   Kaga S, 2005, J MOL CELL CARDIOL, V39, P813, DOI 10.1016/j.yjmcc.2005.08.003
   Kamei M, 2010, METHOD CELL BIOL, V100, P27, DOI 10.1016/B978-0-12-384892-5.00002-5
   Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013
   Madreiter-Sokolowski CT, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101117
   Murase T, 2009, BIOGERONTOLOGY, V10, P423, DOI 10.1007/s10522-008-9177-z
   Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011
   Pollack RM, 2017, J GERONTOL A-BIOL, V72, P1703, DOI 10.1093/gerona/glx041
   Prior SJ, 2016, J GERONTOL A-BIOL, V71, P1096, DOI 10.1093/gerona/glw017
   Ringholm S, 2013, EXP GERONTOL, V48, P1311, DOI 10.1016/j.exger.2013.08.012
   Rodríguez-Bies E, 2016, BRIT J NUTR, V116, P979, DOI 10.1017/S0007114516002920
   Rosenberg IH, 1997, J NUTR, V127, pS990, DOI 10.1093/jn/127.5.990S
   Schiaffino S, 2012, NEUROMUSCULAR DISORD, V22, P199, DOI 10.1016/j.nmd.2011.10.005
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]
   SULLIVAN MJ, 1990, CIRCULATION, V81, P518, DOI 10.1161/01.CIR.81.2.518
   Sun C, 2007, CELL METAB, V6, P307, DOI 10.1016/j.cmet.2007.08.014
   Toniolo L, 2018, EXP GERONTOL, V111, P170, DOI 10.1016/j.exger.2018.07.012
   Vielhaber S, 2001, J NEUROPATH EXP NEUR, V60, P1032, DOI 10.1093/jnen/60.11.1032
   Vitrac X, 2003, LIFE SCI, V72, P2219, DOI 10.1016/S0024-3205(03)00096-1
   Wan JJ, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.194
   Wu RE, 2013, MOLECULES, V18, P4689, DOI 10.3390/molecules18044689
NR 36
TC 12
Z9 13
U1 3
U2 9
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0963-7486
EI 1465-3478
J9 INT J FOOD SCI NUTR
JI Int. J. Food Sci. Nutr.
PD 2021 JAN 2
PY 2021
VL 72
IS 1
BP 37
EP 44
DI 10.1080/09637486.2020.1769569
EA MAY 2020
PG 8
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA PB6HW
UT WOS:000539987400001
PM 32449407
OA Green Submitted
DA 2024-02-19
ER

PT J
AU Choudhury, M
   Jonscher, KR
   Friedman, JE
AF Choudhury, Mahua
   Jonscher, Karen R.
   Friedman, Jacob E.
TI Reduced mitochondrial function in obesity-associated fatty liver: SIRT3
   takes on the fat
SO AGING-US
LA English
DT Article
DE aging; metabolism; obesity; SIRT3; mitochondria
ID ENDOPLASMIC-RETICULUM STRESS; METABOLISM; INFLAMMATION; ACETYLATION;
   OXIDATION; PATHWAY
AB Aging is associated with various metabolic disorders that may have their origin in the liver, including nonalcoholic fatty liver disease, obesity, type 2 diabetes mellitus, and atherosclerosis. Although well-characterized in models of caloric restriction, relatively little is known about the role of sirtuins and acetylation under conditions of caloric excess. Sirtuins are NAD (+)-dependent protein deacetylases that mediate adaptive responses to a variety of stresses, including calorie restriction and metabolic stress. Sirtuin 3 (SIRT3) is localized within the mitochondrial matrix, where it regulates acetylation levels of a diverse set of metabolic enzymes. When normal mice are fed a high fat diet they demonstrate reduced SIRT3 activity, impaired mitochondrial function, and hyperacetylation of a diverse set of proteins in their livers. Furthermore, SIRT3 knockout mice have signs of accelerated aging and cancer. Understanding SIRT3's biochemical function and regulation in the liver under conditions of caloric excess may potentially increase our understanding of the normal aging process and diseases associated with aging, such as diabetes, fatty liver disease, or cancer.
C1 [Choudhury, Mahua; Friedman, Jacob E.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA.
   [Jonscher, Karen R.] Univ Colorado, Sch Med, Dept Anesthesiol, Aurora, CO 80045 USA.
   [Friedman, Jacob E.] Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA.
C3 University of Colorado System; University of Colorado Anschutz Medical
   Campus; University of Colorado System; University of Colorado Anschutz
   Medical Campus; University of Colorado System; University of Colorado
   Anschutz Medical Campus
RP Friedman, JE (corresponding author), Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA.
EM jed.friedman@ucdenver.edu
OI Jonscher, Karen/0000-0002-7929-4886
CR Fessler MB, 2009, CURR OPIN LIPIDOL, V20, P379, DOI 10.1097/MOL.0b013e32832fa5c4
   Garten A, 2009, TRENDS ENDOCRIN MET, V20, P130, DOI 10.1016/j.tem.2008.10.004
   Gentile CL, 2008, CURR OPIN INVEST DR, V9, P1084
   Gregor MF, 2007, J LIPID RES, V48, P1905, DOI 10.1194/jlr.R700007-JLR200
   Hafner AV, 2010, AGING-US, V2, P914, DOI 10.18632/aging.100252
   Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778
   Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034
   Hummasti S, 2010, CIRC RES, V107, P579, DOI 10.1161/CIRCRESAHA.110.225698
   Hwang JH, 2009, DIABETES, V58, P965, DOI 10.2337/db08-1183
   Kendrick AA, 2011, BIOCHEM J, V433, P505, DOI 10.1042/BJ20100791
   Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023
   Lee Y, 2001, J BIOL CHEM, V276, P5629, DOI 10.1074/jbc.M008553200
   Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07
   Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846
   OPIE LH, 1963, NEW ENGL J MED, V268, P757, DOI 10.1056/NEJM196304042681404
   Pillai JB, 2005, J BIOL CHEM, V280, P43121, DOI 10.1074/jbc.M506162200
   Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667
   Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015
   Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200
   Schaeffler A, 2009, IMMUNOLOGY, V126, P233, DOI 10.1111/j.1365-2567.2008.02892.x
   Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103
   Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898
   Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002
   Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162
   Verdin E, 2010, TRENDS BIOCHEM SCI, V35, P669, DOI 10.1016/j.tibs.2010.07.003
   Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687
   Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1
   Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035
   Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689
NR 29
TC 58
Z9 67
U1 1
U2 9
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD FEB
PY 2011
VL 3
IS 2
BP 175
EP 178
DI 10.18632/aging.100289
PG 4
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 732FM
UT WOS:000288170400014
PM 21386135
OA gold, Green Published, Green Submitted
DA 2024-02-19
ER

PT J
AU Sasaki, M
   Ikeda, H
   Yamaguchi, J
   Nakada, S
   Nakanuma, Y
AF Sasaki, Motoko
   Ikeda, Hiroko
   Yamaguchi, Junpei
   Nakada, Satoko
   Nakanuma, Yasuni
TI Telomere shortening in the damaged small bile ducts in primary biliary
   cirrhosis reflects ongoing cellular senescence
SO HEPATOLOGY
LA English
DT Article
ID IN-SITU HYBRIDIZATION; CHRONIC HEPATITIS-C; HEPATOCELLULAR-CARCINOMA;
   HUMAN LIVER; CHROMOSOMAL INSTABILITY; REPLICATIVE SENESCENCE; DUCTULAR
   REACTIONS; LENGTH; CELLS; IDENTIFICATION
AB Telomere shortening is a trigger of cellular senescence. Biliary epithelial cells in damaged small bile ducts in primary biliary cirrhosis (PBC) show senescent features such as the expression of senescence-associated beta-galactosidase and the increased expression of p16(INK4a) and p21(WAF1/Cip1). We investigated whether the telomere shortening is involved in the pathogenesis of biliary cellular senescence in PBC. We analyzed the telomere length of biliary epithelial cells using quantitative fluorescence in situ hybridization in livers taken from the patients with PBC (n = 13) and control livers (n = 13). We also assessed immunohistochemically the prevalence of DNA damage and the expression of p16(INK4a) and p21(WAF1/Cip1). The study showed a significant decrease in telomere length in biliary epithelial cells in the damaged small bile ducts and bile ductules in PBC compared with normal-looking bile ducts and bile ductules in PBC, chronic viral hepatitis, and normal livers (P < 0.01). gamma H2AX-DNA-damage-foci were detected in biliary epithelial cells in damaged small bile ducts and bile ductules in PBC but were absent in biliary epithelial cells in chronic viral hepatitis and normal livers. The expression of p16(INK4a) and p21(WAF1/Cip1) was increased corresponding to telomere shortening and gamma H2AX-DNA-damage-foci in the damaged small bile ducts in PBC. Conclusion: Telomere shortening and an accumulation of DNA damage coincide with increased expression of p16(INK4a) and p21(WAF1/Cip1) in the damaged bile ducts, characterize biliary cellular senescence, and may play a role in the following progressive bile duct loss in PBC.
C1 [Sasaki, Motoko; Ikeda, Hiroko; Yamaguchi, Junpei; Nakada, Satoko; Nakanuma, Yasuni] Kanazawa Univ, Grad Sch Med, Dept Human Pathol, Kanazawa, Ishikawa 9208640, Japan.
C3 Kanazawa University
RP Nakanuma, Y (corresponding author), Kanazawa Univ, Grad Sch Med, Dept Human Pathol, Kanazawa, Ishikawa 9208640, Japan.
EM pbcpsc@kenroku.kanazawa-u.ac.jp
RI Sasaki, Motoko/K-5913-2015; YAMAGUCHI, Junpei/E-4440-2015; Nakada,
   Satoko/IST-1554-2023
OI Sasaki, Motoko/0000-0003-2514-760X; 
CR Aikata H, 2000, EXP CELL RES, V256, P578, DOI 10.1006/excr.2000.4862
   [Anonymous], 2001, PATHOLOGY LIVER
   BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0
   Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656
   Brodsky W Y, 1977, Int Rev Cytol, V50, P275
   Canela A, 2007, P NATL ACAD SCI USA, V104, P5300, DOI 10.1073/pnas.0609367104
   Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003
   d'Adda diFagagna F., 2003, Nature, V426, P194, DOI DOI 10.1038/NATURE02118
   Demetris AJ, 1996, AM J PATHOL, V149, P439
   DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629
   Ferlicot S, 2003, J PATHOL, V200, P661, DOI 10.1002/path.1392
   Finley JC, 2006, CANCER EPIDEM BIOMAR, V15, P1451, DOI 10.1158/1055-9965.EPI-05-0837
   Flores I, 2006, CURR OPIN CELL BIOL, V18, P254, DOI 10.1016/j.ceb.2006.03.003
   FUSSEY SPM, 1988, P NATL ACAD SCI USA, V85, P8654, DOI 10.1073/pnas.85.22.8654
   GERSHWIN ME, 1987, J IMMUNOL, V138, P3525
   Kaplan MM, 1996, NEW ENGL J MED, V335, P1570, DOI 10.1056/NEJM199611213352107
   Kapoor Veena, 2004, Methods Mol Biol, V263, P385
   Kita H, 2002, J CLIN INVEST, V109, P1231, DOI 10.1172/JCI200214698
   LEVY MZ, 1992, J MOL BIOL, V225, P951, DOI 10.1016/0022-2836(92)90096-3
   LUDWIG J, 1991, SEMIN LIVER DIS, V11, P11, DOI 10.1055/s-2008-1040417
   Lunz JG, 2001, AM J PATHOL, V158, P1379, DOI 10.1016/S0002-9440(10)64089-8
   Meeker AK, 2002, AM J PATHOL, V160, P1259, DOI 10.1016/S0002-9440(10)62553-9
   Nakajima T, 2006, LIVER INT, V26, P23, DOI 10.1111/j.1478-3231.2005.01178.x
   Nakajima T, 2004, BIOCHEM BIOPH RES CO, V325, P1131, DOI 10.1016/j.bbrc.2004.10.152
   Nakamura M, 2007, HEPATOLOGY, V45, P118, DOI 10.1002/hep.21472
   NAKANUMA Y, 1979, GASTROENTEROLOGY, V76, P1326
   NAKANUMA Y, 1989, HEPATOLOGY, V10, P174, DOI 10.1002/hep.1840100209
   Nishimoto A, 2001, ONCOGENE, V20, P828, DOI 10.1038/sj.onc.1204165
   O'Sullivan JN, 2002, NAT GENET, V32, P280, DOI 10.1038/ng989
   Paradis V, 2001, HUM PATHOL, V32, P327, DOI 10.1053/hupa.2001.22747
   Plentz RR, 2005, HEPATOLOGY, V42, P522, DOI 10.1002/hep.20847
   Plentz RR, 2007, HEPATOLOGY, V45, P968, DOI 10.1002/hep.21552
   Rahman SM, 1996, PATHOL INT, V46, P267, DOI 10.1111/j.1440-1827.1996.tb03609.x
   Roskams TA, 2004, HEPATOLOGY, V39, P1739, DOI 10.1002/hep.20130
   Sasaki M, 2005, J PATHOL, V205, P451, DOI 10.1002/path.1729
   Sasaki M, 2006, AM J PATHOL, V169, P831, DOI 10.2353/ajpath.2006.051237
   Saxena R, 2002, HUM PATHOL, V33, P983, DOI 10.1053/hupa.2002.128060
   Sekoguchi S, 2007, J GASTROEN HEPATOL, V22, P182, DOI 10.1111/j.1440-1746.2006.04454.x
   Shibuya A, 2002, HEPATOLOGY, V35, P1172, DOI 10.1053/jhep.2002.33157
   Shimoda S, 1998, J CLIN INVEST, V102, P1831, DOI 10.1172/JCI4213
   Shimoda S, 2003, GASTROENTEROLOGY, V124, P1915, DOI 10.1016/S0016-5085(03)00387-1
   Sigal SH, 1999, AM J PHYSIOL-GASTR L, V276, pG1260, DOI 10.1152/ajpgi.1999.276.5.G1260
   Tan JY, 2002, LIVER, V22, P365, DOI 10.1034/j.1600-0676.2002.01622.x
   Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5
   von Zglinicki T, 2005, MECH AGEING DEV, V126, P111, DOI 10.1016/j.mad.2004.09.034
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   Zhou HC, 2007, HEPATOLOGY, V45, P716, DOI 10.1002/hep.21557
NR 49
TC 92
Z9 95
U1 1
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD JUL
PY 2008
VL 48
IS 1
BP 186
EP 195
DI 10.1002/hep.22348
PG 10
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 321JP
UT WOS:000257301100023
PM 18536059
DA 2024-02-19
ER

PT J
AU Noyan-Ashraf, MH
   Sadeghmejad, Z
   Davies, GF
   Ross, AR
   Saucier, D
   Harkness, TAA
   Juurlink, BHJ
AF Noyan-Ashraf, Mohammad Hossein
   Sadeghmejad, Zahra
   Davies, Gerald F.
   Ross, Andrew R.
   Saucier, Deborah
   Harkness, Troy A. A.
   Juurlink, Bernhard H. J.
TI Phase 2 Protein Inducers in the Diet Promote Healthier Aging
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
DE Antioxidant response; Oxidative stress; Inflammation; Diet; Healthy
   aging
ID ACTIVATED RECEPTOR-GAMMA; ANTIOXIDANT BUTYLATED HYDROXYANISOLE;
   GLUTATHIONE S-TRANSFERASES; FACTOR-KAPPA-B; OXIDATIVE STRESS; CALORIC
   RESTRICTION; GENE-EXPRESSION; INFLAMMATORY MARKERS; FACTOR NRF2; LIVER
AB Oxidative stress drives many aging-associated problems. Because oxidative stress can be decreased by induction of phase 2 proteins, we hypothesized that incorporating the phase 2 protein inducer 2(3)-tert-butyl-4-hydroxyanisole (tBHA) into the diet would result in healthier aging. C57BL/6 mice were placed either on control mouse chow diet or on chow containing tBHA and were examined at 6. 12, and 18 months. Dietary tBHA resulted in the antioxidant response activation, decreased both oxidative stress and pro-inflammatory gene expression in tissues examined, counteracted the decrease in the transcription factors peroxisome proliferator-activated receptor-gamma and increase in CCAAT/enhancer binding protein-alpha levels seen in liver with aging, and was associated with mice having less weight gain, despite having no differences in food consumption. and better locomotor function. We conclude that simple changes in the diet such as incorporation of phase 2 protein inducers can have a profound influence on health and, thereby, the aging process.
C1 [Noyan-Ashraf, Mohammad Hossein; Sadeghmejad, Zahra; Davies, Gerald F.; Harkness, Troy A. A.; Juurlink, Bernhard H. J.] Univ Saskatchewan, Coll Med, Dept Anat & Cell Biol, Saskatoon, SK S7N 0W0, Canada.
   [Saucier, Deborah] Univ Saskatchewan, Coll Arts & Sci, Dept Psychol, Saskatoon, SK, Canada.
   [Ross, Andrew R.] Natl Res Council Canada, Inst Plant Biotechnol, Saskatoon, SK S7N 0W9, Canada.
C3 University of Saskatchewan; University of Saskatchewan; National
   Research Council Canada
RP Juurlink, BHJ (corresponding author), Alfaisal Univ, Coll Med, Riyadh, Saudi Arabia.
EM bjuurlitik@gmail.com
OI Harkness, Troy/0000-0002-8271-7229
FU Canadian Institutes of Health Research/Neuromuscular Partnership
   program; College of Medicine
FX This work was supported by the Canadian Institutes of Health
   Research/Neuromuscular Partnership program. Dr. M. H. Noyan-Ashraf was
   supported by postdoctoral funding from the College of Medicine.; We
   thank Connie Wong and Doug Olson for technical assistance. We also thank
   the two anonymous reviewers that offered suggestions that strengthened
   the manuscript.; Drs. Noyan-Ashraf and Sadeghinejad contributed equally
   to the research.; Dr. Noyan-Ashraf is now with the Division of
   Cardiology, University Health Network, Toronto, Ontario, Canada.; Dr.
   Saucier is now with the Canadian Centre for Behavioural Neurosciences,
   University of Lethbridge, Canada.; Dr. Ross is now with the Ocean
   Sciences Division, Institute of Ocean Sciences, Fisheries and Oceans
   Canada, Sidney, BC, Canada.
CR Armeni T, 1998, MECH AGEING DEV, V101, P101, DOI 10.1016/S0047-6374(97)00167-X
   Baloh RW, 2003, ARCH NEUROL-CHICAGO, V60, P835, DOI 10.1001/archneur.60.6.835
   BENSON AM, 1980, P NATL ACAD SCI-BIOL, V77, P5216, DOI 10.1073/pnas.77.9.5216
   Cao SX, 2001, P NATL ACAD SCI USA, V98, P10630, DOI 10.1073/pnas.191313598
   Chanas SA, 2002, BIOCHEM J, V365, P405, DOI 10.1042/BJ20020320
   CHAUBEY M, 1994, COMP BIOCHEM PHYS C, V108, P311, DOI 10.1016/1367-8280(94)90107-4
   Christman JW, 2000, BRAIN PATHOL, V10, P153
   Chung HY, 2006, ANTIOXID REDOX SIGN, V8, P572, DOI 10.1089/ars.2006.8.572
   Colbert LH, 2004, J AM GERIATR SOC, V52, P1098, DOI 10.1111/j.1532-5415.2004.52307.x
   Couillard C, 2005, J CLIN ENDOCR METAB, V90, P6454, DOI 10.1210/jc.2004-2438
   Dayhoff-Brannigan M, 2008, J GERONTOL A-BIOL, V63, P179, DOI 10.1093/gerona/63.2.179
   DELONG MJ, 1985, CANCER RES, V45, P546
   Diep QN, 2004, CAN J PHYSIOL PHARM, V82, P976, DOI 10.1139/Y04-094
   Dinkova-Kostova AT, 2005, P NATL ACAD SCI USA, V102, P4584, DOI 10.1073/pnas.0500815102
   Erden-Inal M, 2002, CELL BIOCHEM FUNCT, V20, P61, DOI 10.1002/cbf.937
   Ershler WB, 2007, J APPL PHYSIOL, V103, P3, DOI 10.1152/japplphysiol.00375.2007
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   Franklin GF, 2007, J HOSP INFECT, V65, P173, DOI 10.1016/j.jhin.2006.10.010
   Gavrilova O, 2003, J BIOL CHEM, V278, P34268, DOI 10.1074/jbc.M300043200
   Heilbronn LK, 2003, AM J CLIN NUTR, V78, P361, DOI 10.1093/ajcn/78.3.361
   HINTON DE, 1968, J GERONTOL, V23, P205, DOI 10.1093/geronj/23.2.205
   Hisaka Toru, 2004, Comp Hepatol, V3, P10, DOI 10.1186/1476-5926-3-10
   Holloszy JO, 2007, EXP GERONTOL, V42, P709, DOI 10.1016/j.exger.2007.03.009
   Hu R, 2006, CANCER LETT, V243, P170, DOI 10.1016/j.canlet.2005.11.050
   Junqueira Virginia B. C., 2004, Molecular Aspects of Medicine, V25, P5, DOI 10.1016/j.mam.2004.02.003
   Juurlink BHJ, 1999, NEUROTOX RES, V1, P119, DOI 10.1007/BF03033276
   Juurlink BHJ, 2001, CAN J PHYSIOL PHARM, V79, P266, DOI 10.1139/cjpp-79-3-266
   Juurlink BHJ, 2004, DIETARY PHASE 2 PROT
   Kalain R, 2006, J GERONTOL A-BIOL, V61, P211, DOI 10.1093/gerona/61.3.211
   Kullberg S, 2001, BRAIN RES, V899, P169, DOI 10.1016/S0006-8993(01)02222-3
   Kwak MK, 2003, J BIOL CHEM, V278, P8135, DOI 10.1074/jbc.M211898200
   Kwak MK, 2002, MOL CELL BIOL, V22, P2883, DOI 10.1128/MCB.22.9.2883-2892.2002
   LAWSON T, 1985, MECH AGEING DEV, V30, P179, DOI 10.1016/0047-6374(85)90006-5
   Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046
   Leung PS, 2003, REGUL PEPTIDES, V116, P61, DOI 10.1016/S0167-0115(03)00192-7
   Lyakhovich VV, 2006, BIOCHEMISTRY-MOSCOW+, V71, P962, DOI 10.1134/S0006297906090033
   MCLELLAN LI, 1989, BIOCHEM J, V263, P393, DOI 10.1042/bj2630393
   Mendoza-Nunez VM, 2007, TOHOKU J EXP MED, V213, P261, DOI 10.1620/tjem.213.261
   Modo M, 2000, J NEUROSCI METH, V104, P99, DOI 10.1016/S0165-0270(00)00329-0
   Morgan T. E., 2007, V35, P83
   Nair S, 2006, PHARM RES-DORDR, V23, P2621, DOI 10.1007/s11095-006-9099-x
   Noyan-Ashraf MH, 2005, NUTR NEUROSCI, V8, P101, DOI 10.1080/10284150500069470
   Noyan-Ashraf MH, 2006, FASEB J, V20, P371, DOI 10.1096/fj.05-4889fje
   Parola M, 2001, J HEPATOL, V35, P297, DOI 10.1016/S0168-8278(01)00142-8
   Penninx BWJH, 2004, J AM GERIATR SOC, V52, P1105, DOI 10.1111/j.1532-5415.2004.52308.x
   Qiao LP, 2006, ENDOCRINOLOGY, V147, P3060, DOI 10.1210/en.2005-1507
   Radák Z, 2004, FASEB J, V18, P749, DOI 10.1096/fj.03-0509fje
   Rebrin I, 2003, FREE RADICAL BIO MED, V35, P626, DOI 10.1016/S0891-5849(03)00388-5
   Roesler WJ, 2001, ANNU REV NUTR, V21, P141, DOI 10.1146/annurev.nutr.21.1.141
   Ross ARS, 2002, PROTEOMICS, V2, P928, DOI 10.1002/1615-9861(200207)2:7<928::AID-PROT928>3.0.CO;2-P
   Samiec PS, 1998, FREE RADICAL BIO MED, V24, P699, DOI 10.1016/S0891-5849(97)00286-4
   Shih PH, 2007, BIOGERONTOLOGY, V8, P71, DOI 10.1007/s10522-006-9033-y
   Shimano H, 2002, VITAM HORM, V65, P167, DOI 10.1016/S0083-6729(02)65064-2
   Stienstra R, 2007, PPAR RES, V2007, DOI 10.1155/2007/95974
   Suh JH, 2004, P NATL ACAD SCI USA, V101, P3381, DOI 10.1073/pnas.0400282101
   Suzuki Koji, 2003, Asian Pac J Cancer Prev, V4, P259
   Sykiotis GP, 2008, DEV CELL, V14, P76, DOI 10.1016/j.devcel.2007.12.002
   Talalay P, 2003, ADV ENZYME REGUL, V43, P121, DOI 10.1016/S0065-2571(02)00038-9
   Talalay P, 1995, TOXICOL LETT, V82-3, P173, DOI 10.1016/0378-4274(95)03553-2
   Tanaka Y, 2008, J PHARMACOL EXP THER, V325, P655, DOI 10.1124/jpet.107.135822
   Thimmulappa RK, 2002, CANCER RES, V62, P5196
   TULLET JM, 2002, CELL, V132, P1025
   van Buul JD, 2007, ARTERIOSCL THROM VAS, V27, P1870, DOI 10.1161/ATVBAHA.107.145821
   Vasto S, 2007, MECH AGEING DEV, V128, P83, DOI 10.1016/j.mad.2006.11.015
   WALLACE JE, 1980, J GERONTOL, V35, P364, DOI 10.1093/geronj/35.3.364
   Wu LY, 2004, P NATL ACAD SCI USA, V101, P7094, DOI 10.1073/pnas.0402004101
   Yang L, 2006, AM J PHYSIOL-GASTR L, V291, pG902, DOI 10.1152/ajpgi.00124.2006
   Ye P, 2006, GERONTOLOGY, V52, P69, DOI 10.1159/000090951
   Yoo HY, 1999, J BIOL CHEM, V274, P23887, DOI 10.1074/jbc.274.34.23887
   Zaman MB, 2007, TRANSPLANTATION, V84, P1272, DOI 10.1097/01.tp.0000288229.53064.e2
NR 70
TC 7
Z9 9
U1 0
U2 3
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD NOV
PY 2008
VL 63
IS 11
BP 1168
EP 1176
DI 10.1093/gerona/63.11.1168
PG 9
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA 379KR
UT WOS:000261395600005
PM 19038831
DA 2024-02-19
ER

PT J
AU Barazzoni, R
AF Barazzoni, R
TI Skeletal muscle mitochondrial protein metabolism and function in ageing
   and type 2 diabetes
SO CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
LA English
DT Article
DE mitochondria; ageing; type 2 diabetes; skeletal muscle; insulin
   resistance
ID CYTOCHROME-C-OXIDASE; UNCOUPLING PROTEIN-3; GENE-EXPRESSION; CALORIC
   RESTRICTION; INSULIN-RESISTANCE; POINT MUTATIONS; AGE; RAT; DNA; LIVER
AB Purpose of review
   Mitochondria are the site of oxidative substrate utilization to produce adenosine triphosphate for normal tissue function. Tissue substrate utilization is impaired in ageing and type 2 diabetes. Defects in mitochondrial gene expression, protein synthesis and function occur with ageing in various tissues including skeletal muscle, and are emerging in individuals with type 2 diabetes. The current review will discuss advances in the understanding of skeletal muscle mitochondrial alterations associated with age and type 2 diabetes.
   Recent findings
   Insulin acutely stimulates skeletal muscle mitochondrial protein synthesis and adenosine triphosphate production. These insulin effects are impaired in insulin-resistant patients with type 2 diabetes who also exhibit defective basal muscle mitochondrial function. The age-related reduction in mitochondrial adenosine triphosphate production has been confirmed in vivo in skeletal muscle in humans and rodents.
   Summary
   The emerging concept that insulin stimulates mitochondrial protein synthesis and function indicates potential novel molecular mechanisms of metabolic defects in type 2 diabetes, particularly in the post-prandial period characterized by acute increments of plasma insulin concentrations. The potential relationship between insulin resistance and basal post-absorptive muscle mitochondrial defects should be further investigated. As ageing is characterized by insulin resistance, the hypothesis that impaired insulin action could contribute to age-related muscle mitochondrial dysfunction, and metabolic alterations should be addressed.
C1 Univ Trieste, Inst Clin Med, Dept Clin Morphol & Technol Sci, Trieste, Italy.
C3 University of Trieste
RP Barazzoni, R (corresponding author), Osped Cattinara, Med Clin, Strada Flume 447, Trieste, Italy.
EM barazzon@units.it
CR Adey D, 2000, AM J PHYSIOL-ENDOC M, V278, pE219, DOI 10.1152/ajpendo.2000.278.2.E219
   Attie AD, 2003, NAT GENET, V34, P244, DOI 10.1038/ng0703-244
   Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343
   Barazzoni R, 2001, AM J PHYSIOL-ENDOC M, V280, pE413, DOI 10.1152/ajpendo.2001.280.3.E413
   Biolo G, 2003, CURR OPIN CLIN NUTR, V6, P55, DOI 10.1097/00075197-200301000-00009
   Boirie Y, 2001, DIABETES, V50, P2652, DOI 10.2337/diabetes.50.12.2652
   Chang JS, 2003, MECH AGEING DEV, V124, P33, DOI 10.1016/S0047-6374(02)00167-7
   Clapham JC, 2000, NATURE, V406, P415, DOI 10.1038/35019082
   DARLEYUSMAR V, 1994, MITOCHONDRIA DNA PRO, P1
   Del Bo R, 2002, J NEUROL SCI, V202, P85, DOI 10.1016/S0022-510X(02)00247-2
   Drew B, 2003, AM J PHYSIOL-REG I, V284, pR474, DOI 10.1152/ajpregu.00455.2002
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   Goodpaster Bret H, 2002, Curr Diab Rep, V2, P216, DOI 10.1007/s11892-002-0086-2
   Halvatsiotis P, 2002, DIABETES, V51, P2395, DOI 10.2337/diabetes.51.8.2395
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831
   HOUMARD JA, 1995, DIABETES, V44, P555, DOI 10.2337/diabetes.44.5.555
   Huang X, 1999, DIABETES, V48, P1508, DOI 10.2337/diabetes.48.8.1508
   Hudson EK, 1998, MECH AGEING DEV, V103, P179, DOI 10.1016/S0047-6374(98)00043-8
   Jaburek M, 1999, J BIOL CHEM, V274, P26003, DOI 10.1074/jbc.274.37.26003
   Jubrias SA, 1997, PFLUG ARCH EUR J PHY, V434, P246, DOI 10.1007/s004240050392
   Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944
   Kerner J, 2001, AM J PHYSIOL-ENDOC M, V281, pE1054
   Kruszynska YT, 1998, DIABETES, V47, P1107, DOI 10.2337/diabetes.47.7.1107
   LENNMARKEN C, 1985, CLIN PHYSIOL, V5, P243
   MARCUS DL, 1982, EXP GERONTOL, V17, P429, DOI 10.1016/S0531-5565(82)80004-1
   MARCUS DL, 1982, EXP GERONTOL, V17, P333, DOI 10.1016/0531-5565(82)90033-X
   McKenzie D, 2002, EUR J BIOCHEM, V269, P2010, DOI 10.1046/j.1432-1033.2002.02867.x
   MOKDAD AH, 2001, JAMA-J AM MED ASSOC, V289, P76, DOI DOI 10.1001/JAMA.289.1.76
   Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180
   NAIR KS, 1988, J CLIN INVEST, V82, P198, DOI 10.1172/JCI113570
   Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100
   Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889
   PIKO L, 1988, MECH AGEING DEV, V43, P279, DOI 10.1016/0047-6374(88)90037-1
   Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012
   Rasmussen UF, 2003, EXP GERONTOL, V38, P877, DOI 10.1016/S0531-5565(03)00092-5
   Rattan SIS, 1996, EXP GERONTOL, V31, P33, DOI 10.1016/0531-5565(95)02022-5
   Rooyackers OE, 1996, P NATL ACAD SCI USA, V93, P15364, DOI 10.1073/pnas.93.26.15364
   Schrauwen P, 2002, CURR OPIN CLIN NUTR, V5, P265, DOI 10.1097/00075197-200205000-00005
   SHIMOKATA H, 1991, DIABETES, V40, P44, DOI 10.2337/diabetes.40.1.44
   Short K, 2003, DIABETES, V52, pA346
   Short KR, 2003, DIABETES, V52, P1888, DOI 10.2337/diabetes.52.8.1888
   Simoneau JA, 1997, J APPL PHYSIOL, V83, P166, DOI 10.1152/jappl.1997.83.1.166
   Sreekumar R, 2002, AM J PHYSIOL-ENDOC M, V283, pE38, DOI 10.1152/ajpendo.00387.2001
   Sreekumar R, 2002, DIABETES, V51, P1913, DOI 10.2337/diabetes.51.6.1913
   Stump CS, 2003, P NATL ACAD SCI USA, V100, P7996, DOI 10.1073/pnas.1332551100
   Terjung RL, 2002, INT J SPORT NUTR EXE, V12, P368, DOI 10.1123/ijsnem.12.3.368
   Tonkonogi M, 2003, PFLUG ARCH EUR J PHY, V446, P261, DOI 10.1007/s00424-003-1044-9
   TRAPPE SW, 1995, J APPL PHYSIOL, V78, P823, DOI 10.1152/jappl.1995.78.3.823
   TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0
   VONDRA K, 1977, DIABETOLOGIA, V13, P527, DOI 10.1007/BF01234508
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   WOLFSON L, 1995, J GERONTOL A-BIOL, V50, P64
   Zarchin N, 2002, COMP BIOCHEM PHYS A, V132, P117, DOI 10.1016/S1095-6433(01)00537-2
   Zhang JL, 2002, MECH AGEING DEV, V123, P1363, DOI 10.1016/S0047-6374(02)00075-1
NR 55
TC 37
Z9 39
U1 0
U2 6
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1363-1950
EI 1473-6519
J9 CURR OPIN CLIN NUTR
JI Curr. Opin. Clin. Nutr. Metab. Care
PD JAN
PY 2004
VL 7
IS 1
BP 97
EP 102
DI 10.1097/00075197-200401000-00015
PG 6
WC Endocrinology & Metabolism; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA 771TT
UT WOS:000188802700015
PM 15090909
DA 2024-02-19
ER

PT J
AU Huang, HF
   Zhao, Y
AF Huang, Haifeng
   Zhao, Yan
TI Effect of clove on improving running ability in aging mice
SO JOURNAL OF FOOD BIOCHEMISTRY
LA English
DT Article; Early Access
DE D-galactose; mRNA; oxidative; sport; Syringa oblata Lindl
ID OXIDATIVE STRESS; EXERCISE PERFORMANCE; FATIGUE; ALPHA; RUTIN
AB In this study, a D-galactose-induced aging mouse model was established, and Syringa oblata Lindl. extract (SOLE) was administered orally to observe the effect and mechanism of SOLE on the running ability of aging mice. The role of SOLE was evaluated by H&E histopathological observation, detection of serum biochemical indices, and detection of mRNA expression levels by qPCR experiments. The experimental results showed that SOLE could increase the exhaustive running time of aging mice and reduce the oxidative aging of the liver and kidney. At the same time, the levels of BUN, lactic acid, GOT, GPT, MDA, iNOS, and TNF-alpha in the serum of the mice were decreased, and the relative mRNA expression levels of nNOS, iNOS, TNF-alpha and syncytin-1 in the liver tissue and skeletal muscle tissue of the mice were downregulated. In addition, it increased the levels of CAT, GSH-Px, and T-SOD in mouse serum and upregulated the relative mRNA expression of Cu/Zn-SOD, Mn-SOD, and CAT in mouse liver tissue and muscle tissue. The analysis results showed that SOLE mainly contained rutin, isoquercitrin, ferulic acid, dihydroquercetin, and quercitrin. In summary, SOLE can enhance the running ability and exercise ability of aging mice and slow down aging. Practical applications Clove is used as health tea or traditional Chinese medicine in China, but there is no relevant research and application on the improvement of human exercise ability. This study found this new function of clove, which accumulated a theoretical basis for further popularizing its application.
C1 [Huang, Haifeng; Zhao, Yan] South China Agr Univ, Dept Phys Educ, Guangzhou 510642, Peoples R China.
C3 South China Agricultural University
RP Zhao, Y (corresponding author), South China Agr Univ, Dept Phys Educ, Guangzhou 510642, Peoples R China.
EM pk635782775@scau.edu.cn
CR Aschner M, 2021, FREE RADICAL BIO MED, V162, P266, DOI 10.1016/j.freeradbiomed.2020.10.024
   Bloomer RJ, 2009, INT J SPORT NUTR EXE, V19, P457, DOI 10.1123/ijsnem.19.5.457
   Bondonno NP, 2020, BRIT J NUTR, V123, P182, DOI 10.1017/S0007114519002137
   Cao N, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.316
   Dimitrov VG, 2012, EUR J APPL PHYSIOL, V112, P1399, DOI 10.1007/s00421-011-2095-9
   Fan LM, 2017, FREE RADICAL BIO MED, V108, P940, DOI 10.1016/j.freeradbiomed.2017.05.008
   Gadhwal MK, 2013, INDIAN J PHARM SCI, V75, P233
   Grandi N, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0301-x
   Hsu YJ, 2016, NUTRIENTS, V8, DOI 10.3390/nu8100648
   Kamalakkannan N, 2006, BASIC CLIN PHARMACOL, V98, P97, DOI 10.1111/j.1742-7843.2006.pto_241.x
   Katzman WB, 2017, OSTEOPOROSIS INT, V28, P2831, DOI 10.1007/s00198-017-4109-x
   Kim TW, 2019, J EXERC REHABIL, V15, P751, DOI 10.12965/jer.1938712.356
   Lanza IR, 2009, AM J CLIN NUTR, V89, p467S, DOI 10.3945/ajcn.2008.26717D
   Lee FT, 2009, AM J CHINESE MED, V37, P557, DOI 10.1142/S0192415X09007053
   Leung FP, 2008, SPORTS MED, V38, P1009, DOI 10.2165/00007256-200838120-00005
   Maleki BH, 2018, CYTOKINE, V102, P18, DOI 10.1016/j.cyto.2017.12.016
   Meng J.M., 2018, CHINA PHARM, V21, P1762, DOI [10.3969/j.issn.1008-049X.2018.10.014, DOI 10.3969/J.ISSN.1008-049X.2018.10.014]
   Mooren FC, 2020, EUR J APPL PHYSIOL, V120, P1591, DOI 10.1007/s00421-020-04382-w
   Ogura Y, 2011, ACTA PHYSIOL, V202, P683, DOI 10.1111/j.1748-1716.2011.02284.x
   Oluwole OSA, 2007, AMYOTROPH LATERAL SC, V8, P67, DOI 10.1080/17482960600864207
   Park JH, 2018, EXP DERMATOL, V27, P378, DOI 10.1111/exd.13437
   Srinivasan M, 2007, J CLIN BIOCHEM NUTR, V40, P92, DOI 10.3164/jcbn.40.92
   Vitale G, 2013, NAT REV ENDOCRINOL, V9, P228, DOI 10.1038/nrendo.2013.29
   Vladimirov YA, 2009, BIOCHEMISTRY-MOSCOW+, V74, P301, DOI 10.1134/S0006297909030092
   Wille CM, 2014, J ORTHOP SPORT PHYS, V44, P825, DOI 10.2519/jospt.2014.5367
   Yano H, 2010, EUR J APPL PHYSIOL, V110, P797, DOI 10.1007/s00421-010-1560-1
   Yi RK, 2021, FRONT NUTR, V8, DOI 10.3389/fnut.2021.641544
   Yoon GA, 2014, NUTR RES PRACT, V8, P618, DOI 10.4162/nrp.2014.8.6.618
   Yu M., 2012, ZHONGGUO ZHIYE YAOSH, V9, P35
   Yu XL, 2015, FOOD FUNCT, V6, P3296, DOI 10.1039/c5fo00500k
   Zhao X, 2018, MOLECULES, V23, DOI 10.3390/molecules23010204
   Zheng J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142542
NR 32
TC 0
Z9 0
U1 2
U2 14
PU WILEY-HINDAWI
PI LONDON
PA ADAM HOUSE, 3RD FL, 1 FITZROY SQ, LONDON, WIT 5HE, ENGLAND
SN 0145-8884
EI 1745-4514
J9 J FOOD BIOCHEM
JI J. Food Biochem.
PD 2022 OCT
PY 2022
VL 46
IS 10
AR e14339
DI 10.1111/jfbc.14339
EA JUL 2022
PG 12
WC Biochemistry & Molecular Biology; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Food Science & Technology
GA 8F0LA
UT WOS:000826996700001
PM 35852118
DA 2024-02-19
ER

PT J
AU Carvalho, CRO
   Brenelli, SL
   Silva, AC
   Nunes, ALB
   Velloso, LA
   Saad, MJA
AF Carvalho, CRO
   Brenelli, SL
   Silva, AC
   Nunes, ALB
   Velloso, LA
   Saad, MJA
TI Effect of aging on insulin receptor, insulin receptor substrate-1, and
   phosphatidylinositol 3-kinase in liver and muscle of rats
SO ENDOCRINOLOGY
LA English
DT Article
ID SKELETAL-MUSCLE; KINASE-ACTIVITY; TYROSINE PHOSPHORYLATION; SIGNAL
   TRANSDUCTION; GLUCOSE-UPTAKE; ANIMAL-MODELS; IRS-1; ASSOCIATION;
   PROTEIN; RESISTANCE
AB Insulin stimulates the tyrosine kinase activity of its receptor, resulting in the phosphorylation of its cytosolic substrate, insulin receptor substrate-1 (IRS-1), which, in turn, associates with phosphatidylinositol 3-kinase (PI 3-kinase), thereby activating the latter. Aging is associated with insulin resistance, but the exact molecular mechanism is unknown. In the present study, we examined the levels and phosphorylation status of the insulin receptor and IRS-1 as well as the association between IRS-1 and PI 3-kinase in the liver and muscle of 2-, 5-, 12-, and 20-month-old rats.
   There were no changes in the insulin receptor concentration in the liver and muscle of rats 2-20 months old, as determined by immunoblotting using antibody to the COOH-terminus of the receptor. However, insulin stimulation of receptor autophosphorylation, as determined by immunoblotting with antiphosphotyrosine antibody was reduced by 25% (P < 0.05) in the liver and muscle of rats at 20 months. Interestingly, IRS-1 protein levels decrease at an early stage (5 months) by 58 +/- 9%. (P < 0.01) and remained at low levels thereafter in muscle, but not in liver. In samples previously immunoprecipitated with anti-IRS-1 antibody and blotted with antiphosphotyrosine antibody, there were 60 +/- 9% (P < 0.001) and 92 +/- 4% (P < 0.001) decreases in the insulin-stimulated IRS-1 phosphorylation levels in liver and muscle, respectively, of 20-month-old rats. The insulin-stimulated TRS-1 association with PI 3-kinase was decreased by 70 +/- 2% in the liver (P < 0.001) and by 98 +/- 3% (P < 0.001) in the muscle of 20-month-old rats, with no change in the PI 3-kinase protein levels. The phosphotyrosine-associated PI 3-kinase activity after insulin stimulation was dramatically reduced in liver and muscle of 20-month-old rats compared to that in 8-month-old rats. Finally, by immunoprecipitation, the detection of insulin-stimulated IRS-2 phosphorylation followed the same pattern as that for IRS-1 in both liver of 2- and 20-month-old rats. These data suggest that changes in the early steps of insulin signal transduction may have an important role in the insulin resistance observed in old animals.
C1 UNIV ESTADUAL CAMPINAS, FCM, DEPT INTERNAL MED, BR-13081 CAMPINAS, BRAZIL.
C3 Universidade Estadual de Campinas
RI Saad, Mario/ABD-8262-2020; Velloso, Licio/AAJ-3778-2020; Carvalho, Carla
   R. O./H-6476-2018
OI Carvalho, Carla R. O./0000-0001-5824-8656
CR ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0
   BACKER JM, 1992, EMBO J, V11, P3469, DOI 10.1002/j.1460-2075.1992.tb05426.x
   BARNARD RJ, 1992, AM J PHYSIOL, V262, pE619, DOI 10.1152/ajpendo.1992.262.5.E619
   CARRASCOSA JM, 1989, BIOCHEM BIOPH RES CO, V160, P303, DOI 10.1016/0006-291X(89)91656-2
   CHEATHAM B, 1994, MOL CELL BIOL, V14, P4902, DOI 10.1128/MCB.14.7.4902
   CHOU CK, 1987, J BIOL CHEM, V262, P1842
   DAVIDSON MB, 1978, METABOLISM, V27, P1994, DOI 10.1016/S0026-0495(78)80015-8
   EBINA Y, 1987, P NATL ACAD SCI USA, V84, P704, DOI 10.1073/pnas.84.3.704
   FINK RI, 1983, J CLIN INVEST, V71, P1523, DOI 10.1172/JCI110908
   FOLLI F, 1993, J CLIN INVEST, V92, P1787, DOI 10.1172/JCI116768
   GIORGETTI S, 1993, J BIOL CHEM, V268, P7358
   GIORGINO F, 1993, J CLIN INVEST, V91, P2020, DOI 10.1172/JCI116424
   GOODMAN MN, 1983, AM J PHYSIOL, V244, pE93, DOI 10.1152/ajpendo.1983.244.1.E93
   GULVE EA, 1993, AM J PHYSIOL, V264, pE319, DOI 10.1152/ajpendo.1993.264.3.E319
   HADARI YR, 1992, J BIOL CHEM, V267, P17483
   KANAI F, 1993, BIOCHEM BIOPH RES CO, V195, P762, DOI 10.1006/bbrc.1993.2111
   KELLY KL, 1993, J BIOL CHEM, V268, P4391
   KERN M, 1992, AM J PHYSIOL, V263, pE362, DOI 10.1152/ajpendo.1992.263.2.E362
   KONO S, 1990, AM J PHYSIOL, V259, pE27, DOI 10.1152/ajpendo.1990.259.1.E27
   KUHNE MR, 1993, J BIOL CHEM, V268, P11479
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LAMPHERE L, 1994, AM J PHYSIOL, V266, pE487
   LAVAN BE, 1992, J BIOL CHEM, V267, P11631
   MAEGAWA H, 1988, J BIOL CHEM, V261, P16597
   MATHAEI S, 1990, J ENDOCRINOL, V126, P99
   MOMOMURA K, 1987, BIOCHEM BIOPH RES CO, V155, P1181
   NADIV O, 1992, ENDOCRINOLOGY, V130, P1515, DOI 10.1210/en.130.3.1515
   NADIV O, 1994, BIOCHEM J, V298, P443, DOI 10.1042/bj2980443
   OLEFSKY JM, 1975, ENDOCRINOLOGY, V96, P1486, DOI 10.1210/endo-96-6-1486
   PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0
   QUON MJ, 1994, J BIOL CHEM, V269, P27920
   REED MJ, 1993, J GERONTOL, V48, pB139, DOI 10.1093/geronj/48.4.B139
   RICE KM, 1994, BIOCHEM BIOPH RES CO, V198, P523, DOI 10.1006/bbrc.1994.1077
   RUDERMAN NB, 1990, P NATL ACAD SCI USA, V87, P1411, DOI 10.1073/pnas.87.4.1411
   SAAD MJA, 1992, J CLIN INVEST, V90, P1839, DOI 10.1172/JCI116060
   SAAD MJA, 1993, J CLIN INVEST, V92, P2065, DOI 10.1172/JCI116803
   SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0
   SUN XJ, 1992, J BIOL CHEM, V267, P22662
   TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   WHITE MF, 1985, NATURE, V318, P183, DOI 10.1038/318183a0
   WHITE MF, 1994, J BIOL CHEM, V269, P1
   YAMAUCHI K, 1995, P NATL ACAD SCI USA, V92, P664, DOI 10.1073/pnas.92.3.664
   YOSHIMASA Y, 1988, AM J PHYSIOL, V254, pE92
   ZOPPINI G, 1992, DIABETOLOGIA, V3, P109
NR 45
TC 151
Z9 157
U1 0
U2 7
PU ENDOCRINE SOC
PI CHEVY CHASE
PA 8401 CONNECTICUT AVE, SUITE 900, CHEVY CHASE, MD 20815-5817 USA
SN 0013-7227
EI 1945-7170
J9 ENDOCRINOLOGY
JI Endocrinology
PD JAN
PY 1996
VL 137
IS 1
BP 151
EP 159
DI 10.1210/en.137.1.151
PG 9
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA TL323
UT WOS:A1996TL32300022
PM 8536607
OA Bronze
DA 2024-02-19
ER

PT J
AU Rusli, F
   Deelen, J
   Andriyani, E
   Boekschoten, MV
   Lute, C
   van den Akker, EB
   Müller, M
   Beekman, M
   Steegenga, WT
AF Rusli, Fenni
   Deelen, Joris
   Andriyani, Evi
   Boekschoten, Mark V.
   Lute, Carolien
   van den Akker, Erik B.
   Muller, Michael
   Beekman, Marian
   Steegenga, Wilma T.
TI Fibroblast growth factor 21 reflects liver fat accumulation and
   dysregulation of signalling pathways in the liver of C57BL/6J mice
SO SCIENTIFIC REPORTS
LA English
DT Article
ID ENDOPLASMIC-RETICULUM STRESS; SERUM FGF21 LEVELS; NONALCOHOLIC
   STEATOHEPATITIS; METABOLIC SYNDROME; GENE-EXPRESSION; BETA-KLOTHO;
   PPAR-ALPHA; TCA CYCLE; DISEASE; OBESITY
AB Fibroblast growth factor 21 (Fgf21) has emerged as a potential plasma marker to diagnose nonalcoholic fatty liver disease (NAFLD). To study the molecular processes underlying the association of plasma Fgf21 with NAFLD, we explored the liver transcriptome data of a mild NAFLD model of aging C57BL/6J mice at 12, 24, and 28 months of age. The plasma Fgf21 level significantly correlated with intrahepatic triglyceride content. At the molecular level, elevated plasma Fgf21 levels were associated with dysregulated metabolic and cancer-related pathways. The up-regulated Fgf21 levels in NAFLD were implied to be a protective response against the NAFLD-induced adverse effects, e.g. lipotoxicity, oxidative stress and endoplasmic reticulum stress. An in vivo PPAR alpha challenge demonstrated the dysregulation of PPAR alpha signalling in the presence of NAFLD, which resulted in a stochastically increasing hepatic expression of Fgf21. Notably, elevated plasma Fgf21 was associated with declining expression of Klb, Fgf21's crucial co-receptor, which suggests a resistance to Fgf21. Therefore, although liver fat accumulation is a benign stage of NAFLD, the elevated plasma Fgf21 likely indicated vulnerability to metabolic stressors that may contribute towards progression to end-stage NAFLD. In conclusion, plasma levels of Fgf21 reflect liver fat accumulation and dysregulation of metabolic pathways in the liver.
C1 [Rusli, Fenni; Andriyani, Evi; Boekschoten, Mark V.; Lute, Carolien; Steegenga, Wilma T.] Wageningen Univ, Div Human Nutr, Nutr Metab & Genom Grp, NL-6700 EV Wageningen, Netherlands.
   [Deelen, Joris; van den Akker, Erik B.; Beekman, Marian] Leiden Univ, Dept Mol Epidemiol, Med Ctr, Leiden, Netherlands.
   [van den Akker, Erik B.] Delft Univ Technol, Delft Bioinformat Lab, Mekelweg 4, NL-2628 CD Delft, Netherlands.
   [Muller, Michael] Univ East Anglia, Norwich Med Sch, Norwich, Norfolk, England.
C3 Wageningen University & Research; Leiden University - Excl LUMC; Leiden
   University; Leiden University Medical Center (LUMC); Delft University of
   Technology; University of East Anglia
RP Steegenga, WT (corresponding author), Wageningen Univ, Div Human Nutr, Nutr Metab & Genom Grp, NL-6700 EV Wageningen, Netherlands.
EM wilma.steegenga@wur.nl
RI Deelen, Joris/H-3201-2019; Beekman, Marian/L-3004-2019; Muller,
   Michael/B-5795-2008; Boekschoten, Mark/AAS-4597-2021; Muller,
   Michael/M-5724-2019
OI Deelen, Joris/0000-0003-4483-3701; Beekman, Marian/0000-0003-0585-6206;
   Muller, Michael/0000-0002-5930-9905; Boekschoten,
   Mark/0000-0002-2139-0795; Muller, Michael/0000-0002-5930-9905; van den
   Akker, Erik/0000-0002-7693-0728
FU European Union's Seventh Framework Programme (FP7) IDEAL-aging [259679]
FX This work was financially supported by European Union's Seventh
   Framework Programme (FP7/2007-2011) IDEAL-aging under grant agreement
   no. 259679.
CR Alisi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067160
   Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80
   Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002
   Bellentani S, 2010, DIGEST DIS, V28, P155, DOI 10.1159/000282080
   Berson A, 1998, GASTROENTEROLOGY, V114, P764, DOI 10.1016/S0016-5085(98)70590-6
   Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185
   Buettner R, 2007, OBESITY, V15, P798, DOI 10.1038/oby.2007.608
   Chalasani N, 2012, AM J GASTROENTEROL, V107, P811, DOI 10.1038/ajg.2012.128
   Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179
   Ding XS, 2012, CELL METAB, V16, P387, DOI 10.1016/j.cmet.2012.08.002
   Duseja A, 2013, HEPATOL INT, V7, pS755, DOI 10.1007/s12072-013-9480-x
   Dushay J, 2010, GASTROENTEROLOGY, V139, P456, DOI 10.1053/j.gastro.2010.04.054
   Duval C, 2010, DIABETES, V59, P3181, DOI 10.2337/db10-0224
   Fisher FM, 2010, DIABETES, V59, P2781, DOI 10.2337/db10-0193
   Flurkey K., 2007, The Mouse in Biomedical Research, P637
   Fuchs BC, 2013, J HEPATOL, V59, P992, DOI 10.1016/j.jhep.2013.06.026
   Hillebrandt S, 2005, NAT GENET, V37, P835, DOI 10.1038/ng1599
   Hui ST, 2015, ELIFE, V4, DOI 10.7554/eLife.05607
   Hyötyläinen T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms9994
   Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003
   Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015
   Jiang S, 2014, J BIOL CHEM, V289, P29751, DOI 10.1074/jbc.M114.565960
   Kharitonenkov A, 2008, J CELL PHYSIOL, V215, P1, DOI 10.1002/jcp.21357
   Kharitonenkov A, 2015, TRENDS ENDOCRIN MET, V26, P608, DOI 10.1016/j.tem.2015.09.007
   Kim SH, 2015, DIABETOLOGIA, V58, P809, DOI 10.1007/s00125-014-3475-6
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Koliaki C, 2015, CELL METAB, V21, P739, DOI 10.1016/j.cmet.2015.04.004
   Koot BGP, 2013, OBESITY, V21, P583, DOI 10.1002/oby.20173
   Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559
   Lazo M, 2013, AM J EPIDEMIOL, V178, P38, DOI 10.1093/aje/kws448
   Li HT, 2013, FRONT MED-PRC, V7, P25, DOI 10.1007/s11684-013-0244-8
   Li HT, 2010, J HEPATOL, V53, P934, DOI 10.1016/j.jhep.2010.05.018
   Lin K, 2011, J INTEGR BIOINFORMAT, V8, DOI 10.2390/biecoll-jib-2011-160
   Marchesini G, 2016, HEPATOLOGY, V63, P2032, DOI 10.1002/hep.28392
   Mofrad P, 2003, HEPATOLOGY, V37, P1286, DOI 10.1053/jhep.2003.50229
   Muise ES, 2008, MOL PHARMACOL, V74, P403, DOI 10.1124/mol.108.044826
   Nault JC, 2013, GASTROENTEROLOGY, V144, P888, DOI 10.1053/j.gastro.2013.02.032
   Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769
   Ogawa Y, 2007, P NATL ACAD SCI USA, V104, P7432, DOI 10.1073/pnas.0701600104
   Reinehr T, 2012, J CLIN ENDOCR METAB, V97, P2143, DOI 10.1210/jc.2012-1221
   Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007
   Rusli F, 2015, MOL NUTR FOOD RES, V59, P533, DOI 10.1002/mnfr.201400621
   Saadeh S, 2002, GASTROENTEROLOGY, V123, P745, DOI 10.1053/gast.2002.35354
   Sartor MA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-538
   Satapathy SK, 2015, SEMIN LIVER DIS, V35, P221, DOI 10.1055/s-0035-1562943
   Satapati S, 2012, J LIPID RES, V53, P1080, DOI 10.1194/jlr.M023382
   Schaap FG, 2013, BIOCHIMIE, V95, P692, DOI 10.1016/j.biochi.2012.10.019
   Shen JY, 2012, J HEPATOL, V56, P1363, DOI 10.1016/j.jhep.2011.12.025
   Steegenga WT, 2014, BIOL SEX DIFFER, V5, DOI 10.1186/s13293-014-0011-9
   Stickel F, 2010, GUT, V59, P1303, DOI 10.1136/gut.2009.199661
   Sunny NE, 2011, CELL METAB, V14, P804, DOI 10.1016/j.cmet.2011.11.004
   van Norren K, 2015, J CACHEXIA SARCOPENI, V6, P253, DOI 10.1002/jcsm.12024
   van Ommen B, 2014, GENES NUTR, V9, DOI 10.1007/s12263-014-0423-5
   Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154
   Yan HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024895
   Yang CF, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-67
   Yano E, 2001, J CLIN EPIDEMIOL, V54, P945, DOI 10.1016/S0895-4356(01)00355-9
   Yilmaz Y, 2010, EUR J CLIN INVEST, V40, P887, DOI 10.1111/j.1365-2362.2010.02338.x
   Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476
NR 59
TC 63
Z9 68
U1 1
U2 23
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUL 29
PY 2016
VL 6
AR 30484
DI 10.1038/srep30484
PG 16
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA DS2UY
UT WOS:000380640300001
PM 27470139
OA Green Accepted, Green Published, gold
DA 2024-02-19
ER

PT J
AU Xu, P
   Zeng, R
   Wan, QY
   Xie, Y
   Liu, XY
   An, SL
   Jiang, J
   Yang, J
   Zhou, YZ
   Shen, XB
AF Xu, Pei
   Zeng, Rong
   Wan, Qiyou
   Xie, Yan
   Liu, Xingyan
   An, Songlin
   Jiang, Jing
   Yang, Jing
   Zhou, Yuanzhong
   Shen, Xubo
TI Aging-related increases in serum sex hormone-binding globulin levels in
   men might be related to increased synthesis
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE Sex hormone -binding globulin; Men; Reproductive; Testosterone; Aging
ID LATE-ONSET HYPOGONADISM; NECROSIS-FACTOR-ALPHA; TOTAL TESTOSTERONE;
   METABOLIC SYNDROME; ASSOCIATIONS; WOMEN
AB Background: Previous studies have indicated that serum sex hormone-binding globulin (SHBG) levels increase with age; however, the causes remain unknown. The present study aimed to clarify whether the increase in SHBG levels is attributable to aging-related increases in SHBG synthesis.Methods: We examined and evaluated the association of serum SHBG levels with synthesis-related factors in men aged 18-80 years. Additionally, we examined the serum and liver levels of SHBG, hepatic nuclear factor 4 & alpha; (HNF-4 & alpha;), and peroxisome proliferator-activated receptor & gamma; (PPAR-& gamma;) in young, middle-aged, and old Spra-gue-Dawley rats.Results: The study included 209 men in the young group (median age, 33 & PLUSMN; 10 years), 174 men in the middle-aged group (median age, 53 & PLUSMN; 8 years), and 98 men in the elderly group (median age, 71 & PLUSMN; 8 years). Serum SHBG levels increased with age (P < 0.05), whereas HNF-4 & alpha; and PPAR-& gamma; levels decreased with age (both P < 0.05). Compared with the findings in the young group, the average decline in HNF-4 & alpha; levels was 2.61 % and 18.46 % in the middle-aged and elderly groups, respectively; the average decreases in PPAR-& gamma; levels in these groups were 12.86 % and 20.76 %, respectively. The results in rats illustrated that liver SHBG and HNF-4 & alpha; levels increased with age, whereas PPAR-& gamma; and chicken ovalbumin upstream promoter-transcription factor (COUP-TF) levels decreased with age (all P < 0.05). Serum SHBG levels increased in rats with age, whereas HNF-4 & alpha; and PPAR-& gamma; levels decreased with age (all P < 0.05).Conclusions: The aging-related increased liver levels of the SHBG synthesis promoter HNF-4 & alpha; and decreased levels of the SHBG inhibitory factors PPAR-& gamma; and COUP-TF suggest that the aging-related increases in SHBG levels are associated with increased SHBG synthesis.
C1 [Xu, Pei; Zeng, Rong; Wan, Qiyou; Xie, Yan; Liu, Xingyan; An, Songlin; Jiang, Jing; Yang, Jing; Zhou, Yuanzhong; Shen, Xubo] Zunyi Med Univ, Sch Publ Hlth, 6 Xuefu West Rd, Zunyi 563000, Guizhou, Peoples R China.
C3 Zunyi Medical University
RP Zhou, YZ; Shen, XB (corresponding author), Zunyi Med Univ, Sch Publ Hlth, 6 Xuefu West Rd, Zunyi 563000, Guizhou, Peoples R China.
EM zhouyuanzhong@zmu.edu.cn; shenxubo@zmu.edu.cn
FU National Natural Science Foundation of China [81860269]; Science and
   Technology Fund Project of Guizhou Provincial Health and Family Planning
   Commission [gzwjkj [2018] -1-065]; High-level innovative talents in
   Guizhou Province; Zunyi Medical University Master starting fund [GCC
   [2022]039-1]; Natural Science Foundation of Guizhou Province;  [F-967]; 
   [QKH-J[2022] YB612]
FX This work was supported by the National Natural Science Foundation of
   China (81860269), the Science and Technology Fund Project of Guizhou
   Provincial Health and Family Planning Commission (gzwjkj [2018]-1-065),
   High-level innovative talents in Guizhou Province (GCC [2022]039-1),
   Zunyi Medical University Master starting fund (F-967), and the Natural
   Science Foundation of Guizhou Province (QKH-J[2022] YB612).
CR Aribas E, 2021, J CLIN ENDOCR METAB, V106, P2890, DOI 10.1210/clinem/dgab470
   Aydin BK, 2016, J PEDIATR-US, V177, P334, DOI 10.1016/j.jpeds.2016.06.040
   Briansó-Llort L, 2020, MOL NUTR FOOD RES, V64, DOI 10.1002/mnfr.201901253
   Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422
   Ceccarelli V, 2011, MOL CELL BIOCHEM, V347, P29, DOI 10.1007/s11010-010-0609-0
   Chubb SAP, 2008, EUR J ENDOCRINOL, V158, P785, DOI 10.1530/EJE-07-0893
   Chung TH, 2020, AGING MALE, V23, P93, DOI 10.1080/13685538.2018.1501015
   Diver MJ, 2006, ANN CLIN BIOCHEM, V43, P3, DOI 10.1258/000456306775141803
   DUNN JF, 1981, J CLIN ENDOCR METAB, V53, P58, DOI 10.1210/jcem-53-1-58
   Flechtner-Mors M, 2014, HORM METAB RES, V46, P287, DOI 10.1055/s-0033-1354369
   Hammond GL, 2011, BIOL REPROD, V85, P431, DOI 10.1095/biolreprod.111.092593
   Hogeveen KN, 2002, J CLIN INVEST, V109, P973, DOI 10.1172/JCI14060
   Huang MN, 2018, J DIABETES, V10, P467, DOI 10.1111/1753-0407.12550
   Kaufman JM, 2019, ENDOCR REV, V40, P906, DOI 10.1210/er.2018-00178
   Li HG, 2020, AGING-US, V12, P26012, DOI 10.18632/aging.202227
   Liu ZS, 2015, REPROD BIOL ENDOCRIN, V13, DOI 10.1186/s12958-015-0107-z
   MCCLURE RD, 1987, UROL CLIN N AM, V14, P471
   Moon H, 2017, CLIN ENDOCRINOL, V87, P523, DOI 10.1111/cen.13390
   Mousavinasab F, 2006, ENDOCRINE, V30, P185, DOI 10.1385/ENDO:30:2:185
   Pugeat M, 2010, MOL CELL ENDOCRINOL, V316, P53, DOI 10.1016/j.mce.2009.09.020
   Pye SR, 2014, J CLIN ENDOCR METAB, V99, P1357, DOI 10.1210/jc.2013-2052
   Rastrelli G, 2018, CLIN ENDOCRINOL, V88, P556, DOI 10.1111/cen.13530
   Sáez-López C, 2019, J CLIN ENDOCR METAB, V104, P1500, DOI 10.1210/jc.2018-00740
   Selva DM, 2007, J CLIN INVEST, V117, P3979, DOI 10.1172/JCI32249
   Selva DM, 2009, ENDOCRINOLOGY, V150, P2183, DOI 10.1210/en.2008-1289
   Seo IH, 2017, YONSEI MED J, V58, P731, DOI 10.3349/ymj.2017.58.4.731
   Shen XB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164116
   Simó R, 2015, TRENDS ENDOCRIN MET, V26, P376, DOI 10.1016/j.tem.2015.05.001
   Simó R, 2014, ENDOCRINOLOGY, V155, P2820, DOI 10.1210/en.2014-1072
   Simó R, 2012, MOL ENDOCRINOL, V26, P1917, DOI 10.1210/me.2012-1152
   Simó R, 2012, DIABETES, V61, P372, DOI 10.2337/db11-0727
   SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353
   Tajar A, 2012, J CLIN ENDOCR METAB, V97, P1508, DOI 10.1210/jc.2011-2513
   Thaler MA, 2015, BEST PRACT RES CL EN, V29, P749, DOI 10.1016/j.beem.2015.06.005
   Tsai EC, 2004, DIABETES CARE, V27, P861, DOI 10.2337/diacare.27.4.861
   Wang A, 2019, EUR J PREV CARDIOL, V26, P847, DOI 10.1177/2047487318819142
   Wang C, 2008, EUR J ENDOCRINOL, V159, P507, DOI 10.1530/EJE-08-0601
   Wang W.Q, 2017, STUDY REGULATORY MEC
   Xia FZ, 2017, NEUROENDOCRINOLOGY, V104, P291, DOI 10.1159/000446656
   Zhao JV, 2021, J AM SOC NEPHROL, V32, P686, DOI 10.1681/ASN.2020050659
   Zhu JL, 2019, CLIN CHIM ACTA, V499, P142, DOI 10.1016/j.cca.2019.09.010
NR 41
TC 2
Z9 2
U1 1
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD AUG
PY 2023
VL 179
AR 112249
DI 10.1016/j.exger.2023.112249
EA JUL 2023
PG 7
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA M9CL4
UT WOS:001033119200001
PM 37392803
OA hybrid
DA 2024-02-19
ER

PT J
AU Yamamura, S
   Kawaguchi, T
   Nakano, D
   Tomiyasu, Y
   Yoshinaga, S
   Doi, Y
   Takahashi, H
   Anzai, K
   Eguchi, Y
   Torimura, T
   Shiba, N
AF Yamamura, Sakura
   Kawaguchi, Takumi
   Nakano, Dan
   Tomiyasu, Yoshiko
   Yoshinaga, Shinobu
   Doi, Yumi
   Takahashi, Hirokazu
   Anzai, Keizo
   Eguchi, Yuichiro
   Torimura, Takuji
   Shiba, Naoto
TI Profiles of advanced hepatic fibrosis evaluated by FIB-4 index and shear
   wave elastography in health checkup examinees
SO HEPATOLOGY RESEARCH
LA English
DT Article; Early Access
DE 2-D shear wave elastography; data-mining analysis; lifestyle; liver
   stiffness; non-invasive test algorithm
ID FATTY LIVER-DISEASE; HEPATOCELLULAR-CARCINOMA; TRANSIENT ELASTOGRAPHY;
   METABOLIC SYNDROME; STIFFNESS; ALCOHOL; INFLAMMATION; POPULATION;
   ULTRASOUND; MUSCLE
AB Aim Advanced hepatic fibrosis is seen in individuals with potential hepatocellular carcinoma and cardiovascular disease. Hepatic fibrosis can be assessed using a combination of the FIB-4 index and imaging modalities, including shear wave elastography. We aimed to investigate the prevalence of advanced fibrosis in the general population and the profiles associated with advanced fibrosis using a data-mining analysis. Methods We enrolled 1155 health checkup examinees (median age 53 years, 685 women, 470 male). Advanced fibrosis was defined by FIB-4 index >= 1.3 and liver stiffness >= 8.07 kPa using shear wave elastography. Participants were classified as normal-mild fibrosis (n = 1035) or advanced fibrosis (n = 120). Factors associated with advanced fibrosis were analyzed by logistic regression and decision-tree analyses. Results Advanced fibrosis was observed in 10.4% of participants (120/1155). In the logistic regression analysis, independent factors for advanced fibrosis were age (>= 75 years; OR 2.12, 95% CI 1.021-4.415; P = 0.0419) and the presence of metabolic syndrome (OR 2.51, 95% CI 1.416-4.462; P = 0.0017). The decision-tree analysis showed two profiles associated with advanced fibrosis: profile 1 - individuals aged >= 65 years with metabolic syndrome and mild-to-moderate alcohol consumption (prevalence of advanced fibrosis 73.3%); and profile 2 - individuals without metabolic syndrome, aged >= 75 years, with no exercise habit (prevalence of advanced fibrosis 56.3%). Conclusions Advanced fibrosis was observed in 10.4% of health checkup examinees. Furthermore, we showed that aging, metabolic syndrome with mild-to-moderate alcohol consumption, and physical inactivity were associated with advanced fibrosis. Thus, prevention of metabolic syndrome and alcohol withdrawal, as well as exercise habits, might inhibit the progression of hepatic fibrosis.
C1 [Yamamura, Sakura; Kawaguchi, Takumi; Nakano, Dan; Torimura, Takuji] Kurume Univ, Dept Med, Div Gastroenterol, Sch Med, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan.
   [Shiba, Naoto] Kurume Univ, Dept Orthoped, Sch Med, Kurume, Fukuoka, Japan.
   [Tomiyasu, Yoshiko; Yoshinaga, Shinobu; Doi, Yumi] Saga Prefectural Hlth Promot Fdn, Publ Util Fdn, Med Examinat Sect, Med Examinat Part Facil, Saga, Japan.
   [Takahashi, Hirokazu; Anzai, Keizo; Eguchi, Yuichiro] Saga Univ, Fac Med, Div Metab & Endocrinol, Saga, Japan.
   [Eguchi, Yuichiro] Saga Univ Hosp, Liver Ctr, Saga, Japan.
C3 Kurume University; Kurume University; Saga University; Saga University
RP Kawaguchi, T (corresponding author), Kurume Univ, Dept Med, Div Gastroenterol, Sch Med, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan.
EM takumi@med.kurume-u.ac.jp
RI 中野, 暖/IYJ-2642-2023
FU Japan Agency for Medical Research and Development (AMED) [19fk0210040]
FX This research was supported by Japan Agency for Medical Research and
   Development (AMED) under Grant Number 19fk0210040.
CR Åberg F, 2018, HEPATOLOGY, V67, P2141, DOI 10.1002/hep.29631
   Amano H, 2019, CELL METAB, V29, P1274, DOI 10.1016/j.cmet.2019.03.001
   Angulo P, 2013, GASTROENTEROLOGY, V145, P782, DOI 10.1053/j.gastro.2013.06.057
   [Anonymous], NIPPON NAIKA GAKKAI
   [Anonymous], 2018, BMI CLASSIFICATION
   Barr RG, 2018, ABDOM RADIOL, V43, P800, DOI 10.1007/s00261-017-1375-1
   Blasco MA, 2007, NAT CHEM BIOL, V3, P640, DOI 10.1038/nchembio.2007.38
   Castéra L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018
   Castera L, 2019, GASTROENTEROLOGY, V156, P1264, DOI 10.1053/j.gastro.2018.12.036
   Delogu W, 2019, DIGEST LIVER DIS, V51, P1400, DOI 10.1016/j.dld.2019.03.002
   Dietrich CF, 2017, ULTRASCHALL MED, V38, pE16, DOI 10.1055/s-0043-103952
   Fialho A, 2016, NUTR METAB CARDIOVAS, V26, P773, DOI 10.1016/j.numecd.2016.04.007
   Friedman SL, 2018, NAT MED, V24, P908, DOI 10.1038/s41591-018-0104-9
   Fuster D, 2018, NEW ENGL J MED, V379, P2579, DOI 10.1056/NEJMc1814129
   Herrmann E, 2018, HEPATOLOGY, V67, P260, DOI 10.1002/hep.29179
   Iijima H, 2019, HEPATOL RES, V49, P676, DOI 10.1111/hepr.13319
   Kanda M, 2019, ANN SURG ONCOL, V26, P3718, DOI 10.1245/s10434-019-07512-7
   Kawaguchi T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28650-0
   Kawaguchi T, 2018, HEPATOL RES, V48, P882, DOI 10.1111/hepr.13190
   Koehler EM, 2016, HEPATOLOGY, V63, P138, DOI 10.1002/hep.27981
   Loomba R, 2009, ALIMENT PHARM THER, V30, P1137, DOI 10.1111/j.1365-2036.2009.04141.x
   Loomba R, 2013, AM J EPIDEMIOL, V177, P333, DOI 10.1093/aje/kws252
   Lourenco MV, 2019, NAT MED, V25, P165, DOI 10.1038/s41591-018-0275-4
   Mulabecirovic A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203486
   Oh S, 2017, SCI REP-UK, V7, P1, DOI 10.1038/srep43029
   Oh S, 2015, HEPATOLOGY, V61, P1205, DOI 10.1002/hep.27544
   Peake J, 2010, AM J PHYSIOL-REG I, V298, pR1485, DOI 10.1152/ajpregu.00467.2009
   Petta S, 2017, LIVER INT, V37, P1389, DOI 10.1111/liv.13397
   Petta S, 2017, J CLIN ENDOCR METAB, V102, P2660, DOI 10.1210/jc.2017-00056
   Ratziu V, 2016, AM J PHYSIOL-GASTR L, V311, pG942, DOI 10.1152/ajpgi.00276.2016
   Roulot D, 2011, GUT, V60, P977, DOI 10.1136/gut.2010.221382
   Roulot D, 2008, J HEPATOL, V48, P606, DOI 10.1016/j.jhep.2007.11.020
   Saadeh S, 2002, GASTROENTEROLOGY, V123, P745, DOI 10.1053/gast.2002.35354
   Shiotsuki H, 2019, J STROKE CEREBROVASC, V28, P1604, DOI 10.1016/j.jstrokecerebrovasdis.2019.02.034
   Simpson RJ, 2016, BRAIN BEHAV IMMUN, V56, P10, DOI 10.1016/j.bbi.2016.05.015
   Son BK, 2019, GERONTOLOGY, V65, P397, DOI 10.1159/000499826
   Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178
   Tanaka K, 2019, HEPATOL RES, V49, P296, DOI 10.1111/hepr.13282
   Tapper EB, 2018, NAT REV GASTRO HEPAT, V15, P274, DOI 10.1038/nrgastro.2018.10
   Wong VWS, 2012, GUT, V61, P409, DOI 10.1136/gutjnl-2011-300342
   Xiao GQ, 2017, HEPATOLOGY, V66, P1486, DOI 10.1002/hep.29302
   Yamada S, 2014, HEPATOL RES, V44, P837, DOI 10.1111/hepr.12192
   You SC, 2015, WORLD J GASTROENTERO, V21, P1158, DOI 10.3748/wjg.v21.i4.1158
NR 43
TC 26
Z9 26
U1 1
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1386-6346
EI 1872-034X
J9 HEPATOL RES
JI Hepatol. Res.
PD 2020 FEB
PY 2020
VL 50
IS 2
BP 199
EP 213
DI 10.1111/hepr.13436
EA NOV 2019
PG 15
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA KK8YU
UT WOS:000497206500001
PM 31634983
DA 2024-02-19
ER

PT J
AU Bartucci, R
   van der Meer, AZ
   Boersma, YL
   Olinga, P
   Salvati, A
AF Bartucci, Roberta
   van der Meer, Alex Z.
   Boersma, Ykelien L.
   Olinga, Peter
   Salvati, Anna
TI Nanoparticle-induced inflammation and fibrosis in ex vivo murine
   precision-cut liver slices and effects of nanoparticle exposure
   conditions
SO ARCHIVES OF TOXICOLOGY
LA English
DT Article; Early Access
DE Liver slices; Ex vivo; Corona-coated nanoparticles; Aging; Inflammation;
   Fibrosis
AB Chronic exposure and accumulation of persistent nanomaterials by cells have led to safety concerns on potential long-term effects induced by nanoparticles, including chronic inflammation and fibrosis. With this in mind, we used murine precision-cut liver tissue slices to test potential induction of inflammation and onset of fibrosis upon 72 h exposure to different nanomaterials (0-200 mu g/ml). Tissue slices were chosen as an advanced ex vivo 3D model to better resemble the complexity of the in vivo tissue environment, with a focus on the liver where most nanomaterials accumulate. Effects on the onset of fibrosis and inflammation were investigated, with particular care in optimizing nanoparticle exposure conditions to tissue. Thus, we compared the effects induced on slices exposed to nanoparticles in the presence of excess free proteins (in situ), or after corona isolation. Slices exposed to daily-refreshed nanoparticle dispersions were used to test additional effects due to ageing of the dispersions. Exposure to amino-modified polystyrene nanoparticles in serum-free conditions led to strong inflammation, with stronger effects with daily-refreshed dispersions. Instead, no inflammation was observed when slices were exposed to the same nanoparticles in medium supplemented with serum to allow corona formation. Similarly, no clear signs of inflammation nor of onset of fibrosis were detected after exposure to silica, titania or carboxylated polystyrene in all conditions tested. Overall, these results show that liver slices can be used to test nanoparticle-induced inflammation in real tissue, and that the exposure conditions and ageing of the dispersions can strongly affect tissue responses to nanoparticles.
C1 [Bartucci, Roberta; van der Meer, Alex Z.; Salvati, Anna] Univ Groningen, Dept Nanomed & Drug Targeting, Groningen Res Inst Pharm, A Deusinglaan 1, NL-9713 AV Groningen, Netherlands.
   [Bartucci, Roberta; Olinga, Peter] Univ Groningen, Dept Pharmaceut Technol & Biopharm, Groningen Res Inst Pharm, A Deusinglaan 1, NL-9713 Groningen, Netherlands.
   [Bartucci, Roberta; Boersma, Ykelien L.] Univ Groningen, Groningen Res Inst Pharm, Dept Chem & Pharmaceut Biol, A Deusinglaan 1, NL-9713 AV Groningen, Netherlands.
C3 University of Groningen; University of Groningen; University of
   Groningen
RP Salvati, A (corresponding author), Univ Groningen, Dept Nanomed & Drug Targeting, Groningen Res Inst Pharm, A Deusinglaan 1, NL-9713 AV Groningen, Netherlands.; Olinga, P (corresponding author), Univ Groningen, Dept Pharmaceut Technol & Biopharm, Groningen Res Inst Pharm, A Deusinglaan 1, NL-9713 Groningen, Netherlands.
EM p.olinga@rug.nl; a.salvati@rug.nl
OI Olinga, Peter/0000-0003-4855-8452; Bartucci,
   Roberta/0000-0002-4116-0516; Salvati, Anna/0000-0002-9339-0161
FU University of Groningen
FX M.H. de Jager is kindly acknowledged for technical help with organ
   extraction and preparation, and C. Reker-Smit for the optimization of
   collagen staining. A.S. and Y.L.B. also acknowledge the University of
   Groningen for additional funding (Rosalind Franklin Fellowship).
CR Accomasso L, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00228
   Ajdary M, 2018, NANOMATERIALS-BASEL, V8, DOI 10.3390/nano8090634
   Alepee N, 2014, ALTEX-ALTERN ANIM EX, V31, P441, DOI 10.14573/altex.1406111
   Armstead AL, 2016, INT J NANOMED, V11, P6421, DOI 10.2147/IJN.S121238
   Arts JHE, 2007, FOOD CHEM TOXICOL, V45, P1856, DOI 10.1016/j.fct.2007.04.001
   Bartucci R, 2020, SMALL, V16, DOI 10.1002/smll.201906523
   Bexiga MG, 2011, NANOTOXICOLOGY, V5, P557, DOI 10.3109/17435390.2010.539713
   Böhmert L, 2018, PART FIBRE TOXICOL, V15, DOI 10.1186/s12989-018-0278-9
   Burden N, 2017, NANO TODAY, V12, P10, DOI 10.1016/j.nantod.2016.06.007
   Casals E, 2010, ACS NANO, V4, P3623, DOI 10.1021/nn901372t
   Cavaillon JM, 2001, CELL MOL BIOL, V47, P695
   Chan WT, 2017, INT J NANOMED, V12, P3421, DOI 10.2147/IJN.S126823
   Chen JY, 2009, J APPL TOXICOL, V29, P330, DOI 10.1002/jat.1414
   Cho EC, 2011, NAT NANOTECHNOL, V6, P385, DOI [10.1038/NNANO.2011.58, 10.1038/nnano.2011.58]
   Graaf IAM, 2007, EXPERT OPIN DRUG MET, V3, P879, DOI 10.1517/17425255.3.6.879
   de Graaf IAM, 2010, NAT PROTOC, V5, P1540, DOI 10.1038/nprot.2010.111
   De Jong WH, 2008, BIOMATERIALS, V29, P1912, DOI 10.1016/j.biomaterials.2007.12.037
   DELRASO NJ, 1993, TOXICOL LETT, V68, P91, DOI 10.1016/0378-4274(93)90122-E
   Devasena T., 2017, THERAPEUTIC DIAGNOST, P53
   Dragoni S, 2012, TOXICOL SCI, V128, P186, DOI 10.1093/toxsci/kfs150
   Drasler B, 2017, NANOIMPACT, V8, P99, DOI 10.1016/j.impact.2017.08.002
   Duan GX, 2015, NANOSCALE, V7, P15214, DOI 10.1039/c5nr01839k
   Feliu N, 2017, LANGMUIR, V33, P6639, DOI 10.1021/acs.langmuir.6b04629
   Ge CC, 2011, P NATL ACAD SCI USA, V108, P16968, DOI 10.1073/pnas.1105270108
   Giau VV, 2019, FRONT CHEM SCI ENG, V13, P90, DOI 10.1007/s11705-018-1766-z
   Godoy P, 2013, ARCH TOXICOL, V87, P1315, DOI 10.1007/s00204-013-1078-5
   Gore E, 2019, BIOCHEM PHARMACOL, V169, DOI 10.1016/j.bcp.2019.113633
   Gubicza J, 2013, MATER CHEM PHYS, V138, P449, DOI 10.1016/j.matchemphys.2013.01.012
   Guggenheim EJ, 2018, NANOIMPACT, V10, DOI 10.1016/j.impact.2018.02.008
   Gustafson HH, 2015, NANO TODAY, V10, P487, DOI 10.1016/j.nantod.2015.06.006
   Hadjidemetriou M, 2017, NAT NANOTECHNOL, V12, P288, DOI 10.1038/nnano.2017.61
   Holmes AM, 2010, TOXICOLOGY, V267, P14, DOI 10.1016/j.tox.2009.11.006
   Hong J, 2016, NANOTECHNOLOGY, V27, DOI 10.1088/0957-4484/27/11/112001
   Jasbi NE, 2016, J THEOR APPL PHYS, V10, P157, DOI 10.1007/s40094-016-0212-1
   Kastl L, 2013, ACS NANO, V7, P6605, DOI 10.1021/nn306032k
   Kim JA, 2012, NAT NANOTECHNOL, V7, P62, DOI [10.1038/NNANO.2011.191, 10.1038/nnano.2011.191]
   Krewski D, 2010, J TOXICOL ENV HEAL B, V13, P51, DOI 10.1080/10937404.2010.483176
   Krug HF, 2014, ANGEW CHEM INT EDIT, V53, P12304, DOI 10.1002/anie.201403367
   Kuchibhata SVNT, 2012, J PHYS CHEM C, V116, P14108, DOI 10.1021/jp300725s
   Landsiedel R, 2017, J NANOPART RES, V19, DOI 10.1007/s11051-017-3850-6
   Lee IC, 2018, NANOTOXICOLOGY, V12, P637, DOI 10.1080/17435390.2018.1472313
   Lesniak A, 2012, ACS NANO, V6, P5845, DOI 10.1021/nn300223w
   Loos C, 2014, BEILSTEIN J NANOTECH, V5, P2403, DOI 10.3762/bjnano.5.250
   Lu HT, 2017, J HAZARD MATER, V325, P113, DOI 10.1016/j.jhazmat.2016.11.013
   Lundqvist M, 2011, ACS NANO, V5, P7503, DOI 10.1021/nn202458g
   Lunov O, 2011, ACS NANO, V5, P9648, DOI 10.1021/nn203596e
   Mahony C, 2018, ARCH TOXICOL, V92, P1015, DOI 10.1007/s00204-017-2145-0
   Materne EM, 2013, LAB CHIP, V13, P3481, DOI 10.1039/c3lc50240f
   Monopoli MP, 2012, NAT NANOTECHNOL, V7, P779, DOI [10.1038/nnano.2012.207, 10.1038/NNANO.2012.207]
   Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397
   Ogawara K, 1999, J CONTROL RELEASE, V59, P15, DOI 10.1016/S0168-3659(99)00015-2
   Olinga P, 2001, J HEPATOL, V35, P187, DOI 10.1016/S0168-8278(01)00103-9
   Olinga P, 2013, J HEPATOL, V58, P1252, DOI 10.1016/j.jhep.2013.01.009
   Park EJ, 2009, TOXICOL LETT, V184, P18, DOI 10.1016/j.toxlet.2008.10.012
   PARRISH AR, 1995, LIFE SCI, V57, P1887, DOI 10.1016/0024-3205(95)02176-J
   PEARSON RM, 1986, HUM REPROD, V1, P559, DOI 10.1093/oxfordjournals.humrep.a136473
   Pham BT, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12323
   Poon W, 2019, ACS NANO, V13, P5785, DOI 10.1021/acsnano.9b01383
   Rim KT, 2013, SAF HEALTH WORK-KR, V4, P177, DOI 10.1016/j.shaw.2013.07.006
   Sadauskas Evaldas, 2007, Part Fibre Toxicol, V4, P10, DOI 10.1186/1743-8977-4-10
   Singh AV, 2019, TOXICOL MECH METHOD, V29, P378, DOI 10.1080/15376516.2019.1566425
   Soldatow VY, 2013, TOXICOL RES-UK, V2, P23, DOI 10.1039/c2tx20051a
   Starokozhko V, 2018, J TISSUE ENG REGEN M, V12, pE227, DOI 10.1002/term.2385
   Starokozhko V, 2017, ARCH TOXICOL, V91, P2079, DOI 10.1007/s00204-016-1865-x
   Starokozhko V, 2017, EXPERT OPIN DRUG MET, V13, P125, DOI 10.1080/17425255.2017.1246537
   Starokozhko V, 2015, TOXICOL IN VITRO, V30, P288, DOI 10.1016/j.tiv.2015.10.008
   Suker Dhamia K, 2018, Gastroenterol Hepatol Bed Bench, V11, P159
   Thurnherr T, 2011, TOXICOL LETT, V200, P176, DOI 10.1016/j.toxlet.2010.11.012
   Tsoi KM, 2016, NAT MATER, V15, P1212, DOI [10.1038/NMAT4718, 10.1038/nmat4718]
   Usta OB, 2015, TECHNOLOGY, V3, P1, DOI 10.1142/S2339547815300012
   Valentini X, 2019, J TOXICOL-US, V2019, DOI 10.1155/2019/5767012
   Wang FJ, 2013, NANOMED-NANOTECHNOL, V9, P1159, DOI 10.1016/j.nano.2013.04.010
   Wang FJ, 2013, NANOSCALE, V5, P10868, DOI 10.1039/c3nr03249c
   Westra IM, 2013, XENOBIOTICA, V43, P98, DOI 10.3109/00498254.2012.723151
   Westra IM, 2016, TOXICOL IN VITRO, V35, P77, DOI 10.1016/j.tiv.2016.05.012
   Westra IM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095462
   Westra IM, 2014, TOXICOL APPL PHARM, V274, P328, DOI 10.1016/j.taap.2013.11.017
   Wick P, 2015, EUR J NANOMED, V7, P169, DOI 10.1515/ejnm-2014-0049
   Xia T, 2008, ACS NANO, V2, P85, DOI 10.1021/nn700256c
   Xie GP, 2010, ARCH TOXICOL, V84, P183, DOI 10.1007/s00204-009-0488-x
   Yu Y, 2017, INT J NANOMED, V12, P6045, DOI 10.2147/IJN.S132304
   Zeisberg M, 2013, AM J PHYSIOL-CELL PH, V304, pC216, DOI 10.1152/ajpcell.00328.2012
   Zhang YN, 2016, J CONTROL RELEASE, V240, P332, DOI 10.1016/j.jconrel.2016.01.020
NR 83
TC 8
Z9 8
U1 1
U2 18
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-5761
EI 1432-0738
J9 ARCH TOXICOL
JI Arch. Toxicol.
PD 2021 APR
PY 2021
VL 95
IS 4
BP 1267
EP 1285
DI 10.1007/s00204-021-02992-7
EA FEB 2021
PG 19
WC Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Toxicology
GA RK3SW
UT WOS:000616034500002
PM 33555372
OA hybrid, Green Published
DA 2024-02-19
ER

PT J
AU Jiang, MH
   Zhang, YH
   Liu, M
   Lan, MS
   Fei, J
   Fan, WW
   Gao, X
   Lu, DR
AF Jiang, Minghong
   Zhang, Yuhao
   Liu, Meng
   Lan, Michael Shihli
   Fei, Jing
   Fan, Weiwei
   Gao, Xin
   Lu, Daru
TI Hypermethylation of Hepatic Glucokinase and L-Type Pyruvate Kinase
   Promoters in High-Fat Diet-Induced Obese Rats
SO ENDOCRINOLOGY
LA English
DT Article
ID DNA METHYLATION; GENE-EXPRESSION
AB Obesity-dependent insulin resistance and type 2 diabetes mellitus are closely associated with decreased glucose utilization and down-regulation of hepatic glycolytic enzymes expression. Previously, we showed that DNA hypermethylation is involved in age-dependent susceptibility to hepatic insulin resistance and diabetes. However, what we cannot distinguish is whether the age-related obesity contributes to DNA hypermethylation in those natural aging rats. In the present study, we hypothesize that DNA methylation plays a crucial role in the regulation of glycolytic enzymes in the high-fat diet-induced obesity. Here, we report that DNA hypermethylation is correlated with a decline in hepatic glucokinase (Gck) and L-type pyruvate kinase (LPK) expression in high-fat diet-induced obese rats as compared with the control diet group. Down-regulation of Gck and LPK expression are reversed by the 5-aza-2'-deoxycytidine in the cell model of steatosis. These novel observations indicate that DNA methylation is involved in the development of metabolic diseases, such as obesity, insulin resistance, type2diabetesmellitus, and nonalcoholic steatohepatitis, suggesting that the hypermethylation level of Gck and LPK promoters may be a useful parameter for the evaluation of obesity-induced insulin resistance and fatty liver. (Endocrinology 152: 1284-1289, 2011)
C1 [Jiang, Minghong; Zhang, Yuhao; Fei, Jing; Fan, Weiwei; Lu, Daru] Fudan Univ, State Key Lab Genet Engn, Inst Genet, Sch Life Sci, Shanghai 200433, Peoples R China.
   [Jiang, Minghong; Zhang, Yuhao; Fei, Jing; Fan, Weiwei; Lu, Daru] Fudan Univ, Minist Educ, Key Lab Contemporary Anthropol, Sch Life Sci, Shanghai 200433, Peoples R China.
   [Jiang, Minghong] Tsinghua Univ, Inst Basic Med Sci, Peking Union Med Coll, Natl Key Lab Med Mol Biol, Beijing 100084, Peoples R China.
   Chinese Acad Med Sci, Beijing 100084, Peoples R China.
   [Liu, Meng; Gao, Xin] Fudan Univ, Dept Endocrinol & Metab, Zhongshan Hosp, Shanghai 200032, Peoples R China.
   [Lan, Michael Shihli] Louisiana State Univ, Med Ctr, Dept Pediat, Res Inst Children,Childrens Hosp, New Orleans, LA 70112 USA.
C3 Fudan University; Fudan University; Institute of Basic Medical Sciences
   - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical
   College; Peking Union Medical College; Tsinghua University; Chinese
   Academy of Medical Sciences - Peking Union Medical College; Fudan
   University; Children's Hospital of New Orleans; Louisiana State
   University System
RP Lu, DR (corresponding author), Fudan Univ, State Key Lab Genet Engn, Inst Genet, Sch Life Sci, Shanghai 200433, Peoples R China.
EM gao.xin@zs-hospital.sh.cn; drlu@fudan.edu.cn
RI Frank, Viki/GXZ-9902-2022; Lan, Michael/CAF-1839-2022; zhang,
   yuhao/O-4356-2015
CR Barrès R, 2009, CELL METAB, V10, P189, DOI 10.1016/j.cmet.2009.07.011
   Bonora E, 2000, DIABETES CARE, V23, P57, DOI 10.2337/diacare.23.1.57
   Brons C, 2010, J CLIN ENDOCR METAB, V95, P3048, DOI 10.1210/jc.2009-2413
   Chang XX, 2010, J LIPID RES, V51, P2504, DOI 10.1194/jlr.M001958
   Grunau C, 2001, NUCLEIC ACIDS RES, V29, P270, DOI 10.1093/nar/29.1.270
   Jiang MH, 2008, DIABETOLOGIA, V51, P1525, DOI 10.1007/s00125-008-1034-8
   Jiang MH, 2010, LAB INVEST, V90, P282, DOI 10.1038/labinvest.2009.132
   Ling C, 2007, J CLIN INVEST, V117, P3427, DOI 10.1172/JCI30938
   Maier S, 2002, J NUTR, V132, p2440S, DOI 10.1093/jn/132.8.2440S
   Park JH, 2008, J CLIN INVEST, V118, P2316, DOI [10.1172/JC133655, 10.1172/JCI33655]
   Pereira S, 2008, DIABETES, V57, P56, DOI 10.2337/db07-0887
   Ramchandani S, 1999, P NATL ACAD SCI USA, V96, P6107, DOI 10.1073/pnas.96.11.6107
   Rönn T, 2008, DIABETOLOGIA, V51, P1159, DOI 10.1007/s00125-008-1018-8
   Vaissière T, 2008, MUTAT RES-REV MUTAT, V659, P40, DOI 10.1016/j.mrrev.2008.02.004
NR 14
TC 60
Z9 69
U1 0
U2 16
PU ENDOCRINE SOC
PI WASHINGTON
PA 2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA
SN 0013-7227
EI 1945-7170
J9 ENDOCRINOLOGY
JI Endocrinology
PD APR
PY 2011
VL 152
IS 4
BP 1284
EP 1289
DI 10.1210/en.2010-1162
PG 6
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 739EM
UT WOS:000288696300011
PM 21239437
OA Bronze
DA 2024-02-19
ER

PT J
AU Liao, CH
   Chen, BH
   Chiang, HS
   Chen, CW
   Chen, MF
   Ke, CC
   Wang, YY
   Lin, WN
   Wang, CC
   Lin, YH
AF Liao, Chun-Hou
   Chen, Bing-Huei
   Chiang, Han-Sun
   Chen, Chiu-Wei
   Chen, Mei-Feng
   Ke, Chih-Chun
   Wang, Ya-Yun
   Lin, Wei-Ning
   Wang, Chi-Chung
   Lin, Ying-Hung
TI Optimizing a Male Reproductive Aging Mouse Model by D-Galactose
   Injection
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE aging; male infertility; mouse model
ID BROWN-NORWAY RAT; MALE-INFERTILITY; RANDOMIZED TRIAL; FREE-RADICALS;
   VITAMIN-C; AGE; SPERM; MICE; PROTEIN; MEN
AB The D-galactose (D-gal)-injected animal model, which is typically established by administering consecutive subcutaneous D-gal injections to animals for approximately six or eight weeks, has been frequently used for aging research. In addition, this animal model has been demonstrated to accelerate aging in the brain, kidneys, liver and blood cells. However, studies on aging in male reproductive organs that have used this animal model remain few. Therefore, the current study aimed to optimize a model of male reproductive aging by administering D-gal injections to male mice and to determine the possible mechanism expediting senescence processes during spermatogenesis. In this study, C57Bl/6 mice were randomized into five groups (each containing 8-10 mice according to the daily intraperitoneal injection of vehicle control or 100 or 200 mg/kg dosages of D-gal for a period of six or eight weeks). First, mice subjected to D-gal injections for six or eight weeks demonstrated considerably decreased superoxide dismutase activity in the serum and testis lysates compared to those in the control group. The lipid peroxidation in testis also increased in the D-gal-injected groups. Furthermore, the D-gal-injected groups exhibited a decreased ratio of testis weight/body weight and sperm count compared to the control group. The percentages of both immotile sperm and abnormal sperm increased considerably in the D-gal-injected groups compared to those of the control group. To determine the genes influenced by the D-gal injection during murine spermatogenesis, a c-DNA microarray was conducted to compare testicular RNA samples between the treated groups and the control group. The D-gal-injected groups exhibited RNA transcripts of nine spermatogenesis-related genes (Cycl2, Hk1, Pltp, Utp3, Cabyr, Zpbp2, Speer2, Csnka2ip and Katnb1) that were up-or down-regulated by at least two-fold compared to the control group. Several of these genes are critical for forming sperm-head morphologies or maintaining nuclear integration (e.g., cylicin, basic protein of sperm head cytoskeleton 2 (Cylc2), casein kinase 2, alpha prime interacting protein (Csnka2ip) and katanin p80 (WD40-containing) subunit B1 (Katnb1)). These results indicate that D-gal-injected mice are suitable for investigating male reproductive aging.
C1 [Liao, Chun-Hou] Fu Jen Catholic Univ, PhD Program Nutr & Food Sci, 510 Zhongzheng Rd, New Taipei 242, Taiwan.
   [Liao, Chun-Hou] Cardinal Tien Hosp, Dept Surg, Div Urol, 362 Zhongzheng Rd, New Taipei 231, Taiwan.
   [Liao, Chun-Hou; Chiang, Han-Sun] Fu Jen Catholic Univ, Sch Med, 510 Zhongzheng Rd, New Taipei 242, Taiwan.
   [Chen, Bing-Huei] Fu Jen Catholic Univ, Dept Food Sci, 510 Zhongzheng Rd, New Taipei 242, Taiwan.
   [Chiang, Han-Sun; Chen, Chiu-Wei; Lin, Wei-Ning; Wang, Chi-Chung; Lin, Ying-Hung] Fu Jen Catholic Univ, Grad Inst Basic Med, 510 Zhongzheng Rd, New Taipei 242, Taiwan.
   [Chen, Mei-Feng] Chang Gung Univ, Res Ctr Emerging Viral Infect, 259 Wen Hwa 1st Rd, Taoyuan 333, Taiwan.
   [Ke, Chih-Chun] En Chu Kong Hosp, Dept Urol, 399 Fuxing Rd, New Taipei 237, Taiwan.
   [Wang, Ya-Yun] Fu Jen Catholic Univ, Dept Chem, 510 Zhongzheng Rd, New Taipei 242, Taiwan.
C3 Fu Jen Catholic University; Fu Jen Catholic University; Fu Jen Catholic
   University; Fu Jen Catholic University; Chang Gung University; Fu Jen
   Catholic University
RP Lin, YH (corresponding author), Fu Jen Catholic Univ, Grad Inst Basic Med, 510 Zhongzheng Rd, New Taipei 242, Taiwan.
EM liaoch22@gmail.com; 002622@mail.fju.edu.tw; 053824@mail.fju.edu.tw;
   okwapnice@hotmail.com; mfchen0@gmail.com; koacurtis@gmail.com;
   vic0009@gmail.com; 081551@mail.fju.edu.tw; 075006@mail.fju.edu.tw;
   084952@mail.fju.edu.tw
RI chen, chen wen/GZM-3705-2022; Lin, Ying-Hung/AAC-6327-2019; Chen, Mei
   Feng/I-2763-2016; CHEN, CHEN/HDM-6657-2022; Chen, Bing
   Huei/HHZ-2893-2022
OI Lin, Ying-Hung/0000-0002-1574-1579; Chen, Mei Feng/0000-0002-7170-0843;
   Chen, Bing Huei/0000-0002-6313-8627; Liao, Chun-Hou/0000-0002-7340-110X
FU Ministry of Science and Technology of the Republic of China [National
   Science Council (NSC) 101-2313-B-030-006-, NSC 102-2320-B-030-006-MY3];
   Cardinal Tien Hospital [CTH-102-1-2B10]
FX This study was supported by grants from the Ministry of Science and
   Technology of the Republic of China (Ying-Hung Lin: National Science
   Council (NSC) 101-2313-B-030-006- and NSC 102-2320-B-030-006-MY3) and
   from Cardinal Tien Hospital (Ying-Hung Lin: CTH-102-1-2B10).
CR ABEL BJ, 1982, BRIT J UROL, V54, P780, DOI 10.1111/j.1464-410X.1982.tb13647.x
   Ahangarpour A, 2014, WORLD J MENS HEALTH, V32, P176, DOI 10.5534/wjmh.2014.32.3.176
   [Anonymous], 1999, WHO laboratory manual for the examination of human semen and sperm-cervical mucus interaction
   ARMSTRONG D, 1994, ADV EXP MED BIOL, V366, P43
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   BETHEA CL, 1979, J GERONTOL, V34, P21, DOI 10.1093/geronj/34.1.21
   Blahak P., 1947, CESKE GYNAEKOL, V12, P80
   BRUNI JF, 1977, BIOL REPROD, V17, P309, DOI 10.1095/biolreprod17.3.309
   Bucala R, 1992, Adv Pharmacol, V23, P1
   Charlton BG, 2007, MED HYPOTHESES, V69, P237, DOI 10.1016/j.mehy.2007.03.005
   Cocuzza M, 2008, UROLOGY, V71, P490, DOI 10.1016/j.urology.2007.11.041
   DAGATA R, 1990, INT J ANDROL, V13, P344, DOI 10.1111/j.1365-2605.1990.tb01042.x
   Desai N, 2010, UROLOGY, V75, P14, DOI 10.1016/j.urology.2009.05.025
   HARGREAVE TB, 1984, BRIT J UROL, V56, P740, DOI 10.1111/j.1464-410X.1984.tb06160.x
   Hartman JJ, 1998, CELL, V93, P277, DOI 10.1016/S0092-8674(00)81578-0
   HESS H, 1995, EXP CELL RES, V218, P174, DOI 10.1006/excr.1995.1145
   Ho SC, 2003, BIOGERONTOLOGY, V4, P15, DOI 10.1023/A:1022417102206
   Kovac JR, 2013, ASIAN J ANDROL, V15, P723, DOI 10.1038/aja.2013.92
   Lu J, 2007, BIOCHEM PHARMACOL, V74, P1078, DOI 10.1016/j.bcp.2007.07.007
   Luo LD, 2006, J ANDROL, V27, P240, DOI 10.2164/jandrol.05075
   Mukhopadhyay D, 2010, FERTIL STERIL, V93, P2247, DOI 10.1016/j.fertnstert.2009.01.135
   Muller FL, 2007, FREE RADICAL BIO MED, V43, P477, DOI 10.1016/j.freeradbiomed.2007.03.034
   NOVAK R, 1980, SCIENCE, V207, P86, DOI 10.1126/science.7350646
   O'Donnell L, 2014, ANDROLOGY-US, V2, P884, DOI 10.1111/andr.276
   O'Donnell L, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002698
   Paul C, 2011, BIOL REPROD, V85, P1269, DOI 10.1095/biolreprod.111.094219
   PIRKE KM, 1978, ACTA ENDOCRINOL-COP, V89, P393, DOI 10.1530/acta.0.0890393
   Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1
   Ross C, 2010, REPROD BIOMED ONLINE, V20, P711, DOI 10.1016/j.rbmo.2010.03.008
   Sharma RK, 1996, UROLOGY, V48, P835, DOI 10.1016/S0090-4295(96)00313-5
   Song X, 1999, MECH AGEING DEV, V108, P239, DOI 10.1016/S0047-6374(99)00022-6
   Tsai SJ, 2012, EUR J PHARMACOL, V689, P81, DOI 10.1016/j.ejphar.2012.05.018
   VONBULOW M, 1995, EXP CELL RES, V219, P407, DOI 10.1006/excr.1995.1246
   Wyrobek AJ, 2006, P NATL ACAD SCI USA, V103, P9601, DOI 10.1073/pnas.0506468103
NR 34
TC 43
Z9 46
U1 0
U2 16
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD JAN
PY 2016
VL 17
IS 1
AR 98
DI 10.3390/ijms17010098
PG 10
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA DK0DW
UT WOS:000374583800093
PM 26771610
OA gold, Green Submitted, Green Published
DA 2024-02-19
ER

PT J
AU Tateishi, T
   Watanabe, M
   Nakura, H
   Tanaka, M
   Kumai, T
   Kobayashi, S
AF Tateishi, T
   Watanabe, M
   Nakura, H
   Tanaka, M
   Kumai, T
   Kobayashi, S
TI Sex- or age-related differences were not detected in the activity of
   dihydropyrimidine dehydrogenase from rat liver
SO PHARMACOLOGICAL RESEARCH
LA English
DT Article
DE dihydropyrimidine dehydrogenase; 5-fluorouracil; Sprague-Dawley rats;
   ageing; gender difference
ID FLUOROURACIL; POPULATION; CLEARANCE; DRUG
AB We examined the influence of ageing and gender on the activity of dihydropyrimidine dehydrogenase (DPD) in male and female Sprague-Dawley rats at 3, 8, 40 and older than 60 weeks of age. The body and liver weights of male rats at 8 weeks and older of age were heavier than those of female rats at the same age and the ratio of liver to body weight was significantly reduced with ageing. The amount of produced 5FU metabolites, dihydrofluorouracil and fluoroureidopropionic acid, remained unchanged in the reaction mixture with the cytosol from any group of the rats. The formation rates of 5FU metabolite were 1.03+/-0.08/1.12+/-0.06, 0.98+/-0.11/1.16+/-0.10, 1.13+/-0.09/1.13+/-0.11 and 1.17+/-0.16/1.24+/-0.08 nmol min(-1) mg protein(-1) (mean+/-SD, male/female) in rats at 3, 8, 40 and older than 60 weeks of age, respectively. The results suggest that the DPD activity in the rat liver may not be affected by ageing or gender. (C) 1997 The Italian Pharmacological Society.
RP Tateishi, T (corresponding author), ST MARIANNA UNIV,SCH MED,DEPT PHARMACOL,2-16-1 SUGAO,KAWASAKI,KANAGAWA 216,JAPAN.
CR ETIENNE MC, 1994, J CLIN ONCOL, V12, P2248, DOI 10.1200/JCO.1994.12.11.2248
   HARRIS RZ, 1995, DRUGS, V50, P222, DOI 10.2165/00003495-199550020-00003
   IMAOKA S, 1991, BIOCHIM BIOPHYS ACTA, V1097, P187, DOI 10.1016/0925-4439(91)90034-7
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   LU ZH, 1995, CLIN PHARMACOL THER, V58, P512, DOI 10.1016/0009-9236(95)90171-X
   MILANO G, 1992, J CLIN ONCOL, V10, P1171, DOI 10.1200/JCO.1992.10.7.1171
   NAGUIB FNM, 1985, CANCER RES, V45, P5405
   PINEDO HM, 1988, J CLIN ONCOL, V6, P1653, DOI 10.1200/JCO.1988.6.10.1653
   PORT RE, 1991, ONCOLOGY, V48, P277
   Tateishi T, 1996, CLIN CHIM ACTA, V252, P1, DOI 10.1016/0009-8981(96)06315-2
   WOODHOUSE K, 1992, DRUG AGING, V2, P243, DOI 10.2165/00002512-199202030-00007
   ZAPHIROPOULOS PG, 1989, TRENDS PHARMACOL SCI, V10, P149, DOI 10.1016/0165-6147(89)90167-3
NR 12
TC 6
Z9 7
U1 0
U2 0
PU ACADEMIC PRESS LTD
PI LONDON
PA 24-28 OVAL RD, LONDON, ENGLAND NW1 7DX
SN 1043-6618
J9 PHARMACOL RES
JI Pharmacol. Res.
PD FEB
PY 1997
VL 35
IS 2
BP 103
EP 106
DI 10.1006/phrs.1996.0109
PG 4
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA WZ951
UT WOS:A1997WZ95100005
PM 9175577
DA 2024-02-19
ER

PT J
AU Zhou, XR
   Sun, HL
   Tan, F
   Yi, RK
   Zhou, CL
   Deng, YH
   Mu, JF
   Zhao, X
AF Zhou, Xianrong
   Sun, Hailan
   Tan, Fang
   Yi, Ruokun
   Zhou, Chaolekang
   Deng, Yuhan
   Mu, Jianfei
   Zhao, Xin
TI Anti-aging effect of <i>Lactobacillus plantarum</i> HFY09-fermented
   soymilk on D-galactose-induced oxidative aging in mice through
   modulation of the Nrf2 signaling pathway
SO JOURNAL OF FUNCTIONAL FOODS
LA English
DT Article; Early Access
DE Soy isoflavone; Peptides; Lactobacillus plantarum; Fermented soymilk;
   Aging; D-galactose; Nrf2 signaling pathway
AB After soymilk fermented by L. plantarum HFY09, the bound soybean isoflavones content was reduced, but free soybean isoflavones and peptides increased. In vivo results show that L. plantarum HFY09-fermented soymilk increased the T-SOD, MDA, GSH-Px, GSH, CAT, and NO in the serum, liver, and brain tissues of mice. The aforementioned soymilk also increased the Col I and hyaluronic acid, and reduced the contents of Col III, H2O2, and AGEs in the skin. L. plantarum HFY09-fermented soymilk upregulated Nrf2, HO-1, NOS1, NOS3, SOD1, SOD2, CAT, Nqol, Gclm expression in the liver and the spleen, reduced the NOS2 expression, and upregulated SOD1 SOD2, CAT, GSH-Px, TIMP1, and TIMP2 expression in skin, downregulated MMP3, and MMP9 expression. These results show that L. plantarum HFY09-fermented soymilk could effectively alleviate aging in D-galactose-induced aging mice, the mechanism may be related to the activation of Nrf2 signaling pathway by soy isoflavone aglycone and small molecule peptides.
C1 [Zhou, Xianrong; Yi, Ruokun; Zhou, Chaolekang; Deng, Yuhan; Mu, Jianfei; Zhao, Xin] Chongqing Univ Educ, Chongqing Collaborat Innovat Ctr Funct Food, Chongqing Engn Res Ctr Funct Food, Chongqing Engn Lab Res & Dev Funct Food, Chongqing 400067, Peoples R China.
   [Sun, Hailan] Chongqing Hlth Ctr Women & Children, Dept Nutr, Chongqing 400021, Peoples R China.
   [Tan, Fang] Our Lady Fatima Univ, Dept Publ Hlth, Valenzuela 838, Philippines.
C3 Chongqing University of Education; Our Lady of Fatima University
RP Zhao, X (corresponding author), Chongqing Univ Educ, Chongqing Collaborat Innovat Ctr Funct Food, Chongqing Engn Res Ctr Funct Food, Chongqing Engn Lab Res & Dev Funct Food, Chongqing 400067, Peoples R China.
EM zhaoxin@cque.edu.cn
OI Tan, Fang/0000-0003-2406-129X
FU Chongqing University Innovation Research Group Project, China
   [CXQTP20033]; Science and Technology Project of Chongqing Education
   Commission, China [KJQN202001604]; Research Project of Chongqing
   University of Education, China [KY201920C]
FX This research was funded by Chongqing University Innovation Research
   Group Project (CXQTP20033) , the Science and Technology Project of
   Chongqing Education Commission (KJQN202001604) and the Research Project
   of Chongqing University of Education (KY201920C) , China.
CR Battistini C, 2018, BRAZ J MICROBIOL, V49, P303
   Béchade C, 2014, GLIA, V62, P956, DOI 10.1002/glia.22652
   Booth LN, 2016, MOL CELL, V62, P728, DOI 10.1016/j.molcel.2016.05.013
   Buendia I, 2016, PHARMACOL THERAPEUT, V157, P84, DOI 10.1016/j.pharmthera.2015.11.003
   Bukhari SNA, 2018, INT J BIOL MACROMOL, V120, P1682, DOI [10.1016/j.fibiomac.2018.09.188, 10.1016/j.ijbiomac.2018.09.188]
   Calabriso N, 2016, MOLECULES, V21, DOI 10.3390/molecules21091147
   Calcerrada P, 2011, CURR PHARM DESIGN, V17, P3905, DOI 10.2174/138161211798357719
   Chatterjee C, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091211
   Chen J, 2017, FOOD FUNCT, V8, P4414, DOI [10.1039/C7FO00701A, 10.1039/c7fo00701a]
   De Mejia E, 2006, SEX REPROD MENOP, V4, P91, DOI [DOI 10.1016/J.SRAM.2006.08.012, 10.1016/j.sram.2006.08.012]
   de Queirós LD, 2020, APPL MICROBIOL BIOT, V104, P10019, DOI 10.1007/s00253-020-10986-1
   Du ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079698
   F.J. Chen, 2013, FOOD SCI HUM WELL, V2, P46
   Fan J, 2017, CARBOHYD POLYM, V157, P629, DOI 10.1016/j.carbpol.2016.10.040
   Guo K, 2020, CHEMOSPHERE, V249, DOI 10.1016/j.chemosphere.2020.125858
   Höhn A, 2017, REDOX BIOL, V11, P482, DOI 10.1016/j.redox.2016.12.001
   Izumi T, 2000, J NUTR, V130, P1695, DOI 10.1093/jn/130.7.1695
   Kano M, 2016, NUTRIENTS, V8, DOI 10.3390/nu8080514
   Katayama S, 2014, J AGR FOOD CHEM, V62, P3563, DOI 10.1021/jf405416s
   Kim DB, 2016, FOOD CHEM, V194, P920, DOI 10.1016/j.foodchem.2015.08.094
   Kok CR, 2018, NUTR REV, V76, P4, DOI 10.1093/nutrit/nuy056
   Kong SZ, 2018, MAR DRUGS, V16, DOI 10.3390/md16060181
   Kumar BV, 2015, J FOOD SCI TECH MYS, V52, P6112, DOI 10.1007/s13197-015-1795-2
   Larsson L, 2019, PHYSIOL REV, V99, P427, DOI 10.1152/physrev.00061.2017
   Leonel C, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-49
   Li F, 2020, FOOD SCI NUTR, V8, P379, DOI 10.1002/fsn3.1318
   Li J, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060849
   Li YN, 2019, J MOL MED, V97, P541, DOI 10.1007/s00109-019-01759-z
   Lim J, 2015, ENDOCRINOLOGY, V156, P3329, DOI 10.1210/en.2015-1206
   Lin L, 2017, BMC IMMUNOL, V18, DOI 10.1186/s12865-016-0187-3
   Loboda A, 2016, CELL MOL LIFE SCI, V73, P3221, DOI 10.1007/s00018-016-2223-0
   LOVELL CR, 1987, BRIT J DERMATOL, V117, P419, DOI 10.1111/j.1365-2133.1987.tb04921.x
   Luo SL, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/9146528
   Marazza JA, 2012, J FUNCT FOODS, V4, P594, DOI 10.1016/j.jff.2012.03.005
   Murota K, 2002, J NUTR, V132, P1956, DOI 10.1093/jn/132.7.1956
   Nguyen H P, 2015, Skin Therapy Lett, V20, P1
   Sajadimajd S, 2018, CURR CANCER DRUG TAR, V18, P538, DOI 10.2174/1568009617666171002144228
   Singh BP, 2014, PEPTIDES, V54, P171, DOI 10.1016/j.peptides.2014.01.022
   Sinha R. J., 2009, Indian Journal of Cancer, V46, P146
   Spencer RP, 1996, MED HYPOTHESES, V46, P59, DOI 10.1016/S0306-9877(96)90000-6
   Tajiri K, 2013, WORLD J GASTROENTERO, V19, P8459, DOI 10.3748/wjg.v19.i46.8459
   Takagi A, 2015, INT J MOL SCI, V16, P10907, DOI 10.3390/ijms160510907
   Tsikas D, 2017, ANAL BIOCHEM, V524, P13, DOI 10.1016/j.ab.2016.10.021
   Turner VM, 2017, BIOGERONTOLOGY, V18, P723, DOI 10.1007/s10522-017-9707-7
   Vandenbussche F, 2017, J VIROL METHODS, V246, P90, DOI 10.1016/j.jviromet.2017.04.014
   Wang WY, 2005, COMPR REV FOOD SCI F, V4, P63, DOI 10.1111/j.1541-4337.2005.tb00075.x
   Wang Xin, 2017, Adv Food Nutr Res, V82, P117, DOI 10.1016/bs.afnr.2016.12.006
   Wang YY, 2018, CAN J MICROBIOL, V64, P327, DOI 10.1139/cjm-2017-0716
   Wyss-Coray T, 2016, NATURE, V539, P180, DOI 10.1038/nature20411
   Xing GL, 2017, J AGR FOOD CHEM, V65, P11125, DOI 10.1021/acs.jafc.7b04456
   Zhang RF, 2012, ANAL BIOCHEM, V427, P116, DOI 10.1016/j.ab.2012.05.008
   Zhao X, 2019, J DAIRY SCI, V102, P5899, DOI 10.3168/jds.2018-16033
   Zhou XR, 2019, J DAIRY SCI, V102, P9570, DOI 10.3168/jds.2019-16840
   Zhu YY, 2020, APPL MICROBIOL BIOT, V104, P5759, DOI 10.1007/s00253-020-10649-1
NR 54
TC 11
Z9 11
U1 8
U2 55
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1756-4646
EI 2214-9414
J9 J FUNCT FOODS
JI J. Funct. Food.
PD 2021 MAR
PY 2021
VL 78
AR 104386
DI 10.1016/j.jff.2021.104386
EA FEB 2021
PG 14
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA QQ3IG
UT WOS:000624417200001
OA gold
DA 2024-02-19
ER

PT J
AU Gao, XP
   Liu, J
   Luo, YN
   Lei, Y
   Long, WW
   Wang, K
   Zhou, J
   Lei, M
   Yang, N
   Zou, HY
   Huang, FH
   Wan, RL
AF Gao, Xiaoping
   Liu, Jun
   Luo, Yuanning
   Lei, Yu
   Long, Wenwen
   Wang, Kai
   Zhou, Jian
   Lei, Ming
   Yang, Nan
   Zou, Hongyu
   Huang, Feihong
   Wan, Runlan
TI Various Fractions of Alcoholic Extracts from<i> Dendrobium</i><i>
   nobile</i> Functionalized Antioxidation and Antiaging in
   D-Galactose-Induced Aging Mice
SO FRONTIERS IN BIOSCIENCE-LANDMARK
LA English
DT Article
DE antioxidation; antiaging; Dendrobium nobile Lindl; extracts; gut
   microbiota
ID OXIDATIVE STRESS; TOTAL FLAVONOIDS; WORKING-MEMORY; GUT MICROBIOTA;
   POLYSACCHARIDES; POLYPHENOLS; METABOLISM; MECHANISMS; EXPRESSION;
   DISEASE
AB Background: The theory of free radical oxidative stress (ROS) is one of the leading theories of ageing, and antioxidants play an important role in antiaging. Dendrobium has always been popular as a natural antioxidant. Methods: This study investigated the effects of various polarity fractions of ethanol extracts from Dendrobium nobile Lindl. (D. nobile) on D-galactose-induced aging mice. D. nobile stems were extracted by ethanol to form the crude extract (EA), which was sequentially extracted by trichloromethane, ethyl acetate, and n-butanol to yield the secondary extracts, named TCM, EAC, and NBA, respectively. EA, TCM, EAC and NBA were intragastrically administered at a dose of 200 mg/kg b.w. to the aging mice induced by D-galactose for 8 weeks. Results: Compared with the aging control group (AC), D. nobile extracts reduced body weight and lipid accumulation and enhanced endurance and immunity by increasing the index of the spleens and thymus. Meanwhile, D. nobile extracts showed antioxidant properties by lowering Malondialdehyde (MDA) levels and increasing the activities of superoxide dismutase (SOD), catalase (CAT), and Glutathione peroxidase (GSH-Px) in the skin, blood, liver, and brain. Furthermore, D. nobile extracts had a good protective effect on the cell structure and function against lesions of the skin, liver, brain, kidney, and ovary of aging mice. In particular, EA and EAC had better antioxidant and antiaging effects, suggesting that the most effective components were flavonoids and polyphenols that existed in EAC. Both EA and EAC downregulated the expression of aging-related genes such as Il1a, Il1b, Il1rn, Ccl3, Ccl4, Fos and Gck in the brain at the transcriptome level. Both EA and EAC reversed the increase in the Firmicutes/Bacteroidota ratio in aging mice, increased the abundance of probiotic bacteria Lactobacillus and Muribaculum, and decreased the abundance of pathogenic bacteria such as Staphylococcus, Corynebacterium and Brevibacterium. Conclusions: The EA and EAC extracts of D. nobile have better effects on immunity improvement, antioxidation and antiaging by remodelling the intestinal microecosystem and downregulating the expression of age-promoting genes in the brain. D. nobile, especially EA and EAC extracts, could be used as an antiaging drug or functional food.
C1 [Gao, Xiaoping; Luo, Yuanning; Lei, Yu; Wan, Runlan] Southwest Med Univ, Affiliated Hosp, Dept Oncol, Luzhou 646000, Sichuan, Peoples R China.
   [Gao, Xiaoping; Lei, Ming] Southwest Med Univ, Key Lab Med Electrophysiol, Minist Educ, Luzhou 646000, Sichuan, Peoples R China.
   [Gao, Xiaoping; Lei, Ming] Southwest Med Univ, Inst Cardiovasc Res, Med Electrophysiol Key Lab Sichuan Prov, Luzhou 646000, Sichuan, Peoples R China.
   [Liu, Jun] Harbin Inst Technol HIT, Sch Comp Sci & Technol, Harbin 150000, Heilongjiang, Peoples R China.
   [Long, Wenwen; Yang, Nan; Zou, Hongyu; Huang, Feihong] Southwest Med Univ, Sch Pharm, Luzhou 646000, Sichuan, Peoples R China.
   [Wang, Kai] Southwest Med Univ, Res Ctr Preclin Med, Luzhou 646000, Sichuan, Peoples R China.
   [Zhou, Jian] Southwest Med Univ, Affiliated Hosp, Pathol Dept, Luzhou 646000, Sichuan, Peoples R China.
C3 Southwest Medical University; Southwest Medical University; Southwest
   Medical University; Harbin Institute of Technology; Southwest Medical
   University; Southwest Medical University; Southwest Medical University
RP Wan, RL (corresponding author), Southwest Med Univ, Affiliated Hosp, Dept Oncol, Luzhou 646000, Sichuan, Peoples R China.; Huang, FH (corresponding author), Southwest Med Univ, Sch Pharm, Luzhou 646000, Sichuan, Peoples R China.
EM huangfeihong@swmu.edu.cn; WanRunlan@swmu.edu.cn
RI Lei, Ming/JAD-1050-2023
FU Key Research and Development Project from the Science & Technology
   Department of Sichuan Province; Science & Technology Program from the
   Administration for Market Regulation of Sichuan Province [2019YFS0176];
   Sichuan Provincial College Student Innovation and Entrepreneurship
   Training Program [SCSJ2021009]; Strategy Project of Luzhou Science &
   Technology Bureau [S202110632237]; Open Fund of the Key Laboratory of
   Medical Electrophysiology of Ministry of Education and Sichuan Province,
   China [2017CDLZ-S01]; University-level Science and Technology Program of
   Southwest Medical University [KeyME-2020-001];  [2019ZQN023]
FX This research was funded by the Key Research and Development Project
   from the Science & Technology Department of Sichuan Province (Grant No.
   2019YFS0176), Science & Technology Program from the Administration for
   Market Regulation of Sichuan Province (Grant No. SCSJ2021009), Sichuan
   Provincial College Student Inno-vation and Entrepreneurship Training
   Program (Grant No. S202110632237), Strategy Project of Luzhou Science &
   Technology Bureau (Grant No. 2017CDLZ-S01), Open Fund of the Key
   Laboratory of Medical Electrophysiol-ogy of Ministry of Education and
   Sichuan Province, China (No. KeyME-2020-001), and University-level
   Science and Technology Program of Southwest Medical University (Grant
   No. 2019ZQN023).
CR Ali T, 2015, J PINEAL RES, V58, P71, DOI 10.1111/jpi.12194
   Bárcena C, 2019, NAT MED, V25, P1234, DOI 10.1038/s41591-019-0504-5
   Barroso FAL, 2021, MICROORGANISMS, V9, DOI 10.3390/microorganisms9010107
   Bravo L, 1998, NUTR REV, V56, P317, DOI 10.1111/j.1753-4887.1998.tb01670.x
   Bukovsky A, 2015, REPROD BIOL ENDOCRIN, V13, DOI 10.1186/s12958-015-0001-8
   Cheng NL, 2015, AGING CELL, V14, P200, DOI 10.1111/acel.12294
   Cui MZ, 2006, CHINESE J COMP MED, P118
   Fei Wen, 2015, Chinese Journal of Applied and Environmental Biology, V21, P623, DOI 10.3724/SP.J.1145.2015.01047
   Fusco D, 2007, CLIN INTERV AGING, V2, P377
   Gao Y, 2021, FOOD FUNCT, V12, P373, DOI [10.1039/d0fo02794d, 10.1039/D0FO02794D]
   Hodges H, 1996, NEUROSCIENCE, V72, P959, DOI 10.1016/0306-4522(96)00004-8
   Hu Jian-mei, 2014, Zhong Yao Cai, V37, P130
   Huang Qin, 2014, Chinese Journal of Applied and Environmental Biology, V20, P438, DOI 10.3724/SP.J.1145.2014.04028
   Jin SL, 2012, FOOD CHEM TOXICOL, V50, P3814, DOI 10.1016/j.fct.2012.07.046
   Keller JN, 2006, AGEING RES REV, V5, P1, DOI 10.1016/j.arr.2005.06.002
   Kondratova AA, 2012, NAT REV NEUROSCI, V13, P325, DOI 10.1038/nrn3208
   Li He, 2019, Zhongguo Zhong Yao Za Zhi, V44, P4677, DOI 10.19540/j.cnki.cjcmm.20190510.401
   LI YP, 2018, CHINA PHARMACY, V29, P330, DOI DOI 10.6039/j.issn.1001-0408.2018.03.10
   [林为艺 Lin Weiyi], 2016, [中药药理与临床, Pharmacology and Clinics of Chinese Materia Medica], V32, P138
   [令狐楚 Linghu Chu], 2021, [中草药, Chinese Traditional and Herbal Drugs], V52, P7693
   Liu CS, 2016, APPL MICROBIOL BIOT, V100, P1421, DOI 10.1007/s00253-015-7039-6
   Liu LM, 2008, DIGEST DIS SCI, V53, P1316, DOI 10.1007/s10620-007-9994-y
   Liu LF, 2021, ANAL BIOANAL CHEM, V413, P1485, DOI 10.1007/s00216-020-03118-1
   Moldogazieva NT, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/3085756
   Norheim KB, 2011, RHEUMATOLOGY, V50, P1009, DOI 10.1093/rheumatology/keq454
   Rehman SU, 2017, MOL NEUROBIOL, V54, P255, DOI 10.1007/s12035-015-9604-5
   Remigante A, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23147781
   Remigante A, 2022, J CELL PHYSIOL, V237, P1586, DOI 10.1002/jcp.30632
   Ren Y.e.a., 2022, IMETA, V1, P12
   Sato N, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.02174
   Sbisa AM, 2017, NEUROBIOL LEARN MEM, V144, P147, DOI 10.1016/j.nlm.2017.07.010
   Schafer MJ, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.133668
   Shi B. S., 2017, J KUNMING MED U, V38, P124, DOI [10.3969/j.issn.1003-4706.2017.10.027, DOI 10.3969/J.ISSN.1003-4706.2017.10.027]
   Singh S, 2017, WORLD J GASTROENTERO, V23, P6549, DOI 10.3748/wjg.v23.i36.6549
   Sun LL, 2020, J DAIRY SCI, V103, P7851, DOI 10.3168/jds.2020-18187
   Vitetta L, 2014, INFLAMMOPHARMACOLOGY, V22, P69, DOI 10.1007/s10787-014-0199-7
   Wang R, 2021, MOLECULES, V26, P1
   Wu YY, 2018, BIOMED PHARMACOTHER, V101, P953, DOI 10.1016/j.biopha.2018.03.030
   Wyss-Coray T, 2016, NATURE, V539, P180, DOI 10.1038/nature20411
   Xiao Y, 2021, MICROBIOME, V9, DOI 10.1186/s40168-021-01108-8
   Xiong TW, 2021, BRAIN RES, V1771, DOI 10.1016/j.brainres.2021.147647
   Xu YY, 2017, J PHARM PHARMACOL, V69, P1409, DOI 10.1111/jphp.12778
   Zhang H, 2018, FRONT AGING NEUROSCI, V10, P1
   [张晓敏 Zhang Xiaomin], 2014, [中国现代应用药学, Chinese Journal of Modern Applied Pharmacy], V31, P895
   Zhang XQ, 2020, J FOOD BIOCHEM, V44, DOI 10.1111/jfbc.13509
   Zhang Y, 2021, BIOMED PHARMACOTHER, V137, DOI 10.1016/j.biopha.2021.111307
   Zhao JC, 2018, FOOD FUNCT, V9, P917, DOI [10.1039/c7fo01574g, 10.1039/C7FO01574G]
   Zhao XY, 2017, BIOMED PHARMACOTHER, V94, P72, DOI 10.1016/j.biopha.2017.07.096
   Zhou DD, 2021, OXID MED CELL LONGEV, V2021, DOI 10.1155/2021/9932218
   [朱庆磊 Zhu Qinglei], 2003, [中国老年学杂志, Chinese Journal of Gerontology], V23, P448
NR 50
TC 3
Z9 3
U1 10
U2 34
PU IMR PRESS
PI ROBINSON
PA 112 ROBINSON RD, ROBINSON, SINGAPORE
SN 2768-6701
EI 2768-6698
J9 FRONT BIOSCI-LANDMRK
JI Front. Biosci.
PD NOV 3
PY 2022
VL 27
IS 11
AR 315
DI 10.31083/j.fbl2711315
PG 13
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA 8A3EZ
UT WOS:000916126200011
PM 36472113
OA gold
DA 2024-02-19
ER

PT J
AU Yin, X
   Li, YS
   Ye, SZ
   Zhang, T
   Zhang, YW
   Xi, Y
   Tang, HB
AF Yin, Xin
   Li, Yu-Sang
   Ye, Sha-Zhou
   Zhang, Ting
   Zhang, Yi-Wen
   Xi, Yang
   Tang, He-Bin
TI Promotion Effect of Coexposure to a High-Fat Diet and
   Nano-Diethylnitrosamine on the Progression of Fatty Liver Malignant
   Transformation into Liver Cancer
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE high-fat diet; nano-diethylnitrosamine; fatty liver; liver cancer;
   transcriptomics
ID BETA-CATENIN; HEPATOCELLULAR-CARCINOMA; INFLAMMATION; OBESITY; INJURY;
   INHIBITION; FIBROSIS; LEVEL; MODEL; CDK4
AB Overconsumption of high-fat foods increases the risk of fatty liver disease (FLD) and liver cancer with long pathogenic cycles. It is also known that the intake of the chemical poison nitrosamine and its nanopreparations can promote the development of liver injuries, such as FLD, and hepatic fibrosis, and significantly shorten the formation time of the liver cancer cycle. The present work confirmed that the coexposure of a high-fat diet (HFD) and nano-diethylnitrosamine (nano-DEN) altered the tumor microenvironment and studied the effect of this coexposure on the progression of fatty liver malignant transformation into liver cancer. Gene transcriptomics and immunostaining were used to evaluate the tumor promotion effect of the coexposure in mice. After coexposure treatment, tumor nodules were obviously increased, and inflammation levels were elevated. The liver transcriptomics analysis showed that the expression levels of inflammatory, fatty, and fibrosis-related factors in the coexposed group were increased in comparison with the nano-DEN- and high-fat-alone groups. The Kyoto Encyclopedia of Genes and Genomes (KEGG) results showed that coexposure aggravated the high expression of genes related to the carcinomatous pathway and accelerated the formation of the tumor microenvironment. The immunohistochemical staining results showed that the coexposure significantly increased the abnormal changes in proteins related to inflammation, proliferation, aging, and hypoxia in mouse liver tissues. The coexposure of high fat and nano-DEN aggravated the process of steatosis and carcinogenesis. In conclusion, the habitual consumption of pickled foods containing nitrosamines in a daily HFD significantly increases the risk of liver pathology lesions progressing from FLD to liver cancer.
C1 [Yin, Xin; Li, Yu-Sang; Zhang, Ting; Zhang, Yi-Wen; Tang, He-Bin] South Cent Minzu Univ, Sch Pharmaceut Sci, Lab Hepatopharmacol & Ethnopharmacol, 182 Minyuan Rd, Wuhan 430074, Peoples R China.
   [Ye, Sha-Zhou; Xi, Yang] Ningbo Univ, Inst Biochem & Mol Biol, Sch Med, 818 Fenghua Rd, Ningbo 315211, Peoples R China.
C3 South Central Minzu University; Ningbo University
RP Tang, HB (corresponding author), South Cent Minzu Univ, Sch Pharmaceut Sci, Lab Hepatopharmacol & Ethnopharmacol, 182 Minyuan Rd, Wuhan 430074, Peoples R China.; Xi, Y (corresponding author), Ningbo Univ, Inst Biochem & Mol Biol, Sch Med, 818 Fenghua Rd, Ningbo 315211, Peoples R China.
EM kno521521@163.com; liys2006@mail.scuec.edu.cn; yeshazhou@foxmail.com;
   kinima988@outlook.com; 2021120621@mail.scuec.edu.cn; xiyang@nbu.edu.cn;
   hbtang2006@mail.scuec.edu.cn
OI Yin, Xin/0000-0002-8768-0234; Tang, He-Bin/0000-0002-2673-7882
FU We would like to thank the specialists and the staff members involved in
   the research for their valuable advice.
FX We would like to thank the specialists and the staff members involved in
   the research for their valuable advice.
CR Ando A, 2019, CANCER SCI, V110, P1959, DOI 10.1111/cas.14027
   Asgharpour A, 2016, J HEPATOL, V65, P579, DOI 10.1016/j.jhep.2016.05.005
   Boudina S, 2014, EXP PHYSIOL, V99, P1168, DOI 10.1113/expphysiol.2014.081414
   Cai Charles, 2017, React Oxyg Species (Apex), V3, P218
   Chen Fengzhen, 2020, Yichuan, V42, P799, DOI 10.16288/j.yczz.20-080
   Desjonqueres E, 2022, LIVER INT, V42, P492, DOI 10.1111/liv.15152
   Dickson MA, 2014, CLIN CANCER RES, V20, P3379, DOI 10.1158/1078-0432.CCR-13-1551
   García-García VA, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10081906
   Guo XQ, 2020, DATABASE-OXFORD, DOI 10.1093/database/baaa055
   Healy ME, 2016, SCI REP-UK, V6, DOI 10.1038/srep22292
   Hernandez-Segura A, 2018, TRENDS CELL BIOL, V28, P436, DOI 10.1016/j.tcb.2018.02.001
   Kaidi A, 2007, NAT CELL BIOL, V9, P210, DOI 10.1038/ncb1534
   Karin M, 2016, NATURE, V529, P307, DOI 10.1038/nature17039
   Kawano Y, 2013, J GASTROENTEROL, V48, P434, DOI 10.1007/s00535-013-0758-5
   Kim MH, 2018, FREE RADICAL BIO MED, V123, P27, DOI 10.1016/j.freeradbiomed.2018.05.061
   Kisseleva T, 2021, NAT REV GASTRO HEPAT, V18, P151, DOI 10.1038/s41575-020-00372-7
   Krishna Murli, 2021, Clin Liver Dis (Hoboken), V17, P222, DOI 10.1002/cld.1014
   Lai YS, 2016, J AGR FOOD CHEM, V64, P2062, DOI 10.1021/acs.jafc.5b06159
   Li WX, 2016, SCI REP-UK, V6, DOI 10.1038/srep24580
   Li YS, 2016, TOXICOL RES-UK, V5, P210, DOI 10.1039/c5tx00317b
   Li YS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129701
   Li YS, 2012, J PHARMACOL SCI, V118, P43, DOI 10.1254/jphs.11160FP
   Liu HJ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001249
   Llovet JM, 2015, NAT REV CLIN ONCOL, V12, P408, DOI [10.1038/nrclinonc.2015.103, 10.1038/nrclinonc.2015.121]
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014
   Marengo A, 2016, ANNU REV MED, V67, P103, DOI 10.1146/annurev-med-090514-013832
   Matsumoto M, 2013, INT J EXP PATHOL, V94, P93, DOI 10.1111/iep.12008
   Monga SP, 2015, GASTROENTEROLOGY, V148, P1294, DOI 10.1053/j.gastro.2015.02.056
   Nakagawa H, 2009, INT J CANCER, V125, P2264, DOI 10.1002/ijc.24720
   Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485
   Neuschwander-Tetri BA, 2010, HEPATOLOGY, V52, P774, DOI 10.1002/hep.23719
   Park SJ, 2016, FOOD CHEM TOXICOL, V93, P5, DOI 10.1016/j.fct.2016.04.017
   Pirgon Ö, 2013, J CLIN RES PEDIATR E, V5, P33, DOI 10.4274/Jcrpe.825
   Povero D, 2010, HISTOL HISTOPATHOL, V25, P1075, DOI 10.14670/HH-25.1075
   Qu JL, 2020, INT J BIOL MACROMOL, V161, P24, DOI 10.1016/j.ijbiomac.2020.05.196
   Sekiya T, 2004, J BIOL CHEM, V279, P6840, DOI 10.1074/jbc.M310876200
   Serra S, 2018, J CLIN PATHOL, V71, P853, DOI 10.1136/jclinpath-2018-205216
   Sherr CJ, 2016, CANCER DISCOV, V6, P353, DOI 10.1158/2159-8290.CD-15-0894
   Sun BC, 2013, FRONT MED-PRC, V7, P242, DOI 10.1007/s11684-013-0256-4
   Sun BC, 2012, J HEPATOL, V56, P704, DOI 10.1016/j.jhep.2011.09.020
   Sung H, 2021, CA-CANCER J CLIN, V71, P209, DOI 10.3322/caac.21660
   Wong VWS, 2009, INT J CANCER, V124, P2766, DOI 10.1002/ijc.24281
   Wu TZ, 2021, INNOVATION-AMSTERDAM, V2, DOI 10.1016/j.xinn.2021.100141
   Yang Yoon Mee, 2015, Curr Pathobiol Rep, V3, P253
   Yang ZF, 2021, ACTA BIOMATER, V135, P582, DOI 10.1016/j.actbio.2021.08.054
   Yin X, 2014, J CLIN ENDOCR METAB, V99, pE209, DOI 10.1210/jc.2013-3042
   Yin X, 2022, FRONT PHARMACOL, V13, DOI 10.3389/fphar.2022.913098
   Yu XJ, 2022, CELL MOL GASTROENTER, V13, P1701, DOI 10.1016/j.jcmgh.2022.02.013
   Zhang T, 2022, J ETHNOPHARMACOL, V285, DOI 10.1016/j.jep.2021.114917
   Zhang WK, 2017, NANOMED-NANOTECHNOL, V13, P701, DOI 10.1016/j.nano.2016.09.017
NR 51
TC 0
Z9 0
U1 4
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1661-6596
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD SEP
PY 2023
VL 24
IS 18
AR 14162
DI 10.3390/ijms241814162
PG 20
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA S7BH6
UT WOS:001072679200001
PM 37762463
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Naudí, A
   Jové, M
   Cacabelos, D
   Ayala, V
   Cabre, R
   Caro, P
   Gomez, J
   Portero-Otín, M
   Barja, G
   Pamplona, R
AF Naudi, Alba
   Jove, Mariona
   Cacabelos, Daniel
   Ayala, Victoria
   Cabre, Rosanna
   Caro, Pilar
   Gomez, Jose
   Portero-Otin, Manuel
   Barja, Gustavo
   Pamplona, Reinald
TI Formation of <i>S</i>-(carboxymethyl)-cysteine in rat liver
   mitochondrial proteins: effects of caloric and methionine restriction
SO AMINO ACIDS
LA English
DT Article
DE Aging; Carboxymethylated proteins; Dietary restriction; Oxidative
   stress; Protein damage; Protein cysteine content; Sulfhydryl groups
ID GLYCATION END-PRODUCTS; OXIDATIVE STRESS; LIFE-SPAN; ANTIOXIDANT
   DEFENSE; REDOX STATE; DAMAGE; LONGEVITY; CYSTEINE; GENERATION; AGE
AB Maillard reaction contributes to the chemical modification and cross-linking of proteins. This process plays a significant role in the aging process and determination of animal longevity. Oxidative conditions promote the Maillard reaction. Mitochondria are the primary site of oxidants due to the reactive molecular species production. Mitochondrial proteome cysteine residues are targets of oxidative attack due to their specific chemistry and localization. Their chemical, non-enzymatic modification leads to dysfunctional proteins, which entail cellular senescence and organismal aging. Previous studies have consistently shown that caloric and methionine restrictions, nutritional interventions that increase longevity, decrease the rate of mitochondrial oxidant production and the physiological steady-state levels of markers of oxidative damage to macromolecules. In this scenario, we have detected S-(carboxymethyl)-cysteine (CMC) as a new irreversible chemical modification in mitochondrial proteins. CMC content in mitochondrial proteins significantly correlated with that of the lysine-derived analog N (epsilon)-(carboxymethyl)-lysine. The concentration of CMC is, however, one order of magnitude lower compared with CML likely due in part to the lower content of cysteine with respect to lysine of the mitochondrial proteome. CMC concentrations decreases in liver mitochondrial proteins of rats subjected to 8.5 and 25 % caloric restriction, as well as in 40 and 80 % methionine restriction. This is associated with a concomitant and significant increase in the protein content of sulfhydryl groups. Data presented here evidence that CMC, a marker of Cys-AGE formation, could be candidate as a biomarker of mitochondrial damage during aging.
C1 [Naudi, Alba; Jove, Mariona; Cacabelos, Daniel; Ayala, Victoria; Cabre, Rosanna; Portero-Otin, Manuel; Pamplona, Reinald] Univ Lleida IRBLleida, Dept Expt Med, Fac Med, Lleida 25008, Spain.
   [Caro, Pilar; Gomez, Jose; Barja, Gustavo] Univ Complutense, Dept Anim Physiol 2, E-28040 Madrid, Spain.
C3 Universitat de Lleida; Complutense University of Madrid
RP Pamplona, R (corresponding author), Univ Lleida IRBLleida, Dept Expt Med, Fac Med, St Montserrat Roig 2, Lleida 25008, Spain.
EM reinald.pamplona@mex.udl.cat
RI Barja, Gustavo/AAA-5903-2019; Naudí, Alba/B-5594-2009; Ayala, Maria
   Victoria/A-7391-2010; Pamplona, Reinald/A-7359-2010; Portero-Otin,
   Manuel/B-7122-2009; Jové, Mariona/M-9104-2016; Gustavo,
   Barja/B-5591-2012; Gomez, Jose/G-9705-2015
OI Barja, Gustavo/0000-0001-5736-4735; Naudí, Alba/0000-0003-0699-1004;
   Ayala, Maria Victoria/0000-0002-1496-966X; Pamplona,
   Reinald/0000-0003-4337-6107; Portero-Otin, Manuel/0000-0002-1823-0299;
   Jové, Mariona/0000-0001-5577-6162; Gomez, Jose/0000-0003-1758-4746;
   Caro, Pilar/0000-0002-7531-3234
FU Spanish Ministry of Science and Innovation [BFU2008-00335/BFI,
   BFU2011-23888, BFU2009-11879/BFI]; BSCH-UCM; Spanish Ministry of Health
   [PI11/01532]; Generalitat of Catalunya [2009SGR00735]; Ministry of
   Education and Science
FX This study was supported in part by I + D grants from the Spanish
   Ministry of Science and Innovation (BFU2008-00335/BFI and
   BFU2011-23888), and BSCH-UCM (2009-2010) to G. B; grant from the Spanish
   Ministry of Health (PI11/01532) to M.P.O; and grants from the Spanish
   Ministry of Science and Innovation (BFU2009-11879/BFI), and the
   Generalitat of Catalunya (2009SGR00735) to R. P. P. Caro and J. Gomez
   received predoctoral fellowships from the Ministry of Education and
   Science. We thank David Argiles for excellent technical assistance. The
   authors are grateful to the anonymous reviewers for criticisms and
   suggestions, which improved the manuscript. No competing financial
   interests exist.
CR AGARWAL S, 1994, MECH AGEING DEV, V75, P11, DOI 10.1016/0047-6374(94)90024-8
   Ahmed N, 2003, INVEST OPHTH VIS SCI, V44, P5287, DOI 10.1167/iovs.03-0573
   Alt N, 2004, ARCH BIOCHEM BIOPHYS, V425, P200, DOI 10.1016/j.abb.2004.03.012
   Ayala V, 2007, J GERONTOL A-BIOL, V62, P352, DOI 10.1093/gerona/62.4.352
   Bota DA, 2001, MITOCHONDRION, V1, P33, DOI 10.1016/S1567-7249(01)00005-8
   Caro P, 2008, BIOGERONTOLOGY, V9, P183, DOI 10.1007/s10522-008-9130-1
   Dean RT, 1997, BIOCHEM J, V324, P1
   Dröge W, 2002, EXP GERONTOL, V37, P1333, DOI 10.1016/S0531-5565(02)00175-4
   Fu MX, 1996, J BIOL CHEM, V271, P9982, DOI 10.1074/jbc.271.17.9982
   Hamada Y, 1996, BIOCHEM BIOPH RES CO, V228, P539, DOI 10.1006/bbrc.1996.1695
   Hulbert AJ, 2007, PHYSIOL REV, V87, P1175, DOI 10.1152/physrev.00047.2006
   Hurd TR, 2005, ANTIOXID REDOX SIGN, V7, P999, DOI 10.1089/ars.2005.7.999
   Jolly RD, 2002, ARCH GERONTOL GERIAT, V34, P205, DOI 10.1016/S0167-4943(01)00219-9
   Kemp M, 2008, FREE RADICAL BIO MED, V44, P921, DOI 10.1016/j.freeradbiomed.2007.11.008
   López-Lluch G, 2006, P NATL ACAD SCI USA, V103, P1768, DOI 10.1073/pnas.0510452103
   Martínez A, 2010, BRAIN PATHOL, V20, P281, DOI 10.1111/j.1750-3639.2009.00326.x
   MIQUEL J, 1995, EUR J PHARM-ENVIRON, V292, P333, DOI 10.1016/0926-6917(95)90041-1
   Monnier VM, 2003, ARCH BIOCHEM BIOPHYS, V419, P1, DOI 10.1016/j.abb.2003.08.014
   Moosmann B, 2008, AGING CELL, V7, P32, DOI 10.1111/j.1474-9726.2007.00349.x
   Moskovitz J, 2001, P NATL ACAD SCI USA, V98, P12920, DOI 10.1073/pnas.231472998
   Mostafa AA, 2007, MOL CELL BIOCHEM, V302, P35, DOI 10.1007/s11010-007-9422-9
   Nagai R, 2007, J BIOL CHEM, V282, P34219, DOI 10.1074/jbc.M703551200
   Negre-Salvayre A, 2009, ANTIOXID REDOX SIGN, V11, P3071, DOI 10.1089/ARS.2009.2484
   Pamplona R, 2011, BIOGERONTOLOGY
   Pamplona R, 2008, BBA-BIOENERGETICS, V1777, P1249, DOI 10.1016/j.bbabio.2008.07.003
   Pamplona R, 2007, AGEING RES REV, V6, P189, DOI 10.1016/j.arr.2007.06.002
   Pamplona R, 2006, BBA-BIOENERGETICS, V1757, P496, DOI 10.1016/j.bbabio.2006.01.009
   Portero-Otín M, 1999, DIABETES, V48, P2215, DOI 10.2337/diabetes.48.11.2215
   Rabbani N, 2008, BIOCHEM SOC T, V36, P1045, DOI 10.1042/BST0361045
   Rebrin I, 2004, EXP GERONTOL, V39, P1513, DOI 10.1016/j.exger.2004.08.014
   Requena JR, 2001, P NATL ACAD SCI USA, V98, P69, DOI 10.1073/pnas.011526698
   Sanz A, 2006, ANTIOXID REDOX SIGN, V8, P582, DOI 10.1089/ars.2006.8.582
   Schindeldecker M, 2011, MECH AGEING DEV, V132, P171, DOI 10.1016/j.mad.2011.03.002
   Schlotterer A, 2009, DIABETES, V58, P2450, DOI 10.2337/db09-0567
   Sohal RS, 2002, FREE RADICAL BIO MED, V33, P37, DOI 10.1016/S0891-5849(02)00856-0
   Stadtman ER, 2004, ARCH BIOCHEM BIOPHYS, V423, P2, DOI 10.1016/j.abb.2003.10.001
   Thornalley PJ, 2003, BIOCHEM J, V375, P581, DOI 10.1042/BJ20030763
   Thorpe SR, 2003, AMINO ACIDS, V25, P275, DOI 10.1007/s00726-003-0017-9
   Wang Y, 2002, THESIS U S CAROLINA
   Zeng JM, 2005, CHEM RES TOXICOL, V18, P1232, DOI 10.1021/tx050074u
NR 40
TC 20
Z9 21
U1 0
U2 18
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0939-4451
J9 AMINO ACIDS
JI Amino Acids
PD FEB
PY 2013
VL 44
IS 2
BP 361
EP 371
DI 10.1007/s00726-012-1339-2
PG 11
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 074ED
UT WOS:000313794600006
PM 22722543
DA 2024-02-19
ER

PT J
AU Choi, MS
   Saxena, A
   Chilukuri, N
AF Choi, Moonsuk S.
   Saxena, Ashima
   Chilukuri, Nageswararao
TI A strategy for the production of soluble human senescence marker
   protein-30 in <i>Escherichia coli</i>
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Senescence marker protein-30 (SMP30); Diisopropyl fluorophosphatase
   (DFPase); Bacterial expression; Molecular chaperones; Solubility;
   Two-step growth
ID RECOMBINANT PROTEINS; TRIGGER FACTOR; DIISOPROPYL PHOSPHOROFLUORIDATE;
   INCLUSION-BODIES; LIVER; PURIFICATION; AGGREGATION; CHAPERONES;
   EXPRESSION; PROMOTES
AB Senescence marker protein-30 (SMP30) has been reported to hydrolyze diisopropyl fluorophosphate (DFP), a surrogate compound of chemical warfare nerve agents. Thus, SMP30 has the potential to be useful as a prophylactic against chemical warfare nerve agent toxicity. Our efforts to generate human SMP30 in bacteria using a variety of expression vectors invariably resulted in insoluble and inactive preparations. In this study, properly folded and active recombinant human SMP30 (rHuSMP30) was produced in Escherichia coli by coexpressing it with molecular chaperones in a combined strategy. The coexpression of rHuSMP30 with GroES/GroEL/Tf at 15 degrees C, combined with the addition of a membrane fluidizer, increased osmolytes, and a two-step expression resulted in the highest enhancement of solubility and DFPase activity. Our results pave the way for exploring the use of rHuSMP30 against organophosphate and nerve agent toxicity. (C) 2010 Elsevier Inc. All rights reserved.
C1 [Choi, Moonsuk S.; Saxena, Ashima] Walter Reed Army Inst Res, Div Bacterial & Rickettsial Dis, Silver Spring, MD 20910 USA.
   [Chilukuri, Nageswararao] Walter Reed Army Inst Res, Div Biochem, Silver Spring, MD 20910 USA.
C3 United States Department of Defense; United States Army; Walter Reed
   Army Institute of Research (WRAIR); United States Department of Defense;
   United States Army; Walter Reed Army Institute of Research (WRAIR)
RP Choi, MS (corresponding author), Walter Reed Army Inst Res, Div Bacterial & Rickettsial Dis, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.
EM moonsuk.choi@amedd.army.mil
FU Defense Threat Reduction Agency [D.0024_07_WR_C]; Department of Defense
   (DOD)
FX This work is supported by a grant from Defense Threat Reduction Agency
   (DTRA, Project No. D.0024_07_WR_C to Dr. N Chilukuri) from the
   Department of Defense (DOD). We also thank Dr. Veeraswamy Manne for
   suggestions with the preparation of the manuscript.
CR ANFINSEN CB, 1972, BIOCHEM J, V128, P737, DOI 10.1042/bj1280737
   Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029
   Billecke SS, 1999, CHEM-BIOL INTERACT, V119, P251, DOI 10.1016/S0009-2797(99)00034-4
   BLUM P, 1992, BIO-TECHNOL, V10, P301, DOI 10.1038/nbt0392-301
   de Marco A, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-32
   Diamant S, 2001, J BIOL CHEM, V276, P39586, DOI 10.1074/jbc.M103081200
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7
   GOLOUBINOFF P, 1989, NATURE, V337, P44, DOI 10.1038/337044a0
   Hannig G, 1998, TRENDS BIOTECHNOL, V16, P54, DOI 10.1016/S0167-7799(97)01155-4
   Hoffmann F, 2004, ADV BIOCHEM ENG BIOT, V89, P143
   Horváth I, 1998, P NATL ACAD SCI USA, V95, P3513, DOI 10.1073/pnas.95.7.3513
   Kandror O, 1997, J BIOL CHEM, V272, P1730, DOI 10.1074/jbc.272.3.1730
   KANDROR O, 1995, EMBO J, V14, P6021, DOI 10.1002/j.1460-2075.1995.tb00290.x
   KIEFHABER T, 1991, BIO-TECHNOL, V9, P825, DOI 10.1038/nbt0991-825
   Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103
   Kondo Y, 2004, FEBS LETT, V570, P57, DOI 10.1016/j.febslet.2004.06.028
   LITTLE JS, 1989, BIOCHEM PHARMACOL, V38, P23, DOI 10.1016/0006-2952(89)90144-5
   Nishihara K, 2000, APPL ENVIRON MICROB, V66, P884, DOI 10.1128/AEM.66.3.884-889.2000
   Schroedel Andrea, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-10
   Shigapova N, 2005, BIOCHEM BIOPH RES CO, V328, P1216, DOI 10.1016/j.bbrc.2005.01.081
   Ventura S, 2006, TRENDS BIOTECHNOL, V24, P179, DOI 10.1016/j.tibtech.2006.02.007
   Warizaya M, 2004, ACTA CRYSTALLOGR D, V60, P2019, DOI 10.1107/S0907444904020608
   WILKINSON DL, 1991, BIO-TECHNOL, V9, P443, DOI 10.1038/nbt0591-443
NR 23
TC 11
Z9 13
U1 0
U2 4
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD MAR 12
PY 2010
VL 393
IS 3
BP 509
EP 513
DI 10.1016/j.bbrc.2010.02.036
PG 5
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 574GW
UT WOS:000275978400031
PM 20152811
DA 2024-02-19
ER

PT J
AU Davis, NM
   Lissner, MM
   Richards, CL
   Chevée, V
   Gupta, AS
   Gherardini, FC
   Schneider, DS
AF Davis, Nicole M.
   Lissner, Michelle M.
   Richards, Crystal L.
   Chevee, Victoria
   Gupta, Avni S.
   Gherardini, Frank C.
   Schneider, David S.
TI Metabolomic Analysis of Diverse Mice Reveals Hepatic Arginase-1 as
   Source of Plasma Arginase in <i>Plasmodium chabaudi</i> Infection
SO MBIO
LA English
DT Article
DE malaria; Plasmodium chabaudi; metabolomics; disease severity; arginine;
   Plasmodium
ID ARYL-HYDROCARBON RECEPTOR; DISEASE TOLERANCE; IMMUNE-RESPONSE; MOUSE
   MODEL; MALARIA; PHENYLALANINE; PATHOGENESIS; DISRUPTION; DEFICIENCY;
   CHILDREN
AB Infections disrupt host metabolism, but the factors that dictate the nature and magnitude of metabolic change are incompletely characterized. To determine how host metabolism changes in relation to disease severity in murine malaria, we performed plasma metabolomics on eight Plasmodium chabaudi-infected mouse strains with diverse disease phenotypes. We identified plasma metabolic biomarkers for both the nature and severity of different malarial pathologies. A subset of metabolic changes, including plasma arginine depletion, match the plasma metabolomes of human malaria patients, suggesting new connections between pathology and metabolism in human malaria. In our malarial mice, liver damage, which releases hepatic arginase-1 (Arg1) into circulation, correlated with plasma arginine depletion. We confirmed that hepatic Arg1 was the primary source of increased plasma arginase activity in our model, which motivates further investigation of liver damage in human malaria patients. More broadly, our approach shows how lever-aging phenotypic diversity can identify and validate relationships between metabolism and the pathophysiology of infectious disease.
   IMPORTANCE Malaria is a severe and sometimes fatal infectious disease endemic to tropical and subtropical regions. Effective vaccines against malaria-causing Plasmodium parasites remain elusive, and malaria treatments often fail to prevent severe disease. Small molecules that target host metabolism have recently emerged as candidates for therapeutics in malaria and other diseases. However, our limited understanding of how metabolites affect pathophysiology limits our ability to develop new metabolite therapies. By providing a rich data set of metabolite-pathology correlations and by validating one of those correlations, our work is an important step toward harnessing metabolism to mitigate disease. Specifically, we showed that liver damage in P. chabaudi-infected mice releases hepatic arginase-1 into circulation, where it may deplete plasma arginine, a candidate malaria therapeutic that mitigates vascular stress. Our data suggest that liver damage may confound efforts to increase levels of arginine in human malaria patients.
C1 [Davis, Nicole M.; Lissner, Michelle M.; Chevee, Victoria; Gupta, Avni S.; Schneider, David S.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA.
   [Richards, Crystal L.; Gherardini, Frank C.] NIAID, Lab Bacteriol, NIH, Rocky Mt Labs, Hamilton, MT USA.
C3 Stanford University; National Institutes of Health (NIH) - USA; NIH
   National Institute of Allergy & Infectious Diseases (NIAID)
RP Schneider, DS (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA.
EM david.schneider@stanford.edu
OI Schneider, David/0000-0002-2391-9963; Chevee,
   Victoria/0009-0002-5936-0302; Davis, Nicole/0000-0002-6602-6399
FU National Science Foundation Graduate Research Fellowship Program
   [DGE-1656518]; National Institutes of Health [T32 AI007328]; Defense
   Advanced Research Projects Agency [W911NF-16-0052]; Stanford Discovery
   Grant; SUMS seed grant; Division of Intramural Research, National
   Institute of Allergy and Infectious Diseases, National Institutes of
   Health, Bethesda, MD, USA
FX We thank Peter Murray for providing Arg1 null primers for genotyping and
   Karolina Krasinska and Beryl Xia at Stanford University Mass
   Spectrometry (SUMS) for data and method development. Thanks to Tsukushi
   Kamiya and to members of the Schneider, Monack, and Sonnenburg labs for
   helpful discussions and reagents. Thanks to Johanna Daily for providing
   metabolic data. This work was supported by the following funding
   sources: National Science Foundation Graduate Research Fellowship
   Program (DGE-1656518, N.M.D.) , National Institutes of Health T32
   AI007328 (N.M.D. and M.M.L.) , Defense Advanced Research Projects Agency
   W911NF-16-0052 (D.S.S.) , a Stanford Discovery Grant (D.S.S.) , and a
   SUMS seed grant (N.M.D. and D.S.S.) . This research was supported by the
   Division of Intramural Research, National Institute of Allergy and
   Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
   Funders were not involved in study design, data collection, analysis, or
   interpretation, writing of the manuscript or decision on where to submit
   for publication. We declare that we have no competing interests with the
   contents of this article. The content is solely the responsibility of
   the authors and does not necessarily represent the official views of the
   National Institutes of Health.
CR Alkaitis MS, 2016, J INFECT DIS, V214, P1840, DOI 10.1093/infdis/jiw452
   Andrianova NV, 2020, METABOLITES, V10, DOI 10.3390/metabo10040142
   Ballantyne LL, 2016, MOL GENET METAB REP, V9, P54, DOI 10.1016/j.ymgmr.2016.10.003
   Ballantyne LL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125967
   Beri D, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37816-9
   Bessede A, 2014, NATURE, V511, P184, DOI 10.1038/nature13323
   Brant F, 2014, INFECT IMMUN, V82, P3127, DOI 10.1128/IAI.01733-14
   Brugat T, 2014, CELL MICROBIOL, V16, P687, DOI 10.1111/cmi.12212
   Cao KAL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-253
   Chau JY, 2013, INFECT IMMUN, V81, P3515, DOI 10.1128/IAI.00380-13
   Churchill GA, 2012, MAMM GENOME, V23, P713, DOI 10.1007/s00335-012-9414-2
   Conroy AL, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw046
   Cordy RJ, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.125156
   Cumnock K, 2018, CURR BIOL, V28, P1635, DOI 10.1016/j.cub.2018.04.009
   de Menezes MN, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44125-2
   El Kasmi KC, 2008, NAT IMMUNOL, V9, P1399, DOI 10.1038/ni.1671
   Elahi S, 2013, NATURE, V504, P158, DOI 10.1038/nature12675
   Elbahesh H, 2016, SCI REP-UK, V6, DOI 10.1038/srep26437
   ELIA M, 1981, BRIT MED J, V282, P351, DOI 10.1136/bmj.282.6261.351
   Enwonwu CO, 1999, QJM-INT J MED, V92, P495, DOI 10.1093/qjmed/92.9.495
   Fletcher JR, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00089-18
   Fritz JH, 2013, INFECT IMMUN, V81, P3500, DOI 10.1128/IAI.00789-13
   Ganeshan K, 2019, CELL, V177, P399, DOI 10.1016/j.cell.2019.01.050
   Gupta S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175686
   Haque A, 2011, INFECT IMMUN, V79, P1882, DOI 10.1128/IAI.01210-10
   Holecek M, 2018, NUTR METAB, V15, DOI 10.1186/s12986-018-0271-1
   Hosten AO., 1990, CLIN METHODS HIST PH, P874
   Ikemoto M, 2001, CLIN CHEM, V47, P946
   Iyer RK, 2002, MOL CELL BIOL, V22, P4491, DOI 10.1128/MCB.22.13.4491-4498.2002
   Knackstedt SL, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aaw0336
   Knottnerus SJG, 2018, REV ENDOCR METAB DIS, V19, P93, DOI 10.1007/s11154-018-9448-1
   Koni PA, 2001, J EXP MED, V193, P741, DOI 10.1084/jem.193.6.741
   Kure S, 2004, MOL GENET METAB, V83, P150, DOI 10.1016/j.ymgme.2004.06.016
   Kurtz SL, 2020, MSPHERE, V5, DOI 10.1128/mSphere.00097-20
   Leist SR, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2483-y
   Leopold SJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43044-6
   Leopold SJ, 2019, J INFECT DIS, V219, P1766, DOI 10.1093/infdis/jiy727
   Lever M, 2010, CLIN BIOCHEM, V43, P732, DOI 10.1016/j.clinbiochem.2010.03.009
   Líndez AAM, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.132975
   Lissner MM, 2020, ELIFE, V9, DOI 10.7554/eLife.60165
   Lopansri BK, 2006, INFECT IMMUN, V74, P3355, DOI 10.1128/IAI.02106-05
   Luan HH, 2019, CELL, V178, P1231, DOI 10.1016/j.cell.2019.07.033
   Mackintosh CL, 2004, TRENDS PARASITOL, V20, P597, DOI 10.1016/j.pt.2004.09.006
   McDonald CR, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan6007
   McHugh KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082865
   McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217
   Melchor SJ, 2020, J IMMUNOL, V204, P3329, DOI 10.4049/jimmunol.2000159
   Miller LH, 2013, NAT MED, V19, P156, DOI 10.1038/nm.3073
   Morris CR, 2005, JAMA-J AM MED ASSOC, V294, P81, DOI 10.1001/jama.294.1.81
   Morris SM, 2016, J NUTR, V146, P2579, DOI 10.3945/jn.115.226621
   Niazi MKK, 2015, DIS MODEL MECH, V8, P1141, DOI 10.1242/dmm.020867
   Noll KE, 2019, CELL HOST MICROBE, V25, P484, DOI 10.1016/j.chom.2019.03.009
   Nzila A, 2005, TRENDS PARASITOL, V21, P292, DOI 10.1016/j.pt.2005.04.002
   Olszewski KL, 2009, CELL HOST MICROBE, V5, P191, DOI 10.1016/j.chom.2009.01.004
   Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000371
   Pietrocola F, 2017, AUTOPHAGY, V13, P567, DOI 10.1080/15548627.2016.1271513
   Reuling IJ, 2018, EBIOMEDICINE, V36, P131, DOI 10.1016/j.ebiom.2018.09.018
   Roberts A, 2007, MAMM GENOME, V18, P473, DOI 10.1007/s00335-007-9045-1
   Rohart F, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005752
   Rubach MP, 2019, INFECT IMMUN, V87, DOI [10.1128/IAI.00655-18, 10.1128/iai.00655-18]
   Sanchez KK, 2018, CELL, V175, P146, DOI 10.1016/j.cell.2018.07.016
   Scaccabarozzi D, 2018, MALARIA J, V17, DOI 10.1186/s12936-017-2159-3
   Schieber AMP, 2015, SCIENCE, V350, P558, DOI 10.1126/science.aac6468
   Shi O, 2001, MOL CELL BIOL, V21, P811, DOI 10.1128/MCB.21.3.811-813.2001
   Spence PJ, 2011, NAT PROTOC, V6, P553, DOI 10.1038/nprot.2011.313
   Stephens R, 2012, TRENDS PARASITOL, V28, P73, DOI 10.1016/j.pt.2011.10.006
   Surowiec I, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv062
   TANAKA K, 1966, P NATL ACAD SCI USA, V56, P236, DOI 10.1073/pnas.56.1.236
   Torres BY, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002436
   Uppal K, 2018, MTBLS664
   Velenosi TJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42992-3
   Wang A, 2018, P NATL ACAD SCI USA, V115, P11042, DOI 10.1073/pnas.1806376115
   Wang A, 2016, CELL, V166, P1512, DOI 10.1016/j.cell.2016.07.026
   Weinberg JB, 2016, SCI REP-UK, V6, DOI 10.1038/srep29151
   WHITE NJ, 1983, NEW ENGL J MED, V309, P61, DOI 10.1056/NEJM198307143090201
   Yeo TW, 2007, J EXP MED, V204, P2693, DOI 10.1084/jem.20070819
   Yeo TW, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004667
   Yeo TW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069587
   Yeo TW, 2009, J INFECT DIS, V200, P1522, DOI 10.1086/644641
NR 79
TC 7
Z9 7
U1 1
U2 4
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD SEP-OCT
PY 2021
VL 12
IS 5
AR e02424-21
DI 10.1128/mBio.02424-21
PG 20
WC Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology
GA YI9UG
UT WOS:000744185400003
PM 34607466
OA Green Submitted, Green Published
DA 2024-02-19
ER

PT J
AU da Silva, EFG
   Lima, KG
   Krause, GC
   Haute, GV
   Pedrazza, L
   Catarina, AV
   Gassen, RB
   Basso, BD
   Dias, HB
   Luft, C
   Garcia, MCR
   Costa, BP
   Antunes, GL
   Basso, LA
   Donadio, MVF
   Machado, P
   de Oliveira, JR
AF da Silva, Elisa Feller Goncalves
   Lima, Kelly Goulart
   Krause, Gabriele Catyana
   Haute, Gabriela Viegas
   Pedrazza, Leonardo
   Catarina, Anderson Velasque
   Gassen, Rodrigo Benedetti
   de Souza Basso, Bruno
   Dias, Henrique Bregolin
   Luft, Carolina
   Garcia, Maria Claudia Rosa
   Costa, Bruna Pasqualotto
   Antunes, Gessica Luana
   Basso, Luiz Augusto
   Donadio, Marcio Vinicius Fagundes
   Machado, Pablo
   de Oliveira, Jarbas Rodrigues
TI CPBMF65, a synthetic human uridine phosphorylase-1 inhibitor, reduces
   HepG2 cell proliferation through cell cycle arrest and senescence
SO INVESTIGATIONAL NEW DRUGS
LA English
DT Article; Early Access
DE Human uridine phosphorylase-1; HepG2 cells; Hepatocellular carcinoma;
   Cell cycle arrest; Senescence
ID CANCER; AUTOPHAGY; APOPTOSIS; PROTEINS
AB Hepatocellular carcinoma (HCC) is the most prevalent type of tumor among primary liver tumors and is the second highest cause of cancer-related deaths worldwide. Current therapies are controversial, and more research is needed to identify effective treatments. A new synthetic compound, potassium 5-cyano-4-methyl-6-oxo-1,6-dihydropyridine-2-olate (CPBMF65), is a potent inhibitor of the human uridine phosphorylase-1 (hUP1) enzyme, which controls the cell concentration of uridine (Urd). Urd is a natural pyrimidine nucleoside involved in cellular processes, such as RNA synthesis. In addition, it is considered a promising biochemical modulator, as it may reduce the toxicity caused by chemotherapeutics without impairing its anti-tumor activity. Thus, the objective of this study is to evaluate the effects of CPBMF65 on the proliferation of the human hepatocellular carcinoma cell line (HepG2). Cell proliferation, cytotoxicity, apoptosis, senescence, autophagy, intracellular Urd levels, cell cycle arrest, and drug resistance were analyzed. Results demonstrate that, after incubation with CPBMF65, HepG2 cell proliferation decreased, mainly through cell cycle arrest and senescence, increasing the levels of intracellular Urd and maintaining cell proliferation reduced during chronic treatment. In conclusion, results show, for the first time, the ability of a hUP1 inhibitor (CPBMF65) to reduce HepG2 cell proliferation through cell cycle arrest and senescence.
C1 [da Silva, Elisa Feller Goncalves; Lima, Kelly Goulart; Krause, Gabriele Catyana; Haute, Gabriela Viegas; Pedrazza, Leonardo; de Souza Basso, Bruno; Dias, Henrique Bregolin; Luft, Carolina; Garcia, Maria Claudia Rosa; Costa, Bruna Pasqualotto; Antunes, Gessica Luana; Donadio, Marcio Vinicius Fagundes; de Oliveira, Jarbas Rodrigues] Pontificia Univ Catolica Rio Grande Sul PUCRS, Lab Pesquisa Biofis Celular & Inflamacao, Porto Alegre, RS, Brazil.
   [Catarina, Anderson Velasque] Pontificia Univ Catolica Rio Grande Sul PUCRS, Lab Biofis Celular Mol & Computac, Porto Alegre, RS, Brazil.
   [Gassen, Rodrigo Benedetti] Pontificia Univ Catolica Rio Grande Sul PUCRS, Lab Imunol Celular & Mol, Porto Alegre, RS, Brazil.
   [Basso, Luiz Augusto; Machado, Pablo] Pontificia Univ Catolica Rio Grande Sul PUCRS, Ctr Pesquisas Biol Mol & Func CPBMF, Porto Alegre, RS, Brazil.
C3 Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia
   Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade
   Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio
   Grande Do Sul
RP Antunes, GL (corresponding author), Pontificia Univ Catolica Rio Grande Sul PUCRS, Lab Pesquisa Biofis Celular & Inflamacao, Porto Alegre, RS, Brazil.
EM gessica.antunes@edu.pucrs.br
RI Luft, Carolina/G-1340-2017; Machado, Pablo/M-4356-2013; Donadio, Marcio
   Vinicius Fagundes/E-7702-2013; Lima, Kelly/T-2012-2019; Costa,
   Bruna/IAQ-7650-2023; Antunes, Géssica/AAP-8862-2021
OI Luft, Carolina/0000-0001-9044-0701; Machado, Pablo/0000-0001-5616-9583;
   Donadio, Marcio Vinicius Fagundes/0000-0001-8836-9109; Costa,
   Bruna/0000-0002-5327-9653; Antunes, Géssica/0000-0003-2172-5484; Catyana
   Krause Milaneze, Gabriele/0000-0001-8340-4534; Goulart Lima,
   Kelly/0000-0002-1912-2150; Pasqualotto Costa, Bruna/0000-0003-4810-4717
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES),
   Brasil [001]
FX This study was financed, in part, by the Coordenacao de Aperfeicoamento
   de Pessoal de Nivel Superior (CAPES), Brasil. Finance Code 001.
CR Attwa MH, 2015, WORLD J HEPATOL, V7, P1632, DOI 10.4254/wjh.v7.i12.1632
   Byam Jerome, 2013, Hepatobiliary Surg Nutr, V2, P22, DOI 10.3978/j.issn.2304-3881.2012.11.03
   Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981
   Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003
   Filippi-Chiela EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042522
   da Silva EFG, 2016, ONCOL REP, V36, P2647, DOI 10.3892/or.2016.5111
   Haute GV, 2015, TOXICOL IN VITRO, V30, P309, DOI 10.1016/j.tiv.2015.10.005
   Huang RZ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040778
   Iwamoto A, 2014, CHRONOBIOL INT, V31, P189, DOI 10.3109/07420528.2013.837478
   Khemlina G, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0712-x
   KIM TM, 2012, J VET SCI
   Krause GC, 2019, EXCLI J, V18, P540, DOI 10.17179/excli2019-1415
   Krause GC, 2017, EUR J PHARMACOL, V809, P32, DOI 10.1016/j.ejphar.2017.05.015
   Lee YH, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20112716
   LEYVA A, 1984, CANCER RES, V44, P5928
   Lima KG, 2018, TOXICOL IN VITRO, V48, P11, DOI 10.1016/j.tiv.2017.12.017
   Luo Y, 2005, EXPERT REV ANTICANC, V5, P333, DOI 10.1586/14737140.5.2.333
   Matheson CJ, 2016, TRENDS PHARMACOL SCI, V37, P872, DOI 10.1016/j.tips.2016.06.006
   Mills CC, 2018, CANCER RES, V78, P320, DOI 10.1158/0008-5472.CAN-17-2782
   Otto T, 2017, NAT REV CANCER, V17, P93, DOI 10.1038/nrc.2016.138
   Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002
   Pizzorno G, 2002, BBA-MOL BASIS DIS, V1587, P133, DOI 10.1016/S0925-4439(02)00076-5
   Renck D, 2014, INVEST NEW DRUG, V32, P1301, DOI 10.1007/s10637-014-0135-0
   Renck D, 2013, J MED CHEM, V56, P8892, DOI 10.1021/jm401389u
   Rundle S, 2017, CANCERS, V9, DOI 10.3390/cancers9050041
   Sachdeva M, 2015, WORLD J HEPATOL, V7, P2080, DOI 10.4254/wjh.v7.i17.2080
   Salminen A, 2013, AGEING RES REV, V12, P520, DOI 10.1016/j.arr.2012.11.004
   Sampson VB, 2016, ONCOTARGET, V7, P86594, DOI 10.18632/oncotarget.13358
   Sapisochin G, 2017, NAT REV GASTRO HEPAT, V14, P203, DOI 10.1038/nrgastro.2016.193
   Schmidt A, 2007, EMBO J, V26, P1624, DOI 10.1038/sj.emboj.7601637
   SQUADRITO F, 2017, FRONT PHARM
   Suzuki Kazufumi, 2011, J Biomed Biotechnol, V2011, P978312, DOI 10.1155/2011/978312
   Donato MT, 2015, METHODS MOL BIOL, V1250, P77, DOI 10.1007/978-1-4939-2074-7_5
   VANGROENINGEN CJ, 1992, SEMIN ONCOL
   Yang JD, 2019, NAT REV GASTRO HEPAT, V16, P589, DOI 10.1038/s41575-019-0186-y
   Zdanov S, 2006, ANN NY ACAD SCI, V1067, P210, DOI 10.1196/annals.1354.025
NR 36
TC 3
Z9 3
U1 2
U2 5
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0167-6997
EI 1573-0646
J9 INVEST NEW DRUG
JI Invest. New Drugs
PD 2020 DEC
PY 2020
VL 38
IS 6
BP 1653
EP 1663
DI 10.1007/s10637-020-00941-2
EA MAY 2020
PG 11
WC Oncology; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Pharmacology & Pharmacy
GA OF8YE
UT WOS:000530195100002
PM 32367200
OA Green Published
DA 2024-02-19
ER

PT J
AU Srivastava, A
   Barth, E
   Ermolaeva, MA
   Guenther, M
   Frahm, C
   Marz, M
   Witte, OW
AF Srivastava, Akash
   Barth, Emanuel
   Ermolaeva, Maria A.
   Guenther, Madlen
   Frahm, Christiane
   Marz, Manja
   Witte, Otto W.
TI Tissue-specific Gene Expression Changes Are Associated with Aging in
   Mice
SO GENOMICS PROTEOMICS & BIOINFORMATICS
LA English
DT Article
DE Aging; RNA-seq analysis; Inflammaging; Electron transport chain; Tissue
   aging
ID OXIDATIVE STRESS; EXTRACELLULAR-MATRIX; BRAIN; RNA; CELLS; INFLAMMATION;
   LIPOCALIN-2; PROTEINS; ELEGANS; GROWTH
AB Aging is a complex process that can be characterized by functional and cognitive decline in an individual. Aging can be assessed based on the functional capacity of vital organs and their intricate interactions with one another. Thus, the nature of aging can be described by focusing on a specific organ and an individual itself. However, to fully understand the complexity of aging, one must investigate not only a single tissue or biological process but also its complex interplay and interdependencies with other biological processes. Here, using RNA-seq, we monitored changes in the transcriptome during aging in four tissues (including brain, blood, skin and liver) in mice at 9 months, 15 months, and 24 months, with a final evaluation at the very old age of 30 months. We identified several genes and processes that were differentially regulated during aging in both tissue-dependent and tissue-independent manners. Most importantly, we found that the electron transport chain (ETC) of mitochondria was similarly affected at the transcriptome level in the four tissues during the aging process. We also identified the liver as the tissue showing the largest variety of differentially expressed genes (DEGs) over time. Lcn2 (Lipocalin-2) was found to be similarly regulated among all tissues, and its effect on longevity and survival was validated using its orthologue in Caenorhabditis elegans. Our study demonstrated that the molecular processes of aging are relatively subtle in their progress, and the aging process of every tissue depends on the tissue's specialized function and environment. Hence, individual gene or process alone cannot be described as the key of aging in the whole organism.
C1 [Srivastava, Akash; Guenther, Madlen; Frahm, Christiane; Witte, Otto W.] Friedrich Schiller Univ Jena, Univ Hosp Jena, Hans Berger Dept Neurol, D-07747 Jena, Germany.
   [Barth, Emanuel; Marz, Manja] Friedrich Schiller Univ Jena, Bioinformat High Throughput Anal, D-07743 Jena, Germany.
   [Barth, Emanuel; Ermolaeva, Maria A.; Marz, Manja] FLI Leibniz Inst Age Res, D-07745 Jena, Germany.
C3 Friedrich Schiller University of Jena; Friedrich Schiller University of
   Jena; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut
   (FLI)
RP Witte, OW (corresponding author), Friedrich Schiller Univ Jena, Univ Hosp Jena, Hans Berger Dept Neurol, D-07747 Jena, Germany.; Barth, E; Marz, M (corresponding author), Friedrich Schiller Univ Jena, Bioinformat High Throughput Anal, D-07743 Jena, Germany.; Barth, E; Marz, M (corresponding author), FLI Leibniz Inst Age Res, D-07745 Jena, Germany.
EM emanuel.barth@uni-jena.de; manja@uni-jena.de; otto.witte@med.uni-jena.de
RI ; , Otto/P-4127-2018
OI Marz, Manja/0000-0003-4783-8823; Barth, Emanuel/0000-0003-0803-8858;
   Srivastava, Akash/0000-0002-5959-3926; , Otto/0000-0003-2101-4105
FU Carl Zeiss Stiftung; Thuringian country programme ProExzellenz
   (RegenerAging) of the Thuringian Ministry for Research (TMWWDG)
   [FSUI03/14]; Deutsche Forschungsgemeinschaft (DFG) [1738 B2];
   Bundesministerum fuer Bildung und Forschung (BMBF) Bernstein Fokus
   [01GQ0923]; BMBF Gerontosys JenAge [0315581A/B]; EU BrainAge
   [FP7/HEALTH.2011.2.2.22, 279281]; BMBF Irestra [16SV7209]
FX We thank Ivonne Goerlich and Ivonne Heinze for their skillful and
   diligent technical assistance in NGS data acquisition and Marco Groth
   and Matthias Platzer for providing RNAseq data sets. This work has been
   partially financed by Carl Zeiss Stiftung and the Thuringian country
   programme ProExzellenz (RegenerAgingFSUI03/14) of the Thuringian
   Ministry for Research (TMWWDG) . This work was also supported by the
   Deutsche Forschungsgemeinschaft (DFG) for 1738 B2, the Bundesministerum
   fuer Bildung und Forschung (BMBF) Bernstein Fokus (Grant No. 01GQ0923) ,
   the BMBF Gerontosys JenAge (Grant No. 0315581A/B) , the EU BrainAge
   (Grant Nos. FP7/HEALTH.2011.2.2.22 and 279281) , and the BMBF Irestra
   (Grant No. 16SV7209) .
CR Al Nimer F, 2016, NEUROL-NEUROIMMUNOL, V3, DOI 10.1212/NXI.0000000000000191
   Anantharaju A, 2002, GERONTOLOGY, V48, P343, DOI 10.1159/000065506
   Antoniou J, 1996, SPINE, V21, P1153, DOI 10.1097/00007632-199605150-00006
   Bauernfeind F, 2016, J IMMUNOL, V197, P2900, DOI 10.4049/jimmunol.1501336
   BEAL MF, 1995, ANN NEUROL, V38, P357, DOI 10.1002/ana.410380304
   Bellaver B, 2017, MOL NEUROBIOL, V54, P2969, DOI 10.1007/s12035-016-9880-8
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Brown KS, 2004, CELL SIGNAL, V16, P71, DOI 10.1016/S0898-6568(03)00113-X
   Bruunsgaard H, 2001, CURR OPIN HEMATOL, V8, P131, DOI 10.1097/00062752-200105000-00001
   Burhans WC, 2007, NUCLEIC ACIDS RES, V35, P7545, DOI 10.1093/nar/gkm1059
   Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8
   Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   Chinn IK, 2012, SEMIN IMMUNOL, V24, P309, DOI 10.1016/j.smim.2012.04.005
   Cuervo AM, 2008, TRENDS GENET, V24, P604, DOI 10.1016/j.tig.2008.10.002
   Ferreira AC, 2015, PROG NEUROBIOL, V131, P120, DOI 10.1016/j.pneurobio.2015.06.005
   Fisher GJ, 2002, ARCH DERMATOL, V138, P1462, DOI 10.1001/archderm.138.11.1462
   Frahm C, 2017, NEUROBIOL AGING, V52, P23, DOI 10.1016/j.neurobiolaging.2016.12.016
   Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057
   Freitas AA, 2011, MUTAT RES-REV MUTAT, V728, P12, DOI 10.1016/j.mrrev.2011.05.001
   Gohlke S, 2014, AGE, V36, P57, DOI 10.1007/s11357-013-9543-x
   Goldberg EL, 2015, IMMUNOL REV, V265, P63, DOI 10.1111/imr.12295
   Hashimshony T, 2015, NATURE, V519, P219, DOI 10.1038/nature13996
   Heinze I, 2018, BMC BIOL, V16, DOI 10.1186/s12915-018-0547-y
   Hermani A, 2005, CLIN CANCER RES, V11, P5146, DOI 10.1158/1078-0432.CCR-05-0352
   Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554
   Hoffmann S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000502
   Hong Y, 2009, NEUROTOXICOLOGY, V30, P538, DOI 10.1016/j.neuro.2009.04.011
   Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183
   Irizar PA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02395-2
   Jonker MJ, 2013, AGING CELL, V12, P901, DOI 10.1111/acel.12118
   Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27
   Karakasilioti I, 2014, AGING-US, V6, P7, DOI 10.18632/aging.100635
   Kim CH, 2010, J BLOOD MED, V1, P13, DOI 10.2147/JBM.S7224
   Kim Y, 2007, AGING CELL, V6, P489, DOI 10.1111/j.1474-9726.2007.00302.x
   Koon JC, 2010, J BIOL CHEM, V285, P13437, DOI 10.1074/jbc.M110.107011
   Kovtonyuk LV, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00502
   Kwong LK, 2000, ARCH BIOCHEM BIOPHYS, V373, P16, DOI 10.1006/abbi.1999.1495
   Lans H, 2015, DNA REPAIR, V32, P141, DOI 10.1016/j.dnarep.2015.04.025
   Lee HG, 2009, NEUROCHEM INT, V54, P84, DOI 10.1016/j.neuint.2008.10.013
   Lei LY, 2017, MOL THER-NUCL ACIDS, V6, P183, DOI 10.1016/j.omtn.2016.12.005
   Li XY, 2002, MOL CELL BIOL, V22, P1158, DOI 10.1128/MCB.22.4.1158-1171.2002
   Loerch PM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003329
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Ma XT, 2006, CANCER RES, V66, P1169, DOI 10.1158/0008-5472.CAN-05-2891
   Mansfeld J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10043
   Orre M, 2014, NEUROBIOL AGING, V35, P1, DOI 10.1016/j.neurobiolaging.2013.07.008
   Panieri E, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.105
   Prolla TA, 2002, CHEM SENSES, V27, P299, DOI 10.1093/chemse/27.3.299
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Ronn LCB, 2000, INT J DEV NEUROSCI, V18, P193, DOI 10.1016/S0736-5748(99)00088-X
   Sancho P, 2016, BRIT J CANCER, V114, P1305, DOI 10.1038/bjc.2016.152
   Schwarze SR, 1998, FREE RADICAL BIO MED, V25, P740, DOI 10.1016/S0891-5849(98)00153-1
   Shepherd CE, 2006, NEUROBIOL AGING, V27, P1554, DOI 10.1016/j.neurobiolaging.2005.09.033
   Sondersorg AC, 2014, J BIOL CHEM, V289, P17529, DOI 10.1074/jbc.M113.499699
   Soreq L, 2017, CELL REP, V18, P557, DOI 10.1016/j.celrep.2016.12.011
   Soro-Arnaiz I, 2016, CELL REP, V16, P2991, DOI 10.1016/j.celrep.2016.08.041
   Stilling RM, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00373
   Suk K, 2016, PROG NEUROBIOL, V144, P158, DOI 10.1016/j.pneurobio.2016.08.001
   TAKEDA K, 1992, J CELL PHYSIOL, V153, P450, DOI 10.1002/jcp.1041530303
   Terman A, 2010, ANTIOXID REDOX SIGN, V12, P503, DOI 10.1089/ars.2009.2598
   Urbach A, 2008, STROKE, V39, P3064, DOI 10.1161/STROKEAHA.108.518076
   WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x
   Winter JM, 2008, CLIN CANCER RES, V14, P412, DOI 10.1158/1078-0432.CCR-07-0487
   Wood SH, 2013, AGE, V35, P763, DOI 10.1007/s11357-012-9410-1
   Zou Y, 2003, FASEB J, V17, P320, DOI 10.1096/fj.03-0849fje
NR 67
TC 20
Z9 24
U1 1
U2 4
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1672-0229
EI 2210-3244
J9 GENOM PROTEOM BIOINF
JI Genom. Proteomics Bioinformatics
PD AUG
PY 2020
VL 18
IS 4
BP 430
EP 442
DI 10.1016/j.gpb.2020.12.001
PG 13
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA TA5EV
UT WOS:000667272600006
PM 33309863
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Tung, BT
   Rodríguez-Bies, E
   Talero, E
   Gamero-Estévez, E
   Motilva, V
   Navas, P
   López-Lluch, G
AF Bui Thanh Tung
   Rodriguez-Bies, Elisabeth
   Talero, Elena
   Gamero-Estevez, Enrique
   Motilva, Virginia
   Navas, Placido
   Lopez-Lluch, Guillermo
TI Anti-inflammatory effect of resveratrol in old mice liver
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE Aging; Resveratrol; Inflammation; Cytokines; Liver
ID NLRP3 INFLAMMASOME; TNF-ALPHA; INTERLEUKIN-1-BETA; CYCLOOXYGENASE-2;
   MACROPHAGES; MODULATION; DISEASE; OBESITY; HEALTH; CANCER
AB Inflammation is a hallmark of aging. Caloric restriction and resveratrol (RSV) have shown important effects on prevention of oxidative stress and inflammation. Here, we investigate the progression of proinflammatory markers in liver during aging and the effect of RSV on inflammation markers in the liver of old male C57BL/6J mice. Young (2 months), mature (12 months) and old (18 months) mice were fed during 6 months with RSV. Levels of IL-1 beta, IL-6, IL-10, IL-17 and TNF-alpha were evaluated by ELISA in mice liver. Levels of pro-inflammatory cytokines, IL-1 beta, IL-6, IL-17 and TNF-alpha and also their respective mRNA increased in the liver from old mice. However, RSV decreased these levels in the case of IL-1 beta and TNF-alpha but only in old mice showing no effect on young and mature animals. This reduction was also found at the mRNA level. Levels of mRNA of the components of NALP-3 inflammasome, ASC, CASP-1, NALP-1 and NALP-3, also showed an age-dependent increase that was reversed by RSV. Furthermore, cyclooxygenase 2 levels, a marker of proinflammatory innate immune activity, were also upregulated in aged liver and reversed again by RSV. In conclusion, our study confirms that aging is accompanied by an increase in the proinflammatory pattern in the liver and that RSV reduces this pattern in old mice liver. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Bui Thanh Tung; Rodriguez-Bies, Elisabeth; Gamero-Estevez, Enrique; Navas, Placido; Lopez-Lluch, Guillermo] Univ Pablo de Olavide, Ctr Andaluz Biol Desarrollo CABD, CSIC, CIBERER,Inst Salud San Carlos III, Carretera Utrera Km 1, Seville 41013, Spain.
   [Bui Thanh Tung; Talero, Elena; Motilva, Virginia] Univ Seville, Fac Farm, Dept Farmacol, Seville 41012, Spain.
C3 CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo
   Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de
   Olavide; CSIC - Andalusian Center for Developmental Biology (CABD);
   University of Sevilla
RP López-Lluch, G (corresponding author), Univ Pablo de Olavide, Ctr Andaluz Biol Desarrollo CABD, CSIC, CIBERER,Inst Salud San Carlos III, Carretera Utrera Km 1, Seville 41013, Spain.
EM glopllu@upo.es
RI NAVAS, PLACIDO/R-5943-2019; Rodríguez-Bies, Elisabet/A-4459-2016;
   Lopez-Lluch, Guillermo/N-4742-2014; Talero, Elena/I-2613-2015
OI NAVAS, PLACIDO/0000-0002-4115-7966; Rodríguez-Bies,
   Elisabet/0000-0002-5910-2920; Lopez-Lluch,
   Guillermo/0000-0001-9830-8502; Gamero-Estevez,
   Enrique/0000-0003-0717-0531
FU Andalusian Government as the BIO177 group through FEDER funds (European
   Commission); Spanish Government grant [DEP2012-39985]; AECID program
   (Spanish Ministry of Foreign Affair)
FX The research group is financed by the Andalusian Government as the
   BIO177 group through FEDER funds (European Commission). The research has
   been financed by the Spanish Government grant DEP2012-39985 (Spanish
   Ministry of Economy and Competitiveness). Tung Bui Thanh received a
   fellowship from the AECID program (Spanish Ministry of Foreign Affair).
   ERB, PN and GLL are also members of the Centro de Investigacion
   Biomedica en Red de Enfermedades Raras (CIBERER), Instituto Carlos III.
CR Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9
   Aravinthan A, 2014, EXP GERONTOL, V60, P37, DOI 10.1016/j.exger.2014.09.011
   Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363
   Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Brenner C, 2013, J HEPATOL, V59, P583, DOI 10.1016/j.jhep.2013.03.033
   Bruunsgaard H, 2000, CLIN EXP IMMUNOL, V121, P255, DOI 10.1046/j.1365-2249.2000.01281.x
   Brüünsgaard H, 2003, IMMUNOL ALLERGY CLIN, V23, P15, DOI 10.1016/S0889-8561(02)00056-5
   Tung BT, 2014, J GERONTOL A-BIOL, V69, P398, DOI 10.1093/gerona/glt102
   Chung HY, 2011, J DENT RES, V90, P830, DOI 10.1177/0022034510387794
   Chung HY, 2006, ANTIOXID REDOX SIGN, V8, P572, DOI 10.1089/ars.2006.8.572
   DEVRIES JE, 1995, ANN MED, V27, P537, DOI 10.3109/07853899509002465
   Di Iorio A, 2003, CYTOKINE, V22, P198, DOI 10.1016/S1043-4666(03)00152-2
   Dobbs RJ, 1999, ACTA NEUROL SCAND, V100, P34, DOI 10.1111/j.1600-0404.1999.tb00721.x
   Feng YH, 2004, INT IMMUNOPHARMACOL, V4, P713, DOI 10.1016/j.intimp.2004.02.006
   Fu Y, 2013, INT J MOL SCI, V14, P14105, DOI 10.3390/ijms140714105
   Fulgenzi A, 2001, TRANSPLANT P, V33, P2341, DOI 10.1016/S0041-1345(01)02015-2
   Gao XH, 2001, BIOCHEM PHARMACOL, V62, P1299, DOI 10.1016/S0006-2952(01)00775-4
   Gee JR, 2005, EXP GERONTOL, V40, P409, DOI 10.1016/j.exger.2005.01.010
   Glasgow SC, 2007, AM J PHYSIOL-LUNG C, V293, pL491, DOI 10.1152/ajplung.00009.2007
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Huang T. T., 2013, INNATE IMMUN
   Jung KJ, 2009, FREE RADICAL BIO MED, V47, P983, DOI 10.1016/j.freeradbiomed.2009.07.009
   Lanzilli G, 2012, INFLAMMATION, V35, P240, DOI 10.1007/s10753-011-9310-z
   Martinez J, 2000, BIOCHEM PHARMACOL, V59, P865, DOI 10.1016/S0006-2952(99)00380-9
   Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516
   Martinon F, 2010, EUR J IMMUNOL, V40, P616, DOI 10.1002/eji.200940168
   Rivera L, 2009, BIOCHEM PHARMACOL, V77, P1053, DOI 10.1016/j.bcp.2008.11.027
   Saiko P, 2008, MUTAT RES-REV MUTAT, V658, P68, DOI 10.1016/j.mrrev.2007.08.004
   Salminen A, 2012, AGING-US, V4, P166, DOI 10.18632/aging.100444
   Schmucker DL, 1998, J GERONTOL A-BIOL, V53, pB315, DOI 10.1093/gerona/53A.5.B315
   Schroder K, 2010, SCIENCE, V327, P296, DOI 10.1126/science.1184003
   Schwabe RF, 2006, AM J PHYSIOL-GASTR L, V290, pG583, DOI 10.1152/ajpgi.00422.2005
   Shakibaei M, 2009, MOL NUTR FOOD RES, V53, P115, DOI 10.1002/mnfr.200800148
   Subbaramaiah K, 1998, J BIOL CHEM, V273, P21875, DOI 10.1074/jbc.273.34.21875
   Subbaramaiah K, 2003, TRENDS PHARMACOL SCI, V24, P96, DOI 10.1016/S0165-6147(02)00043-3
   Szabo G, 2012, J HEPATOL, V57, P642, DOI 10.1016/j.jhep.2012.03.035
   Szkudelska K, 2010, EUR J PHARMACOL, V635, P1, DOI 10.1016/j.ejphar.2010.02.054
   Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279
   Williams LA, 2008, MOL IMMUNOL, V45, P2446, DOI 10.1016/j.molimm.2007.12.011
   Wunderlich FT, 2010, CELL METAB, V12, P237, DOI 10.1016/j.cmet.2010.06.011
   Yang SJ, 2014, METABOLISM, V63, P693, DOI 10.1016/j.metabol.2014.02.003
   Ye ZM, 2008, CURR OPIN IMMUNOL, V20, P3, DOI 10.1016/j.coi.2008.01.003
   Zhong M, 1999, PHYTOMEDICINE, V6, P79, DOI 10.1016/S0944-7113(99)80039-7
   Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831
NR 45
TC 56
Z9 60
U1 0
U2 17
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD APR
PY 2015
VL 64
BP 1
EP 7
DI 10.1016/j.exger.2015.02.004
PG 7
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA CD1CZ
UT WOS:000350812800001
PM 25687021
DA 2024-02-19
ER

PT J
AU Mattocks, DAL
   Mentch, SJ
   Shneyder, J
   Ables, GP
   Sun, DX
   Richie, JP
   Locasale, JW
   Nichenametla, SN
AF Mattocks, Dwight A. L.
   Mentch, Samantha J.
   Shneyder, Jelena
   Ables, Gene P.
   Sun, Dongxiao
   Richie, John P., Jr.
   Locasale, Jason W.
   Nichenametla, Sailendra N.
TI Short term methionine restriction increases hepatic global DNA
   methylation in adult but not young male C57BL/6J mice
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE Aging; DNA methylation; Methionine; Caloric restriction; One-carbon
   cycle; Sulfur amino acids
ID S-ADENOSYLMETHIONINE; HISTONE METHYLATION; ADIPOSE-TISSUE; LIFE-SPAN;
   LIVER; BETAINE; ADENOSYLHOMOCYSTEINE; HOMOCYSTEINE; DEFICIENCY;
   METABOLISM
AB Despite well-documented evidence for lifespan extension by methionine restriction (MR), underlying mechanisms remain unknown. As methionine can alter S-adenosylmethionine (SAM) and S-adenosylhomocysteine (SAH), the substrate and product of DNA methyltransferase-1 (DNMT1), we hypothesized that MR diet alters DNA methylation. Young (8-week-old) and adult (1-year-old) male C57BL/6J mice were fed diets with different levels of methionine (0.12%-MR, 0.84%-CD) for 12 weeks. Functional indicators of DNA methylation, including global methylation (GM), gene-specific methylation (GSM) and LINE-1 methylation; and biochemical factors affecting DNA methylation, SAH, SAM, and DNMT1 were assessed in different tissues. MR altered DNA methylation depending on the age of intervention. While MR had no effect on hepatic GM in young animals, it increased GM by 27% over CD in adults (p < 0.01). In comparison with young animals, hepatic GM levels were 17% lower in CD adults (p < 0.05), but not different in MR adults. The MR-induced increase in hepatic GM was associated with a 38% decrease in SAH levels in adults (p < 0.001), with SAH and GM levels being negatively correlated (r(2) = 033, p < 0.001). No changes were observed in DNMT protein levels in liver. In adipose tissue, MR caused a 6% decline in GM in adults (p < 0.05), a corresponding 2-fold increase in SAH (p < 0.05), and a 2-fold decrease in DNMT1 (p < 0.01). MR caused both increases and decreases in GSM of liver and adipose. No changes were observed in LINE-1. Together, these findings provide evidence for protective effects of MR diet on hepatic DNA hypomethylation in adults, apparently mediated by SAH. These findings also indicate that altered DNA methylation might be playing a role in benefits conferred by MR diet. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Mattocks, Dwight A. L.; Shneyder, Jelena; Ables, Gene P.; Nichenametla, Sailendra N.] Orentreich Fdn Adv Sci, Anim Sci Lab, Cold Spring On Hudson, NY 10516 USA.
   [Mentch, Samantha J.; Locasale, Jason W.] Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.
   [Sun, Dongxiao] Penn State Coll Med, Dept Pharmacol, Mass Spectrometry Core Facil, Hershey, PA 17033 USA.
   [Richie, John P., Jr.] Penn State Coll Med, Dept Publ Hlth Sci, Hershey, PA 17033 USA.
C3 Duke University; Pennsylvania Commonwealth System of Higher Education
   (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania
   Commonwealth System of Higher Education (PCSHE); Pennsylvania State
   University; Penn State Health
RP Nichenametla, SN (corresponding author), Orentreich Fdn Adv Sci, 855 Route 301, Cold Spring On Hudson, NY 10516 USA.
EM snichenametla@orentreich.org
RI Locasale, Jason W/ABE-6505-2020; Nichenametla, Sailendra
   Nath/B-2733-2009
OI Locasale, Jason W/0000-0002-7766-3502; Nichenametla, Sailendra
   Nath/0000-0002-5969-3572; Ables, Gene/0000-0002-8238-0726; Richie,
   John/0000-0001-8239-2850
FU Orentreich Foundation for the Advancement of Science
FX This work was supported by funds alloted to project ASL15 from
   Orentreich Foundation for the Advancement of Science.
CR Ables GP, 2015, SCI REP-UK, V5, DOI 10.1038/srep08886
   Altmann S, 2012, EPIGENETICS-US, V7, P239, DOI 10.4161/epi.7.3.19183
   Barak AJ, 1996, ALCOHOL, V13, P395, DOI 10.1016/0741-8329(96)00030-4
   Bollati V, 2009, MECH AGEING DEV, V130, P234, DOI 10.1016/j.mad.2008.12.003
   Brown-Borg Holly M, 2014, Longev Healthspan, V3, P10, DOI 10.1186/2046-2395-3-10
   Caudill MA, 2001, J NUTR, V131, P2811, DOI 10.1093/jn/131.11.2811
   Chalitchagorn K, 2004, ONCOGENE, V23, P8841, DOI 10.1038/sj.onc.1208137
   Cheng X.D., 1999, S-Adenosylmethionine-Dependent Methyltransferases: Structures and Functions
   Do Amaral CL, 2011, MUTAT RES-GEN TOX EN, V722, P78, DOI 10.1016/j.mrgentox.2011.03.006
   FINKELSTEIN JD, 1986, J BIOL CHEM, V261, P1582
   Hasek BE, 2013, DIABETES, V62, P3362, DOI 10.2337/db13-0501
   Hens J. R., 2016, BMC CANCER
   HOFFMAN DR, 1979, CAN J BIOCHEM CELL B, V57, P56, DOI 10.1139/o79-007
   Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115
   Jjingo D, 2012, ONCOTARGET, V3, P462, DOI 10.18632/oncotarget.497
   Johnson AA, 2012, REJUV RES, V15, P483, DOI 10.1089/rej.2012.1324
   Jones MJ, 2015, AGING CELL, V14, P924, DOI 10.1111/acel.12349
   Li YY, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-98
   Liu XJ, 2014, JOVE-J VIS EXP, DOI 10.3791/51358
   Malloy VL, 2013, METABOLISM, V62, P1651, DOI 10.1016/j.metabol.2013.06.012
   Mato JM, 2002, FASEB J, V16, P15, DOI 10.1096/fj.01-0401rev
   Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165
   McCauley BS, 2014, BBA-GENE REGUL MECH, V1839, P1454, DOI 10.1016/j.bbagrm.2014.05.008
   Mentch SJ, 2015, CELL METAB, V22, P861, DOI 10.1016/j.cmet.2015.08.024
   Mercier S, 2006, AM J CLIN NUTR, V83, P291
   Miller RA, 2005, AGING CELL, V4, P119, DOI 10.1111/j.1474-9726.2005.00152.x
   MUDD SH, 1975, METABOLISM, V24, P721, DOI 10.1016/0026-0495(75)90040-2
   Muñoz-Najar U, 2011, ANTIOXID REDOX SIGN, V14, P241, DOI 10.1089/ars.2010.3250
   Obeid R, 2013, NUTRIENTS, V5, P3481, DOI 10.3390/nu5093481
   Olthof MR, 2003, J NUTR, V133, P4135, DOI 10.1093/jn/133.12.4135
   ORENTREICH N, 1993, J NUTR, V123, P269
   Ouattara Amadou, 2016, Bone Rep, V5, P33, DOI 10.1016/j.bonr.2016.02.002
   Perrone CE, 2012, J NUTRIGENET NUTRIGE, V5, P132, DOI 10.1159/000339347
   Pogribny IP, 2012, MOL NUTR FOOD RES, V56, P116, DOI 10.1002/mnfr.201100524
   Pogribny IP, 2010, EPIGENETICS OF AGING, P11, DOI 10.1007/978-1-4419-0639-7_2
   RICHIE JP, 1994, FASEB J, V8, P1302, DOI 10.1096/fasebj.8.15.8001743
   Sibani S, 2002, CARCINOGENESIS, V23, P61, DOI 10.1093/carcin/23.1.61
   SINGHAL RP, 1987, MECH AGEING DEV, V41, P199, DOI 10.1016/0047-6374(87)90040-6
   Sinha R, 2014, PROSTATE, V74, P1663, DOI 10.1002/pros.22884
   STRAMENTINOLI G, 1977, J GERONTOL, V32, P392, DOI 10.1093/geronj/32.4.392
   Sun L, 2009, J GERONTOL A-BIOL, V64, P711, DOI 10.1093/gerona/glp051
   Thompson RF, 2010, AGING CELL, V9, P506, DOI 10.1111/j.1474-9726.2010.00577.x
   Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003
NR 43
TC 42
Z9 49
U1 1
U2 12
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD FEB
PY 2017
VL 88
BP 1
EP 8
DI 10.1016/j.exger.2016.12.003
PG 8
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA EL1TC
UT WOS:000394402900001
PM 27940170
OA Green Accepted
DA 2024-02-19
ER

PT J
AU URSINI, F
   VUGMAN, M
   FERNANDES, LC
   CURI, CMON
   CURI, R
AF URSINI, F
   VUGMAN, M
   FERNANDES, LC
   CURI, CMON
   CURI, R
TI METABOLIC CHANGES OF SEVERAL ADIPOSE DEPOTS AS CAUSED BY AGING
SO PHYSIOLOGY & BEHAVIOR
LA English
DT Article
DE ADIPOSE TISSUE; GLUTAMINOLYSIS; PENTOSE-PHOSPHATE PATHWAY; KREBS CYCLE;
   AGING; LIPOGENESIS
ID RAT-LIVER; LYMPHOCYTES; TISSUE; ACID; ENZYMES; AGE
AB In this study, metabolic changes of several adipose depots as caused by aging were investigated.  Key enzyme activity of glutaminolysis, pentose-phosphate pathway and Krebs cycle were measured.  The rates of lipogenesis from (H2O)-H-3, lipoprotein lipase (LPL) activity and rate of lipolysis in vitro were also determined.  The results obtained indicate a reduced capacity for lipogenesis in several adipose depots by aging.  The authors concluded that hypertrophy of adipose tissue reported during aging is possible due to increased LPL activity and reduced rate of lipolysis.
C1 ESCOLA PAULISTA MED SCH,DEPT PHYSIOL,RUA BOTUCATU,862-2 ANDAR,BR-04023 SAO PAULO,BRAZIL.
   SAO PAULO UNIV,INST BIOMED SCI,DEPT PHYSIOL & BIOPHYS,BR-05508 BUTIANTRAN,SP,BRAZIL.
C3 Universidade Federal de Sao Paulo (UNIFESP)
RI Nascimento, Claudia Maria Oller do/T-4151-2019; Curi, Rui/C-9351-2012;
   Fernandes, Luiz C/I-4907-2014
OI Nascimento, Claudia Maria Oller do/0000-0001-5755-3392; 
CR ALMEIDA A F D, 1989, International Journal of Biochemistry, V21, P937
   ARDAWI MSM, 1985, ESSAYS BIOCHEM, V21, P1
   BUETOW DE, 1985, CRC HDB CELL BIOL AG, P1
   CAPARROTTA L, 1983, BRIT J PHARMACOL, V80, P663, DOI 10.1111/j.1476-5381.1983.tb10056.x
   CLEARY MP, 1979, AM J PHYSIOL, V5, pE508
   COONEY G, 1982, TRENDS BIOCHEM SCI, V9, P303
   COONEY GJ, 1981, BIOCHEM J, V200, P701, DOI 10.1042/bj2000701
   CRABTREE B, 1979, TECHNIQUES METABOLIC, P1
   CRYER A, 1981, INT J BIOCHEM, V13, P525, DOI 10.1016/0020-711X(81)90177-4
   CURI R, 1987, BIOCHEM SOC T, V15, P1071, DOI 10.1042/bst0151071
   CURI R, 1989, BIOCHEM INT, V19, P755
   CURI R, 1989, INT J BIOCHEM, V21, P1133, DOI 10.1016/0020-711X(89)90055-4
   CURI R, 1986, BIOCHEM BIOPH RES CO, V138, P318, DOI 10.1016/0006-291X(86)90282-2
   DONASCIMENTO CMO, 1986, BIOCHEM J, V239, P233
   EGGSTEIN M, 1966, KLIN WOCHENSCHR, V44, P262, DOI 10.1007/BF01747716
   GREENWOOD MRC, 1974, J LIPID RES, V15, P475
   GREGERMAN RI, 1963, ENDOCRINOLOGY, V72, P382, DOI 10.1210/endo-72-3-382
   HIETANEN E, 1977, J LIPID RES, V18, P480
   KHANDELWAL RL, 1984, MECH AGEING DEV, V28, P13, DOI 10.1016/0047-6374(84)90149-0
   KNITTLE JL, 1968, J CLIN INVEST, V47, P2091, DOI 10.1172/JCI105894
   KOWALCHUK JM, 1988, BIOCHEM J, V249, P705, DOI 10.1042/bj2490705
   KREISBERG RA, 1987, GERIATRICS, V42, P67
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MASORO EJ, 1981, HDB PHYSL AGING, P411
   Newsholme E A, 1987, Biochem Soc Symp, V54, P145
   NEWSHOLME EA, 1988, NUTRITION, V4, P261
   NEWSHOLME EA, 1989, PERSPECT CLIN NUTR, V6, P71
   POUND CM, 1986, BR J NUTR, V56, P29
   ROBINSON AM, 1978, BIOCHEM J, V170, P609, DOI 10.1042/bj1700609
   STANSBIE D, 1976, BIOCHEM J, V160, P413, DOI 10.1042/bj1600413
   VIEIRA R, 1989, ARQ BIOL TECNOL, V32, P495
   VITORICA J, 1981, ENZYME, V26, P144
NR 32
TC 18
Z9 18
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0031-9384
J9 PHYSIOL BEHAV
JI Physiol. Behav.
PD AUG
PY 1991
VL 50
IS 2
BP 317
EP 321
DI 10.1016/0031-9384(91)90072-V
PG 5
WC Psychology, Biological; Behavioral Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Psychology; Behavioral Sciences
GA GG616
UT WOS:A1991GG61600008
PM 1745675
DA 2024-02-19
ER

PT J
AU Nguyen, AT
   Emelyanov, A
   Chor, HVK
   Spitsbergen, JM
   Lam, SH
   Mathavan, S
   Parinov, S
   Gong, ZY
AF Anh Tuan Nguyen
   Emelyanov, Alexander
   Chor Hui Vivien Koh
   Spitsbergen, Jan M.
   Lam, Siew Hong
   Mathavan, Sinnakaruppan
   Parinov, Serguei
   Gong, Zhiyuan
TI A high level of liver-specific expression of oncogenic
   Kras<SUP>V12</SUP> drives robust liver tumorigenesis in transgenic
   zebrafish
SO DISEASE MODELS & MECHANISMS
LA English
DT Article
ID HUMAN HEPATOCELLULAR-CARCINOMA; GENE-EXPRESSION; SPOTTED-MICROARRAY;
   TARGETED THERAPIES; INDUCED SENESCENCE; MOUSE MODELS; BETA-CATENIN;
   IN-VIVO; CANCER; TUMORS
AB Human liver cancer is one of the deadliest cancers worldwide, with hepatocellular carcinoma (HCC) being the most common type. Aberrant Ras signaling has been implicated in the development and progression of human HCC, but a complete understanding of the molecular mechanisms of this protein in hepatocarcinogenesis remains elusive. In this study, a stable in vivo liver cancer model using transgenic zebrafish was generated to elucidate Ras-driven tumorigenesis in HCC. Using the liver-specific fabp10 (fatty acid binding protein 10) promoter, we overexpressed oncogenic kras(V12) specifically in the transgenic zebrafish liver. Only a high level of kras(V12) expression initiated liver tumorigenesis, which progressed from hyperplasia to benign and malignant tumors with activation of the Ras-Raf-MEK-ERK and Wnt-beta-catenin pathways. Histological diagnosis of zebrafish tumors identified HCC as the main lesion. The tumors were invasive and transplantable, indicating malignancy of these HCC cells. Oncogenic kras(V12) was also found to trigger p53-dependent senescence as a tumor suppressive barrier in the pre-neoplastic stage. Microarray analysis of zebrafish liver hyperplasia and HCC uncovered the deregulation of several stage-specific and common biological processes and signaling pathways responsible for kras(V12)-driven liver tumorigenesis that recapitulated the molecular hallmarks of human liver cancer. Cross-species comparisons of cancer transcriptomes further defined a HCC-specific gene signature as well as a liver cancer progression gene signature that are evolutionarily conserved between human and zebrafish. Collectively, our study presents a comprehensive portrait of molecular mechanisms during progressive Ras-induced HCC. These observations indicate the validity of our transgenic zebrafish to model human liver cancer, and this model might act as a useful platform for drug screening and identifying new therapeutic targets.
C1 [Anh Tuan Nguyen; Emelyanov, Alexander; Parinov, Serguei] Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117604, Singapore.
   [Anh Tuan Nguyen; Chor Hui Vivien Koh; Lam, Siew Hong; Gong, Zhiyuan] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore.
   [Spitsbergen, Jan M.] Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA.
   [Spitsbergen, Jan M.] Oregon State Univ, Marine & Freshwater Biomed Sci Ctr, Corvallis, OR 97331 USA.
   [Mathavan, Sinnakaruppan] Genome Inst Singapore, Singapore 138672, Singapore.
C3 National University of Singapore; National University of Singapore;
   Oregon State University; Oregon State University; Agency for Science
   Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore
   (GIS)
RP Parinov, S (corresponding author), Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117604, Singapore.
EM sergeypa@tll.org.sg; dbsgzy@nus.edu.sg
RI Lam, Siew Hong/H-8483-2012; Spitsbergen, Jan M/A-8395-2009; Gong,
   Zhiyuan/H-8794-2012
OI Gong, Zhiyuan/0000-0002-9660-5260; Emelyanov,
   Alexander/0000-0002-8693-794X
FU Biomedical Research Council of Singapore
FX This work was supported by the Biomedical Research Council of Singapore.
   We also thank Thomas Look for providing tp53 mutant zebrafish.
CR Amatruda JF, 2008, INT REV CEL MOL BIO, V271, P1, DOI 10.1016/S1937-6448(08)01201-X
   Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102
   Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296
   Calvisi DF, 2006, GASTROENTEROLOGY, V130, P1117, DOI 10.1053/j.gastro.2006.01.006
   Chang QS, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-64
   Chen YC, 2005, J BIOL CHEM, V280, P32505, DOI 10.1074/jbc.M501449200
   Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a
   Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327
   DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0
   Emelyanov A, 2008, DEV BIOL, V320, P113, DOI 10.1016/j.ydbio.2008.04.042
   Emelyanov A, 2006, GENETICS, V174, P1095, DOI 10.1534/genetics.106.061184
   Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934
   Harada N, 2004, CANCER RES, V64, P48, DOI 10.1158/0008-5472.CAN-03-2123
   Hayashi J, 2000, HEPATOLOGY, V32, P958, DOI 10.1053/jhep.2000.19343
   Hematulin A, 2008, CELL SIGNAL, V20, P2276, DOI 10.1016/j.cellsig.2008.08.017
   Her GM, 2003, FEBS LETT, V538, P125, DOI 10.1016/S0014-5793(03)00157-1
   Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033
   Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438
   Korzh S, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-84
   Lam SH, 2006, NAT BIOTECHNOL, V24, P73, DOI 10.1038/nbt1169
   Lam SH, 2006, CELL CYCLE, V5, P573, DOI 10.4161/cc.5.6.2550
   Lam Siew Hong, 2009, V546, P175, DOI 10.1007/978-1-60327-977-2_12
   Lam Siew Hong, 2009, V546, P197, DOI 10.1007/978-1-60327-977-2_13
   Langenau DM, 2007, GENE DEV, V21, P1382, DOI 10.1101/gad.1545007
   Le XN, 2007, P NATL ACAD SCI USA, V104, P9410, DOI 10.1073/pnas.0611302104
   Lee JS, 2004, NAT GENET, V36, P1306, DOI 10.1038/ng1481
   Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091
   Llovet JM, 2008, HEPATOLOGY, V48, P1312, DOI 10.1002/hep.22506
   Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205
   Markiewski MM, 2008, NAT IMMUNOL, V9, P1225, DOI 10.1038/ni.1655
   Martin J, 2008, WORLD J GASTROENTERO, V14, P1720, DOI 10.3748/wjg.14.1720
   Michailidou C, 2009, DIS MODEL MECH, V2, P399, DOI 10.1242/dmm.001149
   Mizgirev I, 2010, NAT PROTOC, V5, P383, DOI 10.1038/nprot.2010.8
   Parant JM, 2010, DIS MODEL MECH, V3, P45, DOI 10.1242/dmm.003749
   Parinov S, 2004, DEV DYNAM, V231, P449, DOI 10.1002/dvdy.20157
   Park SW, 2008, GASTROENTEROLOGY, V134, P2080, DOI 10.1053/j.gastro.2008.02.084
   SANDGREN EP, 1989, ONCOGENE, V4, P715
   Schmidt CM, 1997, BIOCHEM BIOPH RES CO, V236, P54, DOI 10.1006/bbrc.1997.6840
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Sharpless NE, 2006, NAT REV DRUG DISCOV, V5, P741, DOI 10.1038/nrd2110
   Spitsbergen Jan M., 2003, Toxicologic Pathology, V31, P62, DOI 10.1080/01926230390174959
   Strausberg RL, 2002, CANCER INVEST, V20, P1038, DOI 10.1081/CNV-120005922
   Sun PQ, 2007, CELL, V128, P295, DOI 10.1016/j.cell.2006.11.050
   Sweet-Cordero A, 2005, NAT GENET, V37, P48, DOI 10.1038/ng1490
   Takai A, 2009, ONCOGENE, V28, P469, DOI 10.1038/onc.2008.415
   Torimura T, 2004, J HEPATOL, V40, P799, DOI 10.1016/j.jhep.2004.01.027
   Villanueva A, 2010, ANNU REV MED, V61, P317, DOI 10.1146/annurev.med.080608.100623
   Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037
   Wei Y, 2002, HEPATOLOGY, V36, P692, DOI 10.1053/jhep.2002.35342
   Westerfield M., 2000, The Zebrafish Book, a Guide for the Laboratory Use of Zebrafish (Danio rerio) OR, V4th ed.
   Wong QWL, 2008, GASTROENTEROLOGY, V135, P257, DOI 10.1053/j.gastro.2008.04.003
   Wurmbach E, 2007, HEPATOLOGY, V45, P938, DOI 10.1002/hep.21622
   Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529
   Yokoyama Y, 2006, INT J ONCOL, V28, P625
NR 54
TC 82
Z9 92
U1 0
U2 29
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL,
   CAMBS, ENGLAND
SN 1754-8403
J9 DIS MODEL MECH
JI Dis. Model. Mech.
PD NOV
PY 2011
VL 4
IS 6
BP 801
EP 813
DI 10.1242/dmm.007831
PG 13
WC Cell Biology; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Pathology
GA 844QD
UT WOS:000296761500012
PM 21729876
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Wang, J
   Ying, YY
   Chen, ZH
   Shao, KD
   Zhang, WP
   Lin, SY
AF Wang, Jue
   Ying, Yin-yin
   Chen, Zhao-hui
   Shao, Ke-ding
   Zhang, Wei-ping
   Lin, Sheng-you
TI Guilu Erxian Glue Inhibits Chemotherapy-Induced Bone Marrow
   Hematopoietic Stem Cell Senescence in Mice May via
   p16<SUP>INK4a</SUP>-Rb Signaling Pathway
SO CHINESE JOURNAL OF INTEGRATIVE MEDICINE
LA English
DT Article; Early Access
DE bone marrow suppression; hematopoietic stem cell senescence; p16(INK4a);
   Guilu Erxian Glue; Chinese medicine
ID P53; MYELOSUPPRESSION; PREVENTION
AB Objective To evaluate the effect of Guilu Erxian Glue , GEG) on cyclophosphamide (CTX)-induced bone marrow hematopoietic stem cells (HSCs) senescence in mice and explore the underlying mechanism. Methods The H(22)liver cancer ascites lump model was established in male Kunming mice by injecting intraperitoneally (i.p.) with 5 x 10(6)/mL H(22)cells per mouse. Fifty tumor-bearing mice were divided into the control, model, pifithrin-alpha, GEG, and GEG+pifithrin-alpha groups using a random number table, 10 mice in each group. CTX (100 mg/kg i.p.) was administrated to mice from day 1 to day 3 (d1-d3) continuously except for the control group. The mice in the pifithrin-alpha, GEG and GEG+pifithrin-alpha groups were treated with pifithrin-alpha(2.2 mg/(kg center dot d) i.p.) for 6 consecutive days (d4-d9), GEG (9.5 g/(kg center dot d) i.p.) for 9 consecutive days (d1-d9), and GEG plus pifithrin-alpha, respectively. HSCs were collected after 9-d drug treatment. The anti-aging effect of GEG was studied by cell viability, cell cycle, and beta -galactosidase (beta -gal) assays. The mRNA and protein expressions of cyclin-dependent kinase 2 (CDK2), CDK4, inhibitor of cyclin-dependent kinase 4a encoding the tumor suppressor protein p16 (p16(INK4a)), p21(Cip1/Waf1), p53, and phosphorylated retinoblastoma (pRb) were evaluated by quantitative real-time reverse transcription-polymerase chain reaction and semi-quantitative Western blot, respectively. Results Compared with the model group, GEG increased cell viability as well as proliferation (PP<0.01) and reduced beta -gal expression. Furthermore, GEG significantly decreased the expressions of p16(INK4a), p53 and p21(Cip1/Waf1)proteins, and increased the expressions of CDK2, CDK4 and pRb proteins compared with the model group (PP<0.01). Conclusion GEG can alleviate CTX-induced HSCs senescence in mice, and the p16(INK4a)-Rb signaling pathway might be the underlying mechanism.
C1 [Wang, Jue; Ying, Yin-yin; Zhang, Wei-ping] Zhejiang Chinese Med Univ, Affiliated Hosp 3, Dept Oncol, Hangzhou 310005, Peoples R China.
   [Chen, Zhao-hui] Ningbo Forth Hosp, Dept Oncol, Ningbo 315700, Zhejiang, Peoples R China.
   [Shao, Ke-ding] Zhejiang Chinese Med Univ, Sci Res Dept, Hangzhou 310053, Peoples R China.
   [Lin, Sheng-you] Hangzhou Hosp Tradit Chinese Med, Dept Oncol, Hangzhou 310007, Peoples R China.
C3 Zhejiang Chinese Medical University; Zhejiang Chinese Medical University
RP Lin, SY (corresponding author), Hangzhou Hosp Tradit Chinese Med, Dept Oncol, Hangzhou 310007, Peoples R China.
EM linsy0628@163.com
OI Ying, Yinyin/0000-0002-2774-0709
FU National Natural Science Foundation of China [81904197]; Natural Science
   Foundation of Zhejiang Province [LQ15H290002]; 2019 Research and
   Innovation Fund Project for Young and Middle-aged Researchers of
   Zhejiang Chinese Medical University [KC201944]
FX Supported by the National Natural Science Foundation of China (No.
   81904197), Natural Science Foundation of Zhejiang Province (No.
   LQ15H290002), and 2019 Research and Innovation Fund Project for Young
   and Middle-aged Researchers of Zhejiang Chinese Medical University (No.
   KC201944)
CR Basu A, 2015, MUTAGENESIS, V30, P509, DOI 10.1093/mutage/gev011
   Chang JY, 1996, BIOCHEM BIOPH RES CO, V218, P753, DOI 10.1006/bbrc.1996.0134
   Henricks LM, 2015, ANN ONCOL, V82, P153
   Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159
   Karol SE, 2017, CANCER-AM CANCER SOC, V123, P3602, DOI 10.1002/cncr.30762
   Kumar KBH, 2005, PHYTOMEDICINE, V12, P494, DOI 10.1016/j.phymed.2004.03.009
   Lin SY, 2008, CHIN J TRADIT MED SC, V15, P172
   Liu HJ, 2013, STEM CELLS DEV, V22, P913, DOI 10.1089/scd.2012.0370
   Lu L, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060905
   Malik MZ, 2015, COMPUT BIOL CHEM, V59, P55, DOI 10.1016/j.compbiolchem.2015.07.014
   Othieno-Abinya N A, 2007, East Afr Med J, V84, P8
   Pant V, 2012, BLOOD, V120, P5118, DOI 10.1182/blood-2012-05-356014
   Perez-Campo FM, 2014, STEM CELLS, V32, P1591, DOI 10.1002/stem.1606
   Roemer K, 2012, ADV EXP MED BIOL, V727, P223, DOI 10.1007/978-1-4614-0899-4_17
   Sun X, 2018, CHIN J INTEGR MED, V24, P200, DOI 10.1007/s11655-017-2754-8
   Toussaint O, 2000, EXP GERONTOL, V35, P927, DOI 10.1016/S0531-5565(00)00180-7
   Wang BH, 2013, ZHONG LIU JI CHU YU, V26, P162
   Wang JW, 2014, BLOOD, V124, P3237, DOI 10.1182/blood-2014-04-568055
   Wang Jue, 2014, Zhongguo Zhong Xi Yi Jie He Za Zhi, V34, P947
   Wang LF, 2017, CHIN J INTEGR MED, V23, P105, DOI 10.1007/s11655-016-2503-4
   Yue Z, 2014, GENET MOL RES, V13, P10086, DOI 10.4238/2014.December.4.3
NR 21
TC 2
Z9 5
U1 5
U2 15
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1672-0415
EI 1993-0402
J9 CHIN J INTEGR MED
JI Chin. J. Integr. Med.
PD 2020 NOV
PY 2020
VL 26
IS 11
BP 819
EP 824
DI 10.1007/s11655-020-3098-3
EA SEP 2020
PG 6
WC Integrative & Complementary Medicine
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Integrative & Complementary Medicine
GA OV3IG
UT WOS:000568468100001
PM 32915425
DA 2024-02-19
ER

PT J
AU Meng, FS
   Zhou, YZ
   Wagner, A
   Bülow, JM
   Köhler, K
   Neunaber, C
   Bundkirchen, K
   Relja, B
AF Meng, Fanshuai
   Zhou, Yuzhuo
   Wagner, Alessa
   Buelow, Jasmin Maria
   Koehler, Kernt
   Neunaber, Claudia
   Bundkirchen, Katrin
   Relja, Borna
TI Impact of age on liver damage, inflammation, and molecular signaling
   pathways in response to femoral fracture and hemorrhage
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Article
DE femur fracture; hemorrhagic shock; aging; liver injury; inflammasome;
   NF-KappaB; Akt
ID NF-KAPPA-B; REDUCES MORTALITY; HEPATIC-INJURY; EXPRESSION; APOPTOSIS;
   ISCHEMIA; TRAUMA; AKT; CONTRIBUTES; PERSPECTIVE
AB BackgroundTrauma causes disability and mortality globally, leading to fractures and hemorrhagic shock. This can trigger an irregular inflammatory response that damages remote organs, including liver. Aging increases the susceptibility to dysregulated immune responses following trauma, raising the risk of organ damage, infections, and higher morbidity and mortality in elderly patients. This study investigates how aging affects liver inflammation and damage post-trauma.Methods24 male C57BL/6J mice were randomly divided into four groups. Twelve young (17-26 weeks) and 12 aged (64-72 weeks) mice were included. Mice further underwent either hemorrhagic shock (trauma/hemorrhage, TH), and femoral fracture (osteotomy) with external fixation (Fx) (THFx, n=6) or sham procedures (n=6). After 24 hours, mice were sacrificed. Liver injury and apoptosis were evaluated using hematoxylin-eosin staining and activated caspase-3 immunostaining. CXCL1 and infiltrating polymorphonuclear leukocytes (PMNL) in the liver were assessed by immunostaining, and concentrations of CXCL1, TNF, IL-1 & beta;, and IL-10 in the liver tissue were determined by ELISA. Gene expression of Tnf, Cxcl1, Il-1 & beta;, and Cxcl2 in the liver tissue was determined by qRT-PCR. Finally, western blot was used to determine protein expression levels of I & kappa;B & alpha;, Akt, and their phosphorylated forms.ResultsTHFx caused liver damage and increased presence of active caspase-3-positive cells compared to the corresponding sham group. THFx aged group had more severe liver injury than the young group. CXCL1 and PMNL levels were significantly higher in both aged groups, and THFx caused a greater increase in CXCL and PMNL levels in aged compared to the young group. Pro-inflammatory TNF and IL-1 & beta; levels were elevated in aged groups, further intensified by THFx. Anti-inflammatory IL-10 levels were lower in aged groups. Tnf and Cxcl1 gene expression was enhanced in the aged sham group. Phosphorylation ratio of I & kappa;B & alpha; was significantly increased in the aged sham group versus young sham group. THFx-induced I & kappa;B & alpha; phosphorylation in the young group was significantly reduced in the aged THFx group. Akt phosphorylation was significantly reduced in the THFx aged group compared to the THFx young group.ConclusionThe findings indicate that aging may lead to increased vulnerability to liver injury and inflammation following trauma due to dysregulated immune responses.
C1 [Meng, Fanshuai; Zhou, Yuzhuo; Wagner, Alessa; Buelow, Jasmin Maria; Relja, Borna] Ulm Univ, Dept Trauma Hand Plast & Reconstruct Surg, Translat & Expt Trauma Res, Med Ctr, Ulm, Germany.
   [Meng, Fanshuai] Uniklin RWTH Aachen, Dept Trauma & Reconstruct Surg, Aachen, Germany.
   [Zhou, Yuzhuo; Neunaber, Claudia; Bundkirchen, Katrin] Hannover Med Sch, Dept Trauma Surg, Hannover, Germany.
   [Koehler, Kernt] Justus Liebig Univ Giessen, Inst Vet Pathol, Giessen, Germany.
C3 Ulm University; RWTH Aachen University; RWTH Aachen University Hospital;
   Hannover Medical School; Justus Liebig University Giessen
RP Relja, B (corresponding author), Ulm Univ, Dept Trauma Hand Plast & Reconstruct Surg, Translat & Expt Trauma Res, Med Ctr, Ulm, Germany.
EM info@bornarelja.com
FU German Research Foundation DFG [DFG RE 3304/9-1, NE 1932/1-3]
FX This research was funded by the German Research Foundation DFG with the
   grant numbers DFG RE 3304/9-1, and NE 1932/1-3.
CR Adjei-Mosi J, 2023, AGING CELL, V22, DOI 10.1111/acel.13811
   Bai D, 2009, INT J CANCER, V125, P2863, DOI 10.1002/ijc.24748
   Balistreri CR, 2013, IMMUN AGEING, V10, DOI 10.1186/1742-4933-10-24
   Barkaway A, 2021, IMMUNITY, V54, P1494, DOI 10.1016/j.immuni.2021.04.025
   Basisty N, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000599
   Bloomer SA, 2021, AM J PHYSIOL-GASTR L, V320, pG496, DOI 10.1152/ajpgi.00286.2020
   Bortolotti P, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01900
   Bundkirchen K, 2023, BIOENGINEERING-BASEL, V10, DOI 10.3390/bioengineering10010070
   Bundkirchen K, 2018, J TRAUMA ACUTE CARE, V85, P359, DOI 10.1097/TA.0000000000001952
   Bundkirchen K, 2017, CLIN ORTHOP RELAT R, V475, P2783, DOI 10.1007/s11999-017-5473-8
   Freitas Maria Célia de, 2002, Rev. Latino-Am. Enfermagem, V10, P221
   Duggal NA, 2013, AGING CELL, V12, P873, DOI 10.1111/acel.12114
   Dutta S, 2016, LIFE SCI, V152, P244, DOI 10.1016/j.lfs.2015.10.025
   Fabregat I, 2007, LIVER INT, V27, P155, DOI 10.1111/j.1478-3231.2006.01409.x
   Fine N, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.571085
   Franceschi C, 2000, ANN NY ACAD SCI, V908, P244
   Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016
   Fulop T, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01960
   Gomez CR, 2009, SHOCK, V31, P178, DOI 10.1097/SHK.0b013e318180feb8
   Hildebrand F, 2004, INJURY, V35, P678, DOI 10.1016/j.injury.2004.03.004
   Hill JK, 1999, BRAIN RES, V820, P45, DOI 10.1016/S0006-8993(98)01140-8
   Huber N, 2009, HEPATOLOGY, V49, P1718, DOI 10.1002/hep.22840
   Huber-Lang M, 2018, NAT IMMUNOL, V19, P327, DOI 10.1038/s41590-018-0064-8
   Jin CJ, 2020, AM J PHYSIOL-GASTR L, V318, pG736, DOI 10.1152/ajpgi.00345.2018
   Karin M, 2000, SEMIN IMMUNOL, V12, P85, DOI 10.1006/smim.2000.0210
   Lane MK, 2015, ORTHOPEDICS, V38, pE588, DOI 10.3928/01477447-20150701-56
   Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910
   LLOYD AR, 1992, IMMUNOL TODAY, V13, P169, DOI 10.1016/0167-5699(92)90121-M
   Lord JM, 2014, LANCET, V384, P1455, DOI 10.1016/S0140-6736(14)60687-5
   Lu QM, 2017, INT J CLIN EXP PATHO, V10, P7340
   Meng FY, 2002, J BIOL CHEM, V277, P29674, DOI 10.1074/jbc.M112464200
   Mörs K, 2016, IMMUNOBIOLOGY, V221, P904, DOI 10.1016/j.imbio.2016.03.005
   Mullonkal CJ, 2007, J INVEST SURG, V20, P195, DOI 10.1080/08941930701366471
   Neary JT, 2005, J NEUROTRAUM, V22, P491, DOI 10.1089/neu.2005.22.491
   Nyugen J, 2010, J CLIN IMMUNOL, V30, P806, DOI 10.1007/s10875-010-9448-8
   Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034
   Okaya T, 2005, SHOCK, V24, P421, DOI 10.1097/01.shk.0000181282.14050.11
   Patel NM, 2023, ANN SURG, V277, pE624, DOI 10.1097/SLA.0000000000005357
   Patel NM, 2022, FRONT IMMUNOL, V13, DOI 10.3389/fimmu.2022.886421
   Pestka JJ, 2008, FOOD CHEM TOXICOL, V46, P2826, DOI 10.1016/j.fct.2008.05.016
   Relja B, 2012, BRIT J PHARMACOL, V165, P1188, DOI 10.1111/j.1476-5381.2011.01595.x
   Relja B, 2020, EUR J TRAUMA EMERG S, V46, P751, DOI 10.1007/s00068-019-01235-w
   Relja B, 2010, SHOCK, V34, P46, DOI 10.1097/SHK.0b013e3181cd8d05
   Renshaw M, 2002, J IMMUNOL, V169, P4697, DOI 10.4049/jimmunol.169.9.4697
   Robinson MW, 2016, CELL MOL IMMUNOL, V13, P267, DOI 10.1038/cmi.2016.3
   Sadatomo A, 2017, J IMMUNOL, V199, P3306, DOI 10.4049/jimmunol.1700717
   Sander LE, 2010, J EXP MED, V207, P1453, DOI 10.1084/jem.20091474
   Senftleben U, 2002, CRIT CARE MED, V30, pS18, DOI 10.1097/00003246-200201001-00003
   Shi YL, 2021, SHOCK, V55, P630, DOI 10.1097/SHK.0000000000001556
   Störmann P, 2020, EUR J TRAUMA EMERG S, V46, P31, DOI 10.1007/s00068-019-01098-1
   Tang B, 2016, INT J NANOMED, V11, P6401, DOI 10.2147/IJN.S101285
   Wafaisade A, 2011, CRIT CARE MED, V39, P621, DOI 10.1097/CCM.0b013e318206d3df
   Wilgus TA, 2013, ADV WOUND CARE, V2, P379, DOI 10.1089/wound.2012.0383
   World Health Organization, 2022, Preventing injuries and violence: an overview
NR 54
TC 1
Z9 1
U1 2
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD AUG 24
PY 2023
VL 14
AR 1239145
DI 10.3389/fimmu.2023.1239145
PG 13
WC Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology
GA Q8EN7
UT WOS:001059800900001
PM 37691959
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Shiu, TY
   Shih, YL
   Feng, AC
   Lin, HH
   Huang, SM
   Huang, TY
   Hsieh, CB
   Chang, WK
   Hsieh, TY
AF Shiu, Tzu-Yue
   Shih, Yu-Lueng
   Feng, An-Chieh
   Lin, Hsuan-Hwai
   Huang, Shih-Ming
   Huang, Tien-Yu
   Hsieh, Chung-Bao
   Chang, Wei-Kuo
   Hsieh, Tsai-Yuan
TI HCV core inhibits hepatocellular carcinoma cell replicative senescence
   through downregulating microRNA-138 expression
SO JOURNAL OF MOLECULAR MEDICINE-JMM
LA English
DT Article
DE Hepatitis C virus; Hepatocellular carcinoma; MicroRNA; Telomerase
   reverse transcriptase
ID HEPATITIS-C VIRUS; SIGNAL PEPTIDE PEPTIDASE; TELOMERASE
   REVERSE-TRANSCRIPTASE; VIRAL PROPAGATION; PROTEIN; MIR-138; CANCER;
   METASTASIS; INVASION; CHEMOSENSITIVITY
AB Hepatitis C virus (HCV) infection is a major cause of chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma (HCC). HCV core protein is considered as a positive regulator of telomerase activity. In this study, we focused on the deregulated microRNA-138 (miR-138) in HCV-associated HCC. Differential expression of miR-138 was determined by TaqMan quantitative real-time PCR. The target gene of miR-138 was verified by luciferase reporter assay, quantitative real-time PCR, and Western blotting. Moreover, three assays based on telomerase activity, cell proliferation, and senescence-associated beta-galactosidase activity were performed. The correlation analysis revealed a significantly negative correlation between miR-138 and telomerase reverse transcriptase (TERT) mRNA expression in HCC. Further, we showed that mature HCV core protein of 173 amino acids, but not full-length form of 191 amino acids, suppressed miR-138 expression. TERT was verified as a direct target of miR-138 in HCC cells. Furthermore, TERT-targeting miR-138 supplementation can prevent HCV core protein from repressing HCC cell replicative senescence. Collectively, HCV core protein can enhance TERT protein expression through downregulating TERT-targeting miR-138 expression, which in turn inhibits HCC cell replicative senescence. This study may further help our understanding on the pathogenic mechanisms of HCV core protein in HCV-associated HCC development.
C1 [Shiu, Tzu-Yue; Shih, Yu-Lueng; Lin, Hsuan-Hwai; Huang, Tien-Yu; Chang, Wei-Kuo; Hsieh, Tsai-Yuan] Triserv Gen Hosp, Div Gastroenterol, Dept Internal Med, Natl Def Med Ctr, Taipei, Taiwan.
   [Feng, An-Chieh; Hsieh, Chung-Bao] Triserv Gen Hosp, Div Gen Surg, Dept Surg, Natl Def Med Ctr, Taipei, Taiwan.
   [Huang, Shih-Ming] Natl Def Med Ctr, Dept & Grad Inst Biochem, Taipei, Taiwan.
C3 National Defense Medical Center; Tri-Service General Hospital;
   Tri-Service General Hospital; National Defense Medical Center; National
   Defense Medical Center
RP Hsieh, TY (corresponding author), Triserv Gen Hosp, Div Gastroenterol, Dept Internal Med, Natl Def Med Ctr, Taipei, Taiwan.
EM tyh1216@ms46.hinet.net
FU Foundation for Medical Research of Tri-Service General Hospital;
   Ministry of Science and Technology [TSGH-C102-063, TSGH-C103-069,
   TSGH-C104-061, MOST 103-2314-B-016-009]
FX This study was supported by grants from the Foundation for Medical
   Research of Tri-Service General Hospital and Ministry of Science and
   Technology (TSGH-C102-063, TSGH-C103-069, TSGH-C104-061 and MOST
   103-2314-B-016-009). We thank King-Song Jeng and Michael M.C. Lai at the
   Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan,
   Republic of China, for providing the full-length HCV replicon of HCV-N
   strain of genotype 1b.
CR Aizawa S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11379
   Bailey SM, 2006, NUCLEIC ACIDS RES, V34, P2408, DOI 10.1093/nar/gkl303
   Bartosch B, 2009, J HEPATOL, V51, P810, DOI 10.1016/j.jhep.2009.05.008
   Bellon M, 2008, JNCI-J NATL CANCER I, V100, P98, DOI 10.1093/jnci/djm269
   Braconi C, 2010, CLIN CANCER RES, V16, P957, DOI 10.1158/1078-0432.CCR-09-2123
   Cerone MA, 2001, HUM MOL GENET, V10, P1945, DOI 10.1093/hmg/10.18.1945
   Chakrabarti M, 2013, EXP CELL RES, V319, P1575, DOI 10.1016/j.yexcr.2013.02.025
   Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934
   Guo XL, 2008, CANCER BIOL THER, V7, P1555, DOI 10.4161/cbt.7.10.6539
   Hayes J, 2014, TRENDS MOL MED, V20, P460, DOI 10.1016/j.molmed.2014.06.005
   Jiang L, 2010, INT J CANCER, V127, P505, DOI 10.1002/ijc.25320
   Kawakami Y, 2000, ONCOGENE, V19, P3888, DOI 10.1038/sj.onc.1203733
   Li J, 2014, NUCLEIC ACIDS RES, V42, P458, DOI 10.1093/nar/gkt839
   Liu DJ, 2015, BIOCHEM BIOPH RES CO, V464, P1215, DOI 10.1016/j.bbrc.2015.07.107
   Long LM, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-275
   Ma F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126499
   Mitomo S, 2008, CANCER SCI, V99, P280, DOI 10.1111/j.1349-7006.2007.00666.x
   Moradpour D, 2013, CURR TOP MICROBIOL, V369, P113, DOI 10.1007/978-3-642-27340-7_5
   Moriishi K, 2003, J VIROL, V77, P10237, DOI 10.1128/JVI.77.19.10237-10249.2003
   Moriishi K, 2007, P NATL ACAD SCI USA, V104, P1661, DOI 10.1073/pnas.0607312104
   Moriishi K, 2010, HEPATOLOGY, V52, P411, DOI 10.1002/hep.23680
   Okamoto K, 2008, J VIROL, V82, P8349, DOI 10.1128/JVI.00306-08
   Ozturk N, 2006, P NATL ACAD SCI USA, V103, P2178, DOI 10.1073/pnas.0510877103
   Pène V, 2009, J VIRAL HEPATITIS, V16, P705, DOI 10.1111/j.1365-2893.2009.01118.x
   Ray RB, 2000, VIROLOGY, V271, P197, DOI 10.1006/viro.2000.0295
   Satyanarayana A, 2004, CELL CYCLE, V3, P1138
   Shay JW, 2005, CARCINOGENESIS, V26, P867, DOI 10.1093/carcin/bgh296
   Shiu TY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061089
   Shrivastava S, 2015, GENES DIS, V2, P35, DOI 10.1016/j.gendis.2015.01.001
   Suzuki R, 2005, J VIROL, V79, P1271, DOI 10.1128/JVI.79.2.1271-1281.2005
   Targett-Adams P, 2008, J BIOL CHEM, V283, P16850, DOI 10.1074/jbc.M802273200
   Wang C, 1997, Zhonghua Zhong Liu Za Zhi, V19, P85
   Wang Q, 2013, ONCOL REP, V29, P2046, DOI 10.3892/or.2013.2304
   Wang W, 2012, CARCINOGENESIS, V33, P1113, DOI 10.1093/carcin/bgs113
   Yeh YM, 2013, INT J CANCER, V133, P867, DOI 10.1002/ijc.28086
   Zhang HJ, 2013, CELL PHYSIOL BIOCHEM, V31, P56, DOI 10.1159/000343349
   Zhang J, 2016, BIOMED PHARMACOTHER, V77, P135, DOI 10.1016/j.biopha.2015.12.018
   Zhu ZW, 2010, J MED VIROL, V82, P239, DOI 10.1002/jmv.21644
NR 38
TC 15
Z9 16
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0946-2716
EI 1432-1440
J9 J MOL MED
JI J. Mol. Med.
PD JUN
PY 2017
VL 95
IS 6
BP 629
EP 639
DI 10.1007/s00109-017-1518-4
PG 11
WC Genetics & Heredity; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity; Research & Experimental Medicine
GA EV8GA
UT WOS:000402017500007
PM 28258280
DA 2024-02-19
ER

PT J
AU Reece, AS
AF Reece, Albert Stuart
TI Chronic immune stimulation as a contributing cause of chronic disease in
   opiate addiction including multi-system ageing
SO MEDICAL HYPOTHESES
LA English
DT Article
ID C-REACTIVE PROTEIN; DENSITY-LIPOPROTEIN CHOLESTEROL; MAINTENANCE
   TREATMENT PATIENTS; OBSTRUCTIVE PULMONARY-DISEASE; BONE-MINERAL DENSITY;
   TOLL-LIKE RECEPTOR-4; TNF-ALPHA PRODUCTION; 3RD MAJOR SYSTEM;
   CRYSTAL-STRUCTURE; STATIN THERAPY
AB Evidence of immune stimulation has been noted in opiate dependent patients for many decades. Documented changes have included lymphadenopathy, round cell infiltration of the hepatic portal triads, diffuse pen-bronchitis, hyperglobulinaemia, lymphocytosis, monocytosis, systemic cytokine stimulation, and cytokine and chemokine activation within the neuraxis. A parallel literature describes an elevated list of chronic degenerative disease as common in such patients including neurodegenerative conditions, atherosclerosis, nephrosclerosis, hepatic fibrosis and cirrhosis, chronic obstructive and fibrotic lung disease, osteoporosis, chronic periodontitis, various cancers, hair greying, and stem cell suppression. All of these disorders are now known to have an important immunological role in their pathogenic pathways. The multisystem nature of these myriad changes strongly suggest that the ageing process itself is stimulated in these patients. The link between the immunostimulation on the one hand and the elevated and temporally advanced nature of the chronic degenerative diseases on the other appears not to have been made in the literature. Moreover as immunostimulation is also believed to be an important, potent and principal contributor to the ageing process it appears that experimental and studies of this putative link are warranted. Verification of such an hypothesis would also carry management implications for dose and duration of chronic pain and addiction treatment, pharmacotherapeutic selection, and novel treatments such as long term naltrexone implant therapy and heroin trials. (C) 2010 Elsevier Ltd. All rights reserved.
C1 Univ Western Australia, Sch Psychiat & Clin Neurosci, Nedlands, WA 6009, Australia.
C3 University of Western Australia
RP Reece, AS (corresponding author), Univ Western Australia, Sch Psychiat & Clin Neurosci, Nedlands, WA 6009, Australia.
EM sreece@bigpond.net.au
RI Reece, Albert/AGM-5055-2022
CR Adler MW, 2005, AAPS J, V7, pE865, DOI 10.1208/aapsj070484
   Adler MW, 2005, J LEUKOCYTE BIOL, V78, P1204, DOI 10.1189/jlb.0405222
   Albert MA, 2001, JAMA-J AM MED ASSOC, V286, P64, DOI 10.1001/jama.286.1.64
   Alberts B, 2008, MOL BIOL CELL
   Andresz V, 2006, ADDICTION, V101, P1347, DOI 10.1111/j.1360-0443.2006.01521.x
   Angelini F, 2007, INT J IMMUNOPATH PH, V20, P59, DOI 10.1177/039463200702000107
   Arnsten JH, 2006, CLIN INFECT DIS, V42, P1014, DOI 10.1086/501015
   Arnsten JH, 2007, AIDS, V21, P617, DOI 10.1097/QAD.0b013e3280148c05
   Backmund M, 2005, J ADDICT DIS, V24, P17, DOI 10.1300/J69v24n0402
   Bailey MT, 2009, PHYSIOL BEHAV, V98, P351, DOI 10.1016/j.physbeh.2009.06.013
   Barnes N, 2007, THORAX, V62, P927, DOI 10.1136/thx.2007.082677
   Bauer S, 2007, NAT REV NEUROSCI, V8, P221, DOI 10.1038/nrn2054
   BEHMARD S, 1981, ACTA CYTOL, V25, P142
   Bhat R, 2009, NEURON, V64, P123, DOI 10.1016/j.neuron.2009.09.015
   Bland ST, 2009, BRAIN BEHAV IMMUN
   Blandino P, 2009, BRAIN BEHAV IMMUN, V23, P958, DOI 10.1016/j.bbi.2009.04.013
   Boulanger LM, 2009, NEURON, V64, P93, DOI 10.1016/j.neuron.2009.09.001
   Brunton L. L., 2018, GOODMAN GILMANS PHAR
   Burns L, 2009, ADDICTION, V104, P1363, DOI 10.1111/j.1360-0443.2009.02633.x
   Camí J, 2003, NEW ENGL J MED, V349, P975, DOI 10.1056/NEJMra023160
   Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003
   Carpentier PA, 2009, NEURON, V64, P79, DOI 10.1016/j.neuron.2009.08.038
   CARTER EF, 1978, AUST DENT J, V23, P308, DOI 10.1111/j.1834-7819.1978.tb03528.x
   CERIELLO A, 1987, HORM METAB RES, V19, P430, DOI 10.1055/s-2007-1011844
   CERIELLO A, 1988, DIABETES CARE, V11, P443, DOI 10.2337/diacare.11.5.443
   CHAO CC, 1992, J PHARMACOL EXP THER, V262, P19
   Chaturvedi AK, 2010, J CLIN ONCOL
   Cheng F, 2009, MOL BIOL CELL, V20, P319, DOI 10.1091/mbc.E08-07-0681
   Chien KR, 2005, CELL, V120, P533, DOI 10.1016/j.cell.2005.02.006
   Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003
   Cosio MG, 1999, AM J RESP CRIT CARE, V160, pS21, DOI 10.1164/ajrccm.160.supplement_1.7
   Covacu R, 2009, J IMMUNOL, V182, P6889, DOI 10.4049/jimmunol.0802907
   DARKE S, 1992, DRUG ALCOHOL DEPEN, V31, P31, DOI 10.1016/0376-8716(92)90005-W
   Darke S, 2006, ADDICTION, V101, P1299, DOI 10.1111/j.1360-0443.2006.01495.x
   Davis G, 2009, NEUROSCI LETT, V465, P282, DOI 10.1016/j.neulet.2009.09.035
   de Calignon A, 2010, NATURE, V464, P1201, DOI 10.1038/nature08890
   Decramer M, 2008, COPD, V5, P235, DOI 10.1080/15412550802237531
   Desvarieux M, 2003, STROKE, V34, P2120, DOI 10.1161/01.STR.0000085086.50957.22
   Deverman BE, 2009, NEURON, V64, P61, DOI 10.1016/j.neuron.2009.09.002
   Dos Santos Silva I, 2010, INT J EPIDEMIOL
   Dozio E, 2009, CURR PROTEIN PEPT SC, V10, P577, DOI 10.2174/138920309789630561
   Dyer KR, 1997, ADDICTION, V92, P1445, DOI 10.1111/j.1360-0443.1997.tb02866.x
   Eisch AJ, 2004, AM J PSYCHIAT, V161, P426, DOI 10.1176/appi.ajp.161.3.426
   Eisch AJ, 2002, PROG BRAIN RES, V138, P315, DOI 10.1016/S0079-6123(02)38085-3
   Eisch AJ, 2000, P NATL ACAD SCI USA, V97, P7579, DOI 10.1073/pnas.120552597
   Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100
   Ekhlassi S, 2008, J PERIODONTAL RES, V43, P431, DOI 10.1111/j.1600-0765.2008.01090.x
   Erlinger TP, 2004, JAMA-J AM MED ASSOC, V291, P585, DOI 10.1001/jama.291.5.585
   FAHMY MS, 1983, COMMUNITY DENT ORAL, V11, P50, DOI 10.1111/j.1600-0528.1983.tb01354.x
   Fan Jing, 2006, Subst Abus, V27, P25, DOI 10.1300/J465v27n01_04
   Fauci AS, 2008, HARRISONS PRINCIPLES
   Fellin Tommaso, 2007, ScientificWorldJournal, V7, P89
   Flores I, 2008, GENE DEV, V22, P654, DOI 10.1101/gad.451008
   FRANCESCHI C, 1995, IMMUNOL TODAY, V16, P12, DOI 10.1016/0167-5699(95)80064-6
   Friedewald VE, 2009, J PERIODONTOL, V80, P1021, DOI 10.1902/jop.2009.097001
   Frost RA, 2004, AM J PHYSIOL-CELL PH, V287, pC1605, DOI 10.1152/ajpcell.00010.2004
   Gamonal J, 2000, J PERIODONTOL, V71, P1535, DOI 10.1902/jop.2000.71.10.1535
   Garrod R, 2007, MED HYPOTHESES, V68, P291, DOI 10.1016/j.mehy.2006.07.028
   Ghavamzadeh A, 2001, SEMIN ONCOL, V28, P153, DOI [10.1053/sonc.2001.21957, 10.1016/S0093-7754(01)90086-7]
   Gimeno D, 2009, PSYCHOL MED, V39, P413, DOI 10.1017/S0033291708003723
   Gosnell BA, 2009, INT J OBESITY, V33, pS54, DOI 10.1038/ijo.2009.73
   Gosselin D, 2007, BRAIN BEHAV IMMUN, V21, P281, DOI 10.1016/j.bbi.2006.12.004
   Gottschalk L A, 1979, NIDA Res Monogr, V29, P1
   Gutiérrez-Venegas G, 2006, LIFE SCI, V78, P2577, DOI 10.1016/j.lfs.2005.10.033
   Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430
   Haraszthy VI, 2000, J PERIODONTOL, V71, P1554, DOI 10.1902/jop.2000.71.10.1554
   Hennighausen L, 2001, DEV CELL, V1, P467, DOI 10.1016/S1534-5807(01)00064-8
   Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446
   Hoge EA, 2009, DEPRESS ANXIETY, V26, P447, DOI 10.1002/da.20564
   Howren MB, 2009, PSYCHOSOM MED, V71, P171, DOI 10.1097/PSY.0b013e3181907c1b
   Hser YI, 2004, J BEHAV MED, V27, P607, DOI 10.1007/s10865-004-0005-x
   Hutchinson Mark R, 2007, ScientificWorldJournal, V7, P98
   Hutchinson MR, 2010, BRAIN BEHAV IMMUN, V24, P83, DOI 10.1016/j.bbi.2009.08.004
   Hutchinson MR, 2009, BRAIN BEHAV IMMUN, V23, P240, DOI 10.1016/j.bbi.2008.09.012
   Hutchinson MR, 2009, NEUROSCIENCE
   Hutchinson MR, 2009, BRAIN BEHAV IMMUN
   ISBELL H, 1953, AM J MED, V14, P558, DOI 10.1016/0002-9343(53)90371-4
   Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007
   Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008
   Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018
   Kiechl S, 2002, NEW ENGL J MED, V347, P185, DOI 10.1056/NEJMoa012673
   Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002
   Kim TW, 2006, DRUG ALCOHOL DEPEN, V85, P258, DOI 10.1016/j.drugalcdep.2006.05.027
   Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027
   Kolarzyk Emilia, 2005, Przegl Lek, V62, P373
   Kravitz BA, 2009, ALZHEIMERS DEMENT, V5, P318, DOI 10.1016/j.jalz.2009.04.1230
   Kriszbacher I, 2005, NEW ENGL J MED, V353, P429
   LASKY DI, 1977, PHARMACOL BIOCHEM BE, V7, P281, DOI 10.1016/0091-3057(77)90147-2
   Lavie E, 2009, DRUG ALCOHOL DEPEN, V99, P338, DOI 10.1016/j.drugalcdep.2008.07.017
   Lawrence Diane M P, 2007, ScientificWorldJournal, V7, P86
   Lee HH, 2007, PROTEINS, V69, P672, DOI 10.1002/prot.21504
   Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293
   Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028
   Mancinella A, 2009, ARCH GERONTOL GERIAT, V49, P185, DOI 10.1016/j.archger.2009.09.028
   Mao JR, 2002, J NEUROSCI, V22, P7650
   Mark LL, 2000, J PERIODONTAL RES, V35, P172, DOI 10.1034/j.1600-0765.2000.035003172.x
   Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532
   Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004
   Martinon F, 2007, SEMIN IMMUNOPATHOL, V29, P213, DOI 10.1007/s00281-007-0079-y
   Masters SL, 2009, ANNU REV IMMUNOL, V27, P621, DOI 10.1146/annurev.immunol.25.022106.141627
   MATTILA KJ, 1993, EUR HEART J, V14, P51
   Melmed S, 1997, TRENDS ENDOCRIN MET, V8, P391, DOI 10.1016/S1043-2760(97)00156-2
   Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533
   Mora S, 2006, AM J CARDIOL, V97, p33A, DOI 10.1016/j.amjcard.2005.11.014
   Moraska A, 2002, J APPL PHYSIOL, V93, P207, DOI 10.1152/japplphysiol.01151.2001
   Mousavi MRA, 2003, LARYNGOSCOPE, V113, P1939, DOI 10.1097/00005537-200311000-00016
   Neri S, 2005, PSYCHOPHARMACOLOGY, V179, P700, DOI 10.1007/s00213-005-2239-x
   Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0
   Nieto FJ, 1998, AM J EPIDEMIOL, V148, P937, DOI 10.1093/oxfordjournals.aje.a009570
   Nissen SE, 2005, NEW ENGL J MED, V352, P29, DOI 10.1056/NEJMoa042000
   O'Bryant SE, 2010, J GERIATR PSYCH NEUR, V23, P49, DOI 10.1177/0891988709351832
   Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111
   Olszewski PK, 2001, NEUROREPORT, V12, P1727, DOI 10.1097/00001756-200106130-00042
   Osborn M, 2003, AUST DENT J, V48, P34, DOI 10.1111/j.1834-7819.2003.tb00006.x
   Park YK, 2007, ANGEW CHEM INT EDIT, V46, P8230, DOI 10.1002/anie.200702324
   PASSARIELLO N, 1986, J ENDOCRINOL INVEST, V9, P353, DOI 10.1007/BF03346942
   PASSARIELLO N, 1983, METABOLISM, V32, P1163, DOI 10.1016/0026-0495(83)90065-3
   Peles E, 2007, J AFFECT DISORDERS, V99, P213, DOI 10.1016/j.jad.2006.09.017
   Raghavendra V, 2004, NEUROPSYCHOPHARMACOL, V29, P327, DOI 10.1038/sj.npp.1300315
   Raghavendra V, 2002, J NEUROSCI, V22, P9980, DOI 10.1523/jneurosci.22-22-09980.2002
   Ray KK, 2005, J AM COLL CARDIOL, V46, P1417, DOI 10.1016/j.jacc.2005.08.024
   Reece AS, 2007, AUST DENT J, V52, P144, DOI 10.1111/j.1834-7819.2007.tb00480.x
   Reece A, 2007, AUST NZ J OBSTET GYN, V47, P419, DOI 10.1111/j.1479-828X.2007.00769.x
   Reece AS, 2007, SUBST ABUSE TREAT PR, V2, DOI 10.1186/1747-597X-2-19
   Reece Albert Stuart, 2007, Immun Ageing, V4, P6, DOI 10.1186/1742-4933-4-6
   Reece S, 2009, AUST DENT J, V54, P185, DOI 10.1111/j.1834-7819.2009.01116_7.x
   Ridker PM, 2001, NEW ENGL J MED, V344, P1959, DOI 10.1056/NEJM200106283442601
   Ridker PM, 2005, NEW ENGL J MED, V352, P20, DOI 10.1056/NEJMoa042378
   Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993
   Roberts RO, 2010, ALZ DIS ASSOC DIS, V24, P11, DOI 10.1097/WAD.0b013e3181a4485c
   Roberts RO, 2009, ALZHEIMERS DEMENT, V5, P398, DOI 10.1016/j.jalz.2009.01.025
   Rolls A, 2007, NAT CELL BIOL, V9, P1081, DOI 10.1038/ncb1629
   Rosen D, 2008, AM J GERIAT PSYCHIAT, V16, P488, DOI 10.1097/JGP.0b013e31816ff35a
   Rückerl R, 2009, CLIN CHEM, V55, P322, DOI 10.1373/clinchem.2008.112334
   SADEGHI A, 1978, CANCER, V42, P353, DOI 10.1002/1097-0142(197807)42:1<353::AID-CNCR2820420153>3.0.CO;2-W
   SADEGHI A, 1977, CANCER, V40, P841, DOI 10.1002/1097-0142(197708)40:2<841::AID-CNCR2820400237>3.0.CO;2-K
   SADEGHI A, 1979, CANCER-AM CANCER SOC, V43, P2315, DOI 10.1002/1097-0142(197906)43:6<2315::AID-CNCR2820430622>3.0.CO;2-J
   Sadeghian S, 2007, EUR J CARDIOV PREV R, V14, P715, DOI 10.1097/HJR.0b013e328045c4e9
   Salvemini D, 2009, TRENDS PHARMACOL SCI, V30, P194, DOI 10.1016/j.tips.2008.12.005
   SANSONI P, 1993, BLOOD, V82, P2767
   Schaefer AS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000378
   Schroder K, 2010, SCIENCE, V327, P296, DOI 10.1126/science.1184003
   Schurr E, 2009, NEW ENGL J MED, V361, P2666, DOI 10.1056/NEJMe0910690
   Shimon I, 1997, J CLIN INVEST, V100, P357, DOI 10.1172/JCI119541
   Singhal P, 2001, ADV EXP MED BIOL, V493, P127
   Singhal PC, 2002, J IMMUNOL, V168, P4025, DOI 10.4049/jimmunol.168.8.4025
   Singhal PC, 2000, IMMUNOLOGY, V100, P57, DOI 10.1046/j.1365-2567.2000.00007.x
   Skipworth RJ, 2010, SUPPORT CARE CANC
   Stein MD, 1999, PSYCHIAT CLIN N AM, V22, P351, DOI 10.1016/S0193-953X(05)70081-2
   Steingrímsson E, 2005, CELL, V121, P9, DOI 10.1016/j.cell.2005.03.021
   Stewart JC, 2009, BRAIN BEHAV IMMUN, V23, P936, DOI 10.1016/j.bbi.2009.04.011
   Sundelöf J, 2009, J ALZHEIMERS DIS, V18, P79, DOI 10.3233/JAD-2009-1126
   Svensson AL, 2008, P NATL ACAD SCI USA, V105, P7304, DOI 10.1073/pnas.0802531105
   Thompson PD, 2003, ARTERIOSCL THROM VAS, V23, pE42, DOI 10.1161/01.ATV.0000089628.63625.D4
   Ting JPY, 2010, SCIENCE, V327, P286, DOI 10.1126/science.1184004
   Vestergaard P, 2006, J INTERN MED, V260, P76, DOI 10.1111/j.1365-2796.2006.01667.x
   Watkins LR, 2000, ANNU REV PSYCHOL, V51, P29, DOI 10.1146/annurev.psych.51.1.29
   Watkins LR, 2009, TRENDS PHARM SCI
   WEAVER JM, 1966, ACTA CYTOL, V10, P154
   Weizman T, 2003, AUST NZ J PSYCHIAT, V37, P458, DOI 10.1046/j.1440-1614.2003.01211.x
   White F, 2010, NEUROPHARMACOLOGY, V58, P35, DOI 10.1016/j.neuropharm.2009.07.012
   Wikby A, 2005, J GERONTOL A-BIOL, V60, P556, DOI 10.1093/gerona/60.5.556
   Wu TJ, 2000, AM J EPIDEMIOL, V151, P273, DOI 10.1093/oxfordjournals.aje.a010203
   Wu TJ, 2000, ARCH INTERN MED, V160, P2749, DOI 10.1001/archinte.160.18.2749
   Yano Y, 2010, J GERONTOL A-BIOL, V65, P547, DOI 10.1093/gerona/glq030
   Yin DL, 2006, J NEUROIMMUNOL, V174, P101, DOI 10.1016/j.jneuroim.2006.02.001
   ZAGON IS, 1977, EXPERIENTIA, V33, P1486, DOI 10.1007/BF01918824
   ZAGON IS, 1977, PHARMACOLOGY, V15, P276, DOI 10.1159/000136699
   ZAGON IS, 1977, PHARMACOLOGY, V15, P302, DOI 10.1159/000136703
   Zagon IS, 2002, BRAIN RES REV, V38, P351, DOI 10.1016/S0165-0173(01)00160-6
   ZAGON IS, 1977, EXP NEUROL, V56, P538, DOI 10.1016/0014-4886(77)90320-X
   Zheng H, 2007, J NEUROSCI, V27, P11075, DOI 10.1523/JNEUROSCI.3542-07.2007
NR 172
TC 14
Z9 14
U1 0
U2 13
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0306-9877
EI 1532-2777
J9 MED HYPOTHESES
JI Med. Hypotheses
PD DEC
PY 2010
VL 75
IS 6
BP 613
EP 619
DI 10.1016/j.mehy.2010.07.047
PG 7
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA 715VO
UT WOS:000286918300041
PM 20800362
DA 2024-02-19
ER

PT J
AU Wang, Y
   Wang, JH
   Li, HH
   Lao, JL
   Jia, D
   Liu, JL
   Wang, JM
   Luo, JX
   Guan, GQ
   Yin, H
   Li, YQ
AF Wang, Ya
   Wang, Jiahui
   Li, Hehai
   Lao, Jianlong
   Jia, Dan
   Liu, Junlong
   Wang, Jinming
   Luo, Jianxun
   Guan, Guiquan
   Yin, Hong
   Li, Youquan
TI Antioxidant effects of <i>Bifidobacterium longum</i> T37a in mice weight
   loss and aging model induced by D-galactose
SO BMC MICROBIOLOGY
LA English
DT Article
DE Bifidobacterium longum; Antioxidant; Anti-aging
ID MECHANISMS
AB BackgroundProbiotics can reduce free radical scavenging rate and oxidative damage, and improve activity of crucial antioxidative enzymes in host cells. This study aimed to isolate Bifidobacterium spp. from faeces of babies, and investigate the antioxidant effects of the Bif. longum T37a in mice weight loss and aging model induced by D-galactose.ResultsT37a have good antioxidant properties in the DPPH assay and anti-lipid peroxidation test. Compared with the model group, T37a low group significantly increased the thymus index and the levels of T-AOC and GSH-Px of mice. T37a high group significantly decreased the spleen and liver index of mice and the levels of MDA in liver, significantly increased in liver HDL-C levels, and decreased LDL-C in liver.ConclusionsT37a may be an anti-aging and weight-loss probiotics for its antioxidant capacity, and it is necessary to study further the molecular mechanism of T37a as antioxidant.
C1 [Wang, Ya; Wang, Jiahui; Li, Hehai; Lao, Jianlong; Jia, Dan; Li, Youquan] Guangdong Ocean Univ, Coll Coastal Agr Sci, Dept Vet Med, Zhanjiang 524088, Guangdong, Peoples R China.
   [Wang, Ya; Wang, Jiahui] Lanzhou Univ Technol, Coll Life Sci & Engn, Lanzhou 730050, Peoples R China.
   [Wang, Jiahui; Jia, Dan; Liu, Junlong; Wang, Jinming; Luo, Jianxun; Guan, Guiquan; Yin, Hong; Li, Youquan] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Key Lab Vet Parasitol Gansu Prov, Lanzhou 730046, Peoples R China.
C3 Guangdong Ocean University; Lanzhou University of Technology; Chinese
   Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute,
   CAAS
RP Wang, Y; Li, YQ (corresponding author), Guangdong Ocean Univ, Coll Coastal Agr Sci, Dept Vet Med, Zhanjiang 524088, Guangdong, Peoples R China.; Wang, Y (corresponding author), Lanzhou Univ Technol, Coll Life Sci & Engn, Lanzhou 730050, Peoples R China.; Li, YQ (corresponding author), Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Key Lab Vet Parasitol Gansu Prov, Lanzhou 730046, Peoples R China.
EM youquan-li@163.com
RI wang, xiao/HZI-9156-2023
CR Agerholm-Larsen L, 2000, EUR J CLIN NUTR, V54, P288, DOI 10.1038/sj.ejcn.1600937
   Araki M, 2014, REPROD BIOL ENDOCRIN, V12, P1, DOI 10.1186/1477-7827-12-108
   Ashraf R, 2014, CRIT REV FOOD SCI, V54, P938, DOI 10.1080/10408398.2011.619671
   Azman KF, 2019, BIOGERONTOLOGY, V20, P763, DOI 10.1007/s10522-019-09837-y
   Babbar N, 2011, FOOD RES INT, V44, P391, DOI 10.1016/j.foodres.2010.10.001
   Bergey DH, 2012, ACTINOBACTERIA
   Cebe T, 2014, EXP GERONTOL, V57, P132, DOI 10.1016/j.exger.2014.05.017
   Chen P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19732-0
   Damodharan K, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00768
   Diamanti-Kandarakis E, 2017, EUR J ENDOCRINOL, V176, pR283, DOI 10.1530/EJE-16-1061
   Du YJ, 2021, GUT MICROBES, V13, DOI 10.1080/19490976.2021.1994835
   Horácková S, 2018, BIOTECHNOL ADV, V36, P682, DOI 10.1016/j.biotechadv.2017.12.005
   Hou QC, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02045
   [International bioethics committee UNESCO], 2015, SHSYESIBC22152REV2 U
   Kong SZ, 2018, MAR DRUGS, V16, DOI 10.3390/md16060181
   Lee DK, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-310
   Li Z, 2021, BIOGERONTOLOGY, V22, P165, DOI 10.1007/s10522-021-09910-5
   Mishra V, 2015, J AGR FOOD CHEM, V63, P3615, DOI 10.1021/jf506326t
   Nezametdinova VZ, 2014, ARCH MICROBIOL, V196, P125, DOI 10.1007/s00203-013-0949-8
   Palaniyandi SA, 2020, PROBIOTICS ANTIMICRO, V12, P1161, DOI 10.1007/s12602-019-09585-y
   Pinto-Sanchez MI, 2017, GASTROENTEROLOGY, V153, P448, DOI 10.1053/j.gastro.2017.05.003
   Rodrigo R, 2011, CLIN CHIM ACTA, V412, P410, DOI 10.1016/j.cca.2010.11.034
   Sadowska-Bartosz I, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/404680
   Soleimani A, 2017, KIDNEY INT, V91, P435, DOI 10.1016/j.kint.2016.09.040
   Suo HY, 2018, J DAIRY SCI, V101, P10664, DOI 10.3168/jds.2018-14758
   Tamura K, 2021, MOL BIOL EVOL, V38, P3022, DOI 10.1093/molbev/msab120
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Tomova A, 2019, FRONT NUTR, V6, DOI 10.3389/fnut.2019.00047
   Volkert D, 2019, CLIN NUTR, V38, P10, DOI 10.1016/j.clnu.2018.05.024
   Wang GQ, 2019, FOOD FUNCT, V10, P1684, DOI [10.1039/C8FO02181C, 10.1039/c8fo02181c]
   Wang HY, 2019, AM J GASTROENTEROL, V114, P1152, DOI 10.14309/ajg.0000000000000203
   Zhao HD, 2018, FOOD NUTR RES, V62, DOI 10.29219/fnr.v62.1371
NR 32
TC 0
Z9 0
U1 6
U2 9
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2180
J9 BMC MICROBIOL
JI BMC Microbiol.
PD APR 15
PY 2023
VL 23
IS 1
AR 103
DI 10.1186/s12866-023-02846-5
PG 10
WC Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology
GA D5UH2
UT WOS:000969377000002
PM 37061697
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Jourdan, M
   Cynober, L
   Moinard, C
   Blanc, MC
   Neveux, N
   De Bandt, JP
   Aussel, C
AF Jourdan, M.
   Cynober, L.
   Moinard, C.
   Blanc, M. C.
   Neveux, N.
   De Bandt, J. P.
   Aussel, C.
TI Splanchnic sequestration of amino acids in aged rats: in vivo and ex
   vivo experiments using a model of isolated perfused liver
SO AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE
   PHYSIOLOGY
LA English
DT Article
DE aging; nitrogen metabolism; isolated perfused liver; high-protein diet
ID MUSCLE PROTEIN-SYNTHESIS; SKELETAL-MUSCLE; ELDERLY-MEN; DIETARY-PROTEIN;
   SOLEUS MUSCLE; OLD; METABOLISM; NITROGEN; CITRULLINE; ORNITHINE
AB Splanchnic sequestration of amino acids (SSAA) is a process observed during aging that leads to decreased peripheral amino acid (AA) availability. The mechanisms underlying SSAA remain unknown. The aim of the present study was to determine whether a high-protein diet could increase nitrogen retention in aged rats by saturating SSAA and whether SSAA could be explained by dysregulation of hepatic nitrogen metabolism. Adult and aged male Sprague-Dawley rats were housed in individual metabolic cages and fed a normal-protein (17% protein) or high-protein diet (27%) for 2 wk. Nitrogen balance (NB) was calculated daily. On day 14, livers were isolated and perfused for 90 min to study AA and urea fluxes. NB was lower in aged rats fed a normal-protein diet than in adults, but a high-protein diet restored NB to adult levels. Isolated perfused livers from aged rats showed decreased urea production and arginine uptake, together with a release of alanine (vs. uptake in adult rats) and a hepatic accumulation of alanine. The in vivo data suggest that SSAA is a saturable process that responds to an increase in dietary protein content. The hepatic metabolism of AA in aged rats is greatly modified, and urea production decreases. This result refutes the hypothesis that SSAA is associated with an increase in AA disposal via urea production.
C1 [Jourdan, M.; Cynober, L.; Moinard, C.; Blanc, M. C.; Neveux, N.; De Bandt, J. P.; Aussel, C.] Univ Paris 05, Fac Pharm, Lab Biol Nutr, F-75270 Paris 06, France.
   [Cynober, L.; Blanc, M. C.; Neveux, N.; De Bandt, J. P.] Hop Hotel Dieu, AP HP, F-75181 Paris, France.
   [Aussel, C.] Emile Roux Hosp, AP HP, Biol Lab, Limeil Brevannes, France.
C3 Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP);
   Universite Paris Cite; Hopital Universitaire Hotel-Dieu - APHP; Hopital
   Universitaire Paul-Brousse - APHP; Assistance Publique Hopitaux Paris
   (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital
   Universitaire Emile-Roux - APHP; Universite Paris Cite; Hopital
   Universitaire Hotel-Dieu - APHP; Hopital Universitaire Paul-Brousse -
   APHP
RP Cynober, L (corresponding author), Univ Paris 05, Fac Pharm, Lab Biol Nutr, 4 Ave Observ, F-75270 Paris 06, France.
EM luc.cynober@htd.aphp.fr
RI Cynober, Luc/ABB-2368-2020; De BANDT, Jean Pascal/C-4822-2013; De Bandt,
   Jean-Pascal/ABA-4382-2020
CR Altun M, 2007, MUSCLE NERVE, V36, P223, DOI 10.1002/mus.20808
   Anantharaju A, 2002, GERONTOLOGY, V48, P343, DOI 10.1159/000065506
   Arnal MA, 1999, AM J CLIN NUTR, V69, P1202
   Arnal MA, 2002, J NUTR, V132, P1002, DOI 10.1093/jn/132.5.1002
   Blanc MC, 2000, CLIN CHEM LAB MED, V38, P465, DOI 10.1515/CCLM.2000.067
   Boirie Y, 1997, AM J CLIN NUTR, V65, P489
   Curis E, 2005, AMINO ACIDS, V29, P177, DOI 10.1007/s00726-005-0235-4
   Dargelos E, 2007, EXP GERONTOL, V42, P1088, DOI 10.1016/j.exger.2007.08.009
   DEBANDT JP, 1990, J SURG RES, V49, P8, DOI 10.1016/0022-4804(90)90102-8
   DEBANDT JP, 1995, NUTR CLIN METAB, V9, P123
   FIATARONE MA, 1994, NEW ENGL J MED, V330, P1769, DOI 10.1056/NEJM199406233302501
   FONG AD, 1990, BIOCHIM BIOPHYS ACTA, V1022, P325, DOI 10.1016/0005-2736(90)90281-R
   GRIMBLE G, 1991, JPEN-PARENTER ENTER, V15, P696, DOI 10.1177/0148607191015006696
   Hallemeesch MM, 2001, LAB ANIM-UK, V35, P101, DOI 10.1258/0023677011911426
   HENSGENS HESJ, 1980, BIOCHEM J, V186, P1
   Hoetzel A, 2006, ANESTHESIOLOGY, V104, P101, DOI 10.1097/00000542-200601000-00016
   Jourdan M, 2004, EXP GERONTOL, V39, P1341, DOI 10.1016/j.exger.2004.07.004
   JOURDAN M, 2004, CLIN NUTR, V23, P815
   Katsanos CS, 2005, AM J CLIN NUTR, V82, P1065, DOI 10.1093/ajcn/82.5.1065
   Kimball SR, 2004, AM J PHYSIOL-ENDOC M, V287, pE772, DOI 10.1152/ajpendo.00535.2003
   Kinnard RS, 2005, BIOGERONTOLOGY, V6, P173, DOI 10.1007/s10522-005-7953-6
   KLITGAARD H, 1990, ACTA PHYSIOL SCAND, V140, P41, DOI 10.1111/j.1748-1716.1990.tb08974.x
   LeBoucher J, 1997, CLIN CHEM, V43, P1421
   LECAM A, 1977, J BIOL CHEM, V252, P148
   LIN CP, 1982, J NUTR, V112, P1067, DOI 10.1093/jn/112.6.1067
   Martini C, 2007, J CELL BIOCHEM, V101, P235, DOI 10.1002/jcb.21158
   MEIJER AJ, 1990, PHYSIOL REV, V70, P701, DOI 10.1152/physrev.1990.70.3.701
   Minet-Quinared R, 2004, AM J PHYSIOL-ENDOC M, V287, pE671, DOI 10.1152/ajpendo.00185.2003
   Moinard C, 2004, CLIN NUTR, V23, P485, DOI 10.1016/j.clnu.2003.08.006
   MORIMOTO BH, 1990, BIOCHEM J, V272, P671, DOI 10.1042/bj2720671
   Morley JE, 2001, J LAB CLIN MED, V137, P231, DOI 10.1067/mlc.2001.113504
   Nair K S, 2000, Mayo Clin Proc, V75 Suppl, pS14
   Neveux N, 2000, J HEPATOL, V33, P68, DOI 10.1016/S0168-8278(00)80161-0
   Neveux N, 2004, Metabolic and therapeutic aspects of amino acids in clinical nutrition, V2nd, P17
   NIELSEN NC, 1963, SCAND J CLIN LAB INV, V15, P613, DOI 10.3109/00365516309051344
   O'Sullivan D, 2000, AM J PHYSIOL-ENDOC M, V278, pE516, DOI 10.1152/ajpendo.2000.278.3.E516
   OBLED C, 1992, J NUTR, V122, P2167, DOI 10.1093/jn/122.11.2167
   Osowska S, 2006, AM J PHYSIOL-ENDOC M, V291, pE582, DOI 10.1152/ajpendo.00398.2005
   Pistilli EE, 2007, AM J PHYSIOL-CELL PH, V292, pC1298, DOI 10.1152/ajpcell.00496.2006
   PRICE GM, 1994, CLIN SCI, V86, P91, DOI 10.1042/cs0860091
   Quinn R, 2005, NUTRITION, V21, P775, DOI 10.1016/j.nut.2005.04.002
   RAFOTH RJ, 1975, J CLIN INVEST, V56, P1170, DOI 10.1172/JCI108193
   Rice KM, 2006, J GERONTOL A-BIOL, V61, P1119, DOI 10.1093/gerona/61.11.1119
   Rosant C, 2007, EXP GERONTOL, V42, P301, DOI 10.1016/j.exger.2006.10.007
   Sinha A, 1996, AM J GASTROENTEROL, V91, P2406
   Strasser A, 2006, AGING CLIN EXP RES, V18, P179
   TAKADA S, 1979, J BIOCHEM-TOKYO, V85, P1309
   VAUBOURDOLLE M, 1989, SCAND J GASTROENTERO, V24, P467, DOI 10.3109/00365528909093076
   Volpi E, 2001, JAMA-J AM MED ASSOC, V286, P1206, DOI 10.1001/jama.286.10.1206
   Volpi E, 1999, AM J PHYSIOL-ENDOC M, V277, pE513, DOI 10.1152/ajpendo.1999.277.3.E513
   Wakabayashi Y., 2004, METABOLIC THERAPEUTI, P135
   Walrand S, 2000, AM J CLIN NUTR, V72, P816
   Wang P, 1996, AM J PHYSIOL-REG I, V270, pR927, DOI 10.1152/ajpregu.1996.270.5.R927
   Welle S, 1996, J CLIN ENDOCR METAB, V81, P3239, DOI 10.1210/jc.81.9.3239
   Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001
   YARASHESKI KE, 1993, AM J PHYSIOL, V265, pE210, DOI 10.1152/ajpendo.1993.265.2.E210
NR 56
TC 21
Z9 21
U1 0
U2 1
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0363-6119
EI 1522-1490
J9 AM J PHYSIOL-REG I
JI Am. J. Physiol.-Regul. Integr. Comp. Physiol.
PD MAR
PY 2008
VL 294
IS 3
BP R748
EP R755
DI 10.1152/ajpregu.00291.2007
PG 8
WC Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology
GA 271HE
UT WOS:000253778700009
PM 18056986
DA 2024-02-19
ER

PT J
AU Harridge, SDR
AF Harridge, SDR
TI Ageing and local growth factors in muscle
SO SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS
LA English
DT Article
DE muscle; exercise; ageing; IGF-I
ID CONTRACTION-INDUCED INJURY; MYOSIN HEAVY-CHAIN; SKELETAL-MUSCLE;
   FACTOR-I; RESISTANCE EXERCISE; ELDERLY MEN; PROTEIN EXPRESSION;
   HYPERTROPHY; STRENGTH; HORMONE
AB Muscle responds to mechanical overload by increasing its size. In contrast, as a muscle gets older it atrophies. The mechanisms regulating these differing responses are not fully understood. Animal studies have shown that older muscles are less well able to repair following contraction-induced injury than young muscles. It is becoming clear that local growth factors produced within the muscle may play important roles in both repair, adaptation and ageing. The growth hormone/insulin like growth factor 1 (GH/IGF-I) axis is important during growth and development, but circulating levels of these hormones decline in later life. However, many tissues including muscle, produce IGF-I for autocrine and paracrine actions. Genetic manipulation of IGF-I in muscle has shown that it has considerable anabolic affects on muscle both in young and old animals. Insulin like growth factor 1 exists in multiple isoforms and one isoform, which differs from the systemic or liver type (IGF-IEa), appears to be particularly sensitive to mechanical signals and to muscle damage. This isoform (IGF-IEc) has been termed mechano growth factor (MGF). The anabolic actions of IGF-I and MGF are through stimulating protein synthesis and by playing a role in the activation, proliferation and differentiation of satellite cells. These effects are discussed in relation to human studies of muscle adaptation to strength training in older people who seem to retain an ability to increase muscle mass and strength through this type of exercise .
C1 UCL Royal Free & Univ Coll Med Sch, Dept Physiol, London NW3 2PF, England.
C3 University of London; University College London; UCL Medical School
RP Harridge, SDR (corresponding author), UCL Royal Free & Univ Coll Med Sch, Dept Physiol, Rowland Hill St, London NW3 2PF, England.
OI Harridge, Stephen/0000-0002-8203-0769
CR Adams GR, 1998, EXERCISE SPORT SCI R, V26, P31
   Adams GR, 1996, J APPL PHYSIOL, V81, P2509, DOI 10.1152/jappl.1996.81.6.2509
   ANDERSEN JL, SCAND J MED SCI SPOR, P40
   Balagopal P, 1997, AM J PHYSIOL-ENDOC M, V273, pE790, DOI 10.1152/ajpendo.1997.273.4.E790
   Barton-Davis ER, 1998, P NATL ACAD SCI USA, V95, P15603, DOI 10.1073/pnas.95.26.15603
   Brahm H, 1997, CALCIFIED TISSUE INT, V60, P175, DOI 10.1007/s002239900210
   BROOKS SV, 1990, AM J PHYSIOL, V258, pC436, DOI 10.1152/ajpcell.1990.258.3.C436
   CAMPBELL MJ, 1973, J NEUROL NEUROSUR PS, V36, P174, DOI 10.1136/jnnp.36.2.174
   CUNEO RC, 1991, J APPL PHYSIOL, V70, P688, DOI 10.1152/jappl.1991.70.2.688
   FAULKNER JA, 1995, J GERONTOL A-BIOL, V50, P124
   FLORINI JR, 1987, MUSCLE NERVE, V10, P577, DOI 10.1002/mus.880100702
   Goldberg LS, 2000, OPT PHOTONICS NEWS, V11, P27
   Goldspink G., 1996, Journal of Physiology (Cambridge), V495P, p162P
   GRIFFITHS RD, 2001, OXFORD TXB GERIATRIC, P972
   HADDAD F, 2001, IUPS C NEW ZEAL
   Hameed M, 2002, EXERC SPORT SCI REV, V30, P15, DOI 10.1097/00003677-200201000-00004
   HAMEED M, 2002, J PHYSL
   HARRIDGE SDR, 1995, ACTA PHYSIOL SCAND, V154, P469, DOI 10.1111/j.1748-1716.1995.tb09932.x
   HARRIDGE SDR, 1999, ADV REHABILITATION 1, V2, P123
   Hasten DL, 2000, AM J PHYSIOL-ENDOC M, V278, pE620, DOI 10.1152/ajpendo.2000.278.4.E620
   Kadi F, 1999, MED SCI SPORT EXER, V31, P1528, DOI 10.1097/00005768-199911000-00006
   KLITGAARD H, 1990, ACTA PHYSIOL SCAND, V140, P41, DOI 10.1111/j.1748-1716.1990.tb08974.x
   Lange KHW, 2002, J CLIN ENDOCR METAB, V87, P513, DOI 10.1210/jc.87.2.513
   LEXELL J, 1988, J NEUROL SCI, V84, P275, DOI 10.1016/0022-510X(88)90132-3
   McKoy G, 1999, J PHYSIOL-LONDON, V516, P583, DOI 10.1111/j.1469-7793.1999.0583v.x
   Musarò A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839
   Owino V, 2001, FEBS LETT, V505, P259, DOI 10.1016/S0014-5793(01)02825-3
   Phelan JN, 1997, ANAT REC, V247, P179, DOI 10.1002/(SICI)1097-0185(199702)247:2<179::AID-AR4>3.0.CO;2-T
   Rennie MJ, 2000, ANNU REV NUTR, V20, P457, DOI 10.1146/annurev.nutr.20.1.457
   Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009
   ROTWEIN P, 1986, J BIOL CHEM, V261, P4828
   RUDMAN D, 1981, J CLIN INVEST, V67, P1361, DOI 10.1172/JCI110164
   Seale P, 2000, DEV BIOL, V218, P115, DOI 10.1006/dbio.1999.9565
   Singh MAF, 1999, AM J PHYSIOL-ENDOC M, V277, pE135
   Stewart CEH, 1996, PHYSIOL REV, V76, P1005, DOI 10.1152/physrev.1996.76.4.1005
   WELLE S, 1993, AM J PHYSIOL, V264, pE693, DOI 10.1152/ajpendo.1993.264.5.E693
   Yang SY, 1996, J MUSCLE RES CELL M, V17, P487, DOI 10.1007/BF00123364
   YARASHESKI KE, 1992, AM J PHYSIOL, V262, pE261, DOI 10.1152/ajpendo.1992.262.3.E261
   YARASHESKI KE, 1995, AM J PHYSIOL-ENDOC M, V268, pE268, DOI 10.1152/ajpendo.1995.268.2.E268
   ZERBA E, 1990, AM J PHYSIOL, V258, P429
NR 40
TC 38
Z9 43
U1 0
U2 2
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0905-7188
J9 SCAND J MED SCI SPOR
JI Scand. J. Med. Sci. Sports
PD FEB
PY 2003
VL 13
IS 1
BP 34
EP 39
DI 10.1034/j.1600-0838.2003.20235.x
PG 6
WC Sport Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Sport Sciences
GA 635WN
UT WOS:000180423100006
PM 12535315
DA 2024-02-19
ER

PT J
AU Derks, TGJ
   van Rijn, M
AF Derks, Terry G. J.
   van Rijn, Margreet
TI Lipids in hepatic glycogen storage diseases: pathophysiology, monitoring
   of dietary management and future directions
SO JOURNAL OF INHERITED METABOLIC DISEASE
LA English
DT Article
ID MEDIUM-CHAIN TRIGLYCERIDES; ELEVATED TRIGLYCERIDES; GLUCOSE-PRODUCTION;
   METABOLIC-CONTROL; CHILDREN; HYPERTRIGLYCERIDEMIA; HYPERLIPIDEMIA;
   INFANCY; 1A; IA
AB Hepatic glycogen storage diseases (GSD) underscore the intimate relationship between carbohydrate and lipid metabolism. The hyperlipidemias in hepatic GSD reflect perturbed intracellular metabolism, providing biomarkers in blood to monitor dietary management. In different types of GSD, hyperlipidemias are of a different origin. Hypertriglyceridemia is most prominent in GSD type Ia and associated with long-term outcome morbidity, like pancreatitis and hepatic adenomas. In the ketotic subtypes of GSD, hypertriglyceridemia reflects the age-dependent fasting intolerance, secondary lipolysis and increased mitochondrial fatty acid oxidation. The role of high protein diets is established for ketotic types of GSD, but non-traditional dietary interventions (like medium-chain triglycerides and the ketogenic diet) in hepatic GSD are still controversial and necessitate further studies. Patients with these rare inherited disorders of carbohydrate metabolism meet several criteria of the metabolic syndrome, therefore close monitoring for cardiovascular diseases in ageing GSD patients may be justified.
C1 [Derks, Terry G. J.; van Rijn, Margreet] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Sect Metab Dis, NL-9700 RB Groningen, Netherlands.
C3 University of Groningen
RP Derks, TGJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Sect Metab Dis, POB 30 001, NL-9700 RB Groningen, Netherlands.
EM t.g.j.derks@umcg.nl
RI Derks, Terry G. J./AGT-9822-2022
OI Derks, Terry G. J./0000-0002-7259-1095
FU Recordati Rare Diseases; Danone Nutricia; Vitaflo; Sigma Tau; Nutricia
   Netherlands
FX In the last 5 years, Terry GJ Derks had received speaker's fees from
   Recordati Rare Diseases, Danone Nutricia and Vitaflo, research fees from
   Sigma Tau and Vitaflo, and training support from Sigma Tau and Genzyme.;
   Margreet van Rijn is a member of the European Nutrition Expert Panel
   (Merck Serono), Danone Research and Development consultant, Member of
   the Advisory Board Element (Danone-Nutricia), Financial research support
   of Nutricia Netherlands, Honoraria for lecturing and guideline
   development (Orphan Europe, Excemed, Nutricia).
CR [Anonymous], [No title captured]
   Bandsma RHJ, 2008, PEDIATR RES, V63, P702, DOI 10.1203/PDR.0b013e31816c9013
   Bernier A, 2008, J INHERIT METAB DIS, V31, P729, DOI 10.1007/s10545-008-0919-5
   Bernier AV, 2009, J PEDIATR-US, V154, P588, DOI 10.1016/j.jpeds.2008.10.048
   Bernstein LE, 2010, J INHERIT METAB DIS, V33, pS173
   BIER DM, 1977, DIABETES, V26, P1016, DOI 10.2337/diabetes.26.11.1016
   Brambilla A, 2014, JIMD REP, V17, P91, DOI 10.1007/8904_2014_343
   Burns CE, 2009, MOL GENET METAB, V98, P56
   BURR IM, 1974, J PEDIATR-US, V85, P792, DOI 10.1016/S0022-3476(74)80342-2
   CHEN YT, 1984, NEW ENGL J MED, V310, P171, DOI 10.1056/NEJM198401193100306
   CUTTINO J T JR, 1970, Pediatrics, V46, P925
   Dagli A.I., 1993, GENEREVIEWS
   Das AM, 2010, ANN NUTR METAB, V56, P225, DOI 10.1159/000283242
   Derks TGJ, 2015, J INHERIT METAB DIS, V38, P545, DOI 10.1007/s10545-014-9756-x
   Derks TGJ, 2013, MOL GENET METAB, V109, P1, DOI 10.1016/j.ymgme.2013.02.005
   El-Gharbawy AH, 2014, MOL GENET METAB, V111, P284
   FERNANDES J, 1974, ACTA PAEDIATR SCAND, V63, P695, DOI 10.1111/j.1651-2227.1974.tb16992.x
   FERNANDES J, 1969, AM J CLIN NUTR, V22, P617
   GREENE HL, 1976, NEW ENGL J MED, V294, P423, DOI 10.1056/NEJM197602192940805
   Grefhorst A, 2010, BIOCHEM J, V432, P249, DOI 10.1042/BJ20101225
   HAYDE M, 1990, EUR J PEDIATR, V149, P630, DOI 10.1007/BF02034750
   Hershkovitz E, 2001, J INHERIT METAB DIS, V24, P863, DOI 10.1023/A:1013996325720
   Huidekoper HH, 2014, ARCH DIS CHILD, V99, P1098, DOI 10.1136/archdischild-2013-305718
   Huidekoper HH, 2010, J INHERIT METAB DIS, V33, P25, DOI 10.1007/s10545-009-9030-9
   Kasapkara ÇS, 2014, EUR J CLIN NUTR, V68, P101, DOI 10.1038/ejcn.2013.186
   KELSCH RC, 1969, PEDIATR RES, V3, P160, DOI 10.1203/00006450-196903000-00008
   Laforet P, 2011, INBORN METABOLIC DIS
   Moses SW, 2002, EUR J PEDIATR, V161, pS2, DOI 10.1007/s00431-002-0997-6
   Nagasaka H, 2007, EUR J PEDIATR, V166, P1009, DOI 10.1007/s00431-006-0372-0
   Oosterveer MH, 2014, CELL MOL LIFE SCI, V71, P1453, DOI 10.1007/s00018-013-1505-z
   Rajas F, 2013, Diabetes Metab, V39, P377, DOI 10.1016/j.diabet.2013.03.002
   Rajas F, 2015, J INHERIT METAB DIS, V38, P521, DOI 10.1007/s10545-014-9761-0
   Rake JP, 2002, EUR J PEDIATR, V161, pS112, DOI 10.1007/BF02680007
   Rake JP, 2002, EUR J PEDIATR, V161, pS20, DOI [10.1007/s00431-002-0999-4, 10.1007/BF02679990]
   Shah KK, 2013, J HUM NUTR DIET, V26, P329, DOI 10.1111/jhn.12030
   SMIT GPA, 1984, PEDIATR RES, V18, P879, DOI 10.1203/00006450-198409000-00015
   Ubels FL, 2002, EUR J PEDIATR, V161, pS62, DOI 10.1007/s00431-002-1006-9
   Valayannopoulos V, 2011, PEDIATR RES, V70, P638, DOI 10.1203/PDR.0b013e318232154f
   van Dijk TH, 2001, J BIOL CHEM, V276, P25727, DOI 10.1074/jbc.M101223200
   Wang DQ, 2011, J PEDIATR-US, V159, P442, DOI 10.1016/j.jpeds.2011.02.031
   White FJ, 2011, J INHERIT METAB DIS, V34, P631, DOI 10.1007/s10545-011-9335-3
   Xue JT, 2014, APPL SPECTROSC, V68, P428, DOI 10.1366/13-07250
NR 42
TC 34
Z9 37
U1 1
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0141-8955
EI 1573-2665
J9 J INHERIT METAB DIS
JI J. Inherit. Metab. Dis.
PD MAY
PY 2015
VL 38
IS 3
BP 537
EP 543
DI 10.1007/s10545-015-9811-2
PG 7
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental
   Medicine
GA CI1JJ
UT WOS:000354500000019
PM 25633903
OA Green Published, Green Submitted, hybrid
DA 2024-02-19
ER

PT J
AU Chen, Z
   Zhu, YP
   Lu, MT
   Yu, L
   Tan, SM
   Ren, TY
AF Chen, Zhen
   Zhu, Yuping
   Lu, Mintao
   Yu, Lu
   Tan, Shuming
   Ren, Tingyuan
TI Effects of <i>Rosa roxburghii Tratt</i> glycosides and quercetin on
   D-galactose-induced aging mice model
SO JOURNAL OF FOOD BIOCHEMISTRY
LA English
DT Article; Early Access
DE aging; flavonoids of Rosa roxburghii Tratt; inflammatory response;
   oxidative stress; Rosa roxburghii Tratt
ID OXIDATIVE STRESS; IN-VITRO; ANTIOXIDANT; METABOLISM; POLYSACCHARIDES;
   METFORMIN; LIVER; FRUIT
AB To investigate the effects of RRT (Rosa roxburghii Tratt) glucosides and quercetin on oxidative stress and chronic inflammation in D-galactose-induced aging mice, 90 mice (8 weeks old) were randomly divided into the normal group (NC), aging model group (D-gal), isoquercitrin group (D-gal+isoquercitrin), quercitrin group (D-gal+quercitrin), quercetin group (D-gal+quercetin) and positive control group (D-gal+Metformin). The aging model was established by subcutaneous injection of D-galactose (100 mg/kg). After 42 days of the administration, antioxidant and inflammatory indexes were measured, HE staining was used to investigate pathological changes in liver and brain tissue, and Western blot was used to determine the protein abundance of nuclear factor E2-related factor (Nrf2) and heme oxygenase (HO-1) in the brain. The results showed that, when compared to the NC group, the D-gal group had a significantly lower brain, liver, kidney, and spleen indexes; the contents of MDA, L-1 beta, IL-6, and TNF-alpha in serum, liver, and brain were significantly higher, but the levels of CAT, SOD, and GSH-Px were significantly lower. Isoquercitrin, quercitrin, and quercetin significantly increased organ indexes and activities of CAT, SOD, and GSH-Px while decreasing MDA, IL-1 beta, IL-6, and TNF-alpha levels in serum, liver, and brain tissues compared to the D-gal group. The morphological changes in the brain and liver tissue were significantly restored by glycosides and quercetin, as observed in HE staining. Furthermore, Western blot results revealed that glycosides and quercetin increased the protein levels of Nrf2, HO-1, and NQO1. Finally, the antioxidant and anti-inflammatory effects of RRT glycoside and quercetin in aging may be attributed to an activated Nrf2/HO-1 signaling pathway. Practical applications Aging is characterized by physical changes and dysfunction of numerous biological systems caused by a variety of factors. The oxidative stress and inflammatory effects of RRT glycosides and quercetin on D-galactose-induced aging mice were investigated in this study. RRT glycosides and quercetin were found to protect organ atrophy, liver, and brain tissue in aging mice by regulating oxidative stress and chronic inflammation. It served as the theoretical foundation for the investigation of Rosa roxburghii Tratt as a health product and pharmaceutical raw material.
C1 [Chen, Zhen; Lu, Mintao; Yu, Lu; Tan, Shuming; Ren, Tingyuan] Guizhou Univ, Coll Brewing & Food Engn, Guiyang 550025, Peoples R China.
   [Zhu, Yuping] Guizhou Med Univ, Coll Basic Med, Guiyang, Peoples R China.
   [Ren, Tingyuan] Guizhou Acad Agr Sci, Inst Guizhou Distinct Plant Resources Conservat, Guiyang, Peoples R China.
C3 Guizhou University; Guizhou Medical University; Guizhou Academy of
   Agricultural Sciences
RP Ren, TY (corresponding author), Guizhou Univ, Coll Brewing & Food Engn, Guiyang 550025, Peoples R China.
EM tyren@gzu.edu.cn
OI Ren, Tingyuan/0000-0002-3251-268X
FU Guizhou Science and Technology Department project (Guizhou Science and
   Technology Cooperation Foundation) [[2020]1Y431]; Industry and
   Information of Guizhou Province [[2020]307]; Key Laboratory of
   Environmental Pollution Monitoring and Disease Control (Guizhou Medical
   University); Science and Technology Project of Forestry Bureau of
   Guizhou Province [[2020]2011]
FX Guizhou Science and Technology Department project (Guizhou Science and
   Technology Cooperation Foundation, Grant/Award Number: [2020]1Y431;
   Industry and Information of Guizhou Province, Rosa roxburghii Special
   Project, Grant/Award Number: [2020]307; Key Laboratory of Environmental
   Pollution Monitoring and Disease Control (Guizhou Medical University,
   Ministry of Education]; Science and Technology Project of Forestry
   Bureau of Guizhou Province, Grant/Award Number: [2020]2011
CR Azman KF, 2019, BIOGERONTOLOGY, V20, P763, DOI 10.1007/s10522-019-09837-y
   Bai B, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.622262
   Campisi J, 2019, NATURE, V571, P183, DOI 10.1038/s41586-019-1365-2
   Chang YM, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040466
   Chen GJ, 2018, INT J BIOL MACROMOL, V107, P166, DOI 10.1016/j.ijbiomac.2017.08.160
   Chowdhury AA, 2018, PHARMACOL REP, V70, P372, DOI 10.1016/j.pharep.2017.09.006
   Chowdhury AR, 2020, REDOX BIOL, V36, DOI 10.1016/j.redox.2020.101606
   Daniele G, 2020, DIABETES OBES METAB, V22, P648, DOI 10.1111/dom.13940
   De la Fuente M, 2009, CURR PHARM DESIGN, V15, P3003, DOI 10.2174/138161209789058110
   Ding QY, 2016, INT J BIOL MACROMOL, V85, P133, DOI 10.1016/j.ijbiomac.2015.12.058
   Fan J, 2017, CARBOHYD POLYM, V157, P629, DOI 10.1016/j.carbpol.2016.10.040
   Fidaleo M, 2017, BIOCHEM PHARMACOL, V141, P63, DOI 10.1016/j.bcp.2017.05.016
   Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003
   Garaschuk O, 2018, AGEING RES REV, V43, P26, DOI 10.1016/j.arr.2018.02.003
   Guo QP, 2020, SCI CHINA LIFE SCI, V63, P866, DOI 10.1007/s11427-019-9591-5
   He WS, 2013, FOOD CHEM, V140, P9, DOI 10.1016/j.foodchem.2013.02.062
   Hou YJ, 2019, NAT REV NEUROL, V15, P565, DOI 10.1038/s41582-019-0244-7
   Hu JJ, 2021, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.605065
   Hu Q, 2018, BIOFACTORS, V44, P123, DOI 10.1002/biof.1395
   Huang M, 2014, J PLANT PHYSIOL, V171, P1205, DOI 10.1016/j.jplph.2014.03.010
   Huang YY, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16030356
   Jing HJ, 2018, INT J BIOL MACROMOL, V106, P1270, DOI 10.1016/j.ijbiomac.2017.08.138
   Jurk D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5172
   Khallaghi B, 2016, LIFE SCI, V148, P286, DOI 10.1016/j.lfs.2016.02.024
   Khan SS, 2017, AGING CELL, V16, P624, DOI 10.1111/acel.12601
   Kim SH, 2006, BIOFACTORS, V26, P209, DOI 10.1002/biof.5520260306
   Li CY, 2013, J AGR FOOD CHEM, V61, P523, DOI 10.1021/jf3046158
   Li Qi-Ji, 2016, Zhongguo Zhong Yao Za Zhi, V41, P451, DOI 10.4268/cjcmm20160316
   Liao CH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010098
   Liu MH, 2016, MOLECULES, V21, DOI 10.3390/molecules21091204
   Liu RM, 2020, EXP GERONTOL, V132, DOI 10.1016/j.exger.2020.110836
   Moukette Moukette Bruno, 2015, J Complement Integr Med, V12, P195, DOI 10.1515/jcim-2015-0002
   Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200
   Niu Yan Long, 2021, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V37, P433, DOI 10.12047/j.cjap.6064.2021.034
   Peng MF, 2020, J KING SAUD UNIV SCI, V32, P2426, DOI 10.1016/j.jksus.2020.03.032
   Rehman SU, 2017, MOL NEUROBIOL, V54, P255, DOI 10.1007/s12035-015-9604-5
   Ren TY, 2017, J MOL ENDOCRINOL, V58, P113, DOI [10.1530/JME-16-0218, 10.1530/jme-16-0218]
   Rena G, 2018, CIRCULATION, V137, P422, DOI 10.1161/CIRCULATIONAHA.117.031735
   Schöttker B, 2015, J GERONTOL A-BIOL, V70, P518, DOI 10.1093/gerona/glu111
   Song Y, 2016, J NEUROIMMUNOL, V301, P1, DOI 10.1016/j.jneuroim.2016.11.001
   Sun XQ, 2019, INT IMMUNOPHARMACOL, V74, DOI 10.1016/j.intimp.2019.05.019
   Tian L, 2020, NEUROSCIENCE, V429, P119, DOI 10.1016/j.neuroscience.2019.12.025
   Wang YL, 2020, EVID-BASED COMPL ALT, V2020, DOI 10.1155/2020/7023420
   Wang ZL, 2018, MOL MED REP, V17, P6269, DOI 10.3892/mmr.2018.8659
   Wyss-Coray T, 2016, NATURE, V539, P180, DOI 10.1038/nature20411
   Yuan S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76249-1
   Zhang XL, 2013, FOOD CHEM TOXICOL, V58, P50, DOI 10.1016/j.fct.2013.04.006
NR 47
TC 4
Z9 4
U1 16
U2 44
PU WILEY-HINDAWI
PI LONDON
PA ADAM HOUSE, 3RD FL, 1 FITZROY SQ, LONDON, WIT 5HE, ENGLAND
SN 0145-8884
EI 1745-4514
J9 J FOOD BIOCHEM
JI J. Food Biochem.
PD 2022 DEC
PY 2022
VL 46
IS 12
AR e14425
DI 10.1111/jfbc.14425
EA SEP 2022
PG 10
WC Biochemistry & Molecular Biology; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Food Science & Technology
GA 7T2OX
UT WOS:000855424300001
PM 36125966
OA gold
DA 2024-02-19
ER

PT J
AU Columbano, A
   Simbula, M
   Pibiri, M
   Perra, A
   Pisanu, A
   Uccheddu, A
   Ledda-Columbano, GM
AF Columbano, Amedeo
   Simbula, Michela
   Pibiri, Monica
   Perra, Andrea
   Pisanu, Adolfo
   Uccheddu, Alessandro
   Ledda-Columbano, Giovanna M.
TI Potential utility of xenobiotic mitogens in the context of liver
   regeneration in the elderly and living-related transplantation
SO LABORATORY INVESTIGATION
LA English
DT Article
DE TCPOBOP; partial hepatectomy; liver regeneration; aging; cyclins
ID HEPATOCYTE PROLIFERATION; ALPHA; AGE; GROWTH; OLDER; MICE; TNF; DNA
AB Although liver regeneration occurring after partial hepatectomy (PH) is greatly reduced in aged mice, liver hyperplasia induced by xenobiotic mitogens was found to be age independent. Here, we investigated the potential utility of mitogens in stimulating liver regeneration in old mice subjected to two-third PH. Although virtually no hepatocytes entered S phase 48 h after PH, pretreatment (2 h prior to surgery) with 1,4-bis(2-(3,5-dichloropyridyloxy) benzene (TCPOBOP), a ligand of constitutive androstane receptor, induced an increase of bromodeoxyuridine incorporation and enhanced the expression of cyclin D1, cyclin A and proliferating cell nuclear antigen. Next, we investigated the potential utility of mitogens in the context of donor conditioning prior to living-related transplantation. Three days after TCPOBOP administration to intact young mice, an almost doubling of the liver mass and DNA content occurred; the regenerative response to two-third resection of the TCPOBOP-induced hyperplastic liver was similar to that of mice subjected to PH alone, suggesting that an increased liver mass at the time of surgery does not inhibit the regenerative capacity. The present results suggest that mitogen-induced hyperplasia is a promising tool in conditions characterized by reduced regenerative capacity, such as in the elderly, or when a rapid increase of liver mass is required, such as in living-related transplantation.
C1 [Columbano, Amedeo; Simbula, Michela; Pibiri, Monica; Perra, Andrea; Ledda-Columbano, Giovanna M.] Sez Oncol & Patol Mol, Dipartimento Tossicol, I-09124 Cagliari, Italy.
   [Pisanu, Adolfo; Uccheddu, Alessandro] Univ Cagliari, Clin Chirurg, I-09124 Cagliari, Italy.
C3 University of Cagliari
RP Columbano, A (corresponding author), Sez Oncol & Patol Mol, Dipartimento Tossicol, Via Porcell 4, I-09124 Cagliari, Italy.
EM columbano@unica.it
RI simbula, michela/P-6171-2018; Columbano, Amedeo/C-7463-2011
OI simbula, michela/0000-0002-7473-5494; Columbano,
   Amedeo/0000-0002-6956-9030; PIBIRI, MONICA/0000-0002-9660-9616
FU Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom
CR Ben-Haim M, 2001, LIVER TRANSPLANT, V7, P948, DOI 10.1053/jlts.2001.29033
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   BUCHER NLR, 1964, CANCER RES, V24, P509
   BURTON K, 1956, BIOCHEM J, V62, P315, DOI 10.1042/bj0620315
   Calbó J, 2002, J BIOL CHEM, V277, P50263, DOI 10.1074/jbc.M209181200
   Columbano A, 2005, HEPATOLOGY, V42, P1118, DOI 10.1002/hep.20883
   Columbano A, 2003, CELL DEATH DIFFER, V10, pS19, DOI 10.1038/sj.cdd.4401113
   Columbano A, 1996, FASEB J, V10, P1118, DOI 10.1096/fasebj.10.10.8751714
   Emre S, 1996, TRANSPLANTATION, V62, P62, DOI 10.1097/00007890-199607150-00013
   FORTNER JG, 1990, ANN SURG, V211, P141, DOI 10.1097/00000658-199002000-00005
   FRY M, 1984, J CELL PHYSIOL, V118, P225, DOI 10.1002/jcp.1041180302
   Higgins GM, 1931, ARCH PATHOL, V12, P186
   Iakova P, 2003, CELL, V113, P495, DOI 10.1016/S0092-8674(03)00318-0
   Keswani RN, 2004, LIVER TRANSPLANT, V10, P957, DOI 10.1002/lt.20155
   Ledda-Columbano GM, 2004, HEPATOLOGY, V40, P981, DOI 10.1002/hep.20403
   Ledda-Columbano GM, 1998, ONCOGENE, V17, P1039, DOI 10.1038/sj.onc.1202018
   Malik R, 2005, AM J TRANSPLANT, V5, P1801, DOI 10.1111/j.1600-6143.2005.00949.x
   Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172
   Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60
   Moore DD, 2006, PHARMACOL REV, V58, P742, DOI 10.1124/pr.58.4.6
   Petrowsky H, 2005, WORLD J SURG, V29, P1093, DOI 10.1007/s00268-005-1130-6
   Pibiri M, 2001, FASEB J, V15, P1006, DOI 10.1096/fj.00-0416com
   PLOEG RJ, 1993, TRANSPLANTATION, V55, P807, DOI 10.1097/00007890-199304000-00024
   Redaelli CA, 2002, WORLD J SURG, V26, P1126, DOI 10.1007/s00268-002-6321-9
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Wang XH, 2001, P NATL ACAD SCI USA, V98, P11468, DOI 10.1073/pnas.201360898
   Yamada Y, 1997, P NATL ACAD SCI USA, V94, P1441, DOI 10.1073/pnas.94.4.1441
NR 27
TC 5
Z9 6
U1 0
U2 3
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0023-6837
EI 1530-0307
J9 LAB INVEST
JI Lab. Invest.
PD APR
PY 2008
VL 88
IS 4
BP 408
EP 415
DI 10.1038/labinvest.2008.3
PG 8
WC Medicine, Research & Experimental; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pathology
GA 278QA
UT WOS:000254300200008
PM 18268477
OA Bronze, Green Published
DA 2024-02-19
ER

PT J
AU Szymkowicz, SM
   May, PE
   Weeks, JW
   O'Connell, D
   Sheese, ALN
AF Szymkowicz, Sarah M.
   May, Pamela E.
   Weeks, Justin W.
   O'Connell, Debra
   Nelson Sheese, Amelia L.
TI Psychometric properties of the Montreal Cognitive Assessment (MoCA) in
   inpatient liver transplant candidates
SO APPLIED NEUROPSYCHOLOGY-ADULT
LA English
DT Article; Early Access
DE Adults; brief assessment; cognitive screening; liver disease;
   psychometrics
ID HEPATIC-ENCEPHALOPATHY; IMPAIRMENT; VALIDITY; DISEASE; SCREEN
AB Hepatic encephalopathy (HE) is a consequence of liver disease and often diagnosed via psychometric testing. With inpatients, the Montreal Cognitive Assessment (MoCA) may be used as part of cognitive screening for transplant candidacy. However, the MoCA was developed to detect mild cognitive impairment in aging populations and its psychometric properties in inpatients with liver disease have not been determined. Retrospective chart review identified inpatient liver transplant candidates who were administered a MoCA as part of their neuropsychological screening and had either no cognitive dysfunction or a diagnosis of HE made by a neuropsychologist (n = 57, mean age = 48.8 +/- 12.6 years). Psychometric analyses were conducted and regression analysis was performed to determine the predictive value of different variables on total MoCA scores. Internal consistency of MoCA domain scores was good (alpha = 0.80). Significant inverse relationships were found with Trail Making Test, Parts A and B (r's = -0.43 and -0.71, respectively). A cutoff score of 24 or below had the best sensitivity (0.72) and specificity (0.77) for identifying those with a diagnosis of HE. Increasing age and the presence of altered mental status were the strongest predictors of lower MoCA scores (both p's < 0.05, eta(2)(p) = 0.10-0.14). The MoCA is appropriate to use with inpatient liver transplant candidates, with a cutoff of 24 or below to detect abnormal cognition. In addition to the clinical interview and other neuropsychological tests (including, but not limited to, the Trail Making Test, Parts A and B), low MoCA scores can help determine the presence of HE.
C1 [Szymkowicz, Sarah M.] Vanderbilt Univ, Med Ctr, Dept Psychiat & Behav Sci, 1601 23rd Ave South, Nashville, TN 37235 USA.
   [May, Pamela E.; O'Connell, Debra; Nelson Sheese, Amelia L.] Univ Nebraska Med Ctr, Dept Neurol Sci, Omaha, NE USA.
   [Weeks, Justin W.] Nebraska Med, Dept Psychol, Omaha, NE USA.
C3 Vanderbilt University; University of Nebraska System; University of
   Nebraska Medical Center
RP Szymkowicz, SM (corresponding author), Vanderbilt Univ, Med Ctr, Dept Psychiat & Behav Sci, 1601 23rd Ave South, Nashville, TN 37235 USA.
EM sarah.szymkowicz@vumc.org
FU National Institutes of Health [5R01MH118013-02, 3U24MH100925-08S1]
FX The authors have no competing interests to report. This research did not
   receive any specific grant from funding agencies in the public,
   commercial, or not-for-profit sectors. Pamela E. May is partially
   supported by the National Institutes of Health under Grants
   5R01MH118013-02 and 3U24MH100925-08S1.
CR Amer Assoc Study Liver Dis, 2014, J HEPATOL, V61, P642, DOI 10.1016/j.jhep.2014.05.042
   Bruijnen CJWH, 2020, INT J PSYCHIAT CLIN, V24, P293, DOI 10.1080/13651501.2020.1746348
   Carson N, 2018, INT J GERIATR PSYCH, V33, P379, DOI 10.1002/gps.4756
   Celikbilek A, 2018, EUR J GASTROEN HEPAT, V30, P944, DOI 10.1097/MEG.0000000000001131
   Dalrymple-Alford JC, 2010, NEUROLOGY, V75, P1717, DOI 10.1212/WNL.0b013e3181fc29c9
   de Souza AC, 2017, EPIDEMIOL SERV SAUDE, V26, P649, DOI 10.5123/S1679-49742017000300022
   Dixon RA, 2019, AGING THE BRAIN, P217, DOI 10.1037/0000143-009
   Elsaid MI, 2020, CLIN LIVER DIS, V24, P157, DOI 10.1016/j.cld.2020.01.001
   Freitas S, 2018, APPL NEUROPSYCH-ADUL, V25, P57, DOI 10.1080/23279095.2016.1243108
   Hassanein T, 2009, AM J GASTROENTEROL, V104, P1392, DOI 10.1038/ajg.2009.160
   IBM Corp, 2020, IBM SPSS Statistics for Windows, version 27.0
   Lam B, 2013, J AM GERIATR SOC, V61, P2181, DOI 10.1111/jgs.12541
   Lezak M., 2004, NEUROPSYCHOLOGICAL A
   Milani Sadaf Arefi, 2018, Alzheimers Dement (Amst), V10, P773, DOI 10.1016/j.dadm.2018.09.003
   Milanini B, 2014, JAIDS-J ACQ IMM DEF, V67, P67, DOI 10.1097/QAI.0000000000000220
   Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x
   Ney M, 2018, AM J GASTROENTEROL, V113, P1506, DOI 10.1038/s41395-018-0243-0
   Nguyen GC, 2008, HEPATOLOGY, V47, P1058, DOI 10.1002/hep.22223
   Oudman E, 2014, CLIN NEUROPSYCHOL, V28, P1123, DOI 10.1080/13854046.2014.960005
   Sánchez-Cubillo I, 2009, J INT NEUROPSYCH SOC, V15, P438, DOI 10.1017/S1355617709090626
   Stewart CA, 2007, LIVER TRANSPLANT, V13, P1366, DOI 10.1002/lt.21129
   Teperman LW, 2013, INT J HEPATOL, V2013, DOI 10.1155/2013/952828
   Tiffin-Richards FE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106700
   Villeneuve S, 2012, CHEST, V142, P1516, DOI 10.1378/chest.11-3035
   Vogel Sally J, 2015, Alzheimers Dement (Amst), V1, P289, DOI 10.1016/j.dadm.2015.05.002
   Zhan TZ, 2012, DTSCH ARZTEBL INT, V109, P180, DOI 10.3238/arztebl.2012.0180
NR 26
TC 3
Z9 3
U1 1
U2 3
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 2327-9095
EI 2327-9109
J9 APPL NEUROPSYCH-ADUL
JI Appl. Neuropsychol.-Adult
PD 2024 JAN 2
PY 2024
VL 31
IS 1
BP 19
EP 26
DI 10.1080/23279095.2021.1986510
EA OCT 2021
PG 8
WC Clinical Neurology; Psychology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Psychology
GA DN0J8
UT WOS:000705442100001
PM 34622723
DA 2024-02-19
ER

PT J
AU Yamagishi, R
   Kamachi, F
   Nakamura, M
   Yamazaki, S
   Kamiya, T
   Takasugi, M
   Cheng, Y
   Nonaka, Y
   Yukawa-Muto, Y
   Thuy, LTT
   Harada, Y
   Arai, T
   Loo, TM
   Yoshimoto, S
   Ando, T
   Nakajima, M
   Taguchi, H
   Ishikawa, T
   Akiba, H
   Miyake, S
   Kubo, M
   Iwakura, Y
   Fukuda, S
   Chen, WY
   Kawada, N
   Rudensky, A
   Nakae, S
   Hara, E
   Ohtani, N
AF Yamagishi, Ryota
   Kamachi, Fumitaka
   Nakamura, Masaru
   Yamazaki, Shota
   Kamiya, Tomonori
   Takasugi, Masaki
   Cheng, Yi
   Nonaka, Yoshiki
   Yukawa-Muto, Yoshimi
   Le Thi Thanh Thuy
   Harada, Yohsuke
   Arai, Tatsuya
   Loo, Tze Mun
   Yoshimoto, Shin
   Ando, Tatsuya
   Nakajima, Masahiro
   Taguchi, Hayao
   Ishikawa, Takamasa
   Akiba, Hisaya
   Miyake, Sachiko
   Kubo, Masato
   Iwakura, Yoichiro
   Fukuda, Shinji
   Chen, Wei-Yu
   Kawada, Norifumi
   Rudensky, Alexander
   Nakae, Susumu
   Hara, Eiji
   Ohtani, Naoko
TI Gasdermin D-mediated release of IL-33 from senescent hepatic stellate
   cells promotes obesity-associated hepatocellular carcinoma
SO SCIENCE IMMUNOLOGY
LA English
DT Article
ID LIVER-CANCER; INFLAMMATION; INTERLEUKIN-33; PATHWAY; MAINTENANCE;
   IL-1-BETA; PHENOTYPE; PROTEASES; CYTOKINE; BLOCKADE
AB Long-term senescent cells exhibit a secretome termed the senescence-associated secretory phenotype (SASP). Although the mechanisms of SASP factor induction have been intensively studied, the release mechanism and how SASP factors influence tumorigenesis in the biological context remain unclear. In this study, using a mouse model of obesity-induced hepatocellular carcinoma (HCC), we identified the release mechanism of SASP factors, which include interleukin-1 beta (IL-1 beta)- and IL-1 beta-dependent IL-33, from senescent hepatic stellate cells (HSCs) via gasdermin D (GSDMD) amino-terminal-mediated pore. We found that IL-33 was highly induced in senescent HSCs in an IL-1 beta-dependent manner in the tumor microenvironment. The release of both IL-33 and IL-1 beta was triggered by lipoteichoic acid (LTA), a cell wall component of gut microbiota that was transferred and accumulated in the liver tissue of high-fat diet-fed mice, and the release of these factors was mediated through cell membrane pores formed by the GSDMD amino terminus, which was cleaved by LTA-induced caspase-11. We demonstrated that IL-33 release from HSCs promoted HCC development via the activation of ST2-positive T-reg cells in the liver tumor microenvironment. The accumulation of GSDMD amino terminus was also detected in HSCs from human NASH-associated HCC patients, suggesting that similar mechanism could be involved in a certain type of human HCC. These results uncover a release mechanism for SASP factors from sensitized senescent HSCs in the tumor microenvironment, thereby facilitating obesity-associated HCC progression. Furthermore, our findings highlight the therapeutic potential of inhibitors of GSDMD-mediated pore formation for HCC treatment.
C1 [Yamagishi, Ryota; Kamachi, Fumitaka; Kamiya, Tomonori; Takasugi, Masaki; Cheng, Yi; Yukawa-Muto, Yoshimi; Ohtani, Naoko] Osaka Metropolitan Univ, Dept Pathophysiol, Grad Sch Med, Osaka, Japan.
   [Kamachi, Fumitaka; Nakamura, Masaru; Yamazaki, Shota; Arai, Tatsuya; Loo, Tze Mun; Ando, Tatsuya; Nakajima, Masahiro; Taguchi, Hayao; Ohtani, Naoko] Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biol Sci, Noda, Chiba, Japan.
   [Nonaka, Yoshiki] Osaka City Univ, Grad Sch Med, Dept Pathophysiol, Osaka, Japan.
   [Yukawa-Muto, Yoshimi; Le Thi Thanh Thuy; Kawada, Norifumi] Osaka Metropolitan Univ, Dept Hepatol, Grad Sch Med, Osaka, Japan.
   [Harada, Yohsuke] Tokyo Univ Sci, Fac Pharmaceut Sci, Lab Pharmaceut Immunol, Noda, Chiba, Japan.
   [Loo, Tze Mun; Yoshimoto, Shin] Japanese Fdn Canc Res, Canc Inst, Koto Ku, Tokyo, Japan.
   [Ishikawa, Takamasa; Fukuda, Shinji] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan.
   [Akiba, Hisaya; Miyake, Sachiko] Juntendo Univ, Dept Immunol, Sch Med, Tokyo, Japan.
   [Kubo, Masato] Tokyo Univ Sci, Res Inst Biomed Sci, Div Mol Pathol, Noda, Chiba, Japan.
   [Kubo, Masato] RIKEN Yokohama Inst, Res Ctr Integrat Med Sci IMS, Lab Cytokine Regulat, Yokohama, Kanagawa, Japan.
   [Iwakura, Yoichiro] Tokyo Univ Sci, Ctr Anim Dis Models, Res Inst Biomed Sci, Noda, Chiba, Japan.
   [Fukuda, Shinji] Kanagawa Inst Ind Sci & Technol, Gut Environm Design Grp, Kawasaki, Kanagawa, Japan.
   [Fukuda, Shinji] Univ Tsukuba, Transborder Med Res Ctr, Tsukuba, Ibaraki, Japan.
   [Chen, Wei-Yu] Kaohsiung Chang Gung Mem Hosp, Inst Translat Res Biomed, Kaohsiung, Taiwan.
   [Chen, Wei-Yu] Natl Cheng Kung Univ, Coll Med, Dept Biochem & Mol Biol, Tainan, Taiwan.
   [Rudensky, Alexander] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst & Immunol Program, 1275 York Ave, New York, NY 10021 USA.
   [Nakae, Susumu] Hiroshima Univ, Grad Sch Integrated Sci Life, Higashihiroshima, Hiroshima, Japan.
   [Nakae, Susumu] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Saitama, Japan.
   [Hara, Eiji] Osaka Univ, Res Inst Microbial Dis, Suita, Osaka, Japan.
   [Hara, Eiji] Osaka Univ, Immunol Frontier Res Ctr IFReC, Suita, Osaka, Japan.
   [Hara, Eiji] Osaka Univ, Ctr Infect Dis Educ & Res CiDER, Suita, Osaka, Japan.
   [Ohtani, Naoko] Japan Agcy Med Res & Dev, AMED CREST, Tokyo, Japan.
C3 Osaka Metropolitan University; Tokyo University of Science; Osaka
   Metropolitan University; Osaka Metropolitan University; Tokyo University
   of Science; Japanese Foundation for Cancer Research; Keio University;
   Juntendo University; Tokyo University of Science; RIKEN; Tokyo
   University of Science; Kanagawa Academy Science & Technology; University
   of Tsukuba; Chang Gung Memorial Hospital; National Cheng Kung
   University; Memorial Sloan Kettering Cancer Center; Hiroshima
   University; Japan Science & Technology Agency (JST); Osaka University;
   Osaka University; Osaka University
RP Ohtani, N (corresponding author), Osaka Metropolitan Univ, Dept Pathophysiol, Grad Sch Med, Osaka, Japan.; Ohtani, N (corresponding author), Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biol Sci, Noda, Chiba, Japan.; Ohtani, N (corresponding author), Japan Agcy Med Res & Dev, AMED CREST, Tokyo, Japan.
EM naoko.ohtani@omu.ac.jp
RI Chen, Wei-Yu/ABH-4523-2020; Iwakura, Yoichiro/E-5457-2011; Yoshimoto,
   Shin/ACD-1941-2022
OI Chen, Wei-Yu/0000-0002-9325-8734; Iwakura, Yoichiro/0000-0002-9934-5775;
   Yoshimoto, Shin/0000-0001-8405-0301; Ohtani, Naoko/0000-0001-8934-0797;
   Harada, Yohsuke/0000-0002-8023-1030; Yamagishi,
   Ryota/0000-0002-6827-2382; Thuy, Le Thi Thanh/0000-0003-4460-735X;
   Fukuda, Shinji/0000-0001-5161-9880
FU AMED (Japan Agency for Medical Research and Development); AMED-CREST
   [JP20gm1010009]; AMED [JP20fk0210050, JP19ck0106260, JP20cm0106401,
   JP20gm5010001]; Precursory Research for Embryonic Science and Technology
   (PRESTO) [JPMJPR18H6]; Exploratory Research for Advanced Technology
   (ERATO) [JPMJER1902]; Japan Society for the Promotion of Science (JSPS)
   [19H04002, 19H03641, 18H02847, 21H02963, 20K16121, 20K15695, 20K16309];
   Japan Science and Technology agency (JST) [JPMJFS 2138]; Takeda Science
   Foundation; Yakult Bio-Science Foundation; Research Grant of the
   Princess Takamatsu Cancer Research Fund [18-25003]
FX This work was supported by AMED (Japan Agency for Medical Research and
   Development); AMED-CREST under grant number JP20gm1010009 (N.O.); AMED
   under grant numbers JP20fk0210050 (N.K.), JP19ck0106260 (N.O.),
   JP20cm0106401 (E.H.), and JP20gm5010001 (E.H.); Precursory Research for
   Embryonic Science and Technology (PRESTO) under grant number JPMJPR18H6
   (S.N.); and Exploratory Research for Advanced Technology (ERATO) under
   grant number JPMJER1902 (S.F.). This study was also supported by the
   Japan Society for the Promotion of Science (JSPS) under grant numbers
   19H04002 (N.O.), 19H03641 (N.K.), 18H02847 (S.N.), 21H02963 (S.N.),
   20K16121 (T.K.), 20K15695 (M.T.), and 20K16309 (R.Y.) and Japan Science
   and Technology agency (JST), the establishment of university fellowships
   toward the creation of science technology innovation, under grant number
   JPMJFS 2138 (Y.N.), as well as grants from Takeda Science Foundation
   (N.O. and F.K.), Yakult Bio-Science Foundation (T.K. and N.O.), and
   Research Grant of the Princess Takamatsu Cancer Research Fund 18-25003
   (N.O.).
CR Adam M, 2017, DEVELOPMENT, V144, P3625, DOI 10.1242/dev.151142
   Ameri AH, 2019, P NATL ACAD SCI USA, V116, P2646, DOI 10.1073/pnas.1815016116
   Anstee QM, 2019, NAT REV GASTRO HEPAT, V16, P411, DOI 10.1038/s41575-019-0145-7
   Bali KK, 2017, PAIN, V158, P2243, DOI 10.1097/j.pain.0000000000001032
   Bernier M, 2020, CELL METAB, V32, P203, DOI 10.1016/j.cmet.2020.04.019
   Brestoff JR, 2015, NATURE, V519, P242, DOI 10.1038/nature14115
   Broz P, 2020, NAT REV IMMUNOL, V20, P143, DOI 10.1038/s41577-019-0228-2
   Cayrol C, 2018, IMMUNOL REV, V281, P154, DOI 10.1111/imr.12619
   Cayrol C, 2014, CURR OPIN IMMUNOL, V31, P31, DOI 10.1016/j.coi.2014.09.004
   Chen WY, 2015, P NATL ACAD SCI USA, V112, P7249, DOI 10.1073/pnas.1424236112
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   De Boeck A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18569-4
   Dou ZX, 2017, NATURE, V550, P402, DOI 10.1038/nature24050
   Eissmann MF, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10676-1
   Ercolano G, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22764-2
   Evavold CL, 2018, IMMUNITY, V48, P35, DOI 10.1016/j.immuni.2017.11.013
   Faget DV, 2019, NAT REV CANCER, V19, P439, DOI 10.1038/s41568-019-0156-2
   Freund A, 2012, MOL BIOL CELL, V23, P2066, DOI 10.1091/mbc.E11-10-0884
   Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005
   Horai R, 1998, J EXP MED, V187, P1463, DOI 10.1084/jem.187.9.1463
   Hu JJ, 2020, NAT IMMUNOL, V21, P736, DOI 10.1038/s41590-020-0669-6
   Ito A, 1996, J BIOL CHEM, V271, P14657, DOI 10.1074/jbc.271.25.14657
   Jin ZQ, 2018, J IMMUNOL, V201, P3770, DOI 10.4049/jimmunol.1800627
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541
   Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560
   Laberge RM, 2015, NAT CELL BIOL, V17, P1049, DOI 10.1038/ncb3195
   Lefrançais E, 2014, P NATL ACAD SCI USA, V111, P15502, DOI 10.1073/pnas.1410700111
   Lefrançais E, 2012, P NATL ACAD SCI USA, V109, P1673, DOI 10.1073/pnas.1115884109
   Li A, 2019, CELL REP, V29, P2998, DOI 10.1016/j.celrep.2019.10.120
   Li T, 2018, J EXP MED, V215, P1287, DOI 10.1084/jem.20180139
   Liew FY, 2016, NAT REV IMMUNOL, V16, P676, DOI 10.1038/nri.2016.95
   Loo TM, 2017, CANCER DISCOV, V7, P522, DOI 10.1158/2159-8290.CD-16-0932
   Lujambio A, 2013, CELL, V153, P449, DOI 10.1016/j.cell.2013.03.020
   Mederacke I, 2015, NAT PROTOC, V10, P305, DOI 10.1038/nprot.2015.017
   Mederacke I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3823
   Moral JA, 2020, NATURE, V579, P130, DOI 10.1038/s41586-020-2015-4
   Oboki K, 2010, P NATL ACAD SCI USA, V107, P18581, DOI 10.1073/pnas.1003059107
   Ohkura N, 2013, IMMUNITY, V38, P414, DOI 10.1016/j.immuni.2013.03.002
   Ohno T, 2012, ALLERGY, V67, P1203, DOI 10.1111/all.12004
   Orning P, 2019, J EXP MED, V216, P2453, DOI 10.1084/jem.20190545
   Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239
   Pastille E, 2019, MUCOSAL IMMUNOL, V12, P990, DOI 10.1038/s41385-019-0176-y
   Peine M, 2016, TRENDS IMMUNOL, V37, P321, DOI 10.1016/j.it.2016.03.007
   Rathinam VAK, 2016, CELL, V165, P792, DOI 10.1016/j.cell.2016.03.046
   Ringelhan M, 2018, NAT IMMUNOL, V19, P222, DOI 10.1038/s41590-018-0044-z
   Ruan L, 2010, J BIOL CHEM, V285, P27624, DOI 10.1074/jbc.M110.138867
   Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017
   Sakaguchi S, 2013, NAT REV IMMUNOL, V13, P461, DOI 10.1038/nri3464
   Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535
   Schönbeck U, 1998, J IMMUNOL, V161, P3340
   Scott IC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21589-2
   Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514
   Steinmann S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-57985-w
   Takahashi A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03555-8
   Taniguchi S, 2020, SCIENCE, V369, P269, DOI 10.1126/science.aay1813
   Vasanthakumar A, 2015, NAT IMMUNOL, V16, P276, DOI 10.1038/ni.3085
   Wang WX, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02661-w
   Wen YH, 2019, CANCER IMMUNOL IMMUN, V68, P221, DOI 10.1007/s00262-018-2265-2
   Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
   Young ARJ, 2009, EMBO REP, V10, P228, DOI 10.1038/embor.2009.22
   Zhao RR, 2019, AM J MED SCI, V358, P279, DOI 10.1016/j.amjms.2019.07.008
NR 63
TC 31
Z9 32
U1 3
U2 27
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 2470-9468
J9 SCI IMMUNOL
JI Sci. Immunol.
PD JUN
PY 2022
VL 7
IS 72
AR eabl7209
DI 10.1126/sciimmunol.abl7209
PG 16
WC Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology
GA 5P9RG
UT WOS:000873479000003
PM 35749514
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Dasari, BVM
   Schlegel, A
   Mergental, H
   Perera, MTPR
AF Dasari, Bobby V. M.
   Schlegel, Andrea
   Mergental, Hynek
   Perera, M. Thamara P. R.
TI The use of old donors in liver transplantation
SO BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY
LA English
DT Article
DE Elderly donors; Extended criteria donors; Marginal donors; Liver
   transplantation
ID ISCHEMIA-REPERFUSION INJURY; SINGLE-CENTER; ELDERLY DONORS; AGE;
   SURVIVAL; RISK; GRAFTS; ALLOGRAFTS; PATHOPHYSIOLOGY; PRESERVATION
AB The process of ageing has an impact on the entire human body including the organ systems. In transplantation, professionals are daily faced with risk assessment of suitable donor offers, whether to accept a liver graft for a specific recipient. In this context, livers from elderly donors are more frequently accepted for transplantation, to increase the donor pool and compensate the high waiting list mortality. In the current practice it is not unusual to accept 60-year old donor livers for transplantation, as the donor demographics have significantly changed over the years. However, controversy exists regarding the use of livers from donors above 70 or 80 years, particular in combination with other risk factors, e.g. liver steatosis, warm ischaemia or long cold storage. This review focuses first on the impact of ageing on liver morphology and function. Second, we will highlight outcome after transplantation from elderly donors. Finally, we describe further risk factors and donor recipient selection under the scope of old donor organs and include our institutional experience and policy. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Dasari, Bobby V. M.; Schlegel, Andrea; Mergental, Hynek; Perera, M. Thamara P. R.] Queen Elizabeth Hosp, Liver Unit, Birmingham B15 2TH, W Midlands, England.
C3 University of Birmingham
RP Perera, MTPR (corresponding author), Queen Elizabeth Hosp, Liver Unit, Birmingham B15 2TH, W Midlands, England.
EM Bobby.Dasari@uhb.nhs.uk; Andrea.Schlegel@uhb.nhs.uk;
   Hynek.Mergental@uhb.nhs.uk; Thamara.Perera@uhb.nhs.uk
RI Mergental, Hynek/AAY-7122-2021; Mergental, Hynek/H-9485-2013; Schlegel,
   Andrea/AAN-3166-2020
OI Mergental, Hynek/0000-0001-5480-9380; Mergental,
   Hynek/0000-0001-5480-9380; Schlegel, Andrea/0000-0002-9385-9847; Perera,
   Thamara/0000-0002-5417-3850
CR Alamo JM, 2013, TRANSPL P, V45, P3633, DOI 10.1016/j.transproceed.2013.10.031
   Alamo JM, 2011, TRANSPL P, V43, P2227, DOI 10.1016/j.transproceed.2011.05.016
   [Anonymous], EXPERT OPIN BIOL THE
   Belli LS, 2016, J HEPATOL, V65, P524, DOI 10.1016/j.jhep.2016.05.010
   Borchert D, 2005, TRANSPL INT, V18, P709, DOI 10.1111/j.1432-2277.2005.00128.x
   Briceno J, 2000, TRANSPL INT, V13, pS249, DOI [10.1111/j.1432-2277.2000.tb02029.x, DOI 10.1111/J.1432-2277.2000.TB02029.X]]
   Brooks-Wilson AR, 2013, HUM GENET, V132, P1323, DOI 10.1007/s00439-013-1342-z
   Busuttil RW, 2003, LIVER TRANSPLANT, V9, P651, DOI 10.1053/jlts.2003.50105
   Cameron AM, 2006, ANN SURG, V243, P748, DOI 10.1097/01.sla.0000219669.84192.b3
   Cassuto JR, 2008, J SURG RES, V148, P38, DOI 10.1016/j.jss.2008.03.018
   Cescon M, 2003, LIVER TRANSPLANT, V9, P1174, DOI 10.1053/jlts.2003.50234
   Cescon M, 2008, LIVER TRANSPLANT, V14, P672, DOI 10.1002/lt.21433
   Chedid MF, 2014, HPB, V16, P852, DOI 10.1111/hpb.12221
   DALESSANDRO AM, 1991, TRANSPLANTATION, V51, P157, DOI 10.1097/00007890-199101000-00024
   Dutkowski P, 2015, ANN SURG, V262, P764, DOI 10.1097/SLA.0000000000001473
   Dutkowski P, 2012, ANN SURG, V256, P861, DOI 10.1097/SLA.0b013e318272dea2
   Dutkowski P, 2011, ANN SURG, V254, P745, DOI 10.1097/SLA.0b013e3182365081
   Ekong UD, 2008, LIVER TRANSPLANT, V14, P1582, DOI 10.1002/lt.21549
   Emre S, 1996, TRANSPLANTATION, V62, P62, DOI 10.1097/00007890-199607150-00013
   Evans HM, 2006, HEPATOLOGY, V43, P1109, DOI 10.1002/hep.21152
   Feng S, 2006, AM J TRANSPLANT, V6, P783, DOI 10.1111/j.1600-6143.2006.01242.x
   Fiel MI, 2011, J HEPATOL, V55, P582, DOI 10.1016/j.jhep.2010.12.018
   Figueras J, 1996, TRANSPLANTATION, V61, P410, DOI 10.1097/00007890-199602150-00016
   Fouzas I, 2008, TRANSPL P, V40, P3198, DOI 10.1016/j.transproceed.2008.08.061
   Gastaca M, 2005, TRANSPLANT P, V37, P3851, DOI 10.1016/j.transproceed.2005.10.040
   Ghinolfi D, 2014, AM J TRANSPLANT, V14, P2062, DOI 10.1111/ajt.12843
   Hodgson R, 2015, HPB, V17, P222, DOI 10.1111/hpb.12339
   Hübscher SG, 2011, J HEPATOL, V55, P702, DOI 10.1016/j.jhep.2011.03.005
   Jiménez-Romero C, 2014, WORLD J GASTROENTERO, V20, P10691, DOI 10.3748/wjg.v20.i31.10691
   Jung T, 2007, ANN NY ACAD SCI, V1119, P97, DOI 10.1196/annals.1404.008
   Karatzas T, 1997, TRANSPLANT P, V29, P2830, DOI 10.1016/S0041-1345(97)00695-7
   Kim DY, 2011, CLIN TRANSPLANT, V25, P270, DOI 10.1111/j.1399-0012.2010.01222.x
   Knapowski J, 2002, J PHYSIOL PHARMACOL, V53, P135
   Laging M, 2012, TRANSPL INT, V25, P1150, DOI 10.1111/j.1432-2277.2012.01539.x
   Lai Q, 2011, J GASTROINTEST LIVER, V20, P383
   Le Couteur DG, 2008, ANAT REC, V291, P672, DOI 10.1002/ar.20661
   Martins PN, 2011, HPB, V13, P212, DOI 10.1111/j.1477-2574.2010.00275.x
   McLean AJ, 2003, J PATHOL, V200, P112, DOI 10.1002/path.1328
   Mergental H, 2016, AM J TRANSPLANT, V16, P3235, DOI 10.1111/ajt.13875
   Nardo B, 2004, AM J TRANSPLANT, V4, P1139, DOI 10.1111/j.1600-6143.2004.00472.x
   NOVITZKY D, 1987, TRANSPLANTATION, V43, P852, DOI 10.1097/00007890-198743060-00016
   Oh CK, 2000, CLIN TRANSPLANT, V14, P386, DOI 10.1034/j.1399-0012.2000.14040502.x
   Okaya T, 2005, SHOCK, V24, P421, DOI 10.1097/01.shk.0000181282.14050.11
   Park Y, 2007, J SURG RES, V137, P96, DOI 10.1016/j.jss.2006.08.013
   Rana A, 2008, AM J TRANSPLANT, V8, P2537, DOI 10.1111/j.1600-6143.2008.02400.x
   Ravaioli M, 2009, TRANSPL INT, V22, P423, DOI 10.1111/j.1432-2277.2008.00812.x
   Ravikumar R, 2016, AM J TRANSPLANT, V16, P1779, DOI 10.1111/ajt.13708
   Reiniers MJ, 2014, ANTIOXID REDOX SIGN, V21, P1119, DOI 10.1089/ars.2013.5486
   Romero CJ, 1999, TRANSPLANTATION, V68, P572, DOI 10.1097/00007890-199908270-00021
   Saidi RF, 2010, AM J TRANSPLANT, V10, P2536, DOI 10.1111/j.1600-6143.2010.03215.x
   Santori G, 2005, TRANSPLANT P, V37, P2576, DOI 10.1016/j.transproceed.2005.06.074
   Schlatter AF, 2016, AIDS RES TREAT, V2016, DOI [10.1111/ajt.14065, 10.1155/2016/1654938]
   Schlegel A, 2015, Curr Transplant Rep, V2, P52
   Schlegel A, 2015, TRANSPL INT, V28, P677, DOI 10.1111/tri.12354
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Schmucker DL, 1998, J GERONTOL A-BIOL, V53, pB315, DOI 10.1093/gerona/53A.5.B315
   Segev DL, 2007, HEPATOLOGY, V46, P1907, DOI 10.1002/hep.21888
   Selzner M, 2007, LIVER TRANSPLANT, V13, P382, DOI 10.1002/lt.21100
   Stewart ZA, 2009, LIVER TRANSPLANT, V15, P1688, DOI 10.1002/lt.21946
   STRASBERG SM, 1994, HEPATOLOGY, V20, P829, DOI 10.1002/hep.1840200410
   Sutherland Andrew Ian, 2016, J Nat Sci Biol Med, V7, P10, DOI 10.4103/0976-9668.175017
   Uemura T, 2012, TRANSPL INT, V25, P671, DOI 10.1111/j.1432-2277.2012.01474.x
   Verran D, 2003, LIVER TRANSPLANT, V9, P500, DOI 10.1053/jlts.2003.50099
   Wight C, 1996, BRIT MED J, V312, P989
   WYNNE HA, 1989, HEPATOLOGY, V9, P297, DOI 10.1002/hep.1840090222
NR 65
TC 26
Z9 29
U1 0
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1521-6918
EI 1532-1916
J9 BEST PRACT RES CL GA
JI Best Pract. Res. Clin. Gastroenterol.
PD APR
PY 2017
VL 31
IS 2
BP 211
EP 217
DI 10.1016/j.bpg.2017.03.002
PG 7
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA EZ9KL
UT WOS:000405049200010
PM 28624109
DA 2024-02-19
ER

PT J
AU Iannetta, M
   Crea, AMA
   Di Lorenzo, A
   Campogiani, L
   Teti, E
   Malagnino, V
   Compagno, M
   Coppola, L
   Piermatteo, L
   Palmieri, G
   Cimino, C
   Salpini, R
   Zingaropoli, MA
   Ciardi, MR
   Mastroianni, CM
   Parisi, SG
   Svicher, V
   Andreoni, M
   Sarmati, L
AF Iannetta, Marco
   Crea, Angela M. A.
   Di Lorenzo, Andrea
   Campogiani, Laura
   Teti, Elisabetta
   Malagnino, Vincenzo
   Compagno, Mirko
   Coppola, Luigi
   Piermatteo, Lorenzo
   Palmieri, Giampiero
   Cimino, Carolina
   Salpini, Romina
   Zingaropoli, Maria A.
   Ciardi, Maria R.
   Mastroianni, Claudio M.
   Parisi, Saverio G.
   Svicher, Valentina
   Andreoni, Massimo
   Sarmati, Loredana
TI Hepatitis B-Related Hepatic Flare During Immune Reconstitution Syndrome
   After Antiretroviral Treatment Initiation in an HBV Surface
   Antigen-Positive Patient With HIV: Viroimmunological and Histological
   Characterization
SO OPEN FORUM INFECTIOUS DISEASES
LA English
DT Article
DE HBV; AIDS; IRIS; biopsy; cccDNA; immune activation; pgRNA
ID INFLAMMATORY SYNDROME; VIRUS; COINFECTION; THERAPY
AB HIV and hepatitis B virus (HBV) coinfection is relatively common. Initiation of antiretroviral therapy (ART) in people with HIV (PWH) causes a progressive restoration of cell-mediated immune functions. In the presence of overt or occult coinfections, immune restoration might lead to immune reconstitution inflammatory syndrome (IRIS). Here, we describe the clinical, immunological, virological, and histological characterization of a case of HBV-related IRIS hepatitis in a PWH after ART initiation. A liver biopsy was performed during HBV-related IRIS hepatic flare, and liver samples were analyzed through immunohistochemistry and molecular techniques, with the assessment of intrahepatic HBV-DNA, covalently closed circular DNA, and HBV pregenomic RNA through a droplet digital polymerase chain reaction system. Immune activation and senescence were also longitudinally assessed. In this clinical case, the hepatic flare occurred 6 weeks after ART initiation with a therapeutic regimen including tenofovir alafenamide (TAF) and emtricitabine (FTC). The episode was self-limiting, characterized by hyperactivation of peripheral blood CD4+ and CD8+ T-lymphocytes, and resolved without ART discontinuation, leading to the achievement of HBsAg seroconversion (HBsAg-/HBsAb+) and HBV-DNA plasma undetectability. Notably, hyperactivation of the immune system plays a pivotal role in promoting the control of HBV replication, thus triggering the achievement of HBsAg seroconversion during treatment with TAF/FTC.
C1 [Iannetta, Marco; Crea, Angela M. A.; Di Lorenzo, Andrea; Campogiani, Laura; Teti, Elisabetta; Malagnino, Vincenzo; Compagno, Mirko; Coppola, Luigi; Andreoni, Massimo; Sarmati, Loredana] Tor Vergata Univ, Dept Syst Med, Via Montpellier 1, I-00133 Rome, Italy.
   [Piermatteo, Lorenzo; Salpini, Romina; Svicher, Valentina] Tor Vergata Univ, Dept Expt Med, Rome, Italy.
   [Palmieri, Giampiero; Cimino, Carolina] Tor Vergata Univ, Dept Biomed & Prevent, Rome, Italy.
   [Zingaropoli, Maria A.; Ciardi, Maria R.; Mastroianni, Claudio M.] Sapienza Univ, Dept Publ Hlth & Infect Dis, Rome, Italy.
   [Parisi, Saverio G.] Univ Padua, Dept Mol Med, Padua, Italy.
   [Svicher, Valentina] Tor Vergata Univ, Dept Biol, Rome, Italy.
C3 University of Rome Tor Vergata; University of Rome Tor Vergata;
   University of Rome Tor Vergata; Sapienza University Rome; University of
   Padua; University of Rome Tor Vergata
RP Iannetta, M (corresponding author), Tor Vergata Univ, Dept Syst Med, Via Montpellier 1, I-00133 Rome, Italy.
EM marco.iannetta@uniroma2.it
RI Zingaropoli, Maria Antonella/IQU-9746-2023; Malagnino,
   Vincenzo/HKM-4994-2023; Piermatteo, Lorenzo/J-5796-2018; Iannetta,
   Marco/B-5596-2017
OI Piermatteo, Lorenzo/0000-0002-3500-0858; COPPOLA,
   LUIGI/0009-0005-4728-261X; Iannetta, Marco/0000-0002-6938-8627;
   Malagnino, Vincenzo/0000-0002-6561-5298; Di Lorenzo,
   Andrea/0009-0008-1772-196X
CR Abdullahi A, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy251
   Avihingsanon A, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-6
   Bloquel B, 2010, J MED VIROL, V82, P206, DOI 10.1002/jmv.21685
   Chiang CJ, 2013, JAMA-J AM MED ASSOC, V310, P974, DOI 10.1001/jama.2013.276701
   Crane M, 2008, CURR OPIN HIV AIDS, V3, P446, DOI 10.1097/COH.0b013e3282fdc953
   Crane M, 2009, J INFECT DIS, V199, P974, DOI 10.1086/597276
   den Brinker M, 2000, AIDS, V14, P2895, DOI 10.1097/00002030-200012220-00011
   Haddow LJ, 2009, CLIN INFECT DIS, V49, P1424, DOI 10.1086/630208
   Iannetta M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160277
   Lacombe K, 2012, GUT, V61, P47, DOI 10.1136/gutjnl-2012-302062
   Mack CL, 2020, HEPATOLOGY, V72, P671, DOI 10.1002/hep.31065
   Magoro T, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0636-x
   Malagnino V, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-83616-z
   Malagnino V, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46976-1
   Mitsumoto F, 2015, J INFECT CHEMOTHER, V21, P264, DOI 10.1016/j.jiac.2014.12.003
   Mitsumoto F, 2014, INTERNAL MED, V53, P2165, DOI 10.2169/internalmedicine.53.2503
   Nevola R, 2022, BIOLOGY-BASEL, V11, DOI 10.3390/biology11040609
   Huong TC, 2022, PLOS ONE, V17, DOI 10.1371/journal.pone.0266134
   Rowley MW, 2019, ANN HEPATOL, V18, P220, DOI 10.5604/01.3001.0012.7918
   Sagnelli E, 2014, WORLD J GASTROENTERO, V20, P7635, DOI 10.3748/wjg.v20.i24.7635
   Salpini R, 2011, ANTIVIR RES, V92, P382, DOI 10.1016/j.antiviral.2011.08.013
   Salpini R, 2019, J INFECT DIS, V220, P1935, DOI 10.1093/infdis/jiz411
   Sereti I, 2010, CURR OPIN HIV AIDS, V5, P504, DOI 10.1097/COH.0b013e32833ed774
   Soriano V, 2013, CLIN LIVER DIS, V17, P489, DOI 10.1016/j.cld.2013.05.008
   Svicher V, 2021, GUT, V70, P2337, DOI 10.1136/gutjnl-2020-323300
   Yoshikawa S, 2021, J INFECT DIS, V223, P2080, DOI 10.1093/infdis/jiaa662
NR 26
TC 2
Z9 2
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 2328-8957
J9 OPEN FORUM INFECT DI
JI Open Forum Infect. Dis.
PD SEP 2
PY 2022
VL 9
IS 9
AR ofac451
DI 10.1093/ofid/ofac451
PG 7
WC Immunology; Infectious Diseases; Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Infectious Diseases; Microbiology
GA 4J3VK
UT WOS:000851193700010
PM 36092833
OA Green Published
DA 2024-02-19
ER

PT J
AU Li, N
   Bates, DJ
   An, J
   Terry, DA
   Wang, E
AF Li, Na
   Bates, David J.
   An, Jin
   Terry, Derek A.
   Wang, Eugenia
TI Up-regulation of key microRNAs, and inverse down-regulation of their
   predicted oxidative phosphorylation target genes, during aging in mouse
   brain
SO NEUROBIOLOGY OF AGING
LA English
DT Article
DE MicroRNA; Proteomics; Mitochondrial complexes; F0F1-ATPase
ID MITOCHONDRIAL CREATINE-KINASE; RAT-BRAIN; DYSFUNCTION; METABOLISM;
   RESPIRATION; CARDIOLIPIN; EXPRESSION; DISORDERS; NEURONS; CELLS
AB Although significant advances have been made in the study of the molecular mechanisms controlling brain aging, post-transcriptional gene regulation in normal brain aging has yet to be explored. Our lab recently reported that predominant microRNA up-regulation is observed in liver during aging, with key microRNAs predicted to target detoxification genes. Here we examine the role of microRNA regulation in brain during the normal aging process. MicroRNA microarrays and global proteomic profiling were used to compare the brain tissues of 10-, 18-, 24-, and 33-month-old mice. Our results suggest that: (1) like liver, during aging the brain exhibits predominant microRNA up-regulation, and this trend starts in mid-life; (2) of the 70 up-regulated microRNAs, 27 are predicted to target 10 genes of mitochondrial complexes III, IV, and F0F1-ATPase, which exhibit inversely correlated expression; (3) mice of extreme longevity (33-month old) exhibit fewer microRNA expression changes from 10-month-old levels than do old adult mice (24-month old). We found unique de-regulated microRNAs shared between aging brain and aging liver, as well as brain- vs. liver-specific microRNAs during normal aging. Published by Elsevier Inc.
C1 [Bates, David J.; Wang, Eugenia] Univ Louisville, Sch Med, Dept Biochem & Mol Biol, Louisville, KY 40202 USA.
   [Li, Na; Bates, David J.; An, Jin; Terry, Derek A.; Wang, Eugenia] Univ Louisville, Sch Med, Gheens Ctr Aging, Louisville, KY 40202 USA.
C3 University of Louisville; University of Louisville
RP Wang, E (corresponding author), Univ Louisville, Sch Med, Dept Biochem & Mol Biol, 580 S Preston St, Louisville, KY 40202 USA.
EM Eugenia.Wang@Louisville.edu
FU U.S. National Aeronautics and Space Administration (NASA) [NNX08AP23G]
FX This work is supported by grant NNX08AP23G from the U.S. National
   Aeronautics and Space Administration (NASA) to EW. We would like to
   thank Mrs. Vickie Chen and Mr. Alan N. Bloch for proofreading the
   manuscript, as well as Patrick R. Lyninger for computational and
   technical services.
CR Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871
   BATES DJ, 2009, BIOCH BIOPH IN PRESS
   BINO J, 2004, PLOS BIOL, V2, pe363
   Bonawitz ND, 2006, MOL CELL BIOL, V26, P4818, DOI 10.1128/MCB.02360-05
   Boveris A, 2008, IUBMB LIFE, V60, P308, DOI 10.1002/iub.46
   Chen SY, 1998, J BIOL CHEM, V273, P35194, DOI 10.1074/jbc.273.52.35194
   Dencher NA, 2007, ANN NY ACAD SCI, V1100, P291, DOI 10.1196/annals.1395.030
   FRIEDMAN DL, 1994, J COMP NEUROL, V343, P500, DOI 10.1002/cne.903430311
   Fujimoto T, 2008, PSYCHIAT RES-NEUROIM, V164, P58, DOI 10.1016/j.pscychresns.2006.12.014
   Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952
   Hertz L, 2007, METAB BRAIN DIS, V22, P199, DOI 10.1007/s11011-007-9068-z
   Lacelle C, 2002, J GERONTOL A-BIOL, V57, pB285, DOI 10.1093/gerona/57.7.B285
   Maes OC, 2008, MECH AGEING DEV, V129, P534, DOI 10.1016/j.mad.2008.05.004
   Maes OC, 2009, CURR GENOMICS, V10, P154, DOI 10.2174/138920209788185252
   Monge C, 2008, MOL CELL BIOCHEM, V318, P147, DOI 10.1007/s11010-008-9865-7
   Mukobata S, 2002, BIOCHEM BIOPH RES CO, V297, P722, DOI 10.1016/S0006-291X(02)02284-2
   Navarro A, 2008, AM J PHYSIOL-REG I, V294, pR501, DOI 10.1152/ajpregu.00492.2007
   Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5
   Petrosillo G, 2008, NEUROCHEM INT, V53, P126, DOI 10.1016/j.neuint.2008.07.001
   Reeve Amy K., 2008, Biotechnology Journal, V3, P750, DOI 10.1002/biot.200800066
   Sen T, 2007, NEUROCHEM INT, V50, P719, DOI 10.1016/j.neuint.2007.01.007
   Slemmer JE, 2008, CURR MED CHEM, V15, P404, DOI 10.2174/092986708783497337
   Spindler SR, 2007, ANNU REV NUTR, V27, P193, DOI 10.1146/annurev.nutr.27.061406.093743
   Thibault O, 1996, SCIENCE, V272, P1017, DOI 10.1126/science.272.5264.1017
   Wang E, 2002, J GERONTOL A-BIOL, V57, pB400, DOI 10.1093/gerona/57.11.B400
   Wang E, 2007, AGEING RES REV, V6, P1, DOI 10.1016/j.arr.2007.02.004
NR 26
TC 104
Z9 121
U1 0
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0197-4580
J9 NEUROBIOL AGING
JI Neurobiol. Aging
PD MAY
PY 2011
VL 32
IS 5
BP 944
EP 955
DI 10.1016/j.neurobiolaging.2009.04.020
PG 12
WC Geriatrics & Gerontology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology; Neurosciences & Neurology
GA 755SP
UT WOS:000289957000018
PM 19487051
DA 2024-02-19
ER

PT J
AU Pan, CC
   Maeso-Díaz, R
   Lewis, TR
   Xiang, K
   Tan, LM
   Liang, YS
   Wang, LY
   Yang, FR
   Yin, T
   Wang, C
   Du, K
   Huang, D
   Oh, SH
   Wang, EG
   Lim, BJW
   Chong, MY
   Alexander, PB
   Yao, XB
   Arshavsky, VY
   Li, QJ
   Diehl, AM
   Wang, XF
AF Pan, Christopher C.
   Maeso-Diaz, Raquel
   Lewis, Tylor R.
   Xiang, Kun
   Tan, Lianmei
   Liang, Yaosi
   Wang, Liuyang
   Yang, Fengrui
   Yin, Tao
   Wang, Calvin
   Du, Kuo
   Huang, De
   Oh, Seh Hoon
   Wang, Ergang
   Lim, Bryan Jian Wei
   Chong, Mengyang
   Alexander, Peter B.
   Yao, Xuebiao
   Arshavsky, Vadim Y.
   Li, Qi-Jing
   Diehl, Anna Mae
   Wang, Xiao-Fan
TI Antagonizing the irreversible thrombomodulin-initiated proteolytic
   signaling alleviates age-related liver fibrosis via senescent cell
   killing
SO CELL RESEARCH
LA English
DT Article; Early Access
ID PROTEASE-ACTIVATED RECEPTOR-1; MITOCHONDRIAL-FUNCTION; C ACTIVATION;
   DYSFUNCTION; EXPRESSION; THROMBIN; PAR1; PROTEOSTASIS; ENDOTHELIUM;
   INHIBITORS
AB Cellular senescence is a stress-induced, stable cell cycle arrest phenotype which generates a pro-inflammatory microenvironment, leading to chronic inflammation and age-associated diseases. Determining the fundamental molecular pathways driving senescence instead of apoptosis could enable the identification of senolytic agents to restore tissue homeostasis. Here, we identify thrombomodulin (THBD) signaling as a key molecular determinant of the senescent cell fate. Although normally restricted to endothelial cells, THBD is rapidly upregulated and maintained throughout all phases of the senescence program in aged mammalian tissues and in senescent cell models. Mechanistically, THBD activates a proteolytic feed-forward signaling pathway by stabilizing a multi-protein complex in early endosomes, thus forming a molecular basis for the irreversibility of the senescence program and ensuring senescent cell viability. Therapeutically, THBD signaling depletion or inhibition using vorapaxar, an FDA-approved drug, effectively ablates senescent cells and restores tissue homeostasis in liver fibrosis models. Collectively, these results uncover proteolytic THBD signaling as a conserved pro-survival pathway essential for senescent cell viability, thus providing a pharmacologically exploitable senolytic target for senescence-associated diseases.
C1 [Pan, Christopher C.; Xiang, Kun; Tan, Lianmei; Liang, Yaosi; Yin, Tao; Wang, Calvin; Huang, De; Wang, Ergang; Chong, Mengyang; Alexander, Peter B.; Arshavsky, Vadim Y.; Wang, Xiao-Fan] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA.
   [Maeso-Diaz, Raquel; Du, Kuo; Oh, Seh Hoon; Diehl, Anna Mae] Duke Univ, Dept Med, Div Gastroenterol, Durham, NC USA.
   [Lewis, Tylor R.; Arshavsky, Vadim Y.] Duke Univ, Dept Med, Div Ophthalmol, Durham, NC USA.
   [Wang, Liuyang] Duke Univ, Dept Mol Genet & Microbiol, Durham, NC USA.
   [Yang, Fengrui; Yao, Xuebiao] Morehouse Sch Med, Dept Physiol, Atlanta, GA USA.
   [Lim, Bryan Jian Wei; Li, Qi-Jing] Duke Univ, Dept Immunol, Durham, NC USA.
C3 Duke University; Duke University; Duke University; Duke University;
   Morehouse School of Medicine; Duke University
RP Wang, XF (corresponding author), Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA.
EM xiao.fan.wang@duke.edu
RI lei, lei/JSL-3106-2023; li, mengyang/JWO-9551-2024; Li,
   Xinyue/JVN-4601-2024; wang, yingying/JSK-6741-2023; chen,
   gang/JRX-1197-2023; ZHU, JIALI/JNE-3065-2023; cheng, chen/JHS-9462-2023;
   Ding, Yang/JUV-4842-2023; wang, jiaqi/JSL-7112-2023; li,
   tao/JVO-9006-2024; xu, wei/JZD-2112-2024; Wang, Xiaojun/JUU-9683-2023;
   wang, chen/JED-7289-2023; Lu, Wang/JVO-0416-2024; Chen,
   Fang/JZE-4446-2024; LEI, LEI/JTS-4675-2023; zhang, jt/JVE-1333-2024;
   Liu, yujing/JQI-7225-2023; Yang, Min/JPY-3791-2023; Liu,
   Zhiyu/JNR-8043-2023; Wei, Wei/JVM-8876-2024; zhang, hao/JOJ-7093-2023;
   Zhang, Chi/JSK-0744-2023; Liu, Zhihao/JUF-7651-2023; Lu,
   Lu/JPE-5187-2023; Liu, Shaobo/JUU-5767-2023; Wang, Liuyang/A-7833-2011
OI Liu, Zhiyu/0000-0001-8351-1268; Wei, Wei/0000-0002-4109-3878; Liang,
   Yaosi/0000-0002-3478-0864; Lewis, Tylor R/0000-0001-6832-7972; Xiang,
   Kun/0000-0001-7793-4352; Yao, Xuebiao/0000-0001-8982-5911; Wang,
   Liuyang/0000-0001-9556-2361
CR Aird Katherine M, 2013, Methods Mol Biol, V965, P185, DOI 10.1007/978-1-62703-239-1_12
   Alexander PB, 2015, CELL RES, V25, P135, DOI 10.1038/cr.2014.141
   Amor C, 2020, NATURE, V583, P127, DOI 10.1038/s41586-020-2403-9
   Antoniak S, 2018, J MOL CELL CARDIOL, V122, P80, DOI 10.1016/j.yjmcc.2018.08.008
   Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031
   Arif SA, 2015, AM J HEALTH-SYST PH, V72, P1615, DOI 10.2146/ajhp140758
   Arsenault KA, 2012, NAT REV CARDIOL, V9, P402, DOI 10.1038/nrcardio.2012.61
   Bae JS, 2007, P NATL ACAD SCI USA, V104, P2867, DOI 10.1073/pnas.0611493104
   Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600
   Baker N, 2015, P NATL ACAD SCI USA, V112, P9112, DOI 10.1073/pnas.1505411112
   Beerman I, 2022, J CLIN INVEST, V132, DOI 10.1172/JCI158871
   Campisi J, 2000, IN VIVO, V14, P183
   Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Carpenter VJ, 2021, CANCERS, V13, DOI 10.3390/cancers13040723
   Chang JH, 2016, NAT MED, V22, P78, DOI 10.1038/nm.4010
   Chao TH, 2014, INT J CARDIOL, V172, P340, DOI 10.1016/j.ijcard.2014.01.009
   Chen BX, 2014, J BIOL CHEM, V289, P1580, DOI 10.1074/jbc.M113.528273
   Chen B, 2011, J BIOL CHEM, V286, P40760, DOI 10.1074/jbc.M111.299776
   Chen SF, 2018, BIOINFORMATICS, V34, P884, DOI 10.1093/bioinformatics/bty560
   Cheng T, 2003, NAT MED, V9, P338, DOI 10.1038/nm826
   Cheng Y, 2012, MOL ENDOCRINOL, V26, P331, DOI 10.1210/me.2011-1187
   Childs BG, 2015, NAT MED, V21, P1424, DOI 10.1038/nm.4000
   Chondrogianni N, 2005, EXP GERONTOL, V40, P931, DOI 10.1016/j.exger.2005.09.004
   Chong MY, 2018, EMBO REP, V19, DOI 10.15252/embr.201745274
   Christian LS, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.109118
   Coffey EE, 2014, NEUROSCIENCE, V263, P111, DOI 10.1016/j.neuroscience.2014.01.001
   Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003
   Cui AY, 2021, DIABETES, V70, P653, DOI 10.2337/dbi20-0006
   Cullen PJ, 2018, NAT REV MOL CELL BIO, V19, P679, DOI 10.1038/s41580-018-0053-7
   De Ceunynck K, 2018, P NATL ACAD SCI USA, V115, pE982, DOI 10.1073/pnas.1718600115
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Dolgin E, 2021, NAT BIOTECHNOL, V39, P1308, DOI 10.1038/s41587-021-01073-5
   Du K, 2021, LIVER INT, V41, P2214, DOI 10.1111/liv.14945
   Finn RS, 2016, NEW ENGL J MED, V375, P1925, DOI 10.1056/NEJMoa1607303
   Finn RS, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0721-5
   Fleury H, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10460-1
   Gasek NS, 2021, NATURE AGING, V1, P870, DOI 10.1038/s43587-021-00121-8
   Giri H, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2022248118
   Giri H, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20081851
   Goel S, 2017, NATURE, V548, P471, DOI 10.1038/nature23465
   Grimsey N, 2014, METHOD ENZYMOL, V535, P389, DOI 10.1016/B978-0-12-397925-4.00022-5
   Grimsey NJ, 2016, CURR OPIN HEMATOL, V23, P274, DOI 10.1097/MOH.0000000000000232
   Grimsey NJ, 2016, J BIOL CHEM, V291, P2223, DOI 10.1074/jbc.M115.702993
   Guerrero-Navarro L., 2022, CELLS-BASEL, V11, P1
   Gustavsson EK, 2022, BIOINFORMATICS, V38, P3844, DOI 10.1093/bioinformatics/btac409
   Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830
   He SH, 2017, CELL, V169, P1000, DOI 10.1016/j.cell.2017.05.015
   Hernandez-Segura A, 2017, CURR BIOL, V27, P2652, DOI 10.1016/j.cub.2017.07.033
   Hughes AL, 2012, NATURE, V492, P261, DOI 10.1038/nature11654
   Isermann B, 2007, NAT MED, V13, P1349, DOI 10.1038/nm1667
   Johmura Y, 2021, SCIENCE, V371, P265, DOI 10.1126/science.abb5916
   Joy J, 2021, DEV CELL, V56, P2043, DOI 10.1016/j.devcel.2021.06.009
   Justice JN, 2019, EBIOMEDICINE, V40, P554, DOI 10.1016/j.ebiom.2018.12.052
   Kaushik S, 2015, NAT MED, V21, P1406, DOI 10.1038/nm.4001
   Koizume S, 2016, CANCERS, V8, DOI 10.3390/cancers8010002
   Kosar M, 2011, CELL CYCLE, V10, P457, DOI 10.4161/cc.10.3.14707
   Kovacovicova K, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00459
   Li GY, 2022, J TRANSL MED, V20, DOI 10.1186/s12967-022-03247-4
   Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656
   Liu PY, 2021, NAT CELL BIOL, V23, P355, DOI 10.1038/s41556-021-00656-3
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Love M., 2014, Genome Biol, V15, P10, DOI DOI 10.1186/S13059-014-0550-8
   Lyu GL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04994-z
   Maeso-Díaz R, 2022, AGING CELL, V21, DOI 10.1111/acel.13530
   Martin FA, 2013, AM J PHYSIOL-HEART C, V304, pH1585, DOI 10.1152/ajpheart.00096.2013
   Martínez-Zamudio RI, 2020, NAT CELL BIOL, V22, P842, DOI 10.1038/s41556-020-0529-5
   McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151
   Meller A, 2021, EXP CELL RES, V399, DOI 10.1016/j.yexcr.2021.112474
   Molinar-Inglis O, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2106623118
   Mosnier LO, 2012, BLOOD, V120, P5237, DOI 10.1182/blood-2012-08-452169
   Munro J, 2004, EXP CELL RES, V295, P525, DOI 10.1016/j.yexcr.2004.01.017
   Murphy JE, 2009, P NATL ACAD SCI USA, V106, P17615, DOI 10.1073/pnas.0906541106
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Okamoto T, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/614545
   Palfy M, 2012, TRENDS CELL BIOL, V22, P447, DOI 10.1016/j.tcb.2012.06.004
   Passman AM, 2015, DIS MODEL MECH, V8, P1635, DOI 10.1242/dmm.022020
   Poole LG, 2020, RES PRACT THROMB HAE, V4, P906, DOI 10.1002/rth2.12403
   Riewald M, 2003, J ENDOTOXIN RES, V9, P317, DOI 10.1179/096805103225002584
   Ritschka B, 2020, GENE DEV, V34, P489, DOI 10.1101/gad.332643.119
   Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094
   Ruano D, 2021, FRONT MOL BIOSCI, V8, DOI 10.3389/fmolb.2021.658742
   Saez I, 2014, CURR GENOMICS, V15, P38, DOI 10.2174/138920291501140306113344
   Schuepbach RA, 2012, J THROMB HAEMOST, V10, P1675, DOI 10.1111/j.1538-7836.2012.04825.x
   Sharma AK, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00354
   Sinha RK, 2018, BLOOD, V131, P1163, DOI 10.1182/blood-2017-10-810895
   Smith A, 2019, AM FAM PHYSICIAN, V100, P759
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Sun YN, 2020, ELIFE, V9, DOI 10.7554/eLife.55745
   Sun-Wang JL, 2020, AGEING RES REV, V64, DOI 10.1016/j.arr.2020.101203
   Sungkaworn T, 2017, NATURE, V550, P543, DOI 10.1038/nature24264
   Suvarna V, 2019, EUR J PHARMACOL, V862, DOI 10.1016/j.ejphar.2019.172655
   Takenaka Y, 2022, FEBS J, V289, P1650, DOI 10.1111/febs.16249
   Tian YQ, 2019, AGING CELL, V18, DOI 10.1111/acel.12858
   Trejo J, 1998, P NATL ACAD SCI USA, V95, P13698, DOI 10.1073/pnas.95.23.13698
   TSIANG M, 1992, J BIOL CHEM, V267, P6164
   van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193
   Vierbuchen T, 2017, MOL CELL, V68, P1067, DOI 10.1016/j.molcel.2017.11.026
   Wandrer F, 2018, ALIMENT PHARM THER, V48, P270, DOI 10.1111/apt.14802
   Wang FD, 2022, FRONT PHARMACOL, V13, DOI 10.3389/fphar.2022.787748
   Wang LH, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-1081-0
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   Wolter J, 2016, J THROMB HAEMOST, V14, P2212, DOI 10.1111/jth.13494
   Wootten D, 2018, NAT REV MOL CELL BIO, V19, P638, DOI 10.1038/s41580-018-0049-3
   Xiang HD, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.19
   Yambire KF, 2019, ELIFE, V8, DOI 10.7554/eLife.51031
   Yousefzadeh MJ, 2020, AGING CELL, V19, DOI 10.1111/acel.13094
   Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118
   Yuan LF, 2018, CELL RES, V28, P625, DOI 10.1038/s41422-018-0043-5
   Zhang L, 2021, MECH AGEING DEV, V200, DOI 10.1016/j.mad.2021.111587
   Zhu Y, 2015, AGING CELL, V14, P644, DOI 10.1111/acel.12344
NR 111
TC 6
Z9 7
U1 2
U2 5
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 1001-0602
EI 1748-7838
J9 CELL RES
JI Cell Res.
PD 2023 JUL
PY 2023
VL 33
IS 7
BP 516
EP 532
DI 10.1038/s41422-023-00820-4
EA MAY 2023
PG 17
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA K5DC7
UT WOS:000985220400001
PM 37169907
DA 2024-02-19
ER

PT J
AU Zhou, B
   Yang, L
   Li, SF
   Huang, JL
   Chen, HY
   Hou, L
   Wang, JB
   Green, CD
   Yan, Z
   Huang, X
   Kaeberlein, M
   Zhu, L
   Xiao, HS
   Liu, Y
   Han, JDJ
AF Zhou, Bing
   Yang, Liu
   Li, Shoufeng
   Huang, Jialiang
   Chen, Haiyang
   Hou, Lei
   Wang, Jinbo
   Green, Christopher D.
   Yan, Zhen
   Huang, Xun
   Kaeberlein, Matt
   Zhu, Li
   Xiao, Huasheng
   Liu, Yong
   Han, Jing-Dong J.
TI Midlife gene expressions identify modulators of aging through dietary
   interventions
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE systems biology; diet-induced obesity
ID ELEGANS LIFE-SPAN; MITOCHONDRIAL BIOGENESIS; TRANSCRIPTIONAL PROFILE;
   CAENORHABDITIS-ELEGANS; HUMAN BRAIN; C-ELEGANS; AGED MICE; RESTRICTION;
   PEROXISOMES; PATTERNS
AB Dietary interventions are effective ways to extend or shorten lifespan. By examining midlife hepatic gene expressions in mice under different dietary conditions, which resulted in different lifespans and aging-related phenotypes, we were able to identify genes and pathways that modulate the aging process. We found that pathways transcriptionally correlated with diet-modulated lifespan and physiological changes were enriched for lifespan-modifying genes. Intriguingly, mitochondrial gene expression correlated with lifespan and anticorrelated with aging-related pathological changes, whereas peroxisomal gene expression showed an opposite trend. Both organelles produce reactive oxygen species, a proposed causative factor of aging. This finding implicates a contribution of peroxisome to aging. Consistent with this hypothesis, lowering the expression levels of peroxisome proliferation genes decreased the cellular peroxide levels and extended the lifespan of Drosophila melanogaster and Caenorhabditis elegans. These findings show that transcriptional changes resulting from dietary interventions can effectively reflect causal factors in aging and identify previously unknown or under-appreciated longevity pathways, such as the peroxisome pathway.
C1 [Yang, Liu; Li, Shoufeng; Liu, Yong] Chinese Acad Sci, Key Lab Nutr & Metab, Inst Nutr Sci, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China.
   [Zhou, Bing; Huang, Jialiang; Hou, Lei; Green, Christopher D.; Han, Jing-Dong J.] Chinese Acad Sci, Key Lab Computat Biol, Max Planck Partner Inst Computat Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China.
   [Zhou, Bing; Huang, Jialiang; Hou, Lei] Chinese Acad Sci, Ctr Mol Syst Biol, Inst Genet & Dev Biol, Beijing 100101, Peoples R China.
   [Zhou, Bing; Huang, Jialiang; Hou, Lei; Wang, Jinbo] Chinese Acad Sci, Grad Univ, Beijing 100049, Peoples R China.
   [Chen, Haiyang; Wang, Jinbo; Huang, Xun] Chinese Acad Sci, State Key Lab Mol Dev Biol, Inst Genet & Dev Biol, Beijing 100101, Peoples R China.
   [Yan, Zhen] Univ Virginia, Robert M Berne Cardiovasc Res Ctr, Dept Med Cardiovasc Med, Charlottesville, VA 22908 USA.
   [Yan, Zhen] Univ Virginia, Robert M Berne Cardiovasc Res Ctr, Dept Pharmacol, Charlottesville, VA 22908 USA.
   [Yan, Zhen] Univ Virginia, Robert M Berne Cardiovasc Res Ctr, Ctr Skeletal Muscle Res, Charlottesville, VA 22908 USA.
   [Kaeberlein, Matt] Univ Washington, Dept Pathol, Seattle, WA 98195 USA.
   [Zhu, Li; Xiao, Huasheng] Chinese Acad Sci, Key Lab Syst Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China.
C3 Chinese Academy of Sciences; Chinese Academy of Sciences; Max Planck
   Society; Chinese Academy of Sciences; Institute of Genetics &
   Developmental Biology, CAS; Chinese Academy of Sciences; University of
   Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute
   of Genetics & Developmental Biology, CAS; University of Virginia;
   University of Virginia; University of Virginia; University of
   Washington; University of Washington Seattle; Chinese Academy of
   Sciences
RP Liu, Y (corresponding author), Chinese Acad Sci, Key Lab Nutr & Metab, Inst Nutr Sci, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China.
EM liuy@sibs.ac.cn; jdhan@genetics.ac.cn
RI Zhu, Li/GWV-0143-2022
OI Zhu, Li/0000-0001-5249-6536; Chen, Haiyang/0000-0001-8305-4060; LIU,
   YONG/0000-0001-7771-4181; Yan, Zhen/0000-0002-4826-9813
FU Chinese Ministry of Science and Technology [2011CB910900, 2011CB504206,
   2012CB524900]; National Natural Science Foundation of China [81021002,
   30988002, 30830033, 30890033, 91019019]; Chinese Academy of Sciences
   [KSCX2-EW-R-09, KSCX2-EW-R-02, KSCX2-EW-J-15, XDA01010303]
FX We thank Prof. Hong Zhang from the National Institute for Biological
   Sciences and Dangsheng Li from Cell Research for invaluable suggestions.
   We also thank Christopher B. Newgard (Duke University) for initial
   design of the intervention study in mice. This work was supported by
   Chinese Ministry of Science and Technology Grants 2011CB910900 (to
   Y.L.), 2011CB504206 (to J.-D.J.H.), and 973 Program 2012CB524900;
   National Natural Science Foundation of China Grants 81021002 (to Y.L.),
   30988002 (to Y.L.), 30830033 (to Y.L.), 30890033 (to J.-D.J.H.), and
   91019019 (to J.-D.J.H.); and Chinese Academy of Sciences Grants
   KSCX2-EW-R-09 (to Y.L.), KSCX2-EW-R-02 (to J.-D.J.H.), KSCX2-EW-J-15 (to
   J.-D.J.H.), and XDA01010303 (to J.-D.J.H.). M. K. is an Ellison Medical
   Foundation New Scholar in Aging.
CR Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354
   Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055
   BRENNER S, 1974, GENETICS, V77, P71
   Cantó C, 2009, TRENDS ENDOCRIN MET, V20, P325, DOI 10.1016/j.tem.2009.03.008
   Cha DR, 2007, AM J NEPHROL, V27, P479, DOI 10.1159/000106485
   Chen HY, 2010, HUM MOL GENET, V19, P494, DOI 10.1093/hmg/ddp518
   Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076
   Curran SP, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030056
   D'Antona G, 2010, CELL METAB, V12, P362, DOI 10.1016/j.cmet.2010.08.016
   de Magalhaes JP, 2005, NUCLEIC ACIDS RES, V33, pD537, DOI 10.1093/nar/gki017
   Delille HK, 2009, HISTOCHEM CELL BIOL, V131, P441, DOI 10.1007/s00418-009-0561-9
   Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191
   Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539
   GOODRICK CL, 1983, J GERONTOL, V38, P36, DOI 10.1093/geronj/38.1.36
   Guarente LP, 2007, MOL BIOL AGING, P409
   Gurd BJ, 2011, APPL PHYSIOL NUTR ME, V36, P589, DOI [10.1139/H11-070, 10.1139/h11-070]
   Hagopian K, 2005, AM J PHYSIOL-ENDOC M, V288, pE674, DOI 10.1152/ajpendo.00382.2004
   Hagopian K, 2011, J BIOENERG BIOMEMBR, V43, P227, DOI 10.1007/s10863-011-9353-8
   Hietakangas V, 2009, ANNU REV GENET, V43, P389, DOI 10.1146/annurev-genet-102108-134815
   Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476
   Jin CY, 2011, CELL METAB, V14, P161, DOI 10.1016/j.cmet.2011.07.001
   Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002
   Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278
   Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002
   Khaitovich P, 2004, GENOME RES, V14, P1462, DOI 10.1101/gr.2538704
   Kim SK, 2007, J EXP BIOL, V210, P1607, DOI 10.1242/jeb.004887
   KLEIBER M, 1947, PHYSIOL REV, V27, P511, DOI 10.1152/physrev.1947.27.4.511
   Lee SJ, 2010, CURR BIOL, V20, P2131, DOI 10.1016/j.cub.2010.10.057
   Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056
   López-Lluch G, 2006, P NATL ACAD SCI USA, V103, P1768, DOI 10.1073/pnas.0510452103
   Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661
   Lund J, 2002, CURR BIOL, V12, P1566, DOI 10.1016/S0960-9822(02)01146-6
   McCarroll SA, 2004, NAT GENET, V36, P197, DOI 10.1038/ng1291
   Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261
   Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728
   Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011
   Pletcher SD, 2002, CURR BIOL, V12, P712, DOI 10.1016/S0960-9822(02)00808-4
   Russell SJ, 2007, NAT REV MOL CELL BIO, V8, P681, DOI 10.1038/nrm2234
   Schibler U, 2005, EMBO REP, V6, pS9, DOI 10.1038/sj.embor.7400424
   Schrader M, 2004, HISTOCHEM CELL BIOL, V122, P383, DOI 10.1007/s00418-004-0673-1
   Somel M, 2009, P NATL ACAD SCI USA, V106, P5743, DOI 10.1073/pnas.0900544106
   Steffen KK, 2008, CELL, V133, P292, DOI 10.1016/j.cell.2008.02.037
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Xue HL, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100189
   Zahn JM, 2007, PLOS GENET, V3, P2326, DOI 10.1371/journal.pgen.0030201
   Zahn JM, 2006, PLOS GENET, V2, P1058, DOI 10.1371/journal.pgen.0020115
NR 46
TC 49
Z9 55
U1 0
U2 30
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD MAY 8
PY 2012
VL 109
IS 19
BP E1201
EP E1209
DI 10.1073/pnas.1119304109
PG 9
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 942ZQ
UT WOS:000304090600010
PM 22509016
OA Green Published, Bronze
DA 2024-02-19
ER

PT J
AU Sato, T
   Wu, X
   Shimogaito, N
   Takino, J
   Yamagishi, S
   Takeuchi, M
AF Sato, Takashi
   Wu, Xuegang
   Shimogaito, Noriko
   Takino, Jun-ichi
   Yamagishi, Sho-ichi
   Takeuchi, Masayoshi
TI Effects of high-AGE beverage on RAGE and VEGF expressions in the liver
   and kidneys
SO EUROPEAN JOURNAL OF NUTRITION
LA English
DT Article
DE Lactobacillus beverage; food-derived AGEs; lifestyle-related diseases;
   VEGF; RAGE
ID GLYCATION END-PRODUCTS; ENDOTHELIAL GROWTH-FACTOR; DIABETIC
   COMPLICATIONS; DIETARY GLYCOTOXINS; INDUCED APOPTOSIS; RISK-FACTOR;
   CELLS; RECEPTOR; OVEREXPRESSION; ENDPRODUCTS
AB The formation and accumulation of advanced glycation end products (AGEs) increase in some lifestyle-related diseases as well as in aging; however, little is known about the relationship between food-derived AGEs and the pathology of such diseases.
   To explore whether food items containing high levels of AGEs are involved in the development of lifestyle-related diseases, rats were orally administered a commercial high-AGE beverage [Lactobacillus beverage-A (LB-A)]. With a particular focus on angiogenesis-associated diseases, the gene expressions of vascular endothelial growth factor (VEGF) and the receptor for AGEs (RAGE) were examined in the liver and kidneys using real-time reverse transcription-polymerase chain reaction. Moreover, AGE deposition was immunohistochemically investigated in these tissues.
   Hepatic VEGF expression was significantly increased in rats administered LB-A (P < 0.01 vs. control). Furthermore, immunohistochemical analysis detected glucose-derived AGE-positive cells in the liver from the LB-A group. These results suggest that AGE-rich beverages increase hepatic VEGF expression and AGE accumulation, bringing about early events associated with lifestyle-related diseases.
C1 [Sato, Takashi; Wu, Xuegang; Shimogaito, Noriko; Takino, Jun-ichi; Takeuchi, Masayoshi] Hokuriku Univ, Fac Pharmaceut Sci, Dept Pathophysiol Sci, Kanazawa, Ishikawa 9201181, Japan.
   [Yamagishi, Sho-ichi] Kurume Univ, Sch Med, Dept Pathophysiol & Therapeut Diabet Vasc Complic, Kurume, Fukuoka 830, Japan.
C3 Hokuriku University; Kurume University
RP Sato, T (corresponding author), Hokuriku Univ, Fac Pharmaceut Sci, Dept Pathophysiol Sci, Ho 3 Kanagawa Machi, Kanazawa, Ishikawa 9201181, Japan.
EM t-sato@hokuriku-u.ac.jp
FU Japan Society for the Promotion of Science [19300254]; Hokuriku
   University [FY2007]; Grants-in-Aid for Scientific Research [19300254]
   Funding Source: KAKEN
FX This work was supported in part by a grant from the Japan Society for
   the Promotion of Science (Grant-in-Aid for Scientific Research [ B], #
   19300254) to Masayoshi Takeuchi and by the Specific Research Fund of
   Hokuriku University (category B, code No. 230007, FY2007) to Takashi
   Sato and Masayoshi Takeuchi.
CR Adams LA, 2005, J HEPATOL, V42, P132, DOI 10.1016/j.jhep.2004.09.012
   Ahmed N, 2005, DIABETES RES CLIN PR, V67, P3, DOI 10.1016/j.diabres.2004.09.004
   El-Serag HB, 2004, GASTROENTEROLOGY, V126, P460, DOI 10.1053/j.gastro.2003.10.065
   Fehrenbach H, 2001, HEPATOLOGY, V34, P943, DOI 10.1053/jhep.2001.28788
   Goldberg T, 2004, J AM DIET ASSOC, V104, P1287, DOI 10.1016/j.jada.2004.05.214
   Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3
   Kitajima S, 2005, LAB INVEST, V85, P1517, DOI 10.1038/labinvest.3700346
   Koschinsky T, 1997, P NATL ACAD SCI USA, V94, P6474, DOI 10.1073/pnas.94.12.6474
   Lin RY, 2003, ATHEROSCLEROSIS, V168, P213, DOI 10.1016/S0021-9150(03)00050-9
   Lin RY, 2002, ATHEROSCLEROSIS, V163, P303, DOI 10.1016/S0021-9150(02)00008-4
   Lyungberg M, 2006, ANN NY ACAD SCI, V1079, P360, DOI 10.1196/annals.1375.055
   Mise M, 1996, HEPATOLOGY, V23, P455
   Pertynska-Marczewska M, 2004, CYTOKINE, V28, P35, DOI 10.1016/j.cyto.2004.06.006
   Rafter J, 2007, AM J CLIN NUTR, V85, P488, DOI 10.1093/ajcn/85.2.488
   Resta-Lenert S, 2006, GASTROENTEROLOGY, V130, P731, DOI 10.1053/j.gastro.2005.12.015
   Sato T, 2006, CURR MOL MED, V6, P351, DOI 10.2174/156652406776894536
   Smedsrod B, 1997, BIOCHEM J, V322, P567, DOI 10.1042/bj3220567
   Takeuchi M, 1999, MOL MED, V5, P393, DOI 10.1007/BF03402128
   Takeuchi M, 2000, MOL MED, V6, P114, DOI 10.1007/BF03401779
   Treins C, 2001, J BIOL CHEM, V276, P43836, DOI 10.1074/jbc.M106534200
   Vlassara H, 2002, P NATL ACAD SCI USA, V99, P15596, DOI 10.1073/pnas.242407999
   Yadav H, 2007, NUTRITION, V23, P62, DOI 10.1016/j.nut.2006.09.002
   Yamagishi S, 2002, J BIOL CHEM, V277, P20309, DOI 10.1074/jbc.M202634200
   Yamagishi S, 2002, BIOCHEM BIOPH RES CO, V290, P973, DOI 10.1006/bbrc.2001.6312
   Yoshiji H, 2003, GUT, V52, P1347, DOI 10.1136/gut.52.9.1347
   Zareie M, 2006, GUT, V55, P1553, DOI 10.1136/gut.2005.080739
NR 26
TC 23
Z9 25
U1 1
U2 5
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1436-6207
EI 1436-6215
J9 EUR J NUTR
JI Eur. J. Nutr.
PD FEB
PY 2009
VL 48
IS 1
BP 6
EP 11
DI 10.1007/s00394-008-0753-4
PG 6
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 399FF
UT WOS:000262785100002
PM 19083041
DA 2024-02-19
ER

PT J
AU Zheng, WM
   Jimenez-Linan, M
   Rubin, BS
   Halvorson, LM
AF Zheng, Weiming
   Jimenez-Linan, Mercedes
   Rubin, Beverly S.
   Halvorson, Lisa M.
TI Anterior pituitary gene expression with reproductive aging in the female
   rat
SO BIOLOGY OF REPRODUCTION
LA English
DT Article
DE aging; follistatin; gene regulation; pituitary; steroid hormone
   receptors
ID GONADOTROPIN-RELEASING-HORMONE; MIDDLE-AGED RATS;
   MESSENGER-RIBONUCLEIC-ACID; STEROIDOGENIC FACTOR-I; LIVER RECEPTOR
   HOMOLOG-1; ORPHAN NUCLEAR RECEPTOR; PERSISTENT-ESTROUS RATS; INDUCED LH
   SURGE; ALPHA ER-ALPHA; LUTEINIZING-HORMONE
AB Although reproductive aging in women is classically attributed to loss of ovarian follicles, recent data have suggested that the entire hypothalamic-pituitary-ovarian axis undergoes functional changes with time. The aim of this study was to characterize age-related changes in pituitary gene expression for factors with known importance for gonadotroph function, including 1) steroid hormone receptors (Esr and Pgr), 2) orphan nuclear receptors [Nr5a1 (steroidogenic factor-1) and Nr5a2 (liver receptor homologue-1)], and 3) pituitary-derived polypeptides (activin, inhibin, and follistatin), as well as 4) gonadotropin subunits and 5) GnRH receptors. We chose to utilize a middle-aged rat model for these studies. Young (Y; 3-mo-old) and middle-aged (MA; 9- to 12-mo-old) rats were ovariectomized, primed with estradiol, and injected with progesterone to induce an LH surge. The mRNA levels for the gonadotropin subunits and GnRH receptors were decreased in middle-aged females relative to young animals. Nr5a1 and follistatin mRNA levels were significantly greater in Y versus MA animals following ovariectomy. Furthermore, steroid-induced regulation of these genes was lost in the MA animals. Regulation of the Nr5a2, Inhba, and Inhbb transcripts was also limited to the young animals. In contrast, there were no significant differences in the mRNA levels of Esr or Pgr family members between age groups at any time point. Although this in vivo model normalizes ovarian steroid levels, it does not control for potential differences in GnRH stimulation with aging. Therefore, in a second set of experiments, we used an in vitro perifusion system to compare the effects of pulsatile GnRH in the two age groups. Nr5a1 mRNA expression was greater in Y than MA animals and was significantly decreased by GnRH pulses in both age groups. Follistatin mRNA levels increased significantly with GnRH treatment in Y animals but were not significantly changed in the MA females. Taken together, these data demonstrate gene-specific blunting of pituitary gene expression postovariectomy and during the steroid-induced surge in middle-aged rats. We propose that age-related changes in pituitary physiology may contribute to reproductive senescence.
C1 Univ Texas, SW Med Ctr, Dept Obstet & Gynecol, Div Reprod Endocrinol, Dallas, TX 75390 USA.
   Tufts Univ, Sch Med, Dept Anat & Cellular Biol, Boston, MA 02111 USA.
C3 University of Texas System; University of Texas Dallas; University of
   Texas Southwestern Medical Center Dallas; Tufts University
RP Halvorson, LM (corresponding author), Univ Texas, SW Med Ctr, Dept Obstet & Gynecol, Div Reprod Endocrinol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.
EM Lisa.Halvorson@utsouthwestern.edu
RI zheng, weiming/B-1911-2012
FU NIA NIH HHS [R01 AG 021250, AG 14974] Funding Source: Medline
CR Bailey JS, 2004, MOL ENDOCRINOL, V18, P1158, DOI 10.1210/me.2003-0442
   BARNHART KM, 1994, MOL ENDOCRINOL, V8, P878, DOI 10.1210/me.8.7.878
   BauerDantoin AC, 1996, ENDOCRINOLOGY, V137, P1634, DOI 10.1210/en.137.5.1634
   Bethea CL, 1996, ENDOCRINOLOGY, V137, P4372, DOI 10.1210/en.137.10.4372
   Bilezikjian LM, 2003, ENDOCRINOLOGY, V144, P732, DOI 10.1210/en.2002-220703
   BILEZIKJIAN LM, 1993, ENDOCRINOLOGY, V133, P2554, DOI 10.1210/en.133.6.2554
   Brann DW, 2005, STEROIDS, V70, P273, DOI 10.1016/j.steroids.2004.12.008
   BRITO AN, 1994, EUR J ENDOCRINOL, V130, P540, DOI 10.1530/eje.0.1300540
   Brown P, 1997, INT J BIOCHEM CELL B, V29, P1513, DOI 10.1016/S1357-2725(97)00082-4
   Burger H G, 2000, Climacteric, V3, P17, DOI 10.3109/13697130009167595
   Burger HG, 2002, RECENT PROG HORM RES, V57, P257, DOI 10.1210/rp.57.1.257
   Chakraborty TR, 2003, J COMP NEUROL, V466, P409, DOI 10.1002/cne.10906
   Chakraborty TR, 2003, ENDOCRINOLOGY, V144, P4164, DOI 10.1210/en.2003-0052
   Cherrington BD, 2005, MOL ENDOCRINOL, V19, P898, DOI 10.1210/me.2004-0214
   COOPER RL, 1980, BIOL REPROD, V23, P611, DOI 10.1095/biolreprod23.3.611
   Dalkin AC, 1999, ENDOCRINOLOGY, V140, P903, DOI 10.1210/en.140.2.903
   Dorn C, 1999, J BIOL CHEM, V274, P13870, DOI 10.1074/jbc.274.20.13870
   Duval DL, 1997, BIOL REPROD, V56, P160, DOI 10.1095/biolreprod56.1.160
   Friend KE, 1997, MOL CELL ENDOCRINOL, V131, P147, DOI 10.1016/S0303-7207(97)00098-1
   Funabashi T, 2000, NEUROSCI RES, V38, P85, DOI 10.1016/S0168-0102(00)00150-4
   Gore AC, 2001, BRAIN RES REV, V37, P235, DOI 10.1016/S0165-0173(01)00121-7
   Haisenleder DJ, 1996, ENDOCRINOLOGY, V137, P5719, DOI 10.1210/en.137.12.5719
   Hall JE, 2001, ENDOCRIN METAB CLIN, V30, P631, DOI 10.1016/S0889-8529(05)70205-X
   Halvorson LM, 1996, FERTIL STERIL, V65, P459
   Halvorson LM, 1996, J BIOL CHEM, V271, P6645, DOI 10.1074/jbc.271.12.6645
   HALVORSON LM, 1994, ENDOCRINOLOGY, V134, P1247, DOI 10.1210/en.134.3.1247
   HOGG BB, 1992, AM J OBSTET GYNECOL, V167, P303, DOI 10.1016/S0002-9378(11)91405-7
   INGRAHAM HA, 1994, GENE DEV, V8, P2302, DOI 10.1101/gad.8.19.2302
   Jimenez-Linan M, 2001, BRAIN RES, V922, P71, DOI 10.1016/S0006-8993(01)03151-1
   KAISER UB, 1993, J CLIN INVEST, V91, P2523, DOI 10.1172/JCI116488
   Kaiser UB, 1997, ENDOCRINOLOGY, V138, P1224, DOI 10.1210/en.138.3.1224
   Kaiser UB, 1997, ENDOCR REV, V18, P46, DOI 10.1210/er.18.1.46
   KRIEG RJ, 1995, NEUROENDOCRINOLOGY, V61, P318
   Krylova IN, 2005, CELL, V120, P343, DOI 10.1016/j.cell.2005.01.024
   Liu DL, 2003, BIOL REPROD, V69, P508, DOI 10.1095/biolreprod.102.011767
   LLOYD JM, 1994, ENDOCRINOLOGY, V134, P1800, DOI 10.1210/en.134.4.1800
   LU J, 1983, CHANGES OVARIAN FUNC
   MATT DW, 1993, NEUROENDOCRINOLOGY, V57, P351, DOI 10.1159/000126379
   MATT DW, 1992, NEUROENDOCRINOLOGY, V56, P780, DOI 10.1159/000126308
   Mitchner NA, 1998, ENDOCRINOLOGY, V139, P3976, DOI 10.1210/en.139.9.3976
   NASS TE, 1984, J ENDOCRINOL, V100, P43, DOI 10.1677/joe.0.1000043
   Norwitz ER, 2002, J BIOL CHEM, V277, P37469, DOI 10.1074/jbc.M206571200
   Norwitz ER, 1999, J SOC GYNECOL INVEST, V6, P169, DOI 10.1016/S1071-5576(99)00022-2
   PAUL SJ, 1990, MOL ENDOCRINOL, V4, P1943, DOI 10.1210/mend-4-12-1943
   Prendergast KA, 2004, BIOL REPROD, V70, P364, DOI 10.1095/biolreprod.103.021733
   ROBERTS V, 1989, ENDOCRINOLOGY, V124, P552, DOI 10.1210/endo-124-1-552
   Robertson DM, 2002, ACTA OBSTET GYN SCAN, V81, P612, DOI 10.1034/j.1600-0412.2002.810706.x
   ROSSMANITH WG, 1991, NEUROENDOCRINOLOGY, V54, P211, DOI 10.1159/000125878
   RUBIN BS, 1994, BIOL REPROD, V51, P1264, DOI 10.1095/biolreprod51.6.1264
   Rubin BS, 2000, BIOL REPROD, V63, P968, DOI 10.1095/biolreprod63.4.968
   RUBIN BS, 1989, NEUROENDOCRINOLOGY, V49, P225, DOI 10.1159/000125121
   Santoro N, 1996, J CLIN ENDOCR METAB, V81, P1495, DOI 10.1210/jc.81.4.1495
   Schirman-Hildesheim TD, 2005, ENDOCRINOLOGY, V146, P3401, DOI 10.1210/en.2005-0240
   Schreihofer DA, 2000, ENDOCRINOLOGY, V141, P2174, DOI 10.1210/en.141.6.2174
   Shupnik MA, 1996, BIOL REPROD, V54, P279, DOI 10.1095/biolreprod54.2.279
   SMITH WA, 1982, ENDOCRINOLOGY, V111, P1843, DOI 10.1210/endo-111-6-1843
   Szabo M, 2000, BIOL REPROD, V62, P95, DOI 10.1095/biolreprod62.1.95
   Tébar M, 2000, LIFE SCI, V67, P2549, DOI 10.1016/S0024-3205(00)00839-0
   Tremblay JJ, 1999, MOL CELL BIOL, V19, P2567
   Turgeon JL, 2000, ENDOCRINOLOGY, V141, P3422, DOI 10.1210/en.141.9.3422
   Turgeon JL, 1999, ENDOCRINOLOGY, V140, P2318, DOI 10.1210/en.140.5.2318
   Turgeon JL, 2001, ENDOCRINOLOGY, V142, P4479, DOI 10.1210/en.142.10.4479
   Turzillo AM, 1997, ENDOCRINE, V6, P251, DOI 10.1007/BF02820500
   Valensise G., 2001, ANN GEOFISICA S, V44, P1
   WATKINS BE, 1975, ENDOCRINOLOGY, V97, P543, DOI 10.1210/endo-97-3-543
   WEISS J, 1993, ENDOCRINOLOGY, V132, P2307, DOI 10.1210/en.132.6.2307
   Welt C, 2002, EXP BIOL MED, V227, P724, DOI 10.1177/153537020222700905
   Welt CK, 2002, CURR OPIN OBSTET GYN, V14, P317, DOI 10.1097/00001703-200206000-00012
   WILFINGER WW, 1984, TISSUE CELL, V16, P483, DOI 10.1016/0040-8166(84)90026-0
   Wilkes M M, 1978, Adv Exp Med Biol, V113, P127
   WILKES MM, 1979, NEUROENDOCRINOLOGY, V29, P255, DOI 10.1159/000122930
   Wilson ME, 2002, MECH AGEING DEV, V123, P593, DOI 10.1016/S0047-6374(01)00406-7
   WISE PM, 1984, ENDOCRINOLOGY, V115, P810, DOI 10.1210/endo-115-2-810
   WISE PM, 1987, J STEROID BIOCHEM, V27, P713, DOI 10.1016/0022-4731(87)90141-5
   Wise PM, 1999, ENDOCR REV, V20, P243, DOI 10.1210/er.20.3.243
   Wolfe MW, 1999, MOL ENDOCRINOL, V13, P752, DOI 10.1210/me.13.5.752
   Zhao LP, 2001, MOL CELL ENDOCRINOL, V185, P27, DOI 10.1016/S0303-7207(01)00621-9
   Zheng WM, 2007, J MOL ENDOCRINOL, V38, P207, DOI 10.1677/JME-06-0001
NR 78
TC 19
Z9 21
U1 0
U2 3
PU SOC STUDY REPRODUCTION
PI MADISON
PA 1603 MONROE ST, MADISON, WI 53711-2021 USA
SN 0006-3363
J9 BIOL REPROD
JI Biol. Reprod.
PD JUN
PY 2007
VL 76
IS 6
BP 1091
EP 1102
DI 10.1095/biolreprod.106.057877
PG 12
WC Reproductive Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Reproductive Biology
GA 175LL
UT WOS:000247015000019
PM 17344471
OA Bronze
DA 2024-02-19
ER

PT J
AU Reddy, SK
   Barbas, AS
   Turley, RS
   Gamblin, TC
   Geller, DA
   Marsh, JW
   Tsung, A
   Clary, BM
   Lagoo-Deenadayalan, S
AF Reddy, Srinevas K.
   Barbas, Andrew S.
   Turley, Ryan S.
   Gamblin, T. Clark
   Geller, David A.
   Marsh, J. Wallis
   Tsung, Allan
   Clary, Bryan M.
   Lagoo-Deenadayalan, Sandhya
TI Major Liver Resection in Elderly Patients: A Multi-Institutional
   Analysis
SO JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
LA English
DT Article
ID COMPREHENSIVE GERIATRIC ASSESSMENT; RANDOMIZED PHASE-III;
   HEPATOCELLULAR-CARCINOMA; ADJUVANT CHEMOTHERAPY; COLORECTAL-CANCER;
   TRANSARTERIAL CHEMOEMBOLIZATION; HEPATIC METASTASES; OLDER PATIENTS;
   SURGERY; AGE
AB BACKGROUND: Because of the aging United States population, increase in overall life expectancy, and rising incidence of hepatobiliary tumors, more elderly patients are considered for hepatic resection. The objective of this study was to assess the influence of age on postoperative outcomes after major hepatectomy among a contemporary cohort from 2 high volume centers.
   STUDY DESIGN: Demographics, diagnoses, surgical treatments, and postoperative outcomes of patients who underwent major hepatic resection were reviewed.
   RESULTS: There were 856 patients who underwent major hepatectomy (resection of 3 or more segments) from 2002 to 2009. Postoperative mortality and morbidity occurred in 53 (6.2%) and 403 (47.1%) patients, respectively. Increasing age was independently associated with postoperative mortality (p = 0.0345). Each 1-year and 10-year increase in age resulted in an odds ratio of mortality after major hepatic resection of 1.036 (95% CI [1.003-1.071]) and 1.426 (95% CI [1.026-1.982]), respectively. This relationship was independent of American Society of Anesthesiology (ASA) score. Increasing age was associated with postoperative sepsis (p = 0.0224, odds ratio for each year 1.025 [range 1.003 to 1.048]) after major hepatic resection, but not overall postoperative morbidity.
   CONCLUSIONS: In the contemporary era, increasing age is independently associated with postoperative mortality after major hepatic resection at high volume academic centers. (J Am Coll Surg 2011;212:787-795. (C) 2011 by the American College of Surgeons)
C1 [Reddy, Srinevas K.; Barbas, Andrew S.; Turley, Ryan S.; Clary, Bryan M.; Lagoo-Deenadayalan, Sandhya] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA.
   [Geller, David A.; Marsh, J. Wallis; Tsung, Allan] Univ Pittsburgh, Med Sch Ctr, Pittsburgh, PA USA.
   [Gamblin, T. Clark] Med Coll Wisconsin, Dept Surg Oncol, Milwaukee, WI 53226 USA.
C3 Duke University; Pennsylvania Commonwealth System of Higher Education
   (PCSHE); University of Pittsburgh; Medical College of Wisconsin
RP Reddy, SK (corresponding author), UPMC Liver Canc Ctr, Dept Surg, 3459 5th Ave, Pittsburgh, PA 15213 USA.
EM reddysk@upmc.edu
RI Marsh, Wallis/C-6796-2013; Barbas, Andrew/O-4138-2018; Geller, David
   A/AAV-8082-2020
OI Marsh, Wallis/0000-0002-8143-9511; Barbas, Andrew/0000-0003-3476-2313;
   Geller, David A/0000-0003-0735-1068
CR Adam R, 2010, BRIT J SURG, V97, P366, DOI 10.1002/bjs.6889
   Aldrighetti L, 2004, AM SURGEON, V70, P453
   Asahina Y, 2010, HEPATOLOGY, V52, P518, DOI 10.1002/hep.23691
   Audisio RA, 2008, CRIT REV ONCOL HEMAT, V65, P156, DOI 10.1016/j.critrevonc.2007.11.001
   Cescon M, 2003, ARCH SURG-CHICAGO, V138, P547, DOI 10.1001/archsurg.138.5.547
   Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7
   Christmas C, 2006, J AM COLL SURGEONS, V203, P746, DOI 10.1016/j.jamcollsurg.2006.08.006
   Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae
   Ettorre GM, 2001, BRIT J SURG, V88, P73, DOI 10.1046/j.1365-2168.2001.01629.x
   Fong Y, 1997, BRIT J SURG, V84, P1386
   Fukuse T, 2005, CHEST, V127, P886, DOI 10.1378/chest.127.3.886
   Hutchins LF, 1999, NEW ENGL J MED, V341, P2061, DOI 10.1056/NEJM199912303412706
   Jessup JM, 2005, JAMA-J AM MED ASSOC, V294, P2703, DOI 10.1001/jama.294.21.2703
   Kahn KL, 2010, JAMA-J AM MED ASSOC, V303, P1037, DOI 10.1001/jama.2010.272
   Kanemitsu Y, 2009, JPN J CLIN ONCOL, V39, P406, DOI 10.1093/jjco/hyp035
   Kemeny MM, 2002, J CLIN ONCOL, V20, P1499, DOI 10.1200/JCO.20.6.1499
   Kemeny NE, 2006, J CLIN ONCOL, V24, P1395, DOI 10.1200/JCO.2005.03.8166
   Koperna T, 1998, WORLD J SURG, V22, P406, DOI 10.1007/s002689900405
   Kristjansson SR, 2010, CRIT REV ONCOL HEMAT, V76, P208, DOI 10.1016/j.critrevonc.2009.11.002
   Lau WY, 2008, ANN SURG, V247, P43, DOI 10.1097/SLA.0b013e3181571047
   Leporrier J, 2006, BRIT J SURG, V93, P465, DOI 10.1002/bjs.5278
   Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857
   Manfredi S, 2006, ANN SURG, V244, P254, DOI 10.1097/01.sla.0000217629.94941.cf
   Menon KV, 2006, J AM COLL SURGEONS, V203, P677, DOI 10.1016/j.jamcollsurg.2006.07.025
   Mirici-Cappa F, 2010, GUT, V59, P387, DOI 10.1136/gut.2009.194217
   Monson K, 2003, ARCH SURG-CHICAGO, V138, P1061, DOI 10.1001/archsurg.138.10.1061
   Neugut AI, 2002, J CLIN ONCOL, V20, P2643, DOI 10.1200/JCO.2002.08.062
   Nordlinger B, 2008, LANCET, V371, P1007, DOI 10.1016/S0140-6736(08)60455-9
   Okusaka T, 2009, J HEPATOL, V51, P1030, DOI 10.1016/j.jhep.2009.09.004
   Pasetto LM, 2007, CRIT REV ONCOL HEMAT, V64, P10, DOI 10.1016/j.critrevonc.2007.08.001
   Petrowsky H, 2005, WORLD J SURG, V29, P1093, DOI 10.1007/s00268-005-1130-6
   Portier G, 2006, J CLIN ONCOL, V24, P4976, DOI 10.1200/JCO.2006.06.8353
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Shirabe K, 2009, WORLD J SURG, V33, P1927, DOI 10.1007/s00268-009-0122-3
   Smith BD, 2009, J CLIN ONCOL, V27, P2758, DOI 10.1200/JCO.2008.20.8983
   Strasberg SM, 2009, ANN SURG, V250, P177, DOI 10.1097/SLA.0b013e3181afde41
   Unger JM, 2006, J CLIN ONCOL, V24, P141, DOI 10.1200/JCO.2005.02.8928
   Ychou M, 2009, ANN ONCOL, V20, P1964, DOI 10.1093/annonc/mdp236
   Yee KWL, 2003, J CLIN ONCOL, V21, P1618, DOI 10.1200/JCO.2003.12.044
   Zhong C, 2009, J CANCER RES CLIN, V135, P1437, DOI 10.1007/s00432-009-0588-2
   Zhou WP, 2009, ANN SURG, V249, P195, DOI 10.1097/SLA.0b013e3181961c16
NR 41
TC 84
Z9 84
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1072-7515
EI 1879-1190
J9 J AM COLL SURGEONS
JI J. Am. Coll. Surg.
PD MAY
PY 2011
VL 212
IS 5
BP 787
EP 795
DI 10.1016/j.jamcollsurg.2010.12.048
PG 9
WC Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Surgery
GA 768RU
UT WOS:000290956000006
PM 21435922
DA 2024-02-19
ER

PT J
AU El-Zayat, E
   Amer, SA
AF El-Zayat, E
   Amer, SA
TI Protective effects of antioxidants on age-related changes in the
   electrophoretic patterns of cardiac LDH, hepatic ALP and serum proteins
   in male golden hamster
SO CELL BIOCHEMISTRY AND FUNCTION
LA English
DT Article
DE aging; antioxidants; isoenzymes; hamster
ID VITAMIN-E; SELENIUM; SUPPLEMENTATION; PARAMETERS; BLOOD
AB Basal and antioxidant-induced changes in the isoenzyme and isoform patterns of cardiac lactate dehydrogenase (EC 1.1.1.27) and hepatic alkaline phosphatase (EC 3.1.3.1), respectively, as well as the electrophoretic patterns of serum proteins in different age groups of male golden hamster were compared. This is to test whether age-induced changes could be corrected by long-term administration of antioxidants. Data indicated that aging causes no remarkable change in the total activity of either cardiac LDH or hepatic ALP, however a significant increase in the fractional activity of some cardiac LDH isoenzymes and a significant reduction in the fractional activity of some hepatic ALP isoforms were induced by aging. On the other hand, long-term administration of antioxidants appeared to manifest a clear counteracting effect on the age-related changes in old age. This effect was indicated in the fractional activity of cardiac LDH isoenzymes and of hepatic ALP isoform. The present study has also shown a wide-range variation in serum protein patterns due to aging and/or antioxidant administration, which indirectly reflect a parallel variation in the process of gene expression and/or proteolytic activity. Copyright (C) 2003 John Wiley Sons, Ltd.
C1 Nagoya Univ, Grad Sch Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan.
   Cairo Univ, Fac Sci, Dept Zool, Giza, Egypt.
C3 Nagoya University; Egyptian Knowledge Bank (EKB); Cairo University
RP Amer, SA (corresponding author), Nagoya Univ, Grad Sch Sci, Chikusa Ku, Room C123,Furo Cho, Nagoya, Aichi 4648602, Japan.
EM yasser92us@yahoo.com
OI Amer, Sayed/0000-0002-9142-9528
CR Aksakal M., 1996, Turk Veterinerlik ve Hayvancilik Dergisi, V20, P185
   AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   Avallone L, 1996, EUR J CLIN CHEM CLIN, V34, P961
   BALIN AK, 1986, DERMATOL CLIN, V4, P347, DOI 10.1016/S0733-8635(18)30798-8
   BEDWELL S, 1989, BIOCHEM J, V262, P707, DOI 10.1042/bj2620707
   Çay M, 1999, CELL BIOCHEM FUNCT, V17, P143, DOI 10.1002/(SICI)1099-0844(199906)17:2<143::AID-CBF802>3.0.CO;2-H
   *DGKC, 1970, Z CLIN CHEM, V8, P658
   *DGKC, 1972, Z KLIN CHEM KLIN BIO, V10, P191
   DONALD W, 1983, CLIN LAB MED, V6, P507
   El-Zayat E. M., 1996, J EGYPT GER SOC ZO A, V20, P115
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   Klungland A, 1999, P NATL ACAD SCI USA, V96, P13300, DOI 10.1073/pnas.96.23.13300
   KOWALD A, 1994, J THEOR BIOL, V168, P75, DOI 10.1006/jtbi.1994.1089
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   MERRY BJ, 1991, COMP BIOCHEM PHYS A, V98, P559, DOI 10.1016/0300-9629(91)90446-J
   Monget AL, 1996, EUR J CLIN NUTR, V50, P443
   MOUSTAFA AS, 1994, J MED SCI, V15, P347
   MOUSTAFA SA, 1995, GERONTOLOGY, V41, P301, DOI 10.1159/000213699
   Mueller A, 1998, J ANDROL, V19, P450
   Nakano T, 2001, CLIN HEMORHEOL MICRO, V24, P85
   NAZIROGLU M, TR J VET AN SCI, V20, P39
   POWERS SK, 1992, J APPL PHYSIOL, V72, P2317, DOI 10.1152/jappl.1992.72.6.2317
   Prathima S, 1999, MECH AGEING DEV, V108, P61, DOI 10.1016/S0047-6374(99)00004-4
   Pritsos CA, 2000, CHEM-BIOL INTERACT, V127, P1, DOI 10.1016/S0009-2797(00)00159-9
   REDDY PG, 1985, J DAIRY SCI, V68, P2259, DOI 10.3168/jds.S0022-0302(85)81098-5
   RILEY RT, 1991, TOXICOL APPL PHARM, V109, P108, DOI 10.1016/0041-008X(91)90195-K
   ROSALKI SB, 1974, CLIN BIOCHEM, V7, P29, DOI 10.1016/S0009-9120(74)90232-X
   Stähelin HB, 1999, INT J VITAM NUTR RES, V69, P146, DOI 10.1024/0300-9831.69.3.146
   Syakalima M, 1997, J VET MED SCI, V59, P905, DOI 10.1292/jvms.59.905
   Warren S, 2000, TOXICOLOGY, V142, P119, DOI 10.1016/S0300-483X(99)00132-8
   Wong HK, 2001, ANTICANCER RES, V21, P393
NR 31
TC 3
Z9 3
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0263-6484
EI 1099-0844
J9 CELL BIOCHEM FUNCT
JI Cell Biochem. Funct.
PD JUN
PY 2003
VL 21
IS 2
BP 137
EP 145
DI 10.1002/cbf.1010
PG 9
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA 679ZK
UT WOS:000182951700007
PM 12736903
DA 2024-02-19
ER

PT J
AU Jonker, MJ
   Melis, JPM
   Kuiper, RV
   van der Hoeven, TV
   Wackers, PFK
   Robinson, J
   van der Horst, GTJ
   Dollé, MET
   Vijg, J
   Breit, TM
   Hoeijmakers, JHJ
   van Steeg, H
AF Jonker, Martijs J.
   Melis, Joost P. M.
   Kuiper, Raoul V.
   van der Hoeven, Tessa V.
   Wackers, Paul F. K.
   Robinson, Joke
   van der Horst, Gijsbertus T. J.
   Dolle, Martijn E. T.
   Vijg, Jan
   Breit, Timo M.
   Hoeijmakers, Jan H. J.
   van Steeg, Harry
TI Life spanning murine gene expression profiles in relation to
   chronological and pathological aging in multiple organs
SO AGING CELL
LA English
DT Article
DE database; pathology; aging dynamics; in vivo; gene expression
ID CALORIC RESTRICTION; MOUSE MODELS; MICE; CANCER; AGE; BIOMARKERS;
   LONGEVITY; RECEPTOR; LESIONS; TISSUE
AB Summary
   Aging and age-related pathology is a result of a still incompletely understood intricate web of molecular and cellular processes. We present a C57BL/6J female mice in vivo aging study of five organs (liver, kidney, spleen, lung, and brain), in which we compare genome-wide gene expression profiles during chronological aging with pathological changes throughout the entire murine life span (13, 26, 52, 78, 104, and 130 weeks). Relating gene expression changes to chronological aging revealed many differentially expressed genes (DEGs), and altered gene sets (AGSs) were found in most organs, indicative of intraorgan generic aging processes. However, only <= 1% of these DEGs are found in all organs. For each organ, at least one of 18 tested pathological parameters showed a good age-predictive value, albeit with much inter- and intraindividual (organ) variation. Relating gene expression changes to pathology-related aging revealed correlated genes and gene sets, which made it possible to characterize the difference between biological and chronological aging. In liver, kidney, and brain, a limited number of overlapping pathology-related AGSs were found. Immune responses appeared to be common, yet the changes were specific in most organs. Furthermore, changes were observed in energy homeostasis, reactive oxygen species, cell cycle, cell motility, and DNA damage. Comparison of chronological and pathology-related AGSs revealed substantial overlap and interesting differences. For example, the presence of immune processes in liver pathology-related AGSs that were not detected in chronological aging. The many cellular processes that are only found employing aging-related pathology could provide important new insights into the progress of aging.
C1 [Jonker, Martijs J.; van der Hoeven, Tessa V.; Wackers, Paul F. K.; Breit, Timo M.] Univ Amsterdam, Fac Sci FNWI, SILS, MicroArray Dept, Amsterdam, Netherlands.
   [Jonker, Martijs J.; van der Hoeven, Tessa V.; Wackers, Paul F. K.; Breit, Timo M.] Univ Amsterdam, Fac Sci FNWI, SILS, Integrat Bioinformat Unit MAD IBU, Amsterdam, Netherlands.
   [Jonker, Martijs J.; Wackers, Paul F. K.; Breit, Timo M.] Netherlands Bioinformat Ctr NBIC, Nijmegen, Netherlands.
   [Melis, Joost P. M.; Kuiper, Raoul V.; Wackers, Paul F. K.; Robinson, Joke; Dolle, Martijn E. T.; van Steeg, Harry] Natl Inst Publ Hlth & Environm RIVM, Ctr Hlth Protect, Bilthoven, Netherlands.
   [Melis, Joost P. M.; van Steeg, Harry] Leiden Univ, Med Ctr, Dept Toxicogenet, Leiden, Netherlands.
   [Kuiper, Raoul V.; Robinson, Joke] Univ Utrecht, Fac Vet Med, Dept Pathobiol, Dutch Mol Pathol Ctr, Utrecht, Netherlands.
   [van der Horst, Gijsbertus T. J.; Hoeijmakers, Jan H. J.] Erasmus Univ, Med Ctr, CGC Dept Genet, Rotterdam, Netherlands.
   [Vijg, Jan] Albert Einstein Coll Med, Dept Genet, New York, NY USA.
C3 Vrije Universiteit Amsterdam; University of Amsterdam; Vrije
   Universiteit Amsterdam; University of Amsterdam; Netherlands National
   Institute for Public Health & the Environment; Leiden University; Leiden
   University Medical Center (LUMC); Leiden University - Excl LUMC; Utrecht
   University; Erasmus University Rotterdam; Erasmus MC; Yeshiva University
RP van Steeg, H (corresponding author), Natl Inst Publ Hlth & Environm, Lab Hlth Protect Res, POB 1, NL-3720 BA Bilthoven, Netherlands.
EM Harry.van.Steeg@rivm.nl
RI van der Horst, Gijsbertus (Bert)/E-3661-2015; Hoeijmakers,
   Jan/AAX-6972-2021
OI van der Horst, Gijsbertus (Bert)/0000-0002-7773-6396; Wackers,
   Paul/0000-0002-6598-4173; Kuiper, Raoul/0000-0001-5645-2389
FU IOP Genomics [IGE03009]; NIH/NIA [3PO1 AG017242]; STW [STW-LGC.6935];
   Netherlands Bioinformatics Center (NBIC) BioRange; Markage; LifeSpan
   [LSHG-CT-2007-036894]; European Research Council
FX We thank the Animal Facilities of the Netherlands Vaccine Institute
   (NVI) for their skillful (bio)technical support. The work presented here
   was in part financially supported by IOP Genomics IGE03009, NIH/NIA
   (3PO1 AG017242), STW Grant STW-LGC.6935, and Netherlands Bioinformatics
   Center (NBIC) BioRange II - BR4.1. Support was also obtained from
   Markage (FP7-Health-2008-200880), LifeSpan (LSHG-CT-2007-036894),
   European Research Council (ERC advanced scientist grant JHJH).
CR Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101
   Anisimov VN, 2010, AM J PATHOL, V176, P2092, DOI 10.2353/ajpath.2010.091050
   Barger JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002264
   Blüher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223
   BRONSON RT, 1991, GROWTH DEVELOP AGING, V55, P169
   Cui H., 2012, J SIGNAL TRANSDUCT, V2012
   de Leeuw Wim C, 2008, BMC Res Notes, V1, P66, DOI 10.1186/1756-0500-1-66
   de Magalhaes JP, 2009, BIOINFORMATICS, V25, P875, DOI 10.1093/bioinformatics/btp073
   Garinis GA, 2008, NAT CELL BIOL, V10, P1241, DOI 10.1038/ncb1108-1241
   Goodridge HS, 2011, NATURE, V472, P471, DOI 10.1038/nature10071
   Gray Douglas A, 2005, Sci Aging Knowledge Environ, V2005, pre1, DOI 10.1126/sageke.2005.5.re1
   Grondahl ML, 2010, HUM REPROD, V25, P957, DOI 10.1093/humrep/deq014
   Haines DC, 2001, TOXICOL PATHOL, V29, P653, DOI 10.1080/019262301753385988
   Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221
   Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298
   Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249
   Jung T, 2007, ANN NY ACAD SCI, V1119, P97, DOI 10.1196/annals.1404.008
   Keniry M, 2008, ONCOGENE, V27, P5477, DOI 10.1038/onc.2008.248
   Kim J, 2010, TRENDS CELL BIOL, V20, P311, DOI 10.1016/j.tcb.2010.03.003
   KUNSTYR I, 1975, J GERONTOL, V30, P157, DOI 10.1093/geronj/30.2.157
   Lesnefsky EJ, 2006, AGEING RES REV, V5, P402, DOI 10.1016/j.arr.2006.04.001
   Lipman RD, 1999, J GERONTOL A-BIOL, V54, pB466, DOI 10.1093/gerona/54.11.B466
   Maslov AY, 2009, BBA-GEN SUBJECTS, V1790, P963, DOI 10.1016/j.bbagen.2009.03.020
   Melis JPM, 2008, CANCER RES, V68, P1347, DOI 10.1158/0008-5472.CAN-07-6067
   Michaud J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-363
   Okatani Y, 2002, J PINEAL RES, V33, P127, DOI 10.1034/j.1600-079X.2002.02109.x
   Park SK, 2009, AGING CELL, V8, P484, DOI 10.1111/j.1474-9726.2009.00496.x
   Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534
   Schumacher B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000161
   Southworth LK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000776
   Storey JD, 2005, P NATL ACAD SCI USA, V102, P12837, DOI 10.1073/pnas.0504609102
   Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100
   Swindell W. R., 2012, PLOS ONE, V7
   Swindell WR, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-353
   Swindell WR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-585
   Thoolen B, 2010, TOXICOL PATHOL, V38, p5S, DOI 10.1177/0192623310386499
   Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935
   Treiber N, 2011, AGING CELL, V10, P239, DOI 10.1111/j.1474-9726.2010.00658.x
   West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973
   Wijnhoven SWP, 2007, MUTAT RES-FUND MOL M, V614, P77, DOI 10.1016/j.mrfmmm.2005.12.018
   Wijnhoven SWP, 2005, DNA REPAIR, V4, P1314, DOI 10.1016/j.dnarep.2005.07.002
   Zahn JM, 2007, PLOS GENET, V3, P2326, DOI 10.1371/journal.pgen.0030201
   Zahn JM, 2006, PLOS GENET, V2, P1058, DOI 10.1371/journal.pgen.0020115
   Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025
NR 44
TC 49
Z9 56
U1 0
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9726
J9 AGING CELL
JI Aging Cell
PD OCT
PY 2013
VL 12
IS 5
BP 901
EP 909
DI 10.1111/acel.12118
PG 9
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 217RA
UT WOS:000324376300018
PM 23795901
OA Green Submitted, Green Published, Green Accepted
DA 2024-02-19
ER

PT J
AU Slivca, O
   Olowofela, AS
   Serrano, OK
   Pruett, TL
AF Slivca, Oleg
   Olowofela, Ayokunle S.
   Serrano, Oscar K.
   Pruett, Timothy L.
TI Maximizing Deceased-Donor Allograft Utilization: Management of a Celiac
   Artery Aneurysm in a Deceased-Donor Liver
SO EXPERIMENTAL AND CLINICAL TRANSPLANTATION
LA English
DT Article
DE Celiomesenteric aneurysm; Extended criteria donor; Liver transplant
ID VASCULAR COMPLICATIONS; TRANSPLANTATION
AB As the scarcity of transplantable organs continues to rise, compounded with an aging donor population, transplant surgeons are increasingly confronted with organ offers from less than ideal donors. The presence of a celiomesenteric aneurysm involving the vascular supply of a donor allograft may predispose to vascular complications in the transplanted liver. We present a 61-year-old brain-dead donor who was discovered to have a celiac artery aneurysm during organ recovery. After gross atherosclerotic or mycotic involvement was ruled out and after careful consideration of the vascular reconstructive options, the donor common hepatic artery was divided distal to the aneurysmal dilatation and anastomosed to the recipient bifurcation of the left and right hepatic artery in an end-to-end beveled anastomosis. The postoperative course was unremarkable, with normal blood flow through the anastomosis and no significant com plications. The recipient is doing well 6 months after transplant. The presence of a celiomesenteric aneurysm should not discourage the use of an otherwise adequate liver graft. Careful vascular reconstruction is encouraged to increase the rate of marginal graft utilization and minimize vascular complications. Liberal postoperative imaging can enable early detection of vascular complication and prompt intervention. Through this case, we demons trate the remarkable potential of less-than-ideal grafts with acceptable posttransplant outcomes.
C1 [Slivca, Oleg; Olowofela, Ayokunle S.; Serrano, Oscar K.; Pruett, Timothy L.] Univ Minnesota, Sch Med, Dept Surg, Div Transplantat, Minneapolis, MN 55455 USA.
   [Serrano, Oscar K.] Hartford Hosp, Transplant Program, Hartford, CT 06115 USA.
   [Serrano, Oscar K.] Univ Connecticut, Sch Med, Farmington, CT USA.
C3 University of Minnesota System; University of Minnesota Twin Cities;
   Hartford Hospital; University of Connecticut
RP Slivca, O (corresponding author), Dept Surg, Div Transplantat, Mayo Mail Code 195,420 Delaware St SE, Minneapolis, MN 55455 USA.
EM slivc001@umn.edu
CR Carmeci C, 2000, AM J SURG, V179, P486, DOI 10.1016/S0002-9610(00)00380-9
   Carr SC, 1996, SURGERY, V120, P627, DOI 10.1016/S0039-6060(96)80009-2
   Carr SC, 2001, J VASC SURG, V33, P806, DOI 10.1067/mva.2001.112320
   Dasari BVM, 2017, BEST PRACT RES CL GA, V31, P211, DOI 10.1016/j.bpg.2017.03.002
   di Francesco F, 2012, ANN TRANSPL, V17, P140
   ESQUIVEL CO, 1987, J PEDIATR-US, V110, P545, DOI 10.1016/S0022-3476(87)80545-0
   FLINT EW, 1988, AM J ROENTGENOL, V151, P481, DOI 10.2214/ajr.151.3.481
   Karatzas T, 1997, TRANSPLANT P, V29, P2853, DOI 10.1016/S0041-1345(97)00706-9
   LANGNAS AN, 1991, AM J SURG, V161, P76, DOI 10.1016/0002-9610(91)90364-J
   LARSON PA, 1988, CARDIOVASC INTER RAD, V11, P75, DOI 10.1007/BF02577063
   MOR E, 1993, TRANSPLANTATION, V56, P1548
   National Data OPTN Web site, 2017, ORGAN PROCUREMENT TR
   Nosher JL, 2006, RADIOGRAPHICS, V26, P1687, DOI 10.1148/rg.266055732
   Pasha SF, 2007, MAYO CLIN PROC, V82, P472, DOI 10.4065/82.4.472
   Pawlak J, 2003, TRANSPLANT P, V35, P2313, DOI 10.1016/S0041-1345(03)00836-4
   Pulli R, 2008, J VASC SURG, V48, P334, DOI 10.1016/j.jvs.2008.03.043
   STANLEY JC, 1970, ARCH SURG-CHICAGO, V101, P689
   STANLEY JC, 1986, J VASC SURG, V3, P836, DOI 10.1067/mva.1986.avs0030836
   Vodkin I, 2017, CLIN LIVER DIS, V21, P289, DOI 10.1016/j.cld.2016.12.004
NR 19
TC 0
Z9 0
U1 0
U2 0
PU BASKENT UNIV
PI ANKARA
PA TASKENT CADDESI NO 77, KAT 4, BAHCELIEVLER, ANKARA, 06490, TURKEY
SN 1304-0855
EI 2146-8427
J9 EXP CLIN TRANSPLANT
JI Exp. Clin. Transplant.
PD OCT
PY 2021
VL 19
IS 10
BP 1103
EP 1105
DI 10.6002/ect.2019.0023
PG 3
WC Transplantation
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Transplantation
GA WJ6IG
UT WOS:000709145900015
PM 31250741
DA 2024-02-19
ER

PT J
AU King, V
   Tower, J
AF King, V
   Tower, J
TI Aging-specific expression of <i>Drosophila hsp22 </i>
SO DEVELOPMENTAL BIOLOGY
LA English
DT Article
DE molecular chaperone; heat stress; heat shock; transgenic
ID HEAT-SHOCK PROTEINS; CAENORHABDITIS-ELEGANS; GENE-EXPRESSION;
   DEVELOPMENTAL REGULATION; TEMPORAL PATTERNS; ALPHA-CRYSTALLIN; OXIDATIVE
   STRESS; EXTENDED LIFE; RAT-LIVER; MELANOGASTER
AB hsp22 is among the least abundantly expressed Drosophila Pleat shock (hs) genes during both development and heat stress. In contrast, hsp22 was found to be the most abundantly expressed hs gene during Drosophila aging. During aging, hsp22 RNA was induced 60-fold in the head, with somewhat lower level induction in abdomen and thorax. Induction of the other hs gene RNAs was less than or equal to 3-fold, except for hsp23, which was induced similar to 5-fold in thorax. hsp22 protein was detected using rat anti-hsp22 polyclonal antisera and was induced >150-fold, with particularly abundant expression in eye tissue. Aging-specific induction of hsp22 was reproduced by hsp22:lacZ fusion reporter constructs in transgenic flies. Analysis of specific promoter mutations in transgenic flies indicated that functional heat shock response elements are required for hsp22 induction during aging. Finally, comparison of hsp22 RNA and protein expression patterns suggests that aging-specific expression of hsp22 is regulated at both the transcriptional and the posttranscriptional levels. Aging-specific induction of hsp22 is discussed with regard to current evolutionary theories of aging, (C) 1999 Academic Press.
C1 Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA.
C3 University of Southern California
RP Tower, J (corresponding author), Univ So Calif, Dept Biol Sci, SHS 172,Univ Pk, Los Angeles, CA 90089 USA.
EM jtower@mizar.usc.edu
FU NIA NIH HHS [AG11833] Funding Source: Medline
CR AMIN J, 1988, MOL CELL BIOL, V8, P3761, DOI 10.1128/MCB.8.9.3761
   AMIN J, 1991, MOL CELL BIOL, V11, P5937, DOI 10.1128/MCB.11.12.5937
   ANANTHAN J, 1986, SCIENCE, V232, P522, DOI 10.1126/science.3083508
   [Anonymous], 1990, Longevity, senescence and the genome
   ARKING R, 1991, DEV GENET, V12, P362, DOI 10.1002/dvg.1020120505
   Arrigo A.P., 1994, BIOL HEAT SHOCK PROT, P335
   ARRIGO AP, 1991, HEAT SHOCK DEV, P106
   ASHBRUNER M, 1989, DROSOPHILA LAB HDB
   BOWMAN BH, 1990, BIOESSAYS, V12, P317, DOI 10.1002/bies.950120703
   Charlesworth B., 1994, EVOLUTION AGE STRUCT
   CHATTERJEE B, 1989, FASEB J, V3, P169, DOI 10.1096/fasebj.3.2.2464518
   CHATTERJEE B, 1987, J BIOL CHEM, V262, P822
   CHENEY CM, 1983, DEV BIOL, V95, P325, DOI 10.1016/0012-1606(83)90033-7
   CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   CHU DTW, 1989, DEV BIOL, V136, P104, DOI 10.1016/0012-1606(89)90134-6
   DUDLER R, 1984, CELL, V38, P391, DOI 10.1016/0092-8674(84)90494-X
   Force AG, 1995, DEV GENET, V17, P340, DOI 10.1002/dvg.1020170407
   FRANK LH, 1992, DEVELOPMENT, V114, P481
   GERSHON H, 1970, NATURE, V227, P1214, DOI 10.1038/2271214a0
   GILMOUR DS, 1985, MOL CELL BIOL, V5, P2009, DOI 10.1128/MCB.5.8.2009
   GLASER RL, 1990, MOL CELL BIOL, V10, P131, DOI 10.1128/MCB.10.1.131
   GOSS JR, 1991, NEUROBIOL AGING, V12, P165, DOI 10.1016/0197-4580(91)90056-P
   GRAVES JL, 1992, PHYSIOL ZOOL, V65, P268, DOI 10.1086/physzool.65.2.30158253
   HAASS C, 1990, J CELL SCI, V96, P413
   HELFAND SL, 1995, GENETICS, V140, P549
   HOFFMAN E, 1986, MOL CELL BIOL, V6, P663, DOI 10.1128/MCB.6.2.663
   HOLMGREN R, 1981, P NATL ACAD SCI-BIOL, V78, P3775, DOI 10.1073/pnas.78.6.3775
   HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449
   JAKOB U, 1993, J BIOL CHEM, V268, P1517
   Jedlicka P, 1997, EMBO J, V16, P2452, DOI 10.1093/emboj/16.9.2452
   Khazaeli AA, 1997, J GERONTOL A-BIOL, V52, pB48, DOI 10.1093/gerona/52A.1.B48
   KLEMENZ R, 1986, MOL CELL BIOL, V6, P2011, DOI 10.1128/MCB.6.6.2011
   KNOWLES WJ, 1983, METHOD ENZYMOL, V96, P305
   Kumar JP, 1995, DEVELOPMENT, V121, P4359
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905
   LAWSON R, 1985, DEV BIOL, V110, P321, DOI 10.1016/0012-1606(85)90091-0
   LEE HS, 1992, GENE DEV, V6, P284, DOI 10.1101/gad.6.2.284
   LINDQUIST S, 1980, DEV BIOL, V77, P463, DOI 10.1016/0012-1606(80)90488-1
   LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215
   Lindsley D.L., 1992, GENOME DROSOPHILA ME
   LIS J, 1993, CELL, V74, P1, DOI 10.1016/0092-8674(93)90286-Y
   LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540
   LITHGOW GJ, 1994, J GERONTOL, V49, pB270, DOI 10.1093/geronj/49.6.B270
   Lithgow GJ, 1996, BIOESSAYS, V18, P809, DOI 10.1002/bies.950181007
   MARIN R, 1993, DEV GENET, V14, P69, DOI 10.1002/dvg.1020140109
   Marin R, 1996, CELL STRESS CHAPERON, V1, P40, DOI 10.1379/1466-1268(1996)001<0040:CSHSIO>2.3.CO;2
   MASON PJ, 1984, MOL GEN GENET, V194, P73, DOI 10.1007/BF00383500
   MATOCHA MF, 1987, BIOCHEM BIOPH RES CO, V147, P1, DOI 10.1016/S0006-291X(87)80078-5
   MERCK KB, 1993, J BIOL CHEM, V268, P1046
   Michaud S, 1997, CELL MOL LIFE SCI, V53, P104, DOI 10.1007/PL00000572
   MORGAN TE, 1999, IN PRESS NEUROSCIENC
   MORGANELLI CM, 1985, P NATL ACAD SCI USA, V82, P5865, DOI 10.1073/pnas.82.17.5865
   Morimoto R.I., 1994, The biology of heat shock proteins and molecular chaperones
   Murakami S, 1996, GENETICS, V143, P1207
   OCONNELL P, 1984, NUCLEIC ACIDS RES, V12, P5495, DOI 10.1093/nar/12.13.5495
   PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253
   PARTRIDGE L, 1993, NATURE, V362, P305, DOI 10.1038/362305a0
   PICARD D, 1990, NATURE, V348, P166, DOI 10.1038/348166a0
   RICHARDSON A, 1987, J BIOL CHEM, V262, P12821
   RIDDIHOUGH G, 1986, EMBO J, V5, P1653, DOI 10.1002/j.1460-2075.1986.tb04408.x
   Rogina B, 1997, MECH DEVELOP, V63, P89, DOI 10.1016/S0925-4773(97)00033-6
   ROSE MR, 1992, EXP GERONTOL, V27, P241, DOI 10.1016/0531-5565(92)90048-5
   Rose MR, 1991, EVOLUTIONARY BIOL AG
   ROUGVIE AE, 1988, CELL, V54, P795, DOI 10.1016/S0092-8674(88)91087-2
   RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436
   SERVICE PM, 1987, PHYSIOL ZOOL, V60, P321, DOI 10.1086/physzool.60.3.30162285
   SIERRA F, 1989, MOL CELL BIOL, V9, P5610, DOI 10.1128/MCB.9.12.5610
   SIMON JA, 1985, CELL, V40, P805, DOI 10.1016/0092-8674(85)90340-X
   SIMON JA, 1987, NUCLEIC ACIDS RES, V15, P2971, DOI 10.1093/nar/15.7.2971
   SIROTKIN K, 1982, DEV BIOL, V89, P196, DOI 10.1016/0012-1606(82)90307-4
   SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4
   SMITH JM, 1958, NATURE, V181, P496, DOI 10.1038/181496a0
   SMITH JM, 1958, J EXP BIOL, V35, P832
   STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616
   TAKAHASHI A, 1970, J GERONTOL, V25, P210, DOI 10.1093/geronj/25.3.210
   TAKAHASHI A, 1970, J GERONTOL, V25, P218, DOI 10.1093/geronj/25.3.218
   TAKAHASHI A, 1970, J GERONTOL, V25, P222, DOI 10.1093/geronj/25.3.222
   Tatar M, 1997, NATURE, V390, P30, DOI 10.1038/36237
   THUMMEL CS, 1988, GENE, V74, P445, DOI 10.1016/0378-1119(88)90177-1
   TOPOL J, 1985, CELL, V42, P527, DOI 10.1016/0092-8674(85)90110-2
   Tower J, 1996, BIOESSAYS, V18, P799, DOI 10.1002/bies.950181006
   VANFLETEREN JR, 1993, BIOCHEM J, V292, P605, DOI 10.1042/bj2920605
   WAGGONER S, 1990, GENETIC EFFECTS AGIN, V2, P255
   WESTWOOD JT, 1991, NATURE, V353
   WHEELER JC, 1995, P NATL ACAD SCI USA, V92, P10408, DOI 10.1073/pnas.92.22.10408
   XIAO H, 1988, SCIENCE, V239, P1139, DOI 10.1126/science.3125608
   Yoshida T, 1996, NEUROSCI LETT, V215, P107, DOI 10.1016/S0304-3940(96)12966-9
   YOST HJ, 1990, POSTTRANSCRIPTIONAL
   ZIMMERMAN JL, 1983, CELL, V32, P1161
NR 91
TC 93
Z9 109
U1 0
U2 6
PU ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0012-1606
J9 DEV BIOL
JI Dev. Biol.
PD MAR 1
PY 1999
VL 207
IS 1
BP 107
EP 118
DI 10.1006/dbio.1998.9147
PG 12
WC Developmental Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Developmental Biology
GA 175GQ
UT WOS:000079085400009
PM 10049568
OA hybrid
DA 2024-02-19
ER

PT J
AU He, W
   Yuan, T
   Choezom, D
   Hunkler, H
   Annamalai, K
   Lupse, B
   Maedler, K
AF He, Wei
   Yuan, Ting
   Choezom, Dolma
   Hunkler, Hannah
   Annamalai, Karthika
   Lupse, Blaz
   Maedler, Kathrin
TI Ageing potentiates diet-induced glucose intolerance, β-cell failure and
   tissue inflammation through TLR4
SO SCIENTIFIC REPORTS
LA English
DT Article
ID INDUCED INSULIN-RESISTANCE; HIGH-FAT DIET; TOLL-LIKE RECEPTOR-4;
   ADIPOSE-TISSUE; MACROPHAGE POLARIZATION; OXIDATIVE STRESS;
   IMMUNE-SYSTEM; FED MICE; OBESITY; EXPRESSION
AB Ageing and obesity are two major risk factors for the development of type 2 diabetes (T2D). A chronic, low-grade, sterile inflammation contributes to insulin resistance and beta-cell failure. Toll-like receptor-4 (TLR4) is a major pro-inflammatory pathway; its ligands as well as downstream signals are increased systemically in patients with T2D and at-risk individuals. In the present study we investigated the combined effects of high fat/high sucrose diet (HFD) feeding, ageing and TLR4-deficiency on tissue inflammation, insulin resistance and beta-cell failure. In young mice, a short-term HFD resulted in a mildly impaired glucose tolerance and reduced insulin secretion, together with a beta-cell mass compensation. In older mice, HFD further deteriorated insulin secretion and induced a significantly impaired glucose tolerance and augmented tissue inflammation in adipose, liver and pancreatic islets, all of which was attenuated by TLR4 deficiency. Our results show that ageing exacerbates HFD-induced impairment of glucose homeostasis and pancreatic beta-cell function and survival, and deteriorates HFD-induced induction of mRNA expression of inflammatory cytokines and pro-inflammatory macrophage markers. TLR4-deficiency protects against these combined deleterious effects of a high fat diet and ageing through a reduced expression of inflammatory products in both insulin sensitive tissues and pancreatic islets.
C1 [He, Wei; Yuan, Ting; Choezom, Dolma; Hunkler, Hannah; Annamalai, Karthika; Lupse, Blaz; Maedler, Kathrin] Univ Bremen, Ctr Biomol Interact, Bremen, Germany.
C3 University of Bremen
RP He, W; Maedler, K (corresponding author), Univ Bremen, Ctr Biomol Interact, Bremen, Germany.
EM hewei@uni-bremen.de; kmaedler@uni-bremen.de
RI Yuan, Ting/JJD-1973-2023; Maedler, Kathrin/ABE-3022-2021
OI Yuan, Ting/0000-0001-6098-8733; Maedler, Kathrin/0000-0002-7436-1197;
   ANNAMALAI, KARTHIKA/0000-0002-7558-8035; He, Wei/0000-0003-2377-7456;
   Hunkler, Hannah Jill/0009-0008-3345-5585
FU German Research Foundation (DFG); European Research Council (ERC)
FX This work was supported by the German Research Foundation (DFG) and the
   European Research Council (ERC). We thank Katrischa Hennekens
   (University of Bremen) for excellent technical assistance.
CR Aguayo-Mazzucato C, 2017, CELL METAB, V25, P898, DOI 10.1016/j.cmet.2017.03.015
   Almaça J, 2014, P NATL ACAD SCI USA, V111, P17612, DOI 10.1073/pnas.1414053111
   Amyot J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036200
   [Anonymous], DIABETOLOGIA
   Ardestani A, 2014, NAT MED, V20, P385, DOI 10.1038/nm.3482
   Bouzakri K, 2009, J BIOL CHEM, V284, P27892, DOI 10.1074/jbc.M109.048058
   Brix JM, 2010, J CLIN ENDOCR METAB, V95, P4877, DOI 10.1210/jc.2010-0148
   Cani PD, 2008, PATHOL BIOL, V56, P305, DOI 10.1016/j.patbio.2007.09.008
   Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403
   Chen HA, 2009, GENE DEV, V23, P975, DOI 10.1101/gad.1742509
   COUTINHO A, 1977, EUR J IMMUNOL, V7, P325, DOI 10.1002/eji.1830070517
   Creely SJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE740, DOI 10.1152/ajpendo.00302.2006
   Cucak H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090685
   Dasu MR, 2010, DIABETES CARE, V33, P861, DOI 10.2337/dc09-1799
   Davis JE, 2009, HORM METAB RES, V41, P523, DOI 10.1055/s-0029-1202852
   Davis JE, 2008, OBESITY, V16, P1248, DOI 10.1038/oby.2008.210
   Dhawan S, 2009, GENE DEV, V23, P906, DOI 10.1101/gad.1742609
   Donath MY, 2014, NAT REV DRUG DISCOV, V13, P465, DOI 10.1038/nrd4275
   Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925
   Ferrucci L, 2005, BLOOD, V105, P2294, DOI 10.1182/blood-2004-07-2599
   Fink LN, 2014, OBESITY, V22, P747, DOI 10.1002/oby.20615
   Han MS, 2013, SCIENCE, V339, P218, DOI 10.1126/science.1227568
   Herder C, 2006, DIABETOLOGIA, V49, P921, DOI 10.1007/s00125-006-0190-y
   Hill AA, 2014, IMMUNOL REV, V262, P134, DOI 10.1111/imr.12216
   Horrillo Daniel, 2011, Archives of Physiology and Biochemistry, V117, P140, DOI 10.3109/13813455.2011.577435
   Hwang D, 2001, FASEB J, V15, P2556, DOI 10.1096/fj.01-0432com
   Jackaman C, 2013, AGING CELL, V12, P345, DOI 10.1111/acel.12062
   Jia L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4878
   Johnson GB, 2004, FASEB J, V18, P1282, DOI 10.1096/fj.04-1572fje
   Keane KN, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/181643
   Kraakman MJ, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00470
   Kuwabara T, 2014, CLIN EXP NEPHROL, V18, P584, DOI 10.1007/s10157-013-0922-5
   Lee JY, 2001, J BIOL CHEM, V276, P16683, DOI 10.1074/jbc.M011695200
   Li J, 2013, ACTA BIOCH BIOPH SIN, V45, P1030, DOI 10.1093/abbs/gmt092
   Lin LG, 2016, AGING-US, V8, P178, DOI 10.18632/aging.100888
   Lumeng CN, 2011, J IMMUNOL, V187, P6208, DOI 10.4049/jimmunol.1102188
   Maedler K, 2006, DIABETES, V55, P2455, DOI 10.2337/db05-1586
   Mahbub S, 2012, J INTERF CYTOK RES, V32, P18, DOI 10.1089/jir.2011.0058
   Mehta NN, 2010, DIABETES, V59, P172, DOI 10.2337/db09-0367
   Meneilly GS, 2001, J GERONTOL A-BIOL, V56, pM5, DOI 10.1093/gerona/56.1.M5
   Meyer A, 2015, DIABETES, V64, P2138, DOI 10.2337/db14-0864
   Montgomery MK, 2013, DIABETOLOGIA, V56, P1129, DOI 10.1007/s00125-013-2846-8
   Morris DL, 2015, MOL ENDOCRINOL, V29, P946, DOI 10.1210/me.2014-1393
   Nackiewicz D, 2014, DIABETOLOGIA, V57, P1645, DOI 10.1007/s00125-014-3249-1
   Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200
   Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003
   Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894
   Orr JS, 2012, DIABETES, V61, P2718, DOI 10.2337/db11-1595
   Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627
   Pal D, 2012, NAT MED, V18, P1279, DOI 10.1038/nm.2851
   Pedersen M, 2003, MECH AGEING DEV, V124, P495, DOI 10.1016/S0047-6374(03)00027-7
   Poggi M, 2007, DIABETOLOGIA, V50, P1267, DOI 10.1007/s00125-007-0654-8
   Reers C, 2009, EUR J ENDOCRINOL, V160, P185, DOI 10.1530/EJE-08-0596
   Saberi M, 2009, CELL METAB, V10, P419, DOI 10.1016/j.cmet.2009.09.006
   Salvioli S, 2006, CURR PHARM DESIGN, V12, P3161, DOI 10.2174/138161206777947470
   Sauter NS, 2008, ENDOCRINOLOGY, V149, P2208, DOI 10.1210/en.2007-1059
   Schulthess FT, 2009, CELL METAB, V9, P125, DOI 10.1016/j.cmet.2009.01.003
   Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898
   Stefan N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092238
   Suganami T, 2007, BIOCHEM BIOPH RES CO, V354, P45, DOI 10.1016/j.bbrc.2006.12.190
   SURWIT RS, 1995, METABOLISM, V44, P645, DOI 10.1016/0026-0495(95)90123-X
   Tschen SI, 2009, DIABETES, V58, P1312, DOI 10.2337/db08-1651
   WANG SY, 1988, J CLIN INVEST, V81, P176, DOI 10.1172/JCI113291
   Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102
   Xiong Y., 2017, DIABETES
   Yang T, 2015, DIABETOLOGIA, V58, P1610, DOI 10.1007/s00125-015-3570-3
NR 66
TC 24
Z9 26
U1 0
U2 5
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD FEB 9
PY 2018
VL 8
AR 2767
DI 10.1038/s41598-018-20909-w
PG 12
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA FV5PG
UT WOS:000424634000021
PM 29426925
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Schumacher, B
   van der Pluijm, I
   Moorhouse, MJ
   Kosteas, T
   Robinson, AR
   Suh, Y
   Breit, TM
   van Steeg, H
   Niedernhofer, LJ
   van IJcken, W
   Bartke, A
   Spindler, SR
   Hoeijmakers, JHJ
   van der Horst, GTJ
   Garinis, GA
AF Schumacher, Bjoern
   van der Pluijm, Ingrid
   Moorhouse, Michael J.
   Kosteas, Theodore
   Robinson, Andria Rasile
   Suh, Yousin
   Breit, Timo M.
   van Steeg, Harry
   Niedernhofer, Laura J.
   van IJcken, Wilfred
   Bartke, Andrzej
   Spindler, Stephen R.
   Hoeijmakers, Jan H. J.
   van der Horst, Gijsbertus T. J.
   Garinis, George A.
TI Delayed and Accelerated Aging Share Common Longevity Assurance
   Mechanisms
SO PLOS GENETICS
LA English
DT Article
ID NUCLEOTIDE EXCISION-REPAIR; LIFE-SPAN; CALORIE RESTRICTION; GENOME
   MAINTENANCE; OXIDATIVE STRESS; GENE-EXPRESSION; MAMMALIAN MODEL; MICE;
   MOUSE; DISRUPTION
AB Mutant dwarf and calorie-restricted mice benefit from healthy aging and unusually long lifespan. In contrast, mouse models for DNA repair-deficient progeroid syndromes age and die prematurely. To identify mechanisms that regulate mammalian longevity, we quantified the parallels between the genome-wide liver expression profiles of mice with those two extremes of lifespan. Contrary to expectation, we find significant, genome-wide expression associations between the progeroid and long-lived mice. Subsequent analysis of significantly over-represented biological processes revealed suppression of the endocrine and energy pathways with increased stress responses in both delayed and premature aging. To test the relevance of these processes in natural aging, we compared the transcriptomes of liver, lung, kidney, and spleen over the entire murine adult lifespan and subsequently confirmed these findings on an independent aging cohort. The majority of genes showed similar expression changes in all four organs, indicating a systemic transcriptional response with aging. This systemic response included the same biological processes that are triggered in progeroid and long-lived mice. However, on a genome-wide scale, transcriptomes of naturally aged mice showed a strong association to progeroid but not to long-lived mice. Thus, endocrine and metabolic changes are indicative of "survival'' responses to genotoxic stress or starvation, whereas genome-wide associations in gene expression with natural aging are indicative of biological age, which may thus delineate pro- and anti-aging effects of treatments aimed at health-span extension.
C1 [Schumacher, Bjoern; van der Pluijm, Ingrid; Hoeijmakers, Jan H. J.; van der Horst, Gijsbertus T. J.; Garinis, George A.] Erasmus Univ, Med Ctr, Dept Genet, Rotterdam, Netherlands.
   [Moorhouse, Michael J.] Erasmus Univ, Med Ctr, Dept Internal Med, Rotterdam, Netherlands.
   [Kosteas, Theodore; Garinis, George A.] FORTH, Inst Mol Biol & Biotechnol, Iraklion, Crete, Greece.
   [Robinson, Andria Rasile; Niedernhofer, Laura J.] Univ Pittsburgh, Sch Med, Dept Mol Genet & Biochem, Inst Canc, Pittsburgh, PA 15261 USA.
   [Suh, Yousin] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78229 USA.
   [Suh, Yousin] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA.
   [Breit, Timo M.] Univ Amsterdam, Fac Sci, Inst Informat, Integrat Bioinformat Unit, Amsterdam, Netherlands.
   [van Steeg, Harry] Natl Inst Publ Hlth & Environm RIVM, Lab Toxicol Pathol & Genet TOX, Bilthoven, Netherlands.
   [van IJcken, Wilfred] Erasmus Univ, Med Ctr, Erasmus Ctr Biom, Rotterdam, Netherlands.
   [Bartke, Andrzej] So Illinois Univ, Sch Med, Dept Internal Med, Springfield, IL USA.
   [Spindler, Stephen R.] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.
C3 Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam;
   Erasmus MC; Foundation for Research & Technology - Hellas (FORTH);
   Pennsylvania Commonwealth System of Higher Education (PCSHE); University
   of Pittsburgh; University of Texas System; University of Texas Health
   Science Center at San Antonio; University of Texas System; University of
   Texas Health Science Center at San Antonio; University of Amsterdam;
   Netherlands National Institute for Public Health & the Environment;
   Erasmus University Rotterdam; Erasmus MC; Southern Illinois University
   System; Southern Illinois University; University of California System;
   University of California Riverside
RP Schumacher, B (corresponding author), Erasmus Univ, Med Ctr, Dept Genet, Rotterdam, Netherlands.
EM g.vanderhorst@erasmusmc.nl
RI van der Horst, Gijsbertus (Bert)/E-3661-2015; Schumacher,
   Björn/I-4829-2013; van ijcken, willem/N-9805-2018; van der Pluijm,
   Ingrid/HKO-1880-2023; Garinis, George A./B-2943-2012; Bartke,
   Andzej/D-6640-2017; Hoeijmakers, Jan/AAX-6972-2021
OI van der Horst, Gijsbertus (Bert)/0000-0002-7773-6396; Schumacher,
   Björn/0000-0001-6097-5238; van ijcken, willem/0000-0002-0421-8301;
   Garinis, George A./0000-0002-3200-5004; Bartke,
   Andzej/0000-0002-2569-557X; Kosteas, Theodoros/0000-0003-2174-911X
FU Netherlands Organization for Scientific Research (NWO); Research
   Institute Diseases of the Elderly; Netherlands Genomics Initiative /
   Netherlands Organisation for Scientific Research (NGI / NWO) [05040202];
   SenterNovem IOP-Genomics [IGE03009]; NIH [1PO1 AG17242-02]; NIEHS [1UO1
   ES011044]; EC [QRTL-1999-02002]; Dutch Cancer Society [EUR 99-2004];
   EMBO, Marie Curie and NWO Veni; Ellison Medical Foundation [AG-NS-0303];
   NCI [CA111525, CA10370]
FX This research was supported by the Netherlands Organization for
   Scientific Research (NWO) through the foundation of the Research
   Institute Diseases of the Elderly, a stimulation grant from the
   Netherlands Genomics Initiative / Netherlands Organisation for
   Scientific Research (NGI / NWO) (grant number 05040202; Netherlands
   Initiative into Healthy Ageing) as well as grants from SenterNovem
   IOP-Genomics (IGE03009), NIH (1PO1 AG17242-02), NIEHS (1UO1 ES011044),
   EC (QRTL-1999-02002), and the Dutch Cancer Society (EUR 99-2004). BS was
   supported by EMBO, Marie Curie and NWO Veni postdoctoral fellowships;
   LJN is supported by The Ellison Medical Foundation (AG-NS-0303) and the
   NCI (CA111525 and CA10370). The authors declare no competing financial
   interest.
CR Adler AS, 2007, GENE DEV, V21, P3244, DOI 10.1101/gad.1588507
   Andersen B, 1995, DEV BIOL, V172, P495, DOI 10.1006/dbio.1995.8040
   Bartke A, 2004, CURR TOP DEV BIOL, V63, P189, DOI 10.1016/S0070-2153(04)63006-7
   Bartke A, 2002, NEUROPEPTIDES, V36, P201, DOI 10.1054/npep.2002.0889
   Bootsma D.K., 2001, The Metabolic and Molecular Basis of Inherited Disease, P677
   Boylston WH, 2004, AGING CELL, V3, P283, DOI 10.1111/j.1474-9728.2004.00115.x
   Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090
   Brown-Borg HM, 2000, EXP GERONTOL, V35, P199, DOI 10.1016/S0531-5565(00)00079-6
   Brown-Borg HM, 1999, ENDOCRINE, V11, P41, DOI 10.1385/ENDO:11:1:41
   de Boer J, 2002, SCIENCE, V296, P1276, DOI 10.1126/science.1070174
   DEVRIES A, 1995, NATURE, V377, P169, DOI 10.1038/377169a0
   Dolle MET, 1997, NAT GENET, V17, P431, DOI 10.1038/ng1297-431
   Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898
   Garinis GA, 2008, HORM-INT J ENDOCRINO, V7, P9, DOI 10.14310/horm.2002.1111032
   Hanawalt PC, 2002, ONCOGENE, V21, P8949, DOI 10.1038/sj.onc.1206096
   Hasty P, 2003, SCIENCE, V299, P1355, DOI 10.1126/science.1079161
   Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232
   Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298
   Hursting SD, 2003, ANNU REV MED, V54, P131, DOI 10.1146/annurev.med.54.101601.152156
   Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027
   Koubova J, 2003, GENE DEV, V17, P313, DOI 10.1101/gad.1052903
   KRIETE A, 2006, SCI AGING KNOWLEDGE, pPE1
   Landis GN, 2004, P NATL ACAD SCI USA, V101, P7663, DOI 10.1073/pnas.0307605101
   LI S, 1990, NATURE, V347, P528, DOI 10.1038/347528a0
   Liang HY, 2003, EXP GERONTOL, V38, P1353, DOI 10.1016/j.exger.2003.10.019
   Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319
   Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578
   Longo VD, 2003, SCIENCE, V299, P1342, DOI 10.1126/science.1077991
   Martin GM, 2000, NATURE, V408, P263, DOI 10.1038/35041705
   Martin GM, 2005, CELL, V120, P523, DOI 10.1016/j.cell.2005.01.031
   McElwee JJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r132
   Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456
   Pinkston JM, 2006, SCIENCE, V313, P971, DOI 10.1126/science.1121908
   Rowland JE, 2005, MOL CELL BIOL, V25, P66, DOI 10.1128/MCB.25.1.66-77.2005
   Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095
   Tsuchiya T, 2004, PHYSIOL GENOMICS, V17, P307, DOI 10.1152/physiolgenomics.00039.2004
   van der Pluijm I, 2007, PLOS BIOL, V5, P23, DOI 10.1371/journal.pbio.0050002
   vanderHorst GTJ, 1997, CELL, V89, P425, DOI 10.1016/S0092-8674(00)80223-8
   Weeda G, 1997, CURR BIOL, V7, P427, DOI 10.1016/S0960-9822(06)00190-4
   WIJNHOVEN SW, 2005, DNA REPAIR AMST
   Zahn JM, 2007, PLOS GENET, V3, P2326, DOI 10.1371/journal.pgen.0030201
   Zhou YH, 1997, P NATL ACAD SCI USA, V94, P13215, DOI 10.1073/pnas.94.24.13215
NR 42
TC 159
Z9 177
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7404
J9 PLOS GENET
JI PLoS Genet.
PD AUG
PY 2008
VL 4
IS 8
AR e1000161
DI 10.1371/journal.pgen.1000161
PG 13
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 365MN
UT WOS:000260410800025
PM 18704162
OA Green Published, gold, Green Accepted, Green Submitted
DA 2024-02-19
ER

PT J
AU Ross, KS
   Powrie, YSL
   Smith, C
AF Ross, K. S.
   Powrie, Y. S. L.
   Smith, C.
TI Accelerated ageing profile in inflammatory arthritis is unique and
   tissue compartment specific
SO INFLAMMOPHARMACOLOGY
LA English
DT Article; Early Access
DE FRAP; IL-10; Preventative medicine; Telomere length; Polyphenol;
   Accelerated ageing
ID COLLAGEN-INDUCED ARTHRITIS; SEED PROANTHOCYANIDIN EXTRACT; OXIDATIVE
   STRESS; RHEUMATOID-ARTHRITIS; SKELETAL-MUSCLE; INHIBITION; AGE
AB Rheumatoid arthritis is prevalent in more than 1% of the global population, with the highest occurrence between ages 35 and 50, which places a huge burden on the economy. Drug discovery for the prevention of this chronic disease is; therefore, a priority. It is known that subclinical progression of many chronic non-communicable diseases is exacerbated via accelerated ageing, a pro-inflammatory phenotype shift. However, rheumatoid arthritis additionally has significant humoral immune activation, inflammatory signalling-and thus the accelerated ageing profile-may differ from other chronic inflammatory diseases. The current study simulated inflammatory arthritis onset in a collagen-induced arthritis (CIA) rodent model, to characterise the redox and inflammatory profile at the onset of clinical symptoms, in different tissues, in the presence and absence of preventative antioxidant treatment. The data illustrate that an increased free radical level are evident already very early on in RA disease progression. Furthermore, oxidative stress seems to somewhat precede a significant pro-inflammatory state, perhaps due to humoral immune activation. Our data across different compartments further suggest that the compensatory increase in endogenous antioxidant activity is gradually exhausted at a different pace, with the liver showing the first signs of oxidant damage, even before significant evidence exist in circulation. The current data further suggest that preventative antioxidant intervention may have a sparing effect on endogenous antioxidant mechanisms and preserve telomere length to delay disease progression-or at least the accelerated ageing known to exacerbate RA symptoms-although it did not seem to have a significant direct effect on the autoimmune activity.
C1 [Ross, K. S.; Powrie, Y. S. L.; Smith, C.] Stellenbosch Univ, Fac Sci, Dept Physiol Sci, Stellenbosch, South Africa.
C3 Stellenbosch University
RP Smith, C (corresponding author), Stellenbosch Univ, Fac Sci, Dept Physiol Sci, Stellenbosch, South Africa.
EM csmith@sun.ac.za
RI Powrie, Yigael/CAG-1220-2022; Smith, Carine/D-7159-2012; Powrie,
   Yigael/R-1094-2018
OI Smith, Carine/0000-0001-5924-9204; Powrie, Yigael/0000-0001-8044-9390;
   (Petersen) Ross, Kelly/0000-0003-2887-6568
FU South African NRF; Brenn-o-kem (Pty) Ltd
FX The South African NRF is acknowledged for financial assistance and a
   bursary to KSR. Brenn-o-kem (Pty) Ltd is acknowledged for their donation
   of the antioxidant polyphenol.
CR Arntz OJ, 2015, MOL NUTR FOOD RES, V59, P1701, DOI 10.1002/mnfr.201500222
   Bagchi D, 2000, TOXICOLOGY, V148, P187, DOI 10.1016/S0300-483X(00)00210-9
   Bendele A, 1999, TOXICOL PATHOL, V27, P134, DOI 10.1177/019262339902700125
   Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292
   Burton DGA, 2018, AGEING RES REV, V43, P17, DOI 10.1016/j.arr.2018.02.001
   Cásedas G, 2017, FOOD FUNCT, V8, P4187, DOI [10.1039/c7fo01205e, 10.1039/C7FO01205E]
   Chedea VS, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/313684
   Choi EM, 2007, J APPL TOXICOL, V27, P472, DOI 10.1002/jat.1228
   Corrêa MG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204414
   Dragos D, 2017, NUTRIENTS, V9, DOI 10.3390/nu9010070
   El-Ghazaly MA, 2020, INT J RADIAT BIOL, V96, P857, DOI 10.1080/09553002.2020.1748911
   Giorgio Marco, 2007, Nat Rev Mol Cell Biol, V8, P722, DOI 10.1038/nrm2240
   Greenhill CJ, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0419-y
   Holsapple MP, 2003, BIRTH DEFECTS RES B, V68, P321, DOI 10.1002/bdrb.10035
   IBRAHEEM AS, 2013, J BASIC APPL ZOOL, V66, P195, DOI DOI 10.1016/J.JOBAZ.2012.12.005
   Kruger MJ, 2012, MED SCI SPORT EXER, V44, P872, DOI 10.1249/MSS.0b013e31823dbff3
   Liu HP, 2017, INT J ADV ROBOT SYST, V14, DOI 10.1177/1729881417717056
   Mikuls TR, 2003, BEST PRACT RES CL RH, V17, P729, DOI 10.1016/S1521-6942(03)00041-X
   MILLER NJ, 1993, CLIN SCI, V84, P407, DOI 10.1042/cs0840407
   Myburgh KH, 2012, J NUTR BIOCHEM, V23, P1072, DOI 10.1016/j.jnutbio.2011.05.014
   O'Callaghan NJ, 2011, BIOL PROCED ONLINE, V13, DOI 10.1186/1480-9222-13-3
   Oyenihi AB, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/2484678
   Pajuelo D, 2011, J AGR FOOD CHEM, V59, P4279, DOI 10.1021/jf200322x
   Park HK, 2017, SAUDI J BIOL SCI, V24, P444, DOI 10.1016/j.sjbs.2016.01.013
   Petersen KS, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/6236309
   Petersen KS, 2018, INFLAMMOPHARMACOLOGY, V26, P1349, DOI 10.1007/s10787-018-0511-z
   Saleem A, 2020, INFLAMMOPHARMACOLOGY, V28, P1633, DOI 10.1007/s10787-020-00688-5
   Sapey E, 2014, BLOOD, V123, P239, DOI 10.1182/blood-2013-08-519520
   Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624
   Smith C, 2018, J PHYSIOL BIOCHEM, V74, P549, DOI 10.1007/s13105-018-0621-5
   Stamp LK, 2012, RHEUMATOLOGY, V51, P1796, DOI 10.1093/rheumatology/kes193
   Szekanecz Z, 1998, SPRINGER SEMIN IMMUN, V20, P115, DOI 10.1007/BF00832002
   Umar S, 2013, CELL IMMUNOL, V284, P51, DOI 10.1016/j.cellimm.2013.07.004
   Umar S, 2012, CHEM-BIOL INTERACT, V197, P40, DOI 10.1016/j.cbi.2012.03.003
   Ungprasert P, 2016, NEUROL INDIA, V64, P56, DOI 10.4103/0028-3886.173623
   van Onna M, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1038-3
   vanRoon JAG, 1996, ARTHRITIS RHEUM, V39, P829, DOI 10.1002/art.1780390516
   VARSHNEY R, 1990, INT J RADIAT BIOL, V58, P733, DOI 10.1080/09553009014552121
   Vasanthi P, 2009, INT J RHEUM DIS, V12, P29, DOI 10.1111/j.1756-185X.2009.01375.x
   Vervoordeldonk Margriet J B M, 2002, Curr Rheumatol Rep, V4, P208, DOI 10.1007/s11926-002-0067-0
   Veselinovic M, 2014, MOL CELL BIOCHEM, V391, P225, DOI 10.1007/s11010-014-2006-6
   Wang GY, 2020, BIOFACTORS, V46, P441, DOI 10.1002/biof.1599
   Wilson-Gerwing TD, 2013, COMPARATIVE MED, V63, P498
   Wright HL, 2014, NAT REV RHEUMATOL, V10, P593, DOI 10.1038/nrrheum.2014.80
   Yang GL, 2018, J AGR FOOD CHEM, V66, P12953, DOI 10.1021/acs.jafc.8b05047
   Zhang P, 2008, INFLAMM RES, V57, P322, DOI 10.1007/s00011-008-8070-1
NR 46
TC 2
Z9 2
U1 0
U2 2
PU SPRINGER BASEL AG
PI BASEL
PA PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND
SN 0925-4692
EI 1568-5608
J9 INFLAMMOPHARMACOLOGY
JI Inflammopharmacology
PD 2020 AUG
PY 2020
VL 28
IS 4
BP 967
EP 977
DI 10.1007/s10787-020-00731-5
EA JUN 2020
PG 11
WC Immunology; Pharmacology & Pharmacy; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Pharmacology & Pharmacy; Toxicology
GA MK3NG
UT WOS:000543684600002
PM 32594363
DA 2024-02-19
ER

PT J
AU Parrado, J
   Absi, EH
   Machado, A
   Ayala, A
AF Parrado, J
   Absi, EH
   Machado, A
   Ayala, A
TI "In vitro" effect of cumene hydroperoxide on hepatic elongation factor-2
   and its protection by melatonin
SO BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
LA English
DT Article
DE elongation factor-2; cumene hydroperoxide; AAPH; hydrogen peroxide;
   melatonin; lipid peroxidation
ID LIPID-PEROXIDATION PRODUCTS; OXIDATIVE STRESS; MEDIATED FRAGMENTATION;
   PROTEIN-SYNTHESIS; OXYGEN RADICALS; CARBONYL GROUPS; DAMAGE; PROTEASOME;
   MECHANISM; MEMBRANE
AB We have examined by immunoblotting the effect of three oxidant compounds on the level of hepatic elongation factor-2 (eEF-2). Rat liver homogenates were exposed to cumene hydroperoxide (CH), 2-2 -azobis (2-aminopropane) dihydrochloride (AAPH) and H2O2. Only CH treatment produced the disappearance of eEF-2, probably due to a phenomena of peptide bond cleavage. The direct implication of free radical species in this process is evident because of the fact that the inclusion of a free radical scavenger such as melatonin prevented the eEF-2 depletion. The results also suggest that the disappearance of eEF-2 induced by CH can be linked to a lipid peroxidant process, which could account for the decline of protein synthesis in aging and other circumstances where lipid peroxidation is high. (C) 2003 Published by Elsevier B.V.
C1 Univ Seville, Fac Farm, Dept Bioquim Bromatol & Toxicol, E-41012 Seville, Spain.
C3 University of Sevilla
RP Ayala, A (corresponding author), Univ Seville, Fac Farm, Dept Bioquim Bromatol & Toxicol, C Tramontana S-N, E-41012 Seville, Spain.
EM aayala@us.es
RI IBIS, ENVEJECIMIENTO/O-9381-2015; Ayala, Antonio/N-7591-2019; Parrado,
   Juan/E-6637-2010
OI Ayala, Antonio/0000-0001-9711-3711; Parrado, Juan/0000-0002-1462-408X
CR Ayala A, 1996, J BIOL CHEM, V271, P23105, DOI 10.1074/jbc.271.38.23105
   Burcham PC, 1996, BIOCHEM BIOPH RES CO, V220, P996, DOI 10.1006/bbrc.1996.0521
   Cabiscol E, 2000, J BIOL CHEM, V275, P27393
   Castilho RF, 1996, MOL CELL BIOCHEM, V159, P105, DOI 10.1007/BF00420912
   Choi SY, 1999, BBA-GEN SUBJECTS, V1472, P651, DOI 10.1016/S0304-4165(99)00189-0
   Choi SY, 2000, BIOCHIMIE, V82, P175, DOI 10.1016/S0300-9084(00)00380-1
   DAVIES KJA, 1987, J BIOL CHEM, V262, P8227
   Dean RT, 1997, BIOCHEM J, V324, P1
   DEAN RT, 1987, BIOCHEM BIOPH RES CO, V148, P1277, DOI 10.1016/S0006-291X(87)80271-1
   DEAN RT, 1986, BIOCHEM J, V240, P489, DOI 10.1042/bj2400489
   DEAN RT, 1986, BIOMED BIOCHIM ACTA, V45, P1563
   Dukan S, 1999, J BIOL CHEM, V274, P26027, DOI 10.1074/jbc.274.37.26027
   Escames G, 1997, NEUROSCI LETT, V230, P147, DOI 10.1016/S0304-3940(97)00498-9
   ESTERBAUER H, 1990, METHOD ENZYMOL, V186, P407
   ESTERBAUER H, 1985, BIOCHEM J, V228, P363, DOI 10.1042/bj2280363
   Fiorentini D, 1999, FREE RADICAL BIO MED, V26, P661, DOI 10.1016/S0891-5849(98)00255-X
   FRANZINI E, 1993, BIOCHIM BIOPHYS ACTA, V1203, P11, DOI 10.1016/0167-4838(93)90030-U
   Gieseg SP, 2001, FREE RADICAL RES, V34, P123, DOI 10.1080/10715760100300121
   GIOVANE A, 1987, BIOCHEM J, V244, P337, DOI 10.1042/bj2440337
   GIRONCALLE J, 1994, ARCH BIOCHEM BIOPHYS, V315, P1, DOI 10.1006/abbi.1994.1463
   Gomes-Marcondes MCC, 2002, CANCER LETT, V180, P69, DOI 10.1016/S0304-3835(02)00006-X
   HALLIWELL B, 1990, METHOD ENZYMOL, V186, P1
   Hashimoto R, 2000, BBA-MOL CELL BIOL L, V1483, P236, DOI 10.1016/S1388-1981(99)00167-5
   Hawkins CL, 1998, BIOCHEM J, V332, P617, DOI 10.1042/bj3320617
   Headlam HA, 2003, FREE RADICAL BIO MED, V34, P44, DOI 10.1016/S0891-5849(02)01181-4
   Headlam HA, 2002, FREE RADICAL BIO MED, V32, P1171, DOI 10.1016/S0891-5849(02)00814-6
   HERSHEY JWB, 1991, ANNU REV BIOCHEM, V60, P717, DOI 10.1146/annurev.bi.60.070191.003441
   HUNT JV, 1988, BIOCHEM J, V250, P87, DOI 10.1042/bj2500087
   IGLEWSKI WJ, 1994, MOL CELL BIOCHEM, V138, P131, DOI 10.1007/BF00928454
   Kang JH, 1997, MOL CELLS, V7, P553
   Kato Y, 1999, J BIOL CHEM, V274, P20406, DOI 10.1074/jbc.274.29.20406
   LECOMTE E, 1993, CLIN CHIM ACTA, V218, P39, DOI 10.1016/0009-8981(93)90220-X
   LEE MH, 1995, BIOCHEM MOL BIOL INT, V35, P1093
   Levine RL, 2000, METH MOL B, V99, P15
   MERRICK WC, 1990, ENZYME, V44, P7, DOI 10.1159/000468743
   MOLDAVE K, 1985, ANNU REV BIOCHEM, V54, P1109, DOI 10.1146/annurev.bi.54.070185.005333
   NOGUCHI N, 1993, BIOCHIM BIOPHYS ACTA, V1168, P348
   Ogino T, 1995, BBA-GEN SUBJECTS, V1245, P359, DOI 10.1016/0304-4165(95)00101-8
   Parrado J, 1999, FREE RADICAL BIO MED, V26, P362, DOI 10.1016/S0891-5849(98)00202-0
   Parrado J, 1999, FREE RADICAL BIO MED, V26, P1079, DOI 10.1016/S0891-5849(98)00316-5
   POOT M, 1988, MECH AGEING DEV, V43, P1, DOI 10.1016/0047-6374(88)90093-0
   Rattan SIS, 1996, EXP GERONTOL, V31, P33, DOI 10.1016/0531-5565(95)02022-5
   REINHECKEL T, 1995, BBA-BIOMEMBRANES, V1239, P45, DOI 10.1016/0005-2736(95)00142-P
   Reiter RJ, 1998, PROG NEUROBIOL, V56, P359, DOI 10.1016/S0301-0082(98)00052-5
   RICHARDSON A, 1983, REV BIOL RES AGING, P255
   RIVETT AJ, 1985, J BIOL CHEM, V260, P300
   Salvi A, 2001, BIOCHEM PHARMACOL, V61, P1237, DOI 10.1016/S0006-2952(01)00607-4
   SHACTER E, 1994, FREE RADICAL BIO MED, V17, P429, DOI 10.1016/0891-5849(94)90169-4
   Shringarpure R, 2002, FREE RADICAL BIO MED, V32, P1084, DOI 10.1016/S0891-5849(02)00824-9
   Stadtman ER, 2000, ANN NY ACAD SCI, V899, P191
   UCHIDA K, 1990, BIOCHEM BIOPH RES CO, V169, P265, DOI 10.1016/0006-291X(90)91463-3
   UEDA K, 1985, ANNU REV BIOCHEM, V54, P73, DOI 10.1146/annurev.bi.54.070185.000445
   VARTIO T, 1989, J BIOL CHEM, V264, P4471
   Winterbourn CC, 2000, CRIT CARE MED, V28, P143, DOI 10.1097/00003246-200001000-00024
   Yang CF, 1999, BIOCHEM PHARMACOL, V57, P273, DOI 10.1016/S0006-2952(98)00299-8
   YANSHAN M, 1999, ARCH BIOCHEM BIOPHYS, V363, P129
   Zaidi A, 1999, FREE RADICAL BIO MED, V27, P810, DOI 10.1016/S0891-5849(99)00128-8
   [No title captured]
NR 58
TC 17
Z9 18
U1 0
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0304-4165
EI 1872-8006
J9 BBA-GEN SUBJECTS
JI Biochim. Biophys. Acta-Gen. Subj.
PD DEC 5
PY 2003
VL 1624
IS 1-3
BP 139
EP 144
DI 10.1016/j.bbagen.2003.10.006
PG 6
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 750AP
UT WOS:000186962500019
PM 14642824
DA 2024-02-19
ER

PT J
AU Wang, H
   Zhu, JL
   Jia, Z
   Lu, SC
AF Wang, Hao
   Zhu, Jiali
   Jia, Zhe
   Lu, Sucai
TI Pretreatment of diabetic aged rats with combination of ginsenoside-Mc1
   and silibinin protects liver from ischemia-reperfusion injury through an
   AMPK-dependent mechanism
SO TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI
LA English
DT Article; Early Access
DE aging; diabetes; ginsenoside compound-Mc1; liver ischemia reperfusion
   injury; oxidative stress; silibinin
ID ISCHEMIA/REPERFUSION INJURY; METABOLIC SYNDROME; OXIDATIVE STRESS;
   GINSENG
AB Objectives This study evaluated the protective efficacy of combination treatment with ginsenoside-Mc1 and silibinin against hepatic ischemia-reperfusion (IR) injury in diabetic-aged rats, and further explored AMPK's role in this protection. Methods A high-fat diet/streptozotocin was used to induce type-2 diabetes in aged rats (20-24 months). Diabetic-aged rats were pretreated with ginsenoside-Mc1 (10 mg/kg, IP) and silibinin (50 mg/kg, IP), alone or in combination, for 4 weeks before induction of hepatic IR injury. Results Induction of IR injury in diabetic-aged rats significantly elevated plasma levels of hepatic alanine and aspartate aminotransferases and negatively affected liver histology. Levels of 8-isoprostane, ROS production, Bax, and cleaved-caspase-3 expression were higher and manganese-superoxide dismutase (MnSOD), glutathione, and Bcl2 and p-AMPK were lower in IR-receiving group. In comparison to individual treatments, the combination of ginsenoside-Mc1 and silibinin powerfully restored IR-induced changes in liver enzymes and histopathological indices, oxidative markers, AMPK, and apoptotic protein expressions. Inhibition of AMPK using compound-C in H2O2-stimulated HepG2 cells significantly abolished the protective effects of combination treatment. Conclusions Combination of ginsenoside-Mc1 and silibinin was superior to their alone usage in protecting hepatocytes of diabetic-aged rats from oxidative/apoptotic damages following IR injury, through an AMPK-mediated mechanism.
C1 [Lu, Sucai] Hebei Univ, Affiliated Hosp, Gastroenterol Dept, Baoding City 071030, Hebei, Peoples R China.
   [Wang, Hao; Zhu, Jiali; Jia, Zhe] Hebei Univ, Affiliated Hosp, Gastroenterol Dept, Baoding, Hebei, Peoples R China.
C3 Hebei University; Hebei University
RP Lu, SC (corresponding author), Hebei Univ, Affiliated Hosp, Gastroenterol Dept, Baoding City 071030, Hebei, Peoples R China.
EM lsc3065123@sina.com
RI ZHU, JIALI/JNE-3065-2023
FU TYHebei Provincial Government-funded Project for provincial Clinical
   Medical
FX TYHebei Provincial Government-funded Project for provincial Clinical
   Medical Talents in 2017.
CR Abenavoli L, 2010, PHYTOTHER RES, V24, P1423, DOI 10.1002/ptr.3207
   Ahmed-Belkacem A, 2010, GASTROENTEROLOGY, V138, P1112, DOI 10.1053/j.gastro.2009.11.053
   Akbari-Kordkheyli V, 2019, IRAN J BASIC MED SCI, V22, P789, DOI 10.22038/ijbms.2019.34967.8313
   Bonomini F, 2015, AGING DIS, V6, P109, DOI 10.14336/AD.2014.0305
   Chen YH, 2020, INT J BIOL SCI, V16, P1972, DOI 10.7150/ijbs.39259
   Chu C, 2018, ARCH PHARM RES, V41, P785, DOI 10.1007/s12272-018-1047-x
   Deep G, 2010, CANCER METAST REV, V29, P447, DOI 10.1007/s10555-010-9237-0
   Han X, 2019, PEERJ, V7, DOI 10.7717/peerj.7568
   Hong SH, 2020, J GINSENG RES, V44, P664, DOI 10.1016/j.jgr.2019.08.006
   Huang ES, 2014, JAMA INTERN MED, V174, P251, DOI 10.1001/jamainternmed.2013.12956
   Huang Q, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18051063
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Kim JH, 2018, J GINSENG RES, V42, P264, DOI 10.1016/j.jgr.2017.10.004
   Ligeret H, 2008, J ETHNOPHARMACOL, V115, P507, DOI 10.1016/j.jep.2007.10.024
   Liguori I, 2018, CLIN INTERV AGING, V13, P757, DOI 10.2147/CIA.S158513
   Mohamed Jamaludin, 2016, Sultan Qaboos Univ Med J, V16, pe132, DOI 10.18295/squmj.2016.16.02.002
   Mohamed S, 2014, TRENDS FOOD SCI TECH, V35, P114, DOI 10.1016/j.tifs.2013.11.001
   Nastos C, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/906965
   Pradhan SC, 2006, INDIAN J MED RES, V124, P491
   RASOOL M, 2014, EVID-BASED COMPL ALT, V2014, DOI DOI 10.1155/2014/641597
   Reinisalo M, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/340520
   Roh E, 2020, J ETHNOPHARMACOL, V259, DOI 10.1016/j.jep.2020.112927
   Salomone F, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101086
   Shin KC, 2016, CRIT REV BIOTECHNOL, V36, P1036, DOI 10.3109/07388551.2015.1083942
   Sun L, 2015, INT J BIOL MACROMOL, V75, P152, DOI 10.1016/j.ijbiomac.2015.01.025
   Tamamoto LC, 2010, J FOOD SCI, V75, pS271, DOI 10.1111/j.1750-3841.2010.01655.x
   Tsaroucha AK, 2018, J INVEST SURG, V31, P491, DOI 10.1080/08941939.2017.1360416
   Voces J, 2004, BRAZ J MED BIOL RES, V37, P1863, DOI 10.1590/S0100-879X2004001200012
   Xia R, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/767930
   Xie CL, 2015, LIFE SCI, V121, P145, DOI 10.1016/j.lfs.2014.12.002
   Xu QF, 2003, J ETHNOPHARMACOL, V84, P187, DOI 10.1016/S0378-8741(02)00317-3
   Zhang M, 2017, AM J TRANSL RES, V9, P823
   Zhong WZ, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm-20-2822
NR 33
TC 3
Z9 3
U1 0
U2 2
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 0250-4685
EI 1303-829X
J9 TURK J BIOCHEM
JI Turk. J. Biochem.
PD 2022 MAR 8
PY 2022
VL 47
IS 1
BP 23
EP 32
DI 10.1515/tjb-2021-0010
EA JUN 2021
PG 10
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA ZP6CU
UT WOS:000740004300002
OA gold
DA 2024-02-19
ER

PT J
AU Moreno, E
   Martínez-Sanz, J
   Martín-Mateos, R
   Diaz-Alvarez, J
   Serrano-Villar, S
   Burgos-Santamaria, D
   Luna, L
   Vivancos, MJ
   Moreno-Zamora, A
   Pérez-Elías, MJ
   Moreno, S
   Dronda, F
   Montes, ML
   Sánchez-Conde, M
AF Moreno, Elena
   Martinez-Sanz, Javier
   Martin-Mateos, Rosa
   Diaz-Alvarez, Jorge
   Serrano-Villar, Sergio
   Burgos-Santamaria, Diego
   Luna, Laura
   Vivancos, Maria Jesus
   Moreno-Zamora, Ana
   Perez-Elias, Maria Jesus
   Moreno, Santiago
   Dronda, Fernando
   Montes, Maria Luisa
   Sanchez-Conde, Matilde
TI Global DNA methylation and telomere length as markers of accelerated
   aging in people living with HIV and non-alcoholic fatty liver disease
SO BMC GENOMICS
LA English
DT Article
DE DNA methylation; MAFLD; PLWH
ID HUMAN-IMMUNODEFICIENCY-VIRUS; INFLAMMATION; INFECTION; PHENOTYPE; AGE
AB Metabolic-dysfunction-associated fatty liver disease (MAFLD) is a comorbidity that generally increases in people living with HIV (PLWH). This condition is usually accompanied by persistent inflammation and premature immune system aging. In this prospective cohort study, we describe a straightforward methodology for quantifying biomarkers of aging, such as DNA methylation and telomere length, in PLWH and in the context of another relevant condition, such as MAFLD. Fifty-seven samples in total, thirty-eight from PLWH and nineteen from non-PLWH participants with or without MAFLD, were obtained and subjected to DNA extraction from peripheral blood mononuclear cells (PBMCs). Global DNA methylation and telomere length quantification were performed using an adapted enzyme-linked immunosorbent assay (ELISA) and qPCR, respectively. The quantification results were analysed and corrected by clinically relevant variables in this context, such as age, sex, and metabolic syndrome. Our results show an increased association of these biomarkers in PLWH regardless of their MAFLD status. Thus, we propose including the quantification of these age-related factors in studies of comorbidities. This will allow a better understanding of the effect of comorbidities of HIV infection and MAFLD and prevent their effects in these populations in the future.
C1 [Moreno, Elena; Martinez-Sanz, Javier; Diaz-Alvarez, Jorge; Serrano-Villar, Sergio; Luna, Laura; Vivancos, Maria Jesus; Moreno-Zamora, Ana; Perez-Elias, Maria Jesus; Moreno, Santiago; Dronda, Fernando; Sanchez-Conde, Matilde] Hosp Univ Ramon Y Cajal, Dept Infect Dis, Inst Ramon Y Cajal Invest Sanitaria IRYCIS, Madrid 28034, Spain.
   [Moreno, Elena; Martinez-Sanz, Javier; Diaz-Alvarez, Jorge; Serrano-Villar, Sergio; Luna, Laura; Vivancos, Maria Jesus; Moreno-Zamora, Ana; Perez-Elias, Maria Jesus; Moreno, Santiago; Dronda, Fernando; Montes, Maria Luisa; Sanchez-Conde, Matilde] Inst Salud Carlos III, CIBER Enfermedades Infecciosas CIBERINFEC, Madrid 28029, Spain.
   [Martin-Mateos, Rosa; Burgos-Santamaria, Diego] Hosp Univ Ramon Y Cajal, Inst Ramon Y Cajal Invest Sanitaria IRYCIS, Dept Gastroenterol & Hepatol, Metab Liver Dis Clin, Madrid 28034, Spain.
   [Martin-Mateos, Rosa; Moreno, Santiago] Univ Alcala, Madrid 28871, Spain.
   [Montes, Maria Luisa] Hosp Univ La Paz, Internal Med Serv, IdiPAZ, Madrid 28046, Spain.
C3 Hospital Universitario Ramon y Cajal; Instituto de Salud Carlos III;
   Hospital Universitario Ramon y Cajal; Universidad de Alcala; Hospital
   Universitario La Paz
RP Moreno, E; Sánchez-Conde, M (corresponding author), Hosp Univ Ramon Y Cajal, Dept Infect Dis, Inst Ramon Y Cajal Invest Sanitaria IRYCIS, Madrid 28034, Spain.; Moreno, E; Sánchez-Conde, M (corresponding author), Inst Salud Carlos III, CIBER Enfermedades Infecciosas CIBERINFEC, Madrid 28029, Spain.
EM emolmo@salud.madrid.org
RI Serrano Villar, Sergio/AEU-8833-2022; Moreno, Santiago/KBB-0894-2024;
   Diaz, Jorge/P-6976-2015
OI Serrano Villar, Sergio/0000-0002-5447-3554; Moreno,
   Santiago/0000-0002-2843-1094; Diaz, Jorge/0000-0002-9017-1174; Luna,
   Laura/0000-0003-2373-8131
FU Instituto de Salud Carlos III [PI17/01717]
FX This work was supported by the Instituto de Salud Carlos III, grant
   number PI17/01717 Plan Estatal de Investigacion Cientifica y Tecnica y
   de Innovacion 2013-2016.
CR Aladdin H, 2000, SCAND J IMMUNOL, V52, P212
   Alejos B, 2019, HIV MED, V20, P691, DOI 10.1111/hiv.12791
   Banszerus VL, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20123032
   Bergstedt J, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-33511-6
   Blanco JR, 2021, EXPERT REV ANTI-INFE, V19, P719, DOI 10.1080/14787210.2021.1848546
   Borowa-Mazgaj B, 2019, TOXICOL SCI, V170, P273, DOI 10.1093/toxsci/kfz110
   Breitling LP, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0186-5
   Brenner C, 2013, J HEPATOL, V59, P583, DOI 10.1016/j.jhep.2013.03.033
   Busca C, 2022, FRONT PHARMACOL, V13, DOI 10.3389/fphar.2022.905126
   Busca C, 2022, OPEN FORUM INFECT DI, V9, DOI 10.1093/ofid/ofac279
   Calado RT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007926
   Carrasco I, 2022, AIDS, V36, P805, DOI 10.1097/QAD.0000000000003170
   Chalouni M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230772
   Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756
   Desplats P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102555
   Donati B, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030383
   Dong YT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04493-z
   Eslam M, 2020, J HEPATOL, V73, P202, DOI 10.1016/j.jhep.2020.03.039
   Esteban-Cantos A, 2023, EBIOMEDICINE, V88, DOI 10.1016/j.ebiom.2022.104434
   Gao Y, 2020, REDOX BIOL, V36, DOI 10.1016/j.redox.2020.101635
   Guaraldi G, 2017, AIDS, V31, pS147, DOI [10.1097/qad.0000000000001483, 10.1097/QAD.0000000000001483]
   Han WM, 2023, HIV MED, V24, P1000, DOI 10.1111/hiv.13499
   Hardy T, 2017, GUT, V66, P1321, DOI 10.1136/gutjnl-2016-311526
   Hartmann D, 2011, HEPATOLOGY, V53, P1608, DOI 10.1002/hep.24217
   Horvath S, 2022, GEROSCIENCE, V44, P1609, DOI 10.1007/s11357-022-00560-0
   Horvath S, 2015, J INFECT DIS, V212, P1563, DOI 10.1093/infdis/jiv277
   Hu F, 2014, PROTEIN CELL, V5, P21, DOI 10.1007/s13238-013-0002-3
   Joglekar MV, 2020, METHOD PROTOCOL, V3, DOI 10.3390/mps3020027
   Kim D, 2021, J HEPATOL, V75, P1284, DOI 10.1016/j.jhep.2021.07.035
   Kim J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-997
   Koo B.K., 2022, Clinical Obesity in Adults and Children, P159
   Lai ZW, 2020, OBESITY, V28, P197, DOI 10.1002/oby.22667
   Lee Y, 2019, AGING-US, V11, P5876, DOI 10.18632/aging.102230
   Li D, 2022, BIOMED PHARMACOTHER, V153, DOI 10.1016/j.biopha.2022.113290
   Lin J, 2019, PSYCHONEUROENDOCRINO, V99, P271, DOI 10.1016/j.psyneuen.2018.10.005
   Liu JCY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124426
   Lonardo A, 2018, LIVER INT, V38, P1730, DOI 10.1111/liv.13935
   Loomba R, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.96685
   Manzano-Nunez R, 2023, J INT AIDS SOC, V26, DOI 10.1002/jia2.26072
   Maricato J.T., 2015, PLoS One
   Martínez-Sanz J, 2022, J CLIN MED, V11, DOI 10.3390/jcm11133842
   Mohan J, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms222112020
   Montano Monty, 2022, Lancet Healthy Longev, V3, pe194, DOI 10.1016/s2666-7568(21)00278-6
   Montejano R, 2018, J INFECT DIS, V218, P1531, DOI 10.1093/infdis/jiy364
   Montejano R, 2017, JAIDS-J ACQ IMM DEF, V76, P102, DOI 10.1097/QAI.0000000000001391
   Montpetit AJ, 2014, NURS RES, V63, P289, DOI 10.1097/NNR.0000000000000037
   Moon JH, 2022, GUT LIVER, V16, P433, DOI 10.5009/gnl210167
   Moustakas II, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22073446
   Nasi M, 2017, CLIN EXP IMMUNOL, V187, P44, DOI 10.1111/cei.12814
   Navarro J, 2022, AIDS REV, V24, P87, DOI 10.24875/AIDSRev.M22000052
   Bogoi RN, 2018, CLIN EPIGENETICS, V10, DOI 10.1186/s13148-018-0448-5
   Piazzolla VA, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9041005
   Raschenberger J, 2016, SCI REP-UK, V6, DOI 10.1038/srep25398
   Raza S, 2021, FRONT BIOSCI-LANDMRK, V26, P206, DOI 10.2741/4892
   Rodríguez-Centeno J, 2022, J ANTIMICROB CHEMOTH, V77, P1125, DOI 10.1093/jac/dkab492
   Sánchez-Conde M, 2019, EPIGENOMICS-UK, V11, P501, DOI 10.2217/epi-2018-0130
   Sherman KE, 2017, HEPATOL COMMUN, V1, P987, DOI 10.1002/hep4.1112
   Shu C, 2020, EPIGENOMICS-UK, V12, P1917, DOI 10.2217/epi-2020-0123
   Soares LS, 2020, INT IMMUNOPHARMACOL, V84, DOI 10.1016/j.intimp.2020.106568
   Sodum N, 2021, PHARMACOL RES, V167, DOI 10.1016/j.phrs.2021.105484
   Stella-Ascariz N, 2018, J INFECT DIS, V218, P1523, DOI 10.1093/infdis/jiy399
   Sung KC, 2018, ATHEROSCLEROSIS, V275, P50, DOI 10.1016/j.atherosclerosis.2018.05.042
   Tafesh ZH, 2017, CURR OPIN INFECT DIS, V30, P12, DOI 10.1097/QCO.0000000000000344
   Titanji BK, 2022, FRONT GENET, V13, DOI 10.3389/fgene.2022.1020871
   Torgersen J, 2019, BMC GASTROENTEROL, V19, DOI 10.1186/s12876-019-0969-1
   Unnikrishnan A, 2019, PHARMACOL THERAPEUT, V195, P172, DOI 10.1016/j.pharmthera.2018.11.001
   Vaiserman A, 2021, FRONT GENET, V11, DOI 10.3389/fgene.2020.630186
   Wang LJ, 2014, J NUTR BIOCHEM, V25, P329, DOI 10.1016/j.jnutbio.2013.11.007
   Wing EJ, 2016, INT J INFECT DIS, V53, P61, DOI 10.1016/j.ijid.2016.10.004
   Xu L, 2021, AM J PHYSIOL-GASTR L, V320, pG1034, DOI 10.1152/ajpgi.00431.2020
   Xu S, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0821-0
   Yang JCZ, 2019, NUTRIENTS, V11, DOI 10.3390/nu11040872
   Zhang XY, 2016, EPIGENETICS-US, V11, P750, DOI 10.1080/15592294.2016.1221569
NR 73
TC 0
Z9 0
U1 2
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2164
J9 BMC GENOMICS
JI BMC Genomics
PD SEP 23
PY 2023
VL 24
IS 1
AR 567
DI 10.1186/s12864-023-09653-2
PG 11
WC Biotechnology & Applied Microbiology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA S4JN2
UT WOS:001070847700001
PM 37741970
OA Green Submitted, Green Published, gold
DA 2024-02-19
ER

PT J
AU Shrivastava, S
   Kottilil, S
   Sherman, KE
   Masur, H
   Tang, LY
AF Shrivastava, Shikha
   Kottilil, Shyam
   Sherman, Kenneth E.
   Masur, Henry
   Tang, Lydia
TI CCR5+T-Cells Homed to the Liver Exhibit Inflammatory and Profibrogenic
   Signatures in Chronic HIV/HCV-Coinfected Patients
SO VIRUSES-BASEL
LA English
DT Article
DE HIV; hepatitis C; fibrosis; hepatic fibrogenesis; CCR5; HIV/HCV
   coinfection
ID HUMAN-IMMUNODEFICIENCY-VIRUS; CHRONIC HEPATITIS-C; CHEMOKINE; FIBROSIS;
   RECEPTOR; CELLS; CCR5; HIV; EXPRESSION; INFECTION
AB Liver fibrosis is accelerated in patients coinfected with hepatitis C virus and human immunodeficiency virus (HIV), compared with HCV monoinfected patients, although the underlying mechanisms are unknown. We hypothesize that T cells expressing the HIV co-receptor, chemokine receptor 5 (CCR5), preferentially migrate to the inflamed liver and contribute to enhanced fibrogenesis. We compared the peripheral and intrahepatic CCR5 expression on CD4+ and CD8+ T cells in 21 HIV/HCV-coinfected patients with 14 chronic HCV monoinfected patients. Using 12-color flow cytometry, phenotypic and functional characterization of CCR5+ and negative cells pre- and post-stimulation with HCV genotype specific overlapping pooled peptides was conducted. Patients with HIV/HCV coinfection had significantly more CD4+CCR5+ and CD8+CCR5+ T cells in the liver as compared with peripheral blood (p = 0.0001 for both). Compared with patients with HCV monoinfection, patients with HIV/HCV coinfection also had fewer peripheral CD4+CCR5+ and CD8+CCR5+ T cells (p = 0.02, p = 0.001 respectively), but more intrahepatic CD4+CCR5+ and CD8+CCR5+ cells (p = 0.0001 for both). Phenotypic analysis of CCR5+ sorted cells demonstrated an increased expression of markers of exhaustion, senescence, immune activation and liver homing (PD1, CD57, CD38, HLADR, and CXCR3). Post-stimulation with HCV peptides, CCR5+ T cells secreted more proinflammatory and profibrogenic cytokines and chemokines rather than antiviral cytokines. Phenotypic and functional analyses of CCR5+ T cells in HIV/HCV-coinfected patients revealed a pathogenic role for CCR5+ T cells in hepatic fibrogenesis. These cells are functionally proinflammatory, pro-fibrogenic and preferentially accumulate in liver, accelerating fibrosis. These findings suggest that targeting CCR5 may be a therapeutic strategy for be ameliorating liver fibrosis.
C1 [Shrivastava, Shikha] Walter Reed Army Inst Res, Lab Adjuvant & Antigen Res, US Mil HIV Res Program, Silver Spring, MD 20910 USA.
   [Kottilil, Shyam; Tang, Lydia] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA.
   [Kottilil, Shyam; Tang, Lydia] Univ Maryland, Marlene & Stewart Greenebaum Comprehens Canc Ctr, Program Oncol, Baltimore, MD 21201 USA.
   [Sherman, Kenneth E.] Univ Cincinnati, Div Digest Dis, Cincinnati, OH 45267 USA.
   [Masur, Henry] NIH, Bldg 10, Bethesda, MD 20892 USA.
C3 Walter Reed Army Institute of Research (WRAIR); United States Department
   of Defense; United States Army; University System of Maryland;
   University of Maryland Baltimore; University System of Maryland;
   University of Maryland Baltimore; University System of Ohio; University
   of Cincinnati; National Institutes of Health (NIH) - USA
RP Tang, LY (corresponding author), Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA.; Tang, LY (corresponding author), Univ Maryland, Marlene & Stewart Greenebaum Comprehens Canc Ctr, Program Oncol, Baltimore, MD 21201 USA.
EM sshrivastava@hivresearch.org; SKottilil@ihv.umaryland.edu;
   shermake@ucmail.uc.edu; hmasur@nih.gov; LydiaTang@IHV.Umaryland.edu
RI Kottilil, Shyam/ABF-7605-2021
OI Tang, Lydia/0000-0001-8682-9220; KOTTILIL, SHYAM/0000-0001-7471-0812
CR Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955
   Apolinario A, 2002, AM J GASTROENTEROL, V97, P2861, DOI 10.1111/j.1572-0241.2002.07054.x
   Backus LI, 2005, AIDS, V19, pS13, DOI 10.1097/01.aids.0000192065.09281.01
   Barrett L, 2015, J VIRAL HEPATITIS, V22, P281, DOI 10.1111/jvh.12291
   Berres ML, 2010, J CLIN INVEST, V120, P4129, DOI 10.1172/JCI41732
   Brenchley JM, 2003, BLOOD, V101, P2711, DOI 10.1182/blood-2002-07-2103
   Butera D, 2005, BLOOD, V106, P1175, DOI 10.1182/blood-2005-01-0126
   Chen JY, 2014, NAT REV GASTRO HEPAT, V11, DOI 10.1038/nrgastro.2014.17
   Chen TY, 2009, CLIN INFECT DIS, V49, P1605, DOI 10.1086/644771
   Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005
   Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0
   Fätkenheuer G, 2005, NAT MED, V11, P1170, DOI 10.1038/nm1319
   Friedman SL, 2018, HEPATOLOGY, V67, P1754, DOI 10.1002/hep.29477
   Glässner A, 2013, J HEPATOL, V59, P427, DOI 10.1016/j.jhep.2013.04.029
   Graham CS, 2001, CLIN INFECT DIS, V33, P562, DOI 10.1086/321909
   Helbig KJ, 2009, J VIROL, V83, P836, DOI 10.1128/JVI.01388-08
   Hernando V, 2012, J HEPATOL, V57, P743, DOI 10.1016/j.jhep.2012.06.010
   Kern F, 1999, EUR J IMMUNOL, V29, P2908, DOI 10.1002/(SICI)1521-4141(199909)29:09<2908::AID-IMMU2908>3.0.CO;2-8
   Kruger AJ, 2018, HEPATOL COMMUN, V2, P529, DOI 10.1002/hep4.1160
   Larrubia JR, 2007, J HEPATOL, V47, P632, DOI 10.1016/j.jhep.2007.04.009
   Lieberman J, 1999, AIDS, V13, P891, DOI 10.1097/00002030-199905280-00004
   Lin WY, 2013, J INFECT DIS, V207, pS13, DOI 10.1093/infdis/jis926
   Lo Re V, 2014, ANN INTERN MED, V160, P369, DOI 10.7326/M13-1829
   Mastroianni CM, 2014, INT J MOL SCI, V15, P9184, DOI 10.3390/ijms15069184
   Papagno L, 2004, PLOS BIOL, V2, P173, DOI 10.1371/journal.pbio.0020020
   Ratziu V, 2020, HEPATOLOGY, V72, P892, DOI 10.1002/hep.31108
   Reynes J, 2000, J INFECT DIS, V181, P927, DOI 10.1086/315315
   Schwabe RF, 2003, AM J PHYSIOL-GASTR L, V285, pG949, DOI 10.1152/ajpgi.00215.2003
   Seki E, 2009, J CLIN INVEST, V119, P1858, DOI 10.1172/JCI37444
   Sherman KE, 2002, CLIN INFECT DIS, V34, P831, DOI 10.1086/339042
   Sherman KE, 2019, CLIN INFECT DIS, V68, P1911, DOI 10.1093/cid/ciy807
   Shields PL, 1999, J IMMUNOL, V163, P6236
   Shrivastava S, 2017, J VIRAL HEPATITIS, V24, P742, DOI 10.1111/jvh.12702
   Wald O, 2007, CYTOKINE, V39, P50, DOI 10.1016/j.cyto.2007.05.013
   Weng SY, 2018, EBIOMEDICINE, V29, P92, DOI 10.1016/j.ebiom.2018.01.028
   Zeremski M, 2011, J HEPATOL, V55, P545, DOI 10.1016/j.jhep.2010.12.033
NR 36
TC 0
Z9 0
U1 0
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD OCT
PY 2021
VL 13
IS 10
AR 2074
DI 10.3390/v13102074
PG 12
WC Virology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Virology
GA WQ9NF
UT WOS:000714135700001
PM 34696504
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Mori, K
   Blackshear, PE
   Lobenhofer, EK
   Parker, JS
   Orzech, DP
   Roycroft, JH
   Walker, KL
   Johnson, KA
   Marsh, TA
   Irwin, RD
   Boorman, GA
AF Mori, Kazuhiko
   Blackshear, Pamela E.
   Lobenhofer, Edward K.
   Parker, Joel S.
   Orzech, Denise P.
   Roycroft, Joseph H.
   Walker, Kimwa L.
   Johnson, Kennita A.
   Marsh, Tiwanda A.
   Irwin, Richard D.
   Boorman, Gary A.
TI Hepatic transcript levels for genes coding for enzymes associated with
   xenobiotic metabolism are altered with age
SO TOXICOLOGIC PATHOLOGY
LA English
DT Article
DE liver; rat; transcriptome; aging; cytochrome P450; xenobiotic metabolism
ID WISTAR RATS; CYTOCHROME-P450 ISOFORMS; DRUG-METABOLISM; SENESCENT MALE;
   FEMALE RATS; EXPRESSION; LIVER; SEX; INDUCTION; TOXICITY
AB Metabolism studies are crucial for data interpretation from rodent toxicity and carcinogenicity studies. Metabolism studies are usually conducted in 6 to 8 week old rodents. Long-term studies often continue beyond 100 weeks of age. The potential for age-related changes in transcript levels of genes encoding for enzymes associated with metabolism was evaluated in the liver of male F344/N rats at 32, 58, and 84 weeks of age. Differential expression was found between the young and old rats for genes whose products are involved in both phase I and phase II metabolic pathways. Thirteen cytochrome P450 genes from CYP families 1-3 showed alterations in expression in the older rats. A marked age-related decrease in expression was found for 4 members of the Cyp3a family that are critical for drug metabolism in the rat. Immunohistochemical results confirmed a significant decrease in Cyp3a2 and Cyp2c11 protein levels with age. This indicates that the metabolic capacity of male rats changes throughout a long-term study. Conducting multiple hepatic microarray analyses during the conduct of a long-term study can provide a global view of potential metabolic changes that might occur. Alterations that are considered crucial to the interpretation of long-term study results could then be confirmed by subsequent metabolic studies.
C1 Natl Inst Environm Hlth Sci, Environm Toxicol Program, Res Triangle Pk, NC 27709 USA.
   Integrated Lab Syst Inc, Res Triangle Pk, NC 27709 USA.
   Cogenics, Morrisville, NC 27564 USA.
   Constella Grp Inc, Res Triangle Pk, NC 27709 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute of
   Environmental Health Sciences (NIEHS)
RP Boorman, GA (corresponding author), Natl Inst Environm Hlth Sci, Environm Toxicol Program, POB 12233,111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.
EM boorman@niehs.nih.gov
RI Parker, Joel/AAG-1108-2019
OI Johnson, Kennita/0000-0002-2304-3367
CR Agrawal AK, 2003, DRUG METAB DISPOS, V31, P612, DOI 10.1124/dmd.31.5.612
   Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101
   Arlt VM, 2005, CANCER RES, V65, P2644, DOI 10.1158/0008-5472.CAN-04-3544
   Bai JX, 2006, TOXICOL SCI, V91, P365, DOI 10.1093/toxsci/kfj165
   Bebia Z, 2004, CLIN PHARMACOL THER, V76, P618, DOI 10.1016/j.clpt.2004.08.021
   BIRNBAUM LS, 1991, ANNU REV PHARMACOL, V31, P101
   Boorman GA, 2005, TOXICOL PATHOL, V33, P102, DOI 10.1080/01926230590522211
   Caron E, 2005, J BIOCHEM MOL TOXIC, V19, P368, DOI 10.1002/jbt.20103
   Cashman JR, 2005, BIOCHEM BIOPH RES CO, V338, P599, DOI 10.1016/j.bbrc.2005.08.009
   CHANG TKH, 1996, CYTOCHROMES P450 MET, V1, P99
   CHEN LH, 1994, ARCH GERONTOL GERIAT, V18, P191, DOI 10.1016/0167-4943(94)90013-2
   Cheung C, 2003, TOXICOLOGY, V184, P97, DOI 10.1016/S0300-483X(02)00552-8
   Cusack Barry J, 2004, Am J Geriatr Pharmacother, V2, P274, DOI 10.1016/j.amjopharm.2004.12.005
   Dhir RN, 2003, P NATL ACAD SCI USA, V100, P15224, DOI 10.1073/pnas.2434273100
   Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863
   FUJITA S, 1990, J PHARMACOL EXP THER, V253, P369
   GALINSKY RE, 1986, J PHARMACOL EXP THER, V237, P107
   Gnerre C, 2004, PHARMACOGENETICS, V14, P635, DOI 10.1097/00008571-200410000-00001
   Handler JA, 1997, BIOCHEM PHARMACOL, V54, P159, DOI 10.1016/S0006-2952(97)00159-7
   HE L, 2006, IN PRESS J BIOL CHEM
   Hoffman SMG, 2001, PHARMACOGENETICS, V11, P687, DOI 10.1097/00008571-200111000-00007
   Huang HZ, 2005, CHEM RES TOXICOL, V18, P1371, DOI 10.1021/tx050072+
   ILAR, 1996, GUID CAR US LAB AN
   IMAOKA S, 1991, BIOCHIM BIOPHYS ACTA, V1097, P187, DOI 10.1016/0925-4439(91)90034-7
   Karanth S, 2000, TOXICOL SCI, V58, P282, DOI 10.1093/toxsci/58.2.282
   Kawai M, 2000, BIOCHEM PHARMACOL, V59, P1277, DOI 10.1016/S0006-2952(00)00247-1
   KAWAJIRI K, 1996, CYTOCHROMES P450 MET, V1, P77
   Klaassen CD, 1998, CHEM-BIOL INTERACT, V109, P299, DOI 10.1016/S0009-2797(97)00141-5
   Klaassen CD., 2001, CASARETT DOULLS TOXI, P133, DOI DOI 10.1036/0071470514
   Landowski CP, 2006, J PHARMACOL EXP THER, V316, P572, DOI 10.1124/jpet.105.092726
   LARSEN MC, 1994, ARCH BIOCHEM BIOPHYS, V315, P24, DOI 10.1006/abbi.1994.1466
   Lee SJ, 1998, IEEE COMMUN LETT, V2, P153, DOI 10.1109/4234.681356
   Lewis DFV., 2001, GUIDE CYTOCHROMES P4
   Lockley DJ, 2005, ARCH TOXICOL, V79, P160, DOI 10.1007/s00204-004-0619-3
   Mikhailova ON, 2005, TOXICOLOGY, V210, P189, DOI 10.1016/j.tox.2005.01.018
   MILLER JA, 1994, CHEM-BIOL INTERACT, V92, P329, DOI 10.1016/0009-2797(94)90074-4
   Nebert D W, 1994, Prog Liver Dis, V12, P63
   Nielsen TO, 2002, LANCET, V359, P1301, DOI 10.1016/S0140-6736(02)08270-3
   Ohhira S, 2006, TOXICOL APPL PHARM, V210, P32, DOI 10.1016/j.taap.2005.06.013
   OKAMOTO M, 1994, PHARMACOL TOXICOL, V75, P1, DOI 10.1111/j.1600-0773.1994.tb00316.x
   OMAHONY MS, 1994, PHARMACOL THERAPEUT, V61, P279, DOI 10.1016/0163-7258(94)90066-3
   Peng FC, 2005, J TOXICOL ENV HEAL A, V68, P1871, DOI 10.1080/15287390500226763
   Sanz N, 2002, BBA-MOL BASIS DIS, V1587, P12, DOI 10.1016/S0925-4439(02)00048-0
   SATOH T, 2005, TOXICOL APPL PHARM, V207, pS11
   SATTERWHITE JH, 1992, BIOPHARM DRUG DISPOS, V13, P197, DOI 10.1002/bdd.2510130306
   TEPHLY TR, 1990, CHEM RES TOXICOL, V3, P509, DOI 10.1021/tx00018a004
   Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498
   VANBEZOOIJEN CFA, 1984, MECH AGEING DEV, V25, P1, DOI 10.1016/0047-6374(84)90126-X
   Warrington JS, 2004, J PHARM PHARMACOL, V56, P819, DOI 10.1211/0022357023529
   Warrington JS, 2004, J PHARMACOL EXP THER, V309, P720, DOI 10.1124/jpet.103.061077
   Wauthier V, 2004, TOXICOL IN VITRO, V18, P879, DOI 10.1016/j.tiv.2004.04.013
   Wauthier V, 2004, ARCH TOXICOL, V78, P131, DOI 10.1007/s00204-003-0526-z
   Zollner G, 2006, AM J PHYSIOL-GASTR L, V290, pG923, DOI 10.1152/ajpgi.00490.2005
NR 53
TC 41
Z9 48
U1 0
U2 5
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0192-6233
EI 1533-1601
J9 TOXICOL PATHOL
JI Toxicol. Pathol.
PY 2007
VL 35
IS 2
BP 242
EP 251
DI 10.1080/01926230601156286
PG 10
WC Pathology; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology; Toxicology
GA 148ZZ
UT WOS:000245117200005
PM 17366318
DA 2024-02-19
ER

PT J
AU Yoshioka, N
   Tanaka, M
   Ochi, K
   Watanabe, A
   Ono, K
   Sawada, M
   Ogi, T
   Itoh, M
   Ito, A
   Shiraki, Y
   Enomoto, A
   Ishigami, M
   Fujishiro, M
   Ogawa, Y
   Suganami, T
AF Yoshioka, Naoki
   Tanaka, Miyako
   Ochi, Kozue
   Watanabe, Akiko
   Ono, Kenji
   Sawada, Makoto
   Ogi, Tomoo
   Itoh, Michiko
   Ito, Ayaka
   Shiraki, Yukihiro
   Enomoto, Atsushi
   Ishigami, Masatoshi
   Fujishiro, Mitsuhiro
   Ogawa, Yoshihiro
   Suganami, Takayoshi
TI The sodium-glucose cotransporter-2 inhibitor Tofogliflozin prevents the
   progression of nonalcoholic steatohepatitis-associated liver tumors in a
   novel murine model
SO BIOMEDICINE & PHARMACOTHERAPY
LA English
DT Article; Early Access
DE Diabetes; Nonalcoholic steatohepatitis; Hepatocellular carcinoma; Animal
   model; Sodium glucose cotransporter 2 inhibitor; Cellular senescence
ID INSULIN-RESISTANCE; WEIGHT-LOSS; CANCER; SENESCENCE; OBESITY;
   TUMORIGENESIS; MECHANISMS; DISEASE; RISK; NASH
AB Background: Diabetes and obesity contribute to the pathogenesis of nonalcoholic steatohepatitis (NASH) and hepatocellular carcinoma (HCC). However, how diabetes and obesity accelerate liver tumorigenesis remains to be fully understood. Moreover, to verify the therapeutic potential of anti-diabetic drugs, there exists a strong need for appropriate animal models that recapitulate human pathophysiology of NASH and HCC. Methods: We established a novel murine model of NASH-associated liver tumors using genetically obese melanocortin 4 receptor-deficient mice fed on Western diet in combination with a chemical procarcinogen, and verified the validity of our model in evaluating drug efficacy. Findings: Our model developed multiple liver tumors together with obesity, diabetes, and NASH within a relatively short period (approximately 3 months). In this model, sodium glucose cotransporter 2 inhibitor Tofogliflozin prevented the development of NASH-like liver phenotypes and the progression of liver tumors. Tofogliflozin attenuated p21 expression of hepatocytes in non-tumorous lesions in the liver. Interpretation: Tofogliflozin treatment attenuates cellular senescence of hepatocytes under obese and diabetic conditions. This study provides a unique animal model of NASH-associated liver tumors, which is applicable for assessing drug efficacy to prevent or treat NASH-associated HCC.
C1 [Yoshioka, Naoki; Tanaka, Miyako; Ochi, Kozue; Watanabe, Akiko; Itoh, Michiko; Ito, Ayaka; Ogawa, Yoshihiro; Suganami, Takayoshi] Nagoya Univ, Res Inst Environm Med, Dept Mol Med & Metab, Nagoya, Aichi, Japan.
   [Ono, Kenji; Sawada, Makoto] Nagoya Univ, Res Inst Environm Med, Dept Brain Funct, Nagoya, Aichi, Japan.
   [Ogi, Tomoo] Nagoya Univ, Res Inst Environm Med, Dept Genet, Nagoya, Aichi, Japan.
   [Yoshioka, Naoki; Ishigami, Masatoshi; Fujishiro, Mitsuhiro] Nagoya Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Nagoya, Aichi, Japan.
   [Tanaka, Miyako; Ito, Ayaka; Suganami, Takayoshi] Nagoya Univ, Grad Sch Med, Dept Immunometab, Nagoya, Aichi, Japan.
   [Ono, Kenji; Sawada, Makoto] Nagoya Univ, Grad Sch Med, Dept Mol Pharmacokinet, Nagoya, Aichi, Japan.
   [Ogi, Tomoo] Nagoya Univ, Grad Sch Med, Dept Human Genet & Mol Biol, Nagoya, Aichi, Japan.
   [Shiraki, Yukihiro; Enomoto, Atsushi] Nagoya Univ, Grad Sch Med, Dept Pathol, Nagoya, Aichi, Japan.
   [Itoh, Michiko] Kanagawa Inst Ind Sci & Technol, Ebina, Kanagawa, Japan.
   [Ogawa, Yoshihiro] Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Fukuoka, Japan.
C3 Nagoya University; Nagoya University; Nagoya University; Nagoya
   University; Nagoya University; Nagoya University; Nagoya University;
   Nagoya University; Kyushu University
RP Tanaka, M; Suganami, T (corresponding author), Nagoya Univ, Res Inst Environm Med, Dept Mol Med & Metab, Nagoya, Aichi, Japan.
EM tanaka@riem.nagoya-u.ac.jp; suganami@riem.nagoya-u.ac.jp
RI Ono, Kenji/I-6163-2014; Shiraki, Yukihiro/AIA-7918-2022; Enomoto,
   Atsushi/I-7272-2014
OI Ono, Kenji/0000-0002-5402-6535; Shiraki, Yukihiro/0000-0003-3666-0556;
   Enomoto, Atsushi/0000-0002-9206-6116; Fujishiro,
   Mitsuhiro/0000-0002-4074-1140; Ogawa, Yoshihiro/0000-0002-0834-2836;
   Suganami, Takayoshi/0000-0002-1918-0465; Ogi, Tomoo/0000-0002-5492-9072
FU Ministry of Education, Culture, Sports, Science and Technology of Japan
   [20H03447, 20H05503, 20H04944, 18K08508]; Japan Agency for Medical
   Research and Development (CREST) [JP20gm1210009s0102,
   JP20fk0210082s0101, JP21fk0210094]; Hori Sciences and Arts Foundation,
   Japan; DAIKO Foundation, Japan; Kobayashi Foundation, Japan; Takeda
   Science Foundation, Japan; Grants-in-Aid for Scientific Research
   [18K08508, 20H04944, 20H05503, 20H03447] Funding Source: KAKEN
FX This work was supported in part by Grants-in-Aid for Scientific Research
   from the Ministry of Education, Culture, Sports, Science and Technology
   of Japan (20H03447, 20H05503, and 20H04944 to T.S. and 18K08508 to M.T.)
   and Japan Agency for Medical Research and Development (CREST)
   (JP20gm1210009s0102 to T.S.) and Research Program on Hepatitis
   (JP20fk0210082s0101 to T.S. and JP21fk0210094 to M.T.). This study was
   also supported by research grants from The Hori Sciences and Arts
   Foundation, Japan, DAIKO Foundation, Japan, Kobayashi Foundation, Japan,
   and Takeda Science Foundation, Japan (T.S.).
CR Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784
   Albarado DC, 2004, ENDOCRINOLOGY, V145, P243, DOI 10.1210/en.2003-0452
   Anstee QM, 2019, NAT REV GASTRO HEPAT, V16, P411, DOI 10.1038/s41575-019-0145-7
   Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031
   Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035
   Chiyonobu N, 2018, AM J PATHOL, V188, P1213, DOI 10.1016/j.ajpath.2018.01.012
   Connor F, 2018, J HEPATOL, V69, P840, DOI 10.1016/j.jhep.2018.06.009
   Cowie MR, 2020, NAT REV CARDIOL, V17, P761, DOI 10.1038/s41569-020-0406-8
   Dow M, 2018, P NATL ACAD SCI USA, V115, pE9879, DOI 10.1073/pnas.1811029115
   El-Serag HB, 2006, CLIN GASTROENTEROL H, V4, P369, DOI 10.1016/j.cgh.2005.12.007
   Ferrannini E, 2016, DIABETES, V65, P1190, DOI 10.2337/db15-1356
   Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0
   Itoh M, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92902
   Itoh M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082163
   Itoh M, 2011, AM J PATHOL, V179, P2454, DOI 10.1016/j.ajpath.2011.07.014
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Karagozian R, 2014, METABOLISM, V63, P607, DOI 10.1016/j.metabol.2014.01.011
   Kawakubo M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-57935-6
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698
   Larsson SC, 2007, BRIT J CANCER, V97, P1005, DOI 10.1038/sj.bjc.6603932
   Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844
   Michelotti GA, 2013, NAT REV GASTRO HEPAT, V10, P656, DOI 10.1038/nrgastro.2013.183
   Obara K, 2017, ONCOTARGET, V8, P58353, DOI 10.18632/oncotarget.16874
   Obata A, 2016, ENDOCRINOLOGY, V157, P1029, DOI 10.1210/en.2015-1588
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Papatheodoridi AM, 2020, HEPATOLOGY, V71, P363, DOI 10.1002/hep.30834
   Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052
   Parrinello S, 2005, J CELL SCI, V118, P485, DOI 10.1242/jcs.01635
   Promrat K, 2010, HEPATOLOGY, V51, P121, DOI 10.1002/hep.23276
   Ranjbar G, 2019, METABOLISM, V101, DOI 10.1016/j.metabol.2019.154001
   Shiba K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19658-7
   Tilg H, 2017, NAT REV GASTRO HEPAT, V14, P32, DOI 10.1038/nrgastro.2016.147
   Utzschneider KM, 2010, OBESITY, V18, P1781, DOI 10.1038/oby.2010.77
   Vaisse C, 2000, J CLIN INVEST, V106, P253, DOI 10.1172/JCI9238
   Verna L, 1996, PHARMACOL THERAPEUT, V71, P57, DOI 10.1016/0163-7258(96)00062-9
   Vilar-Gomez E, 2015, GASTROENTEROLOGY, V149, P367, DOI 10.1053/j.gastro.2015.04.005
   Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529
   Yip TCF, 2018, CLIN GASTROENTEROL H, V16, P765, DOI 10.1016/j.cgh.2017.12.009
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
   Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431
   Yu LX, 2017, NAT REV GASTRO HEPAT, V14, P527, DOI 10.1038/nrgastro.2017.72
   Zhang XY, 2012, AM J PHYSIOL-GASTR L, V302, pG558, DOI 10.1152/ajpgi.00032.2011
NR 43
TC 9
Z9 9
U1 0
U2 4
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 0753-3322
EI 1950-6007
J9 BIOMED PHARMACOTHER
JI Biomed. Pharmacother.
PD 2021 AUG
PY 2021
VL 140
AR 111738
DI 10.1016/j.biopha.2021.111738
EA MAY 2021
PG 12
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA TE6FJ
UT WOS:000670106300004
PM 34029949
OA gold
DA 2024-02-19
ER

PT J
AU Vanhooren, V
   Dewaele, S
   Kuro-o, M
   Taniguchi, N
   Dollé, L
   van Grunsven, LA
   Makrantonaki, E
   Zouboulis, CC
   Chen, CYC
   Libert, C
AF Vanhooren, Valerie
   Dewaele, Sylviane
   Kuro-o, Makoto
   Taniguchi, Naoyuki
   Dolle, Laurent
   van Grunsven, Leo A.
   Makrantonaki, Evgenia
   Zouboulis, Christos C.
   Chen, Cuiying C.
   Libert, Claude
TI Alteration in N-glycomics during mouse aging: a role for FUT8
SO AGING CELL
LA English
DT Article
DE N-glycan; glycosylation; aging; Snell Dwarf; klotho mouse; caloric
   restriction
ID CALORIE RESTRICTION; CORE FUCOSYLATION; MUTANT MICE; SNELL DWARF;
   LIFE-SPAN; IN-VITRO; GROWTH; AGE; GLYCOSYLATION; RECEPTOR
AB We recently reported that N-glycosylation changes during human aging. To further investigate the molecular basis determining these alterations, the aging process in mice was studied. N-glycan profiling of mouse serum glycoproteins in different age groups of healthy C57BL/6 mice showed substantial age-related changes in three major N-glycan structures: under-galactosylated biantennary (NGA2F), biantennary (NA2), and core alpha-1,6-fucosylated-beta-galactosylated biantennary structures (NA2F). Mice defective in klotho gene expression (kl/kl), which have a shortened lifespan, displayed a similar but accelerated trend. Interestingly, the opposite trend was observed in slow-aging Snell Dwarf mice (dw/dw) and in mice fed a calorically restricted diet. We also discovered that increased expression and activity of alpha-1,6-fucosyltransferase (FUT8) in the liver are strongly linked to the age-related changes in glycosylation and that this increased FUT8 and fucosylation influence IGF-1 signaling. These data demonstrate that the glycosylation machinery in liver cells is significantly affected during aging and that age-related increased FUT8 activity could influence the aging process by altering the sensitivity of the IGF-1R signaling pathway.
C1 [Vanhooren, Valerie; Dewaele, Sylviane; Chen, Cuiying C.; Libert, Claude] VIB, Dept Mol Biomed Res, B-9000 Ghent, Belgium.
   [Vanhooren, Valerie; Dewaele, Sylviane; Chen, Cuiying C.; Libert, Claude] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium.
   [Kuro-o, Makoto] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA.
   [Taniguchi, Naoyuki] RIKEN, Adv Sci Inst, Syst Glycobiol Res Grp, Dept Biol Chem, Wako, Saitama, Japan.
   [Dolle, Laurent; van Grunsven, Leo A.] Vrije Univ Brussel, Dept Cell Biol, Liver Cell Biol Lab, B-1090 Brussels, Belgium.
   [Makrantonaki, Evgenia; Zouboulis, Christos C.] Dessau Med Ctr, Dept Dermatol, D-06847 Dessau, Germany.
   [Makrantonaki, Evgenia; Zouboulis, Christos C.] Dessau Med Ctr, Dept Venereol, D-06847 Dessau, Germany.
   [Makrantonaki, Evgenia; Zouboulis, Christos C.] Dessau Med Ctr, Dept Allergol, D-06847 Dessau, Germany.
   [Makrantonaki, Evgenia; Zouboulis, Christos C.] Dessau Med Ctr, Dept Immunol, D-06847 Dessau, Germany.
   [Makrantonaki, Evgenia] Charite, Lab Biogerontol Dermatopharmacol & Dermatoendocri, Inst Clin Pharmacol & Toxicol, D-12200 Berlin, Germany.
C3 Flanders Institute for Biotechnology (VIB); Ghent University; University
   of Texas System; University of Texas Southwestern Medical Center Dallas;
   RIKEN; Vrije Universiteit Brussel; Dessau Medical Center; Dessau Medical
   Center; Dessau Medical Center; Dessau Medical Center; Free University of
   Berlin; Humboldt University of Berlin; Charite Universitatsmedizin
   Berlin
RP Libert, C (corresponding author), Univ Ghent VIB, Dept Biochem Mol Biol, Technol Pk 927, B-9052 Ghent, Belgium.
EM chitty@dmbr.ugent.be; Claude@dmbr.vib-ugent.be
RI Taniguchi, Naoyuki/I-4182-2014; Dollé, Laurent/H-4612-2014;
   Makrantonaki, Evgenia/G-1769-2010; van Grunsven, Leo A./E-5839-2010;
   Taniguchi, Naoyuki/A-7086-2016; Prof. Dr. Zouboulis, Christos
   C./I-4493-2013
OI Taniguchi, Naoyuki/0000-0001-5889-5968; Makrantonaki,
   Evgenia/0000-0001-8522-2128; van Grunsven, Leo A./0000-0002-0990-7034;
   Prof. Dr. Zouboulis, Christos C./0000-0003-1646-2608
FU Ghent University (BOF) [01106205]; Flanders-China Bilateral project
   [011S605]; FWO; BELSPO [IUAP-VI/18]
FX We thank Dr Amin Bredan for editing the manuscript. This work was
   supported by a grant from Ghent University (BOF No. 01106205),
   Flanders-China Bilateral project (011S605), the FWO and BELSPO
   (IUAP-VI/18).
CR Andressoo JO, 2005, MUTAT RES-FUND MOL M, V577, P179, DOI 10.1016/j.mrfmmm.2005.04.004
   Bakkers J, 1997, P NATL ACAD SCI USA, V94, P7982, DOI 10.1073/pnas.94.15.7982
   BIELSCHOWSKY F, 1959, BRIT J CANCER, V13, P302, DOI 10.1038/bjc.1959.36
   Fagnani C, 2006, TWIN RES HUM GENET, V9, P799, DOI 10.1375/twin.9.6.799
   Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898
   Flurkey K, 2002, MECH AGEING DEV, V123, P121, DOI 10.1016/S0047-6374(01)00339-6
   Freeze HH, 2005, CURR OPIN STRUC BIOL, V15, P490, DOI 10.1016/j.sbi.2005.08.010
   Gonçalves LA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-169
   Ihara H, 2006, GLYCOBIOLOGY, V16, P333, DOI 10.1093/glycob/cwj068
   Ingram DK, 2006, AGING CELL, V5, P97, DOI 10.1111/j.1474-9726.2006.00202.x
   Kondo A, 2006, BBA-PROTEINS PROTEOM, V1764, P1881, DOI 10.1016/j.bbapap.2006.10.011
   Kukuruzinska MA, 1998, CRIT REV ORAL BIOL M, V9, P415, DOI 10.1177/10454411980090040301
   Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285
   Lautenschlager NT, 2006, CURR OPIN PSYCHIATR, V19, P190, DOI 10.1097/01.yco.0000214347.38787.37
   LI S, 1990, NATURE, V347, P528, DOI 10.1038/347528a0
   Liu XE, 2010, LIVER INT, V30, P1221, DOI 10.1111/j.1478-3231.2010.02279.x
   Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028
   Makrantonaki E, 2008, EXP GERONTOL, V43, P939, DOI 10.1016/j.exger.2008.07.005
   Mariani E, 2005, J CHROMATOGR B, V827, P65, DOI 10.1016/j.jchromb.2005.04.023
   Matsumura K, 2007, J BIOL CHEM, V282, P15700, DOI 10.1074/jbc.M701195200
   MATSUSHIMA M, 1986, INT J ANDROL, V9, P132, DOI 10.1111/j.1365-2605.1986.tb00876.x
   Miyoshi E, 1997, INT J CANCER, V72, P1117
   Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019
   PAREKH R, 1988, J EXP MED, V167, P1731, DOI 10.1084/jem.167.5.1731
   Raman R, 2005, NAT METHODS, V2, P817, DOI 10.1038/NMETH807
   Razzaque MS, 2006, TRENDS MOL MED, V12, P298, DOI 10.1016/j.molmed.2006.05.002
   RENNELS EG, 1965, TEX REP BIOL MED, V23, P776
   Riedemann J, 2007, BIOCHEM BIOPH RES CO, V355, P707, DOI 10.1016/j.bbrc.2007.02.012
   Russell SJ, 2007, NAT REV MOL CELL BIO, V8, P681, DOI 10.1038/nrm2234
   Schnaar R.L., 2009, Essentials of Glycobiology, Glycosphingolipids
   Skytthe A, 2006, TWIN RES HUM GENET, V9, P763
   Smith DL, 2010, EUR J CLIN INVEST, V40, P440, DOI 10.1111/j.1365-2362.2010.02276.x
   Toogood AA, 1996, J CLIN ENDOCR METAB, V81, P460, DOI 10.1210/jc.81.2.460
   Vanhooren V, 2008, BIOGERONTOLOGY, V9, P351, DOI 10.1007/s10522-008-9140-z
   Vanhooren V, 2007, REJUV RES, V10, P521, DOI 10.1089/rej.2007.0556
   Vanhooren V, 2010, EXP GERONTOL, V45, P738, DOI 10.1016/j.exger.2010.08.009
   Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102
   Wang XC, 2006, J BIOL CHEM, V281, P2572, DOI 10.1074/jbc.M510893200
   Wang XC, 2006, METHOD ENZYMOL, V417, P11, DOI 10.1016/S0076-6879(06)17002-0
   Wang XC, 2009, J BIOCHEM, V145, P643, DOI 10.1093/jb/mvp022
   WEINDRUCH R, 1988, J GERONTOL, V43, pB40, DOI 10.1093/geronj/43.2.B40
   Zhao YY, 2006, J BIOL CHEM, V281, P38343, DOI 10.1074/jbc.M608764200
NR 42
TC 23
Z9 26
U1 1
U2 9
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD DEC
PY 2011
VL 10
IS 6
BP 1056
EP 1066
DI 10.1111/j.1474-9726.2011.00749.x
PG 11
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 847WS
UT WOS:000297003800015
PM 21951615
DA 2024-02-19
ER

PT J
AU Xiao, K
   Song, LL
   Li, YS
   Li, CJ
   Zhang, SC
AF Xiao, Kun
   Song, Lili
   Li, Yishuai
   Li, Congjun
   Zhang, Shicui
TI Dietary intake of microplastics impairs digestive performance, induces
   hepatic dysfunction, and shortens lifespan in the annual fish
   <i>Nothobranchius guentheri</i>
SO BIOGERONTOLOGY
LA English
DT Article; Early Access
DE MPs; Aging acceleration; Oxidative stress induction; Digestive system
   disturbance; Hepatic dysfunction
ID ANNUAL CYPRINODONT FISH; AGE-RELATED MARKERS; OXIDATIVE STRESS;
   VERTEBRATE MODEL; AGING CHANGES; FRESH-WATER; INGESTION; GROWTH; ONSET;
   ACCUMULATION
AB Microplastics (MPs) are ubiquitous in aquatic and terrestrial ecosystem, increasingly becoming a serious concern of human health. Many studies have explored the biological effects of MPs on animal and plant life in recent years. However, information regarding the effects of MPs on aging and lifespan is completely lacking in vertebrate species to date. Here we first confirm the bioavailability of MPs by oral delivery in the annual fish N. guentheri. We then show for the first time that administration of MPs not only shortens the lifespan but also accelerates the development of age-related biomarkers in N. guentheri. We also demonstrate that administration of MPs induces oxidative stress, suppresses antioxidant enzymes, reduces digestive enzymes, and causes hepatic dysfunction. Therefore, we propose that administration of MPs reduces lifespan of N. guentheri via induction of both suppressed antioxidant system and digestive disturbance as well as hepatic damage. Our results also suggest that smaller MPs appear more toxic to digestion, metabolism and growth of animals.
C1 [Xiao, Kun; Song, Lili; Li, Yishuai; Li, Congjun; Zhang, Shicui] Ocean Univ China, Inst Evolut & Marine Biodivers, 5 Yushan Rd, Qingdao 266003, Peoples R China.
   [Xiao, Kun; Song, Lili; Li, Yishuai; Li, Congjun; Zhang, Shicui] Ocean Univ China, Dept Marine Biol, 5 Yushan Rd, Qingdao 266003, Peoples R China.
   [Zhang, Shicui] Pilot Natl Lab Marine Sci & Technol Qingdao, Lab Marine Biol & Biotechnol, Qingdao 266003, Peoples R China.
C3 Ocean University of China; Ocean University of China; Laoshan Laboratory
RP Zhang, SC (corresponding author), Ocean Univ China, Inst Evolut & Marine Biodivers, 5 Yushan Rd, Qingdao 266003, Peoples R China.; Zhang, SC (corresponding author), Ocean Univ China, Dept Marine Biol, 5 Yushan Rd, Qingdao 266003, Peoples R China.
EM sczhang@ouc.edu.cn
FU Ministry of Science and Technology (MOST) of China; Natural Science
   Foundation of China [2018YFD0900505];  [32073000]
FX This work was supported by the Ministry of Science and Technology (MOST)
   of China (2018YFD0900505) and the Natural Science Foundation of China
   (32073000).
CR Alimba CG, 2019, ENVIRON TOXICOL PHAR, V68, P61, DOI 10.1016/j.etap.2019.03.001
   AMES BN, 1992, ANN NY ACAD SCI, V663, P85, DOI 10.1111/j.1749-6632.1992.tb38652.x
   Andrady AL, 2011, MAR POLLUT BULL, V62, P1596, DOI 10.1016/j.marpolbul.2011.05.030
   Au SY, 2015, ENVIRON TOXICOL CHEM, V34, P2564, DOI 10.1002/etc.3093
   Avio CG, 2015, ENVIRON POLLUT, V198, P211, DOI 10.1016/j.envpol.2014.12.021
   BALMER RT, 1982, EXP GERONTOL, V17, P139, DOI 10.1016/0531-5565(82)90048-1
   Banaee M., 2014, Int. J. Aquat. Biol., V2, P58, DOI [10.22034/ijab.v2i2.32, DOI 10.22034/IJAB.V2I2.32]
   Barnes DKA, 2009, PHILOS T R SOC B, V364, P1985, DOI 10.1098/rstb.2008.0205
   Brennecke D, 2015, MAR POLLUT BULL, V96, P491, DOI 10.1016/j.marpolbul.2015.05.001
   Browne MA, 2008, ENVIRON SCI TECHNOL, V42, P5026, DOI 10.1021/es800249a
   Browne MA, 2011, ENVIRON SCI TECHNOL, V45, P9175, DOI 10.1021/es201811s
   Checa J, 2020, J INFLAMM RES, V13, P1057, DOI 10.2147/JIR.S275595
   Chen W, 2022, MECH AGEING DEV, V207, DOI 10.1016/j.mad.2022.111723
   Cole M, 2011, MAR POLLUT BULL, V62, P2588, DOI 10.1016/j.marpolbul.2011.09.025
   COOPER EL, 1983, EXP GERONTOL, V18, P29, DOI 10.1016/0531-5565(83)90048-7
   da Costa JP, 2016, SCI TOTAL ENVIRON, V566, P15, DOI 10.1016/j.scitotenv.2016.05.041
   Dantas DV, 2012, ENVIRON SCI POLLUT R, V19, P600, DOI 10.1007/s11356-011-0579-0
   Ding JN, 2018, ENVIRON POLLUT, V238, P1, DOI 10.1016/j.envpol.2018.03.001
   Dong Y, 2017, FISH PHYSIOL BIOCHEM, V43, P309, DOI 10.1007/s10695-016-0288-1
   Eerkes-Medrano D, 2015, WATER RES, V75, P63, DOI 10.1016/j.watres.2015.02.012
   Foley CJ, 2018, SCI TOTAL ENVIRON, V631-632, P550, DOI 10.1016/j.scitotenv.2018.03.046
   Frydkjær CK, 2017, B ENVIRON CONTAM TOX, V99, P655, DOI 10.1007/s00128-017-2186-3
   Giordano M, 2013, CURR OPIN HEMATOL, V20, P327, DOI 10.1097/MOH.0b013e328362370f
   Guo TT, 2020, COMP BIOCHEM PHYS C, V230, DOI 10.1016/j.cbpc.2020.108709
   Hamed M, 2020, ENVIRON SCI POLLUT R, V27, P14581, DOI 10.1007/s11356-020-07898-y
   Horton AA, 2017, SCI TOTAL ENVIRON, V586, P127, DOI 10.1016/j.scitotenv.2017.01.190
   Hsu CY, 2009, AGING CELL, V8, P726, DOI 10.1111/j.1474-9726.2009.00525.x
   Hsu CY, 2008, J GERONTOL A-BIOL, V63, P1267, DOI 10.1093/gerona/63.12.1267
   Huang JN, 2020, SCI TOTAL ENVIRON, V733, DOI 10.1016/j.scitotenv.2020.138929
   Iheanacho SC, 2020, ENVIRON SCI POLLUT R, V27, P21159, DOI 10.1007/s11356-020-08611-9
   Imhof HK, 2013, CURR BIOL, V23, pR867, DOI 10.1016/j.cub.2013.09.001
   Izvekova GI, 2021, J FISH DIS, V44, P1951, DOI 10.1111/jfd.13508
   Jabeen K, 2017, ENVIRON POLLUT, V221, P141, DOI 10.1016/j.envpol.2016.11.055
   Jovanovic B, 2018, MAR POLLUT BULL, V130, P123, DOI 10.1016/j.marpolbul.2018.03.016
   Jovanovic B, 2017, INTEGR ENVIRON ASSES, V13, P510, DOI 10.1002/ieam.1913
   Khosrovyan A, 2020, CHEMOSPHERE, V244, DOI 10.1016/j.chemosphere.2019.125487
   Kishi S, 2003, EXP GERONTOL, V38, P777, DOI 10.1016/S0531-5565(03)00108-6
   Li CJ, 2022, BIOGERONTOLOGY, V23, P99, DOI 10.1007/s10522-021-09948-5
   Liang BY, 2022, ARCH INSECT BIOCHEM, V110, DOI 10.1002/arch.21909
   Liu CS, 2012, BIOGERONTOLOGY, V13, P501, DOI 10.1007/s10522-012-9395-2
   Liu S, 2018, FISH SHELLFISH IMMUN, V80, P473, DOI 10.1016/j.fsi.2018.06.027
   Liu TT, 2015, REJUV RES, V18, P225, DOI 10.1089/rej.2014.1618
   Lu YF, 2016, ENVIRON SCI TECHNOL, V50, P4054, DOI 10.1021/acs.est.6b00183
   MARKOFSKY J, 1976, EXP GERONTOL, V11, P171, DOI 10.1016/0531-5565(76)90030-9
   MARKOFSKY J, 1973, EXP GERONTOL, V8, P65, DOI 10.1016/0531-5565(73)90016-8
   MARKOFSKY J, 1979, EXP GERONTOL, V14, P149, DOI 10.1016/0531-5565(79)90030-5
   MARKOFSKY J, 1972, EXP GERONTOL, V7, P131, DOI 10.1016/0531-5565(72)90007-1
   MARKOFSKY J, 1979, EXP GERONTOL, V14, P11, DOI 10.1016/0531-5565(79)90003-2
   Meller K, 2016, J CHROMATOGR A, V1440, P45, DOI 10.1016/j.chroma.2016.02.070
   Mosiichuk N, 2021, CHEM RES TOXICOL, V34, P2441, DOI 10.1021/acs.chemrestox.1c00174
   Okutan Huseyin, 2004, Interact Cardiovasc Thorac Surg, V3, P519, DOI 10.1016/j.icvts.2004.05.005
   Phuong NN, 2016, ENVIRON POLLUT, V211, P111, DOI 10.1016/j.envpol.2015.12.035
   Reichwald K, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r16
   Rochman CM, 2013, SCI REP-UK, V3, DOI 10.1038/srep03263
   Schwabl P, 2019, ANN INTERN MED, V171, P453, DOI 10.7326/M19-0618
   Shang X, 2020, SCI TOTAL ENVIRON, V705, DOI 10.1016/j.scitotenv.2019.135837
   Shi L, 2015, CURR OPIN CELL BIOL, V33, P125, DOI 10.1016/j.ceb.2015.02.003
   SHIHABI ZK, 1971, CLIN CHEM, V17, P1150
   SOHAL RS, 1993, P NATL ACAD SCI USA, V90, P7255, DOI 10.1073/pnas.90.15.7255
   Song LL, 2022, BIOGERONTOLOGY, V23, P201, DOI 10.1007/s10522-022-09955-0
   Song LL, 2020, MOL IMMUNOL, V117, P160, DOI 10.1016/j.molimm.2019.10.019
   SPITZ DR, 1989, ANAL BIOCHEM, V179, P8, DOI 10.1016/0003-2697(89)90192-9
   Su L, 2016, ENVIRON POLLUT, V216, P711, DOI 10.1016/j.envpol.2016.06.036
   Terzibasi E, 2009, AGING CELL, V8, P88, DOI 10.1111/j.1474-9726.2009.00455.x
   Torres-Agullo A, 2021, SCI TOTAL ENVIRON, V800, DOI 10.1016/j.scitotenv.2021.149555
   Triebskorn R, 2019, TRAC-TREND ANAL CHEM, V110, P375, DOI 10.1016/j.trac.2018.11.023
   Valenzano DR, 2006, AGING CELL, V5, P275, DOI 10.1111/j.1474-9726.2006.00212.x
   Valenzano DR, 2006, CELL CYCLE, V5, P1027, DOI 10.4161/cc.5.10.2739
   Vatner SF, 2020, AGEING RES REV, V64, DOI 10.1016/j.arr.2020.101194
   Wan ZQ, 2019, CHEMOSPHERE, V217, P646, DOI 10.1016/j.chemosphere.2018.11.070
   Wang WF, 2020, ECOTOX ENVIRON SAFE, V189, DOI 10.1016/j.ecoenv.2019.109913
   Wang WF, 2019, ECOTOX ENVIRON SAFE, V173, P110, DOI 10.1016/j.ecoenv.2019.01.113
   Wang Xia, 2018, Oncotarget, V9, P14882, DOI 10.18632/oncotarget.23957
   Wang X, 2017, BIOGERONTOLOGY, V18, P383, DOI 10.1007/s10522-017-9699-3
   Wang X, 2014, REJUV RES, V17, P507, DOI 10.1089/rej.2014.1581
   Wang Y, 2022, CHEMOSPHERE, V299, DOI 10.1016/j.chemosphere.2022.134370
   Wei JT, 2020, J GERONTOL A-BIOL, V75, P2042, DOI 10.1093/gerona/glaa109
   Wong JKH, 2020, SCI TOTAL ENVIRON, V719, DOI 10.1016/j.scitotenv.2020.137512
   World Health Organization, 2019, MICR DRINK
   Xia XH, 2020, SCI TOTAL ENVIRON, V716, DOI 10.1016/j.scitotenv.2019.136479
   Yan LJ, 2014, REDOX BIOL, V2, P165, DOI 10.1016/j.redox.2014.01.002
   Yong CQY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051509
   Zhang K, 2017, ENVIRON SCI TECHNOL, V51, P3794, DOI 10.1021/acs.est.7b00369
   Zhou Y, 2019, BIOGERONTOLOGY, V20, P225, DOI 10.1007/s10522-018-09789-9
NR 84
TC 7
Z9 8
U1 8
U2 13
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1389-5729
EI 1573-6768
J9 BIOGERONTOLOGY
JI Biogerontology
PD 2023 APR
PY 2023
VL 24
IS 2
BP 207
EP 223
DI 10.1007/s10522-022-10007-w
EA JAN 2023
PG 17
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 9T1MZ
UT WOS:000906606100002
PM 36592268
DA 2024-02-19
ER

PT J
AU de Haan, G
AF de Haan, G
TI Hematopoietic stem cells: Self-renewing or aging?
SO CELLS TISSUES ORGANS
LA English
DT Article
DE stem cells; aging; hematopoiesis; plasticity
ID X-CHROMOSOME INACTIVATION; IN-VIVO PROLIFERATION; ADULT BONE-MARROW;
   LIFE-SPAN; LONG-TERM; SOMATIC MUTATIONS; FETAL LIVER; SERIAL
   TRANSPLANTATION; OXIDATIVE STRESS; REPAIR SYNDROME
AB Stem cells are defined by their extensive self-renewal properties, and yet there is abundant evidence of erosion of stem cell functioning during aging. Whereas intracellular repair and protection mechanisms determine the lifespan of an individual cell, here an argument is made that somatic stem cells determine the lifespan of an entire tissue, and thus play a key role in the organismal aging process. Recently it has been shown that the developmental potential of somatic stem cells may be far greater than previously anticipated. Although the mechanisms regulating stem cell plasticity are far from clear, it is challenging to discuss the potential relevance of these findings in the aging process. Copyright (C) 2002 S. Karger AG, Basel.
C1 Univ Groningen, Dept Stem Cell Biol, NL-9713 AV Groningen, Netherlands.
C3 University of Groningen
RP de Haan, G (corresponding author), Univ Groningen, Dept Stem Cell Biol, A Deusinglaan 1, NL-9713 AV Groningen, Netherlands.
EM g.de.haan@med.rug.nl
RI de Haan, Gerald/AAF-8963-2019; de Haan, Gerald/D-2081-2015
OI de Haan, Gerald/0000-0001-9706-0138; de Haan, Gerald/0000-0001-9706-0138
CR ABKOWITZ JL, 1995, P NATL ACAD SCI USA, V92, P2031, DOI 10.1073/pnas.92.6.2031
   Abkowitz JL, 1996, NAT MED, V2, P190, DOI 10.1038/nm0296-190
   Abkowitz JL, 1998, P NATL ACAD SCI USA, V95, P3862, DOI 10.1073/pnas.95.7.3862
   Alison MR, 2000, NATURE, V406, P257, DOI 10.1038/35018642
   Baguisi A, 1999, NAT BIOTECHNOL, V17, P456, DOI 10.1038/8632
   BESSLER M, 1994, EMBO J, V13, P110, DOI 10.1002/j.1460-2075.1994.tb06240.x
   Bjornson CRR, 1999, SCIENCE, V283, P534, DOI 10.1126/science.283.5401.534
   Bradford GB, 1997, EXP HEMATOL, V25, P445
   Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775
   CAPEL B, 1990, BLOOD, V75, P2267
   CAPEL B, 1989, P NATL ACAD SCI USA, V86, P4564, DOI 10.1073/pnas.86.12.4564
   Champion KM, 1997, BRIT J HAEMATOL, V97, P920, DOI 10.1046/j.1365-2141.1997.1933010.x
   Chen JC, 1999, EXP HEMATOL, V27, P928, DOI 10.1016/S0301-472X(99)00018-1
   Chen JC, 2000, EXP HEMATOL, V28, P442, DOI 10.1016/S0301-472X(99)00157-5
   Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804
   Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120
   Christensen K, 2000, BLOOD, V95, P2449, DOI 10.1182/blood.V95.7.2449.007k06_2449_2451
   Clarke DL, 2000, SCIENCE, V288, P1660, DOI 10.1126/science.288.5471.1660
   de Boer J, 1998, MOL CELL, V1, P981, DOI 10.1016/S1097-2765(00)80098-2
   De Haan G, 1999, FASEB J, V13, P707, DOI 10.1096/fasebj.13.6.707
   de Haan G, 1999, BLOOD, V93, P3294, DOI 10.1182/blood.V93.10.3294.410k07_3294_3301
   deHaan G, 1997, BLOOD, V89, P1543, DOI 10.1182/blood.V89.5.1543.1543_1543_1550
   Dollé MET, 2000, P NATL ACAD SCI USA, V97, P8403, DOI 10.1073/pnas.97.15.8403
   Drize NJ, 1996, BLOOD, V88, P2927, DOI 10.1182/blood.V88.8.2927.bloodjournal8882927
   Ferrari G, 1998, SCIENCE, V281, P923
   Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528
   Finch CE, 1997, SCIENCE, V278, P407, DOI 10.1126/science.278.5337.407
   Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433
   Gale RE, 1997, BRIT J HAEMATOL, V98, P512, DOI 10.1046/j.1365-2141.1997.2573078.x
   Galli R, 2000, NAT NEUROSCI, V3, P986, DOI 10.1038/79924
   GELMAN R, 1988, GENETICS, V118, P693
   Guarente L, 1998, P NATL ACAD SCI USA, V95, P11034, DOI 10.1073/pnas.95.19.11034
   Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919
   HARRISON DE, 1972, NATURE-NEW BIOL, V237, P220, DOI 10.1038/newbio237220a0
   HARRISON DE, 1988, P NATL ACAD SCI USA, V85, P822, DOI 10.1073/pnas.85.3.822
   HARRISON DE, 1982, J EXP MED, V156, P1767, DOI 10.1084/jem.156.6.1767
   Harrison DE, 1997, EXP HEMATOL, V25, P293
   HARRISON DE, 1989, J IMMUNOL, V142, P3833
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   Iscove NN, 1997, CURR BIOL, V7, P805, DOI 10.1016/S0960-9822(06)00341-1
   Jackson KA, 1999, P NATL ACAD SCI USA, V96, P14482, DOI 10.1073/pnas.96.25.14482
   Jaenisch R, 2001, SCIENCE, V291, P2552, DOI 10.1126/science.1060463
   Jazwinski SM, 2000, ACTA BIOCHIM POL, V47, P269, DOI 10.18388/abp.2000_4007
   Johnson FB, 1999, CELL, V96, P291, DOI 10.1016/S0092-8674(00)80567-X
   JORDAN CT, 1990, GENE DEV, V4, P220, DOI 10.1101/gad.4.2.220
   Kamminga LM, 2000, EXP HEMATOL, V28, P1451, DOI 10.1016/S0301-472X(00)00543-9
   Kato Y, 1998, SCIENCE, V282, P2095, DOI 10.1126/science.282.5396.2095
   KELLER G, 1990, J EXP MED, V171, P1407, DOI 10.1084/jem.171.5.1407
   KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0
   Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942
   Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711
   Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2
   Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326
   LAJTHA LG, 1979, DIFFERENTIATION, V14, P23, DOI 10.1111/j.1432-0436.1979.tb01007.x
   LAJTHA LG, 1975, BRIT J HAEMATOL, V29, P529, DOI 10.1111/j.1365-2141.1975.tb02739.x
   Liechty KW, 2000, NAT MED, V6, P1282, DOI 10.1038/81395
   Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319
   Lin YJ, 1998, SCIENCE, V282, P943, DOI 10.1126/science.282.5390.943
   LYON MF, 1971, NATURE-NEW BIOL, V232, P229, DOI 10.1038/newbio232229a0
   Makino S, 1999, J CLIN INVEST, V103, P697, DOI 10.1172/JCI5298
   Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8
   Melov S, 2000, SCIENCE, V289, P1567, DOI 10.1126/science.289.5484.1567
   Mezey É, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779
   MICKLEM HS, 1972, J CELL PHYSIOL, V79, P293, DOI 10.1002/jcp.1040790214
   Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311
   Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011
   MULLER AM, 1994, IMMUNITY, V1, P291, DOI 10.1016/1074-7613(94)90081-7
   Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587
   Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242
   Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168
   PIETRZYK ME, 1985, BLOOD, V66, P1460
   Polejaeva IA, 2000, NATURE, V407, P86, DOI 10.1038/35024082
   POTTEN CS, 1990, DEVELOPMENT, V110, P1001
   Prchal JT, 1996, J EXP MED, V183, P561, DOI 10.1084/jem.183.2.561
   Rebel VI, 1996, BLOOD, V87, P3500, DOI 10.1182/blood.V87.8.3500.bloodjournal8783500
   Rebel VI, 1996, EXP HEMATOL, V24, P638
   ROSS EAM, 1982, J EXP MED, V155, P432, DOI 10.1084/jem.155.2.432
   RUSSEL ES, 1966, BIOL LAB MOUSE, V2, P511
   Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0
   SIMINOVITCH L, 1964, J CELL COMPAR PHYSL, V64, P23, DOI 10.1002/jcp.1030640104
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   SZILVASSY SJ, 1990, P NATL ACAD SCI USA, V87, P8736, DOI 10.1073/pnas.87.22.8736
   Taylor BA, 1999, MAMM GENOME, V10, P335, DOI 10.1007/s003359900998
   TEJERO C, 1989, EXP HEMATOL, V17, P66
   Tonon L, 1998, BRIT J HAEMATOL, V102, P996, DOI 10.1046/j.1365-2141.1998.00867.x
   Torrente Y, 2001, J CELL BIOL, V152, P335, DOI 10.1083/jcb.152.2.335
   vanderHorst GTJ, 1997, CELL, V89, P425, DOI 10.1016/S0092-8674(00)80223-8
   VANZANT G, 1991, EXP HEMATOL, V19, P941
   VANZANT G, 1990, J EXP MED, V171, P1547, DOI 10.1084/jem.171.5.1547
   Vickers MA, 2001, BLOOD, V97, P1274, DOI 10.1182/blood.V97.5.1274
   Vijg J, 2000, MUTAT RES-FUND MOL M, V447, P117, DOI 10.1016/S0027-5107(99)00202-X
   Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615
   Weeda G, 1997, CURR BIOL, V7, P427, DOI 10.1016/S0960-9822(06)00190-4
   Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0
NR 95
TC 7
Z9 7
U1 0
U2 1
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1422-6405
EI 1422-6421
J9 CELLS TISSUES ORGANS
JI Cells Tissues Organs
PY 2002
VL 171
IS 1
BP 27
EP 37
DI 10.1159/000057689
PG 11
WC Anatomy & Morphology; Cell Biology; Developmental Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Anatomy & Morphology; Cell Biology; Developmental Biology
GA 560RY
UT WOS:000176096200004
PM 12021489
DA 2024-02-19
ER

PT J
AU Tomiyama, T
   Yamamoto, T
   Takahama, S
   Toshima, T
   Itoh, S
   Harada, N
   Shimokawa, M
   Okuzaki, D
   Mori, M
   Yoshizumi, T
AF Tomiyama, Takahiro
   Yamamoto, Takuya
   Takahama, Shokichi
   Toshima, Takeo
   Itoh, Shinji
   Harada, Noboru
   Shimokawa, Mototsugu
   Okuzaki, Daisuke
   Mori, Masaki
   Yoshizumi, Tomoharu
TI Up-regulated LRRN2 expression as a marker for graft quality in living
   donor liver transplantation
SO HEPATOLOGY COMMUNICATIONS
LA English
DT Article; Early Access
ID CYNOMOLGUS MONKEY; REGENERATION; MODEL; MMP-9; SENESCENCE; INDUCTION;
   DISEASE; OLDER
AB The quality and size of liver grafts are critical factors that influence living-donor liver transplantation (LDLT) function and safety. However, the biomarkers used for predicting graft quality are lacking. In this study, we sought to identify unique graft quality markers, aside from donor age, by using the livers of non-human primates. Hepatic gene microarray expression data from young and elderly cynomolgus macaques revealed a total of 271 genes with significantly increased expression in the elderly. These candidate genes were then narrowed down to six through bioinformatics analyses. The expression patterns of these candidate genes in human donor liver tissues were subsequently examined. Importantly, we found that grafts exhibiting up-regulated expression of these six candidate genes were associated with an increased incidence of liver graft failure. Multivariable analysis further revealed that upregulated expression of LRRN2 (encoding leucine-rich repeat protein, neuronal 2) in donor liver tissue served as an independent risk factor for graft failure (odds ratio 4.50, confidence interval 2.08-9.72). Stratification based on graft expression of LRRN2 and donor age was also significantly associated with 6-month graft survival rates. Conclusion: Up-regulated LRRN2 expression of liver graft is significantly correlated with graft failure in LDLT. In addition, combination of graft LRRN2 expression and donor age may represent a promising marker for predicting LDLT graft quality.
C1 [Tomiyama, Takahiro; Toshima, Takeo; Itoh, Shinji; Harada, Noboru; Mori, Masaki; Yoshizumi, Tomoharu] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka, Japan.
   [Yamamoto, Takuya; Takahama, Shokichi] Natl Inst Biomed Innovat Hlth & Nutr, Lab Immunosenescence, 7-6-8 Saito, Ibaraki, Osaka, Japan.
   [Yamamoto, Takuya] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Aging & Immune Regulat, Osaka, Japan.
   [Yamamoto, Takuya] Osaka Univ, Grad Sch Med, Dept Virol & Immunol, Osaka, Japan.
   [Shimokawa, Mototsugu] Yamaguchi Univ, Dept Biostat, Grad Sch Med, Yamaguchi, Japan.
   [Okuzaki, Daisuke] Osaka Univ, WPI Immunol Frontier Res Ctr, Human Immunol, Single Cell Genom, Osaka, Japan.
   [Okuzaki, Daisuke] Osaka Univ, Genome Informat Res Ctr, Res Inst Microbial Dis, Osaka, Japan.
   [Okuzaki, Daisuke] Osaka Univ, Inst Open & Transdisciplinary Res Initiat, Osaka, Japan.
C3 Kyushu University; Osaka University; Osaka University; Yamaguchi
   University; Osaka University; Osaka University; Osaka University
RP Yamamoto, T (corresponding author), Natl Inst Biomed Innovat Hlth & Nutr, Lab Immunosenescence, 7-6-8 Saito, Ibaraki, Osaka, Japan.; Yoshizumi, T (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka, Fukuoka, Japan.
EM yamamotot2@nibiohn.go.jp; yoshizumi.tomoharu.717@m.kyushu-u.ac.jp
RI Okuzaki, Daisuke/AAN-5641-2020; Yamamoto, Takuya/L-2642-2013
OI Okuzaki, Daisuke/0000-0002-4552-783X; Yoshizumi,
   Tomoharu/0000-0002-4497-1816; Yamamoto, Takuya/0000-0003-3753-1211;
   Tomiyama, Takahiro/0000-0003-4684-1617; Takahama,
   Shokichi/0000-0002-5651-4217; fei, Jiang/0009-0001-0212-9030
FU AMED [21fk0310106h005, 21fk0210085 s0601, 21wm0325004s0202,
   21fk0210057h0003, 21fk0 410040h0001, 21am0401030h0001]; JSPS KAK ENHI
   [21K08685, 19K09198, 20H03728]
FX Supported by AMED (21fk0310106h005, 21fk0210085 s0601, 21wm0325004s0202,
   21fk0210057h0003, 21fk0 410040h0001, and 21am0401030h0001) and JSPS KAK
   ENHI (21K08685, 19K09198, and 20H03728). The funding sources had no role
   in the collection, analysis, or interpretation of data, nor in the
   decision to submit the article for publication.
CR Abdallah A, 2021, ASIAN J SURG, V44, P452, DOI 10.1016/j.asjsur.2020.10.016
   Almanzar N, 2020, NATURE, V583, P590, DOI 10.1038/s41586-020-2496-1
   Almeida A, 1998, ONCOGENE, V16, P2997, DOI 10.1038/sj.onc.1201828
   Baiocchini A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151736
   Bronikowski AM, 2011, SCIENCE, V331, P1325, DOI 10.1126/science.1201571
   CARLSON CS, 1994, J ORTHOP RES, V12, P331, DOI 10.1002/jor.1100120305
   Cholongitas E, 2006, LIVER TRANSPLANT, V12, P1049, DOI 10.1002/lt.20824
   Chu MJJ, 2015, J GASTROINTEST SURG, V19, P1713, DOI 10.1007/s11605-015-2832-1
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Didier ES, 2016, VET PATHOL, V53, P277, DOI 10.1177/0300985815622974
   Durand F, 2019, J HEPATOL, V70, P745, DOI 10.1016/j.jhep.2018.12.009
   Gao SY, 2021, BMC CANCER, V21, DOI 10.1186/s12885-021-08520-1
   Goldaracena N, 2016, ANN SURG, V263, P979, DOI 10.1097/SLA.0000000000001337
   Hidaka M, 2016, TRANSPLANT DIRECT, V2, DOI 10.1097/TXD.0000000000000608
   Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172
   Kato H, 2014, J HEPATOL, V60, P1032, DOI 10.1016/j.jhep.2013.12.022
   Kato Y, 2017, COMPARATIVE MED, V67, P436
   Kim SH, 2017, LIVER TRANSPLANT, V23, P1305, DOI 10.1002/lt.24823
   Kubota T, 2018, ANN SURG, V267, P1126, DOI 10.1097/SLA.0000000000002194
   Kuyvenhoven JP, 2004, THROMB HAEMOSTASIS, V91, P506, DOI 10.1160/TH03-05-0272
   Lane MA, 2000, EXP GERONTOL, V35, P533, DOI 10.1016/S0531-5565(00)00102-9
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027
   PICCININO F, 1986, J HEPATOL, V2, P165, DOI 10.1016/S0168-8278(86)80075-7
   Prystupa A, 2015, ANN AGR ENV MED, V22, P325, DOI 10.5604/12321966.1152088
   RAIA S, 1989, LANCET, V2, P497
   Ryaboshapkina M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10930-w
   Schaum N, 2020, NATURE, V583, P596, DOI 10.1038/s41586-020-2499-y
   Scheuermann U, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-68314-6
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Seda O, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00270
   Segev DL, 2008, AM J TRANSPLANT, V8, P658, DOI 10.1111/j.1600-6143.2007.02108.x
   Sheikh A, 2016, CANCER SCI, V107, P1223, DOI 10.1111/cas.13003
   Shoji H, 2016, SCI REP-UK, V6, DOI 10.1038/srep28814
   Slawik M, 2006, AGEING RES REV, V5, P144, DOI 10.1016/j.arr.2006.03.004
   Soejima Y, 2012, AM J TRANSPLANT, V12, P1877, DOI 10.1111/j.1600-6143.2012.04022.x
   Soejima Y, 2003, LIVER TRANSPLANT, V9, P581, DOI 10.1053/jlts.2003.50114
   Sogawa H, 2008, TRANSPLANTATION, V86, P615, DOI 10.1097/TP.0b013e3181821bac
   STRONG RW, 1990, NEW ENGL J MED, V322, P1505, DOI 10.1056/NEJM199005243222106
   Tanemura A, 2012, WORLD J SURG, V36, P1102, DOI 10.1007/s00268-012-1496-1
   Timchenko NA, 2009, TRENDS ENDOCRIN MET, V20, P171, DOI 10.1016/j.tem.2009.01.005
   Toshima T, 2014, HEPATOLOGY, V60, P290, DOI 10.1002/hep.27140
   URATA K, 1995, HEPATOLOGY, V21, P1317, DOI 10.1016/0270-9139(95)90053-5
   Vons C, 2009, AM J PRIMATOL, V71, P400, DOI 10.1002/ajp.20667
   Yoshizumi T, 2008, TRANSPL INT, V21, P833, DOI 10.1111/j.1432-2277.2008.00678.x
   Yoshizumi T, 2021, J HEPATOL, V74, DOI 10.1016/j.jhep.2020.08.017
   Yoshizumi T, 2014, LIVER TRANSPLANT, V20, P1089, DOI 10.1002/lt.23924
   Yoshizumi T, 2014, LIVER TRANSPLANT, V20, P323, DOI 10.1002/lt.23804
   Yousefzadeh MJ, 2021, NATURE, V594, P100, DOI 10.1038/s41586-021-03547-7
   Zhu CZ, 2014, J GASTROEN HEPATOL, V29, P1102, DOI 10.1111/jgh.12468
NR 50
TC 3
Z9 4
U1 0
U2 1
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
EI 2471-254X
J9 HEPATOL COMMUN
JI Hepatol. Commun.
PD 2022 OCT
PY 2022
VL 6
IS 10
BP 2836
EP 2849
DI 10.1002/hep4.2033
EA JUL 2022
PG 14
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 4V0ZE
UT WOS:000830587000001
PM 35894759
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Hasegawa, G
   Yamasaki, M
   Kadono, M
   Tanaka, M
   Asano, M
   Senmaru, T
   Kondo, Y
   Fukui, M
   Obayashi, H
   Maruyama, N
   Nakamura, N
   Ishigami, A
AF Hasegawa, Goji
   Yamasaki, Masahiro
   Kadono, Mayuko
   Tanaka, Muhei
   Asano, Mai
   Senmaru, Takafumi
   Kondo, Yoshitaka
   Fukui, Michiaki
   Obayashi, Hiroshi
   Maruyama, Naoki
   Nakamura, Naoto
   Ishigami, Akihito
TI Senescence Marker Protein-30/Gluconolactonase Deletion Worsens Glucose
   Tolerance through Impairment of Acute Insulin Secretion
SO ENDOCRINOLOGY
LA English
DT Article
ID PROTEIN-30 KNOCKOUT MOUSE; BETA-CELL FUNCTION; VITAMIN-C; OXIDATIVE
   STRESS; SMP30 DEFICIENCY; LIVER; MICE; BIOSYNTHESIS; SENSITIVITY; ISLETS
AB Senescence marker protein-30 (SMP30) is an androgen-independent factor that decreases with age. We recently identified SMP30 as the lactone-hydrolyzing enzyme gluconolactonase (GNL), which is involved in vitamin C biosynthesis in animal species. To examine whether the age-related decrease in SMP30/GNL has effects on glucose homeostasis, we used SMP30/GNL knockout ( KO) mice treated with L-ascorbic acid. In an ip glucose tolerance test at 15 wk of age, blood glucose levels in SMP30/GNL KO mice were significantly increased by 25% at 30 min after glucose administration compared with wildtype (WT) mice. Insulin levels in SMP30/GNL KO mice were significantly decreased by 37% at 30 min after glucose compared with WT mice. Interestingly, an insulin tolerance test showed a greater glucose-lowering effect in SMP30/GNL KO mice. High-fat diet feeding severely worsened glucose tolerance in both WT and SMP30/GNL KO mice. Morphometric analysis revealed no differences in the degree of high-fat diet-induced compensatory increase in beta-cell mass and proliferation. In the static incubation study of islets, insulin secretion in response to 20 mM glucose or KCl was significantly decreased in SMP30/GNL KO mice. On the other hand, islet ATP content at 20 mM in SMP30/GNL KO mice was similar to that in WT mice. Collectively, these data indicate that impairment of the early phase of insulin secretion due to dysfunction of the distal portion of the secretion pathway underlies glucose intolerance in SMP30/GNL KO mice. Decreased SMP30/GNL may contribute to the worsening of glucose tolerance that occurs in normal aging. (Endocrinology 151: 529-536, 2010)
C1 [Hasegawa, Goji] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Endocrinol & Metab, Kamikyo Ku, Kyoto 6028566, Japan.
   [Kondo, Yoshitaka; Maruyama, Naoki] Tokyo Metropolitan Inst Gerontol, Tokyo 1730015, Japan.
   [Obayashi, Hiroshi] Inst Bioresponse Informat, Kyoto 6128016, Japan.
   [Ishigami, Akihito] Toho Univ, Dept Biochem, Fac Pharmaceut Sci, Chiba 2748510, Japan.
C3 Kyoto Prefectural University of Medicine; Tokyo Metropolitan Institute
   of Gerontology; Toho University
RP Hasegawa, G (corresponding author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Endocrinol & Metab, Kamikyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.
EM goji@koto.kpu-m.ac.jp
RI Yoshitaka, Kondo/AFK-7721-2022
OI Yoshitaka, Kondo/0000-0002-0046-9429; Ishigami,
   Akihito/0000-0001-7875-7482; Fukui, Michiaki/0000-0003-0903-1797
FU Japan Society for the Promotion of Science [20591066, 18590355];
   Grants-in-Aid for Scientific Research [20591066, 18590355] Funding
   Source: KAKEN
FX We thank Fumie Takenaka, Hiroko Kawamura, and Sayoko Horibe for their
   secretarial assistance. Vitamin C powder was kindly provided by DSM
   Nutrition Japan (Tokyo, Japan).; Address all correspondence and requests
   for reprints to: Goji Hasegawa, M. D., Department of Endocrinology and
   Metabolism, Kyoto Prefectural University of Medicine Graduate School of
   Medical Science, 465 Kajii-cho, Hirokoji, Kawaramachi-dori, Kamikyo-ku,
   Kyoto 602-8566, Japan. E-mail: goji@koto.kpum.ac.jp.; This work was
   supported by Grants-in-Aid for Scientific Research (20591066 to G.H. and
   18590355 to A.I.) from the Japan Society for the Promotion of Science.;
   Disclosure Summary: The authors have nothing to disclose.
CR Chang AM, 2003, AM J PHYSIOL-ENDOC M, V284, pE7, DOI 10.1152/ajpendo.00366.2002
   Chang AM, 2006, J CLIN ENDOCR METAB, V91, P3303, DOI 10.1210/jc.2006-0913
   Colombo C, 2003, J BIOL CHEM, V278, P3992, DOI 10.1074/jbc.M207665200
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7
   Fujita T, 1998, BIOCHEM BIOPH RES CO, V250, P374, DOI 10.1006/bbrc.1998.9327
   Furusawa H, 2008, BIOL PHARM BULL, V31, P1673, DOI 10.1248/bpb.31.1673
   HASEGAWA G, 1990, HORM METAB RES, V22, P408, DOI 10.1055/s-2007-1004935
   Inoue H., 1999, CLIN EXP NEPHROL, V3, P261, DOI [10.1007/s101570050045, DOI 10.1007/S101570050045]
   Ishigami A, 2004, BIOCHEM BIOPH RES CO, V315, P575, DOI 10.1016/j.bbrc.2004.01.091
   Ishigami A, 2002, AM J PATHOL, V161, P1273, DOI 10.1016/S0002-9440(10)64404-5
   Ishigarni A, 2007, GERIATR GERONTOL INT, V7, P316, DOI 10.1111/j.1447-0594.2007.00420.x
   Kaneto H, 1999, DIABETES, V48, P2398, DOI 10.2337/diabetes.48.12.2398
   Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103
   Kondo Y, 2008, BIOCHEM BIOPH RES CO, V377, P291, DOI 10.1016/j.bbrc.2008.09.132
   LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35
   Maedler K, 2006, DIABETES, V55, P2455, DOI 10.2337/db05-1586
   Mori T, 2004, PATHOL INT, V54, P167, DOI 10.1111/j.1440-1827.2003.01603.x
   Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889
   ROBERTSON H, 1990, HISTOCHEM J, V22, P209, DOI 10.1007/BF02386007
   Sato T, 2006, AM J RESP CRIT CARE, V174, P530, DOI 10.1164/rccm.200511-1816OC
   Sato Y, 2008, BIOCHEM BIOPH RES CO, V375, P346, DOI 10.1016/j.bbrc.2008.08.020
   Scheen AJ, 2005, DIABETES METAB, V31, pS27
   Son TG, 2006, MECH AGEING DEV, V127, P451, DOI 10.1016/j.mad.2006.01.005
   Sone H, 2005, DIABETOLOGIA, V48, P58, DOI 10.1007/s00125-004-1605-2
   Szoke E, 2008, DIABETES CARE, V31, P539, DOI 10.2337/dc07-1443
   Terauchi Y, 2007, J CLIN INVEST, V117, P246, DOI 10.1172/JCI17645
   Uchizono Y, 2004, ENDOCRINOLOGY, V145, P2264, DOI 10.1210/en.2003-1152
NR 27
TC 28
Z9 32
U1 0
U2 1
PU ENDOCRINE SOC
PI WASHINGTON
PA 2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA
SN 0013-7227
EI 1945-7170
J9 ENDOCRINOLOGY
JI Endocrinology
PD FEB
PY 2010
VL 151
IS 2
BP 529
EP 536
DI 10.1210/en.2009-1163
PG 8
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 548GR
UT WOS:000273948600012
PM 19934374
OA Bronze
DA 2024-02-19
ER

PT J
AU Sun, XY
   Yu, JT
   Wang, Y
   Luo, JM
   Zhang, GW
   Peng, XC
AF Sun, Xiaoyan
   Yu, Juntong
   Wang, Yong
   Luo, Jianming
   Zhang, Guangwen
   Peng, Xichun
TI Flaxseed oil ameliorates aging in d-galactose induced rats <i>via</i>
   altering gut microbiota and mitigating oxidative damage
SO JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE
LA English
DT Article; Early Access
DE flaxseed oil; aging; gut microbiota; transcriptome
ID LINOLENIC ACID; DIET; INFLAMMATION; IMPAIRMENT; DISEASE; LIVER
AB BACKGROUND Aging causes decreased antioxidant capacity and chronic inflammation and may even elevate cancer risks. Previous studies reported that flaxseed oil (FO) can alleviate age-related diseases, including improving alcoholic liver disease, atherosclerosis and diabetes. However, whether the intestinal microbiota accountable for this alleviation is still unknown. This study aims to study the antioxidant effects of FO in an aging rat model and the underlying mechanism between the intestinal microbiota and aging. RESULTS Our results presented that serum and liver antioxidant capacities in FO group were up-regulated, and liver inflammation in FO group was reduced. The 16S rDNA sequencing showed that FO regulated the microbial community, including up-regulation of four families of Lactobacillus and six families of Clostridium. In addition, FO had also adjusted the relative abundance of several genera such as Ruminococcaceae_UCG-005 and Prevotella_9, which may be the key bacteria associated with the aging process. Colonic transcriptome analysis showed that there were 1679 differentially expressed genes (DEGs) in the Model group and the FO group (134 up-regulated and 1545 down-regulated). Gene set enrichment analysis (GSEA) revealed FO down-regulates the expression of the upstream genes Ptprc, Lck, Zap70, Lat and Lcp2 in the T cell receptor signaling pathway. CONCLUSION In conclusion, FO improved antioxidant capacity and reduced intestinal microbial disturbances caused by aging damage, indicating that dietary FO has the potential to fight aging damage. This study provides a more comprehensive view of dietary intervention to improve aging. (c) 2022 Society of Chemical Industry.
C1 [Sun, Xiaoyan; Yu, Juntong; Wang, Yong; Luo, Jianming; Zhang, Guangwen; Peng, Xichun] Jinan Univ, Dept Food Sci & Engn, Guangzhou 510632, Guangdong, Peoples R China.
C3 Jinan University
RP Zhang, GW; Peng, XC (corresponding author), Jinan Univ, Dept Food Sci & Engn, Guangzhou 510632, Guangdong, Peoples R China.
EM tzgw@jnu.edu.cn; tpxchun@jnu.edu.cn
RI Wang, Yining/JQW-2010-2023; li, wei/IUQ-2973-2023; Zhang,
   Lanyue/JNS-8209-2023; Li, Ly/JCD-4746-2023; wang, wenjuan/JGD-0428-2023
OI wang, wenjuan/0000-0002-4220-8817; sun, sun xiao yan/0000-0002-0953-4477
FU China National Key Research and Development Project [2017YFD0400200]
FX This work was supported by the China National Key Research and
   Development Project (No. 2017YFD0400200).
CR Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784
   Appiah MO, 2020, CRYOBIOLOGY, V94, P57, DOI 10.1016/j.cryobiol.2020.04.010
   Azman KF, 2019, BIOGERONTOLOGY, V20, P763, DOI 10.1007/s10522-019-09837-y
   Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   Biagi E, 2011, AGEING RES REV, V10, P428, DOI 10.1016/j.arr.2011.03.004
   Cândido FG, 2018, INT J FOOD SCI NUTR, V69, P125, DOI 10.1080/09637486.2017.1343286
   Cannons JL, 2010, IMMUNITY, V32, P253, DOI 10.1016/j.immuni.2010.01.010
   Courtney AH, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aaw8151
   Degen C, 2016, PSYCHIAT RES, V240, P42, DOI 10.1016/j.psychres.2016.04.009
   Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]
   Erkkilä A, 2008, PROG LIPID RES, V47, P172, DOI 10.1016/j.plipres.2008.01.004
   Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057
   Fraser HC, 2022, AGING CELL, V21, DOI 10.1111/acel.13524
   Gaud G, 2018, NAT REV IMMUNOL, V18, P485, DOI 10.1038/s41577-018-0020-8
   Gorentla Balachandra K, 2012, J Clin Cell Immunol, V2012, P5
   Han H, 2018, J FUNCT FOODS, V40, P417, DOI 10.1016/j.jff.2017.11.031
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Huse M, 2009, J CELL SCI, V122, P1269, DOI 10.1242/jcs.042762
   Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213
   Khan SA, 2017, PHARM BIOL, V55, P1817, DOI 10.1080/13880209.2017.1331363
   Kolodziejczyk AA, 2019, NAT REV MICROBIOL, V17, P742, DOI 10.1038/s41579-019-0256-8
   Laissouf A., 2013, IJMPS, V3, P87
   Lee WT, 2018, J AGR FOOD CHEM, V66, P7384, DOI 10.1021/acs.jafc.8b02166
   Leeson GW, 2018, J POPUL AGEING, V11, P107, DOI 10.1007/s12062-018-9225-7
   Li BL, 2018, FOOD FUNCT, V9, P6587, DOI 10.1039/c8fo01768a
   Li XK, 2021, FRONT CELL DEV BIOL, V09, DOI 10.3389/fcell.2021.641315
   Liu DL, 2017, RSC ADV, V7, P48136, DOI 10.1039/c7ra07651g
   Liu JS, 2020, FOOD RES INT, V138, DOI 10.1016/j.foodres.2020.109811
   Man AL, 2014, CELL IMMUNOL, V289, P112, DOI 10.1016/j.cellimm.2014.04.001
   Martinez-Guryn K, 2018, CELL HOST MICROBE, V23, P458, DOI 10.1016/j.chom.2018.03.011
   Nagpal Ravinder, 2018, Nutr Healthy Aging, V4, P267, DOI 10.3233/NHA-170030
   O'Shea JJ, 2009, MICROBES INFECT, V11, P599, DOI 10.1016/j.micinf.2009.04.007
   Park JE, 2021, ATHEROSCLEROSIS, V324, P58, DOI 10.1016/j.atherosclerosis.2021.03.020
   Patrone V, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5202-z
   [Переверзев А.П. Pereverzev A.P.], 2021, [Медицинский совет, Medical Council, Meditsinskii sovet], P48, DOI 10.21518/2079-701X-2021-4-48-58
   Ping, 2021, FARM PROD PROCES, V04, P64
   Proust R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043200
   Qu LL, 2019, FOOD CHEM TOXICOL, V125, P85, DOI 10.1016/j.fct.2018.12.046
   Rauf S, 2021, JCPSP-J COLL PHYSICI, V31, P756, DOI 10.29271/jcpsp.2021.06.756
   Rea IM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00586
   Rengarajan J, 2002, NAT IMMUNOL, V3, P48, DOI 10.1038/ni744
   Ritschka B, 2017, GENE DEV, V31, P172, DOI 10.1101/gad.290635.116
   Sala-Vila A, 2011, CLIN LIPIDOL, V6, P365, DOI 10.2217/CLP.11.36
   Seki E, 2012, J PHYSIOL-LONDON, V590, P447, DOI 10.1113/jphysiol.2011.219691
   Simón J, 2021, AGING-US, V13, P3165, DOI 10.18632/aging.202666
   Smith X, 2016, IMMUNOL LETT, V176, P122, DOI 10.1016/j.imlet.2016.04.007
   Vaiserman AM, 2017, AGEING RES REV, V35, P36, DOI 10.1016/j.arr.2017.01.001
   Vemuri R, 2019, NUTRIENTS, V11, DOI 10.3390/nu11061297
   Walrath T, 2021, J LEUKOCYTE BIOL, V109, P1045, DOI 10.1002/JLB.3RI0620-405RR
   Wang YA, 2022, MOL OMICS, V18, P430, DOI 10.1039/d2mo00041e
   Xu Z., 2021, CHINA OILS FATS, V46
   Yin RY, 2020, FOOD AGR IMMUNOL, V31, P723, DOI 10.1080/09540105.2020.1761302
   Zhang J, 2019, FOOD FUNCT, V10, P6385, DOI [10.1039/c9fo00189a, 10.1039/C9FO00189A]
   Zhang QJ, 2020, MOL NUTR FOOD RES, V64, DOI 10.1002/mnfr.201901024
NR 54
TC 2
Z9 2
U1 3
U2 30
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-5142
EI 1097-0010
J9 J SCI FOOD AGR
JI J. Sci. Food Agric.
PD 2022 NOV
PY 2022
VL 102
IS 14
BP 6432
EP 6442
DI 10.1002/jsfa.12010
EA JUN 2022
PG 11
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Agriculture; Chemistry; Food Science & Technology
GA 4Z8GD
UT WOS:000804723300001
PM 35567370
OA Bronze
DA 2024-02-19
ER

PT J
AU Zhou, XY
   Tian, XJ
   Song, L
   Luo, L
   Ma, ZR
   Zhang, FM
AF Zhou, Xueyan
   Tian, Xiaojing
   Song, Li
   Luo, Li
   Ma, Zhongren
   Zhang, Fumei
TI Donkey whey protein and peptides regulate gut microbiota community and
   physiological functions of D-galactose-induced aging mice
SO FOOD SCIENCE & NUTRITION
LA English
DT Article; Early Access
DE aging; donkey whey hydrolysate; donkey whey protein; gut microbiota
ID OXIDATIVE STRESS; MILK; CONCENTRATE; MODULATION; PROFILES; PATHWAY
AB The prolongation of life span has attracted more and more attention in the current world. Gut microbiota is considered one of the most critical elements and is essential in regulating life span and quality. The effects of donkey whey protein (DWP) and donkey whey hydrolysate (DWPP) on physiological functions and gut microbiota of D-galactose-induced aging mice were investigated to find new strategies for resisting aging. Our results showed that DWP and DWPP could increase the body weight gain velocity, superoxide dismutase (SOD) activity, and thymus index, whereas decrease the level of reactive oxygen species (ROS) and malondialdehyde (MDA), and improve the aging of the body in the liver congestion, oozy draw focal sclerosis of chronic inflammation. The effects of medium and high concentrations of DWP and low and medium concentrations of DWPP were the same as the vitamin C (Vc)-positive control group. It was found that both DWP and DWPP could change alpha-diversity; the relative abundance of Lactobacillus increased, whereas the relative abundance of Helicobacter and Stenotrophomonas decreased after being treated with DWP and DWPP. The correlation between intestinal microflora and physiological indexes showed that chao1, ACE, and observed species indexes in the alpha index were positively correlated with weight gain velocity, SOD activity, and thymus index. The relative abundance of Lactobacillus was positively correlated with SOD and thymus index but negatively correlated with MDA. The relative abundance of Stenotrophomonas was opposite to that of Lactobacillus. The Anaerobiospirillum, Fusobacterium, and Dubosiella had a significant positive correlation with the weight gain velocity. The study provided a deeper more profound understanding of the potential use of DWP and DWPP in senescence delays.
C1 [Zhou, Xueyan; Tian, Xiaojing; Ma, Zhongren] Northwest Minzu Univ, Coll Life Sci & Engn, Lanzhou, Peoples R China.
   [Zhou, Xueyan; Tian, Xiaojing; Ma, Zhongren; Zhang, Fumei] Northwest Minzu Univ, Biomed Res Ctr, China Malaysia Natl Joint Lab, Lanzhou, Peoples R China.
   [Zhou, Xueyan; Tian, Xiaojing; Song, Li; Luo, Li; Ma, Zhongren; Zhang, Fumei] Gannan Res Inst Yak Milk, Hezuo, Peoples R China.
   [Zhang, Fumei] Northwest Minzu Univ, Dept Med, Lanzhou 730124, Gansu, Peoples R China.
C3 Northwest Minzu University; Northwest Minzu University; Northwest Minzu
   University
RP Zhang, FM (corresponding author), Northwest Minzu Univ, Dept Med, Lanzhou 730124, Gansu, Peoples R China.
EM zhangfumei1978@163.com
OI Zhang, Fumei/0000-0002-0810-6331
FU Fundamental Research Funds for Gansu Province Science and Technology
   Funding [21JR1RA202];  [31920210006];  [31920210126];  [2022QB-021]
FX Fundamental Research Funds for Gansu Province Science and Technology
   Funding, Grant/Award Number: 21JR1RA202; The Central Universities
   through Project, Grant/Award Number: 31920210006 and 31920210126; Young
   Doctor Fund Project, Grant/Award Number: 2022QB-021
CR Adriansjach J, 2020, J GERONTOL A-BIOL, V75, P1293, DOI 10.1093/gerona/glaa048
   Almeida Cristine C., 2016, Journal of Dietary Supplements, V13, P313, DOI 10.3109/19390211.2015.1036187
   [Anonymous], 1990, OFFICIAL METHODS ANA, V1
   Ashoush I. S., 2013, Annals of Agricultural Science (Cairo), V58, P27, DOI 10.1016/j.aoas.2013.01.005
   Azman KF, 2019, BIOGERONTOLOGY, V20, P763, DOI 10.1007/s10522-019-09837-y
   Boscaini S, 2020, PHYSIOL REP, V8, DOI 10.14814/phy2.14523
   Considine J., 2013, COMPLETE GUIDE QUALI
   Cunsolo V, 2017, FOOD RES INT, V99, P41, DOI 10.1016/j.foodres.2017.07.002
   Dai M., 2008, J ACUPUNCT TUINA SCI, V6, P79, DOI DOI 10.1007/S11726-008-0079-Z
   Dzau VJ, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.abd3816
   Farhangi MA, 2017, INFLAMMATION, V40, P1688, DOI 10.1007/s10753-017-0610-9
   Fouhy F, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09252-4
   Fukawa A, 2017, BIOSCI BIOTECH BIOCH, V81, P1941, DOI 10.1080/09168451.2017.1356215
   Gruber J, 2017, CELL, V169, P1168, DOI 10.1016/j.cell.2017.05.048
   Gu CM, 2008, INT J MOL SCI, V9, P464, DOI 10.3390/ijms9040464
   Hahn WH, 2018, ASIA PAC J CLIN NUTR, V27, P204, DOI 10.6133/apjcn.032017.16
   Han B, 2017, CELL, V169, P1249, DOI 10.1016/j.cell.2017.05.036
   Jackson M, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0262-7
   Kareb Ourdia, 2019, Probiotics Antimicrob Proteins, V11, P348, DOI 10.1007/s12602-018-9427-6
   Kim J, 2013, J NUTR SCI VITAMINOL, V59, P198
   Kim S, 2018, GERONTOLOGY, V64, P513, DOI 10.1159/000490615
   Kong SZ, 2018, MAR DRUGS, V16, DOI 10.3390/md16060181
   Kumar Manish, 2016, Nutr Healthy Aging, V4, P3, DOI 10.3233/NHA-150002
   Li MH, 2020, J DAIRY SCI, V103, P992, DOI 10.3168/jds.2019-17448
   Liu AL, 2020, J GERONTOL A-BIOL, V75, P1284, DOI 10.1093/gerona/glz263
   Lloyd-Price J, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0307-y
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Ma ZL, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248329
   Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123
   Martini M, 2018, J DAIRY RES, V85, P445, DOI 10.1017/S0022029918000687
   O'Keeffe MB, 2014, INT DAIRY J, V36, P128, DOI 10.1016/j.idairyj.2014.01.013
   O'Toole PW, 2015, SCIENCE, V350, P1214, DOI 10.1126/science.aac8469
   Odamaki T, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0708-5
   Park SH, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0386-8
   Partridge L, 2018, NATURE, V561, P45, DOI 10.1038/s41586-018-0457-8
   Pyo MC, 2016, BIOL PHARM BULL, V39, P1437, DOI 10.1248/bpb.b16-00029
   Radic I, 2019, HUM EXP TOXICOL, V38, P632, DOI 10.1177/0960327119829518
   Rasmussen K L, 1989, P R Health Sci J, V8, P65
   Rastall RA, 2005, FEMS MICROBIOL ECOL, V52, P145, DOI 10.1016/j.femsec.2005.01.003
   Reimer RA, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201700484
   Sagi H, 2020, EXP GERONTOL, V130, DOI 10.1016/j.exger.2019.110795
   Sánchez-Moya T, 2017, FOOD FUNCT, V8, P3053, DOI [10.1039/c7fO00197e, 10.1039/C7FO00197E, 10.1039/c7fo00197e]
   Santoro A, 2018, CELL MOL LIFE SCI, V75, P129, DOI 10.1007/s00018-017-2674-y
   Sarti L, 2019, ITAL J PEDIATR, V45, DOI 10.1186/s13052-019-0700-4
   Sié A, 2021, BMC PEDIATR, V21, DOI 10.1186/s12887-021-02601-7
   Sinha R, 2007, FOOD CHEM, V101, P1484, DOI 10.1016/j.foodchem.2006.04.021
   Souroullas K, 2018, FOOD RES INT, V109, P416, DOI 10.1016/j.foodres.2018.04.051
   Stahr S, 2021, EXPOS HEALTH, V13, P269, DOI 10.1007/s12403-020-00381-6
   Teixeira FJ, 2019, PHARMACOL RES, V144, P245, DOI 10.1016/j.phrs.2019.04.019
   Toyomizu M, 1995, BRIT J NUTR, V74, P797, DOI 10.1079/BJN19950007
   Vatani DS, 2012, APPETITE, V59, P673, DOI 10.1016/j.appet.2012.08.005
   Wang PX, 2020, CHINESE MED J-PEKING, V133, P808, DOI 10.1097/CM9.0000000000000696
   WEHMEIER KR, 1994, FREE RADICAL BIO MED, V17, P83, DOI 10.1016/0891-5849(94)90010-8
   Woodmansey EJ, 2004, APPL ENVIRON MICROB, V70, P6113, DOI 10.1128/AEM.70.10.6113-6122.2004
   Xu CM, 2019, BMC MICROBIOL, V19, DOI 10.1186/s12866-019-1616-2
   Yin YB, 2019, DRUG DISCOV TODAY, V24, P1784, DOI 10.1016/j.drudis.2019.06.006
   Zhong G, 2019, NANOSCALE, V11, P11605, DOI 10.1039/c9nr03060c
NR 57
TC 1
Z9 1
U1 2
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2048-7177
J9 FOOD SCI NUTR
JI Food Sci. Nutr.
PD 2023 FEB
PY 2023
VL 11
IS 2
BP 752
EP 764
DI 10.1002/fsn3.3111
EA OCT 2022
PG 13
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA 8Y4YY
UT WOS:000870686100001
PM 36789044
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Groth, JB
   Kao, SY
   Briët, MC
   Stankovic, KM
AF Groth, Jane Bjerg
   Kao, Shyan-Yuan
   Briet, Martijn C.
   Stankovic, Konstantina M.
TI Hepatocyte Nuclear Factor-4 Alpha in Noise-Induced Cochlear Neuropathy
SO DEVELOPMENTAL NEUROBIOLOGY
LA English
DT Article
DE noise-induced hearing loss; temporary threshold shift; gene expression;
   molecular pathways; hepatocyte nuclear factor 4 alpha; aging; cochlear
   neuropathy
ID INDUCED HEARING-LOSS; TEMPORARY THRESHOLD SHIFT; FACTOR-KAPPA-B; RAT
   COCHLEA; INNER-EAR; NERVE DEGENERATION; MAMMALIAN COCHLEA; OXIDATIVE
   STRESS; GUINEA-PIG; C-JUN
AB Noise-induced hearing loss (NIHL) is a problem of profound clinical significance and growing magnitude. Alarmingly, even moderate noise levels, previously assumed to cause only temporary shifts in auditory thresholds ("temporary" NIHL), are now known to cause cochlear synaptopathy and subsequent neuropathy. To uncover molecular mechanisms of this neuropathy, a network analysis of genes reported to have significantly altered expression after temporary threshold shift-inducing noise exposure was performed. The transcription factor Hepatocyte Nuclear Factor-4 alpha (HNF4 alpha), which had not previously been studied in the context of cochlear response to noise, was identified as a hub of a top-ranking network. Hnf4 alpha expression and localization using quantitative RT-PCR and in situ hybridization, respectively, were described in adolescent and adult mice exposed to neuropathic noise levels in adolescence. Iso-forms alpha 3 and alpha 12 in the cochlea were also identified. At every age examined, Hnf4 alpha mRNA expression in the cochlear apex was similar to expression in the base. Hnf4 alpha expression was evident in select cochlear cells, including spiral ganglion neurons (SGNs) and hair cells, and was significantly upregulated from 6 to 70 weeks of age, especially in SGNs. This age-related Hnf4 alpha upregulation was inhibited by neuropathic noise exposure in adolescence. Hnf4 alpha silencing with shRNA transfection into auditory neuroblast cells (VOT-33) reduced cell viability, as measured with the MTT assay, suggesting that Hnf4 alpha may be involved in SGN survival. Our results motivate future studies of HNF4 alpha in cochlear pathophysiology, especially because HNF4 alpha mutations and polymorphisms are associated with human diseases that may include hearing loss. (C) 2016 Wiley Periodicals, Inc.
C1 [Groth, Jane Bjerg; Kao, Shyan-Yuan; Briet, Martijn C.; Stankovic, Konstantina M.] Massachusetts Eye & Ear Infirm, Eaton Peabody Labs, Boston, MA 02114 USA.
   [Groth, Jane Bjerg; Kao, Shyan-Yuan; Briet, Martijn C.; Stankovic, Konstantina M.] Massachusetts Eye & Ear Infirm, Dept Otolaryngol, 243 Charles St, Boston, MA 02114 USA.
   [Groth, Jane Bjerg; Stankovic, Konstantina M.] Harvard Med Sch, Dept Otol & Laryngol, Boston, MA 02115 USA.
   [Groth, Jane Bjerg] Univ Copenhagen, Dept Biomed Sci, DK-2200 Copenhagen, Denmark.
   [Briet, Martijn C.] Leiden Univ, Dept Otorhinolaryngol, Med Ctr, NL-2333 ZA Leiden, Netherlands.
   [Stankovic, Konstantina M.] Harvard Med Sch, Program Speech & Hearing Biosci & Technol, Boston, MA 02115 USA.
C3 Harvard University; Massachusetts Eye & Ear Infirmary; Harvard
   University; Massachusetts Eye & Ear Infirmary; Harvard University;
   Harvard Medical School; University of Copenhagen; Leiden University -
   Excl LUMC; Leiden University; Leiden University Medical Center (LUMC);
   Harvard University; Harvard Medical School
RP Stankovic, KM (corresponding author), Massachusetts Eye & Ear Infirm, Eaton Peabody Labs, Boston, MA 02114 USA.; Stankovic, KM (corresponding author), Massachusetts Eye & Ear Infirm, Dept Otolaryngol, 243 Charles St, Boston, MA 02114 USA.; Stankovic, KM (corresponding author), Harvard Med Sch, Dept Otol & Laryngol, Boston, MA 02115 USA.; Stankovic, KM (corresponding author), Harvard Med Sch, Program Speech & Hearing Biosci & Technol, Boston, MA 02115 USA.
EM konstantina_stankovic@meei.harvard.edu
OI bjerg groth, jane/0000-0002-7315-003X
FU DoD grant [W81XWH-15-1-0472]; NIDCD [K08 DC010419]; Bertarelli
   Foundation; Nancy Sayles Day Foundation; Lauer Tinnitus Research Center;
   Aase & Ejnar Danielsen's Foundation
FX Contract grant sponsor: DoD grant; contract grant number:
   W81XWH-15-1-0472 (KMS).; Contract grant sponsor: NIDCD; contract grant
   number: K08 DC010419 (KMS).; Contract grant sponsors: Grants from
   Bertarelli Foundation (KMS), Nancy Sayles Day Foundation (KMS), Lauer
   Tinnitus Research Center (KMS), and Aase & Ejnar Danielsen's Foundation
   (JBJ).
CR Adams JC, 2009, NEUROSCIENCE, V160, P530, DOI 10.1016/j.neuroscience.2009.02.073
   Babeu JP, 2014, WORLD J GASTROENTERO, V20, P22, DOI 10.3748/wjg.v20.i1.22
   Bainbridge KE, 2011, DIABETES CARE, V34, P1540, DOI 10.2337/dc10-2161
   Battaglia A, 2003, NEUROSCIENCE, V122, P1025, DOI 10.1016/j.neuroscience.2003.08.041
   Bodmer D, 2002, LARYNGOSCOPE, V112, P2057, DOI 10.1097/00005537-200211000-00028
   Briançon N, 2006, EMBO J, V25, P1253, DOI 10.1038/sj.emboj.7601021
   Caelers A, 2010, AUDIOL NEURO-OTOL, V15, P282, DOI 10.1159/000279760
   Caravelli A, 2004, HEARING RES, V198, P36, DOI 10.1016/j.heares.2004.07.011
   Cho YS, 2004, MOL BRAIN RES, V130, P134, DOI 10.1016/j.molbrainres.2004.07.017
   Gratton MA, 2011, HEARING RES, V277, P211, DOI 10.1016/j.heares.2010.12.014
   Gupta RK, 2004, TRENDS MOL MED, V10, P521, DOI 10.1016/j.molmed.2004.09.004
   Harries LW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007855
   Henderson D, 2006, EAR HEARING, V27, P1, DOI 10.1097/01.aud.0000191942.36672.f3
   Hickox AE, 2014, J NEUROPHYSIOL, V111, P552, DOI 10.1152/jn.00184.2013
   Huang JM, 2009, EXP CELL RES, V315, P1200, DOI 10.1016/j.yexcr.2009.01.004
   Jensen JB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125160
   Kao SY, 2016, AGING CELL, V15, P301, DOI 10.1111/acel.12437
   Kao SY, 2013, NEUROBIOL DIS, V56, P25, DOI 10.1016/j.nbd.2013.04.008
   KIKUCHI T, 1995, ANAT EMBRYOL, V191, P101, DOI 10.1007/BF00186783
   Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009
   Kurioka T, 2014, BRAIN RES, V1583, P201, DOI 10.1016/j.brainres.2014.07.052
   Lang HN, 2006, J NEUROSCI, V26, P3541, DOI 10.1523/JNEUROSCI.2488-05.2006
   Lawoko-Kerali G, 2004, MECH DEVELOP, V121, P287, DOI 10.1016/j.mod.2003.12.006
   Le Prell CG, 2012, EAR HEARING, V33, pE44, DOI 10.1097/AUD.0b013e31825f9d89
   Liberman MC, 2014, J ACOUST SOC AM, V135, P2311, DOI [10.1121/1.4877618, DOI 10.1523/JNEUROSCI.2845-09.2009]
   Lin HW, 2011, JARO-J ASSOC RES OTO, V12, P605, DOI 10.1007/s10162-011-0277-0
   Lu CC, 2011, J NEUROSCI, V31, P10903, DOI 10.1523/JNEUROSCI.2358-11.2011
   Marcil V, 2010, J BIOL CHEM, V285, P40448, DOI 10.1074/jbc.M110.155358
   Matsunobu T, 2009, ACTA OTO-LARYNGOL, V129, P18, DOI 10.1080/00016480902933056
   Meltser I, 2010, NEUROSCIENCE, V165, P1439, DOI 10.1016/j.neuroscience.2009.11.025
   Meltser I, 2009, J NEUROTRAUM, V26, P1835, DOI 10.1089/neu.2008.0874
   Miyao M, 2008, LARYNGOSCOPE, V118, P1801, DOI 10.1097/MLG.0b013e31817e2c27
   Nordmann AS, 2000, HEARING RES, V139, P13, DOI 10.1016/S0378-5955(99)00163-X
   Potashkin JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043595
   Ruan QW, 2007, ACTA OTO-LARYNGOL, V127, P594, DOI 10.1080/00016480600951459
   Shen J, 2015, DATABASE-OXFORD, V24, P2015
   Shizuki K, 2002, NEUROSCI LETT, V320, P73, DOI 10.1016/S0304-3940(02)00059-9
   SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353
   Stamatiou GA, 2013, OTOL NEUROTOL, V34, P961, DOI 10.1097/MAO.0b013e3182898272
   Taggart R. Thomas, 2001, Noise Health, V3, P1
   Tahera Y, 2006, J NEUROSCI RES, V83, P1066, DOI 10.1002/jnr.20795
   Vlajkovic SM, 2004, NEUROSCIENCE, V126, P763, DOI 10.1016/j.neuroscience.2004.04.023
   Wang J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3106
   Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0
   Yamashita D, 2008, J NEUROSCI RES, V86, P920, DOI 10.1002/jnr.21533
   Zhou YD, 2013, AUDIOL NEURO-OTOL, V18, P89, DOI 10.1159/000345208
NR 46
TC 4
Z9 4
U1 0
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-8451
EI 1932-846X
J9 DEV NEUROBIOL
JI Dev. Neurobiol.
PD DEC
PY 2016
VL 76
IS 12
BP 1374
EP 1386
DI 10.1002/dneu.22399
PG 13
WC Developmental Biology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Developmental Biology; Neurosciences & Neurology
GA EF0II
UT WOS:000390008700006
PM 27112738
DA 2024-02-19
ER

PT J
AU Jin, W
AF Jin, Wei
TI Age-related increase of β<sub>1</sub>-adrenergic receptor gene
   expression in rat liver: a potential mechanism contributing to increased
   β-adrenergic receptor density and responsiveness during aging
SO JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION
LA English
DT Article
DE beta AR; receptor density; aging; gene expression; liver
ID C-MYC TRANSCRIPT; ADENYLATE-CYCLASE; MOLECULAR-CLONING; CYCLIC-AMP;
   TISSUE; GLYCOGENOLYSIS; STATE; RNA
AB In this study we examined whether the levels of gene expressions of the three beta-adrenergic receptor (PAR) subtypes, beta(1), beta(2), and beta(3), contribute to age-related increase in beta AR density. Liver membranes and total RNA were prepared from young (4- to 6-month-old) and old (24-month-old) male Fischer 344 rats. beta AR density (B-max) in liver membranes was measured by a radioligand receptor binding assay using the receptor subtype nonselective beta AR antagonist I-125-pindolol as the radioligand. Steady-state levels of beta(2)AR mRNA in rat liver were measured by Northern blot analysis; because of the low abundance of beta(1)AR and beta(3)AR mRNA in rat liver, the expressions of these genes were measured by a semiquantitative RT-PCR or an RT-PCR. Scatchard analysis of saturation binding curves of the binding assay confirmed an age-related increase in B-max (young: 7.1 +/- 0.8 fmol/mg protein vs. old: 18.1 +/- 4.3 fmol/mg protein). No age-related differences were found in the levels of beta(2)AR mRNA. However, semiquantitative RT-PCR revealed an approximately twofold increase in beta(1)AR mRNA level between young and old rats (P < 0.05). beta(1)AR mRNA levels were also correlated with B-max for I-125-pindolol binding sites in individual rats (r = 0.67; P = 0.012). beta(3)AR mRNA, which was demonstrable in rat white adipose tissue by RT-PCR, was generally not detected in livers from young or old rats, with the exception of two old rats with the highest B-max. These results suggest that an age-related increase of beta(1)AR gene expression contributes to increased beta AR density and beta adrenergic responsiveness in rat liver during aging.
C1 [Jin, Wei] Univ Texas Hlth Sci Ctr San Antonio, GRECC, Audie L Murphy Mem Vet Hosp, San Antonio, TX 78229 USA.
   [Jin, Wei] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA.
C3 US Department of Veterans Affairs; Veterans Health Administration (VHA);
   Audie L. Murphy Memorial Veterans Hospital; Geriatric Research Education
   & Clinical Center; University of Texas System; University of Texas
   Health Science Center at San Antonio; University of Texas System;
   University of Texas Health Science Center at San Antonio
RP Jin, W (corresponding author), 2451-200-13-301 Zhong Shan Bei Rd, Shanghai 200063, Peoples R China.
EM mazwang@fudan.edu.cn
CR [Anonymous], 1989, MOL CLONING LAB MANU
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   DAX EM, 1986, J RECEPTOR RES, V6, P165, DOI 10.3109/10799898609073931
   DAX EM, 1987, ENDOCRINOLOGY, V120, P1534, DOI 10.1210/endo-120-4-1534
   DAX EM, 1998, GERONTOLOGIST, V28, pA137
   GRAHAM SM, 1987, AM J PHYSIOL, V253, pE277, DOI 10.1152/ajpendo.1987.253.3.E277
   GRANNEMAN JG, 1991, MOL PHARMACOL, V40, P895
   KATZ MS, 1987, BIOCHEM BIOPH RES CO, V147, P724, DOI 10.1016/0006-291X(87)90990-9
   KATZ MS, 1985, AM J PHYSIOL, V248, pE712, DOI 10.1152/ajpendo.1985.248.6.E712
   KATZ MS, 1993, EXP GERONTOL, V28, P329, DOI 10.1016/0531-5565(93)90060-Q
   KATZ MS, 1988, AM J PHYSIOL, V254, pE54, DOI 10.1152/ajpendo.1988.254.1.E54
   MAKINO R, 1984, NATURE, V310, P697, DOI 10.1038/310697a0
   Marone Maria, 2001, Biological Procedures Online, V3, P19, DOI 10.1251/bpo20
   MATOCHA MF, 1987, BIOCHEM BIOPH RES CO, V147, P1, DOI 10.1016/S0006-291X(87)80078-5
   Moffett S, 2001, J NEUROCHEM, V76, P269, DOI 10.1046/j.1471-4159.2001.00005.x
   MUZZIN P, 1991, J BIOL CHEM, V266, P24053
   ROSSBY SP, 1991, J CELL PHYSIOL, V147, P55, DOI 10.1002/jcp.1041470108
   SAKAI M, 1989, CANCER RES, V49, P5633
   SCARPACE PJ, 1987, J GERONTOL, V42, P442, DOI 10.1093/geronj/42.4.442
   SCHLEIFER LS, 1989, J CELL PHYSIOL, V140, P52, DOI 10.1002/jcp.1041400107
   SEMSEI I, 1989, ONCOGENE, V4, P465
   SHERLINE P, 1972, ENDOCRINOLOGY, V91, P680, DOI 10.1210/endo-91-3-680
   TRAIANEDES K, 1995, J BIOL CHEM, V270, P20891, DOI 10.1074/jbc.270.36.20891
NR 23
TC 7
Z9 7
U1 0
U2 2
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 1079-9893
J9 J RECEPT SIG TRANSD
JI J. Recept. Signal Transduct.
PD FEB
PY 2010
VL 30
IS 1
BP 24
EP 30
DI 10.3109/10799890903358206
PG 7
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA 572WG
UT WOS:000275864200003
PM 19883205
DA 2024-02-19
ER

PT J
AU Li, QJ
   Chen, CJ
   Chen, X
   Han, MM
   Li, J
AF Li, Qijian
   Chen, Chaojin
   Chen, Xi
   Han, Mingming
   Li, Juan
TI Dexmedetomidine attenuates renal fibrosis via α2-adrenergic
   receptor-dependent inhibition of cellular senescence after renal
   ischemia/reperfusion
SO LIFE SCIENCES
LA English
DT Article
DE Dexmedetomidine; Renal ischemia reperfusion; Fibrosis; Senescence;
   Inflammation
ID ACUTE KIDNEY INJURY; LIVER-TRANSPLANTATION; ISCHEMIA-REPERFUSION;
   SIGNALING PATHWAY; MECHANISMS; ACTIVATION
AB Background: Renal ischemia/reperfusion (IR) can induce acute kidney injury (AKI), which often progresses to chronic kidney disease (CKD). Dexmedetomidine (Dex), a highly selective alpha 2 adrenergic receptor (alpha 2-AR) agonist, protects against acute renal IR-induced injury. However, the effects of Dex on the transition of AKI to CKD remain unclear. Therefore, we investigated the mechanisms of Dex on renal fibrosis.
   Methods: Adult male C57BL/6 mice were pretreated with Dex, a specific alpha 2A-adrenergic receptor (AR) blocker (BRL-44408), or a cell senescence inhibitor (rapamycin) in a surgical bilateral renal IR model. The diagnoses of AKI and chronic renal fibrosis were performed by histopathological staining and western blotting. Histopathological changes, cell senescence, tubular fibrotic markers, and the expression of inflammatory factors were studied.
   Results: Pretreatment with Dex alleviated renal IR-induced AKI and chronic tubulointerstitial fibrosis in later stages. Similar to the effects of rapamycin, pretreatment with Dex also decreased the number of senescent tubular cells and weakened the protein expression of senescence-associated markers such as p53, p21, and p16. Furthermore, the expression of inflammatory markers was also decreased in Dex-treated IR mice; and these protective effects of Dex could be abolished by treatment with the specific alpha 2A-AR blocker, BRL-44408.
   Conclusions: The administration of a single dose of Dex protects against AKI and CKD. Dex inhibits tubular cell senescence and inflammation as well as improves renal fibrosis to moderate the AKI-to-CKD transition. The renal protective potential of Dex may provide a novel treatment strategy for high-risk renal injury patients.
C1 [Li, Qijian; Li, Juan] Shandong Univ, Sch Med, Jinan 250012, Shandong, Peoples R China.
   [Li, Qijian; Chen, Xi; Han, Mingming; Li, Juan] Anhui Prov Hosp, Dept Anesthesiol, Hefei 230001, Anhui, Peoples R China.
   [Chen, Chaojin] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Anesthesiol, Guangzhou 510630, Guangdong, Peoples R China.
C3 Shandong University; Sun Yat Sen University
RP Li, J (corresponding author), South Dist Anhui Prov Hosp, Dept Anesthesiol, Swan Lake Rd, Hefei 230001, Anhui, Peoples R China.
EM huamuzi1999@163.com
RI CHEN, Chaojin/AAG-4528-2019
OI CHEN, Chaojin/0000-0001-5101-4101
CR CHEN CJ, 2016, MEDICINE, V95
   Chkhotua AB, 2006, TRANSPL INT, V19, P72, DOI 10.1111/j.1432-2277.2005.00227.x
   Clements ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070464
   Colin PJ, 2017, BRIT J ANAESTH, V119, P200, DOI 10.1093/bja/aex085
   Cui J, 2015, CRIT CARE MED, V43, pE356, DOI 10.1097/CCM.0000000000001035
   Devarajan P, 2006, J AM SOC NEPHROL, V17, P1503, DOI 10.1681/ASN.2006010017
   Ferenbach DA, 2015, NAT REV NEPHROL, V11, P264, DOI 10.1038/nrneph.2015.3
   Haller ST, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.004106
   Humphreys BD, 2018, ANNU REV PHYSIOL, V80, P309, DOI 10.1146/annurev-physiol-022516-034227
   Kable JW, 2000, J PHARMACOL EXP THER, V293, P1
   Karahan MA, 2016, RENAL FAILURE, V38, P693, DOI 10.3109/0886022X.2016.1157746
   Kim J, 2015, KIDNEY INT, V87, P350, DOI 10.1038/ki.2014.300
   Kim J, 2013, J AM SOC NEPHROL, V24, P229, DOI 10.1681/ASN.2012070678
   Kong WL, 2017, AM J TRANSL RES, V9, P5040
   Kuru S, 2015, INT SURG, V100, P87, DOI 10.9738/INTSURG-D-14-00184.1
   Leung JY, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00565-16
   Leung KCW, 2013, NAT REV NEPHROL, V9, P77, DOI 10.1038/nrneph.2012.280
   Li KL, 2007, BIOCELL, V31, P213
   Li X, 2018, J ANESTH, V32, P70, DOI 10.1007/s00540-017-2430-3
   Liu WH, 2017, EXP THER MED, V14, P3602, DOI 10.3892/etm.2017.4954
   Lopez-Soler R., 2016, AM J PHYSIOL-RENAL
   Patschan D, 2016, J NEPHROL, V29, P637, DOI 10.1007/s40620-015-0222-0
   Perry HM, 2018, J AM SOC NEPHROL, V29, P194, DOI 10.1681/ASN.2017060659
   Rahman S, 2017, WORLD J HEPATOL, V9, P823, DOI 10.4254/wjh.v9.i18.823
   Roberts V, 2017, TRANSPLANTATION, V101, pE194, DOI 10.1097/TP.0000000000001679
   Rodrigues CE, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0475-8
   Salvadori Maurizio, 2015, World J Transplant, V5, P52, DOI 10.5500/wjt.v5.i2.52
   Schmitt R, 2017, KIDNEY INT, V92, P569, DOI 10.1016/j.kint.2017.02.036
   Singh P, 2013, CLIN EXP PHARMACOL P, V40, P138, DOI 10.1111/1440-1681.12036
   Singh SP, 2015, DIS MODEL MECH, V8, P931, DOI 10.1242/dmm.020511
   Soltani Ghasem, 2017, Electron Physician, V9, P5578, DOI 10.19082/5578
   Sturmlechner I, 2017, NAT REV NEPHROL, V13, P77, DOI 10.1038/nrneph.2016.183
   Wan Y, 2017, AM J PATHOL, V187, P2788, DOI 10.1016/j.ajpath.2017.08.027
   Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144
   Yao H, 2015, SCI REP-UK, V5, DOI 10.1038/srep16849
   Zhong X, 2017, AM J TRANSL RES, V9, P2920
NR 36
TC 24
Z9 25
U1 2
U2 21
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0024-3205
EI 1879-0631
J9 LIFE SCI
JI Life Sci.
PD AUG 15
PY 2018
VL 207
BP 1
EP 8
DI 10.1016/j.lfs.2018.05.003
PG 8
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA GO3GG
UT WOS:000439876800001
PM 29729264
DA 2024-02-19
ER

PT J
AU SMITH, AG
   CARTHEW, P
   FRANCIS, JE
   EDWARDS, RE
   DINSDALE, D
AF SMITH, AG
   CARTHEW, P
   FRANCIS, JE
   EDWARDS, RE
   DINSDALE, D
TI CHARACTERIZATION AND ACCUMULATION OF FERRITIN IN HEPATOCYTE NUCLEI OF
   MICE WITH IRON OVERLOAD
SO HEPATOLOGY
LA English
DT Article
ID RAT-LIVER NUCLEI; DNA DAMAGE; CELLS; MACROMOLECULES; ENVELOPE; DISEASE;
   INVITRO; STORES; CANCER; MOUSE
AB After a single subcutaneous dose of iron-dextran (600 mg of iron/kg), iron overload developed in C57BL/10ScSn mice.  At 4, 24 and 78 wk liver nonheme iron concentrations were 67-, 42- and 21-fold higher than controls, respectively.  Much of the iron was in macrophages, but hepatocytes were also strongly positive for Perls' stainable iron.  One feature was the development of iron-positive nuclear inclusions in hepatocytes.  After a delay of at least 8 wk when no stainable iron was evident, a maximum of 37% of periportal hepatocytes contained inclusions by 24 wk.  Although this proportion remained constant for the remainder of the study, the size of the inclusions (which were not membrane-limited) increased to > 3-mu-m in diameter, occupying > 25% of the nuclear volume.  The presence of iron in the inclusions was confirmed by energy dispersive x-ray microanalysis.  Immunocytochemical studies showed that iron was present as aggregates of ferritin. Quantitation of nonaggregated ferritin molecules by image analyses after electron microscopy demonstrated that within 4 wk ferritin levels in cytoplasm and nucleoplasm had greatly increased but that was a concentration gradient of approximately one order of magnitude across the nuclear envelope.
   These findings are consistent with the hypothesis that in iron-loaded mouse hepatocytes there is a slow passage of ferritin-molecules through the nuclear pores; the gradient is maintained by the continual aggregation of ferritin within the nucleus.  Intranuclear ferritin may provide a source of iron for catalyzing hydroxyl radical formation in nuclei during some toxic, carcinogenic and aging processes.
RP SMITH, AG (corresponding author), MRC,TOXICOL UNIT,WOODMANSTERNE RD,CARSHALTON SM5 4EF,SURREY,ENGLAND.
CR ADELMAN R, 1988, P NATL ACAD SCI USA, V85, P2706, DOI 10.1073/pnas.85.8.2706
   AINSWORTH SK, 1972, J HISTOCHEM CYTOCHEM, V20, P225, DOI 10.1177/20.3.225
   ALTMANN HW, 1977, VIRCHOWS ARCH B, V23, P277
   AUST S D, 1985, Journal of Free Radicals in Biology and Medicine, V1, P3, DOI 10.1016/0748-5514(85)90025-X
   BACON BR, 1990, HEPATOLOGY, V11, P127, DOI 10.1002/hep.1840110122
   BEAUMONT C, 1989, J BIOL CHEM, V264, P7498
   BEAUMONT C, 1987, J BIOL CHEM, V262, P10519
   BORG DC, 1988, UCLA S MOL CELLULAR, V82, P427
   COOPER PJ, 1988, HISTOCHEM J, V20, P499, DOI 10.1007/BF01002648
   FELDHERR CM, 1962, J CELL BIOL, V12, P159, DOI 10.1083/jcb.12.1.159
   GERACE L, 1988, ANNU REV CELL BIOL, V4, P335, DOI 10.1146/annurev.cb.04.110188.002003
   HADDOW A, 1960, J NATL CANCER I, V24, P109
   HALLIWELL B, 1987, FASEB J, V1, P358, DOI 10.1096/fasebj.1.5.2824268
   HONDA T, 1981, BRIT J HAEMATOL, V49, P653, DOI 10.1111/j.1365-2141.1981.tb07277.x
   IANCU TC, 1989, ULTRASTRUCT PATHOL, V13, P573, DOI 10.3109/01913128909074536
   IANCU TC, 1985, J HEPATOL, V1, P261, DOI 10.1016/S0168-8278(85)80054-4
   IMLAY JA, 1988, SCIENCE, V240, P640, DOI 10.1126/science.2834821
   JOSHI JG, 1988, TOXICOLOGY, V48, P21, DOI 10.1016/0300-483X(88)90055-8
   KERR DNS, 1960, J ULTRA MOL STRUCT R, V3, P313, DOI 10.1016/S0022-5320(60)80017-2
   KUKIELKA E, 1989, ARCH BIOCHEM BIOPHYS, V273, P319, DOI 10.1016/0003-9861(89)90490-6
   LADDA R, 1962, EXP CELL RES, V28, P595, DOI 10.1016/0014-4827(62)90266-5
   LANFORD RE, 1986, CELL, V46, P575, DOI 10.1016/0092-8674(86)90883-4
   LEDUC EH, 1959, J BIOPHYS BIOCHEM CY, V6, P427, DOI 10.1083/jcb.6.3.427
   LOPEZ A, 1980, ANN ANAT PATHOL, V25, P65
   MASSOVER WH, 1985, BIOCHIM BIOPHYS ACTA, V829, P377, DOI 10.1016/0167-4838(85)90248-1
   MENEGHINI R, 1988, MUTAT RES, V195, P215, DOI 10.1016/0165-1110(88)90001-2
   MOORE RD, 1961, J ULTRA MOL STRUCT R, V5, P244, DOI 10.1016/S0022-5320(61)90018-1
   MYAGKAYA GL, 1982, MICRON, V13, P7, DOI 10.1016/0047-7206(82)90134-0
   NIEDERAU C, 1985, NEW ENGL J MED, V313, P1256, DOI 10.1056/NEJM198511143132004
   PAINE PL, 1972, EXP CELL RES, V74, P81, DOI 10.1016/0014-4827(72)90483-1
   PARK CH, 1987, LAB INVEST, V57, P555
   RICHTER GW, 1961, J BIOPHYS BIOCHEM CY, V9, P263, DOI 10.1083/jcb.9.2.263
   RICHTER GW, 1978, AM J PATHOL, V91, P361
   SCHRODER JM, 1985, MUSCLE NERVE, V8, P52, DOI 10.1002/mus.880080110
   SELBY JV, 1988, INT J CANCER, V41, P677, DOI 10.1002/ijc.2910410507
   SHIRES TK, 1982, BIOCHEM J, V205, P321, DOI 10.1042/bj2050321
   SMITH AG, 1989, INT J CANCER, V43, P492, DOI 10.1002/ijc.2910430325
   SMITH AG, 1990, CARCINOGENESIS, V1, P437
   STACEY DW, 1984, EXP CELL RES, V154, P283, DOI 10.1016/0014-4827(84)90687-6
   STEVENS RG, 1988, NEW ENGL J MED, V319, P1047, DOI 10.1056/NEJM198810203191603
   TERADA T, 1989, HEPATOLOGY, V10, P851, DOI 10.1002/hep.1840100517
   TORRANCE J D, 1968, South African Journal of Medical Sciences, V33, P9
   TORTI SV, 1988, J BIOL CHEM, V263, P12638
   UMEMURA T, 1990, CARCINOGENESIS, V11, P345, DOI 10.1093/carcin/11.2.345
   VACA CE, 1989, BIOCHIM BIOPHYS ACTA, V1001, P35, DOI 10.1016/0005-2760(89)90304-4
   WICKRAMASINGHE SN, 1978, BRIT J HAEMATOL, V38, P23, DOI 10.1111/j.1365-2141.1978.tb07104.x
NR 46
TC 55
Z9 55
U1 0
U2 5
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0270-9139
J9 HEPATOLOGY
JI Hepatology
PD DEC
PY 1990
VL 12
IS 6
BP 1399
EP 1405
DI 10.1002/hep.1840120622
PG 7
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA EQ625
UT WOS:A1990EQ62500021
PM 2258156
OA Bronze
DA 2024-02-19
ER

PT J
AU Pinçon, A
   De Montgolfier, O
   Akkoyunlu, N
   Daneault, C
   Pouliot, P
   Villeneuve, L
   Lesage, F
   Levy, BI
   Thorin-Trescases, N
   Thorin, É
   Ruiz, M
AF Pincon, Anthony
   De Montgolfier, Olivia
   Akkoyunlu, Nilay
   Daneault, Caroline
   Pouliot, Philippe
   Villeneuve, Louis
   Lesage, Frederic
   Levy, Bernard, I
   Thorin-Trescases, Nathalie
   Thorin, Eric
   Ruiz, Matthieu
TI Non-Alcoholic Fatty Liver Disease, and the Underlying Altered Fatty Acid
   Metabolism, Reveals Brain Hypoperfusion and Contributes to the Cognitive
   Decline in APP/PS1 Mice
SO METABOLITES
LA English
DT Article
DE NAFLD; inflammation; polyunsaturated fatty acids; senescence; brain
   hypoperfusion; untargeted and targeted lipidomics; amyloid Beta;
   liver-to-brain axis; Alzheimer disease mouse model
ID CEREBRAL-BLOOD-FLOW; A-BETA-PEPTIDES; WILD-TYPE MICE;
   ALZHEIMERS-DISEASE; MOUSE MODEL; OXIDATIVE STRESS; CHOLESTEROL; DIET;
   DYSFUNCTION; IMPAIRMENT
AB Non-alcoholic fatty liver disease (NAFLD), the leading cause of chronic liver disease, is associated with cognitive decline in middle-aged adults, but the mechanisms underlying this association are not clear. We hypothesized that NAFLD would unveil the appearance of brain hypoperfusion in association with altered plasma and brain lipid metabolism. To test our hypothesis, amyloid precursor protein/presenilin-1 (APP/PS1) transgenic mice were fed a standard diet or a high-fat, cholesterol and cholate diet, inducing NAFLD without obesity and hyperglycemia. The diet-induced NAFLD disturbed monounsaturated and polyunsaturated fatty acid (MUFAs, PUFAs) metabolism in the plasma, liver, and brain, and particularly reduced n-3 PUFAs levels. These alterations in lipid homeostasis were associated in the brain with an increased expression of Tnf, Cox2, p21, and Nox2, reminiscent of brain inflammation, senescence, and oxidative stress. In addition, compared to wild-type (WT) mice, while brain perfusion was similar in APP/PS1 mice fed with a chow diet, NAFLD in APP/PS1 mice reveals cerebral hypoperfusion and furthered cognitive decline. NAFLD reduced plasma (40)- and (42)-amyloid levels and altered hepatic but not brain expression of genes involved in -amyloid peptide production and clearance. Altogether, our results suggest that in a mouse model of Alzheimer disease (AD) diet-induced NAFLD contributes to the development and progression of brain abnormalities through unbalanced brain MUFAs and PUFAs metabolism and cerebral hypoperfusion, irrespective of brain amyloid pathology that may ultimately contribute to the pathogenesis of AD.
C1 [Pincon, Anthony; De Montgolfier, Olivia] Univ Montreal, Fac Med, Dept Pharmacol & Physiol, Montreal, PQ H3T 1J4, Canada.
   [Pincon, Anthony; De Montgolfier, Olivia; Akkoyunlu, Nilay; Daneault, Caroline; Pouliot, Philippe; Villeneuve, Louis; Lesage, Frederic; Thorin-Trescases, Nathalie; Thorin, Eric; Ruiz, Matthieu] Univ Montreal, Res Ctr, Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada.
   [Pouliot, Philippe; Lesage, Frederic] Ecole Polytech Montreal, Dept Elect Engn, Montreal, PQ H3T 1J4, Canada.
   [Levy, Bernard, I] Hop Lariboisiere, Inst Vaisseaux & Sang, F-75010 Paris, France.
   [Thorin, Eric] Univ Montreal, Fac Med, Dept Surg, Montreal, PQ H3T 1J4, Canada.
   [Ruiz, Matthieu] Univ Montreal, Fac Med, Dept Med, Montreal, PQ H3T 1J4, Canada.
   [Akkoyunlu, Nilay] Sorbonne Univ, Campus Pierre & Marie Curie,4 Pl Jussieu, F-75005 Paris, France.
C3 Universite de Montreal; Universite de Montreal; Universite de Montreal;
   Polytechnique Montreal; Universite Paris Cite; Assistance Publique
   Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal
   - APHP; Universite de Montreal; Universite de Montreal; Sorbonne
   Universite
RP Ruiz, M (corresponding author), Univ Montreal, Res Ctr, Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada.
EM anthony.pincon@live.fr; olivia.demontgolfier@gmail.com;
   nilay.akk@gmail.com; caroline.daneault@icm-mhi.org;
   ph.pouliot@gmail.com; louis.villeneuve@icm-mhi.org;
   frederic.lesage@polymtl.ca; bernard.levy@inserm.fr;
   nathalie.trescases@icm-mhi.org; eric.thorin@umontreal.ca;
   matthieu.ruiz@umontreal.ca
RI ; Thorin, Eric/K-3978-2013
OI de MONTGOLFIER, Olivia/0000-0002-0434-907X; Lesage,
   Frederic/0000-0003-3699-1283; Ruiz, Matthieu/0000-0003-4583-9718;
   Thorin, Eric/0000-0001-5827-8935
FU Canadian Institutes of Health Research [14496, 133649]; Heart and Stroke
   foundation of Canada; Foundation of the Montreal Heart Institute; Fonds
   de la recherche du Quebec-Sante (FRQS)
FX This work was supported by Canadian Institutes of Health Research grants
   14496 and 133649 (E.T.), the Grant-in-Aid from the Heart and Stroke
   foundation of Canada (E.T.), the Foundation of the Montreal Heart
   Institute (E.T.), and Fonds de la recherche du Quebec-Sante (FRQS) for a
   postdoctoral fellowships awarded to A. Pincon.
CR Amen DG, 2017, J ALZHEIMERS DIS, V58, P1189, DOI 10.3233/JAD-170281
   Amtul Z, 2011, BRAIN PATHOL, V21, P321, DOI 10.1111/j.1750-3639.2010.00449.x
   Amtul Z, 2011, J BIOL CHEM, V286, P6100, DOI 10.1074/jbc.M110.183608
   Ances BM, 2009, HUM BRAIN MAPP, V30, P1120, DOI 10.1002/hbm.20574
   Asgharpour A, 2016, J HEPATOL, V65, P579, DOI 10.1016/j.jhep.2016.05.005
   Astarita G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012538
   Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613
   Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025
   Bascoul-Colombo C, 2016, BBA-MOL CELL BIOL L, V1861, P524, DOI 10.1016/j.bbalip.2016.03.005
   Bieghs V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030668
   Bowen CV, 2006, MAGN RESON IMAGING, V24, P857, DOI 10.1016/j.mri.2006.04.008
   Bussian TJ, 2018, NATURE, V562, P578, DOI 10.1038/s41586-018-0543-y
   Calderon F, 2004, J NEUROCHEM, V90, P979, DOI 10.1111/j.1471-4159.2004.02520.x
   Chae SW, 2008, NEUROSCI LETT, V436, P205, DOI 10.1016/j.neulet.2008.03.031
   Chen H, 2018, PROSTAG OTH LIPID M, V134, P32, DOI 10.1016/j.prostaglandins.2017.11.004
   Chugh BP, 2012, MAGN RESON MED, V68, P98, DOI 10.1002/mrm.23209
   Cifuentes D, 2015, HYPERTENSION, V65, P218, DOI 10.1161/HYPERTENSIONAHA.114.04139
   Cunnane SC, 2012, J ALZHEIMERS DIS, V29, P691, DOI 10.3233/JAD-2012-110629
   de Angelis-Pereira MC, 2017, ACTA CIR BRAS, V32, P1013, DOI 10.1590/s0102-865020170120000003
   De Montgolfier O., 2018, HYPERTENSION
   Delpech JC, 2015, NEUROPSYCHOPHARMACOL, V40, P525, DOI 10.1038/npp.2014.196
   Fedorova I, 2007, PROSTAG LEUKOTR ESS, V77, P269, DOI 10.1016/j.plefa.2007.10.013
   Fernández-Pérez EJ, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00226
   Ferreri C, 2017, DIAGNOSTICS, V7, DOI 10.3390/diagnostics7010001
   Forest A, 2018, J PROTEOME RES, V17, P3657, DOI 10.1021/acs.jproteome.8b00270
   Gaemers IC, 2011, BBA-MOL BASIS DIS, V1812, P447, DOI 10.1016/j.bbadis.2011.01.003
   Gélinas R, 2011, AM J PHYSIOL-HEART C, V301, pH813, DOI 10.1152/ajpheart.01275.2010
   Gordon GRJ, 2011, EXP PHYSIOL, V96, P393, DOI 10.1113/expphysiol.2010.053132
   Goritz C, 2005, MOL CELL NEUROSCI, V29, P190, DOI 10.1016/j.mcn.2005.02.006
   Grundy T, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00399
   Gu Y, 2018, CURR ALZHEIMER RES, V15, P493, DOI 10.2174/1567205015666180101145619
   Hamilton JA, 2007, J MOL NEUROSCI, V33, P2, DOI 10.1007/s12031-007-0060-1
   Hassan K, 2014, WORLD J GASTROENTERO, V20, P12082, DOI 10.3748/wjg.v20.i34.12082
   Heyward FD, 2012, NEUROBIOL LEARN MEM, V98, P25, DOI 10.1016/j.nlm.2012.04.005
   Ho L, 1999, J NEUROSCI RES, V57, P295
   Hopperton KE, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0721-5
   Jaeger S, 2008, CURR ALZHEIMER RES, V5, P15
   Kelly L, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.04.001
   Kim DG, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-015-0467-5
   Kobayashi N, 2000, CYTOKINE, V12, P1745, DOI 10.1006/cyto.2000.0782
   Koudinov AR, 2001, FASEB J, V15, P1858, DOI 10.1096/fj.00-0815fje
   Lalancette-Hébert M, 2011, STROKE, V42, P2903, DOI 10.1161/STROKEAHA.111.620856
   Lee JC, 2018, BBA-MOL CELL BIOL L, V1863, P980, DOI 10.1016/j.bbalip.2018.05.007
   Legault JT, 2015, CELL REP, V13, P981, DOI 10.1016/j.celrep.2015.09.054
   Leijenaar Jolien F, 2017, Alzheimers Dement (Amst), V9, P76, DOI 10.1016/j.dadm.2017.10.001
   Liao F, 2017, CURR OPIN LIPIDOL, V28, P60, DOI 10.1097/MOL.0000000000000383
   Love S, 2016, BRAIN PATHOL, V26, P607, DOI 10.1111/bpa.12401
   Lynch AM, 2007, NEUROBIOL AGING, V28, P845, DOI 10.1016/j.neurobiolaging.2006.04.006
   Martin DSD, 2002, J BIOL CHEM, V277, P34239, DOI 10.1074/jbc.M205289200
   MASON RP, 1992, NEUROBIOL AGING, V13, P413, DOI 10.1016/0197-4580(92)90116-F
   Matsumoto T, 2009, J PHARMACOL EXP THER, V329, P324, DOI 10.1124/jpet.108.148718
   Matsuzawa N, 2007, HEPATOLOGY, V46, P1392, DOI 10.1002/hep.21874
   McLean FH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30265-4
   Minogue AM, 2007, J NEUROCHEM, V103, P914, DOI 10.1111/j.1471-4159.2007.04848.x
   NISHINA PM, 1990, J LIPID RES, V31, P859
   Niwa K, 2001, AM J PHYSIOL-HEART C, V281, pH2417, DOI 10.1152/ajpheart.2001.281.6.H2417
   Osawa Y, 2002, INFECT IMMUN, V70, P6294, DOI 10.1128/IAI.70.11.6294-6301.2002
   Otaegui-Arrazola A, 2014, EUR J NUTR, V53, P1, DOI 10.1007/s00394-013-0561-3
   Park L, 2008, P NATL ACAD SCI USA, V105, P1347, DOI 10.1073/pnas.0711568105
   Pifferi F, 2007, PROSTAG LEUKOTR ESS, V77, P279, DOI 10.1016/j.plefa.2007.10.011
   Pifferi F, 2005, J NUTR, V135, P2241, DOI 10.1093/jn/135.9.2241
   Pinçon A, 2015, J ALZHEIMERS DIS, V45, P195, DOI 10.3233/JAD-142127
   Pistell PJ, 2010, J NEUROIMMUNOL, V219, P25, DOI 10.1016/j.jneuroim.2009.11.010
   Ren HX, 2017, FASEB J, V31, P282, DOI 10.1096/fj.201600896
   Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449
   Roher AE, 2012, VASC HEALTH RISK MAN, V8, P599, DOI 10.2147/VHRM.S34874
   Rosa Patrizia, 2010, Commun Integr Biol, V3, P352
   Schierwagen R, 2015, SCI REP-UK, V5, DOI 10.1038/srep12931
   Schwarz C, 2018, JPAD-J PREV ALZHEIM, V5, P26, DOI 10.14283/jpad.2017.23
   Schwingshackl L, 2015, NUTRIENTS, V7, P7651, DOI 10.3390/nu7095356
   Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210
   Seo SW, 2016, NEUROLOGY, V86, P1136, DOI 10.1212/WNL.0000000000002498
   Shin HK, 2007, BRAIN, V130, P2310, DOI 10.1093/brain/awm156
   Smith EE, 2009, STROKE, V40, P2601, DOI 10.1161/STROKEAHA.108.536839
   Snowden SG, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002266
   Song C, 2004, MOL PSYCHIATR, V9, P630, DOI 10.1038/sj.mp.4001462
   Sparks DL, 1997, ANN NY ACAD SCI, V826, P128, DOI 10.1111/j.1749-6632.1997.tb48466.x
   Stenger C, 2012, J NEUROCHEM, V123, P467, DOI 10.1111/j.1471-4159.2012.07922.x
   Ucar F, 2013, REDOX REP, V18, P127, DOI 10.1179/1351000213Y.0000000050
   Vance JE, 2000, BBA-MOL CELL BIOL L, V1486, P84, DOI 10.1016/S1388-1981(00)00050-0
   Wu KF, 2016, NEUROSCIENCE, V333, P345, DOI 10.1016/j.neuroscience.2016.07.038
   Wu SY, 2014, AM J CLIN NUTR, V100, P1232, DOI 10.3945/ajcn.114.088880
   Xiong HQ, 2008, NEUROBIOL DIS, V29, P422, DOI 10.1016/j.nbd.2007.10.005
   Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015
   Zdanov S, 2007, EXP CELL RES, V313, P3046, DOI 10.1016/j.yexcr.2007.04.033
NR 85
TC 32
Z9 35
U1 0
U2 7
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2218-1989
J9 METABOLITES
JI Metabolites
PD MAY
PY 2019
VL 9
IS 5
AR 104
DI 10.3390/metabo9050104
PG 20
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA IE8YU
UT WOS:000472660600024
PM 31130652
OA Green Published, gold, Green Accepted
DA 2024-02-19
ER

PT J
AU Shenvi, SV
   Smith, E
   Hagen, TM
AF Shenvi, Swapna V.
   Smith, Eric
   Hagen, Tory M.
TI Identification of age-specific Nrf2 binding to a novel antioxidant
   response element locus in the Gclc promoter: a compensatory means for
   the loss of glutathione synthetic capacity in the aging rat liver?
SO AGING CELL
LA English
DT Article
DE antioxidant response element; Bach1; small maf proteins; CREB-binding
   protein; glutamate cysteine ligase catalytic subunit
ID GAMMA-GLUTAMYLCYSTEINE SYNTHETASE; VASCULAR OXIDATIVE STRESS; DNA
   METHYLATION; SMALL MAF; COORDINATED ACTIVATION; TRANSACTIVATION DOMAIN;
   MEDIATED EXPRESSION; GENE-EXPRESSION; HEAVY SUBUNIT; LIPOIC ACID
AB NFE2-related factor 2 (Nrf2) transcriptionally governs the cellular response to harmful electrophiles, xenobiotics, and reactive oxygen species. Its nuclear levels decline with age (Suh , 2004a), which in part explains the age-related loss of phase II detoxification. However, little work has yet characterized how age affects Nrf2 DNA binding or the role that alterations to the Nrf2 transcriptional apparatus plays in modulating Nrf2-mediated gene expression. In this study, we used immunoprecipitation assays to show that Nrf2 bound to the active antioxidant response element (ARE) of the catalytic subunit of glutamate cysteine ligase (GCLC) is significantly lower in hepatic chromatin from aged vs. young rats. Moreover, the activity at this ARE locus is diminished during aging because of the presence of Bach1 and the absence of CREB-binding protein (CBP), a transcriptional repressor and co-activator, respectively. Further analysis reveals that Nrf2 occupies an alternate ARE site located -2.2 kb downstream from the normally active ARE binding site in livers of old rats, indicating an age-specific adaptation to maintain gene expression. Our results, thus, show that the conversion of Nrf2 binding from an active ARE to an alternative ARE element is not adequate to maintain basal expression of hepatic Gclc in old rats, which provides a potential mechanism for the age-related loss of glutathione synthetic and other phase II enzymes.
C1 [Shenvi, Swapna V.] Oregon State Univ, Mol & Cellular Biol Program, Corvallis, OR 97331 USA.
   [Shenvi, Swapna V.; Smith, Eric; Hagen, Tory M.] Oregon State Univ, Linus Pauling Inst, Corvallis, OR 97331 USA.
   [Smith, Eric; Hagen, Tory M.] Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA.
C3 Oregon State University; Oregon State University; Oregon State
   University
RP Hagen, TM (corresponding author), 307 LPSC, Corvallis, OR 97331 USA.
EM tory.hagen@oregonstate.edu
FU National Center for Complementary and Alternative Medicine (NCCAM) [P01
   AT002034]; National Institute on Aging (NIA) [2R01 AG017141-06A2]
FX This work was supported by grant P01 AT002034 from the National Center
   for Complementary and Alternative Medicine (NCCAM) and 2R01
   AG017141-06A2 from the National Institute on Aging (NIA). Its contents
   are solely the responsibility of the authors and do not necessarily
   represent the official views of NCCAM, NIA, or the National Institutes
   of Health. We would like to acknowledge Dr. Chrissa Kioussi's guidance
   and Mrs. Judy Butler's technical assistance in performing chromatin
   immunoprecipitation experiments. We would also like to thank Dr. Anil
   Jaiswal for providing the Nrf2 expression vector.
CR Bandyopadhyay D, 2002, CANCER RES, V62, P6231
   Burzynski SR, 2005, MED HYPOTHESES, V64, P201, DOI 10.1016/j.mehy.2004.06.010
   Chung YH, 2002, BRAIN RES, V956, P312, DOI 10.1016/S0006-8993(02)03562-X
   Dhakshinamoorthy S, 2005, J BIOL CHEM, V280, P16891, DOI 10.1074/jbc.M500166200
   Dhakshinamoorthy S, 2000, J BIOL CHEM, V275, P40134, DOI 10.1074/jbc.M003531200
   Erickson AM, 2002, J BIOL CHEM, V277, P30730, DOI 10.1074/jbc.M205225200
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   Gupta S, 2006, GENE, V377, P159, DOI 10.1016/j.gene.2006.04.020
   Hagen TM, 2002, ANN NY ACAD SCI, V959, P491, DOI 10.1111/j.1749-6632.2002.tb02119.x
   Hall DM, 2001, J GERONTOL A-BIOL, V56, pB259, DOI 10.1093/gerona/56.6.B259
   HUANG CS, 1993, J BIOL CHEM, V268, P19675
   HUANG CS, 1993, J BIOL CHEM, V268, P20578
   Hyun DH, 2006, P NATL ACAD SCI USA, V103, P19908, DOI 10.1073/pnas.0608008103
   Iakova P, 2003, CELL, V113, P495, DOI 10.1016/S0092-8674(03)00318-0
   Igarashi K, 1998, J BIOL CHEM, V273, P11783, DOI 10.1074/jbc.273.19.11783
   Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074
   Kaspar JW, 2010, J BIOL CHEM, V285, P153, DOI 10.1074/jbc.M109.040022
   Katoh Y, 2001, GENES CELLS, V6, P857, DOI 10.1046/j.1365-2443.2001.00469.x
   Lee JI, 2006, BIOCHEM J, V393, P181, DOI 10.1042/BJ20051111
   Levy S, 2009, FREE RADICAL BIO MED, V47, P1172, DOI 10.1016/j.freeradbiomed.2009.07.036
   Li W, 2008, BBA-MOL CELL RES, V1783, P1847, DOI 10.1016/j.bbamcr.2008.05.024
   Li WG, 2006, J BIOL CHEM, V281, P27251, DOI 10.1074/jbc.M602746200
   Lu SC, 1999, TOXICOL APPL PHARM, V159, P161, DOI 10.1006/taap.1999.8729
   Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005
   Malhotra D, 2010, NUCLEIC ACIDS RES, V38, P5718, DOI 10.1093/nar/gkq212
   Pearson KJ, 2008, P NATL ACAD SCI USA, V105, P2325, DOI 10.1073/pnas.0712162105
   Reichard JF, 2007, NUCLEIC ACIDS RES, V35, P7074, DOI 10.1093/nar/gkm638
   Shen GX, 2004, J BIOL CHEM, V279, P23052, DOI 10.1074/jbc.M401368200
   Shenvi SV, 2008, CURR PROTOC TOXICOL, V14. 7, P1471
   Shenvi SV, 2009, PHARMACOL RES, V60, P229, DOI 10.1016/j.phrs.2009.06.003
   Song IS, 2005, J BIOL CHEM, V280, P28230, DOI 10.1074/jbc.M413103200
   STIO M, 1994, BIOCHEM CELL BIOL, V72, P58, DOI 10.1139/o94-010
   Strunnikova M, 2005, MOL CELL BIOL, V25, P3923, DOI 10.1128/MCB.25.10.3923-3933.2005
   Suh JH, 2004, ARCH BIOCHEM BIOPHYS, V423, P126, DOI 10.1016/j.abb.2003.12.020
   Suh JH, 2004, P NATL ACAD SCI USA, V101, P3381, DOI 10.1073/pnas.0400282101
   Sun Z, 2009, MOL CELL BIOL, V29, P2658, DOI 10.1128/MCB.01639-08
   Theodore M, 2008, J BIOL CHEM, V283, P8984, DOI 10.1074/jbc.M709040200
   Thompson RF, 2010, AGING CELL, V9, P506, DOI 10.1111/j.1474-9726.2010.00577.x
   Toroser D, 2006, BBA-GEN SUBJECTS, V1760, P233, DOI 10.1016/j.bbagen.2005.10.010
   Ungvari Z, 2011, J GERONTOL A-BIOL, V66, P866, DOI 10.1093/gerona/glr092
   Ungvari Z, 2011, AM J PHYSIOL-HEART C, V301, pH363, DOI 10.1152/ajpheart.01134.2010
   Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960
   Wasserman WW, 1997, P NATL ACAD SCI USA, V94, P5361, DOI 10.1073/pnas.94.10.5361
   Yang HP, 2005, BIOCHEM J, V391, P399, DOI 10.1042/BJ20050795
   Zhu M, 2001, BIOCHEM BIOPH RES CO, V289, P212, DOI 10.1006/bbrc.2001.5944
   Zipper LM, 2000, BIOCHEM BIOPH RES CO, V278, P484, DOI 10.1006/bbrc.2000.3830
NR 46
TC 34
Z9 37
U1 0
U2 3
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1474-9718
J9 AGING CELL
JI Aging Cell
PD APR
PY 2012
VL 11
IS 2
BP 297
EP 304
DI 10.1111/j.1474-9726.2011.00788.x
PG 8
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 908WF
UT WOS:000301523000015
PM 22212472
OA Green Accepted, hybrid
DA 2024-02-19
ER

PT J
AU Polo, M
   García-Bravo, M
   Igal, A
   Dumm, INTG
   Goya, RG
AF Polo, M
   García-Bravo, M
   Igal, A
   Dumm, INTG
   Goya, RG
TI Age changes in the activity of liver 3-hydroxy-3-methylglutaryl-CoA
   reductase in female rats:: influence of mammary pathology
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE HMG-CoA reductase; aging; liver; circadian rhythm; mammary tumors; lipid
   composition; pituitary hormones
ID LOW-DENSITY-LIPOPROTEIN; COENZYME-A REDUCTASE; CHOLESTEROL-SYNTHESIS;
   PROLACTIN-BINDING; LIPID-METABOLISM; INACTIVE FORMS; GROWTH-HORMONE;
   MESSENGER-RNA; FATTY-ACIDS; RECEPTOR
AB Hydroxymethylglutaryl-Coenzyme A (HMG-CoA) reductase is a highly regulated enzyme which shows a marked circadian rhythmicity. We studied the impact of aging on this rhythm as well as the degree of correlation between age changes in circulating pituitary hormone levels and liver reductase activity in young (4 months) and old (33 months) Sprague-Dawley female rats. Lipid composition was also assessed in plasma and liver microsomes. The maximal activity (midnight) of HMG-CoA reductase fell from 864 +/- 28 pmol mevalonate/min/mg protein in the young rats to 552 +/- 45 pmol/min/mg protein in the old animals, whereas significant change was not observed in the basal (noon) activity levels of the enzyme. Noon serum cholesterol, but not midnight values, was significantly higher in the old rats. Liver cholesterol levels were similar in young and old rats. In old rats, fatty acid composition of liver microsomes revealed an increase in linoleic acid concurrently with a significant decrease in arachidonic acid (AA). A significant correlation was not detected between the age changes in pituitary hormone (GH, PRL, TSH, FSH) serum levels and those in reductase activity. On the other hand, a significant positive correlation was found in the old rats between hepatic reductase activity and the severity of mammary pathology. We conclude that, like most biological rhythms, HMG-CoA reductase circadian fluctuation decreases in amplitude with age. This change does not seem to be linked to the alterations of neuroendocrine function associated with the aging process. The presence of growing mammary tumors seems to stimulate liver reductase activity, which may constitute an adaptive response of the enzyme to cholesterol demand by the growing neoplastic tissue. (C) 1998 Elsevier Science Ireland Ltd.
C1 Natl Univ La Plata, Fac Ciencias Med, INIBIOLP, RA-1900 La Plata, Argentina.
C3 National University of La Plata
RP Goya, RG (corresponding author), Natl Univ La Plata, Fac Ciencias Med, INIBIOLP, CC 455, RA-1900 La Plata, Argentina.
EM goya@isis.unlp.edu.ar
CR ANGELIN B, 1984, J LIPID RES, V25, P1159
   BIAGI PL, 1991, BIOCHIM BIOPHYS ACTA, V1083, P187, DOI 10.1016/0005-2760(91)90041-F
   Bolzan AD, 1997, EXP GERONTOL, V32, P297, DOI 10.1016/S0531-5565(96)00101-5
   BROCK MA, 1985, REV BIOL RES AGING, V2, P445
   BROWN MS, 1979, J BIOL CHEM, V254, P5144
   DAVE JR, 1983, MECH AGEING DEV, V23, P235, DOI 10.1016/0047-6374(83)90023-4
   DAVE JR, 1982, BIOCHEM BIOPH RES CO, V108, P193, DOI 10.1016/0006-291X(82)91850-2
   DEANTUENO RJ, 1987, BIOCHEM INT, V14, P1097
   DEMACKER PNM, 1991, ARTERIOSCLER THROMB, V11, P1652, DOI 10.1161/01.ATV.11.6.1652
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   GIL G, 1985, CELL, V41, P249, DOI 10.1016/0092-8674(85)90078-9
   GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0
   GOYA RG, 1990, MECH AGEING DEV, V56, P77, DOI 10.1016/0047-6374(90)90116-W
   GRUNDY SM, 1971, J LAB CLIN MED, V78, P94
   GRUNLER J, 1994, BBA-LIPID LIPID MET, V1212, P259, DOI 10.1016/0005-2760(94)90200-3
   HASHIM SA, 1965, J AMER MED ASSOC, V192, P289, DOI 10.1001/jama.1965.03080170017004
   IGAL A, 1994, INT J BIOCHROMATOGR, V1, P137
   KANDUTSCH AA, 1969, J BIOL CHEM, V244, P2299
   LINN TC, 1967, J BIOL CHEM, V242, P990
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MANDON EC, 1986, LIPIDS, V21, P401, DOI 10.1007/BF02534935
   MANIONGUI C, 1993, LIPIDS, V28, P291, DOI 10.1007/BF02536313
   MEITES J, 1981, PROSTATIC CELL STRUC, P1
   NAKANISHI M, 1988, J BIOL CHEM, V263, P8929
   OSBORNE TF, 1988, J BIOL CHEM, V263, P3380
   PELUFFO RO, 1974, J NUTR, V104, P894, DOI 10.1093/jn/104.7.894
   RUDLING M, 1993, P NATL ACAD SCI USA, V90, P8851, DOI 10.1073/pnas.90.19.8851
   RUDLING M, 1992, P NATL ACAD SCI USA, V89, P6983, DOI 10.1073/pnas.89.15.6983
   SHAPIRO DJ, 1969, BIOCHEM BIOPH RES CO, V37, P867, DOI 10.1016/0006-291X(69)90972-3
   SHAPIRO DJ, 1971, J BIOL CHEM, V246, P3210
   SIPERSTEIN MD, 1984, J LIPID RES, V25, P1462
   STANGE EF, 1984, J LIPID RES, V25, P703
   STORY JA, 1976, LIPIDS, V11, P623, DOI 10.1007/BF02532876
   TAKEUCHI N, 1976, EXP GERONTOL, V11, P121, DOI 10.1016/0531-5565(76)90021-8
   UCHIDA K, 1978, J LIPID RES, V19, P544
   VITOLS S, 1991, CANCER CELL-MON REV, V3, P488
   WILSON JD, 1992, WILLIAMS TXB ENDOCRI
   WINDLER EET, 1980, J BIOL CHEM, V255, P464
NR 38
TC 3
Z9 3
U1 0
U2 0
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD JAN 12
PY 1998
VL 100
IS 1
BP 41
EP 51
DI 10.1016/S0047-6374(97)00116-4
PG 11
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA YX974
UT WOS:000072099300004
PM 9509393
DA 2024-02-19
ER

PT J
AU LAGANIERE, S
   FERNANDES, G
AF LAGANIERE, S
   FERNANDES, G
TI STUDY ON THE LIPID-COMPOSITION OF AGING FISCHER-344 RAT LYMPHOID-CELLS -
   EFFECT OF LONG-TERM CALORIE RESTRICTION
SO LIPIDS
LA English
DT Article
ID CHRONIC FOOD RESTRICTION; FATTY-ACIDS; NUTRITIONAL INFLUENCES; IMMUNE
   FUNCTIONS; LINOLEIC-ACID; GLUTATHIONE; ACTIVATION; LIVER; MICE;
   PROSTAGLANDINS
AB Long-term calorie restriction (LCR) is widely known to increase the survival rate of laboratory rodents and appears to retard the aging and senescence process. The present study was undertaken in Fischer-344 male rats maintained on ad libitum (AL) or LCR (40% less food intake than AL starting at 6 weeks of age). Age-associated changes in the proliferative response of lymphoid cells to mitogenic stimuli were studied in relation to alterations in the fatty acid composition of adherent and nonadherent-enriched subpopulations of spleen cells. Increases in spleen cell long-chain highly unsaturated fatty acids (20:4, 22:4 and 22:5) were accompanied by decreases in linoleic acid (18:2) in aging AL-f ed rats. However, LCR stabilized levels of 18:2 and prevented the rise in highly unsaturated fatty acids. In addition, LCR markedly modulated the fatty acid profiles of thymocytes and bone marrow cells. A 70% decline in concanavalin A (Con A) stimulated [H-3]thymidine uptake of spleen cells from AL animals was normalized by LCR. Splenic reduced glutathione (GSH), a potential modulator of the mitogenic response, was unaffected by age and nutritional regimen. Thus, normalization of lymphoid cell fatty acid composition by LCR parallels the preservation of mitogenic responsiveness to Con A.
C1 UNIV TEXAS,HLTH SCI CTR,DEPT MED,7703 FLOYD CURL DR,SAN ANTONIO,TX 78284.
C3 University of Texas System; University of Texas Health Science Center at
   San Antonio
FU NIA NIH HHS [AG01188, AG03617] Funding Source: Medline
CR ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548
   CHAPLIN DD, 1978, CELL IMMUNOL, V36, P303, DOI 10.1016/0008-8749(78)90274-5
   CHEUNG HT, 1982, LIFE SCI, V31, P605
   CRAWFORD M A, 1981, Progress in Lipid Research, V20, P255, DOI 10.1016/0163-7827(81)90049-7
   ERICKSON KL, 1983, LIPIDS, V18, P468, DOI 10.1007/BF02535787
   FERNANDES G, 1984, Pharmacological Reviews, V36, p123S
   FERNANDES G, 1989, HEALTH EFFECTS OF FISH AND FISH OILS, P409
   FERNANDES G, 1976, J IMMUNOL, V116, P782
   FERNANDES G, 1990, Aging Immunology and Infectious Disease, V2, P117
   FERNANDES G, 1987, AGING IMMUNE RESPONS, P225
   FIDELUS RK, 1986, CELL IMMUNOL, V97, P155, DOI 10.1016/0008-8749(86)90385-0
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   GOEPPELTSTRUEBE M, 1986, PROSTAGLANDINS, V32, P373
   GOODWIN JS, 1983, J CLIN IMMUNOL, V3, P295, DOI 10.1007/BF00915791
   GOTTESMAN SRS, 1984, J IMMUNOL, V133, P1782
   HUGHES D, 1975, LANCET, V2, P501
   HWANG D, 1989, FASEB J, V3, P2052, DOI 10.1096/fasebj.3.9.2501132
   IWAI H, 1989, IMMUNOL LETT, V23, P25
   JEFFCOAT R, 1984, NEW COMPREHENSIVE BI, V7, P85
   JOHNSTON PV, 1985, ADV LIPID RES, V21, P103
   KENDALL MD, 1981, THYMUS GLAND, P21
   LAGANIERE S, 1987, BIOCHEM BIOPH RES CO, V145, P1185, DOI 10.1016/0006-291X(87)91562-2
   LAGANIERE S, 1989, MECH AGEING DEV, V48, P221, DOI 10.1016/0047-6374(89)90084-5
   LAGANIERE S, 1989, MECH AGEING DEV, V48, P207, DOI 10.1016/0047-6374(89)90083-3
   LIEPA GU, 1980, AM J PHYSIOL, V238, pE253, DOI 10.1152/ajpendo.1980.238.3.E253
   MAEDA H, 1985, J GERONTOL, V40, P671, DOI 10.1093/geronj/40.6.671
   MASORO EJ, 1982, P NATL ACAD SCI-BIOL, V79, P4239, DOI 10.1073/pnas.79.13.4239
   Meade C J, 1978, Adv Lipid Res, V16, P127
   MEADE CJ, 1978, J NEUROL SCI, V35, P291, DOI 10.1016/0022-510X(78)90010-2
   MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431
   MORON MS, 1979, BIOCHIM BIOPHYS ACTA, V582, P67, DOI 10.1016/0304-4165(79)90289-7
   OSHEROFF PL, 1978, CELL IMMUNOL, V38, P319, DOI 10.1016/0008-8749(78)90063-1
   PISCIOTT.AV, 1967, NATURE, V215, P193, DOI 10.1038/215193a0
   SAMUELSSON B, 1978, ANNU REV BIOCHEM, V47, P997, DOI 10.1146/annurev.bi.47.070178.005025
   SCHROEDER F, 1984, NEUROBIOL AGING, V5, P323, DOI 10.1016/0197-4580(84)90010-1
   SZAMEL M, 1986, J IMMUNOL, V136, P264
   THOMAS IK, 1985, J NATL CANCER I, V74, P675
   TSANG WM, 1976, J NEUROL NEUROSUR PS, V39, P767, DOI 10.1136/jnnp.39.8.767
   UTERMOHLEN V, 1986, P NUTR SOC, V45, P327, DOI 10.1079/PNS19860070
   Walford R. L., 1974, Mechanisms of Ageing and Development, V2, P447
   WEINDRUCH R, 1982, P NATL ACAD SCI-BIOL, V79, P898, DOI 10.1073/pnas.79.3.898
   WEINDRUCH R, 1980, J GERONTOL, V34, P525
   YU BP, 1985, J GERONTOL, V40, P657, DOI 10.1093/geronj/40.6.657
NR 43
TC 30
Z9 32
U1 0
U2 1
PU AMER OIL CHEMISTS SOC
PI CHAMPAIGN
PA 1608 BROADMOOR DRIVE, CHAMPAIGN, IL 61821-0489
SN 0024-4201
J9 LIPIDS
JI Lipids
PD JUN
PY 1991
VL 26
IS 6
BP 472
EP 478
DI 10.1007/BF02536075
PG 7
WC Biochemistry & Molecular Biology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Nutrition & Dietetics
GA FQ560
UT WOS:A1991FQ56000011
PM 1881243
DA 2024-02-19
ER

PT J
AU Park, SC
   Yeo, EJ
   Han, JA
   Hwang, YC
   Choi, JY
   Park, JS
   Park, YH
   Kim, KO
   Kim, IG
   Seong, SC
   Kwak, SJ
AF Park, SC
   Yeo, EJ
   Han, JA
   Hwang, YC
   Choi, JY
   Park, JS
   Park, YH
   Kim, KO
   Kim, IG
   Seong, SC
   Kwak, SJ
TI Aging process is accompanied by increase of transglutaminase C
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
ID GTP-BINDING PROTEIN; PROGRAMMED CELL-DEATH; TISSUE TRANSGLUTAMINASE;
   NEURODEGENERATIVE DISEASES; CROSS-LINKING; RAT-LIVER; IN-VIVO;
   EXPRESSION; APOPTOSIS; G(H)
AB Crosslinking has been suggested as one of the mechanisms involved in the aging process. Among the various random or enzyme-mediated crosslinking reactions, transglutaminase (TGase)-catalyzed crosslinking activity has been proposed for its possible involvement in cell proliferation, differentiation, carcinogenesis, programmed death, and aging. Moreover, recent findings of TGase C as a putative signal transducer and cell cycle regulator has renewed interest in the study of TGase C in relation to aging phenomena. The ubiquitous presence of TGase C compared to the organ-specific localization of other types of TGases has attracted special attention as a cellular aging device. In the present investigation for in vitro studies, we have compared the pattern of TGase C in young and old human red blood cells, separated by density differentiation, and in early and late-passage or hydrogen peroxide-treated human primary fibroblasts. For in vivo study, we monitored the age-dependent changes of TGase C in the liver and brain tissues of 4, 12, 18, and 24-month-old Sprague-Dawley rats. We obtained evidence that both the activity and protein levels of TGase C were high in old RBC and late-passage or hydrogen peroxide-treated fibroblasts. Similar findings were seen in liver and brain tissue such as age-dependent increases in TGase activity and protein level in an organ-specific pattern. These data suggest that TGase C might play an active role in the cellular process with age.
C1 Seoul Natl Univ, Coll Med, Dept Biochem, Seoul 110744, South Korea.
   Seoul Natl Univ, Coll Med, Dept Orthoped Surg, Aging & Phys Culture Res Inst, Seoul, South Korea.
   Dankook Univ, Coll Med, Dept Biochem, Chonan, South Korea.
C3 Seoul National University (SNU); Seoul National University (SNU);
   Dankook University
RP Park, SC (corresponding author), Seoul Natl Univ, Coll Med, Dept Biochem, 28 Yun Kun Dong,Chong No Ku, Seoul 110744, South Korea.
RI Seong, Sang Cheol/J-5514-2012
CR ASHIDA Y, 1994, EXP EYE RES, V59, P467, DOI 10.1006/exer.1994.1132
   BAEK KJ, 1993, J BIOL CHEM, V268, P27390
   BJORKSTEN J, 1968, J AM GERIATR SOC, V16, P408, DOI 10.1111/j.1532-5415.1968.tb02821.x
   BLUMENTHAL EJ, 1993, MECH AGEING DEV, V72, P13, DOI 10.1016/0047-6374(93)90127-D
   Boyce S.T., 1983, J INVEST DERMATOL S, V81, P33
   CHEN Q, 1994, P NATL ACAD SCI USA, V91, P4130, DOI 10.1073/pnas.91.10.4130
   Chen SH, 1996, J BIOL CHEM, V271, P32385, DOI 10.1074/jbc.271.50.32385
   Cummings M, 1996, J PATHOL, V179, P288, DOI 10.1002/(SICI)1096-9896(199607)179:3<288::AID-PATH574>3.0.CO;2-M
   DUDEK SM, 1993, J NEUROCHEM, V61, P1159, DOI 10.1111/j.1471-4159.1993.tb03636.x
   EITAN S, 1993, SCIENCE, V261, P106, DOI 10.1126/science.8100369
   FESUS L, 1987, FEBS LETT, V224, P104, DOI 10.1016/0014-5793(87)80430-1
   FOLK JE, 1985, METHOD ENZYMOL, V113, P358
   FUKUDA K, 1993, HEPATOLOGY, V17, P118, DOI 10.1016/0270-9139(93)90201-W
   GENTILE V, 1992, J CELL BIOL, V119, P463, DOI 10.1083/jcb.119.2.463
   GRASSO P, 1992, MOL CELL ENDOCRINOL, V87, P49, DOI 10.1016/0303-7207(92)90232-U
   GROVE G, 1988, J GERONTOL, V38, P59
   IKURA K, 1993, FEBS LETT, V326, P109, DOI 10.1016/0014-5793(93)81772-R
   IWAKI T, 1994, AM J PATHOL, V145, P776
   Katoh S, 1996, BIOCHEM J, V313, P305, DOI 10.1042/bj3130305
   KNIGHT RL, 1993, EUR J CELL BIOL, V60, P210
   LEE KN, 1989, BIOCHEM BIOPH RES CO, V162, P1370, DOI 10.1016/0006-291X(89)90825-5
   LIU AYC, 1986, J CELL PHYSIOL, V128, P149, DOI 10.1002/jcp.1041280203
   Lorand L, 1996, P NATL ACAD SCI USA, V93, P14310, DOI 10.1073/pnas.93.25.14310
   Mahoney SA, 1996, BIOCHEM BIOPH RES CO, V224, P147, DOI 10.1006/bbrc.1996.0998
   MEHTA K, 1994, INT J CANCER, V58, P400, DOI 10.1002/ijc.2910580316
   MEHUL B, 1995, FEBS LETT, V360, P160, DOI 10.1016/0014-5793(95)00100-N
   MELINO G, 1994, MOL CELL BIOL, V14, P6584, DOI 10.1128/MCB.14.10.6584
   MIAN S, 1995, FEBS LETT, V370, P27, DOI 10.1016/0014-5793(95)00782-5
   NAKAOKA H, 1994, SCIENCE, V264, P1593, DOI 10.1126/science.7911253
   NARA K, 1992, BIOCHEM BIOPH RES CO, V187, P14, DOI 10.1016/S0006-291X(05)81451-2
   Nemes Z, 1996, EUR J CELL BIOL, V70, P125
   Park Sang-Chul, 1994, Journal of Korean Medical Science, V9, P490
   PERSICO P, 1992, PEPTIDES, V13, P151, DOI 10.1016/0196-9781(92)90155-V
   PIACENTINI M, 1991, EUR J CELL BIOL, V54, P246
   PIACENTINI M, 1991, CELL TISSUE RES, V263, P227, DOI 10.1007/BF00318764
   PUCCI P, 1988, BIOCHEM BIOPH RES CO, V154, P735, DOI 10.1016/0006-291X(88)90201-X
   ROSS CA, 1995, NEURON, V15, P493, DOI 10.1016/0896-6273(95)90138-8
   SCOTT KFF, 1982, P NATL ACAD SCI-BIOL, V79, P4093, DOI 10.1073/pnas.79.13.4093
   Smith JR, 1996, SCIENCE, V273, P63, DOI 10.1126/science.273.5271.63
   SUNG LPA, 1992, BLOOD, V79, P2763
   VINCAN E, 1995, J MOL CELL CARDIOL, V27, P2393, DOI 10.1016/S0022-2828(95)92127-3
NR 41
TC 24
Z9 27
U1 0
U2 3
PU GERONTOLOGICAL SOCIETY AMER
PI WASHINGTON
PA 1275 K STREET NW SUITE 350, WASHINGTON, DC 20005-4006 USA
SN 1079-5006
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD FEB
PY 1999
VL 54
IS 2
BP B78
EP B83
DI 10.1093/gerona/54.2.B78
PG 6
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA 168TV
UT WOS:000078709500006
PM 10051854
OA Bronze
DA 2024-02-19
ER

PT J
AU Charpentier, KP
   VonMoltke, LL
   Poku, JW
   Harmatz, JS
   Shader, RI
   Greenblatt, DJ
AF Charpentier, KP
   VonMoltke, LL
   Poku, JW
   Harmatz, JS
   Shader, RI
   Greenblatt, DJ
TI Alprazolam hydroxylation by mouse liver microsomes in vitro: The effect
   of age and phenobarbital induction
SO BIOPHARMACEUTICS & DRUG DISPOSITION
LA English
DT Article
DE alprazolam; microsomes; mouse; age; phenobarbital
ID HEPATIC DRUG-METABOLISM; REUPTAKE-INHIBITOR ANTIDEPRESSANTS; RAT-LIVER;
   IN-VITRO; CLINICAL PHARMACOKINETICS; ENZYME-INDUCTION; THERAPEUTIC
   IMPLICATIONS; N-DEMETHYLATION; CYP3A ISOFORMS; MESSENGER-RNAS
AB The effects of age on hepatic microsomal enzyme induction were studied in male CD-1 mice. Six week old and 1 year old animals were treated with either phenobarbital (80 mg kg(-1)) or saline once daily for 3 d. Twenty-four hours after the last treatment, animals were sacrificed and livers were harvested. Hepatic microsomal fractions were isolated and incubated with alprazolam, a triazolobenzodiazepine metabolized by cytochrome P-450-3A isoforms in humans. Metabolites were identified and quantitated by HPLC. All microsomal preparations produced two principal metabolites (alpha-OH- and 4-OH-alprazolam) while microsomes from phenobarbital-treated animals also produced a third metabolite (alpha, 4-dihydroxyalprazolam). V-max, K-m, and intrinsic clearance (V-max/K-m ratio) for both alpha-OH- and 4-OH-alprazolam in the saline-treated control animals were not significantly different between age groups. V-max and intrinsic clearance for both metabolites were more than three times greater in phenobarbital-treated animals than in the control mice (p < 0.001). Age did not influence the extent of induction, and both pathways were induced to approximately an equal extent. Thus the present in vitro study of liver microsomal preparations from male CD-1 mice does not delineate a mechanism for impaired alprazolam clearance in aging organisms in vivo. There is no evidence that age alters susceptibility to induction by phenobarbital. (C) 1997 by John Wiley & Sons, Ltd.
C1 TUFTS UNIV,SCH MED,DEPT PHARMACOL & EXPT THERAPEUT,BOSTON,MA 02111.
C3 Tufts University
OI Shader, Richard/0000-0002-1888-7565
FU NIDA NIH HHS [DA-05258] Funding Source: Medline; NIMH NIH HHS
   [K21-MH-01237, MH-34223] Funding Source: Medline
CR ABEL SM, 1993, J STEROID BIOCHEM, V45, P445, DOI 10.1016/0960-0760(93)90013-M
   ALTERMAN M, 1993, AGE, V15, P1
   ANDERSSON T, 1994, BRIT J CLIN PHARMACO, V38, P131, DOI 10.1111/j.1365-2125.1994.tb04336.x
   BARNHILL JG, 1990, J PHARMACOL EXP THER, V253, P1153
   CORCOS L, 1992, DRUG METAB DISPOS, V20, P797
   CROWLEY JJ, 1988, J PHARMACOL EXP THER, V245, P513
   DEHLIN O, 1991, PHARMACOL TOXICOL, V68, P121, DOI 10.1111/j.1600-0773.1991.tb02048.x
   DURNAS C, 1990, CLIN PHARMACOKINET, V19, P359, DOI 10.2165/00003088-199019050-00002
   ECHIZEN H, 1994, J PHARMACOL EXP THER, V268, P1518
   FUJITA S, 1990, J PHARMACOL EXP THER, V253, P369
   FUJITA S, 1990, DRUG METAB DISPOS, V18, P812
   FUJITA S, 1989, BIOCHEM PHARMACOL, V38, P3925, DOI 10.1016/0006-2952(89)90669-2
   GREENBLATT DJ, 1982, NEW ENGL J MED, V306, P1081
   GREENBLATT DJ, 1991, CLIN PHARMACOKINET, V21, P165, DOI 10.2165/00003088-199121030-00002
   GREENBLATT DJ, 1993, CLIN PHARMACOKINET, V24, P453, DOI 10.2165/00003088-199324060-00003
   GREENBLATT DJ, 1983, ARCH GEN PSYCHIAT, V40, P287
   GREENBLATT DJ, 1993, J CLIN PSYCHIAT, V54, P4
   GROEN K, 1994, J PHARMACOL EXP THER, V268, P531
   HORBACH GJMJ, 1990, MUTAT RES, V237, P117, DOI 10.1016/0921-8734(90)90017-L
   HORBACH GJMJ, 1990, BIOCHEM PHARMACOL, V40, P529, DOI 10.1016/0006-2952(90)90552-V
   HORBACH GJMJ, 1992, XENOBIOTICA, V22, P515, DOI 10.3109/00498259209053114
   HOUSTON JB, 1994, BIOCHEM PHARMACOL, V47, P1469
   HUNT CM, 1990, BIOCHEM PHARMACOL, V40, P1666, DOI 10.1016/0006-2952(90)90470-6
   HUNT CM, 1992, BIOCHEM PHARMACOL, V44, P275, DOI 10.1016/0006-2952(92)90010-G
   KROBOTH PD, 1990, PSYCHOPHARMACOLOGY, V100, P477, DOI 10.1007/BF02243999
   LEE PC, 1994, BIOCHEM MOL BIOL INT, V34, P861
   LOI CM, 1988, PHARMACOL THERAPEUT, V36, P131, DOI 10.1016/0163-7258(88)90115-5
   PELLINEN P, 1994, EUR J PHARM-ENVIRON, V270, P35, DOI 10.1016/0926-6917(94)90078-7
   PIRMOHAMED M, 1992, BIOCHEM PHARMACOL, V44, P2307, DOI 10.1016/0006-2952(92)90674-8
   POKU JW, UNPUB
   RIKANS LE, 1981, EXP GERONTOL, V16, P253, DOI 10.1016/0531-5565(81)90021-8
   RIKANS LE, 1989, DRUG METAB DISPOS, V17, P114
   RIKANS LE, 1982, J PHARMACOL EXP THER, V220, P574
   SALEM S A M, 1978, Age and Ageing, V7, P68, DOI 10.1093/ageing/7.2.68
   SCHMIDER J, 1995, J PHARMACOL EXP THER, V275, P592
   SCHMUCKER DL, 1985, PHARMACOL REV, V37, P133
   SCHMUCKER DL, 1990, CLIN PHARMACOL THER, V48, P365, DOI 10.1038/clpt.1990.164
   SCHWAB GE, 1988, MOL PHARMACOL, V33, P493
   SHADDOCK JG, 1993, AGE, V16, P105, DOI 10.1007/BF02436142
   SHADER RI, 1993, NEW ENGL J MED, V328, P1398
   SHIMADA T, 1994, J PHARMACOL EXP THER, V270, P414
   SHOU M, 1994, BIOCHEMISTRY-US, V33, P6450, DOI 10.1021/bi00187a009
   SHUSTER L, 1966, J BIOL CHEM, V241, P5361
   TWUMBARIMA Y, 1984, BRIT J CLIN PHARMACO, V17, P595, DOI 10.1111/j.1365-2125.1984.tb02397.x
   Van Bezooijen C. F. A., 1986, DRUGS AGING, P45
   VANBEZOOIJEN CFA, 1984, MECH AGEING DEV, V25, P1, DOI 10.1016/0047-6374(84)90126-X
   VERMEULEN AM, 1992, MECH AGEING DEV, V65, P167, DOI 10.1016/0047-6374(92)90033-A
   VESTAL RE, 1987, J PHARMACOL EXP THER, V241, P488
   Von Moltke Lisa L., 1995, P1461
   VONMOLTKE LL, 1993, CLIN PHARMACOKINET, V24, P141, DOI 10.2165/00003088-199324020-00004
   VONMOLTKE LL, 1994, BRIT J CLIN PHARMACO, V38, P23
   VONMOLTKE LL, 1993, PHARMACOLOGY, V47, P268, DOI 10.1159/000139107
   VONMOLTKE LL, 1995, J CLIN PSYCHOPHARM, V15, P125, DOI 10.1097/00004714-199504000-00008
   WAXMAN DJ, 1992, BIOCHEM J, V281, P577, DOI 10.1042/bj2810577
   YANAGIMOTO T, 1994, BBA-GEN SUBJECTS, V1201, P405, DOI 10.1016/0304-4165(94)90069-8
NR 55
TC 8
Z9 9
U1 0
U2 0
PU JOHN WILEY & SONS LTD
PI W SUSSEX
PA BAFFINS LANE CHICHESTER, W SUSSEX, ENGLAND PO19 1UD
SN 0142-2782
J9 BIOPHARM DRUG DISPOS
JI Biopharm. Drug Dispos.
PD MAR
PY 1997
VL 18
IS 2
BP 139
EP 149
DI 10.1002/(SICI)1099-081X(199703)18:2<139::AID-BDD7>3.0.CO;2-Z
PG 11
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA WP557
UT WOS:A1997WP55700005
PM 9099450
DA 2024-02-19
ER

PT J
AU Enot, DP
   Niso-Santano, M
   Durand, S
   Chery, A
   Pietrocola, F
   Vacchelli, E
   Madeo, F
   Galluzzi, L
   Kroemer, G
AF Enot, David P.
   Niso-Santano, Mireia
   Durand, Sylvere
   Chery, Alexis
   Pietrocola, Federico
   Vacchelli, Erika
   Madeo, Frank
   Galluzzi, Lorenzo
   Kroemer, Guido
TI Metabolomic analyses reveal that anti-aging metabolites are depleted by
   palmitate but increased by oleate <i>in vivo</i>
SO CELL CYCLE
LA English
DT Article
DE aging; amino acids; autophagy; NAD sirtuins; spermidine
ID UNSATURATED FATTY-ACIDS; ACETYL-COENZYME; LIFE-SPAN; AUTOPHAGY;
   SPERMIDINE; LONGEVITY; DISEASE; RESVERATROL; POLYAMINES; PATHWAYS
AB Recently, we reported that saturated and unsaturated fatty acids trigger autophagy through distinct signal transduction pathways. Saturated fatty acids like palmitate (PA) induce autophagic responses that rely on phosphatidylinositol 3-kinase, catalytic subunit type 3 (PIK3C3, best known as VPS34) and beclin 1 (BECN1). Conversely, unsaturated fatty acids like oleate (OL) promote non-canonical, PIK3C3- and BECN1-independent autophagy. Here, we explored the metabolic effects of autophagy-inducing doses of PA and OL in mice. Mass spectrometry coupled to principal component analysis revealed that PA and OL induce well distinguishable changes in circulating metabolites as well as in the metabolic profile of the liver, heart, and skeletal muscle. Importantly, PA (but not OL) causes the depletion of multiple autophagy-inhibitory amino acids in the liver. Conversely, OL (but not PA) increased the hepatic levels of nicotinamide adenine dinucleotide (NAD), an obligate co-factor for autophagy-stimulatory enzymes of the sirtuin family. Moreover, PA (but not OL) raised the concentrations of acyl-carnitines in the heart, a phenomenon that perhaps is linked to its cardiotoxicity. PA also depleted the liver from spermine and spermidine, 2 polyamines have been ascribed with lifespan-extending activity. The metabolic changes imposed by unsaturated and saturated fatty acids may contribute to their health-promoting and health-deteriorating effects, respectively.
C1 [Enot, David P.; Niso-Santano, Mireia; Durand, Sylvere; Chery, Alexis; Pietrocola, Federico; Vacchelli, Erika; Galluzzi, Lorenzo; Kroemer, Guido] Ctr Rech Cordeliers, Equipe Labellisee Ligue Canc 11, Paris, France.
   [Enot, David P.; Niso-Santano, Mireia; Durand, Sylvere; Chery, Alexis; Pietrocola, Federico; Vacchelli, Erika; Galluzzi, Lorenzo; Kroemer, Guido] INSERM U1138, Paris, France.
   [Enot, David P.; Niso-Santano, Mireia; Durand, Sylvere; Chery, Alexis; Pietrocola, Federico; Vacchelli, Erika; Galluzzi, Lorenzo; Kroemer, Guido] Univ Paris 05, Sorbonne Paris Cite, Paris, France.
   [Enot, David P.; Niso-Santano, Mireia; Durand, Sylvere; Chery, Alexis; Pietrocola, Federico; Vacchelli, Erika; Galluzzi, Lorenzo; Kroemer, Guido] Univ Paris 06, Paris, France.
   [Enot, David P.; Durand, Sylvere; Chery, Alexis; Kroemer, Guido] Gustave Roussy Comprehens Canc Inst, Metabol Platform, Villejuif, France.
   [Enot, David P.; Durand, Sylvere; Chery, Alexis; Kroemer, Guido] Gustave Roussy Comprehens Canc Inst, Cell Biol Platform, Villejuif, France.
   [Niso-Santano, Mireia] Univ Extremadura, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Fac Enfermeria & TO, Dept Bioquim & Biol Mol & Genet, Caceres, Spain.
   [Niso-Santano, Mireia; Pietrocola, Federico; Vacchelli, Erika; Galluzzi, Lorenzo] Gustave Roussy Comprehens Canc Inst, Villejuif, France.
   [Madeo, Frank] Graz Univ, NAWI Graz, Inst Mol Biosci, Graz, Austria.
   [Madeo, Frank] BioTechMed Graz, Graz, Austria.
   [Kroemer, Guido] Hop Europeen Georges Pompidou, AP HP, Pole Biol, Paris, France.
C3 Institut National de la Sante et de la Recherche Medicale (Inserm);
   Universite Paris Cite; Sorbonne Universite; Universite Paris Cite;
   Institut National de la Sante et de la Recherche Medicale (Inserm);
   Universite Paris Cite; Sorbonne Universite; CIBERNED; Universidad de
   Extremadura; University of Graz; Assistance Publique Hopitaux Paris
   (APHP); Universite Paris Cite; Hopital Universitaire Europeen
   Georges-Pompidou - APHP; Hopital Universitaire Paul-Brousse - APHP;
   Hopital Universitaire Hotel-Dieu - APHP
RP Kroemer, G (corresponding author), Ctr Rech Cordeliers, Equipe Labellisee Ligue Canc 11, Paris, France.
EM deadoc@vodafone.it; kroemer@orange.fr
RI Pietrocola, Federico/AAW-9621-2020; Niso-Santano, Mireia/AAO-1285-2021;
   Vacchelli, Erika/E-5212-2018; Kroemer, Guido/AAY-9859-2020; Galluzzi,
   Lorenzo/AAH-3286-2021; Galluzzi, Lorenzo/AAG-6432-2019; KROEMER,
   Guido/B-4263-2013; Galluzzi, Lorenzo/AAG-6294-2019
OI Pietrocola, Federico/0000-0002-2930-234X; Vacchelli,
   Erika/0000-0001-8010-0594; KROEMER, Guido/0000-0002-9334-4405;
   Niso-Santano, Mireia/0000-0002-6506-422X; Madeo,
   Frank/0000-0002-5070-1329
FU Ligue contre le Cancer (equipe labelisee); Agence National de la
   Recherche (ANR) - Projets blancs; ANR under frame of E-Rare-2; ERA-Net
   for Research on Rare Diseases; Association pour la recherche sur le
   cancer (ARC); Canceropole Ile-de-France; Institut National du Cancer
   (INCa); Fondation Bettencourt-Schueller; Fondation de France; Fondation
   pour la Recherche Medicale (FRM); European Commission (ArtForce);
   European Research Council (ERC); LabEx Immuno-Oncology; SIRIC Stratified
   Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); SIRIC
   Cancer Research and Personalized Medicine (CARPEM); Paris Alliance of
   Cancer Research Institutes (PACRI); FWF [LIP-OTOX, I1000, P23490-B12,
   P24381-B20]; BMWFW; Austrian Science Fund (FWF) [P24381] Funding Source:
   Austrian Science Fund (FWF); Austrian Science Fund (FWF) [P 24381]
   Funding Source: researchfish
FX GK is supported by the Ligue contre le Cancer (equipe labelisee); Agence
   National de la Recherche (ANR) - Projets blancs; ANR under the frame of
   E-Rare-2, the ERA-Net for Research on Rare Diseases; Association pour la
   recherche sur le cancer (ARC); Canceropole Ile-de-France; Institut
   National du Cancer (INCa); Fondation Bettencourt-Schueller; Fondation de
   France; Fondation pour la Recherche Medicale (FRM); the European
   Commission (ArtForce); the European Research Council (ERC); the LabEx
   Immuno-Oncology; the SIRIC Stratified Oncology Cell DNA Repair and Tumor
   Immune Elimination (SOCRATE); the SIRIC Cancer Research and Personalized
   Medicine (CARPEM); and the Paris Alliance of Cancer Research Institutes
   (PACRI). F. M. is grateful to the FWF for grants LIP-OTOX, I1000 ,
   P23490-B12, and P24381-B20 and the BMWFW for grant "Unconventional
   research."
CR Berraaouan A, 2013, CURR DIABETES REV, V9, P499, DOI 10.2174/15733998113096660081
   Büttner S, 2014, CELL CYCLE, V13, P3903, DOI 10.4161/15384101.2014.973309
   Codogno P, 2012, NAT REV MOL CELL BIO, V13, P7, DOI 10.1038/nrm3249
   Djavaheri-Mergny M, 2010, ONCOGENE, V29, P1717, DOI 10.1038/onc.2009.519
   Draper J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-227
   Efeyan A, 2015, NATURE, V517, P302, DOI 10.1038/nature14190
   Eisenberg T, 2014, CELL METAB, V19, P431, DOI 10.1016/j.cmet.2014.02.010
   Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975
   Enot DP, 2008, NAT PROTOC, V3, P446, DOI 10.1038/nprot.2007.511
   Fattore E, 2013, INT J FOOD SCI NUTR, V64, P648, DOI 10.3109/09637486.2013.768213
   Funderburk SF, 2010, TRENDS CELL BIOL, V20, P355, DOI 10.1016/j.tcb.2010.03.002
   Galluzzi L, 2015, EMBO J, V34, P856, DOI 10.15252/embj.201490784
   Galluzzi L, 2014, CELL, V159, P1263, DOI 10.1016/j.cell.2014.11.006
   Griffiths WJ, 2010, ANGEW CHEM INT EDIT, V49, P5426, DOI 10.1002/anie.200905579
   HARRISON DH, 1991, J HAND SURG-BRIT EUR, V16B, P78, DOI 10.1016/0266-7681(91)90135-B
   Kim H, 2005, BIOINFORMATICS, V21, P187, DOI 10.1093/bioinformatics/bth499
   Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023
   Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Madeo F, 2010, NAT CELL BIOL, V12, P842, DOI 10.1038/ncb0910-842
   Mariño G, 2014, AUTOPHAGY, V10, P930, DOI 10.4161/auto.28235
   Mariño G, 2014, MOL CELL, V53, P710, DOI 10.1016/j.molcel.2014.01.016
   Minois N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.139
   Minois N, 2011, AGING-US, V3, P716, DOI 10.18632/aging.100361
   Morgan D M, 1998, Methods Mol Biol, V79, P3
   Morselli E, 2011, J CELL BIOL, V192, P615, DOI 10.1083/jcb.201008167
   Morselli E, 2009, AGING-US, V1, P961, DOI 10.18632/aging.100110
   Newman JC, 2014, TRENDS ENDOCRIN MET, V25, P42, DOI 10.1016/j.tem.2013.09.002
   Niso-Santano M, 2015, AUTOPHAGY, V11, P575, DOI 10.1080/15548627.2015.1017222
   Niso-Santano M, 2015, EMBO J, V34, P1025, DOI 10.15252/embj.201489363
   Pietrocola F, 2015, CELL DEATH DIFFER, V22, P509, DOI 10.1038/cdd.2014.215
   Riera CE, 2015, NAT CELL BIOL, V17, P196, DOI 10.1038/ncb3107
   Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007
   Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802
   Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030
   Russell RC, 2014, CELL RES, V24, P42, DOI 10.1038/cr.2013.166
   Sales-Campos H, 2013, MINI-REV MED CHEM, V13, P201
   Schroeder S, 2014, AUTOPHAGY, V10, P1335, DOI 10.4161/auto.28919
   Sinclair DA, 2014, ANNU REV PHARMACOL, V54, P363, DOI 10.1146/annurev-pharmtox-010611-134657
   Tsugawa H, 2014, J BIOSCI BIOENG, V117, P122, DOI 10.1016/j.jbiosc.2013.06.009
   Widmer RJ, 2015, AM J MED, V128, P229, DOI 10.1016/j.amjmed.2014.10.014
NR 41
TC 25
Z9 27
U1 0
U2 13
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1538-4101
EI 1551-4005
J9 CELL CYCLE
JI Cell Cycle
PD AUG 3
PY 2015
VL 14
IS 15
BP 2399
EP 2407
DI 10.1080/15384101.2015.1064206
PG 9
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA CP3HK
UT WOS:000359768900011
PM 26098646
OA Green Published, Bronze
DA 2024-02-19
ER

PT J
AU Frohlich, J
   Mazza, T
   Sobolewski, C
   Foti, M
   Vinciguerra, M
AF Frohlich, Jan
   Mazza, Tommaso
   Sobolewski, Cyril
   Foti, Michelangelo
   Vinciguerra, Manlio
TI GDF11 rapidly increases lipid accumulation in liver cancer cells through
   ALK5-dependent signaling
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
LA English
DT Article; Early Access
DE Liver; NAFLD; Growth differentiation factor 11; GDF11; BMP11; Lipid
   accumulation
ID FATTY-ACID-METABOLISM; GROWTH-FACTOR-BETA; HEPATOCELLULAR-CARCINOMA;
   HEPATIC STEATOSIS; DISEASE; ACTIVATION; EXPRESSION; OBESITY;
   EPIDEMIOLOGY; MYOSTATIN
AB Hepatocellular carcinoma (HCC) is one of the fastest-growing causes of cancer-related mortalities worldwide and this trend is mimicked by the surge of non-alcoholic fatty liver disease (NAFLD). Altered hepatic lipid metabolism promotes HCC development through inflammation and activation of oncogenes. GDF11 is a member of the TGF-beta superfamily and recent data have implicated GDF11 as an anti-aging factor that can alleviate high-fat diet induced obesity, hyperglycemia, insulin resistance and NAFLD. However, its role in hepatic lipid metabolism is still not fully delineated. The aim of the present study was to characterize the role of GDF11 in hepatic and HCC cells lipid accumulation. To achieve this, we performed imaging, biochemical, lipidomic, and transcriptomic analyses in primary hepatocytes and in HCC cells treated with GDF11 to study the GDF11-activated signaling pathways. GDF11 treatment rapidly triggered ALK5-dependent SMAD2/3 nuclear translocation and elevated lipid droplets in HCC cells, but not in primary hepatocytes. In HCC cells, ALK5 inhibition hampered GDF11-mediated SMAD2/3 signaling and attenuated lipid accumulation. Using ultra-high-performance liquid chromatography/mass spectrometry, we detected increased accumulation of longer acyl-chain di/tri-acylglycerols and glycerophospholipids. Unbiased transcriptomic analysis identified TGF-beta and PI3K-AKT signaling among the top pathways/cellular processes activated in GDF11 treated HCC cells.
   In summary, GDF11 supplementation promotes pro-lipogenic gene expression and lipid accumulation in HCC cells. Integration of our "omics" data pointed to a GDF11-induced upregulation of de novo lipogenesis through activation of ALK5/SMAD2/3/PI3K-AKT pathways. Thus, GDF11 could contribute to metabolic reprogramming and dysregulation of lipid metabolism in HCC cells, without effects on healthy hepatocytes.
C1 [Frohlich, Jan; Vinciguerra, Manlio] St Annes Univ Hosp, Int Clin Res Ctr, Brno, Czech Republic.
   [Mazza, Tommaso] IRCCS Casa Sollievo Sofferenza, Bioinformat Unit, San Giovanni Rotondo, Italy.
   [Sobolewski, Cyril; Foti, Michelangelo] Univ Geneva, Fac Med, Dept Cell Physiol & Metab, Geneva, Switzerland.
   [Sobolewski, Cyril; Foti, Michelangelo] Univ Geneva, Fac Med, Translat Res Ctr Oncohaematol, Geneva, Switzerland.
   [Vinciguerra, Manlio] Med Univ Varna, Dept Translat Stem Cell Biol, Varna, Bulgaria.
   [Vinciguerra, Manlio] Univ Coll London UCL, Inst Liver & Digest Hlth, Div Med, London, England.
C3 St Anne's University Hospital Brno (FNUSA-ICRC); IRCCS Casa Sollievo
   Della Sofferenza; University of Geneva; University of Geneva; Medical
   University Varna; University of London; University College London
RP Vinciguerra, M (corresponding author), Int Clin Res Ctr FNUSA ICRC, Pekarska 53, Brno 65691, Czech Republic.
EM manlio.vinciguerra@fnusa.cz
RI Frohlich, Jan/AAI-4184-2021; Mazza, Tommaso/I-4531-2019; Sobolewski,
   Cyril/ABA-8197-2021; Vinciguerra, Manlio/N-1309-2015
OI Frohlich, Jan/0000-0002-8312-0483; Mazza, Tommaso/0000-0003-0434-8533;
   Sobolewski, Cyril/0000-0002-9404-6290; Vinciguerra,
   Manlio/0000-0002-1768-3894; Foti, Michelangelo/0000-0001-7199-4135
FU European Social Fund; European Regional Development Fund - Project
   MAGNET [CZ.02.1s01/0.0/0.0/15_003/0000492]; Swiss National Science
   Foundation [310030-172862]
FX This work was supported by the European Social Fund and European
   Regional Development Fund - Project MAGNET (No.
   CZ.02.1s01/0.0/0.0/15_003/0000492, to M.V.), and by the Swiss National
   Science Foundation (Grant no. 310030-172862 to M.F.).
CR Abdelmalek MF, 2007, MED CLIN N AM, V91, P1125, DOI 10.1016/j.mcna.2007.06.001
   Abou-Shady M, 1999, AM J SURG, V177, P209, DOI 10.1016/S0002-9610(99)00012-4
   Barr J, 2010, J PROTEOME RES, V9, P4501, DOI 10.1021/pr1002593
   Beloribi-Djefaflia S, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2015.49
   Benegiamo G, 2012, DIGEST DIS SCI, V57, P1598, DOI 10.1007/s10620-012-2160-1
   Berndt N, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8050512
   Bessone F, 2019, CELL MOL LIFE SCI, V76, P99, DOI 10.1007/s00018-018-2947-0
   Borghesan M, 2016, CANCER RES, V76, P594, DOI 10.1158/0008-5472.CAN-15-1336
   Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466
   Butler LM, 2020, ADV DRUG DELIVER REV, V159, P245, DOI 10.1016/j.addr.2020.07.013
   Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423
   Chmurzynska A, 2006, J APPL GENET, V47, P39, DOI 10.1007/BF03194597
   COLOMBO M, 1991, NEW ENGL J MED, V325, P675, DOI 10.1056/NEJM199109053251002
   Coulouarn C, 2008, HEPATOLOGY, V47, P2059, DOI 10.1002/hep.22283
   Currie E, 2013, CELL METAB, V18, P153, DOI 10.1016/j.cmet.2013.05.017
   Dai Z, 2020, GUT, V69, P1104, DOI 10.1136/gutjnl-2019-318812
   Dyson JK, 2014, FRONTLINE GASTROENTE, V5, P277, DOI 10.1136/flgastro-2013-100404
   Dzieran J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072252
   Eslam M, 2020, GASTROENTEROLOGY, V158, P1999, DOI 10.1053/j.gastro.2019.11.312
   Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280
   Frohlich J, 2020, AGING-US, V12, P20024, DOI 10.18632/aging.104182
   Frohlich J, 2020, GEROSCIENCE, V42, P1475, DOI 10.1007/s11357-020-00279-w
   Gerardo-Ramírez M, 2019, BBA-MOL BASIS DIS, V1865, P1540, DOI 10.1016/j.bbadis.2019.03.003
   Giannelli G, 2014, CANCER RES, V74, P1890, DOI 10.1158/0008-5472.CAN-14-0243
   Giannelli G, 2011, BBA-REV CANCER, V1815, P214, DOI 10.1016/j.bbcan.2010.11.004
   Gluchowski NL, 2017, NAT REV GASTRO HEPAT, V14, P343, DOI 10.1038/nrgastro.2017.32
   Gorden DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022775
   Hammers DW, 2017, EMBO MOL MED, V9, P531, DOI 10.15252/emmm.201607231
   Harper SC, 2018, CIRC RES, V123, P1220, DOI 10.1161/CIRCRESAHA.118.312955
   Hernandez S, 2021, J CELL PHYSIOL, V236, P4076, DOI 10.1002/jcp.30151
   Hu B, 2020, CELL PROLIFERAT, V53, DOI 10.1111/cpr.12772
   Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.21492, 10.3322/caac.20107]
   Jones JE, 2018, CELL REP, V22, P1522, DOI 10.1016/j.celrep.2018.01.044
   Katsimpardi L, 2014, SCIENCE, V344, P630, DOI 10.1126/science.1251141
   Krahmer N, 2013, EMBO MOL MED, V5, P973, DOI 10.1002/emmm.201100671
   Kuhajda FP, 2000, P NATL ACAD SCI USA, V97, P3450, DOI 10.1073/pnas.050582897
   Lazo M, 2008, SEMIN LIVER DIS, V28, P339, DOI 10.1055/s-0028-1091978
   Li HC, 2020, THERANOSTICS, V10, P7053, DOI 10.7150/thno.41388
   Linhart KB, 2015, HEPATOL SURG NUTR, V4, P117, DOI 10.3978/j.issn.2304-3881.2015.01.14
   Liu AD, 2018, FASEB J, V32, P5186, DOI 10.1096/fj.201800195R
   Liu JP, 2006, DEVELOPMENT, V133, P2865, DOI 10.1242/dev.02478
   Liu Q, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-42
   Liu YS, 2019, NAT BIOTECHNOL, V37, P314, DOI 10.1038/s41587-019-0037-y
   Lo Re O, 2018, EPIGENETICS-US, V13, P829, DOI 10.1080/15592294.2018.1514239
   Lo Re O, 2018, HEPATOLOGY, V67, P636, DOI 10.1002/hep.29519
   Loffredo FS, 2013, CELL, V153, P828, DOI 10.1016/j.cell.2013.04.015
   Lu BX, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-02166-1
   Mashek DG, 2013, ADV NUTR, V4, P697, DOI 10.3945/an.113.004648
   Mashima T, 2009, BRIT J CANCER, V100, P1369, DOI 10.1038/sj.bjc.6605007
   McPherron Alexandra C., 2010, Immunology Endocrine & Metabolic Agents in Medicinal Chemistry, V10, P217
   Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222
   Mortezaee K, 2018, J CELL PHYSIOL, V233, P4015, DOI 10.1002/jcp.26209
   Muir K, 2013, CANCER RES, V73, P4722, DOI 10.1158/0008-5472.CAN-12-3797
   Nath A, 2015, SCI REP-UK, V5, DOI 10.1038/srep14752
   Niture S, 2018, CELL COMMUN SIGNAL, V16, DOI 10.1186/s12964-018-0282-6
   Park SH, 2020, J ETHNOPHARMACOL, V260, DOI 10.1016/j.jep.2020.112999
   Patterson AD, 2011, CANCER RES, V71, P6590, DOI 10.1158/0008-5472.CAN-11-0885
   Petta S, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122082
   Podrini C, 2015, FASEB J, V29, P1676, DOI 10.1096/fj.14-262717
   Qiu GH, 2015, CYTOTECHNOLOGY, V67, P1, DOI 10.1007/s10616-014-9761-9
   Rafiq N, 2009, CLIN GASTROENTEROL H, V7, P234, DOI 10.1016/j.cgh.2008.11.005
   Ramadori P, 2010, LAB INVEST, V90, P1306, DOI 10.1038/labinvest.2010.85
   Sangineto M, 2020, CANCERS, V12, DOI 10.3390/cancers12061419
   Simoni-Nieves A, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01039
   Sinha M, 2014, SCIENCE, V344, P649, DOI 10.1126/science.1251152
   Sobolewski C, 2020, GUT, V69, P1841, DOI 10.1136/gutjnl-2019-319019
   Swinnen JV, 2006, CURR OPIN CLIN NUTR, V9, P358, DOI 10.1097/01.mco.0000232894.28674.30
   Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131
   Tan JSY, 2014, J GENET GENOMICS, V41, P251, DOI 10.1016/j.jgg.2014.03.003
   Valenti L, 2013, DIABETES, V62, P4052, DOI 10.2337/db13-0769
   Vinciguerra M, 2008, GASTROENTEROLOGY, V134, P268, DOI 10.1053/j.gastro.2007.10.010
   Walker RG, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61443-y
   Walker RG, 2016, CIRC RES, V118, P1125, DOI 10.1161/CIRCRESAHA.116.308391
   Wang HY, 2014, ONCOL REP, V32, P1465, DOI 10.3892/or.2014.3352
   Wang MD, 2016, HEPAT ONCOL, V3, P241, DOI 10.2217/hep-2016-0012
   Wang WJ, 2019, CLIN SCI, V133, P2069, DOI 10.1042/CS20190441
   Ward PS, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006783
   Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014
   Wobser H, 2009, CELL RES, V19, P996, DOI 10.1038/cr.2009.73
   Xu F, 2020, CELL BIOSCI, V10, DOI 10.1186/s13578-020-00416-0
   Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431
   Zhang J, 2019, STEM CELL REP, V12, P1269, DOI 10.1016/j.stemcr.2019.04.013
   Zhang LQ, 2021, CELL MOL GASTROENTER, V11, P697, DOI 10.1016/j.jcmgh.2020.10.006
   Zhang W, 2018, J ALZHEIMERS DIS, V62, P807, DOI 10.3233/JAD-170474
   Zhang YH, 2018, EXP THER MED, V15, P3495, DOI 10.3892/etm.2018.5861
   Zhang YH, 2017, ONCOTARGET, V8, P81604, DOI 10.18632/oncotarget.20258
   Zhou LD, 2010, MED ONCOL, V27, P255, DOI 10.1007/s12032-009-9201-4
   Zhou Q, 2011, FUTURE ONCOL, V7, P1149, DOI [10.2217/fon.11.95, 10.2217/FON.11.95]
NR 88
TC 11
Z9 11
U1 0
U2 33
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1388-1981
EI 1879-2618
J9 BBA-MOL CELL BIOL L
JI Biochim. Biophys. Acta Mol. Cell Biol. Lipids
PD 2021 JUN
PY 2021
VL 1866
IS 6
AR 158920
DI 10.1016/j.bbalip.2021.158920
EA MAR 2021
PG 15
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA RH2GW
UT WOS:000636044800011
PM 33684566
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU Bergamini, E
   Bizzarri, R
   Cavallini, G
   Cerbai, B
   Chiellini, E
   Donati, A
   Gori, Z
   Manfrini, A
   Parentini, I
   Signori, F
   Tamburini, I
AF Bergamini, E
   Bizzarri, R
   Cavallini, G
   Cerbai, B
   Chiellini, E
   Donati, A
   Gori, Z
   Manfrini, A
   Parentini, I
   Signori, F
   Tamburini, I
TI Ageing and oxidative stress: A role for dolichol in the antioxidant
   machinery of cell membranes?
SO JOURNAL OF ALZHEIMERS DISEASE
LA English
DT Article
DE dolichol; vitamin E; PUFA; antioxidants in membrane; ageing
ID RAT-LIVER; CARBON-TETRACHLORIDE; CALORIC RESTRICTION; PROTEIN OXIDATION;
   METABOLISM; ACCUMULATION; MECHANISM; MACROAUTOPHAGY; PEROXIDATION;
   CHOLESTEROL
AB Dolichol is a polyprenol compound broadly distributed in membranes, biosynthetized by the general isoprenoid pathway from acetate via mevalonate and farnesyl pyrophosphate. Dolichol lays inside the membrane between the two leaflets of the lipid bilayer very close to the tail of phospholipid fatty acids. No definite catabolic pathways for this molecule have yet been identified. Evidence is produced that dolichol levels increase dramatically with increasing age; that anti-ageing caloric restriction retards this age-associated change; that dolichol may act as a radical scavenger of peroxidized lipids belonging to the cell membranes. In view of the polyunsaturated fatty acids (PUFA), dolichol and Vitamin E location and stechiometry, it is proposed that molecules might interact each-other to form a highly matched free-radical-transfer chain, whose malfunctioning might be involved in statin toxicity and neurodegenerative diseases.
C1 Ctr Ric Biol & Patol Invecchiamento, I-56126 Pisa, Italy.
   Univ Pisa, Dipartimento Chim & Chim Ind, Pisa, Italy.
C3 University of Pisa
RP Bergamini, E (corresponding author), Ctr Ric Biol & Patol Invecchiamento, Via Roma 55, I-56126 Pisa, Italy.
EM ebergami@ipg.med.unipi.it
RI Signori, Francesca/G-1937-2010; Bizzarri, Ranieri/ABH-8343-2020;
   Bizzarri, Ranieri/H-1779-2011; Signori, Francesca/Y-6178-2019
OI Signori, Francesca/0000-0002-9211-5352; Bizzarri,
   Ranieri/0000-0002-8222-2672; 
CR Bergamini E, 2003, BIOMED PHARMACOTHER, V57, P203, DOI 10.1016/S0753-3322(03)00048-9
   Bergamini E, 1995, AGING-CLIN EXP RES, V7, P473, DOI 10.1007/BF03324374
   Bergamini E, 1998, AGING-CLIN EXP RES, V10, P174
   BERGAMINI E, 2002, G GERONTOL, V50, P181
   BURGE JA, 1978, METHOD ENZYMOL, V52, P302
   CARROLL KK, 1992, BIOCHEM CELL BIOL, V70, P382, DOI 10.1139/o92-059
   CHOINACKI T, 1988, BIOCHEM J, V251, P1
   DANIELS I, 1990, LIPIDS, V25, P586, DOI 10.1007/BF02536006
   Del Roso A, 2003, EXP GERONTOL, V38, P519, DOI 10.1016/S0531-5565(03)00002-0
   DEROPP JS, 1985, J BIOL CHEM, V260, P5669
   Dirkswager Edward J, 2002, Caloric restriction: A key to understanding and modulating aging
   Dolfi C, 2003, BIOGERONTOLOGY, V4, P113, DOI 10.1023/A:1023304021679
   GOODRICK CL, 1982, GERONTOLOGY, V28, P233, DOI 10.1159/000212538
   HEMMING FW, 1992, BIOCHEM CELL BIOL, V70, P377, DOI 10.1139/o92-058
   Hsu PC, 2002, TOXICOLOGY, V180, P33, DOI 10.1016/S0300-483X(02)00380-3
   KALEN A, 1990, LIPIDS, V25, P93, DOI 10.1007/BF02562211
   KOUMALOVA AS, 2003, EXP GERONTOL, V38, P711
   Marino M, 1998, J GERONTOL A-BIOL, V53, pB87, DOI 10.1093/gerona/53A.2.B87
   MCCARTER RJ, 1992, AM J PHYSIOL, V263, pE448, DOI 10.1152/ajpendo.1992.263.3.E448
   Mortensen A, 2001, ARCH BIOCHEM BIOPHYS, V385, P13, DOI 10.1006/abbi.2000.2172
   Pallottini V, 2003, BIOGERONTOLOGY, V4, P371, DOI 10.1023/B:BGEN.0000006557.92558.60
   Pamplona R, 2002, MECH AGEING DEV, V123, P1437, DOI 10.1016/S0047-6374(02)00076-3
   Pappolla MA, 2002, FREE RADICAL BIO MED, V33, P173, DOI 10.1016/S0891-5849(02)00841-9
   Parentini I, 2003, BIOGERONTOLOGY, V4, P365, DOI 10.1023/B:BGEN.0000006556.76899.29
   Perry G, 2002, FREE RADICAL BIO MED, V33, P1475, DOI 10.1016/S0891-5849(02)01113-9
   POLI G, 1979, EXP MOL PATHOL, V30, P116, DOI 10.1016/0014-4800(79)90086-8
   PULLARKAT RK, 1982, J BIOL CHEM, V257, P5991
   PULLARKAT RK, 1984, BIOCHIM BIOPHYS ACTA, V793, P494, DOI 10.1016/0005-2760(84)90269-8
   RIP JW, 1985, PROG LIPID RES, V24, P269, DOI 10.1016/0163-7827(85)90008-6
   Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5
   Sgarbossa A, 2003, BIOGERONTOLOGY, V4, P379, DOI 10.1023/B:BGEN.0000006558.44482.a4
   SMITH CD, 1992, ANN NY ACAD SCI, V663, P110, DOI 10.1111/j.1749-6632.1992.tb38654.x
   Smith MW, 1997, J CHEM EDUC, V74, P1471, DOI 10.1021/ed074p1471
   Sohal RS, 2002, FREE RADICAL BIO MED, V33, P37, DOI 10.1016/S0891-5849(02)00856-0
   TAKIGAWA T, 1989, CHEM PHYS LIPIDS, V51, P171, DOI 10.1016/0009-3084(89)90004-2
   VanHoute HA, 1997, BBA-LIPID LIPID MET, V1347, P93, DOI 10.1016/S0005-2760(97)00058-1
NR 36
TC 42
Z9 49
U1 0
U2 4
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1387-2877
EI 1875-8908
J9 J ALZHEIMERS DIS
JI J. Alzheimers Dis.
PD APR
PY 2004
VL 6
IS 2
BP 129
EP 135
PG 7
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 862NQ
UT WOS:000224498100004
PM 15096696
DA 2024-02-19
ER

PT J
AU Wen, M
AF Wen, Mei
TI Intervention Effect of Electroacupuncture Combined with EPCs
   Transplantation on the Mice in Aging Model
SO EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE
LA English
DT Article
ID ENDOTHELIAL PROGENITOR CELLS; KLOTHO; MOBILIZATION; INCREASE
AB The results of this experiment suggested that electroacupuncture promotes the endothelialization of liver endothelial progenitor cells (EPCs) for mice in D-gal model and improves the repair of vascular endothelial function, as well as increasing the vascular endothelial growth factor (VEGF) expression in liver tissue fluorescence and KL protein levels. Also, it reduces the malondialdehyde (MDA) activity and delays vascular aging and even overall aging. Results showed that the in vivo fluorescence intensity for D-gal EA group was significantly lower than that of D-gal group, P < 0.05; VEGF fluorescence expression in liver tissue for D-gal EA group was significantly higher than that for D-gal group,P < 0.05; KL protein content in liver tissue for D-gal EA group was significantly higher than that for D-gal group, P < 0.05; MDA activity for D-gal EA group was significantly lower than that for D-gal group, P < 0.05.
C1 [Wen, Mei] Chinese Acad Chinese Med Sci, Inst Acupuncture & Moxibust, Beijing 100700, Peoples R China.
   [Wen, Mei] Inner Mongolia Univ Nationalities, Affiliated Hosp, Tongliao 028000, Peoples R China.
C3 Institute of Acupuncture & Moxibustion, CACMS; China Academy of Chinese
   Medical Sciences; Inner Mongolia University for Nationalities
RP Wen, M (corresponding author), Chinese Acad Chinese Med Sci, Inst Acupuncture & Moxibust, Beijing 100700, Peoples R China.
EM tlwenmei@163.com
CR Anamizu Y, 2005, ACTA NEUROPATHOL, V109, P457, DOI 10.1007/s00401-004-0971-7
   Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964
   Brandes RP, 2005, CARDIOVASC RES, V66, P286, DOI 10.1016/j.cardiores.2004.12.027
   CARDOSO AA, 1993, P NATL ACAD SCI USA, V90, P8707, DOI 10.1073/pnas.90.18.8707
   Case J, 2008, ANTIOXID REDOX SIGN, V10, P1895, DOI 10.1089/ars.2008.2118
   Chang RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061590
   Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573
   Dantas AP, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00325
   Forner A, 2009, J HEPATOL, V51, P981, DOI 10.1016/j.jhep.2009.09.009
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Hristov M, 2003, ARTERIOSCL THROM VAS, V23, P1185, DOI 10.1161/01.ATV.0000073832.49290.B5
   Ishihara T, 2013, TRANSFUS APHER SCI, V49, P539, DOI 10.1016/j.transci.2013.07.033
   Jinag J., 2009, CHONGQING YIXUE, V38, P3111
   Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397
   Kamemori M, 2002, HEARING RES, V171, P103, DOI 10.1016/S0378-5955(02)00483-5
   Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285
   Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200
   Li C. M., 2006, CHINESE J AESTHETIC, V15, P466
   [李艳菊 LI Yan-ju], 2009, [中华肾脏病杂志, Chinese Journal of Nephrology], V25, P241
   Mazzini L, 2008, J NEUROL SCI, V265, P78, DOI 10.1016/j.jns.2007.05.016
   Mitani H, 2002, HYPERTENSION, V39, P838, DOI 10.1161/01.HYP.0000013734.33441.EA
   Nagai Taku, 2003, FASEB Journal, V17, P50
   Oatley JM, 2012, PHYSIOL REV, V92, P577, DOI 10.1152/physrev.00025.2011
   Peysselon F, 2011, MATURITAS, V69, P126, DOI 10.1016/j.maturitas.2011.03.013
   Poon RTP, 2001, AM J SURG, V182, P298, DOI 10.1016/S0002-9610(01)00708-5
   Singla DK, 2015, CELL TRANSPLANT, V24, P1031, DOI 10.3727/096368914X679200
   Söderdahl G, 2003, TRANSPLANTATION, V75, P1061, DOI 10.1097/01.TP.0000058515.02300.5E
   Thum T, 2007, CIRC RES, V100, P434, DOI 10.1161/01.RES.0000257912.78915.af
   Won YW, 2012, J CONTROL RELEASE, V160, P525, DOI 10.1016/j.jconrel.2012.03.010
   Xiao NM, 2004, CHINESE MED J-PEKING, V117, P742
   Xu P, 2012, CHIN J INTEGR MED, V18, P490, DOI 10.1007/s11655-012-1097-8
   Yang H. L., 1998, ADV PATHOPHYSIOLOGY
   Zhang K. Y., 2006, J QIQIHAR MED COLL, V27, P1223
   Zhu SK, 2007, ARTERIOSCL THROM VAS, V27, P113, DOI 10.1161/01.ATV.0000252035.12881.d0
   杜洪霞, 2009, [中国老年学杂志, Chinese Journal of Gerontology], V29, P2190
NR 35
TC 0
Z9 0
U1 1
U2 6
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1741-427X
EI 1741-4288
J9 EVID-BASED COMPL ALT
JI Evid.-based Complement Altern. Med.
PY 2015
VL 2015
AR 972749
DI 10.1155/2015/972749
PG 8
WC Integrative & Complementary Medicine
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Integrative & Complementary Medicine
GA CQ6ZA
UT WOS:000360751400001
PM 26379754
OA Green Published, gold, Green Submitted
DA 2024-02-19
ER

PT J
AU Okuyama, H
   Yoshida, T
   Son, A
   Oka, S
   Wang, DM
   Nakayama, R
   Masutani, H
   Nakamura, H
   Nabeshima, Y
   Yodoi, J
AF Okuyama, Hiroaki
   Yoshida, Toru
   Son, Aoi
   Oka, Shin-ichi
   Wang, Dongmei
   Nakayama, Rika
   Masutani, Hiroshi
   Nakamura, Hajime
   Nabeshima, Yo-ichi
   Yodoi, Junji
TI Thioredoxin Binding Protein 2 Modulates Natural Killer T Cell-Dependent
   Innate Immunity in the Liver: Possible Link to Lipid Metabolism
SO ANTIOXIDANTS & REDOX SIGNALING
LA English
DT Article
ID UP-REGULATED PROTEIN-1; MURINE FATTY LIVERS; ANTIGEN PRESENTATION;
   OXIDATIVE STRESS; CONCANAVALIN-A; CUTTING EDGE; KAPPA-B; MICE; GENE;
   EXPRESSION
AB Thioredoxin binding protein 2 (TBP2) plays a regulatory role in lipid metabolism and immune regulation. We previously reported the effect of TBP2 loss-of-function on lipid metabolism using TBP2 knockout (TBP2KO) mice. In this study, we employed TBP2 transgenic (TBP2TG) mice to analyze the in vivo effect of TBP2 gain-of-function. We revealed a decrease in the percentage of hepatic natural killer T (NKT) cells in TBP2KO mice and an increase in the percentage of hepatic NKT cells in TBP2TG mice. The TBP2KO mice were resistant to concanavalin A (ConA)induced hepatitis, but they were highly susceptible to other types of hepatitis. TBP2 modulates lipid metabolism as well as NKT cell activity. Moreover, TBP2 expression was increased significantly in klotho-deficient mice, which exhibit a syndrome resembling aging human phenotypes. TBP2 may play multiple roles in lipid metabolism, innate immunity, and aging. Antioxid. Redox Signal. 11, 2585-2593.
C1 [Yodoi, Junji] Kyoto Univ, Dept Biol Responses, Inst Virus Res, Sakyo Ku, Kyoto 6068507, Japan.
   [Okuyama, Hiroaki; Nakamura, Hajime] Kyoto Univ Hosp, Thioredoxin Project, Dept Expt Therapeut, Translat Res Ctr, Kyoto 606, Japan.
   [Yoshida, Toru] Mukogawa Womens Univ, Dept Food Sci & Nutr, Sch Human Environm Sci, Nishinomiya, Hyogo, Japan.
   [Nakayama, Rika] RIKEN Kobe, CDB, Lab Anim Resources & Genet Engn, Kobe, Hyogo, Japan.
   [Nabeshima, Yo-ichi] Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Kyoto 6068507, Japan.
C3 Kyoto University; Kyoto University; Mukogawa Women's University; RIKEN;
   Kyoto University
RP Yodoi, J (corresponding author), Kyoto Univ, Dept Biol Responses, Inst Virus Res, Sakyo Ku, 53 Shogoin, Kyoto 6068507, Japan.
EM yodoi@virus.kyoto-u.ac.jp
RI MASUTANI, Hiroshi/JRY-0671-2023; Masutani, Hiroshi/B-5114-2014; WANG,
   DONG-MEI/K-5799-2016; Yodoi, Junji/F-6189-2011
OI MASUTANI, Hiroshi/0000-0001-7633-2827; 
FU National Institute of Biomedical Innovation ( NIBIO)
FX We would like to express our thanks to Ms. Akie Teratani ( Redox
   Bioscience Inc. Kyoto, Japan), Suzuyo Furukawa ( Thioredoxin Project,
   Kyoto University Hospital), and Mr. Akira Yamada ( Redox Bioscience Inc.
   Kyoto, Japan) for their technical support, Ms. Kyoko Miyamoto (
   Thioredoxin Project, Kyoto University Hospital) for her secretarial
   support, and Dr. Yuma Hoshino ( Thioredoxin Project, Kyoto University
   Hospital), Dr. Ahsan Kaimul ( Thioredoxin Project, Kyoto University
   Hospital), Dr. Akira Mitsui ( Ajinomoto Inc, Japan), Dr. Yoshiyuki
   Matsuo ( Institute for Virus Research, Kyoto University) for their
   critical discussion. This work was supported by a Grant- in- Aid for the
   Creation of Innovations through Business- Academic-Public Sector
   Cooperation and Open Competition for the Development of Innovative
   Technology, from the Ministry of Education, Culture, Sports, Science,
   and Technology of Japan. This work was also supported in part by the
   Program for the Promotion of Fundamental Studies in Health Sciences of
   the National Institute of Biomedical Innovation ( NIBIO).
CR Ahsan MK, 2006, ONCOGENE, V25, P2181, DOI 10.1038/sj.onc.1209256
   Anand S, 2006, J CLIN INVEST, V116, P1045, DOI 10.1172/JCI27083
   Brozovic S, 2004, NAT MED, V10, P535, DOI 10.1038/nm1043
   CHEN KS, 1994, BBA-GENE STRUCT EXPR, V1219, P26, DOI 10.1016/0167-4781(94)90242-9
   Czar MJ, 2001, P NATL ACAD SCI USA, V98, P7449, DOI 10.1073/pnas.131193098
   Eberl G, 1999, J IMMUNOL, V163, P4091
   Guebre-Xabier M, 2000, HEPATOLOGY, V31, P633, DOI 10.1002/hep.510310313
   Gumperz JE, 2000, IMMUNITY, V12, P211, DOI 10.1016/S1074-7613(00)80174-0
   HOLMGREN A, 1995, METHOD ENZYMOL, V252, P199
   Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285
   Lee KN, 2005, IMMUNITY, V22, P195, DOI 10.1016/j.immuni.2004.12.012
   Li ZP, 2005, HEPATOLOGY, V42, P880, DOI 10.1002/hep.20826
   Major AS, 2006, TRENDS MOL MED, V12, P270, DOI 10.1016/j.molmed.2006.04.004
   Mitsui A, 2002, ANTIOXID REDOX SIGN, V4, P693, DOI 10.1089/15230860260220201
   MIYAZAKI J, 1989, GENE, V79, P269
   Nakamura H, 1997, ANNU REV IMMUNOL, V15, P351, DOI 10.1146/annurev.immunol.15.1.351
   Nichols KE, 2005, NAT MED, V11, P340, DOI 10.1038/nm1189
   Nishinaka Y, 2004, CANCER RES, V64, P1287, DOI 10.1158/0008-5472.CAN-03-0908
   Nishiyama A, 1999, J BIOL CHEM, V274, P21645, DOI 10.1074/jbc.274.31.21645
   Oka S, 2006, FASEB J, V20, pA45, DOI 10.1096/fj.05-4439fje
   Okuyama H, 2005, J HEPATOL, V42, P117, DOI 10.1016/j.jhep.2004.09.020
   Okuyama H, 2006, J BIOL CHEM, V281, P15554, DOI 10.1074/jbc.M602003200
   Sayos J, 1998, NATURE, V395, P462, DOI 10.1038/26683
   SEAMAN WE, 1987, J IMMUNOL, V138, P4539
   Sivakumar V, 2003, J EXP MED, V197, P1613, DOI 10.1084/jem.20022234
   Son A, 2008, EUR J IMMUNOL, V38, P1358, DOI 10.1002/eji.200737939
   Stanic AK, 2004, J IMMUNOL, V172, P4667, DOI 10.4049/jimmunol.172.8.4667
   Sugita M, 2004, CURR OPIN IMMUNOL, V16, P90, DOI 10.1016/j.coi.2003.11.014
   Takeda K, 2000, P NATL ACAD SCI USA, V97, P5498, DOI 10.1073/pnas.040566697
   TIEGS G, 1992, J CLIN INVEST, V90, P196, DOI 10.1172/JCI115836
   Toyabe S, 1997, J IMMUNOL, V159, P1537
   Tsujikawa H, 2003, MOL ENDOCRINOL, V17, P2393, DOI 10.1210/me.2003-0048
   WATANABE H, 1992, J IMMUNOL METHODS, V146, P145, DOI 10.1016/0022-1759(92)90223-G
   Wu CB, 2001, NAT IMMUNOL, V2, P410, DOI 10.1038/87713
   Yang L, 2007, LAB INVEST, V87, P927, DOI 10.1038/labinvest.3700603
   Yoshida T, 2003, ANTIOXID REDOX SIGN, V5, P563, DOI 10.1089/152308603770310211
   Yoshida T, 2002, ENDOCRINOLOGY, V143, P683, DOI 10.1210/en.143.2.683
   YOSHIDA T, 2003, ANN NY ACAD SCI, V1055, P1
NR 38
TC 13
Z9 14
U1 0
U2 0
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1523-0864
EI 1557-7716
J9 ANTIOXID REDOX SIGN
JI Antioxid. Redox Signal.
PD OCT
PY 2009
VL 11
IS 10
BP 2585
EP 2593
DI 10.1089/ars.2009.2691
PG 9
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA 496NC
UT WOS:000269980200017
PM 19619006
DA 2024-02-19
ER

PT J
AU Battino, M
   Baroni, SS
   Littarru, GP
   Bompadre, S
   Leone, L
   Gorini, A
   Villa, RF
AF Battino, M
   Baroni, SS
   Littarru, GP
   Bompadre, S
   Leone, L
   Gorini, A
   Villa, RF
TI Coenzyme Q homologs and vitamin E in synaptic and non-synaptic occipital
   cerebral cortex mitochondria in the ageing rat
SO MOLECULAR ASPECTS OF MEDICINE
LA English
DT Article; Proceedings Paper
CT 9th International Symposium on Biomedical and Clinical Aspects of
   Coenzyme Q
CY MAY, 1996
CL ANCONA, ITALY
DE coenzyme Q; vitamin E; ageing; rat brain mitochondria
ID NONSYNAPTIC MITOCHONDRIA; BRAIN-REGIONS; LIVER
AB The coenzyme Q(s) (CoQ(s)) and alpha-tocopherol contents of different mitochondrial fractions were investigated from occipital cerebral cortices of different ages. The highest CoQ(s) and vitamin E concentrations were found in non-synaptic free mitochondria (FM) fractions. In several cases heavy mitochondria (HM) fractions displayed the lowest values. Occipital cerebral cortex mitochondria contained higher CoQ(9) and lower CoQ(10) amounts than those typical for other brain regions. (C) 1997 Elsevier Science ltd.
C1 UNIV ANCONA,SCH MED,INST BIOCHEM,ANCONA,ITALY.
   UNIV ANCONA,SCH MED,INST BIOMED SCI,I-60131 ANCONA,ITALY.
   UNIV PAVIA,INST PHARMACOL,I-27100 PAVIA,ITALY.
C3 Marche Polytechnic University; Marche Polytechnic University; University
   of Pavia
RI Battino, Maurizio/E-6103-2012; Svegliati, Silvia/L-2614-2016
OI Battino, Maurizio/0000-0002-7250-1782; Svegliati,
   Silvia/0000-0001-6863-2600
CR BATTINO M, 1991, J BIOENERG BIOMEMBR, V23, P345, DOI 10.1007/BF00762227
   BATTINO M, 1995, MECH AGEING DEV, V78, P173, DOI 10.1016/0047-6374(94)01535-T
   HUERTAS JR, 1991, BIOCHEM BIOPH RES CO, V181, P375, DOI 10.1016/S0006-291X(05)81429-9
   HUERTAS JR, 1991, FEBS LETT, V287, P89, DOI 10.1016/0014-5793(91)80022-U
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
NR 5
TC 5
Z9 5
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0098-2997
J9 MOL ASPECTS MED
JI Mol. Asp. Med.
PY 1997
VL 18
SU S
BP S279
EP S282
PG 4
WC Biochemistry & Molecular Biology; Medicine, Research & Experimental
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Research & Experimental Medicine
GA XR183
UT WOS:A1997XR18300039
PM 9266537
DA 2024-02-19
ER

PT J
AU YU, BP
AF YU, BP
TI ANTIOXIDANT ACTION OF DIETARY RESTRICTION IN THE AGING PROCESS
SO JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY
LA English
DT Article
DE DIETARY RESTRICTION; AGING; ANTIOXIDANTS; MEMBRANE FLUIDITY; DNA DAMAGE;
   LIPID HYDROPEROXIDE; MITOCHONDRIA; MICROSOMES
ID CHRONIC FOOD RESTRICTION; LIPID-PEROXIDATION; FREE-RADICALS; LIVER;
   MEMBRANE; ENZYMES; RATS; AGE; DAMAGE; BRAIN
AB Dietary restriction is widely recognized to be the most effective means of intervening in the aging process in laboratory animals. Recent studies have produced substantial evidence that indicates this nutritional manipulation can modulate many aspects of free radical metabolism, including free radical generation, lipid peroxidation, DNA damage and cytosolic defense systems. Some of our laboratory's recent work is summarized in this presentation.
RP YU, BP (corresponding author), UNIV TEXAS, HLTH SCI CTR, SAN ANTONIO, TX 78284 USA.
FU NIA NIH HHS [AG01188] Funding Source: Medline
CR CHUNG MH, 1992, FREE RADICAL BIO MED, V12, P523, DOI 10.1016/0891-5849(92)90105-P
   DEAN RT, 1991, FREE RADICAL BIO MED, V11, P161, DOI 10.1016/0891-5849(91)90167-2
   ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6
   HARMAN D, 1978, AGE, V1, P143
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   HEGNER D, 1980, MECH AGEING DEV, V14, P101, DOI 10.1016/0047-6374(80)90109-8
   HEYDARI AR, 1992, ANN NY ACAD SCI, V663, P384, DOI 10.1111/j.1749-6632.1992.tb38682.x
   KOIZUMI A, 1987, J NUTR, V117, P361, DOI 10.1093/jn/117.2.361
   KRISTAL BS, 1992, J GERONTOL, V47, pB107, DOI 10.1093/geronj/47.4.B107
   LAGANIERE S, 1987, BIOCHEM BIOPH RES CO, V145, P1185, DOI 10.1016/0006-291X(87)91562-2
   LAGANIERE S, 1993, GERONTOLOGY, V39, P7, DOI 10.1159/000213509
   LAGANIERE S, 1989, MECH AGEING DEV, V48, P221, DOI 10.1016/0047-6374(89)90084-5
   LAGANIERE S, 1989, MECH AGEING DEV, V48, P207, DOI 10.1016/0047-6374(89)90083-3
   LEBEL CP, 1990, NEUROCHEM INT, V17, P435, DOI 10.1016/0197-0186(90)90025-O
   Lee D W, 1990, Aging (Milano), V2, P357
   LEONG SF, 1984, J NEUROCHEM, V42, P1306, DOI 10.1111/j.1471-4159.1984.tb02788.x
   OBERLEY LW, 1988, FREE RADICAL BIO MED, V5, P113, DOI 10.1016/0891-5849(88)90036-6
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   PIERI C, 1991, ANN NY ACAD SCI, V621, P353
   PORTA EA, 1988, CELLULAR ANTIOXIDANT, V3, P1
   SAWADA M, 1992, J CELL BIOCHEM, V48, P296, DOI 10.1002/jcb.240480310
   STEINBERG D, 1991, CIRCULATION, V84, P1420, DOI 10.1161/01.CIR.84.3.1420
   SUN Y, 1990, FREE RADICAL BIO MED, V8, P583, DOI 10.1016/0891-5849(90)90156-D
   Weindruch R., 1988, RETARDATION AGING DI
   YOUNGMAN LD, 1992, P NATL ACAD SCI USA, V89, P9112, DOI 10.1073/pnas.89.19.9112
   YU BP, 1992, MECH AGEING DEV, V65, P17, DOI 10.1016/0047-6374(92)90123-U
   YU BP, 1985, J GERONTOL, V40, P657, DOI 10.1093/geronj/40.6.657
   YU BP, 1993, IN PRESS FREE RADICA
   ZAHN H, 1992, MECH AGEING DEV, V62, P111
NR 29
TC 18
Z9 18
U1 0
U2 1
PU CENTER ACADEMIC PUBL JAPAN
PI TOKYO
PA 2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN
SN 0301-4800
EI 1881-7742
J9 J NUTR SCI VITAMINOL
JI J. Nutr. Sci. Vitaminol.
PY 1993
VL 39
SU S
BP S75
EP S83
PG 9
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA MR861
UT WOS:A1993MR86100010
PM 8164070
OA gold
DA 2024-02-19
ER

PT J
AU ONO, T
   YAMAMOTO, S
   KURISHITA, A
   YAMAMOTO, K
   YAMAMOTO, Y
   UJENO, Y
   SAGISAKA, K
   FUKUI, Y
   MIYAMOTO, M
   TAWA, R
   HIROSE, S
   OKADA, S
AF ONO, T
   YAMAMOTO, S
   KURISHITA, A
   YAMAMOTO, K
   YAMAMOTO, Y
   UJENO, Y
   SAGISAKA, K
   FUKUI, Y
   MIYAMOTO, M
   TAWA, R
   HIROSE, S
   OKADA, S
TI COMPARISON OF AGE-ASSOCIATED CHANGES OF C-MYC GENE METHYLATION IN LIVER
   BETWEEN MAN AND MOUSE
SO MUTATION RESEARCH
LA English
DT Article
DE AGING; C-MYC; DNA METHYLATION; MAN AND MOUSE; LIVER
ID DNA METHYLATION; NUCLEOTIDE-SEQUENCE; CHROMOSOME-TRANSLOCATION; MURINE
   PLASMACYTOMAS; ONCOGENE; LOCUS; MICE; ACTIVATION; RADIATION; INVITRO
AB Age-associated changes in DNA methylation of the c-myc gene in liver were compared between humans and mice which have large differences in aging rate. Although the overall methylation profiles of the gene and their age-related changes were found to be similar, the rate of change was much slower in humans than in mice. It suggests that the age-associated alteration of c-myc gene methylation is closely related to biological aging rather than to chronological aging.
C1 KYOTO UNIV, CTR RADIAT BIOL, KYOTO 606, JAPAN.
   KYOTO PHARMACEUT UNIV, DEPT ANALYT CHEM, KYOTO 607, JAPAN.
   KYOTO UNIV, FAC MED, KYOTO 606, JAPAN.
   KYOTO UNIV, INST RES REACTOR, OSAKA 59004, JAPAN.
   TOHOKU UNIV, SCH MED, DEPT FORENS MED, SENDAI, MIYAGI 980, JAPAN.
   OSAKA UNIV, FAC MED, DEPT PATHOL, OSAKA 530, JAPAN.
C3 Kyoto University; Kyoto Pharmaceutical University; Kyoto University;
   Kyoto University; Tohoku University; Osaka University
RP ONO, T (corresponding author), TOHOKU UNIV, SCH MED, DEPT RADIAT RES, AOBA KU, SENDAI, MIYAGI 980, JAPAN.
CR ADAMS JM, 1983, P NATL ACAD SCI-BIOL, V80, P1982, DOI 10.1073/pnas.80.7.1982
   ALLEN ND, 1990, CELL, V61, P853, DOI 10.1016/0092-8674(90)90195-K
   ALTMAN PL, 1962, GROWTH INCLUDING REP, P346
   BATTEY J, 1983, CELL, V34, P779, DOI 10.1016/0092-8674(83)90534-2
   BECKER FF, 1985, P NATL ACAD SCI USA, V82, P6055, DOI 10.1073/pnas.82.18.6055
   BERNARD O, 1983, EMBO J, V2, P2375, DOI 10.1002/j.1460-2075.1983.tb01749.x
   BOEHM TLJ, 1983, CANCER RES, V43, P6066
   BRAVO LM, 1989, MUTAT RES, V215, P55, DOI 10.1016/0027-5107(89)90217-0
   COLBY WW, 1983, NATURE, V301, P722, DOI 10.1038/301722a0
   CUTLER RG, 1985, MOL BIOL AGING, P15, DOI DOI 10.2307/2499207
   DELAIGLESIA FA, 1976, AM J PATHOL, V82, P61
   DRINKWATER RD, 1989, MUTAT RES, V219, P29, DOI 10.1016/0921-8734(89)90038-6
   GAZIN C, 1984, EMBO J, V3, P383, DOI 10.1002/j.1460-2075.1984.tb01816.x
   GREENGARD O, 1977, PEDIATR RES, V11, P669, DOI 10.1203/00006450-197705000-00009
   GRUNWALD S, 1989, PROG CLIN BIOCH MED, V9, P61, DOI DOI 10.1007/978-3-642-74734-2_3
   GUMUCIO JJ, 1988, LIVER BIOL PATHOBIOL, P931
   HELDEN EGH, 1989, MUTAT RES, V219, P263
   KALINICH JF, 1989, RADIAT RES, V117, P185, DOI 10.2307/3577319
   KASTAN MB, 1982, CELL, V30, P509, DOI 10.1016/0092-8674(82)90248-3
   LIEBERMAN MW, 1983, CELL, V35, P207, DOI 10.1016/0092-8674(83)90223-4
   LOW M, 1976, INT J RADIAT ONCOL, V1, P289, DOI 10.1016/0360-3016(76)90053-5
   MASORO EJ, 1990, HDB BIOL AGING, P72
   MAYSHOOPES LL, 1989, INT REV CYTOL, V114, P181
   NYCE J, 1986, NUCLEIC ACIDS RES, V14, P4353, DOI 10.1093/nar/14.10.4353
   NYCE J, 1989, CANCER RES, V49, P5829
   ONO T, 1985, MECH AGEING DEV, V32, P227, DOI 10.1016/0047-6374(85)90082-X
   ONO T, 1989, MUTAT RES, V219, P39, DOI 10.1016/0921-8734(89)90039-8
   Sacher G. A., 1978, The genetics of aging., P151
   SINGHAL RP, 1987, MECH AGEING DEV, V41, P199, DOI 10.1016/0047-6374(87)90040-6
   SLAGBOOM PE, 1990, MECH AGEING DEV, V53, P243, DOI 10.1016/0047-6374(90)90042-E
   STANTON LW, 1983, NATURE, V303, P401, DOI 10.1038/303401a0
   STANTON LW, 1984, NATURE, V310, P423, DOI 10.1038/310423a0
   TAUCHI H, 1981, CELLULAR AGING, P11
   TAWA R, 1990, IN PRESS DIFFERENTIA
   TAYA Y, 1984, EMBO J, V3, P2943, DOI 10.1002/j.1460-2075.1984.tb02236.x
   TIMIRAS PS, 1972, DEV PHYSL AGING, P411
   UEHARA Y, 1989, ONCOGENE, V4, P1023
   WILSON VL, 1987, J BIOL CHEM, V262, P9948
   WILSON VL, 1983, CELL, V32, P239, DOI 10.1016/0092-8674(83)90514-7
NR 39
TC 21
Z9 21
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-8262
J9 MUTAT RES
JI Mutat. Res.
PD SEP-NOV
PY 1990
VL 237
IS 5-6
BP 239
EP 246
DI 10.1016/0921-8734(90)90005-C
PG 8
WC Genetics & Heredity; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity; Toxicology
GA FF366
UT WOS:A1990FF36600005
PM 2079963
DA 2024-02-19
ER

PT J
AU Mach, J
   Huizer-Pajkos, A
   Cogger, VC
   McKenzie, C
   Le Couteur, DG
   Jones, BE
   de Cabo, R
   Hilmer, SN
AF Mach, John
   Huizer-Pajkos, Aniko
   Cogger, Victoria C.
   McKenzie, Catriona
   Le Couteur, David G.
   Jones, Brett E.
   de Cabo, Rafael
   Hilmer, Sarah N.
TI The Effect of Aging on Acetaminophen Pharmacokinetics, Toxicity and Nrf2
   in Fischer 344 Rats
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
DE Acetaminophen; Toxicity; Aging; Pharmacokinetics
ID OXIDATIVE STRESS; INDUCED HEPATOTOXICITY; WISTAR RATS; DIETARY
   RESTRICTION; SPRAGUE-DAWLEY; LIVER-INJURY; AGE; PARACETAMOL; MICE;
   NEPHROTOXICITY
AB We investigated the effect of aging on hepatic pharmacokinetics and the degree of hepatotoxicity following a toxic dose of acetaminophen. Young and old male Fischer 344 rats were treated with 800 mg/kg acetaminophen (young n = 8, old n = 5) or saline (young n = 9, old n = 9). Serum measurements showed old rats treated with acetaminophen had significantly lower serum alanine aminotransferase and higher acetaminophen and acetaminophen glucuronide levels and creatinine, compared with acetaminophen treated young rats (p < .05). Immunoblotting and activity assays showed old saline-treated rats had twofold lower cytochrome P450 2E1 activity and threefold higher NAD(P)H quinone oxireductase 1 protein expression and activity than young saline-treated rats (p < .05), although Nrf2, glutathione cysteine ligase-modulatory subunit, glutathione cysteine ligase-catalytic subunit, and cytochrome P450 2E1 protein expressions were unchanged. Primary hepatocytes isolated from young rats treated with 10 mM acetaminophen had lower survival than those from old rats (52.4% +/- 5.8%, young; 83.6% +/- 1.7%, old, p < .05). The pharmacokinetic changes described may decrease susceptibility to acetaminophen-induced hepatotoxicity but may increase risk of nephrotoxicity in old age.
C1 [Mach, John; Huizer-Pajkos, Aniko; Hilmer, Sarah N.] Kolling Inst Med Res, Lab Ageing & Pharmacol, Sydney, NSW, Australia.
   [Mach, John; Huizer-Pajkos, Aniko; Hilmer, Sarah N.] Royal N Shore Hosp, Dept Clin Pharmacol, Sydney, NSW, Australia.
   [Mach, John; Huizer-Pajkos, Aniko; Hilmer, Sarah N.] Royal N Shore Hosp, Dept Aged Care, Sydney, NSW, Australia.
   [Mach, John; Cogger, Victoria C.; Le Couteur, David G.; Jones, Brett E.; Hilmer, Sarah N.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia.
   [Cogger, Victoria C.; Le Couteur, David G.] Concord Hosp, Ctr Educ & Res Aging, Concord, NSW, Australia.
   [Cogger, Victoria C.; Le Couteur, David G.] Concord Hosp, Anzac Res Inst, Concord, NSW, Australia.
   [Cogger, Victoria C.; Le Couteur, David G.] Univ Sydney, Sydney, NSW 2006, Australia.
   [McKenzie, Catriona] Royal Prince Alfred Hosp, Dept Pathol, Sydney, NSW, Australia.
   [Jones, Brett E.] Royal N Shore Hosp, Kolling Inst Med Res, Dept Gastroenterol, Sydney, NSW, Australia.
   [de Cabo, Rafael] NIA, Lab Expt Gerontol, NIH, Baltimore, MD 21224 USA.
C3 University of Sydney; Kolling Institute of Medical Research; University
   of Sydney; Royal North Shore Hospital; Royal North Shore Hospital;
   University of Sydney; University of Sydney; Concord Repatriation General
   Hospital; Concord Repatriation General Hospital; University of Sydney;
   ANZAC Research Institute; University of Sydney; NSW Health; Royal Prince
   Alfred Hospital; University of Sydney; University of Sydney; Kolling
   Institute of Medical Research; Royal North Shore Hospital; National
   Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)
RP Hilmer, SN (corresponding author), Royal N Shore Hosp, Dept Clin Pharmacol, Level 1,Acute Serv Bldg, St Leonards, NSW 2065, Australia.
EM sarah.hilmer@sydney.edu.au
RI Research Institute, ANZAC/CAE-9030-2022; Hilmer, Sarah/AAW-8554-2020; de
   Cabo, Rafael Carlos/E-7996-2010; de Cabo, Rafael/J-5230-2016
OI Hilmer, Sarah/0000-0002-5970-1501; de Cabo, Rafael
   Carlos/0000-0003-2830-5693; de Cabo, Rafael/0000-0002-3354-2442; Le
   Couteur, David/0000-0002-4227-5817; Mckenzie,
   Catriona/0000-0002-6452-4976
FU National Health and Medical Research Council [570968, 570937]; Geoff and
   Elaine Penney Ageing Research Unit, Royal North Shore Hospital
FX The work was supported by the National Health and Medical Research
   Council (# 570968, # 570937) and the Geoff and Elaine Penney Ageing
   Research Unit, Royal North Shore Hospital.
CR Aleksunes LM, 2006, WORLD J GASTROENTERO, V12, P1937, DOI 10.3748/wjg.v12.i12.1937
   ALTURK WA, 1981, DRUG CHEM TOXICOL, V4, P37, DOI 10.3109/01480548109066370
   BEIERSCHMITT WP, 1986, ARCH TOXICOL, V59, P206, DOI 10.1007/BF00290539
   BEIERSCHMITT WP, 1986, LIFE SCI, V39, P2335, DOI 10.1016/0024-3205(86)90664-8
   BELANGER PM, 1987, J PHARMACOKINET BIOP, V15, P133, DOI 10.1007/BF01062340
   BENSON AM, 1980, P NATL ACAD SCI-BIOL, V77, P5216, DOI 10.1073/pnas.77.9.5216
   Bokov AF, 2009, J GERONTOL A-BIOL, V64, P819, DOI 10.1093/gerona/glp052
   Bouchard G, 1998, J GERONTOL A-BIOL, V53, pB340, DOI 10.1093/gerona/53A.5.B340
   Chan KM, 2001, P NATL ACAD SCI USA, V98, P4611, DOI 10.1073/pnas.081082098
   CHEN LH, 1994, AGE, V17, P65, DOI 10.1007/BF02434896
   CORCORAN GB, 1987, J PHARMACOL EXP THER, V241, P921
   DIXON MF, 1975, GUT, V16, P800, DOI 10.1136/gut.16.10.800
   Harper JM, 2006, MECH AGEING DEV, V127, P687, DOI 10.1016/j.mad.2006.04.002
   HERD B, 1991, BRIT J CLIN PHARMACO, V32, P768
   Hine CM, 2012, J CLIN EXPT PATHOL, VS4, P1
   Ishigami F, 2001, TRANSPLANTATION, V72, P1803, DOI 10.1097/00007890-200112150-00016
   Jensen LS, 2004, J PHARMACEUT BIOMED, V34, P585, DOI 10.1016/S0731-7085(03)00573-9
   Jones BE, 2002, ANTIOXID REDOX SIGN, V4, P701, DOI 10.1089/152308602760598846
   Kamzalov S, 2004, EXP GERONTOL, V39, P1199, DOI 10.1016/j.exger.2004.04.007
   Kane A, 2012, AUSTRALAS J AGEING, V31, P190, DOI 10.1111/j.1741-6612.2012.00598.x
   Kislinger T, 2003, MOL CELL PROTEOMICS, V2, P96, DOI 10.1074/mcp.M200074-MCP200
   Lee SM, 1999, BIOCHEM PHARMACOL, V58, P1547, DOI 10.1016/S0006-2952(99)00248-8
   Lee SST, 1996, J BIOL CHEM, V271, P12063, DOI 10.1074/jbc.271.20.12063
   Liu RM, 2000, FREE RADICAL BIO MED, V28, P566, DOI 10.1016/S0891-5849(99)00269-5
   Liukas A, 2011, CLIN PHARMACOKINET, V50, P121, DOI 10.2165/11537240-000000000-00000
   McGill MR, 2012, TOXICOL APPL PHARM, V264, P387, DOI 10.1016/j.taap.2012.08.015
   McGill MR, 2012, J CLIN INVEST, V122, P1574, DOI 10.1172/JCI59755
   McLachlan AJ, 2012, J GERONTOL A-BIOL, V67, P175, DOI 10.1093/gerona/glr118
   Mitchell SJ, 2011, J CLIN PHARM THER, V36, P327, DOI 10.1111/j.1365-2710.2010.01193.x
   Mitchell SJ, 2011, J GERONTOL A-BIOL, V66, P400, DOI 10.1093/gerona/glq221
   Mitchell SJ, 2011, CURR GERONTOL GERIAT, V2011, P1
   Moffit JS, 2007, TOXICOLOGY, V230, P197, DOI 10.1016/j.tox.2006.11.052
   Nioi P, 2004, MUTAT RES-FUND MOL M, V555, P149, DOI 10.1016/j.mrfmmm.2004.05.023
   PRICE VF, 1987, BIOCHEM PHARMACOL, V36, P427, DOI 10.1016/0006-2952(87)90346-7
   PRICE VF, 1982, J PHARMACOL EXP THER, V220, P504
   RAHEJA KL, 1987, FED PROC, V46, P1140
   RIKANS LE, 1988, DRUG CHEM TOXICOL, V11, P237, DOI 10.3109/01480548809017880
   ROBERTS BJ, 1995, BIOCHEM PHARMACOL, V49, P1665, DOI 10.1016/0006-2952(95)00098-K
   Schmidt LE, 2005, GUT, V54, P686, DOI 10.1136/gut.2004.054619
   Schmucker DL, 1998, J GERONTOL A-BIOL, V53, pB315, DOI 10.1093/gerona/53A.5.B315
   Scott KA, 2011, BIOCHEM PHARMACOL, V81, P355, DOI 10.1016/j.bcp.2010.10.011
   Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5
   Shih PH, 2007, BIOGERONTOLOGY, V8, P71, DOI 10.1007/s10522-006-9033-y
   SHOAF SE, 1987, DRUG METAB DISPOS, V15, P676
   SPEARMAN ME, 1983, LIFE SCI, V33, P2615, DOI 10.1016/0024-3205(83)90345-4
   Suh JH, 2004, P NATL ACAD SCI USA, V101, P3381, DOI 10.1073/pnas.0400282101
   Tarloff JB, 1996, FUND APPL TOXICOL, V30, P13, DOI 10.1006/faat.1996.0038
   TARLOFF JB, 1989, FUND APPL TOXICOL, V12, P78, DOI 10.1016/0272-0590(89)90064-X
   Wauthier V, 2004, ARCH TOXICOL, V78, P131, DOI 10.1007/s00204-003-0526-z
   Wauthier V, 2006, LIFE SCI, V79, P1913, DOI 10.1016/j.lfs.2006.06.046
   WOODHOUSE K, 1993, ARCH GERONTOL GERIAT, V16, P111, DOI 10.1016/0167-4943(93)90002-Y
   Xu Y, 1998, AM J PHYSIOL-CELL PH, V275, pC1058, DOI 10.1152/ajpcell.1998.275.4.C1058
NR 52
TC 16
Z9 17
U1 0
U2 10
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD APR
PY 2014
VL 69
IS 4
BP 387
EP 397
DI 10.1093/gerona/glt095
PG 11
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA AD6QI
UT WOS:000333385500003
PM 23863315
OA Green Published
DA 2024-02-19
ER

PT J
AU Zhou, JY
   Shi, YY
   Yang, C
   Lu, S
   Zhao, LS
   Liu, XL
   Zhou, D
   Luo, L
   Yin, ZM
AF Zhou, Jinyi
   Shi, Yingying
   Yang, Chen
   Lu, Shuai
   Zhao, Lishuang
   Liu, Xianli
   Zhou, Da
   Luo, Lan
   Yin, Zhimin
TI γ-glutamylcysteine alleviates insulin resistance and hepatic steatosis
   by regulating adenylate cyclase and IGF-1R/IRS1/PI3K/Akt signaling
   pathways
SO JOURNAL OF NUTRITIONAL BIOCHEMISTRY
LA English
DT Article; Early Access
DE gamma-glutamylcysteine; type 2 diabetes mellitus; insulin resistance;
   hepatic steatosis; CD36; GLUT4
ID DIABETES-MELLITUS; PATHOGENESIS; MUTATION; FAMILY
AB Type 2 diabetes mellitus (T2DM), a complex metabolism disease, which was characterized by metabolic disorders including hyperglycemia, has become a major health problem due to the increasing prevalence worldwide gamma-glutamylcysteine (gamma-GC) as an immediate precursor of glutathione (GSH) was originally used for the treatment of sepsis, inflammation bowel disease, and senescence. Here, we evaluated the capacity of gamma-GC on diabetes-related metabolic parameters in db/db mice and insulin resistance (IR) amelioration in cells induced by palmitic acid (PA). Our data suggested that gamma-GC treatment decreased body weight, reduced adipose tissue size, ameliorated ectopic fat deposition in liver, increased the GSH content in liver, improved glucose control and other diabetes-related metabolic parameters in vivo. Moreover, in vitro experiments showed that gamma-GC could maintain the balance of free fatty acids (FFAs) and glucose uptake through regulating the translocation of CD36 and GLUT4 from cytoplasm to plasma membrane. Furthermore, our finding also provided evidence that gamma-GC could activate Akt not only via adenylate cyclase (AC)/cAMP/PI3K signaling pathway, but also via IGF-1R/IRS1/PI3K signaling pathway to improve IR and hepatic steatosis. Blocking either of two signaling pathways could not activate Akt activation induced by gamma-GC. This unique characteristic ensures the important role of gamma-GC in glucose metabolism. Collectively, these results suggested that gamma-GC could serve as a candidate dipeptide for the treatment of T2DM and related chronic diabetic complications via activating AC and IGF-1R/IRS1/PI3K/Akt signaling pathways to regulate CD36 and GLUT4 trafficking. (c) 2023ElsevierInc. Allrightsreserved.
C1 [Zhou, Jinyi; Shi, Yingying; Yang, Chen; Lu, Shuai; Zhao, Lishuang; Liu, Xianli; Yin, Zhimin] Nanjing Normal Univ, Coll Life Sci, Jiangsu Prov Key Lab Mol & Med Biotechnol, Nanjing, Jiangsu, Peoples R China.
   [Luo, Lan] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China.
   [Zhou, Da] Fudan Univ, Zhongshan Hosp, Dept Gastroenterol & Hepatol, Shanghai, Peoples R China.
   [Yin, Zhimin] Nanjing Normal Univ, Coll Life Sci, Jiangsu Prov Key Lab Mol & Med Biotechnol, 1 Wenyuan Rd, Nanjing 210046, Peoples R China.
   [Luo, Lan] Nanjing Univ, Sch Life Sci, State Key Lab Pharmceut Biotechnol, 163 Xianlin Rd, Nanjing 210023, Peoples R China.
   [Zhou, Da] Fudan Univ, Zhongshan Hosp, Dept Gastroenterol & Hepatol, 180 Fenglin Rd, Shanghai 200032, Peoples R China.
C3 Nanjing Normal University; Nanjing University; Fudan University; Nanjing
   Normal University; Nanjing University; Fudan University
RP Yin, ZM (corresponding author), Nanjing Normal Univ, Coll Life Sci, Jiangsu Prov Key Lab Mol & Med Biotechnol, 1 Wenyuan Rd, Nanjing 210046, Peoples R China.; Luo, L (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmceut Biotechnol, 163 Xianlin Rd, Nanjing 210023, Peoples R China.; Zhou, D (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Gastroenterol & Hepatol, 180 Fenglin Rd, Shanghai 200032, Peoples R China.
EM zhou.da@zshospital.sh.cn; lanluo@nju.edu.cn; yinzhimin@njnu.edu.cn
RI luo, lan/JTT-0853-2023
FU Natural Science Foundation of China [81671565]; Priority Academic
   Program Development of Jiangsu Higher Education Institution (PAPD); 
   [81771703]
FX This work was funded by the Natural Science Foundation of China (grant
   numbers 81771703 , 81671565) and the Priority Academic Program
   Development of Jiangsu Higher Education Institution (PAPD) .
CR Ahmed B, 2021, BIOMED PHARMACOTHER, V137, DOI 10.1016/j.biopha.2021.111315
   Bergantin Leandro B., 2020, Central Nervous System Agents in Medicinal Chemistry, V20, P103, DOI 10.2174/1871524920666200129121232
   Boden G, 2003, EXP CLIN ENDOCR DIAB, V111, P121, DOI 10.1055/s-2003-39781
   Carmichael J, 2021, FRONT ENDOCRINOL, V12, DOI 10.3389/fendo.2021.671257
   Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5
   Chen Z, 2020, FREE RADICAL BIO MED, V152, P116, DOI 10.1016/j.freeradbiomed.2020.02.025
   Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728
   Cordero-Herrera I, 2014, FOOD CHEM TOXICOL, V64, P10, DOI 10.1016/j.fct.2013.11.014
   Duan JY, 2021, J FOOD BIOCHEM, V45, DOI 10.1111/jfbc.13668
   Dugani SB, 2021, DIABETES-METAB RES, V37, DOI 10.1002/dmrr.3410
   Feldman-Billard S, 2021, DIABETES METAB, V47, DOI 10.1016/j.diabet.2021.101279
   Ferguson D, 2021, NAT REV ENDOCRINOL, V17, P484, DOI 10.1038/s41574-021-00507-z
   Foretz M, 2015, NAT REV ENDOCRINOL, V11, P390, DOI 10.1038/nrendo.2015.85
   Forman HJ, 2009, MOL ASPECTS MED, V30, P1, DOI 10.1016/j.mam.2008.08.006
   Galicia-Garcia U, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21176275
   George S, 2004, SCIENCE, V304, P1325, DOI 10.1126/science.1096706
   Grabner GF, 2021, NAT METAB, V3, P1445, DOI 10.1038/s42255-021-00493-6
   Guilherme A, 2023, TRENDS CELL BIOL, V33, P340, DOI 10.1016/j.tcb.2022.07.009
   Hanke S, 2009, MOL CELL PROTEOMICS, V8, P519, DOI 10.1074/mcp.M800407-MCP200
   Harding JL, 2019, DIABETOLOGIA, V62, P3, DOI 10.1007/s00125-018-4711-2
   Hari Kumar K V S, 2020, Med J Armed Forces India, V76, P4, DOI 10.1016/j.mjafi.2019.07.001
   Ikeda K, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00498
   Kawano Y, 2013, J GASTROENTEROL, V48, P434, DOI 10.1007/s00535-013-0758-5
   Kerner W, 2014, EXP CLIN ENDOCR DIAB, V122, P384, DOI 10.1055/s-0034-1366278
   Khunti K, 2018, LANCET DIABETES ENDO, V6, P821, DOI 10.1016/S2213-8587(18)30025-1
   KLIP A, 1993, CELL SIGNAL, V5, P519, DOI 10.1016/0898-6568(93)90047-P
   Lim CY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6951
   Lu S, 2022, FOOD FUNCT, V13, P7560, DOI [10.1039/d2fo01246d, 10.1039/D2FO01246D]
   Luiken JJFP, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2020.165775
   Machado MV, 2016, GASTROENTEROLOGY, V150, P1769, DOI 10.1053/j.gastro.2016.02.066
   Malone JI, 2019, PEDIATR DIABETES, V20, P5, DOI 10.1111/pedi.12787
   Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009
   Mistry JJ, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-27460-9
   O'Neil RG, 2005, MOL IMAGING BIOL, V7, P388, DOI 10.1007/s11307-005-0011-6
   Ogurtsova K, 2017, DIABETES RES CLIN PR, V128, P40, DOI 10.1016/j.diabres.2017.03.024
   Prasad M, 2022, J NUTR BIOCHEM, V107, DOI 10.1016/j.jnutbio.2022.109037
   Quintana-Cabrera R, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1722
   Raucci A, 2021, CELL MOL LIFE SCI, V78, P7355, DOI 10.1007/s00018-021-03979-4
   Salem ESB, 2018, JOVE-J VIS EXP, DOI 10.3791/58323
   Shin AC, 2021, INT J OBESITY, V45, P383, DOI 10.1038/s41366-020-00688-z
   Stephens JW, 2020, DIABETES OBES METAB, V22, P32, DOI 10.1111/dom.13942
   Sun A, 2021, CELL MOL LIFE SCI, V78, P2839, DOI 10.1007/s00018-020-03669-7
   Suzuki K, 2021, J GASTROENTEROL, V56, P168, DOI 10.1007/s00535-020-01750-3
   Tanase DM, 2020, J DIABETES RES, V2020, DOI 10.1155/2020/3920196
   Targher G, 2021, NAT REV GASTRO HEPAT, V18, P599, DOI 10.1038/s41575-021-00448-y
   Tengholm A, 2017, DIABETES OBES METAB, V19, P42, DOI 10.1111/dom.12993
   Tilg H, 2017, NAT REV GASTRO HEPAT, V14, P32, DOI 10.1038/nrgastro.2016.147
   Vacurova E, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-29486-z
   Wessels B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100525
   Yan FJ, 2016, J NUTR BIOCHEM, V36, P68, DOI 10.1016/j.jnutbio.2016.07.004
   Yang Y, 2019, REDOX BIOL, V20, P157, DOI 10.1016/j.redox.2018.09.019
   Yao HY, 2023, J BIOL CHEM, V299, DOI 10.1016/j.jbc.2022.102845
   Zarka MH, 2017, REDOX BIOL, V11, P631, DOI 10.1016/j.redox.2017.01.014
   Zeng H, 2022, MOL METAB, V57, DOI 10.1016/j.molmet.2021.101428
   Zheng Y, 2018, NAT REV ENDOCRINOL, V14, P88, DOI 10.1038/nrendo.2017.151
   Zhou JY, 2023, INFLAMM RES, V72, P603, DOI 10.1007/s00011-023-01691-6
NR 56
TC 2
Z9 2
U1 7
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0955-2863
EI 1873-4847
J9 J NUTR BIOCHEM
JI J. Nutr. Biochem.
PD 2023 SEP
PY 2023
VL 119
AR 109404
DI 10.1016/j.jnutbio.2023.109404
EA JUL 2023
PG 17
WC Biochemistry & Molecular Biology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Nutrition & Dietetics
GA Q2RW0
UT WOS:001056048700001
PM 37311491
DA 2024-02-19
ER

PT J
AU BATTINO, M
   GORINI, A
   VILLA, RF
   GENOVA, ML
   BOVINA, C
   SASSI, S
   LITTARRU, GP
   LENAZ, G
AF BATTINO, M
   GORINI, A
   VILLA, RF
   GENOVA, ML
   BOVINA, C
   SASSI, S
   LITTARRU, GP
   LENAZ, G
TI COENZYME-Q CONTENT IN SYNAPTIC AND NONSYNAPTIC MITOCHONDRIA FROM
   DIFFERENT BRAIN-REGIONS IN THE AGING RAT
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE COENZYME Q; SYNAPTIC AND NONSYNAPTIC MITOCHONDRIA; RAT BRAIN AREAS; FREE
   RADICALS
ID NONSYNAPTIC MITOCHONDRIA; RESPIRATORY-CHAIN; OXIDATIVE STRESS; Q
   UBIQUINONE; Q HOMOLOGS; LIVER; BIOSYNTHESIS; HIPPOCAMPUS; ENZYMES; HEART
AB We investigated the Coenzyme Q (CoQ) content of different mitochondrial fractions [free mitochondria (FM), synaptic heavy (HM) and light mitochondria (LM)I from three brain areas (cortex, striatum, hippocampus) of rats at different ages. In rats from 2 to 26 months of age, we observed only small differences in total CoQ content (CoQ(9) + CoQ(10)). In FM and LM fractions, values are very similar and appear to be much higher than in HM fractions. The CoQ(10)/CoQ(9) ratios are much higher in brain mitochondria than in other organs, suggesting possible modifications of CoQ biosynthetic pathways in brain; nevertheless they appear to remain constant during ageing. CoQ(9) and CoQ(10) contents slowly decrease reaching their minimum in rats of 18 months of age, then increase in the older ages. Considering ageing as partially driven by a summation of free radical-mediated processes, we can hypothesize that damage occurring to biological structures in the first half of life might be followed by induction phenomena tending to re-establish the primitive levels of antioxidant molecules.
C1 UNIV BOLOGNA,DIPARTMENTO BIOCHIM,I-40126 BOLOGNA,ITALY.
   UNIV ANCONA,IST BIOCHIM,I-60100 ANCONA,ITALY.
   UNIV PAVIA,IST FARMACOL,I-27100 PAVIA,ITALY.
C3 University of Bologna; Marche Polytechnic University; University of
   Pavia
RI Genova, Maria Luisa/H-6921-2012; Battino, Maurizio/E-6103-2012
OI Genova, Maria Luisa/0000-0002-9176-3630; Battino,
   Maurizio/0000-0002-7250-1782
CR ANDERSSON M, 1990, FEBS LETT, V269, P15, DOI 10.1016/0014-5793(90)81107-Y
   APPELKVIST EL, 1991, BIOMED CLIN, V6, P141
   BATTINO M, 1991, J BIOENERG BIOMEMBR, V23, P345, DOI 10.1007/BF00762227
   BATTINO M, 1990, MEMBRANE BIOCHEM, V9, P179, DOI 10.3109/09687689009025839
   BATTINO M, 1990, INT J TISSUE REACT, V12, P137
   BATTINO M, 1993, FREE RADICALS ANTIOX, V6, P37
   BEYER RE, 1985, MECH AGEING DEV, V32, P267, DOI 10.1016/0047-6374(85)90085-5
   BEYER RE, 1984, ARCH BIOCHEM BIOPHYS, V234, P323, DOI 10.1016/0003-9861(84)90277-7
   BEYER RE, 1985, PATHOBIOLOGY CARDIOV, P489
   BURDON RH, 1989, FREE RADICAL RES COM, V7, P149, DOI 10.3109/10715768909087937
   CHUNG LY, 1993, 2ND P EUR C ADV WOUN, P149
   ESPOSTI MD, 1981, ITAL J BIOCHEM, V30, P437
   FOLKERS K, 1993, CLIN INVESTIGATOR, V71, pS51
   FOLKERS K, 1981, BIOMEDICAL CLIN ASPE, V3
   FOLKERS K, 1984, BIOMEDICAL CLIN ASPE, V4
   FOLKERS K, 1991, BIOMEDICAL CLIN ASPE, V6
   FOLKERS K, 1977, BIOMEDICAL CLIN ASPE, V1
   FOLKERS K, 1986, BIOMEDICAL CLIN ASPE, V5
   HANSFORD RG, 1983, BIOCHIM BIOPHYS ACTA, V726, P41, DOI 10.1016/0304-4173(83)90010-1
   HARMAN D, 1984, AGE, V7, P111, DOI 10.1007/BF02431866
   HUERTAS JR, 1991, BIOCHEM BIOPH RES CO, V181, P375, DOI 10.1016/S0006-291X(05)81429-9
   HUERTAS JR, 1991, FEBS LETT, V287, P89, DOI 10.1016/0014-5793(91)80022-U
   KALEN A, 1989, LIPIDS, V24, P579, DOI 10.1007/BF02535072
   Kroger A, 1978, Methods Enzymol, V53, P579
   LAI JCK, 1977, J NEUROCHEM, V28, P625, DOI 10.1111/j.1471-4159.1977.tb10434.x
   LENAZ G, 1990, FREE RADICAL RES COM, V8, P317, DOI 10.3109/10715769009053365
   LENAZ G, 1990, HIGHLIGHTS UBIQUINON
   LENAZ G, 1985, COENZYME Q
   LEONG SF, 1984, J NEUROCHEM, V42, P1306, DOI 10.1111/j.1471-4159.1984.tb02788.x
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MATSURA T, 1991, BIOCHIM BIOPHYS ACTA, V1083, P277, DOI 10.1016/0005-2760(91)90083-T
   MAYER H, 1971, METHODS ENZYMOL C, V18, P182
   NICHOLLS P, 1976, BIOCHIM BIOPHYS ACTA, V430, P30, DOI 10.1016/0005-2728(76)90219-X
   OLSON RE, 1983, VITAM HORM, P1
   RAUCHOVA H, 1992, J BIOENERG BIOMEMBR, V24, P235, DOI 10.1007/BF00762682
   SCARPA M, 1987, P SOC EXP BIOL MED, V185, P129
   VANNESTE WH, 1966, BIOCHIM BIOPHYS ACTA, V113, P175, DOI 10.1016/S0926-6593(66)80132-7
   VILLA RF, 1989, CELL MOL NEUROBIOL, V9, P247, DOI 10.1007/BF00713032
   VILLA RF, 1989, MECH AGEING DEV, V49, P211, DOI 10.1016/0047-6374(89)90072-9
   YAMAMOTO T, 1989, ARCH BIOCHEM BIOPHYS, V269, P86, DOI 10.1016/0003-9861(89)90089-1
   YAMAMURA Y, 1980, BIOMEDICAL CLIN ASPE, V2
NR 41
TC 76
Z9 78
U1 0
U2 1
PU ELSEVIER SCI PUBL IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD MAR 17
PY 1995
VL 78
IS 3
BP 173
EP 187
DI 10.1016/0047-6374(94)01535-T
PG 15
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA QR683
UT WOS:A1995QR68300001
PM 7596200
DA 2024-02-19
ER

PT J
AU Liu, R
   Fu, ZK
   Zhang, FJ
   Mao, QZ
   Luan, CG
   Han, XL
   Xue, J
   Wang, DL
   Qin, S
   Hao, FK
AF Liu, Rong
   Fu, Zukang
   Zhang, Fengjie
   Mao, Qingzhong
   Luan, Chunguang
   Han, Xinglin
   Xue, Jie
   Wang, Deliang
   Qin, Si
   Hao, Feike
TI Effect of yellow rice wine on anti-aging ability in aged mice induced by
   <i>D</i>-galactose
SO FOOD SCIENCE AND HUMAN WELLNESS
LA English
DT Article
DE Yellow rice wine; Aging; Antioxidant; Antifatigue; Cognitive impairment;
   Apoptosis
ID ANTI-FATIGUE ACTIVITY; MORRIS WATER MAZE; OXIDATIVE STRESS; APOPTOSIS;
   MEMORY; RATS; POLYSACCHARIDES; ANTIOXIDANT; HIPPOCAMPUS; DAMAGE
AB The present study is focused on investigation of the health protective effect of yellow rice wine (YRW) in mice and the potential underlying mechanism. Symptoms of aging were induced in mice by using D-galactose (D-gal), and different doses of YRW (4, 8, and 12 mL/kg BW) were orally administrated to D-gal-treated mice for a period of six weeks. The in vivo data obtained in the present study preliminary indicated that YRW markedly increased the activity of antioxidant enzymes and reduced the concentration of MDA both in the brain and liver. Furthermore, a forced swim test showed that moderate intake of YRW (8 mL/kg BW) significantly decreased the duration of immobility, reduced the blood content of urea nitrogen and lactic acid, and increased hepatic glycogen storage. Besides, results from the Morris water maze test suggested that YRW significantly reversed cognitive impairment and also alleviated neuroapoptosis in the experimental mice by regulating the gene expressions of Bax/Bcl-2 and caspase-3. The above results indicated YRW has a potential anti-aging effect in mice and provided us certain molecular evidence for this action. (C) 2020 "Society information". Production and hosting by Elsevier B.V. on behalf of KeAi Communications Co., Ltd.
C1 [Liu, Rong; Qin, Si] Hunan Agr Univ, Coll Food Sci & Technol, 1 Nongda Rd, Changsha 410128, Peoples R China.
   [Fu, Zukang; Mao, Qingzhong] Kuaijishan Shaoxing Rice Wine CO Ltd, Shaoxing 312030, Peoples R China.
   [Zhang, Fengjie; Luan, Chunguang; Han, Xinglin; Xue, Jie; Wang, Deliang; Hao, Feike] China Natl Res Inst Food & Fermentat Ind, 24 Jiuxianqiao Middle Rd, Beijing 100015, Peoples R China.
C3 Hunan Agricultural University
RP Qin, S (corresponding author), Hunan Agr Univ, Coll Food Sci & Technol, 1 Nongda Rd, Changsha 410128, Peoples R China.; Hao, FK (corresponding author), China Natl Res Inst Food & Fermentat Ind, 24 Jiuxianqiao Middle Rd, Beijing 100015, Peoples R China.
EM qinsiman@hunau.edu.cn; haofeike@outlook.com
RI Qin, Si/GLU-9233-2022
OI Qin, Si/0000-0002-0788-2099
FU Natural Science Foundation of Hunan Province (2019); Double First-Class
   Construction Project of Hunan Agricultural University [SYL201802025]
FX This work was partially supported by Natural Science Foundation of Hunan
   Province (2019) and Double First-Class Construction Project of Hunan
   Agricultural University (No. SYL201802025) to Si Qin.
CR Andreasson KI, 2001, J NEUROSCI, V21, P8198
   Avlund K, 2010, AGING CLIN EXP RES, V22, P100, DOI 10.1007/BF03324782
   Aydin AF, 2016, METAB BRAIN DIS, V31, P337, DOI 10.1007/s11011-015-9755-0
   Chen H., 2016, BOUND VALUE PROBL, V2016, P1, DOI DOI 10.1214/15-STS531
   Cui X, 2006, J NEUROSCI RES, V83, P1584, DOI 10.1002/jnr.20845
   D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4
   DETOLEDOMORRELL L, 1984, BEHAV NEURAL BIOL, V42, P1, DOI 10.1016/S0163-1047(84)90364-9
   Diamanti-Kandarakis E, 2017, EUR J ENDOCRINOL, V176, pR283, DOI 10.1530/EJE-16-1061
   Dillin A, 2014, CURR OPIN CELL BIOL, V26, P107, DOI 10.1016/j.ceb.2013.12.003
   Ding JF, 2011, FOOD HYDROCOLLOID, V25, P1350, DOI 10.1016/j.foodhyd.2010.12.013
   EVANS GW, 1984, J GERONTOL, V39, P452, DOI 10.1093/geronj/39.4.452
   Fernandez-Tome S, 2014, FOOD RES INT, V62, P793, DOI 10.1016/j.foodres.2014.04.054
   Forman HJ, 2016, FREE RADICAL BIO MED, V97, P398, DOI 10.1016/j.freeradbiomed.2016.07.003
   Gao X., 2018, Liq.-Mak. Sci. Technol, V1, P91, DOI [10.13746/j.njkj.2017226, DOI 10.13746/J.NJKJ.2017226]
   HASAN M, 1973, EXP GERONTOL, V8, P75, DOI 10.1016/0531-5565(73)90017-X
   Ho SC, 2003, BIOGERONTOLOGY, V4, P15, DOI 10.1023/A:1022417102206
   Huang Y., 2013, ACTA NUTRIMENTA SINI, V35
   JARRARD LE, 1993, BEHAV NEURAL BIOL, V60, P9, DOI 10.1016/0163-1047(93)90664-4
   Jeong DU, 2017, BMC NEUROSCI, V18, DOI 10.1186/s12868-017-0345-4
   Li X, 2016, EXP GERONTOL, V83, P89, DOI 10.1016/j.exger.2016.07.012
   Nam SY, 2016, BIOMED PHARMACOTHER, V84, P51, DOI 10.1016/j.biopha.2016.09.012
   Ni Li, 2012, Journal of Chinese Institute of Food Science and Technology, V12, P1
   Ni WH, 2013, J ETHNOPHARMACOL, V150, P529, DOI 10.1016/j.jep.2013.08.055
   Ola MS, 2011, MOL CELL BIOCHEM, V351, P41, DOI 10.1007/s11010-010-0709-x
   PORSOLT RD, 1978, EUR J PHARMACOL, V47, P379, DOI 10.1016/0014-2999(78)90118-8
   Qiao DL, 2009, CARBOHYD POLYM, V78, P199, DOI 10.1016/j.carbpol.2009.03.018
   Que F, 2006, FOOD RES INT, V39, P581, DOI 10.1016/j.foodres.2005.12.001
   Tharakan B, 2006, PHYTOTHER RES, V20, P165, DOI 10.1002/ptr.1773
   Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116
   Voss P, 2006, FREE RADICAL RES, V40, P1339, DOI 10.1080/10715760600953859
   [王璟 Wang Jing], 2016, [食品科学, Food Science], V37, P224
   Xiang WL, 2019, J SCI FOOD AGR, V99, P5577, DOI 10.1002/jsfa.9831
   Xu LQ, 2016, FOOD FUNCT, V7, P4545, DOI 10.1039/c6fo01057a
   Yu B, 2008, EUR FOOD RES TECHNOL, V226, P415, DOI 10.1007/s00217-006-0552-1
   Yu Y, 2017, BEHAV BRAIN RES, V334, P155, DOI 10.1016/j.bbr.2017.07.003
   Zhao HD, 2018, FOOD NUTR RES, V62, DOI 10.29219/fnr.v62.1371
   [郑飞 Zheng Fei], 2014, [食品科学, Food Science], V35, P249
   Zheng L, 2015, J SCI FOOD AGR, V95, P3117, DOI 10.1002/jsfa.7048
   Zhou YZ, 2017, RSC ADV, V7, P47758, DOI 10.1039/c7ra07110h
   Zhou YY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132088
   Zhu SY, 2014, PHARMACOGN MAG, V10, pS92, DOI 10.4103/0973-1296.127353
NR 41
TC 11
Z9 13
U1 5
U2 51
PU KEAI PUBLISHING LTD
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING, DONGHENG DISTRICT 100717,
   PEOPLES R CHINA
EI 2213-4530
J9 FOOD SCI HUM WELL
JI Food Sci. Human Wellness
PD JUN
PY 2020
VL 9
IS 2
BP 184
EP 191
DI 10.1016/j.fshw.2020.02.003
PG 8
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA MH7FU
UT WOS:000546891000011
OA gold
DA 2024-02-19
ER

PT J
AU Marotta, F
   Lecroix, P
   Harada, M
   Masulair, K
   Safran, P
   Lorenzetti, A
   Ono-Nita, SK
   Marandola, P
AF Marotta, F.
   Lecroix, P.
   Harada, M.
   Masulair, K.
   Safran, P.
   Lorenzetti, A.
   Ono-Nita, S. K.
   Marandola, P.
TI Liver exposure to xenobiotics: The aging factor and potentials for
   functional foods
SO REJUVENATION RESEARCH
LA English
DT Article
ID IN-VIVO; ANTIOXIDANT; MECHANISMS; TOXICITY; K-17.22
AB Hepatocytes isolated from 20- and 4-month Wistar rats and cultured with or without a-linolenic acid (LNA) were then added with nutraceutical YHK or sylibin before the test with iron or copper. Overall, YHK proved to be more effective than sylibin in Fe/Cu-induced peroxidative damage on normal and LNA-loaded hepatocytes (p < 0.05). YHK exerted a significant protection against DPPH radical-scavenging activity in the "'old" group (p versus sylibin) and against lipophilic generators in both age groups (p < 0.05 versus sylibin). Both compounds were ineffective on age-related increase of surface-charge density. These preliminary data suggest that age per se enhances the vulnerability of hepatocytes to xenobiotics, whereas some safe nutraceuticals seem to exert significant protective effects.
C1 San Giuseppe Hosp, Hepatogastroenterol Dept, I-20146 Milan, Italy.
   Inst Hlth Care Oriental Med, Tokyo, Japan.
   MCH Hosp, Tokyo, Japan.
   Univ Sao Paulo, Hepatogastroenterol Dept, Sao Paulo, Brazil.
   GAIA Age Management Fdn, Pavia, Italy.
C3 Universidade de Sao Paulo
RP Marotta, F (corresponding author), San Giuseppe Hosp, Hepatogastroenterol Dept, Via Pisanello 4, I-20146 Milan, Italy.
EM fmarchimede@libero.it
RI Ono, Suzane K/I-3107-2012; Safran, Patrick/O-2170-2016; Marotta,
   Francesco/ABI-1960-2020
OI Safran, Patrick/0000-0002-5440-4719; Marotta,
   Francesco/0000-0002-6016-1864
CR AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   Barrow G. M., 1996, Physical Chemistry, V6th
   HARADA M, 2002, 1 JSH SINGL TOP C TH
   HILLAIRE S, 1995, HEPATOLOGY, V22, P82, DOI 10.1016/0270-9139(95)90356-9
   Hsieh CL, 2000, LIFE SCI, V66, P1387, DOI 10.1016/S0024-3205(00)00450-1
   Keum YS, 2000, CANCER LETT, V150, P41, DOI 10.1016/S0304-3835(99)00369-9
   Killilea DW, 2004, ANN NY ACAD SCI, V1019, P365, DOI 10.1196/annals.1297.063
   Konovalova GG, 2000, B EXP BIOL MED+, V130, P658, DOI 10.1007/BF02682098
   KRYSINSKI P, 1987, PROG SURF SCI, V23, P317, DOI 10.1016/0079-6816(86)90016-X
   López-Diazguerrero NE, 2005, LIFE SCI, V77, P2840, DOI 10.1016/j.lfs.2005.05.034
   Marotta F, 2001, BIOMED RES-TOKYO, V22, P167, DOI 10.2220/biomedres.22.167
   Marotta F, 2001, BIOMED RES-TOKYO, V22, P221, DOI 10.2220/biomedres.22.221
   OLSSON GM, 1990, ANAL CELL PATHOL, V2, P179
   Pallottini V, 2004, MECH AGEING DEV, V125, P633, DOI 10.1016/j.mad.2004.08.001
   Pourahmad J, 2003, TOXICOL IN VITRO, V17, P803, DOI 10.1016/S0887-2333(03)00123-1
   SELBY JV, 1988, INT J CANCER, V41, P677, DOI 10.1002/ijc.2910410507
   Stadtman ER, 1998, DRUG METAB REV, V30, P225, DOI 10.3109/03602539808996310
   STOHS SJ, 1995, FREE RADICAL BIO MED, V18, P321, DOI 10.1016/0891-5849(94)00159-H
   Warrington JS, 2004, J PHARM PHARMACOL, V56, P819, DOI 10.1211/0022357023529
   Zhang HY, 2005, CANCER BIOL THER, V4, P207
NR 20
TC 2
Z9 3
U1 0
U2 1
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1549-1684
EI 1557-8577
J9 REJUV RES
JI Rejuv. Res.
PD SUM
PY 2006
VL 9
IS 2
BP 338
EP 341
DI 10.1089/rej.2006.9.338
PG 4
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 046RE
UT WOS:000237827900028
PM 16706665
DA 2024-02-19
ER

PT J
AU Kannan, L
   Knudsen, J
   Jolly, CA
AF Kannan, L
   Knudsen, J
   Jolly, CA
TI Aging and acyl-CoA binding protein alter mitochondrial
   glycerol-3-phosphate acyltransferase activity
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
LA English
DT Article
DE glycerol-3-phosphate acyltransferase; acyl-CoA binding protein;
   phosphatidic acid biosynthesis; aging; liver
ID PHOSPHATIDIC-ACID; RAT; LIVER; BIOSYNTHESIS; EXPRESSION; ACBP
AB It is well known that cellular function declines with age. Since phosphatidic acid (PtdOH) biosynthesis is central to the generation of membrane phospholipids, the hypothesis that aging decreases PtdOH biosynthesis was tested. Glycerol-3-phosphate acyltransferase (GPAT) and lysophosphatidic acid acyltransferase (LAT) activities were examined in isolated mitochondria and microsomes from young and old rat liver. The results show that mitochondrial GPAT preference for palmitoyl-CoA over oleoyl-CoA was only observed if albumin or acyl-CoA binding protein (ACBP) were present in the assay in the young rats. Furthermore, mitochondrial GPAT activity was significantly reduced in the presence of albumin and ACBP in aged mitochondria using palmitoyl-CoA as the substrate. These data show, for the first time, that mitochondrial GPAT acyl-CoA preference is due to the presence of a protein that binds acyl-CoAs, not the enzyme itself, and that aging significantly reduces mitochondrial GPAT activity. (C) 2002 Elsevier Science B.V All rights reserved.
C1 Univ Texas, Div Nutr Sci, Austin, TX 78712 USA.
   Univ Texas, Inst Mol & Cellular Biol, Austin, TX 78712 USA.
   Odense Univ, Inst Biochem, DK-5230 Odense, Denmark.
C3 University of Texas System; University of Texas Austin; University of
   Texas System; University of Texas Austin; University of Southern Denmark
RP Jolly, CA (corresponding author), Univ Texas, Div Nutr Sci, Gearing Room 117-A2700, Austin, TX 78712 USA.
FU NIA NIH HHS [AG19990-01] Funding Source: Medline
CR Bell RM, 1983, ENZYMES, V16, P87
   BHUIYAN J, 1995, METABOLISM, V44, P1185, DOI 10.1016/0026-0495(95)90013-6
   BOWERS WE, 1967, J CELL BIOL, V32, P325, DOI 10.1083/jcb.32.2.325
   Dircks L, 1999, PROG LIPID RES, V38, P461, DOI 10.1016/S0163-7827(99)00012-0
   Dircks LK, 1997, BBA-LIPID LIPID MET, V1348, P17, DOI 10.1016/S0005-2760(97)00106-9
   Gossett RE, 1996, LIPIDS, V31, P895, DOI 10.1007/BF02522684
   JALINK K, 1990, J BIOL CHEM, V265, P12232
   JAMDAR SC, 1986, LIPIDS, V21, P460, DOI 10.1007/BF02536404
   Jolly CA, 2002, LIPIDS, V37, P475, DOI 10.1007/s11745-002-0920-4
   Jolly CA, 2001, CELL IMMUNOL, V213, P122, DOI 10.1006/cimm.2001.1866
   Jolly CA, 1997, ARCH BIOCHEM BIOPHYS, V341, P112, DOI 10.1006/abbi.1997.9957
   Jolly CA, 1998, BBA-LIPID LIPID MET, V1390, P258, DOI 10.1016/S0005-2760(97)00186-0
   Jolly CA, 2000, BBA-MOL CELL BIOL L, V1483, P185, DOI 10.1016/S1388-1981(99)00170-5
   KELKER HC, 1979, J BIOL CHEM, V254, P5364
   Kragelund BB, 1999, BBA-MOL CELL BIOL L, V1441, P150, DOI 10.1016/S1388-1981(99)00151-1
   Lewin TM, 2001, ARCH BIOCHEM BIOPHYS, V396, P119, DOI 10.1006/abbi.2001.2604
   MONROY G, 1972, J BIOL CHEM, V247, P6884
   RASMUSSEN JT, 1994, BIOCHEM J, V299, P165, DOI 10.1042/bj2990165
   RICKWOOD D, 1979, MITOCHONDRIA PRACTIC, P1
   Starodub O, 2000, AM J PHYSIOL-CELL PH, V279, pC1259, DOI 10.1152/ajpcell.2000.279.4.C1259
   TAKENAKA R, 1983, BIOCHIM BIOPHYS ACTA, V754, P28, DOI 10.1016/0005-2760(83)90078-4
   YANG SY, 1994, AGE RELATED MEMBRANE
   YET SF, 1995, BIOCHEMISTRY-US, V34, P7303, DOI 10.1021/bi00022a003
NR 23
TC 30
Z9 32
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1388-1981
J9 BBA-MOL CELL BIOL L
JI Biochim. Biophys. Acta Mol. Cell Biol. Lipids
PD FEB 20
PY 2003
VL 1631
IS 1
BP 12
EP 16
DI 10.1016/S1388-1981(02)00367-0
PG 5
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 645UQ
UT WOS:000180998200002
PM 12573444
DA 2024-02-19
ER

PT J
AU Erickson, RR
   Dunning, LM
   Holtzman, JL
AF Erickson, Richard R.
   Dunning, Lisa M.
   Holtzman, Jordan L.
TI The effect of aging on the chaperone concentrations in the hepatic,
   endoplasmic reticulum of male rats: The possible role of protein
   misfolding due to the loss of chaperones in the decline in physiological
   function seen with age
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
ID DIPLOID CELL STRAINS; DISULFIDE-ISOMERASE; ALZHEIMERS-DISEASE;
   MEMBRANE-PROTEINS; COVALENT BINDING; FAMILY-MEMBERS; THIOL;
   GLYCOSYLATION; EXPRESSION; TYROSINASE
AB The endoplasmic reticulum (ER) chaperones are highly conserved proteins that catalyze the posttranslational processing of all secretory and membrane proteins. Our studies suggest that chaperone declines are one of the two central defects in Alzheimer's disease. We propose that similar declines in other organ systems underlie the physiological deficits of aging. Rats were maintained in a colony from age 21 days to death. Animals were killed at regular intervals, and hepatic, ER chaperone contents were determined by immunoblotting. ERp55, ERp57, ERp72, BiP, and calnexin constitutive levels declined 30%-50% with age. Calreticulin was unaffected. BiP (also known as GRP78), ERp55, and ERp57 showed marked swings with peaks occurring in midwinter and midsummer. This cyclics declined 73% with age. Considering the role of the ER chaperones in membrane and secretory protein posttranslational processing, these data support the concept that their loss could lead to many of the physiological declines associated with aging.
C1 Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA.
   Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA.
   Univ Minnesota, Div Environm Hlth Sci, Minneapolis, MN 55455 USA.
   Vet Affairs Med Ctr, Res Serv, Minneapolis, MN 55417 USA.
   Vet Affairs Med Ctr, Med Serv, Minneapolis, MN 55417 USA.
C3 University of Minnesota System; University of Minnesota Twin Cities;
   University of Minnesota System; University of Minnesota Twin Cities;
   University of Minnesota System; University of Minnesota Twin Cities; US
   Department of Veterans Affairs; Veterans Health Administration (VHA);
   Minneapolis VA Health Care System; US Department of Veterans Affairs;
   Veterans Health Administration (VHA); Minneapolis VA Health Care System
RP Holtzman, JL (corresponding author), 4710 Girard Ave S, Minneapolis, MN 55419 USA.
EM holtz003@umn.edu
CR BISSETTE G, 1995, ENDOCRINOLOGY, V136, P622, DOI 10.1210/en.136.2.622
   BJELLAND S, 1983, BIOCHIM BIOPHYS ACTA, V747, P197, DOI 10.1016/0167-4838(83)90097-3
   CALA SE, 1993, J BIOL CHEM, V268, P2969
   Callahan LM, 2002, J NEUROPATH EXP NEUR, V61, P384, DOI 10.1093/jnen/61.5.384
   Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0
   Chen NQ, 1996, BIOCHEMISTRY-US, V35, P8299, DOI 10.1021/bi960296e
   ELLIOTT JG, 1997, J BIOL CHEM, V275, P86
   Erickson RR, 2005, BIOCHEM BIOPH RES CO, V332, P50, DOI 10.1016/j.bbrc.2005.04.090
   FARGNOLI J, 1990, P NATL ACAD SCI USA, V87, P846, DOI 10.1073/pnas.87.2.846
   GELMAN MS, 1995, J BIOL CHEM, V270, P15085, DOI 10.1074/jbc.270.25.15085
   Haigh NG, 2002, J CELL BIOL, V156, P261, DOI 10.1083/jcb.200110074
   Halaban R, 2002, J BIOL CHEM, V277, P14821, DOI 10.1074/jbc.M111497200
   Halaban R, 2001, J BIOL CHEM, V276, P11933, DOI 10.1074/jbc.M008703200
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   Heber S, 2000, J NEUROSCI, V20, P7951
   Herms J, 2004, EMBO J, V23, P4106, DOI 10.1038/sj.emboj.7600390
   HEYDARI AR, 1993, MOL CELL BIOL, V13, P2909, DOI 10.1128/MCB.13.5.2909
   HEYDARI AR, 1995, J NUTR, V125, P410
   Holtzman JL, 1997, J INVEST MED, V45, P28
   HOLTZMAN JL, 1965, J NUTR, V87, P101, DOI 10.1093/jn/87.1.101
   HOLTZMAN JL, 1998, PROLYL 4 HYDROXYLASE, P13
   Jazwinski SM, 1996, SCIENCE, V273, P54, DOI 10.1126/science.273.5271.54
   JUDAH J. D., 1965, FEDERATION PROC, V24, P1217
   Kopito Ron R., 1999, Physiological Reviews, V79, pS167
   Kopito RR, 2000, NAT CELL BIOL, V2, pE207, DOI 10.1038/35041139
   KOUSVELARI EE, 1988, MECH AGEING DEV, V42, P173, DOI 10.1016/0047-6374(88)90072-3
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LAMANTIA M, 1991, P NATL ACAD SCI USA, V88, P4453, DOI 10.1073/pnas.88.10.4453
   LAMANTIA ML, 1993, CELL, V74, P899, DOI 10.1016/0092-8674(93)90469-7
   Lipman RD, 1996, J GERONTOL A-BIOL, V51, pB54, DOI 10.1093/gerona/51A.1.B54
   Lithgow GJ, 1996, SCIENCE, V273, P80, DOI 10.1126/science.273.5271.80
   Maes M, 1997, CLIN ENDOCRINOL, V46, P587, DOI 10.1046/j.1365-2265.1997.1881002.x
   MARTH JD, 1999, ESSENTIALS GLYCOBIOL, P85
   Martin J, 1997, CURR OPIN STRUC BIOL, V7, P41, DOI 10.1016/S0959-440X(97)80006-1
   MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245
   McCracken AA, 2003, BIOESSAYS, V25, P868, DOI 10.1002/bies.10320
   MILLER DL, 1993, ARCH BIOCHEM BIOPHYS, V301, P41, DOI 10.1006/abbi.1993.1112
   MORI H, 1992, J BIOL CHEM, V267, P17082
   NARAHARA HT, 1959, J BIOL CHEM, V234, P71
   NIGAM SK, 1994, J BIOL CHEM, V269, P1744
   Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3
   Oliver JD, 1997, SCIENCE, V275, P86, DOI 10.1126/science.275.5296.86
   ORLANDO R, 1992, BIOCHEM BIOPH RES CO, V184, P686, DOI 10.1016/0006-291X(92)90644-Z
   Rabek JP, 2003, BIOCHEM BIOPH RES CO, V305, P566, DOI 10.1016/S0006-291X(03)00826-X
   RAPOPORT TA, 1991, FASEB J, V5, P2792, DOI 10.1096/fasebj.5.13.1916103
   Sadlish H, 2004, J MEMBRANE BIOL, V202, P115, DOI 10.1007/s00232-004-0715-6
   Sanders CR, 2000, CURR OPIN STRUC BIOL, V10, P438, DOI 10.1016/S0959-440X(00)00112-3
   Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   SRIVASTAVA SP, 1990, J BIOL CHEM, V265, P8392
   SRIVASTAVA SP, 1991, J BIOL CHEM, V266, P20337
   TESTA JR, 1994, CANCER RES, V54, P2778
   TOBIAN L, 1992, CLIN EXP HYPERTENS A, V14, P35, DOI 10.3109/10641969209036169
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   Ujvári A, 2001, J BIOL CHEM, V276, P5924, DOI 10.1074/jbc.M009203200
   VOLPE JJ, 1987, DEV BRAIN RES, V33, P277, DOI 10.1016/0165-3806(87)90160-X
   Zhang KZ, 2004, J BIOL CHEM, V279, P25935, DOI 10.1074/jbc.R400008200
   ZHOU LX, 1995, ARCH BIOCHEM BIOPHYS, V322, P390, DOI 10.1006/abbi.1995.1479
   Zhou LX, 1996, CHEM RES TOXICOL, V9, P1176
NR 61
TC 67
Z9 80
U1 0
U2 2
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD MAY
PY 2006
VL 61
IS 5
BP 435
EP 443
DI 10.1093/gerona/61.5.435
PG 9
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA 046NL
UT WOS:000237818200003
PM 16720739
OA Green Submitted, Bronze
DA 2024-02-19
ER

PT J
AU Zhang, X
   Wu, JZ
   Lin, ZX
   Yuan, QJ
   Li, YC
   Liang, JL
   Zhan, JYX
   Xie, YL
   Su, ZR
   Liu, YH
AF Zhang, Xie
   Wu, Jia-Zhen
   Lin, Zhi-Xiu
   Yuan, Qiu-Ju
   Li, Yu-Cui
   Liang, Jia-Li
   Zhan, Janis Ya-Xian
   Xie, You-Liang
   Su, Zi-Ren
   Liu, Yu-Hong
TI Ameliorative effect of supercritical fluid extract of <i>Chrysanthemum
   indicum</i> Linnen against D-galactose induced brain and liver injury in
   senescent mice via suppression of oxidative stress, inflammation and
   apoptosis
SO JOURNAL OF ETHNOPHARMACOLOGY
LA English
DT Article
DE Chrysanthemum indicum Linnen; D-galactose; Senescent; Anti-oxidative;
   Anti-inflammatory; Anti-apoptotic
ID COGNITIVE IMPAIRMENT; CELLULAR SENESCENCE; CYTOKINE PRODUCTION; FLOWERS;
   MODEL; CO2
AB Ethnopharmacological relevance: Chrysanthemum indicum Linne (C. indicum), a healthy food and folk medicine in China for thousands of years, has been reported to exert heat-clearing and detoxifying effects and extensively applied to treat various symptoms such as inflammation diseases, hepatitis and headache.
   Aim of this study: The purpose of the present study was to investigate the protective effect of the supercritical carbon dioxide fluid extract from flowers and buds of C. indicum (CISCFE) on D-galactose-induced brain and liver damage during aging process and to illuminate the underlying mechanisms.
   Materials and methods: Mice were orally administrated with CISCFE (100, 150 and 300 mg/kg) after injection with D-galactose. 24 h after the last administration, the blood samples, whole brain and liver tissues were collected for biochemical analysis, histological examination and western blot analysis. The body weight, spleen and thymus indexes, alanine transaminase (ALT), aspartate transaminase (AST), total antioxidant capacity (T-AOC), superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GSH-Px), malondialdehyde (MDA) in brain and liver, interleukin-1 beta (IL-1 beta), interleukin-6 (IL-6), and necrosis factor-alpha (TNF-alpha) were detected. Besides, the expressions of Bax, Bcl-2 and cleaved caspase-3 were determined by western blot assay.
   Results: The results indicated that CISCFE effectively increased the suppressed body weight, attenuated the decline of thymus and spleen indexes, and reduced the elevated levels of ALT and AST induced by D-gal. Furthermore, CISCFE might notably alleviate D-gal-induced abnormal alterations in structure and function of brain and liver dose-dependently via renewing normal antioxidant enzymes activities (SOD, CAT, GSH-Px), reducing MDA accumulation, decreasing inflammatory cytokines productions (IL-1 beta, IL-6, TNF-alpha), as well as attenuating the increase of Bax/Bcl-2 ratio and cleaved caspase-3 activation in the liver and brain.
   Conclusions: Taken together, our present results suggested that CISCFE treatment could effectively mitigate the D gal-induced hepatic and cerebral injury, and the underlying mechanism might be tightly related to the decreased oxidative stress, inflammation and apoptosis, indicating CISCFE might be an alternative and promising agent for the treatment of aging and age-associated brain and liver diseases.
C1 [Zhang, Xie; Li, Yu-Cui; Liang, Jia-Li; Zhan, Janis Ya-Xian; Xie, You-Liang; Su, Zi-Ren; Liu, Yu-Hong] Guangzhou Univ Chinese Med, Math Engn Acad Chinese Med, Guangdong Prov Key Lab New Drug Dev & Res Chinese, Guangzhou 510006, Guangdong, Peoples R China.
   [Zhang, Xie; Lin, Zhi-Xiu; Yuan, Qiu-Ju] Chinese Univ Hong Kong, Sch Chinese Med, Fac Med, Shatin, Hong Kong, Peoples R China.
   [Wu, Jia-Zhen] Guangzhou Univ Chinese Med, Affiliated Hosp Chinese Med 1, Guangzhou 510405, Guangdong, Peoples R China.
   [Xie, You-Liang; Su, Zi-Ren] Guangzhou Univ Chinese Med, Dongguan Math Engn Acad Chinese Med, Dongguan 523808, Peoples R China.
C3 Guangzhou University of Chinese Medicine; Chinese University of Hong
   Kong; Guangzhou University of Chinese Medicine; Guangzhou University of
   Chinese Medicine
RP Su, ZR; Liu, YH (corresponding author), Guangzhou Univ Chinese Med, Math Engn Acad Chinese Med, Guangdong Prov Key Lab New Drug Dev & Res Chinese, Guangzhou 510006, Guangdong, Peoples R China.
EM zhangxie@link.cuhk.edu.hk; zhen3305@gmail.com;
   linzx@eservices.cuhk.edu.hk; yuanqj@cuhk.edu.hk; liyucui@gzucm.edu.cn;
   jiali.liang@students.mq.edu.au; zyx@gzucm.edu.cn; xieyl@gzucm.edu.cn;
   suziren@gzucm.edu.cn; liuyuhong@gzucm.edu.cn
RI ZHAO, S/IWV-4219-2023; Liu, Yuhong/AAT-9680-2021; Liu,
   Yuhong/Y-4597-2019; lin, qing/JED-5250-2023; Lin, Zhi-Xiu/H-2807-2016;
   liang, liang/IAO-8518-2023; Su, Zi-Ren/O-5014-2019; Yuan,
   Qiuju/AAJ-3101-2020; Zhang, Xiaofeng/JMC-6060-2023
OI Liu, Yuhong/0000-0001-8070-6369; Zhang, Xiaofeng/0000-0003-2738-3286;
   Su, Zi-Ren/0000-0002-7018-3207
FU Hongkong, Macao and Taiwan Science & Technology Cooperation Program of
   China [2014DFH30010]; Science and Technology Planning Project of
   Guangdong Province, China [2013B090600007, 2013B090800052,
   2013B090600026]; Guangdong International Cooperation Project
   [2013508102016]
FX This work was supported by grants from Hongkong, Macao and Taiwan
   Science & Technology Cooperation Program of China (No. 2014DFH30010),
   Science and Technology Planning Project of Guangdong Province, China
   (No. 2013B090600007 &2013B090800052 &2013B090600026), Guangdong
   International Cooperation Project (No. 2013508102016).
CR Akifusa S, 2009, FREE RADICAL BIO MED, V46, P1308, DOI 10.1016/j.freeradbiomed.2009.02.014
   Akindele AJ, 2010, J ETHNOPHARMACOL, V129, P46, DOI 10.1016/j.jep.2010.02.024
   Aunan JR, 2016, BRIT J SURG, V103, pE29, DOI 10.1002/bjs.10053
   Budni J, 2016, BEHAV BRAIN RES, V302, P35, DOI 10.1016/j.bbr.2015.12.041
   Chen CJ, 2017, NEUROLOGY, V88, P2043, DOI 10.1212/WNL.0000000000003952
   Cheng WM, 2005, J ETHNOPHARMACOL, V101, P334, DOI 10.1016/j.jep.2005.04.035
   Cheon MS, 2009, J ETHNOPHARMACOL, V122, P473, DOI 10.1016/j.jep.2009.01.034
   Chu CC, 2016, J FUNCT FOODS, V26, P585, DOI 10.1016/j.jff.2016.08.025
   Çoban J, 2014, GERIATR GERONTOL INT, V14, P490, DOI 10.1111/ggi.12096
   Dai Dao-Fu, 2014, Longev Healthspan, V3, P6, DOI 10.1186/2046-2395-3-6
   Damoiseaux J.S., 2017, NEUROIMAGE
   Debnath T, 2013, J FOOD BIOCHEM, V37, P440, DOI 10.1111/j.1745-4514.2011.00644.x
   Feng Y, 2016, PHARM BIOL, V54, P1027, DOI 10.3109/13880209.2015.1093510
   Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057
   Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003
   Gambino V, 2013, AGING CELL, V12, P435, DOI 10.1111/acel.12060
   Gao J, 2016, METAB BRAIN DIS, V31, P771, DOI 10.1007/s11011-016-9813-2
   Garg G, 2017, REJUV RES, V20, P173, DOI 10.1089/rej.2016.1883
   Gill R, 2010, FREE RADICAL BIO MED, V48, P1121, DOI 10.1016/j.freeradbiomed.2010.01.006
   Gong YS, 2016, EXP GERONTOL, V74, P21, DOI 10.1016/j.exger.2015.11.020
   Haider S, 2015, LIFE SCI, V124, P110, DOI 10.1016/j.lfs.2015.01.016
   Han CH, 2014, FOOD CHEM TOXICOL, V65, P356, DOI 10.1016/j.fct.2014.01.012
   Harman D, 2003, ANTIOXID REDOX SIGN, V5, P557, DOI 10.1089/152308603770310202
   Hwang Eun-Sun, 2013, Prev Nutr Food Sci, V18, P111, DOI 10.3746/pnf.2013.18.2.111
   Ihunwo AO, 2016, NEURAL REGEN RES, V11, P1869, DOI 10.4103/1673-5374.195278
   Jeong SC, 2013, CHIN MED-UK, V8, DOI 10.1186/1749-8546-8-7
   Juergens UR, 2004, PULM PHARMACOL THER, V17, P281, DOI 10.1016/j.pupt.2004.06.002
   Kim IS, 2011, FOOD CHEM TOXICOL, V49, P963, DOI 10.1016/j.fct.2011.01.002
   Kim M, 2014, INT J MOL MED, V33, P870, DOI 10.3892/ijmm.2014.1656
   Kim SJ, 2014, EUR J PHARMACOL, V738, P66, DOI 10.1016/j.ejphar.2014.05.024
   Kumar A, 2010, FOOD CHEM TOXICOL, V48, P626, DOI 10.1016/j.fct.2009.11.043
   Lassmann H, 2016, BBA-MOL BASIS DIS, V1862, P506, DOI 10.1016/j.bbadis.2015.09.018
   Lee WC, 2010, AM J EMERG MED, V28, P1024, DOI 10.1016/j.ajem.2009.06.005
   Li CL, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/3878740
   Ma YC, 2017, MOLECULES, V22, DOI 10.3390/molecules22010007
   Matsuda H, 2002, CHEM PHARM BULL, V50, P972, DOI 10.1248/cpb.50.972
   Nilsson GE, 1996, J EXP BIOL, V199, P603
   Paradies G, 2011, NEUROCHEM INT, V58, P447, DOI 10.1016/j.neuint.2010.12.016
   Park SY, 2014, INT IMMUNOPHARMACOL, V19, P253, DOI 10.1016/j.intimp.2014.01.017
   POPPER H, 1986, PROG LIVER DIS, V8, P659
   Pourmemar E, 2017, EXP GERONTOL, V87, P16, DOI 10.1016/j.exger.2016.11.011
   Qian YF, 2008, CELL BIOL INT, V32, P304, DOI 10.1016/j.cellbi.2007.10.004
   Rehman SU, 2017, MOL NEUROBIOL, V54, P255, DOI 10.1007/s12035-015-9604-5
   Saeed S.A., 2005, INT J PHARMACOL, V1, P210
   Sahena F, 2009, J FOOD ENG, V95, P240, DOI 10.1016/j.jfoodeng.2009.06.026
   Schon EA, 2003, J CLIN INVEST, V111, P303, DOI 10.1172/JCI200317741
   Su JY, 2012, J ETHNOPHARMACOL, V141, P608, DOI 10.1016/j.jep.2011.08.055
   Tal Y, 2016, J FUNCT FOODS, V23, P359, DOI 10.1016/j.jff.2016.02.039
   Uddin MN, 2010, J IMMUNOTOXICOL, V7, P165, DOI 10.3109/15476910903510806
   Minh Doan V, 2015, FOOD FUNCT, V6, P1712, DOI [10.1039/C5FO00238A, 10.1039/c5fo00238a]
   Wang HM, 2016, MOL MED REP, V13, P4215, DOI 10.3892/mmr.2016.5052
   Wu XL, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/246407
   Wu XL, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/413237
   Yoo KY, 2016, NEURAL REGEN RES, V11, P270, DOI 10.4103/1673-5374.177735
   Zhang X, 2015, REJUV RES, V18, P437, DOI 10.1089/rej.2014.1651
   Zhang ZF, 2009, FOOD CHEM TOXICOL, V47, P496, DOI 10.1016/j.fct.2008.12.005
   Zhou Y, 2013, FOOD CHEM TOXICOL, V59, P412, DOI 10.1016/j.fct.2013.06.009
NR 57
TC 49
Z9 51
U1 2
U2 118
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-8741
J9 J ETHNOPHARMACOL
JI J. Ethnopharmacol.
PD APR 24
PY 2019
VL 234
BP 44
EP 56
DI 10.1016/j.jep.2018.12.050
PG 13
WC Plant Sciences; Chemistry, Medicinal; Integrative & Complementary
   Medicine; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary
   Medicine
GA HP1CZ
UT WOS:000461404300006
PM 30610932
DA 2024-02-19
ER

PT J
AU Citu, IM
   Coricovac, D
   Kerti, V
   Duicu, O
   Privistirescu, A
   Ardelean, S
   Muntean, D
   Dehelean, C
AF Citu, Ioana Mihaela
   Coricovac, Dorina
   Kerti, Viorica
   Duicu, Oana
   Privistirescu, Andreea
   Ardelean, Simona
   Muntean, Danina
   Dehelean, Cristina
TI DECREASED RESPIRATORY FUNCTION IN LIVER MITOCHONDRIA ISOLATED FROM
   HEALTY OLD RATS
SO FARMACIA
LA English
DT Article
DE rat liver mitochondria; ageing; respirometry
ID BRAIN; SERUM
AB Mitochondrion dysfunction has been constantly associated with ageing yet a significant variation across animal species and investigated tissues has been reported. We have previously demonstrated that healthy ageing is associated with impairment in heart mitochondria function. The purpose of the present study was to compare mitochondrial respiratory function in liver mitochondria of from old (20-24 months) vs. adult (4-6 months) healthy rats. Mitochondria were isolated by differential centrifugations and the respiratory function was assessed at 37 degrees C using a Clark-type oxygen electrode in the presence of NAD(+)-linked substrates (glutamate/malate) and a FAD-linked substrate (succinate in the presence of rotenone), respectively. Basal (State 2) and ADP-stimulated (State 3) respiratory rates were measured and expressed as natoms O-2/min/mg of mitochondrial protein. The respiratory control ratio (RCR) was calculated as the ratio of State 3 and State 2 respiratory rates. The intactness of mitochondria was verified by adding exogenous cytochrome c. Our data showed a significant decline in both State 2 and 3 respiratory rates in mitochondria isolated from old as compared to adult rodents when using either NAD(+) (20.68 +/- 2.43 vs. 24.46 +/- 2.38,p < 0.001; 101.11 +/- 5.40 vs. 121.60 +/- 17.74, p < 0.001, respectively) or FAD(+) (33.55 +/- 3.28 vs. 42.75 +/- 1.83, p < 0.0001; 123.92 +/- 5.02 vs. 140.69 +/- 15.37, p < 0.001, respectively) linked substrates. In conclusion, the impairment of respiratory parameters in the senescent group supports the hypothesis that a decrease of respiratory function in liver mitochondria occurs during healthy ageing.
C1 [Citu, Ioana Mihaela; Kerti, Viorica; Duicu, Oana; Privistirescu, Andreea; Muntean, Danina] Victor Babes Univ Med & Pharm, Fac Med, Timisoara 300041, Romania.
   [Coricovac, Dorina; Dehelean, Cristina] Victor Babes Univ Med & Pharm, Fac Pharm, Timisoara 300041, Romania.
   [Ardelean, Simona] Vasile Goldis Univ Med & Pharm, Fac Pharm, Bucharest, Romania.
C3 Victor Babes University of Medicine & Pharmacy, Timisoara; Victor Babes
   University of Medicine & Pharmacy, Timisoara; Carol Davila University of
   Medicine & Pharmacy; Vasile Goldis Western University of Arad
RP Ardelean, S (corresponding author), Vasile Goldis Univ Med & Pharm, Fac Pharm, Bucharest, Romania.
EM simonaaardelean@yahoo.com
RI MUNTEAN, Danina M./G-3138-2016; CITU, IOANA/AHC-8035-2022
OI MUNTEAN, Danina M./0000-0001-6186-5321; CITU, IOANA/0000-0001-8728-5413
FU Hungarian-Romanian cross-border project [HURO/1101/086/2.2.1]; European
   Social Found, Human Resources Development Operational Programme
   [POSDRU/159/1.5/S/136893]
FX Research supported by the Hungarian-Romanian cross-border project code
   HURO/1101/086/2.2.1. This paper was published under the frame of
   European Social Found, Human Resources Development Operational Programme
   2007-2013, project no. POSDRU/159/1.5/S/136893.
CR BROWN GC, 1992, BIOCHEM J, V284, P1
   Cahill A, 2005, AM J PHYSIOL-GASTR L, V289, pG1115, DOI 10.1152/ajpgi.00193.2005
   Crisan D, 2013, FARMACIA, V61, P1082
   DARNOLD JR, 1990, MECH AGEING DEV, V53, P157, DOI 10.1016/0047-6374(90)90067-P
   Duicu OM, 2013, CAN J PHYSIOL PHARM, V91, P657, DOI 10.1139/cjpp-2013-0048
   Duicu OM, 2013, CAN J PHYSIOL PHARM, V91, P593, DOI 10.1139/cjpp-2012-0422
   GORNALL AG, 1949, J BIOL CHEM, V177, P751
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   Hayflick L, 1998, EXP GERONTOL, V33, P639, DOI 10.1016/S0531-5565(98)00023-0
   HORTON AA, 1981, MECH AGEING DEV, V17, P253, DOI 10.1016/0047-6374(81)90062-2
   Jezek P, 2005, INT J BIOCHEM CELL B, V37, P2478, DOI 10.1016/j.biocel.2005.05.013
   Kerner J, 2001, AM J PHYSIOL-ENDOC M, V281, pE1054
   KERTI V, 2012, B UASMV VET MED, V69, P101
   Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027
   Maklashina E, 2004, AGING CELL, V3, P21, DOI 10.1111/j.1474-9728.2003.00078.x
   Marchi S., 2011, J SIGNAL T, V2012, P1
   Meng QY, 2007, MECH AGEING DEV, V128, P286, DOI 10.1016/j.mad.2006.12.008
   Modi HR, 2008, J MEMBRANE BIOL, V221, P51, DOI 10.1007/s00232-007-9086-0
   Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200
   Navarro A., 2006, AM J PHYSIOL-CELL PH, V292, P670, DOI DOI 10.1152/AJPCELL.00213.2006
   Nicolae AC, 2013, FARMACIA, V61, P658
   Ramsey J.J., 2004, AM J PHYSIOL-ENDOC M, V286, P31
   Salmon AB, 2010, FREE RADICAL BIO MED, V48, P642, DOI 10.1016/j.freeradbiomed.2009.12.015
   TUMMINO PJ, 1991, MECH AGEING DEV, V59, P177, DOI 10.1016/0047-6374(91)90083-C
   WEINBACH EC, 1959, J BIOL CHEM, V234, P412
NR 25
TC 3
Z9 3
U1 2
U2 5
PU SOC STIINTE FARMACEUTICE ROMANIA
PI BUCURESTI
PA BUCURESTI, STR TRAIAN VUIA 6, SECT 1, BUCURESTI, 020956, ROMANIA
SN 0014-8237
EI 2065-0019
J9 FARMACIA
JI Farmacia
PD JAN-FEB
PY 2015
VL 63
IS 1
BP 99
EP 103
PG 5
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA CB6MY
UT WOS:000349742300016
DA 2024-02-19
ER

PT J
AU Dong, YH
   Yin, ST
   Jiang, C
   Luo, XH
   Guo, X
   Zhao, C
   Fan, LH
   Meng, YB
   Lu, JX
   Song, XH
   Zhang, XD
   Chen, N
   Hu, HB
AF Dong, Yinhui
   Yin, Shutao
   Jiang, Cheng
   Luo, Xiaohe
   Guo, Xiao
   Zhao, Chong
   Fan, Lihong
   Meng, Yubing
   Lu, Junxuan
   Song, Xinhua
   Zhang, Xudong
   Chen, Ni
   Hu, Hongbo
TI Involvement of autophagy induction in
   penta-1,2,3,4,6-O-galloyl-β-D-glucose-induced senescence-like growth
   arrest in human cancer cells
SO AUTOPHAGY
LA English
DT Article
DE PGG; autophagy; senescence; UPR; apoptosis; MAPK8/9/10
ID BETA-D-GLUCOSE; ENDOPLASMIC-RETICULUM STRESS; TUMOR-GROWTH;
   UP-REGULATION; IN-VITRO; APOPTOSIS; ACTIVATION; KINASE; TUMORIGENESIS;
   CHEMOTHERAPY
AB Growing evidence has demonstrated that autophagy plays important and paradoxical roles in carcinogenesis, while senescence is considered to be a crucial tumor-suppressor mechanism in cancer prevention and treatment. In the present study we demonstrated that both autophagy and senescence were induced in response to penta-1,2,3,4,6-O-galloyl--D-glucose (PGG), a chemopreventive polyphonolic compound, in multiple types of cancer cells. Analysis of these 2 events over the experimental time course indicated that autophagy and senescence occurred in parallel early in the process and dissociated later. The long-term culture study suggested that a subpopulation of senescent cells may have the capacity to reenter the cell cycle. Inhibition of autophagy by either a chemical inhibitor or RNA interference led to a significant reduction of PGG-induced senescence, followed by induction of apoptosis. These results suggested that autophagy promoted senescence induction by PGG and that PGG might exert its anticancer activity through autophagy-mediated senescence. For the first time, these findings uncovered the relationships among autophagy, senescence, and apoptosis induced by PGG. In addition, we identified that unfolded protein response signaling played a pivotal role in the autophagy-mediated senescence phenotype. Furthermore, our data showed that activation of MAPK8/9/10 (mitogen-activated protein kinase 8/9/10/c-Jun N-terminal kinases) was an essential upstream signal for PGG-induced autophagy. Finally, the key in vitro results were validated in vivo in a xenograft mouse model of human HepG2 liver cancer. Our findings provided novel insights into understanding the mechanisms and functions of PGG-induced autophagy and senescence in human cancer cells.
C1 [Dong, Yinhui; Yin, Shutao; Guo, Xiao; Zhao, Chong; Song, Xinhua; Zhang, Xudong; Chen, Ni; Hu, Hongbo] China Agr Univ, Beijing Key Lab Funct Food Plant Resources, Coll Food Sci & Nutr Engn, Dept Nutr & Hlth, Beijing 100094, Peoples R China.
   [Dong, Yinhui; Jiang, Cheng; Lu, Junxuan] Texas Tech Univ, Sch Pharm, Dept Biomed Sci, Amarillo, TX USA.
   [Luo, Xiaohe] Harbin Med Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Harbin, Heilongjiang, Peoples R China.
   [Fan, Lihong] China Agr Univ, Coll Vet Med, Beijing 100094, Peoples R China.
   [Meng, Yubing] Nanyang Adm Tradit Chinese Med, Nanyang, Henan, Peoples R China.
C3 China Agricultural University; Texas Tech University System; Texas Tech
   University Health Science Center; Harbin Medical University; China
   Agricultural University
RP Hu, HB (corresponding author), China Agr Univ, Beijing Key Lab Funct Food Plant Resources, Coll Food Sci & Nutr Engn, Dept Nutr & Hlth, Beijing 100094, Peoples R China.
EM hongbo@cau.edu.cn
RI zhang, xu/GRX-9733-2022; sun, huan/IUN-8843-2023; LI,
   Xiang/JBJ-8387-2023; LIU, Qing Yu/IWV-1159-2023; sun, huan/JEO-7152-2023
OI Lu, Junxuan/0000-0002-2354-7186
FU National Natural Science Foundation of China (NSFC) [31071533, 31371752,
   30972172]; Ministry of Science and Technology of China [2012BAD33B09];
   US. National Cancer Institute [R01 CA136953]
FX This work was supported by grants from National Natural Science
   Foundation of China (NSFC, 31071533, 31371752, 30972172), Ministry of
   Science and Technology of China (2012BAD33B09), and the US. National
   Cancer Institute (R01 CA136953).
CR Byun JY, 2009, CARCINOGENESIS, V30, P1880, DOI 10.1093/carcin/bgp235
   Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003
   Chen N, 2010, FEBS LETT, V584, P1427, DOI 10.1016/j.febslet.2009.12.034
   Christov KT, 2003, EUR J CANCER, V39, P230, DOI 10.1016/S0959-8049(02)00497-5
   Gewirtz DA, 2008, BIOCHEM PHARMACOL, V76, P947, DOI 10.1016/j.bcp.2008.06.024
   Gewirtz DA, 2014, J CELL PHYSIOL, V229, P6, DOI 10.1002/jcp.24420
   Gewirtz DA, 2013, AUTOPHAGY, V9, P808, DOI 10.4161/auto.23922
   Goehe RW, 2012, J PHARMACOL EXP THER, V343, P763, DOI 10.1124/jpet.112.197590
   Hart LS, 2012, J CLIN INVEST, V122, P4621, DOI 10.1172/JCI62973
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   Heiss EH, 2007, J BIOL CHEM, V282, P26759, DOI 10.1074/jbc.M703229200
   Herman-Antosiewicz A, 2006, CANCER RES, V66, P5828, DOI 10.1158/0008-5472.CAN-06-0139
   Hornsby PJ, 2007, J CLIN ONCOL, V25, P1852, DOI 10.1200/JCO.2006.10.3101
   Hu HB, 2008, MOL CANCER THER, V7, P2681, DOI 10.1158/1535-7163.MCT-08-0456
   Hu HB, 2009, MOL CANCER THER, V8, P2833, DOI 10.1158/1535-7163.MCT-09-0288
   Hu HB, 2009, CARCINOGENESIS, V30, P818, DOI 10.1093/carcin/bgp059
   Huh JE, 2005, CARCINOGENESIS, V26, P1436, DOI 10.1093/carcin/bgi097
   Jia GH, 2006, IMMUNOL CELL BIOL, V84, P448, DOI 10.1111/j.1440-1711.2006.01454.x
   Jin SK, 2007, AUTOPHAGY, V3, P28, DOI 10.4161/auto.3269
   Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487
   Knizhnik AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055665
   Koren I, 2012, SCIENCE, V338, P889, DOI 10.1126/science.1230577
   Kuo PT, 2009, J AGR FOOD CHEM, V57, P3331, DOI 10.1021/jf803725h
   Lee HJ, 2011, CARCINOGENESIS, V32, P804, DOI 10.1093/carcin/bgr015
   Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018
   Li L, 2011, J PHARMACEUT BIOMED, V54, P545, DOI 10.1016/j.jpba.2010.09.028
   Li Y, 2012, AUTOPHAGY, V8, P273, DOI 10.4161/auto.8.2.18941
   Lorin S, 2009, CANCER RES, V69, P6924, DOI 10.1158/0008-5472.CAN-09-1270
   Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048
   Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639
   Moretti L, 2007, CELL CYCLE, V6, P793, DOI 10.4161/cc.6.7.4036
   Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06
   Oh GS, 2001, CANCER LETT, V174, P17, DOI 10.1016/S0304-3835(01)00680-2
   Puissant A, 2010, CANCER RES, V70, P1042, DOI 10.1158/0008-5472.CAN-09-3537
   Roberson RS, 2005, CANCER RES, V65, P2795, DOI 10.1158/0008-5472.CAN-04-1270
   Singh K, 2012, AUTOPHAGY, V8, P236, DOI 10.4161/auto.8.2.18600
   Takamura A, 2011, GENE DEV, V25, P795, DOI 10.1101/gad.2016211
   Volkmann K, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.199737
   Wang Q, 2011, INT J CANCER, V128, P1546, DOI 10.1002/ijc.25482
   Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001
   Wong CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009996
   Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102
   Yin ST, 2011, MOL CARCINOGEN, V50, P592, DOI 10.1002/mc.20743
   Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709
   Zhang JH, 2009, PHARM RES-DORDR, V26, P2066, DOI 10.1007/s11095-009-9932-0
   Zhao C, 2013, AUTOPHAGY, V9, P196, DOI 10.4161/auto.22805
NR 46
TC 29
Z9 31
U1 0
U2 25
PU LANDES BIOSCIENCE
PI AUSTIN
PA 1806 RIO GRANDE ST, AUSTIN, TX 78702 USA
SN 1554-8627
EI 1554-8635
J9 AUTOPHAGY
JI Autophagy
PD FEB 1
PY 2014
VL 10
IS 2
BP 296
EP 310
DI 10.4161/auto.27210
PG 15
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 304AC
UT WOS:000330716600011
PM 24389959
OA Green Published, Bronze
DA 2024-02-19
ER

PT J
AU Lin, XN
   Xia, YJ
   Wang, GQ
   Xiong, ZQ
   Zhang, H
   Lai, FX
   Ai, LZ
AF Lin, Xiangna
   Xia, Yongjun
   Wang, Guangqiang
   Xiong, Zhiqiang
   Zhang, Hui
   Lai, Fengxi
   Ai, Lianzhong
TI <i>Lactobacillus plantarum</i> AR501 Alleviates the Oxidative Stress of
   D-Galactose-Induced Aging Mice Liver by Upregulation of Nrf2-Mediated
   Antioxidant Enzyme Expression
SO JOURNAL OF FOOD SCIENCE
LA English
DT Article
DE antioxidant activity invivo; D-galactose; hepatotoxicity; lactic acid
   bacteria; nuclear factor erythroid-2-related factor 2
ID IN-VITRO; NRF2; CASEI; RATS; APOPTOSIS; STRAINS; PATHWAY; CELLS; HEME;
   VIVO
AB Lactic acid bacteria (LAB) have been used as ingredients of functional foods to promote health and prevent diseases because of their beneficial effects. This study aimed to investigate the antioxidative effects of LAB on the hepatotoxicity in D-galactose-induced aging mice. LAB were isolated from the traditional Chinese fermented foods and screened by the tolerance of hydrogen peroxide (H2O2). Male ICR (Institute of Cancer Research) mice were subcutaneously injected with D-galactose for 5 weeks and then gastric gavage with LAB for 6 weeks. The results showed that Lactobacillus plantarum AR113 and AR501, and Pediococcu pentosaceus AR243 could tolerate up to 1.5 mM H(2)O(2)invitro, and they could live through simulated gastrointestinal tract (GIT) to colonizing the GIT of host. Invivo, oral administration of L. plantarum AR113 and AR501 improved the antioxidant status of D-galactose-induced oxidative stress mice such as alleviated liver damages and reduced abnormal activities of superoxide dismutase, glutathione peroxidase, and catalase to normal levels. In addition, L. plantarum AR501 markedly elevated the gene expression of nuclear factor erythroid-2-related factor 2 and upregulated the expressions of several antioxidant genes such as glutathione reductase, glutathione S-transferase, glutamate-cysteine ligase catalytic subunit, glutamate-cysteine ligase modifier subunit, and NAD(P)H quinone oxidoreductase 1 in the liver of an aging mice. Therefore, L. plantarum AR501 could be a good candidate for producing antiaging functional foods.
C1 [Lin, Xiangna; Xia, Yongjun; Wang, Guangqiang; Xiong, Zhiqiang; Zhang, Hui; Lai, Fengxi; Ai, Lianzhong] Univ Shanghai Sci & Technol, Sch Med Instrument & Food Engn, Shanghai Engn Res Ctr Food Microbiol, 516 Jungong Rd, Shanghai 200093, Peoples R China.
C3 University of Shanghai for Science & Technology
RP Ai, LZ (corresponding author), Univ Shanghai Sci & Technol, Sch Med Instrument & Food Engn, Shanghai Engn Res Ctr Food Microbiol, 516 Jungong Rd, Shanghai 200093, Peoples R China.
EM ailianzhong@hotmail.com
RI luo, yuan/JLS-6416-2023
OI Xiong, Zhi-Qiang/0000-0002-7984-3662
FU National Natural Science Foundation of China [31371809, 31771956]; "Shu
   Guang" project of Shanghai Municipal Education Commission [15SG42];
   Shanghai Education Development Foundation [15SG42]; Natural Science
   Foundation of Shanghai [15ZR1428900]
FX This work was supported by the National Natural Science Foundation of
   China (grant numbers 31371809, 31771956), the "Shu Guang" project of
   Shanghai Municipal Education Commission and Shanghai Education
   Development Foundation (grant number 15SG42), and Natural Science
   Foundation of Shanghai (grant number 15ZR1428900).
CR Amdekar S, 2013, J INTERF CYTOK RES, V33, P1, DOI 10.1089/jir.2012.0034
   Arlt A, 2013, ONCOGENE, V32, P4825, DOI 10.1038/onc.2012.493
   Buchmeier N, 1997, INFECT IMMUN, V65, P3725, DOI 10.1128/IAI.65.9.3725-3730.1997
   Cleusix V, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-101
   Daly MJ, 2004, SCIENCE, V306, P1025, DOI 10.1126/science.1103185
   HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001
   Hamada Y, 2009, BONE, V45, pS35, DOI 10.1016/j.bone.2009.02.004
   Hsieh HM, 2011, LIFE SCI, V88, P82, DOI 10.1016/j.lfs.2010.10.021
   Ianniello RG, 2015, LWT-FOOD SCI TECHNOL, V60, P817, DOI 10.1016/j.lwt.2014.10.020
   Jones RM, 2015, CELL REP, V12, P1217, DOI 10.1016/j.celrep.2015.07.042
   Kim HS, 2005, ASIAN AUSTRAL J ANIM, V18, P255, DOI 10.5713/ajas.2005.255
   Kullisaar T, 2002, INT J FOOD MICROBIOL, V72, P215, DOI 10.1016/S0168-1605(01)00674-2
   Li JJ, 2015, BRAIN RES, V1595, P19, DOI 10.1016/j.brainres.2014.10.012
   Li YW, 2014, DISCRETE DYN NAT SOC, V2014, DOI 10.1155/2014/784107
   Lin MY, 1999, J AGR FOOD CHEM, V47, P1460, DOI 10.1021/jf981149l
   Nielsen F, 1997, CLIN CHEM, V43, P1209
   Pan DD, 2010, CARBOHYD POLYM, V80, P908, DOI 10.1016/j.carbpol.2010.01.005
   Persichetti E, 2014, NUTRITION, V30, P936, DOI 10.1016/j.nut.2013.12.009
   Qu J, 2011, BIOCHEM BIOPH RES CO, V411, P32, DOI 10.1016/j.bbrc.2011.06.071
   Ren DM, 2011, P NATL ACAD SCI USA, V108, P1433, DOI 10.1073/pnas.1014275108
   Sun Z, 2007, MOL CELL BIOL, V27, P6334, DOI 10.1128/MCB.00630-07
   Tang W, 2016, APPL MICROBIOL BIOT, V100, P7193, DOI 10.1007/s00253-016-7581-x
   Wagner AE, 2015, J NUTR BIOCHEM, V26, P661, DOI 10.1016/j.jnutbio.2015.01.004
   Wang CQ, 2010, PHYTOMEDICINE, V17, P527, DOI 10.1016/j.phymed.2009.09.006
   Wang D, 2008, FOOD CHEM, V107, P1421, DOI 10.1016/j.foodchem.2007.09.072
   Wu R, 2009, J BASIC MICROB, V49, P318, DOI 10.1002/jobm.200800047
   Wu X, 2014, BIOCHEM BIOPH RES CO, V452, P340, DOI 10.1016/j.bbrc.2014.08.063
   Yi ZJ, 2009, EXP GERONTOL, V44, P760, DOI 10.1016/j.exger.2009.08.011
   Yu YH, 2015, MOL CELL BIOCHEM, V403, P287, DOI 10.1007/s11010-015-2358-6
   Zhang L, 2013, INT J BIOL MACROMOL, V54, P270, DOI 10.1016/j.ijbiomac.2012.12.037
   Zhang MJ, 2013, PROG NEUROBIOL, V100, P30, DOI 10.1016/j.pneurobio.2012.09.003
   Zhang Y, 2010, EUR FOOD RES TECHNOL, V231, P151, DOI 10.1007/s00217-010-1255-1
NR 32
TC 49
Z9 53
U1 5
U2 55
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-1147
EI 1750-3841
J9 J FOOD SCI
JI J. Food Sci.
PD JUL
PY 2018
VL 83
IS 7
BP 1990
EP 1998
DI 10.1111/1750-3841.14200
PG 9
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA GM5WM
UT WOS:000438216600027
PM 29905928
DA 2024-02-19
ER

PT J
AU Kim, DH
   Lee, KJ
   Park, J
   Chi, S
   Han, JKY
   Bang, Y
   Kim, SM
   Kang, SG
   Cha, SH
   Han, YH
AF Kim, Dong-Hyun
   Lee, Kyeong-Jin
   Park, Jinjoo
   Chi, Susan
   Han, Jaekyu
   Bang, Yewon
   Kim, Sun-Mi
   Kang, Seung Goo
   Cha, Sang-Hoon
   Han, Yong-Hyun
TI Disruption of IL-18 signaling via engineered IL-18BP biologics
   alleviates experimental cholestatic liver disease
SO BIOMEDICINE & PHARMACOTHERAPY
LA English
DT Article
DE IL-18 binding protein; APB-R3; Primary sclerosing cholangitis; Fibrosis;
   Senescence
ID BARRIER FUNCTION
AB Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease characterized by progressive inflammation and fibrosis around intrahepatic and extrahepatic bile ducts leading to severe hepatic cirrhosis and high mortality. Although there is an urgent clinical unmet need for PSC, no effective medical therapy has been developed to delay the disease progression until today. IL-18 binding protein (IL-18BP) is well-known to be a natural negative feedback regulator for IL-18, and we have developed a recombinant long-acting IL-18BP referred to as APB-R3 as a therapeutic agent to treat IL-18-related inflammatory diseases. Here, we aimed to study whether disrupted IL-18 signaling by APB-R3 treatment can inhibit PSC injuries in the experimental DDC diet-induced PSC rodent model. First, we found that the amounts of free IL-18 are augmented under PSC condition with increased expression of biliary IL-18 receptors. Administration of APB-R3 effectively attenuated key diagnostic parameters of PSC such as plasma ALP and GGT levels as well as bile acids levels. We also observed that blockade of IL-18 suppressed ductular reactive and proliferative phenotypes of cholangiocytes. Additionally, APB-R3 significantly ameliorated DDC diet-induced periductal fibrosis and transcriptional expressions of pro fibrotic marker genes. Enhanced senescence associated secretory phenotype (SASP) markers in cholestatic liver disease were diminished by APB-R3 treatment. Our findings clearly demonstrate that the administration of IL-18BP biologics, APB-R3, effectively alleviates DDC diet-induced biliary injuries in rodent PSC model, implying APB-R3 can be a promising therapeutic reagent which warrants clinical human trials as new therapeutic options.
C1 [Kim, Dong-Hyun; Lee, Kyeong-Jin; Han, Yong-Hyun] Kangwon Natl Univ, Coll Pharm, Lab Pathol & Physiol, Chunchon 24341, South Korea.
   [Han, Yong-Hyun] Kangwon Natl Univ, Multidimens Genom Res Ctr, Chunchon 24341, South Korea.
   [Kang, Seung Goo; Cha, Sang-Hoon] Kangwon Natl Univ, Coll Biomed Sci, Div Biomed Convergence, Chunchon 24341, South Korea.
   [Kang, Seung Goo] Kangwon Natl Univ, Coll Biomed Sci, Inst Biosci & Biotechnol, Chunchon 24341, South Korea.
   [Park, Jinjoo; Chi, Susan; Han, Jaekyu; Bang, Yewon; Kim, Sun-Mi; Cha, Sang-Hoon] Kangwon Natl Univ, AprilBio Co Ltd, Rm602,Biomed Sci Bldg, Chunchon 24341, South Korea.
   [Kang, Seung Goo] Kangwon Natl Univ, Inst Biosci & Biotechnol, Coll Biomed Sci, Div Biomed Convergence, 1 Kangwondaehak Gil, Chunchon 24341, Gangwon Do, South Korea.
   [Cha, Sang-Hoon] Kangwon Natl Univ, AprilBio Co Ltd, Rm602,Biomed Sci Bldg,1 Kangwondaehak Gil, Chunchon 24341, Gangwon Do, South Korea.
   [Han, Yong-Hyun] Kangwon Natl Univ, Coll Pharm, Lab Pathol & Physiol, 1 Kangwondaehak Gil, Chunchon 24341, Gangwon Do, South Korea.
C3 Kangwon National University; Kangwon National University; Kangwon
   National University; Kangwon National University; Kangwon National
   University; Kangwon National University; Kangwon National University;
   Kangwon National University
RP Han, YH (corresponding author), Kangwon Natl Univ, Coll Pharm, Lab Pathol & Physiol, Chunchon 24341, South Korea.; Kang, SG; Cha, SH (corresponding author), Kangwon Natl Univ, Coll Biomed Sci, Div Biomed Convergence, Chunchon 24341, South Korea.
EM sgkang@kangwon.ac.kr; chash@aprilbio.com; yhhan1015@kangwon.ac.kr
OI Chi, Susan/0009-0001-2890-3864; Han, Yong-Hyun/0000-0002-1868-4784
FU National Research Foundation of Korea (NRF) - Korea government (MSIT)
   [2021R1C1C1004023, 2021R1A4A3031661, 2021R1A2C1012421]; Korea Basice
   Science Institute (National research Facilities and Equipment Center) -
   Ministry of Education [2022R1A6C101A739]; AprilBio Co., Ltd.
FX This work was supported by the National Research Foundation of Korea
   (NRF) grant funded by the Korea government (MSIT) (2021R1C1C1004023 and
   2021R1A4A3031661 to Y.H.H, and 2021R1A2C1012421 to S.G.K) , Korea Basice
   Science Institute (National research Facilities and Equipment Center)
   grant funded by the Ministry of Education (No. 2022R1A6C101A739) , and
   by the internal research fund from AprilBio Co., Ltd.
CR Alsuraih M, 2021, JHEP REP, V3, DOI 10.1016/j.jhepr.2021.100250
   Banales JM, 2019, NAT REV GASTRO HEPAT, V16, P269, DOI 10.1038/s41575-019-0125-y
   Belkaya S, 2019, J EXP MED, V216, P1777, DOI 10.1084/jem.20190669
   Beuers U, 2009, J HEPATOL, V51, P237, DOI 10.1016/j.jhep.2009.04.009
   Castillo-dela Cruz P, 2019, CELL REP, V29, P2270, DOI 10.1016/j.celrep.2019.10.042
   Cazzagon N, 2021, JHEP REP, V3, DOI 10.1016/j.jhepr.2021.100286
   DATTO MB, 1995, P NATL ACAD SCI USA, V92, P5545, DOI 10.1073/pnas.92.12.5545
   El-Sayed IH, 2003, CLIN CHIM ACTA, V336, P123, DOI 10.1016/S0009-8981(03)00336-X
   Faggioni R, 2001, J IMMUNOL, V167, P5913, DOI 10.4049/jimmunol.167.10.5913
   Ferreira-Gonzalez S, 2018, NAT COMMUN, V9, DOI [10.1038/s41467-018-03299-5, 10.1038/s41467-018-06183-4]
   González MI, 2020, BIOSCIENCE REP, V40, DOI 10.1042/BSR20200689
   Guicciardi ME, 2020, HEPATOLOGY, V71, P741, DOI 10.1002/hep.31067
   Harel M, 2022, CYTOKINE, V150, DOI 10.1016/j.cyto.2021.155781
   Hirschfield GM, 2019, J HEPATOL, V70, P483, DOI 10.1016/j.jhep.2018.10.035
   Holtmann TM, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10102618
   Jang YS, 2023, bioRxiv, DOI [10.1101/2023.05.30.542831, DOI 10.1101/2023.05.30.542831, 10.1101/2023.05.30.542831]
   Jiang XJ, 2017, NAT REV GASTRO HEPAT, V14, P279, DOI 10.1038/nrgastro.2016.154
   Kliewer SA, 2015, DIGEST DIS, V33, P327, DOI 10.1159/000371670
   Knorr J, 2023, HEPATOLOGY, V77, P1968, DOI 10.1002/hep.32776
   Kowdley KV, 2020, J HEPATOL, V73, P94, DOI 10.1016/j.jhep.2020.02.033
   Liao LJ, 2019, GUT, V68, P1477, DOI 10.1136/gutjnl-2018-316670
   Lindor KD, 2009, HEPATOLOGY, V50, P808, DOI 10.1002/hep.23082
   Maroni L, 2017, AM J PATHOL, V187, P366, DOI 10.1016/j.ajpath.2016.10.010
   Meadows V, 2021, FRONT MOL BIOSCI, V8, DOI 10.3389/fmolb.2021.803098
   Netea MG, 2006, NAT MED, V12, P650, DOI 10.1038/nm1415
   Novick D, 2001, CYTOKINE, V14, P334, DOI 10.1006/cyto.2001.0914
   Nowarski R, 2015, CELL, V163, P1444, DOI 10.1016/j.cell.2015.10.072
   Park SY, 2022, BIOMEDICINES, V10, DOI 10.3390/biomedicines10071750
   Pizarro TT, 1999, J IMMUNOL, V162, P6829
   Qu JW, 2019, INT IMMUNOPHARMACOL, V70, P147, DOI 10.1016/j.intimp.2019.02.016
   Reiter FP, 2016, WORLD J HEPATOL, V8, P401, DOI 10.4254/wjh.v8.i8.401
   Tabibian James H, 2018, Gastroenterol Hepatol (N Y), V14, P293
   Trauner M, 2019, HEPATOLOGY, V70, P788, DOI 10.1002/hep.30509
   Zhang LM, 2019, BIOMED PHARMACOTHER, V113, DOI 10.1016/j.biopha.2019.108756
   Zhang X, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-35256-8
NR 35
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 0753-3322
EI 1950-6007
J9 BIOMED PHARMACOTHER
JI Biomed. Pharmacother.
PD NOV
PY 2023
VL 167
AR 115587
DI 10.1016/j.biopha.2023.115587
EA SEP 2023
PG 8
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA U5QK8
UT WOS:001085346700001
PM 37774670
OA gold
DA 2024-02-19
ER

PT J
AU Setvaag, E
   Jacobsen, N
   Thomsen, K
AF Setvaag, E
   Jacobsen, N
   Thomsen, K
TI Facial premature ageing as a side-effect following bone marrow
   transplantation
SO JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
LA English
DT Article
ID VERSUS-HOST DISEASE; GRAFT; RECIPIENTS
AB Two female patients developed an acute graft versus host reaction with generalized erythema and subsequent desquamation after allogeneic bone marrow transplantation. Later, over a period of months both developed chronic graft versus host reactions with involvement of liver and lungs. Shortly after the diagnosis of the chronic graft versus host disease both patients developed severe elastosis of the facial skin.
   The pathogenetic linkage of the clinical picture, which resembles photodamage to graft versus host disease and autoimmunity is discussed.
C1 Univ Copenhagen, Bispebjerg Hosp, Dept Dermatol, DK-2400 Copenhagen NV, Denmark.
   Univ Copenhagen, Rigshosp, Dept Hematol, DK-2100 Copenhagen O, Denmark.
C3 University of Copenhagen; Bispebjerg Hospital; Rigshospitalet;
   University of Copenhagen
RP Setvaag, E (corresponding author), Univ Copenhagen, Bispebjerg Hosp, Dept Dermatol, Bispebjerg Bakke 23, DK-2400 Copenhagen NV, Denmark.
CR Aractingi S, 1996, BRIT J DERMATOL, V134, P325
   ATKINSON K, 1990, BLOOD, V75, P2459
   CHOI EKK, 1988, ANN RHEUM DIS, V47, P313, DOI 10.1136/ard.47.4.313
   Fisher GJ, 1996, NATURE, V379, P335, DOI 10.1038/379335a0
   Gilchrest BA, 1996, BRIT J DERMATOL, V135, P867, DOI 10.1046/j.1365-2133.1996.d01-1088.x
   GIROLOMONI G, 1991, Journal of Dermatology (Tokyo), V18, P314
   KATELARIS A, 1992, J INVEST DERMATOL, V99, P779, DOI 10.1111/1523-1747.ep12614736
   Nagler A, 1996, BRIT J DERMATOL, V134, P780, DOI 10.1111/j.1365-2133.1996.tb06991.x
   Prummer O, 1996, BONE MARROW TRANSPL, V17, P617
   Spelman LJ, 1996, J AM ACAD DERMATOL, V35, P17, DOI 10.1016/S0190-9622(96)90489-2
   Wynn RF, 1998, LANCET, V351, P178, DOI 10.1016/S0140-6736(97)08256-1
NR 11
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0926-9959
EI 1468-3083
J9 J EUR ACAD DERMATOL
JI J. Eur. Acad. Dermatol. Venereol.
PD SEP
PY 2003
VL 17
IS 5
BP 566
EP 568
DI 10.1046/j.1468-3083.2003.00755.x
PG 3
WC Dermatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Dermatology
GA 773VF
UT WOS:000188944300016
PM 12941096
DA 2024-02-19
ER

PT J
AU Chang, TM
   Hung, WC
AF Chang, Tsung-Ming
   Hung, Wen-Chun
TI The homeobox transcription factor Prox1 inhibits proliferation of
   hepatocellular carcinoma cells by inducing p53-dependent senescence-like
   phenotype
SO CANCER BIOLOGY & THERAPY
LA English
DT Article
DE Prox1; Twist; p53; senescence; hepatocellular carcinoma
ID CELLULAR SENESCENCE; TUMOR-REGRESSION; TARGET GENES; TWIST; RESTORATION;
   PROGRESSION; RECK
AB The homeobox transcription factor Prox1 is highly expressed in adult hepatocytes and is involved in the regulation of bile acid synthesis and gluconeogenesis in the liver by interacting with other transcriptional activators or repressors. Recent studies showed that Prox1 could inhibit proliferation of hepatocellular carcinoma (HCC) cells and reduced Prox1 expression was associated with poor prognosis of HCC patients. However, the underlying mechanism by which Prox1 attenuates HCC growth is still unclear. In this study, we demonstrated that Prox1 induced senescence-like phenotype of HCC cells to reduce cell proliferation. Our results indicated that the tumor suppressor p53 is a key mediator of Prox1-induced growth suppression because Prox1 only induced senescence-like phenotype in HCC cells harboring wild type p53. In addition, knockdown of p53 by shRNA reversed the effect of Prox1. However, chromatin immunoprecipitation assay did not demonstrate the direct binding of Prox1 to proximal promoter of human p53 gene suggesting Prox1 might not directly activate p53 transcription. We found that Prox1 suppressed Twist expression in HCC cells and subsequently relieved its inhibition on p53 gene transcription. The involvement of Twist in the regulation of p53 by Prox1 was supported by the following evidence: (1) Prox1 inhibited Twist expression and promoter activity; (2) knockdown of Twist in SK-HEP-1 cells upregulated p53 expression and (3) ectopic expression of Twist counteracted Prox1-induced p53 transcription and senescence-like phenotype. We also indentified an E-box located at p53 promoter which is required for Twist to inhibit p53 expression. Finally, our animal experiment confirmed that Prox1 suppressed HCC growth in vivo. Collectively, we conclude that Prox1 suppresses proliferation of HCC cells via inhibiting Twist to trigger p53-dependent senescence-like phenotype.
C1 [Chang, Tsung-Ming] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung 80424, Taiwan.
   [Hung, Wen-Chun] Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan.
C3 National Sun Yat Sen University; National Health Research Institutes -
   Taiwan
RP Hung, WC (corresponding author), Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan.
EM hung1228@ms10.hinet.net
RI Hung, Wen-Chun/F-4846-2011
FU National Science Council, Republic of China [NSC 99-2628-B-400-004-MY3];
   Department of Health, Taiwan, Republic of China [DOH 101-TD-C-111-002,
   DOH 101-TD-C-111-004]
FX We thank Dr M. H. Tai, Dr Y.H. Xie, Dr L. H. Wang and Dr W. S. Lee for
   providing experimental materials. This study was supported by the
   following grants: (1) NSC 99-2628-B-400-004-MY3 from National Science
   Council, Republic of China; (2) DOH 101-TD-C-111-002 and DOH
   101-TD-C-111-004 from Department of Health, Taiwan, Republic of China.
CR Acosta JC, 2012, TRENDS CELL BIOL, V22, P211, DOI 10.1016/j.tcb.2011.11.006
   Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005
   Campaner S, 2010, NAT CELL BIOL, V12, P54, DOI 10.1038/ncb2004
   Castanon I, 2002, GENE, V287, P11, DOI 10.1016/S0378-1119(01)00893-9
   Chang TM, 2012, FEBS LETT, V586, P3746, DOI 10.1016/j.febslet.2012.08.034
   Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918
   Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a
   Dadras SS, 2008, J INVEST DERMATOL, V128, P2798, DOI 10.1038/jid.2008.176
   Dudas J, 2004, ANAT EMBRYOL, V208, P359, DOI 10.1007/s00429-004-0403-4
   Dudas J, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-92
   Duncan MK, 2002, MECH DEVELOP, V112, P195, DOI 10.1016/S0925-4773(01)00645-1
   El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061
   El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683
   Elsir T, 2010, J NEUROPATH EXP NEUR, V69, P129, DOI 10.1097/NEN.0b013e3181ca4767
   Gullaud M, 2003, CELL DEATH DIFFER, V10, P641, DOI 10.1038/sj.cdd.4401222
   Hsu MC, 2006, J BIOL CHEM, V281, P4718, DOI 10.1074/jbc.M510937200
   Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560
   Kurz DJ, 2000, J CELL SCI, V113, P3613
   Laerm A, 2007, J HEPATOL, V46, P89, DOI 10.1016/j.jhep.2006.07.033
   Leu MH, 2012, CLIN CANC RES
   Liu LT, 2003, CANCER RES, V63, P3069
   Maestro R, 1999, GENE DEV, V13, P2207, DOI 10.1101/gad.13.17.2207
   Nagai H, 2003, GENE CHROMOSOME CANC, V38, P13, DOI 10.1002/gcc.10248
   Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X
   OLIVER G, 1993, MECH DEVELOP, V44, P3, DOI 10.1016/0925-4773(93)90012-M
   Pan MR, 2009, J BIOL CHEM, V284, P2746, DOI 10.1074/jbc.M806223200
   Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131
   Petrova TV, 2008, CANCER CELL, V13, P407, DOI 10.1016/j.ccr.2008.02.020
   Risebro CA, 2009, DEVELOPMENT, V136, P495, DOI 10.1242/dev.030007
   Shimoda M, 2006, CLIN CANCER RES, V12, P6005, DOI 10.1158/1078-0432.CCR-06-0712
   Shiota M, 2008, ONCOGENE, V27, P5543, DOI 10.1038/onc.2008.176
   Sosa-Pineda B, 2000, NAT GENET, V25, P254, DOI 10.1038/76996
   Takahashi M, 2006, NEOPLASIA, V8, P1003, DOI 10.1593/neo.06595
   Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541
   Versmold B, 2007, INT J CANCER, V121, P547, DOI 10.1002/ijc.22705
   Wigle JT, 1999, NAT GENET, V21, P318, DOI 10.1038/6844
   Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1
   Wu CH, 2007, P NATL ACAD SCI USA, V104, P13028, DOI 10.1073/pnas.0701953104
   Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529
   Zinovieva RD, 1996, GENOMICS, V35, P517, DOI 10.1006/geno.1996.0392
NR 40
TC 16
Z9 18
U1 0
U2 12
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1538-4047
EI 1555-8576
J9 CANCER BIOL THER
JI Cancer Biol. Ther.
PD MAR
PY 2013
VL 14
IS 3
BP 222
EP 229
DI 10.4161/cbt.23293
PG 8
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA 102VX
UT WOS:000315873600003
PM 23291986
OA Bronze, Green Published
DA 2024-02-19
ER

PT J
AU Novelle, MG
   Ali, A
   Diéguez, C
   Bernier, M
   de Cabo, R
AF Novelle, Marta G.
   Ali, Ahmed
   Dieguez, Carlos
   Bernier, Michel
   de Cabo, Rafael
TI Metformin: A Hopeful Promise in Aging Research
SO COLD SPRING HARBOR PERSPECTIVES IN MEDICINE
LA English
DT Article
ID ACTIVATED PROTEIN-KINASE; EXTENDS LIFE-SPAN; INHIBITS HEPATIC
   GLUCONEOGENESIS; CAENORHABDITIS-ELEGANS; CALORIC RESTRICTION; DIETARY
   RESTRICTION; C.-ELEGANS; SPONTANEOUS TUMORIGENESIS;
   CLINICAL-IMPLICATIONS; MAMMARY-TUMORS
AB Even though the inevitable process of aging by itself cannot be considered a disease, it is directly linked to life span and is the driving force behind all age-related diseases. It is an undisputable fact that age-associated diseases are among the leading causes of death in the world, primarily in industrialized countries. During the last several years, an intensive search of antiaging treatments has led to the discovery of a variety of drugs that promote health span and/or life extension. The biguanide compound metformin is widely used for treating people with type 2 diabetes and appears to show protection against cancer, inflammation, and age-related pathologies. Here, we summarize the recent developments about metformin use in translational aging research and discuss its role as a potential geroprotector.
C1 [Novelle, Marta G.; Ali, Ahmed; Bernier, Michel; de Cabo, Rafael] NIA, Translat Gerontol Branch, NIH, Baltimore, MD 21224 USA.
   [Novelle, Marta G.] Univ Santiago de Compostela, Inst Invest Sanitaria, Res Ctr Mol Med & Chron Dis CIMUS, Santiago De Compostela 15782, Spain.
   [Novelle, Marta G.; Dieguez, Carlos] CIBER Fisiopatol Obesidad & Nutr CIBERobn, Santiago De Compostela 15706, Spain.
C3 National Institutes of Health (NIH) - USA; NIH National Institute on
   Aging (NIA); Universidade de Santiago de Compostela; CIBER - Centro de
   Investigacion Biomedica en Red; CIBEROBN
RP de Cabo, R (corresponding author), NIA, Translat Gerontol Branch, NIH, Baltimore, MD 21224 USA.
EM decabora@grc.nia.nih.gov
RI NOVELLE, MARTA G/AAB-9200-2019; Bernier, Michel/Y-7139-2019; de Cabo,
   Rafael Carlos/E-7996-2010; Bernier, Michel/AAO-3983-2021; de Cabo,
   Rafael/J-5230-2016
OI NOVELLE, MARTA G/0000-0003-0285-7182; de Cabo, Rafael
   Carlos/0000-0003-2830-5693; Bernier, Michel/0000-0002-5948-368X; de
   Cabo, Rafael/0000-0002-3354-2442; dieguez, carlos/0000-0002-0919-4337
FU National Institute on Aging, National Institutes of Health
FX This work is supported by the Intramural Research Program of the
   National Institute on Aging, National Institutes of Health. CIBER de
   Fisiopatologia de la Obesidad y Nutricion is an initiative of ISCIII.
   The funding agency had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Adeyemo MA, 2015, DIABETES OBES METAB, V17, P363, DOI 10.1111/dom.12426
   Aldea M, 2014, TUMOR BIOL, V35, P5101, DOI 10.1007/s13277-014-1676-8
   Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014
   Anisimov VN, 2008, CELL CYCLE, V7, P2769, DOI 10.4161/cc.7.17.6625
   Anisimov VN, 2015, CELL CYCLE, V14, P46, DOI 10.4161/15384101.2014.973308
   Anisimov VN, 2014, ANN TRANSL MED, V2, DOI 10.3978/j.issn.2305-5839.2014.06.02
   Anisimov VN, 2012, EXPERT OPIN DRUG DIS, V7, P85, DOI 10.1517/17460441.2012.642361
   Anisimov VN, 2011, AGING-US, V3, P148, DOI 10.18632/aging.100273
   Anisimov VN, 2010, AGING-US, V2, P945, DOI 10.18632/aging.100245
   Anisimov VN, 2010, CELL CYCLE, V9, P188, DOI 10.4161/cc.9.1.10407
   Anisimov VN, 2005, B EXP BIOL MED+, V139, P721, DOI 10.1007/s10517-005-0389-9
   Anisimov VN, 2005, EXP GERONTOL, V40, P685, DOI 10.1016/j.exger.2005.07.007
   Bailey CJ, 1996, NEW ENGL J MED, V334, P574, DOI 10.1056/NEJM199602293340906
   Batandier C, 2006, J BIOENERG BIOMEMBR, V38, P33, DOI 10.1007/s10863-006-9003-8
   Baur JA, 2014, CELL METAB, V20, P197, DOI 10.1016/j.cmet.2014.07.013
   Ben Sahra I, 2011, CANCER RES, V71, P4366, DOI 10.1158/0008-5472.CAN-10-1769
   Berstein LM, 2012, AGING-US, V4, P320, DOI 10.18632/aging.100455
   Blagosklonny MV, 2008, CELL CYCLE, V7, P2615, DOI 10.4161/cc.7.17.6626
   Blagosklonny MV, 2013, AGING-US, V5, P227, DOI 10.18632/aging.100551
   Bulterijs S, 2011, REJUV RES, V14, P469, DOI 10.1089/rej.2011.1153
   Cabreiro F, 2013, EMBO MOL MED, V5, P1300, DOI 10.1002/emmm.201100972
   Cabreiro F, 2013, CELL, V153, P228, DOI 10.1016/j.cell.2013.02.035
   Cao J, 2014, J BIOL CHEM, V289, P20435, DOI 10.1074/jbc.M114.567271
   Cazzaniga M, 2013, BRIT J CANCER, V109, P2792, DOI 10.1038/bjc.2013.657
   Chen SN, 2013, CURR DRUG METAB, V14, P1070, DOI 10.2174/1389200214666131211153933
   Cho YM, 2011, DIABETOLOGIA, V54, P219, DOI 10.1007/s00125-010-1986-3
   Choi CI, 2008, J NEUROL SCI, V268, P40, DOI 10.1016/j.jns.2007.10.024
   Collier CA, 2006, AM J PHYSIOL-ENDOC M, V291, pE182, DOI 10.1152/ajpendo.00272.2005
   Contreras C, 2013, HORM METAB RES, V45, P935, DOI 10.1055/s-0033-1351281
   de Cabo R, 2014, CELL, V157, P1515, DOI 10.1016/j.cell.2014.05.031
   De Haes W, 2014, P NATL ACAD SCI USA, V111, pE2501, DOI 10.1073/pnas.1321776111
   Dhahbi JM, 2005, PHYSIOL GENOMICS, V23, P343, DOI 10.1152/physiolgenomics.00069.2005
   Diamanti-Kandarakis E, 2010, EUR J ENDOCRINOL, V162, P193, DOI 10.1530/EJE-09-0733
   Dowling RJO, 2007, CANCER RES, V67, P10804, DOI 10.1158/0008-5472.CAN-07-2310
   El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223
   Eurich DT, 2013, CIRC-HEART FAIL, V6, P395, DOI 10.1161/CIRCHEARTFAILURE.112.000162
   Fontaine Eric, 2014, Biochem J, V463, pe3, DOI 10.1042/BJ20141020
   Foretz M, 2014, CELL METAB, V20, P953, DOI 10.1016/j.cmet.2014.09.018
   Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671
   Fullerton MD, 2013, NAT MED, V19, P1649, DOI 10.1038/nm.3372
   Glueck CJ, 2001, METABOLISM, V50, P856, DOI 10.1053/meta.2001.24192
   Gong L, 2012, PHARMACOGENET GENOM, V22, P820, DOI 10.1097/FPC.0b013e3283559b22
   Greenhill Claire, 2015, Nat Rev Gastroenterol Hepatol, V12, P124, DOI 10.1038/nrgastro.2015.9
   Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007
   Gunton JE, 2003, J CLIN ENDOCR METAB, V88, P1323, DOI 10.1210/jc.2002-021394
   Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311
   Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420
   Hirsch HA, 2013, P NATL ACAD SCI USA, V110, P972, DOI 10.1073/pnas.1221055110
   Hong J, 2013, DIABETES CARE, V36, P1304, DOI 10.2337/dc12-0719
   Isoda K, 2006, ARTERIOSCL THROM VAS, V26, P611, DOI 10.1161/01.ATV.0000201938.78044.75
   Jafari M, 2007, BIOGERONTOLOGY, V8, P639, DOI 10.1007/s10522-007-9105-7
   Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861
   Kalender A, 2010, CELL METAB, V11, P390, DOI 10.1016/j.cmet.2010.03.014
   Kaneb HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024189
   Kim MH, 2014, J ENDOCRINOL, V220, P117, DOI 10.1530/JOE-13-0381
   Kim YD, 2008, DIABETES, V57, P306, DOI 10.2337/db07-0381
   Kita Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043056
   Ko EM, 2015, GYNECOL ONCOL, V136, P341, DOI 10.1016/j.ygyno.2014.12.001
   Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967
   Lapierre LR, 2012, TRENDS ENDOCRIN MET, V23, P637, DOI 10.1016/j.tem.2012.07.007
   Larue BL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016790
   Laskov I, 2014, GYNECOL ONCOL, V134, P607, DOI 10.1016/j.ygyno.2014.06.014
   Lenaerts I, 2008, J GERONTOL A-BIOL, V63, P242, DOI 10.1093/gerona/63.3.242
   Li WG, 2012, DIABETES RES CLIN PR, V96, P187, DOI 10.1016/j.diabres.2011.12.028
   Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009
   Lin JJ, 2015, AM J RESP CRIT CARE, V191, P448, DOI 10.1164/rccm.201407-1395OC
   Logie L, 2012, DIABETES, V61, P1423, DOI 10.2337/db11-0961
   Ma TC, 2007, NEUROSCI LETT, V411, P98, DOI 10.1016/j.neulet.2006.10.039
   Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270
   Mahmood K, 2013, EUR J INTERN MED, V24, P20, DOI 10.1016/j.ejim.2012.10.011
   Maida A, 2011, DIABETOLOGIA, V54, P339, DOI 10.1007/s00125-010-1937-z
   Martin-Castillo B, 2010, CELL CYCLE, V9, P1057, DOI 10.4161/cc.9.6.10994
   Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192
   Menendez JA, 2011, AGING-US, V3, P348, DOI 10.18632/aging.100316
   Meng SM, 2015, J BIOL CHEM, V290, P3793, DOI 10.1074/jbc.M114.604421
   Mercken EM, 2012, AGEING RES REV, V11, P390, DOI 10.1016/j.arr.2011.11.005
   Miles JM, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0490-4
   Miller RA, 2013, NATURE, V494, P256, DOI 10.1038/nature11808
   Na HJ, 2013, MECH AGEING DEV, V134, P381, DOI 10.1016/j.mad.2013.07.003
   Ng TP, 2014, J ALZHEIMERS DIS, V41, P61, DOI 10.3233/JAD-131901
   Olsen A, 2006, ANN NY ACAD SCI, V1067, P120, DOI 10.1196/annals.1354.015
   Onken B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008758
   Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607
   Patrone C, 2014, LANCET DIABETES ENDO, V2, P256, DOI 10.1016/S2213-8587(13)70125-6
   Pawlyk AC, 2014, DIABETES, V63, P2590, DOI 10.2337/db13-1367
   Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011
   Pernicova I, 2014, NAT REV ENDOCRINOL, V10, P143, DOI 10.1038/nrendo.2013.256
   Pulito C, 2014, ANN TRANSL MED, V2, DOI 10.3978/j.issn.2305-5839.2014.06.03
   Rego DF, 2015, ORAL ONCOL, V51, P416, DOI 10.1016/j.oraloncology.2015.01.007
   Rice S, 2009, ENDOCRINOLOGY, V150, P4794, DOI 10.1210/en.2009-0540
   Scarpello JHB, 2003, DIABETES METAB, V29, pS36
   Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011
   Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221
   Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781
   Shoshani T, 2002, MOL CELL BIOL, V22, P2283, DOI 10.1128/MCB.22.7.2283-2293.2002
   Slack C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047699
   Smith DL, 2010, J GERONTOL A-BIOL, V65, P468, DOI 10.1093/gerona/glq033
   Spindler SR, 2006, AGING CELL, V5, P39, DOI 10.1111/j.1474-9726.2006.00194.x
   Stenesen D, 2013, CELL METAB, V17, P101, DOI 10.1016/j.cmet.2012.12.006
   Stephenne X, 2011, DIABETOLOGIA, V54, P3101, DOI 10.1007/s00125-011-2311-5
   Stevanovic D, 2012, NEUROENDOCRINOLOGY, V96, P24, DOI 10.1159/000333963
   Tohyama D, 2010, BIOCHEM BIOPH RES CO, V394, P112, DOI 10.1016/j.bbrc.2010.02.126
   Wang CP, 2014, J ENDOCRINOL DIABETE, V2, P1030
   Woo SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091111
   Yin M, 2013, ONCOLOGIST, V18, P1248, DOI 10.1634/theoncologist.2013-0111
   Yuan L, 2003, ACTA PHARMACOL SIN, V24, P55
   Zarse K, 2012, CELL METAB, V15, P451, DOI 10.1016/j.cmet.2012.02.013
   Zhang G, 2013, NATURE, V497, P211, DOI 10.1038/nature12143
   Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505
   Zou MH, 2004, J BIOL CHEM, V279, P43940, DOI 10.1074/jbc.M404421200
NR 110
TC 96
Z9 105
U1 3
U2 31
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI COLD SPRING HARBOR
PA 1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA
SN 2157-1422
J9 CSH PERSPECT MED
JI Cold Spring Harb. Perspect. Med.
PD MAR
PY 2016
VL 6
IS 3
AR a025932
DI 10.1101/cshperspect.a025932
PG 12
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA DF2LX
UT WOS:000371175800005
PM 26931809
OA Green Published, Bronze
DA 2024-02-19
ER

PT J
AU Wang, YF
   Zheng, Q
   Sun, Z
   Wang, CH
   Cen, J
   Zhang, XJ
   Jin, Y
   Wu, BH
   Yan, TT
   Wang, ZY
   Gu, QX
   Lv, XY
   Nan, JJ
   Wu, ZY
   Sun, WB
   Pan, GY
   Zhang, LD
   Hui, LJ
   Cai, XJ
AF Wang, Yifan
   Zheng, Qiang
   Sun, Zhen
   Wang, Chenhua
   Cen, Jin
   Zhang, Xinjie
   Jin, Yan
   Wu, Baihua
   Yan, Tingting
   Wang, Ziyuan
   Gu, Qiuxia
   Lv, Xingyu
   Nan, Junjie
   Wu, Zhongyu
   Sun, Wenbin
   Pan, Guoyu
   Zhang, Ludi
   Hui, Lijian
   Cai, Xiujun
TI Report Reversal of liver failure using a bioartificial liver device
   implanted with clinical-grade human-induced hepatocytes
SO CELL STEM CELL
LA English
DT Article; Early Access
ID PORCINE MODEL; GENE-EXPRESSION; IN-VITRO; HEPATECTOMY; CELLS;
   FIBROBLASTS; SENESCENCE; ALPPS; TRIAL
AB Liver resection is the first-line treatment for primary liver cancers, providing the potential for a cure. However, concerns about post-hepatectomy liver failure (PHLF), a leading cause of death following extended liver resection, have restricted the population of eligible patients. Here, we engineered a clinical-grade bioartificial liver (BAL) device employing human-induced hepatocytes (hiHeps) manufactured under GMP conditions. In a porcine PHLF model, the hiHep-BAL treatment showed a remarkable survival benefit. On top of the support-ive function, hiHep-BAL treatment restored functions, specifically ammonia detoxification, of the remnant liver and facilitated liver regeneration. Notably, an investigator-initiated study in seven patients with extended liver resection demonstrated that hiHep-BAL treatment was well tolerated and associated with improved liver function and liver regeneration, meeting the primary outcome of safety and feasibility. These encouraging re-sults warrant further testing of hiHep-BAL for PHLF, the success of which would broaden the population of patients eligible for liver resection.
C1 [Wang, Yifan; Zheng, Qiang; Zhang, Xinjie; Jin, Yan; Yan, Tingting; Wang, Ziyuan; Gu, Qiuxia; Lv, Xingyu; Nan, Junjie; Wu, Zhongyu; Cai, Xiujun] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Gen Surg, Hangzhou 310016, Peoples R China.
   [Wang, Yifan; Cai, Xiujun] Zhejiang Minimal Invas Diag & Treatment Technol Re, Hangzhou 310016, Peoples R China.
   [Wang, Yifan; Cai, Xiujun] Key Lab Laparoscop Technol Zhejiang Prov, Hangzhou 310016, Peoples R China.
   [Sun, Zhen; Hui, Lijian] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China.
   [Wang, Chenhua; Cen, Jin; Wu, Baihua; Zhang, Ludi; Hui, Lijian] Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, CAS Ctr Excellence Mol Cell Sci,State Key Lab Cel, Shanghai 200031, Peoples R China.
   [Sun, Wenbin] Univ Chinese Acad Sci, Hangzhou Inst Adv Study, Sch Life Sci, Hangzhou 310024, Peoples R China.
   [Pan, Guoyu] Chinese Acad Sci, Shanghai Inst Materia Med, Shanghai 201203, Peoples R China.
C3 Zhejiang University; ShanghaiTech University; Chinese Academy of
   Sciences; Center for Excellence in Molecular Cell Science, CAS;
   University of Chinese Academy of Sciences, CAS; Chinese Academy of
   Sciences; University of Chinese Academy of Sciences, CAS; Chinese
   Academy of Sciences; Shanghai Institute of Materia Medica, CAS
RP Cai, XJ (corresponding author), Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Gen Surg, Hangzhou 310016, Peoples R China.; Cai, XJ (corresponding author), Zhejiang Minimal Invas Diag & Treatment Technol Re, Hangzhou 310016, Peoples R China.; Cai, XJ (corresponding author), Key Lab Laparoscop Technol Zhejiang Prov, Hangzhou 310016, Peoples R China.; Hui, LJ (corresponding author), ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China.; Zhang, LD; Hui, LJ (corresponding author), Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, CAS Ctr Excellence Mol Cell Sci,State Key Lab Cel, Shanghai 200031, Peoples R China.
EM zhangludi@sibcb.ac.cn; ljhui@sibcb.ac.cn; srrsh_cxj@zju.edu.cn
RI Zhang, Yunxuan/IXD-9283-2023; li, qing/JEF-9044-2023; li,
   song/JVO-5938-2024
FU National Key Research and Development Project [2020YFA0112503,
   2020YFC2002803]; "Strategic Priority Research Program" of the Chinese
   Academy of Sciences (CAS) [XDA16020201]; National Natural Science
   Foundation of China (NSFC) [32221002, 32070797]; Shanghai Municipal
   Commission for Science and Technology [22JC1403001]; Key Research and
   Development Project of Zhejiang Province [2018C03083, 2020C03122]; Youth
   Innovation Promotion Association CAS; SA-SIBS Scholarship Program
FX We are thankful to Drs. John Lake (University of Minnesota) and Ira Fox
   (University of Pittsburgh) for their critical suggestions during
   manuscript prepara-tion and Jingqi Wu, Yajing Shu (CEMCS) , Dongni Lin
   (Shanghai Jiao Tong University) , Qi Xue, E Tian, Chenxi Yang, and
   Xusheng Ding (Hexaell Biotech) for cell manufacture. We are grateful to
   the patients who participated in this study and their families. This
   project was supported by the National Key Research and Development
   Project (2020YFA0112503 and 2020YFC2002803) , the "Strategic Priority
   Research Program" of the Chinese Academy of Sciences (CAS, XDA16020201)
   , the National Natural Science Foundation of China (NSFC) (32221002 and
   32070797) , Shanghai Municipal Commission for Science and Technology
   (22JC1403001) , Key Research and Development Project of Zhejiang
   Province (2018C03083 and 2020C03122) , the Youth Innovation Promotion
   Association CAS, and the SA-SIBS Scholarship Program.
CR Aldridge DR, 2015, J CLIN EXP HEPATOL, V5, pS7, DOI 10.1016/j.jceh.2014.06.004
   Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638
   Arkadopoulos N, 2011, J SURG RES, V170, pE233, DOI 10.1016/j.jss.2011.06.006
   Baccarani U, 2004, AM J TRANSPLANT, V4, P286, DOI 10.1046/j.1600-6143.2003.00310.x
   Carpentier B, 2009, GUT, V58, P1690, DOI 10.1136/gut.2008.175380
   Chamuleau RAFM, 2006, THER APHER DIAL, V10, P168, DOI 10.1111/j.1744-9987.2006.00359.x
   Chang BD, 2000, P NATL ACAD SCI USA, V97, P4291, DOI 10.1073/pnas.97.8.4291
   Chen HS, 2019, HEPATOLOGY, V69, P329, DOI 10.1002/hep.30184
   Chen ST, 2020, CELL RES, V30, DOI 10.1038/s41422-019-0261-5
   Court FG, 2004, J SURG RES, V116, P181, DOI 10.1016/j.jss.2003.08.007
   Court FG, 2003, BRIT J SURG, V90, P440, DOI 10.1002/bjs.4053
   de Santibañes E, 2012, ANN SURG, V255, P415, DOI 10.1097/SLA.0b013e318248577d
   Dimitroulis D, 2014, WORLD J GASTROENTERO, V20, P7887, DOI 10.3748/wjg.v20.i24.7887
   Du YY, 2014, CELL STEM CELL, V14, P394, DOI 10.1016/j.stem.2014.01.008
   Forner A, 2018, LANCET, V391, P1301, DOI 10.1016/S0140-6736(18)30010-2
   Fu GB, 2019, CELL RES, V29, P8, DOI 10.1038/s41422-018-0103-x
   Gao YM, 2017, STEM CELL REP, V9, P1813, DOI 10.1016/j.stemcr.2017.10.019
   Henderson JM, 2004, ANN SURG, V239, P667
   Hoppo T, 2011, GASTROENTEROLOGY, V140, P656, DOI 10.1053/j.gastro.2010.11.006
   Huang PY, 2014, CELL STEM CELL, V14, P370, DOI 10.1016/j.stem.2014.01.003
   ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6
   Jin S, 2013, WORLD J GASTROENTERO, V19, P7983, DOI 10.3748/wjg.v19.i44.7983
   KANEMATSU T, 1985, ARCH SURG-CHICAGO, V120, P1303
   Katsuda T, 2019, ELIFE, V8, DOI 10.7554/eLife.47313
   Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]
   Kim Y, 2019, J HEPATOL, V70, P97, DOI 10.1016/j.jhep.2018.09.007
   Ladurner R, 2005, EUR SURG RES, V37, P365, DOI 10.1159/000090338
   Lehmann K, 2012, GASTROENTEROLOGY, V143, P1609, DOI 10.1053/j.gastro.2012.08.043
   Lewis PS, 2020, J HEPATOL, V73, P349, DOI 10.1016/j.jhep.2020.02.031
   Li D, 2016, HEPATOLOGY, V64, P1105, DOI [10.1002/hep.28637, 10.1002/hep.28837]
   Li WJ, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aba5146
   Li ZW, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1967-5
   Linecker M, 2016, ANN SURG, V264, P763, DOI 10.1097/SLA.0000000000001914
   Liu Y, 2008, COMPARATIVE MED, V58, P580
   Llovet JM, 2021, NAT REV DIS PRIMERS, V7, DOI 10.1038/s41572-020-00240-3
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Makuuchi Masatoshi, 2013, Int J Surg, V11 Suppl 1, pS47, DOI 10.1016/S1743-9191(13)60015-1
   Mazariegos GV, 2001, ASAIO J, V47, P471, DOI 10.1097/00002480-200109000-00015
   Michalopoulos GK, 2021, NAT REV GASTRO HEPAT, V18, P40, DOI 10.1038/s41575-020-0342-4
   Nyberg SL, 2012, LIVER TRANSPLANT, V18, pS10, DOI 10.1002/lt.23506
   Rahbari NN, 2011, SURGERY, V149, P713, DOI 10.1016/j.surg.2010.10.001
   Sampaziotis F, 2015, HEPATOLOGY, V62, P303, DOI 10.1002/hep.27651
   Samuel D, 2002, TRANSPLANTATION, V73, P257, DOI 10.1097/00007890-200201270-00019
   [桑剑锋 Sang Jianfeng], 2017, [中国实验动物学报, Acta Laboratorium Animalis Scientia Sinica], V25, P174
   Sauer IM, 2003, J HEPATOL, V39, P649, DOI 10.1016/S0168-8278(03)00348-9
   Shi XL, 2016, CELL RES, V26, P206, DOI 10.1038/cr.2016.6
   Soreide JA, 2021, EJSO-EUR J SURG ONC, V47, P216, DOI 10.1016/j.ejso.2020.09.001
   Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016
   van Wenum M, 2014, EXPERT OPIN BIOL TH, V14, P1745, DOI 10.1517/14712598.2014.950651
   Wang Y, 2017, JOVE-J VIS EXP, DOI 10.3791/55355
   Wüstefeld T, 2000, HEPATOLOGY, V32, P514, DOI 10.1053/jhep.2000.16604
   Zhang K, 2018, CELL STEM CELL, V23, P806, DOI 10.1016/j.stem.2018.10.018
   Zhou J, 2018, LIVER CANCER, V7, P235, DOI 10.1159/000488035
NR 53
TC 4
Z9 4
U1 13
U2 20
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1934-5909
EI 1875-9777
J9 CELL STEM CELL
JI Cell Stem Cell
PD 2023 MAY 4
PY 2023
VL 30
IS 5
BP 617
EP +
DI 10.1016/j.stem.2023.03.013
EA MAY 2023
PG 24
WC Cell & Tissue Engineering; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA I9ZR6
UT WOS:001006296100001
PM 37059100
OA hybrid
DA 2024-02-19
ER

PT J
AU Kim, HS
   Je, JH
   Son, TG
   Park, HR
   Ji, ST
   Pokharel, YR
   Jeon, HM
   Kang, KW
   Kang, HS
   Chang, SC
   Kim, HS
   Chung, HY
   Lee, J
AF Kim, Hyun Soo
   Je, Jeong Hwan
   Son, Tae Gen
   Park, Hee Ra
   Ji, Seung Taek
   Pokharel, Yuba Raj
   Jeon, Hyun Min
   Kang, Keon Wook
   Kang, Ho Sung
   Chang, Seung-Cheol
   Kim, Hyung Sik
   Chung, Hae Young
   Lee, Jaewon
TI The hepatoprotective effects of adenine nucleotide translocator-2
   against aging and oxidative stress
SO FREE RADICAL RESEARCH
LA English
DT Article
DE adenine nucleotide translocator-2; aging; liver fibrosis; mitochondrial
   membrane potential; oxidative stress
ID MITOCHONDRIAL PERMEABILITY TRANSITION; CELL-DEATH; IN-VIVO; APOPTOSIS;
   HEPATOCYTES; BUTYLHYDROPEROXIDE; DEFICIENCY; EXPRESSION; DISEASE; ANT1
AB Mitochondrial adenine nucleotide translocator (ANT) plays important roles in the regulation of mitochondrial permeability transition and cell bioenergetics. The mouse has three ANT isoforms (1, 2 and 4) showing tissue-specific expression patterns. Although ANT1 is known to have a pro-apoptotic property, the specific functions of ANT2 have not been well determined. In the present study, ANT2 expression was significantly lower in the aged rat liver and in a liver fibrosis model. To explore the protective role of ANT2 in the liver, we established a hepa1c1c7 cell line overexpressing ANT2. Overexpression of ANT2 caused hepa1c1c7 cells to be more resistant to oxidative stress, and mitochondrial membrane potential (MMP, Delta Psi m) was relatively intact in ANT2-overexpressing cells under oxidative stress. In addition, ANT2 was found to increase ATP production by influencing mitochondrial bioenergetics. These results imply that the hepatoprotective effect of ANT2 is due to the stabilization of MMP and enhanced ATP production, and thus, maintaining ANT2 levels in the liver might be important to enhance resistance to aging and oxidative stress.
C1 [Kim, Hyun Soo; Je, Jeong Hwan; Son, Tae Gen; Park, Hee Ra; Ji, Seung Taek; Kim, Hyung Sik; Chung, Hae Young; Lee, Jaewon] Pusan Natl Univ, Dept Pharm, Coll Pharm, Pusan 609735, South Korea.
   [Kim, Hyun Soo; Je, Jeong Hwan; Son, Tae Gen; Park, Hee Ra; Ji, Seung Taek; Kim, Hyung Sik; Chung, Hae Young; Lee, Jaewon] Pusan Natl Univ, Res Inst Drug Dev, Mol Inflammat Res Ctr Aging Intervent, Longev Life Sci Inst, Pusan 609735, South Korea.
   [Kim, Hyun Soo; Je, Jeong Hwan; Son, Tae Gen; Park, Hee Ra; Ji, Seung Taek; Kim, Hyung Sik; Chung, Hae Young; Lee, Jaewon] Pusan Natl Univ, Res Inst Drug Dev, Mol Inflammat Res Ctr Aging Intervent, Longev Technol Inst, Pusan 609735, South Korea.
   [Je, Jeong Hwan] Natl Acad Agr Sci, Rural Dev Adm, Suwon, South Korea.
   [Pokharel, Yuba Raj] Chosun Univ, Coll Pharm, Kwangju, South Korea.
   [Jeon, Hyun Min] Pusan Natl Univ, Dept Mol Biol, Coll Nat Sci, Pusan 609735, South Korea.
   [Kang, Keon Wook] Seoul Natl Univ, Coll Pharm, Seoul, South Korea.
   [Son, Tae Gen] Dongnam Inst Radiol & Med Sci, Res Ctr, Dept Expt Radiat, Pusan, South Korea.
   [Chang, Seung-Cheol] Pusan Natl Univ, Inst BioPhysio Sensor Technol, Pusan, South Korea.
C3 Pusan National University; Pusan National University; Pusan National
   University; Rural Development Administration (RDA); Chosun University;
   Pusan National University; Seoul National University (SNU); Korea
   Institute of Radiological & Medical Sciences; Pusan National University
RP Lee, J (corresponding author), Pusan Natl Univ, Dept Pharm, Coll Pharm, Pusan 609735, South Korea.
EM neuron@pusan.ac.kr
RI Lee, Jaewon/N-9064-2013; Lee, Jaewon/IQR-8432-2023; chang,
   seung-cheol/K-8778-2017; Pokharel, Yuba/Q-3927-2018
OI Lee, Jaewon/0000-0003-3203-2130; Pokharel, Yuba/0000-0002-1202-5120;
   Chang, Seung-Cheol/0000-0002-2333-9424
FU National Research Foundation of Korea (NRF); Ministry of Education,
   Science and Technology [KRF-2008-331-C00260]
FX This research was supported by the Basic Science Research Program
   through the National Research Foundation of Korea (NRF) funded by the
   Ministry of Education, Science and Technology (grant no.
   KRF-2008-331-C00260). The authors report no conflicts of interest. The
   authors alone are responsible for the content and writing of the paper.
CR Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   Belzacq AS, 2001, ONCOGENE, V20, P7579, DOI 10.1038/sj.onc.1204953
   Brower JV, 2007, J BIOL CHEM, V282, P29658, DOI 10.1074/jbc.M704386200
   Byrne AM, 1999, HEPATOLOGY, V29, P1523, DOI 10.1002/hep.510290521
   Eguchi Y, 1997, CANCER RES, V57, P1835
   Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820
   Galganska H, 2010, BBA-BIOENERGETICS, V1797, P1276, DOI 10.1016/j.bbabio.2010.02.004
   Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226
   HARMAN D, 1957, J GERONTOL, V12, P199, DOI 10.1093/geronj/12.2.199
   Hyde BB, 2010, SEMIN CELL DEV BIOL, V21, P575, DOI 10.1016/j.semcdb.2010.01.003
   Jang JY, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1857
   Jang JY, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-160
   Lee J, 2009, BBA-BIOENERGETICS, V1787, P364, DOI 10.1016/j.bbabio.2009.01.014
   Levy SE, 2000, GENE, V254, P57, DOI 10.1016/S0378-1119(00)00252-3
   Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317
   NIEMINEN AL, 1995, BIOCHEM J, V307, P99, DOI 10.1042/bj3070099
   Qian T, 1999, TOXICOL APPL PHARM, V154, P117, DOI 10.1006/taap.1998.8580
   Richter C, 1996, FEBS LETT, V378, P107, DOI 10.1016/0014-5793(95)01431-4
   Sharer JD, 2005, IUBMB LIFE, V57, P607, DOI 10.1080/15216540500217735
   Shimizu S, 1998, P NATL ACAD SCI USA, V95, P1455, DOI 10.1073/pnas.95.4.1455
   Truscott KN, 2010, BIOCHEM CELL BIOL, V88, P97, DOI [10.1139/O09-167, 10.1139/o09-167]
   Van Remmen H, 2001, EXP GERONTOL, V36, P957
   Zamora M, 2004, FEBS LETT, V563, P155, DOI 10.1016/S0014-5793(04)00293-5
NR 23
TC 11
Z9 11
U1 1
U2 8
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 1071-5762
J9 FREE RADICAL RES
JI Free Radic. Res.
PD JAN
PY 2012
VL 46
IS 1
BP 21
EP 29
DI 10.3109/10715762.2011.636042
PG 9
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 858PV
UT WOS:000297814900004
PM 22034909
DA 2024-02-19
ER

PT J
AU NISHITA, T
   KANOU, T
   ASARI, M
   KOBUNE, K
AF NISHITA, T
   KANOU, T
   ASARI, M
   KOBUNE, K
TI DETERMINATION AND DEVELOPMENTAL-CHANGES IN CARBONIC ANHYDRASE-III IN
   SWINE LIVER
SO COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR
   BIOLOGY
LA English
DT Article
ID SENSITIVE ENZYME-IMMUNOASSAY; SKELETAL-MUSCLE; GROWTH-HORMONE;
   RAT-LIVER; DIFFERENTIATION; PURIFICATION; LOCALIZATION; TISSUES; SEX
AB 1.  CA-III was measured by enzyme-immunoassay in the livers of male and female swine aged from the fetus to 5 years old.
   2.  No sexual dimorphism in porcine liver could be detected at 6 months, but stag showed twice as much as swine of the same age.
   3.  The concentration of CA-III in the liver increased during development up to 6 months of age, followed by decline due to senescence.
C1 AZABU UNIV,SCH VET MED,VET ANAT LAB,KANAGAWA 229,JAPAN.
C3 Azabu University
RP NISHITA, T (corresponding author), AZABU UNIV,SCH VET MED,VET PHYSIOL LAB,1-17-71 SAGAMIHARA,KANAGAWA 229,JAPAN.
CR CARTER N, 1979, BIOCHEM GENET, V17, P837, DOI 10.1007/BF00504307
   CARTER ND, 1984, ANN NY ACAD SCI, V429, P287, DOI 10.1111/j.1749-6632.1984.tb12352.x
   DUBREUIL P, 1988, DOMEST ANIM ENDOCRIN, V5, P157, DOI 10.1016/0739-7240(88)90016-1
   ENGBERG P, 1985, ARCH BIOCHEM BIOPHYS, V241, P628, DOI 10.1016/0003-9861(85)90589-2
   JEFFERY S, 1988, BIOCHEM J, V250, P303, DOI 10.1042/bj2500303
   JEFFERY S, 1984, FEBS LETT, V175, P129, DOI 10.1016/0014-5793(84)80584-0
   JEFFERY S, 1980, BIOCHEM GENET, V18, P843, DOI 10.1007/BF00500117
   JEFFERY S, 1990, BIOCHEM J, V266, P69, DOI 10.1042/bj2660069
   KATO K, 1984, CLIN CHIM ACTA, V141, P169
   MODE A, 1982, ENDOCRINOLOGY, V111, P1692, DOI 10.1210/endo-111-5-1692
   NISHITA T, 1981, BIOCHEM BIOPH RES CO, V103, P573, DOI 10.1016/0006-291X(81)90490-3
   NISHITA T, 1987, EQUINE VET J, V19, P509, DOI 10.1111/j.2042-3306.1987.tb02660.x
   NISHITA T, 1990, EQUINE VET J, V22, P247, DOI 10.1111/j.2042-3306.1990.tb04262.x
   NISHITA T, 1988, COMP BIOCHEM PHYS B, V91, P91, DOI 10.1016/0305-0491(88)90118-6
   PULLAN LM, 1985, BIOCHIM BIOPHYS ACTA, V839, P147, DOI 10.1016/0304-4165(85)90031-5
   REGISTER AM, 1978, J BIOL CHEM, V253, P4143
   SHIELS A, 1983, BIOSCIENCE REP, V3, P475, DOI 10.1007/BF01121959
   SHIELS A, 1983, BIOCHIM BIOPHYS ACTA, V760, P335, DOI 10.1016/0304-4165(83)90370-7
   SHIMA K, 1983, ACTA NEUROPATHOL, V59, P237, DOI 10.1007/BF00703210
   SIERS DG, 1971, J ANIM SCI, V32, P1229, DOI 10.2527/jas1971.3261229x
NR 20
TC 1
Z9 1
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0305-0491
J9 COMP BIOCHEM PHYS B
JI Comp. Biochem. Physiol. B-Biochem. Mol. Biol.
PD JAN-FEB
PY 1992
VL 101
IS 1-2
BP 231
EP 233
DI 10.1016/0305-0491(92)90184-S
PG 3
WC Biochemistry & Molecular Biology; Zoology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Zoology
GA HG019
UT WOS:A1992HG01900036
PM 1499269
DA 2024-02-19
ER

PT J
AU Bailey-Downs, LC
   Mitschelen, M
   Sosnowska, D
   Toth, P
   Pinto, JT
   Ballabh, P
   Valcarcel-Ares, MN
   Farley, J
   Koller, A
   Henthorn, JC
   Bass, C
   Sonntag, WE
   Ungvari, Z
   Csiszar, A
AF Bailey-Downs, Lora C.
   Mitschelen, Matthew
   Sosnowska, Danuta
   Toth, Peter
   Pinto, John T.
   Ballabh, Praveen
   Valcarcel-Ares, M. Noa
   Farley, Julie
   Koller, Akos
   Henthorn, Jim C.
   Bass, Caroline
   Sonntag, William E.
   Ungvari, Zoltan
   Csiszar, Anna
TI Liver-Specific Knockdown of IGF-1 Decreases Vascular Oxidative Stress
   Resistance by Impairing the Nrf2-Dependent Antioxidant Response: A Novel
   Model of Vascular Aging
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
DE vascular aging; endocrine
ID GROWTH-FACTOR-I; AMES DWARF MICE; HEME OXYGENASE-1 EXPRESSION;
   AGE-RELATED PATHOLOGY; KAPPA-B ACTIVATION; TRANSCRIPTION FACTOR;
   ENDOTHELIAL DYSFUNCTION; CARDIOVASCULAR-DISEASE; PREMATURE MORTALITY;
   HEART-FAILURE
AB Recent studies demonstrate that age-related dysfunction of NF-E2-related factor-2 (Nrf2)-driven pathways impairs cellular redox homeostasis, exacerbating age-related cellular oxidative stress and increasing sensitivity of aged vessels to oxidative stress-induced cellular damage. Circulating levels of insulin-like growth factor (IGF)-1 decline during aging, which significantly increases the risk for cardiovascular diseases in humans. To test the hypothesis that adult-onset IGF-1 deficiency impairs Nrf2-driven pathways in the vasculature, we utilized a novel mouse model with a liver-specific adeno-associated viral knockdown of the Igf1 gene using Cre-lox technology (Igf1(f/f) + MUP-iCre-AAV8), which exhibits a significant decrease in circulating IGF-1 levels (similar to 50%). In the aortas of IGF-1-deficient mice, there was a trend for decreased expression of Nrf2 and the Nrf2 target genes GCLC, NQO1 and HMOX1. In cultured aorta segments of IGF-1-deficient mice treated with oxidative stressors (high glucose, oxidized low-density lipoprotein, and H2O2), induction of Nrf2-driven genes was significantly attenuated as compared with control vessels, which was associated with an exacerbation of endothelial dysfunction, increased oxidative stress, and apoptosis, mimicking the aging phenotype. In conclusion, endocrine IGF-1 deficiency is associated with dysregulation of Nrf2-dependent antioxidant responses in the vasculature, which likely promotes an adverse vascular phenotype under pathophysiological conditions associated with oxidative stress (eg, diabetes mellitus, hypertension) and results in accelerated vascular impairments in aging.
C1 [Bailey-Downs, Lora C.; Mitschelen, Matthew; Sosnowska, Danuta; Toth, Peter; Valcarcel-Ares, M. Noa; Farley, Julie; Henthorn, Jim C.; Sonntag, William E.; Ungvari, Zoltan; Csiszar, Anna] Univ Oklahoma, Hlth Sci Ctr, Donald W Reynolds Dept Geriatr Med, Reynolds Oklahoma Ctr Aging, Oklahoma City, OK 73104 USA.
   [Pinto, John T.] New York Med Coll, Dept Biochem, Valhalla, NY 10595 USA.
   [Pinto, John T.; Koller, Akos] New York Med Coll, Dept Physiol, Valhalla, NY 10595 USA.
   [Ballabh, Praveen] New York Med Coll, Dept Pediat, Valhalla, NY 10595 USA.
   [Ballabh, Praveen] New York Med Coll, Dept Anat & Cell Biol, Valhalla, NY 10595 USA.
   [Koller, Akos] Univ Pecs, Sch Med, Dept Pathophysiol & Gerontol, Pecs, Hungary.
   [Bass, Caroline] Wake Forest Univ Hlth Sci, Dept Physiol, Winston Salem, NC USA.
   [Bass, Caroline] Wake Forest Univ Hlth Sci, Dept Pharmacol, Winston Salem, NC USA.
C3 University of Oklahoma System; University of Oklahoma Health Sciences
   Center; New York Medical College; New York Medical College; New York
   Medical College; New York Medical College; University of Pecs; Wake
   Forest University; Wake Forest University School of Medicine; Wake
   Forest University; Wake Forest University School of Medicine
RP Csiszar, A (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Geriatr Med, Reynolds Oklahoma Ctr Aging, 975N E 10th St,BRC 1303, Oklahoma City, OK 73104 USA.
EM anna-csiszar@ouhsc.edu
RI Wrong, Wrong/ADU-0095-2022; Ungvari, Zoltan/GZK-8127-2022; Ákos,
   Koller/Q-4672-2019
OI Bass, Caroline/0000-0002-5856-6387; sonntag,
   William/0000-0003-1850-2407; Valcarcel-Ares, Marta
   Noa/0000-0003-0668-8961
FU American Diabetes Association; American Federation for Aging Research;
   Oklahoma Center for the Advancement of Science and Technology;
   University of Oklahoma College of Medicine Alumni Association; American
   Heart Association; National Institutes of Health [AG031085, AT006526,
   AG038747, NS056218, P01 AG11370]; Donald W. Reynolds Foundation
FX This work was supported by grants from the American Diabetes Association
   (to Z.U.), American Federation for Aging Research (to A.C.), the
   Oklahoma Center for the Advancement of Science and Technology (to A.C.
   and Z.U.), the University of Oklahoma College of Medicine Alumni
   Association (to A.C.), the American Heart Association (A.C.), and the
   National Institutes of Health (AG031085 to A.C.; AT006526 to Z.U.;
   AG038747, NS056218, and P01 AG11370 to W.E.S.).; The authors would like
   to thank Dr. S. Yakar for the Igf-1<SUP>f/f</SUP> animals and express
   their gratitude for the support of the Donald W. Reynolds Foundation,
   which funds aging research at the University of Oklahoma Health Sciences
   Center under its Aging and Quality of Life Program.
CR Bates AS, 1996, J CLIN ENDOCR METAB, V81, P1169, DOI 10.1210/jc.81.3.1169
   Bokov AF, 2009, J GERONTOL A-BIOL, V64, P819, DOI 10.1093/gerona/glp052
   BREESE CR, 1991, J GERONTOL, V46, pB180, DOI 10.1093/geronj/46.5.B180
   Bulow B, 1997, CLIN ENDOCRINOL, V46, P75, DOI 10.1046/j.1365-2265.1997.d01-1749.x
   Collins AR, 2009, CIRC RES, V104, pe42, DOI 10.1161/CIRCRESAHA.108.188771
   Conover CA, 2010, J GERONTOL A-BIOL, V65, P590, DOI 10.1093/gerona/glq032
   Csiszar A, 2004, PHYSIOL GENOMICS, V17, P21, DOI 10.1152/physiolgenomics.00136.2003
   Csiszar A, 2002, CIRC RES, V90, P1159, DOI 10.1161/01.RES.0000020401.61826.EA
   Csiszar A, 2008, AM J PHYSIOL-HEART C, V295, pH1882, DOI 10.1152/ajpheart.412.2008
   Csiszar A, 2008, J APPL PHYSIOL, V105, P1333, DOI 10.1152/japplphysiol.90470.2008
   Csiszar A, 2007, AGING CELL, V6, P783, DOI 10.1111/j.1474-9726.2007.00339.x
   Csiszar A, 2007, AM J PATHOL, V170, P388, DOI 10.2353/ajpath.2007.060708
   Csiszar A, 2006, AM J PHYSIOL-HEART C, V291, pH1694, DOI 10.1152/ajpheart.00340.2006
   Csiszar A, 2009, MECH AGEING DEV, V130, P518, DOI 10.1016/j.mad.2009.06.004
   DCOSTA AP, 1993, J REPROD FERTIL, P87
   Delafontaine P, 2004, ARTERIOSCL THROM VAS, V24, P435, DOI 10.1161/01.ATV.0000105902.89459.09
   Denti L, 2004, AM J MED, V117, P312, DOI 10.1016/j.amjmed.2004.02.049
   Evans LM, 1999, CLIN ENDOCRINOL, V50, P457
   Feng J, 2011, J CELL BIOCHEM, V112, P1524, DOI 10.1002/jcb.23065
   Forman K, 2011, J GERONTOL A-BIOL, V66, P823, DOI 10.1093/gerona/glr083
   Guevara-Aguirre J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001845
   Harper JM, 2007, AGING CELL, V6, P1, DOI 10.1111/j.1474-9726.2006.00255.x
   Harper JM, 2006, MECH AGEING DEV, V127, P687, DOI 10.1016/j.mad.2006.04.002
   Hauck SJ, 2002, HORM METAB RES, V34, P481, DOI 10.1055/s-2002-34787
   Higashi Y, 2010, TRENDS ENDOCRIN MET, V21, P245, DOI 10.1016/j.tem.2009.12.005
   Ho KJ, 2008, AM J PHYSIOL-GASTR L, V295, pG412, DOI 10.1152/ajpgi.00590.2007
   Hsieh CC, 2009, AGING-US, V1, P784, DOI 10.18632/aging.100077
   Kaplan RC, 2008, AM HEART J, V155, P1006, DOI 10.1016/j.ahj.2007.12.031
   Kennedy MA, 2003, EXP GERONTOL, V38, P997, DOI 10.1016/S0531-5565(03)00164-5
   Khan AS, 2002, CARDIOVASC RES, V54, P25, DOI 10.1016/S0008-6363(01)00533-8
   Kwak MK, 2002, MOL CELL BIOL, V22, P2883, DOI 10.1128/MCB.22.9.2883-2892.2002
   Labinskyy N, 2009, AM J PHYSIOL-HEART C, V296, pH946, DOI 10.1152/ajpheart.00693.2008
   Laughlin GA, 2004, J CLIN ENDOCR METAB, V89, P114, DOI 10.1210/jc.2003-030967
   Li YX, 2003, ARTERIOSCL THROM VAS, V23, P2178, DOI 10.1161/01.ATV.0000099788.31333.DB
   Liu JL, 1998, MOL ENDOCRINOL, V12, P1452, DOI 10.1210/me.12.9.1452
   Louis A, 2010, J GERONTOL A-BIOL, V65, P344, DOI 10.1093/gerona/glq018
   Martin D, 2004, J BIOL CHEM, V279, P8919, DOI 10.1074/jbc.M309660200
   Masternak MM, 2010, J GERONTOL A-BIOL, V65, P24, DOI 10.1093/gerona/glp172
   Mitschelen M, 2011, NEUROSCIENCE, V185, P50, DOI 10.1016/j.neuroscience.2011.04.032
   Morrison CD, 2010, J NEUROCHEM, V114, P1581, DOI 10.1111/j.1471-4159.2010.06865.x
   Oflaz H, 2007, CLIN ENDOCRINOL, V66, P524, DOI 10.1111/j.1365-2265.2007.02767.x
   Okouchi M, 2006, CURR NEUROVASC RES, V3, P249, DOI 10.2174/156720206778792876
   Panici JA, 2010, FASEB J, V24, P5073, DOI 10.1096/fj.10-163253
   Panici JA, 2009, J GERONTOL A-BIOL, V64, P1126, DOI 10.1093/gerona/glp111
   Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011
   Pearson KJ, 2008, P NATL ACAD SCI USA, V105, P2325, DOI 10.1073/pnas.0712162105
   ROSEN T, 1990, LANCET, V336, P285, DOI 10.1016/0140-6736(90)91812-O
   Roubenoff R, 2003, AM J MED, V115, P429, DOI 10.1016/j.amjmed.2003.05.001
   RUDMAN D, 1981, J CLIN INVEST, V67, P1361, DOI 10.1172/JCI110164
   Shai SY, 2011, AM J PHYSIOL-HEART C, V300, pH1898, DOI 10.1152/ajpheart.01081.2010
   Shai SY, 2010, ARTERIOSCL THROM VAS, V30, P1916, DOI 10.1161/ATVBAHA.110.210831
   Sharma S, 2010, EXP GERONTOL, V45, P936, DOI 10.1016/j.exger.2010.08.013
   Sonntag WE, 2005, ENDOCRINOLOGY, V146, P2920, DOI 10.1210/en.2005-0058
   Sukhanov S, 2007, ARTERIOSCL THROM VAS, V27, P2684, DOI 10.1161/ATVBAHA.107.156257
   Sun LY, 2005, NEUROBIOL AGING, V26, P929, DOI 10.1016/j.neurobiolaging.2004.07.010
   Tomlinson JW, 2001, LANCET, V357, P425, DOI 10.1016/S0140-6736(00)04006-X
   Ungvari Z, 2008, CIRC RES, V102, P519, DOI 10.1161/CIRCRESAHA.107.168369
   Ungvari Z, 2008, AM J PHYSIOL-HEART C, V294, pH2121, DOI 10.1152/ajpheart.00012.2008
   Ungvari Z, 2007, AM J PHYSIOL-HEART C, V293, pH37, DOI 10.1152/ajpheart.01346.2006
   Ungvari Z, 2011, J GERONTOL A-BIOL, V66, P866, DOI 10.1093/gerona/glr092
   Ungvari Z, 2011, AM J PHYSIOL-HEART C, V301, pH363, DOI 10.1152/ajpheart.01134.2010
   Ungvari Z, 2011, J GERONTOL A-BIOL, V66, P741, DOI 10.1093/gerona/glr044
   Ungvari Z, 2011, J GERONTOL A-BIOL, V66, P501, DOI 10.1093/gerona/glr004
   Ungvari Z, 2011, AM J PHYSIOL-HEART C, V300, pH1133, DOI 10.1152/ajpheart.00402.2010
   Ungvari Z, 2010, J GERONTOL A-BIOL, V65, P1145, DOI 10.1093/gerona/glq147
   Ungvari Z, 2010, J GERONTOL A-BIOL, V65, P1028, DOI 10.1093/gerona/glq113
   Ungvari Z, 2010, AM J PHYSIOL-HEART C, V299, pH18, DOI 10.1152/ajpheart.00260.2010
   Vasan RS, 2003, ANN INTERN MED, V139, P642, DOI 10.7326/0003-4819-139-8-200310210-00007
   Wang JW, 1997, J CLIN INVEST, V100, P1425, DOI 10.1172/JCI119663
NR 69
TC 133
Z9 139
U1 2
U2 11
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD APR
PY 2012
VL 67
IS 4
BP 313
EP 329
DI 10.1093/gerona/glr164
PG 17
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA 914TE
UT WOS:000301974500001
PM 22021391
OA Bronze, Green Published
DA 2024-02-19
ER

PT J
AU Pouget, M
   Perrot, M
   Denis, P
   Vuichoud, J
   Dardevet, D
   Vidal, K
   Breuillé, D
   Papet, I
AF Pouget, Melanie
   Perrot, Marie
   Denis, Philippe
   Vuichoud, Jacques
   Dardevet, Dominique
   Vidal, Karine
   Breuille, Denis
   Papet, Isabelle
TI Long-term dietary supplementation with cystathionine improves tissue
   glutathione in ageing rats
SO AGING CLINICAL AND EXPERIMENTAL RESEARCH
LA English
DT Article
DE Ageing; Cystathionine; Glutathione; Acute phase proteins; Rat
ID OLDER-PEOPLE; CYSTEINE; METABOLISM; FRAILTY
AB Background Ageing is associated with decrease in tissue glutathione that can be reduced by food fortification with the amino acid cysteine. However, cysteine is not stable in solution and generates bad taste. Cystathionine, the direct precursor of cysteine, could be a valuable alternative.
   Aims This study aimed to determine whether long-term dietary supplementation with cystathionine induces an increase in glutathione pools.
   Methods Aged rats (20.5-month-old) were fed ad libitum during 29 weeks with either a cystathionine-supplemented diet (7.3 g/kg, n = 90 rats) or a control iso-nitrogenous alanine-supplemented diet (2.9 g/kg, n = 90 rats).
   Results Cystathionine was detected in the plasma of the cystathionine-supplemented rats but not in the control alanine-supplemented rats. Cystathionine increased glutathione concentrations in liver, small intestine and gastrocnemius muscle (P < 0.03). No adverse effect was observed.
   Conclusion Cystathionine supplementation being able to increase moderately glutathione in healthy old rats could be considered as a candidate for nutritional supports aiming to revert the stronger glutathione depletions occurring in unhealthy elderly.
C1 [Pouget, Melanie; Denis, Philippe; Dardevet, Dominique; Papet, Isabelle] Clermont Univ, Univ Auvergne, Unite Nutr Humaine, BP 10448, F-63000 Clermont Ferrand, France.
   [Pouget, Melanie; Denis, Philippe; Dardevet, Dominique; Papet, Isabelle] UNH, CRNH Auvergne, INRA, UMR 1019, F-63000 Clermont Ferrand, France.
   [Perrot, Marie] Nestle Res Ctr, Dept Taste & Behav Sci, CH-10000 Lausanne 26, Switzerland.
   [Vuichoud, Jacques; Vidal, Karine; Breuille, Denis] Nestle Res Ctr, Dept Nutr & Hlth, CH-10000 Lausanne 26, Switzerland.
C3 Universite Clermont Auvergne (UCA); INRAE; Nestle SA; Nestle SA
RP Papet, I (corresponding author), Clermont Univ, Univ Auvergne, Unite Nutr Humaine, BP 10448, F-63000 Clermont Ferrand, France.; Papet, I (corresponding author), UNH, CRNH Auvergne, INRA, UMR 1019, F-63000 Clermont Ferrand, France.
EM Isabelle.Papet@clermont.inra.fr
RI Dardevet, Dominique/IAM-3666-2023
OI Dardevet, Dominique/0000-0001-7320-9970
FU Institut National de la Recherche Agronomique (INRA), France; Nestec
   Ltd, Switzerland
FX This work was supported by Institut National de la Recherche Agronomique
   (INRA), France and Nestec Ltd, Switzerland.
CR Abdulla A, 2013, AGE AGEING, V42, pI1, DOI 10.1093/ageing/afs200
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   BREUILLE D, 1997, CLIN NUTR, V16, P17
   Cho MK, 2001, BIOCHEM PHARMACOL, V61, P15, DOI 10.1016/S0006-2952(00)00518-9
   Kawai M, 2012, AMINO ACIDS, V43, P2349, DOI 10.1007/s00726-012-1315-x
   KITAMURA Y, 1989, J PHARMACOL EXP THER, V250, P667
   Koponen MPH, 2013, DRUG AGING, V30, P129, DOI 10.1007/s40266-012-0046-8
   Lu SC, 2013, BBA-GEN SUBJECTS, V1830, P3143, DOI 10.1016/j.bbagen.2012.09.008
   Malmezat T, 1998, J NUTR, V128, P97, DOI 10.1093/jn/128.1.97
   Mayot G, 2007, EXP GERONTOL, V42, P498, DOI 10.1016/j.exger.2007.01.003
   Mosoni L, 2004, EXP GERONTOL, V39, P203, DOI 10.1016/j.exger.2003.10.014
   R Development Core Team, 2011, LANG ENV STAT COMP
   Stipanuk MH, 2011, J INHERIT METAB DIS, V34, P17, DOI 10.1007/s10545-009-9006-9
   Vidal K, 2014, EUR J NUTR, V53, P963, DOI 10.1007/s00394-013-0600-0
   Wu JH, 2013, BBA-GEN SUBJECTS, V1830, P3350, DOI 10.1016/j.bbagen.2012.11.016
NR 15
TC 2
Z9 2
U1 0
U2 9
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1594-0667
EI 1720-8319
J9 AGING CLIN EXP RES
JI Aging Clin. Exp. Res.
PD AUG
PY 2016
VL 28
IS 4
BP 781
EP 785
DI 10.1007/s40520-015-0465-6
PG 5
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA DQ2LW
UT WOS:000379034800026
PM 26514972
DA 2024-02-19
ER

PT J
AU Meier, P
   Seitz, HK
AF Meier, Patrick
   Seitz, Helmut K.
TI Age, alcohol metabolism and liver disease
SO CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
LA English
DT Article
DE age; alcohol; alcoholic liver disease; ethanol metabolism
ID DEHYDROGENASE ACTIVITY; 1ST-PASS METABOLISM; ETHANOL; MECHANISMS;
   CONSUMPTION; INGESTION; FIBROSIS; ANTIGEN
AB Purpose of review
   Alcohol consumption among the elderly has increased. Alcohol metabolism changes with age and the elderly are more sensitive to the toxic effects; this increased consumption is therefore of great clinical relevance.
   Recent findings
   Metabolism of ethanol changes with advancing age because activity of the enzymes involved, such as alcohol and acetalclehyde dehydrogenase and cytochrome P-4502E1, diminish with age. The water distribution volume also decreases with age. Both lead to increased blood concentrations of ethanol. Also, elderly people take more drugs, and ethanol and these drugs may interact; therefore, alcohol consumption can modify serum drug concentrations and their toxicity. Finally, elderly people may suffer more frequently from other types of liver disease, and alcohol may exacerbate these.
   Summary
   Over recent decades alcohol consumption has increased among those who are older than 65 years. Alcohol is more toxic in the ageing organism because of changes in its metabolism, distribution and elimination, which lead to central nervous system effects at lower levels of intake; also, ageing organs such as brain and liver are more sensitive to the toxicity of alcohol. For these reasons, alcohol should be used in moderation, especially among those of older age.
C1 [Meier, Patrick; Seitz, Helmut K.] Salem Med Ctr, Dept Med, D-69121 Heidelberg, Germany.
   [Meier, Patrick; Seitz, Helmut K.] Salem Med Ctr, Lab Alcohol Res Liver Dis & Nutr, D-69121 Heidelberg, Germany.
RP Seitz, HK (corresponding author), Salem Med Ctr, Dept Med, Zeppelinstr 11-33, D-69121 Heidelberg, Germany.
EM helmut_karl.seitz@urz.uni-heidelberg.de
CR Albano E, 2002, ETHANOL AND THE LIVER: MECHANISMS AND MANAGEMENT, P153
   Allen JR, 1996, JAMA-J AM MED ASSOC, V275, P797
   Ammon E, 1996, CLIN PHARMACOL THER, V59, P503, DOI 10.1016/S0009-9236(96)90178-2
   BENDER AD, 1965, J AM GERIATR SOC, V13, P192, DOI 10.1111/j.1532-5415.1965.tb02665.x
   Clot P, 1996, GASTROENTEROLOGY, V111, P206, DOI 10.1053/gast.1996.v111.pm8698201
   CLOT P, 1995, GASTROENTEROLOGY, V108, P201, DOI 10.1016/0016-5085(95)90025-X
   Cusack Barry J, 2004, Am J Geriatr Pharmacother, V2, P274, DOI 10.1016/j.amjopharm.2004.12.005
   Dan Z, 2005, FASEB J, V19, P845, DOI 10.1096/fj.04-2809fje
   Dupont I, 1998, J HEPATOL, V28, P564, DOI 10.1016/S0168-8278(98)80279-1
   FELVER ME, 1990, ALCOHOL CLIN EXP RES, V14, P255, DOI 10.1111/j.1530-0277.1990.tb00482.x
   FEUERLEIN W, 1998, ALCOHOLISM MISUSE DE
   Frank A, 2004, CARCINOGENESIS, V25, P1027, DOI 10.1093/carcin/bgh089
   Gartner U, 1996, Z GASTROENTEROL, V34, P675
   Gouillon ZQ, 2000, P SOC EXP BIOL MED, V224, P302, DOI 10.1046/j.1525-1373.2000.22435.x
   IBER FL, 1986, NUTR AGING, P169
   JOHN W, 2006, GERIATRICS, V61, P23
   LIEBER CS, 1994, GASTROENTEROLOGY, V106, P1085, DOI 10.1016/0016-5085(94)90772-2
   Mirand AL, 1996, AM J PUBLIC HEALTH, V86, P978, DOI 10.2105/AJPH.86.7.978
   Mundle G, 1997, SUCHT, V43, P201
   OHNISHI K, 1982, CANCER, V49, P672, DOI 10.1002/1097-0142(19820215)49:4<672::AID-CNCR2820490415>3.0.CO;2-#
   Oneta CM, 1998, GUT, V43, P612, DOI 10.1136/gut.43.5.612
   Oneta CM, 2001, Z GASTROENTEROL, V39, P783, DOI 10.1055/s-2001-17196
   Pedrosa MC, 1996, SCAND J GASTROENTERO, V31, P671, DOI 10.3109/00365529609009148
   Piguet O, 2006, EUR ARCH PSY CLIN N, V256, P504, DOI 10.1007/s00406-006-0671-5
   Purohit V, 2006, HEPATOLOGY, V43, P872, DOI 10.1002/hep.21107
   ROINE R, 1990, JAMA-J AM MED ASSOC, V264, P2406, DOI 10.1001/jama.264.18.2406
   Sawabe M, 2006, PATHOL INT, V56, P315, DOI 10.1111/j.1440-1827.2006.01966.x
   SCHUCKIT MA, 1982, J CLIN PSYCHIAT, V43, P396
   Seitz HK, 2007, FALK SYMP, V157, P16, DOI 10.1007/978-1-4020-6523-1_2
   Seitz HK, 2007, CLIN GERIATR MED, V23, P905, DOI 10.1016/j.cger.2007.06.010
   Seitz HK, 2007, NAT REV CANCER, V7, P599, DOI 10.1038/nrc2191
   Seitz HK, 2006, BIOL CHEM, V387, P349, DOI 10.1515/BC.2006.047
   SEITZ HK, 1993, GUT, V34, P1433, DOI 10.1136/gut.34.10.1433
   SEITZ HK, 1989, GASTROENTEROLOGY, V97, P446, DOI 10.1016/0016-5085(89)90082-6
   SEITZ HK, 1990, NEW ENGL J MED, V323, P58
   Seitz HK, 1998, NUTR REV, V56, P52, DOI 10.1111/j.1753-4887.1998.tb01692.x
   SEITZ HK, 1992, RES EXP MED, V192, P205, DOI 10.1007/BF02576276
   SEITZ HK, 2007, IN PRESS CLIN HEPATO
   Simanowski UA, 1998, DIGESTION, V59, P314, DOI 10.1159/000007508
   *SWISS FED STAT OF, 2006, POP GROWTH DEM AG VI
   Westin J, 2002, J VIRAL HEPATITIS, V9, P235, DOI 10.1046/j.1365-2893.2002.00356.x
   Wynne Hilary, 2005, J Br Menopause Soc, V11, P51, DOI 10.1258/136218005775544589
   Yin M, 2001, J IMMUNOL, V166, P4737, DOI 10.4049/jimmunol.166.7.4737
NR 43
TC 141
Z9 162
U1 4
U2 29
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1363-1950
EI 1473-6519
J9 CURR OPIN CLIN NUTR
JI Curr. Opin. Clin. Nutr. Metab. Care
PD JAN
PY 2008
VL 11
IS 1
BP 21
EP 26
DI 10.1097/MCO.0b013e3282f30564
PG 6
WC Endocrinology & Metabolism; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA 247HO
UT WOS:000252069300004
PM 18090653
DA 2024-02-19
ER

PT J
AU Carrillo-Carrasco, N
   Chandler, RJ
   Chandrasekaran, S
   Venditti, CP
AF Carrillo-Carrasco, Nuria
   Chandler, Randy J.
   Chandrasekaran, Suma
   Venditti, Charles P.
TI Liver-Directed Recombinant Adeno-Associated Viral Gene Delivery Rescues
   a Lethal Mouse Model of Methylmalonic Acidemia and Provides Long-Term
   Phenotypic Correction
SO HUMAN GENE THERAPY
LA English
DT Article
ID COA MUTASE DEFICIENCY; KIDNEY TRANSPLANTATION; PROPIONIC ACIDURIA;
   MASS-SPECTROMETRY; SKELETAL-MUSCLE; INBORN ERROR; METABOLISM;
   MANAGEMENT; THERAPY; EXPRESSION
AB Methylmalonic acidemia is a severe metabolic disorder caused by a deficiency of the ubiquitously expressed mitochondrial enzyme, methylmalonyl-CoA mutase (MUT). Liver transplantation has been used to treat a small number of patients with variable success, and whether liver-directed gene therapy might be employed in such a pleiotropic metabolic disorder is uncertain. In this study, we examined the therapeutic effects of hepatocyte-directed delivery of the Mut gene to mice with a severe form of methylmalonic acidemia. We show that a single intrahepatic injection of recombinant adeno-associated virus serotype 8 expressing the Mut gene under the control of the liver-specific thyroxine-binding globulin (TBG) promoter is sufficient to rescue Mut(-/-) mice from neonatal lethality and provide long-term phenotypic correction. Treated Mut(-/-) mice lived beyond 1 year of age, had improved growth, lower plasma methylmalonic acid levels, and an increased capacity to oxidize [1-(13)C] propionate in vivo. The older treated mice showed increased Mut transcription, presumably mediated by upregulation of the TBG promoter during senescence. The results indicate that the stable transduction of a small number of hepatocytes with the Mut gene can be efficacious in the phenotypic correction of an inborn error of organic acid metabolism and support the rapid translation of liver-directed gene therapy vectors already optimized for human subjects to patients with methylmalonic acidemia.
C1 [Carrillo-Carrasco, Nuria; Chandler, Randy J.; Chandrasekaran, Suma; Venditti, Charles P.] NHGRI, Organ Acid Res Sect, Genet & Mol Biol Branch, NIH, Bethesda, MD 20892 USA.
   [Chandler, Randy J.] George Washington Univ, Inst Biomed Sci, Washington, DC 20052 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Human Genome
   Research Institute (NHGRI); George Washington University
RP Venditti, CP (corresponding author), NHGRI, Organ Acid Res Sect, Genet & Mol Biol Branch, NIH, Bldg 49 Room 4A18, Bethesda, MD 20892 USA.
EM venditti@mail.nih.gov
RI Carrillo-Carrasco, Nuria/B-9034-2009; Chandler, Randy Joseph/Y-1164-2019
OI Carrillo-Carrasco, Nuria/0000-0003-0374-0808; Chandler, Randy
   Joseph/0000-0002-6047-5230
FU National Human Genome Research Institute, National Institutes of Health
FX The authors thank Stephen Wincovitch for confocal microscopy guidance,
   Denise Larson for performing frozen sections of liver, Cherry Yang and
   Irene Ginty for mouse care and technical assistance, David M. Bodine IV
   for providing a critical reading of the manuscript, and the University
   of Pennsylvania Vector Core for AAV preparations and advice. N.C.C.,
   R.J.C., S. C., and C. P. V. were supported, in part, by the Intramural
   Research Program of the National Human Genome Research Institute,
   National Institutes of Health.
CR ALLEN RH, 1993, METABOLISM, V42, P978, DOI 10.1016/0026-0495(93)90010-L
   Brantly ML, 2009, P NATL ACAD SCI USA, V106, P16363, DOI 10.1073/pnas.0904514106
   Chandler RJ, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-64
   Chandler RJ, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-24
   Chandler RJ, 2008, HUM GENE THER, V19, P53, DOI 10.1089/hum.2007.0118
   Chandler RJ, 2010, MOL THER, V18, P11, DOI 10.1038/mt.2009.247
   Chandler RJ, 2009, FASEB J, V23, P1252, DOI 10.1096/fj.08-121848
   de Baulny HO, 2005, J INHERIT METAB DIS, V28, P415, DOI 10.1007/s10545-005-7056-1
   de Keyzer Y, 2009, PEDIATR RES, V66, P91, DOI 10.1203/PDR.0b013e3181a7c270
   Dionisi-Vici C, 2006, J INHERIT METAB DIS, V29, P383, DOI 10.1007/s10545-006-0278-z
   Fenton WA, 2001, METABOLIC MOL BASES, P2165
   Franco LM, 2005, MOL THER, V12, P876, DOI 10.1016/j.ymthe.2005.04.024
   Gao GP, 2002, P NATL ACAD SCI USA, V99, P11854, DOI 10.1073/pnas.182412299
   HAYASAKA K, 1982, TOHOKU J EXP MED, V137, P329, DOI 10.1620/tjem.137.329
   HAYASHI Y, 1993, MOL ENDOCRINOL, V7, P1049, DOI 10.1210/me.7.8.1049
   Hörster F, 2007, PEDIATR RES, V62, P225
   Hsui Jui-Yu, 2003, Acta Paediatrica Taiwanica, V44, P171
   Kaplan P, 2006, MOL GENET METAB, V88, P322, DOI 10.1016/j.ymgme.2006.04.003
   Kasahara M, 2006, PEDIATR TRANSPLANT, V10, P943, DOI 10.1111/j.1399-3046.2006.00585.x
   Kayler LK, 2002, PEDIATR TRANSPLANT, V6, P295, DOI 10.1034/j.1399-3046.2002.02009.x
   KRAHENBUHL S, 1991, J BIOL CHEM, V266, P20998
   Lebherz C, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-15
   Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358
   MARCELL PD, 1985, ANAL BIOCHEM, V150, P58, DOI 10.1016/0003-2697(85)90440-3
   MATSUI SM, 1983, NEW ENGL J MED, V308, P857, DOI 10.1056/NEJM198304143081501
   Morioka D, 2007, AM J TRANSPLANT, V7, P2782, DOI 10.1111/j.1600-6143.2007.01986.x
   Moscioni D, 2006, MOL THER, V14, P25, DOI 10.1016/j.ymthe.2006.03.009
   Nagarajan S, 2005, J INHERIT METAB DIS, V28, P517, DOI 10.1007/s10545-005-0517-8
   Nicolaides P, 1998, ARCH DIS CHILD, V78, P508, DOI 10.1136/adc.78.6.508
   Nyhan WL, 2002, EUR J PEDIATR, V161, P377, DOI 10.1007/s00431-002-0970-4
   OBERHOLZ.VG, 1967, ARCH DIS CHILD, V42, P492, DOI 10.1136/adc.42.225.492
   SAVU L, 1991, BIOCHIM BIOPHYS ACTA, V1097, P19, DOI 10.1016/0925-4439(91)90017-4
   STOKKE O, 1967, SCAND J CLIN LAB INV, V20, P313, DOI 10.3109/00365516709076961
   van't Hoff WG, 1998, J PEDIATR-US, V132, P1043, DOI 10.1016/S0022-3476(98)70407-X
   VANDERMEER SB, 1994, J PEDIATR-US, V125, P903, DOI 10.1016/S0022-3476(05)82005-0
   Wang LL, 2010, MOL THER, V18, P126, DOI 10.1038/mt.2009.245
   Wang LL, 2010, MOL THER, V18, P118, DOI 10.1038/mt.2009.246
   WILKEMEYER MF, 1993, BIOCHEM J, V296, P663, DOI 10.1042/bj2960663
   Xiao WD, 1998, J VIROL, V72, P10222, DOI 10.1128/JVI.72.12.10222-10226.1998
NR 39
TC 47
Z9 57
U1 0
U2 5
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1043-0342
J9 HUM GENE THER
JI Hum. Gene Ther.
PD SEP
PY 2010
VL 21
IS 9
BP 1147
EP 1154
DI 10.1089/hum.2010.008
PG 8
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine,
   Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Research &
   Experimental Medicine
GA 648UU
UT WOS:000281720700015
PM 20486773
OA Green Published
DA 2024-02-19
ER

PT J
AU Sasaki, M
   Hsu, M
   Yeh, MM
   Nakanuma, Y
AF Sasaki, Motoko
   Hsu, Maylee
   Yeh, Matthew M.
   Nakanuma, Yasuni
TI In recurrent primary biliary cirrhosis after liver transplantation,
   biliary epithelial cells show increased expression of mitochondrial
   proteins
SO VIRCHOWS ARCHIV
LA English
DT Article
DE Primary biliary cirrhosis; Post-liver transplant rejection; Pyruvate
   dehydrogenase complex-E2 component; Biliary epithelial cell; Autophagy
   and cellular senescence
ID SMALL BILE-DUCTS; CELLULAR SENESCENCE; AUTOPHAGY; P21(WAF1/CIP1);
   REJECTION; TREE
AB In biliary epithelial lesions in primary biliary cirrhosis (PBC), mitochondrial proteins associated with deregulated autophagy are abnormally expressed. We examined whether this could be used as a diagnostic marker for end-stage PBC and recurrent PBC after liver transplantation. We examined the expression of the mitochondrial protein pyruvate dehydrogenase complex-E2 component and cytochrome c oxidase, subunit I (CCO), the autophagy-related marker microtubule-associated protein-light chain 3 (LC3), and p62/sequestosome-1 and the senescence markers p16(Ink4a) and p21(WAF1/Cip1) in small bile ducts and bile ductules in explanted livers from patients with PBC (n = 20) in comparison with liver tissue from control patients (n = 21) and post-transplant samples including recurrent PBC and cellular rejection (n = 28). Intense granular expression of mitochondrial proteins was significantly more frequent in small bile ducts in explanted livers with PBC than in control livers (p < 0.05). Post-transplant samples comprised of three groups: group A (positive for mitochondrial proteins, n = 7), group B (positive for either autophagy-related or senescence markers but negative for mitochondrial proteins, n = 7), and group C (all negative, n = 14). All but one case of group A were clinically and histologically diagnosed as recurrent PBC. In contrast, all cases of group B were diagnosed as cellular rejection. This study suggests that the expression of mitochondrial proteins in small bile ducts may be a useful diagnostic marker for end-stage PBC and recurrent PBC after liver transplantation.
C1 [Sasaki, Motoko; Nakanuma, Yasuni] Kanazawa Univ, Grad Sch Med, Dept Human Pathol, Kanazawa, Ishikawa 9208640, Japan.
   [Hsu, Maylee; Yeh, Matthew M.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA.
   [Nakanuma, Yasuni] Shizuoka Canc Ctr, Div Pathol, Shizuoka, Japan.
C3 Kanazawa University; University of Washington; University of Washington
   Seattle; Shizuoka Cancer Center
RP Sasaki, M (corresponding author), Kanazawa Univ, Grad Sch Med, Dept Human Pathol, Kanazawa, Ishikawa 9208640, Japan.
EM m8sasaki@med.kanazawa-u.ac.jp
RI Sasaki, Motoko/K-5913-2015
OI Sasaki, Motoko/0000-0003-2514-760X
FU Ministry of Education, Culture, Sports and Science and Technology of
   Japan [24590409, 15K08341]; Grants-in-Aid for Scientific Research
   [15K08341, 24590409] Funding Source: KAKEN
FX This study was supported in part by a Grant-in-Aid for Scientific
   Research (C) from the Ministry of Education, Culture, Sports and Science
   and Technology of Japan (24590409 and 15K08341).
CR Brain JG, 2013, AM J TRANSPLANT, V13, P1688, DOI 10.1111/ajt.12271
   Hubscher S, 2012, PATHOLOGY LIVER, P853
   Kaplan MM, 2005, NEW ENGL J MED, V353, P1261, DOI 10.1056/NEJMra043898
   Lindor KD, 2009, HEPATOLOGY, V50, P291, DOI 10.1002/hep.22906
   Lunz JG, 2001, AM J PATHOL, V158, P1379, DOI 10.1016/S0002-9440(10)64089-8
   NAKANUMA Y, 1979, GASTROENTEROLOGY, V76, P1326
   NAKANUMA Y, 1989, HEPATOLOGY, V10, P174, DOI 10.1002/hep.1840100209
   NEUBERGER J, 1995, HEPATOLOGY, V22, P798, DOI 10.1002/hep.1840220316
   Portmann B, 2007, PATHOLOGY LIVER, P517
   Robertson H, 2007, HEPATOLOGY, V45, P977, DOI 10.1002/hep.21624
   Roskams TA, 2004, HEPATOLOGY, V39, P1739, DOI 10.1002/hep.20130
   Sasaki M, 2005, J PATHOL, V205, P451, DOI 10.1002/path.1729
   Sasaki M, 2008, J AUTOIMMUN, V31, P73, DOI 10.1016/j.jaut.2008.03.005
   Sasaki M, 2008, HEPATOLOGY, V48, P186, DOI 10.1002/hep.22348
   Sasaki M, 2006, AM J PATHOL, V169, P831, DOI 10.2353/ajpath.2006.051237
   Sasaki M, 2013, LIVER INT, V33, P312, DOI 10.1111/liv.12049
   Sasaki M, 2012, LIVER INT, V32, P487, DOI 10.1111/j.1478-3231.2011.02656.x
   Sasaki M, 2010, LAB INVEST, V90, P835, DOI 10.1038/labinvest.2010.56
   VandeWater J, 1996, HEPATOLOGY, V24, P1079
NR 19
TC 8
Z9 8
U1 0
U2 4
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0945-6317
EI 1432-2307
J9 VIRCHOWS ARCH
JI Virchows Arch.
PD OCT
PY 2015
VL 467
IS 4
BP 417
EP 425
DI 10.1007/s00428-015-1819-3
PG 9
WC Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology
GA CT8HM
UT WOS:000363055900006
PM 26259963
DA 2024-02-19
ER

PT J
AU Ochoa, JJ
   Quiles, JL
   Ibáñez, S
   Martínez, E
   López-Frías, ML
   Huertas, JR
   Mataix, J
AF Ochoa, JJ
   Quiles, JL
   Ibáñez, S
   Martínez, E
   López-Frías, ML
   Huertas, JR
   Mataix, J
TI Aging-related oxidative stress depends on dietary lipid source in rat
   postmitotic tissues
SO JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
LA English
DT Article
DE aging; lipid peroxidation; dietary fat; olive oil; mitochondria; liver;
   heart; muscle; antioxidants
ID POLYUNSATURATED FATTY-ACIDS; MITOCHONDRIAL COMPOSITION; VITAMIN-E;
   PEROXIDATION; EXERCISE; AGE; OXIDANTS
AB We investigate mitochondrial-lipid peroxidation of mitotic (liver) and postmitotic (heart and skeletal muscle) tissues of rats fed lifelong on two different lipid sources: virgin olive oil (monounsaturated fatty acids) and sunflower oil (n-6 polyunsaturated fatty acids). Two groups of 80 rats each were fed over 24 months on a diet differing in the lipid source (virgin olive oil or sunflower oil). Twenty rats per group were killed at 6, 12, 18, and 24 months; liver, heart, and skeletal muscle mitochondria were isolated and the lipid profile, hydroperoxides, vitamin E, and ubiquinone as well as catalase activity measured. Lipid peroxidation was higher in postmitotic tissues, and sunflower oil led to a higher degree of polyunsaturation and peroxidation. The levels of alpha-tocopherol adapted to oxidative stress and preferentially accumulated during aging in heart and skeletal muscle. In conclusion, the type of dietary fat should be considered in studies on aging, since oxidative stress is directly modulated by this factor. This study confirms that postmitotic tissues are more prone to oxidative stress during aging and proposes a hypothesis to explain this phenomenon.
C1 Univ Granada, Inst Nutr & Food Technol, Dept Physiol, Granada 18071, Spain.
C3 University of Granada
RP Ochoa, JJ (corresponding author), Univ Granada, Inst Nutr & Food Technol, Dept Physiol, C Ramon & Cajal 4, Granada 18071, Spain.
EM jjoh@ugr.es
RI Quiles, José L./C-6911-2013; Ochoa, Julio/L-8733-2014; /AAB-6832-2019;
   Huertas, Jesus Francisco Rodriguez/G-8188-2015
OI Quiles, José L./0000-0002-9048-9086; Ochoa, Julio/0000-0001-8976-6296;
   /0000-0002-8479-4658; Huertas, Jesus Francisco
   Rodriguez/0000-0002-7446-0857
CR AEBI H, 1984, METHOD ENZYMOL, V105, P121
   AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   Barja G, 2002, FREE RADICAL BIO MED, V33, P1167, DOI 10.1016/S0891-5849(02)00910-3
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   Brown-Borg HM, 2000, EXP GERONTOL, V35, P199, DOI 10.1016/S0531-5565(00)00079-6
   Carrié I, 2000, BRIT J NUTR, V83, P439
   DogruAbbasoglu S, 1997, MECH AGEING DEV, V98, P177, DOI 10.1016/S0047-6374(97)00082-1
   Feller SE, 2002, J AM CHEM SOC, V124, P318, DOI 10.1021/ja0118340
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   Fleischer S, 1979, Methods Enzymol, V55, P32
   Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Imre S, 2000, ARCH GERONTOL GERIAT, V31, P5, DOI 10.1016/S0167-4943(00)00058-3
   JIANG ZY, 1992, ANAL BIOCHEM, V202, P384, DOI 10.1016/0003-2697(92)90122-N
   Kipling D, 2001, MATURITAS, V38, P25, DOI 10.1016/S0378-5122(00)00189-4
   Kroger A, 1978, Methods Enzymol, V53, P579
   Lenaz G, 1998, BBA-BIOENERGETICS, V1366, P53, DOI 10.1016/S0005-2728(98)00120-0
   LEPAGE G, 1986, J LIPID RES, V27, P114
   Linnane AW, 2002, ANN NY ACAD SCI, V959, P396, DOI 10.1111/j.1749-6632.2002.tb02110.x
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Lutz M, 1999, LIPIDS, V34, pS119, DOI 10.1007/BF02562256
   Mataix J, 1998, FREE RADICAL BIO MED, V24, P511, DOI 10.1016/S0891-5849(97)00288-8
   Meydani M, 2001, ANN NY ACAD SCI, V928, P226
   Molina H, 1997, MECH AGEING DEV, V97, P1, DOI 10.1016/S0047-6374(97)01876-9
   Ochoa-Herrera JJ, 2001, J NUTR BIOCHEM, V12, P357, DOI 10.1016/S0955-2863(01)00150-4
   Pamplona R, 2000, MECH AGEING DEV, V112, P169, DOI 10.1016/S0047-6374(99)00045-7
   PAMPLONA R, 2002, ANN NY ACAD SCI, V595, P475
   Quiles JL, 2002, J BIOENERG BIOMEMBR, V34, P517, DOI 10.1023/A:1022530512096
   Quiles JL, 2001, J BIOENERG BIOMEMBR, V33, P127, DOI 10.1023/A:1010700515071
   Quiles JL, 1999, INT J VITAM NUTR RES, V69, P243, DOI 10.1024/0300-9831.69.4.243
   Rikans LE, 1997, BBA-MOL BASIS DIS, V1362, P116, DOI 10.1016/S0925-4439(97)00067-7
   Salvioli S, 2001, FEBS LETT, V492, P9, DOI 10.1016/S0014-5793(01)02199-8
   Sohal RS, 2002, FREE RADICAL BIO MED, V33, P575, DOI 10.1016/S0891-5849(02)00886-9
   Souza-Pinto NC, 1999, NUCLEIC ACIDS RES, V27, P1935, DOI 10.1093/nar/27.8.1935
   Trichopoulou A, 2000, BRIT J NUTR, V84, pS205, DOI 10.1079/096582197388554
   ULMANN L, 1991, LIPIDS, V26, P127, DOI 10.1007/BF02544006
   van der Loo B, 2002, CIRCULATION, V105, P1635, DOI 10.1161/01.CIR.0000014986.29834.71
NR 37
TC 45
Z9 45
U1 0
U2 10
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0145-479X
EI 1573-6881
J9 J BIOENERG BIOMEMBR
JI J. Bioenerg. Biomembr.
PD JUN
PY 2003
VL 35
IS 3
BP 267
EP 275
DI 10.1023/A:1024615816839
PG 9
WC Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biophysics; Cell Biology
GA 698JD
UT WOS:000183994500008
PM 13678277
DA 2024-02-19
ER

PT S
AU Oxenkrug, GF
   Requintina, PJ
AF Oxenkrug, GF
   Requintina, PJ
BE Slikker, W
   Andrews, RJ
   Trembly, B
TI Mating attenuates aging-associated increase of lipid peroxidation
   activity in C57BL/6J mice
SO NEUROPROTECTIVE AGENTS
SE Annals of the New York Academy of Sciences
LA English
DT Article; Proceedings Paper
CT 6th International Conference on Neuroprotective Agents
CY SEP 15-19, 2002
CL HILTON HEAD ISL, SC
DE lipid peroxidation; aging; mating; C57BI/6J mice; malonaldehyde and
   4-hydroxyalkenal (MDA plus HAE)
ID BODY-WEIGHT; AGE
AB In the frame of the free-radical hypothesis of aging and literature data on increased life span of mated animals, we evaluated brain, kidney, and liver lipid peroxidation in C57B1/6J mice of various ages and compared lipid peroxidation activity in mated and non-mated mice of both genders. An aging-associated increase (from 3 to 12 months of age) of lipid peroxidation, as measured by malonaldehyde and 4-hydroxyalkenals (MDA+HAE) levels, was observed in the liver and kidney, but not in the brain. Tissue MDA + HAE levels were lower in 12-month old mated mice (housed with animals of opposite gender from three to five months of age) than in 12-month old non-mated animals. There were no gender differences in the observed effect. It is suggested that mating might attenuate the increase of lipid peroxidation associated with aging.
C1 St Elizabeths Med Ctr, Pineal Res Lab, Dept Psychiat, Brighton, MA 02135 USA.
   Tufts Univ, Sch Med, Boston, MA 02111 USA.
   VA Med Ctr, Providence, RI USA.
C3 St. Elizabeth's Medical Center; Tufts University; US Department of
   Veterans Affairs; Veterans Health Administration (VHA); Providence VA
   Medical Center
RP Oxenkrug, GF (corresponding author), St Elizabeths Med Ctr, Pineal Res Lab, Dept Psychiat, QN-3P,736 Cambridge St, Brighton, MA 02135 USA.
EM gregory_oxenkrug@cchcs.org
OI Oxenkrug, Gregory/0000-0002-7193-9117
CR ANSARI KA, 1989, GROWTH DEVELOP AGING, V53, P117
   Barrat FS, 1999, IMMUNOLOGY, V98, P604, DOI 10.1046/j.1365-2567.1999.00918.x
   CINI M, 1995, NEUROBIOL AGING, V16, P53, DOI 10.1016/0197-4580(95)80007-E
   DRORI D, 1969, EXP GERONTOL, V4, P263, DOI 10.1016/0531-5565(69)90014-X
   Exton MS, 2001, PSYCHONEUROENDOCRINO, V26, P287, DOI 10.1016/S0306-4530(00)00053-6
   GARTNER K, 1992, J EXP ANIM SCI, V35, P125
   Gerhard GS, 2002, MECH AGEING DEV, V123, P167, DOI 10.1016/S0047-6374(01)00329-3
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   Head E, 2002, J NEUROCHEM, V82, P375, DOI 10.1046/j.1471-4159.2002.00969.x
   Imre S, 2000, ARCH GERONTOL GERIAT, V31, P5, DOI 10.1016/S0167-4943(00)00058-3
   INGRAM DK, 1982, EXP GERONTOL, V17, P295, DOI 10.1016/0531-5565(82)90019-5
   KNOLL J, 1994, LIFE SCI, V54, P1047, DOI 10.1016/0024-3205(94)00415-3
   Müller HG, 2002, J GERONTOL A-BIOL, V57, pB202, DOI 10.1093/gerona/57.5.B202
   Oxenkrug G, 2001, ANN NY ACAD SCI, V939, P190
   Shingo T, 2003, SCIENCE, V299, P117, DOI 10.1126/science.1076647
   SIEGEL LI, 1981, PHYSIOL BEHAV, V27, P943, DOI 10.1016/0031-9384(81)90065-2
   ULSAN M, 1989, MECH AGEING DEV, V48, P85
   WEIZENBAUM FA, 1981, MECH AGEING DEV, V16, P303, DOI 10.1016/0047-6374(81)90014-2
NR 18
TC 7
Z9 7
U1 0
U2 3
PU NEW YORK ACAD SCIENCES
PI NEW YORK
PA 2 EAST 63RD ST, NEW YORK, NY 10021 USA
SN 0077-8923
BN 1-57331-469-2; 1-57331-468-4
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PY 2003
VL 993
BP 161
EP 167
DI 10.1111/j.1749-6632.2003.tb07526.x
PG 7
WC Multidisciplinary Sciences; Neurosciences
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics; Neurosciences & Neurology
GA BX10T
UT WOS:000184303000021
PM 12853310
DA 2024-02-19
ER

PT J
AU Tveden-Nyborg, P
   Hasselholt, S
   Miyashita, N
   Moos, T
   Poulsen, HE
   Lykkesfeldt, J
AF Tveden-Nyborg, Pernille
   Hasselholt, Stine
   Miyashita, Namiyo
   Moos, Torben
   Poulsen, Henrik E.
   Lykkesfeldt, Jens
TI Chronic Vitamin C Deficiency does not Accelerate Oxidative Stress in
   Ageing Brains of Guinea Pigs
SO BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
LA English
DT Article
ID ASCORBIC-ACID; LIPID-PEROXIDATION; RAT-BRAIN; COGNITIVE PERFORMANCE;
   DEHYDROASCORBIC ACID; BIOLOGICAL SAMPLES; ANTIOXIDANT INTAKE;
   DNA-REPAIR; CELL-DEATH; MITOCHONDRIAL
AB Increased oxidative stress in the brain has consistently been implied in ageing and in several degenerative brain disorders. Acting as a pivotal antioxidant in the brain, vitamin C is preferentially retained during deficiency and may play an essential role in neuroprotection during ageing. Thus, a lack of vitamin C could be associated with an increase in redox imbalance in the ageing brain. The present study compared oxidative stress of ageing to that of a long-term non-scorbutic vitamin C deficiency in guinea pigs. Adults (39 months old) were compared to old (3642 months old) animals during a 6-month dietary intervention by assessing vitamin C transport and redox homoeostasis in the brain. In contrast to our hypothesis, chronic vitamin C deficiency did not affect the measured markers of oxidative stress in the brains of adult and aged animals. However, aged animals generally showed increased lipid oxidation (p < 0.001), decreased glutathione (p < 0.05), increased p53 mRNA expression (p < 0.01) and somewhat elevated DNA oxidation (p = 0.08) compared to adult counterparts irrespective of dietary vitamin C intake. Increased mRNA expression of sod1 (p < 0.05) and svct2 (p = 0.05) was observed in aged animals together with increased superoxide dismutase activity (p < 0.01) and cerebrospinal fluid vitamin C status (p < 0.001) suggesting a compensatory effort that did not counterbalance the effects of ageing. Essentially, no effects of age were observed in the liver demonstrating the brain's unique susceptibility to redox imbalance. Consistent with previous findings, we show that ageing per se constitutes a considerable oxidative insult in the brain. However, our data also suggest that a long-term poor vitamin C status does not accelerate this process.
C1 [Tveden-Nyborg, Pernille; Hasselholt, Stine; Miyashita, Namiyo; Lykkesfeldt, Jens] Univ Copenhagen, Sect Biomed, Dept Dis Biol, Fac Life Sci, Ridebanevej 9, DK-1870 Copenhagen C, Denmark.
   [Moos, Torben] Aalborg Univ, Dept Hlth Sci & Technol, Aalborg, Denmark.
   [Poulsen, Henrik E.] Copenhagen Univ Hosp, Dept Clin Pharmacol Q, Copenhagen, Denmark.
C3 University of Copenhagen; Aalborg University; University of Copenhagen
RP Lykkesfeldt, J (corresponding author), Univ Copenhagen, Sect Biomed, Dept Dis Biol, Fac Life Sci, Ridebanevej 9, DK-1870 Copenhagen C, Denmark.
EM jopl@life.ku.dk
RI Lykkesfeldt, Jens/A-1072-2011
OI Lykkesfeldt, Jens/0000-0002-6514-8407; Poulsen, Henrik
   Enghusen/0000-0003-4242-9924; Moos, Torben/0000-0001-9989-0207;
   Tveden-Nyborg, Pernille/0000-0002-5574-5742
FU Danish National Research Council; University of Copenhagen, Faculty of
   Life Science
FX The authors wish to thank Annie Bjergby Kristensen and Jytte Nielsen for
   excellent technical assistance. This study was supported by grants from
   The Danish National Research Council and the SHARE programme at
   University of Copenhagen, Faculty of Life Science. The authors declare
   no conflicts of interest which could influence the presented work.
CR Ames BN, 2010, MECH AGEING DEV, V131, P473, DOI 10.1016/j.mad.2010.04.005
   Bagh MB, 2011, BIOGERONTOLOGY, V12, P119, DOI 10.1007/s10522-010-9301-8
   BARABAS J, 1995, ARCH GERONTOL GERIAT, V21, P43, DOI 10.1016/0167-4943(95)00654-4
   Barja G, 2000, FASEB J, V14, P312, DOI 10.1096/fasebj.14.2.312
   BARNETT YA, 1995, MUTAT RES-DNAGING G, V338, P115, DOI 10.1016/0921-8734(95)00017-Z
   Berger UV, 2003, J NEUROCHEM, V86, P896, DOI 10.1046/j.1471-4159.2003.01891.x
   Cai QY, 1996, EXP GERONTOL, V31, P373, DOI 10.1016/0531-5565(95)02027-6
   Cenini G, 2008, J CELL MOL MED, V12, P987, DOI 10.1111/j.1582-4934.2008.00163.x
   Clark AG, 2002, MATRIX BIOL, V21, P175, DOI 10.1016/S0945-053X(01)00193-7
   Culmsee Carsten, 2006, Current Alzheimer Research, V3, P269, DOI 10.2174/156720506778249461
   de Pedro-Cuesta J, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-55
   Deschamps V, 2001, NEUROEPIDEMIOLOGY, V20, P7, DOI 10.1159/000054752
   Di Domenico F, 2009, NEUROCHEM RES, V34, P727, DOI 10.1007/s11064-009-9924-9
   Engelhart MJ, 2002, JAMA-J AM MED ASSOC, V287, P3223, DOI 10.1001/jama.287.24.3223
   Fotuhi M, 2008, ALZHEIMERS DEMENT, V4, P223, DOI 10.1016/j.jalz.2008.01.004
   Gedik CM, 2005, FASEB J, V19, P82, DOI 10.1096/fj.04-1767fje
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   Hediger MA, 2002, NAT MED, V8, P445, DOI 10.1038/nm0502-445
   HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2
   KUO CH, 1979, J NUTR SCI VITAMINOL, V25, P9, DOI 10.3177/jnsv.25.9
   Larson EB, 1998, J AM GERIATR SOC, V46, P1576, DOI 10.1111/j.1532-5415.1998.tb01546.x
   LEVINE M, 1985, J BIOL CHEM, V260, P5598
   Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431
   Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661
   Lykkesfeldt J, 2000, ANAL BIOCHEM, V282, P89, DOI 10.1006/abio.2000.4592
   Lykkesfeldt J, 2001, CLIN CHEM, V47, P1725
   Lykkesfeldt J, 2007, BRIT J NUTR, V98, P1116, DOI 10.1017/S0007114507787457
   Lykkesfeldt J, 2007, CANCER EPIDEM BIOMAR, V16, P2513, DOI 10.1158/1055-9965.EPI-07-0639
   Lyuesfeldt J, 2005, MECH AGEING DEV, V126, P892, DOI 10.1016/j.mad.2005.03.010
   MARKLUND S, 1974, EUR J BIOCHEM, V47, P469
   Matthews FE, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000180
   MIELE M, 1994, NEUROSCIENCE, V62, P87, DOI 10.1016/0306-4522(94)90316-6
   Morris MC, 2012, P NUTR SOC, V71, P1, DOI 10.1017/S0029665111003296
   Morris MC, 2002, ARCH NEUROL-CHICAGO, V59, P1125, DOI 10.1001/archneur.59.7.1125
   Mun GH, 2006, J NEUROSCI RES, V83, P919, DOI 10.1002/jnr.20751
   Peacock JM, 2000, PUBLIC HEALTH NUTR, V3, P337, DOI 10.1017/S1368980000000380
   ROSENTHAL M, 1995, J CEREBR BLOOD F MET, V15, P655, DOI 10.1038/jcbfm.1995.81
   Tsukaguchi H, 1999, NATURE, V399, P70, DOI 10.1038/19986
   Tveden-Nyborg P, 2009, REDOX REP, V14, P2, DOI 10.1179/135100009X392412
   Vohra BPS, 2001, INDIAN J BIOCHEM BIO, V38, P321
   Wang Y, 2009, EUR J NEUROSCI, V30, P2258, DOI 10.1111/j.1460-9568.2009.07025.x
   Wengreen HJ, 2007, J NUTR HEALTH AGING, V11, P230
NR 42
TC 23
Z9 24
U1 0
U2 14
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1742-7835
EI 1742-7843
J9 BASIC CLIN PHARMACOL
JI Basic Clin. Pharmacol. Toxicol.
PD JUN
PY 2012
VL 110
IS 6
BP 524
EP 529
DI 10.1111/j.1742-7843.2011.00852.x
PG 6
WC Pharmacology & Pharmacy; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Toxicology
GA 945CY
UT WOS:000304251600007
PM 22212866
DA 2024-02-19
ER

PT J
AU Xiong, YT
   Wang, JF
   Niu, XX
   Fu, YM
   Wang, KX
   Wang, CY
   Li, QQ
   Wang, JJ
   Zhao, J
   Ji, D
AF Xiong, Yu-Ting
   Wang, Jian-Fei
   Niu, Xiao-Xia
   Fu, Yi-Ming
   Wang, Ke-Xin
   Wang, Chun-Yan
   Li, Qian-Qian
   Wang, Jian-Jun
   Zhao, Jun
   Ji, Dong
TI Autoimmunity associates with severity of illness in elderly patients
   with drug-induced liver injury
SO FRONTIERS IN PHARMACOLOGY
LA English
DT Article
DE drug-induced liver injury (DILI); elderly; hepatic fibrosis;
   autoimmunity; liver biopsy
ID CAUSALITY ASSESSMENT; HEPATITIS; DIAGNOSIS; OUTCOMES; CHRONICITY;
   DEFINITION; METABOLISM; MANAGEMENT; FEATURES; AGE
AB Background: Drug-induced liver injury (DILI) is a potentially serious adverse drug reaction. Due to the lack of definite etiology, specific clinical manifestations, and diagnostic methods, its prediction and diagnosis are challenging. Elderly individuals are deemed to be at high risk for DILI due to abnormal pharmacokinetics, aging tissue repair function, comorbidities, and taking multiple drugs. This study aimed to identify the clinical characteristics and explore the risk factors associated with the severity of illness in elderly patients with DILI.Methods: In the present study, the clinical characteristics at the time of liver biopsy of consecutive patients with biopsy-proven DILI who presented at our hospital from June 2005 to September 2022 were evaluated. Hepatic inflammation and fibrosis were assessed according to the Scheuer scoring system. The presence of autoimmunity was considered if IgG level > 1.1 x ULN (1826 mg/dL), or high titer (> 1:80) of ANA, or SMA.Results: In total, 441 patients were enrolled, and the median age was 63.3 years (IQR, 61.0-66.0); 122 (27.7%), 195 (44.2%), or 124 (28.1%) were classified as having minor, moderate, or severe hepatic inflammation, respectively; and 188 (42.6%), 210 (47.6%) or 43 (9.8%) patients presented minor, significant fibrosis or cirrhosis, respectively. Female sex (73.5%) and the cholestatic pattern (47.6%) were dominant in elderly DILI patients. Autoimmunity existed in 201 patients (45.6%). Comorbidities were not directly associated with the severity of DILI. PLT (OR: 0.994, 95% CI: 0.991-0.997; p < 0.001), AST (OR: 1.001, 95% CI: 1.000-1.003, p = 0.012), TBIL (OR: 1.006, 95% CI: 1.003-1.010, p < 0.001), and autoimmunity (OR: 1.831, 95% CI: 1.258-2.672, p = 0.002) were associated with the degree of hepatic inflammation. Meanwhile, PLT (OR: 0.990, 95% CI: 0.986-0.993, p < 0.001), TBIL (OR: 1.004, 95% CI: 1.000-1.007, p = 0.028), age (OR: 1.123, 95% CI: 1.067-1.183, p < 0.001), and autoimmunity (OR: 1.760, 95% CI: 1.191-2.608, p = 0.005) were associated with the stage of hepatic fibrosis.Conclusion: This study revealed that the presence of autoimmunity represents a more serious illness state of DILI, deserving more intensive monitoring and progressive treatment.
C1 [Xiong, Yu-Ting; Niu, Xiao-Xia; Fu, Yi-Ming; Wang, Ke-Xin; Wang, Chun-Yan; Li, Qian-Qian; Wang, Jian-Jun; Zhao, Jun; Ji, Dong] Chinese Peoples Liberat Army Gen Hosp, Dept Hepatol, Med Ctr 5, Beijing, Peoples R China.
   [Xiong, Yu-Ting; Wang, Ke-Xin; Ji, Dong] Anhui Med Univ, Clin Med Coll PLA 307, Beijing, Peoples R China.
   [Wang, Jian-Fei] Chinese Peoples Liberat Army Gen Hosp, Emergency Dept, Med Ctr 7, Beijing, Peoples R China.
   [Zhao, Jun; Ji, Dong] Chinese PLA Med Sch, Beijing, Peoples R China.
C3 Fifth Medical Center of Chinese PLA General Hospital; Chinese People's
   Liberation Army General Hospital; Anhui Medical University; Seventh
   Medical Center of Chinese PLA General Hospital; Chinese People's
   Liberation Army General Hospital
RP Zhao, J; Ji, D (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Hepatol, Med Ctr 5, Beijing, Peoples R China.; Ji, D (corresponding author), Anhui Med Univ, Clin Med Coll PLA 307, Beijing, Peoples R China.; Zhao, J; Ji, D (corresponding author), Chinese PLA Med Sch, Beijing, Peoples R China.
EM jidg302@126.com; zhj68@263.net
RI chen, Chen/JKJ-2122-2023; Li, Qianqian/HKM-8091-2023
OI Li, Qianqian/0000-0001-7716-0481
FU Beijing Municipal Science and Technology Commission [Z181100001718034];
   Beijing Chen Jumei Foundation [2018JM12603003]
FX Funding This work was supported by Beijing Municipal Science and
   Technology Commission (Z181100001718034) and Beijing Chen Jumei
   Foundation (2018JM12603003). The funders had no role in study design,
   data collection, analysis, decision to publish, or preparation of the
   manuscript.
CR Agrawal A, 2012, EXPERT REV CLIN IMMU, V8, P73, DOI [10.1586/eci.11.77, 10.1586/ECI.11.77]
   Aithal GP, 2011, CLIN PHARMACOL THER, V89, P806, DOI 10.1038/clpt.2011.58
   Amacher DE, 2014, HUM EXP TOXICOL, V33, P928, DOI 10.1177/0960327113512860
   Andrade RJ, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0105-0
   Andrade RJ, 2019, J HEPATOL, V70, P1222, DOI 10.1016/j.jhep.2019.02.014
   [Anonymous], 2015, J HEPATOL, V63, P237, DOI 10.1016/j.jhep.2015.04.006
   Ashby K, 2021, J HEPATOL, V75, P333, DOI 10.1016/j.jhep.2021.03.021
   Björnsson ES, 2022, FRONT PHARMACOL, V13, DOI 10.3389/fphar.2022.820724
   Bonkovsky HL, 2017, HEPATOLOGY, V65, P1267, DOI 10.1002/hep.28967
   Chalasani N, 2015, GASTROENTEROLOGY, V148, P1340, DOI 10.1053/j.gastro.2015.03.006
   Chalasani NP, 2021, AM J GASTROENTEROL, V116, P878, DOI 10.14309/ajg.0000000000001259
   Chen MJ, 2015, J HEPATOL, V63, P503, DOI 10.1016/j.jhep.2015.04.016
   Chen MJ, 2011, DRUG DISCOV TODAY, V16, P697, DOI 10.1016/j.drudis.2011.05.007
   DANAN G, 1993, J CLIN EPIDEMIOL, V46, P1323, DOI 10.1016/0895-4356(93)90101-6
   de Boer YS, 2017, CLIN GASTROENTEROL H, V15, P103, DOI 10.1016/j.cgh.2016.05.043
   deLemos AS, 2014, SEMIN LIVER DIS, V34, P194, DOI 10.1055/s-0034-1375959
   EASL, 2016, DIABETOLOGIA, V59, P1121, DOI 10.1007/s00125-016-3902-y
   Foureau DM, 2015, CLIN EXP IMMUNOL, V180, P40, DOI 10.1111/cei.12558
   García-Cortés M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040537
   Gerussi A, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22094557
   Grewal P, 2019, WORLD J GASTROENTERO, V25, P6704, DOI 10.3748/wjg.v25.i46.6704
   He TT, 2022, CLIN RES HEPATOL GAS, V46, DOI 10.1016/j.clinre.2022.102009
   Hirschfield GM, 2017, J HEPATOL, V67, P145, DOI 10.1016/j.jhep.2017.03.022
   Hunt CM, 2014, REGUL TOXICOL PHARM, V70, P519, DOI 10.1016/j.yrtph.2014.09.007
   Lucena MI, 2009, HEPATOLOGY, V49, P2001, DOI 10.1002/hep.22895
   Ji D, 2018, J HEPATOL, V68, pS155, DOI 10.1016/S0168-8278(18)30523-3
   Kleiner DE, 2014, HEPATOLOGY, V59, P661, DOI 10.1002/hep.26709
   Klotz U, 2009, DRUG METAB REV, V41, P67, DOI 10.1080/03602530902722679
   Koçak FOK, 2022, ANN GERIATR MED RES, V26, P233, DOI 10.4235/agmr.22.0096
   Kullak-Ublick GA, 2017, GUT, V66, P1154, DOI 10.1136/gutjnl-2016-313369
   Lee Brian T, 2021, Curr Gastroenterol Rep, V23, P6, DOI 10.1007/s11894-021-00804-7
   Li ZB, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.734090
   Lindor KD, 2015, AM J GASTROENTEROL, V110, P646, DOI 10.1038/ajg.2015.112
   Liu WH, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.723940
   Marcum ZA, 2012, AM J GERIATR PHARMAC, V10, P264, DOI 10.1016/j.amjopharm.2012.05.002
   Medina-Caliz I, 2016, J HEPATOL, V65, P532, DOI 10.1016/j.jhep.2016.05.003
   Mosedale M, 2017, CLIN PHARMACOL THER, V101, P469, DOI 10.1002/cpt.564
   Moulton VR, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02279
   Navarro VJ, 2014, HEPATOLOGY, V60, P1399, DOI 10.1002/hep.27317
   Ostapowicz G, 2002, ANN INTERN MED, V137, P947, DOI 10.7326/0003-4819-137-12-200212170-00007
   Raschi E, 2017, WORLD J HEPATOL, V9, P30, DOI 10.4254/wjh.v9.i1.30
   Sakiani S, 2013, NAT REV ENDOCRINOL, V9, P56, DOI 10.1038/nrendo.2012.206
   Santos G, 2021, PHYTOTHER RES, V35, P6, DOI 10.1002/ptr.6746
   SCHEUER PJ, 1991, J HEPATOL, V13, P372, DOI 10.1016/0168-8278(91)90084-O
   Singal AK, 2018, AM J GASTROENTEROL, V113, P175, DOI 10.1038/ajg.2017.469
   Stevens JL, 2009, DRUG DISCOV TODAY, V14, P162, DOI 10.1016/j.drudis.2008.11.009
   Tajiri K, 2013, WORLD J GASTROENTERO, V19, P8459, DOI 10.3748/wjg.v19.i46.8459
   Te H, 2019, CLIN TRANSPLANT, V33, DOI 10.1111/ctr.13514
   Teschke R, 2013, EXPERT OPIN DRUG SAF, V12, P339, DOI 10.1517/14740338.2013.774371
   Tian FY, 2022, FRONT PHARMACOL, V13, DOI 10.3389/fphar.2022.862561
   Tostmann A, 2008, J GASTROEN HEPATOL, V23, P192, DOI 10.1111/j.1440-1746.2007.05207.x
   Wagner KH, 2018, CRIT REV CL LAB SCI, V55, P129, DOI 10.1080/10408363.2018.1428526
   Wai CT, 2007, LIVER INT, V27, P465, DOI 10.1111/j.1478-3231.2007.01461.x
   Wang CY, 2022, HEPATOLOGY, V75, P1373, DOI 10.1002/hep.32283
   Wang QL, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.627133
   Weaver RJ, 2020, NAT REV DRUG DISCOV, V19, P131, DOI 10.1038/s41573-019-0048-x
   Weersink RA, 2021, CLIN PHARMACOL THER, V109, P1147, DOI 10.1002/cpt.2108
   Yeong TT, 2016, HEPATOL RES, V46, pE79, DOI 10.1111/hepr.12532
   Zhu Yun, 2016, Zhongguo Zhong Xi Yi Jie He Za Zhi, V36, P44
NR 59
TC 1
Z9 1
U1 1
U2 1
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 1663-9812
J9 FRONT PHARMACOL
JI Front. Pharmacol.
PD FEB 16
PY 2023
VL 14
AR 1071709
DI 10.3389/fphar.2023.1071709
PG 11
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 9M4LR
UT WOS:000942203900001
PM 36874016
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Chiba, T
   Tsuchiya, T
   Komatsu, T
   Mori, R
   Hayashi, H
   Shimano, H
   Spindler, SR
   Shimokawa, I
AF Chiba, Takuya
   Tsuchiya, Tomoshi
   Komatsu, Toshimitsu
   Mori, Ryoichi
   Hayashi, Hiroko
   Shimano, Hitoshi
   Spindler, Stephen R.
   Shimokawa, Isao
TI Development of a bioassay to screen for chemicals mimicking the
   anti-aging effects of calorie restriction
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Calorie restriction; Aging; Metabolism; Biosensing; Drug discovery
ID LIFE-SPAN EXTENSION; LONGEVITY MODELS; GENE-EXPRESSION; BINDING-SITES;
   INSULIN; IDENTIFICATION; THERAPEUTICS; RESVERATROL; ACTIVATORS;
   SEQUENCES
AB Suppression of the growth hormone/insulin-like growth factor-I pathway in Ames dwarf (DF) mice, and caloric restriction (CR) in normal mice extends lifespan and delays the onset of age-related disorders. In combination, these interventions have an additive effect on lifespan in Ames DF mice. Therefore, common signaling pathways regulated by DF and CR could have additive effects on longevity. In this study, we tried to identity the signaling mechanism and develop a system to assess pro-longevity status in cells and mice. We previously identified genes up-regulated in the liver of DF and CR mice by DNA microarray analysis. Motif analysis of the upstream sequences of those genes revealed four major consensus sequence motifs, which have been named dwarfism and calorie restriction-responsive elements (DFCR-REs). One of the synthesized sequences bound to hepatocyte nuclear factor-4 alpha (HNF-4 alpha), an important transcription factor involved in liver metabolism. Furthermore, using this sequence information, we developed a highly sensitive bioassay to identify chemicals mimicking the anti-aging effects of CR. When the reporter construct, containing an element upstream of a secreted alkaline phosphatase (SEAP) gene, was co-transfected with HNF-4 alpha and its regulator peroxisome proliferator-activated receptor (PPAR) gamma coactivator-1 alpha (PGC-1 alpha). SEAP activity was increased compared with untransfected controls. Moreover, transient transgenic mice established using this construct showed increased SEAP activity in CR mice compared with ad libitum-fed mice. These data suggest that because of its rapidity, ease of use, and specificity, our bioassay will be more useful than the systems currently employed to screen for CR mimetics, which mimic the beneficial effects of CR. Our system will be particularly useful for high-throughput screening of natural and synthetic candidate molecules. (C) 2010 Elsevier Inc. All rights reserved.
C1 [Chiba, Takuya; Komatsu, Toshimitsu; Mori, Ryoichi; Hayashi, Hiroko; Shimokawa, Isao] Nagasaki Univ, Grad Sch Biomed Sci, Dept Invest Pathol, Nagasaki 8528523, Japan.
   [Tsuchiya, Tomoshi] Nagasaki Univ, Grad Sch Biomed Sci, Div Surg Oncol, Nagasaki 8528501, Japan.
   [Shimano, Hitoshi] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Internal Med Endocrinol & Metab, Tsukuba, Ibaraki 3058575, Japan.
   [Spindler, Stephen R.] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.
C3 Nagasaki University; Nagasaki University; University of Tsukuba;
   University of California System; University of California Riverside
RP Chiba, T (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Invest Pathol, 1-12-4 Sakamoto, Nagasaki 8528523, Japan.
EM takuya@nagasaki-u.ac.jp
RI Shimano, Hitoshi/V-1761-2019; Shimano, Hitoshi/AAI-5648-2020
OI Shimano, Hitoshi/0000-0002-5562-5572; Mori, Ryoichi/0000-0002-7596-9620;
   Tsuchiya, Tomoshi/0000-0002-8419-1478; Shimokawa,
   Isao/0000-0001-8901-1029
FU Japan Society for the Promotion of Science [20790306]; Nagasaki
   University; Takeda Science Foundation; Grants-in-Aid for Scientific
   Research [20790306, 22790383] Funding Source: KAKEN
FX We are grateful to the staff at the Biomedical Research Center at Center
   for Frontier Life Sciences, Nagasaki University, for technical
   assistance and animal care. We thank Yutaka Araki and Yuko Moriyama for
   technical assistance. This work was supported in part by a Grant-in-Aid
   for Young Scientists (B) from the Japan Society for the Promotion of
   Science No. 20790306, Nagasaki University, and Takeda Science Foundation
   (TC).
CR BAILEY IL, 1994, P 2 INT C INT SYST M, P28
   Bartke A, 2001, NATURE, V414, P412, DOI 10.1038/35106646
   Bonkowski MS, 2006, P NATL ACAD SCI USA, V103, P7901, DOI 10.1073/pnas.0600161103
   Chiba T, 2007, CURR GENOMICS, V8, P423, DOI 10.2174/138920207783591726
   Chiba T, 1999, AM J PATHOL, V155, P1319, DOI 10.1016/S0002-9440(10)65234-0
   Chiba T, 2009, NEUROBIOL AGING, V30, P474, DOI 10.1016/j.neurobiolaging.2007.07.008
   Chiba T, 2008, EXP GERONTOL, V43, P595, DOI 10.1016/j.exger.2008.03.003
   Chiba T, 2007, MAMM GENOME, V18, P105, DOI 10.1007/s00335-006-0119-2
   Chiba T, 2009, MOL CELL ENDOCRINOL, V309, P17, DOI 10.1016/j.mce.2009.05.001
   Hirota K, 2005, INT J MOL MED, V15, P487
   Hirota K, 2003, J BIOL CHEM, V278, P13056, DOI 10.1074/jbc.C200553200
   Ingram DK, 2006, AGING CELL, V5, P97, DOI 10.1111/j.1474-9726.2006.00202.x
   Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200
   Kasai A, 2004, ANAL BIOCHEM, V335, P73, DOI 10.1016/j.ab.2004.08.017
   Kurachi S, 1999, SCIENCE, V285, P739, DOI 10.1126/science.285.5428.739
   Kurachi S, 2009, P NATL ACAD SCI USA, V106, P7921, DOI 10.1073/pnas.0902191106
   Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261
   Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682
   Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012
   Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939
   Shimokawa I, 2003, FASEB J, V17, P1108, DOI 10.1096/fj.02-0819fje
   Shimokawa I, 2008, MOL CELLS, V26, P427
   Spindler SR, 2007, GERONTOLOGY, V53, P306, DOI 10.1159/000103924
   Spindler SR, 2010, AGEING RES REV, V9, P324, DOI 10.1016/j.arr.2009.10.003
   Tsuchiya T, 2004, PHYSIOL GENOMICS, V17, P307, DOI 10.1152/physiolgenomics.00039.2004
   Yamaza H, 2010, AGING CELL, V9, P372, DOI 10.1111/j.1474-9726.2010.00563.x
   Zhang HB, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf120
NR 27
TC 9
Z9 9
U1 0
U2 6
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD OCT 15
PY 2010
VL 401
IS 2
BP 213
EP 218
DI 10.1016/j.bbrc.2010.09.032
PG 6
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 672GT
UT WOS:000283571700009
PM 20846506
OA Green Submitted
DA 2024-02-19
ER

PT J
AU Guedj, A
   Volman, Y
   Geiger-Maor, A
   Bolik, J
   Schumacher, N
   Künzel, S
   Baines, JF
   Nevo, Y
   Elgavish, S
   Galun, E
   Amsalem, H
   Schmidt-Arras, D
   Rachmilewitz, J
AF Guedj, Avital
   Volman, Yael
   Geiger-Maor, Anat
   Bolik, Julia
   Schumacher, Neele
   Kuenzel, Sven
   Baines, John F.
   Nevo, Yuval
   Elgavish, Sharona
   Galun, Eithan
   Amsalem, Hagai
   Schmidt-Arras, Dirk
   Rachmilewitz, Jacob
TI Gut microbiota shape 'inflamm-ageing' cytokines and account for
   age-dependent decline in DNA damage repair
SO GUT
LA English
DT Article
ID DIET-INDUCED OBESITY; DOUBLE-STRAND BREAKS; INTESTINAL PERMEABILITY;
   CALORIE RESTRICTION; GENE-EXPRESSION; INNATE IMMUNITY; HEALTH; LIVER;
   MACROPHAGES; PROFILE
AB Objective Failing to properly repair damaged DNA drives the ageing process. Furthermore, age-related inflammation contributes to the manifestation of ageing. Recently, we demonstrated that the efficiency of repair of diethylnitrosamine (DEN)-induced double-strand breaks (DSBs) rapidly declines with age. We therefore hypothesised that with age, the decline in DNA damage repair stems from age-related inflammation.
   Design We used DEN-induced DNA damage in mouse livers and compared the efficiency of their resolution in different ages and following various permutations aimed at manipulating the liver age-related inflammation.
   Results We found that age-related deregulation of innate immunity was linked to altered gut microbiota. Consequently, antibiotic treatment, MyD88 ablation or germ-free mice had reduced cytokine expression and improved DSBs rejoining in 6-month-old mice. In contrast, feeding young mice with a high-fat diet enhanced inflammation and facilitated the decline in DSBs repair. This latter effect was reversed by antibiotic treatment. Kupffer cell replenishment or their inactivation with gadolinium chloride reduced proinflammatory cytokine expression and reversed the decline in DSBs repair. The addition of proinflammatory cytokines ablated DSBs rejoining mediated by macrophage-derived heparin-binding epidermal growth factor-like growth factor.
   Conclusions Taken together, our results reveal a previously unrecognised link between commensal bacteria-induced inflammation that results in age-dependent decline in DNA damage repair. Importantly, the present study support the notion of a cell non-autonomous mechanism for age-related decline in DNA damage repair that is based on the presence of 'inflamm-ageing' cytokines in the tissue microenvironment, rather than an intrinsic cellular deficiency in the DNA repair machinery.
C1 [Guedj, Avital; Volman, Yael; Geiger-Maor, Anat; Galun, Eithan; Rachmilewitz, Jacob] Hebrew Univ Jerusalem, Hadassah Med Ctr, Goldyne Savad Inst Gene Therapy, IL-91120 Jerusalem, Israel.
   [Bolik, Julia; Schumacher, Neele; Schmidt-Arras, Dirk] Univ Kiel, Inst Biochem, Kiel, Germany.
   [Kuenzel, Sven; Baines, John F.] Max Planck, Inst Evolutionary Biol, Plon, Germany.
   [Baines, John F.] Univ Kiel, Inst Expt Med, Kiel, Germany.
   [Nevo, Yuval; Elgavish, Sharona] Hebrew Univ Jerusalem, I CORE Computat Ctr, Bioinformat Unit, Jerusalem, Israel.
   [Nevo, Yuval; Elgavish, Sharona] Hadassah Hebrew Univ, Med Ctr, Jerusalem, Israel.
   [Amsalem, Hagai] Hadassah Univ Hosp Mt Scopus, Dept Obstet & Gynecol, Jerusalem, Israel.
C3 Hebrew University of Jerusalem; Hadassah University Medical Center;
   University of Kiel; Max Planck Society; University of Kiel; Hebrew
   University of Jerusalem; Hebrew University of Jerusalem; Hadassah
   University Medical Center; Hebrew University of Jerusalem
RP Rachmilewitz, J (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Ctr, Goldyne Savad Inst Gene Therapy, IL-91120 Jerusalem, Israel.
EM rjacob444@gmail.com
RI Galun, Eithan/AAD-9117-2022; Schmidt-Arras, Dirk/ABB-6644-2020; Baines,
   John F/B-3580-2010
OI Galun, Eithan/0000-0002-6243-6702; Schmidt-Arras,
   Dirk/0000-0002-1072-7495; Baines, John F/0000-0002-8132-4909
CR Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011
   Baruch K, 2014, SCIENCE, V346, P89, DOI 10.1126/science.1252945
   Bischoff SC, 2016, CURR OPIN CLIN NUTR, V19, P26, DOI 10.1097/MCO.0000000000000242
   Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403
   Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319
   Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035
   Csiszar A, 2014, AM J PHYSIOL-HEART C, V307, pH292, DOI 10.1152/ajpheart.00307.2014
   de La Serre CB, 2010, AM J PHYSIOL-GASTR L, V299, pG440, DOI 10.1152/ajpgi.00098.2010
   de Magalhaes JP, 2009, BIOINFORMATICS, V25, P875, DOI 10.1093/bioinformatics/btp073
   Dollé MET, 2011, PATHOBIOL AGING AGE, V1, DOI 10.3402/pba.v1i0.7219
   Ershler WB, 2000, ANNU REV MED, V51, P245, DOI 10.1146/annurev.med.51.1.245
   Furman D, 2017, NAT MED, V23, P174, DOI 10.1038/nm.4267
   Geiger-Maor A, 2015, CANCER RES, V75, P2663, DOI 10.1158/0008-5472.CAN-14-3635
   Guedj A, 2016, AGING-US, V8, P3131, DOI 10.18632/aging.101120
   HARDONK MJ, 1992, J LEUKOCYTE BIOL, V52, P296, DOI 10.1002/jlb.52.3.296
   HIGASHIYAMA S, 1991, SCIENCE, V251, P936, DOI 10.1126/science.1840698
   Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615
   Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490
   Iida N, 2013, SCIENCE, V342, P967, DOI 10.1126/science.1240527
   Jin CC, 2013, J ALLERGY CLIN IMMUN, V132, P287, DOI 10.1016/j.jaci.2013.06.022
   Jurk D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5172
   Kounatidis I, 2017, CELL REP, V19, P836, DOI 10.1016/j.celrep.2017.04.007
   Kulecka M, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0116-8
   Langille MG, 2014, MICROBIOME, V2, DOI 10.1186/s40168-014-0050-9
   Lee JE, 2011, EXP GERONTOL, V46, P891, DOI 10.1016/j.exger.2011.07.009
   Lee YH, 2014, SCI WORLD J, DOI 10.1155/2014/951216
   Leng SX, 2007, J AM GERIATR SOC, V55, P864, DOI 10.1111/j.1532-5415.2007.01186.x
   Li Z, 2016, CELL DEATH DIFFER, V23, P1765, DOI 10.1038/cdd.2016.65
   Ljungman M, 2010, ENVIRON MOL MUTAGEN, V51, P879, DOI 10.1002/em.20597
   Lynch SV, 2016, NEW ENGL J MED, V375, P2369, DOI 10.1056/NEJMra1600266
   Man AL, 2015, CLIN SCI, V129, P515, DOI 10.1042/CS20150046
   Mello AM, 2016, DIGEST DIS, V34, P194, DOI 10.1159/000443350
   Nicoletti C, 2015, EXPERT REV GASTROENT, V9, P1467, DOI 10.1586/17474124.2015.1092872
   O'Toole PW, 2015, SCIENCE, V350, P1214, DOI 10.1126/science.aac8469
   Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002
   Rao LVM, 2003, MOL CELL BIOCHEM, V253, P131, DOI 10.1023/A:1026004208822
   Santaolalla R, 2012, CURR OPIN GASTROEN, V28, P124, DOI 10.1097/MOG.0b013e3283506559
   Sedelnikova OA, 2008, AGING CELL, V7, P89, DOI 10.1111/j.1474-9726.2007.00354.x
   Shaw AC, 2013, NAT REV IMMUNOL, V13, P875, DOI 10.1038/nri3547
   Thevaranjan N, 2017, CELL HOST MICROBE, V21, P455, DOI 10.1016/j.chom.2017.03.002
   Tulstrup MVL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144854
   van der Heijden RA, 2015, AGING-US, V7, P256, DOI 10.18632/aging.100738
   van Tongeren SP, 2005, APPL ENVIRON MICROB, V71, P6438, DOI 10.1128/AEM.71.10.6438-6442.2005
   Vaquero A, 2009, GENE DEV, V23, P1849, DOI 10.1101/gad.1807009
   Vermeij WP, 2016, NATURE, V537, P427, DOI 10.1038/nature19329
   Verna L, 1996, PHARMACOL THERAPEUT, V71, P57, DOI 10.1016/0163-7258(96)00062-9
   White DE, 2006, CANCER RES, V66, P11594, DOI 10.1158/0008-5472.CAN-06-4138
   White RR, 2016, MOL CELL, V63, P729, DOI 10.1016/j.molcel.2016.08.004
   White RR, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2061-8
   White RR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7790
   Xu XM, 2015, CELL PHYSIOL BIOCHEM, V37, P1257, DOI 10.1159/000430248
   Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446
NR 52
TC 27
Z9 28
U1 4
U2 34
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0017-5749
EI 1468-3288
J9 GUT
JI Gut
PD JUN
PY 2020
VL 69
IS 6
BP 1064
EP 1075
DI 10.1136/gutjnl-2019-318491
PG 12
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA LV0FW
UT WOS:000538121200017
PM 31586932
DA 2024-02-19
ER

PT J
AU Pallottini, V
   Montanari, L
   Cavallini, G
   Bergamini, E
   Gori, Z
   Trentalance, A
AF Pallottini, V
   Montanari, L
   Cavallini, G
   Bergamini, E
   Gori, Z
   Trentalance, A
TI Mechanisms underlying the impaired regulation of
   3-hydroxy-3-methylglutaryl coenzyme A reductase in aged rat liver
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE ageing; cholesterol; diet restriction; HMG-CoA reductase; rat liver
ID HMG-COA REDUCTASE; DEGRADATION; CHOLESTEROL; PROTEASOME; BIOSYNTHESIS;
   DOLICHOL; DISEASES; INSIG-1; PATHWAY
AB As the main risk factor for cardiovascular disease, hypercholesterolemia is one of the most studied age-related metabolic alterations. In the liver. cholesterol homeostasis is strictly regulated through the modulation of the 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG-CoA reductase), the key enzyme of cholesterol biosynthesis. With ageing, hepatic HMG-CoA reductase becomes completely activated and cholesterol content increases in the blood.
   The research reported in this paper uses the regulatory enzymes of reductase (i.e., the AMP-dependent kinase (AMPK) and the protein phosphatase 2A (PP2A)), the HMG-CoA reductase thermodependent activity and the "in vitro" enzyme degradation to elucidate the role played by the HMG-CoA reductase regulation and its membrane interaction. Related experiments were performed on 3 and 24 months "ad libitum" (AL) fed rats and 24 months caloric-restricted rats. The results show no changes in the PP2A level and the activation state of AMP dependent kinase in aged "ad libitum" fed rats. By contrast, the activation state of the kinase is enhanced in the aged caloric-restricted animals. With respect to the adult, the thermodependent activity of reductase remains unchanged, while the degradation rate of the HMG-CoA reductase, is slower and independent on proteasome. These findings support the hypothesis that a different arrangement of the HMG-CoA reductase membrane domain in aged rats is a cause of reductase deregulation. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
C1 Univ Roma Tre, Dept Biol, I-00146 Rome, Italy.
   Univ Pisa, Dept Expt Pathol, Pisa, Italy.
C3 Roma Tre University; University of Pisa
RP Trentalance, A (corresponding author), Univ Roma Tre, Dept Biol, Viale Marconi 446, I-00146 Rome, Italy.
EM trentala@uniroma3.it
RI Pallottini, Valentina/AAA-3218-2021
OI Pallottini, Valentina/0000-0003-2511-6168
CR BRUSCALUPI G, 1985, CELL MOL BIOL, V31, P365
   Ching YP, 1996, EUR J BIOCHEM, V237, P800, DOI 10.1111/j.1432-1033.1996.0800p.x
   EDWARDS PA, 1991, BIOCH LIPIDS LIPOPRO, P383
   Facchini FS, 2000, FREE RADICAL BIO MED, V29, P1302, DOI 10.1016/S0891-5849(00)00438-X
   Feramisco JD, 2004, J BIOL CHEM, V279, P8487, DOI 10.1074/jbc.M312623200
   Gaczynska M, 2001, MECH AGEING DEV, V122, P235, DOI 10.1016/S0047-6374(00)00246-3
   Gardner RG, 2001, J BIOL CHEM, V276, P8681, DOI 10.1074/jbc.M007888200
   GAUSSIN V, 1997, FEBS LETT, V413, P445
   GEELEN MJH, 1986, FEBS LETT, V201, P183, DOI 10.1016/0014-5793(86)80604-4
   GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0
   Grune T, 2003, BIOCHEM BIOPH RES CO, V305, P709, DOI 10.1016/S0006-291X(03)00809-X
   HARMAN D, 1984, AGE, V7, P111, DOI 10.1007/BF02431866
   Istvan ES, 2000, BBA-MOL CELL BIOL L, V1529, P9, DOI 10.1016/S1388-1981(00)00134-7
   LEONI S, 1985, J CELL PHYSIOL, V125, P507, DOI 10.1002/jcp.1041250321
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Marino M, 1998, J GERONTOL A-BIOL, V53, pB87, DOI 10.1093/gerona/53A.2.B87
   Marino M, 2002, MECH AGEING DEV, V123, P1183, DOI 10.1016/S0047-6374(02)00009-X
   Masoro EJ, 1996, TOXICOL PATHOL, V24, P738, DOI 10.1177/019262339602400617
   Ravid T, 2000, J BIOL CHEM, V275, P35840, DOI 10.1074/jbc.M004793200
   Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5
   Sever N, 2003, MOL CELL, V11, P25, DOI 10.1016/S1097-2765(02)00822-5
   van der Vlies D, 2003, AMINO ACIDS, V25, P397, DOI 10.1007/s00726-003-0025-9
NR 22
TC 39
Z9 46
U1 0
U2 3
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD SEP
PY 2004
VL 125
IS 9
BP 633
EP 639
DI 10.1016/j.mad.2004.08.001
PG 7
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 873BU
UT WOS:000225254600008
PM 15491682
DA 2024-02-19
ER

PT J
AU Aghaei, S
   Nilforoushzadeh, MA
   Aghaei, M
AF Aghaei, Shahrzad
   Nilforoushzadeh, Mohammad Ali
   Aghaei, Maryam
TI The role of peroxisome proliferator-activated receptor-coactivator-1
   gene in skin aging
SO JOURNAL OF RESEARCH IN MEDICAL SCIENCES
LA English
DT Article
DE Free radicals; mitochondria; peroxisome proliferator-activated
   receptor-coactivator-1; replication; skin aging; wrinkle
ID TRANSCRIPTIONAL COACTIVATOR; HEPATIC GLUCONEOGENESIS; GAMMA
   COACTIVATOR-1; UNCOUPLING PROTEIN; RECEPTOR; EXPRESSION; TISSUE;
   PATHOPHYSIOLOGY; MECHANISMS; LONGEVITY
AB Skin aging is a continuous process that exhibits fine and deep wrinkles, thin and transparent skin, loss of underlying fat, dry skin and itch, following decreased collagen and elastin synthesis. Both extrinsic and intrinsic agents are considered in the pathogenesis on skin aging. Extrinsic factors such as sun exposure, windy and dry weather, nutrition, and lifestyle may induce premature aging, toxic-free radicals, and reactive oxygen species due to decreasing normal function of mitochondria which play the major intrinsic factors in premature skin aging. One of the major genetic factors in mitochondrial function is peroxisome proliferator-activated receptor-coactivator-1 (PGC-1) gene. This factor could delay skin aging by increasing the mitochondrial biogenesis and replication and oxidative phosphorylation and so may induce free radical scavenging. This review is focused on intrinsic skin aging and the role of PGC-1 protein in decreasing effect of aging causes.
C1 [Aghaei, Shahrzad] Shahrekord Univ, Dept Genet, Shahrekord, Iran.
   [Nilforoushzadeh, Mohammad Ali] Univ Tehran Med Sci, Skin & Stem Cell Res Ctr, Tehran, Iran.
   [Aghaei, Maryam] Isfahan Univ Med Sci, Skin Dis & Leishmaniasis Res Ctr, Esfahan, Iran.
C3 Shahrekord University; Tehran University of Medical Sciences; Isfahan
   University Medical Science
RP Aghaei, M (corresponding author), Med Sci Isfahan Univ, Skin Dis & Leishmaniasis Res Ctr, Esfahan, Iran.
EM maryam.aghaei2008@gmail.com
RI aghaei, shahrzad/JJF-2414-2023
CR Ali NM, 2012, J DERMATOL TREAT, V23, P136, DOI 10.3109/09546634.2010.500322
   Amano S, 2009, J INVEST DERM SYMP P, V14, P2, DOI 10.1038/jidsymp.2009.5
   Asilian A, 2014, J RES MED SCI, V19, P556
   Bennett H., 2014, WASHINGTON POST
   Berneburg M, 2004, J INVEST DERMATOL, V122, P1277, DOI 10.1111/j.0022-202X.2004.22502.x
   CASSARDDOULCIER AM, 1994, J BIOL CHEM, V269, P24335
   Dawkins R, 1976, SELFISH GENE, P224
   Demierre MF, 1999, J AM ACAD DERMATOL, V41, P27, DOI 10.1016/S0190-9622(99)70401-9
   Du C, 2013, FREE RADICAL BIO MED, V63, P254, DOI 10.1016/j.freeradbiomed.2013.05.023
   Ellen L., 2007, SKIN SURFACE SUBSTAN, P44
   EVANS MJ, 1990, GENE DEV, V4, P1023, DOI 10.1101/gad.4.6.1023
   Faghihi G, 2011, J DRUGS DERMATOL, V10, P1439
   Ferguson SB, 2010, 1 WORLD C TARG MIT S
   Fisher GJ, 2005, CUTIS, V75, P5
   Ganceviciene R, 2012, DERM-ENDOCRINOL, V4, DOI 10.4161/derm.22804
   Godic A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/860479
   Grice E A, 2009, EMERGING TRENDS ANTI, P224
   Hayden EC, 2007, NATURE, V450, P603, DOI 10.1038/450603a
   Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131
   Heutling D, 2008, INTERNIST, V49, P570, DOI 10.1007/s00108-008-2110-3
   Holliday R, 2000, MUTAT RES-REV MUTAT, V463, P173, DOI 10.1016/S1383-5742(00)00048-X
   Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385
   Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980
   Koch H, 2001, J INVEST DERMATOL, V117, P892, DOI 10.1046/j.0022-202x.2001.01513.x
   Kohl E, 2011, J EUR ACAD DERMATOL, V25, P873, DOI 10.1111/j.1468-3083.2010.03963.x
   Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096
   Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268
   Lupo MP, 2007, DERMATOL THER, V20, P343, DOI 10.1111/j.1529-8019.2007.00148.x
   McKay BC, 2001, ONCOGENE, V20, P6805, DOI 10.1038/sj.onc.1204901
   Michael LF, 2001, P NATL ACAD SCI USA, V98, P3820, DOI 10.1073/pnas.061035098
   NELSON BD, 1990, BIOCHIM BIOPHYS ACTA, V1018, P275, DOI 10.1016/0005-2728(90)90266-7
   Nilforoushzadeh Mohammad Ali, 2011, Indian J Dermatol, V56, P171, DOI 10.4103/0019-5154.80411
   Nilforoushzadeh MA, 2010, J RES MED SCI, V15, P167
   OIKARINEN A, 1994, PHOTODERMATOL PHOTO, V10, P47
   Ostler EL, 2000, J PEDIATR ENDOCR MET, V13, P1467
   Partridge L, 1999, TRENDS ECOL EVOL, V14, P438, DOI 10.1016/S0169-5347(99)01646-8
   Proksch E, 2008, EXP DERMATOL, V17, P1063, DOI 10.1111/j.1600-0625.2008.00786.x
   Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368
   Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5
   Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012
   Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2
   Rattan SIS, 1996, EXP GERONTOL, V31, P33, DOI 10.1016/0531-5565(95)02022-5
   Rattan SIS, 2006, FREE RADICAL RES, V40, P1230, DOI 10.1080/10715760600911303
   Rera M, 2011, CELL METAB, V14, P623, DOI 10.1016/j.cmet.2011.09.013
   Sears IB, 1996, MOL CELL BIOL, V16, P3410
   Tabata N, 2000, DERMATOLOGY, V200, P308, DOI 10.1159/000018393
   Takubo K, 2000, J GERONTOL A-BIOL, V55, pB533, DOI 10.1093/gerona/55.11.B533
   Wang CH, 2013, EXP BIOL MED, V238, P450, DOI 10.1177/1535370213493069
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
   Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050
NR 50
TC 10
Z9 10
U1 3
U2 12
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 1735-1995
EI 1735-7136
J9 J RES MED SCI
JI J. Res. Med. Sci.
PY 2016
VL 21
PG 6
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA DZ4GN
UT WOS:000385816800004
PM 27904582
OA Green Published, Green Submitted, gold
DA 2024-02-19
ER

PT J
AU Yamano, T
   DeCicco, LA
   Rikans, LE
AF Yamano, T
   DeCicco, LA
   Rikans, LE
TI Attenuation of cadmium-induced liver injury in senescent male fischer
   344 rats: Role of Kupffer cells and inflammatory cytokines
SO TOXICOLOGY AND APPLIED PHARMACOLOGY
LA English
DT Article
DE cadmium; cyclosporin A; gadolinium chloride; cytokine-induced neutrophil
   chemoattractant; interleukin IL-1 beta; inflammatory liver injury;
   Kupffer cells
ID NECROSIS-FACTOR-ALPHA; NEUTROPHIL CHEMOATTRACTANT; INDUCED
   HEPATOTOXICITY; AGED RATS; IMMUNE-SYSTEM; HEPATOCYTES; MECHANISMS;
   ENDOTOXIN; TOXICITY; INTERLEUKIN-8
AB In the previous study we showed that senescent male Fischer 344 rats were resistant to Cd-induced hepatotoxicity compared with young-adult rats. In the present study we investigated the role of Kupffer cells and inflammatory cytokines in this effect of aging. The phagocytic activity of Kupffer cells, determined as the removal of carbon from blood, was stimulated by the administration of a hepatotoxic dose of Cd (3 mg/kg sc) in young-adult (5 months) rats but not in old (28 months) rats. Hepatic concentrations of interleukin (IL)-1 beta and cytokine-induced neutrophil chemoattractant (CINC), but not of tumor necrosis factor-alpha or IL-6, were elevated in young rats treated with Cd, In old rats, however, the increase in IL-1 beta produced by Cd was not statistically significant and the increase in CINC was much lower than in young-adult rats. Pretreatment with gadolinium chloride or cyclosporin A inhibited the elevations in hepatic cytokines and attenuated Cd-induced liver damage, assessed on the basis of serum alanine aminotransferase and sorbitol dehydrogenase activities. Cd-induced hepatotoxicity in the different treatment groups correlated well with hepatic levels of CINC (r = 0.98, p < 0.001) but not with those of IL-1 beta. The results suggest that (1) Kupffer cell activation is essential for inflammatory liver damage from Cd, (2) IL-1 beta and CINC are important mediators of the inflammatory response induced by Cd, and (3) the attenuation of Cd-induced liver injury in senescent rats is caused by an impairment in Kupffer cell activation, leading to a lower production of CINC and less inflammatory liver injury. (C) 2000 Academic Press.
C1 Osaka City Inst Publ Hlth & Environm Sci, Osaka 543, Japan.
   Univ Oklahoma, Hlth Sci Ctr, Dept Pharmaceut Sci, Oklahoma City, OK USA.
C3 University of Oklahoma System; University of Oklahoma Health Sciences
   Center
RP Yamano, T (corresponding author), Osaka City Inst Publ Hlth & Environm Sci, Osaka 543, Japan.
CR ALEXANDER HR, 1992, SURGERY, V112, P188
   Anthony D, 1998, CURR BIOL, V8, P923, DOI 10.1016/S0960-9822(07)00373-9
   Badger DA, 1997, TOXICOLOGY, V121, P143, DOI 10.1016/S0300-483X(97)00065-6
   BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97
   BOERMEESTER MA, 1995, HEPATOLOGY, V22, P1499, DOI 10.1002/hep.1840220525
   BRADLEY SF, 1989, J LEUKOCYTE BIOL, V45, P510, DOI 10.1002/jlb.45.6.510
   BROUWER A, 1995, CLIN SCI, V88, P211, DOI 10.1042/cs0880211
   CRESKOFF AJ, 1963, RAT LAB INVESTIGATIO, P406
   DAVILA DR, 1990, FASEB J, V4, P2906, DOI 10.1096/fasebj.4.11.2165948
   Dong WM, 1998, TOXICOL APPL PHARM, V151, P359, DOI 10.1006/taap.1998.8481
   DURHAM SK, 1990, J PATHOL, V162, P341, DOI 10.1002/path.1711620412
   HALPERN BN, 1953, BRIT J EXP PATHOL, V34, P426
   HOFFMANN EO, 1975, LAB INVEST, V32, P655
   Horan MA, 1997, AGE AGEING, V26, P15, DOI 10.1093/ageing/26.suppl_4.15
   Jaeschke H, 1997, J LEUKOCYTE BIOL, V61, P647, DOI 10.1002/jlb.61.6.647
   KAUFFMAN CA, 1986, EXP GERONTOL, V21, P75, DOI 10.1016/0531-5565(86)90055-0
   KAYAMA F, 1995, TOXICOL APPL PHARM, V131, P224, DOI 10.1006/taap.1995.1065
   KOIZUMI T, 1994, TOXICOLOGY, V92, P115, DOI 10.1016/0300-483X(94)90171-6
   LIU J, 1993, IMMUNOL TODAY, V15, P274
   Matsuda T, 1998, J TRAUMA, V44, P475, DOI 10.1097/00005373-199803000-00009
   Mawet E, 1996, HEPATOLOGY, V23, P353
   Miller RA, 1996, SCIENCE, V273, P70, DOI 10.1126/science.273.5271.70
   MULLER L, 1986, TOXICOLOGY, V40, P285, DOI 10.1016/0300-483X(86)90061-2
   Ohkubo K, 1998, J GASTROEN HEPATOL, V13, P696, DOI 10.1111/j.1440-1746.1998.tb00716.x
   Rikans LE, 1996, MECH AGEING DEV, V91, P165, DOI 10.1016/S0047-6374(96)01784-8
   Sauer JM, 1997, TOXICOLOGY, V121, P155, DOI 10.1016/S0300-483X(97)00062-0
   STOWE HD, 1972, ARCH PATHOL, V94, P389
   Strubelt O, 1996, J TOXICOL ENV HEALTH, V47, P267, DOI 10.1080/009841096161780
   SZABO S, 1983, LIFE SCI, V33, P1975, DOI 10.1016/0024-3205(83)90735-X
   Tapia G, 1998, HEPATOLOGY, V27, P1311, DOI 10.1002/hep.510270517
   Thompson K, 1996, HEPATO-GASTROENTEROL, V43, P15
   WATANABE K, 1989, BIOCHEM BIOPH RES CO, V161, P1093, DOI 10.1016/0006-291X(89)91355-7
   Yamano T, 1998, TOXICOL APPL PHARM, V151, P9, DOI 10.1006/taap.1998.8401
NR 33
TC 100
Z9 107
U1 0
U2 4
PU ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0041-008X
J9 TOXICOL APPL PHARM
JI Toxicol. Appl. Pharmacol.
PD JAN 1
PY 2000
VL 162
IS 1
BP 68
EP 75
DI 10.1006/taap.1999.8833
PG 8
WC Pharmacology & Pharmacy; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Toxicology
GA 279CY
UT WOS:000085026800009
PM 10631129
DA 2024-02-19
ER

PT J
AU Chernukha, I
   Fedulova, L
   Vasilevskaya, E
   Kulikovskii, A
   Kupaeva, N
   Kotenkova, E
AF Chernukha, Irina
   Fedulova, Liliya
   Vasilevskaya, Ekaterina
   Kulikovskii, Andrei
   Kupaeva, Nadezhda
   Kotenkova, Elena
TI Antioxidant effect of ethanolic onion (Allium cepa) husk extract in
   ageing rats
SO SAUDI JOURNAL OF BIOLOGICAL SCIENCES
LA English
DT Article; Early Access
DE Ageing; Oxidative stress; Plant antioxidants; Vegetable waste; Onion
   husk; Antioxidant system
ID OXIDATIVE STRESS; REDOX THEORY; L.; CAPACITY; QUERCETIN
AB The role of natural antioxidants in preventing of age-relating diseases is evident. The vegetable industry generates a large amount of waste, which is a good source of antioxidants.
   The aim of the study was the investigation of the antioxidant effect of long-term consumption of ethanolic yellow onion husk extract in ageing laboratory rodents.
   Twenty male Wistar albino rats were divided randomly into two groups (n = 10): a control group and an experimental group that received ethanolic yellow onion husk extract (2 mL/rat diluted with distilled water; activity of 4.44 mmol-equiv. quercetin) for 188 days. Oxygen radical absorbance capacity and ferric reducing antioxidant power assays were used to determine the total antioxidant capacity of the extract, which amounted to 941.4 ? 32.7 mmol equiv. Trolox/g raw material and 167.4 ? 16.4 mmol-equiv. quercetin/g raw material, respectively. Oral intake of the onion husk extract affected the indicators of the antioxidant system of the liver and the brain but not of the blood and plasma, mainly due to elevations in the activity of catalase and superoxide dismutase in the liver by 44.4% and 79.1%, respectively, and in the brain by three-fold and 79.1%, respectively.
   The availability, cheapness and high antioxidant potential of onion waste qualifies it a good source of functional ingredients and bioactive substances applicable in the food and pharmaceutical industries.
   (c)& nbsp;2021 The Author(s). Published by Elsevier B.V. on behalf of King Saud University. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
C1 [Chernukha, Irina; Fedulova, Liliya; Vasilevskaya, Ekaterina; Kulikovskii, Andrei; Kupaeva, Nadezhda; Kotenkova, Elena] RAS, VM Gorbatov Fed Res Ctr Food Syst, Talalikhina St 26, Moscow 109316, Russia.
C3 Russian Academy of Sciences
RP Kotenkova, E (corresponding author), RAS, VM Gorbatov Fed Res Ctr Food Syst, Talalikhina St 26, Moscow 109316, Russia.
EM imcher@inbox.ru; fedulova@vniimp.ru; rina715@yandex.ru;
   a.kulikovskii@fncps.ru; NVkupaeva@yandex.ru; lazovlena92@yandex.ru
RI Chernukha, Irina M/P-8740-2015; Kotenkova, Elena/Z-5666-2019;
   Vasilevskaya, Ekaterina/HJY-5272-2023; Kotenkova, Elena A/GQB-4327-2022;
   Vasilevskaya, Ekaterina R./M-3494-2016; Kupaeva, Nadezhda
   Vladimirovna/AAN-2197-2020; Kotenkova, Elena/M-3525-2016; Fedulova,
   Liliya LV/L-8273-2016; Lisitsyn, Andrey/P-6710-2015
OI Chernukha, Irina M/0000-0003-4298-0927; Kotenkova, Elena
   A/0000-0003-1864-8115; Vasilevskaya, Ekaterina R./0000-0002-4752-3939;
   Kupaeva, Nadezhda Vladimirovna/0000-0002-1066-5589; Kotenkova,
   Elena/0000-0003-1864-8115; Fedulova, Liliya LV/0000-0003-3573-930X;
   Lisitsyn, Andrey/0000-0002-4079-6950
FU  [013.20.05]
FX This article is published as a part of the scientific research, No.
   013.20.05, under the state assignment of V.M. Gorbatov Federal Research
   Centre for Food Systems of RAS.
CR Airaodion E.O., 2019, J BIOSCI BIOTECHNOL, V11
   Akash MSH, 2014, NUTRITION, V30, P1128, DOI 10.1016/j.nut.2014.02.011
   [Anonymous], National Center for Biotechnology Information
   Aremu OO, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8080309
   Arora S, 2017, International Research Journal of Pharmacy, V8, P69, DOI [10.7897/2230-8407.08699, DOI 10.7897/2230-8407.08699]
   Arung ET, 2011, FOOD CHEM, V124, P1024, DOI 10.1016/j.foodchem.2010.07.067
   Aversa R., 2016, Am. J. Eng. Appl. Sci, V9, P1112, DOI [10.3844/ajeassp.2016.1112.1126, DOI 10.3844/AJEASSP.2016.1112.1126]
   Bardaweel SK, 2018, EURASIAN J MED, V50, P193, DOI 10.5152/eurasianjmed.2018.17397
   Bedrnicek J, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9100974
   Bedrnícek J, 2019, CZECH J FOOD SCI, V37, P268, DOI 10.17221/68/2018-CJFS
   BEERS RF, 1952, J BIOL CHEM, V195, P133
   Benítez V, 2012, EUR FOOD RES TECHNOL, V234, P617, DOI 10.1007/s00217-012-1674-2
   Benítez V, 2011, PLANT FOOD HUM NUTR, V66, P48, DOI 10.1007/s11130-011-0212-x
   Benkeblia N, 2005, BRAZ ARCH BIOL TECHN, V48, P753, DOI 10.1590/S1516-89132005000600011
   Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292
   BONDY SC, 1992, TOXICOL LETT, V63, P231, DOI 10.1016/0378-4274(92)90086-Y
   Brazhe N. A., 2014, Human Physiology, V40, P804, DOI 10.1134/S0362119714070020
   Burri SCM, 2017, J FUNCT FOODS, V38, P119, DOI 10.1016/j.jff.2017.09.003
   Cui XJ, 2020, FRONT AGING NEUROSCI, V12, DOI 10.3389/fnagi.2020.00209
   ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6
   Freitas HR, 2017, NUTRIENTS, V9, DOI 10.3390/nu9111263
   Galadari S, 2017, FREE RADICAL BIO MED, V104, P144, DOI 10.1016/j.freeradbiomed.2017.01.004
   Go YM, 2017, CLIN SCI, V131, P1669, DOI 10.1042/CS20160897
   Hariharapura RC, 2014, ANTIOXIDANTS, V3, P526, DOI 10.3390/antiox3030526
   Hayes JD, 2020, CANCER CELL, V38, P167, DOI 10.1016/j.ccell.2020.06.001
   Helen A, 2000, TOXICOL LETT, V116, P61, DOI 10.1016/S0378-4274(00)00208-3
   Hernández JA, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/1543809
   Hollman PCH, 2000, J SCI FOOD AGR, V80, P1081, DOI 10.1002/(SICI)1097-0010(20000515)80:7&lt;1081::AID-JSFA566&gt;3.0.CO;2-G
   Ige S.F., 2020, INT J BIOMED SCI, V16, P11
   Kim HY, 2007, FOOD SCI BIOTECHNOL, V16, P434
   Kim MH, 2010, FOOD SCI BIOTECHNOL, V19, P159, DOI 10.1007/s10068-010-0022-1
   Kotenkova EA, 2019, IOP C SER EARTH ENV, V333, DOI 10.1088/1755-1315/333/1/012031
   Kupaeva N.V, 2019, FOOD SYST, V2, P17, DOI DOI 10.21323/2618-9771-2019-2-3-17-19
   Kwak JH, 2017, SAUDI J BIOL SCI, V24, P1387, DOI 10.1016/j.sjbs.2016.05.014
   Liguori I., 2018, CLIN INTERV AGING, V13, P757, DOI [10.2147/CIA.S158513, DOI 10.2147/CIA.S158513]
   Lubrano Valter, 2015, World J Exp Med, V5, P218, DOI 10.5493/wjem.v5.i4.218
   Malfa GA, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9090847
   Malta L.G., 2014, ENCY AGR FOOD SYSTEM
   MARKLUND S, 1974, EUR J BIOCHEM, V47, P469
   Marrelli M, 2019, MOLECULES, V24, DOI 10.3390/molecules24010119
   Meng J, 2017, REDOX BIOL, V11, P365, DOI 10.1016/j.redox.2016.12.026
   Mittler R, 2017, TRENDS PLANT SCI, V22, P11, DOI 10.1016/j.tplants.2016.08.002
   Namdev P., 2015, J PHARMACOGN PHYTOCH, V4, P282
   Naseri MKG, 2008, IRAN J PHARM RES, V7, P155
   Obanda M, 1997, J SCI FOOD AGR, V74, P209, DOI 10.1002/(SICI)1097-0010(199706)74:2&lt;209::AID-JSFA789&gt;3.0.CO;2-4
   Ojieh A.E., 2015, INT J SCI ENG, V6, P23
   Okoro I. O., 2019, The Thai Journal of Pharmaceutical Sciences, V43, P14
   Oyewole AO, 2014, FASEB J, V28, P485, DOI 10.1096/fj.13-237008
   Piechowiak T, 2020, LWT-FOOD SCI TECHNOL, V117, DOI 10.1016/j.lwt.2019.108614
   Pohl F, 2018, MOLECULES, V23, DOI 10.3390/molecules23123283
   Prasad KN, 2017, MECH AGEING DEV, V164, P61, DOI 10.1016/j.mad.2017.04.004
   Ren FY, 2020, FOOD RES INT, V132, DOI 10.1016/j.foodres.2019.108953
   Sadowska-Bartosz I, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/404680
   Saravanan Ramalingam, 2005, BMC Complement Altern Med, V5, P14, DOI 10.1186/1472-6882-5-14
   Siddeeg A, 2021, SAUDI J BIOL SCI, V28, P1633, DOI 10.1016/j.sjbs.2020.11.064
   Sidhu JS, 2019, J FOOD SCI TECH MYS, V56, P1811, DOI 10.1007/s13197-019-03625-9
   Teshika JD, 2019, CRIT REV FOOD SCI, V59, pS39, DOI 10.1080/10408398.2018.1499074
   Vaiserman A, 2020, FRONT BIOENG BIOTECH, V7, DOI 10.3389/fbioe.2019.00447
   Yegorov YE, 2020, MOL BIOL+, V54, P311, DOI 10.1134/S002689332003005X
   Zaki SM, 2019, FOLIA MORPHOL, V78, P554, DOI 10.5603/FM.a2018.0117
   Zhao L, 2016, J AGR FOOD CHEM, V64, P7291, DOI 10.1021/acs.jafc.6b02907
NR 61
TC 16
Z9 17
U1 0
U2 3
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1319-562X
EI 2213-7106
J9 SAUDI J BIOL SCI
JI Saudi J. Biol. Sci.
PD 2021 MAY
PY 2021
VL 28
IS 5
BP 2877
EP 2885
DI 10.1016/j.sjbs.2021.02.020
EA APR 2021
PG 9
WC Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics
GA RW8HQ
UT WOS:000646761100034
PM 34025165
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Akdogan, HA
   Sen, A
AF Akdogan, H. Ardag
   Sen, A.
TI Characterization of drug metabolizing enzymes and assessment of aging in
   the gilthead seabream (<i>Sparus aurata</i>) liver
SO VETERINARNI MEDICINA
LA English
DT Article
DE Sparus aurata; gilthead seabream; drug metabolizing enzymes; fish
ID AGE-RELATED-CHANGES; ONTOGENIC DEVELOPMENT; DISPOSITION; SOLE
AB Organic anthropogenic compounds such as polycyclic aromatic hydrocarbons, polychlorinated biphenyls, nitroaromatics, dioxins, various pesticides and natural compounds can enter the aquatic environment. These lipophilic compounds are readily taken up into the tissues of aquatic organisms where biotransformation via Phase I and Phase II metabolism can in part, determine the fate and toxicity of the xenobiotics. In this study on gilthead seabream (Sparus aurata), liver microsomal ethoxyresorufin O-deethylase (EROD), methoxyresorufin O-demethylase (MROD), penthyloxyresorufin O-depenthylase (PROD), benzyloxyresorufin O-debenzylase (BROD), aniline 4-hydroxylase (A4H), N-nitrosodimethylamine N-demethylase (NDMA-DE), aminopyrine N-demethylase (APND), caffeine N-demethylase (CN3D) and erythromycin N-demethylase (ERND) were determined. A4H, ERND, NDMA-ND, EROD and PROD activities increased in gilthead seabream (Sparus aurata) liver microsomes of different ages, while CN3D and APND activities decreased. MROD activities were barely detectable in mature fish whereas BROD activities were not detectable at all ages studied. Results were also recorded at the protein level by Western blotting using anti-CYP1A, CYP2E and CYP3A antibodies. In conclusion, elevated levels of gilthead seabream liver microsomal CYP450 enzyme activities might reveal possible exposure to various exogenous compounds, which might affect the desired responses to drugs, hormones and dietary supplements used during breeding.
C1 [Sen, A.] Pamukkale Univ, Fac Arts & Sci, Dept Chem, TR-20070 Kinikli, Denizli, Turkey.
C3 Pamukkale University
RP Sen, A (corresponding author), Pamukkale Univ, Fac Arts & Sci, Dept Chem, Kinikli Campus, TR-20070 Kinikli, Denizli, Turkey.
EM sena@pau.edu.tr
RI SEN, Alaattin/H-3463-2011
OI SEN, Alaattin/0000-0002-8444-376X
FU Scientific Research Projects Council of Pamukkale University
   [PAUBAP-2005FBE020]
FX Supported by the Scientific Research Projects Council of Pamukkale
   University (Grant No. PAUBAP-2005FBE020).
CR [Anonymous], ECOTOXICOLOGICAL SER
   Arinç E, 1999, MAR ENVIRON RES, V48, P147, DOI 10.1016/S0141-1136(99)00038-0
   BACH B, 1981, CLIN PHARMACOKINET, V6, P389, DOI 10.2165/00003088-198106050-00005
   BAGGOT JD, 2001, PHYSL BASIS VET CLIN, P252
   Baldini M, 2000, FOOD ADDIT CONTAM, V17, P679, DOI 10.1080/02652030050083204
   BOWMAN BA, 1991, NUTR ELDERLY, P43
   BROZEK J, 1952, FED PROC, V11, P784
   BRUCE A, 1980, SCANDINAVIAN J CLIN, V40, P1
   BURKE MD, 1974, DRUG METAB DISPOS, V5, P1
   COCHIN J, 1959, J PHARMACOL EXP THER, V125, P105
   Coulet M, 1996, CAN J PHYSIOL PHARM, V74, P32, DOI 10.1139/cjpp-74-1-32
   FORBES GB, 1970, METABOLIS, V19, P653, DOI 10.1016/0026-0495(70)90062-4
   GIBSON GG, 1994, INTRO DRUG METABOLIS, P119
   GREENBLATT DJ, 1982, NEW ENGL J MED, V306, P1081
   HABIG WH, 1974, J BIOL CHEM, V249, P7130
   IMAI Y, 1966, J BIOCHEM, V60, P417, DOI 10.1093/oxfordjournals.jbchem.a128453
   JEFFREY AH, 1997, BIOCHEM PHARMACOL, V54, P159
   KADDOURI M, 1992, J STEROID BIOCHEM, V42, P499, DOI 10.1016/0960-0760(92)90262-H
   KADIISKA M, 1985, ARCH TOXICOL, V56, P167, DOI 10.1007/BF00333421
   KAWALEK JC, 1990, AM J VET RES, V51, P1742
   KAWALEK JC, 1994, AM J VET RES, V55, P1579
   Lakritz J, 2000, AM J VET RES, V61, P152, DOI 10.2460/ajvr.2000.61.152
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MALINS DC, 1985, CARCINOGENESIS, V6, P1463, DOI 10.1093/carcin/6.10.1463
   Mikhailova ON, 2005, TOXICOLOGY, V210, P189, DOI 10.1016/j.tox.2005.01.018
   Monshouwer M, 2000, VET QUART, V22, P17, DOI 10.1080/01652176.2000.9695017
   NASH T, 1953, BIOCHEM J, V55, P416, DOI 10.1042/bj0550416
   Nebbia C, 2003, VET J, V165, P53, DOI 10.1016/S1090-0233(02)00174-0
   PAYNE JF, 1987, COMP BIOCHEM PHYS C, V86, P233, DOI 10.1016/0742-8413(87)90074-0
   PEGGINS JO, 1984, DRUG METAB DISPOS, V12, P379
   SCHOELLER DA, 1989, AM J CLIN NUTR, V50, P1176, DOI 10.1093/ajcn/50.5.1176
   Tanaka E, 1998, J CLIN PHARM THER, V23, P247
   TSANG P, 1990, CLIN LAB MED, V10, P479
   Walker CH, 1998, ECOTOX ENVIRON SAFE, V40, P65, DOI 10.1006/eesa.1998.1643
   Wilkinson GR, 1997, ADV DRUG DELIVER REV, V27, P129, DOI 10.1016/S0169-409X(97)00040-9
   WOODHOUSE K, 1992, DRUG AGING, V2, P243, DOI 10.2165/00002512-199202030-00007
NR 36
TC 7
Z9 7
U1 1
U2 27
PU CZECH ACADEMY AGRICULTURAL SCIENCES
PI PRAGUE
PA TESNOV 17, PRAGUE, 117 05, CZECH REPUBLIC
SN 0375-8427
EI 1805-9392
J9 VET MED-CZECH
JI Vet. Med.
PY 2010
VL 55
IS 9
BP 463
EP 471
DI 10.17221/2982-VETMED
PG 9
WC Veterinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Veterinary Sciences
GA 661EY
UT WOS:000282708500007
OA gold
DA 2024-02-19
ER

PT J
AU Maria, CS
   Ayala, A
   Revilla, E
AF Maria, CS
   Ayala, A
   Revilla, E
TI Changes in superoxide dismutase activity in liver and lung of old rats
SO FREE RADICAL RESEARCH
LA English
DT Article
DE superoxide dismutase; aging; antioxidant defense; oxidative damage
ID ENZYMATIC-ACTIVITY; 6-PHOSPHOGLUCONATE DEHYDROGENASE;
   HISTIDINE-RESIDUES; OXYGEN-TOXICITY; PROTEINS
AB Superoxide dismutase activity was measured in liver and lung from 3 and 24 month-old rats. Both total SOD and Mn-SOD activity decreased significantly in the liver of old rats. Recent results from our laboratory have indicated that during aging, the activity of Cu/Zn-SOD decreases in rat liver and that there is an accumulation of altered protein. It was also shown that the old Cu/Zn-SOD had one histidine fewer than the young one. In the present study, the immunoprecipitation experiments showed that the amount of immunoprecipitable Mn-SOD from liver of old rats was greater than from young ones, but when amino acid residues were measured in purified young and old Mn-SOD from liver, no change was observed. In lung, no significant age-related differences in total SOD, Cu/Zn-SOD and Mn-SOD activity were found, nor was there accumulation of altered protein during aging.
C1 UNIV SEVILLA, FAC FARM, DEPT BIOQUIM BROMATOL & TOXICOL, E-41012 SEVILLE, SPAIN.
C3 University of Sevilla
RI Ayala, Antonio/N-7591-2019; Torres, Mª Elisa Revilla/K-5897-2014;
   Santa-Maria Perez, Consuelo/K-7879-2014
OI Ayala, Antonio/0000-0001-9711-3711; Torres, Mª Elisa
   Revilla/0000-0001-8867-8446; Santa-Maria Perez,
   Consuelo/0000-0001-9195-2792
CR BARRA D, 1984, J BIOL CHEM, V259, P2595
   Beauchamp C., 1971, ANAL BIOCHEM, V44, P276, DOI DOI 10.1016/0003-2697(71)90370-8
   CUTLER RG, 1991, AM J CLIN NUTR, V53, pS373, DOI 10.1093/ajcn/53.1.373S
   DANH HC, 1983, J NEUROCHEM, V40, P1003, DOI 10.1111/j.1471-4159.1983.tb08084.x
   DENEKE SM, 1982, BRIT J ANAESTH, V54, P737, DOI 10.1093/bja/54.7.737
   ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6
   FRANK L, 1978, J APPL PHYSIOL, V45, P699, DOI 10.1152/jappl.1978.45.5.699
   GORDILLO E, 1988, J BIOL CHEM, V263, P8053
   GORDILLO E, 1989, J BIOL CHEM, V264, P17024
   GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114
   HALLIWELL B, 1989, FREE RADICAL BIO MED, P266
   HANSFORD RG, 1983, BIOCHIM BIOPHYS ACTA, V726, P41, DOI 10.1016/0304-4173(83)90010-1
   HARMAN D, 1992, MUTAT RES, V275, P257, DOI 10.1016/0921-8734(92)90030-S
   ISCHIROPOULOS H, 1990, MECH AGEING DEV, V52, P11, DOI 10.1016/0047-6374(90)90141-2
   KELLOGG EW, 1976, J GERONTOL, V31, P405, DOI 10.1093/geronj/31.4.405
   KOHTARO A, 1984, ANAL BIOCHEM, V136, P336
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MACHADO A, 1991, ARCH GERONTOL GERIAT, V12, P187, DOI 10.1016/0167-4943(91)90027-N
   MARIA CS, 1995, FEBS LETT, V374, P85
   MARIA CS, 1988, MECH AGEING DEV, V44, P115
   MCCORD JM, 1969, J BIOL CHEM, V244, P6049
   MCCORD JM, 1979, CURRENT TOPICS BIOL, V3, P1
   NISHIKIMI M, 1972, BIOCHEM BIOPH RES CO, V46, P849, DOI 10.1016/S0006-291X(72)80218-3
   PARKE DV, 1978, DRUG METABOLISM MAN, P61
   RIKANS LE, 1992, GERONTOLOGY, V38, P133
   SALIN ML, 1978, ARCH BIOCHEM BIOPHYS, V187, P223, DOI 10.1016/0003-9861(78)90027-9
   STADTMAN ER, 1986, TRENDS BIOCHEM SCI, V11, P11, DOI 10.1016/0968-0004(86)90221-5
   TOPHAM CM, 1986, EUR J BIOCHEM, V155, P87, DOI 10.1111/j.1432-1033.1986.tb09461.x
   TUENGLER P, 1977, BIOCHIM BIOPHYS ACTA, V484, P1, DOI 10.1016/0005-2744(77)90108-5
   WARNER HR, 1994, FREE RADICAL BIO MED, V17, P249, DOI 10.1016/0891-5849(94)90080-9
   YAMASAKI RB, 1981, ANAL BIOCHEM, V111, P220, DOI 10.1016/0003-2697(81)90557-1
NR 32
TC 16
Z9 16
U1 0
U2 2
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1071-5762
EI 1029-2470
J9 FREE RADICAL RES
JI Free Radic. Res.
PY 1996
VL 25
IS 5
BP 401
EP 405
DI 10.3109/10715769609149062
PG 5
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA VN494
UT WOS:A1996VN49400004
PM 8902538
DA 2024-02-19
ER

PT J
AU LaRusso, NF
   Tabibian, JH
   O'Hara, SP
AF LaRusso, Nicholas F.
   Tabibian, James H.
   O'Hara, Steven P.
TI Role of the Intestinal Microbiome in Cholestatic Liver Disease
SO DIGESTIVE DISEASES
LA English
DT Article; Proceedings Paper
CT 24th International Bile Acid Meeting on Bile Acids in Health and Disease
CY JUN 17-18, 2016
CL Dusseldorf, GERMANY
DE Microbiota; Liver diseases; Senescence; Sclerosing cholangitis
ID PRIMARY SCLEROSING CHOLANGITIS; ACTIVATION
AB Hepatobiliary health and disease is influenced by multiple factors including genetics, epigenetics, and the environment. Recently, multiple lines of evidence suggest that the microbiome also plays a central role in the initiation and/or progression of several liver diseases. Our current understanding of the dynamic interplay between microbes, microbial products and liver health and pathophysiology is incomplete. However, exciting insights are continually being made that support both a central role of the microbiome and a need for further interrogation of the microbes or microbe associated molecules involved in the initiation and progression of select liver diseases. (C) 2017 S. Ka rger AG, Basel
C1 [LaRusso, Nicholas F.; Tabibian, James H.; O'Hara, Steven P.] Mayo Clin, Div Gastroenterol & Hepatol, 200 First St SW, Rochester, MN 55905 USA.
C3 Mayo Clinic
RP LaRusso, NF (corresponding author), Mayo Clin, Div Gastroenterol & Hepatol, 200 First St SW, Rochester, MN 55905 USA.
EM larusso.nicholas@mayo.edu
FU National Institutes of Health [DK57993]; Optical Microscopy Cores of the
   Mayo Clinic Center for Cell Signaling in Gastroenterology [P30DK084567]
FX This work was supported by the National Institutes of Health Grants
   DK57993 (to N.F.L.), and Optical Microscopy Cores of the Mayo Clinic
   Center for Cell Signaling in Gastroenterology (P30DK084567).
CR Björnsson ES, 2000, HEPATO-GASTROENTEROL, V47, P1504
   Chen XM, 2005, J IMMUNOL, V175, P7447, DOI 10.4049/jimmunol.175.11.7447
   Lazaridis KN, 2016, NEW ENGL J MED, V375, P1161, DOI 10.1056/NEJMra1506330
   Marschall HU, 2016, HEPATOLOGY, V63, P26, DOI 10.1002/hep.28135
   Mueller T, 2011, LIVER INT, V31, P1574, DOI 10.1111/j.1478-3231.2011.02635.x
   O'Hara SP, 2013, J HEPATOL, V58, P575, DOI 10.1016/j.jhep.2012.10.011
   Tabibian JH, 2016, HEPATOLOGY, V63, P185, DOI 10.1002/hep.27927
   Tabibian JH, 2014, HEPATOLOGY, V59, P2263, DOI 10.1002/hep.26993
   Tabibian JH, 2012, CLIN GASTROENTEROL H, V10, P819, DOI 10.1016/j.cgh.2012.01.024
NR 9
TC 10
Z9 11
U1 0
U2 3
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0257-2753
EI 1421-9875
J9 DIGEST DIS
JI Dig. Dis.
PY 2017
VL 35
IS 3
BP 166
EP 168
DI 10.1159/000450906
PG 3
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Gastroenterology & Hepatology
GA EM5MP
UT WOS:000395356000003
PM 28249266
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Liang, GB
   He, ZH
   Chen, Y
   Zhang, HB
   Peng, HH
   Zong, DD
   Long, YJ
AF Liang, Guibin
   He, Zhihui
   Chen, Yan
   Zhang, Hongbo
   Peng, Huaihuai
   Zong, Dandan
   Long, Yingjiao
TI Existence of multiple organ aging in animal model of emphysema induced
   by cigarette smoke extract
SO TOBACCO INDUCED DISEASES
LA English
DT Article
DE cigarette smoke; decitabine; emphysema; multiple organs; aging
ID BONE-MARROW; SCF; EXPRESSION; LIVER; RECOVERY; IMPAIRS; STRESS; SPLEEN;
   INJURY; MICE
AB INTRODUCTION It is commonly considered that COPD or at least emphysema represents accelerated lung aging induced in part by oxidative damage from cigarette smoke components. However, the issue if there are any aging signs in other organs in patients with COPD or emphysema remains unclear. The aim of this study is to explore whether there is multiple organ aging in the animal model of emphysema induced by cigarette smoke extract (CSE), and to ascertain the possible mechanisms, if any. METHODS The animal model of emphysema was induced by CSE. Histomorphological changes in lung, heart, liver, kidney and spleen tissues were measured after staining with hematoxylin and eosin (H&E). The concentrations of stem cell factor (SCF), CyclinD1 and superoxide dismutase (SOD) in serum were determined by ELISA kit. The expressions of p16 (INK4a), Sca-1, eNOS proteins and mRNA in lung, heart, liver, kidney and spleen tissues were detected by Western blotting and quantitative reverse transcriptase polymerase chain reaction (qRT-PCR), respectively. Decitabine (Dec) was applied to examine whether it could alter the changes caused by CSE. RESULTS The histomorphology of lung tissue was significantly changed, while other organs exhibited normal structure and histomorphology. The concentrations of SCF, CyclinD1 and SOD in serum were lower in the CSE group than in the control group. The expression levels of p16(INK4a) protein and mRNA in lung, heart, liver, kidney and spleen tissues were higher in the CSE group than in the control group, while the expression levels of Sca-1 and eNOS proteins and mRNA were lower in the CSE group than in the control group, in the tissues described above. Dec could partly alleviate the damages caused by CSE and the degree of alleviation resulted by Dec varied from organ to organ. CONCLUSIONS In addition to the aging of the lung tissue in the emphysema animal model induced by CSE, the tissues of the heart, liver, kidney and spleen were also in the progress of aging, but the sensibility and affinity of lung to CSE were higher than those of the other organs. Multiple organ aging may also exist in the animal model of emphysema induced by CSE. DEC can partly alleviate the multiple organ aging caused by CSE.
C1 [Liang, Guibin; He, Zhihui] Cent South Univ, Xiangya Hosp 3, Dept Crit Care Med, Changsha 410013, Hunan, Peoples R China.
   [Chen, Yan; Zong, Dandan; Long, Yingjiao] Cent South Univ, Xiangya Hosp 2, Dept Resp Med, Changsha, Peoples R China.
   [Zhang, Hongbo] Cent South Univ, Xiangya Hosp 2, Dept Pathol, Changsha, Peoples R China.
   [Peng, Huaihuai] Cent South Univ, Xiangya Hosp 2, Dept Intens Care Unit, Changsha, Peoples R China.
C3 Central South University; Central South University; Central South
   University; Central South University
RP He, ZH (corresponding author), Cent South Univ, Xiangya Hosp 3, Dept Crit Care Med, Changsha 410013, Hunan, Peoples R China.
EM hzh703@csu.edu.cn
FU Natural Science Foundation of China [81870040]; Hunan province science
   and technology project [2015JC3033]
FX This study was supported by the Natural Science Foundation of China
   (81870040) and Hunan province science and technology project
   (2015JC3033).
CR World Medical Association, 2002, Am J Physiol Regul Integr Comp Physiol, V283, pR281, DOI 10.1152/ajpregu.00279.2002
   Arfian N, 2018, PHYSIOL RES, V67, pS137, DOI 10.33549/physiolres.933823
   Bailey B, 2012, CIRC RES, V111, P750, DOI 10.1161/CIRCRESAHA.112.274662
   Bengatta S, 2009, J AM SOC NEPHROL, V20, P787, DOI 10.1681/ASN.2008050515
   Camarata TD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129561
   Esmaili M, 2014, MOL BIOL RES COMMUN, V3, P141
   Ferjani H, 2016, MUTAT RES-GEN TOX EN, V810, P48, DOI 10.1016/j.mrgentox.2016.10.002
   He ZH, 2017, INT J CHRONIC OBSTR, V12, P3149, DOI 10.2147/COPD.S131090
   He ZH, 2016, EXP BIOL MED, V241, P131, DOI 10.1177/1535370215598402
   He ZH, 2015, TOB INDUC DIS, V13, DOI 10.1186/s12971-015-0033-z
   He ZH, 2017, MED SCI MONITOR, V23, DOI 10.12659/MSM.902746
   Ito K, 2009, CHEST, V135, P173, DOI 10.1378/chest.08-1419
   Jung M, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0118-4
   Kammerl IE, 2016, AM J RESP CRIT CARE, V193, P1230, DOI 10.1164/rccm.201506-1122OC
   Kuzmac S, 2014, EXP HEMATOL, V42, P966, DOI 10.1016/j.exphem.2014.07.262
   Lehrke S, 2006, CIRC RES, V99, P553, DOI 10.1161/01.RES.0000238375.88582.d8
   Li X, 2017, J CELL MOL MED, V21, P265, DOI 10.1111/jcmm.12962
   Liu X, 2019, INT J BIOL MACROMOL, V129, P41, DOI 10.1016/j.ijbiomac.2019.02.011
   Liu Y, 2015, INT J CLIN EXP PATHO, V8, P6554
   Mapel D, 2014, CURR OPIN PULM MED, V20, P186, DOI 10.1097/MCP.0000000000000024
   Sandhu C, 2000, CANCER RES, V60, P2616
   Tan KS, 2015, BIOL OPEN, V4, P596, DOI 10.1242/bio.201410686
   Triposkiadis F, 2019, J AM COLL CARDIOL, V74, P804, DOI 10.1016/j.jacc.2019.06.053
   Tsuchiya A, 2008, BIOCHEM BIOPH RES CO, V365, P595, DOI 10.1016/j.bbrc.2007.10.150
   Wan N, 2019, J CELL PHYSIOL, V234, P13693, DOI 10.1002/jcp.28050
   Wu D, 2018, BIOCHEM BIOPH RES CO, V495, P1620, DOI 10.1016/j.bbrc.2017.11.193
   Xu XL, 2020, BIOSCIENCE REP, V40, DOI 10.1042/BSR20193667
   Zhang Y, 2013, EXP LUNG RES, V39, P18, DOI 10.3109/01902148.2012.745910
   Zhang YT, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1155-z
NR 29
TC 5
Z9 5
U1 2
U2 14
PU EUROPEAN PUBLISHING
PI HERAKLION
PA SCIENCE & TECHNOLGY PARK CRETE, (STEP-C), N PLASTIRA 100, VASSILIKA
   VOUTWN, HERAKLION, CRETE 00000, GREECE
SN 1617-9625
J9 TOB INDUC DIS
JI Tob. Induc. Dis.
PD JAN
PY 2022
VL 20
BP 1
EP 11
DI 10.18332/tid/143853
PG 11
WC Substance Abuse; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Substance Abuse; Public, Environmental & Occupational Health
GA YJ9BG
UT WOS:000744820800001
PM 35087358
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Bae, SH
   Ryu, H
   Rhee, KJ
   Oh, JE
   Baik, SK
   Shim, KY
   Kong, JH
   Hyun, SY
   Pack, HS
   Im, C
   Shin, HC
   Kim, YM
   Kim, HS
   Eom, YW
   Lee, JI
AF Bae, Sung Hae
   Ryu, Hoon
   Rhee, Ki-Jong
   Oh, Ji-Eun
   Baik, Soon Koo
   Shim, Kwang Yong
   Kong, Jee Hyun
   Hyun, Shin Young
   Pack, Hyun Sung
   Im, Changjo
   Shin, Ha Cheol
   Kim, Yong Man
   Kim, Hyun Soo
   Eom, Young Woo
   Lee, Jong In
TI L-Ascorbic acid 2-phosphate and fibroblast growth factor-2 treatment
   maintains differentiation potential in bone marrow-derived mesenchymal
   stem cells through expression of hepatocyte growth factor
SO GROWTH FACTORS
LA English
DT Article
DE Bone marrow-derived mesenchymal stem cell; fibroblast growth factor-2;
   hepatocyte growth factor; L-ascorbic acid 2-phosphate; stemness
ID HYDROGEN-PEROXIDE; REDOX REGULATION; FACTOR RECEPTOR; VITAMIN-C;
   PROLIFERATION; INVOLVEMENT; GENERATION; INDUCTION; SENESCENT
AB L-ascorbic acid 2-phosphate (Asc-2P) acts as an antioxidant and a stimulator of hepatocyte growth factor (HGF) production. Previously, we reported that depletion of growth factors such as fibroblast growth factor (FGF)-2, epidermal growth factor (EGF), FGF-4 and HGF during serial passage could induce autophagy, senescence and down-regulation of stemness (proliferation via FGF-2/-4 and differentiation via HGF). In this study, we investigated the proliferation and differentiation potential of BMSCs by FGF-2 and Asc-2P. Co-treatment with FGF-2 and Asc-2P induced optimal proliferation of BMSCs and increased the accumulation rate of BMSC numbers during a 2-month culture period. Moreover, differentiation potential was maintained by co-treatment with FGF-2 and Asc-2P via HGF expression. Adipogenic differentiation potential by FGF-2 and Asc-2P was dramatically suppressed by c-Met inhibitors (SU11274). These data suggest that co-treatment with FGF-2 and Asc-2P would be beneficial in obtaining BMSCs that possess "stemness'' during long-term culture.
C1 [Bae, Sung Hae; Oh, Ji-Eun; Baik, Soon Koo; Eom, Young Woo] Yonsei Univ, Cell Therapy & Tissue Engn Ctr, Wonju Coll Med, Wonju 220701, Gangwon Do, South Korea.
   [Ryu, Hoon] Yonsei Univ, Dept Gen Surg, Wonju Coll Med, Wonju 220701, Gangwon Do, South Korea.
   [Rhee, Ki-Jong] Yonsei Univ, Dept Biomed Lab Sci, Wonju Coll Med, Wonju 220701, Gangwon Do, South Korea.
   [Baik, Soon Koo] Yonsei Univ, Dept Internal Med, Wonju Coll Med, Wonju 220701, Gangwon Do, South Korea.
   [Shim, Kwang Yong; Kong, Jee Hyun; Hyun, Shin Young; Pack, Hyun Sung; Im, Changjo; Lee, Jong In] Yonsei Univ, Dept Hematol Oncol, Wonju Coll Med, Wonju 220701, Gangwon Do, South Korea.
   [Shin, Ha Cheol; Kim, Yong Man; Kim, Hyun Soo] Pharmicell Co Ltd, Songnam, South Korea.
C3 Yonsei University; Yonsei University; Yonsei University; Yonsei
   University; Yonsei University
RP Eom, YW (corresponding author), Yonsei Univ, Cell Therapy & Tissue Engn Ctr, Wonju Coll Med, 20 Ilsan Ro, Wonju 220701, Gangwon Do, South Korea.
EM yweom@yonsei.ac.kr
RI Eom, Young/AAW-4659-2021; Oh, Ji-Eun/HMV-9113-2023
OI Hyun, Shin Young/0000-0002-8137-8675; Eom, Young Woo/0000-0002-5985-6490
FU Yonsei University Wonju College of Medicine [YUWCM-2005-02]; Basic
   Science Research Program through the National Research Foundation of
   Korea (NRF) - Ministry of Education [NRF-2012R1A1A2004981]
FX The authors report no conflicts of interest. This research was partly
   supported by a research grant from Yonsei University Wonju College of
   Medicine (YUWCM-2005-02) and Basic Science Research Program through the
   National Research Foundation of Korea (NRF) funded by the Ministry of
   Education (NRF-2012R1A1A2004981).
CR BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706
   Bowers DC, 2000, CANCER RES, V60, P4277
   Choi KM, 2008, J BIOSCI BIOENG, V105, P586, DOI 10.1263/jbb.105.586
   Colavitti R, 2002, J BIOL CHEM, V277, P3101, DOI 10.1074/jbc.M107711200
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Eom YW, 2014, BIOCHEM BIOPH RES CO, V445, P16, DOI 10.1016/j.bbrc.2014.01.084
   Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095
   Gohda Eiichi, 2002, Nihon Yakurigaku Zasshi, V119, P287
   Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494
   Haneline LS, 2008, ANTIOXID REDOX SIGN, V10, P1849, DOI 10.1089/ars.2008.2141
   HATA RI, 1989, J CELL PHYSIOL, V138, P8, DOI 10.1002/jcp.1041380103
   Jang YO, 2014, LIVER INT, V34, P33, DOI 10.1111/liv.12218
   Jang YY, 2007, BLOOD, V110, P3056, DOI 10.1182/blood-2007-05-087759
   Joyce NC, 2009, INVEST OPHTH VIS SCI, V50, P2116, DOI 10.1167/iovs.08-3007
   KRUSE FE, 1994, INVEST OPHTH VIS SCI, V35, P2405
   LO YYC, 1995, J BIOL CHEM, V270, P11727, DOI 10.1074/jbc.270.20.11727
   MAY JM, 1979, J BIOL CHEM, V254, P2214
   Naka K, 2008, ANTIOXID REDOX SIGN, V10, P1883, DOI 10.1089/ars.2008.2114
   OHBA M, 1994, J CELL BIOL, V126, P1079, DOI 10.1083/jcb.126.4.1079
   Padayatty SJ, 2003, J AM COLL NUTR, V22, P18, DOI 10.1080/07315724.2003.10719272
   Park SG, 2011, EXPERT OPIN THER TAR, V15, P1297, DOI 10.1517/14728222.2011.628315
   PHILLIPS CL, 1994, J INVEST DERMATOL, V103, P228, DOI 10.1111/1523-1747.ep12393187
   Rhee S G, 2000, Sci STKE, V2000, ppe1
   Saretzki G, 1998, J GERONTOL A-BIOL, V53, pB438, DOI 10.1093/gerona/53A.6.B438
   Sauer H, 1999, J CELL BIOCHEM, V75, P710, DOI 10.1002/(SICI)1097-4644(19991215)75:4<710::AID-JCB16>3.0.CO;2-Z
   SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296
   Takamizawa S, 2004, CELL BIOL INT, V28, P255, DOI 10.1016/j.cellbi.2004.01.010
   Truong TH, 2012, BIOCHEMISTRY-US, V51, P9954, DOI 10.1021/bi301441e
   Ushio-Fukai M, 2006, CARDIOVASC RES, V71, P226, DOI 10.1016/j.cardiores.2006.04.015
   Wu YL, 1998, GROWTH HORM IGF RES, V8, P421, DOI 10.1016/S1096-6374(98)80313-4
   Zahm JM, 2000, J CELL PHYSIOL, V185, P447, DOI 10.1002/1097-4652(200012)185:3<447::AID-JCP16>3.0.CO;2-D
NR 31
TC 19
Z9 19
U1 0
U2 9
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0897-7194
EI 1029-2292
J9 GROWTH FACTORS
JI Growth Factors
PD APR
PY 2015
VL 33
IS 2
BP 71
EP 78
DI 10.3109/08977194.2015.1013628
PG 8
WC Cell Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Endocrinology & Metabolism
GA CI1EZ
UT WOS:000354486700002
PM 25714612
DA 2024-02-19
ER

PT J
AU Jin, SL
   Yin, YG
AF Jin, Sheng-lang
   Yin, Yong-guang
TI In vivo antioxidant activity of total flavonoids from indocalamus leaves
   in aging mice caused by D-galactose
SO FOOD AND CHEMICAL TOXICOLOGY
LA English
DT Article
DE Indocalamus leaves; Total flavonoids; D-galactose; Aging; Antioxidant
   activity
ID OXIDATIVE STRESS; LIPID PEROXIDES; BAMBOO; ESTABLISHMENT; CHEMISTRY;
   EXTRACT; ASSAY
AB Objective: The aim of this thesis is to explore antioxidant activity of total flavonoids extracted from indocalamus leaves. Methods: Aging mice model was established by D-galactose induction. Three groups of mice were treated with total flavonoids extracted from indocalamus leaves at doses of 20, 40 and 80 mg/kg d bw, respectively. The antioxidant status in the aging mice was measured by determining the activities of superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), catalase (CAT) and total anti-oxidant capability (T-AOC) in the serum and liver and malondialdehyde (MDA) content in the serum, liver and brain. Results: Compared with control group, extracts of indocalamus leaves significantly enhanced activities of SOD, GSH-Px, CAT in the serum and liver, and decreased MDA content in the serum, liver and brain at the tested doses. Conclusion: Total flavonoids extracted from indocalamus leaves demonstrated the potent antioxidant activity. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Jin, Sheng-lang; Yin, Yong-guang] Jilin Univ, Sch Biol & Agr Engn, Changchun 130022, Jilin Province, Peoples R China.
   [Jin, Sheng-lang] Huangshan Univ, Tourism Coll, Huangshan 245041, Anhui, Peoples R China.
C3 Jilin University; Huangshan University
RP Jin, SL (corresponding author), Jilin Univ, Sch Biol & Agr Engn, Changchun 130022, Jilin Province, Peoples R China.
EM jinshenglang@163.com
RI Yin, Yongguang/D-1695-2010
FU Anhui Provincial Natural Science College [KJ2011B165]; Huangshan
   University [2011xkj003]
FX This work is supported by 2011 Anhui Provincial Natural Science College
   Research Project (NO. KJ2011B165) and 2011 Huangshan University Sciences
   Research Project (NO. 2011xkj003).
CR Aebi H, 1984, Methods Enzymol, V105, P121
   Aherne SA, 2002, NUTRITION, V18, P75, DOI 10.1016/S0899-9007(01)00695-5
   Ajay M, 2003, LIFE SCI, V74, P603, DOI 10.1016/j.lfs.2003.06.039
   Ardestani A, 2007, FOOD CHEM, V104, P21, DOI 10.1016/j.foodchem.2006.10.066
   ARMSTRONG D, 1994, ADV EXP MED BIOL, V366, P43
   Arora A, 1998, FREE RADICAL BIO MED, V24, P1355, DOI 10.1016/S0891-5849(97)00458-9
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   Cao GH, 1997, FREE RADICAL BIO MED, V22, P749, DOI 10.1016/S0891-5849(96)00351-6
   Cao HaiQun, 2004, Entomologia Sinica, V11, P267, DOI 10.1111/j.1744-7917.2004.tb00423.x
   Chen J.Y., 2001, CHINESE WILD PLANT R, V20, P22
   CHEN YT, 1990, FREE RADICAL BIO MED, V9, P19, DOI 10.1016/0891-5849(90)90045-K
   Cui J, 2011, JPC-J PLANAR CHROMAT, V24, P394, DOI 10.1556/JPC.24.2011.5.6
   Cui X, 2006, J NEUROSCI RES, V84, P647, DOI 10.1002/jnr.20899
   Foti M, 1996, J AGR FOOD CHEM, V44, P497, DOI 10.1021/jf950378u
   FREI B, 1988, P NATL ACAD SCI USA, V85, P9748, DOI 10.1073/pnas.85.24.9748
   Giovanelli G, 2009, FOOD CHEM, V112, P903, DOI 10.1016/j.foodchem.2008.06.066
   Gong G.Q., 1991, J CHINA PHARM U, V22, P101
   Grune T, 2000, BIOGERONTOLOGY, V1, P31, DOI 10.1023/A:1010037908060
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Ho SC, 2003, BIOGERONTOLOGY, V4, P15, DOI 10.1023/A:1022417102206
   Hu C, 2000, J AGR FOOD CHEM, V48, P3170, DOI 10.1021/jf0001637
   Hwang J, 2000, FREE RADICAL BIO MED, V29, P79, DOI 10.1016/S0891-5849(00)00322-1
   Jiao JJ, 2007, PHYTOTHER RES, V21, P1135, DOI 10.1002/ptr.2223
   Jiao JJ, 2007, J AGR FOOD CHEM, V55, P10086, DOI 10.1021/jf0716533
   Ju H.S., 1991, CHINESE PHARMACOL B, V6, P97
   Jun M., 2004, Forestry Studies in China, V6, P1, DOI 10.1007/s11632-004-0001-9
   Kirakosyan A, 2010, FOOD CHEM, V122, P78, DOI 10.1016/j.foodchem.2010.02.017
   Kweon MH, 2001, J AGR FOOD CHEM, V49, P4646, DOI 10.1021/jf010514x
   Lei M, 2008, BIOCHEM BIOPH RES CO, V369, P1082, DOI 10.1016/j.bbrc.2008.02.151
   Li W.B., 1995, CHIN J PHARM TOXICOL, V9, P93
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   OYANAGUI Y, 1984, ANAL BIOCHEM, V142, P290
   Rodgers EH, 1998, CHEM-BIOL INTERACT, V116, P213, DOI 10.1016/S0009-2797(98)00092-1
   Rogina B, 2000, BIOGERONTOLOGY, V1, P163, DOI 10.1023/A:1010039813107
   Scurlock JMO, 2000, BIOMASS BIOENERG, V19, P229, DOI 10.1016/S0961-9534(00)00038-6
   Song X, 1999, MECH AGEING DEV, V108, P239, DOI 10.1016/S0047-6374(99)00022-6
   Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142
   Zhang Y, 2005, J CHROMATOGR A, V1065, P177, DOI 10.1016/j.chroma.2004.12.086
   Zhang Y, 2008, FOOD CHEM, V107, P1326, DOI 10.1016/j.foodchem.2007.09.037
NR 39
TC 39
Z9 48
U1 3
U2 57
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0278-6915
EI 1873-6351
J9 FOOD CHEM TOXICOL
JI Food Chem. Toxicol.
PD OCT
PY 2012
VL 50
IS 10
BP 3814
EP 3818
DI 10.1016/j.fct.2012.07.046
PG 5
WC Food Science & Technology; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Toxicology
GA 021PF
UT WOS:000309897100055
PM 22874925
DA 2024-02-19
ER

PT J
AU Jiao, JJ
   Wei, Y
   Chen, JN
   Chen, XY
   Zhang, Y
AF Jiao, Jingjing
   Wei, Yan
   Chen, Jingnan
   Chen, Xinyu
   Zhang, Yu
TI Anti-aging and redox state regulation effects of A-type
   proanthocyanidins-rich cranberry concentrate and its comparison with
   grape seed extract in mice
SO JOURNAL OF FUNCTIONAL FOODS
LA English
DT Article
DE Cranberry concentrate; Grape seed extract; Proanthocyanidins Redox
   state; Anti-aging
ID TANDEM MASS-SPECTROMETRY; PERFORMANCE LIQUID-CHROMATOGRAPHY; OXIDATIVE
   STRESS; VACCINIUM-MACROCARPON; SUPEROXIDE-DISMUTASE;
   GLUTATHIONE-PEROXIDASE; ANTIOXIDANT CAPACITY; PROCYANIDIN EXTRACT;
   METABOLIC SYNDROME; D-GALACTOSE
AB We investigated the anti-aging and redox state regulation effects by A-type proanthocyanidins (PACs) rich cranberry concentrate (CBC) and its comparison with B-type PACs-rich grape seed extract (GSE). Using the Q-Extractive mass spectrometry, PACs dimer A and B were identified as predominant phenolic compounds of CBC and GSE, respectively, while epicatechin was present in both extracts. Using the D-galactose-induced aging mice model, effects were investigated via an 8-week oral gavage considering water-soluble vitamin E as the positive control. Both CBC and GSE reduced hepatic and brain thiobarbituric acid reactive substances, and plasma 8-isoprostane levels by 30-57%, 24-30% and 11-62%, respectively, and decreased brain and plasma monoamine oxidase activities by 27-59% and 65-71%, respectively. CBC could improve hepatic glutathione peroxidase activity by 42%, while GSE increased hepatic superoxide dismutase activity by 13%. Therefore, both extracts exerted anti-aging effects probably via regulating in vivo redox state. However, neither generated any effect on catalase activities. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Jiao, Jingjing] Zhejiang Univ, Dept Nutr, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China.
   [Wei, Yan; Chen, Jingnan; Chen, Xinyu; Zhang, Yu] Zhejiang Univ, Coll Biosyst Engn & Food Sci, Dept Food Sci & Nutr, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.
   [Wei, Yan; Chen, Jingnan; Chen, Xinyu; Zhang, Yu] Zhejiang Univ, Fuli Inst Food Sci, Zhejiang R&D Ctr Food Technol & Equipment, Zhejiang Key Lab Agrofood Proc, Hangzhou 310058, Zhejiang, Peoples R China.
C3 Zhejiang University; Zhejiang University; Zhejiang University
RP Zhang, Y (corresponding author), Zhejiang Univ, Coll Biosyst Engn & Food Sci, Dept Food Sci & Nutr, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.
EM y_zhang@zju.edu.cn
RI chen, xinyu/HNR-2708-2023
FU National Natural Science Foundation of China [31401659]; Foundation for
   the Author of a Nationally Excellent Doctoral Dissertation of China
   [201260]
FX This research was financially supported by the National Natural Science
   Foundation of China (Grant No. 31401659) and by the Foundation for the
   Author of a Nationally Excellent Doctoral Dissertation of China (Grant
   No. 201260).
CR Anhê FF, 2015, GUT, V64, P872, DOI 10.1136/gutjnl-2014-307142
   [Anonymous], MITOCHONDRIA
   Babich H, 2012, PHYTOTHER RES, V26, P1358, DOI 10.1002/ptr.3735
   Bagchi D, 2014, MUTAT RES-FUND MOL M, V768, P69, DOI 10.1016/j.mrfmmm.2014.04.004
   Basu A, 2011, NUTR RES, V31, P190, DOI 10.1016/j.nutres.2011.02.003
   BATESMITH EC, 1975, PHYTOCHEMISTRY, V14, P1107, DOI 10.1016/0031-9422(75)85197-1
   Blumberg JB, 2013, ADV NUTR, V4, P618, DOI 10.3945/an.113.004473
   Bodet C, 2008, CRIT REV FOOD SCI, V48, P672, DOI 10.1080/10408390701636211
   Boer JL, 2014, ARCH BIOCHEM BIOPHYS, V544, P142, DOI 10.1016/j.abb.2013.09.002
   Brouwers O, 2011, J BIOL CHEM, V286, P1374, DOI 10.1074/jbc.M110.144097
   Carpenter JL, 2014, J SCI FOOD AGR, V94, P2738, DOI 10.1002/jsfa.6618
   Carradori S, 2014, MOL DIVERS, V18, P219, DOI 10.1007/s11030-013-9490-6
   Castillo J, 2005, ANAL BIOCHEM, V343, P293, DOI 10.1016/j.ab.2005.05.027
   Chedea VS, 2010, FOOD CHEM, V121, P132, DOI 10.1016/j.foodchem.2009.12.020
   Chen JY, 2016, J FUNCT FOODS, V21, P290, DOI 10.1016/j.jff.2015.12.023
   Chen Q, 2013, ENVIRON TOXICOL PHAR, V36, P759, DOI 10.1016/j.etap.2013.07.006
   China National Standard, 2010, 5413182010 GB
   China National Standard, 2010, 541392010 GB
   Cho ML, 2009, IMMUNOL LETT, V124, P102, DOI 10.1016/j.imlet.2009.05.001
   Côté J, 2010, CRIT REV FOOD SCI, V50, P872, DOI 10.1080/10408390903042069
   Dimitrijevic DS, 2014, OXID COMMUN, V37, P755
   Duthie SJ, 2006, EUR J NUTR, V45, P113, DOI 10.1007/s00394-005-0572-9
   Elberry AA, 2010, FOOD CHEM TOXICOL, V48, P1178, DOI 10.1016/j.fct.2010.02.008
   Evran B, 2014, PHARMACOL REP, V66, P81, DOI 10.1016/j.pharep.2013.08.008
   Feghali K, 2012, J AGR FOOD CHEM, V60, P5728, DOI 10.1021/jf203304v
   Gaeta LM, 2002, CLIN CHIM ACTA, V322, P117, DOI 10.1016/S0009-8981(02)00163-8
   Gambino V, 2013, AGING CELL, V12, P435, DOI 10.1111/acel.12060
   Ge YW, 2016, ANAL BIOANAL CHEM, V408, P3555, DOI 10.1007/s00216-016-9433-z
   Ge ZZ, 2015, J AGR FOOD CHEM, V63, P8991, DOI 10.1021/acs.jafc.5b03657
   Giera M, 2012, CHROMATOGRAPHIA, V75, P433, DOI 10.1007/s10337-012-2237-1
   GOTH L, 1991, CLIN CHIM ACTA, V196, P143, DOI 10.1016/0009-8981(91)90067-M
   Grace MH, 2012, J FOOD SCI, V77, pH176, DOI 10.1111/j.1750-3841.2012.02788.x
   Gray R, 2014, LANCET, V384, P1196, DOI 10.1016/S0140-6736(14)60683-8
   Hamlaoui-Gasmi S, 2012, CAN J PHYSIOL PHARM, V90, P547, DOI [10.1139/Y2012-025, 10.1139/y2012-025]
   Henderson BC, 2007, EUR J HEART FAIL, V9, P450, DOI 10.1016/j.ejheart.2006.12.008
   Jia ZY, 2011, MOL VIS, V17, P210
   Koerner JL, 2009, J CHROMATOGR A, V1216, P1403, DOI 10.1016/j.chroma.2008.12.086
   Kowalska K, 2016, J FUNCT FOODS, V20, P171, DOI 10.1016/j.jff.2015.11.001
   Labuschagne CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080935
   Labuschagne CF, 2013, AGEING RES REV, V12, P918, DOI 10.1016/j.arr.2013.09.003
   Lee J, 2013, J FUNCT FOODS, V5, P144, DOI 10.1016/j.jff.2012.09.005
   Li HJ, 2007, ANAL CHEM, V79, P1739, DOI 10.1021/ac061823v
   Lu XL, 2014, FOOD FUNCT, V5, P2892, DOI 10.1039/c4fo00391h
   Masaki H, 2010, J DERMATOL SCI, V58, P85, DOI 10.1016/j.jdermsci.2010.03.003
   Mateos R, 2005, J CHROMATOGR B, V827, P76, DOI 10.1016/j.jchromb.2005.06.035
   Mizuno K, 2015, J PHARMACEUT BIOMED, V112, P36, DOI 10.1016/j.jpba.2015.04.020
   Muller FL, 2007, FREE RADICAL BIO MED, V43, P477, DOI 10.1016/j.freeradbiomed.2007.03.034
   Musiek ES, 2005, LIPIDS, V40, P987, DOI 10.1007/s11745-005-1460-7
   Neto CC, 2007, MOL NUTR FOOD RES, V51, P652, DOI 10.1002/mnfr.200600279
   Nourooz-Zadeh J, 2008, BIOCHEM SOC T, V36, P1060, DOI 10.1042/BST0361060
   Rolim A, 2005, J AOAC INT, V88, P1015
   Ryan L, 2010, INT J FOOD SCI TECH, V45, P1191, DOI 10.1111/j.1365-2621.2010.02254.x
   Su L, 2011, TOXICOL MECH METHOD, V21, P487, DOI 10.3109/15376516.2011.556156
   Tian Y, 2011, FOOD CHEM TOXICOL, V49, P1728, DOI 10.1016/j.fct.2011.04.018
   Uysal U, 2013, CURR PHARM DESIGN, V19, P6094, DOI 10.2174/1381612811319340004
   Wang XH, 2013, PHYTOTHER RES, V27, P869, DOI 10.1002/ptr.4793
   Weydert CJ, 2010, NAT PROTOC, V5, P51, DOI 10.1038/nprot.2009.197
   Yin HY, 2011, CHEM REV, V111, P5944, DOI 10.1021/cr200084z
   Yin HY, 2003, J BIOL CHEM, V278, P16720, DOI 10.1074/jbc.M300604200
   Zhou HC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107606
   Zhou MJ, 1997, ANAL BIOCHEM, V253, P169, DOI 10.1006/abio.1997.2392
NR 61
TC 25
Z9 33
U1 2
U2 79
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1756-4646
J9 J FUNCT FOODS
JI J. Funct. Food.
PD MAR
PY 2017
VL 30
BP 63
EP 73
DI 10.1016/j.jff.2016.12.039
PG 11
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA EL9FF
UT WOS:000394924700008
DA 2024-02-19
ER

PT S
AU Cottrell, DA
   Blakely, EL
   Borthwick, GM
   Johnson, MA
   Taylor, GA
   Brierley, EJ
   Ince, PG
   Turnbull, DM
AF Cottrell, DA
   Blakely, EL
   Borthwick, GM
   Johnson, MA
   Taylor, GA
   Brierley, EJ
   Ince, PG
   Turnbull, DM
BE Toussaint, O
   Osiewacz, HD
   Lithgow, GJ
   Brack, C
TI Role of mitochondrial DNA mutations in disease and aging
SO MOLECULAR AND CELLULAR GERONTOLOGY
SE Annals of the New York Academy of Sciences
LA English
DT Article; Proceedings Paper
CT EMBO Workshop on Molecular and Cellular Gerontology
CY SEP 18-22, 1999
CL SERPIANO, SWITZERLAND
SP European Molec Biol Org, AETAS, Biogerontology, Kluwer Acad Publishers, Clontech AG, Crossair Ltd Co Reg European Air Transport, F Hoffmann La Roche AG, Freiwillege Akad Gesell, Geriatr Univ Clin, Novartis Pharma AG, Psychiat Univ Clin, Res Into Aging, London, Swiss Acad Med Sci, Verum, Fdn Behav & Environm
ID AGE-RELATED-CHANGES; OXIDATIVE DAMAGE; RESPIRATORY-CHAIN;
   LIPID-COMPOSITION; 4977-BP DELETION; DEOXYRIBONUCLEIC-ACID;
   SUPEROXIDE-DISMUTASE; PARKINSONS-DISEASE; MUSCLE-FIBERS; RAT-LIVER
AB Since Harman in 1972 first proposed a role in the process of aging for the mitochondrial genome, a wealth of evidence has been accumulated to support this theory. We discuss the hereditary mitochondrial DNA disorders, which we believe may give insight into both normal aging and neurodegenerative conditions. We then review the evidence for the role of mitochondrial DNA mutations in both aging and age-related disorders and also discuss new approaches for investigating the mitochondrial genome at a single cell level, by observing the activity of the mitochondrial enzyme cytochrome c oxidase.
C1 Newcastle Univ, Sch Med, Dept Neurol, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
C3 Newcastle University - UK
RP Cottrell, DA (corresponding author), Newcastle Univ, Sch Med, Dept Neurol, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM d.a.cottrell@ncl.ac.uk
RI Ince, Paul G/A-5064-2009
OI Ince, Paul G/0000-0001-6677-8753
CR Barreau E, 1996, INVEST OPHTH VIS SCI, V37, P384
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   BYRNE E, 1992, MUTAT RES, V275, P125, DOI 10.1016/0921-8734(92)90017-J
   CHENG KC, 1992, J BIOL CHEM, V267, P166
   Chinnery PF, 1999, LANCET, V354, pSI17
   COOPER JM, 1992, J NEUROL SCI, V113, P91, DOI 10.1016/0022-510X(92)90270-U
   CORRALDEBRINSKI M, 1991, JAMA-J AM MED ASSOC, V266, P1812, DOI 10.1001/jama.266.13.1812
   CORRALDEBRINSKI M, 1994, GENOMICS, V23, P471, DOI 10.1006/geno.1994.1525
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   COTTRELL DA, 1999, UNPUB ANN NEUROL
   DIDONATO S, 1993, NEUROLOGY, V43, P2262, DOI 10.1212/WNL.43.11.2262
   FELDMAN D, 1981, CANCER RES, V41, P2151
   FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533
   FRENZEL H, 1984, MECH AGEING DEV, V27, P29, DOI 10.1016/0047-6374(84)90080-0
   Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309
   Hagen TM, 1997, P NATL ACAD SCI USA, V94, P3064, DOI 10.1073/pnas.94.7.3064
   HARMAN D, 1972, AM J CLIN NUTR, V25, P839
   HAYAKAWA M, 1991, BIOCHEM BIOPH RES CO, V179, P1023, DOI 10.1016/0006-291X(91)91921-X
   HAYAKAWA M, 1992, BIOCHEM BIOPH RES CO, V189, P979, DOI 10.1016/0006-291X(92)92300-M
   HRUSZKEWYCZ AM, 1992, MUTAT RES, V275, P243, DOI 10.1016/0921-8734(92)90028-N
   IKEBE S, 1990, BIOCHEM BIOPH RES CO, V170, P1044, DOI 10.1016/0006-291X(90)90497-B
   KAO SH, 1995, BIOL REPROD, V52, P729, DOI 10.1095/biolreprod52.4.729
   Khrapko K, 1999, NUCLEIC ACIDS RES, V27, P2434, DOI 10.1093/nar/27.11.2434
   KITAGAWA T, 1993, BIOL REPROD, V49, P730, DOI 10.1095/biolreprod49.4.730
   KUCHINO Y, 1987, NATURE, V327, P77, DOI 10.1038/327077a0
   LEE HC, 1994, BBA-MOL BASIS DIS, V1226, P37, DOI 10.1016/0925-4439(94)90056-6
   LEZZA AMS, 1994, BIOCHEM BIOPH RES CO, V205, P772, DOI 10.1006/bbrc.1994.2732
   LINNANE AW, 1995, BBA-MOL BASIS DIS, V1271, P191, DOI 10.1016/0925-4439(95)00027-2
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   MECOCCI P, 1993, ANN NEUROL, V34, P609, DOI 10.1002/ana.410340416
   MECOCCI P, 1994, ANN NEUROL, V36, P747, DOI 10.1002/ana.410360510
   MERRIWETHER DA, 1991, J MOL EVOL, V33, P543, DOI 10.1007/BF02102807
   MULLERHOCKER J, 1990, J NEUROL SCI, V100, P14, DOI 10.1016/0022-510X(90)90006-9
   MULLERHOCKER J, 1993, VIRCHOWS ARCH A, V422, P7, DOI 10.1007/BF01605127
   PANG CY, 1994, ARCH BIOCHEM BIOPHYS, V312, P534, DOI 10.1006/abbi.1994.1342
   PARADIES G, 1990, BIOCHIM BIOPHYS ACTA, V1016, P207, DOI 10.1016/0005-2728(90)90060-H
   PARADIES G, 1991, ARCH BIOCHEM BIOPHYS, V284, P332, DOI 10.1016/0003-9861(91)90304-2
   Porteous WK, 1998, EUR J BIOCHEM, V257, P192, DOI 10.1046/j.1432-1327.1998.2570192.x
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   ROBIN ED, 1988, J CELL PHYSIOL, V136, P507, DOI 10.1002/jcp.1041360316
   RUGGIERO FM, 1992, J NEUROCHEM, V59, P487, DOI 10.1111/j.1471-4159.1992.tb09396.x
   SEMSEI I, 1991, MECH AGEING DEV, V58, P13, DOI 10.1016/0047-6374(91)90116-H
   SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0
   SIMONETTI S, 1992, BIOCHIM BIOPHYS ACTA, V1180, P113, DOI 10.1016/0925-4439(92)90059-V
   SOHAL RS, 1990, FREE RADICAL BIO MED, V9, P495, DOI 10.1016/0891-5849(90)90127-5
   SOHAL RS, 1990, MECH AGEING DEV, V56, P223, DOI 10.1016/0047-6374(90)90084-S
   SOHAL RS, 1991, MECH AGEING DEV, V57, P187, DOI 10.1016/0047-6374(91)90034-W
   SOHAL RS, 1994, MECH AGEING DEV, V74, P121, DOI 10.1016/0047-6374(94)90104-X
   SPARACO M, 1993, J NEUROPATH EXP NEUR, V52, P1, DOI 10.1097/00005072-199301000-00001
   Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142
   WOOD ML, 1990, BIOCHEMISTRY-US, V29, P7024, DOI 10.1021/bi00482a011
   YANG JH, 1994, ARCH DERMATOL RES, V286, P386, DOI 10.1007/BF00371798
NR 53
TC 26
Z9 35
U1 0
U2 4
PU NEW YORK ACAD SCIENCES
PI NEW YORK
PA 2 EAST 63RD ST, NEW YORK, NY 10021 USA
SN 0077-8923
BN 1-57331-272-X; 1-57331-271-1
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PY 2000
VL 908
BP 199
EP 207
PG 9
WC Biochemistry & Molecular Biology; Cell Biology; Geriatrics & Gerontology
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology; Geriatrics & Gerontology
GA BQ53H
UT WOS:000088671200018
PM 10911959
DA 2024-02-19
ER

PT J
AU Nangami, GN
   Sakwe, AM
   Izban, MG
   Rana, T
   Lammers, PE
   Thomas, P
   Chen, ZB
   Ochieng, J
AF Nangami, Gladys N.
   Sakwe, Amos M.
   Izban, Michael G.
   Rana, Tanu
   Lammers, Philip E.
   Thomas, Portia
   Chen, Zhenbang
   Ochieng, Josiah
TI Fetuin-A (alpha 2HS glycoprotein) modulates growth, motility, invasion,
   and senescence in high-grade astrocytomas
SO CANCER MEDICINE
LA English
DT Article
DE Fetuin-A; glioblastoma; growth; invasion; motility; senescence
ID UP-REGULATION; TUMOR-CELLS; EXOSOMES; CANCER; ALPHA-2HS-GLYCOPROTEIN;
   APOPTOSIS; ONCOGENE; ADHESION; BIOLOGY; PROTEIN
AB Glioblastomas (high-grade astrocytomas) are highly aggressive brain tumors with poor prognosis and limited treatment options. In the present studies, we have defined the role of fetuin-A, a liver-derived multifunctional serum protein, in the growth of an established glioblastoma cell line, LN229. We hereby demonstrate that these cells synthesize ectopic fetuin-A which supports their growth in culture in the absence of serum. We have demonstrated that a panel of tissue microarray (TMA) of glioblastomas also express ectopic fetuin-A. Knocking down fetuin-A using shRNA approach in LN229, significantly reduced their in vitro growth as well as growth and invasion in vivo. The fetuin-A knockdown subclones of LN229 (A and D) also had reduced motility and invasive capacity. Treatment of LN229 cells with asialofetuin (ASF), attenuated their uptake of labeled fetuin-A, and induced senescence in them. Interestingly, the D subclone that had similar to 90% reduction in ectopic fetuin-A, underwent senescence in serum-free medium which was blunted in the presence of purified fetuin-A. Uptake of labeled exosomes was attenuated in fetuin-A knockdown subclones A and D. Taken together, the studies demonstrate the impact of fetuin-A as significant node of growth, motility, and invasion signaling in glioblastomas that can be targeted for therapy.
C1 [Nangami, Gladys N.; Sakwe, Amos M.; Rana, Tanu; Thomas, Portia; Chen, Zhenbang; Ochieng, Josiah] Meharry Med Coll, Dept Biochem & Canc Biol, 1005 DB Todd Blvd, Nashville, TN 37208 USA.
   [Izban, Michael G.] Meharry Med Coll, Dept Pathol, 1005 DB Todd Blvd, Nashville, TN 37208 USA.
   [Lammers, Philip E.] Meharry Med Coll, Dept Internal Med, 1005 DB Todd Blvd, Nashville, TN 37208 USA.
C3 Meharry Medical College; Meharry Medical College; Meharry Medical
   College
RP Ochieng, J (corresponding author), Meharry Med Coll, Dept Biochem & Canc Biol, 1005 DB Todd Blvd, Nashville, TN 37208 USA.
EM jochieng@mmc.edu
RI Rana, Tanu/K-9579-2013; Sakwe, Amos/AAU-7639-2020
OI Sakwe, Amos/0000-0002-2283-794X
FU MMC Institutional Bridge Funding;  [2 U54 MD007593-06];  [5 U54
   CA163069-03]
FX This work was supported by grants 2 U54 MD007593-06 (P.L. and J.O.) and
   5 U54 CA163069-03 (P.L.) and MMC Institutional Bridge Funding (J.O.)
CR Chan YK, 2015, INT J CANCER, V137, P1830, DOI 10.1002/ijc.29562
   Chen J, 2013, PANCREATOLOGY, V13, P290, DOI 10.1016/j.pan.2013.03.010
   Chen NX, 2007, AM J PHYSIOL-RENAL, V292, pF599, DOI 10.1152/ajprenal.00303.2006
   Childs BG, 2014, EMBO REP, V15, P1139, DOI 10.15252/embr.201439245
   Christianson HC, 2013, P NATL ACAD SCI USA, V110, P17380, DOI 10.1073/pnas.1304266110
   Demetriou M, 1996, J BIOL CHEM, V271, P12755, DOI 10.1074/jbc.271.22.12755
   Dubois LG, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00418
   Furtak V, 2001, BIOCHEM BIOPH RES CO, V289, P845, DOI 10.1006/bbrc.2001.6064
   Gorgoulis VG, 2010, CURR OPIN CELL BIOL, V22, P816, DOI 10.1016/j.ceb.2010.07.013
   Goustin AS, 2013, CELL SIGNAL, V25, P981, DOI 10.1016/j.cellsig.2012.12.011
   Guillory B, 2010, AM J PATHOL, V177, P2635, DOI 10.2353/ajpath.2010.100177
   Higginbotham JN, 2011, CURR BIOL, V21, P779, DOI 10.1016/j.cub.2011.03.043
   Hoelzinger DB, 2007, J NATL CANCER I, V99, P1583, DOI 10.1093/jnci/djm187
   Koumangoye RB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024234
   Kundranda MN, 2005, CANCER RES, V65, P499
   Louis DN, 2007, ACTA NEUROPATHOL, V114, P547, DOI 10.1007/s00401-007-0278-6
   Louis DN, 2006, ANNU REV PATHOL-MECH, V1, P97, DOI 10.1146/annurev.pathol.1.110304.100043
   MCFARLANE IG, 1983, CLIN SCI, V64, P127, DOI 10.1042/cs0640127
   Mintz PJ, 2015, P NATL ACAD SCI USA, V112, P2515, DOI 10.1073/pnas.1500097112
   Mori K, 2012, ADV CLIN CHEM, V56, P175, DOI 10.1016/B978-0-12-394317-0.00010-8
   Naito C, 2016, ATHEROSCLEROSIS, V246, P344, DOI 10.1016/j.atherosclerosis.2016.01.037
   Nangami G, 2014, EXP CELL RES, V328, P388, DOI 10.1016/j.yexcr.2014.08.037
   Nangami GN, 2013, BIOCHEM BIOPH RES CO, V438, P660, DOI 10.1016/j.bbrc.2013.07.125
   Ochieng J, 2009, EXP CELL RES, V315, P1875, DOI 10.1016/j.yexcr.2009.03.010
   Oie HK, 1996, J CELL BIOCHEM, P24
   Pal D, 2012, NAT MED, V18, P1279, DOI 10.1038/nm.2851
   Petrik V, 2008, CLIN CHEM, V54, P713, DOI 10.1373/clinchem.2007.096792
   Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094
   Sakwe AM, 2010, J BIOL CHEM, V285, P41827, DOI 10.1074/jbc.M110.128926
   Schäfer C, 2003, J CLIN INVEST, V112, P357, DOI [10.1172/JCI200317202, 10.1172/JCI17202]
   Schönemeier B, 2016, PANCREAS, V45, P1018, DOI 10.1097/MPA.0000000000000573
   Stone Louise, 2015, Nat Rev Urol, V12, P178, DOI 10.1038/nrurol.2015.34
   Sun Y, 2014, CLIN THER, V36, P863, DOI 10.1016/j.clinthera.2014.04.018
   Takano S, 2010, J ONCOL, V2010, DOI 10.1155/2010/351908
   Thompson PD, 2014, EXP CELL RES, V321, P123, DOI 10.1016/j.yexcr.2013.12.003
   Voelkl J, 2014, CELL PHYSIOL BIOCHEM, V33, P1911, DOI 10.1159/000362968
   Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002
   Watson K, 2012, FEBS LETT, V586, P3458, DOI 10.1016/j.febslet.2012.07.071
   Wu N, 2013, BRIT J CANCER, V109, P2853, DOI 10.1038/bjc.2013.672
   Zeng T, 2015, FRONT BIOSCI-LANDMRK, V20, P1104, DOI 10.2741/4362
NR 40
TC 18
Z9 18
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2045-7634
J9 CANCER MED-US
JI Cancer Med.
PD DEC
PY 2016
VL 5
IS 12
BP 3532
EP 3543
DI 10.1002/cam4.940
PG 12
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA EE7YK
UT WOS:000389841200017
PM 27882696
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Gil, M
   Hortós, M
   Sárraga, C
AF Gil, M
   Hortós, M
   Sárraga, C
TI Calpain and cathepsin activities, and protein extractability during
   ageing of <i>longissimus</i> porcine muscle from normal and PSE meat
SO FOOD CHEMISTRY
LA English
DT Article
ID POSTMORTEM TENDERIZATION; BETA-GLUCURONIDASE; RAT-LIVER; CHICKEN;
   PURIFICATION; DEGRADATION; MYOFIBRILS; INHIBITOR; LYSOSOMES; STORAGE
AB Proteolytic activity on commercial substrates and protein extractability in solutions of different ionic strength were compared for normal and exudative longissimus porcine muscles during ageing at 4 degrees C. No effect of meat quality on calpain and cathepsin activities was observed, whereas ageing time had a statistically significant effect on cal:pain activity and cathepsin B+L activity. Protein extractability depended on meat quality and it was higher in normal meat than in exudative meat. Differences in accessibility of the myofibrils, according to meat quality, can determine the differences in the action of proteolytic enzymes and in protein extractability. It is suggested that myofibrillar protein extractability could be a suitable meat quality indicator. (C) 1998 Elsevier Science Ltd. All rights reserved.
C1 IRTA, Unitat Tecnol Analit, Ctr Tecnol Carn, Monells 17121, Girona, Spain.
C3 IRTA
RP Gil, M (corresponding author), IRTA, Unitat Tecnol Analit, Ctr Tecnol Carn, Granja Camps & Armet S-N, Monells 17121, Girona, Spain.
RI Hortos, M./L-2595-2017
OI Hortos, M./0000-0001-7823-9626
CR ANASTASI A, 1983, BIOCHEM J, V211, P129, DOI 10.1042/bj2110129
   ARNAU J, 1991, THESIS U AUTONOMA BA
   BARRETT AJ, 1987, TRENDS BIOCHEM SCI, V12, P193, DOI 10.1016/0968-0004(87)90092-2
   BRISKEY EJ, 1961, J FOOD SCI, V26, P297, DOI 10.1111/j.1365-2621.1961.tb01658.x
   BRISKEY ERNEST J., 1964, ADVANCE FOOD RES, V13, P89
   CASSENS RG, 1975, ADV FOOD RES, V21, P72
   CENA P, 1990, 36 INT C MEAT SCI TE, P209
   DILBERVANGRIETH.E, 1991, 37 INT C MEAT SCI TE, P340
   DRANSFIELD E, 1992, MEAT SCI, V31, P75, DOI 10.1016/0309-1740(92)90073-D
   DUFOUR E, 1989, BIOCHIMIE, V71, P625, DOI 10.1016/0300-9084(89)90156-9
   ETHERINGTON DJ, 1972, BIOCHEM J, V127, P685, DOI 10.1042/bj1270685
   ETHERINGTON DJ, 1982, J CELL SCI, V58, P139
   ETHERINGTON DJ, 1987, MEAT SCI, V20, P1, DOI 10.1016/0309-1740(87)90046-5
   ETHERINGTON DJ, 1990, MEAT SCI, V28, P99, DOI 10.1016/0309-1740(90)90034-4
   GAUTHIER F, 1986, CYSTEINE PROTEINASES, P719
   GOLL DE, 1983, J FOOD BIOCHEM, V7, P137, DOI 10.1111/j.1745-4514.1983.tb00795.x
   Guerrero L, 1996, J SCI FOOD AGR, V70, P526, DOI [10.1002/(SICI)1097-0010(199604)70:4<526::AID-JSFA534>3.3.CO;2-Q, 10.1002/(SICI)1097-0010(199604)70:4&lt;526::AID-JSFA534&gt;3.0.CO;2-Z]
   HELANDER E, 1957, ACTA PHYSL SCAN S141, V41
   HONIKEL KO, 1986, FLEISCHWIRTSCHAFT, V66, P349
   HORTOS M, 1994, SCI ALIMENT, V14, P503
   Hortos M., 1995, THESIS U AUTONOMA BA
   Kalichman S.C., 1990, ANN SEX RES, V3, P129, DOI DOI 10.1111/J.1745-4573.1990.TB00360.X
   KOOHMARAIE M, 1991, J ANIM SCI, V69, P4823, DOI 10.2527/1991.69124823x
   KOOHMARAIE M, 1987, MEAT SCI, V19, P187, DOI 10.1016/0309-1740(87)90056-8
   KOOHMARAIE M, 1992, P INT C MEAT SCI TEC, V38, P61
   LOPEZBOTE C, 1989, MEAT SCI, V26, P167, DOI 10.1016/0309-1740(89)90018-1
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Ludvigsen J, 1954, BERETNING FORSOGSLAB, V1, P272
   MIKAMI M, 1987, MEAT SCI, V21, P81, DOI 10.1016/0309-1740(87)90022-2
   MURRAY AC, 1994, 40 INT C MEAT SCI TE
   OBLED A, 1984, BIOCHIMIE, V66, P609, DOI 10.1016/0300-9084(84)90114-7
   OLIVER MA, 1993, MEAT SCI, V35, P105, DOI 10.1016/0309-1740(93)90073-Q
   Park H. K., 1975, Japanese Journal of Zootechnical Science, V46, P360
   Penny I. F., 1969, Journal of Food Technology, V4, P269, DOI 10.1361/15477020419866
   *PRES GOB, 1979, BOE, V207, P20233
   Roncales P., 1995, EXPRESSION TISSUE PR, P311
   *SAS, 1985, SAS US GUID BAS VERS
   SAYRE RN, 1963, J FOOD SCI, V28, P675, DOI 10.1111/j.1365-2621.1963.tb01673.x
   STAHL PD, 1971, J BIOL CHEM, V246, P5398
   TAYLOR RG, 1995, J ANIM SCI, V73, P1351
   Webb A. J., 1987, Evaluation and control of meat quality in pigs. A seminar in the CEC Agricultural Research Programme, held in Dublin, Ireland, 21-22 November 1985., P297
NR 41
TC 19
Z9 21
U1 0
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0308-8146
J9 FOOD CHEM
JI Food Chem.
PD NOV
PY 1998
VL 63
IS 3
BP 385
EP 390
DI 10.1016/S0308-8146(98)00003-X
PG 6
WC Chemistry, Applied; Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry; Food Science & Technology; Nutrition & Dietetics
GA 122WD
UT WOS:000076093700013
DA 2024-02-19
ER

PT J
AU Caro, P
   Gómez, J
   Sanz, A
   Portero-Otin, M
   Pamplona, R
   Barja, G
AF Caro, Pilar
   Gomez, Jose
   Sanz, Alberto
   Portero-Otin, Manel
   Pamplona, Reinald
   Barja, Gustavo
TI Effect of graded corticosterone treatment on aging-related markers of
   oxidative stress in rat liver mitochondria
SO BIOGERONTOLOGY
LA English
DT Article
DE mitochondria corticosterone; free radicals; DNA damage; oxidative
   damage; protein damage; fatty acids
ID CALORIC RESTRICTION; DNA-DAMAGE; RADICAL PRODUCTION; DEXAMETHASONE;
   PROTEINS; INSULIN; MUSCLE; HEART
AB Caloric restriction (CR) decreases aging rate and lowers the rate of reactive oxygen species (ROS) production at mitochondria in different organs, but the signal responsible for this last change is unknown. Glucocorticoids could constitute such a signal since it is well known that their levels increase during CR, and available studies failed to find consistent effects of insulin, the other better described hormone that varies during CR, on mitochondrial oxidative stress. In addition, there is almost no information on the possible in vivo effects of glucocorticoids on specific markers of mitochondrial and tissue oxidative stress. In this investigation, male Wistar rats were treated with corticosterone at doses of 150 and 400 mg/kg of diet during 4 weeks. After that time, oxidative stress-related parameters were measured in the liver. The corticosterone treatments did not change the rate of ROS production or the rate of oxygen consumption of rat liver mitochondria. The two lipoxidation protein markers measured (malondialdehyde-lysine and carboxymethyllysine) were decreased by both corticosterone treatments. These changes were associated with decreases in fatty acid unsaturation, especially with lowered levels of the highly unsaturated araquidonic and docosahexaenoic acids, which decrease the sensitivity to lipid peroxidation processes. The specific protein carbonyl glutamic semialdehyde, a marker of protein oxidation, was also lowered at 400 mg/kg corticosterone. The protein glycoxydation marker carboxyethyllysine and the level of oxidative damage to mtDNA (8-oxo-7,8-dihydro-2 9-deoxyguanosine) were increased by corticosterone. The results do not support the idea that corticosterone is the signal responsible for the decrease in mitochondrial ROS generation during CR. However, they show that this hormone modulates the level of oxidative stress both in proteins and in mtDNA. Some of these changes can contribute to the chronic effects of the hormone at tissue level.
C1 Univ Complutense Madrid, Fac Ciencias Biol, Dept Anim Physiol 2, E-28040 Madrid, Spain.
   Univ Lleida, Dept Basic Med Sci, Lleida 25008, Spain.
C3 Complutense University of Madrid; Universitat de Lleida
RP Barja, G (corresponding author), Univ Complutense Madrid, Fac Ciencias Biol, Dept Anim Physiol 2, C-Antonio Novais 2, E-28040 Madrid, Spain.
EM gbarja@bio.ucm.es
RI Gomez, Jose/G-9705-2015; SANZ, ALBERTO/F-8432-2011; Sanz,
   Alberto/O-2329-2015; Barja, Gustavo/AAA-5903-2019; Pamplona,
   Reinald/A-7359-2010; Portero-Otin, Manuel/B-7122-2009; Gustavo,
   Barja/B-5591-2012
OI Gomez, Jose/0000-0003-1758-4746; Sanz, Alberto/0000-0003-2149-1753;
   Barja, Gustavo/0000-0001-5736-4735; Pamplona,
   Reinald/0000-0003-4337-6107; Portero-Otin, Manuel/0000-0002-1823-0299;
   Caro, Pilar/0000-0002-7531-3234
CR Ahmed MU, 1997, BIOCHEM J, V324, P565, DOI 10.1042/bj3240565
   Barja G, 2004, BIOL REV, V79, P235, DOI 10.1017/S1464793103006213
   Barja G, 2002, J BIOENERG BIOMEMBR, V34, P227, DOI 10.1023/A:1016039604958
   Bartke A, 2001, NATURE, V414, P412, DOI 10.1038/35106646
   BIELSKI BHJ, 1983, J BIOL CHEM, V258, P4759
   Brenner RR, 2001, LIPIDS, V36, P1337, DOI 10.1007/s11745-001-0850-1
   Cook H.W., 1996, New Comprehensive Biochemistry, V31, P129, DOI 10.1016/S0167-7306(08)60512-8
   DeLaAsuncion JG, 1996, FASEB J, V10, P333, DOI 10.1096/fasebj.10.2.8641567
   DUMM IND, 1999, ACTA PHYSL PHARM THE, V49, P124
   Gonzalez AA, 2004, AM J PHYSIOL-ENDOC M, V287, pE1032, DOI 10.1152/ajpendo.00172.2004
   Gredilla R, 2005, ENDOCRINOLOGY, V146, P3713, DOI 10.1210/en.2005-0378
   Gredilla R, 2001, J BIOENERG BIOMEMBR, V33, P279, DOI 10.1023/A:1010603206190
   HARRIS SB, 1994, MECH AGEING DEV, V73, P209, DOI 10.1016/0047-6374(94)90053-1
   Iuchi T, 2003, CIRC RES, V92, P81, DOI 10.1161/01.RES.0000050588.35034.3C
   Julian D, 2004, AM J PHYSIOL-REG I, V286, pR20, DOI 10.1152/ajpregu.00522.2003
   KLEBANOV S, 1995, J GERONTOL A-BIOL, V50, pB78, DOI 10.1093/gerona/50A.2.B78
   KNECHT KJ, 1991, DIABETES, V40, P190, DOI 10.2337/diabetes.40.2.190
   LATORRE A, 1986, P NATL ACAD SCI USA, V83, P8649, DOI 10.1073/pnas.83.22.8649
   Lin H, 2004, COMP BIOCHEM PHYS B, V139, P737, DOI 10.1016/j.cbpc.2004.09.013
   Loft S, 1999, METHOD ENZYMOL, V300, P166
   Mitsui T, 2002, ACTA NEUROPATHOL, V104, P260, DOI 10.1007/s00401-002-0553-5
   ODEDRA BR, 1983, BIOCHEM J, V214, P617, DOI 10.1042/bj2140617
   Pamplona R, 2005, J BIOL CHEM, V280, P21522, DOI 10.1074/jbc.M502255200
   Pandya JD, 2004, DRUG CHEM TOXICOL, V27, P389, DOI 10.1081/DCT-200039778
   Requena JR, 1997, BIOCHEM J, V322, P317, DOI 10.1042/bj3220317
   Requena JR, 2001, P NATL ACAD SCI USA, V98, P69, DOI 10.1073/pnas.011526698
   Roussel D, 2004, BIOCHEM J, V382, P491, DOI 10.1042/BJ20040696
   Sanz A, 2005, BIOGERONTOLOGY, V6, P15, DOI 10.1007/s10522-004-7380-0
   Sanz A, 2004, J BIOENERG BIOMEMBR, V36, P545, DOI 10.1007/s10863-004-9001-7
   SANZ A, 2006, IN PRESS FASEB J
   SUZUKI H, 1995, HYPERTENSION, V25, P1083, DOI 10.1161/01.HYP.25.5.1083
   Zhu ZJ, 1998, CARCINOGENESIS, V19, P2101, DOI 10.1093/carcin/19.12.2101
NR 32
TC 31
Z9 31
U1 0
U2 8
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1389-5729
EI 1573-6768
J9 BIOGERONTOLOGY
JI Biogerontology
PD FEB
PY 2007
VL 8
IS 1
BP 1
EP 11
DI 10.1007/s10522-006-9026-x
PG 11
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 123UO
UT WOS:000243321800001
PM 16823605
DA 2024-02-19
ER

PT J
AU Mizukami, S
   Watanabe, Y
   Nakajima, K
   Hasegawa-Baba, Y
   Jin, ML
   Yoshida, T
   Shibutani, M
AF Mizukami, Sayaka
   Watanabe, Yousuke
   Nakajima, Kota
   Hasegawa-Baba, Yasuko
   Jin, Meilan
   Yoshida, Toshinori
   Shibutani, Makoto
TI Downregulation of TMEM70 in Rat Liver Cells After Hepatocarcinogen
   Treatment Related to the Warburg Effect in Hepatocarcinogenesis
   Producing GST-P-Expressing Proliferative Lesions
SO TOXICOLOGICAL SCIENCES
LA English
DT Article
DE Hepatocarcinogenesis; Rat; Transmembrane protein 70 (TMEM70);
   Mitochondrial oxidative phosphorylation; Glutathione S-transferase
   placental form (GST-P); Warburg effect
ID PRENEOPLASTIC HEPATIC FOCI; CELLULAR SENESCENCE; TUMOR PROMOTION; C-MYC;
   ABERRANT ACTIVATION; GENE-EXPRESSION; PYRUVATE-KINASE; EARLY-STAGE;
   CARCINOGENESIS; CANCER
AB We previously observed downregulation of mitochondrial oxidative phosphorylation-related protein, TMEM70, which is suggestive of disrupted cellular senescence, in GST-P-expressing((+)) proliferative lesions from early hepatocarcinogenesis stages in rats. The present study investigated the immunohistochemical relationship between TMEM70 downregulation and cellular metabolic changes in carcinogenic processes, as well as the onset of the liver cell respiratory changes after repeated hepatocarcinogen treatment in rats. At the early hepatocarcinogenesis stage in a 2-stage model, GST-P+ preneoplastic lesions showing TMEM70 downregulation also downregulated the mitochondrial ATPase, ATPB, but upregulated glycolysis-related glucose transporter member 1 (GLUT1) and glucose-6-phosphate dehydrogenase, suggesting a metabolic shift from oxidative phosphorylation to glycolysis, known as the Warburg effect. Combined downregulation of TMEM70 and ATPB increased proliferation activity in GST-P+ preneoplastic lesions, suggesting cell proliferation facilitation by reducing mitochondrial respiration. Concurrent GLUT1-upregulation and TMEM70-downregulation increased nuclear phosphorylated c-MYC+ cells in GST-P+ preneoplastic lesions, suggesting c-MYC-mediated transcription facilitation to promote glycolysis and cell proliferation. The TMEM70-related metabolic shift was enhanced in GST-P+ neoplastic lesions, suggesting a contribution to tumor progression. Conversely, the TMEM70-related metabolic shift was lacking in peroxisome proliferator-activated receptor-alpha agonist-induced hepatocarcinogenesis, as well as in carcinogenic processes targeting other organs. Transcript expression analysis following 28-and 90-day repeated hepatocarcinogen treatment showed downregulation of Tmem70 from day 28 and upregulation of Pkm and Myc at day 90, suggesting early onset of a catastrophic cellular senescence-related metabolic shift beginning from depressed mitochondrial respiration in the liver. These results suggest a contribution of TMEM70 downregulation to the Warburg effect, which directs tumor promotion and progression in GST-P+-linked hepatocarcinogenesis in rats.
C1 [Mizukami, Sayaka; Watanabe, Yousuke; Nakajima, Kota; Hasegawa-Baba, Yasuko; Yoshida, Toshinori; Shibutani, Makoto] Tokyo Univ Agr & Technol, Inst Agr, Div Anim Life Sci, Lab Vet Pathol, 3-5-8 Saiwai Cho, Tokyo 1838509, Japan.
   [Mizukami, Sayaka; Watanabe, Yousuke; Nakajima, Kota] Gifu Univ, United Grad Sch Vet Sci, Pathogenet Vet Sci, Gifu 5011193, Japan.
   [Jin, Meilan] Southwest Univ, Coll Anim Sci & Technol, Dept Vet Med, Lab Vet Pathol, Chongqing 400715, Peoples R China.
C3 Tokyo University of Agriculture & Technology; Gifu University; Southwest
   University - China
RP Shibutani, M (corresponding author), Tokyo Univ Agr & Technol, Inst Agr, Div Anim Life Sci, Lab Vet Pathol, 3-5-8 Saiwai Cho, Tokyo 1838509, Japan.
EM mshibuta@cc.tuat.ac.jp
RI Shibutani, Makoto/AGK-2801-2022; Shibutani, Makoto/C-2510-2013; Yoshida,
   Toshinori/B-7255-2015
OI Shibutani, Makoto/0000-0003-3417-9697; Yoshida,
   Toshinori/0000-0003-2476-7794
FU Japan Society for the Promotion of Science (JSPS) [22380163];
   Grants-in-Aid for Scientific Research [22380163] Funding Source: KAKEN
FX This work was supported by a Grant-in-Aid for Scientific Research (B)
   from the Japan Society for the Promotion of Science (JSPS; Grant No.
   22380163).
CR [Anonymous], 2000, Toxic Rep Ser, V46, P1
   BECKER FF, 1983, J NATL CANCER I, V71, P553
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   ENZMANN H, 1989, VIRCHOWS ARCH B, V57, P99, DOI 10.1007/BF02899070
   Formentini L, 2012, MOL CELL, V45, P731, DOI 10.1016/j.molcel.2012.01.008
   Gabriel SS, 2016, CELL DEATH DISCOV, V2, DOI 10.1038/cddiscovery.2016.47
   Gambhir SS, 2002, NAT REV CANCER, V2, P683, DOI 10.1038/nrc882
   Gao F, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0533-9
   GERVASI PG, 1989, J CANCER RES CLIN, V115, P29, DOI 10.1007/BF00391596
   Hayashi H, 2012, J TOXICOL SCI, V37, P517
   Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809
   Hejzlarová K, 2011, BBA-BIOENERGETICS, V1807, P144, DOI 10.1016/j.bbabio.2010.10.005
   Hirose M, 1998, INT J CANCER, V77, P773, DOI 10.1002/(SICI)1097-0215(19980831)77:5<773::AID-IJC17>3.0.CO;2-2
   IMAMURA K, 1972, J BIOCHEM-TOKYO, V71, P1043, DOI 10.1093/oxfordjournals.jbchem.a129852
   Isidoro A, 2004, BIOCHEM J, V378, P17, DOI 10.1042/BJ20031541
   Ito Nobuyuki, 1998, Journal of Toxicological Sciences, V23, P103
   Kemmochi S, 2012, EXP BIOL MED, V237, P728, DOI 10.1258/ebm.2012.011319
   Kikuchihara Y, 2015, EXP TOXICOL PATHOL, V67, P349, DOI 10.1016/j.etp.2015.03.002
   Kimura M, 2016, J APPL TOXICOL, V36, P223, DOI 10.1002/jat.3163
   Kitano M, 1998, CARCINOGENESIS, V19, P1475, DOI 10.1093/carcin/19.8.1475
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   LUCIAKOVA K, 1992, EUR J BIOCHEM, V205, P1187, DOI 10.1111/j.1432-1033.1992.tb16889.x
   Mizukami S, 2017, TOXICOL LETT, V266, P13, DOI 10.1016/j.toxlet.2016.11.022
   Muguruma M, 2009, ARCH TOXICOL, V83, P183, DOI 10.1007/s00204-008-0340-8
   National Toxicology Program, 1993, Natl Toxicol Program Tech Rep Ser, V425, P1
   Okamoto T, 2015, ARCH BIOCHEM BIOPHYS, V586, P10, DOI 10.1016/j.abb.2015.09.022
   Osthus RC, 2000, J BIOL CHEM, V275, P21797, DOI 10.1074/jbc.C000023200
   Passos JF, 2007, NUCLEIC ACIDS RES, V35, P7505, DOI 10.1093/nar/gkm893
   Samali A, 1999, EMBO J, V18, P2040, DOI 10.1093/emboj/18.8.2040
   Sano Masashi, 1999, Journal of Toxicological Sciences, V24, P177
   Schmidt EV, 1999, ONCOGENE, V18, P2988, DOI 10.1038/sj.onc.1202751
   Shirai T, 1997, TOXICOL PATHOL, V25, P453, DOI 10.1177/019262339702500504
   Shoda T, 1999, TOXICOL PATHOL, V27, P553, DOI 10.1177/019262339902700509
   Shrode LD, 1997, J BIOENERG BIOMEMBR, V29, P393, DOI 10.1023/A:1022407116339
   Steinberg P, 1999, VIRCHOWS ARCH, V434, P213, DOI 10.1007/s004280050330
   Taniai E, 2012, J TOXICOL SCI, V37, P1093, DOI 10.2131/jts.37.1093
   Taniai E, 2012, J TOXICOL SCI, V37, P1113, DOI 10.2131/jts.37.1113
   Taniai E, 2009, CANCER SCI, V100, P813, DOI 10.1111/j.1349-7006.2009.01120.x
   Wada S, 1998, CANCER LETT, V123, P127, DOI 10.1016/S0304-3835(97)00407-2
   Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519
   Wu CH, 2007, P NATL ACAD SCI USA, V104, P13028, DOI 10.1073/pnas.0701953104
   Yafune A, 2013, TOXICOL LETT, V219, P203, DOI 10.1016/j.toxlet.2013.03.012
   Yang WW, 2012, CELL, V150, P685, DOI 10.1016/j.cell.2012.07.018
   Zhang Y, 2013, CANCER BIOL THER, V14, P81, DOI 10.4161/cbt.22958
NR 44
TC 3
Z9 3
U1 0
U2 6
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1096-6080
EI 1096-0929
J9 TOXICOL SCI
JI Toxicol. Sci.
PD SEP
PY 2017
VL 159
IS 1
BP 211
EP 223
DI 10.1093/toxsci/kfx131
PG 13
WC Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Toxicology
GA FF8FY
UT WOS:000409253100020
PM 28903497
OA Bronze
DA 2024-02-19
ER

PT J
AU Zupo, R
   Castellana, F
   De Nucci, S
   De Pergola, G
   Lozupone, M
   Bortone, I
   Castellana, M
   Sborgia, G
   Lampignano, L
   Giannelli, G
   Panza, F
   Sardone, R
AF Zupo, Roberta
   Castellana, Fabio
   De Nucci, Sara
   De Pergola, Giovanni
   Lozupone, Madia
   Bortone, Ilaria
   Castellana, Marco
   Sborgia, Giancarlo
   Lampignano, Luisa
   Giannelli, Gianluigi
   Panza, Francesco
   Sardone, Rodolfo
TI Liver Fibrosis and 8-Year All-Cause Mortality Trajectories in the Aging
   Cohort of the Salus in Apulia Study
SO BIOMEDICINES
LA English
DT Article
DE chronic liver disease; frailty; survival; biomarkers; liver fibrosis
ID NONALCOHOLIC FATTY LIVER; DISEASE; ASSOCIATION; POPULATION; OUTCOMES;
   INDEX; STAGE; FIB-4; APRI; AGE
AB Age is a major contributor to the liver fibrosis rate and its adverse health-related outcomes, including mortality, but older populations are still under-explored. We investigated multimorbidity and inflammatory biomarkers in relation to the increasing liver fibrosis risk to delineate 8-year all-cause mortality trajectories in 1929 older adults from the population-based Salus in Apulia Study. Liver fibrosis risk was assumed using the fibrosis-4 (FIB-4) score, assigned to three liver fibrosis risk groups (low, intermediate, high). In the secondary analyses, the APRI score was also calculated to allow for comparisons. Male subjects (prevalence difference: -13.49, 95% confidence interval (CI): -18.96 to -8.03), a higher multimorbidity burden (effect size, ES: -0.14, 95% CI: -0.26 to -0.02), a higher prevalence of physical frailty (ES: 6.77, 95% CI: 0.07 to 13.47), and a more pronounced inflammatory pattern as indicated by tumor growth factor-alpha circulating levels (ES: -0.12, 95% CI: -0.23 to -0.01) were significantly more common in the highest-risk FIB-4 score group. Liver function characterized by lipid profile and platelet levels worsened with increasing FIB-4 risk score. The 8-year risk of death was nearly double in subjects in the highest-risk FIB-4 score group, even after controlling for possible confounders. Furthermore, a steeper mortality curve was clearly observed for FIB-4 scores as compared with the APRI scoring system with respect to liver fibrosis risk. In conclusion, using a scoring tool based on simple routine biomarkers to detect liver fibrosis risk may enhance biological knowledge of age-related outcomes of chronic liver disease and be helpful in the clinical setting to identify subjects at risk for adverse health-related outcomes, including mortality.
C1 [Zupo, Roberta; Castellana, Fabio; De Nucci, Sara; Lozupone, Madia; Bortone, Ilaria; Castellana, Marco; Lampignano, Luisa; Panza, Francesco; Sardone, Rodolfo] Res Hosp, Natl Inst Gastroenterol Saverio Bellis, Unit Data Sci & Technol Innovat Populat Hlth, I-70013 Bari, Italy.
   [De Pergola, Giovanni] Res Hosp, Natl Inst Gastroenterol Saverio Bellis, Unit Geriatr & Internal Med, I-70013 Bari, Italy.
   [Sborgia, Giancarlo] Univ Bari Aldo Moro, Dept Basic Med Sci Neurosci & Sense Organs, I-70124 Bari, Italy.
   [Giannelli, Gianluigi] Res Hosp, Natl Inst Gastroenterol Saverio Bellis, Sci Direct, I-70124 Bari, Italy.
C3 IRCCS Saverio de Bellis; IRCCS Saverio de Bellis; Universita degli Studi
   di Bari Aldo Moro; IRCCS Saverio de Bellis
RP Sardone, R (corresponding author), Res Hosp, Natl Inst Gastroenterol Saverio Bellis, Unit Data Sci & Technol Innovat Populat Hlth, I-70013 Bari, Italy.
EM zuporoberta@gmail.com; fabio.castellana@irccsdebellis.it;
   sara.denucci@irccsdebellis.it; gdepergola@libero.it;
   madia.lozupone@gmail.com; lariabortone@gmail.com;
   mcastellana01@yahoo.it; gcsborgia@hotmail.it;
   gianluigi.giannelli@irccsdebellis.it; f_panza@hotmail.com;
   rodolfo.sardone@irccsdebellis.it
RI Zupo, Roberta/GPT-3724-2022; Castellana, Fabio/AAC-4919-2022;
   Lampignano, Luisa/AAA-3108-2022; Sardone, Rodolfo/AAM-2727-2020;
   Lozupone, Madia/F-7262-2018; Zupo, Roberta/AAO-9103-2020; Bortone,
   Ilaria/O-3143-2019; Bortone, Ilaria/HPE-3696-2023; Panza,
   Francesco/M-6804-2017
OI Castellana, Fabio/0000-0002-6439-8228; Sardone,
   Rodolfo/0000-0003-1383-1850; Lozupone, Madia/0000-0002-1674-9724; Zupo,
   Roberta/0000-0001-9885-1185; Bortone, Ilaria/0000-0002-4767-5334; Panza,
   Francesco/0000-0002-7220-0656; Sborgia, Giancarlo/0000-0001-7271-0536;
   Lampignano, Luisa/0000-0001-9299-3211; Castellana,
   Marco/0000-0002-1175-8998; DE PERGOLA, Giovanni/0000-0003-0020-3273
CR Angulo P, 2015, GASTROENTEROLOGY, V149, P389, DOI 10.1053/j.gastro.2015.04.043
   Asrani SK, 2019, J HEPATOL, V70, P151, DOI 10.1016/j.jhep.2018.09.014
   Burra P, 2013, LIVER TRANSPLANT, V19, P122, DOI 10.1002/lt.23574
   Carnovale E., 1987, EUROPEAN FOOD COMPOS, P63, DOI [10.1007/978-3-642-82989-5_11, DOI 10.1007/978-3-642-82989-5_11]
   Castellana F, 2021, J AM MED DIR ASSOC, V22, P598, DOI 10.1016/j.jamda.2020.12.026
   Chang AY, 2019, LANCET PUBLIC HEALTH, V4, pE159, DOI 10.1016/S2468-2667(19)30019-2
   Cozzolongo R, 2009, AM J GASTROENTEROL, V104, P2740, DOI 10.1038/ajg.2009.428
   De Vincentis A, 2019, DIGEST LIVER DIS, V51, P1330, DOI 10.1016/j.dld.2019.01.017
   Feigin VL, 2017, LANCET NEUROL, V16, P877, DOI 10.1016/S1474-4422(17)30299-5
   GBD 2015 Mortality and Causes of Death Collaborators, 2016, LANCET, V388, P1459, DOI DOI 10.1016/S0140-6736(16)31012-1
   Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1161/01.cir.0000437741.48606.98, 10.1016/j.jacc.2013.11.005]
   Guy Jennifer, 2013, Gastroenterol Hepatol (N Y), V9, P633
   Jármay K, 2005, WORLD J GASTROENTERO, V11, P6422, DOI 10.3748/wjg.v11.i41.6422
   Jayakumar Saumya, 2016, Curr Hepatol Rep, V15, P86
   Kim J.J., 2005, EFFECT SIZES RES BRO
   Kim SU, 2020, MOD RHEUMATOL, V30, P70, DOI 10.1080/14397595.2018.1558760
   Kurokawa T, 2017, WORLD J GASTROENTERO, V23, P3228, DOI 10.3748/wjg.v23.i18.3228
   Lee J, 2021, LIVER INT, V41, P261, DOI 10.1111/liv.14669
   Li YJ, 2021, HEPATOL COMMUN, V5, P434, DOI 10.1002/hep4.1650
   Loaeza-del-Castillo A, 2008, ANN HEPATOL, V7, P350, DOI 10.1016/S1665-2681(19)31836-8
   Marchesini G, 2016, J HEPATOL, V64, P1388, DOI 10.1016/j.jhep.2015.11.004
   McPherson S, 2017, AM J GASTROENTEROL, V112, P740, DOI 10.1038/ajg.2016.453
   Obesity, 2000, Obesity: Preventing and managing the global epidemic, V894, P1
   Palmieri VO, 2015, CLIN EXP MED, V15, P65, DOI 10.1007/s10238-013-0267-0
   Park HJ, 2019, BMC GASTROENTEROL, V19, DOI 10.1186/s12876-019-1007-z
   Pimpin L, 2018, J HEPATOL, V69, P718, DOI 10.1016/j.jhep.2018.05.011
   Sardone R, 2021, JAMA OTOLARYNGOL, V147, P561, DOI 10.1001/jamaoto.2020.5334
   Sato Y, 2017, OPEN HEART, V4, DOI 10.1136/openhrt-2017-000598
   Shah AG, 2009, CLIN GASTROENTEROL H, V7, P1104, DOI 10.1016/j.cgh.2009.05.033
   Singh S, 2015, CLIN GASTROENTEROL H, V13, P643, DOI 10.1016/j.cgh.2014.04.014
   So-Armah KA, 2020, PROG CARDIOVASC DIS, V63, P184, DOI 10.1016/j.pcad.2020.02.010
   Solfrizzi V, 2020, ALZH DEMENT-TRCI, V6, DOI 10.1002/trc2.12065
   Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178
   Stroffolini T, 2020, EUR J INTERN MED, V75, P55, DOI 10.1016/j.ejim.2020.01.008
   Taylor RS, 2020, GASTROENTEROLOGY, V158, P1611, DOI 10.1053/j.gastro.2020.01.043
   Villén N, 2020, BMC GERIATR, V20, DOI 10.1186/s12877-020-01580-1
   Zupo R, 2022, GEROSCIENCE, V44, P835, DOI 10.1007/s11357-021-00434-x
   Zupo R, 2020, NUTRIENTS, V12, DOI 10.3390/nu12041070
NR 38
TC 2
Z9 2
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2227-9059
J9 BIOMEDICINES
JI Biomedicines
PD NOV
PY 2021
VL 9
IS 11
AR 1617
DI 10.3390/biomedicines9111617
PG 13
WC Biochemistry & Molecular Biology; Medicine, Research & Experimental;
   Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Research & Experimental Medicine;
   Pharmacology & Pharmacy
GA XK8WE
UT WOS:000727737700001
PM 34829846
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Forrest, L
   Sedmak, C
   Sikder, S
   Grewal, S
   Harman, SM
   Blackman, MR
   Muniyappa, R
AF Forrest, Lala
   Sedmak, Caroline
   Sikder, Shanaz
   Grewal, Shivraj
   Harman, S. Mitchell
   Blackman, Marc R.
   Muniyappa, Ranganath
TI Effects of growth hormone on hepatic insulin sensitivity and glucose
   effectiveness in healthy older adults
SO ENDOCRINE
LA English
DT Article
DE Growth hormone; Insulin resistance; Glucose effectiveness; Aging
ID BETA-CELL FUNCTION; ADIPOSE-TISSUE; BODY-COMPOSITION; AGED WOMEN;
   SUBSTRATE METABOLISM; REPLACEMENT THERAPY; RISK-FACTORS; IN-VIVO; IGF-I;
   RESISTANCE
AB PurposeGrowth hormone (GH) replacement decreases insulin sensitivity in healthy individuals. However, the effects of GH on organ-specific insulin sensitivity and glucose effectiveness are not well characterized. The purpose of this study was to evaluate the effects of GH administration for 26 weeks on muscle and hepatic insulin sensitivity and glucose effectiveness in healthy older individuals.MethodsThis report is from a 26-week randomized, double-blind, placebo-controlled parallel-group trial in healthy, ambulatory, community-dwelling older women and men. We compared surrogate indices of insulin sensitivity [quantitative insulin-sensitivity check index (QUICKI), muscle insulin sensitivity index (MISI), hepatic insulin resistance index (HIRI)] and glucose effectiveness [oral glucose effectiveness index (oGE)] derived from oral glucose tolerance tests (OGTTs) in subjects before and after 26 weeks of administration of GH (n=17) or placebo (n=15) as an exploratory outcome.ResultsGH administration for 26 weeks significantly increased fasting insulin concentrations and HIRI but did not significantly change MISI or oGE compared to placebo.ConclusionsGH administration for 26 weeks in healthy older subjects impairs insulin sensitivity in the liver but not skeletal muscle and does not alter glucose effectiveness.
C1 [Forrest, Lala; Sedmak, Caroline; Sikder, Shanaz; Grewal, Shivraj; Muniyappa, Ranganath] NIDDK, Clin Endocrine Sect, Diabet Endocrinol & Obes Branch, NIH, Bethesda, MD 20892 USA.
   [Harman, S. Mitchell] Phoenix VA Hlth Care Syst, Endocrinol Sect, Dept Med, Phoenix, AZ USA.
   [Blackman, Marc R.] Vet Affairs Med Ctr, Res Serv, 50 Irving St NW, Washington, DC 20422 USA.
   [Blackman, Marc R.] Georgetown Univ, Sch Med, Dept Med, Washington, DC 20007 USA.
   [Blackman, Marc R.] George Washington Univ, Sch Med, Dept Med, Washington, DC 20052 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute of
   Diabetes & Digestive & Kidney Diseases (NIDDK); US Department of
   Veterans Affairs; Veterans Health Administration (VHA); Georgetown
   University; George Washington University
RP Muniyappa, R (corresponding author), NIDDK, Clin Endocrine Sect, Diabet Endocrinol & Obes Branch, NIH, Bethesda, MD 20892 USA.
EM muniyapr@mail.nih.gov
RI Blackman, Marc/AAT-5771-2021
OI Forrest, Lala/0000-0001-5407-4206; Muniyappa,
   Ranganath/0000-0003-4198-1055; Grewal, Shivraj/0000-0002-5314-963X
FU Intramural Research Programs of the National Institute on Aging (NIA),
   Baltimore, Maryland; National Institutes of Health Research [RO-1
   AG11005]; Research Service, Veterans Affairs Medical Center, Washington
   DC; National Institute of Diabetes and Digestive and Kidney Diseases
   (NIDDK), Washington, DC; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE
   AND KIDNEY DISEASES [ZIADK075007] Funding Source: NIH RePORTER
FX This work was supported in part by the Intramural Research Programs of
   the National Institute on Aging (NIA), Baltimore, Maryland and the
   National Institute of Diabetes and Digestive and Kidney Diseases
   (NIDDK), Washington, DC, National Institutes of Health Research Grants
   RO-1 AG11005 (to MRB), and the Research Service, Veterans Affairs
   Medical Center, Washington DC.
CR Abdul-Ghani MA, 2007, DIABETES CARE, V30, P89, DOI 10.2337/dc06-1519
   Alexopoulou O, 2014, PITUITARY, V17, P81, DOI 10.1007/s11102-013-0471-7
   American Diabetes Association, 2017, Clin Diabetes, V35, P5, DOI 10.2337/cd16-0067
   Bastard Jean-Philippe, 2007, Diabetes Care, V30, pe84, DOI 10.2337/dc07-0622
   Basu R, 2006, DIABETES, V55, P2001, DOI 10.2337/db05-1692
   Blackman MB, 2002, JAMA-J AM MED ASSOC, V288, P2282, DOI 10.1001/jama.288.18.2282
   Clausen JO, 1996, J CLIN INVEST, V98, P1195, DOI 10.1172/JCI118903
   Corbit KC, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91001
   Dominici FP, 2005, GROWTH HORM IGF RES, V15, P324, DOI 10.1016/j.ghir.2005.07.001
   Fieffe S, 2011, EUR J ENDOCRINOL, V164, P877, DOI 10.1530/EJE-10-1050
   Garg A, 2002, J CLIN ENDOCR METAB, V87, P3019, DOI 10.1210/jcem.87.7.8736
   Geer EB, 2009, GENDER MED, V6, P60, DOI 10.1016/j.genm.2009.02.002
   Giorgino F, 2005, ACTA PHYSIOL SCAND, V183, P13, DOI 10.1111/j.1365-201X.2004.01385.x
   Goedecke JH, 2014, MED SPORT SCI, V60, P82, DOI 10.1159/000357338
   Guevara-Aguirre J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001845
   HANSEN I, 1986, AM J PHYSIOL, V250, pE269, DOI 10.1152/ajpendo.1986.250.3.E269
   Henriksen JE, 2000, DIABETES, V49, P1209, DOI 10.2337/diabetes.49.7.1209
   Higham CE, 2009, J CLIN ENDOCR METAB, V94, P2459, DOI 10.1210/jc.2008-2086
   Jessen N, 2005, AM J PHYSIOL-ENDOC M, V288, pE194, DOI 10.1152/ajpendo.00149.2004
   Kasayama S, 2000, CLIN ENDOCRINOL, V52, P549, DOI 10.1046/j.1365-2265.2000.00986.x
   Kehlenbrink S, 2012, DIABETOLOGIA, V55, P3021, DOI 10.1007/s00125-012-2662-6
   Kinoshita Y, 2011, EUR J ENDOCRINOL, V164, P467, DOI 10.1530/EJE-10-1096
   KOLACZYNSKI JW, 1994, ANN INTERN MED, V120, P47, DOI 10.7326/0003-4819-120-1-199401010-00009
   Kotronen A, 2008, J CLIN ENDOCR METAB, V93, P4867, DOI 10.1210/jc.2008-1245
   KROTKIEWSKI M, 1983, J CLIN INVEST, V72, P1150, DOI 10.1172/JCI111040
   Kuk JL, 2009, AGEING RES REV, V8, P339, DOI 10.1016/j.arr.2009.06.001
   Laursen T, 2001, J CLIN ENDOCR METAB, V86, P1222, DOI 10.1210/jc.86.3.1222
   List EO, 2011, ENDOCR REV, V32, P356, DOI 10.1210/er.2010-0009
   McLaughlin T, 2011, J CLIN ENDOCR METAB, V96, pE1756, DOI 10.1210/jc.2011-0615
   MOLLER N, 1992, J CLIN ENDOCR METAB, V74, P1012, DOI 10.1210/jc.74.5.1012
   MOLLER N, 1989, DIABETOLOGIA, V32, P105, DOI 10.1007/BF00505182
   Moller N, 2009, ENDOCR REV, V30, P152, DOI 10.1210/er.2008-0027
   Moore MC, 2003, BEST PRACT RES CL EN, V17, P343, DOI 10.1016/S1521-690X(03)00036-8
   Münzer T, 2009, J CLIN ENDOCR METAB, V94, P3833, DOI 10.1210/jc.2009-1275
   Muniyappa R, 2008, AM J PHYSIOL-ENDOC M, V294, pE15, DOI 10.1152/ajpendo.00645.2007
   Münzer T, 2006, AM J PHYSIOL-ENDOC M, V290, pE1006, DOI 10.1152/ajpendo.00166.2005
   Münzer T, 2001, J CLIN ENDOCR METAB, V86, P3604, DOI 10.1210/jc.86.8.3604
   Nagasaka S, 2012, ACTA DIABETOL, V49, pS195, DOI 10.1007/s00592-012-0417-y
   Nielsen S, 2001, DIABETES, V50, P2301, DOI 10.2337/diabetes.50.10.2301
   ORSKOV L, 1989, J CLIN ENDOCR METAB, V68, P276, DOI 10.1210/jcem-68-2-276
   Paolisso G, 1999, J AM GERIATR SOC, V47, P1312, DOI 10.1111/j.1532-5415.1999.tb07431.x
   Pedersen MH, 2017, J CLIN ENDOCR METAB, V102, P1340, DOI 10.1210/jc.2016-3835
   Perry RJ, 2015, CELL, V160, P745, DOI 10.1016/j.cell.2015.01.012
   Piatti PM, 1999, J CLIN ENDOCR METAB, V84, P1658, DOI 10.1210/jc.84.5.1658
   Pratipanawatr T, 2002, AM J PHYSIOL-ENDOC M, V282, pE1360, DOI 10.1152/ajpendo.00335.2001
   RABEN MS, 1962, NEW ENGL J MED, V266, P31, DOI 10.1056/NEJM196201042660109
   RIZZA RA, 1982, DIABETES, V31, P663, DOI 10.2337/diabetes.31.8.663
   Rosenfalck AM, 2000, J CLIN ENDOCR METAB, V85, P4173, DOI 10.1210/jc.85.11.4173
   Segerlantz M, 2001, J CLIN ENDOCR METAB, V86, P5813, DOI 10.1210/jc.86.12.5813
   Svensson J, 2002, J CLIN ENDOCR METAB, V87, P2121, DOI 10.1210/jc.87.5.2121
   Thankamony A, 2014, J CLIN ENDOCR METAB, V99, P639, DOI 10.1210/jc.2013-3264
   Vangipurapu J, 2011, DIABETOLOGIA, V54, P540, DOI 10.1007/s00125-010-1966-7
   Weiss R, 2015, DIABETES CARE, V38, P689, DOI 10.2337/dc14-2183
   Wheatcroft SB, 2009, TRENDS ENDOCRIN MET, V20, P153, DOI 10.1016/j.tem.2009.01.002
NR 54
TC 7
Z9 7
U1 1
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1355-008X
EI 1559-0100
J9 ENDOCRINE
JI Endocrine
PD MAR
PY 2019
VL 63
IS 3
BP 497
EP 506
DI 10.1007/s12020-018-01834-4
PG 10
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA HP0XS
UT WOS:000461390500010
PM 30617738
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Nevedomskaya, E
   Meissner, A
   Goraler, S
   de Waard, M
   Ridwan, Y
   Zondag, G
   van der Pluijm, I
   Deelder, AM
   Mayboroda, OA
AF Nevedomskaya, Ekaterina
   Meissner, Axel
   Goraler, Sibel
   de Waard, Monique
   Ridwan, Yanto
   Zondag, Gerben
   van der Pluijm, Ingrid
   Deelder, Andre M.
   Mayboroda, Oleg A.
TI Metabolic Profiling of Accelerated Aging ERCC1<SUP>d/-</SUP> Mice
SO JOURNAL OF PROTEOME RESEARCH
LA English
DT Article
DE NMR; metabolic profiling; serum; urine; aging
ID CALORIC RESTRICTION; NUCLEAR ABNORMALITIES; METABONOMICS; SPECTROSCOPY;
   SYSTEMS; LINK
AB Aging is a fundamental biological process for which the mechanism is still largely unknown due to its complex and multifactorial nature. Animal models allow us to simplify this complexity and to study individual factors separately. As there are many causative links between DNA repair deficiency and aging, we studied the ERCC1(d/-) mouse, which has a modified ERCC1 gene, involved in the Nucleotide Excision Repair, and as a result has a premature aging phenotype. Profiling of these mice on different levels can give an insight into the mechanisms underlying the aging phenotype. In the current study, we have performed metabolic profiling of serum and urine of these mice in comparison to wild type and in relation to aging by H-1 NMR spectroscopy. Analysis of metabolic trajectories of animals from 8 to 20 weeks suggested that wild type and ERCC1(d/-) mutants have similar age-related patterns of changes; however, the difference between genotypes becomes more prominent with age. The main differences between these two genetically diverse groups of mice were found to be associated with altered lipid and energy metabolism, transition to ketosis, and attenuated functions of the liver and kidney.
C1 [Nevedomskaya, Ekaterina; Meissner, Axel; Goraler, Sibel; Deelder, Andre M.; Mayboroda, Oleg A.] Leiden Univ, Med Ctr, Dept Parasitol, Biomol Mass Spectrometry Unit, NL-2333 ZA Leiden, Netherlands.
   [de Waard, Monique] Erasmus MC, Rotterdam, Netherlands.
   [Ridwan, Yanto; Zondag, Gerben; van der Pluijm, Ingrid] DNage BV, Leiden, Netherlands.
C3 Leiden University; Leiden University Medical Center (LUMC); Leiden
   University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC
RP Nevedomskaya, E (corresponding author), Leiden Univ, Med Ctr, Dept Parasitol, Biomol Mass Spectrometry Unit, Albinusdreef 2, NL-2333 ZA Leiden, Netherlands.
RI Mayboroda, Oleg/B-5634-2008; Mayboroda, Oleg/N-4850-2019; van der
   Pluijm, Ingrid/HKO-1880-2023
OI Mayboroda, Oleg/0000-0001-8739-9875; Mayboroda,
   Oleg/0000-0001-8739-9875; Zondag, Gerben/0009-0006-2087-1024
CR Anderson RM, 2009, TOXICOL PATHOL, V37, P47, DOI 10.1177/0192623308329476
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   Cloarec O, 2005, ANAL CHEM, V77, P1282, DOI 10.1021/ac048630x
   Dollé MET, 2006, MUTAT RES-FUND MOL M, V596, P22, DOI 10.1016/j.mrfmmm.2005.11.008
   Dröge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001
   Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833
   Findeisen M, 2007, MAGN RESON CHEM, V45, P175, DOI 10.1002/mrc.1941
   GORDON EE, 1963, J CLIN INVEST, V42, P137, DOI 10.1172/JCI104700
   Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700
   HARPER AE, 1984, ANNU REV NUTR, V4, P409, DOI 10.1146/annurev.nu.04.070184.002205
   Holmes E, 2008, CELL, V134, P714, DOI 10.1016/j.cell.2008.08.026
   Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682
   KUMAR A, 1980, BIOCHEM BIOPH RES CO, V95, P1, DOI 10.1016/0006-291X(80)90695-6
   Lehmann AR, 2003, BIOCHIMIE, V85, P1101, DOI 10.1016/j.biochi.2003.09.010
   Lindon JC, 1999, ANNU REP NMR SPECTRO, V38, P1, DOI 10.1016/S0066-4103(08)60035-6
   Lindon JC, 2008, TRAC-TREND ANAL CHEM, V27, P194, DOI 10.1016/j.trac.2007.08.009
   MCGARRY JD, 1980, ANNU REV BIOCHEM, V49, P395, DOI 10.1146/annurev.bi.49.070180.002143
   MCWHIR J, 1993, NAT GENET, V5, P217, DOI 10.1038/ng1193-217
   Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a
   Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047
   NICHOLSON JK, 1985, MOL PHARMACOL, V27, P644
   Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456
   Niedernhofer LJ, 2004, MOL CELL BIOL, V24, P5776, DOI 10.1128/MCB.24.13.5776-5787.2004
   Nielsen NPV, 1998, J CHROMATOGR A, V805, P17, DOI 10.1016/S0021-9673(98)00021-1
   Rezzi S, 2009, EXP GERONTOL, V44, P356, DOI 10.1016/j.exger.2009.02.008
   Robertson DG, 2005, TOXICOL SCI, V85, P809, DOI 10.1093/toxsci/kfi102
   Schumacher B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000161
   Taylor L, 2004, BIOCHEM MOL BIOL EDU, V32, P291, DOI 10.1002/bmb.2004.494032050388
   Trygg J, 2007, J PROTEOME RES, V6, P469, DOI 10.1021/pr060594q
   van de Ven Marieke, 2006, PLoS Genet, V2, pe192, DOI 10.1371/journal.pgen.0020192
   Wang YL, 2007, J PROTEOME RES, V6, P1846, DOI 10.1021/pr060685n
   Weeda G, 1997, CURR BIOL, V7, P427, DOI 10.1016/S0960-9822(06)00190-4
   Wishart DS, 2005, AM J TRANSPLANT, V5, P2814, DOI 10.1111/j.1600-6143.2005.01119.x
   WU DH, 1995, J MAGN RESON SER A, V115, P260, DOI 10.1006/jmra.1995.1176
NR 34
TC 23
Z9 27
U1 0
U2 17
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1535-3893
J9 J PROTEOME RES
JI J. Proteome Res.
PD JUL
PY 2010
VL 9
IS 7
BP 3680
EP 3687
DI 10.1021/pr100210k
PG 8
WC Biochemical Research Methods
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 618BY
UT WOS:000279327500030
PM 20507129
DA 2024-02-19
ER

PT J
AU Jimenez-Romero, C
   Cambra, F
   Caso, O
   Manrique, A
   Calvo, J
   Marcacuzco, A
   Rioja, P
   Lora, D
   Justo, I
AF Jimenez-Romero, Carlos
   Cambra, Felix
   Caso, Oscar
   Manrique, Alejandro
   Calvo, Jorge
   Marcacuzco, Alejandro
   Rioja, Paula
   Lora, David
   Justo, Iago
TI Octogenarian liver grafts: Is their use for transplant currently
   justified?
SO WORLD JOURNAL OF GASTROENTEROLOGY
LA English
DT Article
DE Older liver; Donor age; Marginal liver; Liver transplant; Aging liver
ID DONORS OLDER; HEPATIC ALLOGRAFTS; MARGINAL DONORS; RISK-FACTORS; AGE;
   SURVIVAL; PATIENT; IMPACT; SEPTUAGENARIAN; CRITERIA
AB AIM
   To analyse the impact of octogenarian donors in liver transplantation.
   METHODS
   We present a retrospective single-center study, performed between November 1996 and March 2015, that comprises a sample of 153 liver transplants. Recipients were divided into two groups according to liver donor age: recipients of donors <= 65 years (group A; n = 102), and recipients of donors = 80 years (group B; n = 51). A comparative analysis between the groups was performed. Quantitative variables were expressed as mean values and SD, and qualitative variables as percentages. Differences in properties between qualitative variables were assessed by. 2 test. Comparison of quantitative variables was made by t-test. Graft and patient survivals were estimated using the Kaplan-Meier method.
   RESULTS
   One, 3 and 5-year overall patient survival was 87.3%, 84% and 75.2%, respectively, in recipients of younger grafts vs 88.2%, 84.1% and 66.4%, respectively, in recipients of octogenarian grafts (P = 0.748). One, 3 and 5-year overall graft survival was 84.3%, 83.1% and 74.2%, respectively, in recipients of younger grafts vs 84.3%, 79.4% and 64.2%, respectively, in recipients of octogenarian grafts (P = 0.524). After excluding the patients with hepatitis C virus cirrhosis (16 in group A and 10 in group B), the 1, 3 and 5-year patient (P = 0.657) and graft (P = 0.419) survivals were practically the same in both groups. Multivariate Cox regression analysis demonstrated that overall patient survival was adversely affected by cerebrovascular donor death, hepatocarcinoma, and recipient preoperative bilirubin, and overall graft survival was adversely influenced by cerebrovascular donor death, and recipient preoperative bilirubin.
   CONCLUSION
   The standard criteria for utilization of octogenarian liver grafts are: normal gross appearance and consistency, normal or almost normal liver tests, hemodynamic stability with use of < 10 mu g/kg per minute of vasopressors before procurement, intensive care unit stay < 3 d, CIT < 9 h, absence of atherosclerosis in the hepatic and gastroduodenal arteries, and no relevant histological alterations in the pre-transplant biopsy, such as fibrosis, hepatitis, cholestasis or macrosteatosis > 30%.
C1 [Jimenez-Romero, Carlos; Cambra, Felix; Caso, Oscar; Manrique, Alejandro; Calvo, Jorge; Marcacuzco, Alejandro; Rioja, Paula; Lora, David; Justo, Iago] Univ Hosp Doce de Octubre, HPB Surg & Abdominal Organ Transplantat Unit, 4a Planta,Ctra Andalucia Km 5,4, Madrid 28041, Spain.
   [Jimenez-Romero, Carlos; Cambra, Felix; Caso, Oscar; Manrique, Alejandro; Calvo, Jorge; Marcacuzco, Alejandro; Rioja, Paula; Lora, David; Justo, Iago] UCM, Fac Med, Dept Surg, Madrid 28041, Spain.
C3 Hospital Universitario 12 de Octubre; Complutense University of Madrid
RP Jimenez-Romero, C (corresponding author), Univ Hosp Doce de Octubre, HPB Surg & Abdominal Organ Transplantat Unit, 4a Planta,Ctra Andalucia Km 5,4, Madrid 28041, Spain.
EM carlos.jimenez@inforboe.es
RI Justo, Iago/AAL-5709-2020
OI Marcacuzco Quinto, Alberto Alejandro/0000-0001-6266-8792; Calvo,
   Jorge/0000-0003-3144-4555; Justo, Iago/0000-0002-0553-5835
CR ADAM R, 1995, TRANSPLANT P, V27, P1181
   Anderson CD, 2008, J AM COLL SURGEONS, V207, P847, DOI 10.1016/j.jamcollsurg.2008.08.009
   Bernat JL, 2006, AM J TRANSPLANT, V6, P281, DOI 10.1111/j.1600-6143.2005.01194.x
   Borchert DH, 2005, TRANSPL P, V37, P1186, DOI 10.1016/j.transproceed.2004.12.261
   Briceño J, 2002, TRANSPLANTATION, V74, P522, DOI 10.1097/01.TP.0000026307.14572.8D
   Busquets J, 2001, TRANSPLANTATION, V71, P1765, DOI 10.1097/00007890-200106270-00011
   Busuttil RW, 2003, LIVER TRANSPLANT, V9, P651, DOI 10.1053/jlts.2003.50105
   Cescon M, 2003, LIVER TRANSPLANT, V9, P1174, DOI 10.1053/jlts.2003.50234
   Cescon M, 2008, LIVER TRANSPLANT, V14, P672, DOI 10.1002/lt.21433
   Chedid MF, 2014, HPB, V16, P852, DOI 10.1111/hpb.12221
   Darius T, 2012, TRANSPL P, V44, P2861, DOI 10.1016/j.transproceed.2012.09.076
   Emre S, 1996, TRANSPLANTATION, V62, P62, DOI 10.1097/00007890-199607150-00013
   Feng S, 2006, AM J TRANSPLANT, V6, P783, DOI 10.1111/j.1600-6143.2006.01242.x
   Gastaca M, 2005, TRANSPLANT P, V37, P3851, DOI 10.1016/j.transproceed.2005.10.040
   Ghinolfi D, 2014, AM J TRANSPLANT, V14, P2062, DOI 10.1111/ajt.12843
   González FR, 2002, TRANSPL P, V34, P233, DOI 10.1016/S0041-1345(01)02738-5
   GREIG PD, 1990, TRANSPLANT P, V22, P2072
   JAMES OFW, 1983, CLIN GASTROENTEROL, V12, P671
   Jiménez-Romero C, 2014, WORLD J GASTROENTERO, V20, P10691, DOI 10.3748/wjg.v20.i31.10691
   Jiménez-Romero C, 2013, WORLD J SURG, V37, P2211, DOI 10.1007/s00268-013-2085-7
   Kim DY, 2005, TRANSPLANT INT, V18, P73, DOI 10.1111/j.1432-2277.2004.00017.x
   López-Navidad A, 2003, CLIN TRANSPLANT, V17, P308, DOI 10.1034/j.1399-0012.2003.00119.x
   Marino IR, 1995, HEPATOLOGY, V22, P1754, DOI 10.1002/hep.1840220622
   Markmann JF, 2001, TRANSPLANTATION, V72, P1113, DOI 10.1097/00007890-200109270-00023
   Martins PN, 2011, HPB, V13, P212, DOI 10.1111/j.1477-2574.2010.00275.x
   Moore DE, 2005, ARCH SURG-CHICAGO, V140, P273, DOI 10.1001/archsurg.140.3.273
   Nardo B, 2004, AM J TRANSPLANT, V4, P1139, DOI 10.1111/j.1600-6143.2004.00472.x
   Petridis I, 2008, TRANSPL P, V40, P1976, DOI 10.1016/j.transproceed.2008.05.063
   POPPER H, 1985, HEPATOLOGY, V5, P1224, DOI 10.1002/hep.1840050627
   Rauchfuss F, 2010, TRANSPL P, V42, P175, DOI 10.1016/j.transproceed.2009.11.020
   Ravaioli M, 2009, TRANSPL INT, V22, P423, DOI 10.1111/j.1432-2277.2008.00812.x
   Regev A, 2001, GASTROENTEROL CLIN N, V30, P547, DOI 10.1016/S0889-8553(05)70195-3
   Renz JF, 2005, ANN SURG, V242, P556, DOI 10.1097/01.sla.0000183973.49899.b1
   Romero CJ, 1999, TRANSPLANTATION, V68, P572, DOI 10.1097/00007890-199908270-00021
   Segev DL, 2007, HEPATOLOGY, V46, P1907, DOI 10.1002/hep.21888
   Singhal A, 2010, EXP CLIN TRANSPLANT, V8, P196
   Spanish National Transplant Organization (ONT), 2015, DOSS ACT TRASPL HEP
   STRASBERG SM, 1994, HEPATOLOGY, V20, P829, DOI 10.1002/hep.1840200410
   Ureña MAG, 1998, TRANSPLANT P, V30, P3288, DOI 10.1016/S0041-1345(98)01033-1
   WALL W, 1993, LANCET, V341, P121, DOI 10.1016/0140-6736(93)92604-R
   WYNNE HA, 1989, HEPATOLOGY, V9, P297, DOI 10.1002/hep.1840090222
   WYNNE HA, 1990, AGE AGEING, V19, P1, DOI 10.1093/ageing/19.1.1
   Yersiz H, 2003, ANN SURG, V238, P496, DOI 10.1097/01.sla.0000089852.29654.72
   Zapletal C, 2005, TRANSPL P, V37, P1182, DOI 10.1016/j.transproceed.2004.11.056
NR 44
TC 15
Z9 15
U1 0
U2 2
PU BAISHIDENG PUBLISHING GROUP INC
PI PLEASANTON
PA 8226 REGENCY DR, PLEASANTON, CA 94588 USA
SN 1007-9327
EI 2219-2840
J9 WORLD J GASTROENTERO
JI World J. Gastroenterol.
PD MAY 7
PY 2017
VL 23
IS 17
BP 3099
EP 3110
DI 10.3748/wjg.v23.i17.3099
PG 12
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA EU8WX
UT WOS:000401320300011
PM 28533667
OA Green Published, Green Submitted, hybrid
DA 2024-02-19
ER

PT J
AU Gibson, A
   Randall, D
   Degenhardt, L
AF Gibson, Amy
   Randall, Deborah
   Degenhardt, Louisa
TI The increasing mortality burden of liver disease among opioid-dependent
   people: cohort study
SO ADDICTION
LA English
DT Article
DE Cancer; cohort; hepatitis; heroin; mortality
ID INJECTING DRUG-USERS; HEPATITIS-C; PREVALENCE; PROVISION; AUSTRALIA;
   OUTCOMES; HEROIN; HIV; HCV
AB Aims Hepatitis C (HCV) infection is highly prevalent among injection drug users (IDUs) and likely to cause significant mortality over time, but little research attention has focused upon the magnitude of this risk, particularly among ageing users. This study examined trends over time in mortality attributed to liver disease, and in particular contrasting this with other more commonly studied causes of death [acquired immune deficiency syndrome (AIDS), suicide and overdose] among an ageing cohort of heroin-dependent people in Australia. Design Data linkage study of methadone treatment entrants with the National Deaths Index. Setting A cohort entering methadone treatment for heroin dependence in New South Wales, Australia, 1980-85. Participants A total of 2489 people entering methadone treatment for heroin dependence and 54 847 person-years (PY) of follow-up. Measurements Linkage of data on all methadone entrants between 1980 and 1985 with data from the Australian National Deaths Index, linked using probabilistic record linkage software. Findings There were 8.2 deaths per 1000 PY [95% confidence interval (CI) 7.5-9.0], with standardized mortality ratios (SMRs) of 4.6 (95% CI 4.2-5.0). Almost one in five (17%) of deaths were from underlying liver-related causes, most commonly viral hepatitis. The overall mortality rate for any liver cause was 1.4 deaths per 1000 PY (95% CI 1.1-1.7), 17 times higher than to the general population (95% CI 13.4-21.3), with relative elevations more marked for females (SMR 27.9; 95% CI 17.7-41.9) than males (SMR 14.5; 95% CI 10.8-19.0). Liver mortality increased over time, becoming the most common cause of death by the end of follow-up. Conclusions Liver disease has become the most common cause of mortality among ageing opioid-dependent people in an ageing Australian cohort. There is an imperative to reduce the long-term risks of HCV and other risks to the liver, including alcohol consumption, which are typically not the major clinical focus for this group.
C1 [Degenhardt, Louisa] Burnet Inst, Melbourne, Vic 3004, Australia.
   [Gibson, Amy] Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia.
   [Randall, Deborah] Univ Western Sydney, Sydney, NSW, Australia.
   [Degenhardt, Louisa] Univ Melbourne, Sch Populat Hlth, Ctr Hlth Policy Programs & Econ, Melbourne, Vic 3010, Australia.
C3 Burnet Institute; University of New South Wales Sydney; Western Sydney
   University; University of Melbourne
RP Degenhardt, L (corresponding author), Burnet Inst, 85 Commercial Rd, Melbourne, Vic 3004, Australia.
EM louisa@burnet.edu.au
RI Degenhardt, Louisa J/D-4515-2012
OI Degenhardt, Louisa J/0000-0002-8513-2218; Randall,
   Deborah/0000-0002-5075-0227
FU Australian Government Department of Health and Ageing; Australian NHMRC
FX The National Drug and Alcohol Research Centre receives core funding from
   the Australian Government Department of Health and Ageing. Louisa
   Degenhardt is supported by an Australian NHMRC Senior Research
   Fellowship. These funders had no role in the study's conception, design,
   conduct or interpretation of findings.
CR Amin J, 2006, LANCET, V368, P938, DOI 10.1016/S0140-6736(06)69374-4
   [Anonymous], AUSTR NSP SURV NAT D
   [Anonymous], HEPATITIS C INJECTIN
   Australian Bureau of Statistics, 2007, 2005 CAUS DEATH AUST
   Australian Bureau of Statistics, 2006, INF PAP ABS CAUS DEA
   Australian Bureau of Statistics, 2003, DRUG IND DEATHS AUST
   Coutinho RA, 1998, BRIT MED J, V317, P424, DOI 10.1136/bmj.317.7156.424
   Darke S, 1997, DRUG ALCOHOL DEPEN, V48, P135, DOI 10.1016/S0376-8716(97)00117-8
   Darke S., 2006, Mortality amongst illicit drug users
   Degenhardt L., 2008, CAUSE SPECIFIC MORTA
   Degenhardt Louisa, 2010, Lancet, V376, P285, DOI 10.1016/S0140-6736(10)60742-8
   Degenhardt L, 2011, ADDICTION, V106, P32, DOI 10.1111/j.1360-0443.2010.03140.x
   Degenhardt L, 2009, DRUG ALCOHOL DEPEN, V105, P9, DOI 10.1016/j.drugalcdep.2009.05.021
   Dore GJ, 2002, J GASTROEN HEPATOL, V17, P423, DOI 10.1046/j.1440-1746.2002.02730.x
   Gillies M, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-721
   Hagan H, 2007, INT J DRUG POLICY, V18, P341, DOI 10.1016/j.drugpo.2007.01.016
   Hallinan R, 2005, J GASTROEN HEPATOL, V20, P1082, DOI 10.1111/j.1440-1746.2005.03882.x
   Kariminia A, 2005, AUST NZ J PUBL HEAL, V29, P572, DOI 10.1111/j.1467-842X.2005.tb00253.x
   Kimber J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3172
   Law MG, 2003, INT J EPIDEMIOL, V32, P717, DOI 10.1093/ije/dyg101
   Martin NK, 2011, J HEPATOL, V54, P1137, DOI 10.1016/j.jhep.2010.08.029
   Martin NK, 2011, J THEOR BIOL, V274, P58, DOI 10.1016/j.jtbi.2010.12.041
   Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2
   McDonald SA, 2011, J VIRAL HEPATITIS, V18, pe126, DOI 10.1111/j.1365-2893.2010.01380.x
   Ministerial Advisory Committee on AIDS Sexual Health and Hepatitis Hepatitis C Sub-Committee, 2006, HEP C VIR PROJ WORK
   Nelson PK, 2011, LANCET, V378, P571, DOI 10.1016/S0140-6736(11)61097-0
   Palmateer N, 2010, ADDICTION, V105, P844, DOI 10.1111/j.1360-0443.2009.02888.x
   Population Health Division, 2006, HLTH PEOPL NEW S WAL
   Randall D., 2009, 301 NDARC
   Randall D, 2011, AUST NZ J PUBL HEAL, V35, P220, DOI 10.1111/j.1753-6405.2011.00682.x
   Stoové MA, 2008, DRUG ALCOHOL DEPEN, V96, P281, DOI 10.1016/j.drugalcdep.2008.03.006
   von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X
   Wodak A, 1995, B NEW YORK ACAD MED, V72, P339
NR 33
TC 48
Z9 54
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0965-2140
EI 1360-0443
J9 ADDICTION
JI Addiction
PD DEC
PY 2011
VL 106
IS 12
BP 2186
EP 2192
DI 10.1111/j.1360-0443.2011.03575.x
PG 7
WC Substance Abuse; Psychiatry
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Substance Abuse; Psychiatry
GA 841SU
UT WOS:000296534200020
PM 21749525
OA Bronze
DA 2024-02-19
ER

PT J
AU Kim, D
   Li, AA
   Ahmed, A
AF Kim, Donghee
   Li, Andrew A.
   Ahmed, Aijaz
TI Leucocyte telomere shortening is associated with nonalcoholic fatty
   liver disease-related advanced fibrosis
SO LIVER INTERNATIONAL
LA English
DT Article
DE fatty liver; fibrosis; hepatic steatosis; National Health and Nutrition
   Examination Survey; telomerase
ID SERUM ALANINE AMINOTRANSFERASE; OXIDATIVE STRESS; LENGTH; NAFLD; RISK;
   PROGRESSION; SENESCENCE; CIRRHOSIS; ALCOHOL; MARKERS
AB Background & AimTelomere length and telomerase have been linked with cirrhosis and hepatocellular carcinoma. However, the impact of telomere length on nonalcoholic fatty liver disease and advanced fibrosis in a large national population sample is not well understood.
   MethodsCross-sectional data from the National Health and Nutrition Examination Survey 1999-2002 were utilized. Suspected nonalcoholic fatty liver disease was diagnosed if serum alanine aminotransferase was >30IU/L for men and >19IU/L for women in the absence of other causes of chronic liver disease. Presence of advanced fibrosis was determined by the nonalcoholic fatty liver disease fibrosis score, aspartate aminotransferase to platelet ratio index and FIB-4 score.
   ResultsOf the 6738 participants (mean age 46.3years, 48.4% male), suspected nonalcoholic fatty liver disease prevalence was inversely associated with leucocyte telomere length in young adults aged 20-39years, though this was not seen in the overall population. Percentage of participants with advanced fibrosis increased corresponding with leucocyte telomere length (longest to shortest). The shortest quartile of leucocyte telomere length was associated with a significantly higher odds ratio (95% confidence interval) of advanced fibrosis of 2.36 (1.32-4.24) in a univariate model compared to the longest quartile, and 2.01 (1.13-3.58) in a multivariate model adjusted for age, gender, ethnicity, waist circumference, smoking, diabetes, hypertension, total cholesterol and high-density lipoprotein cholesterol (P for trend <.05 respectively).
   ConclusionsIn this large nationally representative sample of American adults, leucocyte telomere shortening was associated with increased risk of advanced fibrosis in the setting of suspected nonalcoholic fatty liver disease independent of other known risk factors.
   See Article on Page 1730
C1 [Kim, Donghee; Ahmed, Aijaz] Stanford Univ, Sch Med, Div Gastroenterol & Hepatol, Stanford, CA 94305 USA.
   [Li, Andrew A.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA.
C3 Stanford University; Stanford University
RP Ahmed, A (corresponding author), Stanford Univ, Sch Med, Div Gastroenterol & Hepatol, Palo Alto, CA 94304 USA.
EM aijazahmed@stanford.edu
RI Kim, Donghee/C-4288-2013
OI Kim, Donghee/0000-0003-1919-6800; Li, Andrew/0000-0002-1295-8115
CR Aikata H, 2000, EXP CELL RES, V256, P578, DOI 10.1006/excr.2000.4862
   Angulo P, 2007, HEPATOLOGY, V45, P846, DOI 10.1002/hep.21496
   [Anonymous], 1994, VITAL HLTH STAT, V32, P1
   Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41
   Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031
   Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3
   Calado RT, 2011, HEPATOLOGY, V53, P1600, DOI 10.1002/hep.24173
   Carulli L, 2014, WORLD J GASTROENTERO, V20, P6287, DOI 10.3748/wjg.v20.i20.6287
   Correia-Melo Clara, 2014, Longev Healthspan, V3, P1, DOI 10.1186/2046-2395-3-1
   Demissie S, 2006, AGING CELL, V5, P325, DOI 10.1111/j.1474-9726.2006.00224.x
   Dlouha D, 2014, PHYSIOL RES, V63, pS343, DOI 10.33549/physiolres.932856
   Donati B, 2017, CANCER MED-US, V6, P1930, DOI 10.1002/cam4.1078
   Donati B, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030383
   Dowman JK, 2010, QJM-INT J MED, V103, P71, DOI 10.1093/qjmed/hcp158
   Eslam M, 2018, J HEPATOL, V68, P268, DOI 10.1016/j.jhep.2017.09.003
   Kim D, 2013, HEPATOLOGY, V57, P1357, DOI 10.1002/hep.26156
   KITADA T, 1995, BIOCHEM BIOPH RES CO, V211, P33, DOI 10.1006/bbrc.1995.1774
   Koehler EM, 2012, J HEPATOL, V57, P1305, DOI 10.1016/j.jhep.2012.07.028
   Laish I, 2016, CYTOGENET GENOME RES, V150, P93, DOI 10.1159/000454654
   Needham BL, 2013, SOC SCI MED, V85, P1, DOI 10.1016/j.socscimed.2013.02.023
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Permutt Z, 2012, ALIMENT PHARM THER, V36, P22, DOI 10.1111/j.1365-2036.2012.05121.x
   Prati D, 2002, ANN INTERN MED, V137, P1, DOI 10.7326/0003-4819-137-1-200207020-00006
   Rudolph KL, 2000, SCIENCE, V287, P1253, DOI 10.1126/science.287.5456.1253
   Ruhl CE, 2005, CLIN GASTROENTEROL H, V3, P1260, DOI 10.1016/S1542-3565(05)00743-3
   Salamone F, 2010, J HEPATOL, V53, P1146, DOI 10.1016/j.jhep.2010.06.013
   Salpea KD, 2010, ATHEROSCLEROSIS, V209, P42, DOI 10.1016/j.atherosclerosis.2009.09.070
   Shah AG, 2009, CLIN GASTROENTEROL H, V7, P1104, DOI 10.1016/j.cgh.2009.05.033
   van der Poorten D, 2013, HEPATOLOGY, V57, P2180, DOI 10.1002/hep.26072
   Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   Willeit P, 2010, JAMA-J AM MED ASSOC, V304, P69, DOI 10.1001/jama.2010.897
   Wojcicki JM, 2017, INT J HEPATOL, V2017, DOI 10.1155/2017/8435178
   Younossi ZM, 2017, HEPATOLOGY, V66, p9A
   Zhang JW, 2016, AGEING RES REV, V25, P55, DOI 10.1016/j.arr.2015.11.006
NR 35
TC 22
Z9 23
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1478-3223
EI 1478-3231
J9 LIVER INT
JI Liver Int.
PD OCT
PY 2018
VL 38
IS 10
BP 1839
EP 1848
DI 10.1111/liv.13886
PG 10
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA GU8VZ
UT WOS:000445622400017
PM 29797393
DA 2024-02-19
ER

PT J
AU Niimi, K
   Takahashi, E
   Itakura, C
AF Niimi, Kimie
   Takahashi, Eiki
   Itakura, Chitoshi
TI Adiposity-Related Biochemical Phenotype in Senescence-Accelerated Mouse
   Prone 6 (SAMP6)
SO COMPARATIVE MEDICINE
LA English
DT Article
ID BONE-FORMATION; SERUM ADIPONECTIN; ADIPOCYTE DIFFERENTIATION; ENHANCES
   OSTEOGENESIS; ENERGY-BALANCE; MURINE MODEL; IN-VITRO; MARROW; OBESITY;
   ADIPOGENESIS
AB Senescence-accelerated mouse prone 6 (SAMP6) is a model of senile osteoporosis. From 10 to 22 wk of age, SAMP6 mice were heavier than age-matched AKR/J and SAMR1 mice. Body mass indices of 10- and 25-wk-old SAMP6 mice were higher than those of age-matched AKR/J and SAMR1 mice, indicating obesity in the SAMP6 animals. We compared the blood biochemical values among SAMP6, SAMR1, and AKR/J mice to assess whether the SAMP6 strain has abnormal obesity-related parameters. Plasma glucose, triglyceride, insulin, and leptin levels were higher in 10-wk-old SAMP6 mice than in age-matched SAMR1 and AKR/J mice, whereas plasma glucagon and adiponectin levels in 25-wk-old SAMP6 were lower compared with those in age-matched SAMR1 and AKR/J. Total cholesterol levels in SAMR1 and SAMP6 mice at 10 and 25 wk of age were higher than those in AKR/J mice. Hepatic lipid levels were higher in 10- and 25-wk-old SAMP6 mice compared with age-matched AKR/J and SAMR1 animals. These results indicate that SAMP6 mice exhibit obesity and hyperlipidemia, suggesting that the SAMP6 strain is a potential tool for the study of hyperlipidemia.
C1 [Niimi, Kimie; Takahashi, Eiki; Itakura, Chitoshi] RIKEN, Brain Sci Inst, Res Resources Ctr, Saitama, Japan.
   [Niimi, Kimie] Brain Sci & Life Technol Res Fdn, Tokyo, Japan.
C3 RIKEN
RP Takahashi, E (corresponding author), RIKEN, Brain Sci Inst, Res Resources Ctr, Saitama, Japan.
EM etakahashi@brain.riken.jp
RI Niimi, Kimie/S-8264-2019; Takahashi, Eiki/N-6998-2015
OI Niimi, Kimie/0000-0001-5240-5745; 
CR Akune T, 2004, J CLIN INVEST, V113, P846, DOI 10.1172/JCI200419900
   Asayama K, 2003, OBES RES, V11, P1072, DOI 10.1038/oby.2003.147
   Dang ZC, 2002, J BONE MINER RES, V17, P394, DOI 10.1359/jbmr.2002.17.3.394
   Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5
   Enomoto H, 2004, J CELL SCI, V117, P417, DOI 10.1242/jcs.00866
   Flood JF, 1998, NEUROSCI BIOBEHAV R, V22, P1
   Garrett IR, 2002, ARTHRITIS RES, V4, P237, DOI 10.1186/ar413
   GIMBLE JM, 1994, J CELL BIOCHEM, V54, P122, DOI 10.1002/jcb.240540113
   Hata K, 2005, MOL CELL BIOL, V25, P1971, DOI 10.1128/MCB.25.5.1971-1979.2005
   Ichida F, 2004, J BIOL CHEM, V279, P34015, DOI 10.1074/jbc.M403621200
   IKEO T, 2001, J OSAKA ODONTOL SOC, V64, P358
   Jéquier E, 2002, ANN NY ACAD SCI, V967, P379, DOI 10.1111/j.1749-6632.2002.tb04293.x
   Jilka RL, 1996, J CLIN INVEST, V97, P1732, DOI 10.1172/JCI118600
   Justesen J, 2001, BIOGERONTOLOGY, V2, P165, DOI 10.1023/A:1011513223894
   Kanbay A, 2008, RESPIRATION, V76, P324, DOI 10.1159/000134010
   Kasai S, 2004, J BONE MINER METAB, V22, P207, DOI 10.1007/s00774-003-0471-1
   Kodama Y, 1998, J BONE MINER RES, V13, P1370, DOI 10.1359/jbmr.1998.13.9.1370
   Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5
   Kotani K, 2007, HEART VESSELS, V22, P291, DOI 10.1007/s00380-006-0969-2
   Luo XH, 2005, EXP CELL RES, V309, P99, DOI 10.1016/j.yexcr.2005.05.021
   Majima T, 2008, ENDOCR J, V55, P143, DOI 10.1507/endocrj.K07E-004
   Matsubara M, 2002, EUR J ENDOCRINOL, V147, P173, DOI 10.1530/eje.0.1470173
   MATSUSHITA M, 1986, AM J PATHOL, V125, P276
   Meister B, 2000, Vitam Horm, V59, P265, DOI 10.1016/S0083-6729(00)59010-4
   Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946
   Niimi K, 2008, BEHAV BRAIN RES, V188, P329, DOI 10.1016/j.bbr.2007.11.014
   Niimi K, 2009, NEUROSCI LETT, V458, P53, DOI 10.1016/j.neulet.2009.04.042
   Niimi K, 2009, PHYSIOL BEHAV, V96, P464, DOI 10.1016/j.physbeh.2008.11.012
   Numata T, 2002, BIOCHEM BIOPH RES CO, V297, P517, DOI 10.1016/S0006-291X(02)02155-1
   Okazaki R, 2002, ENDOCRINOLOGY, V143, P2349, DOI 10.1210/en.143.6.2349
   Rodríguez JP, 2008, CURR STEM CELL RES T, V3, P208, DOI 10.2174/157488808785740325
   PACY PJ, 1986, SPORTS MED, V3, P89, DOI 10.2165/00007256-198603020-00002
   Palacios VG, 2001, PROSTAG LEUKOTR ESS, V65, P215, DOI 10.1054/plef.2001.0314
   Rosen CJ, 2009, CRIT REV EUKAR GENE, V19, P109, DOI 10.1615/CritRevEukarGeneExpr.v19.i2.20
   Rosen ED, 2000, GENE DEV, V14, P1293
   Rossmeisl M, 2003, DIABETES, V52, P1958, DOI 10.2337/diabetes.52.8.1958
   Rosso LG, 2009, NUTR METAB CARDIOVAS, V19, P135, DOI 10.1016/j.numecd.2008.02.008
   Shimano Y, 1998, Hokkaido Igaku Zasshi, V73, P557
   Sone M, 2001, Pituitary, V4, P15, DOI 10.1023/A:1012978525492
   SPARKS JD, 1994, BBA-LIPID LIPID MET, V1215, P9, DOI 10.1016/0005-2760(94)90088-4
   Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9
   Tagami T, 2004, J CLIN ENDOCR METAB, V89, P1833, DOI 10.1210/jc.2003-031260
   Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8
   Takeda T, 1997, EXP GERONTOL, V32, P105, DOI 10.1016/S0531-5565(96)00036-8
   Uchida K, 2009, EXP ANIM TOKYO, V58, P181, DOI 10.1538/expanim.58.181
   WEST DB, 1995, AM J PHYSIOL-REG I, V268, pR658, DOI 10.1152/ajpregu.1995.268.3.R658
NR 46
TC 13
Z9 13
U1 0
U2 2
PU AMER ASSOC LABORATORY ANIMAL SCIENCE
PI MEMPHIS
PA 9190 CRESTWYN HILLS DR, MEMPHIS, TN 38125 USA
SN 1532-0820
J9 COMPARATIVE MED
JI Comparative Med.
PD OCT
PY 2009
VL 59
IS 5
BP 431
EP 436
PG 6
WC Veterinary Sciences; Zoology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Veterinary Sciences; Zoology
GA 519WH
UT WOS:000271799500003
PM 19887026
DA 2024-02-19
ER

PT J
AU Vermeij, WP
   Dollé, MET
   Reiling, E
   Jaarsma, D
   Payan-Gomez, C
   Bombardieri, CR
   Wu, H
   Roks, AJM
   Botter, SM
   van der Eerden, BC
   Youssef, SA
   Kuiper, RV
   Nagarajah, B
   van Oostrom, CT
   Brandt, RMC
   Barnhoorn, S
   Imholz, S
   Pennings, JLA
   de Bruin, A
   Gyenis, A
   Pothof, J
   Vijg, J
   van Steeg, H
   Hoeijmakers, JHJ
AF Vermeij, W. P.
   Dolle, M. E. T.
   Reiling, E.
   Jaarsma, D.
   Payan-Gomez, C.
   Bombardieri, C. R.
   Wu, H.
   Roks, A. J. M.
   Botter, S. M.
   van der Eerden, B. C.
   Youssef, S. A.
   Kuiper, R. V.
   Nagarajah, B.
   van Oostrom, C. T.
   Brandt, R. M. C.
   Barnhoorn, S.
   Imholz, S.
   Pennings, J. L. A.
   de Bruin, A.
   Gyenis, A.
   Pothof, J.
   Vijg, J.
   van Steeg, H.
   Hoeijmakers, J. H. J.
TI Restricted diet delays accelerated ageing and genomic stress in
   DNA-repair-deficient mice
SO NATURE
LA English
DT Article
ID CALORIC RESTRICTION; NUCLEAR ABNORMALITIES; COCKAYNE-SYNDROME; GROWTH;
   DEGENERATION; COMPONENT; MODELS; CANCER; P53
AB Mice deficient in the DNA excision-repair gene Ercc1 (Ercc1(Delta/-)) show numerous accelerated ageing features that limit their lifespan to 4-6 months(1-4). They also exhibit a 'survival response', which suppresses growth and enhances cellular maintenance. Such a response resembles the anti-ageing response induced by dietary restriction (also known as caloric restriction)(1,5). Here we report that a dietary restriction of 30% tripled the median and maximal remaining lifespans of these progeroid mice, strongly retarding numerous aspects of accelerated ageing. Mice undergoing dietary restriction retained 50% more neurons and maintained full motor function far beyond the lifespan of mice fed ad libitum. Other DNA-repair-deficient, progeroid Xpg(-/-) (also known as Ercc5(-/-)) mice, a model of Cockayne syndrome(6), responded similarly. The dietary restriction response in Ercc1(Delta/-) mice closely resembled the effects of dietary restriction in wild-type animals. Notably, liver tissue from Ercc1(Delta/-) mice fed ad libitum showed preferential extinction of the expression of long genes, a phenomenon we also observed in several tissues ageing normally. This is consistent with the accumulation of stochastic, transcription-blocking lesions that affect long genes more than short ones. Dietary restriction largely prevented this declining transcriptional output and reduced the number of gamma H2AX DNA damage foci, indicating that dietary restriction preserves genome function by alleviating DNA damage. Our findings establish the Ercc1(Delta/-) mouse as a powerful model organism for health-sustaining interventions, reveal potential for reducing endogenous DNA damage, facilitate a better understanding of the molecular mechanism of dietary restriction and suggest a role for counterintuitive dietary-restriction-like therapy for human progeroid genome instability syndromes and possibly neurodegeneration in general.
C1 [Vermeij, W. P.; Reiling, E.; Payan-Gomez, C.; Bombardieri, C. R.; Botter, S. M.; Brandt, R. M. C.; Barnhoorn, S.; Gyenis, A.; Pothof, J.; Hoeijmakers, J. H. J.] Erasmus Univ, Dept Mol Genet, Med Ctr Rotterdam, POB 2040, NL-3000 CA Rotterdam, Netherlands.
   [Dolle, M. E. T.; Reiling, E.; Nagarajah, B.; van Oostrom, C. T.; Imholz, S.; Pennings, J. L. A.; van Steeg, H.] Natl Inst Publ Hlth & Environm RIVM, Ctr Hlth Protect, POB 1, NL-3720 BA Bilthoven, Netherlands.
   [Jaarsma, D.] Erasmus Univ, Med Ctr Rotterdam, Dept Neurosci, POB 2040, NL-3000 CA Rotterdam, Netherlands.
   [Payan-Gomez, C.] Univ Rosario, Fac Ciencias Nat & Matemat, Carrera 24,63C-69, Bogota, Colombia.
   [Wu, H.; Roks, A. J. M.] Erasmus Univ, Div Vasc Med & Pharmacol, Dept Internal Med, Med Ctr Rotterdam, POB 2040, NL-3000 CA Rotterdam, Netherlands.
   [Botter, S. M.] Balgrist Univ Hosp, Lab Orthoped Res, Forchstr 340, CH-8008 Zurich, Switzerland.
   [van der Eerden, B. C.] Erasmus Univ, Dept Internal Med, Med Ctr Rotterdam, POB 2040, NL-3000 CA Rotterdam, Netherlands.
   [Youssef, S. A.; Kuiper, R. V.; de Bruin, A.] Univ Utrecht, Dept Pathobiol, Dutch Mol Pathol Ctr, Fac Vet Med, POB 80125, NL-3508 TC Utrecht, Netherlands.
   [de Bruin, A.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Div Mol Genet, POB 30001, NL-9700 RB Groningen, Netherlands.
   [Vijg, J.] Albert Einstein Coll Med, Dept Genet, 1300 Morris Pk Ave, Bronx, NY 10461 USA.
   [van Steeg, H.] Leiden Univ, Med Ctr, Dept Human Genet, POB 9600, NL-2300 RC Leiden, Netherlands.
   [Hoeijmakers, J. H. J.] Univ Cologne, CECAD Forschungszentrum, Joseph Stelzmann Str 26, D-50931 Cologne, Germany.
   [Kuiper, R. V.] Karolinska Inst, Dept Lab Med, SE-17177 Stockholm, Sweden.
C3 Erasmus University Rotterdam; Erasmus MC; Netherlands National Institute
   for Public Health & the Environment; Erasmus University Rotterdam;
   Erasmus MC; Universidad del Rosario; Erasmus University Rotterdam;
   Erasmus MC; University of Zurich; Erasmus University Rotterdam; Erasmus
   MC; Utrecht University; University of Groningen; Yeshiva University;
   Albert Einstein College of Medicine; Leiden University; Leiden
   University Medical Center (LUMC); Leiden University - Excl LUMC;
   University of Cologne; Karolinska Institutet
RP Hoeijmakers, JHJ (corresponding author), Erasmus Univ, Dept Mol Genet, Med Ctr Rotterdam, POB 2040, NL-3000 CA Rotterdam, Netherlands.; Dollé, MET (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Ctr Hlth Protect, POB 1, NL-3720 BA Bilthoven, Netherlands.
EM martijn.dolle@rivm.nl; j.hoeijmakers@erasmusmc.nl
RI de Bruin, Alain/AAL-9195-2020; van der Eerden, Bram CJ/I-7496-2012;
   Hoeijmakers, Jan/AAX-6972-2021; Payan-Gomez, Cesar/G-8589-2016
OI van der Eerden, Bram CJ/0000-0003-4403-6497; Dolle,
   Martijn/0000-0001-6137-6544; Vermeij, Wilbert/0000-0002-9690-1385;
   Brandt, Renata M. C./0000-0003-0514-5623; Botter,
   Sander/0000-0003-1695-1700; Roks, Anton J.M./0000-0001-7155-1756;
   Pennings, Jeroen L.A./0000-0002-9188-6358; Gyenis,
   Akos/0000-0002-8104-7681; Payan-Gomez, Cesar/0000-0002-0633-1332;
   Kuiper, Raoul/0000-0001-5645-2389
FU National Institute of Health (NIH)/National Institute of Ageing (NIA)
   [1PO1 AG-17242-02]; National Institute for Public Health and the
   Environment; Ministry of Health, Welfare and Sport of The Netherlands
   [S/340005]; European Research Council; European commission
   [FP7-Health-2008-200880]; DNA Repair [LSHG-CT-2005-512113]; EU ITN
   Address [GA-316390]; KWO Dutch Cancer Society [5030]; Dutch CAA
   Foundation; Royal Academy of Arts and Sciences of the Netherlands;
   European Community [HEALTH-F2-2010-259893]
FX We thank P. de With, J. Rigters, E. Haasdijk, S. Gabriels, E. J. M.
   Stynenbosch, N. van Vliet, Y. van Loon, J. Baan and the animal
   caretakers for general assistance with mouse experiments. We thank A. H.
   J. Danser and J. P. van Leeuwen for support. We acknowledge financial
   support from the National Institute of Health (NIH)/National Institute
   of Ageing (NIA) (1PO1 AG-17242-02), the National Institute for Public
   Health and the Environment and the Ministry of Health, Welfare and Sport
   of The Netherlands (S/340005), European Research Council Advanced Grant
   DamAge and Proof of Concept Grant Dementia to J. H. J. H., the European
   commission FP7 Markage (FP7-Health-2008-200880), DNA Repair
   (LSHG-CT-2005-512113), EU ITN Address (GA-316390), the KWO Dutch Cancer
   Society (5030), the Dutch CAA Foundation and the Royal Academy of Arts
   and Sciences of the Netherlands (academia professorship to J. H. J. H.).
   The research leading to these results has received funding from the
   European Community's Seventh Framework Programme (FP7/2007-2013) under
   grant agreement number HEALTH-F2-2010-259893. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Barnhoorn S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004686
   Bartke A, 2013, PHYSIOL REV, V93, P571, DOI 10.1152/physrev.00006.2012
   Barzilai N, 2012, DIABETES, V61, P1315, DOI 10.2337/db11-1300
   Bogliolo M, 2013, AM J HUM GENET, V92, P800, DOI 10.1016/j.ajhg.2013.04.002
   Borgesius NZ, 2011, J NEUROSCI, V31, P12543, DOI 10.1523/JNEUROSCI.1589-11.2011
   Botter SM, 2009, OSTEOARTHR CARTILAGE, V17, P636, DOI 10.1016/j.joca.2008.09.018
   Campisi J, 2014, INTERD T GERONT GERI, V39, P45, DOI 10.1159/000358899
   Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   de Graaf EL, 2013, MOL CELL PROTEOMICS, V12, P1350, DOI 10.1074/mcp.M112.024950
   de Waard MC, 2010, ACTA NEUROPATHOL, V120, P461, DOI 10.1007/s00401-010-0715-9
   Derks KWJ, 2015, RNA BIOL, V12, P30, DOI 10.1080/15476286.2015.1017202
   Dollé MET, 2011, PATHOBIOL AGING AGE, V1, DOI 10.3402/pba.v1i0.7219
   Duncan AW, 2010, NATURE, V467, P707, DOI 10.1038/nature09414
   Durik M, 2012, CIRCULATION, V126, P468, DOI 10.1161/CIRCULATIONAHA.112.104380
   Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97
   Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539
   Garinis GA, 2009, NAT CELL BIOL, V11, P604, DOI 10.1038/ncb1866
   Gates KS, 2009, CHEM RES TOXICOL, V22, P1747, DOI 10.1021/tx900242k
   Halagappa VKM, 2007, NEUROBIOL DIS, V26, P212, DOI 10.1016/j.nbd.2006.12.019
   He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939
   Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615
   Jaarsma D, 2013, MECH AGEING DEV, V134, P180, DOI 10.1016/j.mad.2013.04.003
   Jonker MJ, 2013, AGING CELL, V12, P901, DOI 10.1111/acel.12118
   Kashiyama K, 2013, AM J HUM GENET, V92, P807, DOI 10.1016/j.ajhg.2013.04.007
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Mair W, 2003, SCIENCE, V301, P1731, DOI 10.1126/science.1086016
   Marteijn JA, 2014, NAT REV MOL CELL BIO, V15, P465, DOI 10.1038/nrm3822
   MCWHIR J, 1993, NAT GENET, V5, P217, DOI 10.1038/ng1193-217
   Navarro F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132767
   Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456
   Partridge L, 2007, NATURE, V450, P165, DOI 10.1038/450165a
   Raj DDA, 2014, NEUROBIOL AGING, V35, P2147, DOI 10.1016/j.neurobiolaging.2014.03.025
   Ringnér M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303
   Schumacher B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000161
   Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23
   Speakman JR, 2011, MOL ASPECTS MED, V32, P159, DOI 10.1016/j.mam.2011.07.001
   Stranahan AM, 2012, J ALZHEIMERS DIS, V30, pS5, DOI 10.3233/JAD-2011-110899
   Swenberg JA, 2011, TOXICOL SCI, V120, pS130, DOI 10.1093/toxsci/kfq371
   Swindell WR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-585
   van der Pluijm I, 2007, PLOS BIOL, V5, P23, DOI 10.1371/journal.pbio.0050002
   Vermeij WP, 2016, ANNU REV PHARMACOL, V56, P427, DOI 10.1146/annurev-pharmtox-010814-124316
   Waarsing JH, 2004, J BONE MINER RES, V19, P1640, DOI 10.1359/JBMR.040705
   Weeda G, 1997, CURR BIOL, V7, P427, DOI 10.1016/S0960-9822(06)00190-4
   Wijnhoven SWP, 2005, DNA REPAIR, V4, P1314, DOI 10.1016/j.dnarep.2005.07.002
   Wilson BT, 2016, GENET MED, V18, P483, DOI 10.1038/gim.2015.110
NR 46
TC 174
Z9 193
U1 1
U2 89
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD SEP 15
PY 2016
VL 537
IS 7620
BP 427
EP +
DI 10.1038/nature19329
PG 21
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA DV7EC
UT WOS:000383098000059
PM 27556946
OA Green Accepted, Green Published
DA 2024-02-19
ER

PT J
AU Sha, AL
   Liu, Y
   Hao, HY
AF Sha, Ailong
   Liu, Yi
   Hao, Haiyan
TI Study on the Anti-aging effect of<i> Suaeda</i><i> rigida</i>
   Polysaccharides
SO LATIN AMERICAN JOURNAL OF PHARMACY
LA English
DT Article
DE anti-aging; glutathione; nitric oxide; organ indexes; oxygen radical;
   Suaeda rigida polysaccharides
ID ANTIOXIDANT
AB The objective of this study was to investigate the anti-aging effect of Suaeda rigida polysaccha-rides. The subacute aging model mice were established by subcutaneous injection of D-galactose, to observe the effects of different concentrations of S. rigida polysaccharides (100, 200 and 400 mg/kg) on mice (the nor-mal control group and aging model group were intragastric administrated with an equal volume of normal saline). Specifically, the effects on the indexes of brain and organs, the contents of oxygen free radicals and the activities of several related enzymes in brain tissue, the GSH content and the activities of two related enzymes in liver tissue, and the NOS-NO-cGMP signal pathway in the serum of aging model mice were observed. The results showed that S. rigida polysaccharides could obviously increase the brain and organ indexes, the CAT activity in brain tissue, the GSH content and the activities of GSH-px, GST in liver tissue. It can obviously decrease the contents of H2O2, MDA and the activity of XOD in brain tissue, the contents of center dot OH, NO, cGMP and the activities of TNOS, iNOS in the serums. All the results suggested that S. rigida polysaccharides can play an anti-aging role by delaying the atrophy and degeneration of the brain and organs in animals, scavenging free radicals and enhancing the activities of antioxidant enzymes in vivo, inhibiting NOS and ultimately inhibiting the cytotoxicity of NO.
C1 [Sha, Ailong] Chongqing Three Gorges Univ, Sch Teacher Educ, Chongqing 404120, Peoples R China.
   [Liu, Yi] Chongqing Three Gorges Univ, Sch Biol & Food Engn, Chongqing 404120, Peoples R China.
   [Hao, Haiyan] Chongqing Three Gorges Univ, Sch Environm & Chem Engn, Chongqing 404120, Peoples R China.
C3 Chongqing Three Gorges University; Chongqing Three Gorges University;
   Chongqing Three Gorges University
RP Sha, AL (corresponding author), Chongqing Three Gorges Univ, Sch Teacher Educ, Chongqing 404120, Peoples R China.
EM lyshaailong@163.com
RI Hao, Haiyan/AFK-0917-2022
FU Science and technology research project of Chongqing Education
   Commission [KJQN20201226, KJQN202101247]
FX The authors are pleased to acknowledge the financial support of this
   research by the Science and technology research project of Chongqing
   Education Commission (KJQN20201226, KJQN202101247). The authors are very
   grateful to Chenchen Chang, Bei Ye, Xuesong Cao, and the experimental
   station, School of Animal Sciences (Tarim University, Alar, Xinjiang,
   China).
CR [Gong Yanling 公衍玲], 2016, [食品科学, Food Science], V37, P1
   Hao H.Y., 2017, XINJIANG NONGYE DAXU, V40, P20
   Hao H.Y., 2013, Food Sci Tech, V38, P244
   Jing HJ, 2018, INT J BIOL MACROMOL, V106, P1270, DOI 10.1016/j.ijbiomac.2017.08.138
   Kim TY, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9070583
   Kohlhaas M, 2017, J PHYSIOL-LONDON, V595, P3781, DOI 10.1113/JP273750
   Le Bras A, 2020, LAB ANIMAL, V49, P22, DOI 10.1038/s41684-019-0448-x
   Li Da, 2022, Food Research and Development, V43, P68, DOI 10.12161/j.issn.1005-6521.2022.08.09
   Li H.H., 2021, FOOD SCI TECH-BRAZIL, V46, P168
   Li SS, 2018, INT J BIOL MACROMOL, V106, P1297, DOI 10.1016/j.ijbiomac.2017.08.135
   Li Xu, 2019, Food Research and Development, V40, P43
   Liu HuanQi, 2010, Chinese Journal of Veterinary Science, V30, P493
   Liu XX, 2019, CARBOHYD POLYM, V215, P99, DOI 10.1016/j.carbpol.2019.03.059
   Lu C.X., 2018, CHIN J GERONTOL, V38, P248
   Luo X.H., 2022, MOD FOOD SCI TECHNOL, V38, P25, DOI [10.13982/j.mfst.1673-9078.2022.3.0521, DOI 10.13982/J.MFST.1673-9078.2022.3.0521]
   Moon Y, 2017, ANTIOXID REDOX SIGN, V26, P966, DOI 10.1089/ars.2016.6630
   Mzoughi Z, 2018, CARBOHYD POLYM, V185, P127, DOI 10.1016/j.carbpol.2018.01.022
   Sha AL, 2022, ARQ BRAS MED VET ZOO, V74, P259, DOI 10.1590/1678-4162-12481
   Sha Ai-Long, 2016, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V32, P121, DOI 10.13459/j.cnki.cjap.2016.02.007
   [沙爱龙 Sha Ailong], 2021, [中山大学学报. 自然科学版, Acta Scientiarum Naturalium Universitatis Sunyatseni], V60, P19
   [沙爱龙 Sha Ailong], 2013, [四川动物, Sichuan Journal of Zoology], V32, P90
   Sugiharto S., 2019, MALAYS J SCI, V38
   Hui Y, 2019, INT J BIOL MACROMOL, V121, P1203, DOI 10.1016/j.ijbiomac.2018.10.096
   Zhang ZS, 2013, FOOD RES DEV, V1, P15
NR 24
TC 1
Z9 1
U1 7
U2 14
PU COLEGIO FARMACEUTICOS PROVINCIA DE BUENOS AIRES
PI LA PLATA
PA DEPT CIENTIFICO, CALLE 5 NO 966, LA PLATA, 00000, ARGENTINA
SN 0326-2383
J9 LAT AM J PHARM
JI Lat. Am. J. Pharm.
PY 2022
VL 41
IS 12
BP 2419
EP 2426
PG 8
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 6Z5CU
UT WOS:000897795400012
DA 2024-02-19
ER

PT J
AU Lo Re, V
   Zeldow, B
   Kallan, MJ
   Tate, JP
   Carbonari, DM
   Hennessy, S
   Kostman, JR
   Lim, JK
   Goetz, MB
   Gross, R
   Justice, AC
   Roy, JA
AF Lo Re, Vincent, III
   Zeldow, Bret
   Kallan, Michael J.
   Tate, Janet P.
   Carbonari, Dena M.
   Hennessy, Sean
   Kostman, Jay R.
   Lim, Joseph K.
   Goetz, Matthew Bidwell
   Gross, Robert
   Justice, Amy C.
   Roy, Jason A.
TI Risk of liver decompensation with cumulative use of mitochondrial toxic
   nucleoside analogues in HIV/hepatitis C virus coinfection
SO PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
LA English
DT Article
DE drug-induced liver injury; hepatic decompensation; hepatitis C;
   hepatotoxicity; HIV; mitochondrial toxicity; pharmacoepidemiology
ID HUMAN-IMMUNODEFICIENCY-VIRUS; INVERSE PROBABILITY WEIGHTS; MARGINAL
   STRUCTURAL MODELS; HEPATITIS-C; ANTIRETROVIRAL-THERAPY; FIBROSIS
   PROGRESSION; INFECTED PATIENTS; HIV; HEPATOTOXICITY; VETERANS
AB PurposeAmong patients dually infected with human immunodeficiency virus (HIV) and chronic hepatitis C virus (HCV), use of antiretroviral therapy (ART) containing mitochondrial toxic nucleoside reverse transcriptase inhibitors (mtNRTIs) might induce chronic hepatic injury, which could accelerate HCV-associated liver fibrosis and increase the risk of hepatic decompensation and death.
   MethodsWe conducted a cohort study among 1747 HIV/HCV patients initiating NRTI-containing ART within the Veterans Aging Cohort Study (2002-2009) to determine if cumulative mtNRTI use increased the risk of hepatic decompensation and death among HIV-/HCV-coinfected patients. Separate marginal structural models were used to estimate hazard ratios (HRs) of each outcome associated with cumulative exposure to ART regimens that contain mtNRTIs versus regimens that contain other NRTIs.
   ResultsOver 7033 person-years, we observed 97 (5.6%) decompensation events (incidence rate, 13.8/1000 person-years) and 125 (7.2%) deaths (incidence rate, 17.8 events/1000 person-years). The risk of hepatic decompensation increased with cumulative mtNRTI use (1-11mo: HR, 1.79 [95% confidence interval (CI), 0.74-4.31]; 12-35mo: HR, 1.39 [95% CI, 0.68-2.87]; 36-71mo: HR, 2.27 [95% CI, 0.92-5.60]; >71mo: HR, 4.66 [95% CI, 1.04-20.83]; P=.045) versus nonuse. Cumulative mtNRTI use also increased risk of death (1-11mo: HR, 2.24 [95% CI, 1.04-4.81]; 12-35mo: HR, 2.05 [95% CI, 0.68-6.20]; 36-71mo: HR, 3.04 [95% CI, 1.12-8.26]; >71mo: HR, 3.93 [95% CI, 0.75-20.50]; P=.030).
   ConclusionsThese findings suggest that cumulative mtNRTI use may increase the risk of hepatic decompensation and death in HIV/HCV coinfection. These drugs should be avoided when alternatives exist for HIV/HCV patients.
C1 [Lo Re, Vincent, III; Gross, Robert] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA.
   [Lo Re, Vincent, III; Zeldow, Bret; Kallan, Michael J.; Carbonari, Dena M.; Hennessy, Sean; Gross, Robert; Roy, Jason A.] Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA.
   [Lo Re, Vincent, III; Zeldow, Bret; Kallan, Michael J.; Carbonari, Dena M.; Hennessy, Sean; Gross, Robert; Roy, Jason A.] Univ Penn, Perelman Sch Med, Ctr Pharmacoepidemiol Res & Training, Philadelphia, PA 19104 USA.
   [Lo Re, Vincent, III; Gross, Robert] Corporal Michael J Crescenz VA Med Ctr, Med Serv, Philadelphia, PA USA.
   [Tate, Janet P.; Lim, Joseph K.; Justice, Amy C.] VA Connecticut Healthcare Syst, West Haven, CT USA.
   [Tate, Janet P.; Lim, Joseph K.; Justice, Amy C.] Yale Univ, Sch Med, New Haven, CT USA.
   [Kostman, Jay R.] John Bell Hlth Ctr, Philadelphia Field Initiating Grp HIV Trials, Philadelphia, PA USA.
   [Goetz, Matthew Bidwell] Univ Calif Los Angeles, VA Greater Los Angeles Healthcare Syst, Los Angeles, CA USA.
   [Goetz, Matthew Bidwell] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.
C3 University of Pennsylvania; University of Pennsylvania; University of
   Pennsylvania; US Department of Veterans Affairs; Veterans Health
   Administration (VHA); VA Connecticut Healthcare System; Yale University;
   University of California System; University of California Los Angeles;
   US Department of Veterans Affairs; Veterans Health Administration (VHA);
   VA Greater Los Angeles Healthcare System; University of California
   System; University of California Los Angeles; University of California
   Los Angeles Medical Center; David Geffen School of Medicine at UCLA
RP Lo Re, V (corresponding author), Univ Penn, Ctr Clin Epidemiol & Biostat, 836 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.
EM vincentl@mail.med.upenn.edu
RI Carbonari, Dena M/H-3366-2011; Goetz, Matthew Bidwell/GPX-4090-2022
OI Carbonari, Dena M/0000-0003-0310-270X; Goetz,
   Matthew/0000-0003-4542-992X
FU Center for Pharmacoepidemiology Research and Training at the Perelman
   School of Medicine, University of Pennsylvania; Agency for Healthcare
   Research and Quality [R01 HS018372]; National Institute on Alcohol Abuse
   and Alcoholism [U01 AA13566, U24 AA20794, U01 AA20790]
FX Center for Pharmacoepidemiology Research and Training at the Perelman
   School of Medicine, University of Pennsylvania; Agency for Healthcare
   Research and Quality, Grant/ Award Number: R01 HS018372; National
   Institute on Alcohol Abuse and Alcoholism, Grant/Award Number: U01
   AA13566, U24 AA20794 and U01 AA20790
CR Aceti A, 2002, J ACQ IMMUN DEF SYND, V29, P41, DOI 10.1097/00042560-200201010-00005
   Bani-Sadr F, 2008, CLIN INFECT DIS, V46, P768, DOI 10.1086/527565
   Berenguer J, 2009, HEPATOLOGY, V50, P407, DOI 10.1002/hep.23020
   Bonfanti P, 2001, J ACQ IMMUN DEF SYND, V27, P316
   Bräu N, 2006, J HEPATOL, V44, P47, DOI 10.1016/j.jhep.2005.07.006
   Brinkman K, 1999, LANCET, V354, P1112, DOI 10.1016/S0140-6736(99)06102-4
   Butt AA, 2004, HEPATOLOGY, V40, P115, DOI 10.1002/hep.20289
   Butt AA, 2009, AIDS, V23, P1227, DOI 10.1097/QAD.0b013e32832bd7af
   Chalasani N, 2015, GASTROENTEROLOGY, V148, P1340, DOI 10.1053/j.gastro.2015.03.006
   Cole SR, 2008, AM J EPIDEMIOL, V168, P656, DOI 10.1093/aje/kwn164
   Edelman EJ, 2013, PHARMACOEPIDEM DR S, V22, P1352, DOI 10.1002/pds.3517
   Edelman EJ, 2013, DRUG AGING, V30, P613, DOI 10.1007/s40266-013-0093-9
   FISHER SG, 1995, AM J EPIDEMIOL, V141, P242, DOI 10.1093/oxfordjournals.aje.a117426
   Frederick T, 2009, AIDS PATIENT CARE ST, V23, P915, DOI 10.1089/apc.2009.0111
   FREEDMAN VA, 1995, DEMOGRAPHY, V32, P459, DOI 10.2307/2061691
   FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963
   Fultz SL, 2006, MED CARE, V44, pS25, DOI 10.1097/01.mlr.0000223670.00890.74
   Gandhi NR, 2013, PHARMACOEPIDEM DR S, V22, P1019, DOI 10.1002/pds.3476
   Garcia-Tsao G, 2010, HEPATOLOGY, V51, P1445, DOI 10.1002/hep.23478
   Gruber S, 2015, STAT MED, V34, P106, DOI 10.1002/sim.6322
   Günthard HF, 2016, JAMA-J AM MED ASSOC, V316, P191, DOI 10.1001/jama.2016.8900
   Halekoh U, 2006, J STAT SOFTW, V15, P1, DOI 10.18637/jss.v015.i02
   Hernán MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012
   Justice AC, 2004, AIDS, V18, pS49, DOI 10.1097/00002030-200401001-00008
   Kazis LE, 1998, ARCH INTERN MED, V158, P626, DOI 10.1001/archinte.158.6.626
   Limketkai BN, 2012, JAMA-J AM MED ASSOC, V308, P370, DOI 10.1001/jama.2012.7844
   Lo Re V, 2014, ANN INTERN MED, V160, P369, DOI 10.7326/M13-1829
   Lo Re V, 2011, PHARMACOEPIDEM DR S, V20, P689, DOI 10.1002/pds.2148
   Loko MA, 2011, J VIRAL HEPATITIS, V18, pE307, DOI 10.1111/j.1365-2893.2010.01417.x
   Macías J, 2012, HEPATOLOGY, V56, P1261, DOI 10.1002/hep.25791
   Neugebauer R, 2013, J CLIN EPIDEMIOL, V66, pS99, DOI 10.1016/j.jclinepi.2013.01.016
   Núñez M, 2001, J ACQ IMMUN DEF SYND, V27, P426, DOI 10.1097/00126334-200108150-00002
   PETRI H, 1991, STAT MED, V10, P577, DOI 10.1002/sim.4780100409
   Pineda JA, 2007, HEPATOLOGY, V46, P622, DOI 10.1002/hep.21757
   Qurishi N, 2003, LANCET, V362, P1708, DOI 10.1016/S0140-6736(03)14844-1
   Raymond HF, 2011, SEX TRANSM DIS, V38, P219, DOI 10.1097/OLQ.0b013e3181f68ed4
   Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011
   Rodríguez-Rosado R, 1998, AIDS, V12, P1256, DOI 10.1097/00002030-199810000-00025
   Royston P, 2005, STATA J, V5, P188, DOI 10.1177/1536867X0500500204
   Ryom L, 2016, AIDS, V30, P1731, DOI 10.1097/QAD.0000000000001018
   Savès M, 2000, ANTIMICROB AGENTS CH, V44, P3451, DOI 10.1128/AAC.44.12.3451-3455.2000
   Scourfield A, 2011, ANTIVIR THER, V16, P941, DOI 10.3851/IMP1875
   Servoss JC, 2006, JAIDS-J ACQ IMM DEF, V43, P320, DOI 10.1097/01.qai.0000243054.58074.59
   Sherman KE, 2002, CLIN INFECT DIS, V34, P831, DOI 10.1086/339042
   Soriano V, 2008, AIDS, V22, P1, DOI 10.1097/QAD.0b013e3282f0e2fd
   Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178
   Sulkowski MS, 2007, AIDS, V21, P2209, DOI 10.1097/QAD.0b013e3282f10de9
   Sulkowski MS, 2000, JAMA-J AM MED ASSOC, V283, P74, DOI 10.1001/jama.283.1.74
   van der Laan MJ, 2007, STAT APPL GENET MOL, V6, DOI 10.2202/1544-6115.1309
   Walker AM, 1996, EPIDEMIOLOGY, V7, P335
   Walker UA, 2004, HEPATOLOGY, V39, P311, DOI 10.1002/hep.20074
   Wit FWNM, 2002, J INFECT DIS, V186, P23, DOI 10.1086/341084
   Yang W, 2012, PHARMACOEPIDEM DR S, V21, P241, DOI 10.1002/pds.2306
NR 53
TC 7
Z9 7
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1053-8569
EI 1099-1557
J9 PHARMACOEPIDEM DR S
JI Pharmacoepidemiol. Drug Saf.
PD OCT
PY 2017
VL 26
IS 10
BP 1172
EP 1181
DI 10.1002/pds.4258
PG 10
WC Public, Environmental & Occupational Health; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Public, Environmental & Occupational Health; Pharmacology & Pharmacy
GA FI6KV
UT WOS:000412105600005
PM 28722244
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Teker, HT
   Ceylani, T
   Keskin, S
   Samgane, G
   Mansuroglu, S
   Baba, B
   Allahverdi, H
   Acikgoz, E
   Gurbanov, R
AF Teker, Hikmet Taner
   Ceylani, Taha
   Keskin, Seda
   Samgane, Gizem
   Mansuroglu, Sina
   Baba, Burcu
   Allahverdi, Huseyin
   Acikgoz, Eda
   Gurbanov, Rafig
TI Age-related differences in response to plasma exchange in male rat liver
   tissues: insights from histopathological and machine-learning assisted
   spectrochemical analyses
SO BIOGERONTOLOGY
LA English
DT Article; Early Access
DE Aging; FTIR spectroscopy; Machine learning prediction; Liver; LDA; SVM
ID INFRARED-SPECTROSCOPY
AB This study aimed to examine the biological effects of blood plasma exchange in liver tissues of aged and young rats using machine learning methods and spectrochemical and histopathological approaches. Linear Discriminant Analysis (LDA) and Support Vector Machine (SVM) were the machine learning algorithms employed. Young plasma was given to old male rats (24 months), while old plasma was given to young male rats (5 weeks) for thirty days. LDA (95.83-100%) and SVM (87.5-91.67%) detected significant qualitative changes in liver biomolecules. In old rats, young plasma infusion increased the length of fatty acids, triglyceride, lipid carbonyl, and glycogen levels. Nucleic acid concentration, phosphorylation, and carbonylation rates of proteins were also increased, whereas a decrease in protein concentration was measured. Aged plasma decreased protein carbonylation, triglyceride, and lipid carbonyl levels. Young plasma infusion improved hepatic fibrosis and cellular degeneration and reduced hepatic microvesicular steatosis in aged rats. Otherwise, old plasma infusion in young rats caused disrupted cellular organization, steatosis, and increased fibrosis. Young plasma administration increased liver glycogen accumulation and serum albumin levels. Aged plasma infusion raised serum ALT levels while diminished ALP concentrations in young rats, suggesting possible liver dysfunction. Young plasma increased serum albumin levels in old rats. The study concluded that young plasma infusion might be associated with declined liver damage and fibrosis in aged rats, while aged plasma infusion negatively impacted liver health in young rats. These results imply that young blood plasma holds potential as a rejuvenation therapy for liver health and function.
C1 [Teker, Hikmet Taner] Ankara Medipol Univ, Dept Med Biol & Genet, Ankara, Turkiye.
   [Ceylani, Taha; Allahverdi, Huseyin] Mus Alparslan Univ, Dept Mol Biol & Genet, Mus, Turkiye.
   [Ceylani, Taha] Mus Alparslan Univ, Dept Food Qual Control & Anal, Mus, Turkiye.
   [Keskin, Seda; Acikgoz, Eda] Van Yuzuncu Yil Univ, Dept Histol & Embryol, Van, Turkiye.
   [Samgane, Gizem; Mansuroglu, Sina; Gurbanov, Rafig] Bilecik Seyh Edebali Univ, Dept Bioengn, Bilecik, Turkiye.
   [Baba, Burcu] Yuksek Ihtisas Univ, Dept Med Biochem, Ankara, Turkiye.
   [Gurbanov, Rafig] Bilecik Seyh Edebali Univ, Cent Res Lab, Bilecik, Turkiye.
C3 Ankara Medipol University; Mus Alparslan University; Mus Alparslan
   University; Yuzuncu Yil University; Bilecik Seyh Edebali University;
   Yuksek Ihtisas University; Bilecik Seyh Edebali University
RP Gurbanov, R (corresponding author), Bilecik Seyh Edebali Univ, Dept Bioengn, Bilecik, Turkiye.; Gurbanov, R (corresponding author), Bilecik Seyh Edebali Univ, Cent Res Lab, Bilecik, Turkiye.
EM rafiq.qurbanov@gmail.com
RI Ceylani, Taha/HJH-8007-2023; Teker, Hikmet Taner/JNS-8334-2023; Teker,
   Taner Hikmet/JKI-9155-2023; Keskin, Seda/A-4616-2019; GURBANOV,
   RAFIG/AFH-3654-2022
OI Teker, Hikmet Taner/0000-0002-6621-3071; Teker, Taner
   Hikmet/0000-0002-6621-3071; Keskin, Seda/0000-0002-4726-982X; Samgane,
   Gizem/0000-0003-4267-0152; GURBANOV, RAFIG/0000-0002-5293-6447; Ceylani,
   Taha/0000-0002-3041-6010
CR Aksoy C, 2019, METHODS MOL BIOL, V2045, P201, DOI 10.1007/7651_2018_119
   Aksoy C, 2012, SPECTROSC-INT J, V27, P167, DOI 10.1155/2012/513286
   Andziak B, 2006, AGING CELL, V5, P463, DOI 10.1111/j.1474-9726.2006.00237.x
   Ardahanli I, 2022, BIOPHYS CHEM, V289, DOI 10.1016/j.bpc.2022.106873
   Baker MJ, 2014, NAT PROTOC, V9, P1771, DOI 10.1038/nprot.2014.110
   Ballweg S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14528-1
   Bompard J, 2020, LANGMUIR, V36, P5134, DOI 10.1021/acs.langmuir.0c00262
   Castellano JM, 2019, GERONTOLOGY, V65, P84, DOI 10.1159/000492573
   Ceylani T, 2023, ARCH GERONTOL GERIAT, V111, DOI 10.1016/j.archger.2023.105003
   Ceylani T, 2022, ANAL BIOCHEM, V654, DOI 10.1016/j.ab.2022.114825
   Ceylani T, 2022, ARCH MICROBIOL, V204, DOI 10.1007/s00203-022-03154-8
   Cloos PAC, 2004, BIOGERONTOLOGY, V5, P139, DOI 10.1023/B:BGEN.0000031152.31352.8b
   Dicko A, 1998, CHEM PHYS LIPIDS, V96, P125, DOI 10.1016/S0009-3084(98)00084-X
   Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384
   Dogan A, 2021, TURK J BIOL, V45, P549, DOI 10.3906/biy-2105-65
   Dreier LB, 2019, J PHYS CHEM B, V123, P1085, DOI 10.1021/acs.jpcb.8b12297
   Erdogan K, 2023, EXP GERONTOL, V172, DOI 10.1016/j.exger.2022.112042
   Finch CE, 2016, P NATL ACAD SCI USA, V113, P1121, DOI 10.1073/pnas.1524017113
   Goh GBB, 2015, DIGEST DIS SCI, V60, P1825, DOI 10.1007/s10620-015-3529-8
   Gong YT, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1029-8
   Gurbanov R., 2017, J. Food Health Sci, V3, P117, DOI [DOI 10.3153/JFHS17015, 10.3153/JFHS17015]
   Gurbanov R, 2021, PROBIOTICS ANTIMICRO, V13, P195, DOI 10.1007/s12602-020-09678-z
   HEYDARI AR, 1989, MECH AGEING DEV, V50, P227, DOI 10.1016/0047-6374(89)90102-4
   Huang Q, 2018, J GERONTOL A-BIOL, V73, P421, DOI 10.1093/gerona/glx183
   Jin JL, 2009, MOL CELL BIOL, V29, P3867, DOI 10.1128/MCB.00456-09
   Kazarian SG, 2006, BBA-BIOMEMBRANES, V1758, P858, DOI 10.1016/j.bbamem.2006.02.011
   Kennedy BK, 2014, CELL, V159, P708, DOI 10.1016/j.cell.2014.10.039
   Keskin S, 2023, PHOTOCHEM PHOTOBIOL, V99, P132, DOI 10.1111/php.13664
   Krisko A, 2019, OPEN BIOL, V9, DOI 10.1098/rsob.180249
   Liu AD, 2018, AGING CELL, V17, DOI 10.1111/acel.12708
   Liu JF, 2022, PROTEOME SCI, V20, DOI 10.1186/s12953-022-00194-2
   Loffredo FS, 2013, CELL, V153, P828, DOI 10.1016/j.cell.2013.04.015
   Mohamad M, 2016, AGING CELL, V15, P706, DOI 10.1111/acel.12481
   Morsiani C, 2019, AGEING RES REV, V51, P24, DOI 10.1016/j.arr.2019.02.002
   Ohto T, 2015, J PHYS CHEM LETT, V6, P4499, DOI 10.1021/acs.jpclett.5b02141
   Paraboni MLR., 2022, BRAZ J ONCOL, V18, P1, DOI [10.5935/2526-8732.20220302, DOI 10.5935/2526-8732.20220302]
   Severcan F, 2012, ADV BIOMED SPECTROSC, V6, P1
   Singh P, 2011, J GERONTOL A-BIOL, V66, P944, DOI 10.1093/gerona/glr094
   Ticinesi A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11071633
   Timchenko NA, 2009, TRENDS ENDOCRIN MET, V20, P171, DOI 10.1016/j.tem.2009.01.005
   Tripathi SS, 2021, REJUV RES, V24, P206, DOI 10.1089/rej.2020.2354
   Villeda SA, 2014, NAT MED, V20, P659, DOI 10.1038/nm.3569
   Wang L, 2022, MED RES REV, V42, P946, DOI 10.1002/med.21867
NR 43
TC 1
Z9 1
U1 2
U2 5
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1389-5729
EI 1573-6768
J9 BIOGERONTOLOGY
JI Biogerontology
PD 2023 AUG
PY 2023
VL 24
IS 4
BP 563
EP 580
DI 10.1007/s10522-023-10032-3
EA APR 2023
PG 18
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA I7WW3
UT WOS:000963657000002
PM 37017896
DA 2024-02-19
ER

PT J
AU Akahori, M
   Takatori, A
   Kawamura, S
   Itagaki, S
   Yoshikawa, Y
AF Akahori, M
   Takatori, A
   Kawamura, S
   Itagaki, S
   Yoshikawa, Y
TI No regional differences of cytochrome p450 expression in the liver of
   cynomolgus monkeys (Macaca fascicularis)
SO EXPERIMENTAL ANIMALS
LA English
DT Article
DE cynomolgus monkeys; CYP450 isozyme; hepatic cytochrome P450; western
   blot
ID AGE-RELATED-CHANGES; DRUG-METABOLISM; PHASE-I; TRIAZOLAM
   BIOTRANSFORMATION; MOLECULAR-CLONING; RHESUS-MONKEY; GENDER; MICROSOMES;
   SEQUENCES; MOUSE
AB Non-human primates are frequently used in toxicological studies the result of which are extrapolated to humans, but background data on drug metabolism ability among monkeys derived from different countries has not been published, especially on the key enzyme, cytochrome P450 (CYP450). We assessed the amounts of hepatic CYP450 obtained from cynomolgus monkeys of different ages and from different countries in this study. There were no regional differences of total P450 content, as well as major CYP450 isozymes (CYP 1A, 2A, 2B, 2C, 2D, 2E1 and 3A4) in cynomolgus monkeys by westernblot analysis. Similarly, there were no significant differences with hybrid cynomolgus monkeys, but variations in individual values were large. As for aging, total P450 contents declined in old cynomolgus monkeys (12-32 years of age). These results indicate the usefulness of basic data of hepatic CYP450 obtained from cynomolgus monkeys of different ages and from different countries.
C1 Univ Tokyo, Sch Agr & Life Sci, Dept Biomed Sci, Tokyo 1138657, Japan.
C3 University of Tokyo
RP Akahori, M (corresponding author), Univ Tokyo, Sch Agr & Life Sci, Dept Biomed Sci, 1-1-1 Yayoi, Tokyo 1138657, Japan.
CR Amato G, 1998, DRUG METAB DISPOS, V26, P483
   BULLOCK P, 1995, DRUG METAB DISPOS, V23, P736
   Dragoni S, 2003, XENOBIOTICA, V33, P181, DOI 10.1080/0049825021000048827
   EDWARDS RJ, 1994, CARCINOGENESIS, V15, P829, DOI 10.1093/carcin/15.5.829
   GEORGE J, 1995, BIOCHEM PHARMACOL, V50, P727, DOI 10.1016/0006-2952(95)00192-3
   HONJO S, 1984, ADV VET SCI COMP MED, V28, P51
   HUNT CM, 1992, BIOCHEM PHARMACOL, V44, P275, DOI 10.1016/0006-2952(92)90010-G
   Igarashi T, 1997, ARCH BIOCHEM BIOPHYS, V339, P85, DOI 10.1006/abbi.1996.9852
   IMAOKA S, 1991, BIOCHIM BIOPHYS ACTA, V1097, P187, DOI 10.1016/0925-4439(91)90034-7
   Kerremans ALM, 1996, NETH J MED, V48, P237, DOI 10.1016/0300-2977(96)00002-2
   KOMORI M, 1992, BIOCHIM BIOPHYS ACTA, V1171, P141, DOI 10.1016/0167-4781(92)90113-E
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Le Couteur DG, 1998, CLIN PHARMACOKINET, V34, P359, DOI 10.2165/00003088-199834050-00003
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Nelson DR, 1996, PHARMACOGENETICS, V6, P1, DOI 10.1097/00008571-199602000-00002
   Nelson DR, 2004, PHARMACOGENETICS, V14, P1, DOI 10.1097/00008571-200401000-00001
   OMURA T, 1964, J BIOL CHEM, V239, P2370
   Patki KC, 2004, J PHARMACOL EXP THER, V308, P874, DOI 10.1124/jpet.103.059311
   Perloff MD, 2000, J PHARMACOL EXP THER, V292, P618
   RIKANS LE, 1982, J PHARMACOL EXP THER, V220, P574
   Scheinin H, 1998, CLIN PHARMACOL THER, V64, P402, DOI 10.1016/S0009-9236(98)90071-6
   SCHMUCKER DL, 1990, CLIN PHARMACOL THER, V48, P365, DOI 10.1038/clpt.1990.164
   Schmucker DL, 2001, DRUG AGING, V18, P837, DOI 10.2165/00002512-200118110-00005
   Schmucker DL, 1998, J GERONTOL A-BIOL, V53, pB315, DOI 10.1093/gerona/53A.5.B315
   SHARER JE, 1995, DRUG METAB DISPOS, V23, P1231
   STEVENS JC, 1993, DRUG METAB DISPOS, V21, P753
   Warrington JS, 2000, DRUG METAB DISPOS, V28, P392
   WOODHOUSE K, 1992, BIOPHARM DRUG DISPOS, V13, P311, DOI 10.1002/bdd.2510130502
   WOODHOUSE K, 1992, DRUG AGING, V2, P243, DOI 10.2165/00002512-199202030-00007
   WYNNE H, 1987, AGE AGEING, V16, P153, DOI 10.1093/ageing/16.3.153
   Zuber R, 2002, J CELL MOL MED, V6, P189, DOI 10.1111/j.1582-4934.2002.tb00186.x
NR 31
TC 11
Z9 11
U1 1
U2 4
PU INT PRESS EDITING CENTRE INC
PI TOKYO
PA 1-2-3 SUGAMO, TOSHIMA-KU, TOKYO, 170 0002, JAPAN
SN 1341-1357
EI 1881-7122
J9 EXP ANIM TOKYO
JI Exp. Anim.
PD APR
PY 2005
VL 54
IS 2
BP 131
EP 136
DI 10.1538/expanim.54.131
PG 6
WC Veterinary Sciences; Zoology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Veterinary Sciences; Zoology
GA 922GI
UT WOS:000228824300004
PM 15897621
OA Bronze
DA 2024-02-19
ER

PT J
AU Keller, JN
   Hanni, KB
   Markesbery, WR
AF Keller, JN
   Hanni, KB
   Markesbery, WR
TI Possible involvement of proteasome inhibition in aging: implications for
   oxidative stress
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE aging; 4-hydroxynonenal; multicatalytic proteasome; neuron; reactive
   oxygen species
ID LIPID-PEROXIDATION; OXIDIZED PROTEINS; NERVOUS-SYSTEM; 26S PROTEASOME;
   FREE-RADICALS; DEGRADATION; LIVER; CELL; 20S; DYSFUNCTION
AB Oxidative stress may contribute to the cellular alterations, which occur as the result of aging, and the nervous system is particularly vulnerable to aging associated oxidative injury. The multicatalytic proteasome (MCP) is responsible for the majority of protein degradation and is sensitive to oxidative stress. To determine if MCP activity is altered during aging, studies were conducted in multiple tissues from aged Fisher 344 rats. Analysis of heart, lung, kidney, and liver revealed decreased MCP activity in 12, 24, and 28 month old rats, compared with 3 week or 3 month old animals. The spinal cord, hippocampus, and cerebral cortex demonstrated age dependent decreases in MCP activity, but at no timepoint was MCP activity decreased in either the brain stem or cerebellum. Oxidative injury and the lipid oxidation product 4-hydroxynonenal caused decreased MCP activity in neural PC6 cells, while application of MCP inhibitors was sufficient to induce cell death in neural PC6 cells. Together, these data indicate a role for MCP inhibition in cellular dysfunction associated with aging and oxidative injury. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
C1 Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA.
   Univ Kentucky, Dept Neurol, Lexington, KY 40536 USA.
   Univ Kentucky, Dept Neuropathol, Lexington, KY 40536 USA.
C3 University of Kentucky; University of Kentucky; University of Kentucky
RP Markesbery, WR (corresponding author), Univ Kentucky, Sanders Brown Ctr Aging, 101 Sanders Brown, Lexington, KY 40536 USA.
RI Keller, Jeffrey N/N-1975-2017
OI keller, jeffrey/0000-0002-9892-7423
FU NIA NIH HHS [1-PO1-AG05119] Funding Source: Medline
CR Anselmi B, 1998, J GERONTOL A-BIOL, V53, pB173, DOI 10.1093/gerona/53A.3.B173
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   Bruce-Keller AJ, 1999, ANN NEUROL, V45, P8, DOI 10.1002/1531-8249(199901)45:1<8::AID-ART4>3.0.CO;2-V
   Conconi M, 1997, MOL BIOL REP, V24, P45, DOI 10.1023/A:1006852506884
   FIGUEIREDOPEREIRA ME, 1994, J NEUROCHEM, V63, P1578
   Friguet B, 1997, FEBS LETT, V405, P21, DOI 10.1016/S0014-5793(97)00148-8
   Girotti AW, 1998, J LIPID RES, V39, P1529
   Grilli M, 1999, BIOCHEM PHARMACOL, V57, P1, DOI 10.1016/S0006-2952(98)00214-7
   Grimm L M, 1999, Results Probl Cell Differ, V23, P209
   Grune T, 1996, J BIOL CHEM, V271, P15504, DOI 10.1074/jbc.271.26.15504
   Grune T, 1997, FASEB J, V11, P526, DOI 10.1096/fasebj.11.7.9212076
   GUTTERIDGE JMC, 1992, MED LAB SCI, V49, P313
   HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x
   Hayashi T, 1998, MECH AGEING DEV, V102, P55, DOI 10.1016/S0047-6374(98)00011-6
   Keller JN, 1998, REV NEUROSCIENCE, V9, P105
   Keller JN, 1998, J NEUROSCI, V18, P687
   Knight JA, 1998, ANN CLIN LAB SCI, V28, P331
   Lezoualc'h F, 1998, MOL PSYCHIATR, V3, P15, DOI 10.1038/sj.mp.4000295
   Lopes UG, 1997, J BIOL CHEM, V272, P12893, DOI 10.1074/jbc.272.20.12893
   Masoro EJ, 1998, J TOXICOL ENV HEAL B, V1, P243, DOI 10.1080/10937409809524554
   Masoro EJ, 1998, AGING-CLIN EXP RES, V10, P173
   MATSUO M, 1992, MECH AGEING DEV, V64, P273, DOI 10.1016/0047-6374(92)90084-Q
   Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534
   Reinheckel T, 1998, BIOCHEM J, V335, P637, DOI 10.1042/bj3350637
   ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6
   SCHMITZ ML, 1995, IMMUNOBIOLOGY, V193, P116, DOI 10.1016/S0171-2985(11)80534-6
   Sitte N, 1998, FEBS LETT, V440, P399, DOI 10.1016/S0014-5793(98)01495-1
   Tanaka K, 1998, GENES CELLS, V3, P499, DOI 10.1046/j.1365-2443.1998.00207.x
   Tanaka K, 1998, J BIOCHEM-TOKYO, V123, P195
NR 29
TC 210
Z9 235
U1 0
U2 3
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD JAN 24
PY 2000
VL 113
IS 1
BP 61
EP 70
DI 10.1016/S0047-6374(99)00101-3
PG 10
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 283TJ
UT WOS:000085291600005
PM 10708250
DA 2024-02-19
ER

PT J
AU Qi, RJ
   Jiang, R
   Xiao, HXZ
   Wang, ZL
   He, SY
   Wang, L
   Wang, YP
AF Qi, Rongjia
   Jiang, Rong
   Xiao, Hanxianzhi
   Wang, Ziling
   He, Siyuan
   Wang, Lu
   Wang, Yaping
TI Ginsenoside Rg1 protects against D -galactose induced fatty liver
   disease in a mouse model via FOXO1 transcriptional factor
SO LIFE SCIENCES
LA English
DT Article
ID CELLULAR SENESCENCE; OXIDATIVE STRESS; SECRETORY PHENOTYPE; STEM-CELLS;
   AUTOPHAGY; APOPTOSIS; ACTIVATION; EXPRESSION; INJURY; MICE
C1 [Qi, Rongjia; Jiang, Rong; Xiao, Hanxianzhi; Wang, Ziling; He, Siyuan; Wang, Lu; Wang, Yaping] Med Univ, Dept Histol & Embryol, Lab Stem Cell & Tissue Engn, Chongqing 400016, Peoples R China.
RP Wang, L; Wang, YP (corresponding author), Med Univ, Dept Histol & Embryol, Lab Stem Cell & Tissue Engn, Chongqing 400016, Peoples R China.
EM luwang@cqmu.edu.cn; ypwangcq@aliyun.com
RI 王, 璐/HTO-2844-2023
FU National Natural Science Foundation of China [30973818, 81873103]
FX This work was supported by the National Natural Science Foundation of
   China [grant number 30973818 and 81873103].
CR Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784
   Aravinthan A, 2015, HUM CELL, V28, P51, DOI 10.1007/s13577-015-0110-x
   Aravinthan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072904
   Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031
   Calabuig-Navarro V, 2015, J BIOL CHEM, V290, P15581, DOI 10.1074/jbc.M115.650994
   Chalasani N, 2018, HEPATOLOGY, V67, P328, DOI 10.1002/hep.29367
   Chang JH, 2016, NAT MED, V22, P78, DOI 10.1038/nm.4010
   Chen AJ, 2015, MED SCI MONIT BASIC, V21, P86, DOI 10.12659/MSMBR.893608
   Chen LB, 2018, NEUROCHEM RES, V43, P430, DOI 10.1007/s11064-017-2438-y
   Cheng WD, 2017, NUTRIENTS, V9, DOI 10.3390/nu9030263
   Cheng YJ, 2017, AGING-US, V9, P1359, DOI 10.18632/aging.101232
   Childs BG, 2014, EMBO REP, V15, P1139, DOI 10.15252/embr.201439245
   Chistiakov DA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/238463
   Chu SF, 2019, ACTA PHARMACOL SIN, V40, P13, DOI 10.1038/s41401-018-0154-z
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Deng X, 2012, J BIOL CHEM, V287, P20132, DOI 10.1074/jbc.M112.347211
   Dong X Charlie, 2017, Liver Res, V1, P168, DOI 10.1016/j.livres.2017.11.004
   Dragos D, 2017, NUTRIENTS, V9, DOI 10.3390/nu9010070
   Gao Y, 2017, FREE RADICAL RES, V51, P1, DOI 10.1080/10715762.2016.1234710
   Guo XJ, 2019, ARTIF CELL NANOMED B, V47, P2972, DOI 10.1080/21691401.2019.1640712
   Haeusler RA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6190
   Haeusler RA, 2010, J BIOL CHEM, V285, P35245, DOI 10.1074/jbc.C110.175851
   Hoare M, 2010, J HEPATOL, V53, P950, DOI 10.1016/j.jhep.2010.06.009
   Hu WX, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0642-3
   Inoue-Yamauchi A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16078
   Jakhar R, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20102547
   Jin C, 2017, PROG NEURO-PSYCHOPH, V75, P183, DOI 10.1016/j.pnpbp.2016.09.006
   Kim JH, 2017, J GINSENG RES, V41, P435
   Kim Myeong-Hwan, 2016, Lab Anim Res, V32, P217, DOI 10.5625/lar.2016.32.4.217
   Kondo Y, 2014, FEBS OPEN BIO, V4, P522, DOI 10.1016/j.fob.2014.05.003
   Kondo Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065698
   Kousteni S, 2012, BONE, V50, P437, DOI 10.1016/j.bone.2011.06.034
   Lapierre LR, 2015, AUTOPHAGY, V11, P867, DOI 10.1080/15548627.2015.1034410
   Li JP, 2014, ACTA PHARMACOL SIN, V35, P1031, DOI 10.1038/aps.2014.41
   Li J, 2016, SCI REP-UK, V6, DOI 10.1038/srep39336
   Li QH, 2017, CELL PHYSIOL BIOCHEM, V44, P21, DOI 10.1159/000484578
   Liu W, 2018, MOLECULES, V23, DOI 10.3390/molecules23092120
   Liu XT, 2018, AGING-US, V10, P2016, DOI 10.18632/aging.101526
   Lohr K, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12988
   Mao YQ, 2016, HEPATIC MED-EVID RES, V8, P27, DOI 10.2147/HMER.S98120
   Markowski DN, 2013, GENES NUTR, V8, P449, DOI 10.1007/s12263-013-0354-6
   Ning CQ, 2018, INT IMMUNOPHARMACOL, V61, P266, DOI 10.1016/j.intimp.2018.06.008
   Nishida N, 2016, J GASTROEN HEPATOL, V31, P1646, DOI 10.1111/jgh.13318
   O-Sullivan I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8079
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Park JK, 2010, HEPATOLOGY, V51, P1766, DOI 10.1002/hep.23499
   Perumpail BJ, 2017, WORLD J GASTROENTERO, V23, P8263, DOI 10.3748/wjg.v23.i47.8263
   Ritschka B, 2017, GENE DEV, V31, P172, DOI 10.1101/gad.290635.116
   Salminen A, 2011, CELL MOL LIFE SCI, V68, P1021, DOI 10.1007/s00018-010-0597-y
   Schafer MJ, 2016, DIABETES, V65, P1606, DOI 10.2337/db15-0291
   Shalini S, 2012, CELL DEATH DIFFER, V19, P1370, DOI 10.1038/cdd.2012.13
   Sharpless NE, 2015, NAT REV CANCER, V15, P397, DOI 10.1038/nrc3960
   Shi YM, 2020, EVID-BASED COMPL ALT, V2020, DOI 10.1155/2020/1903627
   Tao RY, 2013, J LIPID RES, V54, P2745, DOI 10.1194/jlr.M039339
   Tao RY, 2011, J BIOL CHEM, V286, P14681, DOI 10.1074/jbc.M110.201061
   Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098
   Tomita K, 2012, J HEPATOL, V57, P837, DOI 10.1016/j.jhep.2012.05.013
   Tomobe K, 2013, ARCH GERONTOL GERIAT, V57, P417, DOI 10.1016/j.archger.2013.06.004
   Wang J, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/674690
   Wang KW, 2015, CELL CYCLE, V14, P1631, DOI 10.1080/15384101.2015.1038685
   Wang T, 2016, J ETHNOPHARMACOL, V188, P234, DOI 10.1016/j.jep.2016.05.005
   Wang ZL, 2018, MOL MED REP, V17, P6269, DOI 10.3892/mmr.2018.8659
   Xiang Y, 2019, STEM CELLS INT, V2019, DOI 10.1155/2019/5010184
   Xiong XW, 2012, J BIOL CHEM, V287, P39107, DOI 10.1074/jbc.M112.412569
   Xu ZM, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113658
   Yang JCZ, 2019, NUTRIENTS, V11, DOI 10.3390/nu11040872
   Yang P, 2018, ACTA BIOCH BIOPH SIN, V50, P144, DOI 10.1093/abbs/gmx136
   Younossi Z, 2018, NAT REV GASTRO HEPAT, V15, P11, DOI 10.1038/nrgastro.2017.109
   Zhang LM, 2017, ONCOTARGET, V8, P55384, DOI 10.18632/oncotarget.19526
   Zhang W, 2016, CELL REP, V15, P349, DOI 10.1016/j.celrep.2016.03.021
   Zhu Y, 2015, AGING CELL, V14, P644, DOI 10.1111/acel.12344
   Zu G, 2016, SCI REP-UK, V6, DOI 10.1038/srep38480
NR 72
TC 25
Z9 26
U1 5
U2 24
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0024-3205
EI 1879-0631
J9 LIFE SCI
JI Life Sci.
PD AUG 1
PY 2020
VL 254
AR 117776
DI 10.1016/j.lfs.2020.117776
PG 11
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA LZ8SC
UT WOS:000541489500010
PM 32437790
DA 2024-02-19
ER

PT J
AU Yamamoto, K
   Iwagaki, Y
   Watanabe, K
   Nochi, T
   Aso, H
   Tsuduki, T
AF Yamamoto, Kazushi
   Iwagaki, Yui
   Watanabe, Kouichi
   Nochi, Tomonori
   Aso, Hisashi
   Tsuduki, Tsuyoshi
TI Effects of a moderate-fat diet that is enriched with fish oil on
   intestinal lipid absorption in a senescence-accelerated prone mouse
   model
SO NUTRITION
LA English
DT Article
DE Aging; Fish oil; Lipid absorption; SAM-P8; Small intestine
ID PEROXISOMAL BETA-OXIDATION; BILE-ACID SYNTHESIS; GLUCOSE-INTOLERANCE;
   GENE-EXPRESSION; MURINE MODEL; RAT-LIVER; MICE; CELLS; ACCUMULATION;
   TISSUE
AB Objectives: We examined a moderate-fat (MF) diet that is enriched with fish oil (FO) and assessed whether lipid absorption was inhibited in senescence-accelerated prone mice (SAM-P8).
   Methods: All mice (N = 70) were fed a normal diet that contained 4 g soybean oil/100 g of diet for 6 mo and then divided the mice into four groups (n =10 or 20/group). Mice in the baseline group were euthanized at 6 mo old, those in the control group continued on a normal diet until 15 mo of age, those in the MF diet group switched to an MF diet (8 g soybean oil/100 g of diet) until 15 mo of age, and those in the MF + FO group switched to an MF diet that was enriched with FO (6.4 g soybean oil + 1.6 g FO/100 g of diet) until 15 mo of age.
   Results: The area under the curve for lipid absorption decreased with age but lipid absorption tended to be less attenuated with an MF diet that contained FO. Messenger RNA (mRNA) levels of apolipoprotein B, fatty acid transport protein 4, and microsomal triacylglycerol transfer protein in the small intestine decreased with age but tended to be maintained with an MF diet with or without FO. A histologic analysis of the small intestine showed that villi degenerated with age but the decline was less in mice in the MF + FO group.
   Conclusions: The results of this study suggest that MF + FO diets can inhibit the attenuation of lipid absorption commensurate with aging in SAM-P8 via a delay of the natural degeneration that occurs in small intestinal villi over time. (C) 2017 Elsevier Inc. All rights reserved.
C1 [Yamamoto, Kazushi; Iwagaki, Yui; Tsuduki, Tsuyoshi] Tohoku Univ, Grad Sch Agr, Lab Food & Biomol Sci, Sendai, Miyagi, Japan.
   [Watanabe, Kouichi; Nochi, Tomonori; Aso, Hisashi] Tohoku Univ, Int Educ & Res Ctr Food & Agr Immunol CFAI, Grad Sch Agr, Sendai, Miyagi, Japan.
   [Watanabe, Kouichi; Nochi, Tomonori; Aso, Hisashi] Tohoku Univ, Grad Sch Agr, Lab Funct Morphol, Sendai, Miyagi, Japan.
C3 Tohoku University; Tohoku University; Tohoku University
RP Tsuduki, T (corresponding author), Tohoku Univ, Grad Sch Agr, Lab Food & Biomol Sci, Sendai, Miyagi, Japan.
EM tsudukit@m.tohoku.ac.jp
RI Tsuduki, Tsuyoshi/T-2697-2019; Nochi, Tomonori/U-2533-2019
OI Tsuduki, Tsuyoshi/0000-0001-7810-0528; Nochi,
   Tomonori/0000-0003-1800-6972
FU Japan Society for the Promotion of Science (JSPS) [16 J00821];
   Grants-in-Aid for Scientific Research [16K15021, 16J00821, 17K19882,
   16H06207] Funding Source: KAKEN
FX This work was supported by a Grant-in-Aid for Scientific Research to Dr.
   Kazushi Yamamoto from the Japan Society for the Promotion of Science
   (JSPS; no. 16 J00821).
CR Asseburg H, 2016, NEUROMOL MED, V18, P378, DOI 10.1007/s12017-016-8428-4
   Butterfield DA, 2005, EXP GERONTOL, V40, P774, DOI 10.1016/j.exger.2005.05.007
   Chen JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013704
   Choudhery MS, 2012, CELL BIOL INT, V36, P747, DOI 10.1042/CBI20110183
   Drozdowski L, 2006, WORLD J GASTROENTERO, V12, P7578, DOI 10.3748/wjg.v12.i47.7578
   Fiamoncini J, 2013, OBESITY, V21, P1200, DOI 10.1002/oby.20132
   Gehrmann W, 2010, DIABETES OBES METAB, V12, P149, DOI 10.1111/j.1463-1326.2010.01265.x
   Honma T, 2013, J JPN SOC FOOD SCI, V60, P541, DOI 10.3136/nskkk.60.541
   Honma T, 2013, J CLIN BIOCHEM NUTR, V52, P234, DOI 10.3164/jcbn.12-85
   Honma T, 2012, BIOGERONTOLOGY, V13, P93, DOI 10.1007/s10522-011-9363-2
   Ide T, 2000, BBA-MOL CELL BIOL L, V1485, P23, DOI 10.1016/S1388-1981(00)00026-3
   Kim EH, 2012, BIOCHEM PHARMACOL, V84, P1359, DOI 10.1016/j.bcp.2012.08.029
   Li TY, 2016, FOOD FUNCT, V7, P1147, DOI 10.1039/c5fo01036e
   Murashita K, 2013, COMP BIOCHEM PHYS A, V166, P361, DOI 10.1016/j.cbpa.2013.07.015
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   Petit V, 2007, J LIPID RES, V48, P278, DOI 10.1194/jlr.M600283-JLR200
   Ren JK, 2011, J NUTR BIOCHEM, V22, P691, DOI 10.1016/j.jnutbio.2010.06.002
   REUBSAET FAG, 1988, BIOCHIM BIOPHYS ACTA, V958, P434, DOI 10.1016/0005-2760(88)90229-9
   ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316
   Sato H, 2016, GASTROENTEROLOGY, V18, pS16
   Shibata A, 2008, BIOCHEM PHARMACOL, V76, P330, DOI 10.1016/j.bcp.2008.05.017
   Shinohara N, 2012, BBA-MOL CELL BIOL L, V1821, P980, DOI 10.1016/j.bbalip.2012.04.001
   STAHLBERG D, 1991, LIPIDS, V26, P349, DOI 10.1007/BF02537197
   Sukhotnik I, 2004, PEDIATR SURG INT, V20, P185, DOI 10.1007/s00383-004-1143-5
   TAKEDA T, 1991, J AM GERIATR SOC, V39, P911, DOI 10.1111/j.1532-5415.1991.tb04460.x
   Takeda T, 1997, EXP GERONTOL, V32, P117, DOI 10.1016/S0531-5565(96)00068-X
   TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1
   Tao J, 2016, EXP THER MED, V12, P3433, DOI 10.3892/etm.2016.3789
   Tsuduki T, 2013, J OLEO SCI, V62, P825, DOI 10.5650/jos.62.825
   Tsuduki T, 2011, NUTRITION, V27, P334, DOI 10.1016/j.nut.2010.05.017
   Tsuzuki T, 2005, LIPIDS, V40, P1117, DOI 10.1007/s11745-005-1475-0
   Tsuzuki T, 2004, CARCINOGENESIS, V25, P1417, DOI 10.1093/carcin/bgh109
   Tsuzuki T, 2008, CARCINOGENESIS, V29, P797, DOI 10.1093/carcin/bgm298
   Tsuzuki T, 2007, BBA-MOL CELL BIOL L, V1771, P20, DOI 10.1016/j.bbalip.2006.11.006
   Tsuzuki T, 2006, J NUTR BIOCHEM, V17, P518, DOI 10.1016/j.jnutbio.2005.09.006
   Winter TA, 2007, NUTRITION, V23, P29, DOI 10.1016/j.nut.2006.10.005
   Winzell MS, 2007, METABOLISM, V56, P122, DOI 10.1016/j.metabol.2006.09.008
   Yamamoto K, 2015, J CLIN BIOCHEM NUTR, V57, P204, DOI 10.3164/jcbn.15-60
   Yamamoto K, 2014, BIOGERONTOLOGY, V15, P463, DOI 10.1007/s10522-014-9512-5
   Yanaka M, 2011, BIOSCI BIOTECH BIOCH, V75, P1098, DOI 10.1271/bbb.100909
   Yang L, 2014, NEUROL SCI, V35, P289, DOI 10.1007/s10072-013-1509-3
   Yang Q, 2012, PEDIATR RES, V72, P38, DOI 10.1038/pr.2012.41
NR 42
TC 6
Z9 6
U1 0
U2 13
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0899-9007
EI 1873-1244
J9 NUTRITION
JI Nutrition
PD JUN
PY 2018
VL 50
BP 26
EP 35
DI 10.1016/j.nut.2017.10.015
PG 10
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA GF3HF
UT WOS:000431835500004
PM 29547795
DA 2024-02-19
ER

PT J
AU Xu, C
   Bai, B
   Fan, PC
   Cai, Y
   Huang, BS
   Law, IKM
   Liu, L
   Xu, AM
   Tung, CL
   Li, XC
   Siu, FM
   Che, CM
   Vanhoutte, PM
   Wang, Y
AF Xu, Cheng
   Bai, Bo
   Fan, Pengcheng
   Cai, Yu
   Huang, Bosheng
   Law, Ivy K. M.
   Liu, Ling
   Xu, Aimin
   Tung, Chunling
   Li, Xuechen
   Siu, Fung-Ming
   Che, Chi-Ming
   Vanhoutte, Paul M.
   Wang, Yu
TI Selective overexpression of human SIRT1 in adipose tissue enhances
   energy homeostasis and prevents the deterioration of insulin sensitivity
   with ageing in mice
SO AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH
LA English
DT Article
DE SIRT1; NAD(+)-dependent deacetylase; adipose tissue; biotin; longevity
   regulator
ID INCREASES STRESS RESISTANCE; LIFE-SPAN; BIOTIN DEFICIENCY;
   SKELETAL-MUSCLE; GENE-EXPRESSION; BIOTINYLATION; LIVER; NICOTINAMIDE;
   INHIBITION; TARGETS
AB SIRT1, a longevity regulator and NAD(+)- dependent deacetylase, plays a critical role in promoting metabolic fitness associated with calorie restriction and healthy ageing. Using a tissue-specific transgenic approach, the present study demonstrates that over-expression of human SIRT1 selectively in adipose tissue of mice prevents ageing-induced deterioration of insulin sensitivity and ectopic lipid distribution, reduces whole body fat mass and enhances locomotor activity. During ageing, the water-soluble vitamin biotin is progressively accumulated in adipose tissue. Over-expression of SIRT1 alleviates ageing-associated biotin accumulation and reduces the amount of biotinylated proteins, including acetyl CoA carboxylase, a major reservoir of biotin in adipose tissues. Chronic biotin supplementation increases adipose biotin contents and abolishes adipose SIRT1-mediated beneficial effects on insulin sensitivity, lipid metabolism and locomotor activity. Biochemical, spectrometric and chromatographic analysis revealed that biotin and its metabolites act as competitive inhibitors of SIRT1-mediated deacetylation. In summary, these results demonstrate that adipose SIRT1 is a key player in maintaining systemic energy homeostasis and insulin sensitivity; enhancing its activity solely in adipose tissue can prevent ageing-associated metabolic disorders.
C1 [Xu, Cheng; Bai, Bo; Fan, Pengcheng; Cai, Yu; Huang, Bosheng; Law, Ivy K. M.; Liu, Ling; Xu, Aimin; Vanhoutte, Paul M.; Wang, Yu] Univ Hong Kong, Dept Pharmacol & Pharm, Inst Mol Technol Drug Discovery & Synth, Hong Kong, Hong Kong, Peoples R China.
   [Tung, Chunling; Li, Xuechen; Siu, Fung-Ming; Che, Chi-Ming] Univ Hong Kong, Dept Chem, Inst Mol Technol Drug Discovery & Synth, Hong Kong, Hong Kong, Peoples R China.
   [Tung, Chunling; Li, Xuechen; Siu, Fung-Ming; Che, Chi-Ming] Univ Hong Kong, Open Lab Chem Biol, Inst Mol Technol Drug Discovery & Synth, Hong Kong, Hong Kong, Peoples R China.
C3 University of Hong Kong; University of Hong Kong; University of Hong
   Kong
RP Wang, Y (corresponding author), Univ Hong Kong, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China.
EM yuwanghk@hku.hk
RI Law, Ka Man (Ivy)/AAF-7097-2020; LIU, HAO/JBI-9623-2023; Wang,
   Yu/B-4534-2009
OI Law, Ka Man (Ivy)/0000-0002-7430-1215; wang, yu/0000-0001-8697-2940
FU University of Hong Kong, Research Grant Council [HKU777908M,
   HKU779712M]; Area of Excellent Scheme [AoE/P-10-01]; Special Equipment
   Grant Scheme under University Grants Committee, HKSAR [SEGHKU02]
FX This work was supported in part by grants from Seeding Funds for Basic
   Research of the University of Hong Kong, Research Grant Council grants
   (HKU777908M and HKU779712M); the Area of Excellent Scheme (AoE/P-10-01)
   and the Special Equipment Grant Scheme (SEGHKU02) established under
   University Grants Committee, HKSAR.
CR Ahima RS, 2009, NAT MED, V15, P996, DOI 10.1038/nm0909-996
   [Anonymous], ACTA BIOCH BIOPHYS S
   Avalos JL, 2005, MOL CELL, V17, P855, DOI 10.1016/j.molcel.2005.02.022
   Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014
   Baur JA, 2012, NAT REV DRUG DISCOV, V11, P443, DOI 10.1038/nrd3738
   Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200
   Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031
   Chakrabarti P, 2011, J LIPID RES, V52, P1693, DOI 10.1194/jlr.M014647
   Chalkiadaki A, 2012, CELL METAB, V16, P180, DOI 10.1016/j.cmet.2012.07.003
   Chalkiadaki A, 2012, NAT REV ENDOCRINOL, V8, P287, DOI 10.1038/nrendo.2011.225
   Chapman-Smith A, 1999, TRENDS BIOCHEM SCI, V24, P359, DOI 10.1016/S0968-0004(99)01438-3
   CHAUHAN J, 1991, J BIOL CHEM, V266, P10035
   Cho KW, 2011, DIABETES, V60, P3100, DOI 10.2337/db11-1308
   Chow KHM, 2010, CANCER RES, V70, P329, DOI 10.1158/0008-5472.CAN-09-3324
   Coppari R, 2012, TRENDS ENDOCRIN MET, V23, P179, DOI 10.1016/j.tem.2012.01.002
   Fernandez-Mejia C, 2005, J NUTR BIOCHEM, V16, P424, DOI 10.1016/j.jnutbio.2005.03.018
   Fukuwatari T, 2008, J NUTR SCI VITAMINOL, V54, P357, DOI 10.3177/jnsv.54.357
   Gillum MP, 2011, DIABETES, V60, P3235, DOI 10.2337/db11-0616
   Hawse WF, 2008, STRUCTURE, V16, P1368, DOI 10.1016/j.str.2008.05.015
   Healy S, 2009, PROTEIN SCI, V18, P314, DOI 10.1002/pro.37
   Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778
   Hoff KG, 2006, STRUCTURE, V14, P1231, DOI 10.1016/j.str.2006.06.006
   Hughes VA, 2002, AM J CLIN NUTR, V76, P473, DOI 10.1093/ajcn/76.2.473
   Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622
   Kuroishi T, 2011, MOL GENET METAB, V104, P537, DOI 10.1016/j.ymgme.2011.08.030
   Landenberger A, 2004, J NUTR BIOCHEM, V15, P591, DOI 10.1016/j.jnutbio.2004.04.006
   Law IKM, 2010, DIABETES, V59, P872, DOI 10.2337/db09-1541
   Law IKM, 2009, PROTEOMICS, V9, P2444, DOI 10.1002/pmic.200800738
   Mao JQ, 2009, P NATL ACAD SCI USA, V106, P17576, DOI 10.1073/pnas.0909055106
   Min JR, 2001, CELL, V105, P269, DOI 10.1016/S0092-8674(01)00317-8
   Minor RK, 2011, SCI REP-UK, V1, DOI 10.1038/srep00070
   MOCK DM, 1988, J NUTR, V118, P342, DOI 10.1093/jn/118.3.342
   Pettersson US, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046057
   Picard F, 2005, INT J OBESITY, V29, pS36, DOI 10.1038/sj.ijo.0802912
   Pluskal T, 2011, FEBS J, V278, P1299, DOI 10.1111/j.1742-4658.2011.08050.x
   Qiang L, 2012, CELL, V150, P620, DOI 10.1016/j.cell.2012.06.027
   Qiu LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018778
   Rios-Avila L, 2012, J NUTR BIOCHEM, V23, P1559, DOI 10.1016/j.jnutbio.2011.10.009
   ROSS SR, 1990, P NATL ACAD SCI USA, V87, P9590, DOI 10.1073/pnas.87.24.9590
   ROTH KS, 1981, AM J CLIN NUTR, V34, P1967, DOI 10.1093/ajcn/34.9.1967
   SAID HM, 1990, EXP GERONTOL, V25, P67, DOI 10.1016/0531-5565(90)90011-P
   Schoiswohl G, 2010, J LIPID RES, V51, P490, DOI 10.1194/jlr.M001073
   Shan TZ, 2013, FASEB J, V27, P277, DOI 10.1096/fj.12-211516
   SHRIVER BJ, 1993, J NUTR, V123, P1140
   Smith EM, 2007, J NUTR, V137, P2006, DOI 10.1093/jn/137.9.2006
   Tanner KG, 2000, P NATL ACAD SCI USA, V97, P14178, DOI 10.1073/pnas.250422697
   Tchkonia T, 2010, AGING CELL, V9, P667, DOI 10.1111/j.1474-9726.2010.00608.x
   Tong L, 2006, J CELL BIOCHEM, V99, P1476, DOI 10.1002/jcb.21077
   Tonkin J, 2012, CURR OPIN PHARMACOL, V12, P372, DOI 10.1016/j.coph.2012.02.010
   WAKIL SJ, 1983, ANNU REV BIOCHEM, V52, P537, DOI 10.1146/annurev.bi.52.070183.002541
   Wang Y, 2008, BIOCHEM J, V409, P623, DOI 10.1042/BJ20071492
   Wang Y, 2012, PHARMACOL THERAPEUT, V136, P305, DOI 10.1016/j.pharmthera.2012.08.009
   WITTERS LA, 1988, P NATL ACAD SCI USA, V85, P5473, DOI 10.1073/pnas.85.15.5473
   Xu F, 2012, ENDOCRINOLOGY, V153, P1706, DOI 10.1210/en.2011-1667
   Yashin Anatoliy I., 2013, Frontiers in Genetics, V4, P3, DOI 10.3389/fgene.2013.00003
   Zechner R, 2009, J LIPID RES, V50, P3, DOI 10.1194/jlr.R800031-JLR200
   Zhang XM, 2011, DIABETES, V60, P486, DOI 10.2337/db10-0650
   Zhang XM, 2010, J BIOL CHEM, V285, P32869, DOI 10.1074/jbc.M110.135509
   Zhao KH, 2004, P NATL ACAD SCI USA, V101, P8563, DOI 10.1073/pnas.0401057101
   Zhou MY, 2008, HEPATOLOGY, V48, P1087, DOI 10.1002/hep.22444
   Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747
NR 61
TC 37
Z9 40
U1 0
U2 13
PU E-CENTURY PUBLISHING CORP
PI MADISON
PA 40 WHITE OAKS LN, MADISON, WI 53711 USA
SN 1943-8141
J9 AM J TRANSL RES
JI Am. J. Transl. Res.
PY 2013
VL 5
IS 4
BP 412
EP U142
PG 39
WC Oncology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Research & Experimental Medicine
GA 172EP
UT WOS:000320983100004
PM 23724165
DA 2024-02-19
ER

PT J
AU Ho, SC
   Liu, JH
   Wu, RYY
AF Ho, SC
   Liu, JH
   Wu, RYY
TI Establishment of the mimetic aging effect in mice caused by D-galactose
SO BIOGERONTOLOGY
LA English
DT Article
DE D-dalactose; free radical; malondialdehyde; mimetic aging model;
   superoxide dismutase; total antioxidant status
ID ZN-SUPEROXIDE-DISMUTASE; OXIDATIVE STRESS; ADVANCED GLYCATION;
   ENZYME-ACTIVITIES; PRODUCTS; MODELS; BRAIN; CU
AB We successfully established an oxidant damage of mimetic aging model using mice induced by D-galactose, and the mimetic aging model is relative to free radical and the accumulation of waste substances in metabolism. The animals were divided into 3 groups: (1) phosphate-buffered saline (PBS); (2) 1 % D-galactose; (3) 5 % D-galactose by subcutaneous injection every day. After 45 days, mice treated with D-galactose showed a significant increase in the malondialdehyde (MDA), total antioxidant status (TAS) and a decrease in superoxide dismutase (SOD) in the blood compared with the PBS group. In the brain, the D-galactose treated mice exhibited a higher level MDA and a lower level SOD activity. In the liver, only the 5% D-galactose group indicated a significant increase in MDA. By reference to the oxidative biomarkers in blood, brain and liver, we have confirmed the reliability of the mimetic aging model.
C1 Dev Ctr Biotechnol, Tradit Chinese Med Div, Taipei, Taiwan.
RP Ho, SC (corresponding author), Dev Ctr Biotechnol, Tradit Chinese Med Div, 81 Chang Hsing St, Taipei, Taiwan.
CR Andersen HR, 1997, CLIN CHEM, V43, P562
   ARAI K, 1987, J BIOL CHEM, V262, P16969
   BALZ F, 1988, P NATL ACAD SCI USA, V85, P9748
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   BENEDETTI MS, 1980, J NEUROCHEM, V35, P1026, DOI 10.1111/j.1471-4159.1980.tb07856.x
   BROWNLEE M, 1995, ANNU REV MED, V46, P223, DOI 10.1146/annurev.med.46.1.223
   Chellan P, 2001, J BIOL CHEM, V276, P3895, DOI 10.1074/jbc.M008626200
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   Gong G.Q., 1991, J CHINA PHARM U, V22, P101
   Grune T, 2000, BIOGERONTOLOGY, V1, P31, DOI 10.1023/A:1010037908060
   Guo Jianli, 1999, Acta Nutrimenta Sinica, V21, P149
   Harman D, 1957, J GERONTOL, V2, P298
   Inal ME, 2001, CLIN CHIM ACTA, V305, P75, DOI 10.1016/S0009-8981(00)00422-8
   Ingram DK, 1999, NEUROBIOL AGING, V20, P137, DOI 10.1016/S0197-4580(99)00033-0
   Jucker M, 1997, BEHAV BRAIN RES, V85, P1, DOI 10.1016/S0166-4328(96)02243-7
   LI G, 2000, HEILONGLIANG MED PHA, V23, P4
   LI K, 2000, HEILONGLIANG MED PHA, V23, P1
   Li W.B., 1995, CHIN J PHARM TOXICOL, V9, P93
   Liu HB, 2000, CHIN J NEW DRUGS, V9, P236
   Rogina B, 2000, BIOGERONTOLOGY, V1, P163, DOI 10.1023/A:1010039813107
   SALO DC, 1988, FREE RADICAL BIO MED, V5, P335, DOI 10.1016/0891-5849(88)90105-0
   Sevanian A, 2000, FREE RADICAL BIO MED, V29, P306, DOI 10.1016/S0891-5849(00)00342-7
   Singh R, 2001, DIABETOLOGIA, V44, P129, DOI 10.1007/s001250051591
   Song X, 1999, MECH AGEING DEV, V108, P239, DOI 10.1016/S0047-6374(99)00022-6
   STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616
   VANFLETEREN JR, 1993, BIOCHEM J, V292, P605, DOI 10.1042/bj2920605
   Wang Shufen, 1999, Journal of China Medical University, V28, P164
   WANG Z, 1999, LAB ANIM SCI ADM, V16, P23
   WITTAKER MM, 1988, J BIOL CHEM, V263, P6074
   XU FB, 1985, P 2 NAT C AG RES HER
   Xu XH, 2002, ACTA PHARMACOL SIN, V23, P587
   YANG HY, 2000, CHIN PHARM B, V16, P397
   YOUNG S, 1993, NEW SCI, V17, P10
   ZUO S, 1998, CHIN J BIOCH PHARM, V19, P15
NR 34
TC 298
Z9 356
U1 4
U2 89
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1389-5729
J9 BIOGERONTOLOGY
JI Biogerontology
PY 2003
VL 4
IS 1
BP 15
EP 18
DI 10.1023/A:1022417102206
PG 4
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 646ZZ
UT WOS:000181067900003
PM 12652185
DA 2024-02-19
ER

PT J
AU Fathi, E
   Farahzadi, R
   Sheikhzadeh, N
AF Fathi, Ezzatollah
   Farahzadi, Raheleh
   Sheikhzadeh, Najmeh
TI Immunophenotypic characterization, multi-lineage differentiation and
   aging of zebrafish heart and liver tissue-derived mesenchymal stem cells
   as a novel approach in stem cell-based therapy
SO TISSUE & CELL
LA English
DT Article
DE Zebrafish heart and liver tissue-derived MSCs; Characterization;
   Multi-lineage differentiation; Regenerative medicine
ID ADIPOSE-TISSUE; BONE-MARROW; L-CARNITINE; IDENTIFICATION
AB Mesenchymal stem cells (MSCs) are a good model for preclinical and clinical investigations, and alternative sources of MSCs are subject to intensive experiments. In this study, mesenchymal stem cells (MSCs) were isolated from heart and liver tissue of Zebrafish (Danio rerio). The flow-cytometry as well as RT-PCR were used to analyze the expression of a panel of cell surface markers CD44, CD90, CD31 and CD34. In the following, alizarin red, oil red-O and toluidine blue staining were carried out to evaluate the multi-lineage differentiation of zebrafish heart and liver tissue-derived MSCs. Subsequently, the gene and protein expression of Oct4, Sox2 and Nanog as pluripotent markers were analyzed by RT-PCR and western blotting, respectively. In addition, MTT assay was used for cell proliferation potential and population doubling time (PDT) assessment. Also, the aging of cells was investigated by beta-galactosidase activity assay. The results showed that, like other MSCs, zebrafish heart and liver tissue-derived MSCs were positive for mesenchymal, negative for hematopoietic markers and expressed pluripotent markers Oct4, Sox2 and Nanog. Moreover, these cells were differentiated to osteocyte, adipocyte, and chondrocyte lineages following directed differentiation. It was found that PDT of zebrafish heart and liver tissue-derived MSCs were 50.67 and 46.61 h, respectively. These cells had significantly more rapid growth on day 4. Our results show that zebrafish heart and liver tissue-derived MSCs exhibited typical MSC characteristics including fibroblast morphology, multi-lineage differentiation capacity, pluripotency potential and expression of a typical set of classic MSC surface markers.
C1 [Fathi, Ezzatollah] Univ Tabriz, Fac Vet Med, Dept Clin Sci, Shohadaye Ghavvas Blvd,Opposite Khavaran Town, Tabriz, Iran.
   [Farahzadi, Raheleh] Tabriz Univ Med Sci, Hematol & Oncol Res Ctr, Tabriz, Iran.
   [Sheikhzadeh, Najmeh] Univ Tabriz, Fac Vet Med, Dept Food Hyg & Aquat Anim, Tabriz, Iran.
C3 University of Tabriz; Tabriz University of Medical Science; University
   of Tabriz
RP Fathi, E (corresponding author), Univ Tabriz, Fac Vet Med, Dept Clin Sci, Shohadaye Ghavvas Blvd,Opposite Khavaran Town, Tabriz, Iran.; Farahzadi, R (corresponding author), Tabriz Univ Med Sci, Shahid Ghazi Hosp, Hematol & Oncol Res Ctr, Golgasht Ave, Tabriz, Iran.
EM ez.fathi@tabrizu.ac.ir; farahzadir@tbzmed.ac.ir
RI Fathi, Ezzatollah/H-1923-2017; Farahzadi, Raheleh/W-4103-2019;
   Farahzadi, Raheleh/L-8950-2017
OI Farahzadi, Raheleh/0000-0003-3159-9522; Sheikhzadeh,
   Najmeh/0000-0002-0909-7270
FU University of Tabriz, Tabriz, Iran [1396/01/16-855]
FX This work was supported by a grant (No. 1396/01/16-855) from the
   University of Tabriz, Tabriz, Iran.
CR Aqmasheh S, 2017, ADV PHARM BULL, V7, P165, DOI 10.15171/apb.2017.021
   Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180
   Cai M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28250
   Campagnoli C, 2001, BLOOD, V98, P2396, DOI 10.1182/blood.V98.8.2396
   Crop M, 2009, TRANSPL INT, V22, P365, DOI 10.1111/j.1432-2277.2008.00786.x
   Dey D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005329
   Ejtehadifar M, 2016, ADV PHARM BULL, V6, P645, DOI 10.15171/apb.2016.079
   Farahzadi R, 2018, TISSUE CELL, V54, P105, DOI 10.1016/j.tice.2018.08.012
   Farahzadi R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188052
   Fathi E, 2017, BIOL TRACE ELEM RES, P1
   Fathi E., 2016, BRAZ ARCH BIOL TECHN, V59
   FRIEDENSTEIN AJ, 1976, EXP HEMATOL, V4, P267
   Ghasemzadeh-Hasankolai M, 2012, BIOL TRACE ELEM RES, V150, P137, DOI 10.1007/s12011-012-9484-8
   Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111
   Kisiel AH, 2012, AM J VET RES, V73, P1305, DOI 10.2460/ajvr.73.8.1305
   Ma DD, 2011, BLOOD, V118, P289, DOI 10.1182/blood-2010-12-327403
   Mançanares CAF, 2015, THERIOGENOLOGY, V84, P887, DOI 10.1016/j.theriogenology.2015.05.031
   Mansoub NH, 2018, BIOIMPACTS, V8, P5, DOI 10.15171/bi.2018.02
   Mobarak H, 2017, VET RES COMMUN, V41, P41, DOI 10.1007/s11259-016-9670-9
   Nadri S, 2007, CYTOTHERAPY, V9, P729, DOI 10.1080/14653240701656061
   Pers YM, 2015, OSTEOARTHR CARTILAGE, V23, P2027, DOI 10.1016/j.joca.2015.07.004
   Pirmoradi S, 2018, DRUG RES, V68, P213, DOI 10.1055/s-0043-119635
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Rafi MA, 2011, BIOIMPACTS, V1, P213, DOI 10.5681/bi.2011.030
   Ranera B, 2012, EQUINE VET J, V44, P33, DOI 10.1111/j.2042-3306.2010.00353.x
   Saleh M, 2015, ADV PHARM BULL, V5, P299, DOI 10.15171/apb.2015.042
   Shao J, 2015, BIOL RES, V48, DOI [10.1186/s40659-015-0053-4, 10.1186/S40659-015-0053-4]
   Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221
   Somal A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156821
   Sun SK, 2003, STEM CELLS, V21, P527, DOI 10.1634/stemcells.21-5-527
   Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213
   Zhang XL, 2009, IMMUNOBIOLOGY, V214, P179, DOI 10.1016/j.imbio.2008.07.030
   Zhao K, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0276-z
NR 33
TC 29
Z9 29
U1 2
U2 16
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0040-8166
J9 TISSUE CELL
JI Tissue Cell
PD APR
PY 2019
VL 57
BP 15
EP 21
DI 10.1016/j.tice.2019.01.006
PG 7
WC Anatomy & Morphology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Anatomy & Morphology; Cell Biology
GA HR1YK
UT WOS:000462932200003
PM 30947959
DA 2024-02-19
ER

PT J
AU Xing, WM
   Gao, WY
   Zhao, ZL
   Xu, XG
   Bu, HY
   Su, HL
   Mao, GX
   Chen, J
AF Xing, Wenmin
   Gao, Wenyan
   Zhao, Zhenlei
   Xu, Xiaogang
   Bu, Hongyan
   Su, Huili
   Mao, Genxiang
   Chen, Jun
TI Dietary flavonoids intake contributes to delay biological aging process:
   analysis from NHANES dataset
SO JOURNAL OF TRANSLATIONAL MEDICINE
LA English
DT Article
DE Flavonoids intake; Aging; Biological age; Heart biological age; NHANES
ID AGE
AB BackgroundDiet may influence biological aging and the discrepancy ( increment age) between a subject's biological age (BA) and chronological age (CA). We aimed to investigate the correlation of dietary flavonoids with the increment age of organs (heart, kidney, liver) and the whole body.MethodA total of 3193 United States adults were extracted from the National Health and Nutrition Examination Survey (NHANES) in 2007-2008 and 2017-2018. Dietary flavonoids intake was assessed using 24-h dietary recall method. Multiple linear regression analysis was performed to evaluate the association of dietary flavonoids intake with the increment age of organs (heart, kidney, liver) and the whole body. BA was computed based on circulating biomarkers, and the resulting increment age was tested as an outcome in linear regression analysis.ResultsThe increment age of the whole body, heart, and liver was inversely associated with higher flavonoids intake (the whole body increment age & beta; = - 0.58, cardiovascular increment age & beta; = - 0.96, liver increment age & beta; = - 3.19) after adjustment for variables. However, higher flavonoids intake positively related to renal increment age (& beta; = 0.40) in participants with chronic kidney disease (CKD). Associations were influenced by population characteristics, such as age, health behavior, or chronic diseases. Anthocyanidins, isoflavones and flavones had the strongest inverse associations between the whole body increment age and cardiovascular increment age among all the flavonoids subclasses.ConclusionFlavonoids intake positively contributes to delaying the biological aging process, especially in the heart, and liver organ, which may be beneficial for reducing the long-term risk of cardiovascular or liver disease.
C1 [Xing, Wenmin; Zhao, Zhenlei; Xu, Xiaogang; Su, Huili; Mao, Genxiang; Chen, Jun] Zhejiang Hosp, Dept Geriatr, Zhejiang Prov Key Lab Geriatr, 1229 Gudun Rd, Hangzhou 310013, Peoples R China.
   [Gao, Wenyan; Bu, Hongyan] Hangzhou Med Coll, Sch Pharm, Hangzhou, Peoples R China.
C3 Hangzhou Medical College
RP Su, HL; Mao, GX; Chen, J (corresponding author), Zhejiang Hosp, Dept Geriatr, Zhejiang Prov Key Lab Geriatr, 1229 Gudun Rd, Hangzhou 310013, Peoples R China.
EM huili_su@163.com; maogenxiang@163.com; zjdxcj@126.com
OI Xu, Xiaogang/0000-0003-4364-5856
FU project of the Health Bureau of Zhejiang Province [2021ZB009,
   2020ZQ002]; Prevention and Treatment Research Center for Senescent
   Disease, Zhejiang University School of Medicine [2022060002,
   2022060003]; National Key Research and Development Program of China
   [2022YFC3501802]
FX This study was supported by the project of the Health Bureau of Zhejiang
   Province ((2021ZB009 and 2020ZQ002), the Prevention and Treatment
   Research Center for Senescent Disease, Zhejiang University School of
   Medicine (2022060002 and 2022060003) and National Key Research and
   Development Program of China (2022YFC3501802).
CR Cassidy A, 2013, CIRCULATION, V127, P188, DOI 10.1161/CIRCULATIONAHA.112.122408
   Cassidy A, 2011, AM J CLIN NUTR, V93, P338, DOI 10.3945/ajcn.110.006783
   Chen WH, 2022, FRONT NUTR, V9, DOI 10.3389/fnut.2022.744397
   Clark JL, 2015, NUTR REV, V73, P799, DOI 10.1093/nutrit/nuv048
   Crous-Bou M, 2019, ADV NUTR, V10, pS296, DOI 10.1093/advances/nmz026
   Curtis PJ, 2019, AM J CLIN NUTR, V109, P1535, DOI 10.1093/ajcn/nqy380
   Diebel LWM, 2021, CURR ONCOL REP, V23, DOI 10.1007/s11912-021-01097-9
   Elliott ML, 2021, MOL PSYCHIATR, V26, P3829, DOI 10.1038/s41380-019-0626-7
   Engemann DA, 2020, ELIFE, V9, DOI 10.7554/eLife.54055
   Esposito S, 2021, NUTRIENTS, V13, DOI 10.3390/nu13051701
   Fiorito G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16391-5
   Gialluisi A, 2022, EUR J EPIDEMIOL, V37, P35, DOI 10.1007/s10654-021-00797-7
   Gudkov SV, 2023, AGEING RES REV, V83, DOI 10.1016/j.arr.2022.101775
   Hamczyk MR, 2020, J AM COLL CARDIOL, V75, P919, DOI 10.1016/j.jacc.2019.11.062
   Hastings WJ, 2019, PSYCHONEUROENDOCRINO, V106, P171, DOI 10.1016/j.psyneuen.2019.03.012
   Hibler E, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-019-0707-0
   Hodgson JM, 2006, CLIN EXP PHARMACOL P, V33, P838, DOI 10.1111/j.1440-1681.2006.04450.x
   Jylhävä J, 2017, EBIOMEDICINE, V21, P29, DOI 10.1016/j.ebiom.2017.03.046
   Kalt W, 2020, ADV NUTR, V11, P224, DOI 10.1093/advances/nmz065
   Kanasi E, 2016, PERIODONTOL 2000, V72, P13, DOI 10.1111/prd.12126
   Kim J, 2022, NUTRIENTS, V14, DOI 10.3390/nu14091731
   Li J, 2018, ENVIRON HEALTH PERSP, V126, DOI 10.1289/EHP2773
   Maleki SJ, 2019, FOOD CHEM, V299, DOI 10.1016/j.foodchem.2019.125124
   Mamoshina P, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-35704-w
   Mazidi M, 2019, J NUTR BIOCHEM, V65, P66, DOI 10.1016/j.jnutbio.2018.10.001
   Middleton E, 2000, PHARMACOL REV, V52, P673
   Muraki I, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5001
   Nie C, 2022, CELL REP, V38, DOI 10.1016/j.celrep.2022.110459
   Parhiz H, 2015, PHYTOTHER RES, V29, P323, DOI 10.1002/ptr.5256
   Petkovich DA, 2017, CELL METAB, V25, P954, DOI 10.1016/j.cmet.2017.03.016
   Qu Y, 2022, OXID MED CELL LONGEV, V2022, DOI 10.1155/2022/8878923
   Rattan P, 2022, HEPATOL COMMUN, V6, P399, DOI 10.1002/hep4.1803
   Reis JF, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-1076-5
   Rufino AT, 2021, MED RES REV, V41, P556, DOI 10.1002/med.21740
   Sebastian RS, 2022, NUTRIENTS, V14, DOI 10.3390/nu14091924
   Taylor S, 2021, J MED INTERNET RES, V23, DOI 10.2196/26988
   U.S. Department of Agriculture FSRGFD, 2022, US
   Wang K, 2022, SIGNAL TRANSDUCT TAR, V7, DOI 10.1038/s41392-022-01211-8
   Wu Q, 2022, SIGNAL TRANSDUCT TAR, V7, DOI 10.1038/s41392-022-01104-w
   Wu XL, 2018, J AGR FOOD CHEM, V66, P9172, DOI 10.1021/acs.jafc.8b03201
   Zhang DY, 2022, JAMA NETW OPEN, V5, DOI 10.1001/jamanetworkopen.2022.18183
   Zhang KX, 2022, FRONT PUBLIC HEALTH, V10, DOI 10.3389/fpubh.2022.998710
   Zhu JM, 2023, SCI TOTAL ENVIRON, V858, DOI 10.1016/j.scitotenv.2022.159768
   Zhu Y, 2013, NUTR METAB CARDIOVAS, V23, P843, DOI 10.1016/j.numecd.2012.06.005
NR 44
TC 0
Z9 0
U1 12
U2 13
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1479-5876
J9 J TRANSL MED
JI J. Transl. Med.
PD JUL 21
PY 2023
VL 21
IS 1
AR 492
DI 10.1186/s12967-023-04321-1
PG 12
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA N1BF3
UT WOS:001034444200001
PM 37480074
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Zou, YF
   JiZe, XP
   Li, CY
   Zhang, CW
   Fu, YP
   Yin, ZQ
   Li, YP
   Song, X
   Li, LX
   Zhao, XH
   Feng, B
   Huang, C
   Ye, G
   Tang, HQ
   Li, NY
   Chen, J
   Chen, XF
   Tian, ML
AF Zou, Yuan-Feng
   JiZe, Xiao-Ping
   Li, Cen-Yu
   Zhang, Chao-Wen
   Fu, Yu-Ping
   Yin, Zhong-Qiong
   Li, Yang-Ping
   Song, Xu
   Li, Li-Xia
   Zhao, Xing-Hong
   Feng, Bin
   Huang, Chao
   Ye, Gang
   Tang, Hua-Qiao
   Li, Ning-Yuan
   Chen, Ji
   Chen, Xing-Fu
   Tian, Meng-Liang
TI Polysaccharide from aerial part of <i>Chuanminshen violaceum</i>
   alleviates oxidative stress and inflammatory response in aging mice
   through modulating intestinal microbiota
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Article
DE Chuanminshen violaceum; polysaccharide; antioxidation; antiinflammatory;
   gut-liver axis; gut microbiota
ID FATTY LIVER-DISEASE; ANTIOXIDANT ACTIVITIES; GUT MICROBIOME; HEALTH;
   STAPHYLOCOCCUS; MECHANISMS; CIRRHOSIS; CANCER
AB Aging is a biological process of progressive deterioration of physiological functions, which poses a serious threat to individual health and a heavy burden on public health systems. As population aging continues, research into anti-aging drugs that prolong life and improve health is of particular importance. In this study, the polysaccharide from stems and leaves of Chuanminshen violaceum was obtained with water extraction and alcohol precipitation, and then separated and purified with DEAE anion exchange chromatography and gel filtration to obtain CVP-AP-I. We gavaged natural aging mice with CVP-AP-I and performed serum biochemical analysis, histological staining, quantitative real-time PCR (qRT-PCR) and ELISA kit assays to analyze inflammation and oxidative stress-related gene and protein expression in tissues, and 16SrRNA to analyze intestinal flora. We found that CVP-AP-I significantly improved oxidative stress and inflammatory responses of the intestine and liver, restored the intestinal immune barrier, and balanced the dysbiosis of intestinal flora. In addition, we revealed the potential mechanism behind CVP-AP-I to improve intestinal and liver function by regulating intestinal flora balance and repairing the intestinal immune barrier to regulate the intestinal-liver axis. Our results indicated that C. violaceum polysaccharides possessed favorable antioxidant, anti-inflammatory and potentially anti-aging effects in vivo.
C1 [Zou, Yuan-Feng; JiZe, Xiao-Ping; Li, Cen-Yu; Zhang, Chao-Wen; Fu, Yu-Ping; Yin, Zhong-Qiong; Song, Xu; Li, Li-Xia; Zhao, Xing-Hong; Ye, Gang; Tang, Hua-Qiao; Li, Ning-Yuan] Sichuan Agr Univ, Coll Vet Med, Nat Med Res Ctr, Chengdu, Peoples R China.
   [Zou, Yuan-Feng; Huang, Chao] Sichuan Agr Univ, Coll Vet Med, Key Lab Anim Dis & Human Hlth Sichuan Prov, Chengdu, Peoples R China.
   [Li, Yang-Ping] State Key Lab Crop Gene Explorat & Utilizat Southw, Chengdu, Peoples R China.
   [Feng, Bin] Sichuan Agr Univ, Anim Nutr Inst, Chengdu, Peoples R China.
   [Li, Yang-Ping; Chen, Ji; Chen, Xing-Fu; Tian, Meng-Liang] Sichuan Agr Univ, Coll Agron, Chengdu, Peoples R China.
C3 Sichuan Agricultural University; Key Laboratory of Animal Disease &
   Human Health of Sichuan Province; Sichuan Agricultural University;
   Sichuan Agricultural University; Sichuan Agricultural University
RP Tian, ML (corresponding author), Sichuan Agr Univ, Coll Agron, Chengdu, Peoples R China.
EM secondat@sicau.edu.cn
RI Wang, Luyao/JLL-2001-2023; li, wl/JJC-0768-2023; LIU,
   LIYING/KAM-4121-2024; Zhao, Xinghong/AAK-6568-2020; Wang,
   Yahui/JCO-6233-2023
CR Agarwal A, 2003, FERTIL STERIL, V79, P829, DOI 10.1016/S0015-0282(02)04948-8
   Albillos A, 2020, J HEPATOL, V72, P558, DOI 10.1016/j.jhep.2019.10.003
   Bajaj JS, 2014, J HEPATOL, V60, P940, DOI 10.1016/j.jhep.2013.12.019
   Boursier J, 2016, HEPATOLOGY, V63, P764, DOI 10.1002/hep.28356
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Cao YG, 2022, CELL HOST MICROBE, V30, P1295, DOI 10.1016/j.chom.2022.07.015
   Capaldo CT, 2017, J MOL MED, V95, P927, DOI 10.1007/s00109-017-1557-x
   Cockburn DW, 2016, J MOL BIOL, V428, P3230, DOI 10.1016/j.jmb.2016.06.021
   Cox LM, 2017, INT J SYST EVOL MICR, V67, P4289, DOI 10.1099/ijsem.0.002339
   Davalli P, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3565127
   De Martinis M, 2005, FEBS LETT, V579, P2035, DOI 10.1016/j.febslet.2005.02.055
   de Oliveira LS, 2022, CLIN NUTR, V41, P2644, DOI 10.1016/j.clnu.2022.10.003
   Dong HM, 2016, INT J BIOL MACROMOL, V86, P224, DOI 10.1016/j.ijbiomac.2016.01.002
   Dong HM, 2015, IND CROP PROD, V76, P290, DOI 10.1016/j.indcrop.2015.04.051
   DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017
   Equbal J, 2022, ENVIRON MONIT ASSESS, V194, DOI 10.1007/s10661-022-10132-6
   Fan J, 2017, CARBOHYD POLYM, V157, P629, DOI 10.1016/j.carbpol.2016.10.040
   Feng HB, 2015, INT J BIOL MACROMOL, V78, P405, DOI 10.1016/j.ijbiomac.2015.04.044
   Fougère B, 2017, J GERONTOL A-BIOL, V72, P1218, DOI 10.1093/gerona/glw240
   Guerbette T, 2022, MOL METAB, V63, DOI 10.1016/j.molmet.2022.101546
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490
   Hu C, 2022, AGING DIS, V13, P103, DOI 10.14336/AD.2021.0927
   Huang C, 2021, FOOD FUNCT, V12, P10828, DOI [10.1039/d1fo02354c, 10.1039/D1FO02354C]
   Huang C, 2021, J ENVIRON MANAGE, V299, DOI 10.1016/j.jenvman.2021.113607
   Huang YZ, 2022, INT J BIOL MACROMOL, V213, P967, DOI 10.1016/j.ijbiomac.2022.06.049
   Jeon SG, 2019, AGING DIS, V10, P307, DOI 10.14336/AD.2018.0328
   Ju TT, 2019, ISME J, V13, P1520, DOI 10.1038/s41396-019-0364-5
   Kang L, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-84031-0
   KATZ D, 1987, DIGEST DIS SCI, V32, P285, DOI 10.1007/BF01297055
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Kim MJ, 2021, MOLECULES, V26, DOI 10.3390/molecules26113197
   Kim Minhoo, 2020, Transl Med Aging, V4, P103
   Krabbe PFM, 2007, MED DECIS MAKING, V27, P395, DOI 10.1177/0272989X07302131
   Lai WJ, 2022, NPJ SCI FOOD, V6, DOI 10.1038/s41538-022-00149-z
   Lai Z, 2022, J DAIRY SCI, V105, P6601, DOI 10.3168/jds.2021-21355
   Lan Y, 2022, FOOD FUNCT, V13, P2925, DOI [10.1039/D1FO03147C, 10.1039/d1fo03147c]
   Li B, 2013, WATER RES, V47, P4207, DOI 10.1016/j.watres.2013.04.021
   Li XT, 2012, INT J MOL SCI, V13, P1747, DOI 10.3390/ijms13021747
   Li Y, 2020, DRUG DES DEV THER, V14, P5547, DOI 10.2147/DDDT.S280922
   Li ZQ, 2022, MOL MED, V28, DOI 10.1186/s10020-022-00463-y
   Lin S, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8080266
   Liu B, 2020, INT J BIOL MACROMOL, V143, P651, DOI 10.1016/j.ijbiomac.2019.12.041
   Liu JY, 2016, MICROB PATHOGENESIS, V101, P56, DOI 10.1016/j.micpath.2016.10.028
   Lü J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224213
   Lundberg DS, 2013, NAT METHODS, V10, P999, DOI 10.1038/nmeth.2634
   Ma LY, 2020, GUT MICROBES, V12, DOI 10.1080/19490976.2020.1832857
   MA TY, 1992, EXP GERONTOL, V27, P321, DOI 10.1016/0531-5565(92)90059-9
   Ma ZL, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248329
   Mangutov E O, 2022, Klin Lab Diagn, V67, P519, DOI 10.51620/0869-2084-2022-67-9-519-524
   Marshall JC, 1998, CAN J PHYSIOL PHARM, V76, P479, DOI 10.1139/cjpp-76-5-479
   Milosevic I, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20020395
   Mu QH, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00757
   Munoz-Price LS, 2008, NEW ENGL J MED, V358, P1271, DOI 10.1056/NEJMra070741
   Nasim F, 2021, INFECT GENET EVOL, V93, DOI 10.1016/j.meegid.2021.104928
   O'Callaghan J, 2013, CURR TOP MICROBIOL, V358, P119, DOI 10.1007/82_2011_187
   Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07
   Perino A, 2021, PHYSIOL REV, V101, P683, DOI 10.1152/physrev.00049.2019
   Piao SH, 2020, BIOMED PHARMACOTHER, V121, DOI 10.1016/j.biopha.2019.109421
   Romero FJ, 1998, ENVIRON HEALTH PERSP, V106, P1229, DOI 10.2307/3433990
   Saffrey MJ, 2014, AGE, V36, P1019, DOI 10.1007/s11357-013-9603-2
   Saha S, 2020, MOLECULES, V25, DOI 10.3390/molecules25225474
   Sen P, 2016, CELL, V166, P822, DOI 10.1016/j.cell.2016.07.050
   Singleton V. L., 1965, American Journal of Enology and Viticulture, V16, P144, DOI [10.5344/ajev.1965.16.3.144, DOI 10.12691/IJEBB-2-1-5]
   Soenen S, 2016, CURR OPIN CLIN NUTR, V19, P12, DOI 10.1097/MCO.0000000000000238
   Sohal RS, 2012, FREE RADICAL BIO MED, V52, P539, DOI 10.1016/j.freeradbiomed.2011.10.445
   Song CM, 2021, EXP GERONTOL, V153, DOI 10.1016/j.exger.2021.111476
   Song X, 2013, J GEN VIROL, V94, P2164, DOI 10.1099/vir.0.054270-0
   Sookoian S, 2015, WORLD J GASTROENTERO, V21, P711, DOI 10.3748/wjg.v21.i3.711
   Sun Z, 2007, MOL CELL BIOL, V27, P6334, DOI 10.1128/MCB.00630-07
   SZILARD L, 1959, P NATL ACAD SCI USA, V45, P30, DOI 10.1073/pnas.45.1.30
   Taguchi K, 2011, GENES CELLS, V16, P123, DOI 10.1111/j.1365-2443.2010.01473.x
   TARAO K, 1977, GASTROENTEROLOGY, V73, P539
   TRIGER DR, 1978, GUT, V19, P935, DOI 10.1136/gut.19.10.935
   Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653
   Vaiserman A, 2020, BMC MICROBIOL, V20, DOI 10.1186/s12866-020-01903-7
   Vaiserman AM, 2017, AGEING RES REV, V35, P36, DOI 10.1016/j.arr.2017.01.001
   Vatner SF, 2020, AGEING RES REV, V64, DOI 10.1016/j.arr.2020.101194
   Wahlström A, 2016, CELL METAB, V24, P41, DOI 10.1016/j.cmet.2016.05.005
   Wang Hongwei, 2009, Chin Med, V4, P20, DOI 10.1186/1749-8546-4-20
   Wang ZL, 2013, EXP GERONTOL, V48, P705, DOI 10.1016/j.exger.2013.05.059
   Wei HL, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-6219-7
   Wu Y, 2021, GUT MICROBES, V13, DOI 10.1080/19490976.2021.1897211
   Xing YY, 2021, ECOTOX ENVIRON SAFE, V223, DOI 10.1016/j.ecoenv.2021.112566
   Xu YS, 2021, FRONT CELL INFECT MI, V11, DOI 10.3389/fcimb.2021.696186
   Yang XW, 2013, FOOD CHEM TOXICOL, V55, P297, DOI 10.1016/j.fct.2012.12.039
   Yi ZW, 2021, FOOD FUNCT, V12, P2925, DOI [10.1039/d0fo03345f, 10.1039/D0FO03345F]
   Yu Y, 2018, CARBOHYD POLYM, V183, P91, DOI 10.1016/j.carbpol.2017.12.009
   Zhang Z, 2021, FOOD FUNCT, V12, P4504, DOI [10.1039/d1fo00249j, 10.1039/D1FO00249J]
   Zhao XH, 2015, INT J CLIN EXP MED, V8, P558
   Zhao Y, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/9310245
   Zinger A, 2017, AGING DIS, V8, P611, DOI 10.14336/AD.2016.1230
   Zou YF, 2022, J ETHNOPHARMACOL, V295, DOI 10.1016/j.jep.2022.115446
   Zou YF, 2022, FRONT PHARMACOL, V13, DOI 10.3389/fphar.2022.786141
   Zou YF, 2021, J SCI FOOD AGR, V101, P6043, DOI 10.1002/jsfa.11261
NR 95
TC 2
Z9 2
U1 14
U2 22
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD APR 21
PY 2023
VL 14
AR 1159291
DI 10.3389/fimmu.2023.1159291
PG 15
WC Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology
GA F1QX7
UT WOS:000980173800001
PM 37153605
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Kim, H
   Oh, BK
   Roncalli, M
   Park, C
   Yoon, SM
   Yoo, JE
   Park, YN
AF Kim, Haeryoung
   Oh, Bong-Kyeong
   Roncalli, Massimo
   Park, Chanil
   Yoon, So-Mi
   Yoo, Jeong Eun
   Park, Young Nyun
TI Large Liver Cell Change in Hepatitis B Virus-Related Liver Cirrhosis
SO HEPATOLOGY
LA English
DT Article
ID HUMAN HEPATOCELLULAR-CARCINOMA; HUMAN HEPATOCARCINOGENESIS;
   MACROREGENERATIVE NODULES; CHROMOSOME-ABERRATIONS; REPLICATIVE
   SENESCENCE; PREDICTIVE-VALUE; DNA-PLOIDY; DYSPLASIA; CANCER; INSTABILITY
AB Large liver cell change (LLCC) refers to microscopic lesions often found in various chronic liver diseases; however, its nature is still controversial. Thirty-four formalin-fixed and 19 fresh frozen hepatitis B virus (HBV)-related cirrhosis samples were examined for the presence of LLCC, small liver cell change (SLCC), and hepatocellular carcinoma (HCC). The cell cycle checkpoint status (p21, p27, p16, Tp53), cell dynamics (proliferating cell nuclear antigen, Ki-67, terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick-end labeling, M30), DNA damage (gamma-H2AX [H2A histone family, member X]), telomere lengths, chromosomal instability (micronuclei index), and senescence-associated P-galactosidase (SA-beta-Gal) activity were evaluated using an in situ approach and compared to those in normal liver (n = 5) and liver with chronic cholestasis (34 cases of hepatolithiasis and three cases of primary biliary cirrhosis). In HBV-related cirrhosis, the p21, p27, and p 16 cell cycle checkpoint markers were activated in normal-looking cirrhotic hepatocytes (NLCH), but diminished gradually from LLCC, SLCC, to HCC, with an increase in Tp53 expression. There was a general decrease in telomere length from NLCH, LLCC, SLCC, to HCC. Micronuclei,,gamma-H2AX foci, and net cellular gain were significantly increased from normal hepatocytes, NLCH, LLCC, SLCC, to HCC. The SA-beta-Gal activity was weaker in LLCC compared to NLCH and absent in SLCC and HCC. In contrast, cholestatic LLCC showed retained expression of cell cycle checkpoint markers and decreased net cellular gain compared to adjacent normal-looking hepatocytes. HBV-related LLCC showed significantly higher Tp53 labeling index, gamma-H2AX labeling index, and micronuclei index; shorter telomere length; decreased SA-beta-Gal activity;, and increased net cellular gain compared to cholestatic LLCC. Conclusion: The nature of LLCC is rather heterogeneous depending on the biological setting. The characteristics of HBV-related LLCC are more consistent with dysplastic rather than merely reactive hepatocytes, whereas cholestatic LLCC more likely represents reactive change with more stringent cell cycle checkpoint control. (HEPATOLOGY 2009;50:752-762.)
C1 [Park, Chanil; Yoon, So-Mi; Yoo, Jeong Eun; Park, Young Nyun] Yonsei Univ, Coll Med, Dept Pathol, Brain Korea Project Med Sci 21,Ctr Chron Metab Di, Seoul 120752, South Korea.
   [Kim, Haeryoung] Seoul Natl Univ, Bundang Hosp, Dept Pathol, Songnam, South Korea.
   [Oh, Bong-Kyeong] Konkuk Univ, Bio Mol Informat Ctr, Seoul, South Korea.
   [Roncalli, Massimo] Univ Milan, Sch Med, Dept Pathol, Milan, Italy.
   [Roncalli, Massimo] Ist Ricovero & Cura Carattere Sci Humanitas Clin, Milan, Italy.
   [Park, Young Nyun] Yonsei Univ, Coll Med, Inst Gastroenterol, Seoul 120752, South Korea.
C3 Yonsei University; Yonsei University Health System; Seoul National
   University (SNU); Konkuk University; University of Milan; Yonsei
   University; Yonsei University Health System
RP Park, YN (corresponding author), Yonsei Univ, Coll Med, Dept Pathol, Brain Korea Project Med Sci 21,Ctr Chron Metab Di, 134 Shinchon Dong, Seoul 120752, South Korea.
EM young0608@yuhs.ac
RI Oh, Bong Kyeong/D-6815-2011; Roncalli, Massimo/HJZ-1838-2023
OI Roncalli, Massimo/0000-0002-7901-8910; Park, Young
   Nyun/0000-0003-0357-7967; Kim, Haeryoung/0000-0002-4205-9081
FU Korea government (Ministry of Science and Technology)
   [R13-2002-054-03004-0]; SNUBH Research Fund [11-2008-019]
FX This work was supported by the Korea Science and Engineering Foundation
   (KOSEF) grant funded by the Korea government (Ministry of Science and
   Technology) (R13-2002-054-03004-0), and partly by grant number
   11-2008-019 from the SNUBH Research Fund (to H.K.).
CR ANTHONY PP, 1973, J CLIN PATHOL, V26, P217, DOI 10.1136/jcp.26.3.217
   BORZIO M, 1995, GASTROENTEROLOGY, V108, P812, DOI 10.1016/0016-5085(95)90455-7
   COHEN C, 1994, MODERN PATHOL, V7, P536
   Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a
   Collado M, 2006, NAT REV CANCER, V6, P472, DOI 10.1038/nrc1884
   CRAWFORD JM, 1990, SEMIN DIAGN PATHOL, V7, P115
   de Almeida TMB, 2004, CANCER GENET CYTOGEN, V150, P16, DOI 10.1016/j.cancergencyto.2003.08.001
   Deng YB, 2007, LAB INVEST, V87, P1071, DOI 10.1038/labinvest.3700673
   di Fagagna FD, 2004, GENE DEV, V18, P1781, DOI 10.1101/gad.1214504
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   El-Sayed SS, 2004, CAN J GASTROENTEROL, V18, P87, DOI 10.1155/2004/638136
   Fenech M, 2000, MUTAT RES-FUND MOL M, V455, P81, DOI 10.1016/S0027-5107(00)00065-8
   GanneCarrie N, 1996, HEPATOLOGY, V23, P1112
   Gisselsson D, 2005, SEMIN CANCER BIOL, V15, P13, DOI 10.1016/j.semcancer.2004.09.002
   HYTIROGLOU P, 1995, HEPATOLOGY, V21, P703, DOI 10.1002/hep.1840210316
   Koo JS, 2008, J CLIN GASTROENTEROL, V42, P738, DOI 10.1097/MCG.0b013e318038159d
   Koo JS, 2005, INTERVIROLOGY, V48, P16, DOI 10.1159/000082090
   LeBail B, 1997, J HEPATOL, V27, P835, DOI 10.1016/S0168-8278(97)80321-2
   Lee RG, 1997, HEPATOLOGY, V26, P1415
   LEFKOWITCH JH, 1993, GASTROENTEROLOGY, V104, P595, DOI 10.1016/0016-5085(93)90432-C
   Libbrecht L, 2005, LIVER INT, V25, P16, DOI 10.1111/j.1478-3231.2005.01016.x
   Libbrecht L, 2001, HISTOPATHOLOGY, V39, P66, DOI 10.1046/j.1365-2559.2001.01172.x
   Marchio A, 2001, J CLIN PATHOL-MOL PA, V54, P270, DOI 10.1136/mp.54.4.270
   Morgan D. O., 2007, CELL CYCLE PRINCIPLE, P28
   Natarajan S, 1997, AM J SURG PATHOL, V21, P312, DOI 10.1097/00000478-199703000-00007
   ORSATTI G, 1993, HEPATOLOGY, V17, P621, DOI 10.1002/hep.1840170416
   Ozturk N, 2006, P NATL ACAD SCI USA, V103, P2178, DOI 10.1073/pnas.0510877103
   Paradis V, 1998, HEPATOLOGY, V28, P953, DOI 10.1002/hep.510280409
   Paradis V, 2001, HUM PATHOL, V32, P327, DOI 10.1053/hupa.2001.22747
   Park YN, 2006, J HEPATOL, V45, P734, DOI 10.1016/j.jhep.2006.08.002
   Plentz RR, 2005, HEPATOLOGY, V42, P522, DOI 10.1002/hep.20847
   Plentz RR, 2004, HEPATOLOGY, V40, P80, DOI 10.1002/hep.20271
   Plentz RR, 2007, HEPATOLOGY, V45, P968, DOI 10.1002/hep.21552
   Quereda V, 2007, ONCOGENE, V26, P7665, DOI 10.1038/sj.onc.1210578
   RONCALLI M, 1989, INT J CANCER, V44, P204, DOI 10.1002/ijc.2910440203
   RUBIN EM, 1994, MODERN PATHOL, V7, P677
   Sharpless NE, 2005, NATURE, V436, P636, DOI 10.1038/436636a
   Shay JW, 2004, ONCOGENE, V23, P2919, DOI 10.1038/sj.onc.1207518
   Terris B, 1997, J HEPATOL, V27, P313, DOI 10.1016/S0168-8278(97)80177-8
   THOMAS RM, 1992, HUM PATHOL, V23, P496, DOI 10.1016/0046-8177(92)90126-N
   WATANABE S, 1983, CANCER, V51, P2197, DOI 10.1002/1097-0142(19830615)51:12<2197::AID-CNCR2820511208>3.0.CO;2-5
   ZHAO M, 1994, VIRCHOWS ARCH, V424, P613, DOI 10.1007/BF01069741
   Zhao M, 1997, J CLIN PATHOL, V50, P394, DOI 10.1136/jcp.50.5.394
   Zondervan PE, 2000, J PATHOL, V192, P207, DOI 10.1002/1096-9896(2000)9999:9999&lt;::AID-PATH690&gt;3.0.CO;2-#
NR 44
TC 47
Z9 48
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD SEP
PY 2009
VL 50
IS 3
BP 752
EP 762
DI 10.1002/hep.23072
PG 11
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 491BE
UT WOS:000269551100014
PM 19585549
DA 2024-02-19
ER

PT J
AU ZHAN, H
   SUN, CP
   LIU, CG
   ZHOU, JH
AF ZHAN, H
   SUN, CP
   LIU, CG
   ZHOU, JH
TI AGE-RELATED CHANGE OF FREE-RADICAL GENERATION IN LIVER AND SEX GLANDS OF
   RATS
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE AGING; FREE RADICAL; LIVER; SEX GLAND; RAT
ID LIPID-PEROXIDATION; DEPENDENT CHANGES; SUPEROXIDE; REPERFUSION;
   METABOLISM; BRAIN
AB Many investigations have been made on age-related changes of lipid peroxidation in tissue homogenates and subcellular fractions.  However, to date there are few reports on the age-related change of free radicals in living organs during aging.  In our study, we investigated free radical concentration in liver and sex glands of different aged rats by using electron spin resonance (ESR) technique.  A significant reduction of free radicals in liver and sex glands of old aged rats was observed when compared with those of young or middle-aged ones.  The decrease of free radical generation during aging is discussed.
C1 INST PHARMACOL & TOXICOL,DEPT NEUROPHARMACOL,BEIJING 100850,PEOPLES R CHINA.
CR BAKER JE, 1988, P NATL ACAD SCI USA, V85, P2786, DOI 10.1073/pnas.85.8.2786
   FINKELSTEIN E, 1980, ARCH BIOCHEM BIOPHYS, V200, P1, DOI 10.1016/0003-9861(80)90323-9
   HARMAN D, 1984, AGE, V7, P111, DOI 10.1007/BF02431866
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   HAYFLICK L, 1985, EXP GERONTOL, V20, P145, DOI 10.1016/0531-5565(85)90032-4
   PELUSO JJ, 1979, EXP AGING RES, V5, P319, DOI 10.1080/03610737908257208
   PLAYER TJ, 1977, BIOCHEM BIOPH RES CO, V78, P1397, DOI 10.1016/0006-291X(77)91447-4
   POPPER H, 1989, SEMIN LIVER DIS, V5, P221
   ROSEN GM, 1984, METHOD ENZYMOL, V105, P204
   SAI Y, 1988, 5TH SE AS W PAC REG, P191
   SAWADA M, 1987, MECH AGEING DEV, V41, P125, DOI 10.1016/0047-6374(87)90057-1
   SCHMUCKER DL, 1983, EXP GERONTOL, V18, P313, DOI 10.1016/0531-5565(83)90043-8
   SUN J, 1986, EXP GERONTOL, V21, P523, DOI 10.1016/0531-5565(86)90005-7
   TAKEUCHI N, 1976, EXP GERONTOL, V11, P179, DOI 10.1016/0531-5565(76)90031-0
   UYSAL M, 1989, MECH AGEING DEV, V48, P85, DOI 10.1016/0047-6374(89)90028-6
   VANELLA A, 1982, GERONTOLOGY, V28, P108, DOI 10.1159/000212519
   YANG SJ, 1989, CHIN J PHARM TOXICOL, V3, P218
   ZWEIER JL, 1987, P NATL ACAD SCI USA, V84, P1404, DOI 10.1073/pnas.84.5.1404
NR 18
TC 16
Z9 16
U1 0
U2 1
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD FEB
PY 1992
VL 62
IS 2
BP 111
EP 116
DI 10.1016/0047-6374(92)90047-H
PG 6
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA HF590
UT WOS:A1992HF59000001
PM 1314923
DA 2024-02-19
ER

PT J
AU Cho, SW
   Steel, J
   Tsung, A
   Marsh, JW
   Geller, DA
   Gamblin, TC
AF Cho, S. W.
   Steel, J.
   Tsung, A.
   Marsh, J. W.
   Geller, D. A.
   Gamblin, T. Clark
TI Safety of Liver Resection in the Elderly: How Important Is Age?
SO ANNALS OF SURGICAL ONCOLOGY
LA English
DT Article; Proceedings Paper
CT 63rd Annual Meeting of the Society-of-Surgical-Oncology
CY MAR 03-07, 2010
CL St Louis, MO
SP Soc Surg Oncol
ID HEPATIC RESECTION; HEPATOCELLULAR-CARCINOMA; COLORECTAL METASTASES;
   MAJOR HEPATECTOMY; IMPACT; RISK; CHEMOTHERAPY; STEATOSIS; SURGERY; OLDER
AB With the aging population, more elderly patients are being considered for hepatic resection. We investigated whether advanced age was associated with higher rate and severity of postoperative complications.
   A total of 75 patients aged a parts per thousand yen70 years (group E) were matched with 75 patients aged < 70 years (group Y) by the extent of liver resection and by operative indications. Primary outcome measures were rates and severity of complications. Secondary outcome measures were length of hospital stay and discharge destination. Univariate analysis was also performed to identify variables associated with higher surgical risk.
   Male-to-female ratio was 43:32 in both groups. Overall complication rates were 44 and 33.3% in group E and Y, respectively (P = 0.241; odds ratio = 1.57; 95% confidence interval [95% CI], 0.81-3.05). There was no mortality in both groups. The only postoperative age-related morbidity was confusion in the elderly. There was no difference in the rates of severe complications (grade a parts per thousand yen3) between group E and group Y (16 vs. 14.7%; P = 0.744; odds ratio = 1.11; 95% CI, 0.46-2.70). Median length of hospital stay were 7 and 6 days, respectively (P = 0.01). Nineteen percent and 1% of patients in group E and group Y were discharge to rehabilitation facilities, respectively (P = 0.001). Univariate analysis showed that preoperative systemic chemotherapy and longer operative time were associated with higher morbidity in the elderly.
   Liver resection can be performed in patients aged a parts per thousand yen70 years as safely as in younger patients. Duration and timing of systemic chemotherapy before liver resection should be optimized to minimize postoperative morbidity.
C1 [Cho, S. W.; Steel, J.; Tsung, A.; Marsh, J. W.; Geller, D. A.] Univ Pittsburgh, Med Ctr, UPMC Liver Canc Ctr, Pittsburgh, PA 15260 USA.
   [Gamblin, T. Clark] Med Coll Wisconsin, Div Surg Oncol, Milwaukee, WI 53226 USA.
C3 Pennsylvania Commonwealth System of Higher Education (PCSHE); University
   of Pittsburgh; Medical College of Wisconsin
RP Cho, SW (corresponding author), Univ Pittsburgh, Med Ctr, UPMC Liver Canc Ctr, Pittsburgh, PA 15260 USA.
EM tcgamblin@mcw.edu
RI Marsh, Wallis/C-6796-2013; Geller, David A/AAV-8082-2020
OI Marsh, Wallis/0000-0002-8143-9511; Geller, David A/0000-0003-0735-1068
CR Adam R, 2010, BRIT J SURG, V97, P366, DOI 10.1002/bjs.6889
   Aldrighetti L, 2003, WORLD J SURG, V27, P1149, DOI 10.1007/s00268-003-7072-y
   Belghiti J, 2000, J AM COLL SURGEONS, V191, P38, DOI 10.1016/S1072-7515(00)00261-1
   Carino ND, 2008, CRIT REV ONCOL HEMAT, V67, P273, DOI 10.1016/j.critrevonc.2008.05.003
   Cescon M, 2003, ARCH SURG-CHICAGO, V138, P547, DOI 10.1001/archsurg.138.5.547
   Cleary JM, 2009, ONCOLOGIST, V14, P1095, DOI 10.1634/theoncologist.2009-0152
   Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae
   Ferrero A, 2005, WORLD J SURG, V29, P1101, DOI 10.1007/s00268-005-7768-2
   Fong Y, 1997, BRIT J SURG, V84, P1386
   FORTNER JG, 1990, ANN SURG, V211, P141, DOI 10.1097/00000658-199002000-00005
   Hanazaki K, 2001, J AM COLL SURGEONS, V192, P38, DOI 10.1016/S1072-7515(00)00778-X
   Huang J, 2009, J GASTROINTEST SURG, V13, P1627, DOI 10.1007/s11605-009-0933-4
   IJtsma AJC, 2008, J GASTROINTEST SURG, V12, P2196, DOI 10.1007/s11605-008-0563-2
   Jamagin WR, 2002, ANN SURG, V236, P397, DOI 10.1097/01.SLA.0000029003.66466.B3
   Karoui M, 2006, ANN SURG, V243, P1, DOI 10.1097/01.sla.0000193603.26265.c3
   Kondo K, 2008, WORLD J SURG, V32, P2223, DOI 10.1007/s00268-008-9688-4
   Kooby DA, 2003, J GASTROINTEST SURG, V7, P1034, DOI 10.1016/j.gassur.2003.09.012
   Mann CD, 2008, EJSO-EUR J SURG ONC, V34, P428, DOI 10.1016/j.ejso.2007.03.013
   Mazzoni G, 2007, INT J COLORECTAL DIS, V22, P77, DOI 10.1007/s00384-006-0096-7
   Menon KV, 2006, J AM COLL SURGEONS, V203, P677, DOI 10.1016/j.jamcollsurg.2006.07.025
   Moller JT, 1998, LANCET, V351, P857, DOI 10.1016/S0140-6736(97)07382-0
   Nagano Y, 2005, J AM COLL SURGEONS, V201, P511, DOI 10.1016/j.jamcollsurg.2005.05.010
   Nordlinger B, 2006, J CLIN ONCOL, V24, P4954, DOI 10.1200/JCO.2006.07.9244
   Nuzzo G, 2007, J GASTROINTEST SURG, V11, P318, DOI 10.1007/s11605-006-0070-2
   Oishi K, 2009, J GASTROINTEST SURG, V13, P695, DOI 10.1007/s11605-008-0758-6
   Petrowsky H, 2005, WORLD J SURG, V29, P1093, DOI 10.1007/s00268-005-1130-6
   Poon RT, 2004, ANN SURG, V240, P698, DOI 10.1097/01.sla.0000141195.66155.0c
   Shirabe K, 2009, WORLD J SURG, V33, P1927, DOI 10.1007/s00268-009-0122-3
   Vauthey JN, 2006, J CLIN ONCOL, V24, P2065, DOI 10.1200/JCO.2005.05.3074
   Veteläinen R, 2007, ANN SURG, V245, P20, DOI 10.1097/01.sla.0000225113.88433.cf
NR 30
TC 56
Z9 57
U1 0
U2 4
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1068-9265
EI 1534-4681
J9 ANN SURG ONCOL
JI Ann. Surg. Oncol.
PD APR
PY 2011
VL 18
IS 4
BP 1088
EP 1095
DI 10.1245/s10434-010-1404-6
PG 8
WC Oncology; Surgery
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Oncology; Surgery
GA 732TW
UT WOS:000288213600029
PM 21046265
DA 2024-02-19
ER

PT J
AU Tuo, BG
   Ju, ZY
   Riederer, B
   Engelhardt, R
   Manns, MP
   Rudolph, KL
   Seidler, U
AF Tuo, Biguang
   Ju, Zhenyu
   Riederer, Brigitte
   Engelhardt, Regina
   Manns, Michael P.
   Rudolph, K. Lenhard
   Seidler, Ursula
TI Telomere shortening is associated with reduced duodenal
   HCO<sub>3</sub><SUP>-</SUP> secretory but normal gastric acid secretory
   capacity in aging mice
SO AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
LA English
DT Article
DE telomere shortening; gastric acid secretion; duodenal HCO3- secretion;
   duodenal ulcer; aging
ID PEPTIC-ULCER DISEASE; HELICOBACTER-PYLORI; TIME TRENDS; PREVALENCE;
   LENGTH; AGE; EXPRESSION; EPITHELIUM; MORTALITY; CANCER
AB Tuo B, Ju Z, Riederer B, Engelhardt R, Manns MP, Rudolph KL, Seidler U. Telomere shortening is associated with reduced duodenal HCO3- secretory but normal gastric acid secretory capacity in aging mice. Am J Physiol Gastrointest Liver Physiol 303: G1312-G1321, 2012. First published September 27, 2012; doi: 10.1152/ajpgi.00035.2012.-The incidence of duodenal ulcer, especially Helicobacter pylori-negative duodenal ulcer, strongly increases with age. In humans, telomere length shortening is considered to be one critical factor in cellular senescence and organ survival. In this study, we compared basal and stimulated gastric acid and duodenal HCO3- secretory rates in aged late-generation (G(3)) telomerase-deficient (mTERC(-/-)) mice, which are characterized by severe telomere dysfunction due to the inability to elongate telomeres during cell division. We found that basal and forskolin-timulated HCO3- secretion and short-circuit current (I-sc) in isolated duodenal mucosa of G(3) mTERC(-/-) mice were markedly reduced compared with age-matched wild-type mice. In contrast, basal and forskolin-stimulated acid secretory rates in isolated G(3) mTERC(-/-) gastric mucosa were not significantly altered. Correspondingly, duodenal mucosa of G(3) mTERC(-/-) mice showed slimming and shortening of villi, whereas gastric mucosal histology was not significantly altered. However, the ratios of cystic fibrosis transmembrane conductance regulator (CFTR) and solute-linked carrier 26 gene family (Slc26a6) mRNA expression in relation to cytokeratin-18 were not altered in duodenal mucosa. The further knockout of p21, which is a downstream effector of telomere shortening-induced senescence, rescued villus atrophy of duodenal mucosa, and basal and forskolin-timulated duodenal HCO3- secretion and I-sc in mTERC(-/-) p21(-/-) double-knockout mice were not different from wild-type controls. In conclusion, genetic ablation of telomerase resulted in p21-dependent duodenal mucosal atrophy and reduced duodenal HCO3- secretory capacity, whereas gastric morphology and acid secretory function were preserved. This suggests that telomere shortening during aging may result in an imbalance between aggressive and protective secretions against duodenal mucosa and thus predispose to ulcer formation.
C1 [Tuo, Biguang] Zunyi Med Coll, Affiliated Hosp, Dept Gastroenterol, Zunyi 563003, Peoples R China.
   [Ju, Zhenyu] Hangzhou Normal Univ, Coll Med, Inst Aging Res, Max Planck Partner Grp Stem Cell Aging, Hangzhou, Zhejiang, Peoples R China.
   [Tuo, Biguang; Ju, Zhenyu; Riederer, Brigitte; Engelhardt, Regina; Manns, Michael P.; Rudolph, K. Lenhard; Seidler, Ursula] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-3000 Hannover, Germany.
   [Rudolph, K. Lenhard] Univ Ulm, Inst Mol Med, Ulm, Germany.
   [Rudolph, K. Lenhard] Univ Ulm, Max Planck Res Dept Stem Cell Aging, Ulm, Germany.
   [Tuo, Biguang] Digest Dis Inst Guizhou Prov, Zunyi, Peoples R China.
C3 Zunyi Medical University; Max Planck Society; Hangzhou Normal
   University; Hannover Medical School; Ulm University; Ulm University; Max
   Planck Society
RP Tuo, BG (corresponding author), Zunyi Med Coll, Affiliated Hosp, Dept Gastroenterol, Dalian Rd 149, Zunyi 563003, Peoples R China.
EM tuobiguang@yahoo.com.cn
RI Seidler, Ursula/HII-8049-2022
OI Seidler, Ursula/0000-0002-9600-2769; Rudolph, Karl
   Lenhard/0000-0002-4839-2862
FU National Natural Science Foundation of China [30860092]; International
   Scientific and Technological Cooperation Program of China
   [2008DFA32260]; Deutsche Forschungsgemeinschaft [SFB621-C9, Se460/13-2,
   Se460/13-4, Ru745-10]
FX This work was supported by the National Natural Science Foundation of
   China (30860092) and the International Scientific and Technological
   Cooperation Program of China (2008DFA32260) to B. Tuo and the Deutsche
   Forschungsgemeinschaft Grants SFB621-C9 and Se460/13-2 and 13-4 to U.
   Seidler and Ru745-10 to K. L. Rudolph.
CR Aida J, 2007, HUM PATHOL, V38, P1192, DOI 10.1016/j.humpath.2006.11.023
   Allen A, 2005, AM J PHYSIOL-CELL PH, V288, pC1, DOI 10.1152/ajpcell.00102.2004
   Arents NLA, 2004, EUR J GASTROEN HEPAT, V16, P779, DOI 10.1097/01.meg.0000108367.19243.73
   Aro P, 2006, AM J EPIDEMIOL, V163, P1025, DOI 10.1093/aje/kwj129
   Asaka M, 1996, Helicobacter, V1, P52, DOI 10.1111/j.1523-5378.1996.tb00008.x
   Aubert G, 2008, PHYSIOL REV, V88, P557, DOI 10.1152/physrev.00026.2007
   Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4
   Chen TS, 2010, J GASTROEN HEPATOL, V25, P919, DOI 10.1111/j.1440-1746.2009.06139.x
   Choudhury AR, 2007, NAT GENET, V39, P99, DOI 10.1038/ng1937
   Choung RS, 2008, CURR MOL MED, V8, P253, DOI 10.2174/156652408784533823
   Corazza GR, 1998, MECH AGEING DEV, V104, P1, DOI 10.1016/S0047-6374(98)00044-X
   Craig WL, 2003, EUR J GASTROEN HEPAT, V15, P1195, DOI 10.1097/00042737-200311000-00008
   CRYER B, 1992, GASTROENTEROLOGY, V102, P1118
   Dahse R, 1997, CLIN CHEM, V43, P708
   Del Valle Chey WDJ, TXB GASTROENTEROLOGY, P1381
   Dorwart MR, 2008, PHYSIOLOGY, V23, P104, DOI 10.1152/physiol.00037.2007
   Durant ST, 2012, J CANCER, V3, P67, DOI 10.7150/jca.3965
   FARINATI F, 1993, GERONTOLOGY, V39, P146
   Feldman M, 1996, GASTROENTEROLOGY, V110, P1043, DOI 10.1053/gast.1996.v110.pm8612992
   Garrow D, 2010, DIGEST DIS SCI, V55, P66, DOI 10.1007/s10620-008-0708-x
   Gilley D, 2008, MECH AGEING DEV, V129, P27, DOI 10.1016/j.mad.2007.10.010
   Guo N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017858
   Hillesheim J, 2007, PFLUG ARCH EUR J PHY, V454, P575, DOI 10.1007/s00424-007-0239-x
   Hiyama E, 1996, INT J ONCOL, V9, P453
   Ju ZY, 2007, ANN NY ACAD SCI, V1100, P333, DOI 10.1196/annals.1395.036
   Jyotheeswaran S, 1998, AM J GASTROENTEROL, V93, P574, DOI 10.1111/j.1572-0241.1998.167_b.x
   KHANNA PB, 1988, AGE AGEING, V17, P257, DOI 10.1093/ageing/17.4.257
   KIM SW, 1990, ANN SURG, V212, P332, DOI 10.1097/00000658-199009000-00011
   KITADA T, 1995, BIOCHEM BIOPH RES CO, V211, P33, DOI 10.1006/bbrc.1995.1774
   Kuhlow D, 2010, AGING-US, V2, P650, DOI 10.18632/aging.100200
   Lou ZJ, 2009, AGING-US, V1, P608, DOI 10.18632/aging.100066
   Majumdar APN, 1997, P SOC EXP BIOL MED, V215, P134, DOI 10.3181/00379727-215-44120
   Maruyama Y, 1997, JPN J CLIN ONCOL, V27, P216, DOI 10.1093/jjco/27.4.216
   McColl KEL, 2009, GASTROENTEROL CLIN N, V38, P353, DOI 10.1016/j.gtc.2009.03.004
   McDaniel N, 2005, AM J PHYSIOL-GASTR L, V289, pG550, DOI 10.1152/ajpgi.00095.2005
   MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7
   Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2
   Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787
   Seidler U, 2012, PHYSL GASTROINTESTIN, P1311
   Simon NM, 2006, BIOL PSYCHIAT, V60, P432, DOI 10.1016/j.biopsych.2006.02.004
   Simpson JE, 2005, AM J PHYSIOL-GASTR L, V288, pG1241, DOI 10.1152/ajpgi.00493.2004
   Singh AK, 2010, AM J PHYSIOL-CELL PH, V298, pC1057, DOI 10.1152/ajpcell.00454.2009
   Singh AK, 2009, J CLIN INVEST, V119, P540, DOI 10.1172/JCI35541
   Sonnenberg A, 2007, GASTROENTEROLOGY, V132, P2320, DOI 10.1053/j.gastro.2007.03.108
   Sonnenberg A, 2007, AM J GASTROENTEROL, V102, P1101, DOI 10.1111/j.1572-0241.2007.01157.x
   Takubo K, 2010, GERIATR GERONTOL INT, V10, pS197, DOI 10.1111/j.1447-0594.2010.00605.x
   Tuo BG, 2011, GASTROENTEROLOGY, V141, P854, DOI 10.1053/j.gastro.2011.05.044
   Urquidi V, 2000, ANNU REV MED, V51, P65, DOI 10.1146/annurev.med.51.1.65
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   Wong GLH, 2009, GASTROENTEROLOGY, V137, P525, DOI 10.1053/j.gastro.2009.05.006
   Wu HC, 2008, DIGEST DIS SCI, V53, P2650, DOI 10.1007/s10620-007-0177-7
   Yakabi Koji, 2010, Nihon Rinsho, V68, P2001
NR 52
TC 4
Z9 4
U1 1
U2 16
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0193-1857
EI 1522-1547
J9 AM J PHYSIOL-GASTR L
JI Am. J. Physiol.-Gastroint. Liver Physiol.
PD DEC
PY 2012
VL 303
IS 12
BP G1312
EP G1321
DI 10.1152/ajpgi.00035.2012
PG 10
WC Gastroenterology & Hepatology; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology; Physiology
GA 056PH
UT WOS:000312502600003
PM 23019197
DA 2024-02-19
ER

PT J
AU Arndtz, K
   Hirschfield, GM
AF Arndtz, Katherine
   Hirschfield, Gideon M.
TI The Pathogenesis of Autoimmune Liver Disease
SO DIGESTIVE DISEASES
LA English
DT Article
DE Autoimmune; Cholangitis; Cirrhosis; Hepatitis; Pathophysiology
ID PRIMARY BILIARY-CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; SMALL
   BILE-DUCTS; CELLULAR SENESCENCE; EPITHELIAL-CELLS; TIGHT JUNCTIONS;
   MOUSE MODEL; HEPATITIS; MICE; INJURY
AB Background: Autoimmune liver disease (AILD) encompasses 3 main distinct clinical diseases: autoimmune hepatitis, primary biliary cholangitis (formally known as cirrhosis, PBC) and primary sclerosing cholangitis (PSC). These conditions are an important, yet under-appreciated cause of patient morbidity and mortality with ongoing unmet needs for further research and clinical advances. Key Messages: There is observational evidence for genetic predisposition, with all 3 conditions being more common in first degree relatives. AILD is associated with the presence of auto-antibodies and higher risks of other non-hepatic auto-immune conditions. Genetic risk association studies have identified HLA and non-HLA risk loci for the development of disease, with some HLA loci providing prognostic information. This re-enforces the concept that genetic predisposition to autoimmunity is important, likely in the context of environmental exposures. Such environmental triggers are unclear but relevant risks include smoking, drug and xenobiotic exposure as well as the complexities of the microbiome. There is evidence for a loss of immune tolerance to self-antigens playing a part in the development of these conditions. In particular the IL-2 and IL-12 regulatory pathways have been implicated in predisposing to an unopposed inflammatory response within the liver. Main immunological themes revolve around loss of immune tolerance leading to T-cell mediated injury, imbalance in the regulation of immune cells and defective immune response to foreign antigens. For PBC and PSC, there is then the added complexity of the consequences of cholestasis on hepato-biliary injury, immune regulation and liver fibrosis. Conclusions: Whilst specific disease causes and triggers are still lacking, AILD arises on the background of collective genetic and environmental risk, leading to chronic and abnormal hepato-biliary immune responses. Effective and more rational therapy will ultimately be developed when the multiple pathways to liver injury are better understood. (C) 2016 S. Karger AG, Basel
C1 [Arndtz, Katherine; Hirschfield, Gideon M.] Univ Birmingham, NIHR Birmingham Liver Biomed Res Unit, Liver Res Ctr, Wolfson Dr, Birmingham B15 2TT, W Midlands, England.
C3 University of Birmingham
RP Hirschfield, GM (corresponding author), Univ Birmingham, Liver Res Ctr, Wolfson Dr, Birmingham B15 2TT, W Midlands, England.
EM g.hirschfield@bham.ac.uk
RI Hirschfield, Gideon/M-2143-2015
OI Hirschfield, Gideon/0000-0002-6736-2255
FU NIHR Birmingham Liver Biomedical Research Unit; MRC; EU (Career
   Integration Award)
FX K.A. and G.M.H. are funded in part by the NIHR Birmingham Liver
   Biomedical Research Unit. G.M.H. is a co-investigator for the MRC funded
   stratified medicine platform, UK-PBC. G.M.H. has received support from
   the EU (Career Integration Award). The views expressed are those of the
   authors and not necessarily those of the NHS, the NIHR or the Department
   of Health.
CR Abdalian R, 2006, HEPATOLOGY, V44, P1063, DOI 10.1002/hep.21405
   Alexandropoulos K, 2015, INT J MOL SCI, V16, P1980, DOI 10.3390/ijms16011980
   Andersen IM, 2014, CLIN GASTROENTEROL H, V12, P1019, DOI 10.1016/j.cgh.2013.09.024
   Bonito AJ, 2013, J CLIN INVEST, V123, P3510, DOI 10.1172/JCI65414
   Boonstra K, 2012, J HEPATOL, V56, P1181, DOI 10.1016/j.jhep.2011.10.025
   Bowlus CL, 2011, CLIN REV ALLERG IMMU, V41, P139, DOI 10.1007/s12016-010-8221-3
   Chalasani N, 2000, HEPATOLOGY, V31, P7, DOI 10.1002/hep.510310103
   Chen RCY, 2013, HEPATOLOGY, V57, P1498, DOI 10.1002/hep.26157
   Cheng MH, 2012, ANNU REV IMMUNOL, V30, P393, DOI 10.1146/annurev-immunol-020711-074953
   Corpechot C, 2008, HEPATOLOGY, V48, P871, DOI 10.1002/hep.22428
   Corrigan M, 2015, BRIT MED BULL, V114, P181, DOI 10.1093/bmb/ldv021
   Czaja AJ, 2011, DIGEST DIS SCI, V56, P958, DOI 10.1007/s10620-011-1611-4
   Elkayam O, 1999, SEMIN ARTHRITIS RHEU, V28, P392, DOI 10.1016/S0049-0172(99)80004-3
   Eriksson U, 2001, J IMMUNOL, V167, P5464, DOI 10.4049/jimmunol.167.9.5464
   Gershwin ME, 2005, HEPATOLOGY, V42, P1194, DOI 10.1002/hep.20907
   Guo SH, 2013, AM J PATHOL, V182, P375, DOI 10.1016/j.ajpath.2012.10.014
   Harada K, 2009, CLIN EXP IMMUNOL, V157, P261, DOI 10.1111/j.1365-2249.2009.03947.x
   HASHIMOTO E, 1993, MAYO CLIN PROC, V68, P1049, DOI 10.1016/S0025-6196(12)60897-0
   Hirschfield GM, 2009, NEW ENGL J MED, V360, P2544, DOI 10.1056/NEJMoa0810440
   Hohenester S, 2012, HEPATOLOGY, V55, P173, DOI 10.1002/hep.24691
   Juran BD, 2014, SEMIN LIVER DIS, V34, P265, DOI 10.1055/s-0034-1383726
   Katt J, 2013, HEPATOLOGY, V58, P1084, DOI 10.1002/hep.26447
   KURIKI J, 1983, GASTROENTEROLOGY, V84, P596
   Lamireau T, 2003, LIFE SCI, V72, P1401, DOI 10.1016/S0024-3205(02)02408-6
   Liang Y, 2011, HEPATOL RES, V41, P572, DOI 10.1111/j.1872-034X.2011.00806.x
   Liaskou E, 2014, SEMIN IMMUNOPATHOL, V36, P553, DOI 10.1007/s00281-014-0439-3
   Liaskou E, 2011, HEPATOLOGY, V53, P661, DOI 10.1002/hep.24085
   Liu XD, 2010, NAT GENET, V42, P658, DOI 10.1038/ng.627
   Loftus EV, 2005, GUT, V54, P91, DOI 10.1136/gut.2004.046615
   Mieli-Vergani G, 2011, NAT REV GASTRO HEPAT, V8, P320, DOI 10.1038/nrgastro.2011.69
   Montano-Loza AJ, 2006, LIVER INT, V26, P1201, DOI 10.1111/j.1478-3231.2006.01387.x
   MORI Y, 1984, CLIN EXP IMMUNOL, V57, P85
   Moritoki Y, 2009, GASTROENTEROLOGY, V136, P1037, DOI 10.1053/j.gastro.2008.11.035
   Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896
   Obermayer-Straub P, 2001, GASTROENTEROLOGY, V121, P668, DOI 10.1053/gast.2001.27103
   Odin JA, 2001, J CLIN INVEST, V108, P223, DOI 10.1172/JCI10716
   Oude Elferink RP, 2007, PFLUGERS ARCH, V453, P601
   Peedikayil MC, 2006, ANN PHARMACOTHER, V40, P1888, DOI 10.1345/aph.1H136
   Prieto J, 1999, GASTROENTEROLOGY, V117, P167, DOI 10.1016/S0016-5085(99)70564-0
   Sakisaka S, 2001, HEPATOLOGY, V33, P1460, DOI 10.1053/jhep.2001.25086
   Sasaki M, 2005, J PATHOL, V205, P451, DOI 10.1002/path.1729
   Sasaki M, 2008, HEPATOLOGY, V48, P186, DOI 10.1002/hep.22348
   SCHEIFFA.F, 1967, J IMMUNOL, V98, P396
   Sebode M, 2014, J HEPATOL, V60, P1010, DOI 10.1016/j.jhep.2013.12.027
   Sherigar JM, 2012, CLINICS PRACT, V2, P206, DOI 10.4081/cp.2012.e83
   Sheth P, 2007, AM J PHYSIOL-GASTR L, V293, pG308, DOI 10.1152/ajpgi.00582.2006
   TIEGS G, 1992, J CLIN INVEST, V90, P196, DOI 10.1172/JCI115836
   Trivedi PJ, 2012, ALIMENT PHARM THER, V36, P517, DOI 10.1111/j.1365-2036.2012.05223.x
   Trivedi PJ, 2016, EXPERT REV CLIN PHAR, V9, P13, DOI 10.1586/17512433.2015.1092381
   Wakabayashi K, 2006, HEPATOLOGY, V44, P1240, DOI 10.1002/hep.21385
   Webb GJ, 2016, J AUTOIMMUN, V66, P25, DOI 10.1016/j.jaut.2015.08.016
   Yang CY, 2014, HEPATOLOGY, V59, P1944, DOI 10.1002/hep.26979
   Yang L, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00138
   Yao Y, 2014, J AUTOIMMUN, V51, P99, DOI 10.1016/j.jaut.2014.02.009
   Zhao L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018909
   Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212
NR 56
TC 31
Z9 34
U1 0
U2 9
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0257-2753
EI 1421-9875
J9 DIGEST DIS
JI Dig. Dis.
PY 2016
VL 34
IS 4
BP 327
EP 333
DI 10.1159/000444471
PG 7
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA DL6WS
UT WOS:000375781300006
PM 27170385
OA Green Published
DA 2024-02-19
ER

PT J
AU CANTAFORA, A
   MASELLA, R
   PIGNATELLI, E
   VERNA, R
AF CANTAFORA, A
   MASELLA, R
   PIGNATELLI, E
   VERNA, R
TI AGE-RELATED-CHANGES IN BLOOD AND LIVER LIPIDS OF MALE WISTAR RATS
SO ARCHIVES OF GERONTOLOGY AND GERIATRICS
LA English
DT Article
DE RAT; LIVER; LIPOPROTEIN; ERYTHROCYTE; LIPIDS; CHOLESTEROL; AGING
ID CHOLESTEROL-METABOLISM; DENSITY-LIPOPROTEINS; PLASMA-LIPOPROTEINS;
   PHOSPHATIDYLCHOLINE
AB The results of this study indicate that the age-dependent plasma cholesterol increase observed in male Wistar rats is correlated with changes in both the distribution of high-density lipoprotein fractions and the storage of hepatic cholesterol. Specifically, the lipoprotein distribution showed a significant increase in the proportion of HDL1 and a symmetrical decrease in both the HDL2 and HDL3 fractions during the 3 month to 18 month age period. There were no significant changes in the very-low density and low-density lipoprotein fractions. The chemical composition of lipoproteins showed many age-related variations, especially in the proportion of cholesteryl ester and in the distribution of HDL subfractions. A study of fatty acyl composition of the major lipid classes showed that, within cholesteryl ester found in liver, there was an increase in the proportion of saturated fatty acids. Polyunsaturated fatty acids increased in the cholesteryl esters found in high-density lipoproteins of older rats. These observations suggest that the age-dependent accumulation of body cholesterol occurs by a reduced catabolism of HDL, fraction, and modifications in plasma and liver lipids.
C1 UNIV LAQUILA,CATTEDRA PATOL CLIN,I-67100 LAQUILA,ITALY.
C3 University of L'Aquila
RP CANTAFORA, A (corresponding author), IST SUPER SANITA,DEPT METAB & PATHOL BIOCHEM,VIALE REGINA ELENA 299,I-00161 ROME,ITALY.
RI Masella, Roberta/B-4109-2015
OI Masella, Roberta/0000-0002-3173-1573; VERNA, Roberto/0000-0002-1869-3912
CR ALVARO D, 1986, BIOCHIM BIOPHYS ACTA, V878, P216, DOI 10.1016/0005-2760(86)90149-9
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   BRENNER RR, 1990, LIPIDS, V25, P581, DOI 10.1007/BF02536005
   CANTAFORA A, 1992, ARCH GERONTOL GERI S, V3, P93
   CHAPMAN MJ, 1981, J LIPID RES, V22, P339
   CHAPMAN MJ, 1986, METHOD ENZYMOL, V128, P70
   CHOI YS, 1987, MECH AGEING DEV, V41, P149, DOI 10.1016/0047-6374(87)90059-5
   CHOI YS, 1987, EXP GERONTOL, V22, P339, DOI 10.1016/0531-5565(87)90032-5
   DIBIASE A, 1989, ITAL J GASTROENTEROL, V21, P204
   DUPONT J, 1985, LIPIDS, V26, P349
   EISENBERG S, 1984, J LIPID RES, V25, P1017
   ERICSSON S, 1991, J CLIN INVEST, V87, P591, DOI 10.1172/JCI115034
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   FORTE TM, 1986, METHOD ENZYMOL, V128, P442
   GIGANTI MG, 1991, BIOTECHNOLOGY CELL R, P457
   GOODMAN DS, 1964, J BIOL CHEM, V239, P1335
   GRAY JE, 1977, CRC CR REV TOXICOL, V5, P115, DOI 10.3109/10408447709003377
   HASHIMOTO S, 1984, CIRC RES, V34, P176
   HOLLANDER D, 1979, EXP GERONTOL, V14, P201, DOI 10.1016/0531-5565(79)90020-2
   HRUZA Z, 1969, EXP GERONTOL, V4, P245, DOI 10.1016/0531-5565(69)90012-6
   INNIS SM, 1986, BIOCHIM BIOPHYS ACTA, V875, P353
   JOHNSON WJ, 1991, BIOCHIM BIOPHYS ACTA, V1085, P273, DOI 10.1016/0005-2760(91)90132-2
   KALEN A, 1989, LIPIDS, V24, P579, DOI 10.1007/BF02535072
   KANNEL WB, 1988, NUTR REV, V46, P68, DOI 10.1111/j.1753-4887.1988.tb05389.x
   KREISBERG RA, 1987, AM J MED, V82, P54, DOI 10.1016/0002-9343(87)90272-5
   MALHOTRA S, 1978, MECH AGEING DEV, V8, P445, DOI 10.1016/0047-6374(78)90044-1
   MILLER NE, 1987, ATHEROSCLEROSIS, V67, P163, DOI 10.1016/0021-9150(87)90276-0
   MILLER NE, 1988, ATHEROSCLEROSIS, V70, P275, DOI 10.1016/0021-9150(88)90179-7
   OSCHRY Y, 1982, J LIPID RES, V23, P1099
   RIVABENE R, 1992, BIOSCIENCE REP, V12, P425, DOI 10.1007/BF01121506
   SHEFER S, 1972, J LIPID RES, V13, P402
   STAHLBERG D, 1991, LIPIDS, V26, P349, DOI 10.1007/BF02537197
   STANGE EF, 1984, J LIPID RES, V25, P703
   STORY JA, 1974, EXPERIENTIA, V30, P242, DOI 10.1007/BF01934803
   SUBBAIAH PV, 1988, BIOCHIM BIOPHYS ACTA, V963, P445, DOI 10.1016/0005-2760(88)90313-X
   TANAKA M, 1987, LIPIDS, V22, P677, DOI 10.1007/BF02533950
   TARUGI P, 1991, J LIPID RES, V32, P1675
   YAMAMOTO M, 1971, ATHEROSCLEROSIS, V13, P365, DOI 10.1016/0021-9150(71)90079-7
NR 38
TC 8
Z9 10
U1 0
U2 1
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0167-4943
J9 ARCH GERONTOL GERIAT
JI Arch. Gerontol. Geriatr.
PD MAY-JUN
PY 1993
VL 16
IS 3
BP 249
EP 262
DI 10.1016/0167-4943(93)90036-H
PG 14
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA LP300
UT WOS:A1993LP30000006
PM 15374338
DA 2024-02-19
ER

PT J
AU Le Couteur, DG
   Blyth, FM
   Creasey, HM
   Handelsman, DJ
   Naganathan, V
   Sambrook, PN
   Seibel, MJ
   Waite, LM
   Cumming, RG
AF Le Couteur, David G.
   Blyth, Fiona M.
   Creasey, Helen M.
   Handelsman, David J.
   Naganathan, Vasi
   Sambrook, Philip N.
   Seibel, Markus J.
   Waite, Louise M.
   Cumming, Robert G.
TI The Association of Alanine Transaminase With Aging, Frailty, and
   Mortality
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
DE Alanine transaminase; Aging; Biomarker of aging; Frailty; Liver;
   Mortality
ID OLDER PERSONS; SERUM-ALBUMIN; AMINOTRANSFERASE ACTIVITY; TOTAL
   CHOLESTEROL; OBESITY; BIOMARKERS; AGE; INFLAMMATION; DISABILITY; DECLINE
AB The relationships between blood tests of liver function and injury (alanine transaminase [ALT], gamma-glutamyl transferase, bilirubin, and albumin) with age, frailty, and survival were investigated in 1,673 community-dwelling men aged 70 years or older. ALT was lower in older participants. Those participants with ALT below the median at baseline had reduced survival (hazard ratio 2.10, 95% confidence interval [CI] 1.53-2.87) up to 4.9 years. Older age, frailty, low albumin, low body mass index, and alcohol abstinence also were associated with reduced survival, with age and frailty being the most powerful predictors. Low ALT was associated with frailty (odds ratio 3.54, 95% CI 2.45-5.11), and the relationship between ALT and survival disappeared once frailty and age were included in the survival analysis. Low ALT activity is a predictor of reduced survival; however, this seems to be mediated by its association with frailty and increasing age. ALT has potential value as a novel biomarker of aging.
C1 [Le Couteur, David G.; Blyth, Fiona M.; Creasey, Helen M.; Naganathan, Vasi; Waite, Louise M.; Cumming, Robert G.] Univ Sydney, Concord RG Hosp, Ctr Educ & Res Ageing, Concord, NSW 2139, Australia.
   [Le Couteur, David G.; Handelsman, David J.; Seibel, Markus J.; Cumming, Robert G.] Univ Sydney, Concord RG Hosp, ANZAC Res Inst, Concord, NSW 2139, Australia.
   [Blyth, Fiona M.; Cumming, Robert G.] Univ Sydney, Sch Publ Hlth, Concord, NSW 2139, Australia.
   [Blyth, Fiona M.] Univ Sydney, Royal N Shore Hosp, Pain Management Res Inst, Concord, NSW 2139, Australia.
   [Sambrook, Philip N.] Univ Sydney, Royal N Shore Hosp, Inst Bone & Joint Res, Concord, NSW 2139, Australia.
C3 Concord Repatriation General Hospital; University of Sydney; University
   of Sydney; ANZAC Research Institute; Concord Repatriation General
   Hospital; University of Sydney; Royal North Shore Hospital; University
   of Sydney; Royal North Shore Hospital; University of Sydney
RP Le Couteur, DG (corresponding author), Univ Sydney, Concord RG Hosp, Ctr Educ & Res Ageing, Hosp Rd, Concord, NSW 2139, Australia.
EM david.lecouteur@sydney.edu.au
RI Ekanayake, Kanchana/P-8817-2016; Research Institute,
   ANZAC/CAE-9030-2022; Handelsman, David/AAR-9580-2021; Cumming, Robert
   G/R-1548-2016; Blyth, Fiona M/JDN-3541-2023
OI Cumming, Robert G/0000-0002-0261-6103; Blyth, Fiona
   M/0000-0003-1128-6756; Le Couteur, David/0000-0002-4227-5817; Waite,
   Louise/0000-0001-9056-6996; Handelsman, David/0000-0002-4200-7476;
   Seibel, Markus J/0000-0002-2701-378X; Naganathan,
   Vasikaran/0000-0001-7243-0796
FU Australian National Health and Medical Research Council (NHMRC) [301916,
   512364]; Ageing and Alzheimer's Research Foundation; Medical Foundation
   of the University of Sydney
FX This work was supported by the Australian National Health and Medical
   Research Council (NHMRC Project Grant No. 301916 and 512364), the Ageing
   and Alzheimer's Research Foundation, and the Medical Foundation of the
   University of Sydney.
CR Blyth FM, 2008, PAIN, V140, P224, DOI 10.1016/j.pain.2008.08.011
   Camargo CA, 1997, ARCH INTERN MED, V157, P79, DOI 10.1001/archinte.157.1.79
   Carriere I, 2008, J AM GERIATR SOC, V56, P840, DOI 10.1111/j.1532-5415.2008.01677.x
   Chapman IM, 2008, FRONT HORM RES, V36, P97, DOI 10.1159/000115358
   CORTI MC, 1994, JAMA-J AM MED ASSOC, V272, P1036, DOI 10.1001/jama.272.13.1036
   Crimmins E, 2008, ADV CLIN CHEM, V46, P161, DOI 10.1016/S0065-2423(08)00405-8
   Elinav E, 2005, AM J GASTROENTEROL, V100, P2201, DOI 10.1111/j.1572-0241.2005.41822.x
   Elinav E, 2006, J AM GERIATR SOC, V54, P1719, DOI 10.1111/j.1532-5415.2006.00921.x
   Fraser A, 2009, LIVER INT, V29, P1494, DOI 10.1111/j.1478-3231.2009.02090.x
   Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146
   Kanapuru B, 2009, AM J MED, V122, P605, DOI 10.1016/j.amjmed.2009.01.030
   Le Couteur DG, 2010, CALORIE RESTRICTION, AGING AND LONGEVITY, P191, DOI 10.1007/978-90-481-8556-6_11
   Marchesini G, 2008, J CLIN ENDOCR METAB, V93, pS74, DOI 10.1210/jc.2008-1399
   McAuley P, 2007, AM J MED, V120, P518, DOI 10.1016/j.amjmed.2006.07.032
   McLean AJ, 2004, PHARMACOL REV, V56, P163, DOI 10.1124/pr.56.2.4
   Okamura T, 2008, J AM GERIATR SOC, V56, P529, DOI 10.1111/j.1532-5415.2007.01549.x
   Ozer J, 2008, TOXICOLOGY, V245, P194, DOI 10.1016/j.tox.2007.11.021
   Reuben DB, 1999, J AM GERIATR SOC, V47, P402, DOI 10.1111/j.1532-5415.1999.tb07230.x
   Santos-Eggimann B, 2009, J GERONTOL A-BIOL, V64, P675, DOI 10.1093/gerona/glp012
   Schalk BWM, 2004, AGE AGEING, V33, P266, DOI 10.1093/ageing/afh073
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Topinková E, 2008, ANN NUTR METAB, V52, P6, DOI 10.1159/000115340
   Zamboni M, 2005, INT J OBESITY, V29, P1011, DOI 10.1038/sj.ijo.0803005
NR 23
TC 121
Z9 125
U1 1
U2 6
PU GERONTOLOGICAL SOC AMER
PI WASHINGTON
PA 1030 15TH ST NW, STE 250, WASHINGTON, DC 20005202-842 USA
SN 1079-5006
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD JUL
PY 2010
VL 65
IS 7
BP 712
EP 717
DI 10.1093/gerona/glq082
PG 6
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA 615CN
UT WOS:000279109500004
PM 20498223
OA Bronze, Green Published
DA 2024-02-19
ER

PT J
AU Duan, YN
   Lyu, L
   Zhu, DD
   Wang, JX
   Chen, JL
   Chen, LT
   Yang, CZ
   Sun, XL
AF Duan, Yinong
   Lyu, Lei
   Zhu, Dandan
   Wang, Jianxin
   Chen, Jinling
   Chen, Liuting
   Yang, Chunzhao
   Sun, Xiaolei
TI Recombinant SjP40 protein enhances p27 promoter expression in hepatic
   stellate cells via an E2F1-dependent mechanism
SO ONCOTARGET
LA English
DT Article
DE liver fibrosis; P40; p27; E2F1; Schistosoma japonicum
ID SOLUBLE EGG ANTIGENS; STAT3/P53/P21 PATHWAY; SIGNALING PATHWAY; LIVER
   FIBROSIS; ACTIVATION; SENESCENCE; APOPTOSIS; CYCLE; SCHISTOSOMIASIS;
   PROLIFERATION
AB The p27 protein plays a critical role in cell cycle arrest. Our previous studies have demonstrated that recombinant P40 protein from Schistosoma japonicum (rSjP40) could induce G1 phase arrest of cell cycle. We, therefore, attempted to observe the effect of rSjP40 on p27 promoter activity in LX-2 cells and to explore its potential mechanisms in this study. Using both Western blot and dual-luciferase reporter assay, we demonstrated that rSjP40 could enhance the expression of p27 in LX-2 cells. Results obtained using truncated fragments of p27 promoter showed that rSjP40 increased p27 promoter activity in LX-2 cells, mainly via some transcription factors that bind to the -1740/-873 region of p27 promoter. Further studies confirmed that the enhancement of p27 promoter activity induced by rSjP40 was related to E2F1 in LX-2 cells. Transfection of siRNA of E2F1 could also restore the effect of rSjP40 on expression of p27 and partially on alpha-SMA. Therefore, our study provided further insights into the mechanism by which rSjP40 induces LX-2 cell cycle arrest at G1 phase and inhibits HSC activation. Our results provide basis for future study of the blocking effect of rSjP40 in liver fibrosis.
C1 [Duan, Yinong; Lyu, Lei; Zhu, Dandan; Chen, Jinling; Chen, Liuting; Yang, Chunzhao; Sun, Xiaolei] Nantong Univ, Sch Med, Dept Pathogen Biol, Nantong 226001, Jiangsu, Peoples R China.
   [Wang, Jianxin] Nantong Univ, Lab Med Ctr, Affiliated Hosp, Nantong 226001, Jiangsu, Peoples R China.
C3 Nantong University; Nantong University
RP Duan, YN (corresponding author), Nantong Univ, Sch Med, Dept Pathogen Biol, Nantong 226001, Jiangsu, Peoples R China.
EM yinongduan@aliyun.com
RI liu, jiajia/ISS-0316-2023; wang, xiao/HZI-9156-2023; Duan,
   yinong/GSD-9438-2022
OI Chen, Jinling/0000-0003-2992-6571
FU National Natural Science Foundation of China [81471975, 81501763,
   81401683, 81171589]; Jiangsu provincial Natural Science Foundation
   [BK20140435]; Priority Academic Program Development of Jiangsu Higher
   Education Institutions (PAPD); Graduate Student Research and Innovation
   Program of Nantong University [YKC15054]
FX This work was supported by National Natural Science Foundation of China
   (Grant Numbers 81471975, 81501763, 81401683, 81171589), the Jiangsu
   provincial Natural Science Foundation (Grant Number BK20140435), the
   Priority Academic Program Development of Jiangsu Higher Education
   Institutions (PAPD) and the Graduate Student Research and Innovation
   Program of Nantong University (Grant Number YKC15054).
CR Abouel-Nour MF, 2006, MEM I OSWALDO CRUZ, V101, P365, DOI 10.1590/S0074-02762006000400004
   An JY, 2016, DIGEST DIS SCI, V61, P1107, DOI 10.1007/s10620-015-3976-2
   Andrade ZA, 2009, PARASITE IMMUNOL, V31, P656, DOI 10.1111/j.1365-3024.2009.01157.x
   Anthony B, 2010, EXP PARASITOL, V124, P409, DOI 10.1016/j.exppara.2009.12.009
   Anthony BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068479
   Anthony BJ, 2012, TRENDS PARASITOL, V28, P572, DOI 10.1016/j.pt.2012.09.005
   Bedir R, 2016, BALK MED J, V33, P121, DOI 10.5152/balkanmedj.2016.16442
   Bohanon FJ, 2015, MOL CELL BIOCHEM, V410, P293, DOI 10.1007/s11010-015-2562-4
   Chang CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092793
   Chen JL, 2016, SCI REP-UK, V6, DOI 10.1038/srep30957
   Chen JL, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.228
   Duan YN, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005268
   Duan YN, 2014, INT J PARASITOL, V44, P217, DOI 10.1016/j.ijpara.2013.11.003
   Egozi D, 2007, FASEB J, V21, P2807, DOI 10.1096/fj.06-7758com
   Li A, 2015, EUR J PHARMACOL, V747, P71, DOI 10.1016/j.ejphar.2014.11.040
   Li XW, 2015, INT IMMUNOPHARMACOL, V27, P53, DOI 10.1016/j.intimp.2015.04.048
   Pearce EJ, 2002, NAT REV IMMUNOL, V2, P499, DOI 10.1038/nri843
   Peng Y, 2014, AM J PHYSIOL-GASTR L, V306, pG253, DOI 10.1152/ajpgi.00471.2012
   Sun XL, 2015, PARASITOL RES, V114, P4251, DOI 10.1007/s00436-015-4663-0
   Wang CG, 2005, J BIOL CHEM, V280, P12339, DOI 10.1074/jbc.C400536200
   Wang J, 2015, ONCOTARGET, V6, P7325, DOI 10.18632/oncotarget.2621
   Wang JX, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003106
   Wang N, 2016, EVID-BASED COMPL ALT, V2016
   Xu TH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00326-1
   Yang JH, 2016, EUR J PHARMACOL, V783, P92, DOI 10.1016/j.ejphar.2016.04.042
   Ye D, 2016, SCI REP-UK, V6, DOI 10.1038/srep30276
   Zhong S, 2016, MOLECULES, P21
NR 27
TC 6
Z9 6
U1 0
U2 5
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
EI 1949-2553
J9 ONCOTARGET
JI Oncotarget
PD JUN 20
PY 2017
VL 8
IS 25
BP 40705
EP 40712
DI 10.18632/oncotarget.17248
PG 8
WC Oncology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Cell Biology
GA EY8YG
UT WOS:000404283700062
PM 28489573
OA Green Published, Green Submitted, gold
DA 2024-02-19
ER

PT J
AU Jing, HJ
   Li, J
   Zhang, JJ
   Wang, WS
   Li, SS
   Ren, ZZ
   Gao, Z
   Song, XL
   Wang, XX
   Jia, L
AF Jing, Huijuan
   Li, Juan
   Zhang, Jianjun
   Wang, Wenshuai
   Li, Shangshang
   Ren, Zhenzhen
   Gao, Zheng
   Song, Xinling
   Wang, Xiuxiu
   Jia, Le
TI The antioxidative and anti-aging effects of acidic- and
   alkalic-extractable mycelium polysaccharides by <i>Agrocybe aegerita</i>
   (Brig.) Sing
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Acidic- and alkalic-extractable; Agrocybe aegerita (Brig.) Sing;
   Antioxidative and anti-aging effects; Mycelium polysaccharides
ID ERYNGII VAR. TUOLIENSIS; ZINC POLYSACCHARIDES; FREE-RADICALS; IN-VITRO;
   ANTITUMOR; MUSHROOM; MICE; DISEASE; MUSCLE; VIVO
AB Two extractable polysaccharides of Ac-MPS and Al-MPS were extracted from the mycelium of Agrocybe aegerita (Brig.) Sing and the in vitro antioxidant activities and in vivo anti-aging activities in a D-gal-induced aging mice were investigated in the present study. The in vitro antioxidant analysis showed that Ac-MPS showed superior scavenging effects on hydroxyl of 68.62 +/- 2.59% and DPPH of 85.19 +/- 3.26% at the concentration of 4500 mu g/mL. Biochemical indices and antioxidant analysis in vivo showed that Ac-MPS had better effects in raising hepatic activities of SOD, CAT, GPx and T-AOC, inhibiting hepatic contents of LPO and MDA, as well as improving serum lipid levels of LDL-C, HDL-C, LDL-C/HDL-C, TG and TC. Furthermore, HYP measurements suggested that skin collagen in aging mice could be maintained. This study suggested that both Ac-MPS and Al-MPS could be used as potential natural agents or dietary supplements in attenuating aging and its complications. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Jing, Huijuan; Zhang, Jianjun; Wang, Wenshuai; Li, Shangshang; Ren, Zhenzhen; Gao, Zheng; Song, Xinling; Wang, Xiuxiu; Jia, Le] Shandong Agr Univ, Coll Life Sci, Tai An 271018, Shandong, Peoples R China.
   [Li, Juan] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Minist Agr, Key Lab Plant Nutr & Fertilizer, Beijing 100081, Peoples R China.
C3 Shandong Agricultural University; Chinese Academy of Agricultural
   Sciences; Institute of Agricultural Resources & Regional Planning, CAAS;
   Ministry of Agriculture & Rural Affairs
RP Jia, L (corresponding author), Shandong Agr Univ, Coll Life Sci, Tai An 271018, Shandong, Peoples R China.
EM ourlaboratory@163.com
RI zhang, jian/HPD-1712-2023; li, zhang/JHV-1750-2023; Wang,
   Shuai/JAZ-0277-2023; zhan, y/ISA-2807-2023; Wang, Luyao/JLL-2001-2023
FU Mushroom Technology System of Shandong Province [SDAIT-07-05];
   Fundamental Research Funds for Central Non-profit Scientific Institution
   [1610132016041]
FX This work was supported by grants from Mushroom Technology System of
   Shandong Province (SDAIT-07-05) and Fundamental Research Funds for
   Central Non-profit Scientific Institution (1610132016041).
CR [Anonymous], EVID BASED COMPLEMEN, DOI DOI 10.3343/ALM.2016.36.1.73
   Chao J, 2009, J ETHNOPHARMACOL, V125, P297, DOI 10.1016/j.jep.2009.06.024
   Chen Q. J., 2016, RES PUBLIC HLTH, V13, P235
   Chen Y, 2008, FOOD CHEM, V107, P231, DOI 10.1016/j.foodchem.2007.08.021
   Colgrave ML, 2008, J CHROMATOGR A, V1212, P150, DOI 10.1016/j.chroma.2008.10.011
   DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017
   Govindan S, 2016, EXP TOXICOL PATHOL, V68, P329, DOI 10.1016/j.etp.2016.04.001
   Guerra D. C. M. P., 2014, ANTIOXIDANTS, V3, P730
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Jukema JW, 2005, CURR MED RES OPIN, V21, P1865, DOI 10.1185/030079905X74952
   Kantachumpoo A., 2010, Kasetsart Journal, Natural Sciences, V44, P220
   Lara J, 2016, MATURITAS, V93, P1, DOI 10.1016/j.maturitas.2016.08.020
   Li H. E., 2009, CHIN J FOOD HYG, V21, P406
   Lin L, 2016, CARBOHYD POLYM, V146, P388, DOI 10.1016/j.carbpol.2016.03.071
   Liu J, 2010, CARBOHYD POLYM, V82, P1278, DOI 10.1016/j.carbpol.2010.07.008
   Liu M, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/8145785
   Liu Q, 2014, J AGR FOOD CHEM, V62, P8858, DOI 10.1021/jf502632c
   Lv L, 2007, FOOD CHEM, V104, P1678, DOI 10.1016/j.foodchem.2007.03.022
   Mizuno M, 2000, BIOFACTORS, V12, P275, DOI 10.1002/biof.5520120141
   NOHL H, 1993, BRIT MED BULL, V49, P653, DOI 10.1093/oxfordjournals.bmb.a072638
   OYAIZU M, 1986, Japanese Journal of Nutrition, V44, P307
   Pansarasa O, 2000, FREE RADICAL RES, V33, P287, DOI 10.1080/10715760000301451
   Petrovic J, 2015, J FOOD SCI TECH MYS, V52, P6711, DOI 10.1007/s13197-015-1783-6
   Petrovic J, 2014, FOOD FUNCT, V5, P3296, DOI [10.1039/c4fo00819g, 10.1039/C4FO00819G]
   Ren DY, 2014, INT J BIOL MACROMOL, V69, P296, DOI 10.1016/j.ijbiomac.2014.05.064
   Ribeiro B, 2007, FOOD CHEM TOXICOL, V45, P1805, DOI 10.1016/j.fct.2007.03.015
   Sheng JC, 2007, FOOD CHEM, V105, P533, DOI 10.1016/j.foodchem.2007.04.018
   SMIRNOFF N, 1989, PHYTOCHEMISTRY, V28, P1057, DOI 10.1016/0031-9422(89)80182-7
   Soares JR, 1997, FREE RADICAL RES, V26, P469, DOI 10.3109/10715769709084484
   STAUB A. M., 1965, METHOD CARBOHYD CHEM, V5, P5
   Su J, 2016, INT J BIOL MACROMOL, V87, P597, DOI 10.1016/j.ijbiomac.2016.03.022
   Sun YF, 2013, FOOD CHEM TOXICOL, V58, P184, DOI 10.1016/j.fct.2013.04.034
   Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001
   Visser M, 2005, AM J CLIN NUTR, V82, P531
   Xu N, 2017, INT J BIOL MACROMOL, V95, P204, DOI 10.1016/j.ijbiomac.2016.11.060
   Xu N, 2017, CARBOHYD POLYM, V157, P196, DOI 10.1016/j.carbpol.2016.09.082
   Yao DC, 2005, FREE RADICAL BIO MED, V39, P1385, DOI 10.1016/j.freeradbiomed.2005.07.015
   Young IS, 2001, J CLIN PATHOL, V54, P339, DOI 10.1136/jcp.54.5.339
   Yuan JF, 2008, CARBOHYD POLYM, V74, P822, DOI 10.1016/j.carbpol.2008.04.040
   Zaslavsky Cláudio, 2002, Arq. Bras. Cardiol., V79, P635
   Zhang JJ, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0964-1
   Zhang JJ, 2015, INT J MED MUSHROOMS, V17, P671, DOI 10.1615/IntJMedMushrooms.v17.i7.70
   Zhang W. J., 2006, EDILE FUNGI, V1, P40
   Zhang WX, 2015, CARBOHYD POLYM, V133, P154, DOI 10.1016/j.carbpol.2015.07.018
   Zhao HJ, 2016, CARBOHYD POLYM, V151, P1227, DOI 10.1016/j.carbpol.2016.06.058
   Zhao LY, 2012, FOOD CHEM, V134, P964, DOI 10.1016/j.foodchem.2012.03.001
   Zhong WQ, 2013, INT J BIOL MACROMOL, V60, P355, DOI 10.1016/j.ijbiomac.2013.06.018
   Zhu ZY, 2013, CARBOHYD POLYM, V92, P872, DOI 10.1016/j.carbpol.2012.10.007
NR 48
TC 29
Z9 32
U1 9
U2 67
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD JAN
PY 2018
VL 106
BP 1270
EP 1278
DI 10.1016/j.ijbiomac.2017.08.138
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA FP5LS
UT WOS:000417661600141
PM 28851637
DA 2024-02-19
ER

PT J
AU Zhang, ZS
   Li, XY
   Xu, XG
   Mao, GX
   Sun, X
   Xu, NJ
   Wang, XM
AF Zhang, Zhongshan
   Li, Xinyue
   Xu, Xiaogang
   Mao, Genxiang
   Sun, Xue
   Xu, Nianjun
   Wang, Xiaomei
TI <i>Gracilariopsis lemaneiformis</i> Polysaccharide Attenuates
   D-Galactose-Induced Aging of Mice by Regulating Oxidative Stress and Gut
   Microbiota
SO FRONTIERS IN MARINE SCIENCE
LA English
DT Article
DE G; lemaneiformis; polysaccharide; aging; oxidative stress; gut
   microbiota
ID INTESTINAL MICROBIOTA; DAMAGE
AB Gracilariopsis lemaneiformis polysaccharide (GP) exerted protective effects in an aging mouse model administered with D-galactose, and its mechanism was revealed. GP increased the activity of antioxidant enzymes, reduced malondialdehyde levels in the brain and serum, alleviated D-galactose-induced damage to the liver, and ameliorated mild cognitive impairment. Abundance of the gut microbiota differed significantly between GP and control groups. GP alleviated liver and brain injuries by regulating oxidative stress and modulating the composition and metabolism of the gut microbiota.
C1 [Zhang, Zhongshan; Li, Xinyue; Wang, Xiaomei] Huzhou Univ, Key Lab Vector Biol & Pathogen Control Zhejiang Pr, Huzhou, Peoples R China.
   [Xu, Xiaogang; Mao, Genxiang] Zhejiang Hosp, Key Lab Geriatr, Dept Geriatr, Hangzhou, Peoples R China.
   [Xu, Xiaogang; Mao, Genxiang] Zhejiang Hosp, Geriatr Inst Zhejiang Prov, Dept Geriatr, Hangzhou, Peoples R China.
   [Sun, Xue; Xu, Nianjun] Ningbo Univ, Sch Marine Sci, Natl Engn Res Lab Marine Biotechnol & Engn, Key Lab Marine Biotechnol Zhejiang Prov, Ningbo, Peoples R China.
C3 Huzhou University; Ningbo University
RP Zhang, ZS; Wang, XM (corresponding author), Huzhou Univ, Key Lab Vector Biol & Pathogen Control Zhejiang Pr, Huzhou, Peoples R China.; Xu, NJ (corresponding author), Ningbo Univ, Sch Marine Sci, Natl Engn Res Lab Marine Biotechnol & Engn, Key Lab Marine Biotechnol Zhejiang Prov, Ningbo, Peoples R China.
EM 01959@zjhu.edu.cn; xunianjun@nbu.edu.cn; 01960@zjhu.edu.cn
RI liu, junyang/IXD-1252-2023; Wu, Wenli/IYJ-1598-2023; wu,
   jun/ISB-8607-2023; zhang, wb/JGM-5316-2023; zhang, yue/JAC-3705-2023;
   wang, dong/HMP-1439-2023; Li, Xiaoli/JVZ-4089-2024; Ma,
   Xiaodong/JAN-7473-2023; Zhang, Jinfan/JPK-7588-2023; LI,
   XIAO/IQV-9318-2023; Liu, Han/HMD-9231-2023; Liu, Ying/ISU-1216-2023; LI,
   XIAO/JCE-6169-2023; LI, QI/IUM-8577-2023; LIU, HAO/JBI-9623-2023; cheng,
   shu/IZE-4788-2023; yan, xiao/JVP-0766-2024; Wang, He/JCO-3900-2023; Liu,
   Shao/JFK-0166-2023; li, yang/IQV-3559-2023; lu, qian/IUN-7445-2023;
   liang, shuang/JOK-5869-2023; Liu, DY/JPL-4171-2023; wang,
   yue/ISA-4119-2023; li, bo/JJC-2664-2023; Zhang, Zhongshan/GRE-8458-2022;
   zhang, yuyang/IVV-5089-2023; liu, junyang/IXD-1201-2023; ZHAO,
   S/IWV-4219-2023; Zhou, heng/JCN-6493-2023; Lu, Xiaomei/IUQ-2139-2023;
   Zhang, Can/JUU-9511-2023; JIN, LIYING/JFB-1980-2023; li,
   xiao/HKV-8405-2023; Chen, Shuo/JEO-6350-2023; wang, xu/IAN-4886-2023;
   wang, xiao/HZI-9156-2023; Li, Li/IAQ-0885-2023; Wang,
   lili/IXD-9828-2023; lu, yang/IWE-3635-2023; Zhang,
   Zhentao/JQV-7389-2023; zhang, yu/HNS-5948-2023; Li, June/JEF-1173-2023;
   liang, YU/IYT-4334-2023
OI Liu, Han/0000-0002-5269-8477; Zhang, Zhongshan/0000-0003-4991-0016;
   liang, YU/0009-0007-3922-3454; Xu, Xiaogang/0000-0003-4364-5856
FU Zhejiang Province Basic public welfare research project [LGN21D060001];
   Zhejiang Provincial Natural Science Foundation [LGF21H250002]; National
   Natural Science Foundation of China [31700307, 81771520]; Chinese
   Traditional Medicine Science and Technology Projects of Zhejiang
   Province [2021ZB002, 2022ZB002]
FX Funding This research was funded by the Zhejiang Province Basic public
   welfare research project (LGN21D060001), Zhejiang Provincial Natural
   Science Foundation (LGF21H250002), National Natural Science Foundation
   of China (31700307 and 81771520), and Chinese Traditional Medicine
   Science and Technology Projects of Zhejiang Province (2021ZB002 and
   2022ZB002).
CR Baynes JW, 2001, EXP GERONTOL, V36, P1527, DOI 10.1016/S0531-5565(01)00138-3
   Borgoni S, 2021, AGEING RES REV, V70, DOI 10.1016/j.arr.2021.101410
   Cui X, 2006, J NEUROSCI RES, V83, P1584, DOI 10.1002/jnr.20845
   Forman HJ, 2016, FREE RADICAL BIO MED, V97, P398, DOI 10.1016/j.freeradbiomed.2016.07.003
   Galkin F, 2019, AGEING RES REV, V49, P104, DOI 10.1016/j.arr.2018.11.008
   García-Peña C, 2017, ARCH MED RES, V48, P681, DOI 10.1016/j.arcmed.2017.11.005
   Gu YP, 2020, AGEING RES REV, V59, DOI 10.1016/j.arr.2020.101036
   Heeney DD, 2018, CURR OPIN BIOTECH, V49, P140, DOI 10.1016/j.copbio.2017.08.004
   Ionescu-Tucker A, 2021, NEUROBIOL AGING, V107, P86, DOI 10.1016/j.neurobiolaging.2021.07.014
   Lakshminarayanan B, 2014, J NUTR HEALTH AGING, V18, P773, DOI [10.1007/s12603-014-0549-6, 10.1007/s12603-014-0513-5]
   Quagliariello A, 2016, NUTRIENTS, V8, DOI 10.3390/nu8100660
   Rehman SU, 2017, MOL NEUROBIOL, V54, P255, DOI 10.1007/s12035-015-9604-5
   Sendama W, 2020, AGEING RES REV, V57, DOI 10.1016/j.arr.2019.101000
   Turroni F, 2022, CURR OPIN BIOTECH, V73, P81, DOI 10.1016/j.copbio.2021.07.012
   Vlassara H, 1997, DIABETES, V46, pS19, DOI 10.2337/diab.46.2.S19
   Wang L, 2022, SEMIN ARTHRITIS RHEU, V52, DOI 10.1016/j.semarthrit.2021.11.002
   Wang XM, 2021, FOOD RES INT, V143, DOI 10.1016/j.foodres.2021.110313
   Wang XM, 2019, INT J BIOL MACROMOL, V140, P600, DOI 10.1016/j.ijbiomac.2019.08.186
   Wang XM, 2019, INT J BIOL MACROMOL, V124, P568, DOI 10.1016/j.ijbiomac.2018.11.244
   Xu LQ, 2016, FOOD FUNCT, V7, P4545, DOI 10.1039/c6fo01057a
   Yosri N, 2021, INT J BIOL MACROMOL, V193, P1767, DOI 10.1016/j.ijbiomac.2021.10.229
   Zhang ZS, 2018, INT J BIOL MACROMOL, V112, P796, DOI 10.1016/j.ijbiomac.2018.01.192
NR 22
TC 2
Z9 2
U1 11
U2 31
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 2296-7745
J9 FRONT MAR SCI
JI Front. Mar. Sci.
PD JUN 30
PY 2022
VL 9
AR 932147
DI 10.3389/fmars.2022.932147
PG 10
WC Environmental Sciences; Marine & Freshwater Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Environmental Sciences & Ecology; Marine & Freshwater Biology
GA 2Z2VW
UT WOS:000826442400001
OA gold
DA 2024-02-19
ER

PT J
AU Khole, S
   Mittal, S
   Jagadish, N
   Ghosh, D
   Gadgil, V
   Sinkar, V
   Ghaskadbi, S
AF Khole, Swati
   Mittal, Smriti
   Jagadish, Nidhi
   Ghosh, Debjani
   Gadgil, Vijay
   Sinkar, Vilas
   Ghaskadbi, Saroj
TI Andrographolide enhances redox status of liver cells by regulating
   microRNA expression
SO FREE RADICAL BIOLOGY AND MEDICINE
LA English
DT Article
DE Liver/hepatocytes; Oxidative stress; Transcription/transcription factors
ID CYSTEINE LIGASE EXPRESSION; HEME OXYGENASE-1; P38 MAPK; PATHWAY; P53;
   THIOREDOXIN; PROTECTS; NRF2; TRANSCRIPTION; ACTIVATION
AB Andrographis paniculata Nees and its principal compound andrographolide are well known for exerting beneficial effects by modulating signaling pathways in different biological systems. Our earlier studies have demonstrated the ability of andrographolide as well as andrographolide enriched extracts to activate Nrf2/HO-1 pathway through adenosine A(2a) receptor. Present study investigated ability of andrographolide to regulate Nrf2 induced antioxidant defense systems by miRNAs using HepG2 cells. Andrographolide strongly induced Nrf2 which in turn modulated enzymes of glutathione and thioredoxin antioxidant systems. It also regulated crucial transcription factors viz. hepatocyte nuclear factor alpha (HNF4A) and tumor suppressor protein 53 (p53). Downregulation of HNF4A by andrographolide led to decrease in miRNAs regulating Heme oxygenase-1 (miR-377) and glutathione cysteine ligase (miR-433). Upregulation of p53 on the other hand led to increase in miRNAs regulating thioredoxin interacting protein (miR-17, miR-224) and glutathione peroxidase (miR-181a). Involvement of p53 and HNF4A in modulation of these miRNAs was confirmed by chromatin immunoprecipitation assay. Overall, the work reveals that andrographolide through modulation of p53 and HNF4A, regulates miRNAs leading to upregulation of HO-1, glutathione and thioredoxin systems. Andrographolide thus, can play a beneficial role in modulating antioxidant defense in oxidative stress induced diseases such as diabetes, ageing etc.
C1 [Khole, Swati; Mittal, Smriti; Ghaskadbi, Saroj] SPPU, Dept Zool, Pune 411007, Maharashtra, India.
   [Jagadish, Nidhi; Ghosh, Debjani; Gadgil, Vijay; Sinkar, Vilas] Unilever R&D Bangalore, Strateg Sci Grp Nat & Tradit Med, 64 Main Rd, Bangalore 560066, Karnataka, India.
   [Khole, Swati] SPPU, Dept Biotechnol, Pune 411007, Maharashtra, India.
C3 Savitribai Phule Pune University; Unilever; Savitribai Phule Pune
   University
RP Ghaskadbi, S (corresponding author), SPPU, Dept Zool, Pune 411007, Maharashtra, India.
EM ssg@unipune.ac.in
FU Unilever Industries Pvt Ltd, Banglore India [OIB-643]; Department of
   Science and Technology - Promotion of University Research and Scientific
   Excellence (DST-PURSE) [GOI-A-670]; University Grant Commision-Career
   Advancecement Scheme (UGC-CAS) program of the Department of Zoology,
   Savitribai Phule Pune University, India [F-5-2/2005(SAP-II)]; Unilever
   Pvt Ltd, Bangalore India; DS Kothari fellowship; Departmental Research
   and Development Program grant from Department of Biotechnology,
   Savitribai Phule Pune University, Pune, India
FX This study was supported by grants from Unilever Industries Pvt Ltd
   (OIB-643), Banglore India. Authors acknowledge financial support from
   Department of Science and Technology - Promotion of University Research
   and Scientific Excellence (DST-PURSE, GOI-A-670) and University Grant
   Commision-Career Advancecement Scheme (UGC-CAS, F-5-2/2005(SAP-II)
   program of the Department of Zoology, Savitribai Phule Pune University,
   India. SK is a recipient of fellowship from Unilever Pvt Ltd, Bangalore
   India. SPM was a receipient of DS Kothari fellowship and would like to
   acknowlege Departmental Research and Development Program grant from
   Department of Biotechnology, Savitribai Phule Pune University, Pune,
   India. Authors thank Dr. Abhijeet Kulkarni for help in analyzing in
   silico transcriptional regulation of microRNAs.
CR Ago T, 2007, ANTIOXID REDOX SIGN, V9, P679, DOI 10.1089/ars.2007.1529
   Beckman JD, 2011, J BIOL CHEM, V286, P3194, DOI 10.1074/jbc.M110.148726
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30
   Chen Y, 2005, FEBS LETT, V579, P3683, DOI 10.1016/j.febslet.2005.05.053
   Cheng XH, 2013, FREE RADICAL BIO MED, V64, P4, DOI 10.1016/j.freeradbiomed.2013.07.025
   Deponte M, 2013, BBA-GEN SUBJECTS, V1830, P3217, DOI 10.1016/j.bbagen.2012.09.018
   Espinosa-Diez C, 2015, REDOX BIOL, V6, P183, DOI 10.1016/j.redox.2015.07.008
   Espinosa-Diez C, 2015, ANTIOXID REDOX SIGN, V23, P1092, DOI 10.1089/ars.2014.6025
   Fiore R, 2009, EMBO J, V28, P697, DOI 10.1038/emboj.2009.10
   Goldberg D.M., 1983, METHOD ENZYMAT AN, VIII, P258, DOI DOI 10.1016/B978-0-12-091302-2.X5001-4
   Guan SP, 2013, BRIT J PHARMACOL, V168, P1707, DOI 10.1111/bph.12054
   Hadjal Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.246
   Hattori I, 2004, ANTIOXID REDOX SIGN, V6, P81, DOI 10.1089/152308604771978372
   Jayakumar T, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/846740
   Kinoshita C, 2015, AIMS MOL SCI, V2, P124, DOI 10.3934/molsci.2015.2.124
   Kishore V, 2017, CURR TOP MED CHEM, V17, P845, DOI 10.2174/1568026616666160927150452
   Knoll S, 2014, EMBO REP, V15, P1315, DOI 10.15252/embr.201439392
   Kramer M. F., 2015, CURR PROTOC MOL BIOL, P10
   LAWRENCE RA, 1976, BIOCHEM BIOPH RES CO, V71, P952, DOI 10.1016/0006-291X(76)90747-6
   Lee JC, 2014, BRIT J PHARMACOL, V171, P237, DOI 10.1111/bph.12440
   Li R, 2013, KIDNEY INT, V84, P1129, DOI 10.1038/ki.2013.272
   Lin Q, 2017, ONCOTARGET, V8, P15961, DOI 10.18632/oncotarget.14392
   Lu CY, 2014, BIOCHEM PHARMACOL, V91, P40, DOI 10.1016/j.bcp.2014.06.024
   Lu SC, 2013, BBA-GEN SUBJECTS, V1830, P3143, DOI 10.1016/j.bbagen.2012.09.008
   MEISTER A, 1988, J BIOL CHEM, V263, P17205
   Miska EA, 2005, CURR OPIN GENET DEV, V15, P563, DOI 10.1016/j.gde.2005.08.005
   Mittal SPK, 2016, BBA-GEN SUBJECTS, V1860, P2377, DOI 10.1016/j.bbagen.2016.07.005
   Perfettini JL, 2005, J EXP MED, V201, P279, DOI 10.1084/jem.20041502
   Ramani K, 2012, J BIOL CHEM, V287, P36341, DOI 10.1074/jbc.M112.370775
   Ravuri C, 2013, FREE RADICAL RES, V47, P394, DOI 10.3109/10715762.2013.781270
   Re A, 2009, MOL BIOSYST, V5, P854, DOI 10.1039/b900177h
   Saha K, 2014, J BIOL CHEM, V289, P11443, DOI 10.1074/jbc.M113.543165
   Sanchez-Prieto R, 2000, CANCER RES, V60, P2464
   Sangokoya C, 2010, BLOOD, V116, P4338, DOI 10.1182/blood-2009-04-214817
   Shan Y, 2004, J BIOL CHEM, V279, P51769, DOI 10.1074/jbc.M409463200
   Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199
   Origassa CST, 2013, WORLD J HEPATOL, V5, P541, DOI 10.4254/wjh.v5.i10.541
   Teixeira HD, 1996, BIOCHEM J, V315, P821, DOI 10.1042/bj3150821
   Tsunoda T, 1999, BIOINFORMATICS, V15, P622, DOI 10.1093/bioinformatics/15.7.622
   Upadhyay S, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/504253
   Wang L, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/960362
   Wang XF, 2006, ASSAY DRUG DEV TECHN, V4, P203, DOI 10.1089/adt.2006.4.203
   Woo AYH, 2008, J PHARMACOL EXP THER, V325, P226, DOI 10.1124/jpet.107.133918
   Xu Y, 2003, CELL DEATH DIFFER, V10, P1213, DOI 10.1038/sj.cdd.4401292
   Xu Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014356
   Yamamoto M, 2008, ANTIOXID REDOX SIGN, V10, P43, DOI 10.1089/ars.2007.1586
   Yan GR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063656
   Yan H, 2016, CURR PHARM DESIGN, V22, P499, DOI 10.2174/1381612821666150921110716
   Yang MH, 2011, BREAST CANCER RES TR, V129, P983, DOI 10.1007/s10549-011-1604-1
   Yen TL, 2016, TRANSL RES, V170, P57, DOI 10.1016/j.trsl.2015.12.002
   Yoshihara E, 2010, METHOD ENZYMOL, V474, P67, DOI 10.1016/S0076-6879(10)74005-2
   Zehavi L, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-44
   Zhou R, 2010, NUCLEIC ACIDS RES, V38, P3222, DOI 10.1093/nar/gkq056
NR 54
TC 15
Z9 15
U1 1
U2 17
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0891-5849
EI 1873-4596
J9 FREE RADICAL BIO MED
JI Free Radic. Biol. Med.
PD JAN
PY 2019
VL 130
BP 397
EP 407
DI 10.1016/j.freeradbiomed.2018.11.004
PG 11
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA HG9RR
UT WOS:000455347000036
PM 30414976
DA 2024-02-19
ER

PT J
AU Castillo, C
   Salazar, V
   Ariznavarreta, C
   Vara, E
   Tresguerres, JAF
AF Castillo, C
   Salazar, V
   Ariznavarreta, C
   Vara, E
   Tresguerres, JAF
TI Effect of growth hormone and estrogen administration on hepatocyte
   alterations in old ovariectomized female wistar rats
SO ENDOCRINE
LA English
DT Article
DE growth hormone; estrogens; menopause; oxidative stress; aging;
   hepatocyte
ID SEPSIS-RELATED CYTOKINES; OXIDATIVE DAMAGE; GENE-EXPRESSION; ENDOTHELIAL
   DYSFUNCTION; VASCULAR REACTIVITY; REPLACEMENT THERAPY; BODY-COMPOSITION;
   LIPID-SYNTHESIS; HEME OXYGENASE; IN-VITRO
AB Aging could be due to the accumulation of oxidative damage. On the other hand, growth hormone (GH) and estrogen deficiency induce deleterious effects on different tissues, and hormonal replacement could counteract these effects. We have investigated whether GH and estrogen administration modify some parameters related to oxidative stress and inflammation in hepatocytes isolated from old ovariectomized female rats. Twenty-two month-old ovariectomized animals were divided into control rats, rats treated with GH, rats treated with estradiol, and rats treated with GH+estradiol. Two-month-old intact female rats were used as young reference group. Hepatocytes were isolated, cultured, and CO and NO release, ATP, cyclic-guanosyl monophosphate (cGMP), and lipid peroxide (LPO) content of cells, as well as phosphatidylcholine (PC) synthesis, were measured. Hepatocytes isolated from old ovariectomized rats showed a decrease in ATP content and PC synthesis compared to young rats. Age also induced an increase in LPO, NO, CO, and cGMP. Treating old rats with GH significantly increased ATP and reduced CO and cGMP levels. Estradiol administration improved all the parameters that were altered. Co-administration of GH and estrogens induced a more marked effect than estrogens alone only in cGMP content. In conclusion, administration of estrogens to old ovariectomized females seemed to prevent oxidative changes in hepatocytes, whereas the effect of GH is not so evident.
C1 Univ Complutense, Sch Med, Lab Expt Endocrinol, Dept Physiol, Madrid 28040, Spain.
   Univ Complutense, Sch Med, Dept Biochem & Mol Biol, Madrid, Spain.
C3 Complutense University of Madrid; Complutense University of Madrid
RP Tresguerres, JAF (corresponding author), Univ Complutense, Sch Med, Lab Expt Endocrinol, Dept Physiol, Avda Complutense S-N, Madrid 28040, Spain.
EM guerres@med.ucm.es
CR Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593
   Anantharaju A, 2002, GERONTOLOGY, V48, P343, DOI 10.1159/000065506
   Andrawis N, 2000, J AM GERIATR SOC, V48, P193
   ARIASDIAZ J, 1993, EUR J SURG, V159, P535
   Arivazhagan P, 2001, CHEM-BIOL INTERACT, V138, P189, DOI 10.1016/S0009-2797(01)00268-X
   Barañano DE, 2001, P NATL ACAD SCI USA, V98, P10996, DOI 10.1073/pnas.191351298
   Bejma J, 2000, ACTA PHYSIOL SCAND, V169, P343
   Borrás C, 2003, FREE RADICAL BIO MED, V34, P546, DOI 10.1016/S0891-5849(02)01356-4
   BREESE CR, 1991, J GERONTOL, V46, pB180, DOI 10.1093/geronj/46.5.B180
   Castells MC, 2004, ALLERGY ASTHMA PROC, V25, P33
   CastillaCortazar I, 1997, GASTROENTEROLOGY, V113, P1682, DOI 10.1053/gast.1997.v113.pm9352873
   Castillo C, 2003, EXP GERONTOL, V38, P971, DOI 10.1016/S0531-5565(03)00156-6
   CASTILLO C, 2005, IN PRESS BIOGERONTOL
   Chung HY, 2002, MICROSC RES TECHNIQ, V59, P264, DOI 10.1002/jemt.10203
   Compston JE, 2001, PHYSIOL REV, V81, P419, DOI 10.1152/physrev.2001.81.1.419
   Cuttica CM, 1997, AGING CLIN EXP RES, V9, P193, DOI 10.1007/BF03340149
   Cuzzocrea S, 2001, MOL MED, V7, P478, DOI 10.1007/BF03401853
   De Lama MAR, 2000, EUR J ENDOCRINOL, V142, P517, DOI 10.1530/eje.0.1420517
   Evans LM, 1999, CLIN ENDOCRINOL, V50, P457
   Evans LM, 2000, EUR J ENDOCRINOL, V142, P254, DOI 10.1530/eje.0.1420254
   Gasbarrini A, 1998, SCAND J GASTROENTERO, V33, P1107
   Guo X, 2001, LIFE SCI, V69, P3113, DOI 10.1016/S0024-3205(01)01417-5
   Gustafsson H, 2002, EUR J ENDOCRINOL, V146, P267, DOI 10.1530/eje.0.1460267
   HARMAN D, 1992, MUTAT RES, V275, P257, DOI 10.1016/0921-8734(92)90030-S
   HOLLOWAY L, 1994, J CLIN ENDOCR METAB, V79, P470, DOI 10.1210/jc.79.2.470
   Isaksson OGP, 2000, ENDOCR J, V47, pS9, DOI 10.1507/endocrj.47.SupplMarch_S9
   Jeschke MG, 2002, MOL MED, V8, P238, DOI 10.1007/BF03402149
   Jeschke MG, 1999, J SURG RES, V83, P122, DOI 10.1006/jsre.1999.5577
   Kajstura J, 2001, DIABETES, V50, P1414, DOI 10.2337/diabetes.50.6.1414
   LACORT M, 1995, LIPIDS, V30, P141, DOI 10.1007/BF02538267
   Leal AM, 1998, BIOCHEM PHARMACOL, V56, P1463, DOI 10.1016/S0006-2952(98)00248-2
   Liu Y, 2002, WORLD J GASTROENTERO, V8, P363
   LU KH, 1979, BIOL REPROD, V21, P193, DOI 10.1095/biolreprod21.1.193
   Mikkola TS, 2002, CARDIOVASC RES, V53, P605, DOI 10.1016/S0008-6363(01)00466-7
   Nathan L, 1998, SEMIN REPROD ENDOCR, V16, P309, DOI 10.1055/s-2007-1016289
   Ohlsson C, 1998, ENDOCR REV, V19, P55, DOI 10.1210/er.19.1.55
   Palomero J, 2001, FREE RADICAL BIO MED, V30, P836, DOI 10.1016/S0891-5849(01)00471-3
   Persky AM, 2000, P SOC EXP BIOL MED, V223, P59, DOI 10.1046/j.1525-1373.2000.22308.x
   Pinzani M, 2001, J HEPATOL, V34, P764, DOI 10.1016/S0168-8278(01)00055-1
   Reiter RJ, 1998, PROG NEUROBIOL, V56, P359, DOI 10.1016/S0301-0082(98)00052-5
   RUDMAN D, 1990, NEW ENGL J MED, V323, P1, DOI 10.1056/NEJM199007053230101
   RuizLarrea MB, 1997, J PHYSIOL BIOCHEM, V53, P225
   Ryter SW, 2002, MOL CELL BIOCHEM, V234, P249, DOI 10.1023/A:1015957026924
   Sader MA, 2002, CARDIOVASC RES, V53, P597, DOI 10.1016/S0008-6363(01)00473-4
   SALAZAR V, 2003, J PHYSL P, V548, pP194
   Sastre J, 2000, IUBMB LIFE, V49, P427
   SCHMUCKER DL, 1990, EXP GERONTOL, V25, P403, DOI 10.1016/0531-5565(90)90029-2
   Shimizu H, 2001, EXP TOXICOL PATHOL, V53, P11, DOI 10.1078/0940-2993-00156
   Sohal RS, 2002, FREE RADICAL BIO MED, V33, P575, DOI 10.1016/S0891-5849(02)00886-9
   Sonntag WE, 1997, ENDOCRINOLOGY, V138, P3515, DOI 10.1210/en.138.8.3515
   SUGIOKA K, 1987, FEBS LETT, V210, P37, DOI 10.1016/0014-5793(87)81293-0
   Szabó C, 2003, TOXICOL LETT, V140, P105, DOI 10.1016/S0378-4274(02)00507-6
   Tani Yoshiro, 2001, Journal of Toxicological Sciences, V26, P25, DOI 10.2131/jts.26.25
   Tollet-Egnell P, 2001, MOL ENDOCRINOL, V15, P308, DOI 10.1210/me.15.2.308
   Toogood AA, 1998, BAILLIERE CLIN ENDOC, V12, P281, DOI 10.1016/S0950-351X(98)80023-2
   Toogood AA, 1996, J CLIN ENDOCR METAB, V81, P460, DOI 10.1210/jc.81.2.460
   Troen BR, 2003, MT SINAI J MED, V70, P3
   Van Remmen H, 2001, EXP GERONTOL, V36, P957
   Vara E, 1996, AM J PHYSIOL-LUNG C, V271, pL359, DOI 10.1152/ajplung.1996.271.3.L359
   VARA E, 1994, HEPATOLOGY, V20, P924, DOI 10.1002/hep.1840200422
   VARELA I, 1986, 1 C BIOCH PHARM CLIN, P25
   Vom Saal Frederick S., 1994, P1213
   Wight E, 2000, J SOC GYNECOL INVEST, V7, P106, DOI 10.1016/S1071-5576(00)00036-8
   Xu JW, 2002, WORLD J GASTROENTERO, V8, P883, DOI 10.3748/wjg.v8.i5.883
   Youn YK, 1998, J BURN CARE REHABIL, V19, P542, DOI 10.1097/00004630-199811000-00015
NR 65
TC 8
Z9 8
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1355-008X
EI 1559-0100
J9 ENDOCRINE
JI Endocrine
PD FEB
PY 2005
VL 26
IS 1
BP 11
EP 18
DI 10.1385/ENDO:26:1:011
PG 8
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 932EB
UT WOS:000229535900002
PM 15805580
DA 2024-02-19
ER

PT J
AU Qvigstad, C
   Tait, RC
   Rauchensteiner, S
   Berntorp, E
   de Moerloose, P
   Schutgens, RE
   Holme, PA
AF Qvigstad, Christian
   Tait, Robert Campbell
   Rauchensteiner, Stephan
   Berntorp, Erik
   de Moerloose, Philippe
   Schutgens, Roger E.
   Holme, Pal Andre
CA ADVANCE Working Grp
TI The elevated prevalence of risk factors for chronic liver disease among
   ageing people with hemophilia and implications for treatment
SO MEDICINE
LA English
DT Article
DE chronic liver disease; CLD; diabetes; hemophilia; HCV; HIV; PWH
ID HEPATITIS-C VIRUS; BLEEDING DISORDERS; INSULIN-RESISTANCE;
   DIABETES-MELLITUS; NATURAL-HISTORY; FACTOR-VIII; INFECTION; MORTALITY;
   HCV; COHORT
AB Chronic liver disease (CLD) is frequently seen in the hemophilia population. The ADVANCE Working Group conducted a cross-sectional study in which people with hemophilia (PWH) aged >= 40 years were included. This study aimed to assess the associations between CLD and its risk factors using data from the H3 study, and to suggest implications for optimal care.
   Data from 13 European countries were collected at a single time-point (2011-2013). Univariate and multivariate logistic regression (MLR) analyses were performed.
   A total of 532 PWH were included with either hemophilia A (n=467) or hemophilia B(n=65). A total of 127 (24%) were diagnosed with CLD. Hepatitis C virus (HCV), human immunodeficiency virus (HIV), total cholesterol, and severe hemophilia were significant risk factors in univariate logistic regressions. In MLR, HCV Ab+/PCR+ (OR=17.6, P<.001), diabetes (OR=3.0, P=.02), and HIV (OR=1.9, P=.049) were positively associated with CLD. Total cholesterol (OR=0.6, P=.002) was negatively associated with CLD. We found no evidence of interaction effects among the explanatory variables. No significant associations with age and type of or severity of hemophilia were observed in MLR.
   The main risk factors for CLD in this European cohort also apply to the general population, but the prevalence of HCV and HIV is considerably larger in this cohort. With new and improved treatment options, intensified eradication therapy for HCV seems justified to prevent CLD. Similarly, intensified monitoring and treatment of diabetes seem warranted.
C1 [Qvigstad, Christian; Holme, Pal Andre] Oslo Univ Hosp, Dept Haematol, Oslo, Norway.
   [Qvigstad, Christian; Holme, Pal Andre] Univ Oslo, Inst Clin Med, Oslo, Norway.
   [Tait, Robert Campbell] Royal Infirm, Glasgow, Lanark, Scotland.
   [Rauchensteiner, Stephan] Bayer Healthcare, Berlin, Germany.
   [Berntorp, Erik] Lund Univ, Malmo, Sweden.
   [de Moerloose, Philippe] Univ Hosp, Geneva, Switzerland.
   [de Moerloose, Philippe] Fac Med Geneva, Geneva, Switzerland.
   [Schutgens, Roger E.] Univ Med Ctr Utrecht, Dept Hematol Van Creveldklin, Utrecht, Netherlands.
C3 University of Oslo; University of Oslo; Royal Infirmary of Edinburgh;
   Bayer AG; Bayer Healthcare Pharmaceuticals; Lund University; University
   of Geneva; University of Geneva; Utrecht University; Utrecht University
   Medical Center
RP Qvigstad, C (corresponding author), Oslo Univ Hosp, Dept Haematol, Rikshosp, POB 4950 Nydalen, NO-0424 Oslo, Norway.
EM Christian.Qvigstad@medisin.uio.no
RI Tait, Robert/AAC-6541-2022; Qvigstad, Christian/AAA-4738-2022; Tait,
   Campbell/AFQ-8204-2022
OI Tait, Robert/0000-0003-4842-6783; Qvigstad,
   Christian/0000-0003-1419-6465; Tait, Campbell/0000-0003-4842-6783;
   Schutgens, Roger/0000-0002-2762-6033
FU Bayer Healthcare
FX The ADVANCE Working Group is supported by grant funding from Bayer
   Healthcare. The sponsor played no role in data collection, but was
   present in meetings and discussions related to the study. SR is an
   employee of Bayer Consumer Care AG.
CR [Anonymous], R LANG ENV STAT COMP
   Arnold DM, 2006, BLOOD, V108, P460, DOI 10.1182/blood-2005-11-4407
   Carr A, 2000, LANCET, V356, P1423, DOI 10.1016/S0140-6736(00)02854-3
   Coppola A, 2013, SEMIN THROMB HEMOST, V39, P803, DOI 10.1055/s-0033-1354421
   Dai CY, 2008, J HEPATOL, V49, P9, DOI 10.1016/j.jhep.2008.03.016
   Darby SC, 1997, LANCET, V350, P1425, DOI 10.1016/S0140-6736(97)05413-5
   Eyster ME, 2016, AM J HEMATOL, V91
   Fartoux L, 2005, GUT, V54, P1003, DOI 10.1136/gut.2004.050302
   Felmlee DJ, 2013, VIRUSES-BASEL, V5, P1292, DOI 10.3390/v5051292
   FLETCHER ML, 1983, BRIT MED J, V287, P1754, DOI 10.1136/bmj.287.6407.1754
   García-Compeán D, 2016, DIGEST DIS SCI, V61, P371, DOI 10.1007/s10620-015-3907-2
   Goedert JJ, 2002, BLOOD, V100, P1584
   Goehringer F, 2017, AIDS RES HUM RETROV, V33, P187, DOI [10.1089/aid.2016.0222, 10.1089/AID.2016.0222]
   Holme PA, 2016, HAEMOPHILIA, V22, P248, DOI 10.1111/hae.12847
   Hosmer DW, 1997, STAT MED, V16, P965
   Hui JM, 2003, GASTROENTEROLOGY, V125, P1695, DOI 10.1053/j.gastro.2003.08.032
   Kovari H, 2017, CLIN INFECT DIS, V64, P490, DOI 10.1093/cid/ciw809
   Maasoumy B, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2015.02.010
   Mazepa MA, 2016, BLOOD, V127, P3073, DOI 10.1182/blood-2015-10-675140
   Mocroft A, 2005, AIDS, V19, P2117, DOI 10.1097/01.aids.0000194799.43799.ea
   Morlat P, 2014, AIDS, V28, P1181, DOI 10.1097/QAD.0000000000000222
   Naggie S, 2015, NEW ENGL J MED, V373, P705, DOI 10.1056/NEJMoa1501315
   Negro F, 2014, J HEPATOL, V61, pS69, DOI 10.1016/j.jhep.2014.08.003
   Negro F, 2010, GUT, V59, P1279, DOI 10.1136/gut.2009.192732
   Popescu CI, 2010, BIOL CELL, V102, P63, DOI 10.1042/BC20090125
   Posthouwer D, 2007, BLOOD, V109, P3667, DOI 10.1182/blood-2006-08-038349
   Ragni MV, 2001, J INFECT DIS, V183, P1112, DOI 10.1086/319273
   Ryom L, 2016, AIDS, V30, P1731, DOI 10.1097/QAD.0000000000001018
   SCHIMPF K, 1987, NEW ENGL J MED, V316, P918, DOI 10.1056/NEJM198704093161505
   Stepanova M, 2010, GUT, V59, P1410, DOI 10.1136/gut.2010.213553
   Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218
   van de Putte DEF, 2013, THROMB HAEMOSTASIS, V109, P16, DOI 10.1160/TH12-05-0332
   van de Putte DEF, 2014, J HEPATOL, V60, P39, DOI 10.1016/j.jhep.2013.08.010
   van der Helm J, 2013, GASTROENTEROLOGY, V144, P751, DOI 10.1053/j.gastro.2012.12.026
   Vanni E, 2016, DIGEST LIVER DIS, V48, P105, DOI 10.1016/j.dld.2015.10.016
   Walsh CE, 2017, HAEMOPHILIA, V23, P198, DOI 10.1111/hae.13178
   Westbrook RH, 2014, J HEPATOL, V61, pS58, DOI 10.1016/j.jhep.2014.07.012
   White DL, 2008, J HEPATOL, V49, P831, DOI 10.1016/j.jhep.2008.08.006
   Yee TT, 2000, GUT, V47, P845, DOI 10.1136/gut.47.6.845
NR 39
TC 10
Z9 10
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0025-7974
EI 1536-5964
J9 MEDICINE
JI Medicine (Baltimore)
PD SEP
PY 2018
VL 97
IS 39
AR e12551
DI 10.1097/MD.0000000000012551
PG 7
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA GZ4NQ
UT WOS:000449373500075
PM 30278553
OA Green Published, gold, Green Accepted
DA 2024-02-19
ER

PT J
AU Andrawus, M
   Sharvit, L
   Touitou, N
   Lerrer, B
   Cohen, HY
   Atzmon, G
AF Andrawus, Mariana
   Sharvit, Lital
   Touitou, Noga
   Lerrer, Batia
   Cohen, Haim Y.
   Atzmon, Gil
TI Copy number variation as a tool for implementing pregnancy as an aging
   model
SO AGING-US
LA English
DT Article
DE aging; pregnancy; copy number variation; gene expression
ID GENETICS; DISEASE
AB Copy number variations (CNV) are a major contributor to genome variability and have been linked to aging and other degradable phenotypes such as pregnancy physiology. To demonstrate how pregnancy can be used as a model of aging, we used CNVs from pregnant mice. Candidate CNVs were selected by applying case-control analysis in human centenarians compared with control groups. These CNVs were aligned with the mouse genome and their copy variation was assessed using qRT-PCR in liver and blood tissue samples from pregnant mice throughout pregnancy (baseline; first, second, and third trimester; post-partum). Eight of the ten selected CNVs demonstrated a significant decline/increase trend throughout the pregnancy followed by opposite direction soon after delivery in the liver and blood of the mouse tissues. Furthermore, significant differential expression was detected among the candidate CNVs' close vicinity genes (APA2A, LSS, RBDHF1, PLAAT1, and SCL17A2), but not in the WSCD2 gene. Establishing a genetic link between longevity and pregnancy is a significant step toward implementing the pregnancy process as a model for aging. These results in pregnant mice highlight the mechanism and similarities between pregnancy and aging. Investigating the mechanisms that cause such rejuvenation after labor could change our aging treatment paradigm.
C1 [Andrawus, Mariana; Sharvit, Lital; Atzmon, Gil] Univ Haifa, Dept Human Biol, IL-3498838 Haifa, Israel.
   [Touitou, Noga; Lerrer, Batia; Cohen, Haim Y.] Bar Ilan Univ, Fac Life Sci, IL-5290002 Ramat Gan, Israel.
C3 University of Haifa; Bar Ilan University
RP Atzmon, G (corresponding author), Univ Haifa, Dept Human Biol, IL-3498838 Haifa, Israel.
EM gatzmon@univ.haifa.ac.il
RI atzmon, gil/N-3967-2017
OI atzmon, gil/0000-0001-6895-3607
FU Israel Science Foundation (ISF) [193/16]
FX We gratefully acknowledge the following: The Israel Science Foundation
   (ISF) personal grant (193/16). And a gift from Prof. Rajat Singh at
   David Geffen School of Medicine at UCLA.
CR Abyzov A, 2012, NATURE, V492, P438, DOI 10.1038/nature11629
   Bassett AS, 2010, AM J PSYCHIAT, V167, P899, DOI 10.1176/appi.ajp.2009.09071016
   Bjelica A, 2018, GINEKOL POL, V89, P102, DOI 10.5603/GP.a2018.0017
   Blaydon DC, 2012, AM J HUM GENET, V90, P340, DOI 10.1016/j.ajhg.2011.12.008
   Brown TC, 2016, SURGERY, V159, P250, DOI 10.1016/j.surg.2015.08.038
   Buizer-Voskamp JE, 2013, HUM GENET, V132, P443, DOI 10.1007/s00439-012-1261-4
   Bushel PR, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-05148-4
   Casamassa A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21051860
   Chen JA, 2015, ANNU REV PATHOL-MECH, V10, P111, DOI 10.1146/annurev-pathol-012414-040405
   Fan L, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.545856
   Gao C, 2017, GENET EPIDEMIOL, V41, P353, DOI 10.1002/gepi.22042
   Giller A, 2020, AGEING RES REV, V62, DOI 10.1016/j.arr.2020.101093
   Hannibal RL, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004290
   Kasak L, 2017, SCI REP-UK, V7, DOI 10.1038/srep45327
   Kasak L, 2015, SCI REP-UK, V5, DOI 10.1038/srep08342
   Lee JH, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0113-2
   Nelson PT, 2020, J NEUROPATH EXP NEUR, V79, P568, DOI 10.1093/jnen/nlaa024
   O'Huallachain M, 2012, P NATL ACAD SCI USA, V109, P18018, DOI 10.1073/pnas.1213736109
   Peng XM, 2018, FASEB J, V32, P5577, DOI 10.1096/fj.201800016R
   Pös O, 2021, BIOMED J, V44, P548, DOI 10.1016/j.bj.2021.02.003
   Pu JT, 2023, CARCINOGENESIS, V44, P143, DOI 10.1093/carcin/bgac098
   Raj T, 2018, NAT GENET, V50, P1584, DOI 10.1038/s41588-018-0238-1
   Sheng YR, 2021, GENES-BASEL, V12, DOI 10.3390/genes12020141
   Smeester L, 2011, CHEM RES TOXICOL, V24, P165, DOI 10.1021/tx1004419
   Taneera J, 2015, HUM MOL GENET, V24, P1945, DOI 10.1093/hmg/ddu610
   Wang J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26555-6
   Wu P, 2018, EPIGENETICS-US, V13, P122, DOI 10.1080/15592294.2016.1166321
   Yan J, 2018, J MATERN-FETAL NEO M, V31, P2115, DOI 10.1080/14767058.2017.1336225
   Yanai H, 2015, AGING-US, V7, P167, DOI 10.18632/aging.100726
   Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217
   Zou HF, 2009, FASEB J, V23, P425, DOI 10.1096/fj.08-112771
NR 31
TC 0
Z9 0
U1 0
U2 0
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD AUG 30
PY 2023
VL 15
IS 16
BP 7922
EP 7932
PG 11
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA R9TT5
UT WOS:001067709900005
PM 37639552
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Hashimoto, M
   Shahdat, MH
   Shimada, T
   Yamasaki, H
   Fujii, Y
   Ishibashi, Y
   Shido, O
AF Hashimoto, M
   Shahdat, MH
   Shimada, T
   Yamasaki, H
   Fujii, Y
   Ishibashi, Y
   Shido, O
TI Relationship between age-related increases in rat liver lipid
   peroxidation and bile canalicular plasma membrane fluidity
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE aging; canalicular plasma membrane; membrane fluidity; lipid
   peroxidation; antioxidant; rats
ID DOCOSAHEXAENOIC ACID; ANTIOXIDANT ENZYMES; GLUTATHIONE; BRAIN; BETA;
   FLOW
AB Aging is associated with increased cellular levels of lipid peroxides and reactive oxygen species. This increase in the radical species may affect membrane fluidity and consequently membrane functions. We attempted to determine whether age-related increases in lipid peroxide and reactive oxygen species levels affect the annular fluidity of the bile canalicular plasma membrane in young (2-3 weeks old), adult (20 weeks old) and old (100 weeks old) rats. Hepatic levels of lipid peroxides measured with thiobarbituric acid reactive substances (TBARS), reactive oxygen species and reduced glutathione were significantly higher in the old rats than in the young and adult rats. Arachidonic acid (AA) levels increased and docosahexaenoic acid (DHA) levels decreased in the isolated canalicular plasma membrane of the old rats, and the ratio of DHA to AA thus decreased significantly with rat aging. Hepatic TBARS levels correlated negatively with molar ratios of DHA to AA. The annular fluidity of the bile canalicular plasma membrane decreased significantly in the old rats compared with that in the young and adult rats. These results suggest that the age-related decrease in DHA content of the bile canalicular plasma membrane and the molar ratio of DHA to AA may be associated with age-related deterioration of membrane annular fluidity. (C) 2001 Elsevier Science Inc. All rights reserved.
C1 Shimane Med Univ, Dept Physiol, Dept Internal Med 4, Izumo, Shimane 6938501, Japan.
C3 Shimane University
RP Hashimoto, M (corresponding author), Shimane Med Univ, Dept Physiol, Dept Internal Med 4, Izumo, Shimane 6938501, Japan.
EM michio1@shimane-med.ac.jp
RI Hossain, Shahdat/ABI-8106-2020; Hossain, Md. Shahdat/AAC-3851-2022;
   Hossain, Shahdat/K-9725-2013
OI Hossain, Md. Shahdat/0000-0003-2970-2324; Hossain,
   Shahdat/0000-0003-2970-2324
CR Avdulov NA, 1997, J NEUROCHEM, V68, P2086
   BALLATORI N, 1992, AM J PHYSIOL, V263, pG617, DOI 10.1152/ajpgi.1992.263.5.G617
   BASS DA, 1983, J IMMUNOL, V130, P1910
   BENEDETTI A, 1988, BIOCHEM BIOPH RES CO, V156, P840, DOI 10.1016/S0006-291X(88)80920-3
   BONDY SC, 1994, ALCOHOL ALCOHOLISM, V29, P375
   Bouchard G, 1998, J GERONTOL A-BIOL, V53, pB340, DOI 10.1093/gerona/53A.5.B340
   BUCZYNSKI A, 1993, ATHEROSCLEROSIS, V100, P223, DOI 10.1016/0021-9150(93)90208-C
   CATHCART R, 1983, ANAL BIOCHEM, V134, P111, DOI 10.1016/0003-2697(83)90270-1
   COLLES S, 1995, BIOCHEMISTRY-US, V34, P5945, DOI 10.1021/bi00017a024
   DAVIS RA, 1978, P NATL ACAD SCI USA, V75, P4130, DOI 10.1073/pnas.75.9.4130
   DogruAbbasoglu S, 1997, MECH AGEING DEV, V98, P177, DOI 10.1016/S0047-6374(97)00082-1
   DUYSTER J, 1993, BIOCHEM J, V292, P203, DOI 10.1042/bj2920203
   Fleuranceau-Morel P, 1999, NEUROSCI LETT, V277, P91, DOI 10.1016/S0304-3940(99)00652-7
   Galán AI, 1999, J PHARMACOL EXP THER, V290, P774
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   Hashimoto M, 1999, EXP GERONTOL, V34, P687, DOI 10.1016/S0531-5565(99)00025-X
   Hashimoto M, 1999, LIPIDS, V34, P1297, DOI 10.1007/s11745-999-0481-6
   HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2
   Hossain MS, 1999, J NEUROCHEM, V72, P1133, DOI 10.1046/j.1471-4159.1999.0721133.x
   Hossain MS, 1998, LIFE SCI, V64, P135, DOI 10.1016/S0024-3205(98)00543-8
   KEEFFE EB, 1980, GASTROENTEROLOGY, V79, P222
   LAROSE L, 1990, BIOCHEM J, V267, P379, DOI 10.1042/bj2670379
   LENTZ BR, 1976, BIOCHEMISTRY-US, V15, P4529, DOI 10.1021/bi00665a030
   LEPAGE G, 1986, J LIPID RES, V27, P114
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Mason RP, 1999, J BIOL CHEM, V274, P18801, DOI 10.1074/jbc.274.26.18801
   Meier PJ, 2000, NEWS PHYSIOL SCI, V15, P89
   Müller M, 1998, J HEPATOL, V28, P344, DOI 10.1016/0168-8278(88)80024-2
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   OHTA M, 1988, BIOCHEM PHARMACOL, V37, P935
   ROSARIO J, 1988, BIOCHEMISTRY-US, V27, P3939, DOI 10.1021/bi00411a008
   SAITO M, 1994, INT J VITAM NUTR RES, V64, P144
   SALEM N JR, 1988, Advances in Alcohol and Substance Abuse, V7, P183
   Salem N. Jr., 1986, Health effects of polyunsaturated fatty acids in seafoods, P263
   SCHACHTER D, 1984, HEPATOLOGY, V4, P140, DOI 10.1002/hep.1840040124
   SHAN XQ, 1990, PHARMACOL THERAPEUT, V47, P61, DOI 10.1016/0163-7258(90)90045-4
   Thomas J.A., 1994, MODERN NUTR HLTH DIS, P501
   VANDERVLIET A, 1992, CHEM-BIOL INTERACT, V85, P95, DOI 10.1016/0009-2797(92)90055-P
   Vittorini S, 1999, J GERONTOL A-BIOL, V54, pB318, DOI 10.1093/gerona/54.8.B318
NR 39
TC 23
Z9 24
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD DEC
PY 2001
VL 37
IS 1
BP 89
EP 97
DI 10.1016/S0531-5565(01)00164-4
PG 9
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 503GU
UT WOS:000172791400010
PM 11738150
DA 2024-02-19
ER

PT J
AU Yao, X
   Wang, AQ
   Gao, B
   Xue, Y
   Zhao, XL
   Wang, XY
   Wang, R
   Zhuang, M
   Wei, CQ
   Cheng, WD
   Zhang, J
   Strappe, P
   Zhou, ZK
AF Yao, Xuan
   Wang, Anqi
   Gao, Bo
   Xue, Yu
   Zhao, Xueling
   Wang, Xuanyu
   Wang, Rui
   Zhuang, Min
   Wei, Changqing
   Cheng, Weidong
   Zhang, Jian
   Strappe, Padraig
   Zhou, Zhongkai
TI Impact of de-branched starch molecules and fatty acid complexes on the
   attenuation of ageing-induced cognitive impairment
SO JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE
LA English
DT Article; Early Access
DE de-branched starch-fatty acid complexes; ageing; gut microbiota; memory
   impairment; antioxidant; transcriptome
AB BACKGROUNDAgeing and associated cognitive impairments are becoming serious issues around the world. In this study, the physiological properties of three kinds of complexes of fatty acid (capric, stearic and oleic acid, respectively) and de-branched starch molecules were investigated via a d-galactose-induced ageing model. This study revealed differences in the regulation of cognitive impairment and brain damage following intervention of different complexes, which might highlight a potent approach for the prevention of this chronic disease. RESULTSData indicated that three complexes improved response time and cognitive function and the bio-parameter markers associated with oxidative stress in ageing rats. Among them, the complexes prepared from de-branched starch-oleic acid showed a greater improvement compared to others. In addition, de-branched starch-capric acid complex showed a higher improvement in the morphology of colon cells and hippocampal neuronal cells. The consumption of de-branched starch-capric acid and -oleic acid complexes generated more short-chain fatty acids in the gut. More importantly, the complexation of de-branched starch with either caprate or stearate enhanced gut Akkermansia. Therefore, it was proposed that the richness in Akkermansia and gut metabolites might be associated with reduced damage of the hippocampal neuronal cells induced by the ageing progress. Moreover, the AMPK (AMP-activated protein kinase) pathway was activated in liver in de-branched starch-capric acid complex diet. In summary, de-branched starch-capric acid complex exhibited a greater effect on the attenuation of ageing-induced cognitive impairment. CONCLUSIONThis study might highlight a new approach for intervening in the cognitive impairment during the ageing progress via a food supply. (c) 2023 Society of Chemical Industry.
C1 [Yao, Xuan; Wang, Anqi; Gao, Bo; Xue, Yu; Zhao, Xueling; Wang, Xuanyu; Wang, Rui; Zhuang, Min; Wei, Changqing; Cheng, Weidong; Zhang, Jian; Zhou, Zhongkai] Shihezi Univ, Key Lab Proc & Qual Safety Control Characterist Ag, Minist Agr & Rural Affairs, Shihezi 832003, Peoples R China.
   [Yao, Xuan; Wang, Anqi; Gao, Bo; Xue, Yu; Zhao, Xueling; Wang, Xuanyu; Wang, Rui; Zhuang, Min; Wei, Changqing; Cheng, Weidong; Zhang, Jian; Strappe, Padraig; Zhou, Zhongkai] Tianjin Univ Sci & Technol, Coll Food Sci & Engn, Tianjin, Peoples R China.
   [Yao, Xuan; Wang, Anqi; Gao, Bo; Xue, Yu; Zhao, Xueling; Wang, Xuanyu; Wang, Rui; Zhuang, Min; Zhou, Zhongkai] Cent Queensland Univ, Sch Med & Appl Sci, Rockhampton, Qld, Australia.
   [Strappe, Padraig] Charles Sturt Univ, Gulbali Inst Agr Water Environm, Wagga Wagga, NSW, Australia.
C3 Shihezi University; Ministry of Agriculture & Rural Affairs; Tianjin
   University Science & Technology; Central Queensland University; Charles
   Sturt University
RP Zhou, ZK (corresponding author), Shihezi Univ, Key Lab Proc & Qual Safety Control Characterist Ag, Minist Agr & Rural Affairs, Shihezi 832003, Peoples R China.
EM zzhou@csu.edu.au
OI WEI, Changqing/0000-0002-3743-7279; Zhou, Zhongkai/0000-0003-1918-413X
FU Natural Science Foundation of Tianjin [20JCZDJC00040]; High-End Foreign
   Expert Introduction Program [G2022034003L]; Major Scientific and
   Technological Innovation Projects [XQZDZX-202006]
FX This work was financially supported by the Natural Science Foundation of
   Tianjin (20JCZDJC00040), High-End Foreign Expert Introduction Program
   (G2022034003L) and Major Scientific and Technological Innovation
   Projects (XQZDZX-202006).
CR Amorim JA, 2022, NAT REV ENDOCRINOL, V18, P243, DOI 10.1038/s41574-021-00626-7
   Arroyo-García LE, 2021, MOL PSYCHIATR, V26, P4784, DOI 10.1038/s41380-020-0809-2
   Chen JB, 2022, ANTIOXIDANTS-BASEL, V11, DOI 10.3390/antiox11051020
   Chen SY, 2022, FOOD FUNCT, V13, P7168, DOI [10.1039/d1fo04418d, 10.1039/D1FO04418D]
   Cruz-Pereira JS, 2020, ANNU REV PSYCHOL, V71, P49, DOI 10.1146/annurev-psych-122216-011613
   De Meo E, 2022, MOL PSYCHIATR, V27, P1010, DOI 10.1038/s41380-021-01345-1
   Fan R, 2022, J NUTR BIOCHEM, V103, DOI 10.1016/j.jnutbio.2022.108959
   Flanagan E, 2020, AGEING RES REV, V62, DOI 10.1016/j.arr.2020.101079
   Ge YC, 2022, BIOCHIMIE, V195, P100, DOI 10.1016/j.biochi.2021.11.008
   Ghosh TS, 2022, NAT REV GASTRO HEPAT, V19, P565, DOI 10.1038/s41575-022-00605-x
   Gutiérrez TJ, 2021, TRENDS FOOD SCI TECH, V109, P711, DOI 10.1016/j.tifs.2021.01.078
   Hassani B, 2022, OXID MED CELL LONGEV, V2022, DOI 10.1155/2022/4201533
   Huang WJ, 2022, NAT REV NEPHROL, V18, P611, DOI 10.1038/s41581-022-00601-z
   Kan XC, 2021, J CELL PHYSIOL, V236, P2684, DOI 10.1002/jcp.30035
   Krishnan S, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-34465-5
   Kumar H, 2022, APPL MICROBIOL BIOT, V106, P4831, DOI 10.1007/s00253-022-12041-7
   Leyane TS, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23137273
   Morais LH, 2021, NAT REV MICROBIOL, V19, P241, DOI 10.1038/s41579-020-00460-0
   Ooi KLM, 2021, NEUROCHEM INT, V149, DOI 10.1016/j.neuint.2021.105143
   Ouyang J, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00645
   Ratsika A, 2023, HEALTH POLICY, V128, DOI 10.1016/j.conb.2022.102652
   Soheili M, 2022, LIFE SCI, V301, DOI 10.1016/j.lfs.2022.120605
   Teratani T, 2020, NATURE, V585, P591, DOI 10.1038/s41586-020-2425-3
   Wang AQ, 2020, J FUNCT FOODS, V73, DOI 10.1016/j.jff.2020.104142
   Wang AQ, 2019, FOOD FUNCT, V10, P7940, DOI [10.1039/C9FO01771B, 10.1039/c9fo01771b]
   Wang R, 2021, FOOD HYDROCOLLOID, V119, DOI 10.1016/j.foodhyd.2021.106833
   Wang SG, 2021, J AGR FOOD CHEM, V69, P2773, DOI 10.1021/acs.jafc.0c07798
   Wu ML, 2021, BEHAV BRAIN RES, V402, DOI 10.1016/j.bbr.2021.113125
   Zhang TY, 2020, J ALZHEIMERS DIS, V78, P887, DOI 10.3233/JAD-200558
   Zhu XD, 2021, SIGNAL TRANSDUCT TAR, V6, DOI 10.1038/s41392-021-00646-9
NR 30
TC 0
Z9 0
U1 4
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-5142
EI 1097-0010
J9 J SCI FOOD AGR
JI J. Sci. Food Agric.
PD 2023 SEP
PY 2023
VL 103
IS 12
BP 5839
EP 5848
DI 10.1002/jsfa.12679
EA MAY 2023
PG 10
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Agriculture; Chemistry; Food Science & Technology
GA N5ZH5
UT WOS:000992287100001
PM 37127920
DA 2024-02-19
ER

PT J
AU Wilkinson, JE
   Burmeister, L
   Brooks, SV
   Chan, CC
   Friedline, S
   Harrison, DE
   Hejtmancik, JF
   Nadon, N
   Strong, R
   Wood, LK
   Woodward, MA
   Miller, RA
AF Wilkinson, John E.
   Burmeister, Lisa
   Brooks, Susan V.
   Chan, Chi-Chao
   Friedline, Sabrina
   Harrison, David E.
   Hejtmancik, James F.
   Nadon, Nancy
   Strong, Randy
   Wood, Lauren K.
   Woodward, Maria A.
   Miller, Richard A.
TI Rapamycin slows aging in mice
SO AGING CELL
LA English
DT Article
DE interventions; longevity pathology; TOR
ID LIFE-SPAN EXTENSION; AMES DWARF MICE; CELL-CYCLE; TOR; PATHWAY; TARGET;
   CANCER; RESTRICTION; METABOLISM; FERTILITY
AB Rapamycin increases lifespan in mice, but whether this represents merely inhibition of lethal neoplastic diseases, or an overall slowing in multiple aspects of aging is currently unclear. We report here that many forms of age-dependent change, including alterations in heart, liver, adrenal glands, endometrium, and tendon, as well as age-dependent decline in spontaneous activity, occur more slowly in rapamycin-treated mice, suggesting strongly that rapamycin retards multiple aspects of aging in mice, in addition to any beneficial effects it may have on neoplastic disease. We also note, however, that mice treated with rapamycin starting at 9 months of age have significantly higher incidence of testicular degeneration and cataracts; harmful effects of this kind will guide further studies on timing, dosage, and tissue-specific actions of rapamycin relevant to the development of clinically useful inhibitors of TOR action.
C1 [Wilkinson, John E.; Burmeister, Lisa; Friedline, Sabrina; Miller, Richard A.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA.
   [Burmeister, Lisa; Friedline, Sabrina; Miller, Richard A.] Univ Michigan, Geriatr Ctr, Ann Arbor, MI 48109 USA.
   [Wilkinson, John E.] Univ Michigan, Unit Lab Anim Med, Ann Arbor, MI 48109 USA.
   [Brooks, Susan V.; Wood, Lauren K.] Univ Michigan, Dept Mol & Integrat Physiol & Biomed Engn, Ann Arbor, MI 48109 USA.
   [Chan, Chi-Chao] NEI, Histol Core, NIH, Bethesda, MD 20892 USA.
   [Harrison, David E.] Jackson Lab, Bar Harbor, ME 04609 USA.
   [Hejtmancik, James F.] NEI, Ophthalm Genet & Visual Funct Branch, NIH, Bethesda, MD 20892 USA.
   [Nadon, Nancy] NIA, Div Aging Biol, Bethesda, MD 20892 USA.
   [Woodward, Maria A.] Univ Michigan, WK Kellogg Eye Ctr, Dept Ophthalmol, Ann Arbor, MI 48105 USA.
   [Strong, Randy] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA.
   [Strong, Randy] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA.
   [Strong, Randy] S Texas Vet Hlth Care Syst, Res Serv, San Antonio, TX 78229 USA.
   [Strong, Randy] S Texas Vet Hlth Care Syst, Geriatr Res Educ & Clin Ctr, San Antonio, TX 78229 USA.
C3 University of Michigan System; University of Michigan; University of
   Michigan System; University of Michigan; University of Michigan System;
   University of Michigan; University of Michigan System; University of
   Michigan; National Institutes of Health (NIH) - USA; NIH National Eye
   Institute (NEI); Jackson Laboratory; National Institutes of Health (NIH)
   - USA; NIH National Eye Institute (NEI); National Institutes of Health
   (NIH) - USA; NIH National Institute on Aging (NIA); University of
   Michigan System; University of Michigan; University of Texas System;
   University of Texas Health Science Center at San Antonio; University of
   Texas System; University of Texas Health Science Center at San Antonio;
   US Department of Veterans Affairs; Veterans Health Administration (VHA);
   Audie L. Murphy Memorial Veterans Hospital; Geriatric Research Education
   & Clinical Center; US Department of Veterans Affairs; Veterans Health
   Administration (VHA); Audie L. Murphy Memorial Veterans Hospital
RP Miller, RA (corresponding author), Univ Michigan, Dept Pathol, BSRB Room 3001,Box 2200,109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.
EM millerr@umich.edu
RI Wilkinson, John/JTV-0835-2023
OI Woodward, Maria/0000-0001-7060-9004; Zaseck, Lauren/0000-0002-8604-0032;
   Brooks, Susan/0000-0003-1954-967X
FU  [AG022303];  [AG007996];  [AG013283]
FX This work was supported by grants AG022303, AG007996, and AG013283. We
   thank Vivian Diaz, Lynn Winkleman, and Mike Astle for expert technical
   assistance.
CR Ahuja P, 2007, PHYSIOL REV, V87, P521, DOI 10.1152/physrev.00032.2006
   Amador-Noguez D, 2007, AGING CELL, V6, P453, DOI 10.1111/j.1474-9726.2007.00300.x
   Anisimov VN, 2011, CELL CYCLE, V10, P4230, DOI 10.4161/cc.10.24.18486
   Anisimov VN, 2010, AM J PATHOL, V176, P2092, DOI 10.2353/ajpath.2010.091050
   Blagosklonny MV, 2006, CELL CYCLE, V5, P2087, DOI 10.4161/cc.5.18.3288
   Caccamo A, 2010, J BIOL CHEM, V285, P13107, DOI 10.1074/jbc.M110.100420
   Chen C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000559
   CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112
   Davis B. J., 1999, PATHOLOGY MOUSE, P409
   Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898
   Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221
   Hidalgo M, 2000, ONCOGENE, V19, P6680, DOI 10.1038/sj.onc.1204091
   Ikeno Y, 2003, J GERONTOL A-BIOL, V58, P291
   Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255
   Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535
   Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059
   Kinney BA, 2001, PHYSIOL BEHAV, V72, P653, DOI 10.1016/S0031-9384(01)00423-1
   Kinney BA, 2001, HORM BEHAV, V39, P277, DOI 10.1006/hbeh.2001.1654
   Liu HL, 2010, MOL VIS, V16, P1646
   Miller RA, 2011, J GERONTOL A-BIOL, V66, P191, DOI 10.1093/gerona/glq178
   Mohr U, 1996, PATHOBIOLOGY AGEING
   Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406
   RADOVSKY A, 1999, PATHOLOGY MOUSE, P381
   Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221
   Sharp ZD, 2005, J GERONTOL A-BIOL, V60, P293, DOI 10.1093/gerona/60.3.293
   Strong R, 2008, AGING CELL, V7, P641, DOI 10.1111/j.1474-9726.2008.00414.x
   Sun L, 2009, J GERONTOL A-BIOL, V64, P711, DOI 10.1093/gerona/glp051
   Thoolen B, 2010, TOXICOL PATHOL, V38, p5S, DOI 10.1177/0192623310386499
   Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a
   Vergara M, 2004, J GERONTOL A-BIOL, V59, P1244, DOI 10.1093/gerona/59.12.1244
   Wang ZY, 2011, J HUAZHONG U SCI-MED, V31, P555, DOI 10.1007/s11596-011-0489-x
   Weindruch R, 1997, NEW ENGL J MED, V337, P986, DOI 10.1056/NEJM199710023371407
   WEINDRUCH R, 1986, J NUTR, V116, P641, DOI 10.1093/jn/116.4.641
   Wood LK, 2011, J APPL PHYSIOL, V111, P999, DOI 10.1152/japplphysiol.00460.2011
   Zuber J, 2008, AM J TRANSPLANT, V8, P1471, DOI 10.1111/j.1600-6143.2008.02267.x
NR 35
TC 479
Z9 558
U1 3
U2 69
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD AUG
PY 2012
VL 11
IS 4
BP 675
EP 682
DI 10.1111/j.1474-9726.2012.00832.x
PG 8
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 973ZY
UT WOS:000306400600014
PM 22587563
OA Green Submitted, Green Accepted, hybrid
DA 2024-02-19
ER

PT J
AU Sastre, J
   Millan, A
   delaAsuncion, JG
   Pla, R
   Juan, G
   Pallardo, FV
   OConnor, E
   Martin, JA
   DroyLefaix, MT
   Vina, J
AF Sastre, J
   Millan, A
   delaAsuncion, JG
   Pla, R
   Juan, G
   Pallardo, FV
   OConnor, E
   Martin, JA
   DroyLefaix, MT
   Vina, J
TI A Ginkgo biloba extract (EGb 761) prevents mitochondrial aging by
   protecting against oxidative stress
SO FREE RADICAL BIOLOGY AND MEDICINE
LA English
DT Article
DE Ginkgo biloba extract; EGb 761; mitochondrial aging; DNA oxidative
   damage; glutathione oxidation
ID RAT-LIVER MITOCHONDRIA; DEGENERATIVE DISEASES; DNA; AGE; DAMAGE;
   GLUTATHIONE; TRANSITION; EVOLUTION; ENZYMES; CELLS
AB The effect of aging on indices of oxidative damage in rat mitochondria and the protective effect of the Ginkgo biloba extract EGb 761 was investigated. Mitochondrial DNA from brain and liver of old rats exhibited oxidative damage that is significantly higher than that from young rats. Mitochondrial glutathione is also more oxidized In old than in young rats, Peroxide formation in mitochondria from old animals was higher than in those from young ones, According to morphological parameters (size and complexity), there are two populations of mitochondria. One is composed of large, highly complex mitochondria, and the other population is smaller and less complex. Brain and liver from old animals had a higher proportion of the large. highly complex mitochondria than from young animals, Treatment with the Ginkgo biloba extract EGb 761 partially prevented these morphological changes as well as the indices of oxidative damage observed in brain and Liver mitochondria from old animals. (C) 1998 Elsevier Science Inc.
C1 UNIV VALENCIA,FAC MED,DEPT BIOQUIM,VALENCIA 46010,SPAIN.
   IPSEN,F-75016 PARIS,FRANCE.
C3 University of Valencia
RP Sastre, J (corresponding author), UNIV VALENCIA,FAC MED,DEPT FISIOL,AVDA BLASCO IBANEZ 17,VALENCIA 46010,SPAIN.
RI Vina, Jose/AAB-3069-2021; Pallardo, Federico V./T-1156-2017
OI Vina, Jose/0000-0001-9709-0089; Pallardo, Federico
   V./0000-0003-3715-1980; Sastre, Juan/0000-0002-4260-6604
CR AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   ASENSI M, 1994, ANAL BIOCHEM, V217, P323, DOI 10.1006/abio.1994.1126
   BEAL MF, 1993, TRENDS NEUROSCI, V16, P125, DOI 10.1016/0166-2236(93)90117-5
   BENZI G, 1995, FREE RADICAL BIO MED, V19, P77, DOI 10.1016/0891-5849(94)00244-E
   BRIGELIUS R, 1983, BIOCHEM PHARMACOL, V32, P2526
   BROWN MA, 1988, ARCH BIOCHEM BIOPHYS, V260, P798, DOI 10.1016/0003-9861(88)90510-3
   CHEN LB, 1988, ANNU REV CELL BIOL, V4, P155, DOI 10.1146/annurev.cellbio.4.1.155
   CORBISIER P, 1990, MECH AGEING DEV, V51, P249, DOI 10.1016/0047-6374(90)90075-Q
   DeLaAsuncion JG, 1996, FASEB J, V10, P333, DOI 10.1096/fasebj.10.2.8641567
   DELACRUZ J, 1990, INT J BIOCHEM, V22, P729, DOI 10.1016/0020-711X(90)90008-Q
   DRIEU K, 1986, PRESSE MED, V15, P1455
   EMAUS RK, 1986, BIOCHIM BIOPHYS ACTA, V850, P436, DOI 10.1016/0005-2728(86)90112-X
   GARDESALBERT M, 1993, ADV GINKGO, V2, P1
   HANSFORD RG, 1978, BIOCHEM J, V170, P285, DOI 10.1042/bj1700285
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HAYAKAWA M, 1991, BIOCHEM BIOPH RES CO, V179, P1023, DOI 10.1016/0006-291X(91)91921-X
   JOHNS DR, 1995, NEW ENGL J MED, V333, P638, DOI 10.1056/NEJM199509073331007
   LATORRE A, 1986, P NATL ACAD SCI USA, V83, P8649, DOI 10.1073/pnas.83.22.8649
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MARCOCCI L, 1994, METHOD ENZYMOL, V234, P462
   MECOCCI P, 1993, ANN NEUROL, V34, P609, DOI 10.1002/ana.410340416
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   MIQUEL J, 1986, FREE RADICALS AGING, V8, P51
   PETIT PX, 1990, EUR J BIOCHEM, V194, P389, DOI 10.1111/j.1432-1033.1990.tb15632.x
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   Rickwood D., 1987, Mitochondria: a pratical approach, P1
   ROYALL JA, 1993, ARCH BIOCHEM BIOPHYS, V302, P348, DOI 10.1006/abbi.1993.1222
   SAIJA A, 1995, FREE RADICAL BIO MED, V19, P481, DOI 10.1016/0891-5849(94)00240-K
   Sastre J, 1996, HEPATOLOGY, V24, P1199, DOI 10.1002/hep.510240536
   SCALETTAR BA, 1991, P NATL ACAD SCI USA, V88, P8057, DOI 10.1073/pnas.88.18.8057
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   SOHAL RS, 1991, MECH AGEING DEV, V60, P189, DOI 10.1016/0047-6374(91)90130-R
   SOHAL RS, 1990, FREE RADICAL BIO MED, V9, P495, DOI 10.1016/0891-5849(90)90127-5
   SOTTOCASA GL, 1967, J CELL BIOL, V32, P415, DOI 10.1083/jcb.32.2.415
   TAKEYAMA N, 1993, BIOCHEM J, V294, P719, DOI 10.1042/bj2940719
   TROUNCE I, 1989, LANCET, P637
   TUMMINO PJ, 1991, MECH AGEING DEV, V59, P177, DOI 10.1016/0047-6374(91)90083-C
   WALLACE DC, 1994, P NATL ACAD SCI USA, V91, P8739, DOI 10.1073/pnas.91.19.8739
   YEN TC, 1989, BIOCHEM BIOPH RES CO, V165, P994, DOI 10.1016/0006-291X(89)92701-0
NR 40
TC 169
Z9 187
U1 0
U2 12
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0891-5849
J9 FREE RADICAL BIO MED
JI Free Radic. Biol. Med.
PD JAN 15
PY 1998
VL 24
IS 2
BP 298
EP 304
DI 10.1016/S0891-5849(97)00228-1
PG 7
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA YL368
UT WOS:A1998YL36800012
PM 9433905
DA 2024-02-19
ER

PT J
AU Ge, QF
   Yang, B
   Liu, R
   Jiang, DL
   Yu, H
   Wu, MG
   Zhang, WG
AF Ge, Qingfeng
   Yang, Bo
   Liu, Rui
   Jiang, Donglei
   Yu, Hai
   Wu, Mangang
   Zhang, Wangang
TI Antioxidant activity of <i>Lactobacillus plantarum</i> NJAU-01 in an
   animal model of aging
SO BMC MICROBIOLOGY
LA English
DT Article
DE Lactobacillus plantarum NJAU-01; Jinhua Ham; D-galactose-induced aging
   animal; Malondialdehyde; Antioxidant capacity
ID LACTIC-ACID BACTERIA; OXIDATIVE STRESS; IN-VITRO; MICE; PATHWAY; DAMAGE;
   BRAIN; MILK; RATS
AB Background Excessive reactive oxygen species (ROS) can cause serious damage to the human body and may cause various chronic diseases. Studies have found that lactic acid bacteria (LAB) have antioxidant and anti-aging effects, and are important resources for the development of microbial antioxidants. This paper was to explore the potential role of an antioxidant strain, Lactobacillus plantarum NJAU-01 screened from traditional dry-cured meat product Jinhua Ham in regulating D-galactose-induced subacute senescence of mice. A total of 48 specific pathogen free Kun Ming mice (SPF KM mice) were randomly allocated into 6 groups: control group with sterile saline injection, aging group with subcutaneously injection of D-galactose, treatments groups with injection of D-galactose and intragastric administration of 10(7), 10(8), and 10(9) CFU/mL L. plantarum NJAU-01, and positive control group with injection of D-galactose and intragastric administration of 1 mg/mL Vitamin C. Results The results showed that the treatment group of L. plantarum NJAU-01 at 10(9) CFU/mL showed higher total antioxidant capacity (T-AOC) and the antioxidant enzymatic activities of superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), and catalase (CAT) than those of the other groups in serum, heart and liver. In contrast, the content of the oxidative stress marker malondialdehyde (MDA) showed lower levels than the other groups (P < 0.05). The antioxidant capacity was improved with the supplement of the increasing concentration of L. plantarum NJAU-01. Conclusions Thus, this study demonstrates that L. plantarum NJAU-01 can alleviate oxidative stress by increasing the activities of enzymes involved in oxidation resistance and decreasing level of lipid oxidation in mice.
C1 [Ge, Qingfeng; Yang, Bo; Liu, Rui; Yu, Hai; Wu, Mangang] Yangzhou Univ, Sch Food Sci & Engn, Ind Engn Ctr Huaiyang Cuisine Jiangsu Prov, Yangzhou 225127, Jiangsu, Peoples R China.
   [Ge, Qingfeng; Liu, Rui; Zhang, Wangang] Nanjing Agr Univ, Key Lab Meat Proc & Qual Control, Jiangsu Collaborat Innovat Ctr Meat Prod & Proc, Coll Food Sci & Technol,Minist Educ, Nanjing 210095, Jiangsu, Peoples R China.
   [Jiang, Donglei] Nanjing Univ Finance & Econ, Coll Food Sci & Engn, Collaborat Innovat Ctr Modern Grain Circulat & Sa, Key Lab Grains & Oils Qual Control & Proc, Nanjing 210023, Jiangsu, Peoples R China.
C3 Yangzhou University; Nanjing Agricultural University; Nanjing University
   of Finance & Economics
RP Zhang, WG (corresponding author), Nanjing Agr Univ, Key Lab Meat Proc & Qual Control, Jiangsu Collaborat Innovat Ctr Meat Prod & Proc, Coll Food Sci & Technol,Minist Educ, Nanjing 210095, Jiangsu, Peoples R China.
EM wangang.zhang@yahoo.com
RI Wu, M./J-1663-2019
FU Jiangsu Agriculture Science and Technology Innovation Fund (JASTIF) [CX
   (18)1006, CX (19)2018]; Natural Science Foundation of Jiangsu Province
   [BK20190888]; National Natural Science Foundation of China [31901610]
FX This work has been supported by Jiangsu Agriculture Science and
   Technology Innovation Fund (JASTIF), CX (18)1006, CX (19)2018), Natural
   Science Foundation of Jiangsu Province (BK20190888) and National Natural
   Science Foundation of China (No. 31901610). The funder had no role in
   study design, data collection and analysis, interpretation of data, and
   in writing the manuscript.
CR Antonio JE, 2006, J ENZYME INHIBITION, V2, P231, DOI [10.2174/157340806777934793, DOI 10.2174/157340806777934793]
   Cao CC, 2019, CYTA-J FOOD, V17, P347, DOI 10.1080/19476337.2019.1583687
   Chen L., 2020, J YANGZHOU U, V41, P37, DOI [10.16872/j.cnki.1671-4652.2020.01.007, DOI 10.16872/J.CNKI.1671-4652.2020.01.007]
   Chen ZQ, 2020, FOOD FUNCT, V11, P8099, DOI 10.1039/d0fo01663b
   Danková M, 2019, EUR J HISTOCHEM, V63, P197, DOI 10.4081/ejh.2019.3045
   Dey A, 2013, FOOD FUNCT, V4, P1148, DOI 10.1039/c3fo30317a
   Ding WR, 2017, J FUNCT FOODS, V35, P481, DOI 10.1016/j.jff.2017.06.008
   Ge QF, 2019, FOOD CHEM, V295, P361, DOI 10.1016/j.foodchem.2019.05.154
   Ge QF, 2018, BIOSENS BIOELECTRON, V99, P555, DOI 10.1016/j.bios.2017.08.037
   Hadzi-Petrushev N, 2015, PHYSIOL RES, V64, P61, DOI 10.33549/physiolres.932786
   Ho SC, 2003, BIOGERONTOLOGY, V4, P15, DOI 10.1023/A:1022417102206
   Hsieh CL, 2015, RSC ADV, V5, P30342, DOI 10.1039/c4ra15438j
   Kullisaar T, 2003, BRIT J NUTR, V90, P449, DOI 10.1079/BJN2003896
   Lee J, 2005, J FOOD SCI, V70, pM388, DOI 10.1111/j.1365-2621.2005.tb11524.x
   Li SY, 2012, FOOD CHEM, V135, P1914, DOI 10.1016/j.foodchem.2012.06.048
   Li XR, 2014, MOL BIOSYST, V10, P326, DOI 10.1039/c3mb70373h
   Liguori I., 2018, CLIN INTERV AGING, V13, P757, DOI [10.2147/CIA.S158513, DOI 10.2147/CIA.S158513]
   Limoli CL, 2001, FREE RADICAL BIO MED, V31, P10, DOI 10.1016/S0891-5849(01)00542-1
   Lin XN, 2018, J FOOD SCI, V83, P1990, DOI 10.1111/1750-3841.14200
   Lu J, 2007, BIOCHEM PHARMACOL, V74, P1078, DOI 10.1016/j.bcp.2007.07.007
   Matés JM, 1999, CLIN BIOCHEM, V32, P595, DOI 10.1016/S0009-9120(99)00075-2
   Parameshwaran K, 2010, REJUV RES, V13, P729, DOI 10.1089/rej.2010.1020
   Pessione E, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00876
   Poprac P, 2017, TRENDS PHARMACOL SCI, V38, P592, DOI 10.1016/j.tips.2017.04.005
   Roselló-Soto E, 2015, TRENDS FOOD SCI TECH, V42, P134, DOI 10.1016/j.tifs.2015.01.002
   Saeidnia Soodabeh, 2015, Curr Drug Discov Technol, V12, P218
   Scialò F, 2016, CELL METAB, V23, P725, DOI 10.1016/j.cmet.2016.03.009
   Sharma P, 2005, PLANT GROWTH REGUL, V46, P209, DOI 10.1007/s10725-005-0002-2
   Sies H, 2015, REDOX BIOL, V4, P180, DOI 10.1016/j.redox.2015.01.002
   Smith MA, 2000, BBA-MOL BASIS DIS, V1502, P139, DOI 10.1016/S0925-4439(00)00040-5
   Song X, 1999, MECH AGEING DEV, V108, P239, DOI 10.1016/S0047-6374(99)00022-6
   Tang W, 2017, FOOD CHEM, V221, P1642, DOI 10.1016/j.foodchem.2016.10.124
   Wang AN, 2009, J APPL MICROBIOL, V107, P1140, DOI 10.1111/j.1365-2672.2009.04294.x
   Wang Y, 2017, NUTRIENTS, V9, DOI 10.3390/nu9050521
   Wei HF, 2005, BEHAV BRAIN RES, V157, P245, DOI 10.1016/j.bbr.2004.07.003
   Wickens AP, 2001, RESP PHYSIOL, V128, P379, DOI 10.1016/S0034-5687(01)00313-9
   Xu LQ, 2016, FOOD FUNCT, V7, P4545, DOI 10.1039/c6fo01057a
   Yu XM, 2016, J DAIRY SCI, V99, P903, DOI 10.3168/jds.2015-10265
   Zhao DY, 2016, J NUTR BIOCHEM, V38, P116, DOI 10.1016/j.jnutbio.2016.09.005
NR 39
TC 20
Z9 22
U1 5
U2 44
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2180
J9 BMC MICROBIOL
JI BMC Microbiol.
PD JUN 15
PY 2021
VL 21
IS 1
AR 182
DI 10.1186/s12866-021-02248-5
PG 9
WC Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology
GA SW5YI
UT WOS:000664590700002
PM 34130624
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Bellamy, COC
   Clarke, AR
   Wyllie, AH
   Harrison, DJ
AF Bellamy, COC
   Clarke, AR
   Wyllie, AH
   Harrison, DJ
TI p53 deficiency in liver reduces local control of survival and
   proliferation, but does not affect apoptosis after DNA damage
SO FASEB JOURNAL
LA English
DT Article
DE cell cycle; carcinogenesis; hepatocyte; wild-type cell; liver carcinoma
ID HEPATOCELLULAR-CARCINOMA; P53-DEFICIENT MICE; GAMMA-IRRADIATION;
   IN-VIVO; GROWTH; GENE; RAT; HEPATOCYTES; PROTEIN; HEPATOCARCINOGENESIS
AB Despite good evidence for p53 dysfunction in human hepatocellular carcinomas, little is known of the significance of p53 to normal hepatocytes and whether p53 dysfunction is relevant to early hepatocarcinogenesis. We have therefore examined the consequences of targeted p53 deficiency in hepatocytes for regulation of apoptosis, proliferation, and ploidy. p53 deficiency was silent in normal liver and did not affect progression from diploidy to polyploidy in the aging liver. However, in primary culture the absence of p53 resulted in increased hepatocyte proliferation indices and decreased sensitivity to proliferation inhibition by TGF beta. Moreover, p53-deficient cells continued to survive and proliferate under conditions of minimal trophic support that led to growth arrest and apoptosis of wild-type cells. In vivo, p53-deficient mice had enhanced proliferative responses to both xenobiotic hepatomitogen and CCl4-induced liver necrosis, although lack of persistent proliferation showed that other control mechanisms are important. There was no simple relationship between p53 and apoptosis after DNA damage because UV irradiation led to p53-independent apoptosis, even though p53 was stabilized. However, p53 did couple DNA damage to growth arrest, and abnormal mitoses after gamma-irradiation of regenerating p53 null livers demonstrated circumstances where loss of G(1) and G(2) checkpoints may generate abnormal ploidy. Thus p53 becomes important when hepatocytes are released from G(0) and stressed, sensitizing them to mitogen and cytokine regulators of cell cycle progression and apoptosis. Hence p53 deficiency is likely to be significant in an environment of persistent regenerative stimuli and unfavorable trophic support or in the presence of other enabling genetic lesions. This model is relevant to human hepatocarcinogenesis, which almost always occurs against a background of chronic hepatocellular destruction in hepatitis and cirrhosis. In that context, by reducing the need for cytokine support and disabling DNA damage-induced growth arrest, p53 deficiency should facilitate the expansion of preneoplastic clones in chronic liver disease.
RP Bellamy, COC (corresponding author), UNIV EDINBURGH,SCH MED,DEPT PATHOL,TEVIOT PL,EDINBURGH EH8 9AG,MIDLOTHIAN,SCOTLAND.
RI Clarke, Alan R/A-6256-2008; clarke, alan r/P-2820-2014; Harrison, David
   A/O-4355-2018
OI Harrison, David A/0000-0002-9002-9098; Clarke, Alan/0000-0002-4281-426X;
   harrison, david/0000-0001-9041-9988
CR AGUILAR F, 1994, SCIENCE, V264, P1317, DOI 10.1126/science.8191284
   BELLAMY COC, 1997, IN PRESS APOPTOSIS C
   Brodsky W Y, 1977, Int Rev Cytol, V50, P275
   CATER DB, 1956, ACTA RADIOL, V46, P655, DOI 10.3109/00016925609171460
   CLARKE AR, 1994, ONCOGENE, V9, P1767
   CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0
   DATTO MB, 1995, P NATL ACAD SCI USA, V92, P5545, DOI 10.1073/pnas.92.12.5545
   DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540
   FAUSTO N, 1989, LAB INVEST, V60, P4
   Fausto N, 1986, Symp Fundam Cancer Res, V39, P69
   FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES, P1
   FUKS Z, 1994, CANCER RES, V54, P2582
   GERACI JP, 1994, RADIAT RES, V140, P249, DOI 10.2307/3578909
   GREENBLATT MS, 1994, CANCER RES, V54, P4855
   GUIMARAES JP, 1966, EXPERIENTIA, V22, P661, DOI 10.1007/BF01902428
   HARVEY M, 1993, NAT GENET, V5, P225, DOI 10.1038/ng1193-225
   Hayashi H, 1995, HEPATOLOGY, V22, P1702
   HUANG SN, 1995, HEPATOLOGY, V21, P620, DOI 10.1002/hep.1840210303
   Kaufmann WK, 1996, FASEB J, V10, P238, DOI 10.1096/fasebj.10.2.8641557
   KEMP CJ, 1995, MOL CARCINOGEN, V12, P132, DOI 10.1002/mc.2940120304
   KREAMER BL, 1986, IN VITRO CELL DEV B, V22, P201
   LIANG TJ, 1995, HEPATOLOGY, V22, P1330, DOI 10.1002/hep.1840220445
   LIVNI N, 1995, CANCER, V75, P2420, DOI 10.1002/1097-0142(19950515)75:10<2420::AID-CNCR2820751006>3.0.CO;2-6
   Loyer P, 1996, J BIOL CHEM, V271, P11484, DOI 10.1074/jbc.271.19.11484
   MCWHIR J, 1993, NAT GENET, V5, P217, DOI 10.1038/ng1193-217
   MIDGLEY CA, 1995, J CELL SCI, V108, P1843
   ODA T, 1994, CANCER LETT, V83, P197, DOI 10.1016/0304-3835(94)90319-0
   ODA T, 1992, CANCER RES, V52, P6358
   POLAND A, 1980, MOL PHARMACOL, V18, P571
   Rafferty JA, 1996, ONCOGENE, V12, P693
   RENTON KW, 1978, MOL PHARMACOL, V14, P672
   Romanowski P, 1996, TRENDS CELL BIOL, V6, P184, DOI 10.1016/0962-8924(96)10015-5
   SELL C, 1995, CANCER RES, V55, P303
   SHIMA A, 1985, INT J RADIAT BIOL, V47, P261, DOI 10.1080/09553008514550391
   THOMPSON NL, 1986, CANCER RES, V46, P3111
   TRUANT R, 1995, J VIROL, V69, P1851, DOI 10.1128/JVI.69.3.1851-1859.1995
   TSUJI K, 1994, MOL CARCINOGEN, V9, P167, DOI 10.1002/mc.2940090308
   UEDA H, 1995, NAT GENET, V9, P41, DOI 10.1038/ng0195-41
   VINDELOV LL, 1983, CYTOMETRY, V3, P323, DOI 10.1002/cyto.990030503
   WANG XW, 1994, P NATL ACAD SCI USA, V91, P2230, DOI 10.1073/pnas.91.6.2230
   Wu H, 1996, GENE DEV, V10, P245, DOI 10.1101/gad.10.3.245
   ZHAO M, 1994, VIRCHOWS ARCH, V424, P613, DOI 10.1007/BF01069741
NR 42
TC 71
Z9 72
U1 0
U2 0
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998
SN 0892-6638
J9 FASEB J
JI Faseb J.
PD JUN
PY 1997
VL 11
IS 7
BP 591
EP 599
DI 10.1096/fasebj.11.7.9212083
PG 9
WC Biochemistry & Molecular Biology; Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA XH342
UT WOS:A1997XH34200011
PM 9212083
DA 2024-02-19
ER

PT J
AU Bazwinsky-Wutschke, I
   Zipprich, A
   Dehghani, F
AF Bazwinsky-Wutschke, Ivonne
   Zipprich, Alexander
   Dehghani, Faramarz
TI Daytime-Dependent Changes of Cannabinoid Receptor Type 1 and Type 2
   Expression in Rat Liver
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE endocannabinoid system; diabetes; diurnal rhythmic; hepatic cannabinoid
   receptors; streptozotocin; insulin; aging
ID INDUCED INSULIN-RESISTANCE; ENDOCANNABINOID SYSTEM; CB1 RECEPTOR;
   SIGNAL-TRANSDUCTION; BRAIN; OBESITY; METABOLISM; RHYTHMS; TIME;
   LOCALIZATION
AB The present study was performed to investigate the diurnal expression pattern of cannabinoid receptor type 1 (CB1) and type 2 (CB2) in liver tissue of 12- and 51-week-old normoglycemic Wistar rats. By using real-time RT-PCR, daytime dependent changes in both age groups and, for both, hepatic Cnr1 and Cnr2 receptor mRNA levels were measured. Highest amount of mRNA was detected in the light period (ZT3, ZT6, and ZT9) while the lowest amount was measured in the dark period (ZT18 and ZT21). Diurnal transcript expression pattern was accompanied by comparable changes of protein level for CB1, as shown by Western blotting. The current results support the conclusion that expression pattern of cannabinoid receptors are influenced by light/dark cycle and therefore seems to be under the control of a diurnal rhythm. These findings might explain the differences in the efficacy of cannabinoid receptor agonists or antagonists. In addition, investigation of liver of streptozotocin (STZ)-treated 12- and 51-week-old rats show alterations in the diurnal profile of both receptors Cnr1 and Cnr2 compared to that of normoglycemic Wistar rats. This suggests an influence of diabetic state on diurnal expression levels of cannabinoid receptors.
C1 [Bazwinsky-Wutschke, Ivonne; Dehghani, Faramarz] Martin Luther Univ Halle Wittenberg, Dept Anat & Cell Biol, Grosse Steinstr 52, D-06108 Halle, Saale, Germany.
   [Zipprich, Alexander] Martin Luther Univ Halle Wittenberg, Clin Internal Med 1, Mol Hepatol Lab, Ernst Grube Str 40, D-06120 Halle, Saale, Germany.
C3 Martin Luther University Halle Wittenberg; Martin Luther University
   Halle Wittenberg
RP Bazwinsky-Wutschke, I (corresponding author), Martin Luther Univ Halle Wittenberg, Dept Anat & Cell Biol, Grosse Steinstr 52, D-06108 Halle, Saale, Germany.
EM ivonne.bazwinsky@medizin.uni-halle.de; alexander.zipprich@uk-halle.de;
   faramarz.dehghani@medizin.uni-halle.de
FU Publication Fund of the Martin Luther University
FX The authors thank Candy Rothganger and Sabine Pohl for excellent
   technical help. The publication was supported by the Publication Fund of
   the Martin Luther University.
CR Agius L, 2015, MOL ASPECTS MED, V46, P34, DOI 10.1016/j.mam.2015.09.002
   Agudo J, 2010, DIABETOLOGIA, V53, P2629, DOI 10.1007/s00125-010-1894-6
   ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167
   Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X
   Bátkai S, 2001, NAT MED, V7, P827, DOI 10.1038/89953
   Bermúdez-Silva FJ, 2009, BEST PRACT RES CL EN, V23, P87, DOI 10.1016/j.beem.2008.10.012
   Berrendero F, 1998, DEVELOPMENT, V125, P3179
   BIDAUTRUSSELL M, 1990, J NEUROCHEM, V55, P21, DOI 10.1111/j.1471-4159.1990.tb08815.x
   Blüher M, 2006, DIABETES, V55, P3053, DOI 10.2337/db06-0812
   Buckley NE, 1998, NEUROSCIENCE, V82, P1131
   Burstein S, 2015, BIOORGAN MED CHEM, V23, P1377, DOI 10.1016/j.bmc.2015.01.059
   Chanda D, 2011, J BIOL CHEM, V286, P27971, DOI 10.1074/jbc.M111.224352
   Cooper ME, 2014, BRIT J CLIN PHARMACO, V77, P21, DOI 10.1111/bcp.12102
   Cota D, 2007, DIABETES-METAB RES, V23, P507, DOI 10.1002/dmrr.764
   Dalton GD, 2009, CNS NEUROL DISORD-DR, V8, P422, DOI 10.2174/187152709789824615
   Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500
   de Kloet AD, 2009, ENDOCRINOLOGY, V150, P2531, DOI 10.1210/en.2009-0046
   DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919
   Deveaux V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005844
   Di Marzo V, 2008, DRUG DISCOV TODAY, V13, P1026, DOI 10.1016/j.drudis.2008.09.001
   Díaz-Asensio C, 2008, HORM METAB RES, V40, P454, DOI 10.1055/s-2008-1065323
   Eckel-Mahan K, 2013, PHYSIOL REV, V93, P107, DOI 10.1152/physrev.00016.2012
   FUKUDA H, 1991, BIOCHIM BIOPHYS ACTA, V1086, P261, DOI 10.1016/0005-2760(91)90168-H
   Fukudome Y, 2004, EUR J NEUROSCI, V19, P2682, DOI 10.1111/j.0953-816X.2004.03384.x
   Gatta-Cherifi B, 2016, INT J OBESITY, V40, P210, DOI 10.1038/ijo.2015.179
   Gruden G, 2016, BRIT J PHARMACOL, V173, P1116, DOI 10.1111/bph.13226
   HERKENHAM M, 1991, J NEUROSCI, V11, P563, DOI 10.1523/jneurosci.11-02-00563.1991
   Honma K, 2016, METABOLISM, V65, P482, DOI 10.1016/j.metabol.2015.12.003
   Kallendrusch S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033537
   Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006
   Kunos G, 2008, J BIOL CHEM, V283, P33021, DOI 10.1074/jbc.R800012200
   Kunos G, 2011, BRIT J PHARMACOL, V163, P1423, DOI 10.1111/j.1476-5381.2011.01352.x
   Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105
   Li S, 2015, DIABETES OBES METAB, V17, P33, DOI 10.1111/dom.12520
   Lipina C, 2016, AGING CELL, V15, P325, DOI 10.1111/acel.12438
   Liu J, 2012, GASTROENTEROLOGY, V142, P1218, DOI 10.1053/j.gastro.2012.01.032
   Maccarrone M, 2005, HANDB EXP PHARMACOL, V168, P555
   Maccarrone M, 2015, TRENDS PHARMACOL SCI, V36, P277, DOI 10.1016/j.tips.2015.02.008
   Mallat A, 2013, J HEPATOL, V59, P891, DOI 10.1016/j.jhep.2013.03.032
   Martínez-Vargas M, 2003, NEUROSCIENCE, V117, P197, DOI 10.1016/S0306-4522(02)00820-5
   Massa F, 2005, J MOL MED, V83, P944, DOI 10.1007/s00109-005-0698-5
   MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0
   Mazier W, 2015, TRENDS ENDOCRIN MET, V26, P524, DOI 10.1016/j.tem.2015.07.007
   MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0
   Murillo-Rodríguez E, 2008, PROG NEURO-PSYCHOPH, V32, P1420, DOI 10.1016/j.pnpbp.2008.04.008
   Nogueiras R, 2009, PHARMACOL RES, V60, P93, DOI 10.1016/j.phrs.2009.04.004
   Núñez E, 2004, SYNAPSE, V53, P208, DOI 10.1002/syn.20050
   O'Keefe L, 2014, DIABETES OBES METAB, V16, P294, DOI 10.1111/dom.12144
   Osei-Hyiaman D, 2005, J CLIN INVEST, V115, P1298, DOI 10.1172/JCI200523057
   Osei-Hyiaman D, 2008, J CLIN INVEST, V118, P3160, DOI 10.1172/JCI34827
   Pagotto U, 2006, INT J OBESITY, V30, pS39, DOI 10.1038/sj.ijo.0803277
   Pascual AC, 2014, EXP GERONTOL, V60, P92, DOI 10.1016/j.exger.2014.10.011
   Pascual AC, 2013, BIOFACTORS, V39, P209, DOI 10.1002/biof.1055
   Peschke E, 2008, J PINEAL RES, V45, P439, DOI 10.1111/j.1600-079X.2008.00612.x
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Reddy AB, 2006, CURR BIOL, V16, P1107, DOI 10.1016/j.cub.2006.04.026
   Rueda-Orozco PE, 2008, PSYCHOPHARMACOLOGY, V198, P565, DOI 10.1007/s00213-007-0911-z
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Schmitz K, 2016, INT J OBESITY, V40, P366, DOI 10.1038/ijo.2015.169
   Siegmund SV, 2008, AM J PHYSIOL-GASTR L, V294, pG357, DOI 10.1152/ajpgi.00456.2007
   Siegmund SV, 2007, FASEB J, V21, P2798, DOI 10.1096/fj.06-7717com
   Siegmund SV, 2005, HEPATOLOGY, V41, P1085, DOI 10.1002/hep.20667
   Silvestri C, 2013, CELL METAB, V17, P475, DOI 10.1016/j.cmet.2013.03.001
   Skaper SD, 1996, P NATL ACAD SCI USA, V93, P3984, DOI 10.1073/pnas.93.9.3984
   SONG C, 1995, LIFE SCI, V56, P1983, DOI 10.1016/0024-3205(95)00179-A
   Teixeira-Clerc F, 2006, NAT MED, V12, P671, DOI 10.1038/nm1421
   Tharp WG, 2008, BIOCHEM BIOPH RES CO, V372, P595, DOI 10.1016/j.bbrc.2008.05.077
   Van Sickle MD, 2005, SCIENCE, V310, P329, DOI 10.1126/science.1115740
   Vaughn LK, 2010, BRIT J PHARMACOL, V160, P530, DOI 10.1111/j.1476-5381.2010.00790.x
   Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106
   Weiss L, 2006, AUTOIMMUNITY, V39, P143, DOI 10.1080/08916930500356674
   Weiss L, 2008, NEUROPHARMACOLOGY, V54, P244, DOI 10.1016/j.neuropharm.2007.06.029
   You YM, 2015, FOOD FUNCT, V6, P3144, DOI 10.1039/c5fo00432b
   ZARDOYA R, 1994, REV ESP FISIOL, V50, P239
NR 74
TC 11
Z9 12
U1 0
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD SEP
PY 2017
VL 18
IS 9
AR 1844
DI 10.3390/ijms18091844
PG 16
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA FI4RW
UT WOS:000411963800023
PM 28837063
OA Green Submitted, Green Published, gold
DA 2024-02-19
ER

PT J
AU RANDERATH, K
   ZHOU, GD
   HART, RW
   TURTURRO, A
   RANDERATH, E
AF RANDERATH, K
   ZHOU, GD
   HART, RW
   TURTURRO, A
   RANDERATH, E
TI BIOMARKERS OF AGING - CORRELATION OF DNA I-COMPOUND LEVELS WITH MEDIAN
   LIFE-SPAN OF CALORICALLY RESTRICTED AND AD-LIBITUM FED RATS AND MICE
SO MUTATION RESEARCH
LA English
DT Article
DE DNA MODIFICATIONS; I-COMPOUNDS; LIFE-SPAN; BIOMARKERS; CALORIC
   RESTRICTION; RAT; MOUSE; P-32 POSTLABELING
ID SPRAGUE-DAWLEY RATS; CHOLINE-DEVOID DIET; LIVER DNA; CELLULAR
   SENESCENCE; OXIDATIVE DAMAGE; AGE; REDUCTION; ADDUCTS; CANCER; KIDNEY
AB I-compounds are species-, tissue-, genotype-, gender-, and diet-dependent bulky DNA modifications whose levels increase with animal age. While a few of these DNA modifications represent oxidation products, the majority of I-compounds appear to be derived from as yet unidentified endogenous DNA-reactive intermediates other than reactive oxygen species. Circadian rhythms of certain I-compounds in rodent liver imply that levels of these DNA modifications are precisely regulated. Caloric restriction (CR), the currently most effective method available to retard aging and carcinogenesis, has been previously shown to elicit significant elevations of I-compound levels in tissue DNA from Brown-Norway (BN) and F-344 rats as compared to age-matched ad libitum fed (AL) animals. The present investigation has extended this work by examining liver and kidney DNA I-compound levels in three genotypes of rats (F-344, BN, and F-344 x BN) and two genotypes of mice (C57BL/6N and B6D2F1) under identical experimental conditions in order to determine whether correlations exist between I-compound levels, measured in middle-aged animals, and median lifespan. Levels of a number of liver and kidney I-compounds were found to display genotype- and diet-dependent, statistically significant positive linear correlations with median lifespan in both species. In particular, the longer-lived hybrid F-344 x BN rats and B6D2F1 mice tended to exhibit higher I-compound levels than the parent strains. CR enhanced I-compound levels substantially in both rats and mice. Thus, I-compounds, measured at middle age, reflected the functional capability ('health') of the organism at old age, suggesting their predictive value as biomarkers of aging. The positive linear correlations between levels of certain I-compounds (designated as type I) and lifespan suggest that these modifications may be functionally important and thus not represent endogenous DNA lesions (type II), whose levels would be expected to correlate inversely with lifespan.
C1 NATL CTR TOXICOL RES,DIV BIOMETRY & RISK ASSESSMENT,JEFFERSON,AR 72079.
C3 US Food & Drug Administration (FDA)
RP RANDERATH, K (corresponding author), BAYLOR COLL MED,DEPT PHARMACOL,DIV TOXICOL,HOUSTON,TX 77030, USA.
FU NCI NIH HHS [R37 CA 32157] Funding Source: Medline; NIA NIH HHS [R01 AG
   07750] Funding Source: Medline; NIEHS NIH HHS [P42 ES 04917] Funding
   Source: Medline
CR AMES BN, 1991, MUTAT RES, V250, P3, DOI 10.1016/0027-5107(91)90157-J
   [Anonymous], 1990, Longevity, senescence and the genome
   Bernstein C., 1991, Aging, sex and DNA repair
   BRONSON RT, 1991, GROWTH DEVELOP AGING, V55, P169
   CHANG J, 1993, MUTAT RES, V291, P147, DOI 10.1016/0165-1161(93)90154-R
   DJURIC Z, 1992, TOXICOL APPL PHARM, V115, P156, DOI 10.1016/0041-008X(92)90318-M
   DUFFY PH, 1989, MECH AGEING DEV, V48, P117, DOI 10.1016/0047-6374(89)90044-4
   Fishbein L, 1991, BIOL EFFECTS DIETARY
   FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533
   GENSLER HL, 1981, Q REV BIOL, V56, P279, DOI 10.1086/412317
   GOLDSTEIN S, 1990, SCIENCE, V249, P1129, DOI 10.1126/science.2204114
   GUPTA KP, 1990, MUTAT RES, V237, P17, DOI 10.1016/0921-8734(90)90028-P
   GUPTA RC, 1984, P NATL ACAD SCI-BIOL, V81, P6943, DOI 10.1073/pnas.81.22.6943
   HART RW, 1981, NATURWISSENSCHAFTEN, V68, P552, DOI 10.1007/BF00401663
   HART RW, 1974, P NATL ACAD SCI USA, V71, P2169, DOI 10.1073/pnas.71.6.2169
   HAYFLICK L, 1991, MUTAT RES, V256, P69, DOI 10.1016/0921-8734(91)90002-S
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   HOLMES GE, 1992, MUTAT RES, V275, P305, DOI 10.1016/0921-8734(92)90034-M
   KIRKLAND JL, 1992, CLIN BIOCHEM, V25, P61, DOI 10.1016/0009-9120(92)80047-K
   KIRKWOOD TBL, 1975, J THEOR BIOL, V53, P481, DOI 10.1016/S0022-5193(75)80018-X
   KIRKWOOD TBL, 1991, MUTAT RES, V256, P323, DOI 10.1016/0921-8734(91)90023-5
   LI D, 1989, CARCINOGENESIS, V10, P605, DOI 10.1093/carcin/10.3.605
   LI DG, 1990, CARCINOGENESIS, V11, P2227, DOI 10.1093/carcin/11.12.2227
   LI DH, 1992, CHEM-BIOL INTERACT, V84, P229, DOI 10.1016/0009-2797(92)90126-6
   LI DH, 1992, NUTR CANCER, V17, P205, DOI 10.1080/01635589209514189
   LI DH, 1992, MUTAT RES, V275, P47, DOI 10.1016/0921-8734(92)90008-D
   LI DH, 1990, CANCER RES, V50, P7577
   LI DH, 1991, CARCINOGENESIS, V12, P2389, DOI 10.1093/carcin/12.12.2389
   LI DH, 1990, CARCINOGENESIS, V11, P251, DOI 10.1093/carcin/11.2.251
   LI DH, 1990, CANCER RES, V50, P3991
   MARTIN GM, 1974, AM J PATHOL, V74, P137
   MULLAART E, 1990, MUTAT RES, V237, P189, DOI 10.1016/0921-8734(90)90001-8
   NATH RG, 1991, TOXICOLOGY, V68, P275, DOI 10.1016/0300-483X(91)90075-C
   NATH RG, 1990, CHEM-BIOL INTERACT, V76, P343, DOI 10.1016/0009-2797(90)90101-R
   NATH RG, 1992, BIOCHEM BIOPH RES CO, V189, P545, DOI 10.1016/0006-291X(92)91592-E
   RANDERATH E, 1991, MUTAT RES, V247, P65, DOI 10.1016/0027-5107(91)90034-L
   RANDERATH E, 1993, CHEM-BIOL INTERACT, V88, P175, DOI 10.1016/0009-2797(93)90090-L
   RANDERATH E, 1991, ENDOCRINOLOGY, V129, P3093, DOI 10.1210/endo-129-6-3093
   RANDERATH E, 1991, MECH AGEING DEV, V58, P279, DOI 10.1016/0047-6374(91)90099-L
   RANDERATH K, 1993, MUTAT RES, V295, P11, DOI 10.1016/0921-8734(93)90007-P
   RANDERATH K, 1988, CARCINOGENESIS, V9, P2285, DOI 10.1093/carcin/9.12.2285
   RANDERATH K, 1966, J CHROMATOGR, V22, P110, DOI 10.1016/S0021-9673(01)97076-1
   RANDERATH K, 1988, CARCINOGENESIS, V9, P1843, DOI 10.1093/carcin/9.10.1843
   RANDERATH K, 1993, MUTAT RES, V295, P31, DOI 10.1016/0921-8734(93)90009-R
   RANDERATH K, 1992, EXP GERONTOL, V27, P533, DOI 10.1016/0531-5565(92)90008-N
   RANDERATH K, 1990, MUTAT RES, V238, P245, DOI 10.1016/0165-1110(90)90016-5
   RANDERATH K, 1990, CARCINOGENESIS, V11, P1041, DOI 10.1093/carcin/11.6.1041
   RANDERATH K, 1989, MUTAT RES, V219, P121, DOI 10.1016/0921-8734(89)90023-4
   RANDERATH K, 1991, MUTAT RES, V250, P135, DOI 10.1016/0027-5107(91)90169-O
   RANDERATH K, 1992, CARCINOGENESIS, V13, P125, DOI 10.1093/carcin/13.1.125
   RANDERATH K, 1986, CARCINOGENESIS, V7, P1615, DOI 10.1093/carcin/7.9.1615
   RANDERATH K, 1990, TOXICOL APPL PHARM, V103, P271, DOI 10.1016/0041-008X(90)90229-N
   RANDERATH K, 1993, IARC SCI PUBL, V124, P157
   REDDY MV, 1986, CARCINOGENESIS, V7, P1543, DOI 10.1093/carcin/7.9.1543
   SHIGENAGA MK, 1991, FREE RADICAL BIO MED, V10, P211, DOI 10.1016/0891-5849(91)90078-H
   SIMIC MG, 1991, BIOL EFFECTS DIETARY, P217
   SMITH JR, 1980, MECH AGEING DEV, V13, P387, DOI 10.1016/0047-6374(80)90080-9
   SOHAL RS, 1990, MECH AGEING DEV, V53, P209, DOI 10.1016/0047-6374(90)90039-I
   SOHAL RS, 1989, MECH AGEING DEV, V49, P129, DOI 10.1016/0047-6374(89)90096-1
   SPIERING AL, 1991, MUTAT RES, V256, P263, DOI 10.1016/0921-8734(91)90017-6
   SPROTT RL, 1985, DRUG NUTR INTERACT, V4, P43
   THOMAS J, 1988, EXP GERONTOL, V23, P501, DOI 10.1016/0531-5565(88)90062-9
   Tice R.R., 1985, HDB BIOL AGING, P173
   TURTURRO A, 1992, EXP GERONTOL, V27, P583, DOI 10.1016/0531-5565(92)90013-P
   TURTURRO A, 1991, BIOL EFFECTS DIETARY, P185
   WERAARCHAKUL N, 1989, EXP CELL RES, V181, P197, DOI 10.1016/0014-4827(89)90193-6
   WITT WM, 1991, BIOL EFFECTS DIETARY, P73
   Zar, 2014, BIOSTAT ANAL
NR 68
TC 27
Z9 28
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-8262
J9 MUTAT RES
PD DEC
PY 1993
VL 295
IS 4-6
BP 247
EP 263
DI 10.1016/0921-8734(93)90024-W
PG 17
WC Genetics & Heredity; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity; Toxicology
GA MV034
UT WOS:A1993MV03400009
PM 7507561
DA 2024-02-19
ER

PT J
AU Veldhuis, JD
   Erickson, D
   Iranmanesh, A
   Miles, JM
   Bowers, CY
AF Veldhuis, JD
   Erickson, D
   Iranmanesh, A
   Miles, JM
   Bowers, CY
TI Sex-steroid control of the aging somatotropic axis
SO ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
LA English
DT Article
ID GROWTH-HORMONE GH; I IGF-I; ULTRASENSITIVE CHEMILUMINESCENCE ASSAY;
   PERCENTAGE BODY-FAT; POSTMENOPAUSAL WOMEN; ESTRADIOL SUPPLEMENTATION;
   PREMENOPAUSAL WOMEN; DEFICIENT ADULTS; OLDER MEN; TESTOSTERONE
   CONCENTRATIONS
AB Growth hormone (GH) concentrations decline progressively with increasing age. In contrast, the maximal pituitary secretory capacity, plasma elimination kinetics, and hepatic actions of GH are preserved in older people. Reduced availability of GH and thereby insulin-like growth factor in the elderly has significant implications. In particular, epidemiologic investigations correlate hyposomatotropism with reduced insulin sensitivity, dyslipidemia, increased cardiovascular mortality intra-abdominal adiposity, sarcopenia, osteopenia, and diminished quality of life. Obesity forecasts decreased GH secretion in the adult. In addition, sex steroid depletion after adolescence predicts relative GH deficiency. Conversely, supplementation with estradiol or an aromatizable androgen, such as testosterone, stimulates GH production in aging and hypogonadal adults. Recent developments in this arena allow new clinical perspectives in aging, which are highlighted in this article.
C1 Mayo Clin Rochester, Gen Clin Res Ctr, Dept Internal Med, Endocrine Res Unit,Mayo Sch Grad Med Educ, Rochester, MN 55905 USA.
   Vet Affairs Med Ctr, Endocrine Sect, Med Sect Salem, Salem, VA USA.
   Univ Virginia, Sch Med, Charlottesville, VA USA.
   Tulane Univ, Dept Internal Med, Div Endocrinol & Metab, New Orleans, LA 70118 USA.
C3 Mayo Clinic; US Department of Veterans Affairs; Veterans Health
   Administration (VHA); Salem Veterans Affairs Medical Center; University
   of Virginia; Tulane University
RP Veldhuis, JD (corresponding author), Mayo Clin Rochester, Gen Clin Res Ctr, Dept Internal Med, Endocrine Res Unit,Mayo Sch Grad Med Educ, 200 1st St SW, Rochester, MN 55905 USA.
EM veldhuis.johannes@mayo.edu
RI IRANMANESH, ALI/Y-3331-2019; nanomeghyas, journal/AGA-1829-2022
OI IRANMANESH, ALI/0000-0003-2639-9454; 
FU NCRR NIH HHS [M01 RR 00585, M01 RR000585] Funding Source: Medline; NIA
   NIH HHS [R01 AG014799, R01 AG 19695, R01 AG 14799] Funding Source:
   Medline
CR Achermann JC, 1999, CLIN ENDOCRINOL, V50, P301, DOI 10.1111/j.1365-2265.1999.tb03945.x
   Aimaretti G, 2001, EUR J ENDOCRINOL, V145, P267, DOI 10.1530/eje.0.1450267
   Anderson SM, 2001, J CLIN ENDOCR METAB, V86, P5904, DOI 10.1210/jc.86.12.5904
   Anderson SM, 2001, J CLIN ENDOCR METAB, V86, P551, DOI 10.1210/jc.86.2.551
   Arvat E, 1998, CLIN ENDOCRINOL, V49, P757, DOI 10.1046/j.1365-2265.1998.00613.x
   Arvat E, 1998, Pituitary, V1, P51, DOI 10.1023/A:1009970909015
   Bengtsson BÅ, 1999, LANCET, V354, P1403, DOI 10.1016/S0140-6736(99)00330-X
   Bowers CY, 2004, J CLIN ENDOCR METAB, V89, P2290, DOI 10.1210/jc.2003-031799
   BOWERS CY, 2002, CENTRAL PERIPHERAL M, P163
   Bray MJ, 2001, J CLIN ENDOCR METAB, V86, P3143, DOI 10.1210/jc.86.7.3143
   Camacho-Hübner C, 1999, J CLIN ENDOCR METAB, V84, P1611, DOI 10.1210/jc.84.5.1611
   Carvalho LR, 2003, CLIN ENDOCRINOL, V59, P788, DOI 10.1046/j.1365-2265.2003.01899.x
   CUNEO RC, 1993, METABOLISM, V42, P1519, DOI 10.1016/0026-0495(93)90145-E
   DEVESA J, 1991, J STEROID BIOCHEM, V40, P165, DOI 10.1016/0960-0760(91)90179-9
   Di Vito L, 2002, CLIN ENDOCRINOL, V56, P643, DOI 10.1046/j.1365-2265.2002.01530.x
   Duenas M, 1996, NEUROSCIENCE, V74, P531, DOI 10.1016/0306-4522(96)00142-X
   Erickson D, 2004, J CLIN ENDOCR METAB, V89, P4746, DOI 10.1210/jc.2004-0424
   Evans WS, 2001, J CLIN ENDOCR METAB, V86, P700, DOI 10.1210/jc.86.2.700
   Farhy LS, 2004, AM J PHYSIOL-REG I, V286, pR1030, DOI 10.1152/ajpregu.00473.2003
   Farhy LS, 2002, AM J PHYSIOL-REG I, V282, pR753, DOI 10.1152/ajpregu.00407.2001
   Farhy LS, 2003, AM J PHYSIOL-REG I, V285, pR1240, DOI 10.1152/ajpregu.00086.2003
   Farhy LS, 2001, AM J PHYSIOL-REG I, V281, pR38, DOI 10.1152/ajpregu.2001.281.1.R38
   FARIA ACS, 1992, CLIN ENDOCRINOL, V36, P591, DOI 10.1111/j.1365-2265.1992.tb02270.x
   FINKELSTEIN JW, 1972, J CLIN ENDOCR METAB, V35, P665, DOI 10.1210/jcem-35-5-665
   FRANTZ AG, 1965, J CLIN ENDOCR METAB, V25, P1470, DOI 10.1210/jcem-25-11-1470
   Fryburg DA, 1997, J CLIN ENDOCR METAB, V82, P3710, DOI 10.1210/jc.82.11.3710
   Gentili A, 2002, J CLIN ENDOCR METAB, V87, P825, DOI 10.1210/jc.87.2.825
   Giustina A, 1997, J CLIN ENDOCR METAB, V82, P1210, DOI 10.1210/jc.82.4.1210
   Giustina A, 1998, ENDOCR REV, V19, P717, DOI 10.1210/er.19.6.717
   HARTMAN ML, 1991, AM J PHYSIOL, V260, pE101, DOI 10.1152/ajpendo.1991.260.1.E101
   HARTMAN ML, 1994, J CLIN INVEST, V94, P1277, DOI 10.1172/JCI117446
   Hataya Y, 2001, J CLIN ENDOCR METAB, V86, P4552, DOI 10.1210/jc.86.9.4552
   HO KY, 1987, J CLIN ENDOCR METAB, V64, P51, DOI 10.1210/jcem-64-1-51
   IRANMANESH A, 1994, J CLIN ENDOCR METAB, V78, P526, DOI 10.1210/jc.78.3.526
   Iranmanesh A, 1998, EUR J ENDOCRINOL, V139, P59, DOI 10.1530/eje.0.1390059
   IRANMANESH A, 1991, J CLIN ENDOCR METAB, V73, P1081, DOI 10.1210/jcem-73-5-1081
   Jaffe CA, 2002, AM J PHYSIOL-ENDOC M, V283, pE1008, DOI 10.1152/ajpendo.00513.2001
   Johannsson G, 1997, HORM RES, V48, P72, DOI 10.1159/000191332
   Johannsson G, 1997, J CLIN ENDOCR METAB, V82, P2877, DOI 10.1210/jc.82.9.2877
   Johannsson G, 1996, J CLIN ENDOCR METAB, V81, P1575, DOI 10.1210/jc.81.4.1575
   Johannsson G, 1997, J CLIN ENDOCR METAB, V82, P727, DOI 10.1210/jc.82.3.727
   Juul A, 2002, CIRCULATION, V106, P939, DOI 10.1161/01.CIR.0000027563.44593.CC
   Keenan DM, 2001, P NATL ACAD SCI USA, V98, P4028, DOI 10.1073/pnas.051624198
   Keenan DM, 2004, P NATL ACAD SCI USA, V101, P6740, DOI 10.1073/pnas.0300619101
   Keenan DM, 2003, AM J PHYSIOL-REG I, V285, pR664, DOI 10.1152/ajpregu.00195.2003
   Khorram O, 1997, J CLIN ENDOCR METAB, V82, P1472, DOI 10.1210/jc.82.5.1472
   Laughlin GA, 2004, J CLIN ENDOCR METAB, V89, P114, DOI 10.1210/jc.2003-030967
   Le Roith D, 2001, ENDOCR REV, V22, P53, DOI 10.1210/er.22.1.53
   Lichtenwalner RJ, 2001, NEUROSCIENCE, V107, P603, DOI 10.1016/S0306-4522(01)00378-5
   Lieman HJ, 2001, J CLIN ENDOCR METAB, V86, P3918, DOI 10.1210/jc.86.8.3918
   LINDAHL A, 1987, ENDOCRINOLOGY, V121, P1061, DOI 10.1210/endo-121-3-1061
   Lissett CA, 2003, J CLIN ENDOCR METAB, V88, P4668, DOI 10.1210/jc.2003-022036
   Lissett CA, 2003, CLIN ENDOCRINOL, V58, P238, DOI 10.1046/j.1365-2265.2003.01703.x
   Loche S, 1997, J CLIN ENDOCR METAB, V82, P861, DOI 10.1210/jc.82.3.861
   Low MJ, 2001, J CLIN INVEST, V107, P1571, DOI 10.1172/JCI11941
   Mauras N, 2000, J CLIN ENDOCR METAB, V85, P1686, DOI 10.1210/jc.85.4.1686
   METZGER DL, 1994, J CLIN ENDOCR METAB, V79, P513, DOI 10.1210/jc.79.2.513
   Müller EE, 1999, PHYSIOL REV, V79, P511, DOI 10.1152/physrev.1999.79.2.511
   Nyberg F, 1997, EXP GERONTOL, V32, P521, DOI 10.1016/S0531-5565(96)00170-2
   Ovesen P, 1998, J CLIN ENDOCR METAB, V83, P1662, DOI 10.1210/jc.83.5.1662
   Petersenn S, 2001, ENDOCRINOLOGY, V142, P2649, DOI 10.1210/en.142.6.2649
   Pijl H, 2001, J CLIN ENDOCR METAB, V86, P5509, DOI 10.1210/jc.86.11.5509
   Pincus SM, 1996, P NATL ACAD SCI USA, V93, P14100, DOI 10.1073/pnas.93.24.14100
   Rosilio M, 2004, J CLIN ENDOCR METAB, V89, P1684, DOI 10.1210/jc.2003-030134
   Shah N, 1999, AM J PHYSIOL-REG I, V276, pR1351, DOI 10.1152/ajpregu.1999.276.5.R1351
   Shah N, 1999, J CLIN ENDOCR METAB, V84, P2140, DOI 10.1210/jc.84.6.2140
   Shah N, 2000, J CLIN ENDOCR METAB, V85, P2649, DOI 10.1210/jc.85.8.2649
   Shuto Y, 2002, J CLIN INVEST, V109, P1429, DOI 10.1172/JCI0213300
   Span JPT, 2000, J CLIN ENDOCR METAB, V85, P1121, DOI 10.1210/jc.85.3.1121
   Uberti ECD, 1997, J CLIN ENDOCR METAB, V82, P2885, DOI 10.1210/jc.82.9.2885
   Van den Berghe G, 2000, J CLIN ENDOCR METAB, V85, P183, DOI 10.1210/jc.85.1.183
   VandenBerg G, 1996, J CLIN ENDOCR METAB, V81, P2460, DOI 10.1210/jc.81.7.2460
   vanKesteren P, 1996, J CLIN ENDOCR METAB, V81, P2227, DOI 10.1210/jc.81.6.2227
   VELDHUIS JD, 1995, J CLIN ENDOCR METAB, V80, P3209, DOI 10.1210/jc.80.11.3209
   Veldhuis JD, 2000, J CLIN ENDOCR METAB, V85, P2385, DOI 10.1210/jc.85.7.2385
   Veldhuis JD, 2005, J CLIN ENDOCR METAB, V90, P1613, DOI 10.1210/jc.2004-1303
   Veldhuis JD, 2004, J CLIN ENDOCR METAB, V89, P6325, DOI 10.1210/jc.2004-0430
   Veldhuis JD, 1997, J CLIN ENDOCR METAB, V82, P3414, DOI 10.1210/jc.82.10.3414
   Veldhuis JD, 2004, J CLIN ENDOCR METAB, V89, P6291, DOI 10.1210/jc.2004-0644
   Veldhuis JD, 2004, J CLIN ENDOCR METAB, V89, P1312, DOI 10.1210/jc.2003-031482
   Veldhuis JD, 2004, J CLIN ENDOCR METAB, V89, P1285, DOI 10.1210/jc.2003-031017
   Veldhuis JD, 2004, J CLIN ENDOCR METAB, V89, P840, DOI 10.1210/jc.2003-031081
   Veldhuis JD, 2004, J CLIN ENDOCR METAB, V89, P121, DOI 10.1210/jc.2003-031291
   Veldhuis JD, 2003, J CLIN ENDOCR METAB, V88, P5484, DOI 10.1210/jc.2003-030410
   Veldhuis JD, 2003, ENDOCRINE, V22, P25, DOI 10.1385/ENDO:22:1:25
   Veldhuis JD, 2002, J CLIN ENDOCR METAB, V87, P859, DOI 10.1210/jc.87.2.859
   Veldhuis JD, 2001, ENDOCRINE, V14, P45, DOI 10.1385/ENDO:14:1:045
   Veldhuis JD, 2001, J CLIN ENDOCR METAB, V86, P3304, DOI 10.1210/jc.86.7.3304
   Veldhuis JD, 2005, ENDOCR REV, V26, P114, DOI 10.1210/er.2003-0038
   WEISSBERGER AJ, 1993, J CLIN ENDOCR METAB, V1407, P1412
   WELTMAN A, 1994, J CLIN ENDOCR METAB, V78, P543, DOI 10.1210/jc.78.3.543
   WIEDEMANN E, 1976, J CLIN ENDOCR METAB, V42, P942, DOI 10.1210/jcem-42-5-942
   YEN S S C, 1970, Journal of the American Medical Association, V211, P1513, DOI 10.1001/jama.211.9.1513
   ZADIK Z, 1985, J CLIN ENDOCR METAB, V60, P513, DOI 10.1210/jcem-60-3-513
NR 94
TC 22
Z9 24
U1 0
U2 0
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0889-8529
EI 1558-4410
J9 ENDOCRIN METAB CLIN
JI Endocrinol. Metabol. Clin. North Amer.
PD DEC
PY 2005
VL 34
IS 4
BP 877
EP +
DI 10.1016/j.ecl.2005.07.006
PG 18
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 997QD
UT WOS:000234260700006
PM 16310628
DA 2024-02-19
ER

PT J
AU Tsuboi, I
   Harada, T
   Hirabayashi, Y
   Aizawa, S
AF Tsuboi, Isao
   Harada, Tomonori
   Hirabayashi, Yoko
   Aizawa, Shin
TI Senescence-accelerated mice (SAMP1/TA-1) treated repeatedly with
   lipopolysaccharide develop a condition that resembles hemophagocytic
   lymphohistiocytosis
SO HAEMATOLOGICA
LA English
DT Article
ID MACROPHAGE ACTIVATION SYNDROME; AGE-RELATED-CHANGES; LIVED SAM MICE;
   IMMUNE-RESPONSES; ANIMAL-MODEL; MOUSE MODEL; PATHOGENESIS; DISEASE;
   CELLS; GAMMA
AB Hemophagocytic lymphohistiocytosis is a life-threatening systemic hyperinflammatory disorder with primary and secondary forms. Primary hemophagocytic lymphohistiocytosis is associated with inherited defects in various genes that affect the immunological cytolytic pathway. Secondary hemophagocytic lymphohistiocytosis is not inherited, but complicates various medical conditions including infections, autoinflammatory/autoimmune diseases, and malignancies. When senescence-accelerated mice (SAMP1/TA-1) with latent deterioration of immunological function and senescence-resistant control mice (SAMR1) were treated repeatedly with lipopolysaccharide, SAMP1/TA-1 mice displayed the clinicopathological features of hemophagocytic lymphohistiocytosis such as hepatosplenomegaly, pancytopenia, hypofibrinogenemia, hyperferritinemia, and hemophagocytosis. SAMR1 mice showed no features of hemophagocytic lymphohistiocytosis. Lipopolysaccharide induced upregulation of proinflammatory cytokines such as interleukin-1 beta, interleukin-6, tumor necrosis factor-alpha, and interferon-gamma, and interferon-gamma-inducible chemokines such as c-x-c motif chemokine ligands 9 and 10 in the liver and spleen in both SAMP1/TA-1 and SAMR1 mice. However, upregulation of proinflammatory cytokines and interferon-g-inducible chemokines in the liver persisted for longer in SAMP1/TA-1 mice than in SAMR1 mice. In addition, the magnitude of upregulation of interferon-g in the liver and spleen after lipopolysaccharide treatment was greater in SAMP1/TA-1 mice than in SAMR1 mice. Furthermore, lipopolysaccharide treatment led to a prolonged increase in the proportion of peritoneal M1 macrophages and simultaneously to a decrease in the proportion of M2 macrophages in SAMP1/TA-1 mice compared with SAMR1 mice. Lipopolysaccharide appeared to induce a hyperinflammatory reaction and prolonged inflammation in SAMP1/TA-1 mice, resulting in features of secondary hemophagocytic lymphohistiocytosis. Thus, SAMP1/TA-1 mice represent a useful mouse model to investigate the pathogenesis of bacterial infection-associated secondary hemophagocytic lymphohistiocytosis.
C1 [Tsuboi, Isao; Harada, Tomonori; Aizawa, Shin] Nihon Univ, Dept Funct Morphol, Div Anat Sci, Sch Med, Tokyo, Japan.
   [Hirabayashi, Yoko] Natl Inst Hlth Sci, Natl Ctr Biol Safety & Res, Cellular & Mol Toxicol Div, Kawasaki, Kanagawa, Japan.
C3 Nihon University; National Institute of Health Sciences - Japan
RP Tsuboi, I (corresponding author), Nihon Univ, Dept Funct Morphol, Div Anat Sci, Sch Med, Tokyo, Japan.
EM tsuboi.isao@nihon-u.ac.jp
RI 原田, 智紀/AAX-8274-2020
FU Japan Society for the Promotion of Science [JP18K06846]
FX The authors would like to thank Sonoko Araki and Miyuki Yuda for
   technical assistance. This work was supported in part by a Grant-in Aid
   for Scientific Research C from the Japan Society for the Promotion of
   Science, grant number JP18K06846.
CR Aisaki K, 2012, EXP BIOL MED, V237, P279, DOI 10.1258/ebm.2011.011303
   Behrens EM, 2011, J CLIN INVEST, V121, P2264, DOI 10.1172/JCI43157
   Brisse E, 2016, BRIT J HAEMATOL, V174, P203, DOI 10.1111/bjh.14147
   Brisse E, 2016, J IMMUNOL, V196, P3124, DOI 10.4049/jimmunol.1501035
   Brown DE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009441
   Buatois V, 2017, TRANSL RES, V180, P37, DOI 10.1016/j.trsl.2016.07.023
   Chang KH, 2006, J FORMOS MED ASSOC, V105, P756, DOI 10.1016/S0929-6646(09)60204-7
   Créput C, 2008, INTENS CARE MED, V34, P1177, DOI 10.1007/s00134-008-1111-y
   Crozat K, 2007, J EXP MED, V204, P853, DOI 10.1084/jem.20062447
   Dong L, 2000, J INFECT DIS, V182, P391, DOI 10.1086/315727
   Feldmann J, 2003, CELL, V115, P461, DOI 10.1016/S0092-8674(03)00855-9
   Girard-Guyonvarc'h C, 2018, BLOOD, V131, P1430, DOI 10.1182/blood-2017-06-789552
   Henter JI, 2007, PEDIATR BLOOD CANCER, V48, P124, DOI 10.1002/pbc.21039
   HOSOKAWA T, 1987, IMMUNOLOGY, V62, P419
   HOSOKAWA T, 1987, IMMUNOLOGY, V62, P425
   Janka GE, 2012, ANNU REV MED, V63, P233, DOI 10.1146/annurev-med-041610-134208
   Jordan MB, 2004, BLOOD, V104, P735, DOI 10.1182/blood-2003-10-3413
   Kumagai T, 2000, MECH AGEING DEV, V112, P153, DOI 10.1016/S0047-6374(99)00085-8
   Lehmberg K, 2015, BRIT J HAEMATOL, V170, P539, DOI 10.1111/bjh.13462
   Liao YT, 2019, J MICROBIOL IMMUNOL, V52, P363, DOI 10.1016/j.jmii.2018.10.012
   Machowicz R, 2017, CRIT REV ONCOL HEMAT, V114, P1, DOI 10.1016/j.critrevonc.2017.03.023
   Muise A, 2003, PEDIATRICS, V112, pE495, DOI 10.1542/peds.112.6.e495
   Non LR, 2015, AM J TROP MED HYG, V93, P1068, DOI 10.4269/ajtmh.15-0385
   Pachlopnik SJ, 2009, EMBO MOL MED, V1, P112, DOI DOI 10.1002/EMMM.200900009
   Parodi A, 2009, ARTHRITIS RHEUM-US, V60, P3388, DOI 10.1002/art.24883
   Prencipe G, 2018, J ALLERGY CLIN IMMUN, V141, P1439, DOI 10.1016/j.jaci.2017.07.021
   Ramos-Casals M, 2014, LANCET, V383, P1503, DOI 10.1016/S0140-6736(13)61048-X
   Reinhardt RL, 2015, J IMMUNOL, V194, P2358, DOI 10.4049/jimmunol.1401992
   Ruscitti P, 2017, CLIN RHEUMATOL, V36, P2839, DOI 10.1007/s10067-017-3830-3
   Sato K, 2011, BLOOD, V117, P5663, DOI 10.1182/blood-2010-09-305979
   Sawhney S, 2001, ARCH DIS CHILD, V85, P421, DOI 10.1136/adc.85.5.421
   Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643
   Stepp SE, 1999, SCIENCE, V286, P1957, DOI 10.1126/science.286.5446.1957
   Stohlawetz P, 1999, THROMB HAEMOSTASIS, V81, P613
   Strachinaru DIC, 2018, ACTA CLIN BELG, V73, P220, DOI 10.1080/17843286.2017.1341691
   Strippoli R, 2012, ARTHRITIS RHEUM-US, V64, P1680, DOI 10.1002/art.33496
   Tacchini-Cottier F, 1998, J IMMUNOL, V160, P6182
   TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1
   Taki M, 2014, BIOL PHARM BULL, V37, P1872, DOI 10.1248/bpb.b14-00279
   TSUBOI I, 1991, EXP HEMATOL, V19, P874
   Tsuboi I, 2008, J APPL TOXICOL, V28, P797, DOI 10.1002/jat.1341
   Tsuboi I, 2008, RADIAT RES, V170, P15, DOI 10.1667/RR1182.1
   Tsuboi I, 2016, BIOL PHARM BULL, V39, P1939, DOI 10.1248/bpb.b16-00375
   Tsuboi I, 2010, IMMUNOBIOLOGY, V215, P348, DOI 10.1016/j.imbio.2009.05.004
   Tsuboi I, 2010, PTERIDINES, V21, P7
   Usmani GN, 2013, BRIT J HAEMATOL, V161, P609, DOI 10.1111/bjh.12293
   Voskoboinik I, 2006, NAT REV IMMUNOL, V6, P940, DOI 10.1038/nri1983
   zur Stadt U, 2005, HUM MOL GENET, V14, P827, DOI 10.1093/hmg/ddi076
   zur Stadt U, 2009, AM J HUM GENET, V85, P482, DOI 10.1016/j.ajhg.2009.09.005
NR 49
TC 8
Z9 7
U1 0
U2 0
PU FERRATA STORTI FOUNDATION
PI PAVIA
PA VIA GIUSEPPE BELLI 4, 27100 PAVIA, ITALY
SN 0390-6078
J9 HAEMATOLOGICA
JI Haematologica
PD SEP 30
PY 2019
VL 104
IS 10
BP 1995
EP 2005
DI 10.3324/haematol.2018.209551
PG 11
WC Hematology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Hematology
GA JB4GK
UT WOS:000488513600027
PM 30819910
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Wils, H
   Kleinberger, G
   Pereson, S
   Janssens, J
   Capell, A
   Van Dam, D
   Cuijt, I
   Joris, G
   De Deyn, PP
   Haass, C
   Van Broeckhoven, C
   Kumar-Singh, S
AF Wils, Hans
   Kleinberger, Gernot
   Pereson, Sandra
   Janssens, Jonathan
   Capell, Anja
   Van Dam, Debby
   Cuijt, Ivy
   Joris, Geert
   De Deyn, Peter P.
   Haass, Christian
   Van Broeckhoven, Christine
   Kumar-Singh, Samir
TI Cellular ageing, increased mortality and FTLD-TDP-associated
   neuropathology in progranulin knockout mice
SO JOURNAL OF PATHOLOGY
LA English
DT Article
DE progranulin; TDP-43; FTLD; ageing; liver pathology; mouse model; IGF-1
ID FRONTOTEMPORAL LOBAR DEGENERATION; DNA-BINDING PROTEIN-43; C-TERMINAL
   FRAGMENTS; GROWTH-FACTOR; GENE-EXPRESSION; INCLUSIONS; DEMENTIA;
   DISEASE; PHENOTYPE; AUTOPHAGY
AB Loss-of-function mutations in progranulin (GRN) are associated with frontotemporal lobar degeneration with intraneuronal ubiquitinated protein accumulations composed primarily of hyperphosphorylated TDP-43 (FTLD-TDP). The mechanism by which GRN deficiency causes TDP-43 pathology or neurodegeneration remains elusive. To explore the role of GRN in vivo, we established Grn knockout mice using a targeted genomic recombination approach and Cre-LoxP technology. Constitutive Grn homozygous knockout (Grn(-/-)) mice were born in an expected Mendelian pattern of inheritance and showed no phenotypic alterations compared to heterozygous (Grn(+/-)) or wild-type (Wt) littermates until 10 months of age. From then, Grn(-/-) mice showed reduced survival accompanied by significantly increased gliosis and ubiquitin-positive accumulations in the cortex, hippocampus, and subcortical regions. Although phosphorylated TDP-43 could not be detected in the ubiquitinated inclusions, elevated levels of hyperphosphorylated full-length TDP-43 were recovered from detergent-insoluble brain fractions of Grn(-/-) mice. Phosphorylated TDP-43 increased with age and was primarily extracted from the nuclear fraction. Grn(-/-) mice also showed degenerative liver changes and cathepsin D-positive foamy histiocytes within sinusoids, suggesting widespread defects in lysosomal turnover. An increase in insulin-like growth factor (IGF)-1 was observed in Grn(-/-) brains, and increased IGF-1 signalling has been associated with decreased longevity. Our data suggest that progranulin deficiency in mice leads to reduced survival in adulthood and increased cellular ageing accompanied by hyperphosphorylation of TDP-43, and recapitulates key aspects of FTLD-TDP neuropathology. Copyright (C) 2012 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
C1 [Wils, Hans; Kleinberger, Gernot; Pereson, Sandra; Janssens, Jonathan; Cuijt, Ivy; Joris, Geert; Van Broeckhoven, Christine; Kumar-Singh, Samir] VIB, Dept Mol Genet, Neurodegenerat Brain Dis Grp, Antwerp, Belgium.
   [Wils, Hans; Kleinberger, Gernot; Pereson, Sandra; Janssens, Jonathan; Cuijt, Ivy; Joris, Geert; Van Broeckhoven, Christine; Kumar-Singh, Samir] Univ Antwerp, Inst Born Bunge, Neurogenet Lab, B-2020 Antwerp, Belgium.
   [Capell, Anja; Haass, Christian] Univ Munich, Adolf Butenandt Inst, Munich, Germany.
   [Van Dam, Debby; De Deyn, Peter P.] Univ Antwerp, Inst Born Bunge, Lab Neurochem & Behav, B-2020 Antwerp, Belgium.
   [Haass, Christian] German Ctr Neurodegenerat Dis DZNE, Munich, Germany.
C3 Flanders Institute for Biotechnology (VIB); University of Antwerp;
   University of Munich; University of Antwerp; Helmholtz Association;
   German Center for Neurodegenerative Diseases (DZNE)
RP Van Broeckhoven, C (corresponding author), Univ Antwerp CDE, Neurodegenerat Brain Dis Grp, VIB Dept Mol Genet, Univ Pl 1, B-2610 Antwerp, Belgium.
EM christine.vanbroeckhoven@molgen.vib-ua.be; samir.kumarsingh@ua.ac.be
RI Kumar-Singh, Samir/G-6280-2012; Van Broeckhoven, Christine/M-7853-2019;
   Kumar-SIngh, Samir/IAO-0066-2023; Van Broeckhoven,
   Christine/G-8362-2017; Van Dam, Debby/G-1666-2018
OI Kumar-Singh, Samir/0000-0001-9466-6732; Van Broeckhoven,
   Christine/0000-0003-0183-7665; Van Broeckhoven,
   Christine/0000-0003-0183-7665; Joris, Geert/0009-0008-9744-2468; Van
   Dam, Debby/0000-0003-4739-6076
FU Inter-university Attraction Poles Programme of the Belgian Science
   Policy Office; Medical Foundation Queen Elisabeth (GSKE); Foundation for
   Alzheimer Research (SAO/FRMA); Methusalem Programme of the Flemish
   Government; Research Foundation Flanders (FWO); Agency for Innovation
   through Science and Technology Flanders (IWT); University of Antwerp,
   Belgium; VIB; DZNE; IWT; FWO
FX We thank Dr Manuela Neumann for the TDP-43 C-terminal antibody, Veerle
   Smits for support with experimental mouse work, and the personnel of the
   VIB Genetic Service Facility (http://www.vibgeneticservicefacility.be)
   for genetic analyses. This work was supported in part by the
   Inter-university Attraction Poles Programme of the Belgian Science
   Policy Office, the Medical Foundation Queen Elisabeth (GSKE), the
   Foundation for Alzheimer Research (SAO/FRMA), the Methusalem Programme
   of the Flemish Government, the Research Foundation Flanders (FWO), the
   Agency for Innovation through Science and Technology Flanders (IWT), and
   the Special Research Fund of the University of Antwerp, Belgium. The
   research was performed in the frame of the international consortium of
   Centers of Excellence in Neurodegenerative Brain Diseases (CoEN;
   http://www.coen.org/) supported by the VIB (CVB) and DZNE (CH). JJ and
   SP received a PhD fellowship of the IWT, and GK of the FWO. DVD received
   a postdoctoral fellowship of the FWO.
CR Ahmed Z, 2010, AM J PATHOL, V177, P311, DOI 10.2353/ajpath.2010.090915
   Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093
   Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016
   Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017
   Daniel R, 2000, J HISTOCHEM CYTOCHEM, V48, P999, DOI 10.1177/002215540004800713
   Doetschman T, 1999, LAB ANIM SCI, V49, P137
   Dormann D, 2009, J NEUROCHEM, V110, P1082, DOI 10.1111/j.1471-4159.2009.06211.x
   Ghoshal N, 2012, NEUROBIOL DIS, V45, P395, DOI 10.1016/j.nbd.2011.08.029
   Guerra RR, 2009, BRAZ J MED BIOL RES, V42, P1027, DOI 10.1590/S0100-879X2009005000027
   Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425
   He ZH, 2003, J MOL MED-JMM, V81, P600, DOI 10.1007/s00109-003-0474-3
   Hu FH, 2010, NEURON, V68, P654, DOI 10.1016/j.neuron.2010.09.034
   Igaz LM, 2008, AM J PATHOL, V173, P182, DOI 10.2353/ajpath.2008.080003
   Igaz LM, 2009, J BIOL CHEM, V284, P8516, DOI 10.1074/jbc.M809462200
   Ju JS, 2010, HUM MOL GENET, V19, pR38, DOI 10.1093/hmg/ddq157
   Kayasuga Y, 2007, BEHAV BRAIN RES, V185, P110, DOI 10.1016/j.bbr.2007.07.020
   Kleinberger G, 2010, J NEUROCHEM, V115, P735, DOI 10.1111/j.1471-4159.2010.06961.x
   Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035
   Kumar-Singh S, 2005, AM J PATHOL, V167, P527, DOI 10.1016/S0002-9440(10)62995-1
   Kumar-Singh S, 2011, J MOL NEUROSCI, V45, P561, DOI 10.1007/s12031-011-9625-0
   Lehman NL, 2009, ACTA NEUROPATHOL, V118, P329, DOI 10.1007/s00401-009-0560-x
   Li YH, 2010, J BIOL CHEM, V285, P41001, DOI 10.1074/jbc.M110.138743
   Mackenzie IRA, 2009, ACTA NEUROPATHOL, V117, P15, DOI 10.1007/s00401-008-0460-5
   Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108
   Paxinos G., 2001, The mouse brain in stereotaxic coordinates, V2nd ed.
   Pereson S, 2009, J PATHOL, V219, P173, DOI 10.1002/path.2580
   Petkau TL, 2012, NEUROBIOL DIS, V45, P711, DOI 10.1016/j.nbd.2011.10.016
   Pirici D, 2006, J NEUROPATH EXP NEUR, V65, P289, DOI 10.1097/01.jnen.0000205147.39210.c7
   Porta EA, 2002, ANN NY ACAD SCI, V959, P57, DOI 10.1111/j.1749-6632.2002.tb02083.x
   Riga D, 2006, ANN NY ACAD SCI, V1067, P158, DOI 10.1196/annals.1354.019
   Rincon M, 2005, EXP GERONTOL, V40, P873, DOI 10.1016/j.exger.2005.06.014
   Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030
   Sampathu DM, 2006, AM J PATHOL, V169, P1343, DOI 10.2353/ajpath.2006.060438
   Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005
   Tang W, 2011, SCIENCE, V332, P478, DOI 10.1126/science.1199214
   Tominaga K, 2004, J NEUROSCI RES, V77, P507, DOI 10.1002/jnr.20190
   Van Damme P, 2008, J CELL BIOL, V181, P37, DOI 10.1083/jcb.200712039
   Wils H, 2010, P NATL ACAD SCI USA, V107, P3858, DOI 10.1073/pnas.0912417107
   Xu SQ, 1998, J BIOL CHEM, V273, P20078, DOI 10.1074/jbc.273.32.20078
   Yang JT, 1999, DEV BIOL, V215, P264, DOI 10.1006/dbio.1999.9451
   Yin FF, 2010, FASEB J, V24, P4639, DOI 10.1096/fj.10-161471
   Yin FF, 2010, J EXP MED, V207, P117, DOI 10.1084/jem.20091568
NR 42
TC 96
Z9 110
U1 1
U2 18
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3417
EI 1096-9896
J9 J PATHOL
JI J. Pathol.
PD SEP
PY 2012
VL 228
IS 1
BP 67
EP 76
DI 10.1002/path.4043
PG 10
WC Oncology; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Pathology
GA 996ND
UT WOS:000308095200007
PM 22733568
DA 2024-02-19
ER

PT J
AU Nebbia, C
   Dacasto, M
   Carletti, M
AF Nebbia, C
   Dacasto, M
   Carletti, M
TI Postnatal development of hepatic oxidative, hydrolytic and conjugative
   drug-metabolizing enzymes in female horses
SO LIFE SCIENCES
LA English
DT Article
ID AGE-RELATED-CHANGES; CADMIUM EXPOSURE; RAT-LIVER; MATURATIONAL
   DEVELOPMENT; INDUCTION; EXPRESSION; PROTEINS; SHEEP; DISPOSITION;
   CLENBUTEROL
AB Little is known about the effects of aging on the hepatic drug metabolizing capacity of horses despite the relatively long lifespan characterizing this species. A wide array of cytochrome P450 (CYP)-dependent monooxygenases, carboxylesterases and transferases were assayed in liver microsomes from 50 female horses in an age range between less than I year to over 12 years. Rather unexpectedly, both the CYP content and the activity of NADPH cytochrome c reductase rose as a function of age. Accordingly, a general increasing trend was recorded in the rate of the in vitro metabolism of the substrates reported to be related to CYP2B-, CYP2E- or CYP3A, although, as detected by Western immunoblotting, only the levels of proteins recognized by anti-rat CYP3A- and CYP2B antibodies appeared to increase consistently. Also the carboxylesterases and uridindiphosphoglucuronyl-transferase (UGT) activity toward 1-naphthol displayed a similar trend, glutathione S-transferase accepting 3,4-dichloronitrobenzene as a substrate being the only enzyme activity showing an age-related decline. A positive correlation was also found between liver cadmium content and CYP amount as well as the activities of most monooxygenases (except for those related to CYP1A), carboxylesterases, and UGT. While confirming that a number of enzyme activities are less expressed in foals, our results contradict the general view that the drug metabolizing capacity drops in elder individuals. Although several other factors can influence the kinetics of foreign compounds in aged animals, data from this study may provide insight in understanding possible age-related differences in drug efficacy and the response to toxic substances in horses. (C) 2003 Elsevier Inc. All rights reserved.
C1 Univ Turin, Dept Anim Pathol, Div Pharmacol & Toxicol, I-10095 Grugliasco, Italy.
C3 University of Turin
RP Nebbia, C (corresponding author), Univ Turin, Dept Anim Pathol, Div Pharmacol & Toxicol, Via Leonardo da Vinci 44, I-10095 Grugliasco, Italy.
EM carlo.nebbia@unito.it
CR ANKE M, 1989, ARCH TIERERNAHR, V39, P657, DOI 10.1080/17450398909428335
   ANTOINE B, 1988, BIOCHEM J, V252, P930, DOI 10.1042/bj2520930
   BAARS AJ, 1978, BIOCHEM PHARMACOL, V27, P2487, DOI 10.1016/0006-2952(78)90314-3
   BAGGOT JD, 1984, EQUINE VET J, V16, P364, DOI 10.1111/j.2042-3306.1984.tb01945.x
   BAGGOT JD, 2001, PHYSL BASIS VET CLIN, pCH7
   Baker JR, 2002, BIOCHEM PHARMACOL, V63, P693, DOI 10.1016/S0006-2952(01)00905-4
   Baker JR, 2001, BIOCHEM PHARMACOL, V62, P713, DOI 10.1016/S0006-2952(01)00716-X
   Baldini M, 2000, FOOD ADDIT CONTAM, V17, P679, DOI 10.1080/02652030050083204
   Beldoménico HR, 2001, ARCH ENVIRON CON TOX, V41, P100, DOI 10.1007/s002440010225
   Chauret N, 1997, DRUG METAB DISPOS, V25, P1130
   Coulet M, 1996, CAN J PHYSIOL PHARM, V74, P32, DOI 10.1139/cjpp-74-1-32
   DENT JG, 1976, TOXICOL APPL PHARM, V38, P237, DOI 10.1016/0041-008X(76)90132-0
   FINKGREMMELS J, 1996, EXP TOXICOL PATHOL, V48, P120
   FLAOYEN A, 1991, VET RES COMMUN, V15, P271, DOI 10.1007/BF00430031
   GIBSON GG, 1994, INTRO DRUG METABOLIS, pCH4
   HABIG WH, 1974, J BIOL CHEM, V249, P7130
   HOSOKAWA M, 1984, RES COMMUN CHEM PATH, V46, P245
   KADDOURI M, 1990, J VET PHARMACOL THER, V13, P340, DOI 10.1111/j.1365-2885.1990.tb00787.x
   KADIISKA M, 1985, ARCH TOXICOL, V56, P167, DOI 10.1007/BF00333421
   KAWALEK JC, 1990, AM J VET RES, V51, P1736
   KAWALEK JC, 1990, AM J VET RES, V51, P1742
   KAWALEK JC, 1994, AM J VET RES, V55, P1579
   KOMORI M, 1993, J BIOCHEM-TOKYO, V114, P445, DOI 10.1093/oxfordjournals.jbchem.a124195
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lake B.G., 1987, BIOCH TOXICOLOGY PRA, P182
   Lakritz J, 2000, AM J VET RES, V61, P152, DOI 10.2460/ajvr.2000.61.152
   Lewis DFV, 1996, CYTOCHROMES P450 MET, P355
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Monshouwer M, 2000, VET QUART, V22, P17, DOI 10.1080/01652176.2000.9695017
   MULDER GJ, 1975, BIOCHEM J, V151, P131, DOI 10.1042/bj1510131
   MUYLLE S, 2000, EQUINE DENT, P35
   NEBBIA C, 1993, PHARMACOL TOXICOL, V73, P233, DOI 10.1111/j.1600-0773.1993.tb01570.x
   Nebbia C, 1996, RES VET SCI, V60, P33, DOI 10.1016/S0034-5288(96)90127-7
   Nebbia C, 2003, VET J, V165, P53, DOI 10.1016/S1090-0233(02)00174-0
   Nebbia C, 2001, VET J, V161, P238, DOI 10.1053/tvjl.2000.0561
   NEBBIA C, 2001, J VET PHARMACOL THER, V24, P1
   Nordberg M, 1998, TALANTA, V46, P243, DOI 10.1016/S0039-9140(97)00345-7
   NOUSIANINEN U, 1984, TOXICOLOGY, V32, P243, DOI 10.1016/0300-483X(84)90077-5
   PEGGINS JO, 1984, DRUG METAB DISPOS, V12, P379
   RE G, 1993, AM J VET RES, V54, P438
   ROSENBERG DW, 1991, TOXICOLOGY, V67, P199, DOI 10.1016/0300-483X(91)90143-O
   RUTTEN AAJJL, 1987, ARCH TOXICOL, V61, P27, DOI 10.1007/BF00324544
   Sivapathasundaram S, 2001, BIOCHEM PHARMACOL, V62, P635, DOI 10.1016/S0006-2952(01)00710-9
   Tanaka E, 1998, J CLIN PHARM THER, V23, P247
   THOMFORD PJ, 1986, J ANIM SCI, V63, P1184, DOI 10.2527/jas1986.6341184x
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   UGAZIO G, 1993, TOXICOL LETT, V69, P279, DOI 10.1016/0378-4274(93)90033-T
   WALTNERTOEWS D, 1994, PREV VET MED, V20, P201, DOI 10.1016/0167-5877(94)90083-3
   Werringloer J, 1978, Methods Enzymol, V52, P297
   Wilkinson GR, 1997, ADV DRUG DELIVER REV, V27, P129, DOI 10.1016/S0169-409X(97)00040-9
   Yoshikawa S, 2000, J INORG BIOCHEM, V82, P1, DOI 10.1016/S0162-0134(00)00137-9
   ZEMAITIS MA, 1979, TOXICOL APPL PHARM, V48, P343, DOI 10.1016/0041-008X(79)90041-3
NR 52
TC 16
Z9 16
U1 0
U2 7
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0024-3205
J9 LIFE SCI
JI Life Sci.
PD FEB 13
PY 2004
VL 74
IS 13
BP 1605
EP 1619
DI 10.1016/j.lfs.2003.08.028
PG 15
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA 768JK
UT WOS:000188539700004
PM 14738905
DA 2024-02-19
ER

PT J
AU Memaran, N
   Wilke, H
   Sugianto, RI
   Baumann, U
   Bauer, E
   Swallow, M
   Beuke, E
   Junge, N
   Pfister, ED
   Grabitz, C
   Richter, N
   Goldschmidt, I
   Schmidt, BMW
   Melk, A
AF Memaran, Nima
   Wilke, Hannes
   Sugianto, Rizky, I
   Baumann, Ulrich
   Bauer, Elena
   Swallow, Maxine
   Beuke, Esther
   Junge, Norman
   Pfister, Eva D.
   Grabitz, Carl
   Richter, Nicolas
   Goldschmidt, Imeke
   Schmidt, Bernhard M. W.
   Melk, Anette
TI Telomere length is associated with intima-media thickness in pediatric
   liver transplant patients: A prospective cohort study
SO LIVER TRANSPLANTATION
LA English
DT Article; Early Access
ID CARDIOVASCULAR-DISEASE; SUBCLINICAL ATHEROSCLEROSIS; RISK-FACTORS;
   RECIPIENTS; CHILDREN; HYPERTENSION; SENESCENCE; DAMAGE
AB Leukocyte telomere length (LTL) is a marker for biological age. Pediatric liver transplant recipients show a high rate of subclinical atherosclerosis, indicated by elevated intima-media thickness (IMT). We hypothesized that atherosclerosis is associated with biological age in these patients and investigated the course of LTL over time. We measured LTL from peripheral blood leukocytes by quantitative polymerase chain reaction and IMT from 97 pediatric patients after liver transplantation in a prospective cohort study. Of the patients, 71% (n = 69) had two or more assessments (total, 228 observations; median follow-up, 1.1 years). Lower LTL was associated with higher IMT (beta = -0.701, p = 0.01) and higher aspartate aminotransferase (beta = -0.001, p = 0.02), adjusted for age, sex, and age at transplantation. Of the patients, 45% showed decreasing LTL over time, whereas 55% exhibited stable LTL. Patients with stable LTL showed a decrease in IMT (median, -0.02 mm/year) and a decrease of tacrolimus trough levels (median, -0.08 mu g/L/year). LTL is associated with IMT independent of age in pediatric liver transplant patients, suggesting that early aging contributes to the high burden of subclinical cardiovascular damage and may furthermore negatively affect the graft.
C1 [Memaran, Nima; Wilke, Hannes; Sugianto, Rizky, I; Bauer, Elena; Swallow, Maxine; Beuke, Esther; Grabitz, Carl; Melk, Anette] Hannover Med Sch, Pediat Nephrol, Dept Pediat Kidney Liver & Metab Dis, Hannover, Germany.
   [Baumann, Ulrich; Junge, Norman; Pfister, Eva D.; Goldschmidt, Imeke] Hannover Med Sch, Pediat Gastroenterol & Hepatol, Dept Pediat Kidney Liver & Metab Dis, Hannover, Germany.
   [Richter, Nicolas] Hannover Med Sch, Dept Gen Visceral & Transplantat Surg, Hannover, Germany.
   [Schmidt, Bernhard M. W.] Hannover Med Sch, Dept Nephrol & Hypertens, Hannover, Germany.
C3 Hannover Medical School; Hannover Medical School; Hannover Medical
   School; Hannover Medical School
RP Melk, A (corresponding author), Hannover Med Sch, Dept Pediat Kidney Liver & Metab Dis, Carl Neuberg Str 1, D-30625 Hannover, Germany.
EM melk.anette@mh-hannover.de
OI Sugianto, Rizky Indrameikha/0000-0002-7929-507X; Memaran,
   Nima/0000-0002-9510-3154
FU Bundesministerium fur Bildung und Forschung [01EO0802, 01EO1302]; Roche
   Organ Transplant Research Foundation
FX Bundesministerium fur Bildung und Forschung, Grant/Award Number:
   01EO0802 and 01EO1302; Roche Organ Transplant Research Foundation
CR Baragetti A, 2015, J INTERN MED, V277, P478, DOI 10.1111/joim.12282
   Barraclough JY, 2019, INT J CARDIOL, V278, P250, DOI 10.1016/j.ijcard.2018.12.065
   Blöte R, 2019, TRANSPLANTATION, V103, P2423, DOI 10.1097/TP.0000000000002675
   Calò LA, 2002, J CARDIOVASC PHARM, V40, P625, DOI 10.1097/00005344-200210000-00017
   Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47
   Cinegaglia N, 2019, AGING-US, V11, P5070, DOI 10.18632/aging.102098
   CURTIS JJ, 1988, AM J MED, V85, P134
   De Meyer T, 2009, EUR HEART J, V30, P3074, DOI 10.1093/eurheartj/ehp324
   de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548
   Demanelis K, 2020, SCIENCE, V369, P1333, DOI 10.1126/science.aaz6876
   Doyon A, 2013, HYPERTENSION, V62, P550, DOI 10.1161/HYPERTENSIONAHA.113.01297
   Dzau VJ, 2006, CIRCULATION, V114, P2850, DOI 10.1161/CIRCULATIONAHA.106.655688
   Ekong UD, 2019, PEDIATR TRANSPLANT, V23, DOI 10.1111/petr.13523
   Escribano A, 2016, EUR RESPIR J, V48, P350, DOI 10.1183/13993003.00176-2016
   Fernández-Alvira JM, 2016, J AM COLL CARDIOL, V67, P2467, DOI 10.1016/j.jacc.2016.03.530
   Fitzpatrick AL, 2007, AM J EPIDEMIOL, V165, P14, DOI [10.1093/aje/kwj346, 10.1093/aje/kw346]
   Frenck RW, 1998, P NATL ACAD SCI USA, V95, P5607, DOI 10.1073/pnas.95.10.5607
   Gelson W, 2010, LIVER TRANSPLANT, V16, P577, DOI 10.1002/lt.22033
   Harambat J, 2008, TRANSPLANTATION, V86, P1028, DOI 10.1097/TP.0b013e318187748f
   Huang YQ, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm.2020.03.205
   Jennings P, 2007, AM J PHYSIOL-RENAL, V293, pF831, DOI 10.1152/ajprenal.00005.2007
   Klotz O, 1912, J PATHOL BACTERIOL, V16, P211
   Lorenz MW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191172
   Masi S, 2014, EUR HEART J, V35, P3296, DOI 10.1093/eurheartj/ehu226
   Mclin VA, 2012, AM J TRANSPLANT, V12, P183, DOI 10.1111/j.1600-6143.2011.03772.x
   Memaran N, 2019, LIVER TRANSPLANT, V25, P752, DOI 10.1002/lt.25431
   Nguyen MT, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.012707
   Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555
   O'Donnell CJ, 2008, ARTERIOSCL THROM VAS, V28, P1165, DOI 10.1161/ATVBAHA.107.154849
   O'Rourke MF, 2010, VASC MED, V15, P461, DOI 10.1177/1358863X10382946
   Raeisi S, 2018, J BIOCHEM MOL TOXIC, V32, DOI 10.1002/jbt.22166
   Reichert S, 2017, BIOL LETTERS, V13, DOI 10.1098/rsbl.2017.0463
   Schwartz GJ, 2012, KIDNEY INT, V82, P445, DOI 10.1038/ki.2012.169
   Spigoni V, 2016, ACTA DIABETOL, V53, P661, DOI 10.1007/s00592-016-0857-x
   Touboul PJ, 2004, CEREBROVASC DIS, V18, P346, DOI 10.1159/000081812
   Uziel O, 2013, ANN TRANSPL, V18, P567, DOI 10.12659/AOT.889272
   van de Berg PJEJ, 2010, J IMMUNOL, V184, P3417, DOI 10.4049/jimmunol.0903442
   von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120
   VONZGLINICKI T, 1995, EXP CELL RES, V220, P186, DOI 10.1006/excr.1995.1305
   Watt KDS, 2010, AM J TRANSPLANT, V10, P1420, DOI 10.1111/j.1600-6143.2010.03126.x
   Willeit P, 2010, ARTERIOSCL THROM VAS, V30, P1649, DOI 10.1161/ATVBAHA.110.205492
   Zeichner SL, 1999, BLOOD, V93, P2824
NR 42
TC 0
Z9 0
U1 1
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1527-6465
EI 1527-6473
J9 LIVER TRANSPLANT
JI Liver Transplant.
PD 2022 NOV
PY 2022
VL 28
IS 11
BP 1766
EP 1775
DI 10.1002/lt.26524
EA JUN 2022
PG 10
WC Gastroenterology & Hepatology; Surgery; Transplantation
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology; Surgery; Transplantation
GA 5I9AI
UT WOS:000814107500001
PM 35666175
OA hybrid
DA 2024-02-19
ER

PT J
AU Pallet, V
   Azaïs-Braesco, V
   Enderlin, V
   Grolier, P
   Noël-Suberville, C
   Garcin, H
   Higueret, P
AF Pallet, V
   Azaïs-Braesco, V
   Enderlin, V
   Grolier, P
   Noël-Suberville, C
   Garcin, H
   Higueret, P
TI Aging decreases retinoic acid and triiodothyronine nuclear expression in
   rat liver:: exogenous retinol and retinoic acid differentially modulate
   this decreased expression
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE aging; nuclear receptor; RAR; TR; mRNA; retinol; retinoic acid
ID PROTEIN-KINASE-C; THYROID-HORMONE RECEPTORS; DIETARY VITAMIN-A; MALIC
   ENZYME GENE; TISSUE TRANSGLUTAMINASE; GLUCOCORTICOID RECEPTORS; RESPONSE
   ELEMENT; AGED RATS; BINDING; ALPHA
AB The expression of nuclear receptors of retinoic acid (RAR) and triiodothyronine (TR) was analyzed in the liver of rats aged 2.5 (young), 6 (adult) and 24 (aged) months. In aged rats, decreased binding properties, binding capacity (C-max) and affinity (K-a), of nuclear receptors were observed. This resulted, at least in part, from decreased transcription of receptor genes in that the amount of their mRNA also decreased. Moreover, the activity of malic enzyme (ME) and tissue transglutaminase (tTG), whose genes are TR and RAR responsive, respectively, was reduced in aged rats. These results are in agreement with the decreased binding capacity of these receptors. An inducer-related increase of RAR and TR expression was observed 24 h after a single dose of retinoic acid administration (5 mg/kg), while retinol administration (retinyl palmitate, 13 mg/kg) was without incidence on nuclear receptor expression in aged rats. (C) 1997 Elsevier Science Ireland Ltd.
C1 Univ Bordeaux 1, Lab Nutr, ISTAB, F-33405 Talence, France.
   INRA, Ctr Rech Nutr Humaine, F-63009 Clermont Ferrand, France.
C3 Universite de Bordeaux; INRAE
RP Higueret, P (corresponding author), Univ Bordeaux 1, Lab Nutr, ISTAB, Ave Fac, F-33405 Talence, France.
CR AUDOUINCHEVALLIER I, 1993, J NUTR, V123, P1195, DOI 10.1093/jn/123.7.1195
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   CHIOCCA EA, 1989, J CELL BIOCHEM, V39, P293, DOI 10.1002/jcb.240390309
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   Coustaut M, 1996, BRIT J NUTR, V76, P295, DOI 10.1079/BJN19960033
   DAVIES PJA, 1985, J BIOL CHEM, V260, P5166
   DAVIS PJ, 1979, CLIN ENDOCRINOL META, V8, P603, DOI 10.1016/S0300-595X(79)80033-X
   DECOURCY GP, 1989, SCI ALIMENT, V9, P209
   DEGROOT LJ, 1975, ENDOCRINOLOGY, V96, P357, DOI 10.1210/endo-96-2-357
   DELESCLUSE C, 1991, MOL PHARMACOL, V40, P556
   DETHE H, 1989, EMBO J, V8, P429, DOI 10.1002/j.1460-2075.1989.tb03394.x
   DICE JF, 1988, LIVER BIOL PATHOBIOL, P1245
   FAURE R, 1988, ENDOCRINOLOGY, V123, P1245, DOI 10.1210/endo-123-3-1245
   FINUCANE P, 1995, DRUG AGING, V6, P268, DOI 10.2165/00002512-199506040-00002
   FROLKIS VV, 1978, GERONTOLOGY, V24, P81, DOI 10.1159/000212240
   GAUB MP, 1992, EXP CELL RES, V201, P335, DOI 10.1016/0014-4827(92)90282-D
   GOLDBERG Y, 1988, EMBO J, V7, P2425, DOI 10.1002/j.1460-2075.1988.tb03088.x
   HALLFRISCH J, 1994, AM J CLIN NUTR, V60, P176, DOI 10.1093/ajcn/60.2.176
   HAMADA S, 1979, BIOCHEM J, V182, P371, DOI 10.1042/bj1820371
   HENDRIKS HFJ, 1988, EUR J BIOCHEM, V171, P237, DOI 10.1111/j.1432-1033.1988.tb13782.x
   HENDRIKS HFJ, 1988, FALK S, V47, P349
   KURIE JM, 1993, BIOCHIM BIOPHYS ACTA, V1179, P203, DOI 10.1016/0167-4889(93)90142-C
   KVETNY J, 1985, HORM METAB RES, V17, P35, DOI 10.1055/s-2007-1013441
   MA XJ, 1990, J BIOL CHEM, V265, P18435
   MCLAREN DS, 1979, P NUTR SOC, V38, pA49
   MITSUHASHI T, 1989, J BIOL CHEM, V264, P8900
   MOORADIAN AD, 1990, BIOCHIM BIOPHYS ACTA, V1054, P1, DOI 10.1016/0167-4889(90)90197-L
   MOORADIAN AD, 1994, EUR J ENDOCRINOL, V131, P451, DOI 10.1530/eje.0.1310451
   MURRAY MB, 1988, J BIOL CHEM, V263, P12770
   NAGELKERKE JF, 1983, J BIOL CHEM, V258, P2221
   Nagy L, 1996, J BIOL CHEM, V271, P4355
   NAYER P, 1991, HORM METAB RES, V23, P12
   NUDEL U, 1983, NUCLEIC ACIDS RES, V11, P1759, DOI 10.1093/nar/11.6.1759
   OLSEN T, 1978, J CLIN ENDOCR METAB, V47, P1111, DOI 10.1210/jcem-47-5-1111
   PAILLERRODDE I, 1991, J ENDOCRINOL, V128, P245, DOI 10.1677/joe.0.1280245
   PERIQUET B, 1986, THESIS U P SABATIER
   PETTY KJ, 1990, J BIOL CHEM, V265, P7395
   PIACENTINI M, 1992, BIOCHIM BIOPHYS ACTA, V1135, P171, DOI 10.1016/0167-4889(92)90134-W
   RIAZULHAQ, 1991, P NATL ACAD SCI USA, V88, P8272, DOI 10.1073/pnas.88.18.8272
   ROCHETTEEGLY C, 1992, MOL ENDOCRINOL, V6, P2197, DOI 10.1210/me.6.12.2197
   ROGUE PJ, 1993, FEBS LETT, V334, P351, DOI 10.1016/0014-5793(93)80710-C
   SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875
   SIEBERT PD, 1993, BIOTECHNIQUES, V14, P244
   STRAIT KA, 1990, J BIOL CHEM, V265, P10514
   SUNDBOOM J, 1984, EXP GERONTOL, V19, P257, DOI 10.1016/0531-5565(84)90021-4
   TAHAYATO A, 1993, MOL ENDOCRINOL, V7, P1642, DOI 10.1210/me.7.12.1642
   TAUCHI H, 1994, ARCH GERONTOL GERIAT, V19, P135, DOI 10.1016/0167-4943(94)90035-3
   TERAMOTO S, 1994, AM J RESP CRIT CARE, V150, P238, DOI 10.1164/ajrccm.150.1.8025756
   TORRESANI J, 1975, ENDOCRINOLOGY, V96, P1201, DOI 10.1210/endo-96-5-1201
   WEINER FR, 1992, HEPATOLOGY, V15, P336, DOI 10.1002/hep.1840150226
   WISE EM, 1964, P NATL ACAD SCI USA, V52, P1255, DOI 10.1073/pnas.52.5.1255
   ZELENT A, 1989, NATURE, V339, P714, DOI 10.1038/339714a0
NR 52
TC 22
Z9 22
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD DEC 15
PY 1997
VL 99
IS 2
BP 123
EP 136
DI 10.1016/S0047-6374(97)00098-5
PG 14
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA YM365
UT WOS:000071056300004
PM 9483487
DA 2024-02-19
ER

PT J
AU Malin, SK
   del Rincon, JP
   Huang, H
   Kirwan, JP
AF Malin, Steven K.
   del Rincon, Juan Pablo
   Huang, Hazel
   Kirwan, John P.
TI Exercise-Induced Lowering of Fetuin-A May Increase Hepatic Insulin
   Sensitivity
SO MEDICINE AND SCIENCE IN SPORTS AND EXERCISE
LA English
DT Article
DE OBESITY; INFLAMMATION; EXERCISE TRAINING; AGING; GLUCOSE TOLERANCE
ID RECEPTOR TYROSINE KINASE; FATTY LIVER-DISEASE; METABOLIC SYNDROME;
   ADIPONECTIN; EXPRESSION; RESISTANCE; OBESITY; INHIBITOR; PROGRAM;
   GLUCOSE
AB Introduction: Fetuin-A is a novel hepatokine, and there is preliminary evidence that it may contribute to the pathogenesis of type 2 diabetes. Exercise reduces fetuin-A, but the specific metabolic effects particularly as they relate to the regulation of insulin resistance are unknown. This led us to examine the effect of exercise training on circulating fetuin-A in relation to skeletal muscle and/or hepatic insulin resistance in obese adults. Methods: Twenty older adults (66.3 +/- 0.9 yr; body mass index, 34.1 +/- 1.2 kg.m(-2)) participated in this prospective 12-wk study and underwent supervised exercise training (5 d.wk(-1), 60 min.d(-1) at approximately 85% HRmax). Insulin resistance was assessed using the euglycemic-hyperinsulinemic clamp (40 mU.m(-2).min(-1)) with isotope dilution ([6,6-H-2(2)]-glucose). Skeletal muscle insulin sensitivity (rate of glucose disposal), hepatic insulin resistance (rate of glucose appearance x fasting insulin), metabolic flexibility (respiratory quotient(clamp) - respiratory quotient(fasting)), fetuin-A, high-molecular weight adiponectin, high-sensitivity C-reactive protein, leptin, and body fat (dual energy x-ray absorptiometry) were measured before and after the intervention. Results: Exercise reduced body fat, high-sensitivity C-reactive protein, leptin and hepatic as well as skeletal muscle insulin resistance (each, P < 0.05). Fetuin-A was decreased by approximately 8% (pre, 1.01 +/- 0.08, vs post, 0.89 +/- 0.06 g.L-1; P < 0.05) after the intervention, and lower fetuin-A after exercise correlated with lower hepatic insulin resistance (r = -0.46, P < 0.01), increased metabolic flexibility (r = -0.70, P < 0.01) and high-molecular weight adiponectin (r = -0.57, P < 0.01). Conclusions: Fetuin-A may contribute to exercise training-induced improvements in hepatic insulin resistance, CHO utilization, and inflammation in older obese adults. Further work is required to determine the cellular mechanism(s) of action for fetuin-A because this hepatokine is related to type 2 diabetes risk.
C1 [Malin, Steven K.; del Rincon, Juan Pablo; Huang, Hazel; Kirwan, John P.] Cleveland Clin, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44195 USA.
   [Malin, Steven K.; Kirwan, John P.] Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH USA.
   [Kirwan, John P.] Cleveland Clin, Metab Translat Res Ctr, Endocrinol & Metab Inst, Cleveland, OH 44195 USA.
C3 Cleveland Clinic Foundation; University System of Ohio; Case Western
   Reserve University; Cleveland Clinic Foundation
RP Kirwan, JP (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Pathobiol, 9500 Euclid Ave NE40, Cleveland, OH 44195 USA.
EM kirwanj@ccf.org
RI Malin, Steven/IXX-0225-2023; del Rincon Jarero, Juan
   Pablo/HOH-4795-2023; Kirwan, John P/G-6942-2012; del Rincon, Juan
   P/A-1954-2013
OI del Rincon Jarero, Juan Pablo/0000-0002-3623-3784; Malin,
   Steven/0000-0002-7360-6711
FU National Institutes of Health (NIH) grants [RO1 AG-12834]; NIH National
   Center for Research Resources, Cleveland, OH [UL1RR024989]; NIH [T32
   DK-007319]; Department of Medicine Physician Scientist Pathway at the
   MetroHealth Campus of Case Western Reserve University;  [R01DK089547-S1]
FX This research was supported by National Institutes of Health (NIH)
   grants RO1 AG-12834 (J. P. K.) and NIH National Center for Research
   Resources, UL1RR024989, Cleveland, OH. Support for S. K. M. was provided
   by NIH grant T32 DK-007319, and J. P. D. R. was supported by
   R01DK089547-S1 and the Department of Medicine Physician Scientist
   Pathway at the MetroHealth Campus of Case Western Reserve University.
CR AUBERGER P, 1989, CELL, V58, P631, DOI 10.1016/0092-8674(89)90098-6
   Blüher M, 2012, DIABETES CARE, V35, P342, DOI 10.2337/dc11-1267
   Brons C, 2009, J PHYSIOL-LONDON, V587, P2387, DOI 10.1113/jphysiol.2009.169078
   Choi KM, 2013, CLIN ENDOCRINOL, V79, P356, DOI 10.1111/cen.12076
   Hennige AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001765
   Iwabu M, 2010, NATURE, V464, P1313, DOI 10.1038/nature08991
   Ix JH, 2010, J AM SOC NEPHROL, V21, P406, DOI 10.1681/ASN.2009080820
   Jenkins NT, 2011, METABOLISM, V60, P265, DOI 10.1016/j.metabol.2010.01.026
   Jung TW, 2013, BIOCHEM PHARMACOL, V86, P960, DOI 10.1016/j.bcp.2013.07.034
   Kelly KR, 2012, MED SCI SPORT EXER, V44, P69, DOI 10.1249/MSS.0b013e318228bf85
   Kirk E, 2009, GASTROENTEROLOGY, V136, P1552, DOI 10.1053/j.gastro.2009.01.048
   Lin X, 1998, LIFE SCI, V63, P145, DOI 10.1016/S0024-3205(98)00250-1
   Malin SK, 2013, AM J PHYSIOL-ENDOC M, V305, pE1292, DOI 10.1152/ajpendo.00441.2013
   Malin SK, 2013, J APPL PHYSIOL, V115, P988, DOI 10.1152/japplphysiol.00237.2013
   Mathews ST, 2002, DIABETES, V51, P2450, DOI 10.2337/diabetes.51.8.2450
   Mathews ST, 2006, BIOCHEM BIOPH RES CO, V350, P437, DOI 10.1016/j.bbrc.2006.09.071
   Mori K, 2008, METABOLISM, V57, P1248, DOI 10.1016/j.metabol.2008.04.019
   O'Leary VB, 2007, AM J PHYSIOL-ENDOC M, V293, pE421, DOI 10.1152/ajpendo.00123.2007
   Pal D, 2012, NAT MED, V18, P1279, DOI 10.1038/nm.2851
   Reinehr T, 2008, J CLIN ENDOCR METAB, V93, P4479, DOI 10.1210/jc.2008-1505
   Schultes B, 2010, EXP CLIN ENDOCR DIAB, V118, P754, DOI 10.1055/s-0030-1253418
   Simpson KA, 2008, OBESITY, V16, P241, DOI 10.1038/oby.2007.53
   Stefan N, 2006, DIABETES CARE, V29, P853, DOI 10.2337/diacare.29.04.06.dc05-1938
   Sutherland JP, 2004, METAB SYNDR RELAT D, V2, P82, DOI 10.1089/met.2004.2.82
   Turer AT, 2012, DIABETOLOGIA, V55, P2319, DOI 10.1007/s00125-012-2598-x
   Yang SJ, 2011, CLIN ENDOCRINOL, V75, P464, DOI 10.1111/j.1365-2265.2011.04078.x
   You TJ, 2013, SPORTS MED, V43, P243, DOI 10.1007/s40279-013-0023-3
NR 27
TC 51
Z9 52
U1 0
U2 19
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0195-9131
EI 1530-0315
J9 MED SCI SPORT EXER
JI Med. Sci. Sports Exerc.
PD NOV
PY 2014
VL 46
IS 11
BP 2085
EP 2090
DI 10.1249/MSS.0000000000000338
PG 6
WC Sport Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Sport Sciences
GA AS3AU
UT WOS:000344148600007
PM 24637346
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Miles, ED
   McBride, BW
   Bridges, PJ
   Matthews, JC
AF Miles, Edwena D.
   McBride, Brian W.
   Bridges, Phillip J.
   Matthews, James C.
TI Effect of 17<i>β</i>-estradiol administration on hepatic expression of
   glutamine synthetase, <i>β</i>-catenin, and GPR30 in young and aged beef
   cows
SO CANADIAN JOURNAL OF ANIMAL SCIENCE
LA English
DT Article
DE aging; beta-catenin; cattle; estrogen; G protein-coupled receptor 30
   (GPR30); glutamine synthetase
ID G-PROTEIN; ESTROGEN-RECEPTORS; GENE-EXPRESSION; MESSENGER-RNA;
   WNT/BETA-CATENIN; LIVER; IDENTIFICATION; PATHWAY; PATTERN; ENZYMES
AB To test the hypothesis that increased circulating estradiol increases hepatic glutamine synthetase (GS) content in young and aged cows, and two nonclassical nongenomic estradiol pathway intermediates [beta-catenin, G protein-coupled receptor 30 (GPR30)], 12 young (3-4 yr) and 12 aged (>= 8 yr) cows were randomly allotted (n = 6) and received either none or estradiol (TRT) implants (Compudose (R)) for 28 d. Blood and liver samples were collected on days 16 and 28 and the effects of TRT, cow age (age), time after implant (day), and their interactions were analyzed by analysis of variance (ANOVA). Plasma estradiol was increased by TRT in young and aged cows on days 16 and 28 and on day 28 vs. day 16. An age x day interaction (P = 0.01) revealed lower GS mRNA at day 28 in young cows but increased mRNA in aged cows. Aged cows had less GS protein than young cows, and a TRT x day interaction (P = 0.02) reflected 134% more of GS on day 16 in TRT in aged cows. No main or interaction effects were found for progesterone, beta-catenin, or GPR30. We conclude that hepatic GS expression is transiently stimulated by increased circulating estradiol, whereas expression of beta-catenin or GPR30 was not affected.
C1 [Miles, Edwena D.; Bridges, Phillip J.; Matthews, James C.] Univ Kentucky, Dept Anim & Food Sci, Lexington, KY 40546 USA.
   [McBride, Brian W.] Univ Guelph, Dept Anim & Poultry Sci, Guelph, ON N1G 2W1, Canada.
C3 University of Kentucky; University of Guelph
RP Matthews, JC (corresponding author), Univ Kentucky, Dept Anim & Food Sci, Lexington, KY 40546 USA.
EM jmatthew@uky.edu
RI Matthews, James/HLH-3293-2023; Matthews, James Clyde/Y-1849-2019
FU University of Kentucky Lyman T. Johnson Fellowship; Natural Sciences and
   Engineering Research Council of Canada; National Institute of Food and
   Agriculture; U.S. Department of Agriculture [1000591]; NIFA [689119,
   1000591] Funding Source: Federal RePORTER
FX This is publication No. 16-07-079 of the Kentucky Agricultural
   Experiment Station and is published with approval of the Director. This
   work is supported by the University of Kentucky Lyman T. Johnson
   Fellowship (to E.D.M.), the Natural Sciences and Engineering Research
   Council of Canada (B.W.M.), and the National Institute of Food and
   Agriculture, U.S. Department of Agriculture, Multistate project No.
   1000591 (J.C.M.).
CR Albanito L, 2007, CANCER RES, V67, P1859, DOI 10.1158/0008-5472.CAN-06-2909
   Applied Biosystems, 2004, GUID PERF REL QUANT, P28
   Baker JF, 2003, J ANIM SCI, V81, P1693
   Bif, 1996, GUID UN BEEF IMPR PR
   Blutstein T, 2006, J NEUROENDOCRINOL, V18, P692, DOI 10.1111/j.1365-2826.2006.01466.x
   Brennan KM, 2011, BIOL TRACE ELEM RES, V144, P504, DOI 10.1007/s12011-011-9069-y
   Brown KR, 2009, J ANIM SCI, V87, P748, DOI 10.2527/jas.2008-1108
   Burke ZD, 2006, BIOESSAYS, V28, P1072, DOI 10.1002/bies.20485
   Cadoret A, 2002, ONCOGENE, V21, P8293, DOI 10.1038/sj.onc.1206118
   Chakrabarti S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052357
   Clinkenbeard EL, 2012, HEPATOLOGY, V56, P1892, DOI 10.1002/hep.25819
   Cui K, 2014, GENE, V546, P277, DOI 10.1016/j.gene.2014.05.067
   DANH HC, 1985, GERONTOLOGY, V31, P95, DOI 10.1159/000212686
   Dhahbi JM, 1999, AM J PHYSIOL-ENDOC M, V277, pE352, DOI 10.1152/ajpendo.1999.277.2.E352
   Eyster KM, 2016, METHODS MOL BIOL, V1366, P1, DOI 10.1007/978-1-4939-3127-9_1
   Fuerst-Waltl B, 2004, J DAIRY SCI, V87, P2293, DOI 10.3168/jds.S0022-0302(04)70050-8
   Haghighat N, 2005, NEUROCHEM RES, V30, P661, DOI 10.1007/s11064-005-2754-5
   Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006
   Howell JA, 2001, J ANIM SCI, V79, P1329
   Hsieh YC, 2007, AM J PATHOL, V170, P1210, DOI 10.2353/ajpath.2007.060883
   Jala VR, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-624
   Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558
   Kouzmenko AP, 2004, J BIOL CHEM, V279, P40255, DOI 10.1074/jbc.C400331200
   Liao SF, 2008, J ANIM SCI, V86, P620, DOI 10.2527/jas.2006-727
   Liao SF, 2015, J ANIM SCI, V93, P5659, DOI 10.2527/jas.2015-9193
   Miles E. D., 2015, J ANIM SCI, V93, P5659, DOI [10.2527/jas.2015-9193, DOI 10.2527/JAS.2015-9193]
   NATIONAL RESEARCH COUNCIL - NRC, 1996, NUTR REQ BEEF CATTL, DOI DOI 10.17226/9791
   Pfaffl MW, 2001, APMIS, V109, P345, DOI 10.1034/j.1600-0463.2001.090503.x
   Prossnitz ER, 2011, NAT REV ENDOCRINOL, V7, P715, DOI 10.1038/nrendo.2011.122
   Reinhardt C, 2007, VET CLIN N AM-FOOD A, V23, P309, DOI 10.1016/j.cvfa.2007.03.004
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Sersté T, 2006, ACTA GASTRO-ENT BELG, V69, P296
   Sheng ZG, 2011, ENVIRON HEALTH PERSP, V119, P1775, DOI 10.1289/ehp.1103781
   Sipe G. L., 2004, THESIS U KENTUCKY LE
   Sirma H, 1996, LIVER, V16, P166
   Songeregger S., 2010, PLACENTA, V31, P839, DOI DOI 10.1016/J.PLACENTA.2010.07.011
   Spindler SR, 2001, ANN NY ACAD SCI, V928, P296
   Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064
   Watford M, 2000, J NUTR, V130, p983S, DOI 10.1093/jn/130.4.983S
   Xue Y, 2011, J DAIRY SCI, V94, P3331, DOI 10.3168/jds.2010-3612
   Xue Y, 2010, J ANIM SCI, V88, P707, DOI 10.2527/jas.2009-2101
   Zhao JX, 2011, DOMEST ANIM ENDOCRIN, V40, P222, DOI 10.1016/j.domaniend.2011.01.004
   Zucman-Rossi J, 2007, ONCOGENE, V26, P774, DOI 10.1038/sj.onc.1209824
NR 43
TC 3
Z9 4
U1 0
U2 7
PU CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS
PI OTTAWA
PA 65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA
SN 0008-3984
EI 1918-1825
J9 CAN J ANIM SCI
JI Can. J. Anim. Sci.
PD JUN
PY 2017
VL 97
IS 2
BP 281
EP 289
DI 10.1139/cjas-2016-0002
PG 9
WC Agriculture, Dairy & Animal Science
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Agriculture
GA EW2HC
UT WOS:000402316300015
OA Bronze
DA 2024-02-19
ER

PT J
AU Sun, R
   Wang, X
   Chen, JJ
   Teng, D
   Chan, SX
   Tu, XC
   Wang, ZL
   Zuo, XM
   Wei, X
   Lin, L
   Zhang, Q
   Zhang, XM
   Tang, KC
   Zhang, HB
   Chen, W
AF Sun, Rui
   Wang, Xu
   Chen, Jiajie
   Teng, Da
   Chan, Shixin
   Tu, Xucan
   Wang, Zhenglin
   Zuo, Xiaomin
   Wei, Xiang
   Lin, Li
   Zhang, Qing
   Zhang, Xiaomin
   Tang, Kechao
   Zhang, Huabing
   Chen, Wei
TI Development and validation of a novel cellular senescence-related
   prognostic signature for predicting the survival and immune landscape in
   hepatocellular carcinoma
SO FRONTIERS IN GENETICS
LA English
DT Article
DE hepatocellular carcinoma; lncRNA; senescence; prognosis; immune
   landscape
ID EXPRESSION; LNCRNA; CANCER
AB Background: Cellular senescence is a typical irreversible form of life stagnation, and recent studies have suggested that long non-coding ribonucleic acids (lncRNA) regulate the occurrence and development of various tumors. In the present study, we attempted to construct a novel signature for predicting the survival of patients with hepatocellular carcinoma (HCC) and the associated immune landscape based on senescence-related (sr) lncRNAs. Method: Expression profiles of srlncRNAs in 424 patients with HCC were retrieved from The Cancer Genome Atlas database. Lasso and Cox regression analyses were performed to identify differentially expressed lncRNAs related to senescence. The prediction efficiency of the signature was checked using a receiver operating characteristic (ROC) curve, Kaplan-Meier analysis, Cox regression analyses, nomogram, and calibration. The risk groups of the gene set enrichment analysis, immune analysis, and prediction of the half-maximal inhibitory concentration (IC50) were also analyzed. Quantitative real-time polymerase chain reaction (qPCR) was used to confirm the levels of AC026412.3, AL451069.3, and AL031985.3 in normal hepatic and HCC cell lines. Results: We identified 3 srlncRNAs (AC026412.3, AL451069.3, and AL031985.3) and constructed a new risk model. The results of the ROC curve and Kaplan-Meier analysis suggested that it was concordant with the prediction. Furthermore, a nomogram model was constructed to accurately predict patient prognosis. The risk score also correlated with immune cell infiltration status, immune checkpoint expression, and chemosensitivity. The results of qPCR revealed that AC026412.3 and AL451069.3 were significantly upregulated in hepatoma cell lines. Conclusion: The novel srlncRNA (AC026412.3, AL451069.3, and AL031985.3) signatures may provide insights into new therapies and prognosis predictions for patients with HCC.
C1 [Sun, Rui; Wang, Xu; Chan, Shixin; Tu, Xucan; Wang, Zhenglin; Zuo, Xiaomin; Chen, Wei] Anhui Med Univ, Dept Gen Surg, Affiliated Hosp 1, Hefei, Peoples R China.
   [Chen, Jiajie] Anhui Med Univ, Dept Dermatol, Affiliated Hosp 1, Hefei, Peoples R China.
   [Teng, Da] Anhui Med Univ, Peoples Hosp Chuzhou 1, Dept Hepatopancreatobiliary Surg, Affiliated Chuzhou Hosp, Chuzhou, Peoples R China.
   [Wei, Xiang; Lin, Li; Zhang, Qing; Zhang, Xiaomin; Tang, Kechao; Zhang, Huabing] Anhui Med Univ, Metab Dis Res Ctr, Sch Basic Med, Dept Biochem & Mol Biol, Hefei, Peoples R China.
   [Zhang, Huabing] Anhui Med Univ, Peoples Hosp Chuzhou 1, Affiliated Chuzhou Hosp, Chuzhou, Peoples R China.
C3 Anhui Medical University; Anhui Medical University; Anhui Medical
   University; Anhui Medical University; Anhui Medical University
RP Chen, W (corresponding author), Anhui Med Univ, Dept Gen Surg, Affiliated Hosp 1, Hefei, Peoples R China.; Zhang, HB (corresponding author), Anhui Med Univ, Metab Dis Res Ctr, Sch Basic Med, Dept Biochem & Mol Biol, Hefei, Peoples R China.; Zhang, HB (corresponding author), Anhui Med Univ, Peoples Hosp Chuzhou 1, Affiliated Chuzhou Hosp, Chuzhou, Peoples R China.
EM huabingzhang@ahmu.edu.cn; chenwei366@126.com
RI Zhang, Xiaomin/GVT-8927-2022; zhang, xiaomin/IQX-1078-2023
OI Wang, Xu/0000-0003-1094-1843
FU National Natural Science Foundation of China; Research Fund of the Anhui
   Institute of Translational Medicine [81670517, 81870402]; 
   [2021zhyx-C30]
FX This work was supported by the National Natural Science Foundation of
   China (Nos.81670517 and 81870402) and the Research Fund of the Anhui
   Institute of Translational Medicine (2021zhyx-C30).
CR Adekeye A, 2022, J SURG RES, V271, P154, DOI 10.1016/j.jss.2021.08.033
   Aran D, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1349-1
   Atianand MK, 2017, ANNU REV IMMUNOL, V35, P177, DOI 10.1146/annurev-immunol-041015-055459
   Bagchi S, 2021, ANNU REV PATHOL-MECH, V16, P223, DOI 10.1146/annurev-pathol-042020-042741
   Balachandran VP, 2015, LANCET ONCOL, V16, pE173, DOI 10.1016/S1470-2045(14)71116-7
   Becht E, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1070-5
   Bray F, 2021, CANCER-AM CANCER SOC, V127, P3029, DOI 10.1002/cncr.33587
   Castro-Oropeza R, 2018, CELL ONCOL, V41, P585, DOI 10.1007/s13402-018-0406-4
   Chen Y, 2021, CLIN CANCER RES, V27, P330, DOI 10.1158/1078-0432.CCR-20-2166
   Finotello F, 2019, GENOME MED, V11, DOI 10.1186/s13073-019-0638-6
   Hama K, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-85603-w
   Hanahan D, 2022, CANCER DISCOV, V12, P31, DOI 10.1158/2159-8290.CD-21-1059
   Heery R, 2017, CANCERS, V9, DOI 10.3390/cancers9040038
   Hong WF, 2020, MOL THER-NUCL ACIDS, V22, P937, DOI 10.1016/j.omtn.2020.10.002
   Iasonos A, 2008, J CLIN ONCOL, V26, P1364, DOI 10.1200/JCO.2007.12.9791
   Iyer MK, 2015, NAT GENET, V47, P199, DOI 10.1038/ng.3192
   Jia Y, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.608668
   Kandimalla R, 2020, CLIN CANCER RES, V26, P3641, DOI 10.1158/1078-0432.CCR-19-4044
   Karakousis ND, 2020, LIVER INT, V40, P2917, DOI 10.1111/liv.14659
   Kono K, 2020, GASTRIC CANCER, V23, P565, DOI 10.1007/s10120-020-01090-4
   Li TW, 2017, CANCER RES, V77, pE108, DOI 10.1158/0008-5472.CAN-17-0307
   Liu Y, 2020, ONCOTARGETS THER, V13, P9377, DOI 10.2147/OTT.S261700
   Llovet JM, 2021, NAT REV DIS PRIMERS, V7, DOI 10.1038/s41572-020-00240-3
   Luo ZF, 2016, WORLD J GASTROENTERO, V22, P5254, DOI 10.3748/wjg.v22.i22.5254
   Miao D, 2018, SCIENCE, V359, P801, DOI 10.1126/science.aan5951
   Mittermeier C, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9122540
   Montes M, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22746-4
   Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/NMETH.3337, 10.1038/nmeth.3337]
   Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007
   Song JH, 2021, BIOENGINEERED, V12, P5932, DOI 10.1080/21655979.2021.1972078
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Sung H., 2021, CA Cancer J. Clin, V71, P209, DOI DOI 10.3322/caac.21660
   Tamminga M, 2020, CLIN TRANSL IMMUNOL, V9, DOI 10.1002/cti2.1142
   Tatangelo F, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1725-y
   Thorsson V, 2019, IMMUNITY, V51, P411, DOI [10.1016/j.immuni.2018.03.023, 10.1016/j.immuni.2019.08.004]
   Toor SM, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02936
   van Veldhoven CM, 2011, EUR J CANCER, V47, P748, DOI 10.1016/j.ejca.2010.11.010
   Wei ZJ, 2020, GASTRIC CANCER, V23, P1018, DOI 10.1007/s10120-020-01091-3
   Xiang XH, 2021, THERANOSTICS, V11, P4929, DOI 10.7150/thno.55672
   Xu JJ, 2022, CANCER CELL INT, V22, DOI 10.1186/s12935-022-02508-y
   Zhao LJ, 2019, AGING-US, V11, P7098, DOI 10.18632/aging.102240
   Zhou PC, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.661758
NR 42
TC 6
Z9 6
U1 6
U2 9
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 1664-8021
J9 FRONT GENET
JI Front. Genet.
PD SEP 6
PY 2022
VL 13
AR 949110
DI 10.3389/fgene.2022.949110
PG 13
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 4Q4IV
UT WOS:000856048000001
PM 36147502
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Shrestha, P
   Adepu, S
   Vivès, RR
   El Masri, R
   Klooster, A
   Kaptein, F
   Dam, W
   Bakker, SJL
   van Goor, H
   van de Sluis, B
   van den Born, J
AF Shrestha, Pragyi
   Adepu, Saritha
   Vives, Romain R.
   El Masri, Rana
   Klooster, Astrid
   Kaptein, Fleur
   Dam, Wendy
   Bakker, Stephan J. L.
   van Goor, Harry
   van de Sluis, Bart
   van den Born, Jacob
TI Hypercholesterolemia in Progressive Renal Failure Is Associated with
   Changes in Hepatic Heparan Sulfate-PCSK9 Interaction
SO JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
LA English
DT Article
ID CHRONIC KIDNEY-DISEASE; DENSITY-LIPOPROTEIN RECEPTOR; MOLECULAR-WEIGHT
   HEPARIN; SMOOTH-MUSCLE-CELLS; UP-REGULATION; PLASMA PCSK9;
   CARDIOVASCULAR-DISEASE; GENE-EXPRESSION; POOLED ANALYSIS; PROTEOGLYCANS
AB Background Dyslipidemia is an important risk factor in CKD. The liver clears triglyceride-rich lipoproteins (TRL) via LDL receptor (LDLR), LDLR-related protein-1 (LRP-1), and heparan sulfate proteoglycans (HSPGs), mostly syndecan-1. HSPGs also facilitate LDLR degradation by proprotein convertase subtilisin/kexin type 9 (PCSK9). Progressive renal failure affects the structure and activity of hepatic lipoprotein receptors, PCSK9, and plasma cholesterol.
   Methods Uninephrectomy- and aging-induced CKD in normotensive Wistar rats and hypertensive Munich-Wistar-Fromter (MWF) rats.
   Results Compared with 22-week-old sex- and strain-matched rats, 48-week-old uninephrectomized Wistar-CKD and MWF-CKD rats showed proteinuria, increased plasma creatinine, and hypercholesterolemia (all P<0.05), which were most apparent in hypertensive MWF-CKD rats. Hepatic PCSK9 expression increased in both CKD groups (P<0.05), with unusual sinusoidal localization, which was not seen in 22-week-old rats. Heparan sulfate (HS) disaccharide analysis, staining with anti-HS mAbs, and mRNA expression of HS polymerase exostosin-1 (Ext-1), revealed elongated HS chains in both CKD groups. Solid-phase competition assays showed that the PCSK9 interaction with heparin-albumin (HS-proteoglycan analogue) was critically dependent on polysaccharide chain length. VLDL binding to HS from CKD livers was reduced (P<0.05). Proteinuria and plasma creatinine strongly associated with plasma cholesterol, PCSK9, and HS changes.
   Conclusions Progressive CKD induces hepatic HS elongation, leading to increased interaction with PCSK9. This might reduce hepatic lipoprotein uptake and thereby induce dyslipidemia in CKD. Therefore, PCSK9/HS may be a novel target to control dyslipidemia.
C1 [Shrestha, Pragyi; Adepu, Saritha; Kaptein, Fleur; Dam, Wendy; Bakker, Stephan J. L.; van den Born, Jacob] Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, Groningen, Netherlands.
   [Vives, Romain R.; El Masri, Rana] Univ Grenoble Alpes, Commissariat Engn Atom, CNRS, Inst Biol Struct, Grenoble, France.
   [Klooster, Astrid] Pathol Friesland, Dept Pathol, Leeuwarden, Netherlands.
   [van Goor, Harry] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands.
   [van de Sluis, Bart] Univ Groningen, Univ Med Ctr Groningen, Mol Genet Sect, Dept Pediat, Groningen, Netherlands.
   [van den Born, Jacob] Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, Hanzepl 1,Brug 4th Floor AA53, NL-9713GZ Groningen, Netherlands.
C3 University of Groningen; Communaute Universite Grenoble Alpes;
   Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche
   Scientifique (CNRS); University of Groningen; University of Groningen;
   University of Groningen
RP van den Born, J (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, Hanzepl 1,Brug 4th Floor AA53, NL-9713GZ Groningen, Netherlands.
EM j.van.den.born@umcg.nl
RI van+Goor, Harry/AAS-7712-2020
OI van Goor, Harry/0000-0002-6670-1577; van de Sluis, Bart
   (A.J.A.)/0000-0003-3039-4365; Adepu, Saritha/0000-0002-8617-9421
FU Universitair Medisch Centrum Groningen, Graduate School ofMedical
   Sciences personal talent grant; Jan Kornelis de Cock Stichting personal
   grant; CNRS; Groupement De Recherche Structure, Fonction et Regulation
   des Glycosaminoglycanes (GDR GAG) [3739]; Investissements d'avenir grant
   through the Glyco@Alps program [ANR-15-IDEX02]; Agence Nationale de la
   Recherche [ANR-17-CE11-0040]; Agence Nationale de la Recherche (ANR)
   [ANR-17-CE11-0040] Funding Source: Agence Nationale de la Recherche
   (ANR)
FX This work was supported by a Universitair Medisch Centrum Groningen,
   Graduate School ofMedical Sciences personal talent grant (to P.
   Shrestha), a Jan Kornelis de Cock Stichting personal grant (to P.
   Shrestha), by CNRS grants, Groupement De Recherche Structure, Fonction
   et Regulation des Glycosaminoglycanes (GDR GAG) 3739, Investissements
   d'avenir grant ANR-15-IDEX02 through the Glyco@Alps program, and Agence
   Nationale de la Recherche grant ANR-17-CE11-0040.
CR Adepu S, 2014, AM J TRANSPLANT, V14, P2328, DOI 10.1111/ajt.12842
   AlHaideri M, 1997, BIOCHEMISTRY-US, V36, P12766, DOI 10.1021/bi9631024
   Baass A, 2009, CLIN CHEM, V55, P1637, DOI 10.1373/clinchem.2009.126987
   Bartuzi P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10961
   Bengalorkar GM, 2011, J PHARMACOL PHARMACO, V2, P266, DOI 10.4103/0976-500X.85956
   Bikbov B, 2020, LANCET, V395, P709, DOI 10.1016/S0140-6736(20)30045-3
   Brinkkoetter PT, 2004, J AM SOC NEPHROL, V15, P33, DOI 10.1097/01.ASN.0000102476.50041.44
   Cannon CP, 2015, EUR HEART J, V36, P1186, DOI 10.1093/eurheartj/ehv028
   Canuel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064145
   Cases A, 2005, KIDNEY INT, V68, P87
   Celie JWAM, 2008, AM J PHYSIOL-RENAL, V294, pF253, DOI 10.1152/ajprenal.00429.2007
   Celie JWAM, 2007, AM J PATHOL, V170, P1865, DOI 10.2353/ajpath.2007.070061
   Chang MY, 2000, J BIOL CHEM, V275, P4766, DOI 10.1074/jbc.275.7.4766
   Charytan DM, 2019, J AM COLL CARDIOL, V73, P2961, DOI 10.1016/j.jacc.2019.03.513
   Christianson HC, 2014, MATRIX BIOL, V35, P51, DOI 10.1016/j.matbio.2013.10.004
   Collins AJ, 2003, KIDNEY INT, V64, pS24, DOI 10.1046/j.1523-1755.64.s87.5.x
   Collins LE, 2019, J LEUKOCYTE BIOL, V105, P81, DOI 10.1002/JLB.3RU0618-246R
   DAVID G, 1992, J CELL BIOL, V119, P961, DOI 10.1083/jcb.119.4.961
   Dong B, 2011, INT J MOL MED, V27, P103, DOI 10.3892/ijmm.2010.559
   Eisenga MF, 2017, DIABETES CARE, V40, P894, DOI 10.2337/dc16-2258
   Elewa U, 2016, EUR J CLIN INVEST, V46, P779, DOI 10.1111/eci.12661
   Esko JD, 2009, ESSENTIALS GLYCOBIOL
   Faham S, 1996, SCIENCE, V271, P1116, DOI 10.1126/science.271.5252.1116
   Fan D, 2008, BIOCHEMISTRY-US, V47, P1631, DOI 10.1021/bi7016359
   Farnier M, 2016, INT J CARDIOL, V223, P750, DOI 10.1016/j.ijcard.2016.08.273
   Filippatos Theodosios D, 2017, Arch Med Sci Atheroscler Dis, V2, pe46, DOI 10.5114/amsad.2017.70502
   Foley EM, 2013, ARTERIOSCL THROM VAS, V33, P2065, DOI 10.1161/ATVBAHA.113.301637
   Foley EM, 2010, PROG MOL BIOL TRANSL, V93, P213, DOI 10.1016/S1877-1173(10)93010-X
   Fuki IV, 1997, J CLIN INVEST, V100, P1611, DOI 10.1172/JCI119685
   Gajic-Veljanoski O, 2016, J GEN INTERN MED, V31, P947, DOI 10.1007/s11606-016-3603-8
   Gandhi NS, 2008, CHEM BIOL DRUG DES, V72, P455, DOI 10.1111/j.1747-0285.2008.00741.x
   GOFMAN JW, 1950, SCIENCE, V111, P166, DOI 10.1126/science.111.2877.166
   Gustafsen C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00568-7
   Haas ME, 2016, CIRCULATION, V134, P61, DOI 10.1161/CIRCULATIONAHA.115.020912
   Hijmans RS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178940
   JACKSON RL, 1991, PHYSIOL REV, V71, P481, DOI 10.1152/physrev.1991.71.2.481
   Jin K, 2014, AM J KIDNEY DIS, V63, P584, DOI 10.1053/j.ajkd.2013.10.042
   Kan M, 1996, J BIOL CHEM, V271, P26143, DOI 10.1074/jbc.271.42.26143
   Katta K, 2013, AM J PATHOL, V183, P1571, DOI 10.1016/j.ajpath.2013.07.030
   Kawanami D., 2016, Ren. Replace. Ther., V2, P1, DOI DOI 10.1186/S41100-016-0028-0
   Kaysen GA, 2006, KIDNEY INT, V70, pS55, DOI 10.1038/sj.ki.5001979
   Kereiakes DJ, 2015, AM HEART J, V169, P906, DOI 10.1016/j.ahj.2015.03.004
   Koenig A, 1998, J CLIN INVEST, V101, P877, DOI 10.1172/JCI1509
   Konarzewski M, 2014, AM J NEPHROL, V40, P157, DOI 10.1159/000365935
   Koren MJ, 2014, J AM COLL CARDIOL, V63, P2531, DOI 10.1016/j.jacc.2014.03.018
   Kwakernaak AJ, 2013, ATHEROSCLEROSIS, V226, P459, DOI 10.1016/j.atherosclerosis.2012.11.009
   Kwon HJ, 2008, P NATL ACAD SCI USA, V105, P1820, DOI 10.1073/pnas.0712064105
   Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383
   Lagace TA, 2014, CURR OPIN LIPIDOL, V25, P387, DOI 10.1097/MOL.0000000000000114
   Lambert G, 2012, J LIPID RES, V53, P2515, DOI 10.1194/jlr.R026658
   Langslet G, 2015, EXPERT REV CARDIOVAS, V13, P477, DOI 10.1586/14779072.2015.1030395
   Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200
   Li MM, 2016, J BIOL CHEM, V291, P24160, DOI 10.1074/jbc.M116.751974
   Liang WGG, 2016, P NATL ACAD SCI USA, V113, P5000, DOI 10.1073/pnas.1523981113
   Lim Beom Jin, 2014, Drug Discov Today Dis Models, V11, P45
   Llorente-Cortés V, 2006, J MOL BIOL, V359, P950, DOI 10.1016/j.jmb.2006.04.008
   Llorente-Cortés V, 2002, CIRCULATION, V106, P3104, DOI 10.1161/01.CIR.0000041434.28573.0B
   Llorente-Cortés V, 2007, CARDIOVASC RES, V74, P526, DOI 10.1016/j.cardiores.2007.02.020
   López-Hernández FJ, 2012, CELL TISSUE RES, V347, P141, DOI 10.1007/s00441-011-1275-6
   MacArthur JM, 2007, J CLIN INVEST, V117, P153, DOI 10.1172/JCI29154
   Maxwell KN, 2005, CURR OPIN LIPIDOL, V16, P167, DOI 10.1097/01.mol.0000162321.31925.a3
   Maxwell KN, 2005, P NATL ACAD SCI USA, V102, P2069, DOI 10.1073/pnas.0409736102
   Mayne J, 2008, LIPIDS HEALTH DIS, V7, DOI 10.1186/1476-511X-7-22
   Meyers CD, 2003, J LIPID RES, V44, P2152, DOI 10.1194/jlr.M300252-JLR200
   Mikolasevic I, 2017, INT J NEPHROL RENOV, V10, P35, DOI 10.2147/IJNRD.S101808
   Nangaku M, 2008, HYPERTENS RES, V31, P175, DOI 10.1291/hypres.31.175
   Nozue T, 2012, AM J CARDIOL, V109, P1247, DOI 10.1016/j.amjcard.2011.12.016
   Park PW, 2000, J BIOL CHEM, V275, P29923, DOI 10.1074/jbc.R000008200
   Poirier S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157230
   Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100
   Rashid S, 2005, P NATL ACAD SCI USA, V102, P5374, DOI 10.1073/pnas.0501652102
   Robinson JG, 2015, NEW ENGL J MED, V372, P1489, DOI 10.1056/NEJMoa1501031
   Sabatine MS, 2019, NAT REV CARDIOL, V16, P155, DOI 10.1038/s41569-018-0107-8
   Salanga CL, 2011, EXP CELL RES, V317, P590, DOI 10.1016/j.yexcr.2011.01.004
   Sarrazin S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004952
   Shen HY, 2020, RENAL FAILURE, V42, P405, DOI 10.1080/0886022X.2020.1756846
   Shrestha P, 2019, CELL SIGNAL, V55, P53, DOI 10.1016/j.cellsig.2018.12.001
   Stanford KI, 2009, J CLIN INVEST, V119, P3236, DOI 10.1172/JCI38251
   Stopschinski BE, 2018, J BIOL CHEM, V293, P10826, DOI 10.1074/jbc.RA117.000378
   Sucajtys-Szulc E, 2016, ATHEROSCLEROSIS, V248, P17, DOI 10.1016/j.atherosclerosis.2016.02.027
   Sucajtys-Szulc E, 2016, MOL CELL BIOCHEM, V411, P281, DOI 10.1007/s11010-015-2590-0
   Tannock L, 2008, ENDOTEXT
   Tedla FM, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/132405
   Thomas G, 2003, AM J PATHOL, V162, P977, DOI 10.1016/S0002-9440(10)63892-8
   Thompson S, 2015, J AM SOC NEPHROL, V26, P2504, DOI 10.1681/ASN.2014070714
   Tsimihodimos Vasilis, 2011, Open Cardiovasc Med J, V5, P41, DOI 10.2174/1874192401105010041
   Tuñón J, 2020, EUR HEART J, V41, P4114, DOI 10.1093/eurheartj/ehaa498
   van de Sluis B, 2017, CURR OPIN LIPIDOL, V28, P241, DOI 10.1097/MOL.0000000000000411
   van den Born J, 2005, J BIOL CHEM, V280, P20516, DOI 10.1074/jbc.M502065200
   van Kerkhof P, 2005, EMBO J, V24, P2851, DOI 10.1038/sj.emboj.7600756
   Vaziri ND, 2006, AM J PHYSIOL-RENAL, V290, pF262, DOI 10.1152/ajprenal.00099.2005
   Vivès RR, 2002, BIOCHEMISTRY-US, V41, P14779, DOI 10.1021/bi026459i
   Wang N, 2017, CIRC RES, V120, P1063, DOI 10.1161/CIRCRESAHA.117.310610
   Weiner DE, 2004, J AM SOC NEPHROL, V15, P1307, DOI 10.1097/01.ASN.0000123691.46138.E2
   Wijers M, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.126462
   Williams KJ, 1997, CURR OPIN LIPIDOL, V8, P253
   Wilsie LC, 2006, LIPIDS HEALTH DIS, V5, DOI 10.1186/1476-511X-5-23
   Yang Sundy N. Y., 2009, Archives of Physiology and Biochemistry, V115, P147, DOI 10.1080/13813450903110754
   Zheng-Lin B, 2018, DRUGS, V78, P215, DOI 10.1007/s40265-017-0858-2
NR 99
TC 3
Z9 4
U1 1
U2 1
PU AMER SOC NEPHROLOGY
PI WASHINGTON
PA 1401 H Street NW, Suite 900, WASHINGTON, DC 20005, UNITED STATES
SN 1046-6673
EI 1533-3450
J9 J AM SOC NEPHROL
JI J. Am. Soc. Nephrol.
PD JUN
PY 2021
VL 32
IS 6
BP 1371
EP 1388
DI 10.1681/ASN.2020091376
PG 18
WC Urology & Nephrology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Urology & Nephrology
GA SW0KP
UT WOS:000664206100012
PM 33758009
OA Green Published, Bronze
DA 2024-02-19
ER

PT J
AU Vargas, JA
   Vessey, DA
   Schmucker, DL
AF Vargas, JA
   Vessey, DA
   Schmucker, DL
TI Effect of dehydroepiandrosterone (DHEA) on intestinal mucosal immunity
   in young adult and aging rats
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE dehydroepiandrosterone; cholera toxin; aging; secretory IgA; intestinal
   mucosal immunity
ID CHOLERA-TOXIN; IMMUNIZATION; ANTIBODY; LIVER
AB The present study assesses the effectiveness of oral DHEA on the intestinal mucosal immune response in aging rats. Young adult (6 months) and aging (21 months) female rats received powdered rat chow with or without 0.2% DHEA for 23 days. The animals were immunized intraduodenally with either cholera toxin (CTx) or vehicle alone and boosted two weeks later. Seven days after boosting, serum, bile, small intestinal tissue, and liver were collected for analysis. Anti-CTx IgA antibody titers were measured in serum and bile and the concentration of anti-CTx antibody containing cells (ACCs) in the small intestinal lamina propria and liver were determined by quantitative immunohistochemistry. Intergroup comparisons indicated that there was only one significant difference in serum and none in bile anti-CTx IgA titers between CTx-immunized animals fed DHEA or the diet alone. Immunohistochemical analysis determined that the density and distribution patterns of ACCs within the lamina propria were unaffected by DHEA. Both DHEA-treated and control young immunized animals exhibited similar numbers of ACCs. Only 40% of the aging rats responded to intraduodenal immunization with CTx, as determined by the presence of ACCs in the intestine, regardless of the presence or absence of DHEA in the diet. These data suggest that DHEA in the diet does not enhance the intestinal mucosal immune response to intraduodenal CTx in either young adult or aging rats. (C) 1998 Elsevier Science Inc.
C1 Dept Vet Affairs Med Ctr, Cell Biol & Aging Sect, San Francisco, CA USA.
   Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.
   Univ Calif San Francisco, Dept Med, San Francisco, CA USA.
   Univ Calif San Francisco, Ctr Liver, San Francisco, CA 94143 USA.
C3 University of California System; University of California San Francisco;
   University of California System; University of California San Francisco;
   University of California System; University of California San Francisco
RP Schmucker, DL (corresponding author), DVA Med Ctr, Cell Biol & Aging Sect 151E, 4150 Clement St, San Francisco, CA 94121 USA.
CR ALTORFER J, 1987, GASTROENTEROLOGY, V93, P539, DOI 10.1016/0016-5085(87)90917-6
   DANENBERG HD, 1995, VACCINE, V13, P1445, DOI 10.1016/0264-410X(95)00063-7
   DANIELS CK, 1985, J IMMUNOL, V134, P3855
   DAYNES R A, 1992, Aging Immunology and Infectious Disease, V3, P135
   Daynes RA, 1996, INFECT IMMUN, V64, P1100, DOI 10.1128/IAI.64.4.1100-1109.1996
   ERSHLER WB, 1993, J GERONTOL, V48, pB3, DOI 10.1093/geronj/48.1.B3
   Evans TG, 1996, VACCINE, V14, P1531, DOI 10.1016/S0264-410X(96)00095-3
   GARG M, 1993, INFECT IMMUN, V61, P2238, DOI 10.1128/IAI.61.5.2238-2241.1993
   Khorram O, 1997, J GERONTOL A-BIOL, V52, pM1, DOI 10.1093/gerona/52A.1.M1
   OWEN RL, 1994, J EXP MED, V180, P7, DOI 10.1084/jem.180.1.7
   Schmucker DL, 1996, DIGEST DIS SCI, V41, P1183, DOI 10.1007/BF02088236
   SCHMUCKER DL, 1988, IMMUNOLOGY, V64, P691
   Schmucker DL, 1997, CURR OPIN GASTROEN, V13, P534, DOI 10.1097/00001574-199711000-00015
   Yoshikawa TT, 1997, J INFECT DIS, V176, P1053, DOI 10.1086/516547
NR 14
TC 1
Z9 1
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
J9 EXP GERONTOL
JI Exp. Gerontol.
PD AUG
PY 1998
VL 33
IS 5
BP 499
EP 505
DI 10.1016/S0531-5565(98)00010-2
PG 7
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 105EU
UT WOS:000075060400011
PM 9762527
DA 2024-02-19
ER

PT J
AU Sellmann, C
   Priebs, J
   Landmann, M
   Degen, C
   Engstler, AJ
   Jin, CJ
   Gärttner, S
   Spruss, A
   Huber, O
   Bergheim, I
AF Sellmann, Cathrin
   Priebs, Josephine
   Landmann, Marianne
   Degen, Christian
   Engstler, Anna Janina
   Jin, Cheng Jun
   Gaerttner, Stefanie
   Spruss, Astrid
   Huber, Otmar
   Bergheim, Ina
TI Diets rich in fructose, fat or fructose and fat alter intestinal barrier
   function and lead to the development of nonalcoholic fatty liver disease
   over time
SO JOURNAL OF NUTRITIONAL BIOCHEMISTRY
LA English
DT Article
DE Endotoxin; Macronutrients; NAFLD; Tight junction; Aging
ID INDUCED HEPATIC STEATOSIS; LIPID-ACCUMULATION; INSULIN-RESISTANCE;
   NATURAL-HISTORY; INDUCED OBESITY; MICE; STEATOHEPATITIS; DISRUPTION;
   EPIDEMIOLOGY; INFLAMMATION
AB General overnutrition but also a diet rich in certain macronutrients, age, insulin resistance and an impaired intestinal barrier function may be critical factors in the development of nonalcoholic fatty liver disease (NAFLD). Here the effect of chronic intake of diets rich in different macronutrients, i.e. fructose and/or fat on liver status in mice, was studied over time. C57BL/6J mice were fed plain water, 30% fructose solution, a high-fat diet or a combination of both for 8 and 16 weeks. Indices of liver damage, toll-like receptor 4 (TLR-4) signaling cascade, macrophage polarization and insulin resistance in the liver and intestinal barrier function were analyzed. Chronic exposure to a diet rich in fructose and/or fat was associated with the development of hepatic steatosis that progressed with time to steatohepatitis in mice fed a combination of macronutrients. The development of NAFLD was also associated with a marked reduction of the mRNA expression of insulin receptor, whereas hepatic expressions of TLR-4, myeloid differentiation primary response gene 88 and markers of M1 polarization of macrophages were induced in comparison to controls. Bacterial endotoxin levels in portal plasma were found to be increased while levels of the tight junction protein occludin and zonula occludens 1 were found to be significantly lower in the duodenum of all treated groups after 8 and 16 weeks. Our data suggest that chronic intake of fructose and/or fat may lead to the development of NAFLD over time and that this is associated with an increased translocation of bacterial endotoxin. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Sellmann, Cathrin; Priebs, Josephine; Landmann, Marianne; Degen, Christian; Engstler, Anna Janina; Jin, Cheng Jun; Gaerttner, Stefanie; Bergheim, Ina] Univ Jena, Inst Nutr Sci, Model Syst Mol Nutr, D-07743 Jena, Germany.
   [Spruss, Astrid] Univ Hohenheim, Dept Med Nutr, Stuttgart, Germany.
   [Huber, Otmar] Univ Jena, Univ Hosp Jena, Dept Biochem 2, D-07743 Jena, Germany.
   [Huber, Otmar] Jena Univ Hosp, Ctr Sepsis Control & Care, Jena, Germany.
C3 Friedrich Schiller University of Jena; University Hohenheim; Friedrich
   Schiller University of Jena; Friedrich Schiller University of Jena
RP Bergheim, I (corresponding author), Univ Jena, Inst Nutr Sci, SD Model Syst Mol Nutr, Dornburger Str 25, D-07743 Jena, Germany.
EM ina.bergheim@uni-jena.de
RI Huber, Otmar/AAA-4548-2021
OI Huber, Otmar/0000-0003-4359-1747
FU Bundesministerium fur Bildung und Forschung [FKZ: 01EA1305, FKZ:
   01KU1214A]
FX This work is funded by grants from Bundesministerium fur Bildung und
   Forschung, FKZ: 01EA1305 and FKZ: 01KU1214A (both IB).
CR AOYAMA Y, 1974, J NUTR, V104, P741, DOI 10.1093/jn/104.6.741
   ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0
   Bedogni G, 2005, HEPATOLOGY, V42, P44, DOI 10.1002/hep.20734
   Bergheim I, 2008, J HEPATOL, V48, P983, DOI 10.1016/j.jhep.2008.01.035
   Bhala N, 2013, CURR PHARM DESIGN, V19, P5169, DOI 10.2174/13816128113199990336
   Blachier M, 2013, J HEPATOL, V58, P593, DOI 10.1016/j.jhep.2012.12.005
   Brunt EM, 2009, CLIN LIVER DIS, V13, P533, DOI 10.1016/j.cld.2009.07.008
   Cani PD, 2007, DIABETOLOGIA, V50, P2374, DOI 10.1007/s00125-007-0791-0
   Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403
   Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491
   Cani PD, 2012, GUT MICROBES, V3, P279, DOI 10.4161/gmic.19625
   Desmarchelier C, 2013, BRIT J NUTR, V109, P1518, DOI 10.1017/S0007114512003340
   Fan JG, 2013, J GASTROEN HEPATOL, V28, P81, DOI 10.1111/jgh.12244
   Ferramosca A, 2014, WORLD J GASTROENTERO, V20, P1746, DOI 10.3748/wjg.v20.i7.1746
   Gäbele E, 2011, J HEPATOL, V55, P1391, DOI 10.1016/j.jhep.2011.02.035
   Ganz M, 2014, WORLD J GASTROENTERO, V20, P8525, DOI 10.3748/wjg.v20.i26.8525
   Ghoshal S, 2009, J LIPID RES, V50, P90, DOI 10.1194/jlr.M800156-JLR200
   González-Rodríguez A, 2010, DIABETES, V59, P588, DOI 10.2337/db09-0796
   Hassanin A, 2014, EXP THER MED, V8, P1551, DOI 10.3892/etm.2014.1963
   Ishimoto T, 2013, HEPATOLOGY, V58, P1632, DOI 10.1002/hep.26594
   Kanuri G, 2013, LIVER INT, P18
   Kanuri G, 2009, J NUTR, V139, P482, DOI 10.3945/jn.108.100495
   Kasravi B, 2008, J SURG RES, V146, P96, DOI 10.1016/j.jss.2007.06.013
   Kasravi FB, 2005, J ENDOTOXIN RES, V11, P19, DOI 10.1179/096805105225006731
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Kohli R, 2010, HEPATOLOGY, V52, P934, DOI 10.1002/hep.23797
   Kong WJ, 2009, METABOLISM, V58, P109, DOI 10.1016/j.metabol.2008.08.013
   Kubota N, 2000, DIABETES, V49, P1880, DOI 10.2337/diabetes.49.11.1880
   Lam YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034233
   Ouyang X, 2008, J HEPATOL, V48, P993, DOI 10.1016/j.jhep.2008.02.011
   Reichald A, 2014, J NUTR BIOCHEM, V25, P118, DOI 10.1016/j.jnutbio.2013.09.011
   Schultz A, 2013, INT J MOL SCI, V14, P21873, DOI 10.3390/ijms141121873
   Serino M, 2012, GUT, V61, P543, DOI 10.1136/gutjnl-2011-301012
   Seth RK, 2014, J PHARMACOL EXP THER, P27
   Spruss A, 2012, MOL MED, V18, P1346, DOI 10.2119/molmed.2012.00223
   Spruss A, 2012, LAB INVEST, V92, P1020, DOI 10.1038/labinvest.2012.75
   Spruss A, 2011, ANTIOXID REDOX SIGN, V14, P2121, DOI 10.1089/ars.2010.3263
   Spruss A, 2009, HEPATOLOGY, V50, P1094, DOI 10.1002/hep.23122
   Suzuki T, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-19
   Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x
   Volynets V, 2010, J LIPID RES, V51, P3414, DOI 10.1194/jlr.M007179
   Vreugdenhil ACE, 2003, J IMMUNOL, V170, P1399, DOI 10.4049/jimmunol.170.3.1399
   Wagnerberger S, 2012, BRIT J NUTR, V107, P1727, DOI 10.1017/S0007114511004983
   Wan JH, 2014, AM J PATHOL, V184, P1763, DOI 10.1016/j.ajpath.2014.02.014
   Wan JH, 2014, HEPATOLOGY, V59, P130, DOI 10.1002/hep.26607
   Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116
   Ye DW, 2012, GUT, V61, P1058, DOI 10.1136/gutjnl-2011-300269
NR 47
TC 122
Z9 128
U1 2
U2 46
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0955-2863
EI 1873-4847
J9 J NUTR BIOCHEM
JI J. Nutr. Biochem.
PD NOV
PY 2015
VL 26
IS 11
BP 1183
EP 1192
DI 10.1016/j.jnutbio.2015.05.011
PG 10
WC Biochemistry & Molecular Biology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Nutrition & Dietetics
GA CW4RK
UT WOS:000364979600009
PM 26168700
DA 2024-02-19
ER

PT J
AU Garg, S
   Shivappagowdar, A
   Hada, RS
   Ayana, R
   Bathula, C
   Sen, S
   Kalia, I
   Pati, S
   Singh, AP
   Singh, S
AF Garg, Swati
   Shivappagowdar, Abhishek
   Hada, Rahul S.
   Ayana, Rajagopal
   Bathula, Chandramohan
   Sen, Subhabrata
   Kalia, Inderjeet
   Pati, Soumya
   Singh, Agam P.
   Singh, Shailja
TI Plasmodium Perforin-Like Protein Pores on the Host Cell Membrane
   Contribute in Its Multistage Growth and Erythrocyte Senescence
SO FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
LA English
DT Article
DE perforin like proteins; malaria; erythrocyte; anemia; invasion; egress;
   atomic force microscopy; Raman spectroscopy
ID MALARIA PARASITES; METHEMOGLOBIN; INHIBITORS; EGRESS; ATTACK;
   PHAGOCYTOSIS; DISRUPTION; INFECTION; INVASION; BERGHEI
AB The pore forming Plasmodium Perforin Like Proteins (PPLP), expressed in all stages of the parasite life cycle are critical for completion of the parasite life cycle. The high sequence similarity in the central Membrane Attack Complex/ Perforin (MACPF) domain among PLPs and their distinct functional overlaps define them as lucrative target for developing multi-stage antimalarial therapeutics. Herein, we evaluated the mechanism of Pan-active MACPF Domain (PMD), a centrally located and highly conserved region of PPLPs, and deciphered the inhibitory potential of specifically designed PMD inhibitors. The E. coli expressed rPMD interacts with erythrocyte membrane and form pores of similar to 10.5 nm height and similar to 24.3 nm diameter leading to hemoglobin release and dextran uptake. The treatment with PMD induced erythrocytes senescence which can be hypothesized to account for the physiological effect of disseminated PLPs in loss of circulating erythrocytes inducing malaria anemia. The anti-PMD inhibitors effectively blocked intraerythrocytic growth by suppressing invasion and egress processes and protected erythrocytes against rPMD induced senescence. Moreover, these inhibitors also blocked the hepatic stage and transmission stage parasite development suggesting multi-stage, transmission-blocking potential of these inhibitors. Concievably, our study has introduced a novel set of anti-PMD inhibitors with pan-inhibitory activity against all the PPLPs members which can be developed into potent cross-stage antimalarial therapeutics along with erythrocyte senescence protective potential to occlude PPLPs mediated anemia in severe malaria.
C1 [Garg, Swati; Shivappagowdar, Abhishek; Hada, Rahul S.; Pati, Soumya] Shiv Nader Univ, Sch Nat Sci, Dept Life Sci, Greater Noida, India.
   [Ayana, Rajagopal] Katholieke Univ Leuven, Dept Biol, Lab Neuroplastic & Neuroprote, Leuven, Belgium.
   [Bathula, Chandramohan; Sen, Subhabrata] Shiv Nader Univ, Sch Nat Sci, Dept Chem, Greater Noida, India.
   [Kalia, Inderjeet; Singh, Agam P.] Natl Inst Immunol, Infect Dis Lab, New Delhi, India.
   [Singh, Shailja] Jawaharlal Nehru Univ, Special Ctr Mol Med, New Delhi, India.
C3 Shiv Nadar University; KU Leuven; Shiv Nadar University; Department of
   Biotechnology (DBT) India; National Institute of Immunology (NII);
   Jawaharlal Nehru University, New Delhi
RP Singh, S (corresponding author), Jawaharlal Nehru Univ, Special Ctr Mol Med, New Delhi, India.
EM shailja.jnu@gmail.com
RI Singh, Agam/AAH-2031-2020
OI Singh, Agam/0000-0003-4262-2556; Sen, Subhabrata/0000-0002-4608-5498;
   Ayana, R/0000-0002-9562-4638; HADA, RAHUL SINGH/0000-0003-3972-6004
FU Science and Engineering Research Board (SERB), Drug and Pharmaceuticals
   Research Program (DPRP) [P/569/2016-1/TDT]; National Bioscience Award
   from DBT
FX Funding from Science and Engineering Research Board (SERB), Drug and
   Pharmaceuticals Research Program (DPRP) (Project No. P/569/2016-1/TDT)
   and the National Bioscience Award from DBT for SS is acknowledged. The
   funders had no role in study design, data collection and analysis,
   decision to publish or preparation of the manuscript.
CR Alaganan A, 2017, CURR OPIN HEMATOL, V24, P208, DOI 10.1097/MOH.0000000000000334
   Arashiki N, 2013, BIOCHEMISTRY-US, V52, P5760, DOI 10.1021/bi400405p
   Baran K, 2009, IMMUNITY, V30, P684, DOI 10.1016/j.immuni.2009.03.016
   Barkur S, 2018, J RAMAN SPECTROSC, V49, P1155, DOI 10.1002/jrs.5361
   Behera GC, 2016, INDIAN J HEMATOL BLO, V32, P100, DOI 10.1007/s12288-015-0522-5
   Brown GC, 2012, TRENDS BIOCHEM SCI, V37, P325, DOI 10.1016/j.tibs.2012.05.002
   Callahan MK, 2003, J LEUKOCYTE BIOL, V74, P846, DOI 10.1189/jlb.0902433
   Deligianni E, 2013, CELL MICROBIOL, V15, P1438, DOI 10.1111/cmi.12131
   Dybas J, 2018, ANALYST, V143, P3489, DOI 10.1039/c8an00282g
   Ecker A, 2007, EXP PARASITOL, V116, P504, DOI 10.1016/j.exppara.2007.01.015
   Frostell Asa, 2013, Methods Mol Biol, V1008, P139, DOI 10.1007/978-1-62703-398-5_6
   Garg S., 2019, BIORXIV, DOI 10.1101/756197
   Garg Swati, 2015, Syst Synth Biol, V9, P17, DOI 10.1007/s11693-015-9166-x
   Garg S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2725
   Gaur D, 2007, P NATL ACAD SCI USA, V104, P17789, DOI 10.1073/pnas.0708772104
   Gómez ND, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025477
   Hadders MA, 2007, SCIENCE, V317, P1552, DOI 10.1126/science.1147103
   Haldar Kasturi, 2009, Hematology Am Soc Hematol Educ Program, P87, DOI 10.1182/asheducation-2009.1.87
   Hashimoto M, 2018, ACS CHEM BIOL, V13, P1480, DOI 10.1021/acschembio.8b00270
   Ishino T, 2005, CELL MICROBIOL, V7, P199, DOI 10.1111/j.1462-5822.2004.00447.x
   Jafari R, 2014, NAT PROTOC, V9, P2100, DOI 10.1038/nprot.2014.138
   Kadota K, 2004, P NATL ACAD SCI USA, V101, P16310, DOI 10.1073/pnas.0406187101
   Kafsack BFC, 2009, SCIENCE, V323, P530, DOI 10.1126/science.1165740
   Kataoka T, 1996, BIOSCI BIOTECH BIOCH, V60, P1726, DOI 10.1271/bbb.60.1726
   Kataoka T, 1996, J IMMUNOL, V156, P3678
   Lasonder E, 2002, NATURE, V419, P537, DOI 10.1038/nature01111
   Lena G, 2008, J MED CHEM, V51, P7614, DOI 10.1021/jm801063n
   Metkar SS, 2015, CELL DEATH DIFFER, V22, P74, DOI 10.1038/cdd.2014.110
   Miller CK, 2016, BIOORG MED CHEM LETT, V26, P355, DOI 10.1016/j.bmcl.2015.12.003
   Ni T, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aaq0762
   Pamplona A, 2009, INT J BIOCHEM CELL B, V41, P711, DOI 10.1016/j.biocel.2008.09.020
   Pipkin ME, 2007, CURR OPIN IMMUNOL, V19, P301, DOI 10.1016/j.coi.2007.04.011
   Ramu D, 2017, BIOCHEM PHARMACOL, V129, P26, DOI 10.1016/j.bcp.2016.12.012
   Rettig MP, 1999, BLOOD, V93, P376, DOI 10.1182/blood.V93.1.376.401k41_376_384
   Rosado CJ, 2007, SCIENCE, V317, P1548, DOI 10.1126/science.1144706
   Spicer JA, 2013, J MED CHEM, V56, P9542, DOI 10.1021/jm401604x
   Tavares Joana, 2014, Subcell Biochem, V80, P241, DOI 10.1007/978-94-017-8881-6_12
   TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840
   Umbreit J, 2007, AM J HEMATOL, V82, P134, DOI 10.1002/ajh.20738
   Voskoboinik I, 2005, J BIOL CHEM, V280, P8426, DOI 10.1074/jbc.M413303200
   Vuignier K, 2010, ANAL BIOANAL CHEM, V398, P53, DOI 10.1007/s00216-010-3737-1
   Wagener FADTG, 2001, BLOOD, V98, P1802, DOI 10.1182/blood.V98.6.1802
   Wirth CC, 2015, MOL BIOCHEM PARASIT, V201, P90, DOI 10.1016/j.molbiopara.2015.06.005
   Wirth CC, 2014, CELL MICROBIOL, V16, P709, DOI 10.1111/cmi.12288
   World Health Organization, 2019, WORLD MALARIA REPORT
   Yang ASP, 2017, CELL REP, V18, P3105, DOI 10.1016/j.celrep.2017.03.017
NR 46
TC 10
Z9 10
U1 1
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2235-2988
J9 FRONT CELL INFECT MI
JI Front. Cell. Infect. Microbiol.
PD MAR 24
PY 2020
VL 10
AR 121
DI 10.3389/fcimb.2020.00121
PG 16
WC Immunology; Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Microbiology
GA PC3MR
UT WOS:000596910300001
PM 32266171
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Wei, XL
   Murphy, MA
   Reddy, NA
   Hao, Y
   Eggertsen, TG
   Saucerman, JJ
   Bochkis, IM
AF Wei, Xiaolong
   Murphy, Megan. A. A.
   Reddy, Nihal. A. A.
   Hao, Yi
   Eggertsen, Taylor. G. G.
   Saucerman, Jeffrey. J. J.
   Bochkis, Irina. M. M.
TI Redistribution of lamina-associated domains reshapes binding of pioneer
   factor FOXA2 in development of nonalcoholic fatty liver disease
SO GENOME RESEARCH
LA English
DT Article
ID GENE-EXPRESSION; LIPID-SYNTHESIS; HIGH PREVALENCE; HEPATOCYTE;
   METHYLATION; CELLS; A/C
AB Nonalcoholic fatty liver disease (NAFLD) is highly prevalent in type 2 diabetes mellitus and the elderly, impacting 40% of individuals over 70. Regulation of heterochromatin at the nuclear lamina has been associated with aging and age-dependent metabolic changes. We previously showed that changes at the lamina in aged hepatocytes and laminopathy models lead to redistribution of lamina-associated domains (LADs), opening of repressed chromatin, and up-regulation of genes regulating lipid synthesis and storage, culminating in fatty liver. Here, we test the hypothesis that change in the expression of lamina-associated proteins and nuclear shape leads to redistribution of LADs, followed by altered binding of pioneer factor FOXA2 and by up-regulation of lipid synthesis and storage, culminating in steatosis in younger NAFLD patients (aged 21-51). Changes in nuclear morphology alter LAD partitioning and reduced lamin B1 signal correlate with increased FOXA2 binding before severe steatosis in young mice placed on a western diet. Nuclear shape is also changed in younger NAFLD patients. LADs are redistrubted and lamin B1 signal decreases similarly in mild and severe steatosis. In contrast, FOXA2 binding is similar in normal and NAFLD patients with moderate steatosis and is repositioned only in NAFLD patients with more severe lipid accumulation. Hence, changes at the nuclear lamina reshape FOXA2 binding with progression of the disease. Our results suggest a role for nuclear lamina in etiology of NAFLD, irrespective of aging, with potential for improved stratification of patients and novel treatments aimed at restoring nuclear lamina function.
C1 [Wei, Xiaolong; Murphy, Megan. A. A.; Reddy, Nihal. A. A.; Hao, Yi; Bochkis, Irina. M. M.] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA.
   [Eggertsen, Taylor. G. G.; Saucerman, Jeffrey. J. J.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22908 USA.
C3 University of Virginia; University of Virginia
RP Bochkis, IM (corresponding author), Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA.
EM imb3q@virginia.edu
OI Bochkis, Irina/0000-0001-8073-8408
FU National Institute of Diabetes and Digestive and Kidney Diseases R01
   award [DK121059]
FX We thank L. Berk and M. Thakore for technical assistance. We thank M.
   Lazar for critical reading of the manuscript. I.M.B. is supported by
   National Institute of Diabetes and Digestive and Kidney Diseases R01
   award DK121059. Author contributions: Investigation, visualization,
   review, and editing were by X.W. Software, formal analysis, data
   curation, visualization, and review and editing were by M.A.M.
   Investigation, visualization, and review and editing were by Y.H.
   Software, formal analysis, data curation, visualization, and review and
   editing were by N.A.R. Software, formal analysis, and review and editing
   were by T.G.E. Conceptualization, supervision, and review and editing
   were by J.J.S. Conceptualization, formal analysis, investigation,
   writing the original draft, supervision, project administration, and
   funding acquisition were by I.M.B.
CR Asgharpour A, 2016, J HEPATOL, V65, P579, DOI 10.1016/j.jhep.2016.05.005
   Bochkis IM, 2008, NAT MED, V14, P828, DOI 10.1038/nm.1853
   Bochkis IM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002770
   Bochkis IM, 2009, PHYSIOL GENOMICS, V38, P186, DOI 10.1152/physiolgenomics.90376.2008
   Brady GF, 2018, HEPATOLOGY, V67, P1710, DOI 10.1002/hep.29522
   Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Dutour A, 2011, HUM MOL GENET, V20, P3779, DOI 10.1093/hmg/ddr294
   Galant D, 2016, CELLS-BASEL, V5, DOI 10.3390/cells5020021
   Gan Lay, 2011, Curr Gerontol Geriatr Res, V2011, P831536, DOI 10.1155/2011/831536
   Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947
   Hillman-Jackson Jennifer, 2012, Curr Protoc Bioinformatics, VChapter 10, DOI 10.1002/0471250953.bi1005s38
   Kain J, 2021, MOL METAB, V53, DOI 10.1016/j.molmet.2021.101291
   Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377
   Kwan R, 2017, CELL MOL GASTROENTER, V4, P365, DOI 10.1016/j.jcmgh.2017.06.005
   Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Mariño G, 2008, HUM MOL GENET, V17, P2196, DOI 10.1093/hmg/ddn120
   McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630
   Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8
   Portillo-Sanchez P, 2015, J CLIN ENDOCR METAB, V100, P2231, DOI 10.1210/jc.2015-1966
   Ramírez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365
   Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Rolyan H, 2015, J NEUROSCI, V35, P12002, DOI 10.1523/JNEUROSCI.1668-15.2015
   Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518
   Segovia-Miranda F, 2019, NAT MED, V25, P1885, DOI 10.1038/s41591-019-0660-7
   Shackleton S, 2000, NAT GENET, V24, P153, DOI 10.1038/72807
   Sun Z, 2012, NAT MED, V18, P934, DOI 10.1038/nm.2744
   Tateishi K, 2009, NATURE, V458, P757, DOI 10.1038/nature07777
   Team RC, 2020, R: A Language and Environment for Statistical
   Varela I, 2005, NATURE, V437, P564, DOI 10.1038/nature04019
   Villeneuve LM, 2008, P NATL ACAD SCI USA, V105, P9047, DOI 10.1073/pnas.0803623105
   Wang JY, 2018, INFLAMMATION, V41, P1, DOI 10.1007/s10753-017-0657-7
   Wang LF, 2013, EMBO J, V32, P45, DOI 10.1038/emboj.2012.306
   Whitton H, 2018, AGING CELL, V17, DOI 10.1111/acel.12742
   Xu SLY, 2014, METHODS MOL BIOL, V1150, P97, DOI 10.1007/978-1-4939-0512-6_5
   Zambelli F, 2013, NUCLEIC ACIDS RES, V41, pW535, DOI 10.1093/nar/gkt448
   Zhang LP, 2005, CELL METAB, V2, P141, DOI 10.1016/j.cmet.2005.07.002
NR 39
TC 3
Z9 3
U1 0
U2 0
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI COLD SPRING HARBOR
PA 1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA
SN 1088-9051
EI 1549-5469
J9 GENOME RES
JI Genome Res.
PD NOV-DEC
PY 2022
VL 32
IS 11-12
BP 1981
EP 1992
DI 10.1101/gr.277149.122
PG 12
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity
GA 8Z7XQ
UT WOS:000933587400002
PM 36522168
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU Xiong, WY
   Jiang, XQ
   He, JQ
   Liu, XY
   Zhu, YX
   Liu, B
   Huang, Y
AF Xiong, Wenyu
   Jiang, Xiaoqin
   He, Junqiang
   Liu, Xiaoyan
   Zhu, Yuxian
   Liu, Bin
   Huang, Ying
TI Probiotic Fermentation of Kelp Enzymatic Hydrolysate Promoted its
   Anti-Aging Activity in D-Galactose-Induced Aging Mice by Modulating Gut
   Microbiota
SO MOLECULAR NUTRITION & FOOD RESEARCH
LA English
DT Article; Early Access
DE anti-aging; fermentation; gut microbiota; kelp enzymatic hydrolysate;
   probiotic
ID OXIDATIVE STRESS; BRAIN; HEALTH; ACID; NRF2; DIET
AB ScopeTo investigate anti-aging effects of probiotic-fermented kelp enzymatic hydrolysate culture (KMF), probiotic-fermented kelp enzymatic hydrolysate supernatant (KMFS), and probiotic-fermented kelp enzymatic hydrolysate bacteria suspension (KMFP) in D-galactose-induced aging mice. Methods and resultsThe study uses a probiotic-mixture of Lactobacillus reuteri, Pediococcus pentosaceus, and Lactobacillus acidophilus strains for kelp fermentation. KMF, KMFS, and KMFP prevent D-galactose-induced elevation of malondialdehyde levels in serum and brain tissue of aging mice, and they increase superoxide dismutase and catalase levels and total antioxidant capacity. Furthermore, they improve the cell structure of mouse brain, liver, and intestinal tissue. Compared with the model control group, the KMF, KMFS, and KMFP treatments regulate mRNA and protein levels of genes associated with aging, the concentrations of acetic acid, propionic acid, and butyric acid in the three treatment groups are more than 1.4-, 1.3-, and 1.2-fold increased, respectively. Furthermore, the treatments affect the gut microbiota community structures. ConclusionsThese results suggest that KMF, KMFS, and KMFP can modulate gut microbiota imbalances and positively affect aging-related genes to achieve anti-aging effects.
C1 [Xiong, Wenyu; Jiang, Xiaoqin; He, Junqiang; Zhu, Yuxian; Liu, Bin; Huang, Ying] Fujian Agr & Forestry Univ, Coll Food Sci, Fuzhou 350002, Fujian, Peoples R China.
   [Xiong, Wenyu; Jiang, Xiaoqin; He, Junqiang; Zhu, Yuxian; Liu, Bin; Huang, Ying] Minist Educ, Engn Res Ctr Fujian & Taiwan Special Marine Food P, Fuzhou 350002, Peoples R China.
   [Xiong, Wenyu; Jiang, Xiaoqin; He, Junqiang; Zhu, Yuxian; Liu, Bin; Huang, Ying] Fuzhou Ocean Res Inst Marine Food Res, Dev Ctr, Fuzhou 350002, Peoples R China.
   [Liu, Xiaoyan] Beijing Technol & Business Univ, Beijing Engn & Technol Res Ctr Food Addit, Sch Food & Hlth, Beijing 100048, Peoples R China.
C3 Fujian Agriculture & Forestry University; Beijing Technology & Business
   University
RP Liu, B; Huang, Y (corresponding author), Fujian Agr & Forestry Univ, Coll Food Sci, Fuzhou 350002, Fujian, Peoples R China.; Liu, B; Huang, Y (corresponding author), Minist Educ, Engn Res Ctr Fujian & Taiwan Special Marine Food P, Fuzhou 350002, Peoples R China.; Liu, B; Huang, Y (corresponding author), Fuzhou Ocean Res Inst Marine Food Res, Dev Ctr, Fuzhou 350002, Peoples R China.
EM 000q080003@fafu.edu.cn; 000q815139@fafu.edu.cn
RI li, jing/JEF-8436-2023; li, qing/JEF-9044-2023; LU, Li/JFJ-9011-2023;
   wu, yi/JEP-1581-2023; Jiang, Yuan/JED-3759-2023; Chen, Yu/JLL-0171-2023;
   LI, XIAO/IQV-9318-2023; liu, xy/JEP-3175-2023; li, xiang/JCN-9316-2023;
   zhang, xu/JEO-4879-2023; yang, peng/JEZ-8452-2023; liu,
   peng/JSL-1931-2023; Zhang, Yun/JCN-7026-2023; Yang, Jing/JFK-4046-2023;
   WANG, HUI/JFA-9683-2023; wang, chen/JED-7289-2023; Liu,
   Jie/JCP-1070-2023; Wang, Chao/JHT-6081-2023; liu, xiao/HKE-9880-2023;
   liu, lin/JFK-3401-2023; wu, p/JDW-5015-2023; JIN, LIYING/JFB-1980-2023;
   yang, yun/IZE-1092-2023; Jiang, Yu/JEZ-9814-2023; Wang,
   lingyu/JLM-2013-2023; WANG, YANG/JFA-8821-2023
OI Yang, Jing/0009-0004-8274-9863; 
FU Xiamen Marine Scientific and Technological Achievements Transformation
   and Industrialization Demonstration Project [18CYY026HJ13]; Major
   Science and Technology Project of Fujian Province [2020NZ012010]; Fuzhou
   Institute of Oceanography Science and Technology Project [2021F04];
   Engineering Research Centre of Fujian-Taiwan Special Marine Food
   Processing and Nutrition [(2021ERC02),]; Special Fund Project for
   Scientific and Technological Innovation of Fujian Agriculture and
   Forestry Univesity [KFb22083XA]
FX This work was financially supported by the Xiamen Marine Scientific and
   Technological Achievements Transformation and Industrialization
   Demonstration Project (18CYY026HJ13), Major Science and Technology
   Project of Fujian Province (2020NZ012010), Fuzhou Institute of
   Oceanography Science and Technology Project (2021F04), the Engineering
   Research Centre of Fujian-Taiwan Special Marine Food Processing and
   Nutrition (2021ERC02), and the Special Fund Project for Scientific and
   Technological Innovation of Fujian Agriculture and Forestry Univesity
   (KFb22083XA).
CR Afshin A, 2019, LANCET, V393, P1958, DOI 10.1016/S0140-6736(19)30041-8
   Ait-Belgnaoui A, 2014, NEUROGASTROENT MOTIL, V26, P510, DOI 10.1111/nmo.12295
   Alexander M. V., 2017, AGEING RES REV, V35, P36
   An R, 2019, NUTRIENTS, V11, DOI 10.3390/nu11092193
   Bai B, 2015, BIORESOURCE TECHNOL, V185, P56, DOI 10.1016/j.biortech.2015.02.081
   Biagi E, 2016, CURR BIOL, V26, P1480, DOI 10.1016/j.cub.2016.04.016
   Borrelli RC, 2005, MOL NUTR FOOD RES, V49, P673, DOI 10.1002/mnfr.200500011
   Chen CY, 2022, HELIYON, V8, DOI 10.1016/j.heliyon.2022.e10498
   Chen X, 2022, FOOD BIOSCI, V50, DOI 10.1016/j.fbio.2022.102042
   Chen YF, 2020, AGING-US, V12, P4778, DOI 10.18632/aging.102872
   Chen YK, 2019, AQUAC RES, V50, P1, DOI 10.1111/are.13863
   Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319
   Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004
   DeJong EN, 2020, CELL HOST MICROBE, V28, P180, DOI 10.1016/j.chom.2020.07.013
   Duan H, 2022, FOOD RES INT, V158, DOI 10.1016/j.foodres.2022.111501
   Esmail A. N., 2020, QJM-INT J MED, V10, P1
   Famulski KS, 2005, CURR OPIN NEPHROL HY, V14, P243, DOI 10.1097/01.mnh.0000165890.60254.4e
   Fang X, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.792746
   Feng RT, 2001, MECH AGEING DEV, V122, P547, DOI 10.1016/S0047-6374(01)00232-9
   Freitas-Simoes TM, 2016, METABOLISM, V65, P406, DOI 10.1016/j.metabol.2015.11.004
   He YX, 2021, BIOMED ENVIRON SCI, V34, P789, DOI 10.3967/bes2021.108
   Hu JY, 2022, MICROORGANISMS, V10, DOI 10.3390/microorganisms10061081
   Ian P. W., 2012, BIOMASS BIOENERG, V44, P117
   Ima B., 2020, AM J OBSTET GYNECOL, V222, P296
   Jeong JJ, 2016, BENEF MICROBES, V7, P707, DOI 10.3920/BM2016.0016
   Kaur AP, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11030440
   Kumar A, 2018, ANTIOXID REDOX SIGN, V28, P1724, DOI 10.1089/ars.2017.7111
   Lara J, 2016, MATURITAS, V93, P1, DOI 10.1016/j.maturitas.2016.08.020
   Lee Sang-Jin, 2012, Mycobiology, V40, P117, DOI 10.5941/MYCO.2012.40.2.117
   Leszek M., 2018, INT J COAL GEOL, V201, P51
   Li YY, 2021, BIOMED PHARMACOTHER, V141, DOI 10.1016/j.biopha.2021.111909
   Ling ZX, 2022, CRIT REV FOOD SCI, V62, P3509, DOI 10.1080/10408398.2020.1867054
   Liu D, 2022, INT J BIOL MACROMOL, V194, P422, DOI 10.1016/j.ijbiomac.2021.11.084
   Liu Y, 2022, ALGAL RES, V63, DOI 10.1016/j.algal.2022.102654
   Mi Y. L., 2019, GEROSCIENCE, V41, P935
   Mitchell SJ, 2015, ANNU REV ANIM BIOSCI, V3, P283, DOI 10.1146/annurev-animal-022114-110829
   Montecino-Rodriguez E, 2013, J CLIN INVEST, V123, P958, DOI 10.1172/JCI64096
   Muller PAJ, 2011, J CELL BIOL, V192, P209, DOI 10.1083/jcb.201009059
   Nemoto M, 2017, PROBIOTICS ANTIMICRO, V9, P48, DOI 10.1007/s12602-016-9226-x
   Ni Lochlainn M, 2018, NUTRIENTS, V10, DOI 10.3390/nu10070929
   Noh H, 2021, NUTRIENTS, V13, DOI 10.3390/nu13020366
   Park Y. S., 2003, HANGUK NONGHWA HAKHO, V46, P367
   Patra JK, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01493
   Podhorecka M, 2017, POSTEP HIG MED DOSW, V71, P170
   Riviere A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00979
   Rühmann B, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00565
   Septembre M. A., 2017, FOOD RES INT, V104, P86
   Shc A., 2021, BIOORG MED CHEM LETT, V40
   Shimizu F, 2011, DIABETOLOGIA, V54, P1517, DOI 10.1007/s00125-011-2107-7
   Signorini ML, 2012, RES VET SCI, V93, P250, DOI 10.1016/j.rvsc.2011.05.001
   Spencer SJ, 2017, NEUROBIOL AGING, V58, P88, DOI 10.1016/j.neurobiolaging.2017.06.014
   Stilling RM, 2014, GENES BRAIN BEHAV, V13, P69, DOI 10.1111/gbb.12109
   Takei M, 2017, FOOD BIOSCI, V19, P85, DOI 10.1016/j.fbio.2017.06.006
   Tenorio R. P. A., 2019, J APPL PHYCOL, V31, P3115
   United Nations, 2020, DEP EC SOC AFF, V46, P857
   Vaiserman AM, 2017, AGEING RES REV, V35, P36, DOI 10.1016/j.arr.2017.01.001
   Wang HMD, 2017, BIORESOURCE TECHNOL, V244, P1407, DOI 10.1016/j.biortech.2017.05.198
   Xiong WY, 2022, PLANT FOOD HUM NUTR, V77, P292, DOI 10.1007/s11130-022-00968-1
   Yamamoto M, 2018, PHYSIOL REV, V98, P1169, DOI 10.1152/physrev.00023.2017
   Zacharatos P, 2004, J PATHOL, V203, P744, DOI 10.1002/path.1582
   Zhao LP, 2018, SCIENCE, V359, P1151, DOI 10.1126/science.aao5774
   Zhao PJ, 2019, NUTRIENTS, V11, DOI 10.3390/nu11010060
   Zhu H, 2005, FEBS LETT, V579, P3029, DOI 10.1016/j.febslet.2005.04.058
NR 63
TC 0
Z9 0
U1 20
U2 38
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1613-4125
EI 1613-4133
J9 MOL NUTR FOOD RES
JI Mol. Nutr. Food Res.
PD 2023 APR 2
PY 2023
DI 10.1002/mnfr.202200766
EA APR 2023
PG 13
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA C4NE8
UT WOS:000961692200001
PM 37005336
DA 2024-02-19
ER

PT J
AU MISHRA, SK
   DAS, BR
AF MISHRA, SK
   DAS, BR
TI (ADP-RIBOSYL)ATION PATTERN OF CHROMOSOMAL-PROTEINS DURING AGING
SO CELLULAR AND MOLECULAR BIOLOGY
LA English
DT Article
DE (ADP-RIBOSYL)ATION; HISTONE; NONHISTONE CHROMOSOMAL (NHC) PROTEIN; AGING
ID ADP-RIBOSYLATION; POLY(ADP-RIBOSE) SYNTHESIS; DEVELOPING RATS;
   CHROMATIN; BRAIN; DNA; TRANSCRIPTION; INVITRO; SUPPRESSION; MODULATION
AB (ADP-ribosyl)ation of chromosomal proteins was studied by incubating the nuclei of brain and liver of young and old rats with C-14-NAD+. In brain as well as in liver histone proteins show approximately 2-3 fold higher (ADP-ribosyl)ation than that of non-histone chromosomal (NHC) proteins of both the age groups. H1 seems to be the major target for (ADP-ribosyl)ation. Amongst nucleosomal histones H2B is the main acceptor of C-14-labelled ADP-ribose moieties. A sharp age related decline of (ADP-ribosyl)ation of chromosomal proteins was observed in both the tissues.
C1 INST LIFE SCI,MOLEC BIOL & GENET ENGN UNIT,301 SAHID NAGAR,BHUBANESWAR 751007,INDIA.
C3 Department of Biotechnology (DBT) India; Institute of Life Sciences
   India (ILS)
CR ABRAMOWITZ J, 1991, INT J BIOCHEM, V23, P549
   ADAMIETZ P, 1984, J BIOL CHEM, V259, P6841
   ADAMIETZ P, 1987, EUR J BIOCHEM, V169, P365, DOI 10.1111/j.1432-1033.1987.tb13621.x
   BOULIKAS T, 1990, J BIOL CHEM, V265, P14638
   CHATURVEDI MM, 1983, BIOCHEM INT, V6, P357
   CLEAVER JE, 1985, RADIAT RES, V101, P16, DOI 10.2307/3576300
   DAS BR, 1986, MOL BIOL REP, V11, P195, DOI 10.1007/BF00419596
   DAS BR, 1986, INDIAN J BIOCHEM BIO, V23, P87
   DAS BR, 1986, BIOCHEM INT, V12, P303
   DAS BR, 1987, MOL BIOL REP, V12, P43, DOI 10.1007/BF00580649
   DAS BR, 1986, MOL BIOL REP, V112, P63
   DEMURCIA G, 1986, J BIOL CHEM, V261, P7011
   DEMURCIA G, 1988, BIOCHEM CELL BIOL, V66, P626, DOI 10.1139/o88-072
   ELGIN SCR, 1970, BIOCHEMISTRY-US, V9, P4440, DOI 10.1021/bi00824a027
   GAUDREAU A, 1986, BIOCHEM CELL BIOL, V64, P146, DOI 10.1139/o86-023
   GREER WL, 1986, EXP CELL RES, V166, P399, DOI 10.1016/0014-4827(86)90486-6
   KURL RN, 1985, NUCLEIC ACIDS RES, V13, P89, DOI 10.1093/nar/13.1.89
   LEVY-W B, 1979, Journal of Biological Chemistry, V254, P609
   MATHIS G, 1987, BIOCHEM BIOPH RES CO, V143, P1049, DOI 10.1016/0006-291X(87)90358-5
   MISHRA SK, 1991, QUALITY AGING, P47
   NISHIZUK.Y, 1967, J BIOL CHEM, V242, P3164
   OHASHI Y, 1984, P NATL ACAD SCI-BIOL, V81, P7132, DOI 10.1073/pnas.81.22.7132
   OKAZAKI H, 1980, FEBS LETT, V110, P227, DOI 10.1016/0014-5793(80)80079-2
   POIRIER GG, 1982, P NATL ACAD SCI-BIOL, V79, P3423, DOI 10.1073/pnas.79.11.3423
   SHIMAMURA A, 1989, MOL CELL BIOL, V9, P5573, DOI 10.1128/MCB.9.12.5573
   STONE PR, 1977, EUR J BIOCHEM, V81, P9, DOI 10.1111/j.1432-1033.1977.tb11921.x
   TANIGAWA Y, 1977, BIOCHEM BIOPH RES CO, V76, P406, DOI 10.1016/0006-291X(77)90739-2
   UEDA K, 1992, RECENT ADV CELLULAR, V6, P29
   UEDA K, 1991, MAY P MAND INT M ADP, pC30
   WEINTRAUB H, 1984, CELL, V38, P17, DOI 10.1016/0092-8674(84)90522-1
   WILSON EM, 1973, BIOCHIM BIOPHYS ACTA, V322, P145, DOI 10.1016/0005-2795(73)90185-2
   YAMAGAMI T, 1985, CANCER RES, V45, P1845
NR 32
TC 7
Z9 8
U1 0
U2 0
PU CELLULAR & MOLECULAR BIOLOGY
PI NOISY-LE-GRAND
PA PROF R WEGMANN RESIDENCE HAUSSMANN 1 AVENUE DU PAVE NEUF, 93160
   NOISY-LE-GRAND, FRANCE
SN 0145-5680
J9 CELL MOL BIOL
JI Cell. Mol. Biol.
PD JUL
PY 1992
VL 38
IS 4
BP 457
EP 462
PG 6
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA JC933
UT WOS:A1992JC93300013
PM 1499045
DA 2024-02-19
ER

PT J
AU Mehdipour, M
   Etienne, J
   Chen, CC
   Gathwala, R
   Rehman, M
   Kato, C
   Liu, C
   Liu, YT
   Zuo, Y
   Conboy, MJ
   Conboy, IM
AF Mehdipour, Melod
   Etienne, Jessy
   Chen, Chia-Chien
   Gathwala, Ranveer
   Rehman, Maryam
   Kato, Cameron
   Liu, Chao
   Liu, Yutong
   Zuo, Yi
   Conboy, Michael J.
   Conboy, Irina M.
TI Rejuvenation of brain, liver and muscle by simultaneous pharmacological
   modulation of two signaling determinants, that change in opposite
   directions with age
SO AGING-US
LA English
DT Article
DE muscle repair; TGF-beta; oxytocin; neurogenesis; neuro-inflammation;
   cognition; liver health
ID GROWTH-FACTOR-BETA; SENESCENT CELLS; STEM-CELLS; TGF-BETA; HIPPOCAMPAL
   NEUROGENESIS; HETEROCHRONIC PARABIOSIS; NEUROINFLAMMATION; INFLAMMATION;
   INCREASES; OXYTOCIN
AB We hypothesize that altered intensities of a few morphogenic pathways account for most/all the phenotypes of aging. Investigating this has revealed a novel approach to rejuvenate multiple mammalian tissues by defined pharmacology. Specifically, we pursued the simultaneous youthful in vivo calibration of two determinants: TGF-beta which activates ALK5/pSmad 2,3 and goes up with age, and oxytocin (OT) which activates MAPK and diminishes with age. The dose of Alk5 inhibitor (Alk5i) was reduced by 10-fold and the duration of treatment was shortened (to minimize overt skewing of cell-signaling pathways), yet the positive outcomes were broadened, as compared with our previous studies. Alk5i plus OT quickly and robustly enhanced neurogenesis, reduced neuro-inflammation, improved cognitive performance, and rejuvenated livers and muscle in old mice. Interestingly, the combination also diminished the numbers of cells that express the CDK inhibitor and marker of senescence p16 in vivo. Summarily, simultaneously re-normalizing two pathways that change with age in opposite ways (up vs. down) synergistically reverses multiple symptoms of aging.
C1 [Mehdipour, Melod; Etienne, Jessy; Gathwala, Ranveer; Rehman, Maryam; Kato, Cameron; Liu, Chao; Liu, Yutong; Conboy, Michael J.; Conboy, Irina M.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.
   [Mehdipour, Melod; Etienne, Jessy; Gathwala, Ranveer; Rehman, Maryam; Kato, Cameron; Liu, Chao; Liu, Yutong; Conboy, Michael J.; Conboy, Irina M.] Univ Calif Berkeley, QB3 Inst, Berkeley, CA 94720 USA.
   [Chen, Chia-Chien; Zuo, Yi] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA.
C3 University of California System; University of California Berkeley;
   University of California System; University of California Berkeley;
   University of California System; University of California Santa Cruz
RP Conboy, IM (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.; Conboy, IM (corresponding author), Univ Calif Berkeley, QB3 Inst, Berkeley, CA 94720 USA.
EM iconboy@berkeley.edu
RI ETIENNE, Jessy/ACO-5477-2022; Liu, Yutong/HTN-3455-2023
OI ETIENNE, Jessy/0000-0003-2173-6191; Liu, Yutong/0000-0001-5683-5451;
   Liu, Chao/0000-0001-8683-3473; Zuo, Yi/0000-0001-9020-0003; Mehdipour,
   Melod/0000-0002-6764-7621
FU Packer award; Open Philanthropy research gift; Rogers' Family award; NIH
   [R56 AG058819, R01 HL139605, RO1MH109475, RO1MH104227]; Tom Budinger
   Award
FX This work was supported by Packer award, Open Philanthropy research
   gift, Rogers' Family award, and NIH grants (R56 AG058819 and R01
   HL139605) to IC; Tom Budinger Award to YL, and NIH grants (RO1MH109475
   and RO1MH104227) to YZ.
CR Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z
   Baar MP, 2017, CELL, V169, P132, DOI 10.1016/j.cell.2017.02.031
   Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932
   Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600
   Bakula D, 2018, AGING-US, V10, P3079, DOI 10.18632/aging.101646
   Barraza JA, 2013, EXP CLIN PSYCHOPHARM, V21, P85, DOI 10.1037/a0031581
   Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926
   Chang JH, 2016, NAT MED, V22, P78, DOI 10.1038/nm.4010
   Chen CC, 2018, MOL PSYCHIATR, V23, P1614, DOI 10.1038/mp.2017.159
   Childs BG, 2016, SCIENCE, V354, P472, DOI 10.1126/science.aaf6659
   Colaianni G, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00079
   Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260
   Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573
   Conboy IM, 2015, AGING-US, V7, P754, DOI 10.18632/aging.100819
   Conboy IM, 2012, CELL CYCLE, V11, P2260, DOI 10.4161/cc.20437
   Conboy MJ, 2013, AGING CELL, V12, P525, DOI 10.1111/acel.12065
   Cunha SI, 2011, BLOOD, V117, P6999, DOI 10.1182/blood-2011-01-330142
   Dal Monte O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103677
   Daldrup-Link HE, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85608
   Demaria M, 2015, J INVEST DERMATOL, V135, P1722, DOI 10.1038/jid.2015.108
   Demaria M, 2014, DEV CELL, V31, P722, DOI 10.1016/j.devcel.2014.11.012
   Elabd C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5082
   Hashimoto M, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.87732
   Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159
   Javelaud D, 2005, ONCOGENE, V24, P5742, DOI 10.1038/sj.onc.1208928
   Jeon OH, 2018, J CLIN INVEST, V128, P1229, DOI 10.1172/JCI95147
   Kim IH, 2016, AGE, V38, P291, DOI 10.1007/s11357-016-9938-6
   Kiprov DD, 2001, J CLIN APHERESIS, V16, P130, DOI 10.1002/jca.1024
   Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092
   Kuhn HG, 1996, J NEUROSCI, V16, P2027
   Lee HJ, 2009, PROG NEUROBIOL, V88, P127, DOI 10.1016/j.pneurobio.2009.04.001
   Lee SW, 2012, BEHAV BRAIN RES, V227, P497, DOI 10.1016/j.bbr.2011.10.009
   Lee W, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0324-6
   Li J, 2015, STEM CELLS, V33, P951, DOI 10.1002/stem.1908
   Liu Y, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00698-y
   Loffredo FS, 2013, CELL, V153, P828, DOI 10.1016/j.cell.2013.04.015
   MA D, 1995, IMMUNOLOGY, V86, P263
   MCGEER PL, 1993, GLIA, V7, P84, DOI 10.1002/glia.440070114
   MOKRZYCKI MH, 1994, AM J KIDNEY DIS, V23, P817, DOI 10.1016/S0272-6386(12)80135-1
   Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091
   Moustakas A, 2002, IMMUNOL LETT, V82, P85, DOI 10.1016/S0165-2478(02)00023-8
   Price FD, 2014, NAT MED, V20, P1174, DOI 10.1038/nm.3655
   Rebo J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13363
   Rice RA, 2017, GLIA, V65, P931, DOI 10.1002/glia.23135
   Ruckh JM, 2012, CELL STEM CELL, V10, P96, DOI 10.1016/j.stem.2011.11.019
   Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241
   Sheen YY, 2013, BIOMOL THER, V21, P323, DOI 10.4062/biomolther.2013.072
   Sheppard Dean, 2006, Proc Am Thorac Soc, V3, P413, DOI 10.1513/pats.200601-008AW
   Skaper SD, 2014, CNS NEUROL DISORD-DR, V13, P1654
   Sousa-Victor P, 2014, CELL CYCLE, V13, P3183, DOI 10.4161/15384101.2014.965072
   Sousa-Victor P, 2014, NATURE, V506, P316, DOI 10.1038/nature13013
   Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002
   Szczeklik W, 2013, ANAESTH INTENSIVE TH, V45, P7, DOI 10.5603/AIT.2013.0002
   Takahashi Y, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00144
   Tamma R, 2009, P NATL ACAD SCI USA, V106, P7149, DOI 10.1073/pnas.0901890106
   Valero J, 2017, J ALZHEIMERS DIS, V60, pS161, DOI 10.3233/JAD-170239
   van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368
   Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357
   Wu HPP, 2013, BEHAV BRAIN RES, V237, P238, DOI 10.1016/j.bbr.2012.09.044
   Yirmiya R, 2011, BRAIN BEHAV IMMUN, V25, P181, DOI 10.1016/j.bbi.2010.10.015
   Yousef H, 2015, ONCOTARGET, V6, P11959, DOI 10.18632/oncotarget.3851
NR 61
TC 22
Z9 23
U1 0
U2 4
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD AUG 15
PY 2019
VL 11
IS 15
BP 5628
EP 5645
DI 10.18632/aging.102148
PG 18
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA IR7XT
UT WOS:000481655500027
PM 31422380
OA Green Published, Green Submitted, gold
DA 2024-02-19
ER

PT J
AU Suehiro, A
   Wright, H
   Rousseau, B
AF Suehiro, Atsushi
   Wright, Harry
   Rousseau, Bernard
TI Optimal Concentration of Hepatocyte Growth Factor for Treatment of the
   Aged Rat Vocal Fold
SO LARYNGOSCOPE
LA English
DT Article
DE Aged vocal fold; hepatocyte growth factor; concentration study;
   extracellular matrix
ID AGING VOICE; COLLAGEN; FIBERS
AB Objectives/Hypothesis: Hepatocyte growth factor (HGF) demonstrates beneficial properties in the treatment of aged vocal folds. However, the optimal concentration of HGF remains unknown. The purpose of the present study was to investigate the effects of HGF concentration on treatment of the aged rat vocal fold.
   Study Design: Prospective animal study.
   Methods: Seventy-five rats were studied. The rats were divided into five groups and received serial injections of HGF in 10 id, of phosphate-buffered saline (PBS) at the following concentrations: 10 ng/10 mu L, 50 ng/10 mu L, 100 ng/10 mu L, 200 ng/10 mu L, or control (PBS only). Alcian blue staining was performed to investigate hyaluronan (HA), and immunohistochemistry was performed to investigate collagen type I and III. Gene expression of hyaluronic acid synthase (HAS)-1, -2, matrix metalloproteinases (MMP)-2, -9, and procollagen I and III were also investigated using real-time polymerase chain reaction (RT-PCR).
   Results: Histologic analyses revealed increased HA and decreased collagen type I in rats receiving injections of HGF at 100 ng/10 mu L. Results were supported by RT-PCR revealing upregulated expression of HAS-2, decreased expression of procollagen 1, and a significant increase of MMP-9 mRNA in rats receiving HGF at 100 ng/10 mu L.
   Conclusions: We report the first in vivo concentration study of HGF for treatment of the aged vocal fold. Results revealed desirable biochemical effects of HGF at 100 ng/10 mu L. These data will be used to provide immediate direction to programmatic efforts aimed at examining future applications of HGF for treatment of the aged vocal fold.
C1 [Suehiro, Atsushi; Wright, Harry; Rousseau, Bernard] Vanderbilt Univ, Dept Otolaryngol, Bill Wilkerson Ctr Otolaryngol & Commun Sci, Nashville, TN 37232 USA.
C3 Vanderbilt University
RP Rousseau, B (corresponding author), Vanderbilt Univ, Dept Otolaryngol, Bill Wilkerson Ctr Otolaryngol & Commun Sci, 1313 21st Ave S,Room 602, Nashville, TN 37232 USA.
EM bernard.rousseau@vanderbilt.edu
FU National Institutes of Health, National Institute of Deafness and Other
   Communication Disorders [R21 DC 009873]
FX This research was supported by National Institutes of Health grant R21
   DC 009873 from the National Institute of Deafness and Other
   Communication Disorders. The authors have no other funding, financial
   relationships, or conflicts of interest to disclose.
CR Bloch I, 2001, LARYNGOSCOPE, V111, P2022, DOI 10.1097/00005537-200111000-00029
   Butler JE, 2001, LARYNGOSCOPE, V111, P907, DOI 10.1097/00005537-200105000-00029
   Damrose Edward J, 2003, Curr Opin Otolaryngol Head Neck Surg, V11, P480, DOI 10.1097/00020840-200312000-00013
   Ford C, 2004, ARCH OTOLARYNGOL, V130, P1117, DOI 10.1001/archotol.130.9.1117
   Gray SD, 1999, LARYNGOSCOPE, V109, P845, DOI 10.1097/00005537-199906000-00001
   Hammond TH, 2000, ANN OTO RHINOL LARYN, V109, P913, DOI 10.1177/000348940010901004
   HIRANO M, 1989, ACTA OTO-LARYNGOL, V107, P428, DOI 10.3109/00016488909127535
   Hirano S, 2004, LARYNGOSCOPE, V114, P2161, DOI 10.1097/01.mlg.0000149450.37640.db
   Ohno T, 2009, ANN OTO RHINOL LARYN, V118, P735, DOI 10.1177/000348940911801009
   Ohno T, 2009, LARYNGOSCOPE, V119, P1424, DOI 10.1002/lary.20497
   PEAK W, 1992, LARYNGOSCOPE, V102, P139, DOI 10.1288/00005537-199202000-00007
   Ramig LO, 2001, FOLIA PHONIATR LOGO, V53, P252, DOI 10.1159/000052680
   Sato K, 2002, ANN OTO RHINOL LARYN, V111, P15, DOI 10.1177/000348940211100103
   Sato K, 1997, ANN OTO RHINOL LARYN, V106, P44, DOI 10.1177/000348949710600109
   SATO K, 1995, ANN OTO RHINOL LARYN, V104, P839, DOI 10.1177/000348949510401102
   Tateya T, 2005, ANN OTO RHINOL LARYN, V114, P183, DOI 10.1177/000348940511400303
NR 16
TC 10
Z9 10
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0023-852X
EI 1531-4995
J9 LARYNGOSCOPE
JI Laryngoscope
PD AUG
PY 2011
VL 121
IS 8
BP 1726
EP 1734
DI 10.1002/lary.21816
PG 9
WC Medicine, Research & Experimental; Otorhinolaryngology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Otorhinolaryngology
GA 806JJ
UT WOS:000293803400022
PM 21792961
OA Green Accepted
DA 2024-02-19
ER

PT J
AU SIGAL, SH
   GUPTA, S
   GEBHARD, DF
   HOLST, P
   NEUFELD, D
   REID, LM
AF SIGAL, SH
   GUPTA, S
   GEBHARD, DF
   HOLST, P
   NEUFELD, D
   REID, LM
TI EVIDENCE FOR A TERMINAL DIFFERENTIATION PROCESS IN THE RAT-LIVER
SO DIFFERENTIATION
LA English
DT Article
ID HUMAN DIPLOID CELLS; PRIMARY CULTURE; OVAL CELLS; STEM-CELL;
   HEPATOCYTES; GLUCOSE-6-PHOSPHATASE; GROWTH; CARCINOGENESIS;
   PROLIFERATION; POPULATION
AB In rapidly renewing epithelia, such as skin and gut, as well as hemopoietic cells and stromal fibroblasts, the process of progenitor cell maturation, terminal differentiation and senescence from cells of a fetal phenotype is strikingly similar. To examine hepatocellular maturation, we studied embryonic, suckling and young adult rat liver cells with multiparametric fluorescence activated cell sorting (FAGS), after exclusion of hemopoietic, endothelial, Kupffer, and nonviable cells. With maturation, cell granularity and autofluorescence exponentially increased from fetal liver to suckling and adult liver as the proportion of S phase cells progressively declined from 33.8%+/-1.3% to 4.9%+/-2.8% and 1.1%+/-0.6% (P<0.05), respectively. In liver from fetal and suckling rats, all hepatocytes were mononuclear and contained diploid DNA whereas 21.2%+/-5.9% hepatocytes in adult liver were binucleated. Analysis of nuclear DNA content in adult hepatocytes demonstrated that 53.3%+/-3.9% of the nuclei were diploid, 43.6%+/-3.5% tetraploid and 0.5+/-0.6% octaploid. However, in the adult liver, small, mononuclear cells were also present with granularity and autofluorescence comparable to fetal hepatoblasts, as well as glucose-6-phosphatase activity, diploid DNA in 89.0%+/-2.1% of the nuclei, and with increased granularity in culture. Since general features of terminal cellular differentiation and senescence include cessation of mitotic activity, polyploidy and accumulation of autofluorescent secondary lysosomes, our data suggest that liver cells too undergo a process of terminal differentiation.
C1 YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT MED,BRONX,NY 10461.
   YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT MOLEC PHARMACOL,BRONX,NY 10461.
   YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT MICROBIOL & IMMUNOL,BRONX,NY 10461.
   YESHIVA UNIV ALBERT EINSTEIN COLL MED,MARION BESSIN LIVER RES CTR,BRONX,NY 10461.
C3 Yeshiva University; Albert Einstein College of Medicine; Yeshiva
   University; Albert Einstein College of Medicine; Yeshiva University;
   Albert Einstein College of Medicine; Yeshiva University; Albert Einstein
   College of Medicine
FU NIDDK NIH HHS [T32DK07218-17, DK44266, K08 DK-01909] Funding Source:
   Medline
CR ARBER N, 1988, LIVER, V8, P80
   BARIBAULT H, 1985, J CELL PHYSIOL, V122, P105, DOI 10.1002/jcp.1041220116
   BECKER FF, 1971, JNCI-J NATL CANCER I, V46, P1261
   BENNER U, 1979, HISTOCHEMISTRY, V65, P41, DOI 10.1007/BF00496684
   BRASCH K, 1980, CELL BIOL INT REP, V4, P217, DOI 10.1016/0309-1651(80)90077-6
   Brodsky W Y, 1977, Int Rev Cytol, V50, P275
   BRUNK U, 1972, J ULTRA MOL STRUCT R, V38, P1, DOI 10.1016/S0022-5320(72)90080-9
   CRISTOFALO VJ, 1973, EXP CELL RES, V76, P419, DOI 10.1016/0014-4827(73)90394-7
   GERMAIN L, 1988, CANCER RES, V48, P4909
   Grisham J W, 1980, Ann N Y Acad Sci, V349, P128, DOI 10.1111/j.1749-6632.1980.tb29521.x
   HACKER HJ, 1992, CARCINOGENESIS, V13, P271, DOI 10.1093/carcin/13.2.271
   HARRIS M, 1971, EXP CELL RES, V66, P29
   HIXSON DC, 1990, PATHOBIOLOGY, V58, P65, DOI 10.1159/000163565
   HOFFMANN B, 1989, J CELL PHYSIOL, V139, P654, DOI 10.1002/jcp.1041390328
   JONGKIND JF, 1982, EXP CELL RES, V138, P409, DOI 10.1016/0014-4827(82)90189-6
   KLEINMAN HK, 1986, BIOCHEMISTRY-US, V25, P312, DOI 10.1021/bi00350a005
   LEBOUTON AV, 1970, DEV BIOL, V23, P524, DOI 10.1016/0012-1606(70)90138-7
   LEMIRE JM, 1991, AM J PATHOL, V139, P535
   LESKES A, 1971, J CELL BIOL, V49, P264, DOI 10.1083/jcb.49.2.264
   LIPETZ J, 1972, J ULTRA MOL STRUCT R, V39, P43, DOI 10.1016/S0022-5320(72)80005-4
   MARTINEZHERNAND.A, 1993, EXTRACELLULAR MATRIX, P255
   MCCLOSKEY TW, 1992, HEPATOLOGY, V16, P191, DOI 10.1002/hep.1840160130
   MITAKA T, 1992, HEPATOLOGY, V16, P440, DOI 10.1002/hep.1840160224
   OHASHI M, 1980, EXP GERONTOL, V115, P121
   PLENAT F, 1988, AM J PATHOL, V130, P91
   POST J, 1964, EXP CELL RES, V36, P111, DOI 10.1016/0014-4827(64)90165-X
   REICHEL W, 1968, J GERONTOL, V23, P145, DOI 10.1093/geronj/23.2.145
   RUTENBURG AM, 1969, J HISTOCHEM CYTOCHEM, V17, P517, DOI 10.1177/17.8.517
   SCHWARZE PE, 1984, CARCINOGENESIS, V5, P1267, DOI 10.1093/carcin/5.10.1267
   SELL S, 1989, AM J PATHOL, V134, P1347
   SHIOJIRI N, 1991, CANCER RES, V51, P2611
   SIGAL SH, 1994, HEPATOLOGY, V19, P999
   SIGAL SH, 1992, AM J PHYSIOL, V263, pG139, DOI 10.1152/ajpgi.1992.263.2.G139
   TEUTSCH HF, 1978, HISTOCHEMISTRY, V57, P107, DOI 10.1007/BF00496675
   VARGAS JL, 1987, BIOCHEM BIOPH RES CO, V147, P535, DOI 10.1016/0006-291X(87)90964-8
   VINDELOV LL, 1983, CYTOMETRY, V3, P323, DOI 10.1002/cyto.990030503
   WHITE INH, 1987, BIOCHEM J, V247, P23, DOI 10.1042/bj2470023
   WILSON JW, 1958, J PATHOL BACTERIOL, V76, P441, DOI 10.1002/path.1700760213
   YASWEN P, 1984, CANCER RES, V44, P324
NR 39
TC 63
Z9 68
U1 0
U2 7
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0301-4681
J9 DIFFERENTIATION
JI Differentiation
PD JUL
PY 1995
VL 59
IS 1
BP 35
EP 42
DI 10.1046/j.1432-0436.1995.5910035.x
PG 8
WC Cell Biology; Developmental Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Developmental Biology
GA RM457
UT WOS:A1995RM45700004
PM 7589893
DA 2024-02-19
ER

PT J
AU Gerhard, GS
   Kaufmann, EJ
   Wang, XJ
   Erikson, KM
   Abraham, J
   Grundy, M
   Beard, JL
   Chorney, MJ
AF Gerhard, GS
   Kaufmann, EJ
   Wang, XJ
   Erikson, KM
   Abraham, J
   Grundy, M
   Beard, JL
   Chorney, MJ
TI Genetic differences in hepatic lipid peroxidation potential and iron
   levels in mice
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article; Proceedings Paper
CT 3rd Meeting on Genetic Effects on Aging
CY 2000
CL BAR HARBOR, MAINE
DE lipid peroxidation; QTL; iron; recombinant inbred mice
ID FATTY-ACID COMPOSITION; OXIDATIVE STRESS; CHOLESTEROL ACYLTRANSFERASE;
   DEVELOPMENTAL REGULATION; DIETARY RESTRICTION; CALORIC RESTRICTION;
   MOUSE; MALONDIALDEHYDE; LIVER; AGE
AB Oxidative damage to macromolecules, including lipids, has been hypothesized as a mechanism of aging. One end product of lipid peroxidation, malondialdehyde (MDA), is often quantified as a measure of oxidative damage to lipids. We used a commercial colorimetric assay for MDA (Bioxytech LPO-586, Oxis International, Portland, OR) to measure lipid peroxidation potential in liver tissue from young (2 month) male mice from recombinant inbred (RI) mouse strains from the C57BL/6.1 (136) x DBA/2J (132) series (BXD). The LPO-586 assay (LPO) reliably detected significant differences (P < 0.0001) in lipid peroxidation potential between the 136 and D2 parental strains, and yielded a more than two-fold variation across the BXD RI strains. In both 136 and D2 mice, LPO results were greater in old (23 month) mice, with a target age-related increase in the D2 strain. As the level of iron can influence lipid peroxidation, we also measured hepatic non-heme iron levels in the same strains. Although iron level exhibited a slightly negative overall correlation (r(2) = 0.119) with LPO results among the entire group of BXD RI strains, a sub-group with lower LPO values were highly correlated (r(2) = 0.704). LPO results were also positively correlated with iron levels from a group of 8 other inbred 'mouse strains (r(2) = 0.563). The BXD RI LPO data were statistically analyzed to nominate quantitaive trait loci (QTL), A single marker, Zfp4, which maps to 55.2 cM on chromosome 8, achieved a significance level of P < 0.0006. At least two potentially relevant candidate genes reside close to this chromosomal position. Hepatic lipid peroxidation potential appears to be a strain related trait in mice that is amenable to QTL analysis. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
C1 Penn State Coll Med, Dept Pathol, Hershey, PA USA.
   Dartmouth Coll Sch Med, Dept Pathol, Hanover, NH USA.
   Penn State Univ, Dept Nutr, University Pk, PA USA.
   Penn State Coll Med, Dept Microbiol & Immunol & Pediat, Hershey, PA USA.
C3 Pennsylvania Commonwealth System of Higher Education (PCSHE);
   Pennsylvania State University; Penn State Health; Dartmouth College;
   Pennsylvania Commonwealth System of Higher Education (PCSHE);
   Pennsylvania State University; Pennsylvania State University -
   University Park; Pennsylvania Commonwealth System of Higher Education
   (PCSHE); Pennsylvania State University; Penn State Health
RP Gerhard, GS (corresponding author), Penn State Coll Med, Dept Pathol, Hershey, PA USA.
FU NIA NIH HHS [AG14731] Funding Source: Medline; NIDDK NIH HHS [DK53430]
   Funding Source: Medline
CR BENETT B, 1994, ALCOHOL ALCOHOL S2, V2, P79
   CHEESEMAN KH, 1985, FEBS LETT, V184, P343, DOI 10.1016/0014-5793(85)80635-9
   Clothier B, 2000, BIOCHEM PHARMACOL, V59, P115, DOI 10.1016/S0006-2952(99)00306-8
   Cook CI, 1998, MECH AGEING DEV, V102, P1, DOI 10.1016/S0047-6374(98)00005-0
   Dueland S, 1997, J LIPID RES, V38, P1445
   Esterbauer H, 1996, PATHOL BIOL, V44, P25
   GELMAN R, 1988, GENETICS, V118, P693
   Goyal J, 1997, J BIOL CHEM, V272, P16231, DOI 10.1074/jbc.272.26.16231
   GUTTERIDGE JMC, 1990, TRENDS BIOCHEM SCI, V15, P129, DOI 10.1016/0968-0004(90)90206-Q
   Ibrahim W, 1997, J NUTR, V127, P1401, DOI 10.1093/jn/127.7.1401
   Ingram DK, 1999, NEUROBIOL AGING, V20, P137, DOI 10.1016/S0197-4580(99)00033-0
   Jackson AU, 1999, GENETICS, V151, P785
   JANERO DR, 1988, LIPIDS, V23, P452, DOI 10.1007/BF02535519
   JANERO DR, 1989, LIPIDS, V24, P125, DOI 10.1007/BF02535249
   Jentzsch AM, 1996, FREE RADICAL BIO MED, V20, P251, DOI 10.1016/0891-5849(95)02043-8
   KOIZUMI A, 1987, J NUTR, V117, P361, DOI 10.1093/jn/117.2.361
   KUMAKI K, 1977, J BIOL CHEM, V252, P157
   LAGANIERE S, 1993, GERONTOLOGY, V39, P7, DOI 10.1159/000213509
   LINPISARN S, 1991, INT J HEMATOL, V54, P181
   MAHMOODI H, 1995, LIPIDS, V30, P963, DOI 10.1007/BF02537490
   Marnett LJ, 1999, MUTAT RES-FUND MOL M, V424, P83, DOI 10.1016/S0027-5107(99)00010-X
   MASSIE HR, 1983, EXP GERONTOL, V18, P277, DOI 10.1016/0531-5565(83)90038-4
   MILLER DM, 1993, ARCH BIOCHEM BIOPHYS, V301, P1, DOI 10.1006/abbi.1993.1107
   MINOTTI G, 1992, LIPIDS, V27, P219, DOI 10.1007/BF02536182
   Morse AC, 1999, P SOC EXP BIOL MED, V220, P147, DOI 10.1046/j.1525-1373.1999.d01-22.x
   Oates PS, 2000, J GASTROEN HEPATOL, V15, P665, DOI 10.1046/j.1440-1746.2000.02210.x
   *OX INT I, 1997, BIOXYTECH LPO 586 CO
   PLOMIN R, 1991, BEHAV GENET, V21, P99, DOI 10.1007/BF01066330
   PLOMIN R, 1993, BEHAV GENET, V23, P197, DOI 10.1007/BF01067425
   PORTER NA, 1995, LIPIDS, V30, P277, DOI 10.1007/BF02536034
   Rikans LE, 1997, BBA-MOL BASIS DIS, V1362, P116, DOI 10.1016/S0925-4439(97)00067-7
   ROJAS C, 1993, ARCH BIOCHEM BIOPHYS, V306, P59, DOI 10.1006/abbi.1993.1480
   SAWADA M, 1987, MECH AGEING DEV, V41, P125, DOI 10.1016/0047-6374(87)90057-1
   SCHISLER NJ, 1985, BIOCHEM GENET, V23, P291, DOI 10.1007/BF00504326
   SCHISLER NJ, 1991, BIOCHEM GENET, V29, P65, DOI 10.1007/BF00578241
   SIU GM, 1982, LIPIDS, V17, P349, DOI 10.1007/BF02535193
   Sohal RS, 1999, FREE RADICAL BIO MED, V27, P287, DOI 10.1016/S0891-5849(99)00052-0
   Torrance JD, 1980, Methods in Hematology: Iron, V1, P90
   TSUCHIDA M, 1987, CHEM PHYS LIPIDS, V44, P297, DOI 10.1016/0009-3084(87)90055-7
   Turturro A, 1999, J GERONTOL A-BIOL, V54, pB492, DOI 10.1093/gerona/54.11.B492
   UYSAL M, 1989, MECH AGEING DEV, V48, P85, DOI 10.1016/0047-6374(89)90028-6
   VALENZUELA A, 1991, LIFE SCI, V48, P301, DOI 10.1016/0024-3205(91)90550-U
   VASILIOU V, 1994, PHARMACOGENETICS, V4, P341, DOI 10.1097/00008571-199412000-00007
   WARDEN CH, 1989, J BIOL CHEM, V264, P21573
   XIA EN, 1995, J NUTR, V125, P195
NR 45
TC 18
Z9 18
U1 0
U2 1
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD JAN
PY 2002
VL 123
IS 2-3
BP 167
EP 176
AR PII S0047-6374(01)00329-3
DI 10.1016/S0047-6374(01)00329-3
PG 10
WC Cell Biology; Geriatrics & Gerontology
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 578ZY
UT WOS:000177152000013
PM 11718810
DA 2024-02-19
ER

PT J
AU Toda, K
   Takeda, K
   Akira, S
   Saibara, T
   Okada, T
   Onishi, S
   Shizuta, Y
AF Toda, K
   Takeda, K
   Akira, S
   Saibara, T
   Okada, T
   Onishi, S
   Shizuta, Y
TI Alternations in hepatic expression of fatty-acid metabolizing enzymes in
   ArKO mice and their reversal by the treatment with 17β-estradiol or a
   peroxisome proliferator
SO JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
LA English
DT Article; Proceedings Paper
CT Aromatase 2000 and the 3rd Generation Symposium
CY NOV 03-07, 2000
CL PORT DOUGLAS, AUSTRALIA
SP Prince Henrys Inst Med REs, Astrazeneca, Novartis, Pharmacia Upjohn, Eli Lilly
DE aromatase; Cyp19; knockout mouse; hepatic steatosis; fatty acid
   beta-oxidation; peroxisome proliferator-activated receptor alpha
ID ACTIVATED RECEPTOR-ALPHA; DEFICIENT MICE; BETA-OXIDATION; ESTROGEN;
   APOLIPOPROTEIN; LIPOPROTEIN; LIVER; ESTRADIOL; THERAPY
AB We generated aromatase gene knockout mice (ArKO mice by targeting disruption of Cyp19, which encodes an enzyme responsible for conversion of androgens to estrogens. We found that ArKO males developed hepatic steatosis spontaneously with aging, indicating that the function of Cyp19 is required to maintain constitutive lipid metabolism in male mice. Plasma lipoprotein analysis using a gel permeation chromatography revealed that high density lipoprotein (HDL) -cholesterol levels were slightly higher in ArKO males than in wild-type males, whereas no other obvious alternations in the profiles were detected. Nevertheless, analysis of lipoprotein compositions by SDS-polyacrylamide gel electrophoresis demonstrated apparent reduction in the amounts of apolipoprotein E, functioning in receptor-mediated clearance of lipoproteins in the liver, in the IDL/LDL fraction of ArKO males as compared with that of wild-type males. Biochemical analysis on the ArKO livers revealed suppression of mRNA expression and activity of enzymes involved in fatty acid beta-oxidation. The impairment was reversed to the wild-type levels by treatment with 17beta-estradiol or bezafibrate, the latter is a synthetic peroxisome proliferator. These findings indicated a pivotal role of estrogen in supporting constitutive hepatic expression of genes involved in fatty acid beta-oxidation and in maintaining lipid homeostasis, (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Kochi Med Sch, Dept Med Chem, Nanko Ku, Kochi 7838505, Japan.
   Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Osaka 5650871, Japan.
   Kochi Med Sch, Dept Internal Med, Nanko Ku, Kochi 7838505, Japan.
   Kochi Med Sch, Dept Anat, Nanko Ku, Kochi 7838505, Japan.
C3 Kochi University; Osaka University; Kochi University; Kochi University
RP Toda, K (corresponding author), Kochi Med Sch, Dept Med Chem, Nanko Ku, Kochi 7838505, Japan.
RI Akira, Shizuo/C-3134-2009; Takeda, Kiyoshi/C-9331-2009
CR AJIT R, 1993, EUR J BIOCHEM, V216, P527, DOI 10.1111/j.1432-1033.1993.tb18171.x
   [Anonymous], 1989, MOL CLONING LAB MANU
   Aoyama T, 1998, J BIOL CHEM, V273, P5678, DOI 10.1074/jbc.273.10.5678
   APPLEBAUMBOWDEN D, 1989, J LIPID RES, V30, P1895
   Costet P, 1998, J BIOL CHEM, V273, P29577, DOI 10.1074/jbc.273.45.29577
   Couse JF, 1999, ENDOCR REV, V20, P358, DOI 10.1210/er.20.3.358
   DICKSON RB, 1987, ENDOCR REV, V8, P29, DOI 10.1210/edrv-8-1-29
   Djouadi F, 1998, J CLIN INVEST, V102, P1083, DOI 10.1172/JCI3949
   Grumbach MM, 1999, J CLIN ENDOCR METAB, V84, P4677, DOI 10.1210/jc.84.12.4677
   HAARBO J, 1994, ARTERIOSCLER THROMB, V14, P243, DOI 10.1161/01.ATV.14.2.243
   Hashimoto T, 1999, J BIOL CHEM, V274, P19228, DOI 10.1074/jbc.274.27.19228
   Hashimoto T, 2000, CELL BIOCHEM BIOPHYS, V32, P63, DOI 10.1385/CBB:32:1-3:63
   HAVEL RJ, 1955, J CLIN INVEST, V34, P1346
   HORIE Y, 1992, J BIOL CHEM, V267, P1962
   Huang YD, 1996, J BIOL CHEM, V271, P29146, DOI 10.1074/jbc.271.46.29146
   ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663
   Johnson EF, 1996, FASEB J, V10, P1241, DOI 10.1096/fasebj.10.11.8836037
   Nemoto Y, 2000, J CLIN INVEST, V105, P1819, DOI 10.1172/JCI9575
   Ogawa Y, 1998, LANCET, V351, P725, DOI 10.1016/S0140-6736(05)78493-2
   SACKS FM, 1990, ANN NY ACAD SCI, V592, P272
   Saibara T, 1999, LANCET, V353, P1802, DOI 10.1016/S0140-6736(05)75907-9
   Saibara T, 1999, LANCET, V354, P1299, DOI 10.1016/S0140-6736(05)76071-2
   SHINDO Y, 1978, BIOCHEM PHARMACOL, V27, P2683
   Simpson ER, 1997, RECENT PROG HORM RES, V52, P185
   TANG JJ, 1991, J LIPID RES, V32, P1571
   TODA K, 2000, FRONTIERS SCI SERIES, V29, P141
   WAGNER JD, 1991, J CLIN INVEST, V88, P1995, DOI 10.1172/JCI115526
   WEINSTEIN I, 1978, BIOCHIM BIOPHYS ACTA, V530, P394, DOI 10.1016/0005-2760(78)90159-5
NR 28
TC 38
Z9 50
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-0760
J9 J STEROID BIOCHEM
JI J. Steroid Biochem. Mol. Biol.
PD DEC
PY 2001
VL 79
IS 1-5
SI SI
BP 11
EP 17
AR PII S0960-0760(01)00135-2
DI 10.1016/S0960-0760(01)00135-2
PG 7
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA 535WR
UT WOS:000174669800003
PM 11850202
DA 2024-02-19
ER

PT J
AU Schmeding, M
   Sauer, I
   Hartwig, K
   Theruvath, T
   Pratschke, J
   Neuhaus, R
   Neuhaus, P
   Neumann, UP
AF Schmeding, Maximilian
   Sauer, Igor
   Hartwig, Kerstin
   Theruvath, Tom
   Pratschke, Johann
   Neuhaus, Ruth
   Neuhaus, Peter
   Neumann, Ulf P.
TI Aging of the liver graft and functional quality in the absence of
   recurrent disease: A 10 year histological follow-up
SO ANNALS OF TRANSPLANTATION
LA English
DT Article
DE liver transplantation; fibrosis; alcoholic liver disease; liver biopsy
ID LONG-TERM SURVIVAL; HEPATITIS-C VIRUS; HEPATOCELLULAR-CARCINOMA; DONOR
   AGE; TRANSPLANTATION; RECIPIENTS; FAILURE; PATIENT; RELAPSE; BENEFIT
AB Background: Although considerable information has been acquired concerning the function of older donor liver grafts it remains unclear how long these organs may fare well in their "cumulative life span". As graft challenge due to recurrent underlying disease can best be eliminated and controlled in patients transplanted for alcoholic liver disease (ALD) we analysed liver biopsies of ALD patients during a 10-year follow-up with special emphasis on donor age and parenchymal quality.
   Material/Methods: Biopsies were taken from 271 patients 1, 3, 5, 10 years after LT. Specimen were analysed and staged concerning inflammation, rejection, fatty involution, and fibrosis/cirrhosis. Donor characteristics were recorded along with clinical and serological parameters, immunosuppressive protocols, rejection episodes, and patient and graft survival.
   Results: 1, 3, 5 years after LT >80% of patients displayed only minimal Fibrosis. In the further course fibrosis rates increased among all patients, with slightly more fibrosis for recurrent drinkers. Donor age did not influence fibrosis progression, long-term patient or graft survival. Regardless of alcohol abuse survival was excellent 5 years after LT, after 10 years abstinent patients did significantly better (82%;68%; p=0.017).
   Conclusions: LT for ALD offers excellent long-term survival with minimal histological alteration, especially in abstinent patients. Aged organs generate adequate function in ALD recipients.
C1 [Schmeding, Maximilian; Sauer, Igor; Hartwig, Kerstin; Theruvath, Tom; Pratschke, Johann; Neuhaus, Ruth; Neuhaus, Peter; Neumann, Ulf P.] Charite, Dept Gen & Transplantat Surg, D-13353 Berlin, Germany.
C3 Free University of Berlin; Humboldt University of Berlin; Charite
   Universitatsmedizin Berlin
RP Schmeding, M (corresponding author), Charite, Dept Gen & Transplantat Surg, Campus Virchow Clin,Augustenburger Pl 1, D-13353 Berlin, Germany.
EM maximilian.schmeding@charite.de
RI Sauer, Igor/AAM-4217-2021
OI Sauer, Igor/0000-0001-9355-937X
CR Amin MG, 2004, LIVER TRANSPLANT, V10, P1468, DOI 10.1002/lt.20304
   Bahra M, 2007, TRANSPL INT, V20, P771, DOI 10.1111/j.1432-2277.2007.00517.x
   Berenguer M, 2003, HEPATOLOGY, V38, P34, DOI 10.1053/jhep.2003.50278
   Busquets J, 2001, TRANSPLANTATION, V71, P1765, DOI 10.1097/00007890-200106270-00011
   Busuttil RW, 2003, LIVER TRANSPLANT, V9, P651, DOI 10.1053/jlts.2003.50105
   Cescon M, 2003, LIVER TRANSPLANT, V9, P1174, DOI 10.1053/jlts.2003.50234
   De Gottardi A, 2007, ARCH INTERN MED, V167, P1183, DOI 10.1001/archinte.167.11.1183
   Feng S, 2006, AM J TRANSPLANT, V6, P783, DOI 10.1111/j.1600-6143.2006.01242.x
   Fisher RA, 2007, AM J TRANSPLANT, V7, P1601, DOI 10.1111/j.1600-6143.2007.01802.x
   Gastaca M, 2005, TRANSPLANT P, V37, P3851, DOI 10.1016/j.transproceed.2005.10.040
   Gaynor JJ, 2007, TRANSPLANTATION, V84, P155, DOI 10.1097/01.tp.0000269090.90068.0f
   Gordon F, 2006, LIVER TRANSPLANT, V12, pS73, DOI 10.1002/lt.20948
   Lim JK, 2004, LIVER TRANSPLANT, V10, pS31, DOI 10.1002/lt.20267
   LUCEY MR, 1992, GASTROENTEROLOGY, V102, P1736, DOI 10.1016/0016-5085(92)91737-O
   Mandayam S, 2004, SEMIN LIVER DIS, V24, P217, DOI 10.1055/s-2004-832936
   Merion RM, 2005, AM J TRANSPLANT, V5, P307, DOI 10.1111/j.1600-6143.2004.00703.x
   Mutimer DJ, 2006, TRANSPLANTATION, V81, P7, DOI 10.1097/01.tp.0000188619.30677.84
   Nardo B, 2005, TRANSPL P, V37, P389, DOI 10.1016/j.transproceed.2004.11.063
   Nardo B, 2004, AM J TRANSPLANT, V4, P1139, DOI 10.1111/j.1600-6143.2004.00472.x
   Neumann UP, 2004, J HEPATOL, V41, P830, DOI 10.1016/j.jhep.2004.06.029
   Pfitzmann R, 2007, LIVER TRANSPLANT, V13, P197, DOI 10.1002/lt.20934
   Piscaglia F, 2007, LIVER TRANSPLANT, V13, P857, DOI 10.1002/lt.21155
   Rifai K, 2004, J HEPATOL, V41, P446, DOI 10.1016/j.jhep.2004.05.013
   Roayaie K, 2007, LIVER TRANSPLANT, V13, pS36, DOI 10.1002/lt.21329
   SCHAUBEL DE, 2008, AM J TRANSPLANT
   Schroeder I, 2006, CYTOTHERAPY, V8, P30
   Sebagh M, 2003, HEPATOLOGY, V37, P1293, DOI 10.1053/jhep.2003.50231
   Wiesner R H, 1997, Liver Transpl Surg, V3, P231, DOI 10.1053/jlts.1997.v3.ajlts0030231
   Zapletal C, 2005, TRANSPL P, V37, P1182, DOI 10.1016/j.transproceed.2004.11.056
NR 29
TC 8
Z9 8
U1 0
U2 2
PU INDEX COPERNICUS INT
PI WARSAW
PA AL JEROZOLIMSKIE 146 C STR, WARSAW, 02-305, POLAND
SN 1425-9524
J9 ANN TRANSPL
JI Ann. Transpl.
PD JAN-MAR
PY 2010
VL 15
IS 1
BP 5
EP 13
PG 9
WC Surgery; Transplantation
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Surgery; Transplantation
GA 585JQ
UT WOS:000276821900001
PM 20305312
DA 2024-02-19
ER

PT J
AU Wauthier, V
   Verbeeck, RK
   Calderon, PB
AF Wauthier, V
   Verbeeck, RK
   Calderon, PB
TI The use of precision-cut liver slices from male Wistar rats as a tool to
   study age related changes in CYP3A induction and in formation of
   paracetamol conjugates
SO TOXICOLOGY IN VITRO
LA English
DT Article
DE CYP3A-ageing; p450 induction; rat liver slices; paracetamol
ID COLD HYPOXIC STORAGE; PROTEIN OXIDATION; DRUG-METABOLISM;
   MESSENGER-RNAS; FEMALE RATS; PHASE-I; ACETAMINOPHEN; HEPATOCYTES;
   MICROSOMES; EXPRESSION
AB Precision-cut liver slices (PCLS) offer a lot of advantages because all heterogeneity and cell-cell interactions within the original tissue matrix are maintained. This in vitro model was used to study the effect of ageing on certain aspects of drug metabolism and liver function in young (3 months), adult (9 months) and old (24 months) Wistar male rats. Protein synthesis, an important liver function, was not modified in young, adult and old rats, suggesting that ageing does not impair liver functionality but it affects some specific targets. Among them, a decrease in total P450 in liver microsomes and the loss of CYP3A23 inducibility in PCLS were clearly observed in old rats as compared to adult rats. Finally, the amount of total paracetamol conjugates was not modified between 9 and 24 months but in old rats, sulfoconjugation of paracetamol, its major route of elimination, was decreased. 2004 Elsevier Ltd. All rights reserved.
C1 Univ Catholique Louvain, Dept Pharmaceut Sci, Unite Pharmacocinet Metab Nutr & Toxicol, PMNT, B-1200 Brussels, Belgium.
C3 Universite Catholique Louvain
RP Wauthier, V (corresponding author), Univ Catholique Louvain, Dept Pharmaceut Sci, Unite Pharmacocinet Metab Nutr & Toxicol, PMNT, 73 Ave Mounier, B-1200 Brussels, Belgium.
EM valerie.wauthier@pmnt.ucl.ac.be; calderon@pmnt.ucl.ac.be
OI Verbeeck, Roger/0000-0003-3009-2826; Buc Calderon,
   Pedro/0000-0003-0483-2624
CR Agrawal AK, 2003, DRUG METAB DISPOS, V31, P612, DOI 10.1124/dmd.31.5.612
   BARNETT J L, 1974, Age and Ageing, V3, P229, DOI 10.1093/ageing/3.4.229
   BIRNBAUM LS, 1978, EXP GERONTOL, V13, P299, DOI 10.1016/0531-5565(78)90038-4
   Djordjevic-Markovic R, 1999, EXP GERONTOL, V34, P971, DOI 10.1016/S0531-5565(99)00067-4
   Dorne JLCM, 2003, FOOD CHEM TOXICOL, V41, P201, DOI 10.1016/S0278-6915(02)00209-0
   Evdokimova E, 2002, TOXICOL IN VITRO, V16, P47, DOI 10.1016/S0887-2333(01)00104-7
   Evdokimova E, 2001, ARCH TOXICOL, V75, P452
   Evdokimova E, 2001, TOXICOL IN VITRO, V15, P683, DOI 10.1016/S0887-2333(01)00091-1
   GALINSKY RE, 1990, J PHARMACOL EXP THER, V255, P577
   GALINSKY RE, 1986, PHARMACOLOGY, V32, P313, DOI 10.1159/000138186
   GROEN K, 1994, J PHARMACOL EXP THER, V268, P531
   Hoen Peter A.Chr. 't, 2000, Biochemical Pharmacology, V60, P1509
   HORBACH GJMJ, 1990, MUTAT RES, V237, P117, DOI 10.1016/0921-8734(90)90017-L
   HORBACH GJMJ, 1990, BIOCHEM PHARMACOL, V40, P529, DOI 10.1016/0006-2952(90)90552-V
   Huss JM, 2000, MOL PHARMACOL, V58, P48, DOI 10.1124/mol.58.1.48
   JURIMAROMET M, 1994, DRUG METAB DISPOS, V22, P849
   KAMATAKI T, 1985, J PHARMACOL EXP THER, V233, P222
   Klaassen CD, 1997, FASEB J, V11, P404, DOI 10.1096/fasebj.11.6.9194521
   LAU GSN, 1994, J PHARMACEUT BIOMED, V12, P1563, DOI 10.1016/0731-7085(94)00859-0
   Leclercq I, 1998, J CHROMATOGR A, V828, P291, DOI 10.1016/S0021-9673(98)00588-3
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Luo G, 2002, DRUG METAB DISPOS, V30, P795, DOI 10.1124/dmd.30.7.795
   MAYS PK, 1991, HEPATOLOGY, V14, P1224
   MCMARTIN DN, 1980, TOXICOL APPL PHARM, V54, P411, DOI 10.1016/0041-008X(80)90168-4
   MESSINEO L, 1983, INT J BIOCHEM, V15, P1103, DOI 10.1016/0020-711X(83)90224-0
   MILLER MG, 1993, TOXICOL APPL PHARM, V122, P108, DOI 10.1006/taap.1993.1178
   MOLDEUS P, 1978, BIOCHEM PHARMACOL, V27, P2859, DOI 10.1016/0006-2952(78)90201-0
   Morales H, 1998, J APPL TOXICOL, V18, P103, DOI 10.1002/(SICI)1099-1263(199803/04)18:2<103::AID-JAT473>3.0.CO;2-#
   MOSONI L, 1993, MECH AGEING DEV, V68, P209, DOI 10.1016/0047-6374(93)90152-H
   Oddy EA, 1997, XENOBIOTICA, V27, P369, DOI 10.1080/004982597240523
   OMURA T, 1964, J BIOL CHEM, V239, P2379
   PRICE VF, 1982, J PHARMACOL EXP THER, V220, P504
   Rekka E, 2001, BBA-GEN SUBJECTS, V1568, P245, DOI 10.1016/S0304-4165(01)00225-2
   Rekka E, 2002, BIOCHEM PHARMACOL, V64, P633, DOI 10.1016/S0006-2952(02)01258-3
   Schmucker DL, 2001, DRUG AGING, V18, P837, DOI 10.2165/00002512-200118110-00005
   SCHMUCKER DL, 1981, MECH AGEING DEV, V15, P189, DOI 10.1016/0047-6374(81)90074-9
   SEGLEN PO, 1976, BIOCHIM BIOPHYS ACTA, V442, P391, DOI 10.1016/0005-2787(76)90313-0
   STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616
   STARKEREED PE, 1989, ARCH BIOCHEM BIOPHYS, V275, P559, DOI 10.1016/0003-9861(89)90402-5
   VANBEZOOIJEN CFA, 1984, MECH AGEING DEV, V25, P1, DOI 10.1016/0047-6374(84)90126-X
   Vanhulle VP, 2001, LIFE SCI, V68, P2391, DOI 10.1016/S0024-3205(01)01031-1
   Wauthier V, 2004, ARCH TOXICOL, V78, P131, DOI 10.1007/s00204-003-0526-z
   WAXMAN DJ, 1985, BIOCHEMISTRY-US, V24, P4409, DOI 10.1021/bi00337a023
NR 43
TC 10
Z9 10
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0887-2333
J9 TOXICOL IN VITRO
JI Toxicol. Vitro
PD DEC
PY 2004
VL 18
IS 6
BP 879
EP 885
DI 10.1016/j.tiv.2004.04.013
PG 7
WC Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Toxicology
GA 865PC
UT WOS:000224714000019
PM 15465655
DA 2024-02-19
ER

PT J
AU Suganthi, RU
   Ghosh, J
   Malik, PK
   Awachat, VB
   Krishnamoorthy, P
   Pal, DT
   Nongkhlaw, SS
AF Suganthi, R. U.
   Ghosh, J.
   Malik, P. K.
   Awachat, V. B.
   Krishnamoorthy, P.
   Pal, D. T.
   Nongkhlaw, S. S.
TI Effect of dietary organic selenium (Se) on immune response, hepatic
   antioxidant status, selenoprotein gene expression and meat oxidative
   stability in lambs
SO JOURNAL OF ANIMAL AND FEED SCIENCES
LA English
DT Article
DE antioxidant status; gene expression; immune response; lambs; meat
   quality; selenium; yeasts
ID SUPPLEMENTATION; PERFORMANCE; YEAST; QUALITY; METABOLISM; TOLERANCE;
   BLOOD; LIVER
AB The objective of the study was to examine the effects of different doses of dietary organic selenium (Se) on humoral immune response, hepatic antioxidant status, mRNA expression of key selenoproteins and oxidative stability of lamb meat. Twenty lambs aging 5-6 months received during a 90-day period a basal diet unsupplemented or supplemented with 0.5, 1.5 or 4.5 ppm Se (selenized yeasts). After experimental period, immune response against Peste des petits ruminants (PPR) virus vaccine, hepatic antioxidant status, selenoproteins gene expression, histology of liver, kidney, spleen and thymus, and meat oxidative stability after 0, 3, 7 and 10 days of storage were studied. Significantly higher serum PPR antibody titre and hepatic total antioxidant capacity in lambs fed diet supplemented with 1.5 and 4.5 ppm Se were shown. Gene expression of glutathione peroxidase 1 (GPX1) and GPX3 was increased in group with 0.5 ppm Se supplementation. While selenoprotein 15 and iodothyronine deiodinase 1 (DIO1) mRNA levels were not influenced by supranutritional Se supplementation, DIO3 mRNA level was upregulated at 4.5 ppm Se addition. Selenoprotein P and W1 gene expression were significantly upregulated by 1.5 and 4.5 ppm Se supplementation, respectively. Thioredoxin reductase 1 gene expression was decreased by 4.5 ppm Se. No appreciable dfferences in meat lipid oxidation were observed amongst treatments. So, feeding 1.5 ppm organic Se could be beneficial in improving humoral immune response to PPR vaccine and hepatic antioxidant status in lambs. Further, the expression of genes encoding selenoproteinases depends on their type and dose of Se in the diet. The studied Se doses did not induce toxicity in organs but exhibited limited potential to enhance meat oxidative stability.
C1 [Suganthi, R. U.; Ghosh, J.; Malik, P. K.; Awachat, V. B.; Pal, D. T.; Nongkhlaw, S. S.] Indian Council Agr Res, Natl Inst Anim Nutr & Physiol, Bangalore 560030, Karnataka, India.
   [Krishnamoorthy, P.] Indian Council Agr Res, Natl Inst Vet Epidemiol & Dis Informat, Bangalore 560064, Karnataka, India.
C3 Indian Council of Agricultural Research (ICAR); ICAR - National
   Institute of Animal Nutrition & Physiology; Indian Council of
   Agricultural Research (ICAR); ICAR - National Institute of Veterinary
   Epidemiology & Disease Informatics
RP Suganthi, RU (corresponding author), Indian Council Agr Res, Natl Inst Anim Nutr & Physiol, Bangalore 560030, Karnataka, India.
EM rumayasuganthi@gmail.com
RI Ghosh, Jyotirmoy/A-1003-2011; Krishnamoorthy,
   Paramanandham/ABC-3793-2021; Ghosh, Jyotirmoy/AAA-1617-2021; nianp,
   Library/AAA-6956-2021
OI Krishnamoorthy, Paramanandham/0000-0001-7495-1333; 
CR [Anonymous], 2007, Nutrient requirements of small ruminants
   ARTHUR JR, 1990, BIOCHEM J, V272, P537, DOI 10.1042/bj2720537
   Bancroft JD, 1996, THEORY PRACTICE HIST
   Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292
   Birthal P. S., 2002, TECHNOLOGY OPTIONS S, P20
   Chen G, 2014, J ANIM PHYSIOL AN N, V98, P747, DOI 10.1111/jpn.12136
   Cristaldi LA, 2005, SMALL RUMINANT RES, V56, P205, DOI 10.1016/j.smallrumres.2004.06.001
   Czauderna M, 2018, BIOL TRACE ELEM RES, V184, P378, DOI 10.1007/s12011-017-1211-z
   Davis PA, 2008, SMALL RUMINANT RES, V74, P149, DOI 10.1016/j.smallrumres.2007.05.003
   EFSA Panel, 2011, EFSA J, V9, P2110, DOI DOI 10.2903/J.EFSA.2011.2110
   Elgendy R, 2016, J ANIM SCI, V94, P3169, DOI 10.2527/jas.2016-0363
   Fagan S, 2015, BIOL TRACE ELEM RES, V166, P245, DOI 10.1007/s12011-015-0242-6
   Fairweather-Tait SJ, 2011, ANTIOXID REDOX SIGN, V14, P1337, DOI 10.1089/ars.2010.3275
   Fakri F., 2015, Trials in Vaccinology, V4, P33, DOI 10.1016/j.trivac.2015.03.004
   Fallah AA, 2011, MICROCHEM J, V98, P275, DOI 10.1016/j.microc.2011.02.007
   Gladyshev VN, 2016, J BIOL CHEM, V291, P24036, DOI 10.1074/jbc.M116.756155
   Gordon M., 2001, Antioxidants in Food: Practical Applications, P7, DOI DOI 10.1016/9781855736160.1.5
   Hall JA, 2011, ANIM FEED SCI TECH, V164, P184, DOI 10.1016/j.anifeedsci.2011.01.009
   Hall JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082572
   Han X, 2018, NUCLEIC ACIDS RES, V46, P1038, DOI 10.1093/nar/gkx1272
   Haug Anna, 2007, Microbial Ecology in Health and Disease, V19, P209, DOI 10.1080/08910600701698986
   Hooper KJ, 2014, BIOL TRACE ELEM RES, V161, P308, DOI 10.1007/s12011-014-0134-1
   Hu Y, 2010, BRIT J NUTR, V104, P17, DOI 10.1017/S0007114510000309
   Hugejiletu H, 2013, BIOL TRACE ELEM RES, V154, P28, DOI 10.1007/s12011-013-9716-6
   ICAR-NIANP (Indian Council of Agricultural Research-National Institute of Animal Nutrition and Physiology), 2013, NUTR REQ AN SHEEP GO
   Jones BA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149982
   Juniper DT, 2008, J ANIM SCI, V86, P197, DOI 10.2527/jas.2006-773
   Juszczuk-Kubiak E, 2016, BIOL TRACE ELEM RES, V172, P336, DOI 10.1007/s12011-015-0592-0
   Kieliszek M, 2016, MOLECULES, V21, DOI 10.3390/molecules21050609
   Labunskyy VM, 2014, PHYSIOL REV, V94, P739, DOI 10.1152/physrev.00039.2013
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Luciano G, 2011, FOOD CHEM, V124, P1036, DOI 10.1016/j.foodchem.2010.07.070
   Mariotti M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033066
   Matthews JC, 2014, BIOL TRACE ELEM RES, V160, P321, DOI 10.1007/s12011-014-0050-4
   Mehdi Y, 2016, MOLECULES, V21, DOI 10.3390/molecules21040545
   Mehdi Y, 2013, MOLECULES, V18, P3292, DOI 10.3390/molecules18033292
   OIE (WOAH) and FAO, 2015, Global Strategy for the Control and Eradication of PPR
   Oliveira TFB, 2014, J APPL POULTRY RES, V23, P15, DOI 10.3382/japr.2013-00761
   Pagmantidis V, 2008, AM J CLIN NUTR, V87, P181, DOI 10.1093/ajcn/87.1.181
   Saha U.K., 2017, J AGR SCI BOT, V1, P1
   Shi LG, 2011, SMALL RUMINANT RES, V96, P49, DOI 10.1016/j.smallrumres.2010.11.005
   Singh RP, 2004, VET MICROBIOL, V98, P3, DOI 10.1016/j.vetmic.2003.07.007
   Stoytcheva ZR, 2009, BBA-GEN SUBJECTS, V1790, P1429, DOI 10.1016/j.bbagen.2009.05.012
   Sun B, 2011, BIOL TRACE ELEM RES, V143, P1516, DOI 10.1007/s12011-011-8995-z
   Sunde RA, 2011, ADV NUTR, V2, P138, DOI 10.3945/an.110.000240
   Vignola G, 2009, MEAT SCI, V81, P678, DOI 10.1016/j.meatsci.2008.11.009
   Yuan D, 2013, POULTRY SCI, V92, P2375, DOI 10.3382/ps.2013-03155
   Yue WB, 2009, ASIAN AUSTRAL J ANIM, V22, P365, DOI 10.5713/ajas.2009.80474
   Zhan XA, 2007, ANIM FEED SCI TECH, V132, P202, DOI 10.1016/j.anifeedsci.2006.03.020
   Zhang L, 2013, BIOL TRACE ELEM RES, V156, P111, DOI 10.1007/s12011-013-9830-5
   Zhou JC, 2009, J NUTR, V139, P1061, DOI 10.3945/jn.109.104901
NR 51
TC 7
Z9 8
U1 1
U2 9
PU KIELANOWSKI INST ANIMAL PHYSIOLOGY NUTRITION
PI JABLONNA
PA UL INSTYTUCKA 3, 05-110 JABLONNA, POLAND
SN 1230-1388
J9 J ANIM FEED SCI
JI J. Anim. Feed Sci.
PY 2019
VL 28
IS 2
BP 138
EP 148
DI 10.22358/jafs/109283/2019
PG 11
WC Agriculture, Dairy & Animal Science
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Agriculture
GA IE6HF
UT WOS:000472476300005
OA gold, Green Submitted
DA 2024-02-19
ER

PT J
AU Konkle, BA
AF Konkle, Barbara A.
TI The aging patient with hemophilia
SO AMERICAN JOURNAL OF HEMATOLOGY
LA English
DT Article
ID RECOMBINANT FACTOR-VIIA; PREVIOUSLY UNTREATED PATIENTS; IMMUNE TOLERANCE
   REGISTRY; ACTIVATED FACTOR-VII; SECONDARY PROPHYLAXIS; INHIBITOR
   DEVELOPMENT; BLEEDING EPISODES; CLINICAL-TRIAL; HOME TREATMENT;
   RISK-FACTORS
AB The prospects for many boys born with hemophilia today include a normal life expectancy and minimal to no joint disease. However, despite the availability of safe replacement clotting factor concentrates and effective antiviral treatment, the aging patient with hemophilia today faces many challenges. These include management of their hemophilia as well as the same age-related health issues as experienced in the general population. While increasing, data on the prevalence of comorbidities and their management in the hemophilia population remain limited. This review will focus on issues related to management of hemophilia and complications of cardiovascular, musculoskeletal, hepatic, and renal disease. Available research is summarized and potential approaches to management are discussed. Am. J. Hematol. 87: S27-S32, 2012. (C) 2012 Wiley Periodicals, Inc.
C1 [Konkle, Barbara A.] Puget Sound Blood Ctr, Seattle, WA 98104 USA.
   [Konkle, Barbara A.] Hemophilia Care Program, Seattle, WA 98104 USA.
   [Konkle, Barbara A.] Univ Washington, Sch Med, Seattle, WA USA.
C3 Puget Sound Blood Center; University of Washington; University of
   Washington Seattle
RP Konkle, BA (corresponding author), Puget Sound Blood Ctr, 921 Terry Ave, Seattle, WA 98104 USA.
EM barbarak@psbc.org
RI Konkle, Barbara A/AAD-7712-2022; Konkle, Barbara/GPX-3325-2022
OI Konkle, Barbara A/0000-0002-3959-8797; 
FU Baxter Bioscience; Biogen-Idec Hemophilia; Inspiration; CSL Behring
FX The author has received funding for research (Baxter Bioscience,
   Biogen-Idec Hemophilia, Inspiration, and consultancy (Baxter Bioscience,
   CSL Behring).
CR [Anonymous], 2010, NOVOSEVEN R RT PACK
   Astermark J, 2007, BLOOD, V109, P546, DOI 10.1182/blood-2006-04-017988
   BRACKMANN HH, 1977, LANCET, V2, P933
   BUCHANAN GR, 1978, PEDIATRICS, V62, P767
   Collins PW, 2009, J THROMB HAEMOST, V7, P787, DOI 10.1111/j.1538-7836.2009.03332.x
   CRADDOCK CG, 1947, BLOOD, V2, P505, DOI 10.1182/blood.V2.6.505.505
   DiMichele DM, 2006, HAEMOPHILIA, V12, P81, DOI 10.1111/j.1365-2516.2006.01376.x
   DiMichele DM, 2002, THROMB HAEMOSTASIS, V87, P52
   FEIBA NF, 2011, FEIBA NF PACK INS
   Gouw SC, 2007, J THROMB HAEMOST, V5, P1383, DOI 10.1111/j.1538-7836.2007.02595.x
   Gouw SC, 2007, BLOOD, V109, P4648, DOI 10.1182/blood-2006-11-056291
   Gringeri A, 2011, J THROMB HAEMOST, V9, P700, DOI 10.1111/j.1538-7836.2011.04214.x
   Hay C, 2011, BLOOD
   HEDNER U, 1983, J CLIN INVEST, V71, P1836, DOI 10.1172/JCI110939
   HEDNER U, 1988, LANCET, V2, P1193
   HILGARTNER MW, 1983, BLOOD, V61, P36
   Ho AYL, 2000, DRUGS, V60, P547, DOI 10.2165/00003495-200060030-00003
   Hoots WK, 2008, HAEMOPHILIA, V14, P466, DOI 10.1111/j.1365-2516.2008.01654.x
   Key NS, 1998, THROMB HAEMOSTASIS, V80, P912
   Konkle BA, 2007, J THROMB HAEMOST, V5, P1904, DOI 10.1111/j.1538-7836.2007.02663.x
   KURCZYNSKI EM, 1974, NEW ENGL J MED, V291, P164, DOI 10.1056/NEJM197407252910402
   Lawrence J S, 1941, Trans Am Clin Climatol Assoc, V57, P223
   Leissinger C, 2011, NEW ENGL J MED, V365, P1684, DOI 10.1056/NEJMoa1104435
   Lusher JM, 1998, HAEMOPHILIA, V4, P790
   LUSHER JM, 1983, BLOOD, V62, P1135
   Lusher JM, 1999, THROMB HAEMOSTASIS, V82, P572
   Makris Michael, 2003, Semin Vasc Med, V3, P279
   Manco-Johnson MJ, 2007, NEW ENGL J MED, V357, P535, DOI 10.1056/NEJMoa067659
   Mariani G, 1999, VOX SANG, V77, P25, DOI 10.1159/000056710
   MUNRO FL, 1946, J CLIN INVEST, V25, P422, DOI 10.1172/JCI101724
   Negrier C, 1997, THROMB HAEMOSTASIS, V77, P1113
   Oldenburg J, 2006, HAEMOPHILIA, V12, P15, DOI 10.1111/j.1365-2516.2006.01361.x
   Pindur G, 1999, THROMB RES, V95, pS57, DOI 10.1016/S0049-3848(99)00085-7
   Schneiderman J, 2007, HAEMOPHILIA, V13, P244, DOI 10.1111/j.1365-2516.2007.01451.x
   SELIGSOHN U, 1979, BLOOD, V53, P828
   Shapiro AD, 1998, THROMB HAEMOSTASIS, V80, P773
   SJAMSOEDIN LJM, 1981, NEW ENGL J MED, V305, P717, DOI 10.1056/NEJM198109243051301
   Von Depka M, 2005, HAEMOPHILIA, V11, P18
   Young G, 2008, HAEMOPHILIA, V14, P287, DOI 10.1111/j.1365-2516.2007.01601.x
NR 39
TC 23
Z9 24
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0361-8609
EI 1096-8652
J9 AM J HEMATOL
JI Am. J. Hematol.
PD MAY
PY 2012
VL 87
SU 1
BP S27
EP S32
DI 10.1002/ajh.23161
PG 6
WC Hematology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Hematology
GA 928RB
UT WOS:000302999500006
PM 22430948
OA Bronze
DA 2024-02-19
ER

PT J
AU Mahendra, G
   Gupta, S
   Kanungo, MS
AF Mahendra, G
   Gupta, S
   Kanungo, MS
TI Effect of 17β estradiol and progesterone on the conformation of the
   chromatin of the liver of female Japanese quail during aging
SO ARCHIVES OF GERONTOLOGY AND GERIATRICS
LA English
DT Article
DE Japanese quail; 17 beta estradiol; progesterone; chromatin conformation;
   aging
ID OLD RATS; BRAIN; YOUNG; GENE; DEOXYRIBONUCLEASE; TRANSCRIPTION; SUBUNIT;
   AGE; DNA
AB Plasma levels of 17 beta estradiol and progesterone were measured by radioimmunoassay in immature, adult and old female Japanese quails. The levels of progesterone and the progesterone/estradiol ratio were maximum in adult, egg laying birds. Conformation of the chromatin of the liver of birds of various ages before and after administration of steroid hormones was studied by digesting the nuclei with micrococcal nuclease (MNase) and pancreatic deoxyribonuclease I (DNase I) followed by electrophoretic resolution of the DNA fragments. The pattern of bands shows that the chromatin of the adult is more sensitive to DNase I and MNase than that of young and old birds. Administration of 17 beta estradiol and progesterone enhances the digestion of the chromatin by :DNase I and MNase in old birds. Such enhancement does not occur in adult birds as the chromatin is already in relaxed and open conformation due to the high levels of the hormones already present at this age. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
C1 Banaras Hindu Univ, Dept Zool, Mol Biol Lab, Varanasi 221005, Uttar Pradesh, India.
C3 Banaras Hindu University (BHU)
RP Kanungo, MS (corresponding author), Banaras Hindu Univ, Dept Zool, Mol Biol Lab, Varanasi 221005, Uttar Pradesh, India.
EM kanungo@banaras.ernet.in
CR ABRAHAM GE, 1971, ACTA ENDOCR-COP    S, V183, P1
   [Anonymous], 1989, MOL CLONING LAB MANU
   BERKOWITZ EM, 1983, J NEUROCHEM, V41, P516, DOI 10.1111/j.1471-4159.1983.tb04769.x
   BLOBEL G, 1966, SCIENCE, V154, P1662, DOI 10.1126/science.154.3757.1662
   BURNING JL, 1977, COMPUTATIONAL HDB ST
   CHATURVEDI MM, 1983, BIOCHEM INT, V6, P357
   CHATURVEDI MM, 1985, BIOCHEM BIOPH RES CO, V127, P604, DOI 10.1016/S0006-291X(85)80203-5
   CHATURVEDI MM, 1985, MOL BIOL REP, V10, P215
   CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991
   HEWISH DR, 1973, BIOCHEM BIOPH RES CO, V52, P504, DOI 10.1016/0006-291X(73)90740-7
   KAMAKAKA RT, 1990, EMBO J, V9, P3997, DOI 10.1002/j.1460-2075.1990.tb07621.x
   KANUNGO MS, 1994, GENES AGING, P274
   KORNBERG RD, 1992, ANNU REV CELL BIOL, V8, P563, DOI 10.1146/annurev.cb.08.110192.003023
   KORNBERG RD, 1977, ANNU REV BIOCHEM, V46, P931, DOI 10.1146/annurev.bi.46.070177.004435
   LUTTER LC, 1977, J MOL BIOL, V117, P53, DOI 10.1016/0022-2836(77)90022-5
   MCGHEE JD, 1980, ANNU REV BIOCHEM, V49, P1115, DOI 10.1146/annurev.bi.49.070180.005343
   NOLL M, 1974, NATURE, V251, P249, DOI 10.1038/251249a0
   NOLL M, 1974, NUCLEIC ACIDS RES, V1, P1573, DOI 10.1093/nar/1.11.1573
   NOLL M, 1977, SCIENCE, V187, P1203
   SHARP PA, 1973, BIOCHEMISTRY-US, V12, P3055, DOI 10.1021/bi00740a018
   SINGH S, 1993, BIOCHEM BIOPH RES CO, V193, P440, DOI 10.1006/bbrc.1993.1643
   TURCOTTE B, 1991, J BIOL CHEM, V266, P2582
   Upadhyay R, 1996, BIOCHEM BIOPH RES CO, V226, P356, DOI 10.1006/bbrc.1996.1361
   WILSON SC, 1975, J ENDOCRINOL, V67, P359, DOI 10.1677/joe.0.0670359
NR 24
TC 6
Z9 6
U1 0
U2 2
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0167-4943
J9 ARCH GERONTOL GERIAT
JI Arch. Gerontol. Geriatr.
PD MAR-APR
PY 1999
VL 28
IS 2
BP 149
EP 158
DI 10.1016/S0167-4943(99)00002-3
PG 10
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 182QD
UT WOS:000079508900007
PM 15374094
OA Bronze
DA 2024-02-19
ER

PT J
AU Savage, K
   Porter, C
   Bunnett, E
   Hana, M
   Keegan, A
   Ogden, E
   Stough, C
   Pipingas, A
AF Savage, Karen
   Porter, Claire
   Bunnett, Emily
   Hana, Maher
   Keegan, Andrew
   Ogden, Edward
   Stough, Con
   Pipingas, Andrew
TI Liver and inflammatory biomarker relationships to depression symptoms in
   healthy older adults
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE Depression; Inflammation; Liver disease; Aging; C -reactive protein
ID C-REACTIVE PROTEIN; GAMMA-GLUTAMYL-TRANSFERASE; ALCOHOL-CONSUMPTION
   TYPOLOGIES; ALANINE AMINOTRANSFERASE; VIRAL-HEPATITIS; ASSOCIATION;
   METAANALYSIS; DISEASE; MORTALITY; CYTOKINES
AB Introduction: Early identification and management of physical and mental illness is vital to maintain quality of life as we age. Markers of peripheral inflammation and liver function show elevations with aging, and are also associated with depression symptoms, suggesting a similar pattern in both aging and clinical groups.Methods: The current study examined the relationship between such markers and measures of depression/ negative mood in 284 healthy older adults using data from the Australian Research Council Longevity Intervention (ARCLI). Baseline data in adults aged 60-75 included mood symptoms via Profile of Mood States and Beck Depression Inventory II, and peripheral inflammatory (TNF-alpha, IL-6, hs-CRP) and liver markers (GGT, ALT, AST, AST:ALT ratio) derived from blood samples.Results: The inflammation and liver enzyme relationship significantly predicted mood symptoms scores. Results showed that a significant relationship between C-reactive protein (CRP) and negative mood scores on Total Mood Disturbance and four of the six subscales (all p < .01) was dependent upon higher levels of gamma-glutamyl transferase (GGT).Discussion: Higher levels of normal-range liver metabolic and peripheral inflammatory markers are observed with negative mood in a healthy older sample experiencing the biological impact of aging, but in the absence of clinical depression symptoms, suggesting a possible role of oxidative stress or other biological mechanisms occurring with aging in depression etiology. Lifestyle interventions are discussed.
C1 [Savage, Karen; Porter, Claire; Bunnett, Emily; Hana, Maher; Ogden, Edward; Stough, Con; Pipingas, Andrew] Swinburne Univ Technol, Ctr Human Psychopharmacol, Adv Technol Ctr, 427-451 Burwood Rd, Hawthorn, VIC 3122, Australia.
   [Keegan, Andrew] Med Univ South Carolina, Charleston, SC USA.
   [Ogden, Edward] St Vincents Hosp, Melbourne, VIC 3000, Australia.
   [Ogden, Edward] Goulburn Valley Hlth, Shepparton, VIC 3630, Australia.
   [Savage, Karen] Swinburne Univ Technol, 427-451 Burwood Rd, Hawthorn, VIC, Australia.
C3 Swinburne University of Technology; Medical University of South
   Carolina; St Vincent's Hospital Melbourne; NSW Health; St Vincents
   Hospital Sydney; Swinburne University of Technology
RP Savage, K (corresponding author), Swinburne Univ Technol, 427-451 Burwood Rd, Hawthorn, VIC, Australia.
EM KSavage@swin.edu.au
OI Hana, Maher/0000-0002-6472-9939
FU Australian Research Council; Horphag; Blackmores; Soho-Flordis
FX This baseline data was derived from the larger ARCLI clinical trial.
   Sincere thanks go to the trial participants for their time and efforts.
   ARCLI was funded by the Australian Research Council, Horphag,
   Blackmores, and Soho-Flordis. ARCLI also received generous donations
   from Swinburne Alumni including Doug Mitchell, and Roderic O'Connor.
CR Alexapoulos GS, 2005, LANCET, V365, P1961, DOI 10.1016/S0140-6736(05)66665-2
   Andrade E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205892
   BAUMANN H, 1994, IMMUNOL TODAY, V15, P74, DOI 10.1016/0167-5699(94)90137-6
   Beck A. T., 1996, Manual for the Beck Depression Inventory-II, DOI [DOI 10.1037/T00742-000, 10.1007/978-94-007-0753-5_156, DOI 10.1007/978-94-007-0753-5_156]
   Bell S, 2017, J INTERN MED, V281, P75, DOI 10.1111/joim.12544
   Bell S, 2015, ADDICTION, V110, P1563, DOI 10.1111/add.13012
   Berk M, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-200
   Botros Mona, 2013, Clin Biochem Rev, V34, P117
   Britton A, 2019, DRUG ALCOHOL DEPEN, V194, P225, DOI 10.1016/j.drugalcdep.2018.10.026
   Tung BT, 2015, EXP GERONTOL, V64, P1, DOI 10.1016/j.exger.2015.02.004
   Capuron L, 2011, PHARMACOL THERAPEUT, V130, P226, DOI 10.1016/j.pharmthera.2011.01.014
   Chu AL, 2019, BRAIN BEHAV IMMUN, V76, P74, DOI 10.1016/j.bbi.2018.11.007
   Chung HY, 2019, AGING DIS, V10, P367, DOI 10.14336/AD.2018.0324
   Conigrave KM, 2003, ADDICTION, V98, P31, DOI 10.1046/j.1359-6357.2003.00581.x
   Copeland WE, 2012, BIOL PSYCHIAT, V71, P15, DOI 10.1016/j.biopsych.2011.09.023
   Currais A, 2015, AGEING RES REV, V21, P30, DOI 10.1016/j.arr.2015.02.001
   D'Mello C, 2014, BRAIN BEHAV IMMUN, V35, P9, DOI 10.1016/j.bbi.2013.10.009
   Danner M, 2003, PSYCHOSOM MED, V65, P347, DOI 10.1097/01.PSY.0000041542.29808.01
   DERITIS F, 1957, CLIN CHIM ACTA, V2, P70, DOI 10.1016/0009-8981(57)90027-X
   Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033
   Edelstein B. A., 2015, APA HDB CLIN GEROPSY, V2, P3, DOI DOI 10.1037/14459-001
   Elwing JE, 2006, PSYCHOSOM MED, V68, P563, DOI 10.1097/01.psy.0000221276.17823.df
   Fard MT, 2022, PSYCHONEUROENDOCRINO, V144, DOI 10.1016/j.psyneuen.2022.105870
   Fiske A, 2009, ANNU REV CLIN PSYCHO, V5, P363, DOI 10.1146/annurev.clinpsy.032408.153621
   FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6
   Fraser A, 2009, LIVER INT, V29, P1494, DOI 10.1111/j.1478-3231.2009.02090.x
   GALLAGHER D, 1982, J CONSULT CLIN PSYCH, V50, P152, DOI 10.1037/0022-006X.50.1.152
   Giannini EG, 2005, CAN MED ASSOC J, V172, P367, DOI 10.1503/cmaj.1040752
   Gibson SJ, 1997, J GERONTOL B-PSYCHOL, V52, pP167, DOI 10.1093/geronb/52B.4.P167
   GOLDBERG DM, 1980, CRC CR REV CL LAB SC, V12, P1, DOI 10.3109/10408368009108725
   Hall Philip, 2012, Ulster Med J, V81, P30
   Haroon E, 2018, PSYCHONEUROENDOCRINO, V95, P43, DOI 10.1016/j.psyneuen.2018.05.026
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   Hegeman JM, 2012, BRIT J PSYCHIAT, V200, P275, DOI 10.1192/bjp.bp.111.095950
   Higgins GM, 1931, ARCH PATHOL, V12, P186
   Hiles SA, 2012, BRAIN BEHAV IMMUN, V26, P1180, DOI 10.1016/j.bbi.2012.06.001
   Himmerich H, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00030
   Horvath S, 2014, P NATL ACAD SCI USA, V111, P15538, DOI 10.1073/pnas.1412759111
   Hossain I., 2016, DIABET METAB SYND OB, V105, P525
   Huang AX, 2015, AM J GERIAT PSYCHIAT, V23, P261, DOI 10.1016/j.jagp.2014.04.003
   Huang XQ, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00134
   Jenne CN, 2013, NAT IMMUNOL, V14, P996, DOI 10.1038/ni.2691
   Jiang WL, 2009, J CEREBR BLOOD F MET, V29, P944, DOI 10.1038/jcbfm.2009.18
   Kerner A, 2005, ARTERIOSCL THROM VAS, V25, P193, DOI 10.1161/01.ATV.0000148324.63685.6a
   KEYS A, 1972, J CHRON DIS, V25, P329, DOI 10.1016/0021-9681(72)90027-6
   Dinh KM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214468
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Kim KN, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-026965
   King DE, 2003, AM J CARDIOL, V92, P1335, DOI 10.1016/j.amjcard.2003.08.020
   Koenig G, 2015, DIS MARKERS, V2015, P1, DOI 10.1155/2015/818570
   Köhler CA, 2017, ACTA PSYCHIAT SCAND, V135, P373, DOI 10.1111/acps.12698
   Kwo PY, 2017, AM J GASTROENTEROL, V112, P18, DOI 10.1038/ajg.2016.517
   Labenz C, 2020, HEPATOL COMMUN, V4, P1293, DOI 10.1002/hep4.1541
   Lavretsky H, 2012, AM J GERIAT PSYCHIAT, V20, P729, DOI 10.1097/JGP.0b013e31826573cf
   Lee DH, 2009, J EPIDEMIOL COMMUN H, V63, P884, DOI 10.1136/jech.2008.083592
   Lee DH, 2005, ATHEROSCLEROSIS, V178, P327, DOI 10.1016/j.atherosclerosis.2004.08.027
   Lee DH, 2004, FREE RADICAL RES, V38, P535, DOI 10.1080/10715760410001694026
   Lee DH, 2004, AM J CLIN NUTR, V79, P600
   Lee DS, 2007, ARTERIOSCL THROM VAS, V27, P127, DOI 10.1161/01.ATV.0000251993.20372.40
   Lee K, 2013, PSYCHOSOMATICS, V54, P52, DOI 10.1016/j.psym.2012.09.005
   Liu YZ, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00316
   Lukas Niederreiter HT., 2018, Liver Res, V2, P14, DOI [10.1016/j.livres.2018.03.003, DOI 10.1016/J.LIVRES.2018.03.003]
   Maes M., 1993, PSYCHIAT RES
   Maes M, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-66
   Mahady SE, 2018, J GASTROEN HEPATOL, V33, P1, DOI 10.1111/jgh.14270
   Marrie RA, 2017, J PSYCHOSOM RES, V101, P17, DOI 10.1016/j.jpsychores.2017.07.015
   McNair D.M., 1992, Manual for the Profile of Mood States
   Medzhitov R, 2010, CELL, V140, P771, DOI 10.1016/j.cell.2010.03.006
   Melvin JC, 2012, INT J MOL EPIDEMIOL, V3, P276
   Midanik LT, 2013, ADDICTION, V108, P348, DOI 10.1111/j.1360-0443.2012.04079.x
   Miller AH, 2016, NAT REV IMMUNOL, V16, P22, DOI 10.1038/nri.2015.5
   Miller AH, 2013, DEPRESS ANXIETY, V30, P297, DOI 10.1002/da.22084
   Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029
   Mistry D., 2010, INT J CHRON OBSTRUCT, V7, P283
   Mitchell AJ, 2005, AM J PSYCHIAT, V162, P1588, DOI 10.1176/appi.ajp.162.9.1588
   MORLEY JJ, 1982, ANN NY ACAD SCI, V389, P406, DOI 10.1111/j.1749-6632.1982.tb22153.x
   MOUSSAVIAN SN, 1985, DIGEST DIS SCI, V30, P211
   Netea MG, 2017, NAT IMMUNOL, V18, P826, DOI 10.1038/ni.3790
   Ng A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30487-6
   Nyenhuis DL, 1999, J CLIN PSYCHOL, V55, P79, DOI 10.1002/(SICI)1097-4679(199901)55:1<79::AID-JCLP8>3.0.CO;2-7
   Osna NA, 2017, ALCOHOL RES-CURR REV, V38, P147
   Peach J., 2001, CLIN GERONTOLOGIST, V23, P57, DOI [DOI 10.1300/J018V23N03_06, https://doi.org/10.1300/J018v23n03_06, DOI 10.1300/J018V23N03_]
   Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921
   Polyzos SA, 2016, METABOLISM, V65, P1007, DOI 10.1016/j.metabol.2015.12.009
   Popovic DD, 2015, VOJNOSANIT PREGL, V72, P414, DOI 10.2298/VSP130904007P
   Prasad S, 2012, PREV MED, V54, pS29, DOI 10.1016/j.ypmed.2011.11.011
   Pratt DS, 2000, NEW ENGL J MED, V342, P1266, DOI 10.1056/NEJM200004273421707
   Prina AM, 2015, J PSYCHOSOM RES, V78, P25, DOI 10.1016/j.jpsychores.2014.11.002
   Racanelli V, 2006, HEPATOLOGY, V43, pS54, DOI 10.1002/hep.21060
   Ridker PM, 2007, NUTR REV, V65, pS253, DOI [10.1111/j.1753-4887.2007.tb00372.x, 10.1301/nr.2007.dec.S253-S259]
   Rief P, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003843
   Russ TC, 2015, GASTROENTEROLOGY, V148, P958, DOI 10.1053/j.gastro.2015.02.004
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Segal DL, 2008, BEHAV MODIF, V32, P3, DOI 10.1177/0145445507303833
   Shao Q, 2021, FRONT PSYCHIATRY, V12, DOI 10.3389/fpsyt.2021.711835
   Singh T, 2011, AGEING RES REV, V10, P319, DOI 10.1016/j.arr.2010.11.002
   Smarr KL, 2011, ARTHRIT CARE RES, V63, pS454, DOI 10.1002/acr.20556
   Smart R.G., 1992, ALCOHOL RES HEALTH, V16, P217
   Smith KJ, 2018, EXP GERONTOL, V102, P109, DOI 10.1016/j.exger.2017.12.005
   Sorbi D, 1999, AM J GASTROENTEROL, V94, P1018
   SPOONER RJ, 1982, J CLIN PATHOL, V35, P638, DOI 10.1136/jcp.35.6.638
   Stahl E., 2018, FRONT IMMUNOL, V9, P1
   Sterling P., 1988, HDB LIFE STRESS COGN, P629, DOI [DOI 10.1016/0005-7967(90)90076-U, 10.1016/s0018-506x(02)00024-7]
   Stewart JC, 2009, BRAIN BEHAV IMMUN, V23, P936, DOI 10.1016/j.bbi.2009.04.011
   Stough CK, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-11
   Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489
   Tiemeier H, 2003, EPIDEMIOLOGY, V14, P103, DOI 10.1097/00001648-200301000-00025
   TILG H, 1992, GASTROENTEROLOGY, V103, P264, DOI 10.1016/0016-5085(92)91122-K
   TILLETT WILLIAM S., 1930, JOUR EXP MED, V52, P561, DOI 10.1084/jem.52.4.561
   Tomeno W, 2015, J GASTROEN HEPATOL, V30, P1009, DOI 10.1111/jgh.12897
   Tynjälä J, 2012, ALCOHOL ALCOHOLISM, V47, P558, DOI 10.1093/alcalc/ags072
   Valkanova V, 2013, J AFFECT DISORDERS, V150, P736, DOI 10.1016/j.jad.2013.06.004
   van Beek JHDA, 2013, BEHAV GENET, V43, P329, DOI 10.1007/s10519-013-9593-y
   van den Biggelaar AHJ, 2007, EXP GERONTOL, V42, P693, DOI 10.1016/j.exger.2007.01.011
   Wadee AA, 2001, STRESS HEALTH, V17, P25, DOI 10.1002/1532-2998(200101)17:1<25::AID-SMI873>3.0.CO;2-N
   Weinstein AA, 2011, PSYCHOSOMATICS, V52, P127, DOI 10.1016/j.psym.2010.12.019
   Whitfield JB, 2001, CRIT REV CL LAB SCI, V38, P263, DOI 10.1080/20014091084227
   Woelfer M, 2019, NEUROSCIENCE, V403, P93, DOI 10.1016/j.neuroscience.2018.03.034
   World Health Organization (WHO), 2019, BOD MASS IND BMI
   Yang CH, 2018, J PSYCHOSOM RES, V111, P58, DOI 10.1016/j.jpsychores.2018.05.008
   YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4
   Young JJ, 2014, J AFFECT DISORDERS, V169, P15, DOI 10.1016/j.jad.2014.07.032
   Youssef NA, 2013, LIVER INT, V33, P1062, DOI 10.1111/liv.12165
   Zhou X, 2010, CURR OPIN CLIN NUTR, V13, P541, DOI 10.1097/MCO.0b013e32833cf3bc
NR 124
TC 2
Z9 2
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD JUN 15
PY 2023
VL 177
AR 112186
DI 10.1016/j.exger.2023.112186
EA MAY 2023
PG 10
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA I0IM6
UT WOS:000999697900001
PM 37105503
OA hybrid
DA 2024-02-19
ER

PT J
AU Zhang, YQ
   Ikeno, Y
   Bokov, A
   Gelfond, J
   Jaramillo, C
   Zhang, HM
   Liu, YH
   Qi, WB
   Hubbard, G
   Richardson, A
   Van Remmen, H
AF Zhang, Yiqiang
   Ikeno, Yuji
   Bokov, Alex
   Gelfond, Jon
   Jaramillo, Carlos
   Zhang, Hong-Mei
   Liu, Yuhong
   Qi, Wenbo
   Hubbard, Gene
   Richardson, Arlan
   Van Remmen, Holly
TI Dietary restriction attenuates the accelerated aging phenotype of
   <i>Sod1</i><SUP>-/-</SUP> mice
SO FREE RADICAL BIOLOGY AND MEDICINE
LA English
DT Article
DE Dietary restriction; Aging oxidative stress; Cu/ZnSOD; Free radicals
ID FATAL NEOPLASTIC DISEASES; DISMUTASE-DEFICIENT MICE; CALORIC
   RESTRICTION; OXIDATIVE STRESS; SUPEROXIDE-DISMUTASE; MUSCLE ATROPHY;
   LIFE-SPAN; DELAYED OCCURRENCE; SHORT-TERM; AGE
AB Dietary restriction is a powerful aging intervention that extends the life span of diverse biological species ranging from yeast to invertebrates to mammals, and it has been argued that the antiaging action of dietary restriction occurs through reduced oxidative stress/damage. Using Sod1(-/-) mice, which have previously been shown to have increased levels of oxidative stress associated with a shorter life span and a high incidence of neoplasia, we were able to test directly the ability of dietary restriction to reverse an aging phenotype due to increased oxidative stress/damage. We found that dietary restriction increased the life span of Sod1(-/-) mice 30%, returning it to that of wild-type, control mice fed ad libitum. Oxidative damage in Sod1(-/-) mice was markedly reduced by dietary restriction, as indicated by a reduction in liver and brain F-2-isoprostanes, a marker of lipid peroxidation. Analysis of end of life pathology showed that dietary restriction significantly reduced the overall incidence of pathological lesions in the Sod1(-/-) mice fed the dietary-restricted diet compared to Sod1(-/-) mice fed ad libitum, including the incidence of lymphoma (27 vs 5%) and overall liver pathology. In addition to reduced incidence of overall and liver-specific pathology, the burden and severity of both neoplastic and nonneoplastic lesions was also significantly reduced in the Sod1(-/-) mice fed the dietary-restricted diet. These data demonstrate that dietary restriction can significantly attenuate the accelerated aging phenotype observed in Sod1(-/-) mice that arises from increased oxidative stress/damage. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Zhang, Yiqiang; Ikeno, Yuji; Bokov, Alex; Jaramillo, Carlos; Liu, Yuhong; Qi, Wenbo; Hubbard, Gene; Richardson, Arlan; Van Remmen, Holly] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging studies, San Antonio, TX 78229 USA.
   [Ikeno, Yuji; Hubbard, Gene] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA.
   [Ikeno, Yuji; Richardson, Arlan; Van Remmen, Holly] South Texas Vet Hlth Care Syst, Geriatr Educ Clin & Res Ctr, San Antonio, TX 78229 USA.
   [Bokov, Alex; Gelfond, Jon] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA.
   [Zhang, Hong-Mei] Fourth Mil Med Univ, Dept Clin Oncol, Xijing Hosp, Xian 710032, Peoples R China.
   [Richardson, Arlan; Van Remmen, Holly] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA.
C3 University of Texas System; University of Texas Health Science Center at
   San Antonio; University of Texas System; University of Texas Health
   Science Center at San Antonio; US Department of Veterans Affairs;
   Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans
   Hospital; University of Texas System; University of Texas Health Science
   Center at San Antonio; Air Force Military Medical University; University
   of Texas System; University of Texas Health Science Center at San
   Antonio
RP Van Remmen, H (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging studies, San Antonio, TX 78229 USA.
EM vanremmen@uthscsa.edu
RI Zhang, Yiqiang/AAA-3143-2019; Bokov, Alex/O-9952-2014
OI Bokov, Alex/0000-0002-0511-9815
FU NIH [P01AG020591]; American Federation for Aging Research
FX This study was supported by a NIH grant to H.V.R. and A.R. (P01AG020591)
   and a Julie Martin Mid-career grant from the American Federation for
   Aging Research (H.V.R.).
CR Busuttil RA, 2005, CANCER RES, V65, P11271, DOI 10.1158/0008-5472.CAN-05-2980
   Cao SX, 2001, P NATL ACAD SCI USA, V98, P10630, DOI 10.1073/pnas.191313598
   Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635
   Dhahbi JM, 2004, P NATL ACAD SCI USA, V101, P5524, DOI 10.1073/pnas.0305300101
   Doonan R, 2008, GENE DEV, V22, P3236, DOI 10.1101/gad.504808
   Edwards MG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-80
   Elchuri S, 2005, ONCOGENE, V24, P367, DOI 10.1038/sj.onc.1208207
   Elchuri S, 2007, PROTEOMICS, V7, P2121, DOI 10.1002/pmic.200601011
   Fitzenberger B, 2007, COMPUT STAT DATA AN, V52, P88, DOI 10.1016/j.csda.2007.01.013
   Fontana L, 2009, CURR OPIN GASTROEN, V25, P144, DOI 10.1097/MOG.0b013e32831ef1ba
   Forster MJ, 2003, FASEB J, V17, P690, DOI 10.1096/fj.02-0533fje
   Gartel AL, 2007, CANCER BIOL THER, V6, P1171
   Han ES, 2008, PHYSIOL GENOMICS, V34, P112, DOI 10.1152/physiolgenomics.00239.2007
   Hursting SD, 2003, ANNU REV MED, V54, P131, DOI 10.1146/annurev.med.54.101601.152156
   IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.1080/10618600.1996.10474713, 10.2307/1390807, DOI 10.1080/10618600.1996.10474713]
   Ikeno Y, 2005, J GERONTOL A-BIOL, V60, P1510, DOI 10.1093/gerona/60.12.1510
   Ikeno Y, 2003, J GERONTOL A-BIOL, V58, P291
   Ikeno Y, 2009, J GERONTOL A-BIOL, V64, P522, DOI 10.1093/gerona/glp017
   Jang YC, 2012, AGING CELL, V11, P770, DOI 10.1111/j.1474-9726.2012.00843.x
   Jang YC, 2010, FASEB J, V24, P1376, DOI 10.1096/fj.09-146308
   Jang YC, 2009, J GERONTOL A-BIOL, V64, P1114, DOI 10.1093/gerona/glp100
   Keithley EM, 2005, HEARING RES, V209, P76, DOI 10.1016/j.heares.2005.06.009
   Larson-Meyer DE, 2008, OBESITY, V16, P1355, DOI 10.1038/oby.2008.201
   Lkhagvadorj S, 2010, AM J PHYSIOL-REG I, V298, pR494, DOI 10.1152/ajpregu.00632.2009
   Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012
   McCarter R, 2007, J GERONTOL A-BIOL, V62, P1059, DOI 10.1093/gerona/62.10.1059
   McFadden SL, 1999, NEUROBIOL AGING, V20, P1, DOI 10.1016/S0197-4580(99)00018-4
   Merry BJ, 2004, AGING CELL, V3, P7, DOI 10.1046/j.1474-9728.2003.00074.x
   Muller FL, 2007, FREE RADICAL BIO MED, V43, P477, DOI 10.1016/j.freeradbiomed.2007.03.034
   Muller FL, 2006, FREE RADICAL BIO MED, V40, P1993, DOI 10.1016/j.freeradbiomed.2006.01.036
   Pérez VI, 2009, BBA-GEN SUBJECTS, V1790, P1005, DOI 10.1016/j.bbagen.2009.06.003
   Pérez VI, 2009, AGING CELL, V8, P73, DOI 10.1111/j.1474-9726.2008.00449.x
   Piccio L, 2008, J LEUKOCYTE BIOL, V84, P940, DOI 10.1189/jlb.0208133
   Piper MDW, 2008, CELL METAB, V8, P99, DOI 10.1016/j.cmet.2008.06.012
   Reddy VN, 2004, EXP EYE RES, V79, P859, DOI 10.1016/j.exer.2004.04.005
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   Spindler SR, 2005, MECH AGEING DEV, V126, P960, DOI 10.1016/j.mad.2005.03.016
   Swindell WR, 2008, MECH AGEING DEV, V129, P580, DOI 10.1016/j.mad.2008.06.001
   Turturro A, 1999, J GERONTOL A-BIOL, V54, pB492, DOI 10.1093/gerona/54.11.B492
   Van Remmen H, 2003, PHYSIOL GENOMICS, V16, P29, DOI 10.1152/physiolgenomics.00122.2003
   Van Remmen H, 2001, Novartis Found Symp, V235, P221
   Ward WF, 2005, J GERONTOL A-BIOL, V60, P847, DOI 10.1093/gerona/60.7.847
   WEINDRUCH R, 1992, EXP GERONTOL, V27, P575, DOI 10.1016/0531-5565(92)90012-O
NR 43
TC 26
Z9 31
U1 1
U2 17
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0891-5849
J9 FREE RADICAL BIO MED
JI Free Radic. Biol. Med.
PD JUL
PY 2013
VL 60
BP 300
EP 306
DI 10.1016/j.freeradbiomed.2013.02.026
PG 7
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA 151UU
UT WOS:000319486500033
PM 23459073
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Hsieh, CS
   Tain, YL
   Chen, YC
   Chang, KW
   Jean, YH
   Huang, LT
AF Hsieh, Chih-Sung
   Tain, You-Lin
   Chen, Yu-Chieh
   Chang, Kowaung
   Jean, Yen-Hsuan
   Huang, Li-Tung
TI Carbon dioxide pneumoperitoneum induces anti-inflammatory response and
   hepatic oxidative stress in young rats with bacterial peritonitis
SO PEDIATRIC SURGERY INTERNATIONAL
LA English
DT Article
DE CO2 pneumoperitoneum; Inflammatory response; Oxidative stress;
   Peritonitis
ID CO2 INSUFFLATION; LAPAROSCOPIC SURGERY; ANIMAL-MODEL; TRANSLOCATION;
   DISSEMINATION; HEMODYNAMICS; LAPAROTOMY; PRESSURE; IMPACT; GROWTH
AB The aim of this study was to investigate the effects of carbon dioxide (CO2) pneumoperitoneum on the intra-abdominal spread of bacteria, the local and systemic cytokine expression, and oxidant/antioxidant status in young rats with bacterial peritonitis.
   Young Sprague-Dawley rats, aging 20-27 days and weighing around 50 g, were allocated to six groups of six to nine animals in each. Intra-abdominal infection model was developed by intraperitoneal injection with 1 cc of Escherichia coli (E. coli) (10(8) CFU/mL, ATCC25922 strain) via right lower abdominal wall. Carbon dioxide (CO2) pneumoperitoneum was applied to the rats via umbilical pit insufflation with 20 cc CO2 for 30 min. All survived rats underwent laparotomy and were killed 24 h or 3 days later. Serum levels of CO2 and CRP were measured. Left lower abdomen peritoneum, peritoneal fluid, mesenteric lymph node of terminal ileum, and liver were taken for bacterial culture. Liver and plasma levels of TNF-alpha, IL-1 beta, and IL-6 were examined for the level of local and systemic immunologic response. Oxidant/antioxidant status in liver and plasma were assessed by measuring malondialdehyde (MDA), and reduced to oxidized glutathione ratio (GSH/GSSG).
   Carbon dioxide (CO2) pneumoperitoneum does not facilitate E. coli dissemination to other intra-abdominal organs in rats with localized E. coli peritonitis. Peritonitis rats that underwent abdominal CO2 insufflation have insignificantly higher CRP or lower CO2 levels. Plasma and liver TNF-alpha, IL-1 beta concentrations were not significantly different among the four groups, but plasma IL-6 was significantly increased in rats with E. coli peritonitis and CO2 pneumoperitoneum that were killed 3 days later as compared with that of rats that were killed 24 h later. In rats with E. coli peritonitis, CO2 pneumoperitoneum was significantly associated with decreased hepatic GSH/GSSG ratio. However, plasma and liver MDA levels were not altered after CO2 pneumoperitoneum.
   Carbon dioxide (CO2) pneumoperitoneum is not associated with E. coli dissemination in the presence of local intra-abdominal infection. CO2 pneumoperitoneum elicited systemic anti-inflammatory response at a specific time period and decreased hepatic antioxidant status in young rats with E. coli peritonitis.
C1 [Tain, You-Lin; Chen, Yu-Chieh; Huang, Li-Tung] Chang Gung Univ, Coll Med, Dept Pediat, Chang Gung Mem Hosp,Kaohsiung Med Ctr, Niao Sung Hsiang 833, Kaohsiung Hsien, Taiwan.
   [Hsieh, Chih-Sung] Pingtung Christian Hosp, Dept Pediat Surg, Pingtung, Taiwan.
   [Chang, Kowaung] Chang Gung Univ, Coll Med, Dept Anesthesiol, Chang Gung Mem Hosp,Kaohsiung Med Ctr, Kaohsiung, Taiwan.
   [Jean, Yen-Hsuan] Pingtung Christian Hosp, Dept Med Res, Pingtung, Taiwan.
C3 Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial
   Hospital; Chang Gung University
RP Huang, LT (corresponding author), Chang Gung Univ, Coll Med, Dept Pediat, Chang Gung Mem Hosp,Kaohsiung Med Ctr, 123 Ta Pei Rd, Niao Sung Hsiang 833, Kaohsiung Hsien, Taiwan.
EM huang_li@pie.com.tw
RI Tain, You-Lin/H-2827-2019; Huang, Li/IUQ-0909-2023
OI Tain, You-Lin/0000-0002-7059-6407; 
FU Chang Gung Memorial Hospital [CMRPG890191]; Pingtung Christian Hospital
   [PS98001, PS99033]
FX This study was supported in part by grants from Chang Gung Memorial
   Hospital CMRPG890191 to Dr. Li-Tung Huang, and from Pingtung Christian
   Hospital PS98001 and PS99033 to Dr. Chih-Sung Hsieh.
CR Barbaros U, 2004, SURG ENDOSC, V18, P501, DOI 10.1007/s00464-003-9107-8
   Bickel A, 2002, SURG ENDOSC, V16, P1341, DOI 10.1007/s00464-001-9211-6
   Bickel A, 2007, ANN SURG, V246, P31, DOI 10.1097/01.sla.0000262784.44278.b5
   Didem B, 2008, J PEDIATR SURG, V43, P1494, DOI 10.1016/j.jpedsurg.2008.01.004
   Dinckan A, 2009, SURG ENDOSC, V23, P534, DOI 10.1007/s00464-008-9856-5
   Eleftheriadis E, 1996, WORLD J SURG, V20, P11, DOI 10.1007/s002689900002
   Glantzounis GK, 2001, SURG ENDOSC, V15, P1315, DOI 10.1007/s00464-001-0034-2
   Guler C, 2004, J ENDOUROL, V18, P245, DOI 10.1089/089277904773582840
   Hanly EJ, 2005, J GASTROINTEST SURG, V9, P1245, DOI 10.1016/j.gassur.2005.09.007
   Hanly EJ, 2005, SURGERY, V137, P559, DOI 10.1016/j.surg.2005.01.005
   HANLY EJ, 2007, SURGERY, V241
   Horattas MC, 2003, SURG ENDOSC, V17, P1464, DOI 10.1007/s00464-001-8289-1
   Jakimowicz J, 1998, SURG ENDOSC, V12, P129, DOI 10.1007/s004649900612
   Khoury W, 2009, SURG ENDOSC, V23, P776, DOI 10.1007/s00464-008-0054-2
   Kim ZG, 2002, SURG ENDOSC, V16, P1292, DOI 10.1007/s00464-001-9208-1
   Lindberg F, 2003, SURG ENDOSC, V17, P480, DOI 10.1007/s00464-002-9044-y
   Marathe US, 1996, SURG ENDOSC-ULTRAS, V10, P974, DOI 10.1007/s004649900217
   Neudecker J, 2002, SURG ENDOSC, V16, P1121, DOI 10.1007/s00464-001-9166-7
   Özmen MM, 1999, SURG ENDOSC-ULTRAS, V13, P801, DOI 10.1007/s004649901103
   Papparella A, 2007, PEDIATR SURG INT, V23, P453, DOI 10.1007/s00383-006-1860-z
   Parola M, 2001, J HEPATOL, V35, P297, DOI 10.1016/S0168-8278(01)00142-8
   Pitombo MB, 2006, SURG ENDOSC, V20, P1440, DOI 10.1007/s00464-005-0117-6
   Polat C, 2003, SURG ENDOSC, V17, P1719, DOI 10.1007/s00464-002-9258-z
   Pross M, 2000, SURG ENDOSC, V14, P1180, DOI 10.1007/s004640000189
   Sare M, 2003, J LAPAROENDOSC ADV A, V13, P175, DOI 10.1089/109264203766207690
   Sare M, 1997, SURG LAPAROSC ENDOSC, V7, P38, DOI 10.1097/00019509-199702000-00010
   SAUERLAND S, 2004, COCHRANE LIB
   Schilling MK, 1997, J AM COLL SURGEONS, V184, P378
   Ure BM, 2002, SURG ENDOSC, V16, P836, DOI 10.1007/s00464-001-9093-7
   Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001
   Ypsilantis P, 2009, SURG ENDOSC, V23, P583, DOI 10.1007/s00464-008-9887-y
NR 31
TC 10
Z9 10
U1 0
U2 5
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0179-0358
EI 1437-9813
J9 PEDIATR SURG INT
JI Pediatr. Surg. Int.
PD MAR
PY 2011
VL 27
IS 3
BP 289
EP 294
DI 10.1007/s00383-010-2801-4
PG 6
WC Pediatrics; Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pediatrics; Surgery
GA 723PQ
UT WOS:000287519700011
PM 21110033
DA 2024-02-19
ER

PT J
AU Peng, MF
   Fang, XY
   Miao, MS
   Wang, T
AF Peng, Mengfan
   Fang, Xiaoyan
   Miao, Mingsan
   Wang, Tan
TI Effects of Wuweizi syrup on brain aging mice model induced by
   D-galactose
SO JOURNAL OF KING SAUD UNIVERSITY SCIENCE
LA English
DT Article
DE Brain aging; Immune organs; Oxidative stress; Pathological changes of
   tissues
ID INFLAMMATION; SCHISANDRIN
AB Objective: To observe the effect of Wuweizi syrup on brain aging mice model induced by D-galactose in mice.
   Methods: 72 mice were randomly divided into blank group, model group, naokangling group and low, middle and high dose Wuweizi syrup group. After 3 days of adaptive feeding, except for the blank group, the rest mice were subcutaneously (sc) injected with D-galactose 1.25 g/kg at neck back to replicate the aging model. Sc injection was given for 40 consecutive days, and corresponding drugs were given by gavage on the 11th day of modeling. On the 39th day, the dark experiment was carried out to measure the learning ability of mice. After the last administration for 2 h, brain, liver, thymus and spleen were taken and weighed to calculate the organ index. Blood was taken and CAT, GSH and SOD levels in whole blood were determined. Some brain and liver tissues were taken to prepare homogenates, and MDA levels in tissue homogenates and plasma were measured. Brain, liver, thymus and spleen were stained with HE, and pathological sections were made for observation under light microscope.
   Results: Compared with the blank group, in the model group, the incubation period of mice was significantly reduced and the number of shuttle back and forth was significantly increased (P < 0.01); Spleen and brain indexes decreased significantly (P < 0.05), thymus indexes were decreased significantly, and liver indexes were increased significantly (P < 0.01); The levels of CAT, GSH and SOD in whole blood were significantly decreased (P < 0.01); MDA levels in liver homogenates, brain homogenates and plasma were significantly increased (P < 0.01); Pathological changes of brain, liver, thymus and spleen were observed under microscope. Compared with the model group, naokangling group and low, middle and high dose Wuweizi syrup group can significantly improve the incubation period of mice and reduce the number of shuttle back and forth (P < 0.01), can decrease or increase the organ index with different degree (P < 0.01 or P < 0.05), can significantly increase the levels of CAT, GSH and SOD in whole blood (P < 0.01), and significantly reduce the levels of MDA in plasma, liver homogenate and brain homogenate (P < 0.01), as well as can improve pathological changes of brain, liver, thymus and spleen with different degree.
   Conclusion: The mice aging model was successfully replicated, and Wuweizi syrup can significantly improve the memory, biochemical indexes and pathological status of brain aging model mice. (C) 2020 Published by Elsevier B.V. on behalf of King Saud University.
C1 [Peng, Mengfan; Fang, Xiaoyan; Miao, Mingsan; Wang, Tan] Henan Univ Chinese Med, Coll Pharm, Zhengzhou 450046, Peoples R China.
C3 Henan University of Traditional Chinese Medicine
RP Miao, MS (corresponding author), Henan Univ Chinese Med, Coll Pharm, Zhengzhou 450046, Peoples R China.
EM miaomingsan@163.com
RI chen, gang/JRX-1197-2023
FU Foundation item of National International Cooperation Base [2016-151];
   Achievement Conversion Project in Henan Province [142201610011]
FX This research was financially supported by the Foundation item of
   National International Cooperation Base (2016-151) and Achievement
   Conversion Project in Henan Province (142201610011).
CR Calder PC, 2017, AGEING RES REV, V40, P95, DOI 10.1016/j.arr.2017.09.001
   [付燕 Fu Yan], 2017, [中国运动医学杂志, Chinese Journal of Sports Medicine], V36, P563
   Jiang X., 2017, J BEIHUA U NAT SCI, V18, P603
   Jing S., 2016, J BEIHUA U NAT SCI, V17, P745
   Li LB, 2014, J GASTROEN HEPATOL, V29, P640, DOI 10.1111/jgh.12425
   Li Qian, 2018, Journal of Beihua University, V19, P745, DOI 10.11713/j.issn.1009-4822.2018.06.010
   Lin L., 2019, HER MED, V38, P415, DOI DOI 10.3870/j.issn.1004-0781.2019.04.001
   Liu Cong, 2018, Shipin Kexue / Food Science, V39, P201
   [苗明三 Miao Mingsan], 2018, [中草药, Chinese Traditional and Herbal Drugs], V49, P3074
   Olga G., 2017, E NEUROFORUM, V23, P82
   Pang Y., 2019, CHINESE J VET DRUG, V53, P72
   Peng MF, 2018, SAUDI J BIOL SCI, V25, P1806, DOI 10.1016/j.sjbs.2018.07.003
   Peng XY, 2014, INT DAIRY J, V34, P80, DOI 10.1016/j.idairyj.2013.08.004
   Wang J., 2014, ACTA CHINESE MED PHA, V42, P11
   Wang X., 2019, ASIA PAC TRAD MED, V15, P197
   Xiang Ting-ting, 2017, Chinese Pharmacological Bulletin, V33, P848, DOI 10.3969/j.issn.1001-1978.2017.06.020
   [向玥 Xiang Yue], 2017, [中草药, Chinese Traditional and Herbal Drugs], V48, P3789
   Xie J, 2016, ELECTROANAL, V28, P183, DOI 10.1002/elan.201500486
   Yang M., 2014, SICHUAN J PHYSL SCI, V36, P17
   Zhang ZX, 2017, EXP THER MED, V14, P35, DOI 10.3892/etm.2017.4501
   Zhao L., 2018, GUANGXI MED J, V40, P812
   Zhou Yan-yan, 2013, Chinese Pharmacological Bulletin, V29, P1076, DOI 10.3969/j.issn.1001-1978.2013.08.009
   Zhou Yong-Feng, 2018, Zhongguo Zhong Yao Za Zhi, V43, P3756, DOI 10.19540/j.cnki.cjcmm.20180516.004
   丁云录, 2016, [中国老年学杂志, Chinese Journal of Gerontology], V36, P293
NR 24
TC 4
Z9 4
U1 1
U2 13
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1018-3647
EI 2213-686X
J9 J KING SAUD UNIV SCI
JI J. King Saud Univ. Sci.
PD JUN
PY 2020
VL 32
IS 4
BP 2426
EP 2431
DI 10.1016/j.jksus.2020.03.032
PG 6
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA LT7MU
UT WOS:000537251600002
OA gold
DA 2024-02-19
ER

PT J
AU Le Couteur, DG
   Solon-Biet, SM
   Parker, BL
   Pulpitel, T
   Brandon, AE
   Hunt, NJ
   Wali, JA
   Gokarn, R
   Senior, AM
   Cooney, GJ
   Raubenheimer, D
   Cogger, VC
   James, DE
   Simpson, SJ
AF Le Couteur, David G.
   Solon-Biet, Samantha M.
   Parker, Benjamin L.
   Pulpitel, Tamara
   Brandon, Amanda E.
   Hunt, Nicholas J.
   Wali, Jibran A.
   Gokarn, Rahul
   Senior, Alistair M.
   Cooney, Gregory J.
   Raubenheimer, David
   Cogger, Victoria C.
   James, David E.
   Simpson, Stephen J.
TI Nutritional reprogramming of mouse liver proteome is dampened by
   metformin, resveratrol, and rapamycin
SO CELL METABOLISM
LA English
DT Article; Early Access
ID DIETARY RESTRICTION; LIFE-SPAN; CALORIE RESTRICTION; HEALTH; METABOLISM;
   MECHANISMS; LONGEVITY; MICE; RNA; IDENTIFICATION
AB Nutrient sensing pathways influence metabolic health and aging, offering the possibility that diet might be used therapeutically, alone or with drugs targeting these pathways. We used the Geometric Framework for Nutrition to study interactive and comparative effects of diet and drugs on the hepatic proteome in mice across 40 dietary treatments differing in macronutrient ratios, energy density, and drug treatment (metformin, rapamycin, resveratrol). There was a strong negative correlation between dietary energy and the spliceosome and a strong positive correlation between dietary protein and mitochondria, generating oxidative stress at high protein intake. Metformin, rapamycin, and resveratrol had lesser effects than and dampened responses to diet. Rapamycin and metformin reduced mitochondrial responses to dietary protein while the effects of carbohydrates and fat were downregulated by resveratrol, Dietary composition has a powerful impact on the hepatic proteome, not just on metabolic pathways but fundamental processes such as mitochondrial function and RNA splicing.
C1 [Le Couteur, David G.; Solon-Biet, Samantha M.; Pulpitel, Tamara; Brandon, Amanda E.; Wali, Jibran A.; Gokarn, Rahul; Senior, Alistair M.; Cooney, Gregory J.; Raubenheimer, David; James, David E.; Simpson, Stephen J.] Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia.
   [Le Couteur, David G.; Hunt, Nicholas J.; Cogger, Victoria C.] Concord RG Hosp, Ctr Educ & Res Ageing, Concord West, NSW 2139, Australia.
   [Le Couteur, David G.; Hunt, Nicholas J.; Cogger, Victoria C.] ANZAC Res Inst, Sydney, NSW 2139, Australia.
   [Parker, Benjamin L.] Univ Melbourne, Dept Anat & Physiol, Melbourne, Vic 3010, Australia.
   [Brandon, Amanda E.] Univ Sydney, Sch Med Sci, Sydney, NSW 2006, Australia.
   [Raubenheimer, David; James, David E.; Simpson, Stephen J.] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW 2006, Australia.
C3 University of Sydney; Concord Repatriation General Hospital; University
   of Sydney; ANZAC Research Institute; University of Melbourne; University
   of Sydney; University of Sydney
RP Le Couteur, DG; Simpson, SJ (corresponding author), Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia.; Le Couteur, DG (corresponding author), Concord RG Hosp, Ctr Educ & Res Ageing, Concord West, NSW 2139, Australia.; Le Couteur, DG (corresponding author), ANZAC Res Inst, Sydney, NSW 2139, Australia.; Simpson, SJ (corresponding author), Univ Sydney, Sch Life & Environm Sci, Sydney, NSW 2006, Australia.
EM david.lecouteur@sydney.edu.au; stephen.simpson@sydney.edu.au
RI Ekanayake, Kanchana/P-8817-2016; Wali, Jibran/K-9843-2019; Hunt,
   Nicholas/AAD-6084-2019; Research Institute, ANZAC/CAE-9030-2022
OI Wali, Jibran/0000-0002-8524-5773; Hunt, Nicholas/0000-0002-9001-0602;
   Raubenheimer, David/0000-0001-9050-1447; Simpson, Stephen
   J./0000-0003-0256-7687
FU National Health and Medical Research Coun-cil of Australia (NHMRC)
   [1084267, 1149976]; National Health and Medical Research Council of
   Australia [1084267, 1149976] Funding Source: NHMRC
FX We acknowledge the support by National Health and Medical Research
   Coun-cil of Australia (NHMRC) project grant 1084267, and program grant
   1149976.
CR Austad SN, 2021, CURR OPIN BIOTECH, V70, P56, DOI 10.1016/j.copbio.2020.11.008
   Barger JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120738
   Bauer PV, 2018, CELL METAB, V27, P101, DOI 10.1016/j.cmet.2017.09.019
   Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354
   Bitto A, 2016, ELIFE, V5, DOI 10.7554/eLife.16351
   Bornstein R, 2020, MITOCHONDRION, V54, P72, DOI 10.1016/j.mito.2020.07.007
   Byerly MS, 2013, AM J PHYSIOL-REG I, V304, pR1085, DOI 10.1152/ajpregu.00368.2012
   Chimento A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20061381
   Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635
   Cyphert TJ, 2013, BBA-GENE REGUL MECH, V1829, P905, DOI 10.1016/j.bbagrm.2013.04.009
   Derous D, 2017, AGING-US, V9, P1770, DOI 10.18632/aging.101269
   Fok WC, 2014, AGING CELL, V13, P311, DOI 10.1111/acel.12175
   Fok WC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083988
   Fontana L, 2015, CELL, V161, P106, DOI 10.1016/j.cell.2015.02.020
   Gao Y, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240596
   Gokarn R, 2018, J GERONTOL A-BIOL, V73, P446, DOI 10.1093/gerona/glx186
   Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221
   Heintz C, 2017, NATURE, V541, P102, DOI 10.1038/nature20789
   Holmes AJ, 2017, CELL METAB, V25, P140, DOI 10.1016/j.cmet.2016.10.021
   Howell JJ, 2017, CELL METAB, V25, P463, DOI 10.1016/j.cmet.2016.12.009
   Ingram DK, 2017, AGEING RES REV, V39, P15, DOI 10.1016/j.arr.2017.05.008
   Kajbaf F, 2016, CLIN PHARMACOKINET, V55, P439, DOI 10.1007/s40262-015-0323-x
   Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113
   Karunadharma PP, 2015, AGING CELL, V14, P547, DOI 10.1111/acel.12317
   Kennedy BK, 2016, CELL METAB, V23, P990, DOI 10.1016/j.cmet.2016.05.009
   Le Couteur DG, 2016, CELL MOL LIFE SCI, V73, P1237, DOI 10.1007/s00018-015-2120-y
   Lee BP, 2016, AGING CELL, V15, P903, DOI 10.1111/acel.12499
   Lee KP, 2008, P NATL ACAD SCI USA, V105, P2498, DOI 10.1073/pnas.0710787105
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Luongo TS, 2020, NATURE, V588, P174, DOI 10.1038/s41586-020-2741-7
   Madeo F, 2019, CELL METAB, V29, P592, DOI 10.1016/j.cmet.2019.01.018
   Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192
   McAlister GC, 2014, ANAL CHEM, V86, P7150, DOI 10.1021/ac502040v
   Miller Karl N, 2019, Curr Opin Endocr Metab Res, V5, P37, DOI 10.1016/j.coemr.2019.02.002
   Ohta H, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00024
   Ohta H, 2015, SCI REP-UK, V5, DOI 10.1038/srep10049
   Partridge L, 2020, NAT REV DRUG DISCOV, V19, P513, DOI 10.1038/s41573-020-0067-7
   Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011
   Pecinová A, 2019, BIOFACTORS, V45, P703, DOI 10.1002/biof.1548
   Raubenheimer D, 2016, EXP GERONTOL, V86, P50, DOI 10.1016/j.exger.2016.04.007
   Reifsnyder PC, 2020, J GERONTOL A-BIOL, V75, P50, DOI 10.1093/gerona/glz157
   Rhoads TW, 2020, CELL SYST, V10, P156, DOI 10.1016/j.cels.2019.12.002
   Rhoads TW, 2018, CELL METAB, V27, P677, DOI 10.1016/j.cmet.2018.01.014
   Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024
   Fernandes GFS, 2017, NUTRIENTS, V9, DOI 10.3390/nu9111201
   Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200
   Schwarz J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047303
   Shao S, 2020, TRANSL ANDROL UROL, V9, P673, DOI 10.21037/tau.2020.03.42
   Simpson SJ, 2005, OBES REV, V6, P133, DOI 10.1111/j.1467-789X.2005.00178.x
   Simpson SJ, 1999, P NUTR SOC, V58, P779, DOI 10.1017/S0029665199001068
   Simpson SJ, 2017, AGEING RES REV, V39, P78, DOI 10.1016/j.arr.2017.03.001
   Simpson SJ, 2014, NATURE, V508, pS66, DOI 10.1038/508S66a
   Solon-Biet SM, 2014, CELL METAB, V19, P418, DOI 10.1016/j.cmet.2014.02.009
   Speakman JR, 2016, EXP GERONTOL, V86, P28, DOI 10.1016/j.exger.2016.03.011
   Stachowicz A, 2012, J PROTEOMICS, V77, P167, DOI 10.1016/j.jprot.2012.08.015
   Swindell WR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-585
   Villa-Cuesta E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029513
   Walsh CM, 2013, J BIOL CHEM, V288, P2816, DOI 10.1074/jbc.M112.410803
   Wilkinson ME, 2020, ANNU REV BIOCHEM, V89, P359, DOI 10.1146/annurev-biochem-091719-064225
   ZARAGOZA R, 1987, ARCH BIOCHEM BIOPHYS, V258, P426, DOI 10.1016/0003-9861(87)90364-X
   Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6
NR 61
TC 25
Z9 26
U1 6
U2 56
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1550-4131
EI 1932-7420
J9 CELL METAB
JI Cell Metab.
PD 2021 DEC 7
PY 2021
VL 33
IS 12
BP 2367
EP +
DI 10.1016/j.cmet.2021.10.016
EA DEC 2021
PG 18
WC Cell Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Endocrinology & Metabolism
GA XN6BS
UT WOS:000729588700010
PM 34767745
OA hybrid
DA 2024-02-19
ER

PT J
AU Wagle, S
   Sim, HJ
   Bhattarai, G
   Choi, KC
   Kook, SH
   Lee, JC
   Jeon, YM
AF Wagle, Sajeev
   Sim, Hyun-Jaung
   Bhattarai, Govinda
   Choi, Ki-Choon
   Kook, Sung-Ho
   Lee, Jeong-Chae
   Jeon, Young-Mi
TI Supplemental Ferulic Acid Inhibits Total Body Irradiation-Mediated Bone
   Marrow Damage, Bone Mass Loss, Stem Cell Senescence, and Hematopoietic
   Defect in Mice by Enhancing Antioxidant Defense Systems
SO ANTIOXIDANTS
LA English
DT Article
DE ferulic acid; total body irradiation; bone marrow microenvironment; stem
   cell senescence; bone marrow injury; reactive oxygen species;
   antioxidant defense system
ID OXIDATIVE STRESS; DNA-DAMAGE; NRF2; INJURY; DIFFERENTIATION; INDUCTION;
   PROLIFERATION; ACTIVATION
AB While total body irradiation (TBI) is an everlasting curative therapy, the irradiation can cause long-term bone marrow (BM) injuries, along with senescence of hematopoietic stem cells (HSCs) and mesenchymal stem cells (MSCs) via reactive oxygen species (ROS)-induced oxidative damages. Thus, ameliorating or preventing ROS accumulation and oxidative stress is necessary for TBI-requiring clinical treatments. Here, we explored whether administration of ferulic acid, a dietary antioxidant, protects against TBI-mediated systemic damages, and examined the possible mechanisms therein. Sublethal TBI (5 Gy) decreased body growth, lifespan, and production of circulating blood cells in mice, together with ROS accumulation, and senescence induction of BM-conserved HSCs and MSCs. TBI also impaired BM microenvironment and bone mass accrual, which was accompanied by downregulated osteogenesis and by osteoclastogenic and adipogenic activation in BM. Long-term intraperitoneal injection of ferulic acid (50 mg/kg body weight, once per day for 37 consecutive days) protected mice from TBI-mediated mortality, stem cell senescence, and bone mass loss by restoring TBI-stimulated disorders in osteogenic, osteoclastic, and adipogenic activation in BM. In vitro experiments using BM stromal cells supported radioprotective effects of ferulic acid on TBI-mediated defects in proliferation and osteogenic differentiation. Overall, treatment with ferulic acid prevented TBI-mediated liver damage and enhanced endogenous antioxidant defense systems in the liver and BM. Collectively, these results support an efficient protection of TBI-mediated systemic defects by supplemental ferulic acid, indicating its clinical usefulness for TBI-required patients.
C1 [Wagle, Sajeev; Sim, Hyun-Jaung; Bhattarai, Govinda; Kook, Sung-Ho; Lee, Jeong-Chae; Jeon, Young-Mi] Jeonbuk Natl Univ, Inst Oral Biosci, Cluster Craniofacial Dev & Regenerat Res, Sch Dent, Jeonju 54896, South Korea.
   [Sim, Hyun-Jaung; Kook, Sung-Ho; Lee, Jeong-Chae] Jeonbuk Natl Univ, Dept Bioact Mat Sci & Res Ctr Bioact Mat, Jeonju 54896, South Korea.
   [Choi, Ki-Choon] Natl Inst Anim Sci, Grassland & Forages Res Ctr, Cheonan 31002, South Korea.
C3 Jeonbuk National University; Jeonbuk National University; National
   Institute of Animal Science, Republic of Korea
RP Kook, SH; Lee, JC; Jeon, YM (corresponding author), Jeonbuk Natl Univ, Inst Oral Biosci, Cluster Craniofacial Dev & Regenerat Res, Sch Dent, Jeonju 54896, South Korea.; Kook, SH; Lee, JC (corresponding author), Jeonbuk Natl Univ, Dept Bioact Mat Sci & Res Ctr Bioact Mat, Jeonju 54896, South Korea.
EM swagle@jbnu.ac.kr; skynow@hanmail.net; govinda@jbnu.ac.kr;
   choiwh@korea.kr; kooksh@jbnu.ac.kr; leejc88@jbnu.ac.kr; young@jbnu.ac.kr
RI Wagle, Sajeev/N-1524-2013
OI Wagle, Sajeev/0000-0001-9762-0262
FU National Research Foundation (NRF) - Ministry of Science, Information
   and Communications Technology and Future Planning [2018R1D1A1B07046563,
   2020R1C1C1004968, 2021R1A2C2006032, 2021R111A1A01044453]; RDA, Ministry
   of Agriculture and Forestry, Republic of Korea [PJ013394022021]
FX This research was supported by Basic Science Research Program through
   the National Research Foundation (NRF) funded by the Ministry of
   Science, Information and Communications Technology and Future Planning
   (2018R1D1A1B07046563, 2020R1C1C1004968, 2021R1A2C2006032, and
   2021R111A1A01044453), and by the RDA, Ministry of Agriculture and
   Forestry, Republic of Korea (PJ013394022021).
CR Akune T, 2004, J CLIN INVEST, V113, P846, DOI 10.1172/JCI200419900
   Bai JT, 2020, AM J PHYSIOL-CELL PH, V318, pC1005, DOI 10.1152/ajpcell.00520.2019
   Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   Callaway DA, 2015, J BONE MINER METAB, V33, P359, DOI 10.1007/s00774-015-0656-4
   Cao X, 2011, P NATL ACAD SCI USA, V108, P1609, DOI 10.1073/pnas.1015350108
   Chute JP, 2014, J CLIN INVEST, V124, P960, DOI [10.1172/JC174143, 10.1172/JCI74143]
   Costa S, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00587
   Dai XZ, 2020, TRENDS MOL MED, V26, P185, DOI 10.1016/j.molmed.2019.09.007
   Das U, 2017, FREE RADICAL RES, V51, P47, DOI 10.1080/10715762.2016.1267345
   Das U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097599
   Domen J, 1998, BLOOD, V91, P2272, DOI 10.1182/blood.V91.7.2272.2272_2272_2282
   Dong J, 2008, ANTIOXID REDOX SIGN, V10, P2023, DOI 10.1089/ars.2007.2019
   Frohlich DA, 2008, ONCOGENE, V27, P4353, DOI 10.1038/onc.2008.79
   Grdina DJ, 2009, INT J RADIAT ONCOL, V73, P886, DOI 10.1016/j.ijrobp.2008.10.061
   Herrmann M, 2019, CURR OSTEOPOROS REP, V17, P429, DOI 10.1007/s11914-019-00550-w
   Hu Linping, 2019, Oxid Med Cell Longev, V2019, P5153268, DOI 10.1155/2019/5153268
   Islam MS, 2015, J RADIAT RES, V56, P269, DOI 10.1093/jrr/rru098
   Johnson MB, 2019, STEM CELL TRANSL MED, V8, P925, DOI 10.1002/sctm.18-0112
   Kanski J, 2002, J NUTR BIOCHEM, V13, P273, DOI 10.1016/S0955-2863(01)00215-7
   Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026
   Kim JH, 2014, J CLIN INVEST, V124, P730, DOI 10.1172/JCI70812
   Kim SB, 2012, P NATL ACAD SCI USA, V109, pE2949, DOI 10.1073/pnas.1207718109
   King AD, 2010, EUR J RADIOL, V73, P629, DOI 10.1016/j.ejrad.2008.12.016
   Koc M, 2003, J RADIAT RES, V44, P211, DOI 10.1269/jrr.44.211
   Koh EJ, 2017, MOLECULES, V22, DOI 10.3390/molecules22050745
   Kook SH, 2017, FOOD SCI BIOTECHNOL, V26, P279, DOI 10.1007/s10068-017-0037-y
   Liang JW, 2021, STEM CELL TRANSL MED, V10, P1217, DOI 10.1002/sctm.20-0536
   Lo WJ, 2018, ANN HEMATOL, V97, P697, DOI 10.1007/s00277-018-3231-y
   Ma ZC, 2011, INT J RADIAT BIOL, V87, P130, DOI 10.3109/09553002.2011.523510
   MAUCH P, 1995, INT J RADIAT ONCOL, V31, P1319, DOI 10.1016/0360-3016(94)00430-S
   Naveiras O, 2009, NATURE, V460, P259, DOI 10.1038/nature08099
   Piazzon A, 2012, J AGR FOOD CHEM, V60, P12312, DOI 10.1021/jf304076z
   Rana T, 2012, FREE RADICAL BIO MED, V53, P2298, DOI 10.1016/j.freeradbiomed.2012.10.536
   Schultze-Mosgau S, 2005, INT J RADIAT ONCOL, V61, P1189, DOI 10.1016/j.ijrobp.2004.12.008
   Shao LJ, 2014, BLOOD, V123, P3105, DOI 10.1182/blood-2013-07-515619
   Shao LJ, 2014, ANTIOXID REDOX SIGN, V20, P1447, DOI 10.1089/ars.2013.5635
   Sim HJ, 2019, AGING DIS, V10, P1320, DOI 10.14336/AD.2019.0208
   Srinivasan M, 2007, J CLIN BIOCHEM NUTR, V40, P92, DOI 10.3164/jcbn.40.92
   Wang Y, 2006, BLOOD, V107, P358, DOI 10.1182/blood-2005-04-1418
   Wang Y, 2010, FREE RADICAL BIO MED, V48, P348, DOI 10.1016/j.freeradbiomed.2009.11.005
   Wang Y, 2016, MOL MED REP, V13, P213, DOI 10.3892/mmr.2015.4539
   Yokozawa T, 1998, PHYTOMEDICINE, V5, P367, DOI 10.1016/S0944-7113(98)80019-6
   Zhang R, 2011, BASIC CLIN PHARMACOL, V108, P63, DOI 10.1111/j.1742-7843.2010.00629.x
NR 43
TC 6
Z9 7
U1 4
U2 11
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-3921
J9 ANTIOXIDANTS-BASEL
JI Antioxidants
PD AUG
PY 2021
VL 10
IS 8
AR 1209
DI 10.3390/antiox10081209
PG 17
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Food Science
   & Technology
GA UF6EX
UT WOS:000688666100001
PM 34439457
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Vittorini, S
   Paradiso, C
   Donati, A
   Cavallini, G
   Masini, M
   Gori, Z
   Pollera, M
   Bergamini, E
AF Vittorini, S
   Paradiso, C
   Donati, A
   Cavallini, G
   Masini, M
   Gori, Z
   Pollera, M
   Bergamini, E
TI The age-related accumulation of protein carbonyl in rat liver correlates
   with the age-related decline in liver proteolytic activities
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
ID OXIDATIVE DAMAGE; OXIDIZED PROTEINS; GLUTAMINE-SYNTHETASE; FOOD
   RESTRICTION; DNA DAMAGE; DEGRADATION; PROTEASOME; TISSUES; COMPLEX;
   MECHANISMS
AB Increases of protein carbonyl in animal tissues have been associated with the aging process. So far, the accumulation of oxidized proteins, highly susceptible to proteolysis, has been attributed to age-related changes in proteasomal alkaline proteases. Carbonyl in protein was monitored in sir different tissues of male Sprague-Dawley rats fed ad libitum up to the age of 27 months, and of 24- and 27-month-old rats subjected to anti-aging diet restriction (every-other-day feeding ad libitum). Alkaline protease activities and liver lysosomal proteolysis were studied. The levels of protein carbonyl were significantly different in different tissues, and quite stable throughout life; accumulation was restricted to liver tissue very late in life, between ages 24 and 27 months; was fully prevented by diet restriction; was not accompanied by any diet-restriction-sensitive decline of alkaline protease activity; and was accompanied by a dramatic age-related decline in lysosomal proteolysis that was partially prevented by anti-aging diet restriction. No correlation was found between levels of alkaline protease activity and levels of protein carbonyl in the different tissues from younger animals. It is concluded that the process of autophagy, a well-known mechanism for cell maintenance, may deserve more interest in aging studies.
C1 Univ Pisa, Ist Patol Gen, I-56126 Pisa, Italy.
C3 University of Pisa
RP Bergamini, E (corresponding author), Univ Pisa, Ist Patol Gen, Via Roma 55, I-56126 Pisa, Italy.
EM e.bergamini@ipg.med.unipi.it
CR AGARWAL S, 1994, ARCH BIOCHEM BIOPHYS, V309, P24, DOI 10.1006/abbi.1994.1078
   AMES BN, 1989, FREE RADICAL RES COM, V7, P121, DOI 10.3109/10715768909087933
   BARRETT AJ, 1980, BIOCHEM J, V187, P909, DOI 10.1042/bj1870909
   BERGAMINI E, 1992, ANN NY ACAD SCI, V663, P43, DOI 10.1111/j.1749-6632.1992.tb38647.x
   Blommaart EFC, 1997, HISTOCHEM J, V29, P365, DOI 10.1023/A:1026486801018
   CAO GH, 1995, ARCH BIOCHEM BIOPHYS, V320, P106, DOI 10.1006/abbi.1995.1347
   CAO GH, 1995, ARCH BIOCHEM BIOPHYS, V320, P195, DOI 10.1006/abbi.1995.1359
   CARNEY JM, 1991, P NATL ACAD SCI USA, V88, P3633, DOI 10.1073/pnas.88.9.3633
   CHUNG MH, 1992, FREE RADICAL BIO MED, V12, P523, DOI 10.1016/0891-5849(92)90105-P
   Conconi M, 1997, MOL BIOL REP, V24, P45, DOI 10.1023/A:1006852506884
   CONCONI M, 1994, ARCH BIOCHEM BIOPHYS, V309, P24
   Dunn William A. Jr., 1994, Trends in Cell Biology, V4, P139, DOI 10.1016/0962-8924(94)90069-8
   Grune T, 1997, FASEB J, V11, P526, DOI 10.1096/fasebj.11.7.9212076
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   MAKRIDES SC, 1983, BIOL REV, V58, P343, DOI 10.1111/j.1469-185X.1983.tb00394.x
   MORTIMORE GE, 1989, DIABETES METAB REV, V5, P49, DOI 10.1002/dmr.5610050105
   OLIVER CN, 1987, J BIOL CHEM, V262, P5488
   ORLOWSKI M, 1990, BIOCHEMISTRY-US, V29, P10289, DOI 10.1021/bi00497a001
   PACIFICI RE, 1989, FREE RADICAL BIO MED, V7, P521, DOI 10.1016/0891-5849(89)90028-2
   REZNICK AZ, 1994, METHOD ENZYMOL, V233, P357
   RIVETT AJ, 1994, METHOD ENZYMOL, V244, P331
   RIVETT AJ, 1985, J BIOL CHEM, V260, P300
   RIVETT AJ, 1993, BIOCHEM J, V291, P1
   SAHAKIAN JA, 1995, ARCH BIOCHEM BIOPHYS, V318, P411, DOI 10.1006/abbi.1995.1248
   Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5
   SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889
   SEGLEN PO, 1992, EXPERIENTIA, V48, P158, DOI 10.1007/BF01923509
   Shibatani T, 1996, J GERONTOL A-BIOL, V51, pB175, DOI 10.1093/gerona/51A.2.B175
   Shibatani T, 1996, J GERONTOL A-BIOL, V51, pB316, DOI 10.1093/gerona/51A.5.B316
   SMITH CD, 1991, P NATL ACAD SCI USA, V88, P10540, DOI 10.1073/pnas.88.23.10540
   SOHAL RS, 1993, BIOCHEM BIOPH RES CO, V196, P7, DOI 10.1006/bbrc.1993.2208
   SOHAL RS, 1994, MECH AGEING DEV, V74, P121, DOI 10.1016/0047-6374(94)90104-X
   SOHAL RS, 1993, P NATL ACAD SCI USA, V90, P7255, DOI 10.1073/pnas.90.15.7255
   SOHAL RS, 1994, MECH AGEING DEV, V76, P215, DOI 10.1016/0047-6374(94)91595-4
   SOHAL RS, 1990, EXP GERONTOL, V25, P499, DOI 10.1016/0531-5565(90)90017-V
   SOHAL RS, 1995, MOL ASPECTS AGING
   Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142
   STADTMAN ER, 1995, MOL ASPECTS AGING
   STARKEREED PE, 1989, ARCH BIOCHEM BIOPHYS, V275, P559, DOI 10.1016/0003-9861(89)90402-5
   TIAN LQ, 1995, FREE RADICAL BIO MED, V19, P859, DOI 10.1016/0891-5849(95)00090-K
   VENERANDO R, 1994, AM J PHYSIOL, V266, pC455, DOI 10.1152/ajpcell.1994.266.2.C455
   Vittorini S, 1995, AGING CLIN EXP RES, V7, P480, DOI 10.1007/BF03324380
NR 42
TC 89
Z9 102
U1 0
U2 3
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD AUG
PY 1999
VL 54
IS 8
BP B318
EP B323
DI 10.1093/gerona/54.8.B318
PG 6
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA 331XD
UT WOS:000088043200002
PM 10496537
OA Bronze
DA 2024-02-19
ER

PT J
AU Grosbellet, E
   Zahn, S
   Arrivé, M
   Dumont, S
   Gourmelen, S
   Pévet, P
   Challet, E
   Criscuolo, F
AF Grosbellet, Edith
   Zahn, Sandrine
   Arrive, Mathilde
   Dumont, Stephanie
   Gourmelen, Sylviane
   Pevet, Paul
   Challet, Etienne
   Criscuolo, Francois
TI Circadian desynchronization triggers premature cellular aging in a
   diurnal rodent
SO FASEB JOURNAL
LA English
DT Article
DE circadian rhythm; telomere shortening; chronic jet lag; shift work;
   diabetes
ID CHRONIC JET-LAG; DNA-DAMAGE-RESPONSE; OXIDATIVE STRESS; TELOMERE LENGTH;
   FOOD RESTRICTION; CLOCK GENES; SHIFT WORK; BODY-MASS; LIGHT; LIFE
AB Chronic jet lag or shift work is deleterious to human metabolic health, in that such circadian desynchronization is associated with being overweight and the prevalence of altered glucose metabolism. Similar metabolic changes are observed with age, suggesting that chronic jet lag and accelerated cell aging are intimately related, but the association remains to be determined. We addressed whether jet lag induces metabolic and cell aging impairments in young grass rats (2-3 mo old), using control old grass rats (12-18 mo old) as an aging reference. Desynchronized young and control old subjects had impaired glucose tolerance (+60 and +280%) when compared with control young animals. Despite no significant variation in liver DNA damage, shorter telomeres were characterized, not only in old animal liver cells (-18%), but also at an intermediate level in desynchronized young rats (-9%). The same pattern was found for deacetylase sirtuin (SIRT)-1 (-57 and -29%), confirming that jet-lagged young rats have an intermediate aging profile. Our data indicate that an experimental circadian desynchronization in young animals is associated with a precocious aging profile based on 3 well-known markers, as well as a prediabetic phenotype. Such chronic jet lag-induced alterations observed in a diurnal species constitute proof of principle of the need to develop preventive treatments in jet-lagged persons and shift workers.
C1 [Grosbellet, Edith; Dumont, Stephanie; Gourmelen, Sylviane; Pevet, Paul; Challet, Etienne] Univ Strasbourg, CNRS, Inst Cellular & Integrat Neurosci, Unite Propres Rech 3212, Strasbourg, France.
   [Grosbellet, Edith; Zahn, Sandrine; Arrive, Mathilde; Criscuolo, Francois] Univ Strasbourg, CNRS, Hubert Curien Pluridisciplinary Inst, Dept Ecol Physiol & Ethol,Unite Mixte Rech 7178, Strasbourg, France.
C3 Centre National de la Recherche Scientifique (CNRS); Universites de
   Strasbourg Etablissements Associes; Universite de Strasbourg; Centre
   National de la Recherche Scientifique (CNRS); Universites de Strasbourg
   Etablissements Associes; Universite de Strasbourg
RP Challet, E (corresponding author), Inst Cellular & Integrat Neurosci, 5 Rue Blaise Pascal, F-67084 Strasbourg, France.
EM challet@inci-cnrs.unistra.fr; francois.criscuolo@iphc.cnrs.fr
RI Challet, Etienne/ABF-7553-2020
OI Challet, Etienne/0000-0001-9416-9496
FU Centre National de la Recherche Scientifique; University of Strasbourg;
   University of Strasbourg, Strasbourg, France; French Ministry of Higher
   Education and Research
FX The authors thank Dr. M. P. Felder, J. G. Lorentz, S. Sen, and A. Dumont
   for help with the Western blots, and Dr. D. Sage-Ciocca for expert
   assistance with the actimetry. This research was supported by grants
   from Centre National de la Recherche Scientifique (to F.C. and E.C.),
   the University of Strasbourg (to F.C. and E.C.), and ProjEx H2E
   "Contributions of exotic animal models in the discovery of new
   therapeutic approaches in human pathophysiology" (University of
   Strasbourg, Strasbourg, France; to F.C. and E.C.), and by a doctoral
   fellowship from the French Ministry of Higher Education and Research (to
   E.G.). E.C. and F.C. share senior authorship. The authors declare no
   conflicts of interest.
CR Adaikalakoteswari A, 2007, ATHEROSCLEROSIS, V195, P83, DOI 10.1016/j.atherosclerosis.2006.12.003
   Åkerstedt T, 2003, OCCUP MED-OXFORD, V53, P89, DOI 10.1093/occmed/kqg046
   Arendt J, 2009, SLEEP MED REV, V13, P249, DOI 10.1016/j.smrv.2008.07.011
   Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050
   Barclay JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037150
   Bartol-Munier I, 2006, INT J OBESITY, V30, P60, DOI 10.1038/sj.ijo.0803048
   Beery AK, 2012, BIOL LETTERS, V8, P1063, DOI 10.1098/rsbl.2012.0747
   Bendix L, 2014, J GERONTOL A-BIOL, V69, P231, DOI 10.1093/gerona/glt153
   Bize P, 2009, P R SOC B, V276, P1679, DOI 10.1098/rspb.2008.1817
   Blackburn EH, 2012, NATURE, V490, P169, DOI 10.1038/490169a
   Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1
   Buxton OM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003200
   Caldelas I, 2003, NEUROSCIENCE, V116, P583, DOI 10.1016/S0306-4522(02)00654-1
   Castanon-Cervantes O, 2010, J IMMUNOL, V185, P5796, DOI 10.4049/jimmunol.1001026
   Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7
   Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47
   Chen WD, 2014, BIOCHEM BIOPH RES CO, V451, P408, DOI 10.1016/j.bbrc.2014.07.138
   Cherif H, 2003, NUCLEIC ACIDS RES, V31, P1576, DOI 10.1093/nar/gkg208
   Choi J, 2008, BRAIN BEHAV IMMUN, V22, P600, DOI 10.1016/j.bbi.2007.12.004
   COSTANTINI D., 2014, Oxidative stress and hormesis in evolutionary ecology and physiology: a marriage between mechanistic and evolutionary approaches
   Criscuolo F, 2005, AM NAT, V166, P686, DOI 10.1086/497439
   Cuesta M, 2009, HORM BEHAV, V55, P338, DOI 10.1016/j.yhbeh.2008.10.015
   Dalm S, 2005, NEUROENDOCRINOLOGY, V81, P372, DOI 10.1159/000089555
   Daniali L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2602
   Davidson AJ, 2006, CURR BIOL, V16, pR914, DOI 10.1016/j.cub.2006.09.058
   Dubrovsky YV, 2010, AGING-US, V2, P936, DOI 10.18632/aging.100241
   Evans JA, 2013, PROG MOL BIOL TRANSL, V119, P283, DOI 10.1016/B978-0-12-396971-2.00010-5
   Filipski E, 2004, CANCER RES, V64, P7879, DOI 10.1158/0008-5472.CAN-04-0674
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   Fonken LK, 2010, P NATL ACAD SCI USA, V107, P18664, DOI 10.1073/pnas.1008734107
   Fumagalli M, 2012, NAT CELL BIOL, V14, P355, DOI 10.1038/ncb2466
   Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI21625, 10.1172/JCI20042162S]
   Gale JE, 2011, J BIOL RHYTHM, V26, P423, DOI 10.1177/0748730411416341
   Gardano L, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00146
   Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007
   Halliwell B., 2000, FREE RADICAL BIO MED, V3rd
   Heikkinen S., 2007, CURR PROTOC MOL BIOL, DOI DOI 10.1002/0471142727.MB29B03S77
   Hewitt G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1708
   Hubbard J, 2015, SLEEP, V38, P979, DOI 10.5665/sleep.4754
   Inui T, 2002, EXP CELL RES, V273, P147, DOI 10.1006/excr.2001.5446
   Iwamoto A, 2014, CHRONOBIOL INT, V31, P189, DOI 10.3109/07420528.2013.837478
   Kappei D, 2013, EMBO J, V32, P1681, DOI 10.1038/emboj.2013.105
   Katona C, 1997, PHYSIOL BEHAV, V61, P365, DOI 10.1016/S0031-9384(96)00407-6
   Kawanishi S, 2004, ANN NY ACAD SCI, V1019, P278, DOI 10.1196/annals.1297.047
   Khalsa SBS, 2003, J PHYSIOL-LONDON, V549, P945, DOI 10.1113/jphysiol.2003.040477
   Khapre RV, 2014, AGING-US, V6, P48, DOI 10.18632/aging.100633
   Kiecolt-Glaser JK, 2013, BRAIN BEHAV IMMUN, V34, P29, DOI 10.1016/j.bbi.2013.08.004
   Kirkwood TBL, 2012, BIOESSAYS, V34, P692, DOI 10.1002/bies.201200014
   Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206
   Kondratov RV, 2009, AGING-US, V1, P979, DOI 10.18632/aging.100113
   Kondratova AA, 2012, NAT REV NEUROSCI, V13, P325, DOI 10.1038/nrn3208
   Kunieda T, 2006, CIRC RES, V98, P532, DOI 10.1161/01.RES.0000204504.25798.a8
   la Fleur SE, 1999, J NEUROENDOCRINOL, V11, P643
   la Fleur SE, 2001, DIABETES, V50, P1237, DOI 10.2337/diabetes.50.6.1237
   Leproult R, 2014, DIABETES, V63, P1860, DOI 10.2337/db13-1546
   Liu JL, 2014, CURR BIOL, V24, pR610, DOI 10.1016/j.cub.2014.05.057
   Martino TA, 2008, AM J PHYSIOL-REG I, V294, pR1675, DOI 10.1152/ajpregu.00829.2007
   Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002
   Nandakumar J, 2013, NAT REV MOL CELL BIO, V14, P71, DOI 10.1038/nrm3505
   Noda K, 2010, FASEB J, V24, P2443, DOI 10.1096/fj.09-152678
   Palacios JA, 2010, J CELL BIOL, V191, P1299, DOI 10.1083/jcb.201005160
   Penev PD, 1998, AM J PHYSIOL-HEART C, V275, pH2334
   Pesic V, 2010, PHYSIOL BEHAV, V101, P672, DOI 10.1016/j.physbeh.2010.08.005
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Quinlivan EP, 2008, ANAL BIOCHEM, V373, P383, DOI 10.1016/j.ab.2007.09.031
   Redlin U, 2001, CHRONOBIOL INT, V18, P737, DOI 10.1081/CBI-100107511
   Reichert S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081496
   Ribeiro DCO, 1998, J ENDOCRINOL, V158, P305, DOI 10.1677/joe.0.1580305
   Salgado-Delgado R, 2010, ENDOCRINOLOGY, V151, P1019, DOI 10.1210/en.2009-0864
   Salpea KD, 2010, ATHEROSCLEROSIS, V209, P42, DOI 10.1016/j.atherosclerosis.2009.09.070
   Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106
   Selman C, 2012, TRENDS ECOL EVOL, V27, P570, DOI 10.1016/j.tree.2012.06.006
   Seluanov A, 2007, AGING CELL, V6, P45, DOI 10.1111/j.1474-9726.2006.00262.x
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   Shuboni DD, 2012, J BIOL RHYTHM, V27, P299, DOI 10.1177/0748730412449723
   SOHAL RS, 1994, MECH AGEING DEV, V74, P121, DOI 10.1016/0047-6374(94)90104-X
   Spiegel K, 2009, NAT REV ENDOCRINOL, V5, P253, DOI 10.1038/nrendo.2009.23
   Stier A, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-37
   Tahara Y, 2013, NEUROSCIENCE, V253, P78, DOI 10.1016/j.neuroscience.2013.08.049
   Tevy MF, 2013, TRENDS ENDOCRIN MET, V24, P229, DOI 10.1016/j.tem.2012.12.002
   Tsai LL, 2005, AM J PHYSIOL-ENDOC M, V289, pE212, DOI 10.1152/ajpendo.00603.2004
   Van Someren EJW, 1999, CHRONOBIOL INT, V16, P505, DOI 10.3109/07420529908998724
   VanCauter E, 1997, ENDOCR REV, V18, P716, DOI 10.1210/er.18.5.716
   Vera E, 2012, CELL REP, V2, P732, DOI 10.1016/j.celrep.2012.08.023
   West IC, 2000, DIABETIC MED, V17, P171, DOI 10.1046/j.1464-5491.2000.00259.x
NR 85
TC 30
Z9 33
U1 0
U2 30
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD DEC
PY 2015
VL 29
IS 12
BP 4794
EP 4803
DI 10.1096/fj.14-266817
PG 10
WC Biochemistry & Molecular Biology; Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA CX2JS
UT WOS:000365523600007
PM 26260033
DA 2024-02-19
ER

PT J
AU Kinoo, SM
   Naidoo, P
   Singh, B
   Chuturgoon, A
   Nagiah, S
AF Kinoo, Suman Mewa
   Naidoo, Pragalathan
   Singh, Bhugwan
   Chuturgoon, Anil
   Nagiah, Savania
TI Human Hepatocyte Nuclear Factors (HNF1 and LXRb) Regulate CYP7A1 in
   HIV-Infected Black South African Women with Gallstone Disease: A
   Preliminary Study
SO LIFE-BASEL
LA English
DT Article
DE HIV; gallstones; HNF1; LXRb
ID BILE-ACID SYNTHESIS; CHOLESTEROL GALLSTONES; METABOLIC SYNDROME;
   RECEPTOR LXR; LIVER; TRANSCRIPTION; EXPRESSION; MACROPHAGES; ALPHA; RAT
AB Female sex, high estrogen levels, aging, obesity, and dyslipidemia are some of the risk factors associated with gallstone formation. HIV-infected patients on combination antiretroviral therapy (cART) are more prone to hypercholesterolemia. Bile acid synthesis is initiated by cholesterol 7-alpha hydroxylase (CYP7A1) and regulated by hepatocyte nuclear factors (HNF1 alpha, HNF4 alpha, and LXRb). The aim of this study was to evaluate the expression of HNF1 alpha, HNF4 alpha, LXRb, and miRNAs (HNF4 alpha specific: miR-194-5p and miR-122*_1) that regulate CYP7A1 transcription in HIV-infected Black South African women on cART and presenting with gallstones relative to HIV-negative patients with gallstone disease. Females (n = 96) presenting with gallstone disease were stratified based on HIV status. The gene expression of CYP7A1, HNF1 alpha, HNF4 alpha, LXRb, miR-194-5p, and miR-122*_1 was determined using RT-qPCR. Messenger RNA and miRNA levels were reported as fold change expressed as 2(-Delta Delta Ct) (RQ min; RQ max). Fold changes >2 and <0.5 were considered significant. HIV-infected females were older in age (p = 0.0267) and displayed higher low-density lipoprotein cholesterol (LDL-c) (p = 0.0419), CYP7A1 [2.078-fold (RQ min: 1.278; RQ max: 3.381)], LXRb [2.595-fold (RQ min: 2.001; RQ max: 3.000)], and HNF1 alpha [3.428 (RQ min: 1.806; RQ max: 6.507] levels. HNF4 alpha [0.642-fold (RQ min: 0.266; RQ max: 1.55)], miR-194-5p [0.527-fold (RQ min: 0.37; RQ max: 0.752)], and miR-122*_1 [0.595-fold (RQ min: 0.332; RQ max: 1.066)] levels were lower in HIV-infected females. In conclusion, HIV-infected women with gallstone disease displayed higher LDL-c levels and increased bile acid synthesis, which was evidenced by the elevated expression of CYP7A1, HNF1 alpha, and LXRb. This could have been further influenced by cART and aging.
C1 [Kinoo, Suman Mewa; Naidoo, Pragalathan; Chuturgoon, Anil; Nagiah, Savania] Univ KwaZulu Natal, Coll Hlth Sci, Sch Lab Med & Med Sci, Discipline Med Biochem, ZA-4041 Durban, South Africa.
   [Kinoo, Suman Mewa; Singh, Bhugwan] Univ KwaZulu Natal, Coll Hlth Sci, Sch Clin Med, Discipline Gen Surg, ZA-4001 Durban, South Africa.
   [Nagiah, Savania] Nelson Mandela Univ, Fac Hlth Sci, Med Sch, Dept Human Biol, ZA-6065 Port Elizabeth, South Africa.
C3 University of Kwazulu Natal; University of Kwazulu Natal; Nelson Mandela
   University
RP Chuturgoon, A; Nagiah, S (corresponding author), Univ KwaZulu Natal, Coll Hlth Sci, Sch Lab Med & Med Sci, Discipline Med Biochem, ZA-4041 Durban, South Africa.; Nagiah, S (corresponding author), Nelson Mandela Univ, Fac Hlth Sci, Med Sch, Dept Human Biol, ZA-6065 Port Elizabeth, South Africa.
EM chutur@ukzn.ac.za; savania.nagiah@mandela.ac.za
CR Acalovschi M, 2001, POSTGRAD MED J, V77, P221, DOI 10.1136/pmj.77.906.221
   ADMIRAND WH, 1968, J CLIN INVEST, V47, P1043, DOI 10.1172/JCI105794
   Almobarak AO, 2020, TRANSL GASTROENT HEP, V5, DOI 10.21037/tgh.2019.10.09
   [Anonymous], 2017, LANCET HIV, V4, pE277, DOI 10.1016/S2352-3018(17)30114-5
   Bertolotti M, 2008, CURR MED CHEM, V15, P2271, DOI 10.2174/092986708785747544
   Bjarnason I, 1996, AIDS, V10, P1385, DOI 10.1097/00002030-199610000-00011
   Castro J, 2007, HEPATOLOGY, V45, P1261, DOI 10.1002/hep.21616
   Chawla A, 2000, CELL, V103, P1, DOI 10.1016/S0092-8674(00)00097-0
   Chen J, 1999, BIOCHEM BIOPH RES CO, V260, P829, DOI 10.1006/bbrc.1999.0980
   Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200
   Chiang JYL, 2001, GENE, V262, P257, DOI 10.1016/S0378-1119(00)00518-7
   Cramp ME, 1996, AUST NZ J MED, V26, P368, DOI 10.1111/j.1445-5994.1996.tb01924.x
   Cui HL, 2012, J LIPID RES, V53, P696, DOI 10.1194/jlr.M023119
   De Fabiani E, 2001, J BIOL CHEM, V276, P30708, DOI 10.1074/jbc.M103270200
   Di Ciaula A, 2013, CHOLESTEROL, DOI 10.1155/2013/298421
   El-Sadr W, 2005, HIV MED, V6, P114, DOI 10.1111/j.1468-1293.2005.00273.x
   Feeney Eoin R, 2011, Open Cardiovasc Med J, V5, P49, DOI 10.2174/1874192401105010049
   Feingold KR, 1996, J LIPID RES, V37, P223
   Gälman C, 2004, GASTROENTEROLOGY, V126, P741, DOI 10.1053/j.gastro.2003.12.009
   Gbaguidi GF, 2004, NUCLEIC ACIDS RES, V32, P1113, DOI 10.1093/nar/gkh260
   Goodwin B, 2003, MOL ENDOCRINOL, V17, P386, DOI 10.1210/me.2002-0246
   Hernandez-Nazara Alejandro, 2006, Ann Hepatol, V5, P140
   Horvath S, 2015, J INFECT DIS, V212, P1563, DOI 10.1093/infdis/jiv277
   Ipp H, 2014, CRIT REV CL LAB SCI, V51, P98, DOI 10.3109/10408363.2013.865702
   Kato I, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235542
   Khovidhunkit W, 2003, J LIPID RES, V44, P1728, DOI 10.1194/jlr.M300100-JLR200
   Kinoo SM, 2021, BMC INFECT DIS, V21, DOI 10.1186/s12879-021-05977-0
   Lake JE, 2013, LANCET INFECT DIS, V13, P964, DOI 10.1016/S1473-3099(13)70271-8
   Lau HH, 2018, J HEPATOL, V68, P1033, DOI 10.1016/j.jhep.2017.11.026
   Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137
   Li ZY, 2011, J HEPATOL, V55, P602, DOI 10.1016/j.jhep.2010.12.023
   Lin J.P., 1994, AM J HUM GENET, V55, P1
   Lin KY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137660
   Maher JM, 2006, BIOCHEM PHARMACOL, V72, P512, DOI 10.1016/j.bcp.2006.03.016
   Meir-Shafrir K, 2012, RAMBAM MAIMONIDES ME, V3, DOI 10.5041/RMMJ.10089
   Méndez-Sánchez N, 2005, WORLD J GASTROENTERO, V11, P1653, DOI 10.3748/wjg.v11.i11.1653
   Miao J., 2008, REGULATION BILE ACID
   Miyake JH, 2000, J BIOL CHEM, V275, P21805, DOI 10.1074/jbc.C000275200
   Miyake JH, 2002, ARTERIOSCL THROM VAS, V22, P121, DOI 10.1161/hq0102.102588
   Morimoto A, 2017, J BIOL CHEM, V292, P10574, DOI 10.1074/jbc.M117.785592
   Moschetta A, 2004, NAT MED, V10, P1352, DOI 10.1038/nm1138
   Moschetta A, 2001, J HEPATOL, V34, P492, DOI 10.1016/S0168-8278(00)00046-5
   Mpondo Bonaventura C T, 2016, J Aging Res, V2016, P2404857, DOI 10.1155/2016/2404857
   Mujawar Z, 2006, PLOS BIOL, V4, P1970, DOI 10.1371/journal.pbio.0040365
   Nishijima T, 2014, J ANTIMICROB CHEMOTH, V69, P1385, DOI 10.1093/jac/dkt514
   Pagliarulo M, 2004, DIGEST LIVER DIS, V36, P130, DOI 10.1016/j.dld.2003.10.007
   Pao V, 2008, CURR ATHEROSCLER REP, V10, P61, DOI 10.1007/s11883-008-0010-6
   PAREKH D, 1987, S AFR MED J, V72, P23
   Paula AA, 2013, AIDS RES THER, V10, DOI 10.1186/1742-6405-10-32
   PAUMGARTNER G, 1991, LANCET, V338, P1117, DOI 10.1016/0140-6736(91)91972-W
   Peery A.F., 2017, GASTROENTEROLOGY, V149, P173
   Pullingr CR, 2002, J CLIN INVEST, V110, P109, DOI 10.1172/JCI200215387
   Purushotham A, 2012, MOL CELL BIOL, V32, P1226, DOI 10.1128/MCB.05988-11
   Qayyum F, 2018, EUR HEART J, V39, P2106, DOI 10.1093/eurheartj/ehy068
   Rappocciolo G, 2014, MBIO, V5, DOI 10.1128/mBio.01031-13
   SALEN G, 1975, GASTROENTEROLOGY, V69, P676
   Shaffer Eldon A, 2005, Curr Gastroenterol Rep, V7, P132
   Shih DQ, 2001, NAT GENET, V27, P375, DOI 10.1038/86871
   Shin DJ, 2003, J BIOL CHEM, V278, P50047, DOI 10.1074/jbc.M309736200
   Smith Reuben L., 2013, Frontiers in Genetics, V3, P328, DOI 10.3389/fgene.2012.00328
   Srivastava A, 2010, METABOLISM, V59, P767, DOI 10.1016/j.metabol.2009.09.021
   Stroup D, 2000, J LIPID RES, V41, P1
   WALKER ARP, 1989, AM J GASTROENTEROL, V84, P1383
   Williams K, 2004, BIOCHEM PHARMACOL, V67, P255, DOI 10.1016/j.bcp.2003.08.044
   Willig AL, 2016, CURR HIV-AIDS REP, V13, P289, DOI 10.1007/s11904-016-0330-z
   Wing EJ., 2017, T AM CLIN CLIMAT ASS, V128, P131, DOI DOI 10.1016/J.IJID.2016.10.004
   Wojcicka Grazyna, 2007, Postepy Hig Med Dosw (Online), V61, P736
   Zhou HP, 2006, AM J PHYSIOL-GASTR L, V291, pG1071, DOI 10.1152/ajpgi.00182.2006
NR 68
TC 0
Z9 0
U1 3
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2075-1729
J9 LIFE-BASEL
JI Life-Basel
PD FEB
PY 2023
VL 13
IS 2
AR 273
DI 10.3390/life13020273
PG 11
WC Biology; Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics; Microbiology
GA 9J4OB
UT WOS:000940167000001
PM 36836631
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Kirk, JB
   Goetz, MB
AF Kirk, Jason B.
   Goetz, Matthew Bidwell
TI Human Immunodeficiency Virus in an Aging Population, a Complication of
   Success
SO JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
LA English
DT Article
DE human immunodeficiency virus; acquired immunodeficiency syndrome;
   antiretroviral therapy; immune activation
ID HIV-INFECTED PATIENTS; REVERSE-TRANSCRIPTASE INHIBITORS; ANTIRETROVIRAL
   THERAPY; PATIENTS OLDER; CARE; HEALTH; RISK; AIDS; PREVALENCE;
   INDIVIDUALS
AB The proportion of human immunodeficiency virus (HIV)-infected patients aged 50 and older has greatly increased since the beginning of the epidemic, particularly since 1996, when combination antiretroviral therapy became available. By 2015, 50% of HIV-infected individuals in the United States are likely to be aged 50 and older. The rate of progression of untreated HIV disease, response to therapy, and complicating effects of comorbidities differ in older and younger patients. Older untreated patients with HIV demonstrate faster rates of CD4+ cell loss and more rapid progression to acquired immunodeficiency syndrome (AIDS) and death than younger individuals. Synergistic deleterious effects of chronic immune activation on the course of HIV infection with the immune senescence of aging may promote this accelerated course. Despite the increasing prevalence in older patients and cost-effectiveness analyses that favor HIV testing, older patients are less likely to be routinely evaluated for HIV infection. Consequently, when diagnosed, older patients have more-advanced disease than do younger patients and, upon presentation with AIDS-defining conditions, are less likely to receive timely appropriate therapy. The treatment of older HIV-infected patients is complicated by preexisting comorbid conditions, including cardiovascular, hepatic, and metabolic complications, which in turn may be exacerbated by the effects of HIV infection per se, modest immunodeficiency (i.e., at CD4+ counts > 350 cells/mu L), and the metabolic and other adverse effects of combination antiretroviral therapy. Nevertheless, older patients derive substantial benefit from combination antiretroviral therapy despite having less of an immunological response than expected given their adherence to therapy and excellent virological responses.
C1 VA Greater Los Angeles Healthcare Syst, Infect Dis Sect, Dept Med, Los Angeles, CA 90073 USA.
   Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.
C3 US Department of Veterans Affairs; Veterans Health Administration (VHA);
   VA Greater Los Angeles Healthcare System; University of California
   System; University of California Los Angeles; University of California
   Los Angeles Medical Center; David Geffen School of Medicine at UCLA
RP Goetz, MB (corresponding author), VA Greater Los Angeles Healthcare Syst, Infect Dis Sect 111 F, 11301 Wilshire Blvd, Los Angeles, CA 90073 USA.
EM matthew.goetz@va.gov
RI Goetz, Matthew Bidwell/GPX-4090-2022
OI Goetz, Matthew/0000-0003-4542-992X
CR Aberg JA, 2009, JAIDS-J ACQ IMM DEF, V50, P54, DOI 10.1097/QAI.0b013e31818ceaa4
   [Anonymous], 16 C RETR OPP INF MO
   APPAY V, 2008, J PATHOL, V1, P214
   Babiker A, 2000, LANCET, V355, P1131, DOI 10.1016/S0140-6736(00)02061-4
   Balslev U, 1997, SCAND J INFECT DIS, V29, P337, DOI 10.3109/00365549709011827
   Beral V, 2004, AIDS, V18, P51, DOI [10.1097/01.aids.0000096908.73209.5d, 10.1097/00002030-200401020-00006]
   Bhaskaran K, 2008, JAMA-J AM MED ASSOC, V300, P51, DOI 10.1001/jama.300.1.51
   Braithwaite RS, 2008, ANN INTERN MED, V148, P178, DOI 10.7326/0003-4819-148-3-200802050-00004
   Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1
   Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511
   Brown TT, 2006, AIDS, V20, P2165, DOI 10.1097/QAD.0b013e32801022eb
   Brown TT, 2005, ARCH INTERN MED, V165, P1179, DOI 10.1001/archinte.165.10.1179
   Brown TT, 2005, AIDS, V19, P1375, DOI 10.1097/01.aids.0000181011.62385.91
   Cao W, 2009, JAIDS-J ACQ IMM DEF, V50, P137, DOI 10.1097/QAI.0b013e3181926c28
   *CDCP, 2008, 200618 DEP HLTH HUM
   Centers for Disease Control and Prevention, 2009, HIV AIDS SURV REP 20
   Centers for Disease Control and Prevention (CDC), 1998, MMWR Morb Mortal Wkly Rep, V47, P21
   Cossarizza A, 2004, AIDS, V18, P137, DOI 10.1097/00002030-200401230-00002
   Crothers K, 2006, CHEST, V130, P1326, DOI 10.1378/chest.130.5.1326
   Currier Judith S, 2008, Circulation, V118, pe29, DOI 10.1161/CIRCULATIONAHA.107.189624
   Cutrell A, 2008, LANCET, V371, P1413, DOI 10.1016/s0140-6736(08)60492-4
   De Wit S, 2008, DIABETES CARE, V31, P1224, DOI 10.2337/dc07-2013
   Desquilbet L, 2007, J GERONTOL A-BIOL, V62, P1279, DOI 10.1093/gerona/62.11.1279
   *DHHS PAN ANT GUID, GUID ANT AG HIV INF
   Effros RB, 2008, CLIN INFECT DIS, V47, P542, DOI 10.1086/590150
   Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146
   Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723, DOI 10.1056/NEJMoa062744
   Gandhi RT, 2006, JAIDS-J ACQ IMM DEF, V42, P426, DOI 10.1097/01.qai.0000226789.51992.3f
   Girardi E, 2007, JAIDS-J ACQ IMM DEF, V46, pS3, DOI 10.1097/01.qai.0000286597.57066.2b
   Goetz MB, 2001, AIDS, V15, P1576, DOI 10.1097/00002030-200108170-00017
   Grulich AE, 2007, LANCET, V370, P59, DOI 10.1016/S0140-6736(07)61050-2
   GRUND B, 2008, 48 ANN ICAAC IDSA 46
   Haynes BF, 2000, ANNU REV IMMUNOL, V18, P529, DOI 10.1146/annurev.immunol.18.1.529
   Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7
   JANSSEN RS, 1992, NEUROLOGY, V42, P1472, DOI 10.1212/WNL.42.8.1472
   Kaufmann GR, 2005, CLIN INFECT DIS, V41, P361, DOI 10.1086/431484
   Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252
   LEDERGERBER B, 2008, 15 C RETR OPP INF
   Linley L, 2007, NAT HIV PREV C ATL G
   Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343
   LUNDGREN J, 2009, 16 C RETR OPP INF MO
   MARYKRAUSE M, 2009, 16 C RETR OPP INF MO
   McDavid K, 2006, JAIDS-J ACQ IMM DEF, V42, P101, DOI 10.1097/01.qai.0000199353.11479.08
   MOCROFT A, 2009, 16 C RETR OPP INF MO
   Mocroft A, 2009, AIDS, V23, P71, DOI 10.1097/QAD.0b013e32831cc129
   Monforte AD, 2008, AIDS, V22, P2143, DOI 10.1097/QAD.0b013e3283112b77
   MOORE RD, 2008, 48 ANN ICCAC IDSA 46
   Mussini C, 2008, AIDS, V22, P2461, DOI 10.1097/QAD.0b013e328314b5f1
   Grijalva C. G., 2009, Morbidity and Mortality Weekly Report, V58, P1
   ORTIZ R, EFFICACY SAFETY ONCE
   Owens DK, 2007, AM J PUBLIC HEALTH, V97, P2173, DOI 10.2105/AJPH.2007.110700
   Paul SM, 2007, J AM GERIATR SOC, V55, P1393, DOI 10.1111/j.1532-5415.2007.01295.x
   Perez JL, 2003, CLIN INFECT DIS, V36, P212, DOI 10.1086/345669
   Phillips AN, 2008, AIDS, V22, P2409, DOI 10.1097/QAD.0b013e3283174636
   Qaseem A, 2009, ANN INTERN MED, V150, P125, DOI 10.7326/0003-4819-150-2-200901200-00300
   Sabin CA, 2009, HIV MED, V10, P35, DOI 10.1111/j.1468-1293.2008.00654.x
   Sabin CA, 2008, AIDS, V22, P1463
   Sabin CA, 2008, LANCET, V371, P1417, DOI 10.1016/S0140-6736(08)60423-7
   Sanders GD, 2008, ANN INTERN MED, V148, P889, DOI 10.7326/0003-4819-148-12-200806170-00002
   Silverberg MJ, 2007, ARCH INTERN MED, V167, P684, DOI 10.1001/archinte.167.7.684
   Skiest DJ, 1997, ARCH FAM MED, V6, P289, DOI 10.1001/archfami.6.3.289
   SMITH CD, 16 C RETR OPP INF MO
   Sureka A, 2004, AIDS PATIENT CARE ST, V18, P99, DOI 10.1089/108729104322802524
   Touloumi G, 2003, JAIDS-J ACQ IMM DEF, V34, P76, DOI 10.1097/00126334-200309010-00012
   Triant VA, 2008, J CLIN ENDOCR METAB, V93, P3499, DOI 10.1210/jc.2008-0828
   Valcour V, 2004, NEUROLOGY, V63, P822, DOI 10.1212/01.WNL.0000134665.58343.8D
   Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632
   Winston J, 2008, CLIN INFECT DIS, V47, P1449, DOI 10.1086/593099
   Zingmond DS, 2003, JAIDS-J ACQ IMM DEF, V33, pS84, DOI 10.1097/00126334-200306012-00005
NR 69
TC 133
Z9 148
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0002-8614
EI 1532-5415
J9 J AM GERIATR SOC
JI J. Am. Geriatr. Soc.
PD NOV
PY 2009
VL 57
IS 11
BP 2129
EP 2138
DI 10.1111/j.1532-5415.2009.02494.x
PG 10
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA 512KU
UT WOS:000271248500022
PM 19793157
OA Bronze
DA 2024-02-19
ER

PT J
AU Chung, HY
   Yu, BP
AF Chung, HY
   Yu, BP
TI Significance of hepatic xanthine oxidase and uric acid in aged and
   dietary restricted rats
SO JOURNAL OF THE AMERICAN AGING ASSOCIATION
LA English
DT Article
DE xanthine oxidase; xanthine dehydrogenase; oxidative stress; aging; uric
   acid
ID LIPID-PEROXIDATION; INTESTINAL ISCHEMIA; REPERFUSION INJURY; OXIDATIVE
   STRESS; SUPEROXIDE; RADICALS; LIVER; DEHYDROGENASE; INCREASE; DEFENSE
AB Xanthine oxidase (XOD), one of the major intracellular sources of superoxide production, is well characterized as a causative factor in ischemia/reperfusion related damage. In the present study, we investigated age-effect on the status of XOD, an enzyme interconvertible with xanthine dehydrogenase (XDH) under oxidative stress. We also examined the modulation of the enzyme using the antioxidative action of dietary restriction (DR). We obtained evidence showing XOD activity to be significantly increased by DR, peaking at 24 months, although no progressive, age-related changes were noticed. On the other hand, while XDH activity decreased in ad libitum fed rats with age, DR maintained higher activity levels at 18 and 24 months of age. During aging, the conversion of XDH to XOD was slightly increased, as indicated by the XOD/XDH ratio. One novel finding of the present study is DR's ability to elevate the uric acid level, which likely augments the anti-oxidative defense system, thereby buffering against oxidatively stressed conditions during aging. Based on what is known about the antioxidative abilities of DR and uric acid, we propose that the high uric acid levels we observed in DR rats may well serve as part of a defense strategy to protect redox balance.
C1 Pusan Natl Univ, Dept Mol Biol, Pusan 609735, South Korea.
   Pusan Natl Univ, Dept Pharm, Vasc Aging Res Grp, Pusan 609735, South Korea.
   Univ Texas, Hlth Sci Ctr, Dept Physiol, San Antonio, TX 78284 USA.
C3 Pusan National University; Pusan National University; University of
   Texas System; University of Texas Health Science Center at San Antonio
RP Yu, BP (corresponding author), Pusan Natl Univ, Dept Mol Biol, Pusan 609735, South Korea.
EM yubp@hyowon.pusan.ac.kr
CR AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858
   BAILEY SM, 1990, GASTROENTEROLOGY, V98, P203
   BECKER BF, 1993, FREE RADICAL BIO MED, V14, P615, DOI 10.1016/0891-5849(93)90143-I
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   CATY MG, 1990, J PEDIATR SURG, V25, P218, DOI 10.1016/0022-3468(90)90406-Y
   CHEN JJ, 1995, FREE RADICAL BIO MED, V19, P583, DOI 10.1016/0891-5849(95)00066-7
   Chung H Y, 1999, J Nutr Health Aging, V3, P19
   Chung HY, 1997, AGE, V20, P127, DOI 10.1007/s11357-997-0012-2
   Cutler R., 1984, Free Radicals in Biology, V6, P371
   DAVIES KJA, 1986, BIOCHEM J, V235, P747, DOI 10.1042/bj2350747
   DORION D, 1993, J APPL PHYSIOL, V75, P246, DOI 10.1152/jappl.1993.75.1.246
   ECKL P, 1989, ADV BIOSCI, V76, P141
   ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6
   GRANGER DN, 1981, GASTROENTEROLOGY, V81, P22
   HOWELL RR, 1960, J BIOL CHEM, V235, P3544
   JARASCH ED, 1986, ACTA PHYSIOL SCAND, V126, P39
   KATO S, 1990, GASTROENTEROLOGY, V98, P203, DOI 10.1016/0016-5085(90)91311-S
   KAWACHI M, 1990, CLIN CHIM ACTA, V188, P137, DOI 10.1016/0009-8981(90)90158-O
   Kelley WN, 1989, TXB RHEUMATOLOGY, P1395
   KELLOGG EW, 1977, J BIOL CHEM, V252, P6721
   KOOIJ A, 1992, VIRCHOWS ARCH B, V62, P143, DOI 10.1007/BF02899676
   KOYAMA I, 1985, TRANSPLANTATION, V40, P590, DOI 10.1097/00007890-198512000-00003
   KRENITSKY TA, 1986, ARCH BIOCHEM BIOPHYS, V247, P108, DOI 10.1016/0003-9861(86)90539-4
   Kristal BS, 1996, J BIOL CHEM, V271, P6033, DOI 10.1074/jbc.271.11.6033
   MCCORD JM, 1982, CAN J PHYSIOL PHARM, V60, P1346, DOI 10.1139/y82-201
   MCCORD JM, 1968, J BIOL CHEM, V243, P5753
   ODA T, 1989, SCIENCE, V244, P974, DOI 10.1126/science.2543070
   PARKS DA, 1986, ACTA PHYSIOL SCAND, V126, P87
   RAO PS, 1983, ADV EXP MED BIOL, V161, P347
   RZUCIDLO SJ, 1990, J AGR FOOD CHEM, V38, P1227, DOI 10.1021/jf00095a015
   SAITO T, 1987, Yokohama Medical Bulletin, V38, P151
   SCHEIBE P, 1974, DETERMINATION URIC A, P1951
   TAN S, 1993, PEDIATR RES, V34, P303, DOI 10.1203/00006450-199309000-00013
   TOPHAM RW, 1982, BIOCHEM BIOPH RES CO, V109, P1240, DOI 10.1016/0006-291X(82)91910-6
   TUBARO E, 1980, BIOCHEM PHARMACOL, V29, P1945, DOI 10.1016/0006-2952(80)90108-2
   TUBARO E, 1980, BIOCHEM PHARMACOL, V29, P1939, DOI 10.1016/0006-2952(80)90107-0
   YAMAMOTO M, 1983, STROKE, V14, P977, DOI 10.1161/01.STR.14.6.977
   Yu BP, 1996, FREE RADICAL BIO MED, V21, P651, DOI 10.1016/0891-5849(96)00162-1
   YU BP, 1985, J GERONTOL, V40, P657, DOI 10.1093/geronj/40.6.657
NR 39
TC 6
Z9 6
U1 0
U2 3
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0161-9152
J9 J AM AGING ASSOC
JI J. Am. Aging Assoc.
PD JUL
PY 2000
VL 23
IS 3
BP 123
EP 128
PG 6
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 370AH
UT WOS:000165099600001
PM 23604851
OA Green Published
DA 2024-02-19
ER

PT J
AU Coelho, AMM
   Machado, MCC
   Sampietre, SN
   da Silva, FP
   Cunha, JEM
   D'Albuquerque, LAC
AF Mendonca Coelho, Ana Maria
   Cesar Machado, Marcel Cerqueira
   Sampietre, Sandra Nassa
   da Silva, Fabiano Pinheiro
   Monteiro Cunha, Jose Eduardo
   Carneiro D'Albuquerque, Luiz Augusto
TI Local and systemic effects of aging on acute pancreatitis
SO PANCREATOLOGY
LA English
DT Article
DE Acute pancreatitis; Aging; Cytokines; Bacterial translocation; Liver
   mitochondrial function
ID ACID-BINDING PROTEIN; INTESTINAL BARRIER DYSFUNCTION; AGE-DEPENDENT
   VULNERABILITY; PERMEABILITY; INFLAMMATION; ENDOTOXEMIA; INDUCTION;
   MORTALITY; SEVERITY; ASSAY
AB Background: /Objectives: Evaluation of the local and systemic effects of aging on the severity of acute pancreatitis (AP) in an experimental rat model in elderly animals.
   Methods: AP was induced in Wistar rats by intraductal 2.5% taurocholate injection and divided into two groups: Young (3 month old) and Aged (18 month old). Two and 24 h after AP induction blood samples were collected for determinations of amylase, AST, ALT, urea, creatinine, glucose, and of plasma I-FABP. TNF-alpha and IL-6 levels were determined in serum and ascitic fluid. Liver mitochondrial function and malondialdehyde (MDA) contents, pancreas histological analysis, and pulmonar myeloperoxidade (MPO) activity were performed. Bacterial translocation was evaluated by bacterial cultures of pancreas.
   Results: A significant increase in serum amylase, AST, ALT, urea, creatinine, glucose, I-FABP, and IL-6 levels, and a reduction in serum and ascitic fluid TNF-alpha levels were observed in the aged group compared to the young group. Liver mitochondrial dysfunction, MDA contents, and pulmonary MPO activity were increased in the Aged AP group compared to the Young AP group. Positive bacterial cultures obtained from pancreas tissue in aged group were significantly increased compared to the young group. Acinar necrosis was also increased in aged AP group when compared to young AP group.
   Conclusion: Aging worsens the course of acute pancreatitis evidenced by increased local and systemic lesions and increased bacterial translocation. (C) 2019 IAP and EPC. Published by Elsevier B.V. All rights reserved.
C1 [Mendonca Coelho, Ana Maria; Cesar Machado, Marcel Cerqueira; Sampietre, Sandra Nassa; Monteiro Cunha, Jose Eduardo; Carneiro D'Albuquerque, Luiz Augusto] Univ Sao Paulo, Med Sch, Dept Gastroenterol LIM 37, Sao Paulo, Brazil.
   [Cesar Machado, Marcel Cerqueira; da Silva, Fabiano Pinheiro] Univ Sao Paulo, Med Sch, Dept Clin Emergency, Sao Paulo, Brazil.
C3 Universidade de Sao Paulo; Universidade de Sao Paulo
RP Machado, MCC (corresponding author), Univ Sao Paulo, Sch Med, R Brazil Peixoto Gomide,515 13 Andar, BR-05403000 Sao Paulo, Brazil.
EM mccm37@uol.com.br
RI da Silva, Fabiano Pinheiro/F-3464-2011; Coelho, Ana M/E-5605-2013;
   D'Albuquerque, Luiz Augusto Carneiro/I-4011-2012; machado,
   marcel/E-2129-2012
OI da Silva, Fabiano Pinheiro/0000-0003-2673-2202; Coelho, Ana
   M/0000-0002-0606-6532; D'Albuquerque, Luiz Augusto
   Carneiro/0000-0001-7607-7168; machado, marcel/0000-0002-0729-1635;
   Cunha, Jose/0000-0002-9847-302X
CR Aoun E, 2009, PANCREATOLOGY, V9, P777, DOI 10.1159/000214191
   Barbeiro DF, 2016, PANCREATOLOGY, V16, P52, DOI 10.1016/j.pan.2015.10.012
   Besselink MG, 2009, ANN SURG, V250, P712, DOI 10.1097/SLA.0b013e3181bce5bd
   Bhatia M, 2005, AM J PHYSIOL-GASTR L, V288, pG1259, DOI 10.1152/ajpgi.00435.2004
   Machado MCC, 2012, INT J INFLAMM, V2012, DOI 10.1155/2012/270319
   CHANCE B, 1955, NATURE, V175, P1120, DOI 10.1038/1751120a0
   Chen YM, 2003, WORLD J GASTROENTERO, V9, P795, DOI 10.3748/wjg.v9.i4.795
   Coelho AM, 1977, BRAZ J MED BIOL RES, V30, P947
   Deng WH, 2016, MOL MED REP, V14, P3525, DOI 10.3892/mmr.2016.5678
   Estabrook R.W., 1967, METHOD ENZYMOL, V10, P41, DOI DOI 10.1016/0076-6879(67)10010-4
   Fagenholz PJ, 2007, PANCREAS, V35, P302, DOI 10.1097/MPA.0b013e3180cac24b
   FAN ST, 1988, BRIT J SURG, V75, P463, DOI 10.1002/bjs.1800750520
   Frey C, 2007, J GASTROINTEST SURG, V11, P733, DOI 10.1007/s11605-007-0164-5
   Fu S, 2012, WORLD J GASTROENTERO, V18, P3379, DOI 10.3748/wjg.v18.i26.3379
   Gardner TB, 2008, PANCREATOLOGY, V8, P265, DOI 10.1159/000134274
   GOLDBLUM SE, 1985, J APPL PHYSIOL, V59, P1978, DOI 10.1152/jappl.1985.59.6.1978
   JAMIESON AD, 1969, J DENT RES, V48, P483, DOI 10.1177/00220345690480032701
   Kanda T, 1996, GASTROENTEROLOGY, V110, P339, DOI 10.1053/gast.1996.v110.pm8566578
   LANKISCH PG, 1974, SCAND J GASTROENTERO, V9, P725
   Lieberman JM, 1997, SURGERY, V121, P335, DOI 10.1016/S0039-6060(97)90363-9
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Mather M, 2000, BIOCHEM BIOPH RES CO, V273, P603, DOI 10.1006/bbrc.2000.2994
   Matheus AS, 2009, PANCREATOLOGY, V9, P687, DOI 10.1159/000199438
   Matull WR, 2006, J CLIN PATHOL, V59, P340, DOI 10.1136/jcp.2002.002923
   Miki C, 2008, SURG TODAY, V38, P873, DOI 10.1007/s00595-008-3766-y
   MIYASAKA K, 1992, ARCH GERONTOL GERIAT, V14, P167, DOI 10.1016/0167-4943(92)90051-5
   OCKNER RK, 1974, J CLIN INVEST, V54, P326, DOI 10.1172/JCI107768
   Okamura D, 2012, AGING CELL, V11, P760, DOI 10.1111/j.1474-9726.2012.00841.x
   Pan LY, 2010, PANCREAS, V39, P633, DOI 10.1097/MPA.0b013e3181c79654
   Papa S, 1997, MOL CELL BIOCHEM, V174, P305, DOI 10.1023/A:1006873518427
   Papachristou GI, 2008, WORLD J GASTROENTERO, V14, P6273, DOI 10.3748/wjg.14.6273
   Saito H, 2001, J BIOL CHEM, V276, P29307, DOI 10.1074/jbc.M103740200
   Saito H, 2003, MECH AGEING DEV, V124, P1047, DOI 10.1016/j.mad.2003.08.002
   Scarpace PJ, 2016, J GERONTOL A-BIOL, V71, P891, DOI 10.1093/gerona/glu230
   SCHMIDT J, 1992, ANN SURG, V215, P44, DOI 10.1097/00000658-199201000-00007
   SNOOK JT, 1975, AM J PHYSIOL, V228, P262, DOI 10.1152/ajplegacy.1975.228.1.262
   Song AM, 2002, AM J PHYSIOL-GASTR L, V283, pG1166, DOI 10.1152/ajpgi.00370.2001
   Soriano FG, 2002, SHOCK, V17, P286, DOI 10.1097/00024382-200204000-00008
   Starr ME, 2010, BLOOD, V115, P4886, DOI 10.1182/blood-2009-10-246678
   Starr ME, 2009, J GERONTOL A-BIOL, V64, P723, DOI 10.1093/gerona/glp046
   Storck G, 1971, Acta Chir Scand Suppl, V417, P1
   WALLACE DC, 1995, BBA-MOL BASIS DIS, V1271, P141, DOI 10.1016/0925-4439(95)00021-U
   WARREN JS, 1990, FREE RADICAL BIO MED, V8, P163, DOI 10.1016/0891-5849(90)90089-2
   Yan LJ, 1998, P NATL ACAD SCI USA, V95, P12896, DOI 10.1073/pnas.95.22.12896
NR 44
TC 4
Z9 5
U1 0
U2 7
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1424-3903
EI 1424-3911
J9 PANCREATOLOGY
JI Pancreatology
PD JUL
PY 2019
VL 19
IS 5
BP 638
EP 645
DI 10.1016/j.pan.2019.06.005
PG 8
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA IN5BG
UT WOS:000478690300003
PM 31204259
DA 2024-02-19
ER

PT J
AU Deevska, G
   Dotson, PP
   Mitov, M
   Butterfield, DA
   Nikolova-Karakashian, M
AF Deevska, Gergana
   Dotson, Patrick P., II
   Mitov, Mihail
   Butterfield, D. Allan
   Nikolova-Karakashian, Mariana
TI Onset of Senescence and Steatosis in Hepatocytes as a Consequence of a
   Shift in the Diacylglycerol/Ceramide Balance at the Plasma Membrane
SO CELLS
LA English
DT Article
DE sphingomyelin synthase; diacylglycerol; ceramide; mitochondria; lipid
   droplets; senescence; protein kinase C; AMP kinase
ID SPHINGOMYELIN SYNTHASE 2; HEPATITIS-C VIRUS; REPLICATIVE SENESCENCE;
   QUANTITATIVE-ANALYSIS; CELLULAR SENESCENCE; OXIDATIVE STRESS; LIVER;
   CERAMIDE; AGE; SPHINGOLIPIDS
AB Ceramide and diacylglycerol (DAG) are bioactive lipids and mediate many cellular signaling pathways. Sphingomyelin synthase (SMS) is the single metabolic link between the two, while SMS2 is the only SMS form located at the plasma membrane. SMS2 functions were investigated in HepG2 cell lines stably expressing SMS2. SMS2 overexpression did not alter sphingomyelin (SM), phosphatidylcholine (PC), or ceramide levels. DAG content increased by approx. 40% and led to downregulation of DAG-dependent protein kinase C (PKC). SMS2 overexpression also induced senescence, characterized by positivity for beta-galactosidase activity and heterochromatin foci. HepG2-SMS2 cells exhibited protruded mitochondria and suppressed mitochondrial respiration rates. ATP production and the abundance of Complex V were substantially lower in HepG2-SMS2 cells as compared to controls. SMS2 overexpression was associated with inflammasome activation based on increases in IL-1 beta and nlpr3 mRNA levels. HepG2-SMS2 cells exhibited lipid droplet accumulation, constitutive activation of AMPK based on elevated (172)Thr phosphorylation, increased AMPK abundance, and insensitivity to insulin suppression of AMPK. Thus, our results show that SMS2 regulates DAG homeostasis and signaling in hepatocytes and also provide proof of principle for the concept that offset in bioactive lipids' production at the plasma membrane can drive the senescence program in association with steatosis and, seemingly, by cell-autonomous mechanisms.
C1 [Deevska, Gergana; Dotson, Patrick P., II; Nikolova-Karakashian, Mariana] Univ Kentucky, Coll Med, Dept Physiol, Lexington, KY 40536 USA.
   [Mitov, Mihail; Butterfield, D. Allan] Univ Kentucky, Redox Metab Shared Resource Facil, Markey Canc Ctr, Lexington, KY 40536 USA.
   [Butterfield, D. Allan] Univ Kentucky, Dept Chem, Lexington, KY 40506 USA.
C3 University of Kentucky; University of Kentucky; University of Kentucky
RP Nikolova-Karakashian, M (corresponding author), Univ Kentucky, Coll Med, Dept Physiol, Lexington, KY 40536 USA.
EM gdeevska@idahocom.org; ppdots4@yahoo.com; mmitov@idahocom.org;
   david.butterfield@uky.edu; mariana.karakashian@uky.edu
FU National Institute of Aging [R01AG19223]; AHA postdoctoral award; Redox
   Metabolism Shared Resource Facility of the University of Kentucky Markey
   Cancer Center [P30CA177558]
FX This work was supported by the National Institute of Aging R01AG19223
   (to M.N.K.), by an AHA postdoctoral award, and by the Redox Metabolism
   Shared Resource Facility of the University of Kentucky Markey Cancer
   Center (P30CA177558).
CR Aikata H, 2000, EXP CELL RES, V256, P578, DOI 10.1006/excr.2000.4862
   Aravinthan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072904
   Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031
   Bartke N, 2009, J LIPID RES, V50, pS91, DOI 10.1194/jlr.R800080-JLR200
   Bourbon NA, 2002, J BIOL CHEM, V277, P3286, DOI 10.1074/jbc.M110541200
   Campisi J, 2011, SEMIN CANCER BIOL, V21, P354, DOI 10.1016/j.semcancer.2011.09.001
   Chapman J, 2019, FEBS LETT, V593, P1566, DOI 10.1002/1873-3468.13498
   Csak T, 2011, HEPATOLOGY, V54, P133, DOI 10.1002/hep.24341
   De Clercq N., 2008, LIPID TECHNOL, V20, P232, DOI DOI 10.1002/LITE.200800060
   Deevska GM, 2017, J BIOL CHEM, V292, P5110, DOI 10.1074/jbc.M116.751602
   Deevska GM, 2009, J BIOL CHEM, V284, P8359, DOI 10.1074/jbc.M807800200
   DOBROWSKY RT, 1993, J BIOL CHEM, V268, P15523
   Farinati F, 2007, J VIRAL HEPATITIS, V14, P821, DOI 10.1111/1365-2893.2007.00878.x
   Frenzel M, 2010, EXP GERONTOL, V45, P563, DOI 10.1016/j.exger.2010.02.003
   Fucho R, 2014, J HEPATOL, V61, P1126, DOI 10.1016/j.jhep.2014.06.009
   Gagliano N, 2007, DIGEST DIS, V25, P118, DOI 10.1159/000099475
   Greenberg ME, 2008, J BIOL CHEM, V283, P2385, DOI 10.1074/jbc.M707348200
   Herranz N, 2018, J CLIN INVEST, V128, P1238, DOI 10.1172/JCI95148
   Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034
   Jadhav KS, 2013, MECH AGEING DEV, V134, P548, DOI 10.1016/j.mad.2013.11.002
   Janikiewicz J, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0105-5
   KAHOVCOVA J, 1969, J CHROMATOGR, V40, P90, DOI 10.1016/S0021-9673(01)96622-1
   Kim WJ, 2008, BLOOD, V111, P4716, DOI 10.1182/blood-2007-10-113068
   Kim YJ, 2018, ISCIENCE, V8, P250, DOI 10.1016/j.isci.2018.10.001
   Kolesnick R, 2003, ONCOGENE, V22, P5897, DOI 10.1038/sj.onc.1206702
   Kuypers FA, 2004, CELL MOL BIOL, V50, P147
   Lechel A, 2005, EMBO REP, V6, P275, DOI 10.1038/sj.embor.7400352
   Lee JY, 2000, EXP CELL RES, V261, P303, DOI 10.1006/excr.2000.5028
   Li Y, 2013, ARTERIOSCL THROM VAS, V33, P1513, DOI 10.1161/ATVBAHA.113.301498
   Mai S, 2010, J CELL SCI, V123, P917, DOI 10.1242/jcs.059246
   Martín-Maestro P, 2019, MOL NEUROBIOL, V56, P8220, DOI 10.1007/s12035-019-01665-y
   Mitsutake S, 2013, VITAM HORM, V91, P271, DOI 10.1016/B978-0-12-407766-9.00012-2
   Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009
   Nikolova-Karakashian M, 2021, METHODS MOL BIOL, V2187, P113, DOI 10.1007/978-1-0716-0814-2_7
   Nikolova-Karakashian M, 2018, ADV CANCER RES, V140, P155, DOI 10.1016/bs.acr.2018.05.002
   Noble JM, 1999, J GERONTOL A-BIOL, V54, pM601, DOI 10.1093/gerona/54.12.M601
   Nojima H, 2015, BIOL CHEM, V396, P633, DOI 10.1515/hsz-2014-0296
   Obeng EO, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21072581
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Ohnishi T, 2017, FASEB J, V31, P3816, DOI 10.1096/fj.201601225RR
   Pagadala M, 2012, TRENDS ENDOCRIN MET, V23, P365, DOI 10.1016/j.tem.2012.04.005
   Paradis V, 2001, HUM PATHOL, V32, P327, DOI 10.1053/hupa.2001.22747
   PETKOVA DH, 1986, EXP GERONTOL, V21, P187, DOI 10.1016/0531-5565(86)90072-0
   Pettus BJ, 2002, BBA-MOL CELL BIOL L, V1585, P114, DOI 10.1016/S1388-1981(02)00331-1
   Pezze PD, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003728
   Qi X, 2011, MOL BIOL CELL, V22, P256, DOI 10.1091/mbc.E10-06-0551
   Reuben A, 2008, CURR OPIN GASTROEN, V24, P328, DOI 10.1097/MOG.0b013e3282fbceca
   Revill K, 2013, GASTROENTEROLOGY, V145, P1424, DOI 10.1053/j.gastro.2013.08.055
   Rutkute K, 2007, J LIPID RES, V48, P2443, DOI 10.1194/jlr.M700227-JLR200
   Rutkute K, 2007, HEPATOLOGY, V46, P1166, DOI 10.1002/HEP.21777
   Shaner RL, 2009, J LIPID RES, V50, P1692, DOI 10.1194/jlr.D800051-JLR200
   Shen SD, 2011, J IMMUNOL, V187, P2122, DOI 10.4049/jimmunol.1100495
   SHIMODA R, 1994, CANCER RES, V54, P3171
   Simoes ICM, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9100995
   SPERRY WM, 1950, J BIOL CHEM, V187, P97
   Summers SA, 2010, CURR OPIN LIPIDOL, V21, P128, DOI 10.1097/MOL.0b013e3283373b66
   Tani M, 2009, BIOCHEM BIOPH RES CO, V381, P328, DOI 10.1016/j.bbrc.2009.02.063
   Taniguchi M, 2020, FASEB J, V34, P3838, DOI 10.1096/fj.201901783RR
   Trak-Smayra V, 2004, TRANSPLANTATION, V77, P1755, DOI 10.1097/01.TP.0000131172.75294.A9
   Tseng HC, 2019, J LIPID RES, V60, P1573, DOI 10.1194/jlr.RA119000141
   Vance JE, 2020, BIOL DIRECT, V15, DOI 10.1186/s13062-020-00279-y
   Venable ME, 1995, J BIOL CHEM, V270, P30701, DOI 10.1074/jbc.270.51.30701
   Wang CJ, 2014, DIABETES, V63, P947, DOI 10.2337/db13-1096
   Weber G, 2005, ADV ENZYME REGUL, V45, P37, DOI 10.1016/j.advenzreg.2005.02.008
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   WILLIAMS RD, 1984, ARCH BIOCHEM BIOPHYS, V228, P282, DOI 10.1016/0003-9861(84)90069-9
   Wooten-Blanks LG, 2007, FASEB J, V21, P3386, DOI 10.1096/fj.07-8621com
   Xue J, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.012885
   Yang SQ, 2004, HEPATOLOGY, V39, P403, DOI 10.1002/hep.20082
   Zhang RG, 2007, MOL CELL BIOL, V27, P2343, DOI 10.1128/MCB.02019-06
   Zheng KH, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1303-0
   Zheng W, 2006, BBA-BIOMEMBRANES, V1758, P1864, DOI 10.1016/j.bbamem.2006.08.009
NR 72
TC 2
Z9 2
U1 0
U2 6
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2073-4409
J9 CELLS-BASEL
JI Cells
PD JUN
PY 2021
VL 10
IS 6
AR 1278
DI 10.3390/cells10061278
PG 17
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA SX6FG
UT WOS:000665297800001
PM 34064003
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Hui, L
AF Hui, Liu
TI Quantifying the effects of aging and urbanization on major
   gastrointestinal diseases to guide preventative strategies
SO BMC GASTROENTEROLOGY
LA English
DT Article
DE Gastrointestinal disease; Cancer; Aging; Urbanization; Categorization;
   Epidemiology
ID WAIST CIRCUMFERENCE; CHINA; TRANSITION; PROFILE; REGION; HEALTH; DEATH
AB Background: This study aimed to quantify the effects of aging and urbanization on major gastrointestinal disease (liver cirrhosis, hepatitis B, diarrhea, liver cancer, stomach cancer, pancreas cancer, hepatitis C, esophagus cancer, colon/rectum cancer, gastrointestinal ulcers, diabetes, and appendicitis).
   Methods: We accessed 2004 and 2011 mortality statistics from the most developed cities and least developed rural areas in China using a retrospective design. The relative risk of death associated with urbanization and age was quantified using Generalized linear model (the exp.(B) from model is interpreted as the risk ratio; the greater the B, the greater the impact of urbanized factors or aging factor or effect of aging factor with urbanization). The interaction between region (cities and rural areas) and age was considered as indicator to assess role of age in mortality with urbanization.
   Results: Greater risk of disease with urbanization were, in ascending order, for diabetes, colon/rectum cancer, hepatitis C and pancreas cancer. Stronger the effect of aging with urbanization were, in ascending order, for stomach cancer, ulcer, liver cancer, colon/rectum cancer, pancreas cancer, diabetes, hepatitis C, appendicitis and diarrhea. When the effects of aging and urbanization on diseases were taken together as the dividing value, we were able to further divide the 12 gastrointestinal diseases into three groups to guide the development of medical strategies.
   Conclusions: It was suggested that mortality rate for most gastrointestinal diseases was sensitive to urbanization and control of external risk factors could lead to the conversion of most gastrointestinal disease.
C1 [Hui, Liu] Dalian Med Univ, Dept Clin Immunol, Dalian 116044, Peoples R China.
C3 Dalian Medical University
RP Hui, L (corresponding author), Dalian Med Univ, Dept Clin Immunol, Dalian 116044, Peoples R China.
EM liuhui60@sina.com
CR Amorim CA, 2014, WORLD J GASTROENTERO, V20, P5036, DOI 10.3748/wjg.v20.i17.5036
   Chan FY, 2012, INT J PUBLIC HEALTH, V57, P849, DOI 10.1007/s00038-012-0400-y
   Chen JH, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/348167
   Chinese Center for Disease Control and Prevention, 2013, NAT DIS MORT SURV SY, P171
   Chinese Center for Disease Control and Prevention, 2009, NAT DIS MORT SURV SY, P102
   Doherty ML, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1069
   Du SF, 2014, OBES REV, V15, P8, DOI 10.1111/obr.12122
   Gong P, 2012, LANCET, V379, P843, DOI 10.1016/S0140-6736(11)61878-3
   Hui L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08539-0
   Hui L, 2015, ARCH GERONTOL GERIAT, V60, P178, DOI 10.1016/j.archger.2014.11.002
   Hui L, 2015, EPIDEMIOLOGY, V26, pE9, DOI 10.1097/EDE.0000000000000207
   Idrovo AJ, 2011, CAD SAUDE PUBLICA, V27, P1175, DOI 10.1590/S0102-311X2011000600014
   Liang Y, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-71
   Ma L, 2014, EUR J PEDIATR, V173, P787, DOI 10.1007/s00431-013-2250-x
   Ng SW, 2014, OBES REV, V15, P27, DOI 10.1111/obr.12127
   Sherwin R, 2012, J CLIN ENDOCR METAB, V97, P4293, DOI 10.1210/jc.2012-3487
   Wong Sunny H, 2013, Curr Gastroenterol Rep, V15, P313, DOI 10.1007/s11894-013-0313-9
   World Health Organization, 2018, International Statistical Classification of Diseases and Related Health Problems, 10th Revision
   Wu N, 2014, J EPIDEMIOL, V24, P84, DOI 10.2188/jea.JE20120230
   Xin G, 2014, EXP GERONTOL, V60, P83, DOI 10.1016/j.exger.2014.10.005
   Xin G, 2014, DIABETES RES CLIN PR, V106, P95, DOI 10.1016/j.diabres.2014.07.024
   Zeng ZR, 2013, J GASTROEN HEPATOL, V28, P1148, DOI 10.1111/jgh.12164
   Zhang YP, 2013, ENVIRON HEALTH PERSP, V121, P751, DOI 10.1289/ehp.1205983
NR 23
TC 13
Z9 14
U1 0
U2 9
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-230X
J9 BMC GASTROENTEROL
JI BMC Gastroenterol.
PD OCT 3
PY 2018
VL 18
AR 145
DI 10.1186/s12876-018-0872-1
PG 7
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA GV6QC
UT WOS:000446237400001
PM 30285652
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Motevalian, M
   Maroof, NT
   Nematollahi, MH
   Khajehasani, F
   Fatemi, I
AF Motevalian, Manijeh
   Maroof, Neda Tekyeh
   Nematollahi, Mohammad Hadi
   Khajehasani, Fatemeh
   Fatemi, Iman
TI Atorvastatin modulates the expression of aging-related genes in the
   brain of aging induced by D-galactose in mice
SO IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES
LA English
DT Article
DE Aging; Animal model; Apoptosis; Gene expression; Inflammation
ID CONTRAST-INDUCED NEPHROPATHY; OXIDATIVE STRESS; MITOCHONDRIAL
   DYSFUNCTION; COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; STATINS; MODEL;
   NEUROINFLAMMATION; INFLAMMATION; ACTIVATION
AB Objective(s): Atorvastatin (AT), a competitive inhibitor of 3-hydroxymethyl-3-glutaryl-coenzyme-A reductase, is a cholesterol-lowering drug. AT has been shown to have neuroprotective, antioxidant, and anti-inflammatory properties. Previously, we have reported that AT could attenuate the behavioral, renal, and hepatic manifestations of aging. To clarify further the mechanisms involved, the present study was designed to evaluate the effect of AT on the expression of some aging-related genes in the brain of aging mice induced by D-galactose (DG). Materials and Methods: For this purpose, AT (0.1 and 1 mg/kg/p.o.) was administrated daily in DGreceived (500 mg/kg/p.o.) mice model of aging for six weeks. At the end of the experiment, mice were decapitated to remove the brains. Then, the expression profiles of sirtuin 1 (Sirt1), P53, P21, Bcl-2, Bax, superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), interleukin 1 beta (IL1 beta), tumor necrosis factor-alpha (TNF alpha), inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX2), and brain-derived neurotrophic factor (BDNF) were assessed using the real-time PCR method. Results: The present study shows that DG decreases the expression of Sirt1, Bcl-2, CAT, GPx, and BDNF while increasing the expression of P53, P21, Bax, IL-1 beta, iNOS, COX-2, and TNF-alpha. According to the findings of the present study, AT (more potentially at the dose of 1 mg/kg) modulates the expression of these aging-related genes in the brain of aging mice. Conclusion: The results of the present study confirmed our previous reports on the anti-aging effects of AT at the gene level, the precise mechanisms and underlying pathways need further studies.
C1 [Motevalian, Manijeh; Maroof, Neda Tekyeh] Iran Univ Med Sci, Razi Drug Res Ctr, Tehran, Iran.
   [Motevalian, Manijeh] Iran Univ Med Sci, Sch Med, Dept Pharmacol, Tehran, Iran.
   [Nematollahi, Mohammad Hadi] Kerman Univ Med Sci, Dept Clin Biochem, Kerman, Iran.
   [Khajehasani, Fatemeh] Kerman Univ Med Sci, Afzalipour Fac Med, Dept Radiol, Kerman, Iran.
   [Fatemi, Iman] Kerman Univ Med Sci, Res Ctr Trop & Infect Dis, Kerman, Iran.
C3 Iran University of Medical Sciences; Iran University of Medical
   Sciences; Kerman University of Medical Sciences; Kerman University of
   Medical Sciences; Kerman University of Medical Sciences
RP Fatemi, I (corresponding author), Kerman Univ Med Sci, Res Ctr Trop & Infect Dis, Kerman, Iran.
EM i.fatemi@kmu.ac.ir
RI Fatemi Rabori, Seyediman/I-3054-2017
OI Fatemi Rabori, Seyediman/0000-0002-9666-9651
FU Research Deputy of Iran University of Medical Sciences [30197]
FX This work was supported by the Research Deputy of Iran University of
   Medical Sciences (code 30197) .
CR Ali T, 2015, J PINEAL RES, V58, P71, DOI 10.1111/jpi.12194
   Athyros VG, 2004, J CLIN PATHOL, V57, P728, DOI 10.1136/jcp.2003.012989
   Bedi O, 2016, N-S ARCH PHARMACOL, V389, P695, DOI 10.1007/s00210-016-1252-4
   Beeri MS, 2016, NEUROLOGY, V86, P702, DOI 10.1212/WNL.0000000000002389
   Buchman AS, 2016, NEUROLOGY, V86, P735, DOI 10.1212/WNL.0000000000002387
   Buyuklu M, 2014, EUR REV MED PHARMACO, V18, P461
   Çelik H, 2020, J PHARM PHARMACOL, V72, P424, DOI 10.1111/jphp.13208
   Chang CM, 2015, MOL CELL, V60, P930, DOI 10.1016/j.molcel.2015.10.037
   Chen JL, 2005, J CEREBR BLOOD F MET, V25, P281, DOI 10.1038/sj.jcbfm.9600034
   Cheng SM, 2020, AM J CHINESE MED, V48, P391, DOI 10.1142/S0192415X20500202
   Chu LW, 2015, ACS CHEM NEUROSCI, V6, P889, DOI 10.1021/acschemneuro.5b00032
   Deschênes M, 2017, AGING CELL, V16, P918, DOI 10.1111/acel.12646
   Fatemi I, 2018, FUND CLIN PHARMACOL, V32, P392, DOI 10.1111/fcp.12364
   Fatemi I, 2018, IRAN J BASIC MED SCI, V21, P19, DOI 10.22038/IJBMS.2017.24331.6071
   Gao J, 2016, METAB BRAIN DIS, V31, P771, DOI 10.1007/s11011-016-9813-2
   Ghanbari S, 2012, DARU, V20, DOI 10.1186/2008-2231-20-68
   Gu B, 2012, INT J BIOL SCI, V8, P672, DOI 10.7150/ijbs.4283
   Haendeler J, 2004, CIRCULATION, V110, P856, DOI 10.1161/01.CIR.0000138743.09012.93
   Hakimizadeh E, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10050649
   Hakimizadeh E, 2020, LIFE SCI, V258, DOI 10.1016/j.lfs.2020.118119
   Hakimizadeh E, 2020, IRAN J BASIC MED SCI, V23, P368, DOI 10.22038/IJBMS.2019.40344.9556
   He XY, 2017, MOL MED REP, V15, P1963, DOI 10.3892/mmr.2017.6251
   Ho SC, 2003, BIOGERONTOLOGY, V4, P15, DOI 10.1023/A:1022417102206
   Karimian A, 2016, DNA REPAIR, V42, P63, DOI 10.1016/j.dnarep.2016.04.008
   Kaviani E, 2017, BEHAV BRAIN RES, V334, P55, DOI 10.1016/j.bbr.2017.07.029
   Kennedy BK, 2014, TRANSL RES, V163, P456, DOI 10.1016/j.trsl.2013.11.007
   Khan SS, 2017, AGING CELL, V16, P624, DOI 10.1111/acel.12601
   Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758
   Li QS, 2018, BRAIN RES BULL, V137, P311, DOI 10.1016/j.brainresbull.2018.01.007
   Li W., 1994, CHIN J PHARMACOL TOX, V9, P93
   Liu H, 2020, FOOD FUNCT, V11, P4103, DOI [10.1039/d0fo00633e, 10.1039/D0FO00633E]
   Liu H, 2019, NEUROCHEM RES, V44, P1065, DOI 10.1007/s11064-019-02738-z
   Ludka FK, 2016, J PSYCHIATR RES, V82, P50, DOI 10.1016/j.jpsychires.2016.07.004
   McLean AJ, 2004, PHARMACOL REV, V56, P163, DOI 10.1124/pr.56.2.4
   Mehrzadi S, 2016, CAN J PHYSIOL PHARM, V94, P265, DOI 10.1139/cjpp-2015-0277
   Ng F, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00064
   Ong ALC, 2018, AGEING RES REV, V43, P64, DOI 10.1016/j.arr.2018.02.004
   Prajapati SK, 2017, NEUROTOX RES, V31, P478, DOI 10.1007/s12640-016-9693-6
   Rehman SU, 2017, MOL NEUROBIOL, V54, P255, DOI 10.1007/s12035-015-9604-5
   RENNO T, 1995, J IMMUNOL, V154, P944
   Rodier F, 2007, NUCLEIC ACIDS RES, V35, P7475, DOI 10.1093/nar/gkm744
   Salvemini D, 1996, BRIT J PHARMACOL, V118, P829, DOI 10.1111/j.1476-5381.1996.tb15475.x
   Sander M, 2015, AGE AGEING, V44, P185, DOI 10.1093/ageing/afu189
   Schachter M, 2005, FUND CLIN PHARMACOL, V19, P117, DOI 10.1111/j.1472-8206.2004.00299.x
   Shen QF, 2019, NEUROREPORT, V30, P1256, DOI 10.1097/WNR.0000000000001351
   Simani L, 2017, J MOL NEUROSCI, V61, P32, DOI 10.1007/s12031-016-0814-8
   Strong R, 1998, GERIATRICS, V53, pS9
   Taghipour Z, 2019, PHYSIOL PHARMACOL, V23, P36
   Taniguti EH, 2019, BRAIN RES BULL, V146, P279, DOI 10.1016/j.brainresbull.2019.01.018
   Vasconcelos-Moreno MP, 2017, INT J NEUROPSYCHOPH, V20, P445, DOI 10.1093/ijnp/pyx001
   Woo JY, 2014, ANAEROBE, V27, P22, DOI 10.1016/j.anaerobe.2014.03.003
   Xu F.B., 1985, P 2 NAT C AG RES HER
   Xu L, 2016, MOL NEUROBIOL, V53, P6709, DOI 10.1007/s12035-015-9593-4
   Xu Y, 2009, BIOGERONTOLOGY, V10, P153, DOI 10.1007/s10522-008-9158-2
   Zakeri M, 2019, CLIN EXP PHARMACOL P, V46, P1133, DOI 10.1111/1440-1681.13149
   Zhang JM, 2017, INT J NEUROSCI, V127, P92, DOI 10.3109/00207454.2016.1146882
NR 56
TC 3
Z9 3
U1 1
U2 6
PU MASHHAD UNIV MED SCIENCES
PI MASHHAD
PA VICE-CHANCELLOR FOR RES CTR OFF IJBMS, DANESHGAH ST, PO BOX 9138813944 -
   445, MASHHAD, 00000, IRAN
SN 2008-3866
EI 2008-3874
J9 IRAN J BASIC MED SCI
JI Iran. J. Basic Med. Sci.
PD OCT
PY 2021
VL 24
IS 10
BP 1388
EP 1394
DI 10.22038/IJBMS.2021.58502.12996
PG 7
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA WC0YN
UT WOS:000703990500009
PM 35096297
DA 2024-02-19
ER

PT J
AU Scrofano, MM
   Shang, F
   Nowell, TR
   Gong, X
   Smith, DE
   Kelliher, M
   Dunning, J
   Mura, CV
   Taylor, A
AF Scrofano, MM
   Shang, F
   Nowell, TR
   Gong, X
   Smith, DE
   Kelliher, M
   Dunning, J
   Mura, CV
   Taylor, A
TI Aging, calorie restriction and ubiquitin-dependent proteolysis in the
   livers of Emory mice
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE calorie restriction; aging; ubiquitin; liver; ATP-dependent
ID LENS EPITHELIAL-CELLS; OXIDIZED ALPHA-CRYSTALLINS; DIETARY RESTRICTION;
   PROTEIN-TURNOVER; OXIDATIVE STRESS; FOOD RESTRICTION; RAT-LIVER;
   AFFINITY PURIFICATION; CATARACT FORMATION; ACTIVATING ENZYME
AB Calorie restriction (R), the only known method to delay the aging process and extend mean and maximal lifespan, has been shown to delay the age-related decline in protein degradation. There are several proteolytic pathways. The ubiquitin-and ATP-dependent proteolytic pathway (UPP) is frequently associated with degradation of damaged abnormal and/or regulatory proteins. We examined the effect of aging and R on supernatants of livers taken from young (4.5 months) and old (23 months) Emery mice. Aging was associated with increased levels of endogenous ubiquitin conjugates, enhanced ability to form high molecular weight conjugates and ubiquitin activating (E1) and ubiquitin conjugating (E2) activity in the control (C) liver supernatants. The age-related increase in levels of endogenous ubiquitin conjugates in liver appears to be primarily due to increased E1 and E2 activities. R prevented the age-related increase in E1 and E2 activity, and thus prevented the age-related increase in levels of ubiquitin conjugates. In spite of the age-related increase in ubiquitin conjugates, no age-related changes in ubiquitin-dependent proteolytic pathway were observed in the C animals. R was associated with an enhanced ability (130%) to degrade beta-lactoglobulin by the ubiquitin-dependent proteolytic pathway in livers from 4.5-month-old animals relative to age-matched C livers. However, rates of the ubiquitin-dependent degradation of beta-lactoglobulin in the 23-month-old C and R animals were indistinguishable. There were no age-or diet-related differences in the ability to degrade another substrate, oxidized ribonuclease (RNase). (C) 1998 Elsevier Science Ireland Ltd. All rights reserved.
C1 Tufts Univ, USDA, Jean Mayer Human Nutr Res Ctr Aging, Lab Nutr & Vis Res, Boston, MA 02111 USA.
   Ctr Estudios Cient Santiago, Santiago 9, Chile.
C3 Tufts University; United States Department of Agriculture (USDA)
RP Taylor, A (corresponding author), Tufts Univ, USDA, Jean Mayer Human Nutr Res Ctr Aging, Lab Nutr & Vis Res, 711 Washington St, Boston, MA 02111 USA.
FU NEI NIH HHS [EY08566] Funding Source: Medline; NIA NIH HHS [T32AG00209]
   Funding Source: Medline
CR ADELMAN RC, 1985, MODIFICATIONS PROTEI, V7
   AGARWAL S, 1994, ARCH BIOCHEM BIOPHYS, V309, P24, DOI 10.1006/abbi.1994.1078
   AUGESTEYN RC, 1981, MECH CATARACT FORMAT, P72
   BERGER JJ, 1988, IN VITRO CELL DEV B, V24, P990
   CHIANG HL, 1989, SCIENCE, V246, P382, DOI 10.1126/science.2799391
   CIECHANOVER A, 1980, P NATL ACAD SCI-BIOL, V77, P1365, DOI 10.1073/pnas.77.3.1365
   CIECHANOVER A, 1982, J BIOL CHEM, V257, P2537
   CIECHANOVER A, 1978, BIOCHEM BIOPH RES CO, V81, P1100, DOI 10.1016/0006-291X(78)91249-4
   CIECHANOVER A, 1994, CELLULAR PROTEOLYTIC
   COSTA RC, 1991, BIOCHEM BIOPH RES CO, V179, P1400, DOI 10.1016/0006-291X(91)91728-U
   COSTA RC, 1994, MODERN AGING RES, V9, P151
   DEAN RT, 1993, TRENDS BIOCHEM SCI, V18, P437, DOI 10.1016/0968-0004(93)90145-D
   DICE JF, 1993, PHYSIOL REV, V73, P149, DOI 10.1152/physrev.1993.73.1.149
   DICE JF, 1987, FASEB J, V1, P349, DOI 10.1096/fasebj.1.5.2824267
   DICE JF, 1989, EXP GERONTOL, V24, P451
   DICK LR, 1994, J IMMUNOL, V152, P3884
   EVANS AC, 1985, BIOCHEMISTRY-US, V24, P2915, DOI 10.1021/bi00333a015
   FERLAND G, 1990, MECH AGEING DEV, V56, P143, DOI 10.1016/0047-6374(90)90005-Z
   FINLEY D, 1987, CELL, V48, P1035, DOI 10.1016/0092-8674(87)90711-2
   FINLEY D, 1991, ANNU REV CELL BIOL, V7, P25, DOI 10.1146/annurev.cellbio.7.1.25
   FINLEY D, 1994, MOL CELL BIOL, V14, P5501, DOI 10.1128/MCB.14.8.5501
   GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0
   GOLDBERG A, 1994, EMBO RAPP WORKSH HAI
   GOLDSPINK DF, 1987, EXP GERONTOL, V22, P67, DOI 10.1016/0531-5565(87)90016-7
   GOLDSPINK DF, 1986, CARDIOVASC RES, V20, P672, DOI 10.1093/cvr/20.9.672
   GOLDSPINK DF, 1984, BIOCHEM J, V217, P507, DOI 10.1042/bj2170507
   GOLDSPINK DF, 1988, MECH AGEING DEV, V42, P253, DOI 10.1016/0047-6374(88)90051-6
   GONDA DK, 1989, J BIOL CHEM, V264, P16700
   GRACY RW, 1985, MODIFICATION PROTEIN, P1
   GRUNE T, 1995, J BIOL CHEM, V270, P2344, DOI 10.1074/jbc.270.5.2344
   Grune T, 1997, FASEB J, V11, P526, DOI 10.1096/fasebj.11.7.9212076
   HAAS AL, 1982, J BIOL CHEM, V257, P2543
   HAAS AL, 1995, J BIOL CHEM, V270, P9407, DOI 10.1074/jbc.270.16.9407
   HAAS AL, 1986, J BIOL CHEM, V260, P4694
   HELLERSTEIN MK, 1988, LIVER BIOL PATHOBIOL
   HERSHKO A, 1994, J BIOL CHEM, V269, P4940
   HERSHKO A, 1980, P NATL ACAD SCI-BIOL, V77, P1783, DOI 10.1073/pnas.77.4.1783
   HERSHKO A, 1983, J BIOL CHEM, V258, P8206
   HERSHKO A, 1984, P NATL ACAD SCI-BIOL, V81, P7021, DOI 10.1073/pnas.81.22.7021
   HERSHKO A, 1979, P NATL ACAD SCI USA, V76, P3107, DOI 10.1073/pnas.76.7.3107
   HERSHKO A, 1984, P NATL ACAD SCI-BIOL, V81, P1619, DOI 10.1073/pnas.81.6.1619
   HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553
   HUANG LL, 1993, BIOCHIM BIOPHYS ACTA, V1175, P181, DOI 10.1016/0167-4889(93)90021-G
   HUANG LL, 1995, EXP EYE RES, V61, P45, DOI 10.1016/S0014-4835(95)80057-3
   HUANG LL, 1993, INVEST OPHTH VIS SCI, V34, P1297
   ISHIGAMI A, 1990, ARCH BIOCHEM BIOPHYS, V277, P189, DOI 10.1016/0003-9861(90)90568-J
   ISHIGAMI A, 1990, ARCH BIOCHEM BIOPHYS, V283, P362, DOI 10.1016/0003-9861(90)90655-I
   ISHIGAMI A, 1988, MECH AGEING DEV, V46, P125, DOI 10.1016/0047-6374(88)90120-0
   JAHNGEN JH, 1986, J BIOL CHEM, V261, P3760
   JAHNGENHODGE J, 1992, EXP EYE RES, V55, P897, DOI 10.1016/0014-4835(92)90016-L
   JOHNSTON NL, 1991, BIOCHEMISTRY-US, V30, P7514, DOI 10.1021/bi00244a021
   KUDO T, 1994, BRAIN RES, V639, P1, DOI 10.1016/0006-8993(94)91757-4
   LAVIE L, 1982, BIOCHEM J, V202, P47, DOI 10.1042/bj2020047
   LEWIS SEM, 1985, EXP GERONTOL, V20, P253, DOI 10.1016/0531-5565(85)90050-6
   LIU AYC, 1989, J BIOL CHEM, V264, P12037
   LOETSCHER P, 1991, J BIOL CHEM, V266, P11213
   LOWE J, 1988, J PATHOL, V155, P9, DOI 10.1002/path.1711550105
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MAKRIDES S, 1983, BIOL REV, V58, P393
   MASORO EJ, 1993, J AM GERIATR SOC, V41, P994, DOI 10.1111/j.1532-5415.1993.tb06767.x
   Mura CV, 1996, MECH AGEING DEV, V91, P115, DOI 10.1016/0047-6374(96)01780-0
   MURAKAMI K, 1990, FREE RADICAL BIO MED, V8, P217, DOI 10.1016/0891-5849(90)90066-R
   PETERS JM, 1994, TRENDS BIOCHEM SCI, V19, P377, DOI 10.1016/0968-0004(94)90115-5
   RECHSTEINER M, 1991, CELL, V66, P615, DOI 10.1016/0092-8674(91)90104-7
   REISS Y, 1988, J BIOL CHEM, V263, P2693
   REZNICK AZ, 1985, MODIFICATION PROTEIN, P69
   ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6
   ROSENBERGER RF, 1991, MUTAT RES, V256, P255, DOI 10.1016/0921-8734(91)90016-5
   SAHAKIAN JA, 1995, ARCH BIOCHEM BIOPHYS, V318, P411, DOI 10.1006/abbi.1995.1248
   SCHEFFNER M, 1994, P NATL ACAD SCI USA, V91, P8797, DOI 10.1073/pnas.91.19.8797
   Shaeffer JR, 1996, BIOCHEMISTRY-US, V35, P10886, DOI 10.1021/bi9530705
   SHANG F, 1995, BIOCHEM J, V307, P297, DOI 10.1042/bj3070297
   Shang F, 1997, EXP EYE RES, V64, P21, DOI 10.1006/exer.1996.0176
   Shang F, 1997, J BIOL CHEM, V272, P23086, DOI 10.1074/jbc.272.37.23086
   SHANG F, 1994, CURR EYE RES, V13, P423, DOI 10.3109/02713689408999870
   Shibatani T, 1996, J GERONTOL A-BIOL, V51, pB175, DOI 10.1093/gerona/51A.2.B175
   SOHAL RS, 1994, MECH AGEING DEV, V74, P121, DOI 10.1016/0047-6374(94)90104-X
   SOHAL RS, 1993, P NATL ACAD SCI USA, V90, P7255, DOI 10.1073/pnas.90.15.7255
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   STADTMAN ER, 1991, J BIOL CHEM, V266, P2005
   STADTMAN ER, 1988, J GERONTOL, V43, pB112, DOI 10.1093/geronj/43.5.B112
   Starke-Reed P E, 1989, Prog Clin Biol Res, V287, P269
   STARKEREED PE, 1989, ARCH BIOCHEM BIOPHYS, V275, P559, DOI 10.1016/0003-9861(89)90402-5
   TAYLOR A, 1995, MECH AGEING DEV, V79, P33, DOI 10.1016/0047-6374(94)01541-S
   TAYLOR A, 1995, EXP EYE RES, V61, P55, DOI 10.1016/S0014-4835(95)80058-1
   TAYLOR A, 1987, FREE RADICAL BIO MED, V3, P371, DOI 10.1016/0891-5849(87)90015-3
   TAYLOR A, 1983, INVEST OPHTH VIS SCI, V24, P1172
   TAYLOR A, 1991, AGE, V14, P65, DOI 10.1007/BF02434092
   TAYLOR A, 1989, FASEB J, V3, P1741, DOI 10.1096/fasebj.3.6.2703107
   TAYLOR A, 1992, FREE RADICALS AGING, P266
   VILLARREAL A, 1997, FASEB J, V426, P2464
   VINCENT IJ, 1990, P NATL ACAD SCI USA, V87, P4840, DOI 10.1073/pnas.87.12.4840
   WARD WF, 1988, J GERONTOL, V43, pB121, DOI 10.1093/geronj/43.5.B121
   WARD WF, 1994, MODULATION AGING PRO, P121
   Weindruch R., 1991, POTENTIAL NUTR MODUL, P109
   WEINDRUCH R, 1988, RETARDATION AGING DI
   YOUNGMAN LD, 1992, P NATL ACAD SCI USA, V89, P9112, DOI 10.1073/pnas.89.19.9112
   Yu BP, 1996, FREE RADICAL BIO MED, V21, P651, DOI 10.1016/0891-5849(96)00162-1
NR 98
TC 37
Z9 37
U1 1
U2 2
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD APR 1
PY 1998
VL 101
IS 3
BP 277
EP 296
DI 10.1016/S0047-6374(97)00178-4
PG 20
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA ZM092
UT WOS:000073503900009
PM 9622231
DA 2024-02-19
ER

PT J
AU Leclère, R
   Torregrosa-Muñumer, R
   Kireev, R
   García, C
   Vara, E
   Tresguerres, JAF
   Gredilla, R
AF Leclere, R.
   Torregrosa-Munumer, R.
   Kireev, R.
   Garcia, C.
   Vara, E.
   Tresguerres, J. A. F.
   Gredilla, R.
TI Effect of estrogens on base excision repair in brain and liver
   mitochondria of aged female rats
SO BIOGERONTOLOGY
LA English
DT Article
DE Mitochondria; Estrogens; DNA; Base excision repair; AP endonuclease;
   Aging
ID OXIDATIVE DNA-DAMAGE; GROWTH-HORMONE; GENE-EXPRESSION; IN-VIVO; STRESS;
   NEUROPROTECTION; LONGEVITY; ESTRADIOL; TRANSCRIPTION; RESTRICTION
AB Changes in the endocrine system have been suggested to act as signaling factors in the regulation of age-related events. Among the different hormones that have been linked to the aging process, estrogens have been widely investigated. They have been associated with inflammatory and oxidative processes and several investigations have established a relationship between the protective effects of estrogens and the mitochondrial function. Mitochondrial DNA is subjected to continuous oxidative attack by free radicals, and the base excision repair (BER) pathway is the main DNA repair route present in mitochondria. We have investigated the effect of estrogen levels on some of the key enzymes of BER in brain and liver mitochondria. In both tissues, depletion of estrogens led to an increased mitochondrial AP endonuclease (mtAPE1) activity, while restoration of estrogen levels by exogenous supplementation resulted in restitution of control APE1 activity only in liver. Moreover, in hepatic mitochondria, changes in estrogen levels affected the processing of oxidative lesions but not deaminations. Our results suggest that changes in mtAPE1 activity are related to specific translocation of the enzyme from the cytosol into the mitochondria probably due to oxidative stress changes as a consequence of changes in estrogen levels.
C1 [Leclere, R.; Torregrosa-Munumer, R.; Kireev, R.; Tresguerres, J. A. F.; Gredilla, R.] Univ Complutense, Fac Med, Dept Physiol, E-28040 Madrid, Spain.
   [Garcia, C.; Vara, E.] Univ Complutense, Fac Med, Dept Biochem & Mol Biol, E-28040 Madrid, Spain.
C3 Complutense University of Madrid; Complutense University of Madrid
RP Gredilla, R (corresponding author), Univ Complutense, Fac Med, Dept Physiol, Plaza Ramon & Cajal S-N, E-28040 Madrid, Spain.
EM rgredilla@med.ucm.es
OI GREDILLA, RICARDO/0000-0003-4501-1355; Torregrosa,
   Ruben/0000-0003-3032-9766; Kireev, Roman/0000-0002-6105-2440; Leclere,
   Renaud/0000-0001-8737-6817
FU Spanish Ministry of Science [SAF2007 66878C02 01]; RETICEF
   [RD06/0013/008]; Complutense University/Community of Madrid
   [CCG10-UCM/SAL 4798]
FX This research was supported by grants from the Spanish Ministry of
   Science (SAF2007 66878C02 01) and RETICEF (RD06/0013/008) to JAFT and a
   grant from the Complutense University/Community of Madrid to RG
   (CCG10-UCM/SAL 4798).
CR Alvarez-Delgado C, 2010, EXP GERONTOL, V45, P580, DOI 10.1016/j.exger.2010.01.015
   Araneda S, 2005, NEUROSCIENCE, V136, P135, DOI 10.1016/j.neuroscience.2005.06.080
   Araujo GW, 2008, J NEUROENDOCRINOL, V20, P930, DOI 10.1111/j.1365-2826.2008.01747.x
   Arnold S, 2012, J STEROID BIOCHEM, V131, P2, DOI 10.1016/j.jsbmb.2012.01.012
   Arnold S, 2009, J NEUROCHEM, V110, P1, DOI 10.1111/j.1471-4159.2009.06133.x
   Arnold S, 2008, J MOL ENDOCRINOL, V41, P289, DOI 10.1677/JME-08-0085
   Azcoitia I, 2005, NEUROBIOL AGING, V26, P697, DOI 10.1016/j.neurobiolaging.2004.06.007
   Baeza I, 2010, BIOGERONTOLOGY, V11, P687, DOI 10.1007/s10522-010-9282-7
   Bartke A, 2001, NATURE, V414, P412, DOI 10.1038/35106646
   Boesch P, 2011, BBA-MOL CELL RES, V1813, P186, DOI 10.1016/j.bbamcr.2010.10.002
   Bohr VA, 2002, FREE RADICAL BIO MED, V32, P804, DOI 10.1016/S0891-5849(02)00787-6
   Bohr VA, 1999, J BIOENERG BIOMEMBR, V31, P391, DOI 10.1023/A:1005484004167
   Borrás C, 2003, FREE RADICAL BIO MED, V34, P546, DOI 10.1016/S0891-5849(02)01356-4
   Busso CS, 2010, CELL MOL LIFE SCI, V67, P3609, DOI 10.1007/s00018-010-0487-3
   Caro P, 2007, BIOGERONTOLOGY, V8, P1, DOI 10.1007/s10522-006-9026-x
   Castillo C, 2005, ENDOCRINE, V26, P11, DOI 10.1385/ENDO:26:1:011
   Castro MD, 2012, EXP GERONTOL, V47, P29, DOI 10.1016/j.exger.2011.10.002
   Chen DX, 2002, J NEUROCHEM, V81, P1273, DOI 10.1046/j.1471-4159.2002.00916.x
   Cline SD, 2012, BBA-GENE REGUL MECH, V1819, P979, DOI 10.1016/j.bbagrm.2012.06.002
   Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101
   Dickstein DL, 2007, AGING CELL, V6, P275, DOI 10.1111/j.1474-9726.2007.00289.x
   Dröge W, 2007, AGING CELL, V6, P361, DOI 10.1111/j.1474-9726.2007.00294.x
   Fantini D, 2010, NUCLEIC ACIDS RES, V38, P8239, DOI 10.1093/nar/gkq691
   Foster TC, 2007, AGING CELL, V6, P319, DOI 10.1111/j.1474-9726.2007.00283.x
   Furda AM, 2012, DNA REPAIR, V11, P684, DOI 10.1016/j.dnarep.2012.06.002
   Garcia-Segura LM, 2007, PSYCHONEUROENDOCRINO, V32, pS57, DOI 10.1016/j.psyneuen.2007.03.001
   Garcia-Segura LM, 2009, FRONT NEUROENDOCRIN, V30, pV, DOI 10.1016/j.yfrne.2009.04.006
   Gredilla Ricardo, 2012, Methods Mol Biol, V920, P289, DOI 10.1007/978-1-61779-998-3_20
   Gredilla R, 2012, NEUROBIOL AGING, V33, P694, DOI 10.1016/j.neurobiolaging.2010.06.019
   Gredilla Ricardo, 2010, J Aging Res, V2011, P257093, DOI 10.4061/2011/257093
   Gredilla R, 2010, EXP GERONTOL, V45, P478, DOI 10.1016/j.exger.2010.01.017
   Gredilla R, 2010, NEUROBIOL AGING, V31, P993, DOI 10.1016/j.neurobiolaging.2008.07.004
   Hegde ML, 2012, MECH AGEING DEV, V133, P157, DOI 10.1016/j.mad.2012.01.005
   Hota SK, 2007, NEUROCHEM INT, V51, P384, DOI 10.1016/j.neuint.2007.04.003
   Imam SZ, 2006, NEUROBIOL AGING, V27, P1129, DOI 10.1016/j.neurobiolaging.2005.06.002
   Jang YM, 2004, FEBS LETT, V577, P483, DOI 10.1016/j.febslet.2004.10.053
   Jeppesen DK, 2011, PROG NEUROBIOL, V94, P166, DOI 10.1016/j.pneurobio.2011.04.013
   Julian D, 2004, AM J PHYSIOL-REG I, V286, pR20, DOI 10.1152/ajpregu.00522.2003
   Kireev RA, 2007, J PINEAL RES, V42, P64, DOI 10.1111/j.1600-079X.2006.00385.x
   Kireev RA, 2007, BIOGERONTOLOGY, V8, P469, DOI 10.1007/s10522-007-9089-3
   Kireev RA, 2010, BIOGERONTOLOGY, V11, P229, DOI 10.1007/s10522-009-9242-2
   Klinge CM, 2008, J CELL BIOCHEM, V105, P1342, DOI 10.1002/jcb.21936
   Lafaro KJ, 2015, SURG ONCOL CLIN N AM, V24, P1, DOI 10.1016/j.soc.2014.09.001
   Li MX, 2012, CANCER SCI, V103, P882, DOI 10.1111/j.1349-7006.2012.02239.x
   Li MX, 2010, J BIOL CHEM, V285, P14871, DOI 10.1074/jbc.M109.069591
   Liu PF, 2010, ENVIRON MOL MUTAGEN, V51, P417, DOI 10.1002/em.20576
   López-Torres M, 2002, FREE RADICAL BIO MED, V32, P882, DOI 10.1016/S0891-5849(02)00773-6
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Markesbery WR, 2006, ANTIOXID REDOX SIGN, V8, P2039, DOI 10.1089/ars.2006.8.2039
   Marosi K, 2012, BIOGERONTOLOGY, V13, P413, DOI 10.1007/s10522-012-9386-3
   Mitra S, 2007, DNA REPAIR, V6, P461, DOI 10.1016/j.dnarep.2006.10.010
   Mora F, 2007, BRAIN RES REV, V55, P78, DOI 10.1016/j.brainresrev.2007.03.011
   Nakabeppu Y, 2007, J NEUROSCI RES, V85, P919, DOI 10.1002/jnr.21191
   Persky AM, 2000, P SOC EXP BIOL MED, V223, P59, DOI 10.1046/j.1525-1373.2000.22308.x
   Poynard T, 2001, J HEPATOL, V34, P730, DOI 10.1016/S0168-8278(00)00097-0
   Qiu G, 2012, NEUROBIOL AGING, V33, P2398, DOI 10.1016/j.neurobiolaging.2011.11.025
   Robertson AB, 2009, CELL MOL LIFE SCI, V66, P981, DOI 10.1007/s00018-009-8736-z
   Smigrodzki R, 2004, NEUROBIOL AGING, V25, P1273, DOI 10.1016/j.neurobiolaging.2004.02.020
   Soerensen M, 2012, EXP GERONTOL, V47, P379, DOI 10.1016/j.exger.2012.02.010
   Sykora P, 2012, MECH AGEING DEV, V133, P169, DOI 10.1016/j.mad.2011.11.003
   Tresguerres JAF, 2008, J STEROID BIOCHEM, V108, P318, DOI 10.1016/j.jsbmb.2007.09.010
   Vascotto C, 2011, MOL BIOL CELL, V22, P3887, DOI 10.1091/mbc.E11-05-0391
   Viña J, 2006, FREE RADICAL RES, V40, P1359, DOI 10.1080/10715760600952851
   Vina Jose, 2005, Sci Aging Knowledge Environ, V2005, ppe17, DOI 10.1126/sageke.2005.23.pe17
   Wight E, 2000, J SOC GYNECOL INVEST, V7, P106, DOI 10.1016/S1071-5576(00)00036-8
NR 65
TC 8
Z9 9
U1 0
U2 13
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1389-5729
EI 1573-6768
J9 BIOGERONTOLOGY
JI Biogerontology
PD AUG
PY 2013
VL 14
IS 4
BP 383
EP 394
DI 10.1007/s10522-013-9431-x
PG 12
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 197SX
UT WOS:000322872300003
PM 23666345
DA 2024-02-19
ER

PT J
AU Al-Baqami, NM
   Hamza, RZ
AF Al-Baqami, N. M.
   Hamza, R. Z.
TI Synergistic antioxidant capacities of vanillin and chitosan
   nanoparticles against reactive oxygen species, hepatotoxicity, and
   genotoxicity induced by aging in male Wistar rats
SO HUMAN & EXPERIMENTAL TOXICOLOGY
LA English
DT Article; Early Access
DE Aging; vanillin; chitosan nanoparticles; antioxidant; oxidative stress;
   metabolic dysfunction; hepatotoxicity
ID OXIDATIVE STRESS; IN-VITRO; GLUTATHIONE; MODEL; MOUSE; OLIGOSACCHARIDES;
   CHOLESTEROL; DRUGS; ASSAY
AB This study aimed to evaluate the synergistic effects of both vanillin (V) and chitosan nanoparticles (CNPs) in alleviating hepatotoxicity, oxidative injury, and genotoxicity induced byd-galactose (DG) and resulted from aging in male albino rats. Male Wistar rats were divided into seven groups (10 rats/group) as follows: control group, (DG) group (100 mg/kg), (V) group (100 mg/kg), CNPs either (low dose (LD) or CNPs (high dose (HD) (140 mg/kg) and (280 mg/kg), and CNPs (LD and HD) dose with V- and DG plus V-treated groups. The CNPs were characterized by transmission electron microscopy (TEM), zeta potential, and size distribution of nanoparticles. After 60 consecutive days of exposure, some biochemical parameters were measured as hepatic aminotransferases enzymes, lipid profile, tumor necrosis factor alpha, interleukin-6 (IL-6), markers of inflammation, tissue damage lactate dehydrogenase, C-reactive protein (CRP), mitochondrial potential activities, myeloperoxidase, xanthine oxidase, CRP, succinate dehydrogenase, mitochondria membrane potential, malondialdehyde levels and antioxidant enzymes (superoxide dismutase, catalase, glutathione reductase, and glutathione S-transferase), and adenosine triphosphate content with histological, alkaline comet assay, and TEM examination of the hepatic tissues. CNPs showed that size distribution (polydispersity index) 0.350 nm and the zeta potential measurement of CNPs were found to be -14.9 mV which revealed the high stability of CNPs. DG induced biochemical and cellular alterations in the hepatic tissues. CNPs and V synergistically afforded protection against hepatic injury and oxidative stress resulting from aging that was induced by DG. Consequently, CNPs were an effective agent in the drug delivery in the hepatic diseases medications and act as a carrier for V and thus make synergistic effect between CNPs and V that achieved the high antioxidant capacities. CNPs and V improved the hepatic enzymes, which act as anti-inflammatory and antigenotoxicity, and improved the antioxidant capacities in the hepatic tissues.
C1 [Al-Baqami, N. M.] King Abdulaziz Univ, Dept Biol Sci Zool, Jeddah, Saudi Arabia.
   [Hamza, R. Z.] Zagazig Univ, Fac Sci, Zool Dept, Zagazig, Egypt.
   [Hamza, R. Z.] Taif Univ, Fac Sci, Biol Dept, At Taif, Saudi Arabia.
C3 King Abdulaziz University; Egyptian Knowledge Bank (EKB); Zagazig
   University; Taif University
RP Hamza, RZ (corresponding author), Zagazig Univ, Fac Sci, Zool Dept, Zagazig, Egypt.; Hamza, RZ (corresponding author), Taif Univ, Fac Sci, Biol Dept, At Taif, Saudi Arabia.
EM dr_reham_z@yahoo.com
RI ; Hamza, Reham/N-4030-2018
OI ALbaqami, Dr.Najah/0000-0001-6954-8777; Hamza, Reham/0000-0001-7083-9467
FU Deanship of Scientific Research, King Abdulaziz University, Jeddah [J:
   10-247-1440]
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: The
   funding of this publication was achieved by the Deanship of Scientific
   Research, King Abdulaziz University, Jeddah [project no. J:
   10-247-1440].
CR Abd-Elhakeem MA, 2017, J BIOCH INT, V4, P5
   AEBI H, 1984, METHOD ENZYMOL, V105, P121
   Agrawal P, 2010, ADV DRUG DELIVER REV, V62, P42, DOI 10.1016/j.addr.2009.09.007
   Ahangarpour A, 2017, PATHOBIOL AGING AGE, V8, DOI 10.1080/20010001.2017.1418593
   Al-Eisa RA, 2018, INT J PHARMACOL, V14, P811, DOI 10.3923/ijp.2018.811.825
   Anraku M, 2008, INT J BIOL MACROMOL, V43, P159, DOI 10.1016/j.ijbiomac.2008.04.006
   Anraku M, 2010, BIOL PHARM BULL, V33, P1994, DOI 10.1248/bpb.33.1994
   Arthur CR, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-37
   Ayoubi M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13396-y
   Ben Saad H, 2016, CHEM-BIOL INTERACT, V252, P102, DOI 10.1016/j.cbi.2016.04.015
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   CARR TP, 1993, CLIN BIOCHEM, V26, P39, DOI 10.1016/0009-9120(93)90015-X
   Carvalho C, 2009, J BIOENERG BIOMEMBR, V41, P433, DOI 10.1007/s10863-009-9247-1
   Choi YD, 1999, J UROLOGY, V162, P1508, DOI 10.1016/S0022-5347(05)68349-8
   Chung MJ, 2012, INT IMMUNOPHARMACOL, V12, P453, DOI 10.1016/j.intimp.2011.12.027
   Collins Andrew R, 2002, Methods Mol Biol, V186, P147
   COURI D, 1979, J ENVIRON PATHOL TOX, V3, P451
   ELDENSHARY ES, 2015, SOFT NANOSCI LETT, V5, P36, DOI DOI 10.4236/SNL.2015.52005
   Elsherbiny NM, 2016, PATHOL RES PRACT, V212, P767, DOI 10.1016/j.prp.2016.06.004
   Endoh D, 2002, J VET MED SCI, V64, P761, DOI 10.1292/jvms.64.761
   FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
   Gabe M, 1968, HISTOLOGICAL TECHNIQ
   Gu RL, 2010, BIOMATERIALS, V31, P1270, DOI 10.1016/j.biomaterials.2009.10.023
   HAFEMAN DG, 1974, J NUTR, V104, P580, DOI 10.1093/jn/104.5.580
   Hamza RZ, 2020, TOXICOL REP, V7, P254, DOI 10.1016/j.toxrep.2020.01.012
   Herlong HF, 2012, SCHIFFS DIS LIVER
   Ho K, 2011, FOOD CHEM TOXICOL, V49, P25, DOI 10.1016/j.fct.2010.08.023
   Hsieh HM, 2009, FOOD CHEM TOXICOL, V47, P625, DOI 10.1016/j.fct.2008.12.026
   HU ML, 1994, METHOD ENZYMOL, V233, P380
   Hua XD, 2007, LIFE SCI, V80, P1897, DOI 10.1016/j.lfs.2007.02.030
   Huber KC, 2009, EDIBLE FILMS COATING
   Jia L, 2005, CURR NANOSCI, V1, P237, DOI 10.2174/157341305774642939
   Kim, 2001, J CHITIN CHITOSAN, V6, P163
   Kumar A, 2012, PHARMACOL REP, V64, P1326, DOI 10.1016/S1734-1140(12)70930-1
   Lei M, 2008, BIOCHEM BIOPH RES CO, V369, P1082, DOI 10.1016/j.bbrc.2008.02.151
   Liang JA, 2009, MOL PHARMACOL, V75, P151, DOI 10.1124/mol.108.049502
   LITWACK G, 1953, J BIOL CHEM, V200, P303
   Makni M, 2011, EUR J PHARMACOL, V668, P133, DOI 10.1016/j.ejphar.2011.07.001
   Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727
   MARKLUND S, 1974, EUR J BIOCHEM, V47, P469
   Naserzadeh P, 2018, CUTAN OCUL TOXICOL, V37, P157, DOI 10.1080/15569527.2017.1363227
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   Ormrod DJ, 1998, ATHEROSCLEROSIS, V138, P329, DOI 10.1016/S0021-9150(98)00045-8
   Patel VR, 2011, J ADV PHARM TECHNOL, V2, P81, DOI 10.4103/2231-4040.82950
   Pepys MB, 2003, J CLIN INVEST, V112, P299, DOI 10.1172/JCI200318921C
   Qi LF, 2004, CARBOHYD RES, V339, P2693, DOI 10.1016/j.carres.2004.09.007
   Qi LF, 2007, EUR J CANCER, V43, P184, DOI 10.1016/j.ejca.2006.08.029
   Ragab GMA., 2013, GLOBAL J PHARM, V7, P258, DOI DOI 10.5829/IDOSI.GJP.2013.7.3.7637
   REITMAN S, 1957, AM J CLIN PATHOL, V28, P56, DOI 10.1093/ajcp/28.1.56
   Santhosh S, 2006, TOXICOLOGY, V219, P53, DOI 10.1016/j.tox.2005.11.001
   Santosh K., 2012, INT J BIOL MACROMOL, V50, P493
   Shaughnessy DT, 2006, MUTAT RES-FUND MOL M, V602, P54, DOI 10.1016/j.mrfmmm.2006.08.006
   Sivakumar R., 2007, J CELL ANIM BIOL, V1, P71
   Subhapradha N, 2014, APPL BIOCHEM BIOTECH, V172, P9, DOI 10.1007/s12010-013-0499-1
   SUZUKI K, 1983, ANAL BIOCHEM, V132, P345, DOI 10.1016/0003-2697(83)90019-2
   Tafreshi NK, 2007, J BIOL CHEM, V282, P8641, DOI 10.1074/jbc.M609271200
   Tai A, 2011, BBA-GEN SUBJECTS, V1810, P170, DOI 10.1016/j.bbagen.2010.11.004
   Takma DK, 2017, FOOD CHEM, V221, P187, DOI 10.1016/j.foodchem.2016.09.195
   Tang ZX, 2007, APPL BIOCHEM BIOTECH, V136, P77, DOI 10.1007/BF02685940
   Tzankova V, 2017, BIOMED PHARMACOTHER, V92, P569, DOI 10.1016/j.biopha.2017.05.008
   Vassault A., 1983, METHODS ENZYMATIC AN, V3, P118
   Vo TS, 2012, PROCESS BIOCHEM, V47, P327, DOI 10.1016/j.procbio.2011.10.036
   Wang JL, 2011, COLLOID SURFACE B, V85, P241, DOI 10.1016/j.colsurfb.2011.02.035
   Warnick G.R., 1983, LIN CHEM, V10, P91
   Weakley B., 1981, HDB BIOL TRANSMISSIO, VSecond
   Wen ZS, 2013, MAR DRUGS, V11, P3582, DOI 10.3390/md11103582
   Wen ZS, 2011, MAR DRUGS, V9, P1038, DOI 10.3390/md9061038
   Wener MH, 2000, J RHEUMATOL, V27, P2351
   Ying CY, 2012, EVID-BASED COMPL ALT, V2012, P980276
   Yu Z. B., 2007, OCCUP HEALTH, V19, P4
   Zhang ZF, 2009, FOOD CHEM TOXICOL, V47, P496, DOI 10.1016/j.fct.2008.12.005
   Zhao YB, 2010, J INORG BIOCHEM, V104, P371, DOI 10.1016/j.jinorgbio.2009.11.007
NR 72
TC 18
Z9 18
U1 0
U2 16
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0960-3271
EI 1477-0903
J9 HUM EXP TOXICOL
JI Hum. Exp. Toxicol.
PD 2021 JAN
PY 2021
VL 40
IS 1
BP 183
EP 202
AR 0960327120943267
DI 10.1177/0960327120943267
EA AUG 2020
PG 20
WC Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Toxicology
GA PJ2AO
UT WOS:000563674300001
PM 32857622
DA 2024-02-19
ER

PT J
AU McMahan, RH
   Najarro, KM
   Mullen, JE
   Paul, MT
   Orlicky, DJ
   Hulsebus, HJ
   Kovacs, EJ
AF McMahan, Rachel H.
   Najarro, Kevin M.
   Mullen, Juliet E.
   Paul, Madison T.
   Orlicky, David J.
   Hulsebus, Holly J.
   Kovacs, Elizabeth J.
TI A novel murine model of multi-day moderate ethanol exposure reveals
   increased intestinal dysfunction and liver inflammation with age
SO IMMUNITY & AGEING
LA English
DT Article
DE Alcohol; Aging; Gut barrier; Liver; Antimicrobial peptide
ID FATTY LIVER; ALCOHOLIC STEATOHEPATITIS; PERMEABILITY; PROMOTES;
   DRINKING; INJURY; MICROBIOTA; MODULATION; EXPRESSION; DISEASE
AB Background There are currently > 600 million people over the age of 65 globally and this number is expected to double by the year 2050. Alcohol use among this population is on the rise, which is concerning as aging is associated with increased risk for a number of chronic illnesses. As most studies investigating the effects of alcohol have focused on young/middle-aged populations, there is a dearth of information regarding the consequences of alcohol use in older consumers. In addition, most murine ethanol models have concentrated on exposure to very high levels of ethanol, while the vast majority of elderly drinkers do not consume alcohol in excess; instead, they drink on average 2 alcoholic beverages a day, 3-4 days a week. Methods We designed a murine model of aging and moderate ethanol consumption to determine if the deleterious effects of alcohol on the gut-liver axis are exacerbated in aged, relative to younger, animals. Aged and young mice were exposed to a multi-day moderate exposure ethanol regimen for 4 weeks and changes in gut permeability along with intestinal tight junction protein and antimicrobial peptide gene expression were measured. In addition, hepatic inflammation was assessed by histological analysis, inflammatory gene expression and flow cytometric analysis of inflammatory infiltrate. Results Our results reveal that in aged, but not young mice, moderate ethanol exposure yielded significantly worsened intestinal permeability, including increased bacterial translocation from the gut, elevated serum iFABP and leakage of FITC-dextran from the gut. Interestingly, moderate ethanol exposure in young animals led to gut protective transcriptional changes in the ileum while this protective response was blunted in aged mice. Finally, moderate ethanol exposure in aged mice also resulted in marked inflammatory changes in the liver. Conclusions These results demonstrate that aged mice are more susceptible to ethanol-induced gut barrier dysfunction and liver inflammation, even at moderate doses of ethanol. This increased vulnerability to ethanol's gastrointestinal effects has important implications for alcohol use in the aging population. Future studies will explore whether improving intestinal barrier function can reverse these age-related changes.
C1 [McMahan, Rachel H.; Najarro, Kevin M.; Mullen, Juliet E.; Paul, Madison T.; Hulsebus, Holly J.; Kovacs, Elizabeth J.] Univ Colorado Denver, Dept Surg, Div GI Trauma & Endocrine Surg, Anschutz Med Campus,12700 East 19th Ave,RC2, Aurora, CO 80045 USA.
   [McMahan, Rachel H.; Najarro, Kevin M.; Mullen, Juliet E.; Paul, Madison T.; Hulsebus, Holly J.; Kovacs, Elizabeth J.] Univ Colorado Denver, Alcohol Res Program, Anschutz Med Campus,12700 East 19th Ave,RC2, Aurora, CO 80045 USA.
   [McMahan, Rachel H.; Kovacs, Elizabeth J.] Univ Colorado Denver, GI & Liver Innate Immune Program, Anschutz Med Campus, Aurora, CO 80045 USA.
   [Orlicky, David J.] Univ Colorado Denver, Dept Pathol, Anschutz Med Campus, Aurora, CO 80045 USA.
   [Hulsebus, Holly J.; Kovacs, Elizabeth J.] Univ Colorado Denver, Dept Immunol & Microbiol, Anschutz Med Campus, Aurora, CO 80045 USA.
C3 University of Colorado System; University of Colorado Anschutz Medical
   Campus; Children's Hospital Colorado; Children's Hospital Colorado;
   University of Colorado System; University of Colorado Anschutz Medical
   Campus; University of Colorado System; University of Colorado Anschutz
   Medical Campus; Children's Hospital Colorado; University of Colorado
   System; University of Colorado Anschutz Medical Campus; Children's
   Hospital Colorado; University of Colorado System; University of Colorado
   Anschutz Medical Campus; Children's Hospital Colorado
RP McMahan, RH (corresponding author), Univ Colorado Denver, Dept Surg, Div GI Trauma & Endocrine Surg, Anschutz Med Campus,12700 East 19th Ave,RC2, Aurora, CO 80045 USA.; McMahan, RH (corresponding author), Univ Colorado Denver, Alcohol Res Program, Anschutz Med Campus,12700 East 19th Ave,RC2, Aurora, CO 80045 USA.; McMahan, RH (corresponding author), Univ Colorado Denver, GI & Liver Innate Immune Program, Anschutz Med Campus, Aurora, CO 80045 USA.
EM Rachel.McMahan@CUAnschutz.edu
OI Najarro, Kevin/0000-0002-4485-533X
FU National Institutes of Health [R01 AG018859, R35 GM131831, R21 AA026295,
   F31AA027687]; Veterans Administration [1 I01 BX004335]
FX The work herein was supported in part by the National Institutes of
   Health R01 AG018859 (E.J.K.), R35 GM131831 (E.J.K.), R21 AA026295
   (E.J.K.), F31AA027687 (H.J.H.), and the Veterans Administration 1 I01
   BX004335 (E.J.K.).
CR ADACHI Y, 1994, HEPATOLOGY, V20, P453, DOI 10.1002/hep.1840200227
   Bertola A, 2013, NAT PROTOC, V8, P627, DOI 10.1038/nprot.2013.032
   Blazer DG, 2009, AM J PSYCHIAT, V166, P1162, DOI 10.1176/appi.ajp.2009.09010016
   Chen P, 2015, GASTROENTEROLOGY, V148, P203, DOI 10.1053/j.gastro.2014.09.014
   Cicinnati VR, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-350
   Courtney KE, 2009, PSYCHOL BULL, V135, P142, DOI 10.1037/a0014414
   Diehl GE, 2013, NATURE, V494, P116, DOI 10.1038/nature11809
   Fickert P, 2017, J HEPATOL, V67, P619, DOI 10.1016/j.jhep.2017.04.026
   Flurkey K., 2007, MOUSE BIOMEDICAL RES, P637, DOI DOI 10.1016/B978-012369454-6/50074-1
   Franceschi C, 2000, ANN NY ACAD SCI, V908, P244
   Fuster V, 2017, J AM COLL CARDIOL, V69, P3002, DOI 10.1016/j.jacc.2017.05.013
   Ghosh S. S., 2020, LIVER RES, V4, P81, DOI [10.1016/j.livres.2020.03.002, DOI 10.1016/J.LIVRES.2020.03.002, 10.1016/j.livres.2020.03, DOI 10.1016/J.LIVRES.2020.03]
   Gracz A D, 2012, Methods Mol Biol, V879, P89, DOI 10.1007/978-1-61779-815-3_6
   Grant BF, 2017, JAMA PSYCHIAT, V74, P911, DOI 10.1001/jamapsychiatry.2017.2161
   Günzel D, 2013, PHYSIOL REV, V93, P525, DOI 10.1152/physrev.00019.2012
   Hall KE, 2005, GASTROENTEROLOGY, V129, P1305, DOI 10.1053/j.gastro.2005.06.013
   Hartmann P, 2015, ALCOHOL CLIN EXP RES, V39, P763, DOI 10.1111/acer.12704
   Holahan CJ, 2015, J STUD ALCOHOL DRUGS, V76, P552, DOI 10.15288/jsad.2015.76.552
   Keshavarzian A, 2009, J HEPATOL, V50, P538, DOI 10.1016/j.jhep.2008.10.028
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Kuboki S, 2008, HEPATOLOGY, V48, P1213, DOI 10.1002/hep.22471
   Lamas-Paz A, 2018, WORLD J GASTROENTERO, V24, P5063, DOI 10.3748/wjg.v24.i45.5063
   Lanaspa MA, 2018, J CLIN INVEST, V128, P2226, DOI 10.1172/JCI94427
   Lawson JA, 2000, TOXICOL SCI, V54, P509, DOI 10.1093/toxsci/54.2.509
   Lee SH, 2015, INTEST RES, V13, P11
   LIEBER CS, 1989, HEPATOLOGY, V10, P501, DOI 10.1002/hep.1840100417
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lu YK, 2008, HEPATOLOGY, V47, P1483, DOI 10.1002/hep.22222
   Ma TY, 1999, AM J PHYSIOL-GASTR L, V276, pG965, DOI 10.1152/ajpgi.1999.276.4.G965
   McGettigan B, 2019, HEPATOLOGY, V70, P67, DOI 10.1002/hep.30401
   McMahan RH, 2013, J BIOL CHEM, V288, P11761, DOI 10.1074/jbc.M112.446575
   Meier P, 2008, CURR OPIN CLIN NUTR, V11, P21, DOI 10.1097/MCO.0b013e3282f30564
   Mitchell EL, 2017, J NUTR HEALTH AGING, V21, P354, DOI 10.1007/s12603-016-0725-y
   Moucadel V, 2001, EUR J CELL BIOL, V80, P156, DOI 10.1078/0171-9335-00148
   Mukherjee S, 2015, IMMUNITY, V42, P28, DOI 10.1016/j.immuni.2014.12.028
   Parlesak A, 2000, J HEPATOL, V32, P742, DOI 10.1016/S0168-8278(00)80242-1
   Petrasek J, 2012, J CLIN INVEST, V122, P3476, DOI 10.1172/JCI60777
   Ramirez T, 2017, J HEPATOL, V66, P601, DOI 10.1016/j.jhep.2016.11.004
   Rao R. K., 2008, V447, P171, DOI 10.1007/978-1-59745-242-7_13
   Rendon JL, 2013, SHOCK, V39, P11, DOI 10.1097/SHK.0b013e3182749f96
   Sacco P, 2015, AGING MENT HEALTH, V19, P279, DOI 10.1080/13607863.2014.933307
   Saeedi BJ, 2015, MOL BIOL CELL, V26, P2252, DOI 10.1091/mbc.E14-07-1194
   Schuster S, 2018, NAT REV GASTRO HEPAT, V15, P349, DOI 10.1038/s41575-018-0009-6
   Szabo G, 2015, GASTROENTEROLOGY, V148, P30, DOI 10.1053/j.gastro.2014.10.042
   SZABO S, 1985, GASTROENTEROLOGY, V88, P228, DOI 10.1016/S0016-5085(85)80176-1
   Thevaranjan N, 2017, CELL HOST MICROBE, V21, P455, DOI 10.1016/j.chom.2017.03.002
   Tilg H, 2016, HEPATOLOGY, V64, P955, DOI 10.1002/hep.28456
   Tripathi A, 2018, NAT REV GASTRO HEPAT, V15, P397, DOI 10.1038/s41575-018-0011-z
   U.S. Department of Agriculture and U.S. Department of Health and Human Services, 2020, DIET GUID AM 2020 20, V9th
   Ueno A, 2012, NAT PROTOC, V7, P771, DOI 10.1038/nprot.2012.014
   Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791
   Wang LR, 2016, CELL HOST MICROBE, V19, P227, DOI 10.1016/j.chom.2016.01.003
   Wang Y, 2014, MOL MED REP, V9, P2352, DOI 10.3892/mmr.2014.2126
   Wang YH, 2011, AM J PATHOL, V179, P2866, DOI 10.1016/j.ajpath.2011.08.039
   Wheatley EG, 2020, SHOCK, V53, P71, DOI 10.1097/SHK.0000000000001321
   Yan AW, 2011, HEPATOLOGY, V53, P96, DOI 10.1002/hep.24018
   Zahs A, 2012, AM J PHYSIOL-GASTR L, V303, pG705, DOI 10.1152/ajpgi.00157.2012
   Zhong W, 2010, AM J PHYSIOL-GASTR L, V298, pG625, DOI 10.1152/ajpgi.00350.2009
NR 58
TC 7
Z9 8
U1 1
U2 11
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1742-4933
J9 IMMUN AGEING
JI Immun. Ageing
PD SEP 23
PY 2021
VL 18
IS 1
AR 37
DI 10.1186/s12979-021-00247-8
PG 11
WC Geriatrics & Gerontology; Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology; Immunology
GA UU2RI
UT WOS:000698648100001
PM 34556145
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Simcox, J
   Geoghegan, G
   Maschek, JA
   Bensard, CL
   Pasquali, M
   Miao, R
   Lee, S
   Jiang, L
   Huck, I
   Kershaw, EE
   Donato, AJ
   Apte, U
   Longo, N
   Rutter, J
   Schreiber, R
   Zechner, R
   Cox, J
   Villanueva, CJ
AF Simcox, Judith
   Geoghegan, Gisela
   Maschek, John Alan
   Bensard, Claire L.
   Pasquali, Marzia
   Miao, Ren
   Lee, Sanghoon
   Jiang, Lei
   Huck, Ian
   Kershaw, Erin E.
   Donato, Anthony J.
   Apte, Udayan
   Longo, Nicola
   Rutter, Jared
   Schreiber, Renate
   Zechner, Rudolf
   Cox, James
   Villanueva, Claudio J.
TI Global Analysis of Plasma Lipids Identifies Liver-Derived Acylcarnitines
   as a Fuel Source for Brown Fat Thermogenesis
SO CELL METABOLISM
LA English
DT Article
ID CARNITINE PALMITOYLTRANSFERASE-I; NUCLEAR FACTOR 4-ALPHA; ADIPOSE
   TRIGLYCERIDE LIPASE; TANDEM MASS-SPECTROMETRY; ACTIVATED RECEPTOR-ALPHA;
   GENE-EXPRESSION; NONSHIVERING THERMOGENESIS; HEPATOCELLULAR-CARCINOMA;
   INSULIN-RESISTANCE; COACTIVATOR PGC-1
AB Cold-induced thermogenesis is an energy-demanding process that protects endotherms against a reduction in ambient temperature. Using non-targeted liquid chromatography-mass spectrometry-based lipidomics, we identified elevated levels of plasma acylcarnitines in response to the cold. We found that the liver undergoes a metabolic switch to provide fuel for brown fat thermogenesis by producing acylcarnitines. Cold stimulates white adipocytes to release free fatty acids that activate the nuclear receptor HNF4 alpha, which is required for acylcarnitine production in the liver and adaptive thermogenesis. Once in circulation, acylcarnitines are transported to brown adipose tissue, while uptake into white adipose tissue and liver is blocked. Finally, a bolus of L-carnitine or palmitoylcarnitine rescues the cold sensitivity seen with aging. Our data highlight an elegant mechanism whereby white adipose tissue provides long-chain fatty acids for hepatic carnitilation to generate plasma acylcarnitines as a fuel source for peripheral tissues in mice.
C1 [Simcox, Judith; Geoghegan, Gisela; Maschek, John Alan; Bensard, Claire L.; Miao, Ren; Lee, Sanghoon; Rutter, Jared; Cox, James; Villanueva, Claudio J.] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA.
   [Pasquali, Marzia; Longo, Nicola] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84112 USA.
   [Pasquali, Marzia; Longo, Nicola] Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT 84112 USA.
   [Jiang, Lei] Univ Texas Southwestern Med Ctr Dallas, Childrens Res Inst, Dallas, TX 75390 USA.
   [Huck, Ian; Apte, Udayan] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA.
   [Kershaw, Erin E.] Univ Pittsburgh, Div Endocrinol & Metab, Dept Med, Pittsburgh, PA 15213 USA.
   [Donato, Anthony J.] Vet Affairs Med Ctr, Dept Exercise & Sport Sci, Geriatr Res Educ & Clin Ctr, Salt Lake City, UT 84112 USA.
   [Bensard, Claire L.; Rutter, Jared] Univ Utah, Howard Hughes Med Inst, Sch Med, Salt Lake City, UT 84112 USA.
   [Schreiber, Renate; Zechner, Rudolf] Karl Franzens Univ Graz, Inst Mol Biosci, Heinrichstr 31, A-8010 Graz, Austria.
C3 Utah System of Higher Education; University of Utah; Utah System of
   Higher Education; University of Utah; Utah System of Higher Education;
   University of Utah; University of Texas System; University of Texas
   Southwestern Medical Center Dallas; University of Kansas; University of
   Kansas Medical Center; Pennsylvania Commonwealth System of Higher
   Education (PCSHE); University of Pittsburgh; US Department of Veterans
   Affairs; Veterans Health Administration (VHA); Geriatric Research
   Education & Clinical Center; Utah System of Higher Education; University
   of Utah; Howard Hughes Medical Institute; University of Graz
RP Villanueva, CJ (corresponding author), Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA.
EM villanueva@biochem.utah.edu
RI Kershaw, Erin E/G-9587-2013
OI Kershaw, Erin E/0000-0002-3887-4868; Simcox, Judith/0000-0001-7350-6342;
   Villanueva, Claudio/0000-0002-9731-7463; /0000-0001-8564-2392;
   Schreiber, Renate/0000-0002-3475-157X
FU NIDDK [KO1DK097285, RO3DK103089, RO1DK103930]; Margolis Research
   Foundation; NIDDK DRC [T32DK091317, S10 OD016232-01]
FX The authors are grateful to members of the Diabetes and Metabolism
   Center and the Biochemistry Department at the University of Utah for
   useful discussion and feedback. Lipidomics and metabolic tracer analysis
   was performed at the Metabolomics Core Facility at the University of
   Utah. This study was supported by NIDDK KO1DK097285, NIDDK RO3DK103089,
   NIDDK RO1DK103930, Margolis Research Foundation, NIDDK DRC, T32DK091317,
   and S10 OD016232-01. The content is solely the responsibility of the
   authors and does not necessarily represent the official views of the
   NIH.
CR Ahmadian M, 2011, CELL METAB, V13, P739, DOI 10.1016/j.cmet.2011.05.002
   Alpern D, 2014, ELIFE, V3, DOI 10.7554/eLife.03613
   BACONNIER P, 1979, AM J PHYSIOL, V237, pR334, DOI 10.1152/ajpregu.1979.237.5.R334
   Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297
   Bukong TN, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004424
   Burrage LC, 2016, J PEDIATR-US, V169, P208, DOI 10.1016/j.jpeds.2015.10.045
   CANNON B, 1982, FEBS LETT, V150, P129, DOI 10.1016/0014-5793(82)81319-7
   Chondronikola M, 2014, DIABETES, V63, P4089, DOI 10.2337/db14-0746
   Collins QF, 2006, J BIOL CHEM, V281, P24336, DOI 10.1074/jbc.M602177200
   Costa CCG, 1999, PEDIATR RES, V46, P440, DOI 10.1203/00006450-199910000-00013
   Dhe-Paganon S, 2002, J BIOL CHEM, V277, P37973, DOI 10.1074/jbc.C200420200
   ESSER V, 1993, J BIOL CHEM, V268, P5817
   Festuccia William T, 2011, Front Endocrinol (Lausanne), V2, P84, DOI 10.3389/fendo.2011.00084
   Fingerhut R, 2001, CLIN CHEM, V47, P1763
   Gempel K, 2002, J INHERIT METAB DIS, V25, P17, DOI 10.1023/A:1015109127986
   GENUTH SM, 1981, METABOLISM, V30, P393, DOI 10.1016/0026-0495(81)90121-9
   Golozoubova V, 2001, FASEB J, V15, P2048, DOI 10.1096/fj.00-0536fje
   Gutgesell A, 2009, J MOL ENDOCRINOL, V43, P241, DOI 10.1677/JME-09-0064
   Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965
   Haemmerle G, 2011, NAT MED, V17, P1076, DOI 10.1038/nm.2439
   HAYASHI Y, 1993, MOL ENDOCRINOL, V7, P1049, DOI 10.1210/me.7.8.1049
   Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001
   Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131
   HIATT WR, 1989, J CLIN INVEST, V84, P1167, DOI 10.1172/JCI114281
   HIMMSHAGEN J, 1994, AM J PHYSIOL, V266, pR1371, DOI 10.1152/ajpregu.1994.266.4.R1371
   Hue L, 2009, AM J PHYSIOL-ENDOC M, V297, pE578, DOI 10.1152/ajpendo.00093.2009
   Katajamaa M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-179
   Kinoshita K, 2014, ENDOCRINOLOGY, V155, P3484, DOI 10.1210/en.2014-1175
   LAFONTAN M, 1993, J LIPID RES, V34, P1057
   Liu AP, 2005, J CHROMATOGR B, V827, P193, DOI 10.1016/j.jchromb.2005.09.004
   Longo N, 2006, AM J MED GENET C, V142C, P77, DOI 10.1002/ajmg.c.30087
   Louet JF, 2002, J BIOL CHEM, V277, P37991, DOI 10.1074/jbc.M205087200
   LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0
   Mai M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082459
   Martinez-Jimenez CP, 2010, MOL CELL BIOL, V30, P565, DOI 10.1128/MCB.00927-09
   Mayer N, 2013, NAT CHEM BIOL, V9, P785, DOI [10.1038/NCHEMBIO.1359, 10.1038/nchembio.1359]
   McCoin CS, 2015, NAT REV ENDOCRINOL, V11, P617, DOI 10.1038/nrendo.2015.129
   MCGARRY JD, 1991, BIOCHIMIE, V73, P77, DOI 10.1016/0300-9084(91)90078-F
   Mu X, 2015, J CLIN INVEST, V125, P3891, DOI 10.1172/JCI77995
   Orava J, 2011, CELL METAB, V14, P272, DOI 10.1016/j.cmet.2011.06.012
   Pandey MK, 2012, J MED CHEM, V55, P10674, DOI 10.1021/jm301345v
   Ramsay RR, 2001, BBA-PROTEIN STRUCT M, V1546, P21, DOI 10.1016/S0167-4838(01)00147-9
   Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100
   Rhee J, 2006, J BIOL CHEM, V281, P14683, DOI 10.1074/jbc.M512636200
   RICHES AC, 1973, J PHYSIOL-LONDON, V228, P279, DOI 10.1113/jphysiol.1973.sp010086
   Rodriguez-Cuenca S, 2007, CELL PHYSIOL BIOCHEM, V20, P877, DOI 10.1159/000110448
   SAGGERSON ED, 1982, BIOCHEM J, V204, P373, DOI 10.1042/bj2040373
   Schauer IE, 2009, METABOLISM, V58, P319, DOI 10.1016/j.metabol.2008.10.003
   Schoiswohl G, 2015, ENDOCRINOLOGY, V156, P3610, DOI 10.1210/en.2015-1322
   Schooneman MG, 2013, DIABETES, V62, P1, DOI 10.2337/db12-0466
   Seale P, 2009, GENE DEV, V23, P788, DOI 10.1101/gad.1779209
   Sellayah D, 2014, ENDOCRINOLOGY, V155, P485, DOI 10.1210/en.2013-1629
   Severgnini M, 2012, CYTOTECHNOLOGY, V64, P187, DOI 10.1007/s10616-011-9407-0
   Shekhawat PS, 2005, PEDIATR RES, V57, p78R, DOI 10.1203/01.PDR.0000159631.63843.3E
   Song SL, 2010, MOL CELL ENDOCRINOL, V325, P54, DOI 10.1016/j.mce.2010.05.019
   Tamai I, 1998, J BIOL CHEM, V273, P20378, DOI 10.1074/jbc.273.32.20378
   Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498
   Vilà-Brau A, 2013, J LIPID RES, V54, P592, DOI 10.1194/jlr.M028472
   Walesky C, 2013, HEPATOLOGY, V57, P2480, DOI 10.1002/hep.26251
   Wu QW, 2006, DIABETES, V55, P3229, DOI 10.2337/db06-0749
   Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380
   Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0
   Yamaguti K, 1996, BIOCHEM BIOPH RES CO, V225, P740, DOI 10.1006/bbrc.1996.1244
   Yoneshiro T, 2011, OBESITY, V19, P1755, DOI 10.1038/oby.2011.125
   Yu XX, 2002, FASEB J, V16, P155, DOI 10.1096/fj.01-0568com
   Yuan XH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005609
NR 66
TC 154
Z9 171
U1 3
U2 38
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1550-4131
EI 1932-7420
J9 CELL METAB
JI Cell Metab.
PD SEP 5
PY 2017
VL 26
IS 3
BP 509
EP +
DI 10.1016/j.cmet.2017.08.006
PG 20
WC Cell Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Endocrinology & Metabolism
GA FF8CZ
UT WOS:000409244000007
PM 28877455
OA Green Accepted, hybrid, Green Submitted
DA 2024-02-19
ER

PT J
AU Song, YF
   Tran, M
   Wang, L
   Shin, DJ
   Wu, JG
AF Song, Yongfeng
   Tran, Melanie
   Wang, Li
   Shin, Dong-Ju
   Wu, Jianguo
TI MiR-200c-3p targets SESN1 and represses the IL-6/AKT loop to prevent
   cholangiocyte activation and cholestatic liver fibrosis
SO LABORATORY INVESTIGATION
LA English
DT Article; Early Access
ID BILIARY EPITHELIAL-CELLS; HEPATOCYTE GROWTH-FACTOR; BILE-DUCT LIGATION;
   OXIDATIVE STRESS; INJURY; PROLIFERATION; EXPRESSION; ACIDS;
   INTERLEUKIN-6; SENESCENCE
AB Cholestasis causes ductular reaction in the liver where the reactive cholangiocytes not only proliferate but also gain a neuroendocrine-like phenotype, leading to inflammatory cell infiltration and extracellular matrix deposition and contributing to the development and progression of cholestatic liver fibrosis. This study aims to elucidate the role of miR-200c in cholestasis-induced biliary liver fibrosis and cholangiocyte activation. We found that miR-200c was extremely abundant in cholangiocytes but was reduced by cholestasis in a bile duct ligation (BDL) mouse model; miR-200c was also decreased by bile acids in vitro. Phenotypically, loss of miR-200c exacerbated cholestatic liver injury, including periductular fibrosis, intrahepatic inflammation, and biliary hyperplasia in both the BDL model and the 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) model. We identified sestrin 1 (SESN1) as a target of miR-200c. Sesn1(-/-)-BDL mice showed mitigation of cholestatic liver injury. On a molecular level, the pro-proliferative IL-6/AKT feedback loop was activated in Mir200c(-/-) livers but was inhibited in Sesn1(-/-) livers upon cholestasis in mice. Furthermore, rescuing expression of miR-200c by the adeno-associated virus serotype 8 ameliorated BDL-induced liver injury in Mir200c(-/-) mice. Taken together, this study demonstrates that miR-200c restrains the proliferative and neuroendocrine-like activation of cholangiocytes by targeting SESN1 and inhibiting the IL-6/AKT feedback loop to protect against cholestatic liver fibrosis. Our findings provide mechanistic insights regarding biliary liver fibrosis, which may help to reveal novel therapeutic targets for the treatment of cholestatic liver injury and liver fibrosis.
   Cholangiocytes are the primary targets of cholangiopathies. This study elucidates the role of miR-200c in maintaining cholangiocyte homeostasis making use of cell culture and mouse models of cholestasis. MiR-200c restrains the proliferative and neuroendocrine-like activation of cholangiocytes by targeting sestrin 1(SESN1) and inhibiting the IL-6/AKT feedback loop to prevent cholestatic liver injury. The findings provide critical mechanistic insights into biliary liver fibrosis and suggest miR-200c may be a novel therapeutic target of cholangiopathies.
C1 [Song, Yongfeng; Tran, Melanie; Shin, Dong-Ju] Univ Connecticut, Dept Physiol & Neurobiol, Storrs, CT 06269 USA.
   [Song, Yongfeng] Shandong First Med Univ, Dept Endocrinol & Metab, Shandong Prov Hosp, Tai An, Shandong, Peoples R China.
   [Wu, Jianguo] Cleveland Clin, Dept Inflammat & Immun, Lerner Res Inst, Cleveland, OH 44106 USA.
   [Wu, Jianguo] Case Western Reserve Univ, Dept Mol Med, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA.
C3 University of Connecticut; Shandong First Medical University & Shandong
   Academy of Medical Sciences; Cleveland Clinic Foundation; University
   System of Ohio; Case Western Reserve University; Cleveland Clinic
   Foundation
RP Wu, JG (corresponding author), Cleveland Clin, Dept Inflammat & Immun, Lerner Res Inst, Cleveland, OH 44106 USA.; Wu, JG (corresponding author), Case Western Reserve Univ, Dept Mol Med, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA.
EM wuj6@ccf.org
OI Wu, Jianguo/0000-0001-9801-5267; Song, yongfeng/0000-0001-8934-3154
FU American Heart Association [18POST33960183]; NIH [P50AA024333,
   R01AA027456, U01AA026938, R01AA026322, K01AA029474]; NIH through the
   Cleveland Digestive Diseases Research Core Center (DDRCC)
   Pilot/Feasibility program [P30DK097948]
FX We thank Dr. Meenakshisundaram Ananthanarayanan (Yale University) for
   cholangiocyte-derived MLC and MSC cells. M.T. was supported by an
   American Heart Association postdoctoral fellowship (18POST33960183).
   D.S. is supported by NIH R01AA026322. J.W. is supported by NIH
   P30DK097948 through the Cleveland Digestive Diseases Research Core
   Center (DDRCC) Pilot/Feasibility program (Pilot, to J.W.) and NIH
   K01AA029474 (to J.W.). J.W. was also supported by NIH P50AA024333,
   R01AA027456, and U01AA026938 (all to Laura E. Nagy, Cleveland Clinic).
CR Alpini G, 2002, GASTROENTEROLOGY, V123, P1226, DOI 10.1053/gast.2002.36055
   Benedetti A, 1997, HEPATOLOGY, V26, P9
   Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028
   Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569
   Cai BL, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0403-6
   Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200
   Cordani M, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/8794612
   Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379
   Esteller A, 2008, WORLD J GASTROENTERO, V14, P5641, DOI 10.3748/wjg.14.5641
   Fang ZG, 2021, CELL MOL GASTROENTER, V12, P921, DOI 10.1016/j.jcmgh.2021.04.015
   Feng YY, 2014, CELL PHYSIOL BIOCHEM, V34, P1983, DOI 10.1159/000366394
   Fickert P, 2017, J HEPATOL, V67, P619, DOI 10.1016/j.jhep.2017.04.026
   Gehring S, 2006, GASTROENTEROLOGY, V130, P810, DOI 10.1053/j.gastro.2005.11.015
   Glaser S, 2006, AM J PHYSIOL-GASTR L, V290, pG813, DOI 10.1152/ajpgi.00306.2005
   Glaser S, 2014, GASTROENTEROLOGY, V146, P1795, DOI 10.1053/j.gastro.2014.02.030
   Gu FM, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-150
   Gujral JS, 2004, AM J PHYSIOL-GASTR L, V286, pG499, DOI 10.1152/ajpgi.00318.2003
   Gujral JS, 2003, HEPATOLOGY, V38, P355, DOI 10.1053/jhep.2003.50341
   Hanafi NI, 2018, BIOMOLECULES, V8, DOI 10.3390/biom8040159
   Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407
   Hideshima T, 2001, ONCOGENE, V20, P5991, DOI 10.1038/sj.onc.1204833
   Hong L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160915
   Hou CH, 2011, J CELL PHYSIOL, V226, P2006, DOI 10.1002/jcp.22541
   Humphries B, 2015, ONCOTARGET, V6, P6472, DOI 10.18632/oncotarget.3052
   Johnson Christopher, 2012, Transl Gastrointest Cancer, V1, P58
   Kennedy LL, 2016, LAB INVEST, V96, P1256, DOI 10.1038/labinvest.2016.112
   Kolesnikoff N, 2014, J BIOL CHEM, V289, P11194, DOI 10.1074/jbc.M113.529172
   Lee SM, 2015, HEPATOLOGY, V61, P497, DOI 10.1002/hep.27437
   Magenta A, 2011, CELL DEATH DIFFER, V18, P1628, DOI 10.1038/cdd.2011.42
   Magenta A, 2017, CIRC RES, V120, P1399, DOI 10.1161/CIRCRESAHA.116.310274
   MATSUMOTO K, 1994, HEPATOLOGY, V20, P376
   Meng LK, 2015, AM J PATHOL, V185, P602, DOI 10.1016/j.ajpath.2014.10.027
   Monte MJ, 2009, WORLD J GASTROENTERO, V15, P804, DOI 10.3748/wjg.15.804
   Murakami Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016081
   O'Hara SP, 2013, J HEPATOL, V58, P575, DOI 10.1016/j.jhep.2012.10.011
   Park J, 1999, HEPATOLOGY, V29, P1037, DOI 10.1002/hep.510290423
   Puche JE, 2013, COMPR PHYSIOL, V3, P1473, DOI 10.1002/cphy.c120035
   Pulli B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067976
   Saito JM, 2000, GASTROENTEROLOGY, V118, P1157, DOI 10.1016/S0016-5085(00)70369-6
   Song YF, 2017, HEPATOLOGY, V66, P1183, DOI 10.1002/hep.29209
   Stanger BZ, 2015, ANNU REV PHYSIOL, V77, P179, DOI 10.1146/annurev-physiol-021113-170255
   Sun X, 2014, MOL CELL BIOCHEM, V388, P11, DOI 10.1007/s11010-013-1895-0
   Szabo G, 2013, NAT REV GASTRO HEPAT, V10, P542, DOI 10.1038/nrgastro.2013.87
   Tabibian JH, 2014, HEPATOLOGY, V59, P2263, DOI 10.1002/hep.26993
   Tang LL, 2017, CELL PHYSIOL BIOCHEM, V43, P1950, DOI 10.1159/000484119
   Tran M, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.96094
   Trauner M, 2017, HEPATOLOGY, V65, P1393, DOI 10.1002/hep.28991
   Vallim TQD, 2013, CELL METAB, V17, P657, DOI 10.1016/j.cmet.2013.03.013
   Wang YQ, 2017, HEPATOLOGY, V65, P2005, DOI 10.1002/hep.29076
   Werner M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138655
   Willeit P, 2016, EUR HEART J, V37, P3260, DOI 10.1093/eurheartj/ehw146
   Wruck CJ, 2011, J BIOL CHEM, V286, P4493, DOI 10.1074/jbc.M110.162008
   Wu JG, 2021, BBA-MOL BASIS DIS, V1867, DOI 10.1016/j.bbadis.2021.166083
   Wu JG, 2018, HEPATOLOGY, V68, P1111, DOI 10.1002/hep.29902
   Xiao YT, 2014, CELL SIGNAL, V26, P925, DOI 10.1016/j.cellsig.2014.01.003
   Yang ZH, 2016, MOL CANCER THER, V15, P2294, DOI 10.1158/1535-7163.MCT-16-0153
   Yokomuro S, 2000, HEPATOLOGY, V32, P26, DOI 10.1053/jhep.2000.8535
   Zhang L, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1423-6
   Zhang YC, 2012, LIVER INT, V32, P58, DOI 10.1111/j.1478-3231.2011.02662.x
   Zhang YX, 2016, SCI REP-UK, V6, DOI 10.1038/srep20559
   Zhang YX, 2014, HEPATOLOGY, V60, P919, DOI 10.1002/hep.27121
NR 61
TC 7
Z9 7
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0023-6837
EI 1530-0307
J9 LAB INVEST
JI Lab. Invest.
PD 2022 MAY
PY 2022
VL 102
IS 5
BP 485
EP 493
DI 10.1038/s41374-021-00710-6
EA DEC 2021
PG 9
WC Medicine, Research & Experimental; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pathology
GA 0V4ZR
UT WOS:000728776000001
PM 34880414
OA hybrid, Green Published
DA 2024-02-19
ER

PT J
AU FERDER, L
   INSERRA, F
   ROMANO, L
   ERCOLE, L
   PSZENNY, V
AF FERDER, L
   INSERRA, F
   ROMANO, L
   ERCOLE, L
   PSZENNY, V
TI EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITION ON MITOCHONDRIAL
   NUMBER IN THE AGING MOUSE
SO AMERICAN JOURNAL OF PHYSIOLOGY
LA English
DT Article
DE AGING; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; MITOCHONDRIA;
   GLOMERULOSCLEROSIS; MYOCARDIOSCLEROSIS; SURVIVAL
ID MYOCARDIAL FIBROSIS; GLOMERULAR INJURY; RENAL MASS; HYPERTENSION; RATS;
   CELL; CAPTOPRIL; SYSTEM; HEART; DNA
AB To investigate the effects of angiotensin-converting enzyme (ACE) inhibitors on the cellular function and structure in a variety of organs during the aging process, one hundred CF1 mice were divided into four groups of 25 animals each. Groups A, B, and C received enalapril in drinking water from weaning until the age of 24 mo. Doses administered were (in mg/l): group A, 20; group B, 10; group C, 5. Group D is the control. Animals were killed, and morphometric studies were performed in heart, kidney, liver, and spleen. As a result, there was a decrease of renal and myocardial sclerosis and an increase in the number of mitochondria in heart and liver cells, which is associated with a significant increase in survival of animals receiving ACE inhibitors. These findings lead us to think that natural aging mechanisms have been altered in those animals.
C1 UNIV BUENOS AIRES,JEWISH HOSP,INST NEPHROL,RA-1416 BUENOS AIRES,ARGENTINA.
C3 University of Buenos Aires
OI Romano, Luis/0000-0003-3144-3579
CR ANDERSON S, 1985, J CLIN INVEST, V76, P612, DOI 10.1172/JCI112013
   AZAR S, 1977, KIDNEY INT, V12, P28, DOI 10.1038/ki.1977.76
   BENABE JE, 1992, J HYPERTENS, V10, pS80
   CARDELLACH F, 1989, LANCET, V2, P44
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   CURTI D, 1990, MECH AGEING DEV, V55, P171, DOI 10.1016/0047-6374(90)90024-A
   DELACRUZ J, 1990, INT J BIOCHEM, V22, P729, DOI 10.1016/0020-711X(90)90008-Q
   DUCHESNE J, 1977, J THEOR BIOL, V66, P137, DOI 10.1016/0022-5193(77)90316-2
   FERDER L F, 1991, Journal of the American Society of Nephrology, V2, P677
   FERNANDES G, 1976, P NATL ACAD SCI USA, V73, P1279, DOI 10.1073/pnas.73.4.1279
   FISHER AB, 1988, OXYGEN RADICALS TISS, P34
   FLEG JL, 1986, AM J CARDIOL, V57, P33
   HALLIWELL B, 1991, AM J MED, V91, pS14, DOI 10.1016/0002-9343(91)90279-7
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   Hart R.W., 1983, Review of Biological Research in Aging, V1, P5
   HATTORI K, 1991, AM HEART J, V121, P1735, DOI 10.1016/0002-8703(91)90020-I
   HATTORI K, 1992, Journal of the American College of Cardiology, V19, p69A
   HAYFLICK L, 1980, MECH AGEING DEV, V14, P59, DOI 10.1016/0047-6374(80)90106-2
   HAYSLETT JP, 1979, PHYSIOL REV, V59, P137, DOI 10.1152/physrev.1979.59.1.137
   JALIL JE, 1991, AM J HYPERTENS, V4, P51, DOI 10.1093/ajh/4.1.51
   KARP G, 1984, CELL BIOL, P851
   KRAMER RE, 1990, MOL CELL ENDOCRINOL, V74, P87, DOI 10.1016/0303-7207(90)90111-K
   MENEELY GR, 1958, AM J MED, V25, P713, DOI 10.1016/0002-9343(58)90009-3
   MEYER TW, 1987, KIDNEY INT, V31, P752, DOI 10.1038/ki.1987.62
   MEYER TW, 1991, KIDNEY, P1891
   MILLER JG, 1968, LIVING SYSTEMS, P249
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   MIQUEL J, 1983, REV ESP GERIATR GERO, V18, P59
   MURFITT RR, 1978, MECH AGEING DEV, V8, P197, DOI 10.1016/0047-6374(78)90018-0
   MUSCARI C, 1990, BASIC RES CARDIOL, V85, P172, DOI 10.1007/BF01906970
   PICO L, 1977, NUCLEIC ACIDS RES, V4, P1302
   POLSON CD, 1982, AGE, V5, P5
   SHOCK NW, 1970, J AM DIET ASSOC, V56, P491
   STREHLER RL, 1975, TIME CELLS AGING, P221
   SUN AS, 1975, ARCH BIOCHEM BIOPHYS, V107, P1
   TASHIRO A, 1990, VIRCHOWS ARCH A, V416, P473, DOI 10.1007/BF01600297
   WEBER KT, 1991, CIRCULATION, V83, P1849, DOI 10.1161/01.CIR.83.6.1849
   YOSHIMURA S, 1989, TOHOKU J EXP MED, V157, P241, DOI 10.1620/tjem.157.241
   ZATZ R, 1986, J CLIN INVEST, V77, P1925, DOI 10.1172/JCI112521
NR 39
TC 57
Z9 60
U1 0
U2 0
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814
SN 0002-9513
J9 AM J PHYSIOL
JI Am. J. Physiol.
PD JUL
PY 1993
VL 265
IS 1
BP C15
EP C18
DI 10.1152/ajpcell.1993.265.1.C15
PN 1
PG 4
WC Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology
GA LP431
UT WOS:A1993LP43100003
PM 8338123
DA 2024-02-19
ER

PT J
AU Li, L
   Ng, TB
   Song, M
   Yuan, F
   Liu, ZK
   Wang, CL
   Jiang, Y
   Fu, M
   Liu, F
AF Li, L.
   Ng, T. B.
   Song, M.
   Yuan, F.
   Liu, Z. K.
   Wang, C. L.
   Jiang, Y.
   Fu, M.
   Liu, F.
TI A polysaccharide-peptide complex from abalone mushroom (<i>Pleurotus
   abalonus</i>) fruiting bodies increases activities and gene expression
   of antioxidant enzymes and reduces lipid peroxidation in
   senescence-accelerated mice
SO APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
LA English
DT Article
DE superoxide dismutase; catalase; glutathione peroxidase; lipid
   peroxidation; real-time PCR
ID SUPEROXIDE-DISMUTASE ACTIVITY; GLUTATHIONE-PEROXIDASE; OYSTER MUSHROOM;
   NITRIC-OXIDE; OSTREATUS; CATALASE; INJURY; RAT; PCR; RNA
AB The antioxidant effects of a polysaccharide-peptide complex (F22) from mushroom (Pleurotus abalonus)-fruiting bodies were studied. The activities of superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx) in the liver, kidney, and brain of senescence-accelerated mice showed a marked increase after treatment with the polysaccharide-peptide complex. Concurrently, the gene expression levels of SOD, CAT, and GPx, as determined with real-time polymerase chain reaction, were up-regulated in the liver, kidney, and brain, whereas the MDA content in these organs declined. The maximal lifespan of the mice was prolonged.
C1 Chinese Univ Hong Kong, Fac Med, Dept Biochem, Shatin, Hong Kong, Peoples R China.
   Nankai Univ, Coll Life Sci, Dept Microbiol, Tianjin 300071, Peoples R China.
   Tianjin Key Lab Microbial Funct, Tianjin, Peoples R China.
C3 Chinese University of Hong Kong; Nankai University
RP Ng, TB (corresponding author), Chinese Univ Hong Kong, Fac Med, Dept Biochem, Shatin, Hong Kong, Peoples R China.
EM biochemistry@cuhk.edu.hk; liufang3l2@nankai.edu.cn
CR BLUM J, 1985, ARCH BIOCHEM BIOPHYS, V240, P500, DOI 10.1016/0003-9861(85)90056-6
   BOBEK P, 1995, PHARMAZIE, V50, P441
   Bobek P, 2001, BRIT J BIOMED SCI, V58, P164
   Bor JY, 2006, J AGR FOOD CHEM, V54, P1680, DOI 10.1021/jf0527448
   Gilgun-Sherki Y, 2002, PHARMACOL REV, V54, P271, DOI 10.1124/pr.54.2.271
   Hu SH, 2006, J AGR FOOD CHEM, V54, P2103, DOI 10.1021/jf052890d
   Jayakumar T, 2006, FOOD CHEM TOXICOL, V44, P1989, DOI 10.1016/j.fct.2006.06.025
   JI LL, 1988, ARCH BIOCHEM BIOPHYS, V263, P150, DOI 10.1016/0003-9861(88)90623-6
   KELLOGG DE, 1994, BIOTECHNIQUES, V16, P1134
   KOJIMA T, 1990, CHEM PHARM BULL, V38, P3414, DOI 10.1248/cpb.38.3414
   KONO Y, 1982, J BIOL CHEM, V257, P5751
   Lavi I, 2006, CANCER LETT, V244, P61, DOI 10.1016/j.canlet.2005.12.007
   Li L, 2005, LIFE SCI, V77, P230, DOI 10.1016/j.lfs.2004.12.024
   Liu F, 2000, LIFE SCI, V66, P725, DOI 10.1016/S0024-3205(99)00643-8
   Maruyama Hirofumi, 2005, International Journal of Medicinal Mushrooms, V7, P539, DOI 10.1615/IntJMedMushr.v7.i4.30
   Masaki H, 1998, ARCH DERMATOL RES, V290, P113, DOI 10.1007/s004030050275
   MINOTTI G, 1988, ANN NY ACAD SCI, V551, P34, DOI 10.1111/j.1749-6632.1988.tb22318.x
   Naik GH, 2003, PHYTOCHEMISTRY, V63, P97, DOI 10.1016/S0031-9422(02)00754-9
   Ng TB, 2005, BIOCHEM CELL BIOL, V83, P78, DOI 10.1139/O04-100
   OLIVER CN, 1990, P NATL ACAD SCI USA, V87, P5144, DOI 10.1073/pnas.87.13.5144
   RADI R, 1991, ARCH BIOCHEM BIOPHYS, V288, P481, DOI 10.1016/0003-9861(91)90224-7
   Ririe KM, 1997, ANAL BIOCHEM, V245, P154, DOI 10.1006/abio.1996.9916
   Rodríguez AB, 1998, J PINEAL RES, V24, P9, DOI 10.1111/j.1600-079X.1998.tb00360.x
   SANTAGATI S, 2000, BRAIN RES PROTOC, P217
   Schröter M, 2001, J CLIN MICROBIOL, V39, P765, DOI 10.1128/JCM.39.2.765-768.2001
   Shashoua VE, 2004, BRAIN RES, V1024, P34, DOI 10.1016/j.brainres.2004.06.086
   SIMIC MG, 1988, MUTAT RES, V202, P377, DOI 10.1016/0027-5107(88)90199-6
   Simpson D, 2000, MOL VIS, V6, P178
   SUN Y, 1994, CLIN CHIM ACTA, V226, P101, DOI 10.1016/0009-8981(94)90108-2
   Switala J, 2002, ARCH BIOCHEM BIOPHYS, V401, P145, DOI 10.1016/S0003-9861(02)00049-8
   Wang HX, 1996, BIOCHEM CELL BIOL, V74, P95, DOI 10.1139/o96-010
   Wang YP, 1996, J SOC GYNECOL INVEST, V3, P179, DOI 10.1016/1071-5576(96)00015-9
   Wickens AP, 2001, RESP PHYSIOL, V128, P379, DOI 10.1016/S0034-5687(01)00313-9
   Yang JH, 2001, FOOD CHEM, V72, P465, DOI 10.1016/S0308-8146(00)00262-4
NR 34
TC 41
Z9 45
U1 5
U2 27
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0175-7598
EI 1432-0614
J9 APPL MICROBIOL BIOT
JI Appl. Microbiol. Biotechnol.
PD JUN
PY 2007
VL 75
IS 4
BP 863
EP 869
DI 10.1007/s00253-007-0865-4
PG 7
WC Biotechnology & Applied Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology
GA 190HE
UT WOS:000248049100017
PM 17347821
DA 2024-02-19
ER

PT J
AU Kitani, K
   Tanaka, S
   Zs-Nagy, I
AF Kitani, K
   Tanaka, S
   Zs-Nagy, I
TI Age-dependence of the lateral diffusion coefficient of lipids and
   proteins in the hepatocyte plasma membrane of BN/BiRijHsd rats as
   revealed by the smear-FRAP technique
SO ARCHIVES OF GERONTOLOGY AND GERIATRICS
LA English
DT Article
DE protein lateral mobility; lipid lateral mobility; hepatocyte plasma
   membrane; smear fluorescence recovery after photobleaching technique;
   N-4-nitrobenzo-2-oxa-1,3-diazolyl phosphatidylethanolamine lipid label;
   peroxide-induced autofluorescence label
ID FLUORESCENCE PHOTOBLEACHING RECOVERY; NEURO-BLASTOMA CELLS; LIVER
   SMEARS; MOBILITY; CONSTANT; AUTOFLUORESCENCE; GLYCOPROTEIN;
   CONCANAVALIN; RECEPTORS; DECREASE
AB The lateral diffusion coefficients of lipids (D-1) and proteins (D-p) were measured in hepatocyte plasma membranes in freshly prepared liver smears of Brown Norway (BN/BiRijHsd) rats by means of the fluorescence recovery after photobleaching (FRAP) method. D-1 was measured after staining with N-4-nitrobenzo-2-oxa-1,3-diazolyl phosphatidylethanolamine (NBD-PE) in 14 males in four age groups (4.3-30.4 months), and 12 females (5.0-31.0 months). D-p, was measured after the development of peroxide-induced autofluorescence (PIAF) in 16 males in four age groups (4.7-30.8 months) and 15 females in four age groups (4.0-28.1 months). Highly significant negative, linear age-correlations of 4 (R = -0.972 in males, and -0.840 in females, respectively) were found, the average data being 1.39 x 10(-9) cm(2)/s in the young male rats, and only 9.26 x 10(-10) cm(2)/s in the oldest ones, whereas in females, these two extremes were 1.44 x 10-9 and 8.97 x 10(-10) cm(2)/s, respectively. Protein lateral mobility also declined linearly with age; in the male rats it decreased from 2.7 x 10(-10) to 1.8. x 10(-10) cm(2)/s (R = - 0.903), while in the females It decreased from 2.64 x 10(-10) to 2.21x10(-10) cm(2)/s (R= -0.955) between the youngest and oldest age groups. There were also some characteristic differences in the fractional recoveries (FR%), too. These trends are comparable with those of F344 rats studied previously, supporting the conclusion that the changes in the lateral mobility of plasma membrane proteins and lipids represent important biomarkers of cellular aging also in the BN/BiRijHsd rats. (C) 1998 Elsevier Science Ireland Ltd. All rights reserved.
C1 Natl Inst Longev Sci, Obu, Aichi 474, Japan.
   Debrecen Univ Med, Sch Med, Dept Gerontol, VILEG Hungarian Sect, H-4012 Debrecen, Hungary.
C3 University of Debrecen
RP Zs-Nagy, I (corresponding author), Natl Inst Longev Sci, 36-3 Gengo,Morioka Cho, Obu, Aichi 474, Japan.
CR AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4
   Damjanovich S., 1994, MOBILITY PROXIMITY B
   DAWSON RMC, 1969, DATA BIOCH RES, P507
   DELAAT SW, 1979, BIOCHIM BIOPHYS ACTA, V558, P247, DOI 10.1016/0005-2736(79)90064-6
   DELAAT SW, 1980, P NATL ACAD SCI-BIOL, V77, P1526
   DRAGSTEN P, 1979, P NATL ACAD SCI USA, V76, P5163, DOI 10.1073/pnas.76.10.5163
   GEIGER B, 1983, BIOCHIM BIOPHYS ACTA, V737, P305, DOI 10.1016/0304-4157(83)90005-9
   GOLAN DE, 1980, P NATL ACAD SCI-BIOL, V77, P2537, DOI 10.1073/pnas.77.5.2537
   JACOBSON K, 1984, J CELL BIOL, V99, P1624, DOI 10.1083/jcb.99.5.1624
   KITANI K, 1991, INT CONGR SER, V940, P305
   Kitani K, 1996, INT HEPATOL COMMUN, V5, P236, DOI 10.1016/0928-4346(96)00303-9
   KITANI K, 1992, ARCH GERONTOL GERIAT, V14, P27, DOI 10.1016/0167-4943(92)90004-N
   KITANI K, 1988, HEPATOLOGY, V8, P125, DOI 10.1002/hep.1840080124
   KITANI K, 1991, ARCH GERONTOL GERIAT, V12, P133, DOI 10.1016/0167-4943(91)90024-K
   KLEINFELD AM, 1981, BIOCHIM BIOPHYS ACTA, V649, P471, DOI 10.1016/0005-2736(81)90438-7
   NAGY VZ, 1988, TISSUE CELL, V20, P229, DOI 10.1016/0040-8166(88)90044-4
   NOKUBO M, 1988, BIOCHIM BIOPHYS ACTA, V939, P441, DOI 10.1016/0005-2736(88)90090-9
   NOKUBO M, 1989, BIOCHIM BIOPHYS ACTA, V981, P303, DOI 10.1016/0005-2736(89)90041-2
   OHTA M, 1990, BIOCHEM PHARMACOL, V39, P1223, DOI 10.1016/0006-2952(90)90266-N
   PETTY HR, 1980, P NATL ACAD SCI-BIOL, V77, P6587, DOI 10.1073/pnas.77.11.6587
   SCHLESSINGER J, 1976, P NATL ACAD SCI USA, V73, P2409, DOI 10.1073/pnas.73.7.2409
   SCHLESSINGER J, 1977, P NATL ACAD SCI USA, V74, P2909, DOI 10.1073/pnas.74.7.2909
   SHEETZ MP, 1980, NATURE, V285, P510, DOI 10.1038/285510a0
   SHINITZKY M, 1994, BIOMEMBRANES STRUCTU, V2
   Snedecor GW, 1980, STAT METHODOL, V7th, P39
   SU YX, 1984, BIOCHIM BIOPHYS ACTA, V776, P92, DOI 10.1016/0005-2736(84)90254-2
   TANK DW, 1982, J CELL BIOL, V92, P207, DOI 10.1083/jcb.92.1.207
   WODA BA, 1979, J IMMUNOL, V123, P2161
   WU ES, 1982, P NATL ACAD SCI-BIOL, V79, P4962, DOI 10.1073/pnas.79.16.4962
   YECHIEL E, 1985, J BIOL CHEM, V260, P9132
   YGUERABIDE J, 1982, BIOPHYS J, V40, P69, DOI 10.1016/S0006-3495(82)84459-7
   Zs-Nagy I, 1998, MECH AGEING DEV, V101, P257, DOI 10.1016/S0047-6374(97)00179-6
   Zs-Nagy I., 1994, MEMBRANE HYPOTHESIS
   ZSNAGY I, 1990, ARCH GERONTOL GERIAT, V11, P243, DOI 10.1016/0167-4943(90)90068-H
   ZSNAGY I, 1988, BIOCHIM BIOPHYS ACTA, V939, P551, DOI 10.1016/0005-2736(88)90102-2
   ZSNAGY I, 1989, EXP GERONTOL, V24, P317, DOI 10.1016/0531-5565(89)90004-1
   ZSNAGY I, 1993, J GERONTOL, V48, pB86, DOI 10.1093/geronj/48.3.B86
   ZSNAGY I, 1989, J GERONTOL, V44, pB83, DOI 10.1093/geronj/44.4.B83
   ZSNAGY I, 1986, EXP GERONTOL, V21, P555, DOI 10.1016/0531-5565(86)90007-0
   ZSNAGY I, 1986, ARCH GERONTOL GERIAT, V5, P131, DOI 10.1016/0167-4943(86)90016-6
   ZSNAGY I, 1984, MIKROSKOPIE, V41, P12
   ZsNagy I, 1996, ARCH GERONTOL GERIAT, V23, P81, DOI 10.1016/0167-4943(96)00710-8
   ZsNagy I, 1997, J MOL MED, V75, P703
   ZSNAGY I, 1993, MECH AGEING DEV, V71, P85
NR 44
TC 14
Z9 15
U1 0
U2 2
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0167-4943
EI 1872-6976
J9 ARCH GERONTOL GERIAT
JI Arch. Gerontol. Geriatr.
PD MAY-JUN
PY 1998
VL 26
IS 3
BP 257
EP 273
DI 10.1016/S0167-4943(98)00008-9
PG 17
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA ZY644
UT WOS:000074644400006
PM 18653142
DA 2024-02-19
ER

PT J
AU Almroth, BC
   Sköld, M
   Sköld, HN
AF Almroth, Bethanie Carney
   Skold, Mattias
   Skold, Helen Nilsson
TI Gender differences in health and aging of Atlantic cod subject to size
   selective fishery
SO BIOLOGY OPEN
LA English
DT Article
DE Telomeres; Oxidative stress; Glutathione; Gender differences; Predation
   effects; Egg quality; Fish
ID MICROTITER PLATE ASSAY; LIFE-HISTORY EVOLUTION; TELOMERE LENGTH;
   OXIDATIVE DAMAGE; GLUTATHIONE DISULFIDE; GADUS-MORHUA; AGE; MATURATION;
   STRESS; REPRODUCTION
AB We have analyzed health and physiological aging parameters in male and female Atlantic cod, Gadus morhua, captured in Kattegat, Skagerrak and in Oresund. Gender differences were clearly evident in a number of variables. Males had longer liver telomeres and higher catalase activities than females, while females had higher superoxide dismutase activity, liver somatic index and condition factor. Effects of age were found for males where levels of the antioxidant glutathione and telomere length declined with age, indicating physiological aging. Liver somatic index increased and percentage oxidized glutathione decreased with age. Between-site comparisons of males show that percentage oxidized glutathione and catalase were lowest in Kattegat, whereas protein carbonyls and condition factor were higher in Skagerrak. Females, on the other hand, showed no differences between sites or indications of somatic aging or age-related effects in egg quality, indicating that older and larger female cod are healthy and show no changes in eggs with age. In contrast, males showed indications of physiological aging and lower condition than females. The results emphasize the importance of conserving old mature fish, in particular high egg-productive females, when managing fisheries. (C) 2012. Published by The Company of Biologists Ltd.
C1 [Almroth, Bethanie Carney] Univ Gothenburg, Dept Biol & Environm Sci Zool, SE-40530 Gothenburg, Sweden.
   [Skold, Mattias] Swedish Univ Agr Sci, Dept Aquat Resources, Inst Marine Res, SE-45321 Lysekil, Sweden.
   [Skold, Helen Nilsson] Univ Gothenburg, Dept Biol & Environm Sci Kristineberg, SE-45034 Fiskebackskil, Sweden.
C3 University of Gothenburg; Swedish University of Agricultural Sciences;
   University of Gothenburg
RP Almroth, BC (corresponding author), Univ Gothenburg, Dept Biol & Environm Sci Zool, Box 463, SE-40530 Gothenburg, Sweden.
EM bethanie.carney@zool.gu.se
RI Almroth, Bethanie Carney/Q-6411-2019
OI Almroth, Bethanie Carney/0000-0002-5037-4612
FU Kungliga Hvitfeldtska Stiftelsen; Wahlstroms foundation; Adlerbertska
   Stiftelsen; Johan och Jakob Soderbergs Stiftelse
FX We would like to thank Joakim Hjelm for input into planning this
   experiment, the crew of R/V Argos, especially Kerstin Magnusson and Jan
   Erik Johansson for fish sampling, Maria Hultman for technical assistance
   and Lars Forlin for valuable input. We would also like to thank Kungliga
   Hvitfeldtska Stiftelsen, Wahlstroms foundation, Adlerbertska Stiftelsen
   and Johan och Jakob Soderbergs Stiftelse for financial support. Data
   from catches, number of fish, sex, size, and all measured parameters
   here measured are available upon request from B.C.A.
CR Aebi H., 1984, METHOD ENZYMAT AN, P671
   Almroth BC, 2010, COMP BIOCHEM PHYS B, V155, P442, DOI 10.1016/j.cbpb.2010.01.012
   Anderson M. J., 2005, OTRO
   Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x
   [Anonymous], 2010, LONG TERM IMPACT DIF
   Atzmon G, 2010, P NATL ACAD SCI USA, V107, P1710, DOI 10.1073/pnas.0906191106
   Austad Steven N, 2006, Gend Med, V3, P79, DOI 10.1016/S1550-8579(06)80198-1
   BAKER MA, 1990, ANAL BIOCHEM, V190, P360, DOI 10.1016/0003-2697(90)90208-Q
   Berkeley SA, 2004, ECOLOGY, V85, P1258, DOI 10.1890/03-0706
   Bize P, 2009, P R SOC B, V276, P1679, DOI 10.1098/rspb.2008.1817
   Bonduriansky R, 2008, FUNCT ECOL, V22, P443, DOI 10.1111/j.1365-2435.2008.01417.x
   Bowen RL, 2004, GERONTOLOGY, V50, P265, DOI 10.1159/000079125
   Cardinale M, 2004, FISH RES, V69, P263, DOI 10.1016/j.fishres.2004.04.001
   Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47
   CHANG E, 1995, P NATL ACAD SCI USA, V92, P11190, DOI 10.1073/pnas.92.24.11190
   Dröge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001
   ELGAR MA, 1990, OIKOS, V59, P283, DOI 10.2307/3545546
   Farzaneh-Far R, 2008, ARTERIOSCL THROM VAS, V28, P1379, DOI 10.1161/ATVBAHA.108.167049
   FORLIN L, 1995, ECOTOX ENVIRON SAFE, V30, P164, DOI 10.1006/eesa.1995.1021
   Goto S, 1999, MECH AGEING DEV, V107, P245, DOI 10.1016/S0047-6374(98)00133-X
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Haussmann MF, 2008, MOL BIOL EVOL, V25, P220, DOI 10.1093/molbev/msm244
   Hsu CY, 2008, J GERONTOL A-BIOL, V63, P1267, DOI 10.1093/gerona/63.12.1267
   Hulbert AJ, 2007, PHYSIOL REV, V87, P1175, DOI 10.1152/physrev.00047.2006
   Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199
   Kim SK, 2007, J EXP BIOL, V210, P1607, DOI 10.1242/jeb.004887
   Knutsen H, 2003, MOL ECOL, V12, P385, DOI 10.1046/j.1365-294X.2003.01750.x
   Kyo S, 1999, CANCER RES, V59, P5917
   LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905
   Longhurst A, 2002, FISH RES, V56, P125, DOI 10.1016/S0165-7836(01)00351-4
   McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2
   Medawar P., 1952, UNSOLVED PROBLEM BIO
   Nordeide JT, 2000, FISH FISH, V1, P90, DOI 10.1046/j.1467-2979.2000.00005.x
   Nussey DH, 2008, FUNCT ECOL, V22, P393, DOI 10.1111/j.1365-2435.2008.01408.x
   Olsen E, 2005, CAN J FISH AQUAT SCI, V62, P811, DOI 10.1139/F05-065
   Olsen EM, 2004, NATURE, V428, P932, DOI 10.1038/nature02430
   Ormseth OA, 2009, ICES J MAR SCI, V66, P349, DOI 10.1093/icesjms/fsn156
   Pamplona R, 2011, AM J PHYSIOL-REG I, V301, pR843, DOI 10.1152/ajpregu.00034.2011
   Pauliny A, 2006, MOL ECOL, V15, P1681, DOI 10.1111/j.1365-294X.2006.02862.x
   REZNICK AZ, 1994, METHOD ENZYMOL, V233, P357
   REZNICK DA, 1990, NATURE, V346, P357, DOI 10.1038/346357a0
   Reznick DN, 1997, EXP GERONTOL, V32, P245, DOI 10.1016/S0531-5565(96)00129-5
   Rodríguez-Graña L, 2010, MAR ECOL PROG SER, V401, P1, DOI 10.3354/meps08459
   Sarkar A, 2006, ECOTOXICOLOGY, V15, P333, DOI 10.1007/s10646-006-0069-1
   Sarup P, 2011, AGE, V33, P69, DOI 10.1007/s11357-010-9162-8
   Schreck CB, 2010, GEN COMP ENDOCR, V165, P549, DOI 10.1016/j.ygcen.2009.07.004
   Speakman JR, 2011, BIOESSAYS, V33, P255, DOI 10.1002/bies.201000132
   STEARNS SC, 1986, EVOLUTION, V40, P893, DOI 10.1111/j.1558-5646.1986.tb00560.x
   Stearns SC, 2000, P NATL ACAD SCI USA, V97, P3309, DOI 10.1073/pnas.060289597
   VANDEPUTTE C, 1994, CELL BIOL TOXICOL, V10, P415, DOI 10.1007/BF00755791
   Viña J, 2003, ANTIOXID REDOX SIGN, V5, P549, DOI 10.1089/152308603770310194
   Vitale F, 2006, ICES J MAR SCI, V63, P485, DOI 10.1016/j.icesjms.2005.09.001
   Walsh MR, 2006, ECOL LETT, V9, P142, DOI 10.1111/j.1461-0248.2005.00858.x
   Weismann A., 1889, ESSAYS HEREDITARY KI
   Wright PJ, 2011, ICES J MAR SCI, V68, P1918, DOI 10.1093/icesjms/fsr111
   Young JL, 2006, FISH FISH, V7, P262, DOI 10.1111/j.1467-2979.2006.00225.x
NR 56
TC 7
Z9 7
U1 2
U2 11
PU COMPANY BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND
SN 2046-6390
J9 BIOL OPEN
JI Biol. Open
PD SEP 15
PY 2012
VL 1
IS 9
BP 922
EP 928
DI 10.1242/bio.20121446
PG 7
WC Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics
GA V36IG
UT WOS:000209205400013
PM 23213487
OA Green Published, Green Accepted, gold
DA 2024-02-19
ER

PT J
AU Hirano, S
   Bless, DM
   del Río, AM
   Connor, NP
   Ford, CN
AF Hirano, S
   Bless, DM
   del Río, AM
   Connor, NP
   Ford, CN
TI Therapeutic potential of growth factors for aging voice
SO LARYNGOSCOPE
LA English
DT Article; Proceedings Paper
CT Meeting of the American-Laryngological-Association
CY MAY 02-03, 2003
CL NASHVILLE, TN
SP Amer Laryngol Assoc
DE presbyphonia; basic fibroblast growth factor; hepatocyte growth factor;
   fibroblast; vocal fold; hyaluronic acid; collagen; age
ID AGE-RELATED-CHANGES; MANAGEMENT; EXPRESSION; COLLAGEN
AB Objectives/Hypothesis: It has been reported that in aged vocal folds, dense collagen deposition takes place and hyaluronic acid decreases in the lamina propria, which are thought to contribute to the vocal problems occurring with age (presbyphonia). To restore aged vocal folds to their younger state, it seems crucial to address these age-related lamina propria changes. Intervention that might increase hyaluronic acid and decrease collagen would appear to be a potentially useful approach. The present study examined the effects of growth factors on aged fibroblasts in terms of the production of hyaluronic acid and collagen type I. Study Design: In vitro study using animal model. Methods: Fibroblasts were harvested from young and aged rat vocal folds and cultured with or without hepatocyte growth factor and/or basic fibroblast growth factor at different concentrations. Subsequently, the production of hyaluronic acid and collagen type I was examined in the supernatant culture media using enzyme-linked immunosorbent assay. Results: Aged fibroblasts produced less hyaluronic acid than younger fibroblasts. When aged and young fibroblasts were cultured with basic fibroblast growth factor, hyaluronic acid production increased and collagen type I production decreased regardless of the concentration, whereas the effects of hepatocyte growth factor appeared to vary with concentration. The basic fibroblast growth factor also was associated with stimulation of growth of aged fibroblasts. Conclusion: The present results suggest that growth factors, especially basic fibroblast growth factor, may have therapeutic potential in restoration of aged vocal fold.
C1 Kyoto Natl Hosp, Dept Bronchoesophagol, Kyoto 6128555, Japan.
   Univ Wisconsin, Dept Surg, Div Otolaryngol Head & Neck Surg, Madison, WI USA.
   William S Middleton Mem Vet Adm Med Ctr, Dept Otolaryngol Head & Neck Surg, Madison, WI USA.
C3 University of Wisconsin System; University of Wisconsin Madison; US
   Department of Veterans Affairs; Veterans Health Administration (VHA);
   William S Middleton Memorial Veterans Hospital
RP Hirano, S (corresponding author), Kyoto Natl Hosp, Dept Bronchoesophagol, 1-1 Fukakusa Mukaihata, Kyoto 6128555, Japan.
EM chiraka@aol.com
OI Munoz del Rio, Alejandro/0000-0002-1743-269X
FU NIDCD NIH HHS [R01 DC005935, R01 DC 4428] Funding Source: Medline
CR ASHCROFT GS, 1995, J ANAT, V187, P1
   BROADLEY C, 1995, LARYNGOSCOPE, V105, P23, DOI 10.1288/00005537-199501000-00008
   Butler JE, 2001, LARYNGOSCOPE, V111, P907, DOI 10.1097/00005537-200105000-00029
   Ding H, 2001, J GERONTOL A-BIOL, V56, pB145, DOI 10.1093/gerona/56.4.B145
   Ehrlich HP, 2000, BAS CLIN DERMATOL, P99
   Gray SD, 1999, LARYNGOSCOPE, V109, P845, DOI 10.1097/00005537-199906000-00001
   Hagen P, 1996, SOUTHERN MED J, V89, P204, DOI 10.1097/00007611-199602000-00009
   HELDIN P, 1989, BIOCHEM J, V258, P919, DOI 10.1042/bj2580919
   HIRANO M, 1974, FOLIA PHONIATR, V26, P89, DOI 10.1159/000263771
   Hirano M, 2000, ACTA OTO-LARYNGOL, V120, P336
   Hirano S, 2003, LARYNGOSCOPE, V113, P144, DOI 10.1097/00005537-200301000-00027
   Hong HH, 2002, J PERIODONTOL, V73, P145, DOI 10.1902/jop.2002.73.2.145
   Matsumoto K, 1997, BIOCHEM BIOPH RES CO, V239, P639, DOI 10.1006/bbrc.1997.7517
   Palmon A, 2001, J PERIODONTAL RES, V36, P65, DOI 10.1034/j.1600-0765.2001.360201.x
   Ramig LO, 2001, FOLIA PHONIATR LOGO, V53, P252, DOI 10.1159/000052680
   Sato K, 2002, ANN OTO RHINOL LARYN, V111, P15, DOI 10.1177/000348940211100103
   SATO K, 1995, ANN OTO RHINOL LARYN, V104, P839, DOI 10.1177/000348949510401102
   TUCKER HM, 1988, ANN OTO RHINOL LARYN, V97, P534, DOI 10.1177/000348948809700519
NR 18
TC 64
Z9 78
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0023-852X
EI 1531-4995
J9 LARYNGOSCOPE
JI Laryngoscope
PD DEC
PY 2004
VL 114
IS 12
BP 2161
EP 2167
DI 10.1097/01.mlg.0000149450.37640.db
PG 7
WC Medicine, Research & Experimental; Otorhinolaryngology
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Research & Experimental Medicine; Otorhinolaryngology
GA 878IE
UT WOS:000225639300014
PM 15564837
DA 2024-02-19
ER

PT J
AU Takenaka, Y
   Inoue, I
   Nakano, T
   Ikeda, M
   Kakinuma, Y
AF Takenaka, Yasuhiro
   Inoue, Ikuo
   Nakano, Takanari
   Ikeda, Masaaki
   Kakinuma, Yoshihiko
TI Prolonged disturbance of proteostasis induces cellular senescence via
   temporal mitochondrial dysfunction and subsequent mitochondrial
   accumulation in human fibroblasts
SO FEBS JOURNAL
LA English
DT Article; Early Access
DE aggregate; DNA damage response; lysosome; oxidative stress; proteasome
ID OXIDATIVE STRESS; PROTEASOME; INHIBITION; DEGRADATION; LIVER; INDUCTION;
   INCREASES; PHENOTYPE; LEVEL; CELLS
AB Proteolytic activity declines with age, resulting in the accumulation of aggregated proteins in aged organisms. To investigate how disturbance in proteostasis causes cellular senescence, we developed a stress-induced premature senescence (SIPS) model, in which normal human fibroblast MRC-5 cells were treated with the proteasome inhibitor MG132 or the vacuolar-type ATPase inhibitor bafilomycin A1 (BAFA1) for 5 days. Time-course studies revealed a significant increase in intracellular reactive oxygen species (ROS) and mitochondrial superoxide during and after drug treatment. Mitochondrial membrane potential initially decreased, suggesting temporal mitochondrial dysfunction during drug treatment, but was restored along with mitochondrial accumulation after drug treatment. AMP-activated protein kinase alpha was notably activated during treatment; thereafter, intracellular ATP levels significantly increased. SIPS induction by MG132 or BAFA1 was partially attenuated by co-treatment with vitamin E or rapamycin, in which the levels of ROS, mitochondrial accumulation, and protein aggregates were suppressed, implying the critical involvement of oxidative stress and mitochondrial function in SIPS progression. Rapamycin co-treatment also augmented the expression of HSP70 and activation of AKT, which could recover proteostasis and promote cell survival, respectively. Our study proposes a possible pathway from the disturbed proteostasis to cellular senescence via excess ROS production as well as functional and quantitative changes in mitochondria.
C1 [Takenaka, Yasuhiro; Kakinuma, Yoshihiko] Nippon Med Sch, Grad Sch Med, Dept Physiol, Tokyo, Japan.
   [Takenaka, Yasuhiro; Inoue, Ikuo] Saitama Med Univ, Dept Endocrinol & Diabet, Saitama, Japan.
   [Nakano, Takanari] Saitama Med Univ, Dept Biochem, Saitama, Japan.
   [Ikeda, Masaaki] Saitama Med Univ, Dept Physiol, Saitama, Japan.
C3 Nippon Medical School; Saitama Medical University; Saitama Medical
   University; Saitama Medical University
RP Takenaka, Y (corresponding author), Nippon Med Sch, Grad Sch Med, Dept Physiol, Bunkyo Ku, Tokyo 1138602, Japan.
EM yasuhiro-takenaka@nms.ac.jp
RI Takenaka, Yasuhiro/HDO-7290-2022
OI Kakinuma, Yoshihiko/0000-0001-5470-9128
FU Nippon Medical School; JSPS KAKENHI [21K11605]; Grants-in-Aid for
   Scientific Research [21K11605] Funding Source: KAKEN
FX We are grateful to Santa Cruz Biotechnology, Inc. (Dallas, TX) and Cosmo
   Bio Co., Ltd. (Tokyo, Japan) for providing the sample antibodies listed
   in the Appendix S1. We would like to thank Editage (www.editage.jp) for
   English language editing. This work was supported by a Nippon Medical
   School Grant-inAid for Medical Research and JSPS KAKENHI grant number
   21K11605.
CR Blagosklonny MV, 2011, AGING-US, V3, P94, DOI 10.18632/aging.100281
   Brand MD, 2016, FREE RADICAL BIO MED, V100, P14, DOI 10.1016/j.freeradbiomed.2016.04.001
   Chang BD, 2000, P NATL ACAD SCI USA, V97, P4291, DOI 10.1073/pnas.97.8.4291
   Chao TH, 2014, FREE RADICAL BIO MED, V74, P175, DOI 10.1016/j.freeradbiomed.2014.05.023
   Cho S, 2012, MOL CELLS, V33, P597, DOI 10.1007/s10059-012-0042-1
   Chondrogianni N, 2004, BIOGERONTOLOGY, V5, P55, DOI 10.1023/B:BGEN.0000017687.55667.42
   Chondrogianni N, 2003, J BIOL CHEM, V278, P28026, DOI 10.1074/jbc.M301048200
   CUI W, 2013, OXID MED CELL LONGEV, V2013, DOI DOI 10.1155/2013/306073
   Dibble CC, 2009, MOL CELL BIOL, V29, P5657, DOI 10.1128/MCB.00735-09
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Harston RK, 2011, AM J PHYSIOL-HEART C, V300, pH1696, DOI 10.1152/ajpheart.00545.2010
   Hasty P, 2013, CELL CYCLE, V12, P20, DOI 10.4161/cc.22912
   Hayashi T, 1998, MECH AGEING DEV, V102, P55, DOI 10.1016/S0047-6374(98)00011-6
   Höhn A, 2013, REDOX BIOL, V1, P140, DOI 10.1016/j.redox.2013.01.006
   Huss M, 2009, J EXP BIOL, V212, P341, DOI 10.1242/jeb.024067
   Hwang JS, 2007, J GERONTOL A-BIOL, V62, P490, DOI 10.1093/gerona/62.5.490
   ISHIGAMI A, 1990, ARCH BIOCHEM BIOPHYS, V277, P189, DOI 10.1016/0003-9861(90)90568-J
   Korolchuk VI, 2017, EBIOMEDICINE, V21, P7, DOI 10.1016/j.ebiom.2017.03.020
   Lee HC, 2002, J BIOMED SCI, V9, P517, DOI 10.1159/000064724
   Legesse-Miller A, 2012, MOL BIOL CELL, V23, P3566, DOI 10.1091/mbc.E12-03-0192
   Leontieva OV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026126
   Leontieva OV, 2010, CELL CYCLE, V9, P4323, DOI 10.4161/cc.9.21.13584
   Lerner C, 2013, AGING CELL, V12, P966, DOI 10.1111/acel.12122
   Maejima Y, 2008, AGING CELL, V7, P125, DOI 10.1111/j.1474-9726.2007.00358.x
   Maharjan S, 2014, SCI REP-UK, V4, DOI 10.1038/srep05896
   Martínez-Cisuelo V, 2016, EXP GERONTOL, V83, P130, DOI 10.1016/j.exger.2016.08.002
   Moiseeva O, 2009, MOL CELL BIOL, V29, P4495, DOI 10.1128/MCB.01868-08
   Morita M, 2015, CELL CYCLE, V14, P473, DOI 10.4161/15384101.2014.991572
   Nacarelli T, 2017, MOL CELL ENDOCRINOL, V455, P83, DOI 10.1016/j.mce.2016.08.049
   Nathan JA, 2013, EMBO J, V32, P552, DOI 10.1038/emboj.2012.354
   Ohtake F, 2018, P NATL ACAD SCI USA, V115, pE1401, DOI 10.1073/pnas.1716673115
   Park WH, 2012, ONCOL REP, V27, P1284, DOI 10.3892/or.2012.1642
   Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5
   Ramanathan A, 2009, P NATL ACAD SCI USA, V106, P22229, DOI 10.1073/pnas.0912074106
   Reeg S, 2015, ANTIOXID REDOX SIGN, V23, P239, DOI 10.1089/ars.2014.6062
   Summer R, 2019, AM J PHYSIOL-LUNG C, V316, pL1049, DOI 10.1152/ajplung.00244.2018
   Ukekawa R, 2004, BIOSCI BIOTECH BIOCH, V68, P2395, DOI 10.1271/bbb.68.2395
   Zhao JH, 2015, P NATL ACAD SCI USA, V112, P15790, DOI 10.1073/pnas.1521919112
NR 38
TC 10
Z9 10
U1 1
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1742-464X
EI 1742-4658
J9 FEBS J
JI FEBS J.
PD 2022 MAR
PY 2022
VL 289
IS 6
BP 1650
EP 1667
DI 10.1111/febs.16249
EA NOV 2021
PG 18
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA ZT2CY
UT WOS:000713747700001
PM 34689411
OA Bronze
DA 2024-02-19
ER

PT J
AU Bergamini, E
   Cavallini, G
   Donati, A
   Gori, Z
AF Bergamini, E
   Cavallini, G
   Donati, A
   Gori, Z
TI The anti-ageing effects of caloric restriction may involve stimulation
   of macroautophagy and lysosomal degradation, and can be intensified
   pharmacologically
SO BIOMEDICINE & PHARMACOTHERAPY
LA English
DT Article
DE ageing; autophagy; caloric restriction
ID AGE-RELATED-CHANGES; LIFE-SPAN EXTENSION; RAT-LIVER; AUTOPHAGIC
   PROTEOLYSIS; PROTEIN-DEGRADATION; INSULIN-RECEPTOR; GROWTH-HORMONE;
   DIETARY RESTRICTION; OXIDATIVE STRESS; ACCUMULATION
AB Caloric restriction (CR) and a reduced growth hormone (GH)-insulin-like growth factor (IGF-1) axis are, associated with an extension of lifespan across taxa. Evidence is reviewed showing that CR and reduced insulin of GH-IGF-1 axis may exhibit their effects at least partly by their common stimulatory action on autophagy, the cell repair mechanism responsible for the housekeeping of cell membranes and organelles including the free radical generators peroxisomes and mitochondria. It is shown that the life-long weekly administration of an anti-lipolytic drug may decrease glucose and insulin levels and stimulate autophagy and intensify anti-ageing effects of submaximal CR. (C) 2003 Editions scientifiques et medicales Elsevier SAS. All rights reserved.
C1 Univ Pisa, Ctr Ric Biol & Patol Invecchiamento, Scuola Med, I-56126 Pisa, Italy.
C3 University of Pisa
RP Bergamini, E (corresponding author), Univ Pisa, Ctr Ric Biol & Patol Invecchiamento, Scuola Med, Via Roma 55, I-56126 Pisa, Italy.
EM ebergami@ipg.med.unipi.it
CR Aubert S, 1996, J CELL BIOL, V133, P1251, DOI 10.1083/jcb.133.6.1251
   Bartlett TA, 2001, TELECOMMUN REP INT, V12, P3
   Bergamini E, 1995, AGING-CLIN EXP RES, V7, P473, DOI 10.1007/BF03324374
   BERGAMINI E, 1993, EXP MOL PATHOL, V59, P13, DOI 10.1006/exmp.1993.1023
   BERGAMINI E, 1994, AM J PHYSIOL, V266, pG118, DOI 10.1152/ajpgi.1994.266.1.G118
   Bergamini E, 1998, AGING-CLIN EXP RES, V10, P174
   BERGAMINI E, 2002, G GERONTOL, V50, P181
   Blüher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223
   BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0
   Carter CS, 2002, TRENDS GENET, V18, P295, DOI 10.1016/S0168-9525(02)02696-3
   Cavallini G, 2002, AGING CLIN EXP RES, V14, P152
   Cavallini G, 2001, EXP GERONTOL, V36, P497, DOI 10.1016/S0531-5565(00)00224-2
   CHEN MH, 1994, PLANT J, V6, P625, DOI 10.1046/j.1365-313X.1994.6050625.x
   Cotran R., 1999, Robbins Pathologic Basis of Disease, V6th
   CUBEDDU TL, 1985, BIOCHIM BIOPHYS ACTA, V839, P96, DOI 10.1016/0304-4165(85)90186-2
   Cuervo AM, 2000, EXP GERONTOL, V35, P119, DOI 10.1016/S0531-5565(00)00075-9
   Del Roso A, 1991, Aging (Milano), V3, P407
   Del Roso A, 2003, EXP GERONTOL, V38, P519, DOI 10.1016/S0531-5565(03)00002-0
   DELROSO A, 1991, ACTA BIOL HUNG, V42, P87
   Dolfi C, 2003, BIOGERONTOLOGY, V4, P113, DOI 10.1023/A:1023304021679
   Dominici FP, 2002, J ENDOCRINOL, V173, P81, DOI 10.1677/joe.0.1730081
   Donati A, 2001, J GERONTOL A-BIOL, V56, pB288, DOI 10.1093/gerona/56.7.B288
   Donati A, 2001, J GERONTOL A-BIOL, V56, pB375, DOI 10.1093/gerona/56.9.B375
   Finch CE, 1997, SCIENCE, V278, P407, DOI 10.1126/science.278.5337.407
   Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298
   IVY GO, 1989, BRAIN RES, V498, P360, DOI 10.1016/0006-8993(89)91117-7
   IVY GO, 1989, ADV EXP MED BIOL, V266, P31
   IVY GO, 1984, SCIENCE, V226, P985, DOI 10.1126/science.6505679
   KALEN A, 1989, LIPIDS, V24, P579, DOI 10.1007/BF02535072
   Kealy RD, 2002, J AM VET MED ASSOC, V220, P1315, DOI 10.2460/javma.2002.220.1315
   Kenyon C, 2001, CELL, V105, P165, DOI 10.1016/S0092-8674(01)00306-3
   KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0
   Kim J, 2000, ANNU REV BIOCHEM, V69, P303, DOI 10.1146/annurev.biochem.69.1.303
   Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942
   KITANI K, 1989, ADV EXP MED BIOL, V266, P75
   Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717
   Laron Z, 2002, NOVART FDN SYMP, V242, P125
   Li CM, 2002, MECH AGEING DEV, V123, P603, DOI 10.1016/S0047-6374(01)00408-0
   Marino M, 1998, J GERONTOL A-BIOL, V53, pB87, DOI 10.1093/gerona/53A.2.B87
   MASORO EJ, 2002, RES PROFILES AGING
   MCCARTER RJ, 1992, AM J PHYSIOL, V263, pE448, DOI 10.1152/ajpendo.1992.263.3.E448
   McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63
   MORTIMORE GE, 1987, ANNU REV NUTR, V7, P539, DOI 10.1146/annurev.nu.07.070187.002543
   MORTIMORE GE, 1989, DIABETES METAB REV, V5, P49, DOI 10.1002/dmr.5610050105
   Pamplona R, 2002, MECH AGEING DEV, V123, P1437, DOI 10.1016/S0047-6374(02)00076-3
   Reggiori F, 2002, EUKARYOT CELL, V1, P11, DOI 10.1128/EC.01.1.11-21.2002
   Roth GS, 1999, J AM GERIATR SOC, V47, P896, DOI 10.1111/j.1532-5415.1999.tb03851.x
   SEGLEN PO, 1992, EXPERIENTIA, V48, P158, DOI 10.1007/BF01923509
   Shimokawa I, 2002, AM J PATHOL, V160, P2259, DOI 10.1016/S0002-9440(10)61173-X
   Sohal RS, 2002, FREE RADICAL BIO MED, V33, P37, DOI 10.1016/S0891-5849(02)00856-0
   STEGER RW, 1993, J REPROD FERTIL, P61
   Stevens A., 2000, Pathology
   Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987
   Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447
   Troen BR, 2003, MT SINAI J MED, V70, P3
   Vittorini S, 1999, J GERONTOL A-BIOL, V54, pB318, DOI 10.1093/gerona/54.8.B318
   Yamaza H, 2002, MICROSC RES TECHNIQ, V59, P325, DOI 10.1002/jemt.10212
NR 57
TC 111
Z9 128
U1 2
U2 17
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 0753-3322
EI 1950-6007
J9 BIOMED PHARMACOTHER
JI Biomed. Pharmacother.
PD JUL-AUG
PY 2003
VL 57
IS 5-6
BP 203
EP 208
DI 10.1016/S0753-3322(03)00048-9
PG 6
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA 712ZN
UT WOS:000184829600004
PM 12888255
DA 2024-02-19
ER

PT J
AU Dolle, MET
   Giese, H
   Hopkins, CL
   Martus, HJ
   Hausdorff, JM
   Vijg, J
AF Dolle, MET
   Giese, H
   Hopkins, CL
   Martus, HJ
   Hausdorff, JM
   Vijg, J
TI Rapid accumulation of genome rearrangements in liver but not in brain of
   old mice
SO NATURE GENETICS
LA English
DT Article
ID TRANSGENIC MOUSE MODEL; IN-VIVO MUTATIONS; OXIDATIVE DAMAGE; DNA; AGE;
   8-HYDROXY-2'-DEOXYGUANOSINE; CELLS
AB Somatic mutations have long been considered a possible cause of ageing(1,2). To directly study mutational events in organs and tissues of ageing mammals, a transgenic mouse model has been generated that harbours lacZ reporter genes as part of chromosomally integrated plasmids(3-5). Using this model, we determined spontaneous mutant frequencies and spectra in mouse liver and brain as a function of age. In the liver, mutant frequencies increased with age from birth to 34 months; in the brain, an increase was observed only between birth and 4-6 months. Molecular characterization of the mutations showed that a substantial portion involved genome rearrangement events, with one breakpoint in a reporter gene and the other in the mouse flanking sequence. In the liver, these genome rearrangements did not increase with age until after 27 months, when they increased rapidly. In brain, the frequency of genome rearrangements was lower than in liver and did not increase with age.
C1 BETH ISRAEL DEACONESS MED CTR,BOSTON,MA 02115.
   HARVARD UNIV,SCH MED,INST MED,BOSTON,MA 02115.
C3 Harvard University; Beth Israel Deaconess Medical Center; Harvard
   University; Harvard Medical School
RI Hausdorff, Jeffrey/HLH-2392-2023
FU NIA NIH HHS [P01 1801 AG10829-01, 1 P30 AG13314-01] Funding Source:
   Medline; NIEHS NIH HHS [1 RO1 ES/CA 08797-01] Funding Source: Medline
CR AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   BOERRIGTER METI, 1995, NATURE, V377, P657, DOI 10.1038/377657a0
   Bronson R.T., 1990, GENETICS AGING, P280
   BRONSON RT, 1991, GROWTH DEVELOP AGING, V55, P169
   Dolle MET, 1996, MUTAGENESIS, V11, P111, DOI 10.1093/mutage/11.1.111
   FAILLA G, 1958, ANN NY ACAD SCI, V71, P1124, DOI 10.1111/j.1749-6632.1958.tb46828.x
   FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533
   FUKUCHI K, 1989, P NATL ACAD SCI USA, V86, P5893, DOI 10.1073/pnas.86.15.5893
   GILLE JJP, 1994, CARCINOGENESIS, V15, P2695, DOI 10.1093/carcin/15.12.2695
   GOSSEN JA, 1995, MUTAT RES-FUND MOL M, V331, P89, DOI 10.1016/0027-5107(95)00055-N
   GOSSEN JA, 1992, NUCLEIC ACIDS RES, V20, P3254, DOI 10.1093/nar/20.12.3254
   GOSSEN JA, 1993, MUTAGENESIS, V8, P243, DOI 10.1093/mutage/8.3.243
   HARRISON DE, 1983, EXP AGING RES, V9, P245, DOI 10.1080/03610738308258459
   HSIE AW, 1986, P NATL ACAD SCI USA, V83, P9616, DOI 10.1073/pnas.83.24.9616
   Kaneko T, 1996, MUTAT RES-DNAGING G, V316, P277, DOI 10.1016/S0921-8734(96)90010-7
   Martin GM, 1996, NAT GENET, V13, P25, DOI 10.1038/ng0596-25
   MARTIN GM, 1994, PRINCIPLES GERIATRIC, P19
   MULLAART E, 1988, MECH AGEING DEV, V45, P41, DOI 10.1016/0047-6374(88)90017-6
   MULLAART E, 1990, MUTAT RES, V237, P9, DOI 10.1016/0921-8734(90)90027-O
   ROWE LB, 1994, MAMM GENOME, V5, P253, DOI 10.1007/BF00389540
   SZILARD L, 1959, P NATL ACAD SCI USA, V45, P35
   vanderHorst GTJ, 1997, CELL, V89, P425, DOI 10.1016/S0092-8674(00)80223-8
   Vijg Jan, 1996, P391
   Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258
NR 24
TC 205
Z9 228
U1 0
U2 3
PU NATURE PUBLISHING CO
PI NEW YORK
PA 345 PARK AVE SOUTH, NEW YORK, NY 10010-1707
SN 1061-4036
J9 NAT GENET
JI Nature Genet.
PD DEC
PY 1997
VL 17
IS 4
BP 431
EP 434
DI 10.1038/ng1297-431
PG 4
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA YJ924
UT WOS:A1997YJ92400023
PM 9398844
DA 2024-02-19
ER

PT J
AU Matsumoto, Y
   Yoshizumi, T
   Toshima, T
   Takeishi, K
   Fukuhara, T
   Itoh, S
   Ikegami, T
   Soejima, Y
   Mori, M
AF Matsumoto, Yoshihiro
   Yoshizumi, Tomoharu
   Toshima, Takeo
   Takeishi, Kazuki
   Fukuhara, Takasuke
   Itoh, Shinji
   Ikegami, Toru
   Soejima, Yuji
   Mori, Masaki
TI Ectopic localization of autophagosome in fatty liver is a key factor for
   liver regeneration
SO ORGANOGENESIS
LA English
DT Article; Early Access
DE autophagy; fatty liver; lipophagy; liver regeneration; proteolysis
ID PARTIAL-HEPATECTOMY; ER STRESS; SENESCENCE; CELLS
AB Autophagy has a critical role in liver regeneration. However, no studies have demonstrated autophagic flux in the regenerating fatty liver. The aim of this study was to clarify the dynamics of autophagy in the regeneration of the fatty liver. Following 70% partial hepatectomy (PH) in db/db fatty mice, which is a non-alcoholic fatty liver disease (NAFLD) model, we investigated the survival rate and recovery of liver volume. Histological examination of the regenerating liver was examined using electron microscopy. The 7-day survival rate after PH in db/db mice was 20%, which was significantly lower than that in control mice (P< .01). Liver regeneration within 48 h after PH was significantly impaired in db/db mice (P< .05). The number of proliferating cell nuclear antigen (PCNA) positive cells and the expression levels of cell-cycle markers cyclins D, E, and A were lower in db/db mice compared with controls. In the regenerating liver, LC3-II level was higher in db/db mice, but p62 expression was increased and cathepsin D expression, a marker of autophagolysosome proteolysis, was decreased compared with controls. Additionally, electronic microscopy revealed that autophagosomes during liver regeneration in db/db mice were mainly located in lipid droplets. Our findings indicate that the different localization of autophagosomes in db/db mice compared with controls led to impairment of liver regeneration in the fatty liver.
C1 [Matsumoto, Yoshihiro; Yoshizumi, Tomoharu; Toshima, Takeo; Takeishi, Kazuki; Fukuhara, Takasuke; Itoh, Shinji; Ikegami, Toru; Soejima, Yuji; Mori, Masaki] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka, Japan.
   [Matsumoto, Yoshihiro; Yoshizumi, Tomoharu; Toshima, Takeo; Takeishi, Kazuki; Fukuhara, Takasuke; Itoh, Shinji; Ikegami, Toru; Soejima, Yuji; Mori, Masaki] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka, Japan.
C3 Kyushu University; Kyushu University
RP Yoshizumi, T (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.
EM tomyoshi@surg2.med.kyushu-u.ac.jp
RI Ikegami, Toru/GRI-9889-2022; Takeishi, Kazuki/AAC-9087-2019
OI Takeishi, Kazuki/0000-0002-8448-5396; fei, Jiang/0009-0001-0212-9030
CR Borude P, 2012, HEPATOLOGY, V56, P2344, DOI 10.1002/hep.25918
   Catanese MT, 2013, P NATL ACAD SCI USA, V110, P9505, DOI 10.1073/pnas.1307527110
   Christian P, 2013, BBA-MOL CELL BIOL L, V1831, P819, DOI 10.1016/j.bbalip.2012.12.009
   Clavien PA, 2010, HEPATOLOGY, V52, P715, DOI 10.1002/hep.23713
   Csak T, 2011, HEPATOLOGY, V54, P133, DOI 10.1002/hep.24341
   Ding WX, 2010, J BIOL CHEM, V285, P27879, DOI 10.1074/jbc.M110.119537
   Hamano M, 2014, J GASTROENTEROL, V49, P305, DOI 10.1007/s00535-013-0780-7
   Hamasaki M, 2013, NATURE, V495, P389, DOI 10.1038/nature11910
   Hatting M, 2013, HEPATOLOGY, V57, P2189, DOI 10.1002/hep.26271
   Heijden R. A., 2015, AGING-US, V7, P256, DOI DOI 10.18632/AGING.100738
   Hoppe S, 2015, J INVEST SURG, V28, P24, DOI 10.3109/08941939.2014.971206
   Inami Y, 2011, BIOCHEM BIOPH RES CO, V412, P618, DOI 10.1016/j.bbrc.2011.08.012
   Kauffmann Rondi, 2014, Hepatobiliary Surg Nutr, V3, P238, DOI 10.3978/j.issn.2304-3881.2014.09.01
   Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035
   Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105
   Leroux A, 2012, J HEPATOL, V57, P141, DOI 10.1016/j.jhep.2012.02.028
   Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782
   Lin CW, 2015, SCI REP-UK, V5, DOI 10.1038/srep15807
   Lin T, 2013, HEPATOLOGY, V58, P2176, DOI 10.1002/hep.26600
   Luo GP, 2019, INT J MOL MED, V43, P2033, DOI 10.3892/ijmm.2019.4125
   Mano Y, 2013, HUM PATHOL, V44, P2419, DOI 10.1016/j.humpath.2013.03.022
   Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026
   Murata H, 2007, J GASTROEN HEPATOL, V22, P2173, DOI 10.1111/j.1440-1746.2006.04798.x
   Newberry EP, 2008, HEPATOLOGY, V48, P1097, DOI 10.1002/hep.22473
   Quan W, 2012, DIABETOLOGIA, V55, P392, DOI 10.1007/s00125-011-2350-y
   Shteyer E, 2004, HEPATOLOGY, V40, P1322, DOI 10.1002/hep.20462
   Singh R, 2011, CELL METAB, V13, P495, DOI 10.1016/j.cmet.2011.04.004
   Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976
   Starley BQ, 2010, HEPATOLOGY, V51, P1820, DOI 10.1002/hep.23594
   Stockmann M, 2009, ANN SURG, V250, P119, DOI 10.1097/SLA.0b013e3181ad85b5
   Tanaka S, 2016, HEPATOLOGY, V64, P1994, DOI 10.1002/hep.28820
   Toshima T, 2014, HEPATOLOGY, V60, P290, DOI 10.1002/hep.27140
   Truant S, 2013, ANN SURG, V258, P696, DOI 10.1097/SLA.0b013e3182a61a22
   Tsuchihashi NA, 2015, ONCOTARGET, V6, P3644, DOI 10.18632/oncotarget.2874
   Zhang Q, 2015, INT J BIOL SCI, V11, P559, DOI 10.7150/ijbs.10690
NR 35
TC 6
Z9 6
U1 1
U2 7
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1547-6278
EI 1555-8592
J9 ORGANOGENESIS
JI Organogenesis
PD 2019 JAN 2
PY 2019
VL 15
IS 1
BP 24
EP 34
DI 10.1080/15476278.2019.1633872
EA JUL 2019
PG 11
WC Biochemistry & Molecular Biology; Developmental Biology; Engineering,
   Biomedical
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Developmental Biology; Engineering
GA IT4LX
UT WOS:000476225900001
PM 31280650
OA Green Published, Green Accepted, Bronze
DA 2024-02-19
ER

PT J
AU Vázquez-Memije, ME
   Cárdenas-Méndez, MJ
   Tolosa, A
   El Hafidi, M
AF Vázquez-Memije, ME
   Cárdenas-Méndez, MJ
   Tolosa, A
   El Hafidi, M
TI Respiratory chain complexes and membrane fatty acids composition in rat
   testis mitochondria throughout development and ageing
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE ageing; fatty acids composition; spermatogenesis; testis mitochondria;
   respiratory chain complexes
ID AGE-RELATED-CHANGES; ELECTRON-TRANSPORT CHAIN; HUMAN SKELETAL-MUSCLE;
   OXIDATIVE-PHOSPHORYLATION; LIVER MITOCHONDRIA; HEART MITOCHONDRIA;
   ARACHIDONIC-ACID; INNER MEMBRANE; DNA MUTATIONS; DECLINE
AB Throughout the maturation of germ cells, a morphological, biochemical and functional differentiation of mitochondria has been shown to occur. Ageing is known to cause changes involved in energy metabolism. These changes have been related to molecular and functional alterations in the properties of biological membranes. Variations in membrane lipid composition and lipid-protein interactions occur with ageing in several tissues. The present paper describes the relationship between these membrane alterations and the activities of lipid-dependent enzymes of isolated testis mitochondria in rats of from 10 days of age to 24 months. The specific activities of these enzymes are lower in preparations from adult and aged rats as compared to those from young rats. Temperature breaks of Arrhenius plots show age-dependent shifts to higher temperatures for the NADH-dehydrogenase, succinate-dehydrogenase, cytochrome c oxidase, and ATPase in senescent animals. Analysis of the membrane fatty acid composition reveals a distinct age-dependent fall in the content of polyunsaturated fatty acids accompanied by an increase in the proportion of saturated fatty acids and a decrease in polyunsaturated fatty acid percentage. The results suggest that during spermatogenesis and the ageing process some changes in the composition of the fatty acids in the surrounding membrane affect the protein-lipid interactions, producing a decrease in mitochondrial enzyme activities. (c) 2005 Elsevier Inc. All rights reserved.
C1 Inst Mexicano Seguro Social, Ctr Med Nacl Siglo XX1 IMSS, Unidad Invest Med Genet Humana, Mexico City 06725, DF, Mexico.
   Inst Nacl Cardiol, Dept Bioquim, Mexico City, DF, Mexico.
C3 Instituto Mexicano del Seguro Social; National Institute of Cardiology -
   Mexico
RP Inst Mexicano Seguro Social, Ctr Med Nacl Siglo XX1 IMSS, Unidad Invest Med Genet Humana, Apdo Postal 73-032, Mexico City 06725, DF, Mexico.
EM elisavazquezm@prodigy.net.mx
RI El-Hafidi, Mohammed/AAN-4083-2021
CR Andre J., 1962, J.Ultrastruct. Res, VSuppl.3, P1, DOI [10.1016/S0889-1605(62)80002-0, DOI 10.1016/S0889-1605(62)80002-0]
   ANDREYEV AY, 1989, EUR J BIOCHEM, V182, P585, DOI 10.1111/j.1432-1033.1989.tb14867.x
   BARACCA A, 1986, BIOCHEM BIOPH RES CO, V136, P891, DOI 10.1016/0006-291X(86)90416-X
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   BOFFOLI D, 1994, BBA-MOL BASIS DIS, V1226, P73, DOI 10.1016/0925-4439(94)90061-2
   Boffoli D, 1996, BBA-MOL BASIS DIS, V1315, P66, DOI 10.1016/0925-4439(95)00107-7
   Bourre J M, 2004, J Nutr Health Aging, V8, P163
   BRENNER RR, 1984, PROG LIPID RES, V23, P69, DOI 10.1016/0163-7827(84)90008-0
   Cadenas Enrique, 2004, Molecular Aspects of Medicine, V25, P17, DOI 10.1016/j.mam.2004.02.005
   CARDELLACH F, 1989, LANCET, V2, P44
   Chvojková S, 2001, TOHOKU J EXP MED, V195, P115, DOI 10.1620/tjem.195.115
   Cocco T, 1999, FREE RADICAL BIO MED, V27, P51, DOI 10.1016/S0891-5849(99)00034-9
   Coniglio J G, 1977, Adv Exp Med Biol, V83, P575
   COOPER JM, 1992, J NEUROL SCI, V113, P91, DOI 10.1016/0022-510X(92)90270-U
   Crider BP, 2003, J BIOL CHEM, V278, P44281, DOI 10.1074/jbc.M307372200
   DAUM G, 1985, BIOCHIM BIOPHYS ACTA, V822, P1, DOI 10.1016/0304-4157(85)90002-4
   DELHUMEA.G, 1973, J REPROD FERTIL, V33, P513
   El Hafidi M, 2001, J NUTR BIOCH, V12, P65
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Gohil VM, 2004, J BIOL CHEM, V279, P42612, DOI 10.1074/jbc.M402545200
   GORGANI MN, 1986, MECH AGEING DEV, V35, P1, DOI 10.1016/0047-6374(86)90061-8
   GROOTEGOED JA, 1990, CELLULAR MOL EVENTS, P193
   GUERRIERI F, 1992, ANN NY ACAD SCI, V671, P395, DOI 10.1111/j.1749-6632.1992.tb43813.x
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Junqueira Virginia B. C., 2004, Molecular Aspects of Medicine, V25, P5, DOI 10.1016/j.mam.2004.02.003
   Kwong LK, 2000, ARCH BIOCHEM BIOPHYS, V373, P16, DOI 10.1006/abbi.1999.1495
   LAGANIERE S, 1993, GERONTOLOGY, V39, P7, DOI 10.1159/000213509
   Lenaz G, 1998, BBA-BIOENERGETICS, V1366, P53, DOI 10.1016/S0005-2728(98)00120-0
   Lenaz G, 2000, BBA-BIOENERGETICS, V1459, P397, DOI 10.1016/S0005-2728(00)00177-8
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   LUVISETTO S, 1987, BIOCHEMISTRY-US, V26, P7332, DOI 10.1021/bi00397a021
   MACHADOD.E, 1972, BIOL REPROD, V6, P136, DOI 10.1093/biolreprod/6.1.136
   MANIONGUI C, 1993, LIPIDS, V28, P291, DOI 10.1007/BF02536313
   Meinhardt A, 1999, HUM REPROD UPDATE, V5, P108, DOI 10.1093/humupd/5.2.108
   MULLERHOCKER J, 1992, BRAIN PATHOL, V2, P149, DOI 10.1111/j.1750-3639.1992.tb00683.x
   MullerHocker J, 1997, HEPATOLOGY, V26, P709
   MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167
   Navarro Ana, 2004, Molecular Aspects of Medicine, V25, P37, DOI 10.1016/j.mam.2004.02.007
   Okuyama H, 1998, J PEDIATR SURG, V33, P35, DOI 10.1016/S0022-3468(98)90356-6
   Ostrander DB, 2001, J BIOL CHEM, V276, P25262, DOI 10.1074/jbc.M103689200
   OZAWA T, 1995, BBA-MOL BASIS DIS, V1271, P177, DOI 10.1016/0925-4439(95)00026-Z
   PAPA S, 1996, BIOCHIM BIOPHYS ACTA, V12, P87
   PARADIES G, 1992, BIOCHIM BIOPHYS ACTA, V1103, P324, DOI 10.1016/0005-2736(92)90103-S
   Paradies G, 1997, FEBS LETT, V406, P136, DOI 10.1016/S0014-5793(97)00264-0
   PARENTICASTELLI G, 1979, BIOCHIM BIOPHYS ACTA, V547, P161, DOI 10.1016/0005-2728(79)90104-X
   Pepe S, 1999, AM J PHYSIOL-HEART C, V276, pH149, DOI 10.1152/ajpheart.1999.276.1.H149
   Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200
   PIETROBON D, 1987, BIOCHEMISTRY-US, V26, P7339, DOI 10.1021/bi00397a022
   POLLAK JK, 1975, BIOCHEM J, V150, P477, DOI 10.1042/bj1500477
   ROTTENBERG H, 1986, BIOCHEMISTRY-US, V25, P1747, DOI 10.1021/bi00355a045
   ROTTENBERG H, 1983, P NATL ACAD SCI-BIOL, V80, P3313, DOI 10.1073/pnas.80.11.3313
   Seitz J, 1995, INT J ANDROL, V18, P7
   Sæther T, 2003, BIOL REPROD, V69, P117, DOI 10.1095/biolreprod.102.014035
   STUBBS CD, 1981, BIOCHEMISTRY-US, V20, P4257, DOI 10.1021/bi00518a004
   Surai PF, 2000, J REPROD FERTIL, V120, P257, DOI 10.1530/reprod/120.2.257
   TAKEUCHI Y, 1991, ARCH BIOCHEM BIOPHYS, V289, P33, DOI 10.1016/0003-9861(91)90438-O
   VAZQUEZMEMIJE ME, 1984, ARCH BIOCHEM BIOPHYS, V232, P441, DOI 10.1016/0003-9861(84)90560-5
   VAZQUEZMEMIJE ME, 1988, ARCH BIOCHEM BIOPHYS, V260, P67, DOI 10.1016/0003-9861(88)90425-0
   Wilson P D, 1975, Adv Exp Med Biol, V53, P171
NR 61
TC 21
Z9 25
U1 0
U2 5
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD JUN
PY 2005
VL 40
IS 6
BP 482
EP 490
DI 10.1016/j.exger.2005.03.006
PG 9
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 945WZ
UT WOS:000230534700004
PM 15972255
DA 2024-02-19
ER

PT J
AU Zhang, L
   Yan, JB
   Zhang, C
   Feng, SY
   Zhan, ZL
   Bao, Y
   Zhang, S
   Chao, GQ
AF Zhang, Lan
   Yan, Junbin
   Zhang, Chi
   Feng, Shuyan
   Zhan, Zheli
   Bao, Yang
   Zhang, Shuo
   Chao, Guanqun
TI Improving intestinal inflammaging to delay aging? A new perspective
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article; Early Access
DE Aging; Intestine; Chronic inflammation; Intestinal barrier; Anti-aging;
   Anti-inflammatory therapies
ID CHAIN FATTY-ACIDS; GUT MICROBIOTA; BARRIER DYSFUNCTION; EVOLUTIONARY
   PERSPECTIVE; METABOLITE BUTYRATE; CELL RESPONSES; T-CELLS; AGE; DISEASE;
   PERMEABILITY
AB Greying population is becoming an increasingly critical issue for social development. In advanced aging context, organismal multiple tissues and organs experience a progressive deterioration, initially presenting with functional decline, followed by structural disruption and eventually organ failure. The aging of the gut is one of the key links. Decreased gut function leads to reduced nutrient absorption and can perturb systemic metabolic rates. The degeneration of the intestinal structure causes the migration of harmful components such as pathogens and toxins, inducing pathophysiological changes in other organs through the "brain-gut axis" and "liver-gut axis". There is no accepted singular underlying mechanism of aged gut. While the inflamm-aging theory was first proposed in 2000, the mutual promotion of chronic inflammation and aging has attracted much attention. Numerous studies have established that gut microbiome composition, gut immune function, and gut barrier integrity are involved in the formation of inflammaging in the aging gut. Remarkably, inflammaging additionally drives the development of aging-like phenotypes, such as microbiota dysbiosis and impaired intestinal barrier, via a broad array of inflammatory mediators. Here we demonstrate the mechanisms of inflammaging in the gut and explore whether aging-like phenotypes in the gut can be negated by improving gut inflammaging.
C1 [Zhang, Lan; Zhan, Zheli; Bao, Yang; Chao, Guanqun] Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Gen Practice, Hangzhou 310000, Peoples R China.
   [Yan, Junbin; Zhang, Shuo] Zhejiang Chinese Med Univ, Affiliated Hosp 2, Xin Hua Hosp Zhejiang Prov, Hangzhou 310000, Peoples R China.
   [Zhang, Chi] Zhejiang Univ, Sir Run Run Shaw Hosp, Endoscop Ctr, Hangzhou 310000, Peoples R China.
   [Feng, Shuyan] Zhejiang Chinese Med Univ, Hangzhou 310000, Peoples R China.
C3 Zhejiang University; Zhejiang Chinese Medical University; Zhejiang
   University; Zhejiang Chinese Medical University
RP Chao, GQ (corresponding author), Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Gen Practice, Hangzhou 310000, Peoples R China.; Zhang, S (corresponding author), Zhejiang Chinese Med Univ, Affiliated Hosp 2, Xin Hua Hosp Zhejiang Prov, Hangzhou 310000, Peoples R China.
EM zhangshuotcm@126.com; chaoguanqun@zju.edu.cn
FU National Natural Science Foundation of China [81973598]
FX This research was funded by National Natural Science Foundation of
   China, grant number 81973598.
CR Ahmadi S, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.132055
   Ahmadi S, 2020, J GERONTOL A-BIOL, V75, pE9, DOI 10.1093/gerona/glaa056
   Al-Sadi RM, 2007, J IMMUNOL, V178, P4641, DOI 10.4049/jimmunol.178.7.4641
   Amevor FK, 2022, FRONT IMMUNOL, V13, DOI 10.3389/fimmu.2022.860889
   Appay V, 2014, EXP GERONTOL, V54, P90, DOI 10.1016/j.exger.2014.01.003
   Araújo JR, 2017, BIOCHIMIE, V141, P97, DOI 10.1016/j.biochi.2017.05.019
   Arnold JN, 2023, PROTEIN CELL, V14, P4, DOI 10.1093/procel/pwac012
   Arnold JW, 2021, MICROBIOME, V9, DOI 10.1186/s40168-020-00980-0
   Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726
   Bárcena C, 2019, NAT MED, V25, P1234, DOI 10.1038/s41591-019-0504-5
   Bharath LP, 2020, CELL METAB, V32, P44, DOI 10.1016/j.cmet.2020.04.015
   Biagi E, 2016, CURR BIOL, V26, P1480, DOI 10.1016/j.cub.2016.04.016
   Biagi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010667
   Biragyn A, 2018, LANCET ONCOL, V19, pE295, DOI 10.1016/S1470-2045(18)30095-0
   Bodogai M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat4271
   Booth JS, 2021, IMMUN AGEING, V18, DOI 10.1186/s12979-021-00227-y
   Branca JJV, 2019, AGEING RES REV, V54, DOI 10.1016/j.arr.2019.100938
   Brandhorst S, 2015, CELL METAB, V22, P86, DOI 10.1016/j.cmet.2015.05.012
   Bulut O, 2020, INT IMMUNOL, V32, P741, DOI 10.1093/intimm/dxaa052
   Burkard N, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.756321
   Campisi J, 2019, NATURE, V571, P183, DOI 10.1038/s41586-019-1365-2
   Cao L, 2020, NUTRIENTS, V12, DOI 10.3390/nu12020290
   Cassidy LD, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14187-x
   Chaiyasut C, 2022, FOODS, V11, DOI 10.3390/foods11030268
   Chang AY, 2019, LANCET PUBLIC HEALTH, V4, pE159, DOI 10.1016/S2468-2667(19)30019-2
   Chang PV, 2014, P NATL ACAD SCI USA, V111, P2247, DOI 10.1073/pnas.1322269111
   Choi SI, 2021, J NEUROGASTROENTEROL, V27, P134
   Chung HY, 2009, AGEING RES REV, V8, P18, DOI 10.1016/j.arr.2008.07.002
   Chung JY, 2020, FRONT AGING NEUROSCI, V12, DOI 10.3389/fnagi.2020.588044
   Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107
   Clayburgh DR, 2005, J CLIN INVEST, V115, P2702, DOI 10.1172/JCI24970
   Conway J, 2021, AGEING RES REV, V68, DOI 10.1016/j.arr.2021.101323
   Corrêa RO, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.17
   Côté CD, 2015, NAT MED, V21, P498, DOI 10.1038/nm.3821
   da Costa JP, 2016, AGEING RES REV, V29, P90, DOI 10.1016/j.arr.2016.06.005
   de la Lastra CA, 2005, MOL NUTR FOOD RES, V49, P405
   DeChristopher LR, 2017, ADV NUTR, V8, P679, DOI 10.3945/an.117.016154
   Del Papa MF, 2008, J BACTERIOL, V190, P7147, DOI 10.1128/JB.00952-08
   Ding EM, 2022, HUM GENOMICS, V16, DOI 10.1186/s40246-022-00428-6
   Dock J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182498
   Dönertas HM, 2021, NATURE AGING, V1, P400, DOI 10.1038/s43587-021-00051-5
   Dunn-Walters DK, 2016, CLIN EXP IMMUNOL, V183, P50, DOI 10.1111/cei.12700
   Elderman M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184274
   Fang X, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.792746
   Ferrucci L, 2018, NAT REV CARDIOL, V15, P505, DOI 10.1038/s41569-018-0064-2
   Fortea M, 2021, FRONT NUTR, V8, DOI 10.3389/fnut.2021.718093
   Franceschi C, 2000, ANN NY ACAD SCI, V908, P244
   Franceschi C, 2018, NAT REV ENDOCRINOL, V14, P576, DOI 10.1038/s41574-018-0059-4
   Franceschi C, 2017, TRENDS ENDOCRIN MET, V28, P199, DOI 10.1016/j.tem.2016.09.005
   Frasca D, 2009, CURR OPIN IMMUNOL, V21, P425, DOI 10.1016/j.coi.2009.06.001
   Fulop T, 2023, CLIN REV ALLERG IMMU, V64, P109, DOI 10.1007/s12016-021-08899-6
   Funk MC, 2020, EMBO REP, V21, DOI 10.15252/embr.202050047
   Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721
   Gabandé-Rodríguez E, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9010082
   Gargari G, 2022, EUR J NUTR, V61, P1209, DOI 10.1007/s00394-021-02680-3
   Gebert N, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107565
   Ghosh SS, 2020, ARTERIOSCL THROM VAS, V40, P2561, DOI 10.1161/ATVBAHA.120.315189
   Goronzy JJ, 2013, NAT IMMUNOL, V14, P428, DOI 10.1038/ni.2588
   Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001
   Gustafson CE, 2020, J ALLERGY CLIN IMMUN, V145, P1309, DOI 10.1016/j.jaci.2020.03.017
   Hohman LS, 2022, AGING CELL, V21, DOI 10.1111/acel.13700
   Holscher HD, 2017, GUT MICROBES, V8, P172, DOI 10.1080/19490976.2017.1290756
   Hor YY, 2019, PHARMACOL RES, V146, DOI 10.1016/j.phrs.2019.104312
   Islam MS, 2019, NUTRIENTS, V11, DOI 10.3390/nu11081804
   Jeffery V, 2017, J IMMUNOL, V199, P304, DOI 10.4049/jimmunol.1600960
   Juricic P, 2022, NATURE AGING, V2, P824, DOI 10.1038/s43587-022-00278-w
   Kapahi P, 2010, CELL METAB, V11, P453, DOI 10.1016/j.cmet.2010.05.001
   Kato H, 2003, INT IMMUNOL, V15, P145, DOI 10.1093/intimm/dxg011
   Keith SA, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005823
   Kennedy BK, 2014, CELL, V159, P708, DOI 10.1016/j.cell.2014.10.039
   Khoruts A, 2016, NAT REV GASTRO HEPAT, V13, DOI 10.1038/nrgastro.2016.98
   Kiewiet MBG, 2021, MOL NUTR FOOD RES, V65, DOI 10.1002/mnfr.202000390
   Kong FL, 2016, CURR BIOL, V26, pR832, DOI 10.1016/j.cub.2016.08.015
   Koyuncu S, 2021, NATURE, V596, P285, DOI 10.1038/s41586-021-03781-z
   Kuhle BX, 2007, MATURITAS, V57, P329, DOI 10.1016/j.maturitas.2007.04.004
   Kumar Manish, 2016, Nutr Healthy Aging, V4, P3, DOI 10.3233/NHA-150002
   LaMoia TE, 2021, ENDOCR REV, V42, P77, DOI 10.1210/endrev/bnaa023
   Lawley TD, 2009, INFECT IMMUN, V77, P3661, DOI 10.1128/IAI.00558-09
   Lee HY, 2022, INSECTS, V13, DOI 10.3390/insects13020219
   Tran L, 2013, J GERONTOL A-BIOL, V68, P1045, DOI 10.1093/gerona/glt106
   Li J, 2019, FOOD FUNCT, V10, P333, DOI 10.1039/c8fo01962b
   Li XA, 2021, PHARMACOL RES, V168, DOI 10.1016/j.phrs.2021.105587
   Ling ZX, 2022, CRIT REV FOOD SCI, V62, P3509, DOI 10.1080/10408398.2020.1867054
   Liu AL, 2020, J GERONTOL A-BIOL, V75, P1284, DOI 10.1093/gerona/glz263
   Liu S, 2018, FISH SHELLFISH IMMUN, V80, P473, DOI 10.1016/j.fsi.2018.06.027
   Liu YQ, 2023, J TRANSL MED, V21, DOI 10.1186/s12967-023-04137-z
   Longo VD, 2020, J ALLERGY CLIN IMMUN, V146, P1002, DOI 10.1016/j.jaci.2020.07.035
   Lu YX, 2021, ELIFE, V10, DOI 10.7554/eLife.62233
   Ma AT, 2010, P NATL ACAD SCI USA, V107, P4365, DOI 10.1073/pnas.0915156107
   Ma JL, 2020, GUT MICROBES, V11, P1450, DOI 10.1080/19490976.2020.1763770
   Mabbott NA, 2015, BIOGERONTOLOGY, V16, P133, DOI 10.1007/s10522-014-9498-z
   Madeo F, 2019, AUTOPHAGY, V15, P165, DOI 10.1080/15548627.2018.1530929
   Mall JPG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31492-5
   Man AL, 2015, CLIN SCI, V129, P515, DOI 10.1042/CS20150046
   Mao YQ, 2023, NAT METAB, V5, P96, DOI 10.1038/s42255-022-00716-4
   Marchelletta RR, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI138230
   Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123
   Martel J, 2022, TRENDS ENDOCRIN MET, V33, P247, DOI 10.1016/j.tem.2022.01.002
   Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192
   Martinet KZ, 2014, IMMUN AGEING, V11, DOI 10.1186/1742-4933-11-8
   Mellouk A, 2019, FASEB J, V33, P3225, DOI 10.1096/fj.201800867R
   Metchnikoff E., 1907, PROLONGATION LIFE OP
   Miki T, 2012, J BIOL CHEM, V287, P34844, DOI 10.1074/jbc.M112.399998
   Miyoshi J, 2018, PEERJ, V6, DOI 10.7717/peerj.5166
   Moorefield EC, 2017, AGING-US, V9, P1898, DOI 10.18632/aging.101279
   Morrisette-Thomas V, 2014, MECH AGEING DEV, V139, P49, DOI 10.1016/j.mad.2014.06.005
   Mueller S, 2006, APPL ENVIRON MICROB, V72, P1027, DOI 10.1128/AEM.72.2.1027-1033.2006
   Nagai H, 2021, AUTOPHAGY, V17, P1057, DOI 10.1080/15548627.2021.1904490
   Nalapareddy K, 2017, CELL REP, V18, P2608, DOI 10.1016/j.celrep.2017.02.056
   Nava P, 2010, IMMUNITY, V32, P392, DOI 10.1016/j.immuni.2010.03.001
   Odeh A, 2020, AGING CELL, V19, DOI 10.1111/acel.13045
   Odenwald MA, 2017, NAT REV GASTRO HEPAT, V14, P9, DOI 10.1038/nrgastro.2016.169
   Olsson J, 2000, MECH AGEING DEV, V121, P187
   Palikaras K, 2015, NATURE, V521, P525, DOI 10.1038/nature14300
   Palmas V, 2022, NUTRIENTS, V14, DOI 10.3390/nu14122436
   Park J, 2015, MUCOSAL IMMUNOL, V8, P80, DOI 10.1038/mi.2014.44
   Parker A, 2022, MICROBIOME, V10, DOI 10.1186/s40168-022-01243-w
   Parrish AR, 2017, TISSUE BARRIERS, V5, DOI 10.1080/21688370.2017.1343172
   Pentinmikko N, 2019, NATURE, V571, P398, DOI 10.1038/s41586-019-1383-0
   Perino A, 2021, PHYSIOL REV, V101, P683, DOI 10.1152/physrev.00049.2019
   Pitts AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048360
   Qi YF, 2017, J AM MED DIR ASSOC, V18, DOI 10.1016/j.jamda.2017.05.018
   Rangan P, 2019, CELL REP, V26, P2704, DOI 10.1016/j.celrep.2019.02.019
   Rashidah NH, 2022, AGEING RES REV, V82, DOI 10.1016/j.arr.2022.101744
   Reboldi A, 2016, IMMUNOL REV, V271, P230, DOI 10.1111/imr.12400
   Ren MH, 2022, NUTRIENTS, V14, DOI 10.3390/nu14193931
   Rera M, 2012, P NATL ACAD SCI USA, V109, P21528, DOI 10.1073/pnas.1215849110
   Rooks MG, 2016, NAT REV IMMUNOL, V16, P341, DOI 10.1038/nri.2016.42
   Russler-Germain EV, 2017, MUCOSAL IMMUNOL, V10, P1375, DOI 10.1038/mi.2017.65
   Salvioli S, 2009, CANCER IMMUNOL IMMUN, V58, P1909, DOI 10.1007/s00262-008-0639-6
   Santoro A, 2021, AGEING RES REV, V71, DOI 10.1016/j.arr.2021.101422
   SCHIEFERDECKER HL, 1992, J IMMUNOL, V149, P2816
   Schinaman JM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44106-5
   Schneider AM, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/4898217
   Schwarz BT, 2007, GASTROENTEROLOGY, V132, P2383, DOI 10.1053/j.gastro.2007.02.052
   Shimizu M, 2017, J FOOD DRUG ANAL, V25, P93, DOI 10.1016/j.jfda.2016.12.003
   Shimizu Y, 2022, GEROSCIENCE, V44, P997, DOI 10.1007/s11357-021-00398-y
   Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007
   Singh SB, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11121784
   Sinha SR, 2020, CELL HOST MICROBE, V27, P659, DOI 10.1016/j.chom.2020.01.021
   Sirvinskas D, 2022, ISCIENCE, V25, DOI 10.1016/j.isci.2022.104202
   Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165
   Stebegg M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10430-7
   Stecher B, 2008, TRENDS MICROBIOL, V16, P107, DOI 10.1016/j.tim.2007.12.008
   Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244
   Stecher B, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MBP-0008-2014
   Stelter C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020749
   Storci G, 2019, CELL DEATH DIFFER, V26, P1845, DOI 10.1038/s41418-018-0255-8
   Su LP, 2013, GASTROENTEROLOGY, V145, P407, DOI 10.1053/j.gastro.2013.04.011
   Suenaert P, 2002, AM J GASTROENTEROL, V97, P2000
   Suzuki T, 2011, J BIOL CHEM, V286, P31263, DOI 10.1074/jbc.M111.238147
   Takiishi T, 2017, TISSUE BARRIERS, V5, DOI 10.1080/21688370.2017.1373208
   Tavella T, 2021, GUT MICROBES, V13, DOI 10.1080/19490976.2021.1880221
   Thevaranjan N, 2017, CELL HOST MICROBE, V21, P455, DOI 10.1016/j.chom.2017.03.002
   Thiennimitr P, 2011, P NATL ACAD SCI USA, V108, P17480, DOI 10.1073/pnas.1107857108
   Thyagarajan B, 2022, J GERONTOL A-BIOL, V77, P927, DOI 10.1093/gerona/glab300
   Tremblay S, 2017, IMMUN AGEING, V14, DOI 10.1186/s12979-017-0101-8
   Trentesaux C, 2020, P NATL ACAD SCI USA, V117, P11136, DOI 10.1073/pnas.1917174117
   Tsai PY, 2017, CELL HOST MICROBE, V21, P671, DOI 10.1016/j.chom.2017.05.009
   Ullman TA, 2011, GASTROENTEROLOGY, V140, P1807, DOI 10.1053/j.gastro.2011.01.057
   Untersmayr E, 2022, NUTRIENTS, V14, DOI 10.3390/nu14050949
   van Beek AA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00408
   van der Lugt B, 2019, IMMUN AGEING, V16, DOI 10.1186/s12979-019-0145-z
   Vulevic J, 2008, AM J CLIN NUTR, V88, P1438, DOI 10.3945/ajcn.2008.26242
   Wang BL, 2022, CRIT REV FOOD SCI, DOI 10.1080/10408398.2022.2123444
   Wang FJ, 2006, GASTROENTEROLOGY, V131, P1153, DOI 10.1053/j.gastro.2006.08.022
   Wang JJ, 2022, GUT MICROBES, V14, DOI 10.1080/19490976.2022.2107288
   Weber CR, 2010, J BIOL CHEM, V285, P12037, DOI 10.1074/jbc.M109.064808
   Wei M, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aai8700
   Wilson QN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29473-9
   Winter SE, 2010, NATURE, V467, P426, DOI 10.1038/nature09415
   Wu JY, 2022, GERONTOLOGY, DOI 10.1159/000520054
   Wu L, 2022, NPJ BIOFILMS MICROBI, V8, DOI 10.1038/s41522-022-00366-0
   Yang G, 2017, CRIT REV FOOD SCI, V57, P3830, DOI 10.1080/10408398.2016.1152230
   Yang WH, 2017, SCIENCE, V358, DOI 10.1126/science.aao5610
   Yang XQ, 2020, ACTA PHARM SIN B, V10, P475, DOI 10.1016/j.apsb.2019.07.001
   Zhang HL, 2019, MOL CELL, V76, P110, DOI 10.1016/j.molcel.2019.08.005
   Zhang XH, 2021, J FOOD BIOCHEM, V45, DOI 10.1111/jfbc.13861
   Zheng J, 2021, PHARM BIOL, V59, P183, DOI 10.1080/13880209.2021.1878238
   Zolotarevsky Y, 2002, GASTROENTEROLOGY, V123, P163, DOI 10.1053/gast.2002.34235
   Zwielehner J, 2009, EXP GERONTOL, V44, P440, DOI 10.1016/j.exger.2009.04.002
NR 181
TC 1
Z9 1
U1 6
U2 8
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
EI 1872-6216
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD 2023 SEP
PY 2023
VL 214
AR 111841
DI 10.1016/j.mad.2023.111841
EA JUL 2023
PG 13
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA N5KA1
UT WOS:001037386600001
PM 37393959
DA 2024-02-19
ER

PT J
AU Aydin, S
   Atukeren, P
   Çakatay, U
   Uzun, H
   Altug, T
AF Aydin, Seval
   Atukeren, Pinar
   Cakatay, Ufuk
   Uzun, Hafize
   Altug, Tuncay
TI Gender-dependent oxidative variations in liver of aged rats
SO BIOGERONTOLOGY
LA English
DT Article
DE Aging; Liver; Gender; Protein oxidation; Lipid peroxidation
ID GENE-EXPRESSION; PROTEIN DAMAGE; MITOCHONDRIA; FEMALES; INJURY; TISSUE;
   MALES; ASSAY; MICE
AB A shift from redox regulation to oxidative damage is known to contribute organ dysfunction and aging-related disorders. Exposure to reactive oxygen species throughout the life-span increases the incidence of several liver diseases. A redox basis of the loss of antioxidant capacity of aged livers has not been fully elucidated in both genders. In the current study, we investigated the gender-dependent relations between protein carbonyl (PCO), a commonly used marker of protein oxidation and other protein oxidation parameters such as advanced oxidation protein products (AOPP) and total thiol (T-SH). Our study also covered other oxidative stress markers, such as malondialdehyde (MDA), lipid hydroperoxides (LHP), and glutathione (GSH) in liver tissue of the male and female aged rats. PCO and AOPP levels in old male and female rats were significantly higher than those in the young control groups (P < 0.001 and P < 0.01, respectively for male rats; P < 0.001 for both parameters in female rats). On the other hand, T-SH levels were not found to be different between young and old rat groups. Plasma MDA levels of old male and female rats were significantly higher compared to those of the young control groups (P < 0.01 and P < 0.001, respectively). LHP levels were only found out to be significantly higher in old female rats when compared to those in young male rats. GSH levels in old male and female rats were significantly lower than in the corresponding young control groups (P < 0.01 for male rats; P < 0.05 for female rats). Our results demonstrated greater susceptibility to hepatic oxidative damage in females than in males. This appears to contradict the general assumption that females are less susceptible to oxidative injury than males are.
C1 [Cakatay, Ufuk] Istanbul Univ, Istanbul Fac Med, Cent Lab Clin Biochem, Istanbul, Turkey.
   [Aydin, Seval; Atukeren, Pinar; Uzun, Hafize] Istanbul Univ, Dept Biochem, Cerrahpasa Fac Med, Istanbul, Turkey.
   [Altug, Tuncay] Istanbul Bilim Univ, Fac Med, Dept Med Biol & Genet, Istanbul, Turkey.
C3 Istanbul University; Istanbul University; Istanbul University -
   Cerrahpasa; Demiroglu Bilim University
RP Çakatay, U (corresponding author), Istanbul Univ, Istanbul Fac Med, Cent Lab Clin Biochem, Istanbul, Turkey.
EM cakatay@yahoo.com
RI Atukeren, Pinar/D-3163-2019; Cakatay, Ufuk/D-2752-2015; aydın,
   seval/AAD-3579-2021; Aydın, Seval/D-5026-2019; Uzun, Hafize/D-4811-2019
OI Atukeren, Pinar/0000-0001-8219-4205; Cakatay, Ufuk/0000-0001-9861-7380;
   Aydın, Seval/0000-0001-6873-5730; Uzun, Hafize/0000-0002-1347-8498
FU Research Fund of The University of Istanbul [UDP-4/2010]
FX This work was supported in part by funding from a grant from the
   Research Fund of The University of Istanbul (UDP-4/2010). The
   corresponding author is grateful to linguistic expert Mr. Burak Alkan
   for reading the manuscript and for improvements in the linguistic style.
CR Ali SS, 2006, AGING CELL, V5, P565, DOI 10.1111/j.1474-9726.2006.00252.x
   Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   Borrás C, 2003, FREE RADICAL BIO MED, V34, P546, DOI 10.1016/S0891-5849(02)01356-4
   Borras C, 2007, FRONT BIOSCI, V12, P1008, DOI 10.2741/2120
   Brink TC, 2009, BIOGERONTOLOGY, V10, P549, DOI 10.1007/s10522-008-9197-8
   Buege J A, 1978, Methods Enzymol, V52, P302
   de Grey ADNJ, 2006, FREE RADICAL RES, V40, P1244, DOI 10.1080/10715760600913176
   Gasbarrini A, 2001, DIGEST DIS SCI, V46, P1305, DOI 10.1023/A:1010679716435
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   Humphries KM, 2006, FREE RADICAL RES, V40, P1239, DOI 10.1080/10715760600913184
   Justo R, 2005, AM J PHYSIOL-CELL PH, V289, pC372, DOI 10.1152/ajpcell.00035.2005
   Kayali R, 2007, BIOGERONTOLOGY, V8, P653, DOI 10.1007/s10522-007-9107-5
   Kayali R, 2007, MECH AGEING DEV, V128, P365, DOI 10.1016/j.mad.2007.03.003
   Lang CA, 2002, J LAB CLIN MED, V140, P413, DOI 10.1067/mlc.2002.129504
   Lang CA, 2000, J LAB CLIN MED, V135, P402, DOI 10.1067/mlc.2000.105977
   Langley-Evans SC, 2005, MECH AGEING DEV, V126, P804, DOI 10.1016/j.mad.2005.03.003
   Pérez VI, 2009, BBA-GEN SUBJECTS, V1790, P1005, DOI 10.1016/j.bbagen.2009.06.003
   REZNICK AZ, 1994, METHOD ENZYMOL, V233, P357
   Rodríguez-Cuenca S, 2002, J BIOL CHEM, V277, P42958, DOI 10.1074/jbc.M207229200
   SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4
   STADTMAN ER, 2006, REDOX PROTEOMICS, pCH1
   Timchenko NA, 2009, TRENDS ENDOCRIN MET, V20, P171, DOI 10.1016/j.tem.2009.01.005
   UZUN H, 2009, ARCH GERONTOL G 0219
   WITKO V, 1992, J CLIN LAB ANAL, V6, P47, DOI 10.1002/jcla.1860060110
   WOLFF SP, 1994, METHOD ENZYMOL, V233, P182
NR 25
TC 26
Z9 27
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1389-5729
J9 BIOGERONTOLOGY
JI Biogerontology
PD JUN
PY 2010
VL 11
IS 3
BP 335
EP 346
DI 10.1007/s10522-009-9257-8
PG 12
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 588TH
UT WOS:000277096300008
PM 19946747
DA 2024-02-19
ER

PT J
AU Chen, P
   Lei, JX
   Chen, FC
   Zhou, BH
AF Chen, Peng
   Lei, Jiexin
   Chen, Fuchao
   Zhou, Benhong
TI Ameliorative effect of urolithin A on d-gal-induced liver and kidney
   damage in aging mice <i>via</i> its antioxidative, anti-inflammatory and
   antiapoptotic properties
SO RSC ADVANCES
LA English
DT Article
ID NF-KAPPA-B; D-GALACTOSE; ELLAGIC ACID; TNF-ALPHA; MEMORY IMPAIRMENT; RAT
   MODEL; APOPTOSIS; INFLAMMATION; ACTIVATION; INJURY
AB Urolithin A, a metabolite produced by human colon microflora from ellagic acid and related compounds, has been reported to have antioxidant, anti-inflammatory and antiapoptotic properties. The present study investigates the protective effects of urolithin A (Uro A) on d-galactose (d-gal)-induced liver and kidney injury and the possible mechanisms in mice. In this study, we first investigated the antioxidant ability of Uro A in vitro. Then mice were treated with d-gal subcutaneously (150 mg kg(-1) d(-1)), followed by Uro A at different dosages (50, 100, 150 mg kg(-1) d(-1), administered orally) for 8 weeks. The levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), blood urea nitrogen (BUN) and creatinine (Cr) in the serum were tested. Histopathological features were assessed by hematoxylin and eosin (HE) staining followed by an assessment of the antioxidant and anti-inflammatory activities. Furthermore, we also evaluated the expression levels of the genes Bax, Bcl-2 and cleaved caspase-3 in the liver and kidney. The results showed that Uro A treatment obviously attenuated d-gal-induced liver and kidney damage. The beneficial effects of Uro A were accompanied by a decline in malondialdehyde (MDA) levels and a rise in the superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), catalase (CAT), and total antioxidant capacity (T-AOC) activity in the liver and kidney and downregulation of the levels of inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-alpha), interleukin-1 beta (IL-1 beta) and interleukin-6 (IL-6), in serum. Moreover, Uro A could modulate the expression of Bax, Bcl-2 and cleaved caspase-3 in the livers and kidneys of aging mice. These findings suggested that Uro A ameliorated d-gal-induced liver and kidney injury through attenuating oxidative stress, inflammatory responses and apoptosis.
C1 [Chen, Peng; Zhou, Benhong] Wuhan Univ, Dept Pharm, Renmin Hosp, Wuhan 430060, Hubei, Peoples R China.
   [Lei, Jiexin] Wuhan Univ, Dept Endocrinol, Renmin Hosp, Wuhan 430060, Hubei, Peoples R China.
   [Chen, Fuchao] Hubei Univ Med, Dongfeng Hosp, Dept Pharm, Shiyan 442008, Hubei, Peoples R China.
C3 Wuhan University; Wuhan University; Hubei University of Medicine
RP Zhou, BH (corresponding author), Wuhan Univ, Dept Pharm, Renmin Hosp, Wuhan 430060, Hubei, Peoples R China.
EM benhongzh@whu.edu.cn
FU National Natural Science Foundation of China [31770381]
FX This work was supported by grants from the National Natural Science
   Foundation of China (31770381).
CR Ahangarpour A, 2016, J CHIN MED ASSOC, V79, P589, DOI 10.1016/j.jcma.2016.05.006
   [Anonymous], [No title captured]
   Charrad R, 2016, IMMUNOBIOLOGY, V221, P182, DOI 10.1016/j.imbio.2015.09.009
   Davis HM, 2017, AGING CELL, V16, P551, DOI 10.1111/acel.12586
   Dong ZY, 2017, EXP THER MED, V14, P616, DOI 10.3892/etm.2017.4514
   Duan DD, 2017, REJUV RES, V20, P506, DOI 10.1089/rej.2017.1919
   Fan JJ, 2017, ONCOTARGET, V8, P17475, DOI [10.18632/oncotarget.15420, 10.18632/oncotarget.15728]
   Feng Y, 2016, PHARM BIOL, V54, P1027, DOI 10.3109/13880209.2015.1093510
   Fivenson EM, 2017, NEUROCHEM INT, V109, P202, DOI 10.1016/j.neuint.2017.02.007
   Gao J, 2016, METAB BRAIN DIS, V31, P771, DOI 10.1007/s11011-016-9813-2
   Ghosh M, 2012, FREE RADICAL RES, V46, P116, DOI 10.3109/10715762.2011.644240
   González-Sarrías A, 2015, FOOD FUNCT, V6, P1460, DOI [10.1039/C5FO00120J, 10.1039/c5fo00120j]
   Hoda U, 2017, NUTR NEUROSCI, V20, P497, DOI 10.1080/1028415X.2016.1189057
   Kalaz EB, 2014, J PHYSIOL BIOCHEM, V70, P15, DOI 10.1007/s13105-013-0275-2
   Karaolanis G, 2015, HELL J CARDIOL, V56, P160
   Kurosawa N, 2016, PSYCHOPHARMACOLOGY, V233, P1725, DOI 10.1007/s00213-015-4084-x
   Liu CM, 2010, FOOD CHEM TOXICOL, V48, P2809, DOI 10.1016/j.fct.2010.07.011
   Liu C, 2017, CLIN INTERV AGING, V12, P593, DOI 10.2147/CIA.S132277
   Liu YM, 2015, LAB INVEST, V95, P504, DOI 10.1038/labinvest.2015.34
   Mao XX, 2016, NEUROCHEM RES, V41, P2401, DOI 10.1007/s11064-016-1953-6
   Mejías-Peña Y, 2017, AGING-US, V9, P408, DOI 10.18632/aging.101167
   Mi XJ, 2019, J AGR FOOD CHEM, V67, P1392, DOI 10.1021/acs.jafc.8b05943
   Mohankumar A, 2018, RSC ADV, V8, P33753, DOI 10.1039/c8ra05195j
   Qu Z, 2016, PHYSIOL BEHAV, V154, P114, DOI 10.1016/j.physbeh.2015.11.016
   Ruan QW, 2013, MECH AGEING DEV, V134, P89, DOI 10.1016/j.mad.2012.12.005
   Ryu D, 2016, NAT MED, V22, P879, DOI 10.1038/nm.4132
   Ryzhak AP, 2017, B EXP BIOL MED+, V162, P534, DOI 10.1007/s10517-017-3655-8
   Savi M, 2017, CARDIOVASC DIABETOL, V16, DOI 10.1186/s12933-017-0561-3
   Tang L, 2017, BIOCHEM BIOPH RES CO, V486, P774, DOI 10.1016/j.bbrc.2017.03.119
   Wang ST, 2017, J AGR FOOD CHEM, V65, P6870, DOI 10.1021/acs.jafc.7b02442
   Wang YY, 2018, MICROB PATHOGENESIS, V119, P49, DOI 10.1016/j.micpath.2018.04.002
   Wang Y, 2015, TOXICOL IN VITRO, V29, P1107, DOI 10.1016/j.tiv.2015.04.008
   Wytrykowska A, 2016, J ORAL SCI, V58, P509, DOI 10.2334/josnusd.16-0278
   Xia MY, 2017, FEBS OPEN BIO, V7, P759, DOI 10.1002/2211-5463.12220
   Xiong Y, 2017, DIABETES, V66, P1636, DOI 10.2337/db16-1190
   Yuan JM, 2018, CARCINOGENESIS, V39, P948, DOI 10.1093/carcin/bgy060
   Zhang Y, 2018, FOOD FUNCT, V9, P371, DOI [10.1039/c7fo01511a, 10.1039/C7FO01511A]
   Zhou D, 2017, EUR REV MED PHARMACO, V21, P2785
   Zhou H, 2018, RSC ADV, V8, P10163, DOI 10.1039/c7ra13726e
   Zhuang YL, 2017, FOOD CHEM TOXICOL, V108, P554, DOI 10.1016/j.fct.2017.01.022
NR 40
TC 12
Z9 13
U1 6
U2 38
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
EI 2046-2069
J9 RSC ADV
JI RSC Adv.
PD FEB 25
PY 2020
VL 10
IS 14
BP 8027
EP 8038
DI 10.1039/d0ra00774a
PG 12
WC Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry
GA KW6YY
UT WOS:000521329900003
PM 35497859
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Li, SS
   Liu, H
   Wang, WS
   Wang, XX
   Zhang, C
   Zhang, JJ
   Jing, HJ
   Ren, ZZ
   Gao, Z
   Song, XL
   Jia, L
AF Li, Shangshang
   Liu, Hui
   Wang, Wenshuai
   Wang, Xiuxiu
   Zhang, Chen
   Zhang, Jianjun
   Jing, Huijuan
   Ren, Zhenzhen
   Gao, Zheng
   Song, Xinling
   Jia, Le
TI Antioxidant and anti-aging effects of acidic-extractable polysaccharides
   by <i>Agaricus bisporus</i>
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Acidic-extractable polysaccharides; Purification; Antioxidant and
   anti-aging effects
ID OXIDATIVE STRESS; IN-VIVO; HEPATOPROTECTIVE ACTIVITIES;
   GLUTATHIONE-PEROXIDASE; FLAMMULINA-VELUTIPES; LEPISTA-SORDIDA; MICE;
   PURIFICATION; IMPAIRMENT; ANTITUMOR
AB This study was designed to investigate the antioxidant and anti-aging effects of D-galatose-induced (D-gal-induced) aging mice as well as monosaccharide compositions of acidic-extractable polysaccharides (AcAPS) and its major purified fractions (AcAPS-1, AcAPS-2 and AcAPS-3) from the fruiting body of Agaricus bisporus. In the in vitro assays, AcAPS-2 showed superior scavenging activities on hydroxyl (82.98 +/- 14.67%) and DPPH (64.47 +/- 4.05%) radicals at the concentration of 1.0 mg/mL than AcAPS and other polysaccharides fractions. For in vivo anti-aging analysis, AcAPS-2 showed superior effects on hepatic and nephric protection by improving serum enzyme activities, biochemical levels, lipid contents and antioxidant status, respectively. The monosaccharide analysis showed that rhamnose (Rha) and glucose (Glu) may play vital roles in maintaining the antioxidant and anti-aging activities. The results suggested that both AcAPS and its purified fractions might be suitable for functional foods and natural drugs in preventing the acute aging-associated diseases. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Li, Shangshang; Liu, Hui; Wang, Wenshuai; Wang, Xiuxiu; Zhang, Chen; Zhang, Jianjun; Jing, Huijuan; Ren, Zhenzhen; Gao, Zheng; Song, Xinling; Jia, Le] Shandong Agr Univ, Coll Life Sci, Tai An 271018, Shandong, Peoples R China.
C3 Shandong Agricultural University
RP Jia, L (corresponding author), Shandong Agr Univ, Coll Life Sci, Tai An 271018, Shandong, Peoples R China.
EM jia_le@126.com
RI Wang, Shuai/JAZ-0277-2023; Wang, Luyao/JLL-2001-2023; li,
   zhang/JHV-1750-2023; zhan, y/ISA-2807-2023; zhang, jian/HPD-1712-2023
FU Mushroom Technology System of Shandong Province [SDAIT-07-05]
FX This work was supported by grants from Mushroom Technology System of
   Shandong Province (SDAIT-07-05).
CR Aguilar A, 2007, TRANSPL P, V39, P249, DOI 10.1016/j.transproceed.2006.10.212
   Chen GT, 2012, CARBOHYD POLYM, V89, P61, DOI 10.1016/j.carbpol.2012.02.045
   Cho ML, 2011, FOOD CHEM, V127, P999, DOI 10.1016/j.foodchem.2011.01.072
   Dahech I, 2011, INT J BIOL MACROMOL, V49, P942, DOI 10.1016/j.ijbiomac.2011.08.011
   Delgado-Povedano MD, 2016, J FUNCT FOODS, V24, P403, DOI 10.1016/j.jff.2016.04.020
   Ding QY, 2016, INT J BIOL MACROMOL, V85, P133, DOI 10.1016/j.ijbiomac.2015.12.058
   DINIS TCP, 1994, ARCH BIOCHEM BIOPHYS, V315, P161, DOI 10.1006/abbi.1994.1485
   Enns LC, 2008, CRIT REV EUKAR GENE, V18, P81, DOI 10.1615/CritRevEukarGeneExpr.v18.i1.60
   Govindan S, 2016, EXP TOXICOL PATHOL, V68, P329, DOI 10.1016/j.etp.2016.04.001
   Han QA, 2011, J FOOD SCI, V76, pC462, DOI 10.1111/j.1750-3841.2011.02063.x
   Johansen JS, 2005, CARDIOVASC DIABETOL, V4, DOI 10.1186/1475-2840-4-5
   Kozarski M, 2011, FOOD CHEM, V129, P1667, DOI 10.1016/j.foodchem.2011.06.029
   LAWRENCE RA, 1976, BIOCHEM BIOPH RES CO, V71, P952, DOI 10.1016/0006-291X(76)90747-6
   Li C, 2015, INT J BIOL MACROMOL, V75, P298, DOI 10.1016/j.ijbiomac.2015.01.010
   Li WJ, 2012, J AGR FOOD CHEM, V60, P1413, DOI 10.1021/jf204748a
   Li YJ, 2015, INT J BIOL MACROMOL, V77, P307, DOI 10.1016/j.ijbiomac.2015.03.039
   Lin L, 2016, CARBOHYD POLYM, V146, P388, DOI 10.1016/j.carbpol.2016.03.071
   Liu F, 1997, LIFE SCI, V60, P763, DOI 10.1016/S0024-3205(97)00004-0
   Liu J, 2013, FOOD CHEM TOXICOL, V51, P310, DOI 10.1016/j.fct.2012.10.014
   Liu X, 2012, CARBOHYD POLYM, V90, P1664, DOI 10.1016/j.carbpol.2012.07.047
   Lushchak VI, 2011, COMP BIOCHEM PHYS C, V153, P175, DOI 10.1016/j.cbpc.2010.10.004
   Ma Z, 2015, INT J BIOL MACROMOL, V73, P236, DOI 10.1016/j.ijbiomac.2014.11.028
   Mao Y, 2013, CARBOHYD POLYM, V92, P1602, DOI 10.1016/j.carbpol.2012.11.017
   MARKLUND S, 1974, EUR J BIOCHEM, V47, P469
   Masuko T, 2005, ANAL BIOCHEM, V339, P69, DOI 10.1016/j.ab.2004.12.001
   Miao SS, 2013, INT J BIOL MACROMOL, V60, P235, DOI 10.1016/j.ijbiomac.2013.05.033
   Moktan B, 2008, FOOD RES INT, V41, P586, DOI 10.1016/j.foodres.2008.04.003
   OYAIZU M, 1986, Japanese Journal of Nutrition, V44, P307
   Sarangi I, 2006, INT IMMUNOPHARMACOL, V6, P1287, DOI 10.1016/j.intimp.2006.04.002
   SINHA AK, 1972, ANAL BIOCHEM, V47, P389, DOI 10.1016/0003-2697(72)90132-7
   Sreelatha S, 2009, FOOD CHEM TOXICOL, V47, P702, DOI 10.1016/j.fct.2008.12.022
   Stein O, 1999, ATHEROSCLEROSIS, V144, P285, DOI 10.1016/S0021-9150(99)00065-9
   Tian YT, 2012, CARBOHYD POLYM, V88, P522, DOI 10.1016/j.carbpol.2011.12.042
   Wei DF, 2015, CARBOHYD POLYM, V125, P161, DOI 10.1016/j.carbpol.2015.02.029
   Wen ZS, 2014, INT J BIOL MACROMOL, V68, P98, DOI 10.1016/j.ijbiomac.2014.04.037
   Xiao JH, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/273435
   Xu N, 2017, INT J BIOL MACROMOL, V95, P204, DOI 10.1016/j.ijbiomac.2016.11.060
   Xu RJ, 2012, FOOD CHEM TOXICOL, V50, P2473, DOI 10.1016/j.fct.2011.10.047
   Yan B. J., 2011, CARBOHYD POLYM, V49, P1092
   Yi ZJ, 2009, EXP GERONTOL, V44, P760, DOI 10.1016/j.exger.2009.08.011
   Zhang QB, 2003, PHARMACOL RES, V48, P151, DOI 10.1016/S1043-6618(03)00103-8
   Zheng L, 2014, INT J BIOL MACROMOL, V70, P523, DOI 10.1016/j.ijbiomac.2014.07.037
   Zhong SZ, 2009, J NEUROL SCI, V277, P58, DOI 10.1016/j.jns.2008.10.008
   Zhong WQ, 2013, INT J BIOL MACROMOL, V60, P355, DOI 10.1016/j.ijbiomac.2013.06.018
NR 44
TC 36
Z9 40
U1 3
U2 76
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD JAN
PY 2018
VL 106
BP 1297
EP 1306
DI 10.1016/j.ijbiomac.2017.08.135
PG 10
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA FP5LS
UT WOS:000417661600144
PM 28855134
DA 2024-02-19
ER

PT J
AU Han, QH
   Li, H
   Jia, MY
   Wang, L
   Zhao, YL
   Zhang, ML
   Zhang, Q
   Meng, ZX
   Shao, JM
   Yang, YM
   Zhu, LJ
AF Han, Qunhua
   Li, Hui
   Jia, Mengyuan
   Wang, Lin
   Zhao, Yulan
   Zhang, Mangli
   Zhang, Qin
   Meng, Zhuoxian
   Shao, Jimin
   Yang, Yunmei
   Zhu, Lijun
TI Age-related changes in metabolites in young donor livers and old
   recipient sera after liver transplantation from young to old rats
SO AGING CELL
LA English
DT Article; Early Access
DE liver ageing; metabolic pathways; orthotopic liver transplantation;
   transcriptomics; untargeted metabolomics
ID BILE-ACIDS; EXPRESSION; CYTOSCAPE; SOFTWARE; INJURY; NAFLD
AB Liver ageing not only damages liver function but also harms systemic metabolism. To better understand the mechanisms underlying liver ageing, we transplanted the livers of young rats to young and old rats and performed untargeted metabolomics to detect changes in the metabolites in the liver tissues and sera. A total of 153 metabolites in the livers and 83 metabolites in the sera were different between the old and young rats that did not undergo liver transplantation; among these metabolites, 7 different metabolites were observed in both the livers and sera. Five weeks after liver transplantation, the levels of 25 metabolites in the young donor livers were similar to those in the old rats, and this result probably occurred due to the effect of the whole-body environment of the older recipients on the young livers. The 25 altered metabolites included organic acids and derivatives, lipids and lipid-like molecules, etc. In the sera, the differences in 78 metabolites, which were significant between the young and old rats, were insignificant in the old recipient rats and made the metabolic profile of the old recipients more similar to that of the young recipients. Finally, combining the above metabolomic data with the transcriptomic data from the GEO, we found that the altered metabolites and genes in the liver were enriched in 9 metabolic pathways, including glycerophospholipid, arachidonic acid, histidine and linoleate. Thus, this study revealed important age-related metabolites and potential pathways as well as the interaction between the liver and the whole-body environment.
C1 [Han, Qunhua; Jia, Mengyuan; Zhang, Qin; Yang, Yunmei; Zhu, Lijun] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Geriatr, Hangzhou 310003, Zhejiang, Peoples R China.
   [Han, Qunhua; Jia, Mengyuan; Zhang, Qin; Yang, Yunmei; Zhu, Lijun] Zhejiang Univ, Sch Med, Zhejiang Prov Key Lab Diag & Treatment Aging & Ph, Affiliated Hosp 1, Hangzhou, Peoples R China.
   [Han, Qunhua; Shao, Jimin] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Pathol & Pathophysiol, Hangzhou 310058, Zhejiang, Peoples R China.
   [Han, Qunhua; Shao, Jimin] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Inst Canc, Hangzhou 310058, Zhejiang, Peoples R China.
   [Li, Hui] Zhejiang Univ, Sch Med, Affiliated Hosp 1, NHFPC Key Lab Combined Multiorgan Transplantat, Hangzhou, Peoples R China.
   [Wang, Lin; Zhao, Yulan; Meng, Zhuoxian] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Zhejiang Prov Key Lab Pancreat Dis, Hangzhou, Peoples R China.
   [Zhang, Mangli] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Hepatobiliary & Pancreat Surg, Hangzhou, Peoples R China.
   [Meng, Zhuoxian; Shao, Jimin] Zhejiang Univ, Sch Med, Dept Pathol & Pathophysiol, Hangzhou, Peoples R China.
   [Meng, Zhuoxian; Shao, Jimin] Zhejiang Univ, Sch Med, Key Lab Dis Prote Zhejiang Prov, Hangzhou, Peoples R China.
   [Shao, Jimin] Zhejiang Univ, Ctr Canc, Hangzhou, Peoples R China.
C3 Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang
   University; Zhejiang University; Zhejiang University; Zhejiang
   University; Zhejiang University; Zhejiang University; Zhejiang
   University
RP Yang, YM; Zhu, LJ (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Geriatr, Hangzhou 310003, Zhejiang, Peoples R China.; Shao, JM (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Pathol & Pathophysiol, Hangzhou 310058, Zhejiang, Peoples R China.; Shao, JM (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Inst Canc, Hangzhou 310058, Zhejiang, Peoples R China.
EM shaojimin@zju.edu.cn; 1194070@zju.edu.cn; zhulijun@zju.edu.cn
RI Lang, Ming/HIK-0758-2022; li, wei/IUQ-2973-2023; Zhang,
   Yun/JCN-7026-2023; yang, yang/GWB-9426-2022; Wang, zijun/JNS-5435-2023;
   li, zhang/JHV-1750-2023; Lei, Ming/JAD-1050-2023; wang,
   KiKi/JFZ-3334-2023; Liu, Xiangyan/JTV-4868-2023; wang,
   lin/GSE-3040-2022; yan, xiao/JVP-0766-2024; Zhao, Yi/JFA-7988-2023;
   zhang, lu/GRO-2969-2022
FU National Key R&D Program of China [2016YFC1303401]; Zhejiang Provincial
   key discipline constructional Program of Traditional Chinese Medicine
   (Integrated Chinese and Western Medicine) [2017-XK-A31]; National
   Science and Technology Major Project of China [2018ZX10302206-006-007];
   National Natural Science Foundation of China [81372138, 81771518,
   91849108, 81972270]
FX National Key R&D Program of China, Grant/Award Number: 2016YFC1303401;
   Zhejiang Provincial key discipline constructional Program of Traditional
   Chinese Medicine (Integrated Chinese and Western Medicine), Grant/Award
   Number: 2017-XK-A31; National Science and Technology Major Project of
   China, Grant/Award Number: 2018ZX10302206-006-007; National Natural
   Science Foundation of China, Grant/AwardNumber: 81372138, 81771518,
   91849108 and 81972270
CR Almanzar N, 2020, NATURE, V583, P590, DOI 10.1038/s41586-020-2496-1
   Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41
   Byrne CD, 2015, J HEPATOL, V62, pS47, DOI 10.1016/j.jhep.2014.12.012
   Cascales-Campos PA, 2018, TRANSPL P, V50, P3594, DOI 10.1016/j.transproceed.2018.08.005
   Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260
   Eguchi S, 2011, DIGEST DIS SCI, V56, P1542, DOI 10.1007/s10620-010-1445-5
   Fu ZD, 2013, TOXICOL APPL PHARM, V273, P680, DOI 10.1016/j.taap.2013.10.020
   Martín LG, 2018, TRANSPL P, V50, P184, DOI 10.1016/j.transproceed.2017.12.002
   Gao J, 2010, BIOINFORMATICS, V26, P971, DOI 10.1093/bioinformatics/btq048
   Gyetvai G, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01394
   Hilmer SN, 2005, HEPATOLOGY, V42, P1349, DOI 10.1002/hep.20937
   Hirasawa N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20020376
   Horowitz AM, 2020, SCIENCE, V369, P167, DOI 10.1126/science.aaw2622
   Jia JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121972
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Kroll J, 2012, REJUV RES, V15, P210, DOI 10.1089/rej.2011.1286
   Li M, 2017, MOL ASPECTS MED, V56, P45, DOI 10.1016/j.mam.2017.06.001
   López-Otín C, 2016, CELL, V166, P802, DOI 10.1016/j.cell.2016.07.031
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Mato JM, 2019, WORLD J GASTROENTERO, V25, P3009, DOI 10.3748/wjg.v25.i24.3009
   Murakami M, 2017, CRIT REV IMMUNOL, V37, P121, DOI 10.1615/CritRevImmunol.v37.i2-6.20
   Pang ZQ, 2020, METABOLITES, V10, DOI 10.3390/metabo10050186
   Patel S, 2015, J PHARMACEUT BIOMED, V107, P63, DOI 10.1016/j.jpba.2014.12.020
   Perakakis N, 2020, METABOLISM, V111, DOI 10.1016/j.metabol.2020.154320
   Ramirez T, 2017, J HEPATOL, V66, P601, DOI 10.1016/j.jhep.2016.11.004
   Schaum N, 2020, NATURE, V583, P596, DOI 10.1038/s41586-020-2499-y
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   Son N, 2012, J PROTEOME RES, V11, P2551, DOI 10.1021/pr201263q
   Uwatoko Shugo, 2015, Case Rep Gastroenterol, V9, P49, DOI 10.1159/000368115
   Wen B, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1579-y
   White RR, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2061-8
   WYNNE HA, 1989, HEPATOLOGY, V9, P297, DOI 10.1002/hep.1840090222
   Yokota S, 2016, LIVER TRANSPLANT, V22, P536, DOI 10.1002/lt.24394
   Yu Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4230
   Zahn JM, 2007, PLOS GENET, V3, P2326, DOI 10.1371/journal.pgen.0030201
NR 37
TC 10
Z9 10
U1 4
U2 26
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD 2021 JUL
PY 2021
VL 20
IS 7
AR e13425
DI 10.1111/acel.13425
EA JUN 2021
PG 14
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA TJ7KL
UT WOS:000664264500001
PM 34157207
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Mollica, MP
   Iossa, S
   Soboll, S
   Liverini, G
AF Mollica, MP
   Iossa, S
   Soboll, S
   Liverini, G
TI Acetyl-L-carnitine treatment stimulates oxygen consumption and
   biosynthetic function in perfused liver of young and old rats
SO CELLULAR AND MOLECULAR LIFE SCIENCES
LA English
DT Article
DE gluconeogenesis; urea synthesis; ketogenesis; isolated mitochondria;
   ageing
ID MITOCHONDRIAL DECAY; HEPATOCYTES; OXIDATION; INHIBITION; TISSUES;
   DAMAGE; ADULT
AB The effect of treatment with acetyl-l-carnitine on hepatic mitochondrial respiration and biosynthetic function in perfused liver from young (90 days) and old (22-24 months) rats was studied. Rats were given a 1.5% (w/v) solution of acetyl-1-carnitine in their drinking water for 1 month and oxygen consumption together with the rate of gluconeogenesis, urea synthesis, and ketogenesis with and without added substrates were measured in perfused liver. Mitochondrial oxygen consumption was also assessed in liver homogenate and isolated mitochondria to determine the maximal capacity for oxidative phosphorylation. Acetyl-L-carnitine treatment almost completely restored the age-dependent decline in oxygen consumption, gluconeogenesis, urea synthesis, and ketogenesis found in perfused liver of old rats to the levels found in young rats. In addition, acetyl-l-carnitine treatment increased oxygen consumption and biosynthetic function in perfused liver from young rats. After acetyl-L-carnitine treatment, we found detectable 3-oxoacyl-CoA-transferase activity associated with a consumption of ketone bodies in young and old rats. Finally, oxygen consumption measured in homogenate and isolated mitochondria did not change with age and acetyl-l-carnitine treatment. Our results show that in perfused liver, acetyl-L-carnitine treatment slows the age-associated decline in mitochondrial respiration and biosynthetic function. In addition, treatment of young rats with acetyl-l-carnitine has a stimulating effect on liver metabolism, probably through an increase in ATP production.
C1 Univ Naples Federico II, Dept Gen & Environm Physiol, I-80134 Naples, Italy.
   Univ Dusseldorf, Inst Physiol Chem 1, D-4000 Dusseldorf, Germany.
C3 University of Naples Federico II; Heinrich Heine University Dusseldorf
RP Liverini, G (corresponding author), Univ Naples Federico II, Dept Gen & Environm Physiol, Via Mezzocannone 8, I-80134 Naples, Italy.
RI iossa, susanna/O-1625-2016
OI iossa, susanna/0000-0001-6103-718X; Mollica, Maria
   Pina/0000-0003-2726-7779
CR Bergmeyer H. U., 1974, METHODEN ENZYMATISCH
   CHA YS, 1995, ALCOHOL, V12, P289, DOI 10.1016/0741-8329(95)00007-E
   Gadaleta MN, 1998, BIOCHIMIE, V80, P863, DOI 10.1016/S0300-9084(00)88881-1
   GADALETA MN, 1990, EUR J BIOCHEM, V137, P501
   GANAPATHI MK, 1987, BIOCHEM J, V248, P853, DOI 10.1042/bj2480853
   GROSS CJ, 1986, BIOCHIM BIOPHYS ACTA, V886, P425, DOI 10.1016/0167-4889(86)90178-3
   Hagen TM, 1998, ANN NY ACAD SCI, V854, P214, DOI 10.1111/j.1749-6632.1998.tb09904.x
   Hagen TM, 1997, P NATL ACAD SCI USA, V94, P3064, DOI 10.1073/pnas.94.7.3064
   Hagen TM, 1998, P NATL ACAD SCI USA, V95, P9562, DOI 10.1073/pnas.95.16.9562
   HANSFORD RG, 1978, BIOCHEM J, V170, P285, DOI 10.1042/bj1700285
   HARTREE EF, 1972, ANAL BIOCHEM, V48, P422, DOI 10.1016/0003-2697(72)90094-2
   HUTH W, 1975, EUR J BIOCHEM, V59, P475, DOI 10.1111/j.1432-1033.1975.tb02476.x
   Iossa S, 1998, CELL BIOCHEM FUNCT, V16, P261, DOI 10.1002/(SICI)1099-0844(1998120)16:4<261::AID-CBF796>3.0.CO;2-1
   Krebs HA, 1932, H-S Z PHYSIOL CHEM, V210, P33, DOI 10.1515/bchm2.1932.210.1-2.33
   Mollica MP, 1998, CELL MOL LIFE SCI, V54, P1277, DOI 10.1007/s000180050253
   Pagliassotti MJ, 1997, AM J PHYSIOL-REG I, V272, pR526, DOI 10.1152/ajpregu.1997.272.2.R526
   PARADIES G, 1992, BIOCHIM BIOPHYS ACTA, V1103, P234
   Podolin DA, 1996, AM J PHYSIOL-REG I, V270, pR365, DOI 10.1152/ajpregu.1996.270.2.R365
   Rebouche CJ, 1998, ANNU REV NUTR, V18, P39, DOI 10.1146/annurev.nutr.18.1.39
   SACHAN DS, 1994, BIOCHEM BIOPH RES CO, V203, P1496, DOI 10.1006/bbrc.1994.2354
   Sastre J, 1996, HEPATOLOGY, V24, P1199, DOI 10.1002/hep.510240536
   SCHOLZ R, 1973, EUR J BIOCHEM, V38, P64, DOI 10.1111/j.1432-1033.1973.tb03034.x
   SHAMBAUGH GE, 1978, AM J PHYSIOL, V235, pE330, DOI 10.1152/ajpendo.1978.235.3.E330
   SHAW RD, 1983, AM J PHYSIOL, V245, pG376, DOI 10.1152/ajpgi.1983.245.3.G376
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   SIES H, 1977, ALCOHOL ALDEHYDE MET, V3, P47
   Swamy-Mruthinti S, 1999, EXP EYE RES, V69, P109, DOI 10.1006/exer.1999.0680
   VILLA RF, 1998, NEUROCHEM RES, V10, P909
   WILLIAMS.DH, 1971, BIOCHEM J, V121, P41, DOI 10.1042/bj1210041
   WINDER WW, 1982, AM J PHYSIOL, V243, pR179, DOI 10.1152/ajpregu.1982.243.1.R179
   ZAMMIT VA, 1979, FEBS LETT, V103, P212, DOI 10.1016/0014-5793(79)81329-0
NR 31
TC 16
Z9 18
U1 0
U2 1
PU BIRKHAUSER VERLAG AG
PI BASEL
PA VIADUKSTRASSE 40-44, PO BOX 133, CH-4010 BASEL, SWITZERLAND
SN 1420-682X
J9 CELL MOL LIFE SCI
JI Cell. Mol. Life Sci.
PD MAR
PY 2001
VL 58
IS 3
BP 477
EP 484
DI 10.1007/PL00000871
PG 8
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA 417FZ
UT WOS:000167825900011
PM 11315193
DA 2024-02-19
ER

PT J
AU Fu, CX
   Hickey, M
   Morrison, M
   McCarter, R
   Han, ES
AF Fu, Chunxiao
   Hickey, Morgen
   Morrison, Melissa
   McCarter, Roger
   Han, Eun-Soo
TI Tissue specific and non-specific changes in gene expression by aging and
   by early stage CR
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE gene expression; microarray; aging; calorie restriction
ID CELL-ADHESION MOLECULE-1; AGE-RELATED IMPAIRMENT; CALORIC RESTRICTION;
   OXIDATIVE STRESS; FOOD RESTRICTION; SKELETAL-MUSCLE; RESPONSES; LEVEL;
   TERM; OLD
AB Aging alters the expression of a variety of genes. Calorie restriction (CR), which extends life span in laboratory rodents, also changes gene expression. This study investigated changes in gene expression across three different tissues from the same mouse to examine how aging and early stage CR influence gene expression in different tissues of an organism. Expression profiling of heart, liver, and hypothalamus tissues was done in young (4-6 months) ad libitum fed (AL), young CR (2.5-4.5 months of CR), and old (26-28 months) AL male C57BL/6 mice. Aging significantly altered the expressions of 309, 1819, and 1085 genes in heart, liver, and hypothalamus tissues, respectively. In nine genes, aging altered expression across all three tissues although the regulation directions did not agree across all three tissues for some genes. Early stage CR in young mice significantly changed the expressions of 192, 839, and 100 genes in heart, liver, and hypothalamus tissues, respectively, and seven genes altered expression across all three tissues; three were up regulated and four were down regulated. The results of Gene Ontology (GO) Biological Process analysis indicated up regulation of antigen processing/presentation genes by aging and down regulation of stress response genes by early stage CR in all three tissues. The comparison of the results of aging and short term CR studies showed there were 389 genes, 18 GO biological processes, and 20 GO molecular functions in common. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
C1 Univ Tulsa, Dept Biol Sci, Tulsa, OK 74104 USA.
   Penn State Univ, Ctr Dev & Hlth Genet, University Pk, PA 16802 USA.
C3 University of Tulsa; Pennsylvania Commonwealth System of Higher
   Education (PCSHE); Pennsylvania State University; Pennsylvania State
   University - University Park
RP Han, ES (corresponding author), Univ Tulsa, Dept Biol Sci, 600 S Coll Ave, Tulsa, OK 74104 USA.
EM eun-han@utulsa.edu
FU Intramural NIH HHS [Z01 AG000746] Funding Source: Medline; NIA NIH HHS
   [AG-14674-04S1] Funding Source: Medline
CR *AFFYMETRIX INC, 2004, APP B GENECHIP PROB
   Alexander R W, 1998, Trans Am Clin Climatol Assoc, V109, P129
   AMSTRONG SM, 1991, MED HYPOTHESES, V34, P300
   Bateman H., 1953, HIGHER TRANSCENDENTA
   Blalock EM, 2003, J NEUROSCI, V23, P3807
   Bodyak N, 2002, NUCLEIC ACIDS RES, V30, P3788, DOI 10.1093/nar/gkf497
   Bronikowski AM, 2003, PHYSIOL GENOMICS, V12, P129, DOI 10.1152/physiolgenomics.00082.2002
   Cao SX, 2001, P NATL ACAD SCI USA, V98, P10630, DOI 10.1073/pnas.191313598
   CARRILLO MC, 1994, BIOCHEM PHARMACOL, V47, P1333, DOI 10.1016/0006-2952(94)90331-X
   CHERNOFF H, 1954, ANN MATH STAT, V25, P579, DOI 10.1214/aoms/1177728726
   Chung HY, 2001, ANN NY ACAD SCI, V928, P327
   Cook P, 2004, BIOTECHNIQUES, V37, P990, DOI 10.2144/04376BIN02
   Cook-Mills JM, 2004, BIOCHEM J, V378, P539, DOI 10.1042/BJ20030794
   Dhahbi JM, 2006, J GERONTOL A-BIOL, V61, P218, DOI 10.1093/gerona/61.3.218
   Dhahbi JM, 2004, P NATL ACAD SCI USA, V101, P5524, DOI 10.1073/pnas.0305300101
   Edwards MG, 2003, PHYSIOL GENOMICS, V13, P119, DOI 10.1152/physiolgenomics.00172.2002
   EFFROS RB, 1984, CELL IMMUNOL, V88, P531, DOI 10.1016/0008-8749(84)90184-9
   FREISLEBEN HJ, 1994, J NEURAL TRANSM-SUPP, P231
   Fu CX, 2004, J NUTR, V134, P2965, DOI 10.1093/jn/134.11.2965
   Giardina C, 2002, CELL STRESS CHAPERON, V7, P207, DOI 10.1379/1466-1268(2002)007<0207:GOWNFB>2.0.CO;2
   HAGENBUCHLE O, 1980, CELL, V21, P179, DOI 10.1016/0092-8674(80)90125-7
   Han ES, 2004, J GERONTOL A-BIOL, V59, P306
   Han S, 2004, INT IMMUNOL, V16, P525, DOI 10.1093/intimm/dxh054
   HEYDARI AR, 1993, MOL CELL BIOL, V13, P2909, DOI 10.1128/MCB.13.5.2909
   Hirano M, 2005, GENE EXPR PATTERNS, V5, P439, DOI 10.1016/j.modgep.2004.09.002
   HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710
   Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70
   Jiang CH, 2001, P NATL ACAD SCI USA, V98, P1930, DOI 10.1073/pnas.98.4.1930
   Kayo T, 2001, P NATL ACAD SCI USA, V98, P5093, DOI 10.1073/pnas.081061898
   Lee CK, 2002, P NATL ACAD SCI USA, V99, P14988, DOI 10.1073/pnas.232308999
   Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098
   Liu WL, 2001, J NANOSCI NANOTECHNO, V1, P39, DOI 10.1166/jnn.2001.013
   Liu YF, 2006, FRONT BIOSCI-LANDMRK, V11, P2802, DOI 10.2741/2011
   Lord JM, 2001, MECH AGEING DEV, V122, P1521, DOI 10.1016/S0047-6374(01)00285-8
   Mahay S, 2004, MOL CELL BIOCHEM, V266, P199, DOI 10.1023/B:MCBI.0000049158.85447.4f
   Masoro EJ, 2000, EXP GERONTOL, V35, P299, DOI 10.1016/S0531-5565(00)00084-X
   MASORO EJ, 1992, ANN NY ACAD SCI, V673, P29, DOI 10.1111/j.1749-6632.1992.tb27433.x
   MASORO EJ, 1988, J GERONTOL, V43, pB59, DOI 10.1093/geronj/43.3.B59
   Meager A, 1999, CYTOKINE GROWTH F R, V10, P27, DOI 10.1016/S1359-6101(98)00024-0
   Merat S, 2000, J GERONTOL A-BIOL, V55, pB85
   MIELENZ JR, 1983, P NATL ACAD SCI-BIOL, V80, P5975, DOI 10.1073/pnas.80.19.5975
   Miller RA, 1996, SCIENCE, V273, P70, DOI 10.1126/science.273.5271.70
   Miller RA, 1999, J GERONTOL A-BIOL, V54, pB297, DOI 10.1093/gerona/54.7.B297
   Nagler RM, 2005, AGING CLIN EXP RES, V17, P358
   Plowden J, 2004, CELL IMMUNOL, V229, P86, DOI 10.1016/j.cellimm.2004.07.001
   Plowden J, 2004, AGING CELL, V3, P161, DOI 10.1111/j.1474-9728.2004.00102.x
   Ponnappan Usha, 1998, Frontiers in Bioscience, V3, pD152
   Prolla TA, 2002, CHEM SENSES, V27, P299, DOI 10.1093/chemse/27.3.299
   Renshaw M, 2002, J IMMUNOL, V169, P4697, DOI 10.4049/jimmunol.169.9.4697
   Sambrook J, 1989, MOL CLONING LAB MANU
   Terao A, 2002, J NEUROIMMUNOL, V132, P99, DOI 10.1016/S0165-5728(02)00317-X
   Thomas X, 2005, HEMATOLOGY, V10, P225, DOI 10.1080/10245330500093120
   Tsuchiya T, 2004, PHYSIOL GENOMICS, V17, P307, DOI 10.1152/physiolgenomics.00039.2004
   Wang XY, 2003, CANCER RES, V63, P2553
   Weindruch R, 2001, J NUTR, V131, p918S, DOI 10.1093/jn/131.3.918S
   Yang H, 2004, J GERONTOL A-BIOL, V59, P316
   Yu BP, 2001, DIABETES RES CLIN PR, V54, pS73, DOI 10.1016/S0168-8227(01)00338-2
   Yu BP, 2001, ANN NY ACAD SCI, V928, P39
   YU BP, 1985, J GERONTOL, V40, P657, DOI 10.1093/geronj/40.6.657
   Zou Y, 2006, J GERONTOL A-BIOL, V61, P232, DOI 10.1093/gerona/61.3.232
NR 60
TC 40
Z9 45
U1 0
U2 4
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
EI 1872-6216
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD DEC
PY 2006
VL 127
IS 12
BP 905
EP 916
DI 10.1016/j.mad.2006.09.006
PG 12
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 118XI
UT WOS:000242976400005
PM 17092546
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Brown-Borg, HM
   Bode, AM
   Bartke, A
AF Brown-Borg, HM
   Bode, AM
   Bartke, A
TI Antioxidative mechanisms and plasma growth hormone levels -:
   <i>Potential relationship in the aging process</i>
SO ENDOCRINE
LA English
DT Article
DE dwarf; delayed aging; antioxidative mechanisms; hormones
ID LIFE-SPAN; TRANSGENIC MICE; FACTOR-I; GLUTATHIONE-REDUCTASE; CALORIE
   RESTRICTION; OXIDATIVE STRESS; DWARF MICE; GENE; ENZYMES; MOUSE
AB Factors affecting longevity are complex and poorly understood. We have recently found that Ames dwarf mice (df/df), which are deficient in growth hormone (GH), prolactin, and thyroid-stimulating hormone, live significantly longer than their normal siblings whereas transgenic mice that overexpress GH exhibit reduced life-spans and various indices of premature aging. The production of reactive oxygen species increases with aging and is associated with DNA damage to the tissues. However, several cellular oxygen scavenging/detoxifying systems exist that improve the antioxidative defense capacity of cells. We evaluated the activity of enzymes involved in this defense system in liver, kidney, and heart tissue from dwarf, phosphoenolpyruvate carboxykinase-bovine GH transgenic, and corresponding groups of normal mice. Liver glutathione and ascorbate levels were lower (p < 0.0025) in dwarf animals compared to normal and GH transgenic mice. By contrast, the level of catalase activity, which detoxifies hydrogen peroxide, in dwarf liver and kidney was significantly higher when compared to the other groups. Animals deficient in GH (dwarf) live longer and exhibit enzyme activities and levels that may combat oxidative stress more efficiently than normal mice and those overexpressing GH.
C1 Univ N Dakota, Sch Med & Hlth Sci, Dept Physiol, Grand Forks, ND 58203 USA.
   Univ Oregon, Dept Exercise & Movement Sci, Eugene, OR 97403 USA.
   So Illinois Univ, Sch Med, Dept Physiol, Carbondale, IL 62901 USA.
C3 University of North Dakota Grand Forks; University of Oregon; Southern
   Illinois University System; Southern Illinois University
RP Brown-Borg, HM (corresponding author), Univ N Dakota, Sch Med & Hlth Sci, Dept Physiol, Grand Forks, ND 58203 USA.
EM brownbrg@medicine.nodak.edu
RI Brown-Borg, Holly/IQV-8650-2023; Bartke, Andzej/D-6640-2017
OI Bartke, Andzej/0000-0002-2569-557X
CR ABRAHAM EC, 1978, BIOCHEM J, V174, P819, DOI 10.1042/bj1740819
   Aebi H, 1984, METHODS ENZYMOLOGY
   AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   Amicarelli F, 1997, MECH AGEING DEV, V97, P215, DOI 10.1016/S0047-6374(97)00061-4
   Andersen B, 1995, DEV BIOL, V172, P495, DOI 10.1006/dbio.1995.8040
   [Anonymous], METHODS ENZYMATIC AN
   [Anonymous], 1984, METHODS ENZYMOLOGY
   [Anonymous], 1990, Longevity, senescence and the genome
   [Anonymous], 1994, PHENOTYPES THEIR EPI
   Bartke A, 1998, ENDOCRINE, V8, P103, DOI 10.1385/ENDO:8:2:103
   Bates AS, 1996, J CLIN ENDOCR METAB, V81, P1169, DOI 10.1210/jc.81.3.1169
   BOMPART GJ, 1990, CLIN BIOCHEM, V23, P501, DOI 10.1016/0009-9120(90)80039-L
   BORG KE, 1995, P SOC EXP BIOL MED, V210, P126
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0
   BROWNBORG HM, 1998, 80 ANN M END SOC NEW
   Carlberg I, 1985, METHODS ENZYMOLOGY
   CHANDRASHEKAR V, 1993, BIOL REPROD, V48, P544, DOI 10.1095/biolreprod48.3.544
   CHEN TS, 1990, DRUG METAB DISPOS, V18, P882
   Ciriolo MR, 1997, NEUROSCI LETT, V228, P21, DOI 10.1016/S0304-3940(97)00344-3
   COMFORT A, 1961, SCI AM, V205, P108, DOI 10.1038/scientificamerican0861-108
   Croson WB, 1998, FASEB J, V12, pA120
   EIGENMANN JE, 1984, ACTA ENDOCRINOL-COP, V106, P448, DOI 10.1530/acta.0.1060448
   EIGENMANN JE, 1984, ACTA ENDOCRINOL-COP, V105, P294, DOI 10.1530/acta.0.1050294
   GRIFFITH OW, 1986, METHODS ENZYMATIC AN
   Herbert V, 1996, J NUTR, V126, pS1213, DOI 10.1093/jn/126.suppl_4.1213S
   JI LL, 1990, AM J PHYSIOL, V258, pR918, DOI 10.1152/ajpregu.1990.258.4.R918
   Kim JD, 1996, AGING-CLIN EXP RES, V8, P123, DOI 10.1007/BF03339566
   Lane MA, 1996, P NATL ACAD SCI USA, V93, P4159, DOI 10.1073/pnas.93.9.4159
   LANG CA, 1989, DIETARY RESTRICTION
   LI S, 1990, NATURE, V347, P528, DOI 10.1038/347528a0
   MASORO EJ, 1982, P NATL ACAD SCI-BIOL, V79, P4239, DOI 10.1073/pnas.79.13.4239
   MCGRANE MM, 1988, J BIOL CHEM, V263, P11443
   Meliska CJ, 1997, NEUROBIOL LEARN MEM, V68, P1, DOI 10.1006/nlme.1997.3772
   MILLER DB, 1995, EXP GERONTOL, V30, P383, DOI 10.1016/0531-5565(94)00064-A
   MOTE PL, 1991, J GERONTOL, V46, pB95, DOI 10.1093/geronj/46.3.B95
   Mura CV, 1996, MECH AGEING DEV, V91, P115, DOI 10.1016/0047-6374(96)01780-0
   OOKA H, 1983, MECH AGEING DEV, V22, P113, DOI 10.1016/0047-6374(83)90104-5
   ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730
   PENDERGRASS WR, 1993, J CELL PHYSIOL, V156, P96, DOI 10.1002/jcp.1041560114
   PROMISLOW DEL, 1993, J GERONTOL, V48, pB115, DOI 10.1093/geronj/48.4.B115
   RICHIE JP, 1992, EXP GERONTOL, V27, P615, DOI 10.1016/0531-5565(92)90015-R
   Rollo CD, 1996, CAN J ZOOL, V74, P606, DOI 10.1139/z96-070
   Rubin CD, 1996, EXP GERONTOL, V31, P557, DOI 10.1016/0531-5565(96)00031-9
   RUDMAN D, 1990, NEW ENGL J MED, V323, P1, DOI 10.1056/NEJM199007053230101
   SAMARAS TT, 1992, B WORLD HEALTH ORGAN, V70, P259
   SCHELL DA, 1993, BIOMED CHROMATOGR, V7, P267, DOI 10.1002/bmc.1130070506
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   SOHAL RS, 1995, MOL ASPECTS AGING
   SONKSEN PH, 1991, ACTA PAEDIATR, P139
   STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616
   STEGER RW, 1993, J REPROD FERTIL, P61
   TABATABAIE T, 1994, ARCH BIOCHEM BIOPHYS, V314, P112, DOI 10.1006/abbi.1994.1418
   WANKE R, 1992, HORM RES, V37, P74, DOI 10.1159/000182406
   Weindruch R, 1997, NEW ENGL J MED, V337, P986, DOI 10.1056/NEJM199710023371407
   Weindruch R., 1988, RETARDATION AGING DI
   XIA EN, 1995, J NUTR, V125, P195
   YU BP, 1994, PHYSIOL REV, V74, P139, DOI 10.1152/physrev.1994.74.1.139
   Q J MED NS L1
   WILLIAMS TXB ENDOCRI
   TRANSGENICS
NR 61
TC 124
Z9 131
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1355-008X
EI 1559-0100
J9 ENDOCRINE
JI Endocrine
PD AUG
PY 1999
VL 11
IS 1
BP 41
EP 48
DI 10.1385/ENDO:11:1:41
PG 8
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 256LM
UT WOS:000083726800006
PM 10668640
DA 2024-02-19
ER

PT J
AU La Fata, G
   van Vliet, N
   Barnhoorn, S
   Brandt, RMC
   Etheve, S
   Chenal, E
   Grunenwald, C
   Seifert, N
   Weber, P
   Hoeijmakers, JHJ
   Mohajeri, MH
   Vermeij, WP
AF La Fata, G.
   van Vliet, N.
   Barnhoorn, S.
   Brandt, R. M. C.
   Etheve, S.
   Chenal, E.
   Grunenwald, C.
   Seifert, N.
   Weber, P.
   Hoeijmakers, J. H. J.
   Mohajeri, M. H.
   Vermeij, W. P.
TI Vitamin E Supplementation Reduces Cellular Loss in the Brain of a
   Premature Aging Mouse Model
SO JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE
LA English
DT Article
DE Vitamin E; neurodegeneration; aging; DNA damage repair; anti-aging
   interventions
AB BACKGROUND: Aging is a highly complex biological process driven by multiple factors. Its progression can partially be influenced by nutritional interventions. Vitamin E is a lipid-soluble anti-oxidant that is investigated as nutritional supplement for its ability to prevent or delay the onset of specific aging pathologies, including neurodegenerative disorders.
   PURPOSE: We aimed here to investigate the effect of vitamin E during aging progression in a well characterized mouse model for premature aging.
   METHOD: Xpg-/- animals received diets with low (similar to 2.5 mg/kg feed), medium (75 mg/kg feed) or high (375 mg/kg feed) vitamin E concentration and their phenotype was monitored during aging progression. Vitamin E content was analyzed in the feed, for stability reasons, and in mouse plasma, brain, and liver, for effectiveness of the treatment. Subsequent age-related changes were monitored for improvement by increased vitamin E or worsening by depletion in both liver and nervous system, organs sensitive to oxidative stress.
   RESULTS: Mice supplemented with high levels of vitamin E showed a delayed onset of age-related body weight decline and appearance of tremors when compared to mice with a low dietary vitamin E intake. DNA damage resulting in liver abnormalities such as changes in polyploidy, was considerably prevented by elevated amounts of vitamin E. Additionally, immunohistochemical analyses revealed that high intake of vitamin E, when compared with low and medium levels of vitamin E in the diet, reduces the number of p53-positive cells throughout the brain, indicative of a lower number of cells dying due to DNA damage accumulated over time.
   CONCLUSIONS: Our data underline a neuroprotective role of vitamin E in the premature aging animal model used in this study, likely via a reduction of oxidative stress, and implies the importance of improved nutrition to sustain health.
C1 [La Fata, G.; Etheve, S.; Chenal, E.; Grunenwald, C.; Seifert, N.; Weber, P.; Mohajeri, M. H.] DSM Nutr Prod Ltd, POB 2676, CH-4002 Basel, Switzerland.
   [van Vliet, N.; Barnhoorn, S.; Brandt, R. M. C.; Hoeijmakers, J. H. J.; Vermeij, W. P.] Erasmus Univ, Med Ctr Rotterdam, Dept Mol Genet, POB 2040, NL-3000 CA Rotterdam, Netherlands.
   [Hoeijmakers, J. H. J.] Univ Cologne, CECAD Forschungszentrum, Cologne, Germany.
C3 DSM NV; Erasmus University Rotterdam; Erasmus MC; University of Cologne
RP Mohajeri, MH (corresponding author), DSM Nutr Prod Ltd, POB 2676, CH-4002 Basel, Switzerland.; Vermeij, WP (corresponding author), Erasmus Univ, Med Ctr Rotterdam, Dept Mol Genet, POB 2040, NL-3000 CA Rotterdam, Netherlands.
EM hasan.mohajeri@dsm.com; w.vermeij@erasmusmc.nl
RI Hoeijmakers, Jan/AAX-6972-2021
OI Vermeij, Wilbert/0000-0002-9690-1385; Brandt, Renata M.
   C./0000-0003-0514-5623
FU National Institute of Health (NIH)/National Institute of Ageing (NIA)
   [PO1 AG017242]; European Research Council Advanced Grant DamAge;
   European Research Council Proof of Concept Grant Dementia; European
   commission ITN Address [GA-316390]; European commission ITN Marriage
   [GA-316964]; KWO Dutch Cancer Society [5030]; Dutch CAA Foundation;
   Royal Academy of Arts and Sciences of the Netherlands
FX We thank Yvette van Loon, Lucien Rooth and the animal caretakers for
   general assistance with mouse experiments. Pier Giorgio Mastroberardino
   and Chiara Milanese are acknowledged for their support with the
   oxidative stress measurements. We acknowledge financial support of the
   National Institute of Health (NIH)/National Institute of Ageing (NIA)
   (PO1 AG017242), European Research Council Advanced Grant DamAge and
   Proof of Concept Grant Dementia to JHJH, the European commission ITN
   Address (GA-316390) and ITN Marriage (GA-316964), the KWO Dutch Cancer
   Society (5030), the Dutch CAA Foundation and the Royal Academy of Arts
   and Sciences of the Netherlands (academia professorship to JHJH). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Barnhoorn S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004686
   Brigelius-Flohé R, 1999, FASEB J, V13, P1145, DOI 10.1096/fasebj.13.10.1145
   Clement M, 1997, BBA-GEN SUBJECTS, V1334, P173, DOI 10.1016/S0304-4165(96)00090-6
   Duncan AW, 2010, NATURE, V467, P707, DOI 10.1038/nature09414
   Dunn JD, 2015, REDOX BIOL, V6, P472, DOI 10.1016/j.redox.2015.09.005
   Gaedicke S, 2009, BRIT J NUTR, V102, P398, DOI 10.1017/S000711450819122X
   Gohil K, 2008, BRAIN RES, V1201, P167, DOI 10.1016/j.brainres.2008.01.044
   Goncalves A, 2014, MOL NUTR FOOD RES, V58, P2297, DOI 10.1002/mnfr.201400339
   Harkema L, 2016, VET PATHOL, V53, P366, DOI 10.1177/0300985815625169
   Hilmer SN, 2005, HEPATOLOGY, V42, P1349, DOI 10.1002/hep.20937
   Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615
   Höller U, 2003, J AGR FOOD CHEM, V51, P1539, DOI 10.1021/jf0260038
   Horowitz MP, 2011, ANTIOXID REDOX SIGN, V15, P855, DOI 10.1089/ars.2010.3629
   KamalEldin A, 1996, LIPIDS, V31, P671, DOI 10.1007/BF02522884
   Klungland A, 1999, MOL CELL, V3, P33, DOI 10.1016/S1097-2765(00)80172-0
   La Fata G, 2014, NUTRIENTS, V6, P5453, DOI 10.3390/nu6125453
   Le Couteur DG, 2008, ANAT REC, V291, P672, DOI 10.1002/ar.20661
   Li S, 2015, INT J MOL SCI, V16, P26087, DOI 10.3390/ijms161125942
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Marteijn JA, 2014, NAT REV MOL CELL BIO, V15, P465, DOI 10.1038/nrm3822
   Mocchegiani E, 2014, AGEING RES REV, V14, P81, DOI 10.1016/j.arr.2014.01.001
   Mohajeri MH, 2015, NUTRITION, V31, P261, DOI 10.1016/j.nut.2014.06.016
   Mohajeri MH, 2009, BRAIN RES BULL, V80, P315, DOI 10.1016/j.brainresbull.2009.06.014
   Mu D, 1996, J BIOL CHEM, V271, P8285, DOI 10.1074/jbc.271.14.8285
   Rigotti A, 2007, MOL ASPECTS MED, V28, P423, DOI 10.1016/j.mam.2007.01.002
   Solon-Biet SM, 2014, CELL METAB, V19, P418, DOI 10.1016/j.cmet.2014.02.009
   Stadtman ER, 1998, DRUG METAB REV, V30, P225, DOI 10.3109/03602539808996310
   Trego KS, 2016, MOL CELL, V61, P535, DOI 10.1016/j.molcel.2015.12.026
   Ulatowski L, 2014, NEUROSCIENCE, V260, P120, DOI 10.1016/j.neuroscience.2013.12.001
   Vermeij WP, 2016, NATURE, V537, P427, DOI 10.1038/nature19329
   Vermeij WP, 2016, ANNU REV PHARMACOL, V56, P427, DOI 10.1146/annurev-pharmtox-010814-124316
   Vermeij WP, 2014, CURR OPIN GENET DEV, V26, P124, DOI 10.1016/j.gde.2014.06.006
   Vermeij WP, 2014, METHODS MOL BIOL, V1195, P157, DOI 10.1007/7651_2013_51
   Vermeij WP, 2011, J INVEST DERMATOL, V131, P1435, DOI 10.1038/jid.2010.433
   von Zglinicki T, 2001, EXP GERONTOL, V36, P1049, DOI 10.1016/S0531-5565(01)00111-5
   White RR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7790
   Zafeiriou DI, 2001, PEDIATR RES, V49, P407, DOI 10.1203/00006450-200103000-00016
NR 37
TC 17
Z9 17
U1 0
U2 1
PU EDITIONS SERDI
PI PARIS
PA 320 RUE SAINT-HONORE, PARIS, 75001, FRANCE
SN 2274-5807
EI 2426-0266
J9 JPAD-J PREV ALZHEIM
JI JPAD-J. Prev. Alzheimers Dis.
PY 2017
VL 4
IS 4
BP 226
EP 235
DI 10.14283/jpad.2017.30
PG 10
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA VI1UT
UT WOS:000461783700005
PM 29181487
DA 2024-02-19
ER

PT J
AU Morsi, AA
   Mersal, EA
   Alsabih, AO
   Alakabawy, S
   Elfawal, RG
   Sakr, EM
   Faruk, EM
   Abu-Rashed, M
   Alhaddad, F
   Alkhawajah, Z
   Hasari, A
   Ibrahim, KE
   Abdelmoneim, AM
AF Morsi, Ahmed A.
   Mersal, Ezat A.
   Alsabih, Ahmed Othman
   Alakabawy, Shaimaa
   Elfawal, Riham G.
   Sakr, Eman M.
   Faruk, Eman Mohamed
   Abu-Rashed, Mohammed
   Alhaddad, Fatimah
   Alkhawajah, Zahra
   Hasari, Abdulrahman
   Ibrahim, Khalid Elfaki
   Abdelmoneim, Ahmed M.
TI Bisphenol-A exposure alters liver, kidney, and pancreatic Klotho
   expression by HSP60-activated mTOR/autophagy pathway in male albino rats
SO CELLULAR AND MOLECULAR BIOLOGY
LA English
DT Article
DE Cell stress and senescence; endocrine disruptors; environmental
   pollution; Klotho and HSP60 immunohistochemistry; rat gene study of ULK1
AB The effect of bisphenol-A (BPA) on Klotho protein (aging-suppressing protein) expression in different body organs has not been sufficiently addressed by literature studies. The study investigated the impact of BPA on Klotho expression in multiple organs including the liver, kidney, and pancreas and suggested the involved molecular pathways. Twenty-seven male Wistar albino rats were divided into 3 equal groups: control, low-dose BPA (4.5 mu g/L), and high-dose BPA (8 mu g/L) groups in drinking water for 45 consecutive days. Liver, kidney, and pancreatic specimens were prepared for a gene study of Klotho, HSP60, mTOR, and ULK1 mRNA expressions. Also, the tissue specimens were measured for malondialdehyde (MDA), superoxide dismutase (SOD), and nitric oxide (NO) levels. Paraffinembedded sections were also prepared and subjected to Hematoxylin and Eosin (H&E) staining and immunohistochemical detection of Klotho and HSP60. The results revealed an alteration in the MDA, SOD, NO tissue levels, disturbed gene expression profile, and apoptotic changes in the histological findings of the examined organs which were obvious (p < 0.05) in the high-dose group. The anti-aging Klotho gene/protein expression was reduced (p < 0.05) more in the high-dose BPA group than in the low dose. In contrast, HSP60 gene/protein expression was significantly increased (p < 0.05) more in the high dose. The increased mTOR gene expression was strongly correlated (p < 0.05) with the decreased autophagy related gene ULK1. It was concluded that BPA exposure contributed to cell stress and markedly reduced Klotho protein expression in liver, kidney, and pancreatic tissues, possibly by modulation of the HSP60-activated mTOR/autophagy signaling.
C1 [Morsi, Ahmed A.] Fayoum Univ, Fac Med, Dept Histol & Cell Biol, Al Fayyum, Egypt.
   [Mersal, Ezat A.] Assiut Univ, Fac Sci, Biochem Dept, Assiut, Egypt.
   [Mersal, Ezat A.; Sakr, Eman M.] Vis Coll, Dept Basic Med Sci, Riyadh, Saudi Arabia.
   [Alsabih, Ahmed Othman] King Saud Univ, Coll Med, Dept Physiol, Riyadh, Saudi Arabia.
   [Alakabawy, Shaimaa; Elfawal, Riham G.] Vis Coll, Dept Clin Sci, Riyadh, Saudi Arabia.
   [Elfawal, Riham G.] Alexandria Univ, Fac Med, Clin Pathol Dept, Alexandria, Egypt.
   [Sakr, Eman M.] Natl Inst Oceanog & Fisheries NIOF, Cairo, Egypt.
   [Faruk, Eman Mohamed] Umm Al Qura Univ, Coll Med, Anat Dept, Mecca, Saudi Arabia.
   [Faruk, Eman Mohamed] Benha Univ, Fac Med, Dept Histol & Cytol, Banha, Egypt.
   [Abu-Rashed, Mohammed; Alhaddad, Fatimah; Alkhawajah, Zahra; Hasari, Abdulrahman] Vis Coll, Riyadh, Saudi Arabia.
   [Ibrahim, Khalid Elfaki] King Saud Univ, Coll Sci, Dept Zool, POB 2455, Riyadh 11451, Saudi Arabia.
   [Abdelmoneim, Ahmed M.] Fayoum Univ, Fac Med, Dept Physiol, Al Fayyum, Egypt.
C3 Egyptian Knowledge Bank (EKB); Fayoum University; Egyptian Knowledge
   Bank (EKB); Assiut University; King Saud University; Egyptian Knowledge
   Bank (EKB); Alexandria University; Egyptian Knowledge Bank (EKB);
   National Institute of Oceanography & Fisheries (NIOF); Umm Al Qura
   University; Egyptian Knowledge Bank (EKB); Benha University; King Saud
   University; Egyptian Knowledge Bank (EKB); Fayoum University
RP Morsi, AA (corresponding author), Fayoum Univ, Fac Med, Dept Histol & Cell Biol, Al Fayyum, Egypt.
EM aaa21@fayoum.edu.eg
RI Mersal, Ezat/ADH-7307-2022; Ibrahim, Khalid ELFAKI/AAX-5018-2021; Morsi,
   Ahmed/AAS-9714-2020
OI Mersal, Ezat/0000-0003-1749-2489; Ibrahim, Khalid
   ELFAKI/0000-0002-3617-4876; Morsi, Ahmed/0000-0001-7911-0795
FU King Saud University, Riyadh, Saudi Arabia [RSP-D2023R759]
FX The Researchers Supporting Project number (RSP-D2023R759), King Saud
   University, Riyadh, Saudi Arabia.
CR Aman Y, 2021, NATURE AGING, V1, P634, DOI 10.1038/s43587-021-00098-4
   Bancroft JD., 2018, Bancroft's theory and practice of histological techniques, P126, DOI DOI 10.1016/B978-0-7020-6864-5.00010-4
   Buchanan S, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00560
   Cheikhi A, 2019, J GERONTOL A-BIOL, V74, P1031, DOI 10.1093/gerona/glz061
   Collins BC, 2019, BONE, V123, P137, DOI 10.1016/j.bone.2019.03.033
   Dutta M, 2019, TOXICOL REP, V6, P578, DOI 10.1016/j.toxrep.2019.06.011
   EFSA, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4278
   Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149
   Gomez CR, 2021, GEROSCIENCE, V43, P2515, DOI 10.1007/s11357-021-00394-2
   Grotto D, 2009, QUIM NOVA, V32, P169, DOI 10.1590/S0100-40422009000100032
   Guan SS, 2016, ONCOTARGET, V7, P23072, DOI 10.18632/oncotarget.8604
   Holczer M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-75030-8
   Huang YH, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23010577
   Kaushik S, 2018, NAT REV MOL CELL BIO, V19, P365, DOI 10.1038/s41580-018-0001-6
   Kiernan J.A., 2015, Histol. Histochem. Methods. Theory Pract., P454
   Kikis EA, 2020, ADV PROTEIN CHEM STR, V118, P145, DOI 10.1016/bs.apcsb.2019.07.001
   Kim DY, 2021, MOL MED REP, V23, DOI 10.3892/mmr.2020.11660
   Kishimoto S, 2018, INFLAMM REGEN, V38, DOI 10.1186/s41232-018-0080-y
   Lang BJ, 2021, ARCH TOXICOL, V95, P1943, DOI 10.1007/s00204-021-03070-8
   Liguori I, 2018, CLIN INTERV AGING, V13, P757, DOI 10.2147/CIA.S158513
   Lin MG, 2016, CURR OPIN CELL BIOL, V39, P61, DOI 10.1016/j.ceb.2016.02.010
   Lin ML, 2021, ENVIRON INT, V147, DOI 10.1016/j.envint.2020.106298
   Liu GY, 2020, NAT REV MOL CELL BIO, V21, P183, DOI 10.1038/s41580-019-0199-y
   Mantej J, 2019, CELL STRESS CHAPERON, V24, P283, DOI 10.1007/s12192-018-0951-9
   Mersal EA, 2022, EGYPT J CHEM, V65, P1353, DOI 10.21608/EJCHEM.2022.143376.6258
   MONTGOMERY H, 1961, ANALYST, V86, P414
   Moon MK, 2015, J ENDOCRINOL, V226, P35, DOI 10.1530/JOE-14-0714
   Papadopoli David, 2019, F1000Res, V8, DOI 10.12688/f1000research.17196.1
   Quan C, 2017, ENVIRON TOXICOL, V32, P1977, DOI 10.1002/tox.22339
   Rao ZJ, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01498
   Siddique MA, 2021, FOODS, V10, DOI 10.3390/foods10040714
   Sita GJA, 2019, IUBMB LIFE, V71, P1041, DOI 10.1002/iub.2066
   SUN Y, 1988, CLIN CHEM, V34, P497
   Sun ZH, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.919086
   Tang HP, 2016, SCI REP-UK, V6, DOI 10.1038/srep28388
   Tang YX, 2021, CANCER BIOMARK, V30, P85, DOI 10.3233/CBM-200410
   Typiak M, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22020956
   Wang SS, 2018, J EXP ZOOL PART A, V329, P103, DOI 10.1002/jez.2180
   Weichhart T, 2018, GERONTOLOGY, V64, P127, DOI 10.1159/000484629
   Wu MF, 2022, ECOTOX ENVIRON SAFE, V234, DOI 10.1016/j.ecoenv.2022.113395
   Yan F, 2020, MOL MED REP, V22, P1035, DOI 10.3892/mmr.2020.11178
   Zou D, 2018, BMC NEPHROL, V19, DOI 10.1186/s12882-018-1094-z
NR 42
TC 1
Z9 1
U1 2
U2 2
PU C M B  ASSOC
PI POITIERS
PA 34 BOULEVARD SOLFERINO, 86000 POITIERS, FRANCE
SN 0145-5680
EI 1165-158X
J9 CELL MOL BIOL
JI Cell. Mol. Biol.
PY 2023
VL 69
IS 7
BP 109
EP 117
DI 10.14715/cmb/2023.69.7.18
PG 9
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA U2WO6
UT WOS:001083458600018
PM 37715411
OA hybrid
DA 2024-02-19
ER

PT J
AU Lué, A
   Solanas, E
   Baptista, P
   Lorente, S
   Araiz, JJ
   Garcia-Gil, A
   Serrano, MT
AF Lue, Alberto
   Solanas, Estela
   Baptista, Pedro
   Lorente, Sara
   Araiz, Juan J.
   Garcia-Gil, Agustin
   Serrano, M. Trinidad
TI How important is donor age in liver transplantation?
SO WORLD JOURNAL OF GASTROENTEROLOGY
LA English
DT Article
DE Liver transplantation; Liver regeneration; Graft survival; Old donor;
   Aging
ID RECURRENT HEPATITIS-C; PATIENT SURVIVAL; BILIARY COMPLICATIONS; FIBROSIS
   PROGRESSION; OCTOGENARIAN DONORS; ELDERLY DONORS; GRAFT-SURVIVAL;
   RISK-FACTORS; RECIPIENTS; OLDER
AB The age of liver donors has been increasing in the past several years because of a donor shortage. In the United States, 33% of donors are age 50 years or older, as are more than 50% in some European countries. The impact of donor age on liver transplantation (LT) has been analyzed in several studies with contradictory conclusions. Nevertheless, recent analyses of the largest databases demonstrate that having an older donor is a risk factor for graft failure. Donor age is included as a risk factor in the more relevant graft survival scores, such as the Donor Risk Index, donor age and Model for End-stage Liver Disease, Survival Outcomes Following Liver Transplantation, and the Balance of Risk. The use of old donors is related to an increased rate of biliary complications and hepatitis C virus-related graft failure. Although liver function does not seem to be significantly affected by age, the incidence of several liver diseases increases with age, and the capacity of the liver to manage or overcome liver diseases or external injuries decreases. In this paper, the importance of age in LT outcomes, the role of donor age as a risk factor, and the influence of aging on liver regeneration are reviewed.
C1 [Lue, Alberto; Lorente, Sara; Serrano, M. Trinidad] Univ Hosp Lozano Blesa, Liver Transplantat Unit, Dept Gastroenterol, C San Juan Bosco 15, Zaragoza 50009, Spain.
   [Lue, Alberto; Solanas, Estela; Baptista, Pedro; Lorente, Sara; Garcia-Gil, Agustin; Serrano, M. Trinidad] Hlth Res Inst Aragon IIS, Zaragoza 50009, Spain.
   [Baptista, Pedro] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid 28029, Spain.
   [Araiz, Juan J.] Univ Hosp Lozano Blesa, Transplant Coordinat, Zaragoza 50009, Spain.
   [Garcia-Gil, Agustin] Univ Hosp Lozano Blesa, Dept Surg, Liver Transplant Unit, Zaragoza 50009, Spain.
C3 Lozano Blesa University Clinical Hospital; CIBER - Centro de
   Investigacion Biomedica en Red; CIBEREHD; Lozano Blesa University
   Clinical Hospital; Lozano Blesa University Clinical Hospital
RP Serrano, MT (corresponding author), Univ Hosp Lozano Blesa, Liver Transplantat Unit, Dept Gastroenterol, C San Juan Bosco 15, Zaragoza 50009, Spain.
EM utra.hcu@salud.aragon.es
RI Serrano, Trinidad/K-6138-2019; Solanas, Estela/AAR-7141-2020; Lué,
   Alberto/AAQ-3732-2020
OI Solanas, Estela/0000-0001-8056-5236; Lué, Alberto/0000-0002-9672-6038;
   Serrano Aullo, M. Trinidad/0000-0002-7119-2244; Baptista,
   Pedro/0000-0002-8969-7726; Araiz Burdio, Juan Jose/0000-0001-6033-2216
CR Abt P, 2003, TRANSPLANTATION, V75, P1659, DOI 10.1097/01.TP.0000062574.18648.7C
   Adam P, 2003, LIVER TRANSPLANT, V9, P1231, DOI 10.1016/j.lts.2003.09.018
   Adam R, 2000, LANCET, V356, P621, DOI 10.1016/S0140-6736(00)02603-9
   Adam R, 2012, J HEPATOL, V57, P675, DOI 10.1016/j.jhep.2012.04.015
   Aikata H, 2000, EXP CELL RES, V256, P578, DOI 10.1006/excr.2000.4862
   Aini W, 2012, TRANSPL INT, V25, P956, DOI 10.1111/j.1432-2277.2012.01523.x
   Alamo JM, 2013, TRANSPL P, V45, P3633, DOI 10.1016/j.transproceed.2013.10.031
   Anderson CD, 2008, J AM COLL SURGEONS, V207, P847, DOI 10.1016/j.jamcollsurg.2008.08.009
   Berenguer M, 2003, HEPATOLOGY, V38, P34, DOI 10.1053/jhep.2003.50278
   Berenguer M, 2002, HEPATOLOGY, V36, P202, DOI 10.1053/jhep.2002.33993
   Berenguer M, 2012, LIVER INT, V32, P712, DOI 10.1111/j.1478-3231.2011.02731.x
   Berenguer M, 2009, LIVER TRANSPLANT, V15, P738, DOI 10.1002/lt.21707
   Braat AE, 2012, AM J TRANSPLANT, V12, P2789, DOI 10.1111/j.1600-6143.2012.04195.x
   Burroughs AK, 2006, LANCET, V367, P225, DOI 10.1016/S0140-6736(06)68033-1
   Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260
   Cuervas-Mons V, 2015, MED CLIN-BARCELONA, V144, P337, DOI 10.1016/j.medcli.2014.07.036
   Curry MP, 2015, GASTROENTEROLOGY, V148, P100, DOI 10.1053/j.gastro.2014.09.023
   Cutrin JC, 1996, HEPATOLOGY, V24, P1053
   Dayangac M, 2011, LIVER TRANSPLANT, V17, P548, DOI 10.1002/lt.22276
   de Gray A, 2001, J GERONTOL A-BIOL, V56, pB237
   Denchi EL, 2006, GENE DEV, V20, P2648, DOI 10.1101/gad.1453606
   Dumortier J, 2014, CLIN RES HEPATOL GAS, V38, P292, DOI 10.1016/j.clinre.2014.02.007
   Dutkowski P, 2011, ANN SURG, V254, P745, DOI 10.1097/SLA.0b013e3182365081
   Emre S, 1996, TRANSPLANTATION, V62, P62, DOI 10.1097/00007890-199607150-00013
   Enkhbold C, 2015, J GASTROEN HEPATOL, V30, P1217, DOI 10.1111/jgh.12930
   European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, 2016, J Hepatol, V64, P433, DOI 10.1016/j.jhep.2015.10.006
   Feng S, 2006, AM J TRANSPLANT, V6, P783, DOI 10.1111/j.1600-6143.2006.01242.x
   Fontana RJ, 2016, LIVER TRANSPLANT, V22, P446, DOI 10.1002/lt.24416
   Furrer K, 2011, P NATL ACAD SCI USA, V108, P2945, DOI 10.1073/pnas.1012531108
   Ghinolfi D, 2014, AM J TRANSPLANT, V14, P2062, DOI 10.1111/ajt.12843
   Ghinolfi D, 2016, LIVER TRANSPLANT, V22, P588, DOI 10.1002/lt.24401
   González FR, 2002, TRANSPL P, V34, P233, DOI 10.1016/S0041-1345(01)02738-5
   Halldorson JB, 2009, AM J TRANSPLANT, V9, P318, DOI 10.1111/j.1600-6143.2008.02491.x
   Han JH, 2014, ANN SURG TREAT RES, V86, P184, DOI 10.4174/astr.2014.86.4.184
   Heidenhain C, 2010, TRANSPL INT, V23, P14, DOI 10.1111/j.1432-2277.2009.00947.x
   Hodgson R, 2015, HPB, V17, P222, DOI 10.1111/hpb.12339
   Ikegami T, 2008, TRANSPL P, V40, P1471, DOI 10.1016/j.transproceed.2008.02.084
   Ikegami T, 2000, TRANSPLANTATION, V70, P1703, DOI 10.1097/00007890-200012270-00007
   Iwamoto T, 2008, TRANSPLANTATION, V85, P1240, DOI 10.1097/TP.0b013e31816c7e90
   Kim DY, 2011, CLIN TRANSPLANT, V25, P270, DOI 10.1111/j.1399-0012.2010.01222.x
   Lake JR, 2005, AM J TRANSPLANT, V5, P549, DOI 10.1111/j.1600-6143.2005.00741.x
   Li C, 2012, J SURG RES, V178, P982, DOI 10.1016/j.jss.2012.06.065
   Lüthold SC, 2014, PEDIATR TRANSPLANT, V18, P822, DOI 10.1111/petr.12363
   Machicao VI, 2004, TRANSPLANTATION, V77, P84, DOI 10.1097/01.TP.0000095896.07048.BB
   MARCHESINI G, 1988, HEPATOLOGY, V8, P1079, DOI 10.1002/hep.1840080516
   Mutimer DJ, 2006, TRANSPLANTATION, V81, P7, DOI 10.1097/01.tp.0000188619.30677.84
   NOACK K, 1993, TRANSPLANTATION, V56, P495, DOI 10.1097/00007890-199309000-00001
   Ono Y, 2011, SURGERY, V150, P154, DOI 10.1016/j.surg.2011.05.004
   Rana A, 2008, AM J TRANSPLANT, V8, P2537, DOI 10.1111/j.1600-6143.2008.02400.x
   Reese PP, 2008, TRANSPLANTATION, V85, P1737, DOI 10.1097/TP.0b013e3181722f75
   SCHMUCKER DL, 1990, J ELECTRON MICR TECH, V14, P106, DOI 10.1002/jemt.1060140205
   Schmucker Douglas L, 2011, Curr Gerontol Geriatr Res, V2011, P526379, DOI 10.1155/2011/526379
   Selzner N, 2009, TRANSPLANTATION, V88, P1214, DOI 10.1097/TP.0b013e3181bd783c
   Serrano T, 2006, CELL TRANSPLANT, V15, P777, DOI 10.3727/000000006783981530
   Sundaram V, 2011, LIVER TRANSPLANT, V17, P428, DOI 10.1002/lt.22251
   Takubo K, 2000, J GERONTOL A-BIOL, V55, pB533, DOI 10.1093/gerona/55.11.B533
   Thorsen T, 2015, TRANSPLANTATION, V99, P2534, DOI 10.1097/TP.0000000000000728
   Timchenko NA, 2009, TRENDS ENDOCRIN MET, V20, P171, DOI 10.1016/j.tem.2009.01.005
   Serrano MT, 2010, CLIN TRANSPLANT, V24, P543, DOI 10.1111/j.1399-0012.2009.01135.x
   Uchiyama H, 2016, LIVER TRANSPLANT, V22, P305, DOI 10.1002/lt.24378
   Verdonk RC, 2006, LIVER TRANSPLANT, V12, P726, DOI 10.1002/lt.20714
   Wali M, 2002, GUT, V51, P248, DOI 10.1136/gut.51.2.248
   Wang GL, 2007, J BIOL CHEM, V282, P1468, DOI 10.1074/jbc.M608226200
   Wang K, 2015, HEPATOB PANCREAT DIS, V14, P50, DOI 10.1016/S1499-3872(15)60334-4
   Wang MJ, 2014, HEPATOLOGY, V60, P349, DOI 10.1002/hep.27094
   WYNNE HA, 1989, HEPATOLOGY, V9, P297, DOI 10.1002/hep.1840090222
   Yousef H, 2015, ONCOTARGET, V6, P11959, DOI 10.18632/oncotarget.3851
NR 67
TC 66
Z9 72
U1 1
U2 15
PU BAISHIDENG PUBLISHING GROUP INC
PI PLEASANTON
PA 8226 REGENCY DR, PLEASANTON, CA 94588 USA
SN 1007-9327
EI 2219-2840
J9 WORLD J GASTROENTERO
JI World J. Gastroenterol.
PD JUN 7
PY 2016
VL 22
IS 21
BP 4966
EP 4976
DI 10.3748/wjg.v22.i21.4966
PG 11
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA DN4ZT
UT WOS:000377076400002
PM 27275089
OA Green Published, hybrid, Green Submitted
DA 2024-02-19
ER

PT J
AU Furusawa, H
   Sato, Y
   Tanaka, Y
   Inai, Y
   Amano, A
   Iwama, M
   Kondo, Y
   Handa, S
   Murata, A
   Nishikimi, M
   Goto, S
   Maruyama, N
   Takahashi, R
   Ishigami, A
AF Furusawa, Hajime
   Sato, Yasunori
   Tanaka, Yasukazu
   Inai, Yoko
   Amano, Akiko
   Iwama, Mizuki
   Kondo, Yoshitaka
   Handa, Setsuko
   Murata, Akira
   Nishikimi, Morimitsu
   Goto, Sataro
   Maruyama, Naoki
   Takahashi, Ryoya
   Ishigami, Akihito
TI Vitamin C is not essential for carnitine biosynthesis <i>in vivo</i>::
   Verification in vitamin C-depleted senescence marker
   protein-30/gluconolactonase knockout mice
SO BIOLOGICAL & PHARMACEUTICAL BULLETIN
LA English
DT Article
DE ascorbic acid; gluconolactonase; vitamin C; senescence marker
   protein-30; butyrobetaine; dioxygenase
ID GAMMA-BUTYROBETAINE HYDROXYLASE; EPSILON-N-TRIMETHYLLYSINE;
   ASCORBIC-ACID; NEUROSPORA-CRASSA; RAT-LIVER; SMP30 DEFICIENCY;
   GUINEA-PIGS; PROTEIN-30; METABOLISM; LYSINE
AB Carnitine is an essential cofactor in the transport of long-chain fatty acids into the mitochondrial matrix and plays an important role in energy production via beta-oxidation. Vitamin C (VC) has long been considered a requirement for the activities of two enzymes in the carnitine biosynthetic pathway, i.e., 6-N-trimethyllysine dioxygenase and gamma-butyrobetaine dioxygenase. Our present study using senescence marker protein-30 (SMP30)/gluconolactonase (GNL) knockout (KO) mice, which cannot synthesize VC in vivo, led to the conclusion that this notion is not true. After weaning at 40 d of age, SMP30/GNL KO mice were fed a diet lacking VC and carnitine, (hen given water containing 1.5 g/I VC (VC(+) mice) or no VC (VC(-) mice) for 75 d. Subsequently, total VC and carnitine levels were measured in the cerebrum, cerebellum, liver, kidney, soleus muscle, extensor digitorum longus muscle, heart, plasma and serum. The total VC levels in all tissues an d plasma from VC(-) SMP30/GNL KO mice were negligible, i.e., <2% of the levels in SMP30/GNL KO VC(+) mice; however, the total carnitine levels of both groups were similar in all tissues and serum. In addition, carnitine was produced by incubated liver homogenates from the VC-depleted SMP30/GNL KO mice irrespective of the presence or absence of 1mM VC. Collectively, these results indicate that VC is not essential for carnitine biosynthesis in vivo.
C1 [Furusawa, Hajime; Sato, Yasunori; Goto, Sataro; Takahashi, Ryoya; Ishigami, Akihito] Toho Univ, Fac Pharmaceut Sci, Dept Biochem, Chiba 2748510, Japan.
   [Tanaka, Yasukazu] Tokyo Metropolitan Inst Gerontol, Neurosci & Brain Funct, Tokyo 1730015, Japan.
   [Furusawa, Hajime; Sato, Yasunori; Amano, Akiko; Iwama, Mizuki; Kondo, Yoshitaka; Handa, Setsuko; Goto, Sataro; Maruyama, Naoki; Ishigami, Akihito] Tokyo Metropolitan Inst Gerontol, Aging Regulat, Tokyo 1730015, Japan.
   [Inai, Yoko; Nishikimi, Morimitsu] Wakayama Med Univ, Dept Biochem, Wakayama 6410012, Japan.
   [Murata, Akira] Saha Jr Coll, Dept Food & Nutr, Saga 8400806, Japan.
C3 Toho University; Tokyo Metropolitan Institute of Gerontology; Tokyo
   Metropolitan Institute of Gerontology; Wakayama Medical University
RP Ishigami, A (corresponding author), Toho Univ, Fac Pharmaceut Sci, Dept Biochem, Chiba 2748510, Japan.
EM ishigami@phar.toho-u.ac.jp
RI Yoshitaka, Kondo/AFK-7721-2022
OI Yoshitaka, Kondo/0000-0002-0046-9429; Amano, Akiko/0000-0003-4324-2758;
   Ishigami, Akihito/0000-0001-7875-7482
CR ALKONYI I, 1990, J CLIN CHEM CLIN BIO, V28, P319
   BREMER J, 1983, PHYSIOL REV, V63, P1420, DOI 10.1152/physrev.1983.63.4.1420
   BRENINGSTALL GN, 1990, PEDIATR NEUROL, V6, P75, DOI 10.1016/0887-8994(90)90037-2
   COX RA, 1973, BIOCHEM J, V136, P1075, DOI 10.1042/bj1361075
   COX RA, 1973, BIOCHEM J, V136, P1083, DOI 10.1042/bj1361083
   DUNN WA, 1984, J BIOL CHEM, V259, P764
   ENGLARD S, 1978, J LIPID RES, V19, P1057
   ENGLARD S, 1979, FEBS LETT, V102, P297, DOI 10.1016/0014-5793(79)80022-8
   ENGLARD S, 1978, ARCH BIOCHEM BIOPHYS, V190, P361, DOI 10.1016/0003-9861(78)90287-4
   FRITZ IB, 1963, J LIPID RES, V4, P279
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7
   HOPPEL CL, 1980, BIOCHEM J, V188, P509, DOI 10.1042/bj1880509
   HORNE DW, 1973, J BIOL CHEM, V248, P2170
   HORNE DW, 1971, J BIOL CHEM, V246, P4373
   HUGHES RE, 1980, BRIT J NUTR, V43, P385, DOI 10.1079/BJN19800102
   HULSE JD, 1978, J BIOL CHEM, V253, P1654
   Ishigami A, 2004, BIOCHEM BIOPH RES CO, V315, P575, DOI 10.1016/j.bbrc.2004.01.091
   Ishigami A, 2002, AM J PATHOL, V161, P1273, DOI 10.1016/S0002-9440(10)64404-5
   Ishigarni A, 2007, GERIATR GERONTOL INT, V7, P316, DOI 10.1111/j.1447-0594.2007.00420.x
   KONDO A, 1981, ARCH BIOCHEM BIOPHYS, V212, P338, DOI 10.1016/0003-9861(81)90374-X
   Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103
   Kondo Y, 2004, FEBS LETT, V570, P57, DOI 10.1016/j.febslet.2004.06.028
   Kuwajima M, 1998, J MOL CELL CARDIOL, V30, P773, DOI 10.1006/jmcc.1998.0641
   LINDSTED.G, 1965, J BIOL CHEM, V240, P316
   LINDSTED.G, 1970, BIOCHEMISTRY-US, V9, P4336, DOI 10.1021/bi00824a014
   LINDSTED.G, 1967, BIOCHEMISTRY-US, V6, P1271, DOI 10.1021/bi00857a007
   LINDSTEDT G, 1962, BIOCHEM BIOPH RES CO, V7, P394, DOI 10.1016/0006-291X(62)90322-4
   LINDSTEDT G, 1970, J BIOL CHEM, V245, P4178
   MARGOLIS SA, 1990, CLIN CHEM, V36, P1750
   MARGOLIS SA, 1988, CLIN CHEM, V34, P2217
   Maruyama N, 2004, ANN NY ACAD SCI, V1019, P383, DOI 10.1196/annals.1297.068
   NELSON PJ, 1981, BIOCHIM BIOPHYS ACTA, V672, P123, DOI 10.1016/0304-4165(81)90286-5
   PAIK WK, 1971, SCIENCE, V174, P114, DOI 10.1126/science.174.4005.114
   PUNEKAR NS, 1987, J BIOL CHEM, V262, P6720
   Ramsay RR, 2001, BBA-PROTEIN STRUCT M, V1546, P21, DOI 10.1016/S0167-4838(01)00147-9
   Rebouche CJ, 1998, ANNU REV NUTR, V18, P39, DOI 10.1146/annurev.nutr.18.1.39
   Rebouche CJ, 1995, METABOLISM, V44, P1639, DOI 10.1016/0026-0495(95)90087-X
   REED DJ, 1980, ANAL BIOCHEM, V106, P55, DOI 10.1016/0003-2697(80)90118-9
   SACHAN DS, 1980, BIOCHEM BIOPH RES CO, V96, P870, DOI 10.1016/0006-291X(80)91436-9
   Son TG, 2006, MECH AGEING DEV, V127, P451, DOI 10.1016/j.mad.2006.01.005
   Suenaga M, 2004, BIOL PHARM BULL, V27, P496, DOI 10.1248/bpb.27.496
   TAKAHASHI M, 1994, CLIN CHEM, V40, P817
   TANPHAICHITR V, 1971, J BIOL CHEM, V246, P6364
   TARIQ M, 1973, INDIAN J EXP BIOL, V11, P248
   van Vlies N, 2006, ANAL BIOCHEM, V354, P132, DOI 10.1016/j.ab.2006.04.007
   Vaz FM, 2002, BIOCHEM J, V361, P417, DOI 10.1042/0264-6021:3610417
NR 46
TC 32
Z9 36
U1 0
U2 7
PU PHARMACEUTICAL SOC JAPAN
PI TOKYO
PA 2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN
SN 0918-6158
J9 BIOL PHARM BULL
JI Biol. Pharm. Bull.
PD SEP
PY 2008
VL 31
IS 9
BP 1673
EP 1679
DI 10.1248/bpb.31.1673
PG 7
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 346IJ
UT WOS:000259061700008
PM 18758058
OA Bronze
DA 2024-02-19
ER

PT J
AU Le Goallec, A
   Diai, S
   Collin, S
   Prost, JB
   Vincent, T
   Patel, CJ
AF Le Goallec, Alan
   Diai, Samuel
   Collin, Sasha
   Prost, Jean-Baptiste
   Vincent, Theo
   Patel, Chirag J.
TI Using deep learning to predict abdominal age from liver and pancreas
   magnetic resonance images
SO NATURE COMMUNICATIONS
LA English
DT Article
ID HEPATIC STELLATE CELLS; NEURAL-NETWORKS; MENDELIAN RANDOMIZATION;
   BODY-FAT; ASSOCIATION; HTRA1
AB Approaches to both determine abdominal age and identify risk factors for accelerated abdominal age will help delay the onset of several diseases. Here, the authors build an abdominal age predictor by training convolutional neural networks to predict abdominal age from liver and pancreas MRIs.
   With age, the prevalence of diseases such as fatty liver disease, cirrhosis, and type two diabetes increases. Approaches to both predict abdominal age and identify risk factors for accelerated abdominal age may ultimately lead to advances that will delay the onset of these diseases. We build an abdominal age predictor by training convolutional neural networks to predict abdominal age (or "AbdAge") from 45,552 liver magnetic resonance images [MRIs] and 36,784 pancreas MRIs (R-Squared = 73.3 +/- 0.6; mean absolute error = 2.94 +/- 0.03 years). Attention maps show that the prediction is driven by both liver and pancreas anatomical features, and surrounding organs and tissue. Abdominal aging is a complex trait, partially heritable (h_g(2) = 26.3 +/- 1.9%), and associated with 16 genetic loci (e.g. in PLEKHA1 and EFEMP1), biomarkers (e.g body impedance), clinical phenotypes (e.g, chest pain), diseases (e.g. hypertension), environmental (e.g smoking), and socioeconomic (e.g education, income) factors.
C1 [Le Goallec, Alan; Diai, Samuel; Collin, Sasha; Prost, Jean-Baptiste; Vincent, Theo; Patel, Chirag J.] Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA.
   [Le Goallec, Alan] Harvard Univ, Dept Syst Synthet & Quantitat Biol, Cambridge, MA 02118 USA.
C3 Harvard University; Harvard Medical School; Harvard University
RP Patel, CJ (corresponding author), Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA.
EM chirag_patel@hms.harvard.edu
OI collin, sasha/0000-0002-8732-0829; Diai, Samuel/0000-0003-4779-5501;
   Prost, Jean-Baptiste/0000-0001-9973-727X; Vincent,
   Theo/0000-0002-1723-7405; Le Goallec, Alan/0000-0002-4257-1851
FU UK Biobank [52887]; NIAID [R01 AI127250]; NIEHS [R01 ES032470];
   Massachusetts Life Science Center; Sanofi; NSF [163870]
FX We would like to thank Raffaele Potami from Harvard Medical School
   research computing group for helping us utilize O2's computing
   resources. We thank HMS RC for computing support. We also want to
   acknowledge UK Biobank for providing us with access to the data they
   collected. The UK Biobank project number is 52887. Funding sources
   include NIAID R01 AI127250 (C.J.P., A.G.), NIEHS R01 ES032470 (C.J.P.),
   NSF 163870 (C.J.P., A.G.), Massachusetts Life Science Center (C.J.P.,
   A.G.), Sanofi (C.J.P.). The funders had no role in the study design or
   drafting of the manuscript(s).
CR Agarap A.F., 2018, DEEP LEARNING USING
   Anastácio Lucilene Rezende, 2012, Arq. Gastroenterol., V49, P195, DOI 10.1590/S0004-28032012000300005
   Attia ZI, 2019, CIRC-ARRHYTHMIA ELEC, V12, DOI 10.1161/CIRCEP.119.007284
   Benoist M, 2003, EUR SPINE J, V12, pS86, DOI 10.1007/s00586-003-0593-0
   Bos S, 1996, IEEE IJCNN, P241, DOI 10.1109/ICNN.1996.548898
   Bottou L, 2018, SIAM REV, V60, P223, DOI 10.1137/16M1080173
   Burton R, 2018, LANCET, V392, P987, DOI 10.1016/S0140-6736(18)31571-X
   Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z
   Chetty R, 2016, JAMA-J AM MED ASSOC, V315, P1750, DOI 10.1001/jama.2016.4226
   Chollet F., 2015, Keras
   Chundru S, 2014, DIAGN INTERV RADIOL, V20, P200, DOI 10.5152/dir.2014.13170
   Cieslak KP, 2016, HPB, V18, P691, DOI 10.1016/j.hpb.2016.05.011
   Consortium T., 2015, NATURE, V526
   de La Cuesta-Zuluag J, 2019, MSYSTEMS, V4, DOI 10.1128/mSystems.00261-19
   de Magalhaes JP, 2017, TRENDS BIOTECHNOL, V35, P1062, DOI 10.1016/j.tibtech.2017.07.004
   Demanelis K, 2020, SCIENCE, V369, P1333, DOI 10.1126/science.aaz6876
   Deng J, 2009, PROC CVPR IEEE, P248, DOI 10.1109/CVPRW.2009.5206848
   Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807
   Dinsdale NK, 2021, NEUROIMAGE, V224, DOI 10.1016/j.neuroimage.2020.117401
   Duke Clinical Research Institute Elysium Health., 2019, BIOM STUD EV CORR EP
   Elliott LT, 2018, NATURE, V562, P210, DOI 10.1038/s41586-018-0571-7
   Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007
   Galkin F, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101199
   Gnu P., 2007, BASH 3 2 48
   Goallec A.L., 2021, Predicting arterial age using carotid ultrasound images, pulse wave analysis records, cardiovascular biomarkers and deep learning, DOI [10.1101/2021.06.17.21259120, DOI 10.1101/2021.06.17.21259120]
   Goallec A.L., 2021, Using deep learning to analyze the compositeness of musculoskeletal aging reveals that spine, hip and knee age at different rates, and are associated with different genetic and non-genetic factors, DOI [10.1101/2021.06.14.21258896, DOI 10.1101/2021.06.14.21258896]
   Goallec A. L., 2021, DISSECTING HEART AGE, DOI [10.1101/2021.06.09.21258645 (2021, DOI 10.1101/2021.06.09.21258645(2021]
   Hendifar AE, 2019, ONCOLOGIST, V24, P691, DOI 10.1634/theoncologist.2018-0266
   Horvath S, 2014, P NATL ACAD SCI USA, V111, P15538, DOI 10.1073/pnas.1412759111
   Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115
   Hunt NJ, 2019, COMPUT STRUCT BIOTEC, V17, P1151, DOI 10.1016/j.csbj.2019.07.021
   Hunter G. R., 2005, International Journal of Body Composition Research, V3, P55
   Jha P, 2020, ELIFE, V9, DOI 10.7554/eLife.49979
   Kanda A, 2007, P NATL ACAD SCI USA, V104, P16227, DOI 10.1073/pnas.0703933104
   Karargyris A, 2019, PROC SPIE, V10950, DOI 10.1117/12.2512922
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Krizhevsky Alex, 2017, Communications of the ACM, V60, P84, DOI 10.1145/3065386
   KROGH A, 1992, ADV NEUR IN, V4, P950
   Langner T, 2020, IEEE T MED IMAGING, V39, P1430, DOI 10.1109/TMI.2019.2950092
   Le Goallec, 2021, ANAL MULTIDIMENSIONA, DOI [10.1101/2021.04.25.21255767, DOI 10.1101/2021.04.25.21255767]
   Le Goallec A., 2021, IDENTIFYING GENETIC, DOI [10.1101/2021.06.24.21259471, DOI 10.1101/2021.06.24.21259471]
   Le Goallec A., ANAL MULTIDIMENSIONA
   Le Goallec A, 2020, PLOS COMPUT BIOL, V16, DOI 10.1371/journal.pcbi.1007895
   Lee ATK, 2015, ALCOHOL CLIN EXP RES, V39, P2123, DOI 10.1111/acer.12882
   Lehallier B, 2020, AGING CELL, V19, DOI 10.1111/acel.13256
   Li X, 2020, ELIFE, V9, DOI 10.7554/eLife.51507
   Liu CX, 2020, FAM MED COMMUNITY HE, V8, DOI 10.1136/fmch-2020-000351
   Loh PR, 2018, NAT GENET, V50, P906, DOI 10.1038/s41588-018-0144-6
   Loh PR, 2015, NAT GENET, V47, P1385, DOI 10.1038/ng.3431
   Loh PR, 2015, NAT GENET, V47, P284, DOI 10.1038/ng.3190
   Löhr JM, 2018, J INTERN MED, V283, P446, DOI 10.1111/joim.12745
   Mamoshina P, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00242
   Mancuso P, 2019, FRONT ENDOCRINOL, V10, DOI [10.3389/fendo.2019.00137, 10.3389/fendo.019.00137]
   Matsuda Y, 2019, PATHOL INT, V69, P450, DOI 10.1111/pin.12837
   Matsuda Yoko, 2018, Front Biosci (Elite Ed), V10, P137
   McGrath ER, 2022, J ALZHEIMERS DIS, V85, P1657, DOI 10.3233/JAD-215053
   Meier JM, 2007, SEMIN NUCL MED, V37, P154, DOI 10.1053/j.semnuclmed.2007.02.001
   Mott JW, 1999, AM J CLIN NUTR, V69, P1007
   Ota M, 2020, EUR J APPL PHYSIOL, V120, P1805, DOI 10.1007/s00421-020-04412-7
   Ota M, 2012, ARCH GERONTOL GERIAT, V55, pE26, DOI 10.1016/j.archger.2012.03.007
   Pan SJ, 2010, IEEE T KNOWL DATA EN, V22, P1345, DOI 10.1109/TKDE.2009.191
   Pang TCY, 2017, CARCINOGENESIS, V38, P588, DOI 10.1093/carcin/bgx030
   Pasquinelli F, 2011, MAGN RESON IMAGING, V29, P805, DOI 10.1016/j.mri.2011.02.014
   Poplin R, 2018, NAT BIOMED ENG, V2, P158, DOI 10.1038/s41551-018-0195-0
   Prechelt L, 1998, LECT NOTES COMPUT SC, V1524, P55
   Putin E, 2016, AGING-US, V8, P1021, DOI 10.18632/aging.100968
   Rahman SA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46850-0
   Rask-Andersen M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08000-4
   Ruder S., 2016, arXiv
   Rusk N, 2016, NAT METHODS, V13, P35, DOI 10.1038/nmeth.3707
   Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y
   Sakaue S, 2021, NAT GENET, V53, P1415, DOI 10.1038/s41588-021-00931-x
   Sato T, 2012, EUR J RADIOL, V81, P2093, DOI 10.1016/j.ejrad.2011.07.014
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Shorten C, 2019, J BIG DATA-GER, V6, DOI 10.1186/s40537-019-0197-0
   Simonyan K, 2015, Arxiv, DOI [arXiv:1409.1556, 10.48550/arXiv.1409.1556, DOI 10.48550/ARXIV.1409.1556]
   Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070
   Smith GD, 2005, BMJ-BRIT MED J, V330, P1076, DOI 10.1136/bmj.330.7499.1076
   Smith P, 2018, IEEE INT CONF BIG DA, P2564, DOI 10.1109/BigData.2018.8621891
   Soenen S, 2016, CURR OPIN CLIN NUTR, V19, P12, DOI 10.1097/MCO.0000000000000238
   Srivastava N, 2014, J MACH LEARN RES, V15, P1929
   Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779
   Szegedy C, 2017, AAAI CONF ARTIF INTE, P4278
   Szegedy C, 2016, PROC CVPR IEEE, P2818, DOI 10.1109/CVPR.2016.308
   Tan CQ, 2018, LECT NOTES COMPUT SC, V11141, P270, DOI 10.1007/978-3-030-01424-7_27
   Tan MX, 2019, PR MACH LEARN RES, V97
   Tanaka Noriko I., 2007, Journal of Physiological Anthropology, V26, P527, DOI 10.2114/jpa2.26.527
   Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351
   Watanabe K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01261-5
   Weiss Karl, 2016, Journal of Big Data, V3, DOI 10.1186/s40537-016-0043-6
   WOODHOUSE KW, 1988, CLIN PHARMACOKINET, V15, P287, DOI 10.2165/00003088-198815050-00002
   Yin CY, 2013, J CLIN INVEST, V123, P1902, DOI 10.1172/JCI66369
   Zamboni M, 1997, AM J CLIN NUTR, V66, P111, DOI 10.1093/ajcn/66.1.111
   Zhang J, 2019, WHY GRADIENT CLIPPIN, DOI [DOI 10.48550/ARXIV.1905.11881, 10.48550/arXiv.1905.11881]
   Zhao W, 2017, NAT GENET, V49, P1450, DOI 10.1038/ng.3943
NR 95
TC 11
Z9 12
U1 4
U2 23
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
EI 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD APR 13
PY 2022
VL 13
IS 1
AR 1979
DI 10.1038/s41467-022-29525-9
PG 13
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 0O8FO
UT WOS:000783759500012
PM 35418184
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU HILALI, A
   CRUTZENFAYT, MC
   GERBER, GB
   LEONARD, A
AF HILALI, A
   CRUTZENFAYT, MC
   GERBER, GB
   LEONARD, A
TI EFFECT OF AGE ON THE ABILITY OF RAT-LIVER TISSUES TO TRANSFORM CHEMICAL
   PROMUTAGENS TO MUTAGENS
SO GERONTOLOGY
LA English
DT Article
DE AGING; AMES TEST; PROMUTAGENS; CYTOCHROME P-450
ID CARCINOGENS; ACTIVATION
AB Age-related changes in drug metabolism of the liver from male Lou rats were determined by measuring changes in the production of mutagens. Activation of aflatoxin B1 (AFB1), 2-aminoanthracene (2AA) and benzo[a]pyrene (B[a]P) to mutagenic derivatives was assayed using the Ames salmonella test system. The promutagens were incubated with tissue fractions isolated from rats ranging in age from 3 weeks to 18 months. Hepatic activation of AFB1 and 2AA changes with age and is maximal from 4 to 10 months. In contrast, no significant modification with age was observed for the activation of B[a]P. It is concluded that the composition of different cytochrome P-450 fractions is modified with age thereby altering the specific ability to convert different promutagens to mutagens.
C1 UNIV CATHOLIQUE LOUVAIN,TERATOGENESIS & MUTAGENESIS LAB,B-1200 BRUSSELS,BELGIUM.
C3 Universite Catholique Louvain
CR ADELMAN RC, 1974, FED PROC, V34, P179
   AMES BN, 1975, MUTAT RES, V31, P347, DOI 10.1016/0165-1161(75)90046-1
   KATO R, 1964, BIOCHEM PHARMACOL, V13, P1037, DOI 10.1016/0006-2952(64)90100-5
   KREMERS D, 1989, TOPICS AGEING RES EU, V13, P19
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MULLERHOKER J, 1992, OCT MIT AG WORKSH BA
   NEBERT DW, 1987, ANNU REV BIOCHEM, V56, P945, DOI 10.1146/annurev.bi.56.070187.004501
   ROBERTSON IGC, 1982, CHEM-BIOL INTERACT, V38, P243, DOI 10.1016/0009-2797(82)90043-6
   SCHMUCKER DL, 1985, PHARMACOL REV, V37, P133
   SCHMUCKER DL, 1980, EXP GERONTOL, V15, P321, DOI 10.1016/0531-5565(80)90037-6
   SCHMUCKER DL, 1989, T AGING RES, V13, P3
   SHIMADA T, 1988, BIOCHEM PHARMACOL, V37, P459, DOI 10.1016/0006-2952(88)90215-8
NR 12
TC 1
Z9 1
U1 0
U2 0
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0304-324X
J9 GERONTOLOGY
JI Gerontology
PD MAY-JUN
PY 1993
VL 39
IS 3
BP 125
EP 127
PG 3
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA LU211
UT WOS:A1993LU21100001
PM 8406054
DA 2024-02-19
ER

PT J
AU Song, QL
   Datta, S
   Liang, X
   Xu, XH
   Pavicic, P
   Zhang, XA
   Zhao, YY
   Liu, S
   Zhao, J
   Xu, YT
   Xu, J
   Wu, LH
   Wu, ZH
   Zhang, MH
   Zhao, Z
   Lin, CH
   Wang, YX
   Han, P
   Jiang, P
   Qin, YT
   Li, W
   Zhang, YY
   Luo, YL
   Sen, G
   Stark, GR
   Zhao, CY
   Hamilton, T
   Yang, JB
AF Song, Qiaoling
   Datta, Shyamasree
   Liang, Xue
   Xu, Xiaohan
   Pavicic, Paul
   Zhang, Xiaonan
   Zhao, Yuanyuan
   Liu, Shan
   Zhao, Jun
   Xu, Yuting
   Xu, Jing
   Wu, Lihong
   Wu, Zhihua
   Zhang, Minghui
   Zhao, Zhan
   Lin, Chunhua
   Wang, Yuxin
   Han, Peng
   Jiang, Peng
   Qin, Yating
   Li, Wei
   Zhang, Yingying
   Luo, Yonglun
   Sen, Ganes
   Stark, George R.
   Zhao, Chenyang
   Hamilton, Thomas
   Yang, Jinbo
TI Type I interferon signaling facilitates resolution of acute liver injury
   by priming macrophage polarization
SO CELLULAR & MOLECULAR IMMUNOLOGY
LA English
DT Article; Early Access
DE APAP-ALI; IFN-I; Macrophage polarization; scRNA-seq; STAT2 T403
   phosphorylation; CSF1+neutrophil
ID MONOCYTE-DERIVED MACROPHAGES; IFN-ALPHA; GM-CSF; CELLS; INFLAMMATION;
   EXPRESSION; DYNAMICS; NETWORK; BETA; MICE
AB Due to their broad functional plasticity, myeloid cells contribute to both liver injury and recovery during acetaminophen overdose-induced acute liver injury (APAP-ALI). A comprehensive understanding of cellular diversity and intercellular crosstalk is essential to elucidate the mechanisms and to develop therapeutic strategies for APAP-ALI treatment. Here, we identified the function of IFN-I in the myeloid compartment during APAP-ALI. Utilizing single-cell RNA sequencing, we characterized the cellular atlas and dynamic progression of liver CD11b+ cells post APAP-ALI in WT and STAT2 T403A mice, which was further validated by immunofluorescence staining, bulk RNA-seq, and functional experiments in vitro and in vivo. We identified IFN-I-dependent transcriptional programs in a three-way communication pathway that involved IFN-I synthesis in intermediate restorative macrophages, leading to CSF-1 production in aging neutrophils that ultimately enabled Trem2+ restorative macrophage maturation, contributing to efficient liver repair. Overall, we uncovered the heterogeneity of hepatic myeloid cells in APAP-ALI at single-cell resolution and the therapeutic potential of IFN-I in the treatment of APAP-ALI.
C1 [Song, Qiaoling; Xu, Xiaohan; Zhao, Zhan; Zhao, Chenyang; Yang, Jinbo] Ocean Univ China, Sch Med & Pharm, Key Lab Marine Drugs, Minist Educ, Qingdao, Peoples R China.
   [Datta, Shyamasree; Pavicic, Paul; Sen, Ganes; Hamilton, Thomas] Cleveland Clin Fdn, Lerner Res Inst, Dept Inflammat & Immun, Cleveland, OH 44195 USA.
   [Liang, Xue; Han, Peng; Qin, Yating; Zhang, Yingying; Luo, Yonglun] BGI Shenzhen, BGI Qingdao, Qingdao Europe Adv Inst Life Sci, Lars Bolund Inst Regenerat Med, Shenzhen, Peoples R China.
   [Zhang, Xiaonan; Liu, Shan; Zhao, Jun; Xu, Yuting; Xu, Jing; Wu, Lihong; Wu, Zhihua; Zhang, Minghui; Zhao, Chenyang; Yang, Jinbo] Qingdao Natl Lab Marine Sci & Technol, Innovat Ctr Marine Drug Screening & Evaluat, Qingdao, Peoples R China.
   [Zhao, Yuanyuan; Jiang, Peng; Li, Wei] Qingdao Univ, Affiliated Hosp, Affiliated Hosp, Qingdao, Peoples R China.
   [Lin, Chunhua] Yantai Yuhuangding Hosp, Dept Urol, Yantai, Peoples R China.
   [Wang, Yuxin; Stark, George R.] Cleveland Clin Fdn, Lerner Res Inst, Dept Canc Biol, Cleveland, OH USA.
C3 Ocean University of China; Cleveland Clinic Foundation; Beijing Genomics
   Institute (BGI); Laoshan Laboratory; Qingdao University; Cleveland
   Clinic Foundation
RP Zhao, CY; Yang, JB (corresponding author), Ocean Univ China, Sch Med & Pharm, Key Lab Marine Drugs, Minist Educ, Qingdao, Peoples R China.; Hamilton, T (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Inflammat & Immun, Cleveland, OH 44195 USA.; Zhao, CY; Yang, JB (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Innovat Ctr Marine Drug Screening & Evaluat, Qingdao, Peoples R China.
EM zhaochenyang2021@gmail.com; hamiltt@ccf.org; yangjb@ouc.edu.cn
RI Wang, lingyu/JLM-2013-2023; zhang, ly/JMB-7214-2023; li,
   yao/IYJ-1364-2023; zhang, hao/JOJ-7093-2023; Zhao,
   Chenyang/AAW-3606-2020; LI, QI/IUM-8577-2023; zhang,
   xiang/JJD-7003-2023; Lin, Fan/JZT-1441-2024; liu, huan/JKI-3764-2023;
   Yang, Jing/JFK-4046-2023; yu, zhang/JWO-7724-2024; Yang,
   Lili/JTT-5215-2023; Zhao, Chenyang/JRX-4060-2023; zhu,
   zhu/JDN-0159-2023; Yang, Fan/JMA-9594-2023; Liu, Xiangyan/JTV-4868-2023;
   Luo, Yonglun/C-4708-2013
OI Zhao, Chenyang/0000-0003-2044-0508; Yang, Jing/0009-0004-8274-9863;
   Yang, Lili/0009-0008-2926-484X; Zhao, Chenyang/0000-0002-4716-2002; Han,
   Peng/0000-0002-3405-087X; Luo, Yonglun/0000-0002-0007-7759
FU Key R&D Program of Shandong Province [2020CXGC010503]; Shandong
   Provincial Key Laboratory Platform Project [2021ZDSYS11]; Major Program
   of National Natural Science Foundation of China [81991525]
FX This work was supported by the Key R&D Program of Shandong
   Province(2020CXGC010503), Shandong Provincial Key Laboratory Platform
   Project (2021ZDSYS11),and Major Program of National Natural Science
   Foundation of China (81991525).
CR Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]
   Aswad M, 2017, J IMMUNOL, V199, P1393, DOI 10.4049/jimmunol.1502542
   Bénard A, 2018, AM J RESP CRIT CARE, V197, P801, DOI 10.1164/rccm.201707-1475OC
   Braza MS, 2018, AM J TRANSPLANT, V18, P1247, DOI 10.1111/ajt.14645
   Butenko S, 2021, FASEB J, V35, DOI 10.1096/fj.202002395RR
   Butenko S, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00405
   Chopyk DM, 2020, GASTROENTEROLOGY, V159, P849, DOI 10.1053/j.gastro.2020.04.077
   Fleetwood AJ, 2009, J LEUKOCYTE BIOL, V86, P411, DOI 10.1189/jlb.1108702
   Hamilton TA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00554
   Hassani M, 2020, J LEUKOCYTE BIOL, V107, P809, DOI 10.1002/JLB.5HR0120-459R
   Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009
   Horvatits T, 2019, HEPATOLOGY, V70, P2204, DOI 10.1002/hep.30824
   Jaitin DA, 2006, MOL CELL BIOL, V26, P1888, DOI 10.1128/MCB.26.5.1888-1897.2006
   Jin SQ, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21246-9
   Kolodziejczyk AA, 2020, NAT MED, V26, DOI 10.1038/s41591-020-1102-2
   Kubes P, 2012, GASTROENTEROLOGY, V143, P1158, DOI 10.1053/j.gastro.2012.09.008
   Lazear HM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003118
   Lex A, 2014, IEEE T VIS COMPUT GR, V20, P1983, DOI 10.1109/TVCG.2014.2346248
   Lumbroso D, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00358
   Marwick JA, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0710-y
   McGill MR, 2012, J CLIN INVEST, V122, P1574, DOI 10.1172/JCI59755
   MOORE RN, 1985, J LEUKOCYTE BIOL, V37, P659, DOI 10.1002/jlb.37.5.659
   Mossanen JC, 2016, HEPATOLOGY, V64, P1667, DOI 10.1002/hep.28682
   Mufarrege EF, 2019, AAPS J, V21, DOI 10.1208/s12248-019-0300-7
   Nan J, 2018, P NATL ACAD SCI USA, V115, P3906, DOI 10.1073/pnas.1714102115
   Ng CT, 2016, CELL, V164, P349, DOI 10.1016/j.cell.2015.12.027
   Ng CT, 2012, P NATL ACAD SCI USA, V109, P7823, DOI 10.1073/pnas.1205850109
   Perugorria MJ, 2019, GUT, V68, P533, DOI 10.1136/gutjnl-2017-314107
   Pervolaraki K, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007420
   PRESCOTT LF, 1979, BRIT MED J, V2, P1097, DOI 10.1136/bmj.2.6198.1097
   Ramachandran P, 2019, NATURE, V575, P512, DOI 10.1038/s41586-019-1631-3
   Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711
   Satyanarayanan SK, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10903-9
   Scutera S, 2009, J IMMUNOL, V183, P3004, DOI 10.4049/jimmunol.0804384
   Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443
   Sierro F, 2017, IMMUNITY, V47, P374, DOI 10.1016/j.immuni.2017.07.018
   Sirén J, 2005, J IMMUNOL, V174, P1932, DOI 10.4049/jimmunol.174.4.1932
   Stutchfield BM, 2015, GASTROENTEROLOGY, V149, P1896, DOI 10.1053/j.gastro.2015.08.053
   Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859
   Triantafyllou E, 2018, GUT, V67, P333, DOI 10.1136/gutjnl-2016-313615
   Ushach I, 2016, J LEUKOCYTE BIOL, V100, P481, DOI 10.1189/jlb.3RU0316-144R
   Vannella KM, 2017, ANNU REV PHYSIOL, V79, P593, DOI 10.1146/annurev-physiol-022516-034356
   Wang YX, 2021, CELL RES, V31, P206, DOI 10.1038/s41422-020-0386-6
   Wang YX, 2017, EMBO J, V36, P202, DOI 10.15252/embj.201694834
   Wen YK, 2021, CELL MOL IMMUNOL, V18, P45, DOI 10.1038/s41423-020-00558-8
   Williams JC, 2009, CELL IMMUNOL, V259, P128, DOI 10.1016/j.cellimm.2009.06.006
   Woolbright BL, 2017, J HEPATOL, V66, P836, DOI 10.1016/j.jhep.2016.11.017
   Xie XM, 2020, NAT IMMUNOL, V21, P1119, DOI 10.1038/s41590-020-0736-z
   Yang WT, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09046-8
   Zhang DC, 2015, NATURE, V525, P528, DOI 10.1038/nature15367
   Zhang L, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01390
   Zhang QM, 2019, CELL, V179, P829, DOI 10.1016/j.cell.2019.10.003
   Zigmond E, 2014, J IMMUNOL, V193, P344, DOI 10.4049/jimmunol.1400574
NR 53
TC 3
Z9 3
U1 9
U2 19
PU CHIN SOCIETY IMMUNOLOGY
PI BEING
PA 5 DONGDAN SANTIAO, DONGCHEN DISTRICT, BEING, 100005, PEOPLES R CHINA
SN 1672-7681
EI 2042-0226
J9 CELL MOL IMMUNOL
JI Cell. Mol. Immunol.
PD 2023 FEB
PY 2023
VL 20
IS 2
BP 143
EP 157
DI 10.1038/s41423-022-00966-y
EA JAN 2023
PG 15
WC Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology
GA 8B6LQ
UT WOS:000907078600001
PM 36596875
DA 2024-02-19
ER

PT J
AU Takeda, A
   Ishiwatari, S
   Okada, S
AF Takeda, A
   Ishiwatari, S
   Okada, S
TI Manganese uptake into rat brain during development and aging
SO JOURNAL OF NEUROSCIENCE RESEARCH
LA English
DT Article
DE manganese; development; aging; brain function
ID BASAL GANGLIA; TRACE-METALS; TRANSFERRIN; TRANSPORT; BARRIER; FERRITIN;
   PLASMA; IRON; ZINC
AB Manganese (Mn) is an essential metal and plays an important role in the brain. To evaluate Mn uptake into the brain during development and aging, Mn-54 concentrations in the brain of rats aged from 5 days to 95 weeks were measured after injection of (MnCl2)-Mn-54. Mn-54 concentration in the brain of 5-day-old rats was the highest of all age groups tested. The liver and blood of 5-day-old rats also showed the highest Mn-54 concentrations among the age groups. These results suggest that Mn is required in a high amount during infancy and that a sufficient Mn supply is critical for normal brain development, The high uptake of Mn into the brain of neonatal rats may be due to high levels of Mn in the blood, which may be supplied from the liver. In the 5-day-old brain, Mn-54 was relatively concentrated in the hippocampal CA3 and dentate gyrus and the pens. In the aging brain, Mn-54 was relatively concentrated in the inferior colliculi, olivary nuclei and red nuclei. J, Neurosci, Res. 56:93-98, 1999, (C) 1999 Wiley-Liss, Inc.
C1 Univ Shizuoka, Sch Pharmaceut Sci, Dept Radiobiochem, Shizuoka 4228526, Japan.
C3 University of Shizuoka
RP Takeda, A (corresponding author), Univ Shizuoka, Sch Pharmaceut Sci, Dept Radiobiochem, 52-1 Yada, Shizuoka 4228526, Japan.
RI Ishiwatari, Shioji/N-9994-2019
CR ARCHIBALD FS, 1987, ARCH BIOCHEM BIOPHYS, V256, P638, DOI 10.1016/0003-9861(87)90621-7
   ASCHNER M, 1994, BRAIN RES BULL, V33, P345, DOI 10.1016/0361-9230(94)90204-6
   CALNE DB, 1994, NEUROLOGY, V44, P1583, DOI 10.1212/WNL.44.9.1583
   CARL GF, 1993, EPILEPSIA, V34, P441, DOI 10.1111/j.1528-1157.1993.tb02584.x
   DAUBING J, 1968, PROG BRAIN RES, V29, P417
   DAVIDSSON L, 1989, J NUTR, V119, P1461, DOI 10.1093/jn/119.10.1461
   DEXTER DT, 1991, BRAIN, V114, P1953, DOI 10.1093/brain/114.4.1953
   Fell JME, 1996, LANCET, V347, P1218, DOI 10.1016/S0140-6736(96)90735-7
   Frieden C.L, 1984, BIOCH ESSENTIAL ULTR, P97
   HONG JS, 1984, ENVIRON RES, V34, P242, DOI 10.1016/0013-9351(84)90092-6
   JEFFERIES WA, 1984, NATURE, V312, P162, DOI 10.1038/312162a0
   KRIEGER D, 1995, LANCET, V346, P270, DOI 10.1016/S0140-6736(95)92164-8
   MARKESBERY WR, 1984, NEUROBIOL AGING, V5, P19, DOI 10.1016/0197-4580(84)90081-2
   MAY PM, 1977, J CHEM SOC DALTON, P588, DOI 10.1039/dt9770000588
   MURPHY VA, 1991, J NEUROCHEM, V57, P948, DOI 10.1111/j.1471-4159.1991.tb08242.x
   NEWLAND MC, 1989, EXP NEUROL, V106, P251, DOI 10.1016/0014-4886(89)90157-X
   NORENBERG MD, 1979, J HISTOCHEM CYTOCHEM, V27, P469
   PROHASKA JR, 1987, PHYSIOL REV, V67, P858, DOI 10.1152/physrev.1987.67.3.858
   RABIN O, 1993, J NEUROCHEM, V61, P509
   ROSKAMS AJI, 1994, J NEUROCHEM, V63, P709
   SCHEUHAMMER AM, 1985, BIOCHIM BIOPHYS ACTA, V840, P163, DOI 10.1016/0304-4165(85)90115-1
   SETH PK, 1988, METAL NEUROTOXICITY, P19
   SLOOT WN, 1994, BRAIN RES, V657, P124, DOI 10.1016/0006-8993(94)90959-8
   Takeda A, 1998, J NEUROSCI RES, V51, P454, DOI 10.1002/(SICI)1097-4547(19980215)51:4<454::AID-JNR5>3.0.CO;2-B
   TAKEDA A, 1994, BRAIN RES, V640, P341, DOI 10.1016/0006-8993(94)91891-0
   TAKEDA A, 1995, BRAIN RES, V695, P53, DOI 10.1016/0006-8993(95)00916-E
   Takeda A, 1998, BRAIN RES, V811, P147, DOI 10.1016/S0006-8993(98)00881-6
   Takeda A, 1998, NEUROSCI LETT, V242, P45, DOI 10.1016/S0304-3940(98)00006-8
   Takeda A, 1998, BRAIN RES BULL, V45, P149, DOI 10.1016/S0361-9230(97)00330-4
   WEDLER FC, 1986, MANGANESE METABOLISM, P221
   YAMADA M, 1986, ACTA NEUROPATHOL, V70, P273, DOI 10.1007/BF00686083
NR 31
TC 54
Z9 61
U1 1
U2 4
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0360-4012
J9 J NEUROSCI RES
JI J. Neurosci. Res.
PD APR 1
PY 1999
VL 56
IS 1
BP 93
EP 98
DI 10.1002/(SICI)1097-4547(19990401)56:1<93::AID-JNR12>3.3.CO;2-G
PG 6
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 181UP
UT WOS:000079461100012
PM 10213480
DA 2024-02-19
ER

PT J
AU Tourlakis, ME
   Zhang, SY
   Ball, HL
   Gandhi, R
   Liu, HR
   Zhong, J
   Yuan, JS
   Guidos, CJ
   Durie, PR
   Rommens, JM
AF Tourlakis, Marina E.
   Zhang, Siyi
   Ball, Heather L.
   Gandhi, Rikesh
   Liu, Hongrui
   Zhong, Jian
   Yuan, Julie S.
   Guidos, Cynthia J.
   Durie, Peter R.
   Rommens, Johanna M.
TI <i>In Vivo</i> Senescence in the Sbds-Deficient Murine Pancreas:
   Cell-Type Specific Consequences of Translation Insufficiency
SO PLOS GENETICS
LA English
DT Article
ID SHWACHMAN-DIAMOND-SYNDROME; TGF-BETA; SECRETORY PHENOTYPE; MARROW
   FAILURE; GROWTH; MUTATIONS; ACTIVATION; RIBOSOMES; GENES; MYC
AB Genetic models of ribosome dysfunction show selective organ failure, highlighting a gap in our understanding of cell-type specific responses to translation insufficiency. Translation defects underlie a growing list of inherited and acquired cancer-predisposition syndromes referred to as ribosomopathies. We sought to identify molecular mechanisms underlying organ failure in a recessive ribosomopathy, with particular emphasis on the pancreas, an organ with a high and reiterative requirement for protein synthesis. Biallelic loss of function mutations in SBDS are associated with the ribosomopathy Shwachman-Diamond syndrome, which is typified by pancreatic dysfunction, bone marrow failure, skeletal abnormalities and neurological phenotypes. Targeted disruption of Sbds in the murine pancreas resulted in p53 stabilization early in the postnatal period, specifically in acinar cells. Decreased Myc expression was observed and atrophy of the adult SDS pancreas could be explained by the senescence of acinar cells, characterized by induction of Tgf beta, p15(Ink4b) and components of the senescence-associated secretory program. This is the first report of senescence, a tumour suppression mechanism, in association with SDS or in response to a ribosomopathy. Genetic ablation of p53 largely resolved digestive enzyme synthesis and acinar compartment hypoplasia, but resulted in decreased cell size, a hallmark of decreased translation capacity. Moreover, p53 ablation resulted in expression of acinar dedifferentiation markers and extensive apoptosis. Our findings indicate a protective role for p53 and senescence in response to Sbds ablation in the pancreas. In contrast to the pancreas, the Tgf beta molecular signature was not detected in fetal bone marrow, liver or brain of mouse models with constitutive Sbds ablation. Nevertheless, as observed with the adult pancreas phenotype, disease phenotypes of embryonic tissues, including-marked neuronal cell death due to apoptosis, were determined to be p53-dependent. Our findings therefore point to cell/tissue-specific responses to p53-activation that include distinction between apoptosis and senescence pathways, in the context of translation disruption.
C1 [Tourlakis, Marina E.; Zhang, Siyi; Ball, Heather L.; Gandhi, Rikesh; Liu, Hongrui; Zhong, Jian; Rommens, Johanna M.] Hosp Sick Children, Res Inst, Program Genet & Genome Biol, Toronto, ON M5G 1X8, Canada.
   [Tourlakis, Marina E.; Zhang, Siyi; Liu, Hongrui; Rommens, Johanna M.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada.
   [Yuan, Julie S.; Guidos, Cynthia J.] Univ Toronto, Hosp Sick Children, Dept Immunol, Program Dev & Stem Cell Biol,Res Inst, Toronto, ON M5G 1X8, Canada.
   [Durie, Peter R.] Univ Toronto, Hosp Sick Children, Program Physiol & Expt Med, Res Inst,Div Gastroenterol & Nutr,Dept Paediat, Toronto, ON M5G 1X8, Canada.
C3 University of Toronto; Hospital for Sick Children (SickKids); University
   of Toronto; University of Toronto; Hospital for Sick Children
   (SickKids); University of Toronto; Hospital for Sick Children (SickKids)
RP Tourlakis, ME (corresponding author), Hosp Sick Children, Res Inst, Program Genet & Genome Biol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.
EM jrommens@sickkids.ca
RI Rommens, Johanna/JSK-2107-2023; Rommens, Johanna/AAT-7465-2021
FU Canadian Institutes of Health Research (CIHR) [MOP102506, FRN11530];
   CIHR-University of Toronto Molecular Medicine Training Program;
   Shwachman-Diamond Syndrome Canada; Research Training Centre of The
   Hospital for Sick Children
FX This study was supported by Canadian Institutes of Health Research
   (CIHR) grants MOP102506 (JMR) and FRN11530 (CJG), and training awards
   from CIHR-University of Toronto Molecular Medicine Training Program (MET
   and SZ), Shwachman-Diamond Syndrome Canada (MET), and the Research
   Training Centre of The Hospital for Sick Children (HB, MET and JY). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784
   AGGETT PJ, 1980, ARCH DIS CHILD, V55, P331, DOI 10.1136/adc.55.5.331
   Asano N, 2014, BIOCHEM BIOPH RES CO, V443, P1251, DOI 10.1016/j.bbrc.2013.12.143
   Austin KM, 2008, J CLIN INVEST, V118, P1511, DOI 10.1172/JCI33764
   Ball HL, 2009, HUM MOL GENET, V18, P3684, DOI 10.1093/hmg/ddp316
   Barkic M, 2009, MOL CELL BIOL, V29, P2489, DOI 10.1128/MCB.01588-08
   Bellodi C, 2010, EMBO J, V29, P1865, DOI 10.1038/emboj.2010.83
   Bonal C, 2009, GASTROENTEROLOGY, V136, P309, DOI 10.1053/j.gastro.2008.10.015
   Boocock GRB, 2006, GENOMICS, V87, P758, DOI 10.1016/j.ygeno.2006.01.010
   Boocock GRB, 2003, NAT GENET, V33, P97, DOI 10.1038/ng1062
   Booij J, 2013, AM J MED GENET A, V161A, P102, DOI 10.1002/ajmg.a.35687
   Brown KA, 2007, J CELL BIOCHEM, V101, P9, DOI 10.1002/jcb.21255
   Burwick N, 2012, BLOOD, V120, P5143, DOI 10.1182/blood-2012-04-420166
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Campisi J, 2011, CURR OPIN GENET DEV, V21, P107, DOI 10.1016/j.gde.2010.10.005
   CASE RM, 1978, BIOL REV, V53, P211, DOI 10.1111/j.1469-185X.1978.tb01437.x
   Ceci M, 2003, NATURE, V426, P579, DOI 10.1038/nature02160
   Cipolli M, 1999, J PEDIATR GASTR NUTR, V29, P265, DOI 10.1097/00005176-199909000-00006
   Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Coppé JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009188
   Dhanraj S, 2013, PEDIATR BLOOD CANCER, V60, P754, DOI 10.1002/pbc.24453
   Donadieu J, 2012, HAEMATOL-HEMATOL J, V97, P1312, DOI 10.3324/haematol.2011.057489
   Doyle KP, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-62
   Dror Y, 2002, BRIT J HAEMATOL, V118, P701, DOI 10.1046/j.1365-2141.2002.03585.x
   Dror Y, 2011, ANN NY ACAD SCI, V1242, P40, DOI 10.1111/j.1749-6632.2011.06349.x
   Elghetany MT, 2002, ARCH PATHOL LAB MED, V126, P452
   Finch AJ, 2011, GENE DEV, V25, P917, DOI 10.1101/gad.623011
   Gandin V, 2008, NATURE, V455, P684, DOI 10.1038/nature07267
   Gartmann M, 2010, J BIOL CHEM, V285, P14848, DOI 10.1074/jbc.C109.096057
   Gijsbers A, 2013, BIOCHEM BIOPH RES CO, V437, P349, DOI 10.1016/j.bbrc.2013.06.077
   Ginzberg H, 1999, J PEDIATR-US, V135, P81, DOI 10.1016/S0022-3476(99)70332-X
   Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19
   Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0
   Ip WF, 2002, J PEDIATR-US, V141, P259, DOI 10.1067/mpd.2002.125849
   JOHNSTON GC, 1977, EXP CELL RES, V105, P79, DOI 10.1016/0014-4827(77)90154-9
   Jones NC, 2008, NAT MED, V14, P125, DOI 10.1038/nm1725
   Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850
   Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959
   Keel SB, 2012, EXP HEMATOL, V40, P290, DOI 10.1016/j.exphem.2011.12.003
   KENT A, 1990, ARCH DIS CHILD, V65, P1349, DOI 10.1136/adc.65.12.1349
   Keogh SJ, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-48
   Kerr EN, 2010, J PEDIATR-US, V156, P433, DOI 10.1016/j.jpeds.2009.09.026
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670
   Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610
   Lambertsson A, 1998, ADV GENET, V38, P69, DOI 10.1016/S0065-2660(08)60142-X
   Liu JM, 2006, BLOOD, V107, P4583, DOI 10.1182/blood-2005-12-4831
   Maaloe O., 1966, Control of Macromolecular Synthesis; a Study of DNA, RNA, and Protein Synthesis in Bacteria
   Mäkitie O, 2004, CLIN GENET, V65, P101, DOI 10.1111/j.0009-9163.2004.00198.x
   Marygold SJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r216
   Masek T, 2010, POLYSOME ANAL RNA PU, P293
   MASSAGUE J, 1992, CELL, V69, P1067, DOI 10.1016/0092-8674(92)90627-O
   MATHEWS MB, 2007, TRANSLATIONAL CONTRO
   McGowan KA, 2008, NAT GENET, V40, P963, DOI 10.1038/ng.188
   McGowan KA, 2011, BLOOD, V118, P3622, DOI 10.1182/blood-2010-11-318584
   McGowan KA, 2011, SEMIN HEMATOL, V48, P106, DOI 10.1053/j.seminhematol.2011.02.001
   Menne TF, 2007, NAT GENET, V39, P486, DOI 10.1038/ng1994
   Montanaro L, 2008, AM J PATHOL, V173, P301, DOI 10.2353/ajpath.2008.070752
   Müller J, 2010, CELL CYCLE, V9, P4622, DOI 10.4161/cc.9.23.14211
   Nakaya T, 2014, PATHOL INT, V64, P75, DOI 10.1111/pin.12133
   Narla A, 2010, BLOOD, V115, P3196, DOI 10.1182/blood-2009-10-178129
   Oliver ER, 2004, DEVELOPMENT, V131, P3907, DOI 10.1242/dev.01268
   Orelio C, 2009, HAEMATOL-HEMATOL J, V94, P409, DOI 10.3324/haematol.13733
   Panic L, 2006, MOL CELL BIOL, V26, P8880, DOI 10.1128/MCB.00751-06
   Provost E, 2013, ZEBRAFISH, V10, P161, DOI 10.1089/zeb.2013.0884
   Provost E, 2012, DEVELOPMENT, V139, P3232, DOI 10.1242/dev.077107
   Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094
   Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015
   Ruggero D, 2014, BLOOD, V124, P2784, DOI 10.1182/blood-2014-04-526301
   Sanvito F, 1999, J CELL BIOL, V144, P823, DOI 10.1083/jcb.144.5.823
   Savchenko A, 2005, J BIOL CHEM, V280, P19213, DOI 10.1074/jbc.M414421200
   Schaballie H, 2013, EUR J PEDIATR, V172, P613, DOI 10.1007/s00431-012-1908-0
   Scheper GC, 2007, NAT REV GENET, V8, P711, DOI 10.1038/nrg2142
   Senger B, 2001, MOL CELL, V8, P1363, DOI 10.1016/S1097-2765(01)00403-8
   Senturk S, 2010, HEPATOLOGY, V52, P966, DOI 10.1002/hep.23769
   Seoane J, 2001, NAT CELL BIOL, V3, P400, DOI 10.1038/35070086
   Sezgin G, 2013, PEDIATR BLOOD CANCER, V60, P281, DOI 10.1002/pbc.24300
   Si K, 1999, MOL CELL BIOL, V19, P1416
   Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824
   Singh SA, 2012, PEDIATR BLOOD CANCER, V59, P945, DOI 10.1002/pbc.24052
   Strobel O, 2007, GASTROENTEROLOGY, V133, P1999, DOI 10.1053/j.gastro.2007.09.009
   Tan JB, 2005, NAT IMMUNOL, V6, P671, DOI 10.1038/ni1217
   Toiviainen-Salo S, 2008, AM J MED GENET A, V146A, P1558, DOI 10.1002/ajmg.a.32354
   Toiviainen-Salo S, 2008, J PEDIATR, V152, P434, DOI 10.1016/j.jpeds.2007.12.013
   Tourlakis ME, 2012, GASTROENTEROLOGY, V143, P481, DOI 10.1053/j.gastro.2012.04.012
   Truty MJ, 2007, PANCREATOLOGY, V7, P423, DOI 10.1159/000108959
   Tulpule A, 2013, CELL STEM CELL, V12, P727, DOI 10.1016/j.stem.2013.04.002
   Watkins-Chow DE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003094
   Wong CC, 2011, BLOOD, V118, P4305, DOI 10.1182/blood-2011-06-353938
   Zhang S, 2009, ELUCIDATION FUNCTION
   Zhang SY, 2006, MOL CELL BIOL, V26, P6656, DOI 10.1128/MCB.00091-06
NR 92
TC 35
Z9 40
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7404
J9 PLOS GENET
JI PLoS Genet.
PD JUN
PY 2015
VL 11
IS 6
AR e1005288
DI 10.1371/journal.pgen.1005288
PG 23
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA CM0AW
UT WOS:000357341600037
PM 26057580
OA gold, Green Submitted, Green Published
DA 2024-02-19
ER

PT J
AU Papa, S
   Skulachev, VP
AF Papa, S
   Skulachev, VP
TI Reactive oxygen species, mitochondria, apoptosis and aging
SO MOLECULAR AND CELLULAR BIOCHEMISTRY
LA English
DT Article; Proceedings Paper
CT 1st Colloquium on Mitochondria and Myopathies
CY OCT, 1995
CL HALLE, GERMANY
DE mitochondrial metabolism; mitochondrial DNA; superoxide radicals
ID RAT-LIVER MITOCHONDRIA; ADENINE-NUCLEOTIDE TRANSLOCASE; PERMEABILITY
   TRANSITION PORE; PERIPHERAL BENZODIAZEPINE RECEPTOR;
   PROTON-ELECTROCHEMICAL GRADIENT; F0F1 ATP SYNTHASE; RESPIRATORY-CHAIN;
   SUPEROXIDE-DISMUTASE; ESCHERICHIA-COLI; OXIDATIVE-PHOSPHORYLATION
AB In this paper, we shall review various antioxygen defense systems of the cell paying particular attention to those that prevent superoxide formation rather than scavenge already formed superoxide and its products. The role of uncoupled, decoupled and non-coupled respiration, mitochondrial pore, mitochondrion-linked apoptosis will be considered. Mitochondrial theory of aging will be regarded in context of reactive oxygen species-induced damage of mitochondrial DNA.
C1 MOSCOW MV LOMONOSOV STATE UNIV, AN BELOZERSKY INST PHYSICOCHEM BIOL, MOSCOW 119899, RUSSIA.
   UNIV BARI, INST MED BIOCHEM & CHEM, I-70124 BARI, ITALY.
C3 Lomonosov Moscow State University; Universita degli Studi di Bari Aldo
   Moro
RI Skulachev, Vladimir P/J-4164-2012
OI Skulachev, Vladimir P/0000-0003-4886-2243; Papa,
   Sergio/0000-0002-4417-1763
CR AMES BN, 1991, OXIDATIVE DAMAGE & REPAIR, P181
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   BABCOCK GT, 1992, NATURE, V356, P301, DOI 10.1038/356301a0
   BEINERT H, 1993, FASEB J, V7, P1442, DOI 10.1096/fasebj.7.15.8262329
   BERNARDI P, 1994, J BIOENERG BIOMEMBR, V26, P509, DOI 10.1007/BF00762735
   BERNARDI P, 1992, J BIOL CHEM, V267, P8834
   BERNASSAU JM, 1993, J MOL GRAPHICS, V11, P236, DOI 10.1016/0263-7855(93)80003-A
   BLAIR DF, 1986, BIOPHYS J, V50, P713, DOI 10.1016/S0006-3495(86)83511-1
   BOFFOLI D, 1994, BBA-MOL BASIS DIS, V1226, P73, DOI 10.1016/0925-4439(94)90061-2
   Boffoli D, 1996, BBA-MOL BASIS DIS, V1315, P66, DOI 10.1016/0925-4439(95)00107-7
   BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707
   BRAND MD, 1992, EUR J BIOCHEM, V206, P775, DOI 10.1111/j.1432-1033.1992.tb16984.x
   BRAND MD, 1990, BIOCHIM BIOPHYS ACTA, V1018, P128, DOI 10.1016/0005-2728(90)90232-S
   BROWN GC, 1989, J BIOL CHEM, V264, P14704
   BUTTKE TM, 1994, IMMUNOL TODAY, V15, P7, DOI 10.1016/0167-5699(94)90018-3
   CAPITANIO N, 1991, FEBS LETT, V288, P179, DOI 10.1016/0014-5793(91)81029-8
   CARBONERA D, 1988, BIOCHIM BIOPHYS ACTA, V943, P245, DOI 10.1016/0005-2736(88)90556-1
   CHACON E, 1991, TOXICOL APPL PHARM, V107, P117, DOI 10.1016/0041-008X(91)90336-D
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   COCCO T, 1992, EUR J BIOCHEM, V209, P475, DOI 10.1111/j.1432-1033.1992.tb17312.x
   CORTOPASSI G, 1995, BBA-MOL BASIS DIS, V1271, P171, DOI 10.1016/0925-4439(95)00025-Y
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   CROSS AR, 1991, BIOCHIM BIOPHYS ACTA, V1057, P281, DOI 10.1016/S0005-2728(05)80140-9
   DALTON H, 1969, Journal of General Microbiology, V54, P463
   DALTON H, 1969, J GEN MICROBIOL, V56, P307, DOI 10.1099/00221287-56-3-307
   DASSA J, 1991, MOL GEN GENET, V229, P341, DOI 10.1007/BF00267454
   DOUCE R, 1989, ANNU REV PLANT PHYS, V40, P371, DOI 10.1146/annurev.pp.40.060189.002103
   ERIKSSON O, 1991, FEBS LETT, V279, P45, DOI 10.1016/0014-5793(91)80246-Y
   GARDNER PR, 1995, J BIOL CHEM, V270, P13399, DOI 10.1074/jbc.270.22.13399
   GIRONCALLE J, 1994, ARCH BIOCHEM BIOPHYS, V315, P1, DOI 10.1006/abbi.1994.1463
   GONZALEZGARCIA M, 1994, DEVELOPMENT, V120, P3033
   GRIGOLAVA I V, 1980, Biokhimiya, V45, P75
   GUERRIERI F, 1992, ANN NY ACAD SCI, V671, P395, DOI 10.1111/j.1749-6632.1992.tb43813.x
   GUERRIERI F, 1992, ARCH GERONTOL GERIAT, V14, P299, DOI 10.1016/0167-4943(92)90029-4
   GUERRIERI F, 1993, CARDIOSCIENCE, V4, P93
   GUIDOT DM, 1993, J BIOL CHEM, V268, P26699
   GUNTER TE, 1994, AM J PHYSIOL, V267, pC313, DOI 10.1152/ajpcell.1994.267.2.C313
   HALL PF, 1984, INT REV CYTOL, V86, P53, DOI 10.1016/S0074-7696(08)60177-1
   Halliwell B, 1992, FREE RADICALS BRAIN, P21
   HANSFORD RG, 1983, BIOCHIM BIOPHYS ACTA, V726, P41, DOI 10.1016/0304-4173(83)90010-1
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HARPER ME, 1993, J BIOL CHEM, V268, P14850
   HARPER ME, 1993, BIOCHEM SOC T, V21, P785, DOI 10.1042/bst0210785
   HARRIS EJ, 1982, FEBS LETT, V146, P267, DOI 10.1016/0014-5793(82)80932-0
   HATCH GM, 1993, BIOCHEM J, V293, P143, DOI 10.1042/bj2930143
   HAUSKA G, 1988, J BIOENERG BIOMEMBR, V20, P211, DOI 10.1007/BF00768395
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   HAYASHI JI, 1994, J BIOL CHEM, V269, P6878
   HOCH FL, 1992, BIOCHIM BIOPHYS ACTA, V1113, P71, DOI 10.1016/0304-4157(92)90035-9
   HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0
   HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N
   HOFFMAN PS, 1979, EUR J BIOCHEM, V100, P19, DOI 10.1111/j.1432-1033.1979.tb02029.x
   HOFFMAN PS, 1980, EUR J BIOCHEM, V110, P349, DOI 10.1111/j.1432-1033.1980.tb04874.x
   HORRUM MA, 1995, BIOCHEM MOL BIOL INT, V35, P913
   HORST C, 1989, BIOCHEM J, V261, P945, DOI 10.1042/bj2610945
   JACOBSON MD, 1993, NATURE, V361, P365, DOI 10.1038/361365a0
   JOHNSON TE, 1995, INT S GEN DEATH GLAS
   KADENBACH B, 1995, MUTAT RES-DNAGING G, V338, P161, DOI 10.1016/0921-8734(95)00021-W
   KANE DJ, 1993, SCIENCE, V262, P1274, DOI 10.1126/science.8235659
   Kashkarov K. P., 1994, Biokhimiya, V59, P813
   KELLY MJS, 1990, J BACTERIOL, V172, P6010, DOI 10.1128/jb.172.10.6010-6019.1990
   KITAGAWA T, 1993, BIOL REPROD, V49, P730, DOI 10.1095/biolreprod49.4.730
   KONSTANTINOV AA, 1987, BIOCHIM BIOPHYS ACTA, V894, P1, DOI 10.1016/0005-2728(87)90206-4
   KOTLYAR AB, 1990, FEBS LETT, V264, P17, DOI 10.1016/0014-5793(90)80753-6
   KRAGIE L, 1994, LIFE SCI, V55, P1911, DOI 10.1016/0024-3205(94)00523-0
   KRAJEWSKI S, 1993, CANCER RES, V53, P4701
   KRAMER R, 1989, BIOCHIM BIOPHYS ACTA, V974, P1, DOI 10.1016/S0005-2728(89)80160-4
   Krueger KE, 1995, BBA-REV BIOMEMBRANES, V1241, P453, DOI 10.1016/0304-4157(95)00016-X
   Ksenzenko M Iu, 1982, Biokhimiia, V47, P1577
   KSENZENKO MY, 1989, BIOL MEMBRANY, V6, P840
   LAGANIERE S, 1993, GERONTOLOGY, V39, P7, DOI 10.1159/000213509
   LANNI A, 1993, J ENDOCRINOL, V136, P59, DOI 10.1677/joe.0.1360059
   LAURINDO FRM, 1991, CIRCULATION, V83, P1705, DOI 10.1161/01.CIR.83.5.1705
   LENNON SV, 1991, CELL PROLIFERAT, V24, P203, DOI 10.1111/j.1365-2184.1991.tb01150.x
   LEZZA AMS, 1994, BIOCHEM BIOPH RES CO, V205, P772, DOI 10.1006/bbrc.1994.2732
   LIU SS, 1996, IN PRESS P INT S NAT
   LOTSCHER HR, 1979, P NATL ACAD SCI USA, V76, P4340, DOI 10.1073/pnas.76.9.4340
   LUFT R, 1995, BBA-MOL BASIS DIS, V1271, P1, DOI 10.1016/0925-4439(95)00002-L
   LUFT R, 1994, P NATL ACAD SCI USA, V91, P8731, DOI 10.1073/pnas.91.19.8731
   LUVISETTO S, 1991, J BIOL CHEM, V266, P1034
   LUVISETTO S, 1992, J BIOL CHEM, V267, P15348
   Marchetti P, 1996, CANCER RES, V56, P2033
   MARKOSSIAN KA, 1978, BIOCHEM BIOPH RES CO, V81, P1336, DOI 10.1016/0006-291X(78)91282-2
   MASSEY V, 1994, J BIOL CHEM, V269, P22459
   MIQUEL J, 1995, INT S GEN DEATH GLAS
   MIQUEL J, 1986, MODERN AGING RES, V8, P51
   MIYOSHI H, 1987, BIOCHIM BIOPHYS ACTA, V894, P339, DOI 10.1016/0005-2728(87)90204-0
   MONAGHAN P, 1992, J HISTOCHEM CYTOCHEM, V40, P1819, DOI 10.1177/40.12.1453000
   MULLERHOCKER J, 1993, VIRCHOWS ARCH A, V422, P7, DOI 10.1007/BF01605127
   MURFITT RR, 1978, MECH AGEING DEV, V8, P197, DOI 10.1016/0047-6374(78)90018-0
   MURPHY MP, 1989, BIOCHIM BIOPHYS ACTA, V977, P123, DOI 10.1016/S0005-2728(89)80063-5
   NAGLEY P, 1995, INT S GEN DEATH GLAS
   NEWMEYER DD, 1994, CELL, V79, P353, DOI 10.1016/0092-8674(94)90203-8
   NICHOLLS DG, 1974, EUR J BIOCHEM, V50, P305, DOI 10.1111/j.1432-1033.1974.tb03899.x
   OKUDA M, 1992, ACTA PHYSIOL SCAND, V145, P159, DOI 10.1111/j.1748-1716.1992.tb09351.x
   ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730
   OZAWA T, 1995, BIOCH CELL MEMBRANES, P339
   Papa S, 1996, BBA-BIOENERGETICS, V1276, P87, DOI 10.1016/0005-2728(96)00077-1
   PAPA S, 1991, FEBS LETT, V288, P183, DOI 10.1016/0014-5793(91)81030-C
   PAPA S, 1994, J BIOENERG BIOMEMBR, V26, P609, DOI 10.1007/BF00831535
   PARAIDATHATHU T, 1992, FREE RADICAL BIO MED, V13, P289, DOI 10.1016/0891-5849(92)90176-H
   PETIT PX, 1995, J CELL BIOL, V130, P157, DOI 10.1083/jcb.130.1.157
   PETRONILLI V, 1994, J BIOL CHEM, V269, P16638
   PIETROBON D, 1983, BIOCHIM BIOPHYS ACTA, V723, P317, DOI 10.1016/0005-2728(83)90131-7
   POOLE RK, 1994, ANTON LEEUW INT J G, V65, P289, DOI 10.1007/BF00872215
   PUUSTINEN A, 1989, FEBS LETT, V249, P163, DOI 10.1016/0014-5793(89)80616-7
   PUUSTINEN A, 1991, BIOCHEMISTRY-US, V30, P3936, DOI 10.1021/bi00230a019
   RASMUSSEN UB, 1989, FEBS LETT, V255, P385, DOI 10.1016/0014-5793(89)81128-7
   RIBAS-CARBO M, 1994, BBA-BIOENERGETICS, V1188, P205, DOI 10.1016/0005-2728(94)90037-X
   Richter C, 1996, FEBS LETT, V378, P107, DOI 10.1016/0014-5793(95)01431-4
   ROBINSON NC, 1980, BIOCHEMISTRY-US, V19, P3656, DOI 10.1021/bi00557a003
   ROLFE DFS, 1994, 8 EUR BIOEN C ABSTR, P101
   SCHAGGER H, 1986, METHOD ENZYMOL, V126, P224
   SCHAPIRA AHV, 1995, MCBU, P159
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   Skulachev V. P., 1994, Biokhimiya, V59, P1910
   Skulachev V.P., 1988, Membrane Bioenergetics
   Skulachev VP, 1995, MOL BIOL+, V29, P709
   Skulachev VP, 1996, Q REV BIOPHYS, V29, P169, DOI 10.1017/S0033583500005795
   SKULACHHEV VP, 1995, J MOL MED, V73, pB55
   SLATER AFG, 1995, BBA-MOL BASIS DIS, V1271, P59, DOI 10.1016/0925-4439(95)00010-2
   SLATER AFG, 1995, MCBU, P21
   SOBOLL S, 1993, BIOCHIM BIOPHYS ACTA, V1144, P1, DOI 10.1016/0005-2728(93)90024-A
   SOHAL RS, 1995, J BIOL CHEM, V270, P15671, DOI 10.1074/jbc.270.26.15671
   STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616
   STARKOV AA, 1994, FEBS LETT, V355, P305, DOI 10.1016/0014-5793(94)01211-3
   Starkov AA, 1995, PROG CELL R, V5, P51
   STERLING K, 1986, ENDOCRINOLOGY, V119, P292, DOI 10.1210/endo-119-1-292
   Sterling K, 1987, Trans Assoc Am Physicians, V100, P284
   Sterling K, 1991, Thyroid, V1, P167, DOI 10.1089/thy.1991.1.167
   TEARE JP, 1993, FREE RADICAL BIO MED, V14, P655, DOI 10.1016/0891-5849(93)90147-M
   TERADA H, 1975, BIOCHIM BIOPHYS ACTA, V387, P519, DOI 10.1016/0005-2728(75)90090-0
   TERADA H, 1981, BIOCHIM BIOPHYS ACTA, V639, P225, DOI 10.1016/0304-4173(81)90011-2
   TERADA H, 1988, BIOCHIM BIOPHYS ACTA, V933, P193, DOI 10.1016/0005-2728(88)90070-9
   TOYOKUNI S, 1995, FEBS LETT, V358, P1, DOI 10.1016/0014-5793(94)01368-B
   TRISCHLER HJ, 1994, BIOCHEM MOL BIOL INT, V34, P169
   TURRENS JF, 1982, ARCH BIOCHEM BIOPHYS, V217, P401, DOI 10.1016/0003-9861(82)90518-5
   TURRENS JF, 1980, BIOCHEM J, V191, P421, DOI 10.1042/bj1910421
   TZAGOLOFF A, 1986, ANNU REV BIOCHEM, V55, P249, DOI 10.1146/annurev.biochem.55.1.249
   VANDENBERG JJM, 1993, BIOCHEMISTRY-US, V32, P4962, DOI 10.1021/bi00069a035
   VANDENBERGEN CWM, 1994, EUR J BIOCHEM, V226, P1071
   VERKHOVSKAYA M, 1992, J BIOL CHEM, V267, P14559
   VINOGRADOV AD, 1995, FEBS LETT, V370, P83, DOI 10.1016/0014-5793(95)00803-H
   WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523
   Wikstrom M., 1981, CYTOCHROME OXIDASE S
   Wilson P D, 1975, Adv Exp Med Biol, V53, P171
   WOLVETANG EJ, 1994, FEBS LETT, V339, P40, DOI 10.1016/0014-5793(94)80380-3
   WONG GHW, 1995, BBA-MOL BASIS DIS, V1271, P205, DOI 10.1016/0925-4439(95)00029-4
   YAGUZHINSKY LS, 1973, J BIOENERG, V5, P163, DOI 10.1007/BF01648987
   YANAGIBASHI K, 1988, ENDOCRINOLOGY, V123, P2075, DOI 10.1210/endo-123-4-2075
   YONEDA M, 1995, BIOCHEM BIOPH RES CO, V209, P723, DOI 10.1006/bbrc.1995.1559
   Zamzami N, 1996, J EXP MED, V183, P1533, DOI 10.1084/jem.183.4.1533
   Zamzami N, 1996, FEBS LETT, V384, P53, DOI 10.1016/0014-5793(96)00280-3
   ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A
   Zucchini C, 1995, BIOCHEM MOL BIOL INT, V37, P607
NR 156
TC 409
Z9 463
U1 1
U2 52
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0300-8177
J9 MOL CELL BIOCHEM
JI Mol. Cell. Biochem.
PD SEP
PY 1997
VL 174
IS 1-2
BP 305
EP 319
DI 10.1023/A:1006873518427
PG 15
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Cell Biology
GA XW621
UT WOS:A1997XW62100048
PM 9309704
DA 2024-02-19
ER

PT J
AU Dobrzynska, I
   Szachowicz-Petelska, B
   Skrzydlewska, E
   Figaszewski, Z
AF Dobrzynska, I.
   Szachowicz-Petelska, B.
   Skrzydlewska, E.
   Figaszewski, Z.
TI Effects of green tea on physico-chemical properties of liver cell
   membranes of rats intoxicated with ethanol
SO POLISH JOURNAL OF ENVIRONMENTAL STUDIES
LA English
DT Article; Proceedings Paper
CT 11th International Conference on Chemistry and the Environment/50th
   Congress of the
   Polish-Chemical-Society/Polish-Association-of-Chemical-Engineers
   Congress
CY SEP 09-12, 2007
CL Torun, POLAND
SP EuCheMS-DCE, Polish Chem Soc, Polish Assoc Chem Engineers
DE ethanol; green tea; phospholipids; lipid peroxidation products; surface
   charge density; aging; liver
ID HIGH-FAT DIET; LIPID-PEROXIDATION; OXIDATIVE STRESS; XANTHINE-OXIDASE;
   ACID; POLYPHENOLS; CATECHINS; PHOSPHOLIPIDS; METABOLISM; ALCOHOLISM
AB Changes in the composition and physicochemical properties of liver cell membranes appearing as the result of ethanol intoxication and the aging process are mainly due to reactive oxygen species (ROS). The destructive action of free radicals can be neutralized by administering antioxidants, especially natural ones like green tea. For this reason, the purpose of this study was to estimate the efficacy of green tea's influence on the physicochemical and biochemical properties of the rat liver as affected by the aging process and/or chronic ethanol intoxication. Several methods were used to evaluate this effect. Qualitative and quantitative composition of phospholipids in the membrane was determined by High Performance Liquid Chromatography (HPLC). The electrophoresis technique was used to determine the surface charge density of the rat liver cell membrane. The process of aging causes a decrease in the total amount of phospholipids, increases lipid peroxidation products and surface charge density of liver cell membrane. The results also demonstrate that ethanol administration provoked increase phospholipid composition, lipid peroxidation products and surface charge density in liver cell membrane. The ingestion of green tea with ethanol partially prevented these ethanol-induced and/or aging changes. Moreover, long-term drinking of green tea partially prevents changes in structure and function of membrane phospholipids caused by chronic ethanol intoxication.
C1 [Dobrzynska, I.; Szachowicz-Petelska, B.; Figaszewski, Z.] Univ Bialystok, Inst Chem, PL-15443 Bialystok, Poland.
   [Skrzydlewska, E.] Med Acad Bialystok, Dept Analyt Chem, PL-15230 Bialystok, Poland.
   [Figaszewski, Z.] Univ Warsaw, Fac Chem, Lab Interfacial Electrochem, PL-02093 Warsaw, Poland.
C3 University of Bialystok; University of Warsaw
RP Dobrzynska, I (corresponding author), Univ Bialystok, Inst Chem, Al Pilsudskiego 11-4, PL-15443 Bialystok, Poland.
EM elchem@uwb.edu.pl
OI Skrzydlewska, Elzbieta/0000-0001-5397-7139
CR Aucamp J, 1997, ANTICANCER RES, V17, P4381
   BARCLAY LRC, 1993, CAN J CHEM, V71, P1, DOI 10.1139/v93-001
   Barrow G. M., 1996, Physical Chemistry, V6th
   BARRY JA, 1994, BIOCHEMISTRY-US, V33, P8082, DOI 10.1021/bi00192a013
   Buege J A, 1978, Methods Enzymol, V52, P302
   Chan PT, 1999, J NUTR, V129, P1094, DOI 10.1093/jn/129.6.1094
   CHIU D, 1989, SEMIN HEMATOL, V26, P257
   Dean RT, 1997, BIOCHEM J, V324, P1
   DEAN RT, 1995, BIOCHEM J, V305, P643
   Dobrzynska I, 2005, MOL CELL BIOCHEM, V276, P113, DOI 10.1007/s11010-005-3557-3
   Dobrzynska I, 2004, CELL MOL BIOL LETT, V9, P709
   Dobrzynska I, 2006, BIOELECTROCHEMISTRY, V69, P142, DOI 10.1016/j.bioelechem.2006.01.004
   Dobrzynska L, 2005, CHEM-BIOL INTERACT, V156, P41, DOI 10.1016/j.cbi.2005.07.002
   DOLOWY K, 1984, PROG SURF SCI, V15, P245, DOI 10.1016/0079-6816(84)90013-3
   Evans W H, 1970, Biochem J, V116, P833
   FLOYD RA, 1991, SCIENCE, V254, P1597, DOI 10.1126/science.1684251
   Gennis R.B., 1989, BIOMEMBRANES MOL STR
   GINKEL GV, 1994, METHOD ENZYMOL, V233, P273
   GRAHAM HN, 1992, PREV MED, V21, P334, DOI 10.1016/0091-7435(92)90041-F
   Guo QN, 1996, BBA-LIPID LIPID MET, V1304, P210, DOI 10.1016/S0005-2760(96)00122-1
   Ju JY, 2003, NUTR CANCER, V46, P172, DOI 10.1207/S15327914NC4602_10
   KATO S, 1990, GASTROENTEROLOGY, V98, P203, DOI 10.1016/0016-5085(90)91311-S
   KERANEN A, 1981, LIPIDS, V17, P155
   KLEMM WR, 1992, DRUG ALCOHOL ABUSE R
   KOIVUSAARI U, 1981, TOXICOLOGY, V20, P173, DOI 10.1016/0300-483X(81)90049-4
   KRYSINSKI P, 1986, PROG SURF SCI, V23, P317
   LAGANIERE S, 1991, LIPIDS, V26, P472, DOI 10.1007/BF02536075
   Lee MJ, 2000, ANAL BIOCHEM, V279, P164, DOI 10.1006/abio.2000.4487
   LIEBER CS, 1970, J BIOL CHEM, V245, P2505
   Lieber CS, 1997, CLIN CHIM ACTA, V257, P59, DOI 10.1016/S0009-8981(96)06434-0
   Lindi C, 1998, ALCOHOL, V16, P311, DOI 10.1016/S0741-8329(98)00020-2
   Maiani G, 1997, J CHROMATOGR B, V692, P311, DOI 10.1016/S0378-4347(97)00009-1
   MARIN MS, 1990, BIOCHIMIE, V72, P745, DOI 10.1016/0300-9084(90)90159-E
   NIE Y, 1989, ARCH BIOCHEM BIOPHYS, V268, P349, DOI 10.1016/0003-9861(89)90596-1
   Ostrowska J, 2000, CHEM ANAL-WARSAW, V45, P613
   Rikans LE, 1997, BBA-MOL BASIS DIS, V1362, P116, DOI 10.1016/S0925-4439(97)00067-7
   Sergent O, 2005, J PHARMACOL EXP THER, V313, P104, DOI 10.1124/jpet.104.078634
   Shen JZ, 2003, CLIN EXP PHARMACOL P, V30, P88, DOI 10.1046/j.1440-1681.2003.03796.x
   SLATER SJ, 1993, BIOCHEMISTRY-US, V32, P3714, DOI 10.1021/bi00065a025
   SOHAL RS, 1993, AGING-CLIN EXP RES, V5, P3, DOI 10.1007/BF03324120
   SPRINCE H, 1975, AGENTS ACTIONS, V5, P164, DOI 10.1007/BF02027359
   STEVENS VJ, 1981, J CLIN INVEST, V67, P361, DOI 10.1172/JCI110043
   SUN GY, 1985, ALCOHOL CLIN EXP RES, V9, P164, DOI 10.1111/j.1530-0277.1985.tb05543.x
   TIJBURG LBM, 1988, ARCH BIOCHEM BIOPHYS, V267, P568, DOI 10.1016/0003-9861(88)90064-1
   Tsuchiya H, 1999, PHARMACOLOGY, V59, P34, DOI 10.1159/000028303
   TUMA DJ, 1984, ARCH BIOCHEM BIOPHYS, V234, P377, DOI 10.1016/0003-9861(84)90283-2
   Tyurina YY, 2000, TOXICOLOGY, V148, P93, DOI 10.1016/S0300-483X(00)00199-2
NR 47
TC 10
Z9 12
U1 0
U2 7
PU HARD
PI OLSZTYN 5
PA POST-OFFICE BOX, 10-718 OLSZTYN 5, POLAND
SN 1230-1485
EI 2083-5906
J9 POL J ENVIRON STUD
JI Pol. J. Environ. Stud.
PY 2008
VL 17
IS 3
BP 327
EP 333
PG 7
WC Environmental Sciences
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Environmental Sciences & Ecology
GA 310GR
UT WOS:000256517400004
DA 2024-02-19
ER

PT J
AU Lambert, AJ
   Wang, B
   Yardley, J
   Edwards, J
   Merry, BJ
AF Lambert, AJ
   Wang, B
   Yardley, J
   Edwards, J
   Merry, BJ
TI The effect of aging and caloric restriction on mitochondrial protein
   density and oxygen consumption
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE caloric restriction; aging; mitochondria; respiration; metabolism;
   uncoupling
ID RAT-LIVER MITOCHONDRIA; OXIDATIVE DNA-DAMAGE; DIETARY RESTRICTION;
   BODY-TEMPERATURE; FOOD RESTRICTION; METABOLIC-RATE; RESPIRATION;
   GENERATION; STRESS
AB It has been proposed that part of the anti-aging mechanism of caloric restriction (CR) involves changes in mitochondrial function. To investigate this hypothesis, mitochondria from various tissues of male Brown Norway rats (fully fed and CR) were isolated and respiration rates determined. In mitochondria from liver, heart, brain and kidney, there were no significant effects of CR on state 4 mitochondrial respiration rate. Further experiments using liver mitochondria under a variety of incubation conditions confirmed that CR does not alter mitochondrial respiration rate in this tissue. However, the respiration rate of mitochondria from brown adipose tissue (BAT) of CR animals was approximately three-fold higher compared to mitochondria from fully fed controls. Mitochondrial protein density was significantly higher in liver tissue of CR animals; it was significantly lower in heart and unchanged in BAT. It is concluded that whilst CR results in tissue-specific changes in mitochondrial respiration rate, these effects do not explain the CR-induced changes in free radical production reported previously for these organelles. (C) 2004 Elsevier Inc. All rights reserved.
C1 Univ Liverpool, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England.
   Royal Liverpool Univ Hosp, Dept Med, Neuroendocrine & Obes Biol Res Unit, Liverpool L69 3GA, Merseyside, England.
C3 University of Liverpool; Royal Liverpool & Broadgreen University
   Hospitals NHS Trust; Royal Liverpool University Hospital; University of
   Liverpool
RP Lambert, AJ (corresponding author), MRC, Dunn Human Nutr Unit, Hills Rd, Cambridge CB2 2XY, England.
EM adrian.lambert@mrc-dunn.cam.ac.uk
CR BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   CHENEY KE, 1983, J GERONTOL, V38, P420, DOI 10.1093/geronj/38.4.420
   Gredilla R, 2001, FASEB J, V15, P1589, DOI 10.1096/fj.00-0764fje
   Gredilla R, 2001, J BIOENERG BIOMEMBR, V33, P279, DOI 10.1023/A:1010603206190
   HITTELMAN KJ, 1969, EUR J BIOCHEM, V11, P183, DOI 10.1111/j.1432-1033.1969.tb00759.x
   HOLEHAN AM, 1986, BIOL REV, V61, P329, DOI 10.1111/j.1469-185X.1986.tb00658.x
   Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9
   Lai J C, 1979, Methods Enzymol, V55, P51
   Lal SB, 2001, J GERONTOL A-BIOL, V56, pB116, DOI 10.1093/gerona/56.3.B116
   Lambert AJ, 2004, AM J PHYSIOL-REG I, V286, pR71, DOI 10.1152/ajpregu.00341.2003
   Liu SS, 1997, BIOSCIENCE REP, V17, P259, DOI 10.1023/A:1027328510931
   López-Torres M, 2002, FREE RADICAL BIO MED, V32, P882, DOI 10.1016/S0891-5849(02)00773-6
   MCCARTER RJ, 1992, AM J PHYSIOL, V263, pE448, DOI 10.1152/ajpendo.1992.263.3.E448
   MCCARTER RJ, 1989, AM J PHYSIOL, V257, pE175, DOI 10.1152/ajpendo.1989.257.2.E175
   Mela L, 1979, Methods Enzymol, V55, P39
   MERRY BJ, 2002, MOL CELLULAR GERONTO, P180
   MITCHELL P, 1967, BIOCHEM J, V105, P1147, DOI 10.1042/bj1051147
   NAGY KA, 1987, ECOL MONOGR, V57, P111, DOI 10.2307/1942620
   NICHOLLS D, 1986, BIOCHEM SOC T, V14, P223, DOI 10.1042/bst0140223
   Pedersen P L, 1978, Methods Cell Biol, V20, P411, DOI 10.1016/S0091-679X(08)62030-0
   Ramsey JJ, 2000, EXP GERONTOL, V35, P1131, DOI 10.1016/S0531-5565(00)00166-2
   Ramsey JJ, 2000, FREE RADICAL BIO MED, V29, P946, DOI 10.1016/S0891-5849(00)00417-2
   REYNAFARJE B, 1985, ANAL BIOCHEM, V145, P406, DOI 10.1016/0003-2697(85)90381-1
   Rikke BA, 2003, MECH AGEING DEV, V124, P663, DOI 10.1016/S0047-6374(03)00003-4
   SOHAL RS, 1994, MECH AGEING DEV, V74, P121, DOI 10.1016/0047-6374(94)90104-X
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   Speakman JR, 2002, J NUTR, V132, p1583S, DOI 10.1093/jn/132.6.1583S
   VOLICER L, 1984, J GERONTOL, V39, P178, DOI 10.1093/geronj/39.2.178
   Votyakova TV, 2001, J NEUROCHEM, V79, P266, DOI 10.1046/j.1471-4159.2001.00548.x
   WEINDRUCH R, 1988, RETARDATION AGING DI
   WEINDRUCH RH, 1980, MECH AGEING DEV, V12, P375, DOI 10.1016/0047-6374(80)90070-6
NR 31
TC 76
Z9 85
U1 1
U2 8
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
J9 EXP GERONTOL
JI Exp. Gerontol.
PD MAR
PY 2004
VL 39
IS 3
BP 289
EP 295
DI 10.1016/j.exger.2003.12.009
PG 7
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 804DJ
UT WOS:000220279100002
PM 15036388
DA 2024-02-19
ER

PT J
AU Copple, BL
   Bai, S
   Burgoon, LD
   Moon, JO
AF Copple, Bryan L.
   Bai, Shan
   Burgoon, Lyle D.
   Moon, Jeon-OK
TI Hypoxia-inducible factor-1α regulates the expression of genes in hypoxic
   hepatic stellate cells important for collagen deposition and
   angiogenesis
SO LIVER INTERNATIONAL
LA English
DT Article
DE hepatic stellate cells; hypoxia; hypoxia-inducible factor
ID MIGRATION INHIBITORY FACTOR; GROWTH-FACTOR EXPRESSION; PROLIFERATION;
   ACTIVATION; INDUCTION; STIMULATION; SENESCENCE; CYTOKINES; LIPOCYTES;
   IL-13
AB Background/Aims
   Several studies have shown that regions of hypoxia develop in the liver during chronic injury. Furthermore, it has been demonstrated that hypoxia stimulates the release of mediators from hepatic stellate cells (HSCs) that may affect the progression of fibrosis. The mechanism by which hypoxia modulates gene expression in HSCs is not known. Recent studies demonstrated that the hypoxia-activated transcription factor, hypoxia-inducible factor (HIF)-1 alpha, is critical for the development of fibrosis. Accordingly, the hypothesis was tested that HIF-1 alpha is activated in HSCs and regulates the expression of genes important for HSC activation and liver fibrosis.
   Methods
   Hepatic stellate cells were isolated from mice and exposed to hypoxia. HIF-1 alpha and HIF-2 alpha activation were measured, and gene expression was analysed by gene array analysis. To identify the genes regulated by HIF-1 alpha, HSCs were isolated from control and HIF-1 alpha-deficient mice.
   Results
   Exposure of primary mouse HSCs to 0.5% oxygen activated HIF-1 alpha and HIF-2 alpha. mRNA levels of numerous genes were increased in HSCs exposed to 0.5% oxygen, many of which are important for HSC function, angiogenesis and collagen synthesis. Of the mRNAs increased, chemokine receptor (Ccr) 1, Ccr5, macrophage migration inhibitory factor, interleukin-13 receptor alpha 1 and prolyl-4-hydroxylase alpha 2 (P4h alpha 2) were completely HIF-1 alpha dependent. Upregulation of the vascular endothelial growth factor and the placental growth factor was partially HIF-1 alpha dependent and upregulation of angiopoietin-like 4 and P4h alpha 1 was HIF-1 alpha independent.
   Conclusions
   Results from these studies demonstrate that hypoxia, through activation of HIF-1 alpha, regulates the expression of genes that may alter the sensitivity of HSCs to certain activators and chemotaxins, and regulates the expression of genes important for angiogenesis and collagen synthesis.
C1 [Copple, Bryan L.; Bai, Shan; Moon, Jeon-OK] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA.
   [Burgoon, Lyle D.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.
   [Burgoon, Lyle D.] Michigan State Univ, Dept Quantitat Biol Initiat, E Lansing, MI 48824 USA.
   [Moon, Jeon-OK] Pusan Natl Univ, Sch Pharm, Pusan, South Korea.
C3 University of Kansas; University of Kansas Medical Center; Michigan
   State University; Michigan State University; Pusan National University
RP Copple, BL (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, 4063 KLSIC,3901 Rainbow Blvd, Kansas City, KS 66160 USA.
EM bcopple@kumc.edu
RI Burgoon, Lyle D./I-2894-2019
OI Burgoon, Lyle D./0000-0003-4977-5352
FU National Institutes of Health [DK073566]; Center of Biomedical Research
   Excellence (COBRE) [P20 RR021940]; National Center for Research
   Resources [P20 RR016475]
FX This study was supported by National Institutes of Health grants
   DK073566 (B. L. C.) and Center of Biomedical Research Excellence (COBRE)
   P20 RR021940 as well as the Molecular Biology Core and the Histology
   Core supported by the COBRE grant. In addition, this work was supported
   by a Lied Endowed Basic Science Pilot Research Grant (B. L. C.) and
   grant number P20 RR016475 from the National Center for Research
   Resources. The authors thank Dr Frank J. Gonzalez at the National Cancer
   Institute for providing the HIF-1 alpha<SUP>fl/fl</SUP>-Mx-Cre+ and
   HIF-1 alpha<SUP>fl/fl</SUP>-Mx-Cre - mice for these studies.
CR Akiyoshi F, 1998, DIGEST DIS SCI, V43, P41, DOI 10.1023/A:1018863718430
   Ankoma-Sey V, 2000, HEPATOLOGY, V31, P141, DOI 10.1002/hep.510310122
   Cao YH, 1996, J CLIN INVEST, V98, P2507, DOI 10.1172/JCI119069
   Cash TP, 2007, FREE RADICAL BIO MED, V43, P1219, DOI 10.1016/j.freeradbiomed.2007.07.001
   Chesney J, 1999, MOL MED, V5, P181, DOI 10.1007/BF03402061
   Coleman ML, 2007, ESSAYS BIOCHEM, V43, P1
   Copple BL, 2009, LIVER INT, V29, P1010, DOI 10.1111/j.1478-3231.2009.02015.x
   Corpechot C, 2002, HEPATOLOGY, V35, P1010, DOI 10.1053/jhep.2002.32524
   De Minicis S, 2007, GASTROENTEROLOGY, V132, P1937, DOI 10.1053/j.gastro.2007.02.033
   Fallon PG, 2000, J IMMUNOL, V164, P2585, DOI 10.4049/jimmunol.164.5.2585
   Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003
   FRIEDMAN SL, 1989, J CLIN INVEST, V84, P1780, DOI 10.1172/JCI114362
   FRIEDMAN SL, 1985, P NATL ACAD SCI USA, V82, P8681, DOI 10.1073/pnas.82.24.8681
   Gaber T, 2005, ANN RHEUM DIS, V64, P971, DOI 10.1136/ard.2004.031641
   Georges PC, 2007, AM J PHYSIOL-GASTR L, V293, pG1147, DOI 10.1152/ajpgi.00032.2007
   Hofbauer KH, 2003, EUR J BIOCHEM, V270, P4515, DOI 10.1046/j.1432-1033.2003.03846.x
   Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149
   Kim ND, 2006, TOXICOL SCI, V90, P586, DOI 10.1093/toxsci/kfj111
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125
   Kumagi T, 2001, CLIN BIOCHEM, V34, P189, DOI 10.1016/S0009-9120(01)00214-4
   Le Jan S, 2003, AM J PATHOL, V162, P1521, DOI 10.1016/S0002-9440(10)64285-X
   Moon JO, 2009, AM J PHYSIOL-GASTR L, V296, pG582, DOI 10.1152/ajpgi.90368.2008
   Murphy PM, 2000, PHARMACOL REV, V52, P145
   Myllyharju J, 2003, MATRIX BIOL, V22, P15, DOI 10.1016/S0945-053X(03)00006-4
   Novo E, 2007, AM J PATHOL, V170, P1942, DOI 10.2353/ajpath.2007.060887
   Oben JA, 2003, BIOCHEM BIOPH RES CO, V302, P685, DOI 10.1016/S0006-291X(03)00232-8
   Rosmorduc O, 1999, AM J PATHOL, V155, P1065, DOI 10.1016/S0002-9440(10)65209-1
   Salcedo Mora X., 2005, Rev. esp. enferm. dig., V97, P699, DOI 10.4321/s1130-01082005001000003
   Schwabe RF, 2003, AM J PHYSIOL-GASTR L, V285, pG949, DOI 10.1152/ajpgi.00215.2003
   Seki E, 2009, J CLIN INVEST, V119, P1858, DOI 10.1172/JCI37444
   Shi YF, 2007, FEBS LETT, V581, P203, DOI 10.1016/j.febslet.2006.12.010
   Sugimoto R, 2005, LIVER INT, V25, P420, DOI 10.1111/j.1478-3231.2005.01087.x
   Taura K, 2008, GASTROENTEROLOGY, V135, P1729, DOI 10.1053/j.gastro.2008.07.065
   Tomita S, 2000, MOL ENDOCRINOL, V14, P1674, DOI 10.1210/me.14.10.1674
   Tomita S, 2003, MOL CELL BIOL, V23, P6739, DOI 10.1128/MCB.23.19.6739-6749.2003
   Vrochides D, 1996, HEPATOLOGY, V23, P1650, DOI 10.1053/jhep.1996.v23.pm0008675189
   Welford SM, 2006, GENE DEV, V20, P3366, DOI 10.1101/gad.1471106
   Weng HL, 2009, HEPATOLOGY, V50, P230, DOI 10.1002/hep.22934
   Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683
   Zhou XY, 2004, J BIOL CHEM, V279, P23996, DOI 10.1074/jbc.M311668200
NR 41
TC 125
Z9 145
U1 1
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1478-3223
EI 1478-3231
J9 LIVER INT
JI Liver Int.
PD FEB
PY 2011
VL 31
IS 2
BP 230
EP 244
DI 10.1111/j.1478-3231.2010.02347.x
PG 15
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 702FF
UT WOS:000285879300012
PM 20880076
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Tian, XY
   Thorne, JL
   Moore, JB
AF Tian, Xiaoying
   Thorne, James L. L.
   Moore, J. Bernadette
TI Ergothioneine: an underrecognised dietary micronutrient required for
   healthy ageing?
SO BRITISH JOURNAL OF NUTRITION
LA English
DT Article
DE Ergothioneine; Cardiometabolic disease; CVD; Type 2 diabetes;
   Non-alcoholic fatty liver disease
ID ORGANIC CATION TRANSPORTER; CONDITIONALLY-ESSENTIAL NUTRIENTS;
   FUNCTIONAL-CHARACTERIZATION; RHEUMATOID-ARTHRITIS; CULTIVATED MUSHROOMS;
   OXIDATIVE DAMAGE; CROHNS-DISEASE; IN-VITRO; ANTIOXIDANT; LIVER
AB Ergothioneine is a naturally occurring amino acid and thiol antioxidant found in high amounts in mushrooms and fermented foods. Humans and animals acquire ergothioneine from the diet through the pH-dependent activity of a membrane transporter, the large solute carrier 22A member 4 (SLC22A4), expressed on the apical membrane of the small intestine. The SLC22A4 transporter also functions in the renal reabsorption of ergothioneine in the kidney, with avid absorption and retention of ergothioneine from the diet observed in both animals and humans. Ergothioneine is capable of scavenging a diverse range of reactive oxygen and nitrogen species, has metal chelation properties, and is predicted to directly regulate nuclear factor erythroid 2-related factor 2 (Nrf2) activity. Although not lethal, the genetic knockout of the SLC22A4 gene in multiple organisms increases susceptibility to oxidative stress, damage and inflammation; in agreement with a large body of preclinical data suggesting the physiological function of ergothioneine is as a cellular antioxidant and cytoprotectant agent. In humans, blood levels of ergothioneine decline after the age of 60 years, and lower levels of ergothioneine are associated with more rapid cognitive decline. Conversely, high plasma ergothioneine levels have been associated with significantly reduced cardiovascular mortality and overall mortality risks. In this horizon's manuscript, we review evidence suggesting critical roles for dietary ergothioneine in healthy ageing and the prevention of cardiometabolic disease. We comment on some of the outstanding research questions in the field and consider the question of whether or not ergothioneine should be considered a conditionally essential micronutrient.
C1 [Tian, Xiaoying; Thorne, James L. L.; Moore, J. Bernadette] Univ Leeds, Sch Food Sci & Nutr, Leeds LS2 9JT, England.
C3 University of Leeds
RP Moore, JB (corresponding author), Univ Leeds, Sch Food Sci & Nutr, Leeds LS2 9JT, England.
EM j.b.moore@leeds.ac.uk
OI Tian, Xiaoying/0000-0003-4641-4332; Moore, J
   Bernadette/0000-0003-4750-1550
CR Ames BN, 2018, P NATL ACAD SCI USA, V115, P10836, DOI 10.1073/pnas.1809045115
   [Anonymous], 2014, J FOOD NUTR
   ARDUINI A, 1990, ARCH BIOCHEM BIOPHYS, V281, P41, DOI 10.1016/0003-9861(90)90410-Z
   Asmus KD, 1996, BIOCHEM J, V315, P625, DOI 10.1042/bj3150625
   Ba DM, 2021, NUTR J, V20, DOI 10.1186/s12937-021-00691-8
   Barger G, 1911, J CHEM SOC, V99, P2336, DOI 10.1039/ct9119902336
   Bedirli A, 2004, J SURG RES, V122, P96, DOI 10.1016/j.jss.2004.06.016
   Beelman RB, 2021, AGRONOMY-BASEL, V11, DOI 10.3390/agronomy11112278
   Behof WJ, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-97925-w
   Borodina I, 2020, NUTR RES REV, V33, P190, DOI 10.1017/S0954422419000301
   Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z
   CARGNONI A, 1995, BBA-MOL BASIS DIS, V1270, P173, DOI 10.1016/0925-4439(94)00084-4
   Cheah IK, 2013, FREE RADICAL RES, V47, P1036, DOI 10.3109/10715762.2013.848354
   Cheah IK., 2018, INVESTIGATING EFFICA
   Cheah IK, 2021, REDOX BIOL, V42, DOI 10.1016/j.redox.2021.101868
   Cheah IK, 2017, ANTIOXID REDOX SIGN, V26, P193, DOI 10.1089/ars.2016.6778
   Cheah IK, 2016, BIOCHEM BIOPH RES CO, V478, P162, DOI 10.1016/j.bbrc.2016.07.074
   Cheah IK, 2016, FREE RADICAL RES, V50, P14, DOI 10.3109/10715762.2015.1099642
   Cheah IK, 2012, BBA-MOL BASIS DIS, V1822, P784, DOI 10.1016/j.bbadis.2011.09.017
   CHIPPONI JX, 1982, AM J CLIN NUTR, V35, P1112, DOI 10.1093/ajcn/35.5.1112
   Choi JH, 2021, J FOOD BIOCHEM, V45, DOI 10.1111/jfbc.13838
   Cole IS., 2020, UNRAVELLING FUNCTION
   D'Onofrio N, 2016, FREE RADICAL BIO MED, V96, P211, DOI 10.1016/j.freeradbiomed.2016.04.013
   Dare A, 2021, CAN J PHYSIOL PHARM, V99, P1137, DOI 10.1139/cjpp-2021-0247
   Dare Ayobami, 2022, Cardiovasc Hematol Agents Med Chem, V20, P133, DOI 10.2174/1871525719666210809122541
   Dare A, 2021, BIOMED PHARMACOTHER, V141, DOI 10.1016/j.biopha.2021.111921
   Deiana M, 2004, CLIN NUTR, V23, P183, DOI 10.1016/S0261-5614(03)00108-0
   Dubost NJ, 2007, FOOD CHEM, V105, P727, DOI 10.1016/j.foodchem.2007.01.030
   Dubost N. Joy, 2006, International Journal of Medicinal Mushrooms, V8, P215, DOI 10.1615/IntJMedMushr.v8.i3.30
   Ey J, 2007, J AGR FOOD CHEM, V55, P6466, DOI 10.1021/jf071328f
   Furmaniak MA, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02541
   Grimble George K., 1993, Nutrition Research Reviews, V6, P97, DOI 10.1079/NRR19930008
   Gründemann D, 2005, P NATL ACAD SCI USA, V102, P5256, DOI 10.1073/pnas.0408624102
   Gründemann D, 2022, FEBS LETT, V596, P1252, DOI 10.1002/1873-3468.14269
   Halliwell B, 2020, FREE RADICAL BIO MED, V161, P234, DOI 10.1016/j.freeradbiomed.2020.10.010
   Halliwell B, 2018, FEBS LETT, V592, P3357, DOI 10.1002/1873-3468.13123
   Halliwell B, 2016, BIOCHEM BIOPH RES CO, V470, P245, DOI 10.1016/j.bbrc.2015.12.124
   Harwood MD, 2019, DRUG METAB DISPOS, V47, P854, DOI 10.1124/dmd.119.086959
   Hatano T, 2016, J NEUROL NEUROSUR PS, V87, P295, DOI 10.1136/jnnp-2014-309676
   HEATH H, 1958, BIOCHEM J, V68, P204, DOI 10.1042/bj0680204
   Horie Y, 2020, LWT-FOOD SCI TECHNOL, V118, DOI 10.1016/j.lwt.2019.108812
   Hseu YC, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/2576823
   Hseu YC, 2015, FREE RADICAL BIO MED, V86, P102, DOI 10.1016/j.freeradbiomed.2015.05.026
   Huff CD, 2012, MOL BIOL EVOL, V29, P101, DOI 10.1093/molbev/msr151
   Ito T, 2011, FOOD SCI TECHNOL RES, V17, P103, DOI 10.3136/fstr.17.103
   Jenny KA, 2022, ANTIOXIDANTS-BASEL, V11, DOI 10.3390/antiox11020185
   Jones GW, 2014, GENE, V549, P161, DOI 10.1016/j.gene.2014.07.065
   Kato Y, 2010, PHARM RES-DORDR, V27, P832, DOI 10.1007/s11095-010-0076-z
   KAWANO H, 1983, CHEM PHARM BULL, V31, P1676
   Kendler BS, 2006, J CARDIOVASC NURS, V21, P9, DOI 10.1097/00005082-200601000-00004
   Kerley RN, 2018, FREE RADICAL BIO MED, V117, P145, DOI 10.1016/j.freeradbiomed.2017.12.030
   Ko HJ, 2021, EXP CELL RES, V400, DOI 10.1016/j.yexcr.2021.112516
   Kuwahara M, 2005, ARTHRITIS RHEUM, V52, P2947, DOI 10.1002/art.21244
   Li RWS, 2014, J PHARMACOL EXP THER, V350, P691, DOI 10.1124/jpet.114.214049
   Maeda T, 2007, DRUG METAB DISPOS, V35, P394, DOI 10.1124/dmd.106.012112
   Mantovani A, 2021, LANCET GASTROENTEROL, V6, P903, DOI 10.1016/S2468-1253(21)00308-3
   Martin KR, 2010, J MED FOOD, V13, P1340, DOI 10.1089/jmf.2009.0194
   MELVILLE DB, 1956, J BIOL CHEM, V218, P647
   MELVILLE DB, 1955, J BIOL CHEM, V213, P61
   MELVILLE DB, 1956, J BIOL CHEM, V223, P9
   Moore JB, 2019, P NUTR SOC, V78, P290, DOI 10.1017/S0029665119000570
   MOTOHASHI N, 1977, CHEM PHARM BULL, V25, P2516
   MOTOHASHI N, 1974, CHEM PHARM BULL, V22, P654
   Nakamura T, 2007, PHARM RES-DORDR, V24, P1628, DOI 10.1007/s11095-007-9290-8
   Nakanishi T, 2011, MOL PHARMACEUT, V8, P2142, DOI 10.1021/mp200096r
   Obayashi K, 2005, J COSMET SCI, V56, P17
   Park EJ, 2010, J MED PLANTS RES, V4, P1141
   Paul BD, 2010, CELL DEATH DIFFER, V17, P1134, DOI 10.1038/cdd.2009.163
   Peltekova VD, 2004, NAT GENET, V36, P471, DOI 10.1038/ng1339
   Pfeiffer C, 2015, FREE RADICAL BIO MED, V83, P178, DOI 10.1016/j.freeradbiomed.2015.02.026
   Pfeiffer C, 2011, FOOD CHEM, V129, P1766, DOI 10.1016/j.foodchem.2011.06.047
   Quote Investigator, 2019, ABS EV IS NOT EV ABS
   ROUGEE M, 1988, PHOTOCHEM PHOTOBIOL, V47, P485, DOI 10.1111/j.1751-1097.1988.tb08835.x
   Sakrak O, 2008, J SURG RES, V144, P36, DOI 10.1016/j.jss.2007.04.020
   Salama SA, 2021, J BIOCHEM MOL TOXIC, V35, DOI 10.1002/jbt.22729
   Servillo L, 2017, J CARDIOVASC PHARM, V69, P183, DOI 10.1097/FJC.0000000000000464
   Servillo L, 2015, FREE RADICAL BIO MED, V79, P228, DOI 10.1016/j.freeradbiomed.2014.11.017
   Shinozaki Y, 2017, KIDNEY INT, V92, P1356, DOI 10.1016/j.kint.2017.04.032
   Smith E, 2020, HEART, V106, P691, DOI 10.1136/heartjnl-2019-315485
   Song TY, 2014, FREE RADICAL RES, V48, P1049, DOI 10.3109/10715762.2014.920954
   Song TY, 2010, FOOD CHEM TOXICOL, V48, P3492, DOI 10.1016/j.fct.2010.09.030
   Stampfli AR, 2020, CURR OPIN STRUC BIOL, V65, P1, DOI 10.1016/j.sbi.2020.04.002
   Sugiura T, 2010, DRUG METAB DISPOS, V38, P1665, DOI 10.1124/dmd.110.032763
   Tamai I, 1997, FEBS LETT, V419, P107, DOI 10.1016/S0014-5793(97)01441-5
   Tamai I, 2000, J BIOL CHEM, V275, P40064, DOI 10.1074/jbc.M005340200
   Tang RMY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20021-z
   Tang YL, 2016, J PHARM SCI-US, V105, P1779, DOI 10.1016/j.xphs.2016.02.023
   Tanret C, 1909, ANN CHIM PHYS, V18, P114
   Taubert D, 2009, GUT, V58, P312, DOI 10.1136/gut.2008.164418
   Teruya T, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2022857118
   Nguyen TH, 2012, FOOD CHEM, V133, P585, DOI 10.1016/j.foodchem.2012.01.061
   Tian XY, 2021, PILOT FEASIBILITY ST, V7, DOI 10.1186/s40814-021-00929-6
   Toh DSL, 2013, MOL PHARMACEUT, V10, P2509, DOI 10.1021/mp400193r
   Tokuhiro S, 2003, NAT GENET, V35, P341, DOI 10.1038/ng1267
   Tschirka J, 2018, DRUG METAB DISPOS, V46, P779, DOI 10.1124/dmd.118.080440
   Tsiantas K, 2021, MOLECULES, V26, DOI 10.3390/molecules26071832
   Tucker RAJ, 2019, BIOCHEM BIOPH RES CO, V513, P22, DOI 10.1016/j.bbrc.2019.02.122
   Turck D, 2016, EFSA J, V14, DOI 10.2903/j.efsa.2016.4629
   USFDA, 2018, RE GRAS NOT NO GRN 0
   Venturella G, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22020634
   Weigand-Heller AJ, 2012, PREV MED, V54, pS75, DOI 10.1016/j.ypmed.2011.12.028
   Williamson RD, 2020, HYPERTENSION, V75, P561, DOI 10.1161/HYPERTENSIONAHA.119.13929
   Wu LY, 2022, ANTIOXIDANTS-BASEL, V11, DOI 10.3390/antiox11091717
   Wu X, 2000, BBA-BIOMEMBRANES, V1466, P315, DOI 10.1016/S0005-2736(00)00189-9
   Yang NC, 2012, FOOD CHEM TOXICOL, V50, P3902, DOI 10.1016/j.fct.2012.08.021
   Yee SW, 2020, FASEB J, V34, P15734, DOI 10.1096/fj.202001497R
   Younossi ZM, 2019, J HEPATOL, V71, P793, DOI 10.1016/j.jhep.2019.06.021
NR 107
TC 2
Z9 2
U1 9
U2 26
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 0007-1145
EI 1475-2662
J9 BRIT J NUTR
JI Br. J. Nutr.
PD JAN 14
PY 2023
VL 129
IS 1
BP 104
EP 114
DI 10.1017/S0007114522003592
PG 11
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 8C9FY
UT WOS:000917907500011
PM 38018890
OA Green Published, hybrid
DA 2024-02-19
ER

PT S
AU Bergamini, E
   Cavallini, G
   Donati, A
   Gori, Z
AF Bergamini, Ettore
   Cavallini, Gabriella
   Donati, Alessio
   Gori, Zina
BE Weller, NJ
   Rattan, SIS
TI The role of autophagy in aging - Its essential part in the anti-aging
   mechanism of caloric restriction
SO HEALTHY AGING AND LONGEVITY
SE Annals of the New York Academy of Sciences
LA English
DT Article; Proceedings Paper
CT 3rd International Conference on Healthy Aging and Longevity
CY OCT 13-15, 2006
CL Melbourne, AUSTRALIA
DE aging; autophagy; caloric restriction; antilipolytic drugs
ID DIETARY RESTRICTION; RAT-LIVER; PROTEIN-DEGRADATION; RHESUS-MONKEYS;
   ACCUMULATION; DOLICHOL; MACROAUTOPHAGY; PROTEOLYSIS; INHIBITION;
   LONGEVITY
AB Aging denotes a postmaturationl deterioration of cells and organisms with the passage of time, an increased vulnerability to challenges and prevalence of age-associated diseases, and a decreased ability to survive. Causes of this deterioration may be found in an enhanced production of reactive oxygen species (ROS) and oxidative damage and incomplete "housekeeping." Caloric restriction is the most robust anti-aging intervention known so far. Similar beneficial effects on median and maximum life span were obtained by feeding animals a 40%-reduced diet or by every-other-day ad libitum feeding. In both instances, animals are forced to spend a great part of their time in a state of fasting and activated autophagy. Autophagy is a highly conserved process in eukaryotes, in which the cytoplasm, including excess or aberrant organelles, is sequestered into double-membrane vesicles and delivered to the lysosome/vacuole, for breakdown and eventual recycling of the resulting macromolecules. This process has an essential role in adaptation to fasting and changing environmental conditions, cellular remodeling during development, and accumulation of altered ROS-hypergenerating organelles in older cells. Several pieces of evidence show that autophagy is involved in aging and is an essential part of the anti-aging mechanism of caloric restriction. As an application, intensification of autophagy by the administration of an antilipolytic drug rescued older cells from accumulation of altered mtDNA in less than 6 hours. It is concluded that the pharmacologic intensification of autophagy (PISA treatment) has anti-aging effects and might prove to be a big step toward retardation of aging and prevention of age-associated diseases in humans.
C1 [Bergamini, Ettore; Cavallini, Gabriella; Donati, Alessio; Gori, Zina] Univ Pisa, Ctr Ric Interdipartimentale Biol & Patol Invecchi, Scuola Med, I-56126 Pisa, Italy.
C3 University of Pisa
RP Bergamini, E (corresponding author), Ctr Ric Biol & Patol Invecchiamento, Dipartimento Patol Sperimentale, Scuola Med, Via Roma 55, I-56123 Rome, Italy.
EM ebergami@med.unipi.it
CR Bergamini E, 2005, EXPERT OPIN THER TAR, V9, P77, DOI 10.1517/14728222.9.1.77
   Bergamini E, 1995, AGING-CLIN EXP RES, V7, P473, DOI 10.1007/BF03324374
   BERGAMINI E, 1993, EXP MOL PATHOL, V59, P13, DOI 10.1006/exmp.1993.1023
   BERGAMINI E, 1990, PROTEIN METABOLISM A, P295
   Berrigan D, 2002, CARCINOGENESIS, V23, P817, DOI 10.1093/carcin/23.5.817
   Bodkin NL, 2003, J GERONTOL A-BIOL, V58, P212
   Braeckman BP, 2006, BIOGERONTOLOGY, V7, P127, DOI 10.1007/s10522-006-9003-4
   Cavallini G, 2002, AGING CLIN EXP RES, V14, P152
   Cavallini G, 2001, EXP GERONTOL, V36, P497, DOI 10.1016/S0531-5565(00)00224-2
   CUBEDDU TL, 1985, BIOCHIM BIOPHYS ACTA, V839, P96, DOI 10.1016/0304-4165(85)90186-2
   Del Roso A, 2003, EXP GERONTOL, V38, P519, DOI 10.1016/S0531-5565(03)00002-0
   DELROSO A, 1991, ACTA BIOL HUNG, V42, P87
   Dolfi C, 2003, BIOGERONTOLOGY, V4, P113, DOI 10.1023/A:1023304021679
   Donati A, 2004, EXP GERONTOL, V39, P1061, DOI 10.1016/j.exger.2004.03.025
   Donati A, 2001, J GERONTOL A-BIOL, V56, pB288, DOI 10.1093/gerona/56.7.B288
   Donati Alessio, 2006, Molecular Aspects of Medicine, V27, P455, DOI 10.1016/j.mam.2006.08.003
   Donati A, 2006, REJUV RES, V9, P408, DOI 10.1089/rej.2006.9.408
   Donato L, 2000, ARCH PEDIATRIE, V7, p56S, DOI 10.1016/S0929-693X(00)88821-1
   Fontana L, 2004, P NATL ACAD SCI USA, V101, P6659, DOI 10.1073/pnas.0308291101
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Holliday R, 2006, ANN NY ACAD SCI, V1067, P1, DOI 10.1196/annals.1354.002
   Ingram DK, 2006, BIOGERONTOLOGY, V7, P143, DOI 10.1007/s10522-006-9013-2
   IVY GO, 1989, BRAIN RES, V498, P360, DOI 10.1016/0006-8993(89)91117-7
   IVY GO, 1989, ADV EXP MED BIOL, V266, P31
   IVY GO, 1984, SCIENCE, V226, P985, DOI 10.1126/science.6505679
   Kanazawa T, 2004, J BIOL CHEM, V279, P8452, DOI 10.1074/jbc.M306337200
   Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3
   Marino M, 1998, J GERONTOL A-BIOL, V53, pB87, DOI 10.1093/gerona/53A.2.B87
   Masoro E.J., 1995, HDB PHYSL 11, P1
   Masoro EJ, 2006, BIOGERONTOLOGY, V7, P153, DOI 10.1007/s10522-006-9015-0
   Masoro EJ, 1996, TOXICOL PATHOL, V24, P738, DOI 10.1177/019262339602400617
   MASORO EJ, 1992, J GERONTOL, V47, pB202, DOI 10.1093/geronj/47.6.B202
   MASORO EJ, 2002, RES PROFILE AGING, V1
   Mattison JA, 2003, EXP GERONTOL, V38, P35, DOI 10.1016/S0531-5565(02)00146-8
   Meyer TE, 2006, J AM COLL CARDIOL, V47, P398, DOI 10.1016/j.jacc.2005.08.069
   Mizushima N, 2005, CELL DEATH DIFFER, V12, P1535, DOI 10.1038/sj.cdd.4401728
   MONNIER VM, 1990, J GERONTOL, V45, pB105, DOI 10.1093/geronj/45.4.B105
   MORTIMORE GE, 1987, ANNU REV NUTR, V7, P539, DOI 10.1146/annurev.nu.07.070187.002543
   MORTIMORE GE, 1989, DIABETES METAB REV, V5, P49, DOI 10.1002/dmr.5610050105
   ORGEL LE, 1963, P NATL ACAD SCI USA, V49, P517, DOI 10.1073/pnas.49.4.517
   Parentini H, 2005, J GERONTOL A-BIOL, V60, P39, DOI 10.1093/gerona/60.1.39
   PFEIFER U, 1977, ACTA BIOL MED GER, V36, P1691
   Roth GS, 1999, J AM GERIATR SOC, V47, P896, DOI 10.1111/j.1532-5415.1999.tb03851.x
   Roth GS, 2004, SCIENCE, V305, P1423, DOI 10.1126/science.1102541
   SEGLEN PO, 1992, EXPERIENTIA, V48, P158, DOI 10.1007/BF01923509
   Wang CW, 2003, MOL MED, V9, P65, DOI 10.1007/BF03402040
   Weindruch R, 2006, BIOGERONTOLOGY, V7, P169, DOI 10.1007/s10522-006-9007-0
   Willcox DC, 2006, BIOGERONTOLOGY, V7, P173, DOI 10.1007/s10522-006-9008-z
   Yorimitsu T, 2007, AUTOPHAGY, V3, P160, DOI 10.4161/auto.3653
NR 49
TC 112
Z9 126
U1 1
U2 38
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER STREET, HOBOKEN, NJ, UNITED STATES
SN 0077-8923
BN 978-1-57331-680-4
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PY 2007
VL 1114
BP 69
EP 78
DI 10.1196/annals.1396.020
PG 10
WC Geriatrics & Gerontology; Multidisciplinary Sciences; Physiology
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology; Science & Technology - Other Topics;
   Physiology
GA BHA05
UT WOS:000251775900009
PM 17934054
DA 2024-02-19
ER

PT J
AU DAVIS, LJ
   HAKIM, G
   ROSSI, CA
   WALFORD, RL
   LICASTRO, F
AF DAVIS, LJ
   HAKIM, G
   ROSSI, CA
   WALFORD, RL
   LICASTRO, F
TI DIETARY RESTRICTION DIMINISHES EARLY GLYCATION ADDUCTS ON MURINE HEPATIC
   CYTOSOLIC PROTEINS
SO ARCHIVES OF GERONTOLOGY AND GERIATRICS
LA English
DT Article
DE CALORIC RESTRICTION; AGING; GLYCATION
ID THIOBARBITURIC ACID ASSAY; NONENZYMATIC GLYCOSYLATION; SERUM-ALBUMIN;
   MICE; AGE
AB The effect of three dietary regimes on the amount of Schiff base adducts, as well as acid-stable (Amadori) glycation adducts in murine hepatic cytosolic fractions was studied. The dietary regimes consisted of an unrestricted diet or two different diets in which the caloric restriction was 25 and 50 % of the caloric intake of unrestricted animals. The concentration of the Schiff bases in ad libitum and slightly restricted mice (25 %) was higher than that observed in severely restricted mice (50 %). The concentration of the Schiff bases in the severely restricted mice did not reach values observed in ad libitum or slightly restricted mice even in 45-month old animals. The concentration of the Amadori products was essentially the same for all three dietary groups. Our results show that a severe caloric restriction decreases the formation of early glycation adducts which might influence the rate of aging of laboratory animals under caloric restriction.
C1 UNIV CALIF LOS ANGELES, DEPT PATHOL, LOS ANGELES, CA 90025 USA.
   UNIV BOLOGNA, DEPT EXPTL PATHOL, I-40126 BOLOGNA, ITALY.
C3 University of California System; University of California Los Angeles;
   University of Bologna
RP DAVIS, LJ (corresponding author), UNIV BOLOGNA, DEPT BIOCHEM, VIA IRNERIO 48, I-40126 BOLOGNA, ITALY.
CR BROWNLEE M, 1991, ANNU REV MED, V42, P159, DOI 10.1146/annurev.med.42.1.159
   BUNN HF, 1981, SCIENCE, V213, P222, DOI 10.1126/science.12192669
   CHARD T, 1987, LABORATORY TECHNIQ 2, V6, P19
   DAVIS LJ, 1989, BIOCHEM BIOPH RES CO, V160, P362, DOI 10.1016/0006-291X(89)91664-1
   DAVIS LJ, 1990, PROTEIN METABOLISM A, P55
   DAVIS LJ, 1991, AGING, V52, P435
   DOLHOFER R, 1981, CLIN CHIM ACTA, V112, P197, DOI 10.1016/0009-8981(81)90378-8
   ELBE AS, 1983, J BIOL CHEM, V258, P9406
   FURTH AJ, 1988, ANAL BIOCHEM, V175, P347, DOI 10.1016/0003-2697(88)90558-1
   GO R, 1987, CLIN CHIM ACTA, V163, P63, DOI 10.1016/0009-8981(87)90034-9
   KEENEY M, 1959, J DAIRY SCI, V42, P945, DOI 10.3168/jds.S0022-0302(59)90678-2
   Kingsley GR, 1942, J LAB CLIN MED, V27, P840
   LICASTRO F, 1988, AGE, V11, P48, DOI 10.1007/BF02431772
   MASORO EJ, 1989, J GERONTOL, V44, pB20, DOI 10.1093/geronj/44.1.B20
   MASORO EJ, 1990, PROTEIN METABOLISM A, P257
   MURTIASHAW MH, 1983, CLIN CHIM ACTA, V130, P177, DOI 10.1016/0009-8981(83)90115-8
   NEY KA, 1981, ANAL BIOCHEM, V118, P294, DOI 10.1016/0003-2697(81)90585-6
   PATRICK JS, 1990, J GERONTOL, V45, pB18, DOI 10.1093/geronj/45.1.B18
   WEINDRUCH R, 1986, J NUTR, V116, P641, DOI 10.1093/jn/116.4.641
NR 19
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0167-4943
EI 1872-6976
J9 ARCH GERONTOL GERIAT
JI Arch. Gerontol. Geriatr.
PY 1992
SU 3
BP 145
EP 150
DI 10.1016/S0167-4943(05)80014-7
PG 6
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA JM302
UT WOS:A1992JM30200014
PM 18647684
DA 2024-02-19
ER

PT J
AU MIYAMURA, Y
   TAWA, R
   KOIZUMI, A
   UEHARA, Y
   KURISHITA, A
   SAKURAI, H
   KAMIYAMA, S
   ONO, T
AF MIYAMURA, Y
   TAWA, R
   KOIZUMI, A
   UEHARA, Y
   KURISHITA, A
   SAKURAI, H
   KAMIYAMA, S
   ONO, T
TI EFFECTS OF ENERGY RESTRICTION ON AGE-ASSOCIATED CHANGES OF DNA
   METHYLATION IN MOUSE-LIVER
SO MUTATION RESEARCH
LA English
DT Article
DE AGING; DNA METHYLATION; ENERGY RESTRICTION; LIVER; (MOUSE)
ID C-MYC GENE; DIETARY RESTRICTION; AGING PROCESS; MICE; EXPRESSION;
   TISSUE; STRAIN; RAT; MANIPULATION; ONCOGENE
AB DNA methylation is known to change with age in several mammalian species. Here we have examined the effect of dietary energy restriction on this age-associated change in liver DNA of C3H/SHN mice. The total 5-methyldeoxycytidine level in the genome decreased slightly soon after energy restriction started. The effect, however, diminished with time and no appreciable difference was detected at middle and old ages. The degree of methylation at the c-myc gene, on the other hand, was not affected by energy restriction at early periods, but the age-dependent alterations at later ages were repressed. This is a new finding to show that DNA methylation is one of the molecular indices of aging affected by energy restriction. It suggests an importance of DNA methylation in the aging process.
C1 TOHOKU UNIV, SCH MED,DEPT RADIAT RES,2-1 SEIRYO MACHI,AOBA KU, SENDAI, MIYAGI 980, JAPAN.
   KYOTO PHARMACEUT UNIV, DEPT ANALYT CHEM, KYOTO 607, JAPAN.
   AKITA UNIV, SCH MED, DEPT HYG, AKITA 010, JAPAN.
   KANSAI MED UNIV, INST LIVER RES, MORIGUCHI, OSAKA 570, JAPAN.
C3 Tohoku University; Kyoto Pharmaceutical University; Akita University;
   Kansai Medical University
OI Miyamura, Yoshinori/0000-0002-3050-8580
CR ADAMS RLP, 1985, MOL BIOL DNA METHYLA, P115
   ENGLER P, 1991, CELL, V65, P939, DOI 10.1016/0092-8674(91)90546-B
   HERGERSBERG M, 1991, EXPERIENTIA, V47, P1171, DOI 10.1007/BF01918381
   HORIKAWA S, 1986, BIOCHEM BIOPH RES CO, V140, P574, DOI 10.1016/0006-291X(86)90770-9
   KALINICH JF, 1989, RADIAT RES, V117, P185, DOI 10.2307/3577319
   KIM JW, 1991, BIOCHEM BIOPH RES CO, V180, P1, DOI 10.1016/S0006-291X(05)81246-X
   KOIZUMI A, 1989, MECH AGEING DEV, V49, P93, DOI 10.1016/0047-6374(89)90093-6
   KOIZUMI A, 1987, J NUTR, V117, P361, DOI 10.1093/jn/117.2.361
   KOIZUMI A, 1990, J NUTR, V120, P1401, DOI 10.1093/jn/120.11.1401
   KOIZUMI A, 1992, J NUTR, V122, P1446, DOI 10.1093/jn/122.7.1446
   MASORO EJ, 1988, J GERONTOL, V43, pB59, DOI 10.1093/geronj/43.3.B59
   MATOCHA MF, 1987, BIOCHEM BIOPH RES CO, V147, P1, DOI 10.1016/S0006-291X(87)80078-5
   MAYSHOOPES LL, 1989, INT REV CYTOL, V114, P181
   MERRY BJ, 1985, EXP GERONTOL, V20, P15, DOI 10.1016/0531-5565(85)90005-1
   NAKAMURA KD, 1989, MECH AGEING DEV, V48, P199, DOI 10.1016/0047-6374(89)90051-1
   NYCE J, 1986, NUCLEIC ACIDS RES, V14, P4353, DOI 10.1093/nar/14.10.4353
   ONO T, 1990, MUTAT RES, V237, P239, DOI 10.1016/0921-8734(90)90005-C
   ONO T, 1989, MECH AGEING DEV, V50, P27, DOI 10.1016/0047-6374(89)90056-0
   ONO T, 1985, MECH AGEING DEV, V32, P227, DOI 10.1016/0047-6374(85)90082-X
   ONO T, 1989, MUTAT RES, V219, P39, DOI 10.1016/0921-8734(89)90039-8
   REIK W, 1990, DEVELOPMENT, P99
   SAPIENZA C, 1987, NATURE, V328, P251, DOI 10.1038/328251a0
   SEMSEI I, 1989, ONCOGENE, V4, P465
   SEMSEI I, 1989, BIOCHEM BIOPH RES CO, V164, P620, DOI 10.1016/0006-291X(89)91505-2
   SPICER DB, 1992, MOL CELL BIOL, V12, P1324, DOI 10.1128/MCB.12.3.1324
   SRIVASTAVA VK, 1991, EXP GERONTOL, V26, P97, DOI 10.1016/0531-5565(91)90066-U
   TAWA R, 1992, MECH AGEING DEV, V62, P255, DOI 10.1016/0047-6374(92)90111-P
   TAWA R, 1990, DIFFERENTIATION, V45, P44, DOI 10.1111/j.1432-0436.1990.tb00455.x
   UEHARA Y, 1989, ONCOGENE, V4, P1023
   WEINDRUCH R, 1988, RETARDATION AGING DI, P3
NR 30
TC 25
Z9 27
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-8262
J9 MUTAT RES
JI Mutat. Res.
PD MAR
PY 1993
VL 295
IS 2
BP 63
EP 69
DI 10.1016/0921-8734(93)90002-K
PG 7
WC Genetics & Heredity; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity; Toxicology
GA KP922
UT WOS:A1993KP92200002
PM 7680421
DA 2024-02-19
ER

PT J
AU Velasco, B
   Cacicedo, L
   Melian, E
   Fernández-Vázquez, G
   Sánchez-Franco, F
AF Velasco, B
   Cacicedo, L
   Melian, E
   Fernández-Vázquez, G
   Sánchez-Franco, F
TI Sensitivity to exogenous GH and reversibility of the reduced IGF-I gene
   expression in aging rats
SO EUROPEAN JOURNAL OF ENDOCRINOLOGY
LA English
DT Article
ID GROWTH-FACTOR-I; HORMONE-BINDING PROTEIN; MESSENGER RIBONUCLEIC-ACIDS;
   INITIAL CHARACTERIZATION; DIETARY RESTRICTION; SEXUAL DIMORPHISM; RNA;
   SECRETION; TISSUES; LIVER
AB Background: IGF-I gene expression and IGF-I plasma concentration decline with age. A decreased sensitivity to GH has been suggested to be a contributory mechanism to this, in addition to attenuated GH secretion.
   Objective: This study focuses on the sensitivity to exogenous GH and the reversibility of the reduced IGF-I gene expression in aging male rats.
   Design: Three groups of male Wistar rats aged 3 months (young adult), Ii months (middle-aged) and 27 months told), received recombinant human GH (rhGH) (150 mug/12 h s.c.) for seven consecutive days.
   Results: This rhGH treatment completely reversed plasma immunoreactive IGF-I (IR-IGF-I) and hepatic IGF-I mRNA levels in 11-month-old and 27-month-old animals to the levels of the young group of animals. The sensitivity in the old group (percentage of increment after the same or lower dose of rhGH per body weight) was increased for both parameters: serum IGF-I increment: 15% in 3-month-old, 42.6% in Ii-month-old and 119,1% in 27-month-old rats: and hepatic IGF-Ib mRNA increase: 45% in 3-month-old, 27.8% in Ii-month-old and 64.3% in 27-month-old rats, IGF binding protein-3 (IGFBP-3) mRNA level in the liver was significantly decreased in the old group and only a partial reversion occurred in this group after rhGH treatment; the percentage of increment was also higher in the old group of rats. In extrahepatic tissues IGF-I mRNA was not significantly different in the kidney and the testis of the three groups, and the rhGH treatment produced a significant and similar increase of IGF-I mRNA level in the kidney of the three groups of rats and in the testis of the 27-month-old animals. The GHr/GHBP mRNA remained unchanged in the liver and in the kidney or the testis of the three groups, and was not influenced by the rhGH treatment. Exogenous rhGH decreased pituitary GH mRNA accumulation in a more intense manner in the old group versus control of each group: young adult, 25%; middle-aged, 41.2%: and old rats, 55%, The action of rhGH on pituitary immunoreactive GH (IR-GH) content was only significantly evident in the young group.
   Conclusions: These results establish that exogenous rhGH recovers the attenuated liver IGF-I gene expression and the diminished plasma IR-IGF-I in old rats to the levels of young adult animals. They also indicate that the hepatic and extrahepatic (kidney and testis) sensitivity to one established dose per weight of exogenous rhGH is not altered in old animals, or could be potentially increased in some tissues.
C1 Hosp Carlos III CIC, Serv Endocrinol, Inst Salud Carlos III, Madrid 28029, Spain.
   Hosp Ramon & Cajal, Serv Endocrinol, E-28034 Madrid, Spain.
C3 Hospital Carlos III; Instituto de Salud Carlos III; Hospital
   Universitario Ramon y Cajal
EM fsanchez@hciii.insalud.es
RI Vázquez, Gumersindo Fernández/AAB-3317-2019
CR ALBISTON AL, 1990, BIOCHEM BIOPH RES CO, V166, P892, DOI 10.1016/0006-291X(90)90894-S
   ALBISTON AL, 1992, ENDOCRINOLOGY, V130, P497, DOI 10.1210/en.130.1.497
   BAUMANN G, 1986, J CLIN ENDOCR METAB, V62, P134, DOI 10.1210/jcem-62-1-134
   BAXTER RC, 1989, P NATL ACAD SCI USA, V86, P6898, DOI 10.1073/pnas.86.18.6898
   BREESE CR, 1991, J GERONTOL, V46, pB180, DOI 10.1093/geronj/46.5.B180
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   CORPAS E, 1993, ENDOCR REV, V14, P20, DOI 10.1210/er.14.1.20
   CUNEO RC, 1992, CLIN ENDOCRINOL, V37, P387, DOI 10.1111/j.1365-2265.1992.tb02347.x
   DANIELSON PE, 1988, DNA-J MOLEC CELL BIO, V7, P261, DOI 10.1089/dna.1988.7.261
   DEBOER H, 1995, ENDOCR REV, V16, P63, DOI 10.1210/er.16.1.63
   DOMENE H, 1993, ENDOCRINOLOGY, V133, P675, DOI 10.1210/en.133.2.675
   GOSTELIPETER MA, 1994, ENDOCRINOLOGY, V135, P2558, DOI 10.1210/en.135.6.2558
   HAN VKM, 1987, SCIENCE, V236, P193, DOI 10.1126/science.3563497
   HERINGTON AC, 1986, J CLIN INVEST, V77, P1817, DOI 10.1172/JCI112507
   HYNES MA, 1987, MOL ENDOCRINOL, V1, P233, DOI 10.1210/mend-1-3-233
   JANSSON JO, 1985, ENDOCR REV, V6, P128, DOI 10.1210/edrv-6-2-128
   Johannsson G, 1997, J CLIN ENDOCR METAB, V82, P727, DOI 10.1210/jc.82.3.727
   JORGENSEN JOL, 1991, ACTA ENDOCRINOL-COP, V125, P449
   Kanzaki M, 1999, ENDOCRINOLOGY, V140, P1681, DOI 10.1210/en.140.4.1681
   KULIN HE, 1981, CLIN ENDOCRINOL, V15, P463, DOI 10.1111/j.1365-2265.1981.tb00689.x
   LAJARA R, 1989, AM J PHYSIOL, V257, P252
   LANZI R, 1992, ENDOCRINOLOGY, V130, P780, DOI 10.1210/en.130.2.780
   LIEBERMAN SA, 1994, HORM METAB RES, V26, P229, DOI 10.1055/s-2007-1001671
   Liu JL, 2000, P SOC EXP BIOL MED, V223, P344, DOI 10.1046/j.1525-1373.2000.22349.x
   LopezFernandez J, 1996, ENDOCRINOLOGY, V137, P4384, DOI 10.1210/en.137.10.4384
   LOWE WL, 1988, MOL ENDOCRINOL, V2, P528, DOI 10.1210/mend-2-6-528
   MAITER D, 1992, ENDOCRINOLOGY, V130, P3257, DOI 10.1210/en.130.6.3257
   MAITER D, 1988, ENDOCRINOLOGY, V115, P90
   MASSA G, 1990, ENDOCRINOLOGY, V126, P1976, DOI 10.1210/endo-126-4-1976
   MATHEWS LS, 1989, J BIOL CHEM, V264, P9905
   Melian E, 1997, ENDOCRINOLOGY, V138, P1066, DOI 10.1210/en.138.3.1066
   MOLLER C, 1991, J MOL ENDOCRINOL, V7, P213, DOI 10.1677/jme.0.0070213
   PARK GH, 1991, GERONTOLOGY, V37, P310
   RIVAROLA MA, 1972, PEDIATR RES, V6, P634
   ROBERTS CT, 1987, MOL ENDOCRINOL, V1, P243, DOI 10.1210/mend-1-3-243
   ROBERTS CT, 1986, J BIOL CHEM, V261, P25
   RUDMAN D, 1990, NEW ENGL J MED, V323, P1, DOI 10.1056/NEJM199007053230101
   SEEBURG PH, 1977, NATURE, V270, P486, DOI 10.1038/270486a0
   SONNTAG WE, 1980, ENDOCRINOLOGY, V107, P1875, DOI 10.1210/endo-107-6-1875
   SONNTAG WE, 1992, J GERONTOL, V47, pB159, DOI 10.1093/geronj/47.5.B159
   TAKAHASHI S, 1987, P SOC EXP BIOL MED, V186, P229
   TANNENBAUM GS, 1976, ENDOCRINOLOGY, V98, P562, DOI 10.1210/endo-98-3-562
   Tzanela M, 1997, ENDOCRINOLOGY, V138, P5316, DOI 10.1210/en.138.12.5316
   Velasco B, 1998, ENDOCRINOLOGY, V139, P1314, DOI 10.1210/en.139.3.1314
   VERMEULEN A, 1987, J CLIN ENDOCR METAB, V64, P884, DOI 10.1210/jcem-64-5-884
   WATERS MJ, 1990, ACTA PAEDIATR SC   S, V366, P70
   XU XO, 1995, ENDOCRINOLOGY, V136, P4551, DOI 10.1210/en.136.10.4551
   YMER SI, 1985, MOL CELL ENDOCRINOL, V41, P153, DOI 10.1016/0303-7207(85)90018-8
NR 48
TC 15
Z9 16
U1 0
U2 0
PU BIOSCIENTIFICA LTD
PI BRISTOL
PA EURO HOUSE, 22 APEX COURT WOODLANDS, BRADLEY STOKE, BRISTOL BS32 4JT,
   ENGLAND
SN 0804-4643
EI 1479-683X
J9 EUR J ENDOCRINOL
JI Eur. J. Endocrinol.
PD JUL
PY 2001
VL 145
IS 1
BP 73
EP 85
DI 10.1530/eje.0.1450073
PG 13
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 451EG
UT WOS:000169787700010
PM 11415855
OA Bronze
DA 2024-02-19
ER

PT J
AU Liu, J
   Gao, DX
   Dan, JH
   Liu, D
   Peng, L
   Zhou, RY
   Luo, Y
AF Liu, Jing
   Gao, Dongxiao
   Dan, Juhua
   Liu, Dan
   Peng, Lei
   Zhou, Ruoyu
   Luo, Ying
TI The protective effect of cycloastragenol on aging mouse circadian
   rhythmic disorder induced by d-galactose
SO JOURNAL OF CELLULAR BIOCHEMISTRY
LA English
DT Article; Early Access
DE aging; circadian clock; cycloastragenol
ID POTENT TELOMERASE ACTIVATOR; ASTRAGALOSIDE-IV; MICE; METABOLISM;
   COMPONENT; HEALTH; CELLS
AB Aging process in mammals is associated with a decline in amplitude and a long period of circadian behaviors which are regulated by a central circadian regulator in the suprachiasmatic nucleus (SCN) and local oscillators in peripheral tissues. It is unclear whether enhancing clock function can retard aging. Using fibroblasts expressing per2::lucSV and senescent cells, we revealed cycloastragenol (CAG), a natural aglycone derivative from astragaloside IV, as a clock amplitude enhancing small molecule. CAG could activate telomerase to antiaging, but no reports focused on its effects on circadian rhythm disorders in aging mice. Here we analyze the potential effects of CAG on d-galactose-induced aging mice on the circadian behavior and expression of clock genes. For this purpose, CAG (20 mg/kg orally), was administered daily to d-galactose (150 mg/kg, subcutaneous) mice model of aging for 6 weeks. An actogram analysis of free-running activity of these mice showed that CAG significantly enhances the locomotor activity. We further found that CAG increase expressions of per2 and bmal1 genes in liver and kidney of aging mouse. Furthermore, CAG enhanced clock protein BMAL1 and PER2 levels in aging mouse liver and SCN. Our results indicated that the CAG could restore the behavior of circadian rhythm in aging mice induced by d-galactose. These data of present study suggested that CAG could be used as a novel therapeutic strategy for the treatment of age-related circadian rhythm disruption.
C1 [Liu, Jing; Gao, Dongxiao; Dan, Juhua; Liu, Dan; Peng, Lei; Zhou, Ruoyu; Luo, Ying] Kunming Univ Sci & Technol, Med Sch, Lab Mol Genet Aging & Tumor, 727 South Jing Ming Rd, Kunming 650500, Yunnan, Peoples R China.
C3 Kunming University of Science & Technology
RP Luo, Y (corresponding author), Kunming Univ Sci & Technol, Med Sch, Lab Mol Genet Aging & Tumor, 727 South Jing Ming Rd, Kunming 650500, Yunnan, Peoples R China.
EM yingluo@kmust.edu.cn
RI wang, xiaoqiang/JMT-2783-2023; Luo, Ying/AAQ-7666-2020; luo,
   ying/HJP-8548-2023
FU National Natural Science Foundation of China [81760662]; Nature Science
   Foundation of Yunnan Province [2018FB148]
FX National Natural Science Foundation of China, Grant/Award Number:
   81760662; Nature Science Foundation of Yunnan Province, Grant/Award
   Number: 2018FB148
CR Asai M, 2001, J NEUROSCI RES, V66, P1133, DOI 10.1002/jnr.10010
   de Jesus BB, 2011, AGING CELL, V10, P604, DOI 10.1111/j.1474-9726.2011.00700.x
   Castanon-Cervantes O, 2010, J IMMUNOL, V185, P5796, DOI 10.4049/jimmunol.1001026
   Chen B, 2010, BRAIN RES, V1344, P43, DOI 10.1016/j.brainres.2010.04.082
   Chen JG, 2008, BIOCHEM PHARMACOL, V76, P796, DOI 10.1016/j.bcp.2008.06.020
   Chen Z, 2012, P NATL ACAD SCI USA, V109, P101, DOI 10.1073/pnas.1118034108
   Conlon M, 2007, EPIDEMIOLOGY, V18, P182, DOI 10.1097/01.ede.0000249519.33978.31
   Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007
   Cui X, 2004, BIOGERONTOLOGY, V5, P317, DOI 10.1007/s10522-004-2570-3
   Cui X, 2006, J NEUROSCI RES, V83, P1584, DOI 10.1002/jnr.20845
   Duffy JF, 2015, SLEEP MED CLIN, V10, P423, DOI 10.1016/j.jsmc.2015.08.002
   Eckel-Mahan KL, 2012, P NATL ACAD SCI USA, V109, P5541, DOI 10.1073/pnas.1118726109
   Froy O, 2011, CLIN SCI, V120, P65, DOI 10.1042/CS20100327
   Fuhrmann-Stroissnigg H, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00314-z
   Hastings MH, 2014, J NEUROENDOCRINOL, V26, P2, DOI 10.1111/jne.12125
   Ip FCF, 2014, NEUROSIGNALS, V22, P52, DOI 10.1159/000365290
   Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206
   Ma PK, 2017, XENOBIOTICA, V47, P526, DOI 10.1080/00498254.2016.1204568
   Partch CL, 2014, TRENDS CELL BIOL, V24, P90, DOI 10.1016/j.tcb.2013.07.002
   Shin Kyung Rim, 2003, Nurs Health Sci, V5, P245, DOI 10.1046/j.1442-2018.2003.00161.x
   Song X, 1999, MECH AGEING DEV, V108, P239, DOI 10.1016/S0047-6374(99)00022-6
   Sun LJ, 2015, BIOCHEM BIOPH RES CO, V458, P86, DOI 10.1016/j.bbrc.2015.01.072
   Tahara Y, 2017, NPJ AGING MECH DIS, V3, DOI 10.1038/npjamd.2016.30
   Valentinuzzi VS, 1997, AM J PHYSIOL-REG I, V273, pR1957, DOI 10.1152/ajpregu.1997.273.6.R1957
   Wang SF, 2014, BIOCHEM BIOPH RES CO, V450, P306, DOI 10.1016/j.bbrc.2014.05.117
   Weiss RA, 2014, J DRUGS DERMATOL, V13, P1135
   Yamazaki S, 2002, P NATL ACAD SCI USA, V99, P10801, DOI 10.1073/pnas.152318499
   Zhao Y, 2015, J ETHNOPHARMACOL, V169, P210, DOI 10.1016/j.jep.2015.04.030
   Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118
NR 29
TC 12
Z9 14
U1 0
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0730-2312
EI 1097-4644
J9 J CELL BIOCHEM
JI J. Cell. Biochem.
PD 2019 OCT
PY 2019
VL 120
IS 10
BP 16408
EP 16415
DI 10.1002/jcb.28587
EA JUL 2019
PG 8
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA IU4IQ
UT WOS:000476027900001
PM 31310357
DA 2024-02-19
ER

EF